FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Schmidt, MJ
   Steenkamp, G
   Failing, K
   Caldwell, P
   Kirberger, RM
AF Schmidt, Martin J.
   Steenkamp, Gerhard
   Failing, Klaus
   Caldwell, Peter
   Kirberger, Robert M.
TI A contribution to age determination of cheetahs (Acinonyx jubatus) based
   on radiographic analysis of the skull and postcranial morphology
SO PLOS ONE
LA English
DT Article
ID NORMAL APPENDICULAR SKELETON; ECTOCRANIAL SUTURE CLOSURE; LION
   PANTHERA-LEO; SEXUAL-DIMORPHISM; FLUCTUATING ASYMMETRY; RADIOLOGIC
   ANATOMY; CRANIAL ONTOGENY; PUMA-CONCOLOR; GROWTH; PARDUS
AB The aim of this retrospective cross-sectional study was to present comprehensive information about the age-dependent change of skeletal characteristics in captive cheetahs with known age and to assess the benefit of these variables for age estimation in this species. Radiographs of 162 known-age captive and semi-captive cheetahs were retrospectively examined and age-related changes of skull, axial and appendicular skeletal systems were documented. Metric and non-metric variables were used. These parameters were checked for the best correlation with age using a multiple stepwise regression analysis. An overview about the time frames, in which ossification centers appeared and physeal closure occurred is presented. Multiple stepwise regression analysis revealed the status of closure of the coronal suture, the maximum length of the frontal sinus, the condylobasal-, hard palate, and facial length are most significantly correlated with age. Together with the pulp size of the upper canine, these values can be used for an age approximation in cheetahs.
C1 [Schmidt, Martin J.] Justus Liebig Univ, Dept Vet Clin Sci, Small Anim Clin, Frankfurter Str, Giessen, Germany.
   [Schmidt, Martin J.; Steenkamp, Gerhard; Kirberger, Robert M.] Fac Vet Sci Onderstepoort, Dept Compan Anim Clin Studies, Onderstepoort, South Africa.
   [Failing, Klaus] Justus Liebig Univ Giessen, Unit Biomath & Data Proc, Fac Vet Med, Giessen, Germany.
   [Caldwell, Peter] Old Chapel Vet Clin, Villeria Pretoria, South Africa.
RP Schmidt, MJ (reprint author), Justus Liebig Univ, Dept Vet Clin Sci, Small Anim Clin, Frankfurter Str, Giessen, Germany.; Schmidt, MJ (reprint author), Fac Vet Sci Onderstepoort, Dept Compan Anim Clin Studies, Onderstepoort, South Africa.
EM Martin.J.Schmidt@vetmed.uni-giessen.de
CR ALVEAR J, 1986, ARCH DIS CHILD, V61, P257, DOI 10.1136/adc.61.3.257
   Ashman DL, 1983, W4815 NEV DEP WILDL
   Bechert U, 2002, J ZOO WILDLIFE MED, V33, P16
   Bell KM, 2012, J ANIM PHYSIOL AN N, V96, P182, DOI 10.1111/j.1439-0396.2011.01133.x
   Besana JL, 2010, J FORENSIC SCI, V55, P584, DOI 10.1111/j.1556-4029.2009.01281.x
   Boast LK, 2013, J MAMMAL, V94, P1293, DOI 10.1644/13-MAMM-A-076.1
   Brunner Sylvia, 2004, Systematics and Biodiversity, V2, P83, DOI 10.1017/S1477200004001367
   Cheeke PR, 2010, COMP ANIMAL NUTR MET, P13
   Currier MJP., 1979, THESIS
   de Beer GR, 1937, DEV VERTEBRATE SKULL
   DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S
   Dennis R, 2010, HDB SMALL ANIMAL RAD
   Doutt KJ, 1942, ANN CARNEGIE MUS, V29, P61
   Drake AG, 2011, EVOL DEV, V13, P204, DOI 10.1111/j.1525-142X.2011.00470.x
   Durant SM, 2004, BEHAV ECOL, V15, P11, DOI 10.1093/beheco/arg098
   Evans HE., 1993, MILLERS ANATOMY DOG
   Fabregas MC, 2014, EUR J WILDLIFE RES, V60, P947, DOI 10.1007/s10344-014-0869-1
   Farhadinia MS, 2014, ZOOL MIDDLE EAST, V60, P3
   GarciaPerea R, 1996, J MORPHOL, V229, P241, DOI 10.1002/(SICI)1097-4687(199609)229:3<241::AID-JMOR1>3.0.CO;2-1
   Gay SW, 1996, J MAMMAL, V77, P191, DOI 10.2307/1382720
   Gittleman JL, 1997, J ZOOL, V242, P97, DOI 10.1111/j.1469-7998.1997.tb02932.x
   Hanken J, 1993, SKULL DEV
   Hartstone-Rose A, 2014, FASEB J, V28
   Herring SW, 2000, AM J PHYS ANTHROPOL, V112, P575, DOI 10.1002/1096-8644(200008)112:4<575::AID-AJPA10>3.3.CO;2-S
   Hunter L., 2005, CHEETAH CATS AFRICA
   Hunter L., 2003, CHEETAH
   JASLOW CR, 1990, J BIOMECH, V23, P313, DOI 10.1016/0021-9290(90)90059-C
   Kelly MJ, 2000, CONSERV BIOL, V14, P786, DOI 10.1046/j.1523-1739.2000.98329.x
   KIESER JA, 1991, EVOLUTION, V45, P1175, DOI 10.1111/j.1558-5646.1991.tb04384.x
   Kirberger RM, 2005, J ZOO WILDLIFE MED, V36, P21, DOI 10.1638/03-012
   Kirberger RM, 2005, J ZOO WILDLIFE MED, V36, P29, DOI 10.1638/03-013
   Kunzel W, 2003, ANAT HISTOL EMBRYOL, V32, P218, DOI 10.1046/j.1439-0264.2003.00448.x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Laundre JW, 2000, WILDLIFE SOC B, V28, P963
   LAURENSON MK, 1994, J ZOOL, V234, P387, DOI 10.1111/j.1469-7998.1994.tb04855.x
   Laurenson MK, 1995, BEHAV ECOL, V6, P405, DOI 10.1093/beheco/6.4.405
   Marker L, 2002, THESIS
   Marker LL, 2003, J MAMMAL, V84, P840, DOI 10.1644/BRB-036
   Mazak JH, 2006, MAMM BIOL, V71, P268, DOI 10.1016/j.mambio.2006.02.007
   Mazak JH, 2004, MAMM BIOL, V69, P392, DOI 10.1078/1616-5047-00161
   Mbizah MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164676
   Meijaard E, 2004, J MAMMAL, V85, P302, DOI 10.1644/BER-010
   MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P57, DOI 10.1002/ajpa.1330680106
   MENOTTIRAYMOND M, 1993, P NATL ACAD SCI USA, V90, P3172, DOI 10.1073/pnas.90.8.3172
   Miththapala S., 1992, THESIS
   MODI WS, 1987, EVOLUTION, V41, P227, DOI 10.1111/j.1558-5646.1987.tb05787.x
   MOREY DF, 1992, J ARCHAEOL SCI, V19, P181, DOI 10.1016/0305-4403(92)90049-9
   Morgan AM, 2015, THESIS
   Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791
   Onar V, 1999, ANAT HISTOL EMBRYOL, V28, P253, DOI 10.1046/j.1439-0264.1999.00202.x
   Park K, 2014, J VET SCI, V15, P557, DOI 10.4142/jvs.2014.15.4.557
   Patil Ajinkya A, 2013, Indian J Dent Res, V24, P523, DOI 10.4103/0970-9290.118372
   Paulli S, 1900, MORPH JB, V28, P483
   Perry KL, 2014, J FELINE MED SURG, V16, P149, DOI 10.1177/1098612X13502977
   REGODON S, 1993, ANN ANAT, V175, P361, DOI 10.1016/S0940-9602(11)80043-9
   Reig S, 2001, J ZOOL, V253, P121, DOI 10.1017/S0952836901000115
   Ryser-Degiorgis MP, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-223
   Sabshin SJ, 2007, THESIS
   Sanchez-Villagra MR, 2008, EVOL DEV, V10, P519, DOI 10.1111/j.1525-142X.2008.00267.x
   Schmidt MJ, 2017, J VET INTERN MED, V31, P1487, DOI 10.1111/jvim.14805
   Schmidt MJ, 2011, VET RADIOL ULTRASOUN, V52, P436, DOI 10.1111/j.1740-8261.2011.01825.x
   Schweikher FP, 1930, AM J ANAT, V45, P443, DOI 10.1002/aja.1000450305
   Segura V, 2017, BIOL J LINN SOC, V120, P210
   Segura V, 2015, CAN J ZOOL, V93, P225, DOI 10.1139/cjz-2014-0148
   Segura V, 2013, ZOOL J LINN SOC-LOND, V169, P235, DOI 10.1111/zoj.12047
   Sims Margaret E., 2012, Russian Journal of Theriology, V11, P157
   SMUTS GL, 1978, J ZOOL, V185, P115
   Stander N, 2016, BSAVA MANUAL CANINE, P88
   Stander PE, 1997, AFR J ECOL, V35, P156, DOI 10.1111/j.1365-2028.1997.068-89068.x
   Stefen C, 2012, VERTEBR ZOOL, V62, P281
   Thrall DE, 2011, ATLAS NORMAL RADIOGR
   Tonegrosa V, 2010, GEOBIOS-LYON, V43, P653, DOI 10.1016/j.geobios.2010.05.001
   Van Valkenburgh B, 2002, J VERTEBR PALEONTOL, V22, P164, DOI 10.1671/0272-4634(2002)022[0164:SDSBAI]2.0.CO;2
   WACK RF, 1991, ZOO BIOL, V10, P273, DOI 10.1002/zoo.1430100310
   WATSON AG, 1990, AM J VET RES, V51, P264
   WAYNE RK, 1986, EVOLUTION, V40, P78, DOI 10.1111/j.1558-5646.1986.tb05719.x
   Wei X, 2016, J DENT RES, V95, P1221, DOI 10.1177/0022034516651823
   White PA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153648
   WIIG O, 1986, ACTA THERIOL, V31, P147
   WILLIG MR, 1987, EVOLUTION, V41, P225, DOI 10.1111/j.1558-5646.1987.tb05786.x
   Yeramreddy A, 2017, THESIS
   Zapata SC, 1997, Z SAUGETIERKD, V62, P119
   Zavatsky B.P., 1976, IUCN Publs (New Series), VNo. 40, P275
NR 83
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 11
PY 2019
VL 14
IS 6
AR UNSP e0217999
DI 10.1371/journal.pone.0217999
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IC4XB
UT WOS:000470970000030
PM 31185038
OA DOAJ Gold
DA 2019-07-16
ER

PT J
AU Mallick, L
   Temsah, G
   Wang, WJ
AF Mallick, Lindsay
   Temsah, Gheda
   Wang, Wenjuan
TI Comparing summary measures of quality of care for family planning in
   Haiti, Malawi, and Tanzania
SO PLOS ONE
LA English
DT Article
ID CONTRACEPTIVE USE; SERVICES
AB Measuring quality of care in family planning services is essential for policymakers and stakeholders. However, there is limited agreement on which mathematical approaches are best able to summarize quality of care. Our study used data from recent Service Provision Assessment surveys in Haiti, Malawi, and Tanzania to compare three methods commonly used to create summary indices of quality of care-a simple additive, a weighted additive that applies equal weights among domains, and principal components analysis (PCA) based methods. The PCA results indicated that the first component cannot sufficiently summarize quality of care. For each scoring method, we categorized family planning facilities into low, medium, and high quality and assessed the agreement with Cohen's kappa coefficient between pairs of scores. We found that the agreement was generally highest between the simple additive and PCA rankings. Given the limitations of simple additive measures, and the findings of the PCA, we suggest using a weighted additive method.
C1 [Mallick, Lindsay] Avenir Hlth, Demog & Hlth Surveys DHS Program, Rockville, MD 20850 USA.
   [Temsah, Gheda] ICF, Program Assistance Design Monitoring & Evaluat Su, Washington, DC USA.
   [Wang, Wenjuan] ICF, DHS Program, Rockville, MD USA.
RP Mallick, L (reprint author), Avenir Hlth, Demog & Hlth Surveys DHS Program, Rockville, MD 20850 USA.
EM Lindsay.Mallick@icf.com
FU United States Agency for International Development (USAID) through The
   DHS Program [AID-OAA-C-13-00095]
FX This study was conducted with support provided by the United States
   Agency for International Development (USAID) through The DHS Program
   (#AID-OAA-C-13-00095). The views expressed are those of the authors and
   do not necessarily reflect the views of USAID or the United States
   Government. The funder provided support in the form of salaries for
   authors LM, GT, and WW, but did not have any additional role in the
   study design, data analysis, decision to publish, or preparation of the
   manuscript. The specific roles of these authors are articulated in the
   'author contributions' section.
CR Aiken LS, 1991, MULTIPLE REGRESSION
   Arends-Kuenning M, 2007, J BIOSOC SCI, V39, P1, DOI 10.1017/S0021932005001045
   ASKEW I, 1994, STUD FAMILY PLANN, V25, P268, DOI 10.2307/2138058
   Assaf S, 2015, QUALITY CARE FAMILY
   Assaf S, 2016, PROVIDER COUNSELING
   Bellows B, 2016, QUALITY MEASUREMENT
   Bertrand JT, 1994, HDB INDICATORS FAMIL
   Bessinger RE, 2001, INT FAM PLAN PERSPEC, V27, P63, DOI 10.2307/2673816
   BROWN C, 1995, IEEE 1995 INTERNATIONAL CONFERENCE ON CONSUMER ELECTRONICS - DIGEST OF TECHNICAL PAPERS, P154
   BRUCE J, 1990, STUD FAMILY PLANN, V21, P61, DOI 10.2307/1966669
   Chakraborty N, 2016, QUALITY MEASUREMENT
   Cuellar C, 2016, QUALITY MEASUREMENT
   Do MP, 2007, J BIOSOC SCI, V39, P201, DOI 10.1017/S0021932006001453
   DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743
   DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969
   Dunsch F, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000694
   Dunteman GH, 1989, PRINCIPAL COMPONENTS
   Fruhauf T, 2018, HEALTH POLICY PLANN, V33, P828, DOI 10.1093/heapol/czy058
   Gage AJ, 2017, ETUDE POPUL AFR, V31
   Gelman A, 2009, AM STAT, V63, P1, DOI 10.1198/tast.2009.0001
   Hong R, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-79
   Hutchinson PL, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-203
   IHE ICF International, 2014, HAIT EV PRES SERV SO
   Jayachandran V, 2016, MALAWI MED J, V28, P48, DOI 10.4314/mmj.v28i2.4
   KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19
   Mallick L, 2016, INTEGRATION INFECT D
   Mallick Lindsay, 2017, COMP SUMMARY MEASURE
   Mensch B, 1996, STUD FAMILY PLANN, V27, P59, DOI 10.2307/2138134
   MoH Malawi ICF International, 2014, MAL SERV PROV ASS 20
   MoHSW/ Tanzania, 2016, TANZ SERV PROV ASS S
   RamaRao S, 2003, INT FAM PLAN PERSPEC, V29, P76, DOI 10.2307/3181061
   RamaRao S, 2016, QUALITY MEASUREMENT
   RamaRao S, 2001, IUSSP GEN POP C SALV
   Rani M, 2008, INT J QUAL HEALTH C, V20, P62, DOI 10.1093/intqhc/mzm052
   Reise SP, 2000, PSYCHOL ASSESSMENT, V12, P287, DOI 10.1037//1040-3590.12.3.287
   Shahidzadeh-Mahani A, 2008, INT J QUAL HEALTH C, V20, P284, DOI 10.1093/intqhc/mzn016
   Sharker MAY, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-6
   Shwartz M, 2013, HEALTH SERV RES, V48, P271, DOI 10.1111/j.1475-6773.2012.01437.x
   Sprockett A., 2016, QUALITY MEASUREMENT
   Tessema Gizachew Assefa, 2016, JBI Database System Rev Implement Rep, V14, P103, DOI 10.11124/JBISRIR-2016-003056
   Tumlinson K, 2015, INT PERSPECT SEX R H, V41, P69, DOI 10.1363/4106915
   Wang W, 2015, RELATIONSHIP HLTH SE
   WHO, 2015, SERV AV READ ASS SAR
NR 45
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 7
PY 2019
VL 14
IS 6
AR e0217547
DI 10.1371/journal.pone.0217547
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IC0OB
UT WOS:000470658500017
PM 31173618
OA DOAJ Gold
DA 2019-07-16
ER

PT J
AU Madrazo-Moya, CF
   Cancino-Munoz, I
   Cuevas-Cordoba, B
   Gonzalez-Covarrubias, V
   Barbosa-Amezcua, M
   Soberon, X
   Muniz-Salazar, R
   Martinez-Guarneros, A
   Backer, C
   Zarrabal-Meza, J
   Sampieri-Ramirez, C
   Enciso-Moreno, A
   Lauzardo, M
   Comas, I
   Zenteno-Cuevas, R
AF Francisco Madrazo-Moya, Carlos
   Cancino-Munoz, Irving
   Cuevas-Cordoba, Betzaida
   Gonzalez-Covarrubias, Vanessa
   Barbosa-Amezcua, Martin
   Soberon, Xavier
   Muniz-Salazar, Raquel
   Martinez-Guarneros, Armando
   Backer, Claudia
   Zarrabal-Meza, Jose
   Sampieri-Ramirez, Clara
   Enciso-Moreno, Antonio
   Lauzardo, Michael
   Comas, Inaki
   Zenteno-Cuevas, Roberto
TI Whole genomic sequencing as a tool for diagnosis of drug and
   multidrug-resistance tuberculosis in an endemic region in Mexico
SO PLOS ONE
LA English
DT Article
ID MGIT 960 SYSTEM; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY;
   MUTATIONS; SUSCEPTIBILITY; PYRAZINAMIDE; VERACRUZ; RIFAMPIN; STRAINS;
   INDIA
AB Background
   Whole genome sequencing (WGS) has been proposed as a tool for diagnosing drug resistance in tuberculosis. However, reports of its effectiveness in endemic countries with important numbers of drug resistance are scarce. The goal of this study was to evaluate the effectiveness of this procedure in isolates from a tuberculosis endemic region in Mexico.
   Methods
   WGS analysis was performed in 81 tuberculosis positive clinical isolates with a known phenotypic profile of resistance against first-line drugs (isoniazid, rifampin, ethambutol, pyrazinamide and streptomycin). Mutations related to drug resistance were identified for each isolate; drug resistant genotypes were predicted and compared with the phenotypic profile. Genotypes and transmission clusters based on genetic distances were also characterized.
   Findings
   Prediction by WGS analysis of resistance against isoniazid, rifampicin, ethambutol, pyrazinamide and streptomycin showed sensitivity values of 84%, 96%, 71%, 75% and 29%, while specificity values were 100%, 94%, 90%, 90% and 98%, respectively. Prediction of multidrug resistance showed a sensitivity of 89% and specificity of 97%. Moreover, WGS analysis revealed polymorphisms related to second-line drug resistance, enabling classification of eight and two clinical isolates as pre- and extreme drug-resistant cases, respectively. Lastly, four lineages were identified in the population (L1, L2, L3 and L4). The most frequent of these was L4, which included 90% (77) of the isolates. Six transmission clusters were identified; the most frequent was TC6, which included 13 isolates with a L4.1.1 and a predominantly multidrug-resistant condition.
   Conclusions
   The results illustrate the utility of WGS for establishing the potential for prediction of resistance against first and second line drugs in isolates of tuberculosis from the region. They also demonstrate the feasibility of this procedure for use as a tool to support the epidemiological surveillance of drug-and multidrug-resistant tuberculosis.
C1 [Francisco Madrazo-Moya, Carlos; Sampieri-Ramirez, Clara; Zenteno-Cuevas, Roberto] Univ Veracruzana, Inst Salud Publ, Xalapa, Veracruz, Mexico.
   [Francisco Madrazo-Moya, Carlos; Zenteno-Cuevas, Roberto] Univ Veracruzana, Programa Maestria Ciencias Salud, Inst Ciencias Salud, Xalapa, Veracruz, Mexico.
   [Cancino-Munoz, Irving; Comas, Inaki] CSIC, Biomed Inst Valencia IBV, Valencia, Spain.
   [Cuevas-Cordoba, Betzaida; Gonzalez-Covarrubias, Vanessa; Barbosa-Amezcua, Martin; Soberon, Xavier] Inst Nacl Med Genom, Lab Farmacogenom, Mexico City, DF, Mexico.
   [Muniz-Salazar, Raquel] Univ Autonoma Baja Calif, Lab Epidemiol & Ecol & Mol, Escuela Ciencias Salud, Ensenada, Baja California, Mexico.
   [Martinez-Guarneros, Armando; Backer, Claudia] Inst Nacl Diagnost & Referencia Epidemiol, Lab Micobacterias, Mexico City, DF, Mexico.
   [Zarrabal-Meza, Jose] Secretaria Salud, Lab Estatal Salud Publ, Xalapa, Veracruz, Mexico.
   [Enciso-Moreno, Antonio] IMSS, Unidad Invest Biomed Zacatecas, Zacatecas, Zacatecas, Mexico.
   [Lauzardo, Michael] Univ Florida, Coll Med, Div Infect Dis & Global Med, Gainesville, FL USA.
   [Comas, Inaki] CIBER Epidemiol & Publ Hlth, Madrid, Spain.
RP Zenteno-Cuevas, R (reprint author), Univ Veracruzana, Inst Salud Publ, Xalapa, Veracruz, Mexico.; Zenteno-Cuevas, R (reprint author), Univ Veracruzana, Programa Maestria Ciencias Salud, Inst Ciencias Salud, Xalapa, Veracruz, Mexico.
EM robzencue@gmail.com
RI ; Cuevas-Cordoba, Betzaida/C-4103-2014
OI Madrazo Moya, Carlos Francisco/0000-0002-1131-481X; Cuevas-Cordoba,
   Betzaida/0000-0002-6528-9998
FU CONACyT-Problemas nacionales grant [2015-01-147]; GACD-FONCICYT Conacyt
   [264693];  [I-COOP-2017-COOPB2032]
FX CFM-M was a CONACYT fellow of the Maestria en Ciencias de la Salud of
   the Instituto de Ciencias de la Salud Universidad Veracruzana. RZC and
   IC were partially funded by I-COOP-2017-COOPB2032. RMS was funded by
   CONACyT-Problemas nacionales grant no. 2015-01-147. XS was funded by
   GACD-FONCICYT Conacyt No. 264693.
CR Ali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117771
   Aung HL, 2016, J GLOB ANTIMICROB RE, V6, P113, DOI 10.1016/j.jgar.2016.04.008
   Castellanos-Joya M., 2014, ACTUAL SITUATION TUB
   Chatterjee A, 2017, TUBERCULOSIS, V107, P63, DOI 10.1016/j.tube.2017.08.002
   Chedore P, 2010, J CLIN MICROBIOL, V48, P300, DOI 10.1128/JCM.01775-09
   Cohen KA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001880
   Coll F, 2018, NAT GENET, V50, P307, DOI 10.1038/s41588-017-0029-0
   Coll F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0164-0
   Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812
   Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744
   Cuevas-Cordoba B, 2015, ANTIMICROB AGENTS CH, V59, P5455, DOI 10.1128/AAC.00117-15
   Cuevas-Cordoba B, 2013, INFECT GENET EVOL, V19, P330, DOI 10.1016/j.meegid.2012.12.013
   Cuevas-Cordoba B, 2013, J MICROBIOL IMMUNOL, V46, P30, DOI 10.1016/j.jmii.2012.08.020
   Dymova MA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-77
   Eldholm V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8119
   Eldholm V, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0490-3
   Feuerriegel S, 2015, J CLIN MICROBIOL, V53, P1908, DOI 10.1128/JCM.00025-15
   Flores-Lopez CA, 2017, INFECT GENET EVOL, V55, P378, DOI 10.1016/j.meegid.2016.07.001
   Flores-Trevino S, 2014, SALUD PUBLICA MEXICO, V56, P63
   Grandjean L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126271
   Holt KE, 2018, NAT GENET, V50, P849, DOI 10.1038/s41588-018-0117-9
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mahomed S, 2017, TUBERCULOSIS, V107, P137, DOI 10.1016/j.tube.2017.09.005
   Manson AL, 2017, CLIN INFECT DIS, V64, P1494, DOI 10.1093/cid/cix169
   Juarez-Eusebio DM, 2017, INFECT GENET EVOL, V55, P384, DOI 10.1016/j.meegid.2016.09.012
   Martinez-Guarneros A, 2013, INFECT GENET EVOL, V14, P434, DOI 10.1016/j.meegid.2012.12.024
   Miotto P, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.01599-17, 10.1128/JCM.01599-17]
   Perez-Navarro LM, 2011, GAC MED MEX, V147, P219
   Munro-Rojas D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193626
   Pan American Health Organisation, 2018, TUB AM 2018
   Papaventsis D, 2017, CLIN MICROBIOL INFEC, V23, P61, DOI 10.1016/j.cmi.2016.09.008
   Piersimoni C, 2013, J CLIN MICROBIOL, V51, P291, DOI 10.1128/JCM.01838-12
   Seifert M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119628
   Senghore M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184510
   Serra A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37411-y
   Shea J, 2017, J CLIN MICROBIOL, V55, P1871, DOI 10.1128/JCM.00298-17
   Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641
   Stop TB Partnership W, 2016, GLOB PLAN STOP TB 20, V2020, P1
   Stucki D, 2016, J CLIN MICROBIOL, V54, P1862, DOI 10.1128/JCM.00126-16
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   The CRyPTIC Consortium and the 100 000 Genomes Project, 2018, NEW ENGL J MED
   Van Deun A, 2013, J CLIN MICROBIOL, V51, P2633, DOI 10.1128/JCM.00553-13
   VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578
   Walker TM, 2017, CLIN MICROBIOL INFEC, V23, P161, DOI 10.1016/j.cmi.2016.10.014
   Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3
   WHO, 2016, COMP HDB WHO GUID PR
   Witney AA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0598-2
   Witney AA, 2015, J CLIN MICROBIOL, V53, P1473, DOI 10.1128/JCM.02993-14
   Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46
   World Health Organization, 2017, GLOB TUB REP, V2017, P1
   Zenteno-Cuevas R, 2009, MEM I OSWALDO CRUZ, V104, P468, DOI 10.1590/S0074-02762009000300012
   Zenteno-Cuevas R, 2015, INT J ANTIMICROB AG, V45, P671, DOI 10.1016/j.ijantimicag.2015.02.006
   Zenteno-Cuevas R, 2015, APMIS, V123, P116, DOI 10.1111/apm.12312
   Zenteno-Cuevas R, 2012, CAN J MICROBIOL, V58, P318, DOI [10.1139/W11-127, 10.1139/w11-127]
   Zenteno-Cuevas R, 2011, REV SOC BRAS MED TRO, V44, P282, DOI [10.1590/S0037-86822011005000034, 10.1590/s0037-86822011005000034]
   Zhang Y, 2015, INT J TUBERC LUNG D, P1276
NR 56
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 5
PY 2019
VL 14
IS 6
AR e0213046
DI 10.1371/journal.pone.0213046
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IB2GN
UT WOS:000470087800001
PM 31166945
OA DOAJ Gold
DA 2019-07-16
ER

PT J
AU Pfister, PB
   de Bruin, ED
   Bastiaenen, CHG
   Maurer, B
   Knols, RH
AF Pfister, Pierrette Baschung
   de Bruin, Eling D.
   Bastiaenen, Caroline H. G.
   Maurer, Britta
   Knols, Ruud H.
TI Reliability and validity of the German version of the Myositis
   Activities Profile (MAP) in patients with inflammatory myopathy
SO PLOS ONE
LA English
DT Article
ID CULTURAL-ADAPTATION; POLYMYOSITIS; ADULT; QUESTIONNAIRE; EPIDEMIOLOGY;
   TRANSLATION; VALIDATION
AB The Myositis Activity Profile (MAP) is the only disease-specific questionnaire to assess limitations in activities of daily living (ADL) in patients with inflammatory myopathy (IM). Because a German version does not currently exist, this study's aim was to translate the MAP and assess reliability and construct validity of the new version. Therefore, a cross-cultural adaptation was performed following international guidelines. Forty-eight patients with IM completed the German-MAP, twice within two weeks. They were also assessed using the Health Assessment Questionnaire (HAQ), 36-Item Short Form Survey (SF36), Manual Muscle Test (MMT8), Quantitative Muscle Testing (QMT) and Functional Index (FI-2). For discriminant validity, 48 age-and gender-matched healthy controls completed the German-MAP. Reliability was assessed using weighted kappa (K-w). Correlations between the MAP and the HAQ, the physical (PCM) and mental (MCS) component scores of SF36 and the MMT8 and QMT muscle tests were assessed using Spearman correlation analysis. Discriminative validity was assessed by calculating the Area under the Curve (AUC). The German-MAP showed substantial reliability for the four subscales (K-w: 0.65-0.71) and moderate to substantial reliability for the single items (K-w: 0.57-0.77). The MAP showed good construct validity (high correlations with HAQ and PCM, moderate with FI-2, QMT and MMT8 and poor with MCS and pain) and acceptable discrimination for three subscales and two single items (AUC: 0.65-0.79). In conclusion, the German-MAP appears to be a reliable and valid questionnaire to assess ADL-limitations in patients with IM. Further research is required, both to substantiate these results and to evaluate responsiveness.
C1 [Pfister, Pierrette Baschung; Knols, Ruud H.] Univ Hosp Zurich, Directorate Res & Educ, Physiotherapy Occupat Therapy Res Ctr, Zurich, Switzerland.
   [Pfister, Pierrette Baschung; Bastiaenen, Caroline H. G.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Epidemiol, Maastricht, Netherlands.
   [de Bruin, Eling D.] Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Dept Hlth Sci & Technol, Zurich, Switzerland.
   [de Bruin, Eling D.] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, Huddinge, Sweden.
   [Bastiaenen, Caroline H. G.] Maastricht Univ, Dept Epidemiol, Caphri Res Inst, Res Line Functioning & Rehabil, Maastricht, Netherlands.
   [Maurer, Britta] Univ Hosp Zurich, Div Rheumatol, Zurich, Switzerland.
   [Maurer, Britta] Univ Hosp Zurich, Lab Syst Autoimmune Dis, Zurich, Switzerland.
RP de Bruin, ED (reprint author), Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Dept Hlth Sci & Technol, Zurich, Switzerland.; de Bruin, ED (reprint author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, Huddinge, Sweden.
EM eling.debruin@hest.ethz.ch
RI de Bruin, Eling D./A-4751-2011
OI de Bruin, Eling D./0000-0002-6542-7385
CR Alexanderson H, 2006, ARTHRIT RHEUM-ARTHR, V55, P114, DOI 10.1002/art.21715
   Alexanderson H, 2002, J RHEUMATOL, V29, P2386
   Alexanderson H, 2012, J RHEUMATOL, V39, P2134, DOI 10.3899/jrheum.120504
   Alkotob ML, 2006, CHEST, V130, P176, DOI 10.1378/chest.130.1.176
   Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014
   Bernatsky S, 2011, J RHEUMATOL, V38, P885, DOI 10.3899/jrheum.101083
   BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807
   BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N
   DALAKAS MC, 1991, NEW ENGL J MED, V325, P1487, DOI 10.1056/NEJM199111213252107
   FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202
   Furst DE, 2012, MUSCLE NERVE, V45, P676, DOI 10.1002/mus.23302
   Greenberg SA, 2008, SEMIN NEUROL, V28, P241, DOI 10.1055/s-2008-1062267
   Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543
   Hosmer DW, 2013, APPL LOGISTIC REGRES
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mastaglia FL, 2002, RHEUM DIS CLIN N AM, V28, P723, DOI 10.1016/S0889-857X(02)00021-2
   Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006
   Munro B., 1997, STAT METHODS HLTH CA
   Rider LG, 2011, ARTHRIT CARE RES, V63, pS118, DOI 10.1002/acr.20532
   Rider LG, 2010, ARTHRIT CARE RES, V62, P465, DOI 10.1002/acr.20035
   Schonbrodt FD, 2013, J RES PERS, V47, P609, DOI 10.1016/j.jrp.2013.05.009
   Vet HCWd, 2011, MEASUREMENT MED PRAC
   Vincze M, 2012, BEST PRACT RES CL RH, V26, P25, DOI 10.1016/j.berh.2012.01.013
   Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x
NR 24
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 3
PY 2019
VL 14
IS 6
AR e0217173
DI 10.1371/journal.pone.0217173
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IA9ZE
UT WOS:000469915700010
PM 31158240
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chan, M
   Muriuki, EM
   Emery, S
   Kanthula, R
   Chohan, V
   Frenkel, LM
   Wald, A
   Chohan, B
   Overbaugh, J
   Roxby, AC
AF Chan, Mary
   Muriuki, Eric Munene
   Emery, Sandra
   Kanthula, Ruth
   Chohan, Vrasha
   Frenkel, Lisa M.
   Wald, Anna
   Chohan, Bhavna
   Overbaugh, Julie
   Roxby, Alison C.
TI Correlates of HIV detection among breastfeeding postpartum Kenyan women
   eligible under Option B
SO PLOS ONE
LA English
DT Article
ID TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; VIRAL LOAD; RESISTANT
   HIV-1; PLUS; PREGNANCY; ADHERENCE; CARE; RETENTION; NEVIRAPINE
AB Background
   The Option B+ strategy streamlines delivery of HIV antiretroviral therapy (ART) to pregnant women, but concerns remain about ART treatment adherence and long term outcomes.
   Methods
   We conducted a retrospective analysis of a cohort of HIV-positive, postpartum breastfeeding women receiving ART via Option B+ in Nairobi, Kenya. The primary outcome was virologic failure in plasma (HIV RNA >1000 copies/mL), and detection in breast milk (>150 copies/mL) and endocervical secretions (>100 copies/mL) at 2 postpartum timepoints. Correlates of virologic failure were assessed using univariate tests and multivariate logistic regression.
   Results
   Of 42 women at 6-14 weeks postpartum, 21.4% of women had HIV RNA detected in plasma; 14.3% in breast milk, and 23.7% in endocervical secretions. At 18-24 weeks postpartum, the percentages were 21.1%, 7.1%, and 14.3%, respectively. Younger maternal age, intent to breastfeed for longer, and later ART start in pregnancy were significantly associated with plasma virologic failure (p < 0.05 for each). Odds of plasma virologic failure at 6-14 weeks postpartum were 1.25 times higher (95% CI 1.04, 1.51) for each increase in week of gestation at ART initiation. Only 3 women had resistance mutations to their regimen.
   Conclusions
   Despite months of ART, nearly one-quarter of the women in our cohort did not achieve plasma virologic suppression in the postpartum period. After adjusting for time on ART, earlier ART initiation in pregnancy was significantly associated with plasma suppression. Our findings suggest that postpartum HIV RNA monitoring in Option B+ programs will be needed to achieve elimination of MTCT.
C1 [Chan, Mary; Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
   [Muriuki, Eric Munene] Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya.
   [Emery, Sandra] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.
   [Kanthula, Ruth; Frenkel, Lisa M.] Seattle Childrens Res Inst, Seattle, WA USA.
   [Chohan, Vrasha; Frenkel, Lisa M.; Wald, Anna; Roxby, Alison C.] Univ Washington, Dept Med, Seattle, WA 98195 USA.
   [Frenkel, Lisa M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA.
   [Frenkel, Lisa M.; Wald, Anna] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.
   [Frenkel, Lisa M.; Chohan, Bhavna; Roxby, Alison C.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   [Chohan, Bhavna] Kenya Govt Med Res Ctr, Nairobi, Kenya.
   [Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.
   [Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.
RP Roxby, AC (reprint author), Univ Washington, Dept Med, Seattle, WA 98195 USA.; Roxby, AC (reprint author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
EM aroxby@uw.edu
FU NICHD [K23 HD071788-01A1]; University of Washington Center for AIDS
   Research (CFAR) [P30 AI027757]; Fogarty Fellowship - Fogarty
   International Center; Office of AIDS Research [3R25TW009345]; Gilead
   Sciences; National Center for Advancing Translational Sciences of the
   National Institutes of Health [UL1 TR002319]
FX This research was funded by K23 HD071788-01A1 (ACR) from NICHD, by a New
   Investigator Award to ACR from the University of Washington Center for
   AIDS Research (CFAR) (P30 AI027757), and by a Fogarty Fellowship to EMM,
   funded by the Fogarty International Center and the Office of AIDS
   Research (3R25TW009345). EMM also received a travel award from Gilead
   Sciences. Analysis of HIV drug resistance was performed with assistance
   of the Clinical and Retrovirology Research Core and the Molecular
   Profiling and Computational Biology Core of the UW CFAR (P30 AI027757).
   Study data were collected and managed using REDCap electronic data
   capture tools hosted at the Institute of Translational Health Sciences,
   supported by the National Center for Advancing Translational Sciences of
   the National Institutes of Health (UL1 TR002319). The funders had no
   role in the study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888
   Beek IA, 2002, J CLIN MICROBIOL, V40, P1413, DOI 10.1128/JCM.40.4.1413-1419.2002
   Bispo S, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21251
   Blish CA, 2012, JAIDS-J ACQ IMM DEF, V61, P436, DOI 10.1097/QAI.0b013e31826c2edd
   Council NAC, 2014, KEN AIDS RESP PROGR
   Davis NL, 2016, JAIDS-J ACQ IMM DEF, V73, P572, DOI 10.1097/QAI.0000000000001145
   Geldsetzer P, 2016, J INT AIDS SOC, V19, P1
   Gill MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168671
   Graham SM, 2012, JAIDS-J ACQ IMM DEF, V60, P511, DOI 10.1097/QAI.0b013e31825bd703
   Haas AD, 2016, CLIN INFECT DIS, V63, P1227, DOI 10.1093/cid/ciw500
   Kamuyango Alfred A, 2014, World J AIDS, V4, P332
   Katirayi L, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20919
   Kim MH, 2015, JAIDS-J ACQ IMM DEF, V70, P99, DOI 10.1097/QAI.0000000000000692
   Knettel BA, 2018, JAIDS-J ACQ IMM DEF, V77, P427, DOI 10.1097/QAI.0000000000001616
   Koss CA, 2017, JAIDS-J ACQ IMM DEF, V74, P279, DOI 10.1097/QAI.0000000000001228
   Landes M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3380-7
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   McGrath CJ, 2018, AIDS CARE, V30, P765, DOI 10.1080/09540121.2017.1400642
   Micek MA, 2012, J INFECT DIS, V205, P1811, DOI 10.1093/infdis/jis282
   Micek MA, 2010, CLIN INFECT DIS, V50, P1405, DOI 10.1086/652151
   Mills EJ, 2014, LANCET HIV, V1, pE104, DOI 10.1016/S2352-3018(14)00003-4
   Mwau M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183860
   Myer L, 2017, HIV MED, V18, P80, DOI 10.1111/hiv.12397
   Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f
   Ngarina M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0914-z
   Okonji JA, 2012, JAIDS-J ACQ IMM DEF, V61, P249, DOI 10.1097/QAI.0b013e318262514f
   Panteleeff DD, 2002, J CLIN MICROBIOL, V40, P3929, DOI 10.1128/JCM.40.11.3929-3937.2002
   Slyker JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029777
   Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143
   Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369
   UN Joint Programme on HIV/AIDS (UNAIDS), 2016, PREV GAP REP
   UNAIDS, 2016, FAST TRACK AIDS FREE
   UNICEF, 2017, HIV EP CHILDR AD
   Westreich D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022778
   World Health Organization, 2015, GUID START ANT THER
   World Health Organization (WHO), 2012, PROGR UPD US ANT DRU
NR 36
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 31
PY 2019
VL 14
IS 5
AR e0216252
DI 10.1371/journal.pone.0216252
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IA7TI
UT WOS:000469759100016
PM 31150396
OA DOAJ Gold
DA 2019-07-16
ER

PT J
AU Gattellari, M
   Goumas, C
   Jalaludin, B
   Worthington, J
AF Gattellari, Melina
   Goumas, Chris
   Jalaludin, Bind
   Worthington, John
TI The impact of disease severity adjustment on hospital standardised
   mortality ratios: Results from a service-wide analysis of ischaemic
   stroke admissions using linked pre-hospital, admissions and mortality
   data
SO PLOS ONE
LA English
DT Article
ID 30-DAY MORTALITY; MEDICARE BENEFICIARIES; CARDIAC-SURGERY; CONTROL
   CHARTS; HUNTER REGION; PERFORMANCE; OUTCOMES; QUALITY; SCALE; RISK
AB Background
   Administrative data are used to examine variation in thirty-day mortality across health services in several jurisdictions. Hospital performance measurement may be error-prone as information about disease severity is not typically available in routinely collected data to incorporate into case-mix adjusted analyses. Using ischaemic stroke as a case study, we tested the extent to which accounting for disease severity impacts on hospital performance assessment.
   Methods
   We linked all recorded ischaemic stroke admissions between July, 2011 and June, 2014 to death registrations and a measure of stroke severity obtained at first point of patient contact with health services, across New South Wales, Australia's largest health service jurisdiction. Thirty-day hospital standardised mortality ratios were adjusted for either comorbidities, as is typically done, or for both comorbidities and stroke severity. The impact of stroke severity adjustment on mortality ratios was determined using 95% and 99% control limits applied to funnel plots and by calculating the change in rank order of hospital risk adjusted mortality rates.
   Results
   The performance of the stroke severity adjusted model was superior to incorporating comorbidity burden alone (c-statistic = 0.82 versus 0.75; N = 17,700 patients, 176 hospitals). Concordance in outlier classification was 89% and 97% when applying 95% or 99% control limits to funnel plots, respectively. The sensitivity rates of outlier detection using comorbidity adjustment compared with gold-standard severity and comorbidity adjustment was 74% and 83% with 95% and 99% control limits, respectively. Corresponding positive predictive values were 74% and 91%. Hospital rank order of risk adjusted mortality rates shifted between 0 to 22 places with severity adjustment (Median = 4.0, Inter-quartile Range = 2-7).
   Conclusions
   Rankings of mortality rates varied widely depending on whether stroke severity was taken into account. Funnel plots yielded largely concordant results irrespective of severity adjustment and may be sufficiently accurate as a screening tool for assessing hospital performance.
C1 [Gattellari, Melina; Goumas, Chris] Ingham Inst Appl Med Res, Heart & Brain Collaborat, Sydney, NSW, Australia.
   [Gattellari, Melina; Worthington, John] Royal Prince Alfred Hosp, Inst Clin Neurosci, Sydney, NSW, Australia.
   [Jalaludin, Bind] South Western Sydney Local Hlth Dist, Populat Hlth Intelligence, Hlth People & Places Unit, Sydney, NSW, Australia.
   [Jalaludin, Bind] Univ New South Wales, Sch Publ Hlth, Sydney, NSW, Australia.
   [Worthington, John] Univ New South Wales, South Western Sydney Clin Sch, Sydney, NSW, Australia.
RP Worthington, J (reprint author), Royal Prince Alfred Hosp, Inst Clin Neurosci, Sydney, NSW, Australia.; Worthington, J (reprint author), Univ New South Wales, South Western Sydney Clin Sch, Sydney, NSW, Australia.
EM John.Worthington@health.nsw.gov.au
FU New South Wales Ministry of Health, Office for Health and Medical
   Research; New South Wales Neurological Conditions Translational Research
   Grants Program
FX Funding was provided by the New South Wales Ministry of Health, Office
   for Health and Medical Research. New South Wales Neurological Conditions
   Translational Research Grants Program to JW, BJ, and MG.
   http://www.health.nsw.gov.au/ohmr/Pages/contacts.aspx.The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113
   Alexandrescu R, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0029-x
   Australian Bureau of Statistics, 2008, SOC IND AR SEIFA
   Australian College for Emergency Medicine, GUID IMPL AUSTR TRIA
   Australian Consortium for Classification Development, 2015, INT STAT CLASS DIS H
   Ayerbe L, 2014, J NEUROL NEUROSUR PS, V85, P514, DOI 10.1136/jnnp-2013-306448
   Bardach NS, 2002, STROKE, V33, P1851, DOI 10.1161/01.STR.0000019126.43079.7B
   BLAND JM, 1986, LANCET, V1, P307
   Bray BD, 2014, STROKE, V45, P3374, DOI 10.1161/STROKEAHA.114.006451
   Bridgewater B, 2005, BMJ-BRIT MED J, V330, P506, DOI 10.1136/bmj.330.7490.506
   Bureau of Health Information, 2012, INS SER EXPL CLIN VA
   Cadilhac DA, 2017, MED J AUSTRALIA, V206, P345, DOI 10.5694/mja16.00525
   Canadian Institute for Health Information, 2016, HOSP STAND MORT RAT
   Dr Foster Intelligence, 2014, UND HSMRS TOOLK HOSP
   Fonarow GC, 2012, JAMA-J AM MED ASSOC, V308, P257, DOI 10.1001/jama.2012.7870
   Fonarow GC, 2012, J AM HEART ASSOC, V1, P42, DOI 10.1161/JAHA.111.000034
   Ganesh A, 2016, NEUROLOGY, V86, P898, DOI 10.1212/WNL.0000000000002443
   Glance LG, 2003, INTENS CARE MED, V29, P2223, DOI 10.1007/s00134-003-1959-9
   Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c
   Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X
   Guthrie B, 2005, QUAL SAF HEALTH CARE, V14, P450, DOI 10.1136/qshc.2005.014456
   Hall RE, 2015, CIRC-CARDIOVASC QUAL, V8, pS141, DOI 10.1161/CIRCOUTCOMES.115.002079
   Henderson T, 2006, MED CARE, V44, P1011, DOI 10.1097/01.mlr.0000228018.48783.34
   Jarman B, 2010, QUAL SAF HEALTH CARE, V19, P9, DOI 10.1136/qshc.2009.032953
   Katzan IL, 2014, STROKE, V45, P918, DOI 10.1161/01.str.0000441948.35804.77
   Keyhani S, 2012, CIRC-CARDIOVASC QUAL, V5, P508, DOI 10.1161/CIRCOUTCOMES.111.962936
   Krumholz HM, 2006, CIRCULATION, V113, P456, DOI 10.1161/CIRCULATIONAHA.105.170769
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lichtman JH, 2011, STROKE, V42, P3387, DOI 10.1161/STROKEAHA.111.622613
   MacKenzie TA, 2015, ANN THORAC SURG, V99, P757, DOI 10.1016/j.athoracsur.2014.11.039
   Marsden DL, 2010, CEREBROVASC DIS, V30, P500, DOI 10.1159/000319022
   McCormick N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135834
   Phan TG, 2016, J STROKE CEREBROVASC, V25, P835, DOI 10.1016/j.jstrokecerebrovasdis.2015.12.016
   Pouw ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059160
   Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83
   Reeves MJ, 2015, CIRC-CARDIOVASC QUAL, V8, pS90, DOI 10.1161/CIRCOUTCOMES.115.001775
   Rixom A, 2002, BRIT MED J, V325, P177, DOI 10.1136/bmj.325.7357.177
   Sansom LT, 2015, INT J STROKE, V10, pE70, DOI 10.1111/ijs.12577
   Saposnik G, 2007, NEUROLOGY, V69, P1142, DOI 10.1212/01.wnl.0000268485.93349.58
   Saposnik G, 2013, NEUROLOGY, V81, P448, DOI 10.1212/WNL.0b013e31829d874e
   Schwartz J, 2017, STROKE, V48, P3101, DOI 10.1161/STROKEAHA.117.017960
   Sharabiani MTA, 2012, MED CARE, V50, P1109, DOI 10.1097/MLR.0b013e31825f64d0
   Siregar S, 2012, CIRC-CARDIOVASC QUAL, V5, P403, DOI 10.1161/CIRCOUTCOMES.111.964460
   Spertus JV, 2016, CIRC-CARDIOVASC QUAL, V9, P659, DOI 10.1161/CIRCOUTCOMES.116.002826
   TEASDALE G, 1974, LANCET, V2, P81
   Tekkis PP, 2003, BMJ-BRIT MED J, V326, P786, DOI 10.1136/bmj.326.7393.786
   Thompson MP, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.118.004951
   Thompson MP, 2016, CIRC-CARDIOVASC QUAL, V9, P286, DOI 10.1161/CIRCOUTCOMES.115.002352
   Wang Y, 2003, STROKE, V34, P1144, DOI 10.1161/01.STR.0000067703.71251.B6
   Weir CJ, 2003, QJM-INT J MED, V96, P67, DOI 10.1093/qjmed/hcg008
   Worthington JM, 2017, NEUROEPIDEMIOLOGY, V48, P111, DOI 10.1159/000478016
   Yale New Haven Health Services Corporation/Center for Outcomes Research & Evaluation, 2014, 2014 MEAS UPD SPEC R
   Yu AYX, 2017, NEUROLOGY, V89, P1970, DOI 10.1212/WNL.0000000000004631
NR 53
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 21
PY 2019
VL 14
IS 5
AR e0216325
DI 10.1371/journal.pone.0216325
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HY9HS
UT WOS:000468451000014
PM 31112556
OA DOAJ Gold
DA 2019-07-16
ER

PT J
AU Keogh, JWL
   Cox, A
   Anderson, S
   Liew, B
   Olsen, A
   Schram, B
   Furness, J
AF Keogh, Justin W. L.
   Cox, Alistair
   Anderson, Sarah
   Liew, Bernard
   Olsen, Alicia
   Schram, Ben
   Furness, James
TI Reliability and validity of clinically accessible smartphone
   applications to measure joint range of motion: A systematic review
SO PLOS ONE
LA English
DT Review
ID CONCURRENT VALIDITY; UNIVERSAL GONIOMETER; ABSOLUTE RELIABILITY;
   PERFORMANCE-MEASURES; ANGLE MEASUREMENT; MEASUREMENT TOOL; KNEE RANGE;
   APP; POSITION; AGREEMENT
AB Measuring joint range of motion is an important skill for many allied health professionals. While the Universal Goniometer is the most commonly utilised clinical tool for measuring joint range of motion, the evolution of smartphone technology and applications (apps) provides the clinician with more measurement options. However, the reliability and validity of these smartphones and apps is still somewhat uncertain. The aim of this study was to systematically review the literature regarding the intra- and inter-rater reliability and validity of smartphones and apps to measure joint range of motion. Eligible studies were published in English peer-reviewed journals with full text available, involving the assessment of reliability and/or validity of a non-videographic smartphone app to measure joint range of motion in participants >18 years old. An electronic search using PubMed, Medline via Ovid, EMBASE, CINAHL, and SPORTSDiscus was performed. The risk of bias was assessed using a standardised appraisal tool. Twenty-three of the eligible 25 studies exceeded the minimum 60% score to be classified as a low risk of bias, although 3 of the 13 criteria were not achieved in >50% of the studies. Most of the studies demonstrated adequate intra-rater or inter-rater reliability and/or validity for >50% of the range of motion tests across all joints assessed. However, this level of evidence appeared weaker for absolute (e.g. mean difference limit of agreement, minimal detectable change) than relative (e.g. intraclass correlation, correlation) measures; and for spinal rotation than spinal extension, flexion and lateral flexion. Our results provide clinicians with sufficient evidence to support the use of smartphones and apps in place of goniometers to measure joint motion. Future research should address some methodological limitations of the literature, especially including the inclusion of absolute and not just relative reliability and validity statistics.
C1 [Keogh, Justin W. L.; Olsen, Alicia] Bond Univ, Fac Hlth Sci & Med, Gold Coast, Qld, Australia.
   [Keogh, Justin W. L.] AUT Univ, SPRINZ, Auckland, New Zealand.
   [Keogh, Justin W. L.] Univ Sunshine Coast, Cluster Hlth improvement, Fac Sci Hlth Educ & Engn, Sunshine Coast, Qld, Australia.
   [Cox, Alistair; Anderson, Sarah; Schram, Ben; Furness, James] Bond Univ, Fac Hlth Sci & Med, Dept Physiotherapy, Gold Coast, Qld, Australia.
   [Liew, Bernard] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Ctr Precis Rehabil Spinal Pain CPR Spine, Birmingham, W Midlands, England.
   [Schram, Ben; Furness, James] Bond Univ, Bond Inst Hlth & Sport, Water Based Res Unit, Gold Coast, Qld, Australia.
RP Keogh, JWL (reprint author), Bond Univ, Fac Hlth Sci & Med, Gold Coast, Qld, Australia.; Keogh, JWL (reprint author), AUT Univ, SPRINZ, Auckland, New Zealand.; Keogh, JWL (reprint author), Univ Sunshine Coast, Cluster Hlth improvement, Fac Sci Hlth Educ & Engn, Sunshine Coast, Qld, Australia.
EM jkeogh@bond.edu.au
OI Furness, James/0000-0001-7773-0253; Keogh, Justin/0000-0001-9851-1068;
   Schram, Ben/0000-0002-1865-0488
CR Barrett E, 2014, MANUAL THER, V19, P10, DOI 10.1016/j.math.2013.09.003
   Behnoush Behnam, 2016, Asian J Sports Med, V7, pe30668, DOI 10.5812/asjsm.30668
   Brodie MA, 2008, COMPUT METHOD BIOMEC, V11, P641, DOI 10.1080/10255840802326736
   Brosseau L, 1997, Physiother Res Int, V2, P150
   Chia K, 2017, GAIT POSTURE, V56, P68, DOI 10.1016/j.gaitpost.2017.04.040
   Cronin J, 2006, PHYS THER SPORT, V7, P191, DOI 10.1016/j.ptsp.2006.07.003
   Cruz J, 2016, ARCH PHYS MED REHAB, V97, P1880, DOI 10.1016/j.apmr.2016.05.001
   Derhon V, 2017, HUM MOVEMENT, V18, P38
   Dos Santos RA, 2017, J BODYW MOV THER, V21, P699, DOI 10.1016/j.jbmt.2016.11.008
   Fleiss JL, 1981, MEASUREMENT INTERRAT
   Fox B, 2014, INT PSYCHOGERIATR, V26, P1659, DOI 10.1017/S1041610214001124
   Furness J, 2018, PEERJ, V6, DOI 10.7717/peerj.4431
   Gratton C, 2010, RES METHODS SPORTS S, P77
   Grondin F, 2017, MUSCULOSKEL SCI PRAC, V27, P85, DOI 10.1016/j.math.2016.06.007
   Hambly K, 2012, INT J PHYSIOTHER REH, V2, P1
   Hancock Graeme Ethan, 2018, J Exp Orthop, V5, P46, DOI 10.1186/s40634-018-0161-5
   Jones A, 2014, PHYSIOTHER THEOR PR, V30, P512, DOI 10.3109/09593985.2014.900835
   Jung SH, 2018, PHYSIOTHER THEOR PR, V34, P58, DOI 10.1080/09593985.2017.1368756
   Keogh JWL, 2016, J FITNESS RES    AUG, V5, P14
   Kolber MJ, 2012, INT J SPORTS PHYS TH, V7, P306
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lendner N, 2017, HAND, DOI [10.1177/1558944717730604, DOI 10.1177/1558944717730604]
   Liaw LJ, 2008, DISABIL REHABIL, V30, P656, DOI 10.1080/09638280701400698
   Lim JY, 2015, J PHYS THER SCI, V27, P3119, DOI 10.1589/jpts.27.3119
   Luinge HJ, 2007, J BIOMECH, V40, P78, DOI 10.1016/j.jbiomech.2005.11.011
   MacDermid J C, 1999, J Hand Ther, V12, P187
   Malone JJ, 2017, INT J SPORT PHYSIOL, V12, P18, DOI 10.1123/ijspp.2016-0236
   McBride GB, 2005, PROPOSAL STRENGTH OF
   McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003
   Mehta SP, 2017, J KNEE SURG, V30, P577, DOI 10.1055/s-0036-1593877
   Mejia-Hernandez Kevyn, 2018, JSES Open Access, V2, P109, DOI 10.1016/j.jses.2017.10.001
   Milanese S, 2014, MANUAL THER, V19, P569, DOI 10.1016/j.math.2014.05.009
   Milani P, 2014, PM&R, V6, P1038, DOI 10.1016/j.pmrj.2014.05.003
   Mitchell K, 2014, PHYSIOTHER THEOR PR, V30, P521, DOI 10.3109/09593985.2014.900593
   Modest J, 2018, J HAND THER, DOI [10.1016/j.jht.2018, DOI 10.1016/J.JHT.2018]
   Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005
   MORALES CR, 2017, PEERJ, V5, DOI DOI 10.7717/PEERJ.2820
   Mourcou Q, 2015, SENSORS-BASEL, V15, P23168, DOI 10.3390/s150923168
   Mukaka MM, 2012, MALAWI MED J, V24, P69
   Nitschke JE, 1999, SPINE, V24, P262, DOI 10.1097/00007632-199902010-00013
   Ockendon M, 2012, J KNEE SURG, V25, P341, DOI 10.1055/s-0031-1299669
   Pereira LC, 2017, J KNEE SURG, V30, P223, DOI 10.1055/s-0036-1584184
   Piriyaprasarth P, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-6
   Pourahmadi MR, 2018, SPINE J, V18, P447, DOI 10.1016/j.spinee.2017.08.229
   Pourahmadi MR, 2016, PEERJ, V4, DOI 10.7717/peerj.2355
   Quek J, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-65
   Ramkumar PN, 2018, J SHOULDER ELB SURG, V27, P1198, DOI 10.1016/j.jse.2018.01.013
   Santos C, 2017, HAND SURG REHABIL, V36, P338, DOI 10.1016/j.hansur.2017.06.005
   Seel T, 2014, SENSORS-BASEL, V14, P6891, DOI 10.3390/s140406891
   Shiel F, 2018, J SCI MED SPORT, V21, P1038, DOI 10.1016/j.jsams.2018.03.005
   Shin SH, 2012, MANUAL THER, V17, P298, DOI 10.1016/j.math.2012.02.010
   Tousignant-Laflamme Y, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-69
   Ullucci PA, 2019, J SPORT REHABIL, V28, DOI 10.1123/jsr.2018-0048
   Vargas-Valencia LS, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16122090
   Vauclair Frederic, 2018, Eur J Orthop Surg Traumatol, V28, P415, DOI 10.1007/s00590-017-2058-x
   Werner BS, 2014, J SHOULDER ELB SURG, V23, P1655, DOI 10.1016/j.jse.2014.02.017
   Werner D, 2017, INT J ATHL THER TRAI, V22, P29, DOI 10.1123/ijatt.2016-0047
   Wilken JM, 2012, GAIT POSTURE, V35, P301, DOI 10.1016/j.gaitpost.2011.09.105
   Williams CM, 2013, J SCI MED SPORT, V16, P392, DOI 10.1016/j.jsams.2013.02.001
   Youssef AR, 2017, EXPERT REV MED DEVIC, V14, P481, DOI 10.1080/17434440.2017.1325319
   2012, J EVAL CLIN PRACT, V18, P1126, DOI DOI 10.1111/J.1365-2753.2011.01707.X
   2008, J BIOMECH, V41, P1029, DOI DOI 10.1016/J.JBIOMECH.2007.12.003
   2018, MUSCULOSKEL SCI PRAC, V34, P59, DOI DOI 10.1016/J.MSKSP.2017.12.006
   2014, J BACK MUSCULOSKELET, V27, P161, DOI DOI 10.3233/BMR-130431
   2010, PHYSIOTHERAPY, V96, P179, DOI DOI 10.1016/J.PHYSIO.2009.12.002
   1991, PHYS THER, V71, P98
   1987, PHYS THER, V67, P1867
   1986, PHYS THER, V66, P677
   2017, J ANAT, V230, P484, DOI DOI 10.1111/JOA.12568
   2015, AM J PHYS MED REHABI, V94, P325, DOI DOI 10.1097/PHM.0000000000000221
   2015, J SCI MED SPORT, V18, P262, DOI DOI 10.1016/J.JSAMS.2014.04.008
NR 71
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 8
PY 2019
VL 14
IS 5
AR e0215806
DI 10.1371/journal.pone.0215806
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HX4MT
UT WOS:000467373000020
PM 31067247
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chiu, EC
   Yip, PK
   Woo, P
   Lin, YT
AF Chiu, En-Chi
   Yip, Ping-Keung
   Woo, Peter
   Lin, Yi-Te
TI Test-retest reliability and minimal detectable change of the Cognitive
   Abilities Screening Instrument in patients with dementia
SO PLOS ONE
LA English
DT Article
ID STATISTICAL-METHODS; CHINESE VERSION; AGREEMENT; SCORES; SAMPLE
AB Background
   The Cognitive Abilities Screening Instrument (CASI) is widely used to assess global cognitive function in patients with dementia. It contains nine cognitive domains, namely long-term memory, short-term memory, attention, mental manipulation, orientation, abstraction and judgment, language, visual construction, and list-generating fluency. However, test-retest reliability and minimal detectable change (MDC) of the CASI are largely unknown in patients with dementia, which limits its utility and the explanation of a score change.
   Purpose
   The purpose of this study was to examine test-retest reliability and calculate MDC of the CASI in patients with dementia.
   Methods
   Fifty-two patients with dementia completed the CASI twice with a two-week interval. The frequencies of the scores in the Clinical Dementia Rating (0.5, 1, and. 2) were 38.5, 36.5, and 25.0, respectively. Test-retest reliability was examined using intraclass correlation coefficient (ICC) for the total score and nine domains of the CASI. The MDC was calculated based on standard error of measurement.
   Results
   The ICC value of the CASI total score was 0.97 while the ICC value for the nine domains were 0.65-0.92. The MDC values (MDC%) were 11.6 (12.9%), 2.8 (23.2%), 4.5 (41.2%), 3.4 (42.1%), 4.9 (49.2%), 5.3 (29.2%), 3.4 (28.8%), 2.2 (22.3%), 3.2 (32.1%), and 3.1 (30.7%) for CASI total score, long-term memory, short-term memory, attention, mental manipulation, orientation, abstraction and judgment, language, visual construction, and list-generating fluency, respectively.
   Conclusion
   Our results revealed that the CASI has sufficient test-retest reliability. The MDC values are useful in determining a real change (i.e., improvement or deterioration) between two assessments of an individual patient. However, four domains (i.e., short-term memory, attention, mental manipulation, and list-generating fluency) demonstrated lower ICC values and substantial random measurement errors. Clinicians and researchers should be cautious while using these four domains to explain score changes between repeated assessments of patients with dementia.
C1 [Chiu, En-Chi] Natl Taipei Univ Nursing & Hlth Sci, Dept Long Term Care, Taipei, Taiwan.
   [Yip, Ping-Keung] Fu Jen Catholic Univ, Coll Med, Sch Med, New Taipei, Taiwan.
   [Yip, Ping-Keung; Lin, Yi-Te] Cardinal Tien Hosp, Dept Neurol, New Taipei, Taiwan.
   [Woo, Peter] Cardinal Tien Hosp, Yung Ho Branch, New Taipei, Taiwan.
RP Lin, YT (reprint author), Cardinal Tien Hosp, Dept Neurol, New Taipei, Taiwan.
EM lizarddad@gmail.com
OI Lin, Yi-Te/0000-0002-9639-5523
FU Cardinal Tien Hospital [CTH106A-2D02]
FX This study was supported by Cardinal Tien Hospital (grant no.
   CTH106A-2D02). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Aaronson N, 2002, QUAL LIFE RES, V11, P193
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   Andersen Christian K, 2004, Health Qual Life Outcomes, V2, P52, DOI 10.1186/1477-7525-2-52
   [Anonymous], 2012, DEM PUBL HLTH PRIOR
   Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002
   Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204
   BLAND JM, 1986, LANCET, V1, P307
   Chen HM, 2009, NEUROREHAB NEURAL RE, V23, P435, DOI 10.1177/1545968308331146
   Chiu EC, 2016, ARCH PHYS MED REHAB, V97, P1917, DOI 10.1016/j.apmr.2016.04.023
   Chiu EC, 2014, BRAIN INJURY, V28, P1726, DOI 10.3109/02699052.2014.947618
   Cohen J, 1988, STAT POWER ANAL BEHA
   Haley SM, 2006, PHYS THER, V86, P735
   Hobart JC, 2004, HEALTH TECHNOL ASSES, V8, P1
   Hobart JC, 1996, J NEUROL NEUROSUR PS, V60, P127, DOI 10.1136/jnnp.60.2.127
   HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lin JH, 2009, PHYS THER, V89, P840, DOI 10.2522/ptj.20080285
   Lin Ker-Neng, 2012, Acta Neurol Taiwan, V21, P180
   Lin KN, 2002, DEMENT GERIATR COGN, V14, P176, DOI 10.1159/000066024
   Marin DB, 2001, INT J GERIATR PSYCH, V16, P745, DOI 10.1002/gps.385.abs
   Martyr A, 2012, CLIN NEUROPSYCHOL, V26, P501, DOI 10.1080/13854046.2012.665482
   Mograbi DC, 2014, ANN INDIAN ACAD NEUR, V17, P71, DOI 10.4103/0972-2327.128558
   Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998
   Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100303
   Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602
   Tsai RC, 2004, DEMENT GERIATR COGN, V18, P314, DOI 10.1159/000080125
   Tsai RC, 2007, INT PSYCHOGERIATR, V19, P1051, DOI 10.1017/S1041610207005327
   Tyng CM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01454
   Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5
   2017, CAN PHARM J, V150, P118, DOI DOI 10.1177/1715163517690745PMC5384525
NR 30
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 7
PY 2019
VL 14
IS 5
AR e0216450
DI 10.1371/journal.pone.0216450
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HX1JZ
UT WOS:000467148400030
PM 31063491
OA DOAJ Gold
DA 2019-07-16
ER

PT J
AU Abajas-Bustillo, R
   Amo-Setien, FJ
   Leal-Costa, C
   Ortego-Mate, MD
   Segui-Gomez, M
   Dura-Ros, MJ
   Zonfrillo, MR
AF Abajas-Bustillo, Rebeca
   Jose Amo-Setien, Francisco
   Leal-Costa, Cesar
   del Carmen Ortego-Mate, Maria
   Segui-Gomez, Maria
   Jesus Dura-Ros, Maria
   Zonfrillo, Mark R.
TI Comparison of injury severity scores (ISS) obtained by manual coding
   versus "Two-step conversion" from ICD-9-CM
SO PLOS ONE
LA English
DT Article
ID ABBREVIATED INJURY; AIS 2005; SCALE; VALIDATION; MAP; CLASSIFICATION;
   AGREEMENT
AB Background
   The International Classification of Diseases (ICD) is the standard diagnostic tool for classifying and coding diseases and injuries. The Abbreviated Injury Scale (AIS) is the most widely used injury severity scoring system. Although manual coding is considered the gold standard, it is sometimes unavailable or impractical. There have been many prior attempts to develop programs for the automated conversion of ICD rubrics into AIS codes.
   Objective
   To convert ICD, Ninth Revision, Clinical Modification (ICD-9-CM) codes into AIS 2005 (update 2008) codes via a derived map using a two-step process and, subsequently, to compare Injury Severity Score (ISS) resulting from said conversion with manually coded ISS values.
   Methods
   A cross-sectional retrospective study was designed in which medical records at the Hospital Universitario Marques de Valdecilla of Cantabria (HUMV) and the Complejo Hospitalario of Navarra (CHN), both in Spain, were reviewed. Coding of injuries using AIS 2005 (update 2008) version was done manually by a certified AIS specialist and ISS values were calculated. ICD-9-CM codes were automatically converted into ISS values by another certified AIS specialist in a two-step process. ISS scores obtained from manual coding were compared to those obtained through this conversion process.
   Results
   The comparison of obtained through conversion versus manual ISS resulted in 396 concordant pairs (70.2%); the analysis of values according to ISS categories (ISS< 9, ISS 9-15, ISS 16-24, ISS>24) showed 493 concordant pairs (87.4%). Regarding the criterion of "major trauma" patient (i.e., ISS> 15), 538 matching pairs (95.2%) were obtained. The conversion process resulted in underestimation of ISS in 112 cases (19.9%) and conversion was not possible in 136 cases (19%) for different reasons.
   Conclusions
   The process used in this study has proven to be a useful tool for selecting patients who meet the ISS> 15 criterion for "major trauma". Further research is needed to improve the conversion process.
C1 [Abajas-Bustillo, Rebeca; Jose Amo-Setien, Francisco; del Carmen Ortego-Mate, Maria; Jesus Dura-Ros, Maria] Univ Cantabria, Fac Nursing, Dept Nursing, Cantabria, Spain.
   [Abajas-Bustillo, Rebeca; Jose Amo-Setien, Francisco; del Carmen Ortego-Mate, Maria; Jesus Dura-Ros, Maria] Univ Murcia, Fac Nursing, IDIVAL Nursing Res Grp, Murcia, Spain.
   [Leal-Costa, Cesar] Univ Murcia, Fac Nursing, Dept Nursing, Murcia, Spain.
   [Segui-Gomez, Maria] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Zonfrillo, Mark R.] Brown Univ, Alpert Med Sch, Hasbro Childrens Hosp, Providence, RI 02912 USA.
RP Leal-Costa, C (reprint author), Univ Murcia, Fac Nursing, Dept Nursing, Murcia, Spain.
EM cleal@um.es
RI ; Leal Costa, Cesar/S-8703-2016
OI Carmen, Ortego/0000-0002-5687-5004; Leal Costa,
   Cesar/0000-0002-7711-3877
CR AAAM, 2008, ESC LES ABR 2005 ACT
   Bustillo RA, 2018, EMERGENCIAS, V30, P41
   [Anonymous], 1974, P AM ASS AUT MED ANN
   Clark D, 2010, STAT SOFTWARE COMPON
   COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010
   Di Bartolomeo S, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-17
   Durbin D R, 2001, Inj Prev, V7, P96, DOI 10.1136/ip.7.2.96
   European Center for Injury Prevention University of Navarra, 2006, ALG TRANSF ICD 10 CO
   European Commission Directorate-General for Internal Market Industry Entrepreneurship and SMEs, 2016, COM20160787 EUR COMM
   Fleiss JL, 2013, STAT METHODS RATES P
   Garthe E., 1982, Q J AM ASS AUTOMOTIV, V4, P42
   Glerum KM ZM, 2017, INJURY PREVENTION, V48
   Haas B, 2012, CAN J SURG, V55, P21, DOI 10.1503/cjs.017510
   Hartensuer R, 2015, Z ORTHOP UNFALL
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Loftis KL, 2016, TRAFFIC INJ PREV, V17, P1, DOI 10.1080/15389588.2016.1191069
   MacKenzie E, 1997, ICDMAP 90 USERS GUID
   MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008
   Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009
   Palmer Cameron, 2007, Annu Proc Assoc Adv Automot Med, V51, P13
   Palmer CS, 2016, INJURY, V47, P109, DOI 10.1016/j.injury.2015.07.003
   Palmer CS, 2010, INJURY, V41, P948, DOI 10.1016/j.injury.2009.12.016
   SEMMLOW JL, 1976, HEALTH SERV RES, V11, P45
   Stewart KE, 2011, INJURY, V42, P934, DOI 10.1016/j.injury.2010.05.033
   Tohira H, 2011, J TRAUMA, V71, P1829, DOI 10.1097/TA.0b013e31823cc5c5
   Tohira H, 2011, J TRAUMA, V71, P56, DOI 10.1097/TA.0b013e31821e5a25
   Zonfrillo MR, 2015, TRAFFIC INJ PREV, V16, pS197, DOI 10.1080/15389588.2015.1054987
NR 27
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 1
PY 2019
VL 14
IS 5
AR e0216206
DI 10.1371/journal.pone.0216206
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HW0KS
UT WOS:000466370200062
PM 31042768
OA DOAJ Gold
DA 2019-07-16
ER

PT J
AU Antes, AL
   Kuykendall, A
   DuBois, JM
AF Antes, Alison L.
   Kuykendall, Ashley
   DuBois, James M.
TI The lab management practices of "Research Exemplars" that foster
   research rigor and regulatory compliance: A qualitative study of
   successful principal investigators
SO PLOS ONE
LA English
DT Article
ID PSYCHOLOGICAL SAFETY; RESPONSIBLE CONDUCT; DECISION-MAKING; MEDIATING
   ROLE; LEADERSHIP; SCIENTISTS; COGNITION; SCIENCE; ETHICS; ENOUGH
AB Introduction
   Conducting rigorous scientific inquiry within the bounds of research regulation and acceptable practice requires a principal investigator to lead and manage research processes and personnel. This study explores the practices used by investigators nominated as exemplars of research excellence and integrity to produce rigorous, reproducible research and comply with research regulations.
   Methods
   Using a qualitative research design, we interviewed 52 principal investigators working in the United States at top research universities and the National Institutes of Health Intramural Research Program. We solicited nominations of researchers meeting two criteria: (1) they are federally-funded researchers doing high-quality, high-impact research, and (2) have reputations for professionalism and integrity. Each investigator received an initial nomination addressing both criteria and at least one additional endorsement corroborating criteria 2. A panel of researchers and our research team reviewed the nominations to select finalists who were invited to participate. The cohort of "Research Exemplars" includes highly accomplished researchers in diverse scientific disciplines. The semi-structured interview questions asked them to describe the routine practices they employ to foster rigor and regulatory compliance. We used inductive thematic analysis to identify common practices.
   Results
   The exemplars identified a core set of 8 practices and provided strategies for employing them. The practices included holding regular team meetings, encouraging shared ownership, providing supervision, ensuring adequate training, fostering positive attitudes about compliance, scrutinizing data and findings, and following standard operating procedures. Above all, the use of these practices aim to create a psychologically safe work environment in which lab members openly collaborate to scrutinize their work and share in accountability for rigorous, compliant research.
   Conclusions
   Researchers typically receive limited systematic training in how to lead and manage their research teams. Training and education for principal investigators should include essential leadership and management practices and strategies that support doing high-quality research with integrity.
C1 [Antes, Alison L.; Kuykendall, Ashley; DuBois, James M.] Washington Univ, Sch Med, Div Gen Med Sci, St Louis, MO 63130 USA.
RP Antes, AL (reprint author), Washington Univ, Sch Med, Div Gen Med Sci, St Louis, MO 63130 USA.
EM aantes@wustl.edu
FU National Human Genome Research Institute [K01HG008990]; U.S. Office of
   Research Integrity [IR170030-01-00]; National Center for Advancing
   Translational Sciences Award [UL1 TR002345]
FX This study was funded by the National Human Genome Research Institute
   (K01HG008990 to ALA). This work also received support from the U.S.
   Office of Research Integrity (IR170030-01-00 to JMD) and a National
   Center for Advancing Translational Sciences Award (UL1 TR002345). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Allchin D., 1999, SCI ED, V8, P1, DOI DOI 10.1023/A:1008600230536
   Anderson MS, 2007, J EMPIR RES HUM RES, V2, P3, DOI 10.1525/JERHRE.2007.2.4.3
   [Anonymous], 2010, NAT CELL BIOL, V12, P101, DOI 10.1038/ncb0210-101
   [Anonymous], 2017, PRESIDENT SIGNS OMNI
   Antes AL, 2007, J EMPIR RES HUM RES, V2, P15, DOI [10.1525/jer.2007.2.4.15, 10.1525/JERHRE.2007.2.4.15]
   Antes AL, 2018, MOL CELL, V72, P207, DOI 10.1016/j.molcel.2018.09.015
   Antes AL, 2016, J EMPIR RES HUM RES, V11, P408, DOI 10.1177/1556264616668775
   Antes AL, 2016, ACCOUNT RES, V23, P288, DOI 10.1080/08989621.2016.1171149
   Antes AL, 2011, ADV DEV HUM RESOUR, V13, P318, DOI 10.1177/1523422311424710
   Antes AL, 2012, LEADERSHIP QUART, V23, P425, DOI 10.1016/j.leaqua.2011.10.001
   Baer M, 2003, J ORGAN BEHAV, V24, P45, DOI 10.1002/job.179
   Baker M, 2016, NATURE, V529, P456, DOI 10.1038/529456a
   Begley CG, 2015, NATURE, V525, P25, DOI 10.1038/525025a
   Bennett L. M., 2018, COLLABORATION TEAM S
   Bird SJ, 2001, SCI ENG ETHICS
   Carmeli A, 2014, J CREATIVE BEHAV, V48, P115, DOI 10.1002/jocb.43
   Carmeli A, 2010, CREATIVITY RES J, V22, P250, DOI 10.1080/10400419.2010.504654
   Centers for Disease Control and Prevention, 2018, CS283043B CTR DIS CO
   Cooke N. J, 2015, ENHANCING EFFECTIVEN
   Corbin J. M., 2015, BASICS QUALITATIVE R
   D'Innocenzo L, 2016, J MANAGE, V42, P1964, DOI 10.1177/0149206314525205
   De Vries R, 2006, J EMPIR RES HUM RES, V1, P43, DOI 10.1525/jer.2006.1.1.43
   DuBois JM, 2018, ACAD MED, V93, P550, DOI 10.1097/ACM.0000000000001966
   DuBois JM, 2018, ACAD MED, V93, P586, DOI 10.1097/ACM.0000000000001804
   DuBois JM, 2016, NATURE, V534, P173, DOI 10.1038/534173a
   DuBois JM, 2016, SCI ENG ETHICS, V22, P391, DOI 10.1007/s11948-015-9667-8
   DuBois JM, 2004, ETHICS BEHAV, V14, P383, DOI 10.1207/s15327019eb1404_8
   Edmondson AC, 2014, ANNU REV ORGAN PSYCH, V1, P23, DOI 10.1146/annurev-orgpsych-031413-091305
   Else H, 2018, NATURE, V563, P616, DOI 10.1038/d41586-018-07532-5
   Feist G J, 1998, Pers Soc Psychol Rev, V2, P290, DOI 10.1207/s15327957pspr0204_5
   Friedrich TL, 2009, LEADERSHIP QUART, V20, P933, DOI 10.1016/j.leaqua.2009.09.008
   Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903
   HARRIS SG, 1994, ORGAN SCI, V5, P309, DOI 10.1287/orsc.5.3.309
   Hermanowicz JC, 2006, SCI TECHNOL HUM VAL, V31, P135, DOI 10.1177/0162243905283637
   Institute of Medicine, 2013, CTSA PROGR NIH OPP A
   International Conference on Harmonisation, 2016, GOOD CLIN PRACT ICH
   Jefcoat AM, 2008, LAB ANIMAL, V37, P459, DOI 10.1038/laban1008-459
   Jena GB, 2017, REGUL TOXICOL PHARM, V89, P20, DOI 10.1016/j.yrtph.2017.07.010
   Kalichman MW, 2007, ACAD MED, V82, P870, DOI 10.1097/ACM.0b013e31812f77fe
   Lambert LS, 2012, J APPL PSYCHOL, V97, P913, DOI 10.1037/a0028970
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lawrence KA, 2009, LEADERSHIP QUART, V20, P87, DOI 10.1016/j.leaqua.2009.01.014
   Mumford MA, 2005, CREATIVITY RES J, V17, P105, DOI 10.1207/s15326934crj1702&3_1
   Mumford MD, 2013, ROUT STUD INNOV ORG, V29, P29
   Munafo MR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0021
   National Academy of Science, 2009, BEING SCI GUID RESP
   National Institutes of Health, 2018, BUDG 2018
   Norris D, 2018, NATURE, V557, P302, DOI 10.1038/d41586-018-05146-5
   Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374
   Robledo IC, 2012, J ORGAN BEHAV, V33, P140, DOI 10.1002/job.739
   Saldana J, 2016, CODING MANUAL QUALIT
   Schreier AA, 2006, ACAD MED, V81, P42, DOI 10.1097/00001888-200601000-00010
   Seeliger JC, 2012, NATURE, V483, P511, DOI 10.1038/483511a
   Shamoo A. E., 2015, RESPONSIBLE CONDUCT
   SocioCultural Research Consultants, 2018, DED VERS 8 0 35 WEB
   Sonstein SA, 2014, CLIN RES, V28, P17, DOI DOI 10.14524/CR-14-00002R1
   Steneck N. H., 2007, ORI INTRO RESPONSIBL
   van der Rijt J, 2012, HUM RESOUR DEV Q, V23, P233, DOI 10.1002/hrdq.21129
   Van Noorden R, 2018, NATURE, V557, P294, DOI 10.1038/d41586-018-05143-8
   Vessey WB, 2014, LEADERSHIP QUART, V25, P672, DOI 10.1016/j.leaqua.2014.03.001
   Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18
   Yukl G, 2005, ORGAN DYN, V34, P361, DOI 10.1016/j.orgdyn.2005.08.004
   Yukl G, 2013, LEADERSHIP ORG
NR 63
TC 1
Z9 1
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 24
PY 2019
VL 14
IS 4
AR e0214595
DI 10.1371/journal.pone.0214595
PG 29
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HU6FU
UT WOS:000465375400019
PM 31017929
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Renzi, A
   De Bonis, P
   Morandi, L
   Lenzi, J
   Tinto, D
   Rigillo, A
   Bettini, G
   Bellei, E
   Sabattini, S
AF Renzi, Andrea
   De Bonis, Paola
   Morandi, Luca
   Lenzi, Jacopo
   Tinto, Debora
   Rigillo, Antonella
   Bettini, Giuliano
   Bellei, Emma
   Sabattini, Silvia
TI Prevalence of p53 dysregulations in feline oral squamous cell carcinoma
   and non-neoplastic oral mucosa
SO PLOS ONE
LA English
DT Article
ID IMMUNOHISTOCHEMICAL DETECTION; HEAD; GENE; EXPRESSION; PROTEIN;
   MUTATIONS; CATS; COMPLEXITY; ANTIBODIES; DISEASE
AB Squamous cell carcinoma is the most common malignant oral tumor in cats. The late presentation is one of the factors contributing to the detrimental prognosis of this disease. The immunohistochemical expression of the p53 tumor suppressor protein has been reported in 24% to 65% of feline oral squamous cell carcinomas, but no study has systematically evaluated in this tumor the presence of p53 encoding gene (TP53) mutations. The aim of this retrospective study was to determine whether p53 immunohistochemistry accurately reflects the mutational status of the TP53 gene in feline oral squamous cell carcinoma. Additionally, the prevalence of p53 dysregulation in feline oral squamous cell carcinoma was compared with that of feline non-neoplastic oral mucosa, in order to investigate the relevance of these dysregulations in cancer development. The association between p53 dysregulations and exposure to environmental tobacco smoke and tumor characteristics was further assessed.
   Twenty-six incisional biopsies of oral squamous cell carcinomas and 10 cases each of lingual eosinophilic granuloma, chronic gingivostomatitis and normal oral mucosa were included in the study. Eighteen squamous cell carcinomas (69%) expressed p53 and 18 had mutations in exons 5-8 of TP53. The agreement between immunohistochemistry and mutation analysis was 77%. None of non-neoplastic oral mucosa samples had a positive immunohistochemical staining, while one case each of eosinophilic granuloma and chronic gingivostomatitis harbored TP53 mutations. Unlike previously hypothesized, p53 dysregulations were not associated with exposure to environmental tobacco smoke. These results suggest an important role of p53 in feline oral tumorigenesis. Additionally, the immunohistochemical detection of p53 expression appears to reflect the presence of TP53 mutations in the majority of cases. It remains to be determined if the screening for p53 dysregulations, alone or in association with other markers, can eventually contribute to the early detection of this devastating disease.
C1 [Renzi, Andrea; De Bonis, Paola; Tinto, Debora; Rigillo, Antonella; Bettini, Giuliano; Bellei, Emma; Sabattini, Silvia] Univ Bologna, Dept Vet Med Sci, Bologna, Italy.
   [Morandi, Luca] Univ Bologna, Bellaria Hosp, Dept Biomed & Neuromotor Sci, M Malpighi Sect Anat Pathol, Bologna, Italy.
   [Lenzi, Jacopo] Univ Bologna, Dept Biomed & Neuromotor Sci, Sect Hyg Publ Hlth & Med Stat, Bologna, Italy.
RP Sabattini, S (reprint author), Univ Bologna, Dept Vet Med Sci, Bologna, Italy.
EM silvia.sabattini@unibo.it
RI Lenzi, Jacopo/W-4835-2017; Morandi, Luca/A-3191-2016
OI Lenzi, Jacopo/0000-0003-2882-4223; Sabattini,
   Silvia/0000-0001-7005-2736; Morandi, Luca/0000-0002-3810-9760
FU University of Bologna
FX This study was supported by an academic grant (ALMAIDEA) from the
   University of Bologna. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Albaric O, 2001, HISTOL HISTOPATHOL, V16, P113, DOI 10.14670/HH-16.113
   BAAS IO, 1994, J PATHOL, V172, P5, DOI 10.1002/path.1711720104
   Bertone ER, 2003, J VET INTERN MED, V17, P557, DOI 10.1892/0891-6640(2003)017<0557:EALRFF>2.3.CO;2
   Bilgic O, 2015, J VET DENT, V32, P30, DOI 10.1177/089875641503200104
   BOYLE JO, 1994, AM J SURG, V168, P429, DOI 10.1016/S0002-9610(05)80092-3
   BRENNAN JA, 1995, NEW ENGL J MED, V332, P712, DOI 10.1056/NEJM199503163321104
   Cruz IB, 1998, J PATHOL, V184, P360
   FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7
   Gasco M, 2003, ORAL ONCOL, V39, P222, DOI 10.1016/S1368-8275(02)00163-X
   Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973
   Goldschmidt MH, 2017, TUMORS DOMESTIC ANIM, P97
   Hayes AM, 2007, J SMALL ANIM PRACT, V48, P394, DOI 10.1111/j.1748-5827.2007.00393.x
   HUTSON CA, 1992, J AM VET MED ASSOC, V201, P777
   IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B
   Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028
   Kumar V, 2015, ROBBINS COTRANS PATH, P290
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925
   Liptak JM, 2013, WITHROW MACEWENS SMA, P381
   Marconato L, 2013, VET COMP ONCOL, V11, P101, DOI 10.1111/j.1476-5829.2011.00304.x
   Mayr B, 2000, RES VET SCI, V68, P63, DOI 10.1053/rvsc.1999.0339
   Meuten DJ, 2016, VET PATHOL, V53, P7, DOI 10.1177/0300985815593349
   Morandi L, 2017, ENDOCR-RELAT CANCER, V24, P107, DOI 10.1530/ERC-16-0546
   Munday JS, 2012, VET PATHOL, V49, P538, DOI 10.1177/0300985811419534
   Munday JS, 2019, J FELINE MED SURG, V21, P409, DOI 10.1177/1098612X18808105
   Munday JS, 2017, TUMORS DOMESTIC ANIM, P503
   Nambiar PR, 2001, VET PATHOL, V38, P236, DOI 10.1354/vp.38-2-236
   Nasir L, 2000, CANCER LETT, V155, P1, DOI 10.1016/S0304-3835(00)00337-2
   Nemec A, 2012, J COMP PATHOL, V147, P111, DOI 10.1016/j.jcpa.2011.11.198
   Partridge M, 2007, INT J ORAL MAX SURG, V36, P1123, DOI 10.1016/j.ijom.2007.06.006
   Peltonen JK, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-36
   Piegols Hunter John, 2018, Oncotarget, V9, P33098, DOI 10.18632/oncotarget.26006
   REEVES NCP, 1993, J AM ANIM HOSP ASSOC, V29, P438
   Snyder LA, 2004, VET PATHOL, V41, P209, DOI 10.1354/vp.41-3-209
   STEBBINS KE, 1989, VET PATHOL, V26, P121, DOI 10.1177/030098588902600204
   Supsavhad W., 2016, Veterinary Sciences, V3, P18, DOI 10.3390/vetsci3030018
   Tannehill-Gregg SH, 2006, VET COMP ONCOL, V4, P84, DOI 10.1111/j.1476-5810.2006.00096.x
   Taylor D, 1999, HUM PATHOL, V30, P1221, DOI 10.1016/S0046-8177(99)90041-2
   Teifke JP, 1996, J COMP PATHOL, V114, P205, DOI 10.1016/S0021-9975(96)80010-7
   Wypij Jackie M, 2013, Patholog Res Int, V2013, P502197, DOI 10.1155/2013/502197
   Zacchetti A, 2007, VET COMP ONCOL, V5, P108, DOI 10.1111/j.1476-5829.2006.00120.x
   Zhou G, 2016, J CELL BIOCHEM, V117, P2682, DOI 10.1002/jcb.25592
NR 43
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 18
PY 2019
VL 14
IS 4
AR e0215621
DI 10.1371/journal.pone.0215621
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HU1EQ
UT WOS:000465015500086
PM 30998743
OA DOAJ Gold
DA 2019-07-16
ER

PT J
AU Beard, E
   West, R
   Lorencatto, F
   Gardner, B
   Michie, S
   Owens, L
   Shahab, L
AF Beard, Emma
   West, Robert
   Lorencatto, Fabiana
   Gardner, Ben
   Michie, Susan
   Owens, Lesley
   Shahab, Lion
TI What do cost-effective health behaviour-change interventions contain? A
   comparison of six domains
SO PLOS ONE
LA English
DT Article
ID PHYSICAL-ACTIVITY; SMOKING-CESSATION; IMPLEMENTATION INTENTIONS;
   EFFECTIVENESS THRESHOLD; DECISION-MAKING; ALCOHOL; PREVENTION; OBESITY;
   CARE; METAANALYSIS
AB Objectives
   To help implement behaviour change interventions (BCIs) in practice it is important to be able to characterize their key components. This study compared broad features of cost-effective BCIs that addressed smoking, diet, physical activity, alcohol and sexual health. It also assessed the association of these with the magnitude of the cost-effectiveness estimates.
   Methods
   A content analysis of 79 interventions based on 338 intervention descriptions was conducted, using the Behaviour Change Wheel (BCW) to classify intervention content in terms of intervention functions, and the BCT taxonomy to identify and categorise component Behaviour Change Techniques (BCT). Regression analysis identified the association of these with upper (pessimistic) and lower (optimistic) cost-effectiveness estimates.
   Results
   The most and least common functions and BCT clusters were education (82.3%) and shaping knowledge (79.7%), and coercion (3.8%) and covert learning (2.5%). Smoking interventions contained the largest ((M) over bar = 12) number of BCTs and were most cost-effective. Several other factors were associated with worse (coercion(function) beta(upper) = 36551.24; shaping knowledge(BCT) beta(lower) = 2427.78; comparison of outcomes(BCT) beta(upper) = 9067.32; repetition and substitution(BCT) beta(upper) = 7172.47) and better (modelling(function) beta(lower) = -2905.3; environmental restructuring(function) beta(upper) = -8646.28; reward and threat(BCT) beta(upper) = -5577.59) cost-effectiveness (p< 0.05).
   Discussion
   Cost-effective BCIs rely heavily on education with smoking interventions exhibiting the most comprehensive range of BCTs. Providing an example to aspire to, restructuring the environment and rewarding positive behaviour may be associated with greater cost-effectiveness.
C1 [Beard, Emma; West, Robert; Shahab, Lion] UCL, Dept Behav Sci & Hlth, London, England.
   [Lorencatto, Fabiana; Michie, Susan] UCL, Ctr Outcomes Res & Effectiveness, Dept Clin Educ & Hlth Psychol, London, England.
   [Gardner, Ben] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England.
   [Owens, Lesley] NICE, Natl Inst Hlth & Care Excellence, London, England.
RP Beard, E (reprint author), UCL, Dept Behav Sci & Hlth, London, England.
EM e.beard@ucl.ac.uk
OI Beard, Emma/0000-0001-8586-1261
FU UK's National Institute for Health and Care Excellence (NICE)
FX This study was funded by the UK's National Institute for Health and Care
   Excellence (NICE).
CR Abraham C, 2009, PSYCHOL HEALTH MED, V14, P1, DOI 10.1080/13548500802537903
   [Anonymous], 2013, UNPR NAT FIN EC IMP
   Appleby J, 2007, BRIT MED J, V335, P358, DOI 10.1136/bmj.39308.560069.BE
   Baban A, 2007, J COGN BEHAV PSYCHOT, V7, P45
   Bailey JV, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006483.pub2
   Bandura A., 1977, SOCIAL LEARNING THEO
   Beard E, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3862-7
   CAHILL K, 2008, NICOTINE RECEPTOR PA
   CLARKE GN, 1995, J CONSULT CLIN PSYCH, V63, P718, DOI 10.1037/0022-006X.63.5.718
   Contreary KA, 2015, AM J PREV MED, V49, P800, DOI [10.1016/j.amepre.2015.04.026, 10.1016/j.amepre.2015.03.041]
   Craig P, 2018, TAKING ACCOUNT CONTE
   Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655
   de Vocht F, 2016, J EPIDEMIOL COMMUN H, V70, P231, DOI 10.1136/jech-2015-206040
   Dobbins M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651.pub2
   Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x
   Elliott DS, 2004, PREV SCI, V5, P47, DOI 10.1023/B:PREV.0000013981.28071.52
   Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202
   Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822
   Forbes CA, 2002, INTERVENTIONS TARGET
   Fulton EA, 2016, HEALTHCARE
   Gerrard M, 2005, HEALTH PSYCHOL, V24, P623, DOI 10.1037/0278-6133.24.6.623
   Glazier RH, 2006, DIABETES CARE, V29, P1675, DOI 10.2337/dc05-1942
   Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1013/S0065-2601(06)38002-1
   Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493
   Gordon L, 2007, CHRONIC ILLN, V3, P101, DOI 10.1177/1742395307081732
   Hackshaw L, 2010, TOB CONTROL, V19, P160, DOI 10.1136/tc.2009.032656
   Hartmann-Boyce J, 2014, OBES REV, V15, P598, DOI 10.1111/obr.12165
   HENDERSON DA, 1989, PSYCHOL REP, V64, P251, DOI 10.2466/pr0.1989.64.1.251
   Holmes J, 2014, LANCET, V383, P1655, DOI 10.1016/S0140-6736(13)62417-4
   Husereau D, 2013, VALUE HEALTH, P16
   Husereau Don, 2013, Cost Eff Resour Alloc, V11, P6, DOI 10.1186/1478-7547-11-6
   Jagdeo T P, 1996, Promot Educ, V3, P11, DOI 10.1177/102538239600300305
   Johnston M, 2016, BRIT J HEALTH PSYCH, V21, P1, DOI 10.1111/bjhp.12165
   Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub3
   Kelly-Weeder Susan, 2011, Patient Intell, V2011, P29
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langley T, 2013, EUROPEAN J PUBLIC S1, V23
   Langley T, 2014, ADDICTION, V109, P995, DOI 10.1111/add.12448
   LeBel EP, 2011, REV GEN PSYCHOL, V15, P371, DOI 10.1037/a0025172
   Lesser LI, 2007, PLOS MED, V4, P41, DOI 10.1371/journal.pmed.0040005
   Lewis-Beck MS, 1978, POLITICAL METHODOLOG, P213
   Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167
   Li J, 2017, SOC SCI MED, V177, P177, DOI 10.1016/j.socscimed.2017.01.037
   Litt DM, 2012, J STUD ALCOHOL DRUGS, V73, P961, DOI 10.15288/jsad.2012.73.961
   Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705
   Lorencatto F, 2013, NICOTINE TOB RES, V15, P1273, DOI 10.1093/ntr/nts266
   Makic MBF, 2011, CRIT CARE NURSE, V31, P38, DOI 10.4037/ccn2011908
   Martin J, 2013, INT J OBESITY, V37, P1287, DOI 10.1038/ijo.2013.107
   Mc Sharry J, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0493-4
   McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004
   Michie S, 2014, BEHAV CHANGE WHEEL G
   Michie S, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0641-5
   Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6
   Michie S, 2013, HEALTH PSYCHOL REV, V7, P1, DOI 10.1080/17437199.2011.649445
   Michie S, 2012, ADDICTION, V107, P1431, DOI 10.1111/j.1360-0443.2012.03845.x
   Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42
   Michie S, 2011, ADDICT BEHAV, V36, P315, DOI 10.1016/j.addbeh.2010.11.016
   Michie S, 2010, HEALTH PSYCHOL, V29, P1, DOI 10.1037/a0016939
   Michie S, 2009, HEALTH PSYCHOL, V28, P690, DOI 10.1037/a0016136
   Nash R, 2010, COUGH BALANCING TOBA
   National Institute for Health and Care Excellence, 2006, SMOK WORKPL INT PH5
   National Institute for Health and Care Excellence, 2008, MAT CHILD NUTR PH11
   National Institute for Health and Care Excellence, 2009, PHYS ACT CHILDR YOUN
   National Institute for Health and Care Excellence, 2008, PHYS ACT WORKPL PH13
   National Institute for Health and Care Excellence, 2006, 4 COMM US METH INCR
   National Institute for Health and Care Excellence, 2010, CARD DIS PREV PH25
   National Institute for Health and Care Excellence, 2010, ALC USE DIS PREV PH2
   National Institute for Health and Care Excellence, 2008, STOP SMOK SEV PH10
   National Institute for Health and Care Excellence, 2011, HIV TEST INCR UPT BL
   National Institute for Health and Care Excellence, 2013, BEH CHANG IND APPR P
   National Institute for Health and Care Excellence, 2007, BEH CHANG GEN APPR P
   National Institute for Health and Care Excellence, 2010, WEIGHT MAN PREGN PH2
   National Institute for Health and Care Excellence, 2011, TYP 2 DIAB PREV POP
   National Institute for Health and Care Excellence, 2006, BRIEF INT REF SMOK C
   National Institute for Health and Care Excellence, 2007, SEX TRANSM INF 18 CO
   National Institute for Health and Care Excellence, 2008, PHYS ACT ENV PH8
   National Institute of Health and Care Excellence, 2008, CARD DIS ID SUPP PEO
   NHS National Treatment Agency for Substance Misuse, 2013, ALC TREATM ENGL 2011
   NICE, 2007, BEH CHANG POP COMM I
   Olusegun A. M., 2015, AM J THEOR APPL STAT, V4, P414, DOI [5, DOI 10.11648/J.AJTAS.20150405.22]
   Parrott S, 2000, TOB CONTROL, V9, P187, DOI 10.1136/tc.9.2.187
   Prochaska JJ, 2011, AM J LIFESTYLE MED, V5, P208, DOI 10.1177/1559827610391883
   Raftery J, 1999, J EVAL CLIN PRACT, V5, P361, DOI 10.1046/j.1365-2753.1999.00179.x
   Richard H, 2008, NUDGE IMPROVING DECI
   Robinson KA, 2011, FRAMEWORKS DETERMINI
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403
   Rueda-Clausen CF, 2014, BMJ-BRIT MED J, P348
   Sarafino EP, 2001, BEHAV MODIFICATION
   Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033
   Shaw K, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003818.pub2
   Sheikh I, 1998, PATIENT EDUC COUNS, V35, P35, DOI 10.1016/S0738-3991(98)00081-0
   Shepherd J, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14070
   Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339
   SKINNER BF, 1963, AM PSYCHOL, V18, P503, DOI 10.1037/h0045185
   Stead LF, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009670.pub3
   Suntornsut P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004823
   Sweet SN, 2010, INT J ENV RES PUB HE, V7, P1720, DOI 10.3390/ijerph7041720
   Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187
   Tombor I, 2016, TRANSL BEHAV MED, V6, P533, DOI 10.1007/s13142-016-0438-0
   Tombor I, 2013, DRUG ALCOHOL DEPEN, V133, P740, DOI 10.1016/j.drugalcdep.2013.09.001
   Towse A, 2002, COST EFFECTIVENESS T
   van Duijvenbode DC, 2009, INT J OBESITY, V33, P807, DOI 10.1038/ijo.2009.121
   Walker S., 1984, LEARNING THEORY BEHA
   Warner KE, 1999, TOB CONTROL, V8, P290, DOI 10.1136/tc.8.3.290
   Webb J, 2016, PUBLIC HEALTH, V133, P45, DOI 10.1016/j.puhe.2015.12.009
   West R, 2013, BMJ-BRIT MED J, P347
   West R, 2013, ADDICT PRESS SER, P1
   Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x
   YUKL G, 1972, J APPL PSYCHOL, V56, P19, DOI 10.1037/h0032137
NR 109
TC 0
Z9 0
U1 3
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 17
PY 2019
VL 14
IS 4
AR e0213983
DI 10.1371/journal.pone.0213983
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HU1CQ
UT WOS:000465010000012
PM 30995224
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Barlati, S
   Stefana, A
   Bartoli, F
   Bianconi, G
   Bulgari, V
   Candini, V
   Carra, G
   Cavalera, C
   Clerici, M
   Cricelli, M
   Ferla, MT
   Ferrari, C
   Iozzino, L
   Macis, A
   Vita, A
   de Girolamo, G
   Bava, M
   Conte, G
   Micheletti, L
   Negri, PV
   Ornaghi, A
   Turrina, C
AF Barlati, Stefano
   Stefana, Alberto
   Bartoli, Francesco
   Bianconi, Giorgio
   Bulgari, Viola
   Candini, Valentina
   Carra, Giuseppe
   Cavalera, Cesare
   Clerici, Massimo
   Cricelli, Marta
   Ferla, Maria Teresa
   Ferrari, Clarissa
   Iozzino, Laura
   Macis, Ambra
   Vita, Antonio
   de Girolamo, Giovanni
   Bava, Mattia
   Conte, Giovanni
   Micheletti, Luca
   Negri, Paola Vittorina
   Ornaghi, Alessandra
   Turrina, Cesare
CA VIORMED-2 Grp
TI Violence risk and mental disorders (VIORMED-2): A prospective
   multicenter study in Italy
SO PLOS ONE
LA English
DT Article
ID PSYCHIATRIC RATING-SCALE; PERSONALITY-DISORDERS; PSYCHOMETRIC MEASURES;
   AGGRESSION; BEHAVIOR; PSYCHOSIS; PEOPLE; METAANALYSIS; VALIDATION;
   FACILITIES
AB Background
   The management of mentally ill offenders in the community is one of the great challenges imposed on community psychiatry.
   Aim
   The aim of this study was to analyze the association between sociodemographic, clinical, and psychosocial factors and violent behavior in a sample of outpatients with severe mental disorders.
   Method
   This was a prospective cohort study with a baseline cross-sectional design used to provide a detailed analysis of patients' profiles, followed by a longitudinal design to measure aggressive and violent behavior during a 1-year follow-up. Patients with severe mental disorders, with or without a history of violence, were enrolled in four Italian Departments of Mental Health and underwent a comprehensive multidimensional assessment.
   Results
   The sample included 247 outpatients, for a total of 126 cases and 121 controls. Compared to controls, patients with a history of violence had a greater frequency of lifetime domestic violence, a greater lifetime propensity to misuse substances, and a higher number of compulsory admissions. The forthnightly monitoring during the 1-year follow-up did show statistically significant differences in aggressive and violent behavior rates between the two groups. Verbal aggression was significantly associated with aggression against objects and physical aggression. Moreover, outpatients with an history of violence showed statistically significant higher MOAS scores compared to both residential patients with an history of violence, assessed in the first wave of this project, and all controls.
   Conclusions
   Patients with a history of violence had specific characteristics and showed a greater occurrence of additional community violence during a 1-year observation period. Our results may assist clinicians in implementing standardized methods of patient assessment and violence monitoring in outpatient mental health services and may prompt improved collaboration between different community services.
C1 [Barlati, Stefano; Stefana, Alberto; Vita, Antonio] ASST Spedali Civili Brescia, Dept Mental Hlth & Addict Serv, Brescia, Italy.
   [Barlati, Stefano; Vita, Antonio] Univ Brescia, Dept Clin & Expt Sci, Brescia, Italy.
   [Bartoli, Francesco; Carra, Giuseppe; Clerici, Massimo] Univ Milano Bicocca, Dept Med & Surg, Monza, Italy.
   [Bianconi, Giorgio] ASST Ovest Milanese, Dept Mental Hlth, Milan, Italy.
   [Bulgari, Viola; Candini, Valentina; Cavalera, Cesare; Iozzino, Laura; de Girolamo, Giovanni] IRCCS Ist Ctr San Giovanni di Dio Fatebenefratell, Unit Epidemiol & Evaluat Psychiat, Brescia, Italy.
   [Cavalera, Cesare] Univ Cattolica Sacro Cuore, Dept Psychol, Milan, Italy.
   [Clerici, Massimo] San Gerardo Hosp Monza, Dept Mental Hlth, Monza, Italy.
   [Cricelli, Marta; Ferla, Maria Teresa] ASST Rhodense G Salvini Garbagnate, Dept Mental Hlth, Milan, Italy.
   [Ferrari, Clarissa; Macis, Ambra] IRCCS Ist Ctr San Giovanni di Dio Fatebenefratell, Unit Stat, Brescia, Italy.
RP de Girolamo, G (reprint author), IRCCS Ist Ctr San Giovanni di Dio Fatebenefratell, Unit Epidemiol & Evaluat Psychiat, Brescia, Italy.
EM gdegirolamo@fatebenefratelli.eu
RI Dakanalis, Antonios/I-5105-2013; Stefana, Alberto/C-5954-2016; Bartoli,
   Francesco/K-5755-2016
OI Dakanalis, Antonios/0000-0002-2328-3862; Stefana,
   Alberto/0000-0002-4807-7184; Vita, Antonio/0000-0002-3621-6394; Clerici,
   Massimo/0000-0001-8769-6474; Bartoli, Francesco/0000-0003-2612-4119;
   Macis, Ambra/0000-0003-0281-8570
FU Health Authority of Regione Lombardia, Italy [CUP E42I14000280002, 6848]
FX The VIORMED-2 (Violence Risk and Mental Disorder 2) project was funded
   by the Health Authority of Regione Lombardia, Italy, grant CUP
   E42I14000280002 for "Disturbi mentali gravi e rischio di violenza: uno
   studio prospettico in Lombardia" with Decreto D.G. Salute N. 6848, date
   16.7.2014.
CR Amore M, 2013, COMMUNITY MENT HLT J, V49, P451, DOI 10.1007/s10597-012-9530-1
   Appelbaum PS, 2000, AM J PSYCHIAT, V157, P566, DOI 10.1176/appi.ajp.157.4.566
   Barbui C, 2015, BRIT J PSYCHIAT, V206, P445, DOI 10.1192/bjp.bp.114.153817
   BARRATT ES, 1965, PSYCHOL REP, V16, P547, DOI 10.2466/pr0.1965.16.2.547
   BROWN GL, 1979, PSYCHIAT RES, V1, P131, DOI 10.1016/0165-1781(79)90053-2
   Brucato G, 2018, NEUROPSYCHOPHARMACOL, V43, P264, DOI 10.1038/npp.2017.151
   Bulgari V, 2018, AGGRESS VIOLENT BEH, V41, P119, DOI 10.1016/j.avb.2018.06.002
   BUSS AH, 1957, J CONSULT PSYCHOL, V21, P343, DOI 10.1037/h0046900
   Capuzzi E, 2019, INT J LAW PSYCHIAT, V62, P90, DOI 10.1016/j.ijlp.2018.11.003
   Carli V, 2010, J AFFECT DISORDERS, V123, P116, DOI 10.1016/j.jad.2010.02.119
   Catanesi R, 2007, PUGLIA BASILICATA RA, VI, P63
   Chang WC, 2015, AUST NZ J PSYCHIAT, V49, P914, DOI 10.1177/0004867415603130
   Coid JW, 2016, SCHIZOPHRENIA BULL, V42, P907, DOI 10.1093/schbul/sbw006
   Coid JW, 2013, JAMA PSYCHIAT, V70, P465, DOI 10.1001/jamapsychiatry.2013.12
   Dazzi F, 2016, J PSYCHIATR RES, V81, P140, DOI 10.1016/j.jpsychires.2016.07.001
   de Girolamo G, 2007, EUR ARCH PSY CLIN N, V257, P83, DOI 10.1007/s00406-006-0695-x
   de Girolamo G, 2016, J PSYCHIATR RES, V80, P5, DOI 10.1016/j.jpsychires.2016.05.010
   De Luca V, 2018, INT J RISK RECOVER, V1
   Dolan M, 2004, J FORENSIC PSYCHI PS, V15, P426, DOI 10.1080/14789940410001721048
   Evans L, 2015, J CRIM PSYCHOL, V5, P1, DOI 10.1108/JCP-10-2014-0015
   Ferracuti S, 2019, INT J LAW PSYCHIAT, V62, P45, DOI 10.1016/j.ijlp.2018.10.003
   First MB, 2002, STRUCTURED CLIN INTE
   First MB, 1997, STRUCTURED CLIN INTE
   Fond G, 2017, SCHIZOPHR RES, V182, P84, DOI 10.1016/j.schres.2016.10.023
   Iozzino L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128536
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lievaart M, 2016, J CLIN PSYCHOL, V72, P263, DOI 10.1002/jclp.22253
   Maffei C, 1997, J PERS DISORD, V11, P279, DOI 10.1521/pedi.1997.11.3.279
   Margari F, 2005, INT J METH PSYCH RES, V14, P109, DOI 10.1002/mpr.22
   Mauri MC, 2011, PROG NEURO-PSYCHOPH, V35, P1631, DOI 10.1016/j.pnpbp.2011.05.008
   Montemagni C, 2015, J PSYCHOPATHOL-G PSI, V21, P287
   Picardi A, 2014, J NERV MENT DIS, V202, P451, DOI 10.1097/NMD.0000000000000144
   Pinna F, 2016, INT J LAW PSYCHIAT, V47, P122, DOI 10.1016/j.ijlp.2016.02.015
   Preti A, 2009, PSYCHOL MED, V39, P485, DOI 10.1017/S0033291708003607
   Ramsay J. O., 2005, FUNCTIONAL DATA ANAL
   Rueve Marie E, 2008, Psychiatry (Edgmont), V5, P34
   Singh JP, 2014, BRIT J PSYCHIAT, V204, P180, DOI 10.1192/bjp.bp.113.131938
   Spielberger Charles D., 1985, ANGER HOSTILITY CARD, P5
   Stuart Heather, 2003, World Psychiatry, V2, P121
   Swanson JW, 2006, ARCH GEN PSYCHIAT, V63, P490, DOI 10.1001/archpsyc.63.5.490
   van de Sande R, 2011, BRIT J PSYCHIAT, V199, P473, DOI 10.1192/bjp.bp.111.095141
   van der Veeken FCA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160787
   VENTURA J, 1993, INT J METH PSYCH RES, V3, P221
   Witt K, 2013, PLOS ONE, P8
NR 44
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 16
PY 2019
VL 14
IS 4
AR e0214924
DI 10.1371/journal.pone.0214924
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HT6TE
UT WOS:000464696100017
PM 30990814
OA DOAJ Gold
DA 2019-07-16
ER

PT J
AU Pariyo, GW
   Greenleaf, AR
   Gibson, DG
   Ali, J
   Selig, H
   Labrique, AB
   Al Kibria, GM
   Khan, IA
   Masanja, H
   Flora, MS
   Ahmed, S
   Hyder, AA
AF Pariyo, George W.
   Greenleaf, Abigail R.
   Gibson, Dustin G.
   Ali, Joseph
   Selig, Hannah
   Labrique, Alain B.
   Al Kibria, Gulam Muhammed
   Khan, Iqbal Ansary
   Masanja, Honorati
   Flora, Meerjady Sabrina
   Ahmed, Saifuddin
   Hyder, Adnan A.
TI Does mobile phone survey method matter? Reliability of computer-assisted
   telephone interviews and interactive voice response non-communicable
   diseases risk factor surveys in low and middle income countries
SO PLOS ONE
LA English
DT Article
ID SENSITIVE QUESTIONS; DESIGN; AGREEMENT; MODE; CATI
AB Introduction
   Increased mobile phone subscribership in low- and middle-income countries (LMICs) provides novel opportunities to track population health. The objective of this study was to examine reliability of data in comparing participant responses collected using two mobile phone survey (MPS) delivery modalities, computer assisted telephone interviews (CATI) and interactive voice response (IVR) in Bangladesh (BGD) and Tanzania (TZA).
   Methods
   Using a cross-over design, we used random digit dialing (RDD) to call randomly generated mobile phone numbers and recruit survey participants to receive either a CATI or IVR survey on non-communicable disease (NCD) risk factors, followed 7 days later by the survey mode not received during first contact; either IVR or CATI. Respondents who received the first survey were designated as first contact (FC) and those who consented to being called a second time and subsequently answered the call were designated as follow-up (FU). We used the same questionnaire for both contacts, with response options modified to suit the delivery mode. Reliability of responses was analyzed using the Cohen's kappa statistic for percent agreement between two modes.
   Results
   Self-reported data on demographic characteristics and NCD behavioral risk factors were collected from 482 (CATI-FC) and 653 (IVR-FC) age-eligible and consenting respondents in BGD, and from 387 (CATI-FC) and 674 (IVR-FC) respondents in TZA respectively. Survey follow-up rates were 30.7% (n = 482) for IVR-FU and 53.8% (n = 653) for CATI-FU in BGD; and 42.4% (n = 387) for IVR-FU and 49.9% (n = 674) for CATI-FU in TZA respectively. Overall, there was high consistency between delivery modalities for alcohol consumption in the past 30 days in both countries (kappa = 0.64 for CATI -> IVR (BGD), kappa = 0.54 for IVR -> CATI (BGD); kappa = 0.66 for CATI -> IVR (TZA), kappa = 0.76 for IVR -> CATI (TZA)), and current smoking (kappa = 0.68 for CATI -> IVR (BGD), kappa = 0.69 for IVR -> CATI (BGD); kappa = 0.39 for CATI -> IVR (TZA), kappa = 0.50 for IVR -> CATI (TZA)). There was moderate to substantial consistency in both countries for history of checking for hypertension and diabetes with kappa statistics ranging from 0.43 to 0.67. There was generally lower consistency in both countries for physical activity (vigorous and moderate) with kappa statistics ranging from 0.10 to 0.41, weekly fruit and vegetable with kappa ranging from 0.08 to 0.45, consumption of foods high in salt and efforts to limit salt with kappa generally below 0.3.
   Conclusions
   The study found that when respondents are re-interviewed, the reliability of answers to most demographic and NCD variables is similar whether starting with CATI or IVR. The study underscores the need for caution when selecting questions for mobile phone surveys. Careful design can help ensure clarity of questions to minimize cognitive burden for respondents, many of whom may not have prior experience in taking automated surveys. Further research should explore possible differences and determinants of survey reliability between delivery modes and ideally compare both IVR and CATI surveys to in-person face-to-face interviews. In addition, research is needed to better understand factors that influence survey cooperation, completion, refusal and attrition rates across populations and contexts.
C1 [Pariyo, George W.; Gibson, Dustin G.; Ali, Joseph; Selig, Hannah; Labrique, Alain B.; Al Kibria, Gulam Muhammed; Hyder, Adnan A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.
   [Greenleaf, Abigail R.; Ahmed, Saifuddin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA.
   [Ali, Joseph] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA.
   [Khan, Iqbal Ansary; Flora, Meerjady Sabrina] Inst Epidemiol Dis Control & Res, Dhaka, Bangladesh.
   [Masanja, Honorati] Ifakara Hlth Inst, Dar Es Salaam, Tanzania.
   [Hyder, Adnan A.] George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC USA.
RP Pariyo, GW (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.
EM gpariyo1@jhu.edu
RI Kibria, Gulam Muhammed Al/E-3061-2017; Pariyo, George/K-2335-2017
OI Kibria, Gulam Muhammed Al/0000-0002-7037-6658; Pariyo,
   George/0000-0002-4411-2309
FU Bloomberg Philanthropies [41388.01]
FX This study was made possible by the generous support of Bloomberg
   Philanthropies (https://www.bloomberg.org/) grant no. 41388.01 to AAH
   and the people of Australia through the Department of Foreign Affairs
   and Trade (https://dfat.gov.au/pages/default.aspx). The contents are the
   responsibility of the authors and do not necessarily reflect the views
   of Bloomberg Philanthropies or the Government of Australia. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Ali Joseph, 2019, Glob Public Health, V14, P1167, DOI 10.1080/17441692.2019.1566482
   Ali J, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7326
   Alwin DF, 2016, SOCIOL METHODOL, V46, P121, DOI 10.1177/0081175016641714
   American Association for Public Opinion Research, 2016, STAND DEF FIN DISP C
   Ballivian A, 2015, MOBILE RES METHODS O, P21, DOI 10.5334/bar.c
   Biemer PP, 2010, PUBLIC OPIN QUART, V74, P817, DOI 10.1093/poq/nfq058
   Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031
   Brick JM, 2008, ENCY SURVEY RES METH, P676, DOI [DOI 10.4135/9781412963947, 10.4135/9781412963947]
   Christian LM, 2008, ENCY SURVEY RES METH, P487, DOI [10.4135/9781412963947, DOI 10.4135/9781412963947]
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Corkrey R, 2002, BEHAV RES METH INS C, V34, P354, DOI 10.3758/BF03195463
   Currivan DB, 2008, ENCY SURVEY RES METH, P343, DOI [10.4135/9781412963947, DOI 10.4135/9781412963947]
   Diedhiou A, 2015, GLOB HEALTH, V3, P305, DOI 10.9745/GHSP-D-14-00220
   Figueroa M. E, 2017, J HEAL COMMUN
   Garbarski D, 2015, QUAL LIFE RES, V24, P1443, DOI 10.1007/s11136-014-0861-y
   Gibson DG, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7428
   Gibson DG, 2017, JMIR RES PROTOC, V6, DOI 10.2196/resprot.7534
   Global Adult Tobacco Survey Collaborative Group, 2011, TOB QUEST SURV SUBS
   Green M, 2001, SURVEY RESPONSE PROC
   Greenleaf A., 2018, INTERACTIVE VOICE RE
   Greenleaf AR, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7331
   GROVES RM, 1990, ANNU REV SOCIOL, V16, P221, DOI 10.1146/annurev.so.16.080190.001253
   GSMA, 2015, BRIDG GEND GAP MOB A
   GSMA (b), 2017, GSM ASS, V6, P1
   Haeger H, 2012, ANN FOR ASS I RES, P15
   Himelein K, 2015, SOCIOECONOMIC IMPACT
   Hjortskov M, 2017, PUBLIC ADMIN, V95, P912, DOI 10.1111/padm.12346
   International Diabetes Federation, 2017, IEEE T POWER SYSTEMS, P1, DOI [10.1787/9789264202085-5-en, DOI 10.1109/TP-WRS.2017.2707501]
   Kelly J, 2008, ENCY SURVEY RES METH, V1, P122, DOI [10.4135/9781412963947, DOI 10.4135/9781412963947]
   Kreuter F, 2008, PUBLIC OPIN QUART, V72, P847, DOI 10.1093/poq/nfn063
   KROSNICK J., 1996, NEW DIRECTIONS PROGR, V70, P29, DOI DOI 10.1002/EV.1033
   Labrique A, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7329
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Larmarange J, 2016, POPULATION, V71, P123, DOI 10.3917/popu.1601.0123
   Leo B, 2015, MOBILE PHONE SURVEYS, P1, DOI [10.2139/ssrn.2597885, DOI 10.2139/SSRN.2597885]
   Leo B, 2015, ASKING WHAT PEOPLE W
   Long L, 2018, GLOB HEALTH-SCI PRAC, P1
   Mabmud SM, 2010, ENCY RES DESIGN, DOI [10.4135/9781412961288, DOI 10.4135/9781412961288]
   McHugh ML, 2012, BIOCHEM MEDICA, V22, P276
   Mercer Andrew, 2015, METHODS
   Midanik LT, 2008, J STUD ALCOHOL DRUGS, V69, P580, DOI 10.15288/jsad.2008.69.580
   Olsen R., 2008, ENCY SURVEY RES METH, DOI [10.4135/9781412963947, DOI 10.4135/9781412963947]
   Ongena YP, 2007, APPL COGNITIVE PSYCH, V21, P145, DOI 10.1002/acp.1334
   Open Knowledge Foundation, 2015, SUST DIG FORM
   Pariyo GW, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7302
   Parkin M, 2008, ENCY SURVEY RES METH, DOI [10.4135/9781412963947, DOI 10.4135/9781412963947]
   Riley L, 2016, AM J PUBLIC HEALTH, V106, P74, DOI 10.2105/AJPH.2015.302962
   Robling MR, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-180
   Schreiner M, 2015, THERES NO PLACE HOME
   Simon HA., 1976, STUDY DECISION MAKIN, P31
   Spector P., 2004, SAGE ENCY SOCIAL SCI, P1045, DOI [10.4135/9781412950589, DOI 10.1002/9781444316568]
   StataCorp, 2015, STAT STAT SOFTW REL
   Tourangeau R., 2000, PSYCHOL SURVEY RESPO, DOI [10.1017/CBO9780511819322, DOI 10.1017/CBO9780511819322]
   Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859
   Tourangeau Roger, 2000, PSYCHOL SURVEY RESPO
   UN, 2018, SUST DEV GOALS
   United Nations, 2015, WORLD URB PROSP
   West BT, 2015, SURV RES METHODS-GER, V9, P111
   World Health Organization, 2003, WHOCDSWHOPESGCDPP200, P43
   Yearwood D, 2012, ASEE ANNU CONF EXPO
NR 60
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 10
PY 2019
VL 14
IS 4
AR e0214450
DI 10.1371/journal.pone.0214450
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HS6PA
UT WOS:000463992600024
PM 30969975
OA DOAJ Gold
DA 2019-07-16
ER

PT J
AU Feu, S
   Garcia-Rubio, J
   Gamero, MD
   Ibanez, SJ
AF Feu, Sebastian
   Garcia-Rubio, Javier
   de Gracia Gamero, Maria
   Ibanez, Sergio J.
TI Task planning for sports learning by physical education teachers in the
   pre-service phase
SO PLOS ONE
LA English
DT Article
ID TEACHING GAMES; INVASION GAMES; METHODOLOGY; CHALLENGES; MODEL
AB Planning the learning task is one of the principal actions that a teacher should engage in, and it is important to know how teachers in the pre-service phase plan learning and communication tasks and the feedback that they use in the classroom. The aim of the present study was twofold: i) to characterize the learning tasks designed by the pre-service physical education teachers; and ii) to identify the relationships between the variables that define the learning tasks and the phases into which a session is structured in Physical Education Teacher Education (PETE) in the pre-service phase. The sample comprised 695 learning tasks designed by fourteen pre-service phase teachers. The independent variable was the lesson structure and the dependent variables were the learning means, the game situation, the game phase, the space where the students practice, the use of the ball in the task, and the kind of feedback provided in the learning tasks. The high predominance of exercises, unspecific games, and no opponent situations, coupled with the low percentage of reflexive feedback, indicates that the pre-service teachers give prevalence to technical over tactical learning. In addition, pre-service teachers show preferences for some of the task characteristics for each part of the lesson structure. Teachers in PETE pre-service phase tasks tend to follow a more traditional methodology, despite having received information about the different methods of sports teaching in their initial training. The current findings seems to indicate a resistance to changing a traditional model for other models centered on game comprehension.
C1 [Feu, Sebastian; de Gracia Gamero, Maria; Ibanez, Sergio J.] Univ Extremadura, Dept Didact Mus Plast & Body Express, Badajoz, Spain.
   [Garcia-Rubio, Javier] Univ Autonoma Chile, Fac Educ, Santiago, Chile.
RP Feu, S (reprint author), Univ Extremadura, Dept Didact Mus Plast & Body Express, Badajoz, Spain.
EM sfeu@unex.es
RI Feu, Sebastian/A-6519-2012
OI Feu, Sebastian/0000-0003-2959-5960
FU Govern of Extremadura (Economy and Infrastructures Department)
   [GR18170]; European Union through FEDER
FX This work has been partially supported by the "Ayuda a los Grupos de
   Investigacion (GR18170)" of Govern of Extremadura (Economy and
   Infrastructures Department); with the support of European Union through
   FEDER founds. These have been all the funding or sources of support
   received during this study. There was no additional external funding
   received for this study
CR Acock AC, 2012, GENTLE INTRO STATA R
   AIKEN LR, 1985, EDUC PSYCHOL MEAS, V45, P131, DOI 10.1177/0013164485451012
   Alarcon F., 2010, REV INVESTIGACION ED, V7, P91
   Alarcon F, 2011, REV ESPANOLA EDUCACI, P85
   Ato M, 2013, AN PSICOL-SPAIN, V29, P1038, DOI 10.6018/analesps.29.3.178511
   Biggs D., 1991, J APPL STAT, V18, P49, DOI DOI 10.1080/02664769100000005
   Bunker D., 1982, B PHYS ED, V18, P5
   Butler JI, 2006, SPORT EDUC SOC, V11, P243, DOI 10.1080/13573320600813408
   Canadas M, 2013, REV INT MED CIENC AC, V13, P41
   Caadas M., 2012, CPD, V12, P73, DOI [10.4321/S1578-84232012000200008, 10.4321/s1578-84232012000200008]
   Canadas M, 2013, REV PSICOL DEPORTE, V22, P183
   Canadas M, 2018, J HUM KINET, V62, P123, DOI 10.1515/hukin-2017-0164
   Canadas M, 2015, INT J PERF ANAL SPOR, V15, P572
   Oliva JC, 2015, RETOS-NUEV TEND EDUC, P263
   Castro M, 2012, REV ESP PEDAGOG, V70, P131
   Chow JY, 2013, QUEST, V65, P469, DOI 10.1080/00336297.2013.807746
   Clemente F, 2012, J PHYS ED SPORT, V12, P417
   Den Duyn N., 1996, SPORTS COACH, V19, P6
   Den Duyn N., 1997, GAMES SENSE DEV THIN
   Diaz-Cueto M, 2010, J TEACH PHYS EDUC, V29, P378, DOI 10.1123/jtpe.29.4.378
   Dyson B, 2004, QUEST, V56, P226, DOI 10.1080/00336297.2004.10491823
   Escobar C, 2016, Semergen, V42, P190, DOI 10.1016/j.semerg.2015.07.001
   Field A., 2009, DISCOVERING STAT USI
   Gonzalez-Espinosa S., 2017, RETOS, V31, P107
   Gray S, 2011, PHYS EDUC SPORT PEDA, V16, P15, DOI 10.1080/17408980903535792
   Green K, 2000, SPORT EDUC SOC, V5, P109, DOI 10.1080/713696029
   Grehaigne JF, 2010, PHYS EDUC SPORT PEDA, V15, P257, DOI 10.1080/17408980903273139
   Sanmartin MG, 2007, RICYDE-REV INT CIENC, V3, P39, DOI 10.5232/ricyde2007.008.04
   Harvey S, 2014, PHYS EDUC SPORT PEDA, V19, P278, DOI 10.1080/17408989.2012.754005
   Ibanez SJ, 1999, REV ENTRENAMIENTO DE, V13, P15
   Ibanez SJ, 2016, REV CIENCIAS DEPORTE, V12, P3
   Ibanez SJ, 2016, CONIPE C INT PED ESP
   IGARTUA J. J., 2006, METODOS CUANTITATIVO
   Jones R., 2010, EUROPEAN J PHYS HLTH, V4, P57
   Jones RL, 2003, SPORT EDUC SOC, V8, P213, DOI 10.1080/1357332032000106518
   Kass V., 1980, APPL STAT, V29, P119
   Kirk D, 2002, J TEACH PHYS EDUC, V21, P177, DOI 10.1123/jtpe.21.2.177
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Launder AG, 2001, PLAY PRACTICE GAMES
   Light R, 2008, J TEACH PHYS EDUC, V27, P21, DOI 10.1123/jtpe.27.1.21
   McNeill MC, 2004, SPORT EDUC SOC, V9, P3, DOI 10.1080/1357332042000175791
   Alonso DM, 2015, RETOS-NUEV TEND EDUC, P15
   Mesquita I, 2012, EUR PHYS EDUC REV, V18, P205, DOI 10.1177/1356336X12440027
   Metzler M., 2011, INSTRUCTIONAL MODELS
   Metzler M. W, 2000, INSTRUCTIONAL MODELS
   Miller A, 2015, J TEACH PHYS EDUC, V34, P36, DOI 10.1123/jtpe.2013-0155
   Mitchell S.A., 2013, TEACHING SPORT CONCE
   Mosston M, 2008, TEACHING PHYS ED
   Newell J, 2010, STAT SPORTS EXERCISE
   Olmedilla A., 2007, IBERIAN C BASKETBALL, V4, P38
   Otero FM, 2014, REV INT MED CIENC AC, V14, P69
   Penfield R. D., 2004, MEASUREMENT PHYS ED, V8, P213, DOI DOI 10.1207/S15327841MPEE0804_
   Pill S., 2015, AGORA EDUCACION FISI, V18, P1
   Randolph J. J., 2005, JOENS LEARN INSTR S
   Robinson G, 2007, INT J PERFOMANCE ANA, V7, P12, DOI DOI 10.1080/24748668.2007.11868383
   SAAD M. A., 2007, REV PORTUGUESA CI S1, V7, P21
   SANCHEZ F, 1992, DIDACTICA EDUCACION
   Arazuri ES, 2010, REV PSICOL DEPORTE, V19, P319
   Siedentop D., 1998, J PHYS ED RECREATION, V69, P18, DOI DOI 10.1080/07303084.1998.10605528
   Anguera MT, 2013, E-BALONMANO COM, V9, P135
   Thorpe R., 1986, RETHINKING GAMES TEA
   Tomas SV, 2010, REV INT MED CIENC AC, V10, P502
   Warrens MJ, 2010, ADV DATA ANAL CLASSI, V4, P271, DOI 10.1007/s11634-010-0073-4
NR 63
TC 0
Z9 0
U1 4
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 20
PY 2019
VL 14
IS 3
AR e0212833
DI 10.1371/journal.pone.0212833
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HP6AW
UT WOS:000461765900016
PM 30893311
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Holmstrom, O
   Linder, N
   Moilanen, H
   Suutala, A
   Nordling, S
   Stahls, A
   Lundin, M
   Diwan, V
   Lundin, J
AF Holmstrom, Oscar
   Linder, Nina
   Moilanen, Hannu
   Suutala, Antti
   Nordling, Stig
   Stahls, Anders
   Lundin, Mikael
   Diwan, Vinod
   Lundin, Johan
TI Detection of breast cancer lymph node metastases in frozen sections with
   a point-of care low-cost microscope scanner
SO PLOS ONE
LA English
DT Article
ID BIOPSY; TRIAL
AB Background
   Detection of lymph node metastases is essential in breast cancer diagnostics and staging, affecting treatment and prognosis. lntraoperative microscopy analysis of sentinel lymph node frozen sections is standard for detection of axillary metastases but requires access to a pathologist for sample analysis. Remote analysis of digitized samples is an alternative solution but is limited by the requirement for high-end slide scanning equipment.
   Objective
   To determine whether the image quality achievable with a low-cost, miniature digital microscope scanner is sufficient for detection of metastases in breast cancer lymph node frozen sections.
   Methods
   Lymph node frozen sections from 79 breast cancer patients were digitized using a prototype miniature microscope scanner and a high-end slide scanner. Images were independently reviewed by two pathologists and results compared between devices with conventional light microscopy analysis as ground truth.
   Results
   Detection of metastases in the images acquired with the miniature scanner yielded an overall sensitivity of 91% and specificity of 99% and showed strong agreement when compared to light microscopy (k = 0.91). Strong agreement was also observed when results were compared to results from the high-end slide scanner (k = 0.94). A majority of discrepant cases were micrometastases and sections of which no anticytokeratin staining was available.
   Conclusion
   Accuracy of detection of metastatic cells in breast cancer sentinel lymph node frozen sections by visual analysis of samples digitized using low-cost, point-of-care microscopy is comparable to analysis of digital samples scanned using a high-end, whole slide scanner. This technique could potentially provide a workflow for digital diagnostics in resource-limited settings, facilitate sample analysis at the point-of-care and reduce the need for trained experts on-site during surgical procedures.
C1 [Holmstrom, Oscar; Linder, Nina; Suutala, Antti; Lundin, Mikael; Lundin, Johan] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland.
   [Linder, Nina] Uppsala Univ, Dept Womens & Childrens Hlth, Int Maternal & Child Hlth, Uppsala, Sweden.
   [Moilanen, Hannu] Univ Oulu, Ctr Microscopy & Nanotechnol, Oulu, Finland.
   [Nordling, Stig] Univ Helsinki, Dept Pathol, Helsinki, Finland.
   [Stahls, Anders] Helsinki Univ Hosp, Helsinki, Finland.
   [Stahls, Anders] HUSLAB Pathol Lab, Helsinki, Finland.
   [Diwan, Vinod; Lundin, Johan] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.
RP Holmstrom, O (reprint author), Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland.
EM oscar.holmstrom@helsinki.fi
OI Linder, Nina/0000-0003-3930-0513
FU Swedish Research Council; Sigrid Juselius Foundation; Finska
   Lakaresallskapet; Biomedicum Foundation; Medicinska Understbdsfbreningen
   Liv och Halsa rf and Tekes - the Finnish Funding Agency for Innovation;
   European Advanced Translational Research Infrastructure in Medicine'
   (EATRIS)/Academy of Finland; University of Helsinki
FX This work was supported by grants from the Swedish Research Council,
   Sigrid Juselius Foundation, Finska Lakaresallskapet, Biomedicum
   Foundation, Medicinska Understbdsfbreningen Liv och Halsa rf and Tekes -
   the Finnish Funding Agency for Innovation and University of Helsinki. In
   addition, this study has received funding from the 'European Advanced
   Translational Research Infrastructure in Medicine' (EATRIS)/Academy of
   Finland. We also thank Biocenter Finland and Helsinki Institute of Life
   Science for infrastructure support. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Al-Janabi S, 2012, HISTOPATHOLOGY, V61, P1, DOI 10.1111/j.1365-2559.2011.03814.x
   Andersson Y, 2018, BREAST CANCER RES TR, V171, P359, DOI 10.1007/s10549-018-4820-0
   Bejnordi BE, 2017, JAMA-J AM MED ASSOC, V318, P2199, DOI 10.1001/jama.2017.14585
   Chao C, 2004, AM SURGEON, V70, P414
   FISHER B, 1983, CANCER-AM CANCER SOC, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3
   Gifford AJ, 2012, ANZ J SURG, V82, P803, DOI 10.1111/j.1445-2197.2012.06191.x
   Holck S, 2004, BREAST, V13, P42, DOI 10.1016/S0960-9776(03)00124-3
   Holmstrom O, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1337325
   Holmstrom O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144688
   Isaacs Mike, 2011, J Pathol Inform, V2, P39, DOI 10.4103/2153-3539.84232
   Konsti J, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-29
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liu LC, 2011, CANCER-AM CANCER SOC, V117, P250, DOI 10.1002/cncr.25606
   Liu Y, 2018, ARCH PATHOL LAB MED
   Lucci A, 2007, J CLIN ONCOL, V25, P3657, DOI 10.1200/JCO.2006.07.4062
   Mansel RE, 2006, J NATL CANCER I, V98, P599, DOI 10.1093/jnci/djj158
   Pirnstill CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13368
   Samphao S, 2008, ANN SURG ONCOL, V15, P1282, DOI 10.1245/s10434-008-9863-8
   Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442
   Thorstenson Sten, 2014, J Pathol Inform, V5, P14, DOI 10.4103/2153-3539.129452
   Weinstein RS, 2004, HUM PATHOL, V35, P1303, DOI 10.1016/j.humpath.2004.09.002
   Weiser MR, 2000, ANN SURG ONCOL, V7, P651, DOI 10.1007/s10434-000-0651-3
   Yeh YC, 2015, HISTOPATHOLOGY, V66, P922, DOI 10.1111/his.12468
   Zhu HY, 2013, LAB CHIP, V13, P51, DOI [10.1039/c2lc40864c, 10.1039/c21c40864c]
NR 24
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 19
PY 2019
VL 14
IS 3
AR e0208366
DI 10.1371/journal.pone.0208366
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HP3JN
UT WOS:000461573000002
PM 30889174
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Dong, Y
   Zhou, X
   Lin, Y
   Pan, QC
   Wang, Y
AF Dong, Yuan
   Zhou, Xin
   Lin, Yi
   Pan, Qichao
   Wang, Ying
TI HIV-related posts from a Chinese internet discussion forum: An
   exploratory study
SO PLOS ONE
LA English
DT Article
ID HARD-TO-REACH; SOCIAL MEDIA; HIV/AIDS; SURVEILLANCE; TUBERCULOSIS;
   POPULATIONS; CARE
AB Background
   In China, the introduction of antiretroviral treatment has increased the number of people living with HIV/AIDS (PLWHA). New technologies, such as social media, might be useful for enhancing HIV surveillance, especially given the lack of Chinese research, which is related to stigma and discrimination. Thus, the relative anonymity of social media may make it useful for evaluating "hard to reach" PLWHA.
   Setting
   This study used social media data to assess whether it reflected the prevalence of HIV and to explore PLWHA' needs and online habits.
   Methods
   In 2017, the Baidu Tieba platform was searched to obtain 2,500 HIV-related postings and 2,500 tuberculosis-related postings as a comparative sample. Word clouds and coding schemes were used to analyze the contents and review the users' needs and online habits. Negative binomial regression was used to evaluate the relationships between word cloud geolocations and provincial numbers of men who have sex with men (MSM) PLWHA cases, after controlling for socioeconomic status.
   Results
   Word cloud geolocations were associated with reported MSM-PLWHA cases (p<0.001). Over one-third of the HIV-related posts were seeking advice, with 40.12% being related to medical topics, although these posts received the fewest replies. The number of HIV-related social support requests was approximately 3-fold higher than the number of posts providing social support, although relatively similar proportions of support requests and support provision were observed in the tuberculosis-related postings.
   Conclusion
   Social media may help enhance HIV surveillance. Our findings also indicate that the Chinese government, non-government organizations, and healthcare professionals should offer more online support to PLWHA.
C1 [Dong, Yuan; Zhou, Xin; Pan, Qichao; Wang, Ying] Shanghai Municipal Ctr Dis Control & Prevent, Dept AIDS & STD, Shanghai, Peoples R China.
   [Lin, Yi] Shanghai Inst Prevent Med, Dept AIDS & STD, Shanghai, Peoples R China.
RP Pan, QC; Wang, Y (reprint author), Shanghai Municipal Ctr Dis Control & Prevent, Dept AIDS & STD, Shanghai, Peoples R China.
EM panqichao@scdc.sh.cn; wangying2000@163.com
FU National Natural Science Foundation of China [81602905]; Municipal Human
   Resources Development Program for Outstanding Young Talents in Medical
   and Health Sciences in Shanghai [2018YQ57]; Foundation of Shanghai
   Municipal Commission of Health and Family Planning [20164Y0245]; Natural
   Science Foundation of Shanghai [16ZR1429900]
FX This study was supported by the National Natural Science Foundation of
   China (81602905) to YD http://www.nsfc.gov.cn; Municipal Human Resources
   Development Program for Outstanding Young Talents in Medical and Health
   Sciences in Shanghai (2018YQ57) to YD, Foundation of Shanghai Municipal
   Commission of Health and Family Planning (20164Y0245) to YD, and Natural
   Science Foundation of Shanghai (16ZR1429900) to YL. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Allsworth JE, 2015, AM J EPIDEMIOL, V181, P747, DOI 10.1093/aje/kwv007
   Bassett IV, 2015, AIDS BEHAV, V19, P1888, DOI 10.1007/s10461-015-1012-3
   Bruckman A, 2004, ONLINE SOCIAL RES ME
   Cao BL, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3145-2
   China NBoSo, 2016, NAT DAT 2016
   Colvin CJ, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-31
   Diaz T, 2005, AIDS, V19, pS1, DOI 10.1097/01.aids.0000172871.80723.3e
   Han J, 2016, CYBERPSYCH BEH SOC N, V19, P516, DOI 10.1089/cyber.2016.0133
   Hearst MA, 2008, P 41 ANN HAW INT C S
   Kitahata MM, 2002, BMJ-BRIT MED J, V325, P954, DOI 10.1136/bmj.325.7370.954
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lin CQ, 2012, AIDS CARE, V24, P1341, DOI 10.1080/09540121.2011.648602
   Lin W, 2012, WEST PAC SURVEILL RE, V3, P78, DOI 10.5365/wpsar.2012.3.3.004
   Liu Y, 2016, AIDS PATIENT CARE ST, V30, P70, DOI 10.1089/apc.2015.0296
   Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1
   Mak WWS, 2006, SOC SCI MED, V63, P1912, DOI 10.1016/j.socscimed.2006.04.016
   Martinez O, 2014, J MED INTERNET RES, V16, P168, DOI 10.2196/jmir.3311
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Singer P, 2014, 23 INT C WORLD WID W
   Smith A., 2018, SOCIAL MEDIA USE 201
   Taggart T, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4387
   Wang LX, 2014, LANCET, V383, P2057, DOI 10.1016/S0140-6736(13)62639-2
   WHO, 2015, WHOHIV20158
   Young SD, 2018, PREV MED, V109, P58, DOI 10.1016/j.ypmed.2017.12.016
   Young SD, 2014, TRENDS MICROBIOL, V22, P601, DOI 10.1016/j.tim.2014.08.004
   Young SD, 2014, PREV MED, V63, P112, DOI 10.1016/j.ypmed.2014.01.024
   Zhang DP, 2008, AIDS CARE, V20, P1128, DOI 10.1080/09540120701842829
NR 27
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 28
PY 2019
VL 14
IS 2
AR e0213066
DI 10.1371/journal.pone.0213066
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HN7LS
UT WOS:000460371500074
PM 30818379
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kim, I
   Eom, JS
   Kim, AR
   Lee, CH
   Lee, G
   Jo, EJ
   Kim, MH
   Mok, JH
   Lee, K
   Kim, KU
   Park, HK
   Lee, MK
AF Kim, Insu
   Eom, Jung Seop
   Kim, Ah Rong
   Lee, Chang Hun
   Lee, Geewon
   Jo, Eun Jung
   Kim, Mi-Hyun
   Mok, Jeong Ha
   Lee, Kwangha
   Kim, Ki Uk
   Park, Hye-Kyung
   Lee, Min Ki
TI Molecular analysis of small tissue samples obtained via transbronchial
   lung biopsy using radial probe endobronchial ultrasound
SO PLOS ONE
LA English
DT Article
ID PERIPHERAL PULMONARY-LESIONS; FACTOR-RECEPTOR MUTATIONS; CORE-NEEDLE
   BIOPSY; BRUSH-TIP WASHINGS; GUIDE-SHEATH; INTERNATIONAL-ASSOCIATION;
   CLINICAL-PRACTICE; CELL BLOCKS; CANCER; DIAGNOSIS
AB Background
   Radial probe endobronchial ultrasound using a guide sheath (EBUS-GS) is used to diagnose peripheral lung cancer. The aim was to identify the accuracy of molecular analysis that were performed with EBUS-GS specimens in patients with non-small cell lung cancer (NSCLC).
   Method
   From December 2015 to September 2017, we retrospectively studied 91 patients with peripheral NSCLC who underwent surgery after EBUS-GS. Epidermal growth factor receptor (EGFR) mutational and anaplastic lymphoma kinase (ALK) translocation status obtained from surgical specimens served as the references.
   Results
   Compared to the reference data, EGFR mutational testing of EBUS-GS specimens was in 97% agreement, and the. coefficient was 0.931 (P<0.001). In addition, on ALK translocation testing, the results of all 91 patients were in agreement with the reference data (concordance rate of 100%,. coefficient 1.000; P<0.001).
   Conclusion
   We found that EBUS-GS could be used for molecular diagnosis, such as EGFR mutational and ALK translocation status, in patients with peripheral NSCLC.
C1 [Kim, Insu; Eom, Jung Seop; Jo, Eun Jung; Kim, Mi-Hyun; Mok, Jeong Ha; Lee, Kwangha; Kim, Ki Uk; Park, Hye-Kyung; Lee, Min Ki] Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea.
   [Eom, Jung Seop] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea.
   [Kim, Ah Rong; Lee, Chang Hun] Pusan Natl Univ, Sch Med, Dept Pathol, Busan, South Korea.
   [Lee, Geewon] Pusan Natl Univ, Sch Med, Dept Radiol, Busan, South Korea.
RP Eom, JS (reprint author), Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea.; Eom, JS (reprint author), Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea.
EM ejspulm@gmail.com
RI Park, Hye-Kyung/Q-5586-2019
OI Park, Hye-Kyung/0000-0003-4065-2962
CR Bonney A, 2016, J THORAC DIS, V8, P2551, DOI 10.21037/jtd.2016.08.85
   Bonney A, 2016, ACTA CYTOL, V60, P74, DOI 10.1159/000444044
   Chen CM, 2008, ACTA RADIOL, V49, P991, DOI 10.1080/02841850802294410
   Eberhard DA, 2008, J CLIN ONCOL, V26, P983, DOI 10.1200/JCO.2007.12.9858
   Eberhardt R, 2007, AM J RESP CRIT CARE, V176, P36, DOI 10.1164/rccm.200612-1866OC
   Eom JS, RADIAL PROBE E UNPUB
   Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351
   Han YX, 2017, CLIN CHEM LAB MED, V55, P1817, DOI 10.1515/cclm-2017-0112
   Hayama M, 2015, RESPIRATION, V90, P129, DOI 10.1159/000431383
   Ishida T, 2011, THORAX, V66, P1072, DOI 10.1136/thx.2010.145490
   Jing CW, 2018, MOL MED REP, V18, P2191, DOI 10.3892/mmr.2018.9210
   Kikuchi E, 2004, EUR RESPIR J, V24, P533, DOI 10.1183/09031936.04.00138603
   Kim HR, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-50
   Kurimoto N, 2004, CHEST, V126, P959, DOI 10.1378/chest.126.3.959
   Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lindeman NI, 2018, J MOL DIAGN, V20, P129, DOI 10.1016/j.jmoldx.2017.11.004
   Lu CH, 2012, J THORAC ONCOL, V7, P143, DOI 10.1097/JTO.0b013e318233d7dd
   McHugh ML, 2012, BIOCHEM MEDICA, V22, P276
   Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699
   Moreira AL, 2014, CHEST, V146, P1649, DOI 10.1378/chest.14-0713
   Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0
   Reck M, 2011, LUNG CANCER, V74, P1, DOI 10.1016/j.lungcan.2011.05.002
   Rivera MP, 2013, CHEST, V143, pE142, DOI 10.1378/chest.12-2353
   Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X
   Scagliotti GV, 2009, CURR OPIN ONCOL, V21, P99, DOI 10.1097/CCO.0b013e328321049e
   Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496
   Shinagawa N, 2009, J BRONCHOL INTERN PU, V16, P261, DOI 10.1097/LBR.0b013e3181bb8058
   Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332
   Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]
   Steinfort DP, 2011, EUR RESPIR J, V37, P902, DOI 10.1183/09031936.00075310
   Steinfort DP, 2011, RESP MED, V105, P1704, DOI 10.1016/j.rmed.2011.08.008
   Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038
   Tam AL, 2013, J THORAC ONCOL, V8, P436, DOI 10.1097/JTO.0b013e318287c91e
   Tanaka T, 2007, CANCER SCI, V98, P246, DOI 10.1111/j.1349-7006.2006.00377.x
   Travis WD, 2013, ARCH PATHOL LAB MED, V137, P668, DOI 10.5858/arpa.2012-0263-RA
   VanderLaan PA, 2014, LUNG CANCER, V84, P39, DOI 10.1016/j.lungcan.2014.01.013
   Wu YL, 2017, LUNG CANCER, V104, P119, DOI 10.1016/j.lungcan.2016.11.022
   Xu XN, 2016, SCAND J CLIN LAB INV, V76, P386, DOI 10.1080/00365513.2016.1183813
   Yang F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-474
   Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8
   Yatabe Y, 2007, PATHOL INT, V57, P233, DOI 10.1111/j.1440-1827.2007.02098.x
   Yeo CD, 2013, LUNG CANCER, V81, P207, DOI 10.1016/j.lungcan.2013.04.023
   Yi ES, 2011, J THORAC ONCOL, V6, P459, DOI 10.1097/JTO.0b013e318209edb9
NR 44
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 26
PY 2019
VL 14
IS 2
AR e0212672
DI 10.1371/journal.pone.0212672
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM8EU
UT WOS:000459712100021
PM 30807604
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lopez-Sanmartin, M
   Catanese, G
   Grau, A
   Valencia, JM
   Garcia-March, JR
   Navas, JI
AF Lopez-Sanmartin, Monserrat
   Catanese, Gaetano
   Grau, Amalia
   Maria Valencia, Jose
   Rafa Garcia-March, Jose
   Ignacio Navas, Jose
TI Real-Time PCR based test for the early diagnosis of Haplosporidium
   pinnae affecting fan mussel Pinna nobilis
SO PLOS ONE
LA English
DT Article
ID COEFFICIENT; AGREEMENT
AB Noble pen shell or fan mussel, Pinna nobilis Linnaeus (1758), protected since 1992, was incorporated into the Spanish Catalogue of Threatened Species (Category: Vulnerable, Royal Decree 139/2011). The status is presently in the process of being catalogued as critically endangered, pending approval by Spanish Government (https://www.mapama.gob.es/es/biodiversidad/participacion-publica/Borrador_OM_situacion_critica. aspx). The International Union for the Conservation of Nature (IUCN) alerted the countries of the Mediterranean basin to the "emergent situation" due to serious mortality events suffered by the fan mussel, putting it in serious risk of extinction. Thus, emergency actions have been implemented by Spanish authorities in which several research institutes from all over the country are involved. The parasite, Haplosporidium pinnae, was recently characterized by histology, TEM, SEM and molecular biology techniques and it was considered responsible for the mass mortality of P. nobilis in the Mediterranean Sea. In this context, the aim of this study has been to develop species-specific quantitative PCR (qPCR) protocol carrying out a fast, specific and effective molecular diagnose of H. pinnae. In this sense, the detection limit for qPCR was equal to 30 copies of SSU rDNA / ng of DNA using plasmid alone and when 100ng DNA of non-infected oyster were added. The qPCR assay revealed that 94% of the 32 analysed mantle tissues of fan mussel were infected by H. pinnae, showing a high sensitivity and specificity for its detection (100% if we don't consider negative and too much degraded samples). This technique will allow us to make quicker follow-ups of the disease, allowing us to get a better understanding of its evolution in order to help in the rescue of P. nobilis populations
C1 [Lopez-Sanmartin, Monserrat; Ignacio Navas, Jose] IFAPA Agua Pino, Cartaya, Huelva, Spain.
   [Catanese, Gaetano; Grau, Amalia; Maria Valencia, Jose] LIMIA Govern Illes Balears, Port Dandratx, Mallorca, Spain.
   [Catanese, Gaetano; Grau, Amalia; Maria Valencia, Jose] INAGEA INIA CAIB UIB Ctra, Edifici Guillem Colom Casasnoves, Palma de Mallorca, Illes Balears, Spain.
   [Rafa Garcia-March, Jose] UCV, IMEDMAR, Calpe, Spain.
RP Lopez-Sanmartin, M (reprint author), IFAPA Agua Pino, Cartaya, Huelva, Spain.
EM monserratls@yahoo.es
RI ; Navas, Jose Ignacio/D-9086-2012
OI Lopez-Sanmartin, Monserrat/0000-0001-9077-7515; Navas, Jose
   Ignacio/0000-0002-2774-7978
FU project MAPAMA within LIFE IPE INTERMARES [28-5310, LIFE15 IPE ES 012];
   PHENOFISH Project; State Plan for Scientific and Technical Research and
   Innovation 2013-2016, MINECO [PTA2015-14709-I]; Ministerio de Economia,
   Industria y Competitividad, Gobierno de Espana, INIA CCAA [DOC INIA
   8-2013]; Prince Albert II of Monaco Foundation [BF/HEM 15-1662]; 
   [IFAPA-UCV 014/2018]
FX This research has been funded by the project MAPAMA ref. 28-5310 within
   LIFE IPE INTERMARES(LIFE15 IPE ES 012) and the agreement IFAPA-UCV
   014/2018 and co-funded by PHENOFISH Project. M. Lopez-Sanmartin contract
   is co-financed by the State Plan for Scientific and Technical Research
   and Innovation 2013-2016, MINECO, ref. PTA2015-14709-I. Ministerio de
   Economia, Industria y Competitividad, Gobierno de Espana, INIA CCAA (DOC
   INIA 8-2013), Dr Gaetano Catanese. Garcia-March was supported by the
   project BF/HEM 15-1662 -The study, protection and possible breeding of
   penshell (Pinna nobilis) in the Boka Kotorska bay (Montenegro) of the
   Prince Albert II of Monaco Foundation. We thank to M. Vila, R. Leon and
   I. Giraldez of the Chemistry Department of the University of Huelva
   (Spain).
CR Audemard C, 2004, APPL ENVIRON MICROB, V70, P6611, DOI 10.1128/AEM.70.11.6611-6618.2004
   Berthe FCJ, 1999, BULL EUR ASSN FISH P, V19, P277
   Catanese G, 2018, J INVERTEBR PATHOL, V157, P9, DOI 10.1016/j.jip.2018.07.006
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Darriba S, 2017, J INVERTEBR PATHOL, V148, P14, DOI 10.1016/j.jip.2017.05.006
   Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006
   FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309
   Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091
   Kralik P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00108
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mauri I, 2011, FISH SHELLFISH IMMUN, V30, P1310, DOI 10.1016/j.fsi.2011.03.013
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Ramilo A, 2013, DIS AQUAT ORGAN, V104, P149, DOI 10.3354/dao02597
   Sanna D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067372
   SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013
   Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596
   Vazquez-Luis M, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00220
   Wilbur AE, 2012, DIS AQUAT ORGAN, V102, P107, DOI 10.3354/dao02540
   Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741
NR 19
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 22
PY 2019
VL 14
IS 2
AR e0212028
DI 10.1371/journal.pone.0212028
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM8DR
UT WOS:000459709100033
PM 30794588
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Takasaki, Y
   Irisawa, A
   Shibukawa, G
   Sato, A
   Abe, Y
   Yamabe, A
   Arakawa, N
   Maki, T
   Yoshida, Y
   Igarashi, R
   Yamamoto, S
   Ikeda, T
AF Takasaki, Yusuke
   Irisawa, Atsushi
   Shibukawa, Goro
   Sato, Ai
   Abe, Yoko
   Yamabe, Akane
   Arakawa, Noriyuki
   Maki, Takumi
   Yoshida, Yoshitsugu
   Igarashi, Ryo
   Yamamoto, Shogo
   Ikeda, Tsunehiko
TI New endoscopic ultrasonography criteria for malignant lymphadenopathy
   based on inter-rater agreement
SO PLOS ONE
LA English
DT Article
ID FINE-NEEDLE-ASPIRATION; LYMPH-NODE METASTASIS; ENDOSONOGRAPHIC FEATURES;
   INTEROBSERVER AGREEMENT; ESOPHAGEAL CANCER; PANCREATIC-CANCER; EUS;
   ULTRASOUND; BENIGN; DIAGNOSIS
AB Background and aims
   Various studies have been previously conducted on the diagnosis of lymphadenopathy as benign or malignant, but the results vary. These studies did not describe the inter-rater agreement on the EUS features of lymphadenopathy. In this study, we evaluate the inter-rater agreement on EUS features and propose EUS diagnostic norms for lymphadenopathy based on inter-rater agreement.
   Method
   A total of 68 lymph nodes subjected to EUS-fine needle aspiration (FNA) were reviewed by five endoscopic experts. The EUS features evaluated lymph node size, shape, border, margin, echogenicity, homogeneity, and the hilum of the lymph node. Inter-rater agreement (multi-rater kappa statics) was performed. We established new criteria using results with a high degree of inter-rater agreement from EUS features and compared them with the former criteria.
   Result
   There was a moderate agreement on shape, kappa (K) = 0.44 (95% confidence interval [CI]: 0.34-0.54), and fair agreement on echogenicity, homogeneity, border, and hilum of the lymph node, K (95% CI) = 0.33 (0.17-0.38), 0.34 (0.26-0.35), 0.22 (0.21-0.31), and 0.22 (0.11-0.26), respectively. This resulted in the establishment of new EUS diagnostic criteria using shape, long axis > 20 mm and short axis > 10 mm. New criteria were superior to old criteria (area under the curve 0.82 vs 0.52, P < 0.001).
   Conclusion
   EUS diagnostic criteria for lymphadenopathy based on inter-rater agreement were more accurate than old criteria. This result will be useful for the diagnosis of lymphadenopathy.
C1 [Takasaki, Yusuke; Irisawa, Atsushi; Shibukawa, Goro; Sato, Ai; Abe, Yoko; Yamabe, Akane; Arakawa, Noriyuki; Maki, Takumi; Yoshida, Yoshitsugu; Igarashi, Ryo; Yamamoto, Shogo; Ikeda, Tsunehiko] Fukushima Med Univ, Aizu Med Ctr, Dept Gastroenterol, Aizu Wakamatsu, Fukushima, Japan.
   [Takasaki, Yusuke] Juntendo Univ, Dept Gastroenterol, Tokyo, Japan.
   [Irisawa, Atsushi] Dokkyo Med Univ, Dept Gastroenterol, Mibu, Tochigi, Japan.
   [Abe, Yoko; Arakawa, Noriyuki] Sendai Kousei Hosp, Dept Gastroenterol, Sendai, Miyagi, Japan.
RP Irisawa, A (reprint author), Fukushima Med Univ, Aizu Med Ctr, Dept Gastroenterol, Aizu Wakamatsu, Fukushima, Japan.; Irisawa, A (reprint author), Dokkyo Med Univ, Dept Gastroenterol, Mibu, Tochigi, Japan.
EM irisawa@dokkyomed.ac.jp
OI Takasaki, Yusuke/0000-0002-5036-4545
CR Bhutani MS, 1997, GASTROINTEST ENDOSC, V45, P474, DOI 10.1016/S0016-5107(97)70176-7
   CATALANO MF, 1994, GASTROINTEST ENDOSC, V40, P442, DOI 10.1016/S0016-5107(94)70206-3
   Chen VK, 2004, AM J GASTROENTEROL, V99, P628, DOI 10.1111/j.1572-0241.2004.04064.x
   Chin YK, 2017, WORLD J GASTROENTERO, V23, P5755, DOI 10.3748/wjg.v23.i31.5755
   de Melo SW, 2011, DIGEST DIS SCI, V56, P3204, DOI 10.1007/s10620-011-1725-8
   Eloubeidi MA, 2001, GASTROINTEST ENDOSC, V54, P714, DOI 10.1067/mge.2001.119873
   Faigel DO, 2001, GASTROINTEST ENDOSC, V53, P593, DOI 10.1067/mge.2001.114060
   GIOVANNINI M, 1995, ENDOSCOPY, V27, P171, DOI 10.1055/s-2007-1005657
   Hocke M, 2008, J CANCER RES CLIN, V134, P473, DOI 10.1007/s00432-007-0309-7
   Irisawa A, 2004, J GASTROEN HEPATOL, V19, P1199, DOI 10.1111/j.1400-1746.2004.03468.x
   Kalmin B, 2011, CAN J GASTROENTEROL, V25, P261, DOI 10.1155/2011/302382
   Kumon RE, 2012, GASTROINTEST ENDOSC, V75, P1175, DOI 10.1016/j.gie.2012.01.039
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Okasha H, 2017, ARAB J GASTROENTEROL, V18, P74, DOI 10.1016/j.ajg.2017.05.015
   Thomas M, 2019, CLIN GASTROENTEROLOG, V17, P148
   TOHNOSU N, 1989, J CLIN ULTRASOUND, V17, P101, DOI 10.1002/jcu.1870170206
   Topazian M, 2007, GASTROINTEST ENDOSC, V66, P62, DOI 10.1016/j.gie.2006.09.018
   Vazquez-Sequeiros E, 2006, GASTROINTEST ENDOSC, V63, P204, DOI 10.1016/j.gie.2005.08.053
   Wang L, 2015, ANN THORAC SURG, V100, P1203, DOI 10.1016/j.athoracsur.2015.04.143
   Zhang MM, 2010, GASTROINTEST ENDOSC, V72, P978, DOI 10.1016/j.gie.2010.06.042
   Zhu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063820
NR 21
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 22
PY 2019
VL 14
IS 2
AR e0212427
DI 10.1371/journal.pone.0212427
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM8DR
UT WOS:000459709100067
PM 30794598
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lexchin, J
AF Lexchin, Joel
TI Association between commercial funding of Canadian patient groups and
   their views about funding of medicines: An observational study
SO PLOS ONE
LA English
DT Article
AB Background
   Patient groups represent the interest of their members when it comes to drug funding. Many patient groups receive grants from pharmaceutical companies that make products being considered for funding. This research examines whether there is an association between the positions that Canadian groups take about the products and conflicts of interest with the companies.
   Methods
   The Common Drug Review (CDR) and panCanadian Oncology Drug Review (pCODR) make recommendations to Canadian provincial and federal drug plans about funding particular drug-indications. Both utilize input from patient groups in making their recommendations. Patient group submissions are available from both organizations and these submissions contain statements about conflicts of interest. Views of the patient groups, with and without a conflict with the company making the drug under consideration and without any conflicts at all, were assessed and then compared with the recommendations from CDR and pCODR.
   Results
   There was a total of 222 reports for drug-indications. There were 372 submissions from 93 different patient groups. Groups declared a total of 1896 conflicts with drug companies in 324 (87.1%) individual submissions. There were 268 submissions where groups declared a conflict with the company making the product or said they had no conflict. Irrespective of whether there was a conflict, the views of patient groups about the drug-indications under consideration were the same. There was no statistically significant difference between views of patient groups and the recommendations from CDR and/or pCODR.
   Conclusions
   The large majority of patient groups making submissions about funding of particular drug-indications had conflicts with the companies making the products and their views about the products were almost always positive. This association between funding and views needs to be further investigated to determine if a true cause and effect exists.
C1 [Lexchin, Joel] York Univ, Sch Hlth Policy & Management, Toronto, ON, Canada.
   [Lexchin, Joel] Univ Hlth Network, Emergency Dept, Toronto, ON, Canada.
   [Lexchin, Joel] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada.
RP Lexchin, J (reprint author), York Univ, Sch Hlth Policy & Management, Toronto, ON, Canada.; Lexchin, J (reprint author), Univ Hlth Network, Emergency Dept, Toronto, ON, Canada.; Lexchin, J (reprint author), Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada.
EM jlexchin@yorku.ca
CR [Anonymous], 2016, PCODR EXP REV COMM T
   Batt S., 2017, PHARM FUND CHANG BRE
   Berglas Sarah, 2016, Res Involv Engagem, V2, P21, DOI 10.1186/s40900-016-0036-9
   Burton Bob, 2005, BMJ, V331, P1359, DOI 10.1136/bmj.331.7529.1359-b
   CADTH, 2014, SUBS ENTR BIOL EM TR
   CADTH, 2017, INTR NEW PAT INP TEM
   CADTH Common Drug Review, 2014, CADTH COMM DRUG REV
   Claypool R., 2016, PATIENTS GROUPS BIG
   Facey K, 2017, PATIENT INVOLVEMENT, P67
   Goomansingh C., 2014, GLOBAL NEWS
   Government of Ontario, 2018, HLTH SECT PAYM TRANS
   Hughes David, 2013, Healthc Policy, V9, P52
   Keizer B, 2010, PILOT STUDY POSITION
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   McCoy MS, 2017, NEW ENGL J MED, V376, P880, DOI 10.1056/NEJMsr1610625
   Perehudoff S, 2011, PATIENT CONSUMER VOI
   Rose SL, 2017, JAMA INTERN MED, V177, P344, DOI 10.1001/jamainternmed.2016.8443
   Rubenstein S., 2007, WALL STREET J
   Weeks C., 2016, GLOBE MAIL
NR 19
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 15
PY 2019
VL 14
IS 2
AR e0212399
DI 10.1371/journal.pone.0212399
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HL5KT
UT WOS:000458766300036
PM 30768629
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wang, H
   Tian, D
   Li, C
   Tian, Y
   Zhou, HY
AF Wang, Hu
   Tian, Di
   Li, Chu
   Tian, Yan
   Zhou, Haoyu
TI Plant leaf tooth feature extraction
SO PLOS ONE
LA English
DT Article
ID ARCHITECTURE; LEAVES; THRESHOLD; EVOLUTION; CLIMATE
AB Leaf tooth can indicate several systematically informative features and is extremely useful for circumscribing fossil leaf taxa. Moreover, it can help discriminate species or even higher taxa accurately. Previous studies extract features that are not strictly defined in botany; therefore, a uniform standard to compare the accuracies of various feature extraction methods cannot be used. For efficient and automatic retrieval of plant leaves from a leaf database, in this study, we propose an image-based description and measurement of leaf teeth by referring to the leaf structure classification system in botany. First, image preprocessing is carried out to obtain a binary map of plant leaves. Then, corner detection based on the curvature scale-space (CSS) algorithm is used to extract the inflection point from the edges; next, the leaf tooth apex is extracted by screening the convex points; then, according to the definition of the leaf structure, the characteristics of the leaf teeth are described and measured in terms of number of orders of teeth, tooth spacing, number of teeth, sinus shape, and tooth shape. In this manner, data extracted from the algorithm can not only be used to classify plants, but also provide scientific and standardized data to understand the history of plant evolution. Finally, to verify the effectiveness of the extraction method, we used simple linear discriminant analysis and multiclass support vector machine to classify leaves. The results show that the proposed method achieves high accuracy that is superior to that of other methods.
C1 [Wang, Hu; Li, Chu; Zhou, Haoyu] China Shipbldg Ind Corp, Res Inst 722, Wuhan, Hubei, Peoples R China.
   [Tian, Di] Wenhua Coll, Fac Informat Sci & Technol, Wuhan, Hubei, Peoples R China.
   [Tian, Yan] Huazhong Univ Sci & Technol, Elect & Informat Engn Dept, Wuhan, Hubei, Peoples R China.
RP Tian, D (reprint author), Wenhua Coll, Fac Informat Sci & Technol, Wuhan, Hubei, Peoples R China.
EM tiandi_2015@foxmail.com
OI Wang, Hu/0000-0002-6558-847X
FU China Shipbuilding Industry Corporation [722]
FX The work was supported by China Shipbuilding Industry Corporation, no.
   722 Research Institute. The funder provided support in the form of
   salaries for authors [WH LC ZHY], but did not have any additional role
   in the study design, data collection and analysis, decision to publish,
   or preparation of the manuscript. The specific roles of these authors
   are articulated in the 'author contributions' section.
CR Ash A.W., 1999, MANUAL LEAF ARCHITEC
   Bailey IW, 1916, AM J BOT, V3, P24, DOI 10.2307/2435109
   Bailey IW, 1915, SCIENCE, V41, P831, DOI 10.1126/science.41.1066.831
   Bruno OM, 2008, INFORM SCIENCES, V178, P2722, DOI 10.1016/j.ins.2008.01.023
   Chen Y., 2014, THESIS
   Corney DPA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042112
   Doyle JA, 2007, COUR FOR SEKENBG, V258, P21
   Ellis B, 2009, MANUAL LEAF ARCHITEC
   Espinosa D, 2006, J BIOGEOGR, V33, P1945, DOI 10.1111/j.1365-2699.2006.01566.x
   Gonzalez RC, 2007, QIU QIUQI DIGITAL IM
   He XC, 2004, INT C PATT RECOG, P791, DOI 10.1109/ICPR.2004.1334377
   HICKEY LJ, 1991, ANN MO BOT GARD, V78, P105, DOI 10.2307/2399596
   Huff PM, 2003, PALAIOS, V18, P266, DOI 10.1669/0883-1351(2003)018<0266:DFFPEF>2.0.CO;2
   Jin TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139482
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Li L, 2017, THESIS
   MERRILL EK, 1978, BOT GAZ, V139, P447, DOI 10.1086/337020
   Mokhtarian F, 1998, IEEE T PATTERN ANAL, V20, P1376, DOI 10.1109/34.735812
   OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076
   Powers DMW, 2007, SIE07001 FED U
   Rahmani ME, 2015, 1 INT C BIG DAT SMAL, P75
   Royer DL, 2006, INT J PLANT SCI, V167, P11, DOI 10.1086/497995
   Royer DL, 2005, AM J BOT, V92, P1141, DOI 10.3732/ajb.92.7.1141
   Sajo MG, 2015, BOT J LINEAN SOC, V138, P339
   Soderkvist O., 2001, THESIS
   Sun W, 2008, OPT ENG, V47, DOI 10.1117/1.2896537
   Tsolakidis DG, 2014, LECT NOTES ARTIF INT, V8445, P406, DOI 10.1007/978-3-319-07064-3_33
   Utescher T, 2000, PALAIOS, V15, P430, DOI 10.2307/3515514
   WALKER JW, 1975, ANN MO BOT GARD, V62, P664, DOI 10.2307/2395271
   [ Wang Xiaofeng], 2006, [, Computer Engineering and Application], V42, P190
   Wilf P, 1997, PALEOBIOLOGY, V23, P373, DOI 10.1017/S0094837300019746
   WOLFE JA, 1971, PALAEOGEOGR PALAEOCL, V9, P27, DOI 10.1016/0031-0182(71)90016-2
   Yang L., 2003, STUDY ECOLOGICAL PLA
   Zhang Y., 2012, IMAGE ENG, P304
   [ Zheng Xiaodong], 2011, [, Chinese Agricultural Science Bulletin], V27, P174
NR 35
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 13
PY 2019
VL 14
IS 2
AR e0204714
DI 10.1371/joumal.pone.0204714
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HL5IX
UT WOS:000458761300002
PM 30759085
OA DOAJ Gold
DA 2019-07-16
ER

PT J
AU Schoenherr, D
   Paulick, J
   Strauss, BM
   Deisenhofer, AK
   Schwartz, B
   Rubel, JA
   Lutz, W
   Stangier, U
   Altmann, U
AF Schoenherr, Desiree
   Paulick, Jane
   Strauss, Bernhard M.
   Deisenhofer, Anne-Katharina
   Schwartz, Brian
   Rubel, Julian A.
   Lutz, Wolfgang
   Stangier, Ulrich
   Altmann, Uwe
TI Identification of movement synchrony: Validation of windowed
   cross-lagged correlation and -regression with peak-picking algorithm
SO PLOS ONE
LA English
DT Article
ID NONVERBAL SYNCHRONY; COMMUNICATION; MOTION; MIMICRY
AB In psychotherapy, movement synchrony seems to be associated with higher patient satisfaction and treatment outcome. However, it remains unclear whether movement synchrony rated by humans and movement synchrony identified by automated methods reflect the same construct. To address this issue, video sequences showing movement synchrony of patients and therapists (N = 10) or not (N = 10), were analyzed using motion energy analysis. Three different synchrony conditions with varying levels of complexity (naturally embedded, naturally isolated, and artificial) were generated for time series analysis with windowed cross-lagged correlation/ -regression (WCLC, WCLR). The concordance of ratings (human rating vs. automatic assessment) was computed for 600 different parameter configurations of the WCLC/WCLR to identify the parameter settings that measure movement synchrony best. A parameter configuration was rated as having a good identification rate if it yields high concordance with human-rated intervals (Cohen's kappa) and a low amount of over-identified data points. Results indicate that 76 configurations had a good identification rate (IR) in the least complex condition (artificial). Two had an acceptable IR with regard to the naturally isolated condition. Concordance was low with regard to the most complex (naturally embedded) condition. A valid identification of movement synchrony strongly depends on parameter configuration and goes beyond the identification of synchrony by human raters. Differences between human-rated synchrony and nonverbal synchrony measured by algorithms are discussed.
C1 [Schoenherr, Desiree; Strauss, Bernhard M.; Altmann, Uwe] Jena Univ Hosp, Inst Psychosocial Med & Psychotherapy, Jena, Germany.
   [Paulick, Jane; Deisenhofer, Anne-Katharina; Schwartz, Brian; Rubel, Julian A.; Lutz, Wolfgang] Trier Univ, Dept Clin Psychol & Psychotherapy, Trier, Germany.
   [Stangier, Ulrich] Goethe Univ Frankfurt Main, Dept Clin Psychol & Psychotherapy, Frankfurt, Germany.
RP Schoenherr, D (reprint author), Jena Univ Hosp, Inst Psychosocial Med & Psychotherapy, Jena, Germany.
EM desiree.schoenherr@med.uni-jena.de
OI Schoenherr, Desiree/0000-0001-8919-6908
FU German Research Foundation (DFG) [STR 306/28-1, LU 660/8-1]; German
   Federal Ministry of Education and Research (BMBF) [FKZ 01GV0607]
FX This work was supported by the German Research Foundation (DFG project
   "Timing of nonverbal patient-therapist-interaction and therapeutic
   success of social phobic patients (TIMPATHIN)
   -http://www.dfg.de/en/index.jsp", under funding number GZ BMS: STR
   306/28-1 and WL: LU 660/8-1) and uses video recordings from the
   SOPHO-NET treatment study funded by the German Federal Ministry of
   Education and Research (BMBF, FKZ 01GV0607). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Altmann U., 2011, ANALYSIS OF VERBAL A, P344
   Altmann U, 2019, INTRO PRACTICAL GUID
   Altmann U., 2013, SYNCHRONISATION NONV
   Altorfer A, 1997, Z PSYCHOL, V205, P83
   ANSCOMBE FJ, 1948, BIOMETRIKA, V35, P246, DOI 10.1093/biomet/35.3-4.246
   Anvsoft Inc, 2009, ANY VIDEO CONVERTER
   Ashenfelter KT, 2009, J EXP PSYCHOL HUMAN, V35, P1072, DOI 10.1037/a0015017
   Bailenson JN, 2005, PSYCHOL SCI, V16, P814, DOI 10.1111/j.1467-9280.2005.01619.x
   BERNIERI FJ, 1988, J PERS SOC PSYCHOL, V54, P243, DOI 10.1037/0022-3514.54.2.243
   Bernieri FJ, 1991, FUNDAMENTALS NONVERB, P511
   Bilakhia S, 2015, PATTERN RECOGN LETT, V66, P52, DOI 10.1016/j.patrec.2015.03.005
   Boker S. M., 2002, MIRROR NEURONS EVOLU, P163, DOI DOI 10.1075/AICR.42.14BOK
   Boker SM, 2002, PSYCHOL METHODS, V7, P338, DOI 10.1037//1082-989X.7.3.338
   BOX GEP, 1964, J ROY STAT SOC B, V26, P211
   Bozkurt E, 2016, SPEECH COMMUN, V85, P29, DOI 10.1016/j.specom.2016.10.004
   Campbell N, 2009, AUDIO VISUAL APPROAC
   Chetouani M, 2017, SOCIAL SIGNAL PROCES, V202
   Dean RT, 2016, BEHAV RES METHODS, V48, P783, DOI 10.3758/s13428-015-0611-2
   Delaherche E, 2010, P 2 INT WORKSH SOC S
   Dionisio A, 2004, PHYSICA A, V344, P326, DOI 10.1016/j.physa.2004.06.144
   Feldman R, 2007, J CHILD PSYCHOL PSYC, V48, P329, DOI 10.1111/j.1469-7610.2006.01701.x
   Galbusera L, 2018, PSYCHOTHER RES, V28, P457, DOI 10.1080/10503307.2016.1216624
   GOTTMAN JM, 1981, CHILD DEV, V52, P393, DOI 10.2307/1129157
   Grammer K, 1999, J PERS SOC PSYCHOL, V77, P487, DOI 10.1037/0022-3514.77.3.487
   Grammer K, 1998, J NONVERBAL BEHAV, V22, P3, DOI 10.1023/A:1022986608835
   GREENE MG, 1994, SOC SCI MED, V38, P1279, DOI 10.1016/0277-9536(94)90191-0
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leichsenring F, 2014, AM J PSYCHIAT
   Leichsenring F, 2013, AM J PSYCHIAT, V170, P759, DOI [10.1176/appi.ajp.2013.12081125, 10.1176/appi.ajp.2013.13060744r]
   Louwerse MM, 2012, COGNITIVE SCI, V36, P1404, DOI 10.1111/j.1551-6709.2012.01269.x
   Messinger DS, 2009, INFANCY, V14, P285, DOI 10.1080/15250000902839963
   Michelet Stephane, 2012, Human Behavior Understanding. Proceedings of the Third International Workshop, HBU 2012, P161, DOI 10.1007/978-3-642-34014-7_14
   Moulder RG, 2018, PSYCHOL METHODS, V23, P757, DOI 10.1037/met0000172
   Nagaoka C, 2008, IEICE T INF SYST, VE91D, P1634, DOI 10.1093/ietisy/e91-d.6.1634
   Namy LL, 2002, J LANG SOC PSYCHOL, V21, P422, DOI 10.1177/026192702237958
   Paulick J, 2017, J PSYCHOTHERAPY INTE
   Paxton A, 2013, BEHAV RES METHODS, V45, P329, DOI 10.3758/s13428-012-0249-2
   R Core Team, 2017, R LANG ENV STAT COMP
   Ramseyer F, 2008, SIMULTANEITY TEMPORA, P329, DOI DOI 10.1142/9789812792426_0020
   Ramseyer F, 2016, NONLIN DYNAM PSYCHOL, V20, P145
   Ramseyer F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00979
   Ramseyer F, 2011, J CONSULT CLIN PSYCH, V79, P284, DOI 10.1037/a0023419
   Ramseyer F, 2010, LECT NOTES COMPUT SC, V5967, P182, DOI 10.1007/978-3-642-12397-9_15
   Safran JD, 2011, PSYCHOTHERAPY, V48, P80, DOI 10.1037/a0022140
   Schonbrodt FD, 2013, J RES PERS, V47, P609, DOI 10.1016/j.jrp.2013.05.009
   Schoenherr D, 2018, BEHAV RES METHODS, P1
   Stel M, 2008, PSYCHOL SCI, V19, P984, DOI 10.1111/j.1467-9280.2008.02188.x
   Sun X, 2011, AUTOMATIC VISUAL MIM
   Tonti M, 2016, RES PSYCHOTHER-PSYCH, V19, P102, DOI 10.4081/ripppo.2016.232
   TRONICK ED, 1977, J COMMUN, V27, P74, DOI 10.1111/j.1460-2466.1977.tb01829.x
   Tschacher W, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01323
   WATANABE T, 1983, B JSME, V26, P2244
   Yang N, 2016, IEEE INT CONF CON AU, P611, DOI 10.1109/ICCA.2016.7505345
NR 53
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 11
PY 2019
VL 14
IS 2
AR e0211494
DI 10.1371/journal.pone.0211494
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HL0OI
UT WOS:000458393400014
PM 30742651
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Haines, N
   Southward, MW
   Cheavens, JS
   Beauchaine, T
   Ahn, WY
AF Haines, Nathaniel
   Southward, Matthew W.
   Cheavens, Jennifer S.
   Beauchaine, Theodore
   Ahn, Woo-Young
TI Using computer-vision and machine learning to automate facial coding of
   positive and negative affect intensity
SO PLOS ONE
LA English
DT Article
ID EMOTIONAL EXPRESSION; ELECTROMYOGRAPHIC ACTIVITY; BEHAVIORAL MARKERS;
   BASIC EMOTIONS; VALENCE; RECOGNITION; VALIDATION; SMILE
AB Facial expressions are fundamental to interpersonal communication, including social interaction, and allow people of different ages, cultures, and languages to quickly and reliably convey emotional information. Historically, facial expression research has followed from discrete emotion theories, which posit a limited number of distinct affective states that are represented with specific patterns of facial action. Much less work has focused on dimensional features of emotion, particularly positive and negative affect intensity. This is likely, in part, because achieving inter-rater reliability for facial action and affect intensity ratings is painstaking and labor-intensive. We use computer-vision and machine learning (CVML) to identify patterns of facial actions in 4,648 video recordings of 125 human participants, which show strong correspondences to positive and negative affect intensity ratings obtained from highly trained coders. Our results show that CVML can both (1) determine the importance of different facial actions that human coders use to derive positive and negative affective ratings when combined with interpretable machine learning methods, and (2) efficiently automate positive and negative affect intensity coding on large facial expression databases. Further, we show that CVML can be applied to individual human judges to infer which facial actions they use to generate perceptual emotion ratings from facial expressions.
C1 [Haines, Nathaniel; Southward, Matthew W.; Cheavens, Jennifer S.; Beauchaine, Theodore] Ohio State Univ, Dept Psychol, Columbus, OH USA.
   [Ahn, Woo-Young] Seoul Natl Univ, Dept Psychol, Seoul, South Korea.
RP Ahn, WY (reprint author), Seoul Natl Univ, Dept Psychol, Seoul, South Korea.
EM wahn55@snu.ac.kr
OI Haines, Nathaniel/0000-0001-6654-9010
CR Ahn WY, 2016, CURR OPIN BEHAV SCI, V11, P1, DOI 10.1016/j.cobeha.2016.02.001
   Ahn WY, 2016, DRUG ALCOHOL DEPEN, V161, P247, DOI 10.1016/j.drugalcdep.2016.02.008
   Ahn WY, 2016, FRONT PSYCHIATRY, V7, P290
   Ahn WY, 2017, EASYML EASILY BUILD
   Amirian M, 2016, PROCEEDINGS OF THE 6TH INTERNATIONAL WORKSHOP ON AUDIO/VISUAL EMOTION CHALLENGE (AVEC'16), P67, DOI 10.1145/2988257.2988260
   Bailenson JN, 2008, INT J HUM-COMPUT ST, V66, P303, DOI 10.1016/j.ijhcs.2007.10.011
   Baltrusaitis T, 2016, IEEE WINT CONF APPL
   Barrett LF, 2006, J RES PERS, V40, P35, DOI 10.1016/j.jrp.2005.08.006
   Bartlett MS, 1999, PSYCHOPHYSIOLOGY, V36, P253, DOI 10.1017/S0048577299971664
   Belsky J, 1996, DEV PSYCHOL, V32, P289, DOI 10.1037/0012-1649.32.2.289
   Boehmke B. C., 2018, ARXIV180504755
   Bonanno GA, 2004, PSYCHOL SCI, V15, P482, DOI 10.1111/j.0956-7976.2004.00705.x
   Boukricha H, 2009, P ACII WORKSH, P1
   BROWN SL, 1980, BIOL PSYCHOL, V11, P49, DOI 10.1016/0301-0511(80)90026-5
   CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260
   Celani G, 1999, J AUTISM DEV DISORD, V29, P57, DOI 10.1023/A:1025970600181
   Cohn J. F., 2005, NEW HDB METHODS NONV, P9
   Del Libano M, 2018, ACTA PSYCHOL, V187, P19, DOI 10.1016/j.actpsy.2018.04.019
   Du SC, 2014, P NATL ACAD SCI USA, V111, pE1454, DOI 10.1073/pnas.1322355111
   EKMAN P, 1990, J PERS SOC PSYCHOL, V58, P342, DOI 10.1037/0022-3514.58.2.342
   Ekman P., 2002, FACIAL ACTION CODING
   Ekman P, 2005, WHAT FACE REVEALS BA
   Erickson K, 2003, BRAIN COGNITION, V52, P52, DOI 10.1016/S0278-2626(03)00008-3
   FRANK MG, 1993, J PERS SOC PSYCHOL, V64, P83, DOI 10.1037/0022-3514.64.1.83
   Gunes Hatice, 2010, International Journal of Strategic Synthetic Emotions, V1, P68, DOI 10.4018/jse.2010101605
   Haamer E, 2018, REV EMOTION RECOGNIT
   Haines N, REGRET INDUCES UNPUB
   Hammal Z, 2015, 2015 ACM INT C MULT
   Hastie T. J., 2009, ELEMENTS STAT LEARNI
   IZARD CE, 1992, PSYCHOL REV, V99, P561, DOI 10.1037/0033-295X.99.3.561
   Keltner D, 2000, HDB EMOTIONS, V2, P236
   Korb S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099194
   Kossaifi J, 2017, IMAGE VISION COMPUT, V65, P23, DOI 10.1016/j.imavis.2017.02.001
   Kotsia I, 2007, IEEE T IMAGE PROCESS, V16, P172, DOI 10.1109/TIP.2006.884954
   Krumhuber E, 2007, EMOTION, V7, P730, DOI 10.1037/1528-3542.7.4.730
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lang P. J, 1995, INT AFFECTIVE PICTUR
   Larsen JT, 2003, PSYCHOPHYSIOLOGY, V40, P776, DOI 10.1111/1469-8986.00078
   Lewinski P, 2014, J NEUROSCI PSYCHOL E, V7, P227, DOI 10.1037/npe0000028
   Liaw A, 2002, R NEWS
   Littlewort G, 2011, Proceedings 2011 IEEE International Conference on Automatic Face & Gesture Recognition (FG 2011), P298, DOI 10.1109/FG.2011.5771414
   Martinez AM, 2017, CURR OPIN PSYCHOL, V17, P27, DOI 10.1016/j.copsyc.2017.06.009
   McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30
   Messinger DS, 2012, EMOTION, V12, P430, DOI 10.1037/a0026498
   Mollahosseini A, 2017, IEEE T AFFECT COMPUT, DOI [10.1109/TAFFC.2016.2582490, DOI 10.1109/TAFFC.2016.2582490]
   Nicolaou MA, 2011, IEEE T AFFECT COMPUT, V2, P92, DOI 10.1109/T-AFFC.2011.9
   Philippot P, 1999, ALCOHOL CLIN EXP RES, V23, P1031, DOI 10.1111/j.1530-0277.1999.tb04221.x
   Pu XR, 2015, NEUROCOMPUTING, V168, P1173, DOI 10.1016/j.neucom.2015.05.005
   Reed LI, 2014, PSYCHOL SCI, V25, P1511, DOI 10.1177/0956797614531027
   Reed LI, 2012, EVOL HUM BEHAV, V33, P200, DOI 10.1016/j.evolhumbehav.2011.09.003
   Ringeval F, 2015, 5 INT WORKSH AUD VIS
   Rosenthal R., 2005, NEW HDB METHODS NONV, P199
   RUBINOW DR, 1992, BIOL PSYCHIAT, V31, P947, DOI 10.1016/0006-3223(92)90120-O
   RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714
   SCHLOSBERG H, 1954, PSYCHOL REV, V61, P81, DOI 10.1037/h0054570
   Sikka K, 2015, PEDIATRICS, V136, pE124, DOI 10.1542/peds.2015-0029
   SMITH CA, 1985, J PERS SOC PSYCHOL, V48, P813, DOI 10.1037/0022-3514.48.4.813
   Southward MW, 2017, J SOC CLIN PSYCHOL, V36, P142, DOI 10.1521/jscp.2017.36.2.142
   Srinivasan R, 2016, J NEUROSCI, V36, P4434, DOI 10.1523/JNEUROSCI.1704-15.2016
   Stockli S., 2017, BEHAV RES METHODS, P1
   WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063
   Watson D, 1985, PSYCHOL BULL, V98, P2918
NR 62
TC 1
Z9 1
U1 4
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 5
PY 2019
VL 14
IS 2
AR e0211735
DI 10.1371/journal.pone.0211735
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HK2MO
UT WOS:000457746300024
PM 30721270
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kinlay, S
   Bundy, M
   Chin, M
   Tobin, D
   Quinn, M
   Do, JM
   Johnson, S
   Temiyasathit, S
   Ly, S
AF Kinlay, Scott
   Bundy, Mariah
   Chin, Melissa
   Tobin, Desiree
   Quinn, Margot
   Do, Jacquelyn-My
   Johnson, Shannon
   Temiyasathit, Sara
   Ly, Samantha
TI Reproducibility and validity of a novel invasive method of assessing
   peripheral microvascular vasomotor function
SO PLOS ONE
LA English
DT Article
ID NITRIC-OXIDE; VASODILATION; RESISTANCE; VESSELS; HUMANS
AB In healthy arteries, blood flow is regulated by microvascular tone assessed by changes in blood flow volume and vascular resistance to endothelium-dependent and -independent vasodilators. We developed a novel method of using intravascular ultrasound (IVUS) and a Doppler flow wire to measure changes in blood flow volume and vascular resistance of the profunda arterial bed. We assessed the variability over 6 months in measuring microvascular endothelium-dependent dilation to acetylcholine and endothelium-independent dilation to adenosine in 20 subjects who were part of a larger study of Gulf War Illness without obstructive peripheral artery disease. Vasomotor function was assessed by Infusions of control (dextrose), acetylcholine (10(-6) M), adenosine (50 mu g), and nitroglycerin (25 mu g/ml). 400 IVUS and 240 flow velocity images were measured a mean 6 (SD = 2) months apart blind to measurement and infusion stage. The mean (SD) baseline profunda flow was 227 (172) ml/min and vascular resistance 4.6 x 10(4) (2.4 x 10(4)) dynes-s/cm(5). The intraclass correlation coefficients for 6-month variability for vascular function were excellent (range 0.827-0.995). Bland-Altman analyses showed mean differences of less than 2% for microvascular endothelium-dependent function (flow volume and resistance) and less than 1% for macrovascular endothelium-dependent function with acceptable limits of agreement. In 49 subjects assessing concurrent validity of the technique against atherosclerosis risk factors, we observed greater impairment in microvascular endothelium-dependent function per year of age (flow volume = - 1.4% (p = 0.018), vascular resistance = 1.5% (p = 0.015)) and current smoking (flow volume = - 36.7% (p =.006), vascular resistance = 50.0% (p<0.001)). This novel method of assessing microvascular vasomotor function had acceptable measurement reproducibility and validity.
C1 [Kinlay, Scott; Bundy, Mariah; Chin, Melissa; Tobin, Desiree; Quinn, Margot; Do, Jacquelyn-My; Johnson, Shannon; Temiyasathit, Sara; Ly, Samantha] Vet Affairs Boston Healthcare Syst, Dept Med, Div Cardiovasc, West Roxbury Campus, Boston, MA 02109 USA.
   [Kinlay, Scott] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.
   [Kinlay, Scott] Harvard Med Sch, Boston, MA 02115 USA.
RP Kinlay, S (reprint author), Vet Affairs Boston Healthcare Syst, Dept Med, Div Cardiovasc, West Roxbury Campus, Boston, MA 02109 USA.; Kinlay, S (reprint author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.; Kinlay, S (reprint author), Harvard Med Sch, Boston, MA 02115 USA.
EM scott.kinlay@va.gov
FU VA Clinical Science Research and Development Awards [1/21CX000793,
   1/01CX001549]; Defense for Health Affairs, through the Gulf War Illness
   Research Program [W81XWH-15-1-0216]
FX This research was supported by the VA Clinical Science Research and
   Development Awards 1/21CX000793 and 1/01CX001549 to author SK, and
   Assistant Secretary of Defense for Health Affairs, through the Gulf War
   Illness Research Program under award W81XWH-15-1-0216 to author SK. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Bank A J, 1994, J Card Fail, V1, P35, DOI 10.1016/1071-9164(94)90006-X
   Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6
   Hasdai D, 1997, CIRCULATION, V96, P3390
   Kashyap VS, 2013, J VASC SURG, V58, P1259, DOI 10.1016/j.jvs.2013.05.029
   Kinlay S, 2001, HYPERTENSION, V38, P1049, DOI 10.1161/hy1101.095329
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LIAO JK, 1991, CIRC RES, V68, P1027, DOI 10.1161/01.RES.68.4.1027
   LUDMER PL, 1986, NEW ENGL J MED, V315, P1046, DOI 10.1056/NEJM198610233151702
   Nichols WW, 1998, MCDONALDS BLOOD FLOW, P22
   QUYYUMI AA, 1995, CIRCULATION, V92, P320, DOI 10.1161/01.CIR.92.3.320
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   ZEIHER AM, 1995, CIRCULATION, V91, P2345, DOI 10.1161/01.CIR.91.9.2345
NR 12
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 25
PY 2019
VL 14
IS 1
AR e0211152
DI 10.1371/journal.pone.0211152
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HJ2YV
UT WOS:000457037500114
PM 30682202
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU de-Mateo-Silleras, B
   de-la-Cruz-Marcos, S
   Alonso-Izquierdo, L
   Camina-Martin, MA
   Marugan-de-Miguelsanz, JM
   Redondo-del-Rio, MP
AF de-Mateo-Silleras, Beatriz
   de-la-Cruz-Marcos, Sandra
   Alonso-Izquierdo, Laura
   Alicia Camina-Martin, Ma
   Manuel Marugan-de-Miguelsanz, Jose
   Paz Redondo-del-Rio, Ma
TI Bioelectrical impedance vector analysis in obese and overweight children
SO PLOS ONE
LA English
DT Article
ID BODY-MASS INDEX; TO-HEIGHT RATIO; WAIST CIRCUMFERENCE; DIAGNOSTIC
   PERFORMANCE; CLINICAL-PRACTICE; IDENTIFY OBESITY; NORMAL VALUES;
   ANALYSIS BIVA; FAT; BIOIMPEDANCE
AB Introduction
   BMI is the most commonly used indicator to evaluate overweight and obesity, but it cannot distinguish changes in body composition. Over recent years, it has been demonstrated that bioelectrical impedance analysis (BIA) is a more accurate method for analyzing body composition. Bioelectrical impedance vector analysis (BIVA) has revealed its effectiveness as an indicator of nutritional status and hydration.
   Objective
   To assess the usefulness of bioimpedance analysis on the study of body composition in a group of children with overweight and obesity.
   Materials and methods
   Cross-sectional observational study. The anthropometric parameters of 167 (79 were older than 12 years) overweight and obese children were recorded. Their body composition was analyzed using BIA and BIVA, and was classified based on different criteria. Concordance was analyzed (intraclass correlation coefficient, Bland-Altman analysis and weighted Kappa coefficient). The BIVA of the subgroups was compared using the Mahalanobis distance and Hotelling's T-2. Statistical significance was considered for p<0.05.
   Results
   The BMI revealed that the majority of the assessed subjects were obese, although 12% had a normal percentage of fat mass (%FM). The classification by Z-BMI and Z-%FM significantly discriminate between subjects with different levels of adiposity. In children over the age of 12, the classification of fat mass index also discriminates significantly between obesity and non-obesity. As anticipated, in the tolerance ellipses, most of the individual vectors were situated in the left lower quadrant.
   Conclusions
   BIVA reflects differences in the bioelectric patterns of children who are classified as being overweight or obese (BMI) and who have different levels of %FM and FMI. BIVA permits a fast and easy monitoring of the evolution of the nutritional state and changes associated with body composition, and it identifies those children whose body compartments may be precisely estimated using traditional BIA methods.
C1 [de-Mateo-Silleras, Beatriz; de-la-Cruz-Marcos, Sandra; Alonso-Izquierdo, Laura; Alicia Camina-Martin, Ma; Paz Redondo-del-Rio, Ma] Valladolid Univ, Fac Med, Dept Nutr & Food Sci, Valladolid, Spain.
   [Manuel Marugan-de-Miguelsanz, Jose] Univ Valladolid, Hosp Clin Univ, Dept Pediat, Valladolid, Spain.
RP Redondo-del-Rio, MP (reprint author), Valladolid Univ, Fac Med, Dept Nutr & Food Sci, Valladolid, Spain.
EM mpazredondorio@gmail.com
RI De Mateo Silleras, Beatriz/G-7279-2017
OI De Mateo Silleras, Beatriz/0000-0002-7927-0999
CR Barbosa-Silva MCG, 2005, CURR OPIN CLIN NUTR, V8, P311, DOI 10.1097/01.mco.0000165011.69943.39
   Bluher S, 2013, J CLIN ENDOCR METAB, V98, P3384, DOI 10.1210/jc.2013-1389
   Bosy-Westphal A, 2005, AM J CLIN NUTR, V82, P60
   Buffa R, 2014, EUR J CLIN NUTR, V68, P1234, DOI 10.1038/ejcn.2014.170
   Buffa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058533
   Buffa R, 2013, NUTRITION, V29, P132, DOI 10.1016/j.nut.2012.05.007
   Cole TJ, 2007, ACTA PAEDIATR, V96, P2, DOI 10.1111/j.1651-2227.2007.00162.x
   Cole TJ, 2000, BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240
   Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a
   Munoz AD, 2016, NUTR HOSP, V33, P887, DOI 10.20960/nh.388
   de Farias JC, 2009, REV SAUDE PUBL, V43, P53, DOI 10.1590/s0034-89102009000100007
   de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548
   de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497
   De Palo T, 2000, NUTRITION, V16, P417, DOI 10.1016/S0899-9007(00)00269-0
   Bibiloni MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055849
   Demerath EW, 2006, PEDIATRICS, V117, pE487, DOI 10.1542/peds.2005-0572
   Deurenberg P, 2002, ASIA PAC J CLIN NUTR, V11, P1, DOI 10.1046/j.1440-6047.2002.00258.x
   Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3
   Fields DA, 2000, J APPL PHYSIOL, V89, P613
   Freedman DS, 1999, AM J CLIN NUTR, V69, P308
   Freedman DS, 2005, CURR OPIN CLIN NUTR, V8, P618, DOI 10.1097/01.mco.0000171128.21655.93
   Guida B, 2008, NUTR METAB CARDIOVAS, V18, P133, DOI 10.1016/j.numecd.2006.08.008
   Hirschler Valeria, 2006, Arch. argent. pediatr., V104, P486
   Horan M, 2015, IRISH J MED SCI, V184, P53, DOI 10.1007/s11845-014-1124-1
   Javed A, 2015, PEDIATR OBES, V10, P234, DOI 10.1111/ijpo.242
   Kyle UG, 2015, EUR J CLIN NUTR, V69, P1298, DOI 10.1038/ejcn.2015.86
   Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lukaski H. C, 1991, NEW TECHNIQUES NUTR, P303
   Maffeis C, 2008, J PEDIATR, V152, P207, DOI 10.1016/j.jpeds.2007.09.021
   Marini E, 2013, J NUTR HEALTH AGING, V17, P515, DOI 10.1007/s12603-012-0411-7
   McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232
   McCarthy HD, 2003, BRIT MED J, V326, P624, DOI 10.1136/bmj.326.7390.624
   National Health and Nutrition Examination Survey (NHaNES), 2007, ANTHR PROC MAN
   Nicoletti CF, 2014, NUTRITION, V30, P569, DOI 10.1016/j.nut.2013.10.013
   Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5
   Redondo-del-Rio MP, 2016, EXP GERONTOL, V85, P108, DOI [10.1016/j.exger.2016.10.002, 10.1016/j.exger.201]
   Redondo-del-Rio MP, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22978
   Piccoli A, 2002, NEFROLOGIA, V22, P228
   Piccoli A, 2002, NUTRITION, V18, P153, DOI 10.1016/S0899-9007(01)00665-7
   Piccoli A, 1998, INT J OBESITY, V22, P97, DOI 10.1038/sj.ijo.0800551
   Plachta-Danielzik S, 2012, OBESITY FACTS, V5, P77, DOI 10.1159/000336780
   Alvero-Cruz JR, 2010, MED CLIN-BARCELONA, V135, P8, DOI 10.1016/j.medcli.2010.01.017
   Reilly JJ, 2000, INT J OBESITY, V24, P1623, DOI 10.1038/sj.ijo.0801436
   Rodriguez DP, 2008, ARCH ARGENT PEDIATR, V106, P102, DOI 10.1590/S0325-00752008000200003
   Rolland-Cachera MF, 2011, INT J PEDIATR OBES, V6, P325, DOI 10.3109/17477166.2011.607458
   Shah A, 2008, JPEN-PARENTER ENTER, V32, P638, DOI 10.1177/0148607108325251
   Wells JCK, 2002, INT J OBESITY, V26, P1323, DOI 10.1038/sj.ijo.0802077
   WHO, 2017, 10 FACTS OB
   Wohlfahrt-Veje C, 2014, EUR J CLIN NUTR, V68, P664, DOI 10.1038/ejcn.2013.282
   World Health Organization, 1995, TECHNICAL REPORT SER
NR 51
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 24
PY 2019
VL 14
IS 1
AR e0211148
DI 10.1371/journal.pone.0211148
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HI8IY
UT WOS:000456700400053
PM 30677103
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Baasland, I
   Romundstad, PR
   Eide, ML
   Jonassen, CM
AF Baasland, Ingrid
   Romundstad, Pal R.
   Eide, Maj Liv
   Jonassen, Christine M.
TI Clinical performance of Anyplex II HPV28 by human papillomavirus type
   and viral load in a referral population
SO PLOS ONE
LA English
DT Article
ID HYBRID CAPTURE 2; CERVICAL INTRAEPITHELIAL NEOPLASIA; TEST REQUIREMENTS;
   HR DETECTION; WOMEN; VALIDATION; ASSAY; RISK; PREVALENCE; PREDICTORS
AB Anyplex II HPV28 ('Anyplex') is a semi-quantitative DNA PCR assay divided into set A, comprising 14 high risk (hr)HPV types; and set B, comprising 5 possibly hrHPV types and 9 low risk (I)HPV types. We compared the ability of Anyplex to that of Hybrid Capture 2 (HC2) and PreTect HPV-Proofer ('Proofer') to detect cervical intraepithelial neoplasia grade two or worse (CIN2+) by HPV types and viral load. This cross-sectional study included 296 women referred to colposcopy with abnormal cervical cytology and/or persistent HPV infection. CIN2+ was identified in 175/296 women. Liquid based cytology samples were used to perform HPV testing. The sensitivity of Anyplex to detect CIN2+ was 98.9% (95% CI 95.9-99.9) and specificity 43.0% (95% CI 34.0-52.3). Restricting to medium and high viral loads in Anyplex set A, sensitivity and specificity were 97.1% (95% CI 93.5-99.1) and 59.5% (95% CI 50.2-68.3) with positive (PPV) and negative predictive value (NPV) 77.6% and 93.5%, respectively, comparable to HC2. Restricting Anyplex to the hrHPV types in Proofer, HPV16, 18, 31, 33 and 45, sensitivity and specificity for CIN2+ were 85.1% (95% CI 79.090.1) and 71.1% (95% CI 62.1-79.0), comparable to Proofer's. When adding HPV52 and 58, the sensitivity for CIN2+ was 92.6% (95% CI 87.6-96.0) and CIN3+ 96.5% (95% CI 92.0-98.8). No value of Anyplex set B was found in detecting CIN2+. In conclusion, the clinical performance of medium and high viral loads in Anyplex set A was comparable to HC2. Restricting the test to the 7 hrHPV types included in the 9-valent HPV-vaccine, HPV16, 18, 31, 33, 45, 52 and 58, satisfies the international criteria for cervical cancer screening with relative sensitivity compared to HC2 for CIN2+ and CIN3+ of 0.98 and 1.01, respectively. Detecting all 28 Anyplex HPV types adds no benefit in a referral population.
C1 [Baasland, Ingrid; Romundstad, Pal R.] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Trondheim, Norway.
   [Eide, Maj Liv] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Pathol, Trondheim, Norway.
   [Jonassen, Christine M.] Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, As, Norway.
   [Jonassen, Christine M.] Ostfold Hosp Trust, Ctr Lab Med, Gralum, Norway.
RP Baasland, I (reprint author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Trondheim, Norway.
EM Ingrid.baasland@ntnu.no
FU Liaison Committee
FX The study was supported by the Liaison Committee between the Central
   Norway Regional health Authority (RHA) and the Norwegian University of
   Science and Technology (NTNU).
CR Arbyn M, 2014, J PATHOL, V234, P431, DOI 10.1002/path.4424
   Baasland I, 2016, ACTA OBSTET GYN SCAN, V95, P1258, DOI 10.1111/aogs.13009
   Cameron RL, 2016, EMERG INFECT DIS, V22, P56, DOI 10.3201/eid2201.150736
   Cuzick J, 2016, PAPILLOMAVIRUS RES, V2, P112, DOI 10.1016/j.pvr.2016.05.004
   Depuydt CE, 2012, J CLIN MICROBIOL, V50, P4073, DOI 10.1128/JCM.01231-12
   Depuydt CE, 2015, CANCER MED-US, V4, P1294, DOI 10.1002/cam4.473
   Dickson EL, 2014, GYNECOL ONCOL, V133, P405, DOI 10.1016/j.ygyno.2014.03.552
   Engesaether B NM, 2017, IMPLEMENTERING HPV T
   Estrade C, 2014, J CLIN MICROBIOL, V52, P607, DOI 10.1128/JCM.02749-13
   Hesselink AT, 2016, J CLIN VIROL, V76, P36, DOI 10.1016/j.jcv.2016.01.009
   Holland NT, 2003, MUTAT RES-REV MUTAT, V543, P217, DOI 10.1016/S1383-5742(02)00090-X
   IARC, 2012, MON EV CARC RISKS HU, V100B, P255
   Jung S, 2016, ARCH PATHOL LAB MED, V140, P276, DOI 10.5858/arpa.2015-0117-OA
   Kavanagh K, 2014, BRIT J CANCER, V110, P2804, DOI 10.1038/bjc.2014.198
   Kwon MJ, 2014, J CLIN VIROL, V59, P246, DOI 10.1016/j.jcv.2014.01.015
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Latsuzbaia A, 2016, DIAGN MICR INFEC DIS, V85, P318, DOI 10.1016/j.diagmicrobio.2016.04.011
   Lee DH, 2015, ANN CLIN BIOCH
   Lie AK, 2018, GYNECOL ONCOL, V148, P111, DOI 10.1016/j.ygyno.2017.10.031
   Lim YK, 2016, J CLIN LAB ANAL
   Marcuccilli F, 2015, J VIROL METHODS, V217, P8, DOI 10.1016/j.jviromet.2015.02.018
   Meijer CJLM, 2009, J CLIN VIROL, V46, pS1, DOI 10.1016/S1386-6532(09)00540-X
   Meijer CJLM, 2009, INT J CANCER, V124, P516, DOI 10.1002/ijc.24010
   Norsk gynekologisk forening, 2009, VEL GYN ONK PREM LID
   Ostrbenk A, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01176-18
   Pasquier C, 2017, DIAGN MICR INFEC DIS, V87, P25, DOI 10.1016/j.diagmicrobio.2016.08.022
   Psifidi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115960
   Ratnam S, 2010, J CLIN MICROBIOL, V48, P2779, DOI 10.1128/JCM.00382-10
   Szarewski A, 2008, CANCER EPIDEM BIOMAR, V17, P3033, DOI 10.1158/1055-9965.EPI-08-0508
   Szarewski A, 2012, J CLIN MICROBIOL, V50, P1867, DOI 10.1128/JCM.00181-12
   Tavassoli FA, 2003, WHO CLASSIFICATION T, V5
   Tota JE, 2015, CANCER EPIDEM BIOMAR, V24, P286, DOI 10.1158/1055-9965.EPI-14-0566
   Trope A, 2009, J CLIN MICROBIOL, V47, P2458, DOI 10.1128/JCM.01863-08
   Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064
NR 34
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 23
PY 2019
VL 14
IS 1
AR e0210997
DI 10.1371/journal.pone.0210997
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HI4TC
UT WOS:000456442800062
PM 30673759
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Winking, J
   Hopkins, AL
   Yeoman, M
   Arcak, C
AF Winking, Jeffrey
   Hopkins, Allison L.
   Yeoman, Michelle
   Arcak, Cory
TI M-AAA-nsplaining: Gender bias in questions asked at the American
   Anthropological Association's Annual Meetings
SO PLOS ONE
LA English
DT Article
ID WOMEN
AB A large body of research has revealed the challenges that disproportionately affect women as they climb the academic ladder. One area that has received relatively little attention is women's experiences at academic conferences, which are often integral to academics' professional development. As conferences are attended by professional colleagues and influential players in specific fields, the professional consequences of any gender bias in criticism are likely to be amplified at such venues. Here, we explore the degree to which the likelihood of audience members asking a question and offering criticism is associated with the gender of a presenter. Audience questions were tabulated during the authors' visits to the three American Anthropological Association Annual Meetings. The results suggested that men were indeed marginally more likely to ask a question, both when considering all types of questions and when considering only critical questions. However, there was no evidence that they differentially targeted women for these questions. Future research might explore what motivates assertive and critical speech in men and women and how their experiences in receiving it might differ, particularly in academic settings in which critical speech might be considered more acceptable.
C1 [Winking, Jeffrey; Hopkins, Allison L.; Yeoman, Michelle] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA.
   [Yeoman, Michelle] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA.
   [Arcak, Cory] Texas A&M Univ, MSC LT Jordan Inst Int Awareness, College Stn, TX 77843 USA.
RP Winking, J (reprint author), Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA.
EM jwinking@tamu.edu
FU Diversity Matters Seed Grant; University Libraries; Office of the Vice
   President for Research
FX This research was funded by the Diversity Matters Seed Grant
   administered by the Texas A&M University Office of Diversity. The open
   access publishing fees for this article have been covered by the Texas
   A&M University Open Access to Knowledge Fund (OAKFund), supported by the
   University Libraries and the Office of the Vice President for Research.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Altman D. G., 1991, PRACTICAL STAT MED R
   American Anthropological Association, 2013, 2013 ANN REP FUT PUB
   Anderson KJ, 1998, SEX ROLES, V39, P225, DOI 10.1023/A:1018802521676
   Aries E., 1997, WOMEN MEN GENDER ONG, P91
   CAMERON Deborah, 2008, MYTH MARS VENUS DO M
   Dowdall C., 2014, GRADUATES 2012 REPOR
   Dubois B. L., 1975, LANG SOC, V4, P289
   El Emam K., 1999, Empirical Software Engineering, V4, P113
   Ginsberg D., 2016, SURVEY RESPONDENTS G
   Hill C., 2010, WHY SO FEW WOMEN SCI
   Hopkins AL, 2013, SCIENTOMETRICS, V96, P515, DOI 10.1007/s11192-012-0893-4
   Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581
   Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005
   Isbell LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049682
   James D, 1993, UNDERSTANDING GENDER
   Jesperson Otto, 1922, LANGUAGE ITS NATURE
   Jones TM, 2014, PEERJ, V2, DOI 10.7717/peerj.627
   Karpowitz CF, 2012, AM POLIT SCI REV, V106, P533, DOI 10.1017/S0003055412000329
   Lakoff R., 1975, LANGUAGE WOMANS PLAC
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leaper C, 2007, PERS SOC PSYCHOL REV, V11, P328, DOI 10.1177/1088868307302221
   Machung A., 2012, 2 SHIFT WORKING FAMI
   MacNell L, 2015, INNOV HIGH EDUC, V40, P291, DOI 10.1007/s10755-014-9313-4
   McElhinny B., 2003, HDB LANGUAGE GENDER, P21
   MCMILLAN JR, 1977, SEX ROLES, V3, P545, DOI 10.1007/BF00287838
   Monroe K, 2008, PERSPECT POLIT, V6, P215, DOI 10.1017/S1537592708080572
   Pell AN, 1996, J ANIM SCI, V74, P2843
   Reeves A., 2015, NEXTIONS YELLOW PAPE
   Schroeder J, 2013, J EVOLUTION BIOL, V26, P2063, DOI 10.1111/jeb.12198
   Settles IH, 2014, SEX ROLES, V71, P71, DOI 10.1007/s11199-014-0355-y
   Shen H., 2015, NATURE NEWS
   Solnit R., 2014, MEN EXPLAIN THINGS M
   Tannen Deborah, 1991, YOU JUST DONT UNDERS
   Valian V., 2005, HYPATIA, V20, P198, DOI DOI 10.1111/J.1527-2001.2005.TB00495.X
   Wasson C., 2008, WEVE COME LONG WAY M
   Weatherall A., 2002, GENDER LANGUAGE DISC
   Young LJ, 2003, NEURAL BASIS PAIR BO
NR 37
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 18
PY 2019
VL 14
IS 1
AR e0207691
DI 10.1371/journal.pone.0207691
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HH8XI
UT WOS:000456017000003
PM 30657759
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hong, EH
   Ryu, SJ
   Kang, MH
   Seong, M
   Cho, H
   Yeom, JH
   Shin, YU
AF Hong, Eun Hee
   Ryu, So Jung
   Kang, Min Ho
   Seong, Mincheol
   Cho, Heeyoon
   Yeom, Jong Hun
   Shin, Yong Un
TI Comparison of repeatability of swept-source and spectral-domain optical
   coherence tomography for measuring inner retinal thickness in retinal
   disease
SO PLOS ONE
LA English
DT Article
ID NERVE-FIBER LAYER; CHOROIDAL THICKNESS; EPIRETINAL MEMBRANE;
   REPRODUCIBILITY; AGREEMENT; EYES
AB Purpose
   To compare repeatability between SS-OCT and SD-OCT for measurement of macular, macular retinal nerve fiber (mRNFL), and ganglion cell-inner plexiform layer (GC-IPL) thickness in various retinal diseases.
   Methods
   One hundred and fourteen eyes of 114 subjects were investigated. Seventy-eight eyes with retinal disease and 36 normal eyes underwent two consecutive measurements of macular, mRNFL, and GC-IPL thickness using SS-OCT and SD-OCT. The data were obtained using the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol. The eyes with retinal diseases were divided into three subgroups according to central macular thickness (CMT) for analysis. The intraclass correlation coefficient (ICC) was calculated to determine the repeatability of OCT device.
   Results
   In normal eyes, both OCT devices showed excellent repeatability of macula, mRNFL, and GC-IPL thickness measurements with high ICCs in all ETDRS subfields. In eyes with retinal disease, although SS-OCT showed better repeatability for inner retinal thickness measurements than SD-OCT, the overall ICCs were lower than those in normal eyes. In subgroup analysis, the ICCs in the low CMT group were lower than those in the normal and high CMT groups, particularly when using SD-OCT.
   Conclusions
   Both OCT devices had comparable repeatability for retinal thickness measurement in normal eyes and eyes with retinal disease. However, the possibility of measurement error should be considered in eyes with a thin and atrophic retina.
C1 [Hong, Eun Hee; Ryu, So Jung; Kang, Min Ho; Seong, Mincheol; Cho, Heeyoon; Shin, Yong Un] Hanyang Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea.
   [Yeom, Jong Hun] Hanyang Univ, Dept Anesthesiol & Pain Med, Coll Med, Seoul, South Korea.
RP Shin, YU (reprint author), Hanyang Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea.
EM syu2000@hanmail.net
FU Hanyang University [HY-201800000000614]
FX This work was supported by the research fund of Hanyang University
   (HY-201800000000614) (YUS). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alshareef RA, 2016, BRIT J OPHTHALMOL, V100, P1506, DOI 10.1136/bjophthalmol-2015-308106
   Branchini L, 2012, OPHTHALMOLOGY, V119, P119, DOI 10.1016/j.ophtha.2011.07.002
   CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035
   Copete S, 2014, BRIT J OPHTHALMOL, V98, P334, DOI 10.1136/bjophthalmol-2013-303904
   Donner A, 2002, J ROY STAT SOC D-STA, V51, P367, DOI 10.1111/1467-9884.00324
   Gabriele ML, 2011, INVEST OPHTH VIS SCI, V52, P2425, DOI 10.1167/iovs.10-6312
   Gao E, 2015, COMP RETINAL THICKNE, V10
   Hirata M, 2011, INVEST OPHTH VIS SCI, V52, P4971, DOI 10.1167/iovs.11-7729
   Kafieh Raheleh, 2013, J Med Signals Sens, V3, P45
   Keane PA, 2009, BRIT J OPHTHALMOL, V93, P1461, DOI 10.1136/bjo.2008.155846
   Krebs I, 2010, OPHTHALMOLOGY, V117, P1577, DOI 10.1016/j.ophtha.2010.04.032
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee EK, 2014, OPHTHALMOLOGY, V121, P1579, DOI 10.1016/j.ophtha.2014.02.010
   Lee HJ, 2015, INVEST OPHTH VIS SCI, V56, P4554, DOI 10.1167/iovs.15-16949
   Lee HJ, 2015, AM J OPHTHALMOL, V160, P283, DOI 10.1016/j.ajo.2015.05.015
   Lee SY, 2017, J GLAUCOMA, V26, pE46, DOI [10.1097/IJG.000000000000536, 10.1097/IJG.0000000000000536]
   Mansouri K, 2014, AM J OPHTHALMOL, V157, P1022, DOI 10.1016/j.ajo.2014.02.008
   Matlach J, 2014, INVEST OPHTH VIS SCI, V55, P6536, DOI 10.1167/iovs.14-15072
   Min JK, 2017, CURR EYE RES, V42, P307, DOI 10.3109/02713683.2016.1170855
   Mrejen S, 2013, SURV OPHTHALMOL, V58, P387, DOI 10.1016/j.survophthal.2012.12.001
   Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962
   Polito A, 2002, AM J OPHTHALMOL, V134, P240, DOI 10.1016/S0002-9394(02)01528-3
   PULIAFITO CA, 1995, OPHTHALMOLOGY, V102, P217
   Regatieri CV, 2012, RETINA-J RET VIT DIS, V32, P563, DOI [10.1097/IAE.0B013E31822F5678, 10.1097/IAE.0b013e31822f5678]
   Sabater AL, 2014, BIOMED RES INT, DOI 10.1155/2014/458631
   Seong M, 2010, INVEST OPHTH VIS SCI, V51, P1446, DOI 10.1167/iovs.09-4258
   Shin IH, 2018, RETINA-J RET VIT DIS, V38, P253, DOI 10.1097/IAE.0000000000001535
   Tan CS, 2015, OSLI RETINA, V46, P172, DOI 10.3928/23258160-20150213-23
   Toteberg-Harms M, 2012, GRAEF ARCH CLIN EXP, V250, P279, DOI 10.1007/s00417-011-1811-9
   Wu HJ, 2011, J GLAUCOMA, V20, P470, DOI 10.1097/IJG.0b013e3181f3eb64
   Yasuno Y, 2007, OPT EXPRESS, V15, P6121, DOI 10.1364/OE.15.006121
NR 31
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 16
PY 2019
VL 14
IS 1
AR e0210729
DI 10.1371/journal.pone.0210729
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HH6BK
UT WOS:000455813300073
PM 30650130
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Rodriguez-Morejon, A
   Zamanillo, A
   Iglesias, G
   Moreno-Gamez, A
   Navas-Campana, D
   Moreno-Peral, P
   Rodriguez-Arias, JL
AF Rodriguez-Morejon, Alberto
   Zamanillo, Alberto
   Iglesias, Gabriel
   Moreno-Gamez, Alberto
   Navas-Campana, Desiree
   Moreno-Peral, Patricia
   Luis Rodriguez-Arias, Jose
TI Development of the therapeutic language coding system (SICOLENTE):
   Reliability and construct validity
SO PLOS ONE
LA English
DT Article
ID GENERALIZABILITY THEORY; PSYCHOTHERAPY-RESEARCH; ANALYTIC PROCESS;
   CLIENT; GLORIA; ELLIS; CONVERSATION; BEHAVIOR; ROGERS; PERLS
AB Since the use of language is a core aspect of psychotherapy, its study requires instruments that allow for further research. The aim of this study is to present an observational instrument capable of analyzing the language used in psychotherapeutic settings, both by therapists and clients. The SICOLENTE instrument was applied to two different samples: The Three Approaches to Psychotherapy film and a naturalistic sample. 7710 utterances from 31 sessions (three from the demonstration film and 28 from a naturalistic setting) were coded. Two studies were conducted: in the first study, inter and intra coder reliability (dimension and category levels) and Generalizability theory analyzes were assessed, whilst in the second study, construct validity was tested with several hypotheses. The final instrument resulted in 20 categories with three dimensions: Conversational Act (7 categories), Therapeutic topic (6 categories) and Content (7 categories). The three dimensions showed excellent inter and intra coder reliability and the generalizability coefficients were excellent. Out of the 24 validity hypothesis proposed, 19 were accepted. The finding suggests that the SICOLENTE is a reliable and valid instrument that can be applied to investigate the performance of various theoretical models. Its three dimensional structure gives it the flexibility to be able to carry out macroscopic or microscopic language research.
C1 [Rodriguez-Morejon, Alberto; Zamanillo, Alberto] Univ Malaga, Dept Personal Assessment & Psychol Treatment, Malaga, Spain.
   [Rodriguez-Morejon, Alberto; Moreno-Peral, Patricia] Inst Biomed Res Malaga, Malaga, Spain.
   [Rodriguez-Morejon, Alberto; Moreno-Peral, Patricia] Prevent & Hlth Promot Res Network, Malaga, Spain.
   [Navas-Campana, Desiree] Univ Loyola Andalucia, Seville, Spain.
   [Moreno-Peral, Patricia] Primary Care Dist Malaga Guadalhorce, Res Unit, Malaga, Spain.
   [Luis Rodriguez-Arias, Jose] CHUAC, La Coruna, Spain.
RP Rodriguez-Morejon, A (reprint author), Univ Malaga, Dept Personal Assessment & Psychol Treatment, Malaga, Spain.; Rodriguez-Morejon, A (reprint author), Inst Biomed Res Malaga, Malaga, Spain.; Rodriguez-Morejon, A (reprint author), Prevent & Hlth Promot Res Network, Malaga, Spain.
EM aromore@uma.es
OI Zamanillo Diaz, Alberto/0000-0003-3424-5017; Navas Campana,
   Desiree/0000-0001-6469-1718; Moreno-Peral, Patricia/0000-0003-4130-9090
CR American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Anderson H., 1997, CONVERSATION LANGUAG
   Anguera M. T., 1990, METODOLOGIA INVESTIG, P125
   Bakeman R., 2011, SEQUENTIAL ANAL OBSE
   Barber JP, 1996, DRUG ALCOHOL DEPEN, V43, P125, DOI 10.1016/S0376-8716(96)01305-1
   Barbosa E, 2017, PSYCHOTHER RES, V27, P89, DOI 10.1080/10503307.2015.1072286
   Bavelas J. B., 2000, HUMAN SYSTEMS, V11, P3
   Bavelas J, 2017, J PRAGMATICS, V121, P91, DOI 10.1016/j.pragma.2017.09.006
   Beck A. T., 1979, COGNITIVE THERAPY DE
   Briesch AM, 2014, J SCHOOL PSYCHOL, V52, P13, DOI 10.1016/j.jsp.2013.11.008
   BRUNINK SA, 1979, J CONSULT CLIN PSYCH, V47, P567, DOI 10.1037/0022-006X.47.3.567
   Busch AM, 2009, BEHAV THER, V40, P280, DOI 10.1016/j.beth.2008.07.003
   Campbell C., 2003, COUNS EDUC SUPERV, V43, P15, DOI DOI 10.1002/J.1556-6978
   Carroll KM, 2000, DRUG ALCOHOL DEPEN, V57, P225, DOI 10.1016/S0376-8716(99)00049-6
   CHEN CL, 1981, J COMMUN DISORD, V14, P311, DOI 10.1016/0021-9924(81)90015-0
   Cooper M, 1992, PSYCHODYNAMIC INTERV
   Corsini RJ, 2011, CURRENT PSYCHOTHERAP
   Cronbach LJ, 1972, DEPENDABILITY BEHAV
   Cunha C, 2012, PSYCHOTHERAPY, V49, P536, DOI 10.1037/a0028259
   De Shazer S., 1994, WORDS WERE ORIGINALL
   Ellis A, 2011, RATIONAL EMOTIVE BEH
   ESSIG TS, 1990, PSYCHOTHER, V27, P271, DOI 10.1037/0033-3204.27.2.271
   Fleiss JL, 1981, STAT METHODS RATES P
   Freud Sigmund, 1916, WIT ITS RELATION UNC
   Gabin B, 2012, PROCD SOC BEHV, V46, P4692, DOI 10.1016/j.sbspro.2012.06.320
   Goldfried MR, 1989, CODING SYSTEM THERAP
   Gumz A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01705
   Hayes SC, 2011, ACCEPTANCE COMMITMEN
   HILL CE, 1979, J COUNS PSYCHOL, V26, P198, DOI 10.1037/0022-0167.26.3.198
   Hilsenroth MJ, 2005, PSYCHOTHERAPY, V42, P340, DOI 10.1037/0033-3204.42.3.340
   Hollon SD, 1984, ANN M AM PSYCH ASS
   Korman H., 2013, J SYSTEMIC THERAPIES, V32, P31, DOI DOI 10.1521/JSYT.2013.32.3.31
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mahoney M., 2003, CONSTRUCTIVE PYCHOTH
   Malan DH, 1963, STUDY BRIEF PSYCHOTH
   MERCIER MA, 1984, J COUNS PSYCHOL, V31, P161, DOI 10.1037/0022-0167.31.2.161
   Perls F. S, 1969, GESTALT THERAPY VERB
   PIPER WE, 1987, B MENNINGER CLIN, V51, P532
   Poole MS, 2016, RES INTERACTIVE COMM, P217
   Rodriguez A., 2004, PAPELES PSICOLOGO, P1
   Rodriguez-Arias JL, 2004, PAPELES PSICOLOGO, V25
   Rodriguez-Arias JL, 2006, GUIA SISTEMATIZAR TR
   Rodriguez-Morejon A, 2016, AN PSICOL-SPAIN, V32, P1, DOI 10.6018/analesps.32.1.192551
   Rogers C., 1961, BECOMING PERSON THER
   Ruiz-Sancho EM, 2013, BEHAV MODIF, V37, P516, DOI 10.1177/0145445513477127
   SCHINDLER L, 1989, BRIT J CLIN PSYCHOL, V28, P213, DOI 10.1111/j.2044-8260.1989.tb01371.x
   Shapiro DA, 1990, 1154 U SHEFF
   Shostrom E., 1965, 3 APPROACHES PSYCHOT
   SHOSTROM EL, 1968, J CONSULT CLIN PSYCH, V32, P628, DOI 10.1037/h0026596
   Smock-Jordan S., 2013, J SYSTEMIC THERAPIES, V32, P46
   STILES WB, 1995, J CONSULT CLIN PSYCH, V63, P15, DOI 10.1037/0022-006X.63.1.15
   Tomori C, 2007, J FAM PSYCHOTHER, V18, P25, DOI 10.1300/J085v18n03_03
   Vaughan SC, 1997, INT J PSYCHOANAL, V78, P959
   Waldron S, 2004, PSYCHOANAL QUART, V73, P1079, DOI 10.1002/j.2167-4086.2004.tb00193.x
   Wampold B. E., 2010, BASICS PSYCHOTHERAPY
   Wasserman RH, 2009, PSYCHOTHER RES, V19, P397, DOI 10.1080/10503300802579156
   WEINRACH SG, 1986, PSYCHOTHER, V23, P642, DOI 10.1037/h0085670
   Weinrach SG, 2001, J RATION COGN THER, V19, P43, DOI [10.1023/A:1007895216709, DOI 10.1023/A:1007895216709]
   Weiste E, 2013, RES LANG SOC INTERAC, V46, P299, DOI 10.1080/08351813.2013.839093
   White M, 1990, NARRATIVE MEANS THER
   Wickman SA, 2003, J COUNS DEV, V81, P178, DOI 10.1002/j.1556-6678.2003.tb00239.x
   Young J., 1980, COGNITIVE THERAPY SC
   Zhao X., 2013, COMMUNICATION YB, V36, P419, DOI DOI 10.1080/23808985.2013.11679142
NR 63
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 26
PY 2018
VL 13
IS 12
AR e0209751
DI 10.1371/journal.pone.0209751
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HF7JV
UT WOS:000454416400091
PM 30586469
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Arantes, R
   Welch, JR
   Tavares, FG
   Ferreira, AA
   Vettore, MV
   Coimbra, CEA
AF Arantes, Rui
   Welch, James R.
   Tavares, Felipe Guimaraes
   Ferreira, Aline Alves
   Vettore, Mario Vianna
   Coimbra, Carlos E. A., Jr.
TI Human ecological and social determinants of dental caries among the
   Xavante Indigenous people in Central Brazil
SO PLOS ONE
LA English
DT Article
ID ORAL-HEALTH INEQUALITIES; INDIANS; TRANSITION; GENDER; GROWTH; SALIVA
AB This community study evaluates complex interactions between macro and micro determinants of oral health in a local Indigenous population based on a theoretical framework of demographic, economic, and healthcare transformation over the last half century. The study population included all residents of eight Xavante villages in Central Brazil. Our hypothetical model posited multiple direct and indirect associations between dental caries and village groups with differentiated territorial and oral care histories, as well as household socioeconomic indicators and food acquisition patterns, individual sociodemographic characteristics, use of dental health services, and oral hygiene practices. Structural equation modelling methods were used to evaluate direct and indirect associations linking exogenous factors and dental caries. Results include 18 direct and 14 indirect statistically significant pathways between determinant variables and dental caries. Significant links with dental caries were shown for socioeconomic indicators, oral healthcare variables, household food acquisition patterns, sex, and age. These findings suggest that the oral health of Xavante residents in the villages studied is associated with determinant factors of different epidemiological and historical scales. The specific historical frame of territorial circumscription and demographic crisis followed by rapid population increase since the 1970s should be considered a causeof-cause determinant of the economic, healthcare, and sociodemographic profile contributing to oral health among the Xavante. Considering the limitations of cross-sectional studies, our findings underline the importance for oral health determination of historical currents affecting minority ethnic groups within national societies.
C1 [Arantes, Rui] Fundacao Oswaldo Cruz Mato Grosso do Sul, Campo Grande, MS, Brazil.
   [Welch, James R.; Coimbra, Carlos E. A., Jr.] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil.
   [Tavares, Felipe Guimaraes] Univ Fed Fluminense, Escola Enfermagem Aurora de Afonso Costa, Niteroi, RJ, Brazil.
   [Ferreira, Aline Alves] Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Rio De Janeiro, RJ, Brazil.
   [Vettore, Mario Vianna] Univ Sheffield, Sch Clin Dent, Sheffield, S Yorkshire, England.
RP Arantes, R (reprint author), Fundacao Oswaldo Cruz Mato Grosso do Sul, Campo Grande, MS, Brazil.
EM rui.arantes@fiocruz.br
OI Ferreira, Aline Alves/0000-0001-5081-3462; Guimaraes Tavares,
   Felipe/0000-0002-8308-6203; , Rui/0000-0002-0318-9465; Coimbra Jr.,
   Carlos E. A./0000-0003-4085-1080
FU Escola Nacional de Saude Publica, Fundacao Oswaldo Cruz, through the
   INOVA-ENSP program [0059]
FX Research funding was generously provided by the Escola Nacional de Saude
   Publica, Fundacao Oswaldo Cruz, through the INOVA-ENSP program
   (Registration 0059). No individuals employed or contracted by the
   funders (other than the named authors) played any role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536
   Alves P, 2014, REV PANAM SALUD PUBL, V35, P67
   Andersen AMN, 2007, INT J EPIDEMIOL, V36, P540, DOI 10.1093/ije/dym110
   Anderson I, 2016, LANCET, V388, P131, DOI 10.1016/S0140-6736(16)00345-7
   Arantes R, 2001, Cad Saude Publica, V17, P375, DOI 10.1590/S0102-311X2001000200012
   Arantes Rui, 2010, Rev. bras. epidemiol., V13, P223
   Arantes R, 2016, J HEALTH CARE POOR U, V27, P81, DOI 10.1353/hpu.2016.0043
   Arantes R, 2010, INT DENT J, V60, P235, DOI 10.1922/IDJ_2569Arantes06
   Arantes R, 2009, ANN HUM BIOL, V36, P162, DOI 10.1080/03014460802672844
   Barker Graeme, 2009, AGR REVOLUTION PREHI
   Bocquet-Appel JP, 2011, SCIENCE, V333, P560, DOI 10.1126/science.1208880
   Boing Antonio Fernando, 2014, Rev. bras. epidemiol., V17, P102, DOI 10.1590/1809-4503201400060009
   Bond C, 2007, BANDAIDS EXPLORING U, P229
   Bongaarts J, 2009, PHILOS T R SOC B, V364, P2985, DOI 10.1098/rstb.2009.0137
   Buikstra J. E., 1992, DIS DEMOGRAPHY AM, P87
   CARLOS J. P., 1965, ARCH ORAL BIOL, V10, P739, DOI 10.1016/0003-9969(65)90127-5
   Coimbra CEA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-52
   Coimbra CEA, 2002, XAVANTE TRANSITION H
   Coimbra-JR C. E. A., 1991, CAD SAUDE PUBLICA, V7, P538
   Costa SD, 2013, CIENC SAUDE COLETIVA, V18, P461, DOI 10.1590/S1413-81232013000200017
   Diehl EE, 2014, CAD SAUDE PUBLICA, V30, P867, DOI 10.1590/0102-311X00030014
   Dodds MWJ, 2005, J DENT, V33, P223, DOI 10.1016/j.jdent.2004.10.009
   Eggers S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023962
   Ferreira AA, 2016, ANN HUM BIOL, V43, P293, DOI 10.1080/03014460.2016.1195445
   Ferreira AA, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-3
   Ferreira Aline Alves, 2017, Rev. bras. epidemiol., V20, P102, DOI 10.1590/1980-5497201700010009
   Flowers NM, 1988, S AM INDIAN STUD, V5, P18
   Flowers NM, 1944, S AM INDIAN STUD, V4, P18
   Godoy R, 2005, ANNU REV ANTHROPOL, V34, P121, DOI 10.1146/annurev.anthro.34.081804.120412
   Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4
   Graham Laura, 2014, PERFORMING INDIGENEI, P305
   Guiotoku SK, 2012, REV PANAM SALUD PUBL, V31, P135, DOI 10.1590/S1020-49892012000200007
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   King M, 2009, LANCET, V374, P76, DOI 10.1016/S0140-6736(09)60827-8
   KUH D, 1997, LIFE COURSE APPROACH
   Kuhnlein HV, 1996, ANNU REV NUTR, V16, P417, DOI 10.1146/annurev.nu.16.070196.002221
   Laine MA, 2002, ACTA ODONTOL SCAND, V60, P257, DOI 10.1080/00016350260248210
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lucena JRM, 2016, BMC NUTR, V2
   Lukacs JR, 2006, AM J HUM BIOL, V18, P540, DOI 10.1002/ajhb.20530
   MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037//1082-989X.7.1.83
   Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)71146-6
   Narvai PC, 2006, REV PANAM SALUD PUBL, V19, P385, DOI 10.1590/S1020-49892006000600004
   NEEL JV, 1964, AM J HUM GENET, V16, P52
   NISWANDER JD, 1967, AM J HUM GENET, V19, P543
   Oliver JR, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P185, DOI 10.1007/978-0-387-74907-5_12
   Patrick Donald L, 2006, BMC Oral Health, V6 Suppl 1, pS4, DOI 10.1186/1472-6831-6-S1-S4
   Peres MA, 2013, REV SAUDE PUBL, V47, P78, DOI 10.1590/S0034-8910.2013047004226
   Santos R. V, 2013, HUMAN ENV INTERACTIO, P29
   Schuch HS, 2017, COMMUNITY DENT ORAL, V45, P434, DOI 10.1111/cdoe.12307
   Sisson KL, 2007, COMMUNITY DENT ORAL, V35, P81, DOI 10.1111/j.1600-0528.2007.00354.x
   Thomson WM, 2012, COMMUNITY DENT ORAL, V40, P28, DOI 10.1111/j.1600-0528.2012.00716.x
   Wagner G, 2011, QUATERN INT, V239, P51, DOI 10.1016/j.quaint.2011.03.009
   Watt RG, 2012, COMMUNITY DENT ORAL, V40, P44, DOI 10.1111/j.1600-0528.2012.00719.x
   Watt RG, 2007, COMMUNITY DENT ORAL, V35, P1, DOI 10.1111/j.1600-0528.2007.00348.x
   Welch JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081226
   Welch JR, 2009, HUM ECOL, V37, P13, DOI 10.1007/s10745-009-9216-7
   Welch JR, 2013, 1 MARGEM RIO TERRITO
   Williams DR, 2016, J HEALTH POLIT POLIC, V41, P627, DOI 10.1215/03616878-3620857
   World Health Organization, 1997, ORAL HLTH SURVEYS BA
NR 60
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 19
PY 2018
VL 13
IS 12
AR e0208312
DI 10.1371/journal.pone.0208312
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HE9NT
UT WOS:000453779300034
PM 30566453
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-07-16
ER

PT J
AU Ehsani-Moghaddam, B
   Queenan, JA
   MacKenzie, J
   Birtwhistle, RV
AF Ehsani-Moghaddam, Behrouz
   Queenan, John A.
   MacKenzie, Jennifer
   Birtwhistle, Richard, V
TI Mucopolysaccharidosis type II detection by Naive Bayes Classifier: An
   example of patient classification for a rare disease using electronic
   medical records from the Canadian Primary Care Sentinel Surveillance
   Network
SO PLOS ONE
LA English
DT Article
AB Identifying patients with rare diseases associated with common symptoms is challenging. Hunter syndrome, or Mucopolysaccharidosis type II is a progressive rare disease caused by a deficiency in the activity of the lysosomal enzyme, iduronate 2-sulphatase. It is inherited in an X-linked manner resulting in males being significantly affected. Expression in females varies with the majority being unaffected although symptoms may emerge over time. We developed a Naive Bayes classification (NBC) algorithm utilizing the clinical diagnosis and symptoms of patients contained within their de-identified and unstructured electronic medical records (EMR) extracted by the Canadian Primary Care Sentinel Surveillance Network (CPCSSN). To do so, we created a training dataset using published results in the scientific literature and from all MPS II symptoms and applied the training dataset and its independent features to compute the conditional posterior probabilities of having MPS II disease as a categorical dependent variable for 506497 male patients. The classifier identified 125 patients with the highest likelihood for having the disease and 18 features were selected to be necessary for forecasting. Next, a Recursive Backward Feature Elimination algorithm was employed, for optimal input features of the NBC model, using a k-fold Cross-Validation with 3 replicates. The accuracy of the final model was estimated by the Validation Set Approach technique and the bootstrap resampling. We also investigated that whether the NBC is as accurate as three other Bayesian networks. The Naive Bayes Classifier appears to be an efficient algorithm in assisting physicians with the diagnosis of Hunter syndrome allowing optimal patient management.
C1 [Ehsani-Moghaddam, Behrouz; Queenan, John A.; Birtwhistle, Richard, V] Queens Univ, Dept Family Med, Ctr Studies Primary Care, Kingston, ON, Canada.
   [MacKenzie, Jennifer] McMaster Univ, Dept Pediat, Div Genet, Hamilton, ON, Canada.
RP Ehsani-Moghaddam, B (reprint author), Queens Univ, Dept Family Med, Ctr Studies Primary Care, Kingston, ON, Canada.
EM behrouz.ehsani@dfm.queensu.ca
OI Ehsani-Moghaddam, Behrouz/0000-0002-5038-1118; Birtwhistle,
   Richard/0000-0002-9937-7355
FU Shire Canada [2016SRSC68]
FX This project was entirely funded by a grant from Shire Canada
   (https://www.shirecanada.com) to Dr Richard Birtwhistle's research
   project (2016SRSC68) and there was no additional external funding
   received for this study. Shire Canada has played no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR [Anonymous], 2016, MUCOPOLYSACCHARIDOSI
   [Anonymous], 2018, SUPP CUTT EDG RAR DI
   [Anonymous], 2017, GUID UND NUC MPS 2
   BACH G, 1973, P NATL ACAD SCI USA, V70, P2134, DOI 10.1073/pnas.70.7.2134
   Beleites C, 2013, ANAL CHIM ACTA, V760, P25, DOI 10.1016/j.aca.2012.11.007
   Canada's Rare Disease Strategy, 2017, CAN RAR DIS STRAT
   Cheng J, 2001, P 14 CAN C ART INT
   COOPER GF, 1990, ARTIF INTELL, V42, P393, DOI 10.1016/0004-3702(90)90060-D
   COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110
   Efron B, 1993, INTRO BOOTSTRAP
   Ehsani-Moghaddam B, 2018, ZERO INFLATED UNPUB
   Figueroa RL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-8
   Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199
   Groza T, 2015, AM J HUM GENET, V97, P111, DOI 10.1016/j.ajhg.2015.05.020
   Heckerman D, 1997, DATA MIN KNOWL DISC, V1, P79, DOI 10.1023/A:1009730122752
   HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1023/A:1022623210503
   James G, 2013, SPRINGER TEXTS STAT, V103, P175, DOI 10.1007/978-1-4614-7138-7_5
   Johnson BA, 2013, CURR PROTOC HUM GENE, V79
   Kuhn M., 2016, APPL PREDICTIVE MODE, V19, P491
   Kuhn M, 2008, J STAT SOFTW, V28, P1
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lowd D., 2005, P 22 INT C MACH LEAR, P529
   Madden MG, 2009, RES DEV INTELLIGENT
   Martin R, 2008, PEDIATRICS, V121, pE377, DOI 10.1542/peds.2007-1350
   Menec V, 2000, DEFINING PRACTICE PO
   Miller Tim, 2017, ARXIV170607269
   Mohan V., DECISION TREES COMPA
   Molnar C., 2018, INTERPRETABLE MACHIN
   Muir SW, 2010, PHYS THER, V90, P338, DOI 10.2522/ptj.20090163
   Needham M, 2015, J GENET COUNS, V24, P635, DOI 10.1007/s10897-014-9791-7
   Ribeiro M., 2016, ACM SIGKDD INT C KNO
   Rokach L, 2005, DATA MINING KNOWLEDG
   Schwartz IVD, 2007, ACTA PAEDIATR, V96, P63, DOI 10.1111/j.1651-2227.2007.00212.x
   Shen Feichen, 2017, AMIA Annu Symp Proc, V2017, P1554
   Stern MK, 1999, BAYES CLASSIFIERS US
   Subbalakshmi G., 2011, INDIAN J COMPUTER SC, V2, P170
   Zhang H., 2004, P 17 INT FLOR ART IN
NR 37
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 19
PY 2018
VL 13
IS 12
AR e0209018
DI 10.1371/journal.pone.0209018
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HE9NT
UT WOS:000453779300064
PM 30566525
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU de Knegt, MC
   Haugen, M
   Linde, JJ
   Kuhl, JT
   Nordestgaard, BG
   Kober, LV
   Hove, JD
   Kofoed, KF
AF de Knegt, Martina C.
   Haugen, Morten
   Linde, Jesper J.
   Kuhl, Jorgen Tobias
   Nordestgaard, Borge G.
   Kober, Lars, V
   Hove, Jens D.
   Kofoed, Klaus F.
TI Reproducibility of quantitative coronary computed tomography angiography
   in asymptomatic individuals and patients with acute chest pain
SO PLOS ONE
LA English
DT Article
ID ARTERY-DISEASE; CT ANGIOGRAPHY; PLAQUE BURDEN; HIGH-RISK;
   QUANTIFICATION; AGREEMENT; SOFTWARE; LESIONS
AB Purpose
   Quantitative computed tomography (QCT) provides important prognostic information of coronary atherosclerosis. We investigated intraobserver and interobserver QCT reproducibility in asymptomatic individuals, patients with acute chest pain without acute coronary syndrome (ACS), and patients with acute chest pain and ACS.
   Methods
   Fifty patients from each cohort, scanned between 01/02/2010-14/11/2013 and matched according to age and gender, were retrospectively assessed for inclusion. Patients with no coronary artery disease, previous coronary artery bypass graft surgery, and poor image quality were excluded. Coronary atherosclerosis was measured semi-automatically by 2 readers. Reproducibility of minimal lumen area (MLA), minimal lumen diameter (MLD), area stenosis, diameter stenosis, vessel remodeling, plaque eccentricity, plaque burden, and plaque volumes was assessed using concordance correlation coefficient (CCC), Bland-Altman, coefficient of variation, and Cohen's kappa.
   Results
   A total of 84 patients (63 matched) were included. Intraobserver and interobserver reproducibility estimates were acceptable for MLA (CCC = 0.94 and CCC = 0.91, respectively), MLD (CCC = 0.92 and CCC = 0.86, respectively), plaque burden (CCC = 0.86 and CCC = 0.80, respectively), and plaque volume (CCC = 0.97 and CCC = 0.95, respectively). QCT detected area and diameter stenosis >= 50%, positive remodeling, and eccentric plaque with moderate-good intraobserver and interobserver reproducibility (kappa: 0.64-0.66, 0.69-0.76, 0.46-0.48, and 0.41-0.62, respectively). Reproducibility of plaque composition decreased with decreasing plaque density (intraobserver and interobserver CCC for dense calcium (>0.99; 0.98), fibrotic (0.96; 0.93), fibro-fatty (0.95; 0.91), and necrotic core tissue (0.89; 0.84). Reproducibility generally decreased with worsening clinical risk profile.
   Conclusions
   Semi-automated QCT of coronary plaque morphology is reproducible, albeit with some decline in reproducibility with worsening patient risk profile.
C1 [de Knegt, Martina C.; Haugen, Morten; Linde, Jesper J.; Kuhl, Jorgen Tobias; Kober, Lars, V; Kofoed, Klaus F.] Univ Copenhagen, Fac Hlth Sci, Rigshosp, Dept Cardiol, Copenhagen, Denmark.
   [de Knegt, Martina C.; Hove, Jens D.] Univ Copenhagen, Fac Hlth Sci, Dept Cardiol, Hvidovre Hosp, Copenhagen, Denmark.
   [Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth Sci, Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark.
   [Kofoed, Klaus F.] Univ Copenhagen, Fac Hlth Sci, Rigshosp, Dept Radiol, Copenhagen, Denmark.
RP de Knegt, MC (reprint author), Univ Copenhagen, Fac Hlth Sci, Rigshosp, Dept Cardiol, Copenhagen, Denmark.; de Knegt, MC (reprint author), Univ Copenhagen, Fac Hlth Sci, Dept Cardiol, Hvidovre Hosp, Copenhagen, Denmark.
EM martinadeknegt@gmail.com
OI Kofoed, Klaus/0000-0001-9742-1554; de Knegt, Martina/0000-0001-7668-0338
FU Department of Cardiology, Hvidovre Hospital, Copenhagen, Denmark; Danish
   Agency for Science, Technology and Innovation by The Danish Council for
   Strategic Research [09-066994]
FX This study was funded by Department of Cardiology, Hvidovre Hospital,
   Copenhagen, Denmark and Danish Agency for Science, Technology and
   Innovation by The Danish Council for Strategic Research (EDITORS:
   Eastern Denmark initiative to improve Revascularization Strategies,
   Grant 09-066994). These funding sources had no involvement in study
   design; in the collection, analysis and interpretation of data; in the
   writing of the report; or in the decision to submit the article for
   publication.
CR Arbab-Zadeh A, 2018, CIRC-CARDIOVASC IMAG, V11, DOI 10.1161/CIRCIMAGING.118.007992
   Arbab-Zadeh A, 2015, J AM COLL CARDIOL, V65, P846, DOI 10.1016/j.jacc.2014.11.041
   Blackmon KN, 2009, J THORAC IMAG, V24, P96, DOI 10.1097/RTI.0b013e31819b674b
   BLAND JM, 1986, LANCET, V1, P307
   Boogers MJ, 2012, EUR HEART J, V33, P1007, DOI 10.1093/eurheartj/ehr465
   Broersen A, 2016, INT J CARDIOVAS IMAG, V32, P543, DOI 10.1007/s10554-015-0820-x
   Cho IJ, 2018, J AM COLL CARDIOL, V71, P1998, DOI [10.1016/S0735-1097(18)32539-7, 10.1016/j.jacc.2018.02.079]
   Colak Y, 2015, AM J RESP CRIT CARE, V192, P172, DOI 10.1164/rccm.201502-0302OC
   Dalager MG, 2011, INT J CARDIOVAS IMAG, V27, P593, DOI 10.1007/s10554-010-9695-z
   de Graaf MA, 2013, INT J CARDIOVAS IMAG, V29, P1177, DOI 10.1007/s10554-013-0194-x
   de Knegt Martina C, 2018, Eur Heart J Cardiovasc Imaging, DOI 10.1093/ehjci/jey146
   de Knegt MC, 2016, INT J CARDIOVAS IMAG, V32, P1555, DOI 10.1007/s10554-016-0932-y
   Dey D, 2014, J CARDIOVASC COMPUT, V8, P368, DOI 10.1016/j.jcct.2014.07.007
   Ferencik M, 2015, J CARDIOVASC COMPUT, V9, P538, DOI 10.1016/j.jcct.2015.07.003
   Kang DK, 2011, EUR RADIOL, V21, P712, DOI 10.1007/s00330-010-1970-9
   Kristensen TS, 2011, J AM COLL CARDIOL, V58, P502, DOI 10.1016/j.jacc.2011.01.058
   Kuhl JT, 2017, SCAND CARDIOVASC J, V51, P28, DOI 10.1080/14017431.2016.1207799
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Laqmani A, 2016, ROFO-FORTSCHR RONTG, V188, P933, DOI 10.1055/s-0042-110099
   Leipsic J, 2014, J CARDIOVASC COMPUT, V8, P342, DOI 10.1016/j.jcct.2014.07.003
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Linde JJ, 2013, INT J CARDIOL, V168, P5257, DOI 10.1016/j.ijcard.2013.08.020
   Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044
   Ovrehus KA, 2016, J CARDIOVASC COMPUT, V10, P114, DOI 10.1016/j.jcct.2015.11.003
   Papadopoulou SL, 2013, INT J CARDIOVAS IMAG, V29, P1095, DOI 10.1007/s10554-012-0167-5
   Rinehart S, 2011, J CARDIOVASC COMPUT, V5, P35, DOI 10.1016/j.jcct.2010.09.006
   Szilveszter B, 2016, INT J CARDIOVAS IMAG, V32, P161, DOI 10.1007/s10554-015-0741-8
   Versteylen MO, 2013, J AM COLL CARDIOL, V61, P2296, DOI 10.1016/j.jacc.2013.02.065
   Yang GY, 2012, INT J CARDIOVAS IMAG, V28, P921, DOI 10.1007/s10554-011-9894-2
NR 29
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 14
PY 2018
VL 13
IS 12
AR e0207980
DI 10.1371/journal.pone.0207980
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HE3IQ
UT WOS:000453248000012
PM 30550593
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Rousseau, A
   Rozenberg, P
   Perrodeau, E
   Ravaud, P
AF Rousseau, Anne
   Rozenberg, Patrick
   Perrodeau, Elodie
   Ravaud, Philippe
TI Variation in severe postpartum hemorrhage management: A national
   vignette-based study
SO PLOS ONE
LA English
DT Article
ID PELVIC ARTERIAL EMBOLIZATION; OUTCOMES; PREVENTION; FERTILITY; LABOR
AB Objectives
   To assess variations in management of severe postpartum hemorrhage: 1) between obstetricians in the same situation 2) by the same obstetrician in different situations.
   Study design
   A link to a vignette-based survey was emailed to obstetricians of 215 maternity units; the questionnaire asked them to report how they would manage the PPH described in 2 previously validated case-vignettes of different scenarios of severe PPH. Vignette 1 described a typical immediate, severe PPH, and vignette 2 a less typical case of severe but gradual PPH. They were constructed in 3 successive steps and included multiple-choice questions proposing several types of clinical practice options at each step. Variations in PPH were assessed in a descriptive analysis; agreement about management and its timing between vignette 1 and vignette 2 was assessed with the Kappa coefficient.
   Results
   Analysis of complete responses from 119 (43.4%) obstetricians from 53 (24.6%) maternity units showed delayed or inadequate management in both vignettes. While 82.3% and 83.2% of obstetricians (in vignettes 1 and 2, respectively) would administer oxytocin 15 minutes after PPH diagnosis, only 52.9% and 29.4% would alert other team members. Management by obstetricians of the two vignette situations was inconsistent in terms of choice of treatment and timing of almost all treatments.
   Conclusion
   Case vignettes demonstrated inadequate management as well as variations in management between obstetricians and in different PPH situations. Protocols or procedures are necessary in all maternity units to reduce the variations in practices that may explain a part of the delay in management that leads to PPH-related maternal mortality and morbidity.
C1 [Rousseau, Anne; Rozenberg, Patrick] Poissy St Germain Hosp, Dept Obstet & Gynecol, Poissy, France.
   [Rousseau, Anne; Perrodeau, Elodie; Ravaud, Philippe] Paris Descartes Sorbonne Paris Cite Univ, METHODS Methodes Evaluat Therapeut Malad Chron Re, INSERM U1153, Paris, France.
   [Rozenberg, Patrick] Versailles St Quentin Univ, Res Unit EA 7285, St Quentin En Yvelines, France.
   [Perrodeau, Elodie; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, Paris, France.
RP Rousseau, A (reprint author), Poissy St Germain Hosp, Dept Obstet & Gynecol, Poissy, France.; Rousseau, A (reprint author), Paris Descartes Sorbonne Paris Cite Univ, METHODS Methodes Evaluat Therapeut Malad Chron Re, INSERM U1153, Paris, France.
EM anne.rousseau@uvsq.fr
RI ravaud, philippe/C-1694-2009
FU Departement a la Recherche Clinique Ile-de-France, Assistance
   Publique-Hopitaux de Paris [PHRC-AOR13212]
FX This trial was supported by a research grant from the Departement a la
   Recherche Clinique Ile-de-France, Assistance Publique-Hopitaux de Paris,
   which also sponsored the study (PHRC-AOR13212). The study sponsor did
   not participate in the study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. Authors had full
   access to all the data and had final responsibility for the decision to
   submit for publication.; This cross-sectional cohort study was supported
   by a research grant from the Departement a la Recherche Clinique
   Ile-de-France, Assistance Publique-Hopitaux de Paris, which also
   sponsored the study (PHRC-AOR13212).
CR [Anonymous], 2017, BJOG-INT J OBSTET GY, V124, pe106
   Audureau E, 2009, BJOG-INT J OBSTET GY, V116, P1325, DOI 10.1111/j.1471-0528.2009.02238.x
   Bachmann LM, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-50
   Bonnet MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066882
   Bose P, 2006, BJOG-INT J OBSTET GY, V113, P919, DOI 10.1111/j.1471-0528.2006.01018.x
   Callaghan WM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.011
   Doumouchtsis SK, 2014, BJOG-INT J OBSTET GY, V121, P382, DOI 10.1111/1471-0528.12546
   Doumouchtsis SK, 2007, OBSTET GYNECOL SURV, V62, P540, DOI 10.1097/01.ogx.0000271137.81361.93
   Driessen M, 2011, OBSTET GYNECOL, V117, P21, DOI 10.1097/AOG.0b013e318202c845
   Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4
   Geller SE, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.046
   Kayem G, 2011, BJOG-INT J OBSTET GY, V118, P856, DOI 10.1111/j.1471-0528.2011.02921.x
   Kayem G, 2015, BJOG INT J OBSTET GY
   Kim YJ, 2013, J VASC INTERV RADIOL, V24, P703, DOI 10.1016/j.jvir.2013.02.013
   Laas E, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.028
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leduc D, 2009, J OBSTET GYNAECOL CA, V31, P980, DOI 10.1016/S1701-2163(16)34329-8
   Lee HY, 2012, RADIOLOGY, V264, P903, DOI 10.1148/radiol.12111383
   Morau E, 2017, GYNECOL OBSTET FERTI
   Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715
   Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008
   Pham T, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-128
   Poujade O, 2011, BJOG-INT J OBSTET GY, V118, P433, DOI 10.1111/j.1471-0528.2010.02817.x
   Revert M, 2017, BJOG-INT J OBSTET GY, V124, P1255, DOI 10.1111/1471-0528.14382
   Rousseau A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152863
   Rousseau A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138663
   Saucedo M, 2013, OBSTET GYNECOL, V122, P752, DOI 10.1097/AOG.0b013e31829fc38c
   Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X
   Sentilhes L, 2008, HUM REPROD, V23, P1087, DOI 10.1093/humrep/den049
   Sentilhes L, 2016, EUR J OBSTET GYN R B, V198, P12, DOI 10.1016/j.ejogrb.2015.12.012
   Sentilhes L, 2009, OBSTET GYNECOL, V113, P992, DOI 10.1097/AOG.0b013e3181a114f7
   Sheldon WR, 2014, BJOG-INT J OBSTET GY, V121, P5, DOI 10.1111/1471-0528.12636
   Shields LE, 2017, OBSTET GYNECOL, V130, pE168
   Winter C, 2007, BJOG-INT J OBSTET GY, V114, P845, DOI 10.1111/j.1471-0528.2007.01377.x
   Zhang WH, 2005, BJOG-INT J OBSTET GY, V112, P89, DOI 10.1111/j.1471-0528.2004.00303.x
   Zwart JJ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.003
NR 36
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 13
PY 2018
VL 13
IS 12
AR e0209074
DI 10.1371/journal.pone.0209074
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HE3IL
UT WOS:000453247500070
PM 30543683
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Dareng, EO
   Olaniyan, Y
   Odutola, MK
   Adebamowo, SN
   Famooto, A
   Offiong, R
   Obende, K
   Adewole, SA
   Achara, P
   Dakum, PS
   Adebamowo, CA
AF Dareng, Eileen O.
   Olaniyan, Yinka
   Odutola, Michael K.
   Adebamowo, Sally N.
   Famooto, Ayotunde
   Offiong, Richard
   Obende, Kayode
   Adewole, Stephen A.
   Achara, Peter
   Dakum, Patrick S.
   Adebamowo, Clement A.
TI Secular trend in interobserver agreement of VIA diagnosis for cervical
   cancer screening in Nigeria
SO PLOS ONE
LA English
DT Article
ID VISUAL INSPECTION; ACETIC-ACID; GLOBAL BURDEN; CRYOTHERAPY; PROGRAM
AB Objective
   In low resource settings, visual inspection with acetic acid (VIA) by allied health workers, has been suggested as an alternative for cervical cancer screening. However, there are concerns about the objectivity and time to diagnostic concordance with specialists. We evaluated the secular trend in interobserver agreement between nurse providers and a gynecologist/colposcopist over a five-year period.
   Methods
   Nurses provided VIA screening with digital cervivography to 4,961 participants in five screening clinics from October 2010 to May 2014 in Nigeria in this observational study. Cervigraphs were reviewed at meetings where a gynaecologist/colposcopist made an assessment from the cervigraphs. We used weighted kappa statistics to calculate agreement in diagnosis between nurse providers and the gynecologist/colposcopist; linear regression models to examine overall trend and investigate potential clinic characteristics that may influence agreement; and time series models to characterize month to month variations.
   Results
   Mean age of participants was 37 +/- 8 years. Overall agreement was 0.89 at Site D, 0.78 and 0.73 at Sites A and C respectively, 0.50 for Site E and 0.34 for Site C. The number of trainings attended by nurse providers(beta = 0.47,95%CI:0.02-0.93, p = 0.04), high level of engagement by site gynecologists(beta = 0.11,95%CI:0.01-0.21,p = 0.04) were associated with increased agreement; while increasing distance from the coordinating site(beta = -0.47,95%CI:-0.92-0.02,p = 0.04) was associated with decreased agreement. There were no associations between number of years screening clinics were operational(beta = 0.01,95%CI: -0.01-0.03,p = 0.29), cumulative experience of nurse providers(beta = 0.04,95%CI:-0.03-0.12,p = 0.19) and agreement. There were no significant increases in weighted kappa statistics over time for all sites considered. Monthly variations were significant for only one of two sites considered in time series models (AR1 term = -0.40, 95%CI:-0.71-0.09,p = 0.01).
   Conclusion
   Our results showed a lack of objectivity, persistent variation and lack of convergence of diagnostic capabilities of nurse led VIA cervical cancer screening with the diagnostic capabilities of a specialist in a cervical cancer screening program in Nigeria.
C1 [Dareng, Eileen O.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.
   [Dareng, Eileen O.; Odutola, Michael K.; Famooto, Ayotunde; Dakum, Patrick S.; Adebamowo, Clement A.] Inst Human Virol Nigeria, Dept Strateg Informat & Res, Abuja, Nigeria.
   [Olaniyan, Yinka] Natl Hosp, Dept Obstet & Gynaecol, Abuja, Nigeria.
   [Adebamowo, Sally N.; Adebamowo, Clement A.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA.
   [Adebamowo, Sally N.; Adebamowo, Clement A.] Univ Maryland, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA.
   [Offiong, Richard] Univ Abuja, Dept Obstet & Gynaecol, Teaching Hosp, Gwagwalada, Abuja, Nigeria.
   [Obende, Kayode] Garki Hosp Abuja, Dept Obstet & Gynaecol, Abuja, Nigeria.
   [Adewole, Stephen A.] Mother & Child Hosp Ondo, Dept Obstet & Gynaecol, Ondo, Nigeria.
   [Achara, Peter] Fed Med Ctr, Dept Obstet & Gynaecol, Keffi, Nigeria.
   [Adebamowo, Clement A.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.
RP Adebamowo, CA (reprint author), Inst Human Virol Nigeria, Dept Strateg Informat & Res, Abuja, Nigeria.; Adebamowo, CA (reprint author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA.; Adebamowo, CA (reprint author), Univ Maryland, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA.; Adebamowo, CA (reprint author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.
EM cadebamowo@som.umaryland.edu
OI Odutola, Michael/0000-0002-3612-3702; Dareng, Eileen/0000-0003-0802-419X
FU United States National Institute of Health (NIH) grants Capacity
   Development for Research in AIDS Associated Malignancies [ID43CA153792];
   African Collaborative Center for Microbiome and Genomics Research
   [U54HG006947]; President's Emergency Fund for AIDS Relief (PEPFAR) grant
   - AIDS Care and Treatment in Nigeria (ACTIONPlus) - United States
   Centers for Disease Control and Prevention (CDC) [PS000651]
FX This study was funded by the United States National Institute of Health
   (NIH) grants Capacity Development for Research in AIDS Associated
   Malignancies (ID43CA153792) to CAA; African Collaborative Center for
   Microbiome and Genomics Research (U54HG006947) to CAA and the
   President's Emergency Fund for AIDS Relief (PEPFAR) grant - AIDS Care
   and Treatment in Nigeria (ACTIONPlus) which is supported by the United
   States Centers for Disease Control and Prevention (CDC) (Cooperative
   Agreement No PS000651) to PSD. The content is solely the responsibility
   of the authors and does not necessarily represent the official views of
   the NIH or CDC. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Adefuye PO, 2015, INT J GYNECOL OBSTET, V129, P62, DOI 10.1016/j.ijgo.2014.10.032
   Ajenifuja KO, 2013, INT J GYNECOL CANCER, V23, P507, DOI 10.1097/IGC.0b013e318280f395
   Almonte M, 2007, INT J CANCER, V121, P796, DOI 10.1002/ijc.22757
   Almonte M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115355
   Altobelli E, 2015, INT J GYNECOL CANCER, V25, P474, DOI 10.1097/IGC.0000000000000374
   Box GE, 2015, TIME SERIES ANAL FOR
   Chigbu CO, 2017, NIGER J CLIN PRACT, V20, P239, DOI 10.4103/1119-3077.187315
   DeGregorio G, 2017, ONCOLOGIST, V22, P850, DOI [10.1634/theoncolo-gist.2016-0383, 10.1634/theoncologist.2016-0383]
   DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348
   Ferlay J, 2014, GLOBOCAN 2012 V1 0 C
   Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688
   Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055
   Jeronimo J, 2017, J GLOB ONCOL, V3, P635, DOI 10.1200/JGO.2016.006577
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lantz CA, 1996, J CLIN EPIDEMIOL, V49, P431, DOI 10.1016/0895-4356(95)00571-4
   Parham GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122169
   Sankaranarayanan R, 2004, INT J CANCER, V110, P907, DOI 10.1002/ijc.20190
   Sankaranarayanan R, 2003, PRACTICAL MANUAL VIS
   Sankaranarayanan R, 2012, BEST PRACT RES CL OB, V26, P221, DOI 10.1016/j.bpobgyn.2011.08.003
   Sherris J, 2009, INT PERSPECT SEX R H, V35, P147, DOI [10.1363/3514709, 10.1363/ifpp.35.147.09]
   World Health Organization, 2014, COMPR CERV CANC CONT
NR 21
TC 0
Z9 0
U1 5
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 6
PY 2018
VL 13
IS 12
AR e0208531
DI 10.1371/journal.pone.0208531
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HD1YF
UT WOS:000452307600086
PM 30521595
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Buckton, CH
   Patterson, C
   Hyseni, L
   Katikireddi, SV
   Lloyd-Williams, F
   Elliott-Green, A
   Capewell, S
   Hilton, S
AF Buckton, Christina H.
   Patterson, Chris
   Hyseni, Lirije
   Katikireddi, S. Vittal
   Lloyd-Williams, Ffion
   Elliott-Green, Alex
   Capewell, Simon
   Hilton, Shona
TI The palatability of sugar-sweetened beverage taxation: A content
   analysis of newspaper coverage of the UK sugar debate
SO PLOS ONE
LA English
DT Article
ID NEWSPRINT COVERAGE; CHILDHOOD OBESITY; PUBLIC SUPPORT; MASS-MEDIA;
   POLICY; ALCOHOL; HEALTH; SMOKING; CONSUMPTION; PREVENTION
AB Background
   Excess sugar consumption, including sugar-sweetened beverages (SSBs), contributes to a variety of negative health outcomes, particularly for young people. The mass media play a powerful role in influencing public and policy-makers' perceptions of public health issues and their solutions. We analysed how sugar and SSB policy debates were presented in UK newspapers at a time of heightened awareness and following the announcement of the UK Government's soft drinks industry levy (SDIL), to inform future public health advocacy.
   Methods & findings
   We carried out quantitative content analysis of articles discussing the issues of sugar and SSB consumption published in 11 national newspapers from April 2015 to November 2016. 684 newspaper articles were analysed using a structured coding frame. Coverage peaked in line with evidence publication, campaigner activities and policy events. Articles predominantly supportive of SSB taxation (23.5%) outnumbered those that were predominantly oppositional (14.2%). However, oppositional articles outnumbered supportive ones in the month of the announcement of the SDIL. Sugar and SSB consumption were presented as health risks, particularly affecting young people, with the actions of industry often identified as the cause of the public health problem. Responsibility for addressing sugar overconsumption was primarily assigned to government intervention.
   Conclusion
   Our results suggest that the policy landscape favouring fiscal solutions to curb sugar and SSB consumption has benefited from media coverage characterising the issue as an industry-driven problem. Media coverage may drive greater public acceptance of the SDIL and any future taxation of products containing sugar. However, future advocacy efforts should note the surge in opposition coinciding with the announcement of the SDIL, which echoes similar patterns of opposition observed in tobacco control debates.
C1 [Buckton, Christina H.; Patterson, Chris; Katikireddi, S. Vittal; Hilton, Shona] Univ Glasgow, Inst Hlth & Wellbeing, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.
   [Hyseni, Lirije; Lloyd-Williams, Ffion; Elliott-Green, Alex; Capewell, Simon] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England.
RP Buckton, CH (reprint author), Univ Glasgow, Inst Hlth & Wellbeing, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.
EM christina.buckton@glasgow.ac.uk
OI Hilton, Shona/0000-0003-0633-8152; Katikireddi,
   Srinivasa/0000-0001-6593-9092; Buckton, Christina/0000-0002-6004-4334
FU UK Medical Research Council as part of the Informing Healthy Public
   Policy programme [MC_ UU_ 12017/15]; Chief Scientist Office of the
   Scottish Government Health Directorates at the MRC/CSO Social and Public
   Health Sciences Unit, University of Glasgow [SPHSU15]
FX CHB, CP, SVK and SH received funding from the UK Medical Research
   Council as part of the Informing Healthy Public Policy programme (MC_
   UU_ 12017/15) and from the Chief Scientist Office of the Scottish
   Government Health Directorates (SPHSU15) at the MRC/CSO Social and
   Public Health Sciences Unit, University of Glasgow;
   www.mrc.ac.uk/funding, www.cso.scot.nhs.uk/funding-2.The funders had no
   role in commissioning the study, study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704
   Barry CL, 2013, POLIT PSYCHOL, V34, P327, DOI 10.1111/pops.12018
   Barry CL, 2009, MILBANK Q, V87, P7, DOI 10.1111/j.1468-0009.2009.00546.x
   Bates B, 2017, NATL DIET NUTR SURVE
   Bonilla-Chacin ME, 2016, LEARNING MEXICAN EXP
   BRIGGS ADM, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F6189
   Capewell S, 2016, BMJ, V355
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Colchero MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163463
   Conolly A., 2016, HLTH SURVEY ENGLAND
   Daubler T, 2012, BRIT J POLIT SCI, V42, P937, DOI 10.1017/S0007123412000105
   Dew C., 2016, NHS OUTCOMES FRAMEWO
   Elliott-Green A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011295
   ENTMAN RM, 1993, J COMMUN, V43, P51, DOI 10.1111/j.1460-2466.1993.tb01304.x
   Gander K., 2016, INDEPENDENT
   Gollust SE, 2013, AM J PUBLIC HEALTH, V103, pE96, DOI 10.2105/AJPH.2013.301271
   Gorini G, 2011, ANN I SUPER SANITA, V47, P260, DOI 10.4415/ANN_11_03_04
   Harris JK, 2010, TOB CONTROL, V19, P37, DOI 10.1136/tc.2009.032516
   Her Majesty's Treasury, 2016, BUDG 2016
   Her Majesty's Treasury, 2017, SPRING BUDG 2017
   Her Majesty's Treasury, 2016, SOFT DRINKS IND LEV
   Her Majesty's Treasury, 2016, POL PAP SOFT DRINKS
   Hester JB, 2007, JOURNALISM MASS COMM, V84, P811, DOI 10.1177/107769900708400410
   Hilton S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1116
   Hilton S, 2014, SOC SCI MED, V102, P157, DOI 10.1016/j.socscimed.2013.11.041
   Hilton S, 2012, OBESITY, V20, P1688, DOI 10.1038/oby.2012.27
   Hilton S, 2010, SOC SCI MED, V70, P942, DOI 10.1016/j.socscimed.2009.11.027
   Katikireddi SV, 2015, DRUG-EDUC PREV POLIC, V22, P125, DOI 10.3109/09687637.2014.977228
   Knai C, 2015, FOOD POLICY, V54, P1, DOI 10.1016/j.foodpol.2015.04.002
   Krippendorff K, 2013, CONTENT ANAL INTRO I
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   MCCOMBS ME, 1972, PUBLIC OPIN QUART, V36, P176, DOI 10.1086/267990
   Mekonnen TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081723
   Moody A, 2017, HLTH SURVEY ENGLAND
   National Readership Survey, 2016, NEWSPAPERS SUPPL JAN
   Niederdeppe J, 2013, AM J PUBLIC HEALTH, V103, pE92, DOI 10.2105/AJPH.2012.301023
   OTTEN AL, 1992, HEALTH AFFAIR, V11, P111, DOI 10.1377/hlthaff.11.4.111
   Patterson C, 2016, ADDICTION, V111, P1267, DOI 10.1111/add.13320
   Patterson C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2110-x
   Petticrew M, 2017, J EPIDEMIOL COMMUN H, V71, P1078, DOI 10.1136/jech-2017-209710
   Public Health England, 2017, SUG RED EV ACT 2015
   Riffe D, 1996, JOURNALISM MASS COMM, V73, P159, DOI 10.1177/107769909607300114
   Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033
   Scientific Advisory Committee on Nutrition, 2015, CARB HLTH LOND
   Smith K, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00064
   Stone Deborah, 1997, POLICY PARADOX ART P
   Weishaar H, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3594-8
   Whitehead R, 2016, BEVERAGE DAILY
   Williams SJ, 2008, HEALTH, V12, P251, DOI 10.1177/1363459307086846
   Wood K, 2014, ADDICTION, V109, P578, DOI 10.1111/add.12427
   World Health Organisation, 2015, GUID SUG INT AD CHIL
NR 53
TC 1
Z9 1
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 5
PY 2018
VL 13
IS 12
AR e0207576
DI 10.1371/journal.pone.0207576
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HD0QO
UT WOS:000452212400045
PM 30517133
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Shigueoka, LS
   de Vasconcellos, JPC
   Schimiti, RB
   Reis, ASC
   de Oliveira, GO
   Gomi, ES
   Vianna, JAR
   Lisboa, RDD
   Medeiros, FA
   Costa, VP
AF Shigueoka, Leonardo Seidi
   Cabral de Vasconcellos, Jose Paulo
   Schimiti, Rui Barroso
   Castro Reis, Alexandre Soares
   de Oliveira, Gabriel Ozeas
   Gomi, Edson Satoshi
   Rocha Vianna, Jayme Augusto
   dos Reis Lisboa, Renato Dichetti
   Medeiros, Felipe Andrade
   Costa, Vital Paulino
TI Automated algorithms combining structure and function outperform general
   ophthalmologists in diagnosing glaucoma
SO PLOS ONE
LA English
DT Article
ID MACHINE LEARNING CLASSIFIERS; NERVE-FIBER LAYER; QUANTITATIVE IMAGING
   DEVICES; OPTICAL COHERENCE TOMOGRAPHY; VISUAL-FIELD; EYES;
   DISCRIMINATION; ACCURACY; PERIMETRY; FEATURES
AB Purpose
   To test the ability of machine learning classifiers (MLCs) using optical coherence tomography (OCT) and standard automated perimetry (SAP) parameters to discriminate between healthy and glaucomatous individuals, and to compare it to the diagnostic ability of the combined structure-function index (CSFI), general ophthalmologists and glaucoma specialists.
   Design
   Cross-sectional prospective study.
   Methods
   Fifty eight eyes of 58 patients with early to moderate glaucoma (median value of the mean deviation = -3.44 dB; interquartile range, -6.0 to -2.4 dB) and 66 eyes of 66 healthy individuals underwent OCT and SAP tests. The diagnostic accuracy (area under the ROC curve-AUC) of 10 MLCs was compared to those obtained with the CSFI, 3 general ophthalmologists and 3 glaucoma specialists exposed to the same OCT and SAP data.
   Results
   The AUCs obtained with MLCs ranged from 0.805 (Classification Tree) to 0.931 (Radial Basis Function Network, RBF). The sensitivity at 90% specificity ranged from 51.6% (Classification Tree) to 82.8% (Bagging, Multilayer Perceptron and Support Vector Machine Gaussian). The CSFI had a sensitivity of 79.3% at 90% specificity, and the highest AUC (0.948). General ophthalmologists and glaucoma specialists' grading had sensitivities of 66.2% and 83.8% at 90% specificity, and AUCs of 0.879 and 0.921, respectively. RBF (the best MLC), the CSFI, and glaucoma specialists showed significantly higher AUCs than that obtained by general ophthalmologists (P<0.05). However, there were no significant differences between the AUCs obtained by RBF, the CSFI, and glaucoma specialists (P>0.25).
   Conclusion
   Our findings suggest that both MLCs and the CSFI can be helpful in clinical practice and effectively improve glaucoma diagnosis in the primary eye care setting, when there is no glaucoma specialist available.
C1 [Shigueoka, Leonardo Seidi; Cabral de Vasconcellos, Jose Paulo; Schimiti, Rui Barroso; Castro Reis, Alexandre Soares; Costa, Vital Paulino] Univ Estadual Campinas, Dept Ophthalmol, Glaucoma Serv, Campinas, SP, Brazil.
   [de Oliveira, Gabriel Ozeas; Gomi, Edson Satoshi] Univ Sao Paulo, Polytech Sch, Dept Comp Engn, Sao Paulo, SP, Brazil.
   [Rocha Vianna, Jayme Augusto] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada.
   [dos Reis Lisboa, Renato Dichetti; Medeiros, Felipe Andrade] Duke Univ, Ctr Eye, Dept Ophthalmol, Sch Med, Durham, NC 27710 USA.
RP Shigueoka, LS (reprint author), Univ Estadual Campinas, Dept Ophthalmol, Glaucoma Serv, Campinas, SP, Brazil.
EM leonardo.seidi@yahoo.com.br
RI Vianna, Jayme/L-4307-2019
OI Vianna, Jayme/0000-0001-5302-7950
FU Sao Paulo Research Foundation, FAPESP [07/51281-9]; Novartis; Alcon
   Laboratories; Bausch Lomb; Carl Zeiss Meditec; Heidelberg Engineering;
   Merck; Allergan; Sensimed; Topcon; Reichert; National Eye Institute;
   Patent - RGC index; Uniao Quimica; Glaukos
FX This work was supported by Sao Paulo Research Foundation, FAPESP
   (07/51281-9). Additional support provided by Novartis, Alcon
   Laboratories, Bausch & Lomb, Carl Zeiss Meditec, Heidelberg Engineering,
   Merck, Allergan, Sensimed, Topcon, Reichert, National Eye Institute and
   Patent - RGC index with royalties to FAM; and from Novartis, Alcon
   Laboratories, Uniao Quimica, Allergan and Glaukos to VPC. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Barella KA, 2013, J OPHTHALMOL, DOI 10.1155/2013/789129
   Bowd C, 2008, OPTOMETRY VISION SCI, V85, P396, DOI 10.1097/OPX.0b013e3181783ab6
   Bowd C, 2008, INVEST OPHTH VIS SCI, V49, P945, DOI 10.1167/iovs.07-1083
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Brigatti L, 1996, AM J OPHTHALMOL, V121, P511, DOI 10.1016/S0002-9394(14)75425-X
   Burlina P, 2017, COMPUT BIOL MED, V82, P80, DOI 10.1016/j.compbiomed.2017.01.018
   Caixinha M, 2017, CURR EYE RES, V42, P1, DOI 10.1080/02713683.2016.1175019
   CAPRIOLI J, 1992, INVEST OPHTH VIS SCI, V33, P153
   Caruana R., 2004, P 21 INT C MACH LEAR, P18, DOI DOI 10.1145/1015330.1015432
   Chan KL, 2002, IEEE T BIO-MED ENG, V49, P963, DOI 10.1109/TBME.2002.802012
   Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199
   CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035
   DeLeon-Ortega JE, 2006, INVEST OPHTH VIS SCI, V47, P3374, DOI 10.1167/iovs.05-1239
   DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
   Essock EA, 2003, ARCH OPHTHALMOL-CHIC, V121, P1238, DOI 10.1001/archopht.121.9.1238
   Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010
   Frank E., 2016, DATA MINING PRACTICA
   Frank E, 2014, TECHNICAL REPORT, V4
   Freund Y., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P148
   Goldbaum MH, 2002, INVEST OPHTH VIS SCI, V43, P162
   Greaney MJ, 2002, INVEST OPHTH VIS SCI, V43, P140
   Harwerth RS, 2010, PROG RETIN EYE RES, V29, P249, DOI 10.1016/j.preteyeres.2010.02.001
   Harwerth RS, 2006, ARCH OPHTHALMOL-CHIC, V124, P853, DOI 10.1001/archopht.124.6.853
   Heijl A, 2008, OPHTHALMOLOGY, V115, P1557, DOI 10.1016/j.ophtha.2008.02.005
   Hodapp E, 1993, CLIN DECISIONS GLAUC, P11
   Hood DC, 2007, PROG RETIN EYE RES, V26, P688, DOI 10.1016/j.preteyeres.2007.08.001
   John G. H., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P338
   Keltner JL, 2006, OPHTHALMOLOGY, V113, P1603, DOI 10.1016/j.ophtha.2006.05.061
   Kim SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177726
   Kloppel S, 2008, BRAIN, V131, P2969, DOI 10.1093/brain/awn239
   Kononenko I, 2001, ARTIF INTELL MED, V23, P89, DOI 10.1016/S0933-3657(01)00077-X
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lauande-Pimentel R, 2001, BRIT J OPHTHALMOL, V85, P586, DOI 10.1136/bjo.85.5.586
   Mardin CY, 2006, J GLAUCOMA, V15, P299, DOI 10.1097/01.ijg.0000212232.03664.ee
   Medeiros Felipe A, 2012, Arch Ophthalmol, V130, pE1
   Mwanza JC, 2011, OPHTHALMOLOGY, V118, P241, DOI 10.1016/j.ophtha.2010.06.036
   Peters D, 2014, ACTA OPHTHALMOL, V92, P421, DOI 10.1111/aos.12203
   Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185
   Prum Bruce E Jr, 2016, Ophthalmology, V123, pP41, DOI 10.1016/j.ophtha.2015.10.053
   Quinlan J., 1993, C4 5 PROGRAMS MACHIN
   R Core Team, 2012, R LANG ENV STAT COMP
   Racette L, 2010, J GLAUCOMA, V19, P167, DOI 10.1097/IJG.0b013e3181a98b85
   Raza AS, 2014, INVEST OPHTH VIS SCI, V55, P612, DOI 10.1167/iovs.13-12351
   Sajda P, 2006, ANNU REV BIOMED ENG, V8, P537, DOI 10.1146/annurev.bioeng.8.061505.095802
   Salam AA, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3175-4
   SCHUMAN JS, 1995, ARCH OPHTHALMOL-CHIC, V113, P586, DOI 10.1001/archopht.1995.01100050054031
   Shah NN, 2006, OPHTHALMOLOGY, V113, P1593, DOI 10.1016/j.ophtha.2006.06.004
   Silva FR, 2013, ARQ BRAS OFTALMOL, V76, P170, DOI 10.1590/S0004-27492013000300008
   SOMMER A, 1977, ARCH OPHTHALMOL-CHIC, V95, P2149
   Swanson WH, 2004, INVEST OPHTH VIS SCI, V45, P466, DOI 10.1167/iovs.03-0374
   Vessani RM, 2009, J GLAUCOMA, V18, P253, DOI 10.1097/IJG.0b013e31818153da
   Vidotti VG, 2013, EUR J OPHTHALMOL, V23, P61, DOI 10.5301/ejo.5000183
   Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0
   Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010
   Witten I, 2016, DATA MINING PRACTICA
NR 55
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 5
PY 2018
VL 13
IS 12
AR e0207784
DI 10.1371/journal.pone.0207784
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HD0QO
UT WOS:000452212400067
PM 30517157
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Klein, DO
   Rennenberg, RJMW
   Koopmans, RP
   Prins, MH
AF Klein, Dorthe O.
   Rennenberg, Roger J. M. W.
   Koopmans, Richard P.
   Prins, Martin H.
TI Adverse event detection by medical record review is reproducible, but
   the assessment of their preventability is not
SO PLOS ONE
LA English
DT Review
ID GLOBAL TRIGGER TOOL; PATIENT SAFETY; HOSPITALS; RELIABILITY; CARE; HARM;
   AGREEMENT; QUALITY; DEATHS; RATES
AB Objective
   To assess the reproducibility of adverse event evaluation by a medical record review committee.
   Design
   Cross-sectional reanalysis of medical records.
   Intervention
   Reviewers re-examined fifty medical records of deceased patients regarding the presence of adverse events, their potential preventability and their possible contribution to death. Also we investigated the root causes of the preventable AEs. Differences between the first and second assessment were calculated.
   Results
   The Kappa on the presence of an adverse event was 0.64 and 0.32 for the potential preventability. The intrarater agreement showed a Kappa of 0.61 on the adverse event presence and 0.64 for the potential preventability. Interrater agreement showed a Kappa of 0.66 for the adverse event presence and 0.03 for the potential preventability.
   Conclusion
   We found a fair reproducibility for the detection of adverse events, but a poor reproducibility for the potential preventability. Possibly this was caused by lack of a definition for the preventability of adverse events. We think giving feedback to professionals using the results of medical record review remains valuable, but an improvement of its reproducibility is essential. To our opinion an international consensus on what exactly constitutes preventability of adverse events and agreement on a definition is necessary. This would result in more comparable studies in this field and could then be more informative on the ideal procedure to avoid certain potentially preventable adverse events in the future.
C1 [Klein, Dorthe O.] Maastricht Univ, Med Ctr, Dept Clin Epidemiol & Med Technol Assessment KEMT, Maastricht, Netherlands.
   [Rennenberg, Roger J. M. W.; Koopmans, Richard P.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands.
   [Prins, Martin H.] Maastricht Univ, Sch Publ Hlth & Primary Care, Dept Epidemiol, Maastricht, Netherlands.
RP Klein, DO (reprint author), Maastricht Univ, Med Ctr, Dept Clin Epidemiol & Med Technol Assessment KEMT, Maastricht, Netherlands.
EM dorthe.klein@mumc.nl
RI Rennenberg, Roger/L-6552-2019
CR Baines RJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007380
   Baines RJ, 2013, BMJ QUAL SAF, V22, P290, DOI 10.1136/bmjqs-2012-001126
   Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498
   Brennan T A, 1991, Perspect Healthc Risk Manage, V11, P2
   BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604
   BRENNAN TA, 1989, MED CARE, V27, P1148, DOI 10.1097/00005650-198912000-00006
   Classen DC, 2008, J PATIENT SAF, V4, P169, DOI [10.1097/pts.0b013e318183a475, DOI 10.1097/PTS.0B013E318183A475]
   Contreary K, 2017, J COMP EFFECT RES, V6, P51, DOI 10.2217/cer-2016-0043
   Coutts SB, 2003, STROKE, V34, P1681, DOI 10.1161/01.STR.0000078840.96473.20
   Davis P, 2001, ADVERSE EVENTS NZ PU
   de Wet C, 2009, POSTGRAD MED J, V85, P176, DOI 10.1136/pgmj.2008.075788
   Forster AJ, 2004, CAN MED ASSOC J, V170, P1235, DOI 10.1503/cmaj.1030683
   Hanskamp-Sebregts M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011078
   He L, 2016, J NEUROSURG-PEDIATR, V18, P320, DOI 10.3171/2016.3.PEDS15648
   Hofer TP, 2000, MED CARE, V38, P152, DOI 10.1097/00005650-200002000-00005
   Hogan H, 2012, BMJ QUAL SAF, V21, P737, DOI 10.1136/bmjqs-2011-001159
   Kessomboon Pattapong, 2005, Journal of the Medical Association of Thailand, V88, P1412
   Klein DO, 2017, PREV MED REP, V8, P250, DOI [10.1016/j.pmedr.2017.10.016, DOI 10.1016/J.PMEDR.2017.10.016]
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404
   Localio AR, 1996, ANN INTERN MED, V125, P457, DOI 10.7326/0003-4819-125-6-199609150-00005
   Manaseki-Holland S, 2017, BMJ QUAL SAF, V26, P408, DOI 10.1136/bmjqs-2015-004849
   Millwood Sinead, 2014, BMJ Qual Improv Rep, V3, DOI 10.1136/bmjquality.u203658.w2114
   Mirza SK, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-53
   Mooney MA, 2016, J NEUROSURG, P1, DOI [10.3171/2015.9.JNS152183.test, DOI 10.3171/2016.3.JNS153044]
   Mortaro A, 2017, J PATIENT SAF, DOI [10.1097/PTS.0000000000000381, DOI 10.1097/PTS.0000000000000381]
   Najjar S, 2013, INT J QUAL HEALTH C, V25, P640, DOI 10.1093/intqhc/mzt066
   O'Leary KJ, 2013, BMJ QUAL SAF, V22, P130, DOI 10.1136/bmjqs-2012-001102
   Ramnarayan P, 2003, J AM MED INFORM ASSN, V10, P563, DOI 10.1197/jamil.M1338
   Resar RK, 2003, QUAL SAF HEALTH CARE, V12, pII39, DOI 10.1136/qhc.12.suppl_2.ii39
   Rutberg H, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004879
   Sari ABA, 2007, BMJ-BRIT MED J, V334, P79, DOI 10.1136/bmj.39031.507153.AE
   Sharek PJ, 2011, HEALTH SERV RES, V46, P654, DOI 10.1111/j.1475-6773.2010.01156.x
   Soop M, 2009, INT J QUAL HEALTH C, V21, P285, DOI 10.1093/intqhc/mzp025
   Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae
   Thomas EJ, 2002, ANN INTERN MED, V136, P812, DOI 10.7326/0003-4819-136-11-200206040-00009
   Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003
   Wagner C, 2005, MED CONTACT, V60, P1888
   Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x
   Wolf ZR, 2008, PATIENT SAFETY QUALI
   Zegers M, 2010, J CLIN EPIDEMIOL, V63, P94, DOI 10.1016/j.jclinepi.2009.03.004
   Zwaan L, 2010, ARCH INTERN MED, V170, P1015, DOI 10.1001/archinternmed.2010.146
NR 42
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 29
PY 2018
VL 13
IS 11
AR e0208087
DI 10.1371/journal.pone.0208087
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HC4HL
UT WOS:000451763800092
PM 30496243
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hwee, J
   Sung, L
   Kwong, JC
   Sutradhar, R
   Tu, KR
   Pole, JD
AF Hwee, Jeremiah
   Sung, Lillian
   Kwong, Jeffrey C.
   Sutradhar, Rinku
   Tu, Karen
   Pole, Jason D.
TI Use of physician billing claims to identify infections in children
SO PLOS ONE
LA English
DT Article
ID ADMINISTRATIVE DATA; RESPIRATORY ILLNESS; VALIDATION; CODES;
   HOSPITALIZATIONS; SURVEILLANCE; ACCURACY
AB While medical records have detailed information, they are limited in reach to the availability and accessibility of those records. On the other hand, administrative data while limited in scope, have a much further reach in coverage of an entire population. However, few studies have validated the use of administrative data for identifying infections in pediatric populations. Pediatric patients from Ontario, Canada aged <18 years were randomly sampled from the Electronic Medical Record Administrative data Linked Database (EMRALD). Using physician diagnoses from the electronic medical record (EMR) as the reference standard, we determined the criterion validity of physician billing claims in administrative data for identifying infectious disease syndromes from 2012 to 2014. Diagnosis codes were assessed by infection category (respiratory, skin and soft tissue, gastrointestinal, urinary tract and otitis externa) and for all infections combined. Sensitivity analyses assessed the performance if patients had more than one reason to visit the physician. We analysed 2,139 patients and found 33.3% of all visits were for an infection, and respiratory infections accounted for 67.6% of the infections. When we combined all infection categories, sensitivity was 0.74 (95% CI 0.70-0.77), specificity was 0.95 (95% CI 0.93-0.96), positive predictive value (PPV) was 0.87 (95% CI 0.84-0.90), and negative predictive value (NPV) was 0.88 (95% CI 0.86-0.89). For respiratory infections, sensitivity was 0.77 (95% CI 0.73-0.81), specificity was 0.96 (95% CI 0.95-0.97), PPV was 0.85 (95% CI 0.81-0.88), and NPV was 0.94 (95% CI 0.92-0.95). Similar performance was observed for skin and soft tissue, gastrointestinal, urinary tract, and otitis externa infections, but with lower sensitivity. Performance measures were highest when the patient visited the physician with only one health complaint. We found when using linked EMR data as the reference standard, administrative billing codes are reasonably accurate in identifying infections in a pediatric population.
C1 [Hwee, Jeremiah; Kwong, Jeffrey C.; Sutradhar, Rinku; Pole, Jason D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Hwee, Jeremiah; Kwong, Jeffrey C.; Sutradhar, Rinku; Pole, Jason D.] Inst Clin Evaluat Sci, Toronto, ON, Canada.
   [Sung, Lillian] Hosp Sick Children, Dept Pediat, Div Haematol Oncol, Toronto, ON, Canada.
   [Sung, Lillian] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Child Hlth Evaluat Sci, Toronto, ON, Canada.
   [Sung, Lillian; Sutradhar, Rinku] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
   [Kwong, Jeffrey C.; Tu, Karen] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada.
   [Kwong, Jeffrey C.] Publ Hlth Ontario, Toronto, ON, Canada.
   [Kwong, Jeffrey C.; Tu, Karen] Univ Hlth Network, Toronto Western Family Hlth Team, Toronto, ON, Canada.
   [Pole, Jason D.] Pediat Oncol Grp Ontario, Toronto, ON, Canada.
RP Hwee, J (reprint author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Hwee, J (reprint author), Inst Clin Evaluat Sci, Toronto, ON, Canada.
EM jeremiah.hwee@mail.utoronto.ca
RI Hwee, Jeremiah/L-3477-2019
OI Hwee, Jeremiah/0000-0002-2623-7706
FU Canadian Institutes of Health Research - Institute of Cancer Research
   Frederick Banting and Charles Best Canada Graduate Scholarship to Honour
   Nelson Mandela Doctoral award; Department of Family and Community
   Medicine, University of Toronto; Canadian Institutes of Health Research
   New Investigator Award; Institute for Clinical Evaluative Sciences
   (ICES); Ontario Ministry of Health and Long-Term Care (MOHLTC)
FX Funding was provided by the Canadian Institutes of Health Research -
   Institute of Cancer Research Frederick Banting and Charles Best Canada
   Graduate Scholarship to Honour Nelson Mandela Doctoral award (JH), the
   Department of Family and Community Medicine, University of Toronto (JCK
   and KT), and the Canadian Institutes of Health Research New Investigator
   Award (JCK). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
   This study was supported by the Institute for Clinical Evaluative
   Sciences (ICES), which is funded by an annual grant from the Ontario
   Ministry of Health and Long-Term Care (MOHLTC). The opinions, results
   and conclusions reported in this paper are those of the authors and are
   independent from the funding sources. No endorsement by ICES or the
   Ontario MOHLTC is intended or should be inferred.
CR [Anonymous], 2016, POPULATION SEX AGE G
   Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574
   Beitel AJ, 2004, PEDIATR EMERG CARE, V20, P355, DOI 10.1097/01.pec.0000133608.96957.b9
   Benchimol EI, 2011, J CLIN EPIDEMIOL, V64, P821, DOI 10.1016/j.jclinepi.2010.10.006
   Bourgeois FT, 2006, ANN EMERG MED, V47, P265, DOI 10.1016/j.annemergmed.2005.11.022
   CIHI. Canadian Institute for Health Information, 2011, SNAPSH HLTH CAR CAN
   Cohen E, 2012, PEDIATRICS, V130, pE1463, DOI 10.1542/peds.2012-0175
   du Plessis V, 2002, DEFINITIONS OF RURAL
   Flahault A, 2005, J CLIN EPIDEMIOL, V58, P859, DOI 10.1016/j.jclinepi.2004.12.009
   Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098
   Glazier R, 2012, COMP PRIMARY CARE MO
   Guttmann A, 2010, PEDIATR DIABETES, V11, P122, DOI 10.1111/j.1399-5448.2009.00539.x
   Hasegawa K, 2015, PEDIATR INFECT DIS J, V34, P681, DOI 10.1097/INF.0000000000000704
   Hsu VP, 2005, PEDIATRICS, V115, P78, DOI 10.1542/peds.2004-0860
   Hwee J, 2018, BRIT J CANCER, V118, P127, DOI 10.1038/bjc.2017.360
   Jaakkimainen RL, 2013, CMAJ OPEN, V1, pe120, DOI DOI 10.9778/CMAJ0.20120039
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lazarus R, 2009, J AM MED INFORM ASSN, V16, P18, DOI 10.1197/jamia.M2848
   Matheson FI, 2012, CAN J PUBLIC HEALTH, V103, pS12
   MHLTC. Ontario Ministry of Health and Long-Term Care, 2008, PHPDB MED SERV US GU
   MONTO AS, 1993, EPIDEMIOL INFECT, V110, P145, DOI 10.1017/S0950268800050779
   Niska Richard, 2010, Natl Health Stat Report, P1
   O'Sullivan CE, 2010, J PAEDIATR CHILD H, V46, P176, DOI 10.1111/j.1440-1754.2009.01658.x
   Pisesky A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150416
   Schwartz KL, 2015, HUM VACC IMMUNOTHER, V11, P1840, DOI 10.1080/21645515.2015.1043499
   Shaklee J, 2011, PEDIATR INFECT DIS J, V30, pE38, DOI 10.1097/INF.0b013e3182027c22
   Thomas Eleanor M, 2010, Health Rep, V21, P47
   Tieder JS, 2011, PEDIATRICS, V128, P323, DOI 10.1542/peds.2010-2064
   Toivonen L, 2016, PEDIATR INFECT DIS J, V35, pE362, DOI 10.1097/INF.0000000000001304
   Tu K, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0195-x
   Tu K, 2013, CAN J CARDIOL, V29, P1388, DOI 10.1016/j.cjca.2013.07.676
   Villers MS, 1998, PEDIATR RES, V43, P96, DOI [10.1203/00006450-199804001-00570, DOI 10.1203/00006450-199804001-00570]
   Williams DJ, 2013, JAMA PEDIATR, V167, P851, DOI 10.1001/jamapediatrics.2013.186
NR 33
TC 0
Z9 0
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 12
PY 2018
VL 13
IS 11
AR e0207468
DI 10.1371/journal.pone.0207468
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HA0PF
UT WOS:000449909200075
PM 30419045
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wang, W
   Zhang, C
   Cui, L
   Xie, QY
   Jia, ZY
   Zheng, W
AF Wang, Wei
   Zhang, Chen
   Cui, Lin
   Xie, Qing-yun
   Jia, Zhen-yu
   Zheng, Wei
TI Reliability, validity and responsiveness of the Chinese version of the
   Rotator Cuff Quality of Life Index (RC-QOL) in patients with rotator
   cuff disorders
SO PLOS ONE
LA English
DT Article
ID CROSS-CULTURAL ADAPTATION; SF-36 HEALTH SURVEY; SHOULDER SCORE;
   VALIDATION; QUESTIONNAIRE; TRANSLATION; REPRODUCIBILITY; OSTEOARTHRITIS;
   KNEE; AGREEMENT
AB Background
   The Rotator Cuff Quality of Life Index (RC-QOL) is a scale designed to evaluate the impact of rotator cuff (RC) disorders on the general quality of life of patients. Our study aims to adapt the RC-QOL into Chinese and to assess its reliability, validity and responsiveness in Chinese patients with RC disorders.
   Methods
   First, we developed the Chinese version of RC-QOL (C-RC-QOL) through a five-step procedure. Next, the recruited patients gave three rounds of responses to the C-RC-QOL, Medical Outcomes Study Short Form 36 (SF-36) and Oxford Shoulder Score scales (OSS). Then, we calculated the Cronbach's alpha, standard error of measurement (SEM), minimally detectable change (MDC), intra-class correlation coefficient (ICC), Pearson's correlation coefficient (r), effect size (ES) and standardized response mean (SRM) to evaluate the reliability, validity and responsiveness of the C-RC-QOL respectively. The unidimensionality of each subscale was assessed by principal component analysis (PCA) of the residuals.
   Results
   Overall, 124 patients with RC disorders successfully completed the first two rounds of the scales, and 108 patients completed the last round of the scales. Good or excellent internal consistency (Cronbach's alpha = 0.953) was found in the overall scale and subscales of the C-RC-QOL, and good or excellent test-retest reliability (ICC = 0.854) was found as well. The SEM and MDC values of the C-RC-QOL were 4.6 and 12.8 respectively. Moderate, good or excellent correlations (r = 0.452-0.839) were obtained between the physical subscales of the C-RC-QOL and the OSS, as well as the physical subscales of the SF-36; similar results were obtained between the emotion subscale of the C-RC-QOL and the mental subscales of the SF-36 (r = 0.490-0.733), which, illustrated the good validity of the C-RC-QOL. In addition, high responsiveness was observed in the overall scale and subscales of the C-RC-QOL (ES = 1.77, SRM = 1.98). The unidimensionality of five subscales was respected according to PCA of the residuals.
   Conclusions
   The C-RC-QOL scale is reliable, valid and responsive for the evaluation of Chinese-speaking patients with RC disorders and it would be an effective instrument.
C1 [Wang, Wei; Cui, Lin; Xie, Qing-yun; Zheng, Wei] Chengdu Mil Gen Hosp, Dept Orthoped, Chengdu, Sichuan, Peoples R China.
   [Zhang, Chen; Jia, Zhen-yu] Changhai Hosp, Dept Orthoped, Shanghai, Peoples R China.
RP Xie, QY; Zheng, W (reprint author), Chengdu Mil Gen Hosp, Dept Orthoped, Chengdu, Sichuan, Peoples R China.
EM xqingyun@163.com; zw770880@126.com
FU Department of Science and Technology of Sichuan Province; Chengdu
   Military General Hospital [41732C112];  [2017SZ0128]
FX This work was funded by Department of Science and Technology of Sichuan
   Province and 2017SZ0128 to QX and Chengdu Military General Hospital
   41732C112 to WW. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014
   Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638
   Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204
   BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160
   Cohen J, 1983, APPL MULTIPLE REGRES
   COSTE J, 1995, STAT MED, V14, P331, DOI 10.1002/sim.4780140402
   Dawson J, 1996, J BONE JOINT SURG BR, V78B, P593
   Dawson J, 2009, ARCH ORTHOP TRAUM SU, V129, P119, DOI 10.1007/s00402-007-0549-7
   El O, 2006, RHEUMATOL INT, V26, P1101, DOI 10.1007/s00296-006-0151-2
   Eubank BH, 2017, J SHOULDER ELB SURG, V26, P314, DOI 10.1016/j.jse.2016.07.030
   Franchignoni F, 2015, EUR J PHYS REHAB MED, V51, P429
   Goetz C, 2011, RHEUMATOLOGY, V50, P500, DOI 10.1093/rheumatology/keq357
   GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N
   GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009
   Hollinshead RM, 2000, J SHOULDER ELB SURG, V9, P373, DOI 10.1067/mse.2000.108389
   Huber W, 2005, Z RHEUMATOL, V64, P188, DOI 10.1007/s00393-005-0646-3
   Husted JA, 2000, J CLIN EPIDEMIOL, V53, P459, DOI 10.1016/S0895-4356(99)00206-1
   Kawabata M, 2013, J ORTHOP SCI, V18, P705, DOI 10.1007/s00776-013-0426-x
   Kirkley A, 2003, CLIN J SPORT MED, V13, P84, DOI 10.1097/00042752-200303000-00004
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee Edwin W C, 2004, J Hand Ther, V17, P417, DOI 10.1197/j.jht.2004.07.005
   Leggin BG, 2006, J ORTHOP SPORT PHYS, V36, P138, DOI 10.2519/jospt.2006.36.3.138
   Li L, 2003, J EPIDEMIOL COMMUN H, V57, P259, DOI 10.1136/jech.57.4.259
   Linacre JM, USERS GUIDE WINSTEPS
   Lo IKY, 2001, OSTEOARTHR CARTILAGE, V9, P771, DOI 10.1053/joca.2001.0474
   LYSHOLM J, 1982, AM J SPORT MED, V10, P150, DOI 10.1177/036354658201000306
   MacDermid JC, 2004, J SHOULDER ELB SURG, V13, P593, DOI 10.1016/j.jse.2004.03.009
   MOKKINK LB, 2010, BMC MED RES METHODOL, V10
   Mousavi SJ, 2009, CLIN RHEUMATOL, V28, P293, DOI 10.1007/s10067-008-1042-6
   Naal FD, 2011, ARTHROSCOPY, V27, P339, DOI 10.1016/j.arthro.2010.07.021
   Oliva F, 2015, MLTJ-MUSCLE LIGAMENT, V5, P227, DOI 10.11138/mltj/2015.5.4.227
   Oliva Francesco, 2014, Muscles Ligaments Tendons J, V4, P309
   Ostor AJK, 2004, ANN RHEUM DIS, V63, P1288, DOI 10.1136/ard.2003.014712
   Papalia R, 2010, KNEE SURG SPORT TR A, V18, P1417, DOI 10.1007/s00167-009-0943-5
   PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018
   Pynsent PB, 2001, J BONE JOINT SURG BR, V83B, P792, DOI 10.1302/0301-620X.83B6.11973
   Razmjou H, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-26
   Rockwood Charles A., 2009, SHOULDER
   St-Pierre C, 2016, DISABIL REHABIL, V38, P103, DOI 10.3109/09638288.2015.1027004
   Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012
   VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959
   Wang W, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1283-5
   Wei X, 2012, OSTEOARTHR CARTILAGE, V20, P1563, DOI 10.1016/j.joca.2012.08.018
   Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1
   World Health Organization, 1984, CONST WHO
   Xu XM, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0383-5
   Zhaeentan S, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1014-y
   Zheng W, 2014, CLIN ORTHOP RELAT R, V472, P1545, DOI 10.1007/s11999-013-3403-y
NR 48
TC 0
Z9 0
U1 3
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 8
PY 2018
VL 13
IS 11
AR e0206347
DI 10.1371/journal.pone.0206347
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GZ5ZX
UT WOS:000449512300018
PM 30408054
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zelt, S
   Recker, J
   Schmiedel, T
   vom Brocke, J
AF Zelt, Sarah
   Recker, Jan
   Schmiedel, Theresa
   vom Brocke, Jan
TI Development and validation of an instrument to measure and manage
   organizational process variety
SO PLOS ONE
LA English
DT Article
ID BUSINESS PROCESS MANAGEMENT; INTERORGANIZATIONAL RELATIONSHIPS;
   INFORMATION-TECHNOLOGY; BEHAVIORAL-RESEARCH; ERP IMPLEMENTATION; IMPACT;
   PERFORMANCE; SERVICE; CENTRALIZATION; FORMALIZATION
AB Organizational processes vary. Practitioners have developed simple frameworks to differentiate them. Surprisingly, the academic literature on process management does not-it typically strives for one method to manage all processes. We draw on organizational information-processing theory to systematically develop a new, theoretically motivated classification model for organizational processes. We validate this model using survey data from 141 process practitioners of a global corporation. We derive three distinct types of processes and demonstrate that an understanding of process variety based on process dimensions can differentiate processes better than existing frameworks used in practice. Our findings can enable process managers to make informed decisions and serve as a basis for contingent process management.
C1 [Zelt, Sarah; vom Brocke, Jan] Univ Liechtenstein, Inst Informat Syst, Vaduz, Liechtenstein.
   [Recker, Jan] Univ Cologne, Fac Management Econ & Social Sci, Cologne, Germany.
   [Recker, Jan] Queensland Univ Technol, QUT Business Sch, Brisbane, Qld, Australia.
   [Schmiedel, Theresa] Univ Appl Sci Northwestern Switzerland, Inst Informat Syst, Windisch, Switzerland.
RP Zelt, S (reprint author), Univ Liechtenstein, Inst Informat Syst, Vaduz, Liechtenstein.
EM sarah.zelt@uni.li
RI Brocke, Jan vom/Q-3807-2019; Recker, Jan/J-1040-2012
OI Recker, Jan/0000-0002-2072-5792
CR Ajzen I., 1980, UNDERSTANDING ATTITU
   Akman G, 2008, INT J INNOVATION MAN, V12, P69111
   [Anonymous], 2008, 9000 ISO
   APQC, 2017, PROC CLASS FREAMW V7
   Auh S, 2007, IND MARKET MANAG, V36, P1022, DOI 10.1016/j.indmarman.2006.02.010
   Bailey K. D., 1994, TYPOLOGIES TAXONOMIE
   Bandara W, 2007, P 15 EUROPEAN C INFO
   Benner MJ, 2003, ACAD MANAGE REV, V28, P238, DOI 10.2307/30040711
   BENSAOU M, 1995, MANAGE SCI, V41, P1471, DOI 10.1287/mnsc.41.9.1471
   Brocke JV, 2016, INT J INFORM MANAGE, V36, P486, DOI 10.1016/j.ijinfomgt.2015.10.002
   Chang AS, 2006, CONSTR MANAG ECON, V24, P171, DOI 10.1080/01446190500310353
   Chang AS, 2005, J MANAGE ENG, V21, P179, DOI 10.1061/(ASCE)0742-597X(2005)21:4(179)
   DAFT RL, 1986, MANAGE SCI, V32, P554, DOI 10.1287/mnsc.32.5.554
   DAFT RL, 1981, ADMIN SCI QUART, V26, P207, DOI 10.2307/2392469
   Davenport T.H., 2015, HDB BUSINESS PROCESS, P17
   Donaldson L., 2001, CONTINGENCY THEORY O
   Evermann J, 2011, J ASSOC INF SYST, V12, P632
   Feitzinger E, 1997, HARVARD BUS REV, V75, P116
   Feldman MS, 2003, ADMIN SCI QUART, V48, P94, DOI 10.2307/3556620
   Field JM, 2006, DECISION SCI, V37, P149, DOI 10.1111/j.1540-5915.2006.00120.x
   FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619
   Flynn BB, 1999, DECISION SCI, V30, P1021, DOI 10.1111/j.1540-5915.1999.tb00917.x
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Galbraith J. R., 1973, DESIGNING COMPLEX OR
   Gattiker TF, 2005, MIS QUART, V29, P559
   Gebauer J, 2008, INFORM SYST MANAGE, V25, P71, DOI 10.1080/10580530701777198
   Gibb F, 2006, INT J INFORM MANAGE, V26, P44, DOI 10.1016/j.ijinfomgt.2005.10.007
   GOODHUE DL, 1992, MIS QUART, V16, P293, DOI 10.2307/249530
   Graupner E., 2015, P 23 EUR C INF SYST
   Gronau N, 2005, J UNIVERS COMPUT SCI, V11, P452
   GROVER V, 1993, INFORM MANAGE, V24, P305, DOI 10.1016/0378-7206(93)90028-R
   Hagras H, 1999, ASSEMBLY AUTOM, V19, P323, DOI 10.1108/01445159910295230
   Hair J., 2010, MULTIVARIATE DATA AN
   Hall JM, 2009, HARVARD BUS REV, V87, P58
   Haussmann C, 2012, INTEGR SER INFORM SY, V29, P71, DOI 10.1007/978-1-4419-9707-4_5
   Hayes R., 2004, OPERATIONS STRATEGY
   HAYES RH, 1979, HARVARD BUS REV, V57, P133
   Hoch DJ, 2002, SECRETS SOFTWARE SUC
   Isik O, 2013, BUS PROCESS MANAG J, V19, P515, DOI 10.1108/14637151311319932
   Joreskog K. G., 2001, LISREL 8 NEW STAT FE
   Karimi J, 2007, J MANAGE INFORM SYST, V24, P101, DOI 10.2753/MIS0742-1222240103
   KELLER RT, 1994, ACAD MANAGE J, V37, P167, DOI 10.2307/256775
   Lambert EG, 2006, CRIM JUSTICE STUD, V19, P23, DOI 10.1080/14786010600615967
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lei P.-W., 2007, ED MEASUREMENT ISSUE, V26, P33, DOI [10.1111/j.1745-3992.2007.00099.x, DOI 10.1111/J.1745-3992.2007.00099.X]
   Lillrank P, 2003, ORGAN STUD, V24, P215, DOI 10.1177/0170840603024002344
   Mackelprang AW, 2012, INT J PROD ECON, V138, P183, DOI 10.1016/j.ijpe.2012.03.022
   MacKenzie SB, 2011, MIS QUART, V35, P293
   Mani D., 2006, MIS Q EXEC, V5, P15
   Mani D, 2010, MIS QUART, V34, P39
   Moore GC, 1991, INFORM SYST RES, V2, P192, DOI 10.1287/isre.2.3.192
   Nambisan S, 2002, J ENG TECHNOL MANAGE, V19, P141, DOI 10.1016/S0923-4748(02)00007-3
   Ould M., 1995, BUSINESS PROCESSES M
   Overby E, 2008, ORGAN SCI, V19, P277, DOI 10.1287/orsc.1070.0316
   Pentland BT, 2003, ORGAN SCI, V14, P528, DOI 10.1287/orsc.14.5.528.16760
   PERROW C, 1967, AM SOCIOL REV, V32, P194, DOI 10.2307/2091811
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9101.88.5.879
   Porter M. E., 1995, COMPETITIVE ADVANTAG
   Premkumar G, 2005, J MANAGE INFORM SYST, V22, P257, DOI 10.1080/07421222.2003.11045841
   PUNJ G, 1983, J MARKETING RES, V20, P134, DOI 10.2307/3151680
   Recker Jan, 2010, Scandinavian Journal of Information Systems, V22, P3
   Schafermeyer M, 2012, BUS INFORM SYST ENG+, V4, P261, DOI 10.1007/s12599-012-0224-6
   Schmahl K. E., 1996, Production and Inventory Management Journal, V37, P28
   Schmiedel T, 2014, INFORM MANAGE-AMSTER, V51, P43, DOI 10.1016/j.im.2013.08.005
   Segars AH, 1998, MIS QUART, V22, P139, DOI 10.2307/249393
   Seidel S, 2015, HDB BUSINESS PROCESS, P715
   Setia P, 2013, MIS QUART, V37, P565, DOI 10.25300/MISQ/2013/37.2.11
   Sonnenberg C, 2014, BUS PROCESS MANAG J, V20, P213, DOI 10.1108/BPMJ-12-2012-0136
   Sung-Eui Cho, 2006, International Journal of Electronic Business, V4, P83
   Tanriverdi H, 2007, INFORM SYST RES, V18, P280, DOI 10.1287/isre.1070.0129
   Taylor Frederick Winslow, 2004, SCI MANAGEMENT
   Tenhiala A, 2011, J OPER MANAG, V29, P65, DOI 10.1016/j.jom.2010.05.003
   Tushman M., 1978, ACAD MANAGE REV, V3, P613, DOI DOI 10.2307/257550
   Van Looy A, 2013, INFORM MANAGE-AMSTER, V50, P466, DOI 10.1016/j.im.2013.06.002
   VANDEVEN AH, 1974, ADMIN SCI QUART, V19, P183
   Venkatesh V, 2006, DECISION SCI, V37, P497, DOI 10.1111/j.1540-5414.2006.00136.x
   Vilkas M., 2005, ENG ECON, V43, P35
   WITHEY M, 1983, ACAD MANAGE J, V26, P45, DOI 10.2307/256134
   Zeithaml VA, 1988, EUR J MARKETING, V22, P3764
NR 79
TC 0
Z9 0
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 23
PY 2018
VL 13
IS 10
AR e0206198
DI 10.1371/journal.pone.0206198
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GX8WQ
UT WOS:000448076200036
PM 30352104
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Santana, RS
   Lupatini, ED
   Zanghelini, F
   Ronsoni, RD
   Rech, N
   Leite, SN
AF Santana, Rafael Santos
   Lupatini, Evandro de Oliveira
   Zanghelini, Fernando
   Ronsoni, Ricardo de March
   Rech, Norberto
   Leite, Silvana Nair
TI The different clinical guideline standards in Brazil: High cost
   treatment diseases versus poverty-related diseases
SO PLOS ONE
LA English
DT Article
ID PATIENT PARTICIPATION; HEALTH
AB Each year, evidence-based clinical guidelines gain more space in the health professionals' practice and in services organization. Due to the scarcity of scientific publications focused on diseases of poverty, the development of well-founded clinical guidelines becomes more and more important. In view of that, this paper aims to evaluate the quality of Brazilian guidelines for those diseases. The AGREE II method was used to evaluate 16 guidelines for poverty-related diseases (PRD) and 16 guidelines for global diseases whose treatment require high-cost technologies (HCD), with the ultimate aim of comparing the results. It was found that, in general, the guideline development quality standard is higher for the HCD guidelines than for the PRD guidelines, with emphasis on the "rigour of development" (48% and 7%) and "editorial independence" (43% and 1%) domains, respectively, which had the greatest discrepancies. The HCD guidelines showed results close to or above international averages, whereas the PRD guidelines showed lower results in the 6 domains evaluated. It can be concluded that clinical protocol development priorities need some redirecting in order to qualify the guidelines that define the healthcare organization and the care of vulnerable populations.
C1 [Santana, Rafael Santos] Univ Brasilia, Dept Pharm, Brasilia, DF, Brazil.
   [Lupatini, Evandro de Oliveira] Univ Brasilia, Postgrad Program Collect Hlth, Brasilia, DF, Brazil.
   [Zanghelini, Fernando] Univ Fed Pernambuco, Postgrad Program Therapeut Innovat, Recife, PE, Brazil.
   [Ronsoni, Ricardo de March] Minist Hlth, Dept Pharmaceut Assistance, Brasilia, DF, Brazil.
   [Rech, Norberto; Leite, Silvana Nair] Univ Fed Santa Catarina, Dept Pharmaceut Sci, Florianopolis, SC, Brazil.
RP Leite, SN (reprint author), Univ Fed Santa Catarina, Dept Pharmaceut Sci, Florianopolis, SC, Brazil.
EM silvana.nair.leite@ufsc.br
CR AGREE Next Steps Consortium, 2009, AGREE 2 INSTR VERS P
   Alonso-Coello P, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2010.042077
   Andrieux-Meyer I, 2015, LANCET GLOB HEALTH, V3, pE676, DOI 10.1016/S2214-109X(15)00156-4
   Brasil. Ministerio da Saude, 2014, COMP ESP ASS FARM IN
   Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449
   Crump JA, 2010, AM J TROP MED HYG, V83, P1178, DOI 10.4269/ajtmh.2010.10-0527
   Kredo T, 2016, INT J QUAL HEALTH C, V28, P122, DOI 10.1093/intqhc/mzv115
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Medicos Sem Fronteiras, 2001, DES FAT CRIS PESQ DE
   Mega TP, 2015, GESTAO SAUDE, P3275
   Molino CDRC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166367
   Ribeiro RC, 2010, REV BRAS CLIN MED, V8, P350
   Ronsoni RDM, 2013, AVALIACAO PROTOCOLOS
   Ronsoni RD, 2015, CAD SAUDE PUBLICA, V31, P1157, DOI 10.1590/0102-311X00118814
   Rosenfeld RM, 2009, OTOLARYNG HEAD NECK, V140, P1, DOI 10.1016/j.otohns.2008.11.024
   Santana RS, 2017, CIENC SAUDE COLETIVA, V22, P1417, DOI 10.1590/1413-81232017225.32762016
   Santana RS, 2016, REV PANAM SALUD PUBL, V40, P356
   Serrano-Aguilar P, 2016, EXPERT OPIN ORPHAN D, V4, P691, DOI 10.1080/21678707.2016.1182907
   Smith CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136098
   Utens CMA, 2016, HEALTH POLICY, V120, P120, DOI 10.1016/j.healthpol.2015.10.005
   van de Bovenkamp HM, 2015, HEALTH EXPECT, V18, P942, DOI 10.1111/hex.12067
   van de Bovenkamp HM, 2009, HEALTH CARE ANAL, V17, P198, DOI 10.1007/s10728-008-0099-3
   World Health Organization (WHO) Department of Reproductive Health and Research, 2012, GLOB ACT PLAN CONTR, P1, DOI DOI 10.1016/S0968-8080(12)40660-7
   Zhang ZC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111796
NR 24
TC 0
Z9 0
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 17
PY 2018
VL 13
IS 10
AR e0204723
DI 10.1371/journal.pone.0204723
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GX3PM
UT WOS:000447638200025
PM 30332422
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Alizad, K
   Hagen, SC
   Medeiros, SC
   Bilskie, MV
   Morris, JT
   Balthis, L
   Buckel, CA
AF Alizad, Karim
   Hagen, Scott C.
   Medeiros, Stephen C.
   Bilskie, Matthew V.
   Morris, James T.
   Balthis, Len
   Buckel, Christine A.
TI Dynamic responses and implications to coastal wetlands and the
   surrounding regions under sea level rise
SO PLOS ONE
LA English
DT Article
ID GULF-OF-MEXICO; LAND-COVER DATABASE; STORM-SURGE; TIDAL MARSH;
   VEGETATION; MODEL; BAY; HYDRODYNAMICS; RESTORATION; MISSISSIPPI
AB Two distinct microtidal estuarine systems were assessed to advance the understanding of the coastal dynamics of sea level rise in salt marshes. A coupled hydrodynamic-marsh model (Hydro-MEM) was applied to both a marine-dominated (Grand Bay, Mississippi) and a mixed fluvial/marine (Weeks Bay, Alabama) system to compute marsh productivity, marsh migration, and potential tidal inundation from the year 2000 to 2100 under four sea level rise scenarios. Characteristics of the estuaries such as geometry, sediment availability, and topography, were compared to understand their role in the dynamic response to sea level rise. The results show that the low sea level rise scenario (20 cm) approximately doubled high-productivity marsh coverage in the marine-dominated estuary by the year 2100 due to an equilibrium between the rates of sea level rise and marsh platform accretion. Under intermediate-low sea level rise (50 cm), high-productivity marsh coverage in the year 2100 increased (doubled in the marine-dominated estuary and a seven-fold increase in the mixed estuary) by expanding into higher lands followed by the creation of interior ponds. The results also indicate that marine-dominated estuaries are vulnerable to collapse as a result of low, relatively uniform topography and lack of sediment sources, whereas mixed estuaries are able to expand due to higher elevations and sediment inputs. The results from the higher sea level rise scenarios (the intermediate-high (120 cm) and high (200 cm)) showed expansion of the bays along with marsh migration to higher land, producing a five-fold increase in wetland coverage for the mixed estuary and virtually no net change for the marine-dominated estuary. Additionally, hurricane storm surge simulations showed that under higher sea level rise scenarios, the marine-dominated estuary demonstrated weaker peak stage attenuation indicating that the marsh's ability to dissipate storm surge is sensitive to productivity changes and bay expansion / marsh loss.
C1 [Alizad, Karim; Bilskie, Matthew V.] Louisiana State Univ, Ctr Coastal Resiliency, Baton Rouge, LA 70803 USA.
   [Hagen, Scott C.] Louisiana State Univ, Dept Civil & Environm Engn, Ctr Coastal Resiliency, Ctr Computat & Technol, Baton Rouge, LA 70803 USA.
   [Medeiros, Stephen C.] Univ Cent Florida, Dept Civil Environm & Construct Engn, Orlando, FL 32816 USA.
   [Morris, James T.] Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA.
   [Morris, James T.] Univ South Carolina, Belle W Baruch Inst, Columbia, SC 29208 USA.
   [Balthis, Len; Buckel, Christine A.] NOAA, Natl Ocean Serv, Natl Ctr Coastal Ocean Sci, Silver Spring, MD USA.
   [Alizad, Karim] Univ South Carolina, Belle W Baruch Inst Marine & Coastal Sci, Columbia, SC 29208 USA.
RP Alizad, K (reprint author), Louisiana State Univ, Ctr Coastal Resiliency, Baton Rouge, LA 70803 USA.; Alizad, K (reprint author), Univ South Carolina, Belle W Baruch Inst Marine & Coastal Sci, Columbia, SC 29208 USA.
EM Alizad@SC.edu
OI Bilskie, Matthew/0000-0002-7697-7403; Alizad, Karim/0000-0002-9174-0164
FU National Oceanic and Atmospheric Administration (NOAA) Ecological
   Effects of Sea Level Rise (EESLR) Program [NA10NOS4780146,
   NA16NOS4780208]; National Science Foundation [NSF DEB 1052636,
   ACI-1053575]
FX This work was funded by the National Oceanic and Atmospheric
   Administration (NOAA) Ecological Effects of Sea Level Rise (EESLR)
   Program: Award No. NA10NOS4780146 to Scott C. Hagen, Award No.
   NA16NOS4780208 to Scott C. Hagen; National Science Foundation: Award No.
   NSF DEB 1052636 to James T. Morris, Award No. ACI-1053575 to Scott C.
   Hagen. Scott C. Hagen's role in manuscript preparation was the study
   design, methodology, analysis and supervision as well as review and
   correction. James T. Morri's role in manuscript preparation was the
   study design, data collection and analysis as well as review and
   correction.
CR Alizad K, 2016, EARTHS FUTURE, V4, P483, DOI 10.1002/2016EF000385
   Alizad K, 2016, ECOL MODEL, V327, P29, DOI 10.1016/j.ecolmodel.2016.01.013
   [Anonymous], 1999, RES MDOM MISS COAST
   ArcementJr G., 1989, GUIDE SELECTING MANN
   Augustin LN, 2009, COAST ENG, V56, P332, DOI 10.1016/j.coastaleng.2008.09.004
   Barbier EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058715
   Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1
   Bilskie MV, 2016, J GEOPHYS RES-OCEANS, V121, P3625, DOI 10.1002/2015JC011400
   Bilskie MV, 2016, EARTHS FUTURE, V4, P177, DOI 10.1002/2015EF000347
   Bilskie MV, 2015, ADV WATER RESOUR, V86, P102, DOI 10.1016/j.advwatres.2015.09.020
   Bilskie MV, 2013, ADV WATER RESOUR, V52, P165, DOI 10.1016/j.advwatres.2012.09.003
   BROOME SW, 1988, AQUAT BOT, V32, P1, DOI 10.1016/0304-3770(88)90085-X
   Clough JS, 2011, SLAMM ANAL GRAND BAY
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Crosby SC, 2016, ESTUAR COAST SHELF S, V181, P93, DOI 10.1016/j.ecss.2016.08.018
   D'Alpaos A, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000537
   Dalrymple R. W., 1992, J SEDIMENTARY RES, V62
   Day J, 2011, ESTUAR COAST, V34, P483, DOI 10.1007/s12237-011-9390-x
   DAY JW, 1995, ESTUARIES, V18, P636, DOI 10.2307/1352382
   Donnelly JP, 2001, P NATL ACAD SCI USA, V98, P14218, DOI 10.1073/pnas.251209298
   Eleuterius CK, 1991, POINT CHENES PRESENT
   Enwright NM, 2016, FRONT ECOL ENVIRON, V14, P307, DOI 10.1002/fee.1282
   Esri, 2012, WORLD IM BAS
   Esri, 2012, NAT GEOGR WORLD BAS
   Feagin RA, 2010, ECOLOGY SOC
   Foster-Martinez MR, 2018, COAST ENG, V136, P26, DOI 10.1016/j.coastaleng.2018.02.001
   FRIEDRICHS CT, 1990, COAST ESTUAR STUD, V38, P105
   Ganju NK, 2016, ESTUAR COAST, V39, P311, DOI 10.1007/s12237-015-0011-y
   Gilmer B., 2011, INFORM CONSERVATION
   Guerreiro M, 2015, REV GESTAO COSTEIRA, V15
   Hagen SC, 2013, J WATERW PORT C, V139, P118, DOI 10.1061/(ASCE)WW.1943-5460.0000177
   Hearn C. J., 2001, SEA LEVEL CHANGES TH, P25
   Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829
   Hughes Z. J., 2012, PRINCIPLES TIDAL SED, P269, DOI DOI 10.1007/978-94-007-0123-6_11
   Jin SM, 2013, REMOTE SENS ENVIRON, V132, P159, DOI 10.1016/j.rse.2013.01.012
   Kastner K, 2017, J GEOPHYS RES-EARTH, V122, P696, DOI 10.1002/2016JF004075
   Kirwan ML, 2007, P NATL ACAD SCI USA, V104, P6118, DOI 10.1073/pnas.0700958104
   Kirwan ML, 2016, GEOPHYS RES LETT, V43, P4366, DOI 10.1002/2016GL068507
   Kirwan ML, 2012, J ECOL, V100, P764, DOI 10.1111/j.1365-2745.2012.01957.x
   Knutson P., 1987, ROLE COASTAL MARSHES, P161
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leonard LA, 1995, LIMNOL OCEANOGR, V40, P1474, DOI 10.4319/lo.1995.40.8.1474
   Leorri E., 2011, J INTEGR COAST ZONE, V11, P307, DOI DOI 10.5894/RGCI277
   Linhoss AC, 2015, J COASTAL RES, V31, P36, DOI 10.2112/JCOASTRES-D-13-00215.1
   Lovelace JK, 1992, STORM TIDE ELEVATION, P94
   Lu Z, 1992, ESTUARINE COASTAL MO, P418
   Luettich Jr R.A., 2004, FORMULATION NUMERICA
   Luettich R. A., 2006, ADCIRC PARALLEL ADV
   Mariotti G, 2017, WATER RESOUR RES, V53, P7029, DOI 10.1002/2017WR020461
   Mariotti G, 2016, J GEOPHYS RES-EARTH, V121, P1391, DOI 10.1002/2016JF003900
   Medeiros S, 2015, REMOTE SENS-BASEL, V7, P3507, DOI 10.3390/rs70403507
   Medeiros SC, 2013, INT J NUMER METH FL, V71, P473, DOI 10.1002/fld.3668
   Medeiros SC, 2012, J HYDROL, V452, P139, DOI 10.1016/j.jhydrol.2012.05.043
   Miller-Way T., 1996, 9601 DAUPH ISL SEA L
   Moller I, 2002, J COASTAL RES, P506
   MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W
   Morris J, 2013, AGU FALL M
   Morris JT, 2013, OCEANOGRAPHY, V26, P78, DOI 10.5670/oceanog.2013.48
   Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.2307/3072022
   Morton RA, 2008, J COASTAL RES, V24, P1587, DOI 10.2112/07-0953.1
   Mudd SM, 2009, ESTUAR COAST SHELF S, V82, P377, DOI 10.1016/j.ecss.2009.01.028
   National Oceanic and Atmospheric Administration Center for Operational Oceanographic Products and Services. COOPS, 2017, MEAN SEA LEV TREND D
   Neubauer SC, 2008, ESTUAR COAST SHELF S, V78, P78, DOI 10.1016/j.ecss.2007.11.011
   Nicholls RJ, 1999, GLOBAL ENVIRON CHANG, V9, pS69, DOI 10.1016/S0959-3780(99)00019-9
   NWI, 2008, MISS COAST UPD NWI B
   Osland MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183431
   OSullivan WT, 1995, 62 ANN M MISS AC SCI
   Otvos EG, 1979, BARRIER ISLANDS GULF, P291
   Parris A., 2012, GLOBAL SEA LEVEL RIS
   Passeri DL, 2016, EARTHS FUTURE, V4, P159, DOI 10.1002/2015EF000332
   Passeri DL, 2015, CONT SHELF RES, V111, P150, DOI 10.1016/j.csr.2015.08.001
   Passeri DL, 2015, EARTHS FUTURE, V3, P159, DOI 10.1002/2015EF000298
   Passeri DL, 2015, NAT HAZARDS, V75, P1599, DOI 10.1007/s11069-014-1386-y
   Peterson M. S, 2007, GRAND BAY NATL ESTUA
   Pitchford JL, 2017, HIGH RESOLUTION LAND
   Resio DT, 2008, PHYS TODAY, V61, P33, DOI 10.1063/1.2982120
   Rilo A, 2013, J COASTAL RES, P820, DOI 10.2112/SI65-139.1
   Rodriguez JF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16094
   Savenije H. H., 2006, SALINITY TIDES ALLUV
   Schepers L, 2017, LIMNOL OCEANOGR, V62, P137, DOI 10.1002/lno.10381
   Schieder NW, 2018, ESTUAR COAST, V41, P940, DOI 10.1007/s12237-017-0336-9
   Schile LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088760
   Shepard CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027374
   Shirley LJ, 2006, WETLANDS, V26, P1057, DOI 10.1672/0277-5212(2006)26[1057:AVCICL]2.0.CO;2
   Siverd CG, 2018, COAST ENG, V137, P28, DOI 10.1016/j.coastaleng.2018.03.006
   Spalding EA, 2007, ESTUAR COAST, V30, P214, DOI 10.1007/BF02700165
   Stark J, 2015, LIMNOL OCEANOGR, V60, P1371, DOI 10.1002/lno.10104
   Stralberg D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027388
   Thieler E. R, 1999, NATL ASSESSMENT COAS
   Townend I, 2002, PHILOS T R SOC A, V360, P1477, DOI 10.1098/rsta.2002.1011
   Towns J, 2014, COMPUT SCI ENG, V16, P62, DOI 10.1109/MCSE.2014.80
   Turner RE, 1997, ESTUARIES, V20, P1, DOI 10.2307/1352716
   Turner RE, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P583
   US Army Corps of Engineers, 1963, INT SURV REP, V63
   van de Koppel J, 2012, J EXP BIOL, V215, P962, DOI 10.1242/jeb.060467
   Wamsley TV, 2010, OCEAN ENG, V37, P59, DOI 10.1016/j.oceaneng.2009.07.018
   Wamsley TV, 2009, NAT HAZARDS, V51, P207, DOI 10.1007/s11069-009-9378-z
   Weeks Bay National Estuarine Research Reserve, 2007, WEEKS BAY NAT EST RE
   Wolanski E, 1996, J MARINE SYST, V7, P267, DOI 10.1016/0924-7963(95)00002-X
   Yoskowitz D, 2017, INTEGR ENVIRON ASSES, V13, P431, DOI 10.1002/ieam.1798
NR 100
TC 5
Z9 5
U1 5
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 12
PY 2018
VL 13
IS 10
AR e0205176
DI 10.1371/journal.pone.0205176
PG 27
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GX0UN
UT WOS:000447427300022
PM 30312304
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Atsri, HK
   Konko, Y
   Cuni-Sanchez, A
   Abotsi, KE
   Kokou, K
AF Atsri, Honam Komina
   Konko, Yawo
   Cuni-Sanchez, Aida
   Abotsi, Komla Elikplim
   Kokou, Kouami
TI Changes in the West African forest-savanna mosaic, insights from central
   Togo
SO PLOS ONE
LA English
DT Article
ID DYNAMICS; FRAGMENTATION; BIODIVERSITY; INDICATORS; RESERVE; AREA
AB The West African forest-savanna mosaic, an important habitat for biodiversity and humans, is severely degraded, fragmented and modified by human activities. However, few studies have quantified the land cover changes observed over time and/or analysed the drivers of change. This study focused on Fazao-Malfakassa National Park, the largest in Togo, uses a combination of remote sensing, ground surveys and questionnaires to: (i) quantify vegetation changes, (ii) determine the drivers of change, (iii) compare results with findings elsewhere in the region and (iv) suggest management interventions. The images used were Landsat 5 TM, Landsat 7 ETM and Sentinel-2. Different vegetation indices were computed including: number of fragments, index of dominance, mean area of a vegetation type and mean annual expansion rate. In total, 300 people (including park staff and local populations) were interviewed using a semi-structured questionnaire. Results indicate that between 1987 and 2015 closed-canopy forest and tree-savanna became severely degraded and fragmented, following trends in other parts of the West African forest-savanna mosaic. The main drivers of change were agricultural expansion, bush fires and timber extraction. Observed changes and drivers altered with time: e.g. agricultural expansion was greatest during 1987-2001 (linked with political instability) while illegal timber extraction augmented during 2001-2015 (following increased timber value). Park staff and local populations' perceptions on drivers of change did not differ. Our study highlights that action is urgently needed if we are to preserve this important habitat, the biodiversity it hosts and the services it provides to humans. We suggest several management interventions, learning from successful interventions elsewhere in the region.
C1 [Atsri, Honam Komina; Abotsi, Komla Elikplim; Kokou, Kouami] Univ Lome Togo, Fac Sci, Lab Rech Forestiere, Lome, Togo.
   [Konko, Yawo] Minist Environm & Ressources Forestieres Togo, Agence Natl Gest Environm, Lome, Togo.
   [Cuni-Sanchez, Aida] Univ York, Environm Dept, York, N Yorkshire, England.
RP Atsri, HK (reprint author), Univ Lome Togo, Fac Sci, Lab Rech Forestiere, Lome, Togo.
EM atsri.honam@yahoo.com
RI Atsri, Honam/Q-8052-2019
OI Atsri, Honam/0000-0001-5594-316X
CR Achard F, 1990, APPORTS TELEDETECTIO, P1
   Adjonou K., 2010, BOIS FOR TROP, V306, P33
   Adjoussi P, 2000, CHANGEMENT CLIMATIQU
   Amori G, 2016, ZOOSYSTEMA, V38, P201, DOI 10.5252/z2016n2a3
   Arouna O., 2012, CARTOGRAPHIE MODELIS
   Aubreville A., 1957, Bois et Forets des Tropiques, P23
   Bamba I, 2008, ANN FS AGRO, V1, P12
   Banque mondiale, 2014, POPULATION TOTAL BAN
   Barima Y.S.S., 2010, TELEDETECTION, V9, P129
   Barima YSS, 2010, BIOTECHNOL AGRON SOC, V14, P617
   Belle EMS, 2016, SUMMARY MAIN OUTPUTS
   Blanc-Pamard C., 1984, DEV RURAL QUESTION, V106, P55
   BLOT A, 1988, J AFR EARTH SCI, V7, P159, DOI 10.1016/0899-5362(88)90062-0
   Bogaert J, 2003, CONSERV ECOL, V7
   Bouko BS, 2016, EUR SCI J ESJ, V12
   Caloz R, 1993, CREATION UNE ORTHO, P17
   Camara AA, 2012, CYBERGEO
   Campbell G, 2005, PRIMATE BIRD DIVERSI
   Carr JA, 2014, EVALUATION VULNERABI
   CIBIEN C, 2000, RESERVES BIOSPHERE T
   Cibien C, 2008, DEMARCHE MAB VOIE OP
   Cochrane MA, 2001, CONSERV BIOL, V15, P1515, DOI 10.1046/j.1523-1739.2001.01091.x
   Commission allemande pour l'UNESCO, 2015, GUID GEST RES UNESCO
   Dale Virginia H., 2001, Ecological Indicators, V1, P3, DOI 10.1016/S1470-160X(01)00003-6
   Davidson C, 1998, WILDLIFE SOC B, V26, P32
   Denis G., 2015, EUR SCI J ESJ, V11
   Diallo Hady, 2011, Secheresse (Montrouge), V22, P97, DOI 10.1684/sec.2011.0306
   Dimobe K, 2015, GLOB ECOL CONSERV, V4, P559, DOI 10.1016/j.gecco.2015.10.006
   Diwediga B, 2017, J GEOGR SCI, V27, P579, DOI 10.1007/s11442-017-1394-4
   Djiwa O, 2008, DYNAMIQUE FOERESTIER
   Dourma M, 2012, BOIS FOR TROP, V313
   FFW, 2013, ET EC INV FOR FAUN E
   Gautestad AO, 2010, ECOL MODEL, V221, P2741, DOI 10.1016/j.ecolmodel.2010.08.014
   Grace J, 2006, J BIOGEOGR, V33, P387, DOI 10.1111/j.1365-2699.2005.01448.x
   Groombridge Jenkins MD, 2002, WORLD ATLAS BIODIVER
   GUELLY KA, 2013, ANAL COMPRE HENSION, P88
   Heilig GK, 2012, DEP EC SOC AFF DESA
   Idbraim S., 2009, THESIS
   Inoussa Maman Maarouhi, 2011, Secheresse (Montrouge), V22, P108, DOI 10.1684/sec.2011.0305
   IUCN/PACO, 2008, EV EFF GEST AIR PROT
   James R, 2013, CLIMATIC CHANGE, V117, P859, DOI 10.1007/s10584-012-0581-7
   Johns Andrew Grieser, 1995, Oryx, V29, P205
   Kaiser J, 2001, BIOINDICATORS BIOMAR
   Kemavo A., 2012, CONTRIBUTION TECHNOL
   Kokou K, 2006, PHYTOCOENOLOGIA, V36, P403, DOI 10.1127/0340-269X/2006/0036-0403
   Kone M, 2007, REV TELEDETECTION, V7, P3
   Kouami K, 2009, SCI RES ESSAYS, V4, P881
   Kurtz C., 2009, ANAL MULTIRESOLUTION
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lerman SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043497
   Levine J.S., 1999, WILDLAND FIRES ENV G
   Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771
   Lugo E., 2008, J LAND USE ENV LAW, V23, P243
   Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962
   Masumbuko B, 2014, ANAL LINKS CLIMATE C
   McGarigal K, 1995, PNWGTR351 USDA FOR S
   Ministere de l'Environnement et des Ressources Forestieres, 2016, PLAN NAT AD AUX CHAN, P117
   MPTHU, 2001, COMSTABEX9194 MPTHU
   N'Da HD, 2008, REV TELEDETECTION, V8, P17
   Niemi GJ, 2004, ANNU REV ECOL EVOL S, V35, P89, DOI 10.1146/annurev.ecolsys.35.112202.130132
   Oloukoi J, 2007, TELEDETECTION, V6, P305
   Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2
   Osseni Inoussa A., 2009, CONTRIBUTION GESTION
   Otto H-J, 1998, ECOLOGIE FORESTIERE
   PACO/UICN I, 2012, PAPACO STUD
   Poilecot P, 2009, BOIS FOR TROP, P51
   Possingham HP, 2005, NATURE, V436, P919, DOI 10.1038/436919a
   Programme des Nations unies pour le developpement (PNUD), 2016, RAPP DEV HUM AFR 201
   Prudent P, 2008, 742 ACP RPR
   Puyravaud JP, 2003, FOREST ECOL MANAG, V177, P593, DOI 10.1016/S0378-1127(02)00335-3
   Rabeil T., 2003, DISTRIBUTION POTENTI
   RGPH4, 2011, DIR GEN STAT COMPT N
   Robin A., 2007, THESIS
   Sambieni K, 2015, VERTIGO REV ELECT SC, V15
   Sawadogo L., 2007, ADAPTER APPROCHES AM
   Schulz JJ, 2010, APPL GEOGR, V30, P436, DOI 10.1016/j.apgeog.2009.12.003
   Sinsin B, 2010, ATLAS BIODIVERSITE A
   Smyth RL, 2007, ENVIRON MANAGE, V39, P301, DOI 10.1007/s00267-005-0282-3
   Tankoano B., 2015, International Journal of Biological and Chemical Sciences, V9, P1983, DOI 10.4314/ijbcs.v9i4.23
   Tchamie T. T. K., 1994, UNASYLVA, V45, P22
   Toko Mouhamadou I, 2012, VERTIGO REV ELECT SC, V12
   Vergara PM, 2015, ECOL MODEL, V300, P114, DOI 10.1016/j.ecolmodel.2015.01.006
   Woegan Y. A., 2013, International Journal of Biological and Chemical Sciences, V7, P1951, DOI 10.4314/ijbcs.v7i5.14
   Woegan YA, 2011, ACTA BOT GALLICA, V158, P444
NR 84
TC 0
Z9 0
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 5
PY 2018
VL 13
IS 10
AR e0203999
DI 10.1371/journal.pone.0203999
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GW0HY
UT WOS:000446545500012
PM 30289922
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hojreh, A
   Homolka, P
   Gamper, J
   Unterhumer, S
   Kienzl-Palma, D
   Balassy, C
   Wrba, T
   Prosch, H
AF Hojreh, Azadeh
   Homolka, Peter
   Gamper, Jutta
   Unterhumer, Sylvia
   Kienzl-Palma, Daniela
   Balassy, Csilla
   Wrba, Thomas
   Prosch, Helmut
TI Automated tube voltage selection in pediatric non-contrast chest CT
SO PLOS ONE
LA English
DT Article
ID EUROPEAN CYSTIC-FIBROSIS; COMPUTED-TOMOGRAPHY; KILOVOLTAGE SELECTION;
   SOCIETY STANDARDS; IMAGE QUALITY; POTENTIAL SELECTION; CURRENT
   MODULATION; ANGIOGRAPHY; SCANS; RISK
AB Background
   Modern CT scanners provide automatic dose adjustment systems, which are promising options for reducing radiation dose in pediatric CT scans. Their impact on patient dose, however, has not been investigated sufficiently thus far.
   Objective
   To evaluate automated tube voltage selection (ATVS) in combination with automated tube current modulation (ATCM) in non-contrast pediatric chest CT, with regard to the diagnostic image quality.
   Materials and methods
   There were 160 non-contrast pediatric chest CT scans (8.7 +/- 5.4 years) analyzed retrospectively without and with ATVS. Correlations of volume CT Dose Index (CTDIvol) and effective diameter, with and without ATVS, were compared using Fisher's z-transformation. Image quality was assessed by mean signal-difference-to-noise ratios (SDNR) in the aorta and in the left main bronchus using the independent samples t-test. Two pediatric radiologists and a general radiologist rated overall subjective Image quality. Readers' agreement was assessed using weighted kappa coefficients. A p value <0.05 was considered significant.
   Results
   CTDIvol correlation with the effective diameter was r = 0.62 without and r = 0.80 with ATVS (CI: -0.04 to -0.60; p = 0.025). Mean SDNR was 10.88 without and 10.03 with ATVS (p = 0.0089). Readers' agreement improved with ATVS (weighted kappa between pediatric radiologists from 0.1 (0.03-0.16) to 0.27 (0.09-0.45) with ATVS; between general and each pediatric radiologist from 0.1 (0.06-0.14) to 0.12 (0.05-0.20), and from 0.22 (0.11-0.34) to 0.36 (0.24-0.49)).
   Conclusion
   ATVS, combined with ATCM, results in a radiation dose reduction for pediatric non-contrast chest CT without a loss of diagnostic image quality and prevents errors in manual tube voltage setting, and thus protecting larger children against an unnecessarily high radiation exposure.
C1 [Hojreh, Azadeh; Unterhumer, Sylvia; Kienzl-Palma, Daniela; Balassy, Csilla; Prosch, Helmut] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.
   [Homolka, Peter] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria.
   [Gamper, Jutta] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria.
   [Wrba, Thomas] Med Univ Vienna, IT Syst & Commun, IT4Sci, Vienna, Austria.
RP Hojreh, A (reprint author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.
EM azadeh.hojreh@meduniwien.ac.at
OI Homolka, Peter/0000-0002-2300-3015
CR AAPM, 2011, 204 AAPM, P204
   Austrian Standards Institute, 2010, DIAGN REF LEV XRAY D
   Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149
   Conway S, 2014, J CYST FIBROS, V13, pS3, DOI 10.1016/j.jcf.2014.03.009
   Frellesen C, 2014, EUR RADIOL, V24, P1725, DOI 10.1007/s00330-014-3197-7
   Granata C, 2013, EUR J RADIOL, V82, P1098, DOI 10.1016/j.ejrad.2011.12.008
   Grant K, CARE KV AUTOMATED DO
   Hojreh A, 2015, EUR J RADIOL, V84, P1574, DOI 10.1016/j.ejrad.2015.04.027
   Hough DM, 2012, AM J ROENTGENOL, V199, P1070, DOI 10.2214/AJR.12.8637
   Huda W, 2000, RADIOLOGY, V217, P430, DOI 10.1148/radiology.217.2.r00nv35430
   International Atomic Ernergy Agency, 2013, IAEA HUM HLTH SER, V24
   Krazinski AW, 2014, EUR RADIOL, V24, P2677, DOI 10.1007/s00330-014-3312-9
   Kuo WY, 2014, AM J RESP CRIT CARE, V189, P1328, DOI [10.1164/rccm.201311-2099Cl, 10.1164/rccm.201311-2099CI]
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee CH, 2008, RADIOGRAPHICS, V28, P1451, DOI 10.1148/rg.285075075
   Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360
   National Research Council, 2006, HLTH RISKS EXP LOW L
   Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0
   Peng Y, 2009, ACTA RADIOL, V50, P1175, DOI 10.3109/02841850903241914
   Siegel MJ, 2013, RADIOLOGY, V268, P538, DOI 10.1148/radiol.13122438
   Siegel MJ, 2013, INVEST RADIOL, V48, P584, DOI 10.1097/RLI.0b013e318289f918
   Smyth AR, 2014, J CYST FIBROS, V13, pS23, DOI 10.1016/j.jcf.2014.03.010
   Sorantin E, 2013, EUR J RADIOL, V82, P1043, DOI 10.1016/j.ejrad.2011.11.041
   Spearman JV, 2016, RADIOLOGY, V279, P167, DOI 10.1148/radiol.2015141507
   Stern M, 2014, J CYST FIBROS, V13, pS43, DOI 10.1016/j.jcf.2014.03.011
   Strauss KJ, 2010, AM J ROENTGENOL, V194, P868, DOI 10.2214/AJR.09.4091
   Suh YJ, 2013, RADIOLOGY, V269, P722, DOI 10.1148/radiol.13130408
   Winklehner A, 2015, EUR RADIOL, V25, P2346, DOI 10.1007/s00330-015-3632-4
   Winklehner A, 2011, INVEST RADIOL, V46, P767, DOI 10.1097/RLI.0b013e3182266448
   Yu LF, 2011, RADIOGRAPHICS, V31, P835, DOI 10.1148/rg.313105079
NR 30
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 3
PY 2018
VL 13
IS 10
AR e0204794
DI 10.1371/journal.pone.0204794
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GV7VQ
UT WOS:000446342400057
PM 30281614
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Bauer, AE
   Stella, J
   Lemmons, M
   Croney, CC
AF Bauer, Amy E.
   Stella, Judith
   Lemmons, Matthew
   Croney, Candace C.
TI Evaluating the validity and reliability of a visual dental scale for
   detection of periodontal disease (PD) in non-anesthetized dogs (Canis
   familiaris)
SO PLOS ONE
LA English
DT Article
ID PREVALENCE; DEFINITIONS; POPULATION; DENTISTRY; AGREEMENT; IDENTIFY;
   SURGERY; CATS; CARE; PET
AB Periodontal disease is one of the most common conditions affecting companion dogs. The objectives of this cross-sectional study were: to determine 1) the agreement between visual assessments (VA) of periodontal disease (PD) performed on awake dogs and the reference standard (RS) of a dental examination and radiographs performed with the dog under general anesthesia, and 2) inter-rater reliability (IRR) for two individuals performing VAs of PD on the same dogs. One hundred and eight dogs were recruited from three veterinary practices. An oral examination and visual PD staging based on the American Veterinary Dental College's (AVDC) 5-point scale was performed by the investigators prior to general anesthesia and the dental procedure. After the anesthetic evaluation and radiographs, the attending veterinarian staged each dog based on the AVDC's 5-point scale. Agreement between the VA and RS as well as IRR were determined using percent agreement and a weighted kappa statistic. Eighty-nine dogs received a complete oral examination under general anesthesia with periodontal probing and full-mouth radiographs. Fifty-nine dogs received a VA by both raters. VA agreed with the RS 41.57% of the time with a weighted kappa of 0.42 (95% confidence interval 0.29-0.55), indicating moderate agreement. Between raters, VA agreed 61.02% of the time with a weighted kappa of 0.63 (95% confidence interval 0.49-0.76), indicating substantial IRR. The results of this study reinforce the idea that an oral examination in an awake dog can be a helpful screening tool, but should not be considered a comprehensive evaluation of periodontal health. In facilities housing large numbers of dogs such as shelters, breeding kennels, and research facilities, use of a VA can aid in identifying and prioritizing dogs most in need of procedures such as professional cleaning, periodontal treatment, including closed root planing, or surgical care.
C1 [Bauer, Amy E.; Croney, Candace C.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.
   [Stella, Judith] Purdue Univ, USDA APHIS, W Lafayette, IN 47907 USA.
   [Lemmons, Matthew] MedVet, Carmel, IN USA.
   [Bauer, Amy E.] Pkwy Small Anim & Exot Hosp, Clinton Township, MI USA.
RP Croney, CC (reprint author), Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.
EM ccroney@purdue.edu
FU Pet Food Institute; World Pet Association; MedVet
FX Funding was provided by commercial sources, the Pet Food Institute and
   World Pet Association. Additionally, MedVet provided support in the form
   of salary for author Matthew Lemmons. The specific roles of this author
   are articulated in the 'author contributions' section. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR American Animal Hospital Association (AAHA) and American Veterinary Medical Association (AVMA), AAHA AVMA CAN PREV H
   American Veterinary Dental College (AVDC), VET DENT NOM
   Baelum V, 2013, PERIODONTOL 2000, V62, P37, DOI 10.1111/j.1600-0757.2012.00449.x
   Burn CC, 2011, VET J, V188, P166, DOI 10.1016/j.tvjl.2010.04.021
   Cantor AB, 1996, PSYCHOL METHODS, V1, P150, DOI 10.1037/1082-989X.1.2.150
   Carreira LM, 2015, TOP COMPANION ANIM M, V30, P48, DOI 10.1053/j.tcam.2015.07.002
   Carreira LM, 2015, TOP COMPANION ANIM M, V30, P51, DOI 10.1053/j.tcam.2015.07.001
   COLMERY B, 1986, VET CLIN N AM-SMALL, V16, P817, DOI 10.1016/S0195-5616(86)50303-X
   Diez M, 2015, J SMALL ANIM PRACT, V56, P463, DOI 10.1111/jsap.12365
   Eisner ER, 2013, VET CLIN N AM-SMALL, V43, P447, DOI 10.1016/j.cvsm.2013.02.002
   Eke PI, 2010, J DENT RES, V89, P1208, DOI 10.1177/0022034510377793
   Goldstein G, 2016, J VET SCI TECHNOL, V7, DOI [10.4172/2157-7579.1000312, DOI 10.4172/2157-7579.1000312]
   HAMP SE, 1975, J DENT RES, V54, pL5
   Harvey CE, 1998, VET CLIN N AM-SMALL, V28, P1111, DOI 10.1016/S0195-5616(98)50105-2
   Harvey CE, 2008, J VET DENT, V25, P176, DOI 10.1177/089875640802500303
   Humane Society Veterinary Medical Association (HSVMC), HUSB MED CONC PUPP M
   Hurt M., 2016, EVALUATING PHYS WELF
   Innes JF, 2004, VET RADIOL ULTRASOUN, V45, P143, DOI 10.1111/j.1740-8261.2004.04024.x
   Kanji N, 2012, JAVMA-J AM VET MED A, V240, P427, DOI 10.2460/javma.240.4.427
   Kortegaard HE, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0077-8
   Kyllar M, 2005, VET MED-CZECH, V50, P496, DOI 10.17221/5654-VETMED
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lewis JR, 2013, VET CLIN N AM-SMALL, V43, P471, DOI 10.1016/j.cvsm.2013.02.009
   Lue TW, 2008, JAVMA-J AM VET MED A, V232, P531, DOI 10.2460/javma.232.4.531
   Lund EM, 1999, J AM VET MED ASSOC, V214, P1336
   Marretta SM, 2012, CAN VET J, V53, P1260
   Molven O, 2002, INT ENDOD J, V35, P142, DOI 10.1046/j.0143-2885.2001.00525.x
   Newbury S, GUIDELINES STANDARDS
   Niemiec BA, 2008, TOP COMPANION ANIM M, V23, P72, DOI 10.1053/j.tcam.2008.02.003
   O'Neill DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090501
   Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264
   RUSSELL A. L., 1956, JOUR DENTAL RES, V35, P350, DOI 10.1177/00220345560350030401
   Savage A, 2009, J CLIN PERIODONTOL, V36, P458, DOI 10.1111/j.1600-051X.2009.01408.x
   Tsugawa AJ, 2003, AM J VET RES, V64, P255, DOI 10.2460/ajvr.2003.64.255
   Whyte A, 2014, VET J, V201, P118, DOI 10.1016/j.tvjl.2014.05.005
   Wiggs R, 1997, VET DENT PRINCIPLES, P186
NR 36
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 26
PY 2018
VL 13
IS 9
AR e0203930
DI 10.1371/journal.pone.0203930
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GV3NB
UT WOS:000446000200031
PM 30256813
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tegern, M
   Aasa, U
   Ang, BO
   Harms-Ringdahl, K
   Larsson, H
AF Tegern, Matthias
   Aasa, Ulrike
   Ang, Bjorn O.
   Harms-Ringdahl, Karin
   Larsson, Helena
TI Inter-rater and test-retest reliability of movement control tests for
   the neck, shoulder, thoracic, lumbar, and hip regions in military
   personnel
SO PLOS ONE
LA English
DT Article
ID LOW-BACK-PAIN; HELICOPTER PILOTS; CERVICAL-SPINE; RISK-FACTORS;
   PREMATURE DISCHARGE; MOTOR VARIABILITY; SYSTEM; CLASSIFICATION;
   EPIDEMIOLOGY; DYSFUNCTION
AB Strategies are needed to mitigate the high rates and related risks of musculoskeletal complaints and injuries (MSCI) in the military aviator community. Previous work on Swedish Armed Forces (SwAF) soldiers have shown that proper screening methods have been successful in reducing early discharge from military training. Research has pointed at the importance of optimal spinal movement control in military aviators. The aim of this work was to investigate the inter-rater and test-retest reliability of a battery of clinical tests for evaluating movement control in the neck, shoulders, thoracic, lumbar, and hip regions in a population of SwAF military personnel. Inter-rater and test-retest reliability of 15 movement control tests were assessed by crude and prevalence-adjusted kappa coefficient. The study included 37 (inter-rater) and 45 (test-retest) SwAF personnel and was performed with two physiotherapists simultaneously observing and rating the movements on the first occasion and repeated with one physiotherapist on the second occasion. For inter-rater reliability, the kappa coefficient ranged from .19 to .95. Seven tests showed substantial to almost perfect agreement (kappa > .60). With the adjusted kappa, three more tests reached the level of substantial agreement. The corresponding values for test-retest reliability ranged from .26 to .65. Substantial agreement was attained for two tests, three with adjusted kappa. The following tests can reliably be used when screening for biomechanically less advantageous movement patters in military aviators: Shoulder flexion, and rotation, Neck flexion in sitting and supine, Neck extension and rotation in sitting, Pelvic tilt, Forward lean and Single and Double knee extension tests. Grading criteria for tests in supine and quadruped positions need to be further elaborated.
C1 [Tegern, Matthias; Aasa, Ulrike] Umea Univ, Dept Community Community Med & Rehabil, Physiotherapy, Umea, Sweden.
   [Tegern, Matthias; Ang, Bjorn O.; Harms-Ringdahl, Karin; Larsson, Helena] Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden.
   [Ang, Bjorn O.] Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden.
   [Harms-Ringdahl, Karin] Karolinska Univ Hosp, Allied Hlth Profess Funct Funct Area Occupat Ther, Stockholm, Sweden.
   [Larsson, Helena] Swedish Armed Forces, HQ, Stockholm, Sweden.
RP Tegern, M (reprint author), Umea Univ, Dept Community Community Med & Rehabil, Physiotherapy, Umea, Sweden.; Tegern, M (reprint author), Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden.
EM matthias.tegern@umu.se
CR Aasa B, 2014, EUR J PHYSIOTHER, V16, P173, DOI 10.3109/21679169.2014.917435
   Ang B, 2006, AVIAT SPACE ENVIR MD, V77, P713
   Ang BO, 2008, J ELECTROMYOGR KINES, V18, P538, DOI 10.1016/j.jelekin.2007.01.002
   Caldwell C, 2007, J ORTHOP SPORT PHYS, V37, P551, DOI 10.2519/jospt.2007.2283
   Davids K, 2003, SPORTS MED, V33, P245, DOI 10.2165/00007256-200333040-00001
   De Loose V, 2009, AVIAT SPACE ENVIR MD, V80, P477, DOI 10.3357/ASEM.2408.2009
   Dingenen B, 2018, ASSESSMENT MOVEMENT
   Fersum KV, 2009, MANUAL THER, V14, P555, DOI 10.1016/j.math.2008.08.003
   Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002
   Hoy DG, 2010, BEST PRACT RES CL RH, V24, P783, DOI 10.1016/j.berh.2011.01.019
   Kelley AM, 2017, AEROSP MED HUM PERF, V88, P96, DOI 10.3357/AMHP.4740.2017
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lange B, 2013, CLIN J PAIN, V29, P50, DOI 10.1097/AJP.0b013e3182478678
   Larsson H, 2008, MIL MED, V173, P259, DOI 10.7205/MILMED.173.3.259
   Larsson H, 2012, WORK, V42, P241, DOI 10.3233/WOR-2012-1347
   Larsson H, 2009, MIL MED, V174, P9, DOI 10.7205/MILMED-D-03-7407
   Luomajoki H, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-90
   Luomajoki H, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-170
   Monnier A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007943
   Monnier A, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-263
   Mottram S, 2012, KINETIC CONTROL MANA
   Norman GR, 2008, BIOSTATISTICS BARE E
   O'Leary S, 2009, J ORTHOP SPORT PHYS, V39, P324, DOI 10.2519/jospt.2009.2872
   Patroncini M, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-402
   Rintala H, 2015, MIL MED, V180, P1233, DOI 10.7205/MILMED-D-14-00467
   Roy TC, 2012, AVIAT SPACE ENVIR MD, V83, P1060, DOI 10.3357/ASEM.3341.2012
   Sahrmann S, 2011, MOVEMENT SYSTEM IMPA
   Sahrmann SA, 2002, DIAGNOSIS TREATMENT
   Sandlund J, 2017, HUM MOVEMENT SCI, V51, P17, DOI 10.1016/j.humov.2016.10.009
   Segarra V, 2015, MANUAL THER, V20, P570, DOI 10.1016/j.math.2015.01.007
   Sim J, 2005, PHYS THER, V85, P257
   Srinivasan D, 2012, CLIN BIOMECH, V27, P979, DOI 10.1016/j.clinbiomech.2012.08.007
   Terwee CB, 2011, MEASUREMENT MED PRAC, P96
   van den Oord MHAH, 2010, MIL MED, V175, P55, DOI 10.7205/MILMED-D-09-00038
   Van Dillen LR, 1998, PHYS THER, V78, P979, DOI 10.1093/ptj/78.9.979
   Van Dillen LR, 2003, J ORTHOP SPORT PHYS, V33, P126, DOI 10.2519/jospt.2003.33.3.126
   Vos T, 2016, LANCET, V388, P1545, DOI 10.1016/S0140-6736(16)31678-6
NR 37
TC 0
Z9 0
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 25
PY 2018
VL 13
IS 9
AR e0204552
DI 10.1371/journal.pone.0204552
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GU9BO
UT WOS:000445639700062
PM 30252903
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kruger, M
AF Krueger, Mirko
TI Second language acquisition effects of a primary physical education
   intervention: A pilot study with young refugees
SO PLOS ONE
LA English
DT Article
ID ACADEMIC-ACHIEVEMENT; INTELLIGENCE; CHILDREN; SCHOOL; METAANALYSIS;
   PERFORMANCE; CHILDHOOD; COGNITION; PROGRAM; FITNESS
AB Background
   A physical education (PE) intervention for young refugees was designed combining physical activity within the context of primary PE games with second language learning activities in German. The intervention was based on theoretical implications from the field of second language acquisition and evidence for positive effects of physical activity on cognitive outcomes (e.g. language acquisition). The aim of this study was to analyze short term effects on second language acquisition.
   Methods
   Sixty-one young refugees were included in the study (age: 8.5 +/- 1.4 years). The intervention group participated in language-enriched PE lessons based on an elaborated approach to second language learning acquisition. The control group did not receive any treatment. Both groups were pre-and post-tested in domain specific vocabulary, listening comprehension and use of local prepositions within the context of primary PE games.
   Results
   Results from linear mixed-effect modelling suggest that the intervention group significantly improved domain specific vocabulary and listening comprehension in comparison to the control group.
   Conclusions
   The intervention was successful since the PE lessons contributed to the second language acquisition of young refugees. Therefore, this learning approach might also be useful for physical activity based second language learning activities in other PE contexts for early second language learners in primary school.
C1 [Krueger, Mirko] Univ Duisburg Essen, Div Social Sci Sports, Essen, North Rhine Wes, Germany.
RP Kruger, M (reprint author), Univ Duisburg Essen, Div Social Sci Sports, Essen, North Rhine Wes, Germany.
EM mirko.krueger@uni-due.de
OI Kruger, Mirko/0000-0002-4739-7151
FU Open Access Publication Fund of the University of Duisburg-Essen
FX We acknowledge support by the Open Access Publication Fund of the
   University of Duisburg-Essen.
CR [Anonymous], 1996, BESCHL KULT 25 10 19
   Arden R, 2006, PERS INDIV DIFFER, V41, P39, DOI 10.1016/j.paid.2005.11.027
   Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005
   Best JR, 2010, DEV REV, V30, P331, DOI 10.1016/j.dr.2010.08.001
   Castelli DM, 2007, J SPORT EXERCISE PSY, V29, P239, DOI 10.1123/jsep.29.2.239
   ConnorKuntz FJ, 1996, ADAPT PHYS ACT Q, V13, P302, DOI 10.1123/apaq.13.3.302
   Council of Europe, 2011, MAN LANG TEST DEV EX
   Cummins J, 1979, WORKING PAPERS BILIN, V19, P121
   Davis CL, 2008, HEALTH PSYCHOL, V30, P91
   Derri V, 2010, PHYS EDUC-US, V67, P178
   Ellis L., 2013, SEX DIFFERENCES SUMM
   Ellis N., 2008, ENCY LANGUAGE ED, V6, P1
   Ellis N. C., 2015, THEORIES 2 LANGUAGE, P75
   Ellis R., 2005, SYSTEM, V33.2, P209, DOI DOI 10.1016/J.SYSTEM.2004.12.006
   Fedewa AL, 2011, RES Q EXERCISE SPORT, V82, P521
   Gebken U, 2016, SPORTPADAGOGIK, P58
   Gries ST, 2015, CORPORA, V10, P95, DOI 10.3366/cor.2015.0068
   Herrmann C, 2015, MEAS PHYS EDUC EXERC, V19, P80, DOI 10.1080/1091367X.2014.998821
   Hillman CH, 2008, MED SCI SPORTS EXERC, V37, P1967
   Hillman CH, 2005, MED SCI SPORTS EXERC, V75, P175
   Howie EK, 2012, J SPORT HEALTH SCI, V1, P160, DOI 10.1016/j.jshs.2012.09.003
   Jensen EP, 2008, PHI DELTA KAPPAN, V89, P408, DOI 10.1177/003172170808900605
   Kruger M., 2017, SPORTUNTERRICHT, V66, P175
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Laufer B, 2009, LANG TEACH, V42, P341, DOI 10.1017/S0261444809005771
   Mahar MT, 2006, MED SCI SPORT EXER, V38, P2086, DOI 10.1249/01.mss.0000235359.16685.a3
   Massumi M, 2015, BESTANDSAUFNAHME EMP
   Mullender-Wijnsma MJ, 2015, J SCHOOL HEALTH, V85, P365, DOI 10.1111/josh.12259
   R Core Team, 2017, R LANG ENV STAT COMP
   Renner G, 2012, PSYCHOL ERZIEHUNG UN, V60, P307
   Rindermann H, 2011, PSYCHOL ERZ UNTERR, V58, P210, DOI 10.2378/peu2010.art29d
   Sibley BA, 2003, PEDIATR EXERC SCI, V15, P243, DOI 10.1123/pes.15.3.243
   Steinmayr R, 2010, INTELLIGENCE, V38, P101, DOI 10.1016/j.intell.2009.08.001
   Taras H, 2005, J SCHOOL HEALTH, V75, P214, DOI 10.1111/j.1746-1561.2005.00026.x
   Tellegen PJ, 2012, 640 SONR
   Tomporowski PD, 2008, EDUC PSYCHOL REV, V20, P111, DOI 10.1007/s10648-007-9057-0
   United Nations High Commissioner for Refugees, 1951, CONV PROT REL STAT R
   United Nations Higher Commissioner for Refugees, 2015, STAT YB 2014
   United Nations Higher Commissioner for Refugees, 2017, GLOB TRENDS FORC DIS
   World Medical Association, 2008, DECL HELS ETH PRINC
   Zimmer R, 2015, DRITTER DTSCH KINDER, P395
NR 41
TC 0
Z9 0
U1 2
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 17
PY 2018
VL 13
IS 9
AR e0203664
DI 10.1371/journal.pone.0203664
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GT8SG
UT WOS:000444809400015
PM 30222753
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gillespie, BM
   Bull, C
   Walker, R
   Lin, F
   Roberts, S
   Chaboyer, W
AF Gillespie, Brigid M.
   Bull, Claudia
   Walker, Rachel
   Lin, Frances
   Roberts, Shelley
   Chaboyer, Wendy
TI Quality appraisal of clinical guidelines for surgical site infection
   prevention: A systematic review
SO PLOS ONE
LA English
DT Review
ID CARE-ASSOCIATED INFECTIONS; AGREE II; STRATEGIES; IMPLEMENTATION;
   MANAGEMENT; COMPENDIUM; PATIENT
AB Background
   Surgical site infections (SSI) occur in up to 10% of surgeries. Wound care practices to prevent infections are guided by Clinical Practice Guidelines (CPGs), yet their contribution to improving patient outcomes relies on their quality and adoption in practice. We critically evaluated the quality of CPGs for SSI prevention during pre-, intra- and post-operative phases of care.
   Methods
   We systematically reviewed the literature from 1990-2018 using the Cochrane Library, CINAHL, EMBASE, MEDLINE, ProQuest databases and five guidelines repositories. We extracted characteristics of each guideline using purposely-developed data collection tools. We assessed overall quality using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool.
   Results
   Combined searches of databases and repositories yielded 5,910 citations. Of these, we reviewed 215 full text documents. The final sample included 15 documents: 6 complete CPGs, 3 CPG updates, and 6 supplementary documents. The overall %mean scores across AGREE II domains for CPGs were: 1) scope and purpose (%mean +/- SD = 86.3 +/- 23.5); 2) stakeholder involvement (%mean +/- SD = 64 +/- 31.0); 3) rigour of development (%mean +/- SD = 68.7 +/- 30.6); 4) clarity and presentation (%mean +/- SD = 88.5 +/- 16.7); 5) applicability (%mean +/- SD = 44 +/- 30.2); and, 5) editorial independence (%mean +/- SD = 61 +/- 37.6). Based on individual AGREE II domains and overall scores, we appraised 4 out of 6 CPGs (inclusive of updates) as "recommended" for use in practice. Overall agreement among appraisers was excellent (ICC 0.86 [95% CI 0.73-0.94] - 0.98 [95% CI 0.96-0.99]; p < 0.001).
   Discussion
   International interest in CPG development has resulted in refinements to methodologies, which has led to improvements in the overall quality of the product.
C1 [Gillespie, Brigid M.; Lin, Frances; Chaboyer, Wendy] Griffith Univ, Sch Nursing & Midwifery, Gold Coast, Qld, Australia.
   [Gillespie, Brigid M.] Gold Coast Hosp & Hlth Serv, Gold Coast, Qld, Australia.
   [Gillespie, Brigid M.; Bull, Claudia; Roberts, Shelley; Chaboyer, Wendy] Griffith Univ, Menzies Hlth Inst Queensland, Optimising Hlth Outcomes OHO Grp, Gold Coast, Qld, Australia.
   [Walker, Rachel] Princess Alexandra Hosp, Div Surg, Brisbane, Qld, Australia.
   [Walker, Rachel] Griffith Univ, AVATAR, Brisbane, Qld, Australia.
RP Gillespie, BM (reprint author), Griffith Univ, Sch Nursing & Midwifery, Gold Coast, Qld, Australia.; Gillespie, BM (reprint author), Gold Coast Hosp & Hlth Serv, Gold Coast, Qld, Australia.; Gillespie, BM (reprint author), Griffith Univ, Menzies Hlth Inst Queensland, Optimising Hlth Outcomes OHO Grp, Gold Coast, Qld, Australia.
EM b.gillespie@griffith.edu.au
RI Bull, Claudia/N-1918-2019
OI Gillespie, Brigid/0000-0003-3186-5691; Walker,
   Rachel/0000-0002-6089-8225
FU Gold Coast Health; Gold Coast Hospital Foundation Research Grant
   [RGS2017-LG0007]
FX This study was supported by a Gold Coast Health and the Gold Coast
   Hospital Foundation Research Grant which was obtained by BMG (grant
   number: RGS2017-LG0007; Gold Coast University Hospital url:
   https://www.goldcoast.health.qld.gov.au/hospitals-and-centres/gold-coast
   -university-hospital). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR AGREE, AGREE REX REC EXCELL
   AGREE Next Steps Consortium, 2010, MY AGREE PLUS CAN CA
   AGREE Next Steps Consortium, 2009, AGREE 2 INSTR EL VER
   Anderson DJ, 2014, INFECT CONT HOSP EP, V35, P605, DOI [10.1086/591064, 10.1086/676022, 10.1017/S0899823X00193869]
   [Anonymous], 2000, Bull Am Coll Surg, V85, P23
   Ban KA, 2017, SURG INFECT, V18, P379, DOI 10.1089/sur.2016.214
   Berrios SI, 2017, JAMA SURG, V152, P784, DOI 10.1001/jamasurg.2017.0904
   Bonnar P, 2017, SURG SITE INFECT PRE
   Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449
   Brouwers MC, 2010, CAN MED ASSOC J, V182, P1045, DOI 10.1503/cmaj.091714
   Brownlee S, 2017, LANCET
   Brownlee S, 2017, LANCET, V390, P156, DOI 10.1016/S0140-6736(16)32585-5
   Casarett D, 2016, NEW ENGL J MED, V374, P1203, DOI 10.1056/NEJMp1516803
   Centre for Reviews and Dissemination (CRD), 2009, SYSTEMATIC REV CRDS
   Enia F., 2009, JAMA-J AM MED ASSOC, V302, P142
   European Centre for Disease Prevention and Control (ECDC), 2013, SURV SURG SIT INF EU, DOI [10.1371/journal.pmed.1000097, DOI 10.1371/JOURNAL.PMED.1000097]
   Gagliardi AR, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007047
   Gillespie B, 2012, WOUND PRACT RES, V20, P90
   Gillespie BM, 2017, BRIT J SURG, V104, pE55, DOI 10.1002/bjs.10428
   Gillespie BM, 2015, J MULTIDISCIP HEALTH, V8, P473, DOI 10.2147/JMDH.S73565
   Gillespie BM, 2015, J ADV NURS, V71, P1238, DOI 10.1111/jan.12598
   Gillespie BM, 2014, J CLIN NURS, V23, P3250, DOI 10.1111/jocn.12574
   Greenhalgh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3725
   Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060
   Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1
   Harbarth S, 2003, J HOSP INFECT, V54, P258, DOI 10.1016/S0195-6701(03)00150-6
   Higgins JPT, 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184
   Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002
   Kassavin DS, 2011, AM J SURG, V201, P749, DOI 10.1016/j.amjsurg.2010.03.002
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Li ZY, 2016, INT J CLIN PRACT, V70, P20, DOI 10.1111/ijcp.12744
   Lo Vecchio A, 2011, J PEDIATR GASTR NUTR, V52, P183, DOI 10.1097/MPG.0b013e3181e233ac
   Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Mudge Stephen M., 2008, P1
   National Collaborating Centre for Women's and Children's Health, 2008, SURG SIT INF PREV TR
   National Institute for Health and Care Excellence, 2013, SURG SIT INF EV UPD
   Ocloo J, 2016, BMJ QUAL SAF, V25, P626, DOI 10.1136/bmjqs-2015-004839
   Smith CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136098
   Smith MA, 2013, ORTHOP NURS, V32, P242, DOI 10.1097/NOR.0b013e3182a39c6b
   Squire S., 2006, CRITICAL GOVERNANCE, V11, P8
   Sutherland-Fraser S, 2016, PERIOPERATIVE NURSIN
   Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205
   Ubbink DT, 2015, ADV WOUND CARE, V4, P286, DOI 10.1089/wound.2014.0592
   Whittemore R, 2005, J ADV NURS, V52, P546, DOI 10.1111/j.1365-2648.2005.03621.x
   WHO, 2016, GLOB GUID PREV SURG
   Yokoe Deborah S, 2014, Infect Control Hosp Epidemiol, V35 Suppl 2, pS1, DOI 10.1086/675819
   Yokoe DS, 2014, INFECT CONT HOSP EP, V35, P967, DOI 10.1086/677216
   Yokoe DS, 2008, INFECT CONT HOSP EP, V29, pS3, DOI 10.1086/591063
   Yokoe DS, 2008, INFECT CONT HOSP EP, V29, pS12, DOI 10.1086/591060
NR 50
TC 0
Z9 0
U1 1
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 13
PY 2018
VL 13
IS 9
AR e0203354
DI 10.1371/journal.pone.0203354
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GT5KH
UT WOS:000444545800032
PM 30212487
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Pulido, CM
   Redondo-Sama, G
   Sorde-Marti, T
   Flecha, R
AF Pulido, Cristina M.
   Redondo-Sama, Gisela
   Sorde-Marti, Teresa
   Flecha, Ramon
TI Social impact in social media: A new method to evaluate the social
   impact of research
SO PLOS ONE
LA English
DT Article
ID SCIENCE
AB The social impact of research has usually been analysed through the scientific outcomes produced under the auspices of the research. The growth of scholarly content in social media and the use of altmetrics by researchers to track their work facilitate the advancement in evaluating the impact of research. However, there is a gap in the identification of evidence of the social impact in terms of what citizens are sharing on their social media platforms. This article applies a social impact in social media methodology (SISM) to identify quantitative and qualitative evidence of the potential or real social impact of research shared on social media, specifically on Twitter and Facebook. We define the social impact coverage ratio (SICOR) to identify the percentage of tweets and Facebook posts providing information about potential or actual social impact in relation to the total amount of social media data found related to specific research projects. We selected 10 projects in different fields of knowledge to calculate the SICOR, and the results indicate that 0.43% of the tweets and Facebook posts collected provide linkages with information about social impact. However, our analysis indicates that some projects have a high percentage (4.98%) and others have no evidence of social impact shared in social media. Examples of quantitative and qualitative evidence of social impact are provided to illustrate these results. A general finding is that novel evidences of social impact of research can be found in social media, becoming relevant platforms for scientists to spread quantitative and qualitative evidence of social impact in social media to capture the interest of citizens. Thus, social media users are showed to be intermediaries making visible and assessing evidence of social impact.
C1 [Pulido, Cristina M.] Univ Autonoma Barcelona, Dept Journalism & Commun Studies, Barcelona, Spain.
   [Redondo-Sama, Gisela] Univ Zaragoza, Dept Psychol & Sociol, Zaragoza, Spain.
   [Sorde-Marti, Teresa] Univ Autonoma Barcelona, Dept Sociol, Barcelona, Spain.
   [Flecha, Ramon] Univ Barcelona, Dept Sociol, Barcelona, Spain.
RP Pulido, CM (reprint author), Univ Autonoma Barcelona, Dept Journalism & Commun Studies, Barcelona, Spain.
EM cristina.pulido@uab.cat
RI Pulido, Cristina/Q-3479-2017
OI Pulido, Cristina/0000-0001-8630-7529; Sorde Marti,
   Teresa/0000-0003-0336-3061; Redondo-Sama, Gisela/0000-0003-2240-7795;
   Flecha, Ramon/0000-0001-7230-516X
FU European Commission [613202]
FX The research leading to these results has received funding from the 7th
   Framework Programme of the European Commission under the Grant Agreement
   no 613202 P.I. Ramon Flecha,
   https://ec.europa.eu/research/fp7/index_en.cfm. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR [Anonymous], 2010, EUROPEAN 2020 STRATE
   Bornmann L, 2015, ASLIB J INFORM MANAG, V67, P305, DOI 10.1108/AJIM-09-2014-0115
   Bornmann L, 2013, J AM SOC INF SCI TEC, V64, P217, DOI 10.1002/asi.22803
   Cabre-Olive A J, 2017, J SOCIAL SCI, V6, P70, DOI [10.17583/rimcis.2017.2652, DOI 10.17583/RIMCIS.2017.2652]
   Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118
   Crooks A, 2013, T GIS, V17, P124, DOI 10.1111/j.1467-9671.2012.01359.x
   EC Research & Innovation, 2017, SUCC STOR
   Economic and Social Research Council, 2017, SOC MED BEST PRACT G
   EuroFIT, 2016, EUR INT PP YOUT
   Euronews, 2016, BIG FARM IS WATCH SU
   European Commission, 2012, WORK PROGR 2013 COOP
   European Commission, 2013, WORK PROGR 2013 COOP
   European Commission, 2011, WORK PROGR 2012 COOP
   European Commission, 2017, BETT REG TOOLB, P129
   Flecha R, 2016, SISM METHODOLOGY SOC
   Flecha R, 2015, NATURE, V528, P193, DOI 10.1038/528193d
   FoodRisc Consortium European Commission, 2017, FOODR RES BRIEF 7 FR
   Fresco LO, 2015, CURR SCI INDIA, V109, P430
   Godin B, 2005, INRS URBANISATION CU
   Haustein S, 2014, J ASSOC INF SCI TECH, V65, P656, DOI 10.1002/asi.23101
   Hayes A, 2016, AM J CLIN NUTR, V104, P629, DOI 10.3945/ajcn.116.132530
   HELMING K, 2011, ECOL SOC, V16, pNI353
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lubchenco J, 1998, SCIENCE, V279, P491, DOI 10.1126/science.279.5350.491
   Maitre L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46082
   Martinello N, 2012, INFORM HEALTH SOC CA, V37, P177, DOI 10.3109/17538157.2012.678448
   Murphy L., Q3Q4 GRIT, V3-4
   PhysOrg, 2016, REUS FOOD WAST AN FE
   Poppy G, 2015, NATURE, V526, P7, DOI 10.1038/526007a
   Reale E, 2018, RES EVALUAT, V27, P298, DOI 10.1093/reseval/rvx025
   Research Information Center, 2016, TECHN TRIALL FIGHT A
   Shuai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047523
   Statista, 2017, STAT FACTS SOC MED U
   Townsend L., 2016, SOCIAL MEDIA RES GUI
   Wilder L, 2008, ORYX, V42, P529, DOI 10.1017/S0030605307000671
   Xia F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165997
NR 36
TC 3
Z9 3
U1 4
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 29
PY 2018
VL 13
IS 8
AR e0203117
DI 10.1371/journal.pone.0203117
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GR9JD
UT WOS:000443071400091
PM 30157262
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Pothmann, CEM
   Baumann, S
   Jensen, KO
   Mica, L
   Osterhoff, G
   Simmen, HP
   Sprengel, K
AF Pothmann, Carina Eva Maria
   Baumann, Stephen
   Jensen, Kai Oliver
   Mica, Ladislav
   Osterhoff, Georg
   Simmen, Hans-Peter
   Sprengel, Kai
TI Assessment of polytraumatized patients according to the Berlin
   Definition: Does the addition of physiological data really improve
   interobserver reliability?
SO PLOS ONE
LA English
DT Article
ID INJURY SEVERITY SCORE; TRAUMA; SCALE; INTERRATER; AGREEMENT; TRISS;
   CARE; ISS
AB Background
   Several new definitions for categorizing the severely injured as the Berlin Definition have been developed. Here, severely injured patients are selected by additive physiological parameters and by the general Abbreviated Injury Scale (AIS)-based assessment. However, all definitions should conform to an AIS severity coding applied by an expert. We examined the dependence of individual coding on defining injury severity in general and in identifying polytrauma according to several definitions. A precise definition of polytrauma is important for quality management.
   Methods
   We investigated the interobserver reliability (IR) between several polytrauma definitions for identifying polytrauma using several cut-off levels (ISS >= 16, >= 18, >= 20, >= 25 points, and the Berlin Definition). One hundred and eighty-seven patients were included for analyzing IR of the polytrauma definitions. IR for polytrauma definitions was assessed by Cohen's kappa.
   Results
   IR for identifying polytrauma according to the relevant definitions showed moderate agreement (<0.60) in the ISS cutoff categories (ISS >= 16, >= 18, and >= 20 points), while ISS >= 25 points just reached substantial agreement (0.62) and the Berlin Definition demonstrated a correlation of 0.77 which is nearly perfect agreement (>0.80).
   Conclusion
   Compared with the ISS-based definitions of polytrauma, the Berlin Definition proved less dependent on the individual rater. This underlines the need to redefine the selection of severely injured patients. Using the Berlin Definition for identifying polytrauma could improve the comparability of patient data across studies, in trauma center benchmarking, and in quality assurance.
C1 [Pothmann, Carina Eva Maria; Baumann, Stephen; Jensen, Kai Oliver; Mica, Ladislav; Osterhoff, Georg; Simmen, Hans-Peter; Sprengel, Kai] Univ Hosp Zurich, Dept Trauma, Zurich, Switzerland.
RP Sprengel, K (reprint author), Univ Hosp Zurich, Dept Trauma, Zurich, Switzerland.
EM kai.sprengel@usz.ch
RI Sprengel, Kai/G-4780-2014
OI Sprengel, Kai/0000-0001-5921-8272; Osterhoff, Georg/0000-0001-5051-0998
CR [Anonymous], 1971, JAMA, V215, P277
   BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001
   BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005
   Brown JB, 2017, J TRAUMA ACUTE CARE, V82, P995, DOI 10.1097/TA.0000000000001440
   Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029
   Butcher NE, 2013, J TRAUMA ACUTE CARE, V74, P884, DOI 10.1097/TA.0b013e31827e1bad
   Chawda MN, 2004, INJURY, V35, P347, DOI 10.1016/S0020-1383(03)00140-2
   Costa Carlos Dario da Silva, 2012, Rev. Col. Bras. Cir., V39, P249, DOI 10.1590/S0100-69912012000400002
   Gennarelli T, 2008, ABBREVIATED INJURY S
   Gordic S, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140616
   Joosse P, 2014, HEALTH INF MANAG J, V43, P17, DOI 10.1177/183335831404300203
   Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   MACKENZIE EJ, 1985, MED CARE, V23, P823, DOI 10.1097/00005650-198506000-00008
   MacKenzie EJ, 1978, P AM ASS AUTOMOTIVE, V22, P55
   Moos RM, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14334
   Neale Rachel, 2003, Emerg Med (Fremantle), V15, P38, DOI 10.1046/j.1442-2026.2003.00406.x
   Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009
   Paffrath T, 2014, INJURY, V45, pS64, DOI 10.1016/j.injury.2014.08.020
   Pape HC, 2014, J TRAUMA ACUTE CARE, V77, P780, DOI 10.1097/TA.0000000000000453
   Ringdal KG, 2013, INJURY, V44, P691, DOI 10.1016/j.injury.2012.06.032
   Rogers FB, 1997, J TRAUMA, V43, P65, DOI 10.1097/00005373-199707000-00016
   TEASDALE G, 1974, LANCET, V2, P81
   TSCHERNE H, 1984, LANGENBECK ARCH CHIR, V364, P71, DOI 10.1007/BF01823174
   WAYDHAS C, 1992, UNFALLCHIRURG, V95, P67
   WHO, 2004, GLOBAL BURDEN DIS
   ZOLTIE N, 1993, BMJ-BRIT MED J, V307, P906, DOI 10.1136/bmj.307.6909.906
NR 27
TC 0
Z9 0
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 23
PY 2018
VL 13
IS 8
AR e0201818
DI 10.1371/journal.pone.0201818
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GR6TZ
UT WOS:000442800100025
PM 30138313
OA DOAJ Gold, Green Accepted, Green Published
DA 2019-07-16
ER

PT J
AU Wang, YF
   Casajus, N
   Buddle, C
   Berteaux, D
   Larrivee, M
AF Wang, Yifu
   Casajus, Nicolas
   Buddle, Christopher
   Berteaux, Dominique
   Larrivee, Maxim
TI Predicting the distribution of poorly-documented species, Northern black
   widow (Latrodectus variolus) and Black purse-web spider (Sphodros
   niger), using museum specimens and citizen science data
SO PLOS ONE
LA English
DT Article
ID ECOLOGICAL NICHE MODELS; CLIMATE-CHANGE; ARANEAE THERIDIIDAE; RANGE
   EXPANSION; COLD TOLERANCE; SAMPLING BIAS; ABSENCE DATA; TEMPERATURE;
   ACCURACY; ATYPIDAE
AB Predicting species distributions requires substantial numbers of georeferenced occurrences and access to remotely sensed climate and land cover data. Reliable estimates of the distribution of most species are unavailable, either because digitized georeferenced distributional data are rare or not digitized. The emergence of online biodiversity information databases and citizen science platforms dramatically improves the amount of information available to establish current and historical distribution of lesser-documented species. We demonstrate how the combination of museum and online citizen science databases can be used to build reliable distribution maps for poorly documented species. To do so, we investigated the distribution and the potential range expansions of two north-eastern North American spider species (Arachnida: Araneae), the Northern black widow (Latrodectus variolus) and the Black purse-web spider (Sphodros niger). Our results provide the first predictions of distribution for these two species. We also found that the Northern black widow has expanded north of its previously known range providing valuable information for public health education. For the Black purse-web spider, we identify potential habitats outside of its currently known range, thus providing a better understanding of the ecology of this poorly-documented species. We demonstrate that increasingly available online biodiversity databases are rapidly expanding biogeography research for conservation, ecology, and in specific cases, epidemiology, of lesser known taxa.
C1 [Wang, Yifu; Buddle, Christopher] McGill Univ, Dept Nat Resource Sci, Montreal, PQ, Canada.
   [Casajus, Nicolas; Berteaux, Dominique] Univ Quebec Rimouski, Canada Res Chair Northern Biodivers, Rimouski, PQ, Canada.
   [Larrivee, Maxim] Insectarium Montreal, Montreal, PQ, Canada.
RP Wang, YF (reprint author), McGill Univ, Dept Nat Resource Sci, Montreal, PQ, Canada.
EM yifu.wang@mail.mcgill.ca
OI Casajus, Nicolas/0000-0002-5537-5294
CR Adams-Hosking C, 2011, WILDLIFE RES, V38, P122, DOI 10.1071/WR10156
   Addo-Bediako A, 2002, FUNCT ECOL, V16, P332, DOI 10.1046/j.1365-2435.2002.00634.x
   Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x
   Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Ammunet T, 2012, ECOL ENTOMOL, V37, P212, DOI 10.1111/j.1365-2311.2012.01358.x
   ANDERSON JF, 1994, COMP BIOCHEM PHYS A, V109, P181, DOI 10.1016/0300-9629(94)90325-5
   Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x
   Barghusen LE, 1997, FUNCT ECOL, V11, P4, DOI 10.1046/j.1365-2435.1997.00040.x
   BEATTY JA, 1986, J ARACHNOL, V14, P130
   Bergstrom U, 2013, J APPL ECOL, V50, P680, DOI 10.1111/1365-2664.12083
   Bonte D, 2008, P NATL ACAD SCI USA, V105, P17000, DOI 10.1073/pnas.0806830105
   Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012
   Breed GA, 2013, NAT CLIM CHANGE, V3, P142, DOI [10.1038/nclimate1663, 10.1038/NCLIMATE1663]
   Cao Y, 2013, ECOL MODEL, V259, P30, DOI 10.1016/j.ecolmodel.2013.03.012
   Clements GR, 2012, INTEGR ZOOL, V7, P400, DOI 10.1111/j.1749-4877.2012.00314.x
   COYLE FA, 1981, J ARACHNOL, V9, P317
   COYLE FA, 1985, J ARACHNOL, V13, P291
   Cramer KL, 2008, J ARACHNOL, V36, P136, DOI 10.1636/Sh06-29.1
   Cutler Bruce, 2004, Transactions of the Kansas Academy of Science, V107, P101, DOI 10.1660/0022-8443(2004)107[0101:TPSOKA]2.0.CO;2
   Cuyckens GAE, 2014, ORYX, P1
   Delaney DG, 2008, BIOL INVASIONS, V10, P117, DOI 10.1007/s10530-007-9114-0
   Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347
   Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636
   Donnelly A, 2014, INT J BIOMETEOROL, V58, P1237, DOI 10.1007/s00484-013-0717-0
   Dube D-e, 2015, BLACK WIDOW SPIDER S
   eBird, 2015, BIRD ONLINE DATABASE
   Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x
   Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x
   Finkbeiner SD, 2011, J LEPID SOC, V65, P119
   Gallo T, 2011, BIOSCIENCE, V61, P459, DOI 10.1525/bio.2011.61.6.8
   Gertsch WJ, 1980, REVISION AM SPIDERS
   GREENSTONE MH, 1982, FLA ENTOMOL, V65, P83, DOI 10.2307/3494147
   Harte J, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199593415.001.0001
   Hernandez PA, 2008, BIODIVERS CONSERV, V17, P1353, DOI 10.1007/s10531-007-9314-z
   Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x
   Hu JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111292
   iNaturalist, 2015, INATURALIST ORG COMM
   Jensen GL, 2005, SPIDER IDENTIFICATIO
   Jimenez-Valverde A, 2011, J BIOGEOGR, V38, P1213, DOI 10.1111/j.1365-2699.2010.02465.x
   Karban R, 2004, ECOL ENTOMOL, V29, P251, DOI 10.1111/j.1365-2311.2004.00576.x
   Kerr JT, 2015, SCIENCE, V349, P177, DOI 10.1126/science.aaa7031
   Khatchikian C, 2011, MED VET ENTOMOL, V25, P268, DOI 10.1111/j.1365-2915.2010.00935.x
   Kiss B, 2002, J ARACHNOL, V30, P409, DOI 10.1636/0161-8202(2002)030[0409:COAAWD]2.0.CO;2
   Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096
   Kullenberg C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147152
   Kuper W, 2006, BOT J LINN SOC, V150, P355, DOI 10.1111/j.1095-8339.2006.00494.x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Larrivee M, 2012, B ENTOMOL SOC, V44, P133
   Larrivee M, 2011, ECOL ENTOMOL, V36, P144, DOI 10.1111/j.1365-2311.2010.01255.x
   Leroux SJ, 2013, ECOL APPL, V23, P815, DOI 10.1890/12-1407.1
   Li XH, 2013, INTEGR ZOOL, V8, P124, DOI 10.1111/1749-4877.12000
   Liu CR, 2011, ECOGRAPHY, V34, P232, DOI 10.1111/j.1600-0587.2010.06354.x
   MARETIC Z, 1983, TOXICON, V21, P457, DOI 10.1016/0041-0101(83)90123-X
   McCook HC, 1888, P ACAD NAT SCI PHILA, V40, P203
   McCRONE JOHN D., 1964, PSYCHE, V71, P12, DOI 10.1155/1964/86469
   McFarland KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053986
   McKenney DW, 2006, AGR FOREST METEOROL, V138, P69, DOI 10.1016/j.agrformet.2006.03.012
   McKenney DW, 2011, B AM METEOROL SOC, V92, P1611, DOI [10.1175/2011BAMS3132.1, 10.1175/BAMS-D-10-3132.1]
   Moriyama M, 2009, ENTOMOL SCI, V12, P162, DOI 10.1111/j.1479-8298.2009.00318.x
   MORROW W, 1986, J ARACHNOL, V14, P119
   Naparus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030047
   NatureServe, 2015, NATURESERVE EXPL ONL
   Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630
   North GR, 2013, P NATL ACAD SCI USA, V110, P17169, DOI 10.1073/pnas.1316025110
   Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100
   Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x
   Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1
   Porretta D, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-271
   Proosdij ASJ, 2016, ECOGRAPHY, V39, P542, DOI DOI 10.1111/ECOG.01509
   Pruitt JN, 2011, ETHOLOGY, V117, P318, DOI 10.1111/j.1439-0310.2011.01877.x
   Quillfeldt P, 2013, J BIOGEOGR, V40, P430, DOI 10.1111/jbi.12008
   Rubio GD, 2010, ZOOTAXA, P55
   Saupe EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017731
   SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615
   Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158
   Taucare-Rios A, 2016, ENVIRON ENTOMOL, V45, P1379, DOI 10.1093/ee/nvw118
   Team Core Writing, 2014, CLIMATE CHANGE 2014
   Vink CJ, 2011, BIOL INVASIONS, V13, P1003, DOI 10.1007/s10530-010-9885-6
   Warren DL, 2014, DIVERS DISTRIB, V20, P334, DOI 10.1111/ddi.12160
   Wieczorek J, 2012, GEOREFERENCING QUICK
   Wilson LF, 1967, GREAT LAKES ENTOMOL, V1, P147
   WOINARSKI JCZ, 1984, AUST J ECOL, V9, P207, DOI 10.1111/j.1442-9993.1984.tb01359.x
NR 84
TC 0
Z9 0
U1 1
U2 54
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 8
PY 2018
VL 13
IS 8
AR e0201094
DI 10.1371/journal.pone.0201094
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GP7NS
UT WOS:000441090300030
PM 30089136
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Garon, M
   Lavallee, MM
   Estay, EV
   Beauchamp, MH
AF Garon, Mathieu
   Maxime Lavallee, Marie
   Vera Estay, Evelyn
   Beauchamp, Miriam H.
TI Visual encoding of social cues predicts sociomoral reasoning
SO PLOS ONE
LA English
DT Article
ID TRAUMATIC BRAIN-INJURY; MORAL DEVELOPMENT; EMPATHY; DESIRABILITY;
   COGNITION; AGGRESSION; JUDGMENT; VALIDITY; BEHAVIOR; EYE
AB As the first step of social information processing, visual encoding underlies the interpretation of social cues. Faces, in particular, convey a large amount of affective information, which can be subsequently used in the planning and production of adaptive social behaviors. Sociomoral reasoning is a specific social skill that is associated with engagement in appropriate social behaviors when faced with dilemmas. Previous studies using eye tracking suggest that visual encoding may play an important role in decision-making when individuals are faced with extreme moral dilemmas, but it is not known if this is generalizable to everyday situations. The main objective of this study was to assess the contribution of visual encoding to everyday sociomoral reasoning using eye tracking and ecological visual dilemmas. Participants completed the SocioMoral Reasoning Aptitude Level (SoMoral) task while their eye movements and pupil dilation were recorded. While visual encoding was not a predictor of sociomoral decision-making, sociomoral maturity was predicted by fixation count. Thus, in an ecological context, visual encoding of social cues appears to be associated with sociomoral maturity: the production of a justification is associated with volitional encoding strategies. Implications with regards to the dual-process theory of sociomoral reasoning and social information processing are discussed.
C1 [Garon, Mathieu; Maxime Lavallee, Marie; Vera Estay, Evelyn; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada.
   [Vera Estay, Evelyn] Pontificia Univ Catolica Chile, Ctr Desarrollo Tecnol Inclus, Escuela Psicol, Macul, Chile.
   [Beauchamp, Miriam H.] St Justine Hosp Res Ctr, Montreal, PQ, Canada.
RP Beauchamp, MH (reprint author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.; Beauchamp, MH (reprint author), St Justine Hosp Res Ctr, Montreal, PQ, Canada.
EM miriam.beauchamp@umontreal.ca
OI Garon, Mathieu/0000-0003-1143-8668
FU National Science and Engineering Research Council of Canada [386527];
   National Science and Engineering Research Council of Canada graduate
   scholarship
FX This study was made possible through a National Science and Engineering
   Research Council of Canada (http://www.nserc-crsng.gc.ca) grant
   (#386527) awarded to M.H.B. and through a National Science and
   Engineering Research Council of Canada graduate scholarship for doctoral
   studies awarded to M.G. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adolphs R, 2017, CURR DIR PSYCHOL SCI, V26, P282, DOI 10.1177/0963721417694656
   Arsenio WF, 2004, CHILD DEV, V75, P987, DOI 10.1111/j.1467-8624.2004.00720.x
   Arsenio WF, 2010, J ABNORM CHILD PSYCH, V38, P627, DOI 10.1007/s10802-010-9408-z
   BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1
   Barger B, 2013, J MORAL EDUC, V42, P443, DOI 10.1080/03057240.2013.809517
   BASINGER KS, 1987, PSYCHOL REP, V61, P139, DOI 10.2466/pr0.1987.61.1.139
   Bauman CW, 2014, SOC PERSONAL PSYCHOL, V8, P536, DOI 10.1111/spc3.12131
   Bauminger N, 2005, J LEARN DISABIL-US, V38, P45, DOI 10.1177/00222194050380010401
   Beauchamp M, 2012, ADM CODING MANUAL SO
   Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486
   Birmingham E., 2012, COGNITIVE NEUROSCIEN, P251
   Blake BF, 2006, PERS INDIV DIFFER, V40, P1625, DOI 10.1016/j.paid.2005.12.007
   BLOOM L, 1959, J Genet Psychol, V95, P3
   Bruers S, 2014, PHILOSOPHIA, V42, P251, DOI 10.1007/s11406-013-9507-5
   Chiasson V, 2017, CLIN NEUROPSYCHOL, V31, P515, DOI 10.1080/13854046.2016.1268650
   Christensen JF, 2012, NEUROSCI BIOBEHAV R, V36, P1249, DOI 10.1016/j.neubiorev.2012.02.008
   CHRISTOPHER FS, 1993, J MARRIAGE FAM, V55, P469, DOI 10.2307/352816
   Cottone J, 2007, J SCI STUD RELIG, V46, P37, DOI 10.1111/j.1468-5906.2007.00339.x
   CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74
   Crispo M, 2017, TROLLEYOLOGIE UTILIT
   CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358
   Davis M. H., 1980, MULTIDIMENSIONAL APP
   DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113
   Decety J, 2012, CEREB CORTEX, V22, P209, DOI 10.1093/cercor/bhr111
   Dooley JJ, 2010, BRAIN IMPAIR, V11, P152, DOI 10.1375/brim.11.2.152
   Edmonds D, 2013, WOULD YOU KILL FAT M
   Ehmke C, 2007, IDENTIFYING WEB USAB, P119
   Einhauser W, 2010, FRONTIERS HUMAN NEUR, V4
   ELM DR, 1994, J BUS ETHICS, V13, P341, DOI 10.1007/BF00871762
   FeldmanHall O, 2012, COGNITION, V123, P434, DOI 10.1016/j.cognition.2012.02.001
   Fiedler S, 2015, CURR OPIN PSYCHOL, V6, P139, DOI 10.1016/j.copsyc.2015.08.008
   Fowler K., 2008, EUROPEAN J DEV SCI, V2, P303
   Francis KB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164374
   Freeman JB, 2016, TRENDS COGN SCI, V20, P362, DOI 10.1016/j.tics.2016.03.003
   Gibbs J. C., 2013, MORAL DEV REALITY TH
   GIBBS JC, 1982, CHILD DEV, V53, P895, DOI 10.1111/j.1467-8624.1982.tb01351.x
   Gleichgerrcht E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060418
   Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9
   Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872
   Greene JD, 2009, COGNITION, V111, P364, DOI 10.1016/j.cognition.2009.02.001
   Greenwood JD, 2011, J THEOR SOC BEHAV, V41, P333, DOI 10.1111/j.1468-5914.2011.00472.x
   Gu J, 2013, J EXP PSYCHOL GEN, V142, P307, DOI 10.1037/a0029549
   Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814
   Haidt J, 2008, SOCIAL INTUITIONISTS
   Holmqvist K, COMMON PREDICTORS AC
   Horsley TA, 2010, J ABNORM CHILD PSYCH, V38, P587, DOI 10.1007/s10802-009-9361-x
   Jackson I, 2009, DEVELOPMENTAL SCI, V12, P670, DOI 10.1111/j.1467-7687.2008.00805.x
   Kahane G, 2015, SOC NEUROSCI-UK, V10, P551, DOI 10.1080/17470919.2015.1023400
   Kahneman D, 2005, RES PER NEUROSCI, P91, DOI 10.1007/3-540-29803-7_8
   Kastner R. M., 2010, CHRESTOMATHY, V9, P114
   KOHLBERG L, 1973, GERONTOLOGIST, V13, P497, DOI 10.1093/geront/13.4.497
   Kohlberg L, 1981, PHILOS MORAL DEV MOR
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langdon PE, 2011, AJIDD-AM J INTELLECT, V116, P438, DOI 10.1352/1944-7558-116.6.438
   Latif DA, 2000, J BUS ETHICS, V25, P255, DOI 10.1023/A:1006049605298
   Lawson C, 2010, WORLD POLIT, V62, P561, DOI 10.1017/S0043887110000195
   LEE M, 1988, J ABNORM CHILD PSYCH, V16, P127, DOI 10.1007/BF00913589
   Li JL, 2013, AGGRESS VIOLENT BEH, V18, P357, DOI 10.1016/j.avb.2013.01.001
   Loas G, 1995, LENCEPHALE REV PSYCH
   Maestripieri D, 2017, BEHAV BRAIN SCI, V40
   Malti T, 2013, CHILD DEV, V84, P397, DOI 10.1111/j.1467-8624.2012.01851.x
   McCoy M, 2016, ENCY EVOLUTIONARY PS, P1
   Narvaez D, 2001, J MORAL EDUC, V30, P43, DOI 10.1080/03057240120033802
   Navarrete CD, 2012, EMOTION, V12, P364, DOI 10.1037/a0025561
   Norman E, 2009, FDN TRACING INTUITIO, P32
   Olsen A, 2012, TOBII VT FIXATION FI
   Parnamets P, 2008, THESIS
   Parnamets P, 2015, P NATL ACAD SCI USA, V112, P4170, DOI 10.1073/pnas.1415250112
   Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X
   Patil I, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00501
   Patil I, 2014, SOC NEUROSCI-UK, V9, P94, DOI 10.1080/17470919.2013.870091
   Piaget J., 1932, JUGEMENT MORAL CHEZ
   Porter S, 2010, PSYCHOL CRIME LAW, V16, P477, DOI 10.1080/10683160902926141
   PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512
   Rest JR, 1986, DIT MANUAL DEFINING
   Rogers K, 2007, J AUTISM DEV DISORD, V37, P709, DOI 10.1007/s10803-006-0197-8
   Saunders LF, 2009, 2 MINDS DUAL PROCESS, P335, DOI DOI 10.1093/ACPROF:OSO/9780199230167.001.0001
   Schonfeld AM, 2005, J STUD ALCOHOL, V66, P545, DOI 10.15288/jsa.2005.66.545
   Skulmowski A, 2014, FRONT BEHAV NEUROSCI, V8, DOI [10.3389/fnbeh.2014.00426, 10.3389/fobeh.2014.00426]
   Sneddon A, 2007, PHILOS PSYCHOL, V20, P731, DOI 10.1080/09515080701694110
   Spraggins EF, 1987, EMPATHY CLIN DIETITI
   Stober J, 2001, EUR J PSYCHOL ASSESS, V17, P222, DOI 10.1027//1015-5759.17.3.222
   Tassy S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00250
   Teper R, 2015, PERS SOC PSYCHOL B, V41, P887, DOI 10.1177/0146167215583848
   Teper R, 2011, PSYCHOL SCI, V22, P553, DOI 10.1177/0956797611402513
   Todorov A, 2015, ANNU REV PSYCHOL, V66, P519, DOI 10.1146/annurev-psych-113011-143831
   Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4
   Turiel E., 1983, DEV SOCIAL KNOWLEDGE
   Vera-Estay E, 2015, J MORAL EDUC, V44, P17, DOI 10.1080/03057240.2014.986077
   Vera-Estay E, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00227
   Wechsler D, 1999, MANUAL WECHSLER ABBR
   Zarinpoush F, 2000, J MORAL EDUC, V29, P397, DOI 10.1080/713679391
NR 92
TC 1
Z9 1
U1 4
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 25
PY 2018
VL 13
IS 7
AR e0201099
DI 10.1371/journal.pone.0201099
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GO4AN
UT WOS:000439942500079
PM 30044875
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ringe, KI
   von Falck, C
   Raatschen, HJ
   Wacker, F
   Hinrichs, J
AF Ringe, Kristina, I
   von Falck, Christian
   Raatschen, Hans-Juergen
   Wacker, Frank
   Hinrichs, Jan
TI Evaluation of transient respiratory motion artifact at gadoxetate
   disodium-enhanced MRI-Influence of different contrast agent application
   protocols
SO PLOS ONE
LA English
DT Article
ID HEPATIC ARTERIAL PHASE; GADOBENATE DIMEGLUMINE; LESION APPEARANCE;
   IMAGE-QUALITY; LIVER; ACID; OPTIMIZATION; DTPA; AGREEMENT
AB Purpose
   To evaluate transient severe respiratory motion artifacts (TSM) at gadoxetate disodium-enhanced MRI dependent on the mode of contrast agent application.
   Methods
   200 patients (71f, 129m; mean 51y) were included in this retrospective IRB-approved study. Contrast application protocols (n = 4) differed with regards to injection rate (2ml or 1ml/sec), dose (weight-based or fixed 10ml) and supplemental oxygen administration (yes/no). SNR measurements were performed in the aorta and portal vein. Qualitatively, three readers assessed arterial phase image quality and TSM independently (4- and 5-point scale, respectively). Quantitative and qualitative results were compared (Kruskal-Wallis test, Dunn's multiple comparison test). The influence of different contrast agent application parameters on the occurrence of respiratory motion artifacts was assessed (univariate analysis). Interrater agreement and reliability were calculated (intraclass correlation coefficient, ICC)).
   Results
   Use of a lower contrast injection rate resulted in significantly higher arterial SNR in the aorta and portal vein (p<0.05). TSM was observed in 12% of examinations. Neither injection rate, contrast dose, nor oxygen had a significant influence. Interrater agreement and reliability for evaluation of image quality and respiratory motion were substantial/ almost perfect (ICC = 0.640-0.915).
   Conclusions
   Technical factors regarding the specific mode of contrast application do not seem to significantly reduce the incidence of severe transient respiratory motion artifacts.
C1 [Ringe, Kristina, I; von Falck, Christian; Raatschen, Hans-Juergen; Wacker, Frank; Hinrichs, Jan] Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany.
RP Ringe, KI (reprint author), Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany.
EM ringe.kristina@mh.hannover.de
CR Bashir MR, 2015, RADIOLOGY, V274, P141, DOI 10.1148/radiol.14140386
   Cruite I, 2010, AM J ROENTGENOL, V195, P29, DOI 10.2214/AJR.10.4538
   Davenport MS, 2014, AM J ROENTGENOL, V203, P796, DOI 10.2214/AJR.13.11587
   Davenport MS, 2014, RADIOLOGY, V272, P123, DOI 10.1148/radiol.14132269
   Davenport MS, 2013, RADIOLOGY, V266, P452, DOI 10.1148/radiol.12120826
   Gisev N, 2013, RES SOC ADMIN PHARM, V9, P330, DOI 10.1016/j.sapharm.2012.04.004
   Gutzeit A, 2016, EUROPEAN C RADIOLOGY
   Haradome H, 2010, J MAGN RESON IMAGING, V32, P334, DOI 10.1002/jmri.22241
   Hayashi T, 2015, RADIOLOGY, V276, P756, DOI 10.1148/radiol.2015141646
   Huh J, 2015, KOREAN J RADIOL, V16, P1207, DOI 10.3348/kjr.2015.16.6.1207
   Kim SY, 2015, AM J ROENTGENOL, V204, P1220, DOI 10.2214/AJR.14.13677
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Luetkens JA, 2015, EUR RADIOL, V25, P3207, DOI 10.1007/s00330-015-3736-x
   McClellan TR, 2017, RADIOLOGY, V282, P361, DOI 10.1148/radiol.2016160482
   McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30
   Motosugi U, 2016, RADIOLOGY, V279, P93, DOI 10.1148/radiol.2015150642
   Park YS, 2016, INVEST RADIOL, V51, P127, DOI 10.1097/RLI.0000000000000211
   Pietryga JA, 2014, RADIOLOGY, V271, P426, DOI 10.1148/radiol.13131988
   Ringe KI, 2010, AM J ROENTGENOL, V195, P13, DOI 10.2214/AJR.10.4392
   Schmid-Tannwald C, 2012, ACTA RADIOL, V53, P961, DOI 10.1258/ar.2012.120186
   Tsuboyama T, 2016, EUROPEAN C RADIOLOGY
   Van Montfoort JE, 1999, J PHARMACOL EXP THER, V290, P153
   Yoo JL, 2016, INVEST RADIOL, V51, P440, DOI 10.1097/RLI.0000000000000249
   Zech CJ, 2009, INVEST RADIOL, V44, P305, DOI 10.1097/RLI.0b013e3181a24512
NR 24
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 19
PY 2018
VL 13
IS 7
AR e0200887
DI 10.1371/journal.pone.0200887
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GN5RC
UT WOS:000439120000065
PM 30024930
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Miyazaki, R
   Ando, H
   Hamasaki, T
   Higuchi, Y
   Oshita, K
   Tashiro, T
   Sakane, N
AF Miyazaki, Ryo
   Ando, Hitoshi
   Hamasaki, Tomoko
   Higuchi, Yukito
   Oshita, Kazushige
   Tashiro, Tomoki
   Sakane, Naoki
TI Development and initial validation of the Morningness-Eveningness
   Exercise Preference Questionnaire (MEEPQ) in Japanese university
   students
SO PLOS ONE
LA English
DT Article
ID QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; CIRCADIAN-RHYTHM; CHRONOTYPE;
   ADULTS; PERFORMANCE; PATTERNS
AB The aim of this study was to develop a questionnaire to conveniently assess the diurnal preferences of physical activity (PA) in Japanese university students. A total of 219 subjects completed our novel Morningness-eveningness Exercise Preference Questionnaire (MEEPQ). The MEEPQ consisted of 30 items (15 items for the morning and the same 15 items for the evening) rated on a 5-point Likert scale concerning their preference for participating in PA in the morning and evening. The morning score (MS) and evening score (ES) were determined by summing each of the respective 15 items. The internal consistency and construct validity were assessed, and a factor analysis was conducted. To examine the external validity of the MEEPQ, participants wore an accelerometer for seven consecutive days to measure their PA levels objectively. Finally, the test-retest reliability was evaluated at a one-month interval. The MEEPQ showed excellent internal consistency (Cronbach's alpha = 0.896) and construct validity (morning KMO = 0.913, evening KMO = 0.875). A factor analysis showed a three-factor structure involving Physical Wellness (MEEPQ-W), Psychological Well-Being (MEEPQ-P) and Exercise Barrier (MEEPQ-B). The percent of variance was largest for MEEPQ-W in the morning (45.2%) and MEEPQ-P in the evening (40.8%). Test-retest showed that MEEPQ scores had fair repeatability. Significant and positive associations between scores and objectively measured PA levels were found in the MS and 6-9 AM PA and in the ES and 6-9 PM and 9 PM- 0 AM PA (all p<0.05). In summary, the novel MEEPQ showed relatively good agreement and thus can be used for Japanese university student samples. In the MEEPQ, three factors (the physical wellness, psychological well-being and exercise barrier) contributed to a morning or evening PA preference. The summed scores were significantly associated with the objectively measured PA levels in both the morning and evening. Therefore the MEEPQ appears to be a suitable tool for assessing diurnal PA preferences.
C1 [Miyazaki, Ryo] Shimane Univ, Fac Human Sci, Matsue, Shimane, Japan.
   [Miyazaki, Ryo] Univ East Asia, Fac Human Sci, Dept Sports & Hlth Sci, Yamaguchi, Japan.
   [Ando, Hitoshi] Kanagawa Univ, Grad Sch Med Sci, Dept Cellular & Mol Funct Anal, Yokohama, Ishikawa, Japan.
   [Hamasaki, Tomoko] Kyushu Womens Univ, Fac Home Econ, Dept Nutr, Fukuoka, Fukuoka, Japan.
   [Higuchi, Yukito; Oshita, Kazushige; Tashiro, Tomoki] Kyushu Kyoritsu Univ, Dept Sports Sci, Fukuoka, Fukuoka, Japan.
   [Sakane, Naoki] Natl Hosp Org, Kyoto Med Ctr, Clin Res Inst Endocrine & Metab Dis, Div Prevent Med, Kyoto, Japan.
RP Miyazaki, R (reprint author), Shimane Univ, Fac Human Sci, Matsue, Shimane, Japan.; Miyazaki, R (reprint author), Univ East Asia, Fac Human Sci, Dept Sports & Hlth Sci, Yamaguchi, Japan.
EM miyazaki@hmn.shimane-u.ac.jp
RI ANDO, Hitoshi/O-8199-2016
OI ANDO, Hitoshi/0000-0001-6179-9993; Miyazaki, Ryo/0000-0002-1996-709X
FU Ministry of Education and Science of Japan [26750351]
FX This work was supported by grant-in-aid for Science Research from the
   Ministry of Education and Science of Japan (26750351), URL:
   https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-26750351/. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Allison Kelly C, 2008, Eat Behav, V9, P62, DOI 10.1016/j.eatbeh.2007.03.007
   Arvidsson D, 2013, MED SCI SPORT EXER, V45, P698, DOI 10.1249/MSS.0b013e31827a1d05
   Bonato M, 2017, J SPORT SCI MED, V16, P286
   Brace N, 2012, SPSS PSYCHOL
   Chtourou H, 2014, SPORT SCI HLTH, V10, P143, DOI 10.1007/s11332-014-0185-x
   Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1
   Hatcher L., 1994, STEP BY STEP APPROAC
   Henst RHP, 2015, CHRONOBIOL INT, V32, P858, DOI 10.3109/07420528.2015.1048870
   Hisler GC, 2017, ANN BEHAV MED, V51, P391, DOI 10.1007/s12160-016-9862-0
   HORNE J A, 1976, International Journal of Chronobiology, V4, P97
   ISHIHARA K, 1986, JPN J PSYCHOL, V57, P87, DOI 10.4992/jjpsy.57.87
   Jansen FM, 2018, J PUBLIC HEALTH-UK, V40, P787, DOI 10.1093/pubmed/fdx146
   Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033
   Kunorozva L, 2014, J SPORT SCI, V32, P917, DOI 10.1080/02640414.2013.873139
   Kunorozva L, 2012, CHRONOBIOL INT, V29, P1004, DOI 10.3109/07420528.2012.719966
   Laborde S, 2015, CHRONOBIOL INT, V32, P942, DOI 10.3109/07420528.2015.1055755
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lastella M, 2016, J HUM KINET, V54, P219, DOI 10.1515/hukin-2016-0049
   Antunez JM, 2013, CHRONOBIOL INT, V30, P981, DOI 10.3109/07420528.2013.790397
   Ministry of Health Labour and Welfare, 2010, RES STEP COUNT NAT H
   Pedisic Z, 2014, EUR J SPORT SCI, V14, P492, DOI 10.1080/17461391.2013.844861
   Rae DE, 2015, EUR J APPL PHYSIOL, V115, P1339, DOI 10.1007/s00421-015-3109-9
   Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679
   Roenneberg T, 2015, J BIOL RHYTHM, V30, P487, DOI 10.1177/0748730415603835
   Roveda E, 2017, CHRONOBIOL INT, V34, P551, DOI 10.1080/07420528.2016.1276928
   Schondube A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01414
   SMITH CS, 1989, J APPL PSYCHOL, V74, P728, DOI 10.1037/0021-9010.74.5.728
   Suh S, 2017, BEHAV SLEEP MED, V15, P361, DOI 10.1080/15402002.2016.1141768
   Tanaka C, 2016, J PHYS ACT HEALTH, V13, pS189, DOI 10.1123/jpah.2016-0296
   Vitale JA, 2015, CHRONOBIOL INT, V32, P405, DOI 10.3109/07420528.2014.986273
   Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351
   Yu JH, 2015, J CLIN ENDOCR METAB, V100, P1494, DOI 10.1210/jc.2014-3754
NR 32
TC 0
Z9 0
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 18
PY 2018
VL 13
IS 7
AR e0200870
DI 10.1371/journal.pone.0200870
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GN4SJ
UT WOS:000439022400083
PM 30021011
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Badawi, A
   Velummailum, R
   Ryoo, SG
   Senthinathan, A
   Yaghoubi, S
   Vasileva, D
   Ostermeier, E
   Plishka, M
   Soosaipillai, M
   Arora, P
AF Badawi, Alaa
   Velummailum, Russanthy
   Ryoo, Seung Gwan
   Senthinathan, Arrani
   Yaghoubi, Sahar
   Vasileva, Denitsa
   Ostermeier, Emma
   Plishka, Mikayla
   Soosaipillai, Marcel
   Arora, Paul
TI Prevalence of chronic comorbidities in dengue fever and West Nile virus:
   A systematic review and meta-analysis
SO PLOS ONE
LA English
DT Review
ID TYPE-2 DIABETES-MELLITUS; ACUTE KIDNEY INJURY; RISK-FACTORS;
   HEMORRHAGIC-FEVER; YELLOW-FEVER; CLINICAL-FEATURES; ADULT PATIENTS;
   NEUROINVASIVE DISEASE; JAPANESE ENCEPHALITIS; VASCULAR LEAKAGE
AB Background
   Flavivirus diseases such as dengue fever (DENV), West Nile virus (WNV), Zika and yellow fever represent a substantial global public health concern. Preexisting chronic conditions such as cardiovascular diseases, diabetes, obesity, and asthma were thought to predict risk of progression to severe infections.
   Objective
   We aimed to quantify the frequency of chronic comorbidities in flavivirus diseases to provide an estimate for their prevalence in severe and non-severe infections and examine whether chronic diseases contribute to the increased risk of severe viral expression.
   Methods
   We conducted a comprehensive search in PubMed, Ovid MEDLINE(R), Embase and Embase Classic and grey literature databases to identify studies reporting prevalence estimates of comorbidities in flavivirus diseases. Study quality was assessed with the risk of bias tool. Age-adjusted odds ratios (ORs) were estimated for severe infection in the presence of chronic comorbidities.
   Results
   We identified 65 studies as eligible for inclusion for DENV (47 studies) and WNV (18 studies). Obesity and overweight (i.e., BMI> 25 kg/m(2), prevalence: 24.5%, 95% CI: 18.6-31.6%), hypertension (17.1%, 13.3 - 21.8%) and diabetes (13.3%, 9.3 - 18.8%) were the most prevalent comorbidities in DENV. However, hypertension (45.0%, 39.1 - 51.0%), diabetes (24.7%, 20.2 - 29.8%) and heart diseases (25.6%, 19.5 - 32.7%) were the most prevalent in WNV.ORs of severe flavivirus diseases were about 2 to 4 in infected patients with comorbidities such as diabetes, hypertension and heart diseases. The small number of studies in JEV, YFV and Zika did not permit estimating the prevalence of comorbidities in these infections.
   Conclusion
   Higher prevalence of chronic comorbidities was found in severe cases of flavivirus diseases compared to non-severe cases. Findings of the present study may guide public health practitioners and clinicians to evaluate infection severity based on the presence of comorbidity, a critical public health measure that may avert severe disease outcome given the current dearth of clear prevention practices for some flavivirus diseases.
C1 [Badawi, Alaa] Publ Hlth Agcy Canada, Publ Hlth Risk Sci Div, Toronto, ON, Canada.
   [Badawi, Alaa; Velummailum, Russanthy] Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada.
   [Ryoo, Seung Gwan; Vasileva, Denitsa; Ostermeier, Emma; Plishka, Mikayla] Univ Toronto, Fac Arts & Sci, Toronto, ON, Canada.
   [Senthinathan, Arrani] Mt Sinai Hlth Syst, Toronto, ON, Canada.
   [Yaghoubi, Sahar] Ryerson Univ, Fac Sci, Toronto, ON, Canada.
   [Soosaipillai, Marcel] Univ Waterloo, Fac Sci, Waterloo, ON, Canada.
   [Arora, Paul] Publ Hlth Agcy Canada, Infect Dis Prevent & Control Branch, Natl Microbiol Lab, Toronto, ON, Canada.
RP Badawi, A (reprint author), Publ Hlth Agcy Canada, Publ Hlth Risk Sci Div, Toronto, ON, Canada.; Badawi, A (reprint author), Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada.
EM alaa.badawi@canada.ca
FU Public Health Agency of Canada
FX Public Health Agency of Canada (AB) is the funder of the study and had
   no role in study design, data collection, data analysis, data
   interpretation, or writing the report and the corresponding author had
   full access to all data in the study and had final responsibility for
   the decision to submit for publication.
CR Aamir M, 2015, PAK J MED HEALTH SCI, V9, P99
   Abroug F, 2006, MAYO CLIN PROC, V81, P12, DOI 10.4065/81.1.12
   Assir MZK, 2012, INT J INFECT DIS, V16, pE247, DOI 10.1016/j.ijid.2012.05.877
   Aubry C, 2012, TRAVEL MED INFECT DI, V10, P247, DOI 10.1016/j.tmaid.2012.09.004
   Badawi A, 2016, J PUBLIC HEALTH RES, V5, P130, DOI 10.4081/jphr.2016.733
   Badawi A, 2016, INT J INFECT DIS, V49, P129, DOI 10.1016/j.ijid.2016.06.015
   Badawi A, 2010, DIABETES METAB SYNDR, V3, P173, DOI 10.2147/DMSO.S9089
   Benfield T, 2007, DIABETOLOGIA, V50, P549, DOI 10.1007/s00125-006-0570-3
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BISTRIAN BR, 1981, AM J CLIN NUTR, V34, P238
   Borenstein M, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P193
   Bouzid M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-781
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Calvet GA, 2015, J CLIN VIROL, V74, DOI DOI 10.1016/J.JCV.2015.11
   Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832
   Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253
   CDC, 2016, AV ANN INC W NIL VIR
   Chamnanchanunt S, 2012, SE ASIAN J TROP MED, V43, P890
   Chancey C, 2015, BIOMED RES INT, DOI 10.1155/2015/376230
   Chaturvedi UC, 2000, FEMS IMMUNOL MED MIC, V28, P183, DOI 10.1016/S0928-8244(00)00163-2
   Chen CM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004376
   Chen CY, 2015, INT J MOL SCI, V16, P3820, DOI 10.3390/ijms16023820
   Choi BCK, 2001, DIABETOLOGIA, V44, P1221, DOI 10.1007/s001250100648
   Clayton D, 1993, STAT MODELS EPIDEMIO
   COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666
   COHEN A, 1989, STAT MED, V8, P1485, DOI 10.1002/sim.4780081208
   Cook RL, 2010, AM J TROP MED HYG, V83, P1133, DOI [10.4269/ajtmh.2010.09-0717, 10.4269/ajtmh.2010.09.0717]
   Craven RB, 2001, JAMA-J AM MED ASSOC, V286, P651, DOI 10.1001/jama.286.6.651
   Cunha RV, 1999, T ROY SOC TROP MED H, V93, P247, DOI 10.1016/S0035-9203(99)90008-1
   Danis K, 2011, EMERG INFECT DIS, V17, P1868, DOI 10.3201/eid1710.110525
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dharmashankar K, 2010, CURR HYPERTENS REP, V12, P448, DOI 10.1007/s11906-010-0150-2
   Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8
   Douam F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14781
   Duderstadt SK, 2012, VACCINE, V30, P813, DOI 10.1016/j.vaccine.2011.10.087
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Eosaltay N, 2015, LEADERSHIP ORG OUTCO, P19
   Fernandes-Charpiot I, 2014, TRANSPLANTATION, V98, P260
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Figueiredo MAA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000699
   Fujimoto Denys Eiti, 2014, Rev. Bras. Hematol. Hemoter., V36, P115, DOI 10.5581/1516-8484.20140027
   Gotzsche PC, 2009, ANN INTERN MED, V151, P265
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Hasanat M A, 2010, Mymensingh Med J, V19, P382
   Hasbun R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148898
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1174, DOI 10.3201/eid1108.050289b
   Hayes EB, 2004, PEDIATRICS, V113, P1375, DOI 10.1542/peds.113.5.1375
   Higgins J, 2011, COCHRANE COLLAB, V5, P1, DOI DOI 10.1002/9780470712184
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hoffman JE, 2013, J GERIATR PHYS THER, V36, P55, DOI 10.1519/JPT.0b013e318258bcba
   Hoffman KW, 2016, J INFECT DIS, V214, P634, DOI 10.1093/infdis/jiw179
   Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014
   Htun NSN, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003741
   Huang SY, 2015, AM J TROP MED HYG, V92, P75, DOI 10.4269/ajtmh.14-0343
   International Diabetes Federation, 2015, IDF DIABETES ATLAS, DOI DOI 10.1289/IMAGE.EHP.V119.I03
   Iqtadar S, 2014, INT J INFECT DIS, V21S
   Jaeger VK, 2015, J TRAVEL MED, V22, P161, DOI 10.1111/jtm.12184
   Jean CM, 2007, EMERG INFECT DIS, V13, P1918, DOI 10.3201/eid1312.061265
   Kalayanarooj Siripen, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P378
   Kari K, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-8
   Karunakaran A, 2014, J INFECT PUBLIC HEAL, V7, P114, DOI [10.1016/j.jiph.7013.09.006, 10.1016/j.jiph.2013.09.006]
   Kesavadev Jothydev, 2012, Indian J Endocrinol Metab, V16, P886, DOI 10.4103/2230-8210.102982
   Khairallah M, 2007, OCUL IMMUNOL INFLAMM, V15, P435, DOI 10.1080/09273940701798488
   Krow-Lucal E, 2017, MMWR-MORBID MORTAL W, V66, P51, DOI 10.15585/mmwr.mm6602a3
   Kuo MC, 2008, CLIN J AM SOC NEPHRO, V3, P1350, DOI 10.2215/CJN.00020108
   Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103/141662, 10.3201/eid2103.141662]
   LaBeaud AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-1
   Lahiri M, 2008, T ROY SOC TROP MED H, V102, P1011, DOI 10.1016/j.trstmh.2008.06.005
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Landis JR, 2014, MANTEL HAENSZEL METH, DOI DOI 10.1002/9781118445112.STAT04874
   Laoprasopwattana K, 2010, J PEDIATR-US, V157, P303, DOI 10.1016/j.jpeds.2010.02.008
   Lee CC, 2013, AM J EMERG MED, V31, P783, DOI 10.1016/j.ajem.2013.01.011
   Lee IK, 2008, AM J TROP MED HYG, V79, P149, DOI 10.4269/ajtmh.2008.79.149
   Lee IK, 2013, BIOMED RES INT, DOI 10.1155/2013/965853
   Lee IK, 2009, AM J TROP MED HYG, V80, P651, DOI 10.4269/ajtmh.2009.80.651
   Lee Min-Sheng, 2006, Journal of Microbiology Immunology and Infection, V39, P121
   Lee TH, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004576
   Lenhard T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154143
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700
   Limonta D, 2008, DIABETES VASC DIS RE, V5, P213, DOI 10.3132/dvdr.2008.034
   Lin SZ, 2010, PERITON DIALYSIS INT, V30, P467, DOI 10.3747/pdi.2009.00028
   Lindenbach BD, 2007, FIELDS VIROLOGY, V1, P1101
   Lindsey NP, 2012, AM J TROP MED HYG, V87, P179, DOI 10.4269/ajtmh.2012.12-0113
   Liu CC, 2008, AM J INFECT DIS, V4, P10, DOI 10.3844/ajidsp.2008.10.17
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9
   Lopez-Denman AJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010014
   Low JGH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001191
   Lye DC, 2010, INT J INFECT DIS, V14, pE410, DOI 10.1016/j.ijid.2009.06.026
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Mahmood S, 2013, ISRN TROP MED, V2013, DOI [10.1155/2013/673798, DOI 10.1155/2013/673798]
   Malavige GN, 2017, IMMUNOLOGY, V151, P261, DOI 10.1111/imm.12748
   Mallhi TH, 2016, POSTGRAD MED J, V92, P78, DOI 10.1136/postgradmedj-2015-133582
   Mallhi TH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1141-3
   Mallhi TH, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0138465, DOI 10.1371/JOURNALPONE.0138465]
   Marfin AA, 2001, CLIN INFECT DIS, V33, P1713, DOI 10.1086/322700
   Mercado M, 2016, EUROSURVEILLANCE, V21, P33, DOI 10.2807/1560-7917.ES.2016.21.22.30244
   Mirza AMB, 2016, J PAK MED ASSOC, V66, P1102
   Mohamed NA, 2013, EGYPT J CHEST DIS TU, V62, P319, DOI 10.1016/j.ejcdt.2013.03.002
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Mora A, 2013, CHEST, V144, DOI 10.1378/chest.1701609
   Moraes GH, 2013, AM J TROP MED HYG, V88, P670, DOI 10.4269/ajtmh.11-0774
   Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Murray K, 2006, EPIDEMIOL INFECT, V134, P1325, DOI 10.1017/S0950268806006339
   Murray KO, 2009, ZOONOSES PUBLIC HLTH, V56, P370, DOI 10.1111/j.1863-2378.2008.01197.x
   Mutebi JP, 2002, MICROBES INFECT, V4, P1459, DOI 10.1016/S1286-4579(02)00028-X
   National Heart Lung and Blood Institute, 2014, QUAL ASS TOOL OBS CO
   Ng EL, 2014, INT J INFECT DIS, V21, P447, DOI 10.1016/j.ijid.2014.03.1342
   Pang JX, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0649-2
   Pang JX, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001641
   Pang VJ, 2013, AM J TROP MED HYG, V89
   Papa A, 2010, EUROSURVEILLANCE, V15
   Passos SRL, 2008, INFECTION, V36, P570, DOI 10.1007/s15010-008-7334-6
   Patgiri SJ, 2014, INDIAN J PATHOL MICR, V57, P400, DOI 10.4103/0377-4929.138732
   Pem-Novosel I, 2014, VECTOR-BORNE ZOONOT, V14, P82, DOI 10.1089/vbz.2012.1295
   Petersen LR, 2005, J TRAVEL MED, V12, pS3
   Pinto E, 2007, POSTGRAD MED J, V83, P109, DOI 10.1136/pgmj.2006.048371
   Popovic N, 2013, EUROSURVEILLANCE, V18, P18, DOI 10.2807/1560-7917.ES2013.18.43.20613
   Prow NA, 2016, EMERG INFECT DIS, V22, P1353, DOI 10.3201/eid2208.151719
   Racsa L, 2014, DIAGN MICR INFEC DIS, V78, P132, DOI 10.1016/j.diagmicrobio.2013.11.006
   Ribeiro M, 2009, REV SOC BRAS MED TRO, V42, P523, DOI 10.1590/S0037-86822009000500009
   Richardson JTE, 2011, STAT MED, V30, P890, DOI 10.1002/sim.4116
   Roehrig JT, 2001, ELS, DOI [10.1002/9780470015902.a0002233.pub3, DOI 10.1002/9780470015902.A0002233.PUB3]
   Rosenberger KD, 2016, TROP MED INT HEALTH, V21, P445, DOI 10.1111/tmi.12666
   Sakagianni K, 2013, INTENS CARE MED, V39, pS520
   Saqib Muhammad Arif Nadeem, 2014, BMC Res Notes, V7, P205, DOI 10.1186/1756-0500-7-205
   Sejvar JJ, 2011, VECTOR-BORNE ZOONOT, V11, P161, DOI 10.1089/vbz.2009.0086
   Shamliyan T, 2013, AM J PUBLIC HLTH RES, V1, P183
   Sierra B, 2010, CELL IMMUNOL, V262, P134, DOI 10.1016/j.cellimm.2010.02.005
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Tedesco JM, 2016, FASEB J, V30
   ter Meulen J, 2004, J INFECT DIS, V190, P1821, DOI 10.1086/425016
   Thakare J. P., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P801
   Thein TL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0081060, DOI 10.1371/JOURNAL.PONE.0081060PMID:24278377]
   Thomas L, 2010, MED MALADIES INFECT, V40, P480, DOI 10.1016/j.medmal.2009.10.001
   Toledo J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004284
   Tomashek K, 2013, AM J TROP MED HYG S1, V89
   Tripepi G, 2010, NEPHRON CLIN PRACT, V116, pC317, DOI 10.1159/000319590
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4
   Vrioni G, 2014, VECTOR-BORNE ZOONOT, V14, P52, DOI 10.1089/vbz.2013.1369
   Wang CC, 2007, AM J TROP MED HYG, V77, P151, DOI 10.4269/ajtmh.2007.77.151
   Weatherhead JE, 2015, AM J TROP MED HYG, V92, P1006, DOI 10.4269/ajtmh.14-0616
   Wei HY, 2016, AM J TROP MED HYG, V95, P322, DOI 10.4269/ajtmh.15-0905
   WHO, 1997, DENG HAEM FEV DIAGN
   Wichmann O, 2004, TROP MED INT HEALTH, V9, P1022, DOI 10.1111/j.1365-3156.2004.01295.x
   Wong JGX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148579
   Woon YL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004575
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 153
TC 5
Z9 5
U1 4
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 10
PY 2018
VL 13
IS 7
AR e0200200
DI 10.1371/journal.pone.0200200
PG 27
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GM5IS
UT WOS:000438170300032
PM 29990356
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kupfer, S
   Winklhofer, S
   Becker, AS
   Distler, O
   Chung, CB
   Alkadhi, H
   Finkenstaedt, T
AF Kupfer, Sivert
   Winklhofer, Sebastian
   Becker, Anton S.
   Distler, Oliver
   Chung, Christine B.
   Alkadhi, Hatem
   Finkenstaedt, Tim
TI Gouty arthritis: Can we avoid unnecessary dual-energy CT examinations
   using prior radiographs?
SO PLOS ONE
LA English
DT Article
ID COMPUTED-TOMOGRAPHY; CRYSTAL-ARTHROPATHIES; TOPHACEOUS GOUT; DIAGNOSIS;
   IDENTIFICATION; EXTREMITIES; DEPOSITION; DISEASE; TOPHUS; JOINT
AB Objective
   The dual-energy CT (DECT) algorithm for urate detection is feasible only if hyperdense deposits are present. Based on our experience, around half of the performed DECT examinations show no such deposits and thus were useless for this indication. Our diagnostic accuracy study investigates whether conventional radiographs can serve as gatekeeper test prior to DECT for reliable exclusion of such radiopaque deposits.
   Materials and methods
   In this retrospective study, 77 clinically indicated DECT examinations of the hand (n = 29), foot (n = 36) and ankle (n = 12) of 55 patients (13 female, mean age 62 +/- 15 years) with suspected gouty arthritis were included. Two blinded readers independently evaluated DECT, gray-scale CT images (reference standard) and corresponding standardized radiographs for the presence/location of dense soft tissue deposits.
   Results
   Interreader agreement for detection of soft tissue deposits with DECT and radiographs was excellent (DECT: both readers, K = 1; radiographs: both readers, K = 0.94). DECT showed soft tissue deposits in 54/77 DECT (70%) scans. 30/54 scans (56%) showed deposits on the corresponding radiographs, while in 24 scans (44%) no deposits were seen on radiographs. Test performance of radiographs for soft tissue deposit detection: sensitivity 56%, specificity 100%, PPV 100%, NPV 48.9%, and accuracy 69%. Low density of the deposits was the main reasons for false-negative radiographs (19 cases, 79%), followed by superimposition of deposits by osseous structures (5 cases, 21%).
   Conclusion
   Conventional radiographs of the hand, foot and ankle cannot serve as a gatekeeper test for reliable exclusion of radiopaque soft tissue deposits prior to DECT.
C1 [Kupfer, Sivert; Becker, Anton S.; Alkadhi, Hatem; Finkenstaedt, Tim] Univ Zurich, Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, Zurich, Switzerland.
   [Winklhofer, Sebastian] Univ Zurich, Univ Hosp Zurich, Dept Neuroradiol, Zurich, Switzerland.
   [Distler, Oliver] Univ Zurich, Univ Hosp Zurich, Dept Rheumatol, Zurich, Switzerland.
   [Chung, Christine B.; Finkenstaedt, Tim] Univ Calif San Diego, Sch Med, Dept Radiol, San Diego, CA 92103 USA.
RP Finkenstaedt, T (reprint author), Univ Zurich, Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, Zurich, Switzerland.; Finkenstaedt, T (reprint author), Univ Calif San Diego, Sch Med, Dept Radiol, San Diego, CA 92103 USA.
EM tim.finkenstaedt@usz.ch
RI Becker, Anton S./H-5416-2019
OI Becker, Anton S./0000-0001-8372-6496; Finkenstaedt,
   Tim/0000-0002-8807-7306
CR Abreu M, 2004, SKELETAL RADIOL, V33, P392, DOI 10.1007/s00256-004-0767-9
   BARTHELEMY CR, 1984, SKELETAL RADIOL, V11, P1, DOI 10.1007/BF00361124
   Bely M, 2016, STRUCTURAL CHEM
   BLOCH C, 1980, AM J ROENTGENOL, V134, P781, DOI 10.2214/ajr.134.4.781
   Bongartz T, 2015, ANN RHEUM DIS, V74, P1072, DOI 10.1136/annrheumdis-2013-205095
   Chen J, 2017, Z RHEUMATOL, V76, P723, DOI 10.1007/s00393-016-0250-8
   Cheng Jianguo, 2007, Tech Reg Anesth Pain Manag, V11, P141, DOI 10.1053/j.trap.2007.05.006
   Choi HK, 2009, ANN RHEUM DIS, V68, P1609, DOI 10.1136/ard.2008.099713
   Choi HK, 2012, ANN RHEUM DIS, V71, P1466, DOI 10.1136/annrheumdis-2011-200976
   Cohen JF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012799
   Dalbeth N, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-012-0301-3
   Dalbeth N, 2010, ARTHRITIS RHEUM-US, V62, P1549, DOI 10.1002/art.27356
   Diekhoff T, 2018, INVEST RADIOL, V53, P6, DOI 10.1097/RLI.0000000000000402
   Diekhoff T, 2015, INVEST RADIOL, V50, P255, DOI 10.1097/RLI.0000000000000099
   DIEPPE PA, 1982, ANN RHEUM DIS, V41, P371, DOI 10.1136/ard.41.4.371
   Finkenstaedt T, 2016, EUR RADIOL, V26, P3989, DOI 10.1007/s00330-016-4237-2
   Gamala M, 2018, CLIN RHEUMATOL, V37, P1879, DOI 10.1007/s10067-018-3980-y
   Gentili Amilcare, 2006, Curr Rheumatol Rep, V8, P231, DOI 10.1007/s11926-996-0030-6
   Gerster JC, 2002, ANN RHEUM DIS, V61, P52, DOI 10.1136/ard.61.1.52
   Gerster JC, 1996, ARTHRITIS RHEUM, V39, P1406, DOI 10.1002/art.1780390820
   Girish G, 2013, ARTHRITIS, DOI 10.1155/2013/673401
   Girish G, 2013, AM J ROENTGENOL, V201, P515, DOI 10.2214/AJR.13.10776
   Glazebrook KN, 2011, RADIOLOGY, V261, P516, DOI 10.1148/radiol.11102485
   Kiefer T, 2016, EUR J RADIOL, V85, P1829, DOI 10.1016/j.ejrad.2016.08.004
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mallinson PI, 2014, SKELETAL RADIOL, V43, P277, DOI 10.1007/s00256-013-1771-8
   Mallinson PI, 2014, AM J ROENTGENOL, V203, pW103, DOI 10.2214/AJR.13.11396
   MARTEL W, 1981, RADIOLOGY, V141, P1
   McQueen FM, 2014, RHEUM DIS CLIN N AM, V40, P231, DOI 10.1016/j.rdc.2014.01.004
   Melzer R, 2014, SEMIN ARTHRITIS RHEU, V43, P662, DOI 10.1016/j.semarthrit.2013.11.002
   Neogi T, 2015, ANN RHEUM DIS, V74, P1789, DOI 10.1136/annrheumdis-2015-208237
   Nicolaou S, 2010, AM J ROENTGENOL, V194, P1072, DOI 10.2214/AJR.09.2428
   Pineda C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3223
   RESNICK D, 1974, RADIOLOGY, V113, P633, DOI 10.1148/113.3.633
   Sakellariou G, 2016, ANN RHEUM DIS, V75, P686, DOI 10.1136/annrheumdis-2016-eular.4747
   Saltybaeva N, 2014, RADIOLOGY, V273, P153, DOI 10.1148/radiol.14132903
   Schueller-Weidekamm C, 2007, EUR J RADIOL, V62, P437, DOI 10.1016/j.ejrad.2006.12.005
   Segal JB, 1999, ARTHRIT CARE RES, V12, P376, DOI 10.1002/1529-0131(199912)12:6<376::AID-ART5>3.0.CO;2-5
   Swan A, 2002, ANN RHEUM DIS, V61, P493, DOI 10.1136/ard.61.6.493
   Thornton FJ, 2000, EUR J RADIOL, V36, P123, DOI 10.1016/S0720-048X(00)00214-X
   Yin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095743
NR 41
TC 0
Z9 0
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 10
PY 2018
VL 13
IS 7
AR e0200473
DI 10.1371/journal.pone.0200473
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GM5IS
UT WOS:000438170300053
PM 29990381
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Olugbenga, I
   Taiwo, O
   Laverty, M
   Ngige, E
   Anyaike, C
   Bakare, R
   Ogunleye, V
   Maddox, BLP
   Newman, DR
   Gliddon, HD
   Ofondu, E
   Nurse-Findlay, S
   Taylor, MM
AF Olugbenga, Ijaodola
   Taiwo, Oyelade
   Laverty, Maura
   Ngige, Evelyn
   Anyaike, Chukwuma
   Bakare, Rasheed
   Ogunleye, Veronica
   Maddox, Brandy L. Peterson
   Newman, Daniel R.
   Gliddon, Harriet D.
   Ofondu, Eugenia
   Nurse-Findlay, Stephen
   Taylor, Melanie M.
TI Clinic-based evaluation study of the diagnostic accuracy of a dual rapid
   test for the screening of HIV and syphilis in pregnant women in Nigeria
SO PLOS ONE
LA English
DT Article
AB Background
   Screening pregnant women for HIV and syphilis is recommended by WHO in order to reduce mother-to-child transmission. We evaluated the field performance, feasibility, and acceptability of a dual rapid diagnostic test (RDT) for HIV and syphilis test in antenatal clinic settings in Nigeria.
   Methods and findings
   Participants were recruited at 12 antenatal clinic sites in three states of Nigeria. All consenting individuals were tested according to the national HIV testing algorithm, as well as a dual RDT, the SD BIOLINE HIV/Syphilis Duo Test (Alere, USA), in the clinic. To determine sensitivity, specificity and concordance, whole blood samples were obtained for repeat RDT performance in the laboratory, as well as reference tests for HIV and syphilis. Dual test acceptability and operational characteristics were assessed among participants and clinic staff.
   The prevalence of HIV among the 4,551 enrollees was 3.0% (138/4551) using the national clinic-based HIV testing algorithm. Positive and negative percent agreement of the HIV component of the dual RDT were 100.0% (95% CI 99.7-100.0) and 99.9% (95% CI 99.7-100.0) respectively, when compared with the national rapid testing algorithm. The prevalence of syphilis, using TPHA as the reference test, was low at 0.09% (4/4550). The sensitivity of the syphilis component of the dual RDT could not be calculated as no positive results were observed for patients that were positive for syphilis by TPHA. Each of the only four TPHA-positive specimens had RPR titers of 1:1 (neat), indicative of non-active syphilis. The specificity of the syphilis component of the dual RDT was 99.9% (95% CI 99.8-100.0).
   The dual RDT received favorable feasibility ratings among antenatal care clinic staff. Acceptability among study participants was high with most women reporting preference for rapid dual HIV/syphilis testing.
   Conclusions
   The SD BIOLINE HIV/Syphilis Duo Test showed a high overall diagnostic accuracy for HIV and a high specificity for syphilis diagnosis in antenatal clinic settings. This study adds to a growing body of evidence that supports the clinic-based use of dual tests for HIV and syphilis among pregnant women.
C1 [Olugbenga, Ijaodola; Ngige, Evelyn; Anyaike, Chukwuma] Fed Minist Hlth Nigeria, Natl AIDS & STIs Control Programme, Fct Abuja, Nigeria.
   [Taiwo, Oyelade] WHO Reg Off Africa, Brazzaville, Rep Congo.
   [Laverty, Maura; Gliddon, Harriet D.; Nurse-Findlay, Stephen; Taylor, Melanie M.] World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland.
   [Bakare, Rasheed; Ogunleye, Veronica] Univ Coll Hosp Ibadan, Dept Microbiol, Ibadan, Nigeria.
   [Maddox, Brandy L. Peterson; Newman, Daniel R.; Taylor, Melanie M.] Ctr Dis Control & Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Div STD Prevent, Atlanta, GA 30333 USA.
   [Gliddon, Harriet D.] UCL, London Ctr Nanotechnol, London, England.
   [Ofondu, Eugenia] Fed Med Ctr Owerri, Dermatol & Venereol Dept, Owerri, Nigeria.
RP Taylor, MM (reprint author), World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland.; Taylor, MM (reprint author), Ctr Dis Control & Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Div STD Prevent, Atlanta, GA 30333 USA.
EM mtaylor@who.int
OI Oyelade, Taiwo/0000-0002-3452-975X; Gliddon, Harriet/0000-0002-9623-4252
FU UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction (HRP)
FX This work was funded by the UNDP-UNFPA-UNICEF-WHO-World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction (HRP), a cosponsored program executed by the World Health
   Organization (WHO). The findings and conclusions in this report are
   those of the authors and do not necessarily represent the official
   position of the U.S. Centers for Disease Control and Prevention or the
   World Health Organization. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Black V, 2016, SEX TRANSM INFECT, V92, P495, DOI 10.1136/sextrans-2015-052474
   Bristow CC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1574-3
   Bristow CC, 2016, SEX TRANSM INFECT, V92, P182, DOI 10.1136/sextrans-2015-052326
   Gliddon HD, 2017, SEX TRANSM INFECT, V93, pS3, DOI 10.1136/sextrans-2016-053069
   Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623
   Hess KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112190
   Kahn JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087510
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   PAHO (Pan American Health Organization), 2015, EL MOTH TO CHILD TRA
   R Core Team, 2016, R LANG ENV STAT COMP
   Rotondi MA, 2009, ELEMENTARY EPIDEMIOL
   Taylor M, 2018, LANCET GLOB HEALTH, V6, pE26, DOI 10.1016/S2214-109X(17)30422-9
   UN Joint Programme on HIV/AIDS (UNAIDS), 2016, PREV GAP REP
   UNAIDS, 2016, GLOB AIDS MON 2017
   UNICEF, 2016, MAT NEWB HLTH DISP N
   WHO, 2016, GLOB HLTH SECT HIV 2
   WHO, 2016, GLOB HLTH SECT STRAT
   WHO, 2015, RREP GLOB SEX TRANSM
   World Health Organisation, 2014, GLOB GUID CRIT PROC
   World Health Organization, 2015, WHO PREQ IN VITR DIA
   World Health Organization (WHO), 2017, WHO INF NOT US DUAL
   Yin Yue-Ping, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS22, DOI 10.1016/j.ijgo.2015.04.004
NR 22
TC 2
Z9 2
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 10
PY 2018
VL 13
IS 7
AR e0198698
DI 10.1371/journal.pone.0198698
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GM5IS
UT WOS:000438170300004
PM 29990336
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Scharmga, A
   Peters, M
   van den Bergh, JP
   Geusens, P
   Loeffen, D
   van Rietbergen, B
   Schoonbrood, T
   Vosse, D
   Weijers, R
   van Tubergen, A
AF Scharmga, Andrea
   Peters, Michiel
   van den Bergh, Joop P.
   Geusens, Piet
   Loeffen, Daan
   van Rietbergen, Bert
   Schoonbrood, Thea
   Vosse, Debby
   Weijers, Rene
   van Tubergen, Astrid
TI Development of a scoring method to visually score cortical interruptions
   on high-resolution peripheral quantitative computed tomography in
   rheumatoid arthritis and healthy controls
SO PLOS ONE
LA English
DT Article
ID INFLAMMATORY ARTHRITIS; BONE EROSION; JOINTS
AB Objectives
   To develop a scoring method to visually score cortical interruptions in finger joints on High-Resolution peripheral Quantitative Computed Tomography (HR-pQCT), determine its intra-and inter-reader reliability and test its feasibility.
   Methods
   The scoring method was developed by integrating results from in-depth discussions with experts, consensus meetings, multiple reading experiments and the literature. Cortical interruptions were scored by two independent readers in an imaging dataset with finger joints from patients with rheumatoid arthritis (RA) and healthy controls and assessed for adjacent trabecular distortion. Reliability for the total number of cortical interruptions per joint and per quadrant was calculated using intraclass correlation coefficient (ICC). Feasibility was tested by recording the time to analyze one joint.
   Results
   In 98 joints we identified 252 cortical interruptions, 17% had trabecular distortion. Mean diameter of the interruptions was significantly larger in patients with RA compared with healthy controls (0.88 vs 0.47 mm, p = 0.03). Intra-reader reliability was ICC 0.88 (95% CI 0.83;0.92) per joint and ICC 0.69 (95% CI 0.65;0.73) per quadrant. Inter-reader reliability was ICC 0.48 (95% CI 0.20;0.67) per joint and ICC 0.56 (95% CI 0.49;0.62) per quadrant. The time to score one joint was mean 9.2 (SD 4.9) min.
   Conclusions
   This scoring method allows detection of small cortical interruptions on HR-pQCT imaging of finger joints, which is promising for use in clinical studies.
C1 [Scharmga, Andrea; Peters, Michiel; van den Bergh, Joop P.; Geusens, Piet; Schoonbrood, Thea; Vosse, Debby; van Tubergen, Astrid] Maastricht Univ, Dept Rheumatol, Med Ctr, Maastricht, Netherlands.
   [Scharmga, Andrea; Peters, Michiel; van den Bergh, Joop P.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands.
   [Scharmga, Andrea; Peters, Michiel; Geusens, Piet; van Tubergen, Astrid] Maastricht Univ, CAPHRI Care & Publ Hlth Res Inst, Maastricht, Netherlands.
   [van den Bergh, Joop P.] Viecuri Med Ctr, Dept Internal Med, Venlo, Netherlands.
   [van den Bergh, Joop P.; Geusens, Piet] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium.
   [Loeffen, Daan; Weijers, Rene] Maastricht Univ, Dept Radiol, Med Ctr, Maastricht, Netherlands.
   [van Rietbergen, Bert] Eindhoven Univ Technol, Dept Med Engn, Eindhoven, Netherlands.
   [van Rietbergen, Bert] Maastricht Univ, Dept Orthopaed Surg, Med Ctr, Maastricht, Netherlands.
RP Scharmga, A (reprint author), Maastricht Univ, Dept Rheumatol, Med Ctr, Maastricht, Netherlands.; Scharmga, A (reprint author), Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands.; Scharmga, A (reprint author), Maastricht Univ, CAPHRI Care & Publ Hlth Res Inst, Maastricht, Netherlands.
EM a.scharmga@maastrichtuniversity.nl
OI van den Bergh, Joop/0000-0003-3984-2232; Scharmga,
   Andrea/0000-0001-8940-8827
FU Weijerhorst foundation (JvdB); Pfizer [WS2056904];  [NL42300.068.12 /
   METC 12-2-037]
FX This work was supported by: the Weijerhorst foundation (JvdB)
   http://www.deweijerhorst.nl/weijerhorst/home. Funding that was used to
   purchase the HR-pQCT scanner and pay half of the PhD student salaries of
   MP and AS. It was also supported by Pfizer (PG), grant number:
   WS2056904, http://www.pfizer.nl/. This funding was used to perform the
   study (NL42300.068.12 / METC 12-2-037) of HR-pQCT imaging in patients
   with RA compared to conventional imaging techniques.
CR Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584
   Barnabe C, 2016, J RHEUMATOL, V43, P1935, DOI 10.3899/jrheum.160648
   Barnabe C, 2012, J RHEUMATOL, V39, P1494, DOI 10.3899/jrheum.120218
   Binks DA, 2015, ANN RHEUM DIS, V74, P196, DOI 10.1136/annrheumdis-2013-203972
   Fouque-Aubert A, 2010, ANN RHEUM DIS, V69, P1671, DOI 10.1136/ard.2009.114512
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   McGonagle D, 2009, ARTHRITIS RHEUM-US, V60, P1042, DOI 10.1002/art.24417
   Peters M., 2016, ARTHRITIS RHEUMA S10, V68
   Pialat JB, 2012, BONE, V50, P111, DOI 10.1016/j.bone.2011.10.003
   Scharmga A, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1148-y
   Scharmga A, 2016, ARTHRITIS RHEUMA S10, V68
   Scharmga A, 2016, J RHEUMATOL, V43, P1914, DOI 10.3899/jrheum.160646
   Schett G, 2005, ARTHRITIS RHEUM-US, V52, P3192, DOI 10.1002/art.21343
   Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153
   Sharp JT, 2004, J RHEUMATOL, V31, P1062
   Srikhum W, 2013, J RHEUMATOL, V40, P408, DOI 10.3899/jrheum.120780
   Stach CM, 2010, ARTHRITIS RHEUM-US, V62, P330, DOI 10.1002/art.27252
   van der Heijde D, 2000, J RHEUMATOL, V27, P261
   Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082817
   Zebaze R, 2015, J BONE MINER RES, V30, P24, DOI 10.1002/jbmr.2419
NR 20
TC 0
Z9 0
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 9
PY 2018
VL 13
IS 7
AR e0200331
DI 10.1371/journal.pone.0200331
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GM3UN
UT WOS:000438035500035
PM 29985943
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ibanez, SJ
   Mazo, A
   Nascimento, J
   Garcia-Rubio, J
AF Ibanez, Sergio J.
   Mazo, Aitor
   Nascimento, Juarez
   Garcia-Rubio, Javier
TI The Relative Age Effect in under-18 basketball: Effects on performance
   according to playing position
SO PLOS ONE
LA English
DT Article
ID GAME-RELATED STATISTICS; YOUNG SOCCER PLAYERS; BIRTH DATE;
   ANTHROPOMETRIC CHARACTERISTICS; COMPETITION; SUCCESS; LEVEL;
   NATIONALITY; RELEVANCE; MATURITY
AB The Relative Age Effect (RAE) in sport is defined as the age difference in the same sport group. This chronological difference implies a different level of sport experience and performance due to developmental and maturational processes. The aim of the present study was to analyze the relative age effect in elite u-18 basketball according to playing positions. The variables analyzed were: date of birth, playing position and technical-tactical performance indicators in basketball (TTPI). A descriptive analysis was carried out to characterize the sample, a lineal regression was used to analyze the influence of the date of birth on basketball performance and finally an ANOVA and discriminant analysis were performed to identify the differences among different playing positions. The results show the existence of the RAE in the top European Under-18 basketball competition (S1 = 67%; S2 = 33%). Performance indicators which are predictors of the birth quarter (p< .05) were only found in the small forwards (defensive rebounds (beta: -.463) and fouls received (beta: -.140)) and in the centers (three point throws scored (beta: -.321) and tried (beta: .342)). These results may be of use for coaches and clubs when recruiting players for each playing position. Older forwards and centers are capable of performing at a higher level. Therefore, clubs have to sign up those players born at the beginning of the year.
C1 [Ibanez, Sergio J.; Mazo, Aitor; Garcia-Rubio, Javier] Univ Extremadura, Fac Sports Sci, Caceres, Spain.
   [Nascimento, Juarez] Univ Fed Santa Catarina, Florianopolis, SC, Brazil.
   [Garcia-Rubio, Javier] Univ Autonoma Chile, Fac Educ, Santiago, Chile.
RP Ibanez, SJ (reprint author), Univ Extremadura, Fac Sports Sci, Caceres, Spain.
EM sibanez@unex.es
RI Ibanez, Sergio J/L-3711-2014
OI Ibanez, Sergio J/0000-0001-6009-4086
FU "Ayuda a los Grupos de Investigacion" of Govern of Extremadura (Economy
   and Infrastructures Department) [GR15122]; European Union through FEDER
   founds
FX This work has been partially supported by the "Ayuda a los Grupos de
   Investigacion (GR15122)" of Govern of Extremadura (Economy and
   Infrastructures Department); with the support of European Union through
   FEDER founds. These have been all the funding or sources of support
   received during this study. There was no additional external funding
   received for this study.
CR [Anonymous], 2011, TALENT DEV EXCELLENC
   Arrieta H, 2016, J SPORT SCI, V34, P1530, DOI 10.1080/02640414.2015.1122204
   Barnsley R. H., 1992, INT REV SOCIOL SPORT, V27, P77, DOI DOI 10.1177/101269029202700105
   Carling C, 2009, SCAND J MED SCI SPOR, V19, P3, DOI 10.1111/j.1600-0838.2008.00867.x
   Cobley S, 2009, SPORTS MED, V39, P235, DOI 10.2165/00007256-200939030-00005
   Cote J, 2007, HDB SPORT PSYCHOL, P184, DOI DOI 10.1002/9781118270011.CH8
   Deaner RO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057753
   Delorme N, 2009, SCAND J MED SCI SPOR, V19, P235, DOI 10.1111/j.1600-0838.2008.00781.x
   Esteva S, 2006, APUNTS-MED ESPORT, V41, P25, DOI 10.1016/S1886-6581(06)70004-4
   Field A., 2009, DISCOVERING STAT USI
   Furley P, 2016, J SPORT SCI, V34, P459, DOI 10.1080/02640414.2015.1061198
   Garcia J, 2011, REV EDUCACION FISICA, P13
   Gibbs BG, 2012, INT REV SOCIOL SPORT, V47, P644, DOI 10.1177/1012690211414343
   Gil SM, 2007, J STRENGTH COND RES, V21, P438
   Gomez MA, 2006, J HUM MOVEMENT STUD, V51, P357
   Ruano MAG, 2007, CULT CIENC DEPORTE, V2, P139
   Helsen WF, 2005, J SPORT SCI, V23, P629, DOI 10.1080/02640410400021310
   HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.2307/2289392
   Hoare D G, 2000, J Sci Med Sport, V3, P391, DOI 10.1016/S1440-2440(00)80006-7
   Ibanez SJ, 2015, INT J PERF ANAL SPOR, V15, P897, DOI 10.1080/24748668.2015.11868839
   Ibanez SJ, 2010, OPEN SPORTS SCI J, P118
   Karalejic M, 2011, J SPORT MED PHYS FIT, V51, P103
   Kioumourtzoglou E, 1998, PERCEPT MOTOR SKILL, V86, P771, DOI 10.2466/pms.1998.86.3.771
   Lago-Penas C, 2011, J STRENGTH COND RES, V25, P3358, DOI 10.1519/JSC.0b013e318216305d
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Musch J, 2001, DEV REV, V21, P147, DOI 10.1006/drev.2000.0516
   Nikolaidis PT, 2014, SPORT SCI HLTH, V10, P225, DOI DOI 10.1007/S11332-014-0198-5
   Nolan JE, 2010, INT REV SOCIOL SPORT, V45, P507, DOI 10.1177/1012690210371560
   Ostojic SM, 2014, RES SPORTS MED, V22, P398, DOI 10.1080/15438627.2014.944303
   Petersen AM, 2011, P NATL ACAD SCI USA, V108, P18, DOI 10.1073/pnas.1016733108
   Randolph J. J., 2005, JOENS LEARN INSTR S
   Rees T, 2016, SPORTS MED, V46, P1041, DOI 10.1007/s40279-016-0476-2
   Romann M, 2013, EUR J SPORT SCI, V13, P356, DOI 10.1080/17461391.2011.635699
   Romann M, 2013, J SPORT SCI, V31, P32, DOI 10.1080/02640414.2012.718442
   Sampaio J, 2004, PERCEPT MOTOR SKILL, V99, P1231, DOI 10.2466/PMS.99.7.1231-1238
   Sampaio J, 2008, INT J SPORT PSYCHOL, V39, P205
   Sampaio J, 2006, EUR J SPORT SCI, V6, P173, DOI 10.1080/17461390600676200
   Sampaio J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132894
   Schorer J, 2009, SCAND J MED SCI SPOR, V19, P720, DOI 10.1111/j.1600-0838.2008.00838.x
   Sherar LB, 2007, J SPORT SCI, V25, P879, DOI 10.1080/02640410600908001
   THOMPSON AH, 1991, SOCIOL SPORT J, V8, P146, DOI 10.1123/ssj.8.2.146
   Torres-Unda J, 2016, J STRENGTH COND RES, V30, P1325, DOI 10.1519/JSC.0000000000001224
   Wattie N, 2008, J SPORT SCI, V26, P1403, DOI 10.1080/02640410802233034
   Werneck FZ, 2016, SCI SPORT, V31, P158, DOI 10.1016/j.scispo.2015.08.004
NR 44
TC 2
Z9 2
U1 2
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 9
PY 2018
VL 13
IS 7
AR e0200408
DI 10.1371/journal.pone.0200408
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GM3UN
UT WOS:000438035500042
PM 29985940
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Bataille, Y
   Costerousse, O
   Bertrand, OF
   Moranne, O
   Pottel, H
   Delanaye, P
AF Bataille, Yoann
   Costerousse, Olivier
   Bertrand, Olivier F.
   Moranne, Olivier
   Pottel, Hans
   Delanaye, Pierre
TI One-year mortality of patients with ST-Elevation myocardial infarction:
   Prognostic impact of creatinine-based equations to estimate glomerular
   filtration rate
SO PLOS ONE
LA English
DT Article
ID CHRONIC KIDNEY-DISEASE; COCKCROFT-GAULT EQUATIONS; ESTIMATING
   RENAL-FUNCTION; CHRONIC TOTAL OCCLUSION; CKD-EPI EQUATION; SERUM
   CREATININE; HEART-FAILURE; CYSTATIN-C; RISK PREDICTION; EPIDEMIOLOGY
   COLLABORATION
AB Background
   Renal dysfunction is associated with worse outcomes after primary percutaneous coronary intervention (PCI). However, whether glomerular filtration rate (GFR) estimated with various equations can equally predict outcomes after ST-Elevation Myocardial Infarction (STEMI) is still debated.
   Methods
   We compared the clinical impact of 3 different creatinine-based equations (Cockcroft and Gault (CG), CKD-epidemiology (CKD-EPI) and Full Age Spectrum (FAS)) to predict 1-year mortality in STEMI patients.
   Results
   Among 1755 consecutive STEMI patients who had undergone primary PCI included between 2006 and 2011, median estimated GFR was 79 (61; 96) with the CG, 81 (65; 95) with CKD-EPI and 75 (60; 91) mL/min/1.73 m(2) with FAS equation. Reduced GFR values were independently associated with 1-year mortality risk with the 3 equations. Receiver operating curves (ROC) of CG and FAS equations were significantly superior to the CKD-EPI equation, p = 0.03 and p = 0.01, respectively. Better prediction with FAS and CG equations was confirmed by net reclassification index.
   Conclusions
   Our results suggest that in STEMI patients who have undergone primary PCI, 1-year mortality is better predicted by CG or FAS equations compared to CKD-EPI.
C1 [Bataille, Yoann; Costerousse, Olivier; Bertrand, Olivier F.] Quebec Heart Lung Inst, Quebec City, PQ, Canada.
   [Bataille, Yoann] Ctr Hosp Reg Citadelle, Dept Cardiol, Liege, Belgium.
   [Moranne, Olivier] Univ Montpellier Nimes, Dept Nephrol Dialysis Apheresis, CHU Nimes, Sch Med, Nimes, France.
   [Pottel, Hans] Univ Leuven, Dept Publ Hlth & Primary Care, Kortrijk, Belgium.
   [Delanaye, Pierre] Univ Liege CHU ULg, Dept Nephrol, Dialysis, Transplantat, Liege, Belgium.
RP Delanaye, P (reprint author), Univ Liege CHU ULg, Dept Nephrol, Dialysis, Transplantat, Liege, Belgium.
EM pierre_delanaye@yahoo.fr
CR Abu-Assi E, 2013, INT J CARDIOL, V168, P4300, DOI 10.1016/j.ijcard.2013.04.194
   Abu-Assi E, 2013, INT J CARDIOL, V167, P2325, DOI 10.1016/j.ijcard.2012.11.014
   Akerblom A, 2013, CLIN CHEM, V59, P1369, DOI 10.1373/clinchem.2012.200709
   Almeida I, 2016, EUR HEART J-ACUTE CA, V5, P223, DOI 10.1177/2048872615576219
   Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
   Barra Sergio, 2013, J Atr Fibrillation, V6, P896, DOI 10.4022/jafib.896
   Bataille Y, 2013, AM J CARDIOL, V112, P194, DOI 10.1016/j.amjcard.2013.03.010
   Bataille Y, 2012, HEART, V98, P1732, DOI 10.1136/heartjnl-2012-302376
   Berger JS, 2009, JAMA-J AM MED ASSOC, V302, P874, DOI 10.1001/jama.2009.1227
   Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X
   Bjork J, 2018, CLIN CHEM LAB MED, V56, P422, DOI 10.1515/cclm-2017-0563
   Bjork J, 2018, NEPHROL DIAL TRANSPL, V33, P1380, DOI 10.1093/ndt/gfx272
   Campbell NG, 2012, HEART, V98, P42, DOI 10.1136/heartjnl-2011-300024
   CHRISTENSEN E, 1987, HEPATOLOGY, V7, P1346, DOI 10.1002/hep.1840070628
   Coceani M, 2008, EUR J CARDIOV PREV R, V15, P423, DOI 10.1097/HJR.0b013e3282fa40da
   COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580
   Delanaye P, 2017, NEPHRON, V136, P302, DOI 10.1159/000469669
   Delanaye P, 2016, CLIN KIDNEY J, V9, P700, DOI 10.1093/ckj/sfw071
   Delanaye P, 2016, CLIN KIDNEY J, V9, P682, DOI 10.1093/ckj/sfw070
   Delanaye Pierre, 2016, Clin Biochem Rev, V37, P17
   Delanaye P, 2013, NAT REV NEPHROL, V9, P513, DOI 10.1038/nrneph.2013.143
   Delanaye P, 2012, NEPHROL DIAL TRANSPL, V27, P2664, DOI 10.1093/ndt/gfs265
   Ferreira JP, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0731-2
   Flores-Blanco PJ, 2016, CLIN CARDIOL, V39, P507, DOI 10.1002/clc.22556
   Froissart M, 2005, J AM SOC NEPHROL, V16, P763, DOI 10.1681/ASN.2004070549
   GEHAN EA, 1970, CANCER CHEMOTH REP 1, V54, P225
   Gibson CM, 2003, J AM COLL CARDIOL, V42, P1535, DOI 10.1016/S0735-1097(03)01067-2
   Glassock R, 2015, JAMA-J AM MED ASSOC, V314, P559, DOI 10.1001/jama.2015.6731
   HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT S, V3, P1, DOI DOI 10.1038/kisup.2012.73
   Kontos MC, 2008, AM J CARDIOL, V102, P140, DOI 10.1016/j.amjcard.2008.03.023
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lawesson SS, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008188
   Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004
   Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006
   Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002
   Lin TH, 2015, HEART VESSELS, V30, P441, DOI 10.1007/s00380-014-0504-9
   Mandelli S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136039
   Matsushita K, 2017, LANCET DIABETES ENDO, V5, P718, DOI 10.1016/S2213-8587(17)30183-3
   Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954
   Muhlenbruch K, 2015, EUR J EPIDEMIOL, V30, P299, DOI 10.1007/s10654-015-0001-1
   Orvin K, 2015, AM HEART J, V169, P702, DOI 10.1016/j.ahj.2015.01.012
   Osadnik T, 2014, CLIN RES CARDIOL, V103, P569, DOI 10.1007/s00392-014-0687-1
   Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085
   Pieroni L, 2011, CLIN CHIM ACTA, V412, P2070, DOI 10.1016/j.cca.2011.07.012
   Plischke M, 2013, EUR J HEART FAIL, V15, P763, DOI 10.1093/eurjhf/hft022
   Pottel H, 2008, CLIN CHIM ACTA, V396, P49, DOI 10.1016/j.cca.2008.06.017
   Pottel H, 2017, CLIN KIDNEY J, V10, P545, DOI 10.1093/ckj/sfx026
   Pottel H, 2017, CLIN CHIM ACTA, V471, P164, DOI 10.1016/j.cca.2017.06.005
   Pottel H, 2016, NEPHROL DIAL TRANSPL, V31, P798, DOI 10.1093/ndt/gfv454
   Leston LR, 2018, EUR HEART J-ACUTE CA, V7, P703, DOI 10.1177/2048872617730040
   Sabroe JE, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-15
   Schei J, 2016, CLIN J AM SOC NEPHRO, V11, P280, DOI 10.2215/CJN.07360715
   Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161
   Smilde TDJ, 2006, CIRCULATION, V114, P1572, DOI 10.1161/CIRCULATIONAHA.105.610642
   Szummer K, 2017, OPEN HEART, V4, DOI 10.1136/openhrt-2016-000568
   Szummer K, 2010, AM HEART J, V159, P979, DOI 10.1016/j.ahj.2010.03.028
   Tomaszuk-Kazberuk A, 2011, RENAL FAILURE, V33, P983, DOI 10.3109/0886022X.2011.618922
   Weidmann ZM, 2015, INT J CARDIOL, V201, P650, DOI 10.1016/j.ijcard.2015.08.097
   Zamora E, 2012, J AM COLL CARDIOL, V59, P1709, DOI 10.1016/j.jacc.2011.11.066
NR 61
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 6
PY 2018
VL 13
IS 7
AR e0199773
DI 10.1371/journal.pone.0199773
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GM1FJ
UT WOS:000437809500032
PM 29979700
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Schwiedrzik, CM
   Melloni, L
   Schurger, A
AF Schwiedrzik, Caspar M.
   Melloni, Lucia
   Schurger, Aaron
TI Mooney face stimuli for visual perception research
SO PLOS ONE
LA English
DT Article
ID CONFIDENCE-INTERVALS; OBJECT RECOGNITION; CLOSURE; CORTEX;
   SCHIZOPHRENIA; ORGANIZATION; ACTIVATION; NEURONS; GESTALT; MEMORY
AB In 1957, Craig Mooney published a set of human face stimuli to study perceptual closure: the formation of a coherent percept on the basis of minimal visual information. Images of this type, now known as "Mooney faces", are widely used in cognitive psychology and neuroscience because they offer a means of inducing variable perception with constant visuospatial characteristics (they are often not perceived as faces if viewed upside down). Mooney's original set of 40 stimuli has been employed in several studies. However, it is often necessary to use a much larger stimulus set. We created a new set of over 500 Mooney faces and tested them on a cohort of human observers. We present the results of our tests here, and make the stimuli freely available via the internet. Our test results can be used to select subsets of the stimuli that are most suited for a given experimental purpose.
C1 [Schwiedrzik, Caspar M.] European Neurosci Inst, Neural Circuits & Cognit Lab, Gottingen, Germany.
   [Schwiedrzik, Caspar M.] Univ Med Ctr Goettingen, Gottingen, Germany.
   [Melloni, Lucia] Columbia Univ, Dept Neurosurg, New York, NY USA.
   [Melloni, Lucia] Max Planck Inst Empir Aesthet, Neurosci Dept, Frankfurt, Germany.
   [Schurger, Aaron] INSERM, Cognit Neuroimaging Unit, Gif Sur Yvette, France.
   [Schurger, Aaron] Commissariat Energie Atom, Direct Sci Vivant, I2BM, NeuroSpin Ctr, Gif Sur Yvette, France.
RP Schwiedrzik, CM (reprint author), European Neurosci Inst, Neural Circuits & Cognit Lab, Gottingen, Germany.; Schwiedrzik, CM (reprint author), Univ Med Ctr Goettingen, Gottingen, Germany.; Schurger, A (reprint author), INSERM, Cognit Neuroimaging Unit, Gif Sur Yvette, France.; Schurger, A (reprint author), Commissariat Energie Atom, Direct Sci Vivant, I2BM, NeuroSpin Ctr, Gif Sur Yvette, France.
EM c.schwiedrzik@eni-g.de; aaron.schurger@gmail.com
RI Schurger, Aaron/Y-4459-2018
OI Schurger, Aaron/0000-0003-2985-3253; Schwiedrzik,
   Caspar/0000-0003-0661-8859
FU Human Frontier Science Program [LT001118/2012-L]; European Union
   [706519]; European Community [299372]; Max Planck Society; ERC [640626];
   German Research Foundation; Open Access Publication Funds of the
   Gottingen University
FX CMS was supported by a Human Frontier Science Program
   (http://www.hfsp.org) Long Term Fellowship (LT001118/2012-L), and is
   currently funded by the European Union's Horizon 2020 research and
   innovation programme (https://ec.europa.eu/research/mariecuriereactions)
   under the Marie Sktodowska-Curie grant agreement No. 706519. LM was
   supported by a Marie Curie International Outgoing Fellowship
   (https://ec.europa.eu/research/mariecurieactions) within the 7th
   European Community Framework Programme (grant number 299372) and the Max
   Planck Society (https://www.mpg.de). AS was supported by an ERC Starting
   Grant (https://erc.europa.eu/funding/starting-grants) from the European
   Research Council (grant number 640626). Funding for publication charges
   was provided by the German Research Foundation (http://www.dfg.de) and
   the Open Access Publication Funds of the Gottingen University
   (https://www.sub.unigoettingen.deten/electronic-publishingiopen-
   access). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Brodski-Guerniero A, 2017, J NEUROSCI, V37, P8273, DOI 10.1523/JNEUROSCI.0614-17.2017
   Busigny T, 2010, NEUROPSYCHOLOGIA, V48, P4057, DOI 10.1016/j.neuropsychologia.2010.09.017
   Carbon CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079164
   Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1p042
   CRONBACH LJ, 1951, PSYCHOMETRIKA, V16, P297, DOI DOI 10.1007/BF02310555
   Crouzet SM, 2010, J VISION, V10, DOI 10.1167/10.4.16
   Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309
   FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619
   FOREMAN N, 1991, J GEN PSYCHOL, V118, P13, DOI 10.1080/00221309.1991.9711129
   George N, 2005, COGNITIVE BRAIN RES, V24, P663, DOI 10.1016/j.cogbrainres.2005.03.017
   Grutzner C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00088
   HAUTUS MJ, 1995, BEHAV RES METH INS C, V27, P46, DOI 10.3758/BF03203619
   Hegde J, 2010, J NEUROSCI, V30, P15124, DOI 10.1523/JNEUROSCI.4415-09.2010
   Hsieh PJ, 2010, J NEUROPHYSIOL, V103, P1501, DOI 10.1152/jn.00812.2009
   Imamoglu F, 2012, NEUROIMAGE, V63, P1909, DOI 10.1016/j.neuroimage.2012.07.056
   Jemel B, 2003, COGNITIVE BRAIN RES, V17, P431, DOI 10.1016/S0926-6410(03)00145-9
   Kanwisher N, 1998, COGNITION, V68, pB1, DOI 10.1016/S0010-0277(98)00035-3
   Kemelmacher-Shlizerman I, 2008, IEEE COMPUT SOC C CO, DOI [10.1109/CVPR.2008.4587769, DOI 10.1109/CVPR.2008.4587769]
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leo I, 2009, INFANCY, V14, P641, DOI 10.1080/15250000903264047
   Ludmer R, 2011, NEURON, V69, P1002, DOI 10.1016/j.neuron.2011.02.013
   McKeeff TJ, 2007, CEREB CORTEX, V17, P669, DOI 10.1093/cercor/bhk015
   McKone E, 2004, J EXP PSYCHOL LEARN, V30, P181, DOI 10.1037/0278-7393.30.1.181
   Moeller S, 2017, NAT NEUROSCI, V20, P743, DOI 10.1038/nn.4527
   MOONEY CM, 1957, CAN J PSYCHOLOGY, V11, P219, DOI 10.1037/h0083717
   MOONEY CM, 1956, CAN J PSYCHOLOGY, V10, P191, DOI 10.1037/h0083671
   MOONEY CM, 1957, CAN J PSYCHOLOGY, V11, P21, DOI 10.1037/h0083687
   Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061
   Muth C, 2013, ACTA PSYCHOL, V144, P25, DOI 10.1016/j.actpsy.2013.05.001
   OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4
   PERRETT DI, 1984, HUM NEUROBIOL, V3, P197
   Ramachandran VS, 1998, NATURE, V395, P852, DOI 10.1038/27573
   Rivolta D, 2014, J NEUROSCI, V34, P5909, DOI 10.1523/JNEUROSCI.3752-13.2014
   Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120
   Rossion B, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00225
   Sun LM, 2012, J NEUROSCI, V32, P9563, DOI 10.1523/JNEUROSCI.1073-12.2012
   Taubert J, 2012, COGN NEUROSCI-UK, V3, P21, DOI 10.1080/17588928.2011.578737
   Tovee MJ, 1996, NEUROREPORT, V7, P2757, DOI 10.1097/00001756-199611040-00070
   Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006
   Uhlhaas PJ, 2009, P NATL ACAD SCI USA, V106, P9866, DOI 10.1073/pnas.0900390106
   Verhallen RJ, 2014, NEUROPSYCHOLOGIA, V63, P19, DOI 10.1016/j.neuropsychologia.2014.08.011
   Wasserstein J, 2004, NEUROPSYCHOLOGIA, V42, P158, DOI 10.1016/j.neuropsychologia.2003.07.003
   Yoon JMD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110225
NR 43
TC 1
Z9 1
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 6
PY 2018
VL 13
IS 7
AR e0200106
DI 10.1371/journal.pone.0200106
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GM1FJ
UT WOS:000437809500060
PM 29979727
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Nishigami, T
   Tanaka, K
   Mibu, A
   Manfuku, M
   Yono, S
   Tanabe, A
AF Nishigami, Tomohiko
   Tanaka, Katsuyoshi
   Mibu, Akira
   Manfuku, Masahiro
   Yono, Satoko
   Tanabe, Akihito
TI Development and psychometric properties of short form of central
   sensitization inventory in participants with musculoskeletal pain: A
   cross-sectional study
SO PLOS ONE
LA English
DT Article
ID QUALITY-OF-LIFE; CENTRAL SENSITIVITY SYNDROMES; SELF-EFFICACY
   QUESTIONNAIRE; GENERIC CORE SCALES; CATASTROPHIZING SCALE; DISABILITY
   QUESTIONNAIRE; CULTURAL ADAPTATION; KNEE OSTEOARTHRITIS; NEUROTROPHIC
   FACTOR; COPING STRATEGIES
AB Background
   The central sensitization inventory (CSI) comprises 25 items and is commonly used to measure somatic and emotional symptoms related to central sensitization symptoms. CSI was developed as an easy-to-administer screening instrument for patients at high risk of developing central sensitization in whom it was essential to quickly evaluate the condition. The purpose of the present study was to develop a short form of CSI and evaluate its psychometric properties using a contemporary approach called Rasch analysis.
   Methods
   A total of 505 patients with musculoskeletal disorders were recruited in this study. The CSI, pain intensity, pain interference, and the health-related quality of life (QOL) were evaluated for each participant. The original CSI items were consecutively analyzed using the Rasch model. Successive Rasch analyses were performed until a final set of items satisfied the model fit requirements. We also analyzed the psychometric properties of the original and short forms of CSI.
   Results
   Four consecutive Rasch analyses identified the removable items. Finally, the shortest questionnaire obtained that maintained the correct psychometric properties based on the Rasch model contained only 9 items (CSI-9). Rasch analysis showed that the CSI-9 had acceptable internal consistency, exhibited unidimensionality, had no notable differential item functioning, and was functional on the category rating scale.
   Conclusions
   The nine-item short form of CSI has acceptable psychometric properties and is suitable for use for patients with musculoskeletal pain. Thus, the CSI-9 can be used as a brief instrument to evaluate central sensitization.
C1 [Nishigami, Tomohiko; Mibu, Akira] Konan Womans Univ, Dept Nursing & Phys Therapy, Kobe, Hyogo, Japan.
   [Tanaka, Katsuyoshi; Yono, Satoko; Tanabe, Akihito] Tanabe Orthopaed, Dept Rehabil, Osaka, Osaka, Japan.
   [Manfuku, Masahiro] Breast Care Sensyu Clin, Dept Rehabil, Kishiwada, Japan.
RP Nishigami, T (reprint author), Konan Womans Univ, Dept Nursing & Phys Therapy, Kobe, Hyogo, Japan.
EM t-nishi@konan-wu.ac.jp
FU Health Labour Sciences Research Grant [17948489]
FX This work was supported by Health Labour Sciences Research Grant Number
   17948489, https://mhlw-grants.niph.go.jp, to TN. The funders had a role
   in the Publication Fees.
CR Alcala MJ, 2004, INFLAMM BOWEL DIS, V10, P383, DOI 10.1097/00054725-200407000-00009
   Bennett EE, 2017, WORLD NEUROSURG, V104, P594, DOI 10.1016/j.wneu.2017.04.166
   Bid Dibyendunarayan D, 2016, NATL J INTEGR RES ME, V7, P18
   Bilbao A, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-75
   Bot AGJ, 2014, J MUSCULOSKELET PAIN, V22, P145, DOI 10.3109/10582452.2014.883020
   Browne MW, 1993, TESTING STRUCTURAL E, V154, P136, DOI DOI 10.1177/0049124192021002005
   Cagnie B, 2014, SEMIN ARTHRITIS RHEU, V44, P68, DOI 10.1016/j.semarthrit.2014.01.001
   Caumo W, 2017, J PAIN RES, V10, P2109, DOI 10.2147/JPR.S131479
   Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129
   Cronbach LJ, 2004, EDUC PSYCHOL MEAS, V64, P391, DOI 10.1177/0013164404266386
   Cuesta-Vargas AI, 2018, J PAIN, V19, P317, DOI 10.1016/j.jpain.2017.11.006
   Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005
   Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Hungi N., 2005, APPL RASCH MEASUREME
   Cuesta-Vargas AI, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3515-4
   Jafari P, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-27
   Jensen MP, 2003, PAIN, V104, P453, DOI 10.1016/S0340-3959(03)00076-9
   Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005
   Kim SH, 2015, PAIN PRACT, V15, pE46, DOI 10.1111/papr.12311
   Knezevic A, 2018, PAIN PRACT, V18, P463, DOI 10.1111/papr.12618
   Kook SH, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-41
   Kregel J, 2016, CLIN J PAIN, V32, P624, DOI 10.1097/AJP.0000000000000306
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Linacre J. M., 2005, USERS GUIDE WINSTEPS
   Lluch E, 2014, EUR J PAIN, V18, P1367, DOI 10.1002/j.1532-2149.2014.499.x
   Loeser JD, 2008, PAIN, V137, P473, DOI 10.1016/j.pain.2008.04.025
   Marella M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-900
   Mayer TG, 2012, PAIN PRACT, V12, P276, DOI 10.1111/j.1533-2500.2011.00493.x
   McWilliams LA, 2015, EUR J PAIN, V19, P1342, DOI 10.1002/ejp.665
   Mendoza TR, 2012, J PAIN, V13, P564, DOI 10.1016/j.jpain.2012.03.003
   Moreton BJ, 2015, J REHABIL MED, V47, P655, DOI 10.2340/16501977-1977
   Neblett R, 2017, SPINE J, V17, P1819, DOI 10.1016/j.spinee.2017.06.008
   Neblett R, 2017, PAIN PRACT, V17, P166, DOI 10.1111/papr.12440
   Neblett R, 2015, CLIN J PAIN, V31, P323, DOI 10.1097/AJP.0000000000000113
   Neblett R, 2013, J PAIN, V14, P438, DOI 10.1016/j.jpain.2012.11.012
   Nicholas MK, 2015, J PAIN, V16, P153, DOI 10.1016/j.jpain.2014.11.002
   Nishigami T, 2017, J ORTHOP SCI, V22, P351, DOI 10.1016/j.jos.2016.11.015
   Noten S, 2017, PAIN PRACT, V17, P267, DOI 10.1111/papr.12502
   Pittance L, 2016, MAN THER, V25, pe83, DOI [10.1016/j.math.2016.05.139, DOI 10.1016/J.MATH.2016.05.139]
   Plinsinga ML, 2015, J ORTHOP SPORT PHYS, V45, P864, DOI 10.2519/jospt.2015.5895
   Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087
   Ramp M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-58
   Rasch G, 1960, PROBABILISTIC MODELS
   Riddle DL, 2013, PAIN MED, V14, P265, DOI 10.1111/pme.12007
   Scerbo T, 2018, PAIN PRACT, V18, P544, DOI 10.1111/papr.12636
   Tan G, 2006, J PAIN, V7, P252, DOI 10.1016/j.jpain.2005.11.007
   Tanaka K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188719
   Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108
   Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673
   Trang T, 2011, NEURON GLIA BIOL, V7, P99, DOI 10.1017/S1740925X12000087
   Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231
   Uki J, 1998, J PAIN SYMPTOM MANAG, V16, P364, DOI 10.1016/S0885-3924(98)00098-0
   Van Oosterwijck J, 2013, EUR J PAIN, V17, P299, DOI 10.1002/j.1532-2149.2012.00193.x
   Vergara M, 2016, INFLAMM BOWEL DIS, V22, P955, DOI 10.1097/MIB.0000000000000678
   Weston R, 2006, COUNS PSYCHOL, V34, P719, DOI 10.1177/0011000006286345
   WILLIAMS A, 1990, HEALTH POLICY, V16, P199
   Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140
   Wright B. D, 1982, RATING SCALE ANAL
   Wright B. D., 1994, RASCH MEASUREMENT T, V8, P370
   Wright BD, 1979, BEST TEST DESIGN RAS
NR 61
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 5
PY 2018
VL 13
IS 7
AR e0200152
DI 10.1371/journal.pone.0200152
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GL7YG
UT WOS:000437424500071
PM 29975754
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chasekwa, B
   Maluccio, JA
   Ntozini, R
   Moulton, LH
   Wu, F
   Smith, LE
   Matare, CR
   Stoltzfus, RJ
   Mbuya, MNN
   Tielsch, JM
   Martin, SL
   Jones, AD
   Humphrey, JH
   Fielding, K
AF Chasekwa, Bernard
   Maluccio, John A.
   Ntozini, Robert
   Moulton, Lawrence H.
   Wu, Fan
   Smith, Laura E.
   Matare, Cynthia R.
   Stoltzfus, Rebecca J.
   Mbuya, Mduduzi N. N.
   Tielsch, James M.
   Martin, Stephanie L.
   Jones, Andrew D.
   Humphrey, Jean H.
   Fielding, Katherine
CA SHINE Trial Team
TI Measuring wealth in rural communities: Lessons from the Sanitation,
   Hygiene, Infant Nutrition Efficacy (SHINE) trial
SO PLOS ONE
LA English
DT Article
ID SOCIOECONOMIC-STATUS; HOUSEHOLD WEALTH; HEALTH RESEARCH; POSITION;
   INDEXES; INCOME
AB Background
   Poverty and human capital development are inextricably linked and therefore research on human capital typically incorporates measures of economic well-being. In the context of randomized trials of health interventions, for example, such measures are used to: 1) assess baseline balance; 2) estimate covariate-adjusted analyses; and 3) conduct subgroup analyses. Many factors characterize economic well-being, however, and analysts often generate summary measures such as indices of household socio-economic status or wealth. In this paper, a household wealth index is developed and tested for participants in the cluster-randomized Sanitation, Hygiene, Infant Nutrition Efficacy (SHINE) trial in rural Zimbabwe.
   Methods
   Building on the approach used in the Zimbabwe Demographic and Health Survey (ZDHS), we combined a set of housing characteristics, ownership of assets and agricultural resources into a wealth index using principal component analysis (PCA) on binary variables. The index was assessed for internal and external validity. Its sensitivity was examined considering an expanded set of variables and an alternative statistical approach of polychoric PCA. Correlation between indices was determined using the Spearman's rank correlation coefficient and agreement between quintiles using a linear weighted Kappa statistic. Using the 2015 ZDHS data, we constructed a separate index and applied the loadings resulting from that analysis to the SHINE study population, to compare the wealth distribution in the SHINE study with rural Zimbabwe.
   Results
   The derived indices using the different methods were highly correlated (r>0.9), and the wealth quintiles derived from the different indices had substantial to near perfect agreement (linear weighted Kappa>0.7). The indices were strongly associated with a range of assets and other wealth measures, indicating both internal and external validity. Households in SHINE were modestly wealthier than the overall population of households in rural Zimbabwe.
   Conclusion
   The SHINE wealth index developed here is a valid and robust measure of wealth in the sample.
C1 [Chasekwa, Bernard; Ntozini, Robert; Smith, Laura E.; Humphrey, Jean H.] Zvitambo Inst Maternal & Child Hlth Res, Harare, Zimbabwe.
   [Maluccio, John A.; Wu, Fan] Middlebury Coll, Dept Econ, Middlebury, VT 05753 USA.
   [Moulton, Lawrence H.; Humphrey, Jean H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Matare, Cynthia R.; Stoltzfus, Rebecca J.] Cornell Univ, Div Nutr Sci, Program Int Nutr, Ithaca, NY 14853 USA.
   [Smith, Laura E.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Epidemiol & Environm Hlth, Buffalo, NY USA.
   [Mbuya, Mduduzi N. N.] GAIN, Washington, DC USA.
   [Tielsch, James M.] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Global Hlth, Washington, DC USA.
   [Martin, Stephanie L.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC USA.
   [Jones, Andrew D.] Univ Michigan, Sch Publ Hlth, Dept Nutr Sci, Ann Arbor, MI 48109 USA.
   [Fielding, Katherine] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
RP Chasekwa, B (reprint author), Zvitambo Inst Maternal & Child Hlth Res, Harare, Zimbabwe.
EM bchasekwa@zvitambo.co.zw
RI Smith, Laura/R-4615-2018
OI Smith, Laura/0000-0002-4793-2791; Ntozini, Robert/0000-0002-8543-2835;
   Chasekwa, Bernard/0000-0001-8080-7573
FU Bill and Melinda Gates Foundation [OPP1021542, OPP1143707]; United
   Kingdom Department for International Development (DFID/UKAID); Wellcome
   Trust [093768/Z/10/Z, 108065/Z/15/Z]; Swiss Agency for Development and
   Cooperation
FX This work was supported by Bill and Melinda Gates Foundation (OPP1021542
   and OPP1143707); The United Kingdom Department for International
   Development (DFID/UKAID); Wellcome Trust (093768/Z/10/Z and
   108065/Z/15/Z); Swiss Agency for Development and Cooperation. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Amek N, 2015, ACTA TROP, V144, P24, DOI 10.1016/j.actatropica.2015.01.006
   Balen J, 2010, EMERG THEMES EPIDEMI, V7, DOI 10.1186/1742-7622-7-7
   Boccia D, 2009, AM J TROP MED HYG, V80, P1004, DOI 10.4269/ajtmh.2009.80.1004
   Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879
   Bryman A, 1994, QUANTITATIVE DATA AN, Vxiv
   Chasekwa B, 2015, DEV ASSESSMENT WEALT
   CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112
   Deaton A., 2002, GUIDELINES CONSTRUCT
   FAO, 2016, 360 FHI FAO
   Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292
   Galbraith J, 2002, ANAL INTERPRETATION
   Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001
   Gwatkin DR, 2007, SOCIO ECONOMIC DIFFE
   Hargreaves JR, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-4
   Houweling TAJ, 2003, INT J EQUITY HEALTH, V2, P8, DOI [10.1186/1475-9276-2-8, DOI 10.1186/1475-9276-2-8]
   Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3
   Howe LD, 2009, J EPIDEMIOLOGY COMMU
   Humphrey JH, 2015, CLIN INFECT DIS, V61, pS685, DOI 10.1093/cid/civ844
   Josse J, 2012, J SFDS, V153, P79
   Kennedy G, 2006, PUBLIC HEALTH NUTR, V9, P187, DOI 10.1079/PHN2005835
   Kimuna SR, 2005, INT FAM PLAN PERSPEC, V31, P83, DOI 10.1363/3108305
   Kolenikov S, 2009, REV INCOME WEALTH, V55
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LEE J, 1993, PSYCHIAT RES, V49, P97, DOI 10.1016/0165-1781(93)90033-D
   Luby SP, 2008, TROP MED INT HEALTH, V13, P835, DOI 10.1111/j.1365-3156.2008.02074.x
   Manly BFJ, 1994, MULTIVARIATE STAT ME, Vxiii
   Maxwell D, 2003, COPING STRATEGY INDE
   Montgomery MR, 2000, DEMOGRAPHY, V37, P155, DOI 10.2307/2648118
   Morris SS, 2000, J EPIDEMIOL COMMUN H, V54, P381, DOI 10.1136/jech.54.5.381
   Oakes JM, 2003, SOC SCI MED, V56, P769, DOI 10.1016/S0277-9536(02)00073-4
   Pettersson E, 2010, J RES PERS, V44, P407, DOI 10.1016/j.jrp.2010.03.002
   R Core Team, 2018, R LANG ENV STAT COMP
   Rutstein S, 2008, DHS WEALTH INDEX APP
   Rutstein SO, 2004, DHS WEALTH INDEX
   Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9
   Sharker MAY, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-6
   StataCorp, 2014, STAT STAT SOFTW REL
   Strauss J., 1995, HDB DEV EC, VIIIA, P1883, DOI DOI 10.1016/S1573-4471(05)80006-3
   Traissac P, 2012, INT J EPIDEMIOL, V41, P1207, DOI 10.1093/ije/dys122
   van Buuren S, 2011, J STAT SOFTW, V45, P1
   Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029
   ZIMSTAT, 2013, ZIMB POP CENS 2012
   ZIMSTAT ICF, 2016, ZIMB DEM HLTH SURV 2
   ZIMSTAT (Zimbabwe National Statistics Agency), 2015, ZIMB MULT IND CLUST
   ZNSA International ICF, 2012, ZIMB DEM HLTH SURV 2
NR 45
TC 4
Z9 4
U1 1
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 28
PY 2018
VL 13
IS 6
AR e0199393
DI 10.1371/journal.pone.0199393
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GL0GK
UT WOS:000436645400029
PM 29953495
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Siriwardhana, DD
   Walters, K
   Rait, G
   Bazo-Alvarez, JC
   Weerasinghe, MC
AF Siriwardhana, Dhammika Deepani
   Walters, Kate
   Rait, Greta
   Carlos Bazo-Alvarez, Juan
   Weerasinghe, Manuj Chrishantha
TI Cross-cultural adaptation and psychometric evaluation of the Sinhala
   version of Lawton Instrumental Activities of Daily Living Scale
SO PLOS ONE
LA English
DT Article
ID CONFIRMATORY FACTOR-ANALYSIS; GOODNESS-OF-FIT; INTERRATER RELIABILITY;
   OLDER-ADULTS; HEALTH; QUALITY; VALIDATION; AGREEMENT; POPULATION;
   IMPAIRMENT
AB Introduction
   Instrumental activities of daily living (IADL) are cognitively complex activities related to independent living in the community. Robust IADL scales are needed, however the psychometric properties of instruments have been little evaluated. There is no validated instrument for Sri Lankan older populations. Sri Lanka has the highest proportion of older people in South Asia with rapid population ageing. Therefore, it is essential to have standard instruments to assess activity limitations. We aimed to cross-culturally adapt the original Lawton Instrumental Activities of Daily Living Scale from English to Sinhala and evaluate the psychometric properties of the Sinhala version.
   Methods
   Cross-cultural adaptation of the instrument was performed. The instrument was validated in a sample of 702 community-dwelling older adults aged 60 years and above in Sri Lanka. Reliability (internal consistency and inter-rater reliability) was assessed. Construct validity of the scale was evaluated by performing exploratory and confirmatory factor analysis and testing convergent and divergent validity.
   Results
   The Lawton IADL scale was successfully adapted to Sri Lankan context. Internal consistency of the scale was very high (Cronbach's alpha = 0.91). Very good inter-rater reliability was observed with very good agreement for all items. Inter-class correlations for overall IADL score ranged from 0.57 to 0.91. Results of the exploratory and confirmatory factor analyses supported the unidimensionality of the scale. Goodness of fit indices in confirmatory factor analysis were in acceptable range (CFI = 0.98, SRMR = 0.06, NNFI = 0.97). Strength of associations were significant and in the expected direction. Results of the known group validity were also significant, confirming the convergent and divergent validity.
   Conclusion
   The Lawton IADL scale was successfully translated and culturally adapted to Sinhala language. The Sinhala version demonstrated excellent reliability and construct validity. Given good psychometric properties, this scale would be recommended for use in future research.
C1 [Siriwardhana, Dhammika Deepani; Walters, Kate; Rait, Greta; Carlos Bazo-Alvarez, Juan] UCL, Res Dept Primary Care & Populat Hlth, London, England.
   [Siriwardhana, Dhammika Deepani] Univ Kelaniya, Fac Med, Dept Disabil Studies, Ragama, Sri Lanka.
   [Carlos Bazo-Alvarez, Juan] Univ Catolica Los Angeles Chimbote, ULADECH Catolica, Ctr Estudios Poblac, Chimbote, Peru.
   [Weerasinghe, Manuj Chrishantha] Univ Colombo, Fac Med, Dept Community Med, Colombo, Sri Lanka.
RP Siriwardhana, DD (reprint author), UCL, Res Dept Primary Care & Populat Hlth, London, England.; Siriwardhana, DD (reprint author), Univ Kelaniya, Fac Med, Dept Disabil Studies, Ragama, Sri Lanka.
EM deepani.sirwardhana.15@ucl.ac.uk
OI Siriwardhana, Dhammika Deepani/0000-0003-2313-3095; Bazo-Alvarez, Juan
   Carlos/0000-0002-6169-8049
FU UK government [LKCS-2015-678]
FX DDS is a Commonwealth Scholar, funded by UK government (LKCS-2015-678).
   The funder had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Barrett P, 2007, PERS INDIV DIFFER, V42, P815, DOI 10.1016/j.paid.2006.09.018
   Basto M, 2012, J STAT SOFTWARE, V46
   Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014
   BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238
   Comrey A. L., 1992, 1 COURSE FACTOR ANAL
   de Winter JCF, 2012, J APPL STAT, V39, P695, DOI 10.1080/02664763.2011.610445
   Department of Census and Statistics, 2015, INCR ELD POP SR LANK
   Department of Census and Statistics, 2012, CENS POP HOUS
   Garrido LE, 2013, PSYCHOL METHODS, V18, P454, DOI 10.1037/a0030005
   Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272
   Farias ST, 2013, J INT NEUROPSYCH SOC, V19, P430, DOI 10.1017/S1355617712001609
   FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L
   Fernando DN, 1993, J MED SCI, V36, P9
   Fusco O, 2012, AGING CLIN EXP RES, V24, P68, DOI 10.1007/BF03325356
   Gold DA, 2012, J CLIN EXP NEUROPSYC, V34, P11, DOI 10.1080/13803395.2011.614598
   Goodwin LD, 1999, MEASUREMENT PHYSICAL, V3, P85, DOI [10.1207/s15327841mpee0302_, DOI 10.1207/S15327841MPEE0302_]
   Graf C, 2008, AM J NURS, V108, P52, DOI 10.1097/01.NAJ.0000314810.46029.74
   GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009
   Gwet K. L., 2012, HDB INTERRATER RELIA
   Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600
   Hassani Mehraban Afsoon, 2014, Med J Islam Repub Iran, V28, P25
   Hill J, 2006, PHARMACOECONOMICS, V24, P265, DOI 10.2165/00019053-200624030-00006
   Hinkle D, 1988, APPL STAT BEHAV SCI
   Hokoishi K, 2001, AGING MENT HEALTH, V5, P38, DOI 10.1080/13607860020020627
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Hutcheson G. D., 1999, MULTIVARIATE SOCIAL
   Jackson DL, 2009, PSYCHOL METHODS, V14, P6, DOI 10.1037/a0014694
   Jekel K, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0099-0
   KAISER HF, 1970, PSYCHOMETRIKA, V35, P401, DOI 10.1007/BF02291817
   Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012
   Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LAWTON MP, 1988, PSYCHOPHARMACOL BULL, V24, P609
   LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179
   LAWTON MP, 1982, J GERONTOL, V37, P91, DOI 10.1093/geronj/37.1.91
   Lawton MP, 2003, MULTILEVEL ASSESSMEN
   Li CH, 2016, PSYCHOL METHODS, V21, P369, DOI 10.1037/met0000093
   MAHONEY F I, 1965, Md State Med J, V14, P61
   McIntosh CN, 2007, PERS INDIV DIFFER, V42, P859, DOI 10.1016/j.paid.2006.09.020
   Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8
   Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x
   Ng TP, 2006, J GERONTOL A-BIOL, V61, P726, DOI 10.1093/gerona/61.7.726
   NUGEGODA DB, 1995, SOC SCI MED, V40, P437, DOI 10.1016/0277-9536(94)00144-I
   Nunnally J, 1994, PSYCHOMETRIC THEORY
   Nye CD, 2011, ORGAN RES METHODS, V14, P548, DOI 10.1177/1094428110368562
   Osborne J. W., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI DOI 10.4135/9781412995627.D8
   Ostbye T, 2009, J AM GERIATR SOC, V57, P1376, DOI 10.1111/j.1532-5415.2009.02350.x
   Perera ELSJ, 2017, AGEING POPULATION SR
   Pfeiffer E, 1975, MULTIDIMENSIONAL FUN
   Rajapakse S., 2012, IND J GERONTOL, V26, P351
   Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248
   Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338
   Sikkes S., 2008, J NEUROL NEUROSUR PS, V80, P7
   Sousa LB, 2015, RES AGING, V37, P787, DOI 10.1177/0164027514564469
   Steiger JH, 2007, PERS INDIV DIFFER, V42, P893, DOI 10.1016/j.paid.2006.09.017
   Streiner D. L., 2015, HLTH MEASUREMENT SCA
   Telecommunications Regulatory Commission of Sri Lanka, 2014, STAT 2014
   Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012
   Theotoka I, 2007, PERCEPT MOTOR SKILL, V104, P958, DOI 10.2466/PMS.104.3.958-960
   Tong AYC, 2002, OTJR-OCCUP PART HEAL, V22, P132, DOI 10.1177/153944920202200402
   TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/BF02291170
   van der Vorst A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165127
   Vergara I, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-130
   Wheaton B., 1977, SOCIOL METHODOL, P84, DOI DOI 10.2307/270754
NR 64
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 28
PY 2018
VL 13
IS 6
AR e0199820
DI 10.1371/journal.pone.0199820
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GL0GK
UT WOS:000436645400077
PM 29953501
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wu, AG
   Shah, AS
   Haelle, TS
   Lunos, SA
   Pitt, MB
AF Wu, Andrew G.
   Shah, Ashish S.
   Haelle, Tara S.
   Lunos, Scott A.
   Pitt, Michael B.
TI Choosing the perfect shot - The loaded narrative of imagery in online
   news coverage of vaccines
SO PLOS ONE
LA English
DT Article
ID PERCEIVING VACCINATION RISKS; HESITANCY; INFORMATION; AGE
AB Images in health communication have been shown to affect perspectives and attitudes towards health issues including vaccination. We seek to quantify the frequency of images used in online news coverage of vaccines that may convey varying sentiments about vaccination. To capture a breadth of vaccine-related news coverage, including international sources, we searched the following terms in Google News Archives: "autism and vaccine", "flu and vaccine", and "measles and Disneyland". We developed a coding tool that classified images as negative (eg, screaming child), positive (eg, happy child), neutral (eg, vaccine vial), or irrelevant (eg, picture of journalist). All images were coded independently by two researchers and discussed for consensus. We analyzed 734 images. Of the images which featured vaccines and/or a medical encounter (322), 28% had negative features and 30% had positive features. The remaining 137 images (43%) were neutral. There was no statistically significant difference between proportions of negative and positive imagery for each pair of search terms, which may be a reflection of random image selection. Ultimately, nearly one in eight images included in vaccine-related news coverage contains negative features which may be selected without careful consideration of the potential negative impact on public health initiatives regarding vaccination.
C1 [Wu, Andrew G.; Shah, Ashish S.; Pitt, Michael B.] Univ Minnesota, Dept Pediat, Masonic Childrens Hosp, Minneapolis, MN 55455 USA.
   [Haelle, Tara S.] Covering Hlth, Med Studies, Columbia, MO USA.
   [Lunos, Scott A.] Univ Minnesota, Biostat Design & Anal Ctr, Minneapolis, MN USA.
RP Pitt, MB (reprint author), Univ Minnesota, Dept Pediat, Masonic Childrens Hosp, Minneapolis, MN 55455 USA.
EM mbpitt@umn.edu
OI Pitt, Michael/0000-0002-7123-2613
CR [Anonymous], 2012, TARGET SURVEY SHOWS
   [Anonymous], 2014, SPJ CODE ETHICS NASH
   Betsch C, 2011, MED DECIS MAKING, V31, P742, DOI 10.1177/0272989X11400419
   Betsch C, 2010, J HEALTH PSYCHOL, V15, P446, DOI 10.1177/1359105309353647
   Cline RJW, 2001, HEALTH EDUC RES, V16, P671, DOI 10.1093/her/16.6.671
   Deffenbaugh C., 2016, FOX6 NEWS       1025
   Denzin N. K., 1998, COLLECTING INTERPRET
   Dube E, 2013, HUM VACC IMMUNOTHER, V9, P1763, DOI 10.4161/hv.24657
   Dugas AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056176
   Flaherty DK, 2011, ANN PHARMACOTHER, V45, P1302, DOI 10.1345/aph.1Q318
   Horne Z, 2015, P NATL ACAD SCI USA, V112, P10321, DOI 10.1073/pnas.1504019112
   Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI [10.1016/j.pec.2005.05.004, 10.1016/j.pec.2006.06.023]
   Joffe H, 2008, DIOGENES, V55, P84, DOI 10.1177/0392192107087919
   Joyner BL, 2009, PEDIATRICS, V124, pE416, DOI 10.1542/peds.2008-3735
   Kantor J, 2016, JAMA DERMATOL, V152, P113, DOI 10.1001/jamadermatol.2015.3814
   Kogut T, 2005, J BEHAV DECIS MAKING, V18, P157, DOI 10.1002/bdm.492
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081
   Letchford A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149025
   McLean ACL, 2016, WORLD NEUROSURG, V90, P179, DOI 10.1016/j.wneu.2016.02.045
   Nemeroff C., 2000, IMAGINING IMPOSSIBLE, P1, DOI DOI 10.1017/CBO9780511571381.002
   Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365
   Pitt MB, 2016, CHILDREN-BASEL, V3, DOI 10.3390/children3040023
   Poland GA, 2011, NEW ENGL J MED, V364, P97, DOI 10.1056/NEJMp1010594
   Salazar D., 2016, DRUG STORE NEWS
   Siddiqui M, 2013, HUM VACC IMMUNOTHER, V9, P2643, DOI 10.4161/hv.27243
   Taddio A, 2012, VACCINE, V30, P4807, DOI 10.1016/j.vaccine.2012.05.011
   Willinger M, 2000, JAMA-J AM MED ASSOC, V283, P2135, DOI 10.1001/jama.283.16.2135
   Windrem R., 2013, NBC NEWS
   World Health Organization, 2015, VACC HES GROW CHALL
NR 30
TC 0
Z9 0
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 27
PY 2018
VL 13
IS 6
AR e0199870
DI 10.1371/journal.pone.0199870
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GK9FZ
UT WOS:000436549200071
PM 29949630
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Norton, L
   Thomas, J
   Bevan, N
   Norton, K
AF Norton, Lynda
   Thomas, Jessica
   Bevan, Nadia
   Norton, Kevin
TI Agreement between pre-exercise screening questionnaires completed online
   versus face-to-face
SO PLOS ONE
LA English
DT Article
ID PHYSICAL-ACTIVITY; SAMPLE; HEALTH
AB Objectives
   To investigate the levels of agreement between self-reported responses to the Adult Pre-exercise Screening System (APSS) questionnaire using online versus face-to-face (F2F) modalities.
   Design
   Convenience sample of adults completing a pre-exercise screening questionnaire using different modalities.
   Methods
   Adult volunteers (n = 94) were recruited to complete the APSS using both online and F2F modalities. Participants were provided a URL link to an online APSS questionnaire then followed- up the next day in a F2F interview. Objective health risk factors were also measured. Comparisons between responses were undertaken using kappa and correlation statistics to determine levels of agreement.
   Results
   The levels of agreement between online versus F2F responses for the seven compulsory Stage 1 questions (known diseases and signs and/or symptoms of disease) were >= 94% (kappa = 0.644 +/- 0.794). Response comparisons for Stage 2 questions on health risk factors were also generally high (>= 82% agreement) but there were larger differences between reported and measured risk factors in Stage 3.
   Conclusions
   Levels of agreement between the Stage 1 responses were substantial and support the use of this online option for pre-exercise screening. There were larger differences between self-reported and objectively measured health risk factors in Stages 2 and 3.
C1 [Norton, Lynda; Thomas, Jessica; Bevan, Nadia] Flinders Univ S Australia, Hlth & Exercise Sci, Bedford Pk, SA, Australia.
   [Thomas, Jessica] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia.
   [Norton, Kevin] Univ South Australia, Sch Hlth Sci, Adelaide, SA, Australia.
RP Norton, L (reprint author), Flinders Univ S Australia, Hlth & Exercise Sci, Bedford Pk, SA, Australia.
EM Lynda.norton@flinders.edu.au
OI Thomas, Jessica/0000-0001-6245-6060; Norton, Lynda/0000-0002-4092-9303
CR Albert CM, 2000, NEW ENGL J MED, V343, P1355, DOI 10.1056/NEJM200011093431902
   American College of Sports Medicine, 2013, ACSMS GUIDELINES EXE
   Australian Bureau of Statistics, 2015, AUSTR HLTH SURV 1 RE
   Australian Bureau of Statistics, 2013, AUSTR HLTH SURV BIOM
   BACHORIK PS, 1989, CLIN CHEM, V35, P1734
   Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031
   Bredin SSD, 2013, CAN FAM PHYSICIAN, V59, P273
   Brickwood KJ, 2013, J SCI MED SPORT, V16, P94, DOI 10.1016/j.jsams.2012.04.005
   Christensen A. I., 2013, EUROPEAN J PUBLIC HL, V24, P327, DOI DOI 10.1093/EURPUB/CKT067
   Craig AC, 2015, J PHYS ED SPORTS MAN, V2, P120
   Dietrich J, 2013, AUS NZ SPORTS LAW J, V8, P89
   Franklin BA, 2014, CIRCULATION, V129, P1081, DOI 10.1161/CIRCULATIONAHA.114.007641
   Keyzer P, 2014, AUSTR FITNESS IND RI
   Kim JH, 2012, NEW ENGL J MED, V366, P130, DOI 10.1056/NEJMoa1106468
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   McHugh IJ, 2008, J SCI MED SPORT, V11, P182, DOI 10.1016/j.jsams.2007.05.003
   Norton K, 1998, J Sci Med Sport, V1, P38, DOI 10.1016/S1440-2440(98)80007-8
   Norton K, 2012, SPORT HLTH, V30, p12 
   Norton K, 1996, ANTHROPOMETRICA, P25
   Pandey A, 2017, J AM COLL CARDIOL, V69, P1129, DOI 10.1016/j.jacc.2016.11.081
   Perera N, 2014, BRIT J SPORT MED, V48, P651, DOI [10.1136/bjsports-2014-093494.243, DOI 10.1136/BJSPORTS-2014-093494.243]
   Riebe D, 2015, MED SCI SPORT EXER, V47, P2473, DOI 10.1249/MSS.0000000000000664
   Sim J, 2005, PHYS THER, V85, P257
   Warburton D. E. R., 2011, HLTH FITNESS J CANAD, V4, P38
   Whitfield GP, 2014, CIRCULATION, V129, P1113, DOI 10.1161/CIRCULATIONAHA.113.004160
   Zhang XC, 2017, COMPUT HUM BEHAV, V71, P172, DOI 10.1016/j.chb.2017.02.006
NR 26
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 26
PY 2018
VL 13
IS 6
AR e0199836
DI 10.1371/journal.pone.0199836
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GK7JR
UT WOS:000436377800065
PM 29944718
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Melro, H
   Gomes, J
   Moura, G
   Marques, A
AF Melro, Helder
   Gomes, Jorge
   Moura, Gabriela
   Marques, Alda
TI Genetic profile and patient-reported outcomes in chronic obstructive
   pulmonary disease: A systematic review
SO PLOS ONE
LA English
DT Review
ID QUALITY-OF-LIFE; EXACERBATION FREQUENCY; SMOKING-CESSATION; D
   DEFICIENCY; COPD; POLYMORPHISM; ASSOCIATION; TOOL
AB Background
   Chronic Obstructive Pulmonary Disease (COPD) impacts differently on patients at similar grades, suggesting that factors other than lung function may influence patients' experience of the disease. Recent studies have found associations between genetic variations and patient-reported outcomes (PROs). Identifying these associations might be fundamental to predict the disease progression and develop tailored interventions. This systematic review aimed to identify the genetic variations associated with PROs in COPD.
   Methods and findings
   Databases were searched until July 2017 (PROSPERO: CRD42016041639) and additional searches were conducted scanning the reference list of the articles. Two independent reviewers assessed the quality of studies using the Q-Genie checklist. This instrument is composed of 11 questions, each subdivided in 7 options from 1 poor-7 excellent. Thirteen studies reporting 5 PROs in association with genes were reviewed. Studies were rated between "good quality" (n = 8) and "moderate" (n = 5). The most reported PRO was frequency of exacerbations (n = 7/13), which was mainly associated with MBL2 gene variants. Other PRO's were health-related quality of life (HRQOL) (n = 4/13), depressive symptoms (n = 1/13), exacerbation severity (n = 1/13) and breathlessness, cough and sputum (n = 1/13), which were commonly associated with other genetic variants.
   Conclusions
   Although a limited number of PRO's have been related to genetic variations, findings suggest that there is a significant association between specific gene variants and the number/severity of exacerbations, depressive symptoms and HRQOL. Further research is needed to confirm these findings and assess the genetic influence on other dimensions of patients' lives, since it may enhance our understanding and management of COPD.
C1 [Melro, Helder; Marques, Alda] Univ Aveiro, Sch Hlth Sci, Resp Res & Rehabil Lab Lab3R, Aveiro, Portugal.
   [Melro, Helder; Moura, Gabriela; Marques, Alda] Univ Aveiro, Sch Hlth Sci, IBiMED Inst Biomed, Aveiro, Portugal.
   [Gomes, Jorge] Univ Minho, Sch Engn, Campus Gualtar, Braga, Portugal.
   [Moura, Gabriela] Univ Aveiro, Dept Med Sci, Genome Sequencing & Anal Lab, Aveiro, Portugal.
RP Marques, A (reprint author), Univ Aveiro, Sch Hlth Sci, Resp Res & Rehabil Lab Lab3R, Aveiro, Portugal.; Marques, A (reprint author), Univ Aveiro, Sch Hlth Sci, IBiMED Inst Biomed, Aveiro, Portugal.
EM amarques@ua.pt
RI Marques, Alda Sofia Pires/K-3150-2013
OI Marques, Alda Sofia Pires/0000-0003-4980-6200
FU Programa Operacional de Competitividade e Internacionalizacao - COMPETE,
   through Fundo Europeu de Desenvolvimento Regional - FEDER
   [POCI-01-0145-FEDER-016701]; Fundagao para a Ciencia e Tecnologia
   [PTDC/DTP-PIC/2284/2014];  [Ul D/BIM/04501/2013]; 
   [POCI-01-0145-FEDER-007628]
FX This work was funded by Programa Operacional de Competitividade e
   Internacionalizacao - COMPETE, through Fundo Europeu de Desenvolvimento
   Regional - FEDER (POCI-01-0145-FEDER-016701), Fundagao para a Ciencia e
   Tecnologia (PTDC/DTP-PIC/2284/2014) and under the project Ul
   D/BIM/04501/2013 and POCI-01-0145-FEDER-007628. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alemayehu D, 2012, AM HEALTH DRUG BENEF, V5, P310
   [Anonymous], 2018, GLOB STRAT DIAGN MAN
   Berndt A, 2012, EMBO MOL MED, V4, P1144, DOI 10.1002/emmm.201100627
   Bleecker ER, 2012, CHEST, V142, P320, DOI 10.1378/chest.11-1655
   Cazzola M, 2015, INT J CHRONIC OBSTR, V10, P725, DOI 10.2147/COPD.S77368
   Condreay L, 2016, RESP MED, V114, P123, DOI 10.1016/j.rmed.2016.03.019
   Coventry PA, 2007, J PSYCHOSOM RES, V63, P551, DOI 10.1016/j.jpsychores.2007.08.002
   Ekstrom M, 2016, EXPERT REV RESP MED, V10, P351, DOI 10.1586/17476348.2016.1146595
   Halpin DMG, 2012, INT J CHRONIC OBSTR, V7, P653, DOI 10.2147/COPD.S34186
   Ho LI, 2001, CHEST, V120, P1493, DOI 10.1378/chest.120.5.1493
   Hoidal JR, 2001, EUR RESPIR J, V18, P741, DOI 10.1183/09031936.01.00268501
   Ishii T, 2014, RESPIROLOGY, V19, P590, DOI 10.1111/resp.12277
   Ishii T, 2011, J HUM GENET, V56, P41, DOI 10.1038/jhg.2010.133
   Janssens W, 2010, VITAM NORM, V86, P379, DOI [10.1016/B978-0-127386960-9.00017-4, DOI 10.1016/B978-0-127386960-9.00017-4]
   Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659
   Jones P, 2012, INT J CHRONIC OBSTR, V7, P697, DOI 10.2147/COPD.S32675
   Kaplan RM, 1996, LUNG BIOL HEALTH DIS, V91, P379
   Kim SW, 2015, INT J CHRONIC OBSTR, V10, P1809, DOI 10.2147/COPD.S91576
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leidy NK, 2010, VALUE HEALTH, V13, P965, DOI 10.1111/j.1524-4733.2010.00772.x
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700
   Lin CL, 2011, CHEST, V139, P43, DOI 10.1378/chest.10-0375
   Lou PA, 2016, IRAN J PUBLIC HEALTH, V45, P146
   Mandal J, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0306-3
   Patil SP, 2003, ARCH INTERN MED, V163, P1180, DOI 10.1001/archinte.163.10.1180
   Patrick DL, 2011, COCHRANE HDB SYSTEMA
   Pauwels R, 2004, RESP MED, V98, P99, DOI 10.1016/j.med.2003.09.001
   Pillai SG, 2010, AM J RESP CRIT CARE, V182, P1498, DOI 10.1164/rccm.201002-0151OC
   de Castro MRP, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-78
   Pradhan Vandana, 2011, Indian J Hum Genet, V17, P45, DOI 10.4103/0971-6866.86170
   Quaak M, 2009, EUR RESPIR J, V33, P468, DOI 10.1183/09031936.00056908
   Quint JK, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-28
   Quint JK, 2011, THORAX, V66, P418, DOI 10.1136/thx.2010.152975
   Richardson W S, 1995, ACP J Club, V123, pA12
   Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032
   Seifart Carola, 2007, Int J Chron Obstruct Pulmon Dis, V2, P541
   Sloan JA, 2012, J CLIN ONCOL, V30, P1699, DOI 10.1200/JCO.2010.34.5629
   Sohani ZN, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0211-2
   Takabatake N, 2006, AM J RESP CRIT CARE, V174, P875, DOI 10.1164/rccm.200603-443OC
   Umeda N, 2008, RESPIROLOGY, V13, P346, DOI 10.1111/j.1440-1843.2008.01259.x
   Wood AM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-130
   Yang IA, 2003, GENES IMMUN, V4, P269, DOI 10.1038/sj.gene.6363961
   Zhang JQ, 2015, DRUG DES DEV THER, V9, P6379, DOI 10.2147/DDDT.S91823
   Zhang JQ, 2015, INT J CHRONIC OBSTR, V10, P917, DOI 10.2147/COPD.S79710
NR 44
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 21
PY 2018
VL 13
IS 6
AR e0198920
DI 10.1371/journal.pone.0198920
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GK0LV
UT WOS:000435802500034
PM 29927965
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Franca, AD
   Pompilio, MA
   Pontes, ERJC
   de Oliveira, MP
   Pereira, LOR
   Lima, RB
   Goto, H
   Sanchez, MCA
   Fujimori, M
   Lima, MSD
   Matos, MDC
   Dorval, MEMC
AF Franca, Adriana de Oliveira
   Pompilio, Mauricio Antonio
   Jardim Cury Pontes, Elenir Rose
   de Oliveira, Marcia Pereira
   Ramos Pereira, Luiza Oliveira
   Lima, Rosimar Baptista
   Goto, Hiro
   Arroyo Sanchez, Maria Carmen
   Fujimori, Mahyumi
   da Costa Lima-Juniors, Manoel Sebastiao
   Cepa Matos, Maria de Fatima
   Moraes Cavalheiros Dorval, Maria Elizabeth
TI Leishmania infection in blood donors: A new challenge in leishmaniasis
   transmission?
SO PLOS ONE
LA English
DT Article
ID ASYMPTOMATIC VISCERAL LEISHMANIASIS; AMERICAN TEGUMENTARY LEISHMANIASIS;
   ENDEMIC AREA; KALA-AZAR; DONOVANI INFECTION; NORTHEASTERN BRAZIL;
   INFANTUM INFECTION; DIAGNOSTIC METHODS; PERIPHERAL-BLOOD;
   BALEARIC-ISLANDS
AB Transfusion-transmitted leishmaniasis has been a concern in regions endemic for the disease. Whether immediate or delayed, the risks posed by this mode of transmission call for careful assessment. The purpose of this study was to detect Leishmania infection in blood donors living in an endemic area and to investigate progression to the disease in these individuals. Immunofluorescent antibody test, enzyme-linked immunosorbent assay, leishmaniasis rapid test, and the polymerase chain reaction were applied to 430 donors in an initial evaluation. Of those donors with at least one positive test, 50 were reevaluated four years later by the same methods, as were 25 controls who had been negative on the same tests. In the first evaluation, Leishmania infection was detected in 41.4% (95% CI: 36.7-46.1) of donors (n = 430). None of the 75 reevaluated individuals had developed the disease, but retesting revealed positivity in at least one test in 36.0% (95% CI: 25.1-46.9) of donors. Of the 50 initially testing positive, 50% remained so on retesting. Of the 25 initially negative controls, two tested positive in the subsequent evaluation. The severity of the parasitosis and the risk of transfusion transmission warrant investigation of the potential inclusion of methods for Leishmania detection into blood banks for effective screening of infected donors.
C1 [Franca, Adriana de Oliveira; Moraes Cavalheiros Dorval, Maria Elizabeth] Univ Fed Mato Grosso do Sul, Grad Program Infect & Parasit Dis, Lab Clin Parasitol, Campo Grande, MS, Brazil.
   [Pompilio, Mauricio Antonio] Univ Fed Mato Grosso do Sul, Helio Mandetta Sch Med, Campo Grande, MS USA.
   [Jardim Cury Pontes, Elenir Rose] Univ Fed Mato Grosso do Sul, Grad Program Infect & Parasit Dis, Campo Grande, MS USA.
   [de Oliveira, Marcia Pereira; Ramos Pereira, Luiza Oliveira; Lima, Rosimar Baptista] Inst Oswaldo Cruz, Interdisciplinary Lab Med Res LIPMed, Rio De Janeiro, RJ, Brazil.
   [Goto, Hiro; Arroyo Sanchez, Maria Carmen; Fujimori, Mahyumi] Univ Sao Paulo, Sao Paulo Inst Trop Med, Lab Seroepidemiol & Immunobiol, Sao Paulo, SP, Brazil.
   [da Costa Lima-Juniors, Manoel Sebastiao] Fundacao Oswaldo Cruz, Ageu Magalhaes Res Ctr CPqAM, Lab Immunopathol & Mol Biol, Recife, PE, Brazil.
   [Cepa Matos, Maria de Fatima] Univ Fed Mato Grosso do Sul, Lab Mol Biol & Cell Culture, Campo Grande, MS, Brazil.
RP Franca, AD (reprint author), Univ Fed Mato Grosso do Sul, Grad Program Infect & Parasit Dis, Lab Clin Parasitol, Campo Grande, MS, Brazil.
EM dricaseal@hotmail.com
RI Sanchez, Maria Carmen/D-8886-2012; Goto, Hiro/B-5745-2009; Pereira,
   Luiza O R/P-7606-2018
OI Goto, Hiro/0000-0001-7048-562X; Pereira, Luiza O R/0000-0002-8132-1724
FU Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do
   Estado de Mato Grosso do Sul (Fundect) [0191/12, SIAFEM:020919,
   23/200.686/2012, 114/2014, SIAFEM:023670, 23/200.262/2014]
FX The work received financial support from the Fundacao de Apoio ao
   Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso
   do Sul (Fundect), http://fundect.ledes.net/, termos de outorga no
   0191/12, SIAFEM:020919, Processo: 23/200.686/2012 (to MAP) and no
   114/2014, SIAFEM:023670, Processo: 23/200.262/2014 (to MEMCD).
   e-mail:projetbs@fundectms.gov.br.
CR Barao SC, 2007, AM J TROP MED HYG, V77, P1051, DOI 10.4269/ajtmh.2007.77.1051
   Braga LD, 2015, REV SOC BRAS MED TRO, V48, P622, DOI 10.1590/0037-8682-0043-2015
   BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775
   Caldas A J, 2001, Rev Soc Bras Med Trop, V34, P445, DOI 10.1590/S0037-86822001000500007
   Canavate C, 2011, AM J TROP MED HYG, V84, P102, DOI 10.4269/ajtmh.2011.10-0229
   Cardo LJ, 2006, TRANSFUSION, V46, P1641, DOI 10.1111/j.1537-2995.2006.00941.x
   Cardo LJ, 2005, TRANSFUSION, V45, p30A
   Clemente WT, 2014, AM J TRANSPLANT, V14, P96, DOI 10.1111/ajt.12521
   Costa CHN, 2002, AM J TROP MED HYG, V66, P334, DOI 10.4269/ajtmh.2002.66.334
   Crescente JAB, 2009, T ROY SOC TROP MED H, V103, P1250, DOI 10.1016/j.trstmh.2009.06.010
   Das VNR, 2011, T ROY SOC TROP MED H, V105, P661, DOI 10.1016/j.trstmh.2011.08.005
   Davies CR, 1999, PARASITOLOGY, V119, P247, DOI 10.1017/S0031182099004680
   de Oliveira ALL, 2008, CAD SAUDE PUBLICA, V24, P2827, DOI 10.1590/S0102-311X2008001200011
   Dey A, 2006, Indian J Med Microbiol, V24, P165
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   Fakhar M, 2008, ANN TROP MED PARASIT, V102, P577, DOI 10.1179/136485908X337526
   Fraga TL, 2016, PEDIATR INFECT DIS J, V35, P805, DOI 10.1097/INF.0000000000001172
   Franca AD, 2013, TRANSFUS APHER SCI, V49, P627, DOI 10.1016/j.transci.2013.07.009
   Fukutani KF, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-422
   Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X
   GROGL M, 1993, AM J TROP MED HYG, V49, P308, DOI 10.4269/ajtmh.1993.49.308
   GUEVARA P, 1993, LANCET, V341, P1341, DOI 10.1016/0140-6736(93)90845-8
   Houghton RL, 1998, J INFECT DIS, V177, P1339, DOI 10.1086/515289
   Ibrahim ME, 1999, AM J TROP MED HYG, V61, P941, DOI 10.4269/ajtmh.1999.61.941
   Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682
   Jimenez-Marco T, 2012, VOX SANG, V103, P356, DOI 10.1111/j.1423-0410.2012.01622.x
   Kubar J, 1997, NAT MED, V3, P368, DOI 10.1038/nm0497-368
   Kyriakou DS, 2003, TRANSFUSION MED, V13, P59, DOI 10.1046/j.1365-3148.2003.00420.x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   le Fichoux Y, 1999, J CLIN MICROBIOL, V37, P1953
   Lima ID, 2012, AM J TROP MED HYG, V86, P99, DOI 10.4269/ajtmh.2012.10-0492
   Maia Z, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001484
   Mansueto P, 2014, TRAVEL MED INFECT DI, V12, P617, DOI 10.1016/j.tmaid.2014.10.011
   Martin-Sanchez J, 2004, AM J TROP MED HYG, V70, P545, DOI 10.4269/ajtmh.2004.70.545
   Martinez EZ, 2003, CADERNOS SAUDE COLET, V11, P7
   Mestra L, 2011, TRANSFUSION, V51, P1919, DOI 10.1111/j.1537-2995.2011.03092.x
   Michel G, 2011, ACTA TROP, V119, P69, DOI 10.1016/j.actatropica.2011.05.012
   Ministerio da Saude, 2014, MAN VIG CONTR LEISHM
   Monteiro DCS, 2016, EMERG INFECT DIS, V22, P739, DOI 10.3201/eid2204.150065
   Moral L, 2002, T ROY SOC TROP MED H, V96, P129, DOI 10.1016/S0035-9203(02)90278-6
   Moreno EC, 2006, REV SOC BRAS MED TRO, V39, P421, DOI 10.1590/S0037-86822006000500001
   Morillas-Marquez F, 2002, EXP PARASITOL, V100, P71, DOI 10.1006/expr.2001.4678
   Peruhype-Magalhaes V, 2012, MEM I OSWALDO CRUZ, V107, P951, DOI 10.1590/S0074-02762012000700019
   Pirmez C, 1999, J CLIN MICROBIOL, V37, P1819
   Riera C, 2004, T ROY SOC TROP MED H, V98, P102, DOI 10.1016/S0035-9203(03)00015-4
   Riera C, 2008, TRANSFUSION, V48, P1383, DOI 10.1111/j.1537-2995.2008.01708.x
   Rodrigues KMP, 2011, BRIT J DERMATOL, V164, P1228, DOI 10.1111/j.1365-2133.2011.10240.x
   Romero HD, 2009, AM J TROP MED HYG, V81, P27
   Scarlata F, 2008, T ROY SOC TROP MED H, V102, P394, DOI 10.1016/j.trstmh.2008.01.011
   Schenkel K, 2006, TROP MED INT HEALTH, V11, P1792, DOI 10.1111/j.1365-3156.2006.01735.x
   Silva LA, 2011, AM J TROP MED HYG, V84, P261, DOI 10.4269/ajtmh.2011.10-0092
   Singh S, 2003, J Postgrad Med, V49, P55
   Singh S, 2002, CLIN DIAGN LAB IMMUN, V9, P568, DOI 10.1128/CDLI.9.3.568-572.2002
   Timilsina S, 2016, INDIAN J HEMATOL BLO, V32, P95, DOI 10.1007/s12288-015-0505-6
   Urias Elaine V. R., 2009, Rev. Bras. Hematol. Hemoter., V31, P348
   Viana LD, 2008, T ROY SOC TROP MED H, V102, P548, DOI 10.1016/j.trstmh.2008.02.007
   Werneck GL, 2008, CAD SAUDE PUBLICA, V24, P2937, DOI 10.1590/S0102-311X2008001200023
NR 57
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 14
PY 2018
VL 13
IS 6
AR e0198199
DI 10.1371/journal.pone.0198199
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GJ5MF
UT WOS:000435424900015
PM 29902188
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Decary, S
   Fallaha, M
   Belzile, S
   Martel-Pelletier, J
   Pelletier, JP
   Feldman, D
   Sylvestre, MP
   Vendittoli, PA
   Desmeules, F
AF Decary, Simon
   Fallaha, Michel
   Belzile, Sylvain
   Martel-Pelletier, Johanne
   Pelletier, Jean-Pierre
   Feldman, Debbie
   Sylvestre, Marie-Pierre
   Vendittoli, Pascal-Andre
   Desmeules, Francois
TI Clinical diagnosis of partial or complete anterior cruciate ligament
   tears using patients' history elements and physical examination tests
SO PLOS ONE
LA English
DT Article
ID MENISCAL TEARS; KNEE; ACCURACY; INJURY; RUPTURE; RELIABILITY;
   REGRESSION; SELECTION; REHABILITATION; OSTEOARTHRITIS
AB Objective
   To assess the diagnostic validity of clusters combining history elements and physical examination tests to diagnose partial or complete anterior cruciate ligament (ACL) tears.
   Design
   Prospective diagnostic study. Settings Orthopaedic clinics (n = 2), family medicine clinics (n = 2) and community-dwelling.
   Participants
   Consecutive patients with a knee complaint (n = 279) and consulting one of the participating orthopaedic surgeons (n = 3) or sport medicine physicians (n = 2).
   Interventions
   Not applicable.
   Main outcome measures
   History elements and physical examination tests performed independently were compared to the reference standard: an expert physicians' composite diagnosis including history elements, physical tests and confirmatory magnetic resonance imaging. Penalized logistic regression (LASSO) was used to identify history elements and physical examination tests associated with the diagnosis of ACL tear and recursive partitioning was used to develop diagnostic clusters. Diagnostic accuracy measures including sensitivity (Se), specificity (Sp), predictive values and positive and negative likelihood ratios (LR+/-) with associated 95% confidence intervals (CI) were calculated.
   Results
   Forty-three individuals received a diagnosis of partial or complete ACL tear (15.4% of total cohort). The Lachman test alone was able to diagnose partial or complete ACL tears (LR+: 38.4; 95%CI: 16.0-92.5). Combining a history of trauma during a pivot with a "popping" sensation also reached a high diagnostic validity for partial or complete tears (LR+: 9.8; 95%Cl: 5.6-17.3). Combining a history of trauma during a pivot, immediate effusion after trauma and a positive Lachman test was able to identify individuals with a complete ACL tear (LR+: 17.5; 95%Cl: 9.8-31.5). Finally, combining a negative history of pivot or a negative popping sensation during trauma with a negative Lachman or pivot shift test was able to exclude both partial or complete ACL tears (LR-: 0.08; 95%Cl: 0.03-0.24).
   Conclusion
   Diagnostic clusters combining history elements and physical examination tests can support the differential diagnosis of ACL tears compared to various knee disorders.
C1 [Decary, Simon; Feldman, Debbie; Desmeules, Francois] Univ Montreal, Sch Rehabil, Fac Med, Montreal, PQ, Canada.
   [Decary, Simon; Vendittoli, Pascal-Andre; Desmeules, Francois] Maisonneuve Rosemont Hosp, Orthopaed Clin Res Unit, Res Ctr, Montreal, PQ, Canada.
   [Fallaha, Michel; Vendittoli, Pascal-Andre] Maisonneuve Rosemont Hosp, Dept Surg, Montreal, PQ, Canada.
   [Belzile, Sylvain] Laval Univ, Dept Surg, CHUL, Quebec City, PQ, Canada.
   [Martel-Pelletier, Johanne; Pelletier, Jean-Pierre] Univ Montreal Hosp Res Ctr CRCHUM, Osteoarthrit Res Unit, Montreal, PQ, Canada.
   [Sylvestre, Marie-Pierre] Univ Montreal Hosp Res Ctr CRCHUM, Montreal, PQ, Canada.
RP Decary, S (reprint author), Univ Montreal, Sch Rehabil, Fac Med, Montreal, PQ, Canada.; Decary, S (reprint author), Maisonneuve Rosemont Hosp, Orthopaed Clin Res Unit, Res Ctr, Montreal, PQ, Canada.
EM decary.simon@gmail.com
RI Vendittoli, Pascal-Andre/J-9621-2013
OI Vendittoli, Pascal-Andre/0000-0003-4652-6238
FU Canadian Institute of Health Research (CIHR) [349856]; Fonds de
   Recherche en Sante du Quebec (FRQS)
FX This project has received funding from the Canadian Institute of Health
   Research (CIHR grant number 349856 to FD). SD obtained doctoral training
   award from Fonds de Recherche en Sante du Quebec (FRQS). FD is a CIHR
   scholar. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Anderson MJ, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116634074
   Benjammse A, 2006, J ORTHOP SPORT PHYS, V36, P267, DOI 10.2519/jospt.2006.2011
   Bollen SR, 1996, INJURY, V27, P407, DOI 10.1016/0020-1383(96)00033-2
   Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5527
   Breiman L., 1984, CART CLASSIFICATION
   Cleland K, 2015, NETTERS ORTHOPAEDIC
   Collins NJ, 2016, OSTEOARTHR CARTILAGE, V24, P1317, DOI 10.1016/j.joca.2016.03.010
   Cook C., 2011, ORTHOPEDIC PHYS EXAM
   COPAS JB, 1983, J R STAT SOC B, V45, P311
   Crawford R, 2007, BRIT MED BULL, V84, P5, DOI 10.1093/bmb/ldm022
   Decary S, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1799-3
   Decary S, 2016, PHYS THER SPORT
   Decary S, 2016, MANUAL THER, V26, P172, DOI 10.1016/j.math.2016.09.007
   Desmeules F, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-162
   Felli L, 2016, Musculoskelet Surg, V100, P231
   Geraets SEW, 2015, KNEE SURG SPORT TR A, V23, P968, DOI 10.1007/s00167-013-2769-4
   Hartnett NI, 2001, NEW ZEAL MED J, V114, P11
   Hegedus EJ, 2007, J ORTHOP SPORT PHYS, V37, P541, DOI 10.2519/jospt.2007.2560
   Hegedus EJ, 2010, J MAN MANIP THER, V18, P69, DOI 10.1179/106698110X12640740712699
   Henschke N, 2014, J CLIN EPIDEMIOL, V67, P416, DOI 10.1016/j.jclinepi.2013.11.008
   Jackson JL, 2003, ANN INTERN MED, V139, P575, DOI 10.7326/0003-4819-139-7-200310070-00010
   JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703
   Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310
   Kocabey Y, 2004, ARTHROSCOPY, V20, P696, DOI 10.1016/j.arthro.2004.06.008
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lange T, 2015, MANUAL THER, V20, P402, DOI 10.1016/j.math.2014.11.003
   Leblanc MC, 2015, KNEE SURG SPORT TR A, V23, P2805, DOI 10.1007/s00167-015-3563-2
   Logerstedt DS, 2010, J ORTHOP SPORT PHYS, V40, pA1, DOI [10.2519/jospt.2010.0304, 10.2519/jospt.2010.0303]
   Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396
   Lu FH, 2014, STAT MED, V33, P401, DOI 10.1002/sim.5937
   Lubetzky-Vilnai A, 2014, ARCH PHYS MED REHAB, V95, P188, DOI 10.1016/j.apmr.2013.08.242
   Magee DJ, 2014, ORTHOPEDIC PHYS ASSE
   Micheo W, 2010, PM&R, V2, P935, DOI 10.1016/j.pmrj.2010.06.014
   Mulligan EP, 2015, INT J SPORTS PHYS TH, V10, P52
   OBERLANDER MA, 1993, AM J SPORT MED, V21, P773, DOI 10.1177/036354659302100603
   OShea KJ, 1996, AM J SPORT MED, V24, P164, DOI 10.1177/036354659602400208
   Parwaiz H, 2016, KNEE, V23, P116, DOI 10.1016/j.knee.2015.09.016
   Razmjou H, 2013, PHYSIOTHER CAN, V65, P46, DOI 10.3138/ptc.2011-56
   Reitsma JB, 2009, J CLIN EPIDEMIOL, V62, P797, DOI 10.1016/j.jclinepi.2009.02.005
   Rose NE, 1996, ARTHROSCOPY, V12, P398, DOI 10.1016/S0749-8063(96)90032-8
   Rutjes A W S, 2007, Health Technol Assess, V11, pix
   Sanders TL, 2016, AM J SPORT MED, V44, P1699, DOI 10.1177/0363546516634325
   Sanders TL, 2016, AM J SPORT MED, V44, P1502, DOI 10.1177/0363546516629944
   Silvers HJ, 2007, BRIT J SPORT MED, V41, pI52, DOI 10.1136/bjsm.2007.037200
   Simel DL, 2008, J GEN INTERN MED, V23, P768, DOI 10.1007/s11606-008-0583-3
   SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V
   Spindler KP, 2008, NEW ENGL J MED, V359, P2135, DOI 10.1056/NEJMcp0804745
   Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9
   Suter LG, 2017, ARTHRIT CARE RES, V69, P201, DOI 10.1002/acr.22940
   Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267
   van Eck CF, 2013, KNEE SURG SPORT TR A, V21, P1895, DOI 10.1007/s00167-012-2250-9
   Wagemakers HP, 2010, ARCH PHYS MED REHAB, V91, P1452, DOI 10.1016/j.apmr.2010.06.012
   Whiting PF, 2013, J CLIN EPIDEMIOL, V66, P1093, DOI 10.1016/j.jclinepi.2013.05.014
NR 53
TC 0
Z9 0
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 12
PY 2018
VL 13
IS 6
AR e0198797
DI 10.1371/journal.pone.0198797
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GJ1PQ
UT WOS:000435030900027
PM 29894492
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Duncan, S
   Stewart, T
   Schneller, MB
   Godbole, S
   Cain, K
   Kerr, J
AF Duncan, Scott
   Stewart, Tom
   Schneller, Mikkel Bo
   Godbole, Suneeta
   Cain, Kelli
   Kerr, Jacqueline
TI Convergent validity of ActiGraph and Actical accelerometers for
   estimating physical activity in adults
SO PLOS ONE
LA English
DT Article
ID ACTIVITY MONITORS; ACTIVITY COUNTS; CUT-POINTS; CALIBRATION; CHILDREN;
   OLDER
AB Purpose
   The aim of the present study was to examine the convergent validity of two commonly-used accelerometers for estimating time spent in various physical activity intensities in adults.
   Methods
   The sample comprised 37 adults (26 males) with a mean (SD) age of 37.6 (12.2) years from San Diego, USA. Participants wore ActiGraph GT3X+ and Actical accelerometers for three consecutive days. Percent agreement was used to compare time spent within four physical activity intensity categories under three counts per minute (CPM) threshold protocols: (1) using thresholds developed specifically for each accelerometer, (2) applying ActiGraph thresholds to regression-rectified Actical CPM data, and (3) developing new 'optimal' Actical thresholds.
   Results
   Using Protocol 1, the Actical estimated significantly less time spent in light (-16.3%), moderate (-2.8%), and vigorous (-0.4%) activity than the ActiGraph, but greater time spent sedentary (+20.5%). Differences were slightly more pronounced when the low frequency extension filter on the ActiGraph was enabled. The two adjustment methods (Protocols 2 and 3) improved agreement in this sample.
   Conclusions
   Our findings show that ActiGraph and Actical accelerometers provide significantly different estimates of time spent in various physical activity intensities. Regression and threshold adjustment were able to reduce these differences, although some level of non-agreement persisted. Researchers should be aware of the inherent limitations of count-based physical activity assessment when reporting and interpreting study findings.
C1 [Duncan, Scott; Stewart, Tom] Auckland Univ Technol, Human Potential Ctr, Auckland, New Zealand.
   [Schneller, Mikkel Bo] Univ Southern Denmark, Res Unit Act Living, Odense, Denmark.
   [Schneller, Mikkel Bo] Steno Diabet Ctr, Steno Hlth Promot Res, Gentofte, Denmark.
   [Godbole, Suneeta; Cain, Kelli; Kerr, Jacqueline] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA.
RP Duncan, S (reprint author), Auckland Univ Technol, Human Potential Ctr, Auckland, New Zealand.
EM scott.duncan@aut.ac.nz
RI Cain, Kelli/J-8283-2019; Stewart, Tom/K-7373-2019
OI Stewart, Tom/0000-0001-5915-3843; Cain, Kelli/0000-0002-7934-9680
FU National Cancer Institute [R01 CA127296, U01 CM 30771]
FX Funding for US data collection and coordination was provided by grants
   from the National Cancer Institute (R01 CA127296 and U01 CM 30771;
   www.cancer.gov). The funder had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Cain KL, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-51
   Colley RC, 2011, J SPORT SCI, V29, P783, DOI 10.1080/02640414.2011.557744
   Conn VS, 2011, AM J PUBLIC HEALTH, V101, P751, DOI 10.2105/AJPH.2010.194381
   Esliger DW, 2006, MED SCI SPORT EXER, V38, P2173, DOI 10.1249/01.mss.0000239394.55461.08
   Evenson KR, 2015, MED SCI SPORT EXER, V47, P725, DOI 10.1249/MSS.0000000000000478
   Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196
   Fischer C, 2012, PEDIATR EXERC SCI, V24, P220, DOI 10.1123/pes.24.2.220
   Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021
   John D, 2012, PHYSIOL MEAS, V33, P219, DOI 10.1088/0967-3334/33/2/219
   John D, 2012, MED SCI SPORT EXER, V44, pS86, DOI 10.1249/MSS.0b013e3182399f5e
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Pate RR, 2006, OBESITY, V14, P2000, DOI 10.1038/oby.2006.234
   Paul DR, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-26
   Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56
   Pruitt LA, 2008, J AGING PHYS ACTIV, V16, P416, DOI 10.1123/japa.16.4.416
   Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780
   Sharratt MT, 2007, APPL PHYSIOL NUTR ME, V32, pS9, DOI 10.1139/H07-124
   Straker LM, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-54
   Vaha-Ypya H, 2015, CLIN PHYSIOL FUNCT I, V35, P64, DOI 10.1111/cpf.12127
   Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351
   Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91
   Welk GJ, 2012, MED SCI SPORT EXER, V44, pS39, DOI 10.1249/MSS.0b013e3182399d8f
   World Health Organisation, 2010, GLOB REC PHYS ACT HL
NR 23
TC 1
Z9 1
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 12
PY 2018
VL 13
IS 6
AR e0198587
DI 10.1371/journal.pone.0198587
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GJ1PQ
UT WOS:000435030900020
PM 29894485
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Mackenzie, LJ
   Carey, ML
   Suzuki, E
   Sanson-Fisher, RW
   Asada, H
   Ogura, M
   D'Este, C
   Yoshimura, M
   Toi, M
AF Mackenzie, Lisa Jane
   Carey, Mariko Leanne
   Suzuki, Eiji
   Sanson-Fisher, Robert William
   Asada, Hiromi
   Ogura, Masakazu
   D'Este, Catherine
   Yoshimura, Michio
   Toi, Masakazu
TI Agreement between patients' and radiation oncologists' cancer diagnosis
   and prognosis perceptions: A cross sectional study in Japan
SO PLOS ONE
LA English
DT Article
ID END-OF-LIFE; BREAKING BAD-NEWS; RANDOMIZED CONTROLLED-TRIAL; SKILLS
   TRAINING-PROGRAM; DECISION-MAKING; PALLIATIVE CARE; NEAR-DEATH;
   COMMUNICATION; PREFERENCES; DISCLOSURE
AB This study assessed agreement between radiation oncologist-and cancer patient-reported perceptions about cancer diagnosis, time since diagnosis, treatment purpose, and whether life expectancy had been discussed; and described preferences for prognosis discussions. Adult cancer patients receiving radiotherapy at a Japanese hospital were invited to complete a touchscreen tablet survey. Patient survey responses were linked and comparisons made with a survey completed by their radiation oncologist. Among 146 cancer patient-oncologist dyads, there was almost perfect agreement on cancer diagnosis (kappa = 0.88, 95% CI: 0.82 +/- 0.94), substantial agreement on time since diagnosis (kappa = 0.70, 95% CI: 0.57 +/- 0.83) and moderate agreement on whether treatment goal was curative or palliative (kappa = 0.44, 95% CI: 0.28 +/- 0.57; all p's < 0.0001). Agreement about whether a life expectancy discussion had occurred was less than expected by chance (kappa = -0.06, p = 0.9). Radiation oncologists reported that they had spoken to over two thirds of patients about this, whilst less than one third of patients stated that this discussion had occurred with their radiation oncologist. Over half of the patients who had not discussed life expectancy wanted to. Patients had variable preferences for whether they (80%), their radiation oncologist (78%) or their partner/family (52%) should decide whether they discuss their life expectancy. Although patient self-reported information about diagnosis and time since diagnosis appears to be reasonably accurate (compared with clinician-reported information), limitations of self-reported data about prognostic discussions were highlighted by poor agreement between patient-and clinician-reported information about whether prognostic discussions have occurred. Additional support is needed to improve prognosis communication and understanding in radiation oncology settings.
C1 [Mackenzie, Lisa Jane; Carey, Mariko Leanne; Sanson-Fisher, Robert William] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia.
   [Mackenzie, Lisa Jane] Kyoto Univ Hosp, Grad Sch Med, Kyoto, Japan.
   [Suzuki, Eiji; Toi, Masakazu] Kyoto Univ Hosp, Breast Surg, Kyoto, Japan.
   [Asada, Hiromi] Kyoto Univ Hosp, Dept Nursing, Kyoto, Japan.
   [Ogura, Masakazu; Yoshimura, Michio] Kyoto Univ Hosp, Dept Radiat Oncol & Image Appl Therapy, Kyoto, Japan.
   [D'Este, Catherine] Australian Natl Univ, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Acton, ACT, Australia.
RP Mackenzie, LJ (reprint author), Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia.; Mackenzie, LJ (reprint author), Kyoto Univ Hosp, Grad Sch Med, Kyoto, Japan.
EM lisa.mackenzie@uon.edu.au
OI Mackenzie, Lisa/0000-0002-1286-5242; Sanson-Fisher,
   Rob/0000-0001-6022-2949
FU Dr Lisa Mackenzie's 2011 Prime Ministers' Australia Asia Endeavour Award
   [2485_2011]; Australian National Health and Medical Research Council
   Translating Research into Practice (TRIP) Fellowship [APP1073031];
   Australian National Breast Cancer Foundation [PF-16-011]; Cancer Council
   NSW [CSR11-02]; Hunter Medical Research Institute
FX This work was supported by Dr Lisa Mackenzie's 2011 Prime Ministers'
   Australia Asia Endeavour Award [2485_2011]. A/Prof Mariko Carey is
   supported by an Australian National Health and Medical Research Council
   Translating Research into Practice (TRIP) Fellowship [APP1073031]. Dr
   Lisa Mackenzie is supported by a Postdoctoral Fellowship grant
   [PF-16-011] from the Australian National Breast Cancer Foundation. This
   work was also supported by a Behavioural Science Strategic Research
   Partnership Grant (CSR11-02) from Cancer Council NSW to the Newcastle
   Cancer Control Collaborative, and infrastructure funding from the Hunter
   Medical Research Institute. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Akabayashi A, 1999, LANCET, V354, P1263, DOI 10.1016/S0140-6736(99)02802-0
   Applebaum AJ, 2014, J HEALTH PSYCHOL, V19, P1103, DOI 10.1177/1359105313484782
   Barton M., 2013, REV OPTIMAL RADIOTHE
   Butow PN, 1996, CANCER-AM CANCER SOC, V77, P2630, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2630::AID-CNCR29>3.3.CO;2-K
   Chittem M, 2013, PSYCHO-ONCOLOGY, V22, P1375, DOI 10.1002/pon.3149
   Chow E, 2005, INT J RADIAT ONCOL, V61, P870, DOI 10.1016/j.ijrobp.2004.07.697
   Clayton JM, 2007, MED J AUSTRALIA, V186, pS83
   Clayton JM, 2007, J CLIN ONCOL, V25, P715, DOI 10.1200/JCO.2006.06.7827
   Delaney G, 2005, CANCER-AM CANCER SOC, V104, P1129, DOI 10.1002/cncr.21324
   El-Jawahri A, 2014, CANCER-AM CANCER SOC, V120, P278, DOI 10.1002/cncr.28369
   Elkin EB, 2007, J CLIN ONCOL, V25, P5275, DOI 10.1200/JCO.2007.11.1922
   Elwyr TS, 2002, SOC SCI MED, V54, P281, DOI 10.1016/S0277-9536(01)00028-4
   Epstein AS, 2016, J CLIN ONCOL, V34, P2398, DOI 10.1200/JCO.2015.63.6696
   Epstein RM, 2017, JAMA ONCOL, V3, P92, DOI 10.1001/jamaoncol.2016.4373
   Fagerlind H, 2008, PSYCHO-ONCOL, V17, P975, DOI 10.1002/pon.1410
   Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210
   Fried TR, 2003, J AM GERIATR SOC, V51, P1398, DOI 10.1046/j.1532-5415.2003.51457.x
   Fujimori M, 2007, PSYCHO-ONCOL, V16, P573, DOI 10.1002/pon.1093
   Fujimori M, 2014, PALLIAT SUPPORT CARE, V12, P379, DOI 10.1017/S147895151300031X
   Fujimori M, 2014, J CLIN ONCOL, V32, P2166, DOI 10.1200/JCO.2013.51.2756
   Fujimori M, 2009, JPN J CLIN ONCOL, V39, P201, DOI 10.1093/jjco/hyn159
   Gabbay BB, 2005, ACAD MED, V80, P617, DOI 10.1097/00001888-200507000-00003
   Gattellari M, 2002, J CLIN ONCOL, V20, P503, DOI 10.1200/JCO.20.2.503
   GIRGIS A, 1995, J CLIN ONCOL, V13, P2449, DOI 10.1200/JCO.1995.13.9.2449
   Gramling R, 2016, JAMA ONCOL, V2, P1421, DOI 10.1001/jamaoncol.2016.1861
   Hagerty RG, 2005, ANN ONCOL, V16, P1005, DOI 10.1093/annonc/mdi211
   Hagerty RG, 2004, J CLIN ONCOL, V22, P1721, DOI 10.1200/JCO.2004.04.095
   Han J, 2012, AM J CLIN ONCOL-CANC, V35, P309, DOI 10.1097/COC.0b013e31825eb235
   Hancock K, 2007, PALLIATIVE MED, V21, P507, DOI 10.1177/0269216307080823
   Hancock K, 2007, J PAIN SYMPTOM MANAG, V34, P190, DOI 10.1016/j.jpainsymman.2006.11.009
   Ichikura K, 2015, PALLIAT SUPPORT CARE, V13, P1623, DOI 10.1017/S147895151500005X
   Ishikawa H, 2002, SOC SCI MED, V55, P301, DOI 10.1016/S0277-9536(01)00173-3
   Ishikawa H, 2005, INT J JPN SOCIOL, V14, P84, DOI 10.1111/j.1475-6781.2005.00070.x
   KAI I, 1993, SOC SCI MED, V36, P1151, DOI 10.1016/0277-9536(93)90235-V
   Kaplowitz SA, 2002, HEALTH COMMUN, V14, P221, DOI 10.1207/S15327027HC1402_4
   Koh SJ, 2018, CANCER RES TREAT, V50, P614, DOI 10.4143/crt.2016.446
   Lamont EB, 2001, ANN INTERN MED, V134, P1096, DOI 10.7326/0003-4819-134-12-200106190-00009
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lennes IT, 2013, CANCER-AM CANCER SOC, V119, P691, DOI 10.1002/cncr.27787
   Li J, 2012, PSYCHO-ONCOLOGY, V21, P778, DOI 10.1002/pon.1979
   Mack JW, 2012, J CLIN ONCOL, V30, P4387, DOI 10.1200/JCO.2012.43.6055
   Mack JW, 2012, J CLIN ONCOL, V30, P2715, DOI 10.1200/JCO.2012.42.4564
   Mackenzie LJ, 2012, SUPPORT CARE CANCER, V20, P3335, DOI 10.1007/s00520-012-1477-9
   Mackenzie LJ, 2013, PSYCHO-ONCOLOGY, V22, P2720, DOI 10.1002/pon.3337
   Mitchison D, 2012, PSYCHO-ONCOLOGY, V21, P496, DOI 10.1002/pon.1923
   Miyata H, 2004, BMC MED ETHICS, V5, P7, DOI 10.1186/1472-6939-5-7
   Ngo-Metzger Q, 2008, AM FAM PHYSICIAN, V77, P167
   Okamoto S, 2007, PATIENT EDUC COUNS, V65, P153, DOI 10.1016/j.pec.2006.11.004
   Rodriguez-Osorio CA, 2008, CURR OPIN CRIT CARE, V14, P708, DOI 10.1097/MCC.0b013e328315a611
   Ruhnke GW, 2000, CHEST, V118, P1172, DOI 10.1378/chest.118.4.1172
   Rutten LJF, 2005, PATIENT EDUC COUNS, V57, P250, DOI 10.1016/j.pec.2004.06.006
   Sansoni J, 2014, SYSTEMATIC LIT REV Q
   Shin DW, 2015, PSYCHO-ONCOLOGY, V24, P212, DOI 10.1002/pon.3631
   Suzuki E, 2016, INT J BEHAV MED, V23, P485, DOI 10.1007/s12529-015-9502-2
   Tang ST, 2006, CANCER INVEST, V24, P360, DOI 10.1080/07357900600705284
   Tang ST, 2004, PSYCHO-ONCOL, V13, P1, DOI 10.1002/pon.721
   Teshima T, 2012, J RADIAT RES, V53, P710, DOI 10.1093/jrr/rrs028
   Tseng YD, 2013, INT J RADIAT ONCOL, V87, P471, DOI 10.1016/j.ijrobp.2013.06.2046
   Uchitomi Y, 1997, ANN NY ACAD SCI, V809, P290, DOI 10.1111/j.1749-6632.1997.tb48092.x
   Umezawa S, 2015, CANCER-AM CANCER SOC, V121, P4240, DOI 10.1002/cncr.29635
   Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665
   Yoshida S, 2011, J PAIN SYMPTOM MANAG, V41, P594, DOI 10.1016/j.jpainsymman.2010.06.013
NR 62
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 8
PY 2018
VL 13
IS 6
AR e0198437
DI 10.1371/journal.pone.0198437
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GI7ZT
UT WOS:000434728100023
PM 29883453
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Rengifo, F
   Ruz, GA
   Mascareno, A
AF Rengifo, Francisca
   Ruz, Gonzalo A.
   Mascareno, Aldo
TI Managing the 1920s' Chilean educational crisis: A historical view
   combined with machine learning
SO PLOS ONE
LA English
DT Article
AB In the first decades of the 20 th century, political actors diagnosed the incubation of a crisis in the Chilean schooling process. Low rates of enrollment, literacy, and attendance, inefficiency in the use of resources, poverty, and a reduced number of schools were the main factors explaining the crisis. As a response, the Law on Compulsory Primary Education, considering mandatory for children between 6 and 14 years old to attend any school for at least four years, was passed in 1920. Using data from Censuses of the Republic of Chile from 1920 and 1930, reports of the Ministry of Justice, the Ministry of Education, and the Statistical Yearbooks between 1895 and 1930, we apply machine learning techniques (clustering and decision trees) to assess the impact of this law on the Chilean schooling process between 1920 and 1930. We conclude that the law had a positive impact on the schooling indicators in this period. Even though it did not overcome the differences between urban and rural zones, it brought about a general improvement of the schooling process and a more efficient use of resources and infrastructure in both big urban centers and small-urban and rural zones, thereby managing the so-called crisis of the Republic.
C1 [Rengifo, Francisca; Mascareno, Aldo] Univ Adolfo Ibanez, Sch Govt, Santiago, Chile.
   [Ruz, Gonzalo A.] Univ Adolfo Ibanez, Fac Sci & Engn, Santiago, Chile.
   [Rengifo, Francisca; Ruz, Gonzalo A.; Mascareno, Aldo] Res Ctr Millennium Nucleus Models Crises NS130011, Santiago, Chile.
RP Ruz, GA (reprint author), Univ Adolfo Ibanez, Fac Sci & Engn, Santiago, Chile.; Ruz, GA (reprint author), Res Ctr Millennium Nucleus Models Crises NS130011, Santiago, Chile.
EM gonzalo.ruz@uai.cl
OI Ruz, Gonzalo/0000-0001-7740-9865
FU Research Center Millennium Nucleus Models of Crisis [NS130017];
   Millennium Nucleus Models of Crisis [NS130017]
FX The authors would like to thank the research assistants Josefina Silva
   and Juan Figueroa for collecting and preprocessing the data as well as
   Ricardo Truffello for the construction of the maps. This paper was
   financially supported by the Research Center Millennium Nucleus Models
   of Crisis (NS130017).; This work was supported by Millennium Nucleus
   Models of Crisis, grant number: NS130017, url:
   http://mileniocrisis.uai.cl/. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Baskerville Peter, 2014, 2014 IEEE International Conference on Big Data (Big Data), P5, DOI 10.1109/BigData.2014.7004446
   Bishop C. M., 1995, NEURAL NETWORKS PATT
   Campos F., 1960, DESARROLLO EDUCACION
   Chang CJ, 2009, EXPERT SYST APPL, V36, P510, DOI 10.1016/j.eswa.2007.09.047
   Clark SD, 2009, TRANSPORT RES C-EMER, V17, P526, DOI 10.1016/j.trc.2009.04.004
   Collier Simon, 1996, HIST CHILE 1808 1994
   CORFO, 1950, GEOGRAFIA EC CHILE
   Courvisanos J, 2016, REG STUD, V50, P629, DOI 10.1080/00343404.2015.1034669
   Cox C., 2009, POLITICAS ED COHESIO
   Crymble A, 2015, HIST METHOD, V48, P141, DOI 10.1080/01615440.2015.1007194
   Dunn J. C., 1973, Journal of Cybernetics, V3, P32
   Edwards A, 1928, FRONDA ARISTOCRATICA
   Egana Maria, 2000, EDUCACION PRIMARIA P
   Encina F, 1912, NUESTRA INFERIORIDAD
   Gazmuri C., 1980, TESTIMONIOS CRISIS 1
   Germani G., 1981, SOCIOLOGY MODERNIZAT
   Gonzalbo Pilar, 1999, EDUCACION RURAL INDI
   Hamuy E., 1960, EDUCACION ELEMENTAL
   Johnson ALH, 1981, INTERNAL MIGRATION C
   Kumar A, 2012, INT J MATH ANAL, V6, P2511
   Labarca A., 1943, BASES POLITICA EDCAC
   Labarca A., 1939, HIST ENSENANZA CHILE
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Larrain J., 2001, IDENTITY MODERNITY L
   Mac Iver E, 1900, DISCURSO CRISIS MORA
   Mascareno A, 2016, COMPLEXITY, V21, P13, DOI 10.1002/cplx.21778
   NEWLAND C, 1991, HISPANIC AM HIST REV, V71, P335, DOI 10.2307/2515644
   NEWLAND C, 1994, J LAT AM STUD, V26, P449, DOI 10.1017/S0022216X00016291
   Nunez Ivan, 1982, DESARROLLO EDUCACION
   Pinto J, 2009, POBLACION ARAUCANIA
   RAMIREZ FO, 1987, SOCIOL EDUC, V60, P2, DOI 10.2307/2112615
   Recabarren E, 1910, BALANCE SIGLO RICOS
   Rengifo F, 2012, HISTORIA-SANTIAGO, V45, P123, DOI 10.4067/S0717-71942012000100005
   Republica de Chile, 1895, AN EST 1895 1930
   Republica de Chile, 1921, LEY INSTR RIM OBL
   Serrano Sol, 2012, HIST EDUCACION CHILE, V2
   Tan P.-N., 2005, INTRO DATA MINING
   Tou JT, 1974, PATTERN RECOGNITION
   Vaughan Mary Kay, 1982, STATE ED SOCIAL CLAS
   Venegas Alejandro, 1998, SINCERIDAD CHILE INT
   Witten IH, 2011, MOR KAUF D, P1
NR 41
TC 0
Z9 0
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 30
PY 2018
VL 13
IS 5
AR e0197429
DI 10.1371/journal.pone.0197429
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GH7NG
UT WOS:000433634800033
PM 29847556
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Struik, GM
   Vrijland, WW
   Birnie, E
   Klem, TMAL
AF Struik, Gerson M.
   Vrijland, Wietske W.
   Birnie, Erwin
   Klem, Taco M. A. L.
TI A randomized controlled trial on the effect of a silver
   carboxymethylcellulose dressing on surgical site infections after breast
   cancer surgery
SO PLOS ONE
LA English
DT Article
ID KNEE REPLACEMENT; STATISTICAL SIGNIFICANCE; CLINICALLY MEANINGFUL; TOTAL
   HIP; IMPACT; COSTS
AB Background
   The incidence of surgical site infections (SSIs) after breast cancer surgery is relatively high; ranging from 3 to 19%. The role of wound dressings in the prevention of SSI after breast cancer surgery is unclear. This study compares a silver carboxymethylcellulose dressing (AQUACEL Ag Surgical (Aquacel) with standard wound dressing in SSI rate after breast cancer surgery.
   Patients and methods
   A single-centre randomized controlled trial among women >= 18 years, diagnosed with breast cancer, undergoing breast conserving or ablative surgery, was conducted in a combined in and outpatient setting. The intervention was the use of Aquacel, compared with standard gauze dressing. Primary outcome measure was SSI following CDC criteria.
   Results
   A total of 230 patients were analysed: 106 in the Aquacel group and 124 controls. Seven patients (6.6%) developed SSI in the Aquacel group and 16 patients (12.9%) in the control group (RR 0.51 [95% Confidence Interval (CI): 0.22-1.20]; p = 0.112; adjusted OR 0.49 [0.19-1.25] p = 0.135)). Unplanned exploratory subgroup analysis of breast conserving surgery patients showed that SSI rate was 1/56 (1.8%) in the Aquacel group vs. 7/65 (10.8%) in controls; adjusted OR 0.15 [0.02-1.31] p = 0.087. The Aquacel group showed better patient satisfaction (median 8 vs. 7 on a Numerical Rating Scale, p = 0.006), fewer dressing changes within 48 hours(adjusted OR 0.12 [0.05-0.27] p<0.001), fewer re-operations (0% vs. 3.2%, p = 0.062), and lower mean wound-related treatment costs, both in a high ((sic)265.42 (SD = 908) vs. (sic)470.65 (SD = 1223) [p<0.001]) and low ((sic)59.12 (SD = 129) vs. (sic)67.55 (SD = 172) [p<0.001]) attributable costs of SSI model.
   Conclusion
   In this randomized controlled trial in women undergoing surgery for breast cancer, the use of AQUACEL Ag Surgical wound dressing did not significantly reduce the occurrence of SSIs compared to standard gauze dressing. The use of Aquacel resulted in significantly improved patient satisfaction, reduced dressing changes and reduced wound-related costs.
C1 [Struik, Gerson M.; Vrijland, Wietske W.; Klem, Taco M. A. L.] Franciscus Gasthuis & Vlietland, Dept Surg, Rotterdam, Netherlands.
   [Birnie, Erwin] Franciscus Gasthuis & Vlietland, Dept Stat & Educ, Rotterdam, Netherlands.
   [Birnie, Erwin] Univ Utrecht, Univ Med Ctr Utrecht, Dept Obstet & Gynecol, Div Women & Baby, Utrecht, Netherlands.
RP Struik, GM (reprint author), Franciscus Gasthuis & Vlietland, Dept Surg, Rotterdam, Netherlands.
EM g.struik@franciscus.nl
CR Allan GM, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0821-9
   Avritscher EBC, 2014, SUPPORT CARE CANCER, V22, P527, DOI 10.1007/s00520-013-2006-1
   Barnea Y, 2010, THER CLIN RISK MANAG, V6, P21
   Berry D P, 1996, J Wound Care, V5, P10
   BNF. British National Formulary, 2010, BRIT NAT FORM APP 8
   Bowler PG, 2004, J BURN CARE REHABIL, V25, P192, DOI 10.1097/01.BCR.0000112331.72232.1B
   Cai J, 2014, J ARTHROPLASTY, V29, P1098, DOI 10.1016/j.arth.2013.11.012
   Cannavo M, 1998, J Wound Care, V7, P57
   Clarke J V, 2009, J Wound Care, V18, P5
   Degnim AC, 2012, ANN SURG ONCOL, V19, P4099, DOI 10.1245/s10434-012-2448-6
   Dumville JC, 2014, COCHRANE DATABASE SY
   El-Tamer MB, 2007, ANN SURG, V245, P665, DOI 10.1097/01.sla.0000245833.48399.9a
   Elliott D, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016155
   Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735
   Grocott HP, 2017, ANESTH ANALG, V125, P2167, DOI 10.1213/ANE.0000000000002519
   Gulluoglu BM, 2013, ANN SURG, V257, P37, DOI 10.1097/SLA.0b013e31826d832d
   HALEY RW, 1985, AM J EPIDEMIOL, V121, P206, DOI 10.1093/oxfordjournals.aje.a113991
   Horsman J, 2003, HLTH UTILITIES INDEX, V1, P5440
   Hung M, 2017, POSTGRAD MED, V129, P902, DOI 10.1080/00325481.2017.1383820
   Jones DJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005360.pub4
   Keurentjes JC, 2014, BONE JOINT RES, V3, P7, DOI 10.1302/2046-3758.31.2000141
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langlois J, 2015, INT ORTHOP, V39, P1315, DOI 10.1007/s00264-015-2726-6
   Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X
   Mellis C, 2018, PAEDIATR RESPIR REV, V25, P88, DOI 10.1016/j.prrv.2017.02.002
   Mukesh MB, 2012, EJSO-EUR J SURG ONC, V38, P918, DOI 10.1016/j.ejso.2012.05.008
   NICE, 2008, NICE CLIN GUID 74 SU
   Olsen MA, 2008, ARCH SURG-CHICAGO, V143, P53, DOI 10.1001/archsurg.2007.11
   Reilly J, 2001, J HOSP INFECT, V49, P245, DOI 10.1053/jhin.2001.1086
   Specht K, 2015, ACTA ORTHOP, V86, P702, DOI 10.3109/17453674.2015.1063910
   Springer Bryan D, 2015, Am J Orthop (Belle Mead NJ), V44, P415
   Tsoutsou PG, 2010, ONCOLOGIST, V15, P1169, DOI 10.1634/theoncologist.2010-0187
   van Berckel Marijn M G, 2017, Hand (N Y), V12, P202, DOI 10.1177/1558944716662019
   Vazquez-Aragon P, 2003, J INFECTION, V46, P17, DOI 10.1053/jinf.2002.1073
   Viciano V, 2000, EUR J SURG, V166, P229
   Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0
   Williams N, 2011, SURG INFECT, V12, P469, DOI 10.1089/sur.2011.045
   Xue DQ, 2012, EJSO-EUR J SURG ONC, V38, P375, DOI 10.1016/j.ejso.2012.02.179
NR 38
TC 1
Z9 1
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 23
PY 2018
VL 13
IS 5
AR e0195715
DI 10.1371/journal.pone.0195715
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GH0FF
UT WOS:000433077000004
PM 29791437
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Braekman, E
   Berete, F
   Charafeddine, R
   Demarest, S
   Drieskens, S
   Gisle, L
   Molenberghs, G
   Tafforeau, J
   Van der Heyden, J
   Van Hal, G
AF Braekman, Elise
   Berete, Finaba
   Charafeddine, Rana
   Demarest, Stefaan
   Drieskens, Sabine
   Gisle, Lydia
   Molenberghs, Geert
   Tafforeau, Jean
   Van der Heyden, Johan
   Van Hal, Guido
TI Measurement agreement of the selfadministered questionnaire of the
   Belgian Health Interview Survey: Paper-and-pencil versus web-based mode
SO PLOS ONE
LA English
DT Article
ID EQUIVALENCE; RELIABILITY; INTERNET; COLLECTION; SCL-90-R
AB Before organizing mixed-mode data collection for the self-administered questionnaire of the Belgian Health Interview Survey, measurement effects between the paper-and-pencil and the web-based questionnaire were evaluated. A two-period cross-over study was organized with a sample of 149 employees of two Belgian research institutes (age range 22-62 years, 72% female). Measurement agreement was assessed for a diverse range of health indicators related to general health, mental and psychosocial health, health behaviors and prevention with kappa coefficients and intraclass correlation (ICC). The quality of the data collected by both modes was evaluated by quantifying the missing, 'don't know' and inconsistent values and data entry mistakes. Good to very good agreement was found for all categorical indicators with kappa coefficients superior to 0.60, except for two mental and psychosocial health indicators namely the presence of a sleeping disorder and of a depressive disorder (kappa >= 0.50). For the continuous indicators high to acceptable agreement was observed with ICC superior to 0.70. Inconsistent answers and data-entry mistakes were only occurring in the paper-and-pencil mode. There were no less missing values in the web-based mode compared to the paper-and-pencil mode. The study supports the idea that web-based modes provide, in general, equal responses to paper-and-pencil modes. However, health indicators based upon factual and objective items tend to have higher measurement agreement than indicators requiring an assessment of personal subjective feelings. A web-based mode greatly facilitates the data-entry process and guides the completing of a questionnaire. However, item non-response was not positively affected.
C1 [Braekman, Elise; Berete, Finaba; Charafeddine, Rana; Demarest, Stefaan; Drieskens, Sabine; Gisle, Lydia; Tafforeau, Jean; Van der Heyden, Johan] Sciensano, Dept Epidemiol & Publ Hlth, Brussels, Belgium.
   [Braekman, Elise; Van Hal, Guido] Univ Antwerp, Unit Epidemiol & Social Med, Antwerp, Belgium.
   [Molenberghs, Geert] Univ Leuven, Interunivers Inst Biostat & Stat Bioinformat, Leuven, Belgium.
   [Molenberghs, Geert] Univ Hasselt, Interunivers Inst Biostat & Stat Bioinformat, Diepenbeek, Belgium.
RP Braekman, E (reprint author), Sciensano, Dept Epidemiol & Publ Hlth, Brussels, Belgium.; Braekman, E (reprint author), Univ Antwerp, Unit Epidemiol & Social Med, Antwerp, Belgium.
EM Elise.Braekman@sciensano.be
RI Van Hal, Guido F/B-5948-2017
OI Van Hal, Guido F/0000-0002-4611-4076
FU Federaal Wetenschapsbeleid - Belspo
FX Funded by Federaal Wetenschapsbeleid - Belspo https://www.belspo.be/.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alfonsson S, 2014, J MED INTERNET RES, V16, P86, DOI 10.2196/jmir.3395
   Basnov M, 2009, INFORM HEALTH SOC CA, V34, P53, DOI 10.1080/17538150902779527
   Bech M, 2009, SURVEY RES METHODS, V3, P1, DOI DOI 10.18148/SRM/2009.V3I1.592]
   Booth-Kewley S, 2007, COMPUT HUM BEHAV, V23, P463, DOI 10.1016/j.chb.2004.10.020
   Bot Arjan G J, 2013, Hand (N Y), V8, P210, DOI 10.1007/s11552-013-9511-z
   Broering JM, 2014, QUAL LIFE RES, V23, P495, DOI 10.1007/s11136-013-0493-7
   Campbell N, 2015, QUAL LIFE RES, V24, P1949, DOI 10.1007/s11136-015-0937-3
   Choi N. G, 2013, J MED INTERNET RES, V15
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Cox B, 2009, INT J PUBLIC HEALTH, V54, P55, DOI 10.1007/s00038-009-7104-y
   De Leeuw E. D., 2011, SOCIAL BEHAV RES INT, P45
   Demarest S, 2013, ARCH PUBLIC HEALTH, V71, DOI 10.1186/0778-7367-71-24
   Derogatis L, 1994, SCL 90 R ADM SCORING
   Ekman A, 2007, EUR J EPIDEMIOL, V22, P285, DOI 10.1007/s10654-007-9119-0
   Fang JM, 2016, COMPUT HUM BEHAV, V54, P310, DOI 10.1016/j.chb.2015.08.019
   Gnambs T, 2015, BEHAV RES METHODS, V47, P1237, DOI 10.3758/s13428-014-0533-4
   Goldberg D., 1978, MANUAL GEN HLTH QUES
   Graham A, 2008, J MED INTERNET RES, V10
   Gwaltney CJ, 2008, VALUE HEALTH, V11, P322, DOI 10.1111/j.1524-4733.2007.00231.x
   Heerwegh D, 2008, PUBLIC OPIN QUART, V72, P836, DOI 10.1093/poq/nfn045
   Hoebel J, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-46
   Jackle A, 2010, INT STAT REV, V78, P3, DOI 10.1111/j.1751-5823.2010.00102.x
   KROSNICK JA, 1991, APPL COGNITIVE PSYCH, V5, P213, DOI 10.1002/acp.2350050305
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leeuw E., 2005, J OFF STAT, V21, P233, DOI DOI 10.1111/J.1524-4733.2007.00231.X
   Marx RG, 2003, J CLIN EPIDEMIOL, V56, P730, DOI 10.1016/S0895-4356(03)00084-2
   Messer BL, 2011, PUBLIC OPIN QUART, V75, P429, DOI 10.1093/poq/nfr021
   Ritter P, 2004, J MED INTERNET RES, V6, P19, DOI 10.2196/jmir.6.3.e29
   Schmitz N, 2000, ACTA PSYCHIAT SCAND, V102, P147, DOI 10.1034/j.1600-0447.2000.102002147.x
   Shim JM, 2013, MED CARE, V51, P774, DOI 10.1097/MLR.0b013e31829a4f92
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Touvier M, 2010, EUR J EPIDEMIOL, V25, P287, DOI 10.1007/s10654-010-9433-9
   Vallejo MA, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.1.e2
   Vallejo MA, 2008, J BEHAV THER EXP PSY, V39, P201, DOI 10.1016/j.jbtep.2007.04.001
   van Gelder MMHJ, 2010, AM J EPIDEMIOL, V172, P1292, DOI 10.1093/aje/kwq291
   Vannieuwenhuyze J, 2010, PUBLIC OPIN QUART, V74, P1027, DOI 10.1093/poq/nfq059
   Velikova G, 1999, J CLIN ONCOL, V17, P998, DOI 10.1200/JCO.1999.17.3.998
   Vergnaud AC, 2011, INT J PUBLIC HEALTH, V56, P407, DOI 10.1007/s00038-011-0257-5
   Wang YC, 2005, J ADOLESCENT HEALTH, V37, P289, DOI 10.1016/j.jadohealth.2005.03.017
   Wijndaele K, 2007, COMPUT HUM BEHAV, V23, P1958, DOI 10.1016/j.chb.2006.02.005
NR 40
TC 2
Z9 2
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 21
PY 2018
VL 13
IS 5
AR e0197434
DI 10.1371/journal.pone.0197434
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GG2QJ
UT WOS:000432537100022
PM 29782504
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Livingstone, SR
   Russo, FA
AF Livingstone, Steven R.
   Russo, Frank A.
TI The Ryerson Audio-Visual Database of Emotional Speech and Song
   (RAVDESS): A dynamic, multimodal set of facial and vocal expressions in
   North American English
SO PLOS ONE
LA English
DT Article
ID MULTISENSORY INTEGRATION; CULTURAL SPECIFICITY; PARKINSONS-DISEASE;
   CONGENITAL AMUSIA; NONVERBAL ACCENTS; RESISTANT RULES; BASIC EMOTIONS;
   VALIDATED SET; MUSIC-THERAPY; RECOGNITION
AB The RAVDESS is a validated multimodal database of emotional speech and song. The database is gender balanced consisting of 24 professional actors, vocalizing lexically-matched statements in a neutral North American accent. Speech includes calm, happy, sad, angry, fearful, surprise, and disgust expressions, and song contains calm, happy, sad, angry, and fearful emotions. Each expression is produced at two levels of emotional intensity, with an additional neutral expression. All conditions are available in face-and-voice, face-only, and voice-only formats. The set of 7356 recordings were each rated 10 times on emotional validity, intensity, and genuineness. Ratings were provided by 247 individuals who were characteristic of untrained research participants from North America. A further set of 72 participants provided test-retest data. High levels of emotional validity and test-retest intrarater reliability were reported. Corrected accuracy and composite "goodness" measures are presented to assist researchers in the selection of stimuli.
C1 [Livingstone, Steven R.; Russo, Frank A.] Ryerson Univ, Dept Psychol, Toronto, ON, Canada.
   [Livingstone, Steven R.] Univ Wisconsin, Dept Comp Sci & Informat Syst, River Falls, WI 54022 USA.
RP Livingstone, SR (reprint author), Ryerson Univ, Dept Psychol, Toronto, ON, Canada.; Livingstone, SR (reprint author), Univ Wisconsin, Dept Comp Sci & Informat Syst, River Falls, WI 54022 USA.
EM steven.livingstone@uwrf.edu
RI Livingstone, Steven R./H-5695-2019
OI Livingstone, Steven R./0000-0002-6364-6410
FU FAR-Discovery Grant from the Natural Sciences and Engineering Research
   Council of Canada [2012-341583]; FAR-Hear the world research chair in
   music and emotional speech from Phonak
FX This work was supported by FAR-Discovery Grant (2012-341583) from the
   Natural Sciences and Engineering Research Council of Canada,
   http://www.nserc-crsng.gc.ca/; FAR-Hear the world research chair in
   music and emotional speech from Phonak, https://www.phonak.com.
CR Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x
   Ayotte J, 2002, BRAIN, V125, P238, DOI 10.1093/brain/awf028
   Banziger T, 2007, LECT NOTES COMPUT SC, V4738, P476
   Banziger T, 2012, EMOTION, V12, P1161, DOI 10.1037/a0025827
   Banziger T, 2009, EMOTION, V9, P691, DOI 10.1037/a0017088
   Balconi M, 2011, J COGN PSYCHOL, V23, P132, DOI 10.1080/20445911.2011.473560
   Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614
   Banziger Tanja, 2010, BLUEPRINT AFFECTIVE, P271
   Barrett LF, 1999, CURR DIR PSYCHOL SCI, V8, P10, DOI 10.1111/1467-8721.00003
   Barrett LF, 2006, PERSPECT PSYCHOL SCI, V1, P28, DOI 10.1111/j.1745-6916.2006.00003.x
   BASSILI JN, 1979, J PERS SOC PSYCHOL, V37, P2049, DOI 10.1037/0022-3514.37.11.2049
   Beaupre MG, 2005, J CROSS CULT PSYCHOL, V36, P355, DOI 10.1177/0022022104273656
   Belin P, 2008, BEHAV RES METHODS, V40, P531, DOI 10.3758/BRM.40.2.531
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Bidabadi SS, 2015, J AFFECT DISORDERS, V184, P13, DOI 10.1016/j.jad.2015.04.011
   Biele C, 2006, EXP BRAIN RES, V171, P1, DOI 10.1007/s00221-005-0254-0
   Bould E, 2008, COGNITION EMOTION, V22, P1569, DOI 10.1080/02699930801921156
   BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9
   Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357
   Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6
   Burkhardt F., 2005, 9 EUR C SPEECH COMM
   Busso C, 2017, IEEE T AFFECT COMPUT, V8, P67, DOI 10.1109/TAFFC.2016.2515617
   CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260
   Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001
   Cao HW, 2014, IEEE T AFFECT COMPUT, V5, P377, DOI 10.1109/TAFFC.2014.2336244
   Caria A, 2011, CEREB CORTEX, V21, P2838, DOI 10.1093/cercor/bhr084
   Castro SL, 2010, BEHAV RES METHODS, V42, P74, DOI 10.3758/BRM.42.1.74
   Chang A, 2017, P NATL ACAD SCI USA, V114, pE4134, DOI 10.1073/pnas.1617657114
   Cicchetti D., 1994, PSYCHOL ASSESSMENTS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]
   Cohn JF, 2004, INT J WAVELETS MULTI, V2, P121, DOI DOI 10.1142/S021969130400041X
   Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023
   COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805
   Cowie R, 2001, IEEE SIGNAL PROC MAG, V18, P32, DOI 10.1109/79.911197
   Cowie R, 2011, COGN TECHNOL, P167, DOI 10.1007/978-3-642-15184-2_11
   Cowie R, 2011, COGN TECHNOL, P197, DOI 10.1007/978-3-642-15184-2_12
   Cowie R, 2009, PHILOS T R SOC B, V364, P3515, DOI 10.1098/rstb.2009.0139
   Cramer AOJ, 2016, PSYCHON B REV, V23, P640, DOI 10.3758/s13423-015-0913-5
   Cuddy LL, 2005, MED HYPOTHESES, V64, P229, DOI 10.1016/j.mehy.2004.09.005
   Cunningham DW, 2009, J VISION, V9, DOI 10.1167/9.13.7
   Dalla Bella S, 2001, COGNITION, V80, pB1, DOI 10.1016/S0010-0277(00)00136-0
   Darwin C., 1872, EXPRESSION EMOTIONS
   DAVIDSON J., 1993, PSYCHOL MUSIC, V21, P103, DOI DOI 10.1177/030573569302100201
   De Gelder B, 2003, TRENDS COGN SCI, V7, P460, DOI 10.1016/j.tics.2003.08.014
   de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824
   de Gelder B, 2005, SCHIZOPHR RES, V72, P195, DOI 10.1016/j.schres.2004.02.013
   Delle-Vigne D, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00106
   Descartes R, 1984, PHILOS WORKS DESCART
   DIENER E, 1985, J PERS SOC PSYCHOL, V48, P1253, DOI 10.1037/0022-3514.48.5.1253
   DIXON WJ, 1957, INTRO STAT ANAL
   Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598
   Donegan NH, 2003, BIOL PSYCHIAT, V54, P1284, DOI 10.1016/S0006-3223(03)00636-X
   Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351
   Eerola T, 2011, PSYCHOL MUSIC, V39, P18, DOI 10.1177/0305735610362821
   Egger HL, 2011, INT J METH PSYCH RES, V20, P145, DOI 10.1002/mpr.343
   EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86
   EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068
   Ekman P., 1976, PICTURES FACIAL AFFE
   Ekman Paul, 1978, MANUAL FACIAL ACTION
   Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203
   ERWIN RJ, 1992, PSYCHIAT RES, V42, P231, DOI 10.1016/0165-1781(92)90115-J
   FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619
   Flom R, 2007, DEV PSYCHOL, V43, P238, DOI 10.1037/0012-1649.43.1.238
   Frank MG, 2001, J PERS SOC PSYCHOL, V80, P75, DOI 10.1037/0022-3514.80.1.75
   Friesen W. V., 1983, EMFACS 7 EMOTI UNPUB, V2, P36
   FRIJDA NH, 1988, AM PSYCHOL, V43, P349, DOI 10.1037/0003-066X.43.5.349
   Gabrielsson A., 2001, MUSIC EMOTION THEORY, P223, DOI DOI 10.1525/MP.2004.21.4.561
   Gamer M, 2012, IRR VARIOUS COEFFICI
   Garrido MV, 2017, BEHAV RES METHODS, V49, P1343, DOI 10.3758/s13428-016-0790-5
   Girden E. R., 1992, ANOVA REPEATED MEASU
   Good A, 2017, EAR HEARING, V38, P455, DOI 10.1097/AUD.0000000000000402
   GOSSELIN P, 1995, J PERS SOC PSYCHOL, V68, P83, DOI 10.1037/0022-3514.68.1.83
   Hebert S, 2003, BRAIN, V126, P1838, DOI 10.1093/brain/awg186
   Hess U, 1997, J NONVERBAL BEHAV, V21, P241, DOI 10.1023/A:1024952730333
   Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6
   HOAGLIN DC, 1986, J AM STAT ASSOC, V81, P991, DOI 10.2307/2289073
   HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.2307/2289392
   Hsieh S, 2011, BRAIN, V134, P2523, DOI 10.1093/brain/awr190
   Hutchins S, 2012, J EXP PSYCHOL GEN, V141, P76, DOI 10.1037/a0025064
   Ilie G, 2006, MUSIC PERCEPT, V23, P319, DOI 10.1525/mp.2006.23.4.319
   Izard C. E, 1979, MAXIMALLY DISCRIMINA
   IZARD CE, 1992, PSYCHOL REV, V99, P561, DOI 10.1037/0033-295X.99.3.561
   James W., 1884, MIND, V9, P188, DOI [DOI 10.1093/MIND/OS-IX.34.188, 10.1093/mind/os-IX.34.188]
   Jurgens R, 2015, J NONVERBAL BEHAV, V39, P195, DOI 10.1007/s10919-015-0209-5
   Juslin PN, 2008, EMOTION, V8, P668, DOI 10.1037/a0013505
   Juslin PN, 2001, EMOTION, V1, P381, DOI 10.1037//1528-3542.1.4.381
   Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770
   Juslin PN, 2001, MUSIC EMOTION THEORY, P309
   Kallinen K., 2005, PSYCHOL MUSIC, V33, P373, DOI DOI 10.1177/0305735605056147
   Kanade T, 2000, P 4 IEEE INT C AUT F
   Katselas M., 2008, ACTING CLASS TAKE SE
   Kaulard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032321
   KELTNER D, 1995, J PERS SOC PSYCHOL, V68, P441, DOI 10.1037/0022-3514.68.3.441
   Koelsch S, 2014, NAT REV NEUROSCI, V15, P170, DOI 10.1038/nrn3666
   Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012
   Kreifelts B, 2007, NEUROIMAGE, V37, P1445, DOI 10.1016/j.neuroimage.2007.06.020
   Krumhuber E, 2005, J NONVERBAL BEHAV, V29, P3, DOI 10.1007/s10919-004-0887-x
   Krumhuber EG, 2013, EMOT REV, V5, P41, DOI 10.1177/1754073912451349
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076
   Laukka P, 2011, COMPUT SPEECH LANG, V25, P84, DOI 10.1016/j.csl.2010.03.004
   Lima CF, 2013, BEHAV RES METHODS, V45, P1234, DOI 10.3758/s13428-013-0324-3
   Liu P, 2012, BEHAV RES METHODS, V44, P1042, DOI 10.3758/s13428-012-0203-3
   Livingstone SR, 2016, EMOTION, V16, P365, DOI 10.1037/emo0000106
   Livingstone SR, 2015, Q J EXP PSYCHOL, V68, P952, DOI 10.1080/17470218.2014.971034
   Livingstone SR, 2010, COMPUT MUSIC J, V34, P41, DOI 10.1162/comj.2010.34.1.41
   LoBue Vanessa, 2014, Front Psychol, V5, P1532, DOI 10.3389/fpsyg.2014.01532
   Lundqvist D., 1998, KAROLINSKA DIRECTED
   Maratos AS, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004517.pub2
   Marsh AA, 2003, PSYCHOL SCI, V14, P373, DOI 10.1111/1467-9280.24461
   Marsh AA, 2007, J CROSS CULT PSYCHOL, V38, P284, DOI 10.1177/0022022107300275
   Martin O, 2006, P 22 INT C DAT ENG W
   Massaro DW, 1996, PSYCHON B REV, V3, P215, DOI 10.3758/BF03212421
   Matsumoto D., 1988, JAPANESE CAUCASIAN F
   Matsumoto D, 1993, JAPANESE CAUCASIAN F
   MAZURSKI EJ, 1993, AUST J PSYCHOL, V45, P41, DOI 10.1080/00049539308259117
   Motley M. T., 1988, W J SPEECH COMMUNICA, V52, P1, DOI DOI 10.1080/10570318809389622
   Nelson NL, 2014, EMOTION, V14, P857, DOI 10.1037/a0036789
   ORTONY A, 1990, PSYCHOL REV, V97, P315, DOI 10.1037/0033-295X.97.3.315
   Osgood C., 1967, MEASUREMENT MEANING
   Pacchetti C, 2000, PSYCHOSOM MED, V62, P386, DOI 10.1097/00006842-200005000-00012
   Palermo R, 2004, BEHAV RES METH INS C, V36, P634, DOI 10.3758/BF03206544
   Palmer C, 1997, ANNU REV PSYCHOL, V48, P115, DOI 10.1146/annurev.psych.48.1.115
   Paquette S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00509
   Paulmann S, 2011, MOTIV EMOTION, V35, P192, DOI 10.1007/s11031-011-9206-0
   Pitcher D, 2011, NEUROIMAGE, V56, P2356, DOI 10.1016/j.neuroimage.2011.03.067
   Plant RR, 2002, BEHAV RES METH INS C, V34, P218, DOI 10.3758/BF03195446
   Plutchik Robert, 1980, EMOTION PSYCHOEVOLUT
   Pollick FE, 2003, PERCEPTION, V32, P813, DOI 10.1068/p3319
   Pourtois G, 2000, NEUROREPORT, V11, P1329, DOI 10.1097/00001756-200004270-00036
   Punkanen M, 2011, J AFFECT DISORDERS, V130, P118, DOI 10.1016/j.jad.2010.10.034
   Recio G, 2011, BRAIN RES, V1376, P66, DOI 10.1016/j.brainres.2010.12.041
   Regenbogen C, 2012, COGNITION EMOTION, V26, P995, DOI 10.1080/02699931.2011.631296
   Regenbogen C, 2012, NEUROIMAGE, V60, P2346, DOI 10.1016/j.neuroimage.2012.02.043
   REISENZEIN R, 1994, J PERS SOC PSYCHOL, V67, P525, DOI 10.1037/0022-3514.67.3.525
   RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102
   RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714
   Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145
   Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013
   Sato W, 2004, COGNITION EMOTION, V18, P701, DOI 10.1080/02699930341000176
   Sato W, 2007, COGNITION, V104, P1, DOI 10.1016/j.cognition.2006.05.001
   Sauter DA, 2007, MOTIV EMOTION, V31, P192, DOI 10.1007/s11031-007-9065-x
   Sauter DA, 2010, Q J EXP PSYCHOL, V63, P2251, DOI 10.1080/17470211003721642
   Sauter DA, 2010, P NATL ACAD SCI USA, V107, P2408, DOI 10.1073/pnas.0908239106
   Scherer KR, 2011, INT J PSYCHOL, V46, P401, DOI 10.1080/00207594.2011.626049
   SCHERER KR, 1991, MOTIV EMOTION, V15, P123, DOI 10.1007/BF00995674
   Scherer KR, 2003, SPEECH COMMUN, V40, P227, DOI 10.1016/S0167-6393(02)00084-5
   Schlaug G, 2008, MUSIC PERCEPT, V25, P315, DOI 10.1525/MP.2008.25.4.315
   Schlaug G, 2009, ANN NY ACAD SCI, V1169, P385, DOI 10.1111/j.1749-6632.2009.04587.x
   SCHLOSBERG H, 1952, J EXP PSYCHOL, V44, P229, DOI 10.1037/h0055778
   Schlosberg H, 1941, J EXP PSYCHOL, V29, P497
   SCHLOSBERG H, 1954, PSYCHOL REV, V61, P81, DOI 10.1037/h0054570
   Scotto di Carlo N, 2004, SEMIOTICA, V149, P37
   Sestito M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00368
   SHAVER P, 1987, J PERS SOC PSYCHOL, V52, P1061, DOI 10.1037//0022-3514.52.6.1061
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Simon D, 2008, PAIN, V135, P55, DOI 10.1016/j.pain.2007.05.008
   SONNEMANS J, 1994, COGNITION EMOTION, V8, P329, DOI 10.1080/02699939408408945
   Spencer H, 1855, PRINCIPLES PSYCHOL
   Stanislavsky K., 1936, ACTOR PREPARES
   Tanaka A, 2010, PSYCHOL SCI, V21, P1259, DOI 10.1177/0956797610380698
   Tcherkassof A, 2007, EUR J SOC PSYCHOL, V37, P1325, DOI 10.1002/ejsp.427
   Team R, 2016, RSTUDIO INT DEV R
   Team RC, 2017, R LANG ENV STAT COMP
   Thaut MH, 1996, MOVEMENT DISORD, V11, P193, DOI 10.1002/mds.870110213
   Thomas KM, 2001, BIOL PSYCHIAT, V49, P309, DOI 10.1016/S0006-3223(00)01066-0
   Thompson WF, 2012, P NATL ACAD SCI USA, V109, P19027, DOI 10.1073/pnas.1210344109
   Thompson WF, 2008, COGNITION EMOTION, V22, P1457, DOI 10.1080/02699930701813974
   Tomkins S.S., 1962, AFFECT IMAGERY CONSC
   Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006
   Tracy JL, 2008, P NATL ACAD SCI USA, V105, P11655, DOI 10.1073/pnas.0802686105
   Tracy JL, 2009, EMOTION, V9, P554, DOI 10.1037/a0015766
   Tracy JL, 2004, PSYCHOL SCI, V15, P194, DOI 10.1111/j.0956-7976.2004.01503008.x
   Trautmann SA, 2009, BRAIN RES, V1284, P100, DOI 10.1016/j.brainres.2009.05.075
   van Besouw RM, 2008, MUSIC PERCEPT, V26, P145, DOI 10.1525/MP.2008.26.2.145
   van der Schalk J, 2011, EMOTION, V11, P907, DOI 10.1037/a0023853
   VieIllard S, 2008, COGNITION EMOTION, V22, P720, DOI 10.1080/02699930701503567
   Vines BW, 2011, COGNITION, V118, P157, DOI 10.1016/j.cognition.2010.11.010
   Vurma A, 2006, MUSIC PERCEPT, V23, P331, DOI 10.1525/mp.2006.23.4.331
   WAGNER HL, 1993, J NONVERBAL BEHAV, V17, P3, DOI 10.1007/BF00987006
   WAGNER HL, 1986, J PERS SOC PSYCHOL, V50, P737, DOI 10.1037/0022-3514.50.4.737
   Wan CY, 2010, MUSIC PERCEPT, V27, P287, DOI 10.1525/MP.2010.27.4.287
   Wang L, 1999, J CROSS CULT PSYCHOL, V30, P397, DOI 10.1177/0022022199030004001
   Wehrle T, 2000, J PERS SOC PSYCHOL, V78, P105, DOI 10.1037/0022-3514.78.1.105
   Weyers P, 2006, PSYCHOPHYSIOLOGY, V43, P450, DOI 10.1111/j.1469-8986.2006.00451.x
   Wickham H, 2017, TIDYVERSE EASILY INS
   Wilhelm O, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00404
   Wundt W., 1896, OUTLINES PSYCHOL
   Zhang B, 2016, IEEE INT C AC SPEECH
   Zhang X, 2014, IMAGE VISION COMPUT, V32, P692, DOI 10.1016/j.imavis.2014.06.002
   Zvyagintsev M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00674
NR 190
TC 8
Z9 8
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 16
PY 2018
VL 13
IS 5
AR e0196391
DI 10.1371/journal.pone.0196391
PG 35
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GF9WG
UT WOS:000432329200024
PM 29768426
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Pamboris, GM
   Noorkoiv, M
   Baltzopoulos, V
   Gokalp, H
   Marzilger, R
   Mohagheghi, AA
AF Pamboris, George M.
   Noorkoiv, Marika
   Baltzopoulos, Vasilios
   Gokalp, Hulya
   Marzilger, Robert
   Mohagheghi, Amir A.
TI Effects of an acute bout of dynamic stretching on biomechanical
   properties of the gastrocnemius muscle determined by shear wave
   elastography
SO PLOS ONE
LA English
DT Article
ID MAGNETIC-RESONANCE ELASTOGRAPHY; PROFESSIONAL SOCCER PLAYERS; ANKLE
   JOINT STIFFNESS; IN-VIVO; TENDON UNIT; PASSIVE STIFFNESS; ULTRASOUND
   ELASTOGRAPHY; TRANSIENT ELASTOGRAPHY; SPORTS-MEDICINE; SKELETAL-MUSCLE
AB Aims
   The aim of this study was to examine the acute effects of dynamic stretching (DS) exercise on passive ankle range of motion (RoM), resting localized muscle stiffness, as measured by shear wave speed (SWS) of medial gastrocnemius muscle, fascicle strain, and thickness.
   Methods/Results
   Twenty-three participants performed a DS protocol. Before and after stretching, SWS was measured in the belly of the resting medial gastrocnemius muscle (MGM) using shear wave elastography. DS produced small improvements in maximum dorsiflexion (+1.5 degrees +/- 1.5; mean difference +/- 90% confidence limits) and maximum plantarflexion (+2.3 degrees +/- 1.8), a small decrease in fascicle strain (-2.6% +/- 4.4) and a small increase in SWS at neutral resting angle (+11.4% +/- 1.5). There was also a small increase in muscle thickness (+4.1mm +/- 2.0).
   Conclusions
   Through the use of elastography, this is the first study to suggest that DS increases muscle stiffness, decreases fascicle strain and increases muscle thickness as a result of improved RoM. These results can be beneficial to coaches, exercise and clinical scientists when choosing DS as a muscle conditioning or rehabilitation intervention.
C1 [Pamboris, George M.; Noorkoiv, Marika; Gokalp, Hulya; Mohagheghi, Amir A.] Brunel Univ London, Ctr Human Performance Exercise & Rehabil, Uxbridge, Middx, England.
   [Noorkoiv, Marika; Mohagheghi, Amir A.] Brunel Univ London, Inst Environm Hlth & Soc, Uxbridge, Middx, England.
   [Baltzopoulos, Vasilios] Liverpool John Moores Univ, RISES, Liverpool, Merseyside, England.
   [Marzilger, Robert] Humboldt Univ, Dept Training & Movement Sci, Berlin, Germany.
   [Marzilger, Robert] Humboldt Univ, Berlin Sch Movement Sci, Berlin, Germany.
   [Mohagheghi, Amir A.] Univ Social Welf & Rehabil Sci, Tehran, Iran.
RP Pamboris, GM (reprint author), Brunel Univ London, Ctr Human Performance Exercise & Rehabil, Uxbridge, Middx, England.
EM gpamboris@hotmail.com
OI Pamboris, George/0000-0002-1461-8210
CR Agten CA, 2017, AM J ROENTGENOL, V208, P402, DOI 10.2214/AJR.16.16617
   Akagi R, 2014, SCAND J MED SCI SPOR, V24, P950, DOI 10.1111/sms.12111
   Akagi R, 2013, MED SCI SPORT EXER, V45, P1348, DOI 10.1249/MSS.0b013e3182850e17
   Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002
   Avela J, 1999, J APPL PHYSIOL, V86, P1283
   Ayala F, 2013, J SPORT SCI, V31, P831, DOI 10.1080/02640414.2012.751119
   Bandy WD, 1998, J ORTHOP SPORT PHYS, V27, P295, DOI 10.2519/jospt.1998.27.4.295
   Basford JR, 2002, ARCH PHYS MED REHAB, V83, P1530, DOI 10.1053/apmr.2002.35472
   Batterham AM, 2006, INTJ SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50
   Behm DG, 2016, APPL PHYSIOL NUTR ME, V41, P1, DOI 10.1139/apnm-2015-0235
   Behm DG, 2013, J ELECTROMYOGR KINES, V23, P1215, DOI 10.1016/j.jelekin.2013.05.002
   Bensamoun SF, 2007, J MAGN RESON IMAGING, V26, P708, DOI 10.1002/jmri.21073
   Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425
   Brandenburg JE, 2014, ARCH PHYS MED REHAB, V95, P2207, DOI 10.1016/j.apmr.2014.07.007
   Catheline S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.064301
   CAVAGNA GA, 1964, J APPL PHYSIOL, V19, P249
   Chaouachi A, 2010, J STRENGTH COND RES, V24, P2001, DOI 10.1519/JSC.0b013e3181aeb181
   Chernak LA, 2013, PHYSIOL MEAS, V34, P713, DOI 10.1088/0967-3334/34/6/713
   Chino K, 2016, EUR J APPL PHYSIOL, V116, P823, DOI 10.1007/s00421-016-3339-5
   Chino K, 2015, CLIN BIOMECH, V30, P1230, DOI 10.1016/j.clinbiomech.2015.07.014
   Chleboun GS, 1998, MED SCI SPORT EXER, V30, P529, DOI 10.1097/00005768-199804000-00010
   Cipriani DJ, 2012, J STRENGTH COND RES, V26, P2119, DOI 10.1519/JSC.0b013e31823b862a
   Cohen J, 1977, STAT POWER ANAL BEHA, DOI [10.1016/c2013-0-10517-x, DOI 10.1016/C2013-0-10517-X]
   Correas JM, 2014, EUR J RADIOL, V83, P442, DOI 10.1016/j.ejrad.2014.01.018
   Cramer JT, 2007, J SPORT SCI, V25, P687, DOI 10.1080/02640410600818416
   Cramer JT, 2007, J ORTHOP SPORT PHYS, V37, P130, DOI 10.2519/jospt.2007.2389
   Dubois G, 2015, ULTRASOUND MED BIOL, V41, P2284, DOI 10.1016/j.ultrasmedbio.2015.04.020
   Eby SF, 2013, J BIOMECH, V46, P2381, DOI 10.1016/j.jbiomech.2013.07.033
   Fisher R, 1921, METRON, P3
   Fletcher IM, 2010, J STRENGTH COND RES, V24, P2096, DOI 10.1519/JSC.0b013e3181e312db
   Fletcher IM, 2004, J STRENGTH COND RES, V18, P885
   Freitas SR, 2015, EUR J APPL PHYSIOL, V115, P1263, DOI 10.1007/s00421-015-3104-1
   Gajdosik RL, 1999, PHYS THER, V79, P827
   Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb
   Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013
   Gennisson JL, 2005, J BIOMECH, V38, P1543, DOI 10.1016/j.jbiomech.2004.07.013
   Gennisson JL, 2003, J ACOUST SOC AM, V114, P536, DOI 10.1121/1.1579008
   Guilhem G, 2016, ACTA PHYSIOL, V217, P152, DOI 10.1111/apha.12654
   GUISSARD N, 1988, EUR J APPL PHYSIOL O, V58, P47
   Halbertsma JPK, 1996, ARCH PHYS MED REHAB, V77, P688, DOI 10.1016/S0003-9993(96)90009-X
   Herda TJ, 2013, J SPORT SCI, V31, P479, DOI 10.1080/02640414.2012.736632
   Hirata K, 2016, EUR J APPL PHYSIOL, V116, P911, DOI 10.1007/s00421-016-3349-3
   Hoang PD, 2005, J BIOMECH, V38, P1333, DOI 10.1016/j.jbiomech.2004.05.046
   Hoge KM, 2010, J STRENGTH COND RES, V24, P2618, DOI 10.1519/JSC.0b013e3181e73974
   Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001
   Hopkins WG, 2002, SPORTSCIENCE
   Hopkins WG, 2006, SPORTSCIENCE, V10, P46
   Hopkins WG, 2015, SPORTSCIENCE, V19, P36
   HOPKINS WG, 2007, SPORTSCI, V11, P16
   Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278
   HOWELL JN, 1993, J PHYSIOL-LONDON, V464, P183, DOI 10.1113/jphysiol.1993.sp019629
   Kato E, 2010, EUR J SPORT SCI, V10, P111, DOI 10.1080/17461390903307834
   Kay AD, 2015, MED SCI SPORT EXER, V47, P2181, DOI 10.1249/MSS.0000000000000632
   Kay AD, 2009, J APPL PHYSIOL, V106, P1249, DOI 10.1152/japplphysiol.91476.2008
   KER RF, 1988, J ZOOL, V216, P309, DOI 10.1111/j.1469-7998.1988.tb02432.x
   Koo TK, 2014, CLIN BIOMECH, V29, P33, DOI 10.1016/j.clinbiomech.2013.11.009
   Kot BCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044348
   Kubo K, 2002, J PHYSIOL-LONDON, V538, P219, DOI 10.1113/jphysiol.2001.012703
   Kubo K, 2009, INT J SPORTS MED, V30, P139, DOI 10.1055/s-0028-1104573
   Kubo K, 2001, EUR J APPL PHYSIOL, V85, P226, DOI 10.1007/s004210100463
   Kubo K, 2015, J BIOMECH, V48, P1937, DOI 10.1016/j.jbiomech.2015.04.012
   Kumagai K, 2000, J APPL PHYSIOL, V88, P811
   Lacourpaille L, 2014, ACTA PHYSIOL, V211, P135, DOI 10.1111/apha.12272
   Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee SSM, 2016, CLIN BIOMECH, V31, P20, DOI 10.1016/j.clinbiomech.2015.10.006
   Lee S, 2015, OXID MED CELL LONGEV, DOI 10.1155/2015/632902
   Little T, 2006, J STRENGTH COND RES, V20, P203
   Luomala T, 2014, J BODYW MOV THER, V18, P462, DOI 10.1016/j.jbmt.2013.11.020
   Magnusson SP, 1996, ARCH PHYS MED REHAB, V77, P373, DOI 10.1016/S0003-9993(96)90087-8
   Magnusson SP, 1996, AM J SPORT MED, V24, P622, DOI 10.1177/036354659602400510
   Maisetti O, 2012, J BIOMECH, V45, P978, DOI 10.1016/j.jbiomech.2012.01.009
   Marshall PWM, 2011, J SCI MED SPORT, V14, P535, DOI 10.1016/j.jsams.2011.05.003
   Marzilger R, 2018, EUR J APPL PHYSIOL, V118, P291, DOI 10.1007/s00421-017-3769-8
   McHugh MP, 1999, AM J SPORT MED, V27, P594, DOI 10.1177/03635465990270050801
   Miyamoto N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124311
   Mizuno T, 2016, INT J SPORTS MED, V37, P1044, DOI 10.1055/s-0042-108807
   Morse CI, 2008, J PHYSIOL-LONDON, V586, P97, DOI 10.1113/jphysiol.2007.140434
   Nakamura M, 2017, MUSCULOSKEL SCI PRAC, V32, P98, DOI 10.1016/j.msksp.2017.09.006
   Nakamura M, 2014, ULTRASOUND MED BIOL, V40, P1991, DOI 10.1016/j.ultrasmedbio.2014.03.024
   Nakamura M, 2013, MANUAL THER, V18, P211, DOI 10.1016/j.math.2012.09.010
   Nakamura M, 2011, J ORTHOP RES, V29, P1759, DOI 10.1002/jor.21445
   Nordez A, 2008, J BIOMECH, V41, P2305, DOI 10.1016/j.jbiomech.2008.03.033
   Nordez A, 2010, J BIOMECH, V43, P379, DOI 10.1016/j.jbiomech.2009.07.034
   O'Sullivan K, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-37
   Powers SK, 2012, EXERCISE PHYSL THEOR
   PURSLOW PP, 1989, J BIOMECH, V22, P21, DOI 10.1016/0021-9290(89)90181-4
   Riemann BL, 2001, J ATHL TRAINING, V36, P369
   Ringleb SI, 2007, J MAGN RESON IMAGING, V25, P301, DOI 10.1002/jmri.20817
   Royer D, 2011, J ACOUST SOC AM, V129, P2757, DOI 10.1121/1.3559681
   Samukawa M, 2011, MANUAL THER, V16, P618, DOI 10.1016/j.math.2011.07.003
   Sarvazyan AP, 2013, ULTRASOUND MED BIOL, V39, P1133, DOI 10.1016/j.ultrasmedbio.2013.02.006
   Semenick D, 1994, ESSENTIALS STRENGTH, P258
   Smith TB, 2011, MED SCI SPORT EXER, V43, P2155, DOI 10.1249/MSS.0b013e31821d3f8e
   Spudich JA, 2001, NAT REV MOL CELL BIO, V2, P387, DOI 10.1038/35073086
   Taniguchi K, 2015, SCAND J MED SCI SPOR, V25, P32, DOI 10.1111/sms.12146
   Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002
   Tew GA, 2011, MICROVASC RES, V81, P177, DOI 10.1016/j.mvr.2010.12.001
   WILSON GJ, 1991, INT J SPORTS MED, V12, P403, DOI 10.1055/s-2007-1024702
   WILSON GJ, 1992, MED SCI SPORT EXER, V24, P116
   Witvrouw E, 2007, BRIT J SPORT MED, V41, P224, DOI 10.1136/bjsm.2006.034165
   Witvrouw E, 2004, SPORTS MED, V34, P443, DOI 10.2165/00007256-200434070-00003
   Witvrouw E, 2003, AM J SPORT MED, V31, P41, DOI 10.1177/03635465030310011801
   Witvrouw E, 2000, AM J SPORT MED, V28, P480, DOI 10.1177/03635465000280040701
   Wong D, 2011, J SPORT SCI MED, V10, P408
   Yoshitake Y, 2016, ULTRASOUND MED BIOL, V42, P674, DOI 10.1016/j.ultrasmedbio.2015.11.022
NR 106
TC 1
Z9 1
U1 2
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 3
PY 2018
VL 13
IS 5
AR e0196724
DI 10.1371/journal.pone.0196724
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GE6AF
UT WOS:000431305100058
PM 29723229
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Federer, LM
   Belter, CW
   Joubert, DJ
   Livinski, A
   Lu, YL
   Snyders, LN
   Thompson, H
AF Federer, Lisa M.
   Belter, Christopher W.
   Joubert, Douglas J.
   Livinski, Alicia
   Lu, Ya-Ling
   Snyders, Lissa N.
   Thompson, Holly
TI Data sharing in PLOS ONE: An analysis of Data Availability Statements
SO PLOS ONE
LA English
DT Article
ID REANALYSIS
AB A number of publishers and funders, including PLOS, have recently adopted policies requiring researchers to share the data underlying their results and publications. Such policies help increase the reproducibility of the published literature, as well as make a larger body of data available for reuse and re-analysis. In this study, we evaluate the extent to which authors have complied with this policy by analyzing Data Availability Statements from 47,593 papers published in PLOS ONE between March 2014 (when the policy went into effect) and May 2016. Our analysis shows that compliance with the policy has increased, with a significant decline over time in papers that did not include a Data Availability Statement. However, only about 20% of statements indicate that data are deposited in a repository, which the PLOS policy states is the preferred method. More commonly, authors state that their data are in the paper itself or in the supplemental information, though it is unclear whether these data meet the level of sharing required in the PLOS policy. These findings suggest that additional review of Data Availability Statements or more stringent policies may be needed to increase data sharing.
C1 [Federer, Lisa M.; Belter, Christopher W.; Joubert, Douglas J.; Livinski, Alicia; Lu, Ya-Ling; Snyders, Lissa N.; Thompson, Holly] NIH, NIH Lib, Div Lib Serv, Off Res Serv, Bldg 10, Bethesda, MD 20892 USA.
RP Federer, LM (reprint author), NIH, NIH Lib, Div Lib Serv, Off Res Serv, Bldg 10, Bethesda, MD 20892 USA.
EM lisa.federer@nih.gov
RI Belter, Christopher W/L-6487-2013; Federer, Lisa/D-6818-2014
OI Belter, Christopher W/0000-0001-5221-6880; Federer,
   Lisa/0000-0001-5732-5285
CR [Anonymous], 2017, PLOS DATA AVAILABILI, DOI [10.1371/journal.pgen.1005716, DOI 10.1371/JOURNAL.PGEN.1005716]
   [Anonymous], 2017, SCI EDITORIAL POLICI
   Byrne M, 2017, EVERYONE PLOS ONE CO
   Elsevier, 2017, RES DATA
   Fecher B, 2017, PALGR COMMUN, V3, DOI 10.1057/palcomms.2017.51
   Federer LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129506
   Giofre D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175583
   Holdren John P., 2013, INCREASING ACCESS RE
   Kidwell MC, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002456
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Magee AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110268
   McDonald Laura, 2017, F1000Res, V6, P1708, DOI 10.12688/f1000research.12673.1
   McHugh ML, 2012, BIOCHEM MEDICA, V22, P276
   National Institutes of Health, 2015, NAT I HLTH PLAN INCR, Vhttps://grants.nih.gov/grants/NIH-Public-Access-Plan.pdf
   National Science Foundation, 2010, DISS SHAR RES RES
   Nature Publishing Group, 2017, AV DAT MAT
   Naudet F, 2018, BMJ-BRIT MED J, V360, P1, DOI 10.1136/bmj.k400
   Nuijten MB, 2017, J DATA SHARING POLIC, V3, P1, DOI [10.17605/OSF.IO/SGBTA, DOI 10.17605/OSF.IO/SGBTA]
   Powell K, 2016, MED LIB ASS 2016 ANN
   Rowhani-Farid A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011784
   Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078
   Silva L, 2014, EVERYONE PLOS ONE CO
   Tenopir C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134826
   Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101
   Vines TH, 2014, CURR BIOL, V24, P94, DOI 10.1016/j.cub.2013.11.014
   Watson MS, 2017, GENET MED, V19, P721, DOI 10.1038/gim.2016.196
   Wicherts JM, 2006, AM PSYCHOL, V61, P726, DOI 10.1037/0003-066X.61.7.726
   Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18
NR 28
TC 3
Z9 3
U1 1
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 2
PY 2018
VL 13
IS 5
AR e0194768
DI 10.1371/journal.pone.0194768
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GE5SH
UT WOS:000431281900010
PM 29719004
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kristoffersen, DT
   Helgeland, J
   Clench-Aas, J
   Laake, P
   Veierod, MB
AF Kristoffersen, Doris Tove
   Helgeland, Jon
   Clench-Aas, Jocelyne
   Laake, Petter
   Veierod, Marit B.
TI Observed to expected or logistic regression to identify hospitals with
   high or low 30-day mortality?
SO PLOS ONE
LA English
DT Article
ID MODELS; OUTLIERS; OUTCOMES; SURGERY; IMPACT; SAMPLE; BAYES; BIAS
AB Introduction
   A common quality indicator for monitoring and comparing hospitals is based on death within 30 days of admission. An important use is to determine whether a hospital has higher or lower mortality than other hospitals. Thus, the ability to identify such outliers correctly is essential. Two approaches for detection are: 1) calculating the ratio of observed to expected number of deaths (OE) per hospital and 2) including all hospitals in a logistic regression (LR) comparing each hospital to a form of average over all hospitals. The aim of this study was to compare OE and LR with respect to correctly identifying 30-day mortality outliers. Modifications of the methods, i.e., variance corrected approach of OE (OE-Faris), bias corrected LR (LR-Firth), and trimmed mean variants of LR and LR-Firth were also studied.
   Materials and methods
   To study the properties of OE and LR and their variants, we performed a simulation study by generating patient data from hospitals with known outlier status (low mortality, high mortality, non-outlier). Data from simulated scenarios with varying number of hospitals, hospital volume, and mortality outlier status, were analysed by the different methods and compared by level of significance (ability to falsely claim an outlier) and power (ability to reveal an outlier). Moreover, administrative data for patients with acute myocardial infarction (AMI), stroke, and hip fracture from Norwegian hospitals for 2012-2014 were analysed.
   Results
   None of the methods achieved the nominal (test) level of significance for both low and high mortality outliers. For low mortality outliers, the levels of significance were increased four-to fivefold for OE and OE-Faris. For high mortality outliers, OE and OE-Faris, LR 25% trimmed and LR-Firth 10% and 25% trimmed maintained approximately the nominal level. The methods agreed with respect to outlier status for 94.1% of the AMI hospitals, 98.0% of the stroke, and 97.8% of the hip fracture hospitals.
   Conclusion
   We recommend, on the balance, LR-Firth 10% or 25% trimmed for detection of both low and high mortality outliers.
C1 [Kristoffersen, Doris Tove; Helgeland, Jon] Norwegian Inst Publ Hlth, Div Hlth Serv, Oslo, Norway.
   [Clench-Aas, Jocelyne] Norwegian Inst Publ Hlth, Div Phys & Mental Hlth, Oslo, Norway.
   [Laake, Petter; Veierod, Marit B.] Univ Oslo, Inst Basic Med Sci, Ctr Biostat & Epidemiol, Dept Biostat, Oslo, Norway.
RP Kristoffersen, DT (reprint author), Norwegian Inst Publ Hlth, Div Hlth Serv, Oslo, Norway.
EM DorisTove.Kristoffersen@fhi.no
RI Veierod, Marit B/J-8229-2019
OI Veierod, Marit B/0000-0002-2083-2758; Kristoffersen, Doris
   Tove/0000-0002-8220-2532
FU Research Council of Norway [160340]
FX DTK received support from the Research Council of Norway, grant number
   160340. The funder had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Alexandrescu R, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0029-x
   Alexandrescu R, 2011, J AM COLL SURGEONS, V213, P392, DOI 10.1016/j.jamcollsurg.2011.06.423
   Austin PC, 2007, STAT MED, V26, P2937, DOI 10.1002/sim.2770
   BENDRE SM, 1989, COMMUN STAT THEORY, V18, P697, DOI 10.1080/03610928908829928
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Bottle A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7116
   Brand C., 2013, HOSP MORTALITY INDIC
   DeLong ER, 1997, STAT MED, V16, P2645, DOI 10.1002/(SICI)1097-0258(19971215)16:23<2645::AID-SIM696>3.0.CO;2-D
   Ettinger WH, 2008, AM J MED QUAL, V23, P90, DOI 10.1177/1062860607313141
   Faris PD, 2003, J CLIN EPIDEMIOL, V56, P553, DOI 10.1016/S0895-4356(03)00048-9
   Fedeli U, 2007, J CLIN EPIDEMIOL, V60, P858, DOI 10.1016/j.jclinepi.2006.11.017
   FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.1093/biomet/80.1.27
   Guo WG, 2015, J STAT PLAN INFER, V163, P21, DOI 10.1016/j.jspi.2015.02.009
   Hannan EL, 2005, MED CARE, V43, P726, DOI 10.1097/01.mlr.0000167802.27044.44
   Hassani S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136547
   Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047
   HOSMER DW, 1995, STAT MED, V14, P2161, DOI 10.1002/sim.4780141909
   Huang IC, 2005, MED DECIS MAKING, V25, P20, DOI 10.1177/0272989X04273138
   KIM SJ, 1992, ANN STAT, V20, P1534, DOI 10.1214/aos/1176348783
   Kristoffersen DT, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006741
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Little RJ, 2006, AM STAT, V60, P213, DOI 10.1198/000313006X117837
   Manktelow BN, 2014, BMJ QUAL SAF, V23, P782, DOI 10.1136/bmjqs-2013-002608
   Mohammed MA, 2016, STAT METHODS MED RES, V25, P706, DOI 10.1177/0962280212465165
   Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545
   OECD/ EU, HLTH GLANC EUR 2016
   Pouw ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059160
   R Development Core Team, 2018, R LANG ENV STAT COMP
   Racz MJ, 2010, J AM STAT ASSOC, V105, P48, DOI 10.1198/jasa.2010.ap07175
   Ryan A, 2012, HEALTH SERV RES, V47, P1699, DOI 10.1111/j.1475-6773.2012.01382.x
   SCHEFFE H, 1956, ANN MATH STAT, V27, P251, DOI 10.1214/aoms/1177728258
   Scheffe H., 1959, ANAL VARIANCE, P331
   Searle S., 2009, VARIANCE COMPONENTS
   Shahian DM, 2015, BMJ QUAL SAF, V24, P95, DOI 10.1136/bmjqs-2015-003934
   Sosunov EA, 2016, MED CARE, V54, P373, DOI 10.1097/MLR.0000000000000476
   STIGLER SM, 1973, ANN STAT, V1, P472, DOI 10.1214/aos/1176342412
   THOMAS N, 1994, STAT MED, V13, P889, DOI 10.1002/sim.4780130902
   WHO, 2018, INT CLASS DIS ICD
   Wilcox R, 2014, INTRO ROBUST ESTIMAT
NR 39
TC 1
Z9 1
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 13
PY 2018
VL 13
IS 4
AR e0195248
DI 10.1371/journal.pone.0195248
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GC8EX
UT WOS:000430026900019
PM 29652941
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Stynes, S
   Konstantinou, K
   Ogollah, R
   Hay, EM
   Dunn, KM
AF Stynes, Siobhan
   Konstantinou, Kika
   Ogollah, Reuben
   Hay, Elaine M.
   Dunn, Kate M.
TI Clinical diagnostic model for sciatica developed in primary care
   patients with low back-related leg pain
SO PLOS ONE
LA English
DT Article
ID PHYSICAL-EXAMINATION; DISC HERNIATION; HISTORY; DEFINITIONS; PROGNOSIS;
   SYMPTOMS
AB Background
   Identification of sciatica may assist timely management but can be challenging in clinical practice. Diagnostic models to identify sciatica have mainly been developed in secondary care settings with conflicting reference standard selection. This study explores the challenges of reference standard selection and aims to ascertain which combination of clinical assessment items best identify sciatica in people seeking primary healthcare.
   Methods
   Data on 394 low back-related leg pain consulters were analysed. Potential sciatica indicators were seven clinical assessment items. Two reference standards were used: (i) high confidence sciatica clinical diagnosis; (ii) high confidence sciatica clinical diagnosis with confirmatory magnetic resonance imaging findings. Multivariable logistic regression models were produced for both reference standards. A tool predicting sciatica diagnosis in low back-related leg pain was derived. Latent class modelling explored the validity of the reference standard.
   Results
   Model (i) retained five items; model (ii) retained six items. Four items remained in both models: below knee pain, leg pain worse than back pain, positive neural tension tests and neurological deficit. Model (i) was well calibrated (p = 0.18), discrimination was area under the receiver operating characteristic curve (AUC) 0.95 (95% CI 0.93, 0.98). Model (ii) showed good discrimination (AUC 0.82; 0.78, 0.86) but poor calibration (p = 0.004). Bootstrapping revealed minimal overfitting in both models. Agreement between the two latent classes and clinical diagnosis groups defined by model (i) was substantial, and fair for model (ii).
   Conclusion
   Four clinical assessment items were common in both reference standard definitions of sciatica. A simple scoring tool for identifying sciatica was developed. These criteria could be used clinically and in research to improve accuracy of identification of this subgroup of back pain patients.
C1 [Stynes, Siobhan; Konstantinou, Kika; Ogollah, Reuben; Hay, Elaine M.; Dunn, Kate M.] Keele Univ, Res Inst Primary Care & Hlth Sci, Arthrit Res UK Primary Care Ctr, Keele, Staffs, England.
RP Stynes, S (reprint author), Keele Univ, Res Inst Primary Care & Hlth Sci, Arthrit Res UK Primary Care Ctr, Keele, Staffs, England.
EM s.stynes@keele.ac.uk
FU National Institute for Health Research/Chief Nursing Officer Clinical
   Doctoral Research Fellowship [CDRF-2010055]; Higher Education Funding
   Council for England/National Institute for Health Research Senior
   Clinical Lectureship
FX SS was supported by an National Institute for Health Research/Chief
   Nursing Officer Clinical Doctoral Research Fellowship (CDRF-2010055). KK
   was supported by a Higher Education Funding Council for England/National
   Institute for Health Research Senior Clinical Lectureship. EMH is an
   National Institute for Health Research Senior Investigator. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Al Nezari NH, 2013, SPINE J, V13, P657, DOI 10.1016/j.spinee.2013.02.007
   Austin PC, 2014, STAT MED, V33, P517, DOI 10.1002/sim.5941
   Beattie PF, 2000, SPINE, V25, P819, DOI 10.1097/00007632-200004010-00010
   Bogduk N, 2009, PAIN, V147, P17, DOI 10.1016/j.pain.2009.08.020
   Coggon D, 2005, INT J EPIDEMIOL, V34, P949, DOI 10.1093/ije/dyi012
   Coster S, 2010, J NEUROL, V257, P332, DOI 10.1007/s00415-009-5316-y
   Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94
   Dunn K. M., 2010, PRIM HEALTH CARE RES, V11, P93, DOI DOI 10.1017/S1463423609990296
   Genevay S, 2010, SPINE, V35, P803, DOI 10.1097/BRS.0b013e3181bc9454
   Hill JC, 2011, SPINE, V36, P2168, DOI 10.1097/BRS.0b013e31820712bb
   Hosmer DW, 2000, WILEY PS TX
   Iversen T, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-206
   JENSEN MC, 1994, MAGN RESON QUART, V10, P173
   Karppinen J, 2001, Spine (Phila Pa 1976), V26, pE149, DOI 10.1097/00007632-200104010-00015
   Knottnerus JA, 2002, EVIDENCE BASE CLIN D
   Kongsted A, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-171
   Konstantinou K, 2012, EUR SPINE J, V21, P2306, DOI 10.1007/s00586-012-2398-5
   Konstantinou K, 2012, EUR SPINE J, V21, P1241, DOI 10.1007/s00586-011-2057-2
   Konstantinou K, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-4
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lin CWC, 2014, EUR J PAIN, V18, P455, DOI 10.1002/j.1532-2149.2013.00384.x
   Mathieson S, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-213
   Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698
   Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246
   PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011
   Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3
   Reitsma JB, 2009, J CLIN EPIDEMIOL, V62, P797, DOI 10.1016/j.jclinepi.2009.02.005
   Shultz S, 2015, MANUAL THER, V20, P18, DOI 10.1016/j.math.2014.08.002
   Steyerberg E. W., 2009, CLIN PREDICTION MODE
   Stynes S, 2016, EUR SPINE J, V25, P2734, DOI 10.1007/s00586-015-4359-2
   Suarthana E, 2010, J CLIN EPIDEMIOL, V63, P1011, DOI 10.1016/j.jclinepi.2009.10.008
   Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972
   van der Windt DAWM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007431.pub2
   van Smeden M, 2014, AM J EPIDEMIOL, V179, P423, DOI 10.1093/aje/kwt286
   Verwoerd AJH, 2014, SPINE J, V14, P2028, DOI 10.1016/j.spinee.2013.11.049
   Vroomen PCAJ, 2002, J NEUROL NEUROSUR PS, V72, P630, DOI 10.1136/jnnp.72.5.630
   Vroomen PCAJ, 1999, J NEUROL, V246, P899, DOI 10.1007/s004150050480
   Vucetic N, 1999, CLIN ORTHOP RELAT R, P116
   Wood LRJ, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0899-9
   Worster A, 2008, CAN J EMERG MED, V10, P174
NR 40
TC 1
Z9 1
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 5
PY 2018
VL 13
IS 4
AR e0191852
DI 10.1371/journal.pone.0191852
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GB6TQ
UT WOS:000429206800001
PM 29621243
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Pfister, PB
   de Bruin, ED
   Sterkele, I
   Maurer, B
   de Bie, RA
   Knols, RH
AF Pfister, Pierrette Baschung
   de Bruin, Eling D.
   Sterkele, Iris
   Maurer, Britta
   de Bie, Rob A.
   Knols, Ruud H.
TI Manual muscle testing and hand-held dynamometry in people with
   inflammatory myopathy: An intra- and interrater reliability and validity
   study
SO PLOS ONE
LA English
DT Article
ID INCLUSION-BODY MYOSITIS; REFERENCE VALUES; JUVENILE DERMATOMYOSITIS;
   INTERNATIONAL CONSENSUS; ISOKINETIC DYNAMOMETRY; NORMATIVE VALUES; KNEE
   EXTENSION; STRENGTH; POLYMYOSITIS; ADULT
AB Manual muscle testing (MMT) and hand-held dynamometry (HHD) are commonly used in people with inflammatory myopathy (IM), but their clinimetric properties have not yet been sufficiently studied. To evaluate the reliability and validity of MMT and HHD, maximum isometric strength was measured in eight muscle groups across three measurement events. To evaluate reliability of HHD, intra-class correlation coefficients (ICC), the standard error of measurements (SEM) and smallest detectable changes (SDC) were calculated. To measure reliability of MMT linear Cohen's Kappa was computed for single muscle groups and ICC for total score. Additionally, correlations between MMT8 and HHD were evaluated with Spearman Correlation Coefficients. Fifty people with myositis (56 +/- 14 years, 76% female) were included in the study. Intra-and interrater reliability of HHD yielded excellent ICCs (0.75-0.97) for all muscle groups, except for interrater reliability of ankle extension (0.61). The corresponding SEMs% ranged from 8 to 28% and the SDCs% from 23 to 65%. MMT8 total score revealed excellent intra-and interrater reliability (ICC>0.9). Intrarater reliability of single muscle groups was substantial for shoulder and hip abduction, elbow and neck flexion, and hip extension (0.64-0.69); moderate for wrist (0.53) and knee extension (0.49) and fair for ankle extension (0.35). Interrater reliability was moderate for neck flexion (0.54) and hip abduction (0.44); fair for shoulder abduction, elbow flexion, wrist and ankle extension (0.20-0.33); and slight for knee extension (0.08). Correlations between the two tests were low for wrist, knee, ankle, and hip extension; moderate for elbow flexion, neck flexion and hip abduction; and good for shoulder abduction. In conclusion, the MMT8 total score is a reliable assessment to consider general muscle weakness in people with myositis but not for single muscle groups. In contrast, our results confirm that HHD can be recommended to evaluate strength of single muscle groups.
C1 [Pfister, Pierrette Baschung; Knols, Ruud H.] Univ Hosp Zurich, Physiotherapy Occupat Therapy Res Ctr, Directorate Res & Educ, Zurich, Switzerland.
   [Pfister, Pierrette Baschung] Zurich Univ Appl Sci, Inst Physiotherapy, Dept Hlth, Winterthur, Switzerland.
   [Pfister, Pierrette Baschung] Maastricht Univ, CAPHRI Care & Publ Hlth Res Inst, Functioning & Rehabil, NL-6200 MD Maastricht, Netherlands.
   [de Bruin, Eling D.] Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Dept Hlth Sci & Technol, Zurich, Switzerland.
   [de Bruin, Eling D.] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, SE-14183 Huddinge, Sweden.
   [Sterkele, Iris] Univ Hosp Zurich, Physiotherapy Occupat Therapy, Nursing & Allied Hlth Profess Off, Zurich, Switzerland.
   [Maurer, Britta] Univ Hosp Zurich, Dept Rheumatol, Zurich, Switzerland.
   [de Bie, Rob A.] Maastricht Univ, CAPHRI Care & Publ Hlth Res Inst, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands.
RP de Bruin, ED (reprint author), Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Dept Hlth Sci & Technol, Zurich, Switzerland.; de Bruin, ED (reprint author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, SE-14183 Huddinge, Sweden.
EM eling.debruin@hest.ethz.ch
RI de Bruin, Eling D./A-4751-2011
OI de Bruin, Eling D./0000-0002-6542-7385
CR AITKENS S, 1989, MUSCLE NERVE, V12, P173, DOI 10.1002/mus.880120302
   Andersen H, 1997, EUR NEUROL, V37, P239, DOI 10.1159/000117450
   Andrews AW, 1996, PHYS THER, V76, P248, DOI 10.1093/ptj/76.3.248
   BACKMAN E, 1995, SCAND J REHABIL MED, V27, P109
   BLAND JM, 1986, LANCET, V1, P307
   BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807
   BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706
   Bohannon RW, 2000, PERCEPT MOTOR SKILL, V90, P747, DOI 10.2466/PMS.90.3.747-750
   Bohannon RW, 1997, ARCH PHYS MED REHAB, V78, P26, DOI 10.1016/S0003-9993(97)90005-8
   Bohannon RW, 2001, AM J PHYS MED REHAB, V80, P13, DOI 10.1097/00002060-200101000-00004
   BOHANNON RW, 1993, J ORTHOP SPORT PHYS, V18, P564, DOI 10.2519/jospt.1993.18.4.564
   DALAKAS MC, 1991, NEW ENGL J MED, V325, P1487, DOI 10.1056/NEJM199111213252107
   de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015
   de Winter AF, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-18
   Fleiss J. L., 1999, DESIGN ANAL CLIN EXP, P1, DOI DOI 10.1002/9781118032923.CHL
   Greenberg SA, 2008, SEMIN NEUROL, V28, P241, DOI 10.1055/s-2008-1062267
   Harris-Love MO, 2009, RHEUMATOLOGY, V48, P134, DOI 10.1093/rheumatology/ken441
   HAYES KW, 1992, J ORTHOP SPORT PHYS, V16, P145, DOI 10.2519/jospt.1992.16.3.145
   Hengstman GJD, 2003, EUR NEUROL, V50, P10, DOI 10.1159/000070852
   Isenberg DA, 2004, RHEUMATOLOGY, V43, P49, DOI 10.1093/rheumatology/keg427
   Jain Minal, 2006, Phys Occup Ther Pediatr, V26, P5, DOI 10.1300/J006v26n03_02
   Knols RH, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-31
   Kolber MJ, 2005, PHYS THER REV, V10, P99, DOI 10.1179/108331905X55730
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mastaglia FL, 2002, RHEUM DIS CLIN N AM, V28, P723, DOI 10.1016/S0889-857X(02)00021-2
   McKay MJ, 2017, NEUROLOGY, V88, P36, DOI 10.1212/WNL.0000000000003466
   Meldrum D, 2007, AMYOTROPH LATERAL SC, V8, P47, DOI 10.1080/17482960601012491
   Mentiplay BF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140822
   Meyer A, 2015, RHEUMATOLOGY, V54, P50, DOI 10.1093/rheumatology/keu289
   Noreau L, 1998, SPINAL CORD, V36, P716, DOI 10.1038/sj.sc.3100646
   Pfister PB, 2015, RHEUMATOL INT, V35, P1641, DOI 10.1007/s00296-015-3343-9
   Rider LG, 2004, ARTHRITIS RHEUM, V50, P2281, DOI 10.1002/art.20349
   Rider LG, 2002, RHEUM DIS CLIN N AM, V28, P935, DOI 10.1016/S0889-857X(02)00027-3
   Rider LG, 2011, ARTHRIT CARE RES, V63, pS118, DOI 10.1002/acr.20532
   Rider Lisa G., 2003, Journal of Rheumatology, V30, P603
   Rider LG, 2010, ARTHRIT CARE RES, V62, P465, DOI 10.1002/acr.20035
   Scholtes VA, 2011, INJURY, V42, P236, DOI 10.1016/j.injury.2010.11.042
   Siegel S, 1988, NONPARAMETRIC STAT B
   Sole G, 2007, ARCH PHYS MED REHAB, V88, P626, DOI 10.1016/j.apmr.2007.02.006
   Stark T, 2011, PM&R, V3, P472, DOI 10.1016/j.pmrj.2010.10.025
   STOLL T, 1995, J RHEUMATOL, V22, P473
   Stoll T, 2000, CLIN RHEUMATOL, V19, P105, DOI 10.1007/s100670050026
   Stone CA, 2011, J REHABIL MED, V43, P808, DOI 10.2340/16501977-0860
   Streiner DL, 2008, HLTH MEASUREMENT SCA
   Sultan Shabina M, 2003, Curr Rheumatol Rep, V5, P445, DOI 10.1007/s11926-003-0055-z
   Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012
   VANDERPLOEG RJO, 1991, J NEUROL NEUROSUR PS, V54, P244, DOI 10.1136/jnnp.54.3.244
   Varju C, 2003, CLIN REHABIL, V17, P83, DOI 10.1191/0269215503cr572oa
   Vet HCWd, 2011, MEASUREMENT MED PRAC
NR 49
TC 4
Z9 4
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 29
PY 2018
VL 13
IS 3
AR e0194531
DI 10.1371/journal.pone.0194531
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GA8ZI
UT WOS:000428630000028
PM 29596450
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Pommerening, A
   Ramos, CP
   Kedziora, W
   Haufe, J
   Stoyan, D
AF Pommerening, Arne
   Ramos, Carlos Pallares
   Kedziora, Wojciech
   Haufe, Jens
   Stoyan, Dietrich
TI Rating experiments in forestry: How much agreement is there in tree
   marking?
SO PLOS ONE
LA English
DT Article
ID THINNING INTENSITY; GROWTH; SELECTION; MANAGEMENT; IMPACTS; CHINA; STAND
AB The process of selecting individual trees by humans for forest management purposes is the result of a plethora of factors and processes that are hard to disentangle. And yet in the past many textbooks and other publications have maintained that this selection leads to somewhat unanimous results. In this study, we analysed the data of 36 so-called marteloscope experiments from all over Britain, which are managed by the Ae Training Centre (Scotland, UK). Our objective was (1) to establish how much agreement there actually was when asking test persons (raters) to apply two different thinning methods, low and crown thinning. In addition we (2) were interested in understanding some of the processes leading to certain levels of agreement and in relationships between the agreement measures and characteristics of forest structure. Our analysis was based on multivariate statistics, particularly using Fleiss' kappa. This was the first time that an analysis of rater behaviour was performed at such a large scale and it revealed that the general agreement in tree selection in Britain was only slight to fair, i.e. much lower than in medical experiments. The variability of selecting individual trees was considerable. We also found that agreement in tree selection was much stronger in low-thinning as opposed to crown-thinning experiments. As the latter is an important method of Continuous Cover Forestry and British forestry is increasingly adopting this forest management type, our results suggested that there is a need to provide more training. Interestingly the different levels of agreement as identified by Fleiss' kappa could not be explained by measures of forest structure, however, the mean conformity number, a surrogate of Fleiss' kappa, showed correlations and indicated that conformity increased with increasing complexity of tree stem diameter structure.
C1 [Pommerening, Arne; Ramos, Carlos Pallares] Swedish Univ Agr Sci, Fac Forest Sci, Forest Resource Management Dept, Umea, Sweden.
   [Kedziora, Wojciech] Warsaw Univ Life Sci, Chair Forest Management Planning, Fac Forestry, Warsaw, Poland.
   [Haufe, Jens] Forest Res, Tech Dev, Ae Village, England.
   [Stoyan, Dietrich] Tech Univ Bergakad Freiberg, Inst Stochast, Freiberg, Germany.
RP Pommerening, A (reprint author), Swedish Univ Agr Sci, Fac Forest Sci, Forest Resource Management Dept, Umea, Sweden.
EM arne.pommerening@siu.se
RI Kedziora, Wojciech/K-7097-2019
OI Kedziora, Wojciech/0000-0002-1469-9532
FU Warsaw University of Life Sciences
FX WK gratefully acknowledges a stipend from Warsaw University of Life
   Sciences for funding a research visit to the Swedish University of
   Agricultural Sciences in November 2016 - January 2017. The editor and
   two anonymous reviewers made thorough and constructive comments on an
   earlier draft of this paper.; WK gratefully acknowledges a stipend from
   Warsaw University of Life Sciences for funding a research visit to the
   Swedish University of Agricultural Sciences in November 2016 January
   2017. All other authors received no specific funding for this work. The
   funder had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Agnoletti M., 2006, Schweizerische Zeitschrift fur Forstwesen, V157, P384, DOI 10.3188/szf.2006.0384
   Agnoletti M, 2000, FOREST HIST INT STUD
   Bruciamacchie M, 2005, ANN FOREST SCI, V62, P727, DOI 10.1051/forest:2005070
   Cao HY, 2016, BIOMETRICAL J, V58, P935, DOI 10.1002/bimj.201500029
   Cicchetti D., 1994, PSYCHOL ASSESSMENTS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]
   Clark JS, 2007, ECOL APPL, V17, P1942, DOI 10.1890/06-1039.1
   CONGER AJ, 1980, PSYCHOL BULL, V88, P322, DOI 10.1037/0033-2909.88.2.322
   Crecente-Campo F, 2009, FOREST ECOL MANAG, V257, P1945, DOI 10.1016/j.foreco.2009.02.009
   Daume S, 1997, ALLG FORST JAGDZTG, V169, P21
   Fleiss J, 2003, STAT METHODS RATES P
   FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619
   Fuldner K, 1996, ALLG FORST JAGDZTG, V167, P159
   Gadow KV, 1996, SCI TOTAL ENVIRON, V183, P167, DOI 10.1016/0048-9697(95)04979-7
   Graham RT, 1999, PNWGTR463 USDA FOR S
   Hallgren Kevin A, 2012, Tutor Quant Methods Psychol, V8, P23
   Helms J.A., 1998, DICT FORESTRY
   Hubert L, 1977, PSYCHOL BULL, V61, P277
   Hui G, 2014, FOREST ECOL MANAG, V316, P125, DOI 10.1016/j.foreco.2013.07.029
   Junod P, 2017, FORET BERNOISE, V5, P20
   Kariuki M, 2008, FOREST ECOL MANAG, V256, P2007, DOI 10.1016/j.foreco.2008.07.035
   Kassier H, 1993, THESIS
   Kirby KJ, 2015, EUROPE'S CHANGING WOODS AND FORESTS FROM WILDWOOD TO MANAGED LANDSCAPES, P1, DOI 10.1079/9781780643373.0000
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Makinen H, 2004, FOREST ECOL MANAG, V203, P21, DOI 10.1016/j.foreco.2004.07.028
   Makinen H, 2004, FORESTRY, V77, P349, DOI 10.1093/forestry/77.4.349
   Matonis MS, 2016, J FOREST, V114, P658, DOI 10.5849/jof.15-140
   MURRAY DM, 1991, FOREST SCI, V37, P552
   Nilsen P, 2008, FOREST ECOL MANAG, V256, P201, DOI 10.1016/j.foreco.2008.04.001
   Peltola H, 2002, SILVA FENN, V36, P813, DOI 10.14214/sf.523
   Pommerening A, 2004, FORESTRY, V77, P27, DOI 10.1093/forestry/77.1.27
   Pommerening A, 2015, FOREST FACTS, P9
   Poore A, 2011, THE MARTELOSCOPE, P28
   Pourasghar F, 2014, J CLIN RES GOVERNANC, V3, P124
   R Core Team, 2017, R LANG ENV STAT COMP
   Shouten HJA, 1982, STAT NEERL, V36, P45
   Soucy M, 2016, FOREST CHRON, V92, P418, DOI 10.5558/tfc2016-076
   Spinelli R, 2016, FOREST SCI, V62, P213, DOI 10.5849/forsci.15-062
   Stoyan D, 2017, BIOMETRICAL IN PRESS
   Stoyan D, 2017, J ENV STAT UNPUB
   Swift E, 2013, IMPACTS PARTIAL HARV
   VANCLAY J K, 1989, Journal of Tropical Forest Science, V1, P280
   Vitkova L, 2016, FOREST SCI, V62, P288, DOI 10.5849/forsci.15-133
   Wyckoff PH, 2005, CAN J FOREST RES, V35, P13, DOI 10.1139/x04-142
   Zhang CY, 2014, FOREST ECOL MANAG, V316, P100, DOI 10.1016/j.foreco.2013.07.018
   Zucchini W., 1995, Forest & Landscape Research, V1, P199
NR 45
TC 2
Z9 2
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 22
PY 2018
VL 13
IS 3
AR e0194747
DI 10.1371/journal.pone.0194747
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GA1RF
UT WOS:000428093900101
PM 29566076
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Nikaido, T
   Sumitani, M
   Sekiguchi, M
   Konno, S
AF Nikaido, Takuya
   Sumitani, Masahiko
   Sekiguchi, Miho
   Konno, Shinichi
TI The Spine painDETECT questionnaire: Development and validation of a
   screening tool for neuropathic pain caused by spinal disorders
SO PLOS ONE
LA English
DT Article
ID QUALITY-OF-LIFE; PRIMARY-CARE; INVENTORY; OSTEOARTHRITIS; MECHANISMS;
   DIAGNOSIS; ORIGIN; HEALTH; KNEE
AB Objectives
   To develop screening tools for neuropathic pain caused by spinal disorders, the Spine pain-DETECT questionnaire (SPDQ) and its short-form version (SF-SPDQ), by modifying the Japanese version of the painDETECTquestionnaire (PDQ-J), and to validate these tools.
   Methods
   Using data from patients with neuropathic pain caused by spinal disorders (NeP-SD) and patients with nociceptive pain caused by joint disorders (NocP) as controls, we devised a scoring system for the SPDQ by calculating weighting coefficients for nine PDQ-J items. Simultaneously, we selected some items for the SF-SPDQ. Next, we conducted the validation study primarily using patients with a confirmed diagnosis (a multicenter study) and general patients (a web-based survey). Sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC), along with additional positive/negative predictive values and positive/negative likelihood ratios, were calculated to assess the diagnostic utility of these tools in each population.
   Results
   Data for 85 patients with NeP-SD and 45 patients with NocP were analyzed to develop the SPDQ/SF-SPDQ. The SPDQ had sensitivity of 78.8% and specificity of 75.6% (AUC = 0.77). The SF-SPDQ had 82.4% sensitivity and 66.7% specificity (AUC = 0.75). In the multicenter study (n = 45), both tools had diagnostic utility almost comparable with that demonstrated at development: the SPDQ had sensitivity of 83.3% and specificity of 69.2%, with the SF-SPDQ having 86.2% sensitivity and 68.8% specificity. In the web-based survey (n = 500), while the SPDQ had slightly low sensitivity (74.0%), the SF-SPDQ maintained high sensitivity (84.4%), although specificity was relatively low (61.2%).
   Conclusions
   We developed the SPDQ and SF-SPDQ as valid screening tools for neuropathic pain caused by spinal disorders. Both have moderate utility as screening tools, with the SF-SPDQ perhaps being preferable for clinical use. However, physicians should be vigilant about possible false-positive diagnoses.
C1 [Nikaido, Takuya; Sekiguchi, Miho; Konno, Shinichi] Fukushima Med Univ, Sch Med, Dept Orthopaed Surg, Fukushima, Japan.
   [Sumitani, Masahiko] Univ Tokyo Hosp, Dept Pain & Palliat Med, Tokyo, Japan.
   [Sekiguchi, Miho] Fukushima Med Univ, Sch Med, Lab Anim Res Ctr, Fukushima, Japan.
RP Nikaido, T (reprint author), Fukushima Med Univ, Sch Med, Dept Orthopaed Surg, Fukushima, Japan.
EM tnikaido@fmu.ac.jp
FU Health Labour and Science Research Grant [12944466]; Pfizer Japan
FX The development of the SPDQ and SF-SPDQ was supported by Health Labour
   and Science Research Grant for research on chronic pain (Grant Number:
   12944466). The validation study of the SPDQ and SF-SPDQ was funded by
   Pfizer Japan. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Altman DG, 1990, PRACTICAL STAT MED R
   Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5
   Bouhassira D, 2004, PAIN, V108, P248, DOI 10.1016/j.pain.2003.12.024
   Cedraschi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079988
   Davidson M, 2002, AUST J PHYSIOTHER, V48, P227, DOI 10.1016/S0004-9514(14)60228-2
   Dworkin RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524, DOI 10.1001/archneur.60.11.1524
   Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488
   Haanpaa ML, 2009, AM J MED, V122, pS13, DOI 10.1016/j.amjmed.2009.04.006
   Hara N, 2012, J MUSCULOSKELET PAIN, V4, P37
   Hawker GA, 2008, OSTEOARTHR CARTILAGE, V16, P415, DOI 10.1016/j.joca.2007.12.017
   International Association for the Study of Pain (IASP), 2017, IASP TAX
   Karasugi T, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1311-5
   Koop SMW, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0761-8
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leonardi C, 2015, EUR REV MED PHARMACO, V19, P4898
   Matsubayashi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143350
   Matsubayashi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068013
   Nakamura M, 2014, J ORTHOP SCI, V19, P667, DOI 10.1007/s00776-014-0567-6
   Ohtori S, 2012, YONSEI MED J, V53, P801, DOI 10.3349/ymj.2012.53.4.801
   Schaefer C, 2014, PAIN MED, V15, P2105, DOI 10.1111/pme.12502
   Smith BH, 2007, CLIN J PAIN, V23, P143, DOI 10.1097/01.ajp.0000210956.31997.89
   Tan G, 2004, J PAIN, V5, P133, DOI 10.1016/j.jpain.2003.12.005
   Taylor Rod S, 2006, Pain Pract, V6, P22, DOI 10.1111/j.1533-2500.2006.00054.x
   Team JET, 1998, J HLTH CARE SOC, V8, P109
   Torrance N, 2007, FAM PRACT, V24, P481, DOI 10.1093/fampra/cmm042
   Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59
   Uki J, 1998, J PAIN SYMPTOM MANAG, V16, P364, DOI 10.1016/S0885-3924(98)00098-0
   WILLIAMS A, 1990, HEALTH POLICY, V16, P199
   Yamashita T, 2014, J ORTHOP SCI, V19, P15, DOI 10.1007/s00776-013-0496-9
NR 29
TC 1
Z9 1
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 21
PY 2018
VL 13
IS 3
AR e0193987
DI 10.1371/journal.pone.0193987
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FZ9LE
UT WOS:000427931600047
PM 29561897
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Reisner, SL
   Deutsch, MB
   Peitzmeier, SM
   Hughto, JMW
   Cavanaugh, TP
   Pardee, DJ
   McLean, SA
   Panther, LA
   Gelman, M
   Mimiaga, MJ
   Potter, JE
AF Reisner, Sari L.
   Deutsch, Madeline B.
   Peitzmeier, Sarah M.
   Hughto, Jaclyn M. White
   Cavanaugh, Timothy P.
   Pardee, Dana J.
   McLean, Sarah A.
   Panther, Lori A.
   Gelman, Marcy
   Mimiaga, Matthew J.
   Potter, Jennifer E.
TI Test performance and acceptability of self-versus provider-collected
   swabs for high-risk HPV DNA testing in female-to-male trans masculine
   patients
SO PLOS ONE
LA English
DT Article
ID AMERICAN-CANCER-SOCIETY; PATHOLOGY SCREENING GUIDELINES;
   INTERIM-CLINICAL-GUIDANCE; HUMAN-PAPILLOMAVIRUS DNA; TRANSGENDER
   HEALTH-CARE; CERVICAL-CANCER; UNITED-STATES; INDIVIDUALS PATIENT;
   RANDOMIZED-TRIAL; VAGINAL TAMPONS
AB Background
   High-risk human papillomavirus (hrHPV) causes virtually all cervical cancers. Trans masculine (TM) people (those assigned female at birth who identify with a gender other than female) have low uptake of conventional cervical cancer screening. Self-collected hrHPV DNA testing has high levels of acceptability among cisgender (non-transgender) females and may support increased cervical cancer screening uptake in TM individuals.
   Objective
   To assess the test performance and acceptability of self-collected vaginal specimens in comparison to provider-collected cervical swabs for hrHPV DNA detection in TM individuals ages 21-64 years.
   Methods
   Between March 2015-September 2016, 150 TM participants with a cervix (mean age = 27.5 years; SD = 5.7) completed a one-time study visit comprised of a self-report survey, self collected vaginal HPV DNA swab, clinician-administered cervical HPV swab, and brief interview on acceptability of clinical procedures. Participants were randomized to complete either self- or provider-collection first to minimize ordering effects. Self- and provider-collected samples were tested for 13 hrHPV DNA types using a DNA Hybridization Assay. The primary outcome variable was the concordance (kappa statistic) and performance (sensitivity, specificity) of self-collected vaginal HPV DNA specimens versus provider-collected cervical HPV swabs as the gold standard.
   Results
   Of the 131 participants completing both the self- and provider-collected HPV tests, 21 cases of hrHPV were detected by the provider cervical swab (gold standard; 16.0% hrHPV prevalence); 15 of these cases were accurately detected by the self-collected vaginal swab (71.4% concordance) (Kappa = 0.75, 95% Confidence Interval [CI]: 0.59, 0.92; p<0.001). Compared to the provider-collected cervical hrHPV DNA sample (gold standard), the self collected vaginal hrHPV DNA test demonstrated a sensitivity of 71.4% (95% CI: 0.52, 0.91; p = 0.0495) and specificity of 98.2% (95% CI: 0.96, 1.00; p<0.0001). Over 90% of participants endorsed a preference for the self-collected vaginal swab over provider-collected cervical swab.
   Conclusion Self-collected vaginal swabs are highly acceptable to TM as a means to test for hrHPV DNA. Test performance of this self-collection method for hrHPV detection in TM is consistent with previous studies in cisgender females. Self-collected vaginal swab testing for hrHPV DNA represents a reasonable and patient-centered strategy for primary cervical cancer screening in TM patients unwilling to undergo provider collection of specimens via speculum exam.
C1 [Reisner, Sari L.] Boston Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA.
   [Reisner, Sari L.] Harvard Med Sch, Pediat, Boston, MA 02115 USA.
   [Reisner, Sari L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Reisner, Sari L.; Peitzmeier, Sarah M.; Hughto, Jaclyn M. White; Pardee, Dana J.; McLean, Sarah A.; Panther, Lori A.; Gelman, Marcy; Mimiaga, Matthew J.; Potter, Jennifer E.] Fenway Hlth, Fenway Inst, Boston, MA 02215 USA.
   [Deutsch, Madeline B.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Deutsch, Madeline B.] Univ Calif San Francisco, UCSF Ctr Excellence Transgender Hlth, San Francisco, CA USA.
   [Peitzmeier, Sarah M.] Johns Hopkins Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA.
   [Hughto, Jaclyn M. White] Yale Sch Publ Hlth, Chron Dis Epidemiol, New Haven, CT USA.
   [Cavanaugh, Timothy P.] Fenway Hlth, Transgender Hlth Program, Boston, MA USA.
   [Panther, Lori A.; Potter, Jennifer E.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
   [Mimiaga, Matthew J.] Brown Univ, Sch Publ Hlth, Dept Behav & Social Hlth Sci & Epidemiol, Providence, RI 02912 USA.
   [Mimiaga, Matthew J.] Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Providence, RI 02912 USA.
   [Mimiaga, Matthew J.] Brown Univ, CHER, Providence, RI 02912 USA.
   [Potter, Jennifer E.] Harvard Med Sch, Dept Med, Boston, MA USA.
RP Reisner, SL (reprint author), Boston Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA.; Reisner, SL (reprint author), Harvard Med Sch, Pediat, Boston, MA 02115 USA.; Reisner, SL (reprint author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Reisner, SL (reprint author), Fenway Hlth, Fenway Inst, Boston, MA 02215 USA.
EM sari.reisner@childrens.harvard.edu
FU Patient-Centered Outcomes Research Institute (PCORI) [CER-1403-12625];
   National Institutes of Minority Health and Health Disparities
   [F32MD011203-01]
FX The current study was funded by the Patient-Centered Outcomes Research
   Institute (PCORI), contract CER-1403-12625. All methods were reviewed by
   the PCORI Scientific Committee and found to be in accordance with their
   Methodology Standards. PCORI was not involved in the collection,
   analysis, or interpretation of study data. This study is registered at
   www.clinicaltrials.gov NCT02401867 (Title: Preventive Sexual Health
   Screening Among Female-to-Male Transgender Adult Patients). Dr. Jaclyn
   White Hughto was also supported in part by the National Institutes of
   Minority Health and Health Disparities (F32MD011203-01). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Agenor M, 2016, CULT HEALTH SEX, V18, P1192, DOI 10.1080/13691058.2016.1177203
   Alidjinou EK, 2013, J CLIN VIROL, V57, P161, DOI 10.1016/j.jcv.2013.02.010
   [Anonymous], 2016, Obstet Gynecol, V127, pe1, DOI 10.1097/AOG.0000000000001263
   Arrossi S, 2015, LANCET GLOB HEALTH, V3, pE85, DOI 10.1016/S2214-109X(14)70354-7
   Benard VB, 2014, MMWR-MORBID MORTAL W, V63, P1004
   Breslow N.E., 1980, STAT METHODS CANC RE
   Castle PE, 2006, J INFECT DIS, V194, P1702, DOI 10.1086/509511
   Catarino R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143644
   Centers for Disease Control and Prevention, 2013, INC PREV COST SEX TR
   Chesson HW, 2014, SEX TRANSM DIS, V41, P660, DOI 10.1097/OLQ.0000000000000193
   Dannecker C, 2004, ANN ONCOL, V15, P863, DOI 10.1093/annonc/mdh240
   de Melo Kuil L, 2017, ACTA CYTOL
   Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754
   Driak Daniel, 2005, Acta Medica (Hradec Kralove), V48, P53
   Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813
   Feldman J., 2007, PRINCIPLES TRANSGEND, P33
   Garcia F, 2003, OBSTET GYNECOL, V102, P266, DOI 10.1016/S0029-7844(03)00517-9
   Gok M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1040
   Hariri S, 2011, J INFECT DIS, V204, P566, DOI 10.1093/infdis/jir341
   Harper DM, 2002, AM J OBSTET GYNECOL, V186, P365, DOI 10.1067/mob.2002.121076
   Healthcare for transgender individuals, 2011, OBSTET GYNECOL, V118, P1454
   Holton T, 2008, CYTOPATHOLOGY, V19, P236, DOI 10.1111/j.1365-2303.2007.00525.x
   Hughto JMW, 2015, SOC SCI MED, V147, P222, DOI 10.1016/j.socscimed.2015.11.010
   Huh WK, 2015, GYNECOL ONCOL, V136, P178, DOI 10.1016/j.ygyno.2014.12.022
   Huh WK, 2015, OBSTET GYNECOL, V125, P330, DOI 10.1097/AOG.0000000000000669
   Kaufman R, 2008, FENWAY GUIDE LESBIAN, P331
   Kenagy GP, 2005, HEALTH SOC WORK, V30, P19, DOI 10.1093/hsw/30.1.19
   Khan AM, 2015, BJOG-INT J OBSTET GY, V122, P388, DOI 10.1111/1471-0528.12926
   Lack N, 2005, SEX TRANSM INFECT, V81, P239, DOI 10.1136/sti.2004.010413
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Malila N, 2013, INT J CANCER, V132, P2141, DOI 10.1002/ijc.27850
   Massad LS, 2013, OBSTET GYNECOL, V121, P829, DOI 10.1097/AOG.0b013e3182883a34
   McDowell M, 2017, LGBT HEALTH, V4, P252, DOI 10.1089/lgbt.2016.0187
   Modibbo F, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0123-z
   Moyer VA, 2012, ANN INTERN MED, V156, pW312, DOI DOI 10.7326/0003-4819-156-12-201206190-00424
   Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424
   Nobbenhuis MAE, 2002, J CLIN PATHOL, V55, P435, DOI 10.1136/jcp.55.6.435
   O'Hanlan KA, 2007, OBSTET GYNECOL, V110, P1096, DOI 10.1097/01.AOG.0000286778.44943.5a
   Ogilvie GS, 2005, SEX TRANSM INFECT, V81, P207, DOI 10.1136/sti.2004.011858
   Peitzmeier SM, 2014, AM J PREV MED, V47, P808, DOI 10.1016/j.amepre.2014.07.031
   Peitzmeier SM, 2017, QUAL HLTH RES
   Peitzmeier SM, 2014, J GEN INTERN MED
   Petignat P, 2007, GYNECOL ONCOL, V105, P530, DOI 10.1016/j.ygyno.2007.01.023
   Potter J, 2015, J GEN INTERN MED, V30, P1857, DOI 10.1007/s11606-015-3462-8
   Rachlin K, 2008, J HOMOSEXUAL, V54, P243, DOI 10.1080/00918360801982124
   Reisner SL, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2539-x
   Reisner SL, 2015, MILBANK Q, V93, P484, DOI 10.1111/1468-0009.12127
   Reisner SL, 2015, J URBAN HEALTH, V92, P584, DOI 10.1007/s11524-015-9947-2
   Rijkaart DC, 2012, INT J CANCER, V130, P602, DOI 10.1002/ijc.26056
   Rompalo AM, 2001, CLIN INFECT DIS, V33, P1455, DOI 10.1086/322588
   Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7
   Sargent A, 2008, BRIT J CANCER, V98, P1704, DOI 10.1038/sj.bjc.6604324
   Saslow D, 2016, CA-CANCER J CLIN, V66, P375, DOI 10.3322/caac.21355
   Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139
   Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI 10.1309/AJCPTGD94EVRSJCG
   Seay J, 2017, LGBT HLTH
   Sellors JW, 2000, CAN MED ASSOC J, V163, P513
   Snijders PJF, 2013, INT J CANCER, V132, P2223, DOI 10.1002/ijc.27790
   SocioCultural Research Consultants L, 2017, DED SOFTW
   Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114
   Strauss A., 1997, GROUNDED THEORY PRAC
   Trottier H, 2009, CANCER EPIDEM BIOMAR, V18, P854, DOI 10.1158/1055-9965.EPI-08-1012
   U.S. Preventive Services Task Force (USPSTF), 2016, FIN UPD SUMM CERV CA
   US Cancer Statistics Working Group, US CANC STAT 1999 20
   van Trotsenburg MAA, 2009, INT J TRANSGENDERISM, V11, P238, DOI 10.1080/15532730903439484
   Viens LJ, 2016, MMWR-MORBID MORTAL W, V65, P661, DOI 10.15585/mmwr.mm6526a1
   Wright TC, 2000, JAMA-J AM MED ASSOC, V283, P81, DOI 10.1001/jama.283.1.81
   Wright TC, 2015, GYNECOL ONCOL, V136, P189, DOI 10.1016/j.ygyno.2014.11.076
NR 68
TC 4
Z9 4
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 14
PY 2018
VL 13
IS 3
AR e0190172
DI 10.1371/journal.pone.0190172
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FZ2XG
UT WOS:000427446400003
PM 29538411
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Keller, S
   Aigner, A
   Zenouzi, R
   Kim, AC
   Meijer, A
   Weidemann, SA
   Krech, T
   Lohse, AW
   Adam, G
   Schramm, C
   Yamamura, J
AF Keller, Sarah
   Aigner, Annette
   Zenouzi, Roman
   Kim, Anne C.
   Meijer, Arnoud
   Weidemann, Soeren A.
   Krech, Till
   Lohse, Ansgar W.
   Adam, Gerhard
   Schramm, Christoph
   Yamamura, Jin
TI Association of gadolinium-enhanced magnetic resonance imaging with
   hepatic fibrosis and inflammation in primary sclerosing cholangitis
SO PLOS ONE
LA English
DT Article
ID FUSION-GUIDED BIOPSY; PROSTATE-CANCER; GADOXETIC ACID; LIVER-BIOPSY;
   CHOLANGIOGRAPHY; MRI; ELASTOGRAPHY; COMPLICATIONS; PERFORMANCE;
   DIAGNOSIS
AB Objective
   To evaluate magnetic resonance imaging (MRI) parameters T2 signal, contrast enhancement (CE), and relative liver enhancement (RLE) of extracellular gadolinium-based contrast agent (GBCA)-enhanced MRI as a marker for hepatic fibrosis and inflammation in patients with primary sclerosing cholangitis (PSC).
   Methods
   3.0-Tesla MRI scans and liver biopsies of 40 patients (41.2 +/- 17.1 years) were retrospectively reviewed. Biopsies were obtained within a mean time of 54 +/- 55 days to MRI scans and specimens were categorized according to Ishak modified hepatic activity index (mHAI) and Scheuer staging of fibrosis. T2 signal (N = 40), CE alterations (N = 29), and RLE (N = 29) were assessed by two raters. Mixed-effects regression models were applied to estimate the association between histopathology and MRI parameters.
   Results
   No significant association was observed between T2 signal or CE alterations with stages of fibrosis or mHAI grading. Regression models revealed significant positive associations of portal venous phase RLE with mHAI grade >= 7 points [beta = 25.5; 95% CI (2.53; 48.62); p = 0.04] and delayed phase RLE with stages of fibrosis [stage 2: beta = 35.13; 95% CI (11.35; 58.87); p = 0.007; stage 3/4: beta = 69.24; 95% CI (45.77; 92.75); p < 0.001]. The optimal cutoff value of 66.6% delayed phase RLE distinguished fibrosis stages 0-2 from 3-4 with a sensitivity of 0.833 and specificity of 0.972. Inter-rater reliability (IRR) for quantification of RLE was 'excellent' (r = 0.90-0.98). IRR was 'substantial' for detection of T2 signal in the right liver lobe (RL) (Kappa = 0.77) and 'almost perfect' for T2 signal of the left liver lobe (LL) and CE of both lobes (Kappa = 0.87 +/- 1.0).
   Conclusion
   The simple and reproducible method of RLE quantification on standard extracellular GBCAenhanced MRI may provide a correlate measure of advanced stages of hepatic fibrosis and potentially also inflammation in PSC patients, if validated in larger cohorts.
C1 [Keller, Sarah; Adam, Gerhard; Yamamura, Jin] Univ Med Ctr Hamburg Eppendorf UKE, Dept Diagnost & Intervent Radiol & Nucl Med, Hamburg, Germany.
   [Aigner, Annette] Univ Med Ctr Hamburg Eppendorf UKE, Inst Med Biometry & Epidemiol, Hamburg, Germany.
   [Zenouzi, Roman; Lohse, Ansgar W.; Schramm, Christoph] Univ Med Ctr Hamburg Eppendorf UKE, Dept Med 1, Hamburg, Germany.
   [Kim, Anne C.] Permanente Med Grp Inc, Dept Stroke & Neurovasc Imaging, San Francisco, CA USA.
   [Meijer, Arnoud] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands.
   [Meijer, Arnoud; Weidemann, Soeren A.] Univ Med Ctr Hamburg Eppendorf UKE, Inst Pathol, Hamburg, Germany.
RP Keller, S (reprint author), Univ Med Ctr Hamburg Eppendorf UKE, Dept Diagnost & Intervent Radiol & Nucl Med, Hamburg, Germany.
EM s.keller@uke.de
FU Deutsche Forschungsgemeinschaft (DFG) [SFB841, KFO306]; Helmut and
   Hannelore Greve Foundation; YAEL-Foundation
FX Ansgar W. Lohse and Christoph Schramm were supported by the Deutsche
   Forschungsgemeinschaft (DFG) (SFB841 and KFO306). Christoph Schramm was
   supported by the Helmut and Hannelore Greve Foundation and the
   YAEL-Foundation. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Angulo P, 2000, J HEPATOL, V33, P520, DOI 10.1034/j.1600-0641.2000.033004520.x
   Annet L, 2003, RADIOLOGY, V229, P409, DOI 10.1148/radiol.2292021128
   Bambha K, 2003, GASTROENTEROLOGY, V125, P1364, DOI 10.1053/S0016-5085(03)01356-8
   Bates D., 2015, FITTING LINEAR MIXED, V2015, P48, DOI DOI 10.18637/JSS.V067.I01
   Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009
   Chen BB, 2014, CLIN RADIOL, V69, P473, DOI 10.1016/j.crad.2013.12.003
   Dave M, 2010, RADIOLOGY, V256, P387, DOI 10.1148/radiol.10091953
   Denzer U, 2007, J CLIN GASTROENTEROL, V41, P103, DOI 10.1097/01.mcg.0000225612.86846.82
   Eaton JE, 2016, J GASTROEN HEPATOL, V31, P1184, DOI 10.1111/jgh.13263
   Faria SC, 2009, RADIOGRAPHICS, V29, P1615, DOI 10.1148/rg.296095512
   FLEISS JL, 1969, PSYCHOL BULL, V72, P323, DOI 10.1037/h0028106
   Frenzel C, 2012, LIVER INT, V32, P970, DOI 10.1111/j.1478-3231.2012.02767.x
   Fulcher AS, 2000, RADIOLOGY, V215, P71, DOI 10.1148/radiology.215.1.r00ap2671
   Gamer M, VARIOUS COEFFICIENTS
   Hinrichs H, 2015, EUR RADIOL
   Hirschfield GM, 2013, LANCET, V382, P1587, DOI 10.1016/S0140-6736(13)60096-3
   ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6
   JANES CH, 1993, ANN INTERN MED, V118, P96, DOI 10.7326/0003-4819-118-2-199301150-00003
   Jang YJ, 2013, ANN HEPATOL, V12, P926, DOI 10.1016/S1665-2681(19)31298-0
   Kanematsu M, 2004, J MAGN RESON IMAGING, V20, P242, DOI 10.1002/jmri.20097
   Kaplan GG, 2007, AM J GASTROENTEROL, V102, P1042, DOI 10.1111/j.1572-0241.2007.01103.x
   Kuznetsova A, 2016, LMERTEST TESTS LINEA
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lewin M, 2009, HEPATOLOGY, V50, P528, DOI 10.1002/hep.23024
   Lohse AW, 2015, J HEPATOL, V63, P971, DOI 10.1016/j.jhep.2015.06.030
   Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6
   Martin DR, 2012, J MAGN RESON IMAGING, V36, P422, DOI 10.1002/jmri.23668
   Martin DR, 2004, J MAGN RESON IMAGING, V20, P838, DOI 10.1002/jmri.20192
   Maxeiner A, 2014, AKTUEL UROL, V45, P197, DOI 10.1055/s-0034-1375682
   Maxeiner A, 2015, UROLOGY, V86, P108, DOI 10.1016/j.urology.2015.01.055
   Molodecky NA, 2011, HEPATOLOGY, V53, P1590, DOI 10.1002/hep.24247
   Nilsson H, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120653
   Nilsson H, 2014, J MAGN RESON IMAGING, V39, P879, DOI 10.1002/jmri.24250
   Nolz R, 2014, CLIN RADIOL, V69, P499, DOI 10.1016/j.crad.2013.12.008
   Noren B, 2013, EUR RADIOL, V23, P174, DOI 10.1007/s00330-012-2583-2
   Ponsioen CY, 2002, GUT, V51, P562, DOI 10.1136/gut.51.4.562
   Ponsioen CY, 2016, HEPATOLOGY, V63, P1357, DOI 10.1002/hep.28256
   Ponsioen CY, 2015, DIGEST DIS, V33, P134, DOI 10.1159/000440823
   Portney L, 1999, FDN CLIN RES APPL PR
   Puustinen L, 2017, SCAND J GASTROENTERO, V52, P886, DOI 10.1080/00365521.2017.1315738
   R Development Core Team, 2016, R LANG ENV STAT COMP
   Regev A, 2002, AM J GASTROENTEROL, V97, P2614
   Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77
   Rouviere O, 2006, RADIOLOGY, V240, P440, DOI 10.1148/radiol.2402050606
   SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O
   Schramm C, 2017, HEPATOLOGY, V66, P1675, DOI 10.1002/hep.29293
   Schulze K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140525
   Semelka RC, 2001, J MAGN RESON IMAGING, V13, P385, DOI 10.1002/jmri.1055
   Siddiqui MM, 2013, EUR UROL, V64, P713, DOI 10.1016/j.eururo.2013.05.059
   Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623
   Strasberg SM, 1997, J AM COLL SURGEONS, V184, P413
   Tischendorf JJW, 2007, AM J GASTROENTEROL, V102, P107, DOI 10.1111/j.1572-0241.2006.00872.x
   VanBeers BE, 2014, J HEPATOLOGY
   Watanabe H, 2011, RADIOLOGY, V259, P142, DOI 10.1148/radiol.10100621
   Yin M, 2007, CLIN GASTROENTEROL H, V5, P1207, DOI 10.1016/j.cgh.2007.06.012
   Yoneyama T, 2014, EUR RADIOL, V24, P857, DOI 10.1007/s00330-013-3086-5
NR 56
TC 3
Z9 3
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 7
PY 2018
VL 13
IS 3
AR e0193929
DI 10.1371/journal.pone.0193929
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FY5TA
UT WOS:000426896800090
PM 29513767
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Van Os, JMC
   Mintline, EM
   DeVries, TJ
   Tucker, CB
AF Van Os, Jennifer M. C.
   Mintline, Erin M.
   DeVries, Trevor J.
   Tucker, Cassandra B.
TI Domestic cattle (Bos taurus taurus) are motivated to obtain forage and
   demonstrate contrafreeloading
SO PLOS ONE
LA English
DT Article
ID SUBACUTE RUMINAL ACIDOSIS; FEED-SORTING BEHAVIOR; LACTATING DAIRY-COWS;
   SHORT-COMMUNICATION; DIET SELECTION; RUMEN FILL; INGESTIVE BEHAVIOR;
   BEEF-CATTLE; TIME; HEIFERS
AB Domestic cattle (Bos taurus taurus) are adapted to digest high-roughage diets, but in confinement they are commonly fed low-roughage, high-energy diets. This practice may leave cattle with an unfulfilled need to consume forage. A way to quantify motivation is to require animals to work to access a resource. Using this method, we evaluated cattle motivation to obtain forage when fed high-or low-roughage diets during and 30 d before the study. Individual heifers were fed Sudan grass (Sorghum x drummondii) hay (high roughage, n = 6) or a diet with 12% forage (as fed, low roughage, n = 6) in an open feed trough. In a second trough, 200 g/d of Sudan grass hay were fed behind a push gate, to which additional weight was added daily until heifers no longer pushed. We predicted heifers would push heavier weights, show a shorter latency, and spend more time pushing the gate when fed a low-vs. high-roughage diet. Indeed, heifers fed a low-roughage diet pushed the gate immediately after hay delivery (1.7 min) and much sooner than those fed a high-roughage diet (75.7 min). On the day before they no longer pushed the gate, latency for heifers in the low-roughage treatment remained only 3.2 min after hay delivery. The suddenness with which they ceased pushing the next day suggests they were unable to move heavier weights to express their motivation. This may explain why maximum weight pushed and time spent pushing the gate did not differ between treatments. The gate pushing by heifers with unrestricted hay access is the first demonstration by cattle of contrafreeloading: performing work to obtain a resource that is simultaneously available for free. In conclusion, consuming forage is important to cattle and is affected by both their primary diet and an internal motivation to work to obtain feed.
C1 [Van Os, Jennifer M. C.; Mintline, Erin M.; Tucker, Cassandra B.] Univ Calif Davis, Dept Anim Sci, Ctr Anim Welf, Davis, CA 95616 USA.
   [DeVries, Trevor J.] Univ Guelph, Dept Anim Biosci, Guelph, ON, Canada.
   [Van Os, Jennifer M. C.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA.
RP Tucker, CB (reprint author), Univ Calif Davis, Dept Anim Sci, Ctr Anim Welf, Davis, CA 95616 USA.
EM cbtucker@ucelavis.edu
OI Van Os, Jennifer/0000-0002-7107-2867
FU United States Department of Agriculture (USDA) [NC 1029]
FX The study was funded by the United States Department of Agriculture
   (USDA) Multistate Research Project NC 1029: Applied Animal Behavior and
   Welfare to CT. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Bean D, 1999, BEHAVIOUR, V136, P1267, DOI 10.1163/156853999500712
   Beauchemin KA, 2008, J DAIRY SCI, V91, P2077, DOI 10.3168/jds.2007-0726
   BELOVSKY GE, 1994, J MAMMAL, V75, P816, DOI 10.2307/1382464
   Chilibroste P, 1997, GRASS FORAGE SCI, V52, P249, DOI 10.1046/j.1365-2494.1997.00072.x
   Cooper MD, 2010, J VET BEHAV, V5, P75, DOI 10.1016/j.jveb.2009.09.045
   Costa JHC, 2016, J DAIRY SCI, V99, P5635, DOI 10.3168/jds.2015-10052
   de Jonge FH, 2008, APPL ANIM BEHAV SCI, V114, P359, DOI 10.1016/j.applanim.2008.03.006
   DeVries TJ, 2008, J DAIRY SCI, V91, P3958, DOI 10.3168/jds.2008-1347
   DeVries TJ, 2014, ANIM PROD SCI, V54, P1238, DOI 10.1071/AN14227
   DeVries TJ, 2014, J ANIM SCI, V92, P1728, DOI 10.2527/jas.2013-7252
   DeVries TJ, 2005, J DAIRY SCI, V88, P625, DOI 10.3168/jds.S0022-0302(05)72726-0
   Forkman B, 1996, BEHAVIOUR, V133, P129, DOI 10.1163/156853996X00071
   Fraser D., 2011, Animal welfare, P183
   Galyean ML, 2003, CAN J ANIM SCI, V83, P13, DOI 10.4141/A02-061
   Gonzalez LA, 2009, J ANIM SCI, V87, P2709, DOI 10.2527/jas.2008-1709
   Gregorini P, 2009, J DAIRY SCI, V92, P2095, DOI 10.3168/jds.2008-1803
   Greter AM, 2015, J DAIRY SCI, V98, P1248, DOI 10.3168/jds.2014-8879
   Hagen K, 2004, APPL ANIM BEHAV SCI, V85, P203, DOI 10.1016/j.applanim.2003.11.007
   Hessle A, 2008, APPL ANIM BEHAV SCI, V111, P108, DOI 10.1016/j.applanim.2007.05.017
   Hessle Anna, 2014, International Journal of Biodiversity Science Ecosystem Services & Management, V10, P334, DOI 10.1080/21513732.2014.968805
   Hollenbeck A.R., 1978, OBSERVING BEHAVIOR, P79
   INGLIS IR, 1986, ANIM BEHAV, V34, P614, DOI 10.1016/S0003-3472(86)80136-1
   Inglis IR, 1997, ANIM BEHAV, V53, P1171, DOI 10.1006/anbe.1996.0320
   James SM, 2002, BRIT J NUTR, V88, P81, DOI 10.1079/BJN2002589
   JENSEN GD, 1963, J EXP PSYCHOL, V65, P451, DOI 10.1037/h0049174
   Kelly AK, 2010, J ANIM SCI, V88, P109, DOI 10.2527/jas.2009-2196
   Keunen JE, 2002, J DAIRY SCI, V85, P3304, DOI 10.3168/jds.S0022-0302(02)74419-6
   Kilgour RJ, 2012, APPL ANIM BEHAV SCI, V138, P1, DOI 10.1016/j.applanim.2011.12.002
   Kirkden RD, 2006, APPL ANIM BEHAV SCI, V100, P29, DOI 10.1016/j.applanim.2006.04.009
   Krause KM, 2006, ANIM FEED SCI TECH, V126, P215, DOI 10.1016/j.anifeedsci.2005.08.004
   Kyriazakis I, 1999, P NUTR SOC, V58, P765, DOI 10.1017/S0029665199001044
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langbein J, 2009, APPL ANIM BEHAV SCI, V120, P150, DOI 10.1016/j.applanim.2009.07.006
   Lindqvist CES, 2002, BEHAVIOUR, V139, P1195, DOI 10.1163/15685390260437335
   Lindstrom T, 2000, APPL ANIM BEHAV SCI, V70, P83, DOI 10.1016/S0168-1591(00)00148-9
   Martin P, 2007, MEASURING BEHAV INTR
   Mason GJ, 2001, NATURE, V410, P35, DOI 10.1038/35065157
   Munksgaard L, 2005, APPL ANIM BEHAV SCI, V92, P3, DOI 10.1016/j.applanim.2004.11.005
   Nagaraja TG, 2007, VET CLIN N AM-FOOD A, V23, P333, DOI 10.1016/j.cvfa.2007.04.002
   NRC, 2001, NUTR REQ DAIR CATTL
   Ogura T, 2011, ANIM COGN, V14, P427, DOI 10.1007/s10071-010-0377-y
   Owens FN, 1998, J ANIM SCI, V76, P275
   PROVENZA FD, 1987, APPL ANIM BEHAV SCI, V18, P211, DOI 10.1016/0168-1591(87)90218-8
   Redbo I, 1997, APPL ANIM BEHAV SCI, V53, P193, DOI 10.1016/S0168-1591(96)01145-8
   REDBO I, 1990, APPL ANIM BEHAV SCI, V26, P57, DOI 10.1016/0168-1591(90)90087-T
   SAS Institute Inc, 2014, SAS STAT 13 2 US GUI
   Schutz KE, 2008, APPL ANIM BEHAV SCI, V114, P307, DOI 10.1016/j.applanim.2008.04.001
   Schutz K, 2006, APPL ANIM BEHAV SCI, V101, P253, DOI 10.1016/j.applanim.2006.02.008
   Sih A, 2001, ANIM BEHAV, V61, P379, DOI 10.1006/anbe.2000.1592
   SINGH D, 1970, J COMP PHYSIOL PSYCH, V73, P320, DOI 10.1037/h0030222
   Spinka M., 2011, ANIM WELFARE, V2, P27, DOI DOI 10.1079/9781845936594.0027
   TARTE RD, 1981, PSYCHOL REP, V49, P859, DOI 10.2466/pr0.1981.49.3.859
   Toaff-Rosenstein RL, 2016, APPL ANIM BEHAV SCI, V181, P49, DOI 10.1016/j.applanim.2016.05.016
   USDA. Feedlot, 2011, 6260313 USDAAPHIS 1
   Van Os JMC, 2017, APPL ANIM BEHAV SCI, V197, P68, DOI 10.1016/j.applanim.2017.09.001
   Webb LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088778
   Weiss WP, 1998, J DAIRY SCI, V81, P830, DOI 10.3168/jds.S0022-0302(98)75641-3
   Wood KM, 2011, ANIM FEED SCI TECH, V165, P23, DOI 10.1016/j.anifeedsci.2011.02.011
NR 58
TC 0
Z9 0
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 7
PY 2018
VL 13
IS 3
AR e0193109
DI 10.1371/journal.pone.0193109
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FY5TA
UT WOS:000426896800038
PM 29513705
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Farhate, CVV
   de Souza, ZM
   Oliveira, SRD
   Tavares, RLM
   Carvalho, JLN
AF Vieira Farhate, Camila Viana
   de Souza, Zigomar Menezes
   de Medeiros Oliveira, Stanley Robson
   Moraes Tavares, Rose Luiza
   Nunes Carvalho, Joao Luis
TI Use of data mining techniques to classify soil CO2 emission induced by
   crop management in sugarcane field
SO PLOS ONE
LA English
DT Article
ID CHEMICAL-PROPERTIES; REDUCED TILLAGE; RESPIRATION; TEMPERATURE
AB Soil CO2 emissions are regarded as one of the largest flows of the global carbon cycle and small changes in their magnitude can have a large effect on the CO2 concentration in the atmosphere. Thus, a better understanding of this attribute would enable the identification of promoters and the development of strategies to mitigate the risks of climate change. Therefore, our study aimed at using data mining techniques to predict the soil CO2 emission induced by crop management in sugarcane areas in Brazil. To do so, we used different variable selection methods (correlation, chi-square, wrapper) and classification (Decision tree, Bayesian models, neural networks, support vector machine, bagging with logistic regression), and finally we tested the efficiency of different approaches through the Receiver Operating Characteristic (ROC) curve. The original dataset consisted of 19 variables (18 independent variables and one dependent (or response) variable). The association between cover crop and minimum tillage are effective strategies to promote the mitigation of soil CO2 emissions, in which the average CO2 emissions are 63 kg ha(-1) day(-1). The variables soil moisture, soil temperature (Ts), rainfall, pH, and organic carbon were most frequently selected for soil CO2 emission classification using different methods for attribute selection. According to the results of the ROC curve, the best approaches for soil CO2 emission classification were the following: (I) the Multilayer Perceptron classifier with attribute selection through the wrapper method, that presented rate of false positive of 13,50%, true positive of 94,20% area under the curve (AUC) of 89,90% (II) the Bagging classifier with logistic regression with attribute selection through the Chi-square method, that presented rate of false positive of 13,50%, true positive of 94,20% AUC of 89,90%. However, the (I) approach stands out in relation to (II) for its higher positive class accuracy (high CO2 emission) and lower computational cost.
C1 [Vieira Farhate, Camila Viana; de Souza, Zigomar Menezes; de Medeiros Oliveira, Stanley Robson] Univ Estadual Campinas, Sch Agr Engn, Campinas, SP, Brazil.
   [de Medeiros Oliveira, Stanley Robson] Brazilian Agr Res Corp Embrapa Campinas, Agr Informat Computat Intelligence Lab, Sao Paulo, Brazil.
   [Moraes Tavares, Rose Luiza] Univ Rio Verde, Dept Soil, Rio Verde, Go, Brazil.
   [Nunes Carvalho, Joao Luis] Brazilian Ctr Res Energy & Mat, Brazilian Bioethanol Sci & Technol Lab, Campinas, SP, Brazil.
RP Farhate, CVV (reprint author), Univ Estadual Campinas, Sch Agr Engn, Campinas, SP, Brazil.
EM camila.vieira@feagri.unicamp.br
RI Farhate, Camila/H-2151-2018
OI Farhate, Camila/0000-0002-5027-9295; Souza, Zigomar Menezes
   de/0000-0001-9302-6725
CR Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Corradi MM, 2013, ENG AGR-JABOTICABAL, V33, P699, DOI 10.1590/S0100-69162013000400009
   de Figueiredo EB, 2015, GCB BIOENERGY, V7, P316, DOI 10.1111/gcbb.12151
   DEXTER AR, 1985, J AGR ENG RES, V31, P139, DOI 10.1016/0021-8634(85)90066-6
   Duda R. O., 1973, PATTERN CLASSIFICATI
   Elisabeth M, 2011, MANUAL ANALISE SOLOS
   EMBRAPA - EMPRESA BRASILEIRA DE PESQUISA AGROPECUARIA, 2013, SISTEMA BRASILEIRO C
   Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010
   Freitas LPS, 2016, AN 14 INT C ENG TECH
   Fuentes JP, 2006, SOIL TILL RES, V88, P123, DOI 10.1016/j.still.2005.05.001
   Fuentes M, 2012, PLANT SOIL, V355, P183, DOI 10.1007/s11104-011-1092-4
   Galvao ND, 2009, ACTA PAUL ENFERM, V22, P686, DOI 10.1590/S0103-21002009000500014
   Hall M. A., 1998, CORRELATION BASED FE
   Hall MA, 2003, IEEE T KNOWL DATA EN, V15, P1437, DOI 10.1109/TKDE.2003.1245283
   Han J, 2012, MOR KAUF D, P1
   Iamaguti JL, 2015, REV BRAS ENG AGR AMB, V19, P497, DOI 10.1590/1807-1929/agriambi.v19n5p497-504
   Karhu K, 2014, NATURE, V513, P81, DOI 10.1038/nature13604
   Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493
   Kemper W.D., 1965, METHODS SOIL ANAL 1
   Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X
   La Scala N, 2000, SOIL BIOL BIOCHEM, V32, P1469, DOI 10.1016/S0038-0717(00)00053-5
   La Scala N, 2006, SOIL TILL RES, V91, P244, DOI 10.1016/j.still.2005.11.012
   Lal R, 2009, EUR J SOIL SCI, V60, P158, DOI 10.1111/j.1365-2389.2008.01114.x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liu H, 2005, IEEE T KNOWL DATA EN, V17, P491, DOI 10.1109/TKDE.2005.66
   Lu XL, 2016, SOIL RES, V54, P38, DOI 10.1071/SR14300
   Marcelo AV, 2012, REV BRAS CIENC SOLO, V36, P45, DOI 10.1590/S0100-06832012000100005
   MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468
   Moitinho MR, 2015, SOIL TILL RES, V148, P127, DOI 10.1016/j.still.2014.12.012
   Moitinho MR, 2013, REV BRAS CIENC SOLO, V37, P1720, DOI 10.1590/S0100-06832013000600028
   Tavares RLM, 2016, SCI AGR, V73, P543, DOI 10.1590/0103-9016-2015-0174
   Panosso A. R., 2006, Cientifica (Jaboticabal), V34, P257
   Park SH, 2004, KOREAN J RADIOL, V5, P11, DOI 10.3348/kjr.2004.5.1.11
   Paustian L, 2016, AN C P 1 NAT C CARB
   Prati RC, 2008, IEEE AM LATINA, V6, P1
   Quinlan R., 1993, C4 5 PROGRAMS MACHIN
   Raij B. V, 2001, ANALISE QUIMICA AVAL
   Reuss JODW, 1986, ECOLOGICAL STUDIES
   Torres JLR, 2015, REV BRAS CIENC SOLO, V39, P428, DOI 10.1590/01000683rbcs20140597
   Rustad LE, 2000, BIOGEOCHEMISTRY, V48, P1, DOI 10.1023/A:1006255431298
   Sierra CA, 2015, J ADV MODEL EARTH SY, V7, P335, DOI 10.1002/2014MS000358
   Silva-Olaya AM, 2012, ENVIRON RES LETT, V8, P1
   Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347
   Soil Survey Staff, 2014, KEYS SOIL TAX
   STOLF R, 1991, REV BRASILEIRA CIENC, V15, P229, DOI DOI 10.1590/S0100-06832014000300009
   Tanveer SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072140
   Teixeira LG, 2010, ENG AGR-JABOTICABAL, V30, P224, DOI 10.1590/S0100-69162010000200004
   Teixeira LG, 2013, SCI AGR, V70, P327, DOI 10.1590/S0103-90162013000500007
   Tossell JA, 2009, ENVIRON SCI TECHNOL, V43, P2575, DOI 10.1021/es802393s
   Ussiri DAN, 2009, SOIL TILL RES, V104, P39, DOI 10.1016/j.still.2008.11.008
   VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P697, DOI 10.1016/0038-0717(87)90051-4
   Vincent G, 2006, SOIL BIOL BIOCHEM, V38, P2527, DOI 10.1016/j.soilbio.2006.03.009
   Witten IH, 2011, MOR KAUF D, P3, DOI 10.1016/B978-0-12-374856-0.00001-8
   Zanatta JA, 2014, PROTOCOLO MED FLUXOS
NR 54
TC 2
Z9 2
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 7
PY 2018
VL 13
IS 3
AR e0193537
DI 10.1371/journal.pone.0193537
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FY5TA
UT WOS:000426896800063
PM 29513765
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Clow, KM
   Ogden, NH
   Lindsay, LR
   Russell, CB
   Michel, P
   Pearl, DL
   Jardine, CM
AF Clow, Katie M.
   Ogden, Nicholas H.
   Lindsay, L. Robbin
   Russell, Curtis B.
   Michel, Pascal
   Pearl, David L.
   Jardine, Claire M.
TI A field-based indicator for determining the likelihood of Ixodes
   scapularis establishment at sites in Ontario, Canada
SO PLOS ONE
LA English
DT Article
ID AMBLYOMMA-AMERICANUM ACARI; LYME-DISEASE RISK; BORRELIA-BURGDORFERI;
   PASSIVE SURVEILLANCE; LONG POINT; ANAPLASMA-PHAGOCYTOPHILUM;
   RELATIVE-HUMIDITY; RANGE EXPANSION; IXODIDAE; HABITAT
AB The emergence of the vector Ixodes scapularis in Ontario, Canada poses a significant public health risk. Both passive and active surveillance approaches have been employed by public health professionals (i.e., government employees) to monitor for the range expansion of this tick. Field surveillance using drag sampling for questing ticks is a recognized and effective method to identify reproducing tick populations. The degree of effort (i.e., number of visits per site) can enhance the sensitivity and specificity of surveillance, but increased effort conflicts with the cost to public health for field surveillance. Here we developed an indicator to determine the likelihood of I. scapularis establishment based on field sampling results. Field data from two established populations of I. scapularis in Ontario were incorporated with previous analyses of surveillance data to create the indicator, which is in the form of a scoring system. The life stage(s) collected, overall abundance and past surveillance findings from a site are all considered and a level is assigned for the likelihood of I. scapularis establishment based on current field sampling results. The likelihood levels are non-zero (i.e., no I. scapularis detected, but risk still present due to adventitious ticks), low, medium or high, and recommendations for future surveillance and public health measures are provided. The indicator was validated against field sampling results from five other established sites in the province and correctly categorized all five areas as high likelihood of establishment. The indicator was also applied to field sampling results from 36 sites of unknown status that were visited twice during the period of 2014-2016. There was substantial agreement of levels between measurements, as calculated using a weighted kappa. The indicator can assist public health professionals with the interpretation of field sampling results and direct their efforts for ongoing surveillance and public health interventions for I. scapularis-borne diseases, including Lyme disease.
C1 [Clow, Katie M.; Jardine, Claire M.] Univ Guelph, Dept Pathobiol, Ontario Vet Coll, Guelph, ON, Canada.
   [Ogden, Nicholas H.] Publ Hlth Agcy Canada, Natl Microbiol Lab, St Hyacinthe, PQ, Canada.
   [Lindsay, L. Robbin] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.
   [Russell, Curtis B.] Publ Hlth Ontario, Enter Zoonot & Vector Borne Dis, Communicable & Infect Dis Prevent & Control, Toronto, ON, Canada.
   [Michel, Pascal] Publ Hlth Agcy Canada, Off Chief Sci Officer, Ottawa, ON, Canada.
   [Pearl, David L.] Univ Guelph, Dept Populat Med, Ontario Vet Coll, Guelph, ON, Canada.
   [Jardine, Claire M.] Univ Guelph, Ontario Vet Coll, Canadian Wildlife Hlth Cooperat, Guelph, ON, Canada.
RP Clow, KM (reprint author), Univ Guelph, Dept Pathobiol, Ontario Vet Coll, Guelph, ON, Canada.
EM kclow@uoguelph.ca
FU Public Health Agency of Canada; Natural Sciences and Engineering
   Research Council; Canadian Wildlife Health Cooperative; Ontario
   Veterinary College Fellowship; Blake Graham Fellowship
FX This work was supported by the Public Health Agency of Canada,
   www.phac-aspc.gc.ca; Natural Sciences and Engineering Research Council,
   http://www.nserc-crsng.gc.ca; Canadian Wildlife Health Cooperative,
   www.cwhc-rcsf.ca. KMC received stipend support from an Ontario
   Veterinary College Fellowship, a PostGraduate Scholarship-Doctoral from
   the Natural Sciences and Engineering Research Council and a Blake Graham
   Fellowship. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript. NHO,
   LRL and PM are all employees of the PHAC and CMJ is affiliated with
   CWHC, but they were not directly instructed by the funders.
CR [Anonymous], 1991, Can J Infect Dis, V2, P49
   Artsob H., 2016, HDB TICKS CANADA IXO
   Berger KA, 2014, J MED ENTOMOL, V51, P769, DOI 10.1603/ME13186
   Clow KM, 2017, TICKS TICK-BORNE DIS, V8, P554, DOI 10.1016/j.ttbdis.2017.03.003
   Clow KM, 2016, VECTOR-BORNE ZOONOT, V16, P215, DOI 10.1089/vbz.2015.1890
   Courtney JW, 2004, J CLIN MICROBIOL, V42, P3164, DOI 10.1128/JCM.42.7.3164-3168.2004
   Dibernardo A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-183
   Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395
   Dobson ADM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-344
   Dohoo I, 2009, VET EPIDEMIOLOGIC RE
   Koffi JK, 2012, J MED ENTOMOL, V49, P400, DOI 10.1603/ME11210
   Kulkarni MA, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.33
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x
   Lindsay LR, 1999, J MED ENTOMOL, V36, P255, DOI 10.1093/jmedent/36.3.255
   Lindsay LR, 1998, J MED ENTOMOL, V35, P189, DOI 10.1093/jmedent/35.3.189
   Lindsay LR, 1999, J MED ENTOMOL, V36, P243, DOI 10.1093/jmedent/36.3.243
   May RM, 2001, PHILOS T ROY SOC B, V356, P901, DOI 10.1098/rstb.2001.0866
   McPherson M, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/EHP57, 10.1289/ehp57]
   Nakajima R, 2009, J VET MED SCI, V71, P55, DOI 10.1292/jvms.71.55
   Nelder MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105358
   Ogden N, 2014, CAN COMMUN DIS REP, V40
   Ogden NH, 2008, APPL ENVIRON MICROB, V74, P1780, DOI 10.1128/AEM.01982-07
   Ogden NH, 2006, J MED ENTOMOL, V43, P600, DOI 10.1603/0022-2585(2006)43[600:ISTCBP]2.0.CO;2
   Ogden NH, 2007, PARASITOLOGY, V134, P209, DOI 10.1017/S0031182006001417
   Ogden N H, 2014, Can Commun Dis Rep, V40, P74
   Ogden NH, 2004, J MED ENTOMOL, V41, P622, DOI 10.1603/0022-2585-41.4.622
   Ogden NH, 2006, J MED ENTOMOL, V43, P403, DOI 10.1603/0022-2585(2006)043[0403:IOGLAR]2.0.CO;2
   Ogden NH, 2015, CAN COMMUN DIS REP, V41, P1
   Ogden NH, 2013, J APPL ECOL, V50, P510, DOI [10.1111/, 10.1111/1365-2664.12050]
   Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766
   Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2016, ONT LYM DIS MAP EST
   Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2015, ACT TICK DRAGG STAND
   SCHOLTEN T, 1977, CAN J PUBLIC HEALTH, V68, P494
   Schulze TL, 2005, J MED ENTOMOL, V42, P285, DOI 10.1603/0022-2585(2005)042[0285:IOMAMH]2.0.CO;2
   Schulze TL, 2001, ENVIRON ENTOMOL, V30, P568, DOI 10.1603/0046-225X-30.3.568
   Sider D, 2012, TECHNICAL REPORT
   Vail SG, 2002, J MED ENTOMOL, V39, P842, DOI 10.1603/0022-2585-39.6.842
NR 38
TC 1
Z9 1
U1 3
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 27
PY 2018
VL 13
IS 2
AR e0193524
DI 10.1371/journal.pone.0193524
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FX7BV
UT WOS:000426242400020
PM 29486007
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Sasaki, E
   Sasaki, S
   Chiba, D
   Yamamoto, Y
   Nawata, A
   Tsuda, E
   Nakaji, S
   Ishibashi, Y
AF Sasaki, Eiji
   Sasaki, Shizuka
   Chiba, Daisuke
   Yamamoto, Yuji
   Nawata, Atsushi
   Tsuda, Eiichi
   Nakaji, Shigeyuki
   Ishibashi, Yasuyuki
TI Age-related reduction of trunk muscle torque and prevalence of trunk
   sarcopenia in community-dwelling elderly: Validity of a portable trunk
   muscle torque measurement instrument and its application to a large
   sample cohort study
SO PLOS ONE
LA English
DT Article
ID LOW-BACK-PAIN; ISOKINETIC TRUNK; SKELETAL-MUSCLE; KNEE OSTEOARTHRITIS;
   EXTENSION EFFORT; LUMBAR FUNCTION; ISO-MACHINES; JAPANESE MEN; STRENGTH;
   QUANTIFICATION
AB Trunk muscle weakness and imbalance are risk factors for postural instability, low back pain, and poor postoperative outcomes. The association between trunk muscle strength and aging is poorly understood, and establishing normal reference values is difficult. We aimed to establish the validity of a novel portable trunk muscle torque measurement instrument (PTMI). We then estimated reference data for healthy young adults and elucidated age-related weakness in trunk muscle strength. Twenty-four university students were enrolled to validate values for PTMI, and 816 volunteers from the general population who were recruited to the Iwaki Health Promotion Project were included to estimate reference data for trunk muscle strength. Trunk flexion and extension torque were measured with PTMI and KinCom, and interclass correlation coefficients (ICC) were estimated to evaluate the reliability of PTMI values. Furthermore, from the young adult reference, the age-related reduction in trunk muscle torque and the prevalence of sarcopenia among age-sex groups were estimated. The ICC in flexion and extension torque were 0.807 (p<0.001) and 0.789 (p<0.001), respectively. The prevalence of sarcopenia increased with age, and the prevalence due to flexion torque was double that of extension torque. Flexion torque decreased significantly after 60 years of age, and extension torque decreased after 70 years of age. In males over age 80, trunk muscle torque decreased to 49.1% in flexion and 63.5% in extension. In females over age 80, trunk muscle torque decreased to 60.7% in flexion and 68.4% in extension. The validity of PTMI was confirmed by correlation with KinCom. PTMI produced reference data for healthy young adults, and demonstrated age-related reduction in trunk muscle torque. Trunk sarcopenia progressed with aging, and the loss of flexion torque began earlier than extension torque. At age 80, trunk muscle torque had decreased 60% compared with healthy young adults.
C1 [Sasaki, Eiji; Sasaki, Shizuka; Chiba, Daisuke; Yamamoto, Yuji; Tsuda, Eiichi; Ishibashi, Yasuyuki] Hirosaki Univ, Grad Sch Med, Dept Orthoped Surg, Hirosaki, Aomori, Japan.
   [Sasaki, Eiji; Nakaji, Shigeyuki] Hirosaki Univ, Grad Sch Med, Dept Social Med, Hirosaki, Aomori, Japan.
   [Nawata, Atsushi] ALCARE Co Ltd, Med Engn Lab, Tokyo, Japan.
RP Sasaki, E (reprint author), Hirosaki Univ, Grad Sch Med, Dept Orthoped Surg, Hirosaki, Aomori, Japan.; Sasaki, E (reprint author), Hirosaki Univ, Grad Sch Med, Dept Social Med, Hirosaki, Aomori, Japan.
EM e_sasaki@hirosaki-u.ac.jp
OI Sasaki, Eiji/0000-0002-4859-8473
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [18200044]; Japanese Society for the Promotion of Science [21500676];
   Japanese Orthopaedic Association subsidized Science Project Research
   grant from the Japanese Orthopaedic Association
FX This study was supported in part by some projects: 1. The Ministry of
   Education, Culture, Sports, Science and Technology of Japan (No.
   18200044), https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-18200044/.
   S.N. received this fund. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. 2. The Japanese Society for the Promotion of Science (No.
   21500676), https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-21500676/.
   Y.I. received this fund. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. 3. The Japanese Orthopaedic Association subsidized Science
   Project Research grant from the Japanese Orthopaedic Association,
   https://www.joa.or.jp/. Y.I. received this fund. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript. 4. The Ministry of Education, Culture,
   Sports, Science and Technology of Japan (18200044 to Shigeyuki Nakaji).
   The author A.N. was employed by commercial company: Medical Engineering
   Laboratory, ALCARE Co., Ltd., Tokyo, Japan. However, the funding
   organization did not play a role in the study design, data collection
   and analysis, decision to publish, or preparation of the manuscript. The
   funding organization of A.N. only provided financial support in the form
   of A.N.s salaries and research materials. The specific roles of A.N. was
   articulated in the ideas, data collection, development of methodology,
   provision of study materials, programming and manuscript preparation.
CR Abe T, 2014, AGE, V36, P813, DOI 10.1007/s11357-013-9600-5
   Abe T, 2014, AGE, V36, P417, DOI 10.1007/s11357-013-9539-6
   Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755
   BRADY S, 1994, SPINE, V19, P395, DOI 10.1097/00007632-199402001-00002
   Chan DB, 1978, J OCCUP MED, V20, P403
   Chang MS, 2014, SPINE, V39, pE35, DOI 10.1097/BRS.0000000000000067
   Chiba D, 2016, J ORTHOP SCI, V21, P366, DOI 10.1016/j.jos.2016.02.006
   Chien MY, 2008, J AM GERIATR SOC, V56, P1710, DOI 10.1111/j.1532-5415.2008.01854.x
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   Davis KG, 2000, CLIN BIOMECH, V15, P703, DOI 10.1016/S0268-0033(00)00035-8
   Deutz NEP, 2013, CLIN NUTR, V32, P704, DOI 10.1016/j.clnu.2013.02.011
   Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3
   Dvir Z, 2003, SPINE, V28, P685, DOI 10.1097/00007632-200304010-00012
   Dvir Z, 2001, SPINE, V26, P1046, DOI 10.1097/00007632-200105010-00011
   FARRELL M, 1986, MED SCI SPORT EXER, V18, P44
   Frontera WR, 2000, J APPL PHYSIOL, V88, P1321
   HAZARD RG, 1988, SPINE, V13, P54, DOI 10.1097/00007632-198801000-00013
   Hirano K, 2012, J ORTHOP SCI, V17, P532, DOI 10.1007/s00776-012-0266-0
   Imagama S, 2013, EUR SPINE J, V22, P1346, DOI 10.1007/s00586-013-2721-9
   Imagama S, 2011, EUR SPINE J, V20, P954, DOI 10.1007/s00586-010-1606-4
   Iorio JA, 2016, CURR REV MUSCULOSKE, V9, P290, DOI 10.1007/s12178-016-9350-y
   Jang YC, 2011, EXP GERONTOL, V46, P193, DOI 10.1016/j.exger.2010.08.029
   Kasukawa Y, 2010, J BONE MINER METAB, V28, P82, DOI 10.1007/s00774-009-0107-1
   Kim HJ, 2006, EUR SPINE J, V15, P409, DOI 10.1007/s00586-005-0976-5
   Kortebein P, 2007, JAMA-J AM MED ASSOC, V297, P1772, DOI 10.1001/jama.297.16.1772-b
   Kumagai G, 2014, J ORTHOP SCI, V19, P390, DOI 10.1007/s00776-014-0549-8
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LEAMON TB, 1994, ERGONOMICS, V37, P1959, DOI 10.1080/00140139408964960
   Liu LK, 2013, GERIATR GERONTOL INT, V13, P964, DOI 10.1111/ggi.12040
   MARRAS WS, 1995, SPINE, V20, P2531, DOI 10.1097/00007632-199512000-00013
   MAYER TG, 1985, SPINE, V10, P765, DOI 10.1097/00007632-198510000-00012
   MCGILL SM, 1992, J BIOMECH, V25, P395, DOI 10.1016/0021-9290(92)90259-4
   Mentiplay BF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140822
   Ministry of Health Labour and Welfare, 2014, OUTL RES NAT LIV SUR
   NEWTON M, 1993, SPINE, V18, P812, DOI 10.1097/00007632-199306000-00002
   NEWTON M, 1993, SPINE, V18, P801, DOI 10.1097/00007632-199306000-00001
   Numasawa T, 2012, SPINE, V37, P108, DOI 10.1097/BRS.0b013e31821041f8
   Omori G, 2016, J ORTHOP SCI, V21, P463, DOI 10.1016/j.jos.2016.03.006
   Omori G, 2013, J ORTHOP SCI, V18, P536, DOI 10.1007/s00776-013-0383-4
   Pearce GL, 2010, OSTEOARTHR CARTILAGE, V18, pS117, DOI 10.1016/j.joca.2010.04.014
   Renkawitz Tobias, 2006, Spine J, V6, P673, DOI 10.1016/j.spinee.2006.03.012
   Sasaki E, 2013, INT ORTHOP, V37, P925, DOI 10.1007/s00264-013-1849-x
   SHIRADO O, 1992, J SPINAL DISORD, V5, P175, DOI 10.1097/00002517-199206000-00005
   SMIDT G, 1983, SPINE, V8, P211, DOI 10.1097/00007632-198303000-00014
   SMITH SS, 1985, SPINE, V10, P757, DOI 10.1097/00007632-198510000-00011
   Tanimoto Y, 2014, ARCH GERONTOL GERIAT, V59, P295, DOI 10.1016/j.archger.2014.04.016
   Tarnanen S, 2013, DISABIL REHABIL, V35, P134, DOI 10.3109/09638288.2012.690496
   Tudorascu I, 2014, ROM J MORPHOL EMBRYO, V55, P1295
   Wall BT, 2013, AGEING RES REV, V12, P898, DOI 10.1016/j.arr.2013.07.003
   Yahia A, 2011, JOINT BONE SPINE, V78, P291, DOI 10.1016/j.jbspin.2010.09.008
NR 50
TC 1
Z9 1
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 22
PY 2018
VL 13
IS 2
AR e0192687
DI 10.1371/journal.pone.0192687
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FX1SB
UT WOS:000425831000017
PM 29471310
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Cassol, H
   Petre, B
   Degrange, S
   Martial, C
   Charland-Verville, V
   Lallier, F
   Bragard, I
   Guillaume, M
   Laureys, S
AF Cassol, Helena
   Petre, Benoit
   Degrange, Sophie
   Martial, Charlotte
   Charland-Verville, Vanessa
   Lallier, Francois
   Bragard, Isabelle
   Guillaume, Michele
   Laureys, Steven
TI Qualitative thematic analysis of the phenomenology of near-death
   experiences
SO PLOS ONE
LA English
DT Article
ID CARDIAC-ARREST; HEALTH-CARE; SURVIVORS; FEATURES; STATE
AB Near-death experiences (NDEs) refer to profound psychological events that can have an important impact on the experiencers' (NDErs) lives. Previous studies have shown that NDEs memories are phenomenologically rich. In the present study, we therefore aimed to extract the common themes (referred to as "features" in the NDE literature) reported by NDErs by analyzing all the concepts stored in the narratives of their experiences. A qualitative thematic analysis has been carried out on 34 cardiac arrest survivors' NDE narratives. Our results shed the light on the structure of the narratives by identifying 10 "time-bounded" themes which refer to isolated events encountered during the NDE and 1 "transversal" theme which characterizes the whole narrative and generally appears as a retrospective comment of self-reflection on the experience. The division of narratives into themes provides us with detailed information about the vocabulary used by NDErs to describe their experience. This established thematic method enables a rigorous description of the phenomenon, ensuring the inclusion of all self-reported manifestations of themes in narratives.
C1 [Cassol, Helena; Martial, Charlotte; Charland-Verville, Vanessa; Laureys, Steven] Univ Liege, GIGA Consciousness, Coma Sci Grp, Liege, Belgium.
   [Cassol, Helena; Martial, Charlotte; Charland-Verville, Vanessa; Laureys, Steven] Univ Hosp Liege, Liege, Belgium.
   [Petre, Benoit; Degrange, Sophie; Bragard, Isabelle; Guillaume, Michele] Univ Liege, Dept Publ Hlth, Liege, Belgium.
   [Lallier, Francois] Univ Reims, Dept Family Med, Reims, France.
RP Cassol, H (reprint author), Univ Liege, GIGA Consciousness, Coma Sci Grp, Liege, Belgium.; Cassol, H (reprint author), Univ Hosp Liege, Liege, Belgium.
EM coma@chu.ulg.ac.be
RI Martial, Charlotte/M-9999-2019
OI Martial, Charlotte/0000-0001-6291-3460; laureys,
   steven/0000-0002-3096-3807
FU University Hospital of Liege; Belgian National Funds for Scientific
   Research (FRS-FNRS); European Commission; Luminous [686764]; Center-TBI
   [602150]; Human Brain Project [720270]; James McDonnell Foundation
   [15040574-08]; European Space Agency [C4000105971]; Belspo; Fondazione
   Europea di Ricerca Biomedica; BIAL Foundation [503 323 055]; Wallonia
   Brussels Federation Concerted Research Action [ARC 12/17/01]; Mind
   Science Foundation
FX This research was funded by University and University Hospital of Liege
   (http://www.ulg.ac.be/), the Belgian National Funds for Scientific
   Research (FRS-FNRS) (http://www.fnrs.be/), the European Commission
   (https://ec.europa.eu/), Luminous (grant number: 686764; http://www.
   luminous-project.eu/), Center-TBI (grant number: 602150;
   https://www.center-tbi.eu/), Human Brain Project (grant number: 720270;
   https://www. humanbrainproject.eu/), the James McDonnell Foundation
   (grant number: 15040574-08; https://www.jsmf.org/), the European Space
   Agency (grant number: C4000105971; http://www.esa.int/ESA), Belspo
   (http://www.belspo.be/), the "Fondazione Europea di Ricerca Biomedica"
   (http://www.ferbonlus.com/), the BIAL Foundation (grant number: 503 323
   055; https://www.bial.com/), the Wallonia Brussels Federation Concerted
   Research Action (grant number: ARC 12/17/01), and the Mind Science
   Foundation (https://www. mindscence.org/). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Beauregard M, 2009, RESUSCITATION, V80, P1006, DOI 10.1016/j.resuscitation.2009.05.006
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI DOI 10.1191/1478088706QP0630A
   CHARLANDVERVILLE V, 2014, FRONT HUM NEUROSCI, V8
   Facco E, 2015, MED HYPOTHESES, V85, P85, DOI 10.1016/j.mehy.2015.04.004
   Gabbard G., 1991, J NEAR DEATH STUD, V10, P41, DOI [DOI 10.1007/BF01073295, 10.1007/BF01073295]
   Gabbard G. o., 1981, DO NEAR DEATH EXPERI, V169, P374
   Grayson B., 1987, J NEAR DEATH STUDIES, V6, P41, DOI DOI 10.1007/BF01073267
   GREYSON B, 1992, PSYCHIATRY, V55, P95
   Greyson B, 2003, GEN HOSP PSYCHIAT, V25, P269, DOI 10.1016/S0163-8343(03)00042-2
   GREYSON B, 1983, J NERV MENT DIS, V171, P369, DOI 10.1097/00005053-198306000-00007
   Greyson B, VARIETIES ANOMALOUS
   Greyson B, 2007, RESUSCITATION, V73, P407, DOI 10.1016/j.resuscitation.2006.10.013
   Hou YM, 2013, ANN INDIAN ACAD NEUR, V16, P75, DOI 10.4103/0972-2327.107715
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lange R, 2004, BRIT J PSYCHOL, V95, P161, DOI 10.1348/000712604773952403
   Lange R., 2015, PSYCHOL CONSCIOUSNES, V2, P79
   LEMPERT T, 1994, ANN NEUROL, V36, P233, DOI 10.1002/ana.410360217
   Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6
   Martial C, 2017, CONSCIOUS C IN PRESS
   Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50
   Miles Matthew B, 1994, QUALITATIVE DATA ANA
   Moody R. A., 1975, LIFE LIFE
   Moore LE, 2017, CONSCIOUS COGN, V51, P116, DOI 10.1016/j.concog.2017.03.003
   Nelson KR, 2006, NEUROLOGY, V66, P1003, DOI 10.1212/01.wnl.0000204296.15607.37
   OWENS JE, 1990, LANCET, V336, P1175, DOI 10.1016/0140-6736(90)92780-L
   Palmieri A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00429
   Parnia S, 2001, RESUSCITATION, V48, P149, DOI 10.1016/S0300-9572(00)00328-2
   Pope C, 2002, QUAL SAF HEALTH CARE, V11, P148, DOI 10.1136/qhc.11.2.148
   Pope C, 2006, QUALITATIVE RES
   Ring K, 1980, LIFE AT DEATH A SCIE
   Schwaninger J., 2002, J NEAR DEATH STUD, V20, P215, DOI [10.1023/A:1015258818660, DOI 10.1023/A:1015258818660]
   Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031
   Thonnard M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057620
   Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042
   van Lommel P, 2001, LANCET, V358, P2039, DOI 10.1016/S0140-6736(01)07100-8
NR 35
TC 6
Z9 6
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 14
PY 2018
VL 13
IS 2
AR e0193001
DI 10.1371/journal.pone.0193001
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FW3CM
UT WOS:000425183500107
PM 29444184
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lamas, L
   Drezner, R
   Otranto, G
   Barrera, J
AF Lamas, Leonardo
   Drezner, Rene
   Otranto, Guilherme
   Barrera, Junior
TI Analytic method for evaluating players' decisions in team sports:
   Applications to the soccer goalkeeper
SO PLOS ONE
LA English
DT Article
ID MINIMAX PLAY; ANTICIPATION; PERFORMANCE
AB The aim of this study was to define a method for evaluating a player's decisions during a game based on the success probability of his actions and for analyzing the player strategy inferred from game actions. There were developed formal definitions of i) the stochastic process of player decisions in game situations and ii) the inference process of player strategy based on his game decisions. The method was applied to the context of soccer goalkeepers. A model of goalkeeper positioning, with geometric parameters and solutions to optimize his position based on the ball position and trajectory, was developed. The model was tested with a sample of 65 professional goalkeepers (28.8-4.1 years old) playing for their national teams in 2010 and 2014 World Cups. The goalkeeper's decisions were compared to decisions from a large dataset of other goalkeepers, defining the probability of success in each game circumstance. There were assessed i) performance in a defined set of classes of game plays; ii) entropy of goalkeepers' decisions; and iii) the effect of goalkeepers' positioning updates on the outcome (save or goal). Goalkeepers' decisions were similar to the ones with the lowest probability of goal on the dataset. Goalkeepers' entropy varied between 24% and 71% of the maximum possible entropy. Positioning dynamics in the instants that preceded the shot indicated that, in goals and saves, goalkeepers optimized their position before the shot in 21.87% and 83.33% of the situations, respectively. These results validate a method to discriminate successful performance. In conclusion, this method enables a more precise assessment of a player's decision-making ability by consulting a representative dataset of equivalent actions to define the probability of his success. Therefore, it supports the evaluation of the player's decision separately from his technical skill execution, which overcomes the scientific challenge of discriminating the evaluation of a player's decision performance from the action result.
C1 [Lamas, Leonardo] Univ Brasilia, Fac Phys Educ, Brasilia, DF, Brazil.
   [Drezner, Rene] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, SP, Brazil.
   [Otranto, Guilherme; Barrera, Junior] Univ Sao Paulo, Inst Math & Stat, Sao Paulo, SP, Brazil.
RP Lamas, L (reprint author), Univ Brasilia, Fac Phys Educ, Brasilia, DF, Brazil.
EM llamas@unb.br
FU Sao Paulo Research Foundation [2015/01587-0]; Conselho Nacional de
   Pesquisa [306442/2011-6]
FX This work received support from the following sources: JB received
   funding from Sao Paulo Research Foundation (2015/01587-0).
   http://www.fapesp.br/en/ and Conselho Nacional de Pesquisa
   (306442/2011-6). http://cnpq.br/ The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Cervone D, 2014, P 8 MIT SLOAN SPORTS
   De Baranda PS, 2008, EUR J SPORT SCI, V8, P127, DOI 10.1080/17461390801919045
   Denardi RA, 2017, INT J PERF ANAL SPOR, V17, P442, DOI 10.1080/24748668.2017.1350450
   Duarte R, 2012, SPORTS MED, V42, P633, DOI 10.2165/11632450-000000000-00000
   Emara N., 2014, MINIMAX GRIDIRON SER
   Essig S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053201
   Furley P, 2017, J SPORT SCI, V35, P873, DOI 10.1080/02640414.2016.1195912
   Gonzalez-Villora S, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1462-0
   Hsu SH, 2007, AM ECON REV, V97, P517, DOI 10.1257/aer.97.1.517
   Kovash K, 2009, 15347 NAT BUR EC RES
   Lamas L, 2014, P 20 SIGKDD C WORKSH
   Lamas L, 2014, INT J PERF ANAL SPOR, V14, P307
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lennartsson J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125453
   O'Donoghue P., 2007, INT J PERF ANAL SPOR, V7, P35, DOI DOI 10.1080/24748668.2007.11868386
   Palacios-Huerta I, 2003, REV ECON STUD, V70, P395, DOI 10.1111/1467-937X.00249
   Pollard R, 1997, J ROY STAT SOC D-STA, V46, P541
   Pollard R, 2004, INT J SOCCER SCI, V2, P50
   Savelsbergh GJP, 2010, INT J SPORT PSYCHOL, V41, P24
   Shafizadeh M, 2016, J SPORT SCI, V34, P1596, DOI 10.1080/02640414.2015.1125011
   SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x
   Vilar L, 2014, HUM MOVEMENT SCI, V33, P14, DOI 10.1016/j.humov.2013.08.012
   Vilar L, 2012, SPORTS MED, V42, P1, DOI 10.2165/11596520-000000000-00000
   Walker M, 2001, AM ECON REV, V91, P1521, DOI 10.1257/aer.91.5.1521
   Williams AM, 2004, J APPL SPORT PSYCHOL, V16, P350, DOI 10.1080/10413200490518002
NR 25
TC 1
Z9 1
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 6
PY 2018
VL 13
IS 2
AR e0191431
DI 10.1371/journal.pone.0191431
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FV1EC
UT WOS:000424302800017
PM 29408923
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Laws, MB
   Lee, Y
   Taubin, T
   Rogers, WH
   Wilson, IB
AF Laws, M. Barton
   Lee, Yoojin
   Taubin, Tatiana
   Rogers, William H.
   Wilson, Ira B.
TI Factors associated with patient recall of key information in ambulatory
   specialty care visits: Results of an innovative methodology
SO PLOS ONE
LA English
DT Article
ID SHARED DECISION-MAKING; MEDICAL ENCOUNTERS; COMMUNICATION; PHYSICIAN;
   OUTCOMES; SATISFACTION; INVOLVEMENT; ADHERENCE; MODEL; NONADHERENCE
AB While some studies have assessed patient recall of important information from ambulatory care visits, none has done so recently. Furthermore, little is known about features of clinical interactions which are associated with patient understanding and recall, without which shared decision making, a widely shared ideal for patient care, cannot occur. Our objective was to evaluate characteristics of patients and outpatient encounters associated with patient recall of information after one week, along with observation of elements of shared decision making. This was an observational study based on coded transcripts of 189 outpatient encounters, and post-visit interviews with patients 1 week later. Coding used three previously validated systems, adopted for this study. Forty-nine percent of decisions and recommendations were recalled accurately without prompting; 36% recalled with a prompt; 15% recalled erroneously or not at all. Provider behaviors hypothesized to be associated with patient recall, such as open-questioning and "teach back," were rare. Patients with less than high school education recalled 38% of items freely and accurately, while patients with a college degree recalled 65% (p<.0001). In a multivariate model, the total number of items to be recalled per visit, and percentage of utterances in decision-making processes by the provider ("verbal dominance"), were significant predictors of poorer recall. The item count was associated with poorer recall for lower, but not higher, educated patients.
C1 [Laws, M. Barton; Lee, Yoojin; Taubin, Tatiana; Wilson, Ira B.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA.
   [Rogers, William H.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA.
RP Laws, MB (reprint author), Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA.
EM Michael_Barton_Laws@Brown.edu
OI Laws, M. Barton/0000-0002-0790-5879
FU Patient Centered Outcomes Research Institute
FX This work was supported by Patient Centered Outcomes Research Institute
   (PCORI does not use grant numbers), PCORI.org. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ANDERSON JL, 1979, RHEUMATOL REHABIL, V18, P18, DOI 10.1093/rheumatology/18.1.18
   Austin John L., 1962, DO THINGS WORDS
   Barry MJ, 2012, J AMBUL CARE MANAG, V35, P90, DOI 10.1097/JAC.0b013e318249482f
   Beach MC, 2005, ANN FAM MED, V3, P331, DOI 10.1370/afm.328
   BERTAKIS KD, 1977, J FAM PRACTICE, V5, P217
   BERTAKIS KD, 1991, J FAM PRACTICE, V32, P175
   Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313
   BRODY DS, 1989, J GEN INTERN MED, V4, P506, DOI 10.1007/BF02599549
   Covey J, 2011, J HEALTH COMMUN, V16, P788, DOI 10.1080/10810730.2011.561916
   Elwyn G, 2003, QUAL SAF HEALTH CARE, V12, P93, DOI 10.1136/qhc.12.2.93
   Elwyn G, 2013, PATIENT EDUC COUNS, V93, P265, DOI 10.1016/j.pec.2013.08.005
   Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6
   Fischer MA, 2010, J GEN INTERN MED, V25, P284, DOI 10.1007/s11606-010-1253-9
   Ford S, 2000, SOC SCI MED, V50, P553, DOI 10.1016/S0277-9536(99)00308-1
   Friedman DS, 2008, OPHTHALMOLOGY, V115, P1320, DOI 10.1016/j.ophtha.2007.11.023
   GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921
   HALL JA, 1988, MED CARE, V26, P657, DOI 10.1097/00005650-198807000-00002
   Heisler M, 2003, J GEN INTERN MED, V18, P893, DOI 10.1046/j.1525-1497.2003.21132.x
   Hoffman RM, 2010, MED DECIS MAKING, V30, p53S, DOI 10.1177/0272989X10378701
   Jenkins V, 2011, J CLIN ONCOL, V29, P61, DOI 10.1200/JCO.2010.30.0814
   Joseph-Williams N, 2014, PATIENT EDUC COUNS, V94, P291, DOI 10.1016/j.pec.2013.10.031
   KAPLAN SH, 1995, MED CARE, V33, P1176, DOI 10.1097/00005650-199512000-00002
   KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010
   Kessels RPC, 2003, J ROY SOC MED, V96, P219, DOI 10.1258/jrsm.96.5.219
   KING A, 1992, AM EDUC RES J, V29, P303, DOI 10.2307/1163370
   KUPST MJ, 1975, AM J ORTHOPSYCHIAT, V45, P420, DOI 10.1111/j.1939-0025.1975.tb02553.x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langewitz W, 2015, PATIENT EDUC COUNS, V98, P716, DOI 10.1016/j.pec.2015.02.003
   Laws MB, 2013, PATIENT EDUC COUNS, V91, P192, DOI 10.1016/j.pec.2012.12.012
   Laws MB, 2013, AIDS BEHAV, V17, P148, DOI 10.1007/s10461-012-0143-z
   LERMAN CE, 1990, J GEN INTERN MED, V5, P29, DOI 10.1007/BF02602306
   LEY P, 1979, BRIT J SOC CLIN PSYC, V18, P245, DOI 10.1111/j.2044-8260.1979.tb00333.x
   LIPKIN M, 1984, ANN INTERN MED, V100, P277, DOI 10.7326/0003-4819-100-2-277
   Makoul G, 2006, PATIENT EDUC COUNS, V60, P301, DOI 10.1016/j.pec.2005.06.010
   Marinker M, 2003, BRIT MED J, V326, P348, DOI 10.1136/bmj.326.7385.348
   Bravo BN, 2010, PATIENT EDUC COUNS, V81, P272, DOI 10.1016/j.pec.2010.01.022
   O'Connor AM, 1999, BRIT MED J, V319, P731, DOI 10.1136/bmj.319.7212.731
   O'Keefe DJ, 2007, J HEALTH COMMUN, V12, P623, DOI 10.1080/10810730701615198
   ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M
   Pilnick A, 2011, SOC SCI MED, V72, P1374, DOI 10.1016/j.socscimed.2011.02.033
   Roter DL, 1997, JAMA-J AM MED ASSOC, V277, P350, DOI 10.1001/jama.277.4.350
   SEARLE J, 1969, ESSAY PHILOS LANGUAG
   Silberman J, 2008, J GEN INTERN MED, V23, P1487, DOI 10.1007/s11606-008-0597-x
   Smith RA, 1994, J PERS SOC PSYCHOL, V47, P415
   STEWART MA, 1995, CAN MED ASSOC J, V152, P1423
   Wilson IB, 2007, J GEN INTERN MED, V22, P6, DOI 10.1007/s11606-006-0093-0
   Zikmund-Fisher BJ, 2010, MED DECIS MAKING, V30, p85S, DOI 10.1177/0272989X10380466
NR 47
TC 0
Z9 0
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 1
PY 2018
VL 13
IS 2
AR e0191940
DI 10.1371/journal.pone.0191940
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FU3ZZ
UT WOS:000423793400044
PM 29389994
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kruse, C
   Rosenlund, S
   Broeng, L
   Overgaard, S
AF Kruse, Christine
   Rosenlund, Signe
   Broeng, Leif
   Overgaard, Soren
TI Radiographic cup position following posterior and lateral approach to
   total hip arthroplasty. An explorative randomized controlled trial
SO PLOS ONE
LA English
DT Article
ID ACETABULAR COMPONENT ORIENTATION; ABDUCTOR MUSCLE STRENGTH; SURGICAL
   APPROACH; FEMORAL OFFSET; POLYETHYLENE WEAR; SAFE ZONE; DISLOCATION;
   RISK; REPLACEMENT; PATIENT
AB The two most common surgical approaches to total hip arthroplasty are the posterior approach and lateral approach. The surgical approach may influence cup positioning and restoration of the offset, which may affect the biomechanical properties of the hip joint.
   The primary aim was to compare cup position between posterior approach and lateral approach. Secondary aims were to compare femoral offset, abductor moment arm and leg length discrepancy between the two approaches. Eighty patients with primary hip osteoar-thritis were included in a randomized controlled trial and assigned to total hip arthroplasty using posterior approach or lateral approach. Postoperative radiographs from 38 patients in each group were included in this study for measurement of cup anteversion and inclination. Femoral offset, cup offset, total offset, abductor moment arm and leg length discrepancy were measured on preoperative and postoperative radiographs in 28 patients in each group. We found that mean anteversion was 5 degrees larger in the posterior approach group (95% CI, -8.1 to -1.4; p = 0.006), while mean inclination was 5 degrees less steep (95% CI, 2.7 to 7.2; p<0.001) compared with the lateral approach group. The posterior approach group had a larger mean femoral offset of 4.3mm (95% CI, -7.4 to -1.3, p = 0.006), mean total offset of 6.3mm (95% CI, -9.6 to -3; p<0.001) and mean abductor moment arm of 4.8mm (95% CI, -7.6 to -1.9; p = 0.001) compared with the lateral approach group. We found a larger cup anteversion but less steep cup inclination in the posterior approach group compared with the lateral approach group. Femoral offset and abductor moment arm were restored after total hip arthroplasty using lateral approach but significantly increased when using posterior approach.
C1 [Kruse, Christine; Rosenlund, Signe; Overgaard, Soren] Univ Southern, Odense Univ Hosp, Dept Orthopaed Surg & Traumatol, Odense, Denmark.
   [Kruse, Christine; Rosenlund, Signe; Overgaard, Soren] Univ Southern, Inst Clin Res, Odense, Denmark.
   [Rosenlund, Signe; Broeng, Leif] Zealand Univ Hosp, Dept Orthopaed Surg & Traumatol, Koge, Denmark.
RP Rosenlund, S (reprint author), Univ Southern, Odense Univ Hosp, Dept Orthopaed Surg & Traumatol, Odense, Denmark.; Rosenlund, S (reprint author), Univ Southern, Inst Clin Res, Odense, Denmark.; Rosenlund, S (reprint author), Zealand Univ Hosp, Dept Orthopaed Surg & Traumatol, Koge, Denmark.
EM signe.rosenlund@gmail.com
OI Overgaard, Soren/0000-0001-6829-4787
FU Danish Rheumatism Association [R102-A2116, R108-A2436]; Region of
   Zealand [1641013, 12-000095/64]; Region of Southern Denmark [11/28589];
   Bevica Foundation; Bjarne Jensen Foundation; Odense University Hospital
FX Each author certifies that Signe Rosenlund has received research support
   funding from: The Danish Rheumatism Association (R102-A2116 and
   R108-A2436), https://www. gigtforeningen.dk (SR); Region of Zealand
   (Brevid: 1641013 and Sagsnummer: 12-000095/64),
   http://www.regionsjaelland.dk/Sundhed/forskning/Sider/default.aspx (SR);
   Region of Southern Denmark (j.nr. 11/28589),
   http://www.regionsyddanmark.dk/wm325002 (SR); Bevica Foundation (no
   grant number), http://www.bevica.dk/bevica-fonden/formalansogning (SR);
   Bjarne Jensen Foundation (no grant number),
   http://www.bjarnejensensfond.dk (SR); Odense University Hospital (no
   grant number), http://www.ouh.dk/default.asp?id=402241 (SR SO). None of
   the study sponsors played a role in the study design, data collection,
   data analysis or interpretation; nor did they influence the writing of
   the manuscript or decision to submit the manuscript for publication.
   Each author certifies that Soren Overgaard's institution has received
   funding from Biomet, Depuy, Protesekompagniet, Zimmer, Eli Lilly during
   the study period; however, these were not related to the current study.
CR Abdel MP, 2016, CLIN ORTHOP RELAT R, V474, P386, DOI 10.1007/s11999-015-4432-5
   Amlie E, 2014, ACTA ORTHOP, V85, P463, DOI 10.3109/17453674.2014.934183
   Arthurssoni AJ, 2007, ACTA ORTHOP, V78, P719, DOI 10.1080/17453670710014482
   Biedermann R, 2005, J BONE JOINT SURG BR, V87B, P762, DOI 10.1302/0301-620X.87B6
   Brooks PJ, 2013, BONE JOINT J, V95B, P67, DOI 10.1302/0301-620X.95B11.32645
   Callanan MC, 2011, CLIN ORTHOP RELAT R, V469, P319, DOI 10.1007/s11999-010-1487-1
   Cassidy KA, 2012, J ARTHROPLASTY, V27, P1863, DOI 10.1016/j.arth.2012.05.001
   Cotong D, 2017, DAN MED J, V64
   DELP SL, 1993, J BIOMECH, V26, P485, DOI 10.1016/0021-9290(93)90011-3
   Esposito CI, 2015, J ARTHROPLASTY, V30, P109, DOI 10.1016/j.arth.2014.07.009
   Hailer NP, 2012, ACTA ORTHOP, V83, P442, DOI 10.3109/17453674.2012.733919
   Hoppenfeld S, 2009, HIP SURG EXPOSURES O, P403
   Jacobsen S, 2004, ACTA ORTHOP SCAND, V75, P721, DOI 10.1080/00016470410004094
   Jolles BM, 2002, J ARTHROPLASTY, V17, P282, DOI 10.1054/arth.2002.30286
   Jolles BM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003828.pub3
   Kennedy JG, 1998, J ARTHROPLASTY, V13, P530, DOI 10.1016/S0883-5403(98)90052-3
   Kim YH, 2009, J ARTHROPLASTY, V24, P1258, DOI 10.1016/j.arth.2009.03.017
   Kruse CR S., RADIOGRAPHIC CUP POS
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leslie IJ, 2009, CLIN ORTHOP RELAT R, V467, P2259, DOI 10.1007/s11999-009-0830-x
   LEWINNEK GE, 1978, J BONE JOINT SURG AM, V60, P217, DOI 10.2106/00004623-197860020-00014
   Lu M, 2013, CLIN ORTHOP RELAT R, V471, P2987, DOI 10.1007/s11999-013-3021-8
   Mahmood SS, 2016, ACTA ORTHOP, V87, P36, DOI 10.3109/17453674.2015.1091955
   Masonis JL, 2002, CLIN ORTHOP RELAT R, P46, DOI 10.1097/01.blo.0000038476.05771.6c
   MCGRORY BJ, 1995, J BONE JOINT SURG BR, V77B, P865
   Muller M, 2011, ARCH ORTHOP TRAUM SU, V131, P179, DOI 10.1007/s00402-010-1117-0
   Mulliken BD, 1998, J ARTHROPLASTY, V13, P737, DOI 10.1016/S0883-5403(98)90024-9
   Nho JH, 2012, J BONE JOINT SURG BR, V94B, P32, DOI 10.1302/0301-620X.94B1.27621
   Patel AB, 2010, J ARTHROPLASTY, V25, P1275, DOI 10.1016/j.arth.2009.10.007
   Patil S, 2003, J BONE JOINT SURG AM, V85A, P56, DOI 10.2106/00004623-200300004-00007
   Pedersen DR, 2005, MED ENG PHYS, V27, P323, DOI 10.1016/j.medengphy.2004.09.004
   Ranawat CS, 2001, J ARTHROPLASTY, V16, P715, DOI 10.1054/arth.2001.24442
   Romero AC, 2001, J ARTHROPLASTY, V16, P55, DOI 10.1054/arth.2001.19154
   Rosenlund S, 2017, ACTA ORTHOP, V88, P239, DOI 10.1080/17453674.2017.1291100
   Rosenlund S, 2016, CLIN BIOMECH, V39, P91, DOI 10.1016/j.clinbiomech.2016.09.011
   Rosenlund S, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-354
   Sakalkale DP, 2001, CLIN ORTHOP RELAT R, P125
   Sariali E, 2014, ACTA ORTHOP, V85, P123, DOI 10.3109/17453674.2014.889980
   Seagrave KG, 2017, ACTA ORTHOP, V88, P10, DOI 10.1080/17453674.2016.1251255
   TONNIS D, 1976, CLIN ORTHOP RELAT R, P39
   Wan ZN, 2008, J ARTHROPLASTY, V23, P51, DOI 10.1016/j.arth.2007.06.008
   Wan ZN, 2009, CLIN ORTHOP RELAT R, V467, P32, DOI 10.1007/s11999-008-0597-5
NR 42
TC 0
Z9 0
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 29
PY 2018
VL 13
IS 1
AR e0191401
DI 10.1371/journal.pone.0191401
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FU0AV
UT WOS:000423514700012
PM 29377951
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hong, TT
   Hoa, NP
   Walker, SM
   Hill, PS
   Rao, C
AF Tran Thi Hong
   Nguyen Phuong Hoa
   Walker, Sue M.
   Hill, Peter S.
   Rao, Chalapati
TI Completeness and reliability of mortality data in Viet Nam: Implications
   for the national routine health management information system
SO PLOS ONE
LA English
DT Article
ID VERBAL AUTOPSY; DEATH STATISTICS; QUALITY; REGISTRATION; VALIDATION;
   AGREEMENT; INJURY; COUNTS
AB Background
   Mortality statistics form a crucial component of national Health Management Information Systems (HMIS). However, there are limitations in the availability and quality of mortality data at national level in Viet Nam. This study assessed the completeness of recorded deaths and the reliability of recorded causes of death (COD) in the A6 death registers in the national routine HMIS in Viet Nam.
   Methodology and findings
   1477 identified deaths in 2014 were reviewed in two provinces. A capture-recapture method was applied to assess the completeness of the A6 death registers. 1365 household verbal autopsy (VA) interviews were successfully conducted, and these were reviewed by physicians who assigned multiple and underlying cause of death (UCOD). These UCODs from VA were then compared with the CODs recorded in the A6 death registers, using kappa scores to assess the reliability of the A6 death register diagnoses. The overall completeness of the A6 death registers in the two provinces was 89.3% (95% CI: 87.8-90.8). No COD recorded in the A6 death registers demonstrated good reliability. There is very low reliability in recording of cardiovascular deaths (kappa for stroke = 0.47 and kappa for ischaemic heart diseases = 0.42) and diabetes (kappa = 0.33). The reporting of deaths due to road traffic accidents, HIV and some cancers are at a moderate level of reliability with kappa scores ranging between 0.57-0.69 (p< 0.01). VA methods identify more specific COD than the A6 death registers, and also allow identification of multiple CODs.
   Conclusions
   The study results suggest that data completeness in HMIS A6 death registers in the study sample of communes was relatively high (nearly 90%), but triangulation with death records from other sources would improve the completeness of this system. Further, there is an urgent need to enhance the reliability of COD recorded in the A6 death registers, for which VA methods could be effective. Focussed consultation among stakeholders is needed to develop a suitable mechanism and process for integrating VA methods into the national routine HMIS A6 death registers in Viet Nam.
C1 [Tran Thi Hong] Hanoi Univ Publ Hlth, Fundamental Sci Fac, Hanoi, Vietnam.
   [Tran Thi Hong; Hill, Peter S.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia.
   [Nguyen Phuong Hoa] Hanoi Med Univ, Dept Family Med, Hanoi, Vietnam.
   [Walker, Sue M.] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia.
   [Walker, Sue M.] Queensland Univ Technol, Natl Ctr Hlth Informat Res & Training, Brisbane, Qld, Australia.
   [Rao, Chalapati] Australian Natl Univ, Res Sch Populat Hlth, Dept Global Hlth, Canberra, ACT, Australia.
RP Hong, TT (reprint author), Hanoi Univ Publ Hlth, Fundamental Sci Fac, Hanoi, Vietnam.; Hong, TT (reprint author), Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia.
EM honghsph@gmail.com
RI Hill, Peter/F-2768-2010
OI Hill, Peter/0000-0001-7091-5108
FU Centers for Disease Control and Prevention, Viet Nam [CGH HSR 2015-009]
FX This study was funded by the Centers for Disease Control and Prevention,
   Viet Nam (CGH HSR 2015-009). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR AbouZahr C, 2007, LANCET, V370, P1791, DOI 10.1016/S0140-6736(07)61310-5
   Betty R., 2003, ESSENTIAL MED STAT
   Tran BH, 2013, INT J EPIDEMIOL, V42, P750, DOI 10.1093/ije/dyt053
   Chuc NTK, 2011, XAC DINH NGUYEN NHAN
   Curtis S, 2013, 2013 27 IUSSP INT PO
   Diep Thi Thu Trang, 2011, COMPLETENESS INFANT
   Fottrell E, 2010, EPIDEMIOL REV, V32, P38, DOI 10.1093/epirev/mxq003
   Gupta S, 2012, J NEUROSCI RURAL PRA, V3, P267, DOI 10.4103/0976-3147.102603
   Hanoi University of Public Health, 2012, VIETN NAT INJ SURV 2
   Hansen J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174659
   Hill K, 2007, LANCET, V370, P1726, DOI 10.1016/S0140-736(07)61309-9
   Hong TT, 2009, HEALTH INF MANAG J, V38, P15, DOI 10.1177/183335830903800103
   Huong Dao Lan, 2006, THESIS
   Huong DL, 2003, SCAND J PUBLIC HEALT, V31, P19, DOI 10.1080/14034950310015068
   Huy TQ, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034950310015059
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lanh LT, 2012, NAT C HLTH MAN INF S
   Le TN, 2007, ASIAN PAC J CANCER P, V8, P535
   Maraba N, 2016, T ROY SOC TROP MED H, V110, P510, DOI 10.1093/trstmh/trw058
   Mayanja BN, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-36
   Nausheen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076933
   Ngo Anh D, 2010, BMC Res Notes, V3, P78, DOI 10.1186/1756-0500-3-78
   Ngoan LT, 2012, SE ASIAN J SCI, V1, P9
   Nguyen Cong Luat, 2011, EV COMPL ANT DEL IMM
   Hoa NP, 2012, B WORLD HEALTH ORGAN, V90, P764, DOI 10.2471/BLT.11.100750
   Omar A, 2017, STUDY DETERMINATION, P1
   Piotti B, 2014, HIS DEV STRATEGIC PL
   Rao C., 2013, MORTALITY ESTIMATES, P1196
   Rao C, 2007, INT J EPIDEMIOL, V36, P642, DOI 10.1093/ije/dym003
   Rao C, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-11
   Rao C, 2010, B WORLD HEALTH ORGAN, V88, P58, DOI 10.2471/BLT.08.061630
   Saeki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089011
   SEKAR CC, 1949, J AM STAT ASSOC, V44, P101, DOI 10.2307/2280353
   Stevenson MR, 2012, INJURY PREV, V18, P360, DOI 10.1136/injuryprev-2011-040261
   Tran TK, 2012, SCAND J PUBLIC HEALT, V40, P765, DOI 10.1177/1403494812464444
   Tung DT, 2012, TONG KET CONG TAC DA
   Viera AJ, 2005, FAM MED, V37, P360
   Vietnam Administration of HIV/ AIDS Control (VAAC), 2014, NAT HIV CAS REP
   Vietnam General Statistics Office, 2011, 2009 VIETN POP HOUS
   Vietnam Ministry of Health, 2014, THONG TU QUI DINH HE
   Vietnamese Prime Minister, 2017, QUYET DINH 101 QD TT
   VINE Project, 2012, EV BAS HLTH POL VIET
   Wang LJ, 2007, J EPIDEMIOL COMMUN H, V61, P519, DOI 10.1136/jech.2005.043927
   WHO, 2016, INT STAT CLASS DIS R, V1
   WHO, GLOB HLTH OBS MAP GA
   World Health Organization, 2016, INT STAT CLASS DIS R, V2
   World Health Organization, 2015, VERB AUT STAND 2014
   World Health Organization (WHO), 2008, INT STAT CLASS DIS R
   Yang GH, 2006, INT J EPIDEMIOL, V35, P741, DOI 10.1093/ije/dyi181
NR 49
TC 3
Z9 3
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 25
PY 2018
VL 13
IS 1
AR e0190755
DI 10.1371/journal.pone.0190755
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FT8QE
UT WOS:000423416600020
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Dolka, I
   Czopowicz, M
   Gruk-Jurka, A
   Wojtkowska, A
   Sapierzynski, R
   Jurka, P
AF Dolka, Izabella
   Czopowicz, Michal
   Gruk-Jurka, Anna
   Wojtkowska, Agata
   Sapierzynski, Rafal
   Jurka, Piotr
TI Diagnostic efficacy of smear cytology and Robinson's cytological grading
   of canine mammary tumors with respect to histopathology,
   cytomorphometry, metastases and overall survival
SO PLOS ONE
LA English
DT Article
ID FINE-NEEDLE-ASPIRATION; INVASIVE BREAST-CARCINOMA; GLAND TUMORS; NUCLEAR
   MORPHOMETRY; PROGNOSTIC VALUE; CANCER; BIOPSY; DIFFERENTIATION;
   PREDICTOR; ACCURACY
AB Cytology is a simple, rapid, and inexpensive method used for pre-operative diagnosis of canine mammary tumors (CMTs) in veterinary practice. Studies related to human breast cancer showed the Robinson's grading system-established for invasive ductal carcinoma, not otherwise specified (IDC, NOS) and used on cytological material-to not only closely correspond to the histopathological grading but also be helpful in assessing prognosis and selecting most suitable treatments before surgery. The objectives of this study were: to evaluate the accuracy of cytological diagnosis and cytological Robinson's grading system compared to the histopathological examination of CMTs; to compare of cytological features and cytomorphometric parameters with tumor behavior, as well as cytological and histological grading; and to determine an association of the Robinson's grading system and cytological background details with metastases, and patients' survival. We report substantial diagnostic accuracy in detecting simple types and high grade tumors. Cytological diagnosis of tumor behavior showed relatively low sensitivity and specificity compared to human studies, and this might be caused by the heterogeneous morphology of CMTs. The presence of mucosecretory material and extracellular matrix was not significantly associated with tumor behavior. We report a positive correlation between both grading systems and cytological features (included in Robinson's grading), the presence of necrotic debris, inflammation, and red blood cells. A negative correlation was determined only for the presence of extracellular matrix. The univariate and multivariate analyses confirmed a significantly higher risk of developing metastasis and shorter overall survival for dogs with tumors of grade 2 or 3 on cytology. In addition, these tumors were the most common cause of CMT-related deaths in dogs. Taken together, our findings suggest that the Robinson's method of cytological grading applied for malignant CMTs evaluated in cytological smears regardless of tumor type can be adapted to veterinary cytology. Additionally, some background features seem to aid malignancy assessment.
C1 [Dolka, Izabella; Sapierzynski, Rafal] Warsaw Univ Life Sci SGGW, Fac Vet Med, Dept Pathol & Vet Diagnost, Warsaw, Poland.
   [Czopowicz, Michal] Warsaw Univ Life Sci SGGW, Fac Vet Med, Lab Vet Epidemiol & Econ, Warsaw, Poland.
   [Gruk-Jurka, Anna; Wojtkowska, Agata; Jurka, Piotr] Warsaw Univ Life Sci SGGW, Fac Vet Med, Dept Small Anim Dis Clin, Warsaw, Poland.
RP Dolka, I (reprint author), Warsaw Univ Life Sci SGGW, Fac Vet Med, Dept Pathol & Vet Diagnost, Warsaw, Poland.
EM izabella_dolka@sggw.pl
RI Czopowicz, Michal/U-5452-2018
OI Czopowicz, Michal/0000-0002-4238-8360; Jurka, Piotr/0000-0002-3321-4844;
   Sapierzynski, Rafal/0000-0003-2111-5117; /0000-0002-6904-0700
FU KNOW (Leading National Research Centre) Scientific Consortium "Healthy
   Animal - Safe Food" [05-1/KNOW2/2015]; Department of Pathology and
   Veterinary Diagnostics, Faculty of Veterinary Medicine, Warsaw
   University of Life Sciences (SGGW), Warsaw, Poland
   [505-10-023700-L00182-99]
FX Research was supported by grant no 505-10-023700-L00182-99 received by
   Izabella Dolka from Department of Pathology and Veterinary Diagnostics,
   Faculty of Veterinary Medicine, Warsaw University of Life Sciences
   (SGGW), Warsaw, Poland. The costs of manuscript publication were funded
   by KNOW (Leading National Research Centre) Scientific Consortium
   "Healthy Animal - Safe Food", decision of Ministry of Science and Higher
   Education No. 05-1/KNOW2/2015. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abati A, 1997, DIAGN CYTOPATHOL, V16, P295
   ALLEN SW, 1986, VET PATHOL, V23, P649, DOI 10.1177/030098588602300601
   Allison RW, 2007, DIAGNOSTIC CYTOLOGY, P112
   Altman E., 2000, PREDICTING FINANCIAL, P15
   Barra ADA, 2008, DIAGN CYTOPATHOL, V36, P26, DOI 10.1002/dc.20748
   Cassali GD, 2007, CYTOPATHOLOGY, V18, P191, DOI 10.1111/j.1365-2303.2007.00412.x
   Cassali GD, 2015, VET CLIN PATH, V44, P448, DOI 10.1111/vcp.12269
   Colodel M. M., 2012, Veterinaria e Zootecnia, V19, P557
   Das AK, 2003, INDIAN J MED RES, V118, P247
   de las Mulas JM, 2005, VET PATHOL, V42, P200, DOI 10.1354/vp.42-2-200
   De Vico G, 2007, VET RES COMMUN, V31, P1005, DOI 10.1007/s11259-006-0108-7
   Dennis MM, 2011, VET PATHOL, V48, P73, DOI 10.1177/0300985810388820
   Dias MLD, 2016, PESQUI VET BRASIL, V36, P181, DOI 10.1590/S0100-736X2016000300006
   Dutra AP, 2008, ARQ BRAS MED VET ZOO, V60, P1403, DOI 10.1590/S0102-09352008000600015
   Einstien D, 2014, ISRN ONCOLOGY, P1
   GILCHRIST KW, 1993, J CLIN ONCOL, V11, P1929, DOI 10.1200/JCO.1993.11.10.1929
   Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258
   Gore CR, 2013, INT J PHARM BIOL SC, V3, P564
   Haziroglu R, 2010, REV MED VET-TOULOUSE, V161, P212
   HELLMEN E, 1989, J COMP PATHOL, V101, P443, DOI 10.1016/0021-9975(89)90027-3
   Jayaram G, 2005, ACTA CYTOL, V49, P605, DOI 10.1159/000326247
   Kalhan S, 2010, J CYTOL, V27, P16, DOI 10.4103/0970-9371.66694
   Karayannopoulou M, 2005, J COMP PATHOL, V133, P246, DOI 10.1016/j.jcpa.2005.05.003
   Karim BO, 2008, VET CLIN PATH, V37, P229, DOI 10.1111/j.1939-165X.2008.00030.x
   Khan MZ, 2003, DIAGN CYTOPATHOL, V29, P185, DOI 10.1002/dc.10285
   Khan N, 2009, J CYTOL, V26, P65, DOI 10.4103/0970-9371.55224
   Kocaay Akin Firat, 2016, Niger Med J, V57, P77, DOI 10.4103/0300-1652.182078
   Krishnakanth GVRN, 2016, ANN PATHOL LAB MED, V3, P190
   Lale S, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-7
   Lana SE, 2007, SMALL ANIMAL CLIN ON, P619, DOI DOI 10.1016/B978-072160558-6.50029-0
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Maiorano E, 2010, BREAST CANCER RES TR, V121, P211, DOI 10.1007/s10549-009-0360-y
   Meinkoth JH, 2007, DIAGNOSTIC CYTOLOGY, P37
   Miskovic J, 2016, ACTA CLIN CROAT, V55, P625, DOI 10.20471/acc.2016.55.04.13
   Moe L, 2001, J REP FER S, P439
   Pal S, 2016, J CYTOL, V33, P182, DOI 10.4103/0970-9371.190449
   Park SM, 2010, BIOTECHNOL BIOFUELS, V3, P1, DOI DOI 10.1186/1754-6834-3-10
   Pena L, 2013, VET PATHOL, V50, P94, DOI 10.1177/0300985812447830
   Phukan JP, 2015, SOUTH ASIAN J CANCER, V4, P32, DOI 10.4103/2278-330X.149948
   Pierini A, 2017, J VET DIAGN INVEST, V29, P869, DOI 10.1177/1040638717718886
   Queiroga FL, 2011, IN VIVO, V25, P455
   ROBINSON IA, 1994, LANCET, V343, P947, DOI 10.1016/S0140-6736(94)90066-3
   ROBINSON IA, 1995, DIAGN CYTOPATHOL, V13, P260, DOI 10.1002/dc.2840130315
   Saha K, 2013, J CYTOL, V30, P87, DOI 10.4103/0970-9371.112647
   Salas Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127381
   Sangha S, 2011, BRAZ J VET PATHOL, V4, P13
   Sapierzynski R, 2017, J SMALL ANIM PRACT, V58, P73, DOI 10.1111/jsap.12598
   Schiller AB, 2001, AM J CLIN PATHOL, V115, P219
   Simeonov R., 2006, Bulgarian Journal of Veterinary Medicine, V9, P211
   Simeonov R, 2006, VET CLIN PATH, V35, P88, DOI 10.1111/j.1939-165X.2006.tb00093.x
   Simon D, 2009, VET CLIN PATH, V38, P521, DOI 10.1111/j.1939-165X.2009.00150.x
   Skrbinc B, 2001, CYTOPATHOLOGY, V12, P15, DOI 10.1046/j.1365-2303.2001.00297.x
   Solano-Gallego L, 2009, CANINE FELINE CYTOLO, P274
   Sontas BH, 2012, REPROD DOMEST ANIM, V47, P125, DOI 10.1111/j.1439-0531.2011.01810.x
   Sood N, 2013, PATHOLOG RES INT, V2013
   Taniguchi E, 2000, ACTA CYTOL, V44, P587, DOI 10.1159/000328533
   Uva P, 2009, BMC GENOMICS, V10, DOI [10.1186/1471-2164-10-5, 10.1186/1471-2164-10-135]
   Vascellari M, 2016, PREV VET MED, V126, P183, DOI 10.1016/j.prevetmed.2016.02.008
   Yildirim F, 2012, REV MED VET-TOULOUSE, V163, P116
   Yu GH, 1998, AM J CLIN PATHOL, V109, P315, DOI 10.1093/ajcp/109.3.315
   Zuccari DAPC, 2001, BRAZ J VET RES ANIM, V38, P38, DOI DOI 10.1177/030098588602300601
NR 61
TC 0
Z9 0
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 23
PY 2018
VL 13
IS 1
AR e0191595
DI 10.1371/journal.pone.0191595
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FT4YS
UT WOS:000423161800039
PM 29360854
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Dantas, KC
   de Freitas, RS
   da Silva, MV
   Criado, PR
   Luiz, OD
   Vicentini, AP
AF Dantas, Katia Cristina
   de Freitas, Roseli Santos
   da Silva, Marcos Vinicius
   Criado, Paulo Ricardo
   Luiz, Olinda do Carmo
   Vicentini, Adriana Pardini
TI Comparison of diagnostic methods to detect Histoplasma capsulatum in
   serum and blood samples from AIDS patients
SO PLOS ONE
LA English
DT Article
ID REAL-TIME PCR; VAR. CAPSULATUM; NESTED PCR; MOLECULAR DIAGNOSIS;
   INVASIVE MYCOSES; CLINICAL-SAMPLES; MULTIPLEX PCR; WHOLE-BLOOD;
   IDENTIFICATION; ASSAYS
AB Background
   Although early and rapid detection of histoplasmosis is essential to prevent morbidity and mortality, few diagnostic tools are available in resource-limited areas, especially where it is endemic and HIV/AIDS is also epidemic. Thus, we compared conventional and molecular methods to detect Histoplasma capsulatum in sera and blood from HIV/AIDS patients.
   Methodology
   We collected a total of 40 samples from control volunteers and patients suspected of histoplasmosis, some of whom were also infected with other pathogens. Samples were then analyzed by mycological, serological, and molecular methods, and stratified as histoplasmostic with (group I) or without AIDS (group II), uninfected (group III), and infected with HIV and other pathogens only (group IV). All patients were receiving treatment for histoplasmosis and other infections at the time of sample collection.
   Results
   Comparison of conventional methods with nested PCR using primers against H. capsulatum 18S rRNA (HC18S), 5.8S rRNA ITS (HC5.8S-ITS), and a 100 kDa protein (HC100) revealed that sensitivity against sera was highest for PCR with HC5.8S-ITS, followed by immunoblotting, double immunodiffusion, PCR with HC18S, and PCR with HC100. Specificity was equally high for double immunodiffusion, immunoblotting and PCR with HC100, followed for PCR with HC18S and HC5.8-ITS. Against blood, sensitivity was highest for PCR with HC5.8S-ITS, followed by PCR with HC18S, Giemsa staining, and PCR with HC100.Specificity was highest for Giemsa staining and PCR with HC100, followed by PCR with HC18S and HC5.8S-ITS. PCR was less efficient in patients with immunodeficiency due to HIV/AIDS and/or related diseases.
   Conclusion
   Molecular techniques may detect histoplasmosis even in cases with negative serology and mycology, potentially enabling early diagnosis.
C1 [Dantas, Katia Cristina] Univ Sao Paulo, Med Sch, Dept Pathol, Sao Paulo, Brazil.
   [de Freitas, Roseli Santos; Criado, Paulo Ricardo] Univ Sao Paulo, Med Mycol Lab LIM 53, HCFMUSP, Sao Paulo, Brazil.
   [de Freitas, Roseli Santos; Criado, Paulo Ricardo] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [da Silva, Marcos Vinicius] Catholic Univ Sao Paulo, Dept Med, Minist Hlth, Emilio Ribas Inst Infect Dis, Sao Paulo, Brazil.
   [da Silva, Marcos Vinicius] Dept State Hlth, Program Postgrad Sci & Coordinat Dis Control, Sao Paulo, Brazil.
   [Criado, Paulo Ricardo] ABC Med Sch, Sao Paulo, Brazil.
   [Luiz, Olinda do Carmo] Univ Sao Paulo, Med Sch, Prevent Med Dept, Sao Paulo, Brazil.
   [Vicentini, Adriana Pardini] Adolfo Lutz Inst, Immunol Ctr, Sao Paulo, Brazil.
RP Dantas, KC (reprint author), Univ Sao Paulo, Med Sch, Dept Pathol, Sao Paulo, Brazil.
EM katia.dantas@fm.usp.br
RI Luiz, Olinda/C-6075-2012; Criado, Paulo Ricardo/D-5369-2009
OI Luiz, Olinda/0000-0002-2596-3626; Criado, Paulo
   Ricardo/0000-0001-9785-6099
FU State of Sao Paulo Research Foundation (FAPESP) [2009/50362-0]
FX This study was supported by the State of Sao Paulo Research Foundation
   (FAPESP) under grant n. 2009/50362-0. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Elias NA, 2012, MYCOPATHOLOGIA, V174, P451, DOI 10.1007/s11046-012-9567-2
   Almeida MD, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1427-0
   Bahr Nathan C, 2015, Curr Trop Med Rep, V2, P70
   Bialek R, 2002, AM J CLIN PATHOL, V117, P597
   Bialek R, 2002, J CLIN MICROBIOL, V40, P1644, DOI 10.1128/JCM.40.5.1644-1647.2002
   Bracca A, 2003, J CLIN MICROBIOL, V41, P1753, DOI 10.1128/JCM.41.4.1753-1755.2003
   Buitrago MJ, 2006, EUR J CLIN MICROBIOL, V25, P665, DOI 10.1007/s10096-006-0207-y
   Caceres DH, 2015, AM J TROP MED HYG, V93, P662, DOI 10.4269/ajtmh.15-0108
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Dantas KC, 2013, AN BRAS DERMATOL, V88, P141, DOI 10.1590/S0365-05962013000100025
   De Hoog GS, 2000, ATLAS CLIN FUNGI
   DISALVO AF, 1980, J CLIN MICROBIOL, V11, P238
   ERCOLANI L, 1988, J BIOL CHEM, V263, P15335
   Falci DR, 2017, BRAZ J INFECT DIS, V21, P7, DOI 10.1016/j.bjid.2016.09.012
   Fletcher RH, 1996, EPIDEMIOLOGIA CLIN E, P52
   Freitas RS, 2009, J VENOM ANIM TOXINS, V15, P278, DOI 10.1590/S1678-91992009000200010
   Fujita SI, 2001, J CLIN MICROBIOL, V39, P3617, DOI 10.1128/JCM.39.10.3617-3622.2001
   Garbee DD, 2017, CRIT CARE NURS CLIN, V29, P67, DOI 10.1016/j.cnc.2016.09.011
   Frias-De-Leon M, 2017, FOLIA MICROBIOL, V62, P111, DOI 10.1007/s12223-016-0477-4
   Guimaraes AJ, 2006, BRAZ J MICROBIOL, V37, P1, DOI 10.1590/S1517-83822006000100001
   Kauffman CA, 2008, CURR OPIN INFECT DIS, V21, P421, DOI 10.1097/QCO.0b013e328306eb8d
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Martagon-Villamil J, 2003, J CLIN MICROBIOL, V41, P1295, DOI 10.1128/JCM.41.3.1295-1298.2003
   Nacher M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002319
   Negroni R, 2010, REV ARGENT MICROBIOL, V42, P254, DOI 10.1590/S0325-75412010000400003
   Brilhante RSN, 2010, ANTIMICROB AGENTS CH, V54, P3978, DOI 10.1128/AAC.00793-10
   Ohno H, 2013, J INFECT CHEMOTHER, V19, P999, DOI 10.1007/s10156-013-0548-2
   Ostrosky-Zeichner L, 2012, AM J MED, V125, pS14, DOI 10.1016/j.amjmed.2011.10.008
   Passos AN, 2014, BRAZ J MICROBIOL, V45, P1357, DOI 10.1590/S1517-83822014000400028
   Powers-Fletcher MV, 2016, INFECT DIS CLIN N AM, V30, P37, DOI 10.1016/j.idc.2015.10.005
   Prado M, 2009, MEM I OSWALDO CRUZ, V104, P513, DOI 10.1590/S0074-02762009000300019
   Prattes J, 2016, CURR FUNGAL INFECT R, V10, P43, DOI 10.1007/s12281-016-0254-5
   Rivasi F, 2001, APMIS, V109, P721, DOI 10.1034/j.1600-0463.2001.d01-138.x
   Sampaio ID, 2012, REV IBEROAM MICOL, V29, P34, DOI 10.1016/j.riam.2011.03.008
   Scheel CM, 2014, J CLIN MICROBIOL, V52, P483, DOI 10.1128/JCM.02739-13
   Toranzo AI, 2009, REV ARGENT MICROBIOL, V41, P20
   Wheat LJ, 2006, TRANSPL INFECT DIS, V8, P128, DOI 10.1111/j.1399-3062.2006.00165.x
   Wheat LJ, 2016, INFECT DIS CLIN N AM, V30, P207, DOI 10.1016/j.idc.2015.10.009
   White T. J, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1
   Zancope-Oliveira RM, 1994, CLIN DIAGN LAB IMMUN, V1, P197
NR 40
TC 1
Z9 1
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 17
PY 2018
VL 13
IS 1
AR e0190408
DI 10.1371/journal.pone.0190408
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FS8II
UT WOS:000422653800021
PM 29342162
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kunecke, J
   Mokros, A
   Olderbak, S
   Wilhelm, O
AF Kuenecke, Janina
   Mokros, Andreas
   Olderbak, Sally
   Wilhelm, Oliver
TI Facial responsiveness of psychopaths to the emotional expressions of
   others
SO PLOS ONE
LA English
DT Article
ID AFFECT RECOGNITION; CRIMINAL PSYCHOPATHY; LATENT-VARIABLES; FIT INDEXES;
   MIMICRY; EMPATHY; FACES; CHECKLIST; OFFENDERS; RESONANCE
AB Psychopathic individuals show selfish, manipulative, and antisocial behavior in addition to emotional detachment and reduced empathy. Their empathic deficits are thought to be associated with a reduced responsiveness to emotional stimuli. Immediate facial muscle responses to the emotional expressions of others reflect the expressive part of emotional responsiveness and are positively related to trait empathy. Empirical evidence for reduced facial muscle responses in adult psychopathic individuals to the emotional expressions of others is rare. In the present study, 261 male criminal offenders and non-offenders categorized dynamically presented facial emotion expressions (angry, happy, sad, and neutral) during facial electromyography recording of their corrugator muscle activity. We replicated a measurement model of facial muscle activity, which controls for general facial responsiveness to face stimuli, and modeled three correlated emotion-specific factors (i.e., anger, happiness, and sadness) representing emotion specific activity. In a multi-group confirmatory factor analysis, we compared the means of the anger, happiness, and sadness latent factors between three groups: 1) non-offenders, 2) low, and 3) high psychopathic offenders. There were no significant mean differences between groups. Our results challenge current theories that focus on deficits in emotional responsiveness as leading to the development of psychopathy and encourage further theoretical development on deviant emotional processes in psychopathic individuals.
C1 [Kuenecke, Janina] Humboldt Univ, Dept Psychol, Berlin, Germany.
   [Kuenecke, Janina] Psychol Hsch, Berlin, Germany.
   [Mokros, Andreas] Univ Hosp Psychiat Zurich, Dept Forens Psychiat, Zurich, Switzerland.
   [Olderbak, Sally; Wilhelm, Oliver] Ulm Univ, Dept Psychol, Ulm, Germany.
RP Kunecke, J (reprint author), Humboldt Univ, Dept Psychol, Berlin, Germany.; Kunecke, J (reprint author), Psychol Hsch, Berlin, Germany.
EM j.kuenecke@psychologische-hochschule.de
OI Wilhelm, Oliver/0000-0001-7980-1166
FU German Research Foundation (Deutsche Forschungsgemeinschaft) [OL
   452/3-1]
FX The analysis and publication of these results are supported by a grant
   from the German Research Foundation (Deutsche Forschungsgemeinschaft; OL
   452/3-1) awarded to Sally Olderbak. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abrosoft, 2010, FANTAMORPH VERS 5 0
   Achaibou A, 2008, NEUROPSYCHOLOGIA, V46, P1104, DOI 10.1016/j.neuropsychologia.2007.10.019
   Adolphs R, 2004, J COGNITIVE NEUROSCI, V16, P453, DOI 10.1162/089892904322926782
   Baskin-Sommers AR, 2011, PSYCHOL SCI, V22, P226, DOI 10.1177/0956797610396227
   Blair RJR, 2006, COGNITION, V101, P414, DOI 10.1016/j.cognition.2006.04.005
   Blair RJR, 2005, DEV PSYCHOPATHOL, V17, P865, DOI 10.1017/S0954579405050418
   Blairy S, 1999, J NONVERBAL BEHAV, V23, P5, DOI 10.1023/A:1021370825283
   Bollen K. A, 1989, STRUCTURAL EQUATIONS
   Bollen KA, 2002, ANNU REV PSYCHOL, V53, P605, DOI 10.1146/annurev.psych.53.100901.135239
   Book AS, 2007, CRIM JUSTICE BEHAV, V34, P531, DOI 10.1177/0093854806293554
   Brook M, 2013, CLIN PSYCHOL REV, V33, P979, DOI 10.1016/j.cpr.2013.07.008
   Brook M, 2013, J ABNORM PSYCHOL, V122, P156, DOI 10.1037/a0030261
   BROWN SL, 1980, BIOL PSYCHOL, V11, P49, DOI 10.1016/0301-0511(80)90026-5
   Coid J, 2009, INT J LAW PSYCHIAT, V32, P65, DOI 10.1016/j.ijlp.2009.01.002
   Cooney RE, 2006, PSYCHIAT RES-NEUROIM, V148, P55, DOI 10.1016/j.pscychresns.2006.05.003
   Dawel A, 2012, NEUROSCI BIOBEHAV R, V36, P2288, DOI 10.1016/j.neubiorev.2012.08.006
   de Wied M, 2006, J PSYCHIAT RES, V40, P112, DOI 10.1016/j.jpsychires.2005.08.003
   de Wied M, 2012, J ABNORM CHILD PSYCH, V40, P211, DOI 10.1007/s10802-011-9557-8
   DeCarlo LT, 2010, J MATH PSYCHOL, V54, P304, DOI 10.1016/j.jmp.2010.01.001
   Decety J, 2017, J NEUROPHYSIOL, V114, P493
   Deeley Q, 2006, BRIT J PSYCHIAT, V189, P533, DOI 10.1192/bjp.bp.106.021410
   DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x
   Dolan M, 2005, PERS INDIV DIFFER, V38, P1657, DOI 10.1016/j.paid.2004.09.028
   Draine SC, 2009, INQUISIT VERSION 4 0
   Eisenbarth H, 2017, BIENN M SOC SCI STUD
   Fanti KA, 2016, SOC NEUROSCI-UK, V11, P72, DOI 10.1080/17470919.2015.1034378
   Fowles DC, 2009, CURR DIR PSYCHOL SCI, V18, P179, DOI 10.1111/j.1467-8721.2009.01632.x
   Frick P. J, 2001, ANTISOCIAL PROCESS S
   FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x
   Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418
   Gallese V, 2003, PSYCHOPATHOLOGY, V36, P171, DOI 10.1159/000072786
   Glass SJ, 2006, J ABNORM PSYCHOL, V115, P815, DOI 10.1037/0021-843X.115.4.815
   Goldman AI, 2005, COGNITION, V94, P193, DOI 10.1016/j.cognition.2004.01.005
   Guy LS, 2006, PSYCHOL ASSESSMENT, V18, P225, DOI 10.1037/1040-3590.18.2.225
   Hagenmuller F, 2012, NEUROPSYCHIATRIE, V26, P65, DOI 10.1007/s40211-012-0015-9
   Hare R., 1991, MANUAL HARE PSYCHOPA
   Hare R. D., 2003, HARE PSYCHOPATHY CHE
   Harrison NA, 2010, SOC NEUROSCI-UK, V5, P393, DOI 10.1080/17470911003656330
   Hart S. D, 1995, HARE PSYCHOPATHY CHE
   Herpertz SC, 2001, ARCH GEN PSYCHIAT, V58, P737, DOI 10.1001/archpsyc.58.8.737
   Herpertz SC, 2000, BEHAV SCI LAW, V18, P567, DOI 10.1002/1099-0798(200010)18:5<567::AID-BSL410>3.0.CO;2-8
   Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6
   Hess U, 2017, PSYCHOPHYSIOLOGY, V54, P12, DOI 10.1111/psyp.12676
   Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Huang C. N., 2004, J MED BIOL ENG, V25, P15
   Kosson DS, 2002, EMOTION, V2, P398, DOI [10.1037/1528-3542.2.4.398, 10.1037//1528-3542.2.4.398]
   Kunecke J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084053
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076
   Larsen JT, 2003, PSYCHOPHYSIOLOGY, V40, P776, DOI 10.1111/1469-8986.00078
   Little TD, 2006, STRUCT EQU MODELING, V13, P59, DOI 10.1207/s15328007sem1301_3
   Little TD, 1997, MULTIVAR BEHAV RES, V32, P53, DOI 10.1207/s15327906mbr3201_3
   Losel F., 2001, VIOLENCE PSYCHOPATHY
   LUNDQVIST LO, 1995, SCAND J PSYCHOL, V36, P130, DOI 10.1111/j.1467-9450.1995.tb00974.x
   LUNDQVIST LO, 1995, J PSYCHOPHYSIOL, V9, P203
   LYKKEN DT, 1957, J ABNORM SOC PSYCH, V55, P6, DOI 10.1037/h0047232
   Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003
   McDonald R. P, 1999, TEST THEORY UNIFIED
   Meade AW, 2008, J APPL PSYCHOL, V93, P568, DOI 10.1037/0021-9010.93.3.568
   Mier D, 2014, WORLD J BIOL PSYCHIA, V15, P479, DOI 10.3109/15622975.2014.902541
   Milfont TL, 2010, INT J PSYCHOL RES, V3, P111
   Mokros A, 2014, EUR J PSYCHOL ASSESS, V30, P117, DOI 10.1027/1015-5759/a000178
   Mokros A, 2013, CRIM JUSTICE BEHAV, V40, P1397, DOI 10.1177/0093854813492519
   Morecraft RJ, 2007, J COMP NEUROL, V500, P134, DOI 10.1002/cne.21165
   Neumann CS, 2008, J CONSULT CLIN PSYCH, V76, P893, DOI 10.1037/0022-006X.76.5.893
   Newman JP, 2003, SER AFFECTIVE SCI, P904
   Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930
   Niedenthal PM, 2012, ANNU REV PSYCHOL, V63, P259, DOI 10.1146/annurev.psych.121208.131605
   Olderbak S., 2017, J ABNORMAL PSY UNPUB
   Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018
   R Blair R James, 2013, Dialogues Clin Neurosci, V15, P181
   R Core Team, 2014, R LANG ENV STAT COMP
   RINN WE, 1984, PSYCHOL BULL, V95, P52, DOI 10.1037/0033-2909.95.1.52
   Rosseel Y, 2012, J STAT SOFTW, V48, P1
   Sass D., 2001, J PSYCHOEDUCATIONAL, V29, P347
   Seara-Cardoso A, 2015, J PERS, V83, P723, DOI 10.1111/jopy.12113
   Seibt B, 2013, SOC COGNITION, V31, P613, DOI 10.1521/soco.2013.31.5.613
   Sonnby-Borgstrom M, 2002, SCAND J PSYCHOL, V43, P433, DOI 10.1111/1467-9450.00312
   Sonnby-Borgstrom M, 2002, LAKARTIDNINGEN, V99, P1438
   THORNBERRY TP, 1982, AM SOCIOL REV, V47, P505, DOI 10.2307/2095195
   van de Schoot R, 2012, EUR J DEV PSYCHOL, V9, P486, DOI 10.1080/17405629.2012.686740
   Weyers P, 2009, PSYCHOPHYSIOLOGY, V46, P328, DOI 10.1111/j.1469-8986.2008.00771.x
   Wilson K, 2011, CRIM JUSTICE BEHAV, V38, P659, DOI 10.1177/0093854811404120
   Wittchen H. U., 1997, STRUCTURED CLIN INTE
   Wood A, 2006, TRENDS COGN SCI, V20, P227
NR 86
TC 1
Z9 1
U1 4
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 11
PY 2018
VL 13
IS 1
AR e0190714
DI 10.1371/journal.pone.0190714
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FS7BJ
UT WOS:000419952400049
PM 29324826
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tonen-Wolyec, S
   Batina-Agasa, S
   Muwonga, J
   N'kulu, FF
   Bouassa, RSM
   Belec, L
AF Tonen-Wolyec, Serge
   Batina-Agasa, Salomon
   Muwonga, Jeremie
   N'kulu, Franck Fwamba
   Bouassa, Ralph-Sydney Mboumba
   Belec, Laurent
TI Evaluation of the practicability and virological performance of
   finger-stick whole-blood HIV self-testing in French-speaking sub-Saharan
   Africa
SO PLOS ONE
LA English
DT Article
ID DIAGNOSTIC-TEST; ATTITUDES
AB Background
   Opportunities for HIV testing could be enhanced by offering HIV self-testing (HIVST) in populations that fear stigma and discrimination when accessing conventional HIV counselling and testing in health care facilities. Field experience with HIVST has not yet been reported in French-speaking African countries.
   Methods
   The practicability of HIVST was assessed using the prototype the Exacto (R) Test HIV (Biosynex, Strasbourg, France) self-test in 322 adults living in Kisangani and Bunia, Democratic Republic of the Congo, according to World Health Organization's recommendations. Simplified and easy-to-read leaflet was translated in French, Lingala and Swahili.
   Results
   Forty-nine percent of participants read the instructions for use in French, while 17.1% and 33.9% read the instructions in Lingala and Swahili, respectively. The instructions for use were correctly understood in 79.5% of cases. The majority (98.4%) correctly performed the HIV self-test; however, 20.8% asked for oral assistance. Most of the participants (95.3%) found that performing the self-test was easy, while 4.7% found it difficult. Overall, the results were correctly interpreted in 90.2% of cases. Among the positive, negative, and invalid self-tests, misinterpretation occurred in 6.5%, 11.2%, and 16.0% of cases, respectively (P<0.0001). The Cohen's. coefficient was 0.84. The main obstacle for HIVST was educational level, with execution and interpretation difficulties occurring among poorly educated people. The Exacto (R) Test HIV self-test showed 100.0% (95% CI; 98.8-100.0) sensitivity and 99.2% (95% CI; 97.5-99.8) specificity.
   Conclusions
   Our field observations demonstrate: (i) the need to adapt the instructions for use to the Congolese general public, including adding educational pictograms as well as instructions for use in the local vernacular language(s); (ii) frequent difficulties understanding the instructions for use in addition to frequent misinterpretation of test results; and (iii) the generally good practicability of the HIV self-test despite some limitations. Supervised use of HIVST is recommended among poorly-educated people.
C1 [Tonen-Wolyec, Serge] Ecole Doctorale Reg Africa Cent Infectiol Trop, Franceville, Gabon.
   [Tonen-Wolyec, Serge] Univ Bunia, Fac Med, Bunia, DEM REP CONGO.
   [Tonen-Wolyec, Serge; Batina-Agasa, Salomon] Univ Kisangani, Fac Med & Pharm, Kisangani, DEM REP CONGO.
   [Muwonga, Jeremie] Lab Natl Reference Sida, Kinshasa, DEM REP CONGO.
   [N'kulu, Franck Fwamba] Programme Natl Lutte VIH SIDA & IST, Kinshasa, DEM REP CONGO.
   [Bouassa, Ralph-Sydney Mboumba; Belec, Laurent] Hop Europe Georges Pompidou, Lab Virol, Paris, France.
   [Bouassa, Ralph-Sydney Mboumba; Belec, Laurent] Univ Paris 05, Paris Sorbonne Cite, Paris, France.
RP Tonen-Wolyec, S (reprint author), Ecole Doctorale Reg Africa Cent Infectiol Trop, Franceville, Gabon.; Tonen-Wolyec, S (reprint author), Univ Bunia, Fac Med, Bunia, DEM REP CONGO.; Tonen-Wolyec, S (reprint author), Univ Kisangani, Fac Med & Pharm, Kisangani, DEM REP CONGO.
EM wolyec@gmail.com
OI Tonen-Wolyec, Serge/0000-0002-7734-7729
FU University of Bunia, Democratic Republic of Congo; University of
   Kisangani, Democratic Republic of Congo; Programme National de Lutte
   contre le VIH/SIDA et les Infections Sexuellement Transmissibles,
   Kinshasa, Democratic Republic of Congo; pharmaceutical companies
FX The study was partly sponsored by the University of Bunia, Democratic
   Republic of Congo, the University of Kisangani, Democratic Republic of
   Congo, and by the Programme National de Lutte contre le VIH/SIDA et les
   Infections Sexuellement Transmissibles, Kinshasa, Democratic Republic of
   Congo without a grant from pharmaceutical companies. No grant was
   received from the HIV test manufacturer.
CR Aghokeng AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007702
   Asiimwe S, 2014, AIDS BEHAV, V18, P2477, DOI 10.1007/s10461-014-0765-4
   Battye R, 2000, FRENCH LANGUAGE TODA, P257
   Beaulieu Q, 2017, MED MAL INFECT
   Belza MJ, 2012, SEX TRANSM INFECT, V88, P218, DOI 10.1136/sextrans-2011-050131
   Brown B, 2015, GLOB PUBLIC HEALTH, V10, P354, DOI 10.1080/17441692.2014.947303
   Cambiano V, 2015, J INFECT DIS, V212, P570, DOI 10.1093/infdis/jiv040
   Chappelle R, 2012, FDA APPROVES 1 COUNT
   Cherutich P., 2014, Retrovirology: Research and Treatment, V6, P23
   Choko AT, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001873
   Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102
   Figueroa C, 2015, AIDS BEHAV, V19, P1949, DOI 10.1007/s10461-015-1097-8
   JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703
   Johnson C, 2014, AIDS BEHAV, V18, pS391, DOI 10.1007/s10461-014-0832-x
   Johnson CC, 2016, LANCET HIV, V3, pE243, DOI 10.1016/S2352-3018(16)00044-8
   Kalibala S, 2014, AIDS BEHAV, V18, pS405, DOI 10.1007/s10461-014-0830-z
   Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442
   Klarkowski D, 2014, EXPERT REV ANTI-INFE, V12, P49, DOI 10.1586/14787210.2014.866516
   Klarkowski D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081656
   Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Makomo MJ, 2013, SYNERGIES GRANDS LAC, P45
   Makusha T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122783
   Mbopi-Keou FX, 2014, J CLIN MICROBIOL, V52, P660, DOI 10.1128/JCM.02945-13
   Meiberg Annemarie E, 2008, East Afr J Public Health, V5, P49
   Ministere du Plan et Suivi de la Mise en oeuvre de la Revolution de la Modernite (MPSMRM) Ministere de la Sante Publique (MSP) et ICF International, 2014, ENQ DEM SANT REP DEM
   Organisation Internationale de la Francophonie, 2016, 2016 CONC REAL DUN R
   Pai NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079772
   Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414
   Peck RB, 2014, AIDS BEHAV, V18, pS422, DOI 10.1007/s10461-014-0818-8
   Prazuck T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146755
   Shanks L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059906
   Spielberg F, 2004, LANCET INFECT DIS, V4, P640, DOI 10.1016/S1473-3099(04)01150-8
   Stevens DR, 2017, AIDS BEHAV
   Thirumurthy H, 2016, LANCET HIV, V3, pE266, DOI 10.1016/S2352-3018(16)00041-2
   UN Joint Programme on HIV/AIDS (UNAIDS), 2016, PREV GAP REP
   UNAIDS, 2014, 90 90 90 AMB TREATM
   van Rooyen H, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19445
   Vidal N, 2006, AIDS RES HUM RETROV, V22, P202, DOI 10.1089/aid.2006.22.202
   *WHO, 1997, WKLY EPIDEMIOL REC, V72, P81
   WHO, 2012, SERV DEL APPR HIV TE
   WHO (World Health Organization), 2013, 1 INT S SELF TEST HI
   World Health Organisation (WHO), 2017, MARK TECHN LANDSC HI
   World Health Organization, 2015, CONS GUID HIV TEST S
   World Health Organization, 2016, SUPPL GUID HIV SELF
   World Health Organization, 2016, TECHN SPEC SER SUBM, P26
   World Health Organization & Unitaid, 2016, TECHN LANDSC HIV RAP
   World Health Organization (WHO), 2015, WHO PREQ SAMPL PROD
   YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
NR 49
TC 7
Z9 7
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 10
PY 2018
VL 13
IS 1
AR e0189475
DI 10.1371/journal.pone.0189475
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FS3NS
UT WOS:000419689600009
PM 29320504
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Cevallos, CG
   Jones, LR
   Pando, MA
   Carr, JK
   Avila, MM
   Quarleri, J
AF Cevallos, Cintia G.
   Jones, Leandro R.
   Pando, Maria A.
   Carr, Jean K.
   Avila, Maria M.
   Quarleri, Jorge
TI Genomic characterization and molecular evolution analysis of subtype B
   and BF recombinant HIV-1 strains among Argentinean men who have sex with
   men reveal a complex scenario
SO PLOS ONE
LA English
DT Article
ID NEWLY-DIAGNOSED INDIVIDUALS; DRUG-RESISTANCE; SOUTH-AMERICA;
   BUENOS-AIRES; RISK GROUPS; TYPE-1; IDENTIFICATION; DIVERSITY; SEQUENCES;
   FORM
AB Currently, data on HIV-1 circulating strains among men who have sex with men (MSM) in Argentina is scarce. In South America, the distribution and the prevalence of BF recombinants are dissimilar and exhibit an underappreciated heterogeneity of recombinant structures. Here, we studied for the first time the genetic diversity of HIV-1 BF recombinants and their evolution over time through in-depth phylogenetic analysis and multiple recombination detection methods involving 337 HIV-1 nucleotide sequences (25 near full-length (NFL) and 312 partial pol gene) obtained from Argentinean MSM. The recombination profiles were studied using multiple in silico tools to characterize the genetic mosaicism, and phylogenetic approaches to infer their relationships. The evolutionary history of BF recombinants and subtype B sequences was reconstructed by a Bayesian coalescent-based method. By phylogenetic inference, 81/312 pol sequences clustered within BF clade. Of them, 46 sequences showed a genetic mosaic with CRF12_BF-like patterns, including plausible second-generation recombinants. Other CRFs_BF like (CRF17, 28, 29, 39, 42, 44, 47) and probable URFs_BF were less frequently found. Phylogenetic and recombination analyses on NFL sequences allowed a meticulous definition of new BF mosaics of genomic patterns. The Bayesian analyses pointed out quite consistent onset dates for the CRFs_BF clade based on B and F gene datasets (similar to 1986 and similar to 1991 respectively). These results indicate that the CRFs_BF variants have been circulating among Argentinean MSM for about 30 years. This study reveals, through growing evidence showing the importance of MSM in the dynamics of the HIV-1 epidemic in Argentina, the coexistence of CRF12_BF-like and high diversity of strains exhibiting several BF mosaic patterns, including non-reported URFs that may reflect active clusters as potential intervention targets to hinder HIV-1 transmission.
C1 [Cevallos, Cintia G.; Pando, Maria A.; Avila, Maria M.; Quarleri, Jorge] UBA, Fac Med, Inst Invest Biomed Retrovirus & Sida INBIRS, Buenos Aires, DF, Argentina.
   [Cevallos, Cintia G.; Jones, Leandro R.; Pando, Maria A.; Avila, Maria M.; Quarleri, Jorge] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.
   [Jones, Leandro R.] Univ Nacl Patagonia San Juan Bosco, Sede Trelew, Fac Ciencias Nat & Ciencias Salud, LVGM, Chubut, Argentina.
   [Carr, Jean K.] Lake Erie Coll Osteopath Med, Seton Hill, Greensburg, PA USA.
RP Quarleri, J (reprint author), UBA, Fac Med, Inst Invest Biomed Retrovirus & Sida INBIRS, Buenos Aires, DF, Argentina.; Quarleri, J (reprint author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.
EM quarleri@fmed.uba.ar
FU Agencia Nacional de Promocion Cientifica y Tecnologica-Fondo Nacional
   para la Ciencia y Tecnica [PICT 2013/2229]; Consejo Nacional de
   Investigaciones Cientificas y Tecnicas [PIP 2012/1048]
FX This study was supported by grants obtained by MMA from the Agencia
   Nacional de Promocion Cientifica y Tecnologica-Fondo Nacional para la
   Ciencia y Tecnica (grant number PICT 2013/2229) and the Consejo Nacional
   de Investigaciones Cientificas y Tecnicas (grant number PIP 2012/1048)
   to MMA. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453
   Argentinean National Health Ministry; AIDS and STD Department, 2016, 33 B HIV AIDS ARG
   Aulicino PC, 2012, INFECT GENET EVOL, V12, P443, DOI 10.1016/j.meegid.2012.01.003
   Aulicino PC, 2011, INFECT GENET EVOL, V11, P349, DOI 10.1016/j.meegid.2010.11.008
   Avila MM, 2002, J ACQ IMMUN DEF SYND, V29, P422
   Bello G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-22
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Carr JK, 2001, AIDS, V15, pF41, DOI 10.1097/00002030-200110190-00002
   Carrion G, 2004, AIDS RES HUM RETROV, V20, P1022, DOI 10.1089/aid.2004.20.1022
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   De Sa DJ, 2006, AIDS RES HUM RETROV, V22, P1
   Delgado E, 2010, AIDS RES HUM RETROV, V26, P821, DOI 10.1089/aid.2010.0006
   Dilernia DA, 2007, AIDS RES HUM RETROV, V23, P1201, DOI 10.1089/aid.2007.0068
   Dilernia DA, 2011, AIDS RES HUM RETROV, V27, P569, DOI 10.1089/aid.2010.0118
   Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739
   Gomez-Carrillo M, 2004, AIDS RES HUM RETROV, V20, P885, DOI 10.1089/0889222041725172
   Gomez-Carrillo M, 2006, AIDS RES HUM RETROV, V22, P1186, DOI 10.1089/aid.2006.22.1186
   Guimaraes ML, 2008, AIDS, V22, P433, DOI 10.1097/QAD.0b013e3282f47ad0
   Guindon S, 2010, NEW ALGORITHMS METHO
   Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102
   Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lantz CA, 1996, J CLIN EPIDEMIOL, V49, P431, DOI 10.1016/0895-4356(95)00571-4
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Maydt J, 2006, BIOINFORMATICS, V22, P1064, DOI 10.1093/bioinformatics/btl057
   Pando MA, 2011, AIDS RES HUM RETROV, V27, P17, DOI 10.1089/aid.2010.0013
   Pando MA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-59
   Pando MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039834
   Posada D, 2002, MOL BIOL EVOL, V19, P708, DOI 10.1093/oxfordjournals.molbev.a004129
   Quarleri JF, 2004, AIDS RES HUM RETROV, V20, P1100, DOI 10.1089/aid.2004.20.1100
   Ristic N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017485
   Ruchansky D, 2009, AIDS RES HUM RETROV, V25, P351, DOI 10.1089/aid.2008.0248
   SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423
   Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371
   Segura M, 2007, AIDS RES HUM RETROV, V23, P1322, DOI 10.1089/aid.2007.0063
   Sierra Maria, 2005, Infection Genetics and Evolution, V5, P209, DOI 10.1016/j.meegid.2004.07.010
   Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872
   Thomson MM, 2002, J GEN VIROL, V83, P107, DOI 10.1099/0022-1317-83-1-107
NR 38
TC 2
Z9 2
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 15
PY 2017
VL 12
IS 12
AR e0189705
DI 10.1371/journal.pone.0189705
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FQ2KG
UT WOS:000418184700053
PM 29244833
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Borotikar, B
   Lempereur, M
   Lelievre, M
   Burdin, V
   Ben Salem, D
   Brochard, S
AF Borotikar, Bhushan
   Lempereur, Mathieu
   Lelievre, Mathieu
   Burdin, Valerie
   Ben Salem, Douraied
   Brochard, Sylvain
TI Dynamic MRI to quantify musculoskeletal motion: A systematic review of
   concurrent validity and reliability, and perspectives for evaluation of
   musculoskeletal disorders
SO PLOS ONE
LA English
DT Review
ID PHASE-CONTRAST MRI; REAL-TIME MRI; IN-VIVO; PATELLOFEMORAL PAIN;
   WEIGHT-BEARING; JOINT KINEMATICS; SKELETAL-MUSCLE; KNEE KINEMATICS;
   PATELLAR TRACKING; ACHILLES-TENDON
AB Purpose
   To report evidence for the concurrent validity and reliability of dynamic MRI techniques to evaluate in vivo joint and muscle mechanics, and to propose recommendations for their use in the assessment of normal and impaired musculoskeletal function.
   Materials and methods
   The search was conducted on articles published in Web of science, PubMed, Scopus, Academic search Premier, and Cochrane Library between 1990 and August 2017. Studies that reported the concurrent validity and/or reliability of dynamic MRI techniques for in vivo evaluation of joint or muscle mechanics were included after assessment by two independent reviewers. Selected articles were assessed using an adapted quality assessment tool and a data extraction process. Results for concurrent validity and reliability were categorized as poor, moderate, or excellent.
   Results
   Twenty articles fulfilled the inclusion criteria with a mean quality assessment score of 66% (10.4%). Concurrent validity and/or reliability of eight dynamic MRI techniques were reported, with the knee being the most evaluated joint (seven studies). Moderate to excellent concurrent validity and reliability were reported for seven out of eight dynamic MRI techniques. Cine phase contrast and real-time MRI appeared to be the most valid and reliable techniques to evaluate joint motion, and spin tag for muscle motion.
   Conclusion
   Dynamic MRI techniques are promising for the in vivo evaluation of musculoskeletal mechanics; however results should be evaluated with caution since validity and reliability have not been determined for all joints and muscles, nor for many pathological conditions.
C1 [Borotikar, Bhushan; Lempereur, Mathieu; Burdin, Valerie; Ben Salem, Douraied; Brochard, Sylvain] INSERM, Lab Traitement Informat Med, U1101, Brest, France.
   [Borotikar, Bhushan; Burdin, Valerie] IMT Atlantique, Brest, France.
   [Lempereur, Mathieu; Brochard, Sylvain] CHRU Brest, Hop Morvan, Serv Med Phys & Readaptat, Brest, France.
   [Lelievre, Mathieu; Ben Salem, Douraied; Brochard, Sylvain] Univ Bretagne Occidentale, Brest, France.
   [Ben Salem, Douraied] CHRU Brest, Neuroradiol, Imagerie Medicolegale, Brest, France.
RP Borotikar, B (reprint author), INSERM, Lab Traitement Informat Med, U1101, Brest, France.; Borotikar, B (reprint author), IMT Atlantique, Brest, France.
EM Bhushan.borotikar@imt-atlantique.fr
OI LEMPEREUR, Mathieu/0000-0002-6717-7033; Borotikar,
   Bhushan/0000-0002-3404-6547
FU La Fondation Motrice, Paris, France [2015-A01409-40]; La Fondation de
   l'Avenir, Paris, France [AP-RMA-16-041]
FX Funding for this project was provided by grants from La Fondation
   Motrice (grant no. 2015-A01409-40 to SB), Paris, France and La Fondation
   de l'Avenir (grant no. AP-RMA-16-041 to BB), Paris, France. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Asakawa DS, 2003, J MAGN RESON IMAGING, V18, P734, DOI 10.1002/jmri.10422
   Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002
   Barrance PJ, 2005, J BIOMECH ENG-T ASME, V127, P829, DOI 10.1115/1.1992524
   BARTKO JJ, 1976, PSYCHOL BULL, V83, P762, DOI 10.1037/0033-2909.83.5.762
   Behnam AJ, 2011, J BIOMECH, V44, P193, DOI 10.1016/j.jbiomech.2010.08.029
   Blemker SS, 2007, J MAGN RESON IMAGING, V25, P441, DOI 10.1002/jmri.20805
   Borotikar BS, 2013, OSTEOARTHR CARTILAGE, V21, P1886, DOI 10.1016/j.joca.2013.08.023
   Boutin RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084004
   BROSSMANN J, 1993, RADIOLOGY, V187, P205, DOI 10.1148/radiology.187.1.8451415
   Brown MA, 1999, RADIOLOGY, V213, P647, DOI 10.1148/radiology.213.3.r99dc18647
   Cereatti A, 2014, J BIOMECH, V47, P3771, DOI 10.1016/j.jbiomech.2014.09.021
   Clarke EC, 2015, MED ENG PHYS, V37, P93, DOI 10.1016/j.medengphy.2014.11.003
   Csapo R, 2013, J APPL PHYSIOL, V115, P468, DOI 10.1152/japplphysiol.00395.2013
   d'Entremont AG, 2013, MAGN RESON MED, V69, P1634, DOI 10.1002/mrm.24425
   Dahabreh IJ, 2011, ANN INTERN MED, V155, P616, DOI 10.7326/0003-4819-155-9-201111010-00009
   DONNER A, 1987, STAT MED, V6, P441, DOI 10.1002/sim.4780060404
   DRACE JE, 1994, J MAGN RESON IMAGING, V4, P157, DOI 10.1002/jmri.1880040211
   DRACE JE, 1994, J MAGN RESON IMAGING, V4, P773, DOI 10.1002/jmri.1880040606
   Draper CE, 2008, J MAGN RESON IMAGING, V28, P158, DOI 10.1002/jmri.21413
   Draper CE, 2011, J ORTHOP RES, V29, P312, DOI 10.1002/jor.21253
   Draper CE, 2009, J ORTHOP RES, V27, P571, DOI 10.1002/jor.20790
   ELIASZIW M, 1994, PHYS THER, V74, P777, DOI 10.1093/ptj/74.8.777
   Fellows RA, 2005, J BIOMECH, V38, P1643, DOI 10.1016/j.jbiomech.2004.07.021
   Finni T, 2006, CLIN BIOMECH, V21, P67, DOI 10.1016/j.clinbiomech.2005.08.007
   Gilles B, 2005, ACAD RADIOL, V12, P1285, DOI 10.1016/j.acra.2005.08.006
   Gold GE, 2004, J MAGN RESON IMAGING, V20, P526, DOI 10.1002/jmri.20146
   Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171
   Heale Roberta, 2015, Evid Based Nurs, V18, P66, DOI 10.1136/eb-2015-102129
   Hopfgartner AJ, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20120436
   Jensen ER, 2015, J BIOMECH, V48, P95, DOI 10.1016/j.jbiomech.2014.10.035
   Jung H, 2007, PHYS MED BIOL, V52, P3201, DOI 10.1088/0031-9155/52/11/018
   Jung H, 2009, MAGN RESON MED, V61, P103, DOI 10.1002/mrm.21757
   Kaiser J, 2016, MED ENG PHYS, V38, P1131, DOI 10.1016/j.medengphy.2016.06.016
   Kinugasa R, 2012, J APPL PHYSIOL, V112, P463, DOI 10.1152/japplphysiol.00666.2011
   Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012
   Kulig K, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-8
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langner I, 2015, SKELETAL RADIOL, V44, P1103, DOI 10.1007/s00256-015-2126-4
   Lao LF, 2014, EUR SPINE J, V23, P1725, DOI 10.1007/s00586-014-3385-9
   LEMPEREUR M, 2014, DEV MED CHILD NEUROL, V47, P2219, DOI DOI 10.1016/J.JBIOMECH.2014.04.028
   Lempereur M, 2014, J BIOMECH, V47, P2219, DOI 10.1016/j.jbiomech.2014.04.028
   Lin CC, 2013, MED PHYS, V40, DOI 10.1118/1.4820369
   LINGAMNENI A, 1995, JMRI-J MAGN RESON IM, V5, P331, DOI 10.1002/jmri.1880050318
   Maganaris CN, 2004, EUR J APPL PHYSIOL, V91, P130, DOI 10.1007/s00421-003-1033-x
   McWalter EJ, 2010, J BIOMECH, V43, P1890, DOI 10.1016/j.jbiomech.2010.03.027
   MELCHERT UH, 1992, MAGN RESON IMAGING, V10, P457, DOI 10.1016/0730-725X(92)90517-4
   Moerman KM, 2012, MED PHYS, V39, P1793, DOI 10.1118/1.3685579
   MUHLE C, 1995, RADIOLOGE, V35, P117
   Muhle C, 1999, ACTA RADIOL, V40, P146, DOI 10.3109/02841859909177730
   NIITSU M, 1992, JMRI-J MAGN RESON IM, V2, P155, DOI 10.1002/jmri.1880020208
   PETTIGREW RI, 1989, RADIOL CLIN N AM, V27, P1183
   Pierrart J, 2014, J MAGN RESON IMAGING, V39, P729, DOI 10.1002/jmri.24204
   Powers CM, 1998, J MAGN RESON IMAGING, V8, P724, DOI 10.1002/jmri.1880080332
   Powers CM, 2003, J ORTHOP SPORT PHYS, V33, P677, DOI 10.2519/jospt.2003.33.11.677
   Rebmann AJ, 2003, J MAGN RESON IMAGING, V17, P206, DOI 10.1002/jmri.10253
   Reddy KS, 2016, LANCET, V388, P1448, DOI 10.1016/S0140-6736(16)31743-3
   Sampson M, 2006, J CLIN EPIDEMIOL, V59, P1057, DOI 10.1016/j.jclinepi.2006.01.007
   Sen Jia, 2011, 2011 9th IEEE International Conference on Control and Automation (ICCA 2011), P859, DOI 10.1109/ICCA.2011.6138099
   Shapiro LM, 2012, OSTEOARTHR CARTILAGE, V20, P69, DOI 10.1016/j.joca.2011.11.003
   Sheehan FT, 2008, CLIN ORTHOP RELAT R, V466, P450, DOI 10.1007/s11999-007-0004-7
   Sheehan FT, 2007, J BIOMECH, V40, P1968, DOI 10.1016/j.jbiomech.2006.09.029
   Sheehan FT, 2007, FOOT ANKLE INT, V28, P323, DOI 10.3113/FAI.2007.0323
   Sheehan FT, 2012, CLIN BIOMECH, V27, P525, DOI 10.1016/j.clinbiomech.2011.12.012
   Sheehan FT, 2009, J ORTHOP RES, V27, P561, DOI 10.1002/jor.20783
   Sheehan FT, 1998, J BIOMECH, V31, P21
   SHELLOCK FG, 1993, RADIOLOGY, V188, P575, DOI 10.1148/radiology.188.2.8327718
   Siegler S, 2005, J BIOMECH, V38, P567, DOI 10.1016/j.jbiomech.2004.03.036
   Sinha S, 2004, J MAGN RESON IMAGING, V20, P1008, DOI 10.1002/jmri.20210
   STEIN LA, 1993, AM J ROENTGENOL, V161, P617, DOI 10.2214/ajr.161.3.8352119
   Storheim K, 2014, ANN RHEUM DIS, V73, P949, DOI 10.1136/annrheumdis-2014-205327
   Studler U, 2011, SKELETAL RADIOL, V40, P335, DOI 10.1007/s00256-010-0884-6
   Tashman S, 2004, AM J SPORT MED, V32, P975, DOI 10.1177/0363546503261709
   Tempelaere C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158563
   Thomeer LT, 2017, J BIOMECH, V60, P238, DOI 10.1016/j.jbiomech.2017.06.024
   Tsao J, 2012, J MAGN RESON IMAGING, V36, P543, DOI 10.1002/jmri.23640
   Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511
   Vitaz TW, 2004, SOUTH MED J, V97, P456, DOI 10.1097/00007611-200405000-00008
   Vos T, 2016, LANCET, V388, P1545, DOI 10.1016/S0140-6736(16)31678-6
   Wang EY, 2007, AM J NEURORADIOL, V28, P1126, DOI 10.3174/ajnr.A0487
   Wang YC, 2008, J FORMOS MED ASSOC, V107, P334, DOI 10.1016/S0929-6646(08)60095-9
   Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1
   Westphal CJ, 2013, J BIOMECH, V46, P2045, DOI 10.1016/j.jbiomech.2013.05.027
   Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25
   Yustin D C, 1993, J Prosthodont, V2, P190, DOI 10.1111/j.1532-849X.1993.tb00406.x
   Zhang S, 2011, REAL TIME MAGNETIC R
   Zhu YD, 1999, JMRI-J MAGN RESON IM, V9, P111, DOI 10.1002/(SICI)1522-2586(199901)9:1<111::AID-JMRI15>3.0.CO;2-5
   Zumbo BD, 2014, SOC INDIC RES SER, V54, P1, DOI 10.1007/978-3-319-07794-9
NR 87
TC 3
Z9 3
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 12
PY 2017
VL 12
IS 12
AR e0189587
DI 10.1371/journal.pone.0189587
PG 26
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FP5YF
UT WOS:000417698200059
PM 29232401
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gini, R
   Schuemie, MJ
   Pasqua, A
   Carlini, E
   Profili, F
   Cricelli, I
   Dazzi, P
   Barletta, V
   Francesconi, P
   Lapi, F
   Donatini, A
   Dal Co, G
   Visca, M
   Bellentani, M
   Sturkenboom, M
   Klazinga, N
AF Gini, Rosa
   Schuemie, Martijn J.
   Pasqua, Alessandro
   Carlini, Emanuele
   Profili, Francesco
   Cricelli, Iacopo
   Dazzi, Patrizio
   Barletta, Valentina
   Francesconi, Paolo
   Lapi, Francesco
   Donatini, Andrea
   Dal Co, Giulia
   Visca, Modesta
   Bellentani, Mariadonata
   Sturkenboom, Miriam
   Klazinga, Niek
TI Monitoring compliance with standards of care for chronic diseases using
   healthcare administrative databases in Italy: Strengths and limitations
SO PLOS ONE
LA English
DT Article
AB Background
   A recent comprehensive report on healthcare quality in Italy published by the Organization of Economic Co-operation and Development (OECD) recommended that regular monitoring of quality of primary care by means of compliance with standards of care for chronic diseases is performed. A previous ecological study demonstrated that compliance with standards of care could be reliably estimated on regional level using administrative databases. This study compares estimates based on administrative data with estimates based on GP records for the same persons, to understand whether ecological fallacy played a role in the results of the previous study.
   Methods
   We compared estimates of compliance with diagnostic and therapeutic standards of care for type 2 diabetes (T2DM), hypertension and ischaemic heart disease (IHD) from administrative data (IAD) with estimates from medical records (MR) for the same persons registered with 24 GP's in 2012. Data were linked at an individual level.
   Results
   32,688 persons entered the study, 12,673 having at least one of the three diseases according to at least one data source. Patients not detected by IAD were many, for all three conditions: adding MR increased the number of cases of T2DM, hypertension, and IHD by + 40%, 42%, and + 104%, respectively. IAD had imperfect sensitivity in detecting population compliance with therapies (adding MR increased the estimate, from + 11.5% for statins to + 14.7% for antithrombotics), and, more substantially, with diagnostic recommendations (adding MR increased the estimate, from + 23.7% in glycated hemoglobin tests, to + 50.5% in electrocardiogram). Patients not detected by IAD were less compliant with respect to those that IAD correctly identified (from -4.8 percentage points in proportion of IHD patients compliant with a yearly glycated hemoglobin test, to -40.1 points in the proportion of T2DM patients compliant with the same recommendation). IAD overestimated indicators of compliance with therapeutic standards (significant differences ranged from 3.3. to 3.6 percentage points) and underestimated indicators of compliance with diagnostic standards (significant differences ranged from -2.3 to -14.1 percentage points).
   Conclusion
   IAD overestimated the percentage of patients compliant with therapeutic standards by less than 6 percentage points, and underestimated the percentage of patients compliant with diagnostic standards by a maximum of 14 percentage points. Therefore, both discussions at local level between GP's and local health unit managers and discussions at central level between national and regional policy makers can be informed by indicators of compliance estimated by IAD, which, based on those results, have the ability of signalling critical or excellent clusters. However, this study found that estimates are partly flawed, because a high number of patients with chronic diseases are not detected by IAD, patients detected are not representative of the whole population of patients, and some categories of diagnostic tests are markedly underrecorded in IAD (up to 50% in the case of electrocardiograms). Those results call to caution when interpreting IAD estimates. Audits based on medical records, on the local level, and an interpretation taking into account information external to IAD, on the central level, are needed to assess a more comprehensive compliance with standards.
C1 [Gini, Rosa; Profili, Francesco; Barletta, Valentina; Francesconi, Paolo; Sturkenboom, Miriam] Agenzia Reg Sanita Toscana, Osservatorio Epidemiol, Florence, Italy.
   [Gini, Rosa] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands.
   [Schuemie, Martijn J.] Janssen Res & Dev, Epidemiol, Titusville, NJ USA.
   [Schuemie, Martijn J.] OHDSI, New York, NY USA.
   [Pasqua, Alessandro; Lapi, Francesco] Italian Coll Gen Practitioners & Primary Care, Hlth Search, Florence, Italy.
   [Carlini, Emanuele; Dazzi, Patrizio] CNR, Ist Sci & Tecnol Informaz, Pisa, Italy.
   [Cricelli, Iacopo] Genomedics, Florence, Italy.
   [Donatini, Andrea] Assessorato Polit Salute, Bologna, Italy.
   [Dal Co, Giulia; Visca, Modesta; Bellentani, Mariadonata] Agenzia Nazl Serv Sanit Reg, Rome, Italy.
   [Klazinga, Niek] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands.
RP Gini, R (reprint author), Agenzia Reg Sanita Toscana, Osservatorio Epidemiol, Florence, Italy.; Gini, R (reprint author), Erasmus MC, Dept Med Informat, Rotterdam, Netherlands.
EM rosa.gini@ars.toscana.it
OI Gini, Rosa/0000-0002-6250-877X; Sturkenboom, Miriam/0000-0003-1360-2388;
   Dazzi, Patrizio/0000-0001-8504-1503; Schuemie,
   Martijn/0000-0002-0817-5361
FU project named "Integrazione dei contenuti informativi per la gestione
   sul territorio di pazienti con patologie complesse o con patologie
   croniche"; Italian Ministry of Health
FX This study was funded by the project named "Integrazione dei contenuti
   informativi per la gestione sul territorio di pazienti con patologie
   complesse o con patologie croniche", short name MATRICE, funded by the
   Italian Ministry of Health to M Bellentani. The funding organization did
   not play a role in the study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. I Cricelli, A
   Pasqua and F Lapi are employed by Genomedics, which is a commercial
   company, and M J Schuemie is employed by Janssen Research and
   Development LLC, which is a commercial company. Genomedics and Janssen
   Research and Development LLC provided support in the form of salaries
   for authors I Cricelli, A Pasqua, F Lapi and M J Schuemie, respectively,
   but did not have any additional role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. The specific roles of these authors are articulated in the
   'author contributions' section.
CR [Anonymous], 2015, OECD REV HLTH CAR QU
   Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
   Barletta V, 2016, EUR J PUBLIC HLTH
   Chien AT, 2012, PREV MED, V55, pS80, DOI 10.1016/j.ypmed.2012.05.004
   Gini R, 2016, VALIDATION ODYSSEY B
   Gini R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012413
   Gini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095419
   Gini R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-15
   Health Search, 8 HLTH SEARCH
   Hirsch AG, 2013, AM J MED QUALITY
   Italian National Institute of Statistics, COND SAL RIC SERV SA
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mazzaglia G, 2009, CIRCULATION, V120, P1598, DOI 10.1161/CIRCULATIONAHA.108.830299
   McGovern MP, 2008, FAM PRACT, V25, P33, DOI 10.1093/fampra/cmm073
   Sakshaug JW, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-150
   Sultana J, 2014, EUR J CLIN PHARMACOL, V70, P469, DOI 10.1007/s00228-013-1636-z
   Visca M, 2013, HEALTH POLICY, V113, P188, DOI 10.1016/j.healthpol.2013.05.016
NR 17
TC 2
Z9 2
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 12
PY 2017
VL 12
IS 12
AR e0188377
DI 10.1371/journal.pone.0188377
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FP5YF
UT WOS:000417698200004
PM 29232365
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tanaka, K
   Nishigami, T
   Mibu, A
   Manfuku, M
   Yono, S
   Shinohara, Y
   Tanabe, A
   Ono, R
AF Tanaka, Katsuyoshi
   Nishigami, Tomohiko
   Mibu, Akira
   Manfuku, Masahiro
   Yono, Satoko
   Shinohara, Yoshikazu
   Tanabe, Akihito
   Ono, Rei
TI Validation of the Japanese version of the Central Sensitization
   Inventory in patients with musculoskeletal disorders
SO PLOS ONE
LA English
DT Article
ID CENTRAL SENSITIVITY SYNDROMES; QUALITY-OF-LIFE; TOTAL KNEE ARTHROPLASTY;
   CHRONIC PAIN SAMPLE; LOW-BACK-PAIN; CHRONIC WHIPLASH; POSTOPERATIVE
   PAIN; WIDESPREAD PAIN; GLOBAL BURDEN; HEALTH-STATUS
AB Background
   Many musculoskeletal pain conditions are characterized by hypersensitivity, which is induced by central sensitization (CS). A questionnaire, the Central Sensitization Inventory (CSI), was recently developed to help clinicians identify patients whose presenting symptoms may be related to central sensitivity syndrome (CSS). The aims of the present study were to examine criterion validity and construct validity of the Japanese version of the CSI (CSI-J), and to investigate prevalence rates of CS severity levels in patients with musculoskeletal disorders.
   Methods
   Translation of the CSI into Japanese was conducted using a forward-backward method. Two hundred and ninety patients with musculoskeletal pain disorders completed the resultant CSI-J. A subset of the patients (n = 158) completed the CSI-J again one week later. The relationships between CSI and clinical symptoms, EuroQol 5-dimension (EQ-5D) and Brief Pain Inventory (BPI), were examined for criterion validity. EQ-5D assesses Health-related QOL and BPI measures pain intensity and pain interference. The psychometric properties were evaluated with analyses of construct validity, factor structure and internal consistency, and subsequently investigate the prevalence rates of CS severity levels.
   Results
   The CSI-J demonstrated high internal consistency (Cronbach's a = 0.89) and test-retest reliability was excellent value (ICC = 0.85). The CSI-J was significantly correlated with EQ-5D (r = -0.44), pain intensity (r = 0.42), and pain interference (r = 0.48) (p < 0.01 for all). Ten percent of the participants were above the cutoff "40". The exploratory factor analysis resulted in 5-factor model.
   Conclusions
   This study reported that the CSI-J was a useful and psychometrically sound tool to assess CSS in Japanese patients with musculoskeletal disorders. The finding of the prevalence rates of CS severity levels in patients with musculoskeletal disorders may help clinicians to decide strategy of treatment.
C1 [Tanaka, Katsuyoshi; Mibu, Akira; Manfuku, Masahiro; Yono, Satoko; Shinohara, Yoshikazu; Tanabe, Akihito] Tanabe Orthopaed, Dept Rehabil, Osaka, Osaka, Japan.
   [Tanaka, Katsuyoshi; Ono, Rei] Kobe Univ, Dept Community Hlth Sci, Grad Sch Hlth Sci, Kobe, Hyogo, Japan.
   [Nishigami, Tomohiko; Mibu, Akira] Konan Womens Univ, Dept Nursing & Phys Therapy, Kobe, Hyogo, Japan.
RP Nishigami, T (reprint author), Konan Womens Univ, Dept Nursing & Phys Therapy, Kobe, Hyogo, Japan.
EM t-nishi@konan-wu.ac.jp
FU Japan Society for the Promotion of Science KAKENHI [JP17K01543]; JSPS
   KAKENHI [JP17K01543]
FX Funding provided by the Japan Society for the Promotion of Science
   KAKENHI Grant Number JP17K01543
   (https://www.dsps.go.jp/english/e-grants/). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.; We thank Yuko Inoue, Yuno Yonezaki, and
   Akihisa Watanabe for assistance with data collection and data analysis.
   This study was supported by JSPS KAKENHI Grant Number JP17K01543.
CR Abdel-Aziz Shaimaa Baher, 2017, Asian Pac J Cancer Prev, V18, P2409
   Aggarwal VR, 2006, INT J EPIDEMIOL, V35, P468, DOI 10.1093/ije/dyi265
   Al-Harthy M, 2017, J ORAL REHABIL, V44, P415, DOI 10.1111/joor.12499
   Ang DC, 2011, J PAIN, V12, P384, DOI 10.1016/j.jpain.2010.09.004
   Bennett EE, 2017, WORLD NEUROSURG, V104, P594, DOI 10.1016/j.wneu.2017.04.166
   Brantingham JW, 2013, J MANIP PHYSIOL THER, V36, P143, DOI 10.1016/j.jmpt.2013.04.001
   Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129
   Coombes BK, 2012, CLIN J PAIN, V28, P595, DOI 10.1097/AJP.0b013e31823dd333
   Coppieters I, 2015, PAIN PHYSICIAN, V18, pE389
   Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005
   Ferreira-Valente MA, 2014, CLIN J PAIN, V30, P713, DOI 10.1097/AJP.0000000000000027
   Giesecke T, 2004, ARTHRITIS RHEUM-US, V50, P613, DOI 10.1002/art.20063
   Herren-Gerber R, 2004, PAIN MED, V5, P366, DOI 10.1111/j.1526-4637.2004.04055.x
   Hoy DG, 2014, ANN RHEUM DIS, V73, P982, DOI 10.1136/annrheumdis-2013-204344
   Cuesta-Vargas AI, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3515-4
   Jull G, 2007, PAIN, V129, P28, DOI 10.1016/j.pain.2006.09.030
   Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005
   Kim SH, 2015, PAIN PRACT, V15, pE46, DOI 10.1111/papr.12311
   Kindler LL, 2010, J PAIN, V11, P1320, DOI 10.1016/j.jpain.2010.03.007
   Kregel J, 2016, CLIN J PAIN, V32, P624, DOI 10.1097/AJP.0000000000000306
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lin K, 2017, CLIN ORTHOP RELAT R, V475, P2992, DOI 10.1007/s11999-017-5495-2
   Lluch E, 2014, EUR J PAIN, V18, P1367, DOI 10.1002/j.1532-2149.2014.499.x
   Loeser JD, 2008, PAIN, V137, P473, DOI 10.1016/j.pain.2008.04.025
   Lunn TH, 2013, PAIN, V154, P1878, DOI 10.1016/j.pain.2013.06.008
   Mayer TG, 2012, PAIN PRACT, V12, P276, DOI 10.1111/j.1533-2500.2011.00493.x
   Mease PJ, 2011, J RHEUMATOL, V38, P1546, DOI 10.3899/jrheum.100759
   Meeus M, 2007, CLIN RHEUMATOL, V26, P465, DOI 10.1007/s10067-006-0433-9
   Meeus M, 2012, SEMIN ARTHRITIS RHEU, V41, P556, DOI 10.1016/j.semarthrit.2011.08.001
   Mendoza TR, 2012, J PAIN, V13, P564, DOI 10.1016/j.jpain.2012.03.003
   Moeller-Bertram T, 2014, PAIN MED, V15, P762, DOI 10.1111/pme.12424
   Neblett R, 2017, PAIN PRACT, V17, P166, DOI 10.1111/papr.12440
   Neblett R, 2015, CLIN J PAIN, V31, P323, DOI 10.1097/AJP.0000000000000113
   Neblett R, 2013, J PAIN, V14, P438, DOI 10.1016/j.jpain.2012.11.012
   Osborne J. W., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI DOI 10.4135/9781412995627.D8
   Pitance L, 2016, INT FED ORTH PHYS TH
   Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087
   Rief W, 2001, PSYCHOSOM MED, V63, P595, DOI 10.1097/00006842-200107000-00012
   Robinson-Lane Sheria G, 2017, J Gerontol Nurs, P1, DOI 10.3928/00989134-20170224-03
   Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041
   Roussel NA, 2013, CLIN J PAIN, V29, P625, DOI 10.1097/AJP.0b013e31826f9a71
   Sampalli T, 2012, PATIENT PREFER ADHER, V6, P757, DOI 10.2147/PPA.S35201
   Schur EA, 2007, J GEN INTERN MED, V22, P818, DOI 10.1007/s11606-007-0140-5
   Staud R, 2011, CURR RHEUMATOL REP, V13, P513, DOI 10.1007/s11926-011-0206-6
   Sterling M, 2002, J MUSCULOSKELET PAIN, V10, P69, DOI 10.1300/J094v10n03_05
   Sterling M, 2003, PAIN, V104, P509, DOI 10.1016/S0304-3959(03)00078-2
   Struyf F, 2013, CLIN RHEUMATOL, V32, P73, DOI 10.1007/s10067-012-2093-2
   Suokas AK, 2012, OSTEOARTHR CARTILAGE, V20, P1075, DOI 10.1016/j.joca.2012.06.009
   Tanaka K, 2017, J MUSCULOSKELET PAIN, V9, P34
   Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012
   Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673
   Uki J, 1998, J PAIN SYMPTOM MANAG, V16, P364, DOI 10.1016/S0885-3924(98)00098-0
   van Wilgen CP, 2013, SCAND J MED SCI SPOR, V23, P149, DOI 10.1111/j.1600-0838.2011.01375.x
   VELICER WF, 1990, MULTIVAR BEHAV RES, V25, P1, DOI 10.1207/s15327906mbr2501_1
   Vierck CJ, 2006, PAIN, V124, P242, DOI 10.1016/j.pain.2006.06.001
   Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2
   WILLIAMS A, 1990, HEALTH POLICY, V16, P199
   Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030
   Yunus MB, 2007, BEST PRACT RES CL RH, V21, P481, DOI 10.1016/j.berh.2007.03.006
   Yunus MB, 2007, SEMIN ARTHRITIS RHEU, V36, P339, DOI 10.1016/j.semarthrit.2006.12.009
NR 60
TC 7
Z9 7
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 7
PY 2017
VL 12
IS 12
AR e0188719
DI 10.1371/journal.pone.0188719
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FP0ZD
UT WOS:000417337800037
PM 29216211
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Timmerman, H
   Steegers, MAH
   Huygen, FJPM
   Goeman, JJ
   van Dasselaar, NT
   Schenkels, MJ
   Wilder-Smith, OHG
   Wolff, AAP
   Vissers, KCP
AF Timmerman, Hans
   Steegers, Monique A. H.
   Huygen, Frank J. P. M.
   Goeman, Jelle J.
   van Dasselaar, Nick T.
   Schenkels, Marcel J.
   Wilder-Smith, Oliver H. G.
   Wolff, Andre A. P.
   Vissers, Kris C. P.
TI Investigating the validity of the DN4 in a consecutive population of
   patients with chronic pain
SO PLOS ONE
LA English
DT Article
ID CHRONIC NEUROPATHIC PAIN; IASP GRADING SYSTEM; DIAGNOSTIC QUESTIONNAIRE;
   DIFFERENTIAL-DIAGNOSIS; RELIABILITY; VERSION; VALIDATION; COMPONENTS;
   PRINCIPLES; GUIDELINES
AB Neuropathic pain is clinically described as pain caused by a lesion or disease of the somatosensory nervous system. The aim of this study was to assess the validity of the Dutch version of the DN4, in a cross-sectional multicentre design, as a screening tool for detecting a neuropathic pain component in a large consecutive, not pre-stratified on basis of the target outcome, population of patients with chronic pain. Patients' pain was classified by two independent (pain-) physicians as the gold standard. The analysis was initially performed on the outcomes of those patients (n = 228 out of 291) in whom both physicians agreed in their pain classification. Compared to the gold standard the DN4 had a sensitivity of 75% and specificity of 76%. The DN4-symptoms (seven interview items) solely resulted in a sensitivity of 70% and a specificity of 67%. For the DN4-signs (three examination items) it was respectively 75% and 75%. In conclusion, because it seems that the DN4 helps to identify a neuropathic pain component in a consecutive population of patients with chronic pain in a moderate way, a comprehensive (physical-) examination by the physician is still obligate.
C1 [Timmerman, Hans; Steegers, Monique A. H.; Goeman, Jelle J.; Wilder-Smith, Oliver H. G.; Vissers, Kris C. P.] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, Nijmegen, Netherlands.
   [Huygen, Frank J. P. M.] Univ Ctr Pain Med, ErasmusMC, Dept Anesthesiol, Rotterdam, Netherlands.
   [Goeman, Jelle J.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands.
   [van Dasselaar, Nick T.] Reinier Graaf Gasthuis, Dept Anesthesiol Pain Med & Palliat Care, Delft, Netherlands.
   [Schenkels, Marcel J.] Bernhoven Ziekenhuis, Dept Anesthesiol, Uden, Netherlands.
   [Wilder-Smith, Oliver H. G.] Aalborg Univ, Ctr Sensory Motor Interact, Aalborg, Denmark.
   [Wolff, Andre A. P.] Univ Groningen, Univ Med Ctr Groningen, Pain Ctr, Dept Anesthesiol, Groningen, Netherlands.
RP Timmerman, H (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, Nijmegen, Netherlands.
EM hans.timmerman@radboudumc.nl
RI Vissers, Kris/H-8110-2014; Steegers, M.A.H./L-4668-2015; Goeman,
   Jelle/C-2260-2012; Vissers, Kris/D-3569-2009; Timmerman,
   Hans/D-3425-2009
OI Vissers, Kris/0000-0002-2919-6356; Goeman, Jelle/0000-0003-4283-0259;
   Vissers, Kris/0000-0002-2919-6356; Timmerman, Hans/0000-0002-6082-9043
FU Pfizer
FX This study was performed within DALI for PAIN, a national program that
   focuses on neuropathic pain care optimalisation to APW. DALI for PAIN is
   an initiative of Pfizer. This project is supported by an unrestricted
   grant from Pfizer. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abdallah FW, 2015, PAIN, V156, P740, DOI 10.1097/j.pain.0000000000000108
   ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552
   ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102
   Andermann A, 2008, B WORLD HEALTH ORGAN, V86, P317, DOI 10.2471/BLT.07.050112
   Attal N, 2011, J PAIN, V12, P1080, DOI 10.1016/j.jpain.2011.05.006
   Baron R, 2016, EUR J PAIN, V20, P861, DOI 10.1002/ejp.838
   Bennett MI, 2007, PAIN, V127, P199, DOI 10.1016/j.pain.2006.10.034
   Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010
   Bouhassira D, 2011, PAIN, V152, pS74, DOI 10.1016/j.pain.2010.11.027
   CADTH, 2015, DIAGN METH NEUR PAIN
   Chatila N, 2016, PAIN PRACTICE OFFICI
   Chaudakshetrin Pongparadee, 2007, Journal of the Medical Association of Thailand, V90, P1860
   Cicchetti D. V., 1994, PSYCHOL ASSESSMENT, V6, P6
   CICCHETTI DV, 1981, AM J MENT DEF, V86, P127
   Collins SL, 2001, PAIN, V91, P189, DOI 10.1016/S0304-3959(00)00435-8
   Cruccu G, 2004, EUR J NEUROL, V11, P153, DOI 10.1111/j.1468-1331.2004.00791.x
   Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157
   Dieleman JP, 2008, PAIN, V137, P681, DOI 10.1016/j.pain.2008.03.002
   Dworkin RH, 2013, PAIN, V154, P2249, DOI 10.1016/j.pain.2013.06.004
   El Khouli RH, 2009, J MAGN RESON IMAGING, V30, P999, DOI 10.1002/jmri.21947
   Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9
   Finnerup NB, 2016, PAIN
   Fischer D, 1999, JAMA-J AM MED ASSOC, V282, P1157, DOI 10.1001/jama.282.12.1157
   Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488
   Freynhagen R, 2009, CURR PAIN HEADACHE R, V13, P185, DOI 10.1007/s11916-009-0032-y
   Geber C, 2013, PAIN, V154, P2877, DOI 10.1016/j.pain.2013.08.028
   Geber C, 2009, AM J MED, V122, pS3, DOI 10.1016/j.amjmed.2009.04.005
   Greenhalgh T, 1997, BRIT MED J, V315, P540, DOI 10.1136/bmj.315.7107.540
   Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5
   Guastella V, 2011, PAIN, V152, P74, DOI 10.1016/j.pain.2010.09.004
   Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031
   Haanpaa ML, 2009, AM J MED, V122, pS13, DOI 10.1016/j.amjmed.2009.04.006
   Hallstrom H, 2011, PAIN, V152, P772, DOI 10.1016/j.pain.2010.11.019
   Hamdan A, 2014, EUR J PAIN, V18, P101, DOI 10.1002/j.1532-2149.2013.00350.x
   Harifi G, 2011, PAIN PRACT, V11, P139, DOI 10.1111/j.1533-2500.2010.00399.x
   Haroun OMO, 2012, PAIN, V153, P1620, DOI 10.1016/j.pain.2012.04.007
   IASP, 2015, IASP TAX NEUR PAIN I
   Kim HJ, 2016, YONSEI MED J, V57, P449, DOI 10.3349/ymj.2016.57.2.449
   Kimberlin CL, 2008, AM J HEALTH-SYST PH, V65, P2276, DOI 10.2146/ajhp070364
   La Cesa S, 2015, NEUROL SCI, V36, P2169, DOI 10.1007/s10072-015-2382-z
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lasry-Levy E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000981
   Lavand'homme P, 2015, BONE JOINT J, V97B, P45, DOI 10.1302/0301-620X.97B10.36524
   Ludemann L, 2006, ACTA RADIOL, V47, P303, DOI 10.1080/02841850500539033
   Madani SP, 2014, PAIN PRACT, V14, P427, DOI 10.1111/papr.12088
   Markman JD, 2015, PAIN MED, V16, P520, DOI 10.1111/pme.12612
   Mathieson S, 2015, J CLIN EPIDEMIOL, V68, P957, DOI 10.1016/j.jclinepi.2015.03.010
   METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2
   Mulvey MR, 2014, PAIN, V155, P859, DOI 10.1016/j.pain.2013.11.010
   Nurmikko T, 2009, EUR J NEUROL, V16, pE104, DOI 10.1111/j.1468-1331.2009.02583.x
   Obuchowski NA, 2003, RADIOLOGY, V229, P3, DOI 10.1148/radiol.2291010898
   Perez C, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-66
   Proqolid, 2015, NEUR PAIN 4 QUEST MA
   Sadler A, 2013, CLIN J PAIN, V29, P507, DOI 10.1097/AJP.0b013e318260c16f
   Santos JG, 2010, J PAIN, V11, P484, DOI 10.1016/j.jpain.2009.09.014
   Spallone V, 2012, DIABETIC MED, V29, P578, DOI 10.1111/j.1464-5491.2011.03500.x
   Sykioti P, 2014, PAIN PRACTICE OFFICI
   Tampin B, 2013, PAIN, V154, P2813, DOI 10.1016/j.pain.2013.08.018
   Themistocleous AC, 2016, PAIN, V157, P1132, DOI 10.1097/j.pain.0000000000000491
   Timmerman H, 2013, PAIN PHYSICIAN, P11
   Timmerman H, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-94
   Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59
   Truini A, 2016, PAIN, V157, pS53, DOI 10.1097/j.pain.0000000000000367
   Unal-Cevik I, 2010, J PAIN, V11, P1129, DOI 10.1016/j.jpain.2010.02.003
   Vaegter HB, 2014, PAIN MED, V15, P120, DOI 10.1111/pme.12273
   Van Seventer R, 2010, EUR J PAIN, V14, P58, DOI 10.1016/j.ejpain.2009.01.005
   van Seventer R, 2013, PAIN PRACT, V13, P390, DOI 10.1111/papr.12006
   VanDenKerkhof EG, 2016, PAIN RES MANAG, DOI 10.1155/2016/9815750
   VERSI E, 1992, BRIT MED J, V305, P187, DOI 10.1136/bmj.305.6846.187-b
   VERSI E, 1990, BRIT J OBSTET GYNAEC, V97, P251, DOI 10.1111/j.1471-0528.1990.tb01790.x
   WILSON JMG, 1968, B OFIC SANIT PANAM, V65, P281
NR 71
TC 4
Z9 4
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 30
PY 2017
VL 12
IS 11
AR e0187961
DI 10.1371/journal.pone.0187961
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FO4UI
UT WOS:000416841900025
PM 29190718
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ramirez, JC
   Parrado, R
   Sulleiro, E
   de la Barra, A
   Rodriguez, M
   Villarroel, S
   Irazu, L
   Alonso-Vega, C
   Alves, F
   Curto, MA
   Garcia, L
   Ortiz, L
   Torrico, F
   Gascon, J
   Flevaud, L
   Molina, I
   Ribeiro, I
   Schijman, AG
AF Ramirez, Juan C.
   Parrado, Rudy
   Sulleiro, Elena
   de la Barra, Anabelle
   Rodriguez, Marcelo
   Villarroel, Sandro
   Irazu, Lucia
   Alonso-Vega, Cristina
   Alves, Fabiana
   Curto, Maria A.
   Garcia, Lineth
   Ortiz, Lourdes
   Torrico, Faustino
   Gascon, Joaquim
   Flevaud, Laurence
   Molina, Israel
   Ribeiro, Isabela
   Schijman, Alejandro G.
TI First external quality assurance program for bloodstream Real-Time PCR
   monitoring of treatment response in clinical trials of Chagas disease
SO PLOS ONE
LA English
DT Article
ID POLYMERASE-CHAIN-REACTION; VIRUS TYPE-1 RNA; TRYPANOSOMA-CRUZI;
   MOLECULAR-DETECTION; DNA; AMPLIFICATION; LABORATORIES; MULTICENTER;
   ASSAYS; STANDARDIZATION
AB Real-Time PCR (qPCR) testing is recommended as both a diagnostic and outcome measurement of etiological treatment in clinical practice and clinical trials of Chagas disease (CD), but no external quality assurance (EQA) program provides performance assessment of the assays in use. We implemented an EQA system to evaluate the performance of molecular biology laboratories involved in qPCR based follow-up in clinical trials of CD. An EQA program was devised for three clinical trials of CD: the E1224 (NCT01489228), a pro drug of ravuconazole; the Sampling Study (NCT01678599), that used benznidazole, both conducted in Bolivia; and the CHAGASAZOL (NCT01162967), that tested posaconazole, conducted in Spain. Four proficiency testing panels containing negative controls and seronegative blood samples spiked with 1, 10 and 100 parasite equivalents (par. eq.)/mL of four Trypanosoma cruzistocks, were sent from the Core Lab in Argentina to the participating laboratories located in Bolivia and Spain. Panels were analyzed simultaneously, blinded to sample allocation, at 4-month intervals. In addition, 302 random blood samples from both trials carried out in Bolivia were sent to Core Lab for retesting analysis. The analysis of proficiency testing panels gave 100% of accordance (within laboratory agreement) and concordance (between laboratory agreement) for all T. cruzistocks at 100 par. eq./mL; whereas their values ranged from 71 to 100% and from 62 to 100% at 1 and 10 par. eq./mL, respectively, depending on the T. cruzi stock. The results obtained after twelve months of preparation confirmed the stability of blood samples in guanidine-EDTA buffer. No significant differences were found between qPCR results from Bolivian laboratory and Core Lab for retested clinical samples. This EQA program for qPCR analysis of CD patient samples may significantly contribute to ensuring the quality of laboratory data generated in clinical trials and molecular diagnostics laboratories of CD.
C1 [Ramirez, Juan C.; Curto, Maria A.; Schijman, Alejandro G.] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol Dr Hector N Tor, Buenos Aires, DF, Argentina.
   [Parrado, Rudy; de la Barra, Anabelle; Villarroel, Sandro; Garcia, Lineth] Univ Mayor de San Simon, Inst Invest Biomed IIBISMED, Cochabamba, Bolivia.
   [Sulleiro, Elena; Molina, Israel] Univ Autonoma Barcelona, PROSICS Barcelona, Hosp Univ Vall dHebron, Barcelona, Spain.
   [Rodriguez, Marcelo; Irazu, Lucia] ANLIS Dr Carlos G Malbran, Inst Nacl Enfermedades Infecciosas INEI, Buenos Aires, DF, Argentina.
   [Alonso-Vega, Cristina; Alves, Fabiana; Ribeiro, Isabela] DNDi, Geneva, Switzerland.
   [Ortiz, Lourdes] Univ Autonoma Juan Misael Saracho, Tarija, Bolivia.
   [Torrico, Faustino] Fdn CEADES, Cochabamba, Bolivia.
   [Gascon, Joaquim] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.
   [Flevaud, Laurence] Med Sans Frontieres Operat Ctr Barcelona Athens O, Barcelona, Spain.
RP Schijman, AG (reprint author), Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol Dr Hector N Tor, Buenos Aires, DF, Argentina.
EM schijman@dna.uba.ar
RI Gascon, Joaquim/M-3598-2015
OI Gascon, Joaquim/0000-0002-5045-1585; Molina Romero,
   Israel/0000-0001-6642-7515; Sulleiro, Elena/0000-0002-9783-6060
FU Drugs for Neglected Diseases initiative; National Agency of Science,
   Technology and Productive Innovation [PICT 2011-0207, PICT 2014-0267];
   Wellcome Trust [095422 - E1224, NCT01489228]; Medecins Sans Frontieres
   (Doctors without Borders), International; Ministry of Foreign Affairs,
   Spain; Department for International Development (DFID), UK; Dutch
   Ministry of Foreign Affairs (DGIS), The Netherlands; Rockefeller
   Foundation, USA
FX This work was supported by Drugs for Neglected Diseases initiative and
   by the National Agency of Science, Technology and Productive Innovation
   grants PICT 2011-0207 and PICT 2014-0267. The EQA evaluation for the two
   DNDi-sponsored clinical trials was funded through DNDi by the following
   donors: Strategic Translation Award from the Wellcome Trust grant 095422
   - E1224 trial (NCT01489228); Medecins Sans Frontieres (Doctors without
   Borders), International; Ministry of Foreign Affairs, Spain; Department
   for International Development (DFID), UK; Dutch Ministry of Foreign
   Affairs (DGIS), The Netherlands; Rockefeller Foundation, USA; and
   anonymous donors.
CR Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09
   Burns MJ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-31
   Ramirez JC, 2015, J MOL DIAGN, V17, P605, DOI 10.1016/j.jmoldx.2015.04.010
   Cruz I, 2013, EXP PARASITOL, V134, P281, DOI 10.1016/j.exppara.2013.03.026
   Domingo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036291
   Domingo C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000833
   Duffy T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002000
   Duffy T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000419
   Ezzelle J, 2008, J PHARMACEUT BIOMED, V46, P18, DOI 10.1016/j.jpba.2007.10.010
   Alvarez MG, 2016, ANTIMICROB AGENTS CH, V60, P833, DOI 10.1128/AAC.00745-15
   Grundy JE, 1996, J CLIN MICROBIOL, V34, P1166
   Hirsch HH, 1999, J MED VIROL, V57, P31, DOI 10.1002/(SICI)1096-9071(199901)57:1<31::AID-JMV5>3.0.CO;2-J
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langton SD, 2002, INT J FOOD MICROBIOL, V79, P175, DOI 10.1016/S0168-1605(02)00107-1
   Lefrere JJ, 2000, J VIROL METHODS, V85, P117, DOI 10.1016/S0166-0934(99)00160-3
   Martinez-Perez A, 2016, ACTA TROP, V157, P145, DOI 10.1016/j.actatropica.2016.01.032
   Murphy SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097398
   Muyldermans G, 2005, J CLIN MICROBIOL, V43, P30, DOI 10.1128/JCM.43.1.30-35.2005
   Noordhoek GT, 1996, J CLIN MICROBIOL, V34, P2522
   Nowicki MJ, 2001, J CLIN MICROBIOL, V39, P3760, DOI 10.1128/JCM.39.10.3760-3763.2001
   Pelloux H, 1998, FEMS MICROBIOL LETT, V165, P231, DOI 10.1111/j.1574-6968.1998.tb13151.x
   Pinazo MJ, 2014, EXPERT REV ANTI-INFE, V12, P479, DOI 10.1586/14787210.2014.899150
   Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019
   Porras AI, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003697
   Robertson JS, 1998, BIOLOGICALS, V26, P111, DOI 10.1006/biol.1998.0136
   Schijman AG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000931
   Schweiger B, 1997, J VIROL METHODS, V67, P45, DOI 10.1016/S0166-0934(97)00075-X
   TDR/WHO, 2012, WHO TECHN REP SER, P975
   Torrico F, 2017, LANCET INFECT DIS
   Valentine-Thon E, 2001, J CLIN MICROBIOL, V39, P4407, DOI 10.1128/JCM.39.12.4407-4412.2001
   van Loon AM, 1999, B WORLD HEALTH ORGAN, V77, P217
   Weber T, 1997, J VIROL METHODS, V69, P231, DOI 10.1016/S0166-0934(97)00152-3
   WHO/CDC/CLSI, 2009, CURR LAB PRACT SER
   YenLieberman B, 1996, J CLIN MICROBIOL, V34, P2695
   Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021
   Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009
NR 36
TC 7
Z9 7
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 27
PY 2017
VL 12
IS 11
AR e0188550
DI 10.1371/journal.pone.0188550
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FN8QZ
UT WOS:000416291900096
PM 29176887
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Thorngren, L
   Holthuis, TD
   Lindegarth, S
   Lindegarth, M
AF Thorngren, Linnea
   Holthuis, Thomas Duner
   Lindegarth, Susanne
   Lindegarth, Mats
TI Developing methods for assessing abundance and distribution of European
   oysters (Ostrea edulis) using towed video
SO PLOS ONE
LA English
DT Article
ID MARINE PROTECTED AREA; UNDERWATER VIDEO; CRASSOSTREA-GIGAS; BENTHIC
   HABITATS; MULTIBEAM SONAR; REEFS; SEA; ECOSYSTEM; BIODIVERSITY;
   RESTORATION
AB Due to large-scale habitat losses and increasing pressures, benthic habitats in general, and perhaps oyster beds in particular, are commonly in decline and severely threatened on regional and global scales. Appropriate and cost-efficient methods for mapping and monitoring of the distribution, abundance and quality of remaining oyster populations are fundamental for sustainable management and conservation of these habitats and their associated values. Towed video has emerged as a promising method for surveying benthic communities in a both non-destructive and cost-efficient way. Here we examine its use as a tool for quantification and monitoring of oyster populations by (i) analysing how well abundances can be estimated and how living Ostrea edulis individuals can be distinguished from dead ones, (ii) estimating the variability within and among observers as well as the spatial variability at a number of scales, and finally (iii) evaluating the precision of estimated abundances under different scenarios for monitoring. Overall, the results show that the can be used to quantify abundance and occurrence of Ostrea edulis in heterogeneous environments. There was a strong correlation between abundances determined in the field and abundances estimated by video-analyses (r(2) = 0.93), even though video analyses underestimated the total abundance of living oysters by 20%. Additionally, the method was largely repeatable within and among observers and revealed no evident bias in identification of living and dead oysters. We also concluded that the spatial variability was an order of magnitude larger than that due to observer errors. Subsequent modelling of precision showed that the total area sampled was the main determinant of precision and provided general method for determining precision. This study provides a thorough validation of the application of towed video on quantitative estimations of live oysters. The results suggest that the method can indeed be very useful for this purpose and we therefor recommend it for future monitoring of oysters and other threatened habitats and species.
C1 [Thorngren, Linnea; Holthuis, Thomas Duner] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden.
   [Lindegarth, Susanne; Lindegarth, Mats] Univ Gothenburg, Dept Marine Sci Tjarno, Stromstad, Sweden.
RP Thorngren, L (reprint author), Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden.
EM linnea.thorngren@marine.gu.se
RI Shen, ChengHan/D-1972-2018; Lindegart, Mats/U-2665-2017
OI Lindegart, Mats/0000-0001-5361-5437; Thorngren,
   Linnea/0000-0002-0735-5344
FU County Administrative board [29947-2013-1]; Radman och fru Ernst
   Collianders stiftelse for valgorande andamal
FX This research was funded by The County Administrative board, Grant
   number 29947-2013-1,
   http://www.lansstyrelsen.se/VastraGotaland/En/Pages/default.aspx, and by
   Radman och fru Ernst Collianders stiftelse for valgorande andamal.
CR Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345
   Allen YC, 2005, ESTUARIES, V28, P435, DOI 10.1007/BF02693925
   Alleway HK, 2015, CONSERV BIOL, V29, P795, DOI 10.1111/cobi.12452
   Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x
   Anderson T.J., 2007, MAPPING SEAFLOOR HAB, P71
   ANDREW NL, 1987, OCEANOGR MAR BIOL, V25, P39
   Bates DM, 2012, LME4 LINEAR MIXED EF
   Beaman RJ, 2005, CONT SHELF RES, V25, P1657, DOI 10.1016/j.csr.2005.04.013
   Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5
   Beck MW, 2009, NATURE CONSERVANCY
   BenedettiCecchi L, 1996, MAR ECOL PROG SER, V138, P93, DOI 10.3354/meps138093
   Bernard ATF, 2013, J EXP MAR BIOL ECOL, V443, P75, DOI 10.1016/j.jembe.2013.02.039
   Boman EM, 2016, J SHELLFISH RES, V35, P493, DOI 10.2983/035.035.0222
   Bucas M, 2007, ESTUAR COAST SHELF S, V75, P308, DOI 10.1016/j.ecss.2007.04.038
   Buhl-Mortensen L, 2012, HYDROBIOLOGIA, V685, P191, DOI 10.1007/s10750-011-0988-6
   Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512
   Cano J, 1996, AQUACULT INT, V4, P67
   CARLETON JH, 1995, CORAL REEFS, V14, P35, DOI 10.1007/BF00304070
   Carstensen J, 2016, ECOL INDIC, V67, P306, DOI 10.1016/j.ecolind.2016.03.002
   Chust G, 2010, ESTUAR COAST SHELF S, V89, P200, DOI 10.1016/j.ecss.2010.07.002
   Cochran W., 1977, SAMPLING TECHNIQUES
   Coen L. D, 2016, ENCY ESTUARIES, P89
   Coen LD, 1999, AM FISHERIES SOC S
   Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341299
   Cognie B, 2006, AQUACULTURE, V259, P249, DOI 10.1016/j.aquaculture.2006.05.037
   Commission O, 2008, BIODIVERSITY SERIES, V358, P1
   Costa BM, 2009, REMOTE SENS ENVIRON, V113, P1082, DOI 10.1016/j.rse.2009.01.015
   Crain CM, 2009, ANN NY ACAD SCI, V1162, P39, DOI 10.1111/j.1749-6632.2009.04496.x
   Cranfield HJ, 1999, AQUAT CONSERV, V9, P461, DOI 10.1002/(SICI)1099-0755(199909/10)9:5<461::AID-AQC353>3.3.CO;2-Q
   Edwards E, 1997, TECHNICAL REPORT
   Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088
   Francis FTY, 2014, MAR BIOL, V161, P1375, DOI 10.1007/s00227-014-2425-7
   GIGUERE M, 1994, J SHELLFISH RES, V13, P25
   Gillies C. L., 2015, SHELLFISH REEF HABIT
   Grabowski JH, 2012, BIOSCIENCE, V62, P900, DOI 10.1525/bio.2012.62.10.10
   Greco M., 2008, NATURAL OYSTER GROUN
   Grizzle RE, 2008, J COASTAL RES, V24, P103, DOI 10.2112/06-0672.1
   Grizzle RE, 2003, MAPPING CHARACTERIZI
   Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345
   Harris PT, 2012, ELSEV INSIGHT, P1
   He KS, 2015, REMOTE SENS ECOL CON, V1, P4, DOI 10.1002/rse2.7
   HELCOM, 2013, RED LIST BALT SEA UN
   Herbert RJH, 2016, BIODIVERS CONSERV, V25, P2835, DOI 10.1007/s10531-016-1209-4
   Holmes KW, 2008, CONT SHELF RES, V28, P1800, DOI 10.1016/j.csr.2008.04.016
   Ierodiaconou D, 2011, CONT SHELF RES, V31, pS28, DOI 10.1016/j.csr.2010.01.012
   Kellogg ML, 2014, ESTUAR COAST SHELF S, V151, P156, DOI 10.1016/j.ecss.2014.09.025
   Kennedy R, 1999, BIOL ENV P ROYAL IRI
   Kenny AJ, 2003, ICES J MAR SCI, V60, P411, DOI 10.1016/S1054-3139(03)00006-7
   Kostylev VE, 2001, MAR ECOL PROG SER, V219, P121, DOI 10.3354/meps219121
   Laing I., 2005, FEASIBILITY STUDY NA
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Le Bris A, 2016, ESTUAR COAST SHELF S, V172, P1, DOI 10.1016/j.ecss.2016.01.039
   Letessier TB, 2015, BIOL REV
   Leujak W, 2007, J EXP MAR BIOL ECOL, V351, P168, DOI 10.1016/j.jembe.2007.06.028
   Lindegarth M, 2014, OSTRON OSTREA EDULIS, P43
   Lirman D, 2007, ENVIRON MONIT ASSESS, V125, P59, DOI 10.1007/s10661-006-9239-0
   Loo LO, 1888, OSTRON BLIR ALLMER S
   Mallet D, 2014, FISH RES, V154, P44, DOI 10.1016/j.fishres.2014.01.019
   Mann R, 2004, J SHELLFISH RES, V23, P387
   Murphy HM, 2010, MAR FRESHWATER RES, V61, P236, DOI 10.1071/MF09068
   Nadon MO, 2006, CORAL REEFS, V25, P177, DOI 10.1007/s00338-005-0074-5
   Newell RIE, 2004, J SHELLFISH RES, V23, P51
   Nieuwhof S, 2015, REMOTE SENS-BASEL, V7, P3710, DOI 10.3390/rs70403710
   Ninio R, 2003, ESTIMATING COVER BEN
   OSPAR, 2010, QUAL STAT REP 2010
   Piazza BP, 2005, RESTOR ECOL, V13, P499, DOI 10.1111/j.1526-100X.2005.00062.x
   Powell EN, 2006, ESTUAR COAST SHELF S, V69, P531, DOI 10.1016/j.ecss.2006.05.014
   Rodney WS, 2006, J EXP MAR BIOL ECOL, V335, P39, DOI 10.1016/j.jembe.2006.02.017
   Ross P. G., 2009, POPULATION ASSESSMEN
   Schubert PR, 2015, MAR ECOL PROG SER, V522, P79, DOI 10.3354/meps11133
   Sheehan EV, 2016, METHODS ECOL EVOL, V7, P843, DOI 10.1111/2041-210X.12540
   Sheehan EV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014461
   Smaal A.C., 2015, FEASIBILITY FLAT OYS
   Smith J, 2015, ESTUAR COAST SHELF S, V164, P520, DOI 10.1016/j.ecss.2015.07.036
   Soniat TM, 2014, J SHELLFISH RES, V33, P381, DOI 10.2983/035.033.0207
   Stevens T, 2005, MAR FRESHWATER RES, V56, P111, DOI 10.1071/MF04233
   Stevens TF, 2014, MAR POLICY, V45, P310, DOI 10.1016/j.marpol.2013.09.006
   Stokesbury KDE, 2004, J SHELLFISH RES, V23, P33
   Stunz GW, 2010, MAR ECOL PROG SER, V406, P147, DOI 10.3354/meps08556
   Tarnowski M., 2005, MARYLAND OYSTER POPU
   Taylor JR, 1997, INTRO ERROR ANAL STU
   Team RC, 2016, R LANG ENV STAT COMP
   Team RC, 2014, R LANG ENV STAT COMP
   Thompson AA, 1997, MAR ECOL PROG SER, V154, P53, DOI 10.3354/meps154053
   Tyne JA, 2010, MAR FRESHWATER RES, V61, P1023, DOI 10.1071/MF09240
   Underwood A. J., 1997, EXPT ECOLOGY THEIR L
   van Rein H, 2012, J MAR BIOL ASSOC UK, V92, P49, DOI 10.1017/S0025315411000233
   Van Rein HB, 2009, UNDERWATER TECHNOL, V28, P99, DOI 10.3723/ut.28.099
   Ventura D, 2016, ESTUAR COAST SHELF S, V171, P85, DOI 10.1016/j.ecss.2016.01.030
   Waldbusser GG, 2011, J SHELLFISH RES, V30, P659, DOI 10.2983/035.030.0308
   Wolff WJ, 2005, HELGOLAND MAR RES, V59, P31, DOI 10.1007/s10152-004-0204-4
   Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399
   Zanini JM, 2000, CORAL REEFS, V19, P83, DOI 10.1007/s003380050231
NR 93
TC 2
Z9 2
U1 2
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 15
PY 2017
VL 12
IS 11
AR e0187870
DI 10.1371/journal.pone.0187870
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM7MC
UT WOS:000415260400035
PM 29141028
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Alejo-Cancho, I
   Aviles, FF
   Capon, A
   Rodriguez, C
   Barrachina, J
   Salvador, P
   Valls, ME
   Alvarez-Martinez, MJ
   Zboromyrska, Y
   Vila, J
   Marcos, MA
AF Alejo-Cancho, Izaskun
   Fernandez Aviles, Francesc
   Capon, Alicia
   Rodriguez, Cristina
   Barrachina, Josep
   Salvador, Pilar
   Eugenia Valls, Ma
   Alvarez-Martinez, Miriam J.
   Zboromyrska, Yuliya
   Vila, Jordi
   Angeles Marcos, Ma
TI Evaluation of a multiplex panel for the diagnosis of acute infectious
   diarrhea in immunocompromised hematologic patients
SO PLOS ONE
LA English
DT Article
ID CLOSTRIDIUM-DIFFICILE; TRANSPLANT RECIPIENTS; ESCHERICHIA-COLI; PCR
   ASSAYS; DISEASE
AB Introduction
   Diarrhea is a frequent complication in hematologic patients, being an infectious cause frequently suspected. Rapid and accurate detection of gastrointestinal pathogens is vital in immunocompromised hosts. The aim of this study was to compare routine diagnostic methods versus a multiplex polymerase chain reaction (PCR) assay for the diagnosis of infectious diarrhea in immunocompromised hematologic patients.
   Material and methods
   We conducted a prospective observational study from March 2015 to January 2016 to compare conventional methods for the diagnosis of infectious diarrhea with FIlmArray GI Panel (BioFire-bioMe A rieux, France). Samples from adult immunocompromised hematologic patients with acute diarrhea were collected. In cases with discordant results, a second multiplex assay was performed (Allplex, Seegene, Korea). The result was considered positive or negative when the same result was obtained by at least two of the methods.
   Results
   A total of 95 samples were obtained from 95 patients (median age of 52 years (46-64)). Sixty-one (64%) episodes were hospital-acquired and 34 (36%) were community-acquired diarrhea. Twenty-five (26%) patients had a positive microbiological result, being Clostridium difficile the most frequent pathogen, followed by Campylobacter spp and norovirus. The concordance between FilmArray methods was good (k = 0.79). The FilmArray GI panel showed a sensitivity of 95%, a specificity of 100% for positive results. The time required to obtain results was markedly reduced with the use of multiplex PCR methods.
   Conclusions
   Multiplex molecular panels provide a rapid and sensitive tool for the diagnosis of infectious diarrhea, thereby allowing more timely clinical decisions in immunocompromised hematologic patients.
C1 [Alejo-Cancho, Izaskun; Capon, Alicia; Rodriguez, Cristina; Barrachina, Josep; Salvador, Pilar; Eugenia Valls, Ma; Alvarez-Martinez, Miriam J.; Zboromyrska, Yuliya; Vila, Jordi; Angeles Marcos, Ma] Hosp Clin Barcelona, Microbiol Dept, Barcelona, Spain.
   [Fernandez Aviles, Francesc] Hosp Clin Barcelona, Hematol Dept, Barcelona, Spain.
   [Zboromyrska, Yuliya] Hosp Vilafranca, Microbiol Dept, Barcelona, Spain.
RP Marcos, MA (reprint author), Hosp Clin Barcelona, Microbiol Dept, Barcelona, Spain.
EM mmarcos@clinic.ub.es
RI Vila, Jordi/P-3613-2016
OI Vila, Jordi/0000-0002-8025-3926; Alejo Cancho,
   Izaskun/0000-0003-2488-7139; Alvarez-Martinez, Miriam
   Jose/0000-0003-4157-0117
FU BioMerieux
FX BioMerieux provided us FilmArray panels in order to be evaluate.
   However, the funders had no role in study design, data collection and
   analysis, decision to publish or preparation of the manuscript. When we
   decided to publish the results, BioMerieux offered to pay for the
   publishing fares. They did not, however, have any role in writing the
   manuscript.
CR Amisano G, 2011, NEW MICROBIOL, V34, P45
   Bessede E, 2011, J CLIN MICROBIOL, V49, P941, DOI 10.1128/JCM.01489-10
   Binnicker MJ, 2015, J CLIN MICROBIOL, V53, P3723, DOI 10.1128/JCM.02103-15
   Bobak D, 2008, BONE MARROW TRANSPL, V42, P705, DOI 10.1038/bmt.2008.317
   Coste JF, 2013, J CLIN MICROBIOL, V51, P1841, DOI 10.1128/JCM.03366-12
   De Rauw K, 2016, EUR J CLIN MICROBIOL, V35, P1479, DOI 10.1007/s10096-016-2688-7
   Deng JK, 2015, DIAGN MICR INFEC DIS, V83, P325, DOI 10.1016/j.diagmicrobio.2015.07.024
   Doshi M, 2013, AM J INFECT CONTROL, V41, P820, DOI 10.1016/j.ajic.2012.10.025
   Enserink R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089496
   Gu ZM, 2015, J MOL DIAGN, V17, P715, DOI 10.1016/j.jmoldx.2015.06.003
   Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514
   Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398
   Krones E, 2012, GASTROENTEROL CLIN N, V41, P677, DOI 10.1016/j.gtc.2012.06.009
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   National Institute of Cancer, 2010, NIH PUBL, V2009
   Platts-Mills JA, 2014, AM J TROP MED HYG, V90, P133, DOI 10.4269/ajtmh.13-0439
   Polage CR, 2014, CLIN INFECT DIS, P1
   Spadao F, 2014, REV INST MED TROP SP, V56, P325, DOI 10.1590/S0036-46652014000400010
   Vargas M, 1998, CLIN MICROBIOL INFEC, V4, P682, DOI DOI 10.1111/J.1469-0691.1998.TB00652.X
   Zboromyrska Y, 2016, EXPERT REV MOL DIAGN, V16, P631, DOI 10.1586/14737159.2016.1167599
NR 20
TC 4
Z9 4
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 3
PY 2017
VL 12
IS 11
AR e0187458
DI 10.1371/journal.pone.0187458
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FL6TA
UT WOS:000414377900024
PM 29099868
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Beierfuss, A
   Dietrich, H
   Kremser, C
   Hunjadi, M
   Ritsch, A
   Rulicke, T
   Thome, C
   Mern, DS
AF Beierfuss, Anja
   Dietrich, Hermann
   Kremser, Christian
   Hunjadi, Monika
   Ritsch, Andreas
   Ruelicke, Thomas
   Thome, Claudius
   Mern, Demissew Shenegelegn
TI Knockout of Apolipoprotein E in rabbit promotes premature intervertebral
   disc degeneration: A new in vivo model for therapeutic approaches of
   spinal disc disorders
SO PLOS ONE
LA English
DT Article
ID LOW-BACK-PAIN; CARDIOVASCULAR RISK-FACTORS; MATERNAL
   HYPERCHOLESTEROLEMIA; MESSENGER-RNA; SERUM-LIPIDS; YOUNG-ADULTS; E
   DEFICIENCY; FOLLOW-UP; ATHEROSCLEROSIS; EXPRESSION
AB Intervertebral disc (IVD) degeneration that accelerates the loss of disc structural and functional integrities is recognized as one of the major factors of chronic back pain. Cardiovascular risk factors, such as deficits of apolipoproteins that elevate the levels of cholesterol and triglycerides, are considered critical for the progress of atherosclerosis; notably in the abdominal aorta and its lumbar branching arteries that supply lumbar vertebrae and IVDs. Obstruction of the lumbar arteries by atherosclerosis is presumed to promote lumbar disc degeneration and low back pain. APOE-knockout rabbits have recently been shown to generate hyperlipidemia with increased levels of cholesterol and triglycerides that mimic the symptoms of atherosclerosis in humans. Here, we analysed IVD degeneration in the lumbar spines of ten homozygous APOE-knockout and four wild-type New Zealand White rabbits of matching age to prove accelerated IVD degeneration in APOE-knockout rabbits, since APOE-knockout rabbits could be a beneficial model for therapeutic approaches of degenerative IVD disorders. Experiments were performed using T1/T2-weighted magnetic resonance imaging, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, glucose-oxidase assay, enzyme-linked immunosorbent assay, quantitative reverse transcription PCR and western blot. APOE-knockout lumbar spines showed more advanced IVD degeneration, obstructed lumbar arteries and lower enhancement of contrast agent in IVDs. Moreover, lower concentration of glucose, lower number of viable cells and lower concentrations of aggrecan, collagen II and higher concentration of collagen I were detected in APOE-knockout IVDs (p < 0.0001). APOE-knockout in rabbits could induce structurally deteriorating premature IVD degeneration that mimics the symptoms of accelerated IVD degeneration in humans. APOE-knockout rabbits could be used as beneficial model, as they can bypass the standard surgical interventions that are commonly applied in research animals for the induction of enhanced IVD degeneration. Their parallel use in therapeutic approaches of IVD disorders and atherosclerosis could reduce the number of research animals to be used and contribute to the principles of 3Rs (Replacement, Reduction and Refinement).
C1 [Beierfuss, Anja; Dietrich, Hermann] Med Univ Innsbruck, Cent Lab Anim Facil, Innsbruck, Austria.
   [Kremser, Christian] Med Univ Innsbruck, Dept Radiol, Innsbruck, Austria.
   [Hunjadi, Monika; Ritsch, Andreas] Med Univ Innsbruck, Dept Internal Med 1, Innsbruck, Austria.
   [Ruelicke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci, Vet Pl 1, Vienna, Austria.
   [Thome, Claudius; Mern, Demissew Shenegelegn] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria.
RP Mern, DS (reprint author), Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria.
EM demissew.shenegelegn@i-med.ac.at
OI Hunjadi, Monika/0000-0003-4285-2925; Shenegelegn Mern,
   Demissew/0000-0001-5893-981X
CR Adams MA, 2005, J BIOMECH, V38, P1972, DOI 10.1016/j.jbiomech.2005.03.028
   Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c
   Anderson DG, 2005, SPINE J, V5, P260, DOI DOI 10.1016/J.SPINEE.2005.02.010
   Antoniou J, 1998, MAGN RESON MED, V40, P900, DOI 10.1002/mrm.1910400616
   Battie MC, 2007, PAIN, V131, P272, DOI 10.1016/j.pain.2007.01.010
   Baumgartner C, 2016, PROG BIOPHYS MOL BIO, V121, P131, DOI 10.1016/j.pbiomolbio.2016.05.001
   BELLOSTA S, 1995, J CLIN INVEST, V96, P2170, DOI 10.1172/JCI118271
   Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302
   Bibby SRS, 2004, EUR SPINE J, V13, P695, DOI 10.1007/s00586-003-0616-x
   Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002
   BOTTOMLEY PA, 1994, J MAGN RESON SER B, V104, P159, DOI 10.1006/jmrb.1994.1070
   BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022
   CHIRAS J, 1979, J NEURORADIOLOGY, V6, P169
   CROCK HV, 1976, CLIN ORTHOP RELAT R, P6
   DEYO RA, 1991, ANNU REV PUBL HEALTH, V12, P141, DOI 10.1146/annurev.pu.12.050191.001041
   Fan JL, 2015, PHARMACOL THERAPEUT, V146, P104, DOI 10.1016/j.pharmthera.2014.09.009
   Ferguson SJ, 2003, EUR SPINE J, V12, pS97, DOI 10.1007/s00586-003-0621-0
   Hemingway H, 1999, J EPIDEMIOL COMMUN H, V53, P197, DOI 10.1136/jech.53.4.197
   Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428
   Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347
   Hoyland JA, 2008, RHEUMATOLOGY, V47, P809, DOI 10.1093/rheumatology/ken056
   Jhawar Balraj S, 2006, Spine J, V6, P684, DOI 10.1016/j.spinee.2006.04.016
   Ji DN, 2015, TRANSGENIC RES, V24, P227, DOI 10.1007/s11248-014-9834-8
   KAUPPILA LI, 1994, ACTA RADIOL, V35, P541
   KAUPPILA LI, 1993, J SPINAL DISORD, V6, P124
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leino-Arjas P, 2006, SPINE, V31, P1032, DOI 10.1097/01.brs.0000214889.31505.08
   Leino-Arjas P, 2006, SCAND J WORK ENV HEA, V32, P12, DOI 10.5271/sjweh.971
   Leino-Arjas P, 2008, ATHEROSCLEROSIS, V197, P43, DOI 10.1016/j.atherosclerosis.2007.07.035
   LINLEE YC, 1985, BIOCHEMISTRY-US, V24, P3751, DOI 10.1021/bi00335a050
   MABUCHI H, 1989, METABOLISM, V38, P115, DOI 10.1016/0026-0495(89)90249-7
   Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312
   Mahley RW, 1999, J LIPID RES, V40, P1933
   Mahley RW, 1999, J LIPID RES, V40, P1
   MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935
   MCLEAN JW, 1984, J BIOL CHEM, V259, P6498
   Napoli C, 2000, CIRC RES, V87, P946, DOI 10.1161/01.RES.87.10.946
   Niimi M, 2016, ATHEROSCLEROSIS, V245, P187, DOI 10.1016/j.atherosclerosis.2015.12.002
   OHSHIMA H, 1989, SPINE, V14, P1234, DOI 10.1097/00007632-198911000-00017
   Palinski W, 2001, CIRC RES, V89, P991, DOI 10.1161/hh2301.099646
   Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011
   Roberts S, 1996, SPINE, V21, P415, DOI 10.1097/00007632-199602150-00003
   ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0
   Russell WMS, 1959, PRINCIPLES HUMANE EX
   SCHAEFER EJ, 1986, J CLIN INVEST, V78, P1206, DOI 10.1172/JCI112704
   SOLBERG LA, 1983, ARTERIOSCLEROSIS, V3, P187, DOI 10.1161/01.ATV.3.3.187
   Tannenbaum J, 2015, J AM ASSOC LAB ANIM, V54, P120
   Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52
   Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629
   URBAN JPG, 1982, CLIN ORTHOP RELAT R, P296
   Waddell G, 1996, SPINE, V21, P2820, DOI 10.1097/00007632-199612150-00002
   Zhang XJ, 2008, J NUTR, V138, P515
   Zhdanov VS, 1999, INT J CARDIOL, V68, P95, DOI 10.1016/S0167-5273(98)00339-8
NR 53
TC 1
Z9 2
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 3
PY 2017
VL 12
IS 11
AR e0187564
DI 10.1371/journal.pone.0187564
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FL6TA
UT WOS:000414377900030
PM 29099857
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Annweiler, C
   Kabeshova, A
   Callens, A
   Paty, ML
   Duval, GT
   Holick, MF
AF Annweiler, Cedric
   Kabeshova, Anastasiia
   Callens, Alix
   Paty, Marie-Liesse
   Duval, Guillaume T.
   Holick, Michael F.
TI Self-administered Vitamin D Status Predictor: Older adults are able to
   use a self-questionnaire for evaluating their vitamin D status
SO PLOS ONE
LA English
DT Article
ID ASSESSMENT SCHEDULE 2.0; DEPRESSIVE SYMPTOMS; D DEFICIENCY; PREVENTION;
   SUPPLEMENTATION; METAANALYSIS; PERSPECTIVE; GUIDELINES; CLINICIAN;
   AGREEMENT
AB Background The 16-item Vitamin D Status Predictor (VDSP) questionnaire helps to identify, without resorting to a blood test, older adults with low vitamin D concentrations. Our objective was to determine whether a self-administered VDSP was concordant with the VDSP administered by a physician, and to examine the concordance of every single item of the VDSP.
   Methods A total of 349 older in-and outpatients (mean, 83.2 7.2years; 59% female) were consecutively recruited in the geriatric ward of the University Hospital of Angers, France. All participants completed a self-administered VDSP questionnaire (self-VDSP) in paper format composed of 17 items exploring age, gender, general condition, nutrition, vision, mood, cognition, gait and falls, and osteoporosis. All participants underwent subsequently a full clinical examination by a physician exploring the same areas (rater-VDSP).
   Results The agreement between the self-VDSP and the rater-VDSP was almost perfect for the probability of having low vitamin D concentrations, regardless of the definition used (i.e., <25, <50 or <75 nmol/L). The agreements between physicians' and patients' responses were significant for every single VDSP item. The agreement was fair to perfect for all items, except for cognitive disorders, undernutrition and polymorbidity (poor agreement).
   Conclusions Older adults are able to evaluate their own probabilities of severe vitamin D deficiency, deficiency and insufficiency. A self-questionnaire may promote the use of the VDSP tool in this population, and help clinicians in decisions to supplement their patients in a reasoned way.
C1 [Annweiler, Cedric; Kabeshova, Anastasiia; Duval, Guillaume T.] Angers Univ Hosp, Div Geriatr Med, Dept Neurosci & Aging, Angers, France.
   [Annweiler, Cedric; Kabeshova, Anastasiia; Duval, Guillaume T.] Angers Univ, Memory Clin, Angers, France.
   [Annweiler, Cedric; Kabeshova, Anastasiia; Duval, Guillaume T.] Res Ctr Auton & Longev, Angers, France.
   [Annweiler, Cedric; Kabeshova, Anastasiia; Duval, Guillaume T.] Univ Angers, UNAM, UPRES EA 4638, Angers, France.
   [Annweiler, Cedric] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med Biophys, Roberts Res Inst, London, ON, Canada.
   [Callens, Alix; Paty, Marie-Liesse] Sch Med, Hlth Fac, Angers, France.
   [Holick, Michael F.] Boston Univ, Med Ctr, Dept Med, Sect Endocrinol Diabet & Nutr, Boston, MA USA.
RP Annweiler, C (reprint author), Angers Univ Hosp, Div Geriatr Med, Dept Neurosci & Aging, Angers, France.; Annweiler, C (reprint author), Angers Univ, Memory Clin, Angers, France.; Annweiler, C (reprint author), Res Ctr Auton & Longev, Angers, France.; Annweiler, C (reprint author), Univ Angers, UNAM, UPRES EA 4638, Angers, France.; Annweiler, C (reprint author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Med Biophys, Roberts Res Inst, London, ON, Canada.
EM Cedric.Annweiler@chu-angers.fr
OI Annweiler, Cedric/0000-0002-7199-8109
CR Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343
   Annweiler C, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070658
   Annweiler C, 2016, JAMA INTERN MED, V176, P865, DOI 10.1001/jamainternmed.2016.1612
   Annweiler C, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2015.03.008
   Ayoubi F, 2015, J AM MED DIR ASSOC, V16, P14, DOI 10.1016/j.jamda.2014.06.020
   Beauchet O, 2011, J NUTR HEALTH AGING, V15, P79, DOI 10.1007/s12603-011-0016-6
   Beauchet O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100636
   Bischoff-Ferrari HA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3692
   Bischoff-Ferrari HA, 2016, JAMA INTERN MED, V176, P175, DOI 10.1001/jamainternmed.2015.7148
   Carter GD, 2004, J STEROID BIOCHEM, V89-90, P467, DOI 10.1016/j.jsbmb.2004.03.055
   COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256
   den Braber Maarten, 2013, Ned Tijdschr Geneeskd, V157, pA7028
   Dorz S, 2004, PSYCHOL PSYCHOTHER-T, V77, P353, DOI 10.1348/1476083041839349
   Everett B, 2016, EUR J CARDIOVASC NUR, V15, pE2, DOI 10.1177/1474515114556712
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   French National Authority for Health, 2013, CLIN UT MEAS VIT D S
   Haute Autorite de Sante, 2007, STRAT PRIS CHARG CAS
   Heaney RP, 2014, NUTR REV, V72, P48, DOI 10.1111/nure.12090
   Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385
   Hossein-nezhad A, 2013, MAYO CLIN PROC, V88, P720, DOI 10.1016/j.mayocp.2013.05.011
   Koch, 1982, ENCY STAT SCI, V4, P213, DOI DOI 10.1002/0471667196.ESS1275.PUB2
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee RH, 2013, J AM GERIATR SOC, V61, P707, DOI 10.1111/jgs.12213
   Mogre V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095165
   Muscogiuri G, 2017, ARCH TOXICOL, V91, P97, DOI 10.1007/s00204-016-1804-x
   Pietras SM, 2009, ARCH INTERN MED, V169, P1806, DOI 10.1001/archinternmed.2009.361
   RAMBOER C, 1985, BRIT MED J, V291, P1091, DOI 10.1136/bmj.291.6502.1091
   Ross A, 2011, I MED US COMMITTEE R
   Schmand B, 1997, BRIT J PSYCHIAT, V171, P373, DOI 10.1192/bjp.171.4.373
   Shah A, 1997, AGE AGEING, V26, P217, DOI 10.1093/ageing/26.3.217
   Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975
   Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231
   US Preventive Services Task Force, AHRQ PUBL
   WHO, 1996, EUR SER, V58
NR 34
TC 5
Z9 5
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 1
PY 2017
VL 12
IS 11
DI 10.1371/journal.pone.0186578
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FL4VN
UT WOS:000414229700024
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Nieminen, P
   Virtanen, JI
   Vahanikkila, H
AF Nieminen, Pentti
   Virtanen, Jorma I.
   Vahanikkila, Hannu
TI An instrument to assess the statistical intensity of medical research
   papers
SO PLOS ONE
LA English
DT Article
ID JOURNAL-OF-MEDICINE; PSYCHIATRIC JOURNALS; CLINICAL RESEARCH; DENTAL
   RESEARCH; HIGH AGREEMENT; ARTICLES; FREQUENCY; QUALITY; ERRORS; TRENDS
AB Background
   There is widespread evidence that statistical methods play an important role in original research articles, especially in medical research. The evaluation of statistical methods and reporting in journals suffers from a lack of standardized methods for assessing the use of statistics. The objective of this study was to develop and evaluate an instrument to assess the statistical intensity in research articles in a standardized way.
   Methods
   A checklist-type measure scale was developed by selecting and refining items from previous reports about the statistical contents of medical journal articles and from published guidelines for statistical reporting. A total of 840 original medical research articles that were published between 2007-2015 in 16 journals were evaluated to test the scoring instrument. The total sum of all items was used to assess the intensity between sub-fields and journals. Inter-rater agreement was examined using a random sample of 40 articles. Four raters read and evaluated the selected articles using the developed instrument.
   Results
   The scale consisted of 66 items. The total summary score adequately discriminated between research articles according to their study design characteristics. The new instrument could also discriminate between journals according to their statistical intensity. The inter-observer agreement measured by the ICC was 0.88 between all four raters. Individual item analysis showed very high agreement between the rater pairs, the percentage agreement ranged from 91.7% to 95.2%.
   Conclusions
   A reliable and applicable instrument for evaluating the statistical intensity in research papers was developed. It is a helpful tool for comparing the statistical intensity between sub-fields and journals. The novel instrument may be applied in manuscript peer review to identify papers in need of additional statistical review.
C1 [Nieminen, Pentti] Univ Oulu, Med Informat & Stat Res Grp, Oulu, Finland.
   [Virtanen, Jorma I.; Vahanikkila, Hannu] Univ Oulu, Res Unit Oral Hlth Sci, Fac Med, Oulu, Finland.
   [Virtanen, Jorma I.; Vahanikkila, Hannu] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland.
RP Nieminen, P (reprint author), Univ Oulu, Med Informat & Stat Res Grp, Oulu, Finland.
EM pentti.nieminen@oulu.fi
RI Nieminen, Pentti/A-7571-2012
OI Nieminen, Pentti/0000-0003-0591-586X
CR Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623
   Altman DG, 1998, STAT MED, V17, P2661, DOI 10.1002/(SICI)1097-0258(19981215)17:23<2661::AID-SIM33>3.0.CO;2-B
   ALTMAN DG, 1994, JAMA-J AM MED ASSOC, V272, P129, DOI 10.1001/jama.272.2.129
   Altman DG, 2002, JAMA-J AM MED ASSOC, V287, P2765, DOI 10.1001/jama.287.21.2765
   ALTMAN DG, 1991, STAT MED, V10, P1897, DOI 10.1002/sim.4780101206
   Altman DG, 2000, STAT MED, V19, P3275, DOI 10.1002/1097-0258(20001215)19:23<3275::AID-SIM626>3.0.CO;2-M
   Armitage P, 2002, STAT METHODS
   Arnold LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077301
   Campbell MJ, 1999, MEDICAL STATISTICS A
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   EMERSON JD, 1983, NEW ENGL J MED, V309, P709, DOI 10.1056/NEJM198309223091206
   FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L
   Fleiss J. L., 1971, PSYCHOL BULL, V88, P322
   FLETCHER RH, 1979, NEW ENGL J MED, V301, P180, DOI 10.1056/NEJM197907263010403
   Goodman SN, 1998, J GEN INTERN MED, V13, P753, DOI 10.1046/j.1525-1497.1998.00227.x
   Greenwood DC, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0510-5
   Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600
   Gwet KL, 2014, HANDBOOK OF INTER RA
   Hassan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121268
   HOKANSON JA, 1986, CANCER TREAT REP, V70, P589
   HOKANSON JA, 1986, AM J PSYCHIAT, V143, P1118
   HOKANSON JA, 1987, ARCH PATHOL LAB MED, V111, P202
   HOKANSON JA, 1987, ARCH OTOLARYNGOL, V113, P45
   Horton NJ, 2005, NEW ENGL J MED, V353, P1977, DOI 10.1056/NEJM200511033531823
   Kim JS, 2011, INT DENT J, V61, P163, DOI 10.1111/j.1875-595X.2011.00037.x
   Kyrgidis A, 2010, HIPPOKRATIA, V14, P13
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lang TA, 2015, INT J NURS STUD, V52, P5, DOI 10.1016/j.ijnurstu.2014.09.006
   Lee KP, 2002, JAMA-J AM MED ASSOC, V287, P2805, DOI 10.1001/jama.287.21.2805
   McClean M, 2015, BRIT J DERMATOL, V173, P172, DOI 10.1111/bjd.13907
   Miettunen J, 2002, NORD J PSYCHIAT, V56, P223, DOI 10.1080/080394802317607219
   Motulsky H., 2010, INTUITIVE BIOSTATIST
   Nieminen P., 1995, THERAPEUTIC COMMUNIT, V16, P239
   Nieminen Pentti, 2006, BMC Med Res Methodol, V6, P42, DOI 10.1186/1471-2288-6-42
   Nieminen P, 2007, J CLIN EPIDEMIOL, V60, P939, DOI 10.1016/j.jclinepi.2006.11.014
   Real J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003653
   REZNICK RK, 1987, SURGERY, V101, P611
   Rivoirard R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164275
   Strasak AM, 2007, AM STAT, V61, P47, DOI 10.1198/000313007X170242
   Strasak AM, 2007, SWISS MED WKLY, V137, P44
   Streiner DL, 2003, HLTH MEASUREMENT SCA
   Vahanikkila H, 2016, SCIENTOMETRICS, V108, P1417, DOI 10.1007/s11192-016-2028-9
   Vahanikkila H, 2009, ACTA ODONTOL SCAND, V67, P206, DOI 10.1080/00016350902837922
   Wongpakaran N, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-61
   Yi DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140159
NR 45
TC 1
Z9 1
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 20
PY 2017
VL 12
IS 10
AR e0186882
DI 10.1371/journal.pone.0186882
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FK2MA
UT WOS:000413315100046
PM 29053734
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Persson, K
   Eldholm, RS
   Barca, ML
   Cavallin, L
   Ferreira, D
   Knapskog, AB
   Selbaek, G
   Braekhus, A
   Saltvedt, I
   Westman, E
   Engedal, K
AF Persson, Karin
   Eldholm, Rannveig Sakshaug
   Barca, Maria Lage
   Cavallin, Lena
   Ferreira, Daniel
   Knapskog, Anne-Brita
   Selbaek, Geir
   Braekhus, Anne
   Saltvedt, Ingvild
   Westman, Eric
   Engedal, Knut
TI MRI-assessed atrophy subtypes in Alzheimer's disease and the cognitive
   reserve hypothesis
SO PLOS ONE
LA English
DT Article
ID BRAIN ATROPHY; CORTICAL THICKNESS; DEFINED SUBTYPES; LEWY BODIES;
   DEMENTIA; DIAGNOSIS; EDUCATION; ASSOCIATION; DECLINE; AD
AB Background/Aims
   MRI assessment of the brain has demonstrated four different patterns of atrophy in patients with Alzheimer's disease dementia (AD): typical AD, limbic-predominant AD, hippocampalsparing AD, and a subtype with minimal atrophy, previously referred to as no-atrophy AD. The aim of the present study was to identify and describe the differences between these four AD subtypes in a longitudinal memory-clinic study.
   Methods
   The medial temporal lobes, the frontal regions, and the posterior regions were assessed with MRI visual rating scales to categorize 123 patients with mild AD according to ICD-10 and NINCDS-ADRDA criteria and the clinical dementia rating scale (CDR) into atrophy subtypes. Demographic data, neuropsychological measures, cerebrospinal-fluid biomarkers, and progression rate of dementia at two-year follow-up were compared between the groups.
   Results
   Typical AD was found in 59 patients (48%); 29 (24%) patients had limbic-predominant AD; 19 (15%) had hippocampal-sparing AD; and 16 (13%) belonged to the group with minimal atrophy. No differences were found regarding cognitive test results or progression rates between the different subtypes. Using adjusted logistic regression analysis, we found that the patients in the minimal-atrophy group were less educated, had a lower baseline CDR sum of boxes score, and had higher levels of amyloid beta in the cerebrospinal fluid.
   Conclusion
   Previous results concerning the prevalence and the similar phenotypic expressions of the four AD subtypes were confirmed. The main finding was that patients with minimal atrophy as assessed by MRI had less education than the other AD subtypes and that this could support the cognitive reserve hypothesis and, at least in part, explain the lower degree of atrophy in this group. Patients with less formal education might present with clinically typical AD symptoms before they have positive biomarkers of AD and this finding might challenge suggested biomarker-based criteria for AD.
C1 [Persson, Karin; Barca, Maria Lage; Selbaek, Geir; Braekhus, Anne; Engedal, Knut] Vestfold Hosp Trust, Norwegian Natl Advisory Unit Ageing & Hlth, Tonsberg, Norway.
   [Persson, Karin; Barca, Maria Lage; Braekhus, Anne; Engedal, Knut] Oslo Univ Hosp, Dept Geriatr Med, Oslo, Norway.
   [Persson, Karin; Knapskog, Anne-Brita; Braekhus, Anne] Oslo Univ Hosp, Dept Geriatr Med, Memory Clin, Oslo, Norway.
   [Eldholm, Rannveig Sakshaug; Saltvedt, Ingvild] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway.
   [Cavallin, Lena] Karolinska Inst, Div Med Imaging & Technol, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.
   [Cavallin, Lena] Karolinska Univ Hosp, Dept Radiol, Stockholm, Sweden.
   [Ferreira, Daniel; Westman, Eric] Karolinska Inst, Div Clin Geriatr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.
   [Selbaek, Geir] Innlandet Hosp Trust, Ctr Old Age Psychiat Res, Ottestad, Norway.
   [Selbaek, Geir] Univ Oslo, Inst Hlth & Soc, Oslo, Norway.
   [Braekhus, Anne] Oslo Univ Hosp, Dept Neurol, Oslo, Norway.
   [Saltvedt, Ingvild] Univ Hosp Trondheim, St Olav Hosp, Dept Geriatr, Trondheim, Norway.
RP Persson, K (reprint author), Vestfold Hosp Trust, Norwegian Natl Advisory Unit Ageing & Hlth, Tonsberg, Norway.; Persson, K (reprint author), Oslo Univ Hosp, Dept Geriatr Med, Oslo, Norway.; Persson, K (reprint author), Oslo Univ Hosp, Dept Geriatr Med, Memory Clin, Oslo, Norway.
EM Karin.persson@aldringoghelse.no
RI Westman, Eric/H-5771-2011
OI Eldholm, Rannveig/0000-0002-5585-0446; Westman, Eric/0000-0002-3115-2977
FU Southern and Eastern Norway Regional Health Authority [2013058];
   Norwegian ExtraFoundation for Health and Rehabilitation through
   Norwegian Health Association; Central Norway Regional Health Authority;
   Norwegian University of Science and Technology (NTNU)
FX Southern and Eastern Norway Regional Health Authority for providing
   funding for KP with an unrestricted grant, grant number 2013058
   (https://www.helse-sorost.no/south-eastern-norway-regional-health-author
   ity). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
   Norwegian ExtraFoundation for Health and Rehabilitation through the
   Norwegian Health Association for funding of coauthors RSE and MLB.
   (https://www.extrastiftelsen.no/). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript. Liason Committee between the Central
   Norway Regional Health Authority and the Norwegian University of Science
   and Technology (NTNU) for funding of coauthor RSE. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR ALEXOPOULOS GS, 1988, BIOL PSYCHIAT, V23, P271, DOI 10.1016/0006-3223(88)90038-8
   Barber R, 2000, NEUROLOGY, V54, P1304, DOI 10.1212/WNL.54.6.1304
   Bennett DA, 2005, NEUROLOGY, V65, P953, DOI 10.1212/01.wnl.0000176286.17192.69
   Bennett DA, 2003, NEUROLOGY, V60, P1909, DOI 10.1212/01.WNL.0000069923.64550.9F
   Benton AL, 1976, MULTILINGUAL APHASIA
   Blennow K, 2015, ALZHEIMERS DEMENT, V11, P58, DOI 10.1016/j.jalz.2014.02.004
   Braak H, 1996, ACTA NEUROL SCAND, V93, P3
   Brakhus Anne, 2011, Tidsskr Nor Laegeforen, V131, P2254, DOI 10.4045/tidsskr.11.0786
   Byun MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142756
   Cavallin L, 2012, ACTA RADIOL, V53, P318, DOI 10.1258/ar.2012.110552
   Claus JJ, 2017, PRACTICAL USE VISUAL, V27, P3147
   Csernansky JG, 2004, ALZ DIS ASSOC DIS, V18, P190
   Dickerson BC, 2017, CNS SPECTRUMS, P1
   Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4
   Engedal K, 1988, Compr Gerontol A, V2, P87
   Ferreira D, 2015, J INTERN MED, V278, P277, DOI 10.1111/joim.12358
   Ferreira D, 2017, SCI REP-UK, V7, DOI 10.1038/srep46263
   Ferreira D, 2016, EUR RADIOL, V26, P2597, DOI 10.1007/s00330-015-4101-9
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Goodglass H, 1972, ASSESSMENT APHASIA R
   Guo H, 2014, AM J NEURORADIOL, V35, P504, DOI 10.3174/ajnr.A3709
   Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369
   HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566
   Hwang Jihye, 2016, Alzheimers Dement (Amst), V2, P58, DOI 10.1016/j.dadm.2015.11.008
   Kaplan E., 1983, BOSTON NAMING TEST
   Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233
   Koedam ELGE, 2011, EUR RADIOL, V21, P2618, DOI 10.1007/s00330-011-2205-4
   Koedam ELGE, 2010, J ALZHEIMERS DIS, V19, P1401, DOI 10.3233/JAD-2010-1337
   Kramberger MG, 2017, J ALZHEIMERS DIS, V57, P787, DOI 10.3233/JAD-161109
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liu YW, 2012, NEURORADIOLOGY, V54, P929, DOI 10.1007/s00234-012-1005-0
   Maia LF, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006446
   Manly JJ, 2003, J CLIN EXP NEUROPSYC, V25, P680, DOI 10.1076/jcen.25.5.680.14579
   Mattsson N, 2013, ALZHEIMERS DEMENT, V9, P251, DOI 10.1016/j.jalz.2013.01.010
   MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
   McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005
   Mondragon JD, 2016, DEMENT GER COGN D EX, V6, P486, DOI 10.1159/000449424
   MORRIS JC, 1989, NEUROLOGY, V39, P1159
   Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008
   Murray ME, 2011, LANCET NEUROL, V10, P785, DOI 10.1016/S1474-4422(11)70156-9
   Noh Y, 2014, NEUROLOGY, V83, P1936, DOI 10.1212/WNL.0000000000001003
   Pasquier F, 1996, EUR NEUROL, V36, P268, DOI 10.1159/000117270
   Persson K, 2017, DEMENT GERIATR COGN
   Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105
   REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271
   Rhodius-Meester HFM, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00117
   SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967
   Schweizer TA, 2012, CORTEX, V48, P991, DOI 10.1016/j.cortex.2011.04.009
   Seo SW, 2011, NEUROBIOL AGING, V32, P200, DOI 10.1016/j.neurobiolaging.2009.02.004
   Shpanskaya KS, 2014, J NEURORADIOLOGY, V41, P350, DOI 10.1016/j.neurad.2013.11.004
   Shulman K., 1986, INT J GERIATR PSYCH, V1, P135, DOI DOI 10.1002/GPS.930010209
   Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6
   Teipel SJ, 2009, J ALZHEIMERS DIS, V17, P571, DOI 10.3233/JAD-2009-1077
   Whitwell JL, 2008, NEUROLOGY, V71, P743, DOI 10.1212/01.wnl.0000324924.91351.7d
   Whitwell JL, 2012, LANCET NEUROL, V11, P868, DOI 10.1016/S1474-4422(12)70200-4
   World Health Organization (WHO), 1993, ICD 10 CLASS MENT BE
NR 56
TC 4
Z9 4
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 16
PY 2017
VL 12
IS 10
AR e0186595
DI 10.1371/journal.pone.0186595
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FJ8YP
UT WOS:000413054800049
PM 29036183
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-07-16
ER

PT J
AU Malmstrom, CM
   Butterfield, HS
   Planck, L
   Long, CW
   Eviner, VT
AF Malmstrom, Carolyn M.
   Butterfield, H. Scott
   Planck, Laura
   Long, Christopher W.
   Eviner, Valerie T.
TI Novel fine-scale aerial mapping approach quantifies grassland weed cover
   dynamics and response to management
SO PLOS ONE
LA English
DT Article
ID TAENIATHERUM-CAPUT-MEDUSAE; INVASIVE-PLANT MANAGEMENT; LANDSCAPE
   ECOLOGY; NEW-MEXICO; RANGELAND; VEGETATION; DISPERSAL; DIVERSITY;
   COMMUNITY; CHEATGRASS
AB Invasive weeds threaten the biodiversity and forage productivity of grasslands worldwide. However, management of these weeds is constrained by the practical difficulty of detecting small-scale infestations across large landscapes and by limits in understanding of landscape- scale invasion dynamics, including mechanisms that enable patches to expand, contract, or remain stable. While high-end hyperspectral remote sensing systems can effectively map vegetation cover, these systems are currently too costly and limited in availability for most land managers. We demonstrate application of a more accessible and cost-effective remote sensing approach, based on simple aerial imagery, for quantifying weed cover dynamics over time. In California annual grasslands, the target communities of interest include invasive weedy grasses (Aegilops triuncialis and Elymus caput-medusae) and desirable forage grass species (primarily Avena spp. and Bromus spp.). Detecting invasion of annual grasses into an annual-dominated community is particularly challenging, but we were able to consistently characterize these two communities based on their phenological differences in peak growth and senescence using maximum likelihood supervised classification of imagery acquired twice per year (in mid-and end-of season). This approach permitted us to map weed-dominated cover at a 1-m scale (correctly detecting 93% of weed patches across the landscape) and to evaluate weed cover change over time. We found that weed cover was more pervasive and persistent in management units that had no significant grazing for several years than in those that were grazed, whereas forage cover was more abundant and stable in the grazed units. This application demonstrates the power of this method for assessing fine-scale vegetation transitions across heterogeneous landscapes. It thus provides means for small-scale early detection of invasive species and for testing fundamental questions about landscape dynamics.
C1 [Malmstrom, Carolyn M.; Planck, Laura; Long, Christopher W.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.
   [Malmstrom, Carolyn M.] Michigan State Univ, Ctr Global Change & Earth Observat, E Lansing, MI 48824 USA.
   [Malmstrom, Carolyn M.] Michigan State Univ, Grad Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA.
   [Butterfield, H. Scott] Nature Conservancy, San Francisco, CA USA.
   [Eviner, Valerie T.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.
   [Planck, Laura] Quantum Spatial Inc, Portland, OR USA.
RP Malmstrom, CM (reprint author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.; Malmstrom, CM (reprint author), Michigan State Univ, Ctr Global Change & Earth Observat, E Lansing, MI 48824 USA.; Malmstrom, CM (reprint author), Michigan State Univ, Grad Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA.
EM carolynm@msu.edu
OI Eviner, Valerie/0000-0001-5530-9417
FU United States Department of Agriculture National Institute of Food and
   Agriculture National Research Initiative Controlling Weedy and Invasive
   Plants Program Grant [2006-55320-17247]; Michigan State University
   AgBioResearch; United States Department of Food and Agriculture National
   Institute of Food and Agriculture, Agricultural Experiment Station
   Project [CA-D-PLS-7641-H]; CalFed Bay-Delta Authority Grant
   [2001-H2110-1-N31]
FX This project was supported by the United States Department of
   Agriculture National Institute of Food and Agriculture National Research
   Initiative Controlling Weedy and Invasive Plants Program Grant
   #2006-55320-17247, https://www.nifa.usda.gov/(CMM, VTE); Michigan State
   University AgBioResearch, http://agbioresearch.msu.edu/ (CMM); and by
   the United States Department of Food and Agriculture National Institute
   of Food and Agriculture, Agricultural Experiment Station Project
   CA-D-PLS-7641-H, https://www.nifa.usda.gov (VTE). It built on work
   previously funded by the CalFed Bay-Delta Authority Grant
   2001-H2110-1-N31, http://calwater.ca.gov/calfed/oversight/CBDA/(CMM).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150
   Arianoutsou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079174
   BARTOLOME JW, 1980, J RANGE MANAGE, V33, P4, DOI 10.2307/3898219
   Belnap J, 2012, RANGELAND ECOL MANAG, V65, P569, DOI 10.2111/REM-D-11-00157.1
   Bestelmeyer BT, 2011, J APPL ECOL, V48, P746, DOI 10.1111/j.1365-2664.2011.01982.x
   BOVEY R W, 1987, Reviews of Weed Science, V3, P57
   BOVEY RODNEY W., 1961, WEEDS, V9, P307, DOI 10.2307/4040420
   Bradley BA, 2005, REMOTE SENS ENVIRON, V94, P204, DOI 10.1016/j.rse.2004.08.016
   Bradley BA, 2014, BIOL INVASIONS, V16, P1411, DOI 10.1007/s10530-013-0578-9
   Butterfield HS, 2009, INT J REMOTE SENS, V30, P3133, DOI 10.1080/01431160802558774
   Butterfield HS, 2006, RANGELAND ECOL MANAG, V59, P541, DOI 10.2111/05-184R1.1
   Chase JM, 2013, ECOL LETT, V16, P17, DOI 10.1111/ele.12112
   Chuong J, 2016, RANGELAND ECOL MANAG, V69, P52, DOI 10.1016/j.rama.2015.10.009
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Collins SL, 2015, AM NAT, V185, pE30, DOI 10.1086/679315
   CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B
   Congalton RG, 2009, ASSESSING ACCURACY R
   Daubenmire R., 1968, Advances in Ecological Research, V5, P209, DOI 10.1016/S0065-2504(08)60226-3
   Davies K. W., 2008, RANGELANDS, V30, P13
   Davies KW, 2007, WEED SCI, V55, P178, DOI 10.1614/WS-06-161.1
   Davies KW, 2011, OECOLOGIA, V167, P481, DOI 10.1007/s00442-011-1992-2
   Davy JS, 2015, CALIF AGR, V69, P230, DOI 10.3733/ca.v069n04p230
   Decarolis F, 2014, CENT ISS CONT ECON T, P1, DOI 10.1007/s11119-013-9304-y
   Denison R, 1996, CALIF AGR, V50, P9
   DiTomaso J.M., 2010, RANGELANDS, V32, P43, DOI DOI 10.2111/RANGELANDS-D-09-00007.1
   DiTomaso JM, 2000, WEED SCI, V48, P255, DOI 10.1614/0043-1745(2000)048[0255:IWIRSI]2.0.CO;2
   DiTomaso JM, 2008, INVAS PLANT SCI MANA, V1, P241, DOI 10.1614/IPSM-07-031.1
   Drenovsky RE, 2007, BIOL INVASIONS, V9, P107, DOI 10.1007/s10530-006-0007-4
   Duncan C, 2005, INVASIVE PLANTS RANG
   Duncan CA, 2004, WEED TECHNOL, V18, P1411, DOI 10.1614/0890-037X(2004)018[1411:ATEEAS]2.0.CO;2
   Eviner VT, 2016, ECOSYSTEMS OF CALIFORNIA, P449
   Eviner VT, 2010, RANGELANDS, V32, P21, DOI DOI 10.2111/RANGELANDS-D-09-00005.1
   GAMON JA, 1993, REMOTE SENS ENVIRON, V44, P239, DOI 10.1016/0034-4257(93)90019-T
   GEORGE MR, 1992, J RANGE MANAGE, V45, P436, DOI 10.2307/4002898
   He KS, 2011, DIVERS DISTRIB, V17, P381, DOI 10.1111/j.1472-4642.2011.00761.x
   Hengl T, 2006, COMPUT GEOSCI-UK, V32, P1283, DOI 10.1016/j.cageo.2005.11.008
   Herold M, 2002, ENVIRON PLANN A, V34, P1443, DOI 10.1068/a3496
   Homburger H, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0053-6
   Huang C, 2009, INT J REMOTE SENS, V30, P897, DOI 10.1080/01431160802395243
   Huang CY, 2009, SENSORS-BASEL, V9, P4869, DOI 10.3390/s90604869
   James JJ, 2015, RANGELAND ECOL MANAG, V68, P215, DOI 10.1016/j.rama.2015.03.006
   Jelinski DE, 1996, LANDSCAPE ECOL, V11, P129, DOI 10.1007/BF02447512
   Julia R, 2007, J ENVIRON MANAGE, V85, P876, DOI 10.1016/j.jenvman.2006.10.024
   Laliberte AS, 2011, REMOTE SENS-BASEL, V3, P2529, DOI 10.3390/rs3112529
   Laliberte AS, 2004, REMOTE SENS ENVIRON, V93, P198, DOI 10.1016/j.rse.2004.07.011
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lelong CCD, 2008, SENSORS-BASEL, V8, P3557, DOI 10.3390/s8053557
   Macon D. K., 2016, Rangelands, V38, P222
   Malmstrom CM, 2009, RESTOR ECOL, V17, P526, DOI 10.1111/j.1526-100X.2008.00411.x
   Malmstrom CM, 2004, 01N31 CALFED EC REST
   Mariotte P, 2017, APPL VEG SCI, V20, P28, DOI 10.1111/avsc.12291
   McGarigal K, 2012, FRAGSTATS V4 SPATIAL, DOI citeulike-article-id:287784
   Nafus AM, 2017, INVAS PLANT SCI MANA, V7, P210
   Ndzeidze SK, 2011, DETECTING MEDUSAHEAD
   Nelson P. R, 2005, ANAL MEANS GRAPHICAL
   O'Neill RV, 1988, LANDSCAPE ECOL, V1, P153, DOI 10.1007/BF00162741
   Parece T, 2014, REMOTE SENSING ANAL
   Perovic D, 2015, J APPL ECOL, V52, P505, DOI 10.1111/1365-2664.12394
   Peters A., 1996, Rangelands, V18, P8
   Peterson EB, 2005, INT J REMOTE SENS, V26, P2491, DOI 10.1080/01431160500127815
   Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002
   Plieninger T, 2012, ENVIRON MANAGE, V50, P427, DOI 10.1007/s00267-012-9900-z
   Porensky LM, 2016, J APPL ECOL, V53, P1013, DOI 10.1111/1365-2664.12630
   Powell KI, 2013, SCIENCE, V339, P316, DOI 10.1126/science.1226817
   Sandel B, 2012, J VEG SCI, V23, P906, DOI 10.1111/j.1654-1103.2012.01406.x
   Santos MJ, 2016, ECOL APPL, V26, P1733, DOI 10.1890/15-0615
   Sawalhah MN, 2014, RANGELAND ECOL MANAG, V67, P710, DOI 10.2111/REM-D-14-00047.1
   Seabloom EW, 2005, ECOL MONOGR, V75, P199, DOI 10.1890/03-0841
   Sheley R, 2010, RANGELAND ECOL MANAG, V63, P605, DOI 10.2111/REM-D-09-00187.1
   Sheley R., 2011, CONSERVATION BENEFIT, P291
   Singh N, 2009, INT J REMOTE SENS, V30, P3441, DOI 10.1080/01431160802562222
   Stromberg M, 2007, CALIFORNIA GRASSLAND, P254
   Tamouridou AA, 2017, INT J REMOTE SENS, V38, P2246, DOI 10.1080/01431161.2016.1252475
   Teillet PM, 1997, REMOTE SENS ENVIRON, V61, P139, DOI 10.1016/S0034-4257(96)00248-9
   Thomason MJS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169328
   TORELL PAUL J., 1961, WEEDS, V9, P124, DOI 10.2307/4040395
   Trimble Navigation Limited, 2009, TRIMBL MAPP GIS PROD
   TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0
   Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x
   With KA, 2002, CONSERV BIOL, V16, P1192, DOI 10.1046/j.1523-1739.2002.01064.x
   Wu JG, 1995, Q REV BIOL, V70, P439, DOI 10.1086/419172
NR 81
TC 0
Z9 0
U1 1
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 9
PY 2017
VL 12
IS 10
AR e0181665
DI 10.1371/journal.pone.0181665
PG 28
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FJ3AF
UT WOS:000412601800003
PM 29016604
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Olivera, MJ
   Cucunuba, ZM
   Valencia-Hernandez, CA
   Herazo, R
   Agreda-Rudenko, D
   Florez, C
   Duque, S
   Nicholls, RS
AF Olivera, Mario J.
   Cucunuba, Zulma M.
   Valencia-Hernandez, Carlos A.
   Herazo, Rafael
   Agreda-Rudenko, Diana
   Florez, Carolina
   Duque, Sofia
   Nicholls, Ruben S.
TI Risk factors for treatment interruption and severe adverse effects to
   benznidazole in adult patients with Chagas disease
SO PLOS ONE
LA English
DT Article
ID TOLERANCE; SAFETY; NIFURTIMOX; TRIAL; MODEL
AB Background Etiological treatment of Chagas disease in chronic asymptomatic patients is still in debate and the adverse effects of traditional drugs are one of the main concerns in clinical practice. This study evaluated retrospectively the safety profile of benznidazole (BZN) and identified predictive factors for definite treatment interruption and development of severe reactions in adult patients treated with BZN in Colombia.
   Methods Retrospective follow-up study conducted by review of medical records of adults with chronic Chagas disease treated with BZN in Colombia. A parametric survival analysis based on a generalized gamma distribution was used for assessing risk factors for treatment interruption. A multinomial logistic regression model was used to estimate the probability of severe adverse drug reactions (ADRs). Statistical associations were expressed as time ratios (TR) and adjusted odds ratios (aOR) respectively.
   Results In total 224 adults patients treated with BZN were included; 172 (76.8%) completed the standard therapy (60 days of treatment), 205 (91.5%) presented ADRs and 52 cases (23.2%) required treatment interruption. The predominant symptoms were: rash (37.9%), itching (33.7%), epigastric pain (26.4%), abdominal bloating (24.2%) and nausea (22.1%). ADRs were mild (57.4%), moderate (35.5%) and severe (7.3%). Time to treatment interruption was significantly shorter when using doses of BZN >= 6 mg/ kg/ day (TR 0.55; 95% CI 0.39-0.76), presenting severe ADRs (TR 0.12; 95% CI: 0.07-0.19) and eosinophilia (TR 0.68; 95% CI: 0.49-0.94). Female sex (aOR 3.98; 95% CI 1.56-10.16), dose of BZN >= 6 mg/ kg/ day (aOR 1.41; 95% CI 1.17-1.70) and presence of > 3 ADRs (aOR 6.47; 95% CI 1.24-34.34) were considered as risk factors for developing severe ADRs.
   Conclusions Dose, severity of ADRs, eosinophilia and female sex were the main predictors for treatment interruption or severe ADRs. The potential implications of these findings are discussed.
C1 [Olivera, Mario J.; Cucunuba, Zulma M.; Valencia-Hernandez, Carlos A.; Herazo, Rafael; Agreda-Rudenko, Diana] Red Chagas Colombia, Bogota, Colombia.
   [Olivera, Mario J.; Cucunuba, Zulma M.; Valencia-Hernandez, Carlos A.; Herazo, Rafael; Agreda-Rudenko, Diana; Florez, Carolina; Duque, Sofia; Nicholls, Ruben S.] Inst Nacl Salud, Grp Parasitol, Bogota, Colombia.
RP Olivera, MJ (reprint author), Red Chagas Colombia, Bogota, Colombia.; Olivera, MJ (reprint author), Inst Nacl Salud, Grp Parasitol, Bogota, Colombia.
EM moliverajr@gmail.com
RI Olivera, Mario/T-5486-2018; Cucunuba, Zulma/L-4076-2016
OI Olivera, Mario/0000-0002-6885-6353; Cucunuba, Zulma/0000-0002-8165-3198
CR Altcheh J, 2011, PEDIATRICS, V127, pE212, DOI 10.1542/peds.2010-1172
   Anderson GD, 2008, INT REV NEUROBIOL, V83, P1, DOI 10.1016/S0074-7742(08)00001-9
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33
   Antinori S, 2015, CLIN INFECT DIS, V60, P1873, DOI 10.1093/cid/civ230
   CANADO J. Romeu, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P29, DOI 10.1590/S0036-46652002000100006
   Villar JC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003463.pub2
   Carrilero B, REV ESPANOLA QUIMIOT
   Coelho H L, 1999, Cad Saude Publica, V15, P631, DOI 10.1590/S0102-311X1999000300021
   Cox C, 2007, STAT MED, V26, P4352, DOI 10.1002/sim.2836
   Croft SL, 2005, TRENDS PARASITOL, V21, P508, DOI 10.1016/j.pt.2005.08.026
   de Graauw E, 2015, IMMUNOL ALLERGY CLIN, V35, P545, DOI 10.1016/j.iac.2015.05.005
   Fabbro de Suasnabar Diana, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P99
   Alvarez MG, 2016, ANTIMICROB AGENTS CH, V60, P833, DOI 10.1128/AAC.00745-15
   Hasslocher-Moreno AM, 2012, J ANTIMICROB CHEMOTH, V67, P1261, DOI 10.1093/jac/dks027
   Hosmer Jr DW, 2000, APPL LOGISTIC REGRES
   Jackson Y, 2010, CLIN INFECT DIS, V51, pE69, DOI 10.1086/656917
   Olivera MJ, 2015, AM J TROP MED HYG, V93, P1224, DOI 10.4269/ajtmh.15-0256
   Olivera MJ, 2015, REV SOC BRAS MED TRO, V48, P343, DOI 10.1590/0037-8682-0251-2014
   Kleinbaum DG, 2005, SURVIVAL ANAL SELF L
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee BY, 2013, LANCET INFECT DIS, V13, P342, DOI 10.1016/S1473-3099(13)70002-1
   Lee E. T., 2003, STAT METHODS SURVIVA
   Meibohm B, 2002, CLIN PHARMACOKINET, V41, P329, DOI 10.2165/00003088-200241050-00002
   Miller DA, 2015, CLIN INFECT DIS, V60, P1237, DOI 10.1093/cid/civ005
   Ministerio de la Proteccion Social, 2010, GUIA AT CLIN INT PAC
   Morillo CA, 2015, NEW ENGL J MED, V373, P1295, DOI 10.1056/NEJMoa1507574
   NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154
   Ng ES-W, 2015, PHARM STAT
   de Pontes VMO, 2010, REV SOC BRAS MED TRO, V43, P182, DOI 10.1590/S0037-86822010000200015
   Pinazo MJ, 2010, ANTIMICROB AGENTS CH, V54, P4896, DOI 10.1128/AAC.00537-10
   R Development Core Team, 2013, LANG ENV STAT COMP
   Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X
   Sosa-Estani S, 2004, MEDICINA-BUENOS AIRE, V64, P1
   da Silva GMS, 2014, ANTIMICROB AGENTS CH, V58, P6371, DOI 10.1128/AAC.02842-14
   Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006
   White KD, 2015, J ALLERGY CLIN IMMUN, V136, P219, DOI 10.1016/j.jaci.2015.05.050
NR 36
TC 5
Z9 5
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 26
PY 2017
VL 12
IS 9
AR e0185033
DI 10.1371/journal.pone.0185033
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FI1DL
UT WOS:000411671000022
PM 28949997
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Vaccher, SJ
   Grulich, AE
   Haire, BG
   Conway, DP
   Poynten, IM
   Ooi, C
   Foster, R
   Templeton, DJ
   Zablotska, IB
AF Vaccher, Stefanie J.
   Grulich, Andrew E.
   Haire, Bridget G.
   Conway, Damian P.
   Poynten, Isobel M.
   Ooi, Catriona
   Foster, Rosalind
   Templeton, David J.
   Zablotska, Iryna B.
CA PRELUDE Study Team
TI Validation of participant eligibility for preexposure prophylaxis:
   Baseline data from the PRELUDE demonstration project
SO PLOS ONE
LA English
DT Article
ID AUSTRALIAN HOMOSEXUAL-MEN; HIV-INFECTION; RISK; PREVENTION; TRIAL; SEX
AB Background
   In Australia, pre-exposure prophylaxis (PrEP) is targeted to individuals at high risk for HIV infection. We describe the HIV risk profile and characteristics of PRELUDE participants, and evaluate the population validity of the sample in representing high-risk gay and bisexual men (GBM) eligible for PrEP.
   Methods
   PRELUDE is an on-going, open-label, single-arm observational study. Participants were identified in clinics and screened for eligibility using a paper-based risk assessment tool which followed the New South Wales (NSW) PrEP guidelines. Selection was validated using an independent online behavioural survey, completed by study participants upon enrolment. Demographic information was analysed using descriptive statistics, and kappa tests were used to determine agreement between reporting of high-risk practices in the risk assessment and behavioural survey.
   Results
   During 2014 +/- 15, 471 individuals were targeted for enrolment; 341 were assessed for PrEP eligibility and 313 were enrolled. Of these, 303 (97%) identified as GBM. Overall, 85% of GBM met at least one high-risk criterion; 68% reported receptive intercourse with an HIVpositive or unknown status casual male partner, and 37% reported methamphetamine use in the three months preceding enrolment. The remaining 15% were enrolled based on medium-risk behaviours, or at the clinicians' discretion. We found an 82% total agreement between self-reported high-risk behaviour and clinicians' categorisation of GBM as being at high risk for HIV based on PrEP eligibility criteria.
   Conclusions
   Behavioural eligibility criteria used by clinicians successfully identified individuals at high risk for HIV infection. This targeted approach ensures that the greatest public health and HIV prevention benefits can be derived in a setting without universal access to PrEP.
C1 [Vaccher, Stefanie J.; Grulich, Andrew E.; Haire, Bridget G.; Conway, Damian P.; Poynten, Isobel M.; Foster, Rosalind; Templeton, David J.; Zablotska, Iryna B.] UNSW Sydney, Kirby Inst, Kensington, NSW, Australia.
   [Conway, Damian P.] Sydney Sexual Hlth Ctr, Sydney, NSW, Australia.
   [Ooi, Catriona] Western Sydney Sexual Hlth Ctr, Parramatta, NSW, Australia.
   [Foster, Rosalind] Northern Sydney Sexual Hlth, Clin 16, St Leonards, NSW, Australia.
   [Templeton, David J.] Univ Sydney, Sydney Local Hlth Dist & Cent Clin Sch, RPA Sexual Hlth, Sydney, NSW, Australia.
RP Vaccher, SJ; Zablotska, IB (reprint author), UNSW Sydney, Kirby Inst, Kensington, NSW, Australia.
EM svaccher@kirby.unsw.edu.au; Izablotska@kirby.unsw.edu.au
RI Vaccher, Stefanie/J-8808-2019; Haire, Bridget Gabrielle/H-8292-2019
OI Vaccher, Stefanie/0000-0001-5170-4110; Haire, Bridget
   Gabrielle/0000-0002-0657-9610; Conway, Damian/0000-0003-3316-2199
FU New South Wales (NSW) Ministry of Health
FX The study is funded by the New South Wales (NSW) Ministry of Health
   (http://www.health.nsw.gov.au/Pages/default.aspx). Gilead Sciences Inc
   (http://www.gilead.com/) is providing an in-kind supply of the study
   medication, Truvada. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ASHM, 2015, AUSTR COMM US PUBL H
   Baeten J, 2016, INTEGRATED DELIVERY
   Bekker LG, 2016, S AFR J HIV MED, V17, DOI 10.4102/sajhivmed.v17i1.455
   Caceres CF, 2015, J INT AIDS SOC, V18, P5, DOI [10.7448/IAS.18.4.19949, 10.7448/IAS.18.4.20527]
   Carnegie NB, 2015, JAIDS-J ACQ IMM DEF, V69, P119, DOI 10.1097/QAI.0000000000000555
   Chan PA, 2015, AIDS PATIENT CARE ST, V29, P597, DOI 10.1089/apc.2015.0113
   Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7
   Cremin I, 2015, AIDS, V29, P733, DOI 10.1097/QAD.0000000000000591
   Dolling DI, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1286-4
   EACS. EACS guidelines, 2015, EACS GUID
   Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145
   Food and Drug Administration, 2012, FDA APPR 1 DRUG RED
   Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205
   Grulich A, 2015, HIV TRANSMISSION MAL
   Haire B., 2015, HIV AIDS AUCKL, P241
   Hull P, 2016, GAY COMM PER SURV SY
   Jin FY, 2010, JAIDS-J ACQ IMM DEF, V53, P144, DOI 10.1097/QAI.0b013e3181b48f33
   Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liu AY, 2015, JAMA INTERN MED, V176, P79
   McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2
   McHugh ML, 2012, BIOCHEM MEDICA, V22, P276
   Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273
   Pharmaceutical Benefits Advisory Committee, 2016, PBAC OUTC 1 TIM DEC
   Poynten IM, 2010, HIV MED, V11, P635, DOI 10.1111/j.1468-1293.2010.00833.x
   Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148
   Spinner CD, 2016, INFECTION, V44, P151, DOI 10.1007/s15010-015-0850-2
   Templeton DJ, 2009, AIDS, V23, P2347, DOI 10.1097/QAD.0b013e32833202b8
   The Kirby Institute, 2016, HIV VIR HEP SEX TRAN
   Therapeutic Goods Administration, TRUVADA TEN DIS FUM
   US Public Health Service, 2015, PREEXP PROPH PREV HI
   Vaccher S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012179
   Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778
   Wilton J, 2015, HIV AIDS-RES PALLIAT, V7, P125, DOI 10.2147/HIV.S50025
   World Health Organization, 2015, GUID WHEN START ANT
   Zablotska I., NSW PRESP GUID CLIN
   Zablotska I, 2016, AUSTR EPIC NSW EVID
   Zablotska IB, 2016, SEX HLTH
NR 38
TC 5
Z9 5
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 26
PY 2017
VL 12
IS 9
AR e0185398
DI 10.1371/journal.pone.0185398
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FI1DL
UT WOS:000411671000048
PM 28950022
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lee, SY
   Shin, YR
   Park, HJ
   Rho, MH
   Chung, EC
AF Lee, So-Yeon
   Shin, Yu Ri
   Park, Hee Jin
   Rho, Myung Ho
   Chung, Eun Chul
TI Usefulness of multiecho fast field echo MRI in the evaluation of
   ossification of the posterior longitudinal ligament and dural
   ossification of the cervical spine
SO PLOS ONE
LA English
DT Article
AB Objectives
   The diagnosis of ossification of the posterior longitudinal ligament (OPLL) on magnetic resonance imaging (MRI) is challenging. The purpose of this study is to evaluate the usefulness of the multiecho fast field echo (mFFE) MRI in the detection of ossification of the posterior longitudinal ligament and dural ossification (DO) of the cervical spine.
   Methods
   Sixty-three patients who underwent MRI with mFFE and CT for cervical spine were retrospectively evaluated. The presence of OPLL and DO on MR images was assessed by two independent readers. The sensitivity, specificity, and accuracy of MRI for detecting OPLL and DO were determined using CT as a reference standard. Image contrast ratios were obtained between the OPLL and perilesional structures on each sequence.
   Results
   There were 31 patients with OPLL and 13 DO lesions. The mean sensitivity, specificity, and accuracy of both readers were 94%, 81%, 88% for OPLL and 92%, 81%, 86% for DO, respectively. The contrast ratios for OPLL and intervertebral disc, spinal cord and cerebrospinal fluid were significantly superior on mFFE images, whereas those for OPLL and bone marrow were significantly inferior on mFFE images than those of T1-and T2-weighted images (p <= 0.016).
   Conclusions
   MRI with mFFE may be sufficient for the assessment of OPLL and DO, with good contrasts between OPLL and intervertebral disc, spinal cord, and cerebrospinal fluid.
C1 [Lee, So-Yeon; Park, Hee Jin; Rho, Myung Ho; Chung, Eun Chul] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Radiol, Seoul, South Korea.
   [Shin, Yu Ri] Catholic Univ Korea, Incheon St Marys Hosp, Dept Radiol, Coll Med, Incheon, South Korea.
RP Park, HJ (reprint author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Radiol, Seoul, South Korea.
EM radiology12@paran.com
CR Chang H, 2010, CLIN ORTHOP SURG, V2, P8, DOI 10.4055/cios.2010.2.1.8
   Dorenbeck U, 2004, NEURORADIOLOGY, V46, P306, DOI 10.1007/s00234-004-1175-5
   Held P, 2001, EUR J RADIOL, V38, P64, DOI 10.1016/S0720-048X(00)00253-9
   Hida Kazutoshi, 1997, Neurologia Medico-Chirurgica, V37, P173, DOI 10.2176/nmc.37.173
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee SY, 2008, AM J ROENTGENOL, V191, P81, DOI 10.2214/AJR.07.2945
   Li H, 2011, SPINE J, V11, P1049, DOI 10.1016/j.spinee.2011.09.008
   Min JH, 2007, J NEUROSURG-SPINE, V6, P309, DOI 10.3171/spi.2007.6.4.4
   Mizuno J, 2005, J NEUROSURG-SPINE, V2, P425, DOI 10.3171/spi.2005.2.4.0425
   OTAKE S, 1992, AM J NEURORADIOL, V13, P1059
   TSUYAMA N, 1984, CLIN ORTHOP RELAT R, P71
   YAMASHITA Y, 1990, RADIOLOGY, V175, P843, DOI 10.1148/radiology.175.3.2111569
NR 12
TC 0
Z9 0
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 25
PY 2017
VL 12
IS 8
AR e0183744
DI 10.1371/journal.pone.0183744
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FE7EP
UT WOS:000408370700055
PM 28841680
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Alhazmi, A
   Vargas, E
   Palomo, JM
   Hans, M
   Latimer, B
   Simpson, S
AF Alhazmi, Anwar
   Vargas, Eduardo
   Palomo, J. Martin
   Hans, Mark
   Latimer, Bruce
   Simpson, Scott
TI Timing and rate of spheno-occipital synchondrosis closure and its
   relationship to puberty
SO PLOS ONE
LA English
DT Article
ID BEAM COMPUTED-TOMOGRAPHY; BRIEF COMMUNICATION; SKELETAL MATURATION; AGE
   ESTIMATION; FACIAL GROWTH; CRANIAL BASE; BODY HEIGHT; TIME; FUSION; CT
AB Objectives
   This study examines the relationship between spheno-occipital synchondrosis (SOS) closure and puberty onset in a modern American population. It also investigates the timing and the rate of SOS closure in males and females.
   Materials and methods
   The sample includes cross-sectional and longitudinal 3D Cone Beam Computed Tomography (CBCT) scans of 741 individuals (361 males and 380 females) aged 6-20 years. Each CBCT scan is visualized in the mid-sagittal plane, and the spheno-occipital synchondrosis (SOS) is scored as completely open, partially fused, mostly fused, and completely fused. The Menarche commencement is used as an indicator of puberty onset in females.
   Results
   Mean ages of open, partially-fused, mostly-fused, and completely fused SOS were 11.07, 12.95, 14.44, and 16.41 years in males, and 9.75, 11.67, 13.25, and 15.25 in females, respectively. The results show there is a significant association between the SOS closure stage and the commencement of menarche (Fisher's Exact Test p < 0.001). It was found that females had a higher SOS closure rate (38.60%) per year than males at the age of 10 years. The closure rate in males appears slower than females at age 10, but it lasts a longer time, ranging between 22 and 26% per year from age 11 to 14 years.
   Conclusion
   There is a significant relationship between puberty onset and SOS closure, suggesting its closure is at least partially affected by systemic, hormonal changes in the growing adolescent. Also, SOS closure occurs at a faster rate and at an earlier age in females compared to males.
C1 [Alhazmi, Anwar; Vargas, Eduardo; Palomo, J. Martin; Hans, Mark; Latimer, Bruce] Case Western Reserve Univ, Sch Dent Med, Dept Orthodont, Cleveland, OH 44106 USA.
   [Alhazmi, Anwar; Simpson, Scott] Case Western Reserve Univ, Dept Biol, Sch Art & Sci, Cleveland, OH 44106 USA.
   [Simpson, Scott] Case Western Reserve Univ, Sch Med, Dept Anat, Cleveland, OH USA.
RP Alhazmi, A (reprint author), Case Western Reserve Univ, Sch Dent Med, Dept Orthodont, Cleveland, OH 44106 USA.; Alhazmi, A (reprint author), Case Western Reserve Univ, Dept Biol, Sch Art & Sci, Cleveland, OH 44106 USA.
EM asj29@case.edu
CR Akhlaghi M, 2010, J FORENSIC LEG MED, V17, P304, DOI 10.1016/j.jflm.2010.04.009
   Bassed RB, 2010, FORENSIC SCI INT, V200, P161, DOI 10.1016/j.forsciint.2010.04.009
   BERGERSEN EO, 1972, ANGLE ORTHOD, V42, P319
   BJORK A, 1967, ANGLE ORTHOD, V37, P134
   Bjork A, 1972, Trans Eur Orthod Soc, P61
   Can IO, 2014, J CRANIOFAC SURG, V25, P1212, DOI 10.1097/SCS.0000000000000847
   Cendekiawan T, 2010, OPEN ANAT J, V2, P67
   Coqueugniot H, 2007, AM J PHYS ANTHROPOL, V134, P424, DOI 10.1002/ajpa.20683
   ElSheikh ME, 2006, FOR PHYS ANTHR P AM
   Enlow D.H., 1990, FACIAL GROWTH
   Fatah EEA, 2014, J FORENSIC SCI
   Ford EHR, 1958, AM J ORTHODONTICS, V44, P498
   Franklin D, 2014, AM J PHYS ANTHROPOL, V153, P132, DOI 10.1002/ajpa.22399
   Hardy M.A., 1993, SERIES QUANTITATIVE, P7
   Hayashi I, 2003, EUR J ORTHODONT, V25, P385, DOI 10.1093/ejo/25.4.385
   Hoyte D A, 1991, Neurosurg Clin N Am, V2, P515
   HUNTER CJ, 1966, ANGLE ORTHOD, V36, P44
   INGERVALL B, 1972, ACTA ODONTOL SCAND, V30, P349, DOI 10.3109/00016357209004602
   IRWIN GL, 1960, RADIOLOGY, V75, P450, DOI 10.1148/75.3.450
   Kahana T, 2003, J FORENSIC SCI, V48, P504
   Kocasarac HD, 2017, ACTA ODONTOL SCAND, V75, P79, DOI 10.1080/00016357.2016.1255352
   Kwong JC, 2008, AM J ORTHOD DENTOFAC, V133, P317, DOI 10.1016/j.ajodo.2007.02.053
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lingawi SS., 2012, J BASIC APPL SCI, V8
   Lottering N, 2015, AM J PHYS ANTHROPOL, V157, P42, DOI 10.1002/ajpa.22687
   MADELINE LA, 1995, RADIOLOGY, V196, P747, DOI 10.1148/radiology.196.3.7644639
   Mann SS, 2000, NEUROIMAG CLIN N AM, V10, P1
   MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13
   MELSEN B, 1972, ACTA ANAT, V83, P112
   MELSEN B, 1969, ACTA ODONTOL SCAND, V27, P73, DOI 10.3109/00016356909033580
   Okamoto K, 1996, AM J NEURORADIOL, V17, P117
   Palomo JM, 2008, ORAL SURG ORAL MED O, V105, P773, DOI 10.1016/j.tripleo.2007.12.019
   POWELL TV, 1963, ANAT REC, V147, P15, DOI 10.1002/ar.1091470104
   Reinholt LE, 2009, AM J PHYS ANTHROPOL, V138, P499, DOI 10.1002/ajpa.21001
   ROCHE AF, 1977, J DENT RES, V56, P802, DOI 10.1177/00220345770560071501
   Sahni D, 1998, FORENSIC SCI INT, V98, P41, DOI 10.1016/S0379-0738(98)00135-2
   Scheuer L., 2004, JUVENILE SKELETON, P332
   Scott J., 1958, AM J PHYS ANTHR
   Shirley NR, 2011, J FORENSIC SCI, V56, P580, DOI 10.1111/j.1556-4029.2011.01705.x
   Simmons K, 1943, J PEDIATR-US, V22, P518, DOI 10.1016/S0022-3476(43)80022-6
   Sinanoglu A, 2016, LEGAL MED-TOKYO, V18, P13, DOI 10.1016/j.legalmed.2015.11.004
   Tahiri Y, 2014, J ORAL MAXIL SURG, V72, P1173, DOI 10.1016/j.joms.2013.11.015
NR 42
TC 3
Z9 3
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 21
PY 2017
VL 12
IS 8
AR e0183305
DI 10.1371/journal.pone.0183305
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FE2TT
UT WOS:000408069300020
PM 28827837
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Roveri, MI
   Manoel, ED
   Onodera, AN
   Ortega, NRS
   Tessutti, VD
   Vilela, E
   Evencio, N
   Sacco, ICN
AF Roveri, Maria Isabel
   Manoel, Edison de Jesus
   Onodera, Andrea Naomi
   Ortega, Neli R. S.
   Tessutti, Vitor Daniel
   Vilela, Emerson
   Evencio, Nelson
   Sacco, Isabel C. N.
TI Assessing experience in the deliberate practice of running using a fuzzy
   decision-support system
SO PLOS ONE
LA English
DT Article
ID EXPERT PERFORMANCE; MEDICAL DIAGNOSIS; ACQUISITION; CONSTRAINTS;
   ADAPTATION; PATTERNS; LOGIC
AB The judgement of skill experience and its levels is ambiguous though it is crucial for decision- making in sport sciences studies. We developed a fuzzy decision support system to classify experience of non-elite distance runners. Two Mamdani subsystems were developed based on expert running coaches' knowledge. In the first subsystem, the linguistic variables of training frequency and volume were combined and the output defined the quality of running practice. The second subsystem yielded the level of running experience from the combination of the first subsystem output with the number of competitions and practice time. The model results were highly consistent with the judgment of three expert running coaches (r>0.88, p<0.001) and also with five other expert running coaches (r>0.86, p<0.001). From the expert's knowledge and the fuzzy model, running experience is beyond the so-called "10-year rule" and depends not only on practice time, but on the quality of practice (training volume and frequency) and participation in competitions. The fuzzy rule-based model was very reliable, valid, deals with the marked ambiguities inherent in the judgment of experience and has potential applications in research, sports training, and clinical settings.
C1 [Roveri, Maria Isabel; Onodera, Andrea Naomi; Vilela, Emerson; Evencio, Nelson; Sacco, Isabel C. N.] Univ Sao Paulo, Sch Med, Phys Therapy Speech & Occupat Therapy Dept, Sao Paulo, SP, Brazil.
   [Manoel, Edison de Jesus] Univ Sao Paulo, Sch Phys Educ & Sport, Study Grp Act Dev & Motor Intervent, Sao Paulo, SP, Brazil.
   [Onodera, Andrea Naomi] Dass Nordeste Calcados & Artigos Esport Inc, Ivoti, RS, Brazil.
   [Ortega, Neli R. S.] Univ Sao Paulo, Sch Med, Sao Paulo, SP, Brazil.
   [Tessutti, Vitor Daniel] Ctr Univ Fieo, Osasco, SP, Brazil.
RP Sacco, ICN (reprint author), Univ Sao Paulo, Sch Med, Phys Therapy Speech & Occupat Therapy Dept, Sao Paulo, SP, Brazil.
EM icnsacco@usp.br
RI Sacco, Isabel/D-7172-2011
OI Sacco, Isabel/0000-0003-1254-0007
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   [305606/2014-0]; Dass Nordeste Calgados e Artigos Esportivos Inc.
FX Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
   funded Ms Maria Isabel Roveri; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), 305606/2014-0 funded Dr. Isabel CN
   Sacco; Dass Nordeste Calgados e Artigos Esportivos Inc. funded Ms Andrea
   Naomi Onodera. All funding organizations (CAPES or CNPq) did not play a
   role in the study design, data collection and analysis, decision to
   publish, or preparation of the manuscript. One author receives only a
   salary from Dass Nordeste Calgados e Artigos Esportivos Inc as an
   employee (A.N.O.), that is not a funding organization, and this company
   did not have any additional role in the study design, data collection
   and analysis, decision to publish, or preparation of the manuscript. The
   specific roles of this author (A. N.O) are articulated in the 'author
   contributions' section.; We would like to thank Agency Coordination of
   Improvement of Higher Education Personnel (CAPES) for Roveri's
   scholarship and Conselho Nacional de Ensino e Pesquisa (CNPq) for
   funding I.C.N. Sacco (Process: 305606/2014-0).
CR Abernethy B, 1993, COGNITIVE ISSUES MOT, P317
   ADLASSNIG KP, 1980, METHOD INFORM MED, V19, P141
   Baker Joseph, 2003, J Sports Sci Med, V2, P1
   Baker J, 2014, INT REV SPORT EXER P, V7, P135, DOI 10.1080/1750984X.2014.896024
   Beilock S. L., 2008, INT REV SPORT EXER P, V1, P19, DOI [DOI 10.1080/17509840701836875, 10.1080/17509840701836875]
   Chapman AR, 2008, J ELECTROMYOGR KINES, V18, P359, DOI 10.1016/j.jelekin.2005.12.007
   Chase WG, 1973, VISUAL INFORM PROCES
   de Ruiter CJ, 2014, EUR J SPORT SCI, V14, P251, DOI 10.1080/17461391.2013.783627
   Eccles DW, 2006, J SPORT SCI, V24, P1103, DOI 10.1080/02640410500432854
   ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363
   Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273
   GARDNER H, 1995, AM PSYCHOL, V50, P802, DOI 10.1037/0003-066X.50.9.802
   Greenwood D, 2014, J SPORT SCI, V32, P328, DOI 10.1080/02640414.2013.824599
   Guldenpenning I, 2013, EXP BRAIN RES, V230, P333, DOI 10.1007/s00221-013-3658-2
   Hambrick DZ, 2014, INTELLIGENCE, V45, P34, DOI 10.1016/j.intell.2013.04.001
   Hedge T, 1998, J SPORT EXERCISE PSY, V20, P260
   Helsen WF, 2000, J SPORT SCI, V18, P727
   Hunter Iain, 2017, Int J Exerc Sci, V10, P446
   Gallego DI, 2010, J HUM SPORT EXERC, V5, P462, DOI 10.4100/jhse.2010.53.16
   Kay H., 1970, MECH MOTOR SKILL DEV
   Kosko B., 1994, FUZZY THINKING NEW S
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Licata G, 2007, INTERN EMERG MED, V2, P100, DOI 10.1007/s11739-007-0051-9
   Macnamara BN, 2014, PSYCHOL SCI, V25, P1608, DOI 10.1177/0956797614535810
   Massad E, 2008, STUD FUZZ SOFT COMP, V232, P1
   Maurer C, 2012, GAIT POSTURE, V36, P40, DOI 10.1016/j.gaitpost.2011.12.023
   Oudejans RRD, 1997, J SPORT SCI, V15, P587, DOI 10.1080/026404197367029
   Phillips E, 2008, EXPERT PERFORMANCE S, V40, P703
   Picon AP, 2012, CLINICS, V67, P151, DOI 10.6061/clinics/2012(02)10
   Sacco ICN, 2016, RUNNING FUZZY EXPERI
   Seising R, 2006, ARTIF INTELL MED, V38, P237, DOI 10.1016/j.artmed.2006.06.004
   Theisen D, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-092613
   van Gent RN, 2007, SPORT GENEESKD, V40, P16
   Watari R, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-11
   Wilder B, 2014, J ORTHOP SPORT PHYS, V44, P731, DOI 10.2519/jospt.2014.0116
   Williams M, 2003, CHAMPAIGN HUMAN KINE, P219
   Young BW, 2010, INT J SPORT PSYCHOL, V41, P73
   Zadeh LA, 1965, WORLD SCI
NR 38
TC 1
Z9 1
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 17
PY 2017
VL 12
IS 8
AR e0183389
DI 10.1371/journal.pone.0183389
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FD9QG
UT WOS:000407856600123
PM 28817655
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Mise, K
   Yamaguchi, Y
   Hoshino, J
   Ueno, T
   Sekine, A
   Sumida, K
   Yamanouchi, M
   Hayami, N
   Suwabe, T
   Hiramatsu, R
   Hasegawa, E
   Sawa, N
   Fujii, T
   Hara, S
   Sugiyama, H
   Makino, H
   Wada, J
   Ohashi, K
   Takaichi, K
   Ubara, Y
AF Mise, Koki
   Yamaguchi, Yutaka
   Hoshino, Junichi
   Ueno, Toshiharu
   Sekine, Akinari
   Sumida, Keiichi
   Yamanouchi, Masayuki
   Hayami, Noriko
   Suwabe, Tatsuya
   Hiramatsu, Rikako
   Hasegawa, Eiko
   Sawa, Naoki
   Fujii, Takeshi
   Hara, Shigeko
   Sugiyama, Hitoshi
   Makino, Hirofumi
   Wada, Jun
   Ohashi, Kenichi
   Takaichi, Kenmei
   Ubara, Yoshifumi
TI Paratubular basement membrane insudative lesions predict renal prognosis
   in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
SO PLOS ONE
LA English
DT Article
ID GLOMERULOTUBULAR JUNCTION ABNORMALITIES; TUBULOINTERSTITIAL LESIONS
AB Aims
   Glomerular insudative lesions are a pathological hallmark of diabetic nephropathy (DN). However, paratubular basement membrane insudative lesions (PTBMIL) have not attracted much attention, and the association between such lesions and the renal prognosis remains unclear.
   Methods
   Among 142 patients with biopsy-proven DN and type 2 diabetes encountered from 1998 to 2011, 136 patients were enrolled in this study. Patients were classified into 3 groups (Group 1: mild, Group 2: moderate, Group 3: severe) according to the extent of cortical and medullary PTBMIL. The endpoint was a decline of the estimated glomerular filtration rate (eGFR) by >= 40% from baseline or commencement of dialysis for end-stage renal disease. The Cox proportional hazard model was employed to calculate hazard ratios (HRs) and 95% confidence interval (CIs) for the death-censored endpoint.
   Results
   During a median follow-up period of 1.8 years (IQR: 0.9-3.5), the endpoint occurred in 104 patients. Baseline mean eGFR was 43.9 +/- 22.8 ml/min/1.73 m(2), and 125 patients (92%) had overt proteinuria. After adjusting for known indicators of DN progression, the HR for the endpoint was 2.32 (95% CI: 1.20-4.51) in PTBMIL Group 2 and 3.12 (1.48-6.58) in PTBMIL Group 3 versus PTBMIL Group 1. Furthermore, adding the PTBMIL Group to a multivariate model including known promoters of DN progression improved prediction of the endpoint (cindex increased by 0.02 [95% CI: 0.00-0.04]).
   Conclusions
   PTBMIL may be useful for predicting the renal prognosis of patients with biopsy-proven DN, but further investigation of these lesions in various stages of DN is needed.
C1 [Mise, Koki; Hoshino, Junichi; Ueno, Toshiharu; Sekine, Akinari; Sumida, Keiichi; Yamanouchi, Masayuki; Hayami, Noriko; Suwabe, Tatsuya; Sawa, Naoki; Hara, Shigeko; Takaichi, Kenmei; Ubara, Yoshifumi] Toranomon Hosp Kajigaya, Nephrol Ctr, Kawasaki, Kanagawa, Japan.
   [Mise, Koki; Hoshino, Junichi; Hara, Shigeko; Takaichi, Kenmei; Ubara, Yoshifumi] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Tokyo, Japan.
   [Mise, Koki; Makino, Hirofumi; Wada, Jun] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan.
   [Yamaguchi, Yutaka] Yamaguchis Pathol Lab, Chiba, Japan.
   [Hoshino, Junichi; Sekine, Akinari; Hiramatsu, Rikako; Hasegawa, Eiko; Sawa, Naoki; Hara, Shigeko; Takaichi, Kenmei; Ubara, Yoshifumi] Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan.
   [Fujii, Takeshi; Ohashi, Kenichi] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan.
   [Sugiyama, Hitoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Human Resource Dev Dialysis Therapy Kidney D, Okayama, Japan.
   [Ohashi, Kenichi] Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa, Japan.
RP Mise, K (reprint author), Toranomon Hosp Kajigaya, Nephrol Ctr, Kawasaki, Kanagawa, Japan.; Mise, K (reprint author), Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Tokyo, Japan.; Mise, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan.; Yamaguchi, Y (reprint author), Yamaguchis Pathol Lab, Chiba, Japan.
EM kokims-frz@umin.ac.jp; yutayama14@yahoo.co.jp
RI Wada, Jun/B-2023-2011; Sugiyama, Hitoshi/B-2252-2011
OI Wada, Jun/0000-0003-1468-5170; Sugiyama, Hitoshi/0000-0002-4127-6471
FU Japanese Agency for Medical Research and Development [15ek0310003h0001];
   Japan Association for Diabetes Education and Care; Okinaka Memorial
   Institute for Medical Research; Kidney Foundation, Japan [KFB15-16]
FX A Grant-in-Aid for Practical Research Project for Renal Disease, from
   the Japanese Agency for Medical Research and Development (grant no:
   15ek0310003h0001), Grants for young researchers from Japan Association
   for Diabetes Education and Care, a grant from Okinaka Memorial Institute
   for Medical Research, and a grant from The Kidney Foundation, Japan
   (grant no: JKFB15-16).
CR Brito PL, 1998, KIDNEY INT, V53, P754, DOI 10.1046/j.1523-1755.1998.00809.x
   Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634
   Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344
   Hoshino J, 2015, AM J NEPHROL, V41, P337, DOI 10.1159/000431333
   Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI 10.1007/s13340-012-0069-8
   Kriz W, 2001, J AM SOC NEPHROL, V12, P496
   Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LANE PH, 1993, KIDNEY INT, V43, P661, DOI 10.1038/ki.1993.95
   Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004
   Mise K, 2015, DIABETIC MED, V32, P546, DOI 10.1111/dme.12633
   Mise K, 2017, DIABETES RES CLIN PR, V127, P187, DOI 10.1016/j.diabres.2017.03.006
   Mise K, 2016, CLIN J AM SOC NEPHRO, V11, P593, DOI 10.2215/CJN.04980515
   Mise K, 2015, DIABETES-METAB RES, V31, P572, DOI 10.1002/dmrr.2633
   Mise K, 2014, DIABETES RES CLIN PR, V106, P522, DOI 10.1016/j.diabres.2014.09.051
   Mise K, 2014, NEPHROL DIAL TRANSPL, V29, P109, DOI 10.1093/ndt/gft349
   Najafian B, 2003, J AM SOC NEPHROL, V14, P908, DOI 10.1097/01.ASN.0000057854.32413.81
   Najafian B, 2006, J AM SOC NEPHROL, V17, pS53, DOI 10.1681/ASN.2005121342
   Najafian B, 2011, CONTRIB NEPHROL, V170, P36, DOI 10.1159/000324942
   OLSON JL, 1985, LAB INVEST, V52, P387
   Shimizu M, 2013, DIABETES CARE, V36, P3655, DOI 10.2337/dc13-0298
   STOUT LC, 1994, HUM PATHOL, V25, P1213, DOI 10.1016/0046-8177(94)90039-6
   Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010
   Zhang LW, 2012, DIABETES RES CLIN PR, V96, P286, DOI 10.1016/j.diabres.2011.12.006
   Zoungas S, 2014, NEW ENGL J MED, V371, P1392, DOI 10.1056/NEJMoa1407963
NR 25
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 15
PY 2017
VL 12
IS 8
AR e0183190
DI 10.1371/journal.pone.0183190
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FD5DG
UT WOS:000407550500045
PM 28813476
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ellis, M
   Astell, A
AF Ellis, Maggie
   Astell, Arlene
TI Communicating with people living with dementia who are nonverbal: The
   creation of Adaptive Interaction
SO PLOS ONE
LA English
DT Article
ID NURSING-HOME; CARE; BURNOUT; SUPPORT; NURSES
AB Loss of verbal language production makes people with dementia appear unreachable. We previously presented a case study applying nonverbal communication techniques with a lady with dementia who could no longer speak, which we termed Adaptive Interaction. The current small-n study examines the applicability of Adaptive Interaction as a general tool for uncovering the communication repertoires of non-verbal individuals living with dementia. Communicative responses of 30 interaction sessions were coded and analysed in two conditions: Standard (Baseline) and Adaptive Interaction (Intervention). All participants retained the ability to interact plus a unique communication repertoire comprising a variety of nonverbal components, spanning eye gaze, emotion expression, and movement. In comparison to Baseline sessions, Intervention sessions were characterised by more smiling, looking at ME and imitation behaviour from the people with dementia. These findings allude to the potential of Adaptive Interaction as the basis for interacting with people living with dementia who can no longer speak.
C1 [Ellis, Maggie] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland.
   [Astell, Arlene] Univ Sheffield, ScHARR, Sheffield, S Yorkshire, England.
   [Astell, Arlene] Ontario Shores Ctr Mental Hlth Sci, Res & Acad, Whitby, ON, Canada.
RP Ellis, M (reprint author), Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland.
EM mpe@st-andrews.ac.uk
RI Astell, Arlene J/G-1625-2014
OI Astell, Arlene J/0000-0002-6822-9472; Ellis, Maggie/0000-0002-7957-022X
CR Abad V., 2002, VOICES WORLD FORUM M, V2
   Astell AJ, 2006, INFANT CHILD DEV, V15, P311, DOI 10.1002/icd.455
   ASTROM S, 1991, INT J NURS STUD, V28, P65, DOI 10.1016/0020-7489(91)90051-4
   BERG A, 1994, J ADV NURS, V20, P742, DOI 10.1046/j.1365-2648.1994.20040742.x
   BOWIE P, 1993, INT J GERIATR PSYCH, V8, P857, DOI 10.1002/gps.930081009
   BURGIO LD, 1990, GERONTOLOGIST, V30, P107, DOI 10.1093/geront/30.1.107
   Caldwell P., 2005, FINDING YOU FINDING
   Carstensen L., 1995, J CLIN GEROPSYCHOLOG, V1, P207
   CHAPPELL NL, 1992, GERONTOLOGIST, V32, P351, DOI 10.1093/geront/32.3.351
   CONSTABLE JF, 1986, J HUM STRESS, V12, P20, DOI 10.1080/0097840X.1986.9936762
   Duffy ME, 1999, HDB COUNSELING PSYCH
   Ellis MP, 2008, TECHNIQUES PROMOTING
   Hewett D., 1996, INTERACTIVE APPROACH
   Kempler D, 1995, DEMENTIA COMMUNICATI, P98
   Kitwood T., 1990, AGEING SOC, V10, P177, DOI [10.1017/S0144686x00008060, DOI 10.1017/S0144686X00008060]
   Kitwood T, 1997, DEMENTIA RECONSIDERE, P7
   Klimova B, 2016, J APPL BIOMED, V14, P97, DOI 10.1016/j.jab.2016.02.002
   Kraijo H, 2014, J ALZHEIMERS DIS, V40, P631, DOI 10.3233/JAD-132420
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78
   Nind M., 1996, EUROPEAN J SPECIAL N, V11, P48
   Noldus Information Technology, 2003, OBS VID PRO VERS 5
   Samuel J, 1998, INTRO INTENSIVE INTE
   Stokes G., 2000, CHALLENGING BEHAV DE
   Stothard V., 1998, GRADUAL DEV INTENSIV, P149
   Sweeting H, 1997, SOCIOL HEALTH ILL, V19, P93
   Talbot R, 2015, DEMENTIA
   Todman J. B, 2001, SINGLE CASE SMALL N
   Torke AM, 2014, PALLIATIVE MED, V28, P195, DOI 10.1177/0269216314521354
   Watson J, 1997, BRIT J SPECIAL ED, V24, P80
   Woods RT, 1999, PSYCHOL PROBLEMS AGE
NR 31
TC 1
Z9 1
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 1
PY 2017
VL 12
IS 8
AR e0180395
DI 10.1371/journal.pone.0180395
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FC3VC
UT WOS:000406766500004
PM 28763445
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-07-16
ER

PT J
AU Bachta, A
   Rowicki, K
   Kisiel, BOO
   Zabicka, M
   Elert-Kopec, S
   Plominski, J
   Tlustochowicz, W
   Maliborski, A
AF Bachta, Artur
   Rowicki, Krzysztof
   Kisiel, Bartlomiej
   Zabicka, Magdalena
   Elert-Kopec, Sylwia
   Plominski, Janusz
   Tlustochowicz, Witold
   Maliborski, Artur
TI Ultrasonography versus magnetic resonance imaging in detecting and
   grading common extensor tendon tear in chronic lateral epicondylitis
SO PLOS ONE
LA English
DT Article
ID COLLATERAL LIGAMENT; ELBOW; CADAVERS
AB Objectives
   To investigate the diagnostic performance and reliability of ultrasonography (US) in detecting and grading common extensor tendon (CET) tear in patients with chronic lateral epicondylitis (LE), using magnetic resonance imaging (MRI) as the reference standard.
   Materials and methods
   The study comprised fifty-eight chronic LE patients. Each patient underwent US and MRI. CET status was classified as: high-grade tear (>= 50% thickness), low-grade tear (<50% thickness), suspected tear (possible but not evident tear), no tear. Additionally, the following dichotomous scale was used: confirmed or unconfirmed CET tear. Relative US parameters (versus MRI) for detecting CET tear included: sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy. The agreement between US and MRI findings was measured using the weighted Cohen kappa coefficient (k).
   Results
   US showed moderate agreement with MRI in detecting and grading CET tear (k = 0.49). Sensitivity, specificity, and accuracy in CET tear detecting by US were 64.52%, 85.19%, and 72.73%, respectively. PPV and NPV of US were 83.33% and 67.65%, respectively. No patient with unconfirmed CET tear on US had high-grade CET tear on MRI.
   Conclusion
   Ultrasonography is a valuable imaging modality that can be used as a screening tool to exclude high-grade CET tear in chronic LE patients. Once a tear is evident on US, MRI should be considered to assess precisely the extent of tendon injury.
C1 [Bachta, Artur; Kisiel, Bartlomiej; Elert-Kopec, Sylwia; Tlustochowicz, Witold] Mil Inst Med, Dept Internal Dis & Rheumatol, Ul Szaserow 128, Warsaw, Poland.
   [Bachta, Artur] Mil Inst Med, Musculoskeletal Ultrasound Off, Ul Szaserow 128, Warsaw, Poland.
   [Rowicki, Krzysztof; Plominski, Janusz] Mil Inst Med, Dept Orthoped, Ul Szaserow 128, Warsaw, Poland.
   [Zabicka, Magdalena; Maliborski, Artur] Mil Inst Med, Dept Radiol, Ul Szaserow 128, Warsaw, Poland.
RP Bachta, A (reprint author), Mil Inst Med, Dept Internal Dis & Rheumatol, Ul Szaserow 128, Warsaw, Poland.; Bachta, A (reprint author), Mil Inst Med, Musculoskeletal Ultrasound Off, Ul Szaserow 128, Warsaw, Poland.
EM artur.bachta@gmail.com
OI Kisiel, Bartlomiej/0000-0001-6311-0475
FU Military Institute of Medicine grant [0000000256]
FX The study was supported by the Military Institute of Medicine grant
   (number 0000000256). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Clarke AW, 2010, AM J SPORT MED, V38, P1209, DOI 10.1177/0363546509359066
   COONRAD RW, 1973, J BONE JOINT SURG AM, VA 55, P1177, DOI 10.2106/00004623-197355060-00004
   Hay EM, 1999, BRIT MED J, V319, P964, DOI 10.1136/bmj.319.7215.964
   Herber S, 2001, ROFO-FORTSCHR RONTG, V173, P454, DOI 10.1055/s-2001-13348
   Jacobson JA, 2014, J ULTRAS MED, V33, P1041, DOI 10.7863/ultra.33.6.1041
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Levin D, 2005, RADIOLOGY, V237, P230, DOI 10.1148/radiol.2371040784
   Olaussen M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003564
   Pfahler M, 1998, ARCH ORTHOP TRAUM SU, V118, P121, DOI 10.1007/s004020050330
   Shiri R, 2006, AM J EPIDEMIOL, V164, P1065, DOI 10.1093/aje/kwj325
   Stewart B, 2009, AM J ROENTGENOL, V193, P1615, DOI 10.2214/AJR.09.2812
   Teixeira PAG, 2011, EUR RADIOL, V21, P1492, DOI 10.1007/s00330-011-2076-8
   Vaquero-Picado A, 2016, EFORT OPEN REV, V1, P391, DOI 10.1302/2058-5241.1.000049
NR 13
TC 0
Z9 0
U1 1
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 27
PY 2017
VL 12
IS 7
AR e0181828
DI 10.1371/journal.pone.0181828
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FC1CT
UT WOS:000406575700086
PM 28749994
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Naicker, SN
   Norris, SA
   Mabaso, M
   Richter, LM
AF Naicker, Sara N.
   Norris, Shane A.
   Mabaso, Musawenkosi
   Richter, Linda M.
TI An analysis of retrospective and repeat prospective reports of adverse
   childhood experiences from the South African Birth to Twenty Plus cohort
SO PLOS ONE
LA English
DT Article
ID SEXUAL-ABUSE; PHYSICAL ABUSE; MENTAL-HEALTH; RISK BEHAVIORS; HOUSEHOLD
   DYSFUNCTION; ADULT PSYCHOPATHOLOGY; ADOLESCENT REPORTS;
   SUICIDAL-BEHAVIOR; YOUNG-ADULTS; RELIABILITY
AB Most studies rely on cross-sectional retrospective reports from adult samples to collect information about adverse childhood experiences (ACEs) to examine relationships with adult outcomes. The problems associated with these reports have long been debated, with only a few studies determining their reliability and validity and fewer still reaching consensus on the matter. This paper uses repeat prospective and retrospective reports of adverse childhood experiences from two respondent sources in the South African Birth to Twenty Plus (Bt20+) cohort to explore agreement and concordance in the prospective reporting of ACEs by caregivers and respective children as adolescents and then as young adults. The findings demonstrate little overall agreement between prospective and retrospective accounts of childhood experiences, with 80% of kappa values below the moderate agreement cutoff (k =.41). The highest levels of agreement were found between prospective and retrospective reporting on parental and household death (kappas ranging from.519 to.944). Comparisons between prospective caregiver reports and retrospective young adult reports yielded high concordance rates on sexual and physical abuse and exposure to intimate partner violence (91.0%, 87.7% and 80.2%, respectively). The prevalence of reported ACEs varied with the age of the respondent, with adolescents reporting much higher rates of exposure to violence, physical and sexual abuse than are reported retrospectively or by caregivers. This variation may partly reflect actual changes in circumstances with maturation, but may be influenced by developmental stage and issues of memory, cognition and emotional state more than has been considered in previous analyses. More research, across disciplines, is needed to understand these processes and their effect on recall. Long-term prospective studies are critical for this purpose. In conclusion, methodological research that uses a range of information sources to establish the reliability and validity of both retrospective and prospective reports - recognizing that the two approaches may fundamentally answer different questions - should be encouraged.
C1 [Naicker, Sara N.] Human Sci Res Council, Human & Social Dev Programme, Kwa Zulu, South Africa.
   [Naicker, Sara N.; Norris, Shane A.; Richter, Linda M.] Univ Witwatersrand, MRC Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa.
   [Mabaso, Musawenkosi] Human Sci Res Council, HIV AIDS STIs &TB Programme, Kwa Zulu, South Africa.
   [Richter, Linda M.] Univ Witwatersrand, DST NRF Ctr Excellence Human Dev, Johannesburg, South Africa.
RP Naicker, SN (reprint author), Human Sci Res Council, Human & Social Dev Programme, Kwa Zulu, South Africa.; Naicker, SN (reprint author), Univ Witwatersrand, MRC Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa.
EM snaicker@hsrc.ac.za
FU Wellcome Trust (UK); Medical Research Council of South Africa; Human
   Sciences Research Council; University of the Witwatersrand; DST-NRF
   Centre of Excellence in Human Development at the University of the
   Witwatersrand, Johannesburg
FX The Bt20 study is funded by the Wellcome Trust (UK), the Medical
   Research Council of South Africa, the Human Sciences Research Council,
   the University of the Witwatersrand and supported by the DST-NRF Centre
   of Excellence in Human Development at the University of the
   Witwatersrand, Johannesburg.
CR Anda RF, 2002, PSYCHIAT SERV, V53, P1001, DOI 10.1176/appi.ps.53.8.1001
   Anda R, 2010, HEADACHE, V50, P1473, DOI 10.1111/j.1526-4610.2010.01756.x
   Banyard VL, 2001, J TRAUMA STRESS, V14, P697, DOI 10.1023/A:1013085904337
   Bifulco A, 1997, J CHILD PSYCHOL PSYC, V38, P365, DOI 10.1111/j.1469-7610.1997.tb01520.x
   Bremner JD, 1999, BIOL PSYCHIAT, V45, P797, DOI 10.1016/S0006-3223(99)00009-8
   Brown DW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-20
   Brown DW, 2009, B WORLD HEALTH ORGAN, V87, P447, DOI 10.2471/BLT.07.047423
   Bruffaerts R, 2010, BRIT J PSYCHIAT, V197, P20, DOI 10.1192/bjp.bp.109.074716
   Clark C, 2010, ANN EPIDEMIOL, V20, P385, DOI 10.1016/j.annepidem.2010.02.008
   Cluver L, 2015, J ADOLESCENT HEALTH, V57, P52, DOI 10.1016/j.jadohealth.2015.03.001
   Danese A, 2009, ARCH PEDIAT ADOL MED, V163, P1135, DOI 10.1001/archpediatrics.2009.214
   De Mast J, 2007, AM STAT, V61, P148, DOI 10.1198/000313007X192392
   DiLillo D, 2006, ASSESSMENT, V13, P297, DOI 10.1177/1073191106288391
   Dill DL, 1991, COMPR PSYCHIAT, V32, P297
   Dong M, 2003, ARCH INTERN MED, V163, P1949, DOI 10.1001/archinte.163.16.1949
   Dong MX, 2004, CHILD ABUSE NEGLECT, V28, P771, DOI 10.1016/j.chiabu.2004.01.008
   Dube SR, 2004, CHILD ABUSE NEGLECT, V28, P729, DOI 10.1016/j.chiabu.2003.08.009
   Elstad JI, 2005, EUR J PUBLIC HEALTH, V15, P51, DOI 10.1093/eurpub/cki114
   Everson MD, 2008, CHILD MALTREATMENT, V13, P14, DOI 10.1177/1077559507307837
   Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8
   Fergusson DM, 2011, INT J METH PSYCH RES, V20, P93, DOI 10.1002/mpr.337
   Fergusson DM, 2000, PSYCHOL MED, V30, P529, DOI 10.1017/S0033291799002111
   FINLAYJONES R, 1981, AUST NZ J PSYCHIAT, V15, P27, DOI 10.3109/00048678109159406
   Fisher HL, 2011, CHILD ABUSE NEGLECT, V35, P117, DOI 10.1016/j.chiabu.2010.10.003
   Ford ES, 2011, PREV MED, V53, P188, DOI 10.1016/j.ypmed.2011.06.015
   Friedrich WN, 1997, CHILD MALTREATMENT, V2, P164, DOI DOI 10.1177/1077559597002002009
   Fry RPW, 1996, CHILD ABUSE NEGLECT, V20, P725, DOI 10.1016/0145-2134(96)00060-9
   Fuhrmann D, 2015, TRENDS COGN SCI, V19, P558, DOI 10.1016/j.tics.2015.07.008
   Soares ALG, 2016, CHILD ABUSE NEGLECT, V51, P21, DOI 10.1016/j.chiabu.2015.11.017
   Habermas T, 2000, PSYCHOL BULL, V126, P748, DOI 10.1037//0033-2909.126.5.748
   Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x
   Hardt J, 2006, J NERV MENT DIS, V194, P676, DOI 10.1097/01.nmd.0000235789.79491.1b
   Henry B., 1994, PSYCHOL ASSESSMENT, V6, P92, DOI DOI 10.1037/1040-3590.6.2.92
   Heusser S, 2014, S AFR J PSYCHOL, V44, P83, DOI 10.1177/0081246313516258
   Hillis SD, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e11
   Horwitz AV, 2001, J HEALTH SOC BEHAV, V42, P184, DOI 10.2307/3090177
   Hughes K, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2906-3
   Janssen SMJ, 2008, Q J EXP PSYCHOL, V61, P1847, DOI 10.1080/17470210701774242
   Jewkes R, 2006, SOC SCI MED, V63, P2949, DOI 10.1016/j.socscimed.2006.07.027
   Jewkes RK, 2010, CHILD ABUSE NEGLECT, V34, P833, DOI 10.1016/j.chiabu.2010.05.002
   Jones DJ, 2010, J CLIN CHILD ADOLESC, V39, P667, DOI 10.1080/15374416.2010.501286
   Jones GT, 2009, PAIN, V143, P92, DOI 10.1016/j.pain.2009.02.003
   Kabiru Caroline W, 2010, Child Adolesc Psychiatry Ment Health, V4, P17, DOI 10.1186/1753-2000-4-17
   Kauhanen L, 2011, ADV PREVENTIVE MED, V2011, P1
   Kelly-Irving M, 2013, EUR J EPIDEMIOL, V28, P721, DOI 10.1007/s10654-013-9832-9
   Kessler RC, 2010, BRIT J PSYCHIAT, V197, P378, DOI 10.1192/bjp.bp.110.080499
   Kooiman CG, 2002, CHILD ABUSE NEGLECT, V26, P939, DOI 10.1016/S0145-2134(02)00363-0
   Kounou KB, 2012, SOC PSYCHIAT PSYCHIA, V48
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lansford JE, 2002, ARCH PEDIAT ADOL MED, V156, P824, DOI 10.1001/archpedi.156.8.824
   Leserman J, 1995, BEHAV MED, V21, P141, DOI 10.1080/08964289.1995.9933752
   LEWIS M, 1995, J AM ACAD CHILD PSY, V34, P405, DOI 10.1097/00004583-199504000-00007
   Lipschitz DS, 1999, J TRAUMA STRESS, V12, P641, DOI 10.1023/A:1024717117960
   MARTIN J, 1993, CHILD ABUSE NEGLECT, V17, P383, DOI 10.1016/0145-2134(93)90061-9
   McBeth J, 1999, J RHEMATOLOGY, V28, P2305
   Meade CS, 2012, DRUG ALCOHOL DEPEN, V126, P232, DOI 10.1016/j.drugalcdep.2012.05.024
   Meyer IH, 1996, CHILD ABUSE NEGLECT, V20, P213, DOI 10.1016/S0145-2134(95)00137-9
   Mills K, 2007, J TRAUMA STRESS, V20, P313, DOI 10.1002/jts.20219
   Offer D, 2000, J AM ACAD CHILD PSY, V39, P735, DOI 10.1097/00004583-200006000-00012
   Oladeji BD, 2010, BRIT J PSYCHIAT, V196, P186, DOI 10.1192/bjp.bp.109.063677
   PILLEMER DB, 1989, ADV CHILD DEV BEHAV, V21, P297, DOI 10.1016/S0065-2407(08)60291-8
   Pinto R, 2014, J FAM VIOLENCE, V29, P431, DOI 10.1007/s10896-014-9602-9
   Radford L, 2013, CHILD ABUSE NEGLECT, V37, P801, DOI 10.1016/j.chiabu.2013.02.004
   Ramiro LS, 2010, CHILD ABUSE NEGLECT, V34, P842, DOI 10.1016/j.chiabu.2010.02.012
   Raphael KG, 2001, PAIN, V92, P283, DOI 10.1016/S0304-3959(01)00270-6
   Reuben A, 2016, J CHILD PSYCHOL PSYC, V57, P1103, DOI 10.1111/jcpp.12621
   Reuchlein B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148162
   RICH CL, 1990, AM J PSYCHIAT, V147, P1389
   Richter L, 2007, INT J EPIDEMIOL, V36, P504, DOI 10.1093/ije/dym016
   Richter L, 2014, AIDS BEHAV, V18, P381, DOI 10.1007/s10461-013-0439-7
   Rothman K, 1998, MODERN EPIDEMIOLOGY
   Sacks V, 2014, RES BRIEF PUBLICATIO
   Schilling EA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-30
   Slopen N, 2010, SOC SCI MED, V71, P1847, DOI 10.1016/j.socscimed.2010.08.015
   Stein DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010574
   Swahn MH, 2006, AM J PUBLIC HEALTH, V96, P1849, DOI 10.2105/AJPH.2004.058230
   Tajima EA, 2004, AM J ORTHOPSYCHIAT, V74, P424, DOI 10.1037/0002-9432.74.4.424
   Thomas C, 2008, PEDIATRICS, V121, pE1240, DOI 10.1542/peds.2007-2403
   Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050
   Whitaker RC, 2014, PREV MED, V67, P147, DOI 10.1016/j.ypmed.2014.07.029
   White HR, 2007, PSYCHOL REP, V101, P1079, DOI 10.2466/PR0.101.4.1079-1094
   Widom CS, 2004, CHILD ABUSE NEGLECT, V28, P715, DOI 10.1016/j.chiabu.2004.03.009
   Widom CS, 1999, J CONSULT CLIN PSYCH, V67, P867, DOI 10.1037/0022-006X.67.6.867
   Widom CS, 1997, PSYCHOL ASSESSMENT, V9, P34, DOI 10.1037/1040-3590.9.1.34
   WILLIAMS LM, 1995, J TRAUMA STRESS, V8, P649, DOI 10.1007/BF02102893
   WILLIAMS LM, 1994, J CONSULT CLIN PSYCH, V62, P1167, DOI 10.1037/0022-006X.62.6.1167
   Williams SL, 2007, J TRAUMA STRESS, V20, P845, DOI 10.1002/jts.20252
   Wise LA, 2001, LANCET, V358, P881, DOI 10.1016/S0140-6736(01)06072-X
   World Health Organization, 2014, SURV PREV ADV CHILD
   Yancura LA, 2009, PSYCHOL AGING, V24, P715, DOI 10.1037/a0016203
NR 90
TC 7
Z9 8
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 26
PY 2017
VL 12
IS 7
AR e0181522
DI 10.1371/journal.pone.0181522
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FB8EN
UT WOS:000406371800040
PM 28746343
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Bhattacharjee, D
   Dev, NN
   Gupta, S
   Sau, S
   Sarkar, R
   Biswas, A
   Banerjee, A
   Babu, D
   Mehta, D
   Bhadra, A
AF Bhattacharjee, Debottam
   Dev, Nikhil N.
   Gupta, Shreya
   Sau, Shubhra
   Sarkar, Rohan
   Biswas, Arpita
   Banerjee, Arunita
   Babu, Daisy
   Mehta, Diksha
   Bhadra, Anindita
TI Free-ranging dogs show age related plasticity in their ability to follow
   human pointing
SO PLOS ONE
LA English
DT Article
ID CANIS-LUPUS-FAMILIARIS; OBJECT CHOICE TASK; DOMESTIC DOGS; SOCIAL CUES;
   HIDDEN FOOD; COGNITION; ONTOGENY; WOLVES; GESTURES; OWNER
AB Differences in pet dogs' and captive wolves' ability to follow human communicative intents have led to the proposition of several hypotheses regarding the possession and development of social cognitive skills in dogs. It is possible that the social cognitive abilities of pet dogs are induced by indirect conditioning through living with humans, and studying free-ranging dogs can provide deeper insights into differentiating between innate abilities and conditioning in dogs. Free-ranging dogs are mostly scavengers, indirectly depending on humans for their sustenance. Humans can act both as food providers and as threats to these dogs, and thus understanding human gestures can be a survival need for the free-ranging dogs. We tested the responsiveness of such dogs in urban areas toward simple human pointing cues using dynamic proximal points. Our experiment showed that pups readily follow proximal pointing and exhibit weaker avoidance to humans, but stop doing so at the later stages of development. While juveniles showed frequent and prolonged gaze alternations, only adults adjusted their behaviour based on the reliability of the human experimenter after being rewarded. Thus free-ranging dogs show a tendency to respond to human pointing gestures, with a certain level of behavioural plasticity that allows learning from ontogenic experience.
C1 [Bhattacharjee, Debottam; Dev, Nikhil N.; Gupta, Shreya; Sau, Shubhra; Sarkar, Rohan; Biswas, Arpita; Banerjee, Arunita; Babu, Daisy; Mehta, Diksha; Bhadra, Anindita] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Nadia, W Bengal, India.
   [Dev, Nikhil N.] Indian Inst Sci Educ & Res Thiruvannathapuram, Thiruvannathapuram, Kerala, India.
   [Gupta, Shreya] Indian Inst Sci Educ & Res Bhopal, Bhopal, Madhya Pradesh, India.
   [Mehta, Diksha] Univ Delhi, Shivaji Coll, Delhi, India.
RP Bhadra, A (reprint author), Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Nadia, W Bengal, India.
EM abhadra@iiserkol.ac.in
OI Bhadra, Anindita/0000-0002-3717-9732
FU INSPIRE fellowship of the Department of Science and Technology, India;
   IAS; INSA; NASI; DST [SB/WEA-005/2013]; IISER Kolkata PBIP fellowship;
   DST, IISER Kolkata; IISER Kolkata Summer Research Fellowship
FX Debottam Bhattacharjee is supported by the INSPIRE fellowship of the
   Department of Science and Technology, India. Nikhil Dev N received the
   Summer Research Fellowship jointly funded by IAS, INSA and NASI, the
   three science academies of India. Shreya Gupta, Daisy Babu, Arpita
   Biswas and Diksha Mehta were supported by the IISER Kolkata Summer
   Research Fellowship during this experiment. Shubhra Sau was supported by
   a fellowship from the DST funded project SB/WEA-005/2013. Arunita
   Banerjee received the IISER Kolkata PBIP fellowship. IISER Kolkata
   provided the infrastructure support, but the project itself was not
   funded by any specific project. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.; The authors would like to thank DST, IISER Kolkata for
   their support. The authors would also like to thank Dr. Monique Udell,
   Oregon State University and Dr. Brian Hare, Duke University for their
   inputs on earlier versions of this manuscript.
CR Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107
   Albiach-Serrano A, 2012, APPL ANIM BEHAV SCI, V141, P25, DOI 10.1016/j.applanim.2012.07.005
   APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117
   Bensky MK, 2013, ADV STUD BEHAV, V45, P209, DOI 10.1016/B978-0-12-407186-5.00005-7
   Bhadra A, 2015, ETHOL ECOL EVOL, P9370
   Bhadra A, 2014, J ETHOL, V32, P15, DOI 10.1007/s10164-013-0388-7
   BOITANI L, 1995, ETHOL ECOL EVOL, V7, P49, DOI 10.1080/08927014.1995.9522969
   Butler JRA, 2004, BIOL CONSERV, V115, P369, DOI 10.1016/S0006-3207(03)00152-6
   Clutton-Brock Juliet, 1995, P7
   Deldalle S, 2014, J VET BEHAV, V9, P58, DOI 10.1016/j.jveb.2013.11.004
   Dorey NR, 2010, ANIM BEHAV, V79, P37, DOI 10.1016/j.anbehav.2009.09.032
   Duranton C, 2016, J VET BEHAV, V14, P20, DOI [10.1016/j.jveb.2016, 10.1016/j.jveb.2016.06.011]
   FEKADU M, 1982, AM J EPIDEMIOL, V115, P266, DOI 10.1093/oxfordjournals.aje.a113298
   FREEDMAN DG, 1961, SCIENCE, V133, P1016, DOI 10.1126/science.133.3457.1016
   Gacsi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058475
   Gacsi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006584
   Gacsi M, 2009, ANIM COGN, V12, P471, DOI 10.1007/s10071-008-0208-6
   Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003
   Hare B, 1999, J COMP PSYCHOL, V113, P173, DOI 10.1037/0735-7036.113.2.173
   Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702
   Hernadi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043267
   Horvath Z, 2008, HORM BEHAV, V54, P107, DOI 10.1016/j.yhbeh.2008.02.002
   Hughes J, 2013, BIOL CONSERV, V157, P341, DOI 10.1016/j.biocon.2012.07.005
   Kaminski J, 2005, ANIM BEHAV, V69, P11, DOI 10.1016/j.anbehav.2004.05.008
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927
   Lord K, 2013, ETHOLOGY, V119, P110, DOI 10.1111/eth.12044
   Lord K, 2013, BEHAV PROCESS, V92, P131, DOI 10.1016/j.beproc.2012.10.009
   Majumder SS, 2014, ACTA ETHOL, V17, P1, DOI 10.1007/s10211-013-0158-0
   Maros K, 2008, ANIM COGN, V11, P457, DOI 10.1007/s10071-008-0136-5
   Marshall-Pescini S, 2013, ANIM COGN, V16, P933, DOI 10.1007/s10071-013-0627-x
   Marshall-Pescini S, 2014, THE SOCIAL DOG, P3
   Miklosi A, 2005, J COMP PSYCHOL, V119, P179, DOI 10.1037/0735-7036.119.2.179
   Miklosi A, 2004, ANIM BEHAV, V67, P995, DOI 10.1016/j.anbehav.2003.10.008
   Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X
   Miklosi A, 1998, Anim Cogn, V1, P113, DOI 10.1007/s100710050016
   Miklosi A., 2000, ANIM COGN, V3, P159, DOI DOI 10.1007/S100710000072
   Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1
   Nawroth C, 2014, ANIM COGN, V17, P701, DOI 10.1007/s10071-013-0702-3
   Paul M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170590
   Paul M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150580
   Paul M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19641
   Paul M, 2014, BEHAV PROCESS, V103, P17, DOI 10.1016/j.beproc.2013.10.006
   Petter M, 2009, BEHAV PROCESS, V82, P109, DOI 10.1016/j.beproc.2009.07.002
   Prato-Previde E, 2008, ANIM COGN, V11, P167, DOI 10.1007/s10071-007-0102-7
   R Development Core Team, 2015, R LANG ENV STAT COMP
   Reid PJ, 2009, BEHAV PROCESS, V80, P325, DOI 10.1016/j.beproc.2008.11.002
   Riedel J, 2008, ANIM BEHAV, V75, P1003, DOI 10.1016/j.anbehav.2007.08.010
   Sen Majumder S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32014
   Serpell JA, 1996, APPL ANIM BEHAV SCI, V47, P49, DOI 10.1016/0168-1591(95)01010-6
   Shannon LM, 2015, P NATL ACAD SCI USA, V112, P13639, DOI 10.1073/pnas.1516215112
   SilleroZubiri C, 1996, J WILDLIFE DIS, V32, P80, DOI 10.7589/0090-3558-32.1.80
   Soproni K, 2002, J COMP PSYCHOL, V116, P27, DOI 10.1037//0735-7036.116.1.27
   Soproni K, 2001, J COMP PSYCHOL, V115, P122, DOI 10.1037//0735-7036.115.2.122
   Szetei V, 2003, APPL ANIM BEHAV SCI, V83, P141, DOI 10.1016/S0168-1591(03)00114-X
   Takaoka A, 2015, ANIM COGN, V18, P475, DOI 10.1007/s10071-014-0816-2
   Thapar R., 1990, HIST INDIA
   Udell MAR, 2008, J COMP PSYCHOL, V122, P84, DOI 10.1037/0735-7036.122.1.84
   Udell MAR, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0489
   Vanak AT, 2009, J MAMMAL, V90, P1058, DOI 10.1644/09-MAMM-A-107.1
   Zaine I, 2015, BEHAV PROCESS, V119, P76, DOI 10.1016/j.beproc.2015.07.004
NR 61
TC 2
Z9 2
U1 2
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 17
PY 2017
VL 12
IS 7
AR e0180643
DI 10.1371/journal.pone.0180643
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GS8PU
UT WOS:000443975500014
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Fonseca, AM
   Quinto, L
   Jimenez, A
   Gonzalez, R
   Bardaji, A
   Maculuve, S
   Dobano, C
   Ruperez, M
   Vala, A
   Aponte, JJ
   Sevene, E
   Macete, E
   Menendez, C
   Mayor, A
AF Maria Fonseca, Ana
   Quinto, Llorenc
   Jimenez, Alfons
   Gonzalez, Raquel
   Bardaji, Azucena
   Maculuve, Sonia
   Dobano, Carlota
   Ruperez, Maria
   Vala, Anifa
   Aponte, John J.
   Sevene, Esperanza
   Macete, Eusebio
   Menendez, Clara
   Mayor, Alfredo
TI Multiplexing detection of IgG against Plasmodium falciparum
   pregnancy-specific antigens
SO PLOS ONE
LA English
DT Article
ID CHONDROITIN SULFATE-A; VACCINE CANDIDATE VAR2CSA; INFECTED ERYTHROCYTES;
   MALARIA TRANSMISSION; PLACENTAL MALARIA; CAMEROONIAN WOMEN; ANTIBODIES;
   CHILDREN; BINDING; PERSPECTIVES
AB Background
   Pregnant women exposed to Plasmodium falciparum generate antibodies against VAR2CSA, the parasite protein that mediates adhesion of infected erythrocytes to the placenta. There is a need of high-throughput tools to determine the fine specificity of these antibodies that can be used to identify immune correlates of protection and exposure. Here we aimed at developing a multiplex-immunoassay to detect antibodies against VAR2CSA antigens.
   Methods and findings
   We constructed two multiplex-bead arrays, one composed of 3 VAR2CSA recombinant-domains (DBL3X, DBL5 xi and DBL6 xi) and another composed of 46 new peptides covering VAR2CSA conserved and semi-conserved regions. IgG reactivity was similar in multiplexed and singleplexed determinations (Pearson correlation, protein array: R-2 = 0.99 and peptide array: R-2 = 0.87). IgG recognition of 25 out of 46 peptides and all recombinant-domains was higher in pregnant Mozambican women (n = 106) than in Mozambican men (n = 102) and Spanish individuals (n = 101; p<0.05). Agreement of IgG levels detected in cryopreserved plasma and in elutions from dried blood spots was good after exclusion of inappropriate filter papers. Under heterogeneous levels of exposure to malaria, similar seropositivity cutoffs were obtained using finite mixture models applied to antibodies measured on pregnant Mozambican women and average of antibodies measured on pregnant Spanish women never exposed to malaria. The application of the multiplex-bead array developed here, allowed the assessment of higher IgG levels and seroprevalences against VAR2CSA-derived antigens in women pregnant during 2003-2005 than during 2010-2012, in accordance with the levels of malaria transmission reported for these years in Mozambique.
   Conclusions
   The multiplex bead-based immunoassay to detect antibodies against selected 25 VAR2CSA new-peptides and recombinant-domains was successfully implemented. Analysis of field samples showed that responses were specific among pregnant women and dependent on the level of exposure to malaria. This platform provides a high-throughput approach to investigating correlates of protection and identifying serological markers of exposure for malaria in pregnancy.
C1 [Maria Fonseca, Ana; Quinto, Llorenc; Jimenez, Alfons; Gonzalez, Raquel; Bardaji, Azucena; Dobano, Carlota; Ruperez, Maria; Aponte, John J.; Menendez, Clara; Mayor, Alfredo] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.
   [Maria Fonseca, Ana] Univ Porto, Grad Program Areas Basic & Appl Biol GABBA, Porto, Portugal.
   [Jimenez, Alfons] Spanish Consortium Res Epidemiol & Publ Hlth CIBE, Madrid, Spain.
   [Gonzalez, Raquel; Bardaji, Azucena; Maculuve, Sonia; Dobano, Carlota; Ruperez, Maria; Vala, Anifa; Aponte, John J.; Sevene, Esperanza; Macete, Eusebio; Menendez, Clara; Mayor, Alfredo] CISM, Maputo, Mozambique.
   [Sevene, Esperanza] Eduardo Mondlane Univ, Maputo, Mozambique.
RP Mayor, A (reprint author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.; Mayor, A (reprint author), CISM, Maputo, Mozambique.
EM alfredo.mayor@isglobal.org
RI JIMENEZ, ALFONS/L-2106-2019; Menendez, Clara/Q-3446-2016; Dobano,
   Carlota/N-4119-2014; Alonso, Azucena Bardaji/V-5978-2018; Mayor
   Aparicio, Alfredo Gabriel/H-7488-2017
OI JIMENEZ, ALFONS/0000-0003-0301-3344; Menendez,
   Clara/0000-0002-2641-6907; Dobano, Carlota/0000-0002-6751-4060; Alonso,
   Azucena Bardaji/0000-0002-5135-0540; Mayor Aparicio, Alfredo
   Gabriel/0000-0003-3890-2897
FU Malaria Eradication Scientific Alliance (MESA); European and Developing
   Countries Clinical Trials Partnership (EDCTP); Malaria in Pregnancy
   (MiP) Consortium; Banco de Bilbao; Argentaria Foundation [BBVA 02-0];
   Instituto de Salud Carlos III [PS09/01113, PI13/01478]; Fondo Europeo de
   Desarrollo Regional [FEDER]; AGAUR/Generalitat de Catalunya [2014 SGR
   263]; Fundacao para a Ciencia e Tecnologia [SFRH/BD/51696/2011]; CERCA
   programme/Generalitat de Catalunya; Bill and Melinda Gates Foundation;
   Vizcaya; Spanish Agency for International Cooperation and Development; 
   [CES10/021-I3SNS]
FX Supported by the Malaria Eradication Scientific Alliance (MESA), the
   European and Developing Countries Clinical Trials Partnership (EDCTP),
   the Malaria in Pregnancy (MiP) Consortium, and grants from Banco de
   Bilbao, Vizcaya, Argentaria Foundation (BBVA 02-0), Instituto de Salud
   Carlos III (grants PS09/01113 and PI13/01478 cofounded by the Fondo
   Europeo de Desarrollo Regional [FEDER], and CES10/021-I3SNS to AM),
   AGAUR/Generalitat de Catalunya (2014 SGR 263) and The Fundacao para a
   Ciencia e Tecnologia (SFRH/BD/51696/2011 to AMF). ISGlobal received
   support from the CERCA programme/Generalitat de Catalunya. The Centro de
   Investigacao em Saude da Manhica (CISM) receives core support from the
   Spanish Agency for International Cooperation and Development. The MiP
   Consortium and MESA are funded through a grant from the Bill and Melinda
   Gates Foundation to the Liverpool School of Tropical Medicine and the
   Barcelona Institute of Global Health, respectively. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000397
   Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1
   Alonso PL, 2002, POPULATION HLTH DEV, V1, P189
   Ambrosino E, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-317
   Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042
   [Anonymous], 1998, REV SCI TECH OFF INT
   Ataide R, 2014, TRENDS PARASITOL, V30, P85, DOI 10.1016/j.pt.2013.12.007
   Avril M, 2008, INFECT IMMUN, V76, P1791, DOI 10.1128/IAI.01470-07
   Babakhanyan A, 2016, AM J TROP MED HYG, V94, P640, DOI 10.4269/ajtmh.15-0521
   Babakhanyan A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1023-6
   Babakhanyan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088173
   Badaut C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011276
   Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x
   Beeson JG, 2006, J INFECT DIS, V193, P721, DOI 10.1086/500145
   Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007
   Campo JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025779
   Clement F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-384
   Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195
   Drakeley C, 2009, ADV PARASIT, V69, P299, DOI 10.1016/S0065-308X(09)69005-9
   Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102
   Duffy MF, 2006, INFECT IMMUN, V74, P4875, DOI 10.1128/IAI.01978-05
   Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003
   Fodjo BAY, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1585-y
   Fouda GG, 2006, CLIN VACCINE IMMUNOL, V13, P1307, DOI 10.1128/CVI.00183-06
   Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502
   Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570
   Gangnard S, 2013, J MOL BIOL, V425, P1697, DOI 10.1016/j.jmb.2013.02.014
   Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015
   Gnidehou S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013105
   Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001735
   Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733
   Hoffman SL, 2015, AM J PREV MED, V49, pS319, DOI 10.1016/j.amepre.2015.09.011
   Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09
   Irion A, 2002, J IMMUNOL METHODS, V259, P111, DOI 10.1016/S0022-1759(01)00500-2
   Kerkhof K, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0868-z
   Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mayor A, 2015, NEW ENGL J MED, V373, P1607, DOI 10.1056/NEJMoa1406459
   Mayor A, 2013, J INFECT DIS, V207, P1664, DOI 10.1093/infdis/jit083
   Mayor A, 2011, INFECT IMMUN, V79, P1654, DOI 10.1128/IAI.01000-10
   Mazumdar S, 2010, BIOPROC BIOSYST ENG, V33, P719, DOI 10.1007/s00449-009-0394-x
   Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934
   Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073624
   Ndam NT, 2015, EMERG INFECT DIS, V21, P813, DOI 10.3201/eid2105.141626
   O'Neil-Dunne I, 2001, INFECT IMMUN, V69, P7487, DOI 10.1128/IAI.69.12.7487-7492.2001
   Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6
   Reed GF, 2002, CLIN DIAGN LAB IMMUN, V9, P1235, DOI 10.1128/CDLI.9.6.1235-1239.2002
   Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309
   Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579
   Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x
   Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X
   Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083
   Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012
   Tutterrow YL, 2012, INFECT IMMUN, V80, P1479, DOI 10.1128/IAI.00071-12
   van Eijk AM, 2015, LANCET GLOB HEALTH, V3, pE617, DOI 10.1016/S2214-109X(15)00049-2
   WHO, 2006, MAT IMM TET
NR 56
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 17
PY 2017
VL 12
IS 7
AR e0181150
DI 10.1371/journal.pone.0181150
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GS8PU
UT WOS:000443975500032
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-07-16
ER

PT J
AU Viana, KA
   Daher, A
   Maia, LC
   Costa, PS
   Martins, CD
   Paiva, SM
   Costa, LR
AF Viana, Karolline Alves
   Daher, Anelise
   Maia, Lucianne Cople
   Costa, Paulo Sucasas
   Martins, Carolina de Castro
   Paiva, Saul Martins
   Costa, Luciane Rezende
TI What is the level of evidence for the amnestic effects of sedatives in
   pediatric patients? A systematic review and meta-analyses
SO PLOS ONE
LA English
DT Review
ID PLACEBO-CONTROLLED TRIAL; ORAL MIDAZOLAM; HUMAN-MEMORY; PREANESTHETIC
   MEDICATION; RETROGRADE FACILITATION; PROCEDURAL-SEDATION; CONSCIOUS
   SEDATION; DENTAL EXTRACTIONS; NITROUS-OXIDE; CHILDREN
AB Background Studies have suggested that benzodiazepines are amnestic drug par excellence, but when taken together, what level of evidence do they generate? Are other sedatives as amnestic as benzodiazepines? The aim of this study was to assess the level of scientific evidence for the amnestic effect of sedatives in pediatric patients who undergo health procedures.
   Methods The literature was searched to identify randomized controlled trials that evaluated anterograde and retrograde amnesia in 1-19-year-olds who received sedative drugs during health procedures. Electronic databases, including PubMed, Scopus and Cochrane Library besides clinical trial registries and grey literature were searched. Two independent reviewers performed data extraction and risk of bias assessment using the Cochrane Collaboration's Tool. The meta-analyses were performed by calculating relative risk (RR) to 95% confidence intervals (CI). The quality of the evidence was assessed using Grading of Recommendations Assessment, Development and Evaluation approach.
   Results Fifty-four studies were included (4,168 participants). A higher occurrence of anterograde amnesia was observed when benzodiazepines, the most well-studied sedatives (n = 47), were used than when placebo was used (n = 12) (RR = 3.10; 95% CI: 2.30-4.19, P<0.001; I-2 = 14%), with a moderate level of evidence. Higher doses of alpha2-adrenergic agonists (clonidine/dexmedetomidine) produced more anterograde amnesia than lower doses (n = 2) (RR = 1.83; 95% CI: 1.03-3.25; P =0.038; I-2 = 0%), with a low level of evidence; benzodiazepines' amnestic effects were not dose-dependent (n = 3) (RR = 1.54; 95% CI: 0.96-2.49; P = 0.07; I-2 = 12%) but the evidence was low. A qualitative analysis showed that retrograde amnesia did not occur in 8 out of 10 studies.
   Conclusions In children, moderate evidence support that benzodiazepines induce anterograde amnesia, whereas the evidence for other sedatives is weak and based on isolated and small studies. Further clinical trials focused on the amnesia associated with non-benzodiazepine sedatives are therefore needed.
C1 [Viana, Karolline Alves; Daher, Anelise] Univ Fed Goias, Programa Posgrad Odontol, Goiania, Go, Brazil.
   [Maia, Lucianne Cople] Univ Fed Rio de Janeiro, Dept Odontopediat & Ortodontia, Rio De Janeiro, RJ, Brazil.
   [Costa, Paulo Sucasas] Univ Fed Goias, Fac Med, Dept Pediat, Goiania, Go, Brazil.
   [Martins, Carolina de Castro; Paiva, Saul Martins] Univ Fed Minas Gerais, Fac Odontol, Dept Odontopediat & Ortodontia, Belo Horizonte, MG, Brazil.
   [Costa, Luciane Rezende] Univ Fed Goias, Dept Saude Oral, Goiania, Go, Brazil.
RP Costa, LR (reprint author), Univ Fed Goias, Dept Saude Oral, Goiania, Go, Brazil.
EM lsucasas@ufg.br
RI Costa, Paulo S/L-5460-2016; Costa, Luciane Rezende/H-1732-2012; Daher,
   Anelise/K-7385-2013
OI Costa, Paulo S/0000-0001-9370-9139; Costa, Luciane
   Rezende/0000-0001-7637-0049; Daher, Anelise/0000-0002-0863-031X; Alves
   Viana, Karolline/0000-0002-4647-2682
FU State of Goias Research Foundation (Fundacao de Amparo e Pesquisa do
   Estado de Goias - FAPEG); Coordination for the Improvement of Higher
   Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior CAPES)
FX This study is partially funded by the State of Goias Research Foundation
   (Fundacao de Amparo e Pesquisa do Estado de Goias - FAPEG)and by the
   Coordination for the Improvement of Higher Education Personnel
   (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES).).
   The funders had no role in study design
CR American Society of Anesthesiologists, 2014, CONT DEPTH SED DEF G
   Andrade C, 2015, J CLIN PSYCHIAT, V76, pE1320, DOI 10.4088/JCP.15f10377
   Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
   Auden SM, 2000, ANESTH ANALG, V90, P299, DOI 10.1097/00000539-200002000-00011
   BAHALOMARA N, 1994, EUR J CLIN PHARMACOL, V47, P319
   Buffett-Jerrott SE, 2003, PSYCHOPHARMACOLOGY, V168, P377, DOI 10.1007/s00213-003-1429-7
   Buffett-Jerrott SE, 2002, CURR PHARM DESIGN, V8, P45, DOI 10.2174/1381612023396654
   BURTLES R, 1983, BRIT J ANAESTH, V55, P275, DOI 10.1093/bja/55.4.275
   Coldwell Susan E., 1999, Pediatric Dentistry, V21, P18
   Conway A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009491.pub2
   Cote CJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1212
   DEJONG PC, 1988, ACTA ANAESTH SCAND, V32, P485
   Dubost J, 1991, Cah Anesthesiol, V39, P9
   FELD LH, 1990, ANESTHESIOLOGY, V73, P831, DOI 10.1097/00000542-199011000-00006
   FELL D, 1985, ANAESTHESIA, V40, P12, DOI 10.1111/j.1365-2044.1985.tb10494.x
   FLAITZ CM, 1986, J DENT CHILD, V53, P17
   Funk W, 2000, BRIT J ANAESTH, V84, P335
   Galeotti N, 2004, BEHAV BRAIN RES, V153, P409, DOI 10.1016/j.bbr.2003.12.016
   Ghadami Yazdi A, 2014, IRAN J PED HEMATOL O, V3, P187
   GHONEIM MM, 1990, ANESTHESIOLOGY, V72, P926
   Ghoneim MM, 2004, ANESTHESIOLOGY, V100, P1277, DOI 10.1097/00000542-200405000-00033
   Ghoneim MM, 2004, ANESTHESIOLOGY, V100, P987, DOI 10.1097/00000542-200404000-00033
   Ghoneim MM, 1997, ANESTHESIOLOGY, V87, P734, DOI 10.1097/00000542-199710000-00002
   Godambe SA, 2003, PEDIATRICS, V112, P116, DOI 10.1542/peds.112.1.116
   GORDON NH, 1969, BRIT J ANAESTH, V41, P136, DOI 10.1093/bja/41.2.136
   Heden L, 2009, PEDIATR BLOOD CANCER, V53, P1200, DOI 10.1002/pbc.22233
   Higgins JPT, 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184
   HINRICHS JV, 1984, PSYCHOPHARMACOLOGY, V84, P158, DOI 10.1007/BF00427439
   Jensen B, 2002, ACTA PAEDIATR, V91, P920, DOI 10.1080/080352502760148649
   Jensen B, 1998, ACTA ODONTOL SCAND, V56, P229, DOI 10.1080/00016359850142844
   Kain ZN, 2000, ANESTHESIOLOGY, V93, P676, DOI 10.1097/00000542-200009000-00016
   Kaviani Nasser, 2014, J Dent (Shiraz), V15, P123
   Kennedy RM, 1998, PEDIATRICS, V102, P956, DOI 10.1542/peds.102.4.956
   Koirala Bandana, 2006, J Clin Pediatr Dent, V30, P273
   Kupietzky Ari, 1996, Pediatric Dentistry, V18, P32
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee-Jayaram JJ, 2010, PEDIATR EMERG CARE, V26, P408, DOI 10.1097/PEC.0b013e3181e057cd
   Lembert N, 2002, ANN FR ANESTH, V21, P263, DOI 10.1016/S0750-7658(02)00588-9
   Li BL, 2014, ANAESTHESIA, V69, P240, DOI 10.1111/anae.12533
   Liacouras CA, 1998, GASTROINTEST ENDOSC, V47, P455, DOI 10.1016/S0016-5107(98)70244-5
   LINDGREN L, 1979, BRIT J ANAESTH, V51, P321, DOI 10.1093/bja/51.4.321
   Marx CM, 1997, J CLIN ONCOL, V15, P94, DOI 10.1200/JCO.1997.15.1.94
   Millar K, 2007, ANAESTHESIA, V62, P923, DOI 10.1111/j.1365-2044.2007.05148.x
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   PADFIELD NL, 1986, BRIT J ANAESTH, V58, P487, DOI 10.1093/bja/58.5.487
   Payne K A, 1991, Acta Anaesthesiol Belg, V42, P101
   PETERS CG, 1982, BRIT J ANAESTH, V54, P623, DOI 10.1093/bja/54.6.623
   PIOTROWSKI R, 1989, ANAESTHESIST, V38, P16
   Pringle B, 2003, HEALTH PSYCHOL, V22, P263, DOI 10.1037/0278-6133.22.3.263
   Raadal M, 1999, J DENT RES, V78, P1197, DOI 10.1177/00220345990780060201
   Reder LM, 2007, PSYCHON B REV, V14, P261, DOI 10.3758/BF03194062
   RICHARDSON FJ, 1979, BRIT J ANAESTH, V51, P313, DOI 10.1093/bja/51.4.313
   Sienkiewicz E, 2015, EUR J PEDIATR, V174, P1475, DOI 10.1007/s00431-015-2555-z
   Singh C, 2014, PEDIATR ANESTH, V24, P1252, DOI 10.1111/pan.12493
   Singh Neerja, 2002, J Clin Pediatr Dent, V26, P161
   Singh Vinita, 2005, Indian Journal of Pediatrics, V72, P741, DOI 10.1007/BF02734144
   Stewart SH, 2006, PSYCHOPHARMACOLOGY, V188, P489, DOI 10.1007/s00213-006-0402-7
   Sullivan D C, 2001, Pediatr Dent, V23, P223
   Toomarian Lida, 2013, Dent Res J (Isfahan), V10, P173
   TWERSKY RS, 1993, ANESTHESIOLOGY, V78, P51, DOI 10.1097/00000542-199301000-00009
   Van de Velde A, 1987, Acta Anaesthesiol Belg, V38, P207
   van Houtem CMHH, 2015, APPL COGNITIVE PSYCH, V29, P515, DOI 10.1002/acp.3127
   Veselis RA, 2012, ANESTHESIOLOGY, V117, P940, DOI 10.1097/ALN.0b013e31826be6d6
   Viana KA, 2016, SYST REV, V5, DOI 10.1186/s13643-016-0192-x
   Wilson KE, 2007, ACTA ANAESTH SCAND, V51, P1062, DOI 10.1111/j.1399-6576.2007.01391.x
   Wilson KE, 2006, ANAESTHESIA, V61, P1138, DOI 10.1111/j.1365-2044.2006.04835.x
   Yun MJ., 2003, KOREAN J ANESTHESIOL, V45, P715
   Zsigmond EK, 1996, INT J CLIN PHARM TH, V34, P84
NR 68
TC 0
Z9 0
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 7
PY 2017
VL 12
IS 7
AR e0180248
DI 10.1371/journal.pone.0180248
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FA5DZ
UT WOS:000405464100045
PM 28686702
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lumbala, C
   Bessell, PR
   Lutumba, P
   Baloji, S
   Bieler, S
   Ndung'u, JM
AF Lumbala, Crispin
   Bessell, Paul R.
   Lutumba, Pascal
   Baloji, Sylvain
   Bieler, Sylvain
   Ndung'u, Joseph M.
TI Performance of the SD BIOLINE (R) HAT rapid test in various diagnostic
   algorithms for gambiense human African trypanosomiasis in the Democratic
   Republic of the Congo
SO PLOS ONE
LA English
DT Article
ID BRUCEI-GAMBIENSE; SLEEPING SICKNESS; SERODIAGNOSIS; ELIMINATION;
   ACCURACY; OPTIONS; GENE; DRUG
AB We carried out a study to compare the performance, in terms of sensitivity and specificity, of the new SD BIOLINE (R) HAT rapid diagnostic test (RDT) with the card agglutination test for trypanosomiasis (CATT) for diagnosis of human African trypanosomiasis (HAT) in the Democratic Republic of the Congo (DRC). Participants were enrolled actively by four mobile teams, and passively at four health facilities in three provinces. Consenting participants were tested concurrently with the RDT and CATT on whole blood. Those found positive by either test were tested with CATT on serial dilutions of plasma, and with a parasitological composite reference standard (CRS). Cases were only the individuals found positive by the CRS, while controls were negative by both CATT and RDT, as well as those that were positive by CATT or RDT, but were negative by the CRS, and had no history of HAT. Over five months, 131 cases and 13,527 controls were enrolled. The sensitivity of the RDT was 92.0% (95% confidence interval (CI) = 86.1-95.5), which was significantly higher than CATT (sensitivity 69.1%; 95% CI = 60.7-76.4). The sensitivity of CATT on plasma at a dilution of 1: 8 was 59.0% (95% CI = 50.2-67.2). The specificity of the RDT was 97.1% (95% CIs = 96.8-97.4) while that of CATT was 98.0% (95% CIs = 97.8, 98.2) and specificities of algorithms involving CATT at 1: 8 dilution were 99.6% (95% CI = 99.5-99.7). Reproducibility of results was excellent. We concluded that an algorithm in which the SD BIOLINE (R) HAT RDT is used for screening is optimal for case detection in both passive and active screening settings. However, the lower specificity of the RDT compared to that of CATT would result in a larger number of false positive individuals undergoing confirmatory testing.
C1 [Lumbala, Crispin; Baloji, Sylvain] PNLTHA, Batiment PNMLS,1 Blvd Triomphal, Kinshasa, DEM REP CONGO.
   [Bessell, Paul R.] Epi Intervent Ltd, 32 Bell Pl, Edinburgh, Midlothian, Scotland.
   [Lutumba, Pascal] Univ Kinshasa, Fac Med, Kinshasa, DEM REP CONGO.
   [Lutumba, Pascal] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO.
   [Bieler, Sylvain; Ndung'u, Joseph M.] FIND, Campus Biotech,9 Chemin Mines, Geneva, Switzerland.
RP Bessell, PR (reprint author), Epi Intervent Ltd, 32 Bell Pl, Edinburgh, Midlothian, Scotland.
EM prbessell@gmail.com
FU FIND; Bill & Melinda Gates Foundation; Department for International
   Development (DFID) of the United Kingdom; Epi Interventions Ltd
FX This project was supported by FIND with funding from the Bill & Melinda
   Gates Foundation and the Department for International Development (DFID)
   of the United Kingdom. The funders had no role in study design, data
   collection and analysis, decision to publish, o rpreparation of the
   manuscript. Epi Interventions Ltd. provided support in the form of
   salaries for author PRB, but did not have any additional role in the
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript. The specific role of this author is
   articulated in the 'author contributions'section
CR Barrett MP, 2010, CURR OPIN INFECT DIS, V23, P603, DOI 10.1097/QCO.0b013e32833f9fd0
   Bisser S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004608
   Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1
   Buscher P, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000471
   Buscher P, 2014, LANCET GLOB HEALTH, V2, pE359, DOI 10.1016/S2214-109X(14)70203-7
   Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005
   Checchi F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001233
   DUKES P, 1992, ACTA TROP, V51, P123, DOI 10.1016/0001-706X(92)90054-2
   Eperon G, 2014, EXPERT REV ANTI-INFE, V12, P1407, DOI 10.1586/14787210.2014.959496
   Franco JR, 2014, PARASITOLOGY, V141, P748, DOI 10.1017/S0031182013002102
   Grewal AS, 2016, CURR TOP MED CHEM, V16, P2245, DOI 10.2174/1568026616666160413125335
   Harrell FE, 2014, CONTRIBUTIONS CHARLE
   Hasker E, 2011, TROP MED INT HEALTH, V16, P869, DOI 10.1111/j.1365-3156.2011.02772.x
   Holmes P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003244
   Hutchinson OC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-234
   Ilboudo H, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004469
   Jamonneau V, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003480
   Jamonneau V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000917
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lutumba P, 2006, TROP MED INT HEALTH, V11, P470, DOI 10.1111/j.1365-3159.2006.01591.x
   Lutumba P, 2005, EMERG INFECT DIS, V11, P1382
   Mitashi P, 2015, TROP MED INT HEALTH, V20, P98, DOI 10.1111/tmi.12404
   Mitashi P., 2015, MICROSCOPY RES, V3, P17, DOI DOI 10.4236/MR.2015.32003
   Mitashi P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001919
   Mukadi P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146450
   Nakazawa M., 2014, FMSB FUNCTIONS MED S
   R Core & Team, 2016, LANG ENV STAT COMP
   Robays J, 2004, TROP MED INT HEALTH, V9, P542, DOI 10.1111/j.1365-3156.2004.01240.x
   Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055
   Steinmann P, 2015, TROP MED INT HEALTH, V20, P707, DOI 10.1111/tmi.12483
   Sternberg JM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003373
   Tarral A, 2014, CLIN PHARMACOKINET, V53, P565, DOI 10.1007/s40262-014-0136-3
   Van Nieuwenhove L, 2013, TROP MED INT HEALTH, V18, P461, DOI 10.1111/tmi.12058
   VanMeirvenne N, 1995, ACTA TROP, V60, P189, DOI 10.1016/0001-706X(95)00127-Z
   WHO, 2013, WHO TECH REP SER, V984, P1
   World Health Organization, 1998, WHO TECH REP SER, P1
NR 36
TC 6
Z9 7
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 3
PY 2017
VL 12
IS 7
AR e0180555
DI 10.1371/journal.pone.0180555
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FA2JX
UT WOS:000405268500066
PM 28672036
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Schonfelder, ML
   Bogner, FX
AF Schoenfelder, Mona Lisa
   Bogner, Franz Xaver
TI Individual perception of bees: Between perceived danger and willingness
   to protect
SO PLOS ONE
LA English
DT Article
ID CHILDREN AGED 5-16; ATTITUDES; CONSERVATION; FEAR; ANIMALS; DISGUST;
   SCHOOLCHILDREN; EXPERIENCE; ORGANISMS; AGREEMENT
AB The current loss of biodiversity has found its way into the media. Especially the loss of bees as pollinators has recently received much attention aiming to increase public awareness about the consequence of pollinator loss and strategies for protection. However, pollinating insects like bees often prompt considerable anxiety. Negative emotions such as fear and disgust often lead to lack of support for conservation and appropriate initiatives for protection. Our study monitored perceptions of bees in the contexts of conservation and danger bees possibly represent by applying a semantic differential using contrasting adjectives under the heading "I think bees are... ". Additionally, open questions were applied to examine individual perceptions of danger and conservation of bees. Respondents were students from primary school, secondary school and university. We compared these novices (n = 499) to experts (beekeepers, n = 153). An exploratory factor analysis of the semantic differential responses yielded three major oblique factors: Interest, Danger and Conservation & Usefulness. The inter-correlations of these factors were significant. Although all subgroups showed an overall high willingness to protect bees, the perception of danger scored medium. The individual experience of bee stings was the most prevalent reason for expressing fear. Educational programs focusing on pollinator conservation may reduce the perceived danger through removing misinformation, and supporting interest in the species. Based on the overall positive attitude toward bees, we suggest introducing bees (e.g., Apis mellifera) as a flagship species for pollinator conservation.
C1 [Schoenfelder, Mona Lisa; Bogner, Franz Xaver] Univ Bayreuth, Dept Biol Educ, Bayreuth, Germany.
RP Schonfelder, ML (reprint author), Univ Bayreuth, Dept Biol Educ, Bayreuth, Germany.
EM mona.schoenfelder@uni-bayreuth.de
FU European Union LLP [527891]; University of Bayreuth; German Research
   Foundation (DFG)
FX Financial support was granted by the Gree NET Project funded by European
   Union LLP Grant Agreement No. 527891 (http://greenet.ea.gr/) and the
   University of Bayreuth. Publishing fees were funded by the German
   Research Foundation (DFG) and the University of Bayreuth in the funding
   program Open Access Publishing. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abrol DP, 2011, POLLINAT BIOL BIODIV, P1
   Arrindell WA, 2000, BEHAV RES THER, V38, P509, DOI 10.1016/S0005-7967(99)00097-2
   Ballouard JM, 2012, J HERPETOL, V46, P423, DOI 10.1670/11-118
   Ballouard JM, 2013, ANTHROZOOS, V26, P93, DOI 10.2752/175303713X13534238631560
   Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0
   Binngieer J., 2015, INT J ENV SCI ED, V10, P477, DOI DOI 10.12973/IJESE.2015.255A
   Bixler R. D., 1999, J ENVIRON EDUC, V30, P4, DOI DOI 10.1080/00958969909601871
   Bjerke T, 2004, ANTHROZOOS, V17, P109, DOI 10.2752/089279304786991783
   Bjerke T, 1998, ANTHROZOOS, V11, P227, DOI 10.2752/089279398787000544
   Bjerke T, 1998, ANTHROZOOS, V11, P79, DOI 10.2752/089279398787000742
   Bogner F. X., 1996, ENVIRONMENTALIST, V16, P95, DOI DOI 10.1007/BF01325101
   Bogner F. X., 1998, J ENVIRON EDUC, V29, P17, DOI DOI 10.1080/00958969809599124
   Breuer GB, 2015, INT J SCI EDUC, V37, P2664, DOI 10.1080/09500693.2015.1099171
   Brewer C, 2006, CONSERV BIOL, V20, P689, DOI 10.1111/j.1523-1739.2006.00467.x
   Byrne A, 2009, APIDOLOGIE, V40, P194, DOI 10.1051/apido/2009017
   Calik M, 2005, J RES SCI TEACH, V42, P638, DOI 10.1002/tea.20076
   Ceriaco LMP, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-26
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Crane E, 1999, WORLD HIST BEEKEEPIN
   DAVEY GCL, 1994, BRIT J PSYCHOL, V85, P541, DOI 10.1111/j.2044-8295.1994.tb02540.x
   Davey GCL, 1992, ANXIETY RES, V4, P299, DOI [10.1080/08917779208248798, DOI 10.1080/08917779208248798]
   Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277
   Drissner J, 2013, ISRN ED, V2013, P1
   Eagly A. H., 1993, PSYCHOL ATTITUDES
   Field A., 2013, DISCOVERING STAT USI
   Flavell JH, 1992, PIAGETS THEORY PROSP, P107
   Gerdes ABM, 2009, EVOL HUM BEHAV, V30, P66, DOI 10.1016/j.evolhumbehav.2008.08.005
   Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957
   Gupta RK, 2014, BEEKEEPING POVERTY A
   Herzog Harold, 1988, ANTHROZOOS, V1, P214, DOI DOI 10.2752/089279388787058317
   HILL RJ, 1958, AM SOCIOL REV, V23, P227, DOI 10.2307/2089024
   Hutcheson G. D., 1999, MULTIVARIATE SOCIAL
   Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83
   Kellert S. R., 1984, J ENVIRON EDUC, P43, DOI [DOI 10.1080/00958964.1985.9942709, 10.1080/00958964.1985.9942709]
   KELLERT SR, 1993, CONSERV BIOL, V7, P845, DOI 10.1046/j.1523-1739.1993.740845.x
   KELLERT SR, 1987, WILDLIFE SOC B, V15, P363
   Killermann W, 1996, INT J SCI EDUC, V18, P333, DOI 10.1080/0950069960180306
   Knight AJ, 2008, J ENVIRON PSYCHOL, V28, P94, DOI 10.1016/j.jenvp.2007.10.001
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leach J, 1996, INT J SCI EDUC, V18, P19, DOI 10.1080/0950069960180102
   Leach J, 1996, INT J SCI EDUC, V18, P129, DOI 10.1080/0950069960180201
   Lieflander AK, 2013, ENVIRON EDUC RES, V19, P370, DOI 10.1080/13504622.2012.697545
   Lieflander AK, 2014, J ENVIRON EDUC, V45, P105, DOI 10.1080/00958964.2013.875511
   Lindemann-Matthies P, 2005, INT J SCI EDUC, V27, P655, DOI 10.1080/09500690500038116
   Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2
   Martin-Lopez B, 2007, BIOL CONSERV, V139, P67, DOI 10.1016/j.biocon.2007.06.005
   Mayring P, 2010, HDB QUAL FORSCH PSYC, V1, P144
   Mingo J, 2013, BEES MAKE BEST PETS
   Mintzes JJ, 2005, ELSEVIER, P29
   Munstedt K, 2013, ADV STUD MED SCI, V1, P125
   Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01
   Nisbet EK, 2009, ENVIRON BEHAV, V41, P715, DOI 10.1177/0013916508318748
   Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483
   Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968
   Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007
   Prokop P, 2013, ANIM CONSERV, V16, P458, DOI 10.1111/acv.12014
   Prokop P, 2007, J BIOL EDUC, V42, P36, DOI 10.1080/00219266.2007.9656105
   Prokop P, 2010, ANN ZOOL FENN, V47, P417, DOI 10.5735/086.047.0606
   Prokop P, 2010, ANTHROZOOS, V23, P21, DOI 10.2752/175303710X12627079939107
   Prokop P, 2009, SOC ANIM, V17, P224, DOI 10.1163/156853009X445398
   Prokop P, 2009, ANTHROZOOS, V22, P19, DOI 10.2752/175303708X390446
   RACHMAN S, 1977, BEHAV RES THER, V15, P375, DOI 10.1016/0005-7967(77)90041-9
   Randler C, 2012, SOC ANIM, V20, P61, DOI 10.1163/156853012X614369
   Schlegel J, 2015, ANTHROZOOS, V28, P229, DOI 10.2752/089279315X14219211661732
   SELIGMAN ME, 1971, BEHAV THER, V2, P307, DOI 10.1016/S0005-7894(71)80064-3
   Serpell JA, 2004, ANIM WELFARE, V13, pS145
   Tautz J, 2007, PHANOMEN HONIGBIENE
   Tomazic I, 2011, SOC ANIM, V19, P225, DOI [10.1163/156853011x578901, 10.1163/156853011X578901]
   Wilson C, 2005, J SOCIAL SCI, V1, P47, DOI DOI 10.3844/JSSP.2005.47.51
NR 70
TC 3
Z9 3
U1 2
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 29
PY 2017
VL 12
IS 6
AR e0180168
DI 10.1371/journal.pone.0180168
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EZ3JX
UT WOS:000404608300118
PM 28662124
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Choi, SH
   Ji, SK
   Lee, SA
   Park, MJ
   Chang, MJ
AF Choi, Sang-Hee
   Ji, Suk Kyeong
   Lee, Seung Ah
   Park, Min Jong
   Chang, Moon Jong
TI Magnetic resonance imaging of posterolateral plica of the elbow joint:
   Asymptomatic vs. symptomatic subjects
SO PLOS ONE
LA English
DT Article
ID SYNOVIAL FOLD; PAIN
AB Background
   Magnetic resonance imaging (MRI) may be useful to diagnose a posterolateral plica syndrome of the elbow joint because this syndrome has less clear clinical features. The purposes of this study were to document mediolateral and sagittal dimensions of a posterolateral synovial fold and to determine the proportion of subjects with the posterolateral plica in asymptomatic elbows. We also aimed to determine whether the dimensions of the posterolateral synovial fold and the prevalence of the plica differ between symptomatic and asymptomatic subjects.
   Materials and methods
   This retrospective review of prospectively collected data included 50 asymptomatic elbows (asymptomatic group) and 14 elbows with arthroscopically confirmed posterolateral plicae (plica group). The mediolateral and sagittal dimensions of the posterolateral synovial fold were measured. In addition, the criteria for the prevalence of posterolateral plica was determined with conventional MRI as synovial fold dimension >= 3 mm and coverage of radial head by synovial fold >= 30%.
   Results
   The plica group showed larger posterolateral synovial fold dimensions compared to the asymptomatic group. The median mediolateral and sagittal dimensions of the synovial fold in the asymptomatic group were 3.8 mm and 4.7 mm, respectively. Dimensions in the plica group were 7.0 mm and 7.4 mm, respectively. When the presence of posterolateral plica was determined using the dimension criteria, there was no difference in the prevalence of the plica between the asymptomatic and the plica group. However, using the coverage criteria, the prevalence of posterolateral elbow plica was significantly greater in the plica group than the asymptomatic group (64% vs. 18%; p < 0.001).
   Conclusions
   The patients who underwent arthroscopic surgery for posterolateral plica syndrome had larger dimensions of the posterolateral synovial fold and higher prevalence of the posterolateral plica on conventional MRI compared to the asymptomatic subjects.
C1 [Choi, Sang-Hee; Ji, Suk Kyeong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea.
   [Lee, Seung Ah] Kyung Hee Univ, Dept Phys Med & Rehabil, Coll Med, Seoul, South Korea.
   [Park, Min Jong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthoped Surg, Seoul, South Korea.
   [Chang, Moon Jong] Seoul Natl Univ, Boramae Hosp, Coll Med, Dept Orthoped Surg, Seoul, South Korea.
RP Chang, MJ (reprint author), Seoul Natl Univ, Boramae Hosp, Coll Med, Dept Orthoped Surg, Seoul, South Korea.
EM moonjongchang@gmail.com
OI Chang, Moon Jong/0000-0002-2352-7599
CR Antuna SA, 2001, ARTHROSCOPY, V17, P491, DOI 10.1053/jars.2001.20096
   Awaya H, 2001, AM J ROENTGENOL, V177, P1377, DOI 10.2214/ajr.177.6.1771377
   de Luzuriaga BCR, 2013, SKELETAL RADIOL, V42, P675, DOI 10.1007/s00256-012-1523-1
   Duparc F, 2002, SURG RADIOL ANAT, V24, P302, DOI 10.1007/s00276-002-0055-0
   Husarik DB, 2010, RADIOLOGY, V257, P185, DOI 10.1148/radiol.10092163
   Kim DH, 2006, AM J SPORT MED, V34, P438, DOI 10.1177/0363546505281917
   Kotnis NA, 2012, SKELETAL RADIOL, V41, P369, DOI 10.1007/s00256-011-1343-8
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Ruch DS, 2006, J SHOULDER ELB SURG, V15, P367, DOI 10.1016/j.jse.2005.08.013
   Steinert AF, 2010, ARCH ORTHOP TRAUM SU, V130, P347, DOI 10.1007/s00402-008-0798-0
NR 10
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 16
PY 2017
VL 12
IS 6
AR e0174320
DI 10.1371/journal.pone.0174320
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EX8NF
UT WOS:000403506300001
PM 28622337
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Afshari, M
   Janbabaei, G
   Bahrami, MA
   Moosazadeh, M
AF Afshari, Mahdi
   Janbabaei, Ghasem
   Bahrami, Mohammad Amin
   Moosazadeh, Mahmood
TI Opium and bladder cancer: A systematic review and meta-analysis of the
   odds ratios for opium use and the risk of bladder cancer
SO PLOS ONE
LA English
DT Article
ID SOUTHERN IRAN; SMOKING; EPIDEMIOLOGY; CONSUMPTION; POPULATION; ADDICTION
AB Objective
   The association between opium use and bladder cancer has been investigated in many studies, with varying reporting results reported. This study aims to estimate the total odds ratio for the association between bladder cancer and opium consumption using meta-analysis.
   Methods
   The study was designed according to PRISMA guidelines. Two independent researchers searched for the relevant studies using PubMed, Web of Science, Scopus, OVID, Embase, and Google Scholar. After systematic screening of the studies identified during the first step, Cochrane risk of bias tool was determined for the selected studies. The case-control and the cohort studies were investigated to assess risk of bladder cancer due to opium use. In addition, the cross-sectional studies were analysed separately to assess frequency of opium consumption. These estimates were combined using the inverse variance method. Fixed or random effect models were applied to combine the point odds ratios. The heterogeneity between the primary results was assessed using the Cochran test and I-square index. The suspected factors for heterogeneity were investigated using meta-regression models. An Egger test was conducted to identify any probable publication bias. Forest plots illustrated the point and pooled estimates. All analyses were performed using Stata version 14 software and RevMan version 5.3.
   Results
   We included 17 primary studies (11 case-control, one cohort and five cross-sectional) in the final meta-analysis. The total odds ratios (95% confidence intervals) for developing bladder cancer by opium use alone, and concurrent use of opium and cigarettes were estimated as 3.85 (3.05-4.87) and 5.7 (1.9-16.3) respectively. The odds ratio (95% confidence interval) for opium use with or without cigarette smoking was estimated as 5.3 (3.6-7.7).
   Conclusion
   This meta-analysis showed that opium use similar to cigarette smoking and maybe with similar mechanisms can be a risk factor for bladder cancer. It is therefore expected to be a risk factor for other cancers.
C1 [Afshari, Mahdi] Zabol Univ Med Sci, Dept Community Med, Zabol, Iran.
   [Janbabaei, Ghasem] Mazandaran Univ Med Sci, Gastrointestinal Canc Res Ctr, Fac Med, Sari, Iran.
   [Bahrami, Mohammad Amin] Shahid Sadoughi Univ Med Sci, Healthcare Management Dept, Yazd, Iran.
   [Moosazadeh, Mahmood] Mazandaran Univ Med Sci, Addict Inst, Hlth Sci Res Ctr, Sari, Iran.
RP Moosazadeh, M (reprint author), Mazandaran Univ Med Sci, Addict Inst, Hlth Sci Res Ctr, Sari, Iran.
EM mmoosazadeh1351@gmail.com
RI moosazadeh, mahmood/F-3730-2017
OI moosazadeh, mahmood/0000-0002-5452-514X; bahrami, mohammad
   amin/0000-0003-2276-7440
CR Ahmadi B, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002756
   Ahmadi M, 2012, ASIAN PAC J CANCER P, V13, P5053, DOI 10.7314/APJCP.2012.13.10.5053
   Akbari M, 2015, ARCH IRAN MED, V18, P567, DOI 0151809/AIM.004
   Akbarzadeh pasha A, 2012, JBUMS, V14, P80
   Alberg AJ, 2010, JNCI-J NATL CANCER I, V102, P138, DOI [10.1093/jnci/djp474, 10.1093/jnci/djp385]
   Aliasgari M A, 2004, Urol J, V1, P253
   Aliramaji A, 2015, CASP J INTERN MED, V6, P82
   BEHMARD S, 1981, ACTA CYTOL, V25, P142
   Chavan S, 2014, EUR UROL, V66, P59, DOI 10.1016/j.eururo.2013.10.001
   Ferris J, 2013, ACTAS UROL ESP, V37, P579, DOI 10.1016/j.acuro.2013.02.004
   Gavam-Nasiri MR, 2002, MED J MASHAD U MED S, V45, P49
   Ghadimi T, 2015, SOUTH ASIAN J CANCER, V4, P111, DOI 10.4103/2278-330X.173174
   Gu J, 2011, PERS MED, V8, P365, DOI 10.2217/PME.11.15
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Higgins JPT, 2011, COCHRANE HDB SYSTEMA
   Hosseini SY, 2012, UROLOGY, V80, P169, DOI 10.1016/j.urology.2012.04.006
   Hosseini SY, 2010, UROL ONCOL-SEMIN ORI, V28, P610, DOI 10.1016/j.urolonc.2008.10.016
   Hosseini SY, 2008, INDIAN J UROLOGY S2, pS80
   Kamangar F, 2014, LANCET ONCOL, V15, pE69, DOI 10.1016/S1470-2045(13)70550-3
   Karbakhsh M, 2013, ASIAN PAC J CANCER P, V14, P4723, DOI 10.7314/APJCP.2013.14.8.4723
   Ketabchi A, 2005, J RES MED SCI, V10, P355
   Kobeissi LH, 2013, ASIAN PAC J CANCER P, V14, P3205, DOI 10.7314/APJCP.2013.14.5.3205
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lara J, 2016, J UROLOGY, V196, P1378, DOI 10.1016/j.juro.2016.05.082
   Lotfi M H, 2016, JCHR, V5, P98
   Mahmood Moosazadeh, 2016, PROSPERO
   Mahmoodpoor A, 2014, LANCET ONCOL, V15, pE153, DOI 10.1016/S1470-2045(14)70077-4
   MALAVEILLE C, 1982, CARCINOGENESIS, V3, P577, DOI 10.1093/carcin/3.5.577
   Masaoka H, 2016, JPN J CLIN ONCOL, V46, P273, DOI 10.1093/jjco/hyv188
   Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005
   Mohseni MG, 2005, ARCH IRAN MED, V8, P286
   Nourbakhsh A, 2006, ACTA MED IRANICA, V44, P263
   Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3
   Ramezani M, 2016, IJBC, V8, P43
   Rezaee Mehr B, 2013, J MAZANDARAN U MED S, V22, P209
   SADEGHI A, 1978, CANCER, V42, P353, DOI 10.1002/1097-0142(197807)42:1<353::AID-CNCR2820420153>3.0.CO;2-W
   SADEGHI A, 1979, CANCER, V43, P2315, DOI 10.1002/1097-0142(197906)43:6<2315::AID-CNCR2820430622>3.0.CO;2-J
   Salehi A, 2011, ASIAN PAC J CANCER P, V12, P1323
   Shafi H, 2013, JBUMS, V15
   Shakhssalim N, 2010, ASIAN PAC J CANCER P, V11, P601
   Tootoonchi M, 2000, RES MED, V5, P151
   Vandenbroucke JP, 2014, INT J SURG, V12, P1500, DOI 10.1016/j.ijsu.2014.07.014
   Viswanathan M, 2008, ASSESSING RISK BIAS
   Wyszynski A, 2014, CANCER-AM CANCER SOC, V120, P408, DOI 10.1002/cncr.28394
NR 44
TC 9
Z9 10
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 6
PY 2017
VL 12
IS 6
AR e0178527
DI 10.1371/journal.pone.0178527
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EW9YQ
UT WOS:000402875700017
PM 28586371
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Jirschitzka, J
   Kimmerle, J
   Halatchliyski, I
   Hancke, J
   Meurers, D
   Cress, U
AF Jirschitzka, Jens
   Kimmerle, Joachim
   Halatchliyski, Iassen
   Hancke, Julia
   Meurers, Detmar
   Cress, Ulrike
TI A productive clash of perspectives? The interplay between articles' and
   authors' perspectives and their impact on Wikipedia edits in a
   controversial domain
SO PLOS ONE
LA English
DT Article
ID PREFERENCE-INCONSISTENT RECOMMENDATIONS; REDUCING CONFIRMATION BIAS;
   KNOWLEDGE CONSTRUCTION; SELECTIVE EXPOSURE; COLLECTIVE KNOWLEDGE;
   PRACTICAL GUIDE; INFORMATION; POLARIZATION; COMMUNITIES; SCIENCE
AB This study examined predictors of the development of Wikipedia articles that deal with controversial issues. We chose a corpus of articles in the German-language version of Wikipedia about alternative medicine as a representative controversial issue. We extracted edits made until March 2013 and categorized them using a supervised machine learning setup as either being pro conventional medicine, pro alternative medicine, or neutral. Based on these categories, we established relevant variables, such as the perspectives of articles and of authors at certain points in time, the (im)balance of an article's perspective, the number of non-neutral edits per article, the number of authors per article, authors' heterogeneity per article, and incongruity between authors' and articles' perspectives. The underlying objective was to predict the development of articles' perspectives with regard to the controversial topic. The empirical part of the study is embedded in theoretical considerations about editorial biases and the effectiveness of norms and rules in Wikipedia, such as the neutral point of view policy. Our findings revealed a selection bias where authors edited mainly articles with perspectives similar to their own viewpoint. Regression analyses showed that an author's perspective as well as the article's previous perspectives predicted the perspective of the resulting edits, albeit both predictors interact with each other. Further analyses indicated that articles with more non-neutral edits were altogether more balanced. We also found a positive effect of the number of authors and of the authors' heterogeneity on articles' balance. However, while the effect of the number of authors was reserved to pro-conventional medicine articles, the authors' heterogenity effect was restricted to pro-alternative medicine articles. Finally, we found a negative effect of incongruity between authors' and articles' perspectives that was pronounced for the pro-alternative medicine articles.
C1 [Jirschitzka, Jens; Kimmerle, Joachim; Halatchliyski, Iassen; Hancke, Julia; Cress, Ulrike] Leibniz Inst Wissensmedien, Tubingen, Germany.
   [Kimmerle, Joachim; Cress, Ulrike] Eberhard Karls Univ Tubingen, Dept Psychol, Tubingen, Germany.
   [Meurers, Detmar] Eberhard Karls Univ Tubingen, Dept Linguist, Tubingen, Germany.
RP Kimmerle, J (reprint author), Leibniz Inst Wissensmedien, Tubingen, Germany.; Kimmerle, J (reprint author), Eberhard Karls Univ Tubingen, Dept Psychol, Tubingen, Germany.
EM joachim.kimmerle@uni-tuebingen.de
FU Leibniz ScienceCampus Tuebingen; Deutsche Forschungsgemeinschaft;
   Eberhard Karls University of Tuebingen; LeibnizInstitut fOr
   Wissensmedien, Tuebingen; Leibniz ScienceCampus Tuebingen [WCT-TP2.2]
FX The research reported here was supported by a grant from the Leibniz
   ScienceCampus Tuebingen
   (https://www.wissenschaftscampus-tuebingen.de/www/en/index.html) awarded
   to Ulrike Cress (WCT-TP2.2). We also acknowledge support by Deutsche
   Forschungsgemeinschaft http://www.dfg.de/en/index.jsp), Open Access
   Publishing Fund (JK) of Eberhard Karls University of Tuebingen
   (http://www.uni-tuebingen.de/einrichtungen/universitaetsbibliothek/forsc
   hen-publizierer/open-access-publikationsfonds.html), and the
   LeibnizInstitut fOr Wissensmedien, Tuebingen (https://
   MNI.V.1,vm-tuebingen.de/vmv/entindext.tml). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.; We are grateful to the Wikipedia
   Community for creating and maintaining the wonderful Internet
   encyclopedia Wikipedia. The research reported here was supported by a
   grant from the Leibniz ScienceCampus Tuebingen awarded to Ulrike Cress
   (WCT-TP2.2). We also acknowledge support by Deutsche
   Forschungsgemeinschaft and Open Access Publishing Fund of Eberhard Karls
   University of Tuebingen.
CR Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716
   Aiken LS, 1991, MULTIPLE REGRESSION
   Benkler Y, 2006, J POLIT PHILOS, V14, P394, DOI 10.1111/j.1467-9760.2006.00235.x
   Blumenstock J. E, 2008, P 17 INT C WORLD WID, P1095, DOI DOI 10.1145/1367497.1367673
   Bohnet B, 2010, P C 23 INT C COMP LI, V2, P89
   Borra E, 2015, P 33 ANN ACM C HUM F, P193
   Brandes U, 2008, INFORM VISUAL, V7, P34, DOI 10.1057/palgrave.ivs.9500171
   Bykau S, 2015, PROC INT CONF DATA, P1573, DOI 10.1109/ICDE.2015.7113426
   Cohen J., 2003, APPL MULTIPLE REGRES
   Coxe S, 2009, J PERS ASSESS, V91, P121, DOI 10.1080/00223890802634175
   Cress U, 2016, COMPUT-SUPP COLLAB L, V16, P1, DOI 10.1007/978-3-319-13536-6
   Cress U., 2007, C COMP SUPP COLL, P156
   Cress U, 2016, COMPUT-SUPP COLLAB L, V16, P85, DOI 10.1007/978-3-319-13536-6_5
   Cress U, 2008, INT J COMP-SUPP COLL, V3, P105, DOI 10.1007/s11412-007-9035-z
   Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113
   Detienne F, 2016, INT J HUM-COMPUT ST, V86, P11, DOI 10.1016/j.ijhcs.2015.09.002
   Eysenbach G, 2001, BRIT MED J, V323, P1103, DOI 10.1136/bmj.323.7321.1103
   Festinger L., 1957, THEORY COGNITIVE DIS
   Greenstein S, 2012, 18167 NBER
   Greenstein S, 2016, 15023 HBS
   Halatchliyski I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111958
   Halatchliyski I, 2014, INT J COMP-SUPP COLL, V9, P97, DOI 10.1007/s11412-013-9182-3
   Hall M., 2009, SIGKDD EXPLORATIONS, P11, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]
   Hampton K. N., 2014, SOCIAL MEDIA SPIRAL
   Hart PS, 2012, COMMUN RES, V39, P701, DOI 10.1177/0093650211416646
   Hewitt-Taylor J, 2012, J MED INTERNET RES, V14, P301, DOI 10.2196/jmir.2068
   Holtz P, 2012, J MEDIA PSYCHOL-GER, V24, P55, DOI 10.1027/1864-1105/a000062
   Hookway N, 2008, QUAL RES, V8, P91, DOI 10.1177/1468794107085298
   IBM Corp, 2011, IBM SPSS STAT WIND V
   Jirschitzka J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148283
   Jonas E, 2001, J PERS SOC PSYCHOL, V80, P557, DOI 10.1037/0022-3514.80.4.557
   Kievit RA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00513
   Kimmerle J, 2015, EDUC PSYCHOL-US, V50, P120, DOI 10.1080/00461520.2015.1036273
   Kimmerle J, 2013, COMPUT HUM BEHAV, V29, P1078, DOI 10.1016/j.chb.2012.09.010
   Kimmerle J, 2011, EDUC TECHNOL SOC, V14, P138
   Kimmerle J, 2010, INFORM COMMUN SOC, V13, P1099, DOI 10.1080/13691180903521547
   Kittur A, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P453
   Knobloch-Westerwick S, 2009, COMMUN RES, V36, P426, DOI 10.1177/0093650209333030
   Kobayashi T, 2009, INFORM COMMUN SOC, V12, P929, DOI 10.1080/13691180802158490
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Li CL, 2012, SOC NETW ANAL MIN, V2, P265, DOI 10.1007/s13278-011-0037-5
   Lih A., 2004, P 5 INT S ONL JOURN
   Liu J., 2011, ACM T MANAGEMENT INF, V2, P11
   LORD CG, 1979, J PERS SOC PSYCHOL, V37, P2098, DOI 10.1037/0022-3514.37.11.2098
   MacKinnon DP, 2008, HEALTH PSYCHOL, V27, pS99, DOI 10.1037/0278-6133.27.2(Suppl.).S99
   Mojzisch A, 2010, EUR J SOC PSYCHOL, V40, P946, DOI 10.1002/ejsp.660
   Moskaliuk J, 2009, J COMPUT ASSIST LEAR, V25, P549, DOI [10.1111/J.1365-2729.2009.00331.x, 10.1111/j.1365-2729.2009.00331.x]
   Moskaliuk J, 2012, COMPUT EDUC, V58, P1049, DOI 10.1016/j.compedu.2011.11.024
   Muhr T, 2004, USERS MANUAL ATLAS T
   Nickerson Raymond S., 1998, REV GEN PSYCHOL, V2, P175, DOI DOI 10.1037/1089-2680.2.2.175
   Noelle-Neumann E., 1980, OFFENTLICHE MEINUNG
   Oeberst A, 2014, J LEARN SCI, V23, P149, DOI 10.1080/10508406.2014.888352
   Pariser Eli, 2011, FILTER BUBBLE WHAT I
   Pritschet L, PSYCHOL SCI
   Rad HS, 2011, P 20 INT C COMP WORL, P117
   Rad HS, 2012, C P 8 ANN INT S WIK
   ROYSTON P, 1995, APPL STAT-J ROY ST C, V44, P547, DOI 10.2307/2986146
   Royston P., 1992, STAT COMPUT, V2, P117, DOI DOI 10.1007/BF01891203
   Schwind C, 2012, COMPUT HUM BEHAV, V28, P2280, DOI 10.1016/j.chb.2012.06.035
   Schwind C, 2012, COMPUT EDUC, V58, P787, DOI 10.1016/j.compedu.2011.10.003
   SHINE LC, 1980, EDUC PSYCHOL MEAS, V40, P331, DOI 10.1177/001316448004000207
   SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238
   Steyer R., 2003, WAHRSCHEINLICHKEIT R
   Streiner DL, 2003, CAN J PSYCHIAT, V48, P756, DOI 10.1177/070674370304801108
   Sumi R, 2011, 2011 IEEE 3 INT C PR, P724, DOI DOI 10.1109/PASSAT/S0CIALC0M.2011.47
   Taber CS, 2006, AM J POLIT SCI, V50, P755, DOI 10.1111/j.1540-5907.2006.00214.x
   Vuong B.-Q., 2008, MODELS AND WSDM, V2008, P171, DOI DOI 10.1145/1341531.1341556
   Williams A., 2006, WIKINOMICS MASS COLL
   Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774
   Wyatt S, 2016, SCI TECHNOL STUD, V29, P13
   Yasseri T, 2014, GLOBAL WIKIPEDIA INT, P25, DOI DOI 10.2139/SSRN.2269392
   Yasseri T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038869
NR 72
TC 9
Z9 9
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 2
PY 2017
VL 12
IS 6
AR e0178985
DI 10.1371/journal.pone.0178985
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EW6MJ
UT WOS:000402624300140
PM 28575077
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Guduru, A
   Fleischman, D
   Shin, S
   Zeng, DL
   Baldwin, JB
   Houghton, OM
   Say, EA
AF Guduru, Abhilash
   Fleischman, David
   Shin, Sunyoung
   Zeng, Donglin
   Baldwin, James B.
   Houghton, Odette M.
   Say, Emil A.
TI Ultra-widefield fundus autofluorescence in age-related macular
   degeneration
SO PLOS ONE
LA English
DT Article
ID PERIPHERAL AUTOFLUORESCENCE; GEOGRAPHIC ATROPHY; LIPOFUSCIN;
   CLASSIFICATION; FLUOROPHORE; PREVALENCE; AGREEMENT; PATTERNS; A2E
AB Background
   Establish accuracy and reproducibility of subjective grading in ultra-widefield fundus auto-fluorescence (FAF) imaging in patients with age-related macular degeneration (AMD), and determine if an association exists between peripheral FAF abnormalities and AMD.
   Methods
   This was a prospective, single-blinded case-control study. Patients were consecutively recruited for the study. Patients were excluded if there was a history of prior or active ocular pathology other than AMD or image quality was insufficient for analysis as determined by two independent graders. Control patients were those without any evidence of AMD or other ophthalmic disease apart from cataract. Using the Optos 200Tx (Optos, Marlborough, MA, USA), a ResMax central macula and an ultra-widefield peripheral retina image was taken for each eye in both normal color and short wavelength FAF. Ultra-widefield photographs were modified to mask the macula. Each ResMax and ultra-widefield image was independently graded by two blinded investigators.
   Results
   There were 28 AMD patients and 11 controls. There was a significant difference in the average age between AMD patients and control groups (80 versus 64, respectively P<0.001). There was moderate, statistically significant agreement between observers regarding image interpretation (78.4%, K = 0.524, P<0.001), and 69.0% (K = 0.49, P<0.001) agreement between graders for FAF abnormality patterns. Patients with AMD were at greater risk for peripheral FAF abnormalities (OR: 3.43, P = 0.019) and patients with FAF abnormalities on central macular ResMax images were at greater risk of peripheral FAF findings (OR: 5.19, P = 0.017).
   Conclusion
   Subjective interpretation of FAF images has moderate reproducibility and validity in assessment of peripheral FAF abnormalities. Peripheral FAF abnormalities are seen in both AMD and control patients. Those with AMD, poor visual acuity, and macular FAF abnormalities are at greater risk.
C1 [Guduru, Abhilash] Univ N Carolina, Sch Med, Chapel Hill, NC USA.
   [Fleischman, David; Zeng, Donglin; Baldwin, James B.; Houghton, Odette M.] Univ N Carolina, Dept Ophthalmol, Kittner Eye Ctr, Chapel Hill, NC 27599 USA.
   [Shin, Sunyoung] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA.
   [Shin, Sunyoung] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA.
   [Say, Emil A.] Med Univ South Carolina, Storm Eye Inst, Dept Ophthalmol, Charleston, SC 29425 USA.
RP Fleischman, D (reprint author), Univ N Carolina, Dept Ophthalmol, Kittner Eye Ctr, Chapel Hill, NC 27599 USA.
EM david8fleischman@gmail.com
FU Research to Prevent Blindness, Inc (New York, NY)
FX University of North Carolina is a recipient of an unrestricted grant
   from Research to Prevent Blindness, Inc (New York, NY). The funders had
   no role in the design and conduct of the study, in the collection,
   analysis and interpretation of the data, and in the preparation, review
   or approval of the manuscript.
CR Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200
   Bindewald A, 2005, INVEST OPHTH VIS SCI, V46, P3309, DOI 10.1167/iovs.04-0430
   BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X
   Bourne RRA, 2014, BRIT J OPHTHALMOL, V98, P629, DOI 10.1136/bjophthalmol-2013-304033
   DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P718
   Domalpally A, 2014, INVEST OPHTH VIS SCI, V55
   Domalpally A, 2017, OPHTHALMOLOGY, V124, P479, DOI 10.1016/j.ophtha.2016.12.004
   Friberg TR, 2014, INVEST OPHTH VIS SCI, V55
   Friberg TR, 2015, INVEST OPHTH VIS SCI, V56
   Hardin J. W., 2003, GEN ESTIMATING EQUAT
   Heussen FM, 2012, INVEST OPHTH VIS SCI, V53, P6526, DOI 10.1167/iovs.12-9909
   Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041
   Hosmer DW, 2013, APPL LOGISTIC REGRES
   Kernt Marcus, 2013, Oman J Ophthalmol, V6, pS32, DOI 10.4103/0974-620X.122292
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lengyel I, 2015, OPHTHALMOLOGY, V122, P1340, DOI 10.1016/j.ophtha.2015.03.005
   Nomura Y, 2015, CLIN OPHTHALMOL, V9, P297, DOI 10.2147/OPTH.S78210
   Nordgaard CL, 2006, INVEST OPHTH VIS SCI, V47, P815, DOI 10.1167/iovs.05-0976
   Reznicek L, 2012, INVEST OPHTH VIS SCI, V53, P2193, DOI 10.1167/iovs.11-8483
   Sadatsafavi M, 2008, J CLIN EPIDEMIOL, V61, P722, DOI 10.1016/j.jclinepi.2007.10.023
   Schmitz-Valckenberg S, 2008, RETINA-J RET VIT DIS, V28, P385, DOI 10.1097/IAE.0b013e318164a907
   Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988
   Tan CS, 2013, OPHTHALMOLOGY, V120, P1271, DOI 10.1016/j.ophtha.2012.12.002
   Witmer MT, 2012, ACTA OPHTHALMOL, V90, pe428, DOI 10.1111/j.1755-3768.2012.02434.x
   Wu ZC, 2015, INVEST OPHTH VIS SCI, V56, P1546, DOI 10.1167/iovs.14-16211
NR 25
TC 2
Z9 3
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 1
PY 2017
VL 12
IS 6
AR e0177207
DI 10.1371/journal.pone.0177207
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EW6HZ
UT WOS:000402611800007
PM 28570556
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Mkentane, K
   van Wyk, JC
   Sishi, N
   Gumedze, F
   Ngoepe, M
   Davids, LM
   Khumalo, NP
AF Mkentane, K.
   van Wyk, J. C.
   Sishi, N.
   Gumedze, F.
   Ngoepe, M.
   Davids, L. M.
   Khumalo, N. P.
TI Geometric classification of scalp hair for valid drug testing, 6 more
   reliable than 8 hair curl groups
SO PLOS ONE
LA English
DT Article
ID SHAPE; AGREEMENT; FORM; CORTISOL
AB Introduction
   Curly hair is reported to contain higher lipid content than straight hair, which may influence incorporation of lipid soluble drugs. The use of race to describe hair curl variation (Asian, Caucasian and African) is unscientific yet common in medical literature (including reports of drug levels in hair). This study investigated the reliability of a geometric classification of hair (based on 3 measurements: the curve diameter, curl index and number of waves).
   Materials and methods
   After ethical approval and informed consent, proximal virgin (6cm) hair sampled from the vertex of scalp in 48 healthy volunteers were evaluated. Three raters each scored hairs from 48 volunteers at two occasions each for the 8 and 6-group classifications. One rater applied the 6-group classification to 80 additional volunteers in order to further confirm the reliability of this system. The Kappa statistic was used to assess intra and inter rater agreement.
   Results
   Each rater classified 480 hairs on each occasion. No rater classified any volunteer's 10 hairs into the same group; the most frequently occurring group was used for analysis. The inter-rater agreement was poor for the 8-groups (k = 0.418) but improved for the 6-groups (k = 0.671). The intra-rater agreement also improved (k = 0.444 to 0.648 versus 0.599 to 0.836) for 6-groups; that for the one evaluator for all volunteers was good (k = 0.754).
   Conclusions
   Although small, this is the first study to test the reliability of a geometric classification. The 6-group method is more reliable. However, a digital classification system is likely to reduce operator error. A reliable objective classification of human hair curl is long overdue, particularly with the increasing use of hair as a testing substrate for treatment compliance in Medicine.
C1 [Mkentane, K.; van Wyk, J. C.; Sishi, N.; Khumalo, N. P.] Groote Schuur Hosp, Div Dermatol, Hair & Skin Res Lab, Cape Town, South Africa.
   [Mkentane, K.; Davids, L. M.] Univ Cape Town, Dept Human Biol, Fac Hlth Sci, Cape Town, South Africa.
   [Gumedze, F.] Univ Cape Town, Stat Sci, Fac Sci, Cape Town, South Africa.
   [Ngoepe, M.] Univ Cape Town, Engn, Cape Town, South Africa.
RP Khumalo, NP (reprint author), Groote Schuur Hosp, Div Dermatol, Hair & Skin Res Lab, Cape Town, South Africa.
EM n.khumalo@uct.ac.za
RI ; Van Wyk, Jennifer/B-3179-2016
OI Gumedze, Freedom N/0000-0003-4387-8844; Van Wyk,
   Jennifer/0000-0002-6402-4488
FU The University of Cape Town
FX This work received Seed Funding from The University of Cape Town.
CR Bailey Schliebe S., 1985, HUMAN HAIR, P147
   Bartelink IH, 2013, J CLIN PHARMACOL, VXX, P1
   Barton PMJ, 2011, FORENSIC INVESTIGATI
   Bigby M, 2006, J AM ACAD DERMATOL, V54, P1077, DOI 10.1016/j.jaad.2006.01.036
   Bryant H, 2012, INT J DERMATOL, V51, P8, DOI 10.1111/j.1365-4632.2012.05555.x
   Chi W, 2013, DEVELOPMENT, V140, P1676, DOI 10.1242/dev.090662
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Cruz CF, 2013, INT J COSMETIC SCI, V35, P244, DOI 10.1111/ics.12035
   Davis-Sivasothy A., 2011, SCI BLACK HAIR COMPR
   de la Mettrie R, 2007, HUM BIOL, V79, P265, DOI 10.1353/hub.2007.0045
   Gray J., 2001, HUMAN HAIR DIVERSITY
   HRDY D, 1973, AM J PHYS ANTHROPOL, V39, P7, DOI 10.1002/ajpa.1330390103
   Karlen J, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-12
   Khumalo NP, 2007, J AM ACAD DERMATOL, V56, P709, DOI 10.1016/j.jaad.2006.10.016
   Khumalo NP, 2011, INT J DERMATOL, V50, P1212, DOI 10.1111/j.1365-4632.2010.04655.x
   Khumalo Nonhlanhla P., 2008, HAIR GROWTH DISORDER, P483
   Kirschbaum C, 2009, HAIR RETROSPECTIVE C, P32
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LINDELOF B, 1988, ARCH DERMATOL, V124, P1359, DOI 10.1001/archderm.124.9.1359
   Loussouarn G, 2007, INT J DERMATOL, V46, P2, DOI 10.1111/j.1365-4632.2007.03453.x
   McHugh ML, 2012, BIOCHEM MEDICA, V22, P276
   OGLE RR, 1999, ATLAS HUMAN HAIR MIC
   OIMOMI M, 1988, JPN J MED, V27, P277, DOI 10.2169/internalmedicine1962.27.277
   Porter CE, 2009, BEHAV HAIR DIFFERENT, V109, P97
   Robbins CR., 2012, CHEM PHYS BEHAV HUMA, P537
   Robbins CR., 2012, CHEM PHYS BEHAV HAIR, P177
   Robbins CR, 2012, CHEM COMPOSITON DIFF
   Russell E, 2012, PSYCHONEUROENDOCRINO, V37, P589, DOI 10.1016/j.psyneuen.2011.09.009
   Sauve B, 2007, CLIN INVEST MED, V30, pE183, DOI 10.25011/cim.v30i5.2894
   Schlake T, 2007, SEMIN CELL DEV BIOL, V18, P267, DOI 10.1016/j.semcdb.2007.01.005
   Thibaut S, 2005, BRIT J DERMATOL, V152, P632, DOI 10.1111/j.1365-2133.2005.06521.x
   Viera AJ, 2005, FAM MED, V37, P360
   WICKENHEISER RA, 1990, J FORENSIC SCI, V35, P1323
NR 33
TC 1
Z9 1
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 1
PY 2017
VL 12
IS 6
AR e0172834
DI 10.1371/journal.pone.0172834
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EW6HZ
UT WOS:000402611800001
PM 28570555
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Adewemimo, A
   Kalter, HD
   Perin, J
   Koffi, AK
   Quinley, J
   Black, RE
AF Adewemimo, Adeyinka
   Kalter, Henry D.
   Perin, Jamie
   Koffi, Alain K.
   Quinley, John
   Black, Robert E.
TI Direct estimates of cause-specific mortality fractions and rates of
   under-five deaths in the northern and southern regions of Nigeria by
   verbal autopsy interview
SO PLOS ONE
LA English
DT Article
ID BACTERIAL-MENINGITIS; VALIDATION; INDICATORS; CHILDREN
AB Nigeria's under-five mortality rate is the eighth highest in the world. Identifying the causes of under-five deaths is crucial to achieving Sustainable Development Goal 3 by 2030 and improving child survival. National and international bodies collaborated in this study to provide the first ever direct estimates of the causes of under-five mortality in Nigeria. Verbal autopsy interviews were conducted of a representative sample of 986 neonatal and 2,268 1-59 month old deaths from 2008 to 2013 identified by the 2013 Nigeria Demographic and Health Survey. Cause of death was assigned by physician coding and computerized expert algorithms arranged in a hierarchy. National and regional estimates of age distributions, mortality rates and cause proportions, and zonal- and age-specific mortality fractions and rates for leading causes of death were evaluated. More under-fives and 1-59 month olds in the South, respectively, died as neonates (N = 24.1%, S = 32.5%, p0.001) and at younger ages (p0.001) than in the North. The leading causes of neonatal and 1-59 month mortality, respectively, were sepsis, birth injury/asphyxia and neonatal pneumonia, and malaria, diarrhea and pneumonia. The preterm delivery (N =1.2%, S = 3.7%, p = 0.042), pneumonia (N = 15.0%, S = 21.6%, p = 0.004) and malaria (N = 34.7%, S = 42.2%, p = 0.009) fractions were higher in the South, with pneumonia and malaria focused in the South East and South South; while the diarrhea fraction was elevated in the North (N = 24.8%, S = 13.2%, p 0.001). However, the diarrhea, pneumonia and malaria mortality rates were all higher in the North, respectively, by 222.9% (Z =-10.9, p = 0.000), 27.6% (Z =-2.3, p = 0.020) and 50.6% (Z =-5.7, p = 0.000), with the greatest excesses in older children. The findings support that there is an epidemiological transition ongoing in southern Nigeria, suggest the way forward to a similar transition in the North, and can help guide maternal, neonatal and child health programming and their regional and zonal foci within the country.
C1 [Adewemimo, Adeyinka] Fed Minist Hlth, Dept Planning Res & Stat, Abuja, Nigeria.
   [Kalter, Henry D.; Perin, Jamie; Koffi, Alain K.; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD 21205 USA.
   [Perin, Jamie] Johns Hopkins Sch Med, Ctr Child & Community Hlth Res, Dept Pediat, Baltimore, MD USA.
   [Quinley, John] UNICEF, New York, NY USA.
RP Kalter, HD (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD 21205 USA.
EM hkalter1@jhu.edu
OI Kalter, Henry/0000-0002-4165-2393
FU U.S. Agency for International Development (USAID), Nigeria; Office of
   Population and Reproductive Health, USAID, Washington D.C.
   [GHS-A-00-09-00004-00]; Maternal and Child Epidemiology Estimation
   (MCEE) - Bill and Melinda Gates Foundation [OPP1096225]
FX Funding for the Nigeria VASA study field work was provided by the U.S.
   Agency for International Development (USAID) WM.usaid.gov,Nigeria and
   the Office of Population and Reproductive Health, USAID, Washington
   D.C., through a Leader with Associates (LWA) Cooperative Agreement under
   the terms of award no. GHS-A-00-09-00004-00 to Johns Hopkins University.
   Funding for technical assistance to the study was provided through the
   Maternal and Child Epidemiology Estimation (MCEE) project supported
   under Global Development Grant #OPP1096225 from the Bill and Melinda
   Gates Foundation www.gatesfoundation.org to the Johns Hopkins
   University. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript. The
   authors' views expressed in this publication do not necessarily reflect
   the views of USAID, the United States Government, nor those of and/or
   the decisions, policy, or views of their respective organizations.
CR Agunwamba A, 2009, NIGERIA NEXT GENERAT
   Aigbe G. O., 2012, International Journal of Humanities and Social Science, V2, P206
   Akinyemi JO, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0349-0
   Anker M, 1999, WHOCDSCSRISR994
   Anker M., 2003, SRGAR200312 WHOCDSC
   [Anonymous], 2015, LEV TRENDS CHILD MOR
   [Anonymous], 2004, ICD 10 INT CLASS DIS, V2
   Anyamele OD, 2015, TRENDS DISPARITIES I
   Berkley JA, 2004, PEDIATRICS, V114, pE713, DOI 10.1542/peds.2004-0007
   Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S9
   Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8
   Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3
   Coghill JE, 2011, J TROP PEDIATRICS, V57, P3, DOI 10.1093/tropej/fmr001
   Diddy A., 2011, POPUL HEALTH METR, V9, P6
   Ezeh OK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006779
   Federal Ministry of Health, 2014, NIG HLTH INF SYST PO
   Forae Gerald Dafe, 2014, Niger Med J, V55, P130, DOI 10.4103/0300-1652.129644
   Ganatra HA, 2010, CLIN PERINATOL, V37, P501, DOI 10.1016/j.clp.2010.02.004
   HALL P, 1991, BIOMETRICS, V47, P757, DOI 10.2307/2532163
   Ibeh Christian C, 2008, Afr J Reprod Health, V12, P132
   KALTER HD, 1990, INT J EPIDEMIOL, V19, P380, DOI 10.1093/ije/19.2.380
   Kalter HD, 1999, PAEDIATR PERINAT EP, V13, P99
   Kalter HD, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010601
   Kalter Henry D, 2011, Popul Health Metr, V9, P45, DOI 10.1186/1478-7954-9-45
   Kalter HD, 2015, J GLOB HEALTH, V5, P196, DOI 10.7189/jogh.05.010415
   Koffi AK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177025
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liu L, 2016, LANCET
   Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6
   Marsh DR, 1995, VALIDATION DIAGNOSTI
   Mobley CC, 1996, J TROP PEDIATRICS, V42, P365, DOI 10.1093/tropej/42.6.365
   Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-27
   Mwaniki MK, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-301
   National Population Commission [Nigeria], 2013, ORC MACR NIG DEM HLT
   Ogunjimi LO, 2012, INT J NURSING MIDWIF, V4
   Okereka OP, 2015, J CULTURE SOC DEV, V11, P36
   Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19
   SAS Institute Inc, 2002, SAS PROPR SOFTW 9 4
   Setel PW, 2006, TROP MED INT HEALTH, V11, P5
   UNICEF Nigeria, 2012, SIT AN CHILDR WOM NI
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1
NR 41
TC 5
Z9 5
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 31
PY 2017
VL 12
IS 5
AR e0178129
DI 10.1371/journal.pone.0178129
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EW6GY
UT WOS:000402608700043
PM 28562611
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Watson, ED
   Micklesfield, LK
   van Poppel, MNM
   Norris, SA
   Sattler, MC
   Dietz, P
AF Watson, Estelle D.
   Micklesfield, Lisa K.
   van Poppel, Mireille N. M.
   Norris, Shane A.
   Sattler, Matteo C.
   Dietz, Pavel
TI Validity and responsiveness of the Global Physical Activity
   Questionnaire (GPAQ) in assessing physical activity during pregnancy
SO PLOS ONE
LA English
DT Article
ID ENERGY-EXPENDITURE; ACTIVITY ASSESSMENTS; ACTIVITY PATTERNS; HEALTH;
   EXERCISE; INSTRUMENTS; RELIABILITY; VALIDATION; OUTCOMES; QUALITY
AB The physiological and biomechanical changes that occur during pregnancy make accurate measurement of physical activity (PA) a challenge during this unique period. The Global Physical Activity Questionnaire (GPAQ) has been used extensively in low-to-middle income countries, but has never been validated in a pregnant population. In this longitudinal study, 95 pregnant women (mean age: 29.5 +/- 5.7 years; BMI: 26.9 +/- 5.0 kg/m(2)) completed the GPAQ and were asked to wear an accelerometer for 7 days at two time points during pregnancy (14-18 and 29-33 weeks gestation). There was a significant difference between accelerometry and GPAQ when measuring moderate-to-vigorous physical activity (MVPA) at 29-33 weeks gestation (16.6 vs 21.4 min/day; p = 0.02) as well as sedentary behaviour (SB) at both 14-18 weeks (457.0 vs 300 min/day; p < 0.01) and 29-33 weeks gestation (431.5 vs 300 min/day; p < 0.01). There was poor agreement between the GPAQ and accelerometry for both PA and SB at both time points (ICC: -0.05-0.08). Bland Altman plots indicated that the GPAQ overestimates PA by 14.8 min/day at 14-18 weeks and by 15.8 min/day at 29-33 weeks gestation. It underestimates SB by 127.5min/day at 14-18 weeks and by 89.2 min/day at 29-33 weeks gestation. When compared to accelerometry, the GPAQ shows poor agreement and appears to overestimate PA and underestimate SB during pregnancy.
C1 [Watson, Estelle D.] Univ Witwatersrand, Fac Hlth Sci, Sch Therapeut Sci, Ctr Exercise Sci & Sports Med, Johannesburg, South Africa.
   [Watson, Estelle D.; Micklesfield, Lisa K.; Norris, Shane A.] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat,Sch Clin Med, MRC Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa.
   [van Poppel, Mireille N. M.; Sattler, Matteo C.; Dietz, Pavel] Karl Franzens Univ Graz, Inst Sports Sci, Graz, Austria.
   [van Poppel, Mireille N. M.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.
RP Watson, ED (reprint author), Univ Witwatersrand, Fac Hlth Sci, Sch Therapeut Sci, Ctr Exercise Sci & Sports Med, Johannesburg, South Africa.; Watson, ED (reprint author), Univ Witwatersrand, Fac Hlth Sci, Dept Paediat,Sch Clin Med, MRC Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa.
EM estelle.watson@wits.ac.za
RI Sattler, Matteo Christian/N-7642-2019
OI Sattler, Matteo Christian/0000-0002-0689-1938; Micklesfield,
   Lisa/0000-0002-4994-0779
FU National Research Foundation of South Africa [87944]; Wellcome Trust
   (UK); Medical Research Council of South Africa; MRC/DFID African
   Research Leader Scheme (UK); DST-NRF Centre of Excellence in Human
   Development at the University of the Witwatersrand; Academy of Medical
   Sciences-Newton Advanced Fellowship
FX This work is based on the research supported in part by the National
   Research Foundation of South Africa (grant no. 87944 to EDW). Any
   opinion, finding and conclusion or recommendation expressed in this
   material is that of the authors and the NRF does not accept any
   liability in this regard. The study was funded by the Wellcome Trust
   (UK), Medical Research Council of South Africa. SAN is supported by the
   MRC/DFID African Research Leader Scheme (UK). This submission also
   received support from the DST-NRF Centre of Excellence in Human
   Development at the University of the Witwatersrand, Johannesburg in the
   Republic of South Africa LKM would like to acknowledge funding from the
   Academy of Medical Sciences-Newton Advanced Fellowship. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR American Congress of Obstetricians and Gynecologists, 2015, OBSTET GYNECOL, V126, pe135, DOI DOI 10.1097/AOG.0000000000001214
   Angst F, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-152
   Armstrong T, 2006, J PUBLIC HEALTH-HEID, V14, P66, DOI 10.1007/s10389-006-0024-x
   Aune D, 2014, EPIDEMIOLOGY, V25, P331, DOI 10.1097/EDE.0000000000000036
   Barakat R, 2008, BRIT J SPORT MED, V42, P674, DOI 10.1136/bjsm.2008.047837
   Barakat R, 2015, BRIT J SPORT MED, V49, P1377, DOI 10.1136/bjsports-2015-094756
   Bilic-Zulle L, 2011, BIOCHEM MEDICA, V21, P49
   Borodulin KM, 2008, MED SCI SPORT EXER, V40, P1901, DOI 10.1249/MSS.0b013e31817f1957
   Chandonnet N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038818
   Chasan-Taber L, 2004, MED SCI SPORT EXER, V36, P1750, DOI 10.1249/01.MSS.0000142303.49306.0D
   Cirak Y, 2015, J PHYS THER SCI, V27, P3703, DOI 10.1589/jpts.27.3703
   Cleland CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1255
   Connolly CP, ACCURACY PHYS ACTIVI
   Cramp AG, 2010, MATERN CHILD HLTH J, V14, P343, DOI 10.1007/s10995-009-0462-5
   da Silva SG, 2017, SPORTS MED, V47, P295, DOI 10.1007/s40279-016-0565-2
   Evenson KR, 2012, PAEDIATR PERINAT EP, V26, P479, DOI 10.1111/j.1365-3016.2012.01311.x
   Evenson KR, 2011, PREV MED, V53, P39, DOI 10.1016/j.ypmed.2011.04.014
   Evenson KR, 2010, PREV MED, V50, P123, DOI 10.1016/j.ypmed.2009.12.015
   Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021
   Gaston A, 2011, J SCI MED SPORT, V14, P299, DOI 10.1016/j.jsams.2011.02.006
   GOLDBERG GR, 1993, AM J CLIN NUTR, V57, P494
   Harrison CL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-19
   Hoos T, 2012, J PHYS ACT HEALTH, V9, P698, DOI 10.1123/jpah.9.5.698
   JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012
   Kelly P, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0351-4
   Kinnunen TI, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-501
   Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lof M, 2006, BRIT J NUTR, V95, P296, DOI 10.1079/BJN20051497
   Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8
   Oostdam N, 2013, J SCI MED SPORT, V16, P412, DOI 10.1016/j.jsams.2012.09.001
   PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709
   Perales M, 2016, EARLY HUM DEV, V94, P43, DOI 10.1016/j.earlhumdev.2016.01.004
   Poudevigne MS, 2006, SPORTS MED, V36, P19, DOI 10.2165/00007256-200636010-00003
   Rennie KL, 1998, PUBLIC HEALTH NUTR, V1, P265, DOI 10.1079/PHN19980043
   Russo LM, 2015, OBSTET GYNECOL, V125, P576, DOI 10.1097/AOG.0000000000000691
   Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197
   Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da
   Takito MY, 2010, REV SAUDE PUBL, V44, P90, DOI 10.1590/S0034-89102010000100010
   Tendais I, 2011, CAD SAUDE PUBLICA, V27, P219, DOI 10.1590/S0102-311X2011000200003
   Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98
   US Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A
NR 42
TC 3
Z9 4
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 26
PY 2017
VL 12
IS 5
AR e0177996
DI 10.1371/journal.pone.0177996
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV8VT
UT WOS:000402063000017
PM 28552977
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hu, RR
   Wang, CK
   Racette, L
AF Hu, Rongrong
   Wang, Chenkun
   Racette, Lyne
TI Comparison of matrix frequency-doubling technology perimetry and
   standard automated perimetry in monitoring the development of visual
   field defects for glaucoma suspect eyes
SO PLOS ONE
LA English
DT Article
ID OPEN-ANGLE GLAUCOMA; OCULAR HYPERTENSION TREATMENT;
   LASER-OPHTHALMOSCOPY-ANCILLARY; ACHROMATIC PERIMETRY; AFRICAN DESCENT;
   PROGRESSION; VARIABILITY; THRESHOLD; TESTS; CELLS
AB Background
   Perimetry is indispensable for the clinical management of glaucoma suspects. Our goal is to compare the performance of standard automated perimetry (SAP) and Matrix frequency-doubling technology (FDT) perimetry in monitoring the development of visual field (VF) defects in glaucoma suspect eyes.
   Methods
   Longitudinal data of paired SAP and FDT from 221 eyes of 155 glaucoma suspects enrolled in the Diagnostic Innovations in Glaucoma Study or the African Descent and Glaucoma Evaluation Study were included. All eyes had glaucomatous optic neuropathy or ocular hypertension, but normal SAP and FDT results at baseline. The development of glaucomatous VF defects was defined as the presence of a cluster of >= 3 (less conservative) or >= 4 (more conservative) locations confirmed on >= 2 additional consecutive tests. Risk factors for the development of VF defects were analyzed by COX proportional hazard models. After conversion into common logarithmic units, the rates of change of global VF indices were fitted with linear mixed models.
   Results
   FDT detected more eyes that developed VF defects than SAP using the less conservative criterion, and no significant difference was observed using the more conservative criterion. For those eyes detected by both SAP and FDT, FDT detected the development of VF defects either earlier than SAP or simultaneously in most cases. Baseline structural measurements were not significantly associated with an increased risk for the development of glaucomatous VF defects on either SAP or FDT. Older age was significantly associated with the development of VF defects on FDT but not on SAP. Both SAP and FDT detected a progressing worsening trend of pattern standard deviation over time with a similar rate of change between these test types.
   Conclusions
   Matrix FDT would be useful to monitor the onset of VF defects in glaucoma suspects and may outperform SAP in the early stage of glaucomatous VF damage.
C1 [Hu, Rongrong] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Ophthalmol, Hangzhou, Zhejiang, Peoples R China.
   [Hu, Rongrong; Racette, Lyne] Indiana Univ, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46204 USA.
   [Wang, Chenkun] Indiana Univ, Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA.
   [Wang, Chenkun] Vertex Pharmaceut Inc, Boston, MA USA.
RP Racette, L (reprint author), Indiana Univ, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46204 USA.
EM lracette@iupui.edu
OI Hu, Rongrong/0000-0002-2238-3431
FU NIH grant [EY025756]; Zhejiang Provincial Natural Science Foundation of
   China [LQ17H120003, LY13H120003]; Health and Family Planning Commission
   of Zhejiang Province, China [2016KYA089]; Glaucoma Research Foundation;
   Indiana University-Purdue University Indianapolis DRIVE; NIH
   [P30EY022589, EY021818, EY11008, U1OEY14267, EY019869]; Eyesight
   Foundation of Alabama; New York Glaucoma Research Institute, New York,
   NY; Research to Prevent Blindness, New York, New York; Research to
   Prevent Blindness
FX This research was supported by NIH grant EY025756 (LR) and by grants
   from the Zhejiang Provincial Natural Science Foundation of China (grant
   no: LQ17H120003 and LY13H120003, RH) and from the Health and Family
   Planning Commission of Zhejiang Province, China (grant no: 2016KYA089,
   RH).; Acknowledgment is made to the donors of the National Glaucoma
   Research, a program of BrightFocus Foundation (LR), for support of this
   research. This work was also supported in part by a Shaffer grant from
   the Glaucoma Research Foundation (LR), by an Indiana University-Purdue
   University Indianapolis DRIVE award (LR), and by an unrestricted grant
   from Research to Prevent Blindness (LR). The DIGS and ADAGES studies
   were supported by NIH Grants P30EY022589, EY021818, EY11008, U1OEY14267,
   EY019869; Eyesight Foundation of Alabama; Edith C. Blum Research Fund of
   the New York Glaucoma Research Institute, New York, NY; and unrestricted
   grant from Research to Prevent Blindness, New York, New York. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Amato DA, 1992, COX TYPE REGRESSION
   Anderson AJ, 2005, INVEST OPHTH VIS SCI, V46, P1540, DOI 10.1167/iovs.04-0968
   Anderson AJ, 2011, OPTOMETRY VISION SCI, V88, P806, DOI 10.1097/OPX.0b013e31821861bd
   Anderson DR, 1999, AUTOMATED STATIC PER
   Artes PH, 2010, ARCH OPHTHALMOL-CHIC, V128, P1528, DOI 10.1001/archophthalmol.2010.292
   Artes PH, 2005, INVEST OPHTH VIS SCI, V46, P2451, DOI 10.1167/iovs.05-0135
   Burgansky-Eliash Z, 2007, BRIT J OPHTHALMOL, V91, P933, DOI 10.1136/bjo.2006.110437
   Centofanti M, 2005, OPHTHALMOLOGY, V112, P366, DOI 10.1016/j.ophtha.2004.11.030
   Chauhan BC, 1999, INVEST OPHTH VIS SCI, V40, P648
   Fingeret M, 2005, ESSENTIAL HRT PRIMER
   Fredette MJ, 2015, OPTOMETRY VISION SCI, V92, P527, DOI 10.1097/OPX.0000000000000583
   Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714
   Haymes SA, 2005, INVEST OPHTH VIS SCI, V46, P547, DOI 10.1167/iovs.04-0973
   Hu RR, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002618
   Hu RR, 2014, INVEST OPHTH VIS SCI, V55, P8086, DOI 10.1167/iovs.14-14928
   Keltner JL, 2006, OPHTHALMOLOGY, V113, P1603, DOI 10.1016/j.ophtha.2006.05.061
   Kim KE, 2016, OPHTHALMOLOGY, V123, P532, DOI 10.1016/j.ophtha.2015.11.004
   Kim TW, 2007, OPHTHALMOLOGY, V114, P1053, DOI 10.1016/j.ophtha.2006.09.015
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leeprechanon N, 2007, AM J OPHTHALMOL, V143, P263, DOI 10.1016/j.ajo.2006.10.033
   Liu S, 2014, INVEST OPHTH VIS SCI, V55, P2862, DOI 10.1167/iovs.13-13225
   Liu S, 2014, JAMA OPHTHALMOL, V132, P77, DOI 10.1001/jamaophthalmol.2013.5511
   Liu S, 2011, INVEST OPHTH VIS SCI, V52, P7325, DOI 10.1167/iovs.11-7795
   Maddess T, 1998, VISION RES, V38, P1843, DOI 10.1016/S0042-6989(97)00344-1
   Malik R, 2012, CLIN EXP OPHTHALMOL, V40, P369, DOI 10.1111/j.1442-9071.2012.02770.x
   Marin-Franch I, 2013, J VISION, V13, DOI 10.1167/13.4.10
   Medeiros FA, 2004, AM J OPHTHALMOL, V137, P863, DOI 10.1016/j.ajo.2003.12.009
   Miglior S, 2007, OPHTHALMOLOGY, V114, P3, DOI 10.1016/j.ophtha.2006.05.075
   Nouri-Manhavi K, 2014, CAN J OPHTHALMOL, V49, P497, DOI 10.1016/j.jcjo.2014.10.002
   Patel A, 2007, OPHTHALMOLOGY, V114, P480, DOI 10.1016/j.ophtha.2006.08.009
   Peli E, 1997, VISION RES, V37, P3217, DOI 10.1016/S0042-6989(96)00262-3
   Racette L, 2010, ARCH OPHTHALMOL-CHIC, V128, P551, DOI 10.1001/archophthalmol.2010.58
   Redmond T, 2013, JAMA OPHTHALMOL, V131, P1565, DOI [10.1001/jamaophthalmo1.2013.4382, 10.1001/jamaophthalmol.2013.4382]
   Sample PA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1136, DOI 10.1001/archophthalmol.2009.187
   Spry PGD, 2001, INVEST OPHTH VIS SCI, V42, P1404
   Spry PGD, 2005, BRIT J OPHTHALMOL, V89, P1031, DOI 10.1136/bjo.2004.057778
   Spry PGD, 2002, J GLAUCOMA, V11, P315, DOI 10.1097/01.IJG.0000021880.39151.FC
   Sun H, 2006, OPTOMETRY VISION SCI, V83, P455, DOI 10.1097/01.opx.0000225103.18087.5d
   Swanson WH, 2011, INVEST OPHTH VIS SCI, V52, P764, DOI 10.1167/iovs.10-6158
   Wall M, 2009, INVEST OPHTH VIS SCI, V50, P974, DOI 10.1167/iovs.08-1789
   Weinreb RN, 2010, OPHTHALMOLOGY, V117, P1674, DOI 10.1016/j.ophtha.2010.03.044
   White AJR, 2002, INVEST OPHTH VIS SCI, V43, P3590
   Xin DY, 2011, INVEST OPHTH VIS SCI, V52, P519, DOI 10.1167/iovs.10-5174
   Zangwill LM, 2005, ARCH OPHTHALMOL-CHIC, V123, P1188, DOI 10.1001/archopht.123.9.1188
   Zeppieri M, 2008, OPTOMETRY VISION SCI, V85, P318, DOI 10.1097/OPX.0b013e31816be9fd
NR 45
TC 3
Z9 3
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 18
PY 2017
VL 12
IS 5
AR e0178079
DI 10.1371/journal.pone.0178079
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV3PV
UT WOS:000401672400139
PM 28542536
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Porte, L
   Garcia, P
   Braun, S
   Ulloa, MT
   Lafourcade, M
   Montana, A
   Miranda, C
   Acosta-Jamett, G
   Weitzel, T
AF Porte, Lorena
   Garcia, Patricia
   Braun, Stephanie
   Ulloa, Maria Teresa
   Lafourcade, Monica
   Montana, Alisson
   Miranda, Carolina
   Acosta-Jamett, Gerardo
   Weitzel, Thomas
TI Head-to-head comparison of Microflex LT and Vitek MS systems for routine
   identification of microorganisms by MALDI-TOF mass spectrometry in Chile
SO PLOS ONE
LA English
DT Article
ID DESORPTION-IONIZATION-TIME; CLINICAL MICROBIOLOGY;
   ANTIBIOTIC-RESISTANCE; YEAST IDENTIFICATION; RAPID DETECTION; BACTERIA;
   ORGANISMS; PLATFORMS; DIFFICULT; IDENTIFY
AB Background
   Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (MS) is a new and revolutionary identification method for microorganisms and has recently been introduced into clinical microbiology in many industrialized countries in Europe and North America.
   Objectives
   Our study aimed to compare the performance and practicality of two commercial MALDI-TOF MS platforms in a head-to head manner at a routine laboratory in Chile.
   Methods
   During a five-month period in 2012-13, the diagnostic efficiency (correct identification rate) and agreement between Microflex LT (Bruker Daltonics) and Vitek MS (bioMerieux) was compared in a parallel manner to conventional identification including genotypic analysis for difficult-to-identify strains. The study included 804 microbial isolates: 252 Enterobacteriaceae, 126 non-fermenters, 36 other gram-negative rods, 279 gram-positive cocci, 32 gram-positive rods, 32 anaerobes, and 47 yeasts. Other relevant factors of the two devices such as user friendliness and connectivity were also evaluated and compared.
   Results
   Both systems correctly identified the vast majority (98%) of the isolates to the genus level. Vitek MS reached higher rates of identification to species and species complex level than Microflex LT ( 81% vs. 85% and 87% vs. 93%, respectively), which was mainly based on the higher performance among coagulase negative staphylococci and Candida isolates. The evaluation of user friendliness and other technical aspects showed only marginal differences, which slightly favored Vitek MS, mainly due to its ready-to-use supplies, easier connectivity and workflow integration, and availability of local technical support.
   Conclusions
   Both MALDI-TOF MS systems permitted fast and accurate identification of most microbial strains and showed a high level of user-friendliness. The observed differences were marginal and slightly favored Vitek MS, mainly due to practicality and connectivity issues within our setting.
C1 [Porte, Lorena; Montana, Alisson; Weitzel, Thomas] Univ Desarrollo, Lab Clin, Clin Alemana Santiago, Fac Med Clin Alemana, Santiago, Chile.
   [Porte, Lorena; Braun, Stephanie] Hosp Mil, Lab Clin, Unidad Microbiol, Santiago, Chile.
   [Garcia, Patricia] Pontificia Univ Catolica Chile, Dept Lab Clin, Escuela Med, Santiago, Chile.
   [Ulloa, Maria Teresa] Univ Chile, ICBM Fac Med, Programa Microbiol, Santiago, Chile.
   [Lafourcade, Monica; Montana, Alisson] Clin Santa Maria, Lab Microbiol, Santiago, Chile.
   [Miranda, Carolina] Red Salud UC CHRISTUS, Lab Microbiol, Serv Lab Clin, Santiago, Chile.
   [Acosta-Jamett, Gerardo] Univ Austral Chile, Inst Med Prevent Vet, Fac Ciencias Vet, Valdivia, Chile.
RP Porte, L (reprint author), Univ Desarrollo, Lab Clin, Clin Alemana Santiago, Fac Med Clin Alemana, Santiago, Chile.; Porte, L (reprint author), Hosp Mil, Lab Clin, Unidad Microbiol, Santiago, Chile.
EM lporte@alemana.cl
OI , Lorena/0000-0001-7766-7995; Acosta, Gerardo/0000-0002-9645-3551
CR Alby K, 2013, J CLIN MICROBIOL, V51, P3852, DOI 10.1128/JCM.01618-13
   Bailey D, 2013, CLIN CHEM, V59, P1435, DOI 10.1373/clinchem.2013.204644
   Balada-Llasat JM, 2013, J CLIN MICROBIOL, V51, P2875, DOI 10.1128/JCM.00819-13
   Bilecen K, 2015, BIOMED RES INT, DOI 10.1155/2015/516410
   Biswas S, 2013, J MICROBIOL METH, V92, P14, DOI 10.1016/j.mimet.2012.10.014
   Bizzini A, 2011, J CLIN MICROBIOL, V49, P693, DOI 10.1128/JCM.01463-10
   Carrasco G, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00542
   Cassagne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028425
   Chalupova J, 2014, BIOTECHNOL ADV, V32, P230, DOI 10.1016/j.biotechadv.2013.11.002
   Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09
   Clinical and laboratory standards institute (CLSI), MM18A CLSI
   Conville P, 2015, MANUAL CLIN MICROBIO, P504
   Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x
   Culebras E, 2016, ENFERM INFEC MICR CL, V34, P42, DOI 10.1016/S0213-005X(16)30190-2
   Deak E, 2015, DIAGN MICR INFEC DIS, V81, P27, DOI 10.1016/j.diagmicrobio.2014.09.018
   Degand N, 2008, J CLIN MICROBIOL, V46, P3361, DOI 10.1128/JCM.00569-08
   DeMarco ML, 2013, CLIN LAB MED, V33, P611, DOI 10.1016/j.cll.2013.03.013
   Dieckmann R, 2011, APPL ENVIRON MICROB, V77, P4136, DOI 10.1128/AEM.02418-10
   Dixon P, 2015, EUR J CLIN MICROBIOL, V34, P863, DOI 10.1007/s10096-015-2322-0
   Emonet S, 2010, CLIN MICROBIOL INFEC, V16, P1604, DOI 10.1111/j.1469-0691.2010.03368.x
   Funke G, 1997, CLIN MICROBIOL REV, V10, P125, DOI 10.1128/CMR.10.1.125
   Gaillot O, 2011, J CLIN MICROBIOL, V49, P4412, DOI 10.1128/JCM.05429-11
   Garcia P, 2012, REV CHIL INFECTOL, V29, P263, DOI 10.4067/S0716-10182012000300003
   Garner O, 2014, CLIN MICROBIOL INFEC, V20, P335, DOI 10.1111/1469-0691.12317
   Hrabak J, 2013, CLIN MICROBIOL REV, V26, P103, DOI 10.1128/CMR.00058-12
   Jamal W, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0289-0
   Kiyosuke M, 2015, J MED MICROBIOL, V64, P1144, DOI 10.1099/jmm.0.000136
   Kostrzewa M, 2013, PROTEOM CLIN APPL, V7, P767, DOI 10.1002/prca.201300042
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lartigue MF, 2013, INFECT GENET EVOL, V13, P230, DOI 10.1016/j.meegid.2012.10.012
   Lau SKP, 2014, J CLIN PATHOL, V67, P361, DOI 10.1136/jclinpath-2013-201818
   Leber AL, 2016, CLIN MICROBIOLOGY PR
   Lo CI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145889
   Lohmann C, 2013, J CLIN MICROBIOL, V51, P1231, DOI 10.1128/JCM.03268-12
   Mackinnon A, 2000, COMPUT BIOL MED, V30, P127, DOI 10.1016/S0010-4825(00)00006-8
   Martiny D, 2012, J CLIN MICROBIOL, V50, P1313, DOI 10.1128/JCM.05971-11
   Mirande C, 2015, EUR J CLIN MICROBIOL, V34, P2225, DOI 10.1007/s10096-015-2473-z
   Moon HW, 2013, J MED MICROBIOL, V62, P1301, DOI 10.1099/jmm.0.062950-0
   Nomura F, 2015, BBA-PROTEINS PROTEOM, V1854, P528, DOI 10.1016/j.bbapap.2014.10.022
   Oviano M, 2016, ENFERM INFEC MICR CL, V34, P36, DOI 10.1016/S0213-005X(16)30189-6
   Paauw A, 2015, INT J MED MICROBIOL, V305, P446, DOI 10.1016/j.ijmm.2015.04.001
   Patel R, 2015, CLIN CHEM, V61, P100, DOI 10.1373/clinchem.2014.221770
   Petti CA, 2007, CLIN INFECT DIS, V44, P1108, DOI 10.1086/512818
   Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5
   Posterard B, 2013, EXPERT REV PROTEOMIC, V10, P151, DOI [10.1586/epr.13.8, 10.1586/EPR.13.8]
   Ranque S, 2014, MYCOSES, V57, P135, DOI 10.1111/myc.12115
   Sandrin TR, 2013, MASS SPECTROM REV, V32, P188, DOI 10.1002/mas.21359
   Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885
   Singhal N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00791
   Spinali S, 2015, J CLIN MICROBIOL, V53, P760, DOI 10.1128/JCM.01635-14
   Tan KE, 2012, J CLIN MICROBIOL, V50, P3301, DOI 10.1128/JCM.01405-12
   TeKippe EM, 2014, EUR J CLIN MICROBIOL, V33, P2163, DOI 10.1007/s10096-014-2183-y
   Toh BEW, 2015, J MICROBIOL METH, V118, P128, DOI 10.1016/j.mimet.2015.09.006
   van Prehn J, 2016, DIAGN MICR INFEC DIS, V85, P9, DOI 10.1016/j.diagmicrobio.2016.01.012
   Vaneechoute M, 2000, J CLIN MICROBIOL, V38, P3870
   Vega-Castano S, 2012, ENFERM INFEC MICR CL, V30, P597, DOI 10.1016/j.eimc.2012.03.002
   Vlek ALM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032589
   Wang H, 2012, J CLIN MICROBIOL, V50, P3952, DOI 10.1128/JCM.01130-12
   Welker M, 2011, PROTEOMICS, V11, P3143, DOI 10.1002/pmic.201100049
   Wieser A, 2012, APPL MICROBIOL BIOT, V93, P965, DOI 10.1007/s00253-011-3783-4
   Wilck MB, 2001, J CLIN MICROBIOL, V39, P2025, DOI 10.1128/JCM.39.5.2025-2027.2001
   Yong PVC, 2008, MYCOPATHOLOGIA, V165, P81, DOI 10.1007/s11046-007-9086-8
   Zhang L, 2014, J CLIN MICROBIOL, V52, P572, DOI 10.1128/JCM.02543-13
NR 63
TC 9
Z9 11
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 18
PY 2017
VL 12
IS 5
AR e0177929
DI 10.1371/journal.pone.0177929
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV3PV
UT WOS:000401672400116
PM 28542393
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Vanni, VS
   Somigliana, E
   Reschini, M
   Pagliardini, L
   Marotta, E
   Faulisi, S
   Paffoni, A
   Vigano, P
   Vegetti, W
   Candiani, M
   Papaleo, E
AF Vanni, V. S.
   Somigliana, E.
   Reschini, M.
   Pagliardini, L.
   Marotta, E.
   Faulisi, S.
   Paffoni, A.
   Vigano, P.
   Vegetti, W.
   Candiani, M.
   Papaleo, E.
TI Top quality blastocyst formation rates in relation to progesterone
   levels on the day of oocyte maturation in GnRH antagonist IVF/ICSI
   cycles
SO PLOS ONE
LA English
DT Article
ID IN-VITRO FERTILIZATION; INTRACYTOPLASMIC SPERM INJECTION; FRESH
   EMBRYO-TRANSFER; DEVELOPMENTAL COMPETENCE; ELEVATED PROGESTERONE; SERUM
   PROGESTERONE; PREGNANCY RATE; AGREEMENT; METAANALYSIS; PREDICTORS
AB Cycles with progesterone elevation during controlled ovarian stimulation (COS) for IVF/ICSI are commonly managed with a "freeze-all" strategy, due to a well-recognized detrimental effect of high progesterone levels on endometrial receptivity. However, also a detrimental effect of elevated progesterone on day-3 embryo quality has recently been found with regards to top quality embryo formation rate. Because blastocyst culture and cryopreservation are largely adopted, we deemed relevant to determine whether this detrimental effect is also seen on blastocyst quality on day 5-6. This issue was investigated through a large two-center retrospective study including 986 GnRH antagonist IVF/ICSI cycles and using top quality blastocyst formation rate as the main outcome. Results showed that on multivariate analysis sperm motility (p<0.01) and progesterone levels at ovulation triggering (p = 0.01) were the only two variables that significantly predicted top quality blastocyst formation rate after adjusting for relevant factors including female age, BMI, basal AMH and total dose of FSH used for COS. More specifically, progesterone levels at induction showed an inverse relation with top quality blastocyst formation (correlation coefficient B = -1.08, 95% CI -1.9 to -0.02) and ROC curve analysis identified P level > 1.49 ng/ml as the best cut-off for identification of patients at risk for the absence of top quality blastocysts (AUC 0.55, p< 0.01). Our study is the first to investigate the top quality blastocyst formation rate in relation to progesterone levels in IVF/ICSI cycles, showing that increasing progesterone is associated with lower rates of top quality blastocyst. Hence, the advantages of prolonging COS to maximize the number of collected oocytes might eventually be hindered by a decrease in top quality blastocysts available for transfer, if increasing progesterone levels are observed. This observation extends the results of two recent studies focused on day-3 embryos and deserves further research.
C1 [Vanni, V. S.; Pagliardini, L.; Marotta, E.; Faulisi, S.; Vigano, P.; Papaleo, E.] IRCCS San Raffaele Sci Inst, Ctr Sci Natalita, Milan, Italy.
   [Somigliana, E.; Reschini, M.; Paffoni, A.; Vegetti, W.] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Milan, Italy.
   [Somigliana, E.] Univ Milan, Milan, Italy.
   [Vigano, P.] IRCCS San Raffaele Sci Inst, Div Genet & Cell Biol, Milan, Italy.
   [Candiani, M.] Univ Vita Salute San Raffaele, Milan, Italy.
RP Vigano, P (reprint author), IRCCS San Raffaele Sci Inst, Ctr Sci Natalita, Milan, Italy.; Vigano, P (reprint author), IRCCS San Raffaele Sci Inst, Div Genet & Cell Biol, Milan, Italy.
EM vigano.paola@hsr.it
RI Pagliardini, Luca/K-5886-2016; paffoni, alessio/I-7404-2015
OI Pagliardini, Luca/0000-0002-3960-7454; paffoni,
   alessio/0000-0003-3112-3161; Reschini, Marco/0000-0002-9868-3043;
   Vigano, Paola/0000-0003-3674-5912
CR Al-Azemi M, 2012, REPROD BIOMED ONLINE, V24, P381, DOI 10.1016/j.rbmo.2012.01.010
   ALPHA S, 2011, HUM REPROD, V26, P1270, DOI DOI 10.1093/HUMREP/DER037
   Azem F, 2008, GYNECOL ENDOCRINOL, V24, P368, DOI 10.1080/09513590802196353
   Bu ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100011
   Cai QF, 2011, HUM REPROD, V26, P2532, DOI 10.1093/humrep/der228
   Cai QF, 2014, J ASSIST REPROD GEN, V31, P185, DOI 10.1007/s10815-013-0129-4
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Corti L, 2013, EUR J OBSTET GYN R B, V171, P73, DOI 10.1016/j.ejogrb.2013.08.017
   Dominko T, 1997, THERIOGENOLOGY, V47, P1041, DOI 10.1016/S0093-691X(97)00061-7
   Fair T, 2012, REPROD DOMEST ANIM, V47, P142, DOI 10.1111/j.1439-0531.2012.02068.x
   Fanchin R, 1997, FERTIL STERIL, V68, P648, DOI 10.1016/S0015-0282(97)80464-5
   Fanchin R, 1996, FERTIL STERIL, V65, P1178, DOI 10.1016/S0015-0282(16)58335-6
   Faulisi S, GYNECOL OBSTET INVES
   Ferraretti AP, 2014, HUM REPROD, V29, P1842, DOI 10.1093/humrep/deu139
   Hamilton JAM, 2015, HUM REPROD, V30, P1110, DOI 10.1093/humrep/dev058
   Hill MJ, 2015, FERTIL STERIL, V103, P1477, DOI 10.1016/j.fertnstert.2015.02.038
   HOFMANN GE, 1993, FERTIL STERIL, V60, P675
   Huang B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145895
   Intra G, 2016, REPROD BIOMED ONLINE, V33, P132, DOI 10.1016/j.rbmo.2016.05.008
   Kofinas JD, 2016, J ASSIST REPROD GEN, V33, P1169, DOI 10.1007/s10815-016-0752-y
   Lahoud R, 2012, ARCH GYNECOL OBSTET, V285, P535, DOI 10.1007/s00404-011-2045-0
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Li PF, 2015, SYST BIOL REPROD MED, V61, P161, DOI 10.3109/19396368.2015.1033779
   Navas P, 2017, REPROD BIOMED ONLINE
   O'Shea LC, 2012, SYST BIOL REPROD MED, V58, P88, DOI 10.3109/19396368.2012.656217
   Papaleo E, 2016, REPROD BIOMED ONLINE
   Papanikolaou EG, 2009, FERTIL STERIL, V91, P949, DOI 10.1016/j.fertnstert.2006.12.064
   Restelli L, 2014, J ASSIST REPROD GEN, V31, P1629, DOI 10.1007/s10815-014-0350-9
   Roque M, 2013, FERTIL STERIL, V99, P156, DOI 10.1016/j.fertnstert.2012.09.003
   Rubino P, 2016, HUM REPROD UPDATE, V22, P194, DOI 10.1093/humupd/dmv050
   Shapiro BS, 2010, FERTIL STERIL, V93, P636, DOI 10.1016/j.fertnstert.2009.01.134
   SILVERBERG KM, 1994, FERTIL STERIL, V61, P508
   Storr A, 2017, HUM REPROD, V32, P307, DOI 10.1093/humrep/dew330
   Ubaldi F, 1995, HUM REPROD, V10, P3091, DOI 10.1093/oxfordjournals.humrep.a135864
   Urrego R, 2015, THERIOGENOLOGY, V83, P1179, DOI 10.1016/j.theriogenology.2014.12.024
   Vanni VS, J ENDOCRINOL INVEST
   Venetis CA, 2013, HUM REPROD UPDATE, V19, P433, DOI 10.1093/humupd/dmt014
NR 37
TC 20
Z9 21
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 17
PY 2017
VL 12
IS 5
AR e0176482
DI 10.1371/journal.pone.0176482
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV1DX
UT WOS:000401487700018
PM 28520729
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Laeremans, M
   Dons, E
   Avila-Palencia, I
   Carrasco-Turigas, G
   Orjuela, JP
   Anaya, E
   Brand, C
   Cole-Hunter, T
   de Nazelle, A
   Gotschi, T
   Kahlmeier, S
   Nieuwenhuijsen, M
   Standaert, A
   De Boever, P
   Panis, LI
AF Laeremans, Michelle
   Dons, Evi
   Avila-Palencia, Ione
   Carrasco-Turigas, Gloria
   Pablo Orjuela, Juan
   Anaya, Esther
   Brand, Christian
   Cole-Hunter, Tom
   de Nazelle, Audrey
   Gotschi, Thomas
   Kahlmeier, Sonja
   Nieuwenhuijsen, Mark
   Standaert, Arnout
   De Boever, Patrick
   Panis, Luc Int
TI Physical activity and sedentary behaviour in daily life: A comparative
   analysis of the Global Physical Activity Questionnaire (GPAQ) and the
   SenseWear armband
SO PLOS ONE
LA English
DT Article
ID DAILY ENERGY-EXPENDITURE; SELF-REPORT MEASURES; METABOLIC SYNDROME;
   VALIDITY; RELIABILITY; VALIDATION; RECALL; EXERCISE; MONITORS; WALKING
AB Reduction of sedentary time and an increase in physical activity offer potential to improve public health. However, quantifying physical activity behaviour under real world conditions is a major challenge and no standard of good practice is available. Our aim was to compare the results of physical activity and sedentary behaviour obtained with a self-reported instrument (Global Physical Activity Questionnaire (GPAQ)) and a wearable sensor (SenseWear) in a repeated measures study design. Healthy adults (41 in Antwerp, 41 in Barcelona and 40 in London) wore the SenseWear armband for seven consecutive days and completed the GPAQ on the final day. This was repeated three times. We used the Wilcoxon signed rank sum test, Spearman correlation coefficients, mixed effects regression models and Bland-Altman plots to study agreement between both methods. Mixed models were used to assess the effect of personal characteristics on the absolute and relative difference between estimates obtained with the GPAQ and SenseWear. Moderate to vigorous energy expenditure and duration derived from the GPAQ were significantly lower (p<0.05) compared to the SenseWear, yet these variables showed significant correlations ranging from 0.45 to 0.64. Estimates of vigorous-intensity physical activity in particular showed high similarity (r>0.59). Results for sedentary behaviour did not differ, yet were poorly correlated (r<0.25). The differences between all variables were reproducible across repeated measurements. In addition, we observed a relationship between these differences and BMI, body fat and physical activity domain. Due to the lack of a standardized protocol, results from different studies measuring physical activity and sedentary behaviour are difficult to compare. Therefore, we suggested an easy-to-implement approach for future studies adding the GPAQ to the wearable of choice as a basis for comparisons.
C1 [Laeremans, Michelle; Dons, Evi; Standaert, Arnout; De Boever, Patrick; Panis, Luc Int] Flemish Inst Technol Res VITO, Environm Risk & Hlth Unit MRG, Mol, Belgium.
   [Laeremans, Michelle; Panis, Luc Int] Hasselt Univ, Transportat Res Inst IMOB, Diepenbeek, Belgium.
   [Dons, Evi; De Boever, Patrick] Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium.
   [Avila-Palencia, Ione; Carrasco-Turigas, Gloria; Cole-Hunter, Tom; Nieuwenhuijsen, Mark] Ctr Res Environm Epidemiol, ISGlobal, Barcelona, Spain.
   [Avila-Palencia, Ione; Carrasco-Turigas, Gloria; Cole-Hunter, Tom; Nieuwenhuijsen, Mark] Univ Pompeu Fabra, Barcelona, Spain.
   [Avila-Palencia, Ione; Carrasco-Turigas, Gloria; Cole-Hunter, Tom; Nieuwenhuijsen, Mark] CIBER Epidemiol & Salud Publ, Madrid, Spain.
   [Pablo Orjuela, Juan; Anaya, Esther; de Nazelle, Audrey] Imperial Coll London, CEP, London, England.
   [Brand, Christian] Univ Oxford, Transport Studies Unit, Oxford, England.
   [Cole-Hunter, Tom] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA.
   [Gotschi, Thomas; Kahlmeier, Sonja] Univ Zurich, Epidemiol Biostat & Prevent Inst, Phys Act & Hlth Unit, Zurich, Switzerland.
RP Panis, LI (reprint author), Flemish Inst Technol Res VITO, Environm Risk & Hlth Unit MRG, Mol, Belgium.; Panis, LI (reprint author), Hasselt Univ, Transportat Res Inst IMOB, Diepenbeek, Belgium.
EM luc.intpanis@vito.be
RI Avila-Palencia, Ione/J-1062-2018; Panis, Luc Int/C-8717-2009; Kahlmeier,
   Sonja/B-8141-2014; Dons, Evi/H-7913-2019; Nieuwenhuijsen,
   Mark/C-3914-2017; Cole-Hunter, Tom/N-4063-2014; Anaya Boig,
   Esther/K-5395-2015
OI Avila-Palencia, Ione/0000-0002-4353-2256; Panis, Luc
   Int/0000-0002-2558-4351; Kahlmeier, Sonja/0000-0001-6905-9244; Dons,
   Evi/0000-0002-6745-7246; Nieuwenhuijsen, Mark/0000-0001-9461-7981;
   Cole-Hunter, Tom/0000-0002-6827-6084; Anaya Boig,
   Esther/0000-0002-9204-534X; Brand, Christian/0000-0002-1535-5328; De
   Boever, Patrick/0000-0002-5197-8215
FU European Union [602624]; VITO PhD scholarship; FWO Research Foundation
   Flanders [12L8815N]; Colciencias (Administrative Department of Science,
   Technology and Innovation of the Colombian Government) [646]
FX This research received funding from the European Union's Seventh
   Framework Program to the PASTA project under grant agreement No. 602624
   (FP7-HEALTH-2013-INNOVATION-1) (Physical Activity through Sustainable
   Transport Approaches). Michelle Laeremans is supported by a VITO PhD
   scholarship (no grant number; www.vito.be). Evi Dons holds a
   postdoctoral scholarship from FWO Research Foundation Flanders (grant
   number: 12L8815N; www.fwo.be). Juan Pablo Orjuela received a beneficiary
   grant from Colciencias (Administrative Department of Science, Technology
   and Innovation of the Colombian Government) (grant number 646;
   www.colciencias.gov.co). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adams EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107039
   Ainsworth BE, 2000, MED SCI SPORTS EXERC, V32, P9
   Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7
   Berntsen S, 2010, BRIT J SPORT MED, V44, P657, DOI 10.1136/bjsm.2008.048868
   Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422
   Bland JM, 1996, BMJ-BRIT MED J, V312, P572
   Brazeau AS, 2016, J SCI MED SPORT, V19, P46, DOI 10.1016/j.jsams.2014.11.001
   Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790
   Cleland CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1255
   Clemes SA, 2012, J PHYS ACT HEALTH, V9, P533, DOI 10.1123/jpah.9.4.533
   COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Dons E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2453-3
   Durante R, 1996, MED SCI SPORT EXER, V28, P1282, DOI 10.1097/00005768-199610000-00012
   Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840
   Ford ES, 2005, OBES RES, V13, P608, DOI 10.1038/oby.2005.65
   Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e
   Gerike R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009924
   Gomersall SR, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5531
   Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1
   Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882
   Herrmann SD, 2013, MEAS PHYS EDUC EXERC, V17, P221, DOI 10.1080/1091367X.2013.805139
   Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542
   Johannsen DL, 2010, MED SCI SPORT EXER, V42, P2134, DOI 10.1249/MSS.0b013e3181e0b3ff
   John D, 2013, SENSORS-BASEL, V13, P14754, DOI 10.3390/s131114754
   Kahlmeier S, 2014, HLTH EC ASSESSMENT T
   Keadle SK, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-12
   Koehler K, 2011, MED SCI SPORT EXER, V43, P1328, DOI 10.1249/MSS.0b013e31820750f5
   Lagerros YT, 2007, EUR J EPIDEMIOL, V22, P353, DOI 10.1007/s10654-007-9154-x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mackey DC, 2011, J GERONTOL A-BIOL, V66, P1108, DOI 10.1093/gerona/glr101
   Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067
   Matthews CE, 2007, AM J EPIDEMIOL, V165, P1343, DOI 10.1093/aje/kwm088
   Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2
   Peterman JE, 2016, EUR J APPL PHYSIOL, V116, P1565, DOI 10.1007/s00421-016-3408-9
   Philippaerts RM, 2001, INT J SPORTS MED, V22, P34, DOI 10.1055/s-2001-11359
   Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281
   Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56
   Scheers T, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-71
   Sjostrom M, 2002, SCANDINAVIAN J NUTR, V46, P123, DOI DOI 10.1080/11026480260363251
   Sperlich B, 2012, EUR J APPL PHYSIOL, V112, P4015, DOI 10.1007/s00421-012-2382-0
   St-Onge M, 2007, AM J CLIN NUTR, V85, P742
   Strath SJ, 2003, MED SCI SPORT EXER, V35, P2112, DOI 10.1249/01.MSS.0000099091.38917.76
   Van Hoye A, 2014, SCI SPORT, V29, P78, DOI 10.1016/j.scispo.2013.01.010
   Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351
   Welk GJ, 2007, OBESITY, V15, P918, DOI 10.1038/oby.2007.624
   Welk GJ, 2014, MED SCI SPORT EXER, V46, P2014, DOI 10.1249/MSS.0000000000000314
   WHO, WHO STEPWISE APPR NO
   World Health Organisation, 2010, GLOB REC PHYS ACT HL
   World Health Organization, GLOB PHYS ACT QUEST
NR 50
TC 7
Z9 7
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 16
PY 2017
VL 12
IS 5
AR e0177765
DI 10.1371/journal.pone.0177765
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV1DC
UT WOS:000401485500068
PM 28520781
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Magaard, JL
   Seeralan, T
   Schulz, H
   Brutt, AL
AF Magaard, Julia Luise
   Seeralan, Tharanya
   Schulz, Holger
   Bruett, Anna Levke
TI Factors associated with help-seeking behaviour among individuals with
   major depression: A systematic review
SO PLOS ONE
LA English
DT Review
ID MENTAL-HEALTH-CARE; SERVICE USE; ANXIETY DISORDERS; UNITED-STATES;
   RACIAL-DIFFERENCES; NATIONAL-SURVEY; MOOD DISORDERS; TREATMENT GAP;
   PREVALENCE; COMORBIDITY
AB Psychological models can help to understand why many people suffering from major depression do not seek help. Using the 'Behavioral Model of Health Services Use', this study systematically reviewed the literature on the characteristics associated with helpseeking behaviour in adults with major depression. Articles were identified by systematically searching the MEDLINE, EMBASE and PsycInfo databases and relevant reference lists. Observational studies investigating the associations between individual or contextual characteristics and professional help-seeking behaviour for emotional problems in adults formally diagnosed with major depression were included. The quality of the included studies was assessed, and factors associated with help-seeking behaviour were qualitatively synthesized. In total, 40 studies based on 26 datasets were included. Several studies investigated predisposing (age (N = 17), gender (N = 16), ethnicity (N = 9), education (N = 11), marital status (N = 12)), enabling (income (N = 12)), need (severity (N = 14), duration (N = 9), number of depressive episodes (N = 6), psychiatric comorbidity (N = 10)) and contextual factors (area (N = 8)). Socio-demographic and need factors appeared to influence helpseeking behaviour. Although existing studies provide insight into the characteristics associated with help seeking for major depression, cohort studies and research on beliefs about, barriers to and perceived need for treatment are lacking. Based on this review, interventions to increase help-seeking behaviour can be designed.
C1 [Magaard, Julia Luise; Seeralan, Tharanya; Schulz, Holger; Bruett, Anna Levke] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Ctr Psychosocial Med, Hamburg, Germany.
   [Bruett, Anna Levke] Carl von Ossietzky Univ Oldenburg, Dept Hlth Serv Res, Oldenburg, Germany.
RP Magaard, JL (reprint author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Ctr Psychosocial Med, Hamburg, Germany.
EM j.magaard@uke.de
FU German Research Foundation (DFG) [BR4859/3-1]
FX This study was not funded and part of the dissertation of Julia Luise
   Magaard (JLM). However, JLM, Anna Levke Brutt (ALB) and Tharanya
   Seeralan (TS) received grants from the German Research Foundation for a
   pilot study about help-seeking behavior of patients with depression (DFG
   BR4859/3-1). The German Research Foundation had no role in the study
   design, collection, analysis or interpretation of the data, writing the
   manuscript, or the decision to submit the paper.; This study as not
   funded and part of the dissertation of Julia Luise Magaard (JLM).
   However, Anna Levke Brutt (ALB), Tharanya Seeralan (TS) and JLM received
   grants from the German Research Foundation for a pilot study about
   help-seeking behavior of patients with depression. The German Research
   Foundation had no role in the study design, collection, analysis or
   interpretation of the data, writing the manuscript, or the decision to
   submit the paper. The authors declare that they have no competing
   interests. The authors wish to thank Mr. PD Dr. Levente Kriston for
   valuable and constructive comments on conduction of systematic reviews.
   We thank American Journal Experts (AJE) for English language editing.
CR AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Allin S, 2009, AM J PUBLIC HEALTH, V99, P1849, DOI 10.2105/AJPH.2008.141499
   American Psychiatric Association, 2010, PRACT GUID TREATM PA
   Andersen RM, 2008, MED CARE, V46, P647, DOI 10.1097/MLR.0b013e31817f4d48
   [Anonymous], QUAL ASS TOOL OBS CO
   Aromaa E, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-52
   Babitsch B, 2012, PSYCHOSOCIAL MED, V9
   Birnbaum HG, 2010, DEPRESS ANXIETY, V27, P78, DOI 10.1002/da.20580
   Bland RC, 1997, CAN J PSYCHIAT, V42, P935, DOI 10.1177/070674379704200904
   Boerema AM, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0790-0
   Bonnewyn A, 2009, J AFFECT DISORDERS, V117, P193, DOI 10.1016/j.jad.2009.01.012
   Boyd RC, 2011, J CLIN PSYCHIAT, V72, P1538, DOI 10.4088/JCP.10m06468
   Bristow K, 2002, CAN J PSYCHIAT, V47, P660
   Cabello M, 2012, J AFFECT DISORDERS, V141, P22, DOI 10.1016/j.jad.2011.12.009
   Cairney J, 2002, SOC PSYCH PSYCH EPID, V37, P236, DOI 10.1007/s00127-002-0539-6
   Chartrand H, 2012, J AFFECT DISORDERS, V141, P237, DOI 10.1016/j.jad.2012.03.040
   Chen LY, 2013, PSYCHIAT SERV, V64, P863, DOI 10.1176/appi.ps.201200289
   Cheung AH, 2007, CAN J PSYCHIAT, V52, P228, DOI 10.1177/070674370705200404
   Clement S, 2015, PSYCHOL MED, V45, P11, DOI 10.1017/S0033291714000129
   CORYELL W, 1995, AM J PSYCHIAT, V152, P1124
   Crabb R, 2006, J CLIN PSYCHOL, V62, P299, DOI 10.1002/jclp.20231
   Demyttenaere K, 2006, J AFFECT DISORDERS, V92, P185, DOI 10.1016/j.jad.2006.01.007
   DEW MA, 1991, SOC PSYCH PSYCH EPID, V26, P230, DOI 10.1007/BF00788971
   Diala C, 2000, AM J ORTHOPSYCHIAT, V70, P455, DOI 10.1037/h0087736
   Doblyte S, 2017, QUAL HEALTH RES, V27, P100, DOI 10.1177/1049732316681282
   Elwy AR, 2011, QUAL HEALTH RES, V21, P1495, DOI 10.1177/1049732311413781
   FARAVELLI C, 1989, ACTA PSYCHIAT SCAND, V79, P308, DOI 10.1111/j.1600-0447.1989.tb10263.x
   FARAVELLI C, 1990, J AFFECT DISORDERS, V20, P135, DOI 10.1016/0165-0327(90)90127-T
   Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547
   Gabilondo A, 2011, PSYCHIAT SERV, V62, P152, DOI 10.1176/ps.62.2.pss6202_0152
   Gadalla TM, 2008, WOMEN HEALTH, V47, P1, DOI 10.1300/J013v47n01_01
   Gagne S, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-135
   Gonzalez HM, 2010, ARCH GEN PSYCHIAT, V67, P37, DOI 10.1001/archgenpsychiatry.2009.168
   Gulliver A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-81
   Hamalainen J, 2008, DEPRESS ANXIETY, V25, P27, DOI 10.1002/da.20256
   Hailemariam S, 2012, INT J MENT HEALTH SY, V6, DOI 10.1186/1752-4458-6-23
   Hamalainen J, 2004, J AFFECT DISORDERS, V79, P105, DOI 10.1016/S0165-0327(02)00342-7
   Hankerson SH, 2011, J NATL MED ASSOC, V103, P576, DOI 10.1016/S0027-9684(15)30383-7
   Henshaw EJ, 2009, CLIN PSYCHOL-SCI PR, V16, P420, DOI 10.1111/j.1468-2850.2009.01181.x
   Jorm AF, 1997, MED J AUSTRALIA, V166, P182, DOI 10.5694/j.1326-5377.1997.tb140071.x
   Kadushin C., 1969, WHY PEOPLE GO PSYCHI
   Katz SJ, 1998, J GEN INTERN MED, V13, P77, DOI 10.1046/j.1525-1497.1998.00022.x
   Kleinberg A, 2013, EPIDEMIOL PSYCH SCI, V22, P345, DOI 10.1017/S2045796013000504
   Kleinberg A, 2013, COMMUNITY MENT HLT J, V49, P427, DOI 10.1007/s10597-012-9499-9
   Ko JY, 2012, J WOMENS HEALTH, V21, P830, DOI 10.1089/jwh.2011.3466
   Kohn R, 2004, B WORLD HEALTH ORGAN, V82, P858
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leventhal H., 1984, HDB PSYCHOL HLTH, V4, P219
   Lin E, 1999, J AFFECT DISORDERS, V53, P153, DOI 10.1016/S0165-0327(98)00116-5
   Mackenzie CS, 2012, DEPRESS ANXIETY, V29, P234, DOI 10.1002/da.20911
   Manetti A, 2014, AM J GERIAT PSYCHIAT, V22, P1292, DOI 10.1016/j.jagp.2013.05.001
   Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005
   Mojtabai R, 2006, PSYCHIAT SERV, V57, P631, DOI 10.1176/appi.ps.57.5.631
   Moller-Leimkuhler AM, 2002, J AFFECT DISORDERS, V71, P1, DOI 10.1016/S0165-0327(01)00379-2
   National Health Service, 2013, CRIT APPR SKILLS PRO
   National Health Service, 2013, CRITAICAL APPRAISAL
   NICE, 2009, DEPR TREATM MAN DEPR
   Ohayon MM, 1999, BIOL PSYCHIAT, V45, P300, DOI 10.1016/S0006-3223(98)00011-0
   Pescosolido BA, 1999, CURRENT KNOWLEDGE CH, P392
   Prins MA, 2008, CLIN PSYCHOL REV, V28, P1038, DOI 10.1016/j.cpr.2008.02.009
   Rafful C, 2012, J AFFECT DISORDERS, V138, P165, DOI 10.1016/j.jad.2011.12.040
   ROSENSTOCK IM, 1966, MILBANK FUND Q, V44, P94, DOI 10.2307/3348967
   Roy-Byrne PP, 2000, BRIT J PSYCHIAT, V176, P229, DOI 10.1192/bjp.176.3.229
   SMITH K, 2013, HEALTH N Y, V5, P1561, DOI DOI 10.4236/HEALTH.2013.510212
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   SUSSMAN LK, 1987, SOC SCI MED, V24, P187, DOI 10.1016/0277-9536(87)90046-3
   Tempier R, 2010, CAN J PSYCHIAT, V55, P295, DOI 10.1177/070674371005500505
   Tiwari SK, 2008, SOC PSYCH PSYCH EPID, V43, P866, DOI 10.1007/s00127-008-0373-6
   Wang JL, 2005, CAN J PSYCHIAT, V50, P652, DOI 10.1177/070674370505001012
   Wang JL, 2004, CAN J PSYCHIAT, V49, P37, DOI 10.1177/070674370404900106
   Williams DR, 2007, ARCH GEN PSYCHIAT, V64, P305, DOI 10.1001/archpsyc.64.3.305
   World Health Organization, 2008, GLOB BURD DIS 2004
   Yousaf O, 2015, HEALTH PSYCHOL REV, V9, P264, DOI 10.1080/17437199.2013.840954
NR 73
TC 17
Z9 17
U1 2
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 11
PY 2017
VL 12
IS 5
AR e0176730
DI 10.1371/journal.pone.0176730
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EU8UP
UT WOS:000401314300028
PM 28493904
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Fernandez-Dominguez, JC
   de Pedro-Gomez, JE
   Morales-Asencio, JM
   Bennasar-Veny, M
   Sastre-Fullana, P
   Sese-Abad, A
AF Carlos Fernandez-Dominguez, Juan
   Ernest de Pedro-Gomez, Joan
   Miguel Morales-Asencio, Jose
   Bennasar-Veny, Miquel
   Sastre-Fullana, Pedro
   Sese-Abad, Albert
TI Health Sciences-Evidence Based Practice questionnaire (HS-EBP) for
   measuring transprofessional evidence-based practice: Creation,
   development and psychometric validation
SO PLOS ONE
LA English
DT Article
ID EVIDENCE BASED MEDICINE; FRESNO TEST; KNOWLEDGE; SKILLS; INSTRUMENTS;
   ATTITUDES; BEHAVIOR; BARRIERS; RELIABILITY; VALIDITY
AB Introduction
   Most of the EBP measuring instruments available to date present limitations both in the operationalisation of the construct and also in the rigour of their psychometric development, as revealed in the literature review performed. The aim of this paper is to provide rigorous and adequate reliability and validity evidence of the scores of a new transdisciplinary psychometric tool, the Health Sciences Evidence-Based Practice (HS-EBP), for measuring the construct EBP in Health Sciences professionals.
   Methods
   A pilot study and a subsequent two-stage validation test sample were conducted to progressively refine the instrument until a reduced 60-item version with a five-factor latent structure. Reliability was analysed through both Cronbach's alpha coefficient and intraclass correlations (ICC). Latent structure was contrasted using confirmatory factor analysis (CFA) following a model comparison aproach. Evidence of criterion validity of the scores obtained was achieved by considering attitudinal resistance to change, burnout, and quality of professional life as criterion variables; while convergent validity was assessed using the Spanish version of the Evidence-Based Practice Questionnaire (EBPQ-19).
   Results
   Adequate evidence of both reliability and ICC was obtained for the five dimensions of the questionnaire. According to the CFA model comparison, the best fit corresponded to the five-factor model (RMSEA = 0.049; CI 90% RMSEA = [0.047; 0.050]; CFI = 0.99). Adequate criterion and convergent validity evidence was also provided. Finally, the HS-EBP showed the capability to find differences between EBP training levels as an important evidence of decision validity.
   Conclusions
   Reliability and validity evidence obtained regarding the HS-EBP confirm the adequate operationalisation of the EBP construct as a process put into practice to respond to every clinical situation arising in the daily practice of professionals in health sciences (transprofessional). The tool could be useful for EBP individual assessment and for evaluating the impact of specific interventions to improve EBP.
C1 [Carlos Fernandez-Dominguez, Juan; Ernest de Pedro-Gomez, Joan; Sastre-Fullana, Pedro] Univ Balearic Isl, Dept Nursing & Physiotherapy, Palma De Mallorca, Balearic Island, Spain.
   [Miguel Morales-Asencio, Jose] Univ Malaga, Dept Nursing, Fac Hlth Sci, Andalucia, Spain.
   [Bennasar-Veny, Miquel] Univ Illes Balears, Res Grp Evidence Lifestyles & Hlth, Res Inst Hlth Sci IUNICS, Palma De Mallorca, Baleares, Spain.
   [Sastre-Fullana, Pedro] Son Llatzer Hosp, Balearic Isl Hlth Serv, Palma De Mallorca, Spain.
   [Sese-Abad, Albert] Univ Balearic Isl, Dept Psychol, Palma De Mallorca, Balearic Island, Spain.
RP de Pedro-Gomez, JE (reprint author), Univ Balearic Isl, Dept Nursing & Physiotherapy, Palma De Mallorca, Balearic Island, Spain.
EM depedro@uib.es
RI Bennasar-Veny, Miquel/F-6077-2013; Bennasar-Veny, Miquel/C-5881-2008;
   MORALES-ASENCIO, JOSE MIGUEL/B-4996-2008
OI Bennasar-Veny, Miquel/0000-0003-1668-2141; Bennasar-Veny,
   Miquel/0000-0003-1668-2141; MORALES-ASENCIO, JOSE
   MIGUEL/0000-0001-7911-7487
FU Health Research Fund of the Institute de Salud Carlos III [PI12/02456]
FX This article forms part of a project entitled 'Health Sciences-Evidence
   Based Practice Questionnaire (HS-EBP) for Measuring Transprofessional
   Evidence-Based Practice',financed by the Health Research Fund of the
   Institute de Salud Carlos III (award number: PI12/02456) following a
   rigorous peer-reviewed funding process. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR American Educational Research Association American Psychological Association and National Council on Measurement in Education, 2014, STAND ED PSYCH TEST
   American Educational Research Association American Psychological Association National Council on Measurement in Education, 1999, STAND ED PSYCH TEST
   Arciniega LM, 2009, PERS INDIV DIFFER, V46, P178, DOI 10.1016/j.paid.2008.09.024
   Benner P., 2001, NOVICE EXPERT EXCELL
   Bernal G, 2010, P R HEALTH SCI J, V29, P385
   Buchanan H, 2016, OCCUP THER INT, V23, P59, DOI 10.1002/oti.1398
   Cabezas C, 2000, FMC, V7, P53
   Fernandez-Dominguez JC, 2016, INT J QUAL HEALTH C, V28, P764, DOI 10.1093/intqhc/mzw106
   Fernandez-Dominguez JC, 2014, J EVAL CLIN PRACT, V20, P767, DOI 10.1111/jep.12180
   Dawes Martin, 2005, BMC Med Educ, V5, P1
   Gomez JD, 2009, REV ESP SALUD PUBLIC, V83, P577
   DiCenso A, 2014, EVIDENCE BASED NURSI
   Fritsche L, 2002, BRIT MED J, V325, P1338, DOI 10.1136/bmj.325.7376.1338
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   International Test Commission, 2013, ITC GUID QUAL CONTR
   Joreskog KG., 2006, LISREL 8 80 WINDOWS
   Kaper NM, 2015, J CLIN EPIDEMIOL, V68, P1261, DOI 10.1016/j.jclinepi.2015.06.002
   KRAUS SJ, 1995, PERS SOC PSYCHOL B, V21, P58, DOI 10.1177/0146167295211007
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leung K, 2014, J ADV NURS, V70, P2181, DOI 10.1111/jan.12454
   Martn Jess, 2004, Gac Sanit, V18, P129, DOI 10.1157/13059283
   McEvoy MP, 2010, MED TEACH, V32, pE373, DOI 10.3109/0142159X.2010.494741
   Melnyk BM, 2014, WORLDV EVID-BASED NU, V11, P79, DOI 10.1111/wvn.12032
   Metcalfe C., 2001, PHYSIOTHERAPY, V87, P433, DOI DOI 10.1016/S0031-9406(05)65462-4
   Mokkink LB, 2010, BMC MED RES METHODOL, V10, DOI [10.1186/1471-2288-10-22, 10.1186/1471-2288-10-82]
   Palfreyman Simon, 2003, Br J Nurs, V12, P246
   Pallant J, 2007, SPSS SURVIVAL MANUAL
   Pollock AS, 2000, CLIN REHABIL, V14, P611, DOI 10.1191/0269215500cr369oa
   Ramos KD, 2003, BRIT MED J, V326, P319, DOI 10.1136/bmj.326.7384.319
   Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338
   Scurlock-Evans L, 2014, PHYSIOTHERAPY, V100, P208, DOI 10.1016/j.physio.2014.03.001
   Seisdedos N, 1997, MBI INVENTARIO BURNO
   Streiner DL, 2008, HLTH MEASUREMENT SCA
   Tabachnick B. G., 2007, USING MULTIVARIATE S
   Tilson JK, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-38
   Williams Brett, 2015, Nurse Educ Today, V35, pe34, DOI 10.1016/j.nedt.2014.11.012
NR 36
TC 0
Z9 0
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 9
PY 2017
VL 12
IS 5
AR e0177172
DI 10.1371/journal.pone.0177172
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EU8UM
UT WOS:000401314000052
PM 28486533
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ashaba, S
   Kaida, A
   Coleman, JN
   Burns, BF
   Dunkley, E
   O'Neil, K
   Kastner, J
   Sanyu, N
   Akatukwasa, C
   Bangsberg, DR
   Matthews, LT
   Psaros, C
AF Ashaba, Scholastic
   Kaida, Angela
   Coleman, Jessica N.
   Burns, Bridget F.
   Dunkley, Emma
   O'Neil, Kasey
   Kastner, Jasmine
   Sanyu, Naomi
   Akatukwasa, Cecilia
   Bangsberg, David R.
   Matthews, Lynn T.
   Psaros, Christina
TI Psychosocial challenges facing women living with HIV during the
   perinatal period in rural Uganda
SO PLOS ONE
LA English
DT Article
ID TO-CHILD TRANSMISSION; INTIMATE PARTNER VIOLENCE; QUALITY-OF-LIFE;
   ANTIRETROVIRAL THERAPY; PREGNANT-WOMEN; SOCIAL SUPPORT;
   DEVELOPING-COUNTRIES; DEPRESSIVE SYMPTOMS; ANTENATAL CLINICS;
   HEALTH-SERVICES
AB The complexities of navigating pregnancy while living with HIV predispose women to additional stress. Finding ways to minimize psychosocial challenges during the perinatal period may maximize the well-being of mothers living with HIV and their children. The goal of this study was to explore psychosocial challenges experienced by women living with HIV (WLWH) during pregnancy and the postpartum.
   larger structural environment including partners, family and community member as well as policy makers, funders and program implementers to work together for the common cause. These consolidated efforts may not only lower the risk of psychological distress but has potential to create long lasting solutions to benefit the wider community.We conducted individual in-depth interviews with 20 WLWH recruited from an HIV treatment cohort study in Mbarara, Uganda as part of a larger study exploring perinatal depression. We conducted content analyses to identify themes related to challenges of WLWH during pregnancy and the postpartum. Participants had a median age of 33 years [IQR: 28- 35], a median of 3 living children [IQR: 2-5], and 95% had achieved HIV-RNA suppression. Challenges were organized around the following themes: HIV-related stigma from health professionals, HIV status disclosure dilemma, unintended pregnancy and intimate partner violence, HIV and environmental structural barriers and distress and fear related to maternal and child health. Stigma centered on discrimination by health care professionals and personal shame associated with being pregnant as a WLWH. This led to difficulty engaging in HIV care, particularly when coupled with structural barriers, such as lack of transportation to clinic. Participants experienced intimate partner violence and lacked support from their partners and family members. Distress and fear about the health and uncertainty about the future of the unborn baby due to maternal deteriorating physical health was common. The perinatal period is a time of stress for WLWH. Challenges experienced by WLWH may compromise successful engagement in HIV care and may reduce quality of life for women and their children. Strategies aimed at alleviating the challenges of WLWH should involve the larger structural environment including partners, family and community member as well as policy makers, funders and program implementers to work together for the common cause. These consolidated efforts may not only lower the risk of psychological distress but has potential to create long lasting solutions to benefit the wider community.
C1 [Ashaba, Scholastic; Sanyu, Naomi; Akatukwasa, Cecilia] Mbarara Univ Sci & Technol, Dept Psychiat, Mbarara, Uganda.
   [Kaida, Angela; Dunkley, Emma] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada.
   [Coleman, Jessica N.; Psaros, Christina] Massachusetts Gen Hosp, Dept Psychiat, Behav Med Program, Boston, MA 02114 USA.
   [Burns, Bridget F.; O'Neil, Kasey; Matthews, Lynn T.] Massachusetts Gen Hosp, Div Global Hlth, Boston, MA USA.
   [Kastner, Jasmine] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada.
   [Bangsberg, David R.] Portland State Univ, Oregon Hlth Sci Univ, Sch Publ Hlth, Portland, OR 97207 USA.
   [Matthews, Lynn T.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.
   [Psaros, Christina] Harvard Med Sch, Boston, MA USA.
RP Ashaba, S (reprint author), Mbarara Univ Sci & Technol, Dept Psychiat, Mbarara, Uganda.
EM sashaba@must.ac.ug
FU National institutes of health [R21HD069194 PI AK, K23MH095655 PI LTM,
   R01MH054907 PI DRB, P30AI027763, U01CA066529, K24MH87227 PI DRB,
   K23MH099916 PI CP, R01MH087328 PI DRB, D43TW010128]; Sullivan Family
   Foundation
FX The study was funded by National institutes of health R21HD069194 PI AK,
   K23MH095655 PI LTM, R01MH054907 PI DRB, P30AI027763, U01CA066529,
   K24MH87227 PI DRB, K23MH099916 PI CP, R01MH087328 PI DRB; D43TW010128;
   and the Sullivan Family Foundation. The authors acknowledge U.S salary
   support through National Institute of Health D43TW010128 (SA).The
   funders have no role in the study design, data collection and analysis,
   decision to publish, or preparationof the manuscript.; The authors
   acknowledge U.S salary support through National Institute of Health
   D43TW010128 (SA).
CR Africa IE, 2014, UND PERSP EXP WOM LI
   Africa IE, 2013, UND PERSP EXP WOM LI
   Aggleton P., 2001, CURR SOCIOL, V49, P23, DOI DOI 10.1177/0011392101496005
   Antelman G, 2007, JAIDS-J ACQ IMM DEF, V44, P470, DOI 10.1097/QAI.0b013e31802f1318
   Ashton E, 2005, AIDS PATIENT CARE ST, V19, P587, DOI 10.1089/apc.2005.19.587
   Beauliere A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011213
   Bernstein M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011999
   Bolton P, 2001, J NERV MENT DIS, V189, P238, DOI 10.1097/00005053-200104000-00005
   Bolton P, 2001, CROSS CULTURAL ASSES
   Brou H, 2007, PLOS MED, V4, P1912, DOI 10.1371/journal.pmed.0040342
   Bwirire LD, 2008, T ROY SOC TROP MED H, V102, P1195, DOI 10.1016/j.trstmh.2008.04.002
   Campbell C, 2010, AIDS CARE, V22, P1569, DOI 10.1080/09540121.2010.525812
   Campbell JC, 2008, INT J INJ CONTROL SA, V15, P221, DOI 10.1080/17457300802423224
   Chi BH, 2012, JAIDS-J ACQ IMM DEF, V60, pS78, DOI 10.1097/QAI.0b013e31825f3284
   Chinkonde JR, 2009, REPROD HEALTH MATTER, V17, P143, DOI 10.1016/S0968-8080(09)33440-0
   Clouse K, 2014, JAIDS-J ACQ IMM DEF, V67, pE12, DOI 10.1097/QAI.0000000000000263
   DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102
   Desgrees-du-Lou A, 2009, SOC SCI MED, V69, P892, DOI 10.1016/j.socscimed.2009.05.045
   Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37
   Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4
   Eyal Nir, 2015, 10 INT C HIV TREATM
   Ezechi OC, 2009, ARCH GYNECOL OBSTET, V280, P745, DOI 10.1007/s00404-009-0956-9
   Gielen AC, 2001, SOC SCI MED, V52, P315, DOI 10.1016/S0277-9536(00)00135-0
   Gillespie S, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000300531.74730.72
   HIV/AIDS JUNPo, 2014, THE GAP REP
   HIV/AIDS JUNPo, 2015, THE GAP REP
   Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149
   Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X
   Kaida A, 1999, J ACQUIRED IMMUNE S4, V67, pS179
   Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640
   Kiarie JN, 2006, AIDS, V20, P1763, DOI 10.1097/01.aids.0000242823.51754.0c
   Kim J, 2008, AIDS, V22, pS57, DOI 10.1097/01.aids.0000341777.78876.40
   King R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-530
   Kiula ES, 2013, BMC PUBLIC HEALTH, V13, P1
   Koricho AT, 2010, INT BREASTFEED J, V5, DOI 10.1186/1746-4358-5-12
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Levy NC, 2005, J URBAN HEALTH, V82, P498, DOI 10.1093/jurban/jti090
   Lwanda J., 2002, POLITICS CULTURE MED
   Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331
   Martinez P, 2008, AIDS BEHAV, V12, P605, DOI 10.1007/s10461-007-9312-x
   Matheson R, 2015, J INT AIDS SOC S5, V18
   Matseke G, 2016, J PSYCHOL AFR, V26, P259, DOI 10.1080/14330237.2016.1185912
   Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299
   Medley AM, 2009, QUAL HEALTH RES, V19, P1744, DOI 10.1177/1049732309353417
   Mellins CA, 2008, AIDS CARE, V20, P958, DOI 10.1080/09540120701767208
   Miles M, 1984, QUALITATIVE DATA ANA
   MOH, 2012, UG AIDS IND SURV 201
   Okello ES, 2012, AJAR-AFR J AIDS RES, V11, P37, DOI 10.2989/16085906.2012.671260
   Pereira M, 2012, SPAN J PSYCHOL, V15, P1303, DOI 10.5209/rev_SJOP.2012.v15.n3.39416
   Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252
   Piot P, 2007, PLOS MED, V4, P1571, DOI 10.1371/journal.pmed.0040314
   POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42
   Programme' SAC, 2010, STAT HIV AIDS EP UG
   Quinn TC, 2005, SCIENCE, V308, P1582, DOI 10.1126/science.1112489
   Rahangdale L, 2010, AIDS CARE, V22, P836, DOI 10.1080/09540120903499212
   Ramasundaram S., 2001, AIDS PATIENT CARE ST, V15, P255
   Rotheram-Borus MJ, 2015, AIDS, V29, P2361, DOI 10.1097/QAD.0000000000000837
   Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147
   Sanders LB, 2008, J ASSOC NURSE AIDS C, V19, P47, DOI 10.1016/j.jana.2007.10.002
   Shamu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109447
   Shannon M, 2008, J ASSOC NURSE AIDS C, V19, P114, DOI 10.1016/j.jana.2007.10.004
   Shannon MT, 2015, RES NURS HEALTH, V38, P142, DOI 10.1002/nur.21646
   Spangler SA, 2014, JAIDS-J ACQ IMM DEF, V67, pS235, DOI 10.1097/QAI.0000000000000376
   Stinson K, 2012, AJAR-AFR J AIDS RES, V11, P65, DOI 10.2989/16085906.2012.671263
   Strauss AL, 1998, BASICS QUALITATIVE R
   Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143
   Tsai AC, 2016, SOC SCI MED, V151, P69, DOI 10.1016/j.socscimed.2015.12.042
   Tsai AC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001943
   Tsai AC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001557
   Tsai AC, 2013, ANN BEHAV MED, V46, P285, DOI 10.1007/s12160-013-9514-6
   Tsai AC, 2012, SOC SCI MED, V74, P2012, DOI 10.1016/j.socscimed.2012.02.033
   Turan B, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0400-4
   Turan JM, 2013, AIDS BEHAV, V17, P2528, DOI 10.1007/s10461-013-0446-8
   Turan JM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001295
   Turan JM, 2011, AIDS BEHAV, V15, P1111, DOI 10.1007/s10461-010-9798-5
   Turmen T, 2003, INT J GYNECOL OBSTET, V82, P411, DOI 10.1016/S0020-7292(03)00202-9
   UBOS, 2014, POP REG REP UG ALL C
   Uganda AIDS Indicator Survey (UAIS), 2014, UG HIV AIDS COUNTR P
   UNAIDS, 1998, GEND HIVYAIDS UNAIDS
   van den Borne F., 2003, SERIES HIV AIDS SUBS, V13
   Visser MJ, 2008, AIDS CARE, V20, P1138, DOI 10.1080/09540120701842779
   Vu L, 2012, AIDS BEHAV, V16, P132, DOI 10.1007/s10461-010-9873-y
   Vyavaharkar M, 2010, J ASSOC NURSE AIDS C, V21, P144, DOI 10.1016/j.jana.2009.07.008
   Watson-Jones D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040091
   WHO, 2014, MARCH 2014 2013 CO S
   Winestone LE, 2012, GLOB PUBLIC HEALTH, V7, P149, DOI 10.1080/17441692.2011.621964
   Wolfe WR, 2008, AM J PUBLIC HEALTH, V98, P1865, DOI 10.2105/AJPH.2007.122044
   World Health Organization, 2014, GLOB UPD HLTH SECT R
   World Health Organization, 2009, PMTCT STRAT VIS 2010
   World Health Organization (WHO), 2010, PMTCT STRAT VIS 2010
   Zunner B, 2015, J AFFECT DISORDERS, V174, P619, DOI 10.1016/j.jad.2014.12.017
NR 91
TC 7
Z9 7
U1 2
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 1
PY 2017
VL 12
IS 5
AR e0176256
DI 10.1371/journal.pone.0176256
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET9RJ
UT WOS:000400645000026
PM 28459866
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hylands, M
   Godbout, MP
   Mayer, SK
   Fraser, WD
   Vanasse, A
   Leclair, MA
   Turgeon, AF
   Lauzier, F
   Charbonney, E
   Trottier, V
   Razek, TS
   Roy, A
   D'Aragon, F
   Belley-Cote, E
   Day, AG
   Le Guillan, S
   Sabbagh, R
   Lamontagne, F
AF Hylands, Mathieu
   Godbout, Marie-Pier
   Mayer, Sandeep K.
   Fraser, William D.
   Vanasse, Alain
   Leclair, Marc-Andre
   Turgeon, Alexis F.
   Lauzier, Francois
   Charbonney, Emmanuel
   Trottier, Vincent
   Razek, Tarek S.
   Roy, Andre
   D'Aragon, Frederick
   Belley-Cote, Emilie
   Day, Andrew G.
   Le Guillan, Soazig
   Sabbagh, Robert
   Lamontagne, Francois
TI Vasopressor use following traumatic injury - A single center
   retrospective study
SO PLOS ONE
LA English
DT Article
ID HYPOTENSIVE RESUSCITATION; EMERGENCY-DEPARTMENT; FLUID RESUSCITATION;
   HEMORRHAGIC-SHOCK; MULTIPLE TRAUMA; BRAIN-INJURY; COAGULOPATHY; SYSTEM;
   IMPACT; INDEX
AB Objectives
   Vasopressors are not recommended by current trauma guidelines, but recent reports indicate that they are commonly used. We aimed to describe the early hemodynamic management of trauma patients outside densely populated urban centers.
   Methods
   We conducted a single-center retrospective cohort study in a Canadian regional trauma center. All adult patients treated for traumatic injury in 2013 who died within 24 hours of admission or were transferred to the intensive care unit were included. A systolic blood pressure < 90 mmHg, a mean arterial pressure < 60 mmHg, the use of vasopressors or >= 2 L of intravenous fluids defined hemodynamic instability. Main outcome measures were use of intravenous fluids and vasopressors prior to surgical or endovascular management.
   Results
   Of 111 eligible patients, 63 met our criteria for hemodynamic instability. Of these, 60 (95%) had sustained blunt injury and 22 (35%) had concomitant severe traumatic brain injury. The subgroup of patients referred from a primary or secondary hospital (20 of 63, 32%) had significantly longer transport times (243 vs. 61 min, p < 0.01). Vasopressors, used in 26 patients (41%), were independently associated with severe traumatic brain injury (odds ratio 10.2, 95% CI 2.7-38.5).
   Conclusions
   In this cohort, most trauma patients had suffered multiple blunt injuries. Patients were likely to receive vasopressors during the early phase of trauma care, particularly if they exhibited signs of neurologic injury. While these results may be context-specific, determining the risk-benefit trade-offs of fluid resuscitation, vasopressors and permissive hypotension in specific patients subgroups constitutes a priority for trauma research going forwards.
C1 [Hylands, Mathieu; Godbout, Marie-Pier; Mayer, Sandeep K.] Univ Sherbrooke, Div Gen Surg, Sherbrooke, PQ, Canada.
   [Fraser, William D.; Vanasse, Alain; D'Aragon, Frederick; Belley-Cote, Emilie; Sabbagh, Robert; Lamontagne, Francois] Univ Sherbrooke, Ctr hosp, Ctr Rech, Sherbrooke, PQ, Canada.
   [Fraser, William D.] Univ Sherbrooke, Dept Obstet & Gynecol, Sherbrooke, PQ, Canada.
   [Vanasse, Alain] Univ Sherbrooke, Dept Family Med & Emergency Med, Sherbrooke, PQ, Canada.
   [Leclair, Marc-Andre; Belley-Cote, Emilie; Lamontagne, Francois] Univ Sherbrooke, Dept Med, Sherbrooke, PQ, Canada.
   [Turgeon, Alexis F.] Univ Laval, Dept Anesthesia & Crit Care, Quebec City, PQ, Canada.
   [Turgeon, Alexis F.; Lauzier, Francois; Trottier, Vincent] Univ Quebec, Ctr hosp, Ctr Rech, Quebec City, PQ, Canada.
   [Lauzier, Francois] Univ Laval, Dept Med, Quebec City, PQ, Canada.
   [Charbonney, Emmanuel] Univ Montreal, Dept Crit Care, Montreal, PQ, Canada.
   [Charbonney, Emmanuel] Hop Sacre Coeur, Ctr Rech, Montreal, PQ, Canada.
   [Trottier, Vincent] Univ Laval, Dept Gen Surg, Quebec City, PQ, Canada.
   [Razek, Tarek S.] MUHC Montreal Gen Hosp, Dept Gen Surg, Dept Trauma Surg, Montreal, PQ, Canada.
   [Roy, Andre] Univ Montreal, Dept Physiatry, Montreal, PQ, Canada.
   [Roy, Andre] Univ Montreal, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada.
   [D'Aragon, Frederick] Univ Sherbrooke, Dept Anesthesiol, Sherbrooke, PQ, Canada.
   [Day, Andrew G.] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada.
   [Le Guillan, Soazig] Sacre Coeur Hosp Montreal, Div Traumatol, Div Gen Surg, Montreal, PQ, Canada.
   [Sabbagh, Robert] Univ Sherbrooke, Dept Urol, Sherbrooke, PQ, Canada.
RP Lamontagne, F (reprint author), Univ Sherbrooke, Ctr hosp, Ctr Rech, Sherbrooke, PQ, Canada.; Lamontagne, F (reprint author), Univ Sherbrooke, Dept Med, Sherbrooke, PQ, Canada.
EM Francois.Lamontagne@usherbrooke.ca
FU Department of Surgery of the CIUSSS de l'Estrie CHUS [FRChir-1403,
   FRChir-1524]
FX This study was supported by the Department of Surgery of the CIUSSS de
   l'Estrie CHUS (grant numbers FRChir-1403, FRChir-1524). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9
   Beloncle F, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-13
   BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701
   CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017
   CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006
   Cohn SM, 2011, WORLD J SURG, V35, P430, DOI 10.1007/s00268-010-0875-8
   Dutton RP, 2002, J TRAUMA, V52, P1141, DOI 10.1097/00005373-200206000-00020
   Hill AD, 2014, J TRAUMA ACUTE CARE, V77, P608, DOI 10.1097/TA.0000000000000412
   Jones AE, 2009, CRIT CARE MED, V37, P1649, DOI 10.1097/CCM.0b013e31819def97
   Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19
   KOEHLER JJ, 1986, ANN EMERG MED, V15, P178, DOI 10.1016/S0196-0644(86)80016-6
   Kristiansen T, 2010, INJURY, V41, P444, DOI 10.1016/j.injury.2009.05.027
   Kwan I, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002245.pub2
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lavoie A, 2013, ETMIS, V9, P1
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003
   McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031
   Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea
   Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2
   Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343
   Palm K, 2012, J TRAUMA ACUTE CARE, V73, pS465, DOI 10.1097/TA.0b013e31827548a9
   Palm K, 2012, J TRAUMA ACUTE CARE, V73, pS459, DOI 10.1097/TA.0b013e3182754887
   Palmer C, 2007, ANN P ASS ADV AUT ME
   Plurad DS, 2011, J TRAUMA, V71, P565, DOI 10.1097/TA.0b013e3182213d52
   RADY MY, 1992, AM J EMERG MED, V10, P538, DOI 10.1016/0735-6757(92)90178-Z
   REGEL G, 1995, J TRAUMA, V38, P70, DOI 10.1097/00005373-199501000-00020
   Rotondo MF, 2012, ATLS ADV TRAUMA LIFE
   Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685
   Sperry JL, 2008, J TRAUMA, V64, P9, DOI 10.1097/TA.0b013e31815dd029
   Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae
   Tien HC, 2007, J TRAUMA, V62, P142, DOI 10.1097/01.ta.0000251558.38388.47
   Wang CH, 2014, CRIT CARE MED, V42, P954, DOI 10.1097/CCM.0000000000000050
   Yin W, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-S1-S6
NR 34
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 27
PY 2017
VL 12
IS 4
AR e0176587
DI 10.1371/journal.pone.0176587
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET6EL
UT WOS:000400383600108
PM 28448605
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Pedroso, J
   Toral, N
   Gubert, MB
AF Pedroso, Jessica
   Toral, Natacha
   Gubert, Muriel Bauermann
TI Maternal perception of children's nutritional status in the Federal
   District, Brazil
SO PLOS ONE
LA English
DT Article
ID SELF-REPORTED WEIGHT; MOTHERS PERCEPTIONS; FEEDING PRACTICES;
   DETERMINANTS; ASSOCIATION; OVERWEIGHT; CHILDHOOD; VALIDITY; OBESITY;
   HEIGHT
AB Maternal perception of child's nutritional status has a potential impact on the identification, prevention, and treatment of childhood overweight. Thus, the aim of this study was to evaluate the prevalence of misperception and factors associated with maternal perception of the nutritional status of first-to third-grade elementary school students from private schools in the Federal District, Brazil. This cross- sectional study was conducted with 554 mother-child pairs. Children's nutritional status was assessed by measuring their weight and height. The mothers completed an online questionnaire about sociodemographic data, maternal nutritional status, maternal perception of her own nutritional status (silhouette scale for female adults), and maternal perception of child's nutritional status (silhouette scale for children). Only 30.0% of the mothers were successful in choosing the most appropriate silhouette to represent child's nutritional status. Highly educated mothers (Adjusted OR = 1.51) and mothers of male children (Adjusted OR = 2.53) or of non-overweight children (Adjusted OR = 1.65) were more likely to underestimate child's nutritional status. Conversely, mothers below 35 years of age (Adjusted OR = 1.85) and mothers of female children (Adjusted OR = 2.24) or of overweight children (Adjusted OR = 1.94) were more likely to overestimate child's nutritional status. There was a high prevalence of misperception, which shows the need for interventions for children that take into account the relevance of mother's role and the adequate recognition of child's nutritional status.
C1 [Pedroso, Jessica; Toral, Natacha; Gubert, Muriel Bauermann] Univ Brasilia, Postgrad Program Human Nutr, Brasilia, DF, Brazil.
RP Pedroso, J (reprint author), Univ Brasilia, Postgrad Program Human Nutr, Brasilia, DF, Brazil.
EM jessicapedroso1211@gmail.com
OI Pedroso, Jessica/0000-0001-5446-4319
CR Alm S, 2015, APPETITE, V89, P112, DOI 10.1016/j.appet.2015.02.002
   Rivera JA, 2014, LANCET DIABETES ENDO, V2, P321, DOI 10.1016/S2213-8587(13)70173-6
   Aparicio G, 2013, ATENCION PRIMARIA S2, V45
   Arpini LdSB, 2014, REV BRASILEIRA PESQU, V16, P140
   Bernardo Carla de O., 2012, Rev. bras. epidemiol., V15, P651, DOI 10.1590/S1415-790X2012000300018
   Binkin N, 2013, NUTR METAB CARDIOVAS, V23, P410, DOI 10.1016/j.numecd.2011.09.006
   Molina MDB, 2009, CAD SAUDE PUBLICA, V25, P2285, DOI 10.1590/S0102-311X2009001000018
   Camara Interministerial de Seguranca Alimentar e Nutricional, 2014, ESTR INT PREV CONTR
   Conde WL, 2014, AM J CLIN NUTR, V100, p1617S, DOI 10.3945/ajcn.114.084764
   da Fonseca MDJM, 2004, REV SAUDE PUBL, V38, P392
   Francescatto C, 2014, J PEDIAT-BRAZIL, V90, P332, DOI 10.1016/j.jped.2014.01.009
   Giacomossi MC, REV NUTR
   Peixoto MDG, 2006, REV SAUDE PUBL, V40, P1065, DOI 10.1590/S0034-89102006000700015
   Guevara-Cruz M, 2012, NUTR HOSP, V27, P209, DOI [10.1590/S0212-16112012000100026, 10.3305/nh.2012.27.1.5411]
   Hochdorn A, 2016, J HLTH PSYCHOL  1106
   Hochdorn A, 2014, INDIAN J PEDIATR, V81, pS39, DOI 10.1007/s12098-014-1464-x
   Instituto Brasileiro de Geografia e Estat A o stica, 2010, CENS DEM 2010 ED
   Instituto Brasileiro de Geografia e Estat o A stica, 2010, PESQ ORC FAM 2008 20
   Instituto Brasileiro de Geografia e Estatistica, 2010, CENS DEM 2010 CAR GE
   Kakeshita Idalina Shiraishi, 2009, Psic.: Teor. e Pesq., V25, P263, DOI 10.1590/S0102-37722009000200015
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Larsen PS, 2015, HARVARD REV PSYCHIAT, V23, P395, DOI 10.1097/HRP.0000000000000073
   Lazzeri G, 2006, J Prev Med Hyg, V47, P16
   LdSB Arpini, 2015, DEMETRA, V10, P891
   Loth KA, 2013, APPETITE, V60, P140, DOI 10.1016/j.appet.2012.09.019
   Manios Y, 2010, J AM DIET ASSOC, V110, P1527, DOI 10.1016/j.jada.2010.07.004
   McCabe MP, 2005, J APPL DEV PSYCHOL, V26, P559, DOI 10.1016/j.appdev.2005.06.007
   Ministerio da Educac, 2015, CART NAC AL ESC
   Ministerio da Saude Ministerio da Educac, 2015, CAD GEST PROGR SAUD
   Ministerio da Saude Nacional de Saude Supplementar, 2015, VIG FAT RISC PROT DO
   Moraes Andr Guerra Esteves de, 2014, Nova econ., V24, P409, DOI 10.1590/0103-6351/1564
   Parkinson KN, 2013, CHILD CARE HLTH DEV, V39, P722, DOI 10.1111/cch.12000
   Rietmeijer-Mentink M, 2013, MATERN CHILD NUTR, V9, P3, DOI 10.1111/j.1740-8709.2012.00462.x
   Rosas LG, 2010, MATERN CHILD HLTH J, V14, P886, DOI 10.1007/s10995-009-0534-6
   Sahoo Krushnapriya, 2015, J Family Med Prim Care, V4, P187, DOI 10.4103/2249-4863.154628
   Scaglioni S, 2011, AM J CLIN NUTR, V94, p2006S, DOI 10.3945/ajcn.110.001685
   Trude ACB, PRATICA ATIVIDADE FI
   Warschburger P, 2009, PEDIATRICS, V124, pE60, DOI 10.1542/peds.2008-1845
   Webber L, 2010, AM J CLIN NUTR, V92, P1423, DOI 10.3945/ajcn.2010.30112
   World Health Organization, 2007, GROWTH REF DAT 5 19
   World Health Organization, 2009, ANTHROPLUS PERS COMP
   World Health Organization, 1997, WHO TECHN REP SER
   World Health Organization (WHO), 2016, OB OV
NR 43
TC 4
Z9 4
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 26
PY 2017
VL 12
IS 4
AR e0176344
DI 10.1371/journal.pone.0176344
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET5FI
UT WOS:000400309200047
PM 28445494
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Peters, M
   Scharmga, A
   de Jong, J
   van Tubergen, A
   Geusens, P
   Arts, JJ
   Loeffen, D
   Weijers, R
   van Rietbergen, B
   van den Bergh, J
AF Peters, M.
   Scharmga, A.
   de Jong, J.
   van Tubergen, A.
   Geusens, P.
   Arts, J. J.
   Loeffen, D.
   Weijers, R.
   van Rietbergen, B.
   van den Bergh, J.
TI An automated algorithm for the detection of cortical interruptions on
   high resolution peripheral quantitative computed tomography images of
   finger joints
SO PLOS ONE
LA English
DT Article
ID RHEUMATOID-ARTHRITIS PATIENTS; BONE EROSIONS; MICRO-CT; HR-PQCT;
   MICROARCHITECTURE; QUALITY; QUANTIFICATION; SEGMENTATION; RADIOGRAPHY;
   REPAIR
AB Objectives To introduce a fully-automated algorithm for the detection of small cortical interruptions (>= 0.246mm in diameter) on high resolution peripheral quantitative computed tomography (HR-pQCT) images, and to investigate the additional value of manual correction of the automatically obtained contours (semi-automated procedure).
   Methods Ten metacarpophalangeal joints from seven patients with rheumatoid arthritis (RA) and three healthy controls were imaged with HR-pQCT. The images were evaluated by an algorithm according to the fully-and semi-automated procedure for the number and surface of interruptions per joint. Reliability between the fully-and semi-automated procedure and between two independent operators was tested using intra-class correlation coefficient (ICC) and the proportion of matching interruptions. Validity of single interruptions detected was tested by comparing it to visual scoring, as gold standard. The positive predictive value (PPV) and sensitivity were calculated.
   Results The median number of interruptions per joint was 14 (range 2 to 59) and did not significantly differ between the fully-and semi-automated procedure (p = 0.37). The median interruption surface per joint was significantly higher with the fully-vs. semi-automated procedure (respectively, 8.6mm(2) vs. 5.8mm(2) and 6.1mm(2), p = 0.01). Reliability was almost perfect between the fully-and semi-automated procedure for both the number and surface of interruptions (ICC >= 0.95) and the proportion of matching interruptions was high (>= 76%). Also the inter-operator reliability was almost perfect (ICC >= 0.97, proportion of matching interruptions 92%). The PPV ranged from 27.6% to 29.9%, and sensitivity from 69.7% to 76.3%. Most interruptions detected with the algorithm, did show an interruption on a 2D grayscale image. However, this interruption did not meet the criteria of an interruption with visual scoring.
   Conclusion The algorithm for HR-pQCT images detects cortical interruptions, and its interruption surface. Reliability and validity was comparable for the fully- and semi-automated procedures. However, we advise the use of the semi-automated procedure to assure quality. The algorithm is a promising tool for a sensitive and objective assessment of cortical interruptions in finger joints assessed by HR-pQCT.
C1 [Peters, M.; Scharmga, A.; van Tubergen, A.; Geusens, P.; van den Bergh, J.] Maastricht Univ, Med Ctr, Div Rheumatol, Dept Internal Med, Maastricht, Netherlands.
   [Peters, M.; Scharmga, A.; van Tubergen, A.; Geusens, P.] Maastricht Univ, Sch Publ Hlth & Primary Care, CAPHRI, Maastricht, Netherlands.
   [Peters, M.; Scharmga, A.; van den Bergh, J.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands.
   [de Jong, J.; Loeffen, D.; Weijers, R.] Maastricht Univ, Dept Radiol, Med Ctr, Maastricht, Netherlands.
   [Geusens, P.; van den Bergh, J.] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium.
   [Arts, J. J.; van Rietbergen, B.] Maastricht Univ, Dept Orthopaed Surg, Med Ctr, Maastricht, Netherlands.
   [Arts, J. J.; van Rietbergen, B.] Eindhoven Univ Technol, Fac Biomed Engn, Eindhoven, Netherlands.
   [van den Bergh, J.] VieCuri Med Ctr, Dept Internal Med, Venlo, Netherlands.
RP Peters, M (reprint author), Maastricht Univ, Med Ctr, Div Rheumatol, Dept Internal Med, Maastricht, Netherlands.; Peters, M (reprint author), Maastricht Univ, Sch Publ Hlth & Primary Care, CAPHRI, Maastricht, Netherlands.; Peters, M (reprint author), Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands.
EM michiel.peters@maastrichtuniversity.nl
OI van den Bergh, Joop/0000-0003-3984-2232; Arts,
   Jacobus/0000-0002-2947-8564
FU Weijerhorst Foundation (JvdB); Pfizer [WS2056904]
FX This work was supported by: Weijerhorst Foundation (JvdB),
   http//www.deweijerhorst.nl/ weijerhorst/home. funding that was used to
   purchase the HR-pQCT scanner and pay half of the PhD student salaries of
   MP and AS. It was also supported by Pfizer (PG), grant number:
   WS2056904, http//www.pfizer.nl/. This funding was used to perform our
   study (NL42300.068.12 / METC 12-2-037) of HR-pQCT imaging in patients
   with RA compared to conventional imaging techniques.
CR Albrecht A, 2013, ANN RHEUM DIS, V72, P1351, DOI 10.1136/annrheumdis-2012-201982
   Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584
   Aschenberg S, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4235
   Baillet A, 2011, RHEUMATOLOGY, V50, P1137, DOI 10.1093/rheumatology/keq437
   Barnabe C, 2013, CLIN EXP RHEUMATOL, V31, P243
   Barnabe C, 2016, J RHEUMATOL, V43, P1935, DOI 10.3899/jrheum.160648
   Buie HR, 2007, BONE, V41, P505, DOI 10.1016/j.bone.2007.07.007
   Burghardt AJ, 2010, BONE, V47, P519, DOI 10.1016/j.bone.2010.05.034
   Dohn UM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2378
   Ejbjerg B, 2004, ARTHRITIS RHEUM, V50, P1097, DOI 10.1002/art.20135
   Finzel S, 2013, ANN RHEUM DIS, V72, P396, DOI 10.1136/annrheumdis-2011-201075
   Finzel S, 2011, ANN RHEUM DIS, V70, P1587, DOI 10.1136/ard.2010.148395
   Finzel S, 2011, ARTHRITIS RHEUM-US, V63, P1231, DOI 10.1002/art.30285
   Finzel S, 2011, ANN RHEUM DIS, V70, P122, DOI 10.1136/ard.2010.132423
   Fouque-Aubert A, 2010, ANN RHEUM DIS, V69, P1671, DOI 10.1136/ard.2009.114512
   Geusens P, 2014, NAT REV RHEUMATOL, V10, P304, DOI 10.1038/nrrheum.2014.23
   Geusens P, 2014, RHEUMATOLOGY, V53, P4, DOI 10.1093/rheumatology/ket358
   Hulsmans HMJ, 2000, ARTHRITIS RHEUM, V43, P1927, DOI 10.1002/1529-0131(200009)43:9<1927::AID-ANR3>3.0.CO;2-B
   Kocijan R, 2014, J BONE MINER RES, V29, P1005, DOI 10.1002/jbmr.2109
   Laib A, 1998, Technol Health Care, V6, P329
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lillegraven S, 2012, NAT REV RHEUMATOL, V8, P117, DOI 10.1038/nrrheum.2011.202
   Liu XS, 2010, J BONE MINER RES, V25, P746, DOI 10.1359/jbmr.090822
   MacNeil JA, 2007, MED ENG PHYS, V29, P1096, DOI 10.1016/j.medengphy.2006.11.002
   Pialat JB, 2012, BONE, V50, P111, DOI 10.1016/j.bone.2011.10.003
   Scharmga A, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1148-y
   Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153
   Srikhum W, 2013, J RHEUMATOL, V40, P408, DOI 10.3899/jrheum.120780
   Stach CM, 2010, ARTHRITIS RHEUM-US, V62, P330, DOI 10.1002/art.27252
   Topfer D, 2014, RHEUMATOLOGY, V53, P65, DOI 10.1093/rheumatology/ket259
   VANDERHEIJDE DMFM, 1992, BRIT J RHEUMATOL, V31, P519
   Zebaze R, 2015, J BONE MINER RES, V30, P24, DOI 10.1002/jbmr.2419
NR 32
TC 5
Z9 5
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 20
PY 2017
VL 12
IS 4
AR e0175829
DI 10.1371/journal.pone.0175829
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ES9KM
UT WOS:000399875900055
PM 28426705
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU van Manen, L
   Stegehuis, PL
   Farina-Sarasqueta, A
   de Haan, LM
   Eggermont, J
   Bonsing, BA
   Morreau, H
   Lelieveldt, BPF
   van de Velde, CJH
   Vahrmeijer, AL
   Dijkstra, J
   Mieog, JSD
AF van Manen, Labrinus
   Stegehuis, Paulien L.
   Farina-Sarasqueta, Arantza
   de Haan, Lorraine M.
   Eggermont, Jeroen
   Bonsing, Bert A.
   Morreau, Hans
   Lelieveldt, Boudewijn P. F.
   van de Velde, Cornelis J. H.
   Vahrmeijer, Alexander L.
   Dijkstra, Jouke
   Mieog, J. Sven D.
TI Validation of full-field optical coherence tomography in distinguishing
   malignant and benign tissue in resected pancreatic cancer specimens
SO PLOS ONE
LA English
DT Article
ID DUCTAL ADENOCARCINOMA; R1 RESECTIONS; IN-VIVO; PANCREATICODUODENECTOMY;
   MARGINS; INVOLVEMENT; MICROSCOPY; MORBIDITY; SURVIVAL; ORIGIN
AB Background
   Pancreatic cancer is the fourth leading cause of cancer-related mortality in the United States. The minority of patients can undergo curative-intended surgical therapy due to progressive disease stage at time of diagnosis. Nonetheless, tumor involvement of surgical margins is seen in up to 70% of resections, being a strong negative prognostic factor. Real-time intraoperative imaging modalities may aid surgeons to obtain tumor-free resection margins. Full-field optical coherence tomography (FF-OCT) is a promising diagnostic tool using high-resolution white-light interference microscopy without tissue processing. Therefore, we composed an atlas of FF-OCT images of malignant and benign pancreatic tissue, and investigated the accuracy with which the pathologists could distinguish these.
   Materials and methods
   One hundred FF-OCT images were collected from specimens of 29 patients who underwent pancreatic resection for various indications between 2014 and 2016. One experienced gastrointestinal pathologist and one pathologist in training scored independently the FF-OCT images as malignant or benign blinded to the final pathology conclusion.
   Results
   were compared to those obtained with standard hematoxylin and eosin (H&E) slides. Results Overall, combined test characteristics of both pathologists showed a sensitivity of 72%, specificity of 74%, positive predictive value of 69%, negative predictive value of 79% and an overall accuracy of 73%. In the subset of pancreatic ductal adenocarcinoma patients, 97% of the FF-OCT images (n = 35) were interpreted as tumor by at least one pathologist. Moreover, normal pancreatic tissue was recognised in all cases by at least one pathologist. However, atrophy and fibrosis, serous cystadenoma and neuroendocrine tumors were more often wrongly scored, in 63%, 100% and 25% respectively.
   Conclusion
   FF-OCT could distinguish normal pancreatic tissue from pathologic pancreatic tissue in both processed as non-processed specimens using architectural features. The accuracy in pancreatic ductal adenocarcinoma is promising and warrants further evaluation using improved assessment criteria.
C1 [van Manen, Labrinus; Stegehuis, Paulien L.; Bonsing, Bert A.; van de Velde, Cornelis J. H.; Vahrmeijer, Alexander L.; Mieog, J. Sven D.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands.
   [Stegehuis, Paulien L.; Eggermont, Jeroen; Lelieveldt, Boudewijn P. F.; Dijkstra, Jouke] Leiden Univ, Med Ctr, Div Image Proc, Dept Radiol, Leiden, Netherlands.
   [Farina-Sarasqueta, Arantza; de Haan, Lorraine M.; Morreau, Hans] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands.
RP Mieog, JSD (reprint author), Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands.
EM i.s.d.mieog@lumc.nl
RI Lelieveldt, Boudewijn/B-6501-2008
OI Lelieveldt, Boudewijn/0000-0001-8269-7603; Farina Sarasqueta,
   Aranzazu/0000-0002-6173-592X
FU European Union [FP7-ICT2011-8]; Bas Mulder Award [UL2015-7665]; Alpe
   d'HuZes foundation/Dutch Cancer Society; CARelOCA project [318729]
FX This work was funded by the European Union Seventh Framework Program
   FP7-ICT2011-8 under grant agreement number 318729 (CARelOCA project) and
   by the Bas Mulder Award (grant UL2015-7665) from the Alpe d'HuZes
   foundation/Dutch Cancer Society.
CR Apelian C, 2016, BIOMED OPT EXPRESS, V7, P1511, DOI 10.1364/BOE.7.001511
   Assayag O, 2014, TECHNOL CANCER RES T, V13, P455, DOI [10.7785/tcrt.2013.600254, 10.7785/tcrtexpress.2013.600254]
   Binding J, 2011, OPT EXPRESS, V19, P4833, DOI 10.1364/OE.19.004833
   Boonstra MC, 2015, INT J CANCER, V137, P1910, DOI 10.1002/ijc.29571
   Bredfeldt Jeremy S, 2014, J Pathol Inform, V5, P28, DOI 10.4103/2153-3539.139707
   Campbell F, 2009, HISTOPATHOLOGY, V55, P277, DOI 10.1111/j.1365-2559.2009.03376.x
   de Geus SW, 2016, MOL IMAGING BIOL
   Delpero JR, 2014, HPB, V16, P20, DOI 10.1111/hpb.12061
   Drifka CR, 2015, MODERN PATHOL, V28, P1470, DOI 10.1038/modpathol.2015.97
   Dubois A, 2004, APPL OPTICS, V43, P2874, DOI 10.1364/AO.43.002874
   Dubois A, 2002, APPL OPTICS, V41, P805, DOI 10.1364/AO.41.000805
   Dubois A., 2012, SELECTED TOPICS OPTI, P3
   Eberlin LS, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002108
   Erickson-Bhatt SJ, 2015, CANCER RES, V75, P3706, DOI 10.1158/0008-5472.CAN-15-0464
   Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115
   Esposito I, 2008, ANN SURG ONCOL, V15, P1651, DOI 10.1245/s10434-008-9839-8
   Grieve K, 2005, OPT EXPRESS, V13, P6286, DOI 10.1364/OPEX.13.006286
   Grieve K, 2015, GASTROINTEST ENDOSC, V81, P342, DOI 10.1016/j.gie.2014.06.037
   Handgraaf HJM, 2014, BIOMED RES INT, DOI 10.1155/2014/890230
   Hruban RH, 2007, MODERN PATHOL, V20, pS61, DOI 10.1038/modpathol.3800685
   Hu WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037962
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   Hutteman M, 2011, EUR SURG RES, V47, P90, DOI 10.1159/000329411
   Jamieson NB, 2010, ANN SURG, V251, P1003, DOI 10.1097/SLA.0b013e3181d77369
   la Guillaume EBA, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.2.026005
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lopater J, 2015, WORLD J UROLOGY
   Nelson DW, 2013, AM J SURG, V205, P613, DOI 10.1016/j.amjsurg.2013.01.015
   Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275
   Neoptolemos JP, 2017, LANCET
   Nitschke P, 2016, ANN SURG
   Peters I. T. A., 2016, CLIN CANC RES
   Reddy S, 2009, ANN SURG, V250, P282, DOI 10.1097/SLA.0b013e3181ae9f93
   Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332
   Tao YK, 2014, P NATL ACAD SCI USA, V111, P15304, DOI 10.1073/pnas.1416955111
   Tran KTC, 2004, ANN SURG, V240, P738, DOI 10.1097/01.sla.0000143248.71964.29
   Vakoc BJ, 2012, NAT REV CANCER, V12, P363, DOI 10.1038/nrc3235
   van der Vorst JR, 2012, WORLD J GASTRO SURG, V4, P180, DOI 10.4240/wjgs.v4.i7.180
   Verbeke CS, 2012, BRIT J SURG, V99, P1036, DOI 10.1002/bjs.8734
   Wagner M, 2004, BRIT J SURG, V91, P586, DOI 10.1002/bjs.4484
   Yang C, 2016, PROC SPIE, V9689, DOI 10.1117/12.2210955
   Yeo CJ, 1999, ANN SURG, V229, P613, DOI 10.1097/00000658-199905000-00003
NR 42
TC 2
Z9 2
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 17
PY 2017
VL 12
IS 4
AR e0175862
DI 10.1371/journal.pone.0175862
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ES9KD
UT WOS:000399874800069
PM 28414765
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kishi, A
   Van Dongen, HPA
   Natelson, BH
   Bender, AM
   Palombini, LO
   Bittencourt, L
   Tufik, S
   Ayappa, I
   Rapoport, DM
AF Kishi, Akifumi
   Van Dongen, Hans P. A.
   Natelson, Benjamin H.
   Bender, Amy M.
   Palombini, Luciana O.
   Bittencourt, Lia
   Tufik, Sergio
   Ayappa, Indu
   Rapoport, David M.
TI Sleep continuity is positively correlated with sleep duration in
   laboratory nighttime sleep recordings
SO PLOS ONE
LA English
DT Article
ID STAGE TRANSITIONS; LONG; PERFORMANCE; PHYSIOLOGY; DYNAMICS; DEPRIVATION;
   GUIDELINES; PRESSURE; QUALITY; MODEL
AB Sleep duration varies widely across individuals and appears to be trait-like. Differences in the stability of underlying sleep processes may underlie this phenomenon. To investigate underlying mechanisms, we examined the relationship between sleep duration and sleep continuity in baseline polysomnography (PSG) recordings from three independently collected datasets: 1) 134 healthy controls (ages 37 +/- 13 years) from the Sao Paulo Epidemiologic Sleep Study, who spent one night in a sleep laboratory, 2) 21 obstructive sleep apnea (OSA) patients who were treated with continuous positive airway pressure for at least 2 months (45 +/- 12 years, respiratory disturbance index <15), who spent one night in a sleep laboratory with previous experience of multiple PSG studies, and 3) 62 healthy controls (28 +/- 6 years) who, as part of larger experiments, spent 2 consecutive nights in a sleep laboratory. For each dataset, we used total sleep time (TST) to separate subjects into those with shorter sleep (S-TST) and those with longer sleep (L-TST). In all three datasets, survival curves of continuous sleep segments showed greater sleep continuity in L-TST than in S-TST. Correlation analyses with TST as a continuous variable corroborated the results; and the results also held true after controlling for age. There were no significant differences in baseline waking performance and sleepiness between S-TST and L-TST. In conclusion, in both healthy controls and treated OSA patients, sleep continuity was positively correlated with sleep duration. These findings suggest that S-TST may differ from L-TST in processes underlying sleep continuity, shedding new light on mechanisms underlying individual differences in sleep duration.
C1 [Kishi, Akifumi; Ayappa, Indu; Rapoport, David M.] NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY USA.
   [Kishi, Akifumi; Natelson, Benjamin H.] Beth Israel Deaconess Med Ctr, Pain & Fatigue Study Ctr, New York, NY 10003 USA.
   [Kishi, Akifumi; Natelson, Benjamin H.] Albert Einstein Coll Med, New York, NY USA.
   [Kishi, Akifumi] Univ Tokyo, Grad Sch Educ, Tokyo, Japan.
   [Van Dongen, Hans P. A.; Bender, Amy M.] Washington State Univ, Sleep & Performance Res Ctr, Spokane, WA USA.
   [Palombini, Luciana O.; Bittencourt, Lia; Tufik, Sergio] Univ Fed Sao Paulo, Dept Psicobiol, Discipline Med & Biol Sono, Sao Paulo, SP, Brazil.
   [Natelson, Benjamin H.] Mt Sinai Beth Israel, Dept Neurol, New York, NY USA.
   [Natelson, Benjamin H.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA.
   [Ayappa, Indu; Rapoport, David M.] Icahn Sch Med Mt Sinai, Div Pulm Crit Care & Sleep Med, Dept Med, New York, NY 10029 USA.
RP Kishi, A (reprint author), NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY USA.; Kishi, A (reprint author), Beth Israel Deaconess Med Ctr, Pain & Fatigue Study Ctr, New York, NY 10003 USA.; Kishi, A (reprint author), Albert Einstein Coll Med, New York, NY USA.; Kishi, A (reprint author), Univ Tokyo, Grad Sch Educ, Tokyo, Japan.
EM kishi@p.u-tokyo.ac.jp
RI Bittencourt, Lia/C-6551-2012
OI Bittencourt, Lia/0000-0001-7738-0927; Rapoport,
   David/0000-0002-4855-2600
FU JSPS KAKENHI [15K16416]; Foundation for Research in Sleep Disorders;
   Georg Waechter Foundation; NIH [R01HL70154, R01HL81310]; ONR
   [N00014-13-1-0302]; AFIP; FAPESP [98/14303-3]; the Japan Society for the
   Promotion of Science; CNPq fellowships
FX This work was supported in part by JSPS KAKENHI Grant Number 15K16416,
   grants from the Foundation for Research in Sleep Disorders and the Georg
   Waechter Foundation to A.K., NIH grant R01HL70154 and ONR grant
   N00014-13-1-0302 to H.V.D., NIH grant R01HL81310 to I.A., and AFIP and
   FAPESP (CEPID no. 98/14303-3) grants to L.O.P., L.B. and S.T. In
   addition, A.K. received a Postdoctoral Fellowship for Research Abroad
   from the Japan Society for the Promotion of Science, and L.B. and S.T.
   received CNPq fellowships. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript
CR Aeschbach D, 2003, J CLIN ENDOCR METAB, V88, P26, DOI 10.1210/jc.2002-020827
   Aeschbach D, 2001, NEUROSCIENCE, V102, P493, DOI 10.1016/S0306-4522(00)00518-2
   Aeschbach D, 1996, AM J PHYSIOL-REG I, V270, pR41
   American Academy of Sleep Medicine, 2005, INTERNATIONAL CLASSI
   Ayappa I, 2000, SLEEP, V23, P763, DOI 10.1093/sleep/23.6.763
   Bender AM, 2012, THESIS
   Borbely A A, 1982, Hum Neurobiol, V1, P195
   BRENDEL DH, 1990, PSYCHOPHYSIOLOGY, V27, P677, DOI 10.1111/j.1469-8986.1990.tb03193.x
   CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519
   CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P
   Chen CY, 2013, SLEEP MED, V14, P1076, DOI 10.1016/j.sleep.2013.06.011
   Chu-Shore J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014204
   Comte JC, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.056127
   DAAN S, 1984, AM J PHYSIOL, V246, pR161
   de Castro JM, 2002, PHYSIOL BEHAV, V76, P479, DOI 10.1016/S0031-9384(02)00699-6
   DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977
   Fernandez-Mendoza J, 2010, SLEEP, V33, P459, DOI 10.1093/sleep/33.4.459
   FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1
   Flemons WW, 1999, SLEEP, V22, P667
   GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.1093/biomet/52.1-2.203
   Grant DA, 2013, GENETIC BASIS OF SLEEP AND SLEEP DISORDERS, P189
   Gumenyuk V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059007
   Iber C, 2007, AASM MANUAL SCORING
   JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540
   Kishi A, 2008, AM J PHYSIOL-REG I, V294, pR1980, DOI 10.1152/ajpregu.00925.2007
   Kishi A, 2011, SLEEP, V34, P1423, DOI 10.5665/SLEEP.1292
   Klerman EB, 2004, SLEEP, V27, P793, DOI 10.1093/sleep/27.4.793
   Klerman EB, 2013, NEUROBIOL AGING, V34, P309, DOI 10.1016/j.neurobiolaging.2012.05.018
   Kuo TBJ, 2008, SLEEP, V31, P311, DOI 10.1093/sleep/31.3.311
   Kushida CA, 2008, J CLIN SLEEP MED, V4, P157
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lo CC, 2002, EUROPHYS LETT, V57, P625, DOI 10.1209/epl/i2002-00508-7
   McCauley P, 2009, J THEOR BIOL, V256, P227, DOI 10.1016/j.jtbi.2008.09.012
   Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002
   Norman RG, 2006, SLEEP, V29, P1625, DOI 10.1093/sleep/29.12.1625
   Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255
   Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895
   PARTINEN M, 1983, SLEEP, V6, P179, DOI 10.1093/sleep/6.3.179
   Rasch B, 2007, PSYCHONEUROENDOCRINO, V32, P884, DOI 10.1016/j.psyneuen.2007.06.007
   Rechtschaffen A, 1968, MANUAL STANDARDIZED
   Rupp TL, 2009, SLEEP, V32, P311, DOI 10.1093/sleep/32.3.311
   Santos-Silva R, 2009, SLEEP MED, V10, P679, DOI 10.1016/j.sleep.2008.11.001
   Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6
   Somiah M, 2012, J CLIN SLEEP MED, V8, P489, DOI 10.5664/jcsm.2138
   Tucker AM, 2007, J SLEEP RES, V16, P170, DOI 10.1111/j.1365-2869.2007.00594.x
   Tucker AM, 2010, SLEEP, V33, P47, DOI 10.1093/sleep/33.1.47
   Van Dongen HPA, 2011, SLEEP, V34, P917, DOI 10.5665/SLEEP.1128
   Van Dongen HPA, 2004, METHOD ENZYMOL, V384, P139
   Van Dongen HPA, 2010, FMCSAMCRRR10062
   WEBB WB, 1970, SCIENCE, V168, P146, DOI 10.1126/science.168.3927.146
   Zhang JH, 2011, SLEEP, V34, P225, DOI 10.1093/sleep/34.2.225
NR 51
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 10
PY 2017
VL 12
IS 4
AR e0175504
DI 10.1371/journal.pone.0175504
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET0LV
UT WOS:000399954800042
PM 28394943
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gouveia, L
   Janvier, A
   Dupuis, F
   Duval, M
   Sultan, S
AF Gouveia, Lucie
   Janvier, Annie
   Dupuis, France
   Duval, Michel
   Sultan, Serge
TI Comparing two types of perspective taking as strategies for detecting
   distress amongst parents of children with cancer: A randomised trial
SO PLOS ONE
LA English
DT Article
ID EMPATHY; PATIENT; SYMPTOMS; PROGRAM; BURNOUT; WOULD; RECOGNITION;
   ADOLESCENTS; AGREEMENT; ACCURACY
AB Objective
   To compare two perspective taking strategies on (i) clinicians' ability to accurately identify negative thoughts and feelings of parents of children with cancer, and (ii) clinician distress.
   Methods
   Sixty-three hematology-oncology professionals and nursing students watched a video featuring parents of children with cancer. Participants were randomly assigned to one of two groups. In the imagine-self group, they were instructed to imagine the feelings and life consequences which they would experience if they were in the parents' position. In the imagine-other group, they were instructed to imagine the feelings and life consequences experienced by the parents. Parent-clinician agreement on thoughts/feelings was evaluated (standard stimulus paradigm). Clinician distress was also assessed.
   Results
   The intervention was effective in manipulating perspective type. The groups did not significantly differ on parent-clinician agreement. Concentrating on personal feelings (imagine-self strategy) did predict lower agreement when controlling for trait empathy. Clinician distress was higher in the imagine-self group.
   Conclusion
   Although the link between perspective type and detection of distress remains unclear, the results suggest that clinicians who highly focus on their own feelings tend to be less accurate on parental distress and experience more distress themselves.
   Practice implications
   This research could potentially improve communication training and burnout prevention.
C1 [Gouveia, Lucie; Janvier, Annie; Dupuis, France; Duval, Michel; Sultan, Serge] St Justine Univ Hosp Ctr UHC, Montreal, PQ, Canada.
   [Gouveia, Lucie; Sultan, Serge] Univ Montreal, Dept Psychol, Montreal, PQ, Canada.
   [Janvier, Annie; Duval, Michel; Sultan, Serge] Univ Montreal, Dept Pediat, Montreal, PQ, Canada.
   [Dupuis, France] Univ Montreal, Fac Nursing, Montreal, PQ, Canada.
RP Gouveia, L (reprint author), St Justine Univ Hosp Ctr UHC, Montreal, PQ, Canada.; Gouveia, L (reprint author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.
EM lucie.gouveia@umontreal.ca
FU FRQSC doctoral scholarship; CHU Sainte-Justine Foundation (Center of
   Psychosocial Oncology)
FX This study was supported by an FRQSC 2015-2018 doctoral scholarship
   awarded to Lucie Gouveia and by the CHU Sainte-Justine Foundation
   (Center of Psychosocial Oncology, Dr. Sultan). These funding sources
   were not involved in the study nor in the preparation of this article.
CR Batson C. D., 2009, HDB IMAGINATION MENT, P267
   BATSON CD, 1987, J PERS, V55, P19, DOI 10.1111/j.1467-6494.1987.tb00426.x
   Batson CD, 2003, PERS SOC PSYCHOL B, V29, P1190, DOI 10.1177/0146167203254600
   Batson CD, 1997, PERS SOC PSYCHOL B, V23, P751, DOI 10.1177/0146167297237008
   Bonvicini KA, 2009, PATIENT EDUC COUNS, V75, P3, DOI 10.1016/j.pec.2008.09.007
   Chidambaram S, 2014, J COMMUNITY SUPPORT, V12, P370, DOI 10.12788/jcso.0080
   COKE JS, 1978, J PERS SOC PSYCHOL, V36, P752, DOI 10.1037/0022-3514.36.7.752
   Coulehan JL, 2001, ANN INTERN MED, V135, P221, DOI 10.7326/0003-4819-135-3-200108070-00022
   DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113
   Davis MH, 2004, PERS SOC PSYCHOL B, V30, P1625, DOI 10.1177/0146167204271183
   Davis MH, 1980, JSAS CATALOG SELECTE, V10, P85, DOI DOI 10.1037//0022-3514.44.1.113
   del Barrio V, 2004, PSYCHOL REP, V95, P257, DOI 10.2466/pr0.95.1.257-262
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Fukui S, 2009, PSYCHO-ONCOLOGY, V18, P1156, DOI 10.1002/pon.1429
   Gery I, 2009, PSYCHIAT RES, V165, P252, DOI 10.1016/j.psychres.2007.11.006
   Gouveia Lucie, 2015, BMC Psychol, V3, P6, DOI 10.1186/s40359-015-0063-6
   GROSS JJ, 1995, PERS INDIV DIFFER, V19, P555, DOI 10.1016/0191-8869(95)00055-B
   Gross JJ, 2013, BERKELEY EXPRESSIVIT
   Guttman H, 2002, COMPR PSYCHIAT, V43, P448, DOI 10.1053/comp.2002.35905
   Haverman L, 2013, J PEDIATR-US, V163, P1140, DOI 10.1016/j.jpeds.2013.06.011
   Hojat M, 2011, ACAD MED, V86, P989, DOI 10.1097/ACM.0b013e31822203d8
   ICKES W, 1993, J PERS, V61, P587, DOI 10.1111/j.1467-6494.1993.tb00783.x
   Ickes W., 2013, OXFORD HDB CLOSE REL, P348
   Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015
   Keller M, 2004, ANN ONCOL, V15, P1243, DOI 10.1093/annonc/mdh318
   Laffan AJ, 2015, J PSYCHOSOC ONCOL, V33, P686, DOI 10.1080/07347332.2015.1082170
   Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42
   Lamothe M, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-15
   Lampic C, 1996, CANCER NURS, V19, P419, DOI 10.1097/00002820-199612000-00002
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624
   Leclair T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159773
   Ljungman L, 2015, PSYCHO-ONCOLOGY, V24, P1792, DOI 10.1002/pon.3856
   Lobchuk MM, 2007, J PAIN SYMPTOM MANAG, V33, P130, DOI 10.1016/j.jpainsymman.2006.07.015
   Lobchuk MM, 2006, ONCOL NURS FORUM, V33, P273, DOI 10.1188/06.ONF.273-282
   Lobchuk MM, 2003, SOC SCI MED, V57, P2379, DOI 10.1016/S0277-9536(03)00132-1
   MARANGONI C, 1995, J PERS SOC PSYCHOL, V68, P854, DOI 10.1037/0022-3514.68.5.854
   Merckaert I, 2008, PSYCHO-ONCOLOGY, V17, P260, DOI 10.1002/pon.1233
   Mullins LL, 2015, FAM RELAT, V64, P176, DOI 10.1111/fare.12104
   Myers MW, 2014, MOTIV EMOTION, V38, P224, DOI 10.1007/s11031-013-9377-y
   NIGHTINGALE SD, 1991, J GEN INTERN MED, V6, P420, DOI 10.1007/BF02598163
   Patel SK, 2011, PSYCHO-ONCOLOGY, V20, P1324, DOI 10.1002/pon.1859
   Pehrson C, 2016, PATIENT EDUC COUNS, V99, P610, DOI 10.1016/j.pec.2015.11.021
   Picard J, 2016, PSYCHOL HEALTH MED, V21, P354, DOI 10.1080/13548506.2015.1054407
   Rogers C., 1959, PSYCHOL STUDY SCI, P184
   Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661
   Ruby P, 2001, NAT NEUROSCI, V4, P546
   Schmid PC, 2010, MOTIV EMOTION, V34, P288, DOI 10.1007/s11031-010-9170-0
   Spinetta JJ, 2002, MED PEDIATR ONCOL, V38, P114, DOI 10.1002/mpo.1283
   Sultan S, 2015, EUROPEAN JOURNAL OF
   Werner A, 2012, PSYCHO-ONCOLOGY, V21, P818, DOI 10.1002/pon.1975
   Wiener L, 2015, PEDIATR BLOOD CANCER, V62, pS419, DOI 10.1002/pbc.25675
   Yagil D, 2015, PATIENT EDUC COUNS, V98, P1631, DOI 10.1016/j.pec.2015.07.008
   Yarnold PR, 1996, PSYCHOL HEALTH MED, V1, P207, DOI DOI 10.1080/13548509608400019
   Zenasni F, 2012, BRIT J GEN PRACT, V62, P346, DOI 10.3399/bjgp12X652193
NR 55
TC 4
Z9 4
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 6
PY 2017
VL 12
IS 4
AR e175342
DI 10.1371/journal.pone.0175342
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ES2QB
UT WOS:000399371900160
PM 28384315
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Rosales-Mayor, E
   Polverino, E
   Raguer, L
   Alcaraz, V
   Gabarrus, A
   Ranzani, O
   Menendez, R
   Torres, A
AF Rosales-Mayor, Edmundo
   Polverino, Eva
   Raguer, Laura
   Alcaraz, Victoria
   Gabarrus, Albert
   Ranzani, Otavio
   Menendez, Rosario
   Torres, Antoni
TI Comparison of two prognostic scores (BSI and FACED) in a Spanish cohort
   of adult patients with bronchiectasis and improvement of the FACED
   predictive capacity for exacerbations
SO PLOS ONE
LA English
DT Article
ID CYSTIC-FIBROSIS BRONCHIECTASIS; PSEUDOMONAS-AERUGINOSA; SEVERITY INDEX;
   MICROBIOLOGY; COLONIZATION; VALIDATION; MORTALITY
AB Bronchiectasis (BE) is a chronic and heterogeneous respiratory disease that requires a multidimensional scoring system to properly assess severity. The aim of this study was to compare the severity stratification by 2 validated scores (BSI and FACED) in a BE cohort and to determine their predictive capacity for exacerbations and hospitalizations. Moreover, we proposed a modified version of FACED which was created to better predict the risk of exacerbations in clinical practice. We performed a prospective cohort study including BE patients > 18 years old with a follow-up period of 1-year. One-hundred eighty-two patients (40% males; mean age 68) were studied. Patients were stratified according to the number of exacerbations during the follow-up, and according to BSI and FACED scores. BSI classified most of our patients as severe 99 (54.4%) or moderate 47 (25.8%), while FACED mainly classified as mild 108 (59.3%) or moderate 61 (33.5%). BSI and FACED showed an area under ROC curve (AUC) for exacerbations of 0.808 and 0.734; and for hospitalizations (due to BE exacerbations) of 0.893 and 0.809, respectively. Subsequently, we modified FACED by adding previous exacerbations (Exa-FACED) and this new score classified patients as mild 48.4%, moderate 34.6% and severe 17.0%, with an improved AUC for exacerbations (0.760) and hospitalizations (0.820). Despite previous validations of BSI and FACED, they classified our patients very differently. As expected, FACED showed poor prognostic capacity for exacerbations. We support the Exa-FACED score to predict the risk future exacerbations for been easy to use in clinical practice.
C1 [Rosales-Mayor, Edmundo; Polverino, Eva; Alcaraz, Victoria; Gabarrus, Albert; Ranzani, Otavio; Torres, Antoni] Hosp Clin Barcelona, Serv Neumol, CIBERES, Fundacio Clin,IDIBAPS, Barcelona, Spain.
   [Raguer, Laura] Univ Barcelona, Fac Med, Barcelona, Spain.
   [Menendez, Rosario] Hosp Univ & Politecn La Fe Valencia, Serv Neumol, Inst Invest Sanitaria La Fe, CIBERES, Valencia, Spain.
RP Torres, A (reprint author), Hosp Clin Barcelona, Serv Neumol, CIBERES, Fundacio Clin,IDIBAPS, Barcelona, Spain.
EM atorres@clinic.cat
RI Ranzani, Otavio T./K-1196-2012; Rosales-Mayor, Edmundo/E-6728-2019;
   Torres, Antoni/H-6128-2017; Menendez, Rosario/G-9723-2016
OI Ranzani, Otavio T./0000-0002-4677-6862; Rosales-Mayor,
   Edmundo/0000-0001-9493-1241; Torres, Antoni/0000-0002-8643-2167;
   Menendez, Rosario/0000-0002-3592-3839; Polverino,
   Eva/0000-0002-4058-5109
FU Ayuda a la Investigacion de la Sociedad Espanola de Neumologia y Cirugia
   Toracica (SEPAR),Espana [106/2012]
FX This work was supported by the Ayuda a la Investigacion Nro.106/2012 de
   la Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR),Espana.The
   funder had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscripts.
CR Angrill J, 2002, THORAX, V57, P15, DOI 10.1136/thorax.57.1.15
   Barker AF, 2002, NEW ENGL J MED, V346, P1383, DOI 10.1056/NEJMra012519
   Chalmers JD, 2014, AM J RESP CRIT CARE, V189, P576, DOI 10.1164/rccm.201309-1575OC
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Chawla K, 2015, J GLOB INFECT DIS, V7, P18, DOI 10.4103/0974-777X.150885
   Davies G, 2006, EUR RESPIR J, V28, P974, DOI 10.1183/09031936.06.00074605
   DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
   EFRON B, 1993, MONOGRAPHS STAT APPL
   Ellis HC, 2016, EUR RESPIR J, V47, P482, DOI 10.1183/13993003.01312-2015
   Finch S, 2015, ANN AM THORAC SOC, V12, P1602, DOI 10.1513/AnnalsATS.201506-333OC
   King PT, 2007, RESP MED, V101, P1633, DOI 10.1016/j.rmed.2007.03.009
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Loebinger MR, 2009, EUR RESPIR J, V34, P843, DOI 10.1183/09031936.00003709
   Macfarlane JG, 2010, THORAX, V65, pA177, DOI 10.1136/thx.2010.151068.41
   Martinez-Garcia MA, 2005, CHEST, V128, P739, DOI 10.1378/chest.128.2.739
   Martinez-Garcia MA, 2016, CHRON RESP DIS
   Martinez-Garcia MA, 2014, EUR RESPIR J, V43, P1357, DOI 10.1183/09031936.00026313
   Martinez-Garcia MA, 2007, CHEST, V132, P1565, DOI 10.1378/chest.07-0490
   McDonnell MJ, 2016, MULTIDIMENSIONAL SEV
   McShane PJ, 2013, AM J RESP CRIT CARE, V188, P647, DOI 10.1164/rccm.201303-0411CI
   Minov J, 2015, Open Respir Med J, V9, P46, DOI 10.2174/1874306401509010046
   NICOTRA MB, 1995, CHEST, V108, P955, DOI 10.1378/chest.108.4.955
   Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120
   Polverino E, 2015, J INFECTION, V71, P28, DOI 10.1016/j.jinf.2015.03.009
   Vendrell M, 2008, ARCH BRONCONEUMOL, V44, P629, DOI 10.1016/S1579-2129(08)60117-2
NR 25
TC 9
Z9 9
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 6
PY 2017
VL 12
IS 4
AR e0175171
DI 10.1371/journal.pone.0175171
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ES2QB
UT WOS:000399371900109
PM 28384311
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lebel, A
   Daepp, MIG
   Block, JP
   Walker, R
   Lalonde, B
   Kestens, Y
   Subramanian, SV
AF Lebel, Alexandre
   Daepp, Madeleine I. G.
   Block, Jason P.
   Walker, Renee
   Lalonde, Benoit
   Kestens, Yan
   Subramanian, S. V.
TI Quantifying the foodscape: A systematic review and meta-analysis of the
   validity of commercially available business data
SO PLOS ONE
LA English
DT Review
ID SECONDARY DATA SOURCES; NEIGHBORHOOD FOOD ENVIRONMENT; BODY-MASS INDEX;
   FIELD VALIDATION; NORTH-CAROLINA; QUALITY; ACCESS; OUTLETS; OBESITY;
   HEALTH
AB This paper reviews studies of the validity of commercially available business (CAB) data on food establishments ("the foodscape"), offering a meta-analysis of characteristics associated with CAB quality and a case study evaluating the performance of commonly-used validity indicators describing the foodscape. Existing validation studies report a broad range in CAB data quality, although most studies conclude that CAB quality is "moderate" to "substantial". We conclude that current studies may underestimate the quality of CAB data. We recommend that future validation studies use density-adjusted and exposure measures to offer a more meaningful characterization of the relationship of data error with spatial exposure.
C1 [Lebel, Alexandre; Lalonde, Benoit] Quebec Heart & Lung Inst, Res Ctr, Evaluat Platform Obes Prevent, Quebec City, PQ, Canada.
   [Lebel, Alexandre] Laval Univ, Grad Sch Urban Planning & Land Management, Quebec City, PQ, Canada.
   [Daepp, Madeleine I. G.] MIT, Dept Urban Studies & Planning, Cambridge, MA 02139 USA.
   [Block, Jason P.] Harvard Med Sch, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA USA.
   [Walker, Renee] Univ Wisconsin, Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA.
   [Kestens, Yan] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada.
   [Kestens, Yan] Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ, Canada.
   [Subramanian, S. V.] Harvard Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA.
RP Lebel, A (reprint author), Quebec Heart & Lung Inst, Res Ctr, Evaluat Platform Obes Prevent, Quebec City, PQ, Canada.; Lebel, A (reprint author), Laval Univ, Grad Sch Urban Planning & Land Management, Quebec City, PQ, Canada.
EM alebel@criucpq.ulaval.ca
OI Daepp, Madeleine/0000-0001-9689-2442
FU Evaluation Platform on Obesity Prevention; Foundation of the Quebec
   Heart and Lung Institute [3207]; Quebec's Funds for Health Research
   [FQS109600]; Robert Wood Johnson Investigator Award in Health Policy
   Research; National Institutes of Health [K23HL111211]; University of
   British Columbia; National Science Foundation Graduate Research
   Fellowship
FX This project was supported by the Evaluation Platform on Obesity
   Prevention and the Foundation of the Quebec Heart and Lung Institute
   (3207). AL is partially funded by the Quebec's Funds for Health Research
   (FQS109600). SVS was partially supported by the Robert Wood Johnson
   Investigator Award in Health Policy Research. JB was supported by a
   career development award from the National Institutes of Health
   (K23HL111211). MD was supported by the Li Tze Fong Fellowship from the
   University of British Columbia and a National Science Foundation
   Graduate Research Fellowship.
CR An RP, 2012, AM J PREV MED, V42, P129, DOI 10.1016/j.amepre.2011.10.012
   Bader MDM, 2013, HLTH PLACE IN PRESS
   Bader MDM, 2010, AM J EPIDEMIOL, V171, P609, DOI 10.1093/aje/kwp419
   Block JP, 2011, AM J EPIDEMIOL, V174, P1108, DOI 10.1093/aje/kwr244
   Burgoine T, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-2
   Chaparro MP, 2014, J EPIDEMIOL COMMUN H, V68, P1027, DOI 10.1136/jech-2014-204034
   Clary CM, 2015, PREV MED, V71, P83, DOI 10.1016/j.ypmed.2014.11.023
   Clary CM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-77
   Cummins S, 2009, PREV MED, V49, P527, DOI 10.1016/j.ypmed.2009.10.007
   Currie J., 2009, EFFECT FAST FOOD RES
   Daniel M, 2010, EUR J EPIDEMIOL, V25, P711, DOI 10.1007/s10654-010-9499-4
   Devillers R, 2010, T GIS, V14, P387, DOI 10.1111/j.1467-9671.2010.01212.x
   Fielding JE, 2011, ARCH INTERN MED, V171, P1171, DOI 10.1001/archinternmed.2011.279
   Fleischhacker SE, 2011, OBES REV, V12, pe460, DOI 10.1111/j.1467-789X.2010.00715.x
   Fleischhacker SE, 2013, AM J PREV MED, V45, P462, DOI 10.1016/j.amepre.2013.06.009
   Fleischhacker SE, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-137
   Fletcher RH, 2012, CLIN EPIDEMIOLOGY ES
   Forsyth Ann, 2010, J Transp Land Use, V3, P43
   Frank LD, 2006, J AM PLANN ASSOC, V72, P75, DOI 10.1080/01944360608976725
   Gustafson AA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-688
   Han E, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-46
   Hosler AS, 2010, AM J PREV MED, V39, P41, DOI 10.1016/j.amepre.2010.03.006
   Inagami S, 2009, J URBAN HEALTH, V86, P683, DOI 10.1007/s11524-009-9379-y
   ISD, 2016, DEP BLS
   Janse AJ, 2004, J CLIN EPIDEMIOL, V57, P653, DOI 10.1016/j.jclinepi.2003.11.013
   Jilcott SB, 2010, J PUBLIC HEALTH MAN, V16, P432, DOI 10.1097/PHH.0b013e3181bdebe4
   Karpyn A, 2010, HEALTH AFFAIR, V29, P473, DOI 10.1377/hlthaff.2009.0740
   Kestens Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041418
   Lake AA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-37
   Lake AA, 2010, HEALTH PLACE, V16, P666, DOI 10.1016/j.healthplace.2010.02.004
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lebel A, 2012, J OBESITY, V2012, P9
   Liese AD, 2013, J NUTR EDUC BEHAV, V45, P435, DOI 10.1016/j.jneb.2013.01.021
   Liese AD, 2010, AM J EPIDEMIOL, V172, P1324, DOI 10.1093/aje/kwq292
   Longacre MR, 2011, J AM DIET ASSOC, V111, P577, DOI 10.1016/j.jada.2011.01.008
   Lytle LA, 2009, AM J PREV MED, V36, pS134, DOI 10.1016/j.amepre.2009.01.018
   Ma X, APPL GEOGR, V2013, P45
   Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3
   McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001
   Moore LV, 2009, AM J EPIDEMIOL, V170, P29, DOI 10.1093/aje/kwp090
   Morland K., 2014, LOCAL FOOD ENV FOOD
   Munoz SR, 1997, J APPL STAT, V24, P105, DOI 10.1080/02664769723918
   Paquet C, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-58
   Pearce J, 2009, HEALTH PLACE, V15, P193, DOI 10.1016/j.healthplace.2008.04.003
   Powell LM, 2011, HEALTH PLACE, V17, P1122, DOI 10.1016/j.healthplace.2011.05.010
   Riva M, 2008, INT J HEALTH GEOGR, V7, P1
   Rossen LM, 2012, HEALTH PLACE, V18, P956, DOI 10.1016/j.healthplace.2012.06.012
   Rummo PE, PUBLIC HLTH NUTR, V2014, P1
   Sturm R, 2009, HEALTH AFFAIR, V28, pW1088, DOI 10.1377/hlthaff.28.6.w1088
   Svastisalee CM, 2012, PUBLIC HEALTH NUTR, V15, P1228, DOI 10.1017/S1368980012000845
   Thornton LE, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-71
   Thornton LE, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-28
   Toft U, 2011, SCAND J PUBLIC HEALT, V39, P864, DOI 10.1177/1403494811423431
   Wang MC, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-15
   White M, 2007, OBES REV, V8, P99, DOI 10.1111/j.1467-789X.2007.00327.x
   Williams VSL, 1999, J EDUC BEHAV STAT, V24, P42, DOI 10.2307/1165261
NR 56
TC 7
Z9 7
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 30
PY 2017
VL 12
IS 3
AR e0174417
DI 10.1371/journal.pone.0174417
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ER9VI
UT WOS:000399174800037
PM 28358819
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ryuge, S
   Sato, Y
   Nagashio, R
   Hiyoshi, Y
   Katono, K
   Igawa, S
   Nakashima, H
   Shiomi, K
   Ichinoe, M
   Murakumo, Y
   Saegusa, M
   Satoh, Y
   Masuda, N
AF Ryuge, Shinichiro
   Sato, Yuichi
   Nagashio, Ryo
   Hiyoshi, Yasuhiro
   Katono, Ken
   Igawa, Satoshi
   Nakashima, Hiroyasu
   Shiomi, Kazu
   Ichinoe, Masaaki
   Murakumo, Yoshiki
   Saegusa, Makoto
   Satoh, Yukitoshi
   Masuda, Noriyuki
TI Prognostic significance of nestin expression in patients with resected
   non-small cell lung cancer treated with platinum-based adjuvant
   chemotherapy; relationship between nestin expression and epithelial to
   mesenchymal transition related markers
SO PLOS ONE
LA English
DT Article
ID VINORELBINE PLUS CISPLATIN; STEM-CELLS; CLINICAL-SIGNIFICANCE;
   CARCINOMA; CLASSIFICATION; SURVIVAL; CATENIN; IMPACT
AB Introduction
   Although adjuvant platinum-based chemotherapy (AC) has been shown to improve survival of patients with completely resected stage II and stage IIIA non-small cell lung cancer (NSCLC), its effect is limited. Nestin is a class VI intermediate filament protein expressed in neural stem cells and several cancer cells including NSCLC. In the present study, we aimed to determine its prognostic significance concerning survival in NSCLC patients receiving AC.
   Methods
   Nestin expression in cancer cells was immunohistochemically studied in 90 patients with completely resected stage II and stage IIIA NSCLC treated with AC and its association with clinicopathologic parameters, including ABCG2, E-cadherin, and vimentin expression, was evaluated. Kaplan-Meier survival analysis and Cox proportional hazards models were used to estimate the effect of nestin expression on survival.
   Results
   Nestin expression was observed in 28 of the 90 (31.1%) NSCLCs. Clinicopathologically, nestin expression was associated with loss of E-cadherin expression (P= 0.006) and vimentin positive expression (P< 0.001). In survival analysis, nestin expression was significantly associated with a poorer prognosis (P = 0.028). Multivariable analysis confirmed that nestin expression is an independent prognostic indicator in NSCLC patients receiving AC (HR = 2.56; 95% CI, 1.23-5.30, P= 0.01).
   Conclusion
   The present study reveals that nestin expression is a prognostic indicator of a poorer survival probability in NSCLC patients receiving AC, although its prognostic significance still requires confirmation with larger patient populations.
C1 [Ryuge, Shinichiro; Hiyoshi, Yasuhiro; Igawa, Satoshi; Masuda, Noriyuki] Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan.
   [Sato, Yuichi; Nagashio, Ryo] Kitasato Univ, Sch Allied Hlth Sci, Dept Mol Diagnost, Sagamihara, Kanagawa, Japan.
   [Katono, Ken] Sagamihara Kyodo Hosp, Dept Resp Med, Sagamihara, Kanagawa, Japan.
   [Nakashima, Hiroyasu; Shiomi, Kazu; Satoh, Yukitoshi] Kitasato Univ, Sch Med, Dept Thorac Surg, Sagamihara, Kanagawa, Japan.
   [Ichinoe, Masaaki; Murakumo, Yoshiki; Saegusa, Makoto] Kitasato Univ, Sch Med, Dept Pathol, Sagamihara, Kanagawa, Japan.
RP Sato, Y (reprint author), Kitasato Univ, Sch Allied Hlth Sci, Dept Mol Diagnost, Sagamihara, Kanagawa, Japan.
EM yuichi@med.kitasato-u.ac.jp
FU Japan Society for the Promotion of Science [23590414]; Third Term
   Comprehensive Control Research for Cancer conducted by the Ministry of
   Health, Labour and Welfare of Japan; School of Allied Health Sciences,
   Kitasato University [2011-1006]
FX This study was funded in part by Grants-in-Aid for Scientific Research C
   (23590414) from the Japan Society for the Promotion of Science, and for
   Third Term Comprehensive Control Research for Cancer conducted by the
   Ministry of Health, Labour and Welfare of Japan, and Research Project
   (No. 2011-1006) from the School of Allied Health Sciences, Kitasato
   University.
CR Chang WJ, 2014, LUNG CANCER, V84, P51, DOI 10.1016/j.lungcan.2014.01.017
   Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590
   Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a
   Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x
   Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Le Chevalier T, 2004, NEW ENGL J MED, V350, P351
   Lechner A, 2002, BIOCHEM BIOPH RES CO, V293, P670, DOI 10.1016/S0006-291X(02)00275-9
   LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X
   Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992
   Mo Wei, 2012, Int J Biochem Mol Biol, V3, P1
   Mochizuki T, 2008, AM J SURG PATHOL, V32, P1727, DOI 10.1097/PAS.0b013e3181804302
   Neradil J, 2015, CANCER SCI, V106, P803, DOI 10.1111/cas.12691
   Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030
   Ryuge S, 2011, CHEST, V139, P862, DOI 10.1378/chest.10-1121
   Shi YL, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-89
   Shien K, 2012, LUNG CANCER, V77, P162, DOI 10.1016/j.lungcan.2012.02.006
   Sui H, 2014, ONCOL RES TREAT, V37, P584, DOI 10.1159/000367802
   Sung CO, 2011, MODERN PATHOL, V24, P1060, DOI 10.1038/modpathol.2011.59
   Travis WD, 2004, PATHOLOGY GENETICS T
   van Rens MTM, 2000, CHEST, V117, P374, DOI 10.1378/chest.117.2.374
   Williams CD, 2014, CANCER-AM CANCER SOC, V120, P1939, DOI 10.1002/cncr.28679
   Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623
   Zhang H, 2013, J CLIN PATHOL, V66, P937, DOI 10.1136/jclinpath-2013-201467
   Zhao ZW, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0408-8
NR 25
TC 1
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 30
PY 2017
VL 12
IS 3
AR e0173886
DI 10.1371/journal.pone.0173886
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ER9VI
UT WOS:000399174800012
PM 28358810
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Weiss, A
   Sommer, G
   Kuonen, R
   Scheinemann, K
   Grotzer, M
   Kompis, M
   Kuehni, CE
AF Weiss, Annette
   Sommer, Grit
   Kuonen, Rahel
   Scheinemann, Katrin
   Grotzer, Michael
   Kompis, Martin
   Kuehni, Claudia E.
CA Swiss Paediat Oncology Grp SPOG
TI Validation of questionnaire-reported hearing with medical records: A
   report from the Swiss Childhood Cancer Survivor Study
SO PLOS ONE
LA English
DT Article
ID PLATINUM-INDUCED OTOTOXICITY; STEM-CELL TRANSPLANTATION;
   QUALITY-OF-LIFE; HANDICAP INVENTORY; CHILDREN; COMPLICATIONS;
   POPULATION; ACCURACY; TOXICITY; REGISTRY
AB Background
   Hearing loss is a potential late effect after childhood cancer. Questionnaires are often used to assess hearing in large cohorts of childhood cancer survivors and it is important to know if they can provide valid measures of hearing loss. We therefore assessed agreement and validity of questionnaire-reported hearing in childhood cancer survivors using medical records as reference.
   Procedure
   In this validation study, we studied 361 survivors of childhood cancer from the Swiss Childhood Cancer Survivor Study (SCCSS) who had been diagnosed after 1989 and had been exposed to ototoxic cancer treatment. Questionnaire-reported hearing was compared to the information in medical records. Hearing loss was defined as >= grade 1 according to the SIOP Boston Ototoxicity Scale. We assessed agreement and validity of questionnaire-reported hearing overall and stratified by questionnaire respondents (survivor or parent), sociodemographic characteristics, time between follow-up and questionnaire and severity of hearing loss.
   Results
   Questionnaire reports agreed with medical records in 85% of respondents (kappa 0.62), normal hearing was correctly assessed in 92% of those with normal hearing (n = 249), and hearing loss was correctly assessed in 69% of those with hearing loss (n = 112). Sensitivity of the questionnaires was 92%, 74%, and 39% for assessment of severe, moderate and mild bilateral hearing loss; and 50%, 33% and 10% for severe, moderate and mild unilateral hearing loss, respectively. Results did not differ by sociodemographic characteristics of the respondents, and survivor- and parent-reports were equally valid.
   Conclusions
   Questionnaires are a useful tool to assess hearing in large cohorts of childhood cancer survivors, but underestimate mild and unilateral hearing loss. Further research should investigate whether the addition of questions with higher sensitivity for mild degrees of hearing loss could improve the results.
C1 [Weiss, Annette; Sommer, Grit; Kuonen, Rahel; Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Swiss Childhood Canc Registry, Bern, Switzerland.
   [Scheinemann, Katrin] Univ Childrens Hosp Basel, Div Pediat Hematol Oncol, Basel, Switzerland.
   [Grotzer, Michael] Univ Zurich, Dept Pediat Oncol, Univ Childrens Hosp Zurich, Zurich, Switzerland.
   [Kompis, Martin] Univ Bern, Univ Hosp Bern, Dept ENT Head & Neck Surg, Bern, Switzerland.
   [Kuehni, Claudia E.] Univ Bern, Childrens Univ Hosp Bern, Bern, Switzerland.
RP Kuehni, CE (reprint author), Univ Bern, Inst Social & Prevent Med, Swiss Childhood Canc Registry, Bern, Switzerland.; Kuehni, CE (reprint author), Univ Bern, Childrens Univ Hosp Bern, Bern, Switzerland.
EM claudia.kuehni@ispm.unibe.ch
RI ANSARI, Marc/V-3334-2017
OI Weiss, Annette/0000-0001-8295-3574
FU Swiss Cancer Research [02783-02-2011]; Swiss Cancer League
   [3412-02-2014]; European Union's Seventh Framework Programme for
   research, technological development and demonstration [602030]; Swiss
   Paediatric Oncology Group; Schweizerische Konferenz der kantonalen
   Gesundheitsdirektorinnen und -direktoren; Swiss Cancer Research;
   Kinderkrebshilfe Schweiz; Federal Office of Health (FOH); Institute of
   Cancer Epidemiology and Registration
FX This study was supported by the Swiss Cancer Research (grant no:
   02783-02-2011), Swiss Cancer League (grant no: 3412-02-2014), and
   received funding from the European Union's Seventh Framework Programme
   for research, technological development and demonstration under grant
   agreement no 602030. The work of the Swiss Childhood Cancer Registry is
   supported by the Swiss Paediatric Oncology Group (www.spog.ch),
   Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und
   -direktoren (www gdk.cds.ch), Swiss Cancer Research (www.
   krebsforschung.ch), Kinderkrebshilfe Schweiz (www.kinderkrebshilfe.ch),
   the Federal Office of Health (FOH) and the Institute of Cancer
   Epidemiology and Registration (www.nicer.ch). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bertolini P, 2004, J PEDIAT HEMATOL ONC, V26, P649, DOI 10.1097/01.mph.0000141348.62532.73
   Brock PR, 2012, J CLIN ONCOL, V30, P2408, DOI 10.1200/JCO.2011.39.1110
   Castelan-Martinez OD, 2014, INT J PEDIATR OTORHI, V78, P1456, DOI 10.1016/j.ijporl.2014.06.007
   Children's Oncology Group, 2013, LONG TERM FOLL UP GU
   Christopherson KM, 2014, ACTA ONCOL, V53, P471, DOI 10.3109/0284186X.2013.862596
   Deepthi R, 2012, ARCH GERONTOL GERIAT, V55, P762, DOI 10.1016/j.archger.2012.07.006
   Fleiss JL, 2003, STAT METHODS RATES P, Vxxvii
   Furlong WJ, 2001, ANN MED, V33, P375, DOI 10.3109/07853890109002092
   GATES GA, 1990, EAR HEARING, V11, P247, DOI 10.1097/00003446-199008000-00001
   Gates GA, 2003, J FAM PRACTICE, V52, P56
   Gurney JG, 2007, PEDIATRICS, V120, pE1229, DOI 10.1542/peds.2007-0178
   Gurney JG, 2006, CANCER-AM CANCER SOC, V106, P1402, DOI 10.1002/cncr.21752
   Kamil RJ, 2015, EAR HEARING, V36, P164, DOI 10.1097/AUD.0000000000000075
   Kiely KM, 2012, J AGING HEALTH, V24, P439, DOI 10.1177/0898264311425088
   Kuehni CE, 2012, INT J EPIDEMIOL, V41, P1553, DOI 10.1093/ije/dyr142
   Landier W, 2016, CANCER-AM CANCER SOC, V122, P1647, DOI 10.1002/cncr.29779
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Louie AD, 2000, BONE MARROW TRANSPL, V25, P1191, DOI 10.1038/sj.bmt.1702419
   Michel G, 2007, SWISS MED WKLY, V137, P502
   NOBLE WG, 1979, J AM AUDITORY SOC, V5, P95
   Nondahl DM, 1998, AUDIOLOGY, V37, P295
   Olson JE, 1997, AM J EPIDEMIOL, V145, P58
   Overbeek A, 2013, HUM REPROD, V28, P819, DOI 10.1093/humrep/des405
   Peleva E, 2014, PEDIATR BLOOD CANCER, V61, P2012, DOI 10.1002/pbc.25123
   Ruggiero A, 2013, ANTI-CANCER DRUG, V24, P1007, DOI 10.1097/CAD.0b013e3283650bda
   Salonen J, 2011, INT J AUDIOL, V50, P297, DOI 10.3109/14992027.2010.549517
   Sindhusake D, 2001, INT J EPIDEMIOL, V30, P1371, DOI 10.1093/ije/30.6.1371
   Stark D, 2016, J SPEECH LANG HEAR R, V59, P1247, DOI 10.1044/2016_JSLHR-H-15-0363
   Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910
   Valete-Rosalino Cludia Maria, 2005, Rev. Bras. Otorrinolaringol., V71, P193, DOI 10.1590/S0034-72992005000200013
   VENTRY IM, 1982, EAR HEARING, V3, P128, DOI 10.1097/00003446-198205000-00006
   Weiss A, 2017, PEDIATR BLOOD CANCER, V64, P364, DOI 10.1002/pbc.26212
   Whelan K, 2011, PEDIATR BLOOD CANCER, V57, P126, DOI 10.1002/pbc.23025
NR 33
TC 2
Z9 2
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 23
PY 2017
VL 12
IS 3
AR e0174479
DI 10.1371/journal.pone.0174479
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ER8VS
UT WOS:000399102200103
PM 28333999
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU de Guzman-Barrera, JR
   Martinez, CS
   Boronat-Catala, M
   Montiel-Company, JM
   Paredes-Gallardo, V
   Gandia-Franco, JL
   Almerich-Silla, JM
   Bellot-Arcis, C
AF Rodriguez de Guzman-Barrera, Jorge
   Saez Martinez, Carla
   Boronat-Catala, Montserrat
   Maria Montiel-Company, Jose
   Paredes-Gallardo, Vanessa
   Luis Gandia-Franco, Jose
   Manuel Almerich-Silla, Jose
   Bellot-Arcis, Carlos
TI Effectiveness of interceptive treatment of class III malocclusions with
   skeletal anchorage: A systematic review and meta-analysis
SO PLOS ONE
LA English
DT Review
ID MAXILLARY PROTRACTION; ORTHOPEDIC TREATMENT; FACE MASK
AB Recently, new strategies for treating class III malocclusions have appeared. Skeletal anchorage appears to reduce the dentoalveolar effects while maximising the orthopaedic effect in growing patients. The purpose of this systematic review and meta-analysis is to examine the effectiveness of bone anchorage devices for interceptive treatment of skeletal class III malocclusions. Searches were made in the Pubmed, Embase, Scopus and Cochrane databases, as well as in a grey literature database, and were complemented by hand-searching. The criteria for eligibility were: patients who had undergone orthodontic treatment with skeletal anchorage (miniplates and miniscrews). Patients with syndromes or craniofacial deformities or who had undergone maxillofacial surgery were excluded. The following variables were recorded for each article: author, year of publication, type of study, sample size, dropouts, demographic variables, treatment carried out, radiographic study (2D or 3D), follow-up time, and quality of the articles on the Newcastle-Ottawa Scale. The means and confidence intervals of the following variables were employed: Wits, overjet, ANB, SNA and SNB. Initially, 239 articles were identified. After removing the duplicates and applying the selection criteria, 9 were included in the qualitative synthesis and 7 in the quantitative synthesis (meta-analysis). It may be concluded that skeletal anchorage is an effective treatment for improving skeletal Class III malocclusion, but when compared with other traditional treatments such as disjunction and face mask, there is no clear evidence that skeletal anchorage improves the results.
C1 [Rodriguez de Guzman-Barrera, Jorge; Saez Martinez, Carla; Boronat-Catala, Montserrat] Univ Valencia, Fac Med & Dent, Dept Stomatol, Valencia, Spain.
   [Maria Montiel-Company, Jose; Manuel Almerich-Silla, Jose] Univ Valencia, Fac Med & Dent, Dept Stomatol, Prevent Dent Teaching Unit, Valencia, Spain.
   [Paredes-Gallardo, Vanessa; Luis Gandia-Franco, Jose; Bellot-Arcis, Carlos] Univ Valencia, Fac Med & Dent, Dept Stomatol, Orthodont Teaching Unit, Valencia, Spain.
RP Bellot-Arcis, C (reprint author), Univ Valencia, Fac Med & Dent, Dept Stomatol, Orthodont Teaching Unit, Valencia, Spain.
EM bellot.arcis@gmail.com
RI Montiel-Company, Jose Maria/S-1836-2018
OI Montiel-Company, Jose Maria/0000-0002-3952-7681
CR Baccetti T, 2011, EUR J ORTHODONT, V33, P121, DOI 10.1093/ejo/cjq170
   Barrett AAF, 2010, AM J ORTHOD DENTOFAC, V138, P468, DOI 10.1016/j.ajodo.2008.12.024
   Cevidanes L, 2010, ANGLE ORTHOD, V80, P799, DOI 10.2319/111709-651.1
   Cha B, 2011, SEMIN ORTHOD, V17, P124, DOI [10.1053/j.sodo.2010.12.005, DOI 10.1053/J.S0D0.2010.12.005]
   Cornelis MA, 2008, AM J ORTHOD DENTOFAC, V133, DOI 10.1016/j.ajodo.2006.09.049
   Coscia G, 2012, J CRANIO MAXILL SURG, V40, pE350, DOI 10.1016/j.jcms.2012.01.019
   De Clerck EEB, 2011, ANGLE ORTHOD, V81, P1010, DOI 10.2319/012311-47.1
   De Toffol L, 2008, ANGLE ORTHOD, V78, P561, DOI 10.2319/030207-108.1
   Delaire J, 1971, Trans Eur Orthod Soc, P81
   ELLIS E, 1984, J ORAL MAXIL SURG, V42, P295, DOI 10.1016/0278-2391(84)90109-5
   Feng XX, 2012, ANGLE ORTHOD, V82, P1107, DOI 10.2319/111411-705.1
   Ge YS, 2012, ANGLE ORTHOD, V82, P1083, DOI 10.2319/012912-76.1
   Hardy DK, 2012, OPEN J EPIDEMIOL, V2, P75, DOI DOI 10.4236/OJEPI.2012.24012
   Hino CT, 2013, AM J ORTHOD DENTOFAC, V144, P705, DOI 10.1016/j.ajodo.2013.07.011
   Jamilian A, 2016, J ORTHOD, V43, P102, DOI 10.1080/14653125.2016.1155334
   Kaya D, 2011, ANGLE ORTHOD, V81, P639, DOI 10.2319/081010-473.1
   Koh SD, 2014, ANGLE ORTHOD, V84, P628, DOI 10.2319/060313-421.1
   KOKICH VG, 1985, AM J ORTHOD DENTOFAC, V88, P303, DOI 10.1016/0002-9416(85)90129-0
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee NK, 2012, ANGLE ORTHOD, V82, P846, DOI 10.2319/090811-584.1
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700
   Ludwig Bjorn, 2010, J Clin Orthod, V44, P533
   Nguyen T, 2011, AM J ORTHOD DENTOFAC, V140, P790, DOI 10.1016/j.ajodo.2011.04.025
   Nienkemper M, 2015, ANGLE ORTHOD, V85, P764, DOI 10.2319/071614-497.1
   Proffit WR., 2007, CONT ORTHODONTICS, P689
   Sahin T, 2016, INT ORTHOD, V14, P263, DOI 10.1016/j.ortho.2016.07.004
   Sar C, 2014, AM J ORTHOD DENTOFAC, V145, P41, DOI 10.1016/j.ajodo.2013.09.009
   Wells GA, 2014, NEWCASTLE OTTAWA SCA
   Wilmes B, 2014, J ORTHOD, V41, pS47, DOI 10.1179/1465313314Y.0000000107
   Yang XR, 2014, AM J ORTHOD DENTOFAC, V146, P143, DOI 10.1016/j.ajodo.2014.04.017
NR 30
TC 5
Z9 5
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 22
PY 2017
VL 12
IS 3
AR e0173875
DI 10.1371/journal.pone.0173875
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ER8SZ
UT WOS:000399094700035
PM 28328995
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Pichonnaz, C
   Aminian, K
   Ancey, C
   Jaccard, H
   Lecureux, E
   Duc, C
   Farron, A
   Jolles, BM
   Gleeson, N
AF Pichonnaz, Claude
   Aminian, Kamiar
   Ancey, Celine
   Jaccard, Herve
   Lecureux, Estelle
   Duc, Cyntia
   Farron, Alain
   Jolles, Brigitte M.
   Gleeson, Nigel
TI Heightened clinical utility of smartphone versus body-worn inertial
   system for shoulder function B-B score
SO PLOS ONE
LA English
DT Article
ID OBJECTIVE OUTCOME EVALUATION; AMBULATORY MEASUREMENT; MOTION
   MEASUREMENT; IDIOPATHIC LOSS; KINEMATICS; SENSORS; RANGE; ARM;
   QUESTIONNAIRE; ELBOW
AB Background
   The B-B Score is a straightforward kinematic shoulder function score including only two movements (hand to the Back + lift hand as to change a Bulb) that demonstrated sound measurement properties for patients for various shoulder pathologies. However, the B-B Score results using a smartphone or a reference system have not yet been compared. Provided that the measurement properties are comparable, the use of a smartphone would offer substantial practical advantages. This study investigated the concurrent validity of a smartphone and a reference inertial system for the measurement of the kinematic shoulder function B-B Score.
   Methods
   Sixty-five patients with shoulder conditions (with rotator cuff conditions, adhesive capsulitis and proximal humerus fracture) and 20 healthy participants were evaluated using a smart phone and a reference inertial system. Measurements were performed twice, alternating between two evaluators. The B-B Score differences between groups, differences between devices, relationship between devices, intra- and inter-evaluator reproducibility were analysed.
   Results
   The smartphone mean scores (SD) were 94.1 (11.1) for controls and 54.1 (18.3) for patients (P < 0.01). The difference between devices was non-significant for the control (P = 0.16) and the patient group (P = 0.81). The analysis of the relationship between devices showed 0.97 ICC, -0.6 bias and -13.2 to 12.0 limits of agreement (LOA). The smartphone intraevaluator ICC was 0.92, the bias 1.5 and the LOA-17.4 to 20.3. The smartphone inter evaluator ICC was 0.92, the bias 1.5 and the LOA-16.9 to 20.0.
   Conclusions
   The B-B Score results measured with a smartphone were comparable to those of an inertial system. While single measurements diverged in some cases, the intra- and inter evaluator reproducibility was excellent and was equivalent between devices. The B-B score measured with a smartphone is straightforward and as efficient as a reference inertial system measurement.
C1 [Pichonnaz, Claude; Ancey, Celine; Jaccard, Herve] Univ Appl Sci Western Switzerland, Haute Ecole Sante Vaud HESAV HES SO, Physiotherapy Dept, Lausanne, Switzerland.
   [Pichonnaz, Claude; Jaccard, Herve; Farron, Alain; Jolles, Brigitte M.] Univ Lausanne Hosp, Dept Musculoskeletal Med, Serv Orthopaed & Traumatol, Lausanne, Switzerland.
   [Pichonnaz, Claude; Jaccard, Herve; Farron, Alain; Jolles, Brigitte M.] CHUV UNIL, Lausanne, Switzerland.
   [Aminian, Kamiar; Duc, Cyntia] Ecole Polytech Fed Lausanne, Lab Movement Anal & Measurement, Lausanne, Switzerland.
   [Lecureux, Estelle] CHUV UNIL, Direct Med, Lausanne, Switzerland.
   [Gleeson, Nigel] Queen Margaret Univ, Sch Hlth Sci, Edinburgh, Midlothian, Scotland.
RP Pichonnaz, C (reprint author), Univ Appl Sci Western Switzerland, Haute Ecole Sante Vaud HESAV HES SO, Physiotherapy Dept, Lausanne, Switzerland.; Pichonnaz, C (reprint author), Univ Lausanne Hosp, Dept Musculoskeletal Med, Serv Orthopaed & Traumatol, Lausanne, Switzerland.; Pichonnaz, C (reprint author), CHUV UNIL, Lausanne, Switzerland.
EM Claude.Pichonnaz@hesav.ch
RI Aminian, Kamiar/H-4568-2011
OI Aminian, Kamiar/0000-0002-6582-5375
FU Swiss National Science Foundation [135061]
FX Funded by Swiss National Science Foundation Grant number 135061
   http://p3.snf.ch/Project-135061. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR American Academy of Orthopaedic Surgeons, DASH OUTC MEAS
   Angst F, 2011, ARTHRIT CARE RES, V63, pS174, DOI 10.1002/acr.20630
   Beaton DE, 1996, J BONE JOINT SURG AM, V78A, P882, DOI 10.2106/00004623-199606000-00011
   Bot SDM, 2004, ANN RHEUM DIS, V63, P335, DOI 10.1136/ard.2003.007724
   Coley B, 2008, GAIT POSTURE, V27, P368, DOI 10.1016/j.gaitpost.2007.05.005
   Coley B, 2007, GAIT POSTURE, V25, P523, DOI 10.1016/j.gaitpost.2006.06.016
   Coley B, 2009, MED BIOL ENG COMPUT, V47, P467, DOI 10.1007/s11517-009-0464-x
   Constant CR, 2008, J SHOULDER ELB SURG, V17, P355, DOI 10.1016/j.jse.2007.06.022
   Cutti AG, 2008, MED BIOL ENG COMPUT, V46, P169, DOI 10.1007/s11517-007-0296-5
   de Vries WHK, 2016, J BIOMECH, V49, P73, DOI 10.1016/j.jbiomech.2015.11.019
   Duc C, 2014, PHYSIOL MEAS, V35, P2389, DOI 10.1088/0967-3334/35/12/2389
   Duc C, 2013, GAIT POSTURE, V38, P247, DOI 10.1016/j.gaitpost.2012.11.021
   EuroQol G, EQ 5D STAND INSTR US
   Gait Up, HANDS SHOULD TEST AP
   Handoll HHG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000434.pub3
   Harvie P, 2005, J BONE JOINT SURG BR, V87B, P151, DOI 10.1302/0301-620X.87B2.15305
   Jester A, 2005, J HAND SURG-BRIT EUR, V30B, P23, DOI 10.1016/j.jhsb.2004.08.008
   Jolles BM, 2011, J SHOULDER ELB SURG, V20, P1074, DOI 10.1016/j.jse.2011.05.026
   Kirkley A, 2003, ARTHROSCOPY, V19, P1109, DOI 10.1016/j.arthro.2003.10.030
   Korver RJP, 2014, PHYSIOL MEAS, V35, P167, DOI 10.1088/0967-3334/35/2/167
   Korver RJP, 2014, PHYSIOL MEAS, V35, P677, DOI 10.1088/0967-3334/35/4/677
   Krueger D, 2011, AM J SPORT MED, V39, P71, DOI 10.1177/0363546510379336
   Laboratory of Movement Analysis and Measurement D Swiss Institute of Technology of Lausanne, SMARTPH APP ISHOULD
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lenth R.V., JAVA APPLETS POWER S
   LIPPITT SB, 1993, SHOULDER : A BALANCE OF MOBILITY AND STABILITY, P501
   Liu Zhan-yu, 2007, Journal of Zhejiang University-Science B, V8, P738, DOI 10.1631/jzus.2007.B0738
   Ludewig PM, 2009, J ORTHOP SPORT PHYS, V39, P90, DOI 10.2519/jospt.2009.2808
   Ludewig PM, 2000, PHYS THER, V80, P276
   Luinge HJ, 2007, J BIOMECH, V40, P78, DOI 10.1016/j.jbiomech.2005.11.011
   Luinge HJ, 2005, MED BIOL ENG COMPUT, V43, P273, DOI 10.1007/BF02345966
   Mark DN, 2011, BEGINNING IOS 5 DEV
   Mercer TH, 2002, PHYS THER SPORT, V3, P27, DOI 10.1054/ptsp.2001.0073
   Mitchell K, 2014, PHYSIOTHER THEOR PR, V30, P521, DOI 10.3109/09593985.2014.900593
   Moustgaard H, 2014, J CLIN EPIDEMIOL, V67, P1327, DOI 10.1016/j.jclinepi.2014.06.020
   Oh JH, 2009, AM J SPORT MED, V37, P1161, DOI 10.1177/0363546508330135
   Olley LM, 2008, ANN ROY COLL SURG, V90, P326, DOI 10.1308/003588408X285964
   Othenart L, 2012, GAIT POSTURE S1, V36, pS61
   Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X
   Pichonnaz C, 2015, PHYSIOL MEAS, V36, P547, DOI 10.1088/0967-3334/36/3/547
   Pichonnaz C, 2015, SENSORS-BASEL, V15, P26801, DOI 10.3390/s151026801
   Portney L. G., 2009, FDN CLIN RES APPL PR
   Ragab AA, 2003, BIOMED SCI INSTRUM, V39, P579
   Richards R R, 1994, J Shoulder Elbow Surg, V3, P347, DOI 10.1016/S1058-2746(09)80019-0
   Roy JS, 2009, ARTHRIT RHEUM-ARTHR, V61, P623, DOI 10.1002/art.24396
   Rundquist PJ, 2005, PHYS THER, V85, P636
   Rundquist PJ, 2004, CLIN BIOMECH, V19, P810, DOI 10.1016/j.clinbiomech.2004.05.006
   Rundquist PJ, 2003, ARCH PHYS MED REHAB, V84, P1473, DOI 10.1053/S0003-9993(03)00359-9
   SHER JS, 1995, J BONE JOINT SURG AM, V77A, P10, DOI 10.2106/00004623-199501000-00002
   Shin SH, 2012, MANUAL THER, V17, P298, DOI 10.1016/j.math.2012.02.010
   Soper DS, STAT CALCULATORS
   VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959
   Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5
   Werner BC, 2014, J SHOULDER ELB SURG, V23, pE275, DOI 10.1016/j.jse.2014.02.030
   Wong WY, 2007, PROSTHET ORTHOT INT, V31, P62, DOI 10.1080/03093640600983949
   Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042
NR 56
TC 2
Z9 2
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 20
PY 2017
VL 12
IS 3
AR e0174365
DI 10.1371/journal.pone.0174365
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ER6VC
UT WOS:000398945800071
PM 28319141
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chen, IC
   Lin, MY
   Liu, YC
   Cheng, HC
   Wu, JR
   Hsu, JH
   Dai, ZK
AF Chen, I-Chen
   Lin, Ming-Yen
   Liu, Yi-Ching
   Cheng, Hsiao-Chi
   Wu, Jiunn-Ren
   Hsu, Jong-Hau
   Dai, Zen-Kong
TI The role of transthoracic ultrasonography in predicting the outcome of
   community-acquired pneumonia in hospitalized children
SO PLOS ONE
LA English
DT Article
ID LUNG ULTRASOUND; RADIOGRAPHIC FINDINGS; DIAGNOSIS; SEVERITY
AB Transthoracic ultrasound (TUS) has recently become a valuable tool in the diagnosis of community-acquired pneumonia (CAP). This study assessed the association between TUS findings and clinical outcome in children with CAP. The medical records of pediatric patients hospitalized with CAP who underwent transthoracic ultrasonography within 48 hours of admission were retrospectively reviewed. Associations between the TUS findings and patient outcome were analyzed, including intensive care unit (ICU) admission, length of hospital stay, and tube thoracotomy. The study enrolled 142 patients (median age, 60 months): 28 (19.7%) required ICU admission, 14 (9.89%) underwent tube thoracotomy, and 26 (18.3%) had a hospital stay > 9 days. Multifocal involvement seen by TUS were independently associated with ICU admission, a prolonged hospital stay, and tube thoracotomy (p = 0.0027, p = 0.02, and p = 0.0262, respectively). A pleural effusion and fluid bronchogram were independent predictors of a longer hospital stay (p = 0.003 and p = 0.006, respectively). In addition, a fluid bronchogram was an independent predictor of tube thoracotomy (p = 0.0262).
   Conclusion
   TUS findings of fluid bronchogram, multifocal involvement, and pleural effusion were associated with adverse outcomes, including longer hospital stay, ICU admission, and tube thoracotomy in hospitalized CAP children. Therefore, TUS is a novel tool for prognostic stratifications of CAP in hospitalized children.
C1 [Chen, I-Chen; Liu, Yi-Ching; Cheng, Hsiao-Chi; Wu, Jiunn-Ren; Hsu, Jong-Hau; Dai, Zen-Kong] Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan.
   [Lin, Ming-Yen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan.
   [Lin, Ming-Yen] Kaohsiung Med Univ, Fac Renal Care, Coll Med, Kaohsiung, Taiwan.
   [Wu, Jiunn-Ren; Hsu, Jong-Hau; Dai, Zen-Kong] Kaohsiung Med Univ, Sch Med, Dept Pediat, Coll Med, Kaohsiung, Taiwan.
RP Hsu, JH; Dai, ZK (reprint author), Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan.; Hsu, JH; Dai, ZK (reprint author), Kaohsiung Med Univ, Sch Med, Dept Pediat, Coll Med, Kaohsiung, Taiwan.
EM jhh936@yahoo.com.tw; zenkong@kmu.edu.tw
FU Kaohsiung Medical University Hospital, Taiwan [KMUH103-3M30]; Ministry
   of Science and Technology, R.O.C. [MOST105-2314-B-037-011-, MOST
   103-2314-B-037-023-MY3]
FX This research was supported by the grant from the Kaohsiung Medical
   University Hospital, Taiwan (KMUH103-3M30) and Ministry of Science and
   Technology, R.O.C. (MOST105-2314-B-037-011- and MOST
   103-2314-B-037-023-MY3). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abu-Kishk I, 2014, MINERVA PEDIAT
   Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI 10.1093/cid/cir531
   Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8
   Chen IC, 2015, PEDIAT NEONATOLOGY
   Copetti R, 2008, RADIOL MED, V113, P190, DOI 10.1007/s11547-008-0247-8
   de Hoyos A, 2002, SURG CLIN N AM, V82, P643, DOI 10.1016/S0039-6109(02)00022-1
   Ferrero F, 2010, PEDIATR PULM, V45, P1009, DOI 10.1002/ppul.21287
   Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598
   Ho MC, 2015, PEDIATR NEONATOL, V56, P40, DOI 10.1016/j.pedneo.2014.03.007
   Key NK, 2009, PEDIATR PULM, V44, P249, DOI 10.1002/ppul.20988
   Lai SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130082
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lin Chao-Jen, 2006, Journal of Microbiology Immunology and Infection, V39, P489
   Mathis G, 2011, CHEST SONOGRAPHY
   Patria MF, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-56
   Reali F, 2014, RESPIRATION, V88, P112, DOI 10.1159/000362692
   Reissig A, 2012, EUR J INTERN MED, V23, P391, DOI 10.1016/j.ejim.2012.01.003
   Shah VP, 2013, JAMA PEDIATR, V167, P119, DOI 10.1001/2013.jamapediatrics.107
   Sperandeo M, 2014, RADIOL MED, V119, P729, DOI 10.1007/s11547-014-0385-0
   Trovato GM, 2013, AM J RESP CRIT CARE, V187, P780, DOI 10.1164/ajrccm.187.7.780
   Urbankowska E, 2015, RESP MED, V109, P1207, DOI 10.1016/j.rmed.2015.06.011
   Varshney T, 2016, EMERG MED J, V33, P603, DOI 10.1136/emermed-2015-205302
   Volpicelli G, 2012, INTENS CARE MED, V38, P577, DOI 10.1007/s00134-012-2513-4
   Wallihan R, 2014, J INFECTION, V69, pS87, DOI 10.1016/j.jinf.2014.07.021
   WIENERKRONISH JP, 1985, AM REV RESPIR DIS, V132, P1253
NR 25
TC 3
Z9 3
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 16
PY 2017
VL 12
IS 3
AR e0173343
DI 10.1371/journal.pone.0173343
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN9KE
UT WOS:000396318300033
PM 28301494
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU MacFarlane, H
   Gorman, K
   Ingham, R
   Hill, AP
   Papadakis, K
   Kiss, G
   van Santen, J
AF MacFarlane, Heather
   Gorman, Kyle
   Ingham, Rosemary
   Hill, Alison Presmanes
   Papadakis, Katina
   Kiss, Geza
   van Santen, Jan
TI Quantitative analysis of disfluency in children with autism spectrum
   disorder or language impairment
SO PLOS ONE
LA English
DT Article
ID DIAGNOSTIC OBSERVATION SCHEDULE; HIGH-FUNCTIONING AUTISM; PRAGMATIC
   LANGUAGE; SOCIOECONOMIC-STATUS; ASPERGER-SYNDROME; SPONTANEOUS SPEECH;
   FIELD TRIAL; COMMUNICATION; SPEAKING; ABILITY
AB Deficits in social communication, particularly pragmatic language, are characteristic of individuals with autism spectrum disorder (ASD). Speech disfluencies may serve pragmatic functions such as cueing speaking problems. Previous studies have found that speakers with ASD differ from typically developing (TD) speakers in the types and patterns of disfluencies they produce, but fail to provide sufficiently detailed characterizations of the methods used to categorize and quantify disfluency, making cross-study comparison difficult. In this study we propose a simple schema for classifying major disfluency types, and use this schema in an exploratory analysis of differences in disfluency rates and patterns among children with ASD compared to TD and language impaired (SLI) groups. 115 children ages 4-8 participated in the study (ASD = 51; SLI = 20; TD = 44), completing a battery of experimental tasks and assessments. Measures of morphological and syntactic complexity, as well as word and disfluency counts, were derived from transcripts of the Autism Diagnostic Observation Schedule (ADOS). High inter-annotator agreement was obtained with the use of the proposed schema. Analyses showed ASD children produced a higher ratio of content to filler disfluencies than TD children. Relative frequencies of repetitions, revisions, and false starts did not differ significantly between groups. TD children also produced more cued disfluencies than ASD children.
C1 [MacFarlane, Heather; Gorman, Kyle; Ingham, Rosemary; Hill, Alison Presmanes; Papadakis, Katina; Kiss, Geza; van Santen, Jan] Oregon Hlth & Sci Univ, Inst Dev & Disabil, Ctr Spoken Language Understanding, Portland, OR 97201 USA.
   [Gorman, Kyle; Hill, Alison Presmanes; van Santen, Jan] Oregon Hlth & Sci Univ, Dept Pediat, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA.
RP van Santen, J (reprint author), Oregon Hlth & Sci Univ, Inst Dev & Disabil, Ctr Spoken Language Understanding, Portland, OR 97201 USA.; van Santen, J (reprint author), Oregon Hlth & Sci Univ, Dept Pediat, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA.
EM vansantj@ohsu.edu
OI Ingham, Rosemary/0000-0003-1008-3252; van Santen,
   Jan/0000-0003-3245-5301; Gorman, Kyle/0000-0002-4233-6595; Hill,
   Alison/0000-0002-8082-1890
FU National Institute on Deafness and Other Communication Disorders of the
   National Institutes of Health [R01DC007129, R01DC012033]; Autism Speaks
   under Innovative Technology for Autism Grant [2407]; Oregon Health and
   Science University
FX This material is based on work supported by the National Institute on
   Deafness and Other Communication Disorders of the National Institutes of
   Health (nidcd.nih.gov) under awards R01DC007129 and R01DC012033, and by
   Autism Speaks (autismspeaks.org) under Innovative Technology for Autism
   Grant 2407. All funding was awarded to Jan van Santen at Oregon Health
   and Science University. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adams C, 2002, J CHILD PSYCHOL PSYC, V43, P679, DOI 10.1111/1469-7610.00056
   Allwood J., 1990, NORD J LINGUIST, V13, P1, DOI DOI 10.1017/S0332586500002092
   American Psychiatric Association, 2013, DIAGNOSTIC AND STATI
   American Psychiatric Association, 2000, DIAGNOSTIC AND STATI
   Arnold JE, 2003, J PSYCHOLINGUIST RES, V32, P25, DOI 10.1023/A:1021980931292
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444
   Bishop DVM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158753
   Bishop DVM, 2008, DEV MED CHILD NEUROL, V50, P341, DOI 10.1111/j.1469-8749.2008.02057.x
   Bishop DVM, 2002, J CHILD PSYCHOL PSYC, V43, P917, DOI 10.1111/1469-7610.00114
   Bishop DVM, 2003, THE CHILDRENS COMMUN
   Bishop DVM, SPEECH AND LANGUAGE, P99
   Bortfeld H, 2001, LANG SPEECH, V44, P123, DOI 10.1177/00238309010440020101
   Botting N, 2003, DEV MED CHILD NEUROL, V45, P515
   Boucher J, 2012, J CHILD PSYCHOL PSYC, V53, P219, DOI 10.1111/j.1469-7610.2011.02508.x
   Brennan SE, 2001, J MEM LANG, V44, P274, DOI 10.1006/jmla.2000.2753
   Bretz F, 2010, MULTIPLE COMPARISONS
   Brown R, 1973, A FIRST LANGUAGE THE
   Capps L., 1998, AUTISM, V2, P325, DOI DOI 10.1177/1362361398024002
   CLARK HH, 1994, SPEECH COMMUN, V15, P243, DOI 10.1016/0167-6393(94)90075-2
   Clark HH, 2002, SPEECH COMMUN, V36, P5, DOI 10.1016/S0167-6393(01)00022-X
   Cox A, 1999, J CHILD PSYCHOL PSYC, V40, P719, DOI 10.1111/1469-7610.00488
   Engelhardt PE, 2013, ACTA PSYCHOL, V144, P424, DOI 10.1016/j.actpsy.2013.08.002
   Facon B, 2011, RES DEV DISABIL, V32, P2134, DOI 10.1016/j.ridd.2011.07.029
   Geurts HM, 2008, J AUTISM DEV DISORD, V38, P1931, DOI 10.1007/s10803-008-0587-1
   Gioia G. A., 2003, BEHAVIOR RATING INVE
   Gioia G. A., 2000, BEHAVIOR RATING INVE
   Gorman K, 2016, AUTISM RES, V9, P854, DOI 10.1002/aur.1578
   Gotham K, 2007, J AUTISM DEV DISORD, V37, P613, DOI 10.1007/s10803-006-0280-1
   Guo LY, 2008, J SPEECH LANG HEAR R, V51, P722, DOI 10.1044/1092-4388(2008/051)
   Heeman PA, 2010, P 11 ANN M SPEC INT, P249
   Hoff E, 2003, CHILD DEV, V74, P1368, DOI 10.1111/1467-8624.00612
   Irvine CA, 2016, J AUTISM DEV DISORD, V46, P1061, DOI 10.1007/s10803-015-2651-y
   Kenworthy L, 2008, NEUROPSYCHOL REV, V18, P320, DOI 10.1007/s11065-008-9077-7
   Kidd C, 2011, DEVELOPMENTAL SCI, V14, P925, DOI 10.1111/j.1467-7687.2011.01049.x
   Kim S. H., 2014, HDB AUTISM PERVASIVE, P230
   Kjelgaard MM, 2001, LANG COGNITIVE PROC, V16, P287, DOI 10.1080/01690960042000058
   Klin A, 2000, J AUTISM DEV DISORD, V30, P163, DOI 10.1023/A:1005415823867
   Klin A, HANDBOOK OF AUTISM A, P88
   Klin A, 2007, J AUTISM DEV DISORD, V37, P748, DOI 10.1007/s10803-006-0229-4
   Lake JK, 2011, PSYCHON B REV, V18, P135, DOI 10.3758/s13423-010-0037-x
   Landa R, 2000, ASPERGER SYNDROME, P125
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee LC, 2007, RES AUTISM SPECT DIS, V1, P126, DOI 10.1016/j.rasd.2006.08.004
   Leyfer OT, 2008, AUTISM RES, V1, P284, DOI 10.1002/aur.43
   Lickley RJ, 1998, LANG SPEECH, V41, P203, DOI 10.1177/002383099804100204
   Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947
   Lord C, 1997, HDB ASD PERVASIVE DE, V2, P195
   Losh M, 2003, J AUTISM DEV DISORD, V33, P239, DOI 10.1023/A:1024446215446
   Loucas T, 2008, J CHILD PSYCHOL PSYC, V49, P1184, DOI 10.1111/j.1469-7610.2008.01951.x
   Loukusa S, 2007, J AUTISM DEV DISORD, V37, P1049, DOI 10.1007/s10803-006-0247-2
   MacLurg A., 2014, THESIS
   McKinnon DH, 2007, LANG SPEECH HEAR SER, V38, P5, DOI 10.1044/0161-1461(2007/002)
   Miller J, 1985, SYSTEMATIC ANALYSIS
   Morley E, 2013, P 8 WORKSH INN US NL, P1
   Morley E, 2014, P 1 WORKSH COMP LING, P69
   Paul R, 2009, J AUTISM DEV DISORD, V39, P115, DOI 10.1007/s10803-008-0607-1
   Philofsky A, 2007, AM J SPEECH-LANG PAT, V16, P368, DOI 10.1044/1058-0360(2007/040)
   Pinheiro J. C., 2000, MIXED EFFECTS MODELS
   Prud'hommeaux E, 2012, WORKSH CHILD COMP IN, P1
   Pungello EP, 2009, DEV PSYCHOL, V45, P544, DOI 10.1037/a0013917
   Reilly S, 2014, INT J LANG COMM DIS, V49, P452, DOI 10.1111/1460-6984.12111
   Richels CG, 2013, J COMMUN DISORD, V46, P361, DOI 10.1016/j.jcomdis.2013.07.002
   Rispoli M, 2008, J SPEECH LANG HEAR R, V51, P953, DOI 10.1044/1092-4388(2008/070)
   Royston P, 2011, J STAT SOFTW, V45, P1
   Russell RL, 2008, CLIN CHILD FAM PSYCH, V11, P59, DOI 10.1007/s10567-008-0032-1
   Rutter M., 2003, SOCIAL COMMUNICATION
   Scott KS, 2014, INT J LANG COMM DIS, V49, P75, DOI 10.1111/1460-6984.12048
   Semel E, 2004, CLINICAL EVALUATION
   Semel E., 2003, CLINICAL EVALUATION
   Sharp HM, 2008, PEDIATR CLIN N AM, V55, P1159, DOI 10.1016/j.pcl.2008.07.007
   Shriberg E., 1994, THESIS
   Shriberg LD, 2011, J AUTISM DEV DISORD, V41, P405, DOI 10.1007/s10803-010-1117-5
   Shriberg LD, 2001, J SPEECH LANG HEAR R, V44, P1097, DOI 10.1044/1092-4388(2001/087)
   Shulman C, 2007, J CHILD LANG, V34, P411, DOI 10.1017/S0305000906007963
   SMITH VL, 1993, J MEM LANG, V32, P25, DOI 10.1006/jmla.1993.1002
   SPITZER RL, 1990, J AM ACAD CHILD PSY, V29, P855, DOI 10.1097/00004583-199011000-00003
   Suh J, 2014, J AUTISM DEV DISORD, V44, P1681, DOI 10.1007/s10803-014-2042-9
   Tager-Flusberg H, 2003, PHILOS T ROY SOC B, V358, P303, DOI 10.1098/rstb.2002.1198
   Tager-Flusberg H, 2009, J SPEECH LANG HEAR R, V52, P643, DOI 10.1044/1092-4388(2009/08-0136)
   TagerFlusberg H, 1996, J AUTISM DEV DISORD, V26, P169, DOI 10.1007/BF02172006
   TAGERFLUSBERG H, 2005, HDB AUTISM PERVASIVE, P335, DOI DOI 10.1002/9780470939345
   Thordardottir ET, 2002, BRAIN COGNITION, V48, P587, DOI 10.1006/brcg.2001.1422
   THURBER C, 1993, J AUTISM DEV DISORD, V23, P309, DOI 10.1007/BF01046222
   Tomblin B, 2011, INT J LANG COMM DIS, V46, P127, DOI 10.1111/j.1460-6984.2011.00017.x
   Tree JEF, 2001, MEM COGNITION, V29, P320, DOI 10.3758/BF03194926
   Volden J, 2010, AM J SPEECH-LANG PAT, V19, P204, DOI 10.1044/1058-0360(2010/09-0011)
   Volden J, 2009, J AUTISM DEV DISORD, V39, P388, DOI 10.1007/s10803-008-0618-y
   Wechsler D., 2003, THE WECHSLER INTELLI
   Wechsler D, 2002, WECHSLER PRESCHOOL A
   Weismer SE, 2013, FOLIA PHONIATR LOGO, V65, P68, DOI 10.1159/000353896
   Whitehouse AJO, 2007, J CHILD PSYCHOL PSYC, V48, P822, DOI 10.1111/j.1469-7610.2007.01765.x
   Young EC, 2005, LANG SPEECH HEAR SER, V36, P62, DOI 10.1044/0161-1461(2005/006)
NR 93
TC 2
Z9 2
U1 3
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 15
PY 2017
VL 12
IS 3
AR e0173936
DI 10.1371/journal.pone.0173936
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN9HQ
UT WOS:000396311700080
PM 28296973
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Morrison, PK
   Harris, PA
   Maltin, CA
   Grove-White, D
   Argo, CM
AF Morrison, Philippa K.
   Harris, Patricia A.
   Maltin, Charlotte A.
   Grove-White, Dai
   Argo, Caroline McG.
TI EQUIFAT: A novel scoring system for the semi-quantitative evaluation of
   regional adipose tissues in Equidae
SO PLOS ONE
LA English
DT Article
ID BODY-FAT; INSULIN-RESISTANCE; METABOLIC SYNDROME; EPICARDIAL FAT;
   RISK-FACTORS; HORSES; PONIES; OBESITY; DEPOTS; BREED
AB Anatomically distinct adipose tissues represent variable risks to metabolic health in man and some other mammals. Quantitative-imaging of internal adipose depots is problematic in large animals and associations between regional adiposity and health are poorly understood. This study aimed to develop and test a semi-quantitative system (EQUIFAT) which could be applied to regional adipose tissues. Anatomically-defined, photographic images of adipose depots (omental, mesenteric, epicardial, rump) were collected from 38 animals immediately post-mortem. Images were ranked and depot-specific descriptors were developed (1 = no fat visible; 5 = excessive fat present). Nuchal-crest and ventro-abdominalretroperitoneal adipose depot depths (cm) were transformed to categorical 5 point scores. The repeatability and reliability of EQUIFAT was independently tested by 24 observers. When half scores were permitted, inter-observer agreement was substantial (average kappa(w): mesenteric, 0.79; omental, 0.79; rump 0.61) or moderate (average. w; epicardial, 0.60). Intra-observer repeatability was tested by 8 observers on 2 occasions. Kappa analysis indicated perfect (omental and mesenteric) and substantial agreement (epicardial and rump) between attempts. A further 207 animals were evaluated ante-mortem (age, height, breed-type, gender, body condition score [BCS]) and again immediately post-mortem (EQUIFAT scores, carcass weight). Multivariable, random effect linear regression models were fitted (breed as random effect; BCS as outcome variable). Only height, carcass weight, omental and retroperitoneal EQUIFAT scores remained as explanatory variables in the final model. The EQUIFAT scores developed here demonstrate clear functional differences between regional adipose depots and future studies could be directed towards describing associations between adiposity and disease risk in surgical and post-mortem situations.
C1 [Morrison, Philippa K.; Argo, Caroline McG.] Univ Surrey, Sch Vet Med, Fac Hlth & Med Sci, Guildford, England.
   [Harris, Patricia A.] WALTHAM Ctr Pet Nutr, Equine Studies Grp, Freeby Lane, Melton Mowbray, Leics, England.
   [Maltin, Charlotte A.; Grove-White, Dai] Univ Liverpool, Fac Hlth & Life Sci, Dept Obes & Endocrinol, Leahurst Campus,Chester High Rd, Wirral, Merseyside, England.
   [Maltin, Charlotte A.] Biomics Ltd, Inverurie, Aberdeen, Scotland.
RP Argo, CM (reprint author), Univ Surrey, Sch Vet Med, Fac Hlth & Med Sci, Guildford, England.
EM c.argo@surrey.ac.uk
OI Argo, Caroline/0000-0002-8279-6350; Morrison,
   Philippa/0000-0003-4187-0371
FU WALTHAM
FX This research was funded by a PhD scholarship from WALTHAM. The funders
   (with the exception of Patricia A. Harris, co-author and collaborator)
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.; The lead author was funded
   by a PhD studentship provided by WALTHAM. The authors wish to thank all
   those who participated in using the EQUIFAT scoring system to enable the
   repeatability and reliability to be assessed. In addition, the authors
   wish to acknowledge the statistical advice regarding kappa analysis from
   Dr Joeeph Angell. Finally, the authors wish to acknowledge the kind
   support for research activities offered by the UK equine slaughter
   industry.
CR Argo CM, 2012, VET J
   Argo CM, 2014, FARM ANIMAL IMAGING, P14
   Bailey SR, 2008, AM J VET RES, V69, P122, DOI 10.2460/ajvr.69.1.122
   Bruynsteen L, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-240
   Burns TA, 2010, J VET INTERN MED, V24, P932, DOI 10.1111/j.1939-1676.2010.0551.x
   Burrows AM, 2013, J EQUINE VET SCI, V33, P361
   CARROLL CL, 1988, EQUINE VET J, V20, P41, DOI 10.1111/j.2042-3306.1988.tb01451.x
   Catalano KJ, 2010, DIABETES, V59, P1416, DOI 10.2337/db08-0675
   Chapados N, 2008, BRIT J NUTR, V100, P518, DOI 10.1017/S0007114508921735
   Chaston TB, 2008, INT J OBESITY, V32, P619, DOI 10.1038/sj.ijo.0803761
   Cohen CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066477
   Dugdale AHA, 2011, EQUINE VET J, V43, P552, DOI 10.1111/j.2042-3306.2010.00330.x
   Dugdale AHA, 2012, VET J, V194, P173, DOI 10.1016/j.tvjl.2012.03.024
   Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336
   Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355
   Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002
   Geor RJ, 2008, J EQUINE VET SCI, V28, P753, DOI 10.1016/j.jevs.2008.10.016
   Giles SL, 2014, PEERJ, V2, DOI 10.7717/peerj.299
   Gjerlaug-Enger E, 2012, ANIMAL, V6, P9, DOI 10.1017/S1751731111001455
   Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777
   HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x
   Holbrook TC, 2012, VET IMMUNOL IMMUNOP, V145, P283, DOI 10.1016/j.vetimm.2011.11.013
   Hung C-S, 2014, PLOS ONE, V9
   Kearns CF, 2002, VET J, V163, P260, DOI 10.1053/tvjl.2001.0656
   Kohnke J, 1992, FEEDING NUTR MAKING, P163
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lottati M, 2009, OBESITY, V17, P674, DOI 10.1038/oby.2008.642
   Mair TS, 2005, EQUINE VET J, V37, P296, DOI 10.2746/0425164054529409
   Martin-Gimenez T, 2016, J EQUINE VET SCI, V39, P69, DOI 10.1016/j.jevs.2016.01.010
   Mottet R, 2009, J EQUINE VET SCI, V29, P417
   Newkirk KM, 2014, OPEN J VET MED, P190
   Okada K, 2014, J CARDIOVASC MED, V15, P384, DOI 10.2459/JCM.0b013e32836094da
   Robin CA, 2015, EQUINE VET J, V47, P196, DOI 10.1111/evj.12275
   Ross R, 1992, QUANTIFICATION ADIPO, P787
   Sacks HS, 2009, J CLIN ENDOCR METAB, V94, P3611, DOI 10.1210/jc.2009-0571
   Sim J, 2005, PHYS THER, V85, P257
   Smith SR, 2001, METABOLISM, V50, P425, DOI 10.1053/meta.2001.21693
   Speakman JR, 2003, AGING CELL, V2, P265, DOI 10.1046/j.1474-9728.2003.00061.x
   Trayhurn Paul, 2011, Archives of Physiology and Biochemistry, V117, P47, DOI 10.3109/13813455.2010.535835
   Vick MM, 2007, J ANIM SCI, V85, P1144, DOI 10.2527/jas.2006-673
   Wang CP, 2009, CLIN ENDOCRINOL, V70, P876, DOI 10.1111/j.1365-2265.2008.03411.x
   WESTERVELT RG, 1976, J ANIM SCI, V43, P781
   Wronska A, 2012, ACTA PHYSIOL, V205, P194, DOI 10.1111/j.1748-1716.2012.02409.x
   Wylie CE, 2013, RES VET SCI, V95, P410, DOI 10.1016/j.rvsc.2013.05.004
NR 44
TC 2
Z9 2
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 15
PY 2017
VL 12
IS 3
AR e0173753
DI 10.1371/journal.pone.0173753
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN9HQ
UT WOS:000396311700056
PM 28296956
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Yoo, RE
   Yun, TJ
   Yoon, BW
   Lee, SK
   Lee, ST
   Kang, KM
   Choi, SH
   Kim, JH
   Sohn, CH
   Park, SW
   Han, MH
AF Yoo, Roh-Eul
   Yun, Tae Jin
   Yoon, Byung-Woo
   Lee, Sang Kun
   Lee, Soon-Tae
   Kang, Koung Mi
   Choi, Seung Hong
   Kim, Ji-hoon
   Sohn, Chul-Ho
   Park, Sun-Won
   Han, Moon Hee
TI Identification of cerebral perfusion using arterial spin labeling in
   patients with seizures in acute settings
SO PLOS ONE
LA English
DT Article
ID BLOOD-FLOW; STATUS EPILEPTICUS; LOBE EPILEPSY; MRI; DIFFUSION; FOCUS;
   DIAGNOSIS; EEG
AB This study aimed to explore the utility of arterial spin labeling perfusion-weighted imaging (ASL-PWI) in patients with suspected seizures in acute settings. A total of 164 patients who underwent ASL-PWI for suspected seizures in acute settings (with final diagnoses of seizure [n = 129], poststroke seizure [n = 18], and seizure mimickers [n = 17]), were included in this retrospective study. Perfusion abnormality was analyzed for: (1) pattern, (2) multifocality, and (3) atypical distribution against vascular territories. Perfusion abnormality was detected in 39% (50/129) of the seizure patients, most (94%, 47/50) being the hyperperfusion pattern. Of the patients with perfusion abnormality, multifocality or hemispheric involvement and atypical distribution against vascular territory were revealed in 46% (23/50) and 98% (49/50), respectively. In addition, seizures showed characteristic features including hyperperfusion (with or without non-territorial distribution) on ASL-PWI, thus differentiating them from poststroke seizures or seizure mimickers. In patients in whom seizure focus could be localized on both EEG and ASL-PWI, the concordance rate was 77%. The present study demonstrates that ASL-PWI can provide information regarding cerebral perfusion status in patients with seizures in acute settings and has the potential to be used as a non-invasive imaging tool to identify the cerebral perfusion in patients with seizures.
C1 [Yoo, Roh-Eul; Yun, Tae Jin; Kang, Koung Mi; Choi, Seung Hong; Kim, Ji-hoon; Sohn, Chul-Ho; Park, Sun-Won; Han, Moon Hee] Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea.
   [Yoo, Roh-Eul; Yun, Tae Jin; Kang, Koung Mi; Choi, Seung Hong; Kim, Ji-hoon; Sohn, Chul-Ho; Han, Moon Hee] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.
   [Yoon, Byung-Woo; Lee, Sang Kun; Lee, Soon-Tae] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea.
   [Park, Sun-Won] Seoul Natl Univ, Dept Radiol, Boramae Med Ctr, Seoul, South Korea.
RP Yun, TJ (reprint author), Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea.; Yun, TJ (reprint author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.
EM radiologyyun@gmail.com
OI Lee, Soon-Tae/0000-0003-4767-7564; Yun, Tae Jin/0000-0001-8441-4574
FU Seoul National University Hospital Research Fund [04-2012-1000]; Seoul
   National University College of Medicine Research Fund [800-20140025]
FX This study was supported by a grant from the Seoul National University
   Hospital Research Fund [04-2012-1000] and Seoul National University
   College of Medicine Research Fund [800-20140025]. TJY received the
   funding. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.; This
   study was supported by a grant from the Seoul National University
   Hospital Research Fund [04-2012-1000] and Seoul National University
   College of Medicine Research Fund [80020140025].
CR Alsop DC, 2002, EPILEPSIA, V43, P69, DOI 10.1046/j.1528-1157.2002.043s1069.x
   Arntz R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055498
   Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617
   Bradley WG, 2000, RADIOLOGY, V214, P651, DOI 10.1148/radiology.214.3.r00mr42651
   Calistri V, 2003, AM J NEURORADIOL, V24, P671
   DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106
   Duncan JS, 2010, NAT REV NEUROL, V6, P537, DOI 10.1038/nrneurol.2010.131
   DUNCAN R, 1992, CEREBROVAS BRAIN MET, V4, P105
   Galazzo IB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123975
   Guo XQ, 2015, J MAGN RESON IMAGING, V42, P1386, DOI 10.1002/jmri.24920
   HEISS WD, 1992, J CEREBR BLOOD F MET, V12, P193, DOI 10.1038/jcbfm.1992.29
   Kanazawa Y, 2015, J STROKE CEREBROVASC, V24, P731, DOI 10.1016/j.jstrokecerebrovasdis.2014.09.026
   Kim BS, 2016, EUR J RADIOL, V85, P1295, DOI 10.1016/j.ejrad.2016.04.015
   Kim S, 2011, INT J MOL IMAGING, V2011, DOI DOI 10.1155/2011/813028
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leonhardt G, 2005, EPILEPSIA, V46, P1943, DOI 10.1111/j.1528-1167.2005.00336.x
   Lim YM, 2008, EPILEPSY RES, V82, P183, DOI 10.1016/j.eplepsyres.2008.08.001
   Matsuura K, 2015, J NEUROL SCI, V359, P424, DOI 10.1016/j.jns.2015.10.009
   Oishi M, 2012, NEURORADIOLOGY, V54, P653, DOI 10.1007/s00234-012-1027-7
   Pendse N, 2010, J NEURORADIOLOGY, V37, P60, DOI 10.1016/j.neurad.2009.05.006
   Pizzini F, 2008, EPILEPSY RES, V81, P225, DOI 10.1016/j.eplepsyres.2008.06.009
   Pizzini FB, 2013, MAGN RESON IMAGING, V31, P1001, DOI 10.1016/j.mri.2013.03.023
   Placidi F, 2002, EPILEPSIA, V43, P1515, DOI 10.1046/j.1528-1157.2002.04702.x
   Pollock JM, 2008, J COMPUT ASSIST TOMO, V32, P291, DOI 10.1097/RCT.0b013e31814cf81f
   Schwartz Theodore H, 2007, Epilepsy Curr, V7, P91, DOI 10.1111/j.1535-7511.2007.00183.x
   Smith SJM, 2005, J NEUROL NEUROSUR PS, V76, P2, DOI 10.1136/jnnp.2005.069245
   Stafstrom CE, 2015, COLD SPRING HARB PER, V5
   Sugita K, 2014, SEIZURE-EUR J EPILEP, V23, P318, DOI 10.1016/j.seizure.2014.01.005
   Szabo K, 2005, BRAIN, V128, P1369, DOI 10.1093/brain/awh454
   Toledo M, 2008, EPILEPSIA, V49, P1465, DOI 10.1111/j.1528-1167.2008.01620.x
   Toledo M, 2011, EPILEPTIC DISORD, V13, P336, DOI 10.1684/epd.2011.0445
   WILDERSMITH E, 1991, NEUROLOGY, V41, P2005, DOI 10.1212/WNL.41.12.2005
   WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212
   Wolf RL, 2001, AM J NEURORADIOL, V22, P1334
   Yoo RE, 2013, J MAGN RESON IMAGING, V38, P852, DOI 10.1002/jmri.24026
   Yu JT, 2008, BRAIN RES REV, V59, P34, DOI 10.1016/j.brainresrev.2008.04.008
NR 36
TC 6
Z9 6
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 14
PY 2017
VL 12
IS 3
AR e0173538
DI 10.1371/journal.pone.0173538
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN6DM
UT WOS:000396094700031
PM 28291816
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Borschmann, KN
   Rewell, SS
   Iuliano, S
   Ghasem-Zadeh, A
   Davey, RA
   Ho, HD
   Skeers, PN
   Bernhardt, J
   Howells, DW
AF Borschmann, Karen N.
   Rewell, Sarah S.
   Iuliano, Sandra
   Ghasem-Zadeh, Ali
   Davey, Rachel A.
   Ho, Heidi
   Skeers, Peta N.
   Bernhardt, Julie
   Howells, David W.
TI Reduced bone formation markers, and altered trabecular and cortical bone
   mineral densities of non-paretic femurs observed in rats with ischemic
   stroke: A randomized controlled pilot study
SO PLOS ONE
LA English
DT Article
ID MIDDLE CEREBRAL-ARTERY; MICRO-COMPUTED TOMOGRAPHY; PHYSICAL-ACTIVITY;
   OCCLUSION; MODEL; GUIDELINES; INJURY; MASS
AB Background
   Immobility and neural damage likely contribute to accelerated bone loss after stroke, and subsequent heightened fracture risk in humans.
   Objective
   To investigate the skeletal effect of middle cerebral artery occlusion (MCAo) stroke in rats and examine its utility as a model of human post-stroke bone loss.
   Methods
   Twenty 15-week old spontaneously hypertensive male rats were randomized to MCAo or sham surgery controls. Primary outcome: group differences in trabecular bone volume fraction (BV/TV) measured by Micro-CT (10.5 micron istropic voxel size) at the ultra-distal femur of stroke affected left legs at day 28. Neurological impairments (stroke behavior and foot faults) and physical activity (cage monitoring) were assessed at baseline, and days 1 and 27. Serum bone turnover markers (formation: N-terminal propeptide of type 1 procollagen, PINP; resorption: C-terminal telopeptide of type 1 collagen, CTX) were assessed at baseline, and days 7 and 27.
   Results
   No effect of stroke was observed on BV/TV or physical activity, but PINP decreased by -24.5% (IQR-34.1,-10.5, p= 0.046) at day 27. In controls, cortical bone volume (5.2%, IQR 3.2, 6.9) and total volume (6.4%, IQR 1.2, 7.6) were higher in right legs compared to left legs, but these side-to-side differences were not evident in stroke animals.
   Conclusion
   MCAo may negatively affect bone formation. Further investigation of limb use and physical activity patterns after MCAo is required to determine the utility of this current model as a representation of human post-stroke bone loss.
C1 [Borschmann, Karen N.; Bernhardt, Julie] La Trobe Univ, Sch Allied Hlth, Bundoora, Vic, Australia.
   [Borschmann, Karen N.; Rewell, Sarah S.; Ho, Heidi; Skeers, Peta N.; Bernhardt, Julie; Howells, David W.] Florey Inst Neurosci & Mental Hlth, Stroke Div, Heidelberg, Vic, Australia.
   [Borschmann, Karen N.; Bernhardt, Julie] NHMRC Ctr Res Excellence Stroke Rehabil & Recover, Melbourne, Vic, Australia.
   [Iuliano, Sandra; Ghasem-Zadeh, Ali] Univ Melbourne, Austin Hlth, Dept Endocrinol, Heidelberg, Vic, Australia.
   [Iuliano, Sandra; Ghasem-Zadeh, Ali; Davey, Rachel A.] Univ Melbourne, Austin Hlth, Dept Med, Heidelberg, Vic, Australia.
   [Howells, David W.] Univ Tasmania, Sch Med, Fac Hlth, Hobart, Tas, Australia.
RP Borschmann, KN (reprint author), La Trobe Univ, Sch Allied Hlth, Bundoora, Vic, Australia.; Borschmann, KN (reprint author), Florey Inst Neurosci & Mental Hlth, Stroke Div, Heidelberg, Vic, Australia.; Borschmann, KN (reprint author), NHMRC Ctr Res Excellence Stroke Rehabil & Recover, Melbourne, Vic, Australia.
EM karen.borschmann@florey.edu.au
RI Borschmann, Karen/I-3692-2016; Bernhardt, Julie/F-9538-2015
OI Borschmann, Karen/0000-0001-5364-2718; Howells,
   David/0000-0002-2512-7724; Bernhardt, Julie/0000-0002-2787-8484
CR Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107
   Batchelor PE, 2010, J NEUROTRAUM, V27, P1357, DOI 10.1089/neu.2010.1360
   Bernhardt J, 2016, INT J STROKE
   Bolton DAE, 2006, BEHAV BRAIN RES, V168, P272, DOI 10.1016/j.bbr.2005.11.017
   BORLONGAN CV, 1995, PHYSIOL BEHAV, V58, P909, DOI 10.1016/0031-9384(95)00103-P
   Borschmann K, 2012, STROKE RES TREAT, DOI 10.1155/2012/103697
   Borschmann K, 2012, INT J STROKE, V7, P330, DOI 10.1111/j.1747-4949.2011.00645.x
   Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141
   Chiang C, 2009, J BONE MINER RES, V24, P621, DOI 10.1359/JBMR.081217
   Dion N, 2011, OSTEOPOROSIS RESEARCH: ANIMAL MODELS, P37, DOI 10.1007/978-0-85729-293-3_4
   Driessler F, 2010, J MOL ENDOCRINOL, V45, P175, DOI 10.1677/JME-10-0015
   English C, 2014, PHYS THER, V94, P185, DOI 10.2522/ptj.20130175
   Erben R, 2003, HDB HISTOLOGY METHOD
   Erben RG, 2000, J BONE MINER RES, V15, P1085, DOI 10.1359/jbmr.2000.15.6.1085
   Fisher A, 2013, STROKE RES TREAT, DOI 10.1155/2013/641943
   FOX KM, 1995, ANAT RECORD, V241, P284, DOI 10.1002/ar.1092410215
   Freret T, 2006, BEHAV NEUROSCI, V120, P1285, DOI 10.1037/0735-7044.120.6.1285
   HUGHES PCR, 1970, J ANAT, V106, P371
   Jamsa T, 1999, J BONE MINER RES, V14, P1708, DOI 10.1359/jbmr.1999.14.10.1708
   Jorgensen L, 2001, CALCIFIED TISSUE INT, V68, P11, DOI 10.1007/BF02684997
   Jorgensen L, 2001, BONE, V28, P655, DOI 10.1016/S8756-3282(01)00434-3
   Jorgensen L, 2000, OSTEOPOROSIS INT, V11, P381, DOI 10.1007/s001980070103
   Kanis J, 2001, STROKE, V32, P702, DOI 10.1161/01.STR.32.3.702
   Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x
   Laib A, 2000, MED BIOL ENG COMPUT, V38, P326, DOI 10.1007/BF02347054
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee JI, 2005, BRAIN INJURY, V19, P1207, DOI 10.1080/02699050500309338
   Metz GA, 2009, J VIS EXP
   Miklyaeva EI, 1997, BEHAV BRAIN RES, V88, P143, DOI 10.1016/S0166-4328(97)00043-0
   Pang MYC, 2007, OSTEOPOROSIS INT, V18, P1243, DOI 10.1007/s00198-007-0372-6
   Petullo D, 1999, LIFE SCI, V64, P1099, DOI 10.1016/S0024-3205(99)00038-7
   Quinn LP, 2005, BRAIN RES, V1031, P118, DOI 10.1016/j.brainres.2004.10.036
   Rewell SSJ, 2010, J CEREBR BLOOD F MET, V30, P729, DOI 10.1038/jcbfm.2009.273
   Roach HI, 2003, J HISTOCHEM CYTOCHEM, V51, P373, DOI 10.1177/002215540305100312
   Snow LM, 2012, AM J PHYS MED REHAB, V91, P965, DOI 10.1097/PHM.0b013e31825f18e1
   Stryjek R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066055
   Vasikaran S, 2011, OSTEOPOROSIS INT, V22, P391, DOI 10.1007/s00198-010-1501-1
   Vignaux G, 2015, J BONE MINER RES, V30, P1103, DOI 10.1002/jbmr.2426
   Vignaux G, 2013, J BONE MINER RES, V28, P2136, DOI 10.1002/jbmr.1940
   Windle V, 2005, BRAIN RES, V1044, P25, DOI 10.1016/j.brainres.2005.02.060
   Wong IPL, 2008, SEMIN CELL DEV BIOL, V19, P452, DOI 10.1016/j.semcdb.2008.08.001
   Zebaze R, 2013, BONE, V54, P8, DOI 10.1016/j.bone.2013.01.007
NR 42
TC 0
Z9 0
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 9
PY 2017
VL 12
IS 3
AR e0172889
DI 10.1371/journal.pone.0172889
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN6AW
UT WOS:000396087900131
PM 28278253
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Borlee, F
   Yzermans, CJ
   Krop, E
   Aalders, B
   Rooijackers, J
   Zock, JP
   van Dijk, CE
   Maassen, CBM
   Schellevis, F
   Heederik, D
   Smit, LAM
AF Borlee, Floor
   Yzermans, C. Joris
   Krop, Esmeralda
   Aalders, Bernadette
   Rooijackers, Jos
   Zock, Jan-Paul
   van Dijk, Christel E.
   Maassen, Catharina B. M.
   Schellevis, Francois
   Heederik, Dick
   Smit, Lidwien A. M.
TI Spirometry, questionnaire and electronic medical record based COPD in a
   population survey: Comparing prevalence, level of agreement and
   associations with potential risk factors
SO PLOS ONE
LA English
DT Article
ID OBSTRUCTIVE PULMONARY-DISEASE; IDENTIFY PATIENTS; DEFINITIONS; ASTHMA;
   EPIDEMIOLOGY; VALIDITY; HISTORY; COHORT; ADULTS
AB Background
   COPD-diagnosis is confirmed by post-bronchodilator (BD) spirometry. However, epidemiological studies often rely on pre-BD spirometry, self-reports, or medical records. This population-based study aims to determine COPD-prevalence based on four different operational definitions and their level of agreement, and to compare associations between COPD-definitions and risk factors.
   Methods
   COPD-prevalence in 1,793 adults from the general Dutch population (aged 18-70 years) was assessed based on self-reported data, Electronic Medical Records (EMR), and post-BD spirometry: using the FEV1/FVC below the lower limit of normal (LLN) and GOLD fixed cut-off (FEV1/FVC <0.70). Using spirometry as a reference, sensitivity was calculated for self-reported and EMR-based COPD. Associations between COPD and known risk factors were assessed with logistic regression. Data were collected as part of the cross-sectional VGO study (Livestock Farming and Neighboring Residents' Health Study).
   Results
   The highest prevalence was found based on spirometry (GOLD: 10.9%, LLN: 5.9%), followed by self-report (4.6%) and EMR (2.9%). Self-reported or EMR-based COPD identified less than 30% of all COPD-cases based on spirometry. The direction of association between known risk factors and COPD was similar across the four definitions, however, magnitude and significance varied. Especially indicators of allergy were more strongly associated with self-reported COPD compared to the other definitions.
   Conclusions
   COPD-prevalence varied depending on the used definition. A substantial number of subjects with spirometry-based COPD cannot be identified with questionnaires or medical records which can cause underestimation of COPD-prevalence. The influence of the different COPD-definitions on associations with known risk factors was limited.
C1 [Borlee, Floor; Krop, Esmeralda; Heederik, Dick; Smit, Lidwien A. M.] Univ Utrecht, IRAS, Utrecht, Netherlands.
   [Borlee, Floor; Yzermans, C. Joris; Zock, Jan-Paul; van Dijk, Christel E.; Schellevis, Francois] NIVEL, Inst Hlth Serv Res, Utrecht, Netherlands.
   [Aalders, Bernadette; Rooijackers, Jos] Netherlands Expertise Ctr Occupat Resp Disorders, Utrecht, Netherlands.
   [Maassen, Catharina B. M.] Ctr Infect Dis Control, Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands.
   [Schellevis, Francois] Vrije Univ Amsterdam, Dept Gen Practice & Elderly Care Med, EMGO Inst Hlth & Care Res, Med Ctr, Amsterdam, Netherlands.
RP Smit, LAM (reprint author), Univ Utrecht, IRAS, Utrecht, Netherlands.
EM L.A.Smit@uu.nl
RI Zock, Jan-Paul/P-5034-2018
OI Zock, Jan-Paul/0000-0002-2941-6259; Smit, Lidwien AM/0000-0003-0292-0946
FU Ministry of Health, Welfare and Sports; Ministry of Economic Affairs of
   The Netherlands; Lung Foundation Netherlands [3.2.11.022]
FX The Livestock Farming and Neighbouring Residents' Health (VGO) study was
   funded by the Ministry of Health, Welfare and Sports and the Ministry of
   Economic Affairs of The Netherlands. LAMS received also a grant from the
   Lung Foundation Netherlands (Grant number: 3.2.11.022)
   (www.longfonds.nl/) to support this study. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alexopoulos EC, 2015, INT J CHRONIC OBSTR, V10, P2665, DOI 10.2147/COPD.S91392
   Armstrong BG, 1998, OCCUP ENVIRON MED, V55, P651, DOI 10.1136/oem.55.10.651
   Borlee F, 2015, EUR RESPIR J, V46, P1605, DOI 10.1183/13993003.00265-2015
   Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4
   Burney P, 2015, LUNG FUNCTION PROTOC
   Celli BR, 2003, EUR RESPIR J, V22, P268, DOI 10.1183/09031936.03.00075102
   Cooke CR, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-37
   de Marco R, 2015, EUR RESPIR J, V46, P671, DOI 10.1183/09031936.00008615
   de Marco R, 2011, AM J RESP CRIT CARE, V183, P891, DOI 10.1164/rccm.201007-1125OC
   Dirven JAM, 2010, COPD, V7, P352, DOI 10.3109/15412555.2010.510547
   Doekes G, 1996, OCCUP ENVIRON MED, V53, P63, DOI 10.1136/oem.53.1.63
   Gupta RP, 2014, INT J TUBERC LUNG D, V18, P998, DOI 10.5588/ijtld.13.0910
   Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605
   Jarvis D, 2013, EUR RESP J S57, V42, P1809
   Kjeldgaard P, 2015, INT J CHRONIC OBSTR, V10, P407, DOI 10.2147/COPD.S76047
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leffondre K, 2002, AM J EPIDEMIOL, V156, P813, DOI 10.1093/aje/kwf122
   Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5
   Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805
   Mohangoo AD, 2006, EUR J PUBLIC HEALTH, V16, P101, DOI 10.1093/eurpub/cki043
   Murgia N, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-49
   Peat JK, 2001, THORAX, V56, P406, DOI 10.1136/thorax.56.5.406
   Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205
   Prieto-Centurion V, 2014, AM J RESP CRIT CARE, V190, P989, DOI 10.1164/rccm.201406-1166OC
   Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312
   Romanelli AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149302
   Schermer TRJ, 2008, EUR RESPIR J, V32, P945, DOI 10.1183/09031936.00170307
   Shirtcliffe P, 2007, EUR RESPIR J, V30, P232, DOI 10.1183/09031936.00157906
   van der Molen Thys, 2003, Health Qual Life Outcomes, V1, P13, DOI 10.1186/1477-7525-1-13
   van Dijk CE, 2016, ENV POLLUT
   van Dijk W, 2015, ANN FAM MED, V13, P41, DOI 10.1370/afm.1714
   Verheij R. A., 2014, NIVEL ZORGREGISTRATI
   Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP
   Viegi G, 2007, EUR RESPIR J, V30, P993, DOI 10.1183/09031936.00082507
NR 34
TC 7
Z9 7
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 8
PY 2017
VL 12
IS 3
AR e0171494
DI 10.1371/journal.pone.0171494
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN5VL
UT WOS:000396073700095
PM 28273094
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Nackaerts, E
   Heremans, E
   Smits-Engelsman, BCM
   Broeder, S
   Vandenberghe, W
   Bergmans, B
   Nieuwboer, A
AF Nackaerts, Evelien
   Heremans, Elke
   Smits-Engelsman, Bouwien C. M.
   Broeder, Sanne
   Vandenberghe, Wim
   Bergmans, Bruno
   Nieuwboer, Alice
TI Validity and reliability of a new tool to evaluate handwriting
   difficulties in Parkinson's disease
SO PLOS ONE
LA English
DT Article
ID MOTOR CONTROL; MICROGRAPHIA; DYSFUNCTION; TASKS
AB Background
   Handwriting in Parkinson's disease (PD) features specific abnormalities which are difficult to assess in clinical practice since no specific tool for evaluation of spontaneous movement is currently available.
   Objective
   This study aims to validate the `Systematic Screening of Handwriting Difficulties' (SOS-test) in patients with PD.
   Methods
   Handwriting performance of 87 patients and 26 healthy age-matched controls was examined using the SOS-test. Sixty-seven patients were tested a second time within a period of one month. Participants were asked to copy as much as possible of a text within 5 minutes with the instruction to write as neatly and quickly as in daily life. Writing speed (letters in 5 minutes), size (mm) and quality of handwriting were compared. Correlation analysis was performed between SOS outcomes and other fine motor skill measurements and disease characteristics. Intrarater, interrater and test-retest reliability were assessed using the intraclass correlation coefficient (ICC) and Spearman correlation coefficient.
   Results
   Patients with PD had a smaller (p = 0.043) and slower (p<0.001) handwriting and showed worse writing quality (p = 0.031) compared to controls. The outcomes of the SOS-test significantly correlated with fine motor skill performance and disease duration and severity. Furthermore, the test showed excellent intrarater, interrater and test-retest reliability (ICC > 0.769 for both
   Conclusion
   The SOS-test is a short and effective tool to detect handwriting problems in PD with excellent reliability. It can therefore be recommended as a clinical instrument for standardized screening of handwriting deficits in PD.
C1 [Nackaerts, Evelien; Heremans, Elke; Broeder, Sanne; Nieuwboer, Alice] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium.
   [Smits-Engelsman, Bouwien C. M.] Univ Cape Town, Dept Hlth & Rehabil Sci, Cape Town, South Africa.
   [Vandenberghe, Wim] Katholieke Univ Leuven, Dept Neurosci, Leuven, Belgium.
   [Vandenberghe, Wim] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium.
   [Bergmans, Bruno] AZ Sint Jan Brugge Oostende, Dept Neurol, Brugge, Belgium.
RP Nackaerts, E (reprint author), Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium.
EM evelien.nackaerts@kuleuven.be
OI Nackaerts, Evelien/0000-0002-6580-4902; Broeder,
   Sanne/0000-0002-0891-3264; Nieuwboer, Alice/0000-0003-1193-6229
FU Research Foundation - Flanders (FWO) [G.0906.11]
FX The project was funded by the Research Foundation - Flanders (FWO) with
   grant number G.0906.11. In addition, EN and SB are research assistents,
   EH is a postdoctoral researcher and WV a senior clinical investigator of
   the FWO. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Aly NM, 2007, AGE AGEING, V36, P395, DOI 10.1093/ageing/afm061
   Broeder S, 2014, NEUROSCIENCE, V263, P193, DOI 10.1016/j.neuroscience.2014.01.019
   BROWN TL, 1990, AM J PSYCHOL, V103, P471, DOI 10.2307/1423319
   Chen CC, 2005, J HAND SURG-BRIT EUR, V30B, P207, DOI 10.1016/j.jhsb.2004.12.005
   Dirnberger G, 2013, J NEUROPSYCHOL, V7, P193, DOI 10.1111/jnp.12028
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340
   Harada CN, 2013, CLIN GERIATR MED, V29, P737, DOI 10.1016/j.cger.2013.07.002
   Hayes J. R., 1996, SCI WRITING THEORIES, P1, DOI DOI 10.1007/978-94-007-1048-1_2
   Heremans E, 2016, NEUROREHABIL NEURAL
   Heremans E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142874
   HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427
   Kim EJ, 2005, PARKINSONISM RELAT D, V11, P57, DOI 10.1016/j.parkreldis.2004.08.005
   Koerts J, 2009, CORTEX, V45, P922, DOI 10.1016/j.cortex.2009.02.014
   Kudlicka A, 2011, MOVEMENT DISORD, V26, P2305, DOI 10.1002/mds.23868
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lange KW, 2006, HUM MOVEMENT SCI, V25, P492, DOI 10.1016/j.humov.2006.05.006
   Letanneux A, 2014, MOVEMENT DISORD, V29, P1467, DOI 10.1002/mds.25990
   Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95
   Nackaerts E, 2015, NEUROREHABIL NEURAL
   Nackaerts E, 2016, MOVEMENT DISORD, V31, P1209, DOI 10.1002/mds.26565
   Nackaerts E, 2016, NEUROREHAB NEURAL RE, V30, P431, DOI 10.1177/1545968315601361
   OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4
   Ponsen MM, 2008, PARKINSONISM RELAT D, V14, P199, DOI 10.1016/j.parkreldis.2007.07.019
   Proud EL, 2015, ARCH PHYS MED REHAB, V96, P540, DOI 10.1016/j.apmr.2014.09.016
   Proud EL, 2010, ARCH PHYS MED REHAB, V91, P794, DOI 10.1016/j.apmr.2010.01.008
   Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915
   Rosenblum S, 2013, J NEUROL
   San Luciano M, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0162799
   Saunders-Pullman R, 2008, MOVEMENT DISORD, V23, P531, DOI 10.1002/mds.21874
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Shukla AW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000628
   Smits EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097614
   Teulings HL, 1997, EXP NEUROL, V146, P159, DOI 10.1006/exnr.1997.6507
   Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266
   Tucha O, 2006, HUM MOVEMENT SCI, V25, P536, DOI 10.1016/j.humov.2006.06.002
   van Drempt N, 2011, AUST OCCUP THER J, V58, P321, DOI 10.1111/j.1440-1630.2011.00960.x
   Van Gemmert AWA, 2003, J NEUROL NEUROSUR PS, V74, P1502, DOI 10.1136/jnnp.74.11.1502
   van Gemmert AWA, 1998, ACTA PSYCHOL, V100, P161, DOI 10.1016/S0001-6918(98)00032-8
   van Lummel RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151881
   Van Waelvelde H, 2012, PHYS OCCUP THER PEDI, V32, P306, DOI 10.3109/01942638.2012.678971
   Wu T, 2015, BRAIN
   Wu T, 2015, NEUROBIOL DIS, V82, P226, DOI 10.1016/j.nbd.2015.06.014
   Zhi  N., 2016, IEEE J BIOMED HLTH I
NR 44
TC 3
Z9 4
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 2
PY 2017
VL 12
IS 3
AR e0173157
DI 10.1371/journal.pone.0173157
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN4XX
UT WOS:000396011300084
PM 28253374
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Huber, T
   Alber, G
   Bette, S
   Kaesmacher, J
   Boeckh-Behrens, T
   Gempt, J
   Ringel, F
   Specht, HM
   Meyer, B
   Zimmer, C
   Wiestler, B
   Kirschke, JS
AF Huber, Thomas
   Alber, Georgina
   Bette, Stefanie
   Kaesmacher, Johannes
   Boeckh-Behrens, Tobias
   Gempt, Jens
   Ringel, Florian
   Specht, Hanno M.
   Meyer, Bernhard
   Zimmer, Claus
   Wiestler, Benedikt
   Kirschke, Jan S.
TI Progressive disease in glioblastoma: Benefits and limitations of
   semi-automated volumetry
SO PLOS ONE
LA English
DT Article
ID BRAIN-TUMOR; REGISTRATION TECHNIQUES; RESPONSE ASSESSMENT; ADULT
   GLIOBLASTOMA; MRI; CRITERIA; SEGMENTATION; AGREEMENT; MULTIFORME;
   RESECTION
AB Purpose
   Unambiguous evaluation of glioblastoma (GB) progression is crucial, both for clinical trials as well as day by day routine management of GB patients. 3D-volumetry in the follow-up of GB provides quantitative data on tumor extent and growth, and therefore has the potential to facilitate objective disease assessment. The present study investigated the utility of absolute changes in volume (delta) or regional, segmentation-based subtractions for detecting disease progression in longitudinal MRI follow-ups.
   Methods
   165 high resolution 3-Tesla MRIs of 30 GB patients (23m, mean age 60.2y) were retrospectively included in this single center study. Contrast enhancement (CV) and tumor-related signal alterations in FLAIR images (FV) were semi-automatically segmented. Delta volume (dCV, dFV) and regional subtractions (sCV, sFV) were calculated. Disease progression was classified for every follow-up according to histopathologic results, decisions of the local multidisciplinary CNS tumor board and a consensus rating of the neuro-radiologic report.
   Results
   A generalized logistic mixed model for disease progression (yes / no) with dCV, dFV, sCV and sFV as input variables revealed that only dCV was significantly associated with prediction of disease progression (P = .005). Delta volume had a better accuracy than regional, segmentation-based subtractions (79% versus 72%) and a higher area under the curve by trend in ROC curves (.83 versus .75).
   Conclusion
   Absolute volume changes of the contrast enhancing tumor part were the most accurate volumetric determinant to detect progressive disease in assessment of GB and outweighed FLAIR changes as well as regional, segmentation-based image subtractions. This parameter might be useful in upcoming objective response criteria for glioblastoma.
C1 [Huber, Thomas; Alber, Georgina; Bette, Stefanie; Kaesmacher, Johannes; Boeckh-Behrens, Tobias; Zimmer, Claus; Wiestler, Benedikt; Kirschke, Jan S.] Tech Univ Munich, Klinikum Rechts Isar, Dept Neuroradiol, Munich, Germany.
   [Huber, Thomas] Ludwig Maximilians Univ Hosp, Inst Clin Radiol, Munich, Germany.
   [Gempt, Jens; Ringel, Florian; Meyer, Bernhard] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurosurg, Munich, Germany.
   [Specht, Hanno M.] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, Munich, Germany.
RP Kirschke, JS (reprint author), Tech Univ Munich, Klinikum Rechts Isar, Dept Neuroradiol, Munich, Germany.
EM jan.kirschke@tum.de
RI Ringel, Florian/E-4933-2014; Kirschke, Jan/E-2550-2012; Kaesmacher,
   Johannes/I-6136-2019
OI Kirschke, Jan/0000-0002-7557-0003; Kaesmacher,
   Johannes/0000-0002-9177-2289
FU German Research Foundation (DFG); Technical University of Munich (TUM);
   KKF scholarship of the TUM
FX This work was supported by the German Research Foundation (DFG) and the
   Technical University of Munich (TUM) in the framework of the Open Access
   Publishing Program. BW is supported through the KKF scholarship of the
   TUM. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Allen JS, 2008, NEUROIMAGE, V42, P535, DOI 10.1016/j.neuroimage.2008.05.047
   Bauer S, 2013, PHYS MED BIOL, V58, pR97, DOI 10.1088/0031-9155/58/13/R97
   Bette S, 2016, WORLD NEUROSURG
   Chow DS, 2014, AM J NEURORADIOL, V35, P498, DOI 10.3174/ajnr.A3724
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Cordova JS, 2016, MOL IMAGING BIOL, V18, P454, DOI 10.1007/s11307-015-0900-2
   Egger J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01364
   Ellingson BM, 2015, NEURO-ONCOLOGY, V17, P1188, DOI 10.1093/neuonc/nov095
   Ellingson BM, 2011, NEURO-ONCOLOGY, V13, P401, DOI 10.1093/neuonc/noq206
   Galanis E, 2006, NEURO-ONCOLOGY, V8, P156, DOI 10.1215/15228517-2005005
   Gholipour A, 2007, IEEE T MED IMAGING, V26, P427, DOI 10.1109/TMI.2007.892508
   Gibbs P, 1996, PHYS MED BIOL, V41, P2437, DOI 10.1088/0031-9155/41/11/014
   Gzell CE, 2016, J NEURO-ONCOL, V128, P67, DOI 10.1007/s11060-016-2074-4
   Hojjatoleslami SA, 1998, IEEE T IMAGE PROCESS, V7, P1079, DOI 10.1109/83.701170
   Huber T, 2015, CLIN NEURORADIOL
   Joe BN, 1999, RADIOLOGY, V212, P811, DOI 10.1148/radiology.212.3.r99se22811
   Kanaly CW, 2014, J NEUROSURG, V121, P536, DOI 10.3171/2014.4.JNS121952
   Kerkhof M, 2016, EUR J NEUROL
   Kleesiek J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25007
   Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037
   Kubben PL, 2010, NEUROSURGERY, V67, P1329, DOI 10.1227/NEU.0b013e3181efbb08
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277
   Mazzara GP, 2004, INT J RADIAT ONCOL, V59, P300, DOI 10.1016/j.ijrobp.2004.01.026
   Meier R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23376
   Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694
   Porz N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096873
   Powell MJD, 2003, MATH PROGRAM, V97, P605, DOI 10.1007/s10107-003-0430-6
   Radbruch A, 2012, NEURO-ONCOLOGY, V14, P222, DOI 10.1093/neuonc/nor200
   Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77
   Shah GD, 2006, NEURO-ONCOLOGY, V8, P38, DOI 10.1215/S1522851705000529
   Szwarc P, 2015, COMPUT MED IMAG GRAP, V46, P178, DOI 10.1016/j.compmedimag.2015.06.002
   Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205
   Vos MJ, 2003, NEUROLOGY, V60, P826, DOI 10.1212/01.WNL.0000049467.54667.92
   Wang MY, 2012, EUR J RADIOL, V81, P2370, DOI 10.1016/j.ejrad.2011.05.017
   Wang MY, 2011, NEURORADIOLOGY, V53, P565, DOI 10.1007/s00234-010-0789-z
   Weltens C, 2001, RADIOTHER ONCOL, V60, P49, DOI 10.1016/S0167-8140(01)00371-1
   Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541
   Wma General Assembly, 1964, WORLD MED ASS DECL H, P0
   Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016
   Young RJ, 2011, NEUROLOGY, V76, P1918, DOI 10.1212/WNL.0b013e31821d74e7
NR 41
TC 6
Z9 6
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 28
PY 2017
VL 12
IS 2
AR e0173112
DI 10.1371/journal.pone.0173112
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN4LY
UT WOS:000395980200056
PM 28245291
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chong, JU
   Hwang, HK
   Lee, JH
   Yun, M
   Kang, CM
   Lee, WJ
AF Chong, Jae Uk
   Hwang, Ho Kyoung
   Lee, Jin Ho
   Yun, Mijin
   Kang, Chang Moo
   Lee, Woo Jung
TI Clinically determined type of F-18-fluoro-2-deoxyglucose uptake as an
   alternative prognostic marker in resectable pancreatic cancer
SO PLOS ONE
LA English
DT Article
ID POSITRON-EMISSION-TOMOGRAPHY; METABOLIC TUMOR BURDEN; PREOPERATIVE
   F-18-FDG PET/CT; TOTAL LESION GLYCOLYSIS; RADIATION-THERAPY; FDG-PET;
   VOLUME; ADENOCARCINOMA; RECURRENCE; DIFFERENTIATION
AB Purpose
   To investigate the association between clinical PET (positron emission tomography) type and oncologic outcome in resectable pancreatic cancer.
   Methods
   Between January 2008 and October 2012, patients who underwent potentially curative resection for resectable pancreatic ductal adenocarcinoma without neoadjuvant treatment were retrospectively investigated. Clinical PET type was defined as follows: pancreatic cancer with similar 18 FDG uptake to renal calyx was determined as kidney-type (K-type), and relatively lower 18 FDG uptake than that of renal calyx was regarded as Non-K type.
   Results
   A total of 53 patients were enrolled. After agreement-based reclassification, agreement based K-type (aK-type) was noted in 34 patients (64.2%), and agreement based Non-K type (aNon K-type) was found in 19 patients (35.8%). There was a significant difference between aK-type and aNon K-type pancreatic cancer (tumor size (P = 0.030), adjusted CA 19 - 9 (P = 0.007), maximum standard uptake value (SUVmax, P<0.001), metabolic tumor volume (MTV2.5, P<0.001), total lesion glycolysis (TLG, P<0.001)). K-type pancreatic cancer (n = 31) showed a significantly shorter disease-free time compared with Non-K type (n = 16) (10.8 vs. 24.1 months, P = 0.013). It was also noted that aK-type showed inferior diseasefree survival to that of aNon-K type pancreatic cancer (11.9 vs. 28.6 months, P = 0.012).
   Conclusions
   Clinical PET type is a reliable clinical marker to estimate aggressive tumor biology and can be utilized in predicting tumor recurrence and necessity for postoperative chemotherapy.
C1 [Chong, Jae Uk; Hwang, Ho Kyoung; Kang, Chang Moo; Lee, Woo Jung] Yonsei Univ, Coll Med, Dept Surg, Div Hepatobil & Pancreat Surg, Seoul, South Korea.
   [Chong, Jae Uk; Hwang, Ho Kyoung; Yun, Mijin; Kang, Chang Moo; Lee, Woo Jung] Severance Hosp, Yonsei Canc Ctr, Pancreaticobiliary Canc Clin, Seoul, South Korea.
   [Lee, Jin Ho] Ilsan Hosp, Natl Hlth Insurance Corp, Dept Surg, Goyang, South Korea.
   [Yun, Mijin] Yonsei Univ, Coll Med, Dept Nucl Med, Seoul, South Korea.
RP Kang, CM (reprint author), Yonsei Univ, Coll Med, Dept Surg, Div Hepatobil & Pancreat Surg, Seoul, South Korea.; Kang, CM (reprint author), Severance Hosp, Yonsei Canc Ctr, Pancreaticobiliary Canc Clin, Seoul, South Korea.
EM cmkang@yuhs.ac
OI Lee, Woo jung/0000-0001-9273-261X; Yun, Mijin/0000-0002-1712-163X; Kang,
   Chang Moo/0000-0002-5382-4658; Hwang, Ho Kyoung/0000-0003-4064-7776
CR Adams MC, 2010, AM J ROENTGENOL, V195, P310, DOI 10.2214/AJR.10.4923
   Ahn SJ, 2014, ANN NUCL MED, V28, P430, DOI 10.1007/s12149-014-0833-x
   Bang S, 2006, J CLIN GASTROENTEROL, V40, P923, DOI 10.1097/01.mcg.0000225672.68852.05
   Castell F, 2008, BRIT J CANCER, V98, P1597, DOI 10.1038/sj.bjc.6604330
   Choi HJ, 2015, EUR J NUCL MED MOL I, V42, P841, DOI 10.1007/s00259-014-2907-3
   Choi HJ, 2014, YONSEI MED J, V55, P1498, DOI 10.3349/ymj.2014.55.6.1498
   Choi M, 2010, AM J CLIN ONCOL-CANC, V33, P257, DOI 10.1097/COC.0b013e3181a76a0b
   Dai T, 2014, CURR TREAT OPTION ON, V15, P351, DOI 10.1007/s11864-014-0301-9
   Dholakia AS, 2014, INT J RADIAT ONCOL, V89, P539, DOI 10.1016/j.ijrobp.2014.02.031
   Donswijk ML, 2014, PET CLIN, V9, P421, DOI 10.1016/j.cpet.2014.07.001
   Epelbaum R, 2013, J NUCL MED, V54, P12, DOI 10.2967/jnumed.112.107466
   Fukukura Y, 2014, EUR J RADIOL, V83, P612, DOI 10.1016/j.ejrad.2013.12.016
   Heinrich S, 2008, ANN SURG, V248, P1014, DOI 10.1097/SLA.0b013e318190a6da
   Jacene HA, 2009, J NUCL MED, V50, P1760, DOI 10.2967/jnumed.109.063321
   Kang CM, 2007, J SURG RES, V140, P31, DOI 10.1016/j.jss.2006.10.007
   Kang CM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003452
   Kang CM, 2014, PANCREATOLOGY, V14, P515, DOI 10.1016/j.pan.2014.08.003
   Kang CM, 2013, SURG ONCOL, V22, P123, DOI 10.1016/j.suronc.2013.02.007
   Kawada N, 2015, PANCREAS, V44, P655, DOI 10.1097/MPA.0000000000000313
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee JW, 2014, J NUCL MED, V55, P898, DOI 10.2967/jnumed.113.131847
   Li B, 2014, ASIAN PAC J CANCER P, V15, P3555, DOI 10.7314/APJCP.2014.15.8.3555
   Lodge MA, 1999, EUR J NUCL MED, V26, P22, DOI 10.1007/s002590050355
   Min JH, 2015, EUR J RADIOL, V84, P1036, DOI 10.1016/j.ejrad.2015.03.002
   Minamimoto R, 2007, ANN NUCL MED, V21, P217, DOI 10.1007/s12149-007-0012-4
   Moon SH, 2013, KOREAN J RADIOL, V14, P1, DOI 10.3348/kjr.2013.14.1.1
   Nakamoto Y, 2000, CANCER-AM CANCER SOC, V89, P2547, DOI 10.1002/1097-0142(20001215)89:12<2547::AID-CNCR5>3.0.CO;2-V
   Obara P, 2013, CHINESE J CANCER RES, V25, P615, DOI 10.3978/j.issn.1000-9604.2013.11.10
   Park MS, 2009, RADIOLOGY, V250, P110, DOI 10.1148/radiol.2493080226
   Shi S, 2015, CANCER LETT, V360, P227, DOI 10.1016/j.canlet.2015.02.014
   Smith TAD, 2001, NUCL MED BIOL, V28, P1, DOI 10.1016/S0969-8051(00)00177-3
   Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774
   Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007
   Toriihara A, 2015, AM J NUCL MED MOLEC, V5, P204
   Wang XY, 2014, HEPATO-GASTROENTEROL, V61, P2102, DOI 10.5754/hge14394
   Xu HX, 2014, EUR J NUCL MED MOL I, V41, P1093, DOI 10.1007/s00259-014-2688-8
   YAMADA S, 1995, J NUCL MED, V36, P1301
   Yamamoto T, 2015, ANN SURG ONCOL, V22, P677, DOI 10.1245/s10434-014-4046-2
NR 38
TC 2
Z9 2
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 24
PY 2017
VL 12
IS 2
AR e0172606
DI 10.1371/journal.pone.0172606
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EL5VB
UT WOS:000394688200100
PM 28235029
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hu, BF
   Chen, SC
   Hu, J
   Xia, F
   Xu, JF
   Li, Y
   Shi, Z
AF Hu, Bifeng
   Chen, Songchao
   Hu, Jie
   Xia, Fang
   Xu, Junfeng
   Li, Yan
   Shi, Zhou
TI Application of portable XRF and VNIR sensors for rapid assessment of
   soil heavy metal pollution
SO PLOS ONE
LA English
DT Article
ID RAY-FLUORESCENCE SPECTROMETRY; ORGANIC-MATTER; REFLECTANCE SPECTROSCOPY;
   SPECTRAL LIBRARY; URBAN SOILS; PREDICTION; CONTAMINATION; CHINA;
   FEASIBILITY; REGRESSION
AB Rapid heavy metal soil surveys at large scale with high sampling density could not be conducted with traditional laboratory physical and chemical analyses because of the high cost, low efficiency and heavy workload involved. This study explored a rapid approach to assess heavy metals contamination in 301 farmland soils from Fuyang in Zhejiang Province, in the southern Yangtze River Delta, China, using portable proximal soil sensors. Portable X-ray fluorescence spectroscopy (PXRF) was used to determine soil heavy metals total concentrations while soil pH was predicted by portable visible-near infrared spectroscopy (PVNIR). Zn, Cu and Pb were successfully predicted by PXRF (R-2 > 0.90 and RPD > 2.50) while As and Ni were predicted with less accuracy (R-2 <0.75 and RPD <1.40). The pH values were well predicted by PVNIR. Classification of heavy metals contamination grades in farmland soils was conducted based on previous results; the Kappa coefficient was 0.87, which showed that the combination of PXRF and PVNIR was an effective and rapid method to determine the degree of pollution with soil heavy metals. This study provides a new approach to assess soil heavy metals pollution; this method will facilitate large-scale surveys of soil heavy metal pollution.
C1 [Hu, Bifeng; Hu, Jie; Xia, Fang; Shi, Zhou] Zhejiang Univ, Inst Agr Remote Sensing & Informat Technol Applic, Hangzhou, Zhejiang, Peoples R China.
   [Chen, Songchao] INRA, Ardon, InfoSol Unit, Orleans, France.
   [Chen, Songchao] AGROCAMPUS OUEST, INRA, UMR SAS, Rennes, France.
   [Xu, Junfeng] Hangzhou Normal Univ, Coll Sci, Hangzhou, Zhejiang, Peoples R China.
   [Li, Yan] Zhejiang Univ, Sch Publ Affairs, Inst Land Sci & Property Management, Hangzhou, Zhejiang, Peoples R China.
RP Li, Y (reprint author), Zhejiang Univ, Sch Publ Affairs, Inst Land Sci & Property Management, Hangzhou, Zhejiang, Peoples R China.
EM liyan522@zju.edu.cn
RI Hu, Bifeng/G-2190-2018; shi, Zhou/M-7845-2019; shi, Zhou/A-2283-2015
OI shi, Zhou/0000-0003-3914-5402; shi, Zhou/0000-0003-3914-5402; Chen,
   Songchao/0000-0003-1245-0482
FU Key Research and Development Project of Zhejiang Province
   [2015C02G1320007]; Fundamental Research Funds for the Central
   Universities
FX This work was founded by Key Research and Development Project of
   Zhejiang Province (2015C02G1320007) and Fundamental Research Funds for
   the Central Universities. The authors thankfully acknowledge Professors
   Jie Peng and Shuo Li for their suggestions for this paper. Thanks to
   Zongzheng Liang and Yuanyuan Yang for their assistance in soil samples
   analysis. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Alam N, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4855-1
   Carr R, 2008, ENVIRON GEOCHEM HLTH, V30, P45, DOI 10.1007/s10653-007-9106-0
   Chang CW, 2001, SOIL SCI SOC AM J, V65, P480, DOI 10.2136/sssaj2001.652480x
   Chen SC, 2016, SPECTROSC SPECT ANAL, V36, P1712, DOI 10.3964/j.issn.1000-0593(2016)06-1712-05
   China National Environmental Protection Agency, 1995, GB156181995 CHIN NAT
   China National Environmental Protection Agency, 2004, HJT1662004 CHIN NAT
   Horta A, 2015, GEODERMA, V241, P180, DOI 10.1016/j.geoderma.2014.11.024
   Huang QT, 2009, SPECTROSC SPECT ANAL, V5, P1434
   Huo XD, 2004, APPL SPECTROSCOPY RE, V39, P1
   Ji WJ, 2012, SPECTROSC SPECT ANAL, V32, P2393, DOI 10.3964/j.issn.1000-0593(2012)09-2393-06
   Kibride C, 2006, ENVIRON POLLUT, V143, P16, DOI [10.1016/j.envpol.2005.11.013, DOI 10.1016/J.ENVPOL.2005.11.013]
   Kodom K, 2012, SOIL SEDIMENT CONTAM, V21, P1006, DOI 10.1080/15320383.2012.712073
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Li S, 2008, ENVIRON SCI TECHNOL, P03
   Li S, 2015, REMOTE SENS-BASEL, V7, P7029, DOI 10.3390/rs70607029
   Liu R, 2016, ENVIRON POLLUT, V210, P174, DOI 10.1016/j.envpol.2015.11.044
   Lu AX, 2010, SPECTROSC SPECT ANAL, V30, P2848, DOI 10.3964/j.issn.1000-0593(2010)10-2848-05
   Luo XS, 2012, SCI TOTAL ENVIRON, V421, P17, DOI 10.1016/j.scitotenv.2011.04.020
   Markey AM, 2008, J ENVIRON HEALTH, V70, P24
   NSPCIR, 2014, NAT SOIL POLL COND I
   ORLIC I, 1986, J RADIOAN NUCL CH AR, V102, P203, DOI 10.1007/BF02037961
   Puga AP, 2015, ENVIRON SCI POLLUT R, V22, P17606, DOI 10.1007/s11356-015-4977-6
   Saby NPA, 2009, SCI TOTAL ENVIRON, V407, P5644, DOI 10.1016/j.scitotenv.2009.07.002
   Shi Z, 2015, EUR J SOIL SCI, V66, P679, DOI 10.1111/ejss.12272
   Shi Z, 2014, SCI CHINA EARTH SCI, V57, P1671, DOI 10.1007/s11430-013-4808-x
   Thermo Fisher Scientific, 2012, US GUID ABR XL2 AN V
   Wang DD, 2015, GEODERMA, V243, P157, DOI 10.1016/j.geoderma.2014.12.011
   Wei BG, 2010, MICROCHEM J, V94, P99, DOI 10.1016/j.microc.2009.09.014
   Weindorf DC, 2012, ENVIRON MONIT ASSESS, V184, P217, DOI 10.1007/s10661-011-1961-6
   Wu YZ, 2005, APPL GEOCHEM, V20, P1051, DOI 10.1016/j.apgeochem.2005.01.009
   Wu YZ, 2005, ENVIRON SCI TECHNOL, V39, P873, DOI 10.1021/es0492642
   Xia F, 2015, J INFRARED MILLIM W, V34, P593
   Yang ZP, 2011, J GEOCHEM EXPLOR, V108, P27, DOI 10.1016/j.gexplo.2010.09.006
   Zhang XY, 2009, ENVIRON MONIT ASSESS, V154, P439, DOI 10.1007/s10661-008-0410-7
   Zhang XY, 2008, ENVIRON POLLUT, V156, P1260, DOI 10.1016/j.envpol.2008.03.009
NR 35
TC 15
Z9 16
U1 1
U2 57
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 24
PY 2017
VL 12
IS 2
AR e0172438
DI 10.1371/journal.pone.0172438
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EL5VB
UT WOS:000394688200078
PM 28234944
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Mouton, JP
   Mehta, U
   Rossiter, DP
   Maartens, G
   Cohen, K
AF Mouton, Johannes P.
   Mehta, Ushma
   Rossiter, Dawn P.
   Maartens, Gary
   Cohen, Karen
TI Interrater agreement of two adverse drug reaction causality assessment
   methods: A randomised comparison of the Liverpool Adverse Drug Reaction
   Causality Assessment Tool and the World Health Organization-Uppsala
   Monitoring Centre system
SO PLOS ONE
LA English
DT Article
ID DISAGREEMENT; KAPPA
AB Introduction
   A new method to assess causality of suspected adverse drug reactions, the Liverpool Adverse Drug Reaction Causality Assessment Tool (LCAT), showed high interrater agreement when used by its developers. Our aim was to compare the interrater agreement achieved by LCAT to that achieved by another causality assessment method, the World Health Organization-Uppsala Monitoring Centre system for standardised case causality assessment (WHO-UMC system), in our setting.
   Methods
   Four raters independently assessed adverse drug reaction causality of 48 drug-event pairs, identified during a hospital-based survey. A randomised design ensured that no washout period was required between assessments with the two methods. We compared the methods' interrater agreement by calculating agreement proportions, kappa statistics, and the intraclass correlation coefficient. We identified potentially problematic questions in the LCAT by comparing raters' responses to individual questions.
   Results
   Overall unweighted kappa was 0.61 (95% CI 0.43 to 0.80) on the WHO-UMC system and 0.27 (95% CI 0.074 to 0.46) on the LCAT. Pairwise unweighted Cohen kappa ranged from 0.33 to 1.0 on the WHO-UMC system and from 0.094 to 0.71 on the LCAT. The intraclass correlation coefficient was 0.86 (95% CI 0.74 to 0.92) on the WHO-UMC system and 0.61 (95% CI 0.39 to 0.77) on the LCAT. Two LCAT questions were identified as significant points of disagreement.
   Discussion
   We were unable to replicate the high interrater agreement achieved by the LCAT developers and instead found its interrater agreement to be lower than that achieved when using the WHO-UMC system. We identified potential reasons for this and recommend priority areas for improving the LCAT.
C1 [Mouton, Johannes P.; Mehta, Ushma; Rossiter, Dawn P.; Maartens, Gary; Cohen, Karen] Univ Cape Town, Div Clin Pharmacol, Dept Med, Cape Town, South Africa.
RP Cohen, K (reprint author), Univ Cape Town, Div Clin Pharmacol, Dept Med, Cape Town, South Africa.
EM karen.cohen@uct.ac.za
RI Maartens, Gary/S-2788-2019
OI Maartens, Gary/0000-0003-3080-6606; Cohen, Karen/0000-0002-1892-4207;
   Mouton, Johannes/0000-0002-3511-1259
FU US President's Emergency Plan for AIDS Relief (PEPFAR) through US
   Centers for Disease Control and Prevention (CDC) under terms of
   Cooperative [GGH000371]
FX This research has been supported by the US President's Emergency Plan
   for AIDS Relief (PEPFAR, www.pepfar.gov) through the US Centers for
   Disease Control and Prevention (CDC, www.cdc.gov) under the terms of
   Cooperative Agreement Number GGH000371. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abraira V., 1999, QUESTIIO, V23, P561
   Agbabiaka TB, 2008, DRUG SAFETY, V31, P21, DOI 10.2165/00002018-200831010-00003
   Aronson JK, 2005, DRUG SAFETY, V28, P851, DOI 10.2165/00002018-200528100-00003
   Cicchetti D., 1994, PSYCHOL ASSESSMENTS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]
   CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M
   Conroy EJ, 2015, INT J PHARM PRACT, V23, P447, DOI 10.1111/ijpp.12197
   DAVIES EC, 2011, PHARM MED, V25, P17
   de Vet HCW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2125
   Gallagher RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028096
   Heap GA, 2014, NAT GENET, V46, P1131, DOI 10.1038/ng.3093
   HUTCHINSON TA, 1983, CLIN PHARMACOL THER, V34, P421, DOI 10.1038/clpt.1983.192
   HUTCHINSON TA, 1989, J CLIN EPIDEMIOL, V42, P5, DOI 10.1016/0895-4356(89)90020-6
   KOCHWESER J, 1977, EUR J CLIN PHARMACOL, V11, P75, DOI 10.1007/BF00562895
   Kramer M. S., 1986, DRUG INF J, V20, P433
   KRAMER MS, 1979, JAMA-J AM MED ASSOC, V242, P623, DOI 10.1001/jama.242.7.623
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langerova P, 2014, BASIC CLIN PHARMACOL, V115, P560, DOI 10.1111/bcpt.12264
   Lazaro J, 2008, KAPPA2 GEN WEIGHTED
   LOUIK C, 1985, CLIN PHARMACOL THER, V38, P183, DOI 10.1038/clpt.1985.156
   Meyboom RHB, 1997, DRUG SAFETY, V17, P374, DOI 10.2165/00002018-199717060-00004
   Mouton JP, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003437
   NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154
   Rozich JD, 2003, QUAL SAF HEALTH CARE, V12, P194, DOI 10.1136/qhc.12.3.194
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Smyth RL, 2014, PROGRAMME GRANTS APP, V2
   Theophile H, 2013, DRUG SAFETY, V36, P1033, DOI 10.1007/s40264-013-0083-1
   Uppsala Monitoring Centre, US WHO WMC SYST STAN
NR 27
TC 6
Z9 6
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 24
PY 2017
VL 12
IS 2
AR e0172830
DI 10.1371/journal.pone.0172830
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EL5VB
UT WOS:000394688200148
PM 28235001
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Mern, DS
   Tschugg, A
   Hartmann, S
   Thome, C
AF Mern, Demissew Shenegelegn
   Tschugg, Anja
   Hartmann, Sebastian
   Thome, Claudius
TI Self-complementary adeno-associated virus serotype 6 mediated knockdown
   of ADAMTS4 induces long-term and effective enhancement of aggrecan in
   degenerative human nucleus pulposus cells: A new therapeutic approach
   for intervertebral disc disorders
SO PLOS ONE
LA English
DT Article
ID EFFICIENT TRANSDUCTION; GENE-TRANSFER; THROMBOSPONDIN-1 REPEATS;
   ANIMAL-MODELS; IN-VITRO; VECTORS; EXPRESSION; FAMILY;
   METALLOPROTEINASES; COTRANSFECTION
AB Inhibition of intervertebral disc (IVD) degeneration, which is often accompanied by painful inflammatory and immunopathological processes, is challenging. Current IVD gene therapeutic approaches are based on adenoviral gene delivery systems, which are limited by immune reactions to their viral proteins. Their applications in IVDs near to sensitive neural structure could provoke toxicity and immunological side-effects with neurological deficits. Self-complementary adeno-associated virus (scAAV) vectors, which do not express any viral gene and are not linked with any known disease in humans, are attractive therapeutic gene delivery vectors in degenerative IVDs. However, scAAV-based silencing of catabolic or inflammatory factor has not yet been investigated in human IVD cells. Therefore, we used scAAV6, the most suitable serotype for transduction of human nucleus pulposus (NP) cells, to knockdown the major catabolic gene (ADAMTS4) of IVD degeneration. IVD degeneration grades were determined by preoperative magnetic resonance imaging. Lumbar NP tissues of degeneration grade III were removed from 12 patients by nucleotomy. NP cells were isolated and cultured with low-glucose. Titre of recombinant scAAV6 vectors targeting ADAMTS4, transduction efficiencies, transduction units, cell viabilities and expression levels of target genes were analysed using quantitative PCR, fluorescence microscopy, fluorescence -activated cell sorting, 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide assays, quantitative reverse transcription PCR, western blot and enzyme-linked immunosorbent assays during 48 days of post-transduction. Transduction efficiencies between 98.2% and 37.4% and transduction units between 611 and 245 TU/cell were verified during 48 days of post-transduction (p<0.001). scAAV6-mediated knockdown of ADAMTS4 with maximum 87.7% and minimum 40.1% was confirmed on day 8 and 48 with enhanced the level of aggrecan 48.5% and 30.2% respectively (p<0.001). scAAV6-mediated knockdown of ADAMTS4 showed no impact on cell viability and expression levels of other inflammatory catabolic proteins. Thus, our results are promising and may help to design long-term and less immunogenic gene therapeutic approaches in IVD disorders, which usually need prolonged therapeutic period between weeks and months.
C1 [Mern, Demissew Shenegelegn; Tschugg, Anja; Hartmann, Sebastian; Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria.
RP Mern, DS (reprint author), Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria.
EM demissew.shenegelegn@i-med.ac.at
FU Innsbruck Medical University
FX The study is funded by Innsbruck Medical University. The funder had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Adams MA, 2005, J BIOMECH, V38, P1972, DOI 10.1016/j.jbiomech.2005.03.028
   Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c
   Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y
   Bartlett JS, 2000, J VIROL, V74, P2777, DOI 10.1128/JVI.74.6.2777-2785.2000
   Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7
   Chen SF, 2005, HUM GENE THER, V16, P235, DOI 10.1089/hum.2005.16.235
   Fechner H, 2008, J MOL MED, V86, P987, DOI 10.1007/s00109-008-0363-x
   Gilbertson L, 2008, SPINE J, V8, P449, DOI 10.1016/j.spinee.2006.11.006
   Grieger JC, 2005, ADV BIOCHEM ENG BIOT, V99, P119, DOI 10.1007/10_005
   Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547
   Halbert CL, 2001, J VIROL, V75, P6615, DOI 10.1128/JVI.75.14.6615-6624.2001
   Hashimoto G, 2004, J BIOL CHEM, V279, P32483, DOI 10.1074/jbc.M314216200
   Hashimoto G, 2001, FEBS LETT, V494, P192, DOI 10.1016/S0014-5793(01)02323-7
   Hoyland JA, 2008, RHEUMATOLOGY, V47, P809, DOI 10.1093/rheumatology/ken056
   Kaneyama S, 2008, J ORTHOP SCI, V13, P130, DOI 10.1007/s00776-007-1204-4
   Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200
   Kuno K, 1997, J BIOL CHEM, V272, P556
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lattermann C, 2005, SPINE, V30, P497, DOI 10.1097/01.brs.0000154764.62072.44
   Llamazares M, 2003, J BIOL CHEM, V278, P13382, DOI 10.1074/jbc.M211900200
   Lotz JC, 2004, SPINE, V29, P2742, DOI 10.1097/01.brs.0000146498.04628.f9
   Lozier JN, 2002, HUM GENE THER, V13, P113, DOI 10.1089/10430340152712665
   Mazzolini G, 2001, GENE THER, V8, P259, DOI 10.1038/sj.gt.3301387
   McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514
   Mern DS, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0799-4
   Mern DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096870
   Mern DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081467
   Mern DS, 2014, J TISSUE ENG REGEN M, V8, P925, DOI 10.1002/term.1583
   Moon SH, 2008, SPINE, V33, P1850, DOI 10.1097/BRS.0b013e31817e1cd7
   Nemunaitis J, 2001, GENE THER, V8, P746, DOI 10.1038/sj.gt.3301424
   Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011
   Ren S, 2013, INT J MOL MED, V32, P1063, DOI 10.3892/ijmm.2013.1497
   Ren XF, 2015, GENET MOL RES, V14, P3736, DOI 10.4238/2015.April.22.1
   Rothe D, 2010, OLIGONUCLEOTIDES, V20, P191, DOI 10.1089/oli.2010.0236
   Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1
   SAMULSKI RJ, 1991, EMBO J, V10, P3941, DOI 10.1002/j.1460-2075.1991.tb04964.x
   Tang BL, 1999, FEBS LETT, V445, P223, DOI 10.1016/S0014-5793(99)00119-2
   Tian Y, 2013, AM J PATHOL, V182, P2310, DOI 10.1016/j.ajpath.2013.02.037
   Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200
   Tortorella MD, 2000, J BIOL CHEM, V275, P18566, DOI 10.1074/jbc.M909383199
   Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664
   Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427
   Wagner A, 2013, HUM GENE THER METHOD, V24, P355, DOI 10.1089/hgtb.2013.095
   Wallach CJ, 2003, SPINE, V28, P2331, DOI 10.1097/01.BRS.0000085303.67942.94
   Wang Z, 2003, GENE THER, V10, P2105, DOI 10.1038/sj.gt.3302133
   Wu JQ, 2007, HUM GENE THER, V18, P171, DOI 10.1089/hum.2006.088
   Xi YM, 2013, GENET MOL RES, V12, P4895, DOI 10.4238/2013.February.28.11
   Yamanishi Y, 2002, J IMMUNOL, V168, P1405, DOI 10.4049/jimmunol.168.3.1405
   YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407
NR 49
TC 4
Z9 4
U1 0
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 16
PY 2017
VL 12
IS 2
AR e0172181
DI 10.1371/journal.pone.0172181
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EL2BG
UT WOS:000394424500094
PM 28207788
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ogden, NH
   Arsenault, J
   Hatchette, TF
   Mechai, S
   Lindsay, LR
AF Ogden, Nicholas H.
   Arsenault, Julie
   hatchette, Todd F.
   Mechai, Samir
   Lindsay, L. Robbin
TI Antibody responses to Borrelia burgdorferi detected by western blot vary
   geographically in Canada
SO PLOS ONE
LA English
DT Article
ID LYME-DISEASE; SENSU-STRICTO; SURVEILLANCE; EMERGENCE; DIAGNOSIS;
   GENOTYPE; TICKS; C6
AB Lyme disease is emerging in eastern and central Canada, and most cases are diagnosed using the two-tier serological test (Enzyme Immuno Assay [EIA] followed by Western blot [WB]). Simplification of this algorithm would be advantageous unless it impacts test performance. In this study, accuracy of individual proteins of the IgG WB algorithm in predicting the overall test result in samples from Canadians was assessed. Because Borrelia burgdorferi strains vary geographically in Canada, geographic variations in serological responses were also explored. Metrics of relative sensitivity, specificity and the kappa statistic measure of concordance were used to assess the capacity of responses to individual proteins to predict the overall IgG WB result of 2524 EIA (C6)-positive samples from across Canada. Geographic and interannual variations in proportions of samples testing positive were explored by logistic regression. No one protein was highly concordant with the IgG WB result. Significant variations were found amongst years and geographic regions in the prevalence of samples testing positive using the overall IgG WB algorithm, and for individual proteins of the algorithm. In most cases the prevalence of samples testing positive were highest in Nova Scotia, and lower in samples from Manitoba westwards. These findings suggest that the current two tier test may not be simplified and continued use of the current two-tier test method and interpretation is recommended. Geographic and interannual variations in the prevalence of samples testing positive may be consistent with B. burgdorferi strain variation in Canada, and further studies are needed to explore this.
C1 [Ogden, Nicholas H.] Publ Hlth Agcy Canada, Natl Microbiol Lab, St Hyacinthe, PQ, Canada.
   [Ogden, Nicholas H.; Arsenault, Julie; Mechai, Samir] GREZOSP, St Hyacinthe, PQ, Canada.
   [Arsenault, Julie; Mechai, Samir] Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ, Canada.
   [hatchette, Todd F.] Nova Scotia Hlth Author, Dept Pathol & Lab Med, Halifax, NS, Canada.
   [hatchette, Todd F.] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada.
   [Lindsay, L. Robbin] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.
RP Ogden, NH (reprint author), Publ Hlth Agcy Canada, Natl Microbiol Lab, St Hyacinthe, PQ, Canada.; Ogden, NH (reprint author), GREZOSP, St Hyacinthe, PQ, Canada.
EM nicholas.ogden@phac-aspc.gc.ca
OI Lindsay, Robbin/0000-0001-7236-2930; Arsenault,
   Julie/0000-0001-8382-7326
CR Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572
   Cameron Daniel, 2004, Expert Rev Anti Infect Ther, V2, pS1
   Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590
   Dessau RB, 2015, J MED MICROBIOL, V64, P224, DOI 10.1099/jmm.0.000009
   Fallon BA, 2014, CLIN INFECT DIS, V59, P1705, DOI 10.1093/cid/ciu703
   Ferrouillet C, 2015, CAN J INFECT DIS MED, V26, P151, DOI 10.1155/2015/846963
   Gabriele-Rivet V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131282
   George D., 2003, SPSS WINDOWS STEP ST
   Hanincova K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073066
   Hatchette TF, 2015, EMERG INFECT DIS, V21, P1751, DOI 10.3201/eid2110.141640
   Johnson BJB, 2006, MANUAL OF MOLECULAR AND CLINICAL LABORATORY IMMUNOLOGY, 7TH EDITION, P493
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Magnarelli LA, 2000, J CLIN MICROBIOL, V38, P1735
   Mechai S, 2015, APPL ENVIRON MICROB, V81, P1309, DOI 10.1128/AEM.03730-14
   Molins CR, 2015, CLIN INFECT DIS, V60, P1767, DOI 10.1093/cid/civ185
   Molins CR, 2014, J CLIN MICROBIOL, V52, P3755, DOI 10.1128/JCM.01409-14
   Ogden N H, 2015, Can Commun Dis Rep, V41, P132
   Ogden N H, 2014, Can Commun Dis Rep, V40, P74
   Ogden NH, 2011, APPL ENVIRON MICROB, V77, P3244, DOI 10.1128/AEM.02636-10
   Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766
   Ogden NH, 2009, CAN MED ASSOC J, V180, P1221, DOI 10.1503/cmaj.080148
   Ogden NH, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00046
   Panelius J, 2001, J CLIN MICROBIOL, V39, P4013, DOI 10.1128/JCM.39.11.4013-4019.2001
   Patrick DM, 2015, CLIN INFECT DIS, V61, P1084, DOI 10.1093/cid/civ470
   Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401
   Tugwell P, 1997, ANN INTERN MED, V127, P1109, DOI 10.7326/0003-4819-127-12-199712150-00011
   Wang GQ, 2002, J INFECT DIS, V186, P782, DOI 10.1086/343043
   Wormser GP, 2008, CLIN INFECT DIS, V47, P910, DOI 10.1086/591529
   Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667
   Wormser GP, 2013, DIAGN MICR INFEC DIS, V75, P9, DOI 10.1016/j.diagmicrobio.2012.09.003
NR 30
TC 4
Z9 4
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 9
PY 2017
VL 12
IS 2
AR e0171731
DI 10.1371/journal.pone.0171731
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EK9GJ
UT WOS:000394231800097
PM 28182723
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Varallo, FR
   Planeta, CS
   Herdeiro, MT
   Mastroianni, PD
AF Varallo, Fabiana Rossi
   Planeta, Cleopatra S.
   Herdeiro, Maria Teresa
   Mastroianni, Patricia de Carvalho
TI Imputation of adverse drug reactions: Causality assessment in hospitals
SO PLOS ONE
LA English
DT Article
ID PUBLISHED DECISIONAL ALGORITHMS; EXPERT PANEL; PHARMACOVIGILANCE;
   AGREEMENT; CRITERIA
AB Background & objectives
   Different algorithms have been developed to standardize the causality assessment of adverse drug reactions (ADR). Although most share common characteristics, the results of the causality assessment are variable depending on the algorithm used. Therefore, using 10 different algorithms, the study aimed to compare inter-rater and multi-rater agreement for ADR causality assessment and identify the most consistent to hospitals.
   Methods
   Using ten causality algorithms, four judges independently assessed the first 44 cases of ADRs reported during the first year of implementation of a risk management service in a medium complexity hospital in the state of Sao Paulo (Brazil). Owing to variations in the terminology used for causality, the equivalent imputation terms were grouped into four categories: definite, probable, possible and unlikely. Inter-rater and multi-rater agreement analysis was performed by calculating the Cohen's and Light's kappa coefficients, respectively.
   Results
   None of the algorithms showed 100% reproducibility in the causal imputation. Fair inter rater and multi-rater agreement was found. Emanuele (1984) and WHO-UMC (2010) algorithms showed a fair rate of agreement between the judges (k = 0.36).
   Interpretation & conclusions
   Although the ADR causality assessment algorithms were poorly reproducible, our data suggest that WHO-UMC algorithm is the most consistent for imputation in hospitals, since it allows evaluating the quality of the report. However, to improve the ability of assessing the causality using algorithms, it is necessary to include criteria for the evaluation of drug-related problems, which may be related to confounding variables that underestimate the causal association.
C1 [Varallo, Fabiana Rossi; Planeta, Cleopatra S.; Mastroianni, Patricia de Carvalho] Sao Paulo State Univ UNESP, Sch Pharmaceut Sci, Araraquara, SP, Brazil.
   [Varallo, Fabiana Rossi] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil.
   [Herdeiro, Maria Teresa] Univ Aveiro, Dept Cincias Med, Aveiro, Portugal.
RP Mastroianni, PD (reprint author), Sao Paulo State Univ UNESP, Sch Pharmaceut Sci, Araraquara, SP, Brazil.
EM patriciamastroianni@yahoo.com.br
RI Mastroianni, Patricia/Q-2265-2019; Herdeiro, Maria/H-8195-2013; Varallo,
   Fabiana Rossi/G-9070-2016
OI Mastroianni, Patricia/0000-0001-8467-7278; Herdeiro,
   Maria/0000-0002-0500-4049; Varallo, Fabiana Rossi/0000-0003-4016-1442;
   Planeta, Cleopatra da Silva/0000-0002-1378-6327
FU Coordination of Improvement of Higher Education Personnel (CAPES)
   [014301/2013-00]; Sao Paulo Research Foundation (FAPESP) [2014/12681-2,
   2013/10381-1]; Programa de Apoio ao Desenvolvimento Cientifico da
   Faculdade de Ciencias Farmaceuticas da UNESP-PADC
FX This work was supported by the Coordination of Improvement of Higher
   Education Personnel (CAPES) for the scholarship (PDSE) provided [grant
   number 014301/2013-00]; grant 2013/10381-1, Sao Paulo Research
   Foundation (FAPESP) for partial presentation; grant 2014/12681-2, Sao
   Paulo Research Foundation (FAPESP), for a regular project and the
   Programa de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias
   Farmaceuticas da UNESP-PADC.
CR Agbabiaka TB, 2008, DRUG SAFETY, V31, P21, DOI 10.2165/00002018-200831010-00003
   Angamo MT, 2016, DRUG SAFETY, V39, P847, DOI 10.1007/s40264-016-0444-7
   Arimone Y, 2005, EUR J CLIN PHARMACOL, V61, P169, DOI 10.1007/s00228-004-0869-2
   Belhekar MN, 2014, INDIAN J PHARMACOL, V46, P117, DOI 10.4103/0253-7613.125192
   Classen DC, 2011, HEALTH AFFAIR, V30, P581, DOI 10.1377/hlthaff.2011.0190
   Coloma PM, 2013, DRUG SAFETY, V36, P13, DOI 10.1007/s40264-012-0002-x
   DAVIES EC, 2011, PHARM MED, V25, P17
   de Vries ST, 2014, J PSYCHOSOM RES, V76, P134, DOI 10.1016/j.jpsychores.2013.11.003
   Doherty M., 2009, RESP MED CME 2, V2, P63, DOI DOI 10.1016/J.RMEDC.2009.01.004
   Edwards IR, 2012, BRIT J CLIN PHARMACO, V73, P979, DOI 10.1111/j.1365-2125.2012.04249.x
   Farcas A, 2009, J GASTROINTEST LIVER, V18, P353
   Kamarulzaman A, 2015, CURR OPIN INFECT DIS, V28, P10, DOI 10.1097/QCO.0000000000000125
   Kane-Gill SL, 2006, ANN PHARMACOTHER, V40, P1267, DOI 10.1345/aph.1H088
   Kane-Gill SL, 2012, DRUG SAFETY, V35, P645, DOI 10.2165/11599730-000000000-00000
   Khan LM, 2016, SAUDI PHARM J, V24, P485, DOI 10.1016/j.jsps.2015.01.010
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Macedo AF, 2005, PHARMACOEPIDEM DR S, V14, P885, DOI 10.1002/pds.1138
   Macedo AF, 2003, J CLIN PHARM THER, V28, P137, DOI 10.1046/j.1365-2710.2003.00475.x
   Meyboom RHB, 1999, DRUG SAFETY, V21, P429, DOI 10.2165/00002018-199921060-00001
   Meyboom RHB, 1997, DRUG SAFETY, V17, P374, DOI 10.2165/00002018-199717060-00004
   Moore N, 1998, BRIT J CLIN PHARMACO, V45, P301, DOI 10.1046/j.1365-2125.1998.00667.x
   Mugosa S, 2015, VOJNOSANIT PREGL, V72, P975, DOI 10.2298/VSP140710104M
   OPS, 5 OPS PARF
   Pal SN, 2013, DRUG SAFETY, V36, P75, DOI 10.1007/s40264-012-0014-6
   Seeger JD, 2015, DRUG SAFETY, V38, P847, DOI 10.1007/s40264-015-0342-4
   Shakir SAW, 2002, DRUG SAFETY, V25, P467, DOI 10.2165/00002018-200225060-00012
   Theophile H, 2013, DRUG SAFETY, V36, P1033, DOI 10.1007/s40264-013-0083-1
   Theophile H, 2012, J CLIN EPIDEMIOL, V65, P1069, DOI 10.1016/j.jclinepi.2012.04.015
   *WHO, 1972, WHO TECHN REP SER, V498
   WHO-UMC, 2010, US WHO UMC SYST STAN
   World Health Organization, 2002, IMP PHARM
NR 31
TC 11
Z9 11
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 6
PY 2017
VL 12
IS 2
AR e0171470
DI 10.1371/journal.pone.0171470
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EK1QH
UT WOS:000393700100046
PM 28166274
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Liu, L
   Kalter, HD
   Chu, Y
   Kazmi, N
   Koffi, AK
   Amouzou, A
   Joos, O
   Munos, M
   Black, RE
AF Liu, Li
   Kalter, Henry D.
   Chu, Yue
   Kazmi, Narjis
   Koffi, Alain K.
   Amouzou, Agbessi
   Joos, Olga
   Munos, Melinda
   Black, Robert E.
TI Understanding Misclassification between Neonatal Deaths and Stillbirths:
   Empirical Evidence from Malawi
SO PLOS ONE
LA English
DT Article
ID VERBAL AUTOPSY; PRETERM BIRTH; PREGNANCY; COUNTRIES; VALIDITY; AFRICA
AB Improving the counting of stillbirths and neonatal deaths is important to tracking Sustainable Development Goal 3.2 and improving vital statistics in low-and middle-income countries (LMICs). However, the validity of self-reported stillbirths and neonatal deaths in surveys is often threatened by misclassification errors between the two birth outcomes. We assessed the extent and correlates of stillbirths being misclassified as neonatal deaths by comparing two recent and linked population surveys conducted in Malawi, one being a full birth history (FBH) survey, and the other a follow-up verbal/social autopsy (VASA) survey. We found that one-fifth of 365 neonatal deaths identified in the FBH survey were classified as stillbirths in the VASA survey. Neonatal deaths with signs of movements in the last few days before delivery reported were less likely to be misclassified stillbirths (OR = 0.08, p<0.05). Having signs of birth injury was found to be associated with higher odds of misclassification (OR = 6.17, p<0.05). We recommend replicating our study with larger sample size in other settings. Additionally, we recommend conducting validation studies to confirm accuracy and completeness of live births and neonatal deaths reported in household surveys with events reported in a full birth history and the extent of underestimation of neonatal mortality resulting from misclassifications. Questions on fetal movement, signs of life at delivery and improved probing among older mother may be useful to improve accuracy of reported events.
C1 [Liu, Li] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.
   [Liu, Li; Chu, Yue; Kazmi, Narjis; Koffi, Alain K.; Amouzou, Agbessi; Joos, Olga; Munos, Melinda; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Dept Int Hlth, Baltimore, MD 21205 USA.
   [Kalter, Henry D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Hlth Syst Program, Baltimore, MD USA.
RP Liu, L (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.; Liu, L (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Dept Int Hlth, Baltimore, MD 21205 USA.
EM lliu26@jhu.edu
OI Kalter, Henry/0000-0002-4165-2393; Munos, Melinda/0000-0002-1349-8026;
   Amouzou, Agbessi/0000-0002-6262-3866
FU Foreign Affairs, Trade and Development Canada [7056791]
FX The project was funded by Foreign Affairs, Trade and Development Canada
   (http://www.international.gc.ca/international/index.aspx?lang=eng)
   through the Real-Time Results Tracking grant (#7056791) under the
   Catalytic Initiative to Save a Million Lives. The funders had no role in
   the study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aggarwal AK, 2011, B WORLD HEALTH ORGAN, V89, P31, DOI 10.2471/BLT.10.076828
   Amouzou A, 2013, TROP MED INT HEALTH, V18, P1231, DOI 10.1111/tmi.12167
   Barrett Anna M, 2003, Cogn Behav Neurol, V16, P160, DOI 10.1097/00146965-200309000-00003
   Blencowe H, 2016, LANCET GLOBAL HLTH
   Bradford S, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0694-4
   Bryce Jennifer, 2016, PLoS Med, V13, pe1001912, DOI 10.1371/journal.pmed.1001912
   Engmann C, 2009, INT J GYNECOL OBSTET, V105, P112, DOI 10.1016/j.ijgo.2008.12.012
   Haws RA, 2010, SOC SCI MED, V71, P1764, DOI 10.1016/j.socscimed.2010.03.051
   Helleringer S, 2015, TROP MED INT HEALTH, V20, P1415, DOI 10.1111/tmi.12583
   Kalter HD, 2015, J GLOB HEALTH, V5, P196, DOI 10.7189/jogh.05.010415
   Koffi AK, 2015, J GLOBAL HLTH, V5
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409
   Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3
   Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI [10.1186/1471-2393-S1-S1, 10.1186/1471-2393-10-S1-S1]
   Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016
   Leisher SH, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1071-0
   Liu L, 2016, LANCET
   McTavish S, 2010, SOC SCI MED, V71, P1958, DOI 10.1016/j.socscimed.2010.09.007
   National Population Commission (NPC) [ Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20
   Pullum TW, 2006, ASSESSMENT AGE DATE
   RMM working group, 2014, RMM IN MAL
   Rutstein Shea Oscar, 2014, MAKING DEMOGRAPHIC H
   Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x
   Stacey T, 2011, BIRTH-ISS PERINAT C, V38, P311, DOI 10.1111/j.1523-536X.2011.00490.x
   Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3
   Tolhurst R, 2008, MIDWIFERY, V24, P83, DOI 10.1016/j.midw.2006.09.003
   Tveit JVH, 2009, ACTA OBSTET GYN SCAN, V88, P1345, DOI 10.3109/00016340903348375
   UN, 2015, TRANSF OUR WORLD 203
   World Bank, 2014, GLOB CIV REG VIT STA
NR 30
TC 10
Z9 10
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 28
PY 2016
VL 11
IS 12
AR e0168743
DI 10.1371/journal.pone.0168743
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EG7JB
UT WOS:000391222000073
PM 28030594
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Liebl, ME
   Elmer, N
   Schroeder, I
   Schwedtke, C
   Baack, A
   Reisshauer, A
AF Liebl, Max E.
   Elmer, Nancy
   Schroeder, Isabelle
   Schwedtke, Christine
   Baack, Angelika
   Reisshauer, Anett
TI Introduction of the Charite A Mobility Index (CHARMI) - A Novel Clinical
   Mobility Assessment for Acute Care Rehabilitation
SO PLOS ONE
LA English
DT Article
ID CONTENT VALIDITY; SKELETAL-MUSCLE; BED REST; ELDERLY-PATIENTS;
   BRAIN-INJURY; OLDER-ADULTS; ACUTE STROKE; UNIT; DISABILITY; WEAKNESS
AB Introduction
   Mobility is an essential part of a person's functioning and independence. It encompasses locomotive functions, but also the more basic functions of positioning and transferring. Despite the availability of several mobility-related assessment instruments to date, there is a need for assessment instruments with the specific capability to display the full range of mobilisation. Our aim was to develop and validate a scoring instrument with hierarchical composition where every score value stands for a defined mobility level.
   Participants and Methods
   A previously developed and validated pilot instrument was applied to assess patients (n = 113) admitted to an acute rehabilitation programme. Mobility was assessed during admission, subsequently at weekly intervals and at discharge to acquire a detailed status of mobility at multiple time points and individual mobilisation profiles over time. The scoring instrument was then remodelled based on clinical criteria to establish an easy-to-use scoring system with hierarchical composition. Psychometric properties were calculated using an independent sample of 87 consecutive patients.
   Results
   Content validity could be affirmed. The psychometric tests demonstrated excellent convergent validity with the three mobility items of the Barthel Index (r = 0.93), despite an adequately lower correlation with the whole Barthel Index (r = 0.63). Adequate floor and ceiling effects (20%) and a large responsiveness to change (vertical bar d vertical bar = 1.7, p < 0.001) between admission and discharge values were demonstrated. Inter-rater reliability was excellent (kappa = 0.88).
   Conclusions
   The Charite A Mobility Index (CHARMI) is a promising, easy-to-use hierarchical scoring instrument assessing the full individual spectrum from immobility to unlimited mobility, including positioning, transfer and locomotion items. It allows for monitoring of mobilisation.
C1 [Liebl, Max E.; Elmer, Nancy; Schroeder, Isabelle; Schwedtke, Christine; Baack, Angelika; Reisshauer, Anett] Charite, Dept Phys Med & Rehabil, Berlin, Germany.
   [Baack, Angelika; Reisshauer, Anett] Charite, Charite Physiotherapy & Prevent Ctr, Berlin, Germany.
RP Liebl, ME (reprint author), Charite, Dept Phys Med & Rehabil, Berlin, Germany.
EM max.liebl@charite.de
CR Adams SA, 1997, CLIN REHABIL, V11, P42, DOI 10.1177/026921559701100107
   Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619
   Ayre C, 2014, MEAS EVAL COUNS DEV, V47, P79, DOI 10.1177/0748175613513808
   Berg HE, 1997, J APPL PHYSIOL, V82, P182
   BERG K, 1995, SCAND J REHABIL MED, V27, P27
   BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7
   Beyer J, 2015, PHYS MED REHAB KUROR, V25, P260, DOI 10.1055/s-0035-1564089
   Blottner D, 2006, EUR J APPL PHYSIOL, V97, P261, DOI 10.1007/s00421-006-0160-6
   Cameron S, 2015, J CRIT CARE, V30, P664, DOI 10.1016/j.jcrc.2015.03.032
   Collen F M, 1991, Int Disabil Stud, V13, P50
   Collen F M, 1990, Int Disabil Stud, V12, P6
   de Morton NA, 2008, ARCH PHYS MED REHAB, V89, P641, DOI 10.1016/j.apmr.2007.10.021
   de Morton Natalie A, 2013, J Appl Meas, V14, P159
   DEMORTON NA, 2008, HEALTH QUAL LIFE OUT, V6, DOI DOI 10.1186/1477-7525-6-63
   Fitzpatrick R, 1998, Health Technol Assess, V2, pi
   Gosselink R, 2008, INTENS CARE MED, V34, P1188, DOI 10.1007/s00134-008-1026-7
   GRANGER CV, 1995, INT J TECHNOL ASSESS, V11, P262, DOI 10.1017/S0266462300006875
   GUYATT GH, 1992, J CLIN EPIDEMIOL, V45, P1341, DOI 10.1016/0895-4356(92)90194-R
   Hardy SE, 2007, J AM GERIATR SOC, V55, P1727, DOI 10.1111/j.1532-5415.2007.01413.x
   HOLDEN MK, 1986, PHYS THER, V66, P1530, DOI 10.1093/ptj/66.10.1530
   Keith R A, 1987, Adv Clin Rehabil, V1, P6
   Kelly-Hayes M, 1998, STROKE, V29, P1274, DOI 10.1161/01.STR.29.6.1274
   Kortebein P, 2007, JAMA-J AM MED ASSOC, V297, P1772, DOI 10.1001/jama.297.16.1772-b
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LAWSHE CH, 1975, PERS PSYCHOL, V28, P563, DOI 10.1111/j.1744-6570.1975.tb01393.x
   Liebl M, 2011, 7 EFSMA EUR C SPORTS
   Liebl ME, 2016, CHARITE ARBEITSBEREI
   Lincoln N, 1979, Physiotherapy, V65, P48
   MAHONEY F I, 1965, Md State Med J, V14, P61
   Martin B, 1996, CLIN REHABIL, V10, P44
   Needham DM, 2008, JAMA-J AM MED ASSOC, V300, P1685, DOI 10.1001/jama.300.14.1685
   Nosova EV, 2014, J SURG RES, V190, P672, DOI 10.1016/j.jss.2014.02.001
   PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x
   Schweickert WD, 2007, CHEST, V131, P1541, DOI 10.1378/chest.06-2065
   Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9
   Smith R., 1994, PHYSIOTHERAPY, V80, P744, DOI DOI 10.1016/S0031-9406(10)60612-8
   Sosnowski K, 2015, AUST CRIT CARE, V28, P216, DOI 10.1016/j.aucc.2015.05.002
   Sourdet S, 2015, J AM MED DIR ASSOC, V16, P674, DOI 10.1016/j.jamda.2015.03.011
   TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x
   Trudel G, 2000, ARCH PHYS MED REHAB, V81, P6, DOI 10.1016/S0003-9993(00)90213-2
   Williams GP, 2009, BRAIN INJURY, V23, P307, DOI 10.1080/02699050902774170
   Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711
   World Health Organization (WHO), 2001, ICF INT CLASS FUNCT
   Yosef-Brauner O, 2015, CLIN RESPIR J, V9, P1, DOI 10.1111/crj.12091
NR 44
TC 2
Z9 2
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 22
PY 2016
VL 11
IS 12
AR e0169010
DI 10.1371/journal.pone.0169010
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EI9QH
UT WOS:000392843200123
PM 28006023
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gernaat, SAM
   Isgum, I
   de Vos, BD
   Takx, RAP
   Young-Afat, DA
   Rijnberg, N
   Grobbee, DE
   van der Graaf, Y
   de Jong, PA
   Leiner, T
   van den Bongard, DHJ
   Pignol, JP
   Verkooijen, HM
AF Gernaat, Sofie A. M.
   Isgum, Ivana
   de Vos, Bob D.
   Takx, Richard A. P.
   Young-Afat, Danny A.
   Rijnberg, Noor
   Grobbee, Diederick E.
   van der Graaf, Yolanda
   de Jong, Pim A.
   Leiner, Tim
   van den Bongard, Desiree H. J.
   Pignol, Jean-Philippe
   Verkooijen, Helena M.
TI Automatic Coronary Artery Calcium Scoring on Radiotherapy Planning CT
   Scans of Breast Cancer Patients: Reproducibility and Association with
   Traditional Cardiovascular Risk Factors
SO PLOS ONE
LA English
DT Article
ID CHEST COMPUTED-TOMOGRAPHY; ALL-CAUSE MORTALITY; LUNG-CANCER;
   HEART-DISEASE; VALVE CALCIFICATIONS; PROGNOSTIC VALUE; CARDIAC CT;
   EVENTS; PROGRESSION; POPULATION
AB Objectives
   Coronary artery calcium (CAC) is a strong and independent predictor of cardiovascular disease (CVD) risk. This study assesses reproducibility of automatic CAC scoring on radiotherapy planning computed tomography (CT) scans of breast cancer patients, and examines its association with traditional cardiovascular risk factors.
   Methods
   This study included 561 breast cancer patients undergoing radiotherapy between 2013 and 2015. CAC was automatically scored with an algorithm using supervised pattern recognition, expressed as Agatston scores and categorized into five categories (0, 1-10, 11-100, 101-400, >400). Reproducibility between automatic and manual expert scoring was assessed in 79 patients with automatically determined CAC above zero and 84 randomly selected patients without automatically determined CAC. Interscan reproducibility of automatic scoring was assessed in 294 patients having received two scans (82% on the same day). Association between CAC and CVD risk factors was assessed in 36 patients with CAC scores >100, 72 randomly selected patients with scores 1-100, and 72 randomly selected patients without CAC. Reliability was assessed with linearly weighted kappa and agreement with proportional agreement.
   Results
   134 out of 561 (24%) patients had a CAC score above zero. Reliability of CVD risk categorization between automatic and manual scoring was 0.80 (95% Confidence Interval (CI): 0.74-0.87), and slightly higher for scans with breath-hold. Agreement was 0.79 (95% CI: 0.72-0.85). Interscan reliability was 0.61 (95% CI: 0.50-0.72) with an agreement of 0.84 (95% CI: 0.80-0.89). Ten out of 36 (27.8%) patients with CAC scores above 100 did not have other cardiovascular risk factors.
   Conclusions
   Automatic CAC scoring on radiotherapy planning CT scans is a reliable method to assess CVD risk based on Agatston scores. One in four breast cancer patients planned for radiotherapy have elevated CAC score. One in three patients with high CAC scores don't have other CVD risk factors and wouldn't have been identified as high risk.
C1 [Gernaat, Sofie A. M.; Young-Afat, Danny A.; Grobbee, Diederick E.; van der Graaf, Yolanda] Univ Med Ctr Utrecht, Dept Epidemiol, Julius Ctr, Utrecht, Netherlands.
   [Isgum, Ivana; de Vos, Bob D.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands.
   [Takx, Richard A. P.; de Jong, Pim A.; Leiner, Tim] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.
   [Rijnberg, Noor] Acad Med Ctr, Devis Internal Med, Amsterdam, Netherlands.
   [van den Bongard, Desiree H. J.] Univ Med Ctr Utrecht, Dept Radiat Oncol, Utrecht, Netherlands.
   [Pignol, Jean-Philippe] Erasmus MC, Dept Radiat Oncol, Rotterdam, Netherlands.
   [Verkooijen, Helena M.] Univ Med Ctr Utrecht, Imaging Div, Utrecht, Netherlands.
RP Gernaat, SAM (reprint author), Univ Med Ctr Utrecht, Dept Epidemiol, Julius Ctr, Utrecht, Netherlands.
EM S.A.M.Gernaat@umcutrecht.nl
CR AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T
   Bird BRJH, 2008, CLIN CANCER RES, V14, P14, DOI 10.1158/1078-0432.CCR-07-1033
   Blaha MJ, 2011, LANCET, V378, P684, DOI 10.1016/S0140-6736(11)60784-8
   Borger JH, 2007, INT J RADIAT ONCOL, V69, P1131, DOI 10.1016/j.ijrobp.2007.04.042
   Brenner H, 1996, EPIDEMIOLOGY, V7, P199, DOI 10.1097/00001648-199603000-00016
   Brunner G, 2010, INT J CARDIOVAS IMAG, V26, P829, DOI 10.1007/s10554-010-9608-1
   Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079
   Budoff MJ, 2011, J CARDIOVASC COMPUT, V5, P12, DOI 10.1016/j.jcct.2010.11.004
   Budoff MJ, 2011, J CARDIOVASC COMPUT, V5, P113, DOI 10.1016/j.jcct.2010.11.002
   Chiles C, 2015, RADIOLOGY, V276, P82, DOI 10.1148/radiol.15142062
   CUTTER D, 2011, CANC RES, V71
   Gepner AD, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002262
   Isgum I, 2012, IEEE T MED IMAGING, V31, P2322, DOI 10.1109/TMI.2012.2216889
   Jacobs PC, 2012, AM J ROENTGENOL, V198, P505, DOI 10.2214/AJR.10.5577
   Jairam PM, 2014, RADIOLOGY, V272, P700, DOI 10.1148/radiol.14132211
   Kim SM, 2008, AM J ROENTGENOL, V190, P917, DOI 10.2214/AJR.07.2979
   Kronmal RA, 2007, CIRCULATION, V115, P2722, DOI 10.1161/CIRCULATIONHA.106.674143
   Kurkure U, 2010, INT J CARDIOVAS IMAG, V26, P817, DOI 10.1007/s10554-010-9607-2
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee YC, 2015, BREAST CANC RES TREA
   Lehmann N, 2014, ATHEROSCLEROSIS, V232, P339, DOI 10.1016/j.atherosclerosis.2013.11.045
   Maher JE, 1999, MAYO CLIN PROC, V74, P347, DOI 10.4065/74.4.347
   McGale P, 2011, RADIOTHER ONCOL, V100, P167, DOI 10.1016/j.radonc.2011.06.016
   Mets OM, 2013, JACC-CARDIOVASC IMAG, V6, P899, DOI 10.1016/j.jcmg.2013.02.008
   Nasir K, 2012, CIRC-CARDIOVASC IMAG, V5, P467, DOI 10.1161/CIRCIMAGING.111.964528
   Pinder MC, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.10.4976
   Raggi P, 2001, AM J CARDIOL, V87, p27A
   RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157
   Shahzad R, 2013, ACAD RADIOL, V20, P1, DOI 10.1016/j.acra.2012.07.018
   Shaw LJ, 2006, EUR HEART J, V27, P968, DOI 10.1093/eurheartj/ehi750
   Sobin L, 2009, TNM CLASSIFICATION M
   Takx RAP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091239
   Taunk NK, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00039
   Taylor C. W., 2015, CLIN ONCOL R COLL RA
   Vaidya JS, 2013, NEW ENGL J MED, V368, P2526, DOI 10.1056/NEJMc1304601
   van Hamersvelt RW, 2014, EUR RADIOL, V24, P1557, DOI 10.1007/s00330-014-3191-0
   Vossen LM, 2015, NUTRIENTS, V7, P8905, DOI 10.3390/nu7115443
   Willemink MJ, 2015, INT J CARDIOVAS IMAG, V31, P1243, DOI 10.1007/s10554-015-0664-4
   Wolterink JM, 2015, IEEE T MED IMAGING, V34, P1867, DOI 10.1109/TMI.2015.2412651
   Wu MT, 2008, AM J ROENTGENOL, V190, P923, DOI 10.2214/AJR.07.2974
   Xie Y., 2014, SPIE INT S MED IM 20, V9035
NR 41
TC 8
Z9 9
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 9
PY 2016
VL 11
IS 12
AR e0167925
DI 10.1371/journal.pone.0167925
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE4PU
UT WOS:000389587100232
PM 27936125
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Guillaud, A
   Darbois, N
   Monvoisin, R
   Pinsault, N
AF Guillaud, Albin
   Darbois, Nelly
   Monvoisin, Richard
   Pinsault, Nicolas
TI Reliability of Diagnosis and Clinical Efficacy of Cranial Osteopathy: A
   Systematic Review
SO PLOS ONE
LA English
DT Review
ID RANDOMIZED CONTROLLED-TRIAL; CRANIOSACRAL THERAPY; INTEREXAMINER
   RELIABILITY; INTERRATER RELIABILITY; PALPATION; INTRAEXAMINER; PLACEBO;
   INTERVENTIONS; AGREEMENT; OUTCOMES
AB Context
   In 2010, the World Health Organization released benchmarks for training in osteopathy in which they considered cranial osteopathy as an important osteopathic skill. However, the evidence supporting the reliability of diagnosis and the efficacy of treatment in this field appears scientifically weak and inconsistent.
   Objectives
   To identify and critically evaluate the scientific literature dealing with the reliability of diagnosis and the clinical efficacy of techniques and therapeutic strategies used in cranial osteopathy.
   Methods
   Relevant keywords were used to search the electronic databases MEDLINE, PEDro, OSTMED.DR, Cochrane Library, and in Google Scholar, Journal of American Osteopathy Association and International Journal of Osteopathic Medicine websites. Searches were conducted up to end June 2016 with no date restriction as to when the studies were completed. As a complementary approach we explored the bibliography of included articles and consulted available previous reviews dealing with this topic.
   Study selection
   Regarding diagnostic processes in cranial osteopathy, we analyzed studies that compared the results obtained by at least two examiners or by the same examiner on at least two occasions. For efficacy studies, only randomized-controlled-trials or crossover-studies were eligible. We excluded articles that were not in English or French, and for which the full-text version was not openly available. We also excluded studies with unsuitable study design, in which there was no clear indication of the use of techniques or therapeutic strategies concerning the cranial field, looked at combined treatments, used a non-human examiner and subjects or used healthy subjects for efficacy studies. There was no restriction regarding the type of disease.
   Search Results
   In our electronic search we found 1280 references concerning reliability of diagnosis studies plus four references via our complementary strategy. Based on the title 18 articles were selected for analysis. Nine were retained after applying our exclusion criteria. Regarding efficacy, we extracted 556 references from the databases plus 14 references through our complementary strategy. Based on the title 46 articles were selected. Thirty two articles were not retained on the grounds of our exclusion criteria.
   Data extraction and analysis
   Risk of bias in reliability studies was assessed using a modified version of the quality appraisal tool for studies of diagnostic reliability. The methodological quality of the efficacy studies was assessed using the Cochrane risk of bias tool. Two screeners conducted these analyses.
   Results
   For reliability studies, our analysis leads us to conclude that the diagnostic procedures used in cranial osteopathy are unreliable in many ways. For efficacy studies, the Cochrane risk of bias tool we used shows that 2 studies had a high risk of bias, 9 were rated as having major doubt regarding risk of bias and 3 had a low risk of bias. In the 3 studies with a low risk of bias alternative interpretations of the results, such as a non-specific effect of treatment, were not considered.
   Conclusion
   Our results demonstrate, consistently with those of previous reviews, that methodologically strong evidence on the reliability of diagnostic procedures and the efficacy of techniques and therapeutic strategies in cranial osteopathy is almost non-existent.
C1 [Guillaud, Albin; Darbois, Nelly; Monvoisin, Richard] Univ Grenoble Alpes, CORTECS Team, Grenoble, France.
   [Pinsault, Nicolas] ThEMAS Team, TIMC IMAG Lab, UMR CNRS UGA 5525, Grenoble, France.
   [Pinsault, Nicolas] Grenoble Alpes Univ Hosp, Sch Physiotherapy, Grenoble, France.
   [Guillaud, Albin; Darbois, Nelly; Monvoisin, Richard; Pinsault, Nicolas] Univ Grenoble Alpes, Crit Thinking Res Federat, FED 4270, Grenoble, France.
RP Pinsault, N (reprint author), ThEMAS Team, TIMC IMAG Lab, UMR CNRS UGA 5525, Grenoble, France.; Pinsault, N (reprint author), Grenoble Alpes Univ Hosp, Sch Physiotherapy, Grenoble, France.; Pinsault, N (reprint author), Univ Grenoble Alpes, Crit Thinking Res Federat, FED 4270, Grenoble, France.
EM npinsault@chu-grenoble.fr
OI Darbois, Nelly/0000-0001-9467-9832; Pinsault,
   Nicolas/0000-0001-5034-0802
FU French national council of physiotherapists (Conseil National de l'Ordre
   des Masseurs Kinesitherapeutes, CNOMK)
FX This study was supported by the French national council of
   physiotherapists (Conseil National de l'Ordre des Masseurs
   Kinesitherapeutes, CNOMK). The sponsor had no influence or editorial
   control over the content of the study.
CR Amrovabady Z, 2013, IRAN REHABIL J, V11, P41
   Arnadottir TS, 2013, COMPLEMENT THER CLIN, V19, P11, DOI 10.1016/j.ctcp.2012.09.003
   Atkins D, 2011, J CLIN EPIDEMIOL, V64, P1198, DOI 10.1016/j.jclinepi.2010.11.021
   Bialoszewski Dariusz, 2014, Ortop Traumatol Rehabil, V16, P605, DOI 10.5604/15093492.1135120
   Burke S, 2013, BMC MUSCULOSKEL DIS, V14, P227
   Castro-Sanchez AM, 2016, J ALTERN COMPLEMENT
   Cuthbert Scott C, 2007, Chiropr Osteopat, V15, P4, DOI 10.1186/1746-1340-15-4
   Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466
   Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6
   Elden H, 2013, ACTA OBSTET GYN SCAN, V92, P775, DOI 10.1111/aogs.12096
   Ernst E, 2012, FACT, V17, P197
   Fadipe GT, 2009, THESIS
   FLEISS JL, 1999, DESIGN ANAL CLIN EXP
   GRACELY RH, 1985, LANCET, V1, P43
   Green C, 1999, SYSTEMATIC REV CRITI
   Haller H, 2016, CLIN J PAIN, V32, P441, DOI 10.1097/AJP.0000000000000290
   Halma KD, 2008, J AM OSTEOPATH ASSOC, V108, P493
   Haneline MT, 2009, J MANIP PHYSIOL THER, V32, P379, DOI 10.1016/j.jmpt.2009.04.010
   Hanten W, 1999, J MAN MANIP THER, V7, P64, DOI DOI 10.1016/S0161-4754(00)90190-8
   Hanten WP, 1998, J ORTHOP SPORT PHYS, V27, P213, DOI 10.2519/jospt.1998.27.3.213
   Hartling L, 2013, J CLIN EPIDEMIOL, V66, P973, DOI 10.1016/j.jclinepi.2012.07.005
   Hartman SE, 2002, SCI REV ALTERNATIVE, V6, P23
   Hayden Clive, 2006, Complement Ther Clin Pract, V12, P83, DOI 10.1016/j.ctcp.2005.12.005
   Higgins JP, 2011, COCHRANE COLLABORATI, DOI DOI 10.1002/9780470712184
   Jakel A, 2012, COMPLEMENT THER MED, V20, P456, DOI 10.1016/j.ctim.2012.07.009
   Jakel A, 2011, J AM OSTEOPATH ASSOC, V111, P685
   Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Laslett M, 2008, J MAN MANIP THER, V16, P142, DOI 10.1179/jmt.2008.16.3.142
   Lucas NP, 2010, J CLIN EPIDEMIOL, V63, P854, DOI 10.1016/j.jclinepi.2009.10.002
   Castro-Sanchez AM, 2011, CLIN REHABIL, V25, P25, DOI 10.1177/0269215510375909
   Mataran-Penarrocha GA, 2011, EVID-BASED COMPL ALT, V2011
   Mehl-Madrona L, 2007, EXPLORE-NY, V3, P28, DOI 10.1016/j.explore.2006.10.003
   Moran RW, 2001, J MANIP PHYSIOL THER, V24, P183
   Morton G, 1983, J SOC PSYCHOL, V125, P143
   Norton JM, 1996, CHALLENGE CONCEPT CR
   Nourbakhsh MR, 2008, J HAND THER, V21, P4, DOI 10.1197/j.jht.2007.09.005
   Raith W, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-0984-5
   Rogers JS, 1998, PHYS THER, V78, P1175, DOI 10.1093/ptj/78.11.1175
   Sandhouse ME, 2010, J AM OSTEOPATH ASSOC, V110, P239
   Schulz KF, 2010, ANN INTERN MED, V2010, P152
   Sommerfeld P, 2004, MANUAL THER, V9, P22, DOI 10.1016/S1356-689X(03)00099-7
   Still AT, 1897, AUTOBIOGRAPHY AT STI
   UPLEDGER JE, 1977, J AM OSTEOPATH ASSOC, V76, P890
   Vivian D, 2000, AUSTRALAS MUSCULOSKE, V5, P6
   White P, 2012, PAIN, V153, P455, DOI 10.1016/j.pain.2011.11.007
   WHO, 2010, BENCKM TRAIN TRAD CO
   Wilkinson J, 2015, INT J OSTEOPATH MED, V18, P13, DOI 10.1016/j.ijosm.2014.04.008
   WIRTHPATTULLO V, 1994, PHYS THER, V74, P908, DOI 10.1093/ptj/74.10.908
NR 49
TC 2
Z9 2
U1 0
U2 27
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 9
PY 2016
VL 11
IS 12
AR e0167823
DI 10.1371/journal.pone.0167823
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE4PU
UT WOS:000389587100206
PM 27936211
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Smits, LP
   van Wijk, DF
   Duivenvoorden, R
   Xu, DX
   Yuan, C
   Stroes, ES
   Nederveen, AJ
AF Smits, Loek P.
   van Wijk, Diederik F.
   Duivenvoorden, Raphael
   Xu, Dongxiang
   Yuan, Chun
   Stroes, Erik S.
   Nederveen, Aart J.
TI Manual versus Automated Carotid Artery Plaque Component Segmentation in
   High and Lower Quality 3.0 Tesla MRI Scans
SO PLOS ONE
LA English
DT Article
ID IN-VIVO QUANTIFICATION; ATHEROSCLEROTIC PLAQUE; CEREBROVASCULAR EVENTS;
   REPRODUCIBILITY; CLASSIFICATION; MORPHOLOGY; RESOLUTION; 3.0-TESLA;
   DIAGNOSIS; STENOSIS
AB Purpose
   To study the interscan reproducibility of manual versus automated segmentation of carotid artery plaque components, and the agreement between both methods, in high and lower quality MRI scans.
   Methods
   24 patients with 30-70% carotid artery stenosis were planned for 3T carotid MRI, followed by a rescan within 1 month. A multicontrast protocol (T1w, T2w, PDw and TOF sequences) was used. After co-registration and delineation of the lumen and outer wall, segmentation of plaque components (lipid-rich necrotic cores (LRNC) and calcifications) was performed both manually and automated. Scan quality was assessed using a visual quality scale.
   Results
   Agreement for the detection of LRNC (Cohen's kappa (k) is 0.04) and calcification (k = 0.41) between both manual and automated segmentation methods was poor. In the high-quality scans (visual quality score >= 3), the agreement between manual and automated segmentation increased to k = 0.55 and k = 0.58 for, respectively, the detection of LRNC and calcification larger than 1 mm(2). Both manual and automated analysis showed good interscan reproducibility for the quantification of LRNC (intraclass correlation coefficient (ICC) of 0.94 and 0.80 respectively) and calcified plaque area (ICC of 0.95 and 0.77, respectively).
   Conclusion
   Agreement between manual and automated segmentation of LRNC and calcifications was poor, despite a good interscan reproducibility of both methods. The agreement between both methods increased to moderate in high quality scans. These findings indicate that image quality is a critical determinant of the performance of both manual and automated segmentation of carotid artery plaque components.
C1 [Smits, Loek P.; van Wijk, Diederik F.; Duivenvoorden, Raphael; Stroes, Erik S.] Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands.
   [Xu, Dongxiang; Yuan, Chun] Univ Washington, Dept Radiol, Seattle, WA 98195 USA.
   [Nederveen, Aart J.] Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands.
RP Smits, LP (reprint author), Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands.
EM L.P.Smits@amc.uva.nl
RI Duivenvoorden, Raphael/B-5154-2019
OI Duivenvoorden, Raphael/0000-0003-1446-8336
CR Altaf N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000173
   Balu Niranjan, 2009, Top Magn Reson Imaging, V20, P203, DOI 10.1097/RMR.0b013e3181ea287d
   Biasiolli L, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-69
   Brott TG, 2011, STROKE, V81, pE76
   Coolen B. F., 2015, MAGN RESON MED, V75, P1
   Duivenvoorden R, 2009, CIRC-CARDIOVASC IMAG, V2, P235, DOI 10.1161/CIRCIMAGING.108.788059
   Esposito-Bauer L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067927
   Gao S, 2015, MAGN RESON MATER PHY, V28, P535, DOI 10.1007/s10334-015-0495-2
   Kerwin William, 2007, Top Magn Reson Imaging, V18, P371
   Kerwin WS, 2008, J MAGN RESON IMAGING, V28, P987, DOI 10.1002/jmri.21529
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Li FY, 2010, J MAGN RESON IMAGING, V31, P168, DOI 10.1002/jmri.22014
   Liu F, 2006, MAGN RESON MED, V55, P659, DOI 10.1002/mrm.20814
   Mono ML, 2012, CEREBROVASC DIS, V34, P343, DOI 10.1159/000343227
   Rerkasem K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001081.pub2
   Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3
   Saam T, 2005, ARTERIOSCL THROM VAS, V25, P234, DOI 10.1161/01.ATV.0000149867.61851.31
   Saam T, 2013, J AM COLL CARDIOL, V62, P1081, DOI 10.1016/j.jacc.2013.06.015
   Swain S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a786
   Takaya N, 2006, STROKE, V37, P818, DOI 10.1161/01.STR.0000204638.91099.91
   Takaya N, 2006, J MAGN RESON IMAGING, V24, P203, DOI 10.1002/jmri.20599
   Truijman MTB, 2014, INT J STROKE, V9, P747, DOI 10.1111/ijs.12167
   van Wijk DF, 2013, MAGMA
   van Wijk DF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130878
   van Wijk DF, 2014, MAGN RESON MATER PHY, V27, P219, DOI 10.1007/s10334-013-0407-2
   van 't Klooster R, 2012, AM J NEURORADIOL, V33, P1621, DOI 10.3174/ajnr.A3028
   Yuan C, 2002, J MAGN RESON IMAGING, V15, P62, DOI 10.1002/jmri.10030
NR 27
TC 1
Z9 1
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 8
PY 2016
VL 11
IS 12
AR e0164267
DI 10.1371/journal.pone.0164267
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE4OA
UT WOS:000389580900001
PM 27930665
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Finlayson, K
   Lampe, JF
   Hintze, S
   Wurbel, H
   Melotti, L
AF Finlayson, Kathryn
   Lampe, Jessica Frances
   Hintze, Sara
   Wurbel, Hanno
   Melotti, Luca
TI Facial Indicators of Positive Emotions in Rats
SO PLOS ONE
LA English
DT Article
ID ULTRASONIC VOCALIZATIONS; ANIMAL EMOTION; COGNITIVE BIAS; EAR POSTURES;
   PLAY; REWARD; PAIN; EXPRESSIONS; BEHAVIOR; STRESS
AB Until recently, research in animal welfare science has mainly focused on negative experiences like pain and suffering, often neglecting the importance of assessing and promoting positive experiences. In rodents, specific facial expressions have been found to occur in situations thought to induce negatively valenced emotional states (e.g., pain, aggression and fear), but none have yet been identified for positive states. Thus, this study aimed to investigate if facial expressions indicative of positive emotional state are exhibited in rats. Adolescent male Lister Hooded rats (Rattus norvegicus, N = 15) were individually subjected to a Positive and a mildly aversive Contrast Treatment over two consecutive days in order to induce contrasting emotional states and to detect differences in facial expression. The Positive Treatment consisted of playful manual tickling administered by the experimenter, while the Contrast Treatment consisted of exposure to a novel test room with intermittent bursts of white noise. The number of positive ultrasonic vocalisations was greater in the Positive Treatment compared to the Contrast Treatment, indicating the experience of differentially valenced states in the two treatments. The main findings were that Ear Colour became significantly pinker and Ear Angle was wider (ears more relaxed) in the Positive Treatment compared to the Contrast Treatment. All other quantitative and qualitative measures of facial expression, which included Eyeball height to width Ratio, Eyebrow height to width Ratio, Eyebrow Angle, visibility of the Nictitating Membrane, and the established Rat Grimace Scale, did not show differences between treatments. This study contributes to the exploration of positive emotional states, and thus good welfare, in rats as it identified the first facial indicators of positive emotions following a positive heterospecific play treatment. Furthermore, it provides improvements to the photography technique and image analysis for the detection of fine differences in facial expression, and also adds to the refinement of the tickling procedure.
C1 [Finlayson, Kathryn; Lampe, Jessica Frances; Hintze, Sara; Wurbel, Hanno; Melotti, Luca] Univ Bern, Div Anim Welf, Bern, Switzerland.
RP Melotti, L (reprint author), Univ Bern, Div Anim Welf, Bern, Switzerland.
EM luca.melotti@vetsuisse.unibe.ch
RI ; Wuerbel, Hanno/D-6281-2012
OI Lampe, Jessica/0000-0002-9062-3089; Wuerbel, Hanno/0000-0002-2934-3010
FU Swiss National Science Foundation [31003A_144088]
FX This study was funded by the Swiss National Science Foundation (Project
   n. 31003A_144088). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Anderson A. K., 2008, APPL ANIMAL BEHAV SC, V1, P1, DOI DOI 10.4161/CIB.1.2.6999
   Bardal SK, 2010, APPL PHARM
   Boissy A, 2011, ANIM WELFARE, V20, P47
   Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003
   Briefer EF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09989
   Briefer EF, 2015, ANIM BEHAV, V99, P131, DOI 10.1016/j.anbehav.2014.11.002
   BRUDZYNSKI SM, 1992, PHYSIOL BEHAV, V52, P655, DOI 10.1016/0031-9384(92)90393-G
   Brudzynski SM, 2013, CURR OPIN NEUROBIOL, V23, P310, DOI 10.1016/j.conb.2013.01.014
   Burgdorf J, 2006, NEUROSCI BIOBEHAV R, V30, P173, DOI 10.1016/j.neubiorev.2005.06.001
   Burgdorf J, 2001, PHYSIOL BEHAV, V72, P167, DOI 10.1016/S0031-9384(00)00411-X
   Burgdorf J, 2008, J COMP PSYCHOL, V122, P357, DOI 10.1037/a0012889
   Burn CC, 2008, APPL ANIM BEHAV SCI, V112, P1, DOI 10.1016/j.applanim.2008.02.007
   Butler A. B., 2005, COMP VERTEBRATE NEUR
   BUTTNER D, 1982, LAB ANIM, V16, P319, DOI 10.1258/002367782780935913
   Church JS, 2009, INFRAMATION 2009
   Cicchetti D., 1994, PSYCHOL ASSESSMENTS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]
   Dalla Costa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092281
   DEBOER SF, 1989, PHYSIOL BEHAV, V45, P789, DOI 10.1016/0031-9384(89)90296-5
   Defensor EB, 2012, PHYSIOL BEHAV, V107, P680, DOI 10.1016/j.physbeh.2012.03.024
   EKMAN P, 1976, ENVIRON PSYCH NONVER, V1, P56, DOI 10.1007/BF01115465
   GRANT RT, 1963, J PHYSIOL-LONDON, V167, P311, DOI 10.1113/jphysiol.1963.sp007151
   GRILL HJ, 1978, BRAIN RES, V143, P263, DOI 10.1016/0006-8993(78)90568-1
   Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444
   Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a
   Held SDE, 2011, ANIM BEHAV, V81, P891, DOI 10.1016/j.anbehav.2011.01.007
   Inagaki H, 2005, EXP ANIM TOKYO, V54, P61, DOI 10.1538/expanim.54.61
   KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1
   Keating SCJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044437
   Knutson B, 1998, J COMP PSYCHOL, V112, P65, DOI 10.1037/0735-7036.112.1.65
   Knutson B, 2002, PSYCHOL BULL, V128, P961, DOI 10.1037//0033-2909.128.6.961
   Lampe JF, UNPUB
   Landers R., 2015, COMPUTING INTRACLASS
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322
   Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]
   Langford DJ, 2010, SOC NEUROSCI-UK, V5, P163, DOI 10.1080/17470910903216609
   Leach M., 2012, P MEAS BEHAV, P238
   LIU YC, 1995, IEEE T CONSUM ELECTR, V41, P460, DOI 10.1109/30.468045
   Mahler M, 2014, LAB ANIM
   Makowska IJ, 2013, APPL ANIM BEHAV SCI, V148, P1, DOI 10.1016/j.applanim.2013.07.017
   McDougall SJ, 2000, HYPERTENSION, V35, P126, DOI 10.1161/01.HYP.35.1.126
   Melotti L, 2014, ANIMAL BEHAV COGNITI
   Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303
   Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023
   Panksepp J, 2005, CONSCIOUS COGN, V14, P30, DOI 10.1016/j.concog.2004.10.004
   PANKSEPP J, 1981, DEV PSYCHOBIOL, V14, P327, DOI 10.1002/dev.420140405
   Panksepp J, 2003, PHYSIOL BEHAV, V79, P533, DOI 10.1016/S0031-9384(03)00159-8
   Panksepp J, 2000, BEHAV BRAIN RES, V115, P25, DOI 10.1016/S0166-4328(00)00238-2
   Panksepp J., 1999, SCI CONSCIOUSNESS, VIII, P231
   Parr LA, 2007, EMOTION, V7, P172, DOI 10.1037/1528-3542.7.1.172
   Pellis SM, 1997, NEUROSCI BIOBEHAV R, V21, P105, DOI 10.1016/0149-7634(95)00060-7
   PELLIS SM, 1992, BEHAV BRAIN RES, V50, P135, DOI 10.1016/S0166-4328(05)80295-5
   Pinney CC, 2000, COMPLETE HOME VET GU
   Proctor HS, 2014, APPL ANIM BEHAV SCI, V161, P20, DOI 10.1016/j.applanim.2014.09.015
   Reefmann N, 2009, PHYSIOL BEHAV, V98, P235, DOI 10.1016/j.physbeh.2009.05.017
   Reefmann N, 2009, APPL ANIM BEHAV SCI, V118, P199, DOI 10.1016/j.applanim.2009.02.013
   Rolls ET, 2000, BEHAV BRAIN SCI, V23, P177, DOI 10.1017/S0140525X00002429
   Rygula R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051959
   Schweinhardt P, 2006, NEUROIMAGE, V32, P256, DOI 10.1016/j.neuroimage.2006.03.024
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Siddiqui A, 2011, J DIABETES METAB, V2, DOI 10.4172/2155-6156.1000170
   SIVIY SM, 1987, DEV PSYCHOBIOL, V20, P39, DOI 10.1002/dev.420200108
   Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55
   Soussignan R, 2002, EMOTION, V2, P52, DOI 10.1037/1528-3542.2.1.52
   Steiner JE, 2001, NEUROSCI BIOBEHAV R, V25, P53, DOI 10.1016/S0149-7634(00)00051-8
   VANDERPOEL AM, 1991, BEHAVIOUR, V119, P127, DOI 10.1163/156853991X00409
   Vanderschuren LJMJ, 2010, AM J PLAY, V2, P315
   Varlinskaya EI, 1999, PHYSIOL BEHAV, V67, P475, DOI 10.1016/S0031-9384(98)00285-6
   Waller BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082686
   Wathan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131738
   Wolfe J, 2011, BEHAV NEUROSCI, V125, P900, DOI 10.1037/a0026165
   Wright JM, 2010, PSYCHOPHARMACOLOGY, V211, P1, DOI 10.1007/s00213-010-1859-y
   Zebunke M, 2011, ANIM BEHAV, V81, P481, DOI 10.1016/j.anbehav.2010.11.023
NR 73
TC 16
Z9 16
U1 2
U2 49
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 30
PY 2016
VL 11
IS 11
AR e0166446
DI 10.1371/journal.pone.0166446
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE3FV
UT WOS:000389474100025
PM 27902721
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kim, JW
   Shin, NY
   Kim, YD
   Lee, SK
   Lim, SM
   Oh, SW
AF Kim, Jin Woo
   Shin, Na-Young
   Kim, Young Dae
   Lee, Seung-Koo
   Lim, Soo Mee
   Oh, Se Won
TI Added Value of 3D Proton-Density Weighted Images in Diagnosis of
   Intracranial Arterial Dissection
SO PLOS ONE
LA English
DT Article
ID CARDIOVASCULAR MAGNETIC-RESONANCE; BLACK-BLOOD; VERTEBRAL ARTERY; WALL;
   MRI; SEQUENCE; PLAQUE; ANTICOAGULATION; OPTIMIZATION; SUPPRESSION
AB Background
   An early and reliable diagnosis of intracranial arterial dissection is important to reduce the risk of neurological complication. The purpose of this study was to assess the clinical usefulness of three-dimensional high-resolution MRI (3D-HR-MRI) including pre- and post-contrast T1-weighted volumetric isotropic turbo spin echo acquisition with improved motionsensitized driven equilibrium preparation (3D-iMSDE-T1) and proton-density weighted image (3D-PD) in detecting dissection and to evaluate the added value of 3D-PD in diagnosing intracranial arterial dissection.
   Methods
   We retrospectively recruited patients who underwent 3D-HR-MRI with clinical suspicion of arterial dissection. Among them, we selected patients who were diagnosed with definite dissection according to the Spontaneous Cervicocephalic Arterial Dissections Study criteria. For each patient, the presence of intimal flap, intramural hematoma, and vessel dilatation were evaluated independently by two neuroradiologists on each sequence. Interobserver agreement was assessed.
   Results
   Seventeen patients (mean age: 41 +/- 10 [ SD] years; 13 men) were diagnosed with definite dissection. The intimal flaps were more frequently detected on 3D-PD (88.2%, 15/17) than on 3D-iMSDE-T1 (29.4%, 5/17), and post-contrast 3D-iMSDE-T1 (35.3%, 6/17; P = 0.006 and P = 0.004, respectively). No significant difference was found in the detection rate of intramural hematomas (59-71%) and vascular dilatations (47%) on each sequence. Interobserver agreement for detection of dissection findings showed almost perfect agreement (k = 0.84-1.00), except for detection of intimal flaps on pre-contrast 3D-iMSDE-T1 (k = 0.62).After addition of 3D-PD to pre- and post-contrast 3D-iMSDE-T1, more patients were diagnosed with definite dissection with the initial MRI ( 88.2% vs. 47.1%; P = 0.039).
   Conclusions
   The intimal flap might be better visualized on the 3D-PD sequence than the 3D- iMSDE-T1 sequences, allowing diagnosis of definite dissection without follow-up imaging.
C1 [Kim, Jin Woo] Inje Univ, Ilsan Paik Hosp, Dept Radiol, Goyang, Gyeonggi, South Korea.
   [Shin, Na-Young; Lim, Soo Mee] Ewha Womans Univ, Sch Med, Dept Radiol, Seoul, South Korea.
   [Kim, Young Dae] Yonsei Univ, Sch Med, Dept Neurol, Seoul, South Korea.
   [Lee, Seung-Koo] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea.
   [Oh, Se Won] Soonchunhyang Univ, Cheonan Hosp, Dept Radiol, Cheonan, Chungnam, South Korea.
RP Shin, NY (reprint author), Ewha Womans Univ, Sch Med, Dept Radiol, Seoul, South Korea.
EM nyshin@ewha.ac.kr
CR Beletsky V, 2003, STROKE, V34, P2856, DOI 10.1161/01.STR.0000098649.39767.BC
   BIOUSSE V, 1995, STROKE, V26, P235, DOI 10.1161/01.STR.26.2.235
   CAPLAN LR, 1988, NEUROLOGY, V38, P868, DOI 10.1212/WNL.38.6.868
   deBray JM, 1997, J NEUROL NEUROSUR PS, V63, P46, DOI 10.1136/jnnp.63.1.46
   Edjlali M, 2012, AM J NEURORADIOL, V34, pE103, DOI DOI 10.3174/AJNR.A2599
   Engelter ST, 2007, STROKE, V38, P2605, DOI 10.1161/STROKEAHA.107.489666
   Habs M, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-76
   Han M, 2014, EUR RADIOL, V24, P3017, DOI 10.1007/s00330-014-3296-5
   Kim BM, 2011, NEUROLOGY, V76, P1735, DOI 10.1212/WNL.0b013e31821a7d94
   KITANAKA C, 1994, STROKE, V25, P571, DOI 10.1161/01.STR.25.3.571
   Koktzoglou I, 2007, J CARDIOV MAGN RESON, V9, P33, DOI 10.1080/10976640600843413
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Metso TM, 2007, STROKE, V38, P1837, DOI 10.1161/STROKEAHA.106.479501
   Naggara O, 2010, AM J NEURORADIOL, V31, P1707, DOI 10.3174/ajnr.A2165
   Natori T, 2014, J STROKE CEREBROVASC, V23, P2419, DOI 10.1016/j.jstrokecerebrovasdis.2014.05.019
   Oppenheim C, 2009, RADIOGRAPHICS, V29, P1413, DOI 10.1148/rg.295085183
   Patel NV, 2011, AM J NEURORADIOL, V32, P137, DOI 10.3174/ajnr.A2239
   Qiao Y, 2014, RADIOLOGY, V271, P534, DOI 10.1148/radiol.13122812
   Qiao Y, 2011, J MAGN RESON IMAGING, V34, P22, DOI 10.1002/jmri.22592
   Sakurai K, 2013, J NEURORADIOLOGY, V40, P19, DOI 10.1016/j.neurad.2012.02.005
   Takano K, 2013, NEURORADIOLOGY, V55, P845, DOI 10.1007/s00234-013-1183-4
   Tsukahara T, 2010, ACTA NEUROCHIR SUPPL, V107, P35, DOI 10.1007/978-3-211-99373-6_5
   Turan TN, 2011, J NEUROIMAGING, V21, pe159, DOI 10.1111/j.1552-6569.2009.00442.x
   Wang J, 2007, MAGN RESON MED, V58, P973, DOI 10.1002/mrm.21385
   Wasserman BA, 2005, STROKE, V36, P2504, DOI 10.1161/01.STR.0000185726.83152.00
   Wasserman BA, 2010, J MAGN RESON IMAGING, V31, P406, DOI 10.1002/jmri.22043
   Young VE, 2012, BRIT J RADIOL, V85, P937, DOI 10.1259/bjr/70496948
   Zhu CC, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0061-5
NR 28
TC 3
Z9 3
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 23
PY 2016
VL 11
IS 11
AR e0166929
DI 10.1371/journal.pone.0166929
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ED5KB
UT WOS:000388889500045
PM 27880798
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Boal, EP
   Vallejo, RBD
   Rodriguez, MF
   Lopez, DL
   Iglesias, MEL
AF Perez Boal, Eduardo
   de Bengoa Vallejo, Ricardo Becerro
   Fuentes Rodriguez, Miguel
   Lopez Lopez, Daniel
   Losa Iglesias, Marta Elena
TI Geometry of the Proximal Phalanx of Hallux and First Metatarsal Bone to
   Predict Hallux Abducto Valgus: A Radiological Study
SO PLOS ONE
LA English
DT Article
ID RADIOGRAPHIC ANALYSIS; INTRACLASS CORRELATIONS; FOOT; RELIABILITY; SIZE;
   POPULATION; PREVALENCE
AB Background
   Hallux abducto valgus (HAV) is one of the most common forefoot deformities in adulthood with a variable prevalence but has been reported as high as 48%. The study proposed that HAV development involves a skeletal parameter of the first metatarsal bone and proximal phalanx hallux (PPH) to determine if the length measurements of the metatarsal and PPH can be used to infer adult HAV.
   Methods
   All consecutive patients over 21 years of age with HAV by roentgenographic evaluation were included in a cross-sectional study. The control group included patients without HAV. The study included 160 individuals. We identified and assessed the following radiographic measurements to evaluate HAV: the distances from the medial (LDM), central (LDC), and lateral (LDL) aspects of the base to the corresponding regions of the head of the PPH. The difference between the medial and lateral aspect of PPH was also calculated.
   Results
   The reliability of the variables measured in 40 radiographic films show perfect reliability ranging from 0.941 to 1 with a small error ranging from 0.762 to 0. Also, there were no systematic errors between the two measurements for any variable (P > 0.05). The LDM PPH showed the highest reliability and lowest error.
   Conclusion
   It is more suitable to measure the LDM PPH instead of the LDC PPH when calculating the hallux valgus angle based on our reliability results. When the differences of the medial and lateral PPH are greater, the risk for developing HAV increases.
C1 [Perez Boal, Eduardo; Fuentes Rodriguez, Miguel; Losa Iglesias, Marta Elena] Univ Rey Juan Carlos, Fac Ciencias Salud, Madrid, Spain.
   [de Bengoa Vallejo, Ricardo Becerro] Univ Complutense Madrid, Fac Enfermeria Fisioterapia & Podol, Madrid, Spain.
   [Lopez Lopez, Daniel] Univ A Coruna, Fac Nursing & Podiatry, Dept Hlth Sci, Res Hlth & Podiatry Unit, Coruna, Spain.
RP Iglesias, MEL (reprint author), Univ Rey Juan Carlos, Fac Ciencias Salud, Madrid, Spain.
EM marta.losa@urjc.es
RI de Bengoa Vallejo, Ricardo Becerro/P-4153-2019; Iglesias, Marta E
   Losa/B-8830-2009; Lopez, Daniel Lopez/K-9182-2013
OI Iglesias, Marta E Losa/0000-0001-7588-2069; Lopez, Daniel
   Lopez/0000-0002-9818-6290
FU Ministry of Economy and competitiveness of the Government of Spain
   [DPI2013-44987-R]
FX The authors gratefully acknowledge the support of the Ministry of
   Economy and competitiveness of the Government of Spain through the
   project DPI2013-44987-R.; The authors gratefully acknowledge the support
   of the Ministry of Economy and competitiveness of the Government of
   Spain through the project DPI2013-44987-R
CR Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002
   Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108
   BONNEY G, 1952, J BONE JOINT SURG BR, V34, P366
   Bruton A., 2000, PHYSIOTHERAPY, V86, P94, DOI DOI 10.1016/S0031-9406(05)61211-4
   Bryant A, 2000, J FOOT ANKLE SURG, V39, P39
   CAMASTA CA, 1991, J AM PODIAT MED ASSN, V81, P545, DOI 10.7547/87507315-81-10-545
   Christman RA, 2001, J AM PODIAT MED ASSN, V91, P294, DOI 10.7547/87507315-91-6-294
   Coughlin M J, 1997, Instr Course Lect, V46, P357
   Coughlin Michael J, 2014, SURG FOOT ANKLE, P1546
   Coughlin MJ, 1995, AAOS INSTR COURS LEC, V44, P371
   Coughlin MJ, 2002, FOOT ANKLE INT, V23, P68, DOI 10.1177/107110070202300114
   COUGHLIN MJ, 1995, FOOT ANKLE INT, V16, P682, DOI 10.1177/107110079501601104
   Vallejo RBD, 2012, J FOOT ANKLE SURG, V51, P729, DOI 10.1053/j.jfas.2012.06.004
   Dykyj D, 1989, Clin Podiatr Med Surg, V6, P1
   ELLIS VH, 1951, J BONE JOINT SURG BR, V33, P415
   Ferrari J, 2004, J AM PODIAT MED ASSN, V94, P434, DOI 10.7547/0940434
   Giannestras NJ, 1979, TRASTORNOS PIE, P345
   GOTTSCHALK FAB, 1980, S AFR MED J, V57, P355
   HARDY RH, 1951, J BONE JOINT SURG BR, V33, P376
   HEDEN RI, 1981, J AM POD ASSOC, V71, P200, DOI 10.7547/87507315-71-4-200
   Herring JA, 2013, TACHDJIANS PEDIAT OR
   JOHNSTON O, 1956, Clin Orthop, V8, P146
   KATO T, 1981, CLIN ORTHOP RELAT R, P78
   KILMARTIN TE, 1994, J BONE JOINT SURG BR, V76B, P210
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Laporta DM, 1994, PREOPERATIVE ASSESSM, P107
   Laporta G, 1974, J Am Podiatry Assoc, V64, P544
   Lee KM, 2012, CLIN ORTHOP RELAT R, V470, P2613, DOI 10.1007/s11999-012-2368-6
   Lelievre J, 1982, PATOLOG PIE FISIOLOG, P1
   LUNDBERG BJ, 1972, ACTA ORTHOP SCAND, V43, P576, DOI 10.3109/17453677208991280
   Mancuso John E, 2003, J Foot Ankle Surg, V42, P319, DOI 10.1053/j.jfas.2003.09.001
   MANN RA, 1981, CLIN ORTHOP RELAT R, P31
   MCCREA JD, 1977, J AM POD ASSOC, V67, P837, DOI 10.7547/87507315-67-12-837
   Morales-Orcajo E, 2015, MED BIOL ENG COMPUT, V53, P645, DOI 10.1007/s11517-015-1260-4
   Munuera PV, 2008, INT ORTHOP, V32, P489, DOI 10.1007/s00264-007-0350-9
   Munuera PV, 2007, J AM PODIAT MED ASSN, V97, P460, DOI 10.7547/0970460
   Nix S, 2010, J FOOT ANKLE RES, V3, DOI 10.1186/1757-1146-3-21
   Park MS, 2010, J BONE JOINT SURG AM, V92A, P1732, DOI 10.2106/JBJS.I.00724
   Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340
   Root ML, 1977, NORMAL ABNORMAL FUNC, P478
   Roukis Thomas S, 2005, J Foot Ankle Surg, V44, P13, DOI 10.1053/j.jfas.2004.11.012
   SALTZMAN CL, 1994, FOOT ANKLE INT, V15, P661, DOI 10.1177/107110079401501206
   SHIMAZAKI K, 1981, Kobe Journal of Medical Sciences, V27, P139
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   SIMFOOK L, 1958, J BONE JOINT SURG AM, V40, P1058, DOI 10.2106/00004623-195840050-00007
   SMITH RW, 1984, FOOT ANKLE, V5, P92, DOI 10.1177/107110078400500208
   Steel M W 3rd, 1980, Foot Ankle, V1, P151
   TANAKA Y, 1995, J BONE JOINT SURG AM, V77A, P205, DOI 10.2106/00004623-199502000-00006
   Tanaka Y, 1997, CLIN ORTHOP RELAT R, P186
   Viladot A, 1973, Orthop Clin North Am, V4, P165
   Wu K K, 1987, J Foot Surg, V26, P277
NR 51
TC 0
Z9 0
U1 1
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 18
PY 2016
VL 11
IS 11
AR e0166197
DI 10.1371/journal.pone.0166197
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EC7WC
UT WOS:000388350300035
PM 27861517
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Markopoulou, K
   Chase, BA
   Robowski, P
   Strongosky, A
   Narozanska, E
   Sitek, EJ
   Berdynski, M
   Barcikowska, M
   Baker, MC
   Rademakers, R
   Slawek, J
   Klein, C
   Huckelheim, K
   Kasten, M
   Wszolek, ZK
AF Markopoulou, Katerina
   Chase, Bruce A.
   Robowski, Piotr
   Strongosky, Audrey
   Narozanska, Ewa
   Sitek, Emilia J.
   Berdynski, Mariusz
   Barcikowska, Maria
   Baker, Matt C.
   Rademakers, Rosa
   Slawek, Jaroslaw
   Klein, Christine
   Hueckelheim, Katja
   Kasten, Meike
   Wszolek, Zbigniew K.
TI Assessment of Olfactory Function in MAPT-Associated Neurodegenerative
   Disease Reveals Odor-Identification Irreproducibility as a
   Non-Disease-Specific, General Characteristic of Olfactory Dysfunction
SO PLOS ONE
LA English
DT Article
ID MONTREAL COGNITIVE ASSESSMENT; PONTO-NIGRAL DEGENERATION; G2019S
   MUTATION CARRIERS; EARLY PARKINSONS-DISEASE; LEWY BODY DISEASE;
   FRONTOTEMPORAL DEMENTIA; NONMOTOR SYMPTOMS; TAU GENE;
   ALZHEIMERS-DISEASE; SCREENING TOOL
AB Olfactory dysfunction is associated with normal aging, multiple neurodegenerative disorders, including Parkinson's disease, Lewy body disease and Alzheimer's disease, and other diseases such as diabetes, sleep apnea and the autoimmune disease myasthenia gravis. The wide spectrum of neurodegenerative disorders associated with olfactory dysfunction suggests different, potentially overlapping, underlying pathophysiologies. Studying olfactory dysfunction in presymptomatic carriers of mutations known to cause familial parkinsonism provides unique opportunities to understand the role of genetic factors, delineate the salient characteristics of the onset of olfactory dysfunction, and understand when it starts relative to motor and cognitive symptoms. We evaluated olfactory dysfunction in 28 carriers of two MAPT mutations (p.N279K, p.P301L), which cause frontotemporal dementia with parkinsonism, using the University of Pennsylvania Smell Identification Test. Olfactory dysfunction in carriers does not appear to be allele specific, but is strongly age-dependent and precedes symptomatic onset. Severe olfactory dysfunction, however, is not a fully penetrant trait at the time of symptom onset. Principal component analysis revealed that olfactory dysfunction is not odor-class specific, even though individual odor responses cluster kindred members according to genetic and disease status. Strikingly, carriers with incipient olfactory dysfunction show poor inter-test consistency among the sets of odors identified incorrectly in successive replicate tests, even before severe olfactory dysfunction appears. Furthermore, when 78 individuals without neurodegenerative disease and 14 individuals with sporadic Parkinson's disease were evaluated twice at a one-year interval using the Brief Smell Identification Test, the majority also showed inconsistency in the sets of odors they identified incorrectly, independent of age and cognitive status. While these findings may reflect the limitations of these tests used and the sample sizes, olfactory dysfunction appears to be associated with the inability to identify odors reliably and consistently, not with the loss of an ability to identify specific odors. Irreproducibility in odor identification appears to be a non-disease-specific, general feature of olfactory dysfunction that is accelerated or accentuated in neurodegenerative disease. It may reflect a fundamental organizational principle of the olfactory system, which is more "error-prone" than other sensory systems.
C1 [Markopoulou, Katerina] NorthShore Univ Hlth Syst, Evanston, IL USA.
   [Chase, Bruce A.] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA.
   [Robowski, Piotr; Narozanska, Ewa; Sitek, Emilia J.; Slawek, Jaroslaw] Med Univ Gdansk, Dept Neurol & Psychiat Nursing, Gdansk, Poland.
   [Robowski, Piotr; Narozanska, Ewa; Sitek, Emilia J.; Slawek, Jaroslaw] Copernicus PL Sp Zoo, St Adalbert Hosp, Dept Neurol, Gdansk, Poland.
   [Strongosky, Audrey; Baker, Matt C.; Rademakers, Rosa] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.
   [Berdynski, Mariusz; Barcikowska, Maria] Polish Acad Sci, Dept Neurodegenerat Disorders, Mossakowski Med Res Ctr, Warsaw, Poland.
   [Klein, Christine; Hueckelheim, Katja; Kasten, Meike] Univ Lubeck, Inst Neurogenet, Lubeck, Germany.
   [Hueckelheim, Katja; Kasten, Meike] Univ Lubeck, Dept Psychiat & Psychotherapy, Lubeck, Germany.
   [Wszolek, Zbigniew K.] Mayo Clin Jacksonville, Dept Neurol, Jacksonville, FL USA.
RP Markopoulou, K (reprint author), NorthShore Univ Hlth Syst, Evanston, IL USA.
EM amarkopoulou@northshore.org
RI Berdynski, Mariusz/W-2382-2018; Sitek, Emilia J/I-6913-2013
OI Berdynski, Mariusz/0000-0003-2076-4318; Sitek, Emilia
   J/0000-0003-4141-072X; Markopoulou, Katerina
   (Aikaterini)/0000-0003-3973-5437; Barcikowska, Maria/0000-0001-5657-9670
FU NIH [NS057567, P50 NS072187, R01 NS080882, R01 NS065782, R01 AG026251,
   R01 NS076471, P50 AG16574]; Mayo Clinic Center for Regenerative
   Medicine; Center for Individualized Medicine; Mayo Clinic Neuroscience
   Focused Research Team Grant; German Research Foundation [KL 1134/11-1,
   KL 1134/12-1, KL 1134/13-1, SFB 936, SFB 134, KA 3179/2-1]; German
   Federal Ministry of Education and Research (BMBF) [01ED1406]; StemBANCC
   [15439-2]; Hermann and Lilly Schilling Foundation; ALS Therapy Alliance;
   Consortium for Frontotemporal Degeneration Research; FIRE program at the
   University of Nebraska at Omaha; UCRCA program at the University of
   Nebraska at Omaha
FX KM, PR, AS, EN, EJS, MBer, MBar, MCB, JS and KH report no disclosure.
   ZKW is funded by the NIH (NS057567, P50 NS072187;
   http://www.ninds.nh.gov), the Mayo Clinic Center for Regenerative
   Medicine and Center for Individualized Medicine, the Mayo Clinic
   Neuroscience Focused Research Team Grant, and a gift from Carl Edward
   Bolch Jr. and Susan Bass Bolch. CK is funded by the German Research
   Foundation (KL 1134/11-1; KL 1134/12-1; KL 1134/13-1, SFB 936; SFB 134;
   www.dfg.de/en/research_funding/programmes/index.jsp), the German Federal
   Ministry of Education and Research (BMBF) (01ED1406; www.bmbf.de), and
   StemBANCC (15439-2; stembaocc.org) and is the recipient of a career
   development award from the Hermann and Lilly Schilling Foundation
   (www.schilling-stiftung.de). MK is funded by the German Research
   Foundation (KA 3179/2-1). RR is funded by the NIH (R01 NS080882, R01
   NS065782, R01 AG026251, R01 NS076471, and P50 AG16574), the ALS Therapy
   Alliance (alstherapyalliance.org), and the Consortium for Frontotemporal
   Degeneration Research
   (http://memory.ucsf.edu/ftd/research/laboratory/cfr). BAC is funded by
   the FIRE and UCRCA programs at the University of Nebraska at Omaha
   (http://www.unomaha.edu/office-of-research-and-creative-activity).
   Individuals employed or contracted by the funders, other than the named
   authors, played no role in study design, data collection and analysis,
   the decision to publish, or the preparation of the manuscript.
CR Alves Jorge, 2014, World J Clin Cases, V2, P661, DOI 10.12998/wjcc.v2.i11.661
   Arima K, 2000, NEUROLOGY, V54, P1787, DOI 10.1212/WNL.54.9.1787
   Arvanitakis Z, 2007, PARKINSONISM RELAT D, V13, P230, DOI 10.1016/j.parkreldis.2006.10.007
   Audouze K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093037
   Bohnen NI, 2007, J NEUROL, V254, P84, DOI 10.1007/s00415-006-0284-y
   Bohnen NI, 2013, J NEURAL TRANSM, V120, P571, DOI 10.1007/s00702-012-0956-y
   Borghammer P, 2014, INT J CLIN PRACT, V68, P1345, DOI 10.1111/ijcp.12445
   Braga-Neto P, 2011, PARKINSONISM RELAT D, V17, P353, DOI 10.1016/j.parkreldis.2011.02.004
   Cain WS, 1998, CHEM SENSES, V23, P309, DOI 10.1093/chemse/23.3.309
   Cavaco S, 2015, BEHAV NEUROL, DOI 10.1155/2015/976589
   Chou KL, 2009, PARKINSONISM RELAT D, V15, P640, DOI 10.1016/j.parkreldis.2009.03.004
   Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103
   Devanand DP, 2010, NEUROBIOL AGING, V31, P1593, DOI 10.1016/j.neurobiolaging.2008.09.008
   Doty RL, 2008, ANN NEUROL, V63, P7, DOI 10.1002/ana.21327
   Doty RL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00020
   Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80
   Doty RL, 2012, NEUROBIOL DIS, V46, P527, DOI 10.1016/j.nbd.2011.10.026
   DOTY RL, 1992, J NEUROL NEUROSUR PS, V55, P138, DOI 10.1136/jnnp.55.2.138
   DOTY RL, 1984, LARYNGOSCOPE, V94, P176, DOI 10.1288/00005537-198402000-00004
   Doty RL, 1995, CHEM SENSES, V20, P645, DOI 10.1093/chemse/20.6.645
   Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021
   Doty RL, 2007, REV PARKINSONISM REL, V13, pS225, DOI [10.1016/S1353-8020(08)70006-3, DOI 10.1016/S1353-8020(08)70006-3]
   Driver-Dunckley E, 2014, PARKINSONISM RELAT D, V20, P1260, DOI 10.1016/j.parkreldis.2014.08.006
   Filippi M, 2013, LANCET NEUROL, V12, P12, DOI 10.1016/S1474-4422(12)70288-0
   Fleiss JL, 1981, STAT METHODS RATES P
   Fullard ME, 2016, PARKINSONISM RELAT D, V25, P45, DOI 10.1016/j.parkreldis.2016.02.013
   Georgiopoulos C, 2015, J NEUROL, V262, P2154, DOI 10.1007/s00415-015-7830-4
   Ghosh S, 2013, AM J ALZHEIMERS DIS
   Giessel AJ, 2014, CURR OPIN NEUROBIOL, V24, P120, DOI 10.1016/j.conb.2013.09.010
   Gill DJ, 2008, MOVEMENT DISORD, V23, P1043, DOI 10.1002/mds.22017
   Godoy LMDC, 2015, ARCH OTORHINOLARYNGO, V19, P176
   Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007
   GOETZ CG, 1995, MOVEMENT DISORD, V10, P263, DOI 10.1002/mds.870100305
   Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198
   Goldman JG, 2014, CURR OPIN NEUROL, V27, P434, DOI 10.1097/WCO.0000000000000112
   Grant AC, 2014, EPILEPSY BEHAV, V32, P102, DOI 10.1016/j.yebeh.2014.01.011
   Gwet K. L., 2008, WILEY ENCY CLIN TRIA, P1, DOI DOI 10.1002/9780471462422.EOCT631
   Hagenah JM, 2008, J NEUROL NEUROSUR PS, V79, P1071, DOI 10.1136/jnnp.2007.142174
   Hawkes C, 2006, ADV OTO-RHINO-LARYNG, V63, P133, DOI 10.1159/000093759
   HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427
   Hoops S, 2009, NEUROLOGY, V73, P1738, DOI 10.1212/WNL.0b013e3181c34b47
   Ibarretxe-Bilbao N, 2010, MOVEMENT DISORD, V25, P1888, DOI 10.1002/mds.23208
   Iranzo A, 2013, PARKINSONISM RELAT D, V19, P600, DOI 10.1016/j.parkreldis.2013.02.009
   Joseph A, 2016, J NEUROL NEUROSUR PS, V87, P1146, DOI 10.1136/jnnp-2015-312600
   Kalbe E, 2008, PARKINSONISM RELAT D, V14, P93, DOI 10.1016/j.parkreldis.2007.06.008
   Kasten M, 2013, INT J EPIDEMIOL, V42, P128, DOI 10.1093/ije/dys202
   Kulisevsky J, 2009, MOVEMENT DISORD, V24, P1103, DOI 10.1002/mds.22506
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lone-Sarmiento FE, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045544, DOI 10.1371/JOURNAL.PONE.0045544]
   Hernandez NL, 2015, NEUROLOGIA, V30, P496, DOI 10.1016/j.nrl.2014.03.010
   Ludolph AC, 2009, EUR J NEUROL, V16, P297, DOI 10.1111/j.1468-1331.2008.02513.x
   Luzzi S, 2007, NEUROPSYCHOLOGIA, V45, P1823, DOI 10.1016/j.neuropsychologia.2006.12.008
   Mahlknecht P, 2016, MOVEMENT DISORD, V31, P1408, DOI 10.1002/mds.26637
   Mahlknecht P, 2015, NEUROLOGY, V84, P654, DOI 10.1212/WNL.0000000000001265
   Malek N, 2016, ACTA NEUROL SCAND, V134, P271, DOI 10.1111/ane.12538
   McLaughlin NCR, 2008, ARCH CLIN NEUROPSYCH, V23, P119, DOI 10.1016/j.acn.2007.07.008
   Menon C, 2013, CLIN NEUROPSYCHOL, V27, P946, DOI 10.1080/13854046.2013.796406
   Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917
   Myga B, 2011, EUR J NEUROL, V18, P535, DOI [10.1111/j.1468-1331.2010.03107.x, DOI 10.1111/J.1468-1331.2010.03107.X]
   Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x
   Pardini M, 2009, ARCH NEUROL-CHICAGO, V66, P92, DOI 10.1001/archneurol.2008.521
   Picillo M, 2014, NEUROL SCI, V35, P379, DOI 10.1007/s10072-013-1522-6
   Pont-Sunyer C, 2015, MOVEMENT DISORD, V30, P229, DOI 10.1002/mds.26077
   R Core Team, 2013, R LANG ENV STAT COMP
   Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117
   Roberts RO, 2016, JAMA NEUROL, V73, P93, DOI 10.1001/jamaneurol.2015.2952
   Rolheiser TM, 2011, J NEUROL, V258, P1254, DOI 10.1007/s00415-011-5915-2
   Ross GW, 2008, ANN NEUROL, V63, P167, DOI 10.1002/ana.21291
   Rossi M, 2016, MOVEMENT DISORD, V31, P1414, DOI 10.1002/mds.26687
   Salihoglu M, 2014, LARYNGOSCOPE, V124, P2190, DOI 10.1002/lary.24565
   Saunders-Pullman R, 2011, NEUROLOGY, V77, P319, DOI 10.1212/WNL.0b013e318227041c
   Saunders-Pullman R, 2014, ANN CLIN TRANSL NEUR, V1, P670, DOI 10.1002/acn3.95
   Scherfler C, 2013, BRAIN, V136, P3028, DOI 10.1093/brain/awt234
   Schwab RS, 1969, 3 S PARK DIS, P152
   Secundo L, 2015, P NATL ACAD SCI USA, V112, P8750, DOI 10.1073/pnas.1424826112
   Seelaar H, 2011, J NEUROL NEUROSUR PS, V82, P476, DOI 10.1136/jnnp.2010.212225
   Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006
   Siderowf A, 2012, MOVEMENT DISORD, V27, P406, DOI 10.1002/mds.24892
   Silveira-Moriyama L, 2015, NAT REV NEUROL, V11, P5, DOI 10.1038/nrneurol.2014.235
   Silveira-Moriyama L, 2009, MOVEMENT DISORD, V24, P1144, DOI 10.1002/mds.22494
   Sim J, 2005, PHYS THER, V85, P257
   Sitek EJ, 2009, ACTA NEUROPSYCHIATR, V21, P209, DOI [10.1111/j.1601-5215.2009.0367.x, 10.1111/j.1601-5215.2009.00367.x]
   Skorpil M, 2012, J PARKINSON DIS, V2, P171, DOI 10.3233/JPD-2012-12091
   Swallow DMA, 2016, J PARKINSON DIS, V6, P289, DOI 10.3233/JPD-150741
   Tan LZ, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156639
   Taylor S, 2016, MOVEMENT DISORD, V31, P344, DOI 10.1002/mds.26456
   Tsuboi Y, 2002, ARCH NEUROL-CHICAGO, V59, P943, DOI 10.1001/archneur.59.6.943
   Tunc S, 2015, MOVEMENT DISORD, V30, P531, DOI 10.1002/mds.26100
   Uchida N, 2014, ANNU REV NEUROSCI, V37, P363, DOI 10.1146/annurev-neuro-071013-013941
   Velayudhan L, 2013, INT PSYCHOGERIATR, V25, P1157, DOI 10.1017/S1041610213000446
   WEINSTOCK RS, 1993, PHYSIOL BEHAV, V53, P17, DOI 10.1016/0031-9384(93)90005-Z
   Whitcroft KL, 2017, LARYNGOSCOPE, V127, P291, DOI 10.1002/lary.26229
   Whitwell JL, 2009, NEUROLOGY, V73, P1058, DOI 10.1212/WNL.0b013e3181b9c8b9
   Wilson DA, 2014, PROG BRAIN RES, V208, P275, DOI 10.1016/B978-0-444-63350-7.00011-5
   Wittchen HU, 1997, STRUKTURIERTES KLIN
   Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200
   WSZOLEK ZK, 1992, ANN NEUROL, V32, P312, DOI 10.1002/ana.410320303
   Xiao Q, 2014, NEUROSCI BULL, V30, P134, DOI 10.1007/s12264-013-1390-3
   Yoshida I, 2007, J NEUROSCI, V27, P9105, DOI 10.1523/JNEUROSCI.2720-07.2007
   Zou YM, 2016, NEUROPSYCH DIS TREAT, V12, P869, DOI 10.2147/NDT.S104886
NR 100
TC 2
Z9 2
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 17
PY 2016
VL 11
IS 11
AR e0165112
DI 10.1371/journal.pone.0165112
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EC2AC
UT WOS:000387910200008
PM 27855167
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Molino, CDRC
   Romano-Lieber, NS
   Ribeiro, E
   de Melo, DO
AF Rezende Costa Molino, Caroline de Godoi
   Romano-Lieber, Nicolina Silvana
   Ribeiro, Eliane
   de Melo, Daniela Oliveira
TI Non-Communicable Disease Clinical Practice Guidelines in Brazil: A
   Systematic Assessment of Methodological Quality and Transparency
SO PLOS ONE
LA English
DT Article
ID AGREE II; PRIMARY-CARE; MULTIMORBIDITY; MANAGEMENT; APPRAISAL; CHINA;
   INSTRUMENT
AB Background
   Annually, non-communicable diseases (NCDs) kill 38 million people worldwide, with low and middle-income countries accounting for three-quarters of these deaths. High-quality clinical practice guidelines (CPGs) are fundamental to improving NCD management. The present study evaluated the methodological rigor and transparency of Brazilian CPGs that recommend pharmacological treatment for the most prevalent NCDs.
   Methods
   We conducted a systematic search for CPGs of the following NCDs: asthma, atrial fibrillation, benign prostatic hyperplasia, chronic obstructive pulmonary disease, congestive heart failure, coronary artery disease and/or stable angina, dementia, depression, diabetes, gastroesophageal reflux disease, hypercholesterolemia, hypertension, osteoarthritis, and osteoporosis. CPGs comprising pharmacological treatment recommendations were included. No language or year restrictions were applied. CPGs were excluded if they were merely for local use and referred to NCDs not listed above. CPG quality was independently assessed by two reviewers using the Appraisal of Guidelines Research and Evaluation instrument, version II (AGREE II).
   Main Findings
   "Scope and purpose" and "clarity and presentation" domains received the highest scores. Sixteen of 26 CPGs were classified as low quality, and none were classified as high overall quality. No CPG was recommended without modification (77% were not recommended at all). After 2009, 2 domain scores ("rigor of development" and "clarity and presentation") increased (61% and 73%, respectively). However, "rigor of development" was still rated <30%.
   Conclusion
   Brazilian healthcare professionals should be concerned with CPG quality for the treatment of selected NCDs. Features that undermined AGREE II scores included the lack of a multidisciplinary team for the development group, no consideration of patients' preferences, insufficient information regarding literature searches, lack of selection criteria, formulating recommendations, authors' conflict of interest disclosures, and funding body influence.
C1 [Rezende Costa Molino, Caroline de Godoi] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Pharm, Sao Paulo, Brazil.
   [Romano-Lieber, Nicolina Silvana] Univ Sao Paulo, Sch Publ Hlth, Dept Publ Hlth Practice, Sao Paulo, Brazil.
   [Ribeiro, Eliane] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Pharm, Univ Sao Paulo Hosp, Sao Paulo, Brazil.
   [de Melo, Daniela Oliveira] Univ Fed Sao Paulo, Inst Environm Sci Chem & Pharmaceut, Dept Biol Sci, Sao Paulo, Brazil.
RP de Melo, DO (reprint author), Univ Fed Sao Paulo, Inst Environm Sci Chem & Pharmaceut, Dept Biol Sci, Sao Paulo, Brazil.
EM melo.daniela@unifesp.br
RI de Melo, Daniela Oliveira/J-8247-2015; Ribeiro, Eliane/D-8308-2012;
   Molino, Caroline/J-9504-2015
OI de Melo, Daniela Oliveira/0000-0001-8613-7953; Ribeiro,
   Eliane/0000-0003-0886-368X; Molino, Caroline/0000-0001-6925-1201
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   [164700/2015-3]
FX CGRCM is supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), process number 164700/2015-3. The
   funding source did not influence the content of this study.
CR Agency for Healthcare Research and Quality (AHRQ), NAT GUID CLEAR
   AGREE Next Steps Consortium, 2009, AGREE 2 INSTR EL VER
   Al-Ansary LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053744
   Bancos I, 2012, J CLIN EPIDEMIOL, V65, P520, DOI 10.1016/j.jclinepi.2011.07.014
   Bocchi EA, 2012, ARQ BRAS CARDIOL, V98, P1, DOI 10.1590/S0066-782X2012000700001
   Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775
   Bower P, 2011, FAM PRACT, V28, P579, DOI 10.1093/fampra/cmr018
   Brazil. Ministry of Health, 2014, CLIN PROT THER GUID
   Brazil. Ministry of Health, 2013, CLIN PROT THER GUID
   Brazil. Ministry of Health, 2013, CLIN PROT HER GUID A
   Brazil. Ministry of Health, CLIN PROT THER GUID
   Brazil. Ministry of Health, 2015, CLIN PROT THER GUID
   Brazilian Society of Diabetes, GUID BRAZ SOC DIAB
   Brazilian Society of Pneumology and Tisiology, 2012, J BRASILEIRO PNEU S1, V38, pS1
   Brazilian Society of Pneumology and Tisiology, 2004, J BRAS PNEUMOL, V30, pS1
   Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449
   Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458
   Cavalcanti A, 2006, BENIGN PROSTATIC HYP
   Cesar LA, 2014, ARQ BRAS CARDIOL, V103, P1, DOI 10.5935/abc.2014S004
   Chen YL, 2012, CHINESE MED J-PEKING, V125, P3660, DOI 10.3760/cma.j.issn.0366-6999.2012.20.011
   Chen Y, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008099
   Chui Sin Yan, 2007, Journal of Pharmacy Practice and Research, V37, P124
   Coimbra I, 2011, USE NONSTEROIDAL ANT
   Khan GSC, 2014, CAD SAUDE PUBLICA, V30, P1111, DOI 10.1590/0102-311X00174912
   Dlyernois J-F, 2014, REV EPIDEMIOL SANTE, V62, P305, DOI [10.1016/j.respe.2014.09.002, DOI 10.1016/J.RESPE.2014.09.002]
   Fleck M, 2011, UNIPOLAR DEPRESSION
   Fretheim Atle, 2006, Health Res Policy Syst, V4, P15, DOI 10.1186/1478-4505-4-15
   Gich I, 2010, QUAL SAF HEALTH CARE, V19, pe58, DOI [10.1136/qshc.2010.042077, DOI 10.1136/QSHC.2010.042077]
   Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1
   Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6
   Guiding principles for the care of older adults with multimorbidity: an approach for clinicians, 2012, J Am Geriatr Soc, V60, pE1, DOI 10.1111/j.1532-5415.2012.04188.x
   HAINES A, 1994, BMJ-BRIT MED J, V308, P1488, DOI 10.1136/bmj.308.6942.1488
   da Mota LMH, 2012, REV BRAS REUMATOL, V52, P135
   Hu J, 2013, J EVAL CLIN PRACT, V19, P961, DOI 10.1111/j.1365-2753.2012.01893.x
   Hudon C, 2012, PATIENT EDUC COUNS, V88, P170, DOI 10.1016/j.pec.2012.01.009
   Jardim J, 2012, CHRONIC OBSTRUCTIVE
   Jayaraman S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123780
   Jiang M, 2015, CHEST, V148, P759, DOI 10.1378/chest.14-3201
   Knai C, 2012, HEALTH POLICY, V107, P157, DOI 10.1016/j.healthpol.2012.06.004
   Kryworuchko J, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-49
   Kung J, 2012, ARCH INTERN MED, V172, P1628, DOI 10.1001/2013.jamainternmed.56
   Kunz Regina, 2012, Proc Am Thorac Soc, V9, P229, DOI 10.1513/pats.201208-056ST
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Legido-Quigley H, 2012, HEALTH POLICY, V107, P146, DOI 10.1016/j.healthpol.2012.08.004
   Lopes L, 2011, ALZHEIMERS DIS PREVE
   Lorgunpai SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089447
   Lowry R, 2013, VASSARSTATS WEBSITE
   Macedo G, 2011, TYPE 2 DIABETES MELL
   Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003
   Martins D, 2004, DIABETES MELLITUS TR
   McMaster University, MCMASTER AGREE 2 SCO
   Menotti A, 2001, J CLIN EPIDEMIOL, V54, P680, DOI 10.1016/S0895-4356(00)00368-1
   Murthy L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009401.pub2
   Nasy A, 2011, GASTROESOPHAGEAL REF
   Norris SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047343
   Pan American Health Organization, 2012, HEALTH IN THE AMERIC
   Piano V, 2013, PAIN PRACT, V13, P349, DOI 10.1111/j.1533-2500.2012.00602.x
   Poitras S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2339
   Rayess ZAI, 2014, GIN C MELB
   Ronsoni RD, 2015, CAD SAUDE PUBLICA, V31, P1157, DOI 10.1590/0102-311X00118814
   Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027
   Seron P, 2015, J CARDIOPULM REHABIL, V35, P1, DOI 10.1097/HCR.0000000000000075
   Sgarbi J, 2004, DIABETES MELLITUS PH
   Shaneyfelt TM, 1999, JAMA-J AM MED ASSOC, V281, P1900, DOI 10.1001/jama.281.20.1900
   Siering U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082915
   Smith SM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5205
   Sociedade Brasileira de Cardiologia, 2010, Arq Bras Cardiol, V95, P1
   Soeiro A de M, 2014, ARQ BRAS CARDIOL, V102, P1
   Tudor KI, 2013, PLOS ONE, V8, DOI [10.1371/, DOI 10.1371/LOURNATPONE.0069877]
   U. S. National Library of Medicine, MEDLINE PUBMED
   Vitry AI, 2008, MED J AUSTRALIA, V189, P360
   Vlayen J, 2005, INT J QUAL HEALTH C, V17, P235, DOI 10.1093/intqhc/mzi027
   Wagner E H, 1996, Manag Care Q, V4, P12
   Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1
   Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527
   World Health Organization (WHO), 2015, WHO MEDIACENTRE D FA
   Xavier HT, 2013, ARQ BRAS CARDIOL, V101, P1, DOI 10.5935/abc.2013S010
   Yan JP, 2013, J EVAL CLIN PRACT, V19, P626, DOI 10.1111/j.1365-2753.2012.01873.x
   Zhang ZC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111796
   Zimerman LI, 2009, ARQ BRAS CARDIOL, V92, P1
NR 81
TC 5
Z9 5
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 15
PY 2016
VL 11
IS 11
AR e0166367
DI 10.1371/journal.pone.0166367
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EC0MG
UT WOS:000387794600052
PM 27846245
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Thieler, ER
   Zeigler, SL
   Winslow, LA
   Hines, MK
   Read, JS
   Walker, JI
AF Thieler, E. Robert
   Zeigler, Sara L.
   Winslow, Luke A.
   Hines, Megan K.
   Read, Jordan S.
   Walker, Jordan I.
TI Smartphone-Based Distributed Data Collection Enables Rapid Assessment of
   Shorebird Habitat Suitability
SO PLOS ONE
LA English
DT Article
ID BAYESIAN NETWORK; PIPING PLOVERS; ASSISTED GPS; ECOLOGY; CONSERVATION;
   ACCURACY
AB Understanding and managing dynamic coastal landscapes for beach-dependent species requires biological and geological data across the range of relevant environments and habitats. It is difficult to acquire such information; data often have limited focus due to resource constraints, are collected by non-specialists, or lack observational uniformity. We developed an open-source smartphone application called iPlover that addresses these difficulties in collecting biogeomorphic information at piping plover (Charadrius melodus) nest sites on coastal beaches. This paper describes iPlover development and evaluates data quality and utility following two years of collection (n = 1799 data points over 1500 km of coast between Maine and North Carolina, USA). We found strong agreement between field user and expert assessments and high model skill when data were used for habitat suitability prediction. Methods used here to develop and deploy a distributed data collection system have broad applicability to interdisciplinary environmental monitoring and modeling.
C1 [Thieler, E. Robert; Zeigler, Sara L.] US Geol Survey, Woods Hole, MA 02543 USA.
   [Winslow, Luke A.; Hines, Megan K.; Read, Jordan S.; Walker, Jordan I.] US Geol Survey, Middleton, WI USA.
RP Thieler, ER (reprint author), US Geol Survey, Woods Hole, MA 02543 USA.
EM rthieler@usgs.gov
OI Zeigler, Sara/0000-0002-5472-769X; thieler, e/0000-0003-4311-9717
FU North Atlantic Landscape Conservation Cooperative; U.S. Geological
   Survey Coastal and Marine Geology Program
FX This work was supported by the North Atlantic Landscape Conservation
   Cooperative through the U.S. Department of the Interior Hurricane Sandy
   recovery program under the Disaster Relief Appropriations Act of 2013,
   and the U.S. Geological Survey Coastal and Marine Geology Program.; This
   work was supported by the North Atlantic Landscape Conservation
   Cooperative through the U.S. Department of the Interior Hurricane Sandy
   recovery program under the Disaster Relief Appropriations Act of 2013,
   and the U.S. Geological Survey Coastal and Marine Geology Program.
CR Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968
   Anel JA, 2011, COMMUN ACM, V54, P40, DOI 10.1145/1941487.1941502
   BAYES T, 1958, BIOMETRIKA, V45, P296
   Boccardo P, 2015, SENSORS-BASEL, V15, P15717, DOI 10.3390/s150715717
   BURGER J, 1987, CONDOR, V89, P811, DOI 10.2307/1368529
   Cohen JB, 2009, WILDLIFE MONOGR, P1, DOI 10.2193/2007-553
   Cubasch U, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P119
   Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636
   Faundeen JL, 2013, USGS OPEN-FILE REP, P4, DOI [10.3133/ofr20131265, DOI 10.3133/ofr20131265]
   Galbraith H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108899
   Gieder KD, 2014, ECOL MODEL, V276, P38, DOI 10.1016/j.ecolmodel.2014.01.005
   Godfrey PJ, 1976, TECHN P 1976 BARR IS, P5, DOI 10.1093/biomet/45.3-4.296
   Gregory R., 2012, STRUCTURED DECISION
   Gutierrez BT, 2015, J GEOPHYS RES-EARTH, V120, P2452, DOI 10.1002/2015JF003671
   Gutierrez BT, 2011, J GEOPHYS RES-EARTH, V116, DOI [10.1029/2010JF001891, 10.1029/20101F001891]
   Hecht A, 2009, WATERBIRDS, V32, P64, DOI 10.1675/063.032.0107
   Hermoso V, 2015, J BIOGEOGR, V42, P218, DOI 10.1111/jbi.12393
   Jensen F. V., 2007, BAYESIAN NETWORKS DE
   Karlen W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099266
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x
   Martin J, 2009, ECOL APPL, V19, P1079, DOI 10.1890/08-0255.1
   Martin Robert C., 2002, AGILE SOFTWARE DEV P
   Moser S. C., 2014, CLIMATE CHANGE IMPAC, p[579, 579], DOI [10.7930/J0MS3QNW, DOI 10.7930/J0MS3QNW]
   Sturdivant EJ, 2016, BIOGEOMORPHIC CLASSI, DOI [10.5066/F70V89X3, DOI 10.5066/F70V89X3]
   Takeuchi K, 2010, COMPUT GEOSCI-UK, V36, P573, DOI 10.1016/j.cageo.2009.09.012
   Teacher AGF, 2013, ECOL EVOL, V3, P5268, DOI 10.1002/ece3.888
   U.S. Fish and Wildlife Service, 1996, PIP PLOV CHAR MEL AT
   U.S. Fish and Wildlife Service, 2015, PREL 2012 ATL COAST
   US Fish and Wildlife Service (USFWS), 1985, FED REGISTER, V50, P50726
   Vogels W, 2009, COMMUN ACM, V52, P40, DOI 10.1145/1435417.1435432
   WILCOX LEROY, 1959, AUK, V76, P129
   Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361
   Zandbergen PA, 2011, J NAVIGATION, V64, P381, DOI 10.1017/S0373463311000051
   Zandbergen PA, 2009, T GIS, V13, P5, DOI 10.1111/j.1467-9671.2009.01152.x
NR 35
TC 1
Z9 1
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 9
PY 2016
VL 11
IS 11
AR e0164979
DI 10.1371/journal.pone.0164979
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EB9OG
UT WOS:000387724300023
PM 27828974
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gomes, E
   Capinha, C
   Rocha, J
   Sousa, C
AF Gomes, Eduardo
   Capinha, Cesar
   Rocha, Jorge
   Sousa, Carla
TI Mapping Risk of Malaria Transmission in Mainland Portugal Using a
   Mathematical Modelling Approach
SO PLOS ONE
LA English
DT Article
ID PRESENCE-ONLY DATA; ENVIRONMENTAL SUITABILITY; HABITAT SUITABILITY;
   ANOPHELES-GAMBIAE; AREAS; DISTRIBUTIONS
AB Malaria is currently one of the world's major health problems. About a half-million deaths are recorded every year. In Portugal, malaria cases were significantly high until the end of the 1950s but the disease was considered eliminated in 1973. In the past few years, endemic malaria cases have been recorded in some European countries. With the increasing human mobility from countries with endemic malaria to Portugal, there is concern about the resurgence of this disease in the country. Here, we model and map the risk of malaria transmission for mainland Portugal, considering 3 different scenarios of existing imported infections. This risk assessment resulted from entomological studies on An. atroparvus, the only known mosquito capable of transmitting malaria in the study area. We used the malariogenic potential (determined by receptivity, infectivity and vulnerability) applied over geospatial data sets to estimate spatial variation in malaria risk. The results suggest that the risk exists, and the hotspots are concentrated in the northeast region of the country and in the upper and lower Alentejo regions.
C1 [Gomes, Eduardo; Rocha, Jorge] Univ Lisbon, Inst Geog & Ordenamento Terr, Ctr Estudos Geog, Lisbon, Portugal.
   [Capinha, Cesar] Univ Porto, CIBIO InBIO, Ctr Invest Biodiversidade & Recursos Genet, Catedra Infraestruturas Portugal Biodiversidade, Oporto, Portugal.
   [Capinha, Cesar] Zool Forsch Museum Alexander Koenig, Bonn, Germany.
   [Sousa, Carla] Univ Nova Lisboa, Global Hlth & Trop Med, GHTM, Inst Higiene & Med Trop, Lisbon, Portugal.
RP Gomes, E (reprint author), Univ Lisbon, Inst Geog & Ordenamento Terr, Ctr Estudos Geog, Lisbon, Portugal.
EM eduardojonas@campus.ul.pt
RI Sousa, Carla/G-6531-2012; Gomes, Eduardo/V-6159-2017; Rocha,
   Jorge/F-3185-2017; Capinha, Cesar/K-6439-2017
OI Sousa, Carla/0000-0002-2386-7577; Gomes, Eduardo/0000-0001-8703-1763;
   Rocha, Jorge/0000-0002-7228-6330; Capinha, Cesar/0000-0002-0666-9755
FU EU grant [GOCE-2003-010284 EDEN]; Arbovirus dos mosquitos de Portugal
   [POCTI/35775/ESP/2000, GHTM UID/Multi/04413/2013]
FX This publication was partially funded by: (i) EU grant GOCE-2003-010284
   EDEN (www.edenfp6project.net), (ii) Arbovirus dos mosquitos de Portugal
   (POCTI/35775/ESP/2000) and GHTM UID/Multi/04413/2013. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Afrane YA, 2006, AM J TROP MED HYG, V74, P772, DOI 10.4269/ajtmh.2006.74.772
   Alten B, 2007, ECOL CONT VECTOR-BOR, V1, P35
   Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x
   Becker N., 2003, MOSQUITOES THEIR CON
   Benali A, 2014, REMOTE SENS ENVIRON, V145, P116, DOI 10.1016/j.rse.2014.01.014
   Bueno-Mari R, 2012, TROP BIOMED, V29, P39
   Buttner PG, 2012, IMPLEMENTATION ACHIE
   Cambournac F, 1938, T 3 INT C TROP MED M, V2, P1938
   CAMBOURNAC FJ, 1942, EPIDEMIOLOGIA SEZONI
   Cano J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-21
   Capinha C, 2009, GEOSPATIAL HEALTH, V3, P177, DOI 10.4081/gh.2009.219
   Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   da Saude D-G, 2015, DOENC DECL OBR 2010
   de Saude E, 2011, DOENC DECL OBR 2004
   Detinova T., 1963, METHODES APPL CLASSE
   Elith J, 2006, NOVEL METHODS IMPROV, V2
   Elyazar IRF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037325
   Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7
   Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241
   Gomes ED, 2016, CORDIS, P1
   Grillet ME, 2010, SPAT SPATIO-TEMPORAL, V1, P251, DOI 10.1016/j.sste.2010.09.007
   Hanafi-Bojd AA, 2012, ACTA TROP, V122, P132, DOI 10.1016/j.actatropica.2012.01.003
   Hastie T, 2013, ECOGRAPHY, V36, P864, DOI 10.1111/j.1600-0587.2013.00321.x
   Hijmans R. J, 2016, SPECIES DISTRIBUTION
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017
   INE, 2011, 15 REC GER POP HAB
   Knell A. J., 1991, MALARIA
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lawler JJ, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P271, DOI 10.1007/978-1-4419-7390-0_14
   Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x
   Miranda P., 2006, ALTERACOES CLIMATICA, P45
   Molineaux L, 1988, EPIDEMIOLOGY MALARIA
   Muller S, 2015, MOLECULES, V20, P10511, DOI 10.3390/molecules200610511
   O'Hanley JR, 2009, ECOGRAPHY, V32, P89, DOI 10.1111/j.1600-0587.2008.05601.x
   Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146
   Park YS, 2003, ECOL MODEL, V160, P265, DOI 10.1016/S0304-3800(02)00258-2
   Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x
   Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Pires C. A., 1982, DO I HIG MED TROP, V8, P79
   Poncon N, 2008, QUANTITATIVE RISK AS, V7, P1
   Ramos H, 1978, I HIG MED TROP LISB, V1, P79
   Reisen W. K., 1989, Bulletin of the Society for Vector Ecology, V14, P39
   Ribeiro H, 1992, GARCIA HORTA Z, V16, P137
   Ribeiro H, 2002, GARCIA HORTA Z, V24, P2002
   Ribeiro H, 1999, GARCIA HORTA Z, V23, P1999
   Roura-Pascual N, 2009, BIOL INVASIONS, V11, P1017, DOI 10.1007/s10530-008-9313-3
   Salvi C, 2016, HIST MALARIA ELIMINA
   Santos L, 2012, MALAR J, V11
   Sousa C, 2008, MALARIA VECTORIAL CA
   VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087
   Walther H, 1988, MALARIA PRINCIPLES P
   World Health Organization, 2015, WORLD MAL REP 2015
   Zaniewski AE, 2002, ECOL MODEL, V157, P261, DOI 10.1016/S0304-3800(02)00199-0
NR 56
TC 6
Z9 7
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 4
PY 2016
VL 11
IS 11
AR e0164788
DI 10.1371/journal.pone.0164788
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EA8TH
UT WOS:000386911100004
PM 27814371
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Napoli, PE
   Coronella, F
   Satta, GM
   Iovino, C
   Sanna, R
   Fossarello, M
AF Napoli, Pietro Emanuele
   Coronella, Franco
   Satta, Giovanni Maria
   Iovino, Claudio
   Sanna, Raffaele
   Fossarello, Maurizio
TI A Simple Novel Technique of Infrared Meibography by Means of
   Spectral-Domain Optical Coherence Tomography: A Cross-Sectional Clinical
   Study
SO PLOS ONE
LA English
DT Article
ID MEIBOMIAN GLAND DYSFUNCTION; FILM LIPID LAYER; DRY EYE DISEASE; TEAR
   FILM; LID MARGIN; POPULATION; DIAGNOSIS; SURFACE; SYSTEM
AB Purpose
   To compare a novel spectral-domain optical coherence tomography (SD-OCT) technique with traditional lid transillumination for evaluation of meibomian glands (MGs) and to assess the relation of MG morphologic changes to the glandular atrophy.
   Design
   Evaluation of diagnostic technology.
   Participants
   Sixty-one patients with obstructive MGD (30 men, 31 women; age [mean +/- standard deviation] 45.1 +/- 12.1 years), and 75 control subjects (32 men, 43 women; 44.1 +/- 12.5 years) were recruited in order to have a balanced distribution of glandular features.
   Methods
   Agreement between SD-OCT and lid transillumination examination for the detection of drop-out (partial or complete loss of MGs) and microscopic changes (i.e. shortening, distortion, segmentation and entanglement), as well as the relationship between morphological features and MG atrophy were evaluated.
   Main Outcome Measures
   Agreement between the two meibographic techniques, bias in symmetry of classification, and association analysis between microscopic changes and MG dropout.
   Results
   Overall agreement for all morphological features was substantial (Cohen kappa coefficient = 0.77; p<0.001), even if, the majority of disagreement occurred for cases with segmentation, where agreement was present in only 108 (81.82%) of 132 eyes with adequate images for interpretation, and where SD-OCT tended to diagnose more cases not detected by traditional lid transillumination (McNemar test, p<0.001). Moreover, segmentation and distortion pattern negatively correlated with the degree of drop-out, whereas shortening and entanglement pattern demonstrated only a weak correlation (Spearman's. was -0.691, -0.491, -0.359, -0.385, respectively).
   Conclusions
   Each method has its advantages but in general there was close agreement between these meibographic techniques, particularly for MG dropout, which supports the reliability of our novel, simple and patient-friendly SD-OCT approach.
C1 [Napoli, Pietro Emanuele; Coronella, Franco; Satta, Giovanni Maria; Iovino, Claudio; Sanna, Raffaele; Fossarello, Maurizio] Univ Cagliari, Eye Clin, Dept Surg Sci, Cagliari, Italy.
RP Napoli, PE (reprint author), Univ Cagliari, Eye Clin, Dept Surg Sci, Cagliari, Italy.
EM pietronapoli@ymail.com
RI Iovino, Claudio/O-7680-2019; Fossarello, Maurizio/G-2032-2015
OI Iovino, Claudio/0000-0003-1984-0555; Napoli, Pietro
   Emanuele/0000-0001-7020-0823; Fossarello, Maurizio/0000-0003-1520-7760
CR Amano S, 2010, J EYE ATARASHII GANK, V27, P627
   Arita R, 2014, CURRENT OPHTHALMOL R, V2, P49
   Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI 10.1016/j.ophtha.2007.06.03
   Arita R, 2010, CORNEA, V29, P858, DOI 10.1097/ICO.0b013e3181ca3668
   Arita R, 2009, OPHTHALMOLOGY, V116, P2058, DOI 10.1016/j.ophtha.2009.04.037
   Arita R, 2009, OPHTHALMOLOGY, V116, P379, DOI 10.1016/j.ophtha.2008.10.012
   Breustedt DA, 2006, BBA-PROTEINS PROTEOM, V1764, P161, DOI 10.1016/j.bbapap.2005.12.006
   Bron AJ, 2004, EXP EYE RES, V78, P347, DOI 10.1016/j.exer.2003.09.019
   Bron AJ, 2007, OCUL SURF, V5, P108
   CHEW CKS, 1993, CURR EYE RES, V12, P247, DOI 10.3109/02713689308999470
   Chu R, 2012, OCULAR SURFACE DISOR, V69
   Foulks GN, 2007, SURV OPHTHALMOL, V52, P369, DOI 10.1016/j.survophthal.2007.04.009
   Hwang HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067143
   Hwang HS, 2013, CORNEA, V32, P40, DOI 10.1097/ICO.0b013e318247b2fd
   Johnson ME, 2005, CORNEA, V24, P811, DOI 10.1097/01.ico.0000154378.67495.40
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   MATHERS WD, 1994, ARCH OPHTHALMOL-CHIC, V112, P448, DOI 10.1001/archopht.1994.01090160022008
   MISHIMA S, 1961, EXP EYE RES, V1, P39, DOI 10.1016/S0014-4835(61)80006-7
   MOLINARI JF, 2000, MIL MED, V165, P591
   Napoli PE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30428
   Napoli PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115762
   Napoli PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109843
   Napoli PE, 2014, INVEST OPHTH VIS SCI, V55, P4533, DOI 10.1167/iovs.14-14666
   Napoli PE, 2014, INVEST OPHTH VIS SCI, V55, P3179, DOI 10.1167/iovs.13-13613
   Napoli PE, 2014, CAN J OPHTHALMOL, V49, P210, DOI 10.1016/j.jcjo.2013.10.003
   Nichols JJ, 2005, CORNEA, V24, P382, DOI 10.1097/01.ico.0000148291.38076.59
   ROBIN JB, 1985, OPHTHALMOLOGY, V92, P1423
   SHIMAZAKI J, 1995, ARCH OPHTHALMOL-CHIC, V113, P1266, DOI 10.1001/archopht.1995.01100100054027
   TAPIE R, 1977, ANN OCUL, V210, P637
   Tomlinson A, 2011, INVEST OPHTH VIS SCI, V52, P2006, DOI 10.1167/iovs.10-6997f
   Viso E, 2014, CORNEA, V33, P442, DOI 10.1097/ICO.0000000000000091
   Wise RJ, 2012, SAUDI J OPHTHALMOL, V26, P349, DOI 10.1016/j.sjopt.2012.08.007
   Wu HP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105575
   Ye TT, 2014, J CATARACT REFR SURG, V40, P1377, DOI 10.1016/j.jcrs.2013.11.046
   Yokoi N, 1999, ARCH OPHTHALMOL-CHIC, V117, P723
   Yokoi N, 2007, JPN J OPHTHALMOL, V51, P53, DOI 10.1007/s10384-006-0397-y
NR 36
TC 10
Z9 10
U1 2
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 31
PY 2016
VL 11
IS 10
AR e0165558
DI 10.1371/journal.pone.0165558
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EA6BX
UT WOS:000386711100045
PM 27798696
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU De Castro, O
   Di Maio, A
   Di Febbraro, M
   Imparato, G
   Innangi, M
   Vela, E
   Menale, B
AF De Castro, Olga
   Di Maio, Antonietta
   Di Febbraro, Mirko
   Imparato, Gennaro
   Innangi, Michele
   Vela, Errol
   Menale, Bruno
TI A Multi-Faceted Approach to Analyse the Effects of Environmental
   Variables on Geographic Range and Genetic Structure of a Perennial
   Psammophilous Geophyte: The Case of the Sea Daffodil Pancratium
   maritimum L. in the Mediterranean Basin
SO PLOS ONE
LA English
DT Article
ID MULTILOCUS GENOTYPE DATA; LAST GLACIAL MAXIMUM; CLIMATE-CHANGE;
   POPULATION-STRUCTURE; AMARYLLIDACEAE; SOFTWARE; CONSERVATION; DISPERSAL;
   INFERENCE; FUTURE
AB The Mediterranean coastline is a dynamic and complex system which owes its complexity to its past and present vicissitudes, e.g. complex tectonic history, climatic fluctuations, and prolonged coexistence with human activities. A plant species that is widespread in this habitat is the sea daffodil, Pancratium maritimum (Amaryllidaceae), which is a perennial clonal geophyte of the coastal sands of the Mediterranean and neighbouring areas, well adapted to the stressful conditions of sand dune environments. In this study, an integrated approach was used, combining genetic and environmental data with a niche modelling approach, aimed to investigate: (1) the effect of climate change on the geographic range of this species at different times {past (last inter-glacial, LIG; and last glacial maximum, LGM), present (CURR), near-future (FUT)} and (2) the possible influence of environmental variables on the genetic structure of this species in the current period. The genetic results show that 48 sea daffodil populations (867 specimens) display a good genetic diversity in which the marginal populations (i.e. Atlantic Sea populations) present lower values. Recent genetic signature of bottleneck was detected in few populations (8%). The molecular variation was higher within the populations (77%) and two genetic pools were well represented. Comparing the different climatic simulations in time, the global range of this plant increased, and a further extension is foreseen in the near future thanks to projections on the climate of areas currently-more temperate, where our model suggested a forecast for a climate more similar to the Mediterranean coast. A significant positive correlation was observed between the genetic distance and Precipitation of Coldest Quarter variable in current periods. Our analyses support the hypothesis that geomorphology of the Mediterranean coasts, sea currents, and climate have played significant roles in shaping the current genetic structure of the sea daffodil especially during LGM because of strong variation in coastline caused by glaciations.
C1 [De Castro, Olga; Di Maio, Antonietta; Menale, Bruno] Univ Naples Federico II, Dept Biol, Naples, Italy.
   [Di Febbraro, Mirko] Univ Molise, Dept Biosci & Terr, Pesche, Isernia, Italy.
   [Imparato, Gennaro] Univ Naples Federico II, Dept Elect & Informat Technol Engn, Naples, Italy.
   [Innangi, Michele] Univ Naples 2, Dept Environm Biol Pharmaceut Sci & Technol, Caserta, Italy.
   [Vela, Errol] Univ Montpellier, Res Unit Bot & Modelling Plant Architecture & Veg, Montpellier, France.
RP De Castro, O (reprint author), Univ Naples Federico II, Dept Biol, Naples, Italy.
EM olga.decastro@unina.it
RI Innangi, Michele/M-2205-2015; Di Febbraro, Mirko/I-3167-2019
OI Innangi, Michele/0000-0003-2362-6025; Di Febbraro,
   Mirko/0000-0001-8898-7046; DE CASTRO, Olga/0000-0002-4861-3960
FU Nando and Elsa Peretti Foundation [201283]
FX This work was supported by the Nando and Elsa Peretti Foundation (grant
   number 201283),
   http://www.nandoperettifound.org/en/page.php?project=449, ODC.; This
   work was supported by the Nando and Elsa Peretti Foundation (grant
   number 201283).
CR Abeli T, 2014, J BIOGEOGR, V41, P239, DOI 10.1111/jbi.12215
   Algar AC, 2009, ECOGRAPHY, V32, P22, DOI 10.1111/j.1600-0587.2009.05832.x
   Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x
   Arafeh R, 2006, J BIOGEOGR, V33, P1461, DOI 10.1111/j.1365-2699.2006.01512.x
   Arcangeli G., 1896, B SOC BOT ITALIANA, V8, P278
   Austerlitz F, 2000, GENETICS, V154, P1309
   Balestri E, 2004, J COASTAL RES, V20, P761, DOI 10.2112/1551-5036(2004)20[761:GAEECO]2.0.CO;2
   Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011
   Biju-Duval B, 1977, DSDP INITIAL REPORTS, P951
   Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6
   Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007
   Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x
   BURTT BL, 1970, ISRAEL J BOT, V19, P77
   Bystriakova N, 2014, ANN BOT-LONDON, V113, P453, DOI 10.1093/aob/mct274
   Camprubi A, 2012, PLANT SOIL, V351, P97, DOI 10.1007/s11104-011-0933-5
   Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191
   Ciccarelli D, 2015, ESTUAR COAST SHELF S, V165, P247, DOI 10.1016/j.ecss.2015.05.023
   Corlett RT, 2013, TRENDS ECOL EVOL, V28, P482, DOI 10.1016/j.tree.2013.04.003
   Cornuet JM, 1996, GENETICS, V144, P2001
   Correggiari AM, 1996, J QUATERNARY SCI, V9, P697
   Curr R. H. F., 2000, J COAST CONSERV, V6, P15, DOI DOI 10.1007/BF02730463
   DAFNI A, 1981, ANN MO BOT GARD, V68, P652, DOI 10.2307/2398893
   De Castro O, 2016, PLANT BIOSYST
   De Castro O, 2012, BOT J LINN SOC, V170, P12, DOI 10.1111/j.1095-8339.2012.01268.x
   de Witte LC, 2010, ANN BOT-LONDON, V106, P859, DOI 10.1093/aob/mcq191
   Demir Z, 2010, J FOOD AGRIC ENVIRON, V8, P890
   DeWoody JA, 2006, MOL ECOL NOTES, V6, P951, DOI 10.1111/j.1471-8286.2006.01449.x
   Di Febbraro M, 2015, DIVERS DISTRIB, V21, P1141, DOI 10.1111/ddi.12362
   Di Maio A, 2013, CONSERV GENET RESOUR, V5, P911, DOI 10.1007/s12686-013-9931-7
   Dickson ME, 2007, CLIMATIC CHANGE, V84, P141, DOI 10.1007/s10584-006-9200-9
   DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166
   Dubuis A, 2011, DIVERS DISTRIB, V17, P1122, DOI 10.1111/j.1472-4642.2011.00792.x
   Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7
   EISIKOWITCH D, 1971, Journal of Animal Ecology, V40, P673, DOI 10.2307/3444
   ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895
   Escudero M, 2010, MOL ECOL, V19, P352, DOI 10.1111/j.1365-294X.2009.04449.x
   European Environment Agency, 2014, WHAT IS TREND MEAN S
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47
   Falush D, 2003, GENETICS, V164, P1567
   Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x
   Fascetti S, 2014, ITAL J AGRON, V9, P99, DOI 10.4081/ija.2014.595
   Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088
   Fitzpatrick MC, 2011, ECOGRAPHY, V34, P836, DOI 10.1111/j.1600-0587.2011.06653.x
   Gaetano J., 2013, HOLM BONFERRONI SEQU
   Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005
   Giovino A, 2015, ACTA BOT GALLICA, V162, P289, DOI 10.1080/12538078.2015.1089416
   Goffredo S, 2014, Mediterranean Sea: Its History and Present Challenges, P1, DOI 10.1007/978-94-007-6704-1
   GOUDET J., 2002, FSTAT VERSION 2 9 3
   Grassi F, 2005, BIODIVERS CONSERV, V14, P2159, DOI 10.1007/s10531-004-4666-0
   HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   HOLDSWORTH M., 1961, Journal of the West African Science Association, V7, P28
   Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x
   Innangi M, 2015, CLIM RES, V66, P25, DOI 10.3354/cr01323
   Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233
   Kadereit JW, 2005, TAXON, V54, P861, DOI 10.2307/25065473
   KEREN A, 1974, ISRAEL J BOT, V23, P202
   Khedr AHA, 2003, J EXP BOT, V54, P2553, DOI 10.1093/jxb/erg277
   Lambeck K, 2005, QUATERNARY SCI REV, V24, P1969, DOI 10.1016/j.quascirev.2004.06.025
   Lambeck K, 2014, P NATL ACAD SCI USA, V111, P15296, DOI 10.1073/pnas.1411762111
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x
   Lionello P, 2012, ELSEV INSIGHT, P1
   Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x
   Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238
   Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x
   Luikart G., 1997, THESIS
   Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x
   Mayol M, 2015, NEW PHYTOL, V208, P973, DOI 10.1111/nph.13496
   Medrano M, 1999, FLORA, V194, P13, DOI 10.1016/S0367-2530(17)30875-7
   Medrano M, 2000, AM J BOT, V87, P493, DOI 10.2307/2656592
   Mira S, 2012, 6 EUR BOT GARD C MAY, P102
   Nevill PG, 2014, ANN BOT-LONDON, V113, P55, DOI 10.1093/aob/mct253
   Nikopoulos D, 2008, J FOOD AGRIC ENVIRON, V6, P538
   Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2
   Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808
   Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460
   Perrone R, 2015, FLORA, V213, P20, DOI 10.1016/j.flora.2015.03.001
   Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502
   Prisco I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068850
   Pritchard JK, 2000, GENETICS, V155, P945
   R Development Core Team, 2012, R LANG ENV STAT COMP
   Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y
   Ricciardi M., 2004, Webbia, V59, P1
   RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x
   Rousset F, 1997, GENETICS, V145, P1219
   Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x
   Rovere A, 2012, ALP MEDLTERR QUAT, V25, P3
   Sanaa A, 2016, BIOSYSTEMS, V144, P27, DOI 10.1016/j.biosystems.2016.04.006
   Sanaa A, 2015, BIOSYSTEMS, V129, P19, DOI 10.1016/j.biosystems.2015.02.001
   Sanaa A, 2010, SCI HORTIC-AMSTERDAM, V125, P740, DOI 10.1016/j.scienta.2010.05.014
   Schlacher TA, 2008, MAR ECOL-EVOL PERSP, V29, P70, DOI 10.1111/j.1439-0485.2007.00204.x
   Shaltout M, 2015, OCEANOLOGIA, V57, P293, DOI 10.1016/j.oceano.2015.06.004
   Shaltout M, 2014, OCEANOLOGIA, V56, P411, DOI 10.5697/oc.56-3.411
   Stanley D. J., 1985, GEOLOGICAL EVOLUTION
   Stocker T.F., 2013, CLIMATE CHANGE 2013
   Strubbe D, 2015, ECOGRAPHY, V38, P321, DOI 10.1111/ecog.00632
   SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615
   Thompson J.D., 2005, PLANT EVOLUTION MEDI
   Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x
   Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x
   van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P1, DOI 10.1007/s10584-011-0157-y
   Wang IJ, 2013, EVOLUTION, V67, P3403, DOI 10.1111/evo.12134
   WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x
   WERKER E, 1975, BOT GAZ, V136, P396, DOI 10.1086/336832
   Zahreddine H, 2004, BIOL CONSERV, V120, P11, DOI 10.1016/j.biocon.2004.01.021
   Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x
NR 108
TC 4
Z9 4
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 17
PY 2016
VL 11
IS 10
AR e0164816
DI 10.1371/journal.pone.0164816
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DZ9NL
UT WOS:000386202300032
PM 27749920
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hintze, S
   Smith, S
   Patt, A
   Bachmann, I
   Wurbel, H
AF Hintze, Sara
   Smith, Samantha
   Patt, Antonia
   Bachmann, Iris
   Wurbel, Hanno
TI Are Eyes a Mirror of the Soul? What Eye Wrinkles Reveal about a Horse's
   Emotional State
SO PLOS ONE
LA English
DT Article
ID FACIAL EXPRESSION; FEAR REACTIONS; MOVEMENT; ANIMALS; CATS; PAIN
AB Finding valid indicators of emotional states is one of the biggest challenges in animal welfare science. Here, we investigated in horses whether variation in the expression of eye wrinkles caused by contraction of the inner eyebrow raiser reflects emotional valence. By confronting horses with positive and negative conditions, we aimed to induce positive and negative emotional states, hypothesising that positive emotions would reduce whereas negative emotions would increase eye wrinkle expression. Sixteen horses were individually exposed in a balanced order to two positive (grooming, food anticipation) and two negative conditions (food competition, waving a plastic bag). Each condition lasted for 60 seconds and was preceded by a 60 second control phase. Throughout both phases, pictures of the eyes were taken, and for each horse four pictures per condition and phase were randomly selected. Pictures were scored in random order and by two experimenters blind to condition and phase for six outcome measures: qualitative impression, eyelid shape, markedness of the wrinkles, presence of eye white, number of wrinkles, and the angle between the line through the eyeball and the highest wrinkle. The angle decreased during grooming and increased during food competition compared to control phases, whereas the two phases did not differ during food anticipation and the plastic bag condition. No effects on the other outcome measures were detected. Taken together, we have defined a set of measures to assess eye wrinkle expression reliably, of which one measure was affected by the conditions the horses were exposed to. Variation in eye wrinkle expression might provide valuable information on horse welfare but further validation of specific measures across different conditions is needed.
C1 [Hintze, Sara; Wurbel, Hanno] Univ Bern, Div Anim Welf, Vetsuisse Fac, Bern, Switzerland.
   [Hintze, Sara; Bachmann, Iris] Swiss Natl Stud Farm, Agroscope, Avenches, Switzerland.
   [Smith, Samantha] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland.
   [Patt, Antonia] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.
RP Hintze, S (reprint author), Univ Bern, Div Anim Welf, Vetsuisse Fac, Bern, Switzerland.; Hintze, S (reprint author), Swiss Natl Stud Farm, Agroscope, Avenches, Switzerland.
EM sara.hintze@vetsuisse.unibe.ch
RI Wuerbel, Hanno/D-6281-2012
OI Wuerbel, Hanno/0000-0002-2934-3010
FU Agroscope
FX SH was funded by Agroscope.
CR [Anonymous], ANIM BEHAV, V46, P1191, DOI [10.1006/anbe.1993.1309, DOI 10.1006/ANBE.1993.1309]
   Arellano D, 2014, P 8 INT C AMDO, P31
   Bachmann I, 2003, APPL ANIM BEHAV SCI, V82, P297, DOI 10.1016/S0168-1591(03)00086-8
   Bates D., 2014, J STAT SOFTWAR UNPUB, DOI DOI 10.18637/JSS.V067.I01
   BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981
   Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003
   Caeiro CC, 2013, INT J PRIMATOL, V34, P115, DOI 10.1007/s10764-012-9652-x
   Christensen JW, 2008, EQUINE VET J, V40, P46, DOI [10.2746/042516408X245171, 10.2746/04251640SX245171]
   CHRISTENSEN RHB, 2015, ORDINAL REGRESSION M, P6
   Cicchetti D., 1994, PSYCHOL ASSESSMENTS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]
   Cohn J. F., 2009, AFF COMP INT INT WOR, P1, DOI DOI 10.1109/ACII.2009.5349358
   Crowe J., 2009, BODY LANGUAGE 101 2
   Dalla Costa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092281
   Darwin C., 1872, EXPRESSION EMOTIONS
   Des Roches ADB, 2008, PHYSIOL BEHAV, V94, P487, DOI 10.1016/j.physbeh.2008.03.002
   EKMAN P, 1976, ENVIRON PSYCH NONVER, V1, P56, DOI 10.1007/BF01115465
   Farmer K, 2010, ANIM COGN, V13, P229, DOI 10.1007/s10071-009-0260-x
   Gleerup KB, VET ANAESTH ANALG, V42, P1
   Holden E, 2014, J SMALL ANIM PRACT, V55, P615, DOI 10.1111/jsap.12283
   Keating SCJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044437
   Kohut SA, 2009, J PAIN, V10, P214, DOI 10.1016/j.jpain.2008.08.010
   Landers R., 2015, WINNOWER, V2015, P1
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]
   McBride SD, 2004, J EQUINE VET SCI, V24, P76, DOI [10.1016/j.jevs.2004.01.014, 10.1016/j.jevs.2004.01.005]
   McLennan KM, 2016, APPL ANIM BEHAV SCI, V176, P19, DOI 10.1016/j.applanim.2016.01.007
   Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303
   Moe RO, 2009, APPL ANIM BEHAV SCI, V121, P171, DOI 10.1016/j.applanim.2009.10.002
   Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0
   Ninomiya Shigeru, 2004, Animal Science Journal, V75, P465, DOI 10.1111/j.1740-0929.2004.00214.x
   Pinheiro J., 2015, NLME LINEAR NONLINEA
   Sandem AI, 2002, APPL ANIM BEHAV SCI, V79, P1, DOI 10.1016/S0168-1591(02)00029-1
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55
   Swiss Federal Council, 2011, AN WELF ORD, P20
   van den Bos R, 2003, BEHAV BRAIN RES, V141, P83, DOI 10.1016/S0166-4328(02)00318-2
   Vick SJ, 2007, J NONVERBAL BEHAV, V31, P1, DOI 10.1007/s10919-006-0017-z
   von Borstel UUK, 2010, APPL ANIM BEHAV SCI, V125, P124, DOI 10.1016/j.applanim.2010.04.015
   Waller BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082686
   Wathan J, PLOS ONE, V10
   Wieland K., 2013, WHAT ARE MY HORSES E
NR 41
TC 9
Z9 9
U1 4
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 12
PY 2016
VL 11
IS 10
AR e0164017
DI 10.1371/journal.pone.0164017
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DZ0CQ
UT WOS:000385505300036
PM 27732647
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Han, SB
   Yoon, YC
   Kwon, JW
AF Han, Sol Bee
   Yoon, Young Cheol
   Kwon, Jong Won
TI Comparison Study between Conventional Sequence and Slice-Encoding Metal
   Artifact Correction (SEMAC) in the Diagnosis of Postoperative
   Complications in Patients Receiving Lumbar Inter-Body Fusion and Pedicle
   Screw Fixation Surgery
SO PLOS ONE
LA English
DT Article
ID MRI; SPINE; ARTHROPLASTY; IMPLANTS; REDUCTION; HARDWARE; DTPA
AB Background and Purpose
   Slice-Encoding Metal Artifact Correction (SEMAC) sequence is one of the metal artifact reduction techniques of anatomical structure, but there has been no report about evaluation of post-operative complications. The purpose of this article is to compare the anatomical visibility between fast spin echo (FSE) and FSE-SEMAC and to evaluate the additional value of FSE-SEMAC in diagnostic confidence of the complications.
   Materials and Methods
   We conducted a retrospective study with 54 patients who received lumbar spinal surgery and MR images including FSE-SEMAC. For the semi-quantitative evaluation, the visibility of anatomical structures (neural foramen, bone-inter-body cage interface, central canal, nerve root in epidural space, back muscle, and bone-pedicle screw interface) was evaluated. For qualitative evaluation, we evaluated FSE and FSE with FSE-SEMAC independently, and recorded the diagnostic confidence level of post-operative complications. Generalized estimating equation regression analysis was used for statistical analysis, and a weighted kappa was used for inter-observer agreement.
   Results
   Scores of 6 imaging findings with FSE-SEMAC were significantly higher than that of FSE (P-value < .0001). Inter-observer agreements show good reliability (weighted kappa = 0.45-0.75). Both reviewers deemed 37 (reviewer 1) or 19 more (reviewer 2) post-operative complications with FSE plus FSE-SEMAC, compared to FSE only. Except for central canal stenosis (P-value = .2408), diagnostic confidence level for other post-operative complications were significantly higher with FSE plus FSE-SEMAC (P-value = .0000) than FSE.
   Conclusions
   FSE-SEMAC significantly reduces image distortion, compared to FSE sequence in 3.0-T MR. Also, diagnostic confidence for post-operative complications was higher when FSE with additional FSE-SEMAC compared to FSE only.
C1 [Han, Sol Bee; Yoon, Young Cheol; Kwon, Jong Won] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea.
RP Yoon, YC (reprint author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea.
EM youngcheol.yoon@gmail.com
OI Yoon, Young Cheol/0000-0002-7822-5344
CR Bradley W G, 1999, Magn Reson Imaging Clin N Am, V7, P439
   Cha JG, 2011, RADIOLOGY, V259, P885, DOI 10.1148/radiol.11101856
   Chen CA, 2011, J MAGN RESON IMAGING, V33, P1121, DOI 10.1002/jmri.22534
   Hayashi D, 2012, AM J ROENTGENOL, V199, pW123, DOI 10.2214/AJR.11.6497
   Hayter CL, 2011, AM J ROENTGENOL, V197, pW405, DOI 10.2214/AJR.11.6659
   HUEFTLE MG, 1988, RADIOLOGY, V167, P817, DOI 10.1148/radiology.167.3.2966418
   Koch KM, 2011, MAGN RESON MED, V65, P71, DOI 10.1002/mrm.22523
   Koch KM, 2010, J MAGN RESON IMAGING, V32, P773, DOI 10.1002/jmri.22313
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee GY, 2011, SKELETAL RADIOL, V40, P1127, DOI 10.1007/s00256-011-1153-z
   Lee JB, 2013, SKELETAL RADIOL, V42, P239, DOI 10.1007/s00256-012-1449-7
   Lee S, 2010, AM J ROENTGENOL, V194, P1095, DOI 10.2214/AJR.09.2772
   Lee YH, 2014, MAGN RESON IMAGING, V32, P1001, DOI 10.1016/j.mri.2014.04.009
   Lee YH, 2013, MAGN RESON IMAGING, V31, P703, DOI 10.1016/j.mri.2012.11.004
   Lu WM, 2009, MAGN RESON MED, V62, P66, DOI 10.1002/mrm.21967
   ROSS JS, 1989, AM J ROENTGENOL, V152, P825, DOI 10.2214/ajr.152.4.825
   Rutherford EE, 2007, RADIOGRAPHICS, V27, P1737, DOI 10.1148/rg.276065205
   Shafaie Farid F., 1997, P223
   Song KD, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120524
   Stradiotti P, 2009, EUR SPINE J, V18, pS102, DOI 10.1007/s00586-009-0998-5
   Sutter R, 2013, AM J ROENTGENOL, V201, P1315, DOI 10.2214/AJR.13.10531
   Sutter R, 2012, RADIOLOGY, V265, P204, DOI 10.1148/radiol.12112408
   Van Goethem JWM, 2002, NEURORADIOLOGY, V44, P723, DOI 10.1007/s00234-002-0790-2
   Viano AM, 2000, MAGN RESON IMAGING, V18, P287, DOI 10.1016/S0730-725X(99)00135-6
NR 24
TC 2
Z9 2
U1 1
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 6
PY 2016
VL 11
IS 10
AR e0163745
DI 10.1371/journal.pone.0163745
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DZ2UR
UT WOS:000385697600038
PM 27711137
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tewes, S
   Mokov, N
   Hartung, D
   Schick, V
   Peters, I
   Schedl, P
   Pertschy, S
   Wacker, F
   Voshage, G
   Hueper, K
AF Tewes, Susanne
   Mokov, Nikolaj
   Hartung, Dagmar
   Schick, Volker
   Peters, Inga
   Schedl, Peter
   Pertschy, Stefanie
   Wacker, Frank
   Voshage, Goetz
   Hueper, Katja
TI Standardized Reporting of Prostate MRI: Comparison of the Prostate
   Imaging Reporting and Data System (PI-RADS) Version 1 and Version 2
SO PLOS ONE
LA English
DT Article
ID SCORING SYSTEM; MULTIPARAMETRIC MRI; GUIDED BIOPSY; CANCER; VALIDATION;
   GUIDELINES; AGREEMENT; DIAGNOSIS
AB Introduction
   Objective of our study was to determine the agreement between version 1 (v1) and v2 of the Prostate Imaging Reporting and Data System (PI-RADS) for evaluation of multiparametric prostate MRI (mpMRI) and to compare their diagnostic accuracy, their inter-observer agreement and practicability.
   Material and Methods
   mpMRI including T2-weighted imaging, diffusion-weighted imaging (DWI) and dynamic contrast-enhanced imaging (DCE) of 54 consecutive patients, who subsequently underwent MRI-guided in-bore biopsy were re-analyzed according to PI-RADS v1 and v2 by two independent readers. Diagnostic accuracy for detection of prostate cancer (PCa) was assessed using ROC-curve analysis. Agreement between PI-RADS versions and observers was calculated and the time needed for scoring was determined.
   Results
   MRI-guided biopsy revealed PCa in 31 patients. Diagnostic accuracy for detection of PCa was equivalent with both PI-RADS versions for reader 1 with sensitivities and specificities of 84%/91% (AUC = 0.91 95% CI[0.8-1]) for PI-RADS v1 and 100%/74% (AUC = 0.92 95% CI[0.8-1]) for PI-RADS v2. Reader 2 achieved similar diagnostic accuracy with sensitivity and specificity of 74%/91% (AUC = 0.88 95% CI[0.8-1]) for PI-RADS v1 and 81%/91% (AUC = 0.91 95% CI[0.8-1]) for PI-RADS v2. Agreement between scores determined with different PI-RADS versions was good (reader 1: kappa = 0.62, reader 2: kappa = 0.64). Inter-observer agreement was moderate with PI-RADS v2 (kappa = 0.56) and fair with v1 (kappa = 0.39). The time required for building the PI-RADS score was significantly lower with PI-RADS v2 compared to v1 ( 24.7 +/- 2.3 s vs. 41.9 +/- 2.6 s, p<0.001).
   Conclusion
   Agreement between PI-RADS versions was high and both versions revealed high diagnostic accuracy for detection of PCa. Due to better inter-observer agreement for malignant lesions and less time demand, the new PI-RADS version could be more practicable for clinical routine.
C1 [Tewes, Susanne; Hartung, Dagmar; Pertschy, Stefanie; Wacker, Frank; Hueper, Katja] Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany.
   [Mokov, Nikolaj; Voshage, Goetz] Klinikum Reg Hannover, Inst Diagnost & Intervent Radiol, Hannover, Gehrden, Germany.
   [Schick, Volker; Schedl, Peter] Klinikum Reg Hannover, Urol Clin, Hannover, Gehrden, Germany.
   [Peters, Inga] Hannover Med Sch, Dept Urol & Urol Oncol, Hannover, Germany.
RP Tewes, S (reprint author), Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany.
EM Tewes.Susanne@mh-hannover.de
FU Junge Akademie program Hannover Medical School
FX KH and ST received funding from the Junge Akademie program Hannover
   Medical School. KH has a research collaboration with Siemens Healthcare
   outside the work submitted. FW receives institutional grants from
   Siemens Healthcare and Promedicus Ltd and Delcath Systems Inc. outside
   the work submitted. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ahmed HU, 2009, NAT REV CLIN ONCOL, V6, P197, DOI 10.1038/nrclinonc.2009.18
   Baco E, 2015, EUR UROL, V67, P787, DOI 10.1016/j.eururo.2014.08.077
   Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y
   de Rooij M, 2014, AM J ROENTGENOL, V202, P343, DOI 10.2214/AJR.13.11046
   Delongchamps NB, 2011, BJU INT, V107, P1411, DOI 10.1111/j.1464-410X.2010.09808.x
   Dickinson L, 2011, EUR UROL, V59, P477, DOI 10.1016/j.eururo.2010.12.009
   Hamoen EH, 2014, EUROPEAN UROLOGY
   Heidenreich A, 2014, EUR UROL, V65, P124, DOI 10.1016/j.eururo.2013.09.046
   Hoeks CMA, 2012, EUR UROL, V62, P902, DOI 10.1016/j.eururo.2012.01.047
   Junker D, 2013, BIOMED RES INT, DOI 10.1155/2013/252939
   Komai Y, 2013, J UROLOGY, V190, P867, DOI 10.1016/j.juro.2013.03.078
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mazaheri Y, 2008, MAGN RESON MATER PHY, V21, P379, DOI 10.1007/s10334-008-0138-y
   Muller BG, 2015, RADIOLOGY, DOI DOI 10.1148/RADIOL.2015142818
   Nagel KNA, 2013, RADIOLOGY, V267, P164, DOI 10.1148/radiol.12111683
   Osugi K, 2013, MAGN RESON MED SCI, V12, P271, DOI 10.2463/mrms.2012-0054
   Portalez D, 2012, EUR UROL, V62, P986, DOI 10.1016/j.eururo.2012.06.044
   Quentin M, 2013, ACTA RADIOL, V54, P1224, DOI 10.1177/0284185113492972
   Radiology ACo, MR PROST IM REP DAT
   Rastinehad AR, 2011, J UROLOGY, V185, P815, DOI 10.1016/j.juro.2010.10.076
   Rothke M, 2013, ROFO-FORTSCHR RONTG, V185, P253, DOI 10.1055/s-0032-1330270
   Roethke MC, 2014, EUR RADIOL, V24, P344, DOI 10.1007/s00330-013-3017-5
   Rosenkrantz AB, 2013, RADIOLOGY, V269, P481, DOI 10.1148/radiol.13122233
   Rosenkrantz AB, 2013, AM J ROENTGENOL, V201, pW612, DOI 10.2214/AJR.12.10173
   Schimmoller L, 2013, EUR RADIOL, V23, P3185, DOI 10.1007/s00330-013-2922-y
   Schimmoller L, 2014, EUR RADIOL, V24, P2582, DOI 10.1007/s00330-014-3276-9
   Schoots IG, 2014, EUROPEAN UROLOGY
   Tewes S, 2015, WORLD J UROLOGY
   Turkbey B, 2010, RADIOLOGY, V255, P89, DOI 10.1148/radiol.09090475
   Valerio M, 2014, EUROPEAN UROLOGY
   Vargas HA, 2015, EUROPEAN RADIOLOGY
NR 31
TC 21
Z9 23
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 22
PY 2016
VL 11
IS 9
AR e0162879
DI 10.1371/journal.pone.0162879
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DW8GO
UT WOS:000383893200037
PM 27657729
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ko, CC
   Tai, MH
   Li, CF
   Chen, TY
   Chen, JH
   Shu, G
   Kuo, YT
   Lee, YC
AF Ko, Ching Chung
   Tai, Ming Hong
   Li, Chien Feng
   Chen, Tai Yuan
   Chen, Jeon Hor
   Shu, Ginger
   Kuo, Yu Ting
   Lee, Yu Chang
TI Differentiation between Glioblastoma Multiforme and Primary Cerebral
   Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR
   Imaging
SO PLOS ONE
LA English
DT Article
ID SOLITARY METASTATIC LESIONS; NERVOUS-SYSTEM LYMPHOMA; PRIMARY CNS
   LYMPHOMA; BRAIN-TUMORS; PERITUMORAL EDEMA; COEFFICIENT; PERFUSION;
   GLIOMA
AB The differentiation between glioblastomamultiforme (GBM) and primary cerebral lymphoma (PCL) is importantbecause the treatments are substantially different. The purpose of this article is to describe the MR imaging characteristics of GBM and PCL with emphasis on the quantitative ADC analysis in the tumor necrosis, the most strongly-enhanced tumor area, and the peritumoral edema. This retrospective cohort study collected 104 GBM (WHO grade IV) patients and 22 immune-competent PCL (diffuse large B cell lymphoma) patients. All these patients had pretreatment brain MR DWI and ADC imaging. Analysis of conventional-MR imaging and quantitative ADC measurement including the tumor necrosis (ADCn), the most strongly-enhanced tumor area (ADCt), and the peritumoral edema (ADCe) were done. ROC analysis with optimal cut-off values and area-under-the ROC curve (AUC) was performed. For conventional MR imaging, there are statistical differences in tumor size, tumor location, tumor margin, and the presence of tumor necrosis between GBM and PCL. Quantitative ADC analysis shows that GBM tended to have significantly (P<0.05) higher ADC in the most strongly-enhanced area (ADCt) and lower ADC in the peritumoral edema (ADCe) as compared with PCL. Excellent AUC (0.94) with optimal sensitivity of 90% and specificity of 86% for differentiating between GBM and PCL was obtained by combination of ADC in the tumor necrosis (ADCn), the most strongly-enhanced tumor area (ADCt), and the peritumoral edema (ADCe). Besides, there are positive ADC gradients in the peritumoral edema in a subset of GBMs but not in the PCLs. Quantitative ADC analysis in these three areas can thus be implemented to improve diagnostic accuracy for these two brain tumor types. The histological correlation of the ADC difference deserves further investigation.
C1 [Ko, Ching Chung; Chen, Tai Yuan; Shu, Ginger; Kuo, Yu Ting] Chi Mei Med Ctr, Dept Med Imaging, Tainan, Taiwan.
   [Ko, Ching Chung; Tai, Ming Hong] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan.
   [Li, Chien Feng] Chi Mei Med Ctr, Dept Pathol, Tainan, Taiwan.
   [Chen, Tai Yuan] Chang Jung Christian Univ, Grad Inst Med Sci, Tainan, Taiwan.
   [Chen, Jeon Hor; Lee, Yu Chang] I Shou Univ, E DA Hosp, Dept Radiol, Kaohsiung, Taiwan.
RP Lee, YC (reprint author), I Shou Univ, E DA Hosp, Dept Radiol, Kaohsiung, Taiwan.
EM drtimlee@ms54.hinet.net
CR Ahn SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112948
   Batra A, 2004, Australas Radiol, V48, P388, DOI 10.1111/j.0004-8461.2004.01324.x
   Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073
   Calli C, 2006, EUR J RADIOL, V58, P394, DOI 10.1016/j.ejrad.2005.12.032
   Cha S, 2006, AM J NEURORADIOL, V27, P475
   Chiang IC, 2004, NEURORADIOLOGY, V46, P619, DOI 10.1007/s00234-004-1246-7
   Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7
   DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207
   Doskaliyev A, 2012, EUR J RADIOL, V81, P339, DOI 10.1016/j.ejrad.2010.11.005
   Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063
   Giese A, 2001, J CANCER RES CLIN, V127, P217, DOI 10.1007/s004320000188
   Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637
   Haldorsen IS, 2011, AM J NEURORADIOL, V32, P984, DOI 10.3174/ajnr.A2171
   Horger M, 2009, AM J ROENTGENOL, V193, P1384, DOI 10.2214/AJR.09.2486
   Kickingereder P, 2014, RADIOLOGY, V272, P843, DOI 10.1148/radiol.14132740
   Koeller KK, 1997, RADIOGRAPHICS, V17, P1497, DOI 10.1148/radiographics.17.6.9397461
   Krabbe K, 1997, NEURORADIOLOGY, V39, P483, DOI 10.1007/s002340050450
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee EJ, 2011, AM J ROENTGENOL, V196, P71, DOI 10.2214/AJR.10.4752
   Lemercier P, 2014, AM J ROENTGENOL, V203, P163, DOI 10.2214/AJR.13.11186
   Makino K, 2011, ANN NUCL MED, V25, P432, DOI 10.1007/s12149-011-0483-1
   Matsushima N, 2012, ANN NUCL MED, V26, P262, DOI 10.1007/s12149-012-0570-y
   Oh J, 2005, J MAGN RESON IMAGING, V21, P701, DOI 10.1002/jmri.20335
   Peters S, 2012, ROFO-FORTSCHR RONTG, V184, P713, DOI 10.1055/s-0032-1312862
   Rollin N, 2006, NEURORADIOLOGY, V48, P150, DOI 10.1007/s00234-005-0030-7
   Schlegel Uwe, 2009, Ther Adv Neurol Disord, V2, P93, DOI 10.1177/1756285608101222
   Server A, 2009, ACTA RADIOL, V50, P682, DOI 10.1080/02841850902933123
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Toh CH, 2008, AM J NEURORADIOL, V29, P471, DOI 10.3174/ajnr.A0872
   Toh CH, 2006, J NEUROSURG, V105, P132, DOI 10.3171/jns.2006.105.1.132
   Yamasaki F, 2005, RADIOLOGY, V235, P985, DOI 10.1148/radiol.2353031338
   Yamashita K, 2013, NEURORADIOLOGY, V55, P135, DOI 10.1007/s00234-012-1089-6
NR 32
TC 6
Z9 9
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 15
PY 2016
VL 11
IS 9
AR e0162565
DI 10.1371/journal.pone.0162565
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DW5SJ
UT WOS:000383706900052
PM 27631626
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ayubi, E
   Doosti-Irani, A
   Moghaddam, AS
   Sani, M
   Nazarzadeh, M
   Mostafavi, E
AF Ayubi, Erfan
   Doosti-Irani, Amin
   Moghaddam, Ali Sanjari
   Sani, Mohadeseh
   Nazarzadeh, Milad
   Mostafavi, Ehsan
TI The Clinical Usefulness of Tuberculin Skin Test versus Interferon-Gamma
   Release Assays for Diagnosis of Latent Tuberculosis in HIV Patients: A
   Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID QUANTIFERON-TB GOLD; IMMUNODEFICIENCY-VIRUS-INFECTION; IN-TUBE;
   LOW-PREVALENCE; RISK-FACTORS; INDIVIDUALS; KAPPA; AGREEMENT; BIAS;
   ASSOCIATION
AB Background
   Accurate diagnosis of latent tuberculosis infection (LTBI) is becoming increasingly concerning due to the increasing the HIV epidemic, which have increased the risk for reactivation to active tuberculosis (TB) infection. LTBI is diagnosed by tuberculin skin test (TST) and inter-feron- gamma release assays (IGRAs).
   Objectives
   The aim of the present study was to conduct a meta-analysis of published papers on the agreement (kappa) between TST and QuantiFERON-TB Gold In-Tube (QFT-GIT) tests for diagnosis of LTBI in HIV patient.
   Methods
   Electronic databases including PubMed/ Medline, Elsevier/ Scopus and Embase/ Ovidwere reviewed up Jan. 2016. We performed a random effect model meta-analysis for estimation of pooled Kappa between the two methods of diagnosis. Meta regression was used for assessing potential heterogeneity and Egger's test was used for assessing small study effect and publication bias.
   Results
   The initial search strategy produced 6744 records. Of them, 23 cross-sectional studies met the inclusion criteria and 20 studies entered in meta-analysis. The pooled kappa was andprevalence-adjusted and bias-adjusted kappa (PABAK) were 0.37 (95% CI: 0.28, 0.46) and 0.59 (0.49, 0.69). The discordance of TST-/QFT-GIT+ was more than TST+/QFT-GIT-. Kappa estimate between two tests was linearly associated with age and prevalence index and inversely associated with bias index.
   Conclusion
   Fair agreement between TST and QFT-GIT makes it difficult to know whether TST is as useful as the QFT-GIT in HIV-infected patients. The higher discordance of TST-/QFT-GIT+ in compared to TST+/QFT-GIT-can induce the higher sensitivity of QFT-GIT for diagnosis LTBI in HIV patients. Disagreement between two tests can be influenced by error in measurements and prevalence of HIV.
C1 [Ayubi, Erfan] Shahid Beheshti Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Tehran, Iran.
   [Ayubi, Erfan; Doosti-Irani, Amin; Mostafavi, Ehsan] Pasteur Inst Iran, Dept Epidemiol, Tehran, Iran.
   [Ayubi, Erfan; Doosti-Irani, Amin] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol, Tehran, Iran.
   [Moghaddam, Ali Sanjari] Shahid Beheshti Univ Med Sci, Sch Med, Tehran, Iran.
   [Sani, Mohadeseh] Zabol Univ Med Sci, Sch Med, Zabol, Iran.
   [Nazarzadeh, Milad] Sabzevar Univ Med Sci, Iranian Res Ctr Hlth Aging, Collaborat Ctr Metaanal Res ccMETA, Sabzevar, Iran.
   [Mostafavi, Ehsan] Res Ctr Emerging & Reemerging Infect Dis Akanlu, Hamadan, Iran.
RP Mostafavi, E (reprint author), Pasteur Inst Iran, Dept Epidemiol, Tehran, Iran.; Mostafavi, E (reprint author), Res Ctr Emerging & Reemerging Infect Dis Akanlu, Hamadan, Iran.
EM mmostafavi@pasteur.ac.ir
RI Mostfavi, Ehsan/A-7627-2011; Doosti-Irani, Amin/Q-1260-2016; Nazarzadeh,
   Milad/J-8970-2014
OI Mostfavi, Ehsan/0000-0002-1997-517X; Doosti-Irani,
   Amin/0000-0003-0623-7503; Nazarzadeh, Milad/0000-0002-0576-8874
CR Aichelburg MC, 2014, INT J TUBERC LUNG D, V18, P709, DOI 10.5588/ijtld.13.0813
   Balcells ME, 2008, INT J INFECT DIS, V12, P645, DOI 10.1016/j.ijid.2008.03.005
   Banerjee M, 1997, RES NURS HEALTH, V20, P465, DOI 10.1002/(SICI)1098-240X(199710)20:5<465::AID-NUR10>3.0.CO;2-8
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Blackman NJM, 2000, STAT MED, V19, P723, DOI 10.1002/(SICI)1097-0258(20000315)19:5<723::AID-SIM379>3.0.CO;2-A
   BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V
   Cattamanchi A, 1999, J ACQ IMMUN DEF SYND, V56, P230
   Cheallaigh CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053330
   Chkhartishvili N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-513
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Converse PJ, 1997, J INFECT DIS, V176, P144, DOI 10.1086/514016
   Davarpanah MA, 2009, IRAN RED CRESCENT ME, V11, P71
   Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192
   Fleiss JL, 2013, STAT METHODS RATES P
   Garcia-Elorriaga G, 2013, ASIAN PAC J TROP MED, V6, P135, DOI 10.1016/S1995-7645(13)60009-7
   Gray J, 2012, CLIN INFECT DIS, V54, pE20, DOI 10.1093/cid/cir792
   Hoehler FK, 2000, J CLIN EPIDEMIOL, V53, P499, DOI 10.1016/S0895-4356(99)00174-2
   Jones S, 2007, INT J TUBERC LUNG D, V11, P1190
   Kabeer BSA, 2011, DIAGN MICR INFEC DIS, V71, P236, DOI 10.1016/j.diagmicrobio.2011.07.012
   Kimura M, 1999, J INFECT DIS, V179, P1297, DOI 10.1086/314707
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee YM, 2013, INFECTION, V41, P1089, DOI 10.1007/s15010-013-0478-z
   Luetkemeyer AF, 2007, AM J RESP CRIT CARE, V175, P737, DOI 10.1164/rccm.200608-1088OC
   Mandalakas AM, 2008, INT J TUBERC LUNG D, V12, P417
   Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006
   Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135
   Oni T, 2012, CLIN VACCINE IMMUNOL, V19, P1243, DOI 10.1128/CVI.00166-12
   Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X
   Pullar ND, 2014, INT J TUBERC LUNG D, V18, P180, DOI 10.5588/ijtld.13.0276
   Ramos JM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-169
   Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC
   Richeldi L, 2009, CHEST, V136, P198, DOI 10.1378/chest.08-2575
   Santin M, 2011, DIAGN MICR INFEC DIS, V69, P59, DOI 10.1016/j.diagmicrobio.2010.09.005
   Sauzullo I, 2010, INT J TUBERC LUNG D, V14, P834
   Seshadri C, 2008, East Afr Med J, V85, P442
   Sim J, 2005, PHYS THER, V85, P257
   Stephan C, 2008, AIDS, V22, P2471, DOI 10.1097/QAD.0b013e3283188415
   Talati NJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-264
   Talati NJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-15
   Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1
   von Elm E, 2007, BMJ-BRIT MED J, V335, P806
   Weinfurter P, 2011, INT J TUBERC LUNG D, V15, P1056, DOI 10.5588/ijtld.10.0650
   WHO, 2012, GLOB TUB CONTR WHO R
   World Health Organization, 2014, GLOB TUB CONTR WHO R
   World Health Organization (WHO), TUB COUNTR PROF
NR 47
TC 7
Z9 7
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 13
PY 2016
VL 11
IS 9
AR e0161983
DI 10.1371/journal.pone.0161983
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DW5JR
UT WOS:000383681000011
PM 27622293
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU French, AS
   Zadoks, RN
   Skuce, PJ
   Mitchell, G
   Gordon-Gibbs, DK
   Craine, A
   Shaw, D
   Gibb, SW
   Taggart, MA
AF French, Andrew S.
   Zadoks, Ruth N.
   Skuce, Philip J.
   Mitchell, Gillian
   Gordon-Gibbs, Danielle K.
   Craine, Alexandra
   Shaw, David
   Gibb, Stuart W.
   Taggart, Mark A.
TI Prevalence of Liver Fluke (Fasciola hepatica) in Wild Red Deer (Cervus
   elaphus): Coproantigen ELISA Is a Practicable Alternative to Faecal Egg
   Counting for Surveillance in Remote Populations
SO PLOS ONE
LA English
DT Article
ID RUMEN FLUKE; SPATIAL-DISTRIBUTION; DAIRY HERDS; CATTLE; SHEEP;
   ANTIBODIES; SAMPLES; RUMINANTS; INFECTION; AGREEMENT
AB Red deer (Cervus elaphus) are hosts of liver fluke (Fasciola hepatica); yet, prevalence is rarely quantified in wild populations. Testing fresh samples from remote regions by faecal examination (FE) can be logistically challenging; hence, we appraise frozen storage and the use of a coproantigen ELISA (cELISA) for F. hepatica surveillance. We also present cELISA surveillance data for red deer from the Highlands of Scotland. Diagnoses in faecal samples (207 frozen, 146 fresh) were compared using a cELISA and by FE. For each storage method (frozen or fresh), agreement between the two diagnostics was estimated at individual and population levels, where population prevalence was stratified into cohorts (e.g., by sampling location). To approximate sensitivity and specificity, 65 post-slaughter whole liver examinations were used as a reference. At the individual level, FE and cELISA diagnoses agreed moderately (k(frozen) = 0.46; k(fresh) = 0.51), a likely reflection of their underlying principles. At the population level, FE and cELISA cohort prevalence correlated strongly (Pearson's R = 0.89, p < 0.0001), reflecting good agreement on relative differences between cohort prevalence. In frozen samples, prevalence by cELISA exceeded FE overall (42.8% vs. 25.8%) and in 9/12 cohorts, alluding to differences in sensitivity; though, in fresh samples, no significant difference was found. In 959 deer tested by cELISA across the Scottish Highlands, infection prevalence ranged from 9.6% to 53% by sampling location. We highlight two key advantages of cELISA over FE: i) the ability to store samples long term (frozen) without apparent loss in diagnostic power; and ii) reduced labour and the ability to process large batches. Further evaluation of cELISA sensitivity in red deer, where a range of fluke burdens can be obtained, is desirable. In the interim, the cELISA is a practicable diagnostic for F. hepatica surveillance in red deer, and its application here has revealed considerable geographic, temporal, sex and age related differences in F. hepatica prevalence in wild Scottish Highland red deer.
C1 [French, Andrew S.; Craine, Alexandra; Gibb, Stuart W.; Taggart, Mark A.] Univ Highlands & Islands, Environm Res Inst, North Highland Coll, Castle St, Thurso KW14 7JD, Scotland.
   [Zadoks, Ruth N.; Skuce, Philip J.; Mitchell, Gillian; Gordon-Gibbs, Danielle K.] Moredun Res Inst, Pentlands Sci Pk, Penicuik EH26 0PZ, Midlothian, Scotland.
   [Zadoks, Ruth N.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow G61 1QH, Lanark, Scotland.
   [Shaw, David] Univ Highlands & Islands, UHI Rural Studies Ctr, North Highland Coll, Dale Farm KW12 6UW, Halkirk, Scotland.
RP French, AS (reprint author), Univ Highlands & Islands, Environm Res Inst, North Highland Coll, Castle St, Thurso KW14 7JD, Scotland.
EM Andrew.French@uhi.ac.uk
RI French, Andrew/Q-8012-2016
OI French, Andrew/0000-0001-6662-4113; Gibb, Stuart/0000-0003-3882-338X
FU Highlands and Islands Scotland European Social Fund programme; Scottish
   Government's Rural and Environment Science and Analytical Services
   Division; Biotechnology and Biological Sciences Research Council
   [BB/K015346/1]
FX ASF's studentship was funded by the Highlands and Islands Scotland
   European Social Fund 2007-2013 programme. Funding for contributions by
   GM, PJS and RNZ was obtained from the Scottish Government's Rural and
   Environment Science and Analytical Services Division. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Valero MA, 2009, VET PARASITOL, V159, P77, DOI 10.1016/j.vetpar.2008.10.014
   Alasaad S, 2007, PARASITOL RES, V101, P1245, DOI 10.1007/s00436-007-0628-2
   Arias MS, 2013, RES VET SCI, V95, P1031, DOI 10.1016/j.rvsc.2013.07.027
   BARTH D, 1973, Zeitschrift fuer Jagdwissenschaft, V19, P183, DOI 10.1007/BF01904174
   Bennema SC, 2011, INT J PARASITOL, V41, P225, DOI 10.1016/j.ijpara.2010.09.003
   Bohm M, 2006, VET J, V171, P287, DOI 10.1016/j.tvjl.2004.10.020
   Branscum AJ, 2005, PREV VET MED, V68, P145, DOI 10.1016/j.prevetmed.2004.12.005
   Brockwell YM, 2013, VET PARASITOL, V196, P417, DOI 10.1016/j.vetpar.2013.04.012
   BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   DURBIN C. G., 1952, PROC HELMINTHOL SOC WASHINGTON, V19, P120
   Flanagan AM, 2011, VET PARASITOL, V176, P34, DOI 10.1016/j.vetpar.2010.10.037
   FOREYT WJ, 1986, J AM VET MED ASSOC, V189, P1065
   Fox NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016126
   Gordon DK, 2013, VET PARASITOL, V195, P65, DOI 10.1016/j.vetpar.2013.01.014
   Gordon DK, 2012, VET PARASITOL, V187, P436, DOI 10.1016/j.vetpar.2012.02.009
   Gordon-Gibbs D, 2014, THESIS
   Hoby S, 2006, VET PARASITOL, V138, P337, DOI 10.1016/j.vetpar.2006.01.028
   Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425
   HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508
   Issia L, 2009, VET PARASITOL, V165, P341, DOI 10.1016/j.vetpar.2009.07.011
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LEIPER J. W. G., 1938, JOUR HELMINTHOL, V16, P173
   McCann CM, 2010, VET REC, V166, P612, DOI 10.1136/vr.b4836
   McCann CM, 2010, INT J PARASITOL, V40, P1021, DOI 10.1016/j.ijpara.2010.02.009
   Menard A, 2001, VET RES, V32, P499, DOI 10.1051/vetres:2001141
   Mezo M, 2004, J PARASITOL, V90, P845, DOI 10.1645/GE-192R
   Mezo M, 2010, PARASITOL INT, V59, P610, DOI 10.1016/j.parint.2010.09.001
   Mezo M, 2007, J PARASITOL, V93, P65, DOI 10.1645/GE-925R.1
   Mezo M, 2013, VET PARASITOL, V198, P274, DOI 10.1016/j.vetpar.2013.09.009
   MITCHELL B, 1986, BIOL CONSERV, V37, P237, DOI 10.1016/0006-3207(86)90084-4
   O'Toole A, 2014, PARASITOL RES, V113, P4097, DOI 10.1007/s00436-014-4078-3
   Palmer DG, 2014, AUST VET J, V92, P357, DOI 10.1111/avj.12224
   R Core Team, 2015, R LANG ENV STAT COMP
   Rinaldi L, 2011, VET PARASITOL, V177, P345, DOI 10.1016/j.vetpar.2010.12.010
   Rondelaud D, 2001, PARASITOL RES, V87, P475, DOI 10.1007/s004360100385
   ROSS JG, 1968, VET REC, V82, P587
   RStudio Team, 2015, RSTUDIO INT DEV R
   Shimalov VV, 2000, PARASITOL RES, V86, P342, DOI 10.1007/s004360050056
   Sim J, 2005, PHYS THER, V85, P257
   Arias MS, 2012, J PARASITOL, V98, P754, DOI 10.1645/GE-2804.1
   Toolan DP, 2015, VET PARASITOL, V212, P168, DOI 10.1016/j.vetpar.2015.07.040
   Ubeira FM, 2009, AM J TROP MED HYG, V81, P156, DOI 10.4269/ajtmh.2009.81.156
   van Dijk J, 2010, ANIMAL, V4, P377, DOI 10.1017/S1751731109990991
   van Wyk JA, 2002, ONDERSTEPOORT J VET, V69, P299
   Walker SM, 2011, VET PARASITOL, V177, P179, DOI 10.1016/j.vetpar.2010.11.043
NR 46
TC 2
Z9 2
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 6
PY 2016
VL 11
IS 9
AR e0162420
DI 10.1371/journal.pone.0162420
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV9IT
UT WOS:000383254800065
PM 27598003
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Han, KH
   Kim, AR
   Kim, MY
   Ahn, S
   Oh, SH
   Song, JH
   Choi, BY
AF Han, Kyu-Hee
   Kim, Ah Reum
   Kim, Min Young
   Ahn, Soyeon
   Oh, Seung-Ha
   Song, Ju Hun
   Choi, Byung Yoon
TI Establishment of a Flexible Real-Time Polymerase Chain Reaction-Based
   Platform for Detecting Prevalent Deafness Mutations Associated with
   Variable Degree of Sensorineural Hearing Loss in Koreans
SO PLOS ONE
LA English
DT Article
ID EMBEDDED TISSUE SPECIMENS; CELL LUNG-CANCER; MITOCHONDRIAL
   GENE-MUTATIONS; ANALYTIC PERFORMANCE; VESTIBULAR AQUEDUCT; CDH23
   MUTATIONS; PCR ASSAY; IDENTIFICATION; FREQUENCIES; CHINA
AB Many cutting-edge technologies based on next-generation sequencing (NGS) have been employed to identify candidate variants responsible for sensorineural hearing loss (SNHL). However, these methods have limitations preventing their wide clinical use for primary screening, in that they remain costly and it is not always suitable to analyze massive amounts of data. Several different DNA chips have been developed for screening prevalent mutations at a lower cost. However, most of these platforms do not offer the flexibility to add or remove target mutations, thereby limiting their wider use in a field that requires frequent updates. Therefore, we aimed to establish a simpler and more flexible molecular diagnostic platform based on ethnicity-specific mutation spectrums of SNHL, which would enable bypassing unnecessary filtering steps in a substantial portion of cases. In addition, we expanded the screening platform to cover varying degrees of SNHL. With this aim, we selected 11 variants of 5 genes (GJB2, SLC26A4, MTRNR1, TMPRSS3, and CDH23) showing high prevalence with varying degrees in Koreans and developed the U-TOP (TM) HL Genotyping Kit, a real-time PCR-based method using the MeltingArray technique and peptide nucleic acid probes. The results of 271 DNA samples with wild type sequences or mutations in homo-or heterozygote form were compared between the U-TOP (TM) HL Genotyping Kit and Sanger sequencing. The positive and negative predictive values were 100%, and this method showed perfect agreement with Sanger sequencing, with a Kappa value of 1.00. The U-TOP (TM) HL Genotyping Kit showed excellent performance in detecting varying degrees and phenotypes of SNHL mutations in both homozygote and heterozygote forms, which are highly prevalent in the Korean population. This platform will serve as a useful and cost-effective first-line screening tool for varying degrees of genetic SNHL and facilitate genome-based personalized hearing rehabilitation for the Korean population.
C1 [Han, Kyu-Hee; Song, Ju Hun] Natl Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.
   [Kim, Ah Reum; Kim, Min Young; Choi, Byung Yoon] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea.
   [Kim, Ah Reum] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea.
   [Ahn, Soyeon] Seoul Natl Univ, Bundang Hosp, Med Res Collaborating Ctr, Songnam, South Korea.
   [Oh, Seung-Ha] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.
   [Choi, Byung Yoon] Seoul Natl Univ, Coll Med, Wide River Inst Immunol, Hongcheon, South Korea.
RP Choi, BY (reprint author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea.; Choi, BY (reprint author), Seoul Natl Univ, Coll Med, Wide River Inst Immunol, Hongcheon, South Korea.
EM choiby@snubh.org
FU Daejeon IRPE (Institute for Regional Program Evaluation Promotion)
   Project through Research and Development for Regional Industry of the
   MOTIE (Ministry of Trade, Industry and Energy) Republic of Korea
   [R0004264]; Korean Healthcare Technology R&D Project, Ministry of
   Health, Welfare and Family Affairs, Republic of Korea [HI14C1867,
   H12C0014]
FX This research was supported by the Daejeon IRPE (Institute for Regional
   Program Evaluation Promotion) Project (R0004264) through the Research
   and Development for Regional Industry of the MOTIE (Ministry of Trade,
   Industry and Energy) Republic of Korea. This study was also supported by
   funding from the Korean Healthcare Technology R&D Project, Ministry of
   Health, Welfare and Family Affairs, Republic of Korea (HI14C1867 and
   H12C0014 to BYC). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Anderson S, 2012, ARCH PATHOL LAB MED, V136, P1385, DOI 10.5858/arpa.2011-0505-OA
   Bae JW, 2008, INT J MOL MED, V22, P175, DOI 10.3892/ijmm_00000005
   Bae JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042463
   Catteau A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-58
   Chang MY, 2015, MOL CELLS, V38, P781, DOI 10.14348/molcells.2015.0078
   Chang YS, 2014, CLIN CHIM ACTA, V436, P169, DOI 10.1016/j.cca.2014.05.008
   Choi BY, 2009, GENET TEST MOL BIOMA, V13, P679, DOI 10.1089/gtmb.2009.0054
   Choi SY, 2009, CLIN EXP OTORHINOLAR, V2, P44, DOI 10.3342/ceo.2009.2.1.44
   Chun JY, 2014, J MOL DIAGN, V16, P573, DOI 10.1016/j.jmoldx.2014.04.006
   Chung J, 2014, J MOL MED, V92, P651, DOI 10.1007/s00109-014-1128-3
   Svidnicki MCCM, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0232-8
   de Castro DG, 2012, BRIT J CANCER, V107, P345, DOI 10.1038/bjc.2012.259
   Eriksson M, 1996, NAT STRUCT BIOL, V3, P410, DOI 10.1038/nsb0596-410
   Hur D, 2015, BIOL PROCED ONLINE, V17, DOI 10.1186/s12575-015-0027-5
   Kenneth J., 2011, ASCO ANN M, P10523
   Kim SY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0624-8
   Kim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125416
   Kim SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061592
   Kimura H, 2014, LUNG CANCER, V83, P329, DOI 10.1016/j.lungcan.2013.12.012
   Kudo T, 2000, AM J MED GENET, V90, P141, DOI 10.1002/(SICI)1096-8628(20000117)90:2<141::AID-AJMG10>3.0.CO;2-G
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee S, 2012, VIRCHOWS ARCH, V460, P141, DOI 10.1007/s00428-011-1180-0
   Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036621
   Li ZY, 2005, HUM GENET, V117, P9, DOI 10.1007/s00439-005-1276-1
   Liu XZ, 2001, ANN OTO RHINOL LARYN, V110, P356, DOI 10.1177/000348940111000412
   Lopez-Rios F, 2013, J CLIN PATHOL, V66, P381, DOI 10.1136/jclinpath-2012-201240
   Lopez-Rios F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053733
   Miyagawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040366
   Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700
   Moy AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053753
   O'Donnell P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-210
   Park HJ, 2005, CLIN GENET, V67, P160, DOI 10.1111/j.1399-0004.2004.00386.x
   Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242
   Park HJ, 2000, LARYNGOSCOPE, V110, P1535, DOI 10.1097/00005537-200009000-00023
   Park JH, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0167-8
   Qiu T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09211
   Rah YC, 2015, LARYNGOSCOPE, V125, pE216, DOI 10.1002/lary.25079
   Rebscher SJ, 2008, J REHABIL RES DEV, V45, P731, DOI 10.1682/JRRD.2007.08.0119
   Sagong B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057237
   Usami S, 2000, J MED GENET, V37, P38, DOI 10.1136/jmg.37.1.38
   Wagatsuma M, 2007, CLIN GENET, V72, P339, DOI 10.1111/j.1399-0004.2007.00833.x
   Wang QJ, 2007, CLIN GENET, V72, P245, DOI 10.1111/j.1399-0004.2007.00862.x
   Weegerink NJD, 2011, JARO-J ASSOC RES OTO, V12, P753, DOI 10.1007/s10162-011-0282-3
   Woo HM, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-46
   , 2004, [Korean Journal of Otorhinolaryngology Head and Neck Surgery,  ], V47, P206
NR 45
TC 2
Z9 2
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 1
PY 2016
VL 11
IS 9
AR e0161756
DI 10.1371/journal.pone.0161756
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV3WN
UT WOS:000382855600055
PM 27583405
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Nicolaou, M
   Gademan, MGJ
   Snijder, MB
   Engelbert, RHH
   Dijkshoorn, H
   Terwee, CB
   Stronks, K
AF Nicolaou, M.
   Gademan, M. G. J.
   Snijder, M. B.
   Engelbert, R. H. H.
   Dijkshoorn, H.
   Terwee, C. B.
   Stronks, K.
TI Validation of the SQUASH Physical Activity Questionnaire in a
   Multi-Ethnic Population: The HELIUS Study
SO PLOS ONE
LA English
DT Article
ID CRITERION-RELATED VALIDITY; HEART-RATE; ENERGY-EXPENDITURE; SELF-REPORT;
   ADULTS; ACCELEROMETRY; NETHERLANDS; RELIABILITY; AGREEMENT; ACTIHEART
AB Purpose
   To investigate the reliability and validity of the SQUASH physical activity (PA) questionnaire in a multi-ethnic population living in the Netherlands.
   Methods
   We included participants from the HELIUS study, a population-based cohort study. In this study we included Dutch (n = 114), Turkish (n = 88), Moroccan (n = 74), South-Asian Surinamese (n = 98) and African Surinamese (n = 91) adults, aged 18-70 years. The SQUASH was self-administered twice to assess test-re-test reliability (mean interval 6-7 weeks) and participants wore an accelerometer and heart rate monitor (Actiheart) to enable assessment of construct validity.
   Results
   We observed low test-re-test reliability; Intra class correlation coefficients ranged from low (0.05 for moderate/high intensity PA in African Surinamese women) to acceptable (0.78 for light intensity PA in Moroccan women). The discrepancy between self-reported and measured PA differed on the basis of the intensity of activity: self-reported light intensity PA was lower than measured but self-reported moderate/high intensity PA was higher than measured, with wide limits of agreement. The discrepancy between questionnaire and Actiheart measures of moderate intensity PA did not differ between ethnic minority and Dutch participants with correction for relevant confounders. Additionally, the SQUASH overestimated the number of participants meeting the Dutch PA norm; Cohen's kappas for the agreement were poor, the highest being 0.30 in Dutch women.
   Conclusion
   We found considerable variation in the test-re-test reliability and validity of self-reported PA with no consistency based on ethnic origin. Our findings imply that the SQUASH does not provide a valid basis for comparison of PA between ethnic groups.
C1 [Nicolaou, M.; Gademan, M. G. J.; Snijder, M. B.; Stronks, K.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands.
   [Engelbert, R. H. H.] Univ Appl Sci, ASHP, Educ Phys Therapy, Amsterdam, Netherlands.
   [Engelbert, R. H. H.] Acad Med Ctr, Dept Rehabil, Amsterdam, Netherlands.
   [Dijkshoorn, H.] Publ Hlth Serv Amsterdam, Dept Epidemiol & Hlth Promot, Amsterdam, Netherlands.
   [Terwee, C. B.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands.
   [Terwee, C. B.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
RP Nicolaou, M (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands.
EM m.nicolaou@amc.uva.nl
OI Nicolaou, Mary/0000-0002-0419-5816
FU Netherlands Organisation for Health Research and Development [200400012]
FX Funding for this study was provided by The Netherlands Organisation for
   Health Research and Development, grant number 200400012. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Adams EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107039
   Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009
   [Anonymous], 2010, TRENDRAPPORT BEWEGEN
   Arvidson D, 2014, SCAND J PUBLIC HEALT, V42, P255, DOI 10.1177/1403494813514143
   BLAND JM, 1986, LANCET, V1, P307
   Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118
   Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003
   Buchowski MS, 2009, J PHYS ACT HEALTH, V6, P252, DOI 10.1123/jpah.6.2.252
   Crouter SE, 2008, EUR J CLIN NUTR, V62, P704, DOI 10.1038/sj.ejcn.1602766
   de Hollander EL, 2012, J CLIN EPIDEMIOL, V65, P73, DOI 10.1016/j.jclinepi.2011.05.005
   de Munter JSL, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-85
   Dijkshoorn H, 2014, PUBLIC HEALTH NUTR, V17, P2037, DOI 10.1017/S1368980013002322
   Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840
   Espana-Romero V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087085
   Gauthier AP, 2009, J PHYS ACT HEALTH, V6, pS54, DOI 10.1123/jpah.6.s1.s54
   Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898
   HAYS RD, 1989, EDUC PSYCHOL MEAS, V49, P629, DOI 10.1177/001316448904900315
   Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103
   Koshoedo SA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1893-0
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8
   Nang EEK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-141
   Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780
   Snijder MB, 2015, INT J CARDIOL, V191, P28, DOI 10.1016/j.ijcard.2015.04.234
   Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da
   Stronks K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-402
   Stronks K, 2009, ETHNIC HEALTH, V14, P255, DOI 10.1080/13557850802509206
   Thompson D, 2006, J NUTR, V136, P1037
   van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000
   Warnecke RB, 1997, ANN EPIDEMIOL, V7, P334, DOI 10.1016/S1047-2797(97)00030-6
   Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8
   Wendel-Vos GCW, 2004, SQUASH SHORT QUESTIO
NR 32
TC 7
Z9 7
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 30
PY 2016
VL 11
IS 8
AR e0161066
DI 10.1371/journal.pone.0161066
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV4EE
UT WOS:000382877200016
PM 27575490
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Devocht, EMJ
   Janssen, AML
   Chalupper, J
   Stokroos, RJ
   George, ELJ
AF Devocht, Elke M. J.
   Janssen, A. Miranda L.
   Chalupper, Josef
   Stokroos, Robert J.
   George, Erwin L. J.
TI Monaural Beamforming in Bimodal Cochlear Implant Users: Effect of
   (A)symmetric Directivity and Noise Type
SO PLOS ONE
LA English
DT Article
ID WORKING-MEMORY CAPACITY; DIRECTIONAL MICROPHONE; SPEECH RECOGNITION;
   HEARING-AID; BACKGROUND-NOISE; FLUCTUATING MASKERS; LISTENING EFFORT;
   PERFORMANCE; PERCEPTION; BENEFIT
AB Objective
   To evaluate monaural beamforming in bimodally aided cochlear implant (CI) users.
   Design
   The study enrolled twelve adult bimodal listeners with at least six months of CI-experience and using a contralateral hearing aid (HA) most of the daytime. Participants were uniformly fitted with the same CI speech processor and HA, giving access to an identical monaural beamformer in both ears. A within-subject repeated measures design evaluated three directional configurations [omnidirectional, asymmetric directivity (in CI alone) and symmetric directivity (in both CI and HA)] in two noise types [stationary and fluctuating]. Bimodal speech reception thresholds (SRT) as well as listening effort ratings were assessed in a diffuse noise field.
   Results
   Symmetric monaural beamforming provided a significant SRT improvement of 2.6 dB SNR, compared to 1.6 dB SNR for asymmetric monaural beamforming. Directional benefits were similarly observed in stationary and fluctuating noise. Directivity did not contribute to less listening effort in addition to improvement in speech intelligibility. Bimodal performance was about 7 dB SNR worse in fluctuating than in stationary noise.
   Conclusions
   Monaural beamforming provided substantial benefit for speech intelligibility in noise for bimodal listeners. The greatest benefit occurred when monaural beamforming was activated symmetrically in both CI and HA. Monaural beamforming does not bridge the gap between bimodal and normal hearing performance, especially in fluctuating noise. Results advocate further bimodal co-operation.
C1 [Devocht, Elke M. J.; Janssen, A. Miranda L.; Stokroos, Robert J.; George, Erwin L. J.] Maastricht Univ, Med Ctr, Dept ENT Audiol, Sch Mental Hlth & Neurosci MHENS, Maastricht, Netherlands.
   [Janssen, A. Miranda L.] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Methodol & Stat, Maastricht, Netherlands.
   [Chalupper, Josef] Adv Bion European Res Ctr, Hannover, Germany.
RP Devocht, EMJ (reprint author), Maastricht Univ, Med Ctr, Dept ENT Audiol, Sch Mental Hlth & Neurosci MHENS, Maastricht, Netherlands.
EM elke.devocht@mumc.nl
CR Amlani A M, 2001, J Am Acad Audiol, V12, P202
   Appleton J, 2014, HEAR REV, V21, P40
   Bentler Ruth A, 2005, J Am Acad Audiol, V16, P473, DOI 10.3766/jaaa.16.7.7
   Bentler Ruth A, 2004, J Am Acad Audiol, V15, P649, DOI 10.3766/jaaa.15.9.6
   Bionics Advanced, 2012, WHIT PAP CLEAR VOIC
   Blamey PJ, 2015, EAR HEARING, V36, P408, DOI 10.1097/AUD.0000000000000150
   Brand T, 2002, J ACOUST SOC AM, V111, P2801, DOI 10.1121/1.1479152
   Brockmeyer AM, 2011, J AM ACAD AUDIOL, V22, P65, DOI 10.3766/jaaa.22.2.2
   Buchner A, 2009, AUDIOL NEURO-OTOL, V14, P8, DOI 10.1159/000206490
   Buechner A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095542
   Buechner A, 2010, OTOL NEUROTOL, V31, P1386, DOI 10.1097/MAO.0b013e3181f1cdc6
   Chalupper J, 2013, CIAP LAK TAH CAL
   Ching T Y C, 2007, Trends Amplif, V11, P161, DOI 10.1177/1084713807304357
   Chung K, 2006, J ACOUST SOC AM, V120, P2216, DOI [10.1121/1.2258500, 10.1121/1.2285800]
   Cord MT, 2007, J AM ACAD AUDIOL, V18, P245, DOI 10.3766/jaaa.18.3.6
   Cord MT, 2011, AM J AUDIOL, V20, P111, DOI 10.1044/1059-0889(2011/10-0035)
   Desjardins JL, 2016, J AM ACAD AUDIOL, V27, P29, DOI 10.3766/jaaa.15030
   Devocht EMJ, 2015, AUDIOL NEURO-OTOL, V20, P383, DOI 10.1159/000439344
   Elko G, 1995, IEEE ASSP WORKSH APP, P169, DOI DOI 10.1109/ASPAA.1995.482983
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Fetterman BL, 2002, OTOLARYNG HEAD NECK, V126, P257, DOI 10.1067/mhn.2002.123044
   Francart T, 2013, EAR HEARING, V34, P685, DOI 10.1097/AUD.0b013e31829d14cb
   Francart T, 2011, INT J AUDIOL, V50, P2, DOI 10.3109/14992027.2010.505582
   Frohne-Buchner C, 2004, INT CONGR SER, V1273, P93, DOI 10.1016/j.ics.2004.08.047
   Fu QJ, 2005, JARO-J ASSOC RES OTO, V6, P180, DOI 10.1007/s10162-005-5061-6
   GeiSSler Gunnar, 2015, Cochlear Implants Int, V16, P69, DOI 10.1179/1754762814Y.0000000088
   George ELJ, 2007, J ACOUST SOC AM, V121, P2362, DOI 10.1121/1.2642072
   Gifford RH, 2010, J AM ACAD AUDIOL, V21, P441, DOI 10.3766/jaaa.21.7.3
   Gifford RH, 2010, EAR HEARING, V31, P186, DOI 10.1097/AUD.0b013e3181c6b831
   Hallgren M, 2005, INT J AUDIOL, V44, P574, DOI 10.1080/14992020500190011
   Hersbach AA, 2012, EAR HEARING, V33, pE13, DOI 10.1097/AUD.0b013e31824b9e21
   Holube I., 2011, ISAAR NYB DENM
   Hornsby BWY, 2007, EAR HEARING, V28, P177, DOI 10.1097/AUD.0b013e3180312639
   Houben R, 2015, TRENDS HEAR, V19, DOI 10.1177/2331216515583138
   Houben R, 2014, INT J AUDIOL, V53, P760, DOI 10.3109/14992027.2014.920111
   Illg A, 2014, OTOL NEUROTOL, V35, pE240, DOI 10.1097/MAO.0000000000000529
   Kaandorp MW, 2015, INT J AUDIOL, V54, P48, DOI 10.3109/14992027.2014.945623
   Kam ACS, 2012, CLIN EXPT OTORHINOLA, pS89
   Keidser G, 1999, SCAND AUDIOL, V28, P3, DOI 10.1080/010503999424860
   Keidser G, 2013, J AM ACAD AUDIOL, V24, P955, DOI 10.3766/jaaa.24.10.7
   Keidser G, 2008, AM J AUDIOL, V17, P136, DOI 10.1044/1059-0889(2008/07-0012)
   Kim JS, 2011, INT J AUDIOL, V50, P290, DOI 10.3109/14992027.2010.551786
   Klasen TJ, 2005, INT CONF ACOUST SPEE, P29
   Klink KB, 2012, Z AUDIOL, V51, P60
   Kokkinakis K, 2014, J ACOUST SOC AM, V135, pEL47, DOI 10.1121/1.4831955
   Kompis M, 2001, J ACOUST SOC AM, V109, P1134, DOI 10.1121/1.1338558
   Kramer SE, 1996, AUDIOLOGY, V35, P277
   Krueger B, 2008, OTOL NEUROTOL, V29, P509, DOI 10.1097/MAO.0b013e318171972f
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Luts H, 2010, J ACOUST SOC AM, V127, P1491, DOI 10.1121/1.3299168
   Mackenzie E, 2005, EAR HEARING, V26, P669, DOI 10.1097/01.aud.0000188185.78217.c5
   McCreery RW, 2012, AM J AUDIOL, V21, P295, DOI 10.1044/1059-0889(2012/12-0014)
   Mishra S, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00096
   Morimoto M, 2004, J ACOUST SOC AM, V116, P1607, DOI 10.1121/1.1775276
   Nelson PB, 2004, J ACOUST SOC AM, V115, P2286, DOI 10.1121/1.1703538
   Ng EHN, 2013, INT J AUDIOL, V52, P433, DOI 10.3109/14992027.2013.776181
   Noble W, 2008, EAR HEARING, V29, P112
   Peterson P M, 1987, J Rehabil Res Dev, V24, P103
   Qin MK, 2003, J ACOUST SOC AM, V114, P446, DOI 10.1121/1.1579009
   Ricketts T, 1999, Am J Audiol, V8, P117, DOI 10.1044/1059-0889(1999/018)
   Ricketts TA, 2005, EAR HEARING, V26, P473, DOI 10.1097/01.aud.0000179691.21547.01
   Ricketts TA, 2013, EAR HEARING, V34, P601, DOI 10.1097/AUD.0b013e3182886d1e
   Ronnberg J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00031
   Rudner M, 2014, BIOMED RES INT, DOI 10.1155/2014/869726
   Rudner M, 2012, J AM ACAD AUDIOL, V23, P577, DOI 10.3766/jaaa.23.7.7
   Sarampalis A, 2009, J SPEECH LANG HEAR R, V52, P1230, DOI 10.1044/1092-4388(2009/08-0111)
   Schafer EC, 2011, INT J AUDIOL, V50, P871, DOI 10.3109/14992027.2011.622300
   Scherf FWAC, 2014, ACTA OTO-LARYNGOL, V134, P1151, DOI 10.3109/00016489.2014.914244
   Schulte M, 2008, HEARING COMMUNICTION, P1
   Schulte M., 2007, PRESENTED AT EFAS
   Sheffield SW, 2014, AUDIOL NEURO-OTOL, V19, P151, DOI 10.1159/000357588
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   SOEDE W, 1993, J ACOUST SOC AM, V94, P799, DOI 10.1121/1.408181
   Spriet A, 2007, EAR HEARING, V28, P62, DOI 10.1097/01.aud.0000252470.54246.54
   SUNG GS, 1975, ARCH OTOLARYNGOL, V101, P316
   Theelen-van den Hoek FL, 2014, INT J AUDIOL, V53, P817, DOI 10.3109/14992027.2014.922223
   Weissgerber T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126133
   Wouters J, 2001, EAR HEARING, V22, P420, DOI 10.1097/00003446-200110000-00006
   Wu YH, 2014, EAR HEARING, V35, P623, DOI 10.1097/AUD.0000000000000079
   Zirn S, 2016, INT J AUDIOL, V55, P295, DOI 10.3109/14992027.2015.1128124
   Zurek P. M., 1993, ACOUSTICAL FACTORS A, P255
NR 81
TC 2
Z9 2
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 18
PY 2016
VL 11
IS 8
AR e0160829
DI 10.1371/journal.pone.0160829
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT6ES
UT WOS:000381577000034
PM 27537075
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Santos, FLN
   Celedon, PAF
   Zanchin, NIT
   Brasil, TDC
   Foti, L
   de Souza, WV
   Silva, ED
   Gomes, YD
   Krieger, MA
AF Neves Santos, Fred Luciano
   Fiorani Celedon, Paola Alejandra
   Tonin Zanchin, Nilson Ivo
   Campos Brasil, Tatiana de Arruda
   Foti, Leonardo
   de Souza, Wayner Vieira
   Silva, Edmilson Domingos
   Gomes, Yara de Miranda
   Krieger, Marco Aurelio
TI Performance Assessment of Four Chimeric Trypanosoma cruzi Antigens Based
   on Antigen-Antibody Detection for Diagnosis of Chronic Chagas Disease
SO PLOS ONE
LA English
DT Article
ID SEROLOGICAL DIAGNOSIS; SYNTHETIC PEPTIDE; RECOMBINANT ANTIGENS;
   CLINICAL-DIAGNOSIS; PROTEIN ANTIGENS; ASSAY; SERODIAGNOSIS;
   DETERMINANTS; EPITOPE; INFECTION
AB The performance of serologic tests in chronic Chagas disease diagnosis largely depends on the type and quality of the antigen preparations that are used for detection of anti-Trypanosoma cruzi antibodies. Whole-cell T. cruzi extracts or recombinant proteins have shown variation in the performance and cross-reactivity. Synthetic chimeric proteins comprising fragments of repetitive amino acids of several different proteins have been shown to improve assay performances to detect Chagasic infections. Here, we describe the production of four chimeric T. cruzi proteins and the assessment of their performance for diagnostic purposes. Circular Dichroism spectra indicated the absence of well-defined secondary structures, while polydispersity evaluated by Dynamic Light Scattering revealed only minor aggregates in 50 mM carbonate-bicarbonate (pH 9.6), demonstrating that it is an appropriate buffering system for sensitizing microplates. Serum samples from T. cruzi-infected and non-infected individuals were used to assess the performance of these antigens for detecting antibodies against T. cruzi, using both enzyme-linked immunosorbent assay and a liquid bead array platform. Performance parameters (AUC, sensitivity, specificity, accuracy and J index) showed high diagnostic accuracy for all chimeric proteins for detection of specific anti-T. cruzi antibodies and differentiated seropositive individuals from those who were seronegative. Our data suggest that these four chimeric proteins are eligible for phase II studies.
C1 [Neves Santos, Fred Luciano; de Souza, Wayner Vieira; Gomes, Yara de Miranda] FIOCRUZ PE, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.
   [Fiorani Celedon, Paola Alejandra; Tonin Zanchin, Nilson Ivo; Foti, Leonardo; Krieger, Marco Aurelio] Mol Biol Inst Parana, Curitiba, PR, Brazil.
   [Tonin Zanchin, Nilson Ivo; Campos Brasil, Tatiana de Arruda; Foti, Leonardo; Krieger, Marco Aurelio] FIOCRUZ PR, Carlos Chagas Inst, Curitiba, PR, Brazil.
   [Silva, Edmilson Domingos] FIOCRUZ RJ, Biomanguinhos, Rio De Janeiro, RJ, Brazil.
   [Neves Santos, Fred Luciano] FIOCRUZ BA, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
RP Santos, FLN (reprint author), FIOCRUZ PE, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.; Santos, FLN (reprint author), FIOCRUZ BA, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
EM fred.santos@bahia.fiocruz.br
RI Foti, Leonardo/I-6677-2016; SANTOS, Fred/S-2954-2019; Foti,
   Leonardo/F-1763-2014
OI SANTOS, Fred/0000-0002-3944-0818; Foti, Leonardo/0000-0003-2948-9914;
   Zanchin, Nilson/0000-0002-1153-0694; Souza, Wayner/0000-0002-0939-9332
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq
   [404242/2012-0]; Fundacao de Amparo a Ciencia e Tecnologia do Estado de
   Pernambuco-FACEPE [APQ-1257-2.11/12]; RVE Finep [Convenio
   01.13.0283.00-ref. 0473/12];  [304543/2012-8];  [306222/2013-2]; 
   [590032/2011-9]
FX Funding support was provided by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico-CNPq (Proc. 404242/2012-0), Fundacao de Amparo
   a Ciencia e Tecnologia do Estado de Pernambuco-FACEPE (Proc.
   APQ-1257-2.11/12) and RVE Finep (Convenio 01.13.0283.00-ref. 0473/12).
   Yara de Miranda Gomes, Wayner Vieira de Sousa, and Marco Aurelio Krieger
   are research fellows of CNPq Proc. No. 304543/2012-8, 306222/2013-2, and
   590032/2011-9, respectively.
CR Ackermann AA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-736
   Bottino CG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-568
   Camussone C, 2009, CLIN VACCINE IMMUNOL, V16, P899, DOI 10.1128/CVI.00005-09
   Thomas MC, 2012, CLIN VACCINE IMMUNOL, V19, P167, DOI 10.1128/CVI.05566-11
   Chang CD, 2006, TRANSFUSION, V46, P1737, DOI 10.1111/j.1537-2995.2006.00965.x
   Cheng KY, 2007, CLIN VACCINE IMMUNOL, V14, P355, DOI 10.1128/CVI.00401-06
   da Silveira JF, 2001, TRENDS PARASITOL, V17, P286, DOI 10.1016/S1471-4922(01)01897-9
   DaRocha W, 2002, PARASITOL RES, V88, P292, DOI 10.1007/s00436-001-0540-0
   Ferreira AW, 2001, J CLIN MICROBIOL, V39, P4390, DOI 10.1128/JCM.39.12.4390-4395.2001
   FIESER TM, 1987, P NATL ACAD SCI USA, V84, P8568, DOI 10.1073/pnas.84.23.8568
   Foti L, 2009, MEM I OSWALDO CRUZ, V104, P136, DOI 10.1590/S0074-02762009000900019
   Gadelha AAM, 2003, VOX SANG, V85, P165, DOI 10.1046/j.1423-0410.2003.00340.x
   Gomes YM, 2001, MEM I OSWALDO CRUZ, V96, P497, DOI 10.1590/S0074-02762001000400009
   Gonzalez J, 2013, DIAGNOSIS TREATMENT, P105, DOI [10. 5772/ 55387, DOI 10.5772/55387]
   Goto Y, 2008, INFECT IMMUN, V76, P3967, DOI 10.1128/IAI.00604-08
   Hernandez P, 2010, CLIN VACCINE IMMUNOL, V17, P1598, DOI 10.1128/CVI.00489-08
   HOFT DF, 1989, INFECT IMMUN, V57, P1959
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001498
   Houghton RL, 2009, CLIN VACCINE IMMUNOL, V16, P515, DOI 10.1128/CVI.00383-08
   Houghton RL, 1999, J INFECT DIS, V179, P1226, DOI 10.1086/314723
   Houghton RL, 2000, J INFECT DIS, V181, P325, DOI 10.1086/315165
   IBANEZ CF, 1988, MOL BIOCHEM PARASIT, V30, P27, DOI 10.1016/0166-6851(88)90129-6
   Irwig L, 2002, BRIT MED J, V324, P669, DOI 10.1136/bmj.324.7338.669
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAFAILLE JJ, 1989, MOL BIOCHEM PARASIT, V35, P127, DOI 10.1016/0166-6851(89)90115-1
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LEVIN MJ, 1989, AM J TROP MED HYG, V41, P530, DOI 10.4269/ajtmh.1989.41.530
   Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198
   Manne-Goehler J, 2015, AM J TROP MED HYG, V93, P108, DOI 10.4269/ajtmh.14-0826
   *MIN SAUD, 2005, REV SOC BRAS MED S3, V38, P7
   Ministerio da Saude (BR) Secretaria de Vigilancia em Saude, 2015, B EPIDEMIOL, V46, P1
   Neto V. A., 2000, REV PAT TROP, V29, P115
   Santos FLN, 2016, AM J TROP MED HYG, V94, P1034, DOI 10.4269/ajtmh.15-0820
   Ouchchane L, 2009, BIOSTATISTIQUE, P49
   Pitcovsky TA, 2001, INFECT IMMUN, V69, P1869, DOI 10.1128/IAI.69.3.1869-1875.2001
   Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002
   Reverberi Roberto, 2007, Blood Transfus, V5, P227, DOI 10.2450/2007.0047-07
   Sackett DL, 2002, BRIT MED J, V324, P539, DOI 10.1136/bmj.324.7336.539
   Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003
   SCHOFIELD L, 1991, PARASITOL TODAY, V7, P99, DOI 10.1016/0169-4758(91)90166-L
   Teixeira-Carvalho A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122938
   Umezawa ES, 2004, J CLIN MICROBIOL, V42, P449, DOI 10.1128/JCM.42.1.449-452.2004
   Umezawa ES, 1999, MEM I OSWALDO CRUZ, V94, P285, DOI 10.1590/S0074-02761999000700051
   Benedetti AFV, 2013, TROP MED INT HEALTH, V18, P1103, DOI 10.1111/tmi.12144
   WHO, 2007, WHO CONS INT BIOL RE
NR 46
TC 11
Z9 11
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 12
PY 2016
VL 11
IS 8
AR e0161100
DI 10.1371/journal.pone.0161100
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT3LI
UT WOS:000381382100049
PM 27517281
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Piotti, P
   Kaminski, J
AF Piotti, Patrizia
   Kaminski, Juliane
TI Do Dogs Provide Information Helpfully?
SO PLOS ONE
LA English
DT Article
ID CANIS-FAMILIARIS; DOMESTIC DOGS; SOCIAL COGNITION; COMMUNICATIVE
   INTENTIONS; PET DOGS; GESTURES; HUMANS; WOLVES; RESPONSIVENESS;
   COMPREHENSION
AB Dogs are particularly skilful during communicative interactions with humans. Dogs' abilities to use human communicative cues in cooperative contexts outcompete those of other species, and might be the result of selection pressures during domestication. Dogs also produce signals to direct the attention of humans towards outside entities, a behaviour often referred to as showing behaviour. This showing behaviour in dogs is thought to be something dogs use intentionally and referentially. However, there is currently no evidence that dogs communicate helpfully, i.e. to inform an ignorant human about a target that is of interest to the human but not to the dog. Communicating with a helpful motive is particularly interesting because it might suggest that dogs understand the human's goals and need for information. In study 1, we assessed whether dogs would abandon an object that they find interesting in favour of an object useful for their human partner, a random novel distractor, or an empty container. Results showed that it was mainly self-interest that was driving the dogs' behaviour. The dogs mainly directed their behaviour towards the object they had an interest in, but dogs were more persistent when showing the object relevant to the human, suggesting that to some extent they took the humans interest into account. Another possibility is that dogs' behaviour was driven by an egocentric motivation to interact with novel targets and that the dogs' neophila might have masked their helpful tendencies. Therefore, in study 2 the dogs had initial access to both objects, and were expected to indicate only one (relevant or distractor). The human partner interacted with the dog using vocal communication in half of the trials, and remaining silent in the other half. Dogs from both experimental groups, i.e. indicating the relevant object or indicating the distractor, established joint attention with the human. However, the human's vocal communication and the presence of the object relevant to the human increased the persistency of showing, supporting the hypothesis that the dogs understood the objects' relevance to the human. We propose two nonexclusive explanations. These results might suggest that informative motives could possibly underlie dogs' showing. It is also possible that dogs might have indicated the location of the hidden object because they recognised it as the target of the human's search. This would be consistent with taking into account the objects' relevance, without necessarily implying that the dogs understood the human's state of knowledge.
C1 [Piotti, Patrizia; Kaminski, Juliane] Univ Portsmouth, Dept Psychol, Ctr Comparat & Evolutionary Psychol, Portsmouth, Hants, England.
RP Piotti, P (reprint author), Univ Portsmouth, Dept Psychol, Ctr Comparat & Evolutionary Psychol, Portsmouth, Hants, England.
EM patrizia.piotti@port.ac.uk
RI Piotti, Patrizia/H-1640-2017
OI Piotti, Patrizia/0000-0001-7761-8712; Kaminski,
   Juliane/0000-0002-3437-3484
CR Baayen R. H., 2008, ANAL LINGUISTIC DATA
   Barton K, 2016, MUMIN MULTIMODEL INF
   Bates D, 2015, J STAT SOFTW, V67, P1
   BATES E, 1975, MERRILL PALMER QUART, V21, P205
   Behne T, 2005, DEVELOPMENTAL SCI, V8, P492, DOI 10.1111/j.1467-7687.2005.00440.x
   Brauer J, 2013, APPL ANIM BEHAV SCI, V148, P138, DOI 10.1016/j.applanim.2013.07.009
   Bullinger AF, 2011, DEVELOPMENTAL SCI, V14, P58, DOI 10.1111/j.1467-7687.2010.00952.x
   Burnham KP, 2003, MODEL SELECTION MULT
   Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257
   Camaioni L, 1992, EARLY DEV PARENTING, V1, P15
   Clark HH, 1996, USING LANGUAGE
   Clutton-Brock Juliet, 1995, P7
   Cooper JJ, 2003, APPL ANIM BEHAV SCI, V81, P229, DOI 10.1016/S0168-1591(02)00284-8
   Csibra G, 2003, PHILOS T R SOC B, V358, P447, DOI 10.1098/rstb.2002.1235
   Csibra G, 2007, ACTA PSYCHOL, V124, P60, DOI 10.1016/j.actpsy.2006.09.007
   Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005
   Gacsi M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-31
   Gaunet F, 2014, ANIM COGN, V17, P1137, DOI 10.1007/s10071-014-0746-z
   Gaunet F, 2011, ANIM COGN, V14, P849, DOI 10.1007/s10071-011-0418-1
   Gergely C, 2010, MIND LANG, V25, P141
   Gergely G, 2003, TRENDS COGN SCI, V7, P287, DOI 10.1016/S1364-6613(03)00128-1
   Gomez J. C., 1993, UNDERSTANDING OTHER, P397
   Gomez JC, 2005, TRENDS COGN SCI, V9, P118, DOI 10.1016/j.tics.2005.01.004
   Gomez JC, 2007, CHILD DEV, V78, P729, DOI 10.1111/j.1467-8624.2007.01027.x
   Grice H. P., 1975, SYNTAX SEMANTICS, P41, DOI DOI 10.1017/S0022226700005296
   Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003
   Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702
   Hare B, 1998, EVOLUTION COMMUNICAT, V2, P137, DOI DOI 10.1075/E0C.2.1.06HAR
   HILL AB, 1965, P ROY SOC MED, V58, P295
   Kaminski J, 2013, LEARN MOTIV, V44, P294, DOI 10.1016/j.lmot.2013.05.001
   Kaminski J, 2012, DEVELOPMENTAL SCI, V15, P222, DOI 10.1111/j.1467-7687.2011.01120.x
   Kaminski J, 2011, ANIM BEHAV, V82, P651, DOI 10.1016/j.anbehav.2011.06.015
   Kaminski J, 2011, ANIM BEHAV, V81, P195, DOI 10.1016/j.anbehav.2010.10.001
   Kaulfuss P, 2008, ANIM COGN, V11, P553, DOI 10.1007/s10071-007-0128-x
   Kiraly I, 2013, J EXP CHILD PSYCHOL, V116, P471, DOI 10.1016/j.jecp.2012.12.003
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leavens DA, 2005, CHILD DEV, V76, P291, DOI 10.1111/j.1467-8624.2005.00845.x
   Leavens David A., 2004, Interaction Studies, V5, P387, DOI 10.1075/is.5.3.05lea
   Lenth RV, 2015, LSMEANS LEAST SQUARE
   Liszkowski U, 2008, COGNITION, V108, P732, DOI 10.1016/j.cognition.2008.06.013
   Liszkowski U, 2006, J COGN DEV, V7, P173, DOI 10.1207/s15327647jcd0702_2
   Marshall-Pescini S, 2013, ANIM COGN, V16, P933, DOI 10.1007/s10071-013-0627-x
   Marshall-Pescini S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106530
   MCCONNELL PB, 1990, ANIM BEHAV, V39, P897, DOI 10.1016/S0003-3472(05)80954-6
   Miklosi A, 2004, ANIM BEHAV, V67, P995, DOI 10.1016/j.anbehav.2003.10.008
   Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X
   Miklosi A, 1998, Anim Cogn, V1, P113, DOI 10.1007/s100710050016
   Miklosi A., 2000, ANIM COGN, V3, P159, DOI DOI 10.1007/S100710000072
   Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1
   MOORE C, 1994, DEV REV, V14, P349, DOI 10.1006/drev.1994.1014
   Moore C, 2001, J COGN DEV, V2, P109, DOI 10.1207/S15327647JCD0202_1
   Moore R, 2013, HUMANA MENTE, P27
   Moore R, 2015, DEVELOPMENTAL SCI, V18, P232, DOI 10.1111/desc.12206
   Naderi S, 2002, ACTA BIOL HUNG, V53, P537, DOI 10.1556/ABiol.53.2002.4.13
   Naderi S, 2001, APPL ANIM BEHAV SCI, V74, P59, DOI 10.1016/S0168-1591(01)00152-6
   Ohkita M, 2016, BEHAV PROCESSES
   Ostojic L, 2014, ANIM COGN, V17, P445, DOI 10.1007/s10071-013-0676-1
   R Core Team, 2015, LANG ENV STAT COMP V
   Riedel J, 2008, ANIM BEHAV, V75, P1003, DOI 10.1016/j.anbehav.2007.08.010
   Savalli C, 2012, J VET BEHAV, V8, pe38
   Skoglund P, 2015, CURR BIOL, V25, P1515, DOI 10.1016/j.cub.2015.04.019
   Soproni K, 2002, J COMP PSYCHOL, V116, P27, DOI 10.1037//0735-7036.116.1.27
   Soproni K, 2001, J COMP PSYCHOL, V115, P122, DOI 10.1037//0735-7036.115.2.122
   Tauzin T, 2015, ANIM COGN, V18, P975, DOI 10.1007/s10071-015-0857-1
   Tempelmann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091014
   Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650
   Tomasello M., 2010, ORIGINS HUMAN COMMUN
   Tomasello M, 2007, CHILD DEV, V78, P705, DOI 10.1111/j.1467-8624.2007.01025.x
   Topal J, 2005, J CULT EVOL PSYCHOL, V3, P223, DOI [10.1556/JCEP.3.2005.3-4.1, DOI 10.1556/JCEP.3.2005.3-4.1]
   Topal J., 2014, SOCIAL DOG BEHAV COG, P319, DOI DOI 10.1016/B978-0-12-407818-5.00012-7
   Topal J, 2006, INT J PSYCHOL PSYCHO, V6, P365
   Topal J, 2009, ADV STUD BEHAV, V39, P71, DOI 10.1016/S0065-3454(09)39003-8
   Udell MAR, 2008, ANIM BEHAV, V76, P1767, DOI 10.1016/j.anbehav.2008.07.028
   van der Goot MH, 2014, CHILD DEV, V85, P444, DOI 10.1111/cdev.12141
   Viranyi Z, 2006, ANIM COGN, V9, P13, DOI 10.1007/s10071-005-0257-z
   Viranyi Z, 2004, BEHAV PROCESS, V66, P161, DOI 10.1016/j.beproc.2004.01.012
   Viranyi Z, 2008, ANIM COGN, V11, P373, DOI 10.1007/s10071-007-0127-y
   Wang GD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2814
   Zar J. H, 1999, BIOSTATISTICAL ANAL
NR 79
TC 5
Z9 5
U1 1
U2 33
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 10
PY 2016
VL 11
IS 8
AR e0159797
DI 10.1371/journal.pone.0159797
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT3KR
UT WOS:000381380400014
PM 27508932
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Naylor, JM
   Descallar, J
   Grootemaat, M
   Badge, H
   Harris, IA
   Simpson, G
   Jenkin, D
AF Naylor, Justine M.
   Descallar, Joseph
   Grootemaat, Mechteld
   Badge, Helen
   Harris, Ian A.
   Simpson, Grahame
   Jenkin, Deanne
TI Is Satisfaction with the Acute-Care Experience Higher amongst Consumers
   Treated in the Private Sector? A Survey of Public and Private Sector
   Arthroplasty Recipients
SO PLOS ONE
LA English
DT Article
ID PATIENT-SATISFACTION; MEDICAL-CARE; HEALTH-CARE; TOTAL HIP; KNEE
   ARTHROPLASTY; SURGERY; REPLACEMENT; AGREEMENT; KAPPA; METAANALYSIS
AB Background
   Consumer satisfaction with the acute-care experience could reasonably be expected to be higher amongst those treated in the private sector compared to those treated in the public sector given the former relies on high-level satisfaction of its consumers and their subsequent recommendations to thrive. The primary aims of this study were to determine, in a knee or hip arthroplasty cohort, if surgery in the private sector predicts greater overall satisfaction with the acute-care experience and greater likelihood to recommend the same hospital. A secondary aim was to determine whether satisfaction across a range of service domains is also higher in the private sector.
   Methods
   A telephone survey was conducted 35 days post-surgery. The hospital cohort comprised eight public and seven private high-volume arthroplasty providers. Consumers rated overall satisfaction with care out of 100 and likeliness to recommend their hospital on a 5-point Likert scale. Additional Likert-style questions were asked covering specific service domains. Generalized estimating equation models were used to analyse overall satisfaction (dichotomised as >= 90 or < 90) and future recommendations for care (dichotomised as 'definitely recommend' or 'other'), whilst controlling for covariates. The proportions of consumers in each sector reporting the best Likert response for each individual domain were compared using non-parametric tests.
   Results
   457 survey respondents (n = 210 private) were included. Less patient-reported joint impairment pre-surgery [OR 1.03 (95% CI 1.01-1.05)] and absence of an acute complication (OR 2.13 95% CI 1.41-3.23) significantly predicted higher overall satisfaction. Hip arthroplasty [OR 1.84 (1.1-2.96)] and an absence of an acute complication [OR 2.31 (1.28-4.17] significantly predicted greater likelihood for recommending the hospital. The only care domains where the private out-performed the public sector were hospitality (46.7 vs 35.6%, p <0.01) and frequency of surgeon visitation (76.4 vs 65.8%, p = 0.03).
   Conclusions
   Arthroplasty consumers treated in the private sector are not more satisfied with their acute-care experience nor are they more likely to recommend their hospital provider. Rather, avoidance of complications in either sector appears to result in improved satisfaction as well as a greater likelihood that patients would recommend their hospital provider.
C1 [Naylor, Justine M.; Badge, Helen; Harris, Ian A.; Jenkin, Deanne] Liverpool Hosp, Dept Orthopaed, Liverpool, NSW, Australia.
   [Naylor, Justine M.; Descallar, Joseph; Badge, Helen; Harris, Ian A.; Jenkin, Deanne] UNSW, South West Clin Sch, Randwick, NSW, Australia.
   [Naylor, Justine M.; Descallar, Joseph; Badge, Helen; Harris, Ian A.; Simpson, Grahame; Jenkin, Deanne] Ingham Inst Appl Med Hlth Res, Liverpool, NSW, Australia.
   [Grootemaat, Mechteld] Univ Amsterdam, Amsterdam, Netherlands.
   [Simpson, Grahame] Liverpool Hosp, Brain Injury Rehabil Unit, Liverpool, NSW, Australia.
   [Simpson, Grahame] Griffith Univ, Sch Human Serv & Social Work, Gold Coast, Qld, Australia.
   [Simpson, Grahame] Univ Sydney, John Walsh Ctr Rehabil Res, Sydney, NSW, Australia.
RP Naylor, JM (reprint author), Liverpool Hosp, Dept Orthopaed, Liverpool, NSW, Australia.
EM Justine.Naylor@sswahs.nsw.gov.au
RI Naylor, Justine/R-8459-2019
OI Naylor, Justine/0000-0002-9147-1312
FU HCF Research Foundation [IHIIAMR2012073043]
FX This work was supported by HCF Research Foundation IHIIAMR2012073043
   (JN, IH). The funder had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR ABS, 1301 0 YB AUSTR 2009
   Adie S, 2012, ANZ J SURG, V82, P616, DOI 10.1111/j.1445-2197.2012.06113.x
   Altman D. G., 1991, PRACTICAL STAT MED R
   Australian Commission on Safety and Quality in Health Care, 2012, REV PAT EXP SAT SURV
   Australian Orthopaedic Association National Joint Replacement Registry, 2013, ANN REPORT
   Bannigan K, 2009, J CLIN NURS, V18, P3237, DOI 10.1111/j.1365-2702.2009.02939.x
   Baumann C, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-150
   Bleich SN, 2009, B WORLD HEALTH ORGAN, V87, P271, DOI 10.2471/BLT.07.050401
   Bourne RB, 2010, CLIN ORTHOP RELAT R, V468, P57, DOI 10.1007/s11999-009-1119-9
   Bradbury KJ, 2013, J HEALTH PSYCHOL, V18, P1307, DOI 10.1177/1359105312465101
   Brokelman RBG, 2003, J BONE JOINT SURG BR, V85B, P495, DOI 10.1302/0301-620X.85B4.13411
   Bullens PHJ, 2001, J ARTHROPLASTY, V16, P740, DOI 10.1054/arth.2001.23922
   Cheung K, 2009, USER GUIDE BASIC INF
   Clavien PA, 2009, ANN SURG, V250, P197, DOI 10.1097/SLA.0b013e3181b6dcab
   COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256
   DAVIS K, 2002, HLTH AFF MILLWOOD S, pW311
   Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570
   Draper M, 2001, INT J QUAL HEALTH C, V13, P463, DOI 10.1093/intqhc/13.6.463
   Fenton JJ, 2012, ARCH INTERN MED, V172, P405, DOI 10.1001/archinternmed.2011.1662
   HALL JA, 1990, SOC SCI MED, V30, P811, DOI 10.1016/0277-9536(90)90205-7
   HALL JA, 1988, SOC SCI MED, V27, P935, DOI 10.1016/0277-9536(88)90284-5
   Hamilton DF, 2014, BONE JOINT J, V96B, P622, DOI 10.1302/0301-620X.96B5.32434
   Hamilton DF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002525
   Huynh HP, 2014, J SURG RES, V192, P339, DOI 10.1016/j.jss.2014.05.086
   Jenkinson C, 2002, QUAL SAF HEALTH CARE, V11, P335, DOI 10.1136/qhc.11.4.335
   Katz JN, 2003, ARTHRITIS RHEUM, V48, P560, DOI 10.1002/art.10754
   Katz MH, 1997, J ACQ IMMUN DEF SYND, V14, P35, DOI 10.1097/00042560-199701010-00007
   Kennedy GD, 2014, ANN SURG, V260, P592, DOI 10.1097/SLA.0000000000000932
   Khattak A, 2012, INT J COLLAB RES INT, V4, P713
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Murray DW, 2007, J BONE JOINT SURG BR, V89B, P1010, DOI 10.1302/0301-620X.89B8
   Nunnally J, 1994, PSYCHOMETRIC THEORY
   Pager CK, 2004, CLIN EXP OPHTHALMOL, V32, P482, DOI 10.1111/j.1442-9071.2004.00868.x
   Robertsson O, 2000, ACTA ORTHOP SCAND, V71, P262, DOI 10.1080/000164700317411852
   Suki NM, 2011, INT J HEALTH CARE Q, V24, P42, DOI 10.1108/09526861111098238
   Tateke T, 2012, AFRICAN J PRIMARY HL, V4
   Thompson LA, 2009, PEDIATRICS S, V24, pS420
   Tolley E, 1997, PUBLIC PRIVATE SECTO
   Tooth LR, 2004, ARCH PHYS MED REHAB, V85, P1371, DOI 10.1016/j.apmr.2003.12.002
   Tsai TC, 2015, ANN SURG, V261, P2, DOI 10.1097/SLA.0000000000000765
   Viera AJ, 2005, FAM MED, V37, P360
NR 41
TC 6
Z9 6
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 4
PY 2016
VL 11
IS 8
AR e0159799
DI 10.1371/journal.pone.0159799
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT3GL
UT WOS:000381368900018
PM 27490358
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wang, F
   Chen, W
   Bruening, KS
   Raj, S
   Larsen, DA
AF Wang, Fang
   Chen, Wei
   Bruening, Kay Stearns
   Raj, Sudha
   Larsen, David A.
TI Nutrition Screening Tools and the Prediction of Clinical Outcomes among
   Chinese Hospitalized Gastrointestinal Disease Patients
SO PLOS ONE
LA English
DT Article
ID MALNUTRITION UNDERNUTRITION; TEACHING HOSPITALS; RISK; PREVALENCE;
   SUPPORT; IDENTIFICATION; DOCUMENTATION; POPULATION; ADMISSION; CARE
AB Nutrition risk Screening 2002 (NRS-2002) and Subjective Global Assessment (SGA) are widely used screening tools but have not been compared in a Chinese population. We conducted secondary data analysis of a cross-sectional study which included 332 hospitalized gastrointestinal disease patients, collected by the Gastrointestinal department of Peking Union Medical College Hospital (PUMCH) in 2008. Results of NRS-2002 and SGA screening tools, complications, length of stay (LOS), cost, and death were measured. The agreement between the tools was assessed via Kappa (kappa) statistics. The performance of NRS-2002 and SGA in predicting LOS and cost was assessed via linear regression. The complications and death prediction of tools was assessed using receiver operating characteristic (ROC) curves. NRS-2002 and SGA identified nutrition risk at 59.0% and 45.2% respectively. Moderate agreement (kappa > 0.50) between the two tools was found among all age groups except individuals aged <= 20, which only slight agreement was found (kappa = 0.087). NRS-2002 (R square 0.130) and SGA (R square 0.140) did not perform differently in LOS prediction. The cost prediction of NRS-2002 (R square 0.198) and SGA (R square 0.190) were not significantly different. There was no difference between NRS-2002 (infectious complications: area under ROC (AUROC) = 0.615, death: AUROC = 0.810) and SGA (infectious complications: AUROC = 0.600, death: AUROC = 0.846) in predicting infectious complication and death, but NRS-2002 (0.738) seemed to perform better than SGA (0.552) in predicting non-infectious complications. The risk of malnutrition among patients was high. NRS-2002 and SGA have similar capacity to predict LOS, cost, infectious complications and death, but NRS-2002 performed better in predicting non-infectious complications.
C1 [Wang, Fang] Beijing Union Med Coll Hosp, Dept Nutr, Beijing, Peoples R China.
   [Chen, Wei] Beijing Union Med Coll Hosp, Parenteral & Enteral Dept, Beijing, Peoples R China.
   [Bruening, Kay Stearns; Raj, Sudha; Larsen, David A.] Syracuse Univ, Dept Publ Hlth Food Studies & Nutr, Syracuse, NY 13244 USA.
RP Larsen, DA (reprint author), Syracuse Univ, Dept Publ Hlth Food Studies & Nutr, Syracuse, NY 13244 USA.
EM dalarsen@syr.edu
RI Larsen, David/D-4027-2016
OI Larsen, David/0000-0002-1876-6536
CR Baldwin C, 2004, CLIN NUTR, V23, P1267, DOI 10.1016/j.clnu.2004.07.018
   Bruun LI, 1999, CLIN NUTR, V18, P141, DOI 10.1016/S0261-5614(99)80003-X
   Christensson L, 2002, EUR J CLIN NUTR, V56, P810, DOI 10.1038/sj.ejcn.1601394
   Edington J, 2000, CLIN NUTR, V19, P191, DOI 10.1054/clnu.1999.0121
   FERNANDEZ CC, 2003, NUTR HOSP, V18, P95
   Gout BS, 2009, NUTR DIET, V66, P206, DOI 10.1111/j.1747-0080.2009.01372.x
   Jensen GL, 2010, CLIN NUTR, V29, P151, DOI 10.1016/j.clnu.2009.11.010
   Jensen GL, 2009, JPEN-PARENTER ENTER, V33, P710, DOI 10.1177/0148607109344724
   Kubrak C, 2007, INT J NURS STUD, V44, P1036, DOI 10.1016/j.ijnurstu.2006.07.015
   Kyle UG, 2005, CURR OPIN CLIN NUTR, V8, P397, DOI 10.1097/01.mco.0000172579.94513.db
   Kyle UG, 2003, CLIN NUTR, V22, P473, DOI 10.1016/S0261-5614(03)00049-9
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liang XK, 2008, NUTRITION, V24, P969, DOI 10.1016/j.nut.2008.05.001
   Liang XK, 2009, ASIA PAC J CLIN NUTR, V18, P54
   Marshall JA, 1999, J AM DIET ASSOC, V99, P315, DOI 10.1016/S0002-8223(99)00081-4
   Mason P, 2006, HOSP PHARM, V13, P353, DOI DOI 10.7748/NS2003.
   National Alliance for Infusion Therapy and the ASPEN Public Policy Committee and Board of Directors, 2010, NUTR CLIN PRACT, V25, P548, DOI [doi: 10.1177/ 0884533610378524, DOI 10.1177/0884533610378524]
   Pirlich M, 2006, CLIN NUTR, V25, P563, DOI 10.1016/j.clnu.2006.03.005
   Putwatana P, 2005, NUTRITION, V21, P691, DOI 10.1016/j.nut.2004.10.015
   Raslan M, 2010, NUTRITION, V26, P721, DOI 10.1016/j.nut.2009.07.010
   Rasmussen HH, 2004, CLIN NUTR, V23, P1009, DOI 10.1016/j.clnu.2004.01.001
   Sullivan DH, 1999, JAMA-J AM MED ASSOC, V281, P2013, DOI 10.1001/jama.281.21.2013
   Valero M. A., 2005, Nutr. Hosp., V20, P259
   van Bokhorst-de van der Schueren MAE, 2005, EUR J CLIN NUTR, V59, P1129, DOI 10.1038/sj.ejcn.1602222
   Velasco C, 2011, EUR J CLIN NUTR, V65, P269, DOI 10.1038/ejcn.2010.243
   Waitzberg DL, 2001, NUTRITION, V17, P573, DOI 10.1016/S0899-9007(01)00573-1
   Wei C, 2005, CHINESE J CLIN NUTR, V3
   White JV, 2012, JPEN-PARENTER ENTER, V36, P275, DOI 10.1177/0148607112440285
   Winter TA, 2000, EUR J GASTROEN HEPAT, V12, P191, DOI 10.1097/00042737-200012020-00010
   Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929
   ZWEIG MH, 1993, CLIN CHEM, V39, P561
NR 31
TC 0
Z9 0
U1 2
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 4
PY 2016
VL 11
IS 8
AR e0159436
DI 10.1371/journal.pone.0159436
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT3GL
UT WOS:000381368900010
PM 27490480
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Laessoe, U
   Grarup, B
   Bangshaab, J
AF Laessoe, Uffe
   Grarup, Bo
   Bangshaab, Jette
TI The Use of Cognitive Cues for Anticipatory Strategies in a Dynamic
   Postural Control Task - Validation of a Novel Approach to Dual-Task
   Testing
SO PLOS ONE
LA English
DT Article
ID PARKINSONS-DISEASE; GAIT; WALKING; BALANCE; PEOPLE; FALLS
AB Introduction
   Dual-task testing is relevant in the assessment of postural control. A combination of a primary (motor) and a secondary (distracting cognitive) tasks is most often used. It remains a challenge however, to standardize and monitor the cognitive task. In this study a new dual-task testing approach with a facilitating, rather than distracting, cognitive component was evaluated.
   Methods
   Thirty-one community-dwelling elderly and fifteen young people were tested with respect to their ability to use anticipatory postural control strategies. The motor task consisted of twenty-five repetitive tasks in which the participants needed to exceed their limit of stability in order to touch one out of eight lights. The participants performed three tests. In two of the tests the color cues of the lights allowed the participants to utilize cognitive strategies to plan their next movement and improve their performance time.
   Results
   The young performed the baseline motor task test in an average of 29 seconds, while the average time for the elderly was 44 seconds. When comparing the performance time with a leading cue to the time with no cue, the young group improved their performance time significantly better than the elderly did: young: 17% (5), elderly: 5% (8); p<0.001. Similar differences were seen with a more complicated leading cue: young: 12% (5), elderly: 4% (9); p<0.01. The reliability of the test showed moderate to substantial agreement (ICC = 0.74), with a small learning effect between two sessions.
   Conclusion
   The dual-task test was sensitive enough to discriminate between elderly and young people. It revealed that the elderly did not utilize cognitive cues for their anticipatory postural control strategies as well as the young were able to. The test procedure was feasible and comprehensible for the participants, and it may be relevant to standardize a similar test for an alternative dual-task approach in the clinical setting.
C1 [Laessoe, Uffe; Grarup, Bo] Univ Coll North Denmark, Physiotherapy Dept, Region Nordjylland, Denmark.
   [Laessoe, Uffe; Bangshaab, Jette] Univ Coll North Denmark, Dept Res & Dev, Region Nordjylland, Denmark.
RP Laessoe, U (reprint author), Univ Coll North Denmark, Physiotherapy Dept, Region Nordjylland, Denmark.; Laessoe, U (reprint author), Univ Coll North Denmark, Dept Res & Dev, Region Nordjylland, Denmark.
EM ufl@ucn.dk
OI Laessoe, Uffe/0000-0001-5388-1671
CR ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101
   Dault MC, 2001, GAIT POSTURE, V14, P248, DOI 10.1016/S0966-6362(01)00130-8
   Dite W, 2002, ARCH PHYS MED REHAB, V83, P1566, DOI 10.1053/apmr.2002.35469
   DUNCAN PW, 1992, J GERONTOL, V47, pM93, DOI 10.1093/geronj/47.3.M93
   Fernandes A, 2015, MED ENG PHYS, V37, P1070, DOI 10.1016/j.medengphy.2015.08.011
   Fernandes A, 2015, SOMATOSENS MOT RES, V32, P122, DOI 10.3109/08990220.2014.1002605
   Foreman MD, 1996, GERIATR NURS, V17, P228, DOI 10.1016/S0197-4572(96)80210-2
   Fraizer EV, 2008, GAIT POSTURE, V27, P271, DOI 10.1016/j.gaitpost.2007.04.002
   Hauer K, 2010, GERONTOLOGY, V56, P190, DOI 10.1159/000236027
   Huang H J, 2001, Pediatr Phys Ther, V13, P133, DOI 10.1097/00001577-200110000-00005
   Kandel E. R., 2000, PRINCIPLES NEURAL SC
   Laessoe U, 2008, HUM MOVEMENT SCI, V27, P496, DOI 10.1016/j.humov.2007.12.001
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LundinOlsson L, 1997, LANCET, V349, P617, DOI 10.1016/S0140-6736(97)24009-2
   McIsaac TL, 2015, BIOMED RES INT, DOI 10.1155/2015/591475
   Melzer I, 2001, GERONTOLOGY, V47, P189, DOI 10.1159/000052797
   Menant JC, 2014, AGEING RES REV, V16, P83, DOI 10.1016/j.arr.2014.06.001
   Mulder T, 2002, GAIT POSTURE, V16, P198, DOI 10.1016/S0966-6362(01)00157-6
   Panel on Prevention of Falls in Older Persons American Geriatrics Society and British Geriatrics Society, 2010, JAMGERIATRSOC, V59, P148
   PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x
   Pollock AS, 2000, CLIN REHABIL, V14, P402, DOI 10.1191/0269215500cr342oa
   Prince F, 1997, GAIT POSTURE, V5, P128, DOI 10.1016/S0966-6362(97)01118-1
   Schmidt R. A, 2005, MOTOR CONTROL LEARNI
   Shumway-Cook A, 2001, MOTOR CONTROL THEORY
   Sousa ASP, 2012, SOMATOSENS MOT RES, V29, P131, DOI 10.3109/08990220.2012.725680
   Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4
NR 26
TC 1
Z9 1
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 3
PY 2016
VL 11
IS 8
AR e0157421
DI 10.1371/journal.pone.0157421
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT3GA
UT WOS:000381367800003
PM 27487000
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wahl, J
   Barleon, L
   Morfeld, P
   Lichtmess, A
   Haas-Brahler, S
   Pfeiffer, N
AF Wahl, Jochen
   Barleon, Lorenz
   Morfeld, Peter
   Lichtmess, Andrea
   Haas-Braehler, Sibylle
   Pfeiffer, Norbert
TI The Evonik-Mainz Eye Care-Study (EMECS): Development of an Expert System
   for Glaucoma Risk Detection in a Working Population
SO PLOS ONE
LA English
DT Article
ID OPEN-ANGLE GLAUCOMA; BEAVER-DAM EYE; INTRAOCULAR-PRESSURE; OPTIC DISC;
   PREVALENCE; DEFINITIONS; SENSITIVITY; REVIEWS; NUMBER; HEALTH
AB Purpose
   To develop an expert system for glaucoma screening in a working population based on a human expert procedure using images of optic nerve head (ONH), visual field (frequency doubling technology, FDT) and intraocular pressure (IOP).
   Methods
   4167 of 13037 (32%) employees between 40 and 65 years of Evonik Industries were screened. An experienced glaucoma expert (JW) assessed papilla parameters and evaluated all individual screening results. His classification into "no glaucoma", "possible glaucoma" and "probable glaucoma" was defined as "gold standard". A screening model was developed which was tested versus the gold-standard. This model took into account the assessment of the ONH. Values and relationships of CDR and IOP and the FDT were considered additionally and a glaucoma score was generated. The structure of the screening model was specified a priori whereas values of the parameters were chosen post-hoc to optimize sensitivity and specificity of the algorithm. Simple screening models based on IOP and / or FDT were investigated for comparison.
   Results
   111 persons (2.66%) were classified as glaucoma suspects, thereof 13 (0.31%) as probable and 98 (2.35%) as possible glaucoma suspects by the expert. Re-evaluation by the screening model revealed a sensitivity of 83.8% and a specificity of 99.6% for all glaucoma suspects. The positive predictive value of the model was 80.2%, the negative predictive value 99.6%. Simple screening models showed insufficient diagnostic accuracy.
   Conclusion
   Adjustment of ONH and symmetry parameters with respect to excavation and IOP in an expert system produced sufficiently satisfying diagnostic accuracy. This screening model seems to be applicable in such a working population with relatively low age and low glaucoma prevalence. Different experts should validate the model in different populations.
C1 [Wahl, Jochen] Helios Dr Horst Schmidt Kliniken, Dept Ophthalmol, Wiesbaden, Germany.
   [Wahl, Jochen; Barleon, Lorenz; Pfeiffer, Norbert] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Mainz, Germany.
   [Barleon, Lorenz] Diakonissen Hosp, Dept Ophthalmol, Karlsruhe, Germany.
   [Morfeld, Peter] Univ Cologne, Inst Occupat Med, Cologne, Germany.
   [Morfeld, Peter] Inst Occupat Epidemiol & Risk Assessment Evonik I, Essen, Germany.
   [Lichtmess, Andrea] Bundeswehrzent Krankenhaus Koblenz, Abt Anasthesie Intens Med Notfallmed Schmertz 10, Koblenz, Germany.
   [Haas-Braehler, Sibylle] Evon Ind, Occupat Hlth, Hanau, Germany.
RP Wahl, J (reprint author), Helios Dr Horst Schmidt Kliniken, Dept Ophthalmol, Wiesbaden, Germany.; Wahl, J (reprint author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Mainz, Germany.
EM jochenwahl@freenet.de
FU Evonik Industries
FX Evonik Industries provided an unrestricted grant for this study. Evonik
   Industries provided some of the equipment, qualified personnel,
   transportation and accommodation. The funder provided support in the
   form of salaries for authors [PM, SH], but did not have any additional
   role in the study design, data collection and analysis, decision to
   publish, or preparation of the manuscript. The specific roles of these
   authors are articulated in the 'author contributions' section. This does
   not alter the authors' adherence to PLOS ONE policies on sharing data
   and materials.; The authors wish to thank the workers of Evonik
   Industries who attended the study. This investigation was sponsored by a
   grant from Evonik Industries.
CR ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552
   ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102
   Alward WL, 1998, AM J OPHTHALMOL, V126, P498
   Anton A, 2004, J GLAUCOMA, V13, P371
   Barleon L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098538
   Bishop YM, 2007, DISCRETE MULTIVARIAT
   Bonomi L, 1998, OPHTHALMOLOGY, V105, P209, DOI 10.1016/S0161-6420(98)92665-3
   Brown LD, 2001, STAT SCI, V16, P101
   Burr J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11410
   Cedrone C, 1997, Ophthalmic Epidemiol, V4, P59
   Checkoway H, 2004, OCCUP ENVIRON MED, V61, P953, DOI 10.1136/oem.2004.014886
   Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157
   Ervin A-M, 2012, AHRQ PUBLICATION
   European Glaucoma Society, 2014, CLASS TERM TERM GUID, P93
   Foster Paul J, 2002, Semin Ophthalmol, V17, P50
   Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238
   Foster PJ, 2001, BRIT J OPHTHALMOL, V85, P1277, DOI 10.1136/bjo.85.11.1277
   Garway-Heath DF, 1998, BRIT J OPHTHALMOL, V82, P1118, DOI 10.1136/bjo.82.10.1118
   GIUFFRE G, 1995, ACTA OPHTHALMOL SCAN, V73, P222
   Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714
   Hatt SR, 2009, COCHRANE LIB
   Hitzil W, 2006, KLIN MONATSBL AUGENH, V223, P970, DOI 10.1055/s-2006-927102
   Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029
   KAHN HA, 1980, ARCH OPHTHALMOL-CHIC, V98, P2172, DOI 10.1001/archopht.1980.01020041024003
   KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499
   KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LESKE MC, 1994, ARCH OPHTHALMOL-CHIC, V112, P821, DOI 10.1001/archopht.1994.01090180121046
   Lopes FSS, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-72
   McGinn T, 2004, CAN MED ASSOC J, V171, P1369, DOI 10.1503/cmaj.1031981
   Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1
   Mowatt G, 2008, INVEST OPHTH VIS SCI, V49, P5373, DOI 10.1167/iovs.07-1501
   Nuovo J, 2002, JAMA-J AM MED ASSOC, V287, P2813, DOI 10.1001/jama.287.21.2813
   Pfeiffer N, 2002, J GLAUCOMA, V11, P458, DOI 10.1097/01.IJG.000030432.23569.7A
   QUIGLEY HA, 1982, ANN OPHTHALMOL, V14, P611
   Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224
   Rothman KJ, 2008, MODERN EPIDEMIOLOGY
   Saito H, 2009, OPHTHALMOLOGY, V116, P1854, DOI 10.1016/j.ophtha.2009.03.048
   Sakata K, 2007, INVEST OPHTH VIS SCI, V48, P4974, DOI 10.1167/iovs.07-0342
   Steenland K, 2004, AM J EPIDEMIOL, V160, P384, DOI 10.1093/aje/kwh211
   Susanna R, 2007, CURR OPIN OPHTHALMOL, V18, P122, DOI 10.1097/ICU.0b013e328040bfe0
   Thompson ML, 1998, OCCUP ENVIRON MED, V55, P272, DOI 10.1136/oem.55.4.272
   TIELSCH JM, 1991, AM J EPIDEMIOL, V134, P1102, DOI 10.1093/oxfordjournals.aje.a116013
   Tuck M W, 1998, Ophthalmic Epidemiol, V5, P173, DOI 10.1076/opep.5.4.173.4192
   Wensor MD, 1998, OPHTHALMOLOGY, V105, P733, DOI 10.1016/S0161-6420(98)94031-3
   Wolfs RCW, 2000, INVEST OPHTH VIS SCI, V41, P3309
   Zwinderman AH, 2008, STAT MED, V27, P687, DOI 10.1002/sim.2992
NR 47
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 1
PY 2016
VL 11
IS 8
AR e0158824
DI 10.1371/journal.pone.0158824
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DS9NO
UT WOS:000381110300007
PM 27479301
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Leclair, T
   Carret, AS
   Samson, Y
   Sultan, S
AF Leclair, Tatsiana
   Carret, Anne-Sophie
   Samson, Yvan
   Sultan, Serge
TI Stability and Repeatability of the Distress Thermometer (DT) and the
   Edmonton Symptom Assessment System-Revised (ESAS-r) with Parents of
   Childhood Cancer Survivors
SO PLOS ONE
LA English
DT Article
ID PATIENT HEALTH QUESTIONNAIRE; GENERALIZED ANXIETY DISORDER; PSYCHOMETRIC
   PROPERTIES; VALIDATION; LIFE; VALIDITY; RELIABILITY; CHILDREN;
   PERSONALITY; DEPRESSION
AB Objective
   Parents report psychological distress in association with their child's cancer. Reliable tools are needed to screen parental distress over the cancer trajectory. This study aimed to estimate the stability and repeatability of the Distress Thermometer (DT) and the Depression and Anxiety items of the Edmonton Symptom Assessment System-revised (ESAS-r-D; -A) in parents of children diagnosed with cancer.
   Methods
   Fifty parents (28 mothers, median age = 44) of clinically stable survivors of childhood solid and brain tumours completed questionnaires about their own distress (DT, ESAS-r-D; -A, Brief Symptom Inventory-18: BSI-18, Patient Health Questionnaire-9: PHQ-9, Generalized Anxiety Disorder-7: GAD-7) and their children's quality of life (QoL; Peds Quality of Life: PedsQL) twice, with a month interval between the two assessments. At retest, parents also evaluated life events that occurred between the two time points. Hierarchical regressions explored moderators for the temporal stability of test measures.
   Results
   Stability estimates were ICC = .78 for the DT,.55 for the ESAS-r-D, and.47 for the ESAS-rA. Caseness agreement between test and retest was substantial for the DT, fair for the ESAS-r-D, and slight for the ESAS-r-A. Repeatability analyses indicated that the error range for the DT was more than 2 pts below/above actual measurement, whereas it was more than 3 pts for the ESAS-r-A, and 2.5 for the ESAS-r-D. Instability of the DT could be explained by changes in children's physical QoL, but not by other components of QoL or life events. No moderators of stability could be identified for the ESAS-r items.
   Conclusions
   The DT appears to be a fairly stable measure when the respondent's condition is stable yet with a relatively wide error range. Fluctuations in distress-related constructs may affect the temporal stability of the DT. The lower stability of ESAS-r items may result from shorter time-lapse instructions resulting in a greater sensitivity to change. Findings support future research on the DT as a reliable instrument in caregivers.
C1 [Leclair, Tatsiana; Carret, Anne-Sophie; Samson, Yvan; Sultan, Serge] Ctr Hosp Univ CHU St Justine, Dept Hematol Oncol, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.
   [Leclair, Tatsiana; Sultan, Serge] Univ Montreal, Dept Psychol, Pavillon Marie Victorin,90,Ave Vincent dIndy, Montreal, PQ H2V 2S9, Canada.
RP Sultan, S (reprint author), Ctr Hosp Univ CHU St Justine, Dept Hematol Oncol, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.; Sultan, S (reprint author), Univ Montreal, Dept Psychol, Pavillon Marie Victorin,90,Ave Vincent dIndy, Montreal, PQ H2V 2S9, Canada.
EM serge.sultan@umontreal.ca
FU CHU Sainte-Justine Foundation
FX This work was funded by the CHU Sainte-Justine Foundation,
   http://www.fondationsaintejustine.org/en/. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Andreu Y, 2008, PSICOTHEMA, V20, P844
   Bevans M, 2011, PSYCHO-ONCOLOGY, V20, P615, DOI 10.1002/pon.1906
   Blais MC, 2014, PALLIAT SUPPORT CARE, V12, P25, DOI 10.1017/S1478951513000059
   Bleich C, 2016, PSYCHOONCOLOGY
   Bruera E, 1991, J Palliat Care, V7, P6
   Canadian Cancer Society, 2016, LAT EFF CHILDH CANC
   Carvajal A, 2011, EUR J CANCER, V47, P1863, DOI 10.1016/j.ejca.2011.03.027
   Chang VT, 2000, CANCER, V88, P2164, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5
   Cicchetti D., 1994, PSYCHOL ASSESSMENTS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]
   Cohen J., 1988, STATISTICAL POWER AN
   Derogatis LR, 2000, BRIEF SYMPTOM INVENT
   Dong YX, 2015, J PAIN SYMPTOM MANAG, V50, P712, DOI 10.1016/j.jpainsymman.2015.05.018
   Haverman L, 2013, J PEDIATR-US, V163, P1140, DOI 10.1016/j.jpeds.2013.06.011
   Henderson TO, 2012, INT J RADIAT ONCOL, V84, P224, DOI 10.1016/j.ijrobp.2011.11.022
   Hoven EI, 2013, PSYCHO-ONCOLOGY, V22, P160, DOI 10.1002/pon.2067
   Kazak AE, 2012, PEDIATR BLOOD CANCER, V59, P822, DOI 10.1002/pbc.24166
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Kwon JH, 2013, J PAIN SYMPTOM MANAG, V46, P947, DOI 10.1016/j.jpainsymman.2013.01.012
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Ljungman L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103340
   Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093
   Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003
   McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026
   Mejdahl MK, 2015, J NATL COMPR CANC NE, V13, P995, DOI 10.6004/jnccn.2015.0120
   Ministere de la sante et des services sociaux du Quebec, 2011, RAPP COM ONC PSYCH
   Mitchell AJ, 2012, J AFFECT DISORDERS, V140, P149, DOI 10.1016/j.jad.2011.12.043
   National Comprehensive Cancer Network, 2015, DISTR MAN VERS 3 201
   Norberg AL, 2007, J PSYCHOSOC ONCOL, V25, P113, DOI 10.1300/J077v25n03_07
   Paiva CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132073
   Patel SK, 2011, PSYCHO-ONCOLOGY, V20, P1324, DOI 10.1002/pon.1859
   Pautex S, 2003, CRIT REV ONCOL HEMAT, V47, P281, DOI 10.1016/S1040-8428(03)00043-X
   Rodriguez EM, 2012, J PEDIATR PSYCHOL, V37, P185, DOI 10.1093/jpepsy/jsr054
   Sanders J, 1997, PEDIATRICS, V99, P139
   SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932
   Spitzer RL, 2000, AM J OBSTET GYNECOL, V183, P759, DOI 10.1067/mob.2000.106580
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Sultan S, 2016, EUR J CANCER CARE, V25, P616, DOI 10.1111/ecc.12361
   Tang LL, 2011, CHINESE J CANCER RES, V23, P54, DOI 10.1007/s11670-011-0054-y
   Thorndike RM, 2010, MEASUREMENT EVALUATI, P136
   Vaidya JG, 2002, J PERS SOC PSYCHOL, V83, P1469, DOI 10.1037//0022-3514.83.6.1469
   Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003
   Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10427
   Warner CM, 2011, J PEDIATR ONCOL NURS, V28, P224, DOI 10.1177/1043454211408105
   Watanabe SM, 2011, J PAIN SYMPTOM MANAG, V41, P456, DOI 10.1016/j.jpainsymman.2010.04.020
   Watson D, 2004, J RES PERS, V38, P319, DOI 10.1016/j.jrp.2004.03.001
   Watson D, 2003, J ABNORM PSYCHOL, V112, P298, DOI 10.1037/0021-843X.112.2.298
   Witt WP, 2010, QUAL LIFE RES, V19, P995, DOI 10.1007/s11136-010-9666-9
   Yokomichi N, 2015, J PAIN SYMPTOM MANAG, V50, P718, DOI 10.1016/j.jpainsymman.2015.05.014
   Zwahlen D, 2011, PSYCHO-ONCOLOGY, V20, P394, DOI 10.1002/pon.1744
NR 49
TC 7
Z9 7
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 25
PY 2016
VL 11
IS 7
AR e0159773
DI 10.1371/journal.pone.0159773
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT5ID
UT WOS:000381515200043
PM 27454432
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Plaete, J
   De Bourdeaudhuij, I
   Crombez, G
   Steenhuyzen, S
   Dejaegere, L
   Vanhauwaert, E
   Verloigne, M
AF Plaete, Jolien
   De Bourdeaudhuij, Ilse
   Crombez, Geert
   Steenhuyzen, Saidja
   Dejaegere, Liesbet
   Vanhauwaert, Erika
   Verloigne, Maite
TI The Reliability and Validity of Short Online Questionnaires to Measure
   Fruit and Vegetable Intake in Adults: The Fruit Test and Vegetable Test
SO PLOS ONE
LA English
DT Article
ID TAILORED PHYSICAL-ACTIVITY; FOOD-FREQUENCY QUESTIONNAIRES; ACTIVITY
   INTERVENTION; RELATIVE VALIDITY; INSTRUMENTS; VALIDATION; CONSUMPTION;
   AGREEMENT; REPRODUCIBILITY; ACCEPTABILITY
AB The first aim of this study was to investigate the stability of the Fruit Test and Vegetable Test over time and whether the Fruit Test and Vegetable Test are capable of measuring fruit and vegetable intake with consistency. Second, the study aimed to examine criterion (concurrent) validity of the Fruit Test and Vegetable Test by testing their agreement with 7-day food diary-derived measures of fruit and vegetable intake. In total 58 adults (31% male, mean age = 30.0 +/- 12.09y) completed the Flemish Fruit and Vegetable test by indicating the frequency of days that they ate fruit and vegetables and the number of portions during the past week. Validity was tested by using a 7-day food diary as a golden standard. Adults were asked to register their fruit and vegetable intake daily in a diary during one week. Spearman correlations were measured to compare total intake reported in the Fruit and Vegetable Test and in the 7-day diary. Agreement plots were used to illustrate absolute agreement. Test-retest reliability was evaluated by having participants completing the Fruit Test and Vegetable Test twice. The Fruit Test (ICC = 0.81) and Vegetable Test (ICC = 0.78) showed excellent and substantial reliability. The Fruit Test (rho = 0.73) and Vegetable Test showed good validity. Agreement plots showed modest variability in differences between vegetable and fruit intake as measured by the Vegetable and Fruit Test and the 7-day food diary. Also a small underestimation of fruit intake in the Fruit test and vegetable intake in the Vegetable test against the 7-day food diary was shown. Based on the results, it is suggested to include portion size pictures and consumption of mixed vegetables to prevent underestimation. To prevent overestimation, it is concluded to add a moderate number of representative fruit and vegetable items, questions on portion size, household sizes with sufficient detail and food items highly tailored to the dietary behaviors and local food items of the population surveyed. The questionnaires can easily be adapted for the use in other diets (e.g. Asian diet), but reliability and validity should then be examined again. Also, validity remains to be tested in other population groups (i.e. low socio economic status groups, other age groups).
C1 [Plaete, Jolien; De Bourdeaudhuij, Ilse; Verloigne, Maite] Univ Ghent, Dept Movement & Sports Sci, Ghent, Belgium.
   [Crombez, Geert] Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium.
   [Steenhuyzen, Saidja; Dejaegere, Liesbet] Flemish Inst Hlth Promot & Dis Prevent VIGeZ, Brussels, Belgium.
   [Vanhauwaert, Erika] Univ Coll Leuven Limburg, Knowledge & Innovat Ctr FOOD, Leuven, Belgium.
RP Plaete, J (reprint author), Univ Ghent, Dept Movement & Sports Sci, Ghent, Belgium.
EM Jolien.Plaete@UGent.be
FU Ministry of the Flemish Community, Department of Welfare, Public Health
   and Family; Research Foundation Flanders (FWO) [FWO13/PDO/191]
FX The study was commissioned, financed and steered by the Ministry of the
   Flemish Community, Department of Welfare, Public Health and Family.
   Maite Verloigne is supported by the Research Foundation Flanders (FWO)
   (postdoctoral research fellowship: FWO13/PDO/191).
CR Albar SA, 2016, BRIT J NUTR, V115, P1678, DOI 10.1017/S0007114516000593
   Alcantara I, 2015, PUBLIC HEALTH NUTR, V18, P1932, DOI 10.1017/S1368980014002547
   Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204
   BLAND JM, 1986, LANCET, V1, P307
   Bogers RP, 2004, AM J EPIDEMIOL, V159, P900, DOI 10.1093/aje/kwh123
   Broekhuizen K, 2012, ANN BEHAV MED, V44, P259, DOI 10.1007/s12160-012-9384-3
   Brouwer W, 2009, HEALTH EDUC, V109, P460, DOI 10.1108/09654280911001149
   Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318
   Cade JE, 2004, NUTR RES REV, V17, P5, DOI 10.1079/NRR200370
   Cerin E, 2016, MED SCI SPORT EXER, V48, P1075, DOI 10.1249/MSS.0000000000000870
   Cohen J, 1988, STAT POWER ANAL BEHA
   De Keyzer W, 2011, FOOD NUTR RES, V2011, P55, DOI DOI 10.3402/FNR.V55I0.7307
   Drieskens S, 2014, GEZONDHEIDSENQUETE 2
   EUFIC, 2012, FRUIT VEG CONS EUR D
   Gezondheidsraad Hoge [Belgian Superior Health council], 2009, VOED BELG
   GLOVER JA, 1989, J EDUC PSYCHOL, V81, P392, DOI 10.1037/0022-0663.81.3.392
   Greene GW, 2008, J NUTR, V138, p200S
   Haerens L, 2007, PATIENT EDUC COUNS, V66, P303, DOI 10.1016/j.pec.2007.01.003
   Johnson B, 2001, J HUM NUTR DIET, V14, P457, DOI 10.1046/j.1365-277X.2001.00320.x
   Kim DJ, 2003, PREV MED, V36, P440, DOI 10.1016/S0091-7435(02)00040-3
   Kristjansdottir AG, 2006, EUR J CLIN NUTR, V60, P408, DOI 10.1038/sj.ejcn.1602332
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Laviolle B, 2005, EUR J CARDIOV PREV R, V12, P587, DOI 10.1097/00149831-200512000-00012
   Lean MEJ, 2003, EUR J CLIN NUTR, V57, P667, DOI 10.1038/sj.ejcn.1601596
   Mainvil LA, 2011, APPETITE, V56, P111, DOI 10.1016/j.appet.2010.09.008
   Mayne ST, 2003, J NUTR, V133, p933S, DOI 10.1093/jn/133.3.933S
   Natarajan L, 2006, AM J EPIDEMIOL, V163, P770, DOI 10.1093/aje/kwj082
   NUBEL vzw, 2004, BELG VOED
   Plaete J, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.4835
   Portney L., 2009, FDN CLIN RES
   Rangan AM, 2016, BRIT J NUTR, V115, P2219, DOI 10.1017/S0007114516001525
   Resnicow K, 2000, AM J EPIDEMIOL, V152, P1072, DOI 10.1093/aje/152.11.1072
   Thompson FE, 2004, PUBLIC HEALTH NUTR, V7, P1097, DOI 10.1079/PHN2004642
   Van Holle V, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1785-3
   Vandelanotte C, 2003, HEALTH EDUC RES, V18, P304, DOI 10.1093/her/cyf027
   Vandelanotte C, 2005, J PHYS ACT HEALTH, V2, P63, DOI DOI 10.1123/JPAH.2.1.63
   Vandevijvere S, 2009, PUBLIC HEALTH NUTR, V12, P423, DOI 10.1017/S1368980008002164
   Vanhauwaert E, 2012, ACTIEVE VOEDINGSDRIE
   VIGeZ, 2016, VOED PRAKT VOED
   World Health Organization and Food and Agriculture Organization, 2003, DIET NUTR PREV CHRON
   Yaroch AL, 2012, J ACAD NUTR DIET, V112, P1570, DOI 10.1016/j.jand.2012.06.002
NR 41
TC 4
Z9 4
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 21
PY 2016
VL 11
IS 7
AR e0159834
DI 10.1371/journal.pone.0159834
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DS5CG
UT WOS:000380797500144
PM 27441632
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Morfeld, KA
   Meehan, CL
   Hogan, JN
   Brown, JL
AF Morfeld, Kari A.
   Meehan, Cheryl L.
   Hogan, Jennifer N.
   Brown, Janine L.
TI Assessment of Body Condition in African (Loxodonta africana) and Asian
   (Elephas maximus) Elephants in North American Zoos and Management
   Practices Associated with High Body Condition Scores
SO PLOS ONE
LA English
DT Article
ID RISK-FACTORS; VETERINARY PRACTICES; PLASMA LEPTIN; DAIRY-COW; OBESITY;
   POPULATION; FAT; PREVALENCE; WEIGHT; HORSES
AB Obesity has a negative effect on health and welfare of many species, and has been speculated to be a problem for zoo elephants. To address this concern, we assessed the body condition of 240 elephants housed in North American zoos based on a set of standardized photographs using a 5-point Body Condition Score index (1 = thinnest; 5 = fattest). A multivariable regression analysis was then used to determine how demographic, management, housing, and social factors were associated with an elevated body condition score in 132 African (Loxodonta africana) and 108 Asian (Elephas maximus) elephants. The highest BCS of 5, suggestive of obesity, was observed in 34% of zoo elephants. In both species, the majority of elephants had elevated BCS, with 74% in the BCS 4 (40%) and 5 (34%) categories. Only 22% of elephants had BCS 3, and less than 5% of the population was assigned the lowest BCS categories (BCS 1 and 2). The strongest multi-variable model demonstrated that staff-directed walking exercise of 14 hours or more per week and highly unpredictable feeding schedules were associated with decreased risk of BCS 4 or 5, while increased diversity in feeding methods and being female was associated with increased risk of BCS 4 or 5. Our data suggest that high body condition is prevalent among North American zoo elephants, and management strategies that help prevent and mitigate obesity may lead to improvements in welfare of zoo elephants.
C1 [Morfeld, Kari A.] Lincoln Childrens Zoo, Lincoln, NE USA.
   [Morfeld, Kari A.; Brown, Janine L.] Smithsonian Natl Zool Pk, Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA.
   [Meehan, Cheryl L.; Hogan, Jennifer N.] AWARE Inst, Portland, OR USA.
RP Morfeld, KA (reprint author), Lincoln Childrens Zoo, Lincoln, NE USA.; Morfeld, KA (reprint author), Smithsonian Natl Zool Pk, Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA.
EM karimorfeld@yahoo.com
FU Institute of Museum and Library Services [LG-25-10-0033-10]; Smithsonian
   National Zoological Park; Lincoln Children's Zoo; IMLS; AWARE Institute
FX Funding for this work was provided by a National Leadership Grant to the
   Honolulu Zoological Society from the Institute of Museum and Library
   Services (www.imls.gov) grant number: LG-25-10-0033-10. Employers
   provided financial support in the form of authors' salaries as follows:
   Smithsonian National Zoological Park (JLB, KM); Lincoln Children's Zoo
   (KM). After the IMLS-funded period of performance (November 2010 -
   December 2013) AWARE Institute provided support in the form of salaries
   for author CM and JH. The specific roles of these authors are
   articulated in the 'author contributions' section. Neither the funders
   nor authors' employers had any role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.; In
   addition, special thanks go to the AZA Elephant TAG and TAG Chair Martha
   Fischer for logistical support, Jackie Ogden for communications support,
   and Vistalogic, Inc. for technological support and software services.
   Thanks to the Lincoln Children's Zoo for dedicated laboratory space and
   support, and the Smithsonian National Zoological Park's Veterinary
   Pathology Laboratory for the triglyceride analyses.
CR Ange K, 2001, P NUTR ADV GROUP C, V4, P5
   Brown JL, 2000, ZOO BIOL, V19, P347, DOI 10.1002/1098-2361(2000)19:5<347::AID-ZOO6>3.0.CO;2-V
   Brown JL, 2004, GEN COMP ENDOCR, V136, P360, DOI 10.1016/j.ygcen.2004.01.013
   Burkholder WJ, 2000, J AM VET MED ASSOC, V217, P650, DOI 10.2460/javma.2000.217.650
   Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915
   Christie JL, 2006, CAN VET J, V47, P136
   Clubb R, 2009, ANIM WELFARE, V18, P237
   Clubb R, 2002, REV WELFARE ZOO ELEP
   Clubb R, 2008, SCIENCE, V322, P1649, DOI 10.1126/science.1164298
   COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256
   Cohen J., 2003, APPL MULTIPLE REGRES
   Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374
   Cook RC, 2001, J WILDLIFE MANAGE, V65, P973, DOI 10.2307/3803046
   DiPietro L, 1999, MED SCI SPORT EXER, V31, pS542, DOI 10.1097/00005768-199911001-00009
   EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0
   EDNEY ATB, 1986, VET REC, V118, P391, DOI 10.1136/vr.118.14.391
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723
   Foreman J, 1998, EQUINE INTERNAL MED, P135
   Frazier-Wood Alexis C, 2015, Curr Nutr Rep, V4, P82
   Gallagher AJ, 2014, CONS PHYS, P1
   Ganswindt A, 2010, HORM BEHAV, V57, P506, DOI 10.1016/j.yhbeh.2010.02.009
   Garaulet M, 2013, INT J OBESITY, V37, P604, DOI 10.1038/ijo.2012.229
   Garaulet M, 2014, PHYSIOL BEHAV, V134, P44, DOI 10.1016/j.physbeh.2014.01.001
   German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S
   Giles SL, 2014, PEERJ, V2, DOI 10.7717/peerj.299
   Greco BJ, 2016, PLOS ONE
   Gustine DD, 2010, RANGIFER, V27, P249
   GWINUP G, 1963, AM J CLIN NUTR, V13, P209, DOI 10.1093/ajcn/13.4.209
   Hajian-Tilaki KO, 2007, OBES REV, V8, P3, DOI 10.1111/j.1467-789X.2006.00235.x
   Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215
   Hardin JW, 2013, GEN ESTIMATING EQUAT
   Hatt J. -M., 2006, International Zoo Yearbook, V40, P88, DOI 10.1111/j.1748-1090.2006.00088.x
   Hawn R, 2005, VET TECH, V26, P51
   Hebebrand J, 2009, CHILD ADOL PSYCH CL, V18, P83, DOI 10.1016/j.chc.2008.07.006
   HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x
   Holdgate MR, 2016, PLOS ONE
   Holland JL, 1996, J ANIM SCI, V74, P1252
   Hong Hye-Ryun, 2014, J Exerc Nutrition Biochem, V18, P277, DOI 10.5717/jenb.2014.18.3.277
   Hu FB, 2003, LIPIDS, V38, P103, DOI 10.1007/s11745-003-1038-4
   Garcia AI, 2015, ENDOCRINOL NUTR, V62, P130, DOI 10.1016/j.endonu.2014.11.007
   Ishoika K, 2002, J VET MED SCI, V64, P39
   Jakicic JM, 2002, J NUTR, V132, p3826S
   Jenkins DJA, 1989, NEW ENGL J MED, V321, P919
   Kopelman PG, 2000, NATURE, V404, P635
   Laflamme D, 1997, CANINE PRACT, V22, P10
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lassen J, 2003, J DAIRY SCI, V86, P4123, DOI 10.3168/jds.S0022-0302(03)74026-0
   Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291
   Li G, 2012, VET MED-RES REP, V3, P71, DOI 10.2147/VMRR.S34665
   LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267
   MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155
   Mason GJ, 2010, ZOO BIOL, V29, P256, DOI [10.1002/zoo.20303, 10.1002/zoo.20256]
   Mazrier H, 2006, CAN VET J, V47, P883
   McGreevy PD, 2005, VET REC, V156, P695, DOI 10.1136/vr.156.22.695
   Meehan CL, 2016, PLOS ONE
   Mellish JAE, 2004, J ZOO WILDLIFE MED, V35, P116, DOI 10.1638/03-028
   Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223
   Morfeld KA, 2016, REPROD FERT DEVELOP, V28, P640, DOI 10.1071/RD14140
   Morfeld KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093802
   Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732
   OTTO KL, 1991, J DAIRY SCI, V74, P852, DOI 10.3168/jds.S0022-0302(91)78234-9
   Ozminkowski RJ, 2002, J OCCUP ENVIRON MED, V44, P21, DOI 10.1097/00043764-200201000-00005
   Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x
   Pena C, 2014, J VET MED SCI, V76, P1305, DOI 10.1292/jvms.13-0475
   Phythian CJ, 2012, VET J, V193, P257, DOI 10.1016/j.tvjl.2011.12.006
   POOLE JH, 1989, ANIM BEHAV, V37, P140, DOI 10.1016/0003-3472(89)90014-6
   Prado-Oviedo NA, 2016, PLOS ONE
   Robinson DS, 1970, COMPR BIOCHEM, V18, P51
   Rooney D, 1998, EQUINE INTERNAL MED, P216
   Rothwell ES, 2011, ZOO BIOL, V30, P579, DOI 10.1002/zoo.20364
   Sagawa MM, 2002, AM J VET RES, V63, P7, DOI 10.2460/AJVR.2002.63.7
   Sargison ND, 2010, SMALL RUMINANT RES, V92, P2, DOI 10.1016/j.smallrumres.2010.04.019
   Schroder UJ, 2006, J DAIRY SCI, V89, P1, DOI 10.3168/jds.S0022-0302(06)72064-1
   Stene LC, 2001, BRIT MED J, V322, P889, DOI 10.1136/bmj.322.7291.889
   Stephenson TR, 1998, CAN J ZOOL, V76, P717, DOI 10.1139/cjz-76-4-717
   Suagee JK, 2013, J VET INTERN MED, V27, P157, DOI 10.1111/jvim.12021
   Taylor VJ, 1998, ZOO BIOL, V17, P311, DOI 10.1002/(SICI)1098-2361(1998)17:4<311::AID-ZOO5>3.0.CO;2-C
   Thompson PD, 2013, PLOS ONE, V8
   Wadha PS, 1986, AM J CLIN NUTR, V5, P551
   WAGNER JJ, 1988, J ANIM SCI, V66, P603
   Warren BS, 2011, BRIT J NUTR, V106, pS85, DOI 10.1017/S0007114511001814
   Wemmer C, 2006, ZOO BIOL, V25, P187, DOI 10.1002/zoo.20099
   WILDMAN EE, 1982, J DAIRY SCI, V65, P495, DOI 10.3168/jds.S0022-0302(82)82223-6
   Wyse CA, 2008, VET REC, V162, P590, DOI 10.1136/vr.162.18.590
   Yamka R. M., 2006, International Journal of Applied Research in Veterinary Medicine, V4, P282
   YOUNG CM, 1972, J AM DIET ASSOC, V61, P391
   ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0
NR 87
TC 25
Z9 25
U1 1
U2 38
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 14
PY 2016
VL 11
IS 7
AR e0155146
DI 10.1371/journal.pone.0155146
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DR0DZ
UT WOS:000379579500009
PM 27415629
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU von Websky, MW
   Kitamura, K
   Ludwig-Portugall, I
   Kurts, C
   von Laffert, M
   LeMaoult, J
   Carosella, ED
   Abu-Elmagd, K
   Kalff, JC
   Schafer, N
AF von Websky, Martin W.
   Kitamura, Koji
   Ludwig-Portugall, Isis
   Kurts, Christian
   von Laffert, Maximilian
   LeMaoult, Joel
   Carosella, Edgardo D.
   Abu-Elmagd, Kareem
   Kalff, Joerg C.
   Schaefer, Nico
TI Recombinant HLA-G as Tolerogenic Immunomodulant in Experimental Small
   Bowel Transplantation
SO PLOS ONE
LA English
DT Article
ID INTESTINAL TRANSPLANTATION; T-CELL; ACUTE REJECTION; G EXPRESSION;
   INFLAMMATION; DYSFUNCTION; MUSCULARIS; ALLOGRAFTS; RECIPIENTS; APOPTOSIS
AB The non-classical MHC I paralogue HLA-G is expressed by cytotrophoblast cells and implicated with fetomaternal tolerance by downregulating the maternal adaptive and innate immune response against the fetus. HLA-G expression correlates with favorable graft outcome in humans and recently promising immunosuppressive effects of therapeutic HLA-G in experimental transplantation (skin allograft acceptance) were shown. Consequently, we examined this novel therapeutic approach in solid organ transplantation. In this study, therapeutic recombinant HLA-G5 was evaluated for the first time in a solid organ model of acute rejection (ACR) after orthotopic intestinal transplantation (ITX). Allogenic ITX was performed in rats (Brown Norway to Lewis) with and without HLA-G treatment. It was found that HLA-G treatment significantly reduced histologically proven ACR at both an early and late postoperative timepoint (POD 4/7), concomitant to a functionally preserved graft contractility at POD 7. Interestingly, graft infiltration by myeloperoxidase+ cells was significantly reduced at POD7 by HLA-G treatment. Moreover, HLA-G treatment showed an effect on the allogenic T-cell immune response as assessed by flow cytometry: The influx of recipient-derived CD8(+) T-cells into the graft mesenteric lymphnodes at POD7 was significantly reduced while CD4(+) populations were not affected. As a potential mechanism of action, an induction of T-reg populations in the mesenteric lymphnodes was postulated, but flow cytometric analysis of classical CD4(+)/CD25(+)/FoxP3(+)T(reg)-cells showed no significant alteration by HLA-G treatment. The novel therapeutic approach using recombinant HLA-G5 reported herein demonstrates a significant immunosuppressive effect in this model of allogenic experimental intestinal transplantation. This effect may be mediated via inhibition of recipient-derived CD8(+) T-cell populations either directly or by induction of non-classical T-reg populations.
C1 [von Websky, Martin W.; Kitamura, Koji; Kalff, Joerg C.; Schaefer, Nico] Univ Hosp Bonn, Dept Surg, Bonn, Germany.
   [Kitamura, Koji] Kyoto Univ Hosp, Dept Hepatobiliary Pancreat Surg & Transplantat, Kyoto, Japan.
   [Ludwig-Portugall, Isis; Kurts, Christian] Univ Bonn, Inst Expt Immunol, Bonn, Germany.
   [von Laffert, Maximilian] Charite, Inst Pathol, Berlin, Germany.
   [LeMaoult, Joel; Carosella, Edgardo D.] St Louis Hosp, CEA, iMETI, Res Div Hematol & Immunol, Paris, France.
   [Abu-Elmagd, Kareem] Cleveland Clin, Transplant Ctr, Cleveland, OH 44106 USA.
RP Schafer, N (reprint author), Univ Hosp Bonn, Dept Surg, Bonn, Germany.
EM nico.schaefer@ukb.uni-bonn.de
OI LeMaoult, Joel/0000-0002-4513-9482
FU Else-Kroner Fresenius Foundation
FX Martin W von Websky received a scholarship from the Else-Kroner
   Fresenius Foundation [http://www.ekfs.de/]. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abu-Elmagd K, 1998, J AM COLL SURGEONS, V186, P512, DOI 10.1016/S1072-7515(98)00083-0
   Abu-Elmagd KM, 2009, ANN SURG, V250, P567, DOI 10.1097/SLA.0b013e3181b67725
   Abu-Elmagd KM, 2009, TRANSPL INT, V22, P96, DOI 10.1111/j.1432-2277.2008.00785.x
   Briscoe DDM, 2002, NAT MED, V8, P220, DOI 10.1038/nm0302-220
   Brugiere O, 2009, AM J TRANSPLANT, V9, P1427, DOI 10.1111/j.1600-6143.2009.02650.x
   Carosella ED, 2011, BLOOD, V118, P6499, DOI 10.1182/blood-2011-07-370742
   Contini P, 2003, EUR J IMMUNOL, V33, P125, DOI 10.1002/immu.200390015
   Creput C, 2003, AM J TRANSPLANT, V3, P348, DOI 10.1034/j.1600-6143.2003.00050.x
   Favier B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021011
   Fuzzi B, 2002, EUR J IMMUNOL, V32, P311, DOI 10.1002/1521-4141(200202)32:2<311::AID-IMMU311>3.3.CO;2-#
   Grant D, INTESTINAL TRANSPLAN
   Horne PH, 2007, J IMMUNOL, V179, P80, DOI 10.4049/jimmunol.179.1.80
   Ito T, 2005, J INVEST DERMATOL, V125, P1139, DOI 10.1111/j.0022-202X.2005.23927.x
   Kalff JC, 1999, SURGERY, V126, P498, DOI 10.1016/S0039-6060(99)70091-7
   Kitamura K, 2012, JOVE J VIS EXP NOV, DOI [10.3791/4102, DOI 10.3791/4102]
   KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636
   Krams SM, 1998, J IMMUNOL, V160, P3673
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Le DM, 2003, HUM IMMUNOL, V64, P1039
   Le RS, 2006, J IMMUNOL, V176, P3266
   LeMaoult J, 2013, FASEB J, V27, P3643, DOI 10.1096/fj.13-228247
   Liang SY, 2002, EUR J IMMUNOL, V32, P2418, DOI 10.1002/1521-4141(200209)32:9<2418::AID-IMMU2418>3.0.CO;2-L
   Newell KA, 1997, TRANSPLANTATION, V64, P959, DOI 10.1097/00007890-199710150-00004
   Pech T, 2012, AM J TRANSPLANT, V12, pS9, DOI 10.1111/j.1600-6143.2012.04262.x
   Puppo Francesco, 2002, ScientificWorldJournal, V2, P421
   Riteau B, 1999, J REPROD IMMUNOL, V43, P203, DOI 10.1016/S0165-0378(99)00034-0
   RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520
   Schaefer N, 2007, AM J TRANSPLANT, V7, P1062, DOI 10.1111/j.1600-6143.2007.01747.x
   Schaefer N, 2008, TRANSPLANTATION, V85, P1465, DOI 10.1097/TP.0b013e31816fc189
   Shin CR, 2011, J PEDIATR SURG, V46, P1732, DOI 10.1016/j.jpedsurg.2011.04.016
   Starkey HDV, 2012, J MOL NEUROSCI, V48, P111, DOI 10.1007/s12031-012-9783-8
   Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x
   Tsuruyama T, 2012, TRANSPL INT, V25, P537, DOI 10.1111/j.1432-2277.2012.01450.x
   Turler A, 2002, TRANSPL P, V34, P921
   Wu T, 2003, TRANSPLANTATION, V75, P1241, DOI 10.1097/01.TP.0000062840.49159.2F
NR 35
TC 2
Z9 2
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 12
PY 2016
VL 11
IS 7
AR e0158907
DI 10.1371/journal.pone.0158907
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ9CO
UT WOS:000379508200020
PM 27404095
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kumar, N
   Malik, YS
   Kumar, S
   Sharma, K
   Sircar, S
   Saurabh, S
   Gulati, BR
   Singh, N
   Singh, AK
   Joshi, VG
   Banyai, K
   Dhama, K
AF Kumar, Naveen
   Malik, Yashpal Singh
   Kumar, Satish
   Sharma, Kuldeep
   Sircar, Subhankar
   Saurabh, Sharad
   Gulati, Baldev R.
   Singh, Neeraj
   Singh, Arvind Kumar
   Joshi, Vinay G.
   Banyai, Krisztian
   Dhama, Kuldeep
TI Peptide-Recombinant VP6 Protein Based Enzyme Immunoassay for the
   Detection of Group A Rotaviruses in Multiple Host Species
SO PLOS ONE
LA English
DT Article
ID POLYMERASE-CHAIN-REACTION; BURSAL DISEASE VIRUS; MAJOR CAPSID PROTEIN;
   DIAGNOSING ROTAVIRUS; LATEX AGGLUTINATION; CIRCULAR-DICHROISM;
   CHEMICAL-SYNTHESIS; ESCHERICHIA-COLI; ANTIBODIES; INFECTION
AB We developed a novel enzyme immunoassay for the detection of group A rotavirus (RVA) antigen in fecal samples of multiple host species. The assay is based on the detection of conserved VP6 protein using anti-recombinant VP6 antibodies as capture antibodies and anti-multiple antigenic peptide (identified and constructed from highly immunodominant epitopes within VP6 protein) antibodies as detector antibodies. The clinical utility of the assay was evaluated using a panel of 914 diarrhoeic fecal samples from four different host species (bovine, porcine, poultry and human) collected from diverse geographical locations in India. Using VP6-based reverse transcription-polymerase chain reaction (RT-PCR) as the gold standard, we found that the diagnostic sensitivity (DSn) and specificity (DSp) of the new assay was high [bovine (DSn = 94.2% & DSp = 100%); porcine (DSn = 94.6% & DSp = 93.3%); poultry (DSn = 74.2%& DSp = 97.7%) and human (DSn = 82.1%& DSp = 98.7%)]. The concordance with RT-PCR was also high [weighted kappa (k) = 0.831-0.956 at 95% CI = 0.711-1.0] as compared to RNA-polyacrylamide gel electrophoresis (RNA-PAGE). The performance characteristics of the new immunoassay were comparable to those of the two commercially available ELISA kits. Our results suggest that this peptide-recombinant protein based assay may serve as a preliminary assay for epidemiological surveillance of RVA antigen and for evaluation of vaccine effectiveness especially in low and middle income settings.
C1 [Kumar, Naveen; Malik, Yashpal Singh; Sircar, Subhankar; Saurabh, Sharad; Singh, Neeraj] Indian Vet Res Inst, Biol Standardizat Div, Izatnagar, Uttar Pradesh, India.
   [Kumar, Satish; Singh, Arvind Kumar; Joshi, Vinay G.] Indian Vet Res Inst, Div Anim Biotechnol, Izatnagar, Uttar Pradesh, India.
   [Sharma, Kuldeep] Natl Inst Res Tribal Hlth, Jabalpur, Madhya Pradesh, India.
   [Gulati, Baldev R.] Natl Res Ctr Equines, Hisar, Haryana, India.
   [Banyai, Krisztian] Hungarian Acad Sci, Vet Med Res Inst, Agr Res Ctr, Hungariakrt 21, Budapest, Hungary.
   [Dhama, Kuldeep] Indian Vet Res Inst, Div Vet Immunol, Izatnagar, Uttar Pradesh, India.
   [Kumar, Naveen] Natl Inst High Secur Anim Dis, Bhopal, Madhya Pradesh, India.
RP Malik, YS (reprint author), Indian Vet Res Inst, Biol Standardizat Div, Izatnagar, Uttar Pradesh, India.
EM malikyps@ivri.res.in
RI kumar, naveen/L-1588-2019; Dharma, Kuldeep/B-7852-2015
OI kumar, naveen/0000-0002-3326-5465; Dharma, Kuldeep/0000-0001-7469-4752;
   Banyai, Krisztian/0000-0002-6270-1772; Singh, Arvind
   Kumar/0000-0001-8711-9191; Gulati, Baldev/0000-0002-4338-7941
FU Education Division, Indian Council of Agricultural Research, Ministry of
   Agriculture & Farmer's Welfare, Govt. of India, New Delhi; Hungarian
   Scientific Research Fund (OTKA) [T100727]
FX The financial support from Education Division, Indian Council of
   Agricultural Research, Ministry of Agriculture & Farmer's Welfare, Govt.
   of India, New Delhi in the form of National Fellow project is
   acknowledged. Dr. Krisztian Banyai was supported by the Hungarian
   Scientific Research Fund (OTKA, T100727).
CR Bennett A, 2015, J CLIN MICROBIOL, V53, P1951, DOI 10.1128/JCM.00875-15
   Choi AHC, 2004, PROTEIN EXPRES PURIF, V38, P205, DOI 10.1016/j.pep.2004.08.009
   Choi AHC, 2003, VACCINE, V21, P761, DOI 10.1016/S0264-410X(02)00595-9
   Choi AHC, 2000, J VIROL, V74, P11574, DOI 10.1128/JVI.74.24.11574-11580.2000
   Cunliffe NA, 2010, J INFECT DIS, V202, pS168, DOI 10.1086/653577
   Dechamma HJ, 2006, VET MICROBIOL, V118, P201, DOI 10.1016/j.vetmic.2006.07.023
   DYSON HJ, 1988, ANNU REV BIOPHYS BIO, V17, P305
   Erk I, 2003, J VIROL, V77, P3595, DOI 10.1128/JVI.77.6.3595-3601.2003
   ERNST H, 1988, GENE, V68, P345, DOI 10.1016/0378-1119(88)90037-6
   Espejo RT, 1977, J INFECT DIS, V139, P879
   Gladstone BP, 2011, NEW ENGL J MED, V365, P337, DOI 10.1056/NEJMoa1006261
   GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276
   Greenberg HB, 2009, GASTROENTEROLOGY, V136, P1939, DOI 10.1053/j.gastro.2009.02.076
   Greenfield NJ, 1996, ANAL BIOCHEM, V235, P1, DOI 10.1006/abio.1996.0084
   Iturriza-Gomara M, 2009, EPIDEMIOL INFECT, V137, P922, DOI 10.1017/S0950268808001556
   Jackwood M W, 1995, Adv Exp Med Biol, V380, P213
   Kawada T, 2012, CLIN RADIOL, V67, P940, DOI 10.1016/j.crad.2012.04.002
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LANG E, 1994, J IMMUNOL METHODS, V170, P103, DOI 10.1016/0022-1759(94)90250-X
   LANGEVELD JPM, 1994, J VIROL, V68, P4506
   de Goes ACMA, 2008, J VIROL METHODS, V148, P211, DOI 10.1016/j.jviromet.2007.11.013
   Malik YS, 2012, J VET SCI, V13, P271, DOI 10.4142/jvs.2012.13.3.271
   Mathieu M, 2001, EMBO J, V20, P1485, DOI 10.1093/emboj/20.7.1485
   Matthijnssens J, 2012, ARCH VIROL, V157, P1177, DOI 10.1007/s00705-012-1273-3
   Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z
   McNeal MM, 2007, VIROLOGY, V363, P410, DOI 10.1016/j.virol.2007.01.041
   Merrifield B, 1996, PROTEIN SCI, V5, P1947, DOI 10.1002/pro.5560050925
   Merrifield B., 1963, J AM CHEM SOC, V85, P2149
   Mihalov-Kovacs E, 2015, EMERG INFECT DIS, V21, P660, DOI 10.3201/eid2104.141370
   Mukhopadhya I, 2010, EPIDEMIOL INFECT, V138, P442, DOI 10.1017/S0950268809990732
   Nilsson BL, 2005, ANNU REV BIOPH BIOM, V34, P91, DOI 10.1146/annurev.biophys.34.040204.144700
   Papp H, 2013, VET MICROBIOL, V165, P190, DOI 10.1016/j.vetmic.2013.03.020
   Phillips G, 2009, J CLIN VIROL, V44, P242, DOI 10.1016/j.jcv.2008.12.001
   POSNETT DN, 1988, J BIOL CHEM, V263, P1719
   Sambrook J., 2001, MOL CLONING LAB MANU
   SANEKATA T, 1981, J IMMUNOL METHODS, V41, P377, DOI 10.1016/0022-1759(81)90199-X
   Saravanan P, 2004, ACTA VIROL, V48, P39
   Saravanan P, 2004, J IMMUNOL METHODS, V293, P61, DOI 10.1016/j.jim.2004.07.001
   Seo JH, 2010, KOREAN J PEDIAT GAST, V13, P134
   SIMMONDS P, 1993, J CLIN MICROBIOL, V31, P1493
   SVENSSON L, 1986, J MED VIROL, V18, P101, DOI 10.1002/jmv.1890180202
   TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409
   Tang BZ, 1997, VIROLOGY, V237, P89, DOI 10.1006/viro.1997.8762
   TANIGUCHI K, 1992, EPIDEMIOL INFECT, V109, P303, DOI 10.1017/S0950268800050263
   Tate JE, 2013, EMERG INFECT DIS, V19, P1245, DOI 10.3201/eid1908.130461
   Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   YANG JT, 1986, METHOD ENZYMOL, V130, P208
   Zamorano PI, 1998, VACCINE, V16, P558, DOI 10.1016/S0264-410X(97)00244-2
   Zhu JY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-91
NR 51
TC 1
Z9 1
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 8
PY 2016
VL 11
IS 7
AR e0159027
DI 10.1371/journal.pone.0159027
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DR6IK
UT WOS:000380005400196
PM 27391106
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chae, EY
   Moon, WK
   Kim, HH
   Kim, WH
   Cha, JH
   Shin, HJ
   Choi, WJ
   Han, W
   Noh, DY
   Lee, SB
   Ahn, SH
AF Chae, Eun Young
   Moon, Woo Kyung
   Kim, Hak Hee
   Kim, Won Hwa
   Cha, Joo Hee
   Shin, Hee Jung
   Choi, Woo Jung
   Han, Wonshik
   Noh, Dong-Young
   Lee, Sae Byul
   Ahn, Sei Hyun
TI Association between Ultrasound Features and the 21-Gene Recurrence Score
   Assays in Patients with Oestrogen Receptor-Positive, HER2-Negative,
   Invasive Breast Cancer
SO PLOS ONE
LA English
DT Article
ID RT-PCR ASSAY; GENE-EXPRESSION; ECONOMIC-ANALYSIS; DUCTAL CARCINOMA;
   CHEMOTHERAPY; SUBTYPES; RISK; SONOGRAPHY; THERAPY; RELAPSE
AB A multigene expression assay corresponds to the likelihood of breast cancer recurrence after the initial diagnosis and can be used to guide the decision for additional chemotherapy. However, only few studies have investigated the associations between the imaging features of breast cancer and the results of multigene expression assays. Our study was to identify the relationship between imaging features on ultrasound (US) and the recurrence score (RS) on a 21-gene expression assay in patients with oestrogen receptor (ER)-positive, HER2-negative breast cancer. 267 patients with ER-positive, HER-negative invasive breast cancer who underwent examinations using US and Oncotype DX assay were included. US images were independently reviewed by dedicated breast radiologists who were blind to the RS. Tumour roundness was measured using a laboratory-developed software program. The pathological data were reviewed, including immunohistochemistry results. Univariate analysis was performed to assess the associations between the RS and each variable. Multiple logistic regression analysis was used to identify independent predictors of high RS. Of 267 patients, 147 (55%) had low, 96 (36%) intermediate, and 24 (9%) had high RS. According to the univariate analysis, parallel orientation, presence of calcification in the mass, and tumour roundness were positively associated with high RS. Multiple logistic regression analysis showed that parallel orientation (OR = 5.53) and tumour roundness (OR = 1.70 per 10 increase) were associated with high RS. Parallel orientation and tumour roundness are independent variables that may predict high RS in patients with ER-positive, HER2-negative breast cancer.
C1 [Chae, Eun Young; Kim, Hak Hee; Cha, Joo Hee; Shin, Hee Jung; Choi, Woo Jung] Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea.
   [Chae, Eun Young; Kim, Hak Hee; Cha, Joo Hee; Shin, Hee Jung; Choi, Woo Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea.
   [Moon, Woo Kyung; Kim, Won Hwa] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul Natl Univ Hosp, Seoul, South Korea.
   [Han, Wonshik; Noh, Dong-Young] Seoul Natl Univ, Coll Med, Dept Surg, Seoul Natl Univ Hosp, Seoul, South Korea.
   [Lee, Sae Byul; Ahn, Sei Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea.
RP Kim, HH (reprint author), Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea.; Kim, HH (reprint author), Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea.; Moon, WK (reprint author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul Natl Univ Hosp, Seoul, South Korea.
EM moonwk@snu.ac.kr; hhkim@amc.seoul.kr
RI Han, Wonshik/B-3699-2008
CR American college of radiology, 2013, BI RADS ULTR BI RADS
   Ashraf AB, 2014, RADIOLOGY, V272, P374, DOI 10.1148/radiol.14131375
   Bae MS, 2015, ACTA RADIOL, V56, P269, DOI 10.1177/0284185114524197
   Bardou VJ, 2003, J CLIN ONCOL, V21, P1973, DOI 10.1200/JCO.2003.09.099
   Blaichman J, 2012, AM J ROENTGENOL, V199, pW402, DOI 10.2214/AJR.11.7374
   Cancello G, 2013, ANN ONCOL, V24, P661, DOI 10.1093/annonc/mds430
   Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304
   Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364
   Hong AS, 2005, AM J ROENTGENOL, V184, P1260, DOI 10.2214/ajr.184.4.01841260
   Hornberger J, 2005, AM J MANAG CARE, V11, P313
   Irshad A, 2013, AM J ROENTGENOL, V200, P284, DOI 10.2214/AJR.12.8781
   Lamb PM, 2000, CLIN RADIOL, V55, P40, DOI 10.1053/crad.1999.0333
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lyman GH, 2007, CANCER-AM CANCER SOC, V109, P1011, DOI 10.1002/cncr.22506
   Montemurro F, 2007, EUR RADIOL, V17, P1490, DOI 10.1007/s00330-006-0505-x
   National omprehensive cancer network, 2014, NCCN CLINICAL PRACTI
   Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588
   Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985
   Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093
   Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134
   Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077
   Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098
   Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289
   STAVROS AT, 1995, RADIOLOGY, V196, P123, DOI 10.1148/radiology.196.1.7784555
   Tang G, 2011, J CLIN ONCOL, V29, P4365, DOI 10.1200/JCO.2011.35.3714
   Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026
   Tsoi DT, 2010, ONCOLOGIST, V15, P457, DOI 10.1634/theoncologist.2009-0275
   Uematsu T, 2009, RADIOLOGY, V250, P638, DOI 10.1148/radiol.2503081054
   van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967
   Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284
   Wang X, 2008, J DIGIT IMAGING, V21, P170, DOI 10.1007/s10278-008-9105-4
   Yepes MM, 2014, BREAST CANCER RES TR, V148, P117, DOI 10.1007/s10549-014-3143-z
NR 32
TC 4
Z9 6
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 30
PY 2016
VL 11
IS 6
AR e0158461
DI 10.1371/journal.pone.0158461
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ0CH
UT WOS:000378865200078
PM 27362843
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lisiecka, K
   Rychwalska, A
   Samson, K
   Lucznik, K
   Ziembowicz, M
   Szostek, A
   Nowak, A
AF Lisiecka, Karolina
   Rychwalska, Agnieszka
   Samson, Katarzyna
   Lucznik, Klara
   Ziembowicz, Michal
   Szostek, Agnieszka
   Nowak, Andrzej
TI Medium Moderates the Message. How Users Adjust Their Communication
   Trajectories to Different Media in Collaborative Task Solving
SO PLOS ONE
LA English
DT Article
ID FACE-TO-FACE; COMPENSATORY ADAPTATION; PERFORMANCE; RICHNESS; IMPACT
AB Rapid development of information and communications technologies (ICT) has triggered profound changes in how people manage their social contacts in both informal and professional contexts. ICT mediated communication may seem limited in possibilities compared to face-to-face encounters, but research shows that puzzlingly often it can be just as effective and satisfactory. We posit that ICT users employ specific communication strategies adapted to particular communication channels, which results in a comparable effectiveness of communication. In order to maintain a satisfactory level of conversational intelligibility they calibrate the content of their messages to a given medium's richness and adjust the whole conversation trajectory so that every stage of the communication process runs fluently. In the current study, we compared complex task solving trajectories in chat, mobile phone and face-to-face dyadic conversations. Media conditions did not influence the quality of decision outcomes or users' perceptions of the interaction, but they had impact on the amount of time devoted to each of the identified phases of decision development. In face-to-face contacts the evaluation stage of the discussion dominated the conversation; in the texting condition the orientation-evaluation-control phases were evenly distributed; and the phone condition provided a midpoint between these two extremes. The results show that contemporary ICT users adjust their communication behavior to the limitations and opportunities of various media through the regulation of attention directed to each stage of the discussion so that as a whole the communication process remains effective.
C1 [Lisiecka, Karolina; Rychwalska, Agnieszka; Nowak, Andrzej] Univ Warsaw, Robert B Zajonc Inst Social Studies, Warsaw, Poland.
   [Samson, Katarzyna] Univ Social Sci & Humanities, Fac Wroclaw, Wroclaw, Poland.
   [Lucznik, Klara] Univ Plymouth, Cognit Inst, Plymouth PL4 8AA, Devon, England.
   [Ziembowicz, Michal] Univ Social Sci & Humanities, Fac Warsaw, Warsaw, Poland.
   [Szostek, Agnieszka] Warsaw Acad Fine Arts, Design Dept, Warsaw, Poland.
RP Lisiecka, K (reprint author), Univ Warsaw, Robert B Zajonc Inst Social Studies, Warsaw, Poland.
EM klisiecka@gmail.com
OI Lucznik, Klara/0000-0002-3015-8445; Ziembowicz,
   Karolina/0000-0002-6774-0623
FU ICT Programme of the Commission of the European Communities
   [ICT-2009-238597]; National Science Centre of Poland
   [DEC-2012/05/N/HS6/03937]
FX This work was partially supported by the grant ICT-2009-238597 funded by
   ICT Programme of the Commission of the European Communities
   (http://cordis.europa.eu/fp7/ict/home_en.html), received by AN and
   partially by the grant DEC-2012/05/N/HS6/03937 funded by the National
   Science Centre of Poland (https://www.ncn.gov.pl/), received by KL. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alam M, 2014, INT J, V2, P688
   Bales R. F., 1950, INTERACTION PROCESS
   BALES RF, 1951, J ABNORM SOC PSYCH, V46, P485, DOI 10.1037/h0059886
   Barry B, 2004, ACAD MANAGE REV, V29, P272
   BOYLE EA, 1994, LANG SPEECH, V37, P1, DOI 10.1177/002383099403700101
   Burke K, 1999, MIS QUART, V23, P557, DOI 10.2307/249489
   Burke K., 2001, Information Technology & People, V14, P122, DOI 10.1108/09593840110397894
   Calefato F, 2012, EMPIR SOFTW ENG, V17, P640, DOI 10.1007/s10664-011-9179-3
   Carlson JR, 1999, ACAD MANAGE J, V42, P153, DOI 10.2307/257090
   Clark H. H., 1991, PERSPECTIVES SOCIALL, P13
   Condon SL, 1996, ELECT J COMMUN REV E, V6
   Corbitt G, 2004, SYST SCI 2004 P 37 A, P8
   Culnan MJ, 1987, INFORM TECHNOLOGIES
   DAFT RL, 1986, MANAGE SCI, V32, P554, DOI 10.1287/mnsc.32.5.554
   DeLuca D, 2006, INT J E-COLLAB, V2, P64
   Dennis A. R., 1999, SYST SCI 1999 HICSS
   Dennis AR, 2008, MIS QUART, V32, P575
   Dennis AR, 1996, INFORM EXCHANGE USE
   DohertySneddon G, 1997, J EXP PSYCHOL-APPL, V3, P105, DOI 10.1037/1076-898X.3.2.105
   Dong W, 2007, ICMI'07: PROCEEDINGS OF THE NINTH INTERNATIONAL CONFERENCE ON MULTIMODAL INTERFACES, P271
   Drouin M, 2012, COMPUT HUM BEHAV, V28, P1490, DOI 10.1016/j.chb.2012.03.013
   Dube L, 2009, INFORM SYST J, V19, P3, DOI 10.1111/j.1365-2575.2008.00313.x
   Galegher J., 1992, CSCW '92. Sharing Perspectives. Proceedings of the Conference on Computer-Supported Cooperative Work, P155
   Galegher Jolene, 2014, INTELLECTUAL TEAMWOR
   Hantula DA, 2011, EVOLUTIONARY PSYCHOLOGY IN THE BUSINESS SCIENCES, P339, DOI 10.1007/978-3-540-92784-6_13
   Jonassen DH, 2001, ETR&D-EDUC TECH RES, V49, P35, DOI 10.1007/BF02504505
   Kiesler S., 2014, CULTURE INTERNET
   Kock N., 2002, Information Management & Consulting, V17, P72
   Kock N, 2005, IEEE T PROF COMMUN, V48, P117, DOI 10.1109/TPC.2005.849649
   Kock N, 2001, IEEE T PROF COMMUN, V44, P267, DOI 10.1109/47.968108
   Kock N, 1998, INFORM MANAGE, V34, P295, DOI 10.1016/S0378-7206(98)00066-4
   Kock N, 2005, INF RESOUR MANAG J, V18, P41, DOI 10.4018/irmj.2005040103
   Kock N, 2006, EUR J INFORM SYST, V15, P331, DOI 10.1057/palgreave.ejis.3000612
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lengel RH, 1988, ACAD MANAGE EXEC, V2, P225, DOI DOI 10.5465/AME.1988.4277259
   Leonardi PM, 2013, J COMPUT-MEDIAT COMM, V19, P1, DOI 10.1111/jcc4.12029
   Maznevski ML, 2000, ORGAN SCI, V11, P473, DOI 10.1287/orsc.11.5.473.15200
   Munzer S, 2008, APPL COGNITIVE PSYCH, V22, P663, DOI 10.1002/acp.1387
   Nemiroff PM, 1975, LOST SEA CONSENSUS S
   Newlands A, 2003, APPL COGNITIVE PSYCH, V17, P325, DOI 10.1002/acp.868
   Olaniran BA, 1996, EXPT EXPERIENTIAL AP
   Page S., 2008, DIFFERENCE POWER DIV
   POOLE MS, 1995, HUM COMMUN RES, V22, P90, DOI 10.1111/j.1468-2958.1995.tb00363.x
   Prensky M., 2001, HORIZON, V9, P1, DOI DOI 10.1108/10748120110424816
   Purdy JM, 2000, INT J CONFL MANAGE, V11, P162, DOI 10.1108/eb022839
   Roch SG, 2005, GROUP DYN-THEOR RES, V9, P15, DOI 10.1037/1089-2699.9.1.15
   Setlock L. D., 2004, Computer Supported Cooperative Work Conference Proceedings, P604
   Simon AF, 2006, J SOC PSYCHOL, V146, P349, DOI 10.3200/SOCP.146.3.349-379
   Sins PHM, 2011, COMPUT EDUC, V56, P379, DOI 10.1016/j.compedu.2010.08.022
   Sorensen C., 2011, ENTERPRISE MOBILITY
   Stromso HI, 2007, J COMPUT ASSIST LEAR, V23, P271, DOI 10.1111/j.1365-2729.2007.00221.x
   Suh KS, 1999, INFORM MANAGE, V35, P295, DOI 10.1016/S0378-7206(98)00097-4
   Surowiecki J., 2005, WISDOM CROWDS
   Thompson LF, 2002, GROUP DYN-THEOR RES, V6, P52, DOI 10.1037//1089-2699.6.1.52
   TUCKMAN BW, 1965, PSYCHOL BULL, V63, P384, DOI 10.1037/h0022100
   van Baren Joy, 2004, CTIT WORKSHOP P SERI, V2, P13
   van der Kleij R, 2009, SMALL GROUP RES
   van der Meijden H, 2005, COMPUT HUM BEHAV, V21, P831, DOI 10.1016/j.chb.2003.10.005
   WALTHER JB, 1994, COMMUN RES, V21, P460, DOI 10.1177/009365094021004002
   WALTHER JB, 1992, HUM COMMUN RES, V19, P50, DOI 10.1111/j.1468-2958.1992.tb00295.x
   WALTHER JB, 1992, COMMUN RES, V19, P52, DOI 10.1177/009365092019001003
   Warkentin ME, 1997, DECISION SCI, V28, P975, DOI 10.1111/j.1540-5915.1997.tb01338.x
   Wiggins B, 2005, 20 ANN M SOC IND ORG
   Zhao SY, 2003, PRESENCE-TELEOP VIRT, V12, P445, DOI 10.1162/105474603322761261
NR 64
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 23
PY 2016
VL 11
IS 6
AR e0157827
DI 10.1371/journal.pone.0157827
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DP3JL
UT WOS:000378389200055
PM 27337037
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Robinski, M
   Strich, F
   Mau, W
   Girndt, M
AF Robinski, Maxi
   Strich, Franz
   Mau, Wilfried
   Girndt, Matthias
TI Validating a Patient-Reported Comorbidity Measure with Respect to
   Quality of Life in End-Stage Renal Disease
SO PLOS ONE
LA English
DT Article
ID CHRONIC KIDNEY-DISEASE; DIALYSIS PATIENTS; INTERRATER RELIABILITY;
   MODALITY SELECTION; HIGH AGREEMENT; LOW KAPPA; QUESTIONNAIRE; RISK;
   HEMODIALYSIS; ADJUSTMENT
AB Purpose
   Medical record-derived comorbidity measures such as the Charlson Comorbidity Index (CCI) do not predict functional limitations or quality of life (QoL) in the chronically ill. Although these shortcomings are known since the 1980s, they have been largely ignored by the international literature. Recently, QoL has received growing interest as an end-point of interventional trials in Nephrology. The aim of this study is to compare a patient-reported comorbidity measure and the CCI with respect to its validity regarding QoL.
   Methods
   The German Self-Administered Comorbidity Questionnaire (SCQ-G) was completed by 780 adult end-stage renal disease-patients recruited from 55 dialysis units throughout Germany. Acceptance was evaluated via response rates. Content validity was examined by comparing the typical comorbidity pattern in dialysis patients and the pattern retrieved from our data. Convergent validity was assessed via kappa statistics. Data was compared to the CCI. Linear associations with QoL were examined (criterion validity).
   Results
   The SCQ-G was very well accepted by dialysis patients of all ages (response rate: 99%). Content validity can be interpreted as high (corresponding comorbidity items: 73.7%). Convergent validity was rather weak (.27 <=rho <=.29) but increased when comparing only concordant items (.39 <=rho <=.43). With respect to criterion validity, the SCQ-G performed better than the CCI regarding the correlation with QoL (e.g., SF-12-physical: SCQ-G total score: rho= -.49 vs. CCI:rho = -.36).
   Conclusions
   The patient-reported measure proved to be more valid than the external assessment when aiming at insights on QoL. Due to the inclusion of subjective limitations, the SCQ-G is more substantial with respect to patient-centered outcomes and might be used as additional measure in clinical trials.
C1 [Robinski, Maxi; Strich, Franz; Mau, Wilfried] Univ Halle Wittenberg, Inst Rehabil Med, Fac Med, D-06108 Halle, Saale, Germany.
   [Girndt, Matthias] Univ Halle Wittenberg, Fac Med, Dept Internal Med 2, D-06108 Halle, Saale, Germany.
   [Robinski, Maxi; Strich, Franz; Mau, Wilfried; Girndt, Matthias] Univ Halle Wittenberg, Ctr Hlth Sci, D-06108 Halle, Saale, Germany.
RP Robinski, M (reprint author), Univ Halle Wittenberg, Inst Rehabil Med, Fac Med, D-06108 Halle, Saale, Germany.; Robinski, M (reprint author), Univ Halle Wittenberg, Ctr Hlth Sci, D-06108 Halle, Saale, Germany.
EM maxi.robinski@uk-halle.de
RI Girndt, Matthias/M-1436-2019
OI Girndt, Matthias/0000-0003-2823-0847
FU "Bundesministerium fur Bildung und Forschung" (BMBF) in Germany [Federal
   Ministry of Education and Research] [01GY1324]
FX The study received funding from the "Bundesministerium fur Bildung und
   Forschung" (BMBF) in Germany [Federal Ministry of Education and
   Research]; grant #01GY1324; https://www. bmbf. de/; authors who received
   funding: MG WM. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Baumeister SE, 2010, AM J NEPHROL, V31, P222, DOI 10.1159/000272937
   Bunn F, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0192-4
   BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Chui HC, 2000, ARCH NEUROL-CHICAGO, V57, P191, DOI 10.1001/archneur.57.2.191
   CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M
   Cohen J, 1988, STAT POWER ANAL BEHA
   de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1
   FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L
   Floege J, 2015, KIDNEY INT, V87, P996, DOI 10.1038/ki.2014.419
   Glattacker M, 2007, PHYS MED REHAB KUROR, V17, P260, DOI 10.1055/s-2007-970405
   GREENFIELD S, 1994, AM J KIDNEY DIS, V24, P298, DOI 10.1016/S0272-6386(12)80195-8
   Hemmelgarn BR, 2003, AM J KIDNEY DIS, V42, P125, DOI 10.1016/S0272-6386(03)00415-3
   Huang KW, 2014, DIGEST DIS SCI, V59, P807, DOI 10.1007/s10620-013-2973-6
   Jassal SV, 2002, NEPHROL DIAL TRANSPL, V17, P474, DOI 10.1093/ndt/17.3.474
   KAPLAN MH, 1974, J CHRON DIS, V27, P387, DOI 10.1016/0021-9681(74)90017-4
   Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006
   Kho ME, 2007, AM J CRIT CARE, V16, P378
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lazarus RS, 1996, STRESS APPRAISAL COP
   LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x
   Madero M, 2008, SEMIN DIALYSIS, V21, P29, DOI 10.1111/j.1525-139X.2007.00384.x
   McHugh ML, 2012, BIOCHEM MEDICA, V22, P276
   Miskulin D, 2005, PERITON DIALYSIS INT, V25, P320
   Morfeld M., 2011, SF 36 FRAGEBOGEN ZUM
   Murphy SW, 2000, KIDNEY INT, V57, P1720, DOI 10.1046/j.1523-1755.2000.00017.x
   Murray AM, 2008, ADV CHRONIC KIDNEY D, V15, P123, DOI 10.1053/j.ackd.2008.01.010
   Robinski M, 2017, NEPHROL DIAL TRANSPL, V32, P315, DOI 10.1093/ndt/gfv464
   Robinski M, 2016, PATIENT EDUC COUNS, V99, P562, DOI 10.1016/j.pec.2015.10.014
   Robinski M, 2014, CLIN KIDNEY J, V7, DOI 10.1093/ckj/sfu111
   Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993
   Sirois FM, 2014, J HEALTH PSYCHOL, V7, P1
   Stack AG, 2002, J AM SOC NEPHROL, V13, P1279
   Stolwijk C, 2014, RHEUMATOLOGY, V53, P1054, DOI 10.1093/rheumatology/ket354
   Streibelt M, 2012, ORTHOPADE, V41, P303, DOI 10.1007/s00132-012-1901-3
   Tonelli M, 2015, KIDNEY INT, V88, P859, DOI 10.1038/ki.2015.228
   van Manen JG, 2002, AM J KIDNEY DIS, V40, P82, DOI 10.1053/ajkd.2002.33916
NR 37
TC 1
Z9 1
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 13
PY 2016
VL 11
IS 6
AR e0157506
DI 10.1371/journal.pone.0157506
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO5KF
UT WOS:000377821300049
PM 27294867
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tourino, LFPG
   Correa-Faria, P
   Ferreira, RC
   Bendo, CB
   Zarzar, PM
   Vale, MP
AF Padua Goncalves Tourino, Luciana Fonseca
   Correa-Faria, Patricia
   Ferreira, Raquel Conceciao
   Bendo, Cristiane Baccin
   Zarzar, Patricia Maria
   Vale, Miriam Pimenta
TI Association between Molar Incisor Hypomineralization in Schoolchildren
   and Both Prenatal and Postnatal Factors: A Population-Based Study
SO PLOS ONE
LA English
DT Article
ID ETIOLOGIC FACTORS; DEMARCATED OPACITIES; ENAMEL DEFECTS; PREVALENCE;
   CHILDREN
AB Background
   Although studies throughout the world have investigated potential factors involved in the occurrence of molar incisor hypomineralization (MIH), the findings are varied and inconclusive.
   Objective
   The aim of the present study was to evaluate the prevalence of MIH and identify associated prenatal, perinatal and postnatal factors among Brazilian schoolchildren aged 8 and 9 years.
   Methods
   A cross-sectional study was conducted with a randomly selected population-based sample of 1181 schoolchildren. Information on demographic and socioeconomic characteristics as well as prenatal, perinatal and postnatal aspects was obtained through questionnaires. The clinical examination included the investigation of MIH based on the criteria of the European Academy of Paediatric Dentistry. Dental caries in the permanent dentition and developmental defects of enamel (DDE) on the primary second molars were also recorded. Data analysis involved descriptive statistics, bivariate tests and Poisson regression with robust variance.
   Results
   The prevalence of MIH was 20.4%. MIH was more frequent among children with dental caries in the permanent dentition (PR: 2.67; 95% CI: 1.98-3.61), those with DDE on the primary second molars (PR: 2.54; 95% CI: 1.87-3.45) and those who experienced asthma/bronchitis in the first four years of life (PR: 1.93; 95% CI: 1.45-2.56).
   Conclusions
   The prevalence of MIH was high and was associated with dental caries, the presence of DDE on primary second molars and the experience of asthma/bronchitis in early life. These findings could be useful in the identification of children in need of shorter recall intervals to prevent the consequences of MIH, such as enamel breakdown dental caries.
C1 [Padua Goncalves Tourino, Luciana Fonseca] Ctr Univ Lavras, Dept Pediat Dent, Lavras, MG, Brazil.
   [Correa-Faria, Patricia; Bendo, Cristiane Baccin; Zarzar, Patricia Maria; Vale, Miriam Pimenta] Univ Fed Minas Gerais, Sch Dent, Dept Pediat Dent & Orthodont, Belo Horizonte, MG, Brazil.
   [Ferreira, Raquel Conceciao] Univ Fed Minas Gerais, Sch Dent, Dept Publ Oral Hlth, Belo Horizonte, MG, Brazil.
RP Tourino, LFPG (reprint author), Ctr Univ Lavras, Dept Pediat Dent, Lavras, MG, Brazil.
EM lucianapaduatourino@yahoo.com
RI Bendo, Cristiane Baccin/H-5835-2012; Ferreira, Raquel
   Conceicao/L-5589-2013; Correa-Faria, Patricia/N-9428-2013
OI Bendo, Cristiane Baccin/0000-0003-4849-8779; ZARZAR, PATRICIA
   MARIA/0000-0002-6952-5767; Tourino, Luciana/0000-0002-3640-036X;
   Ferreira, Raquel Conceicao/0000-0001-8897-9345; Correa-Faria,
   Patricia/0000-0002-0528-1425
CR Alaluusua S, 2010, EUR ARCH PAEDIATR DE, V11, P53, DOI 10.1007/BF03262713
   [Anonymous], 1992, Int Dent J, V42, P411
   Arrow P, 2009, COMMUNITY DENT ORAL, V37, P405, DOI 10.1111/j.1600-0528.2009.00480.x
   Beentjes V E, 2002, Eur J Paediatr Dent, V3, P9
   Brogardh-Roth S, 2011, EUR J ORAL SCI, V119, P33, DOI 10.1111/j.1600-0722.2011.00792.x
   Casanova-Rosado AJ, 2011, EUR J PAEDIATR DENT, V12, P155
   Cho SY, 2008, INT J PAEDIATR DENT, V18, P348, DOI 10.1111/j.1365-263X.2008.00927.x
   Crombie F, 2009, INT J PAEDIATR DENT, V19, P73, DOI 10.1111/j.1365-263X.2008.00966.x
   da Costa-Silva CM, 2010, INT J PAEDIATR DENT, V20, P426, DOI 10.1111/j.1365-263X.2010.01097.x
   Fagrell TG, 2008, INT J PAEDIATR DENT, V18, P333, DOI 10.1111/j.1365-263X.2007.00908.x
   Garcia-Margarit M, 2014, INT J PAEDIATR DENT, V24, P14, DOI 10.1111/ipd.12020
   Ghanim A, 2013, INT J PAEDIATR DENT, V23, P197, DOI 10.1111/j.1365-263X.2012.01244.x
   Ghanim A, 2013, INT J PAEDIATR DENT, V23, P48, DOI 10.1111/j.1365-263X.2012.01223.x
   Guergolette RP, 2009, J BRAS PNEUMOL, V35, P295, DOI 10.1590/S1806-37132009000400002
   GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N
   Harju M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1357-6
   Jalevik B, 2010, EUR ARCH PAEDIATR DE, V11, P59
   Jalevik B, 2001, EUR J ORAL SCI, V109, P230, DOI 10.1034/j.1600-0722.2001.00047.x
   Jeremias F, 2013, ACTA ODONTOL SCAND, V71, P870, DOI 10.3109/00016357.2012.734412
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Petrou MA, 2014, INT J PAEDIATR DENT, V24, P434, DOI 10.1111/ipd.12089
   Pitiphat W, 2014, EUR J ORAL SCI, V122, P265, DOI 10.1111/eos.12136
   Souza JF, 2012, EUR ARCH PAEDIATR DE, V13, P164, DOI 10.1007/BF03262865
   Soviero V, 2009, ACTA ODONTOL SCAND, V67, P170, DOI 10.1080/00016350902758607
   Suga S, 1989, Adv Dent Res, V3, P188
   Tung K, 2006, ARCH ORAL BIOL, V51, P464, DOI 10.1016/j.archoralbio.2005.12.001
   VANAMERONGEN WE, 1995, J DENT CHILD, V62, P266
   Voort AMMSVD, 2014, J ALLERGY CLIN IMMUN, V133, P1317, DOI 10.1016/j.jaci.2013.12.1082
   Weerheijm K L, 2004, Dent Update, V31, P9
   Weerheijm K L, 2003, Eur J Paediatr Dent, V4, P110
   Weerheijm K L, 2003, Int J Paediatr Dent, V13, P411, DOI 10.1046/j.1365-263X.2003.00498.x
   Whatling R, 2008, INT J PAEDIATR DENT, V18, P155, DOI 10.1111/j.1365-263X.2007.00901.x
   WHO (World Health Organization), 1997, OR HLTH SURV BAS MET
NR 33
TC 7
Z9 7
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 9
PY 2016
VL 11
IS 6
AR e0156332
DI 10.1371/journal.pone.0156332
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO1TW
UT WOS:000377563000025
PM 27280451
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Mitchell, JT
   Sweitzer, MM
   Tunno, AM
   Kollins, SH
   McClernon, FJ
AF Mitchell, John T.
   Sweitzer, Maggie M.
   Tunno, Angela M.
   Kollins, Scott H.
   McClernon, F. Joseph
TI "I Use Weed for My ADHD": A Qualitative Analysis of Online Forum
   Discussions on Cannabis Use and ADHD
SO PLOS ONE
LA English
DT Article
ID ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; INNOVATIVE DRUG-USERS;
   MARIJUANA-USE; SUBSTANCE USE; PATIENT RELATIONSHIP; HEALTH INFORMATION;
   INTERNET; WEB; EXPECTANCY; MEDICATION
AB Background
   Attention-deficit/hyperactivity disorder (ADHD) is a risk factor for problematic cannabis use. However, clinical and anecdotal evidence suggest an increasingly popular perception that cannabis is therapeutic for ADHD, including via online resources. Given that the Internet is increasingly utilized as a source of healthcare information and may influence perceptions, we conducted a qualitative analysis of online forum discussions, also referred to as threads, on the effects of cannabis on ADHD to systematically characterize the content patients and caregivers may encounter about ADHD and cannabis.
   Methods
   A total of 268 separate forum threads were identified. Twenty percent (20%) were randomly selected, which yielded 55 separate forum threads (mean number of individual posts per forum thread = 17.53) scored by three raters (Cohen's kappa = 0.74). A final sample of 401 posts in these forum threads received at least one endorsement on predetermined topics following qualitative coding procedures.
   Results
   Twenty-five (25%) percent of individual posts indicated that cannabis is therapeutic for ADHD, as opposed to 8% that it is harmful, 5% that it is both therapeutic and harmful, and 2% that it has no effect on ADHD. This pattern was generally consistent when the year of each post was considered. The greater endorsement of therapeutic versus harmful effects of cannabis did not generalize to mood, other (non-ADHD) psychiatric conditions, or overall domains of daily life. Additional themes emerged (e.g., cannabis being considered sanctioned by healthcare providers).
   Conclusions
   Despite that there are no clinical recommendations or systematic research supporting the beneficial effects of cannabis use for ADHD, online discussions indicate that cannabis is considered therapeutic for ADHD-this is the first study to identify such a trend. This type of online information could shape ADHD patient and caregiver perceptions, and influence cannabis use and clinical care.
C1 [Mitchell, John T.; Sweitzer, Maggie M.; Tunno, Angela M.; Kollins, Scott H.; McClernon, F. Joseph] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA.
   [Mitchell, John T.; Sweitzer, Maggie M.; Kollins, Scott H.; McClernon, F. Joseph] Duke Ctr Addict Sci & Technol, Durham, NC USA.
RP Mitchell, JT (reprint author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA.; Mitchell, JT (reprint author), Duke Ctr Addict Sci & Technol, Durham, NC USA.
EM john.mitchell@duke.edu
FU National Institute on Drug Abuse [K23 DA032577, K24 DA023464]
FX This study was supported by the National Institute on Drug Abuse (K23
   DA032577 to JTM and K24 DA023464 to SHK). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Allsop DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044864
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   [Anonymous], 2004, MAR MED NEED SCI BAS
   Barkley RA, 2007, J SAFETY RES, V38, P113, DOI 10.1016/j.jsr.2006.09.004
   Bidwell LC, 2014, DRUG ALCOHOL DEPEN, V135, P88, DOI 10.1016/j.drugalcdep.2013.11.013
   Blakely G, 2014, NURS HEALTH SCI, V16, P387, DOI 10.1111/nhs.12122
   Blume A, 2009, NEUROPSYCHIATRIE, V23, P42
   Boyer Celia, 2004, Stud Health Technol Inform, V100, P159
   Boyer EW, 2007, CYBERPSYCHOL BEHAV, V10, P1, DOI 10.1089/cpb.2006.9999
   Boyer EW, 2005, PEDIATRICS, V115, P302, DOI 10.1542/peds.2004-1199
   Boyer EW, 2001, NEW ENGL J MED, V345, P469, DOI 10.1056/NEJM200108093450619
   Burri M, 2006, NICOTINE TOB RES, V8, pS13, DOI 10.1080/14622200601042513
   Bylund CL, 2007, PATIENT EDUC COUNS, V66, P346, DOI 10.1016/j.pec.2007.01.009
   Crane NA, 2013, NEUROPSYCHOL REV, V23, P117, DOI 10.1007/s11065-012-9222-1
   Crean RD, 2011, J ADDICT MED, V5, P1, DOI 10.1097/ADM.0b013e31820c23fa
   Daniulaityte R, 2013, DRUG ALCOHOL DEPEN, V130, P241, DOI 10.1016/j.drugalcdep.2012.11.003
   De Alwis D, 2014, ADDICT BEHAV, V39, P1278, DOI 10.1016/j.addbeh.2014.04.003
   Del Boca FK, 2002, ALCOHOL CLIN EXP RES, V26, P926, DOI 10.1097/00000374-200206000-00024
   Falck RS, 2004, DRUG ALCOHOL DEPEN, V74, P45, DOI 10.1016/j.drugalcdep.2003.11.009
   Flower A, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-162
   Fox S, 2013, HLTH ONLINE 2013
   Goldman MS, 2002, ALCOHOL CLIN EXP RES, V26, P737, DOI 10.1111/j.1530-0277.2002.tb02599.x
   Griffiths P, 2000, SUBST USE MISUSE, V35, P811, DOI 10.3109/10826080009148423
   Hadland SE, 2015, J DEV BEHAV PEDIATR, V36, P115, DOI 10.1097/DBP.0000000000000129
   Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0
   Hall W, 2009, INT J DRUG POLICY, V20, P458, DOI 10.1016/j.drugpo.2009.02.013
   Harty SC, 2015, SUBST USE MISUSE, V50, P1470, DOI 10.3109/10826084.2015.1018545
   Hechtman L, FUNCTIONAL ADU UNPUB
   Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485
   Johnston LD, 2014, MONITORING FUTURE NA
   Kummervold PE, 2002, NORD J PSYCHIAT, V56, P59, DOI 10.1080/08039480252803945
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lange JE, 2010, DRUG ALCOHOL DEPEN, V108, P138, DOI 10.1016/j.drugalcdep.2009.11.010
   Lee SS, 2011, CLIN PSYCHOL REV, V31, P328, DOI 10.1016/j.cpr.2011.01.006
   Lipsman A, 2015, US DIGITAL FUTURE FO
   Lisdahl KM, 2016, DRUG ALCOHOL DEPEN, V161, P135, DOI 10.1016/j.drugalcdep.2016.01.032
   Lisdahl Krista M, 2014, Curr Addict Rep, V1, P144
   McMullan M, 2006, PATIENT EDUC COUNS, V63, P24, DOI 10.1016/j.pec.2005.10.006
   Miller PG, 2010, ADDICTION, V105, P1557, DOI 10.1111/j.1360-0443.2010.02992.x
   Molina BSG, 2013, J AM ACAD CHILD PSY, V52, P250, DOI 10.1016/j.jaac.2012.12.014
   Mounteney J, 2010, SUBST USE MISUSE, V45, P266, DOI 10.3109/10826080903368598
   Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52
   Poole R, 2015, JMIR MENT HEALTH, V2, DOI 10.2196/mental.4123
   Rasmussen J, 2016, BRAIN IMAGING BEHAV, V10, P761, DOI 10.1007/s11682-015-9438-9
   Saloner B, 2015, PEDIATRICS, V135, P955, DOI 10.1542/peds.2015-0436
   Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362
   Schifano F, 2006, PROG NEURO-PSYCHOPH, V30, P640, DOI 10.1016/j.pnpbp.2005.11.035
   Strohbeck-Kuehner P, 2008, CANNABINOIDS, V3, P1
   Tamm L, 2013, DRUG ALCOHOL DEPEN, V133, P607, DOI 10.1016/j.drugalcdep.2013.08.001
   Volkow ND, 2016, JAMA PSYCHIAT, V73, P292, DOI 10.1001/jamapsychiatry.2015.3278
   Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309
   Wald HS, 2007, PATIENT EDUC COUNS, V68, P218, DOI 10.1016/j.pec.2007.05.016
   Wartella E, 2015, TEENS HLTH TECHNOLOG
   Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006
   Zaman T, 2015, J ADDICT MED, V9, P317, DOI 10.1097/ADM.0000000000000138
NR 55
TC 12
Z9 12
U1 1
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 26
PY 2016
VL 11
IS 5
AR e0156614
DI 10.1371/journal.pone.0156614
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DN2GQ
UT WOS:000376882500160
PM 27227537
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Carrouel, F
   Llodra, JC
   Viennot, S
   Santamaria, J
   Bravo, M
   Bourgeois, D
AF Carrouel, Florence
   Llodra, Juan Carlos
   Viennot, Stephane
   Santamaria, Julie
   Bravo, Manuel
   Bourgeois, Denis
TI Access to Interdental Brushing in Periodontal Healthy Young Adults: A
   Cross-Sectional Study
SO PLOS ONE
LA English
DT Article
ID RISK-FACTOR; PROBE
AB Purpose
   Interdental diameter space is largely undefined in adults, which compromises the decision support for daily interdental cleaning during routine practice in individual oral prophylaxis. This study assesses the distribution of diameter access of interdental spaces in an 18- to 25-year-old adult population free of periodontal disease.
   Methods
   In March-April 2015, a cross-sectional study using random sampling was performed at the University Lyon 1, France. The interproximal dental spaces of 99 individuals were examined using a colorimetric calibrated probe associated with the corresponding calibrated interdental brush (IDB).
   Results
   Of the 2,408 out of 2,608 sites, the overall accessibility prevalence of any interdental brushing was 92.3%. In total, 80.6% of the sites required interdental brushes with smaller diameters (0.6-0.7 mm). In anterior sites, the diameter of the interdental brushes used was smaller (55.8% of IDB with 0.6 mm) than the diameter of the interdental brushes used in posterior sites (26.1% of IDB with 0.6 mm) (p < 0.01). The adjusted ORs indicate a significant association with the location of the sites (approximately doubling the risk of bleeding, i.e., OR = 1.9, in posterior sites).
   Conclusions
   Most interdental sites can be cleaned using interdental brushes. Even in healthy people, interdental hygiene requirements are very high. Strengthening the oral hygiene capacity by specifically using interdental brushes can have an effect on the health of the entire population. Screening of the accessibility of the interdental space should be a component of a routine examination for all patients.
C1 [Carrouel, Florence] Univ Lyon, Inst Funct Genom Lyon, Lyon, France.
   [Llodra, Juan Carlos; Viennot, Stephane; Santamaria, Julie; Bourgeois, Denis] Univ Lyon 1, Fac Med Dent, Dept Publ Hlth, F-69365 Lyon, France.
   [Bravo, Manuel] Univ Granada, Fac Med Dent, Dept Publ Hlth, Granada, Spain.
RP Bourgeois, D (reprint author), Univ Lyon 1, Fac Med Dent, Dept Publ Hlth, F-69365 Lyon, France.
EM denis.bourgeois@univ-lyon1.fr
OI Carrouel, Florence/0000-0002-6823-1636; Bravo Perez,
   Manuel/0000-0001-5508-561X
FU Curaden International AG, Kriens, Switzerland
FX The study was financially supported by Curaden International AG, Kriens,
   Switzerland. The involvement of curaden international ag, kriens,
   switzerland in this study by financial support had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bourgeois D, 2015, OPEN DENT J, V9, P431, DOI 10.2174/1874210601509010431
   Chapple ILC, 2015, J CLIN PERIODONTOL, V42, pS71, DOI 10.1111/jcpe.12366
   Checchi L, 2014, INT J DENT, DOI 10.1155/2014/586537
   Gluch Joan I, 2012, J Evid Based Dent Pract, V12, P81, DOI 10.1016/j.jebdp.2012.03.016
   Halappa Mythri, 2015, J Indian Soc Periodontol, V19, P4, DOI 10.4103/0972-124X.151927
   Hofer D, 2011, INT J DENT HYG, V9, P211, DOI 10.1111/j.1601-5037.2010.00483.x
   Holtfreter B, 2015, J CLIN PERIODONTOL, V42, P407, DOI 10.1111/jcpe.12392
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lockhart PB, 2009, J AM DENT ASSOC, V140, P1238, DOI 10.14219/jada.archive.2009.0046
   Palmer RJ, 2014, PERIODONTOL 2000, V64, P20, DOI 10.1111/j.1600-0757.2012.00453.x
   Poklepovic T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009857.pub2
   Salzer S, 2015, J CLIN PERIODONTOL, V42, pS92, DOI 10.1111/jcpe.12363
   Sicilia Alberto, 2003, Oral Health Prev Dent, V1 Suppl 1, P407
   Slot D E, 2008, Int J Dent Hyg, V6, P253, DOI 10.1111/j.1601-5037.2008.00330.x
   Zijnge V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009321
   Zimmermann H, 2015, COMMUNITY DENT ORAL, V43, P116, DOI 10.1111/cdoe.12126
NR 16
TC 4
Z9 4
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 18
PY 2016
VL 11
IS 5
AR e0155467
DI 10.1371/journal.pone.0155467
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM3ZU
UT WOS:000376286100052
PM 27192409
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chamorro-Moriana, G
   Ridao-Fernandez, C
   Ojeda, J
   Benitez-Lugo, M
   Sevillano, JL
AF Chamorro-Moriana, Gema
   Ridao-Fernandez, Carmen
   Ojeda, Joaquin
   Benitez-Lugo, Marisa
   Luis Sevillano, Jose
TI Reliability and Validity Study of the Chamorro Assisted Gait Scale for
   People with Sprained Ankles, Walking with Forearm Crutches
SO PLOS ONE
LA English
DT Article
ID PARTIAL WEIGHT-BEARING; INTERRATER RELIABILITY; KNEE OSTEOARTHRITIS;
   ASSESSMENT-TOOL; CEREBRAL-PALSY; CLINICAL GAIT; VALIDATION; STROKE;
   REHABILITATION; HEMIPARESIS
AB Objective
   The aim of this study was to design and validate a functional assessment scale for assisted gait with forearm crutches (Chamorro Assisted Gait Scale-CHAGS) and to assess its reliability in people with sprained ankles.
   Design
   Thirty subjects who suffered from sprained ankle (anterior talofibular ligament first and second degree) were included in the study. A modified Delphi technique was used to obtain the content validity. The selected items were: pelvic and scapular girdle dissociation(1), deviation of Center of Gravity(2), crutch inclination(3), steps rhythm(4), symmetry of step length (5), cross support(6), simultaneous support of foot and crutch(7), forearm off(8), facing forward( 9) and fluency(10). Two raters twice visualized the gait of the sample subjects which were recorded. The criterion-related validity was determined by correlation between CHAGS and Coding of eight criteria of qualitative gait analysis (Viel Coding). Internal consistency and inter and intra-rater reliability were also tested.
   Results
   CHAGS obtained a high and negative correlation with Viel Coding. We obtained a good internal consistency and the intra-class correlation coefficients oscillated between 0.97 and 0.99, while the minimal detectable changes were acceptable.
   Conclusion
   CHAGS scale is a valid and reliable tool for assessing assisted gait with crutches in people with sprained ankles to perform partial relief of lower limbs.
C1 [Chamorro-Moriana, Gema; Ridao-Fernandez, Carmen; Benitez-Lugo, Marisa] Univ Seville, Dept Physiotherapy, Res Grp Area Physiotherapy CTS 305, Seville, Spain.
   [Ojeda, Joaquin] Univ Seville, Dept Mech & Manufacture, Res Grp Mech Engn, Seville, Spain.
   [Luis Sevillano, Jose] Univ Seville, Res Grp Robot & Technol Comp, Dept Architecture & Technol Comp, Seville, Spain.
RP Chamorro-Moriana, G (reprint author), Univ Seville, Dept Physiotherapy, Res Grp Area Physiotherapy CTS 305, Seville, Spain.
EM gchamorro@us.es
RI Sevillano, Jose Luis/K-2484-2013; Chamorro-Moriana, Gema/F-7398-2018;
   Benitez-Lugo, Maria-Luisa/J-7487-2018
OI Sevillano, Jose Luis/0000-0002-1392-1832; Chamorro-Moriana,
   Gema/0000-0003-4592-0882; Benitez-Lugo, Maria-Luisa/0000-0003-2058-8799
FU Telefonica Chair "Intelligence in Networks" of the University of
   Seville, Spain
FX This study was funded by the Telefonica Chair "Intelligence in Networks"
   of the University of Seville, Spain
   (http://institucional.us.es/catedratel/). The funder had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Araujo PA, 2009, BRAZ J PHYS THER, V13, P267, DOI 10.1590/S1413-35552009005000033
   Bella GP, 2012, REV BRAS FISIOTER, V16, P134, DOI 10.1590/S1413-35552012000200009
   Bridwell KH, 2005, SPINE, V30, P455, DOI 10.1097/01.brs.0000153393.82368.6b
   BROSKY T, 1995, J ORTHOP SPORT PHYS, V21, P197, DOI 10.2519/jospt.1995.21.4.197
   Carlson N.R., 2012, PHYSL BEHAV
   Chamorro-Moriana G, 2011, CUEST FISIOTER, V40, P155
   Chamorro-Moriana G, 2009, Spanish patent, Patent No. [P200901942, 200901942]
   Chamorro-Moriana G, 2013, GAIT POSTURE, V37, P564, DOI 10.1016/j.gaitpost.2012.09.018
   Creaby MW, 2010, OSTEOARTHR CARTILAGE, V18, P1380, DOI 10.1016/j.joca.2010.08.013
   Cremers J, 2012, PARKINSONISM RELAT D, V18, P759, DOI 10.1016/j.parkreldis.2012.03.012
   Cronbach L, 1951, PHYSCHOMETIKA, V16, P297
   Davis A E, 1996, J Neurosci Nurs, V28, P204
   Domholdt E., 2000, PHYS THERAPY RES PRI
   Dunn A, 2015, STROKE RES TREAT, DOI 10.1155/2015/484813
   Fischer J, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-61
   Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215
   Grunt S, 2010, GAIT POSTURE, V31, P489, DOI 10.1016/j.gaitpost.2010.02.006
   Hale L, 2010, J INTELLECT DEV DIS, V35, P77, DOI 10.3109/13668251003702128
   Hershko Erel, 2008, Am J Orthop (Belle Mead NJ), V37, pE92
   Hol AM, 2010, ARCH ORTHOP TRAUM SU, V130, P547, DOI 10.1007/s00402-009-1017-3
   Jackson AB, 2008, J SPINAL CORD MED, V31, P487, DOI 10.1080/10790268.2008.11753644
   Jones A, 2008, CLINICS, V63, P197, DOI 10.1590/S1807-59322008000200007
   Kim JS, 2011, CLIN REHABIL, V25, P134, DOI 10.1177/0269215510380822
   Kloos AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030903
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lord SE, 1998, CLIN REHABIL, V12, P107, DOI 10.1191/026921598666182531
   Malviya A, 2005, INJURY, V36, P556, DOI 10.1016/j.injury.2004.10.004
   Morgan P, 2014, DISABIL REHABIL, V36, P1, DOI 10.3109/09638288.2013.775359
   Navas-Vinagre I, 2015, REV MED INT SINDR DO
   Nguyen VC, 2007, AM J PHYS MED REHAB, V86, P463, DOI 10.1097/PHM.0b013e31805b8193
   Osaki Y, 2008, EXP BRAIN RES, V185, P121, DOI 10.1007/s00221-007-1139-1
   Peterson DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090634
   Pizzi A, 2007, J REHABIL MED, V39, P170, DOI 10.2340/16501977-0026
   Polit D, 2003, NURSING RES PRINCIPL, P223
   Reid S, 2011, ARCH PHYS MED REHAB, V92, P1060, DOI 10.1016/j.apmr.2011.02.014
   Sedgman R, 1994, ADV REH IN C FAC HLT
   Streiner DL, 2008, HLTH MEASUREMENT SCA
   Thomas M, 2004, J NEUROL SCI, V217, P89, DOI 10.1016/j.jns.2003.09.005
   Toro B, 2007, ARCH PHYS MED REHAB, V88, P321, DOI 10.1016/j.apmr.2006.12.028
   Vasarhelyi A, 2006, GAIT POSTURE, V23, P99, DOI 10.1016/j.gaitpost.2004.12.005
   Viel E., 2000, MARCHE HUMAINE COURS
   Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1
   Wellmon Robert, 2006, J Geriatr Phys Ther, V29, P74
   Zimbelman J, 2012, ARCH PHYS MED REHAB, V93, P129, DOI 10.1016/j.apmr.2011.08.011
NR 44
TC 5
Z9 5
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 11
PY 2016
VL 11
IS 5
AR e0155225
DI 10.1371/journal.pone.0155225
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM8CD
UT WOS:000376587300085
PM 27168236
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gideon, N
   Hawkes, N
   Mond, J
   Saunders, R
   Tchanturia, K
   Serpell, L
AF Gideon, Nicole
   Hawkes, Nick
   Mond, Jonathan
   Saunders, Rob
   Tchanturia, Kate
   Serpell, Lucy
TI Development and Psychometric Validation of the EDE-QS, a 12 Item Short
   Form of the Eating Disorder Examination Questionnaire (EDE-Q)
SO PLOS ONE
LA English
DT Article
ID SELF-REPORT QUESTIONNAIRE; QUALITY-OF-LIFE; BARIATRIC SURGERY
   CANDIDATES; GENERALIZED ANXIETY DISORDER; PATIENT-REPORTED OUTCOMES;
   COMMUNITY SAMPLES; ANOREXIA-NERVOSA; BULIMIA-NERVOSA; THE-LITERATURE;
   INTERVIEW
AB Objective
   The aim of this study was to develop and validate a short form of the Eating Disorder Examination Questionnaire (EDE-Q) for routine, including session by session, outcome assessment.
   Method
   The current, 28-item version (6.0) of the EDE-Q was completed by 489 individuals aged 18-72 with various eating disorders recruited from three UK specialist eating disorder services. Rasch analysis was carried out on factors identified by means of principal component analysis, which in combination with expert ratings informed the development of an EDE-Q short form. The shortened questionnaire's reliability, validity and sensitivity was assessed based on online data collected from students of a UK university and volunteers with a history of eating disorders recruited from a national eating disorders charity aged 18-74 (N = 559).
   Results
   A 12-item short form, the Eating Disorder Examination Questionnaire Short (EDE-QS) was derived. The new measure showed high internal consistency (Cronbach's a = .913) and temporal stability (ICC = .93; p < .001). It was highly correlated with the original EDE-Q (r = .91 for people without ED; r = .82 for people with ED) and other measures of eating disorder and comorbid psychopathology. It was sufficiently sensitive to distinguish between people with and without eating disorders.
   Discussion
   The EDE-QS is a brief, reliable and valid measure of eating disorder symptom severity that performs similarly to the EDE-Q and that lends itself for the use of sessional outcome monitoring in treatment and research.
C1 [Gideon, Nicole; Saunders, Rob; Serpell, Lucy] UCL, Res Dept Clin Educ & Hlth Psychol, London, England.
   [Hawkes, Nick] East London NHS Fdn Trust, Bedfordshire & Luton Eating Disorders Serv, Dunstable, England.
   [Mond, Jonathan] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia.
   [Mond, Jonathan] Univ Western Sydney, Fac Med, Ctr Hlth Res, Campbelltown, NSW, Australia.
   [Tchanturia, Kate] Kings Coll London, Inst Psychiat, Dept Psychol Med Psychol & Neurosci, London, England.
   [Serpell, Lucy] North East London NHS Fdn Trust, Eating Disorders Serv, Ilford, Essex, England.
RP Gideon, N; Serpell, L (reprint author), UCL, Res Dept Clin Educ & Hlth Psychol, London, England.; Serpell, L (reprint author), North East London NHS Fdn Trust, Eating Disorders Serv, Ilford, Essex, England.
EM nicole.gideon.11@ucl.ac.uk; lucy@serpell.com
RI Saunders, Rob/J-4952-2019
OI Saunders, Rob/0000-0002-7077-8729; Tchanturia, Kate/0000-0001-8988-3265;
   Mond, Jonathan/0000-0002-0410-091X
CR Aardoom JJ, 2012, EAT BEHAV, V13, P305, DOI 10.1016/j.eatbeh.2012.09.002
   Allen KL, 2011, EAT BEHAV, V12, P143, DOI 10.1016/j.eatbeh.2011.01.005
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814
   Bauer S, 2005, EUR EAT DISORD REV, V13, P191, DOI 10.1002/erv.637
   BEGLIN SJ, 1992, PSYCHIAT RES, V44, P191, DOI 10.1016/0165-1781(92)90023-V
   Berg KC, 2012, INT J EAT DISORDER, V45, P428, DOI 10.1002/eat.20931
   Berg KC, 2011, PSYCHOL ASSESSMENT, V23, P714, DOI 10.1037/a0023246
   Bohn K, 2008, BEHAV RES THER, V46, P1105, DOI 10.1016/j.brat.2008.06.012
   Bond T, 2010, APPL RASCH MODEL FUN
   Boyce MB, 2013, QUAL LIFE RES, V22, P2265, DOI 10.1007/s11136-013-0390-0
   Carter JC, 2001, INT J EAT DISORDER, V30, P187, DOI 10.1002/eat.1071
   COOPER Z, 1989, BRIT J PSYCHIAT, V154, P807, DOI 10.1192/bjp.154.6.807
   Coste J, 1997, J CLIN EPIDEMIOL, V50, P247, DOI 10.1016/S0895-4356(96)00363-0
   Department of Health, 2011, NO HLTH MENT HLTH DE
   DeVellis R. F, 2012, SCALE DEV THEORY APP
   Doll HA, 2005, QUAL LIFE RES, V14, P705, DOI 10.1007/s11136-004-0792-0
   Fairburn C. G., 2008, CLIN HDB PSYCHOL DIS
   FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363
   FAIRBURN CG, 1993, BINGE EATING NATURE
   Fornari V, INT J EATING DISORDE, V12, P21
   Franchignoni F, 2010, ARCH PHYS MED REHAB, V91, P1370, DOI 10.1016/j.apmr.2010.06.022
   GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6
   Greco LA, 2008, PSYCHOL ASSESSMENT, V20, P93, DOI 10.1037/1040-3590.20.2.93
   Grilo CM, 2001, J CONSULT CLIN PSYCH, V69, P317, DOI 10.1037//0022-006X.69.2.317
   Hilbert A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029125
   Hill LS, 2010, INT J EAT DISORDER, V43, P344, DOI 10.1002/eat.20679
   Hrabosky JI, 2008, OBESITY, V16, P763, DOI 10.1038/oby.2008.3
   Kalarchian MA, 2000, INT J EAT DISORDER, V28, P465, DOI 10.1002/1098-108X(200012)28:4<465::AID-EAT17>3.0.CO;2-2
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lambert MJ, 2013, PSYCHOTHERAPY, V50, P42, DOI 10.1037/a0030682
   Lambert MJ, 2011, PSYCHOTHERAPY, V48, P72, DOI 10.1037/a0022238
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Latner JD, 2014, INT J EAT DISORDER, V47, P647, DOI 10.1002/eat.22296
   Linacre John M, 2002, J Appl Meas, V3, P85
   Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093
   Luce KH, 1999, INT J EAT DISORDER, V25, P349, DOI 10.1002/(SICI)1098-108X(199904)25:3<349::AID-EAT15>3.0.CO;2-M
   Mond JM, 2004, BEHAV RES THER, V42, P551, DOI 10.1016/S0005-7967(03)00161-X
   Mond JM, 2004, INT J EAT DISORDER, V36, P195, DOI 10.1002/eat.20017
   Mond J, 2014, INT J EAT DISORDER, V47, P335, DOI 10.1002/eat.22237
   Mond J, 2012, AUST NZ J PSYCHIAT, V46, P561, DOI 10.1177/0004867411433967
   Morgan JF, 1999, BRIT MED J
   *NAT I CLIN EXC, 2004, EAT DIS COR INT TREA
   National Institute for Mental Health in England, 2008, MENT HLTH COMP
   Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002
   Peterson CB, 2007, INT J EAT DISORDER, V40, P386, DOI 10.1002/eat.20373
   Rasch G, 1960, PROBABILISTIC MODELS
   Rd Nair, 2011, J REHABIL MED, V43, P944, DOI 10.2340/ 16501977- 0858
   Reas DL, 2006, BEHAV RES THER, V44, P43, DOI 10.1016/j.brat.2005.01.004
   Rosenvinge JH, 2001, EUR EAT DISORD REV, V9, P123, DOI 10.1002/erv.371
   Siegert RJ, 2010, J REHABIL MED, V42, P302, DOI 10.2340/16501977-0511
   Simon W, 2013, PSYCHOTHER RES, V23, P287, DOI 10.1080/10503307.2013.787497
   Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Steinhausen HC, 2009, CHILD ADOL PSYCH CL, V18, P225, DOI 10.1016/j.chc.2008.07.013
   Striegel-Moore RH, 2009, INT J EAT DISORDER, V42, P471, DOI 10.1002/eat.20625
   Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108
   Valderas JM, 2008, QUAL LIFE RES, V17, P179, DOI 10.1007/s11136-007-9295-0
   White HJ, 2014, INT J EAT DISORDER, V47, P99, DOI 10.1002/eat.22199
   Wilfley DE, 1997, BEHAV RES THER, V35, P1151, DOI 10.1016/S0005-7967(97)80010-1
   Williams RT, 2009, REHABIL PSYCHOL, V54, P198, DOI 10.1037/a0015529
NR 61
TC 18
Z9 18
U1 0
U2 23
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 3
PY 2016
VL 11
IS 5
AR e0152744
DI 10.1371/journal.pone.0152744
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DL5KK
UT WOS:000375675700007
PM 27138364
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-07-16
ER

PT J
AU Huguet, A
   Rao, S
   McGrath, PJ
   Wozney, L
   Wheaton, M
   Conrod, J
   Rozario, S
AF Huguet, Anna
   Rao, Sanjay
   McGrath, Patrick J.
   Wozney, Lori
   Wheaton, Mike
   Conrod, Jill
   Rozario, Sharlene
TI A Systematic Review of Cognitive Behavioral Therapy and Behavioral
   Activation Apps for Depression
SO PLOS ONE
LA English
DT Review
ID TO-MODERATE DEPRESSION; MOBILE PHONE; SELF-HELP; HEALTH; DISORDERS;
   SYMPTOMS; OUTCOMES; ANXIETY; INTERVENTIONS; PREVENTION
AB Depression is a common mental health condition for which many mobile apps aim to provide support. This review aims to identify self-help apps available exclusively for people with depression and evaluate those that offer cognitive behavioural therapy (CBT) or behavioural activation (BA). One hundred and seventeen apps have been identified after searching both the scientific literature and the commercial market. 10.26% (n = 12) of these apps identified through our search offer support that seems to be consistent with evidence-based principles of CBT or BA. Taking into account the non existence of effectiveness/efficacy studies, and the low level of adherence to the core ingredients of the CBT/BA models, the utility of these CBT/BA apps are questionable. The usability of reviewed apps is highly variable and they rarely are accompanied by explicit privacy or safety policies. Despite the growing public demand, there is a concerning lack of appropiate CBT or BA apps, especially from a clinical and legal point of view. The application of superior scientific, technological, and legal knowledge is needed to improve the development, testing, and accessibility of apps for people with depression.
C1 [Huguet, Anna; McGrath, Patrick J.; Wozney, Lori; Wheaton, Mike; Conrod, Jill; Rozario, Sharlene] IWK Hlth Ctr, Ctr Res Family Hlth, Halifax, NS, Canada.
   [Huguet, Anna] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada.
   [Rao, Sanjay] Annapolis Valley Hlth, Kentville, NS, Canada.
   [Rao, Sanjay] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada.
   [McGrath, Patrick J.] Dalhousie Univ, Dept Pediat & Sci, Halifax, NS, Canada.
   [McGrath, Patrick J.] Nova Scotia Hlth Author, Halifax, NS, Canada.
RP Huguet, A (reprint author), IWK Hlth Ctr, Ctr Res Family Hlth, Halifax, NS, Canada.; Huguet, A (reprint author), Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada.
EM anna.huguet@iwk.nshealth.ca
RI Emchi, Karma/Q-1952-2016
OI Wozney, Lori/0000-0001-6933-9596; McGrath, Patrick/0000-0002-9568-2571;
   Wozney, Lori/0000-0003-4280-3322
CR Aboujaoude E, 2015, WORLD PSYCHIATRY, V14, P223, DOI 10.1002/wps.20218
   Agaku IT, 2014, J AM MED INFORM ASSN, V21, P374, DOI 10.1136/amiajnl-2013-002079
   Aguilera A, 2015, ARBOR, V191, DOI 10.3989/arbor.2015.771n1012
   Beck AT, 2005, ARCH GEN PSYCHIAT, V62, P953, DOI 10.1001/archpsyc.62.9.953
   Ben-Zeev D, 2015, PSYCHIATR REHABIL J, V38, P218, DOI 10.1037/prj0000130
   Ben-Zeev D, 2015, ADM POLICY MENT HLTH, V42, P157, DOI 10.1007/s10488-014-0556-2
   BinDhim NF, 2015, TELEMED E-HEALTH, V21, P97, DOI 10.1089/tmj.2014.0088
   BinDhim NF, 2015, J AM MED INFORM ASSN, V22, P29, DOI 10.1136/amiajnl-2014-002840
   Bitsch JA, 2015, STUD HEALTH TECHNOL, V211, P153, DOI 10.3233/978-1-61499-516-6-153
   Both F, 2010, HEALTHINF 2010: PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON HEALTH INFORMATICS, P375
   Bowman MA, 2012, J AM BOARD FAM MED, V25, P263, DOI 10.3122/jabfm.2012.03.120068
   Burns MN, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1838
   Bush NE, 2014, MIL MED, V179, P1453, DOI 10.7205/MILMED-D-14-00271
   Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003
   Callan J.A., CLIN TRANSLATIONAL S, V4, P120
   Carmi L, 2014, EUR NEUROPSYCHOPHARM, V24, pS734, DOI 10.1016/S0924-977X(14)71183-6
   Chan S, 2015, TELEMED E-HEALTH, V21, P1038, DOI 10.1089/tmj.2015.0002
   Clarke J, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0272-1
   Clough BA, 2015, PROF PSYCHOL-RES PR, V46, P147, DOI 10.1037/pro0000011
   Cuijpers P, 2007, CLIN PSYCHOL REV, V27, P318, DOI 10.1016/j.cpr.2006.11.001
   Dijk SV, 2014, AM J GERIAT PSYCHIAT, V22, pS57, DOI 10.1016/j.jagp.2013.12.058
   Dimitropoulos Linda, 2011, Am J Manag Care, V17, pSP111
   Donker T, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2791
   Dunnebeil S, 2012, INT J MED INFORM, V81, P746, DOI 10.1016/j.ijmedinf.2012.02.002
   Elias BL, 2014, J PSYCHOSOC NURS MEN, V52, P42, DOI 10.3928/02793695-20131126-07
   Giridher T, COMP SCI INF TECHN I
   Gordon M, 2016, J AM MED INFORM ASSN, V23, P105, DOI 10.1093/jamia/ocv109
   Gravenhorst F, 2015, PERS UBIQUIT COMPUT, V19, P335, DOI 10.1007/s00779-014-0829-5
   Harrison V, 2011, J MENT HEALTH, V20, P509, DOI 10.3109/09638237.2011.608746
   International Data Corporation, 2013, SMARTPH EXP GROW 32
   Irvine M., 2013, THE BIG STORY   0313
   Javelot H, 2014, BIOMED RES INT, DOI 10.1155/2014/104658
   Jimenez-Serrano S, 2015, TELEMED E-HEALTH, V21, P567, DOI 10.1089/tmj.2014.0113
   Juengst SB, 2015, BRAIN INJURY, V29, P1351, DOI 10.3109/02699052.2015.1045031
   Kanter JW, 2010, CLIN PSYCHOL REV, V30, P608, DOI 10.1016/j.cpr.2010.04.001
   Karasouli E, 2014, JMIR MENT HEALTH, V1, DOI 10.2196/mental.3708
   Kauer S, 2011, J ADOLESCENT HEALTH, V48, pS91, DOI 10.1016/j.jadohealth.2010.11.191
   Kauer SD, 2012, J MED INTERNET RES, V14, P15, DOI 10.2196/jmir.1858
   Kessler RC, 2001, BIOL PSYCHIAT, V49, P1002, DOI 10.1016/S0006-3223(01)01129-5
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593
   Kessler RC, 2012, PSYCHIAT CLIN N AM, V35, P1, DOI 10.1016/j.psc.2011.11.005
   Kien Hoa Ly, 2015, Internet Interventions, V2, P60, DOI 10.1016/j.invent.2014.12.002
   Kuehnhausen M, 2013, 2013 IEEE INTERNATIONAL MULTI-DISCIPLINARY CONFERENCE ON COGNITIVE METHODS IN SITUATION AWARENESS AND DECISION SUPPORT (COGSIMA), P30, DOI 10.1109/CogSIMA.2013.6523820
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee MD, 2014, STUD HEALTH TECHNOL, V199, P173, DOI 10.3233/978-1-61499-401-5-173
   Ly KH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126559
   Ly KH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003440
   Ly KH, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-62
   Martinez-Perez B, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2600
   Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1
   Michael S., 2011, THESIS U PITTSBURGH
   Moss K, 2012, AGING MENT HEALTH, V16, P625, DOI 10.1080/13607863.2011.651435
   Murugan M, 2013, INDIAN J PSYCHIAT, V55, pS72
   National Collaborating Centre for Mental Health (UK), 2010, DEPR TREATM MAN DEPR
   National Institute for Clinical Excellence, 2004, DEPR MAN DEPR PRIM S
   Nielsen J, 1994, USABILITY INSPECTION
   Parish C., 1987, NURSING STANDARD ROY, V29, P33
   Price M, 2014, CLIN PSYCHOL PSYCHOT, V21, P427, DOI 10.1002/cpp.1855
   Proudfoot J, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-312
   Proudfoot J, 2013, AUST NZ J PSYCHIAT, V47, P111, DOI 10.1177/0004867412471441
   Reid SC, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-84
   Reid SC, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-131
   Reyes-Portillo JA, 2014, J AM ACAD CHILD PSY, V53, P1254, DOI 10.1016/j.jaac.2014.09.005
   Roepke AM, 2015, GAMES HEALTH J, V4, P235, DOI 10.1089/g4h.2014.0046
   Rozbroj T, 2014, J MED INTERNET RES, V16, P84, DOI 10.2196/jmir.3529
   Saeb S, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4273
   Schaffer A, 2013, J CLIN PSYCHOPHARM, V33, P775, DOI 10.1097/JCP.0b013e31829e8359
   Shen N, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3713
   Sunyaev A, 2015, J AM MED INFORM ASSN, V22, pE28, DOI 10.1136/amiajnl-2013-002605
   Torous John, 2015, Internet Interventions, V2, P169, DOI 10.1016/j.invent.2015.03.002
   Torous J, 2015, JMIR MENT HEALTH, V2, DOI 10.2196/mental.3889
   Torous J, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0602-0
   US FDA, 2013, GUID IND FOOD DRUG A
   van't Hof E, 2009, CNS SPECTRUMS, V14, P34, DOI 10.1017/S1092852900027279
   Wan JZ, 2008, 2008 3RD INTERNATIONAL CONFERENCE ON PERVASIVE COMPUTING AND APPLICATIONS, VOLS 1 AND 2, P652
   Warmerdam L, 2012, STUD HEALTH TECHNOL, V181, P339, DOI 10.3233/978-1-61499-121-2-339
   Watanabe N, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0805-z
   Watts S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-49
NR 78
TC 63
Z9 64
U1 3
U2 41
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 2
PY 2016
VL 11
IS 5
AR e0154248
DI 10.1371/journal.pone.0154248
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DL5KB
UT WOS:000375674800015
PM 27135410
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zuk, A
   Fitzpatrick, T
   Rosella, LC
AF Zuk, Aleksandra
   Fitzpatrick, Tiffany
   Rosella, Laura C.
TI Effect of Vitamin D-3 Supplementation on Inflammatory Markers and
   Glycemic Measures among Overweight or Obese Adults: A Systematic Review
   of Randomized Controlled Trials
SO PLOS ONE
LA English
DT Review
ID NECROSIS-FACTOR-ALPHA; NUTRITION EXAMINATION SURVEY; SERUM
   25-HYDROXYVITAMIN D; PLACEBO-CONTROLLED TRIAL; HUMAN ADIPOSE-TISSUE;
   C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; D
   DEFICIENCY; TNF-ALPHA
AB Background
   Obesity induced low-grade chronic inflammation disrupts proper immune and metabolic function. Vitamin D deficiency increases inflammation, which is associated with cardiometabolic risk. This systematic review examines the association between oral vitamin D (VD) supplementation and circulating inflammatory biomarkers and glycemic outcomes from randomized controlled trials (RCTs) of overweight and/or obese adults.
   Methods
   MEDLINE OVID, EMBASE and the Cochrane Central Register of Controlled Trials were searched according to a predefined protocol. Eligible RCTs included adults randomized to receive either oral VD or placebo. Two reviewers independently assessed RCTs for inclusion. Bias was assessed using the Cochrane Collaboration risk of bias tool. Mean differences were calculated comparing end-of-study sample means between the independent VD and placebo groups.
   Results
   Eleven unique RCTs met inclusion criteria from a total of 3,383 identified citations, including 79 screened articles and 14 full text data extractions. Inflammatory and glycemic measures were reported in 7 and 10 RCTs, respectively. Most trial findings were non-significant with considerable heterogeneity in design, participants and outcomes. All but one trial was rated as either high or unclear risk of bias. Two RCTs reported significant changes in inflammatory biomarkers; however, the mean difference between groups was not statistically significant: C-reactive protein 0.19 mg/L (p = 0.88); Tumor Necrosis Factor -0.54 pg/ml (p = 0.20). Two other trials found significant mean differences in fasting plasma glucose -0.32 mmol/L (p = 0.03), Hemoglobin A1c -0.13% (p = 0.04), and Homeostatic Model Assessment -0.86 (p = 0.02) following VD supplementation.
   Conclusions
   Overall, there is no clear established benefit of VD supplementation on inflammatory bio-markers among overweight/obese adults. Baseline serum VD possibly influences the effect of VD repletion on inflammatory markers. Risk of bias was present in most studies, thus supporting the need for higher quality studies in this area to more conclusively understand the role VD supplementation has on inflammatory pathways.
C1 [Zuk, Aleksandra; Rosella, Laura C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada.
   [Fitzpatrick, Tiffany; Rosella, Laura C.] Publ Hlth Ontario, Toronto, ON, Canada.
   [Rosella, Laura C.] Inst Clin Evaluat Sci, Toronto, ON, Canada.
RP Zuk, A (reprint author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada.
EM Aleksandra.zuk@mail.utoronto.ca
CR Akl EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2809
   Al-Badr W, 2008, CLIN J AM SOC NEPHRO, V3, P1555, DOI 10.2215/CJN.01150308
   Alkharfy KM, 2013, BASIC CLIN PHARMACOL, V112, P42, DOI 10.1111/j.1742-7843.2012.00936.x
   Almerighi C, 2009, CYTOKINE, V45, P190, DOI 10.1016/j.cyto.2008.12.009
   Amer M, 2012, AM J CARDIOL, V109, P226, DOI 10.1016/j.amjcard.2011.08.032
   Barba C, 2004, LANCET, V363, P157
   Barker T, 2013, EUR J APPL PHYSIOL, V113, P1523, DOI 10.1007/s00421-012-2582-7
   Beilfuss J, 2012, CYTOKINE, V60, P870, DOI 10.1016/j.cyto.2012.07.032
   Bellia A, 2013, INTERN EMERG MED, V8, P33, DOI 10.1007/s11739-011-0559-x
   Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34
   Bigby M, 2003, ARCH DERMATOL, V139, P795, DOI 10.1001/archderm.139.6.795
   Carrillo AE, 2013, CLIN NUTR, V32, P375, DOI 10.1016/j.clnu.2012.08.014
   Carrillo AE, 2012, EUR J APPL PHYSIOL, V112, P3045, DOI 10.1007/s00421-011-2279-3
   Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051
   Cheng G, 2012, CRITICAL REV IMMUNOL, V32
   Cheng S, 2010, DIABETES, V59, P242, DOI 10.2337/db09-1011
   Chiu KC, 2004, AM J CLIN NUTR, V79, P820
   Cipriani C, 2013, J CLIN ENDOCR METAB, V98, P2709, DOI 10.1210/jc.2013-1586
   Dalgard C, 2011, DIABETES CARE, V34, P1284, DOI 10.2337/dc10-2084
   Dandona P, 2006, DRUG DEVELOP RES, V67, P619, DOI 10.1002/ddr.20137
   Davidson MB, 2013, DIABETES CARE, V36, P260, DOI 10.2337/dc12-1204
   DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003
   Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Diaz L, 2009, J REPROD IMMUNOL, V81, P17, DOI 10.1016/j.jri.2009.02.005
   Ding C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061707
   Ding C, 2012, BRIT J NUTR, V108, P1915, DOI 10.1017/S0007114512003285
   Dumville JC, 2006, BMJ-BRIT MED J, V332, P969, DOI 10.1136/bmj.332.7547.969
   Evans KN, 2006, BIOL REPROD, V75, P816, DOI 10.1095/biolreprod.106.054056
   Field AE, 2013, JAMA-J AM MED ASSOC, V310, P2147, DOI 10.1001/jama.2013.281501
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723
   Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656
   Forouhi NG, 2008, DIABETES, V57, P2619, DOI 10.2337/db08-0593
   Greenberg A., 2006, AM J CLIN NUTR, V83, P461, DOI DOI 10.1093/AJCN/83.2.461S
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88
   Guillot X, 2010, JOINT BONE SPINE, V77, P552, DOI 10.1016/j.jbspin.2010.09.018
   Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387
   Harris SS, 2012, DIABETES OBES METAB, V14, P789, DOI 10.1111/j.1463-1326.2012.01605.x
   Heaney RP, 2012, NEW ENGL J MED, V367, P77, DOI 10.1056/NEJMe1206858
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Holick MF, 2004, AM J CLIN NUTR, V79, P362
   Holick MF, 2008, AM J CLIN NUTR, V87, p1080S
   Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553
   Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385
   Jablonski KL, 2011, HYPERTENSION, V57, P63, DOI 10.1161/HYPERTENSIONAHA.110.160929
   Janssen I, 2004, AM J CLIN NUTR, V79, P379
   Jorde R, 2010, J INTERN MED, V267, P462, DOI 10.1111/j.1365-2796.2009.02181.x
   Jorde R, 2010, CYTOKINE, V50, P175, DOI 10.1016/j.cyto.2009.12.006
   Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779
   Khan H, 2013, P NUTR SOC, V72, P89, DOI 10.1017/S0029665112002765
   Kong J, 2013, J ENDOCRINOL, V216, P265, DOI 10.1530/JOE-12-0344
   Kositsawat J, 2010, DIABETES CARE, V33, P1236, DOI 10.2337/dc09-2150
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LAPIDUS L, 1984, BMJ-BRIT MED J, V289, P1257, DOI 10.1136/bmj.289.6454.1257
   Leal VD, 2013, CLIN CHIM ACTA, V419, P87, DOI 10.1016/j.cca.2013.02.003
   Levine AB, 2006, METABOLIC SYNDROME C, P192
   Littell J. H., 2008, SYSTEMATIC REV METAA
   Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132
   Lundh A, 2012, IND SPONSORSHIP RES
   Maki KC, 2011, INT J FOOD SCI NUTR, V62, P318, DOI 10.3109/09637486.2010.536146
   Manigrasso MR, 2005, J CLIN ENDOCR METAB, V90, P5876, DOI 10.1210/jc.2005-0281
   Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118
   Mitri J, 2014, ENDOCRIN METAB CLIN, V43, P205, DOI 10.1016/j.ecl.2013.09.010
   Mitri J, 2011, AM J CLIN NUTR, V94, P486, DOI 10.3945/ajcn.111.011684
   Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135
   Nagpal J, 2009, DIABETIC MED, V26, P19, DOI 10.1111/j.1464-5491.2008.02636.x
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Olszanecka-Glinianowicz M, 2004, METABOLISM, V53, P1268, DOI 10.1016/j.metabol.2004.07.001
   Olszanecka-Glinianowicz M, 2011, METABOLISM, V60, P531, DOI 10.1016/j.metabol.2010.04.023
   Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398
   Park HS, 2005, DIABETES RES CLIN PR, V69, P29, DOI 10.1016/j.diabres.2004.11.007
   Penckofer S, 2008, DIABETES EDUCATOR, V34, P939, DOI 10.1177/0145721708326764
   de Heredia FP, 2012, P NUTR SOC, V71, P332, DOI 10.1017/S0029665112000092
   Peterson CA, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-10
   Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298
   Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994
   Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016
   Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202
   Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704
   Ryden M, 2007, J INTERN MED, V262, P431, DOI 10.1111/j.1365-2796.2007.01854.x
   Rytka JM, 2011, DIABETES, V60, P56, DOI 10.2337/db10-0697
   Schulz KF, 2002, LANCET, V359, P614, DOI 10.1016/S0140-6736(02)07750-4
   Schwalfenberg G, 2007, CAN FAM PHYSICIAN, V53, P841
   Sim J, 2005, PHYS THER, V85, P257
   Sun XM, 2014, NUTRIENTS, V6, P221, DOI 10.3390/nu6010221
   Tarcin O, 2009, J CLIN ENDOCR METAB, V94, P4023, DOI 10.1210/jc.2008-1212
   Teegarden D, 2009, NUTR RES REV, V22, P82, DOI 10.1017/S0954422409389301
   Theodoratou E, 2014, BMJ-BRIT MED J, P348
   Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035
   Tricco AC, 2008, J CLIN EPIDEMIOL, V61, P422, DOI 10.1016/j.jclinepi.2007.10.017
   Verhagen AP, 2001, J CLIN EPIDEMIOL, V54, P651, DOI 10.1016/S0895-4356(00)00360-7
   Viera AJ, 2005, FAM MED, V37, P360
   Wamberg L, 2013, EUR J INTERN MED, V24, P644, DOI 10.1016/j.ejim.2013.03.005
   Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127
   WHYTE MP, 1979, J CLIN ENDOCR METAB, V48, P906, DOI 10.1210/jcem-48-6-906
   Winkler G, 2003, EUR J ENDOCRINOL, V149, P129, DOI 10.1530/eje.0.1490129
   Wortsman J, 2000, AM J CLIN NUTR, V72, P690
   Wyatt SB, 2006, AM J MED SCI, V331, P166, DOI 10.1097/00000441-200604000-00002
   Zhu W, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-8
   Zittermann A, 2009, AM J CLIN NUTR, V89, P1321, DOI 10.3945/ajcn.2008.27004
NR 100
TC 13
Z9 13
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 26
PY 2016
VL 11
IS 4
AR e0154215
DI 10.1371/journal.pone.0154215
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DK5QB
UT WOS:000374973600050
PM 27116227
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lau, A
   Barrie, J
   Winter, C
   Elamy, AH
   Tyrrell, G
   Long, R
AF Lau, Angela
   Barrie, James
   Winter, Christopher
   Elamy, Abdel-Halim
   Tyrrell, Gregory
   Long, Richard
TI Chest Radiographic Patterns and the Transmission of Tuberculosis:
   Implications for Automated Systems
SO PLOS ONE
LA English
DT Article
ID MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; CONTACT
   INVESTIGATIONS; CLOSED ENVIRONMENT; SMEAR; EPIDEMIOLOGY;
   RECOMMENDATIONS; VARIABILITY; INFECTION; AEROSOLS
AB Background
   Computer-aided detection to identify and diagnose pulmonary tuberculosis is being explored. While both cavitation on chest radiograph and smear-positivity on microscopy are independent risk factors for the infectiousness of pulmonary tuberculosis it is unknown which radiographic pattern, were it detectable, would provide the greatest public health benefit; i.e. reduced transmission. Herein we provide that evidence.
   Objectives
   1) to determine whether pulmonary tuberculosis in a high income, low incidence country is more likely to present with "typical" adult-type pulmonary tuberculosis radiographic features and 2) to determine whether those with "typical" radiographic features are more likely than those without such features to transmit the organism and/or cause secondary cases.
   Methods
   Over a three-year period beginning January 1, 2006 consecutive adults with smear-positive pulmonary tuberculosis in the Province of Alberta, Canada, were identified and their pretreatment radiographs scored by three independent readers as "typical" (having an upper lung zone predominant infiltrate, with or without cavitation but no discernable adenopathy) or "atypical" (all others). Each patient's pre-treatment bacillary burden was carefully documented and, during a 30-month transmission window, each patient's transmission events were recorded. Mycobacteriology, radiology and transmission were compared in those with "typical" versus "atypical" radiographs.
   Findings
   A total of 97 smear-positive pulmonary tuberculosis cases were identified, 69 (71.1%) with and 28 (28.9%) without "typical" chest radiographs. "Typical" cases were more likely to have high bacillary burdens and cavitation (Odds Ratios and 95% Confidence Intervals: 2.75 [1.04-7.31] and 9.10 [2.51-32.94], respectively). Typical cases were also responsible for most transmission events-78% of tuberculin skin test conversions (p<0.002) and 95% of secondary cases in reported close contacts (p<0.01); 94% of secondary cases in "unreported" contacts (p<0.02).
   Conclusion
   As a group, smear-positive pulmonary tuberculosis patients with typical radiographic features constitute the greatest public health risk. This may have implications for automated detection systems.
C1 [Lau, Angela; Elamy, Abdel-Halim; Long, Richard] Univ Alberta, Dept Med, Edmonton, AB, Canada.
   [Barrie, James; Winter, Christopher] Univ Alberta, Dept Radiol, Edmonton, AB, Canada.
   [Long, Richard] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.
   [Tyrrell, Gregory] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada.
   [Tyrrell, Gregory] Alberta Hlth Serv, Prov Lab Publ Hlth, Edmonton, AB, Canada.
   [Tyrrell, Gregory] Alberta Hlth Serv, Prov Lab Publ Hlth, Calgary, AB, Canada.
RP Long, R (reprint author), Univ Alberta, Dept Med, Edmonton, AB, Canada.; Long, R (reprint author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.
EM richard.long@ualberta.ca
CR Alberta Health and Wellness, 2007, TUB PREV CONTR GUID
   Bailey WC, 2002, JAMA-J AM MED ASSOC, V287, P996, DOI 10.1001/jama.287.8.996
   Bark CM, 2011, TUBERCULOSIS, V91, P257, DOI 10.1016/j.tube.2011.01.004
   Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0
   Breuninger M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106381
   Burgos M, 2003, J INFECT DIS, V188, P1878, DOI 10.1086/379895
   Canetti G. J., 1955, TUBERCLE BACILLUS PU
   CATANZARO A, 1982, AM REV RESPIR DIS, V125, P559, DOI 10.1164/arrd.1982.125.5.559
   Dale JW, 2001, INT J TUBERC LUNG D, V5, P216
   Diacon AH, 2014, TUBERCULOSIS, V94, P148, DOI 10.1016/j.tube.2013.12.002
   FALK A, 1969, DIAGNOSTIC STANDARDS, P68
   Fennelly KP, 2012, AM J RESP CRIT CARE, V186, P450, DOI 10.1164/rccm.201203-0444OC
   Ferebee SH, 1969, ADV TUBERC RES, V17, P29
   FERGUSON RG, 1955, STUDIES TUBERCULOSIS
   Grandjean L, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001843
   GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90
   Hernandez-Garduno E, 2004, THORAX, V59, P286, DOI 10.1136/thx.2003.011759
   HOUK VN, 1968, ARCH ENVIRON HEALTH, V16, P26, DOI 10.1080/00039896.1968.10665011
   HOUK VN, 1968, ARCH ENVIRON HEALTH, V16, P4, DOI 10.1080/00039896.1968.10665007
   Jensen M, 2012, INT J TUBERC LUNG D, V16, P43, DOI 10.5588/ijtld.11.0374
   Jones-Lopez EC, 2013, AM J RESP CRIT CARE, V187, P1007, DOI 10.1164/rccm.201208-1422OC
   KHAN MA, 1977, AM J MED, V62, P31, DOI 10.1016/0002-9343(77)90346-1
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LIIPPO KK, 1993, AM REV RESPIR DIS, V148, P235, DOI 10.1164/ajrccm/148.1.235
   Lohmann EM, 2012, INT J TUBERC LUNG D, V16, P1477, DOI 10.5588/ijtld.12.0129
   LONG R, 1991, CHEST, V99, P123, DOI 10.1378/chest.99.1.123
   Long R, 2015, CAN RESPIR J, V22, P317, DOI 10.1155/2015/826035
   Long R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098993
   Loudon RG, 1969, AM REV RESPIR DIS, V99, P1969
   Maduskar P, 2013, INT J TUBERC LUNG D, V17, P1613, DOI 10.5588/ijtld.13.0325
   Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022
   Medlar EM., 1955, AM REV TUBERC LUNG D
   Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07
   Parhar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117036
   Sloot R, 2014, AM J RESP CRIT CARE, V190, P1044, DOI 10.1164/rccm.201406-1159OC
   SULTAN L, 1960, AM REV RESPIR DIS, V82, P358
   The Canadian Lung Association and the Public Health Agency of Canada, 2007, CAN LUNG ASS PUBL HL
   TOMAN K, 1979, TUBERCULOSIS CASE FI
   Van Dyck P, 2003, EUR RADIOL, V13, P1771, DOI 10.1007/s00330-002-1612-y
   van Ginneken B, 2009, EUR J RADIOL, V72, P226, DOI 10.1016/j.ejrad.2009.05.061
   VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406
   Xu T, 2013, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2013-3
NR 42
TC 8
Z9 8
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 22
PY 2016
VL 11
IS 4
AR e0154032
DI 10.1371/journal.pone.0154032
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ9WX
UT WOS:000374565100036
PM 27105337
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Enerly, E
   Bonde, J
   Schee, K
   Pedersen, H
   Lonnberg, S
   Nygard, M
AF Enerly, Espen
   Bonde, Jesper
   Schee, Kristina
   Pedersen, Helle
   Lonnberg, Stefan
   Nygard, Mari
TI Self-Sampling for Human Papillomavirus Testing among Non-Attenders
   Increases Attendance to the Norwegian Cervical Cancer Screening
   Programme
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; GENOTYPE SPECIFICITY; WOMEN; METAANALYSIS;
   PARTICIPATION; REASONS; SWEDEN; AUDIT
AB Increasing attendance to screening offers the best potential for improving the effectiveness of well-established cervical cancer screening programs. Self-sampling at home for human papillomavirus (HPV) testing as an alternative to a clinical sampling can be a useful policy to increase attendance. To determine whether self-sampling improves screening attendance for women who do not regularly attend the Norwegian Cervical Cancer Screening Programme (NCCSP), 800 women aged 25-69 years in the Oslo area who were due to receive a 2nd reminder to attend regular screening were randomly selected and invited to be part of the intervention group. Women in this group received one of two self-sampling devices, Evalyn Brush or Delphi Screener. To attend screening, women in the intervention group had the option of using the self-sampling device (self-sampling subgroup) or visiting their physician for a cervical smear. Self-sampled specimens were split and analyzed for the presence of high-risk (hr) HPV by the CLART (R) HPV2 test and the digene (R) Hybrid Capture (HC)2 test. The control group consisted of 2593 women who received a 2nd reminder letter according to the current guidelines of the NCCSP. The attendance rates were 33.4% in the intervention group and 23.2% in the control group, with similar attendance rates for both self-sampling devices. Women in the self-sampling subgroup responded favorably to both self-sampling devices and cited not remembering receiving a call for screening as the most dominant reason for previous non-attendance. Thirty-two of 34 (94.1%) hrHPV-positive women in the self-sampling subgroup attended follow-up. In conclusion, self-sampling increased attendance rates and was feasible and well received. This study lends further support to the proposal that self-sampling may be a valuable alternative for increasing cervical cancer screening coverage in Norway.
C1 [Enerly, Espen; Schee, Kristina; Nygard, Mari] Oslo Univ Hosp, Canc Registry Norway, Dept Res, Oslo, Norway.
   [Bonde, Jesper; Pedersen, Helle] Copenhagen Univ Hosp Hvidovre, Dept Pathol, Hvidovre, Denmark.
   [Bonde, Jesper; Pedersen, Helle] Copenhagen Univ Hosp Hvidovre, Clin Res Ctr, Hvidovre, Denmark.
   [Lonnberg, Stefan] Oslo Univ Hosp, Cerv Canc Screening Programme, Canc Registry Norway, Oslo, Norway.
RP Enerly, E (reprint author), Oslo Univ Hosp, Canc Registry Norway, Dept Res, Oslo, Norway.
EM espen.enerly@kreftregisteret.no
RI Enerly, Espen/P-4666-2019
OI Enerly, Espen/0000-0002-2974-2273; Bonde, Jesper/0000-0003-4853-6747;
   Lonnberg, Stefan/0000-0002-5561-9041; Nygard, Mari/0000-0002-4100-4855
FU Norwegian Cancer Society [63499]
FX This study was funded by Norwegian Cancer Society (Grant# 63499)
   (https://kreftforeningen.no/en). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Andrae B, 2008, J NATL CANCER I, V100, P622, DOI 10.1093/jnci/djn099
   Andreassen Trude, 2014, Tidsskr Nor Laegeforen, V134, P1122, DOI 10.4045/tidsskr.14.0240
   Arbyn M, 2014, J PATHOL, V234, P431, DOI 10.1002/path.4424
   Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9
   Arbyn M, 2009, EUR J CANCER, V45, P2640, DOI 10.1016/j.ejca.2009.07.018
   Bosgraaf RP, 2014, PREV MED, V64, P108, DOI 10.1016/j.ypmed.2014.04.011
   Broberg G, 2014, INT J CANCER, V134, P2223, DOI 10.1002/ijc.28545
   Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321
   Cancer Registry of Norway, 2012, CANC NORW 2010 CANC
   Castle PE, 2008, J CLIN MICROBIOL, V46, P2595, DOI 10.1128/JCM.00824-08
   Eaker S, 2001, PREV MED, V32, P482, DOI 10.1006/pmed.2001.0844
   Hansen BT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-264
   International Agency for Research on Cancer, 2012, IARC MON EV CARC RIS, V100F
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lonnberg S, 2013, INT J CANCER, V132, P2134, DOI 10.1002/ijc.27844
   Nygard JF, 2005, CANCER CAUSE CONTROL, V16, P463, DOI 10.1007/s10552-004-6295-z
   Nygard JF, 2002, J MED SCREEN, V9, P86, DOI 10.1136/jms.9.2.86
   Poljak M, 2009, J CLIN MICROBIOL, V47, P2611, DOI 10.1128/JCM.00278-09
   Racey CS, 2013, CAN J PUBLIC HEALTH, V104, pE159
   Rebolj M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086835
   Rebolj M, 2013, CURR PHARM DESIGN, V19, P1439
   Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7
   Rossi PG, 2015, BRIT J CANCER, V112, P667, DOI 10.1038/bjc.2015.11
   Rossi PG, 2011, BRIT J CANCER, V104, P248, DOI 10.1038/sj.bjc.6606040
   Sasieni P, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2968
   Skare GB, 2014, MASSEUNDERSOKELSEN M
   Szarewski A, 2011, BRIT J CANCER, V104, P915, DOI 10.1038/bjc.2011.48
   Verdoodt F, 2015, EUR J CANCER, V51, P2375, DOI 10.1016/j.ejca.2015.07.006
NR 28
TC 30
Z9 30
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 13
PY 2016
VL 11
IS 4
AR e0151978
DI 10.1371/journal.pone.0151978
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ3UC
UT WOS:000374131200013
PM 27073929
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chen, KF
   Chaou, CH
   Jiang, JY
   Yu, HW
   Meng, YH
   Tang, WC
   Wu, CC
AF Chen, Kuan-Fu
   Chaou, Chung-Hsien
   Jiang, Jing-Yi
   Yu, Hsueh-Wen
   Meng, Yu-Hsiang
   Tang, Wei-Chen
   Wu, Chin-Chieh
TI Diagnostic Accuracy of Lipopolysaccharide-Binding Protein as Biomarker
   for Sepsis in Adult Patients: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID COMMUNITY-ACQUIRED INFECTIONS; PROCALCITONIN; BACTEREMIA; MARKER; LPS;
   SIRS
AB Introduction
   Lipopolysaccharide-binding protein (LBP) is widely reported as a biomarker to differentiate infected from non-infected patients. The diagnostic use of LBP for sepsis remains a matter of debate. We aimed to perform a systematic review and meta-analysis to assess the diagnostic accuracy of serum LBP for sepsis in adult patients.
   Methods
   We performed a systematic review and meta-analysis to assess the accuracy of LBP for sepsis diagnosis. A systematic search in PubMed and EMBASE for studies that evaluated the diagnostic role of LBP for sepsis through December 2015 was conducted. We searched these databases for original, English language, research articles that studied the diagnostic accuracy between septic and non-septic adult patients. Sensitivity, specificity, and other measures of accuracy, such as diagnostic odds ratio (DOR) and area under the receiver operating characteristic curve (AUC) of LBP were pooled using the Hierarchical Summary Receiver Operating Characteristic (HSROC) method.
   Results
   Our search returned 53 reports, of which 8 fulfilled the inclusion criteria, accounting for 1684 patients. The pooled sensitivity and specificity of LBP for diagnosis of sepsis by the HSROC method were 0.64 (95% CI: 0.56-0.72) and 0.63 (95% CI: 0.53-0.73), respectively. The value of the DOR was 3.0 (95% CI: 2.0-4.0) and the AUC was 0.68 (95% CI: 0.64-0.72). Meta-regression analysis revealed that cut-off values accounted for the heterogeneity of sensitivity and sample size (> = 150) accounted for the heterogeneity of specificity.
   Conclusions
   Based on the results of our meta-analysis, LBP had weak sensitivity and specificity in the detection of sepsis. LBP may not be practically recommended for clinical utilization as a single biomarker.
C1 [Chen, Kuan-Fu; Tang, Wei-Chen; Wu, Chin-Chieh] Chang Gung Mem Hosp, Dept Emergency Med, Keelung, Taiwan.
   [Chen, Kuan-Fu] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan.
   [Chen, Kuan-Fu] Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan.
   [Chaou, Chung-Hsien] Chang Gung Mem Hosp, Dept Emergency Med, Linkou, Taiwan.
   [Jiang, Jing-Yi; Yu, Hsueh-Wen] Chang Gung Univ, Sch Tradit Chinese Med, Taoyuan, Taiwan.
   [Meng, Yu-Hsiang] Chang Gung Univ, Sch Med, Taoyuan, Taiwan.
RP Wu, CC (reprint author), Chang Gung Mem Hosp, Dept Emergency Med, Keelung, Taiwan.
EM wujinja@cgmh.org.tw
OI Chaou, Chung-Hsien/0000-0002-3702-7499
FU National Science Council [NMRPG2A6011]; Chang Gung Memorial Hospital in
   Taiwan [100-2314-B-182A-038-MY3, CMRPG2C0201, CMRPG2B0121, CMRPG2B0271,
   CMRPG2B0371]
FX National Science Council (grant number: NMRPG2A6011) Chang Gung Memorial
   Hospital in Taiwan (grant number: 100-2314-B-182A-038-MY3, CMRPG2C0201,
   CMRPG2B0121, CMRPG2B0271 and CMRPG2B0371). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adib-Conquy M, 2007, FEBS LETT, V581, P3723, DOI 10.1016/j.febslet.2007.03.074
   Blairon L, 2003, J INFECT DIS, V187, P287, DOI 10.1086/346046
   BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644
   Carlet J, 1999, INFECT DIS CLIN N AM, V13, P483, DOI 10.1016/S0891-5520(05)70087-8
   Gaini S, 2007, CRIT CARE, V11, DOI 10.1186/cc5967
   Gaini S, 2006, CRIT CARE, V10, DOI 10.1186/cc4866
   Gibot S, 2012, AM J RESP CRIT CARE, V186, P65, DOI 10.1164/rccm.201201-0037OC
   Gille-Johnson P, 2012, SCAND J INFECT DIS, V44, P745, DOI 10.3109/00365548.2012.689846
   Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2
   Henriquez-Camacho C, 2014, BIOMED RES INT, DOI 10.1155/2014/547818
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139
   Meynaar IA, 2011, CRIT CARE RES PRACT, DOI 10.1155/2011/594645
   MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203
   Nierhaus A, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-8
   Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093
   Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872
   Prucha M, 2003, CRIT CARE, V7, pR154, DOI 10.1186/cc2386
   RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117
   Ratzinger F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082946
   Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942
   Sakr Y, 2008, CRIT CARE MED, V36, P2014, DOI 10.1097/CCM.0b013e31817b86e3
   Song FJ, 2002, INT J EPIDEMIOL, V31, P88, DOI 10.1093/ije/31.1.88
   TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777
   Tromp M, 2012, J INFECTION, V65, P292, DOI 10.1016/j.jinf.2012.06.004
   Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7
   Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009
   WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311
   Wu YP, 2012, CRIT CARE, V16, DOI 10.1186/cc11884
   WURFEL MM, 1994, J EXP MED, V180, P1025, DOI 10.1084/jem.180.3.1025
NR 31
TC 8
Z9 9
U1 1
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 7
PY 2016
VL 11
IS 4
AR e0153188
DI 10.1371/journal.pone.0153188
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DI6KO
UT WOS:000373608000096
PM 27055115
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Shridhar, PB
   Noll, LW
   Shi, XR
   Cernicchiaro, N
   Renter, DG
   Bai, J
   Nagaraja, TG
AF Shridhar, Pragathi B.
   Noll, Lance W.
   Shi, Xiaorong
   Cernicchiaro, Natalia
   Renter, David G.
   Bai, J.
   Nagaraja, T. G.
TI Escherichia coli O104 in Feedlot Cattle Feces: Prevalence, Isolation and
   Characterization
SO PLOS ONE
LA English
DT Article
ID MULTIPLEX PCR; VIRULENCE FACTORS; STRAINS; OUTBREAK; GENES;
   IDENTIFICATION; EXPRESSION; SEROTYPES; SEQUENCE; GERMANY
AB Escherichia coli O104:H4, an hybrid pathotype of Shiga toxigenic and enteroaggregative E. coli, involved in a major foodborne outbreak in Germany in 2011, has not been detected in cattle feces. Serogroup O104 with H type other than H4 has been reported to cause human illnesses, but their prevalence and characteristics in cattle have not been reported. Our objectives were to determine the prevalence of E. coli O104 in feces of feedlot cattle, by culture and PCR detection methods, and characterize the isolated strains. Rectal fecal samples from a total of 757 cattle originating from 29 feedlots were collected at a Midwest commercial slaughter plant. Fecal samples, enriched in E. coli broth, were subjected to culture and PCR methods of detection. The culture method involved immunomagnetic separation with O104-specific beads and plating on a selective chromogenic medium, followed by serogroup confirmation of pooled colonies by PCR. If pooled colonies were positive for the wzx(O104) gene, then colonies were tested individually to identify wzx(O104)-positive serogroup and associated genes of the hybrid strains. Extracted DNA from feces were also tested by a multiplex PCR to detect wzx(O104)-positive serogroup and associated major genes of the O104 hybrid pathotype. Because wzx(O104) has been shown to be present in E. coli O8/O9/O9a, wzx(O104)-positive isolates and extracted DNA from fecal samples were also tested by a PCR targeting wbdD(O8/O9/O9a), a gene specific for E. coli O8/O9/O9a serogroups. Model-adjusted prevalence estimates of E. coli O104 (positive for wzx(O104) and negative for wbdD(O8/O9/O9a)) at the feedlot level were 5.7% and 21.2%, and at the sample level were 0.5% and 25.9% by culture and PCR, respectively. The McNemar's test indicated that there was a significant difference (P < 0.01) between the proportions of samples that tested positive for wzx(O104) and samples that were positive for wzx(O104), but negative for wbdD(O8/O9/O9a) by PCR and culture methods. A total of 143 isolates, positive for the wzx(O104), were obtained in pure culture from 146 positive fecal samples. Ninety-two of the 143 isolates (64.3%) also tested positive for the wbdD(O8/O9/O9a), indicating that only 51 (35.7%) isolates truly belonged to the O104 serogroup (positive for wzx(O104) and negative for wbdD(O8/O9/O9a)). All 51 isolates tested negative for eae, and 16 tested positive for stx1 gene of the subtype 1c. Thirteen of the 16 stx1-positive O104 isolates were from one feedlot. The predominant serotype was O104:H7. Pulsed-field gel electrophoresis analysis indicated that stx1-positive O104:H7 isolates had 62.4% homology to the German outbreak strain and 67.9% to 77.5% homology to human diarrheagenic O104:H7 strains. The 13 isolates obtained from the same feedlot were of the same PFGE subtype with 100% Dice similarity. Although cattle do not harbor the O104:H4 pathotype, they do harbor and shed Shiga toxigenic O104 in the feces and the predominant serotype was O104:H7.
C1 [Shridhar, Pragathi B.; Noll, Lance W.; Shi, Xiaorong; Cernicchiaro, Natalia; Renter, David G.; Nagaraja, T. G.] Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.
   [Bai, J.] Kansas State Univ, Vet Diagnost Lab, Manhattan, KS 66506 USA.
RP Nagaraja, TG (reprint author), Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.
EM tnagaraj@vet.k-state.edu
RI Bai, Jianfa/M-7830-2019
OI Bai, Jianfa/0000-0002-0021-3036
FU National Institute of Food and Agriculture, U. S. Department of
   Agriculture [2012-68003-30155]
FX This material is based upon work that is supported by the National
   Institute of Food and Agriculture, U. S. Department of Agriculture,
   under award number 2012-68003-30155 (to TGN). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   presentation of the manuscript.
CR Amezquita-Lopez BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051565
   Auvray F, 2012, VET MICROBIOL, V158, P443, DOI 10.1016/j.vetmic.2012.02.029
   Bai JF, 2012, FOODBORNE PATHOG DIS, V9, P541, DOI 10.1089/fpd.2011.1082
   Bai JF, 2010, J MICROBIOL METH, V82, P85, DOI 10.1016/j.mimet.2010.05.003
   Baranzoni GM, 2014, INT J FOOD MICROBIOL, V173, P99, DOI 10.1016/j.ijfoodmicro.2013.12.020
   Beutin L, 2007, APPL ENVIRON MICROB, V73, P4769, DOI 10.1128/AEM.00873-07
   Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7
   Blanco A, 2004, J CLIN MICROBIOL, V42, P645, DOI 10.1128/JCM.42.2.645-651.2004
   Blanco M, 2003, J CLIN MICROBIOL, V41, P1351, DOI 10.1128/JCM.41.4.1351-1356.2003
   Cleary J, 2004, MICROBIOL-SGM, V150, P527, DOI 10.1099/mic.0.26740-0
   Delannoy S, 2012, J CLIN MICROBIOL, V50, P3485, DOI 10.1128/JCM.01656-12
   DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008
   Feng P, 2001, J CLIN MICROBIOL, V39, P24, DOI 10.1128/JCM.39.1.24-28.2001
   Friedrich AW, 2003, J CLIN MICROBIOL, V41, P2448, DOI 10.1128/JCM.41.6.2448-2453.2003
   GAMIAN A, 1993, J BACTERIOL, V175, P1508
   Hao WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033971
   Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421
   Karch H, 2012, EMBO MOL MED, V4, P841, DOI 10.1002/emmm.201201662
   KEDZIERSKA B, 1978, EUR J BIOCHEM, V91, P545, DOI 10.1111/j.1432-1033.1978.tb12708.x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129
   Manna SK, 2010, J APPL MICROBIOL, V108, P658, DOI 10.1111/j.1365-2672.2009.04460.x
   McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996
   Miko A, 2013, INT J MED MICROBIOL, V303, P410, DOI 10.1016/j.ijmm.2013.05.006
   Moriel DG, 2012, MBIO, V3, DOI 10.1128/mBio.00118-12
   NATARO JP, 1993, INFECT IMMUN, V61, P1126
   Noll LW, 2015, PLOS ONE IN PRESS
   Paddock ZD, 2013, APPL ENVIRON MICROB, V79, P3522, DOI 10.1128/AEM.00246-13
   Posse B, 2008, FEMS MICROBIOL LETT, V282, P124, DOI 10.1111/j.1574-6968.2008.01121.x
   Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12
   Sekse C, 2011, APPL ENVIRON MICROB, V77, P4949, DOI 10.1128/AEM.00189-11
   Tau NP, 2012, EMERG INFECT DIS, V18, P1314, DOI 10.3201/eid1808.111616
   Wang L, 2001, GENE, V270, P231, DOI 10.1016/S0378-1119(01)00471-1
   Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x
   Wieler LH, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-17
NR 35
TC 9
Z9 9
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 24
PY 2016
VL 11
IS 3
AR e0152101
DI 10.1371/journal.pone.0152101
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH3SV
UT WOS:000372708000088
PM 27010226
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Scholes, S
   Bridges, S
   Fat, LN
   Mindell, JS
AF Scholes, Shaun
   Bridges, Sally
   Fat, Linda Ng
   Mindell, Jennifer S.
TI Comparison of the Physical Activity and Sedentary Behaviour Assessment
   Questionnaire and the Short-Form International Physical Activity
   Questionnaire: An Analysis of Health Survey for England Data
SO PLOS ONE
LA English
DT Article
ID CRITERION-RELATED VALIDITY; RISK-FACTORS; IPAQ; RELIABILITY; ADULTS;
   TIME; AGE; COEFFICIENT; AGREEMENT
AB Background
   The Physical Activity and Sedentary Behaviour Assessment Questionnaire (PASBAQ), used within the Health Survey for England (HSE) at 5-yearly intervals, is not included annually due to funding and interview-length constraints. Policy-makers and data-users are keen to consider shorter instruments such as the Short-form International Physical Activity Questionnaire (IPAQ) for the annual survey. Both questionnaires were administered in HSE 2012, enabling comparative assessment in a random sample of 1252 adults.
   Methods
   Relative agreement using prevalence-adjusted bias-adjusted Kappa (PABAK) statistics was estimated for: sufficient aerobic activity (moderate-to-vigorous physical activity [MVPA] >= 150minutes/week); inactivity (MVPA<30minutes/week); and excessive sitting (>= 540minutes/weekday). Cross-sectional associations with health outcomes were compared across tertiles of MVPA and tertiles of sitting time using logistic regression with tests for linear trend.
   Results
   Compared with PASBAQ data, IPAQ-assessed estimates of sufficient aerobic activity and inactivity were higher and lower, respectively; estimates of excessive sitting were higher. Demographic patterns in prevalence were similar. Agreement using PABAK statistics was fair-to-moderate for sufficient aerobic activity (0.32-0.49), moderate-to-substantial for inactivity (0.42-0.74), and moderate-to-substantial for excessive sitting (0.49-0.75). As with the PASBAQ, IPAQ-assessed MVPA and sitting each showed graded associations with mental well-being (women: P for trend = 0.003 and 0.004, respectively) and obesity (women: P for trend = 0.007 and 0.014, respectively).
   Conclusions
   Capturing habitual physical activity and sedentary behaviour through brief questionnaires is complex. Differences in prevalence estimates can reflect differences in questionnaire structure and content rather than differences in reported behaviour. Treating all IPAQ-assessed walking as moderate-intensity contributed to the differences in prevalence estimates. PASBAQ data will be used for population surveillance every 4 to 5 years. The current version of the Short-form IPAQ was included in HSE 2013-14 to enable more frequent assessment of physical activity and sedentary behaviour; a modified version with different item-ordering and additional questions on walking-pace and effort was included in HSE 2015.
C1 [Scholes, Shaun; Fat, Linda Ng; Mindell, Jennifer S.] UCL, Res Dept Epidemiol & Publ Hlth, Hlth & Social Surveys Res Grp, 1-19 Torrington Pl, London WC1E 6BT, England.
   [Bridges, Sally] NatCen Social Res, 35 Northampton Sq, London EC1V 0AX, England.
RP Scholes, S (reprint author), UCL, Res Dept Epidemiol & Publ Hlth, Hlth & Social Surveys Res Grp, 1-19 Torrington Pl, London WC1E 6BT, England.
EM s.scholes@ucl.ac.uk
RI Mindell, Jennifer S/G-2241-2011
OI Mindell, Jennifer S/0000-0002-7604-6131
FU Health and Social Care Information Centre
FX The Health Survey for England 2012 was funded by the Health and Social
   Care Information Centre. The funders had no role in the study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ainsworth BE, 2006, MED SCI SPORT EXER, V38, P1584, DOI 10.1249/01.mss.0000229457.73333.9a
   Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12
   Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009
   Allender S, 2007, J EPIDEMIOL COMMUN H, V61, P344, DOI 10.1136/jech.2006.050807
   Bauman Adrian, 2006, Promot Educ, V13, P92, DOI 10.1177/10253823060130020103
   Bauman A, 2011, AM J PREV MED, V41, P228, DOI 10.1016/j.amepre.2011.05.003
   Bauman A, 2009, J PHYS ACT HEALTH, V6, pS5, DOI 10.1123/jpah.6.s1.s5
   Becares L, 2009, HLTH SURVEY ENGLAND, V1, P221
   Belanger M, 2011, PREV MED, V52, P247, DOI 10.1016/j.ypmed.2011.02.008
   Bell JA, 2014, DIABETOLOGIA, V57, P2048, DOI 10.1007/s00125-014-3323-8
   Brown W, 2004, AUST NZ J PUBL HEAL, V28, P128, DOI 10.1111/j.1467-842X.2004.tb00925.x
   *CHIEF MED OFF, 2004, LEAST 5 WEEK EV IMP
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314
   Department for Culture Media and Sport Strategy Unit, 2002, GAME PLAN STRAT DEL
   Department of Health, 2011, START ACT STAY ACT
   Dyrstad SM, 2014, MED SCI SPORT EXER, V46, P99, DOI 10.1249/MSS.0b013e3182a0595f
   Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840
   Everage NJ, 2014, BIOMED RES INT, DOI 10.1155/2014/389853
   Flight L, 2015, PHARM STAT, V14, P74, DOI 10.1002/pst.1659
   Ganna A, 2015, LANCET, V386, P533, DOI 10.1016/S0140-6736(15)60175-1
   Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103
   International Physical Activity Questionnaire, 2004, GUID DAT PROC AN INT
   Joint Health Surveys Unit, 2007, HLTH SURV ENGL PHYS
   KANNEL WB, 1985, AM HEART J, V109, P876, DOI 10.1016/0002-8703(85)90653-2
   Knott C, 2012, HLTH SURVEY ENGLAND, V1, P63
   Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Littman AJ, 2004, EPIDEMIOLOGY, V15, P105, DOI 10.1097/01.ede.0000091604.32542.97
   Lordan G, 2015, RISK ANAL, V35, P2069, DOI 10.1111/risa.12417
   Macniven R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-41
   Maddison R, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-62
   Matthews CE, 2005, MED SCI SPORT EXER, V37, P986, DOI 10.1249/01.mss.0000171615.76521.69
   Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199
   Neave A., 2014, RESPONSES HLTH SURVE
   Pols MA, 1998, EUR J EPIDEMIOL, V14, P63, DOI 10.1023/A:1007427831179
   Sabia S, 2014, AM J EPIDEMIOL, V179, P781, DOI 10.1093/aje/kwt330
   Sadarangani KP, 2014, DIABETES CARE, V37, P1016, DOI 10.2337/dc13-1816
   Scholes S, 2012, HLTH SURV ENGL, V1, P1
   Scholes S, 2014, AM J EPIDEMIOL, V179, P1493, DOI 10.1093/aje/kwu087
   Scholes S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-129
   Sim J, 2005, PHYS THER, V85, P257
   Sport & Recreation New Zealand (SPARC), 2004, NZ PHYS ACT QUEST
   Stamatakis E, 2007, AM J PREV MED, V32, P320, DOI 10.1016/j.amepre.2006.12.020
   Stamatakis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073753
   Stamatakis E, 2012, INT J EPIDEMIOL, V41, P1328, DOI 10.1093/ije/dys077
   Stranges S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005878
   Szklo M, 2007, EPIDEMIOLOGY BASICS
   Taylor-Piliae RE, 2006, AM J EPIDEMIOL, V164, P598, DOI 10.1093/aje/kwj248
   Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63
   The Health and Social Care Information Centre, 2014, HLTH SURV ENGL 2012
   Tomioka K, 2011, J EPIDEMIOL, V21, P459, DOI 10.2188/jea.JE20110003
   Troiano RP, 2012, J PHYS ACT HEALTH, V9, pS68, DOI 10.1123/jpah.9.s1.s68
   UKactive, 2014, TURN TID IN
   Wanner M, 2014, BRIT J SPORT MED, V48, P1570, DOI 10.1136/bjsports-2012-092122
   Wareham NJ, 1998, INT J OBESITY, V22, pS30
   Warrens MJ, 2013, J PROBAB STAT, DOI 10.1155/2013/325831
   Watson PF, 2010, THERIOGENOLOGY, V73, P1167, DOI 10.1016/j.theriogenology.2010.01.003
   Weston L., 2014, HLTH SURVEY ENGLAND, V1, P1
   World Health Organisation WHO, 2011, GLOB REC PHYS ACT HL
NR 63
TC 14
Z9 14
U1 1
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 18
PY 2016
VL 11
IS 3
AR e0151647
DI 10.1371/journal.pone.0151647
PG 30
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH1ZE
UT WOS:000372582800083
PM 26990093
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chiatante, G
   Meriggi, A
AF Chiatante, Gianpasquale
   Meriggi, Alberto
TI The Importance of Rotational Crops for Biodiversity Conservation in
   Mediterranean Areas
SO PLOS ONE
LA English
DT Article
ID BIRD SPECIES RICHNESS; PROTECTED AREAS; FARMLAND BIRDS; AGRICULTURAL
   INTENSIFICATION; GAP ANALYSIS; TERRESTRIAL BIODIVERSITY; LANDSCAPE
   HETEROGENEITY; FRUGIVOROUS BIRDS; POPULATION TRENDS; NATURE-RESERVES
AB Nowadays we are seeing the largest biodiversity loss since the extinction of the dinosaurs. To conserve biodiversity it is essential to plan protected areas using a prioritization approach, which takes into account the current biodiversity value of the sites. Considering that in the Mediterranean Basin the agro-ecosystems are one of the most important parts of the landscape, the conservation of crops is essential to biodiversity conservation. In the framework of agro-ecosystem conservation, farmland birds play an important role because of their representativeness, and because of their steady decline in the last Century in Western Europe. The main aim of this research was to define if crop dominated landscapes could be useful for biodiversity conservation in a Mediterranean area in which the landscape was modified by humans in the last thousand years and was affected by the important biogeographical phenomenon of peninsula effect. To assess this, we identify the hotspots and the coldspots of bird diversity in southern Italy both during the winter and in the breeding season. In particular we used a scoring method, defining a biodiversity value for each cell of a 1-km grid superimposed on the study area, using data collected by fieldwork following a stratified random sampling design. This value was analysed by a multiple linear regression analysis and was predicted in the whole study area. Then we defined the hotspots and the coldspots of the study area as 15% of the cells with higher and lower value of biodiversity, respectively. Finally, we used GAP analysis to compare hotspot distribution with the current network of protected areas. This study showed that the winter hotspots of bird diversity were associated with marshes and water bodies, shrublands, and irrigated crops, whilst the breeding hotspots were associated with more natural areas (e.g. transitional wood/shrubs), such as open areas (natural grasslands, pastures and not irrigated crops). Moreover, the results underlined the negative effects of permanent crops, such as vineyards, olive groves, and orchards, in particular during the winter season. This research highlights the importance of farmland areas mainly for wintering species and the importance of open areas for breeding species in the Mediterranean Basin. This may be true even when the species' spatial distribution could be affected by biogeography. An important result showed that the hotspots for breeding species cannot be used as a surrogate for the wintering species, which were often not considered in the planning of protected areas.
C1 [Chiatante, Gianpasquale; Meriggi, Alberto] Univ Pavia, Dept Earth & Environm Sci, Via Ferrata 1, I-27100 Pavia, Italy.
RP Chiatante, G (reprint author), Univ Pavia, Dept Earth & Environm Sci, Via Ferrata 1, I-27100 Pavia, Italy.
EM harrier84@libero.it
FU project "Aggiornamento della carta delle vocazioni faunistiche
   dell'Ambito Territoriale di Caccia Bari e Barletta-Andria-Trani"
   (Hunting District "Bari", Apulia, Italy); project "Aggiornamento della
   carta delle vocazioni faunistiche dell'Ambito Territoriale di Caccia
   Bari e Barletta-Andria-Trani" (Hunting District"Bari", Apulia, Italy)
FX This study was funded by the project "Aggiornamento della carta delle
   vocazioni faunistiche dell'Ambito Territoriale di Caccia Bari e
   Barletta-Andria-Trani" (Hunting District "Bari", Apulia, Italy). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.; We are grateful
   to Giovanni Ferrara of Hunting District "Bari" for his help during the
   project. This study was funded by the project "Aggiornamento della carta
   delle vocazioni faunistiche dell'Ambito Territoriale di Caccia Bari e
   Barletta-Andria-Trani" (Hunting District"Bari", Apulia, Italy). We
   appreciate the improvements in English usage made by Andrew Sturgeon. We
   thank three anonymous referees for reviewing the manuscript.
CR Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_
   Andelman SJ, 2003, ECOL LETT, V6, P818, DOI 10.1046/j.1461-0248.2003.00503.x
   Araujo MB, 2001, CONSERV BIOL, V15, P1710, DOI 10.1046/j.1523-1739.2001.99450.x
   Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P17, DOI 10.1111/j.1466-822X.2004.00128.x
   Araujo MB, 2007, CONSERV BIOL, V21, P1423, DOI 10.1111/j.1523-1739.2007.00827.x
   Bacaro G, 2011, BIODIVERS CONSERV, V20, P1677, DOI 10.1007/s10531-011-0054-8
   Baccetti Nicola, 2002, Biologia e Conservazione della Fauna, V111, P1
   Barabesi L, 2013, ENVIRON ECOL STAT, V20, P215, DOI 10.1007/s10651-012-0216-1
   Benayas JMR, 2003, BIOL CONSERV, V114, P357, DOI 10.1016/S0006-3207(03)00064-8
   Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9
   Bibby C. J., 2000, BIRD CENSUS TECHNIQU
   BirdLife International, 2004, BIRDS EUR POP EST TR
   Bishop JA, 2005, ECOL INDIC, V5, P33, DOI 10.1016/j.ecolind.2004.10.001
   Blondel J, 1999, BIOL WILDLIFE MEDITE
   Boatman ND, 2004, IBIS, V146, P131, DOI 10.1111/j.1474-919X.2004.00347.x
   Boucheker A, 2011, OSTRICH, V82, P167, DOI 10.2989/00306525.2011.607856
   Brambilla M, 2010, BIOL CONSERV, V143, P2770, DOI 10.1016/j.biocon.2010.07.025
   BROWN JW, 1990, J BIOGEOGR, V17, P615, DOI 10.2307/2845143
   Buckland ST, 2006, AUK, V123, P345, DOI 10.1642/0004-8038(2006)123[345:PSFSRM]2.0.CO;2
   Burfield I., 2005, ECOLOGY CONSERVATION, P119
   Burnham K. P, 2002, MODEL SELECTION MULT
   Campedelli T, 2015, AGR ECOSYST ENVIRON, V213, P32, DOI 10.1016/j.agee.2015.07.012
   Campedelli T, 2010, ARDEOLA, V57, P51
   Castro-Caro JC, 2014, J ORNITHOL, V155, P357, DOI 10.1007/s10336-013-1010-z
   Cerezo A, 2011, BIODIVERS CONSERV, V20, P2649, DOI 10.1007/s10531-011-0096-y
   Chamberlain D, 2014, BIRD STUDY, V61, P121, DOI 10.1080/00063657.2013.870527
   Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x
   Chuman T, 2010, LANDSCAPE URBAN PLAN, V98, P200, DOI 10.1016/j.landurbplan.2010.08.003
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   COLWELL RK, 1994, PHILOS T ROY SOC B, V345, P101, DOI 10.1098/rstb.1994.0091
   Covas R, 1998, IBIS, V140, P395, DOI 10.1111/j.1474-919X.1998.tb04600.x
   Crawley MJ, 1993, GLIM ECOLOGISTS
   Danielsen F, 2004, ANIM CONSERV, V7, P79, DOI 10.1017/S1367943003001215
   Das A, 2006, BIOL CONSERV, V133, P16, DOI 10.1016/j.biocon.2006.05.023
   de la Montana E, 2011, BIOL CONSERV, V144, P2468, DOI 10.1016/j.biocon.2011.07.001
   Donald PF, 2002, AGR ECOSYST ENVIRON, V89, P167, DOI 10.1016/S0167-8809(01)00244-4
   Estrada A, 2011, BIOL CONSERV, V144, P1120, DOI 10.1016/j.biocon.2010.12.031
   Farina A, 1997, LANDSCAPE ECOL, V12, P365, DOI 10.1023/A:1007934518160
   Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088
   Fornasari Lorenzo, 2010, Avocetta, V34, P5
   FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467
   Frazee SR, 2003, BIOL CONSERV, V112, P275, DOI 10.1016/S0006-3207(02)00400-7
   Fretwell SD, 1972, POPULATIONS SEASONAL
   Fuller RJ, 1995, CONSERV BIOL, V9, P1425, DOI 10.1046/j.1523-1739.1995.09061425.x
   Gaston KJ, 2006, BIOL CONSERV, V132, P76, DOI 10.1016/j.biocon.2006.03.013
   Genghini M, 2006, BIODIVERS CONSERV, V15, P3077, DOI 10.1007/s10531-005-5400-2
   Gil-Tena A, 2015, AGR ECOSYST ENVIRON, V205, P79, DOI 10.1016/j.agee.2015.03.013
   Gill F. B., 2014, IOC WORLD BIRD LIST
   GOUTNER V, 1992, BIOL CONSERV, V62, P131, DOI 10.1016/0006-3207(92)90934-F
   Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1
   Haslem A, 2008, ECOL APPL, P185
   Hoctor TS, 2000, CONSERV BIOL, V14, P984, DOI 10.1046/j.1523-1739.2000.99075.x
   Huertas DL, 2001, CAN J ZOOL, V79, P279, DOI 10.1139/cjz-79-2-279
   Jackson SF, 2009, BIODIVERS CONSERV, V18, P2143, DOI 10.1007/s10531-009-9578-6
   Jeliazkov A, 2016, AGR ECOSYST ENVIRON, V216, P9, DOI 10.1016/j.agee.2015.09.017
   Jiguet F, 2005, BIODIVERS CONSERV, V14, P3305, DOI 10.1007/s10531-004-0448-y
   Kati V, 2004, BIOL CONSERV, V120, P471, DOI 10.1016/j.biocon.2004.03.020
   Kerr JT, 1997, CONSERV BIOL, V11, P1094, DOI 10.1046/j.1523-1739.1997.96089.x
   Krebs C.J, 1999, ECOLOGICAL METHODOLO
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LAWLOR TE, 1983, AM NAT, V121, P432, DOI 10.1086/284071
   Legendre P., 1998, NUMERICAL ECOLOGY
   Liordos V, 2014, ZOOL STUD, V53, DOI 10.1186/1810-522X-53-12
   Lombard AT, 1995, S AFR J ZOOL, V30, P145
   Magurran AE, 2004, MEASURING BIOL DIVER
   Maiorano L, 2007, CONSERV BIOL, V21, P1433, DOI 10.1111/j.1523-1739.2007.00831.x
   Maiorano L, 2006, BIOL CONSERV, V133, P455, DOI 10.1016/j.biocon.2006.07.015
   Marfil-Daza C, 2013, ANIM CONSERV, V16, P60, DOI 10.1111/j.1469-1795.2012.00569.x
   Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251
   Mendoza AM, 2014, BIODIVERS CONSERV, V23, P909, DOI 10.1007/s10531-014-0642-5
   Meynard CN, 2009, BIODIVERS CONSERV, V18, P3061, DOI 10.1007/s10531-009-9625-3
   Mezquida ET, 2006, ORNIS FENNICA, V83, P11
   Mihoub JB, 2010, BIOL CONSERV, V143, P839, DOI 10.1016/j.biocon.2009.12.026
   Morelli F, 2013, ECOL INDIC, V34, P372, DOI 10.1016/j.ecolind.2013.05.021
   Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501
   Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x
   Oldfield TEE, 2004, BIOL CONSERV, V120, P303, DOI 10.1016/j.biocon.2004.03.003
   Olsvig-Whittaker L, 2005, ISR J PLANT SCI, V53, P149, DOI 10.1560/A1QK-KN7P-0DUY-FL4B
   Pace RM, 2000, J WILDLIFE MANAGE, V64, P933, DOI 10.2307/3803201
   Peronace Valentina, 2012, Avocetta, V36, P11
   PETIT DR, 1989, J FIELD ORNITHOL, V60, P241
   Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626
   Prendergast JR, 1999, CONSERV BIOL, V13, P484, DOI 10.1046/j.1523-1739.1999.97428.x
   PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0
   Reif J, 2008, IBIS, V150, P596, DOI 10.1111/j.1474-919X.2008.00829.x
   Rendon MA, 2008, BIOL CONSERV, V141, P1371, DOI 10.1016/j.biocon.2008.03.006
   Rey PJ, 2011, J APPL ECOL, V48, P228, DOI 10.1111/j.1365-2664.2010.01902.x
   REY PJ, 1993, ARDEA, V81, P151
   Rippa D, 2011, IBIS, V153, P721, DOI 10.1111/j.1474-919X.2011.01156.x
   Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422
   Sancho C. J, 1993, LANDSCAPE URBAN PLAN, V23, P155
   Santos KC, 2008, LANDSCAPE URBAN PLAN, V84, P140, DOI 10.1016/j.landurbplan.2007.07.004
   SAVIN NE, 1977, ECONOMETRICA, V45, P1989, DOI 10.2307/1914122
   Schouten MA, 2010, BIODIVERS CONSERV, V19, P2517, DOI 10.1007/s10531-010-9857-2
   SCOTT J M, 1993, WILDLIFE MONOGR, V123, P3, DOI DOI 10.2307/3830788
   Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2
   Serra P, 2008, APPL GEOGR, V28, P189, DOI 10.1016/j.apgeog.2008.02.001
   Shi H, 2005, CONSERV BIOL, V19, P1273, DOI 10.1111/j.1523-1739.2005.00225.x
   SIMPSON GG, 1964, SYST ZOOL, V13, P57, DOI 10.2307/2411825
   Solymos P, 2005, CONSERV BIOL, V19, P1084, DOI 10.1111/j.1523-1739.2005.00193.x
   Soule ME, 1998, SCIENCE, V279, P2060, DOI 10.1126/science.279.5359.2060
   Stralberg D, 2011, BIODIVERS CONSERV, V20, P19, DOI 10.1007/s10531-010-9943-5
   Suarez-Seone S, 2002, BIOL CONSERV, V105, P333
   Thompson BC, 2001, BIOL CONSERV, V100, P229, DOI 10.1016/S0006-3207(01)00026-X
   Traba J, 2007, BIODIVERS CONSERV, V16, P3255, DOI 10.1007/s10531-006-9138-2
   Troupin D, 2014, BIOL CONSERV, V169, P158, DOI 10.1016/j.biocon.2013.11.009
   Tucker GM, 1994, BIRDS EUROPE THEIR C
   Underwood EC, 2009, CONSERV BIOL, V23, P43, DOI 10.1111/j.1523-1739.2008.01072.x
   Wiersma YF, 2009, BIOL CONSERV, V142, P1639, DOI 10.1016/j.biocon.2009.02.034
   Williams P, 1996, CONSERV BIOL, V10, P155, DOI 10.1046/j.1523-1739.1996.10010155.x
   Williams PH, 2003, BIODIVERS CONSERV, V12, P1297, DOI 10.1023/A:1023092100942
   Wilson JD, 1999, AGR ECOSYST ENVIRON, V75, P13, DOI 10.1016/S0167-8809(99)00064-X
   Wilson KA, 2005, BIOL CONSERV, V122, P99, DOI 10.1016/j.biocon.2004.07.004
   Wretenberg J, 2006, J APPL ECOL, V43, P1110, DOI 10.1111/j.1365-2664.2006.01216.x
   Wright HL, 2012, CONSERV LETT, V5, P11, DOI 10.1111/j.1755-263X.2011.00208.x
   Yip JY, 2004, BIODIVERS CONSERV, V13, P943, DOI 10.1023/B:BIOC.0000014463.32427.cf
   Zenatello M, 2014, RISULTATI CENSIMENTI
   Zuur A., 2009, MIXED EFFECTS MODELS
   Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x
NR 119
TC 3
Z9 3
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 26
PY 2016
VL 11
IS 2
AR e0149323
DI 10.1371/journal.pone.0149323
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DF3UU
UT WOS:000371274400016
PM 26918960
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Cai, XN
   Wang, C
   Chen, SD
   Lu, J
AF Cai, Xiaonan
   Wang, Chen
   Chen, Shengdi
   Lu, Jian
TI Model Development for Risk Assessment of Driving on Freeway under Rainy
   Weather Conditions
SO PLOS ONE
LA English
DT Article
ID YOUNG NOVICE DRIVERS; ACCIDENTS
AB Rainy weather conditions could result in significantly negative impacts on driving on freeways. However, due to lack of enough historical data and monitoring facilities, many regions are not able to establish reliable risk assessment models to identify such impacts. Given the situation, this paper provides an alternative solution where the procedure of risk assessment is developed based on drivers' subjective questionnaire and its performance is validated by using actual crash data. First, an ordered logit model was developed, based on questionnaire data collected from Freeway G15 in China, to estimate the relationship between drivers' perceived risk and factors, including vehicle type, rain intensity, traffic volume, and location. Then, weighted driving risk for different conditions was obtained by the model, and further divided into four levels of early warning (specified by colors) using a rank order cluster analysis. After that, a risk matrix was established to determine which warning color should be disseminated to drivers, given a specific condition. Finally, to validate the proposed procedure, actual crash data from Freeway G15 were compared with the safety prediction based on the risk matrix. The results show that the risk matrix obtained in the study is able to predict driving risk consistent with actual safety implications, under rainy weather conditions.
C1 [Cai, Xiaonan; Lu, Jian] Shanghai Jiao Tong Univ, Sch Naval Architecture Ocean & Civil Engn, Transportat Res Ctr, Shanghai 200030, Peoples R China.
   [Wang, Chen; Lu, Jian] Tongji Univ, Sch Transportat Engn, Shanghai 200092, Peoples R China.
   [Chen, Shengdi] Shanghai Maritime Univ, Coll Transport & Commun, Shanghai, Peoples R China.
RP Wang, C (reprint author), Tongji Univ, Sch Transportat Engn, Shanghai 200092, Peoples R China.
EM wkobec@hotmail.com
FU Shanghai Pujiang Program [15PJC093]; Fundamental Research Funds for the
   Central Universities [1600219254]
FX This research project was partly sponsored by "Shanghai Pujiang Program"
   (15PJC093) and "the Fundamental Research Funds for the Central
   Universities" (1600219254). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Andrey J, 1993, WEATHER HAZARDS DRIV
   Andrey J, 2013, WEATHER INFORM ROAD, V6, P14
   Berdica K, 2002, TRANSPORT POLICY, V9, P117, DOI DOI 10.1016/S0967-070X(02)00011-2
   China Meteorological Administration, 2010, GRAD WEATH COND FREE
   Clarke DD, 2006, ACCIDENT ANAL PREV, V38, P871, DOI 10.1016/j.aap.2006.02.013
   Deery HA, 1999, J SAFETY RES, V30, P225, DOI 10.1016/S0022-4375(99)00018-3
   Department of Transportation of P. R. China, 2004, TECHN STAND HIGHW EN
   Doherty S. T., 1993, CLIMATOLOGICAL B, V27, P154
   Eisenberg D, 2004, ACCIDENT ANAL PREV, V36, P637, DOI 10.1016/S0001-4575(03)00085-X
   ElDessouki WM, 2004, US DEP TRANSPORTATIO
   Gregersen NP, 1996, ACCIDENT ANAL PREV, V28, P229, DOI 10.1016/0001-4575(95)00063-1
   Henry JJ, 1998, NCHRP SYNTHESIS HIGH, V291
   Kamrin MA, 2003, REPORTING RISK JOURN
   Klauer S. G. G., 2006, IMPACT DRIVER INATTE
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Morris RS Mounce JM Button JW Walton NE, 1977, TRANSPORT RES REC, P19
   OECD (Organization for Economic Co-operation and Development) Research Group, 1976, ADV WEATH RED VIS RO
   Office of Operations, 2014, ROAD WEATHER MANAGEM, V10, P16
   Palutikof J. P., 1991, JOURNAL OF HIGHWAY M, P163
   ROSE JG, 1977, TRANSPORT ENG-J ASCE, V103, P491
   SHERRETZ LA, 1978, J APPL METEOROL, V17, P711, DOI 10.1175/1520-0450(1978)017<0711:AAOTRB>2.0.CO;2
   Traffic Management Administration of the Ministry of Public Security, 2012, ANN REP ROAD ACC PEO
   Underwood G, 2007, ERGONOMICS, V50, P1235, DOI 10.1080/00140130701318707
NR 23
TC 1
Z9 1
U1 3
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 19
PY 2016
VL 11
IS 2
AR e0149442
DI 10.1371/journal.pone.0149442
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DF3DG
UT WOS:000371223400054
PM 26894434
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Aymerich, IF
   Oliva, M
   Giralt, S
   Martin-Herrero, J
AF Aymerich, Ismael F.
   Oliva, Marc
   Giralt, Santiago
   Martin-Herrero, Julio
TI Detection of Tephra Layers in Antarctic Sediment Cores with
   Hyperspectral Imaging
SO PLOS ONE
LA English
DT Article
ID SOUTH-SHETLAND-ISLANDS; LIVINGSTON-ISLAND; ANISOTROPIC DIFFUSION; BYERS
   PENINSULA; LAKE; ICE; ERUPTION; ICELAND; QUALITY; RECORD
AB Tephrochronology uses recognizable volcanic ash layers (from airborne pyroclastic deposits, or tephras) in geological strata to set unique time references for paleoenvironmental events across wide geographic areas. This involves the detection of tephra layers which sometimes are not evident to the naked eye, including the so-called cryptotephras. Tests that are expensive, time-consuming, and/or destructive are often required. Destructive testing for tephra layers of cores from difficult regions, such as Antarctica, which are useful sources of other kinds of information beyond tephras, is always undesirable. Here we propose hyperspectral imaging of cores, Self-Organizing Map (SOM) clustering of the preprocessed spectral signatures, and spatial analysis of the classified images as a convenient, fast, non-destructive method for tephra detection. We test the method in five sediment cores from three Antarctic lakes, and show its potential for detection of tephras and cryptotephras.
C1 [Aymerich, Ismael F.; Martin-Herrero, Julio] Univ Vigo, AtlantTIC, Vigo 36310, Spain.
   [Oliva, Marc] Univ Lisbon, Ctr Geog Studies IGOT, P-1699 Lisbon, Portugal.
   [Giralt, Santiago] Inst Earth Sci Jaume Almera CSIC, Barcelona, Spain.
RP Aymerich, IF (reprint author), Univ Vigo, AtlantTIC, Vigo 36310, Spain.
EM ismael.aymerich@gmail.com
RI Oliva, Marc/K-5423-2014; Giralt, Santiago/G-4823-2011; Martin-Herrero,
   Julio/D-3827-2009
OI Oliva, Marc/0000-0001-6521-6388; Giralt, Santiago/0000-0001-8570-7838; 
FU Portuguese Science Foundation through the HOLOANTAR (Holocene
   environmental change in the Maritime Antarctic: Interactions Between
   permafrost and the lacustrine environment) project; Portuguese Polar
   Program (PROPOLAR); AXA Research Fund
FX Core extraction and analyses were funded by the Portuguese Science
   Foundation through the HOLOANTAR (Holocene environmental change in the
   Maritime Antarctic: Interactions Between permafrost and the lacustrine
   environment) project and the Portuguese Polar Program (PROPOLAR). The
   AXA Research Fund sponsored M. Oliva's research activities in
   Antarctica. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Alfaro P, 2010, J IBER GEOL, V36, P21
   Andrews JT, 2006, HOLOCENE, V16, P1035, DOI 10.1177/0959683606069384
   Aymerich IF, 2009, APPL SPECTROSC, V63, P716, DOI 10.1366/000370209788559683
   Bartolini S, 2014, J VOLCANOL GEOTH RES, V285, P150, DOI 10.1016/j.jvolgeores.2014.08.009
   BJORCK S, 1991, ANTARCT SCI, V3, P61, DOI 10.1017/S095410209100010X
   Bjorck S, 1996, LIVINGSTON ISLAND BA, P49
   Blockley SPE, 2005, QUATERNARY SCI REV, V24, P1952, DOI 10.1016/j.quascirev.2004.12.008
   Calvino-Cancela M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102381
   Caseldine C, 1999, HOLOCENE, V9, P635, DOI 10.1191/095968399666026772
   Chen QQ, 2013, POLAR RES, V32, DOI 10.3402/polar.v32i0.19932
   Cioni R, 2014, EARTH PLANET SC LETT, V394, P111, DOI 10.1016/j.epsl.2014.02.051
   DEPERSIA AT, 1995, P SOC PHOTO-OPT INS, V2496, P159, DOI 10.1117/12.211312
   Ferreiro-Arman M, 2006, LECT NOTES COMPUT SC, V4142, P730
   Gehrels MJ, 2008, QUATERN INT, V178, P68, DOI 10.1016/j.quaint.2006.10.014
   Giardino C, 2007, REMOTE SENS ENVIRON, V109, P183, DOI 10.1016/j.rse.2006.12.017
   Grahn H., 2007, TECHNIQUES APPL HYPE
   Grosjean M., 2014, PAGES (Past Global Changes) News, V22, P10
   Gudmundsdottir ER, 2011, J QUATERNARY SCI, V26, P589, DOI 10.1002/jqs.1474
   Himberg J, 2001, PATTERN RECOGN, P38
   Hodgson DA, 1998, ANTARCT SCI, V10, P13, DOI 10.1017/S0954102098000030
   Huang H, 2014, SENSORS-BASEL, V14, P7248, DOI 10.3390/s140407248
   Hunt JB, 2001, J QUATERNARY SCI, V16, P105, DOI 10.1002/jqs.571
   Kim MS, 2001, T ASAE, V44, P721
   KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288
   KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325
   Kohonen T., 1989, SELF ORG ASS MEMORY
   Kohonen T., 1997, SELF ORGANIZING MAPS
   Kruse F. A., 1998, P 9 AUSTR REM SENS C
   Kylander ME, 2012, HOLOCENE, V22, P371, DOI 10.1177/0959683611423688
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee YI, 2007, QUATERNARY SCI REV, V26, P3167, DOI 10.1016/j.quascirev.2007.09.007
   Levy J, 2014, ANTARCT SCI, V26, P565, DOI 10.1017/S0954102013000977
   Liu EJ, 2015, SEDIMENTARY IN PRESS, DOI [10.1016/j.sedgeo.2015.08.002, DOI 10.1016/J.SEDGEO.2015.08.002]
   Majewski W, 2012, MAR GEOL, V326, P67, DOI 10.1016/j.margeo.2012.08.009
   MARTI J., 2013, B VOLCANOL, V75, P1
   Martin-Herrero J, 2004, INT C PATT RECOG, P301, DOI 10.1109/ICPR.2004.1333763
   Martin-Herrero J, 2004, LECT NOTES COMPUT SC, V3212, P323
   Martin-Herrero J, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P2820, DOI 10.1109/ICPR.2010.691
   Martin-Herrero J, 2007, IEEE T GEOSCI REMOTE, V45, P1386, DOI 10.1109/TGRS.2007.894569
   Mehl PM, 2004, J FOOD ENG, V61, P67, DOI 10.1016/S0260-8774(03)00188-2
   Mendez-Rial R, 2012, IEEE T IMAGE PROCESS, V21, P2389, DOI 10.1109/TIP.2011.2179059
   Narcisi B, 2005, EARTH PLANET SC LETT, V239, P253, DOI 10.1016/j.epsl.2005.09.005
   Narcisi B, 2012, QUATERNARY SCI REV, V49, P52, DOI 10.1016/j.quascirev.2012.06.011
   NICODEMU.FE, 1965, APPL OPTICS, V4, P767, DOI 10.1364/AO.4.000767
   Oladottir BA, 2008, B VOLCANOL, V70, P475, DOI 10.1007/s00445-007-0150-5
   Pallas R, 2001, HOLOCENE, V11, P149, DOI 10.1191/095968301669281809
   Parton E, 2013, SPIE PROFESSIONAL, V8
   Pedrazzi D, 2014, J GEOL SOC LONDON, V171, P765, DOI 10.1144/jgs2014-015
   Ponomareva V, 2004, J VOLCANOL GEOTH RES, V136, P199, DOI 10.1016/j.volgeores.2004.05.013
   Ponomareva V, 2013, INT J EARTH SCI, V102, P1673, DOI 10.1007/s00531-013-0898-0
   Reguera-Salgado J, 2012, IEEE T GEOSCI REMOTE, V50, P4409, DOI 10.1109/TGRS.2012.2192938
   SERRA J, 1986, COMPUT VISION GRAPH, V35, P283, DOI 10.1016/0734-189X(86)90002-2
   Severi M, 2012, CLIM PAST, V8, P509, DOI 10.5194/cp-8-509-2012
   Shannon CE, 1998, P IEEE, V86, P447, DOI 10.1109/JPROC.1998.659497
   Shippert P, 2004, PHOTOGRAMM ENG REM S, V70, P377
   Smellie JL, 1999, GLOBAL PLANET CHANGE, V21, P51, DOI 10.1016/S0921-8181(99)00007-7
   Sorg BS, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003369
   Stokman H., 1999, BMVC99. Proceedings of the 10th British Machine Vision Conference, P643
   Thorarinsson S., 1939, GEOGR ANN, V21, P216
   Thorarinsson S., 1967, ERUPTIONS HEKLA HIST
   Toro M, 2013, ANTARCT SCI, V25, P198, DOI 10.1017/S0954102012000788
   ULTSCH A, 1990, INTERNATIONAL NEURAL NETWORK CONFERENCE, VOLS 1 AND 2, P305
   Winter EM, 2004, INT GEOSCI REMOTE SE, P1597
NR 63
TC 4
Z9 5
U1 1
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 27
PY 2016
VL 11
IS 1
AR e0146578
DI 10.1371/journal.pone.0146578
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DC9GD
UT WOS:000369528200017
PM 26815202
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Thorn, CJ
   Bissinger, K
   Thorn, S
   Bogner, FX
AF Thorn, Christine Johanna
   Bissinger, Kerstin
   Thorn, Simon
   Bogner, Franz Xaver
TI "Trees Live on Soil and Sunshine!"-Coexistence of Scientific and
   Alternative Conception of Tree Assimilation
SO PLOS ONE
LA English
DT Article
ID STUDENTS; MISCONCEPTIONS; KNOWLEDGE; AGREEMENT; BIOLOGY; SCIENCE
AB Successful learning is the integration of new knowledge into existing schemes, leading to an integrated and correct scientific conception. By contrast, the co-existence of scientific and alternative conceptions may indicate a fragmented knowledge profile. Every learner is unique and thus carries an individual set of preconceptions before classroom engagement due to prior experiences. Hence, instructors and teachers have to consider the heterogeneous knowledge profiles of their class when teaching. However, determinants of fragmented knowledge profiles are not well understood yet, which may hamper a development of adapted teaching schemes. We used a questionnaire-based approach to assess conceptual knowledge of tree assimilation and wood synthesis surveying 885 students of four educational levels: 6th graders, 10th graders, natural science freshmen and other academic studies freshmen. We analysed the influence of learner's characteristics such as educational level, age and sex on the coexistence of scientific and alternative conceptions. Within all subsamples well-known alternative conceptions regarding tree assimilation and wood synthesis coexisted with correct scientific ones. For example, students describe trees to be living on "soil and sunshine", representing scientific knowledge of photosynthesis mingled with an alternative conception of trees eating like animals. Fragmented knowledge profiles occurred in all subsamples, but our models showed that improved education and age foster knowledge integration. Sex had almost no influence on the existing scientific conceptions and evolution of knowledge integration. Consequently, complex biological issues such as tree assimilation and wood synthesis need specific support e.g. through repeated learning units in class-and seminar-rooms in order to help especially young students to handle and overcome common alternative conceptions and appropriately integrate scientific conceptions into their knowledge profile.
C1 [Thorn, Christine Johanna; Bissinger, Kerstin; Bogner, Franz Xaver] Univ Bayreuth, Dept Biol Educ, Univ Str 30,NW II, D-95447 Bayreuth, Germany.
   [Thorn, Christine Johanna; Bissinger, Kerstin; Bogner, Franz Xaver] Univ Bayreuth, Ctr Math & Sci Educ Z MNU, Univ Str 30,NW II, D-95447 Bayreuth, Germany.
   [Thorn, Simon] Bavarian Forest Natl Pk, Natl Pk,Freyunger Str 2, D-94481 Grafenau, Germany.
RP Thorn, CJ (reprint author), Univ Bayreuth, Dept Biol Educ, Univ Str 30,NW II, D-95447 Bayreuth, Germany.; Thorn, CJ (reprint author), Univ Bayreuth, Ctr Math & Sci Educ Z MNU, Univ Str 30,NW II, D-95447 Bayreuth, Germany.
EM Christine.Thorn@uni-bayreuth.de
FU Open Discovery Space Project - European Union CIP PSP [297229];
   University of Bayreuth; German Research Foundation (DFG)
FX Financial support was granted by the Open Discovery Space Project funded
   by European Union CIP PSP Grant Agreement No. 297229 and the University
   of Bayreuth to FXB (www.opendiscoveryspace.eu). Publishing fees for CJA
   and KB were funded by the German Research Foundation (DFG) and the
   University of Bayreuth in the funding program Open Access Publishing.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abraham JK, 2012, CBE-LIFE SCI EDUC, V11, P152, DOI 10.1187/cbe.11-08-0079
   Agresti A, 2002, CATEGORICAL DATA
   Anderberg MR, 1973, CLUSTER ANAL APPL
   Anderson DL, 2002, J RES SCI TEACH, V39, P952, DOI 10.1002/tea.10053
   Andrews TM, 2012, CBE-LIFE SCI EDUC, V11, P248, DOI 10.1187/cbe.11-12-0107
   Bahar M., 2003, ED SCI THEORY PRACTI, V3, P55
   Bledsoe KE, 2013, ELECT J SCI ED, V17, P1
   Bozniak EC, 1994, PLANT SCI B, V40, P42
   Braun T, 2012, RES BIOL ED 9 C EUR
   Carlsson B, 2002, INT J SCI EDUC, V24, P681, DOI 10.1080/09500690110098868
   Chu HE, 2014, J SCI EDUC TECHNOL, V23, P238, DOI 10.1007/s10956-013-9472-6
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   DiSessa AA, 2004, COGNITIVE SCI, V28, P843, DOI 10.1016/j.cogsci.2004.05.003
   Eikici F., 2007, INT J ENV SCI ED, V2, P111
   Finley FN, 1982, SCI ED, V66, P531, DOI DOI 10.1002/SCE.3730660404
   FISHER KM, 1985, J RES SCI TEACH, V22, P53, DOI 10.1002/tea.3660220105
   Hammer D, 1996, AM J PHYS, V64, P1316, DOI 10.1119/1.18376
   HASLAM F, 1987, J BIOL EDUC, V21, P203, DOI 10.1080/00219266.1987.9654897
   Hokayem H, 2008, J RES SCI TEACH, V45, P395, DOI 10.1002/tea.20233
   Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425
   Kalinowski ST, 2012, CBE-LIFE SCI EDUC, V11, P142, DOI 10.1187/cbe.11-09-0087
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leach J., 1994, ED RES, V23, P5, DOI DOI 10.3102/0013189X023007005
   Liu XF, 2006, J RES SCI TEACH, V43, P320, DOI 10.1002/tea.20114
   Machery E, 2010, BEHAV BRAIN SCI, V33, P195, DOI 10.1017/S0140525X09991531
   Maskiewicz AC, 2013, CBE-LIFE SCI EDUC, V12, P352, DOI 10.1187/cbe.13-01-0014
   Masson S, 2014, MIND BRAIN EDUC, V8, P44, DOI 10.1111/mbe.12043
   Mayring P, 2001, FORUM QUALITATIVE SO, V2
   McCullagh P., 1989, MONOGRAPHS STAT APPL, V37
   Nehm RH, 2008, J RES SCI TEACH, V45, P1131, DOI 10.1002/tea.20251
   Norusis M. J., 1993, SPSS WINDOWS PROFESS
   Piaget J, 1937, CONSTRUCTION REEL CH, V311
   Schneider M, 2013, DEV PSYCHOL, V49, P1639, DOI 10.1037/a0030976
   Schussler EE, 2008, J BIOL EDUC, V42, P112, DOI 10.1080/00219266.2008.9656123
   Sellmann D, 2015, J EDUC RES, V108, P250, DOI 10.1080/00220671.2014.896315
   Shtulman A, 2012, COGNITION, V124, P209, DOI 10.1016/j.cognition.2012.04.005
   Sinatra GM, 2014, EDUC PSYCHOL-US, V49, P123, DOI 10.1080/00461520.2014.916216
   Smith J. P., 1993, J LEARN SCI, V3, P115, DOI DOI 10.1207/S15327809JLS0302_1
   STAVY R, 1987, INT J SCI EDUC, V9, P105, DOI 10.1080/0950069870090111
   Straatemeier M, 2008, J EXP CHILD PSYCHOL, V100, P276, DOI 10.1016/j.jecp.2008.03.004
   Strike KA, 1985, COGNITIVE STRUCTURE, P189
   Thaden-Koch TC, 2006, PHYS ED RES, V2, P1
   Tibshirani R, 2005, J COMPUT GRAPH STAT, V14, P511, DOI 10.1198/106186005X59243
   Tran US, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110391
   TULLBERG A, 1994, INT J SCI EDUC, V16, P145, DOI 10.1080/0950069940160204
   VOSNIADOU S, 1989, SIMILARITY AND ANALOGICAL REASONING, P1, DOI 10.1017/CBO9780511529863.002
   Vosniadou S, 2014, SCI EDUC-NETHERLANDS, V23, P1427, DOI 10.1007/s11191-013-9640-3
NR 47
TC 5
Z9 5
U1 3
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 25
PY 2016
VL 11
IS 1
AR e0147802
DI 10.1371/journal.pone.0147802
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DC9FZ
UT WOS:000369527800213
PM 26807974
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Mills, CA
   Godley, BJ
   Hodgson, DJ
AF Mills, Cheryl A.
   Godley, Brendan J.
   Hodgson, David J.
TI Take Only Photographs, Leave Only Footprints: Novel Applications of
   Non-Invasive Survey Methods for Rapid Detection of Small, Arboreal
   Animals
SO PLOS ONE
LA English
DT Article
ID STOATS MUSTELA-ERMINEA; CAMERA TRAPS; TRACKING TUNNELS; ECOLOGY;
   POPULATIONS; AGREEMENT; DORMOUSE; MAMMALS; SITES
AB The development of appropriate wildlife survey techniques is essential to promote effective and efficient monitoring of species of conservation concern. Here, we demonstrate the utility of two rapid-assessment, non-invasive methods to detect the presence of elusive, small, arboreal animals. We use the hazel dormouse, Muscardinus avellanarius, a rodent of conservation concern, as our focal species. Prevailing hazel dormouse survey methods are prolonged (often taking months to years to detect dormice), dependent on season and habitat, and/or have low detection rates. Alternatives would be of great use to ecologists who undertake dormouse surveys, especially those assessing the need for mitigation measures, as legally required for building development projects. Camera traps and footprint tracking are well-established tools for monitoring elusive large terrestrial mammals, but are rarely used for small species such as rodents, or in arboreal habitats. In trials of these adapted methods, hazel dormice visited bait stations and were successfully detected by both camera traps and tracking equipment at each of two woodland study sites, within days to weeks of installation. Camera trap images and footprints were of adequate quality to allow discrimination between two sympatric small mammal species (hazel dormouse and wood mouse, Apodemus sylvaticus). We discuss the relative merits of these methods with respect to research aims, funds, time available and habitat.
C1 [Mills, Cheryl A.; Godley, Brendan J.; Hodgson, David J.] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Cornwall Campus, Penryn, Cornwall, England.
   [Mills, Cheryl A.] Keele Univ, Sch Life Sci, Keele ST5 5BG, Staffs, England.
RP Hodgson, DJ (reprint author), Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Cornwall Campus, Penryn, Cornwall, England.
EM D.J.Hodgson@exeter.ac.uk
RI godley, brendan/O-1959-2019
OI godley, brendan/0000-0003-3845-0034
CR Alibhai Sky K., 2008, Endangered Species Research, V4, P205, DOI 10.3354/esr00067
   [Anonymous], 2012, R LANG ENV STAT COMP
   BRIGHT PW, 1994, J APPL ECOL, V31, P329, DOI 10.2307/2404547
   Bright PW, 2006, DORMOUSE CONSERVATIO
   Brown NP, 1996, NZ J ECOLOGY, V20, P271
   Capizzi D, 2002, ITAL J ZOOL, V69, P25, DOI 10.1080/11250000209356434
   CAREY AB, 1991, J MAMMAL, V72, P192, DOI 10.2307/1381996
   Chanin P, 2003, 524 ENGL NAT
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Cutler TL, 1999, WILDLIFE SOC B, V27, P571
   De Bondi N, 2010, WILDLIFE RES, V37, P456, DOI 10.1071/WR10046
   Glen AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067940
   Glennon MJ, 2002, J MAMMAL, V83, P734, DOI 10.1644/1545-1542(2002)083<0734:AAFTFE>2.0.CO;2
   Gurnell J, 2006, LIVE TRAPPING SMALL
   Huijser MP, 2000, BIOL CONSERV, V95, P111, DOI 10.1016/S0006-3207(00)00006-9
   Jarvie S, 2014, NEW ZEAL J ZOOL, V41, P210, DOI 10.1080/03014223.2014.911753
   Joseph LN, 2006, CONSERV BIOL, V20, P1679, DOI 10.1111/j.1523-1739.2006.00529.x
   Kelly MJ, 2008, ANIM CONSERV, V11, P182, DOI 10.1111/j.1469-1795.2008.00179.x
   KING CM, 1977, NEW ZEAL J ZOOL, V4, P193, DOI 10.1080/03014223.1977.9517953
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x
   Marsh DM, 2008, CONSERV BIOL, V22, P647, DOI 10.1111/j.1523-1739.2008.00927.x
   Mayer W. V., 1957, Journal of Mammalogy, V38, P531, DOI 10.2307/1376421
   Mccallum J, 2013, MAMMAL REV, V43, P196, DOI 10.1111/j.1365-2907.2012.00216.x
   Meek PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110832
   National Dormouse Database, 2014, NAT DORM DAT
   Palma ART, 2007, REV BRAS ZOOL, V24, P333, DOI 10.1590/S0101-81752007000200011
   Ratz H, 2000, NEW ZEAL J ZOOL, V27, P57, DOI 10.1080/03014223.2000.9518210
   Rendall AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086592
   Reynolds JC, 2004, BIOL CONSERV, V120, P533, DOI 10.1016/j.biocon.2004.03.026
   Rovero F, 2009, J APPL ECOL, V46, P1011, DOI 10.1111/j.1365-2664.2009.01705.x
   Rowcliffe JM, 2008, ANIM CONSERV, V11, P185, DOI 10.1111/j.1469-1795.2008.00180.x
   Russell JC, 2009, ECOLOGY, V90, P2007, DOI 10.1890/08-1069.1
   Silveira L, 2003, BIOL CONSERV, V114, P351, DOI 10.1016/S0006-3207(03)00063-6
   Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x
   Treweek J, 1996, J APPL ECOL, V33, P191, DOI 10.2307/2404742
   Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078
   VANAPELDOORN R, 1993, MAMMALIA, V57, P407, DOI 10.1515/mamm.1993.57.3.407
   Watts CH, 2008, NEW ZEAL J ECOL, V32, P92
NR 39
TC 8
Z9 8
U1 3
U2 74
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 20
PY 2016
VL 11
IS 1
AR e0146142
DI 10.1371/journal.pone.0146142
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DB5BW
UT WOS:000368529100026
PM 26789632
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Calanzani, N
   Higginson, IJ
   Koffman, J
   Gomes, B
AF Calanzani, Natalia
   Higginson, Irene J.
   Koffman, Jonathan
   Gomes, Barbara
TI Factors Associated with Participation, Active Refusals and Reasons for
   Not Taking Part in a Mortality Followback Survey Evaluating End-of-Life
   Care
SO PLOS ONE
LA English
DT Article
ID AFTER-DEATH INTERVIEWS; BEREAVEMENT RESEARCH; POSTAL QUESTIONNAIRES;
   PALLIATIVE CARE; CANCER-PATIENTS; RESPONSE RATES; SAMPLE
   CHARACTERISTICS; METHODOLOGICAL ISSUES; NONRESPONSE BIAS; PREFERRED
   PLACE
AB Background
   Examination of factors independently associated with participation in mortality followback surveys is rare, even though these surveys are frequently used to evaluate end-of-life care. We aimed to identify factors associated with 1) participation versus non-participation and 2) provision of an active refusal versus a silent refusal; and systematically examine reasons for refusal in a population-based mortality followback survey.
   Methods
   Postal survey about the end-of-life care received by 1516 people who died from cancer (aged >= 18), identified through death registrations in London, England (response rate 39.3%). The informant of death (a relative in 95.3% of cases) was contacted 4-10 months after the patient died. We used multivariate logistic regression to identify factors associated with participation/active refusals and content analysis to examine refusal reasons provided by 205 nonparticipants.
   Findings
   The odds of partaking were higher for patients aged 90+ (AOR 3.48, 95% CI: 1.52-8.00, ref: 20-49yrs) and female informants (AOR 1.70, 95% CI: 1.33-2.16). Odds were lower for hospital deaths (AOR 0.62, 95% CI: 0.46-0.84, ref: home) and proxies other than spouses/partners (AORs 0.28 to 0.57). Proxies of patients born overseas were less likely to provide an active refusal (AOR 0.49; 95% CI: 0.32-0.77). Refusal reasons were often multidimensional, most commonly study-related (36.0%), proxy-related and grief-related (25.1% each). One limitation of this analysis is the large number of nonparticipants who did not provide reasons for refusal (715/920).
   Conclusions
   Our survey better reached proxies of older patients while those dying in hospitals were underrepresented. Proxy characteristics played a role, with higher participation from women and spouses/partners. More information is needed about the care received by underrepresented groups. Study design improvements may guide future questionnaire development and help develop strategies to increase response rates.
C1 [Calanzani, Natalia; Higginson, Irene J.; Koffman, Jonathan; Gomes, Barbara] Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England.
   [Calanzani, Natalia] Univ Edinburgh, Sch Med, Usher Inst Populat Hlth Sci & Informat, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.
RP Calanzani, N (reprint author), Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England.
EM natalia.calanzani@ed.ac.uk
RI Higginson, Irene Julie/C-7309-2012
OI Higginson, Irene Julie/0000-0002-3687-1313; Koffman,
   Jonathan/0000-0001-8513-5681; Calanzani, Natalia/0000-0002-5068-2543;
   Gomes, Barbara/0000-0001-8149-1806
FU charity Cicely Saunders International; Medical Research Council
   [G0802654]
FX This study was funded by the charity Cicely Saunders International
   (cicelysaundersinternational.org) as part of Dr Barbara Gomes' PhD
   studies. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Addington-Hall J, 1998, J EPIDEMIOL COMMUN H, V52, P802, DOI 10.1136/jech.52.12.802
   Addington-Hall J, 2002, EUR J CANCER CARE, V11, P220, DOI 10.1046/j.1365-2354.2002.00343.x
   Addington- Hall J, 1999, POLICY
   ADDINGTONHALL J, 1995, PALLIATIVE MED, V9, P27, DOI 10.1177/026921639500900105
   Altman D. G., 1991, PRACTICAL STAT MED R
   [Anonymous], 2012, NAT STAT
   [Anonymous], 2013, NAT STAT
   [Anonymous], 2010, PUBLIC HLTH REPORT
   [Anonymous], 2009, INFORMATION
   [Anonymous], BEREAVEMENT
   Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1
   Barriball KL, 1999, J ADV NURS, V30, P677, DOI 10.1046/j.1365-2648.1999.01117.x
   Beccaro M, 2006, J EPIDEMIOL COMMUN H, V60, P412, DOI 10.1136/j.jech.2005.043646
   Beck AM, 2007, DEATH STUD, V31, P783, DOI 10.1080/07481180701537220
   Burt J, 2010, AGE AGEING, V39, P86, DOI 10.1093/ageing/afp212
   Calanzani N, 2013, ATTACHMENT
   CARTWRIGHT A, 1986, J EPIDEMIOL COMMUN H, V40, P267, DOI 10.1136/jech.40.3.267
   Casarett D, 2010, J AM GERIATR SOC, V58, P2381, DOI 10.1111/j.1532-5415.2010.03175.x
   Caserta M, 2010, HEALTH
   COOK AS, 1995, DEATH STUD, V19, P157, DOI 10.1080/07481189508252722
   Costantini M, 2005, PALLIATIVE MED, V19, P628, DOI 10.1191/0269216305pm1086oa
   Curtis JR, 2002, J PAIN SYMPTOM MANAG, V24, P17, DOI 10.1016/S0885-3924(02)00419-0
   Department for Communities and Local Government, 2009, IMPACT ASSESSMENT
   Edwards P, 2004, CONTROL CLIN TRIALS, V25, P31, DOI 10.1016/j.cct.2003.08.013
   Edwards P, 2002, BRIT MED J, V324, P1183, DOI 10.1136/bmj.324.7347.1183
   Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4
   Emanuel EJ, 2004, ARCH INTERN MED, V164, P1999, DOI 10.1001/archinte.164.18.1999
   Escobar Pinzon LC, 2010, BMC PALLIAT CARE, V9, P16, DOI [10.1186/1472-684X-9-16, DOI 10.1186/1472-684X-9-16]
   Eurostat, 2014, HEALTH
   Evans C, 2015, BMJ SUPPORT PALLIAT, V5, P116
   Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087
   Gomes B, 2011, LIVING AGEING DYING, P3
   Gomes B, 2013, SUPPORT CARE CANCER, P1
   Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606
   Gomes B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0466-5
   Gomes B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-400
   Grande G, 2008, PALLIATIVE MED, V22, P971, DOI 10.1177/0269216308098805
   Grande GE, 2009, PALLIATIVE MED, V23, P248, DOI 10.1177/0269216309102620
   Groves RM, 2008, PUBLIC OPIN QUART, V72, P167, DOI 10.1093/poq/nfn011
   Hanratty B, 2000, BRIT J GEN PRACT, V50, P653
   Higginson IJ, 2010, PALLIATIVE MED, V24, P352, DOI 10.1177/0269216309360489
   Hunt K, 2011, HEALTH
   Ingleton C, 2004, HEALTH SOC CARE COMM, V12, P43, DOI 10.1111/j.1365-2524.2004.00467.x
   Jacoby A, 1999, PALLIATIVE MED, V13, P285, DOI 10.1191/026921699674259562
   Kendall M, 2007, BRIT MED J, V334, P521, DOI 10.1136/bmj.39097.582639.55
   Koffman J, 2012, PALLIATIVE MED, V26, P379, DOI 10.1177/0269216311405091
   Koopman L, 2013, J CLIN EPIDEMIOL, V66, P340, DOI 10.1016/j.jclinepi.2012.09.012
   Kross EK, 2009, CHEST, V136, P1496, DOI 10.1378/chest.09-0589
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lund D, 1993, PRESS, P240
   MacDonald SE, 2009, PUBLIC HEALTH NURS, V26, P95, DOI 10.1111/j.1525-1446.2008.00758.x
   McLennan D, 2011, SOC POLICY
   Menaca A, EUROPE, V82, P387
   Miyashita M, 2008, J CLIN ONCOL, V26, P3845, DOI 10.1200/JCO.2007.15.8287
   Neal MB, 1996, RES AGING, V18, P219, DOI 10.1177/0164027596182004
   Office for National Statistics, 2010, NAT STAT
   Office for National Statistics, 2011, NAT STAT
   Office for National Statistics, 2014, NAT STAT
   PARKES CM, 1995, DEATH STUD, V19, P171, DOI 10.1080/07481189508252723
   Parkes CM, 2010, BEREAVEMENT STUDIES, P137
   Perneger TV, 2005, MED CARE, V43, P374, DOI 10.1097/01.mlr.0000156856.36901.40
   Phipps Etienne J, 2002, Gerontologist, V42 Spec No 3, P104
   Pring A, 2012, NETWORK
   Scott P, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-111
   SEEMAN I, 1989, PUBLIC HEALTH REP, V104, P183
   Skulason Bragi, 2010, BMC Palliat Care, V9, P7, DOI 10.1186/1472-684X-9-7
   Stroebe M, 2003, PALLIATIVE MED, V17, P235, DOI 10.1191/0269216303pm768rr
   STROEBE MS, 1989, OMEGA-J DEATH DYING, V20, P1, DOI 10.2190/C3JE-C9L1-5R91-DWDU
   Teno J M, 2001, J Palliat Med, V4, P457, DOI 10.1089/109662101753381593
   Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88
   Teno Joan M, 2005, J Palliat Med, V8 Suppl 1, pS42
   Williams BR, 2008, DEATH STUD, V32, P197, DOI 10.1080/07481180701881297
   World Health Organisation, 1992, ORGANISATION
NR 73
TC 6
Z9 6
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 8
PY 2016
VL 11
IS 1
AR e0146134
DI 10.1371/journal.pone.0146134
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DA5AX
UT WOS:000367815600027
PM 26745379
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Abdi, A
   Idris, N
   Alguliyev, RM
   Aliguliyev, RM
AF Abdi, Asad
   Idris, Norisma
   Alguliyev, Rasim M.
   Aliguliyev, Ramiz M.
TI An Automated Summarization Assessment Algorithm for Identifying
   Summarizing Strategies
SO PLOS ONE
LA English
DT Article
ID COMPREHENSION
AB Background
   Summarization is a process to select important information from a source text. Summarizing strategies are the core cognitive processes in summarization activity. Since summarization can be important as a tool to improve comprehension, it has attracted interest of teachers for teaching summary writing through direct instruction. To do this, they need to review and assess the students' summaries and these tasks are very time-consuming. Thus, a computer-assisted assessment can be used to help teachers to conduct this task more effectively.
   Design/Results
   This paper aims to propose an algorithm based on the combination of semantic relations between words and their syntactic composition to identify summarizing strategies employed by students in summary writing. An innovative aspect of our algorithm lies in its ability to identify summarizing strategies at the syntactic and semantic levels. The efficiency of the algorithm is measured in terms of Precision, Recall and F-measure. We then implemented the algorithm for the automated summarization assessment system that can be used to identify the summarizing strategies used by students in summary writing.
C1 [Abdi, Asad; Idris, Norisma] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Artificial Intelligence, Kuala Lumpur 50603, Malaysia.
   [Alguliyev, Rasim M.; Aliguliyev, Ramiz M.] Azerbaijan Natl Acad Sci, Inst Informat Technol, AZ-1141 Baku, Azerbaijan.
RP Abdi, A (reprint author), Univ Malaya, Fac Comp Sci & Informat Technol, Dept Artificial Intelligence, Kuala Lumpur 50603, Malaysia.
EM asadabdi55@gmail.com
RI Abdi, Asad/F-6492-2012; Aliguliyev, Ramiz/A-1072-2013; Abdi,
   Asad/L-4984-2019; IDRIS, NORISMA/B-9373-2010; Alguliyev,
   Rasim/V-7265-2018
OI Aliguliyev, Ramiz/0000-0001-9795-1694; Abdi, Asad/0000-0001-5667-730X;
   Alguliyev, Rasim/0000-0003-1223-7411
FU University Malaya (UM) [PG184-2014B]
FX This research is supported by the postgraduate research grant
   (PPP)-research, grant no: PG184-2014B, University Malaya (UM).
CR Abdi A, 2015, EXPERT SYSTEMS APPL
   Abdi A, 2015, SOFT COMPUT, P1
   Abdi A, 2015, INFORM PROCESS MANAG, V51, P340, DOI 10.1016/j.ipm.2015.02.001
   Achananuparp P, 2008, LECT NOTES COMPUT SC, V5182, P305, DOI 10.1007/978-3-540-85836-2_29
   Alguliev RM, 2011, SWARM EVOL COMPUT, V1, P213, DOI 10.1016/j.swevo.2011.06.006
   Aliguliyev RM, 2009, EXPERT SYST APPL, V36, P7764, DOI 10.1016/j.eswa.2008.11.022
   Alonso L., 2004, INTELIGENCIA ARTIFIC, V8, P22
   Aytar Y, 2008, UTILIZING SEMANTIC W
   Bawakid A, 2008, SEMANTIC SUMMARIZATI
   BROWN AL, 1983, J VERB LEARN VERB BE, V22, P1, DOI 10.1016/S0022-5371(83)80002-4
   Chiu CH, 2013, COMPUT EDUC, V67, P229, DOI 10.1016/j.compedu.2013.04.015
   COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256
   de Marneffe M.-C., 2006, GENERATING TYPED DEP
   DEERWESTER S, 1990, J AM SOC INFORM SCI, V41, P391, DOI 10.1002/(SICI)1097-4571(199009)41:6<391::AID-ASI1>3.0.CO;2-9
   Fan Y-C, 2010, ASIAN SOCIAL SCI, V6
   Fattah MA, 2009, COMPUT SPEECH LANG, V23, P126, DOI 10.1016/j.csl.2008.04.002
   FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619
   Franzke M, 2006, BUILDING STUDENT SUM
   Fraser B, 1999, J PRAGMATICS, V31, P931, DOI 10.1016/S0378-2166(98)00101-5
   Galgani F, 2014, INT J HUM-COMPUT ST, V72, P584, DOI 10.1016/j.ijhcs.2014.03.002
   Gupta V., 2010, J EMERGING TECHNOLOG, V2
   Hirschberg J., 1993, Computational Linguistics, V19, P501
   Idris N, 2009, COMPUTER INFORM SCI, V2, pP200
   Johnson NS, 1983, CHILDRENS LANGUAGE, V4, P315
   Kanejiya D, 2003, AUTOMATIC EVALUATION
   KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363
   Kupiec J, 1995, TRAINABLE DOCUMENT S
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lemaire B, 2005, COMPUTATIONAL COGNIT
   Li S, 2006, PEKING U DUC 2006
   Li YH, 2006, IEEE T KNOWL DATA EN, V18, P1138, DOI 10.1109/TKDE.2006.130
   Lin D, 1998, INFORM THEORETIC DEF
   Lin Rouge, 2004, PACKAGE AUTOMATIC EV
   Manning C. D., 2008, INTRO INFORM RETRIEV
   Mihalcea R, 2006, CORPUS BASED KNOWLED
   Mohler M, 2011, LEARNING GRADE SHORT
   Perez D, 2005, AUTOMATIC ASSESSMENT
   Perez Gliozzo AM, 2005, AUTOMATIC ASSESSMENT
   Ponce HR, 2012, COMPUT EDUC, V59, P1170, DOI 10.1016/j.compedu.2012.05.013
   Teufel S, 1997, SENTENCE EXTRACTION
   Tian Y, 2010, MEASURING SIMILARITY
   Tseng JCR, 2008, COMPUT EDUC, V51, P776, DOI 10.1016/j.compedu.2007.08.002
   Warin M., 2004, USING WORDNET SEMANT, V25, P2008
   Westby C, 2010, TOP LANG DISORD, V30, P275, DOI 10.1097/TLD.0b013e3181ff5a88
   Wiemer-Hastings P, 2001, RULES SYNTAX VECTORS
   Wiemer-Hastings P, 2000, ADDING SYNTACTIC INF
   Xie S, 2008, EVALUATING EFFECTIVE
   Xie S, 2008, USING CORPUS KNOWLED
   Xie SS, 2010, COMPUT SPEECH LANG, V24, P495, DOI 10.1016/j.csl.2009.04.007
   Yang GB, 2013, COMPUT EDUC, V68, P233, DOI 10.1016/j.compedu.2013.05.012
   Zhang J, 2005, CUE BASED HUB AUTHOR
   Zipitria I, 2004, HUMAN AUTOMATIC SUMM
NR 52
TC 4
Z9 4
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 6
PY 2016
VL 11
IS 1
AR e0145809
DI 10.1371/journal.pone.0145809
PG 34
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DA4XE
UT WOS:000367805100030
PM 26735139
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Feczko, EJ
   Bliss-Moreau, E
   Walum, H
   Pruett, JR
   Parr, LA
AF Feczko, Eric J.
   Bliss-Moreau, Eliza
   Walum, Hasse
   Pruett, John R., Jr.
   Parr, Lisa A.
TI The Macaque Social Responsiveness Scale (mSRS): A Rapid Screening Tool
   for Assessing Variability in the Social Responsiveness of Rhesus Monkeys
   (Macaca mulatta)
SO PLOS ONE
LA English
DT Article
ID PERVASIVE DEVELOPMENTAL DISORDERS; MATERNAL IMMUNE ACTIVATION; AUTISTIC
   TRAITS; DIAGNOSTIC INTERVIEW; NEONATAL AMYGDALA; PRIMATES; BEHAVIOR;
   VALIDATION; CHILDREN; LESIONS
AB Understanding the biological mechanisms underlying human neuropsychiatric disorders, such as autism spectrum disorder (ASD), has been hindered by the lack of a robust, translational animal model. Rhesus monkeys (Macaca mulatta) display many of the same social behaviors that are affected in ASD, making them an excellent animal species in which to model social impairments. However, the social impairments associated with ASD may reflect extreme ends of a continuous distribution of traits. Thus, to validate the rhesus monkey as an animal model for studying social impairments that has strong translational relevance for ASD, researchers need an easily-implemented measurement tool that can quantify variation in social behavior dimensionally. The Social Responsiveness Scale (SRS) is a 65-item survey that identifies both typical and atypical social behaviors in humans that covary with ASD symptom severity. A chimpanzee SRS has already been validated and the current study adapted this tool for use in the rhesus monkey (mSRS). Fifteen raters completed the mSRS for 105 rhesus monkeys living at the Yerkes National Primate Research Center. The mSRS scores showed a unimodal distribution with a positive skew that identified 6 statistical outliers. Inter-rater reliability was very strong, but only 17 of the 36 questions showed positive intra-item reliability. The results of an exploratory factor analysis identified 3 factors that explained over 60% of the variance, with 12 items significantly loading onto the primary factor. These items reflected behaviors associated with social avoidance, social anxiety or inflexibility and social confidence. These initial findings are encouraging and suggest that variability in the social responsiveness of rhesus monkeys can be quantified using the mSRS: a tool that has strong translational relevance for human disorders. With further modification, the mSRS may provide an promising new direction for research on the biological mechanisms underlying social impairments.
C1 [Feczko, Eric J.; Walum, Hasse; Parr, Lisa A.] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.
   [Feczko, Eric J.; Walum, Hasse; Parr, Lisa A.] Emory Univ, Ctr Translat Social Neurosci, Atlanta, GA 30329 USA.
   [Bliss-Moreau, Eliza] Univ Calif Davis, Calif Natl Primate Res Ctr, Dept Psychiat & Behav Sci, Davis, CA 95616 USA.
   [Pruett, John R., Jr.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.
   [Parr, Lisa A.] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.
RP Parr, LA (reprint author), Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.
EM lparr@emory.edu
FU National Institutes of Mental Health [P50MH073921, P50MH100023,
   R01MH104534, K9910138]; National Institutes for Health and Human
   Development [R01MH093510, R01HD055741]; Swedish Brain Foundation
FX This work was supported by National Institutes of Mental Health
   (P50MH073921, P50MH100023, R01MH104534, www.nih.gov) to LAP, National
   Institutes of Mental Health (K9910138) to EBM, National Institutes of
   Mental Health and National Institutes for Health and Human Development
   (R01MH093510, R01HD055741) to JRP, Swedish Brain Foundation to HW. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR BACHEVALIER J, 1994, NEUROPSYCHOLOGIA, V32, P627, DOI 10.1016/0028-3932(94)90025-6
   Bachevalier J, 2001, BEHAV NEUROSCI, V115, P545, DOI 10.1037//0735-7044.115.3.545
   Bauman MD, 2004, J NEUROSCI, V24, P711, DOI 10.1523/JNEUROSCI.3263-03.2004
   Bauman MD, 2014, BIOL PSYCHIAT, V75, P332, DOI 10.1016/j.biopsych.2013.06.025
   Beisner BA, 2014, AM J PRIMATOL, V76, P111, DOI 10.1002/ajp.22214
   Bliss-Moreau E, 2013, J COGNITIVE NEUROSCI, V25, P2124, DOI 10.1162/jocn_a_00483
   Bliss-Moreau E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071170
   Bolte S, 2008, AUTISM RES, V1, P354, DOI 10.1002/aur.49
   Bowers K, 2015, PEDIATR DRUGS, V17, P115, DOI 10.1007/s40272-014-0106-0
   Brown GR, 2000, PRIMATES, V41, P63, DOI 10.1007/BF02557462
   Constantino JN, 2006, AM J PSYCHIAT, V163, P294, DOI 10.1176/appi.ajp.163.2.294
   Constantino JN, 2004, J CHILD PSYCHOL PSYC, V45, P719, DOI 10.1111/j.1469-7610.2004.00266.x
   Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212
   Constantino JN, 2000, J DEV BEHAV PEDIATR, V21, P2, DOI 10.1097/00004703-200002000-00002
   Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524
   Duvekot J, 2014, J AUTISM DEV DISORDE
   Faughn C, 2015, J AUTISM DEV DISORD, V45, P1483, DOI 10.1007/s10803-014-2273-9
   Frazier TW, 2014, AUTISM, V18, P31, DOI 10.1177/1362361313500382
   Fushing H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017817
   Gruber C, 2005, SOCIAL RESPONSIVENES
   HINDE R. A., 1962, PROC ZOOL SOC LONDON, V138, P1
   Hus V, 2013, J CHILD PSYCHOL PSYC, V54, P216, DOI 10.1111/j.1469-7610.2012.02589.x
   Kamio Y, 2013, ACTA PSYCHIAT SCAND, V128, P45, DOI 10.1111/acps.12034
   Kamphuis S, 2009, EUR J NEUROSCI, V29, P1732, DOI 10.1111/j.1460-9568.2009.06730.x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947
   LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145
   Machado CJ, 2015, BIOL PSYCHIAT, V77, P823, DOI 10.1016/j.biopsych.2014.07.035
   Marrus N, 2011, J AM ACAD CHILD PSY, V50, P508, DOI 10.1016/j.jaac.2011.01.009
   Michopoulos V, 2012, HORM BEHAV, V62, P389, DOI 10.1016/j.yhbeh.2012.07.014
   Miranda-Dominguez O, 2014, J NEUROSCI, V34, P5552, DOI 10.1523/JNEUROSCI.4229-13.2014
   Moadab G, 2015, BEHAV NEUROSCI, V129, P339, DOI 10.1037/bne0000062
   Nelson EE, 2009, NEUROPSYCHOPHARMACOL, V34, P90, DOI 10.1038/npp.2008.150
   Parr LA, 2002, BEHAV NEUROSCI, V116, P378, DOI 10.1037//0735-7044.116.3.378
   Parr LA, 2011, PHILOS T R SOC B, V366, P1764, DOI 10.1098/rstb.2010.0358
   Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543
   Phillips KA, 2014, AM J PRIMATOL, V76, P801, DOI 10.1002/ajp.22281
   Piven J, 1997, AM J PSYCHIAT, V154, P185
   Ruhela RK, 2015, ANN NEUROSCI, V22, P44, DOI 10.5214/ans.0972.7531.220210
   Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477
   Takei R, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0302-z
   THIERRY B, 1985, BEHAV PROCESS, V11, P89, DOI 10.1016/0376-6357(85)90105-6
   Vessey SH, 1984, POLITICAL PSYCHOL, V5, P623
   Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758
   Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280
   Weir RK, 2015, BRAIN BEHAV IMMUN, V48, P139, DOI 10.1016/j.bbi.2015.03.009
   Yuen RKC, 2015, NAT MED, V21, P185, DOI 10.1038/nm.3792
NR 47
TC 6
Z9 6
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 5
PY 2016
VL 11
IS 1
AR e0145956
DI 10.1371/journal.pone.0145956
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DA4VZ
UT WOS:000367801400071
PM 26731103
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hodkinson, P
   Argent, A
   Wallis, L
   Reid, S
   Perera, R
   Harrison, S
   Thompson, M
   English, M
   Maconochie, I
   Ward, A
AF Hodkinson, Peter
   Argent, Andrew
   Wallis, Lee
   Reid, Steve
   Perera, Rafael
   Harrison, Sian
   Thompson, Matthew
   English, Mike
   Maconochie, Ian
   Ward, Alison
TI Pathways to Care for Critically Ill or Injured Children: A Cohort Study
   from First Presentation to Healthcare Services through to Admission to
   Intensive Care or Death
SO PLOS ONE
LA English
DT Article
ID CONFIDENTIAL INQUIRY; DISTRICT HOSPITALS; MORTALITY; DELIVERY
AB Purpose
   Critically ill or injured children require prompt identification, rapid referral and quality emergency management. We undertook a study to evaluate the care pathway of critically ill or injured children to identify preventable failures in the care provided.
   Methods
   A year-long cohort study of critically ill and injured children was performed in Cape Town, South Africa, from first presentation to healthcare services until paediatric intensive care unit (PICU) admission or emergency department death, using expert panel review of medical records and caregiver interview. Main outcomes were expert assessment of overall quality of care; avoidability of severity of illness and PICU admission or death and the identification of modifiable factors.
   Results
   The study enrolled 282 children, 252 emergency PICU admissions, and 30 deaths. Global quality of care was graded good in 10% of cases, with half having at least one major impact modifiable factor. Key modifiable factors related to access to care and identification of the critically ill, assessment of severity, inadequate resuscitation, and delays in decision making and referral. Children were transferred with median time from first presentation to PICU admission of 12.3 hours. There was potentially avoidable severity of illness in 185 (74%) of children, and death prior to PICU admission was avoidable in 17/30 (56.7%) of children.
   Conclusions
   The study presents a novel methodology, examining quality of care across an entire system, and highlighting the complexity of the pathway and the modifiable events amenable to interventions, that could reduce mortality and morbidity, and optimize utilization of scarce critical care resources; as well as demonstrating the importance of continuity and quality of care.
C1 [Hodkinson, Peter; Wallis, Lee] Univ Cape Town, Div Emergency Med, ZA-7925 Cape Town, South Africa.
   [Argent, Andrew] Univ Cape Town, Dept Paediat, ZA-7925 Cape Town, South Africa.
   [Reid, Steve] Univ Cape Town, Directorate Primary Hlth Care, ZA-7925 Cape Town, South Africa.
   [Perera, Rafael; Harrison, Sian; Ward, Alison] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.
   [Thompson, Matthew] Univ Washington, Dept Family Med, Seattle, WA 98195 USA.
   [English, Mike] Univ Oxford, Nuffield Dept Med, Oxford, England.
   [English, Mike] KEMRI Wellcome Trust Res Programme, Nairobi, Kenya.
   [Maconochie, Ian] Univ London Imperial Coll Sci Technol & Med, Paediat Emergency Med, London, England.
   [Maconochie, Ian] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.
RP Hodkinson, P (reprint author), Univ Cape Town, Div Emergency Med, ZA-7925 Cape Town, South Africa.
EM pwhodkinson@gmail.com
RI Argent, Andrew/J-1605-2019
OI Argent, Andrew/0000-0001-9333-2036; Hodkinson,
   Peter/0000-0002-0376-7982; Wallis, Lee/0000-0003-2711-3139; Maconochie,
   Ian/0000-0001-6319-8550
FU Wellcome Trust [WT091107MA]; Nuffield Department of Primary Care Health
   Sciences, Oxford University
FX The study was funded by the Wellcome Trust (WT091107MA) and the Nuffield
   Department of Primary Care Health Sciences, Oxford University. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Barasa EW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001238
   Berry L, 2013, SOUTH AFRICAN CHILD
   Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0
   Brent AJ, 2011, ARCH DIS CHILD, V96, P361, DOI 10.1136/adc.2010.183111
   Campbell H, 2008, PEDIATRICS, V121, pE984, DOI 10.1542/peds.2007-1395
   Christian CW, 2010, PEDIATRICS, V126, P592, DOI 10.1542/peds.2010-2006
   DEVLIN HB, 1985, J ROY SOC MED, V78, P698
   Drife J, 2008, BEST PRACT RES CL OB, V22, P501, DOI 10.1016/j.bpobgyn.2007.10.005
   Drife J, 2012, SAJOG-S AFR J OBSTET, V18, P32
   Egdell P, 2008, EMERG MED J, V25, P745, DOI 10.1136/emj.2007.054965
   English M, 2005, ARCH DIS CHILD, V90, P974, DOI 10.1136/adc.2005.074468
   English M, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-42
   Fleming PJ, 1996, BMJ-BRIT MED J, V313, P191, DOI 10.1136/bmj.313.7051.191
   Harnden A, 2009, BRIT J GEN PRACT, V59, P819, DOI 10.3399/bjgp09X472520
   IBM Corp, 2012, IBM SPSS STAT WIND
   Institute of Medicine Committee on Data Standards for Patient Safety, 2004, ACH NEW STAND CAR
   Kissoon N, 2011, PEDIATR CRIT CARE ME, V12, P494, DOI 10.1097/PCC.0b013e318207096c
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Launay E, 2010, PEDIATR CRIT CARE ME, V11, P469, DOI 10.1097/PCC.0b013e3181ce752e
   Lewis G, 2007, THE SEVENTH REPORT O
   Mathews B, 2008, CHILD MALTREATMENT, V13, P50, DOI 10.1177/1077559507310613
   Modig N., 2012, THIS IS LEAN RESOLVI
   Mohan G, 1996, BRIT J GEN PRACT, V46, P529
   Molyneux E, 2006, B WORLD HEALTH ORGAN, V84, P314, DOI 10.2471/BLT.04.019505
   Mooney H, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5138
   Nadel S, 1998, J ACCID EMERG MED, V15, P298
   Ninis N, 2005, BRIT MED J, V330, P1475, DOI 10.1136/bmj.330.7506.1475
   Papworth S, 2005, SEMIN FETAL NEONAT M, V10, P39, DOI 10.1016/j.siny.2004.09.013
   Paul R, 2012, PEDIATRICS, V130, pE273, DOI 10.1542/peds.2012-0094
   Pearson GA, 2011, ARCH DIS CHILD, V96, P927, DOI 10.1136/adc.2009.177071
   Rimsza ME, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e11
   Seiger N, 2013, PEDIATRICS, V132, pE841, DOI 10.1542/peds.2012-3594
   Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2
   Statistics South Africa, 2012, CENS 2011 MUN REP W
   Tucker KM, 2009, J SPEC PEDIATR NURS, V14, P79, DOI 10.1111/j.1744-6155.2008.00178.x
   Van den Bruel A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6144
   Weindling AM, 2003, ARCH DIS CHILD, V88, P1034, DOI 10.1136/adc.88.12.1034
NR 37
TC 19
Z9 19
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 5
PY 2016
VL 11
IS 1
AR e0145473
DI 10.1371/journal.pone.0145473
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DA4VZ
UT WOS:000367801400036
PM 26731245
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chen, B
   Xu, T
   Zhou, CL
   Wang, LY
   Yang, N
   Wang, Z
   Dong, HM
   Yang, Z
   Zang, YF
   Zuo, XN
   Weng, XC
AF Chen, Bing
   Xu, Ting
   Zhou, Changle
   Wang, Luoyu
   Yang, Ning
   Wang, Ze
   Dong, Hao-Ming
   Yang, Zhi
   Zang, Yu-Feng
   Zuo, Xi-Nian
   Weng, Xu-Chu
TI Individual Variability and Test-Retest Reliability Revealed by Ten
   Repeated Resting-State Brain Scans over One Month
SO PLOS ONE
LA English
DT Article
ID SURFACE-BASED ANALYSIS; FUNCTIONAL CONNECTIVITY; TOPOLOGICAL
   ORGANIZATION; NETWORK STRUCTURE; FMRI; CONNECTOME; CORTEX; SEGMENTATION;
   FLEXIBILITY; HOMOGENEITY
AB Individual differences in mind and behavior are believed to reflect the functional variability of the human brain. Due to the lack of a large-scale longitudinal dataset, the full landscape of variability within and between individual functional connectomes is largely unknown. We collected 300 resting-state functional magnetic resonance imaging (rfMRI) datasets from 30 healthy participants who were scanned every three days for one month. With these data, both intra-and inter-individual variability of six common rfMRI metrics, as well as their test-retest reliability, were estimated across multiple spatial scales. Global metrics were more dynamic than local regional metrics. Cognitive components involving working memory, inhibition, attention, language and related neural networks exhibited high intra-individual variability. In contrast, inter-individual variability demonstrated a more complex picture across the multiple scales of metrics. Limbic, default, frontoparietal and visual networks and their related cognitive components were more differentiable than somatomotor and attention networks across the participants. Analyzing both intra-and inter-individual variability revealed a set of high-resolution maps on test-retest reliability of the multi-scale connectomic metrics. These findings represent the first collection of individual differences in multi-scale and multimetric characterization of the human functional connectomes in-vivo, serving as normal references for the field to guide the use of common functional metrics in rfMRI-based applications.
C1 [Chen, Bing; Zhou, Changle; Weng, Xu-Chu] Xiamen Univ, Sch Informat Sci & Engn, Fujian Prov Key Lab Brain Like Intelligent Syst, Xiamen 361005, Fujian, Peoples R China.
   [Chen, Bing; Wang, Luoyu; Wang, Ze; Zang, Yu-Feng; Weng, Xu-Chu] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou 311121, Zhejiang, Peoples R China.
   [Xu, Ting; Yang, Ning; Dong, Hao-Ming; Yang, Zhi; Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.
   [Xu, Ting; Yang, Ning; Dong, Hao-Ming; Yang, Zhi; Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Magnet Resonance Imaging Res Ctr, Beijing 100101, Peoples R China.
   [Yang, Ning; Dong, Hao-Ming] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Yang, Ning; Dong, Hao-Ming; Yang, Zhi; Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Lab Funct Connectome & Dev, Beijing 100101, Peoples R China.
   [Zuo, Xi-Nian] Southwest Univ, Fac Psychol, Chongqing 400715, Peoples R China.
   [Zuo, Xi-Nian] Guangxi Teachers Educ Univ, Sch Educ Sci, Dept Psychol, Nanning 530001, Guangxi, Peoples R China.
RP Zuo, XN (reprint author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.
EM zuoxn@psych.ac.cn; wengxc@psych.ac.cn
RI Zuo, Xi-Nian/A-7273-2009
OI Zuo, Xi-Nian/0000-0001-9110-585X
FU National Key Basic Research and Development (973) Program
   [2015CB351702]; Major Joint Fund for International Cooperation and
   Exchange of the National Natural Science Foundation [81220108014];
   Hundred Talents Program; Chinese Academy of Sciences [KSZD-EW-TZ-002];
   Natural Science Foundation of China [31070905, 31371134, 81171409,
   81471740]; National Social Science Foundation of China [11AZD119]
FX This work was partially supported by the National Key Basic Research and
   Development (973) Program (2015CB351702, X-NZ), the Major Joint Fund for
   International Cooperation and Exchange of the National Natural Science
   Foundation (81220108014, X-NZ), the Hundred Talents Program and the Key
   Research Program (KSZD-EW-TZ-002, X-NZ) of the Chinese Academy of
   Sciences, the Natural Science Foundation of China (31070905, 31371134,
   81171409 and 81471740) and the National Social Science Foundation of
   China (11AZD119).; This work was partially supported by the National Key
   Basic Research and Development (973) Program (2015CB351702, X-NZ), the
   Major Joint Fund for International Cooperation and Exchange of the
   National Natural Science Foundation (81220108014, X-NZ), the Hundred
   Talents Program and the Key Research Program (KSZD-EW-TZ-002, X-NZ) of
   the Chinese Academy of Sciences, the Natural Science Foundation of China
   (31070905, 31371134, 81171409 and 81471740) and the National Social
   Science Foundation of China (11AZD119). The computations were performed
   on the Dell Blade Cluster System at the Institute of Psychology, Chinese
   Academy of Sciences. We thank Dr. B.T. Thomas Yeo for discussions about
   the use of the cognitive ontology and Dr. Richard F. Betzel for
   proof-reading of the final version of the manuscript.
CR Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352
   Anderson JS, 2014, HUM BRAIN MAPP, V35, P1273, DOI 10.1002/hbm.22251
   Anderson ML, 2014, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00918
   Baker AP, 2014, ELIFE, V3, DOI 10.7554/eLife.01867
   Barttfeld P, 2015, P NATL ACAD SCI USA, V112, P887, DOI 10.1073/pnas.1418031112
   Bassett DS, 2011, TRENDS COGN SCI, V15, P200, DOI 10.1016/j.tics.2011.03.006
   Betzel RF, 2015, ARXIV151106352V1
   Betzel RF, 2016, NEUROIMAGE, V124, P1054, DOI 10.1016/j.neuroimage.2015.09.041
   Betzel RF, 2014, NEUROIMAGE, V102, P345, DOI 10.1016/j.neuroimage.2014.07.067
   BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409
   Biswal BB, 2012, NEUROIMAGE, V62, P938, DOI 10.1016/j.neuroimage.2012.01.090
   Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107
   Blautzik J, 2013, J ALZHEIMERS DIS, V34, P741, DOI 10.3233/JAD-111970
   Buckner RL, 2013, NAT NEUROSCI, V16, P832, DOI 10.1038/nn.3423
   Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009
   Calhoun VD, 2014, NEURON, V84, P262, DOI 10.1016/j.neuron.2014.10.015
   Cao M, 2014, DEV COGN NEUROS-NETH, V7, P76, DOI 10.1016/j.dcn.2013.11.004
   Carp J, 2013, NEUROIMAGE, V76, P436, DOI 10.1016/j.neuroimage.2011.12.061
   Chan MY, 2014, P NATL ACAD SCI USA, V111, pE4997, DOI 10.1073/pnas.1415122111
   Choe AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140134
   Cox RW, 2012, NEUROIMAGE, V62, P743, DOI 10.1016/j.neuroimage.2011.08.056
   Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395
   Deco G, 2014, J NEUROSCI, V34, P7910, DOI 10.1523/JNEUROSCI.4423-13.2014
   Deco G, 2013, J NEUROSCI, V33, P11239, DOI 10.1523/JNEUROSCI.1091-13.2013
   Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78
   Du HX, 2015, CNS NEUROSCI THER, V21, P802, DOI 10.1111/cns.12431
   Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396
   Fukushima M, 2015, ARXIV151106427V1
   Gao W, 2014, J NEUROSCI, V34, P11288, DOI 10.1523/JNEUROSCI.5072-13.2014
   Gonzalez-Castillo J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00138
   Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100
   Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060
   Gu S, 2015, P NATL ACAD SCI USA, V112, P13681, DOI 10.1073/pnas.1502829112
   Guo CC, 2012, NEUROIMAGE, V61, P1471, DOI 10.1016/j.neuroimage.2012.03.027
   He Y, 2016, HUM BRAIN M IN PRESS
   He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226
   Hellyer PJ, 2015, J NEUROSCI, V35, P9050, DOI 10.1523/JNEUROSCI.4648-14.2015
   Holmes AJ, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.31
   Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104
   Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079
   Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015
   Jiang L, 2015, NEUROSCENTI IN PRESS
   Jiang LL, 2015, BRAIN STRUCT FUNCT, V220, P2485, DOI 10.1007/s00429-014-0795-8
   Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246
   Keilholz SD, 2014, BRAIN CONNECT, V4, P769, DOI 10.1089/brain.2014.0250
   Kelly C, 2012, TRENDS COGN SCI, V16, P181, DOI 10.1016/j.tics.2012.02.001
   Kraemer HC, 2014, ANNU REV CLIN PSYCHO, V10, P111, DOI 10.1146/annurev-clinpsy-032813-153739
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Laumann TO, 2015, NEURON, V87, P657, DOI 10.1016/j.neuron.2015.06.037
   Li ZJ, 2012, J MAGN RESON IMAGING, V36, P344, DOI 10.1002/jmri.23670
   Liao XH, 2013, NEUROIMAGE, V83, P969, DOI 10.1016/j.neuroimage.2013.07.058
   Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232
   Messe A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003530
   Mueller S, 2015, HUM BRAIN MAPP, V36, P4664, DOI 10.1002/hbm.22947
   Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028
   Murphy K, 2013, NEUROIMAGE, V80, P349, DOI 10.1016/j.neuroimage.2013.04.001
   Orban P, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.43
   Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411
   Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108
   Poldrack RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9885
   Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018
   Saad ZS, 2013, BRAIN CONNECT, V3, P339, DOI 10.1089/brain.2013.0156
   Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080
   Schaefer A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00195
   Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364
   Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256
   Shen K, 2015, J NEUROSCI, V35, P5579, DOI 10.1523/JNEUROSCI.4903-14.2015
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Smith DV, 2014, NEUROIMAGE, V95, P1, DOI 10.1016/j.neuroimage.2014.03.042
   Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016
   Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039
   Somandepalli K, 2015, DEV COGN NEUROS-NETH, V15, P83, DOI [10.1016/j.den.2015.08.003, 10.1016/j.dcn.2015.08.003]
   Song J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049847
   Thomason ME, 2011, NEUROIMAGE, V55, P165, DOI 10.1016/j.neuroimage.2010.11.080
   Wang DH, 2015, NAT NEUROSCI, V18, P1853, DOI 10.1038/nn.4164
   Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976
   Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026
   Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1
   Wink AM, 2012, BRAIN CONNECT, V2, P265, DOI 10.1089/brain.2012.0087
   Xing XX, 2011, MAGN RESON IMAGING, V29, P731, DOI 10.1016/j.mri.2011.02.007
   Xu T, 2015, SCI BULL, V60, P86, DOI 10.1007/s11434-014-0698-3
   Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081
   Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004
   Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743
   Yang Z, 2014, NEUROIMAGE, V89, P45, DOI 10.1016/j.neuroimage.2013.10.039
   Yeo BTT, 2015, CEREB CORTEX, V25, P3654, DOI 10.1093/cercor/bhu217
   Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011
   Zalesky A, 2014, P NATL ACAD SCI USA, V111, P10341, DOI 10.1073/pnas.1400181111
   Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030
   Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002
   Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198
   Zhao TD, 2015, HUM BRAIN MAPP, V36, P3777, DOI 10.1002/hbm.22877
   Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012
   Zuo XN, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.49
   Zuo XN, 2014, NEUROSCI BIOBEHAV R, V45, P100, DOI 10.1016/j.neubiorev.2014.05.009
   Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017
   Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269
   Zuo XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026703
   Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080
   Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037
NR 100
TC 33
Z9 33
U1 2
U2 34
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 29
PY 2015
VL 10
IS 12
AR e0144963
DI 10.1371/journal.pone.0144963
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DA0IX
UT WOS:000367481900026
PM 26714192
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Shiroma, EJ
   Cook, NR
   Manson, JE
   Buring, JE
   Rimm, EB
   Lee, IM
AF Shiroma, Eric J.
   Cook, Nancy R.
   Manson, Joann E.
   Buring, Julie E.
   Rimm, Eric B.
   Lee, I-Min
TI Comparison of Self-Reported and Accelerometer-Assessed Physical Activity
   in Older Women
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; LOW-DOSE ASPIRIN; SEDENTARY BEHAVIOR;
   ACTIVITY QUESTIONNAIRE; PRIMARY PREVENTION; CARDIOVASCULAR-DISEASE;
   UNITED-STATES; ADULTS; HEALTH; AGE
AB Background
   Self-reported physical activity measures continue to be validated against accelerometers; however, the absence of standardized, accelerometer moderate-to-vigorous physical activity (MVPA) definitions has made comparisons across studies difficult. Furthermore, recent accelerometer models assess accelerations in three axes, instead of only the vertical axis, but validation studies have yet to take incorporate triaxial data.
   Methods
   Participants (n = 10 115) from the Women's Health Study wore a hip-worn accelerometer (ActiGraph GT3X+) for seven days during waking hours (2011-2014). Women then completed a physical activity questionnaire. We compared self-reported with accelerometer-assessed MVPA, using four established cutpoints for MVPA: three using only vertical axis data (760, 1041 and 1952 counts per minute (cpm)) and one using triaxial data (2690 cpm).
   Results
   According to self-reported physical activity, 66.6% of women met the US federal physical activity guidelines, engaging in >= 150 minutes per week of MVPA. The percent of women who met guidelines varied widely depending on the accelerometer MVPA definition (760 cpm: 50.0%, 1041 cpm: 33.0%, 1952 cpm: 13.4%, and 2690 cpm: 19.3%).
   Conclusions
   Triaxial count data do not substantially reduce the difference between self-reported and accelerometer-assessed MVPA.
C1 [Shiroma, Eric J.; Cook, Nancy R.; Manson, Joann E.; Buring, Julie E.; Rimm, Eric B.; Lee, I-Min] Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Sch Med, Boston, MA 02115 USA.
   [Shiroma, Eric J.; Cook, Nancy R.; Manson, Joann E.; Buring, Julie E.; Rimm, Eric B.; Lee, I-Min] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [Shiroma, Eric J.] NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, NIH, Bethesda, MD 20892 USA.
RP Shiroma, EJ (reprint author), Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Sch Med, Boston, MA 02115 USA.
EM Eric.shiroma@nih.gov
FU National Institutes of Health [CA154647, CA047988, HL007575]; National
   Institute on Aging
FX This research was supported by research grants CA154647 and CA047988
   from the National Institutes of Health. EJS was supported in part by and
   the Intramural Research Program of the National Institutes of Health,
   National Institute on Aging and in part by training grant HL007575 from
   the National Institutes of Health. The funders had no role in the study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR AINSWORTH BE, 1993, J CLIN EPIDEMIOL, V46, P1403, DOI 10.1016/0895-4356(93)90140-V
   Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009
   Bonnefoy M, 2001, J AM GERIATR SOC, V49, P28, DOI 10.1046/j.1532-5415.2001.49006.x
   Bornstein DB, 2011, J SCI MED SPORT, V14, P404, DOI 10.1016/j.jsams.2011.03.013
   BULL FC, 2010, PHYS ACTIVITY GUIDEL
   Canadian Society for Exercise Physiology, 2011, CAN PHYS ACT GUID CA
   Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345
   Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3
   Colbert LH, 2011, MED SCI SPORT EXER, V43, P867, DOI 10.1249/MSS.0b013e3181fc7162
   Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47
   Copeland JL, 2009, J AGING PHYS ACTIV, V17, P17, DOI 10.1123/japa.17.1.17
   Crouter SE, 2010, MED SCI SPORT EXER, V42, P1029, DOI 10.1249/MSS.0b013e3181c37458
   Dyrstad SM, 2014, MED SCI SPORT EXER, V46, P99, DOI 10.1249/MSS.0b013e3182a0595f
   Evenson KR, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110109
   Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021
   Gabriel KP, 2009, MED SCI SPORT EXER, V41, P1403, DOI 10.1249/MSS.0b013e31819b2482
   Hagstromer M, 2010, AM J EPIDEMIOL, V171, P1055, DOI 10.1093/aje/kwq069
   Hall KS, 2013, MED SCI SPORT EXER, V45, P574, DOI 10.1249/MSS.0b013e318276c73c
   Hamer M, 2012, J EPIDEMIOL COMMUN H, V66, P1110, DOI 10.1136/jech-2011-200505
   Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354
   Harris TJ, 2009, MED SCI SPORT EXER, V41, P1392, DOI 10.1249/MSS.0b013e31819b3533
   Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103
   Howard VJ, 2015, MED SCI SPORT EXER, V47, P1531, DOI 10.1249/MSS.0000000000000549
   Jacobi D, 2009, EUR J EPIDEMIOL, V24, P171, DOI 10.1007/s10654-009-9329-8
   JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012
   Jefferis BJ, 2015, MED SCI SPORT EXER, V47, P2119, DOI 10.1249/MSS.0000000000000635
   Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee I-M, 2009, EPIDEMIOLOGIC METHOD, P100
   Lee IM, 2014, BRIT J SPORT MED, V48, P197, DOI 10.1136/bjsports-2013-093154
   Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9
   Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56
   Lyden K, 2014, MED SCI SPORT EXER, V46, P386, DOI 10.1249/MSS.0b013e3182a42a2d
   Mathews CE, 2012, EXERC SPORT SCI REV, V40, P118, DOI 10.1097/JES.0b013e31825b34a0
   Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d
   Matthews CE, 2005, MED SCI SPORT EXER, V37, P986, DOI 10.1249/01.mss.0000171615.76521.69
   Miller NE, 2010, J AGING PHYS ACTIV, V18, P158, DOI 10.1123/japa.18.2.158
   Murphy SL, 2009, PREV MED, V48, P108, DOI 10.1016/j.ypmed.2008.12.001
   PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402
   Physical Activity Guideline Committee, 2008, PHYS ACT GUID ADV CO
   Pruitt LA, 2008, J AGING PHYS ACTIV, V16, P416, DOI 10.1123/japa.16.4.416
   Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613
   Rillamas-Sun Eileen, 2015, BMC Res Notes, V8, P270, DOI 10.1186/s13104-015-1229-2
   Rowlands AV, 2014, MED SCI SPORT EXER, V46, P1235, DOI 10.1249/MSS.0000000000000224
   Sabia S, 2014, AM J EPIDEMIOL, V179, P781, DOI 10.1093/aje/kwt330
   Salvo D, 2015, J PHYS ACT HEALTH, V12, P307, DOI 10.1123/jpah.2013-0087
   Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003
   Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710
   Scholes S, 2014, AM J EPIDEMIOL, V179, P1493, DOI 10.1093/aje/kwu087
   Schrack JA, 2014, J GERONTOL A-BIOL, V69, P973, DOI 10.1093/gerona/glt199
   Schuna JM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-126
   Shiroma EJ, 2013, JAMA-J AM MED ASSOC, V310, P2562, DOI 10.1001/jama.2013.278896
   Shiroma EJ, 2010, CIRCULATION, V122, P743, DOI 10.1161/CIRCULATIONAHA.109.914721
   Swartz AM, 2000, MED SCI SPORT EXER, V32, pS450, DOI 10.1097/00005768-200009001-00003
   Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3
   Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546
   Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016
   Tudor-Locke C, 2002, MED SCI SPORT EXER, V34, P2045, DOI 10.1249/01.MSS.0000039300.76400.16
   Tudor-Locke C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-60
   US Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A
   Van Holle V, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1785-3
   Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39
   Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91
   WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991
NR 64
TC 19
Z9 19
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 29
PY 2015
VL 10
IS 12
AR e0145950
DI 10.1371/journal.pone.0145950
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DA0IX
UT WOS:000367481900104
PM 26713857
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lamas, L
   Santana, F
   Heiner, M
   Ugrinowitsch, C
   Fellingham, G
AF Lamas, Leonardo
   Santana, Felipe
   Heiner, Matthew
   Ugrinowitsch, Carlos
   Fellingham, Gilbert
TI Modeling the Offensive-Defensive Interaction and Resulting Outcomes in
   Basketball
SO PLOS ONE
LA English
DT Article
ID TEAM SPORTS; MATCH; GOAL
AB Purpose
   We analyzed the interaction between offensive (i.e. space creation dynamics -SCDs) and defensive (i.e. space protection dynamics-SPDs) actions in six play outcomes (free shot, contested shot, new SCD, reset, foul, and turnover) in Spanish professional basketball games.
   Method
   Data consisted of 1548 SCD-SPD-outcome triples obtained from six play-off games. We used Bayesian methods to compute marginal probabilities of six outcomes following five different SCDs. We also computed probabilities of the six outcomes following the 16 most frequent SCD-SPD combinations.
   Results
   The pick action (e.g. pick and roll, pop and pop) was the most prevalent SCD (33%). However, this SCD did not produce the highest probability of a free shot (0.235). The highest probability of a free shot followed the SCD without ball (0.409). The pick was performed not only to attempt scoring but also to initiate offenses, as it produced the highest probability leading to a new SCD (0.403). Additionally, the SPD performed influenced the outcome of the SCD. This reinforces the notion that the opposition (offensive-defensive interaction) should be considered. To the best of our knowledge, in team sports, this is the first study to successfully model the tactical features involved in offense-defense interactions. Our analyses revealed that the high frequency of occurrence of some SCDs may be justified not only by an associated high probability of free shots but also by the possibility of progressively create more space in the defense (i.e. a new SCD as outcome). In the second case, it evidences offensive strategic features of progressive disruption of the defensive system through the concatenation of subsequent offensive actions.
C1 [Lamas, Leonardo] Univ Brasilia, Fac Phys Educ, Brasilia, DF, Brazil.
   [Santana, Felipe; Ugrinowitsch, Carlos] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil.
   [Heiner, Matthew] Univ Calif Santa Cruz, Dept Appl Math & Stat, Santa Cruz, CA 95064 USA.
   [Fellingham, Gilbert] Brigham Young Univ, Dept Stat, Provo, UT 84602 USA.
RP Lamas, L (reprint author), Univ Brasilia, Fac Phys Educ, Brasilia, DF, Brazil.
EM llamas@unb.br
RI Ugrinowitsch, Carlos/A-3925-2010
OI Ugrinowitsch, Carlos/0000-0001-8547-419X
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/19164-0];
   Conselho Nacional de Pesquisa [304205/2011-7]
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo, grant number 2012/19164-0 (LL) and Conselho Nacional de
   Pesquisa, grant number 304205/2011-7 (CU). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Baghal T, 2012, J QUANTITATIVE ANAL, V1
   Bourbousson J, 2010, JOURNAL OF SPORTS SC, V3, P349, DOI [10.1080/02640410903503640, DOI 10.1080/02640410903503640]
   Cade W, 2013, SESUG, P1
   Cervone D, 2014, MIT SLOAN SPORTS AN, P1
   Correia V, 2013, J SPORT SCI, V31, P546, DOI 10.1080/02640414.2012.738926
   Crum P, 2013, SPACE CREATION DYNAM
   Davids K., 2005, SCI FOOTBALL, VV, P537
   de Campos C, 2011, INT JOINT C ART INT, P2107
   Erculj F, 2015, PLOS ONE, V6, P1
   Franks I.M., 1986, J SPORT BEHAV, V9, P38
   Kubatko J., 2007, J QUANTITATIVE ANAL, V3, P1, DOI DOI 10.2202/1559-0410.1070
   Lamas L, 2011, INT J PERF ANAL SPOR, V11, P71
   Lamas L, 2014, INT J PERF ANAL SPOR, V14, P307
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lucey P, 2014, MIT SLOAN SPORTS AN
   Martin AD, 2011, J STAT SOFTW, V42, P1
   Oh M, 2015, MIT SLOAN SPORTS AN, P2
   Oliver D, 2004, BASKETBALL ON PAPER
   Page GL, 2014, J QUANTITATIVE ANAL, V4
   R Core Team, 2015, R FDN STAT COMP
   Ruiz M, 2014, J QUANTITATIVE ANAL, V1, P27
   Santana Felipe L., 2015, Motriz: rev. educ. fis., V21, P34, DOI 10.1590/S1980-65742015000100005
   Strumbelj E, 2012, INT J FORECASTING, V28, P532, DOI 10.1016/j.ijforecast.2011.01.004
   Vilar L, 2014, HUM MOVEMENT SCI, V33, P14, DOI 10.1016/j.humov.2013.08.012
NR 24
TC 9
Z9 9
U1 1
U2 21
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 14
PY 2015
VL 10
IS 12
AR e0144435
DI 10.1371/journal.pone.0144435
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CY9GR
UT WOS:000366715900049
PM 26659134
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Cheng, H
   Liu, L
   Yu, WM
   Zhang, H
   Luo, DZ
   Zheng, GY
AF Cheng, Hui
   Liu, Li
   Yu, Weimin
   Zhang, Hong
   Luo, Dianzhong
   Zheng, Guoyan
TI Comparison of 2.5D and 3D Quantification of Femoral Head Coverage in
   Normal Control Subjects and Patients with Hip Dysplasia
SO PLOS ONE
LA English
DT Article
ID FEMOROACETABULAR IMPINGEMENT; PERIACETABULAR OSTEOTOMY; RADIOGRAPHIC
   ANALYSIS; ACETABULAR COVERAGE; PELVIC RADIOGRAPHS; RADIATION-EXPOSURE;
   CANCER-RISKS; CT; RELIABILITY; VERSION
AB Hip dysplasia is characterized by insufficient femoral head coverage (FHC). Quantification of FHC is of importance as the underlying goal of the surgery to treat hip dysplasia is to restore a normal acetabular morphology and thereby to improve FHC. Unlike a pure 2D X-ray radiograph-based measurement method or a pure 3D CT-based measurement method, previously we presented a 2.5D method to quantify FHC from a single anteriorposterior (AP) pelvic radiograph. In this study, we first quantified and compared 3D FHC between a normal control group and a patient group using a CT-based measurement method. Taking the CT-based 3D measurements of FHC as the gold standard, we further quantified the bias, precision and correlation between the 2.5D measurements and the 3D measurements on both the control group and the patient group. Based on digitally reconstructed radiographs (DRRs), we investigated the influence of the pelvic tilt on the 2.5D measurements of FHC. The intraclass correlation coefficients (ICCs) for absolute agreement was used to quantify interobserver reliability and intraobserver reproducibility of the 2.5D measurement technique. The Pearson correlation coefficient, r, was used to determine the strength of the linear association between the 2.5D and the 3D measurements. Student's t-test was used to determine whether the differences between different measurements were statistically significant. Our experimental results demonstrated that both the interobserver reliability and the intraobserver reproducibility of the 2.5D measurement technique were very good (ICCs > 0.8). Regression analysis indicated that the correlation was very strong between the 2.5D and the 3D measurements (r = 0.89, p < 0.001). Student's t-test showed that there were no statistically significant differences between the 2.5D and the 3D measurements of FHC on the patient group (p > 0.05). The results of this study provided convincing evidence demonstrating the validity of the 2.5D measurements of FHC from a single AP pelvic radiograph and proved that it could serve as a surrogate for 3D CT-based measurements. Thus it may be possible to use this method to avoid a CT scan for the purpose of estimating 3D FHC in diagnosis and post-operative treatment evaluation of patients with hip dysplasia.
C1 [Cheng, Hui; Zhang, Hong; Luo, Dianzhong] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Orthopaed Surg, Div Joint Surg, Beijing, Peoples R China.
   [Cheng, Hui; Liu, Li; Yu, Weimin; Zheng, Guoyan] Univ Bern, Inst Surg Technol & Biomech, CH-3014 Bern, Switzerland.
RP Zheng, GY (reprint author), Univ Bern, Inst Surg Technol & Biomech, CH-3014 Bern, Switzerland.
EM guoyan.zheng@ieee.org
RI , Guoyan/M-3617-2018
OI , Guoyan/0000-0003-4173-0379
FU Sino-Swiss Science and Technology Cooperation Program [EG 11-032014]
FX This work was partially supported by Sino-Swiss Science and Technology
   Cooperation Program, EG 11-032014 (GZ). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Akiyama M, 2012, SKELETAL RADIOL, V41, P1411, DOI 10.1007/s00256-012-1368-7
   Clohisy JC, 2008, J BONE JOINT SURG AM, V90A, P47, DOI 10.2106/JBJS.H.00756
   Collier MB, 2003, J BONE JOINT SURG AM, V85A, P2410, DOI 10.2106/00004623-200312000-00020
   Cooperman D, 2013, J PEDIATR ORTHOPED, V33, pS2, DOI 10.1097/BPO.0b013e3182770a8d
   COOPERMAN DR, 1983, CLIN ORTHOP RELAT R, P79
   Dandachli W, 2008, J BONE JOINT SURG BR, V90B, P1428, DOI 10.1302/0301-620X.90B11.20073
   Engesaeter IO, 2012, SKELETAL RADIOL, V41, P775, DOI 10.1007/s00256-011-1283-3
   Flohr TG, 2005, RADIOLOGY, V235, P756, DOI 10.1148/radiol.2353040037
   GANZ R, 1988, CLIN ORTHOP RELAT R, P26
   HARRIS WH, 1986, CLIN ORTHOP RELAT R, P20
   KLAUE K, 1988, CLIN ORTHOP RELAT R, P15
   Kleinerman RA, 2006, PEDIATR RADIOL, V36, P121, DOI 10.1007/s00247-006-0191-5
   KONISHI N, 1993, J BONE JOINT SURG AM, V75A, P1318, DOI 10.2106/00004623-199309000-00007
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lembeck B, 2005, ACTA ORTHOP, V76, P517, DOI 10.1080/17453670510041501
   Liu L, 2014, COMPUTER ASSISTED PL, P643
   Liu L, 2015, MED ENG PHY IN PRESS
   Morvan J, 2013, J RHEUMATOL, V40, P1583, DOI 10.3899/jrheum.121544
   MURPHY SB, 1995, J BONE JOINT SURG AM, V77A, P985, DOI 10.2106/00004623-199507000-00002
   Nepple JJ, 2014, AM J SPORT MED, V42, P2393, DOI 10.1177/0363546514542797
   Nho JH, 2012, J BONE JOINT SURG BR, V94B, P32, DOI 10.1302/0301-620X.94B1.27621
   Pedersen DR, 2004, J PEDIATR ORTHOPED, V24, P156, DOI 10.1097/01241398-200403000-00004
   Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427
   Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296
   STEEL HH, 1977, CLIN ORTHOP RELAT R, P116
   Steppacher SD, 2008, CLIN ORTHOP RELAT R, V466, P782, DOI 10.1007/s11999-008-0141-7
   Steppacher SD, 2008, CLIN ORTHOP RELAT R, V466, P1633, DOI 10.1007/s11999-008-0242-3
   Tannast M, 2005, CLIN ORTHOP RELAT R, P182, DOI 10.1097/01.blo.0000167669.26068.c5
   Tannast M, 2008, J ORTHOP RES, V26, P1199, DOI 10.1002/jor.20653
   Wiberg G, 1939, ACTA CHIR SCAND, V83, P53
   Zheng G, 2007, COMPUT METH PROG BIO, V87, P36, DOI 10.1016/j.cmpb.2007.02.010
NR 31
TC 4
Z9 4
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 24
PY 2015
VL 10
IS 11
AR e0143498
DI 10.1371/journal.pone.0143498
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CX7DU
UT WOS:000365862600071
PM 26599869
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chao, WR
   Lee, MY
   Ruan, A
   Sheng, HP
   Hsu, JD
   Han, CP
   Koo, CL
AF Chao, Wan-Ru
   Lee, Ming-Yung
   Ruan, Alexandra
   Sheng, Huang Pin
   Hsu, Jeng-Dong
   Han, Chih-Ping
   Koo, Chiew-Loon
TI Assessment of HER2 Status Using Immunohistochemistry (IHC) and
   Fluorescence In Situ Hybridization (FISH) Techniques in Mucinous
   Epithelial Ovarian Cancer: A Comprehensive Comparison between ToGA
   Biopsy Method and ToGA Surgical Specimen Method
SO PLOS ONE
LA English
DT Article
ID AMERICAN SOCIETY; GUIDELINE UPDATE; AMPLIFICATION
AB We aimed to compare the assay performance characteristics of HER2 status in mucinous epithelial ovarian cancer (EOC) by ToGA (Trastuzumab for Gastric Cancer) biopsy versus ToGA surgical specimen methods. Forty-nine tissue microarray (TMA) samples of mucinous EOC from Asian women were analyzed by immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) tests using ToGA trial HER2 scoring methods. The overall concordance between IHC and FISH by the ToGA surgical specimen method is 97.56% and by the ToGA biopsy specimen method is 97.14%. The agreements of HER2 IHC results under both biopsy and surgical specimen methods were nearly perfect (weighted kappa = 0.845). Additionally, the percentage of Her2 FISH amplification showed increasing trend with increasing HER2 IHC ordinals (negative, equivocal, positive) by both TOGA biopsy (P<0.001) and surgical specimen method (P<0.001). After excluding equivocal cases, the sensitivity (100%), PPV (88.89%) and NPV (100%) of HER2 IHC were unchanged under either surgical specimen method or biopsy method. However, the specificity (96.97%) and accuracy (97.56%) of HER2 IHC was slightly higher under the surgical specimen method than those (specificity 96.30%, accuracy 97.14%) under the biopsy method. Of the total 49 cases, the number (n = 14) of HER2 IHC equivocal results under the ToGA biopsy method was 1.75-fold higher than those (n = 8) under the ToGA surgical specimen method (28.57% vs. 16.32%). Therefore, compared to ToGA surgery specimen method, the ToGA biopsy method caused more equivocal IHC cases to be referred to FISH testing and did not increase the detection rates of Her2 FISH amplification.
C1 [Chao, Wan-Ru; Hsu, Jeng-Dong; Han, Chih-Ping] Chung Shan Med Univ, Dept Pathol, Taichung 40201, Taiwan.
   [Chao, Wan-Ru; Sheng, Huang Pin; Hsu, Jeng-Dong; Han, Chih-Ping] Chung Shan Med Univ Hosp, Taichung 40201, Taiwan.
   [Lee, Ming-Yung] Providence Univ, Dept Stat & Informat Sci, Taichung, Taiwan.
   [Ruan, Alexandra] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA.
   [Sheng, Huang Pin; Han, Chih-Ping] Chung Shan Med Univ, Sch Med, Dept Obstet & Gynecol, Taichung 40201, Taiwan.
   [Koo, Chiew-Loon] Tungs Taichung MetroHarbor Hosp, Dept Pathol, Taichung, Taiwan.
RP Koo, CL (reprint author), Tungs Taichung MetroHarbor Hosp, Dept Pathol, Taichung, Taiwan.
EM hanhaly2@gmail.com
FU Chung Shan Medical University Hospital, Taiwan [2015-C-013, 2015-C-029]
FX This work was supported by Chung Shan Medical University Hospital
   (2015-C-013 and 2015-C-029), Taiwan.
CR Anglesio MS, 2013, J PATHOL, V229, P111, DOI 10.1002/path.4088
   Bang YJ, 2010, LANCET, V376, P1302
   Chao WR, 2014, AM J SURG PATHOL, V38, P1227, DOI 10.1097/PAS.0000000000000268
   Chao WR, 2014, HUM PATHOL, V45, P810, DOI 10.1016/j.humpath.2013.11.016
   Check W., 2005, CAP TODAY
   Chen CK, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000171
   Kallioniemi OP, 2001, HUM MOL GENET, V10, P657, DOI 10.1093/hmg/10.7.657
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   McCaughan H, 2012, J CLIN PATHOL, V65, P670, DOI 10.1136/jclinpath-2011-200616
   Radu OM, 2012, AM J CLIN PATHOL, V137, P583, DOI 10.1309/AJCPXQVS6YGHPDCY
   Ruschoff J, 2010, VIRCHOWS ARCH, V457, P299, DOI 10.1007/s00428-010-0952-2
   Shergill LS, 2004, CURR MED RES OPIN, V20, P707, DOI 10.1185/030079904125003412
   Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984
   Yoon HH, 2013, 2013 GASTR CANC S JA
NR 14
TC 4
Z9 4
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 13
PY 2015
VL 10
IS 11
AR e0142135
DI 10.1371/journal.pone.0142135
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DA2MI
UT WOS:000367628500010
PM 26566289
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Stiglic, G
   Pajnkihar, M
AF Stiglic, Gregor
   Pajnkihar, Majda
TI Evaluation of Major Online Diabetes Risk Calculators and Computerized
   Predictive Models
SO PLOS ONE
LA English
DT Article
ID CAROTID ATHEROSCLEROSIS; ASSESSMENT SCORE; LIFE-STYLE; VALIDATION;
   AGREEMENT; AUSTRALIA; MACHINE
AB Classical paper-and-pencil based risk assessment questionnaires are often accompanied by the online versions of the questionnaire to reach a wider population. This study focuses on the loss, especially in risk estimation performance, that can be inflicted by direct transformation from the paper to online versions of risk estimation calculators by ignoring the possibilities of more complex and accurate calculations that can be performed using the online calculators. We empirically compare the risk estimation performance between four major diabetes risk calculators and two, more advanced, predictive models. National Health and Nutrition Examination Survey (NHANES) data from 1999-2012 was used to evaluate the performance of detecting diabetes and pre-diabetes.
   American Diabetes Association risk test achieved the best predictive performance in category of classical paper-and-pencil based tests with an Area Under the ROC Curve (AUC) of 0.699 for undiagnosed diabetes (0.662 for pre-diabetes) and 47% (47% for pre-diabetes) persons selected for screening. Our results demonstrate a significant difference in performance with additional benefits for a lower number of persons selected for screening when statistical methods are used. The best AUC overall was obtained in diabetes risk prediction using logistic regression with AUC of 0.775 (0.734) and an average 34% (48%) persons selected for screening. However, generalized boosted regression models might be a better option from the economical point of view as the number of selected persons for screening of 30%(47%) lies significantly lower for diabetes risk assessment in comparison to logistic regression (p < 0.001), with a significantly higher AUC (p < 0.001) of 0.774 (0.740) for the pre-diabetes group.
   Our results demonstrate a serious lack of predictive performance in four major online diabetes risk calculators. Therefore, one should take great care and consider optimizing the online versions of questionnaires that were primarily developed as classical paper questionnaires.
C1 [Stiglic, Gregor; Pajnkihar, Majda] Univ Maribor, Fac Hlth Sci, SLO-2000 Maribor, Slovenia.
   [Stiglic, Gregor] Univ Maribor, Fac Elect Engn & Comp Sci, SLO-2000 Maribor, Slovenia.
RP Stiglic, G (reprint author), Univ Maribor, Fac Hlth Sci, SLO-2000 Maribor, Slovenia.
EM gregor.stiglic@um.si
RI Stiglic, Gregor/O-7608-2019
OI Stiglic, Gregor/0000-0002-0183-8679
FU Swiss National Science Foundation through a SCOPES Joint Research
   Projects [IZ73Z0_152415]
FX Both authors of this study were supported by the Swiss National Science
   Foundation through a SCOPES 2013 Joint Research Projects grant
   IZ73Z0_152415 (http://www.snf.ch/en/funding/programmes/scopes/). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abbasi A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5900
   [Anonymous], 2014, ADA DIABETES RISK TE
   Bang HJ, 2009, ANN INTERN MED, V151, P775, DOI 10.7326/0003-4819-151-11-200912010-00005
   Buijsse B, 2011, EPIDEMIOL REV
   Cameron AJ, 2003, MED J AUSTRALIA, V178, P427
   *CDCP, 1999, NAT HLTH NUTR EX SUR
   Chen L, 2010, MED J AUSTRALIA, V192, P197
   Chomutare T, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1874
   COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256
   Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40
   Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103
   Cook AJ, 2004, PAIN, V110, P310, DOI 10.1016/j.pain.2004.04.012
   Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451
   Grant Janet F, 2006, Epidemiol Perspect Innov, V3, P4, DOI 10.1186/1742-5573-3-4
   Gray LJ, 2013, DIABETIC MED, V30, P758, DOI 10.1111/dme.12115
   Gray LJ, 2010, DIABETIC MED, V27, P887, DOI 10.1111/j.1464-5491.2010.03037.x
   Hwang SJ, 1997, CIRCULATION, V96, P4219
   Kaczorowski J, 2009, CAN J DIABETES, V33, P381, DOI 10.1016/S1499-2671(09)34008-3
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450
   NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614
   OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155
   Shortliffe EH, 2014, J BIOMED INFORM, V48, P1, DOI 10.1016/j.jbi.2014.02.016
   Penn L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057143
   R Core Team, 2013, R LANG ENV STAT COMP
   Ridgeway G., 2013, GBM GEN BOOST REGR M
   Robinson CA, 2011, CHRON DIS INJ CAN, V32, P19
   Stiglic G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033812
   Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91
   Yu W, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-16
NR 30
TC 5
Z9 5
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 11
PY 2015
VL 10
IS 11
AR e0142827
DI 10.1371/journal.pone.0142827
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CV7DR
UT WOS:000364433100130
PM 26560153
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Perinetti, G
   Primozic, J
   Franchi, L
   Contardo, L
AF Perinetti, Giuseppe
   Primozic, Jasmina
   Franchi, Lorenzo
   Contardo, Luca
TI Treatment Effects of Removable Functional Appliances in Pre-Pubertal and
   Pubertal Class II Patients: A Systematic Review and Meta-Analysis of
   Controlled Studies
SO PLOS ONE
LA English
DT Article
ID CERVICAL VERTEBRAL MATURATION; TWIN-BLOCK; ORTHODONTIC TREATMENT;
   MANDIBULAR CHANGES; HERBST APPLIANCES; SKELETAL; GROWTH; MALOCCLUSION;
   PUBLICATION; EFFICACY
AB Background
   Treatment effects of removable functional appliances in Class II malocclusion patients according to the pre-pubertal or pubertal growth phase has yet to be clarified.
   Objectives
   To assess and compare skeletal and dentoalveolar effects of removable functional appliances in Class II malocclusion treatment between pre-pubertal and pubertal patients.
   Search methods
   Literature survey using the Medline, SCOPUS, LILACS and SciELO databases, the Cochrane Library from inception to May 31, 2015. A manual search was also performed.
   Selection criteria
   Randomised (RCTs) or controlled clinical trials with a matched untreated control group. No restrictions were set regarding the type of removable appliance whenever used alone.
   Data collection and analysis
   For the meta-analysis, cephalometric parameters on the supplementary mandibular growth were the main outcomes, with other cephalometric parameters considered as secondary outcomes. Risk of bias in individual and across studies were evaluated along with sensitivity analysis for low quality studies. Mean differences and 95% confidence intervals for annualised changes were computed according to a random model. Differences between prepubertal and pubertal patients were assessed by subgroup analyses. GRADE assessment was performed for the main outcomes.
   Results
   Twelve articles (but only 3 RCTs) were included accounting for 8 pre-pubertal and 7 pubertal groups. Overall supplementary total mandibular length and mandibular ramus height were 0.95 mm (0.38, 1.51) and 0.00 mm (-0.52, 0.53) for pre-pubertal patients and 2.91 mm (2.04, 3.79) and 2.18 mm (1.51, 2.86) for pubertal patients, respectively. The subgroup difference was significant for both parameters (p<0.001). No maxillary growth restrain or increase in facial divergence was seen in either subgroup. The GRADE assessment was low for the pre-pubertal patients, and generally moderate for the pubertal patients.
   Conclusions
   Taking into account the limited quality and heterogeneity of the included studies, functional treatment by removable appliances may be effective in treating Class II malocclusion with clinically relevant skeletal effects if performed during the pubertal growth phase.
C1 [Perinetti, Giuseppe; Contardo, Luca] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
   [Primozic, Jasmina] Univ Ljubljana, Fac Med, Dept Orthodont & Jaw Orthopaed, Ljubljana, Slovenia.
   [Franchi, Lorenzo] Univ Florence, Dept Orthodont, Sch Dent, Florence, Italy.
   [Franchi, Lorenzo] Univ Michigan, Sch Dent, Dept Orthodont & Pediat Dent, Ann Arbor, MI 48109 USA.
RP Perinetti, G (reprint author), Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
EM G.Perinetti@fmc.units.it
RI Franchi, Lorenzo/B-2730-2009
OI FRANCHI, LORENZO/0000-0002-2072-460X; Perinetti,
   Giuseppe/0000-0002-7226-5134
CR Antonarakis GS, 2007, ANGLE ORTHOD, V77, P907, DOI 10.2319/061706-244
   Baccetti T, 2000, AM J ORTHOD DENTOFAC, V118, P159, DOI 10.1067/mod.2000.105571
   Baccetti T, 2005, SEMIN ORTHOD, V11, P119, DOI DOI 10.1053/J.S0D0.2005.04.005
   Baccetti Tiziano, 2010, Prog Orthod, V11, P145, DOI 10.1016/j.pio.2010.09.003
   Baysal A, 2014, EUR J ORTHODONT, V36, P164, DOI 10.1093/ejo/cjt013
   Baysal A, 2013, EUR J ORTHODONT, V35, P71, DOI 10.1093/ejo/cjq187
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Borenstein M., 2009, INTRO METAANALYSIS
   Centre for Reviews Dissemination, 2009, SYST REV CRDS GUID U
   Chen JY, 2002, AM J ORTHOD DENTOFAC, V122, P470, DOI 10.1067/mod.2002.126730
   Cozza P, 2006, AM J ORTHOD DENTOFAC, V129, DOI 10.1016/j.ajodo.2005.11.010
   [ Cui Li-juan], 2010, [, Journal of Clinical Rehabilitative Tissue Engineering Research], V14, P1572
   de Almeida-Pedrin RR, 2007, AM J ORTHOD DENTOFAC, V132, P191, DOI 10.1016/j.ajodo.2005.07.030
   Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Ehsani S, 2014, EUR J ORTHODONT, DOI [10.1093/ejo/cju030, DOI 10.1093/EJ0/CJU030]
   Faltin K, 2003, ANGLE ORTHOD, V73, P221
   FISHMAN LS, 1982, ANGLE ORTHOD, V52, P88
   Flores-Mir C, 2007, AM J ORTHOD DENTOFAC, V131, P707, DOI 10.1016/j.ajodo.2007.02.041
   Franchi L, 2000, AM J ORTHOD DENTOFAC, V118, P335, DOI 10.1067/mod.2000.107009
   Franchi L, 2006, ANGLE ORTHOD, V76, P950, DOI 10.2319/110205-385
   Gupta Shreya, 2015, Dental Press J. Orthod., V20, P68, DOI 10.1590/2176-9451.20.2.068-075.oar
   Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011
   Hagg U, 1982, AM J ORTHOD, V82, P309
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008
   Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006
   Marsico E, 2011, AM J ORTHOD DENTOFAC, V139, P24, DOI 10.1016/j.ajodo.2010.04.028
   Martina R, 2013, ORTHOD CRANIOFAC RES, V16, P116, DOI 10.1111/ocr.12013
   Masoud M, 2008, AM J ORTHOD DENTOFAC, V134, P209, DOI 10.1016/j.ajodo.2006.09.063
   MCNAMARA JA, 1982, AM J ORTHOD DENTOFAC, V82, P288, DOI 10.1016/0002-9416(82)90463-8
   McNamara JA, 2001, ORTHODONTICS DENTOFA
   O'Brien K, 2003, AM J ORTHOD DENTOFAC, V124, P234, DOI 10.1016/S0889-5406(03)00352-4
   PANCHERZ H, 1984, AM J ORTHOD DENTOFAC, V85, P125, DOI 10.1016/0002-9416(84)90004-6
   Patil AS, 2012, J CELL PHYSIOL, V227, P1796, DOI 10.1002/jcp.22905
   Perillo L, 2013, PROG ORTHOD, V14, DOI 10.1186/2196-1042-14-18
   Perillo L, 2011, EUR J ORTHODONT, V33, P84, DOI 10.1093/ejo/cjq033
   Perinetti G, 2014, ORTHOD CRANIOFAC RES, V17, P270, DOI 10.1111/ocr.12052
   Perinetti G, 2015, ANGLE ORTHOD, V85, P480, DOI 10.2319/102813-790.1
   Perinetti G, 2014, ANGLE ORTHOD, V84, P951, DOI 10.2319/120913-906.1
   Proff P, 2007, ANN ANAT, V189, P269, DOI 10.1016/j.aanat.2006.09.006
   Quintao C, 2006, EUR J ORTHODONT, V28, P35, DOI 10.1093/ejo/cji067
   Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549
   Shrier I, 2007, AM J EPIDEMIOL, V166, P1203, DOI 10.1093/aje/kwm189
   Singh S, 2010, J CLIN PEDIATR DENT, V35, P233, DOI 10.17796/jcpd.35.2.9572h13218806871
   Stahl F, 2008, AM J ORTHOD DENTOFAC, V134, P125, DOI 10.1016/j.ajodo.2006.06.028
   Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0
   Thiruvenkatachari B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003452.pub3
   Tulloch JFC, 1997, AM J ORTHOD DENTOFAC, V111, P391, DOI 10.1016/S0889-5406(97)80021-2
NR 52
TC 26
Z9 27
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 28
PY 2015
VL 10
IS 10
AR e0141198
DI 10.1371/journal.pone.0141198
PG 35
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CV0DL
UT WOS:000363918100059
PM 26510187
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Xu, ZB
   Asman, AJ
   Baucom, RB
   Abramson, RG
   Poulose, BK
   Landman, BA
AF Xu, Zhoubing
   Asman, Andrew J.
   Baucom, Rebeccah B.
   Abramson, Richard G.
   Poulose, Benjamin K.
   Landman, Bennett A.
TI Quantitative CT Imaging of Ventral Hernias: Preliminary Validation of an
   Anatomical Labeling Protocol
SO PLOS ONE
LA English
DT Article
ID ABDOMINAL-CAVITY VOLUME; INCISIONAL HERNIA; REPAIR; DOMAIN; MESH
AB Objective
   We described and validated a quantitative anatomical labeling protocol for extracting clinically relevant quantitative parameters for ventral hernias (VH) from routine computed tomography (CT) scans. This information was then used to predict the need for mesh bridge closure during ventral hernia repair (VHR).
   Methods
   A detailed anatomical labeling protocol was proposed to enable quantitative description of VH including shape, location, and surrounding environment (61 scans). Intra- and inter-rater reproducibilities were calculated for labeling on 18 and 10 clinically acquired CT scans, respectively. Preliminary clinical validation was performed by correlating 20 quantitative parameters derived from anatomical labeling with the requirement for mesh bridge closure at surgery (26 scans). Prediction of this clinical endpoint was compared with similar models fit on metrics from the semi-quantitative European Hernia Society Classification for Ventral Hernia (EHSCVH).
   Results
   High labeling reproducibilities were achieved for abdominal walls (+/- 2 mm in mean surface distance), key anatomical landmarks (+/- 5 mm in point distance), and hernia volumes (0.8 in Cohen's kappa). 9 out of 20 individual quantitative parameters of hernia properties were significantly different between patients who required mesh bridge closure versus those in whom fascial closure was achieved at the time of VHR (p<0.05). Regression models constructed by two to five metrics presented a prediction with 84.6% accuracy for bridge requirement with cross-validation; similar models constructed by EHSCVH variables yielded 76.9% accuracy.
   Significance
   Reproducibility was acceptable for this first formal presentation of a quantitative image labeling protocol for VH on abdominal CT. Labeling-derived metrics presented better prediction of the need for mesh bridge closure than the EHSCVH metrics. This effort is intended as the foundation for future outcomes studies attempting to optimize choice of surgical technique across different anatomical types of VH.
C1 [Xu, Zhoubing; Asman, Andrew J.; Landman, Bennett A.] Vanderbilt Univ, Elect Engn, Nashville, TN 37235 USA.
   [Baucom, Rebeccah B.; Poulose, Benjamin K.] Vanderbilt Univ, Med Ctr, Dept Surg, Div Gen Surg, Nashville, TN 37235 USA.
   [Abramson, Richard G.; Landman, Bennett A.] Vanderbilt Univ, Radiol & Radiol Sci, Nashville, TN 37235 USA.
RP Xu, ZB (reprint author), Vanderbilt Univ, Elect Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.
EM zhoubing.xu@vanderbilt.edu
RI Landman, Bennett A/A-2343-2009
OI Landman, Bennett A/0000-0001-5733-2127; Poulose,
   Benjamin/0000-0003-1192-6311; Abramson, Richard/0000-0002-1200-0281
FU Vanderbilt Initiative in Surgery and Engineering / Vanderbilt Institute
   for Clinical and Translational Research [VR3029]; National Institutes of
   Health [1R03EB012461]; National Center for Research Resources [UL1
   RR024975-01]; National Center for Advancing Translational Sciences [2
   UL1 TR000445-06]
FX This project was supported by Vanderbilt Initiative in Surgery and
   Engineering (https://www4.vanderbilt.edu/vise) / Vanderbilt Institute
   for Clinical and Translational Research (https://victr.vanderbilt.edu)
   VR3029 and National Institutes of Health (http://nih.gov) 1R03EB012461.
   The project described was also supported by the National Center for
   Research Resources, Grant UL1 RR024975-01, and is now at the National
   Center for Advancing Translational Sciences, Grant 2 UL1 TR000445-06.
   The content is solely the responsibility of the authors and does not
   necessarily represent the official views of the NIH. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Breuing K, 2010, SURGERY, V148, P544, DOI 10.1016/j.surg.2010.01.008
   Cristianini N., 2000, INTRO SUPPORT VECTOR
   Dubay DA, 2007, ANN SURG, V245, P140, DOI 10.1097/01.sla.0000251267.11012.85
   Forbes SS, 2009, BRIT J SURG, V96, P851, DOI 10.1002/bjs.6668
   Hosmer D. W., 2000, INTRO LOGISTIC REGRE
   Kanters AE, 2012, J AM COLL SURGEONS, V215, P787, DOI 10.1016/j.jamcollsurg.2012.08.012
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   McAuliffe M. J., 2001, COMP BAS MED SYST 20
   Millikan KW, 2003, SURG CLIN N AM, V83, P1223, DOI 10.1016/S0039-6109(03)00129-4
   Muysoms FE, 2009, HERNIA, V13, P407, DOI 10.1007/s10029-009-0518-x
   Ousley J, 2014, J AM COLL SURGEONS, V3, pS99
   Poulose BK, 2012, HERNIA, V16, P179, DOI 10.1007/s10029-011-0879-9
   Sabbagh C, 2011, HERNIA, V15, P559, DOI 10.1007/s10029-011-0832-y
   Slater NJ, 2013, HERNIA, P1, DOI [10.1007/s10029-013-, DOI 10.1007/S10029-013-]
   Tanaka EY, 2010, HERNIA, V14, P63, DOI 10.1007/s10029-009-0560-8
   Wahba G, 1990, SPLINE MODELS OBSERV
   Xu ZB, 2013, MED PHYS, V40, DOI 10.1118/1.4828791
   Yao J, 2011, SPIE MED IMAGING
   Yao S, 2012, COMPUT AIDED SURG, V17, P40, DOI 10.3109/10929088.2011.636453
   Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x
NR 21
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 28
PY 2015
VL 10
IS 10
AR e0141671
DI 10.1371/journal.pone.0141671
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CV0DL
UT WOS:000363918100121
PM 26509450
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ernst, M
   Romero, JM
   Buhk, JH
   Cheng, B
   Herrmann, J
   Fiehler, J
   Groth, M
AF Ernst, Marielle
   Romero, Javier M.
   Buhk, Jan-Hendrik
   Cheng, Bastian
   Herrmann, Jochen
   Fiehler, Jens
   Groth, Michael
TI Sensitivity of Hyperdense Basilar Artery Sign on Non-Enhanced Computed
   Tomography
SO PLOS ONE
LA English
DT Article
ID CT ANGIOGRAPHY; STATISTICAL-METHODS; OCCLUSION; AGREEMENT; DIAGNOSIS;
   THROMBUS; STROKE
AB Purpose
   The hyperdense basilar artery sign (HBAS) is an indicator of vessel occlusion on non contrast-enhanced computer tomography (NECT) in acute stroke patients. Since basilar artery occlusion (BAO) is associated with a high mortality and morbidity, its early detection is of great clinical value. We sought to analyze the influence of density measurement as well as a normalized ratio of Hounsfield unit/hematocrit (HU/Hct) ratio on the detection of BAO on NECT in patients with suspected BAO.
   Materials and Methods
   102 patients with clinically suspected BAO were examined with NECT followed immediately by Multidetector computed tomography Angiography. Two observers independently analyzed the images regarding the presence or absence of HBAS on NECT and performed HU measurements in the basilar artery. Receiver operating characteristic curve analysis was performed to determine the optimal density threshold for BAO using attenuation measurements or HU/Hct ratio.
   Results
   Sensitivity of visual detection of the HBAS on NECT was relatively low 81% (95%-CI, 54-95%) while specificity was high 91% (95%-CI, 82-96%). The highest sensitivity was achieved by the combination of visual assessment and additional quantitative attenuation measurements applying a cut-off value of 46.5 HU with 94% sensitivity and 81% specificity for BAO. A HU/Hct ratio >1.32 revealed sensitivity of 88% (95%-CI, 60-98%) and specificity of 84% (95%-CI, 74-90%).
   Conclusion
   In patients with clinically suspected acute BAO the combination of visual assessment and additional attenuation measurement with a cut-off value of 46.5 HU is a reliable approach with high sensitivity in the detection of BAO on NECT.
C1 [Ernst, Marielle; Buhk, Jan-Hendrik; Fiehler, Jens; Groth, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Ctr Radiol & Endoscopy, Hamburg, Germany.
   [Romero, Javier M.] Harvard Univ, Sch Med, Dept Radiol, Div Neuroradiol,Massachusetts Gen Hosp, Boston, MA 02115 USA.
   [Cheng, Bastian] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.
   [Herrmann, Jochen; Groth, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol, Ctr Radiol & Endoscopy, Div Pediat Radiol, Hamburg, Germany.
RP Ernst, M (reprint author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Ctr Radiol & Endoscopy, Hamburg, Germany.
EM m.ernst@uke.de
CR Beyer SE, 2015, STROKE, V46, P1840, DOI 10.1161/STROKEAHA.115.008841
   BLAND JM, 1986, LANCET, V1, P307
   Brandt T, 1999, STROKE, V30, P606, DOI 10.1161/01.STR.30.3.606
   BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491
   Buyck PJ, 2013, AM J NEURORADIOL, V34, P1568, DOI 10.3174/ajnr.A3469
   Connell L, 2012, NEURORADIOLOGY, V54, P321, DOI 10.1007/s00234-011-0887-6
   Costa-Santos C, 2011, J CLIN EPIDEMIOL, V64, P264, DOI 10.1016/j.jclinepi.2009.11.010
   Ernst M, 2014, NEURORADIOLOGY, V56, P1063, DOI 10.1007/s00234-014-1443-y
   Esquevin A, 2013, AM J EMERG MED, V31, P494, DOI 10.1016/j.ajem.2012.09.024
   Goldmakher GV, 2009, STROKE, V40, P134, DOI 10.1161/STROKEAHA.108.516690
   Groth M, 2015, THORACIC PATHOLOGIES
   KUCKEIN D, 1982, COMPUTERTOM SONOGRAP, V2, P120
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lev MH, 2001, J COMPUT ASSIST TOMO, V25, P520, DOI 10.1097/00004728-200107000-00003
   Mair G, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140216
   Schonewille WJ, 2009, LANCET NEUROL, V8, P724, DOI 10.1016/S1474-4422(09)70173-5
   Vergouwen MDI, 2012, STROKE, V43, P3003, DOI 10.1161/STROKEAHA.112.666867
   VONOFAKOS D, 1983, AM J NEURORADIOL, V4, P525
   ZATZ LM, 1977, RADIOLOGY, V124, P91, DOI 10.1148/124.1.91
NR 19
TC 2
Z9 2
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 19
PY 2015
VL 10
IS 10
AR e0141096
DI 10.1371/journal.pone.0141096
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CT7WW
UT WOS:000363026600030
PM 26479718
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Taniguchi, DAA
   Gagnon, Y
   Wheeler, BR
   Johnsen, S
   Jaffe, JS
AF Taniguchi, Darcy A. A.
   Gagnon, Yakir
   Wheeler, Benjamin R.
   Johnsen, Soenke
   Jaffe, Jules S.
TI Cuttlefish Sepia officinalis Preferentially Respond to Bottom Rather
   than Side Stimuli When Not Allowed Adjacent to Tank Walls
SO PLOS ONE
LA English
DT Article
ID DISRUPTIVE BODY PATTERNS; VISUAL-PERCEPTION; CAMOUFLAGE; COLORATION;
   SUBSTRATE; CONTRAST; OBJECTS; SIZE; CUES
AB Cuttlefish are cephalopods capable of rapid camouflage responses to visual stimuli. However, it is not always clear to what these animals are responding. Previous studies have found cuttlefish to be more responsive to lateral stimuli rather than substrate. However, in previous works, the cuttlefish were allowed to settle next to the lateral stimuli. In this study, we examine whether juvenile cuttlefish (Sepia officinalis) respond more strongly to visual stimuli seen on the sides versus the bottom of an experimental aquarium, specifically when the animals are not allowed to be adjacent to the tank walls. We used the Sub Sea Holodeck, a novel aquarium that employs plasma display screens to create a variety of artificial visual environments without disturbing the animals. Once the cuttlefish were acclimated, we compared the variability of camouflage patterns that were elicited from displaying various stimuli on the bottom versus the sides of the Holodeck. To characterize the camouflage patterns, we classified them in terms of uniform, disruptive, and mottled patterning. The elicited camouflage patterns from different bottom stimuli were more variable than those elicited by different side stimuli, suggesting that S. officinalis responds more strongly to the patterns displayed on the bottom than the sides of the tank. We argue that the cuttlefish pay more attention to the bottom of the Holodeck because it is closer and thus more relevant for camouflage.
C1 [Taniguchi, Darcy A. A.; Jaffe, Jules S.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.
   [Gagnon, Yakir; Wheeler, Benjamin R.; Johnsen, Soenke] Duke Univ, Dept Biol, Durham, NC 27708 USA.
RP Taniguchi, DAA (reprint author), MIT, Earth Atmospher & Planetary Sci, Cambridge, MA 02142 USA.
EM datanigu@mit.edu
RI Gagnon, Yakir/C-2665-2008
OI Gagnon, Yakir/0000-0003-2512-4520
FU Office of Naval Research [N00014-09-1-1053]
FX The funding for this work came from the Office of Naval Research, grant
   number N00014-09-1- 1053. The URL for the Office of Naval Research is
   (http://www.onr.navy.mil/). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Allen JJ, 2010, P R SOC B, V277, P1031, DOI 10.1098/rspb.2009.1694
   Barbosa A, 2008, VISION RES, V48, P1242, DOI 10.1016/j.visres.2008.02.011
   Barbosa A, 2008, J COMP PHYSIOL A, V194, P405, DOI 10.1007/s00359-007-0311-1
   Barbosa A, 2007, J EXP BIOL, V210, P1139, DOI 10.1242/jeb.02741
   Barbosa Alexandra, 2004, Biological Bulletin (Woods Hole), V207, P154
   Barbosa A, 2012, P ROY SOC B-BIOL SCI, V279, P84, DOI 10.1098/rspb.2011.0196
   BULLOCK TH, 1991, J COMP PHYSIOL A, V168, P141, DOI 10.1007/BF00217112
   Buresch KC, 2011, VISION RES, V51, P2362, DOI 10.1016/j.visres.2011.09.009
   Chiao CC, 2005, BIOL BULL-US, V208, P7, DOI 10.2307/3593095
   Chiao CC, 2001, BIOL BULL, V201, P269, DOI 10.2307/1543359
   Chiao CC, 2001, J EXP BIOL, V204, P2119
   Chiao CC, 2009, VISION RES, V49, P1647, DOI 10.1016/j.visres.2009.04.002
   Chlao CC, 2007, VISION RES, V47, P2223, DOI 10.1016/j.visres.2007.05.001
   Hanlon RT, 2009, PHILOS T R SOC B, V364, P429, DOI 10.1098/rstb.2008.0270
   Hanlon R.T., 1996, CEPHALOPOD BEHAV
   HANLON RT, 1988, PHILOS T ROY SOC B, V320, P437, DOI 10.1098/rstb.1988.0087
   Jaffe JS, 2011, OCEANS, V6
   Kelman EJ, 2008, J EXP BIOL, V211, P1757, DOI 10.1242/jeb.015149
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mathger LM, 2007, J EXP BIOL, V210, P2657, DOI 10.1242/jeb.004382
   Mathger LM, 2006, VISION RES, V46, P1746, DOI 10.1016/j.visres.2005.09.035
   MUNTZ WRA, 1989, J EXP BIOL, V142, P461
   Shohet AJ, 2006, J EXP BIOL, V209, P4717, DOI 10.1242/jeb.02580
   Shohet A, 2007, BIOL J LINN SOC, V92, P335, DOI 10.1111/j.1095-8312.2007.00842.x
   Ulmer KM, 2013, BIOL BULL-US, V224, P110, DOI 10.1086/BBLv224n2p110
NR 25
TC 1
Z9 1
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 14
PY 2015
VL 10
IS 10
AR e0138690
DI 10.1371/journal.pone.0138690
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CU0CK
UT WOS:000363183100022
PM 26465786
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Xu, S
   Jiao, Q
   Cheng, Y
   Sun, J
   Lu, Q
   Zhong, YS
AF Xu, Shuo
   Jiao, Qin
   Cheng, Yu
   Sun, Jie
   Lu, Qiong
   Zhong, Yisheng
TI Short-Term Reproducibility of Twenty-Four-Hour Intraocular Pressure
   Curves in Untreated Patients with Primary Open-Angle Glaucoma and Ocular
   Hypertension
SO PLOS ONE
LA English
DT Article
ID CONTACT-LENS SENSOR; ON-YELLOW PERIMETRY; CORNEAL THICKNESS; TENSION
   GLAUCOMA; HEALTHY-SUBJECTS; PATTERNS; PROGRESSION; FLUCTUATION; SLEEP;
   PEAK
AB Purpose
   To assess the short-term day-to-day reproducibility of 24-hour intraocular pressure (IOP) curves in various respects in untreated primary open-angle glaucoma (POAG) and ocular hypertension (OHT) patients.
   Methods
   47 subjects with POAG and 34 subjects with OHT underwent IOP measurements every 2 hours in both eyes for consecutive 48 hours by a non-contact tonometer (NCT). IOP values at each time point were recorded. Mean IOP, peak IOP, time difference of peak IOP between two days and IOP fluctuation were also calculated. Intraclass correlation coefficients (ICCs) and Bland-Altman plots were used to evaluate reproducibility.
   Results
   ICCs of the entire IOP values for a complete 24-hour curve were 0.577 and 0.561 in POAG and OHT patients, respectively. ICCs of IOP values at different time points ranged from 0.384 (10am) to 0.686 (4am) in POAG patients and from 0.347 (6am) to 0.760 (4am) in OHT patients. ICCs of mean IOP, peak IOP and IOP fluctuation were respectively 0.832, 0.704, 0.367 in POAG patients and 0.867, 0.816 0.633 in OHT patients. Only 37.23% and 35.29% of the peak IOP time points appeared within the time difference of 2 hours in POAG and OHT patients, respectively, while 53.19% and 48.53% appeared within 4 hours in POAG and OHT patients, respectively.
   Conclusion
   A 24-hour IOP curve in a single day is not highly reproducible in short-term and has limited use for evaluating individual IOP condition. Mean IOP and peak IOP for a 24-hour IOP curve are useful parameters in clinical follow-up, while IOP value at a certain time point, IOP fluctuation and peak IOP time point should be interpreted with caution.
C1 [Xu, Shuo; Jiao, Qin; Cheng, Yu; Zhong, Yisheng] Shanghai Jiao Tong Univ, Ruijin Hosp Affiliated, Dept Ophthalmol, Sch Med, Shanghai 200030, Peoples R China.
   [Sun, Jie; Lu, Qiong] Ruijin Hosp, Dept Ophthalmol, Luwan Branch, Shanghai, Peoples R China.
RP Zhong, YS (reprint author), Shanghai Jiao Tong Univ, Ruijin Hosp Affiliated, Dept Ophthalmol, Sch Med, Shanghai 200030, Peoples R China.
EM yszhong68@126.com
CR Aakre BM, 2003, OPHTHAL PHYSL OPT, V23, P271, DOI 10.1046/j.1475-1313.2003.00117.x
   Aptel F, 2014, JAMA OPHTHALMOL, V132, P1232, DOI 10.1001/jamaophthalmol.2014.1761
   Aptel F, 2014, OPHTHALMOLOGY, V121, P1998, DOI 10.1016/j.ophtha.2014.04.039
   Bengtsson B, 2007, OPHTHALMOLOGY, V114, P205, DOI 10.1016/j.ophtha.2006.07.060
   BLAND JM, 1986, LANCET, V1, P307
   De Smedt S, 2012, J GLAUCOMA, V21, P539, DOI 10.1097/IJG.0b013e31821dac43
   Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015
   Hara T, 2006, ARCH OPHTHALMOL-CHIC, V124, P165, DOI 10.1001/archopht.124.2.165
   Hasegawa K, 2006, JPN J OPHTHALMOL, V50, P449, DOI 10.1007/s10384-006-0343-z
   Hatanaka M, 2013, J GLAUCOMA, V22, P390, DOI 10.1097/IJG.0b013e3182447a03
   Hatanaka M, 2011, CLINICS, V66, P1235, DOI 10.1590/S1807-59322011000700019
   Kida T, 2006, INVEST OPHTH VIS SCI, V47, P4422, DOI 10.1167/iovs.06-0507
   Konstas AGP, 2009, EYE, V23, P73, DOI 10.1038/sj.eye.6702995
   Konstas AGP, 2007, ACTA OPHTHALMOLOGICA, V85
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leonardi M, 2004, INVEST OPHTH VIS SCI, V45, P3113, DOI 10.1167/iovs.04-0015
   Leonardi M, 2009, ACTA OPHTHALMOL, V87, P433, DOI 10.1111/j.1755-3768.2008.01404.x
   Liu JHK, 2003, INVEST OPHTH VIS SCI, V44, P1586, DOI 10.1167/iovs.02-0666
   Mansouri K, 2012, INVEST OPHTH VIS SCI, V53, P8050, DOI 10.1167/iovs.12-10569
   Mansouri K, 2011, BRIT J OPHTHALMOL, V95, P627, DOI 10.1136/bjo.2010.192922
   Medeiros FA, 2008, OPHTHALMOLOGY, V115, P934, DOI 10.1016/j.ophtha.2007.08.012
   Mosaed S, 2005, AM J OPHTHALMOL, V139, P320, DOI 10.1016/j.ajo.2004.09.062
   Mottet B, 2013, JAMA OPHTHALMOL, V131, P1507, DOI 10.1001/jamaophthalmol.2013.5297
   Noel C, 2001, OPHTHALMOLOGY, V108, P139, DOI 10.1016/S0161-6420(00)00411-5
   Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017
   Realini T, 2011, OPHTHALMOLOGY, V118, P47, DOI 10.1016/j.ophtha.2010.04.027
   Realini T, 2010, OPHTHALMOLOGY, V117, P1700, DOI 10.1016/j.ophtha.2010.01.044
   Song YK, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-127
   Stewart WC, 2008, EUR J OPHTHALMOL, V18, P765
   WEBER AK, 1981, ANN OPHTHALMOL, V13, P323
   Willekens K, 2014, GRAEF ARCH CLIN EXP, V252, P477, DOI 10.1007/s00417-013-2533-y
   YAMABAYASHI S, 1991, BRIT J OPHTHALMOL, V75, P652, DOI 10.1136/bjo.75.11.652
   Yilmaz I, 2014, CLIN OPHTHALMOL, V8, P1069, DOI [10.2147/OPTH.S6391, 10.2147/OPTH.S63915]
   [ Yu Hongmei], 2011, [, Chinese Journal of Health Statistics], V28, P497
   Zareei Athar, 2015, J Ophthalmic Vis Res, V10, P43, DOI 10.4103/2008-322X.156105
   Zhong YS, 2013, LASER MED SCI, V28, P361, DOI 10.1007/s10103-012-1055-x
   Zhong YS, 2009, JPN J OPHTHALMOL, V53, P574, DOI 10.1007/s10384-009-0726-z
NR 37
TC 4
Z9 4
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 14
PY 2015
VL 10
IS 10
AR e0140206
DI 10.1371/journal.pone.0140206
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CU0CK
UT WOS:000363183100089
PM 26466325
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Borrelli, S
   Leonardis, D
   Minutolo, R
   Chiodini, P
   De Nicola, L
   Esposito, C
   Mallamaci, F
   Zoccali, C
   Conte, G
AF Borrelli, Silvio
   Leonardis, Daniela
   Minutolo, Roberto
   Chiodini, Paolo
   De Nicola, Luca
   Esposito, Ciro
   Mallamaci, Francesca
   Zoccali, Carmine
   Conte, Giuseppe
TI Epidemiology of CKD Regression in Patients under Nephrology Care
SO PLOS ONE
LA English
DT Article
ID CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; DOMINANT POLYCYSTIC
   KIDNEY; SERUM CREATININE VALUES; CHRONIC NEPHROPATHIES; RENAL-FUNCTION;
   GFR; PROGRESSION; DECLINE; RISK
AB Chronic Kidney Disease (CKD) regression is considered as an infrequent renal outcome, limited to early stages, and associated with higher mortality. However, prevalence, prognosis and the clinical correlates of CKD regression remain undefined in the setting of nephrology care. This is a multicenter prospective study in 1418 patients with established CKD (eGFR: 60-15 ml/min/1.73m(2)) under nephrology care in 47 outpatient clinics in Italy from a least one year. We defined CKD regressors as a Delta GFR >= 0 ml/min/1.73 m(2)/year. Delta GFR was estimated as the absolute difference between eGFR measured at baseline and at follow up visit after 18-24 months, respectively. Outcomes were End Stage Renal Disease (ESRD) and overall-causes Mortality. 391 patients (27.6%) were identified as regressors as they showed an eGFR increase between the baseline visit in the renal clinic and the follow up visit. In multivariate regression analyses the regressor status was not associated with CKD stage. Low proteinuria was the main factor associated with CKD regression, accounting per se for 48% of the likelihood of this outcome. Lower systolic blood pressure, higher BMI and absence of autosomal polycystic disease (PKD) were additional predictors of CKD regression. In regressors, ESRD risk was 72% lower (HR: 0.28; 95% CI 0.14-0.57; p<0.0001) while mortality risk did not differ from that in non-regressors (HR: 1.16; 95% CI 0.73-1.83; p = 0.540). Spline models showed that the reduction of ESRD risk associated with positive Delta GFR was attenuated in advanced CKD stage. CKD regression occurs in about one-fourth patients receiving renal care in nephrology units and correlates with low proteinuria, BP and the absence of PKD. This condition portends better renal prognosis, mostly in earlier CKD stages, with no excess risk for mortality.
C1 [Borrelli, Silvio; Minutolo, Roberto; De Nicola, Luca; Conte, Giuseppe] Univ Naples 2, Div Nephrol, Naples, Italy.
   [Leonardis, Daniela; Mallamaci, Francesca; Zoccali, Carmine] Inst Biomed & Mol Immunol Hosp, Ctr Natl Res, Nephrol Diis, Reggio Di Calabria, Italy.
   [Chiodini, Paolo] Univ Naples 2, Div Med Stat, Naples, Italy.
   [Esposito, Ciro] IRCCS Maugeri Inst Pavia, Div Nephrol, Pavia, Italy.
RP Conte, G (reprint author), Univ Naples 2, Div Nephrol, Naples, Italy.
EM giuseppe.conte@unina2.it
RI Chiodini, Paolo/X-5098-2018; Chiodini, Paolo/E-7290-2014; Zoccali,
   Carmine/B-9445-2009
OI Chiodini, Paolo/0000-0003-0139-2264; Chiodini,
   Paolo/0000-0003-0139-2264; 
CR Al-Aly Z, 2010, J AM SOC NEPHROL, V21, P1961, DOI 10.1681/ASN.2009121210
   Cianciaruso B, 2003, G Ital Nefrol, V20 Suppl 24, pS48
   Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634
   De Nicola L, 2012, KIDNEY INT, V82, P482, DOI 10.1038/ki.2012.174
   De Nicola L, 2011, CLIN J AM SOC NEPHRO, V6, P2421, DOI 10.2215/CJN.01180211
   Dwyer J, 1993, NUTR KIDNEY, P61
   Ecder T, 2000, AM J KIDNEY DIS, V35, P427, DOI 10.1016/S0272-6386(00)70195-8
   Eriksen BO, 2007, KIDNEY INT, V72, P1242, DOI 10.1038/sj.ki.5002472
   Eriksen BO, 2006, KIDNEY INT, V69, P375, DOI 10.1038/sj.ki.5000058
   Glymour MM, 2005, AM J EPIDEMIOL, V162, P267, DOI 10.1093/aje/kwi187
   HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198
   Hogan MC, 2010, J AM SOC NEPHROL, V21, P1052, DOI 10.1681/ASN.2009121291
   Hu B, 2012, J AM SOC NEPHROL, V23, P706, DOI 10.1681/ASN.2011050456
   Jones C, 2006, NEPHROL DIAL TRANSPL, V21, P2133, DOI 10.1093/ndt/gfl198
   *K DOQI, 2004, AM J KIDNEY DIS S, V43, pS1
   Kidney Disease: improving Global Outcomes CKD Work Group, 2012, KIDNEY INT S, V3, P1
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leonardis D, 2012, J NEPHROL, V25, P1081, DOI 10.5301/jn.5000239
   Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180
   Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004
   Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006
   Li L, 2012, AM J KIDNEY DIS, V59, P504, DOI 10.1053/j.ajkd.2011.12.009
   LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x
   Mallamaci F, 2013, KIDNEY INT, V84, P381, DOI 10.1038/ki.2013.132
   Mancia G, 2007, J HYPERTENS, V25, P1105, DOI 10.1097/HJH.0b013e3281fc975a
   Matsushita K, 2009, J AM SOC NEPHROL, V20, P2617, DOI 10.1681/ASN.2009010025
   Minutolo R, 2014, CLIN J AM SOC NEPHRO, V9, P1586, DOI 10.2215/CJN.10481013
   Murthy K, 2005, KIDNEY INT, V68, P1884, DOI 10.1111/j.1523-1755.2005.00608.x
   Perkins RM, 2011, CLIN J AM SOC NEPHRO, V6, P1879, DOI 10.2215/CJN.00470111
   Poggio ED, 2009, KIDNEY INT, V75, P1079, DOI 10.1038/ki.2009.11
   Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699
   Ruggenenti P, 1999, J AM SOC NEPHROL, V10, P997
   Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X
   Stevens LA, 2007, AM J KIDNEY DIS, V50, P21, DOI 10.1053/j.ajkd.2007.04.004
   Tjur T, 2009, AM STAT, V63, P366, DOI 10.1198/tast.2009.08210
   Tseng CL, 2008, ARCH INTERN MED, V168, P55, DOI 10.1001/archinternmed.2007.9
   Turin TC, 2013, KIDNEY INT, V83, P684, DOI 10.1038/ki.2012.443
   Weis L, 2013, PLOS ONE, V8
   Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374
NR 39
TC 9
Z9 10
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 13
PY 2015
VL 10
IS 10
AR e0140138
DI 10.1371/journal.pone.0140138
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CT6ZJ
UT WOS:000362962300058
PM 26462071
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lee, D
   Cho, ES
   Kim, DJ
   Kim, JH
   Yu, JS
   Chung, JJ
AF Lee, Dahye
   Cho, Eun-Suk
   Kim, Dae Jung
   Kim, Joo Hee
   Yu, Jeong-Sik
   Chung, Jae-Joon
TI Validation of 10-Minute Delayed Hepatocyte Phase Imaging with 30 degrees
   Flip Angle in Gadoxetic Acid-Enhanced MRI for the Detection of Liver
   Metastasis
SO PLOS ONE
LA English
DT Article
ID GD-EOB-DTPA; HEPATOCELLULAR-CARCINOMA; IMPROVE CONSPICUOUSNESS;
   PREOPERATIVE EVALUATION; DIAGNOSTIC PERFORMANCE; THERAPEUTIC STRATEGY;
   HEPATOBILIARY PHASE; CLINICAL-EVALUATION; MULTICENTER TRIAL; CONTRAST
   AGENT
AB Objectives
   To compare 10-minute delayed hepatocyte phase imaging using a 30 degrees flip angle (10min-FA30) and 20-minute hepatocyte phase imaging using a 10 degrees FA (20min-FA10) in gadoxetic acid-enhanced MRI of patients with possible liver metastases, regarding lesion-to-liver contrast-to-noise ratio (CNR) and focal hepatic lesion (FHL) detection to evaluate whether 10min-FA30 would be superior to 20min-FA10.
   Materials and Methods
   Eighty-three patients with 248 liver metastases and 78 benign FHLs who underwent gadoxetic acid-enhanced MRI with 10min-FA30 and 20min-FA10 were enrolled. Lesion-to-liver CNRs were compared between the two image groups. Two radiologists independently assessed the presence of FHLs using a four-point scale and detection sensitivity was calculated.
   Results
   The mean CNR for liver metastases on the 10min-FA30 (248.5 +/- 101.6) were significantly higher than that of the 20min-FA10 (187.4 +/- 77.4) (p < 0.001). The mean CNR difference between the two image groups was 61.2 +/- 56.8. There was no significant difference in detection sensitivity of FHLs for two readers between 10min-FA30 (mean 97.7%) and 20min-FA10 (mean 97.9%), irrespective of the lesion size or malignancy.
   Conclusion
   10min-FA30 yielded higher CNR with similar sensitivity compared to 20min-FA10. This finding indicates that 10min-FA30 can potentially replace 20min-FA10 with higher diagnostic performance and save 10 minutes of time.
C1 [Lee, Dahye; Cho, Eun-Suk; Kim, Joo Hee; Yu, Jeong-Sik; Chung, Jae-Joon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea.
   [Kim, Dae Jung] CHA Univ, CHA Bundang Med Ctr, Dept Radiol, Songnam, South Korea.
RP Cho, ES (reprint author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea.
EM jjondol@yuhs.ac
OI Yu, Jeong-Sik/0000-0002-8171-5838
CR Ahn SS, 2010, RADIOLOGY, V255, P459, DOI 10.1148/radiol.10091388
   Bashir MR, 2012, J MAGN RESON IMAGING, V35, P611, DOI 10.1002/jmri.22850
   Bashir MR, 2011, EUR RADIOL, V21, P291, DOI 10.1007/s00330-010-1917-1
   Bluemke DA, 2005, RADIOLOGY, V237, P89, DOI 10.1148/radiol.2371031842
   Brody JM, 2005, J MAGN RESON IMAGING, V21, P391, DOI 10.1002/jmri.20289
   Cho ES, 2015, AM J ROENTGENOL, V204, P69, DOI 10.2214/AJR.13.11903
   Filippone A, 2010, J MAGN RESON IMAGING, V31, P356, DOI 10.1002/jmri.22054
   Frericks BB, 2009, AM J ROENTGENOL, V193, P1053, DOI 10.2214/AJR.08.1946
   Halavaara J, 2006, J COMPUT ASSIST TOMO, V30, P345, DOI 10.1097/00004728-200605000-00001
   HAMM B, 1995, RADIOLOGY, V195, P785, DOI 10.1148/radiology.195.3.7754011
   Hammerstingl R, 2008, EUR RADIOL, V18, P457, DOI 10.1007/s00330-007-0716-9
   Haradome H, 2012, J MAGN RESON IMAGING, V35, P132, DOI 10.1002/jmri.22805
   Huppertz A, 2004, RADIOLOGY, V230, P266, DOI 10.1148/radiol.2301020269
   Jeong HT, 2012, J MAGN RESON IMAGING, V35, P635, DOI 10.1002/jmri.22880
   Kim HJ, 2015, RADIOLOGY, V274, P712, DOI 10.1148/radiol.14140390
   Kim YK, 2010, EUR J RADIOL, V73, P131, DOI 10.1016/j.ejrad.2008.09.027
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Motosugi U, 2009, EUR RADIOL, V19, P2623, DOI 10.1007/s00330-009-1467-6
   Nagle SK, 2012, J MAGN RESON IMAGING, V36, P890, DOI 10.1002/jmri.23713
   Nassif A, 2012, RADIOLOGY, V264, P741, DOI 10.1148/radiol.12112061
   Reimer P, 1997, EUR RADIOL, V7, P275, DOI 10.1007/s003300050150
   Reimer P, 1996, RADIOLOGY, V199, P177, DOI 10.1148/radiology.199.1.8633143
   Ringe KI, 2010, AM J ROENTGENOL, V195, P13, DOI 10.2214/AJR.10.4392
   Rofsky NM, 1999, RADIOLOGY, V212, P876, DOI 10.1148/radiology.212.3.r99se34876
   Scharitzer M, 2013, EUR RADIOL, V23, P2187, DOI 10.1007/s00330-013-2824-z
   Sofue K, 2014, EUR RADIOL, V24, P2532, DOI 10.1007/s00330-014-3233-7
   Sofue K, 2011, EUR RADIOL, V21, P2336, DOI 10.1007/s00330-011-2197-0
   Tamada T, 2013, J MAGN RESON IMAGING, V37, P1093, DOI 10.1002/jmri.23903
   van Kessel CS, 2012, EUR RADIOL, V22, P2153, DOI 10.1007/s00330-012-2486-2
   Vogl TJ, 1996, RADIOLOGY, V200, P59, DOI 10.1148/radiology.200.1.8657946
   Zech CJ, 2008, INVEST RADIOL, V43, P504, DOI 10.1097/RLI.0b013e3181705cd1
NR 31
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 7
PY 2015
VL 10
IS 10
AR e0139863
DI 10.1371/journal.pone.0139863
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CT0TS
UT WOS:000362510600095
PM 26444677
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Grozdanovic, Z
   Almanza, LCB
   Goyal, S
   Hussain, A
   Klassert, TE
   Driesch, D
   Tokaryeva, V
   Loschmann, YYN
   Sumanlatha, G
   Ahmed, N
   Valluri, V
   Schumann, RR
   Lala, B
   Slevogt, H
AF Grozdanovic, Zarko
   Almanza, Luis C. Berrocal
   Goyal, Surabhi
   Hussain, Abid
   Klassert, Tilman E.
   Driesch, Dominik
   Tokaryeva, Viktoriya
   Loeschmann, Yvonne Yi-Na
   Sumanlatha, Gadamm
   Ahmed, Niyaz
   Valluri, Vijayalakshmi
   Schumann, Ralf R.
   Lala, Birgit
   Slevogt, Hortense
TI A Novel Reading Scheme for Assessing the Extent of Radiographic
   Abnormalities and Its Association with Disease Severity in Sputum
   Smear-Positive Tuberculosis: An Observational Study in Hyderabad/India
SO PLOS ONE
LA English
DT Article
ID POST PRIMARY TUBERCULOSIS; QUALITY-OF-LIFE; PULMONARY TUBERCULOSIS;
   MYCOBACTERIUM-TUBERCULOSIS; LUNG-FUNCTION; EPIDEMIOLOGY; OBSTRUCTION;
   PATHOGENESIS; INFECTION; PATHOLOGY
AB Background
   Existing reading schemes for chest X-ray (CXR) used to grade the extent of disease severity at diagnosis in patients with pulmonary tuberculosis (PTB) are often based on numerical scores that summate specific radiographic features. However, since PTB is known to exhibit a wide heterogeneity in pathology, certain features might be differentially associated with clinical parameters of disease severity.
   Objective
   We aimed to grade disease severity in PTB patients at diagnosis and after completion of DOTS treatment by developing a reading scheme based on five different radiographic manifestations and analyze their association with the clinical parameters of systemic involvement and infectivity.
   Methods
   141 HIV-negative adults with newly diagnosed sputum smear-positive PTB were enrolled in a prospective observational study in Hyderabad, India. The presence and extent on CXRs of five radiographic manifestations, i.e., lung involvement, alveolar infiltration, cavitation, lymphadenopathy and pleural effusion, were classified using the new reading scheme by using a four-quadrant approach. We evaluated the inter-reader reliability of each manifestation, and its association with BMI and sputum smear positivity at diagnosis. The presence and extent of these radiographic manifestations were further compared with CXRs on completion of DOTS treatment.
   Results
   At diagnosis, an average lung area of 51.7% +/- 23.3% was affected by radiographic abnormalities. 94% of the patients had alveolar infiltrates, with 89.4% located in the upper quadrants, suggesting post primary PTB and in 34.8% of patients cavities were found. We further showed that the extent of affected lung area was a negative predictor of BMI (beta value - 0.035, p 0.019). No significant association of BMI with any of the other CXR features was found. The extent of alveolar infiltrates, along with the presence of cavitation, were strongly associated with sputum smear positivity. The microbiological cure rate in our cohort after 6 months of DOTS treatment was 95%. The extent of the affected lung area in these patients decreased from 56.0% +/- 21.5% to 31.0 +/- 20% and a decrease was also observed in the extent of alveolar infiltrates from 98.4% to 25.8% in at least one quadrant, presence of cavities from 34.8% to 1.6%, lymphadenopathy from 46.8% to 16.1%, and pleural effusion from 19.4% to 6.5%.
   Conclusions
   We established a new assessment scheme for grading disease severity in PTB by specifically considering five radiographic manifestations which were differently associated with the BMI and sputum smear positivity, changed to a different extent after 6 months of treatment and exhibited an excellent agreement between radiologists. Our results suggest that this reading scheme might contribute to the estimation of disease severity with respect to differences in disease pathology. Further studies are needed to determine a correlation with short and long-term pulmonary function impairment and whether there would be any benefit in lengthening or modulating therapy based on this CXR severity assessment.
C1 [Grozdanovic, Zarko; Loeschmann, Yvonne Yi-Na] Charite, Dept Radiol, D-13353 Berlin, Germany.
   [Almanza, Luis C. Berrocal; Goyal, Surabhi; Schumann, Ralf R.] Charite, Inst Microbiol & Hyg, D-13353 Berlin, Germany.
   [Almanza, Luis C. Berrocal; Klassert, Tilman E.; Slevogt, Hortense] Jena Univ Hosp, Sept Res Ctr, Jena, Germany.
   [Hussain, Abid; Sumanlatha, Gadamm; Valluri, Vijayalakshmi] Bhagwan Mahavir Med Res Ctr, Dept Immunol, Hyderabad, Andhra Pradesh, India.
   [Driesch, Dominik] BioControl Jena GmbH, Jena, Germany.
   [Tokaryeva, Viktoriya] Helios Klinikum Berlin Buch, Dept Radiol, Berlin, Germany.
   [Ahmed, Niyaz] Univ Hyderabad, Dept Biotechnol & Bioinformat, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India.
   [Valluri, Vijayalakshmi] Blue Peter Res Ctr, Immunol & Mol Biol, LEPRA Soc, Hyderabad, Andhra Pradesh, India.
   [Lala, Birgit] Charite, Dept Pediat Radiol, Campus Virchow Klinikum, D-13353 Berlin, Germany.
RP Slevogt, H (reprint author), Jena Univ Hosp, Sept Res Ctr, Jena, Germany.
EM hortense.slevogt@med.uni-jena.de
FU Deutsche Forschungsgemeinschaft (DFG) International Graduate School
   (IRTG) [GRK1673]; Federal Ministry for Education and Science [BMBF
   03Z2JN22]; BioControl Jena GmbH
FX This work was supported by the Deutsche Forschungsgemeinschaft (DFG)
   International Graduate School (IRTG) GRK1673 and by the Federal Ministry
   for Education and Science (grant BMBF 03Z2JN22). BioControl Jena GmbH
   provided support in the form of salaries for authors [DD], but did not
   have any additional role in the study design, data collection and
   analysis, decision to publish, or preparation of the manuscript. The
   specific roles of these authors are articulated in the 'author
   contributions' section.
CR ANNO H, 1955, AM REV TUBERC PULM, V71, P333
   [Anonymous], 2010, TREATMENT OF TUBERCU
   Baez-Saldana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078926
   BARNES PF, 1988, CHEST, V94, P316, DOI 10.1378/chest.94.2.316
   Bernabe-Ortiz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018474
   Bhuniya S, 2012, ANN THORAC MED, V7, P215, DOI 10.4103/1817-1737.102176
   BIRATH G, 1966, SCAND J RESPIR DIS, V47, P27
   BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9
   BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V
   Cardinale L, 2015, ACTA RADIOL, V56, P557, DOI 10.1177/0284185114533247
   de la Mora IL, 2015, INT J TUBERC LUNG D, V19, P808, DOI 10.5588/ijtld.14.0983
   Dittrich N, 2015, TUBERCULOSIS, V95, P328, DOI 10.1016/j.tube.2015.02.045
   Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6
   Gadkowski LB, 2008, CLIN MICROBIOL REV, V21, P305, DOI 10.1128/CMR.00060-07
   Geng E, 2005, JAMA-J AM MED ASSOC, V293, P2740, DOI 10.1001/jama.293.22.2740
   Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003
   Hamilton CD, 2008, INT J TUBERC LUNG D, V12, P1059
   Heo EY, 2009, INT J INFECT DIS, V13, pE371, DOI 10.1016/j.ijid.2009.01.007
   Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2
   Hunter RL, 2014, ANN CLIN LAB SCI, V44, P365
   Hunter RL, 2011, TUBERCULOSIS, V91, P497, DOI 10.1016/j.tube.2011.03.007
   Jones BE, 1997, AM J RESP CRIT CARE, V156, P1270, DOI 10.1164/ajrccm.156.4.9609143
   Khan A, 2006, AM J RESP CRIT CARE, V174, P344, DOI 10.1164/rccm.200511-1834OC
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee JH, 2003, RESP MED, V97, P1237, DOI 10.1016/S0954-6111(03)00255-5
   Lenaerts A, 2015, IMMUNOL REV, V264, P288, DOI 10.1111/imr.12252
   Maguire GP, 2009, INT J TUBERC LUNG D, V13, P1500
   Ministry of Health India, 2005, TECHN OP GUID TUB CO
   Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919
   Nyboe J, 1968, Bull Int Union Tuberc, V41, P115
   Ors F, 2007, J THORAC IMAG, V22, P154, DOI 10.1097/01.rti.0000213590.29472.ce
   Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07
   Pinto LM, 2013, EUR RESPIR J, V42, P480, DOI 10.1183/09031936.00107412
   Pinto LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054235
   Plit ML, 1998, EUR RESPIR J, V12, P351, DOI 10.1183/09031936.98.12020351
   Ralph AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080302
   Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242
   [Revised National Tuberculosis Control Programme (RNTCP)-Training module for general practitioners Ministry of Health India], 2010, REV NAT TUB CONTR PR
   Rieder HL, 2006, PRIORITIES TUBERCULO
   SHAW NJ, 1990, SCOT MED J, V35, P140, DOI 10.1177/003693309003500505
   [Standards for TB care in India World Health Organization], 2014, STAND TB CAR IND 201
   Van Lettow M, 2004, INT J TUBERC LUNG D, V8, P211
   Vandenbroucke JP, 2007, PLOS MED, V4, P1628, DOI 10.1371/journal.pmed.0040297
   Wilcke JTR, 1998, RESP MED, V92, P493, DOI 10.1016/S0954-6111(98)90297-9
   WILLCOX PA, 1989, RESP MED, V83, P195, DOI 10.1016/S0954-6111(89)80031-9
   World Health Organization, SYST SCREEN ACT TUB
   World Health Organization, 2014, GLOB TUB REP
NR 47
TC 4
Z9 4
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 18
PY 2015
VL 10
IS 9
AR e0138070
DI 10.1371/journal.pone.0138070
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CS0ZE
UT WOS:000361790200055
PM 26381644
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Rousseau, A
   Rozenberg, P
   Ravaud, P
AF Rousseau, Anne
   Rozenberg, Patrick
   Ravaud, Philippe
TI Assessing Complex Emergency Management with Clinical Case-Vignettes: A
   Validation Study
SO PLOS ONE
LA English
DT Article
ID POSTPARTUM HEMORRHAGE; PHYSICIAN PRACTICE; CARE; QUALITY; CANCER; LIFE;
   RECOMMENDATIONS; POLICIES
AB Objective
   To evaluate whether responses to dynamic case-vignettes accurately reflect actual practices in complex emergency situations. We hypothesized that when obstetricians were faced with vignette of emergency situation identical to one they previously managed, they would report the management strategy they actually used. On the other hand, there is no reason to suppose that their response to a vignette based on a source case managed by another obstetrician would be the same as the actual management.
   Methods
   A multicenter vignette-based study was used in 7 French maternity units. We chose the example of severe postpartum hemorrhage (PPH) to study the use of case-vignettes for assessing the management of complex situations. We developed dynamic case-vignettes describing incidents of PPH in several steps, using documentation in patient files. Vignettes described the postpartum course and included multiple-choice questions detailing proposed clinical care. Each participating obstetrician was asked to evaluate 4 case-vignettes: 2 directly derived from cases they previously managed and 2 derived from other obstetricians' cases. We compared the final treatment decision in vignette responses to those documented in the source-case by the overall agreement and the Kappa coefficient, both for the cases the obstetricians previously managed and the cases of others.
   Results
   Thirty obstetricians participated. Overall agreement between final treatment decisions in case-vignettes and documented care for cases obstetricians previously managed was 82% (Kappa coefficient: 0.75, 95% CI [ 0.62-0.88]). Overall agreement between final treatment decisions in case-vignettes and documented care in vignettes derived from other obstetricians' cases was only 48% (Kappa coefficient: 0.30, 95% CI [0.12-0.48]). Final agreement with documented care was significantly better for cases based on their own previous cases than for others (p<0.001).
   Conclusions
   Dynamic case-vignettes accurately reflect actual practices in complex emergency situations. Therefore, they can be used to assess the quality of management in these situations.
C1 [Rousseau, Anne; Rozenberg, Patrick] Poissy St Germain Hosp, Dept Obstet & Gynecol, Poissy, France.
   [Rousseau, Anne; Ravaud, Philippe] Paris Descartes Sorbonne Paris Cite Univ, INSERM Res Unit U1153, Paris, France.
   [Rozenberg, Patrick] Versailles St Quentin Univ, Res Unit EA 7285, St Quentin En Yvelines, France.
   [Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75181 Paris, France.
RP Rousseau, A (reprint author), Poissy St Germain Hosp, Dept Obstet & Gynecol, Poissy, France.
EM anne.rousseau@uvsq.fr
RI ravaud, philippe/C-1694-2009
OI Ravaud, Philippe/0000-0001-8264-9206
CR Al-Zirqi I, 2008, BJOG-INT J OBSTET GY, V115, P1265, DOI 10.1111/j.1471-0528.2008.01859.x
   Azoulay E, 2004, INTENS CARE MED, V30, P1384, DOI 10.1007/s00134-004-2316-3
   Bachmann LM, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-50
   Baldwin LM, 2012, ANN INTERN MED, V156, P182, DOI 10.7326/0003-4819-156-3-201202070-00006
   Boggan JC, 2012, PEDIATRICS, V130, pE615, DOI 10.1542/peds.2012-0563
   Bouvier-Colle MH, 2001, BRIT J OBSTET GYNAEC, V108, P898, DOI 10.1111/j.1471-0528.2001.00224.x
   Brush DR, 2012, AM J RESP CRIT CARE, V186, P633, DOI 10.1164/rccm.201202-0354OC
   Deneux-Tharaux C, 2008, J GYNECOL OBST BIO R, V37, P237, DOI 10.1016/j.jgyn.2008.01.007
   Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4
   Goff BA, 2011, OBSTET GYNECOL, V118, P854, DOI 10.1097/AOG.0b013e31822dabc6
   Goff BA, 2011, CANCER-AM CANCER SOC, V117, P4414, DOI 10.1002/cncr.26035
   Haider AH, 2011, JAMA-J AM MED ASSOC, V306, P942, DOI 10.1001/jama.2011.1248
   Henderson TO, 2010, J CLIN ONCOL, V28, P878, DOI 10.1200/JCO.2009.25.6107
   Kayem G, 2011, BJOG-INT J OBSTET GY, V118, P856, DOI 10.1111/j.1471-0528.2011.02921.x
   Laas E, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.028
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Laventhal N, 2011, PEDIATRICS, V127, pE1221, DOI 10.1542/peds.2010-1031
   Meyer AND, 2013, JAMA INTERN MED, V173, P1952, DOI 10.1001/jamainternmed.2013.10081
   Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715
   Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008
   Pham T, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-128
   Roberts CL, 2008, INT J GYNECOL OBSTET, V103, P172, DOI 10.1016/j.ijgo.2008.05.025
   Schwarze ML, 2012, ANN SURG, V256, P10, DOI 10.1097/SLA.0b013e3182580de5
   Spiegel BMR, 2010, AM J GASTROENTEROL, V105, P848, DOI 10.1038/ajg.2010.47
   Suh E, 2014, ANN INTERN MED, V160, P11, DOI 10.7326/M13-1941
   Veloski J, 2005, AM J MED QUAL, V20, P151, DOI 10.1177/1062860605274520
   Winter C, 2007, BJOG-INT J OBSTET GY, V114, P845, DOI 10.1111/j.1471-0528.2007.01377.x
   Zhang WH, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c293
   Zhang WH, 2005, BJOG-INT J OBSTET GY, V112, P89, DOI 10.1111/j.1471-0528.2004.00303.x
NR 29
TC 9
Z9 9
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 18
PY 2015
VL 10
IS 9
AR e0138663
DI 10.1371/journal.pone.0138663
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CS0ZE
UT WOS:000361790200144
PM 26383261
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Jung, CH
   Lee, MJ
   Kang, YM
   Yang, DH
   Kang, JW
   Kim, EH
   Park, DW
   Park, JY
   Kim, HK
   Lee, WJ
AF Jung, Chang Hee
   Lee, Min Jung
   Kang, Yu Mi
   Yang, Dong Hyun
   Kang, Joon-Won
   Kim, Eun Hee
   Park, Duk-Woo
   Park, Joong-Yeol
   Kim, Hong-Kyu
   Lee, Woo Je
TI 2013 ACC/AHA versus 2004 NECP ATP III Guidelines in the Assignment of
   Statin Treatment in a Korean Population with Subclinical Coronary
   Atherosclerosis
SO PLOS ONE
LA English
DT Article
ID COMPUTED-TOMOGRAPHY; PROGNOSTIC VALUE; ARTERY CALCIUM; FOLLOW-UP;
   CARDIOVASCULAR-DISEASE; HEART-DISEASE; RISK-FACTORS; ANGIOGRAPHY;
   PREVENTION; ACCURACY
AB Background
   The usefulness of the 2013 ACC/AHA guidelines for the management of blood cholesterol in the Asian population remains controversial. In this study, we investigated whether eligibility for statin therapy determined by the 2013 ACC/AHA guidelines is better aligned with the presence of subclinical coronary atherosclerosis detected by CCTA (coronary computed tomography angiography) compared to the previously recommended 2004 NCEP ATP III guidelines.
   Methods
   We collected the data from 5,837 asymptomatic subjects who underwent CCTA using MDCT during routine health examinations. Based on risk factor assessment and lipid data, we determined guideline-based eligibility for statin therapy according to the 2013 ACC/AHA and 2004 NCEP ATP III guidelines. We defined the presence and severity of subclinical coronary atherosclerosis detected in CCTA according to the presence of significant coronary artery stenosis (defined as >50% stenosis), plaques, and the degree of coronary calcification.
   Results
   As compared to the 2004 ATP III guidelines, a significantly higher proportion of subjects with significant coronary stenosis (61.8% vs. 33.8%), plaques (52.3% vs. 24.7%), and higher CACS (CACS > 100, 63.6% vs. 26.5%) was assigned to statin therapy using the 2013 ACC/AHA guidelines (P < .001 for all variables). The area under the curves of the pooled cohort equation of the new guidelines in detecting significant stenosis, plaques, and higher CACS were significantly higher than those of the Framingham risk calculator.
   Conclusions
   Compared to the previous ATP III guidelines, the 2013 ACC/AHA guidelines were more sensitive in identifying subjects with subclinical coronary atherosclerosis detected by CCTA in an Asian population.
C1 [Jung, Chang Hee; Lee, Min Jung; Kang, Yu Mi; Park, Duk-Woo; Park, Joong-Yeol; Lee, Woo Je] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea.
   [Yang, Dong Hyun; Kang, Joon-Won] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea.
   [Kim, Eun Hee; Kim, Hong-Kyu] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hlth Screening, Seoul, South Korea.
   [Kim, Eun Hee; Kim, Hong-Kyu] Univ Ulsan, Coll Med, Asan Med Ctr, Promot Ctr, Seoul, South Korea.
RP Kim, HK (reprint author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hlth Screening, Seoul, South Korea.
EM hkkim0801@amc.seoul.kr; lwjatlas@amc.seoul.kr
CR AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T
   Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011
   Amin NP, 2014, J AM COLL CARDIOL, V63, P2789, DOI 10.1016/j.jacc.2014.04.010
   Arai H, 2014, J ATHEROSCLER THROMB, V21, P79
   Bamberg F, 2011, J AM COLL CARDIOL, V57, P2426, DOI 10.1016/j.jacc.2010.12.043
   Bittencourt MS, 2014, J AM COLL CARDIOL, V63, P434, DOI 10.1016/j.jacc.2013.08.1640
   Chia YC, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-163
   Chow BJW, 2010, J AM COLL CARDIOL, V55, P1017, DOI 10.1016/j.jacc.2009.10.039
   DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
   Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100
   Dougoud S, 2014, INT J CARDIOVAS IMAG, V30, P969, DOI 10.1007/s10554-014-0420-1
   Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   Hadamitzky M, 2013, EUR HEART J, V34, P3277, DOI 10.1093/eurheartj/eht293
   Johnson KM, 2014, J AM COLL CARDIOL, V64, P910, DOI 10.1016/j.jacc.2014.05.056
   Jung CH, 2014, OBESITY, V22, P2613, DOI 10.1002/oby.20883
   Kim NH, 2015, J ATHEROSCLER THROMB, V22, P293, DOI 10.5551/jat.26682
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leber AW, 2006, J AM COLL CARDIOL, V47, P672, DOI 10.1016/j.jacc.2005.10.058
   Lee SH, 2014, J CLIN ENDOCR METAB, V99, P1615, DOI 10.1210/jc.2013-3608
   Lloyd-Jones DM, 2014, LANCET, V383, P600, DOI 10.1016/S0140-6736(13)62348-X
   Mollet NR, 2005, CIRCULATION, V112, P2318, DOI 10.1161/CIRCULATIONAHA.105.533471
   Moon JS, 2013, DIABETES METAB J, V37, P54, DOI 10.4093/dmj.2013.37.1.54
   Muntner P, 2014, CIRCULATION, V129, P266, DOI 10.1161/CIRCULATIONAHA.113.007648
   Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I
   Newman AB, 2001, CIRCULATION, V104, P2679, DOI 10.1161/hc4601.099464
   Oei HHS, 2004, EUR HEART J, V25, P48, DOI 10.1016/j.ehj.2003.10.008
   Ostrom MP, 2008, J AM COLL CARDIOL, V52, P1335, DOI 10.1016/j.jacc.2008.07.027
   Pencina MJ, 2014, NEW ENGL J MED, V370, P1422, DOI 10.1056/NEJMoa1315665
   Pursnani A, 2014, ATHEROSCLEROSIS, V237, P314, DOI 10.1016/j.atherosclerosis.2014.09.023
   Raff GL, 2005, J AM COLL CARDIOL, V46, P552, DOI 10.1016/j.jacc.2005.05.056
   Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0
   Sasayama S, 2008, CIRCULATION, V118, P2669, DOI 10.1161/CIRCULATIONAHA.108.837054
   Silverman MG, 2014, EUR HEART J, V35, P2232, DOI 10.1093/eurheartj/eht508
   Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a
   Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048
   Vaucher J, 2014, EUR HEART J, V35, P958, DOI 10.1093/eurheartj/ehu064
NR 38
TC 6
Z9 6
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 15
PY 2015
VL 10
IS 9
AR e0137478
DI 10.1371/journal.pone.0137478
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CR8LR
UT WOS:000361604400024
PM 26372638
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Malone, CD
   Olson, ES
   Mattrey, RF
   Jiang, T
   Tsien, RY
   Nguyen, QT
AF Malone, Christopher D.
   Olson, Emilia S.
   Mattrey, Robert F.
   Jiang, Tao
   Tsien, Roger Y.
   Nguyen, Quyen T.
TI Tumor Detection at 3 Tesla with an Activatable Cell Penetrating Peptide
   Dendrimer (ACPPD-Gd), alpha T1 Magnetic Resonance (MR) Molecular Imaging
   Agent
SO PLOS ONE
LA English
DT Article
ID MATRIX METALLOPROTEINASE-2 ACTIVITY; ACTIVITY IN-VIVO; BREAST-CANCER;
   NONINVASIVE DETECTION; CONTRAST AGENT; MOUSE MODEL; FLUORESCENCE;
   PROGRESSION; METASTASIS; SWITCH
AB Purpose
   The ability to detect small malignant lesions with magnetic resonance imaging (MRI) is limited by inadequate accumulations of Gd with standard chelate agents. To date, no T1-targeted agents have proven superiority to Gd chelates in their ability to detect small tumors at clinically relevant field strengths. Activatable cell-penetrating peptides and their Gd-loaded dendrimeric form (ACPPD-Gd) have been shown to selectively accumulate in tumors. In this study we compared the performance of ACPPD-Gd vs. untargeted Gd chelates to detect small tumors in rodent models using a clinical 3T-MR system.
   Materials and Methods
   This study was approved by the Institutional-Animal Care-and-Use Committee. 2 of 4 inguinal breast fat pads of 16 albino-C57BL/6mice were inoculated with tumor Py8119 cells and the other 2 with saline at random. MRI at 3T was performed at 4, 9, and 14 days after inoculation on 8 mice 24-hours after injection of 0.036mmol Gd/kg (ACPPD-Gd), and before and 2- 3 minutes after 0.1 mmol/kg gadobutrol on the other 8 mice. T1-weighted (T1w) tumor signal normalized to muscle, was compared among the non-contrast, gadobutrol, and ACPPD-Gd groups using ANOVA. Experienced and trainee readers blinded to experimental conditions assessed for the presence of tumor in each of the 4 breast regions. Receiver operator characteristic (ROC) curves and area-under-curve (AUC) values were constructed and analyzed.
   Results
   Tumors >= 1mm(3) were iso-intense to muscle without contrast on T1w sequences. They enhanced diffusely and homogeneously by 57 +/- 20% (p<0.001) 24 hours after ACPPD-Gd and by 25 +/- 13% (p<0.001) immediately after gadobutrol. The nearly 2-fold difference was similar for small tumors (1-5mm(3)) (45 +/- 19% vs. 19 +/- 18%, p = 0.03). ACPPD-Gd tended to improve tumor detection by an experienced reader (AUC 0.98 vs 0.91) and significantly more for a trainee (0.93 vs. 0.82, p = 0.02) compared to gadobutrol. This improvement was more pronounced when obvious tumors (>5mm(3)) were removed from the ROC analysis for both the experienced observer (0.96 vs. 0.86) and more so for the trainee (0.86 vs. 0.69, p = 0.04).
   Conclusion
   ACPPD-Gd enhances MMP-expressing tumors of any size at 3T 24 hours after administration, improving their detection by blinded observers when compared to non-contrast and contrast groups given commercial Gd-chelates and imaged during the equilibrium phase.
C1 [Malone, Christopher D.; Olson, Emilia S.; Mattrey, Robert F.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA.
   [Jiang, Tao; Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, San Diego, CA 92103 USA.
   [Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA.
   [Tsien, Roger Y.] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92103 USA.
   [Nguyen, Quyen T.] Univ Calif San Diego, Dept Otolaryngol Head & Neck Surg, San Diego, CA 92103 USA.
RP Malone, CD (reprint author), Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA.
EM cmalone@ucsd.edu
FU National Institutes of Health (NIH)/National Cancer Institute
   [5R01CA158448]; NIH in vivo cellular and molecular imaging centers
   (ICMIC) [P50-CA128346]; NIH [5T32EB005970-07]; Radiological Society of
   North America (RSNA) [RR1361]; Howard Hughes Medical Institute;
   Burroughs Wellcome Fund - CAMS
FX This study was supported in part by National Institutes of Health
   (NIH)/National Cancer Institute grant 5R01CA158448, www.cancer.gov,
   (RYT); NIH in vivo cellular and molecular imaging centers (ICMIC)
   P50-CA128346,
   http://imaging.cancer.gov/programsandresources/specializedinitiatives/ic
   micp50 (RFM, RYT); NIH 5T32EB005970-07 (ESO, RFM, CDM); Radiological
   Society of North America (RSNA) RR1361,
   http://www.rsna.org/research_resident_grant.aspx (CDM); Howard Hughes
   Medical Institute, http://www.hhmi.org (TJ, RYT); Burroughs Wellcome
   Fund - CAMS,
   http://www.bwfund.org/grant-programs/biomedicalsciences/career-awards-me
   dical-scientists, (QTN).
CR Aguilera TA, 2009, INTEGR BIOL, V1, P371, DOI 10.1039/b904878b
   Artacho-Cordon F, 2012, SURG ONCOL, V21, pE143, DOI 10.1016/j.suronc.2012.06.001
   Biswas T, 2014, CANCER LETT, V346, P129, DOI 10.1016/j.canlet.2013.12.018
   Bremer C, 2001, RADIOLOGY, V221, P523, DOI 10.1148/radiol.2212010368
   Burden-Gulley SM, 2013, TRANSL ONCOL, V6, P329, DOI 10.1593/tlo.12490
   Chatterji M, 2010, MAGN RESON IMAGING C, V18, P207, DOI 10.1016/j.mric.2010.02.011
   Chen S, STROKE UNPUB
   Coumans FAW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-283
   Crisp JL, 2014, MOL CANCER THER, V13, P1514, DOI 10.1158/1535-7163.MCT-13-1067
   Eng J, 2015, ROC ANAL WEB BASED C
   Fang JM, 2000, P NATL ACAD SCI USA, V97, P3884, DOI 10.1073/pnas.97.8.3884
   Hanaoka K, 2008, MAGN RESON IMAGING, V26, P608, DOI 10.1016/j.mri.2007.11.002
   Hua H, 2011, CELL MOL LIFE SCI, V68, P3853, DOI 10.1007/s00018-011-0763-x
   Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101
   Kircher MF, 2012, RADIOLOGY, V263, P633, DOI 10.1148/radiol.12102394
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lebel R, 2008, MAGN RESON MED, V60, P1056, DOI 10.1002/mrm.21741
   Lepage M, 2007, MOL IMAGING, V6, P393, DOI 10.2310/7290.2007.00035
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   Mehner C, 2014, ONCOTARGET, V5, P2736, DOI 10.18632/oncotarget.1932
   Nguyen QT, 2010, P NATL ACAD SCI USA, V107, P4317, DOI 10.1073/pnas.0910261107
   Obuchowski NA, 2005, AM J ROENTGENOL, V184, P364, DOI 10.2214/ajr.184.2.01840364
   Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107
   Olson ES, 2009, INTEGR BIOL-UK, V1, P382, DOI 10.1039/b904890a
   Pais A, 2011, CANCER RES, V71, P7387, DOI 10.1158/0008-5472.CAN-11-1226
   Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77
   Savariar EN, 2013, CANCER RES, V73, P855, DOI 10.1158/0008-5472.CAN-12-2969
   Shazeeb MS, 2011, CANCER RES, V71, P2230, DOI 10.1158/0008-5472.CAN-10-1139
   Tester AM, 2001, CLIN EXP METASTAS, V18, P553, DOI 10.1023/A:1011953118186
   Turnbull LW, 2009, NMR BIOMED, V22, P28, DOI 10.1002/nbm.1273
   Turpeenniemi-Hujanen T, 2005, BIOCHIMIE, V87, P287, DOI 10.1016/j.biochi.2005.01.014
NR 31
TC 7
Z9 7
U1 0
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 3
PY 2015
VL 10
IS 9
AR e0137104
DI 10.1371/journal.pone.0137104
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CQ5AJ
UT WOS:000360615400040
PM 26336058
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU van der Waal, D
   den Heeten, GJ
   Pijnappel, RM
   Schuur, KH
   Timmers, JMH
   Verbeek, ALM
   Broeders, MJM
AF van der Waal, Danielle
   den Heeten, Gerard J.
   Pijnappel, Ruud M.
   Schuur, Klaas H.
   Timmers, Johanna M. H.
   Verbeek, Andre L. M.
   Broeders, Mireille J. M.
TI Comparing Visually Assessed BI-RADS Breast Density and Automated
   Volumetric Breast Density Software: A Cross-Sectional Study in a Breast
   Cancer Screening Setting
SO PLOS ONE
LA English
DT Article
ID FIELD DIGITAL MAMMOGRAMS; PARENCHYMAL PATTERNS; RISK-FACTORS;
   CLASSIFICATION; CATEGORIES; AGREEMENT; VARIABILITY; REPRODUCIBILITY;
   RELIABILITY; INDEX
AB Introduction The objective of this study is to compare different methods for measuring breast density, both visual assessments and automated volumetric density, in a breast cancer screening setting. These measures could potentially be implemented in future screening programmes, in the context of personalised screening or screening evaluation.
   Materials and Methods
   Digital mammographic exams (N = 992) of women participating in the Dutch breast cancer screening programme (age 50-75y) in 2013 were included. Breast density was measured in three different ways: BI-RADS density (5th edition) and with two commercially available automated software programs (Quantra and Volpara volumetric density). BI-RADS density (ordinal scale) was assessed by three radiologists. Quantra (v1.3) and Volpara (v1.5.0) provide continuous estimates. Different comparison methods were used, including Bland-Altman plots and correlation coefficients (e.g., intraclass correlation coefficient [ICC]).
   Results
   Based on the BI-RADS classification, 40.8% of the women had 'heterogeneously or extremely dense' breasts. The median volumetric percent density was 12.1% (IQR: 9.6-16.5) for Quantra, which was higher than the Volpara estimate (median 6.6%, IQR: 4.4-10.9). The mean difference between Quantra and Volpara was 5.19% (95% CI: 5.04-5.34) (ICC: 0.64). There was a clear increase in volumetric percent dense volume as BI-RADS density increased. The highest accuracy for predicting the presence of BI-RADS c+d (heterogeneously or extremely dense) was observed with a cut-off value of 8.0% for Volpara and 13.8% for Quantra.
   Conclusion
   Although there was no perfect agreement, there appeared to be a strong association between all three measures. Both volumetric density measures seem to be usable in breast cancer screening programmes, provided that the required data flow can be realized.
C1 [van der Waal, Danielle; Verbeek, Andre L. M.; Broeders, Mireille J. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, NL-6525 ED Nijmegen, Netherlands.
   [den Heeten, Gerard J.; Pijnappel, Ruud M.; Schuur, Klaas H.; Timmers, Johanna M. H.; Broeders, Mireille J. M.] Dutch Reference Ctr Screening, Nijmegen, Netherlands.
   [den Heeten, Gerard J.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands.
   [Pijnappel, Ruud M.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.
RP van der Waal, D (reprint author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, NL-6525 ED Nijmegen, Netherlands.
EM Danielle.vanderWaal@radboudumc.nl
RI van der Waal, Danielle/A-1386-2016; Broeders, Mireille/C-8820-2015;
   Verbeek, A.L.M./H-8103-2014
OI van der Waal, Danielle/0000-0002-5850-8814; Broeders,
   Mireille/0000-0002-8741-8148; Verbeek, A.L.M./0000-0002-2319-5002
CR Altman DG, 1991, PRACTICAL STAT MED R, P404
   Assi V, 2012, NAT REV CLIN ONCOL, V9, P33, DOI 10.1038/nrclinonc.2011.173
   Berg WA, 2000, AM J ROENTGENOL, V174, P1769, DOI 10.2214/ajr.174.6.1741769
   Bernardi D, 2012, RADIOL MED, V117, P519, DOI 10.1007/s11547-011-0777-3
   Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790
   Brand JS, 2014, CANCER EPIDEM BIOMAR, V23, P1764, DOI 10.1158/1055-9965.EPI-13-1219
   Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008
   Ciatto S, 2006, BREAST, V15, P44, DOI 10.1016/j.breast.2005.04.019
   Ciatto S, 2005, BREAST, V14, P269, DOI 10.1016/j.breast.2004.12.004
   Ciatto S, 2012, BREAST, V21, P503, DOI 10.1016/j.breast.2012.01.005
   de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015
   Eng A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0439-1
   Fleiss JL, 2003, STAT METHODS RATES P, P598
   Garrido-Estepa M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-485
   Gram IT, 1997, EUR J RADIOL, V24, P131, DOI 10.1016/S0720-048X(96)01138-2
   Gubern-Merida A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085952
   Gweon HM, 2013, AM J ROENTGENOL, V201, P692, DOI 10.2214/AJR.12.10197
   Hartman K, 2008, LECT NOTES COMPUT SC, V5116, P33, DOI 10.1007/978-3-540-70538-3_5
   Highnam R, 2010, LECT NOTES COMPUTER, P651
   Jeffreys M, 2010, LECT NOTES COMPUT SC, V6136, P408, DOI 10.1007/978-3-642-13666-5_55
   Kerlikowske K, 2007, NEW ENGL J MED, V356, P297, DOI 10.1056/NEJMe068244
   Ko SY, 2014, KOREAN J RADIOL, V15, P313, DOI 10.3348/kjr.2014.15.3.313
   Kopans DB, 2008, RADIOLOGY, V246, P348, DOI 10.1148/radiol.2461070309
   Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lokate M, 2010, CANCER EPIDEM BIOMAR, V19, P3096, DOI 10.1158/1055-9965.EPI-10-0703
   McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965-EPI-06-0034
   Morrish OW, 2015, RADIOLOGY
   Ng KH, 2012, LANCET ONCOL, V13, P334, DOI 10.1016/S1470-2045(12)70093-1
   Nunnally J, 1994, PSYCHOMETRIC THEORY
   Ooms EA, 2007, BREAST, V16, P568, DOI 10.1016/j.breast.2007.04.007
   Park IH, 2014, ANN SURG ONCOL
   Ray KM, 2015, AM J ROENTGENOL, V204, P257, DOI 10.2214/AJR.14.13558
   Redondo A, 2012, BRIT J RADIOL, V85, P1465, DOI 10.1259/bjr/21256379
   Regini E, 2014, RADIOL MED, V119, P741, DOI 10.1007/s11547-014-0390-3
   Schetter SE, 2014, BREAST CANCER RES TR, V146, P355, DOI 10.1007/s10549-014-3031-6
   Schmachtenberg C, 2015, ACAD RADIOL
   Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003
   Seo JM, 2013, CLIN RADIOL, V68, P690, DOI 10.1016/j.crad.2013.01.011
   Sickles EA, 2013, ACR BI RADS ATLAS BR
   Skippage P, 2013, BREAST J, V19, P79, DOI 10.1111/tbj.12046
   Vachon CM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1829
   van Engeland S, 2006, IEEE T MED IMAGING, V25, P273, DOI 10.1109/TMI.2005.862741
   van Gils CH, 1998, EUR J EPIDEMIOL, V14, P315, DOI 10.1023/A:1007423824675
   Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081653
   WOLFE JN, 1976, AM J ROENTGENOL, V126, P1130, DOI 10.2214/ajr.126.6.1130
   Yaffe MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2102
NR 47
TC 28
Z9 28
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 3
PY 2015
VL 10
IS 9
AR e0136667
DI 10.1371/journal.pone.0136667
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CQ5AJ
UT WOS:000360615400020
PM 26335569
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tapia-Armijos, MF
   Homeier, J
   Espinosa, CI
   Leuschner, C
   de la Cruz, M
AF Fernanda Tapia-Armijos, Maria
   Homeier, Juergen
   Ivan Espinosa, Carlos
   Leuschner, Christoph
   de la Cruz, Marcelino
TI Deforestation and Forest Fragmentation in South Ecuador since the
   1970s-Losing a Hotspot of Biodiversity
SO PLOS ONE
LA English
DT Article
ID LAND-COVER CLASSIFICATION; HABITAT FRAGMENTATION; TROPICAL
   DEFORESTATION; PROTECTED AREAS; RAIN-FORESTS; DYNAMICS; PATTERNS;
   AMAZON; VEGETATION; LANDSCAPE
AB Deforestation and fragmentation are major components of global change; both are contributing to the rapid loss of tropical forest area with important implications for ecosystem functioning and biodiversity conservation. The forests of South Ecuador are a biological 'hotspot' due to their high diversity and endemism levels. We examined the deforestation and fragmentation patterns in this area of high conservation value using aerial photographs and Aster satellite scenes. The registered annual deforestation rates of 0.75% (1976-1989) and 2.86% (1989-2008) for two consecutive survey periods, the decreasing mean patch size and the increasing isolation of the forest fragments show that the area is under severe threat. Approximately 46% of South Ecuador's original forest cover had been converted by 2008 into pastures and other anthropogenic land cover types. We found that deforestation is more intense at lower elevations (premontane evergreen forest and shrubland) and that the deforestation front currently moves in upslope direction. Improved awareness of the spatial extent, dynamics and patterns of deforestation and forest fragmentation is urgently needed in biologically diverse areas like South Ecuador.
C1 [Fernanda Tapia-Armijos, Maria; Ivan Espinosa, Carlos] Univ Tecn Particular Loja, Dept Ciencias Nat, Secc Ecol & Sistemat, Loja, Ecuador.
   [Fernanda Tapia-Armijos, Maria; Homeier, Juergen; Leuschner, Christoph] Univ Gottingen, Plant Ecol, Albrecht von Haller Inst Plant Sci, D-37073 Gottingen, Germany.
   [de la Cruz, Marcelino] Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Dept Biol & Geol, ESCET, Madrid, Spain.
RP Tapia-Armijos, MF (reprint author), Univ Tecn Particular Loja, Dept Ciencias Nat, Secc Ecol & Sistemat, Loja, Ecuador.
EM mftapia@utpl.edu.ec
RI Homeier, Jurgen/G-1662-2011; de la Cruz, Marcelino/M-6124-2015
OI Homeier, Jurgen/0000-0001-5676-3267; de la Cruz,
   Marcelino/0000-0002-9080-4525
FU Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion
   (SENESCYT) [PIC 08 - 000139]; Universidad Tecnica Particular de Loja
   (UTPL); Agencia Espanola de Cooperacion Internacional para el Desarrollo
   (AECID) [A/012436/07, A/021000/08]; German Research Foundation (DFG)
   [FOR 816, HO 3296/2]
FX This research, MFT and CIE were financially supported by the Secretaria
   de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT -
   http://www.educacionsuperior.gob.ec/) - Project PIC 08 - 000139 and the
   Universidad Tecnica Particular de Loja (UTPL - utpl.edu.ec), MFT was
   financially supported by the the Secretaria de Educacion Superior,
   Ciencia, Tecnologia e Innovacion (SENESCYT -
   http://www.educacionsuperior.gob.ec/) scholarship program 2010, MC was
   financially supported by the Agencia Espanola de Cooperacion
   Internacional para el Desarrollo (AECID - http://www.aecid.es/ES) grants
   A/012436/07 and A/021000/08, MFT and JH were financially supported by
   the German Research Foundation (DFG - http://www.dfg.de/en/) research
   unit FOR 816 (project HO 3296/2). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abrams M, 2002, ASTER USER HDB ADV S
   Aide TM, 2013, BIOTROPICA, V45, P262, DOI 10.1111/j.1744-7429.2012.00908.x
   Armenteras D, 2003, BIOL CONSERV, V113, P245, DOI 10.1016/S0006-3207(02)00359-2
   Balslev H, 2002, BOT AUTROECUATORIANA
   Barthlott W, 2005, NOVA ACT LC, V92, P61
   Bendix J, 2006, CLIMATE RES, V30, P133, DOI 10.3354/cr030133
   Bendix J, 1992, ERDKUNDE, V46, P118, DOI DOI 10.3112/ERDKUNDE.1992.02.04
   Brehm G, 2005, J BIOGEOGR, V32, P1621, DOI 10.1111/j.1365-2699.2005.01304.x
   Brehm G., 2008, V198, P15
   Brodie J, 2012, TRENDS ECOL EVOL, V27, P145, DOI 10.1016/j.tree.2011.09.008
   Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795
   Brummitt N, 2003, CONSERV BIOL, V17, P1442, DOI 10.1046/j.1523-1739.2003.02344.x
   Canale GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041671
   Cayuela L, 2006, FOREST ECOL MANAG, V226, P208
   Chavez PS, 1996, PHOTOGRAMM ENG REM S, V62, P1025
   Chuvieco E, 2010, TELEDETECCION AMBIEN
   CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B
   Cueva J, 2010, COBERTURA VEGETAL US
   DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258
   Eastman JR, 2012, IDRISI SELVA EDITION
   Echeverria C, 2006, BIOL CONSERV, V130, P481, DOI 10.1016/j.biocon.2006.01.017
   Ellingson LJ, 2000, FOREST ECOL MANAG, V137, P41, DOI 10.1016/S0378-1127(99)00311-4
   Emck P, 2007, THESIS U ERLANGEN NU
   Espinosa CI, 2012, REV ECOSISTEMAS, V21, P1
   Eva HD, 2012, REMOTE SENS-BASEL, V4, P1369, DOI 10.3390/rs4051369
   Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.2307/3060946
   Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419
   FAO, 2011, STAT WORLDS FOR 2011
   Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183
   Fearnside PM, 2004, ECOL APPL, V14, P982, DOI 10.1890/03-5225
   Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100
   Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287
   Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4
   Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2
   Gottlicher D, 2009, INT J REMOTE SENS, V30, P1867, DOI 10.1080/01431160802541531
   Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098
   Hawbaker TJ, 2006, ECOL APPL, V16, P1222, DOI 10.1890/1051-0761(2006)016[1222:RDHGAL]2.0.CO;2
   Homeier J., 2008, V198, P87
   Homeier J, 2013, ECOL STUD, P93
   Homeier J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047128
   Iniguez-Armijos C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105869
   Janzen DH, 1988, MOST ENDANGERED MAJO
   Jokisch BD, 2002, GEOGR REV, V92, P235, DOI 10.2307/4140972
   Kauffman JB, 2003, FOREST ECOL MANAG, V176, P1, DOI 10.1016/S0378-1127(02)00227-X
   Keating PL, 1998, PHYS GEOGR, V19, P221, DOI 10.1080/02723646.1998.10642648
   Knowlton JL, 2011, ECOL APPL, V21, P2974, DOI 10.1890/10-1886.1
   Kouki J, 2001, SCAND J FOREST RES, P27
   Lambin E, 2003, ANNU REV ENV RESOUR, V28
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009
   Lopez S., 2010, GEOGR B, V51, P3
   Lu D, 2004, INT J REMOTE SENS, V25, P2365, DOI 10.1080/0143116031000139863
   Macedo MN, 2012, P NATL ACAD SCI USA, V109, P1341, DOI 10.1073/pnas.1111374109
   Macleod RD, 1998, PHOTOGRAMM ENG REM S, V64, P207
   Maldonado N, 2002, BOT AUSTROECUATORIAN, P1
   Marquette CM, 1998, HUM ECOL, V26, P573, DOI 10.1023/A:1018797325069
   McGarigal K., 2002, FRAGSTATS V3 SPATIAL
   Mena CF, 2008, PHOTOGRAMM ENG REM S, V74, P737, DOI 10.14358/PERS.74.6.737
   Mendoza JE, 2002, LANDSCAPE URBAN PLAN, V59, P147, DOI 10.1016/S0169-2046(02)00012-9
   MILLETTE TL, 1995, GLOBAL ENVIRON CHANG, V5, P367, DOI 10.1016/0959-3780(95)00071-U
   Ministerio del Ambiente del Ecuador, 2010, RES BIOSF EC LUG EXC
   Ministerio del Ambiente del Ecuador Sistema de Clasificacion de los Ecosistemas del Ecuador Continental, 2012, SUBS PATR NAT, P136
   Noske NM, 2008, BASIC APPL ECOL, V9, P4, DOI 10.1016/j.baae.2007.06.014
   PALA V, 1995, PHOTOGRAMM ENG REM S, V61, P935
   Pan WKY, 2004, AGR ECOSYST ENVIRON, V101, P117, DOI 10.1016/j.agee.2003.09.022
   Peters T, 2013, ECOSYSTEM SERVICES B, P20
   Portillo-Quintero CA, 2010, BIOL CONSERV, V143, P144, DOI 10.1016/j.biocon.2009.09.020
   Puyravaud JP, 2003, FOREST ECOL MANAG, V177, P593, DOI 10.1016/S0378-1127(02)00335-3
   Riano D, 2003, IEEE T GEOSCI REMOTE, V41, P1056, DOI 10.1109/TGRS.2003.811693
   Richter M., 2003, ERDKUNDE, V57, P161, DOI DOI 10.3112/ERDKUNDE.2003.03.01
   Rodriguez-Mahecha JV, 2004, HOTSPOTS REVISTED EA
   Rudel TK, 2002, ANN ASSOC AM GEOGR, V92, P87, DOI 10.1111/1467-8306.00281
   Santos BA, 2008, BIOL CONSERV, V141, P249, DOI 10.1016/j.biocon.2007.09.018
   SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x
   Schowengerdt R.A., 2007, REMOTE SENSING MODEL
   Schulz JJ, 2010, APPL GEOGR, V30, P436, DOI 10.1016/j.apgeog.2009.12.003
   Sierra R, 2002, LANDSCAPE URBAN PLAN, V59, P95, DOI 10.1016/S0169-2046(02)00006-3
   Sierra R, 1998, HUM ECOL, V26, P135, DOI 10.1023/A:1018753018631
   Sierra R, 2000, APPL GEOGR, V20, P1, DOI 10.1016/S0143-6228(99)00014-4
   SKOLE D, 1993, SCIENCE, V260, P1905, DOI 10.1126/science.260.5116.1905
   Southgate D, 1990, P905 U MINN DEP AGR
   Tabarelli M, 2012, BIOL CONSERV, V155, P136, DOI 10.1016/j.biocon.2012.06.020
   Tabarelli M, 2010, CONSERV BIOL, V24, P1654, DOI 10.1111/j.1523-1739.2010.01529.x
   Tapia-Armijos MF, 2011, COBERTURA VEGETAL US
   Thies B, 2012, J LAND USE SCI, P1
   Torracchi E, 2000, AVANCES ANALISIS ESP, P275
   Toutin T, 2004, INT J REMOTE SENS, V25, P1893, DOI 10.1080/0143116031000101611
   Trejo I, 2000, BIOL CONSERV, V94, P133, DOI 10.1016/S0006-3207(99)00188-3
   Valencia R, 2000, LIBRO ROJO PLANTAS E
   Vina A, 2004, AMBIO, V33, P118, DOI 10.1639/0044-7447(2004)033[0118:SCDAOD]2.0.CO;2
   VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591
   Weigend M, 2002, BOT REV, V68, P38, DOI 10.1663/0006-8101(2002)068[0038:OOTBOT]2.0.CO;2
   Weigend Maximilian, 2004, Rev. peru biol., V11, P127
   Werner Florian A., 2005, Ecotropica (Bonn), V11, P21
   Wolf K, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003876
   Wunder S, 2000, EC DEFORESTATION EXA
   Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8
   Young AG, 2000, GENETICS DEMOGRAPHY
NR 98
TC 53
Z9 59
U1 1
U2 107
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 2
PY 2015
VL 10
IS 9
AR e0133701
DI 10.1371/journal.pone.0133701
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CQ4ZT
UT WOS:000360613800005
PM 26332681
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Jobst, BJ
   Wielputz, MO
   Triphan, SMF
   Anjorin, A
   Ley-Zaporozhan, J
   Kauczor, HU
   Biederer, J
   Ley, S
   Sedlaczek, O
AF Jobst, Bertram J.
   Wielpuetz, Mark O.
   Triphan, Simon M. F.
   Anjorin, Angela
   Ley-Zaporozhan, Julia
   Kauczor, Hans-Ulrich
   Biederer, Juergen
   Ley, Sebastian
   Sedlaczek, Oliver
TI Morpho-Functional 1H-MRI of the Lung in COPD: Short-Term Test-Retest
   Reliability
SO PLOS ONE
LA English
DT Article
ID OBSTRUCTIVE-PULMONARY-DISEASE; QUANTITATIVE COMPUTED-TOMOGRAPHY;
   CYSTIC-FIBROSIS; PROTON MRI; PERFUSION; EMPHYSEMA; CT; AGREEMENT;
   DYSFUNCTION; CAPABILITY
AB Purpose
   Non-invasive end-points for interventional trials and tailored treatment regimes in chronic obstructive pulmonary disease (COPD) for monitoring regionally different manifestations of lung disease instead of global assessment of lung function with spirometry would be valuable. Proton nuclear magnetic resonance imaging (1H-MRI) allows for a radiation-free assessment of regional structure and function. The aim of this study was to evaluate the short-term reproducibility of a comprehensive morpho-functional lungMRI protocol in COPD.
   Materials and Methods
   20 prospectively enrolled COPD patients (GOLD I-IV) underwent 1H-MRI of the lung at 1.5T on two consecutive days, including sequences for morphology, 4D contrast-enhanced perfusion, and respiratory mechanics. Image quality and COPD-related morphological and functional changes were evaluated in consensus by three chest radiologists using a dedicated MRI-based visual scoring system. Test-retest reliability was calculated per each individual lung lobe for the extent of large airway (bronchiectasis, wall thickening, mucus plugging) and small airway abnormalities (tree in bud, peripheral bronchiectasis, mucus plugging), consolidations, nodules, parenchymal defects and perfusion defects. The presence of tracheal narrowing, dystelectasis, pleural effusion, pulmonary trunk ectasia, right ventricular enlargement and, finally, motion patterns of diaphragma and chest wall were addressed.
   Results
   Median global scores [10(Q1:8.00; Q3:16.00) vs. 11(Q1:6.00; Q3:15.00)] as well as category subscores were similar between both timepoints, and kappa statistics indicated "almost perfect" global agreement (kappa = 0.86, 95% CI = 0.81-0.91). Most subscores showed at least "substantial" agreement of MRI1 and MRI2 (kappa = 0.64-1.00), whereas the agreement for the diagnosis of dystelectasis/effusion (kappa = 0.42, 95% CI = 0.00-0.93) was "moderate" and of tracheal abnormalities (kappa = 0.21, 95% CI = 0.00-0.75) "fair". Most MRI acquisitions showed at least diagnostic quality at MRI1 (276 of 278) and MRI2 (259 of 264).
   Conclusion
   Morpho-functional 1H-MRI can be obtained with reproducible image quality and high short-term test-retest reliability for COPD-related morphological and functional changes of the lung. This underlines its potential value for the monitoring of regional lung characteristics in COPD trials.
C1 [Jobst, Bertram J.; Wielpuetz, Mark O.; Triphan, Simon M. F.; Anjorin, Angela; Ley-Zaporozhan, Julia; Kauczor, Hans-Ulrich; Biederer, Juergen; Ley, Sebastian; Sedlaczek, Oliver] Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany.
   [Jobst, Bertram J.; Wielpuetz, Mark O.; Triphan, Simon M. F.; Anjorin, Angela; Ley-Zaporozhan, Julia; Kauczor, Hans-Ulrich; Biederer, Juergen; Ley, Sebastian; Sedlaczek, Oliver] Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany.
   [Jobst, Bertram J.; Wielpuetz, Mark O.; Anjorin, Angela; Kauczor, Hans-Ulrich; Sedlaczek, Oliver] Heidelberg Univ, Dept Diagnost & Intervent Radiol Nucl Med, Thoraxklin, Heidelberg, Germany.
   [Triphan, Simon M. F.] Res Ctr Magnet Resonance Bavaria MRB, Wurzburg, Germany.
   [Ley-Zaporozhan, Julia] Univ Hosp Munich, Inst Clin Radiol, Munich, Germany.
   [Biederer, Juergen] Cty Hosp Gross Gerau, Dept Radiol, Radiol Darmstadt, Gross Gerau, Germany.
   [Ley, Sebastian] Surg Hosp Dr Rinecker, Dept Diagnost & Intervent Radiol, Munich, Germany.
RP Jobst, BJ (reprint author), Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany.
EM bertram.jobst@med.uni-heidelberg.de
OI Wielputz, Mark Oliver/0000-0001-6962-037X; Ley,
   Sebastian/0000-0001-9269-2670
FU Competence Network on Asthma/COPD (ASCONET) through a grant from the
   Federal Ministry of Education and Research (Bundesministerium fur
   Bildung und Forschung, BMBF) of the federal government of Germany
   [01GI0870]
FX This work has been supported by the Competence Network on Asthma/COPD
   (ASCONET) through a grant from the Federal Ministry of Education and
   Research (Bundesministerium fur Bildung und Forschung, BMBF) of the
   federal government of Germany (01GI0870, www.bmbf.de/en). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript. The authors declare no
   conflict of interest with regard to the study at hand.
CR Barr R Graham, 2011, Proc Am Thorac Soc, V8, P522, DOI 10.1513/pats.201101-008MW
   Biederer J, 2012, INSIGHTS IMAGING, V3, P355, DOI 10.1007/s13244-011-0146-8
   Biederer J, 2012, INSIGHTS IMAGING, V3, P373, DOI 10.1007/s13244-011-0142-z
   COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Coxson Harvey O, 2008, Proc Am Thorac Soc, V5, P940, DOI 10.1513/pats.200806-057QC
   Coxson HO, 2005, ACAD RADIOL, V12, P1457, DOI 10.1016/j.acra.2005.08.013
   Dournes G, 2015, RADIOLOGY, V276, P258, DOI 10.1148/radiol.15141655
   Eichinger M, 2006, EUR RADIOL, V16, P2147, DOI 10.1007/s00330-006-0257-7
   Eichinger M, 2012, EUR J RADIOL, V81, P1321, DOI 10.1016/j.ejrad.2011.02.045
   Fan L, 2013, EUR RADIOL, V23, P1234, DOI 10.1007/s00330-012-2729-2
   GAY SB, 1994, INVEST RADIOL, V29, P848, DOI 10.1097/00004424-199409000-00009
   Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC
   Henderson AC, 2007, RESP PHYSIOL NEUROBI, V155, P234, DOI 10.1016/j.resp.2006.05.009
   Hopkins SR, 2012, J APPL PHYSIOL, V113, P328, DOI 10.1152/japplphysiol.00320.2012
   Hueper K, 2013, INVEST RADIOL, V48, P223, DOI 10.1097/RLI.0b013e318281057d
   Iwasawa T, 2000, J THORAC IMAG, V15, P191, DOI 10.1097/00005382-200007000-00007
   Iwasawa T, 2002, EUR RESPIR J, V19, P225, DOI 10.1183/09031936.02.00044602
   Johnson KM, 2013, MAGN RESON MED, V70, P1241, DOI 10.1002/mrm.24570
   Kauczor HU, 2011, J THORAC IMAG, V26, P290, DOI 10.1097/RTI.0b013e3182277113
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Ley-Zaporozhan J, 2007, EUR J RADIOL, V63, P76, DOI 10.1016/j.ejrad.2007.01.020
   Ley-Zaporozhan J, 2010, J MAGN RESON IMAGING, V32, P1340, DOI 10.1002/jmri.22376
   Ley-Zaporozhan J, 2010, EUR J RADIOL, V73, P43, DOI 10.1016/j.ejrad.2008.09.029
   Ley-Zaporozhan J, 2008, MAGN RESON IMAGING C, V16, P291, DOI 10.1016/j.mric.2008.02.014
   Lynch DA, RADIOLOGY IN PRESS
   Miller GW, 2014, NMR BIOMED, V27, P1542, DOI 10.1002/nbm.3156
   OSWALDMAMMOSSER M, 1995, CHEST, V107, P1193, DOI 10.1378/chest.107.5.1193
   Puderbach M, 2007, INVEST RADIOL, V42, P715, DOI 10.1097/RLI.0b013e318074fd81
   Puderbach M, 2007, EUR RADIOL, V17, P716, DOI 10.1007/s00330-006-0373-4
   Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO
   Sergiacomi G, 2003, IN VIVO, V17, P319
   Sommer G, 2014, EUR J RADIOL, V83, P600, DOI 10.1016/j.ejrad.2013.11.012
   Suga K, 1999, JMRI-J MAGN RESON IM, V10, P510, DOI 10.1002/(SICI)1522-2586(199910)10:4<510::AID-JMRI3>3.3.CO;2-7
   Tan RT, 1998, CHEST, V113, P1250, DOI 10.1378/chest.113.5.1250
   Thieme SF, 2012, EUR J RADIOL, V81, P360, DOI 10.1016/j.ejrad.2010.11.037
   van der Meer RW, 2005, RADIOLOGY, V235, P798, DOI 10.1148/radiol.2353040893
   Wells JM, 2012, NEW ENGL J MED, V367, P913, DOI 10.1056/NEJMoa1203830
   Wielputz M, 2012, DIAGN INTERV RADIOL, V18, P344, DOI 10.4261/1305-3825.DIR.5365-11.0
   Wielputz MO, 2014, AM J RESP CRIT CARE, V189, P956, DOI 10.1164/rccm.201309-1659OC
   Wielputz MO, 2014, RESPIRATION, V87, P294, DOI 10.1159/000357448
   Xia Y, 2014, COPD, V11, P510, DOI 10.3109/15412555.2014.948990
NR 42
TC 3
Z9 3
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 1
PY 2015
VL 10
IS 9
AR e0137282
DI 10.1371/journal.pone.0137282
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CQ2NK
UT WOS:000360437700106
PM 26327295
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Dane, SK
   Masser, BM
   MacDonald, G
   Duck, JM
AF Dane, Sharon K.
   Masser, Barbara M.
   MacDonald, Geoff
   Duck, Julie M.
TI When "In Your Face" Is Not Out of Place: The Effect of Timing of
   Disclosure of a Same-Sex Dating Partner under Conditions of Contact
SO PLOS ONE
LA English
DT Article
ID CROSS-GROUP FRIENDSHIPS; INTERGROUP CONTACT; SELF-DISCLOSURE; GAY MEN;
   HETEROSEXUALS ATTITUDES; FEMALE HOMOSEXUALS; NEGATIVE CONTACT; GROUP
   MEMBERSHIP; OUT-GROUP; PREJUDICE
AB In a series of experiments we examined heterosexuals' reactions to the timing of disclosure of a gender-matched confederate's same-sex dating partner. Disclosure occurred in a naturalistic context-that is, it occurred when meeting, or expecting to soon meet, a same-sex attracted individual, who voluntarily shared this information with the participant as a natural part of a broader topic of discussion. The confederate, when disclosing early rather than later, was approached more closely (Prestudy) and liked more (Studies 1-2). Those experiencing early disclosure, compared with later, were less drawn to topics of lower intimacy (Study 1), were happier and more excited about meeting the confederate, and more likely to choose to be alone with the confederate for a one-on-one discussion (Study 2). Further, women experiencing early disclosure were more willing to introduce the same-gender confederate to their friends (Study 2). The benefits of knowing sooner, rather than later, continued to apply even when participants were given further time to process the disclosure. To explore the underlying reasons for the more favorable experiences of upfront disclosure, we examined participants' memory of the information shared by the confederate (Study 3). Results revealed that those who experienced delayed disclosure were more likely to incorrectly recall and negatively embellish information related to the confederate's sexual orientation, suggesting that early disclosure resulted in a reduced tendency to focus on the confederate's sexuality as a defining feature. These positive findings for early timing are discussed in light of previous studies that have found benefits for delayed disclosure and those that have failed to investigate the effects of timing of 'coming out' under conditions of contact.
C1 [Dane, Sharon K.; Masser, Barbara M.] Univ Queensland, Sch Psychol, St Lucia, Qld 4072, Australia.
   [MacDonald, Geoff] Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada.
   [Duck, Julie M.] Univ Queensland, Fac Humanities & Social Sci, St Lucia, Qld 4072, Australia.
RP Dane, SK (reprint author), Univ Queensland, Sch Psychol, McElwain Bldg, St Lucia, Qld 4072, Australia.
EM s.dane@psy.uq.edu.au
RI Masser, Barbara M/A-7900-2018
OI Masser, Barbara M/0000-0001-9385-6497
CR Allport Gordon., 1954, NATURE PREJUDICE
   Altemeyer B., 1988, ENEMIES FREEDOM
   Altman L, 1973, SOCIAL PENETRATION T
   ARCHER RL, 1980, J PERS SOC PSYCHOL, V38, P120, DOI 10.1037/0022-3514.38.1.120
   ASCH SE, 1948, PSYCHOL REV, V55, P250, DOI 10.1037/h0057270
   Barlow FK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082228
   Barlow FK, 2012, PERS SOC PSYCHOL B, V38, P1629, DOI 10.1177/0146167212457953
   Becker H. S., 1963, OUTSIDERS STUDIES SO
   Blair IV, 2003, GROUP PROCESS INTERG, V6, P151, DOI 10.1177/1368430203006002002
   Bogardus ES, 1925, J APPL SOCIOL, V9, P299
   BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9
   Brown R, 1999, EUR J SOC PSYCHOL, V29, P741, DOI 10.1002/(SICI)1099-0992(199908/09)29:5/6<741::AID-EJSP972>3.0.CO;2-8
   Brown R, 2005, ADV EXP SOC PSYCHOL, V37, P255, DOI 10.1016/S0065-2601(05)37005-5
   Buck DM, 2011, J EXP SOC PSYCHOL, V47, P333, DOI 10.1016/j.jesp.2010.10.016
   CARLSTON DE, 1980, J EXP SOC PSYCHOL, V16, P303, DOI 10.1016/0022-1031(80)90025-6
   COZBY PC, 1973, PSYCHOL BULL, V79, P73, DOI 10.1037/h0033950
   D'Augelli AR, 1998, AM J ORTHOPSYCHIAT, V68, P361, DOI 10.1037/h0080345
   Dane S. K. Sharon, 2010, NOT SO PRIVATE LIVES, P53
   Davies K, 2011, PERS SOC PSYCHOL REV, V15, P332, DOI 10.1177/1088868311411103
   Dennis MJ, 2001, MEM COGNITION, V29, P152, DOI 10.3758/BF03195749
   DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.1.5
   Dovidio JR, 2003, GROUP PROCESS INTERG, V6, P5, DOI 10.1177/1368430203006001009
   Ensari N, 2002, J PERS SOC PSYCHOL, V83, P313, DOI 10.1037//0022-3514.83.2.313
   Field A., 2013, DISCOVERING STAT USI
   Freedom to Marry, FREED MARR INT
   Galaxy Research, 2012, REL SAM SEX MARR
   Gates GJ, 2012, GALL SPEC REP US AD
   GENTRY CS, 1987, J SOC PSYCHOL, V127, P199, DOI 10.1080/00224545.1987.9713680
   Goldfried MR, 2001, AM PSYCHOL, V56, P977, DOI 10.1037/0003-066X.56.11.977
   Golebiowska EA, 2003, POLIT BEHAV, V25, P313, DOI 10.1023/B:POBE.0000004061.08643.7d
   GROSS AE, 1980, PERS SOC PSYCHOL B, V6, P307, DOI 10.1177/014616728062020
   HASTIE R, 1986, PSYCHOL REV, V93, P258, DOI 10.1037/0033-295X.93.3.258
   Hastie R, 1980, PERSON MEMORY COGNIT
   Hebl MR, 2000, SOCIAL PSYCHOL STIGM, P273
   Herek G. M., 1994, LESBIAN GAY PSYCHOL, P206, DOI DOI 10.4135/9781483326757
   Herek G. M., 2003, PSYCHOL PERSPECTIVES, P270
   Herek GM, 2000, J SOC ISSUES, V56, P251, DOI 10.1111/0022-4537.00164
   Herek GM, 1996, PERS SOC PSYCHOL B, V22, P412, DOI 10.1177/0146167296224007
   Hodson G, 2009, EUR J SOC PSYCHOL, V39, P509, DOI 10.1002/ejsp.558
   JONES EE, 1972, J PERS SOC PSYCHOL, V24, P358, DOI 10.1037/h0033724
   King EB, 2008, GROUP ORGAN MANAGE, V33, P566, DOI 10.1177/1059601108321834
   Kite M. E., 2003, PSYCHOL PERSPECTIVES, P165
   Kleider HM, 2008, APPL COGNITIVE PSYCH, V22, P1, DOI 10.1002/acp.1361
   LaMar L, 1998, J SEX RES, V35, P189, DOI 10.1080/00224499809551932
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Levinson CA, 2011, PERS INDIV DIFFER, V51, P355, DOI 10.1016/j.paid.2011.04.006
   Maass A, 2000, SOCIAL IDENTITY PROC, P96, DOI DOI 10.4135/9781446218617.N7
   MacInnis CC, 2014, J SOCIAL PERSONAL RE, P1
   MACRAE CN, 1993, EUR J SOC PSYCHOL, V23, P77, DOI 10.1002/ejsp.2420230107
   Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6
   Miller N, 2002, J SOC ISSUES, V58, P387, DOI 10.1111/1540-4560.00267
   Mohipp C, 2004, CAN J BEHAV SCI, V36, P36, DOI 10.1037/h0087214
   Moskowitz GB, 2005, SOICAL COGNITION UND
   O'Brien KS, 2013, INT J PSYCHOL, V48, P891, DOI 10.1080/00207594.2012.713107
   Pachankis JE, 2007, PSYCHOL BULL, V133, P328, DOI 10.1037/0033-2909.133.2.328
   Page-Gould E, 2008, J PERS SOC PSYCHOL, V95, P1080, DOI 10.1037/0022-3514.95.5.1080
   Page-Gould E, 2010, J PERS SOC PSYCHOL, V98, P775, DOI 10.1037/a0017880
   Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751
   Pettigrew TF, 1998, ANNU REV PSYCHOL, V49, P65, DOI 10.1146/annurev.psych.49.1.65
   Pettigrew TF, 2008, EUR J SOC PSYCHOL, V38, P922, DOI 10.1002/ejsp.504
   Pettigrew TF, 2007, INT J INTERCULT REL, V31, P411, DOI 10.1016/j.ijintrel.2006.11.003
   Pettigrew TF, 2011, INT J INTERCULT REL, V35, P271, DOI 10.1016/j.ijintrel.2011.03.001
   Pew Research Center, 2013, SURV LGBT AM ATT EXP
   Plant EA, 2003, PERS SOC PSYCHOL B, V29, P790, DOI 10.1177/0146167203252880
   Quinn DM, 2009, J PERS SOC PSYCHOL, V97, P634, DOI 10.1037/a0015815
   REYES RM, 1980, J PERS SOC PSYCHOL, V39, P2, DOI 10.1037/0022-3514.39.1.2
   Rickards T, 2006, HEALTH CARE WOMEN IN, V6, P530
   Roediger III H. L., 2012, MEMORY LAW, P84, DOI DOI 10.1093/ACPROF:OSO/9780199920754.001.0001
   Savin-Williams RC, 2001, J ADOLESCENCE, V24, P5, DOI 10.1006/jado.2000.0369
   Sedikides C, 1998, J PERS SOC PSYCHOL, V74, P378, DOI 10.1037/0022-3514.74.2.378
   Sherman JW, 2000, PERS SOC PSYCHOL B, V26, P26, DOI 10.1177/0146167200261003
   SHERMAN SJ, 1983, J PERS SOC PSYCHOL, V44, P1127
   Shook NJ, 2008, PSYCHOL SCI, V19, P717, DOI 10.1111/j.1467-9280.2008.02147.x
   SKOWRONSKI JJ, 1989, PSYCHOL BULL, V105, P131, DOI 10.1037/0033-2909.105.1.131
   STANGOR C, 1992, PSYCHOL BULL, V111, P42, DOI 10.1037/0033-2909.111.1.42
   Stones CR, 2006, SOC BEHAV PERSONAL, V34, P1137, DOI 10.2224/sbp.2006.34.9.1137
   Tam T, 2006, GROUP PROCESS INTERG, V9, P413, DOI 10.1177/1368430206064642
   Techakesari P, 2015, J CROSS CULT PSYCHOL, V46, P454, DOI 10.1177/0022022115570313
   Tumer RN, 2007, J PERS SOC PSYCHOL, V93, P369, DOI 10.1037/0022-3514.93.3.369
   Turner RN, EUROPEAN REV SOCIAL, P212
   Vonofakou C, 2007, J PERS SOC PSYCHOL, V92, P804, DOI 10.1037/0022-3514.92.5.804
   Whitley BE, 2000, J APPL SOC PSYCHOL, V30, P144, DOI 10.1111/j.1559-1816.2000.tb02309.x
   WORTMAN CB, 1976, J PERS SOC PSYCHOL, V33, P184, DOI 10.1037/0022-3514.33.2.184
   Wright SC, 1997, J PERS SOC PSYCHOL, V73, P73, DOI 10.1037/0022-3514.73.1.73
NR 84
TC 2
Z9 2
U1 1
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 26
PY 2015
VL 10
IS 8
AR e0135023
DI 10.1371/journal.pone.0135023
PG 29
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CP7LO
UT WOS:000360069400046
PM 26308076
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Liu, WW
   Yuan, SW
   Wei, FQ
   Yang, J
   Zhang, Z
   Zhu, CB
   Ma, J
AF Liu, Wenwei
   Yuan, Suwei
   Wei, Fengqing
   Yang, Jing
   Zhang, Zhe
   Zhu, Changbin
   Ma, Jin
TI Reliability and Validity of the Chinese Version Appropriateness
   Evaluation Protocol
SO PLOS ONE
LA English
DT Article
ID TOTAL HIP-ARTHROPLASTY; LENGTH-OF-STAY; HOSPITAL UTILIZATION;
   HEALTH-CARE; ADMISSIONS; EXPERIENCE; DESIGN; SYSTEM; SAMPLE
AB Objective
   To adapt the Appropriateness Evaluation Protocol (AEP) to the specific settings of health care in China and to validate the Chinese version AEP (C-AEP).
   Methods
   Forward and backward translations were carried out to the original criteria. Twenty experts participated in the consultancy to form a preliminary version of the C-AEP. To ensure applicability, tests of reliability and validity were performed on 350 admissions and 3,226 hospital days of acute myocardial infraction patients and total hip replacement patients in two tertiary hospitals by two C-AEP reviewers and two physician reviewers. Overall agreement, specific agreement, and Cohen's Kappa were calculated to compare the concordance of decisions between pairs of reviewers to test inter-rater reliability and convergent validity. The use of "overrides" and opinions of experts were recorded as measurements of content validity. Face validity was tested through collecting perspectives of nonprofessionals. Sensitivity, specificity, and predictive values were also reported.
   Results
   There are 14 admission and 24 days of care criteria in the initial version of C-AEP. Kappa coefficients indicate substantial agreement between reviewers: with regard to inter-rater reliability, Kappa (.) coefficients are 0.746 (95% confidence interval [CI] 0.644-0.834) and 0.743 (95% CI 0.698-0.767) of admission and hospital days, respectively; for convergent validity, the. statistics are 0.678 (95% CI 0.567-0.778) and 0.691 (95% CI 0.644-0.717), respectively. Overrides account for less than 2% of all judgments. Content validity and face validity were confirmed by experts and nonprofessionals, respectively. According to the C-AEP reviewers, 18.3% of admissions and 28.5% of inpatient days were deemed inappropriate.
   Conclusions
   The C-AEP is a reliable and valid screening tool in China's tertiary hospitals. The prevalence of inappropriateness is substantial in our research. To reduce inappropriate utilization, further investigation is needed to elucidate the reasons and risk factors for this inappropriateness.
C1 [Liu, Wenwei] Shanghai Jiao Tong Univ, Antai Coll Econ & Management, Shanghai 200030, Peoples R China.
   [Yuan, Suwei; Wei, Fengqing; Zhang, Zhe; Ma, Jin] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China.
   [Yang, Jing] Shanghai Rui Jin Hosp, Dept Med Adm, Shanghai, Peoples R China.
   [Zhu, Changbin] Erasmus MC, Dept Pathol, Rotterdam, Netherlands.
RP Ma, J (reprint author), 227 South Chong Qing Rd, Shanghai, Peoples R China.
EM majin@shsmu.edu.cn
FU National Natural Science Foundation of China [71273175]; Shanghai
   Municipal Education Commission [13YS022]
FX This study is sponsored by National Natural Science Foundation of China
   [grant number 71273175], http://www.nsfc.gov.cn/publish/portal1/ and
   Shanghai Municipal Education Commission Innovative Project [grant number
   13YS022], http://www.shmec.gov.cn/. The grants were received by JM. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR [Anonymous], AVERAGE LENGTH STAY, DOI [10.1787/health_glance-2013-36-en, DOI 10.1787/HEALTH_GLANCE-2013-36-EN]
   Apolone G, 1991, Qual Assur Health Care, V3, P1
   ASH A, 1995, INT J QUAL HEALTH C, V7, P245, DOI 10.1093/intqhc/7.3.245
   Barber SL, 2014, HEALTH POLICY PLANN, V29, P367, DOI 10.1093/heapol/czt023
   BENTES M, 1995, INT J QUAL HEALTH C, V7, P201, DOI 10.1093/intqhc/7.3.201
   Buetow SA, 1997, SOC SCI MED, V45, P261, DOI 10.1016/S0277-9536(96)00342-5
   Cao JW, 2009, CHINESE HOSP MANAGEM, V29, P37
   Davido A, 1991, Qual Assur Health Care, V3, P227
   ERMANN D, 1988, J HEALTH POLIT POLIC, V13, P683, DOI 10.1215/03616878-13-4-683
   Fontaine P, 2011, HEALTH POLICY, V99, P66, DOI 10.1016/j.healthpol.2010.06.011
   GERTMAN PM, 1981, MED CARE, V19, P855, DOI 10.1097/00005650-198108000-00005
   He MQ, 2008, CHINESE HOSP, V12, P31
   Hwang JI, 2011, INT J QUAL HEALTH C, V23, P437, DOI 10.1093/intqhc/mzr028
   Jimenez-Garcia R, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-43
   Kalant N, 2000, CAN MED ASSOC J, V162, P1809
   KREGER BE, 1989, PEDIATRICS, V84, P242
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LANG T, 1995, INT J QUAL HEALTH C, V7, P233, DOI 10.1093/intqhc/7.3.233
   Lang T, 1999, INT J TECHNOL ASSESS, V15, P185, DOI 10.1017/S0266462399152784
   Lavis JN, 1996, CAN MED ASSOC J, V154, P321
   Leung L. P., 2008, Hong Kong Medical Journal, V14, P273
   Liu K, 2014, CHINESE HOSP MANAGEM, V34, P58
   Liu XZ, 1999, HEALTH POLICY PLANN, V14, P409, DOI 10.1093/heapol/14.4.409
   Long Q, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-40
   Lorenzo S, 1999, INT J QUAL HEALTH C, V11, P419, DOI 10.1093/intqhc/11.5.419
   Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5
   Ministry of Health of the Peoples Republic of China, 2013, CHIN HLTH STAT YB 20
   Panis LJGG, 2002, INT J QUAL HEALTH C, V14, P55, DOI 10.1093/intqhc/14.1.55
   Qiu YZ, 2013, CHINESE HOSP MANAGEM, V33, P19
   RESTUCCIA JD, 1995, INT J QUAL HEALTH C, V7, P253, DOI 10.1093/intqhc/7.3.253
   RISHPON S, 1986, MED CARE, V24, P279, DOI 10.1097/00005650-198603000-00010
   Sangha O, 2002, INT J QUAL HEALTH C, V14, P483, DOI 10.1093/intqhc/14.6.483
   Shoukri MM, 2010, CH CRC BIOSTAT SER, P1, DOI 10.1201/b10433
   Sim J, 2005, PHYS THER, V85, P257
   Smeets PMJH, 2000, INT J QUAL HEALTH C, V12, P483, DOI 10.1093/intqhc/12.6.483
   STRUMWASSER I, 1990, MED CARE, V28, P95, DOI 10.1097/00005650-199002000-00001
   Tang SL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-S1-S8
   [ Tao Jingjing], 2013, [. , Journal of Shanghai Jiaotong University .Medical Science], V33, P1146
   Vorhies JS, 2011, J ARTHROPLASTY, V26, P119, DOI 10.1016/j.arth.2011.04.036
   [ Wang Huan], 2002, [, Chinese Journal of Orthopedics], V22, P17
   Wang X, 2001, J 4 MILITARY MED U, V22, P557
   Zhang WT, 2014, CHINESE HOSP MANAGEM, V3, P38
   Zhang Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0649-3
   Zhou XY, 2013, CHINESE HLTH QUALITY, V20, P33
NR 44
TC 1
Z9 1
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 25
PY 2015
VL 10
IS 8
AR e0136498
DI 10.1371/journal.pone.0136498
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CP6KK
UT WOS:000359995500085
PM 26305363
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Shiba, N
   Matsuse, H
   Takano, Y
   Yoshimitsu, K
   Omoto, M
   Hashida, R
   Tagawa, Y
   Inada, T
   Yamada, S
   Ohshima, H
AF Shiba, Naoto
   Matsuse, Hiroo
   Takano, Yoshio
   Yoshimitsu, Kazuhiro
   Omoto, Masayuki
   Hashida, Ryuki
   Tagawa, Yoshihiko
   Inada, Tomohisa
   Yamada, Shin
   Ohshima, Hiroshi
TI Electrically Stimulated Antagonist Muscle Contraction Increased Muscle
   Mass and Bone Mineral Density of One Astronaut - Initial Verification on
   the International Space Station
SO PLOS ONE
LA English
DT Article
ID EXERCISE; VOLUNTARY; STRENGTH; HYPERTROPHY; SPACEFLIGHT; RESPONSES;
   VOLUME
AB Background
   Musculoskeletal atrophy is one of the major problems of extended periods of exposure to weightlessness such as on the International Space Station (ISS). We developed the Hybrid Training System (HTS) to maintain an astronaut's musculoskeletal system using an electrically stimulated antagonist to resist the volitional contraction of the agonist instead of gravity. The present study assessed the system's orbital operation capability and utility, as well as its preventative effect on an astronaut's musculoskeletal atrophy.
   Methods
   HTS was attached to the non-dominant arm of an astronaut staying on the ISS, and his dominant arm without HTS was established as the control (CTR). 10 sets of 10 reciprocal elbow curls were one training session, and 12 total sessions of training (3 times per week for 4 weeks) were performed. Pre and post flight ground based evaluations were performed by Biodex (muscle performance), MRI (muscle volume), and DXA (BMD, lean [muscle] mass, fat mass). Pre and post training inflight evaluations were performed by a hand held dynamometer (muscle force) and a measuring tape (upper arm circumference).
   Results
   The experiment was completed on schedule, and HTS functioned well without problems. Isokinetic elbow extension torque (Nm) changed -19.4% in HTS, and -21.7% in CTR. Isokinetic elbow flexion torque changed -23.7% in HTS, and there was no change in CTR. Total Work (Joule) of elbow extension changed -8.3% in HTS, and +0.3% in CTR. For elbow flexion it changed -23.3% in HTS and -32.6% in CTR. Average Power (Watts) of elbow extension changed +22.1% in HTS and -8.0% in CTR. For elbow flexion it changed -6.5% in HTS and -4.8% in CTR. Triceps muscle volume according to MRI changed +11.7% and that of biceps was +2.1% using HTS, however -0.1% and -0.4% respectively for CTR. BMD changed +4.6% in the HTS arm and -1.2% for CTR. Lean (muscle) mass of the arm changed only +10.6% in HTS. Fat mass changed -12.6% in HTS and -6.4% in CTR.
   Conclusions
   These results showed the orbital operation capability and utility, and the preventive effect of HTS for an astronaut's musculoskeletal atrophy. The initial flight data together with the ground data obtained so far will be utilized in the future planning of human space exploration.
C1 [Shiba, Naoto; Yoshimitsu, Kazuhiro; Omoto, Masayuki; Hashida, Ryuki] Kurume Univ, Sch Med, Dept Orthoped, Kurume, Fukuoka 830, Japan.
   [Shiba, Naoto; Matsuse, Hiroo; Omoto, Masayuki; Hashida, Ryuki] Kurume Univ, Sch Med, Div Rehabil, Kurume, Fukuoka 830, Japan.
   [Takano, Yoshio] Fukuoka Int Univ Hlth & Welf, Div Phys Therapy, Okawa City, Fukuoka 8318501, Japan.
   [Tagawa, Yoshihiko; Inada, Tomohisa] Kyushu Inst Technol, Dept Mech & Control Engn, Kitakyushu, Fukuoka 804, Japan.
   [Yamada, Shin; Ohshima, Hiroshi] Japan Aerosp Explorat Agcy, Space Environm Utilizat Ctr, Tsukuba, Ibaraki, Japan.
RP Shiba, N (reprint author), Kurume Univ, Sch Med, Dept Orthoped, Kurume, Fukuoka 830, Japan.
EM nshiba@med.kurume-u.ac.jp
FU International Announcement of Utilization at ISS; Grant of ISS Research
   of Japan Space Forum
FX This study was supported by the International Announcement of
   Utilization at ISS 2009 and Grant of ISS Research of Japan Space Forum.
CR Akima H, 2000, MED SCI SPORT EXER, V32, P1743, DOI 10.1097/00005768-200010000-00013
   BALOGUN JA, 1993, ARCH PHYS MED REHAB, V74, P910
   Belavy DL, 2013, J APPL PHYSIOL, V115, P586, DOI 10.1152/japplphysiol.00376.2013
   Bennie SD, 2002, EUR J APPL PHYSIOL, V88, P13, DOI 10.1007/s00421-002-0711-4
   Cavanagh Peter R, 2005, Gravit Space Biol Bull, V18, P39
   Conley MS, 1997, EUR J APPL PHYSIOL O, V75, P443, DOI 10.1007/s004210050186
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   Gopalakrishnan R, 2010, AVIAT SPACE ENVIR MD, V81, P91, DOI 10.3357/ASEM.2583.2010
   HAINAUT K, 1992, SPORTS MED, V14, P100, DOI 10.2165/00007256-199214020-00003
   Iwasaki T, 2006, TOHOKU J EXP MED, V209, P33, DOI 10.1620/tjem.209.33
   Kawaguchi T, 2011, APPL PHYSIOL NUTR ME, V36, P276, DOI [10.1139/h10-108, 10.1139/H10-108]
   Kawaguchi T, 2011, J GASTROENTEROL, V46, P746, DOI 10.1007/s00535-011-0378-x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LeBlanc A, 2000, J APPL PHYSIOL, V89, P2158
   LEBLANC A, 1995, AVIAT SPACE ENVIR MD, V66, P1151
   LeBlanc A, 2013, OSTEOPOROSIS INT, V24, P2105, DOI 10.1007/s00198-012-2243-z
   LeBlanc A., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P157
   LeBlanc A. D., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P33
   Matsugaki Toru, 2010, Kurume Medical Journal, V57, P101
   Matsuse H, 2013, J REHABIL RES DEV, V50, P545, DOI 10.1682/JRRD.2012.04.0067
   Orwoll ES, 2013, J BONE MINER RES, V28, P1243, DOI 10.1002/jbmr.1948
   Ploutz-Snyder LL, 2015, HRP47072 HUM HLTH CO
   Seger JY, 2000, ACTA PHYSIOL SCAND, V169, P63
   Smith SM, 2012, J BONE MINER RES, V27, P1896, DOI 10.1002/jbmr.1647
   Stein RB, 1999, J BIOMECH, V32, P347, DOI 10.1016/S0021-9290(98)00187-0
   Tesch PA, 2005, EUR J APPL PHYSIOL, V93, P463, DOI 10.1007/s00421-004-1236-9
   Tornton WE, 1977, BIOMEDICAL RESULTS S, VSP-377, P191
   Trappe S, 2009, J APPL PHYSIOL, V106, P1159, DOI 10.1152/japplphysiol.91578.2008
   Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1
   Welle S, 1996, J GERONTOL A-BIOL, V51, pM270, DOI 10.1093/gerona/51A.6.M270
   Yanagi T, 2003, ARCH PHYS MED REHAB, V84, P843, DOI 10.1016/S0003-9993(02)04948-1
   Yoshimitsu K, 2010, TOHOKU J EXP MED, V220, P83, DOI 10.1620/tjem.220.83
   Zwart SR, 2005, INT SPORTMED J, V6, P199
NR 33
TC 5
Z9 5
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 21
PY 2015
VL 10
IS 8
AR e0134736
DI 10.1371/journal.pone.0134736
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CP5MR
UT WOS:000359926900015
PM 26296204
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Sugano, K
   Okuyama, T
   Iida, S
   Komatsu, H
   Ishida, T
   Kusumoto, S
   Uchida, M
   Nakaguchi, T
   Kubota, Y
   Ito, Y
   Takahashi, K
   Akechi, T
AF Sugano, Koji
   Okuyama, Toru
   Iida, Shinsuke
   Komatsu, Hirokazu
   Ishida, Takashi
   Kusumoto, Shigeru
   Uchida, Megumi
   Nakaguchi, Tomohiro
   Kubota, Yosuke
   Ito, Yoshinori
   Takahashi, Kazuhisa
   Akechi, Tatsuo
TI Medical Decision-Making Incapacity among Newly Diagnosed Older Patients
   with Hematological Malignancy Receiving First Line Chemotherapy: A
   Cross-Sectional Study of Patients and Physicians
SO PLOS ONE
LA English
DT Article
ID MINI-MENTAL-STATE; CANCER-PATIENTS; COGNITIVE IMPAIRMENT; GERIATRIC
   ASSESSMENT; JAPANESE VERSION; ELDERLY-PATIENTS; DEPRESSION; CAPACITY;
   COMPETENCE; VALIDITY
AB Background
   Decision-making capacity to provide informed consent regarding treatment is essential among cancer patients. The purpose of this study was to identify the frequency of decision-making incapacity among newly diagnosed older patients with hematological malignancy receiving first-line chemotherapy, to examine factors associated with incapacity and assess physicians' perceptions of patients' decision-making incapacity.
   Methods
   Consecutive patients aged 65 years or over with a primary diagnosis of malignant lymphoma or multiple myeloma were recruited. Decision-making capacity was assessed using the Structured Interview for Competency and Incompetency Assessment Testing and Ranking Inventory-Revised (SICIATRI-R). Cognitive impairment, depressive condition and other possible associated factors were also evaluated.
   Results
   Among 139 eligible patients registered for this study, 114 completed the survey. Of these, 28 (25%, 95% confidence interval [CI]: 17%-32%) were judged as having some extent of decision- making incompetency according to SICIATRI-R. Higher levels of cognitive impairment and increasing age were significantly associated with decision-making incapacity. Physicians experienced difficulty performing competency assessment (Cohen's kappa -0.54).
   Conclusions
   Decision-making incapacity was found to be a common and under-recognized problem in older patients with cancer. Age and assessment of cognitive impairment may provide the opportunity to find patients that are at a high risk of showing decision-making incapacity.
C1 [Sugano, Koji; Okuyama, Toru; Uchida, Megumi; Nakaguchi, Tomohiro; Kubota, Yosuke; Ito, Yoshinori; Akechi, Tatsuo] Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Nagoya, Aichi, Japan.
   [Sugano, Koji; Okuyama, Toru; Uchida, Megumi; Nakaguchi, Tomohiro; Ito, Yoshinori; Akechi, Tatsuo] Nagoya City Univ Hosp, Div Psychooncol & Palliat Care, Nagoya, Aichi, Japan.
   [Sugano, Koji; Takahashi, Kazuhisa] Juntendo Univ, Fac Med, Div Resp Med, Tokyo, Japan.
   [Sugano, Koji; Takahashi, Kazuhisa] Grad Sch Med, Tokyo, Japan.
   [Iida, Shinsuke; Komatsu, Hirokazu; Ishida, Takashi; Kusumoto, Shigeru] Nagoya City Univ, Grad Sch Med Sci, Dept Hematol & Oncol, Nagoya, Aichi, Japan.
RP Okuyama, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Nagoya, Aichi, Japan.
EM okuyama@med.nagoya-cu.ac.jp
OI Ishida, Takashi/0000-0002-1060-0777
FU Japanese Ministry of Health, Labor and Welfare [H22-009]; Japanese
   Ministry of Education, Culture, Sports, Science and Technology
   [23659264]
FX This study was supported, in part, by a Grant-in-Aid for Cancer Research
   [grant number H22-009 to T.A.] from the Japanese Ministry of Health,
   Labor and Welfare, and a Grant-in Aid for Challenging Exploratory
   Research [grant number 23659264 to T.A.] from the Japanese Ministry of
   Education, Culture, Sports, Science and Technology. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Akechi T, 2015, PALLIAT SUPPORT CARE, V13, P1529, DOI 10.1017/S1478951513000588
   Amalraj S, 2009, ONCOLOGY-NY, V23, P369
   Appelbaum PS, 2007, NEW ENGL J MED, V357, P1834, DOI 10.1056/NEJMcp074045
   Colleoni M, 2000, LANCET, V356, P1326, DOI 10.1016/S0140-6736(00)02821-X
   Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Hindmarch T, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-54
   Ideno Y, 2012, GERIATR GERONTOL INT, V12, P310, DOI 10.1111/j.1447-0594.2011.00772.x
   Kitamura F, 1998, INT J LAW PSYCHIAT, V21, P223, DOI 10.1016/S0160-2527(98)00016-8
   Kitamura T, 2011, STRUCTURED INTERVIEW
   Klepin HD, 2006, BONE MARROW TRANSPL, V38, P585, DOI 10.1038/sj.bmt.1705486
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lepping P, 2011, BRIT J PSYCHIAT, V199, P355, DOI 10.1192/bjp.bp.111.094938
   Mitchell AJ, 2011, LANCET ONCOL, V12, P160, DOI 10.1016/S1470-2045(11)70002-X
   Muramatsu K, 2007, PSYCHOL REP, V101, P952, DOI 10.2466/PRO.101.3.952-960
   OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014
   Okonkwo O, 2007, NEUROLOGY, V69, P1528, DOI 10.1212/01.wnl.0000277639.90611.d9
   Page K, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-10
   Pal SK, 2010, CA-CANCER J CLIN, V60, P120, DOI 10.3322/caac.20059
   Plassman BL, 2008, ANN INTERN MED, V148, P427, DOI 10.7326/0003-4819-148-6-200803180-00005
   Puts MTE, 2012, JNCI-J NATL CANCER I, V104, P1133, DOI 10.1093/jnci/djs285
   Repetto L, 1998, CANCER, V82, P760, DOI 10.1002/(SICI)1097-0142(19980215)82:4<760::AID-CNCR20>3.3.CO;2-D
   Repetto L, 2003, EUR J CANCER, V39, P870, DOI 10.1016/S0959-8049(03)00062-5
   Sessums LL, 2011, JAMA-J AM MED ASSOC, V306, P420, DOI 10.1001/jama.2011.1023
   Tomoda A, 1997, J CLIN PSYCHOL, V53, P443, DOI 10.1002/(SICI)1097-4679(199708)53:5<443::AID-JCLP4>3.0.CO;2-O
   Weinberger MI, 2011, INT J GERIATR PSYCH, V26, P21, DOI 10.1002/gps.2497
   Zachariae R, 2003, BRIT J CANCER, V88, P658, DOI 10.1038/sj.bjc.6600798
NR 28
TC 4
Z9 4
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 21
PY 2015
VL 10
IS 8
AR e0136163
DI 10.1371/journal.pone.0136163
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CP5MR
UT WOS:000359926900078
PM 26296202
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU McCormick, N
   Bhole, V
   Lacaille, D
   Avina-Zubieta, JA
AF McCormick, Natalie
   Bhole, Vidula
   Lacaille, Diane
   Avina-Zubieta, J. Antonio
TI Validity of Diagnostic Codes for Acute Stroke in Administrative
   Databases: A Systematic Review
SO PLOS ONE
LA English
DT Review
ID ACUTE ISCHEMIC-STROKE; HOSPITAL DISCHARGE REGISTER; BRAIN ATTACK
   SURVEILLANCE; ACUTE TREATMENT COSTS; CASE-FATALITY; ICD-9 CODES;
   INTERNATIONAL-CLASSIFICATION; INTRACEREBRAL HEMORRHAGE; INTRACRANIAL
   HEMORRHAGE; CEREBROVASCULAR EVENTS
AB Objective
   To conduct a systematic review of studies reporting on the validity of International Classification of Diseases (ICD) codes for identifying stroke in administrative data.
   Methods
   MEDLINE and EMBASE were searched (inception to February 2015) for studies: (a) Using administrative data to identify stroke; or (b) Evaluating the validity of stroke codes in administrative data; and (c) Reporting validation statistics (sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), or Kappa scores) for stroke, or data sufficient for their calculation. Additional articles were located by hand search (up to February 2015) of original papers. Studies solely evaluating codes for transient ischaemic attack were excluded. Data were extracted by two independent reviewers; article quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies tool.
   Results
   Seventy-seven studies published from 1976-2015 were included. The sensitivity of ICD-9 430-438/ICD-10 I60-I69 for any cerebrovascular disease was >= 82% in most [>= 50%] studies, and specificity and NPV were both >= 95%. The PPV of these codes for any cerebrovascular disease was >= 81% in most studies, while the PPV specifically for acute stroke was >= 68%. In at least 50% of studies, PPVs were >= 93% for subarachnoid haemorrhage (ICD-9 430/ICD-10 I60), 89% for intracerebral haemorrhage (ICD-9 431/ICD-10 I61), and 82% for ischaemic stroke (ICD-9 434/ICD-10 I63 or ICD-9 434&436). For in-hospital deaths, sensitivity was 55%. For cerebrovascular disease or acute stroke as a cause-of-death on death certificates, sensitivity was >= 71% in most studies while PPV was >= 87%.
   Conclusions
   While most cases of prevalent cerebrovascular disease can be detected using 430-438/I60-I69 collectively, acute stroke must be defined using more specific codes. Most in-hospital deaths and death certificates with stroke as a cause-of-death correspond to true stroke deaths. Linking vital statistics and hospitalization data may improve the ascertainment of fatal stroke.
C1 [McCormick, Natalie] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada.
   [McCormick, Natalie; Bhole, Vidula; Lacaille, Diane; Avina-Zubieta, J. Antonio] Arthrit Res Canada, Richmond, BC, Canada.
   [Lacaille, Diane; Avina-Zubieta, J. Antonio] Univ British Columbia, Dept Med, Div Rheumatol, Vancouver, BC, Canada.
   [Lacaille, Diane; Avina-Zubieta, J. Antonio] CANRAD Network, Cardiovasc Comm, Richmond, BC, Canada.
RP Avina-Zubieta, JA (reprint author), Arthrit Res Canada, Richmond, BC, Canada.
EM azubieta@arthritisresearch.ca
OI McCormick, Natalie/0000-0002-4147-8348
FU Canadian Arthritis Network; Canadian Institutes of Health Research;
   Arthritis Society of Canada; Michael Smith Foundation for Health
   Research
FX This study was funded by the Canadian Arthritis Network
   (http://www.canradnetwork.ca). Natalie McCormick is supported by a
   Doctoral Research Award from the Canadian Institutes of Health Research.
   J. Antonio Avina-Zubieta held a salary award from the Canadian Arthritis
   Network and The Arthritis Society of Canada. He is currently the British
   Columbia Lupus Society Scholar and holds a Scholar Award from the
   Michael Smith Foundation for Health Research. Diane Lacaille holds the
   Mary Pack Chair in Arthritis Research from UBC and The Arthritis Society
   of Canada. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Aboa-Eboule C, 2013, J NEUROL, V260, P605, DOI 10.1007/s00415-012-6686-0
   Agrawal N, 2009, STROKE, V40, P3415, DOI 10.1161/STROKEAHA.109.564633
   Andrade SE, 2012, PHARMACOEPIDEM DR S, V21, P100, DOI 10.1002/pds.2312
   Appelros P, 2011, ACTA NEUROL SCAND, V123, P289, DOI 10.1111/j.1600-0404.2010.01402.x
   Appelros P, 2014, CEREBROVASC DIS, V37, P22, DOI 10.1159/000356346
   Arnason T, 2006, THROMB RES, V118, P253, DOI 10.1016/j.thromres.2005.06.015
   Asi T, 2011, CLIN NEUROL NEUROSUR, V113, P111, DOI 10.1016/j.clineuro.2010.09.014
   Barber C, 2013, ARTHRIT CARE RES, V65, P1343, DOI 10.1002/acr.21959
   Benesch C, 1997, NEUROLOGY, V49, P660, DOI 10.1212/WNL.49.3.660
   Bernatsky S, 2013, J RHEUMATOL, V40, P66, DOI 10.3899/jrheum.120835
   Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9
   BLOTH B, 1976, ACTA MED SCAND, V200, P281
   Borzecki AM, 2004, AM J MED QUAL, V19, P201, DOI 10.1177/106286060401900504
   Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415
   Brown DL, 2007, AM J EPIDEMIOL, V165, P591, DOI 10.1093/aje/kwk042
   Chen GM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-5
   Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087
   Christensen MC, 2009, ACTA NEUROL SCAND, V119, P246, DOI 10.1111/j.1600-0404.2008.01094.x
   Christensen MC, 2008, NEUROEPIDEMIOLOGY, V30, P239, DOI 10.1159/000128323
   Christensen MC, 2009, NEUROEPIDEMIOLOGY, V32, P142, DOI 10.1159/000184747
   Davenport R J, 1996, Health Bull (Edinb), V54, P402
   Demant MN, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-156
   Derby CA, 2000, STROKE, V31, P875, DOI 10.1161/01.STR.31.4.875
   Derby CA, 2001, STROKE, V32, P1487, DOI 10.1161/01.STR.32.7.1487
   Dodel RC, 2004, VALUE HEALTH, V7, P144, DOI 10.1111/j.1524-4733.2004.72314.x
   Ellekjaer H, 1999, STROKE, V30, P56, DOI 10.1161/01.STR.30.1.56
   Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0
   Gaist D, 2000, BRIT MED J, V320, P141, DOI 10.1136/bmj.320.7228.141
   Ghia D, 2010, NEUROEPIDEMIOLOGY, V35, P53, DOI 10.1159/000310338
   Gioldasis G, 2008, ACTA NEUROL SCAND, V118, P268, DOI 10.1111/j.1600-0404.2008.01014.x
   Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602
   Golomb MR, 2006, NEUROLOGY, V67, P2053, DOI 10.1212/01.wnl.0000247281.98094.e2
   Goulart AC, 2012, J STROKE CEREBROVASC, V21, P832, DOI 10.1016/j.jstrokecerebrovasdis.2011.04.017
   Haesebaert J, 2013, STROKE, V44, P1770, DOI 10.1161/STROKEAHA.113.001300
   Hasan M, 1995, INT J QUAL HEALTH C, V7, P407, DOI 10.1093/intqhc/7.4.407
   Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314
   Henderson T, 2006, MED CARE, V44, P1011, DOI 10.1097/01.mlr.0000228018.48783.34
   Hennessy DA, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-99
   Holick CN, 2009, J CLIN PSYCHOPHARM, V29, P453, DOI 10.1097/JCP.0b013e3181b2b828
   Holloway RG, 1996, NEUROLOGY, V46, P854
   Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009
   Hudson M, 2013, J CLIN EPIDEMIOL, V66, P278, DOI 10.1016/j.jclinepi.2012.10.004
   Humphries KH, 2000, J CLIN EPIDEMIOL, V53, P343, DOI 10.1016/S0895-4356(99)00188-2
   ISO H, 1990, AM J EPIDEMIOL, V132, P993, DOI 10.1093/oxfordjournals.aje.a115742
   Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9
   Johnsen SP, 2002, J CLIN EPIDEMIOL, V55, P602, DOI 10.1016/S0895-4356(02)00391-8
   Jones SA, 2014, STROKE, V45, P3219, DOI 10.1161/STROKEAHA.114.006316
   Kirkman MA, 2009, ACTA NEUROL BELG, V109, P114
   Klatsky AL, 2005, NEUROEPIDEMIOLOGY, V25, P26, DOI 10.1159/000085310
   Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1
   Koster M, 2013, NEUROEPIDEMIOLOGY, V40, P240, DOI 10.1159/000345953
   Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143
   Kumamaru H, 2014, CIRC-CARDIOVASC QUAL, V7, P611, DOI 10.1161/CIRCOUTCOMES.113.000743
   Lakshminarayan K, 2014, STROKE, V45, P815, DOI 10.1161/STROKEAHA.113.003408
   Lakshminarayan K, 2009, AM J EPIDEMIOL, V169, P1070, DOI 10.1093/aje/kwp029
   Lambert L, 2012, CAN J CARDIOL, V28, P162, DOI 10.1016/j.cjca.2011.10.005
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012
   Lee WC, 2007, ADV THER, V24, P258, DOI 10.1007/BF02849893
   Lee WC, 2007, CEREBROVASC DIS, V23, P57, DOI 10.1159/000096542
   LEIBSON CL, 1994, STROKE, V25, P2348, DOI 10.1161/01.STR.25.12.2348
   Lentine KL, 2009, CLIN J AM SOC NEPHRO, V4, P1213, DOI 10.2215/CJN.00670109
   Leone MA, 2004, NEUROL SCI, V25, P281, DOI 10.1007/s10072-004-0355-8
   Leong A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075256
   Leppala JM, 1999, EUR J EPIDEMIOL, V15, P155, DOI 10.1023/A:1007504310431
   Levy AR, 1999, CAN J CARDIOL, V15, P1277
   LINDBLAD U, 1993, SCAND J SOC MED, V21, P3, DOI 10.1177/140349489302100102
   Liu LY, 1999, CEREBROVASC DIS, V9, P224, DOI 10.1159/000015960
   Mayo N, 1993, CAN J CARDIOL SD, V9, p121D
   McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104519
   McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092286
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152
   Newton KM, 1999, J CLIN EPIDEMIOL, V52, P199, DOI 10.1016/S0895-4356(98)00161-9
   Olson KL, 2014, AM J MANAG CARE, V20, pE27
   Palmieri L, 2007, CEREBROVASC DIS, V24, P530, DOI 10.1159/000110423
   Phillips S, 1993, CAN J CARDIOL SD, V9, p124D
   Piriyawat P, 2002, AM J EPIDEMIOL, V156, P1062, DOI 10.1093/aje/kwf152
   Ramalle-Gomara E, 2013, NEUROEPIDEMIOLOGY, V41, P185, DOI 10.1159/000354626
   Rampatige R, 2013, HEALTH INF MANAG J, V42, P20, DOI 10.1177/183335831304200302
   Rao C, 2007, INT J EPIDEMIOL, V36, P642, DOI 10.1093/ije/dym003
   Reed SD, 2001, NEUROLOGY, V57, P305, DOI 10.1212/WNL.57.2.305
   REGGIO A, 1995, ITAL J NEUROL SCI, V16, P567, DOI 10.1007/BF02282916
   Reker DM, 2001, J REHABIL RES DEV, V38, P281
   Rinaldi R, 2003, NEUROL SCI, V24, P65, DOI 10.1007/s100720300074
   Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736
   Rossnagel K, 2005, EUR J NEUROL, V12, P862, DOI 10.1111/j.1468-1331.2005.01091.x
   Rournie CL, 2008, PHARMACOEPIDEM DR S, V17, P20, DOI 10.1002/pds.1518
   Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca
   Saka O, 2009, AGE AGEING, V38, P27, DOI 10.1093/ageing/afn281
   SARTI C, 1994, J CLIN EPIDEMIOL, V47, P1259, DOI 10.1016/0895-4356(94)90131-7
   SHAHAR E, 1995, STROKE, V26, P1
   Singh B, 2012, MAYO CLIN PROC, V87, P817, DOI 10.1016/j.mayocp.2012.04.015
   Sinha S, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-74
   Skolarus LE, 2014, STROKE, V45, P224, DOI 10.1161/STROKEAHA.113.002874
   So L, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-161
   Soo Martin, 2014, BMC Res Notes, V7, P253, DOI 10.1186/1756-0500-7-253
   Spolaore P, 2005, STROKE, V36, P1031, DOI 10.1161/01.STR.0000160755.94884.4a
   Sprigg N, 2013, STROKE, V44, P3458, DOI 10.1161/STROKEAHA.113.002201
   STEGMAYR B, 1992, NEUROEPIDEMIOLOGY, V11, P204, DOI 10.1159/000110933
   Sun Y, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-133
   SZCZESNIEWSKA D, 1990, REV EPIDEMIOL SANTE, V38, P435
   Thigpen JL, 2015, CIRC-CARDIOVASC QUAL, V8, P8, DOI 10.1161/CIRCOUTCOMES.113.000371
   Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD
   Tolonen H, 2007, EUR J CARDIOV PREV R, V14, P380, DOI 10.1097/01.hjr.0000239466.26132.f2
   Tu K, 2013, CAN J CARDIOL, V29, P1388, DOI 10.1016/j.cjca.2013.07.676
   Vagal A, 2014, STROKE, V45, P1029, DOI 10.1161/STROKEAHA.113.004332
   Wahl PM, 2010, PHARMACOEPIDEM DR S, V19, P596, DOI 10.1002/pds.1924
   Walker A E, 1981, Stroke, V12, pI13
   Wang GJ, 2014, J STROKE CEREBROVASC, V23, P861, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.017
   Wei JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013041
   Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25
   Widdifield J, 2013, ARTHRIT CARE RES, V65, P1490, DOI 10.1002/acr.21993
   Wildenschild C, 2014, CLIN EPIDEMIOL, V6, P27, DOI 10.2147/CLEP.S50449
   Wu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112257
   Yoneda Y, 2005, HEALTH POLICY, V73, P202, DOI 10.1016/j.healthpol.2004.11.016
NR 116
TC 67
Z9 67
U1 1
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 20
PY 2015
VL 10
IS 8
AR e0135834
DI 10.1371/journal.pone.0135834
PG 26
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CP5KH
UT WOS:000359919900035
PM 26292280
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Noll, LW
   Shridhar, PB
   Dewsbury, DM
   Shi, XR
   Cernicchiaro, N
   Renter, DG
   Nagaraja, TG
AF Noll, Lance W.
   Shridhar, Pragathi B.
   Dewsbury, Diana M.
   Shi, Xiaorong
   Cernicchiaro, Natalia
   Renter, David G.
   Nagaraja, T. G.
TI A Comparison of Culture- and PCR-Based Methods to Detect Six Major
   Non-O157 Serogroups of Shiga Toxin-Producing Escherichia coli in Cattle
   Feces
SO PLOS ONE
LA English
DT Article
ID FEEDLOT CATTLE; UNITED-STATES; IMMUNOMAGNETIC SEPARATION; O157
   SEROGROUPS; BEEF CARCASSES; MULTIPLEX PCR; O26; PREVALENCE; O145; O111
AB Culture-based methods to detect the six major non-O157 (O26, O45, O103, O111, O121 and O145) Shiga toxin-producing E. coli (STEC) are not well established. Our objectives of this study were to develop a culture-based method to detect the six non-O157 serogroups in cattle feces and compare the detection with a PCR method. Fecal samples (n = 576) were collected in a feedlot from 24 pens during a 12-week period and enriched in E. coli broth at 40 degrees C for 6 h. Enriched samples were subjected to immunomagnetic separation, spread-plated onto a selective chromogenic medium, and initially pooled colonies, and subsequently, single colonies were tested by a multiplex PCR targeting six serogroups and four virulence genes, stx1, stx2, eae, and ehxA (culture method). Fecal suspensions, before and after enrichment, were also tested by a multiplex PCR targeting six serogroups and four virulence genes (PCR method). There was no difference in the proportions of fecal samples that tested positive (74.3 vs. 77.4%) for one or more of the six serogroups by either culture or the PCR method. However, each method detected one or more of the six serogroups in samples that were negative by the other method. Both culture method and PCR indicated that O26, O45, and O103 were the dominant serogroups. Higher proportions (P < 0.05) of fecal samples were positive for O26 (44.4 vs. 22.7%) and O121 (22.9 vs. 2.3%) serogroups by PCR than by the culture method. None of the fecal samples contained more than four serogroups. Only a small proportion of the six serogroups (23/640; 3.6%) isolated carried Shiga toxin genes. The culture method and the PCR method detected all six serogroups in samples negative by the other method, highlighting the importance of subjecting fecal samples to both methods for accurate detection of the six non-O157 STEC in cattle feces.
C1 [Noll, Lance W.; Shridhar, Pragathi B.; Dewsbury, Diana M.; Shi, Xiaorong; Cernicchiaro, Natalia; Renter, David G.; Nagaraja, T. G.] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.
RP Nagaraja, TG (reprint author), Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.
EM tnagaraj@vet.k-state.edu
FU Agriculture and Food Research Initiative Competitive Grant from the
   United States Department of Agriculture National Institute of Food and
   Agriculture [2012-68003-30155]
FX Agriculture and Food Research Initiative Competitive Grant no.
   2012-68003-30155 from the United States Department of Agriculture
   National Institute of Food and Agriculture.
CR [Anonymous], 2013, DAILY J US GOVT, P1
   Arthur TM, 2002, APPL ENVIRON MICROB, V68, P4847, DOI 10.1128/AEM.68.10.4847-4852.2002
   Bai JF, 2012, FOODBORNE PATHOG DIS, V9, P541, DOI 10.1089/fpd.2011.1082
   Baltasar P, 2014, J FOOD PROTECT, V77, P722, DOI 10.4315/0362-028X.JFP-13-420
   Bosilevac JM, 2011, APPL ENVIRON MICROB, V77, P2103, DOI 10.1128/AEM.02833-10
   Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536
   Burns F, 2011, J AOAC INT, V94, P1117
   Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET, P1
   Cernicchiaro N, 2013, FOODBORNE PATHOG DIS, V10, P835, DOI 10.1089/fpd.2013.1526
   Dargatz DA, 2013, FOODBORNE PATHOG DIS, V10, P392, DOI 10.1089/fpd.2012.1289
   DebRoy C, 2011, FOODBORNE PATHOG DIS, V8, P651, DOI 10.1089/fpd.2010.0769
   Ekiri AB, 2014, J FOOD PROTECT, V77, P1052, DOI 10.4315/0362-028X.JFP-13-373
   Ennis C, 2012, J APPL MICROBIOL, V113, P1238, DOI 10.1111/j.1365-2672.2012.05421.x
   Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673
   Fox JT, 2008, J FOOD PROTECT, V71, P1761, DOI 10.4315/0362-028X-71.9.1761
   Fratamico PM, 2011, FOODBORNE PATHOG DIS, V8, P601, DOI 10.1089/fpd.2010.0773
   Jacob ME, 2010, J FOOD PROTECT, V73, P1030, DOI 10.4315/0362-028X-73.6.1030
   Ju WT, 2012, FOOD MICROBIOL, V32, P371, DOI 10.1016/j.fm.2012.07.017
   Kalchayanand N, 2013, J FOOD PROTECT, V76, P192, DOI 10.4315/0362-028X.JFP-12-182
   Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LeJeune JT, 2006, J CLIN MICROBIOL, V44, P872, DOI 10.1128/JCM.44.3.872-875.2006
   MARCH SB, 1986, J CLIN MICROBIOL, V23, P869
   Mathusa EC, 2010, J FOOD PROTECT, V73, P1721, DOI 10.4315/0362-028X-73.9.1721
   Monaghan I, 2011, APPL ENVIRON MICROB, V77, P8662, DOI 10.1128/AEM.06190-11
   Omisakin F, 2003, APPL ENVIRON MICROB, V69, P2444, DOI [10.1128/AEM.69.5.2444-2447.2003, 10.1128/AEM.69.2444-2447.2003]
   Paddock ZD, 2014, FOODBORNE PATHOG DIS, V11, P186, DOI 10.1089/fpd.2013.1659
   Paddock Z, 2012, VET MICROBIOL, V156, P381, DOI 10.1016/j.vetmic.2011.11.017
   Pihkala N, 2012, RISK PROFILE PATHOGE, P1
   Posse B, 2008, FEMS MICROBIOL LETT, V282, P124, DOI 10.1111/j.1574-6968.2008.01121.x
   Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739
   Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]
   Verstraete K, 2010, VET MICROBIOL, V145, P106, DOI 10.1016/j.vetmic.2010.03.004
NR 33
TC 22
Z9 22
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 13
PY 2015
VL 10
IS 8
AR e0135446
DI 10.1371/journal.pone.0135446
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO9JX
UT WOS:000359492800071
PM 26270482
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Koo, KA
   Kong, WS
   Nibbelink, NP
   Hopkinson, CS
   Lee, JH
AF Koo, Kyung Ah
   Kong, Woo-Seok
   Nibbelink, Nathan P.
   Hopkinson, Charles S.
   Lee, Joon Ho
TI Potential Effects of Climate Change on the Distribution of Cold-Tolerant
   Evergreen Broadleaved Woody Plants in the Korean Peninsula
SO PLOS ONE
LA English
DT Article
ID SPECIES DISTRIBUTION MODELS; RANGE SHIFTS; VEGETATION CHANGE; MOUNTAIN
   SUMMITS; PRESENCE-ABSENCE; TEMPERATURE; ALPINE; ALPS; RESPIRATION;
   POPULATIONS
AB Climate change has caused shifts in species' ranges and extinctions of high-latitude and altitude species. Most cold-tolerant evergreen broadleaved woody plants (shortened to cold-evergreens below) are rare species occurring in a few sites in the alpine and subalpine zones in the Korean Peninsula. The aim of this research is to 1) identify climate factors controlling the range of cold-evergreens in the Korean Peninsula; and 2) predict the climate change effects on the range of cold-evergreens. We used multimodel inference based on combinations of climate variables to develop distribution models of cold-evergreens at a physiognomic-level. Presence/absence data of 12 species at 204 sites and 6 climatic factors, selected from among 23 candidate variables, were used for modeling. Model uncertainty was estimated by mapping a total variance calculated by adding the weighted average of within-model variation to the between-model variation. The range of cold-evergreens and model performance were validated by true skill statistics, the receiver operating characteristic curve and the kappa statistic. Climate change effects on the cold-evergreens were predicted according to the RCP 4.5 and RCP 8.5 scenarios. Multimodel inference approach excellently projected the spatial distribution of cold-evergreens (AUC = 0.95, kappa = 0.62 and TSS = 0.77). Temperature was a dominant factor in model-average estimates, while precipitation was minor. The climatic suitability increased from the southwest, lowland areas, to the northeast, high mountains. The range of cold-evergreens declined under climate change. Mountain-tops in the south and most of the area in the north remained suitable in 2050 and 2070 under the RCP 4.5 projection and 2050 under the RCP 8.5 projection. Only high-elevations in the northeastern Peninsula remained suitable under the RCP 8.5 projection. A northward and upper-elevational range shift indicates change in species composition at the alpine and subalpine ecosystems in the Korean Peninsula.
C1 [Koo, Kyung Ah] Natl Inst Ecol, Seocheon Gun, Chungnam, South Korea.
   [Kong, Woo-Seok; Lee, Joon Ho] Kyung Hee Univ, Seoul, South Korea.
   [Nibbelink, Nathan P.; Hopkinson, Charles S.] Univ Georgia, Athens, GA 30602 USA.
RP Koo, KA (reprint author), Natl Inst Ecol, Seocheon Gun, Chungnam, South Korea.
EM kyungah.koo@gmail.com
OI hopkinson, charles/0000-0002-7331-8322
FU "Climate Change Response Technology Project" of the Ministry of
   Environment, Republic of Korea [2014001310009]
FX This work was supported by "Climate Change Response Technology Project"
   of the Ministry of Environment, the Republic of Korea (2014001310009).
CR Diaz-Varela RA, 2010, ECOL MODEL, V221, P621, DOI 10.1016/j.ecolmodel.2009.11.010
   Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x
   Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.001000.x
   Atkin OK, 2006, GLOBAL CHANGE BIOL, V12, P500, DOI 10.1111/j.1365-2486.2006.01114.x
   Bauert MR, 1998, MOL ECOL, V7, P1519, DOI 10.1046/j.1365-294x.1998.00470.x
   Bellouin N, 2011, GEOSCI MODEL DEV DIS, V4, P765, DOI [10.5194/gmdd-4-765-2011, DOI 10.5194/GMDD-4-765-2011]
   Briggs D., 1997, PLANT VARIATION EVOL
   Burnham K. P, 2002, MODEL SELECTION MULT
   Carlson BZ, 2014, DIVERS DISTRIB, V20, P1379, DOI 10.1111/ddi.12238
   Carpenter S. R., 2006, MILLENNIUM ECOSYSTEM
   Collins W. J., 2008, 74 HCTN MET OFF HALD, V2, P74, DOI DOI 10.1088/1748-9326/8/2/024024
   Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547
   Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673
   Doak DF, 2010, NATURE, V467, P959, DOI 10.1038/nature09439
   Dullinger S, 2012, NAT CLIM CHANGE, V2, P619, DOI 10.1038/NCLIMATE1514
   Dumais D, 2007, FOREST CHRON, V83, P378, DOI 10.5558/tfc83378-3
   Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x
   Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159
   Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x
   Ernakovich JG, 2014, GLOBAL CHANGE BIOL, V20, P3256, DOI 10.1111/gcb.12568
   Feeley KJ, 2012, GLOBAL CHANGE BIOL, V18, P2636, DOI 10.1111/j.1365-2486.2012.02719.x
   Feeley KJ, 2012, GLOBAL CHANGE BIOL, V18, P1335, DOI 10.1111/j.1365-2486.2011.02602.x
   Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x
   Flagmeier M, 2014, PLANT ECOL DIVERS, V7, P457, DOI 10.1080/17550874.2013.817487
   Freeman EA, 2008, J STAT SOFTW, V23, P1
   Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/NCLIMATE1329, 10.1038/nclimate1329]
   Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x
   Hamrick JL, 2004, FOREST ECOL MANAG, V197, P323, DOI 10.1016/j.foreco.2004.05.023
   Hartley S, 2006, ECOL LETT, V9, P1068, DOI 10.1111/j.1461-0248.2006.00954.x
   Heide OM, 2003, TREE PHYSIOL, V23, P931, DOI 10.1093/treephys/23.13.931
   Heskel MA, 2014, FUNCT PLANT BIOL, V41, P287, DOI 10.1071/FP13137
   Higgins SI, 2003, J ECOL, V91, P341, DOI 10.1046/j.1365-2745.2003.00781.x
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Holden J, 2007, EARTH-SCI REV, V82, P75, DOI 10.1016/j.earscirev.2007.01.003
   Jeong TH, 1965, J SUNGKYUNKWAN U, P329
   Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001
   Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013
   Jones MM, 2006, J ECOL, V94, P181, DOI 10.1111/j.1365-2745.2005.01071.x
   Jung HS, 2002, INT J CLIMATOL, V22, P1327, DOI 10.1002/joc.797
   Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x
   Kiviniemi K, 1999, OIKOS, V86, P241, DOI 10.2307/3546442
   Kong W.-S., 1993, PLANT GEOGRAPHY KORE
   Koo K, 2001, J KOREAN GEOGR SOC, V36, P247
   Koo K, 2000, THESIS KYUNG HEE U S
   Lambers H., 1998, PLANT PHYSL ECOLOGY
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LARIGAUDERIE A, 1995, ANN BOT-LONDON, V76, P245, DOI 10.1006/anbo.1995.1093
   Lee W, 1978, KOREAN J PLANT TAXON
   Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831
   Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x
   Lurgi M, 2012, PHILOS T R SOC B, V367, P2913, DOI 10.1098/rstb.2012.0238
   Matteodo M, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024043
   Mazerolle M. J., 2013, AICCMODAVG MODEL SEL
   Mazerolle M J, 2014, PACKAGE AICCMODAVG
   McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x
   MOONEY HA, 1961, ECOL MONOGR, V31, P1, DOI 10.2307/1950744
   MYKING T, 1995, TREE PHYSIOL, V15, P697, DOI 10.1093/treephys/15.11.697
   Neuner G, 1999, PLANT CELL ENVIRON, V22, P1539, DOI 10.1046/j.1365-3040.1999.00508.x
   Oleksyn J, 1998, FUNCT ECOL, V12, P573, DOI 10.1046/j.1365-2435.1998.00236.x
   Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286
   Pauli H, 2012, SCIENCE, V336, P353, DOI 10.1126/science.1219033
   Pearson RG, 2007, LINC, V3, P54
   PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880
   Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x
   Reisinger A., 2007, 4 IPCC
   Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026
   Rixen C, 2012, OIKOS, V121, P1532, DOI 10.1111/j.1600-0706.2011.20031.x
   Rocchini D, 2012, COMPUT GEOSCI-UK, V39, P145, DOI 10.1016/j.cageo.2011.06.002
   Ross LC, 2012, J VEG SCI, V23, P755, DOI 10.1111/j.1654-1103.2012.01390.x
   Sevanto S, 2006, TREE PHYSIOL, V26, P749, DOI 10.1093/treephys/26.6.749
   Slot M., 2014, OECOLOGIA, P1
   Sproull GJ, 2015, J VEG SCI, V26, P552, DOI 10.1111/jvs.12264
   Stockli V, 2011, PLANT ECOL DIVERS, V4, P415, DOI 10.1080/17550874.2011.651504
   Theurillat JP, 2001, CLIMATIC CHANGE, V50, P77, DOI 10.1023/A:1010632015572
   Theurillat JP, 1998, POLIT SCI ENVIRONM, P225
   Vittoz P, 2008, J VEG SCI, V19, P671, DOI 10.3170/2008-8-18434
   VUUREN D, 2011, CLIMATIC CHANGE, V109, P5, DOI DOI 10.1007/S10584-011-0148-Z
   W-S Kong, 2002, J KOREAN GEOGRAPHICA, P357
   Wipf S, 2013, PLANT ECOL DIVERS, V6, P447, DOI 10.1080/17550874.2013.764943
NR 79
TC 7
Z9 10
U1 2
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 11
PY 2015
VL 10
IS 8
AR e0134043
DI 10.1371/journal.pone.0134043
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO7PP
UT WOS:000359353300016
PM 26262755
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Degarege, A
   Mekonnen, Z
   Levecke, B
   Legesse, M
   Negash, Y
   Vercruysse, J
   Erko, B
AF Degarege, Abraham
   Mekonnen, Zeleke
   Levecke, Bruno
   Legesse, Mengistu
   Negash, Yohannes
   Vercruysse, Jozef
   Erko, Berhanu
TI Prevalence of Schistosoma haematobium Infection among School-Age
   Children in Afar Area, Northeastern Ethiopia
SO PLOS ONE
LA English
DT Article
ID URINARY SCHISTOSOMIASIS; REAGENT STRIPS; AWASH VALLEY; EGG OUTPUT;
   SCHOOLCHILDREN; DIAGNOSIS; EPIDEMIOLOGY; PRAZIQUANTEL; MORBIDITY
AB In this study, the prevalence and intensity of Schistosoma haematobium infection was determined among school-age children living in the Middle and Lower Awash Valley, Afar Regional State of Ethiopia. Between February and May 2014, urine samples were collected from 885 school-age children (5-16 years of age) from the Middle (n = 632; 4 villages) and Lower (n = 253; 3 villages) Awash Valley. All samples were processed using urine filtration to detect and quantify S. haematobium eggs. In addition, a subset of the urine samples was tested for hematuria using a urine dipstick (n = 556). The overall prevalence was 20.8% (95% Confidence Interval (CI) = 18.1%, 23.5%), based on urine filtration but the prevalence considerably varied across villages both in the Middle (from 12.5% to 37.0%) and Lower Awash Valley (from 0 to 5.3%). The overall mean urine egg count (UEC) among the infected children was 4.0 eggs/10 ml of urine (95% CI = 2.43, 5.52). The infection intensity varied from 0.4 eggs/10 ml of urine to 7.7 eggs/10 ml of urine in the Middle Awash Valley, and from 0 to 1.1 eggs/10 ml of urine in Lower Awash Valley. Age and sex were not associated with S. haematobium infection based on the multivariable logistic regression model. The prevalence of hematuria was 56.3% (95% CI = 52.2%, 60.4%) among a subset of the study participants (556) examined using the urine dipstick. The prevalence of hematuria also varies with villages from 8.3% to 93.2%. In conclusion, the prevalence of S. haematobium infection in the Middle Awash Valley was high and it varies across villages. Hence, children living in the present study villages of the Middle Awash Valley need to be treated with praziquantel to reduce morbidity and disrupt transmission.
C1 [Degarege, Abraham; Legesse, Mengistu; Negash, Yohannes; Erko, Berhanu] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia.
   [Degarege, Abraham] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Dept Epidemiol, Miami, FL 33199 USA.
   [Mekonnen, Zeleke] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Med Lab Sci & Pathol, Jimma, Ethiopia.
   [Levecke, Bruno; Vercruysse, Jozef] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.
RP Degarege, A (reprint author), Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia.
EM abrahamdegarege@yahoo.com
OI Levecke, Bruno/0000-0001-8912-5595
FU Aklilu Lemma Institute of Pathobiology, Addis Ababa University; Addis
   Ababa University
FX This work was supported by Aklilu Lemma Institute of Pathobiology, Addis
   Ababa University (www.aau.edu.et/aaubeta/alipb/). AD, ML and BE received
   the fund from Addis Ababa University. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ALI A, 1986, ETHIOPIAN MED J, V24, P73
   Ayele B, 2008, PARASITE, V15, P69, DOI 10.1051/parasite/2008151069
   BRADLEY DJ, 1973, T ROY SOC TROP MED H, V67, P491, DOI 10.1016/0035-9203(73)90080-1
   Casmo V, 2014, REV INST MED TROP SP, V56, P219, DOI 10.1590/S0036-46652014000300007
   Deribew Ketema, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P307, DOI 10.1016/S2221-1691(13)60068-4
   DESOLE G, 1978, AM J TROP MED HYG, V27, P928, DOI 10.4269/ajtmh.1978.27.928
   Farid Z., 1993, Human schistosomiasis., P159
   Fenwick A, 2003, TRENDS PARASITOL, V19, P509, DOI 10.1016/j.pt.2003.09.005
   Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3
   Hamilton JV, 1998, PARASITOLOGY, V117, pS41
   Hammad TA, 1997, AM J TROP MED HYG, V57, P464, DOI 10.4269/ajtmh.1997.57.464
   Hatz CF, 1998, AM J TROP MED HYG, V59, P775, DOI 10.4269/ajtmh.1998.59.775
   Inobaya MT, 2014, RES REP TROP MED, V5, P65, DOI 10.2147/RRTM.S44274
   JEMANEH L, 1993, ETHIOPIAN MED J, V31, P137
   JEMANEH L, 1994, E AFR MED J, V71, P679
   King CH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002431
   KLOOS H, 1977, TROP GEOGR MED, V29, P399
   Koukounari A, 2007, J INFECT DIS, V196, P659, DOI 10.1086/520515
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LEMMA A., 1969, Ethiopian Medical Journal, V7, P147
   Mafiana CF, 2003, TROP MED INT HEALTH, V8, P78, DOI 10.1046/j.1365-3156.2003.00988.x
   Ndyomugyenyi R, 2001, ANN TROP MED PARASIT, V95, P697, DOI 10.1080/00034980120097151
   Pennington LF, 2014, IMMUNE RESPONSE PARA, P93
   PETERS PA, 1976, B WORLD HEALTH ORGAN, V54, P159
   Poggensee G, 2001, ACTA TROP, V79, P193, DOI 10.1016/S0001-706X(01)00086-9
   Poggensee G, 2000, B WORLD HEALTH ORGAN, V78, P542
   Rudge JW, 2008, ACTA TROP, V105, P45, DOI 10.1016/j.actatropica.2007.09-006
   Sacko M, 2011, ACTA TROP, V120, pS142, DOI 10.1016/j.actatropica.2010.12.009
   Satayathum SA, 2006, AM J TROP MED HYG, V75, P83, DOI 10.4269/ajtmh.2006.75.83
   Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7
   STEPHENSON L, 1993, PARASITOLOGY, V107, pS107, DOI 10.1017/S0031182000075545
   van Dam GJ, 2004, J CLIN MICROBIOL, V42, P5458, DOI 10.1128/JCM.42.12.5458-5461.2004
   van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9
   vanEtten L, 1997, AM J TROP MED HYG, V57, P337, DOI 10.4269/ajtmh.1997.57.337
   WHO, 2006, PREV CHEM HUM HELM C
   WHO, 2002, WHO TECH REP SER, V912, P1, DOI DOI 10.1016/J.PARINT.2004.01.001
NR 36
TC 4
Z9 4
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 7
PY 2015
VL 10
IS 8
AR e0133142
DI 10.1371/journal.pone.0133142
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO4HF
UT WOS:000359121100014
PM 26252615
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tougas, ME
   Hayden, JA
   McGrath, PJ
   Huguet, A
   Rozario, S
AF Tougas, Michelle E.
   Hayden, Jill A.
   McGrath, Patrick J.
   Huguet, Anna
   Rozario, Sharlene
TI A Systematic Review Exploring the Social Cognitive Theory of
   Self-Regulation as a Framework for Chronic Health Condition
   Interventions
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; EVALUATING COMPLEX INTERVENTIONS;
   LIFE-STYLE INTERVENTION; WEIGHT-LOSS PROGRAM; PHYSICAL-ACTIVITY;
   OLDER-ADULTS; RHEUMATOID-ARTHRITIS; MANAGEMENT PROGRAM; EXERCISE
   RESEARCH; OVERWEIGHT
AB Background
   Theory is often recommended as a framework for guiding hypothesized mechanisms of treatment effect. However, there is limited guidance about how to use theory in intervention development.
   Methods
   We conducted a systematic review to provide an exemplar review evaluating the extent to which use of theory is identified and incorporated within existing interventions. We searched electronic databases PubMed, PsycINFO, CENTRAL, and EMBASE from inception to May 2014. We searched clinicaltrials.gov for registered protocols, reference lists of relevant systematic reviews and included studies, and conducted a citation search in Web of Science. We included peer-reviewed publications of interventions that referenced the social cognitive theory of self-regulation as a framework for interventions to manage chronic health conditions. Two reviewers independently assessed articles for eligibility. We contacted all authors of included studies for information detailing intervention content. We describe how often theory mechanisms were addressed by interventions, and report intervention characteristics used to address theory.
   Results
   Of 202 articles that reported using the social cognitive theory of self-regulation, 52% failed to incorporate self-monitoring, a main theory component, and were therefore excluded. We included 35 interventions that adequately used the theory framework. Intervention characteristics were often poorly reported in peer-reviewed publications, 21 of 35 interventions incorporated characteristics that addressed each of the main theory components. Each intervention addressed, on average, six of eight self-monitoring mechanisms, two of five self-judgement mechanisms, and one of three self-evaluation mechanisms. The self-monitoring mechanisms 'Feedback' and 'Consistency' were addressed by all interventions, whereas the self-evaluation mechanisms 'Self-incentives' and 'External rewards' were addressed by six and four interventions, respectively. The present review establishes that systematic review is a feasible method of identifying use of theory as a conceptual framework for existing interventions. We identified the social cognitive theory of self-regulation as a feasible framework to guide intervention development for chronic health conditions.
C1 [Tougas, Michelle E.; Hayden, Jill A.; McGrath, Patrick J.; Huguet, Anna] Dalhousie Univ, Community Hlth & Epidemiol, Halifax, NS, Canada.
   [Tougas, Michelle E.] Dalhousie Univ, Psychol & Neurosci, Halifax, NS, Canada.
   [Tougas, Michelle E.; McGrath, Patrick J.; Huguet, Anna; Rozario, Sharlene] IWK Hlth Ctr, Ctr Res Family Hlth, Halifax, NS, Canada.
   [McGrath, Patrick J.] Dalhousie Univ, Canada Res Chair, Halifax, NS, Canada.
   [McGrath, Patrick J.] Dalhousie Univ, Sci Pediat & Psychiat, Halifax, NS, Canada.
   [McGrath, Patrick J.] Capital Dist Hlth Author, Halifax, NS, Canada.
RP Tougas, ME (reprint author), Dalhousie Univ, Community Hlth & Epidemiol, Halifax, NS, Canada.
EM M.Tougas@dal.ca
OI McGrath, Patrick/0000-0002-9568-2571
FU Nova Scotia Cochrane Resource Centre; Department of Community Health and
   Epidemiology
FX MET received funding to complete her Master's thesis from the Nova
   Scotia Cochrane Resource Centre and the Department of Community Health
   and Epidemiology. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Allen NA, 2004, DIABETES EDUCATOR, V30, P805, DOI 10.1177/014572170403000516
   Annesi James J, 2012, Perm J, V16, P7
   BANDURA A, 1991, ORGAN BEHAV HUM DEC, V50, P248, DOI 10.1016/0749-5978(91)90022-L
   Bandura A., 1986, SOCIAL FDN THOUGHT A
   Baptist AP, 2013, J AM GERIATR SOC, V61, P747, DOI 10.1111/jgs.12218
   Burke LE, 2006, CONTEMP CLIN TRIALS, V27, P34, DOI 10.1016/j.cct.2005.08.002
   Burke LE, 2011, J AM DIET ASSOC, V111, P92, DOI 10.1016/j.jada.2010.10.008
   Burkhart PV, 2007, J NURS SCHOLARSHIP, V39, P133, DOI 10.1111/j.1547-5069.2007.00158.x
   Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694
   Clark NM, 2007, CHEST, V132, P88, DOI 10.1378/chest.06-2539
   Collins CE, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1980
   Coryn CLS, 2011, AM J EVAL, V32, P199, DOI 10.1177/1098214010389321
   Craig P, 2013, INT J NURS STUD, V50, P587, DOI 10.1016/j.ijnurstu.2012.09.010
   Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655
   Davies P, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-14
   Furber S, 2010, PATIENT EDUC COUNS, V80, P212, DOI 10.1016/j.pec.2009.11.012
   Gallagher R, 2012, ANN BEHAV MED, V44, P119, DOI 10.1007/s12160-012-9369-2
   Glasziou P, 2008, BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47
   Gray CM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-121
   Hayden JA, 2013, ANN INTERN MED, V158, P280, DOI 10.7326/0003-4819-158-4-201302190-00009
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Hollis JF, 2008, AM J PREV MED, V35, P118, DOI 10.1016/j.amepre.2008.04.013
   Hughes SL, 2004, GERONTOLOGIST, V44, P217, DOI 10.1093/geront/44.2.217
   Keller C, 1999, ONLINE J KNOWL SYN N, V6
   Kiernan M, 2013, J CONSULT CLIN PSYCH, V81, P336, DOI 10.1037/a0030544
   Knittle K, 2010, ARTHRIT CARE RES, V62, P1460, DOI 10.1002/acr.20251
   KOVAR PA, 1992, ANN INTERN MED, V116, P529, DOI 10.7326/0003-4819-116-7-529
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lawler SP, 2010, ANN BEHAV MED, V39, P250, DOI 10.1007/s12160-010-9188-2
   Liebreich T, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-18
   Ma J, 2013, JAMA INTERN MED, V173, P113, DOI 10.1001/2013.jamainternmed.987
   Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3
   Malanda UL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005060.pub3
   Manning VL, 2014, ARTHRIT CARE RES, V66, P217, DOI 10.1002/acr.22102
   McGhan SL, 2003, J ASTHMA, V40, P523, DOI 10.1081/JAS-120018785
   Michie S, 2004, PSYCHOL HEALTH, V19, P29, DOI 10.1080/0887044031000141199
   Miller CK, 2002, PREV MED, V34, P252, DOI 10.1006/pmed.2001.0985
   Mockus DS, 2011, INT J PEDIATR OBES, V6, P197, DOI 10.3109/17477166.2011.590196
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Moore SM, 2002, NURS CLIN N AM, V37, P273, DOI 10.1016/S0029-6465(01)00008-1
   Morgan PJ, 2011, INT J OBESITY, V35, P436, DOI 10.1038/ijo.2010.151
   Morgan PJ, 2009, OBESITY, V17, P2025, DOI 10.1038/oby.2009.85
   Nansel TR, 2007, DIABETES CARE, V30, P2471, DOI 10.2337/dc06-2621
   Noar SM, 2005, HEALTH EDUC RES, V20, P275, DOI 10.1093/her/cyg113
   Padula CA, 2009, APPL NURS RES, V22, P18, DOI 10.1016/j.apnr.2007.02.002
   Painter JE, 2008, ANN BEHAV MED, V35, P358, DOI 10.1007/s12160-008-9042-y
   Patrick K, 2011, ANN BEHAV MED, V42, P391, DOI 10.1007/s12160-011-9296-7
   Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530
   Peterson JC, 2012, ARCH INTERN MED, V172, P329, DOI 10.1001/archinternmed.2011.1311
   Pinto BM, 2011, AM J PREV MED, V41, P274, DOI 10.1016/j.amepre.2011.04.015
   Shao JH, 2013, J ADV NURS, V69, P2458, DOI 10.1111/jan.12121
   Shigaki CL, 2008, CHRONIC ILLN, V4, P239, DOI 10.1177/1742395308097862
   Short CE, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.2776
   Shuger SL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-41
   Siemonsma PC, 2010, J REHABIL MED, V42, P111, DOI 10.2340/16501977-0492
   Tan MY, 2011, HEALTH EDUC RES, V26, P896, DOI 10.1093/her/cyr047
   Tudor-Locke C, 2004, INT J OBESITY, V28, P113, DOI 10.1038/sj.ijo.0802485
   Van Dyck D, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-105
   Walters JAE, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001288.pub3
   World Health Organization (WHO), 2010, GLOB STAT REP NONC D
NR 60
TC 13
Z9 13
U1 1
U2 37
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 7
PY 2015
VL 10
IS 8
AR e0134977
DI 10.1371/journal.pone.0134977
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO4HF
UT WOS:000359121100097
PM 26252889
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tsai, CF
   Lee, YT
   Lee, WJ
   Hwang, JP
   Wang, SJ
   Fuh, JL
AF Tsai, Chia-Fen
   Lee, Yao-Tung
   Lee, Wei-Ju
   Hwang, Jen-Ping
   Wang, Shuu-Jiun
   Fuh, Jong-Ling
TI Depression of Family Caregivers Is Associated with Disagreements on
   Life-Sustaining Preferences for Treating Patients with Dementia
SO PLOS ONE
LA English
DT Article
ID DECISION-MAKING; ALZHEIMERS-DISEASE; CARE; CONCORDANCE; AGREEMENT;
   ATTITUDES; HOSPICE; VERSION; BURDEN; HEALTH
AB Background
   Family caregivers may not agree with patients with dementia regarding attitudes toward end-of-life preferences, and the effects of this type of disagreement are not well understood. This study sought to identify such a disagreement and its predictors.
   Methods
   A cross-sectional sample of 84 family caregivers and patients with dementia was recruited from memory clinics. We used the Mini-Mental State Examination, Neuropsychiatric Inventory, Clinical Dementia Rating, and Katz index of independence in activities of daily living to assess patient symptoms, functions, and severity of dementia. Caregivers completed questionnaires on perceived patient end-of-life care preferences, caregiver end-of-life care preferences for patients, Zarit Burden Interview (ZBI), Center for Epidemiological Studies-Depression Scale (CES-D), and knowledge of clinical complications of advanced dementia.
   Results
   The self-disclosure rates of patient preferences were 34.5% for tube feeding, 39.3% for cardiopulmonary resuscitation, and 45.2% for mechanical ventilation. For patients who had disclosed preferences, the disagreement rate between them and their caregivers was 48.3% for tube feeding, 48.5% for cardiopulmonary resuscitation, and 60.3% for mechanical ventilation. Caregiver depression (i.e., CES-D >= 16) was associated with disagreements on cardiopulmonary resuscitation (adjusted odds ratio (aOR) = 6.6, 95% CI = 1.4-31.1, P = 0.01) and mechanical ventilation (aOR = 14, 95% CI = 2.2-87.2, P = 0.005) preferences.
   Conclusion
   The preferences of end-of-life issues differed greatly between dementia patients and their caregivers. Depression in caregivers is associated with such discrepancy.
C1 [Tsai, Chia-Fen; Hwang, Jen-Ping] Vet Gen Hosp, Neurol Inst, Dept Psychiat, Taipei, Taiwan.
   [Wang, Shuu-Jiun; Fuh, Jong-Ling] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan.
   [Tsai, Chia-Fen] Natl Yang Ming Univ, Sch Med, Inst Brain Sci, Taipei 112, Taiwan.
   [Lee, Wei-Ju] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan.
   [Tsai, Chia-Fen; Lee, Wei-Ju; Hwang, Jen-Ping; Wang, Shuu-Jiun; Fuh, Jong-Ling] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan.
   [Lee, Wei-Ju] Taichung Vet Gen Hosp, Dept Neurol, Taichung, Taiwan.
   [Lee, Yao-Tung] Taipei Med Univ, Shuang Ho Hosp, Dept Psychiat, Taipei, Taiwan.
RP Fuh, JL (reprint author), 201 Sec 2,Shipai Rd, Taipei 112, Taiwan.
EM jlfuh@vghtpe.gov.tw
OI Lee, Wei-Ju/0000-0002-3720-4539
FU Ministry of Science and Technology of Taiwan [NSC
   101-2314-B-075-037-MY2, 101-2314-B-075A-013, 102-2321-B-010-030]; Taipei
   Veterans General Hospital [V103E9-006, V103E3-005, V103C-083]; Ministry
   of Science and Technology support for the Centre for Dynamical
   Biomarkers and Translational Medicine, National Central University,
   Taiwan [NSC 102-2911-I-008-001]; Brain Research Center, National
   Yang-Ming University; Ministry of Education, Aim for the Top University
   Plan
FX This study was supported by the Ministry of Science and Technology of
   Taiwan (NSC 101-2314-B-075-037-MY2, 101-2314-B-075A-013,
   102-2321-B-010-030), Taipei Veterans General Hospital (V103E9-006,
   V103E3-005, V103C-083), Ministry of Science and Technology support for
   the Centre for Dynamical Biomarkers and Translational Medicine, National
   Central University, Taiwan (NSC 102-2911-I-008-001), Brain Research
   Center, National Yang-Ming University and a grant from Ministry of
   Education, Aim for the Top University Plan. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR American Psychiatric Association, 1994, DIAGNOSTIC STAT MANU
   Ayalon L, 2012, INT PSYCHOGERIATR, V24, P1798, DOI 10.1017/S1041610212000877
   Bambauer Kara Zivin, 2007, Am J Hosp Palliat Care, V24, P185
   Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295
   Borum ML, 2000, J AM GERIATR SOC, V48, pS194, DOI 10.1111/j.1532-5415.2000.tb03132.x
   Di Giulio P, 2008, J PALLIAT MED, V11, P1023, DOI 10.1089/jpm.2008.0020
   Fagerlin A, 2001, HEALTH PSYCHOL, V20, P166, DOI 10.1037/0278-6133.20.3.166
   FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Fuh JL, 2001, INT PSYCHOGERIATR, V13, P121, DOI 10.1017/S1041610201007517
   Jennings B, 2003, HASTINGS CENT REP, V33, pS24
   KATZ S, 1983, NEW ENGL J MED, V309, P1218, DOI 10.1056/NEJM198311173092005
   Kim SYH, 2002, AM J GERIAT PSYCHIAT, V10, P151, DOI 10.1176/appi.ajgp.10.2.151
   Ko KT, 2008, AM J GERIAT PSYCHIAT, V16, P513, DOI 10.1097/JGP.0b013e318167ae5b
   Kwok T, 2007, J ADV NURS, V58, P256, DOI 10.1111/j.1365-2648.2007.04230.x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Luchins DJ, 1997, J AM GERIATR SOC, V45, P1054, DOI 10.1111/j.1532-5415.1997.tb05966.x
   MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
   Meuser TM, 2001, GERONTOLOGIST, V41, P658, DOI 10.1093/geront/41.5.658
   Mitchell SL, 2007, J AM GERIATR SOC, V55, P432, DOI 10.1111/j.1532-5412.2007.01086.x
   Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234
   MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a
   Neale R, 2001, INT J EPIDEMIOL, V30, P1383, DOI 10.1093/ije/30.6.1383
   Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Reamy AM, 2013, GERONTOLOGIST, V53, P293, DOI 10.1093/geront/gns078
   Rurup ML, 2006, PATIENT EDUC COUNS, V61, P372, DOI 10.1016/j.pec.2005.04.016
   Sanders S, 2009, DEMENTIA, V8, P117
   Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493
   Siminoff LA, 2006, PSYCHO-ONCOLOGY, V15, P528, DOI 10.1002/989
   Speice J, 2000, PSYCHO-ONCOL, V9, P101, DOI 10.1002/(SICI)1099-1611(200003/04)9:2<101::AID-PON435>3.0.CO;2-D
   Tang ST, 2005, J PAIN SYMPTOM MANAG, V30, P510, DOI 10.1016/j.jpainsymman.2005.05.019
   Winter L, 2007, SOC SCI MED, V65, P1695, DOI 10.1016/j.socscimed.2007.06.012
   Wu YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066252
NR 34
TC 8
Z9 8
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 31
PY 2015
VL 10
IS 7
AR e0133711
DI 10.1371/journal.pone.0133711
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO0JY
UT WOS:000358838400052
PM 26230958
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Yoo, SW
   Guevara, P
   Jeong, Y
   Yoo, K
   Shin, JS
   Mangin, JF
   Seong, JK
AF Yoo, Sang Wook
   Guevara, Pamela
   Jeong, Yong
   Yoo, Kwangsun
   Shin, Joseph S.
   Mangin, Jean-Francois
   Seong, Joon-Kyung
TI An Example-Based Multi-Atlas Approach to Automatic Labeling of White
   Matter Tracts
SO PLOS ONE
LA English
DT Article
ID MASSIVE TRACTOGRAPHY DATASETS; FIBER TRACTS; UNIFIED FRAMEWORK;
   DIFFUSION MRI; HUMAN BRAIN; SEGMENTATION; TRACKING; ANATOMY; SCLEROSIS;
   INFANTS
AB We present an example-based multi-atlas approach for classifying white matter (WM) tracts into anatomic bundles. Our approach exploits expert-provided example data to automatically classify the WM tracts of a subject. Multiple atlases are constructed to model the example data from multiple subjects in order to reflect the individual variability of bundle shapes and trajectories over subjects. For each example subject, an atlas is maintained to allow the example data of a subject to be added or deleted flexibly. A voting scheme is proposed to facilitate the multi-atlas exploitation of example data. For conceptual simplicity, we adopt the same metrics in both example data construction and WM tract labeling. Due to the huge number of WM tracts in a subject, it is time-consuming to label each WM tract individually. Thus, the WM tracts are grouped according to their shape similarity, and WM tracts within each group are labeled simultaneously. To further enhance the computational efficiency, we implemented our approach on the graphics processing unit (GPU). Through nested cross-validation we demonstrated that our approach yielded high classification performance. The average sensitivities for bundles in the left and right hemispheres were 89.5% and 91.0%, respectively, and their average false discovery rates were 14.9% and 14.2%, respectively.
C1 [Yoo, Sang Wook; Seong, Joon-Kyung] Korea Univ, Dept Biomed Engn, Seoul, South Korea.
   [Yoo, Sang Wook; Shin, Joseph S.] Korea Adv Inst Sci & Technol, Dept Comp Sci, Taejon 305701, South Korea.
   [Guevara, Pamela] CEA, I2BM, Gif Sur Yvette, France.
   [Guevara, Pamela; Mangin, Jean-Francois] Inst Federat Rech 49, Gif Sur Yvette, France.
   [Guevara, Pamela; Mangin, Jean-Francois] Univ Concepcion, Concepcion, Chile.
   [Jeong, Yong; Yoo, Kwangsun] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea.
   [Shin, Joseph S.] Handong Global Univ, Pohang, South Korea.
RP Seong, JK (reprint author), Korea Univ, Dept Biomed Engn, Seoul, South Korea.
EM jkseong@korea.ac.kr
RI Shin, Sung Yong/C-1955-2011; Yoo, Kwangsun/F-1408-2014; Guevara,
   Pamela/B-2300-2019; Jeong, Yong/C-1677-2011
OI Yoo, Kwangsun/0000-0002-5213-4575; Guevara, Pamela/0000-0001-9988-400X;
   Jeong, Yong/0000-0002-5907-3787
FU National Research Foundation of Korea (NRF) [NRF-2012R1A1B3004157];
   Korea 565 Health Technology R&D Project through the Korea Health
   Industry Development 566 Institute (KHIDI) - Ministry of Health &
   Welfare, Republic of Korea 567 [HI14C2768]; Institute for Information &
   communications Technology Promotion(IITP) grant - Korea government
   (MSIP) [B0101-15-247]
FX This work was partially supported by the National Research Foundation of
   Korea (NRF) (No. NRF-2012R1A1B3004157), a grant of the Korea 565 Health
   Technology R&D Project through the Korea Health Industry Development 566
   Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic
   of Korea 567 (grant number: HI14C2768), and by Institute for Information
   & communications Technology Promotion(IITP) grant funded by the Korea
   government (MSIP) (No. B0101-15-247). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O
   Bazin PL, 2011, NEUROIMAGE, V58, P458, DOI 10.1016/j.neuroimage.2011.06.020
   Berman JI, 2005, NEUROIMAGE, V27, P862, DOI 10.1016/j.neuroimage.2005.05.018
   Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136
   Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004
   Ceritoglu C, 2009, NEUROIMAGE, V47, P618, DOI 10.1016/j.neuroimage.2009.04.057
   Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7
   Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422
   Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277
   Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424
   Dodero L, 2015, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00087
   Duda R., 2001, PATTERN CLASSIFICATI
   Fowlkes C, 2004, IEEE T PATTERN ANAL, V26, P214, DOI 10.1109/TPAMI.2004.1262185
   Garyfallidis E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00175
   Glenn OA, 2003, J MAGN RESON IMAGING, V18, P641, DOI 10.1002/jmri.10420
   Goh A, 2009, LECT NOTES COMPUT SC, V5761, P877
   Goldberg-Zimring D, 2005, J NEUROIMAGING, V15, p68S, DOI 10.1177/1051228405283363
   Goodlett CB, 2009, NEUROIMAGE, V45, pS133, DOI 10.1016/j.neuroimage.2008.10.060
   Guevara P, 2012, NEUROIMAGE, V61, P1083, DOI 10.1016/j.neuroimage.2012.02.071
   Guevara P, 2011, NEUROIMAGE, V54, P1975, DOI 10.1016/j.neuroimage.2010.10.028
   Guevara P, 2009, MICCAI 2009 WORKSH D
   Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053
   Jin Y, 2014, NEUROIMAGE, V100, P75, DOI 10.1016/j.neuroimage.2014.04.048
   JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588
   Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052
   Kubicki M, 2007, J PSYCHIAT RES, V41, P15, DOI 10.1016/j.jspychires.2005.05.005
   KULLBACK S, 1952, ANN MATH STAT, V23, P88, DOI 10.1214/aoms/1177729487
   KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694
   Labra N, 2014, IEEE ENG MED BIO, P2376, DOI 10.1109/EMBC.2014.6944099
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Li H, 2010, NEUROIMAGE, V49, P1249, DOI 10.1016/j.neuroimage.2009.08.017
   MacQueen J., 1967, P 5 BERK S MATH STAT, V1, P281, DOI DOI 10.1234/12345678
   Maddah M, 2008, MED IMAGE ANAL, V12, P191, DOI 10.1016/j.media.2007.10.003
   Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3
   Nvidia C, 2012, NVIDIA CUDA C PROGR
   O'Donnell LJ, 2007, IEEE T MED IMAGING, V26, P1562, DOI 10.1109/TMI.2007.906785
   O'Donnell LJ, 2012, NEUROIMAGE, V60, P456, DOI 10.1016/j.neuroimage.2011.11.014
   O'Donnell LJ, 2006, AM J NEURORADIOL, V27, P1032
   Pagani E, 2005, NEUROIMAGE, V26, P258, DOI 10.1016/j.neuroimage.2005.01.008
   Perrin M, 2005, LECT NOTES COMPUT SC, V3565, P52
   Perrin M., 2008, INT J BIOMED IMAGING, V2008, DOI [DOI 10.1155/2008/368406, 10.1155/2008/368406]
   Poupon C., 2006, P 12 ANN M ORG HUM B
   Reese TG, 2003, MAGNET RESON MED, V49, P177, DOI 10.1002/mrm.10308
   Santos-Pereira CM, 2002, P COMP STAT PHYS VER, P291
   Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175
   Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688
   Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051
   Tunc B, 2014, NEUROIMAGE, V102, P596, DOI 10.1016/j.neuroimage.2014.08.021
   Visser E, 2011, NEUROIMAGE, V54, P303, DOI 10.1016/j.neuroimage.2010.07.038
   Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640
   Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049
   Wang Q, 2013, HUM BRAIN MAPP, V34, P2089, DOI 10.1002/hbm.22051
   Wang XG, 2011, NEUROIMAGE, V54, P290, DOI 10.1016/j.neuroimage.2010.07.050
   Wassermann D, 2010, NEUROIMAGE, V51, P228, DOI 10.1016/j.neuroimage.2010.01.004
   Wu X, 2012, MAGN RESON IMAGING, V30, P485, DOI 10.1016/j.mri.2011.12.017
   Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023
   Zhang YJ, 2010, NEUROIMAGE, V52, P1289, DOI 10.1016/j.neuroimage.2010.05.049
NR 57
TC 12
Z9 12
U1 1
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 30
PY 2015
VL 10
IS 7
AR e0133337
DI 10.1371/journal.pone.0133337
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO0JT
UT WOS:000358837700018
PM 26225419
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Yang, L
   Xu, L
   Schoepf, UJ
   Wichmann, JL
   Fox, MA
   Yan, J
   Fan, ZM
   Zhang, ZQ
AF Yang, Lin
   Xu, Lei
   Schoepf, U. Joseph
   Wichmann, Julian L.
   Fox, Mary A.
   Yan, Jing
   Fan, Zhanming
   Zhang, Zhaoqi
TI Prospectively ECG-Triggered Sequential Dual-Source Coronary CT
   Angiography in Patients with Atrial Fibrillation: Influence of Heart
   Rate on Image Quality and Evaluation of Diagnostic Accuracy
SO PLOS ONE
LA English
DT Article
ID COMPUTED-TOMOGRAPHY ANGIOGRAPHY; ARTERY-DISEASE; RADIATION-EXPOSURE;
   GATED 16-MDCT; MOTION
AB Objectives
   To evaluate the effects of mean heart rate (HR) and heart rate variation (HRV) on image quality and diagnostic accuracy of prospectively ECG-triggered sequential dual-source coronary CT angiography (CCTA) in patients with atrial fibrillation (AF).
   Methods
   Eighty-five patients (49 women, 36 men; mean age 62.1 +/- 9.5 years) with persistent AF underwent prospectively ECG-triggered sequential second-generation dual-source CCTA. Tube current and voltage were adjusted according to body mass index (BMI) and iterative reconstruction was used. Image quality of coronary segments (four-point scale) and presence of significant stenosis (>50%) were evaluated. Diagnostic accuracy was analyzed in 30 of the 85 patients who underwent additional invasive coronary angiography (ICA).
   Results
   Only 8 of 1102 (0.7%) segments demonstrated poor image quality. No significant impact on image quality was found for mean HR (94.9 +/- 21.8 bpm; r = 0.034, p = 0.758; F = 0.413, p = 0.663) or HRV (67.5 +/- 22.8 bpm; r = 0.097, p = 0.377; F = 0.111, p = 0.895). On per-segment analysis, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 89.7% (26/29), 99.4% (355/357), 92.9% (26/28), and 99.2% (355/358), respectively, with excellent correlation (kappa = 0.91) with ICA. Mean effective dose was 3.3 +/- 1.0 mSv.
   Conclusions
   Prospectively ECG-triggered sequential dual-source CCTA provides diagnostic image quality and good diagnostic accuracy for detection of coronary stenosis in AF patients without significant influence by HR or HRV.
C1 [Yang, Lin; Xu, Lei; Fan, Zhanming; Zhang, Zhaoqi] Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China.
   [Schoepf, U. Joseph; Wichmann, Julian L.; Fox, Mary A.] Med Univ S Carolina, Dept Radiol & Radiol Sci, Charleston, SC 29425 USA.
   [Yan, Jing] Siemens Healthcare China, Shanghai, Peoples R China.
RP Xu, L (reprint author), Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China.
EM leixu2001@hotmail.com
FU Excellent Talents from Beijing City [2011D003034000030]; High Levels of
   Health Technical Personnel in Beijing City Health System [2013-3-011]
FX This work has been supported by a grant for Excellent Talents from
   Beijing City (2011D003034000030), and grant for High Levels of Health
   Technical Personnel in Beijing City Health System (2013-3-011). Jing
   Yan, is employed by a commercial company: Siemens Healthcare China. This
   funder only provided support in the form of salaries for author Jing
   Yan, but did not have any additional role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Chatap G, 2002, DRUG AGING, V19, P819, DOI 10.2165/00002512-200219110-00002
   Fuster V, 2007, CIRCULATION, V116, P1966, DOI [10.1161/CIRCULATIONAHA.107.733444, 10.1161/CIRCULATIONAHA.106.177292]
   Halliburton SS, 2011, J CARDIOVASC COMPUT, V5, P198, DOI 10.1016/j.jcct.2011.06.001
   Hausleiter J, 2012, JACC-CARDIOVASC IMAG, V5, P484, DOI 10.1016/j.jcmg.2011.12.017
   Heuschmid M, 2005, AM J ROENTGENOL, V184, P1413, DOI 10.2214/ajr.184.5.01841413
   Hoffmann MHK, 2005, RADIOLOGY, V234, P86, DOI 10.1148/radiol.2341031408
   Johnson TRC, 2007, INVEST RADIOL, V42, P684, DOI 10.1097/RLI.0b013e31806907d0
   Klass O, 2009, EUR RADIOL, V19, P829, DOI 10.1007/s00330-008-1222-4
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leber AW, 2005, J AM COLL CARDIOL, V46, P147, DOI 10.1016/j.jacc.2005.03.071
   Lee AM, 2012, J CARDIOVASC COMPUT, V6, P172, DOI 10.1016/j.jcct.2012.04.003
   Leschka S, 2009, EUR RADIOL, V19, P2896, DOI 10.1007/s00330-009-1618-9
   Lu B, 2001, INVEST RADIOL, V36, P250, DOI 10.1097/00004424-200105000-00002
   Mao SS, 2000, J COMPUT ASSIST TOMO, V24, P253, DOI 10.1097/00004728-200003000-00012
   Martuscelli E, 2004, EUR HEART J, V25, P1043, DOI 10.1016/j.ehj.2004.03.024
   Mayurasakorn Sureeporn, 2008, Journal of the Medical Association of Thailand, V91, P1076
   Nieman K, 2002, HEART, V88, P470, DOI 10.1136/heart.88.5.470
   Oncel D, 2007, RADIOLOGY, V245, P703, DOI 10.1148/radiol.2453070094
   Pugliese F, 2006, EUR RADIOL, V16, P575, DOI 10.1007/s00330-005-0041-0
   Raff Gilbert L, 2009, J Cardiovasc Comput Tomogr, V3, P122, DOI 10.1016/j.jcct.2009.01.001
   Rist C, 2009, INVEST RADIOL, V44, P159, DOI 10.1097/RLI.0b013e3181948b05
   Schlattmann P, 2011, EUR RADIOL, V21, P1904, DOI 10.1007/s00330-011-2142-2
   Schoenhagen P, 2004, RADIOLOGY, V232, P7, DOI 10.1148/radiol.2321021803
   Schoepf UJ, 2004, RADIOLOGY, V232, P18, DOI 10.1148/radiol.2321030636
   Shim SS, 2005, AM J ROENTGENOL, V184, P649, DOI 10.2214/ajr.184.2.01840649
   Shuman WP, 2008, RADIOLOGY, V248, P431, DOI 10.1148/radiol.2482072192
   Srichai MB, 2013, J CARDIOVASC COMPUT, V7, P102, DOI 10.1016/j.jcct.2013.02.002
   Stolzmann P, 2008, RADIOLOGY, V249, P71, DOI 10.1148/radiol.2483072032
   Sun ZH, 2006, EUR J RADIOL, V60, P279, DOI 10.1016/j.ejrad.2006.06.009
   Uehara M, 2011, INT J CARDIOL, V150, P65, DOI 10.1016/j.ijcard.2010.02.032
   Vanhoenacker PK, 2007, RADIOLOGY, V244, P419, DOI 10.1148/radiol.2442061218
   Vembar M, 2003, MED PHYS, V30, P1683, DOI 10.1118/1.1582812
   Vorre MM, 2013, RADIOLOGY, V267, P376, DOI 10.1148/radiol.13121224
   Wang YN, 2008, EUR J RADIOL, V68, P434, DOI 10.1016/j.ejrad.2008.09.011
   Weustink AC, 2008, RADIOLOGY, V248, P792, DOI 10.1148/radiol.2483072098
   Xu L, 2013, EUR RADIOL, V23, P1822, DOI 10.1007/s00330-013-2793-2
   Xu L, 2010, INT J CARDIOVAS IMAG, V26, P17, DOI 10.1007/s10554-009-9576-5
   Yang L, 2009, AM J ROENTGENOL, V193, P795, DOI 10.2214/AJR.08.2012
NR 38
TC 6
Z9 6
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 29
PY 2015
VL 10
IS 7
AR e0134194
DI 10.1371/journal.pone.0134194
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO0JM
UT WOS:000358836800112
PM 26221952
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Robles-Rubio, CA
   Bertolizio, G
   Brown, KA
   Kearney, RE
AF Robles-Rubio, Carlos Alejandro
   Bertolizio, Gianluca
   Brown, Karen A.
   Kearney, Robert E.
TI Scoring Tools for the Analysis of Infant Respiratory Inductive
   Plethysmography Signals
SO PLOS ONE
LA English
DT Article
ID QUALITATIVE DIAGNOSTIC CALIBRATION; FORMER PRETERM INFANTS;
   POSTOPERATIVE APNEA; GENERAL-ANESTHESIA; PREMATURE-INFANTS; SLEEP;
   OBSTRUCTION; AGREEMENT; EVENTS; RISK
AB Infants recovering from anesthesia are at risk of life threatening Postoperative Apnea (POA). POA events are rare, and so the study of POA requires the analysis of long cardiorespiratory records. Manual scoring is the preferred method of analysis for these data, but it is limited by low intra-and inter-scorer repeatability. Furthermore, recommended scoring rules do not provide a comprehensive description of the respiratory patterns. This work describes a set of manual scoring tools that address these limitations. These tools include: (i) a set of definitions and scoring rules for 6 mutually exclusive, unique patterns that fully characterize infant respiratory inductive plethysmography (RIP) signals; (ii) RIPScore, a graphical, manual scoring software to apply these rules to infant data; (iii) a library of data segments representing each of the 6 patterns; (iv) a fully automated, interactive formal training protocol to standardize the analysis and establish intra-and inter-scorer repeatability; and (v) a quality control method to monitor scorer ongoing performance over time. To evaluate these tools, three scorers from varied backgrounds were recruited and trained to reach a performance level similar to that of an expert. These scorers used RIPScore to analyze data from infants at risk of POA in two separate, independent instances. Scorers performed with high accuracy and consistency, analyzed data efficiently, had very good intra-and inter-scorer repeatability, and exhibited only minor confusion between patterns. These results indicate that our tools represent an excellent method for the analysis of respiratory patterns in long data records. Although the tools were developed for the study of POA, their use extends to any study of respiratory patterns using RIP (e.g., sleep apnea, extubation readiness). Moreover, by establishing and monitoring scorer repeatability, our tools enable the analysis of large data sets by multiple scorers, which is essential for longitudinal and multicenter studies.
C1 [Robles-Rubio, Carlos Alejandro; Kearney, Robert E.] McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada.
   [Bertolizio, Gianluca; Brown, Karen A.] McGill Univ, Ctr Hlth, Dept Anesthesia, Montreal, PQ, Canada.
RP Robles-Rubio, CA (reprint author), McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada.
EM carlos.roblesrubio@mail.mcgill.ca
FU Natural Sciences and Engineering Research Council of Canada [NSERC RGPIN
   1051-13]; Queen Elizabeth Hospital of Montreal Foundation Chair in
   Pediatric Anesthesia, McGill University Faculty of Medicine; Mexican
   National Council for Science and Technology
FX This work was supported in part by the Natural Sciences and Engineering
   Research Council of Canada (www.nserc-crsng.gc.ca, grant NSERC RGPIN
   1051-13), and in part by the Queen Elizabeth Hospital of Montreal
   Foundation Chair in Pediatric Anesthesia, McGill University Faculty of
   Medicine (www.mcgill.ca/medicine/faculty-medicine). CARR was supported
   in part by a scholarship for graduate studies from the Mexican National
   Council for Science and Technology (www.conacyt.gob.mx). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR ALLEN JL, 1991, PEDIATR PULM, V11, P37, DOI 10.1002/ppul.1950110107
   ALLEN JL, 1990, AM REV RESPIR DIS, V141, P337, DOI 10.1164/ajrccm/141.2.337
   American Academy of Sleep M, 2001, INT CLASS SLEEP DIS
   Aoude A, 2006, BIOMEDICAL ENG
   Aoude A A, 2006, Conf Proc IEEE Eng Med Biol Soc, V1, P4631
   Aoude AA, 2011, IEEE T BIO-MED ENG, V58, P1724, DOI 10.1109/TBME.2011.2112657
   Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172
   Bonnet MH, 2007, J CLIN SLEEP MED, V3, P133
   BROUILLETTE RT, 1987, J PEDIATR-US, V111, P377, DOI 10.1016/S0022-3476(87)80457-2
   Brown K, 1998, EUR RESPIR J, V12, P935, DOI 10.1183/09031936.98.12040935
   Brown KA, 2008, CAN J ANAESTH, V55, P739, DOI 10.1007/BF03016346
   Caples SM, 2007, J CLIN SLEEP MED, V3, P147
   Cardillo G, 2007, FLEISSES KAPPA COMPU
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Collop NA, 2002, SLEEP MED, V3, P43, DOI 10.1016/S1389-9457(01)00115-0
   COTE CJ, 1995, ANESTHESIOLOGY, V82, P809, DOI 10.1097/00000542-199504000-00002
   COTE CJ, 1990, ANESTHESIOLOGY, V72, P559, DOI 10.1097/00000542-199003000-00027
   DallAva-Santucci J., 1991, PULMONARY FUNCTION M, P121
   Davidson AJ, 2015, ANESTHESIOLOGY
   De Groote A, 2001, J APPL PHYSIOL, V90, P1025
   Efron B, 1993, INTRO BOOTSTRAP
   FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619
   Flemons WW, 2004, AM J RESP CRIT CARE, V169, P668, DOI 10.1164/rccm.200308-1124PP
   Grigg-Damberger M, 2007, J CLIN SLEEP MED, V3, P201
   Hrynaszkiewicz I, 2010, BMJ, V340
   Iber C, 2007, J CLIN SLEEP MED, V3, P107
   KONNO K, 1967, J APPL PHYSIOL, V22, P407
   KRANE EJ, 1995, ANESTH ANALG, V80, P7, DOI 10.1097/00000539-199501000-00003
   KURTH CD, 1987, ANESTHESIOLOGY, V66, P483, DOI 10.1097/00000542-198704000-00006
   KURTH CD, 1991, ANESTHESIOLOGY, V75, P22, DOI 10.1097/00000542-199107000-00005
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Penzel T, 2007, J CLIN SLEEP MED, V3, P109
   Precup D, 2012, IEEE ENG MED BIO, P5630, DOI 10.1109/EMBC.2012.6347271
   Ramanathan R, 2001, JAMA-J AM MED ASSOC, V285, P2199, DOI 10.1001/jama.285.17.2199
   Redline S, 2007, J CLIN SLEEP MED, V3, P169
   Robles-Rubio CA, 2015, PEDIATR PULM, V50, P479, DOI 10.1002/ppul.23151
   Robles-Rubio CA, 2011, 12 INT S SLEEP BREAT
   Robles-Rubio CA, 2013, 13 INT S SLEEP BREAT
   Robles-Rubio CA, 2013, IEEE ENG MED BIO, P2295, DOI 10.1109/EMBC.2013.6609996
   Robles-Rubio CA, 2012, IEEE ENG MED BIO, P6333, DOI 10.1109/EMBC.2012.6347442
   Robles-Rubio CA, 2011, IEEE ENG MED BIO, P3201, DOI 10.1109/IEMBS.2011.6090871
   Semienchuk SM, 2005, P ANN INT IEEE EMBS, P4420, DOI 10.1109/IEMBS.2005.1615446
   SILBER MH, 2007, J CLIN SLEEP MED, V3, P22
   STEWARD DJ, 1982, ANESTHESIOLOGY, V56, P304, DOI 10.1097/00000542-198204000-00013
   Walters AS, 2007, J CLIN SLEEP MED, V3, P155
   WELBORN LG, 1990, ANESTHESIOLOGY, V72, P838, DOI 10.1097/00000542-199005000-00012
   WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.2307/3001968
NR 47
TC 3
Z9 4
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 28
PY 2015
VL 10
IS 7
AR e0134182
DI 10.1371/journal.pone.0134182
PG 31
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN7ED
UT WOS:000358595900092
PM 26218351
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zhang, TW
   Zhang, L
   Fan, SQ
   Zhang, MZ
   Fu, HH
   Liu, YJ
   Yin, XL
   Chen, H
   Xie, L
   Zhang, JC
   Gavine, PR
   Gu, Y
   Ni, XZ
   Su, XY
AF Zhang, Tianwei
   Zhang, Lin
   Fan, Shuqiong
   Zhang, Meizhuo
   Fu, Haihua
   Liu, Yuanjie
   Yin, Xiaolu
   Chen, Hao
   Xie, Liang
   Zhang, Jingchuan
   Gavine, Paul R.
   Gu, Yi
   Ni, Xingzhi
   Su, Xinying
TI Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully
   Represent Human Tumor Molecular Diversity
SO PLOS ONE
LA English
DT Article
ID CELL LUNG-CANCER; POTENTIAL THERAPEUTIC TARGET; FGFR2 GENE
   AMPLIFICATION; GROWTH-FACTOR RECEPTORS; C-MET INHIBITOR;
   COLORECTAL-CANCER; JUNCTION ADENOCARCINOMA; PROGNOSTIC-SIGNIFICANCE;
   ESTABLISHMENT; EXPRESSION
AB Patient-derived cancer xenografts (PDCX) generally represent more reliable models of human disease in which to evaluate a potential drugs preclinical efficacy. However to date, only a few patient-derived gastric cancer xenograft (PDGCX) models have been reported. In this study, we aimed to establish additional PDGCX models and to evaluate whether these models accurately reflected the histological and genetic diversities of the corresponding patient tumors. By engrafting fresh patient gastric cancer (GC) tissues into immune-compromised mice (SCID and/or nude mice), thirty two PDGCX models were established. Histological features were assessed by a qualified pathologist based on H&E staining. Genomic comparison was performed for several biomarkers including ERBB1, ERBB2, ERBB3, FGFR2, MET and PTEN. These biomarkers were profiled to assess gene copy number by fluorescent in situ hybridization (FISH) and/or protein expression by immunohistochemistry (IHC). All 32 PDGCX models retained the histological features of the corresponding human tumors. Furthermore, among the 32 models, 78% (25/32) highly expressed ERBB1 (EGFR), 22% (7/32) were ERBB2 (HER2) positive, 78% (25/32) showed ERBB3 (HER3) high expression, 66% (21/32) lost PTEN expression, 3% (1/32) harbored FGFR2 amplification, 41% (13/32) were positive for MET expression and 16% (5/32) were MET gene amplified. Between the PDGCX models and their parental tumors, a high degree of similarity was observed for FGFR2 and MET gene amplification, and also for ERBB2 status (agreement rate = 94 similar to 100%; kappa value = 0.81 similar to 1). Protein expression of PTEN and MET also showed moderate agreement (agreement rate = 78%; kappa value = 0.46 similar to 0.56), while ERBB1 and ERBB3 expression showed slight agreement (agreement rate = 59 similar to 75%; kappa value = 0.18 similar to 0.19). ERBB2 positivity, FGFR2 or MET gene amplification was all maintained until passage 12 in mice. The stability of the molecular profiles observed across subsequent passages within the individual models provides confidence in the utility and translational significance of these models for in vivo testing of personalized therapies.
C1 [Zhang, Tianwei; Zhang, Lin; Fan, Shuqiong; Fu, Haihua; Liu, Yuanjie; Yin, Xiaolu; Xie, Liang; Zhang, Jingchuan; Gavine, Paul R.; Gu, Yi; Su, Xinying] AstraZeneca R&D, Asia & Emerging Markets iMed, Shanghai, Peoples R China.
   [Zhang, Meizhuo] AstraZeneca R&D, Res & Dev Informat, Shanghai, Peoples R China.
   [Chen, Hao; Ni, Xingzhi] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai 200030, Peoples R China.
RP Ni, XZ (reprint author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai 200030, Peoples R China.
EM georgeniwjc@163.com; Xinying.Su@astrazeneca.com
FU AstraZeneca
FX This study is fully funded by AstraZeneca. To clarify, AstraZeneca
   authors were fully involved in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Asaoka Y, 2011, EXPERT OPIN INV DRUG, V20, P595, DOI 10.1517/13543784.2011.566863
   Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X
   Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313
   Burgenske DM, 2014, AM J CANCER RES, V4, P824
   Carneiro F, 2000, CANCER, V88, P238, DOI 10.1002/(SICI)1097-0142(20000101)88:1<238::AID-CNCR31>3.0.CO;2-F
   Chen H, 2015, PATHOL ONCO IN PRESS
   Cho EY, 2013, MODERN PATHOL, V26, P677, DOI 10.1038/modpathol.2012.205
   Cho YB, 2014, J SURG RES, V187, P502, DOI 10.1016/j.jss.2013.11.010
   Chong ML, 2014, INT J CANCER, V134, P1232, DOI 10.1002/ijc.28444
   Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210
   de Mello RA, 2013, WORLD J GASTROENTERO, V19, P6165, DOI 10.3748/wjg.v19.i37.6165
   Ferlay J, 2015, INT J CANCER, pE359, DOI [10.1002/ijc.29210, DOI 10.1002/IJC.29210]
   Fichtner I, 2008, CLIN CANCER RES, V14, P6456, DOI 10.1158/1078-0432.CCR-08-0138
   Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5
   Gavine PR, 2015, MOL ONCOL, V9, P323, DOI 10.1016/j.molonc.2014.08.015
   Ha SY, 2013, MODERN PATHOL, V26, P1632, DOI 10.1038/modpathol.2013.108
   Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064
   Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x
   Hong L, 2013, EXPERT REV GASTROENT, V7, P759, DOI 10.1586/17474124.2013.837804
   Ilie M, 2014, CANC MED IN PRESS
   Iveson T, 2014, LANCET ONCOL, V15, P1007, DOI 10.1016/S1470-2045(14)70023-3
   Janjigian YY, 2011, CANCER EPIDEM BIOMAR, V20, P1021, DOI 10.1158/1055-9965.EPI-10-1080
   Jin KT, 2012, ONCOL LETT, V3, P1052, DOI 10.3892/ol.2012.603
   Jin KT, 2011, HEPATO-GASTROENTEROL, V58, P1814, DOI 10.5754/hge11136
   Jin KT, 2010, CLIN TRANSL ONCOL, V12, P473, DOI 10.1007/s12094-010-0540-6
   Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372
   Kang YK, 2014, INVEST NEW DRUG, V32, P355, DOI 10.1007/s10637-013-0057-2
   Kawakami H, 2013, ONCOTARGET, V4, P9, DOI 10.18632/oncotarget.718
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee HE, 2012, BRIT J CANCER, V107, P325, DOI 10.1038/bjc.2012.237
   Lee HE, 2013, EUR J CANCER, V49, P1448, DOI 10.1016/j.ejca.2012.10.018
   Li J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-241
   Lin D, 2014, ASIAN J ANDROL, V16, P407, DOI 10.4103/1008-682X.125394
   Lin D, 2014, CANCER RES, V74, P1272, DOI 10.1158/0008-5472.CAN-13-2921-T
   Liu YJ, 2014, BRIT J CANCER, V110, P1169, DOI 10.1038/bjc.2014.61
   Lu J, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0398-z
   Matsumoto K, 2012, BRIT J CANCER, V106, P727, DOI 10.1038/bjc.2011.603
   Mattie Mike, 2013, Neoplasia, V15, P1138
   Milne ANA, 2007, HUM PATHOL, V38, P903, DOI 10.1016/j.humpath.2006.12.010
   Okamoto W, 2012, MOL CANCER THER, V11, P1557, DOI 10.1158/1535-7163.MCT-11-0934
   Power DG, 2010, CANCER TREAT REV, V36, P384, DOI 10.1016/j.ctrv.2010.01.005
   Salgia R, 2014, CLIN CANCER RES, V20, P1666, DOI 10.1158/1078-0432.CCR-13-2070
   Scott CL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00295
   Stahl P, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0231-4
   Su X, 2014, BRIT J CANCER, V110, P967, DOI 10.1038/bjc.2013.802
   Tajiri R, 2014, HUM PATHOL, V45, P725, DOI 10.1016/j.humpath.2013.11.004
   Teng LS, 2013, INT J MOL MED, V32, P1247, DOI 10.3892/ijmm.2013.1531
   Terashima M, 2012, CLIN CANCER RES, V18, P5992, DOI 10.1158/1078-0432.CCR-12-1318
   Tran TN, 2013, J SURG ONCOL, V108, P113, DOI 10.1002/jso.23357
   Wu XH, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-180
   Xie L, 2013, CLIN CANCER RES, V19, P2572, DOI 10.1158/1078-0432.CCR-12-3898
   Yang JY, 2012, CELL BIOCHEM BIOPHYS, V62, P221, DOI 10.1007/s12013-011-9286-1
   Zhang HY, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3640
   Zhang JC, 2014, LAB INVEST, V94, P917, DOI 10.1038/labinvest.2014.77
   Zhang JC, 2012, CLIN CANCER RES, V18, P6658, DOI 10.1158/1078-0432.CCR-12-2694
   Zhang XC, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-168
   Zhu M, 2015, BRIT J CANCER, V112, P429, DOI 10.1038/bjc.2014.649
   Zhu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08542
   2014, CANC DISCOV, V4, P77970
NR 59
TC 14
Z9 15
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 28
PY 2015
VL 10
IS 7
AR e0134493
DI 10.1371/journal.pone.0134493
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN7ED
UT WOS:000358595900121
PM 26217940
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wang, R
   Ma, JQ
   Niu, G
   Zheng, J
   Liu, Z
   Du, YH
   Yu, BL
   Yang, J
AF Wang, Rong
   Ma, Jiaqi
   Niu, Gang
   Zheng, Jie
   Liu, Zhe
   Du, Yonghao
   Yu, Bolang
   Yang, Jian
TI Differentiation between Solitary Cerebral Metastasis and Astrocytoma on
   the Basis of Subventricular Zone Involvement on Magnetic Resonance
   Imaging
SO PLOS ONE
LA English
DT Article
ID NERVOUS-SYSTEM TUMORS; HIGH-GRADE GLIOMA; GLIOBLASTOMA-MULTIFORME;
   BRAIN-TUMORS; STEM-CELLS; VOLUMETRIC ASSESSMENT; SUBEPENDYMAL PLATE;
   ANGIOGENESIS; SURVIVAL; MRI
AB Purpose
   To determine the relationship between the subventricular zone (SVZ) and astrocytoma based on magnetic resonance imaging (MRI) and whether SVZ involvement can be used to distinguish solitary cerebral metastases (SCMs) from astrocytomas.
   Methods
   This retrospective study involved 154 patients with solitary low-grade astrocytoma (LGA), high-grade astrocytoma (HGA), and SCM, who underwent T1-weighted imaging (T1WI), Gd-DTPA-enhanced T1WI, and T2-weighted imaging (T2WI) or fluid-attenuated inversion recovery (FLAIR) T2WI. The spatial relationship between the tumor and SVZ was classified as "involvement" or "segregation" on contrast-enhanced T1WI for enhanced tumors and T2WI/FLAIR T2WI for non-enhanced tumors. Patient-based SVZ-contact rates were compared between the LGA, HGA, and SCM groups. The frequencies of involvement of various lateral ventricle regions by astrocytoma were compared. The correlation between SVZ involvement and tumor necrosis was analyzed.
   Results
   Patient-based SVZ-contact rates in SCM, LGA, and HGA were 24.1%, 68.8%, and 85.4%, respectively. Univariate analysis showed that the SVZ-contact rate was significantly different between SCM and astrocytoma (24.1% vs. 75.2% P < 0.001), also between LGA and HGA (68.1% vs. 85.4% P=0.037). After the tumor volume was adjusted as a covariate, SVZ-contact rates still differed between SCMs and astrocytomas (Odds ratio [OR]: 4.58, 95% Confidence interval [CI]: 1.65 to 12.8, P=0.004). Tumor volume differed between LGA and HGA (P < 0.001), and influenced the association between SVZ involvement and astrocytoma grade (P = 0.05). Among the lateral ventricle regions, the frontal horn was the most frequently involved by astrocytomas. SVZ-contact rates were higher in necrosis group compared with non-necrosis groups (83.9% vs. 50.0%, P < 0.001) among astrocytoma patients. Necrosis positively correlated with SVZ involvement in astrocytomas (r(s) = 0.342, P < 0.001), but did not correlate with SVZ involvement in SCMs (P = 0.193).
   Conclusions
   Compared to SCMs, solitary cerebral astrocytomas exhibited spatial proximity to the SVZ, which might distinguish the supratentorial astrocytomas from SCMs.
C1 [Wang, Rong; Ma, Jiaqi; Niu, Gang; Liu, Zhe; Du, Yonghao; Yu, Bolang; Yang, Jian] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiol, Xian 710049, Shaanxi, Peoples R China.
   [Zheng, Jie] Xi An Jiao Tong Univ, Affiliated Hosp 1, Clin Res Ctr, Xian 710049, Shaanxi, Peoples R China.
RP Yang, J (reprint author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiol, Xian 710049, Shaanxi, Peoples R China.
EM cjr.yangjian@vip.163.com
OI ZHENG, JIE/0000-0003-4958-2091
FU National Natural Science Foundation of China [30970797, 81201134]; New
   Century Excellent Talent Support Plan from Ministry of Education of
   China [NCET-11-0438]; Fund for National Clinical Key Specialty from
   Ministry of Health of China
FX This work was supported by the grant from National Natural Science
   Foundation of China (No. 30970797 to JY, 81201134 to RW), the 2011 New
   Century Excellent Talent Support Plan from Ministry of Education of
   China (NCET-11-0438) and the Fund for the National Clinical Key
   Specialty from the Ministry of Health of China. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010
   Barami K, 2009, J CLIN NEUROSCI, V16, P195, DOI 10.1016/j.jocn.2008.03.006
   Blanchet L, 2011, AM J NEURORADIOL, V32, P67, DOI 10.3174/ajnr.A2269
   Boxerman JL, 2006, AM J NEURORADIOL, V27, P859
   Chen LD, 2013, INT J RADIAT ONCOL, V86, P616, DOI 10.1016/j.ijrobp.2013.02.014
   Cherubini A, 2010, NEUROSCI LETT, V469, P214, DOI 10.1016/j.neulet.2009.11.077
   Goebell E, 2006, RADIOLOGY, V239, P217, DOI 10.1148/radiol.2383050059
   Hakyemez B, 2010, CLIN RADIOL, V65, P15, DOI 10.1016/j.crad.2009.09.005
   HOPEWELL JW, 1975, J PATHOL, V117, P101, DOI 10.1002/path.1711170208
   Hwang TL, 1996, CANCER, V77, P1551
   Jafri NF, 2013, NEURO-ONCOLOGY, V15, P91, DOI 10.1093/neuonc/nos268
   Jamshidi N, 2014, RADIOLOGY, V270, P212, DOI 10.1148/radiol.13130078
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LANTOS PL, 1976, EXPERIENTIA, V32, P1467, DOI 10.1007/BF01937439
   Larjavaara S, 2007, NEURO-ONCOLOGY, V9, P319, DOI 10.1215/15228517-2007-016
   Law M, 2002, RADIOLOGY, V222, P715, DOI 10.1148/radiol.2223010558
   Lee EJ, 2013, CLIN RADIOL, V68, pE689, DOI 10.1016/j.crad.2013.06.021
   Maher Elizabeth A, 2009, Cancer Res, V69, P6015, DOI 10.1158/0008-5472.CAN-08-4347
   Marsh JC, 2011, INT J RAD ONCOL BIOL
   Mendez O, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-133
   Nimsky C, 2004, NEUROSURGERY, V55, P358, DOI 10.1227/01.NEU.0000129694.64671.91
   Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151
   Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798
   Quinones-Hinojosa A, 2007, EXP NEUROL, V205, P313, DOI 10.1016/j.expneurol.2007.03.016
   Rebetz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001936
   Rhoton AL, 2002, NEUROSURGERY, V51, pS207, DOI 10.1227/01.NEU.0000028161.91504.4F
   Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001
   Sakariassen PO, 2006, P NATL ACAD SCI USA, V103, P16466, DOI 10.1073/pnas.0607668103
   Schellinger PD, 1999, J NEURO-ONCOL, V44, P275, DOI 10.1023/A:1006308808769
   SIMPSON JR, 1993, INT J RADIAT ONCOL, V26, P239, DOI 10.1016/0360-3016(93)90203-8
   Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946
   Singh SK, 2003, CANCER RES, V63, P5821
   Talos IF, 2007, ACAD RADIOL, V14, P431, DOI 10.1016/j.acra.2007.01.033
   Tsuchiya K, 2005, BRIT J RADIOL, V78, P533, DOI 10.1259/bjr/68749637
   Vergani F, 2011, NEUROSURGERY, V68, P1293, DOI 10.1227/NEU.0b013e31820b522a
   Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889
   VICK NA, 1977, ACTA NEUROPATHOL, V40, P63, DOI 10.1007/BF00688574
   Zhong H, 1999, CANCER RES, V59, P5830
   Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004
NR 39
TC 3
Z9 4
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 21
PY 2015
VL 10
IS 7
AR e0133480
DI 10.1371/journal.pone.0133480
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN6LZ
UT WOS:000358547600103
PM 26197398
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Naundrup, PJ
   Svenning, JC
AF Naundrup, Pernille Johansen
   Svenning, Jens-Christian
TI A Geographic Assessment of the Global Scope for Rewilding with
   Wild-Living Horses (Equus ferus)
SO PLOS ONE
LA English
DT Article
ID BUTTERFLY DISTRIBUTION MAPS; ANCIENT FEEDING ECOLOGY; LAND-COVER DATA;
   FERAL HORSES; SPECIES DISTRIBUTIONS; PLEISTOCENE EXTINCTIONS; HABITAT
   SELECTION; CLIMATE-CHANGE; SAMPLING BIAS; EVOLUTIONARY HISTORY
AB Megafaunas worldwide have been decimated during the late Quaternary. Many extirpated species were keystone species, and their loss likely has had large effects on ecosystems. Therefore, it is increasingly considered how megafaunas can be restored. The horse (Equus ferus) is highly relevant in this context as it was once extremely widespread and, despite severe range contraction, survives in the form of domestic, feral, and originally wild horses. Further, it is a functionally important species, notably due to its ability to graze coarse, abrasive grasses. Here, we used species distribution modelling to link locations of wild-living E. ferus populations to climate to estimate climatically suitable areas for wild-living E. ferus. These models were combined with habitat information and past and present distributions of equid species to identify areas suitable for rewilding with E. ferus. Mean temperature in the coldest quarter, precipitation in the coldest quarter, and precipitation in the driest quarter emerged as the best climatic predictors. The distribution models estimated the climate to be suitable in large parts of the Americas, Eurasia, Africa, and Australia and, combined with habitat mapping, revealed large areas to be suitable for rewilding with horses within its former range, including up to 1.5 million ha within five major rewilding areas in Europe. The widespread occurrence of suitable climates and habitats within E. ferus' former range together with its important functions cause it to be a key candidate for rewilding in large parts of the world. Successful re-establishment of wild-living horse populations will require handling the complexity of human-horse relations, for example, potential conflicts with ranchers and other agriculturalists or with other conservation aims, perception as a non-native invasive species in some regions, and coverage by legislation for domestic animals.
C1 [Naundrup, Pernille Johansen; Svenning, Jens-Christian] Aarhus Univ, Sect Ecoinformat & Biodivers, Dept Biosci, Aarhus C, Denmark.
RP Naundrup, PJ (reprint author), Aarhus Univ, Sect Ecoinformat & Biodivers, Dept Biosci, Aarhus C, Denmark.
EM Samic1988@gmail.com; svenning@bios.au.dk
RI Svenning, Jens-Christian/C-8977-2012
OI Svenning, Jens-Christian/0000-0002-3415-0862
FU Aarhus University; Aarhus University Research Foundation under the AU
   IDEAS program
FX We would like to thank Peder Klith Bocher for his assistance in ArcGIS
   and Jonas Nuchel for help with MAXENT. JCS considers this study a
   contribution to Center for Informatics Research on Complexity in
   Ecology, CIRCE (funded by Aarhus University and Aarhus University
   Research Foundation under the AU IDEAS program) and the Danish National
   Research Foundation Niels Bohr professorship project, Aarhus University
   Research on the Anthropocene (AURA).
CR Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109
   Agerskov U, 2012, STAT YB 2012
   Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x
   Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342
   Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010
   Arino O, 2008, ESA BULL-EUR SPACE, P24
   AZZAROLI A, 1991, ANN ZOOL FENN, V28, P151
   Ballesteros-Mejia L, 2013, GLOBAL ECOL BIOGEOGR, V22, P586, DOI 10.1111/geb.12039
   Bennett D, 1992, WORLD ANIMAL SCI S C
   Bennett D., 1999, MAMMALIAN SPECIES, V628, P1, DOI DOI 10.2307/3504442
   Berger J., 1986, WILD HORSES GREAT BA
   Bhattacharyya J, 2011, HUM ECOL, V39, P613, DOI 10.1007/s10745-011-9416-9
   Bignon O, 2005, J ARCHAEOL SCI, V32, P375, DOI 10.1016/j.jas.2004.02.016
   Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385
   Bocherens H, 1999, J ARCHAEOL SCI, V26, P599, DOI 10.1006/jasc.1998.0377
   Bonde AM, 2013, PALEOECOLOGY LATE PA
   Braysher M. L., 1993, MANAGING VERTEBRATE
   Buckley AW, 1983, PUB LAND L REV, V4, P29
   Burke A, 2003, QUATERNARY RES, V59, P459, DOI 10.1016/S0033-5894(03)00059-0
   Buttenschon RM, 2007, GREASNING OG HOSLET
   Cameron EZ, 2001, POPULATIONS DYNAMICS
   Caro T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4535
   Caro T, 2009, NATURE, V462, P985, DOI 10.1038/462985b
   Carpenter D, 2012, BIODIVERS CONSERV, V21, P3385, DOI 10.1007/s10531-012-0369-0
   Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553
   Churcher CS, 1999, PALAEOGEOGR PALAEOCL, V154, P301, DOI 10.1016/S0031-0182(99)00104-2
   Clutton-Brock J., 1999, NATURAL HIST DOMESTI
   Colbert E. H., 1940, American Museum Novitates, Vno. 1099
   Cothran EG, 2001, J S AFR VET ASSOC, V72, P18
   Cran KK, 1997, J RANGE MANAGE, V50, P374, DOI 10.2307/4003303
   Cromsigt JPGM, 2012, DIVERS DISTRIB, V18, P1253, DOI 10.1111/j.1472-4642.2012.00927.x
   Csurhes S., 2009, PEST ANIMAL RISK ASS
   Davies KW, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00171.1
   Dawson M, 2006, P NATL FER HORS MAN
   Dennis RLH, 2000, J INSECT CONSERV, V4, P73, DOI 10.1023/A:1009690919835
   Dennis RLH, 1999, J INSECT CONSERV, V3, P33, DOI 10.1023/A:1009678422145
   Diedrich Cajus G., 2006, Bulletin of Geosciences, V81, P237
   Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817
   Domingo L, 2012, QUATERNARY SCI REV, V55, P103, DOI 10.1016/j.quascirev.2012.08.017
   DUNCAN P, 1983, J ANIM ECOL, V52, P93, DOI 10.2307/4590
   Edwards WE, 1967, P 7 C INT ASS QUART
   Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x
   Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7
   Feranec R, 2010, PALAEOGEOGR PALAEOCL, V297, P263, DOI 10.1016/j.palaeo.2010.08.006
   Ferrusquia-Villafranca I, 2010, QUATERN INT, V217, P53, DOI 10.1016/j.quaint.2009.11.036
   Forsten A, 1998, GEOBIOS-LYON, V31, P545, DOI 10.1016/S0016-6995(98)80125-3
   FORSTEN A, 1986, J MAMMAL, V67, P422, DOI 10.2307/1380904
   FORSTEN A, 1988, PALAEOGEOGR PALAEOCL, V65, P23, DOI 10.1016/0031-0182(88)90109-5
   Fox-Dobbs K, 2008, PALAEOGEOGR PALAEOCL, V261, P30, DOI 10.1016/j.palaeo.2007.12.011
   Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015
   GANSKOPP D, 1987, NORTHWEST SCI, V61, P74
   GARROTT RA, 1991, J WILDLIFE MANAGE, V55, P641, DOI 10.2307/3809513
   Girard TL, 2013, RANGELAND ECOL MANAG, V66, P428, DOI 10.2111/REM-D-12-00081.1
   Girard TL, 2013, ENVIRON MANAGE, V51, P435, DOI [10.1007/s00267-012-9987-2, 10.1007/s00267-012-9987-]
   GOODLOE RB, 1991, J WILDLIFE MANAGE, V55, P412, DOI 10.2307/3808969
   Greyling T, 2007, S AFR J BOT, V73, P328, DOI 10.1016/j.sajb.2007.02.161
   Greyling T, 2005, FACTORS AFFECTING PO
   Griffiths CJ, 2010, CONSERV BIOL, V24, P645, DOI 10.1111/j.1523-1739.2010.01511.x
   Groves CP, 1974, HORSES ASSESS ZEBRAS
   Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9
   Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106
   Hampson BA, 2010, EQUINE VET J, V42, P582, DOI 10.1111/j.2042-3306.2010.00203.x
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Hu J, 2010, J ZOOL, V282, P54, DOI 10.1111/j.1469-7998.2010.00715.x
   Hughes FMR, 2011, J NAT CONSERV, V19, P245, DOI 10.1016/j.jnc.2011.02.003
   IUCN, 2013, IUCN RED LIST THREAT
   Jelinek A, 1967, 7 C INT ASS QUART RE
   Kerley GIH, 2012, ECOGRAPHY, V35, P519, DOI 10.1111/j.1600-0587.2011.07146.x
   Klein RG, 1984, QUARTERNARY EXTINCTI
   Klimov V, 1985, MUSTANGS MANYCH LAKE
   Kuemmerle T, 2011, ECOL APPL, V21, P830, DOI 10.1890/10-0073.1
   Kurten B, 1980, PLEISTOCENE MAMMALS
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Latif QS, 2013, ECOL EVOL, V3, P4348, DOI 10.1002/ece3.790
   Leitao PJ, 2011, INT J GEOGR INF SCI, V25, P439, DOI 10.1080/13658816.2010.531020
   Levin PS, 2002, CONSERV BIOL, V16, P1364, DOI 10.1046/j.1523-1739.2002.01167.x
   Linklater WL, 2000, NEW ZEAL J ECOL, V24, P139
   Linnartz L., 2014, REWILDING HORSES EUR
   Lippold S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-328
   Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x
   Lomolino MV., 2010, BIOGEOGRAPHY, P137
   Long J. L., 2003, INTRO MAMMALS WORLD
   Loydi A, 2010, NAT AREA J, V30, P148
   MacFadden BJ, 1999, SCIENCE, V283, P824, DOI 10.1126/science.283.5403.824
   MacFadden BJ, 1997, PALEOBIOLOGY, V23, P77, DOI 10.1017/S0094837300016651
   MacFadden BJ, 1999, GLOBAL ECOL BIOGEOGR, V8, P137, DOI 10.1046/j.1466-822X.1999.00127.x
   MacFadden BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059277
   Martin PS, 1967, P 7 C INT ASS QUAT R
   Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x
   Menard C, 2002, J APPL ECOL, V39, P120, DOI 10.1046/j.1365-2664.2002.00693.x
   Mihlbachler MC, 2011, SCIENCE, V331, P1178, DOI 10.1126/science.1196166
   MILLER R, 1983, J RANGE MANAGE, V36, P195, DOI 10.2307/3898161
   Moehlman Patricia D., 2002, EQUIDS ZEBRAS ASSES
   Morueta-Holme N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010360
   National Research Counsil, 1980, WILD FREE ROAM HORS
   Nimmo DG, 2007, WILDLIFE RES, V34, P408, DOI 10.1071/WR06102
   Oliveira-Santos LGR, 2010, CONSERV BIOL, V24, P4, DOI 10.1111/j.1523-1739.2009.01379.x
   Orlando L, 2008, J MOL EVOL, V66, P533, DOI 10.1007/s00239-008-9100-x
   Orlando L, 2009, P NATL ACAD SCI USA, V106, P21754, DOI 10.1073/pnas.0903672106
   Ostermann-Kelm Stacey D., 2009, BMC Ecology, V9, P22, DOI 10.1186/1472-6785-9-22
   Ottaviani D, 2009, ECOL MODEL, V220, P111, DOI 10.1016/j.ecolmodel.2008.09.014
   Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594
   OWENSMITH N, 1987, PALEOBIOLOGY, V13, P351
   Palmqvist P, 2003, PALEOBIOLOGY, V29, P205, DOI 10.1666/0094-8373(2003)029<0205:PROALP>2.0.CO;2
   Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x
   Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x
   Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x
   Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x
   Politis GG, 1998, LAT AM ANTIQ, V9, P111, DOI 10.2307/971990
   Prado Jose L., 2011, BMC Ecology, V11, P15, DOI 10.1186/1472-6785-11-15
   PRATT RM, 1986, J APPL ECOL, V23, P539, DOI 10.2307/2404035
   Pratt-Phillips SE, 2011, J EQUINE VET SCI, V31, P640, DOI 10.1016/j.jevs.2011.05.012
   Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x
   Rheinhardt RD, 2004, J RANGE MANAGE, V57, P253, DOI 10.2307/4003793
   Richmond OMW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012899
   Rivals F, 2012, PALEOGEOGR PALEOCLIM
   ROGERS GM, 1991, NEW ZEAL J ECOL, V15, P49
   ROGERS PM, 1980, J APPL ECOL, V17, P545, DOI 10.2307/2402636
   Rubenstein D.I., 1986, P282
   Rubenstein DR, 2006, BIOL CONSERV, V132, P232, DOI 10.1016/j.biocon.2006.04.003
   Saastamoinen MT, 2012, FORAGES GRAZING HORS, V132, DOI [10.3920/978-90-8686-755-4, DOI 10.3920/978-90-8686-755-4]
   SALTER RE, 1979, J RANGE MANAGE, V32, P221, DOI 10.2307/3897127
   Sanchez B, 2006, AMEGHINIANA, V43, P427
   Sandom C., 2013, KEY TOPICS CONSERVAT, V2, P430
   Sandom CJ, 2014, P NATL ACAD SCI USA, V111, P4162, DOI 10.1073/pnas.1311014111
   Scorolli Alberto L., 2006, Mastozool. neotrop., V13, P255
   Seddon PJ, 2014, SCIENCE, V345, P406, DOI 10.1126/science.1251818
   Smith CI, 2005, NATURE, V437, P318, DOI 10.1038/437318a
   Solomonov N G, 2009, Dokl Biol Sci, V427, P358
   Solow AR, 2006, P NATL ACAD SCI USA, V103, P7351, DOI 10.1073/pnas.0509480103
   Sommer RS, 2011, J QUATERNARY SCI, V26, P805, DOI 10.1002/jqs.1509
   Soule M, 1998, WILD EARTH, V8
   SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615
   The Department of Conservation, KAIM WILD HORS PLAN
   Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x
   Turner JW, 2001, SOUTHWEST NAT, V46, P183, DOI 10.2307/3672527
   van Asperen EN, 2010, PALAEOGEOGR PALAEOCL, V297, P584, DOI 10.1016/j.palaeo.2010.09.007
   van Beest FM, 2014, J ANIM ECOL, V83, P147, DOI 10.1111/1365-2656.12115
   van de Vlasakker JWG., 2006, EVALUATION NATURAL G
   van Klink R, 2015, BIOL REV, V90, P347, DOI 10.1111/brv.12113
   VanDierendonck MC, 1996, CONSERV BIOL, V10, P728, DOI 10.1046/j.1523-1739.1996.10030728.x
   vanDierendonck MC, 1996, APPL ANIM BEHAV SCI, V50, P95, DOI 10.1016/0168-1591(96)01089-1
   Vera Frans W.M., 2009, British Wildlife, V20, P28
   Verbruggen H., 2012, OCCURRENCETHINNER VE
   Waring GH, 1983, BEHAV TRAITS ADAPTAT
   Warmuth V, 2012, P NATL ACAD SCI USA, V109, P8202, DOI 10.1073/pnas.1111122109
   Warmuth V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018194
   Weinstock J, 2005, PLOS BIOL, V3, P1373, DOI 10.1371/journal.pbio.0030241
   Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x
   Yang WJ, 2013, J BIOGEOGR, V40, P1415, DOI 10.1111/jbi.12108
   Zalba SM, 2004, ANIM CONSERV, V7, P35, DOI 10.1017/S1367943003001094
   Zeigenfuss LC, 2014, WEST N AM NATURALIST, V74, P286, DOI 10.3398/064.074.0304
NR 154
TC 16
Z9 17
U1 3
U2 94
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 15
PY 2015
VL 10
IS 7
AR e0132359
DI 10.1371/journal.pone.0132359
PG 26
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1RL
UT WOS:000358197600103
PM 26177104
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kasumovic, MM
   Kuznekoff, JH
AF Kasumovic, Michael M.
   Kuznekoff, Jeffrey H.
TI Insights into Sexism: Male Status and Performance Moderates
   Female-Directed Hostile and Amicable Behaviour
SO PLOS ONE
LA English
DT Article
ID VIDEO GAME; SEXUAL SELECTION; DOMINANCE; VIOLENT; PERCEPTIONS;
   PUNISHMENT; EVOLUTION; RESPONSES; STUDENTS; PRESTIGE
AB Gender inequality and sexist behaviour is prevalent in almost all workplaces and rampant in online environments. Although there is much research dedicated to understanding sexist behaviour, we have almost no insight into what triggers this behaviour and the individuals that initiate it. Although social constructionist theory argues that sexism is a response towards women entering a male dominated arena, this perspective doesn't explain why only a subset of males behave in this way. We argue that a clearer understanding of sexist behaviour can be gained through an evolutionary perspective that considers evolved differences in intra-sexual competition. We hypothesised that female-initiated disruption of a male hierarchy incites hostile behaviour from poor performing males who stand to lose the most status. To test this hypothesis, we used an online first-person shooter video game that removes signals of dominance but provides information on gender, individual performance, and skill. We show that lower-skilled players were more hostile towards a female-voiced teammate, especially when performing poorly. In contrast, lower-skilled players behaved submissively towards a male-voiced player in the identical scenario. This difference in gender-directed behaviour became more extreme with poorer focal-player performance. We suggest that low-status males increase female-directed hostility to minimize the loss of status as a consequence of hierarchical reconfiguration resulting from the entrance of a woman into the competitive arena. Higher-skilled players, in contrast, were more positive towards a female relative to a male teammate. As higher-skilled players have less to fear from hierarchical reorganization, we argue that these males behave more positively in an attempt to support and garner a female player's attention. Our results provide the clearest picture of inter-sexual competition to date, highlighting the importance of considering an evolutionary perspective when exploring the factors that affect male hostility towards women.
C1 [Kasumovic, Michael M.] Univ New S Wales, Ecol & Evolut Res Ctr, Sydney, NSW 2052, Australia.
   [Kuznekoff, Jeffrey H.] Miami Univ, Dept Integrat Studies, Middletown, OH 45042 USA.
RP Kasumovic, MM (reprint author), Univ New S Wales, Ecol & Evolut Res Ctr, Sydney, NSW 2052, Australia.
EM m.kasumovic@unsw.edu.au
OI Kuznekoff, Jeffrey/0000-0002-1740-1180; Kasumovic,
   Michael/0000-0003-0158-5517
FU ARC DECRA Fellowship [DE120100214]
FX This research was supported by an ARC DECRA Fellowship (DE120100214) to
   MMK. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Alejos AV, 2014, IEEE GLOB ENG EDUC C, P280, DOI 10.1109/EDUCON.2014.6826103
   Amanatullah ET, 2013, ORGAN BEHAV HUM DEC, V120, P110, DOI 10.1016/j.obhdp.2012.03.006
   Andersson M., 1994, SEXUAL SELECTION
   Archer J, 2009, BEHAV BRAIN SCI, V32, P249, DOI 10.1017/S0140525X09990951
   Benenson JF, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0079
   Conner AL, 2014, SCIENCE, V343, P1200, DOI 10.1126/science.343.6176.1200-a
   Dill KE, 2007, SEX ROLES, V57, P851, DOI 10.1007/s11199-007-9278-1
   Elwer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053246
   ESA T, 2014, ESS FACTS COMP VID G
   Ewoldsen DR, 2012, CYBERPSYCH BEH SOC N, V15, P277, DOI 10.1089/cyber.2011.0308
   Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a
   Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980
   Fox J, 2009, J STAT SOFTW, V32, P1
   Glick P, 1996, J PERS SOC PSYCHOL, V70, P491, DOI 10.1037/0022-3514.70.3.491
   Greitemeyer T, 2014, PERS SOC PSYCHOL B, V40, P578, DOI 10.1177/0146167213520459
   Gurven M., 2006, BIODEMOGRAPHY SOCIAL, V53, P81, DOI DOI 10.1080/19485565.2006.9989118
   Hawley PH, 1999, DEV REV, V19, P97, DOI 10.1006/drev.1998.0470
   Hill AK, 2013, EVOL HUM BEHAV, V34, P334, DOI 10.1016/j.evolhumbehav.2013.05.004
   Hosokawa T, 2012, J NEUROSCI, V32, P7662, DOI 10.1523/JNEUROSCI.6479-11.2012
   Ivarsson M, 2013, PSYCHOSOM MED, V75, P390, DOI 10.1097/PSY.0b013e3182906a4c
   Katsyri J, 2013, CEREB CORTEX, V23, P2829, DOI 10.1093/cercor/bhs259
   Kuznekoff JH, 2013, NEW MEDIA SOC, V15, P541, DOI 10.1177/1461444812458271
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Ogletree SM, 2007, SEX ROLES, V56, P537, DOI 10.1007/s11199-007-9193-5
   Mayer AP, 2014, ACAD MED, V89, P312, DOI 10.1097/ACM.0000000000000089
   McDonald MM, 2012, PHILOS T R SOC B, V367, P670, DOI 10.1098/rstb.2011.0301
   Meyer R, 2006, I C DEPEND SYS NETWO, P467, DOI 10.1109/DSN.2006.12
   Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109
   Oei AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058546
   Oxford J, 2010, EVOL HUM BEHAV, V31, P201, DOI 10.1016/j.evolhumbehav.2009.07.002
   Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003
   Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005
   Richerson P. J., 2005, NOT GENES ALONE CULT
   Rudman LA, 1998, J PERS SOC PSYCHOL, V74, P629, DOI 10.1037/0022-3514.74.3.629
   Stermer SP, 2012, SOC PERSONAL PSYCHOL, V6, P525, DOI 10.1111/j.1751-9004.2012.00442.x
   Stockley P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0073
   Vaillancourt T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0080
   von Rueden C, 2011, P ROY SOC B-BIOL SCI, V278, P2223, DOI 10.1098/rspb.2010.2145
   Winegard BM, 2014, REV GEN PSYCHOL, V18, P34, DOI 10.1037/a0036594
   Yao MZ, 2010, SEX ROLES, V62, P77, DOI 10.1007/s11199-009-9695-4
NR 40
TC 9
Z9 9
U1 1
U2 31
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 15
PY 2015
VL 10
IS 7
AR e0131613
DI 10.1371/journal.pone.0131613
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1RL
UT WOS:000358197600053
PM 26176699
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Matsuzaki, M
   Pant, R
   Kulkarni, B
   Kinra, S
AF Matsuzaki, Mika
   Pant, Rashmi
   Kulkarni, Bharati
   Kinra, Sanjay
TI Comparison of Bone Mineral Density between Urban and Rural Areas:
   Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID HIP-FRACTURES; SWEDISH URBAN; MASS; POPULATION; MORTALITY; MEN;
   OSTEOPOROSIS; URBANIZATION; WOMEN
AB Background
   Studies from high income countries (HIC) have generally shown higher osteoporotic fracture rates in urban areas than rural areas. Low bone mineral density (BMD) increases susceptibility to fractures. This review aimed to assess whether urbanicity is consistently associated with lower BMD globally.
   Method
   Ovid MEDLINE, EMBASE, and Global Health (-April 2013) were searched for articles investigating differences in bone mineral content (BMC) or BMD between urban and rural areas. Ratio of means (RoM) of BMD were used to estimate effect sizes in meta-analysis, with an exception for one study that only presented BMC data.
   Results
   Fifteen articles from eleven distinct populations were included in the review; seven populations from four high income countries and four from three low and middle income countries (LMIC). Meta-analysis showed conflicting evidence for urban-rural difference in BMD; studies from high income countries generally showed higher BMD in rural areas while the results were more mixed in studies from low and middle income countries (HIC RoM = 0.05; 95% CI: 0.03 to 0.06; LMIC RoM = -0.04: 95% CI: -0.1 to 0.01).
   Conclusions
   Urban-rural differences of bone mineral density may be context-specific. BMD may be higher in urban areas in some lower income countries. More studies with robust designs and analytical techniques are needed to understand mechanisms underlying the effects of urbanization on bone mass accrual and loss.
C1 [Matsuzaki, Mika; Kinra, Sanjay] London Sch Hyg & Trop Med, Dept Non Communicable Dis Epidemiol, London WC1, England.
   [Pant, Rashmi] Indian Inst Publ Hlth, Hyderabad, Andhra Pradesh, India.
   [Kulkarni, Bharati] Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India.
RP Matsuzaki, M (reprint author), London Sch Hyg & Trop Med, Dept Non Communicable Dis Epidemiol, London WC1, England.
EM mika.matsuzaki@lshtm.ac.uk
FU Wellcome Trust [084674]
CR Allender S, 2010, B WORLD HEALTH ORGAN, V88, P297, DOI 10.2471/BLT.09.065847
   Bachrach LK, 2001, TRENDS ENDOCRIN MET, V12, P22, DOI 10.1016/S1043-2760(00)00336-2
   Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462
   Brennan SL, 2010, J EPIDEMIOL COMMUN H, V64, P656, DOI 10.1136/jech.2008.085738
   Cohen B, 2006, TECHNOL SOC, V28, P63, DOI 10.1016/j.techsoc.2005.10.005
   Drake MT, 2012, J CLIN ENDOCR METAB, V97, P1861, DOI 10.1210/jc.2011-3058
   Filip RS, 2001, ANN AGR ENV MED, V8, P221
   Friedrich JO, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-32
   GARDSELL P, 1991, J BONE MINER RES, V6, P67
   Gu WJ, 2007, BONE, V41, P393, DOI 10.1016/j.bone.2007.05.010
   Handa R, 2008, BEST PRACT RES CL RH, V22, P693, DOI 10.1016/j.berh.2008.04.002
   Ho-Pham LT, 2009, AM J CLIN NUTR, V90, P943, DOI 10.3945/ajcn.2009.27521
   Kanis JA, 2003, BONE, V32, P468, DOI 10.1016/S8756-3282(03)00061-9
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Li Wanli, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P97
   Marks R, 2003, AGEING RES REV, V2, P57, DOI 10.1016/S1568-1637(02)00045-4
   Meyer HE, 2004, AM J EPIDEMIOL, V160, P1039, DOI 10.1093/aje/kwh337
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Omsland TK, 2011, J BONE MINER RES, V26, P850, DOI 10.1002/jbmr.280
   Pongchaiyakul C, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474/6/5
   Pongchaiyakul C, 2005, OSTEOPOROSIS INT, V16, P1761, DOI 10.1007/s00198-005-1921-5
   Pongchaiyakul Chatlert, 2006, Journal of the Medical Association of Thailand, V89, P160
   Ranathunga RMTK, 2008, TROPICAL AGRICULTURA
   Ringsberg KAM, 2001, GERONTOLOGY, V47, P15, DOI 10.1159/000052765
   Rosengren BE, 2012, SCAND J PUBLIC HEALT, V40, P102, DOI 10.1177/1403494811425604
   Rosengren BE, 2010, ACTA ORTHOP, V81, P453, DOI 10.3109/17453674.2010.492762
   Specker B, 2004, BONE, V35, P1389, DOI 10.1016/j.bone.2004.09.005
   Sundberg M, 1997, ACTA ORTHOP SCAND, V68, P456, DOI 10.3109/17453679708996262
   The World Bank, HOW WE CLASSIFY COUN
   Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4
   Woolf Anthony D, 2005, Curr Osteoporos Rep, V3, P84, DOI 10.1007/s11914-005-0015-9
NR 31
TC 7
Z9 7
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 10
PY 2015
VL 10
IS 7
AR e0132239
DI 10.1371/journal.pone.0132239
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1FD
UT WOS:000358162300105
PM 26162093
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Beijbom, O
   Edmunds, PJ
   Roelfsema, C
   Smith, J
   Kline, DI
   Neal, BP
   Dunlap, MJ
   Moriarty, V
   Fan, TY
   Tan, CJ
   Chan, S
   Treibitz, T
   Gamst, A
   Mitchell, BG
   Kriegman, D
AF Beijbom, Oscar
   Edmunds, Peter J.
   Roelfsema, Chris
   Smith, Jennifer
   Kline, David I.
   Neal, Benjamin P.
   Dunlap, Matthew J.
   Moriarty, Vincent
   Fan, Tung-Yung
   Tan, Chih-Jui
   Chan, Stephen
   Treibitz, Tali
   Gamst, Anthony
   Mitchell, B. Greg
   Kriegman, David
TI Towards Automated Annotation of Benthic Survey Images: Variability of
   Human Experts and Operational Modes of Automation
SO PLOS ONE
LA English
DT Article
ID CORAL-REEFS; CLIMATE-CHANGE; CLASSIFICATION; KAPPA; COVER
AB Global climate change and other anthropogenic stressors have heightened the need to rapidly characterize ecological changes in marine benthic communities across large scales. Digital photography enables rapid collection of survey images to meet this need, but the subsequent image annotation is typically a time consuming, manual task. We investigated the feasibility of using automated point-annotation to expedite cover estimation of the 17 dominant benthic categories from survey-images captured at four Pacific coral reefs. Inter- and intra- annotator variability among six human experts was quantified and compared to semi- and fully- automated annotation methods, which are made available at coralnet.ucsd. edu. Our results indicate high expert agreement for identification of coral genera, but lower agreement for algal functional groups, in particular between turf algae and crustose coralline algae. This indicates the need for unequivocal definitions of algal groups, careful training of multiple annotators, and enhanced imaging technology. Semi-automated annotation, where 50% of the annotation decisions were performed automatically, yielded cover estimate errors comparable to those of the human experts. Furthermore, fully-automated annotation yielded rapid, unbiased cover estimates but with increased variance. These results show that automated annotation can increase spatial coverage and decrease time and financial outlay for image-based reef surveys.
C1 [Beijbom, Oscar; Chan, Stephen; Kriegman, David] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA.
   [Edmunds, Peter J.; Moriarty, Vincent] Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA.
   [Roelfsema, Chris] Univ Queensland, Sch Geog Planning & Environm Management, Biophys Remote Sensing Grp, St Lucia, Qld, Australia.
   [Smith, Jennifer; Kline, David I.; Neal, Benjamin P.; Mitchell, B. Greg] Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA.
   [Neal, Benjamin P.] Univ Queensland, Global Change Inst, Catlin Seaview Survey, St Lucia, Qld, Australia.
   [Dunlap, Matthew J.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.
   [Fan, Tung-Yung; Tan, Chih-Jui] Natl Museum Marine Biol & Aquarium, Checheng, Taiwan.
   [Treibitz, Tali] Univ Haifa, Charney Sch Marine Sci, IL-31999 Haifa, Israel.
   [Gamst, Anthony] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.
RP Beijbom, O (reprint author), Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA.
EM obeijbom@ucsd.edu
RI Roelfsema, Chris/B-1591-2015
OI Edmunds, Peter/0000-0002-9039-9347; Treibitz, Tali/0000-0002-3078-282X;
   Kline, David/0000-0001-5128-9439
FU US National Science Foundation Division of Ocean Sciences (OCE)
   [0941760]; U.S. National Science Foundation's Long Term Ecological
   Research (LTER) program; Moorea Coral Reef (MCR) LTER Site (through OCE)
   [0417412, 1026851, 1236905]
FX This work was supported by the US National Science Foundation Division
   of Ocean Sciences (OCE) 0941760 to BGM. We gratefully acknowledge the
   support of the U.S. National Science Foundation's Long Term Ecological
   Research (LTER) program and the Moorea Coral Reef (MCR) LTER Site
   (through OCE 0417412, 1026851 and 1236905).
CR Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x
   Beijbom O., 2012, ARXIV12114860
   Beijbom O., 2014, ARXIV14107074
   Beijbom O, 2012, PROC CVPR IEEE, P1170, DOI 10.1109/CVPR.2012.6247798
   Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691
   Bewley M. S, 2012, P AUSTR C ROB AUT
   Branson S, 2013, PROC CVPR IEEE, P1806, DOI 10.1109/CVPR.2013.236
   Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711
   Buskey EJ, 2006, HARMFUL ALGAE, V5, P685, DOI 10.1016/j.hal.2006.02.003
   CARLETON JH, 1995, CORAL REEFS, V14, P35, DOI 10.1007/BF00304070
   Carletta J, 1996, COMPUT LINGUIST, V22, P249
   Cesar H.J.S., 2003, CESAR ENV EC CONSULT
   Chatfield K, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.76
   Costanza R, 1998, ECOL ECON, V25, P3, DOI 10.1016/S0921-8009(98)00020-2
   Eleft-heriou A, 2013, METHODS STUDY MARINE
   Fan RE, 2008, J MACH LEARN RES, V9, P1871
   Fleiss J. L, 1981, STAT METHODS RATES P, V2, P212
   Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050
   Gleason ACR, 2010, CORAL REEFS, V29, P253, DOI 10.1007/s00338-009-0544-2
   Gonzalez-Rivero M, 2014, AQUAT CONSERV, V24, P184, DOI 10.1002/aqc.2505
   Good P., 2005, PERMUTATION PARAMETR
   Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509
   Hopkins DJ, 2010, AM J POLIT SCI, V54, P229, DOI 10.1111/j.1540-5907.2009.00428.x
   Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046
   Jaffe J. S., 2001, OCEANOGRAPHY, V14, P66, DOI DOI 10.5670/OCEANOG.2001.24
   Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lewis D.D., 1994, P 11 INT C MACH LEAR, P148, DOI 10.1016/B978-1-55860-335-6.50026-X
   Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x
   Marcos MSAC, 2005, OPT EXPRESS, V13, P8766, DOI 10.1364/OPEX.13.008766
   Miller I, 1999, CORAL REEFS, V18, P353, DOI 10.1007/s003380050212
   Molloy PP, 2013, AQUAT CONSERV, V23, P820, DOI 10.1002/aqc.2372
   MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W
   Nicholson JW, 2008, MAR TECHNOL SOC J, V42, P44, DOI 10.4031/002533208786861272
   Ninio R, 2003, MAR ECOL PROG SER, V265, P107, DOI 10.3354/meps265107
   Olson RJ, 2007, LIMNOL OCEANOGR-METH, V5, P195, DOI 10.4319/lom.2007.5.195
   Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191
   Pante Eric, 2012, Journal of Marine Biology, V2012, P1
   Perronnin F., 2007, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2007.383266
   Phinn SR, 2012, INT J REMOTE SENS, V33, P3768, DOI 10.1080/01431161.2011.633122
   Porter James W., 2002, P749
   Rifkin R, 2004, J MACH LEARN RES, V5, P101
   Shihavuddin ASM, 2013, REMOTE SENS-BASEL, V5, P1809, DOI 10.3390/rs5041809
   Singh H., 2004, SUBSURFACE SENSING T, V5, P25, DOI DOI 10.1023/B:SSTA.0000018445.25977.F3
   Solow A, 2001, MAR ECOL PROG SER, V216, P309, DOI 10.3354/meps216309
   Sosik HM, 2007, LIMNOL OCEANOGR-METH, V5, P204, DOI 10.4319/lom.2007.5.204
   Stokes MD, 2009, LIMNOL OCEANOGR-METH, V7, P157, DOI 10.4319/lom.2009.7.157
   Treibitz T, 2015, SCI REP-UK, V5, DOI 10.1038/srep07694
   Trygonis V, 2012, J EXP MAR BIOL ECOL, V424, P99, DOI 10.1016/j.jembe.2012.04.018
   van Hooidonk R, 2013, NAT CLIM CHANGE, V3, P508, DOI [10.1038/NCLIMATE1829, 10.1038/nclimate1829]
   Zawada DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084570
NR 51
TC 37
Z9 37
U1 3
U2 28
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 8
PY 2015
VL 10
IS 7
AR e0130312
DI 10.1371/journal.pone.0130312
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1EJ
UT WOS:000358159700030
PM 26154157
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Castro-Vale, I
   Severo, M
   Carvalho, D
   Mota-Cardoso, R
AF Castro-Vale, Ivone
   Severo, Milton
   Carvalho, Davide
   Mota-Cardoso, Rui
TI Emotion Recognition Ability Test Using JACFEE Photos: A
   Validity/Reliability Study of a War Veterans' Sample and Their Offspring
SO PLOS ONE
LA English
DT Article
ID AUTISM SPECTRUM DISORDER; NERVOUS-SYSTEM ACTIVITY; FACIAL EXPRESSIONS;
   PERSONALITY-DISORDER; BIPOLAR DISORDER; FACES; PERCEPTION; CHILDREN;
   SCHIZOPHRENIA; VALIDATION
AB Emotion recognition is very important for social interaction. Several mental disorders influence facial emotion recognition. War veterans and their offspring are subject to an increased risk of developing psychopathology. Emotion recognition is an important aspect that needs to be addressed in this population. To our knowledge, no test exists that is validated for use with war veterans and their offspring. The current study aimed to validate the JACFEE photo set to study facial emotion recognition in war veterans and their offspring. The JACFEE photo set was presented to 135 participants, comprised of 62 male war veterans and 73 war veterans' offspring. The participants identified the facial emotion presented from amongst the possible seven emotions that were tested for: anger, contempt, disgust, fear, happiness, sadness, and surprise. A loglinear model was used to evaluate whether the agreement between the intended and the chosen emotions was higher than the expected. Overall agreement between chosen and intended emotions was 76.3%(Cohen kappa = 0.72). The agreement ranged from 63% (sadness expressions) to 91% (happiness expressions). The reliability by emotion ranged from 0.617 to 0.843 and the overall JACFEE photo set Cronbach alpha was 0.911. The offspring showed higher agreement when compared with the veterans (RR: 41.52 vs 12.12, p < 0.001), which confirms the construct validity of the test. The JACFEE set of photos showed good validity and reliability indices, which makes it an adequate instrument for researching emotion recognition ability in the study sample of war veterans and their respective offspring.
C1 [Castro-Vale, Ivone; Mota-Cardoso, Rui] Univ Porto, Med Psychol Unit, Dept Clin Neurosci & Mental Hlth, Fac Med, P-4100 Oporto, Portugal.
   [Severo, Milton] Univ Porto, Dept Clin Epidemiol Predict Med & Publ Hlth, Fac Med, P-4100 Oporto, Portugal.
   [Severo, Milton] Univ Porto, Dept Med Educ & Simulat, Fac Med, P-4100 Oporto, Portugal.
   [Carvalho, Davide] Univ Porto, Dept Endocrinol Diabet & Metab, Fac Med, Ctr Hosp Sao Joao, P-4100 Oporto, Portugal.
   [Carvalho, Davide] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Oporto, Portugal.
RP Castro-Vale, I (reprint author), Univ Porto, Med Psychol Unit, Dept Clin Neurosci & Mental Hlth, Fac Med, Rua Campo Alegre 823, P-4100 Oporto, Portugal.
EM ivonecastrovale@med.up.pt
RI Severo, Milton/I-3497-2012
OI Severo, Milton/0000-0002-5787-4871; Castro-Vale,
   Ivone/0000-0002-5343-0229; Carvalho, Davide/0000-0002-3156-3741
CR ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0
   Adolphs R, 2010, CURR BIOL, V20, pR549, DOI 10.1016/j.cub.2010.05.046
   Atkinson MJ, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-65
   Biehl M, 1997, J NONVERBAL BEHAV, V21, P3, DOI 10.1023/A:1024902500935
   Burkhouse KL, 2016, COGNITION EMOTION, V30, P275, DOI 10.1080/02699931.2014.996531
   Cai LQ, 2012, PSYCHOPATHOLOGY, V45, P294, DOI 10.1159/000334252
   Davidson AC, 2001, AUST NZ J PSYCHIAT, V35, P345, DOI 10.1046/j.1440-1614.2001.00897.x
   Dawel A, 2012, NEUROSCI BIOBEHAV R, V36, P2288, DOI 10.1016/j.neubiorev.2012.08.006
   De Albuquerque Afonso, 2003, Acta Med Port, V16, P309
   Demenescu LR, 2014, EXP AGING RES, V40, P187, DOI 10.1080/0361073X.2014.882210
   Demirbuga S, 2013, SCHIZOPHR RES, V144, P142, DOI 10.1016/j.schres.2012.12.015
   Dickey CC, 2011, SCHIZOPHR RES, V131, P242, DOI 10.1016/j.schres.2011.04.020
   Dodich A, 2014, NEUROL SCI, V35, P1015, DOI 10.1007/s10072-014-1631-x
   EKMAN P, 1993, AM PSYCHOL, V48, P384, DOI 10.1037/0003-066X.48.4.384
   Ekman P, 1978, FACIAL ACTION CODING
   Ekman P, 2011, EMOT REV, V3, P364, DOI 10.1177/1754073911410740
   Elfenbein HA, 2004, COGNITION EMOTION, V18, P613, DOI 10.1080/02699930341000257
   Enticott PG, 2014, COGNITION EMOTION, V28, P1110, DOI 10.1080/02699931.2013.867832
   Farb NAS, 2013, CURR OPIN NEUROBIOL, V23, P393, DOI 10.1016/j.conb.2013.01.015
   Goeleven E, 2008, COGNITION EMOTION, V22, P1094, DOI 10.1080/02699930701626582
   Greimel E, 2014, J NEURAL TRANSM, V121, P1171, DOI 10.1007/s00702-014-1206-2
   Hipp G, 2014, J NEUROL SCI, V338, P178, DOI 10.1016/j.jns.2013.12.047
   Kessler H, 2008, PSYCHOSOC MED, V5
   Kohler CG, 2011, PSYCHIAT RES, V188, P303, DOI 10.1016/j.psychres.2011.04.019
   Kohler CG, 2010, SCHIZOPHRENIA BULL, V36, P1009, DOI 10.1093/schbul/sbn192
   Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076
   Le Masurier M, 2007, PSYCHOL MED, V37, P403, DOI 10.1017/S003391706009184
   LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004
   LEVENSON RW, 1990, PSYCHOPHYSIOLOGY, V27, P363, DOI 10.1111/j.1469-8986.1990.tb02330.x
   LEVENSON RW, 1992, J PERS SOC PSYCHOL, V62, P972, DOI 10.1037/0022-3514.62.6.972
   Lin IM, 2013, PSYCHIAT INVEST, V10, P393, DOI 10.4306/pi.2013.10.4.393
   Lopez-Duran NL, 2013, J CHILD PSYCHOL PSYC, V54, P565, DOI 10.1111/jcpp.12005
   MacPherson SE, 2006, AGING CLIN EXP RES, V18, P418
   Matsumoto D, 2004, J PERS SOC PSYCHOL, V87, P529, DOI 10.1037/0022-3514.87.4.529
   MATSUMOTO D, 1994, AUST J PSYCHOL, V46, P58, DOI 10.1080/00049539408259471
   MATSUMOTO D, 1988, JAPANESE AND CAUCASI, P61760
   McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424
   Meyer D, 2006, J STAT SOFTW, V17
   Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598
   Montagne Barbara, 2005, Cogn Process, V6, P136, DOI 10.1007/s10339-005-0050-6
   Nunnally J, 1994, PSYCHOMETRIC THEORY
   Pedras S, 2014, MIL BEHAV HEALTH, V2, P52
   Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087
   Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9
   Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051
   Poljac E, 2011, CORTEX, V47, P974, DOI 10.1016/j.cortex.2010.10.002
   Ruffman T, 2008, NEUROSCI BIOBEHAV R, V32, P863, DOI 10.1016/j.neubiorev.2008.01.001
   Sareen J, 2007, ARCH GEN PSYCHIAT, V64, P843, DOI 10.1001/archpsyc.64.7.843
   Sauter DA, 2010, P NATL ACAD SCI USA, V107, P2408, DOI 10.1073/pnas.0908239106
   Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331
   Scrimin S, 2009, DEV PSYCHOL, V45, P1341, DOI 10.1037/a0016689
   Sprengelmeyer R, 1996, BRAIN, V119, P1647, DOI 10.1093/brain/119.5.1647
   Surguladze SA, 2010, NEUROIMAGE, V53, P58, DOI 10.1016/j.neuroimage.2010.05.069
   Susskind JM, 2007, NEUROPSYCHOLOGIA, V45, P152, DOI 10.1016/j.neuropsychologia.2006.05.001
   Vandekerckhove M, 2014, NEUROPSYCHOLOGY, V28, P605, DOI 10.1037/neu0000057
   Yehuda R, 2008, J PSYCHIATR RES, V42, P1104, DOI 10.1016/j.jpsychires.2008.01.002
   Yu SH, 2012, BIOMED ENVIRON SCI, V25, P697, DOI 10.3967/0895-3988.2012.06.012
   Zheng LL, 2011, PSYCHIAT CLIN NEUROS, V65, P648, DOI 10.1111/j.1440-1819.2011.02285.x
NR 60
TC 0
Z9 0
U1 1
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 6
PY 2015
VL 10
IS 7
AR e0132293
DI 10.1371/journal.pone.0132293
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1DQ
UT WOS:000358157600233
PM 26147938
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Milioli, HH
   Vimieiro, R
   Riveros, C
   Tishchenko, I
   Berretta, R
   Moscato, P
AF Milioli, Heloisa Helena
   Vimieiro, Renato
   Riveros, Carlos
   Tishchenko, Inna
   Berretta, Regina
   Moscato, Pablo
TI The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic
   Subtype Prediction and Reconciles the Labels in the METABRIC Data Set
SO PLOS ONE
LA English
DT Article
ID DIFFERENTIATION ANTIGEN NY-BR-1; MESSENGER-RNA EXPRESSION;
   LEUCINE-ZIPPER KINASE; ALPHA-B-CRYSTALLIN; ARYLAMINE
   N-ACETYLTRANSFERASES; ESTROGEN-RECEPTOR-ALPHA; TUMOR-SUPPRESSOR GENE;
   BASAL-LIKE; MATRIX METALLOPROTEINASES; NEOADJUVANT CHEMOTHERAPY
AB Background
   The prediction of breast cancer intrinsic subtypes has been introduced as a valuable strategy to determine patient diagnosis and prognosis, and therapy response. The PAM50 method, based on the expression levels of 50 genes, uses a single sample predictor model to assign subtype labels to samples. Intrinsic errors reported within this assay demonstrate the challenge of identifying and understanding the breast cancer groups. In this study, we aim to: a) identify novel biomarkers for subtype individuation by exploring the competence of a newly proposed method named CM1 score, and b) apply an ensemble learning, as opposed to the use of a single classifier, for sample subtype assignment. The overarching objective is to improve class prediction.
   Methods and Findings
   The microarray transcriptome data sets used in this study are: the METABRIC breast cancer data recorded for over 2000 patients, and the public integrated source from ROCK database with 1570 samples. We first computed the CM1 score to identify the probes with highly discriminative patterns of expression across samples of each intrinsic subtype. We further assessed the ability of 42 selected probes on assigning correct subtype labels using 24 different classifiers from the Weka software suite. For comparison, the same method was applied on the list of 50 genes from the PAM50 method.
   Conclusions
   The CM1 score portrayed 30 novel biomarkers for predicting breast cancer subtypes, with the confirmation of the role of 12 well-established genes. Intrinsic subtypes assigned using the CM1 list and the ensemble of classifiers are more consistent and homogeneous than the original PAM50 labels. The new subtypes show accurate distributions of current clinical markers ER, PR and HER2, and survival curves in the METABRIC and ROCK data sets. Remarkably, the paradoxical attribution of the original labels reinforces the limitations of employing a single sample classifiers to predict breast cancer intrinsic subtypes.
C1 [Milioli, Heloisa Helena; Vimieiro, Renato; Riveros, Carlos; Tishchenko, Inna; Berretta, Regina; Moscato, Pablo] Hunter Med Res Inst, Prior Res Ctr Bioinformat Biomarker Discovery & I, New Lambton Hts, NSW, Australia.
   [Milioli, Heloisa Helena] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia.
   [Vimieiro, Renato] Univ Fed Pernambuco, Ctr Informat, Recife, PE, Brazil.
   [Riveros, Carlos; Tishchenko, Inna; Berretta, Regina; Moscato, Pablo] Univ Newcastle, Sch Elect Engn & Comp Sci, Callaghan, NSW 2308, Australia.
RP Moscato, P (reprint author), Hunter Med Res Inst, Prior Res Ctr Bioinformat Biomarker Discovery & I, New Lambton Hts, NSW, Australia.
EM Pablo.Moscato@newcastle.edu.au
RI Vimieiro, Renato/G-8109-2013; Vimieiro, Renato/N-9432-2019
OI Vimieiro, Renato/0000-0002-7911-2456; Vimieiro,
   Renato/0000-0002-7911-2456; Moscato, Pablo/0000-0003-2570-5966;
   Berretta, Regina/0000-0002-4420-3446
FU Australian Research Council (ARC) [FT120100060]; Australian Research
   Council [DP120102576]; Cancer Institute of New South Wales, Australia
   [13/DATA/1-03]
FX PM is supported by Australian Research Council (ARC) Future Fellowship
   FT120100060 (http://arc.gov.au/). This project is partially funded by
   Australian Research Council Discovery Project DP120102576
   (http://arc.gov.au/) and Cancer Institute of New South Wales, Australia,
   Grant 13/DATA/1-03 (http://www.cancerinstitute.org.au/). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Agnati LF, 2007, J NEURAL TRANSM, V114, P21, DOI 10.1007/s00702-006-0564-9
   Aguilar H, 2010, ONCOGENE, V29, P6071, DOI 10.1038/onc.2010.333
   Ahmed ARH, 2012, AM J PATHOL, V180, P904, DOI 10.1016/j.ajpath.2011.11.022
   Ahn SG, 2013, INT J MOL SCI, V14, P23685, DOI 10.3390/ijms141223685
   Albergaria A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2327
   Ambs S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000281
   Andres SA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-326
   Arbitrario JP, 2010, CANCER CHEMOTH PHARM, V65, P707, DOI 10.1007/s00280-009-1076-8
   Augello MA, 2011, EMBO J, V30, P3885, DOI 10.1038/emboj.2011.340
   Badve S, 2007, CLIN CANCER RES, V13, P4415, DOI 10.1158/1078-0432.CCR-07-0122
   Balafoutas D, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-271
   Bandyopadhyay S, 2006, NAT MED, V12, P933, DOI 10.1038/nm1444
   Bastien RRL, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-44
   Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z
   Bernardo GM, 2012, BIOSCIENCE REP, V32, P113, DOI 10.1042/BSR20110046
   Berretta R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012262
   Bertheau P, 2007, PLOS MED, V4, P585, DOI 10.1371/journal.pmed.0040090
   Bolanz KA, 2008, MOL CANCER THER, V7, P271, DOI 10.1158/1535-7163.MCT-07-0478
   Bowen CV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058866
   Browne EP, 2011, EPIGENETICS-US, V6, P1425, DOI 10.4161/epi.6.12.18280
   Bu DW, 2013, CANCER EPIDEM BIOMAR, V22, P2212, DOI 10.1158/1055-9965.EPI-13-0208
   Bush TL, 2013, MOL CANCER THER, V12, P2356, DOI 10.1158/1535-7163.MCT-12-1178
   Campbell-Lloyd AJM, 2013, HEART LUNG CIRC, V22, P759, DOI 10.1016/j.hlc.2013.01.014
   Canevari G, 2013, BIOCHEMISTRY-US, V52, P6380, DOI 10.1021/bi4005864
   Carretero M, 2013, EMBO J, V32, P2938, DOI 10.1038/emboj.2013.230
   Cheng CW, 2010, CLIN CHIM ACTA, V411, P234, DOI 10.1016/j.cca.2009.11.009
   Cimino D, 2008, INT J CANCER, V123, P1327, DOI 10.1002/ijc.23660
   Ciriello G, 2013, BREAST CANCER RES TR, V141, P409, DOI 10.1007/s10549-013-2699-3
   Colak D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063204
   Colombo PE, 2010, BREAST CANCER RES, V13, P1
   Cooper SJ, 2012, MOL CANCER THER, V11, P2105, DOI 10.1158/1535-7163.MCT-11-0873
   Coradini D, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/254085
   Cortesi L, 2009, J PROTEOME RES, V8, P4916, DOI 10.1021/pr900239h
   Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416
   Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983
   Dahl E, 2007, ONCOGENE, V26, P5680, DOI 10.1038/sj.onc.1210345
   de Kruijf EM, 2014, MOL ONCOL, V8, P1014, DOI 10.1016/j.molonc.2014.03.022
   Delassus GS, 2008, J CELL PHYSIOL, V217, P739, DOI 10.1002/jcp.21548
   Delassus GS, 2011, J CELL PHYSIOL, V226, P3378, DOI 10.1002/jcp.22694
   Dhennin-Duthille I, 2011, CELL PHYSIOL BIOCHEM, V28, P813, DOI 10.1159/000335795
   Dowsett M, 2013, J CLIN ONCOL, V31, P2783, DOI 10.1200/JCO.2012.46.1558
   Dumont N, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2457
   Dunbier AK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001382
   Dunning MJ, 2010, LANCET ONCOL, V11, P717, DOI 10.1016/S1470-2045(10)70115-7
   Eiro N, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24010
   Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232
   Ellsworth RE, 2009, CLIN EXP METASTAS, V26, P205, DOI 10.1007/s10585-008-9232-9
   Fadare O, 2013, HUM PATHOL, V44, P1508, DOI 10.1016/j.humpath.2012.12.003
   Fenne IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070096
   Garcia MF, 2010, INT J EXP PATHOL, V91, P324, DOI 10.1111/j.1365-2613.2010.00709.x
   Fiskus W, 2012, BREAST CANCER RES TR, V135, P433, DOI 10.1007/s10549-012-2171-9
   FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619
   Fleiss JL, 2004, MEASUREMENT INTERRAT, P598, DOI DOI 10.1002/0471445428.CH18
   Fletcher GC, 2003, BRIT J CANCER, V88, P579, DOI 10.1038/sj.bjc.6600740
   Fountzilas G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069256
   Fu XY, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2849
   Gauger KJ, 2014, CELL BIOL INT, V38, P124, DOI 10.1002/cbin.10176
   Gauger KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-59
   Giger O, 2010, PATHOL INT, V60, P726, DOI 10.1111/j.1440-1827.2010.02591.x
   Gorski JJ, 2010, BREAST CANCER RES TR, V122, P721, DOI 10.1007/s10549-009-0565-0
   Gostner JM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-45
   Gully CP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-42
   Habashy HO, 2008, EUR J CANCER, V44, P1541, DOI 10.1016/j.ejca.2008.04.020
   Haibe-Kains B, 2012, J NATL CANCER I, V104, P311, DOI 10.1093/jnci/djr545
   Hardwicke MA, 2009, MOL CANCER THER, V8, P1808, DOI 10.1158/1535-7163.MCT-09-0041
   Hebbard LW, 2010, CANCER RES, V70, P8863, DOI 10.1158/0008-5472.CAN-10-1295
   Hegedus L, 2008, J CELL PHYSIOL, V216, P480, DOI 10.1002/jcp.21417
   Hegyi K, 2012, PATHOBIOLOGY, V79, P314, DOI 10.1159/000338082
   Heinonen H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-348
   Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76
   Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96
   HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075
   Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730
   Ikeda H, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2598
   Inoda S, 2009, J IMMUNOTHER, V32, P474, DOI 10.1097/CJI.0b013e3181a1d109
   Itatani Y, 2013, GASTROENTEROLOGY, V145, P1064, DOI 10.1053/j.gastro.2013.07.033
   Jager D, 2007, APPL IMMUNOHISTO M M, V15, P77
   Kabbage M, 2012, TUMOR BIOL, V33, P2279, DOI 10.1007/s13277-012-0490-4
   Kalbfleisch JD, 2011, THE STATISTICAL ANAL
   Kalous O, 2013, BREAST CANCER RES TR, V141, P397, DOI 10.1007/s10549-013-2702-z
   Kasper G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-12
   Katika MR, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3360
   Kelly CM, 2012, ONCOLOGIST, V17, P492, DOI 10.1634/theoncologist.2012-0007
   Kim C, 2011, J CLIN ONCOL, V29, P4160, DOI 10.1200/JCO.2010.32.9615
   Kim H, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-51
   Kim SJ, 2008, ANN ONCOL, V19, P68, DOI 10.1093/annonc/mdm358
   Kim SJ, 2012, ANN ONCOL, V23, P891, DOI 10.1093/annonc/mdr340
   Kim SJ, 2008, ONCOL REP, V19, P663
   Kim SY, 2013, CELL CALCIUM, V53, P102, DOI 10.1016/j.ceca.2012.10.005
   Klopocki E, 2004, INT J ONCOL, V25, P641
   Kong SL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.59
   Kotoula V, 2013, VIRCHOWS ARCH, V462, P141, DOI 10.1007/s00428-012-1357-1
   Kwon YJ, 2011, CLIN EXP METASTAS, V28, P437, DOI 10.1007/s10585-011-9382-z
   Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P1033, DOI 10.1677/ERC-06-0001
   Lan J, 2012, MOL BIOL REP, V39, P2739, DOI 10.1007/s11033-011-1029-2
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Landowski CP, 2011, PHARM RES-DORDR, V28, P322, DOI 10.1007/s11095-010-0249-9
   Lasa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074079
   Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014
   Li XR, 2004, ONCOGENE, V23, P1474, DOI 10.1038/sj.onc.1207249
   Li Y, 2013, BRIT J CANCER, V108, P99, DOI 10.1038/bjc.2012.494
   Liebetrau AM, 1983, MEASURES OF ASSOCIAT, V32
   Lin ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1650
   Liu L, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-71
   Liu N, 2012, MED ONCOL, V29, P2606, DOI 10.1007/s12032-012-0218-8
   Liu Q, 2009, CHINESE MED J-PEKING, V122, P2763, DOI 10.3760/cma.j.issn.0366-6999.2009.22.017
   Liu XF, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-374
   Liu ZZ, 2010, CLIN EXP METASTAS, V27, P251, DOI 10.1007/s10585-010-9323-2
   Lochhead P, 2012, EUR J CANCER, V48, P3405, DOI 10.1016/j.ejca.2012.06.021
   Lopez FJ, 2012, MED BIOL ENG COMPUT, V50, P981, DOI 10.1007/s11517-012-0914-8
   Loussouarn D, 2009, BRIT J CANCER, V101, P166, DOI 10.1038/sj.bjc.6605122
   Mackay A, 2011, JNCI-J NATL CANCER I, V103, P662, DOI 10.1093/jnci/djr071
   Magnani L, 2014, MOL CELL ENDOCRINOL, V382, P633, DOI 10.1016/j.mce.2013.04.026
   Mahasenan KV, 2012, J CHEM INF MODEL, V52, P1345, DOI 10.1021/ci300040c
   Marsden J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066813
   Martens JWM, 2005, CANCER RES, V65, P4101, DOI 10.1158/0008-5472.CAN-05-0064
   Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994
   Martin-Manso G, 2011, ARCH BIOCHEM BIOPHYS, V509, P147, DOI 10.1016/j.abb.2011.03.004
   Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317
   Mehta RJ, 2012, BREAST CANCER RES TR, V131, P881, DOI 10.1007/s10549-011-1482-6
   Mertsch S, 2008, J NEURO-ONCOL, V87, P1, DOI 10.1007/s11060-007-9484-2
   Meyer KB, 2012, NAT GENET, V44, P1176, DOI 10.1038/ng.2449
   Mihaly Z, 2013, BREAST CANCER RES TR, V140, P219, DOI 10.1007/s10549-013-2622-y
   Miksicek RJ, 2002, CANCER RES, V62, P2736
   Miller WR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2611
   Min KW, 2013, ANN SURG ONCOL, V20, pS433, DOI 10.1245/s10434-012-2734-3
   Moy I, 2014, ONCOGENE
   Mukherjee N, 2012, CANCER SCI, V103, P210, DOI 10.1111/j.1349-7006.2011.02131.x
   Murphy KJ, 2010, J NEUROCHEM, V113, P601, DOI 10.1111/j.1471-4159.2010.06617.x
   Nadal R, 2013, INT J CANCER, V133, P2398, DOI 10.1002/ijc.28263
   Naderi A, 2012, NEOPLASIA, V14, P283, DOI 10.1593/neo.12294
   Nguyen MH, 2010, CANCER RES, V70, P5337, DOI 10.1158/0008-5472.CAN-09-4372
   Nguyen PL, 2008, J CLIN ONCOL, V26, P2373, DOI 10.1200/JCO.2007.14.4287
   Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026
   Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282
   Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370
   Parris TZ, 2014, INT J CANCER, V134, P1617, DOI 10.1002/ijc.28497
   Peppercorn J, 2008, CANCER INVEST, V26, P1, DOI 10.1080/07357900701784238
   Perou CM, 2010, LANCET ONCOL, V11, P718, DOI 10.1016/S1470-2045(10)70176-5
   Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093
   Persson S, 2005, MOL PHYLOGENET EVOL, V36, P734, DOI 10.1016/j.ympev.2005.04.002
   Peters AA, 2012, MOL CANCER THER, V11, P2158, DOI 10.1158/1535-7163.MCT-11-0965
   Pickard MR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2350
   Sanchez-Bailon MP, 2012, CELL SIGNAL, V24, P1276, DOI 10.1016/j.cellsig.2012.02.011
   Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534
   Portier BP, 2012, NEW BIOTECHNOL, V29, P665, DOI 10.1016/j.nbt.2012.03.011
   Prat A, 2012, NAT REV CLIN ONCOL, V9, P48, DOI 10.1038/nrclinonc.2011.178
   Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635
   Psyrri A, 2012, ANN ONCOL, V23, P1422, DOI 10.1093/annonc/mdr527
   Qian Y, 2011, CLIN EXP MED, V11, P163, DOI 10.1007/s10238-010-0125-2
   Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111
   Rawat A, 2013, CELL ONCOL, V36, P459, DOI 10.1007/s13402-013-0150-8
   Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0
   Robinson JLL, 2011, EMBO J, V30, P3019, DOI 10.1038/emboj.2011.216
   Roll JD, 2013, EXP MOL PATHOL, V95, P276, DOI 10.1016/j.yexmp.2013.09.001
   Romanelli A, 2012, MOL CANCER THER, V11, P2693, DOI 10.1158/1535-7163.MCT-12-0441-T
   Ruan Q, 2011, MOL CANCER RES, V9, P1632, DOI 10.1158/1541-7786.MCR-11-0327
   Salceda S, 2005, EXP CELL RES, V306, P128, DOI 10.1016/j.yexcr.2005.01.018
   Samanta S, 2012, ONCOGENE, V31, P4689, DOI 10.1038/onc.2011.620
   Samanta S, 2013, J BIOL CHEM, V288, P12569, DOI 10.1074/jbc.C112.442319
   Sandhu R, 2014, INT J ONCOL, V44, P563, DOI 10.3892/ijo.2013.2197
   Sano H, 2012, BREAST CANCER-TOKYO, V19, P37, DOI 10.1007/s12282-011-0263-8
   Sasaki Y, 2012, CANCER BIOL THER, V13, P1512, DOI 10.4161/cbt.22280
   Seil I, 2007, INT J CANCER, V120, P2635, DOI 10.1002/ijc.22620
   Shulewitz M, 2006, ONCOGENE, V25, P4361, DOI 10.1038/sj.onc.1209470
   Sim E, 2008, DRUG METAB REV, V40, P479, DOI [10.1080/03602530802186603, 10.1080/03602530802186603 ]
   Sim E, 2008, TOXICOLOGY, V254, P170, DOI 10.1016/j.tox.2008.08.022
   Sizemore ST, 2012, J BIOL CHEM, V287, P24631, DOI 10.1074/jbc.M112.375865
   Skliris GP, 2008, HISTOPATHOLOGY, V52, P355, DOI 10.1111/j.1365-2559.2007.02955.x
   Soncini C, 2006, CLIN CANCER RES, V12, P4080, DOI 10.1158/1078-0432.CCR-05-1964
   Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100
   Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098
   Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289
   Spicakova T, 2010, MOL CANCER THER, V9, P2970, DOI 10.1158/1535-7163.MCT-10-0780
   Stossi F, 2012, ONCOGENE, V31, P1825, DOI 10.1038/onc.2011.370
   Suh WK, 2006, MOL CELL BIOL, V26, P6403, DOI 10.1128/MCB.00755-06
   Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259
   Symmans WF, 2005, ENDOCR-RELAT CANCER, V12, P1059, DOI 10.1677/erc.01051
   Tan J, 2013, ONCOGENE
   Tanaka S, 2009, CANCER CHEMOTH PHARM, V64, P341, DOI 10.1007/s00280-008-0877-5
   Taylor KJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2593
   Therneau TM, 2000, STAT BIOL HEALTH
   Theurillat JP, 2008, INT J CANCER, V122, P1585, DOI 10.1002/ijc.23241
   Theurillat JP, 2007, CANCER IMMUNOL IMMUN, V56, P1723, DOI 10.1007/s00262-007-0316-1
   Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299
   Tkocz D, 2012, ONCOGENE, V31, P3667, DOI 10.1038/onc.2011.531
   Torikoshi Y, 2013, J CANCER, V4, P697, DOI 10.7150/jca.6248
   Tringler B, 2005, CLIN CANCER RES, V11, P1842, DOI 10.1158/1078-0432.CCR-04-1658
   Ueki T, 2008, ONCOGENE, V27, P5672, DOI 10.1038/onc.2008.186
   Ueki T, 2009, CANCER RES, V69, P8752, DOI 10.1158/0008-5472.CAN-09-1809
   Ugolini F, 2001, ONCOGENE, V20, P5810, DOI 10.1038/sj.onc.1204706
   Ur-Rehman S, 2013, BREAST CANCER RES TR, V139, P907, DOI 10.1007/s10549-013-2593-z
   Valet F, 2013, BREAST, V22, P1052, DOI 10.1016/j.breast.2013.08.015
   Valladares-Ayerbes M, 2009, J CANCER RES CLIN, V135, P1185, DOI 10.1007/s00432-009-0559-7
   van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8
   van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967
   van Zalen S, 2006, J DERMATOL SCI, V43, P11, DOI 10.1016/j.jdermsci.2006.02.008
   van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a
   Varga Z, 2006, CLIN CANCER RES, V12, P2745, DOI 10.1158/1078-0432.CCR-05-2192
   Vargas AC, 2012, BREAST CANCER RES TR, V135, P153, DOI 10.1007/s10549-012-2123-4
   Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386
   Vinh N. X., 2009, P 26 ANN INT C MACH, DOI [10.1145/1553374.1553511, DOI 10.1145/1553374.1553511]
   Walia V, 2012, ONCOGENE, V31, P2237, DOI 10.1038/onc.2011.392
   Walia V, 2009, CANCER RES, V69, P6624, DOI 10.1158/0008-5472.CAN-08-4101
   Walter O, 2009, HUM PATHOL, V40, P1528, DOI 10.1016/j.humpath.2009.05.005
   Waluk DP, 2012, J BIOL CHEM, V287, P16158, DOI 10.1074/jbc.M112.347260
   Waluk DP, 2010, FASEB J, V24, P2795, DOI 10.1096/fj.09-148551
   Wang J, 2013, EUR REV MED PHARMACO, V17, P596
   Wang J, 2012, ONCOGENE, V31, P4798, DOI 10.1038/onc.2011.635
   Wang K, 2013, TUMOR BIOL, V34, P33, DOI 10.1007/s13277-012-0507-z
   Warsow G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081784
   Weigelt B, 2004, BRIT J CANCER, V90, P1531, DOI 10.1038/sj.bjc.6601659
   Weigelt B, 2012, NAT REV CLIN ONCOL, V9, P58, DOI 10.1038/nrclinonc.2011.125
   Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5
   Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648
   Weigelt B, 2009, NAT REV CLIN ONCOL, V6, P718, DOI 10.1038/nrclinonc.2009.166
   Witten IH, 2005, DATA MINING PRACTICA
   Won JR, 2013, MODERN PATHOL, V26, P1438, DOI 10.1038/modpathol.2013.97
   Woodard AH, 2011, AM J CLIN PATHOL, V136, P428, DOI 10.1309/AJCPUFNMEZ3MK1BK
   Wu J, 2012, ONCOGENE, V31, P333, DOI 10.1038/onc.2011.227
   Xia Q, 2014, INT J ONCOL, V44, P735, DOI 10.3892/ijo.2013.2240
   Xing P, 2011, J INVEST MED, V59, P803, DOI 10.2310/JIM.0b013e31821451a1
   Yamamura J, 2004, CANCER SCI, V95, P887, DOI 10.1111/j.1349-7006.2004.tb02198.x
   Yang ZQ, 2009, INT J CANCER, V125, P1613, DOI 10.1002/ijc.24518
   Yeon S, 2012, MODERN PATHOL, V25, P185, DOI 10.1038/modpathol.2011.160
   Yu YN, 2010, INT J ONCOL, V37, P483, DOI 10.3892/ijo_00000697
   Zeng XH, 2011, BREAST CANCER RES TR, V125, P715, DOI 10.1007/s10549-010-0875-2
   Zhang W, 2011, J BIOL CHEM, V286, P35899, DOI 10.1074/jbc.M111.267690
   Zhang W, 2010, CANCER-AM CANCER SOC, V116, P2688, DOI 10.1002/cncr.25084
   Zvelebil M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3403
NR 230
TC 10
Z9 10
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 1
PY 2015
VL 10
IS 7
AR e0129711
DI 10.1371/journal.pone.0129711
PG 35
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1CG
UT WOS:000358153000034
PM 26132585
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Heckel, A
   Weiler, M
   Xia, A
   Ruetters, M
   Pham, M
   Bendszus, M
   Heiland, S
   Baeumer, P
AF Heckel, A.
   Weiler, M.
   Xia, A.
   Ruetters, M.
   Pham, M.
   Bendszus, M.
   Heiland, S.
   Baeumer, P.
TI Peripheral Nerve Diffusion Tensor Imaging: Assessment of Axon and Myelin
   Sheath Integrity
SO PLOS ONE
LA English
DT Article
ID CARPAL-TUNNEL-SYNDROME; MEDIAN NERVE; MULTIPLE-SCLEROSIS; WHITE-MATTER;
   SPINAL-CORD; IN-VIVO; RETINAL ISCHEMIA; MR NEUROGRAPHY; OPTIC-NERVE;
   MOUSE MODEL
AB Purpose
   To investigate the potential of diffusion tensor imaging (DTI) parameters as in-vivo biomarkers of axon and myelin sheath integrity of the median nerve in the carpal tunnel as validated by correlation with electrophysiology.
   Methods
   MRI examinations at 3T including DTI were conducted on wrists in 30 healthy subjects. After manual segmentation of the median nerve quantitative analysis of fractional anisotropy (FA) as well as axial, radial and mean diffusivity (AD, RD, and MD) was carried out. Pairwise Pearson correlations with electrophysiological parameters comprising sensory nerve action potential (SNAP) and compound muscle action potential (CMAP) as markers of axon integrity, and distal motor latency (dml) and sensory nerve conduction velocity (sNCV) as markers of myelin sheath integrity were computed. The significance criterion was set at P=0.05, Bonferroni corrected for multiple comparisons.
   Results
   DTI parameters showed a distinct proximal-to-distal profile with FA, MD, and RD extrema coinciding in the center of the carpal tunnel. AD correlated with CMAP (r=0.50, p=0.04, Bonf. corr.) but not with markers of myelin sheath integrity. RD correlated with sNCV (r=-0.53, p=0.02, Bonf. corr.) but not with markers of axon integrity. FA correlated with dml (r=-0.63, p=0.002, Bonf. corr.) and sNCV (r=0.68, p= 0.001, Bonf. corr.) but not with markers of axon integrity.
   Conclusion
   AD reflects axon integrity, while RD (and FA) reflect myelin sheath integrity as validated by correlation with electrophysiology. DTI parameters consistently indicate a slight decrease of structural integrity in the carpal tunnel as a physiological site of median nerve entrapment. DTI is particularly sensitive, since these findings are observed in healthy participants. Our results encourage future studies to evaluate the potential of DTI in differentiating axon from myelin sheath injury in patients with manifest peripheral neuropathies.
C1 [Heckel, A.; Xia, A.; Ruetters, M.; Pham, M.; Bendszus, M.; Baeumer, P.] Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany.
   [Heckel, A.] Freiburg Univ Hosp, Dept Diagnost Radiol, Freiburg, Germany.
   [Weiler, M.] Univ Heidelberg Hosp, Dept Neurol, Heidelberg, Germany.
   [Weiler, M.] German Canc Res Ctr, Clin Cooperat Unit Neurooncol, Heidelberg, Germany.
   [Heiland, S.] Univ Heidelberg Hosp, Dept Neuroradiol, Sect Expt Neuroradiol, Heidelberg, Germany.
RP Baeumer, P (reprint author), Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany.
EM philipp.baeumer@med.uni-heidelberg.de
FU Medical Faculty of the University of Heidelberg;
   Ruprecht-Karls-Universitat Heidelberg
FX The study was supported by a Postdoctoral Fellowship granted to AH and
   PB from the Medical Faculty of the University of Heidelberg. We
   acknowledge financial support by Ruprecht-Karls-Universitat Heidelberg
   within the funding programme Open Access Publishing. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Aung Wint Yan, 2013, Imaging Med, V5, P427
   Baumer P, 2011, RADIOLOGY, V260, P199, DOI 10.1148/radiol.11102357
   Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O
   BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1
   Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022
   Baumer P, 2014, RADIOLOGY
   Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782
   BEHSE F, 1978, BRAIN, V101, P473, DOI 10.1093/brain/101.3.473
   Bendszus M, 2005, NAT CLIN PRACT NEURO, V1, P45, DOI 10.1038/ncpneuro0017
   BOLTON CF, 1979, NEUROLOGY, V29, P354, DOI 10.1212/WNL.29.3.354
   Bromberg MB, 2013, PHYS MED REH CLIN N, V24, P153, DOI 10.1016/j.pmr.2012.08.020
   Budde MD, 2008, NMR BIOMED, V21, P589, DOI 10.1002/nbm.1229
   Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200
   Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009
   Colak T, 2005, J SCI MED SPORT, V8, P403, DOI 10.1016/S1440-2440(05)80055-6
   Colak T, 2004, BRIT J SPORT MED, V38, P632, DOI 10.1136/bjsm.2003.008029
   Deboy CA, 2007, BRAIN, V130, P2199, DOI 10.1093/brain/awm122
   Fox John, 1991, REGRESSION DIAGNOSTI
   Fox RJ, 2011, NEUROL CLIN, V29, P357, DOI 10.1016/j.ncl.2010.12.011
   Guggenberger R, 2012, RADIOLOGY, V265, P194, DOI 10.1148/radiol.12111403
   Guggenberger R, 2012, SKELETAL RADIOL, V41, P971, DOI 10.1007/s00256-011-1310-4
   Hiltunen J, 2005, CLIN NEUROPHYSIOL, V116, P2315, DOI 10.1016/j.clinph.2005.05.014
   Hiltunen J, 2012, EUR RADIOL, V22, P1310, DOI 10.1007/s00330-012-2381-x
   Jambawalikar S, 2010, SKELETAL RADIOL, V39, P1073, DOI 10.1007/s00256-010-0974-5
   Kabakci N, 2007, AM J ROENTGENOL, V189, P923, DOI 10.2214/AJR.07.2423
   Kakuda T, 2011, NEURORADIOLOGY, V53, P955, DOI 10.1007/s00234-010-0833-z
   Kasprian G, 2014, MUSCLE NERVE
   Khalil C, 2008, EUR RADIOL, V18, P2283, DOI 10.1007/s00330-008-0971-4
   Khalil C, 2010, EUR J RADIOL, V76, P391, DOI 10.1016/j.ejrad.2010.03.012
   Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lehmann HC, 2010, EXP NEUROL, V223, P238, DOI [10.1016/j.expneuro1.2009.10.012, 10.1016/j.expneurol.2009.10.012]
   Lindberg PG, 2013, EUR RADIOL, V23, P3115, DOI 10.1007/s00330-013-2986-8
   LOGIGIAN EL, 1994, MUSCLE NERVE, V17, P1010, DOI 10.1002/mus.880170908
   MEIERRUGE W, 1992, ANN NY ACAD SCI, V673, P260, DOI 10.1111/j.1749-6632.1992.tb27462.x
   Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012
   Peters A, 2002, J NEUROCYTOL, V31, P581, DOI 10.1023/A:1025731309829
   Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452
   Pham M, 2014, NEUROLOGY, V82, P598, DOI 10.1212/WNL.0000000000000128
   Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010
   Sheikh KA, 2010, EXP NEUROL, V223, P72, DOI 10.1016/j.expneurol.2009.07.008
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267
   Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005
   Stein D, 2009, J MAGN RESON IMAGING, V29, P657, DOI 10.1002/jmri.21553
   Sun SW, 2007, NEUROBIOL DIS, V28, P30, DOI 10.1016/j.nbd.2007.06.011
   Sun SW, 2006, NEUROIMAGE, V32, P1195, DOI 10.1016/j.neuroimage.2006.04.212
   Takagi T, 2009, NEUROIMAGE, V44, P884, DOI 10.1016/j.neuroimage.2008.09.022
   Vass A, 2009, J NEUROL NEUROCHIR P, V10, P44
   Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x
   WATSON BV, 1992, MUSCLE NERVE, V15, P701, DOI 10.1002/mus.880150612
   Werner RA, 2002, CLIN NEUROPHYSIOL, V113, P1373, DOI 10.1016/S1388-2457(02)00169-4
   Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965
   Yao L, 2009, SKELETAL RADIOL, V38, P355, DOI 10.1007/s00256-008-0626-1
   Zhou YX, 2012, J MAGN RESON IMAGING, V36, P920, DOI 10.1002/jmri.23709
NR 55
TC 35
Z9 35
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 26
PY 2015
VL 10
IS 6
AR e0130833
DI 10.1371/journal.pone.0130833
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1AM
UT WOS:000358147500099
PM 26114630
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gao, W
   Yang, HX
   Ma, CE
AF Gao, Wei
   Yang, Hong-Xia
   Ma, Cheng-En
TI The Value of BISAP Score for Predicting Mortality and Severity in Acute
   Pancreatitis: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID APACHE-II SCORE; BEDSIDE INDEX; DIAGNOSTIC-TEST; PROCALCITONIN; ACCURACY
AB Purpose
   The Bedside Index for Severity in Acute Pancreatitis (BISAP) score has been developed to identify patients at high risk for mortality or severe disease early during the course of acute pancreatitis. We aimed to undertake a meta-analysis to quantify the accuracy of BISAP score for predicting mortality and severe acute pancreatitis (SAP).
   Materials and Methods
   We searched the databases of Pubmed, Embase, and the Cochrane Library to identify studies using the BISAP score to predict mortality or SAP. The pooled sensitivity, specificity, likelihood ratios, and diagnostic odds ratio (DOR) were calculated from each study and were compared with the traditional scoring systems.
   Results
   Twelve cohorts from 10 studies were included. The overall sensitivity of a BISAP score of >= 3 for mortality was 56% (95% CI, 53%-60%), with a specificity of 91% (95% CI, 90%91%). The positive and negative likelihood ratios were 5.65 (95% CI, 4.23-7.55) and 0.48 (95% CI, 0.41-0.56), respectively. Regarding the outcome of SAP, the pooled sensitivity was 51% (43%-60%), and the specificity was 91% (89%-92%). The pooled positive and negative likelihood ratios were 7.23 (4.21-12.42) and 0.56 (0.44-0.71), respectively. Compared with BISAP score, the Ranson criteria and APACHEIIscore showed higher sensitivity and lower specificity for both outcomes.
   Conclusions
   The BISAP score was a reliable tool to identify AP patients at high risk for unfavorable outcomes. Compared with the Ranson criteria and APACHEIIscore, BISAP score outperformed in specificity, but having a suboptimal sensitivity for mortality as well as SAP.
C1 [Gao, Wei; Yang, Hong-Xia; Ma, Cheng-En] Shandong Univ, Affiliated Hosp 2, Dept Intens Care Unit, Jinan 250033, Peoples R China.
RP Ma, CE (reprint author), Shandong Univ, Affiliated Hosp 2, Dept Intens Care Unit, Jinan 250033, Peoples R China.
EM chengen_m@163.com
CR Bakker OJ, 2014, NAT REV GASTRO HEPAT, V11, P462, DOI 10.1038/nrgastro.2014.39
   Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779
   Bezmarevic M, 2012, VOJNOSANIT PREGL, V69, P425, DOI 10.2298/VSP1205425B
   Bollen TL, 2012, AM J GASTROENTEROL, V107, P612, DOI 10.1038/ajg.2011.438
   Chauhan S, 2010, AM J GASTROENTEROL, V105, P443, DOI 10.1038/ajg.2009.623
   Chen LF, 2013, INT SURG, V98, P6, DOI 10.9738/0020-8868-98.1.6
   Cho YS, 2013, PANCREAS, V42, P483, DOI 10.1097/MPA.0b013e318267c879
   CORFIELD AP, 1985, LANCET, V2, P403
   Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Hess EP, 2010, CAN MED ASSOC J, V182, P1039, DOI 10.1503/cmaj.092119
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703
   Khanna Ajay K, 2013, HPB Surg, V2013, P367581, DOI 10.1155/2013/367581
   Kim BG, 2013, KOREAN J INTERN MED, V28, P322, DOI 10.3904/kjim.2013.28.3.322
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LARVIN M, 1989, LANCET, V2, P201
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Mounzer R, 2012, GASTROENTEROLOGY, V142, P1476, DOI 10.1053/j.gastro.2012.03.005
   Papachristou GI, 2010, AM J GASTROENTEROL, V105, P435, DOI 10.1038/ajg.2009.622
   Park JY, 2013, HEPATOB PANCREAT DIS, V12, P645, DOI 10.1016/S1499-3872(13)60101-0
   Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002
   RANSON JHC, 1974, AM J GASTROENTEROL, V61, P443
   Senapati D, 2014, PANCREATOLOGY, V14, P335, DOI 10.1016/j.pan.2014.07.007
   Singh VK, 2011, CLIN GASTROENTEROL H, V9, P1098, DOI 10.1016/j.cgh.2011.08.026
   Singh VK, 2009, AM J GASTROENTEROL, V104, P966, DOI 10.1038/ajg.2009.28
   Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218
   Whitcomb DC, 2006, NEW ENGL J MED, V354, P2142, DOI 10.1056/NEJMcp054958
   Wu BU, 2008, GUT, V57, P1698, DOI 10.1136/gut.2008.152702
   Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31
   Zhang J, 2014, J HEPATO-BIL-PAN SCI, V21, P689, DOI 10.1002/jhbp.118
NR 31
TC 24
Z9 25
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 19
PY 2015
VL 10
IS 6
AR e0130412
DI 10.1371/journal.pone.0130412
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CL3FE
UT WOS:000356835000117
PM 26091293
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Junginger, J
   Hansmann, F
   Herder, V
   Lehmbecker, A
   Peters, M
   Beyerbach, M
   Wohlsein, P
   Baumgartner, W
AF Junginger, Johannes
   Hansmann, Florian
   Herder, Vanessa
   Lehmbecker, Annika
   Peters, Martin
   Beyerbach, Martin
   Wohlsein, Peter
   Baumgaertner, Wolfgang
TI Pathology in Captive Wild Felids at German Zoological Gardens
SO PLOS ONE
LA English
DT Article
ID TIGER PANTHERA-TIGRIS; CHEETAHS ACINONYX-JUBATUS; IMMUNODEFICIENCY
   VIRUS-INFECTION; LEOPARD NEOFELIS-NEBULOSA; CANINE-DISTEMPER VIRUS;
   CENTRAL-NERVOUS-SYSTEM; CHRONIC-RENAL-FAILURE; LEUKEMIA-VIRUS;
   LENTIVIRUS INFECTION; CLOUDED LEOPARD
AB This retrospective study provides an overview on spontaneous diseases occurring in 38 captive wild felids submitted for necropsy by German zoological gardens between 2004 and 2013. Species included 18 tigers, 8 leopards, 7 lions, 3 cheetahs and 2 cougars with an age ranging from 0.5 to 22 years. Renal lesions, predominantly tubular alterations (intra-tubular concrements, tubular degeneration, necrosis, intra-tubular cellular debris, proteinaceous casts, dilated tubuli) followed by interstitial (lympho-plasmacytic inflammation, fibrosis, metastatic- suppurative inflammation, eosinophilic inflammation) and glomerular lesions (glomerulonephritis, glomerulosclerosis, amyloidosis) were detected in 33 out of 38 animals (87%). Tumors were found in 19 of 38 felids (50%) with 12 animals showing more than one neoplasm. The tumor prevalence increased with age. Neoplasms originated from endocrine (11), genital (8), lympho-hematopoietic (5) and alimentary organs (4) as well as the mesothelium (3). Most common neoplasms comprised uterine/ovarian leiomyomas (5/2), thyroid adenomas/adenocarcinoma (5/1), pleural mesotheliomas (3), hemangiosarcomas (2) and glossal papillomas (2). Inflammatory changes were frequently encountered in the intestine and the lung. Two young animals displayed metastatic mineralization suggestive of a vitamin D-or calcium intoxication. One tiger exhibited degenerative white matter changes consistent with an entity termed large felid leukoencephalomyelopathy. Various hyperplastic, degenerative and inflammatory changes with minor clinical significance were found in several organs. Summarized, renal lesions followed by neoplastic changes as well as inflammatory changes in lung and gastrointestinal tract represent the most frequent findings in captive wild felids living in German zoological gardens.
C1 [Junginger, Johannes; Hansmann, Florian; Herder, Vanessa; Lehmbecker, Annika; Wohlsein, Peter; Baumgaertner, Wolfgang] Univ Vet Med, Dept Pathol, Hannover, Lower Saxony, Germany.
   [Hansmann, Florian; Herder, Vanessa; Lehmbecker, Annika; Baumgaertner, Wolfgang] Ctr Syst Neurosci, Hannover, Lower Saxony, Germany.
   [Peters, Martin] Chem & Veterinaeruntersuchungsamt Westphalia, Arnsberg, North Rhine Wes, Germany.
   [Beyerbach, Martin] Univ Vet Med, Dept Biometry Epidemiol & Informat Proc, Hannover, Lower Saxony, Germany.
RP Baumgartner, W (reprint author), Univ Vet Med, Dept Pathol, Hannover, Lower Saxony, Germany.
EM wolfgang.baumgaertner@tiho-hannover.de
OI Junginger, Johannes/0000-0002-4965-4553; Hansmann,
   Florian/0000-0001-6064-7728
CR ABRAMO F, 1995, AIDS RES HUM RETROV, V11, P1247, DOI 10.1089/aid.1995.11.1247
   Adams H, 2009, J S AFR VET ASSOC, V80, P151
   Adams H, 2010, J ZOO WILDLIFE MED, V41, P608, DOI 10.1638/2009-0137.1
   Agudelo CF, 2005, VET QUART, V27, P174
   Akin EY, 2013, J ZOO WILDLIFE MED, V44, P761, DOI 10.1638/2012-0215R.1
   Barber PJ, 1998, J SMALL ANIM PRACT, V39, P108, DOI 10.1111/j.1748-5827.1998.tb03613.x
   BARR MC, 1989, J ZOO WILDLIFE MED, V20, P265
   BAXBY D, 1982, J HYG-CAMBRIDGE, V89, P365, DOI 10.1017/S0022172400070935
   Beatty J, 2014, VET J, V201, P174, DOI 10.1016/j.tvjl.2014.05.026
   Binns S H, 2000, J Feline Med Surg, V2, P123, DOI 10.1053/jfms.2000.0084
   Bollo E, 2011, RES VET SCI, V91, P116, DOI 10.1016/j.rvsc.2010.08.005
   BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6
   Bracarense APFRL, 2013, J COMP PATHOL, V149, P402, DOI 10.1016/j.jcpa.2013.06.002
   Brower AI, 2014, VET PATHOL, V51, P1013, DOI 10.1177/0300985813506917
   Brown MA, 2008, EMERG INFECT DIS, V14, P252, DOI 10.3201/eid1402.070981
   Calsyn JDR, 2010, J AM ANIM HOSP ASSOC, V46, P36, DOI 10.5326/0460036
   Camus AC, 2004, J VET DIAGN INVEST, V16, P567, DOI 10.1177/104063870401600612
   CARDY RH, 1978, VET PATHOL, V15, P556, DOI 10.1177/030098587801500414
   Carvallo FR, 2010, J VET DIAGN INVEST, V22, P136, DOI 10.1177/104063871002200130
   Choi JH, 2002, J WILDLIFE DIS, V38, P199, DOI 10.7589/0090-3558-38.1.199
   CITINO SB, 1986, J ZOO WILDLIFE MED, V17, P5, DOI 10.2307/20094780
   Cunningham AA, 1998, VET REC, V143, P22, DOI 10.1136/vr.143.1.22
   Cunningham MW, 2008, J WILDLIFE DIS, V44, P537, DOI 10.7589/0090-3558-44.3.537
   DOSTER AR, 1989, J COMP PATHOL, V100, P475, DOI 10.1016/0021-9975(89)90016-9
   Edmondson EF, 2015, VET PATHOL, V52, P338, DOI 10.1177/0300985814533805
   EFFRON M, 1977, JNCI-J NATL CANCER I, V59, P185, DOI 10.1093/jnci/59.1.185
   Elliott J, 1998, J SMALL ANIM PRACT, V39, P78, DOI 10.1111/j.1748-5827.1998.tb03598.x
   Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120
   Erdman SE, 1997, AM J PATHOL, V151, P273
   FENWICK BW, 1983, J AM VET MED ASSOC, V183, P1315
   Fox JG, 1997, VET PATHOL, V34, P225, DOI 10.1177/030098589703400308
   GELBERG HB, 1985, VET PATHOL, V22, P572, DOI 10.1177/030098588502200610
   Gerhauser I, 2009, EUR J WILDLIFE RES, V55, P433, DOI 10.1007/s10344-009-0260-9
   Gupta A, 2013, VET ARHIV, V83, P115
   HANNA PE, 1990, CAN J VET RES, V54, P487
   Harrenstien LA, 1996, J ZOO WILDLIFE MED, V27, P468
   Harrison TM, 2010, VET PATHOL, V47, P952, DOI 10.1177/0300985810375054
   Harrison TM, 2007, J ZOO WILDLIFE MED, V38, P333, DOI 10.1638/1042-7260(2007)038[0333:TOMLIA]2.0.CO;2
   Hartmann K, 2011, VET IMMUNOL IMMUNOP, V143, P190, DOI 10.1016/j.vetimm.2011.06.003
   Helmick KE, 2006, J ZOO WILDLIFE MED, V37, P542, DOI 10.1638/04-042.1
   Henschel P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083500
   HOCHWALD GM, 1984, J NEUROL SCI, V63, P381, DOI 10.1016/0022-510X(84)90161-8
   Hora AS, 2013, J CLIN MICROBIOL, V51, P676, DOI 10.1128/JCM.02462-12
   IUCN, 2014, IUCN RED LIST THREAT
   Jakob W, 1997, J COMP PATHOL, V116, P21, DOI 10.1016/S0021-9975(97)80040-0
   Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759
   Kelly P, 2013, TOP COMPANION ANIM M, V28, P163, DOI 10.1053/j.tcam.2013.09.004
   Kohler K, 2011, TIERARZTLICHE PRAXIS, V39, pA2
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LANE VM, 1985, AM J VET RES, V46, P1550
   LEAV I, 1976, AM J PATHOL, V83, P61
   LIU SK, 1984, J AM VET MED ASSOC, V185, P52
   LOMBARD LS, 1959, CANCER RES, V19, P127
   LOMBARD LS, 1968, PATHOL VET, V5, P127, DOI 10.1177/030098586800500204
   LULICH JP, 1992, COMP CONT EDUC PRACT, V14, P127
   MACEWEN EG, 1990, CANCER METAST REV, V9, P125, DOI 10.1007/BF00046339
   Magden E, 2011, VET IMMUNOL IMMUNOP, V143, P227, DOI 10.1016/j.vetimm.2011.06.016
   Maher ER, 1997, VET CLIN N AM-SMALL, V27, P359, DOI 10.1016/S0195-5616(97)50037-4
   Marker L, 2003, J WILDLIFE DIS, V39, P690, DOI 10.7589/0090-3558-39.3.690
   McAloose D, 2009, NAT REV CANCER, V9, P517, DOI 10.1038/nrc2665
   McCain S, 2009, J ZOO WILDLIFE MED, V40, P147, DOI 10.1638/2008-0008.1
   MCLAUGHLIN BG, 1988, CAN J VET RES, V52, P476
   Mellanby RJ, 2005, J SMALL ANIM PRACT, V46, P334, DOI 10.1111/j.1748-5827.2005.tb00329.x
   Miller MA, 2003, J VET DIAGN INVEST, V15, P515, DOI 10.1177/104063870301500602
   Motta L, 2012, VET J, V192, P153, DOI 10.1016/j.tvjl.2011.10.008
   MULISCH M, 2010, ROMEIS MIKROSKOPISCH
   Munson L, 2002, VET PATHOL, V39, P419, DOI 10.1354/vp.39-4-419
   Munson L, 1999, J ZOO WILDLIFE MED, V30, P342
   Munson Linda, 2007, Breast Dis, V28, P7
   Newkirk KM, 2011, VET PATHOL, V48, P698, DOI 10.1177/0300985810382089
   O'Brien SJ, 2012, VIRUSES-BASEL, V4, P236, DOI 10.3390/v4020236
   Owston MA, 2008, J ZOO WILDLIFE MED, V39, P608, DOI 10.1638/2008-068.1
   PAL M, 1991, MYCOSES, V34, P313
   PEDEN WM, 1985, J WILDLIFE DIS, V21, P301, DOI 10.7589/0090-3558-21.3.301
   Peterson M, 2012, J FELINE MED SURG, V14, P804, DOI 10.1177/1098612X12464462
   POLI A, 1995, J WILDLIFE DIS, V31, P70, DOI 10.7589/0090-3558-31.1.70
   Poncelet L, 2008, VET PATHOL, V45, P140, DOI 10.1354/vp.45-2-140
   PORT CD, 1981, J COMP PATHOL, V91, P115, DOI 10.1016/0021-9975(81)90051-7
   R Core Team, 2014, R LANG ENV STAT COMP
   Reynolds BS, 2013, J FELINE MED SURG, V15, P3, DOI 10.1177/1098612X13495234
   Roelke ME, 2006, J WILDLIFE DIS, V42, P234, DOI 10.7589/0090-3558-42.2.234
   Roelke ME, 2009, VIROLOGY, V390, P1, DOI 10.1016/j.virol.2009.04.011
   RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0
   Roertgen KE, 1996, NEUROBIOL AGING, V17, P243, DOI 10.1016/0197-4580(95)02069-1
   Rosen RF, 2008, J COMP NEUROL, V509, P259, DOI 10.1002/cne.21744
   SCHONING P, 1980, J FORENSIC SCI, V25, P53
   Schrenzel MD, 2010, HELICOBACTER, V15, P126, DOI 10.1111/j.1523-5378.2009.00744.x
   Schultheiss PC, 2004, J VET DIAGN INVEST, V16, P522, DOI 10.1177/104063870401600606
   Seehusen F, 2007, ACTA NEUROPATHOL, V114, P597, DOI 10.1007/s00401-007-0307-5
   Serizawa S, 2012, VET PATHOL, V49, P304, DOI 10.1177/0300985811410719
   Shin NS, 1998, J ZOO WILDLIFE MED, V29, P81
   Simpson K., 2013, CANINE FELINE GASTRO, P606
   Stephenson N, 2013, J WILDLIFE DIS, V49, P408, DOI 10.7589/2012-08-210
   Terio KA, 2012, VET PATHOL, V49, P824, DOI 10.1177/0300985811412620
   Thalwitzer S, 2010, CLIN VACCINE IMMUNOL, V17, P232, DOI 10.1128/CVI.00345-09
   Troxel MT, 2003, J VET INTERN MED, V17, P850, DOI 10.1892/0891-6640(2003)017<0850:FINRRO>2.3.CO;2
   Vail DM, 1998, J VET INTERN MED, V12, P349, DOI 10.1111/j.1939-1676.1998.tb02134.x
   van der Burg SH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-108
   Wada Y, 1996, J COMP PATHOL, V115, P305, DOI 10.1016/S0021-9975(96)80087-9
   Wiedner EB, 2008, J ZOO WILDLIFE MED, V39, P121, DOI 10.1638/2007-0080.1
   Wohlsein P, 2013, VET PATHOL, V50, P122, DOI 10.1177/0300985812450719
   Woo PCY, 2012, P NATL ACAD SCI USA, V109, P5435, DOI 10.1073/pnas.1119972109
   YAMAMOTO JK, 1989, J AM VET MED ASSOC, V194, P213
   YANO BL, 1981, VET PATHOL, V18, P310, DOI 10.1177/030098588101800303
   YANO BL, 1981, VET PATHOL, V18, P621, DOI 10.1177/030098588101800507
NR 105
TC 19
Z9 19
U1 0
U2 44
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 18
PY 2015
VL 10
IS 6
AR e0130573
DI 10.1371/journal.pone.0130573
PG 30
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CK9NT
UT WOS:000356567500116
PM 26086731
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Mpimbaza, A
   Filler, S
   Katureebe, A
   Quick, L
   Chandramohan, D
   Staedke, SG
AF Mpimbaza, Arthur
   Filler, Scott
   Katureebe, Agaba
   Quick, Linda
   Chandramohan, Daniel
   Staedke, Sarah G.
TI Verbal Autopsy: Evaluation of Methods to Certify Causes of Death in
   Uganda
SO PLOS ONE
LA English
DT Article
ID DATA-DERIVED ALGORITHMS; DIAGNOSTIC-ACCURACY; NEONATAL DEATHS; ADULT
   DEATHS; VALIDATION; COMMUNITY; MORTALITY; VALIDITY; NEPAL; MODEL
AB To assess different methods for determining cause of death from verbal autopsy (VA) questionnaire data, the intra-rater reliability of Physician-Certified Verbal Autopsy (PCVA) and the accuracy of PCVA, expert-derived (non-hierarchical) and data-driven (hierarchal) algorithms were assessed for determining common causes of death in Ugandan children. A verbal autopsy validation study was conducted from 2008-2009 in three different sites in Uganda. The dataset included 104 neonatal deaths (0-27 days) and 615 childhood deaths (1-59 months) with the cause(s) of death classified by PCVA and physician review of hospital medical records (the 'reference standard'). Of the original 719 questionnaires, 141 (20%) were selected for a second review by the same physicians; the repeat cause(s) of death were compared to the original, and agreement assessed using the Kappa statistic. Physician reviewers' refined non-hierarchical algorithms for common causes of death from existing expert algorithms, from which, hierarchal algorithms were developed. The accuracy of PCVA, non-hierarchical, and hierarchical algorithms for determining cause(s) of death from all 719 VA questionnaires was determined using the reference standard. Overall, intra-rater repeatability was high (83% agreement, Kappa 0.79 [95% CI 0.76-0.82]). PCVA performed well, with high specificity for determining cause of neonatal (>67%), and childhood (> 83%) deaths, resulting in fairly accurate cause-specific mortality fraction (CSMF) estimates. For most causes of death in children, non-hierarchical algorithms had higher sensitivity, but correspondingly lower specificity, than PCVA and hierarchical algorithms, resulting in inaccurate CSMF estimates. Hierarchical algorithms were specific for most causes of death, and CSMF estimates were comparable to the reference standard and PCVA. Inter-rater reliability of PCVA was high, and overall PCVA performed well. Hierarchical algorithms performed better than non-hierarchical algorithms due to higher specificity and more accurate CSMF estimates. Use of PCVA to determine cause of death from VA questionnaire data is reasonable while automated data-driven algorithms are improved.
C1 [Mpimbaza, Arthur] Makerere Univ, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda.
   [Mpimbaza, Arthur; Katureebe, Agaba; Staedke, Sarah G.] Infect Dis Res Collaborat, Kampala, Uganda.
   [Filler, Scott] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland.
   [Quick, Linda] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Chandramohan, Daniel; Staedke, Sarah G.] London Sch Hyg & Trop Med, London WC1, England.
RP Mpimbaza, A (reprint author), Makerere Univ, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda.
EM arthurwakg@yahoo.com
FU President's Malaria Initiative via the Office of Health, Infectious
   Diseases, and Nutrition, Bureau for Global Health, United States Agency
   for International Development; Centers for Disease Control and
   Prevention
FX This research was made possible through support provided by the
   President's Malaria Initiative via the Office of Health, Infectious
   Diseases, and Nutrition, Bureau for Global Health, United States Agency
   for International Development, under the terms of an Interagency
   Agreement with the Centers for Disease Control and Prevention. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Amek NO, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25581
   Anker M, 1997, INT J EPIDEMIOL, V26, P1090, DOI 10.1093/ije/26.5.1090
   Baqui AH, 2006, B WORLD HEALTH ORGAN, V84, P706, DOI 10.2471/BLT.05.026443
   Bauni E, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-49
   Boulle A, 2001, INT J EPIDEMIOL, V30, P515, DOI 10.1093/ije/30.3.515
   Butler D, 2010, NATURE, V467, P1015, DOI 10.1038/4671015a
   Byass P, 2006, SCAND J PUBLIC HEALT, V34, P26, DOI 10.1080/14034940510032202
   Byass P, 2003, SCAND J PUBLIC HEALT, V31, P8, DOI 10.1080/14034950310015040
   Byass P, 2015, J GLOB HEALTH, V5, P65, DOI 10.7189/jogh.05.010402
   Byass P, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19281
   CHANDRAMOHAN D, 1994, INT J EPIDEMIOL, V23, P213, DOI 10.1093/ije/23.2.213
   Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x
   Desai N, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-20
   Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P417, DOI 10.1111/j.1365-3016.2008.00962.x
   Fantahun M, 2006, B WORLD HEALTH ORGAN, V84, P204, DOI 10.2471/BLT.05.028712
   Flaxman AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-29
   Fottrell E, 2010, EPIDEMIOL REV, V32, P38, DOI 10.1093/epirev/mxq003
   Freeman JV, 2005, PAEDIATR PERINAT EP, V19, P323, DOI 10.1111/j.1365-3016.2005.00652.x
   James SL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-31
   Joshi R, 2009, B WORLD HEALTH ORGAN, V87, P51, DOI 10.2471/BLT.08.051250
   Khademi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011183
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee ACC, 2008, PEDIATRICS, V121, pE1372, DOI 10.1542/peds.2007-2644
   Leitao J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-22
   Leitao J, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.21518
   Lopman BA, 2006, PLOS MED, V3, P1273, DOI 10.1371/journal.pmed.0030312
   Lozano R, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-50
   Montgomery AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033075
   Morris SK, 2010, PLOS ONE, V5, pA170, DOI 10.1371/journal.pone.0009583
   Mpimbaza A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026892
   Murray CJL, 2007, PLOS MED, V4, P1739, DOI 10.1371/journal.pmed.0040327
   Murray CJL, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-5
   Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-27
   Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-18
   Ndila C, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25593
   Quigley MA, 1999, INT J EPIDEMIOL, V28, P1081, DOI 10.1093/ije/28.6.1081
   Quigley MA, 2000, TROP MED INT HEALTH, V5, P33, DOI 10.1046/j.1365-3156.2000.00517.x
   Quigley MA, 1996, B WORLD HEALTH ORGAN, V74, P147
   Rai SK, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25573
   Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x
   Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003
   TODD JE, 1994, ANN TROP PAEDIATR, V14, P31, DOI 10.1080/02724936.1994.11747689
   Weldearegawi B, 2013, HLTH POLICY PLAN
   Weldearegawi B, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25550
   World Health Organization, 2012, VERB AUT STAND VERB
   World Health Organization, 2007, VERB AUT STAND ASC A
   Ye M, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-34
NR 47
TC 4
Z9 4
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 18
PY 2015
VL 10
IS 6
AR e0128801
DI 10.1371/journal.pone.0128801
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CK9NT
UT WOS:000356567500024
PM 26086600
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Farion, KJ
   Wright, M
   Zemek, R
   Neto, G
   Karwowska, A
   Tse, S
   Reid, S
   Jabbour, M
   Poirier, S
   Moreau, KA
   Barrowman, N
AF Farion, Ken J.
   Wright, Megan
   Zemek, Roger
   Neto, Gina
   Karwowska, Anna
   Tse, Sandra
   Reid, Sarah
   Jabbour, Mona
   Poirier, Stephanie
   Moreau, Katherine A.
   Barrowman, Nicholas
TI Understanding Low-Acuity Visits to the Pediatric Emergency Department
SO PLOS ONE
LA English
DT Article
ID CANADIAN TRIAGE; SCALE; REASONS; ACCESS; INTERVENTION; PHYSICIANS;
   AGREEMENT; CHILDREN; OUTCOMES; PROGRAM
AB Background
   Canadian pediatric emergency department visits are increasing, with a disproportionate increase in low-acuity visits locally (33% of volume in 2008-09, 41% in 2011-12). We sought to understand: 1) presentation patterns and resource implications; 2) parents' perceptions and motivations; and 3) alternate health care options considered prior to presenting with low-acuity problems.
   Methods
   We conducted a prospective cohort study at our tertiary pediatric emergency department serving two provinces to explore differences between patients with and without a primary care provider. During four, 2-week study periods over 1 year, parents of low-acuity visits received an anonymous survey. Presentation times, interventions, diagnoses and dispositions were captured on a data collection form linked to the survey by study number.
   Results Parents completed 2,443 surveys (74.1% response rate), with survey-data collection form pairs available for 2,146 visits. Overall, 89.7% of respondents had a primary care provider; 68% were family physicians. Surprisingly, 40% of visits occurred during weekday office hours and 27.3% occurred within 4 hours of symptom onset; 67.5% of those early presenters were for injuries. Few parents sought care from their primary care provider (25%), health information line (20.7%), or urgent care clinic (18.5%); 36% reported that they believed their child's problem required the emergency department. Forty-five percent required only a history, physical exam and reassurance; only 11% required an intervention not available in an office setting. Patients without a primary care provider were significantly more likely to present during weekday office hours (p = 0.003), have longer symptom duration (p<0.001), and not know of other options (p = 0.001).
   Conclusions
   Many parents seek pediatric emergency department care for low-acuity problems despite their child having a primary care provider. Ensuring timely access to these providers may help reduce pediatric emergency department overuse. Educational initiatives should inform parents about low-acuity problems and where appropriate care can/should be accessed.
C1 [Farion, Ken J.; Zemek, Roger; Neto, Gina; Karwowska, Anna; Tse, Sandra; Reid, Sarah; Jabbour, Mona; Moreau, Katherine A.; Barrowman, Nicholas] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada.
   [Farion, Ken J.; Zemek, Roger; Neto, Gina; Karwowska, Anna; Tse, Sandra; Reid, Sarah; Jabbour, Mona] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada.
   [Farion, Ken J.; Wright, Megan; Zemek, Roger; Neto, Gina; Karwowska, Anna; Tse, Sandra; Reid, Sarah; Jabbour, Mona; Poirier, Stephanie] Childrens Hosp Eastern Ontario, Emergency Dept, Ottawa, ON K1H 8L1, Canada.
   [Moreau, Katherine A.] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada.
   [Barrowman, Nicholas] Childrens Hosp Eastern Ontario, Res Inst, Clincial Res Unit, Ottawa, ON K1H 8L1, Canada.
RP Farion, KJ (reprint author), Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada.
EM farion@cheo.on.ca
RI Zemek, Roger/H-1039-2018
CR Alari A, 2014, GEOGRAPHIC VARIATION, DOI [10.1787/9789264216594-7-en, DOI 10.1787/9789264216594-7-EN]
   Ben-Isaac E, 2010, PEDIATRICS, V125, P454, DOI 10.1542/peds.2009-0544
   Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005
   Billings J, 2000, Issue Brief (Commonw Fund), P1
   Brousseau DC, 2011, PEDIATRICS, V127, pE375, DOI 10.1542/peds.2010-1723
   Bullard MJ, 2012, EMERG MED J, V29, P372, DOI 10.1136/emj.2010.103598
   Canadian Institute for Health Information, 2013, NATIONAL HEALTH EXPE
   Canadian Institute for Health Information, 2012, WAITS FOR EMERGENCY
   Canadian Institute for Health Information, 2015, HOW CANADA COMPARES
   DeSalvo A, 2000, Clin Perform Qual Health Care, V8, P35, DOI 10.1108/14664100010333017
   Farion KJ, 2010, CJEM, P12
   Fayerman P, 2013, VANCOUVER SUN
   Fieldston ES, 2013, PEDIATR EMERG CARE, V29, P331, DOI 10.1097/PEC.0b013e31828512c7
   Fieldston ES, 2012, PEDIATR EMERG CARE, V28, P220, DOI 10.1097/PEC.0b013e318248b431
   Glavan KA, 1998, MIL MED, V163, P678
   Glazier RH, 2009, CAN MED ASSOC J, V181, P61, DOI 10.1503/cmaj.091104
   Gravel J, 2013, ANN EMERG MED, V61, P27, DOI 10.1016/j.annemergmed.2012.05.024
   Gravel J, 2012, ANN EMERG MED, V60, P71, DOI 10.1016/j.annemergmed.2011.12.004
   Gravel J, 2008, ACAD EMERG MED, V15, P1262, DOI 10.1111/j.1553-2712.2008.00268.x
   Gravel J, 2009, CAN J EMERG MED, V11, P23
   Henneberry RJ, 2012, CAN J EMERG MED, V14, P106, DOI 10.2310/8000.CAEPPS
   Hoot NR, 2008, ANN EMERG MED, V52, P126, DOI 10.1016/j.annemergmed.2008.03.014
   Howard Michelle, 2008, Healthc Policy, V4, P73
   Hudec JC, 2010, CAN FAM PHYSICIAN, V56, pE361
   Huibers L, 2013, J EVAL CLIN PRACT, V19, P243, DOI 10.1111/j.1365-2753.2011.01806.x
   Kubicek K, 2012, PEDIATR EMERG CARE, V28, P977, DOI 10.1097/PEC.0b013e31826c9aab
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   McWilliams DB, 2008, ARCH PEDIAT ADOL MED, V162, P151, DOI 10.1001/archpediatrics.2007.30
   Mian O, 2012, CAN FAM PHYSICIAN, V58, pE658
   Ministry of Health and Long-Term Care of Ontario, 2012, RESULTS BASED PLAN B
   Ministry of Health and Long-Term Care of Ontario, 2009, RESULTS BASED PLAN B
   Miro O, 1999, Eur J Emerg Med, V6, P105
   Morgan SR, 2013, ACAD EMERG MED, V20, P969, DOI 10.1111/acem.12219
   O'Kelly FD, 2010, EMERG MED J, V27, P770, DOI 10.1136/emj.2009.072686
   O'Malley AS, 2013, HEALTH AFFAIR, V32, P175, DOI 10.1377/hlthaff.2012.0494
   O'Malley Ann S, 2005, Issue Brief Cent Stud Health Syst Change, P1
   OECD, 2014, OECD HEALTH STATISTI, DOI [10.1787/hlthxp-total-table-2013-2-en, DOI 10.1787/HLTHXP-TOTAL-TABLE-2013-2-EN]
   PADGETT DK, 1992, SOC SCI MED, V35, P1189, DOI 10.1016/0277-9536(92)90231-E
   Salami O, 2012, PEDIATR EMERG CARE, V28, P43, DOI 10.1097/PEC.0b013e31823f2412
   Schoen C, 2013, HEALTH AFFAIR, V32, P2205, DOI 10.1377/hlthaff.2013.0879
   Stang AS, 2010, ACAD EMERG MED, V17, P151, DOI 10.1111/j.1553-2712.2009.00631.x
   Stockwell MS, 2010, PEDIATR EMERG CARE, V26, P181, DOI 10.1097/PEC.0b013e3181d1dfc7
   Sturm JJ, 2014, CLIN PEDIATR, V53, P988, DOI 10.1177/0009922814540987
   Sturm JJ, 2010, ACAD PEDIATR, V10, P70, DOI 10.1016/j.acap.2009.10.001
   Timm NL, 2008, ACAD EMERG MED, V15, P832, DOI 10.1111/j.1553-2712.2008.00224.x
   Warren DW, 2008, CAN J EMERG MED, V10, P224
   Wilkin HA, 2012, HEALTH EDUC RES, V27, P1031, DOI 10.1093/her/cys090
NR 47
TC 14
Z9 14
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 17
PY 2015
VL 10
IS 6
AR UNSP e0128927
DI 10.1371/journal.pone.0128927
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CK9NS
UT WOS:000356567400073
PM 26083338
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Nishihara, K
   Ohki, N
   Kamata, H
   Ryo, E
   Horiuchi, S
AF Nishihara, Kyoko
   Ohki, Noboru
   Kamata, Hideo
   Ryo, Eiji
   Horiuchi, Shigeko
TI Automated Software Analysis of Fetal Movement Recorded during a Pregnant
   Woman's Sleep at Home
SO PLOS ONE
LA English
DT Article
ID ULTRASOUND; PATTERNS
AB Fetal movement is an important biological index of fetal well-being. Since 2008, we have been developing an original capacitive acceleration sensor and device that a pregnant woman can easily use to record fetal movement by herself at home during sleep. In this study, we report a newly developed automated software system for analyzing recorded fetal movement. This study will introduce the system and compare its results to those of a manual analysis of the same fetal movement signals (Experiment I). We will also demonstrate an appropriate way to use the system (Experiment II). In Experiment I, fetal movement data reported previously for six pregnant women at 28-38 gestational weeks were used. We evaluated the agreement of the manual and automated analyses for the same 10-sec epochs using prevalence-adjusted bias-adjusted kappa (PABAK) including quantitative indicators for prevalence and bias. The mean PABAK value was 0.83, which can be considered almost perfect. In Experiment II, twelve pregnant women at 24-36 gestational weeks recorded fetal movement at night once every four weeks. Overall, mean fetal movement counts per hour during maternal sleep significantly decreased along with gestational weeks, though individual differences in fetal development were noted. This newly developed automated analysis system can provide important data throughout late pregnancy.
C1 [Nishihara, Kyoko] Inst Sci Labour, Fatigue & Working Life Res Grp, Kawasaki, Kanagawa, Japan.
   [Ohki, Noboru] NoruPro Light Syst, Tokyo, Japan.
   [Kamata, Hideo; Ryo, Eiji] Teikyo Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 173, Japan.
   [Horiuchi, Shigeko] St Lukes Int Univ, Dept Maternal Infant Nursing Midwifery, Tokyo, Japan.
   [Nishihara, Kyoko] Tokyo Metropolitan Inst Med Sci, Integrated Brain Funct Project, Tokyo 113, Japan.
RP Nishihara, K (reprint author), Inst Sci Labour, Fatigue & Working Life Res Grp, Kawasaki, Kanagawa, Japan.
EM nishihara-kk@igakuken.or.jp
OI horiuchi, shigeko/0000-0001-7412-3941
FU Japan Society for the Promotion of Science (JSPS) [B 20390566, C
   23591737]; Suzuken Memorial Foundation
FX The software was created with the help of a Grant-in-Aid for Scientific
   Research (B 20390566) provided by the Japan Society for the Promotion of
   Science (JSPS). Experiment II was supported in part by (C 23591737) of
   the same JSPS, and in part by the Suzuken Memorial Foundation. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR BESINGER RE, 1989, OBSTET GYNECOL, V74, P277
   Blyton DM, 2013, SLEEP, V36, P15, DOI 10.5665/sleep.2292
   BONNET M, 1993, SLEEP, V16, P748
   BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V
   DiPietro JA, 2010, CHILD DEV, V81, P115, DOI 10.1111/j.1467-8624.2009.01384.x
   Froen JF, 2004, J PERINAT MED, V32, P13, DOI 10.1515/JPM.2004.003
   Goldenberg RL, 2011, LANCET, V377, P1798, DOI 10.1016/S0140-6736(10)62235-0
   Koyanagi T, 1993, J REPROD INFANT PSYC, V11, P129
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Maeda K, 1999, CLIN PERINATOL, V26, P829
   Manconi M, 2004, NEUROLOGY, V63, P1065, DOI 10.1212/01.WNL.0000138427.83574.A6
   MANNING FA, 1980, AM J OBSTET GYNECOL, V136, P787, DOI 10.1016/0002-9378(80)90457-3
   Morokuma S, 2013, BRAIN DEV-JPN, V35, P61, DOI 10.1016/j.braindev.2012.01.007
   Nishihara K, 2008, EARLY HUM DEV, V84, P595, DOI 10.1016/j.earthumdev.2008.03.001
   PEARSON JF, 1976, BRIT MED J, V1, P1305, DOI 10.1136/bmj.1.6021.1305
   Ryo E, 2014, J MATERN-FETAL NEO M, V27, P1604, DOI 10.3109/14767058.2013.863868
   Ryo E, 2012, J MATERN-FETAL NEO M, V25, P2629, DOI 10.3109/14767058.2012.704449
   Ryo E, 2012, MED ENG PHYS, V34, P566, DOI 10.1016/j.medengphy.2011.09.001
   SADOVSKY E, 1973, OBSTET GYNECOL, V41, P845
   Stacey T, 2011, BMJ-BRIT MED J, V14, P342
   WILLIAMS RL, 1964, ELECTROEN CLIN NEURO, V17, P376, DOI 10.1016/0013-4694(64)90160-9
   Winer B.J., 1971, STATISTICAL PRINCIPL, P261
NR 22
TC 4
Z9 4
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 17
PY 2015
VL 10
IS 6
AR UNSP e0130503
DI 10.1371/journal.pone.0130503
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CK9NS
UT WOS:000356567400146
PM 26083422
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zhu, Z
   Zhao, XM
   Zhao, YF
   Wang, XY
   Zhou, CW
AF Zhu, Zheng
   Zhao, Xin-ming
   Zhao, Yan-feng
   Wang, Xiao-yi
   Zhou, Chun-wu
TI Feasibility Study of Using Gemstone Spectral Imaging (GSI) and Adaptive
   Statistical Iterative Reconstruction (ASIR) for Reducing Radiation and
   Iodine Contrast Dose in Abdominal CT Patients with High BMI Values
SO PLOS ONE
LA English
DT Article
ID LOW-TUBE-VOLTAGE; QUALITY; EXPOSURE; NOISE; RISK
AB Purpose
   To prospectively investigate the effect of using Gemstone Spectral Imaging (GSI) and adaptive statistical iterative reconstruction (ASIR) for reducing radiation and iodine contrast dose in abdominal CT patients with high BMI values.
   Materials and Methods
   26 patients (weight > 65kg and BMI >= 22) underwent abdominal CT using GSI mode with 300mgI/kg contrast material as study group (group A). Another 21 patients (weight <= 65kg and BMI >= 22) were scanned with a conventional 120 kVp tube voltage for noise index (NI) of 11 with 450mgI/kg contrast material as control group (group B). GSI images were reconstructed at 60keV with 50% ASIR and the conventional 120kVp images were reconstructed with FBP reconstruction. The CT values, standard deviation (SD), signal-noise-ratio (SNR), contrast-noise-ratio (CNR) of 26 landmarks were quantitatively measured and image quality qualitatively assessed using statistical analysis.
   Results
   As for the quantitative analysis, the difference of CNR between groups A and B was all significant except for the mesenteric vein. The SNR in group A was higher than B except the mesenteric artery and splenic artery. As for the qualitative analysis, all images had diagnostic quality and the agreement for image quality assessment between the reviewers was substantial (kappa = 0.684). CT dose index (CTDI) values for non-enhanced, arterial phase and portal phase in group A were decreased by 49.04%, 40.51% and 40.54% compared with group B (P = 0.000), respectively. The total dose and the injection rate for the contrast material were reduced by 14.40% and 14.95% in A compared with B.
   Conclusion
   The use of GSI and ASIR provides similar enhancement in vessels and image quality with reduced radiation dose and contrast dose, compared with the use of conventional scan protocol.
C1 [Zhu, Zheng; Zhao, Xin-ming; Zhao, Yan-feng; Wang, Xiao-yi; Zhou, Chun-wu] Chinese Acad Med Sci, Canc Inst & Hosp, Peking Union Med Coll, Dept Diagnost Radiol, Beijing 100021, Peoples R China.
RP Zhao, XM (reprint author), Chinese Acad Med Sci, Canc Inst & Hosp, Peking Union Med Coll, Dept Diagnost Radiol, Beijing 100021, Peoples R China.
EM xinmingzh@sina.com
CR Amis E Stephen Jr, 2007, J Am Coll Radiol, V4, P272, DOI 10.1016/j.jacr.2007.03.002
   Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149
   Funama Y, 2006, RADIOLOGY, V237, P905, DOI 10.1148/radiol.2373041643
   Gervaise A, 2012, EUR RADIOL, V22, P295, DOI 10.1007/s00330-011-2271-7
   Kalra MK, 2004, RADIOLOGY, V230, P619, DOI 10.1148/radiol.2303021726
   Korn A, 2012, AM J NEURORADIOL, V33, P218, DOI 10.3174/ajnr.A2749
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lauer MS, 2009, NEW ENGL J MED, V361, P841, DOI 10.1056/NEJMp0904735
   Leipsic J, 2010, AM J ROENTGENOL, V195, P649, DOI 10.2214/AJR.10.4285
   Maldjian PD, 2013, AM J ROENTGENOL, V200, P741, DOI 10.2214/AJR.12.9768
   Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094
   Mettler FA, 2009, RADIOLOGY, V253, P520, DOI 10.1148/radiol.2532082010
   Nakayama Y, 2006, RADIOLOGY, V237, P945, DOI 10.1148/radiol.2373041655
   Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0
   Pontana F, 2011, EUR RADIOL, V21, P627, DOI 10.1007/s00330-010-1990-5
   Singh S, 2011, RADIOLOGY, V259, P565, DOI 10.1148/radiol.11101450
   SVANHOLM H, 1989, APMIS, V97, P689, DOI 10.1111/j.1699-0463.1989.tb00464.x
   Thrall JH, 2012, RADIOLOGY, V264, P325, DOI 10.1148/radiol.12121137
   Wagner LK, 2004, RADIOLOGY, V233, P307, DOI 10.1148/radiol.2332040584
   Yeh BM, 2009, AM J ROENTGENOL, V193, P47, DOI 10.2214/AJR.09.2592
   Yoshinaga S, 2004, RADIOLOGY, V233, P313, DOI 10.1148/radiol.2332031119
   Zhang D, 2011, MED PHYS, V38, P1178, DOI 10.1118/1.3551999
NR 22
TC 12
Z9 21
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 16
PY 2015
VL 10
IS 6
AR e0129201
DI 10.1371/journal.pone.0129201
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CK9EB
UT WOS:000356542300019
PM 26079259
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Deng, SM
   Zhang, W
   Zhang, B
   Chen, YY
   Li, JH
   Wu, YW
AF Deng, Sheng-ming
   Zhang, Wei
   Zhang, Bin
   Chen, Yin-yin
   Li, Ji-hui
   Wu, Yi-wei
TI Correlation between the Uptake of F-18-Fluorodeoxyglucose (F-18-FDG) and
   the Expression of Proliferation-Associated Antigen Ki-67 in Cancer
   Patients: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID POSITRON-EMISSION-TOMOGRAPHY; CELL LUNG-CANCER; GASTROINTESTINAL STROMAL
   TUMORS; STANDARDIZED UPTAKE VALUE; GLUCOSE METABOLIC-RATE; SOFT-TISSUE
   SARCOMAS; NON-HODGKIN-LYMPHOMA; BREAST-CANCER; FDG UPTAKE;
   PROGNOSTIC-FACTORS
AB Objective
   To study the correlation between F-18-FDG uptake and cell proliferation in cancer patients by meta-analysis of published articles.
   Methods
   We searched PubMed (MEDLINE included), EMBASE, and Cochrane Database of Systematic Review, and selected research articles on the relationship between F-18-FDG uptake and Ki-67 expression (published between August 1, 1994-August 1, 2014), according to the literature inclusion and exclusion criteria. The publishing language was limited to English. The quality of included articles was evaluated according to the Quality Assessment of Diagnosis Accuracy Studies-2 (QUADAS-2). The correlation coefficient (r) was extracted from the included articles and processed by Fisher's r-to-z transformation. The combined correlation coefficient (r) and the 95% confidence interval (CI) were calculated with STATA 11.0 software under a random-effects model. Begg's test was used to analyze the existence of publication bias and draw funnel plot, and the sources of heterogeneity were explored by sensitivity and subgroup analyses.
   Results
   According to the inclusion and exclusion criteria, 79 articles were finally included, including 81 studies involving a total of 3242 patients. All the studies had a combined r of 0.44 (95% CI, 0.41-0.46), but with a significant heterogeneity (I-2 = 80.9%, P<0.01). Subgroup analysis for different tumor types indicated that most subgroups showed a reduced heterogeneity. Malignant melanoma (n = 1) had the minimum correlation coefficient (-0.22) between F-18-FDG uptake and Ki-67 expression, while the thymic epithelial tumors (TETs; n = 2) showed the maximum correlation coefficient of 0.81. The analytical results confirmed that correlation between F-18-FDG uptake and Ki-67 expression was extremely significant in TETs, significant in gastrointestinal stromal tumors (GISTs), moderate in patients with lung, breast, bone and soft tissue, pancreatic, oral, thoracic, and uterine and ovarian cancers, average in brain, esophageal and colorectal cancers, and poor in head and neck, thyroid, gastric and malignant melanoma tumors. Subgroup analysis indicated that positron emission tomography (PET) or PET/CT imaging technology or Ki-67 and standardized uptake value (SUV) measurement technology did not significantly affect the results of r values, and Begg's test showed no significant publication bias.
   Conclusion
   In cancer patients, F-18-FDG uptake showed a moderate positive correlation with tumor cell proliferation. Different tumor types exhibited varied degree of correlation, and the correlation was significant in TETs and GSTs. However, our results need further validation by clinical trials with a large sample of different tumor types.
C1 [Deng, Sheng-ming; Zhang, Wei; Zhang, Bin; Li, Ji-hui; Wu, Yi-wei] Soochow Univ, Dept Nucl Med, Affiliated Hosp 1, Suzhou, Peoples R China.
   [Deng, Sheng-ming] Soochow Univ, Coll Med, Sch Radiat Med & Protect, Suzhou, Peoples R China.
   [Zhang, Bin] Jiangsu Inst Nucl Med, Jiangsu Key Lab Mol Nucl Med, Minist Hlth, Key Lab Nucl Med, Wuxi, Peoples R China.
   [Chen, Yin-yin] Soochow Univ, Dept Radiol, Affiliated Hosp 1, Suzhou, Peoples R China.
RP Zhang, B (reprint author), Soochow Univ, Dept Nucl Med, Affiliated Hosp 1, Suzhou, Peoples R China.
EM zbnuclmd@126.com
OI Deng, Shengming/0000-0002-1450-7721
FU Open Program of Key Laboratory of Nuclear Medicine, Ministry of Health
   and Jiangsu Key Laboratory of Molecular Nuclear Medicine [KF201305,
   KF201306]; Science and Technology Development Program of Suzhou
   [SYSD2013076]; Application Foundation Research Program of Suzhou
   [SYS201224]
FX This study was supported by the Open Program of Key Laboratory of
   Nuclear Medicine, Ministry of Health and Jiangsu Key Laboratory of
   Molecular Nuclear Medicine (KF201305 and KF201306), Science and
   Technology Development Program of Suzhou (SYSD2013076), Application
   Foundation Research Program of Suzhou (SYS201224). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Avril N, 2001, J NUCL MED, V42, P9
   Bai B, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0339-0
   Barthel H, 2005, EUR J NUCL MED MOL I, V32, P257, DOI 10.1007/s00259-004-1611-0
   Buchmann I, 2003, CANCER BIOTHER RADIO, V18, P327, DOI 10.1089/108497803322285080
   Buchmann I, 2008, CANCER BIOTHER RADIO, V23, P172, DOI 10.1089/cbr.2007.349
   Buck A, 2002, EUR J NUCL MED MOL I, V29, P1317, DOI 10.1007/s00259-002-0880-8
   Buck AC, 2001, J NUCL MED, V42, P721
   Buck AK, 2003, J NUCL MED, V44, P1426
   Buck AK, 2006, CANCER RES, V66, P11055, DOI 10.1158/0008-5472.CAN-06-1955
   Chalkidou A, 2012, EUR J CANCER, V48, P3499, DOI 10.1016/j.ejca.2012.05.001
   Chang CC, 2012, CLIN NUCL MED, V37, pE189, DOI 10.1097/RLU.0b013e318251e16e
   Chen LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079008
   Chen W, 2005, J NUCL MED, V46, P945
   Cheng JY, 2013, J NUCL MED, V54, P333, DOI 10.2967/jnumed.112.111963
   Cher LM, 2006, J NUCL MED, V47, P410
   Cherk MH, 2006, J NUCL MED, V47, P1921
   Chihara D, 2011, INT J HEMATOL, V93, P502, DOI 10.1007/s12185-011-0822-y
   Cochet A, 2012, J NUCL MED, V53, P512, DOI 10.2967/jnumed.111.096834
   Deron P, 2011, NUKLEARMED-NUCL MED, V50, P15, DOI 10.3413/nukmed-0324-10-06
   Folpe AL, 2000, CLIN CANCER RES, V6, P1279
   Francis DL, 2003, GUT, V52, P1602, DOI 10.1136/gut.52.11.1602
   Garcia-Esquinas MG, 2014, Q J NUCL MED MOL IM, V58, P66
   Vicente AMG, 2012, CLIN NUCL MED, V37, P460, DOI 10.1097/RLU.0b013e31823926c9
   Han B, 2009, NUCL MED COMMUN, V30, P831, DOI 10.1097/MNM.0b013e32832dcfc4
   Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364
   Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809
   Hirose Y, 2014, LEUKEMIA LYMPHOMA, V55, P520, DOI 10.3109/10428194.2013.807509
   Hoshikawa H, 2011, MOL IMAGING BIOL, V13, P172, DOI 10.1007/s11307-010-0331-z
   Hu SL, 2013, NUCL MED COMMUN, V34, P533, DOI 10.1097/MNM.0b013e328360668a
   Humbert O, 2014, EUR J NUCL MED MOL I, V41, P416, DOI 10.1007/s00259-013-2616-3
   Ikenaga N, 2007, AM SURGEON, V73, P1151
   Ishii Y, 2012, ACTA HAEMATOL-BASEL, V128, P110, DOI 10.1159/000338263
   Jacob R, 2001, ORL J OTO-RHINO-LARY, V63, P307, DOI 10.1159/000055764
   Kaida H, 2014, NUCL MED COMMUN, V35, P36, DOI 10.1097/MNM.0000000000000019
   Kaira K, 2012, EUR J CANCER, V48, P1244, DOI 10.1016/j.ejca.2012.01.016
   Kaira K, 2009, CANCER SCI, V100, P753, DOI 10.1111/j.1349-7006.2008.01077.x
   Kameyama R, 2009, EUR J NUCL MED MOL I, V36, P382, DOI 10.1007/s00259-008-0970-3
   Kamiyama Y, 2005, WORLD J SURG, V29, P1429, DOI 10.1007/s00268-005-0045-6
   Kato T, 2008, AM J NEURORADIOL, V29, P1176, DOI 10.3174/ajnr.A1008
   Kazama T, 2005, RADIOGRAPHICS, V25, P191, DOI 10.1148/rg.251045045
   Kim IJ, 2010, CANCER BIOTHER RADIO, V25, P309, DOI 10.1089/cbr.2009.0636
   Kim S, 2005, EUR J NUCL MED MOL I, V32, P52, DOI 10.1007/s00259-004-1598-6
   Kitagawa Y, 2003, EUR J NUCL MED MOL I, V30, P63, DOI 10.1007/s00259-002-0978-z
   Kitamura K, 2011, J HEPATOL, V55, P846, DOI 10.1016/j.jhep.2011.01.038
   Koolen BB, 2012, EUR J NUCL MED MOL I, V39, P1830, DOI 10.1007/s00259-012-2211-z
   Kurland BF, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-34
   Kurokawa T, 2004, INT J CANCER, V109, P926, DOI 10.1002/ijc.20057
   Kuyumcu S, 2012, ANN NUCL MED, V26, P689, DOI 10.1007/s12149-012-0628-x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee JW, 2009, EUR J NUCL MED MOL I, V36, P1574, DOI 10.1007/s00259-009-1133-x
   Leonard JP, 2012, BLOOD, V119, P4597, DOI 10.1182/blood-2011-10-388298
   Matsumoto I, 2013, ANN THORAC SURG, V95, P305, DOI 10.1016/j.athoracsur.2012.09.052
   Minamimoto R, 2012, J NUCL MED, V53, P199, DOI 10.2967/jnumed.111.095539
   Miyake K, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/205818
   Miyashita G, 2010, ANN NUCL MED, V24, P579, DOI 10.1007/s12149-010-0398-2
   Murakami S, 2010, EUR J RADIOL, V75, pE62, DOI 10.1016/j.ejrad.2009.11.020
   Nakamura H, 2009, ANN THORAC CARDIOVAS, V15, P304
   Nguyen XC, 2007, EUR J RADIOL, V62, P214, DOI 10.1016/j.ejrad.2006.12.008
   Nishiyama Y, 2012, JPN J CLIN ONCOL, V42, P912, DOI 10.1093/jjco/hys116
   Papajik T, 2011, EUR J HAEMATOL, V86, P32, DOI 10.1111/j.1600-0609.2010.01532.x
   Park JW, 2011, J GASTRIC CANCER, V11, P173, DOI 10.5230/jgc.2011.11.3.173
   Park SG, 2012, NUCL MED BIOL, V39, P1167, DOI 10.1016/j.nucmedbio.2012.07.003
   Riedl CC, 2007, J NUCL MED, V48, P771, DOI 10.2967/jnumed.106.037291
   Rupinski MT, 1996, EDUC PSYCHOL MEAS, V56, P419, DOI 10.1177/0013164496056003004
   Sauter AW, 2012, J NUCL MED, V53, P521, DOI 10.2967/jnumed.111.097865
   Shibata H, 2009, ANN NUCL MED, V23, P609, DOI 10.1007/s12149-009-0278-9
   Shimoda Wataru, 2007, Breast Cancer, V14, P260, DOI 10.2325/jbcs.14.260
   Shimomura H, 2015, INT J CLIN ONCOL, V20, P308, DOI 10.1007/s10147-014-0711-5
   Shou Y, 2012, J CANCER RES THER, V8, P96, DOI 10.4103/0973-1482.95182
   Suzuki S, 2014, BRIT J CANCER, V110, P1985, DOI 10.1038/bjc.2014.142
   Takenaka T, 2009, J SURG ONCOL, V100, P688, DOI 10.1002/jso.21386
   Tanaka R, 2013, CLIN IMAG, V37, P876, DOI 10.1016/j.clinimag.2013.06.001
   Tang BF, 2009, MOL IMAGING BIOL, V11, P296, DOI 10.1007/s11307-009-0226-z
   Tateishi U, 2006, EUR J NUCL MED MOL I, V33, P683, DOI 10.1007/s00259-005-0044-8
   Tchou J, 2010, MOL IMAGING BIOL, V12, P657, DOI 10.1007/s11307-009-0294-0
   Tsujikawa T, 2011, EUR J NUCL MED MOL I, V38, P37, DOI 10.1007/s00259-010-1589-8
   Ueda S, 2011, BREAST CANCER-TOKYO, V18, P299, DOI 10.1007/s12282-010-0212-y
   van Westreenen HL, 2005, J NUCL MED, V46, P400
   Vesselle H, 2008, J THORAC ONCOL, V3, P971, DOI 10.1097/JTO.0b013e31818307a7
   Viti A, 2014, EUR J CARDIO-THORAC, V46, P369, DOI 10.1093/ejcts/ezu030
   Walter F, 2011, PEDIATR HEMAT ONCOL, V28, P579, DOI 10.3109/08880018.2011.602180
   Watanabe K, 2006, JPN J CLIN ONCOL, V36, P403, DOI 10.1093/jjco/hyl043
   Watanabe R, 2010, LEUKEMIA LYMPHOMA, V51, P279, DOI 10.3109/10428190903440953
   Westerterp M, 2008, J CANCER RES CLIN, V134, P227, DOI 10.1007/s00432-007-0275-0
   Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009
   Wu XC, 2012, LEUKEMIA LYMPHOMA, V53, P400, DOI 10.3109/10428194.2011.622420
   Yamada M, 2007, SCAND J GASTROENTERO, V42, P633, DOI 10.1080/00365520601040450
   Yamamoto Y, 2007, EUR J NUCL MED MOL I, V34, P1610, DOI 10.1007/s00259-007-0449-7
   Yamamoto Y, 2009, NUCL MED COMMUN, V30, P841, DOI 10.1097/MNM.0b013e328330294d
   Yang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078192
   Yap CS, 2006, CHEST, V129, P393, DOI 10.1378/chest.129.2.393
   Yoshikawa K, 2013, SURG TODAY, V43, P1162, DOI 10.1007/s00595-012-0411-6
   Zhang J, 2014, INT J CANCER, V134, P606, DOI 10.1002/ijc.28394
   Zhao ZH, 2013, J NUCL MED, V54, P499, DOI 10.2967/jnumed.112.113472
NR 94
TC 24
Z9 24
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 3
PY 2015
VL 10
IS 6
AR e0129028
DI 10.1371/journal.pone.0129028
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CJ7ST
UT WOS:000355700700138
PM 26038827
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gianinazzi, ME
   Rueegg, CS
   Zimmerman, K
   Kuehni, CE
   Michel, G
AF Gianinazzi, Micol E.
   Rueegg, Corina S.
   Zimmerman, Karin
   Kuehni, Claudia E.
   Michel, Gisela
CA SPOG
TI Intra-Rater and Inter-Rater Reliability of a Medical Record Abstraction
   Study on Transition of Care after Childhood Cancer
SO PLOS ONE
LA English
DT Article
ID KAPPA; AGREEMENT; REGISTRY
AB Background
   The abstraction of data from medical records is a widespread practice in epidemiological research. However, studies using this means of data collection rarely report reliability. Within the Transition after Childhood Cancer Study (TaCC) which is based on a medical record abstraction, we conducted a second independent abstraction of data with the aim to assess a) intra-rater reliability of one rater at two time points; b) the possible learning effects between these two time points compared to a gold-standard; and c) inter-rater reliability.
   Method
   Within the TaCC study we conducted a systematic medical record abstraction in the 9 Swiss clinics with pediatric oncology wards. In a second phase we selected a subsample of medical records in 3 clinics to conduct a second independent abstraction. We then assessed intra-rater reliability at two time points, the learning effect over time (comparing each rater at two time-points with a gold-standard) and the inter-rater reliability of a selected number of variables. We calculated percentage agreement and Cohen's kappa.
   Findings
   For the assessment of the intra-rater reliability we included 154 records (80 for rater 1; 74 for rater 2). For the inter-rater reliability we could include 70 records. Intra-rater reliability was substantial to excellent (Cohen's kappa 0-6-0.8) with an observed percentage agreement of 75%-95%. In all variables learning effects were observed. Inter-rater reliability was substantial to excellent (Cohen's kappa 0.70-0.83) with high agreement ranging from 86% to 100%.
   Conclusions
   Our study showed that data abstracted from medical records are reliable. Investigating intra-rater and inter-rater reliability can give confidence to draw conclusions from the abstracted data and increase data quality by minimizing systematic errors.
C1 [Gianinazzi, Micol E.; Rueegg, Corina S.; Michel, Gisela] Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland.
   [Zimmerman, Karin] Univ Childrens Hosp, Pediat Hematol Oncol, Bern, Switzerland.
   [Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Swiss Childhood Canc Registry, Bern, Switzerland.
RP Michel, G (reprint author), Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland.
EM gisela.michel@unilu.ch
RI Rueegg, Corina S/H-7128-2019; Michel, Gisela/G-1081-2018
OI Rueegg, Corina S/0000-0003-3720-4659; Michel,
   Gisela/0000-0002-9589-0928; Kuehni, Claudia/0000-0001-8957-2002
FU Swiss National Science Foundation [PZ00P3_121682/1, PZ00P3-141722];
   Swiss Cancer League [KLS-01605-10-2004, KLS-2215-02-2008,
   KFS-02631-08-2010, KLS-02783-02-2011]; Cancer League Bern; Stiftung zur
   Krebsbekampfung; Swiss Paediatric Oncology Group; Schweizerische
   Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren; Swiss
   Cancer Research; Kinderkrebshilfe Schweiz; Ernst-Gohner Stiftung;
   Stiftung Domarena; National Institute of Cancer Epidemiology and
   Registration
FX This work was supported by the Swiss National Science Foundation
   (Ambizione grant PZ00P3_121682/1 and PZ00P3-141722 to GM); the Swiss
   Cancer League (grant KLS-01605-10-2004, KLS-2215-02-2008,
   KFS-02631-08-2010, KLS-02783-02-2011); Cancer League Bern; and Stiftung
   zur Krebsbekampfung. The work of the Swiss Childhood Cancer Registry is
   supported by the Swiss Paediatric Oncology Group (www.spog.ch),
   Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und
   -direktoren (www.gdk-cds.ch), Swiss Cancer Research
   (www.krebsforschung.ch), Kinderkrebshilfe Schweiz
   (www.kinderkrebshilfe.ch), Ernst-Gohner Stiftung, Stiftung Domarena, and
   National Institute of Cancer Epidemiology and Registration
   (www.nicer.ch). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Allison J J, 2000, Jt Comm J Qual Improv, V26, P115
   BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V
   Eder C, 2011, APPL NURS RES, V18, P50
   FLEISS JL, 1969, PSYCHOL BULL, V72, P323, DOI 10.1037/h0028106
   Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0
   Kottner J, 2011, INT J NURS STUD, V48, P661, DOI 10.1016/j.ijnurstu.2011.01.016
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Michel G, 2008, PEDIATR BLOOD CANCER, V50, P46, DOI 10.1002/pbc.21129
   Michel G, 2007, SWISS MED WKLY, V137, P502
   Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715
   Reeves MJ, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-19
   Sim J, 2005, PHYS THER, V85, P257
   To T, 2008, BMC MED RES METHODOL, P8
   Viera AJ, 2005, FAM MED, V37, P360
   vonKoss Krowchuk H, 1995, J Nurs Meas, V3, P3
   Yawn BP, 2005, AM J EPIDEMIOL, V161, P974, DOI 10.1093/aje/kwi122
NR 16
TC 1
Z9 1
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 22
PY 2015
VL 10
IS 5
AR e0124290
DI 10.1371/journal.pone.0124290
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CI7GR
UT WOS:000354931700005
PM 26001046
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-07-16
ER

PT J
AU Toth, M
   Doorduin, J
   Haggkvist, J
   Varrone, A
   Amini, N
   Halldin, C
   Gulyas, B
AF Toth, Miklos
   Doorduin, Janine
   Haggkvist, Jenny
   Varrone, Andrea
   Amini, Nahid
   Halldin, Christer
   Gulyas, Balazs
TI Positron Emission Tomography studies with [C-11]PBR28 in the Healthy
   Rodent Brain: Validating SUV as an Outcome Measure of Neuroinflammation
SO PLOS ONE
LA English
DT Article
ID PERIPHERAL BENZODIAZEPINE-RECEPTOR; PROTEIN 18 KDA; PERFORMANCE
   EVALUATION; RADIOLIGAND
AB Molecular imaging of the 18 kD Translocator protein (TSPO) with positron emission tomography (PET) is of great value for studying neuroinflammation in rodents longitudinally. Quantification of the TSPO in rodents is, however, quite challenging. There is no suitable reference region and the use of plasma-derived input is not an option for longitudinal studies. The aim of this study was therefore to evaluate the use of the standardized uptake value (SUV) as an outcome measure for TSPO imaging in rodent brain PET studies, using [C-11]PBR28. In the first part of the study, healthy male Wistar rats (n = 4) were used to determine the correlation between the distribution volume (V-T, calculated with Logan graphical analysis) and the SUV. In the second part, healthy male Wistar rats (n = 4) and healthy male C57BL/6J mice (n = 4), were used to determine the test-retest variability of the SUV, with a 7-day interval between measurements. Dynamic PET scans of 63 minutes were acquired with a nanoScan PET/MRI and nanoScan PET/CT. An MRI scan was made for anatomical reference with each measurement. The whole brain V-T of [C-11]PBR28 in rats was 42.9 +/- 1.7. A statistically significant correlation (r(2) = 0.96; p < 0.01) was found between the V-T and the SUV. The test-retest variability in 8 brain region ranged from 8 to 20% in rats and from 7 to 23% in mice. The interclass correlation coefficient (ICC) was acceptable to excellent for rats, but poor to acceptable for mice. In conclusion: The SUV of [C-11]PBR28 showed a high correlation with V-T as well as good test-retest variability. For future longitudinal small animal PET studies the SUV can thus be used to describe [C-11]PBR28 uptake in healthy brain tissue. Based on the present observations, further studies are needed to explore the applicability of this approach in small animal disease models, with special regard to neuroinflammatory models.
C1 [Toth, Miklos; Doorduin, Janine; Haggkvist, Jenny; Varrone, Andrea; Amini, Nahid; Halldin, Christer; Gulyas, Balazs] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden.
   [Doorduin, Janine] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands.
   [Halldin, Christer; Gulyas, Balazs] Nanyang Technol Univ, Lee Chian Kong Sch Med, Imperial Coll NTU, Singapore 639798, Singapore.
RP Toth, M (reprint author), Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden.
EM miklos.toth@ki.se
RI Gulyas, Balazs/F-9508-2015
OI Toth, Miklos/0000-0002-1652-7136
FU European Union [GA 278850]; European Cooperation in Science and
   Technology COST Action [TD1007]
FX CH, BG, and MT received funding from European Union's Seventh Framework
   Program FP7/2007-2013, GA 278850, Imaging of Neuroinflammation in
   Neurodegenerative Diseases (http://www.uni-muenster.de/InMind/). CH and
   BG recieved funding from European Cooperation in Science and Technology
   COST Action TD1007 (http://www.pet-mri.eu/). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Briard E, 2008, J MED CHEM, V51, P17, DOI 10.1021/jm0707370
   Doorduin J, 2009, MOL IMAGING BIOL, V11, P386, DOI 10.1007/s11307-009-0211-6
   Doorduin J, 2008, CURR PHARM DESIGN, V14, P3297, DOI 10.2174/138161208786549443
   Fujita M, 2008, NEUROIMAGE, V40, P43, DOI 10.1016/j.neuroimage.2007.11.011
   Hashimoto K, 1989, Ann Nucl Med, V3, P63
   Hirvonen J, 2012, J NUCL MED, V53, P234, DOI 10.2967/jnumed.111.091694
   Imaizumi M, 2007, NEUROSCI LETT, V411, P200, DOI 10.1016/j.neulet.2006.09.093
   Kreisl WC, 2013, BRAIN, V136, P2228, DOI 10.1093/brain/awt145
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Logan J, 2000, NUCL MED BIOL, V27, P661, DOI 10.1016/S0969-8051(00)00137-2
   Nagy K, 2013, J NUCL MED, V54, P1825, DOI 10.2967/jnumed.112.119065
   Papadopoulos V, 1997, J BIOL CHEM, V272, P32129, DOI 10.1074/jbc.272.51.32129
   Papadopoulos V, 2004, ENDOCR RES, V30, P677, DOI 10.1081/ERC-200043971
   Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005
   Szanda I, 2011, J NUCL MED, V52, P1741, DOI 10.2967/jnumed.111.088260
   Turkheimer FE, 2007, J NUCL MED, V48, P158
   Venneti S, 2006, PROG NEUROBIOL, V80, P308, DOI 10.1016/j.pneurobio.2006.10.002
   Venneti S, 2013, GLIA, V61, P10, DOI 10.1002/glia.22357
   Wang M, 2009, BIOORG MED CHEM LETT, V19, P5636, DOI 10.1016/j.bmcl.2009.08.051
   Yoder KK, 2014, INT S FUNCT NEUR MAP, P87
NR 20
TC 6
Z9 6
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 21
PY 2015
VL 10
IS 5
AR e0125917
DI 10.1371/journal.pone.0125917
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CK7VW
UT WOS:000356444000014
PM 25996996
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lee, JH
   Park, CM
   Park, SJ
   Bae, JS
   Lee, SM
   Goo, JM
AF Lee, Jong Hyuk
   Park, Chang Min
   Park, Sang Joon
   Bae, Jae Seok
   Lee, Sang Min
   Goo, Jin Mo
TI Value of Computerized 3D Shape Analysis in Differentiating Encapsulated
   from Invasive Thymomas
SO PLOS ONE
LA English
DT Article
ID THYMIC EPITHELIAL TUMORS; NONINVASIVE THYMOMA; CT; TOMOGRAPHY
AB Objectives
   To retrospectively investigate the added value of quantitative 3D shape analysis in differentiating encapsulated from invasive thymomas.
   Materials and Methods
   From February 2002 to October 2013, 53 patients (25 men and 28 women; mean age, 53.94 +/- 13.13 years) with 53 pathologically-confirmed thymomas underwent preoperative chest CT scans (slice thicknesses <= 2.5 mm). Twenty-three tumors were encapsulated thymomas and 30 were invasive thymomas. Their clinical and CT characteristics were evaluated. In addition, each thymoma was manually-segmented from surrounding structures, and their 3D shape features were assessed using an in-house developed software program. To evaluate the added value of 3D shape features in differentiating encapsulated from invasive thymomas, logistic regression analysis and receiver-operating characteristics curve (ROC) analysis were performed.
   Results
   Significant differences were observed between encapsulated and invasive thymomas, in terms of cystic changes (p=0.004), sphericity (p=0.016), and discrete compactness (p=0.001). Subsequent binary logistic regression analysis revealed that absence of cystic change (adjusted odds ratio (OR) = 6.636; p=0.015) and higher discrete compactness (OR = 77.775; p=0.012) were significant differentiators of encapsulated from invasive thymomas. ROC analyses revealed that the addition of 3D shape analysis to clinical and CT features (AUC, 0.955; 95% CI, 0.935-0.975) provided significantly higher performance in differentiating encapsulated from invasive thymomas than clinical and CT features (AUC, 0.666; 95% CI, 0.626-0.707) (p<0.001).
   Conclusion
   Addition of 3D shape analysis, particularly discrete compactness, can improve differentiation of encapsulated thymomas from invasive thymomas.
C1 [Lee, Jong Hyuk; Park, Chang Min; Park, Sang Joon; Bae, Jae Seok; Lee, Sang Min; Goo, Jin Mo] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.
   [Lee, Jong Hyuk; Park, Chang Min; Park, Sang Joon; Bae, Jae Seok; Lee, Sang Min; Goo, Jin Mo] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.
   [Park, Chang Min; Park, Sang Joon; Goo, Jin Mo] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea.
RP Park, CM (reprint author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.
EM cmpark@radiol.snu.ac.kr
FU Research of the Korean Foundation for Cancer Research [CB-2011-02-01]
FX This study has received funding by the Research of the Korean Foundation
   for Cancer Research (grant number: CB-2011-02-01). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Aerts M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4789
   Bankier AA, 2010, RADIOLOGY, V257, P14, DOI 10.1148/radiol.10100252
   Benveniste MFK, 2011, RADIOGRAPHICS, V31, P1847, DOI 10.1148/rg.317115505
   Braumann U-D, 2004, BULLETIN, V1, P9
   Bribiesca E, 2008, PATTERN RECOGN, V41, P543, DOI 10.1016/j.patcog.2007.06.029
   Chae HD, 2014, RADIOLOGY, V273, P285, DOI 10.1148/radiol.14132187
   DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
   Doros G, 2010, AM J BIOSTAT, V1, P1, DOI DOI 10.3844/AMJBSP.2010.1.8
   Jeong YJ, 2004, AM J ROENTGENOL, V183, P283, DOI 10.2214/ajr.183.2.1830283
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liu GB, 2012, ASIAN PAC J CANCER P, V13, P5581, DOI 10.7314/APJCP.2012.13.11.5581
   Marom EM, 2013, J THORAC IMAG, V28, P69, DOI 10.1097/RTI.0b013e31828609a0
   Marom EM, 2011, J THORAC ONCOL, V6, P1274, DOI 10.1097/JTO.0b013e31821c4203
   Marom EM, 2010, J THORAC ONCOL, V5, pS296, DOI 10.1097/JTO.0b013e3181f209ca
   Nasseri F, 2010, RADIOGRAPHICS, V30, P413, DOI 10.1148/rg.302095131
   Nishino M, 2006, RADIOGRAPHICS, V26, P335, DOI 10.1148/rg.262045213
   Priola AM, 2010, RADIOL MED, V115, P1, DOI 10.1007/s11547-009-0478-3
   Qu YJ, 2013, ACAD RADIOL, V20, P66, DOI 10.1016/j.acra.2012.08.002
   Ruffini E, 2011, EUR J CARDIO-THORAC, V40, P146, DOI 10.1016/j.ejcts.2010.09.042
   Sadohara J, 2006, EUR J RADIOL, V60, P70, DOI 10.1016/j.ejrad.2006.05.003
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Takahashi K, 2010, J MAGN RESON IMAGING, V32, P1325, DOI 10.1002/jmri.22377
   Tomiyama N, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.4.1790881
   Tomiyama N, 2001, J COMPUT ASSIST TOMO, V25, P388, DOI 10.1097/00004728-200105000-00010
NR 24
TC 2
Z9 2
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 4
PY 2015
VL 10
IS 5
AR e0126175
DI 10.1371/journal.pone.0126175
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CH3PP
UT WOS:000353943000148
PM 25938505
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lisi, G
   Morimoto, J
AF Lisi, Giuseppe
   Morimoto, Jun
TI EEG Single-Trial Detection of Gait Speed Changes during Treadmill Walk
SO PLOS ONE
LA English
DT Article
ID POSTERIOR PARIETAL CORTEX; VIRTUAL-REALITY; BRAIN ACTIVITY; MOVEMENT;
   ARTIFACTS; LOCALIZATION; PERFORMANCE; TRANSFORM; INTERFACE; AGREEMENT
AB In this study, we analyse the electroencephalography (EEG) signal associated with gait speed changes (i.e. acceleration or deceleration). For data acquisition, healthy subjects were asked to perform volitional speed changes between 0, 1, and 2 Km/h, during treadmill walk. Simultaneously, the treadmill controller modified the speed of the belt according to the subject's linear speed. A classifier is trained to distinguish between the EEG signal associated with constant speed gait and with gait speed changes, respectively. Results indicate that the classification performance is fair to good for the majority of the subjects, with accuracies always above chance level, in both batch and pseudo-online approaches. Feature visualisation and equivalent dipole localisation suggest that the information used by the classifier is associated with increased activity in parietal areas, where mu and beta rhythms are suppressed during gait speed changes. Specifically, the parietal cortex may be involved in motor planning and visuomotor transformations throughout the online gait adaptation, which is in agreement with previous research. The findings of this study may help to shed light on the cortical involvement in human gait control, and represent a step towards a BMI for applications in post-stroke gait rehabilitation.
C1 [Lisi, Giuseppe; Morimoto, Jun] ATR Computat Neurosci Labs, Dept Brain Robot Interface, Kyoto, Japan.
RP Lisi, G (reprint author), ATR Computat Neurosci Labs, Dept Brain Robot Interface, Kyoto, Japan.
EM glisi@atr.jp
FU MIC-SCOPE; Ministry of Internal Affairs and Communications entitled
   "Novel and innovative R&D making use of brain structures"; MEXT KAKENHI,
   ImPACT Program of Council for Science, Technology and Innovation
   (Cabinet Office, Government of Japan), Strategic International
   Cooperative Program, Japan Science and Technology Agency (JST)
   [23120004]; JSPS; MIZS: Japan-Slovenia research Cooperative Program
FX This study is the result of "Development of BMI Technologies for
   Clinical Application," carried out under the Strategic Research Program
   for Brain Sciences by the Ministry of Education, Culture, Sports,
   Science and Technology of Japan. Part of this research was supported by
   MIC-SCOPE and a contract with the Ministry of Internal Affairs and
   Communications entitled "Novel and innovative R&D making use of brain
   structures." This research was also partially supported by MEXT KAKENHI
   grant number 23120004, ImPACT Program of Council for Science, Technology
   and Innovation (Cabinet Office, Government of Japan), Strategic
   International Cooperative Program, Japan Science and Technology Agency
   (JST), and by JSPS and MIZS: Japan-Slovenia research Cooperative
   Program. The authors Giuseppe Lisi and Jun Morimoto are affiliated with
   the company ATR Computational Neuroscience Laboratories. ATR
   Computational Neuroscience Laboratories provided support in the form of
   salaries for authors GL and JM, but did not have any additional role in
   the study design, data collection and analysis, decision to publish, or
   preparation of the manuscript. The specific roles of these authors are
   articulated in the "author contributions" section. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Acar ZA, 2013, BRAIN TOPOGR, V26, P378, DOI 10.1007/s10548-012-0274-6
   Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922
   Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303
   Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275
   Bertrand A, 2013, BIOMED CIRC SYST C, P258, DOI 10.1109/BioCAS.2013.6679688
   Billinger M, 2013, PRACTICAL BRAIN COMP, P333, DOI [10.1007/978-3-642-29746-5, DOI 10.1007/978-3-642-29746-5]
   Blank A, 2013, I IEEE EMBS C NEUR E, P1159, DOI 10.1109/NER.2013.6696144
   Blankertz B, 2002, ADV NEUR IN, V14, P157
   Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI [10.1109/MSP.2008.4408441, 10.1109/MSP.200790.900,9]
   Bolognini N, 2007, CURR BIOL, V17, P1890, DOI 10.1016/j.cub.2007.09.057
   Brutsch K, 2011, J REHABIL MED, V43, P493, DOI 10.2340/16501977-0802
   Brutsch K, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-15
   Buneo CA, 2006, NEUROPSYCHOLOGIA, V44, P2594, DOI 10.1016/j.neuropsychologia.2005.10.011
   Castermans T, 2014, NEUROSCI LETT, V561, P166, DOI 10.1016/j.neulet.2013.12.059
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873
   Cuffin BN, 2001, CLIN NEUROPHYSIOL, V112, P46, DOI 10.1016/S1388-2457(00)00488-0
   Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0
   DAUBECHIES I, 1990, IEEE T INFORM THEORY, V36, P961, DOI 10.1109/18.57199
   Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009
   Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004
   Delorme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030135
   Dietz V., 2001, Neural Plasticity, V8, P83, DOI 10.1155/NP.2001.83
   Dornhege G, 2007, TOWARD BRAIN COMPUTE
   Faller J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101168
   Fatourechi M, 2007, CLIN NEUROPHYSIOL, V118, P480, DOI 10.1016/j.clinph.2006.10.019
   Graimann B, 2006, PROG BRAIN RES, V159, P79, DOI 10.1016/S0079-6123(06)59006-5
   Grandchamp R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00236
   Grosse-Wentrup M, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056015
   Gwin JT, 2011, NEUROIMAGE, V54, P1289, DOI 10.1016/j.neuroimage.2010.08.066
   Gwin JT, 2010, J NEUROPHYSIOL, V103, P3526, DOI 10.1152/jn.00105.2010
   Haase-Fielitz A, 2009, CRIT CARE MED, V37, P553, DOI 10.1097/CCM.0b013e318195846e
   Haefeli J, 2011, EUR J NEUROSCI, V33, P338, DOI 10.1111/j.1460-9568.2010.07494.x
   Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497
   Hwang HJ, 2009, J NEUROSCI METH, V179, P150, DOI 10.1016/j.jneumeth.2009.01.015
   Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5
   Jankovic J, 2007, PARKINSONS DISEASE A
   Jiang N, 2014, CLINICAL NEUROPHYSIO
   Jolliffe I. T., 2002, PRINCIPAL COMPONENT
   Joyce CA, 2004, PSYCHOPHYSIOLOGY, V41, P313, DOI 10.1046/j.1469-8986.2003.00141.x
   Kaelin-Lang A, 2005, J NEUROPHYSIOL, V93, P1099, DOI 10.1152/jn.00143.2004
   Koenraadt KLM, 2014, NEUROIMAGE, V85, P415, DOI 10.1016/j.neuroimage.2013.04.070
   Krings T, 1999, CLIN NEUROPHYSIOL, V110, P106, DOI 10.1016/S0013-4694(98)00106-0
   Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4
   Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lisi G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00085
   Lotze M, 2003, BRAIN, V126, P866, DOI 10.1093/brain/awg079
   Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008
   Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176
   MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H
   Min BK, 2008, NEUROSCI LETT, V438, P270, DOI 10.1016/j.neulet.2008.04.067
   Miyakoshi M, 2013, IEEE ENG MED BIO, P3282, DOI 10.1109/EMBC.2013.6610242
   Mognon A, 2011, PSYCHOPHYSIOLOGY, V48, P229, DOI 10.1111/j.1469-8986.2010.01061.x
   Muller-Putz GR, 2007, BRAIN RES, V1137, P84, DOI 10.1016/j.brainres.2006.12.052
   Muralidharan A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00039
   Perfetti B, 2011, J NEUROPHYSIOL, V105, P18, DOI 10.1152/jn.00778.2010
   Petersen TH, 2012, J PHYSIOL-LONDON, V590, P2443, DOI 10.1113/jphysiol.2012.227397
   Petzschner FH, 2012, J NEUROSCI, V32, P4703, DOI 10.1523/JNEUROSCI.0566-12.2012
   Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8
   Presacco A, 2011, J NEUROPHYSIOL, V106, P1875, DOI 10.1152/jn.00104.2011
   Quiroga RQ, 2006, J NEUROSCI, V26, P3615, DOI 10.1523/JNEUROSCI.3468-05.2006
   Raiche G, 2013, METHODOLOGY-EUR, V9, P23, DOI 10.1027/1614-2241/a000051
   Scherg M., 1990, ADV AUDIOL, V6, P40, DOI DOI 10.1016/J.BSPC.2015.01.004
   Schieppati M, 1999, J NEUROL NEUROSUR PS, V66, P313, DOI 10.1136/jnnp.66.3.313
   Schlogl A, 2005, J NEURAL ENG, V2, pL14, DOI 10.1088/1741-2560/2/4/L02
   Schuler T, 2011, NEUROREHABILITATION, V28, P401, DOI 10.3233/NRE-2011-0670
   Seeber M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00485
   Severens M, 2012, IEEE ENG MED BIO, P2764, DOI 10.1109/EMBC.2012.6346537
   SHIK ML, 1976, PHYSIOL REV, V56, P465
   Sipp AR, 2013, J NEUROPHYSIOL, V110, P2050, DOI 10.1152/jn.00744.2012
   Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002
   Tangermann M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00055
   Tombini M, 2009, NEUROIMAGE, V47, P1735, DOI 10.1016/j.neuroimage.2009.04.046
   Wagner J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00093
   Wagner J, 2012, NEUROIMAGE, V63, P1203, DOI 10.1016/j.neuroimage.2012.08.019
   Wang D, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00151
   Wang YJ, 2009, LECT NOTES ARTIF INT, V5638, P437
   Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054
   Widmann A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00233
   Wieser M, 2010, EXP BRAIN RES, V203, P181, DOI 10.1007/s00221-010-2223-5
   Wojcikiewicz W, 2011, INT CONF ACOUST SPEE, P577
   Yamashita O, 2008, NEUROIMAGE, V42, P1414, DOI 10.1016/j.neuroimage.2008.05.050
   Yuan H, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026001
   Zimmerli L, 2013, ARCH PHYS MED REHAB, V94, P1737, DOI 10.1016/j.apmr.2013.01.029
NR 85
TC 19
Z9 19
U1 0
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 1
PY 2015
VL 10
IS 5
AR e0125479
DI 10.1371/journal.pone.0125479
PG 28
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CH2XA
UT WOS:000353887100114
PM 25932947
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hu, TT
   Weng, SQ
   Tang, WQ
   Xue, RY
   Chen, S
   Cai, GX
   Cai, Y
   Shen, XZ
   Zhang, S
   Dong, L
AF Hu, Tingting
   Weng, Shuqiang
   Tang, Wenqing
   Xue, Ruyi
   Chen, She
   Cai, Guoxiang
   Cai, Yu
   Shen, Xizhong
   Zhang, Si
   Dong, Ling
TI Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal
   Cancer
SO PLOS ONE
LA English
DT Article
ID E2/E3 UBIQUITIN LIGASE; S-PHASE ARREST; 1ST-LINE TREATMENT; APOPTOSIS
   PROTEIN; POOR-PROGNOSIS; CELL-GROWTH; IAP; APOLLON; BRUCE; GENE
AB Background and Objective
   Inhibitors of apoptosis proteins (IAPs) have been well investigated in human cancers, where they are frequently overexpressed and associated with poor prognosis. Here we explored the role of baculoviral IAP repeat containing 6 (BIRC6), a member of IAPs, in human colorectal cancer (CRC).
   Methods
   We used Western blotting and immunohistochemistry to examine BIRC6 expression in 7 CRC cell lines and 126 CRC clinical samples. We determined the biological significance of BIRC6 in CRC cell lines by a lentivirus-mediated silencing method.
   Results
   We reported that BIRC6 was overexpressed in CRC cell lines and clinical CRC tissues. BIRC6 overexpression was correlated with tumor size and invasion depth of CRC. BIRC6 overexpression is associated with worse overall survival (OS) (P = 0.001) and shorter disease- free survival (DFS) (P = 0.010). BIRC6 knockdown inhibited cell proliferation, arrested cell cycle at S phase, downregulated cyclin A2, B1, D1 and E1 levels, and sensitized CRC cells to chemotherapy in vitro and in vivo.
   Conclusions
   Taken together, these data suggests that BIRC6 overexpression is a predictor of poor prognosis in colorectal cancer and BIRC6 could be a potential target of CRC therapy.
C1 [Hu, Tingting; Weng, Shuqiang; Tang, Wenqing; Xue, Ruyi; Cai, Yu; Shen, Xizhong; Dong, Ling] Fudan Univ, Zhongshan Hosp, Shanghai Inst Liver Dis, Dept Gastroenterol & Hepatol, Shanghai 200433, Peoples R China.
   [Hu, Tingting] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol & Hepatol, Wenzhou, Peoples R China.
   [Chen, She; Zhang, Si] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China.
   [Cai, Guoxiang] Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai 200433, Peoples R China.
   [Cai, Guoxiang] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China.
RP Zhang, S (reprint author), Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China.
EM zhangsi@fudan.edu.cn; dong.ling@zs-hospital.sh.cn
OI zhang, Si/0000-0002-5682-4995
FU Shanghai Science and Technology Commission [10411950100, 12ZR1405300];
   National Natural Science Foundation of China [81100344, 81173078,
   81371268, 81172273, 81272388, 81472673, 81400628]; National Clinical Key
   Special Subject of China [371]; Shanghai Pujiang Program [13PJD008]
FX This work was supported by Shanghai Science and Technology Commission
   (grant numbers: 10411950100 to XS, 12ZR1405300 to YC), National Natural
   Science Foundation of China (grant numbers: 81100344, 81173078 to SZ,
   81371268 to SC, 81172273, 81272388 to LD, 81472673 to YC, 81272388,
   81400628 to XS), the National Clinical Key Special Subject of China
   (grant number: 371 to XS), and Shanghai Pujiang Program(grant number:
   No. 13PJD008 to GC). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Akin O, 2012, CA-CANCER J CLIN, V62, P364, DOI 10.3322/caac.21156
   Akiyoshi T, 2008, GASTROENTEROLOGY, V134, P131, DOI 10.1053/j.gastro.2007.10.008
   Athanasoula KC, 2014, CANCER LETT, V347, P175, DOI 10.1016/j.canlet.2014.02.014
   Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018
   Bianchini M, 2006, INT J ONCOL, V29, P83
   Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397
   Chen ZH, 1999, BIOCHEM BIOPH RES CO, V264, P847, DOI 10.1006/bbrc.1999.1585
   Chu L, 2008, GENE THER, V15, P484, DOI 10.1038/gt.2008.6
   Dong X, 2013, J THORAC ONCOL, V8, P161, DOI 10.1097/JTO.0b013e31827d5237
   Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860
   Findeisen P, 2005, CANCER RES, V65, P8072, DOI 10.1158/0008-5472.CAN-04-4146
   Fuchs CS, 2008, J CLIN ONCOL, V26, P689, DOI 10.1200/JCO.2007.15.5390
   Fulda S, 2014, LEUKEMIA, V28, P1414, DOI 10.1038/leu.2014.56
   Grothey A, 2004, J CLIN ONCOL, V22, P1209, DOI 10.1200/JCO.2004.11.037
   Guicciardi ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092124
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415
   Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Joe AK, 2002, CLIN CANCER RES, V8, P893
   Kikuchi R, 2014, J BIOL CHEM, V289, P3457, DOI 10.1074/jbc.M113.514430
   LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302
   LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569
   Lamers F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-285
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee YS, 2013, J NAT PROD, V76, P2195, DOI 10.1021/np4005135
   Lopergolo A, 2009, BRIT J CANCER, V100, P739, DOI 10.1038/sj.bjc.6604927
   Lotz K, 2004, MOL CELL BIOL, V24, P9339, DOI 10.1128/MCB.24.21.9339-9350.2004
   Low CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055837
   Morikawa T, 2012, INT J CANCER, V131, P1169, DOI 10.1002/ijc.26495
   Qiu XB, 2004, EMBO J, V23, P800, DOI 10.1038/sj.emboj.7600075
   Qiu XB, 2005, J BIOL CHEM, V280, P174, DOI 10.1074/jbc.M411430200
   Ren JY, 2005, P NATL ACAD SCI USA, V102, P565, DOI 10.1073/pnas.0408744102
   Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008
   Sung KW, 2007, CLIN CANCER RES, V13, P5109, DOI 10.1158/1078-0432.CCR-07-0693
   Suzuki K, 2010, CANCER SCI, V101, P1163, DOI 10.1111/j.1349-7006.2010.01504.x
   Van Houdt WJ, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011353-1, 10.1074/mcp.M111.011353]
   Vernooy SY, 2002, CURR BIOL, V12, P1164, DOI 10.1016/S0960-9822(02)00935-1
   Yang XR, 2009, CLIN CANCER RES, V15, P5518, DOI 10.1158/1078-0432.CCR-09-0151
   Zaanan A, 2011, CELL ONCOL, V34, P155, DOI 10.1007/s13402-011-0024-x
   Zhao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073461
NR 40
TC 11
Z9 11
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 1
PY 2015
VL 10
IS 5
AR e0125281
DI 10.1371/journal.pone.0125281
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CH2XA
UT WOS:000353887100096
PM 25933218
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Jungmann, PM
   Ganter, C
   Schaeffeler, CJ
   Bauer, JS
   Baum, T
   Meier, R
   Nittka, M
   Pohlig, F
   Rechl, H
   von Eisenhart-Rothe, R
   Rummeny, EJ
   Woertler, K
AF Jungmann, Pia M.
   Ganter, Carl
   Schaeffeler, Christoph J.
   Bauer, Jan S.
   Baum, Thomas
   Meier, Reinhard
   Nittka, Mathias
   Pohlig, Florian
   Rechl, Hans
   von Eisenhart-Rothe, Ruediger
   Rummeny, Ernst J.
   Woertler, Klaus
TI View-Angle Tilting and Slice-Encoding Metal Artifact Correction for
   Artifact Reduction in MRI: Experimental Sequence Optimization for
   Orthopaedic Tumor Endoprostheses and Clinical Application
SO PLOS ONE
LA English
DT Article
ID MAGNETIC-SUSCEPTIBILITY; MALIGNANT-TUMOR; LIMB-SALVAGE; OSTEOSARCOMA;
   REPLACEMENT; MANAGEMENT; RESECTION; FEMUR; ARTHROPLASTY; IMPLANTS
AB Background
   MRI plays a major role in follow-up of patients with malignant bone tumors. However, after limb salvage surgery, orthopaedic tumor endoprostheses might cause significant metalinduced susceptibility artifacts.
   Purposes
   To evaluate the benefit of view-angle tilting (VAT) and slice-encoding metal artifact correction (SEMAC) for MRI of large-sized orthopaedic tumor endoprostheses in an experimental model and to demonstrate clinical benefits for assessment of periprosthetic soft tissue abnormalities.
   Methods
   In an experimental setting, tumor endoprostheses (n=4) were scanned at 1.5T with three versions of optimized high-bandwidth turbo-spin-echo pulse sequences: (i) standard, (ii) VAT and (iii) combined VAT and SEMAC (VAT&SEMAC). Pulse sequences included coronal short-tau-inversion-recovery (STIR), coronal T1-weighted (w), transverse T1-w and T2-w TSE sequences. For clinical evaluation, VAT& SEMAC was compared to conventional metal artifact-reducing MR sequences (conventional MR) in n=25 patients with metal implants and clinical suspicion of tumor recurrence or infection. Diameters of artifacts were measured quantitatively. Qualitative parameters were assessed on a five-point scale (1=best, 5=worst): "image distortion", "artificial signal changes at the edges" and "diagnostic confidence". Imaging findings were correlated with pathology. T-tests and Wilcoxon-signed rank tests were used for statistical analyses.
   Results
   The true size of the prostheses was overestimated on MRI (P<0.05). A significant reduction of artifacts was achieved by VAT (P<0.001) and VAT&SEMAC (P=0.003) compared to the standard group. Quantitative scores improved in the VAT and VAT&SEMAC group (P<0.05). On clinical MR images, artifact diameters were significantly reduced in the VAT&SEMAC-group as compared with the conventional-group (P<0.001). Distortion and artificial signal changes were reduced and diagnostic confidence improved (P<0.05). In two cases, tumor-recurrence, in ten cases infection and in thirteen cases other pathologies were diagnosed.
   Conclusions
   Significant reduction of metallic artifacts was achieved by VAT and SEMAC. Clinical results suggest, that these new techniques will be beneficial for detecting periprosthetic pathologies during postoperative follow-up.
C1 [Jungmann, Pia M.; Ganter, Carl; Schaeffeler, Christoph J.; Bauer, Jan S.; Baum, Thomas; Meier, Reinhard; Rummeny, Ernst J.; Woertler, Klaus] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, D-81675 Munich, Germany.
   [Schaeffeler, Christoph J.] Kantonsspital Graubuenden, Musculoskeletal Imaging, CH-7000 Chur, Switzerland.
   [Bauer, Jan S.] Tech Univ Munich, Klinikum Rechts Isar, Dept Neuroradiol, D-81675 Munich, Germany.
   [Nittka, Mathias] Siemens AG, Healthcare Sect, D-91052 Erlangen, Germany.
   [Pohlig, Florian; Rechl, Hans; von Eisenhart-Rothe, Ruediger] Tech Univ Munich, Klinikum Rechts Isar, Dept Orthopaed Surg, D-81675 Munich, Germany.
RP Jungmann, PM (reprint author), Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, Ismaninger Str 22, D-81675 Munich, Germany.
EM pia.jungmann@tum.de
RI Ganter, Carl/U-6895-2017; Baum, Thomas/M-6522-2014; Meier,
   Reinhard/B-2882-2014; Kirschke, Jan/E-2550-2012; von Eisenhart-Rothe,
   Ruediger/E-4839-2017
OI Ganter, Carl/0000-0002-6735-7448; Baum, Thomas/0000-0002-4574-5212;
   Meier, Reinhard/0000-0002-2169-4780; Kirschke, Jan/0000-0002-7557-0003;
   Pohlig, Florian/0000-0002-8867-2973
FU German Research Foundation (DFG); Technische Universitat Munchen within
   the funding programme Open Access Publishing
FX This work was supported by the German Research Foundation (DFG) and the
   Technische Universitat Munchen within the funding programme Open Access
   Publishing. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR ABOULAFIA AJ, 1993, CANCER-AM CANCER SOC, V71, P3358, DOI 10.1002/1097-0142(19930515)71:10+<3358::AID-CNCR2820711738>3.0.CO;2-O
   Beaman FD, 2013, SEMIN MUSCULOSKEL R, V17, P168, DOI 10.1055/s-0033-1343094
   BERQUIST TH, 1989, CLIN ORTHOP RELAT R, P101
   Butts K, 2005, MAGNET RESON MED, V53, P418, DOI 10.1002/mrm.20375
   CHO ZH, 1988, MED PHYS, V15, P7, DOI 10.1118/1.596162
   Choong PFM, 1996, ACTA ORTHOP SCAND, V67, P345, DOI 10.3109/17453679609002328
   Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x
   ECKARDT JJ, 1991, CLIN ORTHOP RELAT R, P202
   Fayad LM, 2012, RADIOLOGY, V265, P340, DOI 10.1148/radiol.12111740
   GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016
   Hargreaves BA, 2011, AM J ROENTGENOL, V197, P547, DOI 10.2214/AJR.11.7364
   Kawai A, 1998, J BONE JOINT SURG AM, V80A, P636, DOI 10.2106/00004623-199805000-00004
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee MJ, 2007, RADIOGRAPHICS, V27, P791, DOI 10.1148/rg.273065087
   Lu WM, 2009, MAGN RESON MED, V62, P66, DOI 10.1002/mrm.21967
   Manaster B J, 2000, Radiology, V215 Suppl, P379
   MORRIS HG, 1994, INT ORTHOP, V18, P90, DOI 10.1007/BF02484417
   Oldrini G, 2011, J RADIOL, V92, P915, DOI 10.1016/j.jradio.2011.07.003
   QUILL G, 1990, CLIN ORTHOP RELAT R, P242
   Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854
   SIM FH, 1995, CLIN ORTHOP RELAT R, P160
   Simon MA, 2005, J BONE JOINT SURG AM, V87A, P2822, DOI 10.2106/JBJS.8712.cl
   Starcukova J, 2008, DENT MATER, V24, P715, DOI 10.1016/j.denta1.2007.07.002
   Stradiotti P, 2009, EUR SPINE J, V18, pS102, DOI 10.1007/s00586-009-0998-5
   Sutter R, 2013, AM J ROENTGENOL, V201, P1315, DOI 10.2214/AJR.13.10531
   Sutter R, 2012, RADIOLOGY, V265, P204, DOI 10.1148/radiol.12112408
   Viano AM, 2000, MAGN RESON IMAGING, V18, P287, DOI 10.1016/S0730-725X(99)00135-6
   Wafa H, 2006, EXPERT REV ANTICANC, V6, P239, DOI 10.1586/14737140.6.2.239
   WENDT RE, 1988, RADIOLOGY, V168, P837, DOI 10.1148/radiology.168.3.3406413
NR 29
TC 12
Z9 13
U1 2
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 24
PY 2015
VL 10
IS 4
AR e0124922
DI 10.1371/journal.pone.0124922
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CG6AH
UT WOS:000353376800115
PM 25909472
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Henriksen, DP
   Pottegard, A
   Laursen, CB
   Jensen, TG
   Hallas, J
   Pedersen, C
   Lassen, AT
AF Henriksen, Daniel Pilsgaard
   Pottegard, Anton
   Laursen, Christian B.
   Jensen, Thoger Gorm
   Hallas, Jesper
   Pedersen, Court
   Lassen, Annmarie Touborg
TI Risk Factors for Hospitalization Due to Community-Acquired Sepsis - A
   Population-Based Case-Control Study
SO PLOS ONE
LA English
DT Article
ID EMERGENCY-DEPARTMENT VISITS; UNITED-STATES; EPIDEMIOLOGY; INFECTION;
   HEALTH; COMORBIDITY; DISPARITIES; MORTALITY; OUTCOMES; DEATH
AB Background
   The aim of the study was to estimate risk factors for hospitalization due to sepsis and to determine whether these risk factors vary by age and gender.
   Methods
   We performed a population-based case-control study of all adult patients admitted to a medical ED from September 2010 to August 2011. Controls were sampled within the hospital catchment-area. All potential cases were manually validated using a structured protocol. Vital signs and laboratory values measured at arrival were registered to define systemic inflammatory response syndrome and organ dysfunction. Multivariable logistic regression was used to elucidate which predefined risk factors were associated with an increased or decreased risk hospitalization due to sepsis.
   Results
   A total of 1713 patients were admitted with sepsis of any severity. The median age was 72 years (interquartile range: 57-81 years) and 793 (46.3%) were male. 621 (36.3%) patients were admitted with sepsis, 1071 (62.5%) with severe sepsis and 21 (1.2%) with septic shock. Episodes with sepsis of any severity were associated with older age (85+ years adjusted OR 6.02 [95% CI: 5.09-7.12]), immunosuppression (4.41 [3.83-5.09]), alcoholism-related conditions (2.90 [2.41-3.50]), and certain comorbidities: psychotic disorder (1.90 [1.58-2.27]), neurological (1.98 [1.73-2.26]), respiratory (3.58 [3.16-4.06]), cardiovascular (1.62 [1.41-1.85]), diabetes (1.82 [1.57-2.12]), cancer (1.44 [1.22-1.68]), gastrointestinal (1.71 [1.44-2.05]) and renal (1.46 [1.13-1.89]). The strength of the observed associations for comorbid factors was strongest among younger individuals.
   Conclusions
   Hospitalization due to sepsis of any severity was associated with several independent risk factors, including age and comorbid factors.
C1 [Henriksen, Daniel Pilsgaard; Lassen, Annmarie Touborg] Odense Univ Hosp, Dept Emergency Med, DK-5000 Odense C, Denmark.
   [Pottegard, Anton; Hallas, Jesper] Univ Southern Denmark, Dept Publ Hlth, Clin Pharmacol, DK-5000 Odense C, Denmark.
   [Laursen, Christian B.] Odense Univ Hosp, Dept Resp Med, DK-5000 Odense C, Denmark.
   [Jensen, Thoger Gorm] Odense Univ Hosp, Dept Clin Microbiol, DK-5000 Odense C, Denmark.
   [Hallas, Jesper] Odense Univ Hosp, Dept Clin Chem & Pharmacol, DK-5000 Odense C, Denmark.
   [Pedersen, Court] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense C, Denmark.
RP Henriksen, DP (reprint author), Odense Univ Hosp, Dept Emergency Med, DK-5000 Odense C, Denmark.
EM dphenriksen@health.sdu.dk
OI Laursen, Christian B./0000-0001-6382-9906; Henriksen, Daniel
   Pilsgaard/0000-0003-1303-6195; Pottegard, Anton/0000-0001-9314-5679
FU Faculty of Health Sciences, Odense University Hospital; Research
   Foundation of Odense University Hospital, University of Southern
   Denmark; private philanthropic fund TrygFonden
FX The study was supported by a stipend for PhD students from the Faculty
   of Health Sciences, Odense University Hospital, as well as a stipend
   from the Research Foundation of Odense University Hospital, University
   of Southern Denmark. ATL received an unrestricted grant from the private
   philanthropic fund TrygFonden given to the University of Southern
   Denmark.
CR Angus DC, 2001, CRIT CARE MED, V29, P1303, DOI 10.1097/00003246-200107000-00002
   Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI 10.1056/NEJMra1208623
   BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644
   Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P241
   Esper AM, 2006, CRIT CARE MED, V34, P2576, DOI 10.1097/01.CCM.0000239114.50519.0E
   Fielding JE, 1999, ANNU REV PUBL HEALTH, V20, pXIII, DOI 10.1146/annurev.publhealth.20.1.0
   Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398
   Ginde AA, 2013, J CRIT CARE, V28, P606, DOI 10.1016/j.jcrc.2013.03.018
   Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562
   Hallas J, 2001, PHARMACOEPIDEM DR S, V10, P619, DOI 10.1002/pds.638
   Harrington R D, 2000, J Gend Specif Med, V3, P27
   Henriksen DP, 2015, CRIT CARE MED, V43, P13, DOI 10.1097/CCM.0000000000000611
   Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002
   Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482
   Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA
   Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139
   Mayr FB, 2010, JAMA-J AM MED ASSOC, V303, P2495, DOI 10.1001/jama.2010.851
   Moss M, 2005, CLIN INFECT DIS, V41, pS490, DOI 10.1086/432003
   O'Brien JM, 2006, CRIT CARE MED, V35, P345, DOI 10.1097/01.CCM.0000254340.91644.B2
   Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965
   Poutsiaka DD, 2009, SCAND J INFECT DIS, V41, P469, DOI 10.1080/00365540902962756
   Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307
   Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964
   Seymour CW, 2010, CHEST, V137, P1289, DOI 10.1378/chest.09-2661
   Soto GJ, 2013, CRIT CARE MED, V41, P2784, DOI 10.1097/CCM.0b013e3182a84a43
   Storgaard M, 2013, SCAND J INFECT DIS, V45, P577, DOI 10.3109/00365548.2013.786836
   Strehlow MC, 2006, ANN EMERG MED, V48, P326, DOI 10.1016/j.annemergmed.2006.05.003
   Sundararajan V, 2005, CRIT CARE MED, V33, P71, DOI 10.1097/01.CCM.0000150027.98160.80
   Thomsen RW, 2011, RESP MED, V105, P1063, DOI 10.1016/j.rmed.2011.01.012
   Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83
   Trifiro G, 2010, ANN INTERN MED, V152, P418, DOI 10.7326/0003-4819-152-7-201004060-00006
   Wang HE, 2007, CRIT CARE MED, V35, P1928, DOI 10.1097/01.CCM.0000277043.85378.C1
   Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307
   Wang HE, 2011, AM J NEPHROL, V34, P330, DOI 10.1159/000330673
NR 36
TC 16
Z9 16
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 21
PY 2015
VL 10
IS 4
AR UNSP e0124838
DI 10.1371/journal.pone.0124838
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CG3XJ
UT WOS:000353212600089
PM 25898024
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Leach, K
   Kelly, R
   Cameron, A
   Montgomery, WI
   Reid, N
AF Leach, Katie
   Kelly, Ruth
   Cameron, Alison
   Montgomery, W. Ian
   Reid, Neil
TI Expertly Validated Models and Phylogenetically-Controlled Analysis
   Suggests Responses to Climate Change Are Related to Species Traits in
   the Order Lagomorpha
SO PLOS ONE
LA English
DT Article
ID OCHOTONA-PRINCEPS; ACTIVITY PATTERNS; EXTINCTION RISK; DISTRIBUTIONS;
   CONSERVATION; EUROPE; FUTURE; PIKAS; CONSEQUENCES; BIODIVERSITY
AB Climate change during the past five decades has impacted significantly on natural ecosystems, and the rate of current climate change is of great concern among conservation biologists. Species Distribution Models (SDMs) have been used widely to project changes in species' bioclimatic envelopes under future climate scenarios. Here, we aimed to advance this technique by assessing future changes in the bioclimatic envelopes of an entire mammalian order, the Lagomorpha, using a novel framework for model validation based jointly on subjective expert evaluation and objective model evaluation statistics. SDMs were built using climatic, topographical, and habitat variables for all 87 lagomorph species under past and current climate scenarios. Expert evaluation and Kappa values were used to validate past and current models and only those deemed 'modellable' within our framework were projected under future climate scenarios (58 species). Phylogenetically-controlled regressions were used to test whether species traits correlated with predicted responses to climate change. Climate change is likely to impact more than two-thirds of lagomorph species, with leporids (rabbits, hares, and jackrabbits) likely to undertake poleward shifts with little overall change in range extent, whilst pikas are likely to show extreme shifts to higher altitudes associated with marked range declines, including the likely extinction of Kozlov's Pika (Ochotona koslowi). Smaller-bodied species were more likely to exhibit range contractions and elevational increases, but showing little poleward movement, and fecund species were more likely to shift latitudinally and elevationally. Our results suggest that species traits may be important indicators of future climate change and we believe multi-species approaches, as demonstrated here, are likely to lead to more effective mitigation measures and conservation management. We strongly advocate studies minimising data gaps in our knowledge of the Order, specifically collecting more specimens for biodiversity archives and targeting data deficient geographic regions.
C1 [Leach, Katie; Kelly, Ruth; Montgomery, W. Ian] Queens Univ Belfast, Sch Biol Sci, Quercus, Belfast, Antrim, North Ireland.
   [Cameron, Alison; Reid, Neil] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland.
   [Cameron, Alison; Reid, Neil] Queens Univ Belfast, IGFS, Belfast, Antrim, North Ireland.
RP Leach, K (reprint author), Queens Univ Belfast, Sch Biol Sci, Quercus, Belfast, Antrim, North Ireland.
EM kleach01@qub.ac.uk
RI Cameron, Alison/D-3911-2009; Kelly, Ruth/J-4012-2015; Reid,
   Neil/M-8517-2019
OI Cameron, Alison/0000-0001-8236-7954; Kelly, Ruth/0000-0001-7982-5993;
   Reid, Neil/0000-0001-8951-8292
FU Queen's University Belfast
FX This project was funded by Queen's University Belfast. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Acevedo P, 2012, GLOBAL CHANGE BIOL, V18, P1509, DOI 10.1111/j.1365-2486.2012.02655.x
   Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x
   Altman D. G., 1991, PRACTICAL STAT MED R
   Anderson BJ, 2009, P ROY SOC B-BIOL SCI, V276, P1415, DOI 10.1098/rspb.2008.1681
   Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6
   Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x
   Barton K., 2013, MUMIN MULTIMODEL INF
   Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x
   Beever EA, 2011, GLOBAL CHANGE BIOL, V17, P2054, DOI 10.1111/j.1365-2486.2010.02389.x
   Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x
   Bland LM, 2015, CONSERV BIOL, V29, P250, DOI 10.1111/cobi.12372
   Calkins MT, 2012, ECOGRAPHY, V35, P780, DOI 10.1111/j.1600-0587.2011.07227.x
   Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030
   Chapman JA, 2008, LAGOMORPH BIOL EVOLU
   Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432
   CONNER DA, 1983, CAN J ZOOL, V61, P411, DOI 10.1139/z83-054
   Cooper N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042190
   DAWSON T, 1966, J CELL PHYSIOL, V67, P463, DOI 10.1002/jcp.1040670311
   Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303
   Day JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001730
   Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x
   Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159
   Estes LD, 2013, GLOBAL ECOL BIOGEOGR, V22, P1007, DOI 10.1111/geb.12034
   Fleiss JL, 1981, STAT METHODS RATES P
   Fordham DA, 2013, ECOGRAPHY, V36, P956, DOI 10.1111/j.1600-0587.2013.00147.x
   Franken RJ, 2004, INTEGR COMP BIOL, V44, P186, DOI 10.1093/icb/44.2.186
   Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873
   Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x
   Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x
   Ge DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059668
   Grange WB, 1932, ALLEN J MAMMAL, V13, P99
   Henry P, 2013, ECOL EVOL, V3, P3906, DOI 10.1002/ece3.776
   HOLT RD, 1990, TRENDS ECOL EVOL, V5, P311, DOI 10.1016/0169-5347(90)90088-U
   Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106
   Jannett FJ, 2007, AM MIDL NAT, V158, P168, DOI 10.1674/0003-0031(2007)158[168:NREOMS]2.0.CO;2
   Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1
   Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096
   Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Larrucea ES, 2008, J ARID ENVIRON, V72, P1636, DOI 10.1016/j.jaridenv.2008.04.002
   LIVERMAN DM, 1991, GLOBAL ENVIRON CHANG, V1, P351, DOI 10.1016/0959-3780(91)90002-B
   Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x
   Maiorano L, 2011, PHILOS T R SOC B, V366, P2681, DOI 10.1098/rstb.2011.0121
   Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x
   Mccain CM, 2014, GLOBAL CHANGE BIOL, V20, P1760, DOI 10.1111/gcb.12499
   MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W
   Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428
   Nowak R. M., 1991, WALKERS MAMMALS WORL
   ORME D, 2012, CAPER COMP ANAL PHYL
   Pachauri R. K., 2007, CONTRIBUTION WORKING
   Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286
   Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100
   Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x
   Peterson A. T., 2011, ECOLOGICAL NICHES GE
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Pike DA, 2013, ANIM CONSERV, V16, P694, DOI 10.1111/acv.12049
   Pinheiro J, 2014, NLME LINEAR NONLINEA
   Reid N, 2010, BIOL CONSERV, V143, P1701, DOI 10.1016/j.biocon.2010.03.041
   Robertson DS, 2004, GEOL SOC AM BULL, V116, P760, DOI 10.1130/B25402.1
   Schai-Braun SC, 2012, MAMM BIOL, V77, P434, DOI 10.1016/j.mambio.2012.07.004
   Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109
   Smith A. T., 2008, LAGOMORPH BIOL EVOLU
   SMITH AT, 1974, ECOLOGY, V55, P1368, DOI 10.2307/1935464
   Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102
   Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705
   VanDerWal J., 2012, SDMTOOLS SPECIES DIS
   Wisz M. S, 2012, BIOL REV, V88, P15, DOI DOI 10.1111/J.1469-185X.2012.00235.X
NR 67
TC 16
Z9 16
U1 1
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 15
PY 2015
VL 10
IS 4
AR e0122267
DI 10.1371/journal.pone.0122267
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CG1EL
UT WOS:000353015800048
PM 25874407
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Snell, RR
AF Snell, Richard R.
TI Menage a Quoi? Optimal Number of Peer Reviewers
SO PLOS ONE
LA English
DT Article
ID GRANT APPLICATIONS; BIAS; RELIABILITY; PROPOSALS; ASSESSMENTS;
   SELECTION; VALIDITY; CHANCE; PANEL
AB Peer review represents the primary mechanism used by funding agencies to allocate financial support and by journals to select manuscripts for publication, yet recent Cochrane reviews determined literature on peer review best practice is sparse. Key to improving the process are reduction of inherent vulnerability to high degree of randomness and, from an economic perspective, limiting both the substantial indirect costs related to reviewer time invested and direct administrative costs to funding agencies, publishers and research institutions. Use of additional reviewers per application may increase reliability and decision consistency, but adds to overall cost and burden. The optimal number of reviewers per application, while not known, is thought to vary with accuracy of judges or evaluation methods. Here I use bootstrapping of replicated peer review data from a Post-doctoral Fellowships competition to show that five reviewers per application represents a practical optimum which avoids large random effects evident when fewer reviewers are used, a point where additional reviewers at increasing cost provides only diminishing incremental gains in chance-corrected consistency of decision outcomes. Random effects were most evident in the relative mid-range of competitiveness. Results support aggressive high-and low-end stratification or triaging of applications for subsequent stages of review, with the proportion and set of mid-range submissions to be retained for further consideration being dependent on overall success rate.
C1 Canadian Inst Hlth Res, Res Knowledge Translat & Eth Portfolio, Ottawa, ON, Canada.
RP Snell, RR (reprint author), Canadian Inst Hlth Res, Res Knowledge Translat & Eth Portfolio, Ottawa, ON, Canada.
EM richard.snell@cihr-irsc.gc.ca
OI Snell, Richard/0000-0001-9184-8063
CR Abdoul H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046054
   Benda WGG, 2011, INT J FORECASTING, V27, P166, DOI 10.1016/j.ijforecast.2010.03.003
   Birukou A, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00056
   Bollen J, 2014, EMBO REP, V15, P131, DOI 10.1002/embr.201338068
   Bornmann L, 2004, BIF FUTURA, V19, P7
   Bornmann L, 2006, RES EVALUAT, V15, P209, DOI 10.3152/147154406781775850
   Bornmann L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003480
   Buffin-Belanger T, 2005, GEOMORPHOLOGY, V68, P77, DOI 10.1016/j.geomorph.2004.09.032
   Canadian Institutes of Health Research, 2012, DES FUT NEW OP SUIT
   CICCHETTI DV, 1991, BEHAV BRAIN SCI, V14, P119, DOI 10.1017/S0140525X00065675
   COLE S, 1981, SCIENCE, V214, P881, DOI 10.1126/science.7302566
   Demicheli V, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000003.pub2
   Fogelholm M, 2012, J CLIN EPIDEMIOL, V65, P47, DOI 10.1016/j.jclinepi.2011.05.001
   Graves N, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4797
   Guthrie S, 2013, ALTERNATIVES PEER RE
   Hodgson C, 1997, J CLIN EPIDEMIOL, V50, P1189, DOI 10.1016/S0895-4356(97)00167-4
   Holbrook JB, 2011, RES EVALUAT, V20, P239, DOI 10.3152/095820211X12941371876788
   Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000016.pub3
   Kaplan D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002761
   Koehler E, 2009, AM STAT, V63, P155, DOI 10.1198/tast.2009.0030
   Kravitz RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010072
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langfeldt L, 2006, RES EVALUAT, V15, P31, DOI 10.3152/147154406781776039
   Lee CJ, 2013, J AM SOC INF SCI TEC, V64, P2, DOI 10.1002/asi.22784
   Lipworth WL, 2011, SOC SCI MED, V72, P1056, DOI 10.1016/j.socscimed.2011.02.002
   Luukkonen T, 2012, RES EVALUAT, V21, P48, DOI 10.1093/reseval/rvs001
   Marsh HW, 2008, AM PSYCHOL, V63, P160, DOI 10.1037/0003-066X.63.3.160
   Mayo NE, 2006, J CLIN EPIDEMIOL, V59, P842, DOI 10.1016/j.jclinepi.2005.12.007
   Obrecht M, 2007, RES EVALUAT, V16, P79
   Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015
   R Core Team, 2014, R LANG ENV STAT COMP
   Roebber PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018680
   ROY R, 1985, SCI TECHNOL HUM VAL, P73
   Schroter S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-62
   Squazzoni F, 2013, RES POLICY, V42, P287, DOI 10.1016/j.respol.2012.04.014
   Tite L, 2007, J EPIDEMIOL COMMUN H, V61, P9, DOI 10.1136/jech.2006.049817
   van Arensbergen P, 2012, HIGH EDUC POLICY, V25, P381, DOI 10.1057/hep.2012.15
   Wessely S, 1998, LANCET, V352, P301, DOI 10.1016/S0140-6736(97)11129-1
NR 38
TC 16
Z9 16
U1 0
U2 21
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 1
PY 2015
VL 10
IS 4
AR e0120838
DI 10.1371/journal.pone.0120838
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CE9AM
UT WOS:000352135600044
PM 25830238
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Jobst, BJ
   Triphan, SMF
   Sedlaczek, O
   Anjorin, A
   Kauczor, HU
   Biederer, J
   Ley-Zaporozhan, J
   Ley, S
   Wielputz, MO
AF Jobst, Bertram J.
   Triphan, Simon M. F.
   Sedlaczek, Oliver
   Anjorin, Angela
   Kauczor, Hans Ulrich
   Biederer, Juergen
   Ley-Zaporozhan, Julia
   Ley, Sebastian
   Wielpuetz, Mark O.
TI Functional Lung MRI in Chronic Obstructive Pulmonary Disease: Comparison
   of T1 Mapping, Oxygen-Enhanced T1 Mapping and Dynamic Contrast Enhanced
   Perfusion
SO PLOS ONE
LA English
DT Article
ID COMPUTED-TOMOGRAPHY; RESPIRATORY PHASE; CYSTIC-FIBROSIS; VENTILATION;
   COPD; STANDARDIZATION; VISUALIZATION; PARENCHYMA; INHALATION; EMPHYSEMA
AB Purpose
   Monitoring of regional lung function in interventional COPD trials requires alternative end-points beyond global parameters such as FEV1. T1 relaxation times of the lung might allow to draw conclusions on tissue composition, blood volume and oxygen fraction. The aim of this study was to evaluate the potential value of lung Magnetic resonance imaging (MRI) with native and oxygen-enhanced T1 mapping for the assessment of COPD patients in comparison with contrast enhanced perfusion MRI.
   Materials and Methods
   20 COPD patients (GOLD I-IV) underwent a coronal 2-dimensional inversion recovery snapshot flash sequence (8 slices/lung) at room air and during inhalation of pure oxygen, as well as dynamic contrast-enhanced first-pass perfusion imaging. Regional distribution of T1 at room air (T1), oxygen-induced T1 shortening (Delta T1) and peak enhancement were rated by 2 chest radiologists in consensus using a semi-quantitative 3-point scale in a zone-based approach.
   Results
   Abnormal T1 and Delta T1 were highly prevalent in the patient cohort. T1 and Delta T1 correlated positively with perfusion abnormalities (r = 0.81 and r = 0.80; p&0.001), and with each other (r = 0.80; p< 0.001). In GOLD stages I and II Delta T1 was normal in 16/29 lung zones with mildly abnormal perfusion (15/16 with abnormal T1). The extent of T1 (r = 0.45; p< 0.05),.T1 (r = 0.52; p< 0.05) and perfusion abnormalities (r = 0.52; p< 0.05) showed a moderate correlation with GOLD stage.
   Conclusion
   Native and oxygen-enhanced T1 mapping correlated with lung perfusion deficits and severity of COPD. Under the assumption that T1 at room air correlates with the regional pulmonary blood pool and that oxygen-enhanced T1 reflects lung ventilation, both techniques in combination are principally suitable to characterize ventilation-perfusion imbalance. This appears valuable for the assessment of regional lung characteristics in COPD trials without administration of i. v. contrast.
C1 [Jobst, Bertram J.; Triphan, Simon M. F.; Sedlaczek, Oliver; Anjorin, Angela; Kauczor, Hans Ulrich; Biederer, Juergen; Ley-Zaporozhan, Julia; Ley, Sebastian; Wielpuetz, Mark O.] Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany.
   [Jobst, Bertram J.; Triphan, Simon M. F.; Sedlaczek, Oliver; Anjorin, Angela; Kauczor, Hans Ulrich; Wielpuetz, Mark O.] Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany.
   [Jobst, Bertram J.; Kauczor, Hans Ulrich; Wielpuetz, Mark O.] Heidelberg Univ, Thoraxklin, Dept Diagnost & Intervent Radiol Nucl Med, Heidelberg, Germany.
   [Ley, Sebastian] Surg Hosp Dr Rinecker, Dept Diagnost & Intervent Radiol, Munich, Germany.
   [Triphan, Simon M. F.] Res Ctr Magnet Resonance Bavaria MRB, Wurzburg, Germany.
   [Biederer, Juergen] Dept Radiol Hosp Gross Gerau, Radiol Darmstadt, Gross Gerau, Germany.
   [Ley-Zaporozhan, Julia] Ludwig Maximilians Univ Hosp Munich, Inst Clin Radiol, Munich, Germany.
RP Jobst, BJ (reprint author), Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany.
EM bertram.jobst@med.uni-heidelberg.de
RI Biederer, Juergen/E-4545-2010
OI Ley, Sebastian/0000-0001-9269-2670; Wielputz, Mark
   Oliver/0000-0001-6962-037X
FU Competence Network on Asthma / COPD (ASCONET) through a grant from the
   Bundesministerium fur Bildung und Forschung (BMBF) of the federal
   government of Germany [01GI0870]
FX This work has been supported by the Competence Network on Asthma / COPD
   (ASCONET) through a grant from the Bundesministerium fur Bildung und
   Forschung (BMBF) of the federal government of Germany (01GI0870,
   www.bmbf.de/en). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. The authors declare no conflict of interest with regard to
   the study at hand.
CR Coxson HO, 2009, AM J RESP CRIT CARE, V180, P588, DOI 10.1164/rccm.200901-0159PP
   Coxson Harvey O, 2008, Proc Am Thorac Soc, V5, P940, DOI 10.1513/pats.200806-057QC
   DEICHMANN R, 1992, J MAGN RESON, V96, P608, DOI 10.1016/0022-2364(92)90347-A
   Edelman RR, 1996, NAT MED, V2, P1236, DOI 10.1038/nm1196-1236
   Eichinger M, 2012, EUR J RADIOL, V81, P1321, DOI 10.1016/j.ejrad.2011.02.045
   Euler U. S. v., 1946, ACTA PHYSIOL SCAND, V12, P301, DOI 10.1111/j.1748-1716.1946.tb00389.x
   Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC
   Hatabu H, 2001, EUR J RADIOL, V37, P172, DOI 10.1016/S0720-048X(00)00298-9
   HOLM S, 1979, SCAND J STAT, V6, P65
   Hopkins SR, 2012, J APPL PHYSIOL, V113, P328, DOI 10.1152/japplphysiol.00320.2012
   Jakob PM, 2004, MAGN RESON MED, V51, P1009, DOI 10.1002/mrm.20051
   Karlik SJ, 2003, AM J ROENTGENOL, V180, P47, DOI 10.2214/ajr.180.1.1800047
   Kohlmann P, 2014, INT J COMPUT ASSIST
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Ley-Zaporozhan Julia, 2007, COPD, V4, P55, DOI 10.1080/15412550701198719
   Ley-Zaporozhan J, 2007, EUR J RADIOL, V63, P76, DOI 10.1016/j.ejrad.2007.01.020
   Ley-Zaporozhan J, 2008, MAGN RESON IMAGING C, V16, P291, DOI 10.1016/j.mric.2008.02.014
   Mai VM, 1999, MAGNET RESON MED, V41, P866, DOI 10.1002/(SICI)1522-2594(199905)41:5<866::AID-MRM2>3.0.CO;2-D
   Marshall H, 2012, THORAX, V67, P613, DOI 10.1136/thoraxjnl-2011-200864
   Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805
   Nakagawa T, 2001, J MAGN RESON IMAGING, V14, P419, DOI 10.1002/jmri.1202
   Ohno Y, 2002, MAGN RESON MED, V47, P1139, DOI 10.1002/mrm.10168
   Ohno Y, 2008, AM J RESP CRIT CARE, V177, P1095, DOI 10.1164/rccm.200709-1322OC
   Ohno Y, 2012, EUR J RADIOL, V81, P1068, DOI 10.1016/j.ejrad.2011.02.004
   QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693
   Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO
   Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522
   Renne J, 2015, J MAGN RESON IMAGING, V41, P60, DOI 10.1002/jmri.24535
   Rodriguez-Roisin R, 2009, J APPL PHYSIOL, V106, P1902, DOI 10.1152/japplphysiol.00085.2009
   Sergiacomi G, 2003, IN VIVO, V17, P319
   Stadler A, 2005, J MAGN RESON IMAGING, V21, P759, DOI 10.1002/jmri.20319
   Stadler A., 2005, P 91 RAD SOC N AM C, P242
   Stadler A, 2008, MAGN RESON MED, V59, P96, DOI 10.1002/mrm.21446
   Stadler A, 2007, INT J BIOMED IMAGING, DOI 10.1155/2007/23624
   Stock KW, 1999, JMRI-J MAGN RESON IM, V9, P557, DOI 10.1002/(SICI)1522-2586(199904)9:4<557::AID-JMRI8>3.0.CO;2-Y
   Tadamura E, 1997, J MAGN RESON IMAGING, V7, P220, DOI 10.1002/jmri.1880070134
   Thabut G, 2005, CHEST, V127, P1531, DOI 10.1378/chest.127.5.1531
   Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP
   WAGNER PD, 1977, J CLIN INVEST, V59, P203, DOI 10.1172/JCI108630
   Wielputz M, 2012, DIAGN INTERV RADIOL, V18, P344, DOI 10.4261/1305-3825.DIR.5365-11.0
NR 40
TC 16
Z9 16
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 30
PY 2015
VL 10
IS 3
AR e0121520
DI 10.1371/journal.pone.0121520
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CE9AD
UT WOS:000352134700113
PM 25822195
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Teixeira, C
   Silva, S
   Severo, M
   Barros, H
AF Teixeira, Cristina
   Silva, Susana
   Severo, Milton
   Barros, Henrique
TI Socioeconomic Position Early in Adolescence and Mode of Delivery Later
   in Life: Findings from a Portuguese Birth Cohort
SO PLOS ONE
LA English
DT Article
ID BRITISH WOMENS HEART; CESAREAN-SECTION; ADULT HEALTH; VAGINAL BIRTHS;
   RISK-FACTORS; FOLLOW-UP; CHILDBIRTH; LIFECOURSE; RATES; PREFERENCE
AB Objective
   This study assessed the influence of socioeconomic position at 12 years of age (SEP-12) on the variability in cesarean rates later in life.
   Methods
   As part of the Portuguese Generation XXI birth cohort we evaluated 7358 women with a singleton pregnancy who delivered at five Portuguese public hospitals serving the region of Porto (April/2005-September/2006). Based on the twelve items that described socioeconomic circumstances at age 12, a latent class analysis was used to classify women's SEP-12 as high, intermediate and low. Multiple Poisson regression was used to estimate adjusted risk ratio (RR) and respective 95% confidence interval (95% CI).
   Results
   The cesarean rates in high, intermediate and low SEP-12 were, respectively, 40.9%, 37.5% and 40.5% (p = 0.100) among primiparous women; 14.2%, 11.6% and 15.5% (p = 0.04) among multiparous women with no previous cesarean and 78.6%, 72.2% and 70.0% (p = 0.08) among women with a previous cesarean. A low to moderate association between SEP-12 and cesarean rates was observed among multiparous women with a previous cesarean, illustrating that women from higher SEP-12 were more likely to have a surgical delivery (RR = 1.12;95% CI:1.01-1.24 comparing high with low SEP-12 and RR = 1.03:95% CI:0.94-1.14 comparing intermediate with low SEP-12) not explained by potential mediating factors. No such association was found either in primiparous or in multiparous women without a previous cesarean.
   Conclusions
   The association between SEP-12 and cesarean rates suggests the effect of past socioeconomic context on the decision concerning the mode of delivery, but only among women who experienced a previous cesarean. Accordingly, it appears that early-life socioeconomic circumstances drive cesarean rates but the effect can be modified by lived experiences concerning childbirth.
C1 [Teixeira, Cristina; Silva, Susana; Severo, Milton; Barros, Henrique] Univ Porto, Inst Publ Hlth, P-4100 Oporto, Portugal.
   [Teixeira, Cristina; Silva, Susana; Severo, Milton; Barros, Henrique] Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med & Publ Hlth, P-4100 Oporto, Portugal.
   [Teixeira, Cristina] Polytech Inst Braganca, Braganca, Portugal.
RP Teixeira, C (reprint author), Univ Porto, Inst Publ Hlth, Rua Campo Alegre 823, P-4100 Oporto, Portugal.
EM cristina.teixeira@ipb.pt
RI Severo, Milton/I-3497-2012; Barros, Henrique/Q-8609-2019; Teixeira,
   Cristina/O-2296-2013; Silva, Susana/E-5828-2012
OI Severo, Milton/0000-0002-5787-4871; Barros,
   Henrique/0000-0003-4699-6571; Teixeira, Cristina/0000-0001-5194-5141;
   Silva, Susana/0000-0002-1335-8648
FU Health Ministry of Portugal (through Programa Operacional de Saude -
   SAUDE XXI); Calouste Gulbenkian Foundation; Portuguese Foundation for
   Science and Technology [PIC/IC/83038/2007, SFRH/PROTEC/67591/2010];
   Health Ministry of Portugal (through Quadro Comunitario de Apoio III);
   Health Ministry of Portugal (through Administracao Regional de Saude do
   Norte)
FX This study was supported by a grant from Health Ministry of Portugal
   (through Programa Operacional de Saude - SAUDE XXI, Quadro Comunitario
   de Apoio III and Administracao Regional de Saude do Norte), the Calouste
   Gulbenkian Foundation and the Portuguese Foundation for Science and
   Technology through institutional [PIC/IC/83038/2007] and individual
   grant (SFRH/PROTEC/67591/2010). The funders had no role in study design,
   data collection, analysis, decision to publish or preparation of the
   manuscript.
CR Abel T, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.066159
   Althabe F, 2004, LANCET, V363, P1934, DOI 10.1016/S0140-6736(04)16406-4
   Alves B, 2005, BJOG-INT J OBSTET GY, V112, P994, DOI 10.1111/j.1471-0528.2005.00657.x
   Amuzu A, 2009, EUR J CARDIOV PREV R, V16, P169, DOI 10.1097/HJR.0b013e328325d64d
   Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21
   Batty GD, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-302
   Behague DP, 2002, BRIT MED J, V324, P942, DOI 10.1136/bmj.324.7343.942
   Borgonovi F, 2010, SOC SCI MED, V71, P1927, DOI 10.1016/j.socscimed.2010.09.018
   Bryant AS, 2009, PAEDIATR PERINAT EP, V23, P454, DOI 10.1111/j.1365-3016.2009.01059.x
   Cammu H, 2011, BIRTH-ISS PERINAT C, V38, P191, DOI 10.1111/j.1523-536X.2011.00476.x
   Cesaroni G, 2008, BIRTH-ISS PERINAT C, V35, P241, DOI 10.1111/j.1523-536X.2008.00245.x
   Clark EAS, 2011, AM J OBSTET GYNECOL, V205, pS2, DOI 10.1016/j.ajog.2011.09.028
   Cohen S, 2010, ANN NY ACAD SCI, V1186, P37, DOI 10.1111/j.1749-6632.2009.05334.x
   Declercq E, 2007, OBSTET GYNECOL, V109, P669, DOI 10.1097/01.AOG.0000255668.20639.40
   Fairley L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-330
   Fenwick J, 2005, MIDWIFERY, V21, P23, DOI 10.1016/j.midw.2004.07.001
   Flamm BL, 2001, BEST PRACT RES CL OB, V15, P81, DOI 10.1053/beog.2000.0150
   Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P7, DOI 10.1136/jech.2004.023531
   Gamble JA, 2001, BIRTH-ISS PERINAT C, V28, P101, DOI 10.1046/j.1523-536X.2001.00101.x
   Graham H, 2010, SOC SCI MED, V70, P582, DOI 10.1016/j.socscimed.2009.10.041
   Graham WJ, 1999, BRIT J OBSTET GYNAEC, V106, P213, DOI 10.1111/j.1471-0528.1999.tb08233.x
   Guihard P, 2001, BRIT J OBSTET GYNAEC, V108, P48, DOI 10.1016/S0306-5456(00)00009-7
   Habiba M, 2006, BJOG-INT J OBSTET GY, V113, P647, DOI 10.1111/j.1471-0528.2006.00933.x
   Hawe P, 2000, SOC SCI MED, V51, P871, DOI 10.1016/S0277-9536(00)00067-8
   Henderson J, 2001, BRIT J OBSTET GYNAEC, V108, P149
   Hildingsson I, 2002, BJOG-INT J OBSTET GY, V109, P618, DOI 10.1016/S1470-0328(02)01393-9
   Hildingsson I, 2008, MIDWIFERY, V24, P46, DOI 10.1016/j.midw.2006.07.007
   Hillsdon M, 2008, J EPIDEMIOL COMMUN H, V62, P344, DOI 10.1136/jech.2006.058610
   Jefferis BJMH, 2004, AM J PUBLIC HEALTH, V94, P279, DOI 10.2105/AJPH.94.2.279
   Johanson R, 2002, BRIT MED J, V324, P892, DOI 10.1136/bmj.324.7342.892
   Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35
   Krieger N, 2004, EPIDEMIOL REV, V26, P92, DOI 10.1093/epirev/mxh009
   Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lawlor DA, 2005, AM J PUBLIC HEALTH, V95, P1245, DOI 10.2105/AJPH.2004.041129
   Leone T, 2008, SOC SCI MED, V67, P1236, DOI 10.1016/j.socscimed.2008.06.032
   Liu SL, 2007, CAN MED ASSOC J, V176, P455, DOI 10.1503/cmaj.060870
   Lynch JW, 1997, SOC SCI MED, V44, P809, DOI 10.1016/S0277-9536(96)00191-8
   Matijasevich A, 2012, J EPIDEMIOL COMMUN H, V66, P127, DOI 10.1136/jech.2010.108605
   Mazzoni A, 2011, BJOG-INT J OBSTET GY, V118, P391, DOI 10.1111/j.1471-0528.2010.02793.x
   Mercer BM, 2008, OBSTET GYNECOL, V111, P285, DOI 10.1097/AOG.0b013e31816102b9
   Niino Y, 2011, BIOSCI TRENDS, V5, P139, DOI 10.5582/bst.2011.v5.4.139
   Pang MW, 2008, BIRTH-ISS PERINAT C, V35, P121, DOI 10.1111/j.1523-536X.2008.00225.x
   PORDATA, 2012, BAS DAD PORT CONT
   Scharoun-Lee M, 2011, DEMOGRAPHY, V48, P625, DOI 10.1007/s13524-011-0024-5
   Severo M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001510
   Simpson KR, 2003, JOGNN, V32, P767, DOI 10.1177/08842217503258528
   Teixeira C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060168
   Tollanes MC, 2007, ACTA OBSTET GYN SCAN, V86, P840, DOI 10.1080/00016340701417422
   van de Mheen H, 1998, INT J EPIDEMIOL, V27, P431, DOI 10.1093/ije/27.3.431
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   Walsh DJ, 2010, SOCIOL HEALTH ILL, V32, P486, DOI 10.1111/j.1467-9566.2009.01207.x
   *WHO, 1985, LANCET, V2, P436, DOI DOI 10.1016/S0140-6736(85)92750-3
   Witt WP, 2015, MATERN CHILD HLTH J, V19, P84, DOI 10.1007/s10995-014-1498-8
   World Health Organization Regional Office for Europe, 2012, EUR HLTH ALL DAT HFA
   Wu JM, 2012, MATERN CHILD HLTH J, V16, P1447, DOI 10.1007/s10995-011-0910-x
   Yuan KH, 2000, SOCIOL METHODOL, V30, P165, DOI 10.1111/0081-1750.00078
   Zlot AI, 2005, MATERN CHILD HLTH J, V9, P11, DOI 10.1007/s10995-005-2447-3
NR 58
TC 2
Z9 2
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 23
PY 2015
VL 10
IS 3
AR e0119517
DI 10.1371/journal.pone.0119517
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CE6ZS
UT WOS:000351987300057
PM 25799142
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zhang, L
   Liu, SR
   Sun, PS
   Wang, TL
   Wang, GY
   Zhang, XD
   Wang, LL
AF Zhang, Lei
   Liu, Shirong
   Sun, Pengsen
   Wang, Tongli
   Wang, Guangyu
   Zhang, Xudong
   Wang, Linlin
TI Consensus Forecasting of Species Distributions: The Effects of Niche
   Model Performance and Niche Properties
SO PLOS ONE
LA English
DT Article
ID CLIMATICALLY SUITABLE AREAS; CLIMATE-CHANGE; RANGE SHIFTS;
   PSEUDO-ABSENCES; PREDICTION; UNCERTAINTY; PROJECTIONS; SCENARIOS;
   ENSEMBLES; PATTERNS
AB Ensemble forecasting is advocated as a way of reducing uncertainty in species distribution modeling (SDM). This is because it is expected to balance accuracy and robustness of SDM models. However, there are little available data regarding the spatial similarity of the combined distribution maps generated by different consensus approaches. Here, using eight niche-based models, nine split-sample calibration bouts (or nine random model-training subsets), and nine climate change scenarios, the distributions of 32 forest tree species in China were simulated under current and future climate conditions. The forecasting ensembles were combined to determine final consensual prediction maps for target species using three simple consensus approaches (average, frequency, and median [PCA]). Species' geographic ranges changed (area change and shifting distance) in response to climate change, but the three consensual projections did not differ significantly with respect to how much or in which direction, but they did differ with respect to the spatial similarity of the three consensual predictions. Incongruent areas were observed primarily at the edges of species' ranges. Multiple stepwise regression models showed the three factors (niche marginality and specialization, and niche model accuracy) to be related to the observed variations in consensual prediction maps among consensus approaches. Spatial correspondence among prediction maps was the highest when niche model accuracy was high and marginality and specialization were low. The difference in spatial predictions suggested that more attention should be paid to the range of spatial uncertainty before any decisions regarding specialist species can be made based on map outputs. The niche properties and singlemodel predictive performance provide promising insights that may further understanding of uncertainties in SDM.
C1 [Zhang, Lei; Zhang, Xudong] Chinese Acad Forestry, Res Inst Forestry, Key Lab Forest Silviculture State Forestry Adm, Beijing, Peoples R China.
   [Liu, Shirong; Sun, Pengsen] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Beijing, Peoples R China.
   [Wang, Tongli] Univ British Columbia, Dept Forest Sci, Ctr Forest Conservat Genet, Vancouver, BC V6T 1W5, Canada.
   [Wang, Guangyu] Univ British Columbia, Fac Forestry, Vancouver, BC V6T 1W5, Canada.
   [Wang, Linlin] Beijing Agr Univ, Beijing 100094, Peoples R China.
RP Liu, SR (reprint author), Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Beijing, Peoples R China.
EM liusr@caf.ac.cn
OI Zhang, Lei/0000-0002-2381-7852
FU China's National Natural Science Foundation [41301056]; Special
   Foundation of Chinese Academy of Forestry [CAFYBB2014QB006, RIF2012-04]
FX This work was funded by the China's National Natural Science Foundation
   (41301056) and the Special Foundation of Chinese Academy of Forestry
   (CAFYBB2014QB006, RIF2012-04). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x
   Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010
   Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x
   Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x
   Bialozyt R, 2012, J BIOGEOGR, V39, P665, DOI 10.1111/j.1365-2699.2011.02665.x
   Botts EA, 2013, GLOBAL ECOL BIOGEOGR, V22, P567, DOI 10.1111/geb.12027
   Broennimann O, 2006, GLOBAL CHANGE BIOL, V12, P1709
   Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x
   Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017
   Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010
   CLEMEN RT, 1989, INT J FORECASTING, V5, P559, DOI 10.1016/0169-2070(89)90012-5
   Crimmins SM, 2013, ECOL MODEL, V266, P126, DOI 10.1016/j.ecolmodel.2013.07.006
   Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x
   Dixon PM, 2005, ECOLOGY, V86, P1114, DOI 10.1890/04-0601
   Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x
   Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x
   Diniz JAF, 2010, REV BRAS ENTOMOL, V54, P339, DOI 10.1590/S0085-56262010000300001
   Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088
   Garcia RA, 2012, GLOBAL CHANGE BIOL, V18, P1253, DOI 10.1111/j.1365-2486.2011.02605.x
   Granitto PM, 2005, ARTIF INTELL, V163, P139, DOI 10.1016/j.artint.2004.09.006
   Grenouillet G, 2014, GLOBAL CHANGE BIOL, V20, P3080, DOI 10.1111/gcb.12570
   Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x
   Iverson LR, 2008, FOREST ECOL MANAG, V254, P390, DOI 10.1016/j.foreco.2007.07.023
   Jones CC, 2012, FOREST ECOL MANAG, V284, P69, DOI 10.1016/j.foreco.2012.07.024
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x
   Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058
   Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x
   Meller L, 2014, DIVERS DISTRIB, V20, P309, DOI 10.1111/ddi.12162
   Meynard CN, 2013, J BIOGEOGR, V40, P1, DOI 10.1111/jbi.12006
   Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1
   Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x
   Peters J, 2007, ECOL MODEL, V207, P304, DOI 10.1016/j.ecolmodel.2007.05.011
   Pinheiro J., 2013, R PACKAGE VERSION, P1, DOI DOI 10.1016/S0006-3207(01)00201-4
   R Development Core Team, 2010, R LANG ENV STAT COMP
   Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x
   Syphard AD, 2009, ECOGRAPHY, V32, P907, DOI 10.1111/j.1600-0587.2009.05883.x
   Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x
   Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x
   Thuiller W, 2010, BIOMOD SPECIES CLIMA
   Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x
   Virkkala R, 2010, ACTA OECOL, V36, P269, DOI 10.1016/j.actao.2010.01.006
   Wang T, 2006, INT J CLIMATOL, V26, P383, DOI 10.1002/joc.1247
   Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x
   Wisz Mary S., 2009, BMC Ecology, V9, P8, DOI 10.1186/1472-6785-9-8
   Zhang Lei, 2011, Chinese Journal of Plant Ecology, V35, P1091, DOI 10.3724/SP.J.1258.2011.01091
NR 46
TC 21
Z9 24
U1 2
U2 34
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 18
PY 2015
VL 10
IS 3
AR e0120056
DI 10.1371/journal.pone.0120056
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CE9BN
UT WOS:000352138500152
PM 25786217
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Becker, NI
   Encarnacao, JA
AF Becker, Nina I.
   Encarnacao, Jorge A.
TI Silvicolous on a Small Scale: Possibilities and Limitations of Habitat
   Suitability Models for Small, Elusive Mammals in Conservation Management
   and Landscape Planning
SO PLOS ONE
LA English
DT Article
ID DORMICE MUSCARDINUS-AVELLANARIUS; SPECIES DISTRIBUTION MODELS;
   NESTING-BEHAVIOR; PRESENCE-ABSENCE; COMMON DORMICE; SAMPLE-SIZE; WIND
   FARMS; ACCURACY; DORMOUSE; CHALLENGES
AB Species distribution and endangerment can be assessed by habitat-suitability modelling. This study addresses methodical aspects of habitat suitability modelling and includes an application example in actual species conservation and landscape planning. Models using species presence-absence data are preferable to presence-only models. In contrast to species presence data, absences are rarely recorded. Therefore, many studies generate pseudo- absence data for modelling. However, in this study model quality was higher with null samples collected in the field. Next to species data the choice of landscape data is crucial for suitability modelling. Landscape data with high resolution and ecological relevance for the study species improve model reliability and quality for small elusive mammals like Muscardinus avellanarius. For large scale assessment of species distribution, models with lowdetailed data are sufficient. For regional site-specific conservation issues like a conflict-free site for new wind turbines, high-detailed regional models are needed. Even though the overlap with optimally suitable habitat for M. avellanarius was low, the installation of wind plants can pose a threat due to habitat loss and fragmentation. To conclude, modellers should clearly state the purpose of their models and choose the according level of detail for species and environmental data.
C1 [Becker, Nina I.; Encarnacao, Jorge A.] Univ Giessen, Mammalian Ecol Grp, Dept Anim Ecol & Systemat, D-35390 Giessen, Germany.
RP Becker, NI (reprint author), Univ Giessen, Mammalian Ecol Grp, Dept Anim Ecol & Systemat, D-35390 Giessen, Germany.
EM Nina.I.Becker@allzool.bio.uni-giessen.de;
   J.Encarnacao@bio.uni-giessen.de
RI Encarnacao, Jorge A./I-8644-2018
OI Encarnacao, Jorge A./0000-0001-8766-0607
CR Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x
   Amori G, 2008, MUSCARDINUS AVELLANA
   Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x
   Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3
   Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x
   Bauschmann G, 1989, LEBENSRAM WALDRAND W
   Becker NI, 2012, EUR J WILDLIFE RES, V58, P945, DOI 10.1007/s10344-012-0637-z
   Belaire JA, 2014, CONSERV BIOL, V28, P541, DOI 10.1111/cobi.12199
   Bell S, 2008, BIODIVERS CONSERV, V17, P3443, DOI 10.1007/s10531-008-9357-9
   Beyer H.L., 2004, HAWTHS ANAL TOOLS AR
   Bosso L, 2013, J NAT CONSERV, V21, P72, DOI 10.1016/j.jnc.2012.10.003
   Brambilla M, 2009, BIOL CONSERV, V142, P2033, DOI 10.1016/j.biocon.2009.03.033
   BRIGHT PW, 1992, J ZOOL, V226, P589, DOI 10.1111/j.1469-7998.1992.tb07502.x
   Bright PW, 1996, MAMMAL REV, V26, P157, DOI 10.1111/j.1365-2907.1996.tb00151.x
   BRIGHT PW, 1991, J ZOOL, V224, P177, DOI 10.1111/j.1469-7998.1991.tb04797.x
   BRIGHT PW, 1990, BIOL CONSERV, V54, P307, DOI 10.1016/0006-3207(90)90143-D
   Bright PW, 1998, ANIM BEHAV, V56, P1485, DOI 10.1006/anbe.1998.0921
   Bright PW, 2006, DORMOUSE CONSERVATIO
   Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x
   Buchner S, 2010, NUL, V8
   Buchner S, 2012, FENA HESSEN FORST, P34
   Buchner S, 2008, ACTA THERIOL, V53, P259, DOI 10.1007/BF03193122
   Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010
   Dormann CF, 2011, MODELLING COMPLEX ECOLOGICAL DYNAMICS: AN INTRODUCTION INTO ECOLOGICAL MODELLING FOR STUDENTS, TEACHERS & SCIENTISTS, P179, DOI 10.1007/978-3-642-05029-9_13
   Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x
   Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159
   Encarnacao JA, 2013, J WILDLIFE DIS, V49, P860, DOI 10.7589/2012-10-262
   Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x
   FENA HF, 2004, ART EUR BIB CAST FIB
   Gottschalk TK, 2007, J ORNITHOL, V148, P427, DOI 10.1007/s10336-007-0155-z
   Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3
   Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Inman RD, 2013, ENDANGER SPECIES RES, V20, P1, DOI 10.3354/esr00487
   Jiang DF, 2013, STAT METHODS MED RES, V22, P505, DOI 10.1177/0962280211428385
   Juskaitis R, 2008, BIODIVERS CONSERV, V17, P3559, DOI 10.1007/s10531-008-9470-9
   Katzner T, 2013, ANIM CONSERV, V16, P367, DOI 10.1111/acv.12067
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lawrence A, 2010, TAKING STOCK NATURE, P251
   Liechti F, 2013, BIOL CONSERV, V162, P24, DOI 10.1016/j.biocon.2013.03.018
   Lindenmayer DB, 1999, BIOL CONSERV, V89, P83, DOI 10.1016/S0006-3207(98)00116-5
   Loe L, 2011, EUR J WILDLIFE RES, P1
   MacKenzie DI, 2005, J WILDLIFE MANAGE, V69, P849, DOI 10.2193/0022-541X(2005)069[0849:WATIWP]2.0.CO;2
   Maclean N, 2010, SILENT SUMMER STATE, P768
   McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x
   Meddins C, 2013, CLOCAENOG FOREST WIN, P49
   Meinig H, 2009, ROTE LISTE GAFAHRDET, V1, P115
   Morris P, 2004, DORMICE
   Mortelliti A, 2013, MAMM BIOL, V78, P309, DOI 10.1016/j.mambio.2012.09.006
   Naim DM, 2014, GENET MOL RES, V13, P167, DOI 10.4238/2014.January.10.8
   Osborne PE, 2001, J APPL ECOL, V38, P458, DOI 10.1046/j.1365-2664.2001.00604.x
   Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1
   R Development Core Team, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]
   REINERS TE, 2012, PECKIANA, V8, P87
   Ridgeway G., 2006, GEN BOOSTED REGRESSI
   Roscioni F, 2013, BIODIVERS CONSERV, V22, P1821, DOI 10.1007/s10531-013-0515-3
   Roscioni F, 2014, LANDSCAPE ECOL, V29, P891, DOI 10.1007/s10980-014-0030-2
   Rota CT, 2011, ECOGRAPHY, V34, P659, DOI 10.1111/j.1600-0587.2010.06433.x
   Russo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110894
   Santos H, 2013, BIOL CONSERV, V157, P178, DOI 10.1016/j.biocon.2012.06.017
   Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x
   Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X
   SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615
   Tabassum-Abbasi, 2014, RENEW SUST ENERG REV, V31, P270, DOI 10.1016/j.rser.2013.11.019
   Temple H. J., 2007, STATUS DISTRIBUTION
   Temple HJ, 2009, FOLIA ZOOL, V58, P248
   Williams GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009264
   Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x
   Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004
   Zabala J, 2005, EUR J WILDLIFE RES, V51, P157, DOI 10.1007/s10344-005-0094-z
NR 70
TC 4
Z9 4
U1 0
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 17
PY 2015
VL 10
IS 3
AR e0120562
DI 10.1371/journal.pone.0120562
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CD7QC
UT WOS:000351284600172
PM 25781894
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Robiou-du-Pont, S
   Li, AH
   Christie, S
   Sohani, ZN
   Meyre, D
AF Robiou-du-Pont, Sebastien
   Li, Aihua
   Christie, Shanice
   Sohani, Zahra N.
   Meyre, David
TI Should We Have Blind Faith in Bioinformatics Software? Illustrations
   from the SNAP Web-Based Tool
SO PLOS ONE
LA English
DT Article
ID ASSOCIATION; ANNOTATION; AGREEMENT; HAPMAP
AB Bioinformatics tools have gained popularity in biology but little is known about their validity. We aimed to assess the early contribution of 415 single nucleotide polymorphisms (SNPs) associated with eight cardio-metabolic traits at the genome-wide significance level in adults in the Family Atherosclerosis Monitoring In earLY Life (FAMILY) birth cohort. We used the popular web-based tool SNAP to assess the availability of the 415 SNPs in the Illumina Cardio-Metabochip genotyped in the FAMILY study participants. We then compared the SNAP output with the Cardio-Metabochip file provided by Illumina using chromosome and chromosomal positions of SNPs from NCBI Human Genome Browser (Genome Reference Consortium Human Build 37). With the HapMap 3 release 2 reference, 201 out of 415 SNPs were reported as missing in the Cardio-Metabochip by the SNAP output. However, the Cardio-Metabochip file revealed that 152 of these 201 SNPs were in fact present in the Cardio-Metabochip array (false negative rate of 36.6%). With the more recent 1000 Genomes Project release, we found a false-negative rate of 17.6% by comparing the outputs of SNAP and the Illumina product file. We did not find any 'false positive' SNPs (SNPs specified as available in the Cardio-Metabochip by SNAP, but not by the Cardio-Metabochip Illumina file). The Cohen's Kappa coefficient, which calculates the percentage of agreement between both methods, indicated that the validity of SNAP was fair to moderate depending on the reference used (the HapMap 3 or 1000 Genomes). In conclusion, we demonstrate that the SNAP outputs for the Cardio-Metabochip are invalid. This study illustrates the importance of systematically assessing the validity of bioinformatics tools in an independent manner. We propose a series of guidelines to improve practices in the fast-moving field of bioinformatics software implementation.
C1 [Robiou-du-Pont, Sebastien; Li, Aihua; Christie, Shanice; Sohani, Zahra N.; Meyre, David] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.
   [Sohani, Zahra N.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.
   [Sohani, Zahra N.] Hamilton Gen Hosp, Hamilton Hlth Sci, Hamilton, ON, Canada.
RP Meyre, D (reprint author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.
EM meyred@mcmaster.ca
RI Robiou-du-Pont, Sebastien/O-1692-2015; Meyre, David/D-7315-2011
OI Robiou-du-Pont, Sebastien/0000-0002-4569-0039; Meyre,
   David/0000-0003-4850-7444
FU Tier 2 Canada Research Chair; Heart and Stroke Foundation of Ontario [NA
   7293]; Ontario Graduate Scholarships
FX DM is supported by a Tier 2 Canada Research Chair. SRP is supported by
   the Heart and Stroke Foundation of Ontario (grant # NA 7293 "Early
   genetic origins of cardiovascular risk factors"). AL and ZNS are funded
   by Ontario Graduate Scholarships. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
   Beck K., 2001, MANIFESTO AGILE SOFT
   Choquet H, 2011, CURR GENOMICS, V12, P154, DOI 10.2174/138920211795677921
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168
   Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liefeld T, 2005, BIOINFORMATICS, V21, P3681, DOI 10.1093/bioinformatics/bti587
   Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022
   McCullough BD, 2006, J MONEY CREDIT BANK, V38, P1093, DOI 10.1353/mcb.2006.0061
   Merali Z, 2010, NATURE, V467, P775, DOI 10.1038/467775a
   Morrison KM, 2009, AM HEART J, V158, P533, DOI 10.1016/j.ahj.2009.07.005
   Ouzounis CA, 2003, BIOINFORMATICS, V19, P2176, DOI 10.1093/bioinformatics/btg309
   Rother K, 2012, BRIEF BIOINFORM, V13, P244, DOI 10.1093/bib/bbr035
   Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616
   Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793
   Wilson GV, 2013, ARXIV12100530
NR 17
TC 6
Z9 6
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 5
PY 2015
VL 10
IS 3
AR e0118925
DI 10.1371/journal.pone.0118925
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CC9KG
UT WOS:000350688100060
PM 25742008
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Song, YB
   Wang, F
   Wang, B
   Tao, SH
   Zhang, HP
   Liu, S
   Ramirez, O
   Zeng, QY
AF Song, Yuanbin
   Wang, Fan
   Wang, Bin
   Tao, Shaohua
   Zhang, Huiping
   Liu, Sai
   Ramirez, Oscar
   Zeng, Qiyi
TI Time Series Analyses of Hand, Foot and Mouth Disease Integrating Weather
   Variables
SO PLOS ONE
LA English
DT Article
ID ENTEROVIRUS 71; RISK-FACTORS; CIRCULATION; ASSOCIATION; INFECTION;
   GUANGZHOU; EPIDEMIC; SHENZHEN; HUMIDITY; CHILDREN
AB Background
   The past decade witnessed an increment in the incidence of hand foot mouth disease (HFMD) in the Pacific Asian region; specifically, in Guangzhou China. This emphasized the requirement of an early warning system designed to allow the medical community to better prepare for outbreaks and thus minimize the number of fatalities.
   Methods
   Samples from 1,556 inpatients (hospitalized) and 11,004 outpatients (non-admitted) diagnosed with HFMD were collected in this study from January 2009 to October 2013. Seasonal Autoregressive Integrated Moving Average (SARIMA) model was applied to establish high predictive model for inpatients and outpatient as well as three viral serotypes (EV71, Pan-EV and CA16). To integrate climate variables in the data analyses, data from eight climate variables were simultaneously obtained during this period. Significant climate variable identified by correlation analyses was executed to improve time series modeling as external repressors.
   Results
   Among inpatients with HFMD, 248 (15.9%) were affected by EV71, 137 (8.8%) were affected by Pan-EV+, and 436 (28.0%) were affected by CA16. Optimal Univariate SARIMA model was identified: (2,0,3)(1,0,0) 52 for inpatients, (0,1,0)(0,0,2) 52 for outpatients as well as three serotypes (EV71, (1,0,1)(0,0,1) 52; CA16, (1,0,1)(0,0,0) 52; Pan-EV, (1,0,1) (0,0,0) 52). Using climate as our independent variable, precipitation (PP) was first identified to be associated with inpatients (r = 0.211, P = 0.001), CA16-serotype (r = 0.171, P = 0.007) and outpatients (r = 0.214, P = 0.01) in partial correlation analyses, and was then shown a significant lag in cross-autocorrelation analyses. However, inclusion of PP [lag -3 week] as external repressor showed a moderate impact on the predictive performance of the SARIMA model described here-in.
   Conclusion
   Climate patterns and HFMD incidences have been shown to be strongly correlated. The SARIMA model developed here can be a helpful tool in developing an early warning system for HFMD.
C1 [Song, Yuanbin; Wang, Bin; Tao, Shaohua; Zeng, Qiyi] Southern Med Univ, Pediat Ctr, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China.
   [Wang, Fan] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA.
   [Ramirez, Oscar] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA.
   [Zhang, Huiping] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA.
   [Liu, Sai] Yale Univ, Dept Psychol, New Haven, CT 06520 USA.
RP Ramirez, O (reprint author), Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA.
EM oscar.ramirez@yale.edu; ZQY_88@163.com
RI Ibrahim, Essam H./G-1960-2018
OI Ibrahim, Essam H./0000-0003-0130-2257
FU Guangzhou medicine technology major projects [201102A211007]; National
   Natural Science Foundation of China [81272070]; Southern Medical
   University research projects for young scientist [B1012039]
FX This work was supported by Guangzhou medicine technology major projects
   (grant 201102A211007), partly by National Natural Science Foundation of
   China (grant 81272070), and Southern Medical University research
   projects for young scientist (grant B1012039). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR [Anonymous], GUANGZH STAT YB 2013
   Bateson TF, 2001, EPIDEMIOLOGY, V12, P654, DOI 10.1097/00001648-200111000-00013
   Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002
   Bo YC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-358
   Box G. E. P., 1970, J AM STAT ASSOC, V65, P1509, DOI [10.1080/01621459.1970.10481180, DOI 10.1080/01621459.1970.10481180]
   Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7
   Chen CJ, 2013, INT CONF BIOMETR
   Chen MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034651
   Chinese Ministry of Health, HAND FOOT MOUTH DIS
   Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8
   Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943
   Fang YR, 2014, SCAND J INFECT DIS, V46, P515, DOI 10.3109/00365548.2014.907929
   Feng HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087916
   He YQ, 2013, J CLIN MICROBIOL, V51, P3560, DOI 10.1128/JCM.01231-13
   Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796
   Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301
   Huang Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-134
   Investigators P, 2011, PROP COR DAT PROT
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee BY, 2010, VACCINE, V28, P7731, DOI 10.1016/j.vaccine.2010.09.065
   Li T, 2014, EPIDEMIOL INFECT, V142, P1741, DOI 10.1017/S0950268813002938
   Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087603
   Li XC, 2013, ATHEROSCLEROSIS, V231, P136, DOI 10.1016/j.atherosclerosis.2013.08.031
   Lin HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065585
   Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933
   Nguyen NTB, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-341
   Nobre FF, 2001, STAT MED, V20, P3051, DOI 10.1002/sim.963.abs
   Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055
   Quenel P, 1998, EUR J EPIDEMIOL, V14, P275, DOI 10.1023/A:1007467814485
   Rajendran K, 2011, INDIAN J MED RES, V133, P138
   Wang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092745
   Wang YR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-539
   WHO/WPRO, 2010, COMM DIS SURV RESP R
   Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6
   Xu W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-8
   Yu LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098241
   Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067157
   Zhao X, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-57
   Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923
NR 39
TC 20
Z9 24
U1 1
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 2
PY 2015
VL 10
IS 3
AR e0117296
DI 10.1371/journal.pone.0117296
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CC9JF
UT WOS:000350684900012
PM 25729897
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lex, H
   Essig, K
   Knoblauch, A
   Schack, T
AF Lex, Heiko
   Essig, Kai
   Knoblauch, Andreas
   Schack, Thomas
TI Cognitive Representations and Cognitive Processing of Team-Specific
   Tactics in Soccer
SO PLOS ONE
LA English
DT Article
ID VISUOMOTOR ADAPTATION PERFORMANCE; DECISION-MAKING; SEARCH; SKILL;
   PLAYERS; SPORTS; PERCEPTION; EXPERTISE; STRATEGIES; ATTENTION
AB Two core elements for the coordination of different actions in sport are tactical information and knowledge about tactical situations. The current study describes two experiments to learn about the memory structure and the cognitive processing of tactical information. Experiment 1 investigated the storage and structuring of team-specific tactics in humans' long-term memory with regard to different expertise levels. Experiment 2 investigated tactical decision-making skills and the corresponding gaze behavior, in presenting participants the identical match situations in a reaction time task. The results showed that more experienced soccer players, in contrast to less experienced soccer players, possess a functionally organized cognitive representation of team-specific tactics in soccer. Moreover, the more experienced soccer players reacted faster in tactical decisions, because they needed less fixations of similar duration as compared to less experienced soccer players. Combined, these experiments offer evidence that a functionally organized memory structure leads to a reaction time and a perceptual advantage in tactical decision-making in soccer. The discussion emphasizes theoretical and applied implications of the current results of the study.
C1 [Lex, Heiko; Essig, Kai; Schack, Thomas] Univ Bielefeld, Res Grp Neurocognit & Act Biomech, D-33615 Bielefeld, Germany.
   [Lex, Heiko; Essig, Kai; Schack, Thomas] Univ Bielefeld, Cognit Interact Technol Ctr Excellence, D-33615 Bielefeld, Germany.
   [Knoblauch, Andreas] Albstadt Sigmaringen Univ, Fac Engn, Albstadt Ebingen, Germany.
RP Lex, H (reprint author), Univ Bielefeld, Res Grp Neurocognit & Act Biomech, D-33615 Bielefeld, Germany.
EM heiko.lex@uni-bielefeld.de
FU Honda Research Institute Europe; Deutsche Forschungsgemeinschaft; Open
   Access Publication Funds of Bielefeld University
FX This work gratefully acknowledges the financial support from Honda
   Research Institute Europe. In addition, we acknowledge support for the
   Article Processing Charge by the Deutsche Forschungsgemeinschaft and the
   Open Access Publication Funds of Bielefeld University. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Abernethy B, 2005, APPL COGNITIVE PSYCH, V19, P705, DOI 10.1002/acp.1102
   Ali A, 2011, SCAND J MED SCI SPOR, V21, P170, DOI 10.1111/j.1600-0838.2010.01256.x
   Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065
   Carling C., 2009, PERFORMANCE ASSESSME
   Carling C, 2005, HDB SOCCER MATCH ANA
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155
   Elferink-Gemser MT, 2004, PERCEPT MOTOR SKILL, V99, P883, DOI 10.2466/pms.99.3.883-895
   Essig K, 2009, P 15 EUR C EYE MOV
   Essig K, 2006, INT J PARALLEL EMERG, V21, P79, DOI 10.1080/17445760500354440
   Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861
   Garganta J., 2009, PORTUGUESE J SPORTS, V9, P81, DOI DOI 10.5628/RPCD.09.01.81
   Gonzaga AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101231
   GREHAIGNE JF, 1995, QUEST, V47, P490, DOI 10.1080/00336297.1995.10484171
   Helsen WF, 1999, APPL COGNITIVE PSYCH, V13, P1
   Hodges NJ, 2007, HDB SPORT PSYCHOL
   Hughes MD, 2002, J SPORT SCI, V20, P739, DOI 10.1080/026404102320675602
   Jones N.M.P., 2004, INT J PERF ANAL SPOR, V4, P61, DOI DOI 10.1080/24748668.2004.11868292
   Kiesel A, 2009, J EXP PSYCHOL LEARN, V35, P292, DOI 10.1037/a0014499
   Koesling H, 2001, P 11 EUR C EYE MOV
   Lago-Ballesteros J, 2010, J HUM KINET, V25, P85
   Land Michael, 2009, LOOKING ACTING VISIO
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lex H, 2014, MIND MACH, V24, DOI [10.7748/ns.29.21.26.s31, DOI 10.7748/NS.29.21.26.S31]
   Lex H, 2014, J MOTOR BEHAV, V46, P389, DOI 10.1080/00222895.2014.920290
   Lex H, 2012, EXP BRAIN RES, V223, P457, DOI 10.1007/s00221-012-3273-7
   Lucchesi M, 2008, PRESSING
   Lucchesi M, 2008, WIE GEGEN WELCHE TAK
   Marzialli F, 2009, MODERNE FUSSBALLTAKT
   McGregor SJ, 1999, J SPORT SCI, V17, P895, DOI 10.1080/026404199365452
   McPherson S. L., 2004, INT J SPORT EXERCISE, V2, P274, DOI [10.1080/1612197X.2004.9671746, DOI 10.1080/1612197X.2004.9671746]
   McPherson SL, 2003, EXPERT PERFORMANCE S, DOI [10.1136/bjsports-2014-094176, DOI 10.1136/BJSPORTS-2014-094176]
   Memmert D., 2006, OPTIMALES TAKTIKTRAI
   Memmert D, 2004, KOGNITIONEN SPORTSPI
   MERVIS CB, 1981, ANNU REV PSYCHOL, V32, P89, DOI 10.1146/annurev.ps.32.020181.000513
   Moura FA, 2012, SPORT BIOMECH, V11, P85, DOI 10.1080/14763141.2011.637123
   O'Donoghue P., 2005, INT J PERF ANAL SPOR, V5, P104, DOI DOI 10.1080/24748668.2005.11868319
   Raab M, 2007, J EXP PSYCHOL-APPL, V13, P158, DOI 10.1037/1076-898X.13.3.158
   Roca A, 2011, COGN PROCESS, V12, P301, DOI 10.1007/s10339-011-0392-1
   Schack T, 2006, NEUROSCI LETT, V391, P77, DOI 10.1016/j.neulet.2005.10.009
   Schack T, 2012, HDB MEASUREMENT SPOR, V1
   Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005
   Sedlmeier P, 2008, FORSCHUNGSMETHODEN S
   SIMON HA, 1973, AM SCI, V61, P394
   Stockel T, 2012, PSYCHOL RES-PSYCH FO, V76, P768, DOI 10.1007/s00426-011-0387-7
   Vaeyens R, 2007, J MOTOR BEHAV, V39, P395, DOI 10.3200/JMBR.39.5.395-408
   Vaeyens R, 2007, J SPORT EXERCISE PSY, V29, P147, DOI 10.1123/jsep.29.2.147
   Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731
   Vickers JN, 2009, PROG BRAIN RES, V174, P279, DOI 10.1016/S0079-6123(09)01322-3
   Vilar L, 2012, SPORTS MED, V42, P1, DOI 10.2165/11596520-000000000-00000
   Ward P, 2003, J SPORT EXERCISE PSY, V25, P93, DOI 10.1123/jsep.25.1.93
   Weigelt M, 2011, PSYCHOL SPORT EXERC, V12, P231, DOI 10.1016/j.psychsport.2010.11.001
   WILLIAMS AM, 1994, RES Q EXERCISE SPORT, V65, P127, DOI 10.1080/02701367.1994.10607607
   Williams AM, 2006, PERCEPTION, V35, P317, DOI 10.1068/p5310
   Williams AM, 1998, RES Q EXERCISE SPORT, V69, P111, DOI 10.1080/02701367.1998.10607677
   Williams AM, 2000, J SPORT SCI, V18, P657, DOI 10.1080/02640410050120041
   WILLIAMS M, 1993, PERCEPT MOTOR SKILL, V76, P579, DOI 10.2466/pms.1993.76.2.579
   Winnick JJ, 2005, MED SCI SPORT EXER, V37, P306, DOI 10.1249/01.MMS.0000152803.35130.A4
NR 57
TC 12
Z9 12
U1 0
U2 29
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 25
PY 2015
VL 10
IS 2
AR e0118219
DI 10.1371/journal.pone.0118219
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CC2IM
UT WOS:000350168700057
PM 25714486
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Dafna, E
   Tarasiuk, A
   Zigel, Y
AF Dafna, Eliran
   Tarasiuk, Ariel
   Zigel, Yaniv
TI Sleep-Wake Evaluation from Whole-Night Non-Contact Audio Recordings of
   Breathing Sounds
SO PLOS ONE
LA English
DT Article
ID ACTIVITY MONITORING DEVICE; WRIST ACTIGRAPHY; APNEA; VALIDATION; ONSET;
   MOVEMENT; RESPIRATION; ADOLESCENTS; ALGORITHM; AGREEMENT
AB Study Objectives
   To develop and validate a novel non-contact system for whole-night sleep evaluation using breathing sounds analysis (BSA).
   Design
   Whole-night breathing sounds (using ambient microphone) and polysomnography (PSG) were simultaneously collected at a sleep laboratory (mean recording time 7.1 hours). A set of acoustic features quantifying breathing pattern were developed to distinguish between sleep and wake epochs (30 sec segments). Epochs (n = 59,108 design study and n = 68,560 validation study) were classified using AdaBoost classifier and validated epoch-by-epoch for sensitivity, specificity, positive and negative predictive values, accuracy, and Cohen's kappa. Sleep quality parameters were calculated based on the sleep/wake classifications and compared with PSG for validity.
   Setting
   University affiliated sleep-wake disorder center and biomedical signal processing laboratory.
   Patients
   One hundred and fifty patients (age 54.0 +/- 14.8 years, BMI 31.6 +/- 5.5 kg/m(2), m/f97/53) referred for PSG were prospectively and consecutively recruited. The system was trained (design study) on 80 subjects; validation study was blindly performed on the additional 70 subjects.
   Measurements and Results
   Epoch-by-epoch accuracy rate for the validation study was 83.3% with sensitivity of 92.2% (sleep as sleep), specificity of 56.6% (awake as awake), and Cohen's kappa of 0.508. Comparing sleep quality parameters of BSA and PSG demonstrate average error of sleep latency, total sleep time, wake after sleep onset, and sleep efficiency of 16.6 min, 35.8 min, and 29.6 min, and 8%, respectively.
   Conclusions
   This study provides evidence that sleep-wake activity and sleep quality parameters can be reliably estimated solely using breathing sound analysis. This study highlights the potential of this innovative approach to measure sleep in research and clinical circumstances.
C1 [Dafna, Eliran; Zigel, Yaniv] Ben Gurion Univ Negev, Fac Engn, Dept Biomed Engn, IL-84105 Beer Sheva, Israel.
   [Tarasiuk, Ariel] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Sleep Wake Disorders Unit, IL-84105 Beer Sheva, Israel.
   [Tarasiuk, Ariel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, IL-84105 Beer Sheva, Israel.
RP Zigel, Y (reprint author), Ben Gurion Univ Negev, Fac Engn, Dept Biomed Engn, IL-84105 Beer Sheva, Israel.
EM yaniv@bgu.ac.il
OI Zigel, Yaniv/0000-0002-1994-4242
FU Israel Ministry of Economics - the Kamin Program [46168]
FX This work was supported by the Israel Ministry of Economics - the Kamin
   Program, award no. 46168 to YZ and AT. The funder had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Acebo C, 1999, SLEEP, V22, P95, DOI 10.1093/sleep/22.1.95
   Akhter S, 2013, IEEE ENG MED BIO, P1318, DOI 10.1109/EMBC.2013.6609751
   Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342
   Appelboom G, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-28
   Ben-Israel N, 2012, SLEEP, V35, P1299, DOI 10.5665/sleep.2092
   Berthomier C, 2007, SLEEP, V30, P1587, DOI 10.1093/sleep/30.11.1587
   Blackwell T, 2008, SLEEP, V31, P283, DOI 10.1093/sleep/31.2.283
   BLAND JM, 1986, LANCET, V1, P307
   Choi JH, 2010, ACTA OTO-LARYNGOL, V130, P838, DOI 10.3109/00016480903431139
   Collop NA, 2007, J CLIN SLEEP MED, V3, P737
   Colrain IM, 1989, VENTILATION DURING S
   COOTE JH, 1982, J EXP BIOL, V100, P223
   COOTE JH, 1993, EUR J APPL PHYSIOL O, V66, P249, DOI 10.1007/BF00235102
   Dafna E, 2012, 34TH ANNUAL INTERNAT
   Dafna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084139
   de Chazal P, 2011, J SLEEP RES, V20, P356, DOI 10.1111/j.1365-2869.2010.00876.x
   DOUGLAS NJ, 1982, THORAX, V37, P840, DOI 10.1136/thx.37.11.840
   Edwards BA, 2011, HEAD NECK-J SCI SPEC, V33, pS37, DOI 10.1002/hed.21841
   Elliott R. J., 1995, HIDDEN MARKOV MODELS
   Fogel RB, 2005, J PHYSIOL-LONDON, V564, P549, DOI 10.1113/jphysiol.2005.083659
   Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504
   Goldshtein E, 2011, IEEE T BIO-MED ENG, V58, P1373, DOI 10.1109/TBME.2010.2100096
   Hasan MK, 2004, IEEE SIGNAL PROC LET, V11, P450, DOI 10.1109/LSP.2004.824017
   Hedner J, 2004, SLEEP, V27, P1560, DOI 10.1093/sleep/27.8.1560
   HOFFSTEIN V, 1994, SLEEP, V17, P522, DOI 10.1093/sleep/17.6.522
   Hwang S, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-26
   Iber C, 2007, THE AASM MANUAL FOR
   Johnson NL, 2007, SLEEP, V30, P899, DOI 10.1093/sleep/30.7.899
   Kantelhardt JW, 2003, PHYSICA A, V319, P447, DOI 10.1016/S0378-4371(02)01502-9
   Kim JW, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.178104
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liao WH, 2008, INT C PATT RECOG, P1774
   Lichstein KL, 2006, SLEEP, V29, P232
   Lotjonen J, 2003, SLEEP, V26, P86
   Malik V, 2012, SLEEP MED CLIN, V7, P497, DOI 10.1016/j.jsmc.2012.06.011
   Marino M, 2013, SLEEP, V36, P1747, DOI 10.5665/sleep.3142
   Montgomery-Downs HE, 2012, SLEEP BREATH, V16, P913, DOI 10.1007/s11325-011-0585-y
   PHILLIPSON EA, 1978, ANNU REV PHYSIOL, V40, P133, DOI 10.1146/annurev.ph.40.030178.001025
   Reuveni H, 2004, SLEEP, V27, P1518, DOI 10.1093/sleep/27.8.1518
   Robinson PA, 2011, PHILOS T R SOC A, V369, P3840, DOI 10.1098/rsta.2011.0120
   Rostig S, 2005, SLEEP, V28, P411, DOI 10.1093/sleep/28.4.411
   Sadeh A, 2002, SLEEP MED REV, V6, P113, DOI 10.1053/smrv.2001.0182
   Scalart P, 1996, INT CONF ACOUST SPEE, P629, DOI 10.1109/ICASSP.1996.543199
   Scatena M, 2012, CLIN NEUROPHYSIOL, V123, P318, DOI 10.1016/j.clinph.2011.07.026
   Smith L, 2012, J APPL PHYSIOL, V113, P691, DOI [10.1152/japplphysiol.00091.2012, DOI 10.1152/JAPPLPHYSIOL.00091.2012]
   Sommermeyer D, 2010, IFMBE PROC, V25, P1271
   Tilmanne J, 2009, J SLEEP RES, V18, P85, DOI 10.1111/j.1365-2869.2008.00706.x
   TRINDER J, 1992, J APPL PHYSIOL, V73, P2462
   Trinder J, 1997, J APPL PHYSIOL, V83, P1986
   Vashist SK, 2014, DIAGNOSTICS, V4, P104, DOI 10.3390/diagnostics4030104
   Wilkinson V, 2008, SLEEP, V31, P525, DOI 10.1093/sleep/31.4.525
   Worsnop C, 2000, J APPL PHYSIOL, V88, P1831
NR 52
TC 15
Z9 16
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 24
PY 2015
VL 10
IS 2
AR UNSP e0117382
DI 10.1371/journal.pone.0117382
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CC9IY
UT WOS:000350683900030
PM 25710495
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Mathur, R
   Ince, PG
   Minett, T
   Garwood, CJ
   Shaw, PJ
   Matthews, FE
   Brayne, C
   Simpson, JE
   Wharton, SB
AF Mathur, Ryan
   Ince, Paul G.
   Minett, Thais
   Garwood, Claire J.
   Shaw, Pamela J.
   Matthews, Fiona E.
   Brayne, Carol
   Simpson, Julie E.
   Wharton, Stephen B.
CA MRC Cognitive Function Ageing
TI A Reduced Astrocyte Response to beta-Amyloid Plaques in the Ageing Brain
   Associates with Cognitive Impairment
SO PLOS ONE
LA English
DT Article
ID APOLIPOPROTEIN-E GENOTYPE; ALZHEIMERS-DISEASE; APOE GENOTYPE; CINGULATE
   CORTEX; CEREBRAL-CORTEX; NEURODEGENERATIVE DISEASE; FRONTOTEMPORAL
   DEMENTIA; NONDEMENTED INDIVIDUALS; MRC CFA; DEPOSITS
AB Aims
   beta-amyloid (A beta) plaques are a key feature of Alzheimer's disease pathology but correlate poorly with dementia. They are associated with astrocytes which may modulate the effect of A beta-deposition on the neuropil. This study characterised the astrocyte response to A beta plaque subtypes, and investigated their association with cognitive impairment.
   Methods
   A beta plaque subtypes were identified in the cingulate gyrus using dual labelling immunohistochemistry to A beta and GFAP(+) astrocytes, and quantitated in two cortical areas: the area of densest plaque burden and the deep cortex near the white matter border (layer VI). Three subtypes were defined for both diffuse and compact plaques (also known as classical or core-plaques): A beta plaque with (1) no associated astrocytes, (2) focal astrogliosis or (3) circumferential astrogliosis.
   Results
   In the area of densest burden, diffuse plaques with no astrogliosis (beta = -0.05, p = 0.001) and with focal astrogliosis (beta = -0.27, p = 0.009) significantly associated with lower MMSE scores when controlling for sex and age at death. In the deep cortex (layer VI), both diffuse and compact plaques without astrogliosis associated with lower MMSE scores (beta = -0.15, p = 0.017 and beta = -0.81, p = 0.03, respectively). Diffuse plaques with no astrogliosis in layer VI related to dementia status (OR = 1.05, p = 0.025). In the area of densest burden, diffuse plaques with no astrogliosis or with focal astrogliosis associated with increasing Braak stage (beta = 0.01, p< 0.001 and beta = 0.07, p< 0.001, respectively), and ApoE epsilon 4 genotype OR = 1.02, p = 0.001 and OR = 1.10, p = 0.016, respectively). In layer VI all plaque subtypes associated with Braak stage, and compact amyloid plaques with little and no associated astrogliosis associated with ApoE epsilon 4 genotype ( OR = 1.50, p = 0.014 and OR = 0.10, p = 0.003, respectively).
   Conclusions
   Reactive astrocytes in close proximity to either diffuse or compact plaques may have a neuroprotective role in the ageing brain, and possession of at least one copy of the ApoEe4 allele impacts the astroglial response to A beta plaques.
C1 [Mathur, Ryan; Ince, Paul G.; Garwood, Claire J.; Shaw, Pamela J.; Simpson, Julie E.; Wharton, Stephen B.] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England.
   [Minett, Thais; Brayne, Carol] Univ Cambridge, Inst Publ Hlth, Cambridge, England.
   [Matthews, Fiona E.] MRC Biostat Unit, Cambridge, England.
RP Simpson, JE (reprint author), Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England.
EM julie.simpson@sheffield.ac.uk
RI Simpson, Julie/C-7914-2009; Matthews, Fiona/O-6932-2015
OI Simpson, Julie/0000-0002-3753-4271; Matthews, Fiona/0000-0002-1728-2388;
   Shaw, Pamela/0000-0002-8925-2567; Brayne, Carol/0000-0001-5307-663X
FU Medical Research Council [MRC/G0900582/1]; Sheffield charity Neurocare;
   MRC [MRJ004308/1]; ARUK [ART:PG2010-5]; Department of Health and the
   Medical Research Council [MRC/G9901400, MRC U.1052.00.0013]; UKNIHR
   Biomedical Research Centre for Ageing and Age-related Disease Award;
   Alzheimers Research UK [ART-PG2010-5]; Medical Research Council
   [MR/L016451/1, G0300126, G0400074, MC_U105292687, G1100540, G9901400,
   MR/L022656/1, G0502157, G0900582, MR/J004308/1, G0900652]; National
   Institute for Health Research [NF-SI-0611-10084]
FX This study was supported by the Medical Research Council
   (MRC/G0900582/1) and the imaging equipment used in this study funded by
   Sheffield charity Neurocare. JES is supported by the MRC (MRJ004308/1).
   CG is supported by ARUK (ART:PG2010-5). CFAS is supported by the
   Department of Health and the Medical Research Council (grants
   MRC/G9901400 and MRC U.1052.00.0013); the UKNIHR Biomedical Research
   Centre for Ageing and Age-related Disease Award to the Newcastle upon
   Tyne Hospitals Foundation Trust; the Cambridge Brain Bank is supported
   by the NIHR Cambridge Biomedical Research Centre; The Cambridgeshire and
   Peterborough NIHR CLAHRC; Nottingham University Hospitals NHS Trust;
   University of Sheffield and the Sheffield Teaching Hospitals NHS
   Foundation Trust; The Thomas Willis Oxford Brain Collection, supported
   by the Oxford Biomedical Research Centre; The Walton Centre NHS
   Foundation Trust, Liverpool. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Akiyama H, 1999, GLIA, V25, P324, DOI 10.1002/(SICI)1098-1136(19990215)25:4<324::AID-GLIA2>3.0.CO;2-5
   Belanger Mireille, 2009, Dialogues Clin Neurosci, V11, P281
   Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934
   BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809
   Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z
   Brayne C, 1998, PSYCHOL MED, V28, P319
   Broe M, 2004, BRAIN, V127, P2214, DOI 10.1093/brain/awh250
   Christensen DZ, 2010, ACTA NEUROPATHOL, V119, P555, DOI 10.1007/s00401-010-0666-1
   Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160
   DeWitt DA, 1998, EXP NEUROL, V149, P329, DOI 10.1006/exnr.1997.6738
   Dickson TC, 2001, NEUROSCIENCE, V105, P99, DOI 10.1016/S0306-4522(01)00169-5
   Esiri MM, 2001, LANCET, V357, P169
   Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175
   GIULIAN D, 1994, DEV NEUROSCI-BASEL, V16, P128, DOI 10.1159/000112099
   Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022
   Gozes I, 1999, ANN NY ACAD SCI, V897, P125, DOI 10.1111/j.1749-6632.1999.tb07884.x
   Greenfield JG, 2008, GREENFIELDS NEUROPAT
   Grutzendler J, 2007, ANN NY ACAD SCI, V1097, P30, DOI 10.1196/annals.1379.003
   Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600
   Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x
   Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2
   Huang CR, 2002, BMC NEUROL, V2, DOI 10.1186/1471-2377-2-9
   IKEDA K, 1992, ACTA NEUROPATHOL, V85, P101, DOI 10.1007/BF00304639
   INCE PG, 1995, DEMENTIA, V6, P162, DOI 10.1159/000106940
   ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X
   Kamphuis W, 2014, NEUROBIOL AGING, V35, P492, DOI 10.1016/j.neurobiolaging.2013.09.035
   Kersaitis C, 2004, ACTA NEUROPATHOL, V108, P515, DOI 10.1007/s00401-004-0917-0
   Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026
   Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z
   Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058
   LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355
   Marlatt MW, 2014, NEURAL PLAST, DOI 10.1155/2014/693851
   Masliah E, 2000, ANN NY ACAD SCI, V924, P68
   Matthews F, 2005, PLOS MED, V2, P753, DOI 10.1371/journal.pmed.0020193
   McNamara MJ, 1998, ARCH NEUROL-CHICAGO, V55, P1001, DOI 10.1001/archneur.55.7.1001
   Medeiros R, 2013, EXP NEUROL, V239, P133, DOI 10.1016/j.expneurol.2012.10.007
   Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114
   Mirra SS, 1997, NEUROBIOL AGING, V18, pS91, DOI 10.1016/S0197-4580(97)00058-4
   Morgan C, 2004, PROG NEUROBIOL, V74, P323, DOI 10.1016/j.pneurobio.2004.10.004
   Nagele RG, 2003, BRAIN RES, V971, P197, DOI 10.1016/S0006-8993(03)02361-8
   Nicoll JAR, 2011, NEUROPATH APPL NEURO, V37, P285, DOI 10.1111/j.1365-2990.2010.01130.x
   Oh D, 1999, ARCH PATHOL LAB MED, V123, P917
   Olichney JM, 1996, NEUROLOGY, V47, P190, DOI 10.1212/WNL.47.1.190
   Overmyer M, 1999, DEMENT GERIATR COGN, V10, P252, DOI 10.1159/000017128
   Paradisi S, 2004, GLIA, V46, P252, DOI 10.1002/glia.20005
   Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x
   Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17
   Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142
   Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172
   Rogers J, 2002, GLIA, V40, P260, DOI 10.1002/glia.10153
   Romito-DiGiacomo RR, 2007, J NEUROSCI, V27, P8496, DOI 10.1523/JNEUROSCI.1008-07.2007
   ROZEMULLER JM, 1989, J NEUROPATH EXP NEUR, V48, P674, DOI 10.1097/00005072-198911000-00009
   Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142
   SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649
   Serrano-Pozo A, 2013, J NEUROPATH EXP NEUR, V72, P462, DOI 10.1097/NEN.0b013e3182933788
   Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189
   Serrano-Pozo A, 2011, AM J PATHOL, V179, P1373, DOI 10.1016/j.ajpath.2011.05.047
   Simpson JE, 2010, NEUROBIOL AGING, V31, P578, DOI 10.1016/j.neurobiolaging.2008.05.015
   Simpson JE, 2011, NEUROBIOL AGING, V32, P1795, DOI 10.1016/j.neurobiolaging.2011.04.013
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Sparks DL, 1996, J NEUROL SCI, V138, P97, DOI 10.1016/0022-510X(96)00008-1
   SUTHERLAND RJ, 1988, J NEUROSCI, V8, P1863
   TAGLIAVINI F, 1988, NEUROSCI LETT, V93, P191, DOI 10.1016/0304-3940(88)90080-8
   Thal DR, 2012, EXP NEUROL, V236, P1, DOI 10.1016/j.expneurol.2012.04.021
   Thal DR, 2000, J NEUROPATH EXP NEUR, V59, P733, DOI 10.1093/jnen/59.8.733
   Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791
   Tiraboschi P, 2004, NEUROLOGY, V62, P1977, DOI 10.1212/01.WNL.0000128091.92139.0F
   Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2
   Wharton SB, 2011, J ALZHEIMERS DIS, V25, P359, DOI 10.3233/JAD-2011-091402
   Wirths O, 2004, J NEUROCHEM, V91, P513, DOI 10.1111/j.1471-4159.2004.02737.x
   Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484
   Yang CN, 2011, NEUROBIOL DIS, V42, P221, DOI 10.1016/j.nbd.2011.01.005
   Yip AG, 2002, J MED GENET, V39, P639, DOI 10.1136/jmg.39.9.639
NR 75
TC 21
Z9 21
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 23
PY 2015
VL 10
IS 2
AR UNSP e0118463
DI 10.1371/journal.pone.0118463
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CC9BI
UT WOS:000350662100184
PM 25707004
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Krix, AC
   Sauerland, M
   Lorei, C
   Rispens, I
AF Krix, Alana C.
   Sauerland, Melanie
   Lorei, Clemens
   Rispens, Imke
TI Consistency across Repeated Eyewitness Interviews: Contrasting Police
   Detectives' Beliefs with Actual Eyewitness Performance
SO PLOS ONE
LA English
DT Article
ID SELF-ADMINISTERED INTERVIEW; STRATEGIC REGULATION; GRAIN-SIZE; MEMORY;
   ACCURACY; RECALL; EVENT
AB In the legal system, inconsistencies in eyewitness accounts are often used to discredit witnesses' credibility. This is at odds with research findings showing that witnesses frequently report reminiscent details (details previously unrecalled) at an accuracy rate that is nearly as high as for consistently recalled information. The present study sought to put the validity of beliefs about recall consistency to a test by directly comparing them with actual memory performance in two recall attempts. All participants watched a film of a staged theft. Subsequently, the memory group (N = 84) provided one statement immediately after the film (either with the Self-Administered Interview or free recall) and one after a one-week delay. The estimation group (N = 81) consisting of experienced police detectives estimated the recall performance of the memory group. The results showed that actual recall performance was consistently underestimated. Also, a sharp decline of memory performance between recall attempts was assumed by the estimation group whereas actual accuracy remained stable. While reminiscent details were almost as accurate as consistent details, they were estimated to be much less accurate than consistent information and as inaccurate as direct contradictions. The police detectives expressed a great concern that reminiscence was the result of suggestive external influences. In conclusion, it seems that experienced police detectives hold many implicit beliefs about recall consistency that do not correspond with actual recall performance. Recommendations for police trainings are provided. These aim at fostering a differentiated view on eyewitness performance and the inclusion of more comprehensive classes on human memory structure.
C1 [Krix, Alana C.; Sauerland, Melanie] Maastricht Univ, Forens Psychol Sect, NL-6200 MD Maastricht, Netherlands.
   [Lorei, Clemens] Univ Appl Sci Police & Adm Hesse, Wiesbaden, Germany.
   [Rispens, Imke] Police Acad Netherlands, Apeldoorn, Netherlands.
RP Krix, AC (reprint author), Maastricht Univ, Forens Psychol Sect, NL-6200 MD Maastricht, Netherlands.
EM Alana.Krix@maastrichtuniversity.nl
FU Studienstiftung des deutschen Volkes (German National Academic
   Foundation)
FX This research was supported by Studienstiftung des deutschen Volkes
   (German National Academic Foundation, http://www.studienstiftung.de)
   that provided AK with a PhD scholarship to cover the living expenses.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Anderson JR, 1983, J VERB LEARN VERB BE, V22, P261
   Bornstein BH, 1998, APPL COGNITIVE PSYCH, V12, P119, DOI 10.1002/(SICI)1099-0720(199804)12:2<119::AID-ACP500>3.0.CO;2-4
   Brainerd CJ, 2013, CURR DIR PSYCHOL SCI, V22, P335, DOI 10.1177/0963721413484468
   Brewer N, 1999, APPL COGNITIVE PSYCH, V13, P297, DOI 10.1002/(SICI)1099-0720(199908)13:4<297::AID-ACP578>3.0.CO;2-S
   Brock P, 1999, PSYCHOL CRIME LAW, V5, P29, DOI 10.1080/10683169908414992
   Cohen J, 1988, STAT POWER ANAL BEHA
   Erdelyi MH, 2010, AM PSYCHOL, V65, P623, DOI 10.1037/a0020440
   Evans JR, 2011, APPL COGNITIVE PSYCH, V25, P501, DOI 10.1002/acp.1722
   Fisher R. P., 2009, HDB PSYCHOL INVESTIG, P121, DOI DOI 10.1002/9780470747599.CH8
   Fisher R. P., 1992, MEMORY ENHANCING TEC
   FISHER RP, 1991, J EXP PSYCHOL LEARN, V17, P722
   Gabbert F, 2009, LAW HUMAN BEHAV, V33, P298, DOI 10.1007/s10979-008-9146-8
   Gilbert JAE, 2006, APPL COGNITIVE PSYCH, V20, P723, DOI 10.1002/acp.1232
   Goldsmith M, 2005, J MEM LANG, V52, P505, DOI 10.1016/j.jml.2005.01.010
   Goldsmith M, 2002, J EXP PSYCHOL GEN, V131, P73, DOI 10.1037//0096-3445.131.173
   Hope L, 2014, APPL COGNITIVE PSYCH, V28, P304, DOI 10.1002/acp.2984
   Hope L, 2011, LEGAL CRIMINOL PSYCH, V16, P211, DOI 10.1111/j.2044-8333.2011.02015.x
   Kebbell MR, 1998, J SOC PSYCHOL, V138, P323, DOI 10.1080/00224549809600384
   Koriat A, 1996, PSYCHOL REV, V103, P490, DOI 10.1037/0033-295X.103.3.490
   Krix AC, 2014, PSYCHOL CRIME LAW, V20, P1005, DOI 10.1080/1068316X.2014.902456
   La Rooy D, 2010, PSYCHOL PUBLIC POL L, V16, P373, DOI 10.1037/a0019909
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Odinot G, 2013, PSYCHOL CRIME LAW, V19, P629, DOI 10.1080/1068316X.2012.660152
   Odinot G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076305
   Oeberst A, 2012, LAW HUMAN BEHAV, V36, P266, DOI 10.1037/h0093966
   Potter R, 1999, PSYCHIAT PSYCHOL LAW, V6, P97, DOI DOI 10.1080/13218719909524952
   Sauerland M, 2014, MEM COGNITION, V42, P978, DOI 10.3758/s13421-014-0401-6
   SCRIVNER E, 1988, J APPL PSYCHOL, V73, P371, DOI 10.1037/0021-9010.73.3.371
   Sixth Circuit Pattern Criminal Jury Instruction Committee, 2014, 6 CIRC CRIM PATT JUR
   Smeets T, 2004, AM J PSYCHOL, V117, P595, DOI 10.2307/4148994
   Sporer S. L., 2011, RES METHODS FORENSIC, P43
   TULVING E, 1975, PSYCHOL REV, V82, P261, DOI 10.1037/h0076782
   UVILLER HR, 1993, DUKE LAW J, V42, P776, DOI 10.2307/1372715
NR 33
TC 12
Z9 12
U1 0
U2 24
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 19
PY 2015
VL 10
IS 2
AR e0118641
DI 10.1371/journal.pone.0118641
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CC0XE
UT WOS:000350062300058
PM 25695428
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Shimanoe, C
   Hara, M
   Nishida, Y
   Nanri, H
   Otsuka, Y
   Nakamura, K
   Higaki, Y
   Imaizumi, T
   Taguchi, N
   Sakamoto, T
   Horita, M
   Shinchi, K
   Tanaka, K
AF Shimanoe, Chisato
   Hara, Megumi
   Nishida, Yuichiro
   Nanri, Hinako
   Otsuka, Yasuko
   Nakamura, Kazuyo
   Higaki, Yasuki
   Imaizumi, Takeshi
   Taguchi, Naoto
   Sakamoto, Tatsuhiko
   Horita, Mikako
   Shinchi, Koichi
   Tanaka, Keitaro
TI Perceived Stress and Coping Strategies in Relation to Body Mass Index:
   Cross-Sectional Study of 12,045 Japanese Men and Women
SO PLOS ONE
LA English
DT Article
ID MULTIINSTITUTIONAL COLLABORATIVE COHORT; C-REACTIVE PROTEIN;
   CARDIOVASCULAR-DISEASE; PSYCHOSOCIAL STRESS; LIFE-STYLE; RISK;
   ASSOCIATIONS; CORTISOL; METAANALYSIS; PREVALENCE
AB Background
   Accumulated evidence suggests a weak positive relationship between psychosocial stress and body mass index (BMI), but little is known about stress coping strategies and BMI.
   Objective
   We aimed to examine if perceived stress and coping strategies are related to BMI, with any of their mutual interactions on BMI.
   Methods
   This cross-sectional study included 5,063 men and 6,982 women aged 40-69 years. A self-administered questionnaire ascertained perceived stress and 5 items of coping strategies (emotion expression, emotional support seeking, positive reappraisal, problem solving, and disengagement). Analyses were performed by gender with adjustment for age, socioeconomic status, and lifestyle factors.
   Results
   No significant associations were detected between perceived stress and BMI in either men (P-trend = 0.09) or women (P-trend = 0.58). In men, however, 'disengagement' showed an inverse association with BMI (P-trend < 0.001), and 'positive reappraisal' and 'problem solving' revealed a positive association with BMI (P-trend = 0.04 and 0.007, respectively) even after controlling for perceived stress. A possible interaction between perceived stress and 'dis-engagement' on BMI was found in men (P-interaction = 0.027); the inverse association between 'disengagement' and BMI was more evident in higher levels of stress (beta = -0.13, P-trend = 0.21 in low; beta = -0.22, P-trend = 0.01 in medium; and beta = -0.24, P-trend = 0.06 in high). In men, 'disengagement' was inversely associated with overweight/obesity (odds ratio 0.79, 95% confidential interval 0.67-0.95), and "positive reappraisal" was positively associated with it (1.25, 1.02-1.54).
   Conclusions
   Coping strategies may have an important role in developing overweight/obesity, particularly in men.
C1 [Shimanoe, Chisato; Hara, Megumi; Nishida, Yuichiro; Nanri, Hinako; Otsuka, Yasuko; Imaizumi, Takeshi; Taguchi, Naoto; Horita, Mikako; Tanaka, Keitaro] Saga Univ, Fac Med, Dept Prevent Med, Saga 840, Japan.
   [Nanri, Hinako] Showa Univ, Sch Med, Dept Publ Hlth, Shinagawa Ku, Tokyo 142, Japan.
   [Nakamura, Kazuyo] St Marys Coll, Fac Nursing, Kurume, Fukuoka, Japan.
   [Higaki, Yasuki] Fukuoka Univ, Fac Sports & Hlth Sci, Exercise Physiol Lab, Fukuoka 81401, Japan.
   [Sakamoto, Tatsuhiko] Fukuoka Prefectural Govt, Chikushi Off Hlth Human Serv & Environm Issues, Onojo, Japan.
   [Shinchi, Koichi] Saga Univ, Fac Med, Div Int Hlth & Nursing, Saga 840, Japan.
RP Shimanoe, C (reprint author), Saga Univ, Fac Med, Dept Prevent Med, Saga 840, Japan.
EM chisatos@cc.saga-u.ac.jp
RI Nishida, Yuichiro/H-8791-2019
OI Nishida, Yuichiro/0000-0003-2320-7234; Shimanoe,
   Chisato/0000-0002-3561-9538; Shinchi, Koichi/0000-0003-2367-7607; Hara,
   Megumi/0000-0002-8708-3237
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
   [17015018, 221S0001, 20249038, 18390182, 20689014, 18790380]
FX This work was supported by Grants-in-Aid for Scientific Research on the
   Special Priority Areas of Cancer (No. 17015018) and Innovative Areas
   (No. 221S0001); Scientific Research (A) (No. 20249038) and (B) (No.
   18390182); and Young Scientists (A) (No. 20689014) and (B) (No.
   18790380) from the Ministry of Education, Culture, Sports, Science and
   Technology, Japan. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Barrington WE, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120001
   Block JP, 2009, AM J EPIDEMIOL, V170, P181, DOI 10.1093/aje/kwp104
   Cai ZJ, 1999, WHO TECH REP SER, V887, P1
   Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352
   Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6
   Chen WQ, 2009, STRESS HEALTH, V25, P431, DOI 10.1002/smi.1263
   Dallman MF, 2004, ENDOCRINOLOGY, V145, P2633, DOI 10.1210/en.2004-0037
   Eller NH, 2006, BIOL PSYCHOL, V73, P280, DOI 10.1016/j.biopsycho.2006.05.003
   Fujimoto S, 1968, Nihon Eiseigaku Zasshi, V23, P443
   Hamajima N, 2007, ASIAN PAC J CANCER P, V8, P317
   Hara M, 2010, J EPIDEMIOL, V20, P40, DOI 10.2188/jea.JE20090062
   Harding JL, 2014, OBESITY, V22, P277, DOI 10.1002/oby.20423
   Health Promotion and Nutrition Division HSB Ministry of Health and Welfare of Japan, 1994, 5 REV REC DIET ALL J
   Iso H, 2002, CIRCULATION, V106, P1229, DOI 10.1161/01.CIR.0000028145.58654.41
   Jiang JY, 2013, PREV MED, V57, P60, DOI 10.1016/j.ypmed.2013.04.014
   Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x
   Kelly SJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-765
   Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5
   Kouvonen A, 2005, PSYCHOSOM MED, V67, P577, DOI 10.1097/01.psy.0000170330.08704.62
   Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LAZARUS RS, 1984, J BEHAV MED, V7, P375, DOI 10.1007/BF00845271
   Martin LA, 2013, INT J BEHAV MED, V20, P97, DOI 10.1007/s12529-011-9204-3
   Nakagawa A, 2011, RES DATABASE REPORT
   Nanri H, 2011, J EPIDEMIOL, V21, P122, DOI 10.2188/jea.JE20100110
   Nicdao EG, 2007, INT J EAT DISORDER, V40, pS22, DOI 10.1002/eat.20450
   Nyberg ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067323
   O'Donnell K, 2008, PSYCHONEUROENDOCRINO, V33, P601, DOI 10.1016/j.psyneuen.2008.01.015
   Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0
   Rosmond R, 2005, PSYCHONEUROENDOCRINO, V30, P1, DOI 10.1016/j.psyneuen.2004.05.007
   Rueggeberg R, 2012, PSYCHOSOM MED, V74, P937, DOI [10.1097/PSY.06013e3182732dc6, 10.1097/PSY.0b013e3182732dc6]
   Sasaki M, 2009, J NURS MANAGE, V17, P359, DOI 10.1111/j.1365-2834.2008.00960.x
   Sasaki Megumi, 2002, Nihon Koshu Eisei Zasshi, V49, P399
   Science Japan and Agency Technology, 2000, STAND TABL FOOD COMP
   Shimanoe C, 2014, INT J BEHAV MED, V21, P821, DOI 10.1007/s12529-013-9341-y
   Steptoe A, 2004, PSYCHOSOM MED, V66, P323, DOI 10.1097/01.psy.0000126198.67070.72
   Strickland OL, 2007, J CARDIOVASC NURS, V22, P272, DOI 10.1097/01.JCN.0000278964.05748.d8
   Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520
   Tokudome Shinkan, 2004, Asian Pac J Cancer Prev, V5, P40
   Tokudome Y, 2005, J EPIDEMIOL, V15, P135, DOI 10.2188/jea.15.135
   Wakai K, 2011, J EPIDEMIOL, V21, P223, DOI 10.2188/jea.JE20100139
   Wardle J, 2000, J PSYCHOSOM RES, V48, P195, DOI 10.1016/S0022-3999(00)00076-3
   Wardle J, 2011, OBESITY, V19, P771, DOI 10.1038/oby.2010.241
   Yang TC, 2014, INT J BEHAV MED, V21, P282, DOI 10.1007/s12529-013-9293-2
NR 44
TC 11
Z9 11
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 12
PY 2015
VL 10
IS 2
AR e0118105
DI 10.1371/journal.pone.0118105
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CB8WX
UT WOS:000349914000040
PM 25675249
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Shin, HS
   Han, DH
   Shin, MS
   Lee, HJ
   Kim, MS
   Kim, HD
AF Shin, Hye-Sun
   Han, Dong-Hun
   Shin, Myung-Seop
   Lee, Hyun-Jin
   Kim, Mi-Sun
   Kim, Hyun-Duck
TI Korean Version of Child Perceptions Questionnaire and Dental Caries
   among Korean Children
SO PLOS ONE
LA English
DT Article
ID QUALITY-OF-LIFE; HEALTH IMPACT PROFILE; ORAL-HEALTH; VALIDATION;
   VALIDITY; RELIABILITY; ADOLESCENTS; TRANSLATION; CPQ(11-14)
AB Although dental caries has been a major oral health problem for children, the association between dental caries and oral health related quality of life has been still controversial. This study aims to evaluate the association between the Korean version of the Child Perceptions Questionnaire (K-CPQ) and dental caries among Korean children. Eight hundred one school children aged 8 to 14 years participated in this study. After the K-CPQ was validated we performed an association study. The K-CPQ was self-reported. Dental caries were evaluated by dentists using the World Health Organization Index. Correlation analyses (intraclass correlation coefficient, Cronbach's alpha and Pearson's correlation coefficient [r]) and linear regression models (partial r) including age, gender and type of school were applied. Untreated deciduous dental caries was associated with the K-CPQ8-10 overall score (partial r = 0.15, P < 0.05). The link was highlighted in the domains of functional limitation and emotional wellbeing. Filled teeth due to caries (FT) was associated with the K-CPQ11-14 overall domain (partial r = 0.14, P = 0.002) as well as with the oral symptoms domain (partial r = 0.16, P = 0.001). This association was highlighted among public school children. Our data indicate that K-CPQ was independently associated with dental caries. The K-CPQ could be a practical tool to evaluate the subjective oral health among Korean children aged 8 to 14.
C1 [Shin, Hye-Sun; Han, Dong-Hun; Shin, Myung-Seop; Lee, Hyun-Jin; Kim, Mi-Sun; Kim, Hyun-Duck] Seoul Natl Univ, Dept Prevent & Social Dent, Sch Dent, Seoul, South Korea.
   [Han, Dong-Hun; Kim, Hyun-Duck] Seoul Natl Univ, Dent Res Inst, Sch Dent, Seoul, South Korea.
RP Kim, HD (reprint author), Seoul Natl Univ, Dept Prevent & Social Dent, Sch Dent, Seoul, South Korea.
EM hyundkim@snu.ac.kr
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education, Science and Technology
   [2013-062881]; NRF Grant, through the Oromaxillofacial Dysfunction
   Research Center for the Elderly at Seoul National University in Korea
   [2013-070465]; Brain Korea 21 at Seoul National University School of
   Dentistry in Korea
FX This work was supported by the grant from Basic Science Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Education, Science and Technology (No. 2013-062881) and the
   NRF Grant, through the Oromaxillofacial Dysfunction Research Center for
   the Elderly (No. 2013-070465) at Seoul National University in Korea. Ms.
   Shin was supported by grants from Brain Korea 21 at Seoul National
   University School of Dentistry in Korea. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aguilar-Diaz FD, 2011, MED ORAL PATOL ORAL, V16, pE430, DOI 10.4317/medoral.16.e430
   Allison P, 1999, J DENT RES, V78, P643, DOI 10.1177/00220345990780020301
   Bae KH, 2007, COMMUNITY DENT ORAL, V35, P73, DOI 10.1111/j.1600-0528.2007.00331.x
   Barbosa Tais S, 2009, BMC Oral Health, V9, P13, DOI 10.1186/1472-6831-9-13
   Barbosa TS, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-32
   Bekes K, 2012, CLIN ORAL INVEST, V16, P165, DOI 10.1007/s00784-010-0496-5
   Bendo CB, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-114
   Brown A, 2006, INT J PAEDIATR DENT, V16, P405, DOI 10.1111/j.1365-263X.2006.00775.x
   Costa AA, 2011, J ORTHOD, V38, P275, DOI 10.1179/14653121141632
   Do LG, 2008, COMMUNITY DENT HLTH, V25, P205, DOI 10.1922/CDH_2241Do06
   Gherunpong Sudaduang, 2004, Community Dent Health, V21, P161
   Goursand D, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-2
   Gururatana O, 2011, COMMUNITY DENT HLTH, V28, P232, DOI 10.1922/CDH_2588Gururatana06
   Jokovic A, 2004, PEDIATR DENT, V26, P512
   Jokovic A, 2002, J DENT RES, V81, P459, DOI 10.1177/154405910208100705
   Kolawole KA, 2011, EUR J PAEDIATR DENT, V12, P55
   Kushnir D, 2004, J PUBLIC HEALTH DENT, V64, P71, DOI 10.1111/j.1752-7325.2004.tb02730.x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Larsson P, 2004, ACTA ODONTOL SCAND, V62, P147, DOI 10.1080/00016350410001496
   Lawrence H P, 2001, Community Dent Health, V18, P207
   Marshman Z, 2005, COMMUNITY DENT HLTH, V22, P151
   McGrath C, 2008, INT J PAEDIATR DENT, V18, P267, DOI [10.1111/j.1365-263X.2007.00878.x, 10.1111/j.1365-263X.2007.00877.x]
   Olivieri A, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-55
   Oscarson N, 2007, CARIES RES, V41, P85, DOI 10.1159/000098040
   Page LAF, 2005, J DENT RES, V84, P649, DOI 10.1177/154405910508400713
   Page LAF, 2013, INT J PAEDIATR DENT, V23, P415, DOI 10.1111/ipd.12011
   Page LAF, 2013, EUR J ORAL SCI, V121, P182, DOI 10.1111/eos.12034
   Page LAF, 2012, J PUBLIC HEALTH DENT, V72, P287, DOI 10.1111/j.1752-7325.2012.00336.x
   Pahel BT, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-6
   Robinson PG, 2003, COMMUNITY DENT ORAL, V31, P90, DOI 10.1034/j.1600-0528.2003.00051.x
   Sheiham A, 2005, B WORLD HEALTH ORGAN, V83, P644
   Slade G D, 1994, Community Dent Health, V11, P3
   Slade GD, 1998, COMMUNITY DENT ORAL, V26, P52
   Torres CS, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-43
   Vargas-Ferreira F, 2011, BRAZ ORAL RES, V25, P531, DOI 10.1590/S1806-83242011000600010
   WHO (World Health Organization), 1997, OR HLTH SURV BAS MET
   Wogelius Pia, 2009, BMC Oral Health, V9, P11, DOI 10.1186/1472-6831-9-11
NR 37
TC 6
Z9 6
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 12
PY 2015
VL 10
IS 2
AR e0116011
DI 10.1371/journal.pone.0116011
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CB8WX
UT WOS:000349914000006
PM 25675410
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Basson, A
   Swart, R
   Jordaan, E
   Mazinu, M
   Watermeyer, G
AF Basson, Abigail
   Swart, Rina
   Jordaan, Esme
   Mazinu, Mikateko
   Watermeyer, Gillian
TI The Association between Childhood Environmental Exposures and the
   Subsequent Development of Crohn's Disease in the Western Cape, South
   Africa
SO PLOS ONE
LA English
DT Article
ID INFLAMMATORY-BOWEL-DISEASE; HUMAN MICROBIOME; SMOKING; EPIDEMIOLOGY;
   HYGIENE; RISK; PREVALENCE; PREDICTORS; TOWN
AB Background: Environmental factors during childhood are thought to play a role in the aetiolgy of Crohn's Disease (CD). However the association between age at time of exposure and the subsequent development of CD in South Africa is unknown.
   Methods: A case control study of all consecutive CD patients seen at 2 large inflammatory bowel disease (IBD) referral centers in the Western Cape, South Africa between September 2011 and January 2013 was performed. Numerous environmental exposures during 3 age intervals; 0-5, 6-10 and 11-18 years were extracted using an investigator administered questionnaire. An agreement analysis was performed to determine the reliability of questionnaire data for all the relevant variables.
   Results: This study included 194 CD patients and 213 controls. On multiple logistic regression analysis, a number of childhood environmental exposures during the 3 age interval were significantly associated with the risk of developing CD. During the age interval 6-10 years, never having had consumed unpasteurized milk (OR=5.84; 95% CI, 2.73-13.53) and never having a donkey, horse, sheep or cow on the property (OR=2.48; 95% CI, 1.09-5.98) significantly increased the risk of developing future CD. During the age interval 11-18 years, an independent risk-association was identified for; never having consumed unpasteurized milk (OR=2.60; 95% CI, 1.17-6.10) and second-hand cigarette smoke exposure (OR=1.93; 95% CI, 1.13-3.35).
   Conclusion: This study demonstrates that both limited microbial exposures and exposure to second-hand cigarette smoke during childhood is associated with future development of CD.
C1 [Basson, Abigail; Swart, Rina] Univ Western Cape, Dietet Dept, ZA-7535 Bellville, Western Cape, South Africa.
   [Jordaan, Esme; Mazinu, Mikateko] Med Res Council South Africa, Biostat Unit, Parow, Western Cape, South Africa.
   [Jordaan, Esme] Univ Western Cape, Stat & Populat Studies Dept, ZA-7535 Bellville, Western Cape, South Africa.
   [Watermeyer, Gillian] Groote Schuur Hosp, Dept Gastroenterol, ZA-7925 Cape Town, Western Cape, South Africa.
   [Watermeyer, Gillian] Univ Cape Town, Dept Med, ZA-7925 Cape Town, Western Cape, South Africa.
RP Basson, A (reprint author), Univ Western Cape, Dietet Dept, ZA-7535 Bellville, Western Cape, South Africa.
EM abbasson@uwc.ac.za
OI Basson, Abigail/0000-0002-8369-919X
FU AstraZeneca/South African Gastroenterology Society (SAGES)
FX This research was supported by the 2011 Scholarship in Gastroenterology;
   a grant from the AstraZeneca/South African Gastroenterology Society
   (SAGES). The funders had no role in the study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
   [http://www.sages.co.za/D_AN_ScholTravel.asp]
CR Aldhous MC, 2007, AM J GASTROENTEROL, V102, P577, DOI 10.1111/j.1572-0241.2007.01064.x
   Ayodele OE, 2010, NEPHROLOGY, V15, P482, DOI 10.1111/j.1440-1797.2010.01290.x
   Basson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104859
   Bernstein CN, 2006, AM J GASTROENTEROL, V101, P993, DOI 10.1111/j.1572-0241.2006.00381.x
   Bisgaard H, 2014, CLIN EXP ALLERGY, V44, P475, DOI 10.1111/cea.12291
   Blanchard JF, 2001, AM J EPIDEMIOL, V154, P328, DOI 10.1093/aje/154.4.328
   Chu KM, 2013, INFLAMM BOWEL DIS, V19, P614, DOI 10.1097/MIB.0b013e31827f27f4
   Duggan AE, 1998, GUT, V43, P494, DOI 10.1136/gut.43.4.494
   EKBOM A, 1991, GASTROENTEROLOGY, V100, P350, DOI 10.1016/0016-5085(91)90202-V
   Epstein D, 2007, ALIMENT PHARM THER, V25, P1373, DOI 10.1111/j.1365-2036.2007.03332.x
   GENT AE, 1994, LANCET, V343, P766, DOI 10.1016/S0140-6736(94)91841-4
   Koloski NA, 2008, WORLD J GASTROENTERO, V14, P165, DOI 10.3748/wjg.14.165
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lasken RS, 2012, NAT REV MICROBIOL, V10, P631, DOI 10.1038/nrmicro2857
   Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063
   Mahid SS, 2007, DIGEST DIS SCI, V52, P2897, DOI 10.1007/s10620-006-9624-0
   Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462
   Mahid SS, 2007, INFLAMM BOWEL DIS, V13, P431, DOI 10.1002/ibd.20070
   Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001
   PERSSON PG, 1990, GUT, V31, P1377, DOI 10.1136/gut.31.12.1377
   Proal AD, 2013, CURR OPIN RHEUMATOL, V25, P234, DOI 10.1097/BOR.0b013e32835cedbf
   SMALL K., 2008, DEMOGRAPHIC SOCIOECO
   Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Wadee S, 2007, RHEUMATOLOGY, V46, P1487, DOI 10.1093/rheumatology/kem180
   WRIGHT JP, 1986, S AFR MED J, V70, P10
   WRIGHT JP, 1983, S AFR MED J, V63, P226
NR 27
TC 5
Z9 5
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 16
PY 2014
VL 9
IS 12
AR e115492
DI 10.1371/journal.pone.0115492
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CA8DI
UT WOS:000349146300060
PM 25514591
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wu, CS
   Lai, MS
   Gau, SSF
   Wang, SC
   Tsai, HJ
AF Wu, Chi-Shin
   Lai, Mei-Shu
   Gau, Susan Shur-Fen
   Wang, Sheng-Chang
   Tsai, Hui-Ju
TI Concordance between Patient Self-Reports and Claims Data on Clinical
   Diagnoses, Medication Use, and Health System Utilization in Taiwan
SO PLOS ONE
LA English
DT Article
ID EPIDEMIOLOGIC RESEARCH; ADMINISTRATIVE DATA; PHARMACY DATA; AGREEMENT;
   PREVALENCE; INSURANCE; RECORDS; CARE; VALIDATION; DATABASES
AB Purpose: The aim of this study was to evaluate the concordance between claims records in the National Health Insurance Research Database and patient self-reports on clinical diagnoses, medication use, and health system utilization.
   Methods: In this study, we used the data of 15,574 participants collected from the 2005 Taiwan National Health Interview Survey. We assessed positive agreement, negative agreement, and Cohen's kappa statistics to examine the concordance between claims records and patient self-reports.
   Results: Kappa values were 0.43, 0.64, and 0.61 for clinical diagnoses, medication use, and health system utilization, respectively. Using a strict algorithm to identify the clinical diagnoses recorded in claims records could improve the negative agreement; however, the effect on positive agreement and kappa was diverse across various conditions.
   Conclusion: We found that the overall concordance between claims records in the National Health Insurance Research Database and patient self-reports in the Taiwan National Health Interview Survey was moderate for clinical diagnosis and substantial for both medication use and health system utilization.
C1 [Wu, Chi-Shin] Far Eastern Mem Hosp, Dept Psychiat, New Taipei City, Taiwan.
   [Wu, Chi-Shin; Lai, Mei-Shu; Gau, Susan Shur-Fen] Natl Taiwan Univ, Coll Publ Hlth, Taipei 10764, Taiwan.
   [Wu, Chi-Shin; Gau, Susan Shur-Fen] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan.
   [Wu, Chi-Shin; Gau, Susan Shur-Fen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan.
   [Wang, Sheng-Chang] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Taiwan.
   [Tsai, Hui-Ju] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Taiwan.
   [Tsai, Hui-Ju] Kaohsiung Med Univ, Coll Med, Dept Med Genet, Kaohsiung, Taiwan.
   [Tsai, Hui-Ju] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA.
RP Tsai, HJ (reprint author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Taiwan.
EM tsaihj@nhri.org.tw
RI Tsai, Hui-Ju/E-3937-2010; Gau, Susan Shur-Fen/P-4726-2017; Wang,
   Sheng-Chang/G-9350-2011
OI Gau, Susan Shur-Fen/0000-0002-2718-8221; Lai,
   Mei-shu/0000-0001-6130-3468; WU, CHI-SHIN/0000-0003-2762-7295
FU National Science Council, Taiwan [NSC 102-2314-B-418 002]; National
   Health Research Institutes, Taiwan [PH-100-PP-14, PH-102-PP-14,
   PH-101SP-14, PH-102-SP-5]
FX No potential financial conflicts of interest relevant to this study were
   reported. Dr. Wu is supported in part by a grant from National Science
   Council, Taiwan (PI: Wu, NSC 102-2314-B-418 002). Dr. Tsai is supported
   in part by grants from the National Health Research Institutes, Taiwan
   (PI: Tsai, PH-100-PP-14, PH-102-PP-14, PH-101SP-14, PH-102-SP-5). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Boudreau DM, 2004, AM J EPIDEMIOL, V159, P308, DOI 10.1093/aje/kwh038
   Chang HY, 2002, CHINESE J PHYSIOL, V45, P187
   Chen GM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-5
   Chen YC, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d637
   Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087
   CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M
   Comino EJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-481
   Curtis JR, 2006, PHARMACOEPIDEM DR S, V15, P710, DOI 10.1002/pds.1226
   Haapea M, 2010, INT J METH PSYCH RES, V19, P88, DOI 10.1002/mpr.304
   Hennessy S, 2002, BRIT MED J, V325, P1070, DOI 10.1136/bmj.325.7372.1070
   HWU HG, 1989, ACTA PSYCHIAT SCAND, V79, P136, DOI 10.1111/j.1600-0447.1989.tb08581.x
   Kwon A, 2003, MED CARE, V41, P368, DOI 10.1097/00005650-200303000-00005
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lin CC, 2005, J FORMOS MED ASSOC, V104, P157
   Liu TC, 2002, SOC SCI MED, V55, P755, DOI 10.1016/S0277-9536(01)00201-5
   MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853
   Muhajarine N, 1997, J CLIN EPIDEMIOL, V50, P711, DOI 10.1016/S0895-4356(97)00019-X
   Pit SW, 2008, DRUG AGING, V25, P71, DOI 10.2165/00002512-200825010-00008
   QUAM L, 1993, MED CARE, V31, P498, DOI 10.1097/00005650-199306000-00003
   Rhodes AE, 2002, INT J METH PSYCH RES, V11, P125, DOI 10.1002/mpr.130
   Sakshaug JW, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-150
   Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012
   Suissa S, 2007, NAT CLIN PRACT RHEUM, V3, P725, DOI 10.1038/ncprheum0652
   Tisnado DM, 2006, MED CARE, V44, P132, DOI 10.1097/01.mlr.0000196952.15921.bf
   Tu Karen, 2007, Open Med, V1, pe18
   Wu CY, 2010, GASTROENTEROLOGY, V139, P1165, DOI 10.1053/j.gastro.2010.06.067
   Yu ST, 2009, J CLIN EPIDEMIOL, V62, P1316, DOI 10.1016/j.jclinepi.2009.01.016
NR 27
TC 47
Z9 47
U1 1
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 2
PY 2014
VL 9
IS 12
AR e112257
DI 10.1371/journal.pone.0112257
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AU8TQ
UT WOS:000345869700011
PM 25464005
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chen, CY
   Yu, C
   Chang, CC
   Lin, CW
AF Chen, Chen-Yu
   Yu, Chun
   Chang, Chia-Chen
   Lin, Chii-Wann
TI Comparison of a Novel Computerized Analysis Program and Visual
   Interpretation of Cardiotocography
SO PLOS ONE
LA English
DT Article
ID FETAL HEART-RATE; RATE TRACINGS; NATIONAL-INSTITUTE; CHILD-HEALTH; RATE
   PATTERN; INTEROBSERVER; MULTICENTER; OBSERVERS; CONSENSUS; SYSTEM
AB Objective: To compare a novel computerized analysis program with visual cardiotocography (CTG) interpretation results.
   Methods: Sixty-two intrapartum CTG tracings with 20- to 30-minute sections were independently interpreted using a novel computerized analysis program, as well as the visual interpretations of eight obstetricians, to evaluate the baseline fetal heart rate (FHR), baseline FHR variability, number of accelerations, number/type of decelerations, uterine contraction (UC) frequency, and the National Institute of Child Health and Human Development (NICHD) 3-Tier FHR classification system.
   Results: There was no significant difference in interobserver variation after adding the components of computerized analysis to results from the obstetricians' visual interpretations, with excellent agreement for the baseline FHR (ICC 0.91), the number of accelerations (ICC 0.85), UC frequency (ICC 0.97), and NICHD category I (kappa statistic 0.91); good agreement for baseline variability (kappa statistic 0.68), the numbers of early decelerations (ICC 0.78) and late decelerations (ICC 0.67), category II (kappa statistic 0.78), and overall categories (kappa statistic 0.80); and moderate agreement for the number of variable decelerations (ICC 0.60), and category III (kappa statistic 0.50).
   Conclusions: This computerized analysis program is not inferior to visual interpretation, may improve interobserver variations, and could play a vital role in prenatal telemedicine.
C1 [Chen, Chen-Yu; Yu, Chun; Chang, Chia-Chen; Lin, Chii-Wann] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.
   [Chen, Chen-Yu; Yu, Chun; Chang, Chia-Chen; Lin, Chii-Wann] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan.
   [Chen, Chen-Yu] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.
   [Chen, Chen-Yu] Mackay Med Coll, Taipei, Taiwan.
   [Chen, Chen-Yu] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan.
RP Lin, CW (reprint author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.
EM cwlinx@ntu.edu.tw
RI Lin, Chii-Wann/B-5527-2009; Chang, Chia-Chen/D-1600-2011
OI Lin, Chii-Wann/0000-0002-8721-3441; Chang, Chia-Chen/0000-0001-5466-4724
CR Alfirevic Z, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066
   Amer-Wahlin I, 2011, ACTA OBSTET GYN SCAN, V90, P990, DOI 10.1111/j.1600-0412.2011.01203.x
   Ayres-de Campos D, 2000, J Matern Fetal Med, V9, P311
   Ayres-De-Campos D, 2004, EUR J OBSTET GYN R B, V117, P174, DOI 10.1016/j.ejogrb.2004.03.013
   Ayres-De-Campos D, 2008, J PERINAT MED, V36, P260, DOI 10.1515/JPM.2008.030
   Blackwell SC, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.086
   Buscicchio G, 2006, J MATERN-FETAL NEO M, V19, P39, DOI 10.1080/14767050500361505
   Caldeyro-Barcia R, 1969, DIAGNOSIS TREATMENT, P205
   Chen CY, 2009, IEEE ENG MED BIO, P2567, DOI 10.1109/IEMBS.2009.5335287
   Chen SW, 2006, COMPUT METH PROG BIO, V82, P187, DOI 10.1016/j.cmpb.2005.11.012
   Chudacek V, 2011, PHYSIOL MEAS, V32, P1347, DOI 10.1088/0967-3334/32/8/022
   CHUNG TKH, 1995, BRIT J OBSTET GYNAEC, V102, P454, DOI 10.1111/j.1471-0528.1995.tb11317.x
   Costa MA, 2010, J PERINAT MED, V38, P191, DOI 10.1515/JPM.2010.030
   Devoe L, 2000, AM J OBSTET GYNECOL, V183, P361, DOI 10.1067/mob.2000.107665
   Di Lieto A, 2003, GYNECOL OBSTET INVES, V55, P37, DOI 10.1159/000068955
   DONKER DK, 1993, EUR J OBSTET GYN R B, V52, P21, DOI 10.1016/0028-2243(93)90220-7
   East CE, 2007, COCHRANE DB SYST REV, V2
   Figueras F, 2005, J PERINAT MED, V33, P241, DOI 10.1515/JPM.2005.044
   Freeman RK, 2002, OBSTET GYNECOL, V100, P813, DOI 10.1016/S0029-7844(02)02211-1
   Graatsma EM, 2009, BJOG-INT J OBSTET GY, V116, P334, DOI 10.1111/j.1471-0528.2008.01951.x
   Huhn EA, 2011, PRENATAL DIAG, V31, P509, DOI 10.1002/pd.2728
   JOHNSON N, 1991, BRIT J OBSTET GYNAEC, V98, P36, DOI 10.1111/j.1471-0528.1991.tb10308.x
   KEITH RDF, 1995, BRIT J OBSTET GYNAEC, V102, P688, DOI 10.1111/j.1471-0528.1995.tb11425.x
   Kruger K, 1999, AM J OBSTET GYNECOL, V181, P1072, DOI 10.1016/S0002-9378(99)70083-9
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lu W, 2006, MED PHYS, V33, P3634, DOI 10.1118/1.2348764
   Macones GA, 2008, OBSTET GYNECOL, V112, P661, DOI 10.1097/AOG.0b013e3181841395
   Maeda K, 2003, FETAL DIAGN THER, V18, P370, DOI 10.1159/000071982
   MODANLOU HD, 1982, AM J OBSTET GYNECOL, V142, P1033, DOI 10.1016/0002-9378(82)90789-X
   Neilson JP, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000116.pub2
   Parer JT, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.037
   Schiermeier S, 2011, GYNECOL OBSTET INVES, V72, P169, DOI 10.1159/000327133
   Serra V, 2009, ULTRASOUND OBST GYN, V34, P74, DOI 10.1002/uog.6365
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Signorini MG, 2003, IEEE T BIO-MED ENG, V50, P365, DOI 10.1109/TBME.2003.808824
   Taylor GM, 2000, BRIT J OBSTET GYNAEC, V107, P1130, DOI 10.1111/j.1471-0528.2000.tb11112.x
   Todros T, 1996, EUR J OBSTET GYN R B, V68, P83, DOI 10.1016/0301-2115(96)02487-6
NR 37
TC 4
Z9 4
U1 1
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 1
PY 2014
VL 9
IS 12
AR e112296
DI 10.1371/journal.pone.0112296
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AX7SK
UT WOS:000347114900012
PM 25437442
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Jia, L
   Chen, JY
   Wang, Y
   Liu, YJ
   Zhang, Y
   Chen, WZ
AF Jia, Lang
   Chen, Jinyun
   Wang, Yan
   Liu, Yingjiang
   Zhang, Yu
   Chen, Wenzhi
TI Magnetic Resonance Imaging of Osteophytic, Chondral, and Subchondral
   Structures in a Surgically-Induced Osteoarthritis Rabbit Model
SO PLOS ONE
LA English
DT Article
ID ARTICULAR-CARTILAGE; KNEE OSTEOARTHRITIS; DISEASE PROGRESSION;
   HISTOLOGIC-CHANGES; HYALINE CARTILAGE; JOINT SPACE; VOLUME; MRI;
   SUPPRESSION; DEFECTS
AB Objective: This study aimed to assess changes in osteophytic, chondral, and subchondral structures in a surgically-induced osteoarthritis (OA) rabbit model in order to correlate MRI findings with the macroscopic progress of OA and to define the timepoint for disease status in this OA model.
   Methods: The OA model was constructed by surgery in thirty rabbits with ten normal rabbits serving as controls (baseline). High-resolution three-dimensional MRI using a 1.5-T coil was performed at baseline, two, four, and eight weeks post-surgery. MRIs of cartilage lesions, subchondral bone lesions, and osteophyte formations were independently assessed by two blinded radiologists. Ten rabbits were sacrificed at baseline, two, four, and eight weeks post-surgery, and macroscopic evaluation was independently performed by two blinded orthopedic surgeons.
   Results: The signal intensities and morphologies of chondral and subchondral structures by MRI accurately reflected the degree of OA. Cartilage defects progressed from a grade of 0.05-0.15 to 1.15-1.30 to 1.90-1.97 to 3.00-3.35 at each successive time point, respectively (p< 0.05). Subchondral bone lesions progressed from a grade of 0.00 to 0.78-0.90 to 1.27-1.58 to 1.95-2.23 at each successive time point, respectively (p=0.000). Osteophytes progressed from a size (mm) of 0.00 to 0.87-1.06 to 1.24-1.87 to 2.21-3.21 at each successive time point, respectively (p=0.000).
   Conclusions: Serial observations revealed that MRI can accurately detect the progression of cartilage lesions and subchondral bone edema over an eight-week period but may not be accurate in detecting osteophyte sizes. Week four post-surgery was considered the timepoint between OA-negative and OA-positive status in this OA model. The combination of this OA model with MRI evaluation should provide a promising tool for the pre-clinical evaluation of new disease-modifying osteoarthritis drugs.
C1 [Jia, Lang; Chen, Jinyun; Wang, Yan; Liu, Yingjiang; Zhang, Yu; Chen, Wenzhi] State Key Lab Ultrasound Engn Med, Chongqing, Peoples R China.
   [Jia, Lang; Chen, Jinyun; Wang, Yan; Liu, Yingjiang; Zhang, Yu; Chen, Wenzhi] Chongqing Med Univ, Minist Sci & Technol, Coll Biomed Engn, Chongqing, Peoples R China.
   [Jia, Lang] Chongqing Med Univ, Affiliated Hosp 2, Dept Rehabil Med, Chongqing, Peoples R China.
RP Chen, WZ (reprint author), State Key Lab Ultrasound Engn Med, Chongqing, Peoples R China.
EM chenwz@cqmu.edu.cn
FU National Basic Research Program 973 of China [2012CB722402,
   2011CB707900]; National Natural Science Foundation of China [81127901,
   30830040, 11274404, 31000435, 30970827]; Medical Scientific Research
   Projects Foundation of ChongQing [2012-2-064]
FX This study was supported in part by the National Basic Research Program
   973 of China (Grant No. 2012CB722402 and Grant No. 2011CB707900),
   National Natural Science Foundation of China (Grant No. 81127901,
   30830040, 11274404, 31000435 and 30970827) and by Medical Scientific
   Research Projects Foundation of ChongQing(Grant No. 2012-2-064). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Anetzberger H, 2014, KNEE SURG SPORT TR A, V22, P112, DOI 10.1007/s00167-012-2297-7
   Baysal O, 2004, SWISS MED WKLY, V134, P283
   Boegard T, 1998, ANN RHEUM DIS, V57, P395, DOI 10.1136/ard.57.7.395
   Boileau C, 2008, ANN RHEUM DIS, V67, P926, DOI 10.1136/ard.2007.077297
   Brandt KD, 2005, ARTHRITIS RHEUM-US, V52, P2015, DOI 10.1002/art.21122
   Brandt KD, 1997, OSTEOARTHR CARTILAGE, V5, P438, DOI 10.1016/S1063-4584(97)80048-9
   Bruyere O, 2007, OSTEOARTHR CARTILAGE, V15, P98, DOI 10.1016/j.joca.2006.06.018
   Calvo E, 2001, OSTEOARTHR CARTILAGE, V9, P463, DOI 10.1053/joca.2001.0413
   Caron JP, 1996, ARTHRITIS RHEUM, V39, P1535, DOI 10.1002/art.1780390914
   Cicuttini FM, 1996, OSTEOARTHR CARTILAGE, V4, P143, DOI 10.1016/S1063-4584(05)80323-1
   Creamer P, 1997, LANCET, V350, P503, DOI 10.1016/S0140-6736(97)07226-7
   Dieppe P, 1999, OSTEOARTHR CARTILAGE, V7, P325, DOI 10.1053/joca.1998.0182
   Dieppe PA, 1997, OSTEOARTHR CARTILAGE, V5, P87, DOI 10.1016/S1063-4584(97)80002-7
   Ding CH, 2005, OSTEOARTHR CARTILAGE, V13, P198, DOI 10.1016/j.joca.2004.11.007
   Disler DG, 1997, AM J ROENTGENOL, V169, P1117, DOI 10.2214/ajr.169.4.9308475
   Disler DG, 1996, AM J ROENTGENOL, V167, P127, DOI 10.2214/ajr.167.1.8659356
   Dougados M, 2001, ARTHRITIS RHEUM-US, V44, P2539, DOI 10.1002/1529-0131(200111)44:11<2539::AID-ART434>3.0.CO;2-T
   Dupuy DE, 1996, ACAD RADIOL, V3, P919, DOI 10.1016/S1076-6332(96)80299-6
   Eckstein F, 2006, OSTEOARTHR CARTILAGE, V14, pA46, DOI 10.1016/j.joca.2006.02.026
   FERNANDEZ JC, 1995, ARTHRITIS RHEUM, V38, P1290, DOI 10.1002/art.1780380918
   Guermazi A, 2003, EUR RADIOL, V13, P1370, DOI 10.1007/s00330-002-1554-4
   HAMERMAN D, 1993, J AM GERIATR SOC, V41, P760, DOI 10.1111/j.1532-5415.1993.tb07469.x
   Hashimoto S, 2002, OSTEOARTHR CARTILAGE, V10, P180, DOI 10.1053/joca.2001.0505
   HULTH A, 1970, ACTA ORTHOP SCAND, V41, P522, DOI 10.3109/17453677008991540
   Jiang D, 2012, ARTHROSCOPY, V28, P1147, DOI 10.1016/j.arthro.2012.01.001
   Jovanovic DV, 2001, ARTHRITIS RHEUM-US, V44, P2320, DOI 10.1002/1529-0131(200110)44:10<2320::AID-ART394>3.0.CO;2-P
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lanyon P, 1998, ANN RHEUM DIS, V57, P595, DOI 10.1136/ard.57.10.595
   LUND F, 1980, ACTA RADIOL DIAGN, V21, P413, DOI 10.1177/028418518002100312
   MCALINDON T, 1990, BRIT J RHEUMATOL, V29, P471
   McAlindon TE, 1999, BEST PRACT RES CL RH, V13, P329, DOI 10.1053/berh.1999.0023
   Messner K, 2001, AM J SPORT MED, V29, P151, DOI 10.1177/03635465010290020701
   Mihara M, 2007, OSTEOARTHR CARTILAGE, V15, P543, DOI 10.1016/j.joca.2006.11.001
   Outerbridge RE, 2001, CLIN ORTHOP RELAT R, P5
   Pelletier JP, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2272
   PELLETIER JP, 2006, ARTHRITIS RHEUM S, V54, P95
   Peterfy CG, 2004, OSTEOARTHR CARTILAGE, V12, P177, DOI 10.1016/j.joca.2003.11.003
   Potter HG, 1998, J BONE JOINT SURG AM, V80A, P1276, DOI 10.2106/00004623-199809000-00005
   Raynauld JP, 2008, ANN RHEUM DIS, V67, P683, DOI 10.1136/ard.2007.073023
   RECHT MP, 1994, AM J ROENTGENOL, V163, P283, DOI 10.2214/ajr.163.2.8037016
   RECHT MP, 1993, RADIOLOGY, V187, P473, DOI 10.1148/radiology.187.2.8475293
   Rijk PC, 2004, ARTHROSCOPY, V20, P911, DOI 10.1016/j.arthro.2004.06.036
   Sittek H, 1996, SKELETAL RADIOL, V25, P55, DOI 10.1007/s002560050032
   Smith M, 2007, OSTEOARTHRITIS DIAGN, P107
   Sonin AH, 2002, AM J ROENTGENOL, V179, P1159, DOI 10.2214/ajr.179.5.1791159
   Tessier JJ, 2003, OSTEOARTHR CARTILAGE, V11, P845, DOI 10.1016/S1063-4584(03)00162-6
   Wachsmuth L, 2003, OSTEOARTHR CARTILAGE, V11, P891, DOI 10.1016/j.joca.2003.08.008
   Wluka A, 2001, ANN RHEUM DIS, V60, P332, DOI 10.1136/ard.60.4.332
   YU LP, 1992, ARTHRITIS RHEUM, V35, P1150, DOI 10.1002/art.1780351007
NR 49
TC 6
Z9 6
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 1
PY 2014
VL 9
IS 12
AR e113707
DI 10.1371/journal.pone.0113707
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AX7SK
UT WOS:000347114900066
PM 25438155
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Clemmensen, L
   van Os, J
   Skovgaard, AM
   Vaever, M
   Blijd-Hoogewys, EMA
   Bartels-Velthuis, AA
   Jeppesen, P
AF Clemmensen, Lars
   van Os, Jim
   Skovgaard, Anne Mette
   Vaever, Mette
   Blijd-Hoogewys, Els M. A.
   Bartels-Velthuis, Agna A.
   Jeppesen, Pia
TI Hyper-Theory-of-Mind in Children with Psychotic Experiences
SO PLOS ONE
LA English
DT Article
ID SCHIZOPHRENIA; DEFICITS; AUTISM; SCHIZOTYPY; DISORDERS; RELIABILITY;
   HYPOTHESIS; SYMPTOMS; SCALE; RISK
AB Background: Alterations in Theory-of-Mind (ToM) are associated with psychotic disorder. In addition, studies in children have documented that alterations in ToM are associated with Psychotic Experiences (PE). Our aim was to examine associations between an exaggerated type of ToM (HyperToM) and PE in children. Children with this type of alteration in ToM infer mental states when none are obviously suggested, and predict behaviour on the basis of these erroneous beliefs. Individuals with HyperToM do not appear to have a conceptual deficit (i.e. lack of representational abilities), but rather they apply their theory of the minds of others in an incorrect or biased way. Method: Hypotheses were tested in two studies with two independent samples: (i) a general population sample of 1630 Danish children aged 11-12 years, (ii) a population-based sample of 259 Dutch children aged 12-13 years, pertaining to a case-control sampling frame of children with auditory verbal hallucinations. Multinomial regression analyses were carried out to investigate the associations between PE and ToM and HyperToM respectively. Analyses were adjusted for gender and proxy measures of general intelligence. Results: Low ToM score was significantly associated with PE in sample I (OR = 1.6 95% CI 1.1-2.3 chi(2) (4) = 12.42 p = 0.010), but not in sample II (OR = 0.9 95% CI 0.5-1.8 x 2 (3) = 7.13 p = 0.816). HyperToM was significantly associated with PE both in sample I (OR = 1.8, 95% CI 1.2-2.7 chi(2) (3) = 10.11 p = 0.006) and II (OR = 4.6, 95% CI 1.3-16.2 chi(2) (2) = 7.56 p = 0.018). HyperToM was associated particularly with paranoid delusions in both sample I (OR = 2.0, 95% CI: 1.1-3.7% chi(2) (4) = 9.93 p = 0.021) and II (OR = 6.2 95% CI: 1.7-23.6% chi(2) (4) = 9.90 p = 0.044). Conclusion: Specific alterations in ToM may be associated with specific types of psychotic experiences. HyperToM may index risk for developing psychosis and paranoid delusions in particular.
C1 [Clemmensen, Lars; Jeppesen, Pia] Mental Hlth Serv, Child & Adolescent Mental Hlth Ctr, Copenhagen, Denmark.
   [van Os, Jim] Maastricht Univ, Med Ctr, Dept Psychiat & Psychol, Maastricht, Netherlands.
   [Skovgaard, Anne Mette] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark.
   [Vaever, Mette] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark.
   [Blijd-Hoogewys, Els M. A.] INTER PSY Groningen, Groningen, Netherlands.
   [Bartels-Velthuis, Agna A.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat Groningen, Groningen Triadegebouw, Netherlands.
RP Clemmensen, L (reprint author), Mental Hlth Serv, Child & Adolescent Mental Hlth Ctr, Copenhagen, Denmark.
EM lars.clemmensen@regionh.dk
OI Jeppesen, Pia/0000-0003-2471-2929; Skovgaard, Anne
   Mette/0000-0002-8793-8303; vaever, mette skovgaard/0000-0002-9675-3423
FU Tryg Foundation [J.nr.7-10-0189, J.nr.7-11-0341]; Lundbeck Foundation
   [j. nr. R54-A5843]
FX AMS recieved funding for CCC2000 from Tryg Foundation (J.nr.7-10-0189
   and J.nr.7-11-0341) (http://www.trygfonden.dk/Om-TrygFonden/In-English),
   and Lundbeck Foundation (j. nr. R54-A5843)
   (http://www.lundbeck.com/global/corporate-responsib/stakeholders/the-lun
   dbeck-foundation). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abu-Akel A, 2003, BRAIN RES REV, V43, P29, DOI 10.1016/S0165-0173(03)00190-5
   Abu-Akel A, 2003, MED HYPOTHESES, V60, P382, DOI 10.1016/S0306-9877(02)00406-1
   Abu-Akel A, 2000, PSYCHOL MED, V30, P735, DOI 10.1017/S0033291799002123
   Abu-Akel A, 2011, NEUROPSYCHOLOGIA, V49, P2971, DOI 10.1016/j.neuropsychologia.2011.07.012
   ALTMAN DG, 1991, ALCOHOL ALCOHOLISM, V26, P481, DOI 10.1093/oxfordjournals.alcalc.a045142
   BARONCOHEN S, 1994, BRIT J PSYCHIAT, V165, P640, DOI 10.1192/bjp.165.5.640
   Barragan M, 2011, PSYCHIAT RES, V186, P225, DOI 10.1016/j.psychres.2010.07.051
   Bartels-Velthuis AA, 2012, EPIDEMIOL PSYCH SCI, V21, P305, DOI 10.1017/S2045796012000108
   Bartels-Velthuis AA, 2011, ACTA PSYCHIAT SCAND, V124, P193, DOI 10.1111/j.1600-0447.2011.01699.x
   Bentall RP, 2001, CLIN PSYCHOL REV, V21, P1143, DOI 10.1016/S0272-7358(01)00106-4
   Biedermann F, 2012, CURR OPIN PSYCHIATR, V25, P71, DOI 10.1097/YCO.0b013e3283503624
   Blijd-Hoogewys EMA, 2008, J AUTISM DEV DISORD, V38, P1907, DOI 10.1007/s10803-008-0585-3
   Blijd-Hoogewys EMA, 2007, TOM STORYBOOK FRANK
   Bora E, 2008, J NERV MENT DIS, V196, P95, DOI 10.1097/NMD.0b013e318162a9e1
   Bora E, 2009, SCHIZOPHR RES, V109, P1, DOI 10.1016/j.schres.2008.12.020
   Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002
   Brunet Eric, 2003, Cogn Neuropsychiatry, V8, P129, DOI 10.1080/13546800244000256
   Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212
   Crespi B, 2008, BEHAV BRAIN SCI, V31, P241, DOI 10.1017/S0140525X08004214
   Fonagy P, 2009, DEV PSYCHOPATHOL, V21, P1355, DOI 10.1017/S0954579409990198
   Freeman D, 2007, CLIN PSYCHOL REV, V27, P425, DOI 10.1016/j.cpr.2006.10.004
   Frith C. D., 1992, Journal of Psychopharmacology, V6, P436, DOI 10.1177/026988119200600314
   Frith CD, 2004, PSYCHOL MED, V34, P385, DOI 10.1017/S0033291703001326
   Frith CD, 1996, PSYCHOL MED, V26, P521, DOI 10.1017/S0033291700035601
   FRITH U, 1994, COGNITION, V50, P115, DOI 10.1016/0010-0277(94)90024-8
   Fyfe S, 2008, CORTEX, V44, P1316, DOI 10.1016/j.cortex.2007.07.009
   GALDOS P, 1995, SCHIZOPHR RES, V14, P105, DOI 10.1016/0920-9964(94)00020-9
   Greig TC, 2004, J NERV MENT DIS, V192, P12, DOI 10.1097/01.nmd.0000105995.67947.fc
   HARDYBAYLE MC, 1994, ENCEPHALE, V20, P393
   Jeppesen P, 2013, SCHIZOPHR B S1, V39, pS1
   Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021
   Kaymaz N., 2012, PSYCHOL MED, P1
   Kelleher I, 2012, PSYCHOL MED, V42, P1857, DOI 10.1017/S0033291711002960
   Kelleher I, 2009, SCHIZOPHRBULL
   Krabbendam L, 2005, BRIT J CLIN PSYCHOL, V44, P113, DOI 10.1348/014466504X19767
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langdon R, 2001, COGNITION, V82, P1, DOI 10.1016/S0010-0277(01)00139-1
   Langdon R, 2010, SCHIZOPHRENIA BULL, V36, P321, DOI 10.1093/schbul/sbn069
   Linscott R, 2012, PSYCHOL MED, V1, P1
   Marjoram D, 2006, PSYCHIAT RES, V144, P29, DOI 10.1016/j.psychres.2006.01.008
   Mehl S, 2010, J NERV MENT DIS, V198, P516, DOI 10.1097/NMD.0b013e3181e4c8d2
   Montag C, 2012, EUR ARCH PSY CLIN N, V262, P217, DOI 10.1007/s00406-011-0250-2
   Montag C, 2011, PSYCHIAT RES, V186, P203, DOI 10.1016/j.psychres.2010.09.006
   OZONOFF S, 1991, J CHILD PSYCHOL PSYC, V32, P1107, DOI 10.1111/j.1469-7610.1991.tb00352.x
   Pickup GJ, 2001, PSYCHOL MED, V31, P207, DOI 10.1017/S0033291701003385
   Polanczyk G, 2010, ARCH GEN PSYCHIAT, V67, P328, DOI 10.1001/archgenpsychiatry.2010.14
   Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053
   Shamay-Tsoory SG, 2007, PSYCHIAT RES, V149, P11, DOI 10.1016/j.psychres.2005.10.018
   Sharp C, 2013, J PERS DISORD, V27, P3, DOI 10.1521/pedi.2013.27.1.3
   Skovgaard AM, 2005, SCAND J PUBLIC HEALT, V33, P197, DOI 10.1080/14034940510005662
   Smeets T, 2009, HORM BEHAV, V55, P507, DOI 10.1016/j.yhbeh.2009.01.011
   Van Dael F, 2006, SCHIZOPHRENIA BULL, V32, P341, DOI 10.1093/schbul/sbj021
   Versmissen D, 2008, SCHIZOPHR RES, V99, P103, DOI 10.1016/j.schres.2007.09.024
NR 53
TC 21
Z9 22
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 14
PY 2014
VL 9
IS 11
AR e113082
DI 10.1371/journal.pone.0113082
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AU4DF
UT WOS:000345558500132
PM 25397582
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Schroter, M
   Rusch, GM
   Barton, DN
   Blumentrath, S
   Norden, B
AF Schroter, Matthias
   Rusch, Graciela M.
   Barton, David N.
   Blumentrath, Stefan
   Norden, Bjorn
TI Ecosystem Services and Opportunity Costs Shift Spatial Priorities for
   Conserving Forest Biodiversity
SO PLOS ONE
LA English
DT Article
ID PROTECTED AREAS; TRADE-OFFS; RICH FORESTS; CONSERVATION; LANDSCAPES;
   STRATEGIES; PAYMENTS; BENEFITS; SCIENCE; NORWAY
AB Inclusion of spatially explicit information on ecosystem services in conservation planning is a fairly new practice. This study analyses how the incorporation of ecosystem services as conservation features can affect conservation of forest biodiversity and how different opportunity cost constraints can change spatial priorities for conservation. We created spatially explicit cost-effective conservation scenarios for 59 forest biodiversity features and five ecosystem services in the county of Telemark (Norway) with the help of the heuristic optimisation planning software, Marxan with Zones. We combined a mix of conservation instruments where forestry is either completely (non-use zone) or partially restricted (partial use zone). Opportunity costs were measured in terms of foregone timber harvest, an important provisioning service in Telemark. Including a number of ecosystem services shifted priority conservation sites compared to a case where only biodiversity was considered, and increased the area of both the partial (+36.2%) and the non-use zone (+3.2%). Furthermore, opportunity costs increased (+6.6%), which suggests that ecosystem services may not be a side-benefit of biodiversity conservation in this area. Opportunity cost levels were systematically changed to analyse their effect on spatial conservation priorities. Conservation of biodiversity and ecosystem services trades off against timber harvest. Currently designated nature reserves and landscape protection areas achieve a very low proportion (9.1%) of the conservation targets we set in our scenario, which illustrates the high importance given to timber production at present. A trade-off curve indicated that large marginal increases in conservation target achievement are possible when the budget for conservation is increased. Forty percent of the maximum hypothetical opportunity costs would yield an average conservation target achievement of 79%.
C1 [Schroter, Matthias] Wageningen Univ, Environm Syst Anal Grp, NL-6700 AP Wageningen, Netherlands.
   [Schroter, Matthias; Rusch, Graciela M.; Barton, David N.; Blumentrath, Stefan; Norden, Bjorn] NINA, Trondheim, Norway.
RP Schroter, M (reprint author), Wageningen Univ, Environm Syst Anal Grp, NL-6700 AP Wageningen, Netherlands.
EM matthias.schroter@wur.nl
RI Schroter, Matthias/B-8883-2017
OI Schroter, Matthias/0000-0003-0207-7311; Rusch,
   Graciela/0000-0003-3769-8345
FU European Research Council [263027]; Research Council of Norway
   (Yggdrasil grant); European Union's Seventh Programme for research,
   technological development and demonstration (POLICYMIX project)
   [244065]; project ECOSERVICE (Approaches for integrated assessment of
   forest ecosystem services under large scale bioenergy utilization) -
   Research Council of Norway, RCN [233641/E50]
FX MS received funding from the European Research Council under grant
   263027 ('Ecospace'), and from the Research Council of Norway (Yggdrasil
   grant). GMR, DNB and SB received funding from the European Union's
   Seventh Programme for research, technological development and
   demonstration under grant agreement No. 244065 (POLICYMIX project
   (http://policymix.nina.no)). BN was supported by the project ECOSERVICE
   (Approaches for integrated assessment of forest ecosystem services under
   large scale bioenergy utilization) financed by the Research Council of
   Norway, RCN grant no 233641/E50. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x
   Barton DN, 2009, J ENVIRON MANAGE, V90, P901, DOI 10.1016/j.jenvman.2008.02.010
   Barton DN, 2013, SOC NATUR RESOUR, V26, P1185, DOI 10.1080/08941920.2013.799727
   Bengtsson J, 2003, AMBIO, V32, P389, DOI 10.1639/0044-7447(2003)032[0389:RRADL]2.0.CO;2
   Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x
   Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106
   Carwardine J, 2010, CONSERV BIOL, V24, P1529, DOI 10.1111/j.1523-1739.2010.01535.x
   Carwardine Josie, 2009, Conservation Letters, V2, P4, DOI 10.1111/j.1755-263X.2008.00042.x
   Certain G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018930
   Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379
   Chan KMA, 2012, ECOL ECON, V74, P8, DOI 10.1016/j.ecolecon.2011.11.011
   Chan KMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024378
   Chape S, 2005, PHILOS T ROY SOC B, V360, P443, DOI 10.1098/rstb.2004.1592
   Chhatre A, 2009, P NATL ACAD SCI USA, V106, P17667, DOI 10.1073/pnas.0905308106
   Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x
   Directorate for Nature Management, 2007, DN HDB, V13
   Egoh B, 2007, ECOL ECON, V63, P714, DOI 10.1016/j.ecolecon.2007.04.007
   Egoh BN, 2014, J APPL ECOL, V51, P899, DOI 10.1111/1365-2664.12251
   Egoh BN, 2011, J ENVIRON MANAGE, V92, P1642, DOI 10.1016/j.jenvman.2011.01.019
   Egoh BN, 2010, CONSERV BIOL, V24, P1021, DOI 10.1111/j.1523-1739.2009.01442.x
   Eigenbrod F, 2009, P ROY SOC B-BIOL SCI, V276, P2903, DOI 10.1098/rspb.2009.0528
   European Commission, 2014, 2014080 EUR COMM
   Faith D, AUST ZOOL IN PRESS, DOI [10.7882/az.2014.7031, DOI 10.7882/AZ.2014.7031]
   Faith D. P., 1995, BIODIVERSITY REGIONA
   Faith DP, 2012, F1000RESEARCH
   Fisher B, 2011, CONSERV LETT, V4, P443, DOI 10.1111/j.1755-263X.2011.00198.x
   Framstad E, 2002, EVALUERING SKOGVERNE, P146
   Framstad E, 2010, 535 NINA
   Framstad E, 2012, 888 NINA
   Gaston KJ, 2006, BIOL CONSERV, V132, P76, DOI 10.1016/j.biocon.2006.03.013
   Gjerde I, 2002, MILJOREGISTRERING SK
   Gotmark F, 2013, FOREST ECOL MANAG, V306, P292, DOI 10.1016/j.foreco.2013.06.014
   Granhus A, 2014, BAEREKRAFTIG SKOGBRU, P90
   Haines-Young R., 2010, PROPOSAL COMMON INT
   Hanski I, 2011, AMBIO, V40, P248, DOI 10.1007/s13280-011-0147-3
   Hauer G, 2010, ECOL MODEL, V221, P2590, DOI 10.1016/j.ecolmodel.2010.07.013
   Izquierdo AE, 2012, FORESTS, V3, P764, DOI 10.3390/f3030764
   Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273
   Kalas J, 2010, 2010 NORWEGIAN RED L
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Larigauderie A, 2012, CURR OPIN ENV SUST, V4, P101, DOI 10.1016/j.cosust.2012.01.007
   Lindenmayer DB, 2006, BIOL CONSERV, V131, P433, DOI 10.1016/j.biocon.2006.02.019
   Luck GW, 2012, F1000RESEARCH
   Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006
   Makino A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078986
   Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962
   Margules CR, 2007, ECOL BIODIVERS CONS, P1
   Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251
   Meteorological Institute, 2012, MONTHL NORM VAL
   Moen A., 1999, NATL ATLAS NORWAY VE
   Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011
   Nalle DJ, 2004, J ENVIRON ECON MANAG, V48, P997, DOI 10.1016/j.jeem.2004.01.001
   NFLI, 2010, AR AR5
   NFLI, 2013, MILJ SKOG
   Norden B, 2012, FOREST ECOL MANAG, V270, P35, DOI 10.1016/j.foreco.2012.01.014
   Norwegian Environmental Agency, 2013, NAT
   Opdam P, 2006, LANDSCAPE URBAN PLAN, V75, P322, DOI 10.1016/j.landurbplan.2005.02.015
   Persha L, 2011, SCIENCE, V331, P1606, DOI 10.1126/science.1199343
   Pichancourt JB, 2014, GLOBAL CHANGE BIOL, V20, P382, DOI 10.1111/gcb.12345
   Reyers B, 2012, LANDSCAPE ECOL, V27, P1121, DOI 10.1007/s10980-012-9761-0
   Reyers B, 2012, BIOSCIENCE, V62, P503, DOI 10.1525/bio.2012.62.5.12
   Ring I, 2011, INSTRUMENT MIXES BIO, P98
   Rusch GM, 2013, BEST PRACTICE GUIDEL
   Sarkar S, 2002, J BIOSCIENCES, V27, P299, DOI 10.1007/BF02704961
   Schroter M, 2014, CONSERV LETT, V7, P514, DOI 10.1111/conl.12091
   Schroter M, 2014, ECOL INDIC, V36, P539, DOI 10.1016/j.ecolind.2013.09.018
   Schroter-Schlaack C, 2014, GERMAN J EC GEOGRAPH, V58, P98
   Skjeggedal T., 2010, FRIVILLIG VERN SKOG
   Sogaard G, 2012, 22012 NFLI
   SSB, 2012, STAT ARB 2012
   Venter O, 2009, SCIENCE, V326, P1368, DOI 10.1126/science.1180289
   Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005
   Wilson KA, 2010, MARXAN GOOD PRACTICE, P18
NR 73
TC 24
Z9 24
U1 4
U2 73
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 13
PY 2014
VL 9
IS 11
AR e112557
DI 10.1371/journal.pone.0112557
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AY6YT
UT WOS:000347709300068
PM 25393951
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Jiang, R
   Du, FZ
   He, C
   Gu, M
   Ke, ZW
   Li, JH
AF Jiang, Rui
   Du, Fei-Zhou
   He, Ci
   Gu, Ming
   Ke, Zhen-Wu
   Li, Jian-Hao
TI The Value of Diffusion Tensor Imaging in Differentiating High-Grade
   Gliomas from Brain Metastases: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID GLIOBLASTOMA-MULTIFORME; PERFUSION METRICS; TUMORS; MRI; UTILITY;
   REGION; EDEMA; 3T
AB Purpose: Differentiation of high-grade gliomas and solitary brain metastases is an important clinical issue because the treatment strategies differ greatly. Our study aimed to investigate the potential value of diffusion tensor imaging (DTI) in differentiating high-grade gliomas from brain metastases using a meta-analytic approach.
   Materials and Methods: We searched Pubmed, Embase and the Cochrane Library for relevant articles published in English. Studies that both investigated high-grade gliomas and brain metastases using DTI were included. Random effect model was used to compare fractional anisotropy (FA) and mean diffusivity (MD) values in the two tumor entities.
   Results: Nine studies were included into the meta-analysis. In the peritumoral region, compared with brain metastases, high-grade gliomas had a significant increase of FA (SMD = 0.47; 95% CI, 0.22-0.71; P <0.01) and a significant decrease of MD (SMD = -1.49; 95% CI, -1.91 to -1.06; P < 0.01). However, in the intratumoral area, no significant change in FA (SMD = 0.16; 95% CI, -0.49 to 0.82; P = 0.73) or MD (SMD = 0.34; 95% CI, -0.91 to 1.60; P = 0.59) was detected between gliomas and metastases.
   Conclusions: High-grade gliomas may be distinguished from brain metastases by comparing the peritumoral FA and MD values. DTI appears to be a promising tool in diagnosing solitary intracranial lesions.
C1 [Jiang, Rui; Du, Fei-Zhou; He, Ci; Gu, Ming; Ke, Zhen-Wu; Li, Jian-Hao] Chengdu Mil Gen Hosp, Dept Med Imaging, Chengdu, Peoples R China.
RP Gu, M (reprint author), Chengdu Mil Gen Hosp, Dept Med Imaging, Chengdu, Peoples R China.
EM gumingcd@126.com
CR Byrnes TJD, 2011, NMR BIOMED, V24, P54, DOI 10.1002/nbm.1555
   Chen R, 2013, NEURORADIOL J, V26, P175, DOI 10.1177/197140091302600207
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hoefnagels FWA, 2014, J NEURO-ONCOL, V120, P187, DOI 10.1007/s11060-014-1544-9
   Kinoshita M, 2008, NEUROIMAGE, V43, P29, DOI 10.1016/j.neuroimage.2008.06.041
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee EJ, 2013, CLIN RADIOL, V68, pE689, DOI 10.1016/j.crad.2013.06.021
   Lu S, 2003, AM J NEURORADIOL, V24, P937
   Lu S, 2004, RADIOLOGY, V232, P221, DOI 10.1148/radiol.2321030653
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Polders DL, 2011, J MAGN RESON IMAGING, V33, P1456, DOI 10.1002/jmri.22554
   Price SJ, 2003, CLIN RADIOL, V58, P455, DOI 10.1016/S0009-9260(03)00115-6
   Rees JH, 1996, RADIOGRAPHICS, V16, P1413, DOI 10.1148/radiographics.16.6.8946545
   Saksena S, 2013, J CLIN DIAGN RES, V7, P320, DOI 10.7860/JCDR/2013/4491.2757
   Sternberg EJ, 2014, AM J NEURORADIOL, V35, P439, DOI 10.3174/ajnr.A3702
   Svolos P, 2013, MAGN RESON IMAGING, V31, P1567, DOI 10.1016/j.mri.2013.06.010
   Toh CH, 2011, AM J NEURORADIOL, V32, P1646, DOI 10.3174/ajnr.A2581
   Tsougos I, 2012, CANCER IMAGING, V12, P423, DOI 10.1102/1470-7330.2012.0038
   Tsuchiya K, 2005, BRIT J RADIOL, V78, P533, DOI 10.1259/bjr/68749637
   van Westen D, 2006, ACTA RADIOL, V47, P311, DOI 10.1080/02841850500539058
   Wang S, 2014, AM J NEURORADIOL, V35, P928, DOI 10.3174/ajnr.A3871
   Wang S, 2011, AM J NEURORADIOL, V32, P507, DOI 10.3174/ajnr.A2333
   Wang SM, 2009, NEUROIMAGE, V44, P653, DOI 10.1016/j.neuroimage.2008.09.027
   Wang W, 2009, AM J NEURORADIOL, V30, P203, DOI 10.3174/ajnr.A1303
   White ML, 2011, AM J NEURORADIOL, V32, P374, DOI 10.3174/ajnr.A2267
   Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25
   Witwer BP, 2002, J NEUROSURG, V97, P568, DOI 10.3171/jns.2002.97.3.0568
   Yang G, 2014, NMR BIOMED, V27, P1103, DOI 10.1002/nbm.3163
   Zamecnik J, 2005, ACTA NEUROPATHOL, V110, P435, DOI 10.1007/s00401-005-1078-5
   Zijlmans M, 2009, J MAGN RESON IMAGING, V30, P256, DOI 10.1002/jmri.21811
NR 31
TC 17
Z9 18
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 7
PY 2014
VL 9
IS 11
AR e112550
DI 10.1371/journal.pone.0112550
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AT3WF
UT WOS:000344863100107
PM 25380185
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tang, L
   Wang, F
   Li, YX
   Zhao, L
   Xi, HJ
   Guo, ZH
   Li, XY
   Gao, CJ
   Wang, J
   Zhou, LJ
AF Tang, Lu
   Wang, Fei
   Li, Yuxiang
   Zhao, Liang
   Xi, Huijun
   Guo, Zhihong
   Li, Xiuyun
   Gao, Chengjie
   Wang, Jian
   Zhou, Lingjun
TI Ultrasound Guidance for Radial Artery Catheterization: An Updated
   Meta-Analysis of Randomized Controlled Trials
SO PLOS ONE
LA English
DT Article
ID CANNULATION; INFANTS; LONG
AB Background: Since a previous meta-analysis reported that ultrasound guidance was associated with a higher first-attempt success rate in catheterization of the radial artery, a number of randomized controlled trials (RCTs) have reported inconsistent results. The aim of the present study is to conduct an updated meta-analysis to clarify the role of ultrasound guidance for radial artery catheterization.
   Methods: A systematic literature search of PubMed, Embase, and Cochrane Central Register of Controlled Trials was conducted using specific search terms. Eligible studies were RCTs that compared ultrasound guidance with traditional palpation for radial artery catheterization. The Mantel-Haenszel method using the random effects model was adopted in this meta-analysis.
   Results: Seven RCTs with 482 patients were included. Compared with traditional palpation, ultrasound guidance significantly increased the first-attempt success rate of radial artery catheterization (RR 1.51, 95% CI 1.07-2.14, P = 0.02). Subgroup analyses suggested that the superiority of ultrasound guidance for radial artery catheterization was significant when the technique was operated by experienced users, performed in small children and infants, and on elective procedures in the operating room. In addition, ultrasound guidance significantly reduced mean-attempts to success (WMD -1.13, 95% CI -1.58 to -0.69, P<0.00001), mean-time to success (WMD -74.77s, 95% CI -137.89s to -11.64s, P = 0.02), and the occurrence of hematoma (RR 0.17, 95% CI 0.07-0.41, P = 0.0001).
   Conclusions: The present meta-analysis suggests a clear benefit from ultrasound guidance for radial artery catheterization compared with the traditional palpation. Preliminary training and familiarization with the ultrasound-guided technique is needed before applying it for radial artery catheterization, especially for inexperienced operators.
C1 [Tang, Lu; Wang, Fei; Guo, Zhihong; Gao, Chengjie; Wang, Jian] Gen Hosp Jinan Mil Command, Dept Anesthesiol, Jinan 250031, Peoples R China.
   [Li, Yuxiang] Ningxia Med Univ, Sch Nursing, Yinchuan 750004, Peoples R China.
   [Zhao, Liang] Guangxi Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanning 530021, Peoples R China.
   [Xi, Huijun] Second Mil Med Univ, Changhai Hosp, Digest Endoscopy Ctr, Shanghai 200433, Peoples R China.
   [Li, Xiuyun] Gen Hosp Jinan Mil Command, Dept Nursing, Jinan 250031, Peoples R China.
   [Zhou, Lingjun] Second Mil Med Univ, Inst Translat Med, Shanghai 200433, Peoples R China.
RP Wang, J (reprint author), Gen Hosp Jinan Mil Command, Dept Anesthesiol, Jinan 250031, Peoples R China.
EM wenhaow2000@hotmail.com; zhoulingjun5771@163.com
CR Amer Soc Anesthesiologists, 2012, ANESTHESIOLOGY, V116, P539, DOI 10.1097/ALN.0b013e31823c9569
   Berk D, 2013, J CLIN MONIT COMPUT, V27, P319, DOI 10.1007/s10877-013-9437-6
   Bobbia X, 2013, AM J EMERG MED, V31, P810, DOI 10.1016/j.ajem.2013.01.029
   Chittoodan S, 2011, MED ULTRASON, V13, P21
   Clemmesen L, 2012, ULTRASCHALL MED, V33, P1
   Ganesh A, 2009, PEDIATR CRIT CARE ME, V10, P45, DOI 10.1097/PCC.0b013e31819368ca
   Gu WJ, 2014, CRIT CARE, V18, DOI 10.1186/cc13862
   HACK WWM, 1990, INTENS CARE MED, V16, P50, DOI 10.1007/BF01706325
   Hansen MA, 2014, ACTA ANAESTH SCAND, V58, P446, DOI 10.1111/aas.12299
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Ishii S, 2013, PEDIATR CRIT CARE ME, V14, P471, DOI 10.1097/PCC.0b013e31828a8657
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Levin PD, 2003, CRIT CARE MED, V31, P481, DOI 10.1097/01.CCM.0000050452.17304.2F
   Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3
   MCCORMACK LJ, 1953, SURG GYNECOL OBSTET, V96, P43
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   National Institute for Health and Clinical Excellence, NICE TECHN APPR 49 C
   REFERENCES Shojania KG, 2001, EVID REP TECHNOL ASS, V43, p[i, 1]
   Scheer BV, 2002, CRIT CARE, V6, P198, DOI 10.1186/cc1489
   Schwemmer U, 2006, EUR J ANAESTH, V23, P476, DOI 10.1017/S0265021506000275
   Shiloh AL, 2011, CHEST, V139, P524, DOI 10.1378/chest.10-0919
   Shiver S, 2006, ACAD EMERG MED, V13, P1275, DOI 10.1197/j.aem.2006.07.015
   Song F, 2000, Health Technol Assess, V4, P1
   Troianos CA, 2012, ANESTH ANALG, V114, P46, DOI 10.1213/ANE.0b013e3182407cd8
   Ueda K, 2013, BRIT J ANAESTH, V110, P281, DOI 10.1093/bja/aes383
   Weiner MM, 2013, J CARDIOTHOR VASC AN, V27, P345, DOI 10.1053/j.jvca.2012.07.007
NR 26
TC 29
Z9 31
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 6
PY 2014
VL 9
IS 11
AR e111527
DI 10.1371/journal.pone.0111527
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AS6XM
UT WOS:000344402600045
PM 25375152
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU O'Connor, C
   Joffe, H
AF O'Connor, Cliodhna
   Joffe, Helene
TI Gender on the Brain: A Case Study of Science Communication in the New
   Media Environment
SO PLOS ONE
LA English
DT Article
ID SOCIAL REPRESENTATIONS; PSYCHOLOGICAL ESSENTIALISM; SYSTEM
   JUSTIFICATION; STEREOTYPE CONTENT; PRESS RELEASES; MASS-MEDIA; SEX BIAS;
   NEUROSCIENCE; BIOTECHNOLOGY; JOURNALISM
AB Neuroscience research on sex difference is currently a controversial field, frequently accused of purveying a 'neurosexism' that functions to naturalise gender inequalities. However, there has been little empirical investigation of how information about neurobiological sex difference is interpreted within wider society. This paper presents a case study that tracks the journey of one high-profile study of neurobiological sex differences from its scientific publication through various layers of the public domain. A content analysis was performed to ascertain how the study was represented in five domains of communication: the original scientific article, a press release, the traditional news media, online reader comments and blog entries. Analysis suggested that scientific research on sex difference offers an opportunity to rehearse abiding cultural understandings of gender. In both scientific and popular contexts, traditional gender stereotypes were projected onto the novel scientific information, which was harnessed to demonstrate the factual truth and normative legitimacy of these beliefs. Though strains of misogyny were evident within the readers' comments, most discussion of the study took pains to portray the sexes' unique abilities as equal and 'complementary'. However, this content often resembled a form of benevolent sexism, in which praise of women's social-emotional skills compensated for their relegation from more esteemed trait-domains, such as rationality and productivity. The paper suggests that embedding these stereotype patterns in neuroscience may intensify their rhetorical potency by lending them the epistemic authority of science. It argues that the neuroscience of sex difference does not merely reflect, but can actively shape the gender norms of contemporary society.
C1 [O'Connor, Cliodhna; Joffe, Helene] UCL, Div Psychol & Language Sci, London, England.
RP O'Connor, C (reprint author), UCL, Div Psychol & Language Sci, London, England.
EM oconnor.c@ucl.ac.uk
OI O'Connor, Cliodhna/0000-0001-8134-075X
FU 'Uses and Abuses of Biology' grants programme [0025 / UAB 008]
FX The research was supported by a grant (ref. TWCF 0025 / UAB 008) awarded
   under the 'Uses and Abuses of Biology' grants programme administered by
   the Faraday Institute at St. Edmund's College, Cambridge
   (http://www.uabgrants.org/). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Allgaier J, 2013, BIOSCIENCE, V63, P284, DOI 10.1525/bio.2013.63.4.8
   Bangerter A, 2004, BRIT J SOC PSYCHOL, V43, P605, DOI 10.1348/0144666042565353
   Bangerter A, 2000, BRIT J SOC PSYCHOL, V39, P521, DOI 10.1348/014466600164615
   Bauer M., 2000, QUALITATIVE RES TEXT, P131, DOI DOI 10.4135
   Bauer MW, 2009, SCI TECHNOL SOC, V14, P221, DOI 10.1177/097172180901400202
   Bauer MW, 2005, INT J PUBLIC OPIN R, V17, P5, DOI 10.1093/ijpor/edh054
   Bauer MW, 1999, J THEOR SOC BEHAV, V29, P163, DOI 10.1111/1468-5914.00096
   Bauer MW, 2002, PUBLIC UNDERST SCI, V11, P93, DOI 10.1088/0963-6625/11/2/301
   Baxter P, 2008, QUAL REP, V13, P544
   Becker JC, 2011, J PERS SOC PSYCHOL, V101, P62, DOI 10.1037/a0022615
   Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002
   Bluhm R, 2012, NEW DIR PHILOS COGN, P1, DOI 10.1057/9780230368385
   Brechman J, 2009, SCI COMMUN, V30, P453, DOI 10.1177/1075547009332649
   Brescoll V, 2004, PSYCHOL SCI, V15, P515, DOI 10.1111/j.0956-7976.2004.00712.x
   Brescoll VL, 2013, J PERS SOC PSYCHOL, V105, P891, DOI 10.1037/a0034701
   Broer C, 2013, SOCIOL HEALTH ILL, V35, P49, DOI 10.1111/j.1467-9566.2012.01477.x
   Brossard D, 2009, PUBLIC UNDERST SCI, V18, P258, DOI 10.1177/0963662507084398
   Brumfiel G, 2009, NATURE, V458, P274, DOI 10.1038/458274a
   Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909
   Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118
   Choudhury S, 2012, CRITICAL NEUROSCIENCE: A HANDBOOK OF THE SOCIAL AND CULTURAL CONTEXTS OF NEUROSCIENCE, P1
   Choudhury S, 2009, BIOSOCIETIES, V4, P61, DOI 10.1017/S1745855209006437
   Coleman JM, 2008, SELF IDENTITY, V7, P34, DOI 10.1080/15298860600980185
   Collins RL, 2011, SEX ROLES, V64, P290, DOI 10.1007/s11199-010-9929-5
   Dar-Nimrod I, 2006, SCIENCE, V314, P435, DOI 10.1126/science.1131100
   de Semir V, 1998, JAMA-J AM MED ASSOC, V280, P294, DOI 10.1001/jama.280.3.294
   Dumit J., 2004, PICTURING PERSONHOOD
   Eliot L, 2011, NEURON, V72, P895, DOI 10.1016/j.neuron.2011.12.001
   Eliot L, 2013, SEX ROLES, V69, P363, DOI 10.1007/s11199-011-0037-y
   Fausto-Sterling Anne., 2000, SEXING BODY GENDER P
   Fine C., 2010, DELUSIONS GENDER
   Fine C, 2013, TRENDS COGN SCI, V17, P550, DOI 10.1016/j.tics.2013.08.010
   Fine C, 2013, NEUROETHICS-NETH, V6, P369, DOI 10.1007/s12152-012-9169-1
   Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878
   Geller SE, 2006, J WOMENS HEALTH, V15, P1123, DOI 10.1089/jwh.2006.15.1123
   Gerring J, 2007, CASE STUDY RES PRINC
   Glick P, 1996, J PERS SOC PSYCHOL, V70, P491, DOI 10.1037/0022-3514.70.3.491
   Haslam N, 2000, BRIT J SOC PSYCHOL, V39, P113, DOI 10.1348/014466600164363
   HILGARTNER S, 1990, SOC STUD SCI, V20, P519, DOI 10.1177/030631290020003006
   Holton G, 1996, DAEDALUS, V125, P183
   Holtzman NA, 2005, COMMUNITY GENET, V8, P133, DOI 10.1159/000086756
   Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110
   Jacobs J.E., 1985, EDUC RES, V14, P20, DOI DOI 10.3102/0013189X014003020
   Jaspal R, 2013, SCI COMMUN, V35, P383, DOI 10.1177/1075547012459274
   Joffe H, 1999, RISK OTHER
   Joffe H, 2013, EARTHQ SPECTRA, V29, P367, DOI 10.1193/1.4000138
   Joffe H, 2011, PUBLIC UNDERST SCI, V20, P446, DOI 10.1177/0963662510391604
   Jordan-Young R, 2010, BRAIN STORM FLAWS SC
   Jordan-Young R, 2012, NEUROETHICS-NETH, V5, P305, DOI 10.1007/s12152-011-9134-4
   Jost JT, 2005, J PERS SOC PSYCHOL, V88, P498, DOI 10.1037/0022-3514.88.3.498
   Jost JT, 2004, POLIT PSYCHOL, V25, P881, DOI 10.1111/j.1467-9221.2004.00402.x
   Jovchelovitch S, 2008, J THEOR SOC BEHAV, V38, P431, DOI 10.1111/j.1468-5914.2008.00378.x
   Kahan D. M., 2007, J EMPIR LEGAL STUD, V4, P465, DOI DOI 10.1111/J.1740-1461.2007.00097.X
   Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246
   Kay AC, 2003, J PERS SOC PSYCHOL, V85, P823, DOI 10.1037/0022-3514.85.5.823
   Keller J, 2005, J PERS SOC PSYCHOL, V88, P686, DOI 10.1037/0022-3514.88.4.686
   Kim AM, 2010, NATURE, V465, P688, DOI 10.1038/465688a
   Koteyko N, 2013, GEOGR J, V179, P74, DOI 10.1111/j.1475-4959.2012.00479.x
   Krippendorf K., 2004, CONTENT ANAL INTRO I
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Laslo E, 2011, JOURNALISM, V12, P847, DOI 10.1177/1464884911412709
   Latour B., 1986, LAB LIFE CONSTRUCTIO
   Lee EJ, 2010, COMMUN RES, V37, P825, DOI 10.1177/0093650210376189
   Matusall S, 2013, SOC STUD SCI, V43, P780, DOI 10.1177/0306312713488843
   McCabe DP, 2008, COGNITION, V107, P343, DOI 10.1016/j.cognition.2007.07.017
   Meurk C, 2014, NEUROETHICS-NETH, V7, P51, DOI 10.1007/s12152-013-9180-1
   Morton TA, 2006, POLIT PSYCHOL, V27, P823, DOI 10.1111/j.1467-9221.2006.00539.x
   Morton TA, 2009, J PERS SOC PSYCHOL, V96, P653, DOI 10.1037/a0012966
   MOSCOVICI S, 1993, J THEOR SOC BEHAV, V23, P343, DOI 10.1111/j.1468-5914.1993.tb00540.x
   MOSCOVICI S, 1988, EUR J SOC PSYCHOL, V18, P211, DOI 10.1002/ejsp.2420180303
   National Science Board, 2012, SCI ENG IND 2012
   Neuendorf KA, 2011, SEX ROLES, V64, P276, DOI 10.1007/s11199-010-9893-0
   Noor K.B.M., 2008, AM J APPL SCI, V5, P1602, DOI DOI 10.3844/AJASSP.2008.1602.1604
   O'Connell G, 2011, EMBO REP, V12, P630, DOI 10.1038/embor.2011.115
   O'Connor C, 2014, SCI COMMUN, V36, P617, DOI 10.1177/1075547014549481
   O'Connor C, 2013, SOC SCI MED, V97, P297, DOI 10.1016/j.socscimed.2012.09.048
   O'Connor C, 2013, PUBLIC UNDERST SCI, V22, P254, DOI 10.1177/0963662513476812
   O'Connor C, 2012, NEURON, V74, P220, DOI 10.1016/j.neuron.2012.04.004
   Pearce W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094785
   Pickersgill M, 2013, CURR SOCIOL, V61, P322, DOI 10.1177/0011392113476464
   Pickersgill M, 2011, SUBJECTIVITY, V4, P346, DOI 10.1057/sub.2011.10
   Prentice DA, 2007, CURR DIR PSYCHOL SCI, V16, P202, DOI 10.1111/j.1467-8721.2007.00504.x
   Racine E, 2006, SCI COMMUN, V28, P122, DOI 10.1177/1075547006291990
   Racine E, 2010, SOC SCI MED, V71, P725, DOI 10.1016/j.socscimed.2010.05.017
   Rose N., 2013, NEURO NEW BRAIN SCI
   Rowe G, 2008, HEALTH RISK SOC, V10, P361, DOI 10.1080/13698570802166456
   Schwartz LM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8164
   Seale C, 2010, SOC SCI MED, V71, P861, DOI 10.1016/j.socscimed.2010.05.048
   Shema H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035869
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Singh I, 2013, SOCIOL HEALTH ILL, V35, P813, DOI 10.1111/j.1467-9566.2012.01531.x
   Smith NW, 2009, J RISK RES, V12, P647, DOI 10.1080/13669870802586512
   Smith N, 2013, PUBLIC UNDERST SCI, V22, P16, DOI 10.1177/0963662512440913
   Stafford T, 2012, TRENDS COGN SCI, V16, P489, DOI 10.1016/j.tics.2012.08.001
   Ten Eyck TA, 2005, PUBLIC UNDERST SCI, V14, P305, DOI 10.1177/0963662505052888
   Thoman DB, 2008, SEX ROLES, V58, P702, DOI 10.1007/s11199-008-9390-x
   Van Eperen L, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-199
   Vidal C, 2012, NEUROETHICS-NETH, V5, P295, DOI 10.1007/s12152-011-9121-9
   Wagner W, 2002, BRIT J SOC PSYCHOL, V41, P323, DOI 10.1348/014466602760344241
   WAGNER W, 1995, EUR J SOC PSYCHOL, V25, P671, DOI 10.1002/ejsp.2420250606
   Wagner W, 2007, PUBLIC UNDERST SCI, V16, P7, DOI 10.1177/0963662506071785
   Washer P, 2006, SOC SCI MED, V62, P457, DOI 10.1016/j.socscimed.2005.06.001
   Weisberg DS, 2008, J COGNITIVE NEUROSCI, V20, P470, DOI 10.1162/jocn.2008.20.3.470
   Whiteley L, 2012, BIOSOCIETIES, V7, P245, DOI 10.1057/biosoc.2012.21
   Yavchitz A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001308
   Yin R. K., 2009, CASE STUDY RES DESIG
NR 106
TC 21
Z9 21
U1 2
U2 81
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 29
PY 2014
VL 9
IS 10
AR e110830
DI 10.1371/journal.pone.0110830
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AT8TG
UT WOS:000345204200041
PM 25354280
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-07-16
ER

PT J
AU Rowbotham, S
   Wardy, AJ
   Lloyd, DM
   Wearden, A
   Holler, J
AF Rowbotham, Samantha
   Wardy, April J.
   Lloyd, Donna M.
   Wearden, Alison
   Holler, Judith
TI Increased Pain Intensity Is Associated with Greater Verbal Communication
   Difficulty and Increased Production of Speech and Co-Speech Gestures
SO PLOS ONE
LA English
DT Article
ID FAKED FACIAL EXPRESSIONS; SEX-DIFFERENCES; GENERAL-POPULATION;
   SELF-REPORT; BEHAVIOR; GENDER; METAANALYSIS; PREVALENCE; DIMENSIONS;
   GENUINE
AB Effective pain communication is essential if adequate treatment and support are to be provided. Pain communication is often multimodal, with sufferers utilising speech, nonverbal behaviours (such as facial expressions), and co-speech gestures (bodily movements, primarily of the hands and arms that accompany speech and can convey semantic information) to communicate their experience. Research suggests that the production of nonverbal pain behaviours is positively associated with pain intensity, but it is not known whether this is also the case for speech and co-speech gestures. The present study explored whether increased pain intensity is associated with greater speech and gesture production during face-to-face communication about acute, experimental pain. Participants (N = 26) were exposed to experimentally elicited pressure pain to the fingernail bed at high and low intensities and took part in video-recorded semi-structured interviews. Despite rating more intense pain as more difficult to communicate (t(25) = 2.21, p = .037), participants produced significantly longer verbal pain descriptions and more co-speech gestures in the high intensity pain condition (Words: t(25) = 3.57, p = .001; Gestures: t(25) = 3.66, p = .001). This suggests that spoken and gestural communication about pain is enhanced when pain is more intense. Thus, in addition to conveying detailed semantic information about pain, speech and co-speech gestures may provide a cue to pain intensity, with implications for the treatment and support received by pain sufferers. Future work should consider whether these findings are applicable within the context of clinical interactions about pain.
C1 [Rowbotham, Samantha; Wardy, April J.; Wearden, Alison] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England.
   [Lloyd, Donna M.] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England.
   [Holler, Judith] Max Planck Inst Psycholinguist, Nijmegen, Netherlands.
RP Rowbotham, S (reprint author), Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England.
EM samantha.rowbotham@manchester.ac.uk
RI Rowbotham, Samantha/I-2229-2019; Holler, Judith/U-9654-2018; Rowbotham,
   Samantha/G-7124-2015
OI Rowbotham, Samantha/0000-0002-2242-6921; Rowbotham,
   Samantha/0000-0002-2242-6921; HOLLER, JUDITH/0000-0003-0671-6651
FU University of Manchester School of Psychological Sciences Postgraduate
   Research Fund; ERC Advanced Grant [269484-INTERACT]
FX Funding for participant payment was provided by The University of
   Manchester School of Psychological Sciences Postgraduate Research Fund.
   JH was supported by ERC Advanced Grant #269484-INTERACT during parts of
   this project. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Alibali MW, 2001, J MEM LANG, V44, P169, DOI 10.1006/jmla.2000.2752
   Badali M, 2008, THESIS U BRIT COLUMB
   BAVELAS JB, 1992, DISCOURSE PROCESS, V15, P469, DOI 10.1080/01638539209544823
   Bavelas JB, 1994, RES LANG SOC INTERAC, V27, P201, DOI DOI 10.1207/S15327973RLSI2703_3
   Briggs Emma, 2010, Nurs Stand, V25, P35
   Catala E, 2002, EUR J PAIN-LONDON, V6, P133, DOI 10.1053/eujp.2001.0310
   Craig KD, 2009, CAN PSYCHOL, V50, P22, DOI 10.1037/a0014772
   CROOK J, 1984, PAIN, V18, P299, DOI 10.1016/0304-3959(84)90824-8
   Cypress IK, 1975, VITAL HLTH STAT DATA, V13
   DINDIA K, 1992, PSYCHOL BULL, V112, P106, DOI 10.1037/0033-2909.112.1.106
   Ekman P., 1968, RES PSYCHOTHER, P179
   Ekman P, 1978, FACIAL ACTION CODING
   Gauthier N, 2011, PAIN RES MANAG, V16, P293, DOI 10.1155/2011/247940
   Hadjistavropoulos HD, 1996, PAIN, V65, P251, DOI 10.1016/0304-3959(95)00218-9
   Hadjistavropoulos T, 2002, BEHAV RES THER, V40, P551, DOI 10.1016/S0005-7967(01)00072-9
   Hadjistavropoulos T, 2011, PSYCHOL BULL, V137, P910, DOI 10.1037/a0023876
   HALL JA, 1994, HEALTH PSYCHOL, V13, P384, DOI 10.1037/0278-6133.13.5.384
   HAYTHORNTHWAITE JA, 1991, PAIN, V46, P177, DOI 10.1016/0304-3959(91)90073-7
   Heath C, 2002, J COMMUN, V52, P597, DOI 10.1111/j.1460-2466.2002.tb02564.x
   Hill ML, 2002, PAIN, V98, P135, DOI 10.1016/S0304-3959(02)00037-4
   Holler J, 2002, SEMIOTICA, V142, P31
   Hostetter AB, 2011, PSYCHOL BULL, V137, P297, DOI 10.1037/a0022128
   Hurwitz B., 2003, PERCEPTIONS PAIN, P7
   Hyden LC, 2002, HEALTH, V6, P325, DOI 10.1177/136345930200600305
   IBM Corp, 2011, IBM SPSS STAT WIND
   KEEFE FJ, 1986, J CONSULT CLIN PSYCH, V54, P665, DOI 10.1037/0022-006X.54.5.665
   Kendon Adam, 2004, GESTURE VISIBLE ACTI
   KLECK RE, 1976, J PERS SOC PSYCHOL, V34, P1211, DOI 10.1037/0022-3514.34.6.1211
   KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3
   Kunz M, 2004, J PAIN, V5, P368, DOI 10.1016/j.jpain.2004.06.002
   Kunz M, 2008, PAIN, V140, P127, DOI 10.1016/j.pain.2008.07.019
   Labus JS, 2003, PAIN, V102, P109, DOI 10.1016/S0304-3959(02)00354-8
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Larochette AC, 2006, PAIN, V126, P64, DOI 10.1016/j.pain.2006.06.013
   McNeill D, 1992, HAND MIND WHAT GESTU
   National Cancer Institute, 2011, PAIN ASS
   Newton-John TRO, 2002, PAIN REV, V9, P7, DOI 10.1191/0968130202pr186ra
   POOLE GD, 1992, J PERS SOC PSYCHOL, V63, P797, DOI 10.1037/0022-3514.63.5.797
   PRKACHIN KM, 1995, J NONVERBAL BEHAV, V19, P191, DOI 10.1007/BF02173080
   PRKACHIN KM, 1989, PAIN, V39, P257, DOI 10.1016/0304-3959(89)90038-9
   Riley JL, 1998, PAIN, V74, P181, DOI 10.1016/S0304-3959(97)00199-1
   Rosenthal R, 2005, NEW HDB METHODS NONV
   Roter D, 2006, DOCTORS TALKING PATI
   Roter DL, 2002, JAMA-J AM MED ASSOC, V288, P756, DOI 10.1001/jama.288.6.756
   Rowbotham S, 2014, I SEE WHAT IN PRESS
   Rowbotham S., 2013, HLTH PSYCHOL UPDATE, V22, P19
   Rowbotham S, 2014, SPEECH COMMUN, V57, P244, DOI 10.1016/j.specom.2013.04.002
   Rowbotham S, 2012, J NONVERBAL BEHAV, V36, P1, DOI 10.1007/s10919-011-0122-5
   Sarlani E, 2004, PAIN, V109, P115, DOI 10.1016/j.pain.2004.01.019
   Sarlani E, 2003, PAIN, V106, P9, DOI 10.1016/S0304-3959(03)00211-2
   Sullivan MJL, 2006, PAIN, V122, P282, DOI 10.1016/j.pain.2006.02.001
   Sullivan MJL, 2006, PAIN, V125, P270, DOI 10.1016/j.pain.2006.06.019
   Sullivan MJL, 2000, COGNITIVE THER RES, V24, P121, DOI 10.1023/A:1005459110063
   Sullivan MJL, 2004, PAIN, V107, P220, DOI 10.1016/j.pain.2003.11.003
   Swann J, 2010, NURS RESIDENTIAL CAR, V12, P212
   Taylor Laurie Jowers, 2005, Rehabil Nurs, V30, P55
   Thibault P, 2008, PAIN, V139, P47, DOI 10.1016/j.pain.2008.02.029
   Thomas E, 2004, PAIN, V110, P361, DOI 10.1016/j.pain.2004.04.017
   Tian TN, 2011, PAIN, V152, P1210, DOI 10.1016/j.pain.2011.02.022
   Vervoort T, 2008, PAIN, V134, P59, DOI 10.1016/j.pain.2007.03.038
   Vervoort T, 2009, PAIN, V146, P170, DOI 10.1016/j.pain.2009.07.021
   Vickers ER, 1998, AUST DENT J, V43, P403, DOI 10.1111/j.1834-7819.1998.tb00200.x
   Ware LJ, 2006, PAIN MANAG NURS, V7, P117, DOI 10.1016/j.pmn.2006.06.005
   WOODROW KM, 1972, PSYCHOSOM MED, V34, P548, DOI 10.1097/00006842-197211000-00007
NR 64
TC 1
Z9 1
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 24
PY 2014
VL 9
IS 10
AR e110779
DI 10.1371/journal.pone.0110779
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AS0BL
UT WOS:000343943500053
PM 25343486
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chou, CT
   Wu, WP
   Chen, CB
   Su, WW
   Chen, RC
   Chen, YL
AF Chou, Chen-Te
   Wu, Wen-Pei
   Chen, Chia-Bang
   Su, Wei-Wen
   Chen, Ran-Chou
   Chen, Yao-Li
TI The Utility of Gadoxetic Acid-Enhanced MR Imaging to Characterize
   Atypical Cirrhotic Nodules Detected on Dynamic CT Images
SO PLOS ONE
LA English
DT Article
ID GD-EOB-DTPA; NONINVASIVE DIAGNOSTIC-CRITERIA; SMALL
   HEPATOCELLULAR-CARCINOMA; TUMOR SIZE; HISTOLOGIC GRADE; HEPATIC NODULES;
   LIVER; GADOLINIUM; DIFFERENTIATION; AGREEMENT
AB Purpose: To evaluate whether gadoxetic acid (Gd-EOB-DTPA)-enhanced MR images of tumors taken during the hepatocyte-specific phase can aid in the differentiation between hepatocellular carcinoma (HCC) and dysplastic nodules (DNs) in patients with atypical cirrhotic nodules detected on dynamic CT images.
   Materials and Methods: Seventy-one patients with 112 nodules showing atypical dynamic enhancement on CT images underwent gadoxetic acid-enhanced MR imaging (MRI) studies. Using a reference standard, we determined that 33 of the nodules were DNs and that 79 were true HCCs. Tumor size, signal intensity on precontrast T1-weighted images (T1WI) and T2WI, and the pattern of dynamic enhancement on MR images taken in the hepatocyte-phase were determined.
   Results: There were significant differences in tumor size, hyperintensity on T2WI, hypointensity on T1WI, typical HCC enhancement pattern on dynamic MR images, or hypointensity on hepatocyte-phase images between DNs and HCC. The sensitivity and specificity were 60.8% and 87.9% for T2WI, 38.0% and 87.9% for T1WI, 17.7% and 100% for dynamic MR imaging, 83.5% and 84.9% for hepatocyte-phase imaging, and 60.8% and 87.9% for tumor size (threshold of 1.7 cm).
   Conclusion: Gd-EOB-DTPA-enhanced hepatocyte-phase imaging is recommended for patients at high risk of HCC who present with atypical lesions on dynamic CT images.
C1 [Chou, Chen-Te; Wu, Wen-Pei; Chen, Ran-Chou] Natl Yang Ming Med Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan.
   [Chou, Chen-Te; Chen, Chia-Bang] Chang Hua Christian Hosp, Dept Radiol, Changhua, Taiwan.
   [Chen, Yao-Li] Chang Hua Christian Hosp, Transplantat Med & Surg Res Ctr, Changhua, Taiwan.
   [Su, Wei-Wen] Chang Hua Christian Hosp, Dept Gastroenterol, Changhua, Taiwan.
   [Chen, Ran-Chou] Taipei City Hosp, Dept Radiol, Taipei, Taiwan.
   [Chen, Yao-Li] Chung Shan Med Univ, Sch Med, Taichung, Taiwan.
   [Chen, Yao-Li] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan.
RP Chen, RC (reprint author), Natl Yang Ming Med Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan.
EM chenranchou@yahoo.com.tw; 31560@cch.org.tw
FU National Science Council, Taiwan [100-2314-B-010-012-MY2]; Chang-hua
   Christian Hospital, Taiwan [101-CCH-IRP-03]
FX The authors thank the National Science Council, Taiwan
   (100-2314-B-010-012-MY2) and the Chang-hua Christian Hospital, Taiwan
   (101-CCH-IRP-03) for financially supporting this research. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199
   Choi JY, 2011, AM J ROENTGENOL, V197, P399, DOI 10.2214/AJR.10.5439
   Donato F, 1997, HEPATOLOGY, V26, P579, DOI 10.1002/hep.510260308
   EGUCHI A, 1992, HEPATOLOGY, V15, P843, DOI 10.1002/hep.1840150516
   Forner A, 2008, HEPATOLOGY, V47, P97, DOI 10.1002/hep.21966
   Frericks BB, 2009, AM J ROENTGENOL, V193, P1053, DOI 10.2214/AJR.08.1946
   Furlan A, 2012, EUR J RADIOL, V81, P2099, DOI 10.1016/j.ejrad.2011.07.010
   Huppertz A, 2004, RADIOLOGY, V230, P266, DOI 10.1148/radiol.2301020269
   Hussain SM, 2002, RADIOGRAPHICS, V22, P1023, DOI 10.1148/radiographics.22.5.g02se061023
   Hyodo T, 2013, RADIOLOGY, V266, P480, DOI 10.1148/radiol.12112677
   Kawada N, 2010, HEPATOL RES, V40, P930, DOI 10.1111/j.1872-034X.2010.00697.x
   KENMOCHI K, 1987, LIVER, V7, P18
   Kim YK, 2009, J MAGN RESON IMAGING, V30, P437, DOI 10.1002/jmri.21839
   Kudo M, 2011, ONCOLOGY-BASEL, V81, P73, DOI 10.1159/000333265
   Kudo M, 2010, ONCOLOGY-BASEL, V78, P87, DOI 10.1159/000315235
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee JH, 2012, BRIT J RADIOL, V85, pE573, DOI 10.1259/bjr/86767895
   Lim JH, 2004, BRIT J RADIOL, V77, P911, DOI 10.1259/bjr/56713551
   Ouedraogo W, 2011, J RADIOL, V92, P688, DOI 10.1016/j.jradio.2011.03.020
   Pauleit D, 2002, RADIOLOGY, V222, P73, DOI 10.1148/radiol.2221001599
   Pawlik TM, 2005, LIVER TRANSPLANT, V11, P1086, DOI 10.1002/lt.20472
   Rampone B, 2009, WORLD J GASTROENTERO, V15, P3210, DOI 10.3748/wjg.15.3210
   SCHUHMANNGIAMPIERI G, 1992, RADIOLOGY, V183, P59, DOI 10.1148/radiology.183.1.1549695
   Szklaruk J, 2003, AM J ROENTGENOL, V180, P441, DOI 10.2214/ajr.180.2.1800441
   Vogl TJ, 1996, RADIOLOGY, V200, P59, DOI 10.1148/radiology.200.1.8657946
   WEINMANN HJ, 1991, MAGNET RESON MED, V22, P233, DOI 10.1002/mrm.1910220214
   Willatt JM, 2008, RADIOLOGY, V247, P311, DOI 10.1148/radiol.2472061331
   Yoon SH, 2009, AM J ROENTGENOL, V193, pW482, DOI 10.2214/AJR.08.1818
NR 28
TC 11
Z9 11
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 13
PY 2014
VL 9
IS 10
AR e107869
DI 10.1371/journal.pone.0107869
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AQ9WZ
UT WOS:000343210300008
PM 25310817
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Miura, K
   Turrell, G
AF Miura, Kyoko
   Turrell, Gavin
TI Contribution of Psychosocial Factors to the Association between
   Socioeconomic Position and Takeaway Food Consumption
SO PLOS ONE
LA English
DT Article
ID NUTRITION KNOWLEDGE; REPORTED CONSUMPTION; PURCHASING BEHAVIOR;
   VEGETABLE INTAKE; DIETARY-INTAKE; UNITED-STATES; US ADULTS; HEALTH;
   DETERMINANTS; INEQUALITIES
AB Objective: To examine whether psychosocial factors mediate (explain) the association between socioeconomic position and takeaway food consumption.
   Design: A cross-sectional postal survey conducted in 2009.
   Setting: Participants reported their usual consumption of 22 takeaway food items, and these were grouped into a "healthy'' and "less healthy'' index based on each items' nutritional properties. Principal Components Analysis was used to derive three psychosocial scales that measured beliefs about the relationship between diet and health (alpha = 0.73), and perceptions about the value (alpha = 0.79) and pleasure (alpha = 0.61) of takeaway food. A nutrition knowledge index was also used. Socioeconomic position was measured by highest attained education level.
   Subjects: Randomly selected adults (n = 1,500) aged between 25-64 years in Brisbane, Australia (response rate = 63.7%, N = 903).
   Results: Compared with those with a bachelor degree or higher, participants with a diploma level of education were more likely to consume "healthy'' takeaway food (p = 0.023) whereas the least educated (high school only) were more likely to consume "less healthy'' choices (p = 0.002). The least educated were less likely to believe in a relationship between diet and health (p<0.001), and more likely to have lower nutritional knowledge compared with their highly educated counterparts (p<0.001). Education differences in beliefs about the relationship between diet and health partly and significantly mediated the association between education and "healthy'' takeaway food consumption. Diet-and health-related beliefs and nutritional knowledge partly and significantly mediated the education differences in "less healthy'' takeaway food consumption.
   Conclusions: Interventions that target beliefs about the relationship between diet and health, and nutritional knowledge may reduce socioeconomic differences in takeaway food consumption, particularly for "less healthy'' options.
C1 [Miura, Kyoko; Turrell, Gavin] Queensland Univ Technol, Fac Hlth, Sch Publ Hlth & Social Work, Kelvin Grove, Qld, Australia.
   [Miura, Kyoko] QIMR Berghofer Med Res Inst, Canc & Populat Studies Grp, Herston, Qld, Australia.
RP Miura, K (reprint author), Queensland Univ Technol, Fac Hlth, Sch Publ Hlth & Social Work, Kelvin Grove, Qld, Australia.
EM Kyoko.Miura@qimrberghofer.edu.au
RI Matsuo, Keitaro/H-6758-2019; Miura, Kyoko/B-9874-2012
OI Matsuo, Keitaro/0000-0003-1761-6314; Miura, Kyoko/0000-0002-2805-7522;
   Turrell, Gavin/0000-0002-3576-8744
FU Queensland University of Technology; National Health and Medical
   Research Council of Australia (NHMRC) Senior Research Fellowship
   [APP1003710]
FX This research was supported by Queensland University of Technology
   (operational aspects of the study). GT is supported by the National
   Health and Medical Research Council of Australia (NHMRC) Senior Research
   Fellowship (APP1003710). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029
   Aikman SN, 2006, APPETITE, V47, P111, DOI 10.1016/j.appet.2006.02.004
   Ball K, 2006, PUBLIC HEALTH NUTR, V9, P623, DOI 10.1079/PHN2005897
   Batty GD, 2009, J EPIDEMIOL COMMUN H, V63, P952, DOI 10.1136/jech.2008.086892
   Beck ME, 2007, BRIT FOOD J, V109, P531, DOI 10.1108/00070700710761527
   Beydoun MA, 2008, PREV MED, V46, P145, DOI 10.1016/j.ypmed.2007.06.016
   Beydoun MA, 2009, PUBLIC HEALTH NUTR, V12, P369, DOI 10.1017/S1368980008002140
   Blanck HM, 2009, HEALTH EDUC BEHAV, V36, P289, DOI 10.1177/1090198107303308
   Burns CM, 2007, HEALTH PLACE, V13, P877, DOI 10.1016/j.healthplace.2007.02.005
   Chand A, 2012, APPETITE, V58, P227, DOI 10.1016/j.appet.2011.10.006
   Conner M, 2006, FRONT NUTR SCI, P41, DOI 10.1079/9780851990323.0041
   Dave JM, 2009, OBESITY, V17, P1164, DOI 10.1038/oby.2009.26
   Devine CM, 2005, J NUTR EDUC BEHAV, V37, P121, DOI 10.1016/S1499-4046(06)60266-2
   Dillman D. A, 2000, MAIL INTERNET SURVEY
   Dunford E, 2010, APPETITE, V55, P484, DOI 10.1016/j.appet.2010.08.015
   Dunn KI, 2008, APPETITE, V51, P331, DOI 10.1016/j.appet.2008.03.003
   Dunn KI, 2011, APPETITE, V57, P349, DOI 10.1016/j.appet.2011.06.004
   Dutton T, 2005, MEASURING SOCIOECONO
   Galobardes B, 2001, INT J EPIDEMIOL, V30, P334, DOI 10.1093/ije/30.2.334
   Girois SB, 2001, AM J PUBLIC HEALTH, V91, P418, DOI 10.2105/AJPH.91.3.418
   Giskes K, 2006, PUBLIC HEALTH NUTR, V9, P75, DOI 10.1079/PHN2005758
   Glanz K, 1998, J AM DIET ASSOC, V98, P1118, DOI 10.1016/S0002-8223(98)00260-0
   Guillaumie L, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-12
   Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3
   Hayes A. F., 2013, INTRO MEDIATION MODE
   James WPT, 1997, BRIT MED J, V314, P1545, DOI 10.1136/bmj.314.7093.1545
   Jaworowska A, 2013, NUTR REV, V71, P310, DOI 10.1111/nure.12031
   Kawachi I, 1999, HEALTH SERV RES, V34, P215
   Kearney M, 2000, PUBLIC HEALTH NUTR, V3, P219
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Le J, 2013, EUR J CLIN NUTR, V67, P808, DOI 10.1038/ejcn.2013.110
   Lea EJ, 2006, EUR J CLIN NUTR, V60, P828, DOI 10.1038/sj.ejcn.1602387
   Lynch JW, 1997, SOC SCI MED, V44, P809, DOI 10.1016/S0277-9536(96)00191-8
   Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1
   Mahon D, 2006, FOOD QUAL PREFER, V17, P474, DOI 10.1016/j.foodqual.2005.06.001
   Miura K, 2014, APPETITE, V74, P116, DOI 10.1016/j.appet.2013.12.007
   Miura K, 2012, PUBLIC HEALTH NUTR, V15, P218, DOI 10.1017/S136898001100139X
   Miura K, 2011, J AM DIET ASSOC, V111, P1556, DOI 10.1016/j.jada.2011.07.009
   New South Wales Health and New South Wales Department of Education and Training, 2006, FRESH TAST SCH NSW H
   Parmenter K, 2000, HEALTH EDUC RES, V15, P163, DOI 10.1093/her/15.2.163
   Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553
   Pujades-Rodriguez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104671
   Queensland Health, 2007, BETT CHOIC HLTH FOOD
   Reidpath DD, 2002, HEALTH PLACE, V8, P141, DOI 10.1016/S1353-8292(01)00028-4
   Rydell SA, 2008, J AM DIET ASSOC, V108, P2066, DOI 10.1016/j.jada.2008.09.008
   Saelens BE, 2007, AM J PREV MED, V32, P273, DOI 10.1016/j.amepre.2006.12.022
   Satia JA, 2004, PUBLIC HEALTH NUTR, V7, P1089, DOI 10.1079/PHN2004662
   Shepherd R, 1999, P NUTR SOC, V58, P807, DOI 10.1017/S0029665199001093
   Smith GD, 1997, P NUTR SOC, V56, P75, DOI 10.1079/PNS19970011
   The Commonwealth Department of Health and Family Services, 1998, AUSTR GUID HLTH EAT
   Thornton LE, 2011, J EPIDEMIOL COMMUN H, V65, P873, DOI 10.1136/jech.2009.099614
   Tolonen H, 2005, EUR J EPIDEMIOL, V20, P887, DOI 10.1007/s10654-005-2672-5
   TUORILA H, 1988, APPETITE, V11, P81, DOI 10.1016/S0195-6663(88)80008-4
   Turrell G, 2003, PUBLIC HEALTH NUTR, V6, P191, DOI 10.1079/PHN2002416
   Turrell G, 2006, PUBLIC HEALTH NUTR, V9, P375, DOI 10.1079/PHN2006850
   Turrell G, 2002, J HUM NUTR DIET, V15, P355, DOI 10.1046/j.1365-277X.2002.00384.x
   Turrell G, 1998, J HUM NUTR DIET, V11, P135, DOI 10.1046/j.1365-277X.1998.00084.x
   van der Horst K, 2011, J HUM NUTR DIET, V24, P596, DOI 10.1111/j.1365-277X.2011.01206.x
   Vue H, 2008, J NUTR EDUC BEHAV, V40, P378, DOI 10.1016/j.jneb.2007.09.009
   Wang YF, 2011, J AM DIET ASSOC, V111, P1904, DOI 10.1016/j.jada.2011.09.036
   Wardle J, 2003, J EPIDEMIOL COMMUN H, V57, P440, DOI 10.1136/jech.57.6.440
   Wardle J, 2000, APPETITE, V34, P269, DOI 10.1006/appe.1999.0311
NR 62
TC 4
Z9 4
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 30
PY 2014
VL 9
IS 9
AR e108799
DI 10.1371/journal.pone.0108799
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AR6CW
UT WOS:000343671700165
PM 25268899
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Meijer, MF
   Boerboom, AL
   Stevens, M
   Bulstra, SK
   Reininga, IHF
AF Meijer, Marrigje F.
   Boerboom, Alexander L.
   Stevens, Martin
   Bulstra, Sjoerd K.
   Reininga, Inge H. F.
TI Assessment of Prosthesis Alignment after Revision Total Knee
   Arthroplasty Using EOS 2D and 3D Imaging: A Reliability Study
SO PLOS ONE
LA English
DT Article
ID LOWER-EXTREMITY; REPRODUCIBILITY; REHABILITATION; AGREEMENT; POSITION;
   ROTATION; SYSTEM
AB Introduction: A new low-dose X-ray device, called EOS, has been introduced for determining lower-limb alignment in 2D and 3D. Reliability has not yet been assessed when using EOS on lower limbs containing a knee prosthesis. Therefore purpose of this study was to determine intraobserver and interobserver reliability of EOS 2D and 3D knee prosthesis alignment measurements after revision total knee arthroplasty (rTKA).
   Methods: Forty anteroposterior and lateral images of 37 rTKA patients were included. Two observers independently performed measurements on these images twice. Varus/valgus angles were measured in 2D (VV2D) and 3D (VV3D). Intraclass correlation coefficients and the Bland and Altman method were used to determine reliability. T-tests were used to test potential differences.
   Results: Intraobserver and interobserver reliability were excellent for VV2D and VV3D. No significant difference or bias between the first and second measurements or the two observers was found. A significant mean and absolute difference of respectively 1.00 degrees and 1.61 degrees existed between 2D and 3D measurements.
   Conclusions: EOS provides reliable varus/valgus measurements in 2D and 3D for the alignment of the knee joint with a knee prosthesis. However, significant differences exist between varus/valgus measurements in 2D and 3D.
C1 [Meijer, Marrigje F.; Boerboom, Alexander L.; Stevens, Martin; Bulstra, Sjoerd K.] Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed, Groningen, Netherlands.
   [Reininga, Inge H. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Trauma Surg, Groningen, Netherlands.
RP Meijer, MF (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed, Groningen, Netherlands.
EM M.F.Meijer@umcg.nl
RI Reininga, Inge/H-4250-2013
CR Baker P, 2012, CLIN ORTHOP RELAT R, V470, P2244, DOI 10.1007/s11999-012-2278-7
   Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638
   Bittersohl B, 2013, J BONE JOINT SURG AM, V95A, DOI 10.2106/JBJS.K.01591
   BLAND JM, 1986, LANCET, V1, P307
   Brouwer R W, 2007, J Knee Surg, V20, P210
   Choong PF, 2009, J ARTHROPLASTY, V24, P560, DOI 10.1016/j.arth.2008.02.018
   Cohen JA, 1960, EDUC PSYCHOL MEAS, V33, P159
   de Vet HCW, 2001, INT J TECHNOL ASSESS, V17, P479
   Dubousset J, 2005, B ACAD NAT MED PARIS, V189, P287
   EOS-imaging, 2011, STEREOS WORKST OP MA
   Fleiss J. L., 1986, DESIGN ANAL CLIN EXP
   Gheno R, 2012, EUR RADIOL, V22, P765, DOI 10.1007/s00330-011-2308-y
   Guenoun B, 2012, ORTHOP TRAUMATOL-SUR, V98, P506, DOI 10.1016/j.otsr.2012.03.014
   Ilharreborde B, 2011, SPINE, V36, pE1306, DOI 10.1097/BRS.0b013e3182293548
   JEFFERY RS, 1991, J BONE JOINT SURG BR, V73, P709
   Kalifa G, 1998, PEDIATR RADIOL, V28, P557, DOI 10.1007/s002470050413
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lazennec JY, 2011, ORTHOP TRAUMATOL-SUR, V97, P373, DOI 10.1016/j.otsr.2011.02.006
   Longstaff LM, 2009, J ARTHROPLASTY, V24, P570, DOI 10.1016/j.arth.2008.03.002
   Lonner JH, 1996, CLIN ORTHOP RELAT R, P102
   Ohl X, 2010, SURG RADIOL ANAT, V32, P153, DOI 10.1007/s00276-009-0566-z
   Radtke K, 2010, ARCH ORTHOP TRAUM SU, V130, P451, DOI 10.1007/s00402-009-0999-1
   Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340
   RITTER MA, 1994, CLIN ORTHOP RELAT R, P153
   Rousseau MA, 2007, SPINE, V32, P2569, DOI 10.1097/BRS.0b013e318158cba2
   Sheng PY, 2006, J BONE JOINT SURG AM, V88A, P1425, DOI 10.2106/JBJS.E.00737
   Somoskeoy S, 2012, SPINE J, V12, P1052, DOI 10.1016/j.spinee.2012.10.002
   STRATFORD P, 1989, PHYS THER, V69, P299, DOI 10.1093/ptj/69.4.299a
   Swanson KE, 2000, CLIN ORTHOP RELAT R, P246
   Thelen P, 2012, SKELETAL RADIOL, V41, P1287, DOI 10.1007/s00256-012-1438-x
   Vidal C, 2013, EUR SPINE J, V22, P1362, DOI 10.1007/s00586-013-2752-2
NR 31
TC 18
Z9 19
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 23
PY 2014
VL 9
IS 9
AR e104613
DI 10.1371/journal.pone.0104613
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AP8TL
UT WOS:000342351800006
PM 25247714
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Launay, E
   Guen, CGL
   Martinot, A
   Assathiany, R
   Martin, E
   Blanchais, T
   Deneux-Tharaux, C
   Roze, JC
   Chalumeau, M
AF Launay, Elise
   Guen, Christele Gras-Le
   Martinot, Alain
   Assathiany, Remy
   Martin, Elise
   Blanchais, Thomas
   Deneux-Tharaux, Catherine
   Roze, Jean-Christophe
   Chalumeau, Martin
TI Why Children with Severe Bacterial Infection Die: A Population-Based
   Study of Determinants and Consequences of Suboptimal Care with a Special
   Emphasis on Methodological Issues
SO PLOS ONE
LA English
DT Article
ID HEALTH-CARE; CAUSAL INFERENCE; EPIDEMIOLOGY; DELIVERY; QUALITY; SEPSIS
AB Introduction: Suboptimal care is frequent in the management of severe bacterial infection. We aimed to evaluate the consequences of suboptimal care in the early management of severe bacterial infection in children and study the determinants.
   Methods: A previously reported population-based confidential enquiry included all children (3 months- 16 years) who died of severe bacterial infection in a French area during a 7-year period. Here, we compared the optimality of the management of these cases to that of pediatric patients who survived a severe bacterial infection during the same period for 6 types of care: seeking medical care by parents, evaluation of sepsis signs and detection of severe disease by a physician, timing and dosage of antibiotic therapy, and timing and dosage of saline bolus. Two independent experts blinded to outcome and final diagnosis evaluated the optimality of these care types. The effect of suboptimal care on survival was analyzed by a logistic regression adjusted on confounding factors identified by a causal diagram. Determinants of suboptimal care were analyzed by multivariate multilevel logistic regression.
   Results: Suboptimal care was significantly more frequent during early management of the 21 children who died as compared with the 93 survivors: 24% vs 13% (p = 0.003). The most frequent suboptimal care types were delay to seek medical care (20%), under-evaluation of severity by the physician (20%) and delayed antibiotic therapy (24%). Young age (under 1 year) was independently associated with higher risk of suboptimal care, whereas being under the care of a paediatric emergency specialist or a mobile medical unit as compared with a general practitioner was associated with reduced risk.
   Conclusions: Suboptimal care in the early management of severe bacterial infection had a global independent negative effect on survival. Suboptimal care may be avoided by better training of primary care physicians in the specifics of pediatric medicine.
C1 [Launay, Elise; Guen, Christele Gras-Le; Martin, Elise; Blanchais, Thomas] CHU Nantes, Hop Mere & Enfant, Clin Med Pediat, Fac Med Nantes, F-44035 Nantes 01, France.
   [Launay, Elise; Deneux-Tharaux, Catherine; Chalumeau, Martin] Paris Descartes Univ, INSERM, Obstetr Perinatal & Pediat Epidemiol Res Team, Res Ctr Epidemiol & Biostat,U1153, Paris, France.
   [Launay, Elise; Deneux-Tharaux, Catherine; Chalumeau, Martin] Paris Descartes Univ, Sorbonne Paris Cite CRESS, Paris, France.
   [Guen, Christele Gras-Le] CHU Nantes, Hop Mere & Enfant, Fac Med Nantes, F-44035 Nantes 01, France.
   [Martinot, Alain] Univ Lille Nord France, CHU Lille, Hop R Salengro, Unite Urgences Pediat & Malad Infect, F-59037 Lille, France.
   [Assathiany, Remy] AFPA, AREPEGE, Issy Les Moulineaux, France.
   [Roze, Jean-Christophe] CHU Nantes, Hop Mere & Enfant, Fac Med Nantes, F-44035 Nantes 01, France.
   [Chalumeau, Martin] Paris Descartes Univ, Hop Necker Enfants Malad, AP HP, Serv Pediat Gen, Paris, France.
RP Launay, E (reprint author), CHU Nantes, Hop Mere & Enfant, Clin Med Pediat, Fac Med Nantes, F-44035 Nantes 01, France.
EM elise.launay@chu-nantes.fr
RI Chalumeau, Martin/F-4293-2017; Deneux-Tharaux, Catherine/R-1111-2016;
   Martinot, Alain/M-6780-2016
OI Chalumeau, Martin/0000-0001-8175-3706; Deneux-Tharaux,
   Catherine/0000-0002-6561-3321; Martinot, Alain/0000-0002-2146-8273;
   Launay, Elise/0000-0002-4081-4653; GRAS-LE GUEN,
   Christele/0000-0001-9060-2344; Roze, Jean-Christophe/0000-0003-3367-512X
FU Bettencourt Foundation (Coups d'elan pour la recherche francaise) [1153]
FX The authors received no specific funding for this work. Inserm Unit 1153
   received a grant from the Bettencourt Foundation (Coups d'elan pour la
   recherche francaise) in support of its research activities. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Ahrens KA, 2013, PAEDIATR PERINAT EP, V27, P258, DOI 10.1111/ppe.12048
   Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080
   Ambler G, 2001, J STAT COMPUT SIM, V69, P89, DOI 10.1080/00949650108812083
   Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI 10.1056/NEJMra1208623
   Aurel M, 2011, ARCH DIS CHILD, V96, P697, DOI 10.1136/adc.2009.180174
   Bouvier-Colle MH, 2002, REV EPIDEMIOL SANTE, V50, P203
   Casanova JL, 2007, EMBO J, V26, P915, DOI 10.1038/sj.emboj.7601558
   Dharmar M, 2008, J PEDIATR-US, V153, P783, DOI 10.1016/j.jpeds.2008.05.025
   Giguere A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004398.pub3
   Gilleland J, 2013, BMJ QUAL SAF
   Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2
   Han YY, 2003, PEDIATRICS, V112, P793, DOI 10.1542/peds.112.4.793
   Harnden A, 2009, BRIT J GEN PRACT, V59, P819, DOI 10.3399/bjgp09X472520
   Hartman ME, 2013, PEDIATR CRIT CARE ME, V14, P686, DOI 10.1097/PCC.0b013e3182917fad
   Health Protection Agency, 2006, GUID PUBL HLTH MAN M
   Hernan MA, 2009, AM J EPIDEMIOL, V170, P959, DOI 10.1093/aje/kwp293
   Katznelson JH, 2014, PEDIATR EMERG CARE, V30, P397, DOI 10.1097/PEC.0000000000000146
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Launay E, 2013, ARCH DIS CHILD, DOI 101136
   Launay E, 2010, PEDIATR CRIT CARE ME, V11, P469, DOI 10.1097/PCC.0b013e3181ce752e
   Mant D, 2011, ARCH DIS CHILD, V96, P613, DOI 10.1136/adc.2010.191510
   McIntyre PB, 2005, ARCH DIS CHILD, V90, P391, DOI 10.1136/adc.2003.037523
   Nadel S, 1998, J ACCID EMERG MED, V15, P298
   Ninis N, 2005, BRIT MED J, V330, P1475, DOI 10.1136/bmj.330.7506.1475
   Peterson J. W., 1996, MED MICROBIOLOGY
   Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011
   Slade E, 2003, CRIT CARE, V7, P1, DOI 10.1186/cc1876
   Snijders T., 1999, MULTILEVEL ANAL INTR
   Societe de Reanimation de Langue Francaise Use of catecholamines during septic shock (adults and children), 15 CONS C FRENCH SOC
   Stahl JP, 2013, MED MALADIES INFECT, V43, P75, DOI 10.1016/j.medmal.2013.01.001
   Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be
   Thompson M, 2008, BRIT J GEN PRACT, V58, P236, DOI 10.3399/bjgp08X279689
   Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6
   Varon E, 2012, CTR NATL REFERENCE P
   von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.1016/j.jclinepi.2007.11.008
NR 35
TC 11
Z9 11
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 23
PY 2014
VL 9
IS 9
AR e107286
DI 10.1371/journal.pone.0107286
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AP8TL
UT WOS:000342351800020
PM 25247401
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Adams, EJ
   Goad, M
   Sahlqvist, S
   Bull, FC
   Cooper, AR
   Ogilvie, D
AF Adams, Emma J.
   Goad, Mary
   Sahlqvist, Shannon
   Bull, Fiona C.
   Cooper, Ashley R.
   Ogilvie, David
CA iConnect Consortium
TI Reliability and Validity of the Transport and Physical Activity
   Questionnaire (TPAQ) for Assessing Physical Activity Behaviour
SO PLOS ONE
LA English
DT Article
ID CRITERION-RELATED VALIDITY; SHORT-FORM; WALKING; ADULTS; ACCELEROMETER;
   IPAQ
AB Background: No current validated survey instrument allows a comprehensive assessment of both physical activity and travel behaviours for use in interdisciplinary research on walking and cycling. This study reports on the test-retest reliability and validity of physical activity measures in the transport and physical activity questionnaire (TPAQ).
   Methods: The TPAQ assesses time spent in different domains of physical activity and using different modes of transport for five journey purposes. Test-retest reliability of eight physical activity summary variables was assessed using intra-class correlation coefficients (ICC) and Kappa scores for continuous and categorical variables respectively. In a separate study, the validity of three survey-reported physical activity summary variables was assessed by computing Spearman correlation coefficients using accelerometer-derived reference measures. The Bland-Altman technique was used to determine the absolute validity of survey-reported time spent in moderate-to-vigorous physical activity (MVPA).
   Results: In the reliability study, ICC for time spent in different domains of physical activity ranged from fair to substantial for walking for transport (ICC = 0.59), cycling for transport (ICC = 0.61), walking for recreation (ICC = 0.48), cycling for recreation (ICC = 0.35), moderate leisure-time physical activity (ICC = 0.47), vigorous leisure-time physical activity (ICC = 0.63), and total physical activity (ICC = 0.56). The proportion of participants estimated to meet physical activity guidelines showed acceptable reliability (k = 0.60). In the validity study, comparison of survey-reported and accelerometer-derived time spent in physical activity showed strong agreement for vigorous physical activity (r = 0.72, p<0.001), fair but non-significant agreement for moderate physical activity (r = 0.24, p = 0.09) and fair agreement for MVPA (r = 0.27, p = 0.05). Bland-Altman analysis showed a mean overestimation of MVPA of 87.6 min/week (p = 0.02) (95% limits of agreement -447.1 to +622.3 min/week).
   Conclusion: The TPAQ provides a more comprehensive assessment of physical activity and travel behaviours and may be suitable for wider use. Its physical activity summary measures have comparable reliability and validity to those of similar existing questionnaires.
C1 [Adams, Emma J.; Goad, Mary] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Natl Ctr Phys Act & Hlth, British Heart Fdn, Loughborough, Leics, England.
   [Sahlqvist, Shannon] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res C PAN, Geelong, Vic 3217, Australia.
   [Bull, Fiona C.] Univ Western Australia, Ctr Built Environm & Hlth, Sch Populat Hlth, Perth, WA 6009, Australia.
   [Cooper, Ashley R.] Univ Bristol, Ctr Exercise Nutr & Hlth Sci, Sch Policy Studies, Bristol, Avon, England.
   [Ogilvie, David] Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England.
   [Ogilvie, David] Univ Cambridge, UKCRC Ctr Diet & Act Res CEDAR, Cambridge, England.
RP Adams, EJ (reprint author), Univ Loughborough, Sch Sport Exercise & Hlth Sci, Natl Ctr Phys Act & Hlth, British Heart Fdn, Loughborough, Leics, England.
EM e.j.adams@lboro.ac.uk
RI ; Cooper, Ashley/D-9956-2014
OI Sahlqvist, Shannon/0000-0002-3714-9533; Adams, Emma
   J/0000-0002-5444-6951; Cooper, Ashley/0000-0001-8644-3870; Rutter,
   Harry/0000-0002-9322-0656
FU Engineering and Physical Sciences Research Council [EP/G00059X/1];
   Medical Research Council [MC_UU_12015/6]; Centre for Diet and Activity
   Research (CEDAR); British Heart Foundation; Economic and Social Research
   Council; Medical Research Council; National Institute for Health
   Research; Wellcome Trust; Economic and Social Research Council
   [ES/G007462/1]; Medical Research Council [MR/K023187/1, MC_UP_1001/1]
FX The iConnect consortium is funded by the Engineering and Physical
   Sciences Research Council (grant reference EP/G00059X/1). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript. DO is also supported by the
   Medical Research Council [Unit Programme number MC_UU_12015/6] and the
   Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health
   Research Centre of Excellence that is funded by the British Heart
   Foundation, Economic and Social Research Council, Medical Research
   Council, National Institute for Health Research and the Wellcome Trust.
   The views expressed in this paper are those of the authors and do not
   necessarily reflect those of the study funders, the NIHR, or the
   Department of Health.
CR Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12
   Badland H, 2006, RES Q EXERCISE SPORT, V77, P386
   Bland JM, 2010, INT J NURS STUD, V47, P931, DOI 10.1016/j.ijnurstu.2009.10.001
   Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790
   Census, 2011, 2011 CENS ENGL WAL
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Craig R, 2009, HLTH SURVEY ENGLAND, V1
   de Nazelle A, 2011, ENVIRON INT, V37, P766, DOI 10.1016/j.envint.2011.02.003
   De Vries SI, 2011, MED SCI SPORT EXER, V43, P1994, DOI 10.1249/MSS.0b013e318219d939
   Department of Health, 2011, START ACT STAY ACT R
   Department of Health and Department for Transport, 2010, ACT TRAV STRAT
   Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840
   Forsyth A, 2010, CAMTI102907
   Forsyth A, 2012, TRANSPORT RES REC, P22, DOI 10.3141/2299-03
   Giles-Corti B, 2006, PREV MED, V42, P455, DOI 10.1016/j.ypmed.2006.01.019
   Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898
   Handy SL, 2002, AM J PREV MED, V23, P64, DOI 10.1016/S0749-3797(02)00475-0
   Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103
   Herrmann SD, 2013, MEAS PHYS EDUC EXERC, V17, P221, DOI 10.1080/1091367X.2013.805139
   Krizek KJ, 2009, ENVIRON PLANN B, V36, P725, DOI 10.1068/b34023
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115
   National Institute for Health and Care Excellence, 2012, WALK CYCL LOC MEAS P, V41
   Ogilvie D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000694
   Ogilvie D, 2011, AM J PUBLIC HEALTH, V101, P473, DOI 10.2105/AJPH.2010.198002
   Sahlqvist S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-62
   Slootmaker SM, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-17
   Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3
   van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000
NR 29
TC 18
Z9 18
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 12
PY 2014
VL 9
IS 9
AR e107039
DI 10.1371/journal.pone.0107039
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AP0SM
UT WOS:000341774300038
PM 25215510
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Shin, NY
   Kim, KE
   Park, M
   Kim, YD
   Kim, DJ
   Ahn, SJ
   Heo, JH
   Lee, SK
AF Shin, Na-Young
   Kim, Kyung-eun
   Park, Mina
   Kim, Young Dae
   Kim, Dong Joon
   Ahn, Sung Jun
   Heo, Ji Hoe
   Lee, Seung-Koo
TI Dual-Phase CT Collateral Score: A Predictor of Clinical Outcome in
   Patients with Acute Ischemic Stroke
SO PLOS ONE
LA English
DT Article
ID PERFUSION-COMPUTED-TOMOGRAPHY; ANGIOGRAPHY SOURCE IMAGES; THROMBOLYTIC
   THERAPY; FLOW; CIRCULATION; OCCLUSION; TRIAL; HYPOPERFUSION; INFARCT
AB Background and Purpose: The presence of good collaterals on CT angiography (CTA) is a well-known predictor for favorable outcome in acute ischemic stroke. Recently, multiphase CT has been introduced as a more accurate method in assessing collaterals. The aim of this study was to assess the ability of dual-phase CT to evaluate collateral status and predict clinical outcome.
   Methods: Forty-three patients who underwent both dual-phase CT and transfemoral cerebral angiography (TFCA) for occluded intracranial internal carotid artery (ICA) and/or middle cerebral artery (M1 segment) were recruited from a prospectively collected database. The collateral status on dual-phase CT was graded by using a 4-point scale: grade 0 = no collaterals; 1 = some collaterals with persistence of some defects; 2 = slow but complete collaterals; and 3 = fast and complete collaterals. Univariate and multivariate analysis were performed to define the independent predictors for favorable outcome at 3 months.
   Results: Dual-phase CT collateral status (rho = 0.744) showed higher correlation with TFCA collateral status than CTA collateral status (rho = 0.596) and substantial interobserver agreement (weighted kappa = 0.776). In the univariate analysis, age, history of hypertension, collateral scores on CTA, dual-phase CT, and TFCA, occlusion in intracranial ICA, final infarct volume, and symptomatic hemorrhage were significantly associated with outcome. Among them, only the dual-phase CT collateral score was an independent predictor for favorable outcome (OR = 26.342 (2.788-248.864); P = 0.004) in the multivariate analysis.
   Conclusions: The collateral status on dual-phase CT can be a useful predictor for clinical outcome in acute stroke patients, especially when advanced CT techniques are not available in emergent situations.
C1 [Shin, Na-Young; Kim, Kyung-eun; Park, Mina; Kim, Dong Joon; Ahn, Sung Jun; Lee, Seung-Koo] Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol, Seoul, South Korea.
   [Kim, Young Dae; Heo, Ji Hoe] Yonsei Univ, Coll Med, Severance Hosp, Dept Neurol, Seoul, South Korea.
RP Lee, SK (reprint author), Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol, Seoul, South Korea.
EM slee@yuhs.ac
OI Kim, Young Dae/0000-0001-5750-2616; Kim, Dong Joon/0000-0002-7035-087X;
   Ahn, Sung Jun/0000-0003-0075-2432; Heo, Ji Hoe/0000-0001-9898-3321; Lee,
   Seung-Koo/0000-0001-5646-4072; PARK, MINA/0000-0002-2005-7560
CR ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35
   Bang OY, 2008, NEUROLOGY, V71, P1804, DOI 10.1212/01.wnl.0000335929.06390.d3
   Bang OY, 2011, STROKE, V42, P693, DOI 10.1161/STROKEAHA.110.595256
   Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6
   Calleja AI, 2013, EUR J NEUROL, V20, P795, DOI 10.1111/ene.12063
   Campbell BCV, 2012, ARCH NEUROL-CHICAGO, V69, P46, DOI 10.1001/archneurol.2011.232
   Caplan LR, 1998, ARCH NEUROL-CHICAGO, V55, P1475, DOI 10.1001/archneur.55.11.1475
   Choi JY, 2011, CEREBROVASC DIS, V31, P346, DOI 10.1159/000322602
   Frolich AMJ, 2014, EUR RADIOL, V24, P390, DOI 10.1007/s00330-013-3024-6
   Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9
   Higashida RT, 2003, STROKE, V34, pE109, DOI 10.1161/01.STR.0000082721.62796.09
   Jung SL, 2011, J NEUROIMAGING, V21, P225, DOI 10.1111/j.1552-6569.2010.00496.x
   Kim SJ, 2012, EUR NEUROL, V67, P252, DOI 10.1159/000334867
   Knauth M, 1997, AM J NEURORADIOL, V18, P1001
   Kucinski T, 2003, NEURORADIOLOGY, V45, P11, DOI 10.1007/s00234-002-0881-0
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee KH, 2000, ARCH NEUROL-CHICAGO, V57, P990, DOI 10.1001/archneur.57.7.990
   Lee SJ, 2004, ARCH NEUROL-CHICAGO, V61, P505, DOI 10.1001/archneur.61.4.505
   Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06
   Lima FO, 2010, STROKE, V41, P2316, DOI 10.1161/STROKEAHA.110.592303
   Maas MB, 2009, STROKE, V40, P3001, DOI 10.1161/STROKEAHA.109.552513
   McVerry F, 2012, AM J NEURORADIOL, V33, P576, DOI 10.3174/ajnr.A2794
   Miteff F, 2009, BRAIN, V132, P2231, DOI 10.1093/brain/awp155
   Mortimer AM, 2013, J NEUROINTERV SURG
   Rosenthal ES, 2008, AM J NEURORADIOL, V29, P1471, DOI 10.3174/ajnr.A1153
   Schramm P, 2002, STROKE, V33, P2426, DOI 10.1161/01.STR.0000032244.03134.37
   Soares BP, 2010, STROKE, V41, pE34, DOI 10.1161/STROKEAHA.109.568766
   Tan IYL, 2009, AM J NEURORADIOL, V30, P525, DOI 10.3174/ajnr.A1408
   Tan JC, 2007, ANN NEUROL, V61, P533, DOI 10.1002/ana.21130
   Wildermuth S, 1998, STROKE, V29, P935, DOI 10.1161/01.STR.29.5.935
   Yoo AJ, 2012, J NEUROIMAGING, V22, P329, DOI 10.1111/j.1552-6569.2011.00627.x
NR 31
TC 9
Z9 10
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 11
PY 2014
VL 9
IS 9
AR e107379
DI 10.1371/journal.pone.0107379
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AP1UA
UT WOS:000341855900068
PM 25210853
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Motte, J
   Alten, F
   Ewering, C
   Osada, N
   Kadas, EM
   Brandt, AU
   Oberwahrenbrock, T
   Clemens, CR
   Eter, N
   Paul, F
   Marziniak, M
AF Motte, Jeremias
   Alten, Florian
   Ewering, Carina
   Osada, Nani
   Kadas, Ella M.
   Brandt, Alexander U.
   Oberwahrenbrock, Timm
   Clemens, Christoph R.
   Eter, Nicole
   Paul, Friedemann
   Marziniak, Martin
TI Vessel Labeling in Combined Confocal Scanning Laser Ophthalmoscopy and
   Optical Coherence Tomography Images: Criteria for Blood Vessel
   Discrimination
SO PLOS ONE
LA English
DT Article
ID MULTIPLE-SCLEROSIS; NEURITIS; FILTER; LAYER
AB Introduction: The diagnostic potential of optical coherence tomography (OCT) in neurological diseases is intensively discussed. Besides the sectional view of the retina, modern OCT scanners produce a simultaneous top-view confocal scanning laser ophthalmoscopy (cSLO) image including the option to evaluate retinal vessels. A correct discrimination between arteries and veins (labeling) is vital for detecting vascular differences between healthy subjects and patients. Up to now, criteria for labeling (cSLO) images generated by OCT scanners do not exist.
   Objective: This study reviewed labeling criteria originally developed for color fundus photography (CFP) images.
   Methods: The criteria were modified to reflect the cSLO technique, followed by development of a protocol for labeling blood vessels. These criteria were based on main aspects such as central light reflex, brightness, and vessel thickness, as well as on some additional criteria such as vascular crossing patterns and the context of the vessel tree.
   Results and Conclusion: They demonstrated excellent inter-rater agreement and validity, which seems to indicate that labeling of images might no longer require more than one rater. This algorithm extends the diagnostic possibilities offered by OCT investigations.
C1 [Motte, Jeremias; Ewering, Carina; Marziniak, Martin] Univ Munster, Dept Neurol, Med Ctr, D-48149 Munster, Germany.
   [Alten, Florian; Clemens, Christoph R.; Eter, Nicole] Univ Munster, Dept Ophthalmol, Med Ctr, D-48149 Munster, Germany.
   [Kadas, Ella M.; Brandt, Alexander U.; Oberwahrenbrock, Timm; Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany.
   [Kadas, Ella M.; Brandt, Alexander U.; Oberwahrenbrock, Timm; Paul, Friedemann] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany.
   [Kadas, Ella M.; Brandt, Alexander U.; Oberwahrenbrock, Timm; Paul, Friedemann] Max Delbruck Ctr Mol Med, Berlin, Germany.
   [Paul, Friedemann] Charite, Dept Neurol, D-13353 Berlin, Germany.
   [Marziniak, Martin] Isar Amper Klinikum, Dept Neurol, Haar, Germany.
   [Osada, Nani] Univ Munster, Inst Med Informat, D-48149 Munster, Germany.
RP Marziniak, M (reprint author), Univ Munster, Dept Neurol, Med Ctr, D-48149 Munster, Germany.
EM Martin.Marziniak@kbo.de
OI Motte, Jeremias/0000-0002-6624-8565; paul,
   friedemann/0000-0002-6378-0070
FU Novartis Germany
FX Novartis Germany has funded the OCT scanner (http://www.novartis.de)
   with an unrestricted grant. The funder had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Albrecht P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034891
   Chraastek R, 2002, P IAPR WORKSH MACH V, P240
   Dorr J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018132
   Fleiss J. L., 2004, STAT METHODS RATES P
   Frohman EM, 2008, NAT CLIN PRACT NEURO, V4, P664, DOI 10.1038/ncpneuro0950
   Frost S, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.150
   Gang L, 2002, IEEE T BIO-MED ENG, V49, P168, DOI 10.1109/10.979356
   Green AJ, 2009, J NEUROL NEUROSUR PS, V80, P1002, DOI 10.1136/jnnp.2008.166207
   Greenberg Benjamin M, 2010, Ther Adv Neurol Disord, V3, P153, DOI 10.1177/1756285610368890
   Hoover A, 2000, IEEE T MED IMAGING, V19, P203, DOI 10.1109/42.845178
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   Kondermann C, 2007, P SPIE MED IMAGING
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Narasimha-Iyer H, 2007, IEEE T BIO-MED ENG, V54, P1427, DOI 10.1109/TBME.2007.900804
   Oberwahrenbrock T, 2013, MULT SCLER J, V19, P1887, DOI 10.1177/1352458513489757
   Oberwahrenbrock T, 2012, MULT SCLER INT, DOI 10.1155/2012/530305
   Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X
   Roth NM, 2013, EUR J NEUROL, V20, P1170, DOI 10.1111/ene.12146
   Sachs L, 2004, ANGEW STAT ANWENDUNG
   Siger M, 2008, J NEUROL, V255, P1555, DOI 10.1007/s00415-008-0985-5
   Stricker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023024
   Subei AM, 2009, CURR OPIN OPHTHALMOL, V20, P462, DOI 10.1097/ICU.0b013e3283313d4e
   Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823
   WELSCH U, 2006, SOBOTTA LEHRBUCH HIS
   Zimmermann H, 2013, MULT SCLER J, V19, P443, DOI 10.1177/1352458512457844
NR 25
TC 6
Z9 6
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 9
PY 2014
VL 9
IS 9
AR e102034
DI 10.1371/journal.pone.0102034
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AQ3IF
UT WOS:000342684500001
PM 25203135
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kriesell, HJ
   Elwen, SH
   Nastasi, A
   Gridley, T
AF Kriesell, Hannah Joy
   Elwen, Simon Harvey
   Nastasi, Aurora
   Gridley, Tess
TI Identification and Characteristics of Signature Whistles in Wild
   Bottlenose Dolphins (Tursiops truncatus) from Namibia
SO PLOS ONE
LA English
DT Article
ID STEREOTYPED CALLS; AFRICAN ELEPHANTS; VOCAL RECOGNITION; CAPTIVE
   DOLPHINS; KILLER WHALES; BEHAVIOR; COMMUNICATION; FREQUENCY; SOUNDS;
   CATEGORIZATION
AB A signature whistle type is a learned, individually distinctive whistle type in a dolphin's acoustic repertoire that broadcasts the identity of the whistle owner. The acquisition and use of signature whistles indicates complex cognitive functioning that requires wider investigation in wild dolphin populations. Here we identify signature whistle types from a population of approximately 100 wild common bottlenose dolphins (Tursiops truncatus) inhabiting Walvis Bay, and describe signature whistle occurrence, acoustic parameters and temporal production. A catalogue of 43 repeatedly emitted whistle types (REWTs) was generated by analysing 79 hrs of acoustic recordings. From this, 28 signature whistle types were identified using a method based on the temporal patterns in whistle sequences. A visual classification task conducted by 5 naive judges showed high levels of agreement in classification of whistles (Fleiss-Kappa statistic, kappa = 0.848, Z = 55.3, P<0.001) and supported our categorisation. Signature whistle structure remained stable over time and location, with most types (82%) recorded in 2 or more years, and 4 identified at Walvis Bay and a second field site approximately 450 km away. Whistle acoustic parameters were consistent with those of signature whistles documented in Sarasota Bay (Florida, USA). We provide evidence of possible two-voice signature whistle production by a common bottlenose dolphin. Although signature whistle types have potential use as a marker for studying individual habitat use, we only identified approximately 28% of those from the Walvis Bay population, despite considerable recording effort. We found that signature whistle type diversity was higher in larger dolphin groups and groups with calves present. This is the first study describing signature whistles in a wild free-ranging T. truncatus population inhabiting African waters and it provides a baseline on which more in depth behavioural studies can be based.
C1 [Kriesell, Hannah Joy] Univ Gottingen, Dept Conservat Biol, D-37073 Gottingen, Germany.
   [Elwen, Simon Harvey; Gridley, Tess] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Hatfield, Gauteng, South Africa.
   [Kriesell, Hannah Joy; Elwen, Simon Harvey; Nastasi, Aurora; Gridley, Tess] Namibian Dolphin Project, Walvis Bay, Namibia.
   [Nastasi, Aurora] Univ Roma La Sapienza, Dipartimento Sci Terra, I-00185 Rome, Italy.
RP Gridley, T (reprint author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Hatfield, Gauteng, South Africa.
EM tessgridley@yahoo.co.uk
OI Gridley, Teresa/0000-0003-0925-5782
FU Nedbank Go Green Fund of Namibia; Rufford Small Grants Foundation; Idea
   Wild Fund; Natural Environment Research Council; University of Pretoria;
   Sapienza University of Rome; Claude Leon Foundation
FX This study was funded by Nedbank Go Green Fund of Namibia
   (www.nedbank.com.na/hdetail.aspx?itemguid =
   833f4cd9-323f-497d-ad1f-9f641b9dfd73), Rufford Small Grants Foundation
   (www.rufford.org), Idea Wild Fund (www.ideawild.org), Natural
   Environment Research Council (www.nerc.ac.uk), University of Pretoria
   (www.up.ac.za), Sapienza University of Rome (www.uniroma1.it), and
   Claude Leon Foundation (www.leonfoundation.co.za). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534
   Aubin T, 2000, P ROY SOC B-BIOL SCI, V267, P1081, DOI 10.1098/rspb.2000.1112
   Badyaev AV, 1997, AUK, V114, P40, DOI 10.2307/4089063
   BAHRICK HP, 1975, J EXP PSYCHOL GEN, V104, P54, DOI 10.1037/0096-3445.104.1.54
   BEST PB, 2007, COMMON BOTTLENOSE DO, P338
   Boughman JW, 2003, SPR HDB AUD, V16, P138
   BRUCK JN, 2013, PROCEEDINGS OF THE R, P280
   Buckstaff KC, 2004, MAR MAMMAL SCI, V20, P709, DOI 10.1111/j.1748-7692.2004.tb01189.x
   Caldwell M. C., 1979, BEHAVIOUR OF MARINE, P369
   Caldwell MC, 1990, THE BOTTLENOSE DOLPH, P199
   Cheney DL, 1996, ANIM BEHAV, V52, P507, DOI 10.1006/anbe.1996.0193
   Chmelnitsky EG, 2012, J ACOUST SOC AM, V131, P4821, DOI 10.1121/1.4707501
   Cook MLH, 2004, P ROY SOC B-BIOL SCI, V271, P1043, DOI 10.1098/rspb.2003.2610
   *CORN BIOAC RES PR, 2011, RAVEN PRO INTERACTIV
   Cortopassi KA, 2006, ANIM BEHAV, V71, P1141, DOI 10.1016/j.anbehav.2005.09.011
   Cranford TW, 1996, J MORPHOL, V228, P223
   CRAWLEY M. J., 2007, R BOOK
   Deecke VB, 2006, J ACOUST SOC AM, V119, P645, DOI 10.1121/1.2139067
   Esch HC, 2009, MAR MAMMAL SCI, V25, P976, DOI 10.1111/j.1748-7692.2009.00289.x
   Esch HC, 2009, J MAMMAL, V90, P638, DOI 10.1644/08-MAMM-A-069R.1
   FINDLAY KP, 1992, S AFR J MARINE SCI, V12, P237
   Fripp D, 2005, ANIM COGN, V8, P17, DOI 10.1007/s10071-004-0225-z
   Gotz T, 2006, BIOL LETTERS, V2, P5, DOI 10.1098/rsbl.2005.0407
   Gridley T, 2011, THESIS
   Gridley T, 2014, MAR MAMMAL SCI, V30, P512, DOI 10.1111/mms.12054
   Gridley T, 2012, J ACOUST SOC AM, V132, P4032, DOI 10.1121/1.4763990
   Harley HE, 2008, BEHAV PROCESS, V77, P243, DOI 10.1016/j.beproc.2007.11.002
   Hawkins ER, 2010, J ACOUST SOC AM, V127, P2652, DOI 10.1121/1.3308465
   Hernandez EN, 2010, J ACOUST SOC AM, V127, P3232, DOI 10.1121/1.3365254
   Illmann G, 2002, BEHAVIOUR, V139, P487, DOI 10.1163/15685390260135970
   Janik VM, 2006, P NATL ACAD SCI USA, V103, P8293, DOI 10.1073/pnas.0509918103
   Janik VM, 2013, J COMP PHYSIOL A, V199, P479, DOI 10.1007/s00359-013-0817-7
   Janik VM, 2013, TRENDS COGN SCI, V17, P157, DOI 10.1016/j.tics.2013.02.005
   Janik VM, 2013, MAR MAMMAL SCI, V29, P109, DOI 10.1111/j.1748-7692.2011.00549.x
   Janik VM, 2009, ADV STUD BEHAV, V40, P123, DOI 10.1016/S0065-3454(09)40004-4
   Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0
   JANIK VM, 1994, BEHAV ECOL SOCIOBIOL, V35, P243, DOI 10.1007/s002650050094
   Janik VM, 2000, SCIENCE, V289, P1355, DOI 10.1126/science.289.5483.1355
   Janik VM, 1999, ANIM BEHAV, V57, P133, DOI 10.1006/anbe.1998.0923
   Janik VM, 1998, ANIM BEHAV, V56, P829, DOI 10.1006/anbe.1998.0881
   Jensen FH, 2011, P ROY SOC B-BIOL SCI, V278, P3017, DOI 10.1098/rspb.2010.2604
   Jones AE, 2001, ANIM BEHAV, V62, P791, DOI 10.1006/anbe.2001.1810
   Jones GJ, 2002, MAR MAMMAL SCI, V18, P374, DOI 10.1111/j.1748-7692.2002.tb01044.x
   King SL, 2013, PROCEEDINGS OF THE R, V280
   King SL, 2013, P NATL ACAD SCI USA, V110, P13216, DOI 10.1073/pnas.1304459110
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lengagne T, 1999, P ROY SOC B-BIOL SCI, V266, P1623, DOI 10.1098/rspb.1999.0824
   LILLY JC, 1961, SCIENCE, V133, P1689, DOI 10.1126/science.133.3465.1689
   LOPEZ DB, 2011, MAMMALIAN BIOLOGY, V76, P180
   Madsen PT, 2013, J EXP BIOL, V216, P4091, DOI 10.1242/jeb.091306
   MADSEN PT, 2011, BIOLOGY LETTERS, V8, P211
   Mathevon N, 1997, IBIS, V139, P513, DOI 10.1111/j.1474-919X.1997.tb04667.x
   May-Collado LJ, 2008, J MAMMAL, V89, P1229, DOI 10.1644/07-MAMM-A-310.1
   McComb K, 2000, ANIM BEHAV, V59, P1103, DOI 10.1006/anbe.2000.1406
   Miksis JL, 2002, J ACOUST SOC AM, V112, P728, DOI 10.1121/1.1496079
   Miller PJO, 2007, J ACOUST SOC AM, V121, P3932, DOI 10.1121/1.2722056
   Miller PJO, 2002, BEHAV ECOL SOCIOBIOL, V52, P262, DOI 10.1007/s00265-002-0508-9
   MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971
   Naguib M, 2003, J ACOUST SOC AM, V113, P1749, DOI 10.1121/1.1539050
   NAKAHARA F, 2011, JOURNAL OF ETHOLOGY
   Nousek AE, 2006, BIOL LETT-UK, V2, P481, DOI 10.1098/rsbl.2006.0517
   POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975
   Quick NJ, 2008, J COMP PSYCHOL, V122, P305, DOI 10.1037/0735-7036.122.3.305
   Quick NJ, 2012, P ROY SOC B-BIOL SCI, V279, P2539, DOI 10.1098/rspb.2011.2537
   R Core Team, 2013, R LANG ENV STAT COMP
   Robertson T, 2012, NAMIBIAS COAST OCEAN
   Sayigh LS, 2007, ANIM BEHAV, V74, P1631, DOI 10.1016/j.anbehav.2007.02.018
   SAYIGH LS, 1995, BEHAV ECOL SOCIOBIOL, V36, P171, DOI 10.1007/s002650050137
   SAYIGH LS, 1990, BEHAV ECOL SOCIOBIOL, V26, P247
   Siegel S., 1988, NONPARAMETRIC STATIS
   Simard P, 2011, J ACOUST SOC AM, V130, P3068, DOI 10.1121/1.3641442
   Smolker R, 1999, ETHOLOGY, V105, P595, DOI 10.1046/j.1439-0310.1999.00441.x
   SMOLKER RA, 1993, BEHAV ECOL SOCIOBIOL, V33, P393
   TERRY AMR, 2005, FRONTIERS IN ZOOLOGY, V2
   TYACK P, 1986, BEHAV ECOL SOCIOBIOL, V18, P251, DOI 10.1007/BF00300001
   van der Woude SE, 2009, J ACOUST SOC AM, V126, P1552, DOI 10.1121/1.3177272
   WANG W, 1995, AQUAT MAMM, V21, P65
   Wanker R, 1998, BEHAV ECOL SOCIOBIOL, V43, P197, DOI 10.1007/s002650050481
   Watwood SL, 2005, ANIM BEHAV, V69, P1373, DOI 10.1016/j.anbehav.2004.08.019
   Watwood SL, 2004, BEHAV ECOL SOCIOBIOL, V55, P531, DOI 10.1007/s00265-003-0724-y
   Wood SN, 2006, GENERALIZED ADDITIVE
   Xitco MJ, 1996, ANIM LEARN BEHAV, V24, P355, DOI 10.3758/BF03199007
NR 82
TC 18
Z9 18
U1 0
U2 68
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 9
PY 2014
VL 9
IS 9
AR UNSP e106317
DI 10.1371/journal.pone.0106317
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AQ3IF
UT WOS:000342684500017
PM 25203814
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Oberoi, S
   Zamperlini-Netto, G
   Beyene, J
   Treister, NS
   Sung, L
AF Oberoi, Sapna
   Zamperlini-Netto, Gabriele
   Beyene, Joseph
   Treister, Nathaniel S.
   Sung, Lillian
TI Effect of Prophylactic Low Level Laser Therapy on Oral Mucositis: A
   Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID NECK-CANCER-PATIENTS; BONE-MARROW-TRANSPLANTATION; BEAM-CONDITIONING
   CHEMOTHERAPY; RADIATION-INDUCED MUCOSITIS; HIGH-DOSE MELPHALAN;
   HELIUM-NEON LASER; LOW-POWER LASER; CONCURRENT CHEMORADIOTHERAPY;
   ASSESSMENT SCALE; CLINICAL-TRIAL
AB Background: Objective was to determine whether prophylactic low level laser therapy (LLLT) reduces the risk of severe mucositis as compared to placebo or no therapy.
   Methods: MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials were searched until February 2014 for randomized controlled trials (RCTs) comparing prophylactic LLLT with placebo or no therapy in patients with cancer or undergoing hematopoietic stem cell transplantation (HSCT). All analyses used random effects models.
   Results: Eighteen RCTs (1144 patients) were included. Prophylactic LLLT reduced the overall risk of severe mucositis (risk ratio (RR) 0.37, 95% confidence interval (CI) 0.20 to 0.67; P = 0.001). LLLT also reduced the following outcomes when compared to placebo/no therapy: severe mucositis at the time of anticipated maximal mucositis (RR 0.34, 95% CI 0.20 to 0.59), overall mean grade of mucositis (standardized mean difference -1.49, 95% CI -2.02 to -0.95), duration of severe mucositis (weighted mean difference -5.32, 95% CI -9.45 to -1.19) and incidence of severe pain (RR 0.26, 95% CI 0.18 to 0.37).
   Conclusion: Prophylactic LLLT reduced severe mucositis and pain in patients with cancer and HSCT recipients. Future research should identify the optimal characteristics of LLLT and determine feasibility in the clinical setting.
C1 [Oberoi, Sapna; Zamperlini-Netto, Gabriele; Sung, Lillian] Hosp Sick Children, Div Haematol Oncol, Toronto, ON M5G 1X8, Canada.
   [Beyene, Joseph; Sung, Lillian] Hosp Sick Children, Program Child Hlth Evaluat Sci, Peter Gilgan Ctr Res & Learning, Toronto, ON M5G 1X8, Canada.
   [Beyene, Joseph] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.
   [Treister, Nathaniel S.] Brigham & Womens Hosp, Div Oral Med & Dent, Boston, MA 02115 USA.
RP Sung, L (reprint author), Hosp Sick Children, Div Haematol Oncol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
EM lillian.sung@sickkids.ca
CR Antunes HS, 2013, RADIOTHER ONCOL, V109, P297, DOI 10.1016/j.radonc.2013.08.010
   Antunes HS, 2007, BLOOD, V109, P2250, DOI 10.1182/blood-2006-07-035022
   Antunes HS, 2013, SUPPORT CARE CANCER, V21, pS199
   Arbabi-Kalati Farshid, 2013, Acta Med Iran, V51, P157
   Bensadoun RJ, 1999, SUPPORT CARE CANCER, V7, P244, DOI 10.1007/s005200050256
   Bensadoun RJ, 2002, J ORAL LASER APPL, P115
   Bjordal JM, 2011, SUPPORT CARE CANCER, V19, P1069, DOI 10.1007/s00520-011-1202-0
   Blijlevens N, 2008, J CLIN ONCOL, V26, P1519, DOI 10.1200/JCO.2007.13.6028
   Bowen JM, 2013, SUPPORT CARE CANCER, V21, P303, DOI 10.1007/s00520-012-1592-7
   Chor A, 2010, EUR J HAEMATOL, V84, P178, DOI 10.1111/j.1600-0609.2009.01336.x
   Collins JJ, 2002, J PAIN SYMPTOM MANAG, V23, P10, DOI 10.1016/S0885-3924(01)00375-X
   Collins JJ, 2000, J PAIN SYMPTOM MANAG, V19, P363, DOI 10.1016/S0885-3924(00)00127-5
   Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5
   Cowen D, 1997, INT J RADIAT ONCOL, V38, P697, DOI 10.1016/S0360-3016(97)00076-X
   COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C
   Cruz LB, 2007, PEDIATR BLOOD CANCER, V48, P435, DOI 10.1002/pbc.20943
   de Lima AG, 2012, INT J RADIAT ONCOL, V82, P270, DOI 10.1016/j.ijrobp.2010.10.012
   Elting LS, 2003, CANCER, V98, P1531, DOI 10.1002/cncr.11671
   Enwemeka CS, 2006, PHOTOMED LASER SURG, V24, P457, DOI 10.1089/pho.2006.24.457
   ENWEMEKA CS, 2001, LASER THER, V13, P95
   Epstein JB, 2007, CANCER-AM CANCER SOC, V109, P1914, DOI 10.1002/cncr.22620
   Gautam AP, 2013, SUPPORT CARE CANCER, V21, P1421, DOI 10.1007/s00520-012-1684-4
   Gautam AP, 2012, RADIOTHER ONCOL, V104, P349, DOI 10.1016/j.radonc.2012.06.011
   Gautam AP, 2012, ORAL ONCOL, V48, P893, DOI 10.1016/j.oraloncology.2012.03.008
   Henry DH, 2008, SUPPORT CARE CANCER, V16, P791, DOI 10.1007/s00520-007-0380-2
   Higginson IJ, 2004, FATIGUE CANC, pxvii
   Hode L, 2005, PHOTOMED LASER SURG, V23, P431, DOI 10.1089/pho.2005.23.431
   Hodgson BD, 2012, SUPPORT CARE CANCER, V20, P1405, DOI 10.1007/s00520-011-1223-8
   Khouri Vivian Youssef, 2009, Braz. Dent. J., V20, P215, DOI 10.1590/S0103-64402009000300008
   Lalla RV, 2014, CANCER
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Silva GBL, 2011, PHOTOMED LASER SURG, V29, P27, DOI 10.1089/pho.2009.2699
   Lopes Carlos de Oliveira, 2006, Radiol Bras, V39, P131, DOI 10.1590/S0100-39842006000200012
   Maiya GA, 2006, INDIAN J MED RES, V124, P399
   McCann S, 2009, BONE MARROW TRANSPL, V43, P141, DOI 10.1038/bmt.2008.299
   Migliorati C, 2013, SUPPORT CARE CANCER, V21, P333, DOI 10.1007/s00520-012-1605-6
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Oton-Leite AF, 2013, SPEC CARE DENT, V33, P294, DOI 10.1111/j.1754-4505.2012.00303.x
   Oton-Leite AF, 2012, HEAD NECK-J SCI SPEC, V34, P398, DOI 10.1002/hed.21737
   Peterman A, 2001, J Natl Cancer Inst Monogr, P45
   Pires-Santos GM, 2012, MED ORAL PATOL ORAL, V17, pS252
   Schubert MM, 2007, SUPPORT CARE CANCER, V15, P1145, DOI 10.1007/s00520-007-0238-7
   SCHUBERT MM, 1992, CANCER, V69, P2469, DOI 10.1002/1097-0142(19920515)69:10<2469::AID-CNCR2820691015>3.0.CO;2-W
   SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408
   Sonis ST, 2004, CANCER-AM CANCER SOC, V100, P1995, DOI 10.1002/cncr.20162
   Sonis ST, 1999, CANCER-AM CANCER SOC, V85, P2103, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0
   Stolik S, 2000, J PHOTOCH PHOTOBIO B, V57, P90, DOI 10.1016/S1011-1344(00)00082-8
   Tardieu C, 1996, ORAL ONCOL, V32B, P381, DOI 10.1016/S0964-1955(96)00026-7
   Trotti A, 2003, RADIOTHER ONCOL, V66, P253, DOI 10.1016/S0167-8140(02)00404-8
   Vera-Llonch M, 2006, CANCER-AM CANCER SOC, V106, P329, DOI 10.1002/cncr.21622
   Vera-Llonch M, 2007, SUPPORT CARE CANCER, V15, P491, DOI 10.1007/s00520-006-0176-9
   Vogelzang NJ, 1997, SEMIN HEMATOL, V34, P4
   WOO SB, 1993, CANCER, V72, P1612, DOI 10.1002/1097-0142(19930901)72:5<1612::AID-CNCR2820720520>3.0.CO;2-Q
   World Health Organization, 1979, WHO PUBL, V48
   Worthington HV, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000978.pub5
NR 55
TC 49
Z9 52
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 8
PY 2014
VL 9
IS 9
AR e107418
DI 10.1371/journal.pone.0107418
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AO4JX
UT WOS:000341304700110
PM 25198431
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ramirez-Castrillon, M
   Mendes, SDC
   Inostroza-Ponta, M
   Valente, P
AF Ramirez-Castrillon, Mauricio
   Camargo Mendes, Sandra Denise
   Inostroza-Ponta, Mario
   Valente, Patricia
TI (GTG)(5) MSP-PCR Fingerprinting as a Technique for Discrimination of
   Wine Associated Yeasts?
SO PLOS ONE
LA English
DT Article
ID SP NOV.; SACCHAROMYCES-CEREVISIAE; SENSU-STRICTO; DNA; DIVERSITY;
   DIFFERENTIATION; IDENTIFICATION; STRAINS; REPRODUCIBILITY; FERMENTATIONS
AB In microbiology, identification of all isolates by sequencing is still unfeasible in small research laboratories. Therefore, many yeast diversity studies follow a screening procedure consisting of clustering the yeast isolates using MSP-PCR fingerprinting, followed by identification of one or a few selected representatives of each cluster by sequencing. Although this procedure has been widely applied in the literature, it has not been properly validated. We evaluated a standardized protocol using MSP-PCR fingerprinting with the primers (GTG)(5) and M13 for the discrimination of wine associated yeasts in South Brazil. Two datasets were used: yeasts isolated from bottled wines and vineyard environments. We compared the discriminatory power of both primers in a subset of 16 strains, choosing the primer (GTG)(5) for further evaluation. Afterwards, we applied this technique to 245 strains, and compared the results with the identification obtained by partial sequencing of the LSU rRNA gene, considered as the gold standard. An array matrix was constructed for each dataset and used as input for clustering with two methods (hierarchical dendrograms and QAPGrid layout). For both yeast datasets, unrelated species were clustered in the same group. The sensitivity score of (GTG)(5) MSP-PCR fingerprinting was high, but specificity was low. As a conclusion, the yeast diversity inferred in several previous studies may have been underestimated and some isolates were probably misidentified due to the compliance to this screening procedure.
C1 [Ramirez-Castrillon, Mauricio; Camargo Mendes, Sandra Denise] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil.
   [Ramirez-Castrillon, Mauricio; Camargo Mendes, Sandra Denise; Valente, Patricia] Univ Fed Rio Grande do Sul, ICBS, Dept Microbiol Imunol & Parasitol, Porto Alegre, RS, Brazil.
   [Camargo Mendes, Sandra Denise] Empresa Pesquisa Agr & Extensao Rural Santa Catar, Lab Anal Vinhos & Derivados, Estacao Expt Videira, Videira, Brazil.
   [Inostroza-Ponta, Mario] Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile.
RP Valente, P (reprint author), Univ Fed Rio Grande do Sul, ICBS, Dept Microbiol Imunol & Parasitol, Rua Sarmento Leite, Porto Alegre, RS, Brazil.
EM patricia.valente@ufrgs.br
RI Valente, Patricia/H-4773-2018; Castrillon, Mauricio Ramirez/G-6516-2012
OI Valente, Patricia/0000-0001-5374-0991; Castrillon, Mauricio
   Ramirez/0000-0001-8525-5341; Inostroza-Ponta, Mario/0000-0003-1295-8972
FU CNPq; CAPES; EMBRAPA; Cantina Santa Augusta; FONDECYT; COLCIENCIAS
FX This work was supported by CNPq, CAPES, EMBRAPA, Cantina Santa Augusta,
   FONDECYT "Iniciacion11121288'' and COLCIENCIAS. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Andrade MJ, 2006, INT J FOOD MICROBIOL, V107, P48, DOI 10.1016/j.ijfoodmicro.2005.08.011
   Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI 10.1038/nrmicro1523
   Barquet M, 2012, APPL MICROBIOL BIOT, V93, P807, DOI 10.1007/s00253-011-3714-4
   Basilio ACM, 2008, FOOD MICROBIOL, V27, P205
   dos Santos SKB, 2007, WORLD J MICROB BIOT, V23, P1613, DOI 10.1007/s11274-007-9407-6
   Capece A, 2003, INT J FOOD MICROBIOL, V84, P33, DOI 10.1016/S0168-1605(02)00392-6
   Caruso M, 2002, LETT APPL MICROBIOL, V34, P323, DOI 10.1046/j.1472-765X.2002.01090.x
   Chang CF, 2012, INT J FOOD MICROBIOL, V153, P10, DOI 10.1016/j.ijfoodmicro.2011.09.012
   Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111
   Couto MMB, 1996, APPL ENVIRON MICROB, V62, P41
   da Silva EA, 2005, ANTON LEEUW INT J G, V88, P13, DOI 10.1007/s10482-004-7283-8
   Dellaglio F, 2003, ANN MICROBIOL, V53, P411
   Fernandez NV, 2012, FEMS MICROBIOL ECOL, V80, P179, DOI 10.1111/j.1574-6941.2011.01287.x
   Gadanho M, 2002, FEMS YEAST RES, V2, P47, DOI 10.1016/S1567-1356(01)00062-9
   Garcia-Hernandez Y, 2012, RES VET SCI, V93, P798, DOI 10.1016/j.rvsc.2011.09.005
   GAVIRIA V. JACKELINE, 2012, Rev.Bio.Agro, V10, P160
   Greppi A, 2013, INT J FOOD MICROBIOL, V165, P200, DOI 10.1016/j.ijfoodmicro.2013.05.004
   Greppi A, 2013, INT J FOOD MICROBIOL, V165, P84, DOI 10.1016/j.ijfoodmicro.2013.05.005
   Guamn-Burneo Cristina, 2009, Univ. Sci., V14, P187
   Hui FL, 2013, ANTON LEEUW INT J G, V103, P47, DOI 10.1007/s10482-012-9785-0
   HUNTER PR, 1990, J CLIN MICROBIOL, V28, P1903
   HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465
   Inostroza-Ponta M, 2007, LECT NOTES ARTIF INT, V4828, P156
   Inostroza-Ponta M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014468
   Kurtzman CP, 2014, INT J SYST EVOL MICR, V64, P325, DOI 10.1099/ijs.0.054197-0
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liberal ATD, 2007, J APPL MICROBIOL, V102, P538, DOI 10.1111/j.1365-2672.2006.03082.x
   Libkind D., 2007, Rev. argent. microbiol., V39, P133
   Libkind D, 2007, APPL ENVIRON MICROB, V73, P1120, DOI 10.1128/AEM.01432-06
   LIECKFELDT E, 1993, J BASIC MICROB, V33, P413, DOI 10.1002/jobm.3620330609
   Loureiro V, 2000, FOOD RES INT, V33, P247, DOI 10.1016/S0963-9969(00)00044-2
   Magalhaes-Guedes K. T., 2013, African Journal of Microbiology Research, V7, P1121, DOI 10.5897/AJMR12.1974
   Maqueda M, 2010, FOOD MICROBIOL, V27, P205, DOI 10.1016/j.fm.2009.10.004
   Matsheka MI, 2006, LETT APPL MICROBIOL, V42, P600, DOI 10.1111/j.1472-765X.2006.01900.x
   MEYER W, 1993, J CLIN MICROBIOL, V31, P2274
   Miguel MGCP, 2013, BRAZ J MICROBIOL, V44, P113, DOI 10.1590/S1517-83822013005000005
   Naumov GI, 2009, MICROBIOLOGY+, V78, P214, DOI 10.1134/S002626170902012X
   Naumova ES, 2003, FEMS YEAST RES, V1531, P1
   ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225
   Orlic S, 2010, WORLD J MICROB BIOT, V26, P1483, DOI 10.1007/s11274-010-0323-9
   Osorio Cadavid Esteban, 2009, Rev. colomb. biotecnol, V11, P125
   Papalexandratou Z, 2013, FOOD MICROBIOL, V35, P73, DOI 10.1016/j.fm.2013.02.015
   Pedersen LL, 2012, INT J FOOD MICROBIOL, V159, P144, DOI 10.1016/j.ijfoodmicro.2012.08.016
   Quan H, 1996, BIOMETRICS, V52, P1195, DOI 10.2307/2532835
   Ramos JP, 2001, LETT APPL MICROBIOL, V33, P206, DOI 10.1046/j.1472-765X.2001.00981.x
   Riveros C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014176
   Rodrigues MG, 2003, INT J SYST EVOL MICR, V53, P607, DOI 10.1099/ijs.0.02437-0
   Ryberg A, 2011, J MICROBIOL METH, V84, P183, DOI 10.1016/j.mimet.2010.11.019
   Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109
   Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014
   Solieri L, 2013, FEMS YEAST RES, V13, P245, DOI 10.1111/1567-1364.12027
   Solieri L, 2013, INT J SYST EVOL MICR, V63, P364, DOI 10.1099/ijs.0.043323-0
   Suh SO, 2013, INT J SYST EVOL MICR, V63, P1922, DOI 10.1099/ijs.0.048058-0
   Taylor JD, 2010, J VET DIAGN INVEST, V22, P366, DOI 10.1177/104063871002200304
   Torriani S, 1999, ANTON LEEUW INT J G, V75, P207, DOI 10.1023/A:1001773916407
   Turchetti B, 2013, FEMS MICROBIOL ECOL, V86, P327, DOI 10.1111/1574-6941.12164
   Urzi C, 1999, J MICROBIOL METH, V36, P95, DOI 10.1016/S0167-7012(99)00014-7
   Valente P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046060
   Weiss S, 2013, FEMS YEAST RES, V13, P117, DOI 10.1111/1567-1364.12017
   White T. J, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1
   Yurkov AM, 2012, FUNGAL ECOL, V5, P24, DOI 10.1016/j.funeco.2011.07.004
NR 61
TC 13
Z9 14
U1 1
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 29
PY 2014
VL 9
IS 8
AR e105870
DI 10.1371/journal.pone.0105870
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AO2EE
UT WOS:000341127500077
PM 25171185
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hirata, K
   Kobayashi, K
   Wong, KP
   Manabe, O
   Surmak, A
   Tamaki, N
   Huang, SC
AF Hirata, Kenji
   Kobayashi, Kentaro
   Wong, Koon-Pong
   Manabe, Osamu
   Surmak, Andrew
   Tamaki, Nagara
   Huang, Sung-Cheng
TI A Semi-Automated Technique Determining the Liver Standardized Uptake
   Value Reference for Tumor Delineation in FDG PET-CT
SO PLOS ONE
LA English
DT Article
ID TOTAL LESION GLYCOLYSIS; SQUAMOUS-CELL CARCINOMA; F-18-FDG PET/CT;
   RESPONSE EVALUATION; NEOADJUVANT CHEMOTHERAPY; PROGNOSTIC VALUE; SOLID
   TUMORS; LUNG-CANCER; PERCIST; VOLUME
AB Background: F-18-fluorodeoxyglucose (FDG) positron emission tomography (PET)-computed tomography (CT) has been an essential modality in oncology. We propose a semi-automated algorithm to objectively determine liver standardized uptake value (SUV), which is used as a threshold for tumor delineation.
   Methods: A large spherical volume of interest (VOI) was placed manually to roughly enclose the right lobe (RL) of the liver. For each voxel in this VOI, a coefficient of variation of voxel values (CVv) was calculated for neighboring voxels within a radius of d/2. The voxel with the minimum CVv was then selected, where a 30-mm spherical VOI was placed at that voxel in accordance with PERCIST criteria. Two nuclear medicine physicians independently defined 30-mm VOIs manually on 124 studies in 62 patients to generate the standard values, against which the results from the new method were compared.
   Results: The semi-automated method was successful in determining the liver SUV that was consistent between the two physicians in all the studies (d = 80 mm). The liver SUV threshold (mean +3 SD within 30-mm VOI) determined by the new semi-automated method (3.12 +/- 0.61) was not statistically different from those determined by the manual method (Physician-1: 3.14 +/- 0.58, Physician-2: 3.15 +/- 0.58). The semi-automated method produced tumor volumes that were not statistically different from those by experts' manual operation. Furthermore, the volume change in the two sequential studies had no statistical difference between semi-automated and manual methods.
   Conclusions: Our semi-automated method could define the liver SUV robustly as the threshold value used for tumor volume measurements according to PERCIST. The method could avoid possible subjective bias of manual liver VOI placement and is thus expected to improve clinical performance of volume-based parameters for prediction of cancer treatment response.
C1 [Hirata, Kenji; Wong, Koon-Pong; Surmak, Andrew; Huang, Sung-Cheng] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
   [Kobayashi, Kentaro; Manabe, Osamu; Tamaki, Nagara] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Sapporo, Hokkaido, Japan.
RP Hirata, K (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
EM kenjihirata@ucla.edu
OI Wong, Koon-Pong/0000-0002-6095-4645
FU National Institutes of Health (NIH) [R01-AG033015, P50-CA086306,
   P01-N5058489]; SNMMI Wagner-Torizuka Fellowship; Hokkaido University
   HIROKO's Fund for Academic Exchange
FX This work was supported in part by the National Institutes of Health
   (NIH) grants R01-AG033015, P50-CA086306, P01-N5058489, by SNMMI
   Wagner-Torizuka Fellowship 2013/2015 (to Kenji Hirata), and by Hokkaido
   University HIROKO's Fund for Academic Exchange 2012 (to Kenji Hirata).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Bauer C, 2012, MED PHYS, V39, P3112, DOI 10.1118/1.4711815
   Bazan JG, 2013, J NUCL MED, V54, P27, DOI 10.2967/jnumed.112.109470
   Ben-Haim S, 2009, J NUCL MED, V50, P88, DOI 10.2967/jnumed.108.054205
   Bi L, 2012, IEEE ENG MED BIO, P5335, DOI 10.1109/EMBC.2012.6347199
   Byun BH, 2013, J NUCL MED, V54, P1725, DOI 10.2967/jnumed.112.117697
   Chen HHW, 2012, RADIOLOGY, V264, P559, DOI 10.1148/radiol.12111148
   Davison A C, 1997, BOOTSTRAP METHODS TH
   Falissard B, 2012, PSY VARIOUS PROCEDUR
   Fencl P, 2012, NUCL MED COMMUN, V33, P1188, DOI 10.1097/MNM.0b013e3283573d0d
   Gilbert J, 2012, CLIN CANCER RES, V18, P1735, DOI 10.1158/1078-0432.CCR-11-2544
   HOLM S, 1979, SCAND J STAT, V6, P65
   Israel O, 2007, J NUCL MED, V48, p28S
   Jhanwar YS, 2006, J NUCL MED, V47, P1326
   Kao CH, 2012, EUR J NUCL MED MOL I, V39, P1297, DOI 10.1007/s00259-012-2127-7
   Kidd EA, 2013, INT J RADIAT ONCOL, V85, P116, DOI 10.1016/j.ijrobp.2012.02.056
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liao SS, 2013, CLIN NUCL MED, V38, P715, DOI 10.1097/RLU.0b013e31829f57fa
   Liao SR, 2012, EUR J NUCL MED MOL I, V39, P27, DOI 10.1007/s00259-011-1934-6
   Mhlanga JC, 2014, EUR J NUCL MED MOL I, V41, P596, DOI 10.1007/s00259-013-2671-9
   Panin VY, 2006, IEEE T MED IMAGING, V25, P907, DOI 10.1109/TMI.2006.876171
   Ryu IS, 2013, J NUCL MED, V54, P1032, DOI 10.2967/jnumed.112.116053
   Skougaard K, 2013, J NUCL MED, V54, P1026, DOI 10.2967/jnumed.112.111757
   Tateishi U, 2012, RADIOLOGY, V263, P53, DOI 10.1148/radiol.12111177
   Thacker CA, 2012, CANCER MED-US, V1, P230, DOI 10.1002/cam4.33
   Usmanij EA, 2013, J NUCL MED, V54, P1528, DOI 10.2967/jnumed.112.116921
   Viner M, 2013, RADIOLOGY, V267, P596, DOI 10.1148/radiol.12121385
   Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307
   Yanagawa M, 2012, J NUCL MED, V53, P872, DOI 10.2967/jnumed.111.098699
NR 28
TC 16
Z9 16
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 27
PY 2014
VL 9
IS 8
AR e105682
DI 10.1371/journal.pone.0105682
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AN8UR
UT WOS:000340880900043
PM 25162396
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Guerbouj, S
   Djilani, F
   Bettaieb, J
   Lambson, B
   Diouani, MF
   Ben Salah, A
   Ben Ismail, R
   Guizani, I
AF Guerbouj, Souheila
   Djilani, Fattouma
   Bettaieb, Jihene
   Lambson, Bronwen
   Diouani, Mohamed Fethi
   Ben Salah, Afif
   Ben Ismail, Riadh
   Guizani, Ikram
TI Evaluation of a gp63-PCR Based Assay as a Molecular Diagnosis Tool in
   Canine Leishmaniasis in Tunisia
SO PLOS ONE
LA English
DT Article
ID POLYMERASE-CHAIN-REACTION; VISCERAL LEISHMANIASIS; INFANTUM INFECTION;
   PCR METHODS; DOGS; PREVALENCE; AREA; DNA; IDENTIFICATION; SERODIAGNOSIS
AB A gp63PCR method was evaluated for the detection and characterization of Leishmania (Leishmania) (L.) parasites in canine lymph node aspirates. This tool was tested and compared to other PCRs based on the amplification of 18S ribosomal genes, a L. infantum specific repetitive sequence and kinetoplastic DNA minicircles, and to classical parasitological (smear examination and/or culture) or serological (IFAT) techniques on a sample of 40 dogs, originating from different L. infantum endemic regions in Tunisia. Sensitivity and specificity of all the PCR assays were evaluated on parasitologically confirmed dogs within this sample (N = 18) and control dogs (N = 45) originating from non-endemic countries in northern Europe and Australia. The gp63 PCR had 83.5% sensitivity and 100% specificity, a performance comparable to the kinetoplast PCR assay and better than the other assays. These assays had comparable results when the gels were southern transferred and hybridized with a radioactive probe. As different infection rates were found according to the technique, concordance of the results was estimated by (kappa) test. Best concordance values were between the gp63PCR and parasitological methods (74.6%, 95% confidence intervals CI: 58.8-95.4%) or serology IFAT technique (47.4%, 95% CI: 23.5-71.3%). However, taken together Gp63 and Rib assays covered most of the samples found positive making of them a good alternative for determination of infection rates. Potential of the gp63PCR-RFLP assay for analysis of parasite genetic diversity within samples was also evaluated using 5 restriction enzymes. RFLP analysis confirmed assignment of the parasites infecting the dogs to L. infantum species and illustrated occurrence of multiple variants in the different endemic foci. Gp63 PCR assay thus constitutes a useful tool in molecular diagnosis of L. infantum infections in dogs in Tunisia.
C1 [Guerbouj, Souheila; Guizani, Ikram] Univ Tunis el Manar, Pasteur Inst Tunis, Lab Mol Epidemiol & Expt Pathol, Tunis, Tunisia.
   [Guerbouj, Souheila; Djilani, Fattouma; Diouani, Mohamed Fethi; Ben Ismail, Riadh; Guizani, Ikram] Pasteur Inst Tunis, Lab Epidemiol & Ecol Parasit Dis, Tunis, Tunisia.
   [Bettaieb, Jihene; Ben Salah, Afif] Pasteur Inst Tunis, Lab Med Epidemiol, Tunis, Tunisia.
   [Lambson, Bronwen] Univ Cambridge, Dept Pathol, Molteno Inst Parasitol, Cambridge CB2 1QP, England.
RP Guizani, I (reprint author), Univ Tunis el Manar, Pasteur Inst Tunis, Lab Mol Epidemiol & Expt Pathol, Tunis, Tunisia.
EM ikram.guizani@pasteur.rns.tn
OI Diouani, mohamed fethi/0000-0001-5192-2927
FU EU-DGXII STD3 [CT930253]; INCO-DC programs [CT970256]; Ministry of
   Higher Education and Research in Tunisia [LR00SP04, LR11IPT04]
FX This work received financial support from the EU-DGXII STD3 (CT930253)
   and INCO-DC (CT970256) programs and from the Ministry of Higher
   Education and Research in Tunisia (LR00SP04 & LR11IPT04). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X
   Andreadou M, 2012, EXP PARASITOL, V131, P419, DOI 10.1016/j.exppara.2012.05.012
   ASHFORD DA, 1995, AM J TROP MED HYG, V53, P251, DOI 10.4269/ajtmh.1995.53.251
   Boelaert M, 1999, EPIDEMIOL INFECT, V123, P499, DOI 10.1017/S0950268899003040
   Chargui N, 2009, PARASITE, V16, P65, DOI 10.1051/parasite/2009161065
   Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291
   Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8
   Diouani M F, 2008, Arch Inst Pasteur Tunis, V85, P55
   FELSENSTEIN J, 1984, EVOLUTION, V38, P16, DOI 10.1111/j.1558-5646.1984.tb00255.x
   Ferreira ED, 2007, VET PARASITOL, V146, P235, DOI 10.1016/j.vetpar.2007.02.015
   Ferroglio E, 2007, VET PARASITOL, V144, P162, DOI 10.1016/j.vetpar.2006.09.017
   Giudice E, 2011, ACTA VET HUNG, V59, P205, DOI 10.1556/AVet.2011.003
   Gomes YM, 2008, VET J, V175, P45, DOI 10.1016/j.tvjl.2006.10.019
   Gramiccia M, 2011, VET PARASITOL, V181, P23, DOI 10.1016/j.vetpar.2011.04.019
   Gramiccia M, 2007, ECOL CONT VECTOR-BOR, V1, P75
   Guerbouj S, 2001, PARASITOLOGY, V122, P25, DOI 10.1017/S0031182000007125
   GUIZANI I, 1994, AM J TROP MED HYG, V50, P632, DOI 10.4269/ajtmh.1994.50.632
   Hamarsheh O, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-183
   Lachaud L, 2002, PARASITOLOGY, V125, P197, DOI 10.1017/S0031182002002081
   Lachaud L, 2002, J CLIN MICROBIOL, V40, P210, DOI 10.1128/JCM.40.1.210-215.2002
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Maia C, 2008, VET PARASITOL, V158, P274, DOI 10.1016/j.vetpar.2008.07.028
   Miro G, 2008, TRENDS PARASITOL, V24, P371, DOI 10.1016/j.pt.2008.05.003
   MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4
   Michalsky EM, 2007, VET PARASITOL, V147, P67, DOI 10.1016/j.vetpar.2007.03.004
   Oliva G, 2006, J CLIN MICROBIOL, V44, P1318, DOI 10.1128/JCM.44.4.1318-1322.2006
   Oskam L, 1996, FEMS IMMUNOL MED MIC, V16, P235, DOI 10.1111/j.1574-695X.1996.tb00141.x
   PIARROUX R, 1993, AM J TROP MED HYG, V49, P364, DOI 10.4269/ajtmh.1993.49.364
   Porrozzi R, 2007, CLIN VACCINE IMMUNOL, V14, P544, DOI 10.1128/CVI.00420-06
   Schantz PM, 2005, JAVMA-J AM VET MED A, V226, P1316, DOI 10.2460/javma.2005.226.1316
   Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2
   Sim J, 2005, PHYS THER, V85, P257
   SMYTH AJ, 1992, PARASITOLOGY, V105, P183, DOI 10.1017/S0031182000074096
   Solano-Gallego L, 2001, J CLIN MICROBIOL, V39, P560, DOI 10.1128/JCM.39.2.560-563.2001
   Solano-Gallego L, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-86
   Solca MD, 2012, VET PARASITOL, V184, P133, DOI 10.1016/j.vetpar.2011.08.026
   Srividya G, 2012, PARASITOL RES, V110, P1065, DOI 10.1007/s00436-011-2680-1
   VANEYS GJJM, 1992, MOL BIOCHEM PARASIT, V51, P133
   Wang JY, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-69
NR 39
TC 3
Z9 3
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 25
PY 2014
VL 9
IS 8
AR e105419
DI 10.1371/journal.pone.0105419
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AN9TR
UT WOS:000340952200045
PM 25153833
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Linder, N
   Turkki, R
   Walliander, M
   Martensson, A
   Diwan, V
   Rahtu, E
   Pietikainen, M
   Lundin, M
   Lundin, J
AF Linder, Nina
   Turkki, Riku
   Walliander, Margarita
   Martensson, Andreas
   Diwan, Vinod
   Rahtu, Esa
   Pietikainen, Matti
   Lundin, Mikael
   Lundin, Johan
TI A Malaria Diagnostic Tool Based on Computer Vision Screening and
   Visualization of Plasmodium falciparum Candidate Areas in Digitized
   Blood Smears
SO PLOS ONE
LA English
DT Article
ID MICROSCOPY; CLASSIFICATION; TANZANIA; IMPACT
AB Introduction: Microscopy is the gold standard for diagnosis of malaria, however, manual evaluation of blood films is highly dependent on skilled personnel in a time-consuming, error-prone and repetitive process. In this study we propose a method using computer vision detection and visualization of only the diagnostically most relevant sample regions in digitized blood smears.
   Methods: Giemsa-stained thin blood films with P. falciparum ring-stage trophozoites (n = 27) and uninfected controls (n = 20) were digitally scanned with an oil immersion objective (0.1 mm/pixel) to capture approximately 50,000 erythrocytes per sample. Parasite candidate regions were identified based on color and object size, followed by extraction of image features (local binary patterns, local contrast and Scale-invariant feature transform descriptors) used as input to a support vector machine classifier. The classifier was trained on digital slides from ten patients and validated on six samples.
   Results: The diagnostic accuracy was tested on 31 samples (19 infected and 12 controls). From each digitized area of a blood smear, a panel with the 128 most probable parasite candidate regions was generated. Two expert microscopists were asked to visually inspect the panel on a tablet computer and to judge whether the patient was infected with P. falciparum. The method achieved a diagnostic sensitivity and specificity of 95% and 100% as well as 90% and 100% for the two readers respectively using the diagnostic tool. Parasitemia was separately calculated by the automated system and the correlation coefficient between manual and automated parasitemia counts was 0.97.
   Conclusion: We developed a decision support system for detecting malaria parasites using a computer vision algorithm combined with visualization of sample areas with the highest probability of malaria infection. The system provides a novel method for blood smear screening with a significantly reduced need for visual examination and has a potential to increase the throughput in malaria diagnostics.
C1 [Linder, Nina; Turkki, Riku; Walliander, Margarita; Lundin, Mikael; Lundin, Johan] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland.
   [Martensson, Andreas; Diwan, Vinod; Lundin, Johan] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.
   [Rahtu, Esa; Pietikainen, Matti] Univ Oulu, Dept Comp Sci & Engn, Oulu, Finland.
RP Linder, N (reprint author), Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland.
EM nina.linder@helsinki.fi
RI Lundin, Johan/I-1843-2018
OI Turkki, Riku/0000-0002-8690-6983; Lundin, Johan/0000-0002-2681-4139;
   Linder, Nina/0000-0003-3930-0513
FU Swedish Research Council; Sigrid Juselius Foundation; Finska
   Lakaresallskapet; Dorothea Olivia, Karl Walter and Jarl Walter Perklen
   Foundation; "European Advanced Translational Research Infra Structure in
   Medicine'' (EATRIS)
FX The study was supported by the Swedish Research Council, Sigrid Juselius
   Foundation, Finska Lakaresallskapet, and the Dorothea Olivia, Karl
   Walter and Jarl Walter Perklen Foundation. In addition, this study has
   received funding from the "European Advanced Translational Research
   Infra Structure in Medicine'' (EATRIS). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ahonen T, 2006, IEEE T PATTERN ANAL, V28, P2037, DOI 10.1109/TPAMI.2006.244
   Bain BJ, 2005, NEW ENGL J MED, V353, P498, DOI 10.1056/NEJMra043442
   Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320
   Di Ruberto C, 2002, IMAGE VISION COMPUT, V20, P133, DOI 10.1016/S0262-8856(01)00092-0
   Diaz G, 2009, J BIOMED INFORM, V42, P296, DOI 10.1016/j.jbi.2008.11.005
   Fan RE, 2008, J MACH LEARN RES, V9, P1871
   Frean J, 2012, B WORLD HEALTH ORGAN, V90, P191, DOI 10.2471/BLT.11.091876
   Garcia LS, 2000, LAB DIAGNOSIS BLOOD
   Kaewkamnerd S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S18
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Le MT, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-15
   Linder E, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000315
   Linder E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002547
   Linder N, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-22
   Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327
   Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410
   Maity M, 2012, INT J COMPUTER APPL, V52, P31
   Mavandadi S, 2012, LAB CHIP, V12, P4102, DOI 10.1039/c2lc40614d
   Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073
   Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07
   Ngasala B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-199
   O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7
   O'Meara WP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-118
   Ohrt C, 2002, J INFECT DIS, V186, P540, DOI 10.1086/341938
   Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623
   Pang S, 2010, LAB CHIP, V10, P411, DOI 10.1039/b919004j
   Prescott WR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-155
   Purwar Y, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-364
   Reyburn H, 2004, BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55
   Tek FB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-153
   Tek FB, 2010, COMPUT VIS IMAGE UND, V114, P21, DOI 10.1016/j.cviu.2009.08.003
   Turkki R, 2013, DIAGNOSTIC PATHOL S1, pS30
   Vedaldi A, 2010, VLFEAT OPEN PORTABLE, P1469
   Vedaldi A, 2009, IEEE I CONF COMP VIS, P606, DOI 10.1109/ICCV.2009.5459183
   Walliander M, 2013, DIAGNOSTIC PATHOLOGY, V8, pS37, DOI DOI 10.1186/1746-1596-8-S1-S37
   White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   WHO, 2010, BAS MAL MICR
   WHO, 2008, TASK SHIFT GLOB REC
   Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119
   World Health Organization, 2009, MAL MICR QUAL ASS MA
   World Health Organization, 2010, GUID TREATM MAL
   Zhu HY, 2013, LAB CHIP, V13, P1282, DOI 10.1039/c3lc41408f
NR 43
TC 25
Z9 25
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 21
PY 2014
VL 9
IS 8
AR e104855
DI 10.1371/journal.pone.0104855
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AO1WL
UT WOS:000341106100026
PM 25144549
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Martins, AES
   Lucena-Silva, N
   Garcia, RG
   Welkovic, S
   Barbosa, A
   Menezes, MLB
   Tenorio, T
   Maruza, M
   Ximenes, RAA
AF Silva Martins, Albert Eduardo
   Lucena-Silva, Norma
   Garcia, Renan Gomes
   Welkovic, Stefan
   Barbosa, Aureliana
   Bezerra Menezes, Maria Luiza
   Tenorio, Terezinha
   Maruza, Magda
   Ximenes, Ricardo A. A.
TI Prognostic Evaluation of DNA Index in HIV-HPV Co-Infected Women Cervical
   Samples Attending in Reference Centers for HIV-AIDS in Recife
SO PLOS ONE
LA English
DT Article
ID HUMAN-PAPILLOMAVIRUS INFECTION; INTRAEPITHELIAL NEOPLASIA;
   ANTIRETROVIRAL THERAPY; POSITIVE WOMEN; FLOW-CYTOMETRY; CANCER;
   PREVALENCE; RISK; ANEUPLOIDY; DYSPLASIA
AB Introduction: Persistence of cervical infection caused by human papillomavirus (HPV) types with high oncogenic risk may lead to cervical intraepithelial neoplasia (CIN). The aim of the present study was to evaluate whether, in HIV-positive women, the presence of aneuploidy in cervical cell samples is associated with presence and evolution of CIN.
   Methods: The present study had two stages. In the first stage, comprising a cross-sectional study, the association between the presence of aneuploidy seen via flow cytometry and sociodemographic characteristics, habits and characteristics relating to HPV and HIV infection was analyzed. In the second stage, comprising a cohort study, it was investigated whether aneuploidy was predictive of CIN evolution.
   Results: No association was observed between the presence of aneuploidy and HPV infection, or between its presence and alterations seen in oncotic cytological analysis. On the other hand, aneuploidy was associated with the presence of CIN (p = 0.030) in histological analysis and with nonuse of antiretroviral therapy (p = 0.001). Most of the HIV-positive women (234/272) presented normal CD4+ T lymphocyte counts (greater than 350 cells/mm(3)) and showed a greater aneuploidy regression rate (77.5%) than a progression rate (23.9%) over a follow-up of up to two years.
   Conclusion: Although there was an association between the presence of cervical tissue lesions and the DNA index, the latter was not predictive of progression of the cervical lesion. This suggests that progression of the cervical lesion to cancer in HIV-positive women may also be changed through improvement of the immunological state enabled by using antiretroviral therapy.
C1 [Silva Martins, Albert Eduardo; Lucena-Silva, Norma; Garcia, Renan Gomes] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Lab Imunogenet, Recife, PE, Brazil.
   [Silva Martins, Albert Eduardo; Lucena-Silva, Norma] Hosp IMIP, Dept Oncol Pediat, Lab Biol Mol, Recife, PE, Brazil.
   [Welkovic, Stefan; Barbosa, Aureliana; Bezerra Menezes, Maria Luiza] Univ Pernambuco, Dept Materno Infantil, Recife, PE, Brazil.
   [Welkovic, Stefan; Barbosa, Aureliana; Bezerra Menezes, Maria Luiza] Univ Pernambuco, Ctr Integrado Saude Amaury Medeiro CISAM UPE, Recife, PE, Brazil.
   [Tenorio, Terezinha] Univ Fed Pernambuco, Dept Materno Infantil, Recife, PE, Brazil.
   [Maruza, Magda] Hosp Correia Picanco, Secretaria Saude Pernambuco, Recife, PE, Brazil.
   [Ximenes, Ricardo A. A.] Univ Fed Pernambuco UFPE, Dept Trop Med, Recife, PE, Brazil.
RP Martins, AES (reprint author), Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Lab Imunogenet, Recife, PE, Brazil.
EM aesmartins@hotmail.com
FU Program for Technological Development in Tools for Health-PDTISFIOCRUZ;
   FACEPE [APQ-IBPG-1802-4]; CNPq [150572/2011-5]; Brazilian Health
   Ministry [322/2005]
FX The Program for Technological Development in Tools for
   Health-PDTISFIOCRUZ gave financial support for gene sequencing. A. E. S.
   M was a Ph.D. student supported by FACEPE (APQ-IBPG-1802-4). N.L.S. is
   the recipient of a postdoctoral fellowship from CNPq (grant #
   150572/2011-5). This work was supported by Brazilian Health Ministry
   (Grant #322/2005). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ahdieh L, 2000, AM J EPIDEMIOL, V151, P1148
   Brandao VDRAB, 2009, MEM I OSWALDO CRUZ, V104, P755, DOI 10.1590/S0074-02762009000500016
   Anton M, 1997, CANCER DETECT PREV, V21, P242
   Bollmann R, 2005, CANCER, V105, P1
   Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003
   Chhavi, 2010, BIOSCI TRENDS, V4, P103
   Dabi MM, 2008, ACTA OBSTET GYNECOL, V187, P366
   de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033
   Doeberitz MV, 2009, ARCH MED RES, V40, P435, DOI 10.1016/j.arcmed.2009.06.002
   Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006
   El-Sayed SS, 2004, CAN J GASTROENTEROL, V18, P87, DOI 10.1155/2004/638136
   Entiauspe LG, 2010, REV SOC BRAS MED TRO, V43, P260, DOI 10.1590/S0037-86822010000300009
   Firnhaber C, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17382
   Garbuglia AR, 2012, J CLIN VIROL, V54, P141, DOI 10.1016/j.jcv.2012.02.013
   Garnett TO, 2006, ARCH VIROL, V151, P2321, DOI 10.1007/s00705-006-0821-0
   Gillet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045201
   Heilmann Volker, 2002, Curr Womens Health Rep, V2, P27
   Klaes R, 1999, CANCER RES, V59, P6132
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lawn SD, 2011, EXPERT REV ANTI-INFE, V9, P415, DOI [10.1586/ERI.11.21, 10.1586/eri.11.21]
   LOOK AT, 1985, BLOOD, V65, P1079
   MacLeod IJ, 2011, J MED VIROL, V83, P1689, DOI 10.1002/jmv.22178
   Mangili G, 2008, ANN ONCOL, V19, P1278, DOI 10.1093/annonc/mdn041
   Massad LS, 2001, GYNECOL ONCOL, V82, P516, DOI 10.1006/gyno.2001.6323
   Melsheimer P, 2004, CLIN CANCER RES, V10, P3059, DOI 10.1158/1078-0432.CCR-03-0565
   Melsheimer P, 2001, CYTOMETRY, V46, P166, DOI 10.1002/cyto.1101
   Naucler P, 2011, J GEN VIROL, V92, P2784, DOI 10.1099/vir.0.034298-0
   Palefsky J, 2006, Adv Dent Res, V19, P99
   SBPTGIC - Sociedade Brasileira de Patologia do Trato Genital Inferior e Colposcopia, 2003, B INF DIR SBPTGIC, V5, P5
   Schneider ML, 1998, ATLAS DIAGNOSTICO DI
   Sharma SK, 2011, INDIAN J MED RES, V134, P866, DOI 10.4103/0971-5916.92632
   Singh M, 2008, J CANCER EPIDEMIOL, DOI 10.1155/2008/298495
   Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878
   Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
NR 36
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 21
PY 2014
VL 9
IS 8
AR e104801
DI 10.1371/journal.pone.0104801
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AO1WL
UT WOS:000341106100023
PM 25144309
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU McCormick, N
   Lacaille, D
   Bhole, V
   Avina-Zubieta, JA
AF McCormick, Natalie
   Lacaille, Diane
   Bhole, Vidula
   Avina-Zubieta, J. Antonio
TI Validity of Heart Failure Diagnoses in Administrative Databases: A
   Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID ELECTRONIC MEDICAL-RECORDS; HOSPITAL DISCHARGE; OUTCOMES RESEARCH;
   CODING ACCURACY; ECONOMIC BURDEN; CLINICAL-DATA; TASK-FORCE; HEALTH;
   COMMUNITY; VALIDATION
AB Objective: Heart failure (HF) is an important covariate and outcome in studies of elderly populations and cardiovascular disease cohorts, among others. Administrative data is increasingly being used for long-term clinical research in these populations. We aimed to conduct the first systematic review and meta-analysis of studies reporting on the validity of diagnostic codes for identifying HF in administrative data.
   Methods: MEDLINE and EMBASE were searched (inception to November 2010) for studies: (a) Using administrative data to identify HF; or (b) Evaluating the validity of HF codes in administrative data; and (c) Reporting validation statistics (sensitivity, specificity, positive predictive value [PPV], negative predictive value, or Kappa scores) for HF, or data sufficient for their calculation. Additional articles were located by hand search (up to February 2011) of original papers. Data were extracted by two independent reviewers; article quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies tool. Using a random-effects model, pooled sensitivity and specificity values were produced, along with estimates of the positive (LR+) and negative (LR-) likelihood ratios, and diagnostic odds ratios (DOR = LR+/LR-) of HF codes.
   Results: Nineteen studies published from 1999-2009 were included in the qualitative review. Specificity was >= 95% in all studies and PPV was >= 87% in the majority, but sensitivity was lower (>= 69% in >= 50% of studies). In a meta-analysis of the 11 studies reporting sensitivity and specificity values, the pooled sensitivity was 75.3% (95% CI: 74.7-75.9) and specificity was 96.8% (95% CI: 96.8-96.9). The pooled LR+ was 51.9 (20.5-131.6), the LR- was 0.27 (0.20-0.37), and the DOR was 186.5 (96.8-359.2).
   Conclusions: While most HF diagnoses in administrative databases do correspond to true HF cases, about one-quarter of HF cases are not captured. The use of broader search parameters, along with laboratory and prescription medication data, may help identify more cases.
C1 [McCormick, Natalie] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada.
   [McCormick, Natalie; Lacaille, Diane; Bhole, Vidula; Avina-Zubieta, J. Antonio] Arthrit Res Ctr Canada, Richmond, BC, Canada.
   [Lacaille, Diane; Avina-Zubieta, J. Antonio] Univ British Columbia, Dept Med, Div Rheumatol, Vancouver, BC, Canada.
   [Lacaille, Diane; Avina-Zubieta, J. Antonio] Canadian Rheumatol Adm Data Network, Cardiovasc Comm, Richmond, BC, Canada.
   [Bhole, Vidula] EpiSolut Consultancy Serv, Thana, India.
RP Avina-Zubieta, JA (reprint author), Arthrit Res Ctr Canada, Richmond, BC, Canada.
EM azubieta@arthritisresearch.ca
OI McCormick, Natalie/0000-0002-4147-8348
FU Canadian Arthritis Network; Canadian Institutes of Health Research;
   Arthritis Society of Canada; Michael Smith Foundation for Health
   Research
FX This study was funded in part by the Canadian Arthritis Network
   (http://www.canradnetwork.ca). Natalie McCormick is supported by a
   Doctoral Research Award from the Canadian Institutes of Health Research.
   J. Antonio Avina-Zubieta held a salary award from the Canadian Arthritis
   Network and The Arthritis Society of Canada. He is currently the British
   Columbia Lupus Society Scholar and holds a Scholar Award from the
   Michael Smith Foundation for Health Research. Diane Lacaille holds the
   Mary Pack Chair in Arthritis Research from UBC and The Arthritis Society
   of Canada. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Alqaisi F, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-237
   Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053
   Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839
   Barber C, 2013, ARTHRIT CARE RES, V65, P1343, DOI 10.1002/acr.21959
   Bernatsky S, 2013, J RHEUMATOL, V40, P66, DOI 10.3899/jrheum.120835
   Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9
   Blecker S, 2013, J AM COLL CARDIOL, V61, P1259, DOI 10.1016/j.jacc.2012.12.038
   Bradley CJ, 2010, HEALTH SERV RES, V45, P1468, DOI 10.1111/j.1475-6773.2010.01142.x
   Braunstein JB, 2003, J AM COLL CARDIOL, V42, P1226, DOI 10.1016/S0735-1097(03)00947-1
   CARLSON KJ, 1985, J CHRON DIS, V38, P733, DOI 10.1016/0021-9681(85)90115-8
   Chen GM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-5
   Chen YT, 1999, AM J MED, V106, P605, DOI 10.1016/S0002-9343(99)00126-6
   Cleland JGF, 2003, EUR HEART J, V24, P442, DOI 10.1016/S0195-668X(02)00823-0
   COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666
   Cook C, 2014, INT J CARDIOL, V171, P368, DOI 10.1016/j.ijcard.2013.12.028
   Dai SL, 2012, CAN J CARDIOL, V28, P74, DOI 10.1016/j.cjca.2011.05.002
   Dean BB, 2009, MED CARE RES REV, V66, P611, DOI 10.1177/1077558709332440
   Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016
   Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309
   Dunlay SM, 2009, J AM COLL CARDIOL, V54, P1695, DOI 10.1016/j.jacc.2009.08.019
   Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061
   Friedlin Jeff, 2006, AMIA Annu Symp Proc, P269
   Friedman C, 1999, J AM MED INFORM ASSN, V6, P76, DOI 10.1136/jamia.1999.0060076
   GAASCH WH, 1994, JAMA-J AM MED ASSOC, V271, P1276
   Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80
   Goff DC, 2000, ARCH INTERN MED, V160, P197, DOI 10.1001/archinte.160.2.197
   Hawkins NM, 2010, EUR J HEART FAIL, V12, P17, DOI 10.1093/eurjhf/hfp160
   Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314
   Heisler CA, 2009, J AM COLL SURGEONS, V209, P119, DOI 10.1016/j.jamcollsurg.2009.03.017
   Henderson T, 2006, MED CARE, V44, P1011, DOI 10.1097/01.mlr.0000228018.48783.34
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hudson M, 2013, J CLIN EPIDEMIOL, V66, P278, DOI 10.1016/j.jclinepi.2012.10.004
   Humphries KH, 2000, J CLIN EPIDEMIOL, V53, P343, DOI 10.1016/S0895-4356(99)00188-2
   Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065
   Ingelsson E, 2005, EUR J HEART FAIL, V7, P787, DOI 10.1016/j.ejheart.2004.12.007
   JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703
   Khand AU, 2005, EUR J HEART FAIL, V7, P792, DOI 10.1016/j.ejheart.2005.04.001
   KRAMER M, 1988, DIAGNOSTIC TESTS CLI, P236
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012
   Leong A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075256
   Levy AR, 1999, CAN J CARDIOL, V15, P1277
   LIU F, 2012, NATURAL LANGUAGE PRO, P305
   MARANTZ PR, 1988, ANN INTERN MED, V109, P55, DOI 10.7326/0003-4819-109-1-55
   McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092286
   MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601
   McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104
   Merry AHH, 2009, EUR J EPIDEMIOL, V24, P237, DOI 10.1007/s10654-009-9335-x
   MILLER RG, 1974, BIOMETRIKA, V61, P1
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Mosterd A, 1997, EUR J EPIDEMIOL, V13, P491
   Onofrei Mihai, 2004, Inform Prim Care, V12, P139
   Pakhomov S, 2007, AM J MANAG CARE, V13, P281
   Quach S, 2010, CAN J CARDIOL, V26, pE306, DOI 10.1016/S0828-282X(10)70438-4
   Rector TS, 2004, HEALTH SERV RES, V39, P1839, DOI 10.1111/j.1475-6773.2004.00321.x
   REMES J, 1992, EUR HEART J, V13, P588, DOI 10.1093/oxfordjournals.eurheartj.a060220
   Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344
   Saczynski JS, 2012, PHARMACOEPIDEM DR S, V21, P129, DOI 10.1002/pds.2313
   Senni M, 1999, ARCH INTERN MED, V159, P29, DOI 10.1001/archinte.159.1.29
   So L, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-161
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Szeto HC, 2002, AM J MANAG CARE, V8, P37
   van Deursen VM, 2014, HEART FAIL REV, V19, P163, DOI 10.1007/s10741-012-9370-7
   van Deursen VM, 2014, EUR J HEART FAIL, V16, P103, DOI 10.1002/ejhf.30
   Walter SD, 2002, STAT MED, V21, P1237, DOI 10.1002/sim.1099
   Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25
   Widdifield J, 2013, ARTHRIT CARE RES, V65, P1490, DOI 10.1002/acr.21993
   Wong CY, 2011, AM J MED, V124, P136, DOI 10.1016/j.amjmed.2010.08.017
   Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31
NR 69
TC 56
Z9 56
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 15
PY 2014
VL 9
IS 8
AR e104519
DI 10.1371/journal.pone.0104519
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AN8UD
UT WOS:000340879300031
PM 25126761
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Nonnemaker, JM
   Allen, JA
   Davis, KC
   Kamyab, K
   Duke, JC
   Farrelly, MC
AF Nonnemaker, James M.
   Allen, Jane A.
   Davis, Kevin C.
   Kamyab, Kian
   Duke, Jennifer C.
   Farrelly, Matthew C.
TI The Influence of Antismoking Television Advertisements on Cessation by
   Race/Ethnicity, Socioeconomic Status, and Mental Health Status
SO PLOS ONE
LA English
DT Article
ID PROMOTE SMOKING-CESSATION; MEDIA CAMPAIGNS; DISADVANTAGED POPULATIONS;
   UNITED-STATES; QUIT SMOKING; ADULTS; DISPARITIES; PREVALENCE; SMOKERS;
   INTERVENTIONS
AB Disparities in tobacco use and smoking cessation by race/ethnicity, education, income, and mental health status remain despite recent successes in reducing tobacco use. It is unclear to what extent media campaigns promote cessation within these population groups. This study aims to (1) assess whether exposure to antitobacco advertising is associated with making a quit attempt within a number of population subgroups, and (2) determine whether advertisement type differentialy affects cessation behavior across subgroups. We used data from the New York Adult Tobacco Survey (NY-ATS), a cross-sectional, random-digit-dial telephone survey of adults aged 18 or older in New York State conducted quarterly from 2003 through 2011 (N = 53,706). The sample for this study consists of 9,408 current smokers from the total NY-ATS sample. Regression methods were used to examine the effect of New York State's antismoking advertising, overall and by advertisement type (graphic and/or emotional), on making a quit attempt in the past 12 months. Exposure to antismoking advertising was measured in two ways: gross rating points (a measure of potential exposure) and self-reported confirmed recall of advertisements. This study yields three important findings. First, antismoking advertising promotes quit attempts among racial/ethnic minority smokers and smokers of lower education and income. Second, advertising effectiveness is attributable in part to advertisements with strong graphic imagery or negative emotion. Third, smokers with poor mental health do not appear to benefit from exposure to antismoking advertising of any type. This study contributes to the evidence about how cessation media campaigns can be used most effectively to increase quit attempts within vulnerable subgroups. In particular, it suggests that a general campaign can promote cessation among a range of sociodemographic groups. More research is needed to understand what message strategies might work for those with poor mental health.
C1 [Nonnemaker, James M.; Allen, Jane A.; Davis, Kevin C.; Kamyab, Kian; Duke, Jennifer C.; Farrelly, Matthew C.] RTI Int, Res Triangle Pk, NC 27709 USA.
RP Nonnemaker, JM (reprint author), RTI Int, Res Triangle Pk, NC 27709 USA.
EM jnonnemaker@rti.org
FU New York State Department of Health [C022586]
FX The New York State Department of Health provided funding for the conduct
   of the research and writing of the article under contract no. C022586.
   The funder had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889
   Allen JA, 2011, HANDBOOK OF AFRICAN AMERICAN HEALTH: SOCIAL AND BEHAVIORAL INTERVENTIONS, P79, DOI 10.1007/978-1-4419-9616-9_5
   Bala M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004704.pub2
   Barbeau EM, 2004, AM J PUBLIC HEALTH, V94, P269, DOI 10.2105/AJPH.94.2.269
   Biener L, 2000, TOB CONTROL, V9, P401, DOI 10.1136/tc.9.4.401
   Bryant J, 2011, ADDICTION, V106, P1568, DOI 10.1111/j.1360-0443.2011.03467.x
   Christiansen B, 2012, J STUD ALCOHOL DRUGS, V73, P874, DOI 10.15288/jsad.2012.73.874
   Cokkinides VE, 2008, AM J PREV MED, V34, P404, DOI 10.1016/j.amepre.2008.02.003
   Davis KC, 2007, J ADOLESCENT HEALTH, V41, P430, DOI 10.1016/j.jadohealth.2007.05.008
   Durkin S, 2012, TOB CONTROL, V21, P127, DOI 10.1136/tobaccocontrol-2011-050345
   Durkin SJ, 2009, AM J PUBLIC HEALTH, V99, P2217, DOI 10.2105/AJPH.2009.161638
   Fagan P, 2007, J HEALTH CARE POOR U, V18, P52, DOI 10.1353/hpu.2007.0119
   Farrelly MC, 2012, AM J PREV MED, V43, P475, DOI 10.1016/j.amepre.2012.07.023
   Farrelly MC, 2011, TOB CONTROL, V20, P279, DOI 10.1136/tc.2010.042234
   Farrelly MC, 2009, AM J PREV MED, V36, P379, DOI 10.1016/j.amepre.2009.01.019
   Farrelly MC, 2005, AM J PUBLIC HEALTH, V95, P425, DOI 10.2105/AJPH.2004.049692
   Hymowitz N, 1996, J NATL MED ASSOC, V88, P249
   Kahende JW, 2011, INT J ENV RES PUB HE, V8, P3871, DOI 10.3390/ijerph8103871
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606
   Levinson AH, 2004, AM J PREV MED, V26, P105, DOI 10.1016/j.amepre.2003.10.012
   McClave AK, 2010, AM J PUBLIC HEALTH, V100, P2464, DOI 10.2105/AJPH.2009.188136
   National Cancer Institute, 2008, TOB CONTR MON, V19
   Niederdeppe J, 2008, SOC SCI MED, V67, P1343, DOI 10.1016/j.socscimed.2008.06.037
   Niederdeppe J, 2008, AM J PUBLIC HEALTH, V98, P916, DOI 10.2105/AJPH.2007.117499
   Niederdeppe J, 2011, SOC SCI MED, V72, P773, DOI 10.1016/j.socscimed.2010.12.025
   Richards CS, 2013, J CONSULT CLIN PSYCH, V81, P263, DOI 10.1037/a0027793
   Southwell BG, 2002, J HEALTH COMMUN, V7, P445, DOI 10.1080/10810730290001800
   Substance Abuse and Mental Health Services Administration, 2011, NSDUH SER H, V11-4658
   Thorndike AN, 2002, AM J PUBLIC HEALTH, V92, P437, DOI 10.2105/AJPH.92.3.437
   Vallone DM, 2011, AM J HEALTH PROMOT, V25, pS38, DOI 10.4278/ajhp.100617-QUAN-201
   Wakefield MA, 2011, HEALTH EDUC RES, V26, P988, DOI 10.1093/her/cyr054
   WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276
   Zhu SH, 2000, AM J PREV MED, V18, P305, DOI 10.1016/S0749-3797(00)00124-0
NR 34
TC 13
Z9 13
U1 0
U2 24
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 17
PY 2014
VL 9
IS 7
AR e102943
DI 10.1371/journal.pone.0102943
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AL8VR
UT WOS:000339418300110
PM 25033449
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Seelandt, JC
   Kaderli, RM
   Tschan, F
   Businger, AP
AF Seelandt, Julia C.
   Kaderli, Reto M.
   Tschan, Franziska
   Businger, Adrian P.
TI The Surgeon's Perspective: Promoting and Discouraging Factors for
   Choosing a Career in Surgery as Perceived by Surgeons
SO PLOS ONE
LA English
DT Article
ID MEDICAL-STUDENTS; GENERAL-SURGERY; CHOICE; BURNOUT; WOMEN; WORK;
   SATISFACTION; PERCEPTIONS; RESIDENTS; DISTRESS
AB Background: The aim of this study was to identify the factors perceived by surgeons that promote surgery as an attractive or unattractive career choice for today's graduates. In addition, it examined whether the perspectives of surgeons in different professional situations converges. The content of work, contextual work conditions, and calling to this job are discussed in the context of choosing surgery as a career.
   Methods: Eight hundred sixty-nine surgeons were asked to answer open-ended questions regarding the factors that promote surgery as an attractive or unattractive career choice for today's graduates. Four hundred ninety-two surgeons participated, and 1,525 statements were analyzed using Mayring's content-analyses method. Chi-square tests were used to analyze the differences among hierarchical positions.
   Results: With respect to the factors that promote surgery as a profession, 40.8% (209/492) of the surgeons stated that surgery is a calling, 29.1% (149/492) of the surgeons provided at least one argument related to the positive task characteristics, and 12.9% (66/492) of the surgeons provided statements related to the positive contextual factors. With respect to the factors that discourage surgery as a profession, 45.7% (234/492) of the surgeons provided at least one argument related to the discouraging work characteristics, and 67.6% (346/492) of the surgeons provided problematic contextual characteristics.
   Conclusion: This study emphasizes the importance of the calling to surgery as an important factor for choosing surgery as a career. However, the extensive workload, training, and poor work-family balance have been identified as factors that discourage graduates from choosing surgery as a career. The identified positive factors could be used to attract and maintain graduates in surgical disciplines.
C1 [Seelandt, Julia C.; Tschan, Franziska] Univ Neuchatel, Inst Work Psychol, CH-2000 Neuchatel, Switzerland.
   [Kaderli, Reto M.] Univ Hosp Bern, Inselspital, Dept Visceral Surg & Med, CH-3010 Bern, Switzerland.
   [Businger, Adrian P.] Swiss Armed Forces, Mil Med Serv, Ittigen Bern, Switzerland.
RP Businger, AP (reprint author), Swiss Armed Forces, Mil Med Serv, Ittigen Bern, Switzerland.
EM adrian.businger@gmx.ch
OI Kaderli, Reto/0000-0001-8190-8771
FU University of Neuchatel; "Commission Egalite des Chances", University of
   Neuchatel
FX The study was partially financed by the University of Neuchatel, and by
   a grant to Julia Seelandt received from the "Commission Egalite des
   Chances", University of Neuchatel. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Andlauer O, 2012, PSYCHIAT DANUB, V24, pS185
   Are C, 2011, AM J SURG, V202, P352, DOI 10.1016/j.amjsurg.2010.08.007
   Are C, 2010, J SURG EDUC, V67, P320, DOI 10.1016/j.jsurg.2010.07.016
   Azizzadeh Ali, 2003, Curr Surg, V60, P210, DOI 10.1016/S0149-7944(02)00679-7
   Balch CM, 2011, ANN SURG, V254, P558, DOI 10.1097/SLA.0b013e318230097e
   Balch CM, 2010, J AM COLL SURGEONS, V211, P609, DOI 10.1016/j.jamcollsurg.2010.06.393
   Balch CM, 2009, ARCH SURG-CHICAGO, V144, P371, DOI 10.1001/archsurg.2008.575
   Baxter N, 1996, AM J SURG, V172, P373, DOI 10.1016/S0002-9610(96)00185-7
   Boyle E, 2013, IRISH J MED SCI, V182, P337, DOI 10.1007/s11845-012-0882-x
   Brundage SI, 2005, J AM COLL SURGEONS, V200, P946, DOI 10.1016/j.jamcollsurg.2005.02.033
   Businger A, 2010, ANN SURG, V252, P390, DOI 10.1097/SLA.0b013e3181e98570
   Businger A, 2010, ARCH SURG-CHICAGO, V145, P558, DOI 10.1001/archsurg.2010.88
   Cochran A, 2005, AM J SURG, V189, P742, DOI 10.1016/j.amjsurg.2005.03.019
   Cochran A, 2013, AM J SURG, V206, P661, DOI 10.1016/j.amjsurg.2013.07.003
   Colletti LM, 2000, ARCH SURG-CHICAGO, V135, P972, DOI 10.1001/archsurg.135.8.972
   Collins John P, 2011, Surgeon, V9 Suppl 1, pS3, DOI 10.1016/j.surge.2010.11.008
   Dayton MT, 2008, ARCH SURG-CHICAGO, V143, P624, DOI 10.1001/archsurg.143.7.624
   Debas HT, 2002, ANN SURG, V236, P263, DOI 10.1097/01.SLA.0000026686.91511.8B
   Donaldson L, 2002, UNFINISHED BUSINESS
   Dyrbye LN, 2011, ARCH SURG-CHICAGO, V146, P211, DOI 10.1001/archsurg.2010.310
   Eccles J. S, 2005, HDB COMPETENCE MOTIV, P105
   Erzurum VZ, 2000, SURGERY, V128, P253, DOI 10.1067/msy.2000.108214
   Gelfand DV, 2002, ARCH SURG-CHICAGO, V137, P941, DOI 10.1001/archsurg.137.8.941
   Glynn RW, 2010, SURG-J R COLL SURG E, V8, P187, DOI 10.1016/j.surge.2009.11.005
   HACKMAN JR, 1976, ORGAN BEHAV HUM PERF, V16, P250, DOI 10.1016/0030-5073(76)90016-7
   Healy NA, 2012, AM J SURG, V204, P256, DOI 10.1016/j.amjsurg.2011.09.031
   Hochberg MS, 2014, AM J SURG, V207, P194, DOI 10.1016/j.amjsurg.2013.10.010
   Humphrey SE, 2007, J APPL PSYCHOL, V92, P1332, DOI 10.1037/0021-9010.92.5.1332
   Iaria G, 2006, TRANSPLANT P, V38, P1203, DOI 10.1016/j.transproceed.2006.03.012
   IBM, 2011, IBM SPSS STAT WIND V
   Kaderli R, 2010, ARCH SURG-CHICAGO, V145, P1119, DOI 10.1001/archsurg.2010.245
   Kahn D, 2006, S AFR J SURG, V44, P108
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lent RW, 2002, J VOCAT BEHAV, V60, P61, DOI 10.1006/jvbe.2001.1814
   Millan Luiz Roberto, 2005, Clinics, V60, P143, DOI 10.1590/S1807-59322005000200011
   Morgeson F. P., 2003, HDB PSYCHOL IND ORG, VTwelve, P423, DOI DOI 10.1002/0471264385.WEI1217
   Morris JB, 2003, J AM COLL SURGEONS, V196, P611, DOI 10.1016/S1072-7515(02)01832-X
   Neumayer L, 2002, AM J SURG, V183, P146, DOI 10.1016/S0002-9610(01)00863-7
   Quillin RC, 2012, J SURG RES, V177, P201, DOI 10.1016/j.jss.2012.05.064
   Reed CE, 2010, J AM COLL SURGEONS, V210, P319, DOI 10.1016/j.jamcollsurg.2009.11.016
   Scott I, 2011, MED TEACH, V33, P1011, DOI 10.3109/0142159X.2011.558533
   Semmer N. K., 2014, INTRO CONT WORK PSYC, P171
   Shanafelt TD, 2009, ANN SURG, V250, P463, DOI 10.1097/SLA.0b013e3181ac4dfd
   Strobel H. W, 2009, FACULTY HLTH ACAD ME, P157, DOI DOI 10.1007/978-1-60327-451-7_12
   Traynor Oscar, 2011, Surgeon, V9 Suppl 1, pS1, DOI 10.1016/j.surge.2011.04.003
   Turner G, 2006, BJOG-INT J OBSTET GY, V113, P350, DOI 10.1111/j.1471-0528.2006.00848.x
   VERBI GmbH, 2013, MAXQDA 10 QUAL DAT A
NR 47
TC 2
Z9 2
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 15
PY 2014
VL 9
IS 7
AR e102756
DI 10.1371/journal.pone.0102756
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AM6RN
UT WOS:000339992400103
PM 25025428
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Calvino-Cancela, M
   Mendez-Rial, R
   Reguera-Salgado, J
   Martin-Herrero, J
AF Calvino-Cancela, Maria
   Mendez-Rial, Roi
   Reguera-Salgado, Javier
   Martin-Herrero, Julio
TI Alien Plant Monitoring with Ultralight Airborne Imaging Spectroscopy
SO PLOS ONE
LA English
DT Article
ID INVASIONS; CLASSIFICATION; COMMUNITIES; HYPERCUBE; KNOWLEDGE; IMAGERY
AB Effective management of invasive plants requires a precise determination of their distribution. Remote sensing techniques constitute a promising alternative to field surveys and hyperspectral sensors (also known as imaging spectrometers, with a large number of spectral bands and high spectral resolution) are especially suitable when very similar categories are to be distinguished (e.g. plant species). A main priority in the development of this technology is to lower its cost and simplify its use, so that its demonstrated aptitude for many environmental applications can be truly realized. With this aim, we have developed a system for hyperspectral imaging (200 spectral bands in the 380-1000 nm range and circa 3 nm spectral resolution) operated on board ultralight aircraft (namely a gyrocopter), which allows a drastic reduction of the running costs and operational complexity of image acquisition, and also increases the spatial resolution of the images (circa 5-8 pixels/m(2) at circa 65 km/h and 300 m height). The detection system proved useful for the species tested (Acacia melanoxylon, Oxalis pes-caprae, and Carpobrotus aff. edulis and acinaciformis), with user's and producer's accuracy always exceeding 90%. The detection accuracy reported corresponds to patches down to 0.125 m(2) (50% of pixels 0.5x0.5 m in size), a very small size for many plant species, making it very effective for initial stages of invasive plant spread. In addition, its low operating costs, similar to those of a 4WD ground vehicle, facilitate frequent image acquisition. Acquired images constitute a permanent record of the status of the study area, with great amount of information that can be analyzed in the future for other purposes, thus greatly facilitating the monitoring of natural areas at detailed spatial and temporal scales for improved management.
C1 [Calvino-Cancela, Maria] Univ Vigo, Dept Ecol & Anim Biol, Vigo 36310, Galicia, Spain.
   [Mendez-Rial, Roi; Reguera-Salgado, Javier; Martin-Herrero, Julio] Univ Vigo, Dept Signal Theory & Commun, Vigo 36310, Galicia, Spain.
RP Calvino-Cancela, M (reprint author), Univ Vigo, Dept Ecol & Anim Biol, Vigo 36310, Galicia, Spain.
EM maria@uvigo.es
RI Martin-Herrero, Julio/D-3827-2009
FU Organismo Autonomo de Parques Nacionales; Ministerio de Medio Ambiente y
   Medio Rural y Marino [023/2008]; ERDF; Xunta de Galicia Consolidation of
   Research Units [2009/062]; AtlanTIC
FX This work was partially supported by the Organismo Autonomo de Parques
   Nacionales, Ministerio de Medio Ambiente y Medio Rural y Marino
   (023/2008), ERDF, Xunta de Galicia Consolidation of Research Units
   (2009/062), and AtlanTIC. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ahrens C, 2011, WEED SCI, V59, P145, DOI 10.1614/WS-D-10-00094.1
   Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2
   Burkart A, 2014, IEEE SENS J, V14, P62, DOI 10.1109/JSEN.2013.2279720
   Calvino-Cancela M, 2007, ECOSCIENCE, V14, P529, DOI 10.2980/1195-6860(2007)14[529:EPTEOA]2.0.CO;2
   Camps-Valls G, 2004, IEEE T GEOSCI REMOTE, V42, P1530, DOI 10.1109/TGRS.2004.827262
   Cook DC, 2007, ECOL APPL, V17, P1832, DOI 10.1890/06-1632.1
   CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411
   Emry DJ, 2011, J APPL ECOL, V48, P1391, DOI 10.1111/j.1365-2664.2011.02050.x
   Giardino C, 2007, REMOTE SENS ENVIRON, V109, P183, DOI 10.1016/j.rse.2006.12.017
   Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x
   He KS, 2011, DIVERS DISTRIB, V17, P381, DOI 10.1111/j.1472-4642.2011.00761.x
   Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616
   Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922
   Jorgensen RH, 2009, FLORA, V204, P289, DOI 10.1016/j.flora.2008.03.002
   KLINKHAMER PGL, 1992, FUNCT ECOL, V6, P308, DOI 10.2307/2389522
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lass LW, 2005, WEED SCI, V53, P242, DOI 10.1614/WS-04-044R2
   Leishman JG, 2002, PRINCIPLES HELICOPTE
   Lucas R, 2008, REMOTE SENS ENVIRON, V112, P2088, DOI 10.1016/j.rse.2007.10.011
   Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2
   MACK RN, 2005, INVASIVE ALIEN SPECI, P179
   Martin-Herrero J, 2007, IEEE T GEOSCI REMOTE, V45, P1386, DOI 10.1109/TGRS.2007.894569
   Mendez-Rial R, 2012, IEEE GEOSCI REMOTE S, V9, P214, DOI 10.1109/LGRS.2011.2164050
   Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517
   Panetta FD, 2005, DIVERS DISTRIB, V11, P435, DOI 10.1111/j.1366-9516.2005.00179.x
   Peerbhay KY, 2013, ISPRS J PHOTOGRAMM, V79, P19, DOI 10.1016/j.isprsjprs.2013.01.013
   Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002
   Platt J, 1999, P ADV KERNEL METHODS, P185
   Reguera-Salgado J, 2012, INT GEOSCI REMOTE SE, P4086, DOI 10.1109/IGARSS.2012.6350729
   Reguera-Salgado J, 2012, IEEE T GEOSCI REMOTE, V50, P4409, DOI 10.1109/TGRS.2012.2192938
   Sanz-Elorza M., 2001, Lazaroa, V22, P121
   Scholkopf B., 1997, SUPPORT VECTOR LEARN
   Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X
   Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x
   Underwood EC, 2007, ENVIRON MANAGE, V39, P63, DOI 10.1007/s00267-005-0228-9
   Vapnik V., 1995, NATURE STAT LEARNING
   Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x
NR 37
TC 14
Z9 14
U1 2
U2 37
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 10
PY 2014
VL 9
IS 7
AR e102381
DI 10.1371/journal.pone.0102381
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AK9RG
UT WOS:000338763800097
PM 25010601
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wang, MTM
   Gamble, G
   Bolland, MJ
   Grey, A
AF Wang, Michael T. M.
   Gamble, Greg
   Bolland, Mark J.
   Grey, Andrew
TI Press Releases Issued by Supplements Industry Organisations and
   Non-Industry Organisations in Response to Publication of Clinical
   Research Findings: A Case-Control Study
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; VITAMIN-D SUPPLEMENTATION;
   CARDIOVASCULAR-DISEASE; FOLIC-ACID; CALCIUM SUPPLEMENTATION;
   MYOCARDIAL-INFARCTION; DIETARY-SUPPLEMENTS; PHYSICIANS HEALTH;
   WOMENS-HEALTH; CANCER-RISK
AB Background: Dietary supplement use is increasing despite lack of evidence of benefits, or evidence of harm. Press releases issued by the supplements industry might contribute to this situation by using 'spin' (strategies to hype or denigrate findings) to distort the results of clinical studies. We assessed press releases issued in response to publication of clinical studies on dietary supplements.
   Methods and Findings: We analyzed 47 supplements industry press releases and 91 non-industry press releases and news stories, generated in response to 46 clinical studies of dietary supplements published between 1/1/2005 and 5/31/2013. The primary outcome was 'spin' content and direction. We also assessed disposition towards use of dietary supplements, reporting of study information, and dissemination of industry press releases. More supplements industry press releases (100%) contained 'spin' than non-industry media documents (55%, P<0.001). Hyping 'spin' scores were higher in industry than non-industry media documents for studies reporting benefit of supplements (median 'spin' score 3.3, 95% CI 1.0-5.5 vs 0.5, 0-1.0; P<0.001). Denigratory 'spin' scores were higher in industry than non-industry media documents for studies reporting no effect (6.0, 5.0-7.0 vs 0, 0-0; P<0.001) or harm (6.0, 5.5-7.5 vs 0, 0-0.5; P<0.001) from a supplement. Industry press releases advocated supplement use in response to >90% of studies that reported no benefit, or harm, of the supplement. Industry press releases less frequently reported study outcomes, sample size, and estimates of effect size than non-industry media documents (all P<0.001), particularly for studies that reported no benefit of supplements. Industry press releases were referenced by 148 news stories on the websites of 6 organizations that inform manufacturers, retailers and consumers of supplements.
   Conclusions: Dietary supplements industry press releases issued in response to clinical research findings are characterized by 'spin' that hypes results that are favourable to supplement use and denigrates results that are not.
C1 [Wang, Michael T. M.; Gamble, Greg; Bolland, Mark J.; Grey, Andrew] Univ Auckland, Dept Med, Auckland, New Zealand.
RP Grey, A (reprint author), Univ Auckland, Dept Med, Auckland, New Zealand.
EM a.grey@auckland.ac.nz
RI Bolland, Mark/A-7554-2008
OI Bolland, Mark/0000-0003-0465-2674; Wang, Michael T.
   M./0000-0001-8334-3911
FU University of Auckland; Health Research Council of New Zealand
FX Michael Wang is the recipient of a University of Auckland summer
   studentship to conduct this work. Mark Bolland is the recipient of a
   Hercus Fellowship from the Health Research Council of New Zealand
   (http://www.hrc.govt.nz/). Neither funder had a role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Albertazzi P, 2002, CLIMACTERIC, V5, P374, DOI 10.1080/713605304
   Armitage JM, 2010, JAMA-J AM MED ASSOC, V303, P2486, DOI 10.1001/jama.2010.840
   Bacon CJ, 2011, NEW ZEAL MED J, V124, P55
   Bailey RL, 2013, JAMA INTERN MED, V173, P355, DOI 10.1001/jamainternmed.2013.2299
   Barry MJ, 2011, JAMA-J AM MED ASSOC, V306, P1344, DOI 10.1001/jama.2011.1364
   Bent S, 2006, NEW ENGL J MED, V354, P557, DOI 10.1056/NEJMoa053085
   Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617
   Bjelakovic G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007176
   Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842
   Bjelakovic G, 2013, JAMA-J AM MED ASSOC, V310, P1178, DOI 10.1001/jama.2013.277028
   Blendon RJ, 2013, JAMA INTERN MED, V173, P74, DOI 10.1001/2013.jamainternmed.311
   Bolland MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3691
   Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227
   Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651
   Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997
   Christen WG, 2009, ARCH INTERN MED, V169, P335, DOI 10.1001/archinternmed.2008.574
   Clarke R, 2010, ARCH INTERN MED, V170, P1622, DOI 10.1001/archinternmed.2010.348
   Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771
   Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351
   de Vet HCW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2125
   Denison HJ, 2012, J NUTR HEALTH AGING, V16, P307, DOI 10.1007/s12603-012-0016-1
   Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622
   Gaziano JM, 2012, JAMA-J AM MED ASSOC, V308, P1871, DOI 10.1001/jama.2012.14641
   Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560
   Grey A, 2014, JAMA INTERN MED, V174, P460, DOI 10.1001/jamainternmed.2013.12765
   Grilli R., 2002, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD000389
   Haas JS, 2004, ANN INTERN MED, V140, P184, DOI 10.7326/0003-4819-140-3-200402030-00009
   Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218
   Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437
   Kramer H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047458
   Kuriya B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002828
   Kwak SM, 2012, ARCH INTERN MED, V172, P686, DOI 10.1001/archinternmed.2012.262
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lappe JM, 2007, AM J CLIN NUTR, V85, P1586
   Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56
   Li KR, 2012, HEART, V98, P920, DOI 10.1136/heartjnl-2011-301345
   Lin J, 2009, JNCI-J NATL CANCER I, V101, P14, DOI 10.1093/jnci/djn438
   Lin J, 2007, ARCH INTERN MED, V167, P1050, DOI 10.1001/archinte.167.10.1050
   Lonn E, 2006, NEW ENGL J MED, V354, P1567
   Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338
   Makrides M, 2010, JAMA-J AM MED ASSOC, V304, P1675, DOI 10.1001/jama.2010.1507
   Michaelsson K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f228
   Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110
   Murdoch DR, 2012, JAMA-J AM MED ASSOC, V308, P1333, DOI 10.1001/jama.2012.12505
   Mursu J, 2011, ARCH INTERN MED, V171, P1625, DOI 10.1001/archinternmed.2011.445
   Neuhouser ML, 2009, ARCH INTERN MED, V169, P294, DOI 10.1001/archinternmed.2008.540
   Park Y, 2009, ARCH INTERN MED, V169, P391, DOI 10.1001/archinternmed.2008.578
   Prasad V, 2012, JAMA-J AM MED ASSOC, V307, P37, DOI 10.1001/jama.2011.1960
   Prince RL, 2006, ARCH INTERN MED, V166, P869, DOI 10.1001/archinte.166.8.869
   Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510
   Reichenbach S, 2007, ANN INTERN MED, V146, P580, DOI 10.7326/0003-4819-146-8-200704170-00009
   Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374
   Sawitzke AD, 2008, ARTHRITIS RHEUM, V58, P3183, DOI 10.1002/art.23973
   Schwartz LM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8164
   Schwartz LM, 2004, ANN INTERN MED, V140, P226, DOI 10.7326/0003-4819-140-3-200402030-00015
   Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600
   Sesso HD, 2012, JAMA-J AM MED ASSOC, V308, P1751, DOI 10.1001/jama.2012.14805
   Shah SA, 2007, LANCET INFECT DIS, V7, P473, DOI 10.1016/S1473-3099(07)70160-3
   Snitz BE, 2009, JAMA-J AM MED ASSOC, V302, P2663, DOI 10.1001/jama.2009.1913
   Tatsioni A, 2007, JAMA-J AM MED ASSOC, V298, P2517, DOI 10.1001/jama.298.21.2517
   The Age-Related Eye Disease Study 2 Research G, 2013, JAMA OPHTHALMOL, P1
   The DIPART Group, 2010, BMJ-BRIT MED J, V340, pb5463, DOI DOI 10.1136/BMJ.B5463
   Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222
   Wandel S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4675
   Woloshin S, 2009, ANN INTERN MED, V150, P613, DOI 10.7326/0003-4819-150-9-200905050-00007
   Xiao Q, 2013, JAMA INTERN MED, V173, P639, DOI 10.1001/jamainternmed.2013.3283
   Yavchitz A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001308
NR 67
TC 7
Z9 7
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 3
PY 2014
VL 9
IS 7
AR e101533
DI 10.1371/journal.pone.0101533
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AO3RT
UT WOS:000341253400086
PM 24992571
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Brown, AW
   Allison, DB
AF Brown, Andrew W.
   Allison, David B.
TI Using Crowdsourcing to Evaluate Published Scientific Literature: Methods
   and Example
SO PLOS ONE
LA English
DT Article
AB Systematically evaluating scientific literature is a time consuming endeavor that requires hours of coding and rating. Here, we describe a method to distribute these tasks across a large group through online crowdsourcing. Using Amazon's Mechanical Turk, crowdsourced workers (microworkers) completed four groups of tasks to evaluate the question, "Do nutrition-obesity studies with conclusions concordant with popular opinion receive more attention in the scientific community than do those that are discordant?'' 1) Microworkers who passed a qualification test (19% passed) evaluated abstracts to determine if they were about human studies investigating nutrition and obesity. Agreement between the first two raters' conclusions was moderate (kappa = 0.586), with consensus being reached in 96% of abstracts. 2) Microworkers iteratively synthesized free-text answers describing the studied foods into one coherent term. Approximately 84% of foods were agreed upon, with only 4 and 8% of ratings failing manual review in different steps. 3) Microworkers were asked to rate the perceived obesogenicity of the synthesized food terms. Over 99% of responses were complete and usable, and opinions of the microworkers qualitatively matched the authors' expert expectations (e.g., sugar-sweetened beverages were thought to cause obesity and fruits and vegetables were thought to prevent obesity). 4) Microworkers extracted citation counts for each paper through Google Scholar. Microworkers reached consensus or unanimous agreement for all successful searches. To answer the example question, data were aggregated and analyzed, and showed no significant association between popular opinion and attention the paper received as measured by Scimago Journal Rank and citation counts. Direct microworker costs totaled $221.75, (estimated cost at minimum wage: $312.61). We discuss important points to consider to ensure good quality control and appropriate pay for microworkers. With good reliability and low cost, crowdsourcing has potential to evaluate published literature in a cost-effective, quick, and reliable manner using existing, easily accessible resources.
C1 [Brown, Andrew W.; Allison, David B.] Univ Alabama Birmingham, Sch Publ Hlth, Nutr Obes Res Ctr, Off Energet, Birmingham, AL 35294 USA.
RP Brown, AW (reprint author), Univ Alabama Birmingham, Sch Publ Hlth, Nutr Obes Res Ctr, Off Energet, Birmingham, AL 35294 USA.
EM awbrown@uab.edu
RI Brown, Andrew W/N-1826-2013
OI Brown, Andrew W/0000-0002-1758-8205; Allison, David/0000-0003-3566-9399
FU National Institutes of Health [NIDDK P30DK056336, NIDDK T32DK62710-01A1]
FX This project was supported by National Institutes of Health
   (http://nih.gov) grants NIDDK P30DK056336 and NIDDK T32DK62710-01A1. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aday L. A, 2011, DESIGNING CONDUCTING
   Brown AW, 2013, AM J CLIN NUTR, V98, P1298, DOI 10.3945/ajcn.113.064410
   CONGER AJ, 1980, PSYCHOL BULL, V88, P322, DOI 10.1037/0033-2909.88.2.322
   Harzing AW, 2013, SCIENTOMETRICS, V94, P1057, DOI 10.1007/s11192-012-0777-7
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mortensen Jonathan M, 2013, AMIA Annu Symp Proc, V2013, P1020
   NAACL, 2010, WORKSH CREAT SPEECH
   Warby SC, 2014, NAT METHODS, V11, P385, DOI [10.1038/NMETH.2855, 10.1038/nmeth.2855]
   Yavchitz A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001308
NR 9
TC 14
Z9 14
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 2
PY 2014
VL 9
IS 7
AR e100647
DI 10.1371/journal.pone.0100647
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AO5BA
UT WOS:000341354100035
PM 24988466
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Taina, M
   Korhonen, M
   Haataja, M
   Muuronen, A
   Arponen, O
   Hedman, M
   Jakala, P
   Sipola, P
   Mustonen, P
   Vanninen, R
AF Taina, Mikko
   Korhonen, Miika
   Haataja, Mika
   Muuronen, Antti
   Arponen, Otso
   Hedman, Marja
   Jakala, Pekka
   Sipola, Petri
   Mustonen, Pirjo
   Vanninen, Ritva
TI Morphological and Volumetric Analysis of Left Atrial Appendage and Left
   Atrium: Cardiac Computed Tomography-Based Reproducibility Assessment
SO PLOS ONE
LA English
DT Article
ID 3-DIMENSIONAL TRANSESOPHAGEAL ECHOCARDIOGRAPHY; CRYPTOGENIC STROKE;
   FIBRILLATION; RISK; ANGIOGRAPHY; CLOSURE; PREDICTOR; FLOW
AB Objectives: Left atrial appendage (LAA) dilatation and morphology may influence an individual's risk for intracardiac thrombi and ischemic stroke. LAA size and morphology can be evaluated using cardiac computed tomography (cCT). The present study evaluated the reproducibility of LAA volume and morphology assessments.
   Methods: A total of 149 patients (47 females; mean age 60.9 +/- 10.6 years) with suspected cardioembolic stroke/transient ischemic attack underwent cCT. Image quality was rated based on four categories. Ten patients were selected from each image quality category (N = 40) for volumetric reproducibility analysis by two individual readers. LAA and left atrium (LA) volume were measured in both two-chamber (2CV) and transversal view (TV) orientation. Intertechnique reproducibility was assessed between 2CV and TV (200 measurement pairs). LAA morphology (A = Cactus, B = ChickenWing, C = WindSock, D = CauliFlower), LAA opening height, number of LAA lobes, trabeculation, and orientation of the LAA tip was analysed in all study subjects by three individual readers (447 interobserver measurement pairs). The reproducibility of volume measurements was assessed by intra-class correlation (ICC) and the reproducibility of LAA morphology assessments by Cohen's kappa.
   Results: The intra-observer and interobserver reproducibility of LAA and LA volume measurements was excellent (ICCs>0.9). The LAA (ICC = 0.954) and LA (ICC = 0.945) volume measurements were comparable between 2CV and TV. Morphological classification (kappa = 0.24) and assessments of LAA opening height (kappa = 0.1), number of LAA lobes (kappa = 0.16), trabeculation (kappa = 0.15), and orientation of the LAA tip (kappa = 0.37) was only slightly to fairly reproducible.
   Conclusions: LA and LAA volume measurements on cCT provide excellent reproducibility, whereas visual assessment of LAA morphological features is challenging and results in unsatisfactory agreement between readers.
C1 [Taina, Mikko; Korhonen, Miika; Haataja, Mika; Muuronen, Antti; Arponen, Otso; Hedman, Marja; Sipola, Petri; Vanninen, Ritva] Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland.
   [Taina, Mikko; Korhonen, Miika; Haataja, Mika; Muuronen, Antti; Arponen, Otso; Sipola, Petri; Vanninen, Ritva] Univ Eastern Finland, Inst Clin Med, Radiol Unit, Kuopio, Finland.
   [Hedman, Marja] Kuopio Univ Hosp, Ctr Heart, SF-70210 Kuopio, Finland.
   [Jakala, Pekka] Kuopio Univ Hosp, NeuroCtr, SF-70210 Kuopio, Finland.
   [Jakala, Pekka] Univ Eastern Finland, Inst Clin Med, Neurol Unit, Kuopio, Finland.
   [Mustonen, Pirjo] Keski Suomi Cent Hosp, Dept Cardiol, Jyvaskyla, Finland.
RP Taina, M (reprint author), Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland.
EM Mikko.Taina@kuh.fi
FU Kuopio University Hospital [5063519]
FX This study was supported by the Kuopio University Hospital (grant number
   5063519). Kuopio University Hospital web site: www.psshp.fi. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Al-Saady NM, 1999, HEART, V82, P547, DOI 10.1136/hrt.82.5.547
   Amarenco P, 2009, CEREBROVASC DIS, V27, P97, DOI 10.1159/000200446
   Anwar AM, 2010, INT J CARDIOVAS IMAG, V26, P519, DOI 10.1007/s10554-010-9593-4
   Artang R, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-16
   Bang OY, 2003, ANN NEUROL, V54, P227, DOI 10.1002/ana.10644
   Bauer M, 2001, Z KARDIOL, V90, P535, DOI 10.1007/s003920170121
   Beinart R, 2011, J CARDIOVASC ELECTR, V22, P10, DOI 10.1111/j.1540-8167.2010.01854.x
   BOUZASMOSQUERA A, 2011, CMAJ, V183, P657, DOI DOI 10.1503/CMAJ.091688.PUBMED:21609990
   Burrell LD, 2013, AM J CARDIOL, V112, P1148, DOI 10.1016/j.amjcard.2013.05.062
   Chen OD, 2012, CHINESE MED J-PEKING, V125, P3416, DOI 10.3760/cma.j.issn.0366-6999.2012.19.010
   Di Biase L, 2012, J AM COLL CARDIOL, V60, P531, DOI 10.1016/j.jacc.2012.04.032
   Erol B, 2011, EUR J RADIOL, V80, pE346, DOI 10.1016/j.ejrad.2010.11.008
   Fagan SM, 2000, ECHOCARDIOGR-J CARD, V17, P365, DOI 10.1111/j.1540-8175.2000.tb01152.x
   Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238
   Handke M, 2005, J AM SOC ECHOCARDIOG, V18, P1366, DOI 10.1016/j.echo.2005.05.006
   Ho ICK, 2007, HEART RHYTHM, V4, P567, DOI 10.1016/j.hrthm.2007.01.014
   Hur J, 2009, RADIOLOGY, V251, P683, DOI 10.1148/radiol.2513090794
   Kamp O, 1999, EUR HEART J, V20, P979, DOI 10.1053/euhj.1998.1453
   Kataoka A, 2011, INT J CARDIOL, V153, P47, DOI 10.1016/j.ijcard.2010.08.036
   Kaur H, 2013, J NEMATOL, V45, P122
   Khurram IM, 2013, HEART RHYTHM, V10, P1843, DOI 10.1016/j.hrthm.2013.09.065
   Kimura T, 2013, HEART RHYTHM, V10, P921, DOI 10.1016/j.hrthm.2013.01.036
   Kondratyev E, 2013, EUR J RADIOL, V82, P2233, DOI [10.1016/j.ejrad.2013.08.053, 10.1016/j.ejrad.2011.08.053]
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Landmesser U, 2012, EUR HEART J, V33, P698, DOI 10.1093/eurheartj/ehr393
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Mahabadi Amir A, 2009, J Cardiovasc Comput Tomogr, V3, P80, DOI 10.1016/j.jcct.2009.02.002
   Michael KA, 2009, J CARDIOVASC ELECTR, V20, P1217, DOI 10.1111/j.1540-8167.2009.01537.x
   Nakajima H, 2010, AM J CARDIOL, V106, P885, DOI 10.1016/j.amjcard.2010.05.014
   Nedios S, 2011, J INTERV CARD ELECTR, V32, P87, DOI 10.1007/s10840-011-9591-z
   Nucifora G, 2011, CIRC-CARDIOVASC IMAG, V4, P514, DOI 10.1161/CIRCIMAGING.111.963892
   Palios John, 2014, Thrombosis, V2014, P832752, DOI 10.1155/2014/832752
   Park HC, 2013, INT J CARDIOVAS IMAG, V29, P935, DOI 10.1007/s10554-012-0161-y
   Sipola P, 2013, CEREBROVASC DIS, V35, P521, DOI 10.1159/000350734
   Stojanovska J, 2011, AM J ROENTGENOL, V197, P631, DOI 10.2214/AJR.10.5955
   Taina M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079519
   Wang Y, 2010, J CARDIOVASC ELECTR, V21, P973, DOI 10.1111/j.1540-8167.2010.01814.x
NR 37
TC 8
Z9 9
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 2
PY 2014
VL 9
IS 7
AR e101580
DI 10.1371/journal.pone.0101580
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AO5BA
UT WOS:000341354100115
PM 24988467
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Asner, SA
   Science, ME
   Tran, D
   Smieja, M
   Merglen, A
   Mertz, D
AF Asner, Sandra A.
   Science, Michelle E.
   Dat Tran
   Smieja, Marek
   Merglen, Arnaud
   Mertz, Dominik
TI Clinical Disease Severity of Respiratory Viral Co-Infection versus
   Single Viral Infection: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID COMMUNITY-ACQUIRED PNEUMONIA; HUMAN METAPNEUMOVIRUS; HOSPITALIZED
   INFANTS; TRACT INFECTIONS; SYNCYTIAL VIRUS; CHILDREN; MULTIPLE
AB Background: Results from cohort studies evaluating the severity of respiratory viral co-infections are conflicting. We conducted a systematic review and meta-analysis to assess the clinical severity of viral co-infections as compared to single viral respiratory infections.
   Methods: We searched electronic databases and other sources for studies published up to January 28, 2013. We included observational studies on inpatients with respiratory illnesses comparing the clinical severity of viral co-infections to single viral infections as detected by molecular assays. The primary outcome reflecting clinical disease severity was length of hospital stay (LOS). A random-effects model was used to conduct the meta-analyses.
   Results: Twenty-one studies involving 4,280 patients were included. The overall quality of evidence applying the GRADE approach ranged from moderate for oxygen requirements to low for all other outcomes. No significant differences in length of hospital stay (LOS) (mean difference (MD) -0.20 days, 95% CI -0.94, 0.53, p = 0.59), or mortality (RR 2.44, 95% CI 0.86, 6.91, p = 0.09) were documented in subjects with viral co-infections compared to those with a single viral infection. There was no evidence for differences in effects across age subgroups in post hoc analyses with the exception of the higher mortality in preschool children (RR 9.82, 95% CI 3.09, 31.20, p<0.001) with viral co-infection as compared to other age groups (I 2 for subgroup analysis 64%, p = 0.04).
   Conclusions: No differences in clinical disease severity between viral co-infections and single respiratory infections were documented. The suggested increased risk of mortality observed amongst children with viral co-infections requires further investigation.
C1 [Asner, Sandra A.; Science, Michelle E.; Dat Tran] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Infect Dis, Toronto, ON M5G 1X8, Canada.
   [Smieja, Marek; Mertz, Dominik] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.
   [Smieja, Marek; Mertz, Dominik] McMaster Univ, Dept Med, Hamilton, ON, Canada.
   [Smieja, Marek] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.
   [Merglen, Arnaud] Univ Toronto, Hosp Sick Children, Div Paediat Med, Toronto, ON M5G 1X8, Canada.
   [Merglen, Arnaud] Univ Toronto, Hosp Sick Children, Paediat Outcomes Res Team, Toronto, ON M5G 1X8, Canada.
   [Merglen, Arnaud] Univ Hosp Geneva, Div Gen Paediat, Geneva, Switzerland.
   [Merglen, Arnaud] Univ Geneva, Fac Med, Geneva, Switzerland.
   [Asner, Sandra A.] Univ Lausanne Hosp, Dept Paediat, Paediat Infect Dis Unit, Lausanne, Switzerland.
   [Asner, Sandra A.] Univ Lausanne Hosp, Div Infect Dis, Dept Med, Lausanne, Switzerland.
   [Smieja, Marek; Mertz, Dominik] Hamilton Hlth Sci, Hamilton, ON, Canada.
   [Smieja, Marek; Mertz, Dominik] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.
RP Mertz, D (reprint author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.
EM mertzd@mcmaster.ca
FU Hamilton Health Sciences Foundation; Swiss National Science Foundation
   [PBGEP3-139828]; Canadian Institutes of Health Research (CIHR)
FX DM is a recipient of a Research Early Career Award from Hamilton Health
   Sciences Foundation (Jack Hirsh Fellowship). AM is a recipient of a
   Swiss National Science Foundation postdoctoral fellowship
   (PBGEP3-139828). Dr. Marek Smieja is a recipient of a Canadian
   Institutes of Health Research (CIHR) New Investigator Award. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Aramburo A, 2011, PEDIATR CRIT CARE ME, V12, pE160, DOI 10.1097/PCC.0b013e3181f36e86
   Blyth CC, 2013, INFLUENZA OTHER RESP, V7, P168, DOI 10.1111/j.1750-2659.2012.00360.x
   Brozek J, 2008, GRADEPRO VERSION 3 2
   Calvo C, 2008, J CLIN VIROL, V42, P268, DOI 10.1016/j.jcv.2008.03.012
   Camargo C, 2012, BRAZ J INFECT DIS, V16, P180, DOI 10.1590/S1413-86702012000200013
   Canducci F, 2008, J MED VIROL, V80, P716, DOI 10.1002/jmv.21108
   Cheuk DKL, 2007, PEDIATR INFECT DIS J, V26, P995, DOI 10.1097/INF.0013618158063
   Choi SH, 2012, AM J RESP CRIT CARE, V186, P325, DOI [10.1164/rccm.201112-2240OC, 10.1164/rccm.201112.2240OC]
   Cilla G, 2008, J MED VIROL, V80, P1843, DOI 10.1002/jmv.21271
   DaPalma T, 2010, VIRUS RES, V149, P1, DOI 10.1016/j.virusres.2010.01.002
   De Paulis M, 2011, J PEDIAT-BRAZIL, V87, P307, DOI [10.2223/JPED.2100, 10.1590/S0021-75572011000400006]
   Drews AL, 1997, CLIN INFECT DIS, V25, P1421, DOI 10.1086/516137
   Esper FP, 2011, J INFECTION, V63, P260, DOI 10.1016/j.jinf.2011.04.004
   Franz A, 2010, J CLIN VIROL, V48, P239, DOI 10.1016/j.jcv.2010.05.007
   Garcia-Garcia ML, 2010, PEDIATR PULM, V45, P585, DOI 10.1002/ppul.21225
   Garcia-Garcia ML, 2006, ARCH DIS CHILD, V91, P290, DOI 10.1136/adc.2005.082388
   Gerna G, 2008, J CLIN VIROL, V41, P49, DOI 10.1016/j.jcv.2007.10.018
   Goka E, 2012, INFLUENZA OTHER RESP
   Guerrier G, 2013, PEDIATR INFECT DIS J, V32, pE8, DOI 10.1097/INF.0b013e31826fd40d
   Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017
   Henssge U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021430
   Horn SD, 2002, J PEDIATR-US, V141, P496, DOI 10.1067/mpd.20020.126925
   Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Manager R, 2011, REVM VERS 5 1
   Marcos MA, 2011, EUR RESPIR J, V38, P739, DOI 10.1183/09031936.00168610
   Marguet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004596
   Martin ET, 2012, INFLUENZA OTHER RESP, V6, P71, DOI 10.1111/j.1750-2659.2011.00265.x
   Metersky ML, 2012, INT J INFECT DIS, V16, pE321, DOI 10.1016/j.ijid.2012.01.003
   Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005
   Nascimento MS, 2010, CLINICS, V65, P1133, DOI 10.1590/S1807-59322010001100014
   Nascimento-Carvalho CM, 2011, INFLUENZA OTHER RESP, V5, P285, DOI 10.1111/j.1750-2659.2011.00206.x
   Prill MM, 2012, PEDIATR INFECT DIS J, V31, P235, DOI 10.1097/INF.0b013e31823e07fe
   Rhedin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051491
   Simunovic N, 2010, CAN MED ASSOC J, V182, P1609, DOI 10.1503/cmaj.092220
   Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117
   Tran D, 2013, J PEDIAT RIO J
   Wells G, 2010, NEWCASTLE OTTAWA SCA
NR 39
TC 43
Z9 45
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 16
PY 2014
VL 9
IS 6
AR e99392
DI 10.1371/journal.pone.0099392
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AJ5PV
UT WOS:000337738600030
PM 24932493
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kim, JT
   Heo, SH
   Lee, JS
   Park, MH
   Oh, DS
   Choi, KH
   Kim, IG
   Ha, YS
   Chang, H
   Choo, IS
   Ahn, SH
   Jeong, SK
   Shin, BS
   Park, MS
   Cho, KH
AF Kim, Joon-Tae
   Heo, Suk-Hee
   Lee, Ji Sung
   Park, Myeong-Ho
   Oh, Dong-Seok
   Choi, Kang-Ho
   Kim, Ihn-Gyu
   Ha, Yeon Soo
   Chang, Hyuk
   Choo, In Sung
   Ahn, Seong Hwan
   Jeong, Seul-Ki
   Shin, Byoung-Soo
   Park, Man-Seok
   Cho, Ki-Hyun
TI To Do or Not to Do; Dilemma of Intra-Arterial Revascularization in Acute
   Ischemic Stroke
SO PLOS ONE
LA English
DT Article
ID IMAGING LESION VOLUME; EARLY CT SCORE; PLASMINOGEN-ACTIVATOR;
   NONCONTRAST CT; MECHANICAL THROMBECTOMY; ENDOVASCULAR TREATMENT;
   COMPUTED-TOMOGRAPHY; DWI-ASPECTS; THERAPY; DIFFUSION
AB Background: There has still been lack of evidence for definite imaging criteria of intra-arterial revascularization (IAR). Therefore, IAR selection is left largely to individual clinicians. In this study, we sought to investigate the overall agreement of IAR selection among different stroke clinicians and factors associated with good agreement of IAR selection.
   Methods: From the prospectively registered data base of a tertiary hospital, we identified consecutive patients with acute ischemic stroke. IAR selection based on the provided magnetic resonance imaging (MRI) results and clinical information were independently performed by 5 independent stroke physicians currently working at 4 different university hospitals. MRI results were also reviewed by 2 independent experienced neurologists blinded to clinical data and physicians' IAR selection. The Alberta Stroke Program Early Computed Tomography Score (ASPECTS) was calculated on initial DWI and MU. We arbitrarily used ASPECTS differences between DWI and MU (D-M ASPECTS) to quantitatively evaluate mismatch.
   Results: The overall interobserver agreement of IAR selection was fair (kappa = 0.398). In patients with DWI-ASPECTS >6, interobserver agreement was moderate to substantial (0.398-0.620). In patients with D-M ASPECTS >4, interobserver agreement was moderate to almost perfect (0.532-1.000). Patients with higher DWI or D-M ASPECTS had better agreement of IAR selection.
   Conclusion: Our study showed that DWI-ASPSECTS >6 and D-M ASPECTS >4 had moderate to substantial agreement of IAR selection among different stroke physicians. However, there is still poor agreement as to whether IAR should not be performed in patients with lower DWI and D-M ASPECTS.
C1 [Kim, Joon-Tae; Park, Myeong-Ho; Oh, Dong-Seok; Choi, Kang-Ho; Kim, Ihn-Gyu; Park, Man-Seok; Cho, Ki-Hyun] Chonnam Natl Univ Hosp, Cerebrovasc Ctr, Dept Neurol, Kwangju, South Korea.
   [Heo, Suk-Hee] Chonnam Natl Univ, Dept Radiol, Hwasun Hosp, Hwasun, South Korea.
   [Lee, Ji Sung] Soonchunhyang Univ, Biostat Consulting Unit, Med Ctr, Seoul, South Korea.
   [Ha, Yeon Soo; Chang, Hyuk] Wonkwang Univ Hosp, Dept Neurol, Iksan, South Korea.
   [Choo, In Sung; Ahn, Seong Hwan] Chosun Univ Hosp, Dept Neurol, Kwangju, South Korea.
   [Jeong, Seul-Ki; Shin, Byoung-Soo] Chonbuk Natl Univ Med Sch & Hosp, Dept Neurol, Jeonju, South Korea.
RP Kim, JT (reprint author), Chonnam Natl Univ Hosp, Cerebrovasc Ctr, Dept Neurol, Kwangju, South Korea.
EM alldelight2@jnu.ac.kr; mspark@jnu.ac.kr
FU Chonnam National University Hospital Biomedical Research Institute [CRI
   13041-21]; Korea Healthcare Technology R&D Project, Ministry of Health
   and Welfare, Republic of Korea [HI10C2020]; Honam Stroke Society
FX This study was supported by a grant (CRI 13041-21) Chonnam National
   University Hospital Biomedical Research Institute. This study was
   supported by a grant of the Korea Healthcare Technology R&D Project,
   Ministry of Health and Welfare, Republic of Korea (HI10C2020). This
   study was supported by a research grant from the Honam Stroke Society.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alshekhlee A, 2012, NEUROLOGY, V79, pS126, DOI 10.1212/WNL.0b013e3182697e89
   Aoki J, 2013, STROKE, V44, P534, DOI 10.1161/STROKEAHA.112.675470
   Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6
   Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300
   Butcher K, 2008, STROKE, V39, P75, DOI 10.1161/STROKEAHA.107.490524
   Ciccone A, 2013, NEW ENGL J MED, V368, P904, DOI 10.1056/NEJMoa1213701
   de Margerie-Mellon C, 2013, STROKE, V44, P3565, DOI 10.1161/STROKEAHA.113.003047
   FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351
   Ferrari J, 2010, NEUROLOGY, V74, P136, DOI 10.1212/WNL.0b013e3181c9188b
   Finlayson O, 2013, STROKE, V44, P234, DOI 10.1161/STROKEAHA.112.665208
   Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003
   Gupta AC, 2012, AM J NEURORADIOL, V33, P1046, DOI 10.3174/ajnr.A2942
   Hill MD, 2002, STROKE, V33, P279, DOI 10.1161/hs0102.101900
   Hussain SI, 2012, NEUROLOGY, V79, pS135, DOI 10.1212/WNL.0b013e31826958a8
   Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a
   Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793
   Kim JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070996
   Kim JT, 2009, CEREBROVASC DIS, V28, P259, DOI 10.1159/000228256
   Kimura K, 2008, STROKE, V39, P2388, DOI 10.1161/STROKEAHA.107.510917
   Kruetzelmann A, 2011, STROKE, V42, P1251, DOI 10.1161/STROKEAHA.110.600148
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X
   Lin K, 2008, AM J NEURORADIOL, V29, P931, DOI 10.3174/ajnr.A0975
   Mazighi M, 2009, LANCET NEUROL, V8, P802, DOI 10.1016/S1474-4422(09)70182-6
   Morita N, 2009, MAGN RESON MED SCI, V8, P47, DOI 10.2463/mrms.8.47
   Nezu T, 2010, NEUROLOGY, V75, P555, DOI 10.1212/WNL.0b013e3181eccf78
   Nogueira RG, 2013, STROKE, V44, P3272, DOI 10.1161/STROKEAHA.113.002380
   Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9
   Psychogios MN, 2013, STROKE, V44, P2188, DOI 10.1161/STROKEAHA.113.001068
   Rajajee V, 2006, NEUROLOGY, V67, P980, DOI 10.1212/01.wnl.0000237520.88777.71
   Rubiera M, 2011, STROKE, V42, P993, DOI 10.1161/STROKEAHA.110.597104
   Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1
   Schellinger PD, 2010, NEUROLOGY, V75, P177, DOI 10.1212/WNL.0b013e3181e7c9dd
   Tei H, 2011, J NEUROL, V258, P559, DOI 10.1007/s00415-010-5787-x
   Yoo AJ, 2009, STROKE, V40, P2046, DOI 10.1161/STROKEAHA.108.541656
NR 35
TC 1
Z9 1
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 6
PY 2014
VL 9
IS 6
AR e99261
DI 10.1371/journal.pone.0099261
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AP1YS
UT WOS:000341869000115
PM 24906122
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Smith, D
   Wilkie, R
   Uthman, O
   Jordan, JL
   McBeth, J
AF Smith, Diane
   Wilkie, Ross
   Uthman, Olalekan
   Jordan, Joanne L.
   McBeth, John
TI Chronic Pain and Mortality: A Systematic Review
SO PLOS ONE
LA English
DT Review
ID CHRONIC WIDESPREAD PAIN; MUSCULOSKELETAL PAIN; PHYSICAL-ACTIVITY;
   FOLLOW-UP; SUBSEQUENT MORTALITY; INCREASED RISK; LIFE-STYLE; BACK-PAIN;
   BODY PAIN; CANCER
AB Background: Chronic pain is common, often widespread and has a substantial impact on health and quality of life. The relationship between chronic pain and mortality is unclear. This systematic review aimed to identify and evaluate evidence for a relationship between chronic pain and mortality.
   Methods: A search of ten electronic databases including EMBASE and MEDLINE was conducted in March 2012, and updated until March 2014. Observational studies investigating the association between chronic or widespread pain (including fibromyalgia) and mortality were included. Risk of bias was assessed and a meta-analysis was undertaken to quantify heterogeneity and pool results. A narrative review was undertaken to explore similarities and differences between the included studies.
   Results: Ten studies were included in the review. Three reported significant associations between chronic or widespread pain and mortality in unadjusted results. In adjusted analyses, four studies reported a significant association. The remaining studies reported no statistically significant association. A meta-analysis showed statistically significant heterogeneity of results from studies using comparable outcome measures (n = 7)(I-2 = 78.8%) and a modest but non-significant pooled estimate (MRR1.14,95% CI 0.95-1.37) for the relationship between chronic pain and all-cause mortality. This association was stronger when analysis was restricted to studies of widespread pain (n = 5, I-2 = 82.3%) MRR1.22(95% CI 0.93-1.60). The same pattern was observed with deaths from cancer and cardiovascular diseases. Heterogeneity is likely to be due to differences in study populations, follow-up time, pain phenotype, methods of analysis and use of confounding factors.
   Conclusion: This review showed a mildly increased risk of death in people with chronic pain, particularly from cancer. However, the small number of studies and methodological differences prevented clear conclusions from being drawn. Consistently applied definitions of chronic pain and further investigation of the role of health, lifestyle, social and psychological factors in future studies will improve understanding of the relationship between chronic pain and mortality.
C1 [Smith, Diane; Wilkie, Ross; Jordan, Joanne L.; McBeth, John] Keele Univ, Res Inst Primary Care & Hlth Sci, Arthrit Res UK Primary Care Ctr, Keele, Staffs, England.
   [Uthman, Olalekan] Univ Warwick, Warwick Med Sch, Div Hlth Sci, WCAHRD, Coventry CV4 7AL, W Midlands, England.
RP Smith, D (reprint author), Keele Univ, Res Inst Primary Care & Hlth Sci, Arthrit Res UK Primary Care Ctr, Keele, Staffs, England.
EM d.smith4@keele.ac.uk
RI Uthman, Olalekan/N-5584-2019; Jordan, Joanne/E-8186-2014
OI Uthman, Olalekan/0000-0002-8567-3081; Jordan,
   Joanne/0000-0002-7191-2977; McBeth, John/0000-0001-7047-2183
FU Arthritis Research UK Primary Care Centre, Primary Care Sciences, Keele
   University; Engineering and Physical Sciences Research Council
   [EP/E500579/1]; Medical Research Council [G0501798]
FX The authors' work was supported by Arthritis Research UK Primary Care
   Centre, Primary Care Sciences, Keele University. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ahmad R, 2005, J GERONTOL A-BIOL, V60, P1052, DOI 10.1093/gerona/60.8.1052
   Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806
   Andersson HI, 2009, DISABIL REHABIL, V31, P1980, DOI 10.3109/09638280902874154
   Andersson HI, 2004, EUR J PAIN, V8, P47, DOI 10.1016/S1090-3801(03)00064-8
   Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433
   Bergman S, 2005, DISABIL REHABIL, V27, P675, DOI 10.1080/09638280400009030
   Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009
   Carnes D, 2007, RHEUMATOLOGY, V46, P1168, DOI 10.1093/rheumatology/kem118
   Centre for Reviews Dissemination, 2009, SYST REV CRDS GUID U
   CROFT P, 1993, J RHEUMATOL, V20, P710
   Crombie IK, 2001, BMJ-BRIT MED J, V323, P662
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dickersin K, 2002, INT J EPIDEMIOL, V31, P6, DOI 10.1093/ije/31.1.6
   Ditre JW, 2008, J ABNORM PSYCHOL, V117, P467, DOI 10.1037/0021-843X.117.2.467
   Dreyer L, 2007, J RHEUMATOL, V34, P201
   Dreyer L, 2010, ARTHRITIS RHEUM-US, V62, P3101, DOI 10.1002/art.27623
   Egger M, 2001, SYSTEMATIC REV HEALT
   Elliott AM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-158
   Fagerstrom K, 2002, DRUGS, V62, P1, DOI 10.2165/00003495-200262002-00001
   Fishbain DA, 2003, PAIN MED, V4, P51, DOI 10.1046/j.1526-4637.2003.03008.x
   Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008
   Hardy SE, 2008, J AM GERIATR SOC, V56, P1910, DOI 10.1111/j.1532-5415.2008.01957.x
   Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010
   HELIOVAARA M, 1995, SPINE, V20, P2109, DOI 10.1097/00007632-199510000-00008
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hochber MC, 2008, CLIN EXP RHEUMATOL, V26, pS120
   House JS, 2001, PSYCHOSOM MED, V63, P273, DOI 10.1097/00006842-200103000-00011
   Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193
   Hunt IM, 1999, RHEUMATOLOGY, V38, P275, DOI 10.1093/rheumatology/38.3.275
   Jordan K, 2010, BR J GEN PRACT, P105
   Jordan KP, 2013, INT J CANCER, V133, P713, DOI 10.1002/ijc.28055
   Kamaleri Y, 2008, PAIN, V138, P41, DOI 10.1016/j.pain.2007.11.002
   Kareholt I, 1998, PAIN, V77, P271, DOI 10.1016/S0304-3959(98)00103-1
   Khang YH, 2010, J WOMENS HEALTH, V19, P109, DOI 10.1089/jwh.2009.1413
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liu YP, 2011, EUR UROL, V60, P1029, DOI 10.1016/j.eururo.2011.07.007
   Macfarlane GJ, 2007, RHEUMATOLOGY, V46, P805, DOI 10.1093/rheumatology/ke1403
   Macfarlane GJ, 2001, BMJ-BRIT MED J, V323, P1
   MAKELA M, 1991, BRIT MED J, V303, P216, DOI 10.1136/bmj.303.6796.216
   Maruta T, 1998, PAIN, V74, P199, DOI 10.1016/S0304-3959(97)00182-6
   McBeth J, 2003, ARTHRITIS RHEUM, V48, P1686, DOI 10.1002/art.10973
   McBeth J, 2009, RHEUMATOLOGY, V48, P74, DOI 10.1093/rheumatology/ken424
   McBeth J, 2007, BEST PRACT RES CL RH, V21, P403, DOI 10.1016/j.berh.2007.03.003
   Merskey H., 1994, CLASSIFICATION CHRON
   Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98
   Moulin Dwight E, 2002, Pain Res Manag, V7, P179
   Mykletun A, 2009, BRIT J PSYCHIAT, V195, P118, DOI 10.1192/bjp.bp.108.054866
   Nitter AK, 2013, SCAND J PAIN, V4, P86, DOI 10.1016/j.sjpain.2012.12.002
   PENTTINEN J, 1994, BRIT MED J, V309, P1267, DOI 10.1136/bmj.309.6964.1267
   Ray L, 2011, PAIN, V152, P53, DOI 10.1016/j.pain.2010.08.043
   Ryan R, 2014, COCHRANE CONSUM COMM, V2014
   Sha MC, 2005, AM J MED, V118, P301, DOI 10.1016/j.amjmed.2004.12.015
   Sjogren P, 2010, CLIN J PAIN, V26, P763, DOI 10.1097/AJP.0b013e3181f15daf
   Smith BH, 2003, BRIT J GEN PRACT, V53, P45
   Tang NKY, 2006, PSYCHOL MED, V36, P575, DOI 10.1017/S0033291705006859
   Torrance N, 2010, EUR J PAIN, V14, P380, DOI 10.1016/j.ejpain.2009.07.006
   VanDenKerkhof EG, 2011, PAIN RES MANAG, V16, P87, DOI 10.1155/2011/727094
   Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351
   WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203
   Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594
   Wolfe F, 2011, ARTHRIT CARE RES, V63, P94, DOI 10.1002/acr.20301
   Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140
   Woolf AD, 2012, BEST PRACT RES CL RH, V26, P183, DOI 10.1016/j.berh.2012.03.005
NR 63
TC 29
Z9 29
U1 0
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 5
PY 2014
VL 9
IS 6
AR e99048
DI 10.1371/journal.pone.0099048
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI4NF
UT WOS:000336841400091
PM 24901358
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Liu, J
   Li, M
   Li, Z
   Zuo, XL
   Li, CQ
   Dong, YY
   Zhou, CJ
   Li, YQ
AF Liu, Jing
   Li, Ming
   Li, Zhen
   Zuo, Xiu-Li
   Li, Chang-Qing
   Dong, Yan-Yan
   Zhou, Cheng-Jun
   Li, Yan-Qing
TI Learning Curve and Interobserver Agreement of Confocal Laser
   Endomicroscopy for Detecting Precancerous or Early-Stage Esophageal
   Squamous Cancer
SO PLOS ONE
LA English
DT Article
ID GASTROINTESTINAL-TRACT; CELL CARCINOMA; DIAGNOSIS; ACCURACY; DYSPLASIA;
   NEOPLASIA; LESIONS
AB Background: Confocal laser endomicroscopy (CLE) can provide in vivo subcellular resolution images of esophageal lesions. However, the learning curve in interpreting CLE images of precancerous or early-stage esophageal squamous cancer is unknown. The goal of this study is to evaluate the diagnostic accuracy and inter-observer agreement for differentiating esophageal lesions in CLE images among experienced and inexperienced observers and to assess the learning curve.
   Method: After a short training, 8 experienced and 14 inexperienced endoscopists evaluated in sequence 4 sets of high-quality CLE images. Their diagnoses were corrected and discussed after each set. For each image, the diagnostic results, confidence in diagnosis, quality and time to evaluate were recorded.
   Results: Overall, diagnostic accuracy was greater for the second, third, fourth set of images as compared with the initial set (odds ratio [OR] 2.01, 95% CI 1.22-3.31; 7.95, 3.74-16.87; and 6.45, 3.14-13.27), respectively, with no difference between the third and fourth sets in accuracy (p = 0.67). Previous experience affected the diagnostic accuracy only in the first set of images (OR 3.70, 1.87-7.29, p < 0.001). Inter-observer agreement was higher for experienced than inexperienced endoscopists (0.732 vs. 0.666, p < 0.01)
   Conclusion: CLE is a promising technology that can be quickly learned after a short training period; previous experience is associated with diagnostic accuracy only at the initial stage of learning.
C1 [Liu, Jing; Li, Ming; Li, Zhen; Zuo, Xiu-Li; Li, Chang-Qing; Dong, Yan-Yan; Li, Yan-Qing] Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan 250100, Peoples R China.
   [Liu, Jing] Shandong Univ, Qilu Hosp, Dept Anesthesiol, Jinan 250100, Peoples R China.
   [Zhou, Cheng-Jun] Shandong Univ, Affiliated Hosp 2, Dept Pathol, Jinan 250100, Peoples R China.
RP Li, YQ (reprint author), Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan 250100, Peoples R China.
EM Liyanqing@sdu.edu.cn
OI Li, Chang-Qing/0000-0003-4380-2284
CR Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010
   Buchner AM, 2011, GASTROINTEST ENDOSC, V73, P556, DOI 10.1016/j.gie.2011.01.002
   DAWSEY SM, 1993, GASTROENTEROLOGY, V105, P1333, DOI 10.1016/0016-5085(93)90137-2
   Gaddam S, 2011, AM J GASTROENTEROL, V106, P1961, DOI 10.1038/ajg.2011.294
   Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20
   Jemal A, 2004, CANCER, V101, P3, DOI 10.1002/cncr.20288
   Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Jeon SR, 2011, GASTROINTEST ENDOSC, V74, P772, DOI 10.1016/j.gie.2011.05.005
   Koh CE, 2011, SURG ENDOSC, V25, P947, DOI 10.1007/s00464-010-1259-8
   Kuiper T, 2012, GASTROINTEST ENDOSC, V75, P1211, DOI 10.1016/j.gie.2012.01.040
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Li M, 2012, GUT
   Li WB, 2011, GUT, V60, P299, DOI 10.1136/gut.2010.223586
   Lim LG, 2011, GASTROINTEST ENDOSC, V73, P1141, DOI 10.1016/j.gie.2011.01.068
   Liu H, 2009, ENDOSCOPY, V41, P99, DOI 10.1055/s-0028-1119492
   Pech O, 2008, CLIN GASTROENTEROL H, V6, P89, DOI 10.1016/j.cgh.2007.10.013
   Polglase AL, 2006, EXPERT REV MED DEVIC, V3, P549, DOI 10.1586/17434440.3.5.549
   Polglase AL, 2005, GASTROINTEST ENDOSC, V62, P686, DOI 10.1016/j.gie.2005.05.021
   Rispo A, 2012, WORLD J GASTRO ENDOS, V4, P414, DOI 10.4253/wjge.v4.i9.414
   Shahid MW, 2012, ENDOSCOPY, V44, P343, DOI 10.1055/s-0031-1291589
   Stolte M, 2003, VIRCHOWS ARCH, V442, P99, DOI 10.1007/s00428-002-0680-3
   Su P, 2013, COLORECTAL DIS, V15, pE1, DOI 10.1111/codi.12033
   Ussui VM, 2012, GASTROENT RES PRACT, DOI 10.1155/2012/545679
NR 23
TC 6
Z9 6
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 4
PY 2014
VL 9
IS 6
AR e99089
DI 10.1371/journal.pone.0099089
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AK4YO
UT WOS:000338430700116
PM 24897112
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tagliafico, A
   Bignotti, B
   Tagliafico, G
   Astengo, D
   Martino, L
   Airaldi, S
   Signori, A
   Sormani, MP
   Houssami, N
   Calabrese, M
AF Tagliafico, Alberto
   Bignotti, Bianca
   Tagliafico, Giulio
   Astengo, Davide
   Martino, Lucia
   Airaldi, Sonia
   Signori, Alessio
   Sormani, Maria Pia
   Houssami, Nehmat
   Calabrese, Massimo
TI Breast Density Assessment Using a 3T MRI System: Comparison among
   Different Sequences
SO PLOS ONE
LA English
DT Article
ID CANCER RISK PREDICTION; X-RAY MAMMOGRAPHY; MAGNETIC-RESONANCE; DIGITAL
   MAMMOGRAPHY; PARENCHYMAL PATTERNS; TISSUE DENSITY; WOMEN; WATER; FAT;
   CLASSIFICATION
AB Purpose: To compare MRI sequences for breast density measurements on a 3T MRI system using IDEAL (Iterative Decomposition of water and fat with Echo Asymmetry and Least squares estimation) as possible physiology-like reference.
   Materials and Methods: MRI examination was performed in 48 consecutive patients (mean age 41, years; range, 35-67 years) on a 3.0T scanner and 46 were included. All (fertile) women, were examined between days 5 and 15 of their menstrual cycle. MRI protocol included: T1-turbo spin-echo (T1-tSE), T2-turbo spin-echo (T2-tSE), VIBRANT (Volume Imaging for Breast Assessment) before and after injection of contrast media and IDEAL. Breast density was calculated with semi-automated software. Statistical analysis was performed with non-parametric tests.
   Results: Mean percentage of breast density calculated in each sequence was: T1-tSE = 56%; T2-tSE = 52%; IDEAL FatOnly = 55%; IDEAL WaterOnly = 53%, VIBRANT = 55%. Significant differences were observed between T2-tSE and both T1-tSE (p<0.001), VIBRANT sequences (p = 0.009), T1-tSE and both IDEAL WaterOnly (p = 0.007) and IDEAL FatOnly (p = 0.047). Breast density percentage showed a positive linear correlation among different sequences: r >= 0.93.
   Conclusions: Differences exist between MRI sequences used to assess breast density percentage. T1-weighted sequences values were similar to IDEAL sequences.
C1 [Tagliafico, Alberto] Univ Genoa, Dept Expt Med, Inst Anat, Genoa, Italy.
   [Bignotti, Bianca; Astengo, Davide; Martino, Lucia; Airaldi, Sonia] Univ Genoa, Dept Radiol, Genoa, Italy.
   [Tagliafico, Giulio] CNR, IMATI, Ist Matemat Applicata & Tecnol Informat, Genoa, Italy.
   [Signori, Alessio; Sormani, Maria Pia] Univ Genoa, Dept Hlth Sci, Inst Stat, Genoa, Italy.
   [Houssami, Nehmat] Univ Sydney, Sydney Med Sch, Sch Publ Hlth, STEP, Sydney, NSW 2006, Australia.
   [Calabrese, Massimo] IRCCS Azienda Osped Univ San Martino, Ist Ist Nazl Ric Canc, Dept Diagnost Senol, Genoa, Italy.
RP Tagliafico, A (reprint author), Univ Genoa, Dept Expt Med, Inst Anat, Genoa, Italy.
EM alberto.tagliafico@unige.it
RI Signori, Alessio/L-3081-2016
OI Signori, Alessio/0000-0001-6289-9144; TAGLIAFICO,
   ALBERTO/0000-0003-1736-0697
CR BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670
   Byng JW, 1998, RADIOGRAPHICS, V18, P1587, DOI 10.1148/radiographics.18.6.9821201
   Darabi H, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3110
   Diorio C, 2005, CANCER EPIDEM BIOMAR, V14, P1065, DOI 10.1158/1055-9965.EPI-04-0706
   DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263
   Eng-Wong J, 2008, CANCER EPIDEM BIOMAR, V17, P1696, DOI 10.1158/1055-9965.EPI-07-2752
   GLOVER GH, 1991, JMRI-J MAGN RESON IM, V1, P521, DOI 10.1002/jmri.1880010504
   Graham SJ, 1996, BRIT J CANCER, V73, P162, DOI 10.1038/bjc.1996.30
   Gram IT, 1997, EUR J RADIOL, V24, P131, DOI 10.1016/S0720-048X(96)01138-2
   Gram IT, 2005, BREAST CANCER RES, V7, pR854, DOI 10.1186/bcr1308
   Harvey JA, 2004, RADIOLOGY, V230, P29, DOI 10.1148/radiol.2301020870
   Highnam R, 2007, PHYS MED BIOL, V52, P5881, DOI 10.1088/0031-9155/52/19/010
   Houssami N, 2012, CURR BREAST CANC REP, DOI [10.1007/s12609-012-0070-z, DOI 10.1007/S12609-012-0070-Z.]
   JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376
   Jordan CD, 2013, J MAGN RESON IMAGING, V37, P227, DOI 10.1002/jmri.23762
   Khazen M, 2008, CANCER EPIDEM BIOMAR, V17, P2268, DOI 10.1158/1055-9965.EPI-07-2547
   Klifa C, 2004, P ANN INT IEEE EMBS, V26, P1667
   Klifa C, 2010, MAGN RESON IMAGING, V28, P8, DOI 10.1016/j.mri.2009.05.040
   Kopans DB, 2008, RADIOLOGY, V246, P348, DOI 10.1148/radiol.2461070309
   Krishnamurthy R, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-68
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee NA, 1997, AM J ROENTGENOL, V168, P501, DOI 10.2214/ajr.168.2.9016235
   Lobbes MBI, 2012, INSIGHTS IMAGING, V3, P91, DOI 10.1007/s13244-011-0139-7
   Lu LJW, 2012, PHYS MED BIOL, V57, P6903, DOI 10.1088/0031-9155/57/21/6903
   Martin LJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1831
   McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965-EPI-06-0034
   Pineda AR, 2005, MAGNET RESON MED, V54, P625, DOI 10.1002/mrm.20623
   POON CS, 1992, J NATL CANCER I, V84, P777, DOI 10.1093/jnci/84.10.777
   Reeder SB, 2004, MAGNET RESON MED, V51, P35, DOI 10.1002/mrm.10675
   Reeder SB, 2007, J MAGN RESON IMAGING, V25, P644, DOI 10.1002/jmri.20831
   Sardanelli F, 2010, EUR J CANCER, V46, P1296, DOI 10.1016/j.ejca.2010.02.015
   Tagliafico A, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130528
   Tagliafico A, 2012, RADIOL MED, V117, P992, DOI 10.1007/s11547-012-0831-9
   Tagliafico A, 2013, BREAST CANCER RES TR, V138, P311, DOI 10.1007/s10549-013-2419-z
   Tagliafico A, 2012, EUR RADIOL, V22, P1265, DOI 10.1007/s00330-012-2380-y
   Tagliafico A, 2011, EUR J ENDOCRINOL, V164, P335, DOI 10.1530/EJE-10-0896
   Tagliafico A, 2009, BREAST, V18, P35, DOI 10.1016/j.breast.2008.09.005
   Thompson DJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2447
   Tice JA, 2005, BREAST CANCER RES TR, V94, P115, DOI 10.1007/s10549-005-5152-4
   Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081653
   Wei J, 2004, MED PHYS, V31, P933, DOI 10.1118/1.1668512
NR 41
TC 18
Z9 18
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 3
PY 2014
VL 9
IS 6
AR e99027
DI 10.1371/journal.pone.0099027
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI5ML
UT WOS:000336911400121
PM 24892933
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ferguson, MK
   Thompson, K
   Huisingh-Scheetz, M
   Farnan, J
   Hemmerich, JA
   Slawinski, K
   Acevedo, J
   Lee, SM
   Rojnica, M
   Small, S
AF Ferguson, Mark K.
   Thompson, Katherine
   Huisingh-Scheetz, Megan
   Farnan, Jeanne
   Hemmerich, Josh A.
   Slawinski, Kris
   Acevedo, Julissa
   Lee, Sang Mee
   Rojnica, Marko
   Small, Stephen
TI Thoracic Surgeons' Perception of Frail Behavior in Videos of
   Standardized Patients
SO PLOS ONE
LA English
DT Article
ID OLDER-ADULTS; SURGICAL OUTCOMES; POSTOPERATIVE COMPLICATIONS; GERIATRIC
   ASSESSMENT; PREDICTION; MORBIDITY; MORTALITY; INDEX; COST; RISK
AB Background: Frailty is a predictor of poor outcomes following many types of operations. We measured thoracic surgeons' accuracy in assessing patient frailty using videos of standarized patients demonstrating signs of physical frailty. We compared their performance to that of geriatrics specialists.
   Methods: We developed an anchored scale for rating degree of frailty. Reference categories were assigned to 31 videos of standarized patients trained to exhibit five levels of activity ranging from "vigorous" to "frail." Following an explanation of frailty, thoracic surgeons and geriatrics specialists rated the videos. We evaluated inter-rater agreement and tested differences between ratings and reference categories. The influences of clinical specialty, clinical experience, and self-rated expertise were examined.
   Results: Inter-rater rank correlation among all participants was high (Kendall's W 0.85) whereas exact agreement (Fleiss' kappa) was only moderate (0.47). Better inter-rater agreement was demonstrated for videos exhibiting extremes of behavior. Exact agreement was better for thoracic surgeons (n = 32) than geriatrics specialists (n = 9; p = 0.045), whereas rank correlation was similar for both groups. More clinical years of experience and self-reported expertise were not associated with better inter-rater agreement.
   Conclusions: Videos of standarized patients exhibiting varying degrees of frailty are rated with internal consistency by thoracic surgeons as accurately as geriatrics specialists when referenced to an anchored scale. Ratings were less consistent for moderate degrees of frailty, suggesting that physicians require training to recognize early frailty. Such videos may be useful in assessing and teaching frailty recognition.
C1 [Ferguson, Mark K.; Rojnica, Marko] Univ Chicago, Dept Surg, Chicago, IL 60637 USA.
   [Thompson, Katherine; Huisingh-Scheetz, Megan; Farnan, Jeanne; Hemmerich, Josh A.] Univ Chicago, Dept Med, Chicago, IL 60637 USA.
   [Slawinski, Kris] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA.
   [Acevedo, Julissa] Univ Chicago, Ctr Res Informat, Chicago, IL 60637 USA.
   [Lee, Sang Mee] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA.
   [Small, Stephen] Univ Chicago, Dept Anesthesiol & Crit Care, Chicago, IL 60637 USA.
RP Ferguson, MK (reprint author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.
EM mferguso@surgery.bsd.uchicago.edu
FU NCATS NIH HHS [UL1 TR000430]
CR Ber R, 2001, ACAD MED, V76, P656, DOI 10.1097/00001888-200106000-00022
   Birkmeyer JD, 2012, ANN SURG, V255, P1, DOI 10.1097/SLA.0b013e3182402c17
   Carey K, 2011, MED CARE RES REV, V68, P490, DOI 10.1177/1077558710396378
   Dale W, 2014, ANN SURG, V259, P960, DOI 10.1097/SLA.0000000000000226
   Dasgupta M, 2009, ARCH GERONTOL GERIAT, V48, P78, DOI 10.1016/j.archger.2007.10.007
   Ferguson MK, 2010, ANN THORAC SURG, V89, P1037, DOI 10.1016/j.athoracsur.2009.12.068
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Hamaker ME, 2012, LANCET ONCOL, V13, pE437, DOI 10.1016/S1470-2045(12)70259-0
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Hodari A, 2013, ANN THORAC SURG, V96, P1240, DOI 10.1016/j.athoracsur.2013.05.051
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Maan ZN, 2012, BRIT J SURG, V99, P1610, DOI 10.1002/bjs.8893
   Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028
   Pol RA, 2011, EUR J VASC ENDOVASC, V42, P824, DOI 10.1016/j.ejvs.2011.07.006
   Revenig LM, 2013, J AM COLL SURGEONS, V217, P665, DOI 10.1016/j.jamcollsurg.2013.06.012
   Robinson TN, 2011, AM J SURG, V202, P511, DOI 10.1016/j.amjsurg.2011.06.017
   Robinson TN, 2011, J AM COLL SURGEONS, V213, P37, DOI 10.1016/j.jamcollsurg.2011.01.056
   Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051
   Sundermann S, 2011, EUR J CARDIO-THORAC, V39, P33, DOI 10.1016/j.ejcts.2010.04.013
   Tsiouris A, 2013, J SURG RES, V183, P40, DOI 10.1016/j.jss.2012.11.059
   Woodfield JC, 2007, WORLD J SURG, V31, P1912, DOI 10.1007/s00268-007-9178-0
NR 21
TC 6
Z9 6
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 3
PY 2014
VL 9
IS 6
AR e98654
DI 10.1371/journal.pone.0098654
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI5ML
UT WOS:000336911400079
PM 24892734
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Fischer, A
   Kraff, O
   Maderwald, S
   Beiderwellen, K
   Ladd, ME
   Forsting, M
   Lauenstein, TC
   Umutlu, L
AF Fischer, Anja
   Kraff, Oliver
   Maderwald, Stefan
   Beiderwellen, Karsten
   Ladd, Mark E.
   Forsting, Michael
   Lauenstein, Thomas C.
   Umutlu, Lale
TI Non-Enhanced T1-Weighted Liver Vessel Imaging at 7 Tesla
SO PLOS ONE
LA English
DT Article
ID NEPHROGENIC SYSTEMIC FIBROSIS; ENHANCED MR-ANGIOGRAPHY; FAST SPIN-ECHO;
   PREOPERATIVE EVALUATION; HEPATIC VASCULATURE; INITIAL-EXPERIENCE; CT
   ANGIOGRAPHY; PRECESSION; ANATOMY; DONORS
AB Objectives: Aim of the study was to assess the feasibility and to compare three non-enhanced T1-weighted (w) sequences for liver vessel imaging at 7 Tesla (T).
   Material and Methods: 12 healthy volunteers were examined on a 7 T whole-body MR-system. The following non-enhanced sequences were acquired: T1w 2D FLASH, T1w 3D FLASH and Time of flight (TOF)-MRA. Qualitative image analysis was performed by two radiologists including over all image quality as well as vessel delineation of the liver arteries, liver veins and portal vein and the presence of artifacts using a five-point scale (5 = excellent vessel delineation to 1 = non-diagnostic). Contrast ratios (CR), SNR und CNR of the above named vessels in correlation to adjacent liver tissue were calculated for quantitative assessment. For statistical analysis, a Wilcoxon Rank Test was applied.
   Results: All three sequences provided a homogenous hyperintense delineation of the assessed liver vessels. Qualitative image analysis demonstrated the superiority of TOF-MRA, providing best overall image quality (TOF 4.17, 2D FLASH 3.42, 3D FLASH 3.46; p < 0.01) as well as highest image quality values for all analyzed liver vessel segments. TOF-MRA was least impaired by B-1 inhomogeneity (4.13) and susceptibility artifacts (4.63) out of all three sequences (p < 0.01). Quantitative image analysis confirmed the superiority of TOF MRA showing significant higher CR values for all liver vessels (e. g. right hepatic artery TOF 0.47, 2D FLASH 0.09, 3D FLASH 0.11 with p = 0.02 and 0.01, respectively). Providing the lowest standard deviation in noise, TOF showed highest values for SNR and CNR.
   Conclusions: Non-enhanced T1w imaging in general and TOF MRA in particular, appear to be promising techniques for high quality non-enhanced liver vessel assessment at 7 T.
C1 [Fischer, Anja; Beiderwellen, Karsten; Ladd, Mark E.; Forsting, Michael; Lauenstein, Thomas C.; Umutlu, Lale] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.
   [Fischer, Anja; Kraff, Oliver; Maderwald, Stefan; Beiderwellen, Karsten; Ladd, Mark E.; Umutlu, Lale] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany.
   [Ladd, Mark E.] German Canc Res Ctr, Heidelberg, Germany.
RP Fischer, A (reprint author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.
EM anja.fischer@uk-essen.de
RI Maderwald, Stefan/B-4241-2011
CR Aslam R, 2010, MAGN RESON IMAGING C, V18, P515, DOI 10.1016/j.mric.2010.08.005
   Bernstein MA, 2006, J MAGN RESON IMAGING, V24, P735, DOI 10.1002/jmri.20698
   Bitz AK, 2009, ISMRM, V4767
   Carr JC, 2003, J VASC INTERV RADIOL, V14, P441, DOI 10.1097/01.RVI.0000064853.87207.42
   Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01
   Dietrich O, 2008, MAGN RESON IMAGING, V26, P754, DOI 10.1016/j.mri.2008.02.001
   Duan Q, 2013, NMR BIOMED, V26, P1070, DOI 10.1002/nbm.2920
   Fischer A, 2013, INVEST RADIOL, V48, P525, DOI 10.1097/RLI.0b013e3182839c2b
   Grinstead JW, 2010, ISMRM, V18, P1429
   Grobner T, 2007, KIDNEY INT, V72, P260, DOI 10.1038/sj.ki5002338
   Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1104, DOI 10.1093/ndt/gfk062
   Hoult DI, 2000, J MAGN RESON IMAGING, V12, P46, DOI 10.1002/1522-2586(200007)12:1<46::AID-JMRI6>3.3.CO;2-4
   *INT EL COMM, 2002, 60601233 IEC
   Johst S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086274
   Ladd Mark E, 2007, Top Magn Reson Imaging, V18, P139, DOI 10.1097/RMR.0b013e3180f612b3
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lauenstein TC, 2007, J MAGN RESON IMAGING, V26, P1198, DOI 10.1002/jmri.21136
   Lee MW, 2007, EUR RADIOL, V17, P1074, DOI 10.1007/s00330-006-0447-3
   Lee MW, 2006, J MAGN RESON IMAGING, V24, P1081, DOI 10.1002/jmri.20726
   Maderwald S, 2008, MAGN RESON MATER PHY, V21, P159, DOI 10.1007/s10334-007-0096-9
   Metzger GJ, 2010, ISMRM, V403
   Metzger GJ, 2013, MAGN RESON MED, V69, P114, DOI 10.1002/mrm.24237
   Monninghoff C, 2009, ROFO-FORTSCHR RONTG, V181, P16, DOI 10.1055/s-2008-1027863
   Moser E, 2012, NMR BIOMED, V25, P695, DOI 10.1002/nbm.1794
   Orzada S, 2009, ISMRM, V2999
   Puippe GD, 2012, EUR J RADIOL, V81, pE823, DOI 10.1016/j.ejrad.2012.02.016
   Ramalho Miguel, 2007, Magn Reson Imaging Clin N Am, V15, P321, DOI 10.1016/j.mric.2007.06.003
   Saba L, 2008, CLIN RADIOL, V63, P312, DOI 10.1016/j.crad.2007.05.023
   Sacolick LI, 2010, MAGN RESON MED, V63, P1315, DOI 10.1002/mrm.22357
   Sahani D, 2004, RADIOGRAPHICS, V24, P1367, DOI 10.1148/rg.245035224
   Shimada K, 2009, AM J ROENTGENOL, V193, P106, DOI 10.2214/AJR.08.1626
   Shimada K, 2009, J MAGN RESON IMAGING, V29, P1140, DOI 10.1002/jmri.21753
   Shimada K, 2009, EUR J RADIOL, V70, P111, DOI 10.1016/j.ejrad.2007.12.010
   Shimada K, 2009, J MAGN RESON IMAGING, V29, P474, DOI 10.1002/jmri.21636
   Streitparth F, 2007, ACTA RADIOL, V48, P20, DOI 10.1080/02841850601045146
   Uchida K, 2010, LIVER TRANSPLANT, V16, P1062, DOI 10.1002/lt.22109
   Umutlu L, 2012, INVEST RADIOL, V36, P714
   Umutlu L, 2013, ACAD RADIOL, V20, P628, DOI 10.1016/j.acra.2012.12.012
   Umutlu L, 2013, EUR J RADIOL, V82, P760, DOI 10.1016/j.ejrad.2011.07.004
   Umutlu L, 2011, INVEST RADIOL, V46, P425, DOI 10.1097/RLI.0b013e31820e1467
   Vaughan TT, 2009, MAGN RESON MED, V61, P244, DOI 10.1002/mrm.21751
   Wrede KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084562
   Wu X, 2014, QUANT IMAGING MED SU, V4, P4
NR 43
TC 4
Z9 4
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 2
PY 2014
VL 9
IS 6
AR e97465
DI 10.1371/journal.pone.0097465
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI6CB
UT WOS:000336956300019
PM 24887206
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zhang, HF
   Wang, F
   Ding, L
   Zhang, ZY
   Sun, DR
   Feng, XM
   An, JL
   Zhu, Y
AF Zhang, Haifei
   Wang, Feng
   Ding, Lin
   Zhang, Zhiyu
   Sun, Deri
   Feng, Xinmin
   An, Jiuli
   Zhu, Yue
TI A Meta Analysis of Lumbar Spinal Fusion Surgery Using Bone Morphogenetic
   Proteins and Autologous Iliac Crest Bone Graft
SO PLOS ONE
LA English
DT Article
ID PROTEIN-2/COMPRESSION RESISTANT MATRIX; INSTRUMENTED POSTEROLATERAL
   FUSIONS; RADIOGRAPHIC OUTCOMES; OSTEOGENIC PROTEIN-1; PUBLICATION BIAS;
   SITE MORBIDITY; RHBMP-2; SAFETY; METAANALYSIS; AUTOGRAFT
AB Background: Bone morphogenetic protein (BMPs) as a substitute for iliac crest bone graft (ICBG) has been increasingly widely used in lumbar fusion. The purpose of this study is to systematically compare the effectiveness and safety of fusion with BMPs for the treatment of lumbar disease.
   Methods: Cochrane review methods were used to analyze all relevant randomized controlled trials (RCTs) published up to nov 2013.
   Results: 19 RCTs (1,852 patients) met the inclusion criteria. BMPs group significantly increased fusion rate (RR: 1.13; 95% CI 1.05-1.23, P = 0.001), while there was no statistical difference in overall success of clinical outcomes (RR: 1.04; 95% CI 0.95-1.13, P = 0.38) and complications (RR: 0.96; 95% CI 0.85-1.09, p = 0.54). A significant reduction of the reoperation rate was found in BMPs group (RR: 0.57; 95% CI 0.42-0.77, p = 0.0002). Significant difference was found in the operating time (MD-0.32; 95% CI-0.55, -0.08; P = 0.009), but no significant difference was found in the blood loss, the hospital stay, patient satisfaction, and work status.
   Conclusion: Compared with ICBG, BMPs in lumbar fusion can increase the fusion rate, while reduce the reoperation rate and operating time. However, it doesn't increase the complication rate, the amount of blood loss and hospital stay. No significant difference was found in the overall success of clinical outcome of the two groups.
C1 [Zhang, Haifei; Wang, Feng; Zhang, Zhiyu; Sun, Deri; Feng, Xinmin; An, Jiuli] China Med Univ, Affiliated Hosp 4, Dept Orthoped, Shenyang, Peoples R China.
   [Ding, Lin] China Med Univ, Ctr Comp, Shenyang, Peoples R China.
   [Zhu, Yue] China Med Univ, Affiliated Hosp 1, Dept Orthoped, Shenyang, Peoples R China.
RP Zhu, Y (reprint author), China Med Univ, Affiliated Hosp 1, Dept Orthoped, Shenyang, Peoples R China.
EM zhuyuedr@163.com
CR Agarwal R, 2009, J NEUROSURG-SPINE, V11, P729, DOI 10.3171/2009.6.SPINE08669
   Ahlmann E, 2002, J BONE JOINT SURG AM, V84A, P716, DOI 10.2106/00004623-200205000-00003
   An H, 2003, SPINE, V28, pS24, DOI 10.1097/00007632-200308011-00005
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300, DOI 10.1097/00003086-199608000-00037
   Assiri I, 2004, CAN J SURG S, V47, P7
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Benglis D, 2008, NEUROSURGERY, V62, P423, DOI 10.1227/01.neu.0000326030.24220.d8
   BLUMENTHAL SL, 1993, SPINE, V18, P1186, DOI 10.1097/00007632-199307000-00010
   Boden SD, 2000, SPINE, V25, P376, DOI 10.1097/00007632-200002010-00020
   Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005
   Burkus JK, 2005, J BONE JOINT SURG AM, V87A, P1205, DOI 10.2106/JBJS.D.02532
   Burkus JK, 2003, SPINE, V28, P372, DOI 10.1097/00007632-200302150-00012
   Burkus JK, 2002, J SPINAL DISORD TECH, V15, P337, DOI 10.1097/00024720-200210000-00001
   Burkus JK, 2002, SPINE, V27, P2396, DOI 10.1097/01.BRS.0000030193.26290.DD
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843
   Chen ZG, 2012, ARCH ORTHOP TRAUM SU, V132, P1725, DOI 10.1007/s00402-012-1607-3
   Dawson E, 2009, J BONE JOINT SURG AM, V91A, P1604, DOI 10.2106/JBJS.G.01157
   Delawi D, 2010, SPINE, V35, P1185, DOI 10.1097/BRS.0b013e3181d3cf28
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dimar JR, 2006, SPINE, V31, P2534, DOI 10.1097/01.brs.0000240715.78657.81
   Dimar JR, 2009, J BONE JOINT SURG AM, V91A, P1377, DOI 10.2106/JBJS.H.00200
   Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019
   Donell S, 2011, BONE MORPHOGENETIC P
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Ferrari J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000964.pub3
   Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006
   Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f
   Glassman SD, 2005, SPINE, V30, P1694, DOI 10.1097/01.brs.0000172157.39513.80
   Glassman SD, 2008, SPINE, V33, P2843, DOI 10.1097/BRS.0b013e318190705d
   Haid Regis W Jr, 2004, Spine J, V4, P527, DOI 10.1016/j.spinee.2004.03.025
   HUTCHINSON MR, 1994, SPINE, V19, P62, DOI 10.1097/00007632-199401000-00013
   Johnsson R, 2002, SPINE, V27, P2654, DOI 10.1097/00007632-200212010-00004
   Kanayama M, 2006, SPINE, V31, P1067, DOI 10.1097/01.brs.0000216444.01888.21
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Michielsen J, 2013, J BONE JOINT SURG AM, V95A, P873, DOI 10.2106/JBJS.L.00137
   Mroz TE, 2010, SPINE, V35, pS86, DOI 10.1097/BRS.0b013e3181d81ef2
   Mussano F, 2007, SPINE, V32, P824, DOI 10.1097/01.brs.0000259227.51180.ca
   Papakostidis C, 2008, SPINE, V33, pE680, DOI 10.1097/BRS.0b013e3181844eca
   Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/01.BRS.0000020734.34957.6A
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012
   Simmonds MC, 2013, ANN INTERN MED, V158, P877, DOI 10.7326/0003-4819-158-12-201306180-00005
   Sutton AJ, 2000, BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vaccaro AR, 2008, SPINE, V33, P2850, DOI 10.1097/BRS.0b013e31818a314d
   Vaccaro AR, 2005, SPINE, V30, P2709, DOI 10.1097/01.brs.0000190812.08447.ba
   Viera AJ, 2005, FAM MED, V37, P360
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 52
TC 8
Z9 8
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 2
PY 2014
VL 9
IS 6
AR e97049
DI 10.1371/journal.pone.0097049
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI6CB
UT WOS:000336956300011
PM 24886911
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Abram, NK
   Xofis, P
   Tzanopoulos, J
   MacMillan, DC
   Ancrenaz, M
   Chung, R
   Peter, L
   Ong, R
   Lackman, I
   Goossens, B
   Ambu, L
   Knight, AT
AF Abram, Nicola K.
   Xofis, Panteleimon
   Tzanopoulos, Joseph
   MacMillan, Douglas C.
   Ancrenaz, Marc
   Chung, Robin
   Peter, Lucy
   Ong, Robert
   Lackman, Isabelle
   Goossens, Benoit
   Ambu, Laurentius
   Knight, Andrew T.
TI Synergies for Improving Oil Palm Production and Forest Conservation in
   Floodplain Landscapes
SO PLOS ONE
LA English
DT Article
ID CLASSIFICATION; EXPANSION; SABAH; DEFORESTATION; CORRIDORS; EMISSIONS;
   STATE; CODE
AB Lowland tropical forests are increasingly threatened with conversion to oil palm as global demand and high profit drives crop expansion throughout the world's tropical regions. Yet, landscapes are not homogeneous and regional constraints dictate land suitability for this crop. We conducted a regional study to investigate spatial and economic components of forest conversion to oil palm within a tropical floodplain in the Lower Kinabatangan, Sabah, Malaysian Borneo. The Kinabatangan ecosystem harbours significant biodiversity with globally threatened species but has suffered forest loss and fragmentation. We mapped the oil palm and forested landscapes (using object-based-image analysis, classification and regression tree analysis and on-screen digitising of high-resolution imagery) and undertook economic modelling. Within the study region (520,269 ha), 250,617 ha is cultivated with oil palm with 77% having high Net-Present-Value (NPV) estimates ($413/ha(-yr)-$637/ha(-yr)); but 20.5% is under-producing. In fact 6.3% (15,810 ha) of oil palm is commercially redundant (with negative NPV of $-299/ha(-yr)-$-65/ha(-yr)) due to palm mortality from flood inundation. These areas would have been important riparian or flooded forest types. Moreover, 30,173 ha of unprotected forest remain and despite its value for connectivity and biodiversity 64% is allocated for future oil palm. However, we estimate that at minimum 54% of these forests are unsuitable for this crop due to inundation events. If conversion to oil palm occurs, we predict a further 16,207 ha will become commercially redundant. This means that over 32,000 ha of forest within the floodplain would have been converted for little or no financial gain yet with significant cost to the ecosystem. Our findings have globally relevant implications for similar floodplain landscapes undergoing forest transformation to agriculture such as oil palm. Understanding landscape level constraints to this crop, and transferring these into policy and practice, may provide conservation and economic opportunities within these seemingly high opportunity cost landscapes.
C1 [Abram, Nicola K.; Tzanopoulos, Joseph; MacMillan, Douglas C.] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England.
   [Abram, Nicola K.; Ancrenaz, Marc; Lackman, Isabelle] HUTAN Kinabatangan Orang Utan Conservat Programme, Kota Kinabalu, Sabah, Malaysia.
   [Abram, Nicola K.] Living Landscape Alliance, Reading, Berks, England.
   [Abram, Nicola K.; Ancrenaz, Marc] People & Nat Consulting Int, Borneo Futures initiat, Jakarta, Indonesia.
   [Xofis, Panteleimon] Technol Educ Inst Kavala, Dept Forestry & Management Nat Environm, Drama, Greece.
   [Ancrenaz, Marc] North England Zool Soc, Chester, Cheshire, England.
   [Chung, Robin] CH Williams Talhar & Wong Sabah Sdn Bhd, Sandakan, Sabah, Malaysia.
   [Peter, Lucy; Goossens, Benoit] Sabah Wildlife Dept, Danau Girang Field Ctr, Kota Kinabalu, Sabah, Malaysia.
   [Ong, Robert] Sabah Wildlife Dept, Forest Res Ctr, Sandakan, Sabah, Malaysia.
   [Goossens, Benoit] Cardiff Univ, Sch Biosci, Organisms & Environm Div, Cardiff CF10 3AX, S Glam, Wales.
   [Goossens, Benoit; Ambu, Laurentius] Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia.
   [Knight, Andrew T.] Imperial Coll London, Dept Life Sci, Ascot, Berks, England.
   [Knight, Andrew T.] Nelson Mandela Metrropolitan Univ, Dept Bot, Port Elizabeth, Eastern Cape, South Africa.
RP Abram, NK (reprint author), Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England.
EM nicola_abram@hotmail.com
RI MA, Lei/I-4597-2014
OI Knight, Andrew/0000-0002-6563-0500
FU RICS Research Trust; U.S. Fish and Wildlife Service's Great Ape Fund;
   Arcus Foundation; Department of Life Sciences at Imperial College
   London, UK; ARC Centre of Excellence in Environmental Decisions,
   University of Queensland, Australia
FX NKA thanks RICS Research Trust, U.S. Fish and Wildlife Service's Great
   Ape Fund and the Arcus Foundation for financial support; Planet Action
   and Trimble for providing satellite imagery and the Definiens eCognition
   License. ATK acknowledges support from the Department of Life Sciences
   at Imperial College London, UK, and ARC Centre of Excellence in
   Environmental Decisions, University of Queensland, Australia. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abram NK, 2013, SPATIAL PLANNING CON
   Abram NK, 2013, ECOSYSTEM SERVICES
   Alexander S, 2011, OPPORTUNITIES CHALLE
   Ancrenaz M, 2004, ANIM CONSERV, V7, P375, DOI 10.1017/S136794300400157X
   Ancrenaz M, ORYX IN PRESS
   [Anonymous], SOIL SUIT MAP AGR
   Benz UC, 2004, ISPRS J PHOTOGRAMM, V58, P239, DOI 10.1016/j.isprsjprs.2003.10.002
   Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024
   Brown KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024107
   Butchart SHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032529
   Butler RA, 2009, TROP CONSERV SCI, V2, P1, DOI 10.1177/194008290900200102
   Carlson KM, 2012, P NATL ACAD SCI USA, V109, P7559, DOI 10.1073/pnas.1200452109
   Cowling RM, 2003, BIOL CONSERV, V112, P1, DOI 10.1016/S0006-3207(02)00418-4
   CRIST EP, 1984, PHOTOGRAMM ENG REM S, V50, P343
   den Besten JW, 2013, EVOLUTION REDD ANAL
   Estes JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044601
   FAO, 2012, FAOSTAT ONL STAT SER
   FAO, 2009, FAOSTAT ONL STAT SER
   Feintrenie L, 2010, SMALL-SCALE FOR, V9, P379, DOI 10.1007/s11842-010-9122-2
   Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012
   Foody GM, 2006, REMOTE SENS ENVIRON, V103, P179, DOI 10.1016/j.rse.2006.04.001
   Garcia-Ulloa J, 2012, CONSERV LETT, V5, P366, DOI 10.1111/j.1755-263X.2012.00254.x
   Gilbert N, 2012, NATURE NEWS
   Gillies CS, 2008, P NATL ACAD SCI USA, V105, P19774, DOI 10.1073/pnas.0803530105
   Goossens B, 2005, MOL ECOL, V14, P441, DOI 10.1111/j.1365-294X.02421.x
   Hai TC, 2001, BALANCING NEED SUSTA
   Heumann BW, 2011, REMOTE SENS-BASEL, V3, P2440, DOI 10.3390/rs3112440
   Hoh C, 2001, OIL PALM CULTIVATION
   IDS, 2007, SAB DEV CORR SOC BLU
   Junk W.J., 1990, P491
   Knight AT, 2007, CONSERV BIOL, V21, P1124, DOI 10.1111/j.1523-1739.2007.00690.x
   Knight AT, 2010, CONSERV BIOL, V24, P1348, DOI 10.1111/j.1523-1739.2010.01494.x
   Koh LP, 2009, TRENDS ECOL EVOL, V24, P67, DOI 10.1016/j.tree.2008.09.006
   Lackman-Ancrenaz I, 2008, KINABATANGAN BIOSPHE
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Levin J, 2012, PROFITABILITY SUSTAI
   Li HT, 2010, INT J REMOTE SENS, V31, P1453, DOI 10.1080/01431160903475266
   Lindermayer DB, 2006, HABITAT FRAGMENTATIO
   Mantel S., 2007, BIOPHYSICAL LAND SUI
   McMorrow J, 2001, GLOBAL ENVIRON CHANG, V11, P217, DOI 10.1016/S0959-3780(00)00059-5
   Monserud RA, 1990, METHOD COMP GLOBAL V, P90
   MPOB, 2012, MAL OIL PALM STAT 20
   MPOB, 2010, PALM OIL COST PROD M
   MPOB, 2010, OIL PALM IND LAB ISS
   Nazeeb ATM, 2008, J OIL PALM RES, P61
   Ng P. H. C., 2013, Planter, V89, P409
   Paterson RRM, 2009, J PHYTOPATHOL, V157, P649, DOI 10.1111/j.1439-0434.2009.01553.x
   Roever CL, 2013, BIOL CONSERV, V157, P128, DOI 10.1016/j.biocon.2012.06.025
   RSPO, 2013, ROUNDT SUST PALM OIL
   Sabah Forestry Department, 2007, VEG ASS CLASS LOW KI
   Sabah Land Ordinance, 2010, STAT SAB LAND ORD SA
   Sabah State Government, 1998, SAB WAT RES EN
   Sabah Wildlife Department, 2012, SABAH WILDLIFE DEP M
   Sha John C.M., 2008, Primate Conservation, V23, P107, DOI 10.1896/052.023.0112
   Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006
   Stark DJ, 2009, PROBOSCIS MONKEY NAS
   Teoh CH, 2000, LAND USE OIL PALM IN
   Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X
   UNEP, 2011, OIL PALM PLANT THREA
   van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671
   Vermeulen S., 2006, BETTER PRACTICE SMAL
   Wilcove DS, 2010, BIODIVERS CONSERV, V19, P999, DOI 10.1007/s10531-009-9760-x
   Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107
NR 63
TC 32
Z9 33
U1 1
U2 69
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 2
PY 2014
VL 9
IS 6
AR e95388
DI 10.1371/journal.pone.0095388
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI6CB
UT WOS:000336956300006
PM 24887555
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Govindan, S
   Shapiro, L
   Langa, KM
   Iwashyna, TJ
AF Govindan, Sushant
   Shapiro, Letitia
   Langa, Kenneth M.
   Iwashyna, Theodore J.
TI Death Certificates Underestimate Infections as Proximal Causes of Death
   in the US
SO PLOS ONE
LA English
DT Article
ID SEVERE SEPSIS; CANCER-MORTALITY; UNITED-STATES; ACCURACY; AUTOPSY;
   TRENDS; STATISTICS; AGREEMENT; DIAGNOSES; DISEASES
AB Background: Death certificates are a primary data source for assessing the population burden of diseases; however, there are concerns regarding their accuracy. Diagnosis-Related Group (DRG) coding of a terminal hospitalization may provide an alternative view. We analyzed the rate and patterns of disagreement between death certificate data and hospital claims for patients who died during an inpatient hospitalization.
   Methods: We studied respondents from the Health and Retirement Study (a nationally representative sample of older Americans who had an inpatient death documented in the linked Medicare claims from 1993-2007). Causes of death abstracted from death certificates were aggregated to the standard National Center for Health Statistics List of 50 Rankable Causes of Death. Centers for Medicare and Medicaid Services (CMS)-DRGs were manually aggregated into a parallel classification. We then compared the two systems via 2x2, focusing on concordance. Our primary analysis was agreement between the two data sources, assessed with percentages and Cohen's kappa statistic.
   Results: 2074 inpatient deaths were included in our analysis. 36.6% of death certificate cause-of-death codes agreed with the reason for the terminal hospitalization in the Medicare claims at the broad category level; when re-classifying DRGs without clear alignment as agreements, the concordance only increased to 61%. Overall Kappa was 0.21, or "fair.'' Death certificates in this cohort redemonstrated the conventional top 3 causes of death as diseases of the heart, malignancy, and cerebrovascular disease. However, hospitalization claims data showed infections, diseases of the heart, and cerebrovascular disease as the most common diagnoses for the same terminal hospitalizations.
   Conclusion: There are significant differences between Medicare claims and death certificate data in assigning cause of death for inpatients. The importance of infections as proximal causes of death is underestimated by current death certificate-based strategies.
C1 [Govindan, Sushant; Shapiro, Letitia; Langa, Kenneth M.; Iwashyna, Theodore J.] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA.
   [Langa, Kenneth M.; Iwashyna, Theodore J.] HSR&D Ctr Excellence, VA Ctr Clin Management Res, Ann Arbor, MI USA.
   [Langa, Kenneth M.; Iwashyna, Theodore J.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA.
RP Iwashyna, TJ (reprint author), Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA.
EM tiwashyn@umich.edu
OI Iwashyna, Theodore/0000-0002-4226-9310
FU National Institutes of Health [K08 HL091249, R01 AG030155, U01 AG09740];
   Department of Veterans Affairs Health Services Research & Development
   Service [IIR 11-109]
FX This work was supported by grants K08 HL091249, R01 AG030155, and U01
   AG09740 from the National Institutes of Health, and IIR 11-109 from the
   Department of Veterans Affairs Health Services Research & Development
   Service. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Angus DC, 2001, CRIT CARE MED, V29, pS109, DOI 10.1097/00003246-200107001-00035
   [Anonymous], 2013, CAUSES DEATH ST 0302
   [Anonymous], 2011, STAT ABSTR US 2012
   Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61
   Burger EH, 2012, J CLIN EPIDEMIOL, V65, P309, DOI 10.1016/j.jclinepi.2011.08.007
   Campbell SE, 2001, J PUBLIC HEALTH MED, V23, P205, DOI 10.1093/pubmed/23.3.205
   Combes A, 2004, ARCH INTERN MED, V164, P389, DOI 10.1001/archinte.164.4.389
   Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI 10.1007/s00134-012-2769-8
   Doria-Rose VP, 2009, LUNG CANCER, V63, P295, DOI 10.1016/j.lungcan.2008.05.019
   Farmer SA, 2013, JAMA-J AM MED ASSOC, V309, P349, DOI 10.1001/jama.2012.191276
   Fauci AS, 2005, EMERG INFECT DIS, V11, P519, DOI 10.3201/eid1104.041167
   Flory J, 2004, HEALTH AFFAIR, V23, P194, DOI 10.1377/hlthaff.23.3.194
   German RR, 2011, CANCER EPIDEMIOL, V35, P126, DOI 10.1016/j.canep.2010.09.005
   HASUO Y, 1989, J CLIN EPIDEMIOL, V42, P577, DOI 10.1016/0895-4356(89)90154-6
   Haut ER, 2012, JAMA-J AM MED ASSOC, V307, P2589, DOI 10.1001/jama.2012.6626
   Heron Melonie, 2013, Natl Vital Stat Rep, V62, P1
   Heron Melonie, 2011, Natl Vital Stat Rep, V59, P1
   Iwashyna TJ, 2012, J AM GERIATR SOC, V60, P1070, DOI 10.1111/j.1532-5415.2012.03989.x
   Iwashyna TJ, 2012, AM J RESP CRIT CARE, V185, P835, DOI 10.1164/rccm.201109-1660OC
   Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553
   Johansson LA, 2002, J EPIDEMIOL COMMUN H, V56, P301, DOI 10.1136/jech.56.4.301
   Karlsson S, 2009, CRIT CARE MED, V37, P1268, DOI 10.1097/CCM.0b013e31819c13ac
   KIRCHER T, 1985, NEW ENGL J MED, V313, P1263, DOI 10.1056/NEJM198511143132005
   Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lund JL, 2010, CANCER INVEST, V28, P758, DOI 10.3109/07357901003630959
   Mlangeni DA, 2011, J HOSP INFECT, V77, P370, DOI 10.1016/j.jhin.2010.12.016
   MODELMOG D, 1992, CANCER CAUSE CONTROL, V3, P541, DOI 10.1007/BF00052751
   Morrow DA, 2012, CIRCULATION, V126, P1408, DOI 10.1161/CIR.0b013e31826890b0
   MOUSSA MAA, 1990, J CLIN EPIDEMIOL, V43, P1285, DOI 10.1016/0895-4356(90)90094-6
   Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x
   Sarrazin MSV, 2012, JAMA-J AM MED ASSOC, V307, P1433, DOI 10.1001/jama.2012.404
   Sehdev AES, 2001, ARCH INTERN MED, V161, P277, DOI 10.1001/archinte.161.2.277
   Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d
NR 34
TC 21
Z9 21
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 30
PY 2014
VL 9
IS 5
AR e97714
DI 10.1371/journal.pone.0097714
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AK0KM
UT WOS:000338101500022
PM 24878897
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Perez-Porcuna, TSM
   Ascaso, C
   Malheiro, A
   Abellana, R
   Martins, M
   Sardinha, JFJ
   Quinco, P
   Antunes, IA
   Garrido, MD
   Buhrer-Sekula, S
   Martinez-Espinosa, FE
AF Perez-Porcuna, Toma S. M.
   Ascaso, Carlos
   Malheiro, Adriana
   Abellana, Rosa
   Martins, Marilaine
   Jardim Sardinha, Jose Felipe
   Quinco, Patricia
   Antunes, Irineide Assumpcao
   Garrido, Marlucia da Silva
   Buehrer-Sekula, Samira
   Martinez-Espinosa, Flor Ernestina
TI Mycobacterium tuberculosis Infection in Young Children: Analyzing the
   Performance of the Diagnostic Tests
SO PLOS ONE
LA English
DT Article
ID GAMMA RELEASE ASSAYS; GUINEA-PIG; SKIN-TEST; IRON; EXPRESSION;
   CHILDHOOD; PROTEINS; IMMUNODIAGNOSIS; SETTINGS; CONTACT
AB Objective: This study evaluated the performance of the Tuberculin Skin Test (TST) and Quantiferon-TB Gold in-Tube (QFT) and the possible association of factors which may modify their results in young children (0-6 years) with recent contact with an index tuberculosis case.
   Materials and Methods: A cross-sectional study including 135 children was conducted in Manaus, Amazonas-Brazil. The TST and QFT were performed and the tests results were analyzed in relation to the personal characteristics of the children studied and their relationship with the index case.
   Results: The rates of positivity were 34.8% (TST) and 26.7% (QFT), with 14.1% of indeterminations by the QFT. Concordance between tests was fair (Kappa = 0.35 P<0.001). Both the TST and QFT were associated with the intensity of exposure (Linear OR = 1.286, P = 0.005; Linear OR = 1.161, P = 0.035 respectively) with only the TST being associated with the time of exposure (Linear OR = 1.149, P = 0.009). The presence of intestinal helminths in the TST+ group was associated with negative QFT results (OR = 0.064, P = 0.049). In the TST- group lower levels of ferritin were associated with QFT+ results (Linear OR = 0.956, P = 0.036).
   Conclusions: Concordance between the TST and QFT was lower than expected. The factors associated with the discordant results were intestinal helminths, ferritin levels and exposure time to the index tuberculosis case. In TST+ group, helminths were associated with negative QFT results suggesting impaired cell-mediated immunity. The TST-&QFT+ group had a shorter exposure time and lower ferritin levels, suggesting that QFT is faster and ferritin may be a potential biomarker of early stages of tuberculosis infection.
C1 [Perez-Porcuna, Toma S. M.; Quinco, Patricia; Garrido, Marlucia da Silva; Buehrer-Sekula, Samira] Univ Estado Amazonas, Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Perez-Porcuna, Toma S. M.; Ascaso, Carlos; Abellana, Rosa] Univ Barcelona, Fac Med, Dept Salut Publ, Barcelona 7, Catalunya, Spain.
   [Perez-Porcuna, Toma S. M.] Hosp Univ Mutua Terrassa, Unitat Invest Fundacio Mutua Terrassa, CAP Valldoreix, Serv Pediat, Terrassa, Catalunya, Spain.
   [Ascaso, Carlos] Inst Invest Biomed August Pi i Sunyer, Barcelona, Catalunya, Spain.
   [Malheiro, Adriana] Fundacao Hematol & Hemoterapia Amazonas, Lab Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.
   [Malheiro, Adriana] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
   [Jardim Sardinha, Jose Felipe] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Antunes, Irineide Assumpcao] Policlin Cardoso Fontes, Ctr Referencia TB, Manaus, Amazonas, Brazil.
   [Garrido, Marlucia da Silva] Fundacao Vigilancia Saude Estado Amazonas, Programa Controle TB, Dept Vigilancia Epidemiol, Manaus, Amazonas, Brazil.
   [Buehrer-Sekula, Samira] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.
   [Martinez-Espinosa, Flor Ernestina] Fundacao Oswaldo Cruz, Fiocruz Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
RP Perez-Porcuna, TSM (reprint author), Univ Estado Amazonas, Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
EM tomas.perez.porcuna@gmail.com
RI Abellana, Rosa/D-7305-2014
OI Abellana, Rosa/0000-0003-4487-4431; Ascaso Terren,
   Carlos/0000-0002-4895-7616; Buhrer-Sekula, Samira/0000-0002-5984-7770;
   Perez-Porcuna, Tomas Maria/0000-0002-9951-7768
FU Brazilian National Counsel of Technological and Scientific Development
   (CNPq); Foundation of Research Support of the State of Amazonas
   (FAPEAM); University of Barcelona
FX This work was financially supported by the Brazilian National Counsel of
   Technological and Scientific Development (CNPq), the Foundation of
   Research Support of the State of Amazonas (FAPEAM), and the University
   of Barcelona. Cellestis Ltd. donated QuantiFERON test kits. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Almeida LMD, 2001, PEDIATR INFECT DIS J, V20, P1061, DOI 10.1097/00006454-200111000-00011
   ANDERSEN P, 1991, INFECT IMMUN, V59, P1905
   Banfield S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038556
   Basaraba RJ, 2008, TUBERCULOSIS, V88, P69, DOI 10.1016/j.tube.2007.09.002
   Bergamini BM, 2009, PEDIATRICS, V123, pe419, DOI [10.1542/peds.2008-1722, DOI 10.1542/PEDS.2008-1722]
   Borkow G, 2000, J CLIN INVEST, V106, P1053, DOI 10.1172/JCI10182
   COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593
   Connell TG, 2008, PLOS ONE, V3, pe2624
   Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc
   Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192
   Friis H, 2009, BRIT J NUTR, V102, P310, DOI 10.1017/S0007114508162122
   Grare M, 2010, DIAGN MICR INFEC DIS, V66, P366, DOI 10.1016/j.diagmicrobio.2009.11.002
   Haile Y, 2002, MICROBIOL-SGM, V148, P3881, DOI 10.1099/00221287-148-12-3881
   Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9
   Haustein T, 2009, PEDIATR INFECT DIS J, V28, P669, DOI 10.1097/INF.0b013e3181a16394
   Hesseling AC, 2009, THORAX, V64, P840, DOI 10.1136/thx.2007.085340
   Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095
   Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192
   Hill PC, 2010, LANCET INFECT DIS, V10, P723, DOI 10.1016/S1473-3099(10)70164-X
   Isanaka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037350
   Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lewinsohn DA, 2008, PEDIATR RES, V63, P115, DOI 10.1203/PDR.0b013e3181652085
   Lutz A. O, 1919, MEM I O CRUZ, V11, P121, DOI DOI 10.1590/S0074-02761919000100006
   Machingaidze S, 2011, PEDIATR INFECT DIS J, V30, P694, DOI 10.1097/INF.0b013e318214b915
   Maher D, 2006, INT J TUBERC LUNG D, V10, P1091
   Manabe YC, 1999, P NATL ACAD SCI USA, V96, P12844, DOI 10.1073/pnas.96.22.12844
   Mandalakas AM, 2011, INT J TUBERC LUNG D, V15, P1018, DOI 10.5588/ijtld.10.0631
   Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392
   Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X
   Pai M, 2009, INT J TUBERC LUNG D, V13, P84
   Pai M, 2007, PLOS MED, V4, pe208, DOI [10.1371/journal.pmed.0040208, DOI 10.1371/J0URNAL.PMED.0040208]
   Pai M, 2006, INT J TUBERC LUNG D, V10, P942
   Powell DA, 2009, PEDIATR INFECT DIS J, V28, P676, DOI 10.1097/INF.0b013e3181ad5490
   Raharimanga V, 2012, TROP MED INT HEALTH, V17, P871, DOI 10.1111/j.1365-3156.2012.03013.x
   Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012
   Reddy PV, 2012, J BACTERIOL, V194, P567, DOI 10.1128/JB.05553-11
   RESENDE CT, 2007, CLIN EXP IMMUNOL, V147, P45, DOI DOI 10.1111/J.1365-2249.2006.03247.X
   Shanaube K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018206
   Starke JR, 2003, TUBERCULOSIS, V83, P208, DOI 10.1016/S1472-9792(02)00088-4
   Thom RE, 2012, VACCINE, V30, P3159, DOI 10.1016/j.vaccine.2012.03.008
   Thomas TA, 2010, PEDIATRICS, V126, pE1522, DOI 10.1542/peds.2010-0885
   Tristo-S Ricardo, 2002, Rev. Soc. Bras. Med. Trop., V35, P533, DOI 10.1590/S0037-86822002000500020
   Veerapathran A, 2008, PLOS ONE, V3, pe1850, DOI [10.1371/journal.pone.0001850, DOI 10.1371/J0URNAL.P0NE.0001850]
   WHO, 2011, GLOB TUB CONTR 2011
   WHO, WHO CHILD GROWTH STA
NR 46
TC 4
Z9 4
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 30
PY 2014
VL 9
IS 5
AR e97992
DI 10.1371/journal.pone.0097992
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AK0KM
UT WOS:000338101500028
PM 24879374
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kim, M
   Lee, EJ
   Seo, JH
   Kim, TW
AF Kim, Mijin
   Lee, Eun Ji
   Seo, Je Hyun
   Kim, Tae-Woo
TI Relationship of Spontaneous Retinal Vein Pulsation with Ocular
   Circulatory Cycle
SO PLOS ONE
LA English
DT Article
ID OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; INTRACRANIAL-PRESSURE; VENOUS
   PULSATION; FREQUENCY; PHASE; FLOW; CAT
AB Purpose: To determine the timing of spontaneous venous pulsation (SVP) relative to the ocular circulatory cycle by using the movie tool of confocal scanning laser ophthalmoloscope.
   Methods: A video recording of the fundus was obtained using a confocal scanning laser ophthalmoscope (Spectralis HRA, Heidelberg Engineering, Heidelberg, Germany) at 8 frames/s in 47 eyes (15 glaucoma patients and 32 glaucoma suspects) with visible pulsation of both the central retinal artery (CRA) and vein (CRV). The timing of the maximum and minimum diameters of the CRA (CRA(max) and CRA(min), respectively) and CRV (CRVmax and CRVmin, respectively) was identified during four pulse cycles. The interval between CRVmin and CRA(min), and between CRVmax and CRA(max) was expressed as the number of frames and as a percentage of the ocular circulatory cycle.
   Results: The ocular circulatory cycle (from one CRA(max) to the next) lasted 7.7 +/- 1.0 frames (958.8 +/- 127.2 ms, mean +/- SD), with a mean pulse rate of 62.6 beats/min. The diameter of the CRA was increased for 2.4 +/- 0.5 frames (301.9 +/- 58.8 ms) and decreased for 5.3 +/- 0.9 frames (656.9 +/- 113.5 ms). CRVmax occurred 1.0 +/- 0.2 frames after CRA(max) (equivalent to 13.0% of the ocular circulatory cycle), while CRVmin occurred 1.1 +/- 0.4 frames after CRA(min) (equivalent to 14.6% of the ocular circulatory cycle).
   Conclusions: During SVP, the diameter of the CRV began to decrease at early diastole, and the reduction persisted until early systole. This finding supports that CRV collapse occurs during ocular diastole.
C1 [Kim, Mijin] Konyang Univ, Kims Eye Hosp, Myung Gok Eye Res Inst, Dept Ophthalmol, Seoul, South Korea.
   [Kim, Mijin; Lee, Eun Ji; Kim, Tae-Woo] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea.
   [Seo, Je Hyun] Pusan Natl Univ, Yangsan Hosp, Dept Ophthalmol, Pusan 609735, South Korea.
RP Kim, TW (reprint author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea.
EM twkim7@snu.ac.kr
OI Kim, Tae-Woo/0000-0002-5180-0978; Seo, Je Hyun/0000-0003-3127-7160
FU National Research Foundation of Korea - Korean Government
   [2013R1A1A1A05004781]
FX Supported by National Research Foundation of Korea Grant funded by the
   Korean Government (2013R1A1A1A05004781). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ATTARIWALA R, 1994, INVEST OPHTH VIS SCI, V35, P1019
   Bailliart P, 1918, ANN OCUL, V155, P453
   Baurmann M, 1925, DTSCH OPHTHALMOL GES, V45, P53
   Coccius E, 1853, UEBER ANWENDUNG AUGE
   DARDENNE G, 1969, EUR NEUROL, V2, P193, DOI 10.1159/000113796
   Davson H, 1996, PHYSL CSF BLOOD BRAI, P697
   Duke-Elder WS, 1926, J PHYSIOL-LONDON, V61, P409, DOI 10.1113/jphysiol.1926.sp002303
   Elliot R H, 1921, Br J Ophthalmol, V5, P481, DOI 10.1136/bjo.5.11.481
   Evans DW, 2002, GRAEF ARCH CLIN EXP, V240, P475, DOI 10.1007/s00417-002-0460-4
   GLUCKSBERG MR, 1993, MICROVASC RES, V45, P158, DOI 10.1006/mvre.1993.1015
   Harder B, 2007, BRIT J OPHTHALMOL, V91, P401, DOI 10.1136/bjo.2006.103341
   Hayashi S, 1998, J BIOMECH ENG-T ASME, V120, P468, DOI 10.1115/1.2798016
   Jonas JB, 2005, OPHTHALMOLOGY, V112, P948, DOI 10.1016/j.ophtha.2004.11.014
   Jonas JB, 2003, BRIT J OPHTHALMOL, V87, P949, DOI 10.1136/bjo.87.8.949
   Jonas JB, 2012, INVEST OPHTH VIS SCI, V53, P6045, DOI 10.1167/iovs.12-10623
   Jones HC, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-1
   Kain S, 2010, BRIT J OPHTHALMOL, V94, P854, DOI 10.1136/bjo.2009.169813
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Legler U, 2007, CLIN EXP OPHTHALMOL, V35, P870, DOI 10.1111/j.1442-9071.2007.01641.x
   Legler U, 2009, J GLAUCOMA, V18, P210, DOI 10.1097/IJG.0b013e318182edd2
   Levine DN, 1998, MICROVASC RES, V56, P154, DOI 10.1006/mvre.1998.2098
   LOW HT, 1995, MED BIOL ENG COMPUT, V33, P545, DOI 10.1007/BF02522512
   MEYERSCHWICKERATH R, 1995, GRAEF ARCH CLIN EXP, V233, P783, DOI 10.1007/BF00184090
   Morgan WH, 2005, INVEST OPHTH VIS SCI, V46, P1307, DOI 10.1167/iovs.04-1126
   Morgan WH, 2004, OPHTHALMOLOGY, V111, P1489, DOI 10.1016/j.ophtha.2003.12.053
   Morgan W, 2012, INVEST OPHTH VIS SCI, V53, P6880, DOI 10.1167/iovs.12-10943
   Morgan WH, 2012, INVEST OPHTH VIS SCI, V53, P4676, DOI 10.1167/iovs.12-9837
   Nicolela MT, 2007, BRIT J OPHTHALMOL, V91, P405, DOI 10.1136/bjo.2006.107797
   Seo JH, 2012, OPHTHALMOLOGY, V119, P2254, DOI 10.1016/j.ophtha.2012.06.007
NR 29
TC 5
Z9 5
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 20
PY 2014
VL 9
IS 5
AR e97943
DI 10.1371/journal.pone.0097943
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AM0UW
UT WOS:000339563400073
PM 24844298
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Legleye, S
   Beck, F
   Spilka, S
   Chau, N
AF Legleye, Stephane
   Beck, Francois
   Spilka, Stanislas
   Chau, Nearkasen
TI Correction of Body-Mass Index Using Body-Shape Perception and
   Socioeconomic Status in Adolescent Self-Report Surveys
SO PLOS ONE
LA English
DT Article
ID CHILD OVERWEIGHT; INTERNATIONAL SURVEY; SOCIAL NORMS; MEASURED BMI;
   WEIGHT; OBESITY; HEIGHT; PREVALENCE; HEALTH; DISSATISFACTION
AB Objectives: To propose a simple correction of body-mass index (BMI) based on self-reported weight and height (reported BMI) using gender, body shape perception and socioeconomic status in an adolescent population.
   Methods: 341 boys and girls aged 17-18 years were randomly selected from a representative sample of 2165 French adolescents living in Paris surveyed in 2010. After an anonymous self-administered pen-and-paper questionnaire asking for height, weight, body shape perception (feeling too thin, about the right weight or too fat) and socioeconomic status, subjects were measured and weighed. BMI categories were computed according to Cole's cut-offs. Reported BMIs were corrected using linear regressions and ROC analyses and checked with cross-validation and multiple imputations to handle missing values. Agreement between actual and corrected BMI values was estimated with Kappa indexes and Intraclass correlation coefficients (ICC).
   Results: On average, BMIs were underreported, especially among girls. Kappa indexes between actual and reported BMI were low, especially for girls: 0.56 95% CI = [0.42-0.70] for boys and 0.45 95% CI = [0.30-0.60] for girls. The regression of reported BMI by gender and body shape perception gave the most balanced results for both genders: the Kappa and ICC obtained were 0.63 95% CI = [0.50-0.76] and 0.67, 95% CI = [0.58-0.74] for boys; 0.65 95% CI = [0.52-0.78] and 0.74, 95% CI = [0.66-0.81] for girls. The regression of reported BMI by gender and socioeconomic status led to similar corrections while the ROC analyses were inaccurate.
   Conclusions: Using body shape perception, or socioeconomic status and gender is a promising way of correcting BMI in self-administered questionnaires, especially for girls.
C1 [Legleye, Stephane] INED, Paris, France.
   [Legleye, Stephane; Chau, Nearkasen] Univ Paris 11, INSERM, U669, Paris, France.
   [Legleye, Stephane; Chau, Nearkasen] Univ Paris 05, UMR S0669, Paris, France.
   [Beck, Francois] INPES, St Denis, France.
   [Beck, Francois] Univ Paris 05, Equipe Cesames Cermes3, Ctr Rech Med, CNRS,UMR 8211,Inserm,U988,EHESS, Paris, France.
   [Spilka, Stanislas] OFDT, French Monitoring Ctr Drugs & Drug Addict, St Denis, France.
RP Legleye, S (reprint author), INED, Paris, France.
EM Stephane.legleye@ined.fr
RI Legleye, Stephane/L-3546-2019
OI Legleye, Stephane/0000-0002-1704-2499; Beck,
   Francois/0000-0002-4880-1638
FU OFDT; INED
FX The study was funded by the OFDT and the INED. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Allen KL, 2008, BODY IMAGE, V5, P261, DOI 10.1016/j.bodyim.2008.03.005
   Benach J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2154
   Bolton-Smith C, 2000, J EPIDEMIOL COMMUN H, V54, P143, DOI 10.1136/jech.54.2.143
   Bostrom G, 1997, INT J EPIDEMIOL, V26, P860, DOI 10.1093/ije/26.4.860
   Brener ND, 2003, J ADOLESCENT HEALTH, V32, P281, DOI 10.1016/S1054-139X(02)00708-5
   Brettschneider Anna-Kristin, 2011, BMC Res Notes, V4, P414, DOI 10.1186/1756-0500-4-414
   Burkhauser RV, 2008, J HEALTH ECON, V27, P519, DOI 10.1016/j.jhealeco.2007.05.005
   Chau N, 2013, BMC PUBLIC IN PRESS
   Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55
   Cole TJ, 2000, BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240
   Dauphinot V, 2009, J EPIDEMIOL COMMUN H, V63, P128, DOI 10.1136/jech.2008.077800
   Dauphinot V, 2006, QUESTIONS EC SANTE, P1
   Dupuy M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-442
   Emery C, 2007, PRESSE MED, V36, P832, DOI 10.1016/j.lpm.2006.12.031
   Etile F, 2007, HEALTH ECON, V16, P945, DOI 10.1002/hec.1251
   Gil J, 2011, ECON HUM BIOL, V9, P78, DOI 10.1016/j.ehb.2010.05.016
   Godart N, 2013, OPEN J EPIDEMIOLOGY, P53
   Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x
   Griffiths LJ, 2010, INT J PEDIATR OBES, V5, P282, DOI 10.3109/17477160903473697
   Hayden-Wade HA, 2005, OBES RES, V13, P1381, DOI 10.1038/oby.2005.167
   Henrion R, 2002, B ACAD NATL MED, V185, P445
   Himes JH, 2005, ANN EPIDEMIOL, V15, P272, DOI 10.1016/j.annepidem.2004.08.010
   Himes JH, 2009, PEDIATRICS, V124, pS3, DOI 10.1542/peds.2008-3586D
   Hox J., 2008, INT HDB SURVEY METHO
   INSEE, 2009, PCS 2003 NIV 1 LIST
   Jansen W, 2008, J ADOLESCENT HEALTH, V42, P128, DOI 10.1016/j.jadohealth.2007.07.015
   Julia C., 2010, Bulletin Epidemiologique Hebdomadaire, P69
   Kurth BM, 2010, OBESITY FACTS, V3, P181, DOI 10.1159/000314638
   Kurth BM, 2008, DTSCH ARZTEBL INT, V105, P406, DOI 10.3238/arztebl.2008.0406
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Legleye S, 2013, INT J DRUG POLICY
   Legleye S, 2012, J ADOLESCENT HEALTH, V50, P395, DOI 10.1016/j.jadohealth.2011.08.004
   Legleye S, 2011, ADDICTION, V106, P1520, DOI 10.1111/j.1360-0443.2011.03447.x
   Lien N, 2001, J EPIDEMIOL COMMUN H, V55, P731, DOI 10.1136/jech.55.10.731
   Lioret S, 2009, OBESITY, V17, P1092, DOI 10.1038/oby.2008.619
   Lobstein T, 2003, Obes Rev, V4, P195, DOI 10.1046/j.1467-789X.2003.00116.x
   McAdams MA, 2007, OBESITY, V15, P188, DOI 10.1038/oby.2007.504
   McCabe MP, 2010, EAT BEHAV, V11, P156, DOI 10.1016/j.eatbeh.2010.01.005
   McCabe MP, 2003, J SOC PSYCHOL, V143, P5, DOI 10.1080/00224540309598428
   Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375
   Olivardia R., 2004, PSYCHOL MEN MASCULIN, V5, P112, DOI DOI 10.1037/1524-9220.5.2.112
   Perrin EM, 2010, INT J EAT DISORDER, V43, P447, DOI 10.1002/eat.20710
   Pitrou I, 2010, OBESITY, V18, P809, DOI 10.1038/oby.2009.278
   Pope HG, 1999, INT J EAT DISORDER, V26, P65, DOI 10.1002/(SICI)1098-108X(199907)26:1<65::AID-EAT8>3.0.CO;2-D
   Rasmussen F, 2007, EUR J CLIN NUTR, V61, P870, DOI 10.1038/sj.ejcn.1602595
   Rey J. M., 1992, INT J METH PSYCH RES, V2, P1
   Rivest L.-P., 2006, METHODES ENQUETES SO, P56
   ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125
   Rubin D. B., 1987, MULTIPLE IMPUTATION
   Saint-Pol, 2010, CORPS DESIRABLE HOMM
   Salanave B, 2009, INT J PEDIATR OBES, V4, P66, DOI 10.1080/17477160902811207
   Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350
   Sherry B, 2007, ARCH PEDIAT ADOL MED, V161, P1154, DOI 10.1001/archpedi.161.12.1154
   Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35
   Stamatakis E, 2010, INT J OBESITY, V34, P41, DOI 10.1038/ijo.2009.217
   Swami V, 2010, PERS SOC PSYCHOL B, V36, P309, DOI 10.1177/0146167209359702
   Swanson SA, 2011, ARCH GEN PSYCHIAT, V68, P714, DOI 10.1001/archgenpsychiatry.2011.22
NR 57
TC 9
Z9 9
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 20
PY 2014
VL 9
IS 5
AR e96768
DI 10.1371/journal.pone.0096768
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AM0UW
UT WOS:000339563400011
PM 24844229
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Niu, L
   Li, GL
   Lin, SL
AF Niu, Liang
   Li, Guoliang
   Lin, Shili
TI Statistical Models for Detecting Differential Chromatin Interactions
   Mediated by a Protein
SO PLOS ONE
LA English
DT Article
ID PROSTATE-CANCER; TRANSCRIPTION; PROMOTER; ORGANIZATION; AGREEMENT;
   LOCUS; GENE
AB Chromatin interactions mediated by a protein of interest are of great scientific interest. Recent studies show that protein-mediated chromatin interactions can have different intensities in different types of cells or in different developmental stages of a cell. Such differences can be associated with a disease or with the development of a cell. Thus, it is of great importance to detect protein-mediated chromatin interactions with different intensities in different cells. A recent molecular technique, Chromatin Interaction Analysis by Paired-End Tag Sequencing (ChIA-PET), which uses formaldehyde cross-linking and paired-end sequencing, is able to detect genome-wide chromatin interactions mediated by a protein of interest. Here we proposed two models (One-Step Model and Two-Step Model) for two sample ChIA-PET count data (one biological replicate in each sample) to identify differential chromatin interactions mediated by a protein of interest. Both models incorporate the data dependency and the extent to which a fragment pair is related to a pair of DNA loci of interest to make accurate identifications. The One-Step Model makes use of the data more efficiently but is more computationally intensive. An extensive simulation study showed that the models can detect those differentially interacted chromatins and there is a good agreement between each classification result and the truth. Application of the method to a two-sample ChIA-PET data set illustrates its utility. The two models are implemented as an R package MDM (available at http://www.stat.osu.edu/similar to statgen/SOFTWARE/MDM).
C1 [Niu, Liang; Lin, Shili] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA.
   [Li, Guoliang] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Key Lab Crop Genet Improvement, Ctr Syst Biol,Ctr Bioinformat,Coll Life Sci & Tec, Wuhan, Hubei, Peoples R China.
RP Lin, SL (reprint author), Ohio State Univ, Dept Stat, Columbus, OH 43210 USA.
EM shili@stat.osu.edu
RI Li, Guoliang/I-1494-2015
OI Li, Guoliang/0000-0003-1601-6640
FU National Science Foundation [DMS-1042946]; Fundamental Research Funds
   for the Central Universities [2662014PY001]
FX LN and SL were supported by the National Science Foundation grant
   DMS-1042946. GL was supported by the Fundamental Research Funds for the
   Central Universities [2662014PY001]. The funders had no role in the
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Decker KF, 2012, NUCLEIC ACIDS RES, V40, P10765, DOI 10.1093/nar/gks888
   Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799
   Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497
   Gelman A, 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136
   Gong FR, 2011, NUCLEIC ACIDS RES, V39, P4640, DOI 10.1093/nar/gkr023
   Guo Y, 2012, P NATL ACAD SCI USA, V109, P21081, DOI 10.1073/pnas.1219280110
   Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857
   Jiang HM, 2008, MOL CELL BIOL, V28, P907, DOI 10.1128/MCB.00909-07
   Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020
   Junier I, 2012, NUCLEIC ACIDS RES, V40, P7718, DOI 10.1093/nar/gks536
   Kohwi-Shigematsu T, 2012, METHODS, V58, P243, DOI 10.1016/j.ymeth.2012.06.019
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014
   Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369
   Niu L, 2013, 876 OH STAT U DEP ST
   Obinata D, 2012, INT J CANCER, V130, P1021, DOI 10.1002/ijc.26043
   Raftery AE, 1995, PRACTICAL MARKOV CHA, P115
   Rousseau M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-414
   Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056
NR 20
TC 5
Z9 5
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 16
PY 2014
VL 9
IS 5
AR e97560
DI 10.1371/journal.pone.0097560
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AM1NZ
UT WOS:000339614800051
PM 24835279
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Oliver, V
   De Rantere, D
   Ritchie, R
   Chisholm, J
   Hecker, KG
   Pang, DSJ
AF Oliver, Vanessa
   De Rantere, Debbie
   Ritchie, Rheanne
   Chisholm, Jessica
   Hecker, Kent G.
   Pang, Daniel S. J.
TI Psychometric Assessment of the Rat Grimace Scale and Development of an
   Analgesic Intervention Score
SO PLOS ONE
LA English
DT Article
ID PAIN SCALE; FACIAL EXPRESSIONS; POSTOPERATIVE PAIN; BEHAVIOR;
   LAPAROTOMY; CARPROFEN; DURATION; MOUSE; MICE; DOGS
AB Our limited ability to assess spontaneous pain in rodent models of painful human conditions may be associated with a translational failure of promising analgesic compounds in to clinical use. If measurement of spontaneous pain behaviours can be used to generate an analgesic intervention score their use could expand to guide the use of analgesics, as mandated by regulatory bodies and ethical and welfare obligations. One such measure of spontaneous pain, the Rat Grimace Scale (RGS), has recently been described and shown to exhibit reliability. However, reliability of measurement scores is context and content specific, and further testing required to assess translation to a heterogenous setting (different model, raters, environment). The objectives of this study were to perform reliability testing with the Rat Grimace Scale in a heterogenous setting and generate an analgesic intervention score for its use. In a randomised, blinded study, sixteen adult female rats received one of three analgesia treatments (0.05 mg/kg buprenorphine subcutaneously, 1 mg/kg meloxicam subcutaneously, 0.2 mg/kg oral buprenorphine in jelly) peri-operatively (telemetry unit implantation surgery). Rats were video-recorded (before, 1-6 and 12 hours post-operatively) and images collected for independent scoring by three blinded raters using the RGS, and five experts based on "pain/no pain'' assessment. Scores were used to calculate inter- and intra-rater reliability with an intraclass correlation coefficient and generate an analgesic intervention score with receiver operating characteristic curve analysis. The RGS scores showed very good inter-and intra-rater reliability (0.85 [0.78-0.90 95% CI] and 0.83 [0.76-0.89], respectively). An analgesic intervention threshold of greater than 0.67 was determined. These data demonstrate that the RGS is a useful tool which can be successfully employed in a heterogenous setting, and has the potential to guide analgesic intervention.
C1 [Oliver, Vanessa; De Rantere, Debbie; Chisholm, Jessica; Hecker, Kent G.; Pang, Daniel S. J.] Univ Calgary, Fac Vet Med, Dept Vet Clin & Diagnost Sci, Calgary, AB, Canada.
   [Ritchie, Rheanne] Univ Calgary, Fac Biol Sci, Dept Zool, Calgary, AB, Canada.
   [Pang, Daniel S. J.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.
RP Pang, DSJ (reprint author), Univ Calgary, Fac Vet Med, Dept Vet Clin & Diagnost Sci, Calgary, AB, Canada.
EM dsjpang@ucalgary.ca
FU NSERC; University of Calgary Faculty of Veterinary Medicine as part of
   the Investigative Medicine student rotation
FX Daniel Pang was supported by an NSERC Discovery Grant. Vanessa Oliver
   was supported by the University of Calgary Faculty of Veterinary
   Medicine as part of the Investigative Medicine student rotation. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Altman DG, 1991, PRACTICAL STAT MED R, P396
   Biau DJ, 2010, STAT MED, V29, P1900, DOI 10.1002/sim.3947
   Brondani JT, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-143
   Holton LL, 1998, J SMALL ANIM PRACT, V39, P469, DOI 10.1111/j.1748-5827.1998.tb03681.x
   Keating SCJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044437
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]
   Leach MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035656
   Leach MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0013347
   Matsumiya LC, 2012, J AM ASSOC LAB ANIM, V51, P42
   Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360
   Mogil JS, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-34
   Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606
   Mogil JS, 2004, PAIN, V112, P12, DOI 10.1016/j.pain.2004.09.028
   Morton CM, 2005, AM J VET RES, V66, P2154, DOI 10.2460/ajvr.2005.66.2154
   National Research Council, 2011, GUIDE CARE USE LAB A
   Office of Laboratory Animal Welfare, 2002, PUBL HLTH SERV POL H
   Olfert ED, 1993, GUIDE CARE USE EXPT
   Ponterotto JG, 2007, PERCEPT MOTOR SKILL, V105, P997, DOI 10.2466/PMS.105.3.997-1014
   Reid J, 2007, ANIM WELFARE, V16, P97
   Rialland P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049480
   Roughan JV, 2004, BEHAV PHARMACOL, V15, P461, DOI 10.1097/00008877-200411000-00002
   Roughan JV, 2003, EUR J PAIN, V7, P397, DOI 10.1016/S1090-3801(02)00140-4
   Roughan JV, 2000, RES VET SCI, V69, P283, DOI 10.1053/rvsc.2000.0430
   Roughan JV, 2001, PAIN, V90, P65, DOI 10.1016/S0304-3959(00)00387-0
   Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55
   Streiner DL, 2007, CAN J PSYCHIAT, V52, P121, DOI 10.1177/070674370705200210
   STREINER DL, 1993, CAN J PSYCHIAT, V38, P140, DOI 10.1177/070674379303800214
   Streiner DL, 2008, RELIABILITY GENERALI, P167
   The National Centre for the Replacement Refinement and Reduction of Animals in Research, 2008, RESP US AN BIOSC RES
   Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080
NR 31
TC 27
Z9 27
U1 1
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 16
PY 2014
VL 9
IS 5
AR e97882
DI 10.1371/journal.pone.0097882
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AM1NZ
UT WOS:000339614800081
PM 24838111
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Shan, GG
   Wilding, GE
AF Shan, Guogen
   Wilding, Gregory E.
TI Powerful Exact Unconditional Tests for Agreement between Two Raters with
   Binary Endpoints
SO PLOS ONE
LA English
DT Article
ID DETECTING TRENDS; WEIGHTED KAPPA; MATCHED-PAIRS; RELIABILITY;
   COEFFICIENT; STATISTICS; PARADOXES
AB Asymptotic and exact conditional approaches have often been used for testing agreement between two raters with binary outcomes. The exact conditional approach is guaranteed to respect the test size as compared to the traditionally used asymptotic approach based on the standardized Cohen's kappa coefficient. An alternative to the conditional approach is an unconditional strategy which relaxes the restriction of fixed marginal totals as in the conditional approach. Three exact unconditional hypothesis testing procedures are considered in this article: an approach based on maximization, an approach based on the conditional p-value and maximization, and an approach based on estimation and maximization. We compared these testing procedures based on the commonly used Cohen's kappa with regards to test size and power. We recommend the following two exact approaches for use in practice due to power advantages: the approach based on conditional p-value and maximization and the approach based on estimation and maximization.
C1 [Shan, Guogen] Univ Nevada, Dept Environm & Occupat Hlth, Epidemiol & Biostat Program, Sch Community Hlth Sci, Las Vegas, NV 89154 USA.
   [Wilding, Gregory E.] SUNY Buffalo, Dept Biostat, Buffalo, NY 14260 USA.
RP Shan, GG (reprint author), Univ Nevada, Dept Environm & Occupat Hlth, Epidemiol & Biostat Program, Sch Community Hlth Sci, Las Vegas, NV 89154 USA.
EM guogen.shan@unlv.edu
CR Andres AM, 2008, COMMUN STAT-THEOR M, V37, P760, DOI 10.1080/03610920701669884
   BARNARD GA, 1945, NATURE, V156, P177
   BASU D, 1977, J AM STAT ASSOC, V72, P355, DOI 10.2307/2286800
   Boschloo R. D., 1970, STAT NEERL, V24, P1, DOI DOI 10.1111/J.1467-9574.1970.TB00104.X
   Brusco MJ, 2008, BRIT J MATH STAT PSY, V61, P439, DOI 10.1348/000711007X227058
   CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Fang KT, 2001, ORTHOGONAL UNIFORM E
   FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L
   Fisher R. A., 1970, STAT METHODS RES WOR
   Fleiss J, 2003, STAT METHODS RATES P
   FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309
   Fleiss JL, 2004, TECHNOMETRICS, V46, P263, DOI DOI 10.1198/TECH.2004.S812
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lloyd CJ, 2008, BIOMETRICS, V64, P716, DOI 10.1111/j.1541-0420.2007.00936.x
   Lloyd CJ, 2008, STAT MED, V27, P3540, DOI 10.1002/sim.3229
   Lloyd CJ, 2008, AUST NZ J STAT, V50, P329, DOI 10.1111/j.1467-842X.2008.00520.x
   Mehta CR, 1998, BIOMETRICS, V54, P1615, DOI 10.2307/2533685
   Shan GG, 2014, STAT PROBABIL LETT, V85, P129, DOI 10.1016/j.spl.2013.11.010
   Shan GG, 2013, HUM HERED, V76, P10, DOI 10.1159/000353205
   Shan GG, 2013, COMPUT STAT DATA AN, V57, P246, DOI 10.1016/j.csda.2012.04.021
   Shan GG, 2012, STAT MED, V31, P155, DOI 10.1002/sim.4411
   Shoukri MM, 1996, STAT MED, V15, P1409
   Sim J, 2005, PHYS THER, V85, P257
   Smedmark V, 2000, MANUAL THER, V5, P97, DOI 10.1054/math.2000.0234
   STORER BE, 1990, J AM STAT ASSOC, V85, P146, DOI 10.2307/2289537
   UMESH UN, 1989, EDUC PSYCHOL MEAS, V49, P835, DOI 10.1177/001316448904900407
NR 27
TC 6
Z9 6
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 16
PY 2014
VL 9
IS 5
AR e97386
DI 10.1371/journal.pone.0097386
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AM1NZ
UT WOS:000339614800041
PM 24837970
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Armijo-Olivo, S
   Ospina, M
   da Costa, BR
   Egger, M
   Saltaji, H
   Fuentes, J
   Ha, C
   Cummings, GG
AF Armijo-Olivo, Susan
   Ospina, Maria
   da Costa, Bruno R.
   Egger, Matthias
   Saltaji, Humam
   Fuentes, Jorge
   Ha, Christine
   Cummings, Greta G.
TI Poor Reliability between Cochrane Reviewers and Blinded External
   Reviewers When Applying the Cochrane Risk of Bias Tool in Physical
   Therapy Trials
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIALS; SYSTEMATIC REVIEWS; METHODOLOGICAL
   QUALITY; EMPIRICAL-EVIDENCE; CLINICAL-TRIALS; INTENTION; EFFICACY;
   TREAT; METAANALYSES; CONCLUSIONS
AB Objectives: To test the inter-rater reliability of the RoB tool applied to Physical Therapy (PT) trials by comparing ratings from Cochrane review authors with those of blinded external reviewers.
   Methods: Randomized controlled trials (RCTs) in PT were identified by searching the Cochrane Database of Systematic Reviews for meta-analysis of PT interventions. RoB assessments were conducted independently by 2 reviewers blinded to the RoB ratings reported in the Cochrane reviews. Data on RoB assessments from Cochrane reviews and other characteristics of reviews and trials were extracted. Consensus assessments between the two reviewers were then compared with the RoB ratings from the Cochrane reviews. Agreement between Cochrane and blinded external reviewers was assessed using weighted kappa (kappa).
   Results: In total, 109 trials included in 17 Cochrane reviews were assessed. Inter-rater reliability on the overall RoB assessment between Cochrane review authors and blinded external reviewers was poor (kappa = 0.02, 95%Cl: -0.06, 0.06]). Inter-rater reliability on individual domains of the RoB tool was poor (median kappa = 0.19), ranging from kappa = -0.04 ("Other bias'') to kappa = 0.62 ("Sequence generation''). There was also no agreement (kappa = -0.29, 95%Cl: -0.81, 0.35]) in the overall RoB assessment at the meta-analysis level.
   Conclusions: Risk of bias assessments of RCTs using the RoB tool are not consistent across different research groups. Poor agreement was not only demonstrated at the trial level but also at the meta-analysis level. Results have implications for decision making since different recommendations can be reached depending on the group analyzing the evidence. Improved guidelines to consistently apply the RoB tool and revisions to the tool for different health areas are needed.
C1 [Armijo-Olivo, Susan; Cummings, Greta G.] Univ Alberta, Fac Nursing, CLEAR Connecting Leadership & Res Outcome Res Pro, Edmonton, AB, Canada.
   [Armijo-Olivo, Susan] Univ Alberta, Fac Rehabil Med, Dept Phys Therapy, Edmonton, AB, Canada.
   [Ospina, Maria] Univ Alberta, Fac Med & Dent, Dept Emergency Med, Emergency Med Strateg Clin Network,Alberta Hlth S, Edmonton, AB, Canada.
   [da Costa, Bruno R.] Florida Int Univ, Dept Phys Therapy, Miami, FL 33199 USA.
   [Egger, Matthias] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.
   [Saltaji, Humam] Univ Alberta, Sch Dent, Orthodont Grad Program, Edmonton, AB, Canada.
   [Fuentes, Jorge] Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada.
   [Fuentes, Jorge] Catholic Univ, Dept Phys Therapy, Maule, Chile.
   [Ha, Christine] Univ Alberta, Fac Rehabil Med, Rehabil Res Ctr, Edmonton, AB, Canada.
RP Armijo-Olivo, S (reprint author), Univ Alberta, Fac Nursing, CLEAR Connecting Leadership & Res Outcome Res Pro, Edmonton, AB, Canada.
EM sla4@ualberta.ca
RI Saltaji, Humam/N-6539-2014; Cummings, Greta/L-6384-2019
OI Saltaji, Humam/0000-0002-8978-458X; Cummings, Greta/0000-0002-0668-6176;
   Egger, Matthias/0000-0001-7462-5132; Ospina, Maria/0000-0001-9305-7521;
   R. da Costa, Bruno/0000-0002-1786-6332
FU Canadian Institutes of Health Research (CIHR); Alberta Innovates Health;
   Alberta Innovates [201300026]
FX This project is funded by the Canadian Institutes of Health Research
   (CIHR), Alberta Innovates Health solution through a knowledge
   translation initiative grant, the Knowledge Translation (KT) Canada
   research Stipend program, and the Physiotherapy Foundation of Canada
   (PFC) through a B. E. Schnurr Memorial Fund Award. The funding bodies
   had no input in the design, collection, analysis, and interpretation of
   data; in the writing of the manuscript; and in the decision to submit
   the manuscript for publication.
CR Abraha I, 2010, BMJ ONLINE, V341, P33
   Armijo-Olivo S, 2012, J EVAL CLIN PRACT, V18, P12, DOI 10.1111/j.1365-2753.2010.01516.x
   Armijo-Olivo S, 2009, PHYS THER REV, V14, P36, DOI 10.1179/174328809X405928
   Boutron I, 2012, J CLIN EPIDEMIOL, V65, P236, DOI 10.1016/j.jclinepi.2011.09.006
   Byrt T, 1996, EPIDEMIOLOGY, V7, P561, DOI 10.1097/00001648-199609000-00030
   COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256
   Davies P, 2010, COCHRANE DATABASE SY
   Effing T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002990.pub2
   Egger M, 2003, Health Technol Assess, V7, P1
   EMERSON JD, 1990, CONTROL CLIN TRIALS, V11, P339, DOI 10.1016/0197-2456(90)90175-2
   Ferrari J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000964.pub3
   Fransen M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007912
   Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f
   Graham N, 2011, SPINE
   Handoll-Helen HG, 2009, COCHRANE DATABASE SY, V2009, DOI 101002
   Hartling L, 2013, J CLIN EPIDEMIOL, V66, P973, DOI 10.1016/j.jclinepi.2012.07.005
   Hartling L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017242
   Hartling L, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4012
   Harvey LA, 2010, COCHRANE DATABASE SY, V2010, DOI 101002/14
   Herbison P, 2006, J CLIN EPIDEMIOL, V59, P1249, DOI 10.1016/j.jclinepi.2006.03.008
   Hewitt CE, 2010, J CLIN EPIDEMIOL, V63, P1264, DOI 10.1016/j.jclinepi.2010.01.010
   Higgins JPT, 2011, BMJ, V343
   Katalinic OM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007455.pub2
   Kjaergard LL, 2002, BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249
   Kramer MS, 2006, COCHRANE DATABASE SY, V2006, DOI 101002/14651858CD000180pub2
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lundh A, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-22
   Manheimer E, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001977.pub2
   Manzoli L, 2007, PEDIATR INFECT DIS J, V26, P97, DOI 10.1097/01.inf.0000253053.01151.bd
   Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X
   Moher D, 1999, Health Technol Assess, V3, pi
   MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W
   Nuesch E, 2009, BMJ-BRIT MED J, V339, P679
   Olivo SA, 2008, PHYS THER, V88, P156, DOI 10.2522/ptj.20070147
   Orozco LJ, 2008, COCHRANE DATABASE SY
   Ostelo-Raymond WJG, 2008, COHRANE DATABASE SYS, V2008
   Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087
   Puhan M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005305.pub2
   Rutjes-Anne WS, 2009, COCHRANE DB SYST REV
   Rutjes-Anne WS, 2010, COCHRANE DATABASE SY, DOI 101002/14651858CD00
   Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537
   Schaafsma F, 2010, COCHRANE DATABASE SY
   Schuck P, 2004, QUAL LIFE RES, V13, P571, DOI 10.1023/B:QURE.0000021318.92272.2a
   SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408
   Sirtori V, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004433.pub2
   States RA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006075.pub2
   Taylor RS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007130.pub2
   Trowman R, 2007, J CLIN EPIDEMIOL, V60, P1229, DOI 10.1016/j.jclinepi.2007.03.014
   Unnebrink K, 2001, STAT MED, V20, P3931, DOI 10.1002/sim.1149
   Villari P, 2004, VACCINE, V22, P3475, DOI 10.1016/j.vaccine.2004.01.068
   WHO, 2011, WORLD REPORT ON DISABILITY, P1
   Wood L, 2008, BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD
   Wright CC, 2003, J CLIN EPIDEMIOL, V56, P833, DOI 10.1016/S0895-4356(03)00155-0
NR 53
TC 46
Z9 47
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 13
PY 2014
VL 9
IS 5
AR e96920
DI 10.1371/journal.pone.0096920
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AH8EY
UT WOS:000336369200041
PM 24824199
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU O'Shea, MK
   Fletcher, TE
   Beeching, NJ
   Dedicoat, M
   Spence, D
   McShane, H
   Cunningham, AF
   Wilson, D
AF O'Shea, Matthew K.
   Fletcher, Thomas E.
   Beeching, Nicholas J.
   Dedicoat, Martin
   Spence, David
   McShane, Helen
   Cunningham, Adam F.
   Wilson, Duncan
TI Tuberculin Skin Testing and Treatment Modulates Interferon-Gamma Release
   Assay Results for Latent Tuberculosis in Migrants
SO PLOS ONE
LA English
DT Article
ID T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; INFECTION; DIAGNOSIS;
   ANTIGENS; GOLD; METAANALYSIS; ENUMERATION; EXPOSURE; CONTACTS
AB Background: Identifying latent tuberculosis infection (LTBI) in people migrating from TB endemic regions to low incidence countries is an important control measure. However, no prospective longitudinal comparisons between diagnostic tests used in such migrant populations are available.
   Objectives: To compare commercial interferon (IFN)-gamma release assays (IGRAs) and the tuberculin skin test (TST) for diagnosing LTBI in a migrant population, and the influence of antecedent TST and LTBI treatment on IGRA performance.
   Materials and Methods: This cohort study, performed from February to September 2012, assessed longitudinal IGRA and TST responses in Nepalese military recruits recently arrived in the UK. Concomitant T-SPOT. TB, QFT-GIT and TST were performed on day 0, with IGRAs repeated 7 and 200 days later, following treatment for LTBI if necessary.
   Results: individuals by QFT-GIT. There was substantial agreement between TST and T-SPOT. TB positives at baseline (71.4% agreement; kappa = 0.62; 95% CI: 0.44-0.79), but only moderate concordance between positive IGRAs (38.1% agreement; kappa = 0.46; 95% CI: 0.25-0.67). When reassessed 7 days following TST, numbers of IGRA-positive individuals changed from 8 to 23 for QFT-GIT (p = 0.0074) and from 21 to 23 for T-SPOT. TB (p=0.87). This resulted in an increase in IGRA concordance to substantial (64.3% agreement; kappa = 0.73; 95% CI: 0.58-0.88). Thus, in total on day 0 and day 7 after testing, 29 out of 166 participants (17.5%) provided a positive IGRA and of these 13 were TST negative. Two hundred days after the study commenced and three months after treatment for LTBI was completed by those who were given chemoprophylaxis, 23 and 21 participants were positive by T-SPOT. TB or QFT-GIT respectively. When individual responses were examined longitudinally within this population 35% of the day 7 QFT-GIT-positive, and 19% T-SPOT. TB-positive individuals, were negative by IGRA. When the change in the levels of secreted IFN-gamma was examined after chemoprophylaxis c the median levels were found to have fallen dramatically by 77.3% from a pre-treatment median concentration of IFN-gamma 2.7 3 IU/ml to a post-treatment median concentration IFN-gamma 0.62 (p = 0.0002).
   Conclusions: This study suggests differences in the capacity of commercially available IGRAs to identify LTBI in the absence of antecedent TST and that IGRAs, in the time periods examined, may not be the optimal tests to determine the success of chemoprophylaxis for LTBI.
C1 [O'Shea, Matthew K.; McShane, Helen] Univ Oxford, Nuffield Dept Med, Jenner Inst, Oxford, England.
   [O'Shea, Matthew K.; Cunningham, Adam F.] Univ Birmingham Edgbaston, MRC Ctr Immune Regulat, Sch Immun & Infect, Birmingham, W Midlands, England.
   [Fletcher, Thomas E.; Beeching, Nicholas J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.
   [Dedicoat, Martin] Birmingham Heartlands Hosp, Dept Infect Dis & Trop Med, Birmingham B9 5ST, W Midlands, England.
   [Spence, David] Friarage Hosp, Dept Resp Med, Northallerton, N Yorkshire, England.
   [Wilson, Duncan] Joint Med Command, Royal Ctr Def Med Acad & Res, Birmingham, W Midlands, England.
RP Cunningham, AF (reprint author), Univ Birmingham Edgbaston, MRC Ctr Immune Regulat, Sch Immun & Infect, Birmingham, W Midlands, England.
EM a.f.cunningham@bham.ac.uk
RI Beeching, Nicholas/L-5363-2017
OI Dedicoat, Martin/0000-0001-9833-4882; Beeching,
   Nicholas/0000-0002-7019-8791
FU UK Surgeon General; Drummond Foundation
FX Funding was received from the UK Surgeon General and the Drummond
   Foundation. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR [Anonymous], TUB CLIN DIAGN MAN T
   [Anonymous], CAN COMMUN DIS REP, V34, P1
   Baker CA, 2009, AM J TROP MED HYG, V80, P628, DOI 10.4269/ajtmh.2009.80.628
   Borsuk S, 2009, TUBERCULOSIS, V89, P423, DOI 10.1016/j.tube.2009.07.003
   Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754
   Chee CBE, 2007, AM J RESP CRIT CARE, V175, P282, DOI 10.1164/rccm.200608-1109OC
   Chee CBE, 2013, RESPIROLOGY, V18, P205, DOI 10.1111/resp.12002
   Chiappini E, 2012, CLIN THER, V34, P1041, DOI 10.1016/j.clinthera.2012.03.006
   Dheda K, 2005, LANCET INFECT DIS, V5, P324, DOI 10.1016/S1473-3099(05)70119-5
   Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110
   Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC
   Dyrhol-Riise AM, 2010, BMC INFECT DIS, V10, P1471
   Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC
   Franken WPJ, 2008, INT J TUBERC LUNG D, V12, P1286
   Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037
   Health Protection Agency, 2012, TUB UK ANN REP TUB S
   Igari H, 2007, INT J TUBERC LUNG D, V11, P788
   Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756
   Kim CH, 2013, CYTOM PART B-CLIN CY, V19, P21110
   Klenerman P, 2002, NAT REV IMMUNOL, V2, P263, DOI 10.1038/nri777
   Lalvani A, 2004, CLIN INFECT DIS, V38, P757, DOI 10.1086/381763
   Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100
   Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee SW, 2012, INFECTION, V40, P431, DOI 10.1007/s15010-012-0265-2
   Leyten EMS, 2007, EUR RESPIR J, V29, P1212, DOI 10.1183/09031936.00117506
   Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908
   Mahomed H, 2006, INT J TUBERC LUNG D, V10, P310
   Mancuso JD, 2012, AM J RESP CRIT CARE, V185, P427, DOI 10.1164/rccm.201107-1244OC
   Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1
   Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120
   Menzies D, 2000, TUBERCULOSIS COMPREH, P279
   Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006
   Naseer A, 2007, EUR RESPIR J, V29, P1282, DOI 10.1183/09031936.0017807
   O'Shea MK, 2014, J ROY ARMY MED CORPS, V7, P2014
   Pai M, 2009, INT J TUBERC LUNG D, V13, P84
   Pai M, 2007, PLOS MED, V4
   Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241
   Pai M, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-7
   Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC
   Pareek M, 2012, THORAX, V12, P12
   Pathan AA, 2000, EUR J IMMUNOL, V30, P2713, DOI 10.1002/1521-4141(200009)30:9<2713::AID-IMMU2713>3.0.CO;2-4
   Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217
   Perry S, 2008, CLIN VACCINE IMMUNOL, V15, P425, DOI 10.1128/CVI.00398-07
   Sauzullo I, 2011, TUBERCULOSIS, V91, P322, DOI 10.1016/j.tube.2011.05.004
   Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969
   The World Health Organisation, 2014, GLOB HLTH OBS DAT RE
   Theron G, 2012, PLOS ONE, V7, P22
   van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517
   van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC
   Vilaplana C, 2008, SCAND J IMMUNOL, V67, P610, DOI 10.1111/j.1365-3083.2008.02103.x
   Wilkinson KA, 2006, J INFECT DIS, V193, P354, DOI 10.1086/499311
NR 52
TC 8
Z9 8
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 9
PY 2014
VL 9
IS 5
AR e97366
DI 10.1371/journal.pone.0097366
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI4LX
UT WOS:000336838000133
PM 24816576
OA DOAJ Gold, Green Accepted, Green Published
DA 2019-07-16
ER

PT J
AU Mern, DS
   Beierfuss, A
   Fontana, J
   Thome, C
   Hegewald, AA
AF Mern, Demissew S.
   Beierfuss, Anja
   Fontana, Johann
   Thome, Claudius
   Hegewald, Aldemar A.
TI Imbalanced Protein Expression Patterns of Anabolic, Catabolic,
   Anti-Catabolic and Inflammatory Cytokines in Degenerative Cervical Disc
   Cells: New Indications for Gene Therapeutic Treatments of Cervical Disc
   Diseases
SO PLOS ONE
LA English
DT Article
ID HUMAN INTERVERTEBRAL DISC; AGE-RELATED-CHANGES; EXTRACELLULAR-MATRIX;
   NUCLEUS PULPOSUS; ANULUS FIBROSUS; GROWTH-FACTORS; TRANSPLANTATION;
   PATHOGENESIS; DIFFUSION; AGREEMENT
AB Degenerative disc disease (DDD) of the cervical spine is common after middle age and can cause loss of disc height with painful nerve impingement, bone and joint inflammation. Despite the clinical importance of these problems, in current publications the pathology of cervical disc degeneration has been studied merely from a morphologic view point using magnetic resonance imaging (MRI), without addressing the issue of biological treatment approaches. So far a wide range of endogenously expressed bioactive factors in degenerative cervical disc cells has not yet been investigated, despite its importance for gene therapeutic approaches. Although degenerative lumbar disc cells have been targeted by different biological treatment approaches, the quantities of disc cells and the concentrations of gene therapeutic factors used in animal models differ extremely. These indicate lack of experimentally acquired data regarding disc cell proliferation and levels of target proteins. Therefore, we analysed proliferation and endogenous expression levels of anabolic, catabolic, ant-catabolic, inflammatory cytokines and matrix proteins of degenerative cervical disc cells in three- dimensional cultures. Preoperative MRI grading of cervical discs was used, then grade III and IV nucleus pulposus (NP) tissues were isolated from 15 patients, operated due to cervical disc herniation. NP cells were cultured for four weeks with low-glucose in collagen I scaffold. Their proliferation rates were analysed using 3-(4, 5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide. Their protein expression levels of 28 therapeutic targets were analysed using enzyme-linked immunosorbent assay. During progressive grades of degeneration NP cell proliferation rates were similar. Significantly decreased aggrecan and collagen II expressions (P < 0.0001) were accompanied by accumulations of selective catabolic and inflammatory cytokines (disintegrin and metalloproteinase with thrombospondin motifs 4 and 5, matrix metalloproteinase 3, interleukin-1 beta, interleukin-1 receptor) combined with low expression of anti-catabolic factor (metalloproteinase inhibitor 3) (P < 0.0001). This study might contribute to inhibit inflammatory catabolism of cervical discs.
C1 [Mern, Demissew S.; Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, A-6020 Innsbruck, Tirol, Austria.
   [Beierfuss, Anja; Fontana, Johann; Hegewald, Aldemar A.] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neurosurg, Mannheim, Baden Wurttembe, Germany.
RP Mern, DS (reprint author), Med Univ Innsbruck, Dept Neurosurg, A-6020 Innsbruck, Tirol, Austria.
EM demissew.shenegelegn-mern@uki.at
RI , Hegewald/H-2847-2019
OI , Hegewald/0000-0002-2022-2060
FU University Medical Center Mannheim of Heidelberg University
FX The study is funded by University Medical Center Mannheim of Heidelberg
   University. The funder had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884
   Bachmeier BE, 2009, EUR SPINE J, V18, P1573, DOI 10.1007/s00586-009-1031-8
   Bibby SRS, 2004, EUR SPINE J, V13, P695, DOI 10.1007/s00586-003-0616-x
   Christe A, 2005, NEURORADIOLOGY, V47, P721, DOI 10.1007/s00234-005-1412-6
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Gruber HE, 2003, SPINE, V28, P186, DOI 10.1097/00007632-200301150-00017
   Hastreiter D, 2001, J ORTHOP RES, V19, P597, DOI 10.1016/S0736-0266(00)00069-3
   Hegewald AA, 2008, FRONT BIOSCI-LANDMRK, V13, P1507, DOI 10.2741/2777
   Kalb S, 2012, WORLD NEUROSURG, V77, P491, DOI 10.1016/j.wneu.2011.07.014
   Kanemoto M, 1996, SPINE, V21, P1, DOI 10.1097/00007632-199601010-00001
   Kolstad F, 2005, EUR J RADIOL, V55, P415, DOI 10.1016/j.ejrad.2005.02.005
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275
   Le Maitre CL, 2005, J PATHOL, V207, P445, DOI 10.1002/path.1862
   Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732
   Le Maitre CL, 2004, J PATHOL, V204, P47, DOI 10.1002/path.1608
   Liebscher T, 2011, SPINE, V36, P153, DOI 10.1097/BRS.0b013e3181cd588c
   Malfait AM, 2002, J BIOL CHEM, V277, P22201, DOI 10.1074/jbc.M200431200
   MAROUDAS A, 1975, J ANAT, V120, P113
   Masuda K, 2004, SPINE, V29, P2757, DOI 10.1097/01.brs.0000146048.14946.af
   Matsumoto M, 1998, J BONE JOINT SURG BR, V80B, P19, DOI 10.1302/0301-620X.80B1.7929
   Meisel HJ, 2007, BIOMOL ENG, V24, P5, DOI 10.1016/j.bioeng.2006.07.002
   Mercer S, 1999, SPINE, V24, P619, DOI 10.1097/00007632-199904010-00002
   Mercer SR, 1996, MAN THER, V2, P76
   Mern DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081467
   Mern DS, 2012, J TISSUE ENG REGEN M, DOI [10.1002/term1583, DOI 10.1002/TERM1583]
   Millward-Sadler SJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2693
   Miyazaki M, 2008, J SPINAL DISORD TECH, V21, P288, DOI 10.1097/BSD.0b013e31813c0e59
   MODIC MT, 1986, RADIOLOGY, V161, P753, DOI 10.1148/radiology.161.3.3786728
   MODIC MT, 1987, RADIOLOGY, V163, P227, DOI 10.1148/radiology.163.1.3823440
   Naito S, 2007, PATHOL INT, V57, P703, DOI 10.1111/j.1440-1827.2007.02167.x
   Nerlich AG, 1997, SPINE, V22, P2781, DOI 10.1097/00007632-199712150-00001
   Nerlich AG, 2007, EUR SPINE J, V16, P547, DOI 10.1007/s00586-006-0213-x
   Nomura T, 2001, CLIN ORTHOP RELAT R, P94
   Rajasekaran S, 2004, SPINE, V29, P2654, DOI 10.1097/01.brs.0000148014.15210.64
   Revell PA, 2007, J MATER SCI-MATER M, V18, P303, DOI 10.1007/s10856-006-0693-6
   Roberts S, 2000, SPINE, V25, P3005, DOI 10.1097/00007632-200012010-00007
   Roberts S, 2006, EUR SPINE J, V15, pS312, DOI 10.1007/s00586-006-0126-8
   Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9
   Singh K, 2009, SPINE, V34, P10, DOI 10.1097/BRS.0b013e31818e5ddd
   Skrzypiec DM, 2007, EUR SPINE J, V16, P1701, DOI 10.1007/s00586-007-0458-z
   Soukane DM, 2007, J BIOMECH, V40, P2645, DOI 10.1016/j.jbiomech.2007.01.003
   Tolonen J, 2006, EUR SPINE J, V15, P588, DOI 10.1007/s00586-005-0930-6
   Weiler C, 2012, Eur Spine J, V21 Suppl 6, pS810, DOI 10.1007/s00586-011-1922-3
   Wigfield CC, 2003, J SPINAL DISORD TECH, V16, P441, DOI 10.1097/00024720-200310000-00002
   Zhao CQ, 2007, AGEING RES REV, V6, P247, DOI 10.1016/j.arr.2007.08.001
   Zhao CQ, 2011, J ORTHOP RES, V29, P718, DOI 10.1002/jor.21285
NR 47
TC 7
Z9 8
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 7
PY 2014
VL 9
IS 5
AR e96870
DI 10.1371/journal.pone.0096870
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AG9HB
UT WOS:000335728900109
PM 24804684
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Pouchot, J
   Despujol, C
   Malamut, G
   Ecosse, E
   Coste, J
   Cellier, C
AF Pouchot, Jacques
   Despujol, Carole
   Malamut, Georgia
   Ecosse, Emmanuel
   Coste, Joel
   Cellier, Christophe
TI Validation of a French Version of the Quality of Life "Celiac Disease
   Questionnaire"
SO PLOS ONE
LA English
DT Article
ID CROSS-CULTURAL ADAPTATION; GLUTEN-FREE DIET; NATIONAL-SURVEY; HEALTH
   SURVEY; GUIDELINES; AGREEMENT; DIAGNOSIS; SCALE; SF-36
AB Background and Objective: Celiac disease (CD) is a common chronic autoimmune disorder. Both the manifestations of the disease and the burden of the compulsory life-long gluten-free diet (GFD) have been shown to be associated with impairment of health-related quality of life. The objectives of this study were to provide a cross-cultural adaptation of the specific quality of life "Celiac Disease Questionnaire" (CDQ) and to analyze its psychometric properties.
   Materials and Methods: A cross-cultural French adaptation of the CDQ (F-CDQ) was obtained according to the revised international guidelines. The questionnaire was administered at baseline to 211 patients with biopsy proven CD followed-up in a single tertiary referral centre. The questionnaire was also administered after 7 days and 6 months. Reliability (intraclass correlation coefficients (ICC), Cronbach's alpha and Bland and Altman graphical analysis), validity (factorial structure and Rasch analysis, convergent validity), and responsiveness (effect size) of the F-CDQ were studied.
   Results: The reliability of the F-CDQ was excellent with ICC and Cronbach's alpha coefficients being between 0.79 and 0.94 for the four subscales and the total score. The factorial structure and the Rasch analysis showed that the four dimensions of the original instrument were retained. Correlations with external measures (a generic measure of quality of life, an anxiety and depression instrument, a self-assessed disease severity, and clinical manifestations) were all in the expected direction confirming the validity of the instrument. Responsiveness was studied and effect sizes >= 0.20 were demonstrated for most of the subscales for patients who reported improvement or deterioration after 6 months.
   Conclusion: The F-CDQ retains the psychometric properties of the original instrument and should be useful in cross-national surveys and to assess outcome in clinical trials involving patients with CD.
C1 [Pouchot, Jacques; Despujol, Carole] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Serv Med Interne,Sorbonne Paris Cite, Paris, France.
   [Pouchot, Jacques; Ecosse, Emmanuel; Coste, Joel] Univ Paris 05, Univ Lorraine, Sorbonne Paris Cite, APEMAC,EA 4360, Paris, France.
   [Malamut, Georgia; Cellier, Christophe] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Serv Gastroenterol,Sorbonne Paris Cite, Paris, France.
RP Pouchot, J (reprint author), Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Serv Med Interne,Sorbonne Paris Cite, Paris, France.
EM jacques.pouchot@egp.aphp.fr
OI Malamut, Georgia/0000-0003-4030-3025; christophe,
   Cellier/0000-0003-0784-2318
FU AFDIAG "Association Francaise des Intolerants Au Gluten"
FX The authors received support from the AFDIAG "Association Francaise des
   Intolerants Au Gluten" for this study. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014
   BLAND JM, 1986, LANCET, V1, P307
   Browne MW, 1993, TESTING STRUCTURAL E, V154, P136, DOI DOI 10.1177/0049124192021002005
   Chand N, 2006, J CLIN GASTROENTEROL, V40, P3, DOI 10.1097/01.mcg.0000190644.01661.2b
   Cranney A, 2007, DIGEST DIS SCI, V52, P1087, DOI 10.1007/s10620-006-9258-2
   CRONBACH LJ, 1951, PSYCHOMETRIKA, V16, P297, DOI DOI 10.1007/BF02310555
   Crosby RD, 2003, J CLIN EPIDEMIOL, V56, P395, DOI 10.1016/S0895-4356(03)00044-1
   Di Sabatino A, 2009, LANCET, V373, P1480, DOI 10.1016/S0140-6736(09)60254-3
   Dorn SD, 2010, ALIMENT PHARM THER, V31, P666, DOI 10.1111/j.1365-2036.2009.04220.x
   Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600
   Green PHR, 2001, AM J GASTROENTEROL, V96, P126, DOI 10.1111/j.1572-0241.2001.03462.x
   GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N
   Hauser W, 2007, J CLIN GASTROENTEROL, V41, P157
   Hauser W, 2006, EUR J GASTROEN HEPAT, V18, P747
   Hallert C, 1998, SCAND J GASTROENTERO, V33, P933, DOI 10.1080/003655298750026949
   Johnston SD, 2004, EUR J GASTROEN HEPAT, V16, P1281, DOI 10.1097/00042737-200412000-00008
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leffler D, 2011, JAMA-J AM MED ASSOC, V306, P1582, DOI [10.1001/jama.2011.1312, 10.1001/jama.306.14.1582]
   LEPLEGE A, 2001, QUESTIONNAIRE MOS SF
   Marchese A, 2013, EUR J INTERN MED, V24, P87, DOI 10.1016/j.ejim.2012.09.015
   Nachman F, 2010, DIGEST LIVER DIS, V42, P685, DOI 10.1016/j.dld.2010.03.004
   Nunnaly JC, 1994, PSYCHOMETRIC THEORY
   O'Leary C, 2002, AM J GASTROENTEROL, V97, P1463, DOI 10.1016/S0002-9270(02)04046-7
   Peyre H, 2011, QUAL LIFE RES, V20, P287, DOI 10.1007/s11136-010-9740-3
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Zarkadas M, 2006, J HUM NUTR DIET, V19, P41, DOI 10.1111/j.1365-277X.2006.00659.x
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
   Zingone F, 2013, DIGEST LIVER DIS, V45, P115, DOI 10.1016/j.dld.2012.10.018
NR 28
TC 8
Z9 8
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 2
PY 2014
VL 9
IS 5
AR e96346
DI 10.1371/journal.pone.0096346
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI1ZS
UT WOS:000336655700077
PM 24788794
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Rummukainen, O
   Radun, J
   Virtanen, T
   Pulkki, V
AF Rummukainen, Olli
   Radun, Jenni
   Virtanen, Toni
   Pulkki, Ville
TI Categorization of Natural Dynamic Audiovisual Scenes
SO PLOS ONE
LA English
DT Article
ID ATTENTIONAL SELECTION; PERCEPTION; SOUNDSCAPES; CONSTRUCTION; MEMORY;
   WORLD; URBAN; MODEL; GIST
AB This work analyzed the perceptual attributes of natural dynamic audiovisual scenes. We presented thirty participants with 19 natural scenes in a similarity categorization task, followed by a semi-structured interview. The scenes were reproduced with an immersive audiovisual display. Natural scene perception has been studied mainly with unimodal settings, which have identified motion as one of the most salient attributes related to visual scenes, and sound intensity along with pitch trajectories related to auditory scenes. However, controlled laboratory experiments with natural multimodal stimuli are still scarce. Our results show that humans pay attention to similar perceptual attributes in natural scenes, and a two-dimensional perceptual map of the stimulus scenes and perceptual attributes was obtained in this work. The exploratory results show the amount of movement, perceived noisiness, and eventfulness of the scene to be the most important perceptual attributes in naturalistically reproduced real-world urban environments. We found the scene gist properties openness and expansion to remain as important factors in scenes with no salient auditory or visual events. We propose that the study of scene perception should move forward to understand better the processes behind multimodal scene processing in real-world environments. We publish our stimulus scenes as spherical video recordings and sound field recordings in a publicly available database.
C1 [Rummukainen, Olli; Pulkki, Ville] Aalto Univ, Dept Signal Proc & Acoust, Espoo, Finland.
   [Radun, Jenni; Virtanen, Toni] Univ Helsinki, Inst Behav Sci, Helsinki, Finland.
RP Rummukainen, O (reprint author), Aalto Univ, Dept Signal Proc & Acoust, Espoo, Finland.
EM olli.rummukainen@aalto.fi
RI Pulkki, Ville/G-2394-2013; Virtanen, Toni I. O./E-9181-2015
OI Virtanen, Toni I. O./0000-0001-5191-2438; Radun,
   Jenni/0000-0003-3269-2999; Pulkki, Ville/0000-0003-3460-9677
FU European Research Council under the European Community/ERC [240453];
   Academy of Finland
FX The research leading to these results has received funding from the
   European Research Council under the European Community's Seventh
   Framework Programme (FP7/2007-2013)/ERC grant agreement No. 240453 and
   from the Academy of Finland. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029
   ATLASti Scientific Software Development GmbH, 2011, ATL TI V 6
   Axelsson O, 2010, J ACOUST SOC AM, V128, P2836, DOI 10.1121/1.3493436
   Bonebright T, 2012, 18 INT C AUD DISPL I, P1
   Botteldooren D, 2011, UNDERSTANDING URBAN, P1
   Botteldooren D, 2012, AC 2012 HONG KONG C, P1
   BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268
   Bregman AS, 1994, AUDITORY SCENE ANAL
   Brockmole JR, 2005, J EXP PSYCHOL HUMAN, V31, P857, DOI 10.1037/0096-1523.31.5.857
   Carmi R, 2006, VISION RES, V46, P4333, DOI 10.1016/j.visres.2006.08.019
   Castelhano MS, 2008, J EXP PSYCHOL HUMAN, V34, P660, DOI 10.1037/0096-1523.34.3.660
   Corbin J., 2008, BASICS QUALITATIVE R
   Coutrot A, 2013, 14 INT WORKSH IM AUD
   Coutrot A, 2012, J EYE MOVEMENT RES, V5
   Davies WJ, 2013, APPL ACOUST, V74, P224, DOI 10.1016/j.apacoust.2012.05.010
   de Leeuw J, 2008, J STAT SOFTW, V31, P1
   Dubois D, 2006, ACTA ACUST UNITED AC, V92, P865
   Fei-Fei L, 2007, J VISION, V7, DOI 10.1167/7.1.10
   Finnish Advisory Board on Research Ethics, 2009, ETH PRINC RES HUM SO
   FRIEDMAN A, 1979, J EXP PSYCHOL GEN, V108, P316, DOI 10.1037/0096-3445.108.3.316
   GAVER WW, 1993, ECOL PSYCHOL, V5, P1, DOI 10.1207/s15326969eco0501_1
   GOLDSTONE R, 1994, J EXP PSYCHOL GEN, V123, P178, DOI 10.1037/0096-3445.123.2.178
   GOLDSTONE RL, 1994, COGNITION, V52, P125, DOI 10.1016/0010-0277(94)90065-5
   Gomez Bolanos J, 2012, AUD ENG SOC 132 CONV, P1
   Greene MR, 2009, PSYCHOL SCI, V20, P464, DOI 10.1111/j.1467-9280.2009.02316.x
   HAIR J, 2005, MULTIVARIATE DATA AN
   Harding S, 2007, LECT NOTES ARTIF INT, V4840, P399
   International Telecommunication Union, 1998, ITU T REC P 911 SUBJ
   Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558
   Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500
   Kayser C, 2005, CURR BIOL, V15, P1943, DOI 10.1016/j.cub.2005.09.040
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mather M, 2011, PERSPECT PSYCHOL SCI, V6, P114, DOI 10.1177/1745691611400234
   MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0
   Nardo D, 2013, HUMAN BRAIN MAPPING, V35, P1
   Oksanen J, 2011, VEGAN COMMUNITY ECOL
   Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724
   Oliva A, 2006, PROG BRAIN RES, V155, P23, DOI 10.1016/S0079-6123(06)55002-2
   Peltonen V, 2001, AUD ENG SOC 110 CONV, P1
   Pheasant R, 2008, J ACOUST SOC AM, V123, P1446, DOI 10.1121/1.2831735
   Pheasant RJ, 2010, J ENVIRON PSYCHOL, V30, P501, DOI 10.1016/j.jenvp.2010.03.006
   Politis A, 2011, AUD ENG SOC 131 CONV, P1
   POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509
   POTTER MC, 1975, SCIENCE, V187, P965, DOI 10.1126/science.1145183
   Pulkki V, 2007, J AUDIO ENG SOC, V55, P503
   Quigley C, 2007, J EYE MOVEMENT RES, V1
   R Development Core Team, 2012, R LANG ENV STAT COMP
   RABINOWITZ GB, 1975, AM J POLIT SCI, V19, P343, DOI 10.2307/2110441
   Rouder JN, 2006, CURR DIR PSYCHOL SCI, V15, P9, DOI 10.1111/j.0963-7214.2006.00397.x
   Sanocki T, 2013, J EXP PSYCHOL HUMAN, V39, P381, DOI 10.1037/a0030718
   Shamma SA, 2011, TRENDS NEUROSCI, V34, P114, DOI 10.1016/j.tins.2010.11.002
   Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P1, DOI 10.3758/BF03206843
   Tardieu J, 2008, APPL ACOUST, V69, P1224, DOI 10.1016/j.apacoust.2007.10.001
   TVERSKY B, 1983, COGNITIVE PSYCHOL, V15, P121, DOI 10.1016/0010-0285(83)90006-3
   Vilkamo J, 2009, J AUDIO ENG SOC, V57, P709
   Vo MLH, 2012, J VISION, V12, DOI 10.1167/12.13.3
   Yantis S, 1993, CURRENT DIRECTIONS P, V2, P156, DOI DOI 10.1111/1467-8721.EP10768973
NR 57
TC 5
Z9 5
U1 1
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 1
PY 2014
VL 9
IS 5
AR e95848
DI 10.1371/journal.pone.0095848
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AG6EE
UT WOS:000335510600053
PM 24788808
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Morfeld, KA
   Lehnhardt, J
   Alligood, C
   Bolling, J
   Brown, JL
AF Morfeld, Kari A.
   Lehnhardt, John
   Alligood, Christina
   Bolling, Jeff
   Brown, Janine L.
TI Development of a Body Condition Scoring Index for Female African
   Elephants Validated by Ultrasound Measurements of Subcutaneous Fat
SO PLOS ONE
LA English
DT Article
ID HOLSTEIN DAIRY-COWS; ZOO ELEPHANTS; REPRODUCTIVE DISORDERS; HORMONE
   CONCENTRATIONS; BLUBBER THICKNESS; CONDITION SCORES; NORTH-AMERICA;
   OBESITY; WOMEN; HORSES
AB Obesity-related health and reproductive problems may be contributing to non-sustainability of zoo African elephant (Loxodonta africana) populations. However, a major constraint in screening for obesity in elephants is lack of a practical method to accurately assess body fat. Body condition scoring (BCS) is the assessment of subcutaneous fat stores based on visual evaluation and provides an immediate appraisal of the degree of obesity of an individual. The objective of this study was to develop a visual BCS index for female African elephants and validate it using ultrasound measures of subcutaneous fat. To develop the index, standardized photographs were collected from zoo (n = 50) and free-ranging (n = 57) female African elephants for identifying key body regions and skeletal features, which were then used to visually determine body fat deposition patterns. This information was used to develop a visual BCS method consisting of a list of body regions and the physical criteria for assigning an overall score on a 5-point scale, with 1 representing the lowest and 5 representing the highest levels of body fat. Results showed that as BCS increased, ultrasound measures of subcutaneous fat thickness also increased (P<0.01), indicating the scores closely coincide with physical measures of fat reserves. The BCS index proved to be reliable and repeatable based on high intra- and inter-assessor agreement across three assessors. In comparing photographs of wild vs. captive African elephants, the median BCS in the free-ranging individuals (BCS = 3, range 1-5) was lower (P<0.001) than that of the zoo population (BCS = 4, range 2-5). In sum, we have developed the first validated BCS index for African elephants. This tool can be used to examine which factors impact body condition in zoo and free-ranging elephants, providing valuable information on how it affects health and reproductive potential of individual elephants.
C1 [Morfeld, Kari A.; Brown, Janine L.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Roya, VA USA.
   [Lehnhardt, John; Bolling, Jeff] Natl Elephant Ctr, Fellsmere, FL USA.
   [Alligood, Christina] Disneys Anim Kingdom, Bay Lake, FL USA.
RP Morfeld, KA (reprint author), Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Roya, VA USA.
EM morfeldk@si.edu
FU Morris Animal Foundation; Shared Earth Foundation; FBB Capital Partners;
   Wolcott Fund; Siemens Medical Solutions Diagnostics
FX Morris Animal Foundation, Shared Earth Foundation, FBB Capital Partners,
   Wolcott Fund, Siemens Medical Solutions Diagnostics. The funders had no
   role in the study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR AZA, 2011, AZA STAND EL MAN CAR
   Bishop CJ, 2009, J WILDLIFE MANAGE, V73, P462, DOI 10.2193/2008-015
   Bray George A., 1997, Human Reproduction (Oxford), V12, P26
   Brown JL, 2004, ZOO BIOL, V23, P309, DOI 10.1002/zoo.20006
   Burkholder WJ, 2000, J AM VET MED ASSOC, V217, P650, DOI 10.2460/javma.2000.217.650
   Carter RA, 2009, VET J, V179, P204, DOI 10.1016/j.tvjl.2008.02.029
   Chang RJ, 2007, NAT CLIN PRACT ENDOC, V3, P688, DOI 10.1038/ncpendmet0637
   CLARK AM, 1995, HUM REPROD, V10, P2705, DOI 10.1093/oxfordjournals.humrep.a135772
   Clingerman KJ, 2012, J AM ASSOC LAB ANIM, V51, P31
   Clubb R, 2009, ANIM WELFARE, V18, P237
   Clubb R, 2002, REV WELFARE ZOO ELEP
   Clubb R, 2008, SCIENCE, V322, P1649, DOI 10.1126/science.1164298
   COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256
   Cook RC, 2001, J WILDLIFE MANAGE, V65, P973, DOI 10.2307/3803046
   de Knegt HJ, 2011, J ANIM ECOL, V80, P270, DOI 10.1111/j.1365-2656.2010.01764.x
   Deurenberg P, 1999, BEST PRACT RES CL EN, V13, P1, DOI 10.1053/beem.1999.0003
   DOMECQ JJ, 1995, J DAIRY SCI, V78, P2308, DOI 10.3168/jds.S0022-0302(95)76857-6
   Dow TL, 2011, ZOO BIOL, V30, P699, DOI 10.1002/zoo.20377
   EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0
   Ellis KJ, 2000, ENDOCRINOLOGIST, V10, p57S, DOI 10.1097/00019616-200010041-00012
   FANELLI MT, 1984, AM J CLIN NUTR, V39, P703
   Fleiss JL, 1981, STAT METHODS RATES P
   Frank N, 2006, JAVMA-J AM VET MED A, V228, P1383, DOI 10.2460/javma.228.9.1383
   Freeman EW, 2009, ZOO BIOL, V28, P1, DOI 10.1002/zoo.20187
   GALES NJ, 1987, AUST J ZOOL, V35, P207, DOI 10.1071/ZO9870207
   Ganswindt A, 2010, HORM BEHAV, V57, P506, DOI 10.1016/j.yhbeh.2010.02.009
   Gebin L, 2012, VET MED RSRCH REPORT, V3, P71
   Gustine DD, 2010, RANGIFER, V27, P249
   Hall AJ, 2007, MAR MAMMAL SCI, V23, P650, DOI 10.1111/j.1748.7692.2007.00132.x
   HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x
   Hile ME, 1997, J ZOO WILDLIFE MED, V28, P424
   Hill JW, 2008, AM J PHYSIOL-ENDOC M, V294, pE827, DOI 10.1152/ajpendo.00670.2007
   Ibrahim MM, 2009, OBES REV, V11, P11
   Irvine LM, 2003, CURR OBSTET GYNAECOL, V13, P179, DOI [10.1016/S0957-5847(03)00005-2, DOI 10.1016/S0957-5847(03)00005-2]
   Kearns C F, 2002, Equine Vet J Suppl, P485
   Keele M., 2011, AZA PUBLICATION
   Laflamme D, 1997, CANINE PRACT, V22, P10
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lassen J, 2003, J DAIRY SCI, V86, P4123, DOI 10.3168/jds.S0022-0302(03)74026-0
   Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291
   Lievense AM, 2002, RHEUMATOLOGY, V41, P1155, DOI 10.1093/rheumatology/41.10.1155
   Lund E. M., 2006, International Journal of Applied Research in Veterinary Medicine, V4, P177
   Lund E. M., 2005, International Journal of Applied Research in Veterinary Medicine, V3, P88
   Marti K, 2011, TECHNICAL REPORT ZOO
   Mason GJ, 2010, ZOO BIOL, V29, P256, DOI [10.1002/zoo.20303, 10.1002/zoo.20256]
   Mellish JAE, 2004, J ZOO WILDLIFE MED, V35, P116, DOI 10.1638/03-028
   Miller PB, 2008, J REPROD MED, V53, P315
   Nguyen NT, 2008, J AM COLL SURGEONS, V207, P928, DOI 10.1016/j.jamcollsurg.2008.08.022
   Norman RJ, 1998, REPROD FERT DEVELOP, V10, P55, DOI 10.1071/R98010
   OTTO KL, 1991, J DAIRY SCI, V74, P852, DOI 10.3168/jds.S0022-0302(91)78234-9
   Pasquali R, 2003, HUM REPROD UPDATE, V9, P359, DOI 10.1093/humupd/dmg024
   Phythian CJ, 2012, VET J, V193, P257, DOI 10.1016/j.tvjl.2011.12.006
   POOLE JH, 1989, ANIM BEHAV, V37, P140, DOI 10.1016/0003-3472(89)90014-6
   Proctor CM, 2010, ZOO BIOL, V29, P127, DOI 10.1002/zoo.20238
   Schroder UJ, 2006, J DAIRY SCI, V89, P1, DOI 10.3168/jds.S0022-0302(06)72064-1
   Sim J, 2005, PHYS THER, V85, P257
   Speaker Kristin J., 2012, BMC Physiology, V12, P8, DOI 10.1186/1472-6793-12-8
   Stephenson TR, 1998, CAN J ZOOL, V76, P717, DOI 10.1139/cjz-76-4-717
   Treiber K, 2012, 7 CRISS ZOOL NUTR S, P1
   Vick MM, 2006, REPROD FERT DEVELOP, V18, P609, DOI 10.1071/RD06016
   VOLZ PA, 1984, MED SCI SPORT EXER, V16, P97, DOI 10.1249/00005768-198401000-00020
   WAGNER JJ, 1988, J ANIM SCI, V66, P603
   Wemmer C, 2006, ZOO BIOL, V25, P187, DOI 10.1002/zoo.20099
   WESTERVELT RG, 1976, J ANIM SCI, V43, P781
   Wiese R. J., 2006, International Zoo Yearbook, V40, P80, DOI 10.1111/j.1748-1090.2006.00080.x
   Wijeyamohan S, 2012, CURR SCI INDIA, V102, P26
   WILDMAN EE, 1982, J DAIRY SCI, V65, P495, DOI 10.3168/jds.S0022-0302(82)82223-6
   WILKINSON MJA, 1991, J NUTR, V121, pS47, DOI 10.1093/jn/121.suppl_11.S47
NR 68
TC 18
Z9 18
U1 0
U2 27
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 9
PY 2014
VL 9
IS 4
AR e93802
DI 10.1371/journal.pone.0093802
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AE9PC
UT WOS:000334339000047
PM 24718304
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Pearce, W
   Holmberg, K
   Hellsten, I
   Nerlich, B
AF Pearce, Warren
   Holmberg, Kim
   Hellsten, Iina
   Nerlich, Brigitte
TI Climate Change on Twitter: Topics, Communities and Conversations about
   the 2013 IPCC Working Group 1 Report
SO PLOS ONE
LA English
DT Article
ID POLITICS; CARBON
AB In September 2013 the Intergovernmental Panel on Climate Change published its Working Group 1 report, the first comprehensive assessment of physical climate science in six years, constituting a critical event in the societal debate about climate change. This paper analyses the nature of this debate in one public forum: Twitter. Using statistical methods, tweets were analyzed to discover the hashtags used when people tweeted about the IPCC report, and how Twitter users formed communities around their conversational connections. In short, the paper presents the topics and tweeters at this particular moment in the climate debate. The most used hashtags related to themes of science, geographical location and social issues connected to climate change. Particularly noteworthy were tweets connected to Australian politics, US politics, geoengineering and fracking. Three communities of Twitter users were identified. Researcher coding of Twitter users showed how these varied according to geographical location and whether users were supportive, unsupportive or neutral in their tweets about the IPCC. Overall, users were most likely to converse with users holding similar views. However, qualitative analysis suggested the emergence of a community of Twitter users, predominantly based in the UK, where greater interaction between contrasting views took place. This analysis also illustrated the presence of a campaign by the non-governmental organization Avaaz, aimed at increasing media coverage of the IPCC report.
C1 [Pearce, Warren; Nerlich, Brigitte] Univ Nottingham, Sch Sociol & Social Policy, Inst Sci & Soc, Nottingham NG7 2RD, England.
   [Holmberg, Kim; Hellsten, Iina] Vrije Univ Amsterdam, Dept Org Sci, Amsterdam, Netherlands.
RP Pearce, W (reprint author), Univ Nottingham, Sch Sociol & Social Policy, Inst Sci & Soc, Nottingham NG7 2RD, England.
EM warren.pearce@nottingham.ac.uk
RI Holmberg, Kim/A-6840-2010
OI Holmberg, Kim/0000-0002-4185-9298; Pearce, Warren/0000-0001-6884-3854;
   Nerlich, Brigitte/0000-0001-6617-7827
FU Economic and Social Research Council [RES-360-25-0068]; Leverhulme Trust
   in the UK [RP2011-SP-013]; Dutch Scientific Organization in the
   Netherlands (NWO-ORA) [464-10-077]
FX The authors acknowledge the support of the Economic and Social Research
   Council (RES-360-25-0068) and the Leverhulme Trust (RP2011-SP-013) in
   the UK, and the Dutch Scientific Organization in the Netherlands
   (NWO-ORA grant 464-10-077). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abbott T, 2012, OUR PLAN ABOLISH CAR
   Adamic Lada A., 2005, P 3 INT WORKSH LINK, V3, P36, DOI DOI 10.1145/1134271.1134277
   [Anonymous], 2013, NOW SEND MESS UK MED
   [Anonymous], 2013, NOW SEND MESS TOP UK
   [Anonymous], 2013, WHOS MOST POW CLIM S
   [Anonymous], 2013, LEADERS DEBATE CLIMA
   Australian Government Department of the Environment, 2011, LAUNCH CLIM COMM
   Bastian M., 2009, ICWSM
   Baxter L. A., 2011, VOICING RELATIONSHIP
   Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008
   Boyd D., 2010, 43 HAW INT C SYST SC, V2010, P1, DOI [DOI 10.1109/HICSS.2010.412, 10.1109/HICSS.2010.412]
   Bruns Axel, 2008, Information Polity, V13, P65
   Bruns A, 2011, USE TWITTER HASHTAGS
   Bruns A, 2012, J TECHNOL HUMAN SERV, V30, P160, DOI 10.1080/15228835.2012.744249
   Cha M, 2012, IEEE T SYST MAN CY A, V42, P991, DOI 10.1109/TSMCA.2012.2183359
   Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118
   Chmiel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022207
   Collins L, 2013, MAK SCI PUBLIC
   Connor S., 2013, INDEPENDENT
   Corner A, 2012, CLIMATIC CHANGE, V114, P463, DOI 10.1007/s10584-012-0424-6
   Crowley K, 2013, WIRES CLIM CHANGE, V4, P603, DOI 10.1002/wcc.239
   Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752
   Elsasser SW, 2013, AM BEHAV SCI, V57, P754, DOI 10.1177/0002764212469800
   Fleiss JL, 1981, STAT METHODS RATES P
   Greenberg S, 2013, INSIDE GOP REPORT FO
   Hoffman AJ, 2011, ORGAN ENVIRON, V24, P3, DOI 10.1177/1086026611404336
   Honey C., 2009, P 42 HAW INT C SYST, P1, DOI DOI 10.1109/HICSS.2009.89
   Huang J., 2010, P 21 ACM C HYP HYP, P173, DOI DOI 10.1145/1810617.1810647
   Hulme M, 2012, NAT CLIM CHANGE, V2, P223, DOI 10.1038/nclimate1459
   Intergovernmental Panel on Climate Change, 2012, PRINC GOV IPCC WORK
   Intergovernmental Panel on Climate Change, 2013, KEY DAT AR5 SCHED
   Jaspal R, 2012, PUBLIC UNDERST SCI
   Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547
   Koteyko N, 2013, GEOGR J, V179, P74, DOI 10.1111/j.1475-4959.2012.00479.x
   Koteyko N, 2010, SCI COMMUN, V32, P25, DOI 10.1177/1075547009340421
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lin Y-R, 2013, RISING TIDES RISING
   Aiello LM, 2013, IEEE T MULTIMEDIA, V15, P1268, DOI 10.1109/TMM.2013.2265080
   Marres N, 2005, MAKING THINGS PUBLIC, P922
   McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x
   Morton O, 2013, HELIOPHAGE
   Moser SC, 2014, ADAPTIVE CHALLENGE C
   Nerlich B, 2009, GLOBAL ENVIRON CHANG, V19, P345, DOI 10.1016/j.gloenvcha.2009.03.001
   Painter J, 2011, POLES APART INT REPO
   Revkin A, 2012, DOT EARTH BLOG
   Royal Society, 2013, NEXT STEPS CLIM SCI
   Royal Society, 2009, GEOENG CLIM SCI GOV
   Sasahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061823
   Small TA, 2011, INFORM COMMUN SOC, V14, P872, DOI 10.1080/1369118X.2011.554572
   Stilgoe J, 2013, GUARD POLIT SCI
   Stocker T.F., 2013, CLIMATE CHANGE 2013
   Swart NC, 2012, NAT CLIM CHANGE, V2, P134, DOI 10.1038/nclimate1421
   Thelwall M, 2009, SYNTHESIS LECT INFOR, V1, P1, DOI [DOI 10.2200/S00176ED1V01Y200903ICR004, 10.2200/S00176ED1V01Y200903ICR004]
   Wilkinson D, 2011, SOC SCI COMPUT REV, V29, P387, DOI 10.1177/0894439310378979
   Yardi Sarita, 2010, B SCI TECHNOL SOC, V30, P316, DOI [DOI 10.1177/0270467610380011, 10.1177/0270467610380011]
NR 55
TC 45
Z9 45
U1 2
U2 82
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 9
PY 2014
VL 9
IS 4
AR e94785
DI 10.1371/journal.pone.0094785
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AE9PC
UT WOS:000334339000145
PM 24718388
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tsou, A
   Thelwall, M
   Mongeon, P
   Sugimoto, CR
AF Tsou, Andrew
   Thelwall, Mike
   Mongeon, Philippe
   Sugimoto, Cassidy R.
TI A Community of Curious Souls: An Analysis of Commenting Behavior on TED
   Talks Videos
SO PLOS ONE
LA English
DT Article
ID SCIENCE; YOUTUBE; COMMUNICATION; SCIENTISTS
AB The TED (Technology, Entertainment, Design) Talks website hosts video recordings of various experts, celebrities, academics, and others who discuss their topics of expertise. Funded by advertising and members but provided free online, TED Talks have been viewed over a billion times and are a science communication phenomenon. Although the organization has been derided for its populist slant and emphasis on entertainment value, no previous research has assessed audience reactions in order to determine the degree to which presenter characteristics and platform affect the reception of a video. This article addresses this issue via a content analysis of comments left on both the TED website and the YouTube platform (on which TED Talks videos are also posted). It was found that commenters were more likely to discuss the characteristics of a presenter on YouTube, whereas commenters tended to engage with the talk content on the TED website. In addition, people tended to be more emotional when the speaker was a woman (by leaving comments that were either positive or negative). The results can inform future efforts to popularize science amongst the public, as well as to provide insights for those looking to disseminate information via Internet videos.
C1 [Tsou, Andrew; Sugimoto, Cassidy R.] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA.
   [Thelwall, Mike] Wolverhampton Univ, Sch Technol, Wolverhampton WV1 1DJ, W Midlands, England.
   [Mongeon, Philippe] Univ Montreal, Ecole Bibliothecon & Sci Informat, Quebec City, PQ, Canada.
RP Tsou, A (reprint author), Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA.
EM atsou@umail.iu.edu
RI ; Thelwall, Mike/C-1449-2013
OI Mongeon, Philippe/0000-0003-1021-059X; Thelwall,
   Mike/0000-0001-6065-205X; Sugimoto, Cassidy/0000-0001-8608-3203
FU international funding initiative Digging into Data; National Science
   Foundation in the United States [1208804]; Joint Information Systems
   Committee (JISC) in the United Kingdom; Social Sciences and Humanities
   Research Council of Canada
FX This manuscript is based upon work supported by the international
   funding initiative Digging into Data. Specifically, funding comes from
   the National Science Foundation in the United States (Grant No. 1208804)
   (URL: http://www.nsf.gov/funding/pgm_summ.jsp?pims_id = 501084), Joint
   Information Systems Committee (JISC) in the United Kingdom, and the
   Social Sciences and Humanities Research Council of Canada. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Bentley P, 2011, PUBLIC UNDERST SCI, V20, P48, DOI 10.1177/0963662510384461
   Berk R. A., 2009, INT J TECHNOLOGY TEA, V5, P1
   Brossard D, 2013, P NATL ACAD SCI US
   Brossard D, 2013, NY TIMES
   Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x
   Chowdhury SA, 2012, 2012 SEVENTH INTERNATIONAL CONFERENCE ON BROADBAND, WIRELESS COMPUTING, COMMUNICATION AND APPLICATIONS (BWCCA 2012), P244, DOI 10.1109/BWCCA.2012.47
   Clifton A, 2011, NURS EDUC TODAY, V31, P311, DOI 10.1016/j.nedt.2010.10.004
   Conte R, 2012, EUR PHYS J-SPEC TOP, V214, P325, DOI 10.1140/epjst/e2012-01697-8
   Davies SR, 2008, SCI COMMUN, V29, P413, DOI 10.1177/1075547008316222
   Desmet Christy, 2009, ENGL J, V1, P65
   DUNWOODY S, 1985, J COMMUN, V35, P26, DOI 10.1111/j.1460-2466.1985.tb01882.x
   Frank A, 2013, NY TIMES
   Gascoigne T, 1997, SCI COMMUN, V18, P265, DOI 10.1177/1075547097018003005
   Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634
   Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107
   Jaffar AA, 2012, ANAT SCI EDUC, V5, P158, DOI 10.1002/ase.1268
   Jones T, 2011, COMPUT SCH, V28, P75, DOI 10.1080/07380569.2011.553149
   Juhasz A, 2009, CINEMA J, V48, P145
   Jurgenson N, 2012, TED
   King G, 2011, SCIENCE, V331, P719, DOI 10.1126/science.1197872
   Kling R, 2007, INFORM SOC, V23, P205, DOI 10.1080/01972240701441556
   Knosel M, 2011, J DENT EDUC, V75, P1558
   LaBarre S., 2013, POPULAR SCI
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742
   Martin-Sempere MJ, 2008, PUBLIC UNDERST SCI, V17, P349, DOI 10.1177/0963662506067660
   Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801
   National Science Board, 2012, SCI ENG IND
   O'Brien C, 2012, LOS ANGELES TIMES
   Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684
   Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00350
   Robbins M, 2012, TROUBLE TED TALKS
   Steyaert J, 2011, J SOCIAL INTERVENTIO, V20, P79
   Sugimoto CR, 2013, J AM SOC INF SCI TEC, V64, P663, DOI 10.1002/asi.22764
   Sugimoto CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062403
   Taleb N., 2010, BLACK SWAN 2 EDITION
   TED, 2012, TED
   TED Blog, 2012, WHAT TALKS HAV RES M
   Thelwall M, 2012, J AM SOC INF SCI TEC, V63, P616, DOI 10.1002/asi.21679
   Top sites, 2013, TOP SIT
   Tsfati Y, 2011, SCI COMMUN, V33, P143, DOI 10.1177/1075547010380385
   Vogel L, 2011, CAN MED ASSOC J, V183, P647, DOI 10.1503/cmaj.109-3812
   Weigold MF, 2001, SCI COMMUN, V23, P164, DOI 10.1177/1075547001023002005
NR 43
TC 15
Z9 15
U1 1
U2 47
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 9
PY 2014
VL 9
IS 4
AR e93609
DI 10.1371/journal.pone.0093609
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AE9PC
UT WOS:000334339000038
PM 24718634
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kuijpers, MAR
   Chiu, YT
   Nada, RM
   Carels, CEL
   Fudalej, PS
AF Kuijpers, Mette A. R.
   Chiu, Yu-Ting
   Nada, Rania M.
   Carels, Carine E. L.
   Fudalej, Piotr S.
TI Three-dimensional Imaging Methods for Quantitative Analysis of Facial
   Soft Tissues and Skeletal Morphology in Patients with Orofacial Clefts:
   A Systematic Review
SO PLOS ONE
LA English
DT Review
ID BEAM COMPUTED-TOMOGRAPHY; SECONDARY ALVEOLAR BONE; DENTAL ARCH
   RELATIONSHIPS; LIP-NOSE DEFORMITY; RAPID MAXILLARY EXPANSION; PRIMARY
   PALATAL REPAIR; CLASS-III MALOCCLUSION; QUALITY-OF-LIFE; UNILATERAL
   CLEFT; ADULT PATIENTS
AB Background: Current guidelines for evaluating cleft palate treatments are mostly based on two-dimensional (2D) evaluation, but three-dimensional (3D) imaging methods to assess treatment outcome are steadily rising.
   Objective: To identify 3D imaging methods for quantitative assessment of soft tissue and skeletal morphology in patients with cleft lip and palate. Data sources: Literature was searched using PubMed (1948-2012), EMBASE (1980-2012), Scopus (2004-2012), Web of Science (1945-2012), and the Cochrane Library. The last search was performed September 30, 2012. Reference lists were hand searched for potentially eligible studies. There was no language restriction.
   Study selection: We included publications using 3D imaging techniques to assess facial soft tissue or skeletal morphology in patients older than 5 years with a cleft lip with/or without cleft palate. We reviewed studies involving the facial region when at least 10 subjects in the sample size had at least one cleft type. Only primary publications were included.
   Data extraction: Independent extraction of data and quality assessments were performed by two observers.
   Results: Five hundred full text publications were retrieved, 144 met the inclusion criteria, with 63 high quality studies. There were differences in study designs, topics studied, patient characteristics, and success measurements; therefore, only a systematic review could be conducted. Main 3D-techniques that are used in cleft lip and palate patients are CT, CBCT, MRI, stereophotogrammetry, and laser surface scanning. These techniques are mainly used for soft tissue analysis, evaluation of bone grafting, and changes in the craniofacial skeleton. Digital dental casts are used to evaluate treatment and changes over time.
   Conclusion: Available evidence implies that 3D imaging methods can be used for documentation of CLP patients. No data are available yet showing that 3D methods are more informative than conventional 2D methods. Further research is warranted to elucidate it.
C1 [Kuijpers, Mette A. R.; Nada, Rania M.; Carels, Carine E. L.; Fudalej, Piotr S.] Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands.
   [Kuijpers, Mette A. R.; Carels, Carine E. L.] Radboud Univ Nijmegen, Med Ctr, Cleft Palate Craniofacial Unit, NL-6525 ED Nijmegen, Netherlands.
   [Chiu, Yu-Ting] Chang Gung Mem Hosp, Dept Dent & Craniofacial Ctr, Taipei 10591, Taiwan.
   [Fudalej, Piotr S.] Univ Bern, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland.
   [Fudalej, Piotr S.] Palacky Univ, Dept Orthodont, CR-77147 Olomouc, Czech Republic.
RP Kuijpers, MAR (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands.
EM orthodontics@dent.umcn.nl
RI Carels, C.E.L./H-8020-2014; Carels, Carine/E-6676-2016; Kuijpers,
   Mette/H-3308-2015
OI Carels, Carine/0000-0002-8974-9223; Kuijpers, Mette/0000-0001-6462-9789
CR Agarwal R, 2012, J CRANIOFAC SURG, V23, P1338, DOI 10.1097/SCS.0b013e31826466d8
   Al-Omari I, 2003, CLEFT PALATE-CRAN J, V40, P530, DOI 10.1597/1545-1569(2003)040<0530:AAOTMO>2.0.CO;2
   Alonso N, 2010, TISSUE ENG PART C-ME, V16, P1183, DOI [10.1089/ten.tec.2009.0824, 10.1089/ten.TEC.2009.0824]
   American Cleft Palate Association, 2009, GUID TEAM EV AM CLEF
   Aras I, 2012, CLEFT PALATE-CRAN J, V49, pE75, DOI 10.1597/12-004
   Arctander K, 2005, SCAND J PLAST RECONS, V39, P11, DOI 10.1080/02844310410021749
   Asquith JA, 2012, CLEFT PALATE-CRAN J, V49, P530, DOI 10.1597/10-099
   Atik B, 2008, J CRANIOFAC SURG, V19, P566, DOI 10.1097/SCS.0b013e31816ae746
   Ayoub A, 2011, CLEFT PALATE-CRAN J, V48, P379, DOI 10.1597/10-057
   Ayoub A, 2011, CLEFT PALATE-CRAN J, V48, P578, DOI 10.1597/09-148
   Ayoub A, 2011, CLEFT PALATE-CRAN J, V48, P571, DOI 10.1597/09-147
   Bejdova S, 2012, J CRANIO MAXILL SURG, V40, P201, DOI 10.1016/j.jcms.2011.04.013
   Bennun RD, 1999, PLAST RECONSTR SURG, V104, P616, DOI 10.1097/00006534-199909030-00002
   Bilwatsch S, 2006, J CRANIO MAXILL SURG, V34, P253, DOI 10.1016/j.jcms.2006.03.001
   Bos A, 2011, ANGLE ORTHOD, V81, P865, DOI 10.2319/070110-365.1
   Brons S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041898
   Bugaighis I, 2010, EUR J ORTHODONT, V32, P514, DOI 10.1093/ejo/cjp140
   Chawla O, 2013, CLEFT PALATE-CRAN J, V50, P182, DOI 10.1597/11-283
   Chawla O, 2012, EUR J ORTHODONT, V34, P768, DOI 10.1093/ejo/cjr096
   Chen PKT, 2011, CLEFT PALATE-CRAN J, V48, P445, DOI 10.1597/09-087
   Cheung T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043405
   Choi J, 2012, J PLAST RECONSTR AES, V65, P1461, DOI 10.1016/j.bjps.2012.05.025
   Chowdhury SKR, 2006, MED J ARMED FORCES I, V62, P231
   Clark HD, 1999, CONTROL CLIN TRIALS, V20, P448, DOI 10.1016/S0197-2456(99)00026-4
   Clark SL, 2011, J CRANIOFAC SURG, V22, P333, DOI 10.1097/SCS.0b013e318200d874
   Contreras V, 2011, J MAXILO, V33, P105
   Dado DV, 1997, PLAST RECONSTR SURG, V99, P1840, DOI 10.1097/00006534-199706000-00006
   Denny AD, 1999, CLEFT PALATE-CRAN J, V36, P144, DOI 10.1597/1545-1569(1999)036<0144:SABGUM>2.3.CO;2
   Devlin MF, 2007, CLEFT PALATE-CRAN J, V44, P391, DOI 10.1597/06-179.1
   Dickinson BP, 2008, PLAST RECONSTR SURG, V121, P209, DOI 10.1097/01.prs.0000293870.64781.12
   Dogan S, 2012, CLEFT PALATE-CRAN J, V49, P347, DOI 10.1597/10-269
   Duffy S, 2000, CLEFT PALATE-CRAN J, V37, P137, DOI 10.1597/1545-1569(2000)037<0137:TDAOTC>2.3.CO;2
   European Commission, 2012, RAD PROT 172 CON BEA
   Feichtinger M, 2006, J CRANIO MAXILL SURG, V34, P144, DOI 10.1016/j.jcms.2005.11.005
   Feichtinger M, 2008, BRIT J ORAL MAX SURG, V46, P278, DOI 10.1016/j.bjoms.2007.12.010
   Feichtinger M, 2007, CLEFT PALATE-CRAN J, V44, P142, DOI 10.1597/06-047.1
   Ferrario VF, 2003, ANN PLAS SURG, V51, P390, DOI 10.1097/01.SAP.0000067966.98832.96
   Ferrario VF, 2003, CLEFT PALATE-CRAN J, V40, P544, DOI 10.1597/1545-1569(2003)040<0544:AQTAOA>2.0.CO;2
   Ferrario VF, 2003, J CRANIOFAC SURG, V14, P739, DOI 10.1097/00001665-200309000-00026
   Ferrario VF, 2003, PLAST RECONSTR SURG, V111, P2149, DOI 10.1097/01.PRS.0000060107.43208.21
   Garib DG, 2012, CLEFT PALATE-CRAN J, V49, P208, DOI 10.1597/10-198
   Gordon JM, 2009, ANGLE ORTHOD, V79, P1000, DOI 10.2319/082108-441.1
   Grewal NS, 2009, PLAST RECONSTR SURG, V124, P1590, DOI 10.1097/PRS.0b013e3181b99e2e
   Hamada Y, 2005, CLEFT PALATE-CRAN J, V42, P128, DOI 10.1597/03-035.1
   Hathaway R, 2011, CLEFT PALATE-CRAN J, V48, P244, DOI 10.1597/09-181.1
   Hegab AF, 2012, J ORAL MAXIL SURG, V70, pE337, DOI 10.1016/j.joms.2012.01.013
   Herford AS, 2007, J ORAL MAXIL SURG, V65, P2136, DOI 10.1016/j.jams.2007.06.670
   Hoefert CS, 2010, J OROFAC ORTHOP, V71, P221, DOI 10.1007/s00056-010-9932-z
   Hoefert CS, 2010, J OROFAC ORTHOP, V71, P136, DOI 10.1007/s00056-010-9931-0
   Honda Y, 2002, CLEFT PALATE-CRAN J, V39, P527, DOI 10.1597/1545-1569(2002)039<0527:RBPPFA>2.0.CO;2
   Honma K, 1999, J ORAL MAXIL SURG, V57, P1209, DOI 10.1016/S0278-2391(99)90488-3
   Iino M, 2005, SCAND J PLAST RECONS, V39, P15, DOI 10.1080/02844310410035410
   Kau Chung H, 2011, Orthodontics (Chic.), V12, P188
   Kawakami S, 2003, CLEFT PALATE-CRAN J, V40, P569, DOI 10.1597/02-052
   Kilpelainen PVJ, 1996, CLEFT PALATE-CRAN J, V33, P483, DOI 10.1597/1545-1569(1996)033<0483:PAICPS>2.3.CO;2
   Kilpelainen PVJ, 1996, CLEFT PALATE-CRAN J, V33, P477, DOI 10.1597/1545-1569(1996)033<0477:PMATOC>2.3.CO;2
   Kim KR, 2008, ANGLE ORTHOD, V78, P631, DOI 10.2319/072907-352.1
   Kita H, 2004, CLEFT PALATE-CRAN J, V41, P36, DOI 10.1597/02-071
   Kolbenstvedt A, 2002, ACTA RADIOL, V43, P567, DOI 10.1034/j.1600-0455.2002.430605.x
   Korbmacher H, 2007, J OROFAC ORTHOP, V68, P278, DOI 10.1007/s00056-007-0653-x
   Kratzsch H, 2000, J Orofac Orthop, V61, P305, DOI 10.1007/PL00001901
   Kratzsch H, 2000, J Orofac Orthop, V61, P421, DOI 10.1007/PL00001910
   Krey KF, 2009, J OROFAC ORTHOP, V70, P237, DOI 10.1007/s00056-009-8814-8
   Krimmel M, 2011, J ORAL MAXIL SURG, V69, P80, DOI 10.1016/j.joms.2010.03.009
   Kuijpers-Jagtman AM, 2000, CLEFT PALATE-CRAN J, V37, P527, DOI 10.1597/1545-1569(2000)037<0527:TIOSAO>2.0.CO;2
   Lagravere MO, 2005, ANGLE ORTHOD, V75, P1046
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee SH, 2011, J ORAL MAXIL SURG, V69, P2644, DOI 10.1016/j.joms.2011.01.004
   Leenarts CMR, 2012, INT J ORAL MAX SURG, V41, P180, DOI 10.1016/j.ijom.2011.11.004
   Li F, 2011, HUA XI KOU QIANG YI, V29, P167
   Li Fang, 2011, Hua Xi Kou Qiang Yi Xue Za Zhi, V29, P161
   Li HQ, 2011, J ORAL MAXIL SURG, V69, pE549, DOI 10.1016/j.joms.2011.07.024
   Li JT, 2012, OR SURG OR MED OR PA, V113, P300, DOI 10.1016/j.tripleo.2011.03.007
   Long RE, 2011, CLEFT PALATE-CRAN J, V48, P239, DOI 10.1597/09-180.1
   Maull DJ, 1999, CLEFT PALATE-CRAN J, V36, P391, DOI 10.1597/1545-1569(1999)036<0391:LTEONM>2.3.CO;2
   McCance AM, 1997, CLEFT PALATE-CRAN J, V34, P58, DOI 10.1597/1545-1569(1997)034<0058:TDATPT>2.3.CO;2
   McCance AM, 1997, CLEFT PALATE-CRAN J, V34, P36, DOI 10.1597/1545-1569(1997)034<0036:TDATPT>2.3.CO;2
   Mercado A, 2011, CLEFT PALATE-CRAN J, V48, P259, DOI 10.1597/09-186.1
   Meyer-Marcotty P, 2011, J CRANIO MAXILL SURG, V39, P158, DOI 10.1016/j.jcms.2010.05.001
   Meyer-Marcotty P, 2010, AM J ORTHOD DENTOFAC, V137, DOI 10.1016/j.ajodo.2008.11.023
   Meyer-Marcotty P, 2009, J OROFAC ORTHOP, V70, P224, DOI 10.1007/s00056-009-8813-9
   Mikoya T, 2010, CLEFT PALATE-CRAN J, V47, P454, DOI 10.1597/09-172
   Millar K, 2013, CLEFT PALATE-CRAN J, V50, P150, DOI 10.1597/10-222
   Miyamoto J, 2007, PLAST RECONSTR SURG, V120, P1612, DOI 10.1097/01.prs.0000267421.69284.c7
   Miyamoto J, 2012, J PLAST RECONSTR AES, V65, P169, DOI 10.1016/j.bjps.2011.08.036
   Miyamoto J, 2010, J PLAST RECONSTR AES, V63, P9, DOI 10.1016/j.bjps.2008.08.071
   Mori A, 2005, BRIT J PLAST SURG, V58, P318, DOI 10.1016/j.bjps.2004.11.019
   Nagasao T, 2008, J CRANIO MAXILL SURG, V36, P321, DOI 10.1016/j.jcms.2008.02.003
   Nagasao T, 2008, PLAST RECONSTR SURG, V121, P2074, DOI 10.1097/PRS.0b013e3181706f87
   Nagasao T, 2009, CLEFT PALATE-CRAN J, V46, P154, DOI 10.1597/07-177.1
   Nagasao T, 2009, CLEFT PALATE-CRAN J, V46, P9, DOI 10.1597/07-169.1
   Nakamura N, 2005, CLEFT PALATE-CRAN J, V42, P633, DOI 10.1597/03-151.1
   Nakamura N, 2011, J ORAL MAXIL SURG, V69, pE469, DOI 10.1016/j.joms.2011.03.041
   Nakamura N, 2011, J CRANIO MAXILL SURG, V39, P305, DOI 10.1016/j.jcms.2010.05.008
   Nakamura N, 2010, J ORAL MAXIL SURG, V68, P2248, DOI 10.1016/j.joms.2009.06.012
   Oberoi S, 2010, CLEFT PALATE-CRAN J, V47, P507, DOI 10.1597/08-171
   Oberoi S, 2009, CLEFT PALATE-CRAN J, V46, P503, DOI 10.1597/08-153.1
   Oh TS, 2011, J CRANIOFAC SURG, V22, P2080, DOI 10.1097/SCS.0b013e3182319971
   Okawachi T, 2011, J ORAL MAXIL SURG, V69, P322, DOI 10.1016/j.joms.2010.05.057
   Ozawa T, 2007, CLEFT PALATE-CRAN J, V44, P286, DOI 10.1597/06-054
   Ozgur F, 2000, ANN PLAS SURG, V44, P8, DOI 10.1097/00000637-200044010-00002
   Padricelli G, 2012, MONDO ORTODONTICO, V37, P46
   Proff P, 2006, J CRANIO MAXILL SURG, V34, P26, DOI 10.1016/S1010-5182(06)60007-3
   Quereshy FA, 2012, J ORAL MAXIL SURG, V70, P188, DOI 10.1016/j.joms.2011.01.027
   Raphael B, 2002, Ann Chir Plast Esthet, V47, P196, DOI 10.1016/S0294-1260(02)00105-X
   Ras F, 1997, CLEFT PALATE-CRAN J, V34, P438, DOI 10.1597/1545-1569(1997)034<0438:SPOTLA>2.3.CO;2
   RAS F, 1994, CLEFT PALATE-CRAN J, V31, P116, DOI 10.1597/1545-1569(1994)031<0116:TDEOFA>2.3.CO;2
   RAS F, 1995, CLEFT PALATE-CRAN J, V32, P463, DOI 10.1597/1545-1569(1995)032<0463:LSOTDC>2.3.CO;2
   RAS F, 1994, CLEFT PALATE-CRAN J, V31, P461, DOI 10.1597/1545-1569(1994)031<0461:FLRDIC>2.3.CO;2
   RAS F, 1995, ANGLE ORTHOD, V65, P233
   Rosenstein SW, 1997, CLEFT PALATE-CRAN J, V34, P199, DOI 10.1597/1545-1569(1997)034<0199:CODCFP>2.3.CO;2
   Russell KA, 2001, CLEFT PALATE-CRAN J, V38, P476, DOI 10.1597/1545-1569(2001)038<0476:NMASPA>2.0.CO;2
   Russell K, 2011, CLEFT PALATE-CRAN J, V48, P265, DOI 10.1597/09-187.1
   Russell KA, 2011, CLEFT PALATE-CRAN J, V48, P28, DOI 10.1597/09-040
   Rychlik D, 2012, J CRANIOFAC SURG, V23, P118, DOI 10.1097/SCS.0b013e318240faa0
   Saijo H, 2010, J PLAST SURG HAND SU, V44, P21, DOI 10.3109/02844310903350857
   Sander M, 2011, CLEFT PALATE-CRAN J, V48, P20, DOI 10.1597/09-007
   Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018
   Santiago PE, 1998, CLEFT PALATE-CRAN J, V35, P77, DOI 10.1597/1545-1569(1998)035<0077:RNFABG>2.3.CO;2
   Schliephake H, 2006, INT J ORAL MAX SURG, V35, P25, DOI 10.1016/j.ijom.2005.06.007
   Schwenzer-Zimmerer K, 2008, CLEFT PALATE-CRAN J, V45, P607, DOI 10.1597/07-116.1
   Schwenzer-Zimmerer K, 2008, J CRANIO MAXILL SURG, V36, P431, DOI 10.1016/j.jcms.2008.05.003
   Sehhati-Chafai-Leuwer S, 2006, J CRANIO MAXILL SURG, V34, P351, DOI 10.1016/j.jcms.2006.03.006
   Seike T, 2012, J MED INVESTIG, V59, P152, DOI 10.2152/jmi.59.152
   Shaw WC, 2000, EUROCLEFT PROJECT 19
   Shirota T, 2010, INT J ORAL MAX SURG, V39, P904, DOI 10.1016/j.ijom.2010.04.050
   Simanca E, 2011, J CRANIOFAC SURG, V22, P1622, DOI 10.1097/SCS.0b013e31822e8ca0
   Smahel Z, 2004, CLEFT PALATE-CRAN J, V41, P416, DOI 10.1597/03-053.1
   Smahel Z, 2003, CLEFT PALATE-CRAN J, V40, P577, DOI 10.1597/1545-1569(2003)040<0577:TMOTPI>2.0.CO;2
   Smahel Z, 2009, CLEFT PALATE-CRAN J, V46, P399, DOI 10.1597/07-199.1
   Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z
   Stauber I, 2008, J OROFAC ORTHOP, V69, P268, DOI 10.1007/s00056-008-0746-1
   Stewart A, 1996, INT J ORAL MAX SURG, V25, P171, DOI 10.1016/S0901-5027(96)80023-3
   Suri S, 2008, AM J ORTHOD DENTOFAC, V134, P418, DOI 10.1016/j.ajodo.2006.09.065
   Suzuki H, 1999, ARCH OTOLARYNGOL, V125, P1000, DOI 10.1001/archotol.125.9.1000
   Suzuki H, 2001, AURIS NASUS LARYNX, V28, P257, DOI 10.1016/S0385-8146(00)00122-X
   Tai CCE, 2000, J ORAL MAXIL SURG, V58, P1241, DOI 10.1053/joms.2000.16623
   Tanikawa C, 2010, CLEFT PALATE-CRAN J, V47, P611, DOI [10.1597/09-099, 10.1597/09.099]
   Tian W, 2010, J CRANIOFAC SURG, V21, P578, DOI 10.1097/SCS.0b013e3181d08bee
   Tian W, 2010, J CRANIOFAC SURG, V21, P568, DOI 10.1097/SCS.0b013e3181d08bd1
   Trindade-Suedam IK, 2012, J CRANIOFAC SURG, V23, P1283, DOI 10.1097/SCS.0b013e3182519ab5
   Trotman CA, 2010, J DENT RES, V89, P728, DOI 10.1177/0022034510365485
   Trotman CA, 2000, PLAST RECONSTR SURG, V105, P1273, DOI 10.1097/00006534-200004040-00003
   Tulunoglu Ozlem, 2011, Eur J Dent, V5, P451
   Vadodaria S, 2000, BRIT J PLAST SURG, V53, P191, DOI 10.1054/bjps.1999.3308
   van der Meij AJW, 2003, ORAL SURG ORAL MED O, V96, P19, DOI 10.1016/S1079-2104(03)00266-X
   Van der Meij AJW, 2001, ORAL SURG ORAL MED O, V92, P136, DOI 10.1067/moe.2001.115274
   van Loon B, 2010, INT J ORAL MAX SURG, V39, P534, DOI 10.1016/j.ijom.2010.03.022
   van Loon B, 2011, RHINOLOGY, V49, P546, DOI [10.4193/Rhino.11.092, 10.4193/Rhino11.092]
   van Vlijmen OJC, 2012, J AM DENT ASSOC, V143, P241, DOI 10.14219/jada.archive.2012.0148
   Vasiliauskas A, 2010, ELEKTRON ELEKTROTECH, P107
   Veli I, 2011, KOREAN J ORTHOD, V41, P431, DOI 10.4041/kjod.2011.41.6.431
   Wehby GL, 2010, ORAL DIS, V16, P3, DOI 10.1111/j.1601-0825.2009.01588.x
   Wojtaszek-Slominska A, 2010, J CRANIO MAXILL SURG, V38, P155, DOI 10.1016/j.jcms.2009.04.005
   Wu YL, 2013, CLEFT PALATE-CRAN J, V50, P696, DOI 10.1597/11-144.1
   Yamawaki Y, 1999, PLAST RECONSTR SURG, V104, P350, DOI 10.1097/00006534-199908000-00004
   Ye B, 2012, CLEFT PALATE-CRAN J, V49, P561, DOI 10.1597/09-236
   Ye B, 2010, J CRANIOFAC SURG, V21, P811, DOI 10.1097/SCS.0b013e3181d879fa
   Yin N, 2001, CHIN J STOMATOL, V36, P133
   Yin NB, 2005, PLAST RECONSTR SURG, V115, P1239, DOI 10.1097/01.PRS.0000156777.99552.1D
   Yoshida S, 2013, CLEFT PALATE-CRAN J, V50, P671, DOI 10.1597/11-062
   Yoshihara M, 2012, AM J ORTHOD DENTOFAC, V141, pS92, DOI 10.1016/j.ajodo.2011.09.011
   Zhang Yong, 2012, Shanghai Kou Qiang Yi Xue, V21, P308
   Zhou WH, 2013, CLEFT PALATE-CRAN J, V50, P88, DOI 10.1597/11-182
   Zreaqat M, 2012, INT J ORAL MAX SURG, V41, P783, DOI 10.1016/j.ijom.2012.02.003
NR 165
TC 32
Z9 32
U1 2
U2 32
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 7
PY 2014
VL 9
IS 4
AR e93442
DI 10.1371/journal.pone.0093442
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AE7EP
UT WOS:000334159800033
PM 24710215
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU van Dalen, MT
   Suijker, JJ
   MacNeil-Vroomen, J
   van Rijn, M
   van Charante, EPM
   de Rooij, SE
   Buurman, BM
AF van Dalen, Marlies T.
   Suijker, Jacqueline J.
   MacNeil-Vroomen, Janet
   van Rijn, Marjon
   van Charante, Eric P. Moll
   de Rooij, Sophia E.
   Buurman, Bianca M.
TI Self-Report of Healthcare Utilization among Community-Dwelling Older
   Persons: A Prospective Cohort Study
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; FUNCTIONAL DECLINE; PHYSICIAN UTILIZATION;
   POSTAL QUESTIONNAIRE; PREDICTIVE-VALIDITY; ELDERLY POPULATION; SERVICES;
   INFORMATION; DISABILITY; VISITS
AB Background: Self-reported data are often used for estimates on healthcare utilization in cost-effectiveness studies.
   Objective: To analyze older adults' self-report of healthcare utilization compared to data obtained from the general practitioners' (GP) electronic medical record (EMR) and to study the differences in healthcare utilization between those who completed the study, those who did not respond, and those lost to follow-up.
   Methods: A prospective cohort study was conducted among community-dwelling persons aged 70 years and above, without dementia and not living in a nursing home. Self-reporting questionnaires were compared to healthcare utilization data extracted from the EMR at the GP-office.
   Results: Overall, 790 persons completed questionnaires at baseline, median age 75 years (IQR 72-80), 55.8% had no disabilities in (instrumental) activities of daily living. Correlations between self-report data and EMR data on healthcare utilization were substantial for 'hospitalizations' and 'GP home visits' at 12 months intraclass correlation coefficient 0.63 (95% CI; 0.58-0.68). Compared to the EMR, self-reported healthcare utilization was generally slightly over-reported. Nonrespondents received more GP home visits (p < 0.05). Of the participants who died or were institutionalized 62.2% received 2 or more home visits (p<0.001) and 18.9% had 2 or more hospital admissions (p<0.001) versus respectively 18.6% and 3.9% of the participants who completed the study. Of the participants lost to follow-up for other reasons 33.0% received 2 or more home visits (p<0.01) versus 18.6 of the participants who completed the study.
   Conclusions: Self-report of hospitalizations and GP home visits in a broadly 'healthy' community-dwelling older population seems adequate and efficient. However, as people become older and more functionally impaired, collecting healthcare utilization data from the EMR should be considered to avoid measurement bias, particularly if the data will be used to support economic evaluation.
C1 [van Dalen, Marlies T.; Suijker, Jacqueline J.; van Charante, Eric P. Moll] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, NL-1105 AZ Amsterdam, Netherlands.
   [MacNeil-Vroomen, Janet; van Rijn, Marjon; de Rooij, Sophia E.; Buurman, Bianca M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Geriatr Sect, NL-1105 AZ Amsterdam, Netherlands.
RP Suijker, JJ (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
EM j.j.suijker@amc.uva.nl
RI van Charante, Eric Moll/L-4856-2019
OI van Charante, Eric Moll/0000-0002-1489-5218
FU Netherlands Organisation for Health Research and development [313020201]
FX This study is funded by The Netherlands Organisation for Health Research
   and development (no. 313020201). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bellon JA, 2000, J EPIDEMIOL COMMUN H, V54, P544, DOI 10.1136/jech.54.7.544
   Bhandari A, 2006, MED CARE RES REV, V63, P217, DOI 10.1177/1077558705285298
   Binder EF, 2002, J AM GERIATR SOC, V50, P1921, DOI 10.1046/j.1532-5415.2002.50601.x
   BOWNS I, 1991, BRIT J GEN PRACT, V41, P100
   Buskens E, 2008, MINIMALE DATA SET AA
   Buurman BM, 2011, EUR J EMERG MED, V18, P215, DOI 10.1097/MEJ.0b013e328344597e
   Byles JE, 2004, MED J AUSTRALIA, V181, P186
   CARSJO K, 1994, J GERONTOL, V49, pS156, DOI 10.1093/geronj/49.3.S156
   CLEARY PD, 1984, MED CARE, V22, P796, DOI 10.1097/00005650-198409000-00003
   Daniels R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-69
   Dendukuri N, 2005, MED CARE, V43, P266, DOI 10.1097/00005650-200503000-00009
   Drummond MF, 2005, METHODS EC EVALUATIO
   Ferrucci L, 2004, J AM GERIATR SOC, V52, P625, DOI 10.1111/j.1532-5415.2004.52174.x
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Gill TM, 2001, ANN INTERN MED, V135, P313, DOI 10.7326/0003-4819-135-5-200109040-00007
   GLANDON GL, 1992, J GERONTOL, V47, pS245, DOI 10.1093/geronj/47.5.S245
   Goossens MEJB, 2000, J CLIN EPIDEMIOL, V53, P688, DOI 10.1016/S0895-4356(99)00177-8
   Hebert R, 1996, AGE AGEING, V25, P159
   Hebert R, 1997, AM J EPIDEMIOL, V145, P935
   Hebert R, 1996, J CLIN EPIDEMIOL, V49, P373, DOI 10.1016/0895-4356(95)00527-7
   Hogan DB, 2001, CAN MED ASSOC J, V165, P537
   Hoogendoorn M, 2009, INT J TECHNOL ASSESS, V25, P588, DOI 10.1017/S0266462309990432
   Huisman M, 2011, INT J EPIDEMIOL, V40, P868, DOI 10.1093/ije/dyq219
   Jordan K, 2006, J CLIN EPIDEMIOL, V59, P791, DOI 10.1016/j.jclinepi.2005.12.008
   Kjoller M, 2005, EUR J PUBLIC HEALTH, V15, P528, DOI 10.1093/eurpub/cki023
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lutomski JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081673
   Mihelic AH, 1997, J GERONTOL B-PSYCHOL, V52, pS37, DOI 10.1093/geronb/52B.1.S37
   Oostenbrink JB, 2002, PHARMACOECONOMICS, V20, P443, DOI 10.2165/00019053-200220070-00002
   Raina P, 2002, HEALTH SERV RES, V37, P751, DOI 10.1111/1475-6773.00047
   Ritter PL, 2001, J CLIN EPIDEMIOL, V54, P136, DOI 10.1016/S0895-4356(00)00261-4
   Roberts RO, 1996, J CLIN EPIDEMIOL, V49, P989, DOI 10.1016/0895-4356(96)00143-6
   Schellevis FG, 2005, J PUBLIC HLTH, V5, P265
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Sommers LS, 2000, ARCH INTERN MED, V160, P1825, DOI 10.1001/archinte.160.12.1825
   Stalenhoef PA, 2002, J CLIN EPIDEMIOL, V55, P1088, DOI 10.1016/S0895-4356(02)00502-4
   Suijker JJ, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-85
   Tas U, 2007, PREV MED, V44, P272, DOI 10.1016/j.ypmed.2006.11.007
   Tas U, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-22
   van Hout HPJ, 2010, J GERONTOL A-BIOL, V65, P734, DOI 10.1093/gerona/glq037
   Wallihan DB, 1999, MED CARE, V37, P662, DOI 10.1097/00005650-199907000-00006
   Wolinsky FD, 2007, MED CARE, V45, P300, DOI 10.1097/01.mlr.0000254576.26353.09
NR 42
TC 13
Z9 13
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 7
PY 2014
VL 9
IS 4
AR e93372
DI 10.1371/journal.pone.0093372
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AE7EP
UT WOS:000334159800029
PM 24710075
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kim, Y
   Lee, JM
   Peters, BP
   Gaesser, GA
   Welk, GJ
AF Kim, Youngwon
   Lee, Jung-Min
   Peters, Bradley P.
   Gaesser, Glenn A.
   Welk, Gregory J.
TI Examination of Different Accelerometer Cut-Points for Assessing
   Sedentary Behaviors in Children
SO PLOS ONE
LA English
DT Article
ID MEASURED PHYSICAL-ACTIVITY; RT3 ACCELEROMETER; UNITED-STATES; TIME
   SPENT; CALIBRATION; VALIDATION; ACTIGRAPH; ADOLESCENTS; OVERWEIGHT;
   AGREEMENT
AB Background: Public health research on sedentary behavior (SB) in youth has heavily relied on accelerometers. However, it has been limited by the lack of consensus on the most accurate accelerometer cut-points as well as by unknown effects caused by accelerometer position (wrist vs. hip) and output (single axis vs. multiple axes). The present study systematically evaluates classification accuracy of different Actigraph cut-points for classifying SB using hip and wrist-worn monitors and establishes new cut-points to enable use of the 3-dimensional vector magnitude data (for both hip and wrist placement).
   Methods: A total of 125 children ages 7-13 yrs performed 12 randomly selected activities (from a set of 24 different activities) for 5 min each while wearing tri-axial Actigraph accelerometers on both the hip and wrist. The accelerometer data were categorized as either sedentary or non-sedentary minutes using six previously studied cut-points: 100counts-perminute (CPM), 200CPM, 300CPM, 500CPM, 800CPM and 1100CPM. Classification accuracy was evaluated with Cohen's Kappa (kappa) and new cut-points were identified from Receiver Operating Characteristic (ROC).
   Results: Of the six cut-points, the 100CPM value yielded the highest classification accuracy (kappa = 0.81) for hip placement. For wrist placement, all of the cut-points produced low classification accuracy (ranges of kappa from 0.44 to 0.67). Optimal sedentary cut-points derived from ROC were 554.3CPM (ROC-AUC of 0.99) for vector magnitude for hip, 1756CPM (ROC-AUC of 0.94) for vertical axis for wrist, and 3958.3CPM (ROC-AUC of 0.93) for vector magnitude for wrist placement.
   Conclusions: The 100CPM was supported for use with vertical axis for hip placement, but not for wrist placement. The ROCderived cut-points can be used to classify youth SB with the wrist and with vector magnitude data.
C1 [Kim, Youngwon; Peters, Bradley P.; Welk, Gregory J.] Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA.
   [Lee, Jung-Min] Univ Nebraska, Sch Hlth Phys Educ & Recreat, Coll Educ, Omaha, NE 68182 USA.
   [Gaesser, Glenn A.] Arizona State Univ, Sch Nutr & Hlth Promot, Phoenix, AZ USA.
RP Kim, Y (reprint author), Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA.
EM myungshingo@gmail.com
FU National Institutes of Health [R01 HL910006]
FX This study was funded by the National Institutes of Health grant (R01
   HL910006) (URL:http://www.nih.gov/). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12
   Atkin AJ, 2013, MED SCI SPORT EXER, V45, P1097, DOI 10.1249/MSS.0b013e318282190e
   Bailey DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057101
   Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7
   Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345
   Chinapaw MJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036657
   Chu EYW, 2007, MED SCI SPORT EXER, V39, P2085, DOI 10.1249/mss.0b0l3e318148436c
   Cliff DP, 2013, OBESITY, V21, P382, DOI 10.1002/oby.20005
   Crouter SE, 2013, MED SCI SPORT EXER, V45, P1403, DOI 10.1249/MSS.0b013e318285f03b
   Dasgupta K, 2006, CIRCULATION, V114, P2663, DOI 10.1161/CIRCULATIONAHA.106.624536
   Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1
   Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196
   Fischer C, 2012, PEDIATR EXERC SCI, V24, P220, DOI 10.1123/pes.24.2.220
   Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba
   Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e
   Freedson PS, 2011, J APPL PHYSIOL, V111, P1804, DOI 10.1152/japplphysiol.00309.2011
   Hanggi JM, 2013, J SCI MED SPORT, V16, P40, DOI 10.1016/j.jsams.2012.05.012
   Hart TL, 2011, MED SCI SPORT EXER, V43, P449, DOI 10.1249/MSS.0b013e3181ef5a93
   Brodersen NH, 2007, BRIT J SPORT MED, V41, P140, DOI 10.1136/bjsm.2006.031138
   Janz KF, 2005, AM J PREV MED, V29, P171, DOI 10.1016/j.amepre.2005.06.001
   Kim Y, 2013, J SCI MED SPORT, V16, P129, DOI 10.1016/j.jsams.2012.05.015
   King AC, 2011, EUR J PUBLIC HEALTH, V21, P424, DOI 10.1093/eurpub/ckq104
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mackintosh KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036919
   Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390
   Ortega FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060871
   Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a
   Pate RR, 2011, BRIT J SPORT MED, V45, P906, DOI 10.1136/bjsports-2011-090192
   Pulsford RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021822
   Ridgers ND, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-15
   Robinson Thomas N, 2003, Ethn Dis, V13, pS65
   Rowlands AV, 2004, MED SCI SPORT EXER, V36, P518, DOI 10.1249/01.MSS.0000117158.14542.E7
   Ruiz JR, 2011, AM J EPIDEMIOL, V174, P173, DOI 10.1093/aje/kwr068
   Santos R, 2014, BRIT J SPORT MED, V48, P1508, DOI 10.1136/bjsports-2012-091610
   Sardinha LB, 2008, DIABETES CARE, V31, P569, DOI 10.2337/dc07-1286
   Steele RM, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-88
   Treuth MS, 2004, MED SCI SPORT EXER, V36, P1259, DOI [10.1249/01.MSS.0000074670.03001.98, 10.1249/01.MSS.0000113666.98463.B0]
   Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3
   Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98
   Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e
   van Grieken A, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-61
   van Sluijs EMF, 2010, BRIT J SPORT MED, V44, P747, DOI 10.1136/bjsm.2008.049783
   Vanhelst J, 2010, J SPORT SCI, V28, P381, DOI 10.1080/02640410903508821
NR 43
TC 24
Z9 24
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 3
PY 2014
VL 9
IS 4
AR e90630
DI 10.1371/journal.pone.0090630
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AE6LR
UT WOS:000334105000012
PM 24699259
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU McCormick, N
   Lacaille, D
   Bhole, V
   Avina-Zubieta, JA
AF McCormick, Natalie
   Lacaille, Diane
   Bhole, Vidula
   Avina-Zubieta, J. Antonio
TI Validity of Myocardial Infarction Diagnoses in Administrative Databases:
   A Systematic Review
SO PLOS ONE
LA English
DT Review
ID CORONARY-HEART-DISEASE; POSITIVE PREDICTIVE-VALUE; HOSPITAL DISCHARGE
   REGISTER; 1ST NATIONS POPULATION; RHEUMATOID-ARTHRITIS;
   CARDIOVASCULAR-DISEASE; LUPUS-ERYTHEMATOSUS; MORTALITY STATISTICS;
   EUROPEAN-SOCIETY; CODING ACCURACY
AB Background: Though administrative databases are increasingly being used for research related to myocardial infarction (MI), the validity of MI diagnoses in these databases has never been synthesized on a large scale. Objective: To conduct the first systematic review of studies reporting on the validity of diagnostic codes for identifying MI in administrative data.
   Methods: MEDLINE and EMBASE were searched (inception to November 2010) for studies: (a) Using administrative data to identify MI; or (b) Evaluating the validity of MI codes in administrative data; and (c) Reporting validation statistics (sensitivity, specificity, positive predictive value (PPV), negative predictive value, or Kappa scores) for MI, or data sufficient for their calculation. Additonal articles were located by handsearch (up to February 2011) of original papers. Data were extracted by two independent reviewers; article quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies tool.
   Results: Thirty studies published from 1984-2010 were included; most assessed codes from the International Classification of Diseases (ICD)-9 th revision. Sensitivity and specificity of hospitalization data for identifying MI in most [>= 50%] studies was >= 86%, and PPV in most studies was >= 93%. The PPV was higher in the more-recent studies, and lower when criteria that do not incorporate cardiac troponin levels (such as the MONICA) were employed as the gold standard. MI as a cause-of-death on death certificates also demonstrated lower accuracy, with maximum PPV of 60% (for definite MI).
   Conclusions: Hospitalization data has higher validity and hence can be used to identify MI, but the accuracy of MI as a cause-of-death on death certificates is suboptimal, and more studies are needed on the validity of ICD-10 codes. When using administrative data for research purposes, authors should recognize these factors and avoid using vital statistics data if hospitalization data is not available to confirm deaths from MI.
C1 [McCormick, Natalie] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada.
   [McCormick, Natalie; Lacaille, Diane; Bhole, Vidula; Avina-Zubieta, J. Antonio] Arthrit Res Ctr Canada, Richmond, BC, Canada.
   [Lacaille, Diane; Bhole, Vidula; Avina-Zubieta, J. Antonio] Univ British Columbia, Dept Med, Div Rheumatol, Vancouver, BC, Canada.
   [Lacaille, Diane; Avina-Zubieta, J. Antonio] CANRAD Network, Cardiovasc Comm, Richmond, BC, Canada.
   EpiSolut Consultancy Serv, Thana, India.
RP Avina-Zubieta, JA (reprint author), Arthrit Res Ctr Canada, Richmond, BC, Canada.
EM azubieta@arthritisresearch.ca
OI McCormick, Natalie/0000-0002-4147-8348
FU Canadian Arthritis Network; Arthritis Society of Canada
FX This study was funded in part by the Canadian Arthritis Network
   (http://www.arthritisnetwork.ca). JAAZ held a salary award from the
   Canadian Arthritis Network and The Arthritis Society of Canada. He is
   currently the British Columbia Lupus Society Scholar. DL holds the Mary
   Pack Chair in Arthritis Research from UBC and The Arthritis Society of
   Canada. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Ainla T, 2006, SCAND J PUBLIC HEALT, V34, P327, DOI 10.1080/14034940500242019
   Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4
   Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839
   Barber C, 2013, ARTHRIT CARE RES, V65, P1343, DOI 10.1002/acr.21959
   Barchielli A, 2012, J EPIDEMIOL COMMUN H, V66, P462, DOI 10.1136/jech.2010.110908
   Barnabe C, 2012, ARTHRIT CARE RES, V64, P1715, DOI 10.1002/acr.21743
   Barnabe C, 2012, ARTHRIT CARE RES, V64, P138, DOI 10.1002/acr.20656
   BEAGLEHOLE R, 1987, AUST NZ J MED, V17, P43, DOI 10.1111/j.1445-5994.1987.tb05048.x
   Bernatsky S, 2007, RHEUMATOLOGY, V46, P1814, DOI 10.1093/rheumatology/kem233
   Bernatsky S, 2011, RHEUMATOL INT, V31, P549, DOI 10.1007/s00296-010-1591-2
   Bernatsky S, 2013, J RHEUMATOL, V40, P66, DOI 10.3899/jrheum.120835
   BOYLE CA, 1995, AUST NZ J MED, V25, P316, DOI 10.1111/j.1445-5994.1995.tb01896.x
   Chen G, 2009, BMC MED RES METHODOL, V9
   De Henauw S, 1998, J EPIDEMIOL COMMUN H, V52, P513, DOI 10.1136/jech.52.8.513
   De Vera MA, 2010, ANN RHEUM DIS, V69, P1162, DOI 10.1136/ard.2009.122770
   Fischer LM, 2004, AM J CARDIOL, V93, P198, DOI 10.1016/j.amjcard.2003.09.037
   Gonzalez A, 2008, ANN RHEUM DIS, V67, P64, DOI 10.1136/ard.2006.059980
   Hammar N, 2001, INT J EPIDEMIOL, V30, pS30, DOI 10.1093/ije/30.suppl_1.S30
   Health Statistics and Informatics Department, 2011, CAUS DEATH 2008 SUMM
   Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314
   Heisler CA, 2009, J AM COLL SURGEONS, V209, P119, DOI 10.1016/j.jamcollsurg.2009.03.017
   Henderson T, 2006, MED CARE, V44, P1011, DOI 10.1097/01.mlr.0000228018.48783.34
   Hudson M, 2013, J CLIN EPIDEMIOL, V66, P278, DOI 10.1016/j.jclinepi.2012.10.004
   Humphries KH, 2000, J CLIN EPIDEMIOL, V53, P343, DOI 10.1016/S0895-4356(99)00188-2
   Ingelsson E, 2005, EUR J HEART FAIL, V7, P787, DOI 10.1016/j.ejheart.2004.12.007
   JACKSON R, 1988, NEW ZEAL MED J, V101, P658
   Kavsak PA, 2006, AM HEART J, V152, P118, DOI 10.1016/j.ahj.2005.09.022
   KENNEDY GT, 1984, AM J CARDIOL, V53, P1000, DOI 10.1016/0002-9149(84)90625-8
   Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013
   Kontos MC, 2003, AM HEART J, V146, P446, DOI 10.1016/S0002-8703(03)00245-X
   Kopec JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P929, DOI 10.1002/art.23827
   Kramer MS, 1988, CLIN EPIDEMIOLOGY BI, P236
   Kuo CF, 2013, RHEUMATOLOGY, V52, P111, DOI 10.1093/rheumatology/kes169
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733
   Levy AR, 1999, CAN J CARDIOL, V15, P1277
   LINDBLAD U, 1993, SCAND J SOC MED, V21, P3, DOI 10.1177/140349489302100102
   LOWEL H, 1991, J CLIN EPIDEMIOL, V44, P249, DOI 10.1016/0895-4356(91)90036-9
   Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA
   Mahonen M, 1997, EUR J EPIDEMIOL, V13, P403, DOI 10.1023/A:1007306110822
   Mahonen M, 1999, J CLIN EPIDEMIOL, V52, P157, DOI 10.1016/S0895-4356(98)00145-0
   McCarthy EP, 2000, MED CARE, V38, P868, DOI 10.1097/00005650-200008000-00010
   Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38
   Merry AHH, 2009, EUR J EPIDEMIOL, V24, P237, DOI 10.1007/s10654-009-9335-x
   *NOV SCOT SASK CAR, 1989, CAN J PUBLIC HLTH, V80, P412
   Office of Cardiovascular Diseases World Health Organization, 1999, MONICA MAN COR EV RE
   Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007
   PALOMAKI P, 1994, J CLIN EPIDEMIOL, V47, P659, DOI 10.1016/0895-4356(94)90213-5
   Parikh NI, 2009, CIRCULATION, V119, P1203, DOI 10.1161/CIRCULATIONAHA.108.825364
   Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x
   Pladevall M, 1996, INT J EPIDEMIOL, V25, P948, DOI 10.1093/ije/25.5.948
   Rahman MM, 2013, ARTHRIT CARE RES, V65, P1951, DOI 10.1002/acr.22092
   Rapola JM, 1997, EUR J EPIDEMIOL, V13, P133, DOI 10.1023/A:1007380408729
   Rawson NSB, 1995, STAT MED, V14, P2627, DOI 10.1002/sim.4780142404
   Roger VL, 2010, CIRCULATION, V121, P863, DOI 10.1161/CIRCULATIONAHA.109.897249
   Rosamond WD, 2004, AM J EPIDEMIOL, V160, P1137, DOI 10.1093/aje/kwh341
   Salomaa V, 2005, EUR HEART J, V26, P1719, DOI 10.1093/eurheartj/ehi185
   Salomaa V, 2006, EUROPREVENT ANN C EU
   Scherrer JF, 2010, AM HEART J, V159, P772, DOI 10.1016/j.ahj.2010.02.033
   Soedamah-Muthu SS, 2006, DIABETES CARE, V29, P798, DOI 10.2337/diacare.29.04.06.dc05-1433
   Solomon DH, 2006, ARTHRITIS RHEUM, V54, P3790, DOI 10.1002/art.22255
   Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001
   TUNSTALL-PEDOE H, 1988, Journal of Clinical Epidemiology, V41, P105
   VANWALRAVEN C, 1990, CAN J CARDIOL, V6, P383
   Varas-Lorenzo C, 2008, PHARMACOEPIDEM DR S, V17, P842, DOI 10.1002/pds.1619
   Varas-Lorenzo C, 2007, ATHEROSCLEROSIS, V192, P376, DOI 10.1016/j.atherosclerosis.2006.05.019
   Wahl PM, 2010, PHARMACOEPIDEM DR S, V19, P596, DOI 10.1002/pds.1924
   Watson DJ, 2003, J RHEUMATOL, V30, P1196
   Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25
   Widdifield J, 2013, ARTHRIT CARE RES, V65, P1490, DOI 10.1002/acr.21993
   WIELGOSZ AT, 1992, CAN J CARDIOL, V8, P253
NR 71
TC 71
Z9 73
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 28
PY 2014
VL 9
IS 3
AR e92286
DI 10.1371/journal.pone.0092286
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AE0TC
UT WOS:000333678100008
PM 24682186
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Basner, M
   Dinges, DF
   Mollicone, DJ
   Savelev, I
   Ecker, AJ
   Di Antonio, A
   Jones, CW
   Hyder, EC
   Kan, K
   Morukov, BV
   Sutton, JP
AF Basner, Mathias
   Dinges, David F.
   Mollicone, Daniel J.
   Savelev, Igor
   Ecker, Adrian J.
   Di Antonio, Adrian
   Jones, Christopher W.
   Hyder, Eric C.
   Kan, Kevin
   Morukov, Boris V.
   Sutton, Jeffrey P.
TI Psychological and Behavioral Changes during Confinement in a 520-Day
   Simulated Interplanetary Mission to Mars
SO PLOS ONE
LA English
DT Article
ID INTERNATIONAL-SPACE-STATION; VIGILANCE TEST PVT; SLEEP-DEPRIVATION; MOOD
   STATES; SOCIAL DESIRABILITY; POLAR EXPEDITIONS; DOSE-RESPONSE;
   PERFORMANCE; DURATION; VALIDITY
AB Behavioral health risks are among the most serious and difficult to mitigate risks of confinement in space craft during long-duration space exploration missions. We report on behavioral and psychological reactions of a multinational crew of 6 healthy males confined in a 550 m(3) chamber for 520 days during the first Earth-based, high-fidelity simulated mission to Mars. Rest-activity of crewmembers was objectively measured throughout the mission with wrist-worn actigraphs. Once weekly throughout the mission crewmembers completed the Beck Depression Inventory-II (BDI-II), Profile of Moods State short form (POMS), conflict questionnaire, the Psychomotor Vigilance Test (PVT-B), and series of visual analogue scales on stress and fatigue. We observed substantial inter-individual differences in the behavioral responses of crewmembers to the prolonged mission confinement and isolation. The crewmember with the highest average POMS total mood disturbance score throughout the mission also reported symptoms of depression in 93% of mission weeks, which reached mild-to-moderate levels in >10% of mission weeks. Conflicts with mission control were reported five times more often than conflicts among crewmembers. Two crewmembers who had the highest ratings of stress and physical exhaustion accounted for 85% of the perceived conflicts. One of them developed a persistent sleep onset insomnia with ratings of poor sleep quality, which resulted in chronic partial sleep deprivation, elevated ratings of daytime tiredness, and frequent deficits in behavioral alertness. Sleep-wake timing was altered in two other crewmembers, beginning in the first few months of the mission and persisting throughout. Two crewmembers showed neither behavioral disturbances nor reports of psychological distress during the 17-month period of mission confinement. These results highlight the importance of identifying behavioral, psychological, and biological markers of characteristics that predispose prospective crewmembers to both effective and ineffective behavioral reactions during the confinement of prolonged spaceflight, to inform crew selection, training, and individualized countermeasures.
C1 [Basner, Mathias; Dinges, David F.; Ecker, Adrian J.; Di Antonio, Adrian; Jones, Christopher W.; Hyder, Eric C.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Mollicone, Daniel J.; Kan, Kevin] Pulsar Informat, Philadelphia, PA USA.
   [Savelev, Igor] Wyle, Houston, TX USA.
   [Savelev, Igor; Sutton, Jeffrey P.] Natl Space Biomed Res Inst, Houston, TX USA.
   [Morukov, Boris V.] Minist Publ Hlth Russia, Inst Biomed Problems, Moscow, Russia.
   [Sutton, Jeffrey P.] Baylor Coll Med, Ctr Space Med, Houston, TX 77030 USA.
   [Sutton, Jeffrey P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
RP Basner, M (reprint author), Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA.
EM basner@upenn.edu
RI Dinges, David/P-7183-2019
FU National Space Biomedical Research Institute (NSBRI) [NASA NCC 9-58];
   Institute for Experimental Psychiatry Research Foundation
FX The research was supported by the National Space Biomedical Research
   Institute (NSBRI) through NASA NCC 9-58, and by the Institute for
   Experimental Psychiatry Research Foundation. The funders had no role in
   study design, data collection and analysis, and decision to publish.
   Jeffrey Sutton is President, CEO and Institute Director of NSBRI. He
   helped in the preparation of the manuscript. The Friedkin Chair for
   Research in Sensory System Integration and Space Medicine to Jeffrey
   Sutton is also acknowledged.
CR Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342
   Antonovsky A, 1987, UNRAVELING MYSTERY H
   Baisden DL, 2008, AVIAT SPACE ENVIR MD, V79, P629, DOI 10.3357/ASEM.2314.2008
   Ball J. R., 2001, SAFE PASSAGE ASTRONA
   Basner M, 2013, P NATL ACAD SCI USA, V110, P2635, DOI [10.1073/pnas.1212646110/-/DCSupplemental, 10.1073/pnas.1212646110]
   Basner M, 2011, ACTA ASTRONAUT, V69, P949, DOI 10.1016/j.actaastro.2011.07.015
   Basner M, 2011, J OCCUP ENVIRON MED, V53, P1146, DOI 10.1097/JOM.0b013e31822b8356
   Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581
   Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13
   Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x
   Blake BF, 2006, PERS INDIV DIFFER, V40, P1625, DOI 10.1016/j.paid.2005.12.007
   Boyd JE, 2007, ACTA ASTRONAUT, V61, P668, DOI 10.1016/j.actaastro.2006.12.002
   CURRAN SL, 1995, PSYCHOL ASSESSMENT, V7, P80, DOI 10.1037/1040-3590.7.1.80
   Feichtinger E, 2012, AER C
   Griofa MO, 2011, AVIAT SPACE ENVIR MD, V82, P434, DOI 10.3357/ASEM.2570.2011
   Inoue N, 2004, AVIAT SPACE ENVIR MD, V75, pC28
   Kanas N, 2009, ACTA ASTRONAUT, V64, P659, DOI 10.1016/j.actaastro.2008.12.005
   KELLY AD, 1993, AVIAT SPACE ENVIR MD, V64, P795
   Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lapierrea J, 2009, ACTA ASTRONAUT, V64, P1304, DOI 10.1016/j.actaastro.2009.01.002
   Leon GR, 2011, J ENVIRON PSYCHOL, V31, P353, DOI 10.1016/j.jenvp.2011.08.001
   Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002
   Mollicone DJ, 2008, ACTA ASTRONAUT, V63, P833, DOI 10.1016/j.actaastro.2007.12.005
   Palinkas LA, 2008, LANCET, V371, P153, DOI 10.1016/S0140-6736(07)61056-3
   Rosnet E, 1998, ACTA ASTRONAUT, V42, P265
   Sandal GM, 2004, AVIAT SPACE ENVIR MD, V75, pC44
   Sandal GM, 1996, AVIAT SPACE ENVIR MD, V67, P227
   SHACHAM S, 1983, J PERS ASSESS, V47, P305, DOI 10.1207/s15327752jpa4703_14
   Shved D M, 2013, Aviakosm Ekolog Med, V47, P19
   Slack KJ, 2009, RISK BEHAV PSYCHIAT
   Stober J, 2001, EUR J PSYCHOL ASSESS, V17, P222, DOI 10.1027//1015-5759.17.3.222
   Stuster J, 2005, AVIAT SPACE ENVIR MD, V76, pB78
   Stuster J, 2000, AVIAT SPACE ENVIR MD, V71, pA17
   Suedfeld P, 1998, J ENVIRON PSYCHOL, V18, P95, DOI 10.1006/jevp.1998.0090
   SUEDFELD P, 1991, ENVIRON BEHAV, V23, P653, DOI 10.1177/0013916591236001
   Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117
NR 37
TC 38
Z9 41
U1 3
U2 35
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 27
PY 2014
VL 9
IS 3
AR e93298
DI 10.1371/journal.pone.0093298
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AE0SW
UT WOS:000333677500107
PM 24675720
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Henriksen, DP
   Nielsen, SL
   Laursen, CB
   Hallas, J
   Pedersen, C
   Lassen, AT
AF Henriksen, Daniel Pilsgaard
   Nielsen, Stig Lonberg
   Laursen, Christian Borbjerg
   Hallas, Jesper
   Pedersen, Court
   Lassen, Annmarie Touborg
TI How Well Do Discharge Diagnoses Identify Hospitalised Patients with
   Community-Acquired Infections? - A Validation Study
SO PLOS ONE
LA English
DT Article
ID RHEUMATOID-ARTHRITIS PATIENTS; SERIOUS BACTERIAL-INFECTIONS;
   ADMINISTRATIVE DATA; UNITED-STATES; SEVERE SEPSIS; CRITERIA; CODES;
   CARE; EPIDEMIOLOGY; SURVEILLANCE
AB Background: Credible measures of disease incidence, trends and mortality can be obtained through surveillance using manual chart review, but this is both time-consuming and expensive. ICD-10 discharge diagnoses are used as surrogate markers of infection, but knowledge on the validity of infections in general is sparse. The aim of the study was to determine how well ICD-10 discharge diagnoses identify patients with community-acquired infections in a medical emergency department (ED), overall and related to sites of infection and patient characteristics.
   Methods: We manually reviewed 5977 patients admitted to a medical ED in a one-year period (September 2010-August 2011), to establish if they were hospitalised with community-acquired infection. Using the manual review as gold standard, we calculated the sensitivity, specificity, predictive values, and likelihood ratios of discharge diagnoses indicating infection.
   Results: Two thousand five hundred eleven patients were identified with community-acquired infection according to chart review (42.0%, 95% confidence interval [95% CI]: 40.8-43.3%) compared to 2550 patients identified by ICD-10 diagnoses (42.8%, 95% CI: 41.6-44.1%). Sensitivity of the ICD-10 diagnoses was 79.9% (95% CI: 78.1-81.3%), specificity 83.9% (95% CI: 82.6-85.1%), positive likelihood ratio 4.95 (95% CI: 4.58-5.36) and negative likelihood ratio 0.24 (95% CI: 0.22-0.26). The two most common sites of infection, the lower respiratory tract and urinary tract, had positive likelihood ratios of 8.3 (95% CI: 7.5-9.2) and 11.3 (95% CI: 10.2-12.9) respectively. We identified significant variation in diagnostic validity related to age, comorbidity and disease severity.
   Conclusion: ICD-10 discharge diagnoses identify specific sites of infection with a high degree of validity, but only a moderate degree when identifying infections in general.
C1 [Henriksen, Daniel Pilsgaard; Lassen, Annmarie Touborg] Odense Univ Hosp, Dept Emergency Med, DK-5000 Odense, Denmark.
   [Nielsen, Stig Lonberg; Pedersen, Court] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark.
   [Laursen, Christian Borbjerg] Odense Univ Hosp, Dept Resp Med, DK-5000 Odense, Denmark.
   [Hallas, Jesper] Univ Southern Denmark, Dept Clin Pharmacol, Odense, Denmark.
RP Henriksen, DP (reprint author), Odense Univ Hosp, Dept Emergency Med, DK-5000 Odense, Denmark.
EM dphenriksen@health.sdu.dk
RI Nielsen, Stig Lonberg/B-8421-2014
OI Nielsen, Stig Lonberg/0000-0002-7780-7131; Laursen, Christian
   B./0000-0001-6382-9906; Henriksen, Daniel Pilsgaard/0000-0003-1303-6195
FU Faculty of Health Sciences, Odense University Hospital; Research
   Foundation of Odense University Hospital, University of Southern
   Denmark; private philanthropic fund TrygFonden
FX The study was funded as a part of the corresponding authors PhD study: A
   stipend for PhD students from the Faculty of Health Sciences, Odense
   University Hospital, as well as a stipend from the Research Foundation
   of Odense University Hospital, University of Southern Denmark and an
   unrestricted grant from the private philanthropic fund TrygFonden given
   to the University of Southern Denmark. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Angus DC, 2001, CRIT CARE MED, V29, P1303, DOI 10.1097/00003246-200107000-00002
   Barber C, 2013, ARTHRIT CARE RES, V65, P1343, DOI 10.1002/acr.21959
   Chalfine A, 2006, INFECT CONT HOSP EP, V27, P794, DOI 10.1086/506393
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Curtis JR, 2007, ARTHRITIS RHEUM-US, V56, P1125, DOI 10.1002/art.22504
   Esteban A, 2007, CRIT CARE MED, V35, P1284, DOI 10.1097/01.CCM.0000260960.94300.DE
   Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398
   Gedeborg R, 2007, J CLIN EPIDEMIOL, V60, P155, DOI 10.1016/j.jclinepi.2006.05.013
   Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562
   Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7
   Guevara RE, 1999, AM J EPIDEMIOL, V149, P282
   Hallas J, 2001, PHARMACOEPIDEM DR S, V10, P619, DOI 10.1002/pds.638
   Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002
   Klouwenberg PMCK, 2013, CRIT CARE MED, V41, P2373, DOI 10.1097/CCM.0b013e3182923712
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482
   Micallef L, 2012, 12 ANN G HOPP CEL WO
   Patkar NM, 2009, J CLIN EPIDEMIOL, V62, P321, DOI 10.1016/j.jclinepi.2008.06.006
   Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965
   Schmidt Morten, 2010, Clin Epidemiol, V2, P195, DOI 10.2147/CLEP.S12171
   Schneeweiss S, 2007, J CLIN EPIDEMIOL, V60, P397, DOI 10.1016/j.jclinepi.2006.07.011
   Shapiro N, 2006, ANN EMERG MED, V48, P583, DOI 10.1016/j.annemergmed.2006.07.007
   Sogaard Mette, 2011, Clin Epidemiol, V3, P85, DOI 10.2147/CLEP.S16931
   van De Garde EMW, 2007, J CLIN EPIDEMIOL, V60, P834, DOI 10.1016/j.jclinepi.2006.10.018
   van Tuijn CFJ, 2010, INT J EMERG MED, V3, P293, DOI 10.1007/s12245-010-0220-x
   Wang HE, 2007, CRIT CARE MED, V35, P1928, DOI 10.1097/01.CCM.0000277043.85378.C1
   Wilhelms SB, 2010, CRIT CARE MED, V38, P1442, DOI 10.1097/CCM.0b013e3181de4406
NR 27
TC 18
Z9 18
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 24
PY 2014
VL 9
IS 3
AR e92891
DI 10.1371/journal.pone.0092891
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AD7QO
UT WOS:000333459900127
PM 24663388
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Beauregard, F
   de Blois, S
AF Beauregard, Frieda
   de Blois, Sylvie
TI Beyond a Climate-Centric View of Plant Distribution: Edaphic Variables
   Add Value to Distribution Models
SO PLOS ONE
LA English
DT Article
ID SPECIES DISTRIBUTION MODELS; HUMUS FORMS; SAMPLE-SIZE; PREDICTIONS;
   ABUNDANCE; FOREST; SCALE; UNCERTAINTIES; BIODIVERSITY; PERFORMANCE
AB Both climatic and edaphic conditions determine plant distribution, however many species distribution models do not include edaphic variables especially over large geographical extent. Using an exceptional database of vegetation plots (n = 4839) covering an extent of similar to 55000 km(2), we tested whether the inclusion of fine scale edaphic variables would improve model predictions of plant distribution compared to models using only climate predictors. We also tested how well these edaphic variables could predict distribution on their own, to evaluate the assumption that at large extents, distribution is governed largely by climate. We also hypothesized that the relative contribution of edaphic and climatic data would vary among species depending on their growth forms and biogeographical attributes within the study area. We modelled 128 native plant species from diverse taxa using four statistical model types and three sets of abiotic predictors: climate, edaphic, and edaphic-climate. Model predictive accuracy and variable importance were compared among these models and for species' characteristics describing growth form, range boundaries within the study area, and prevalence. For many species both the climate-only and edaphic-only models performed well, however the edaphic-climate models generally performed best. The three sets of predictors differed in the spatial information provided about habitat suitability, with climate models able to distinguish range edges, but edaphic models able to better distinguish within-range variation. Model predictive accuracy was generally lower for species without a range boundary within the study area and for common species, but these effects were buffered by including both edaphic and climatic predictors. The relative importance of edaphic and climatic variables varied with growth forms, with trees being more related to climate whereas lower growth forms were more related to edaphic conditions. Our study identifies the potential for non-climate aspects of the environment to pose a constraint to range expansion under climate change.
C1 [Beauregard, Frieda; de Blois, Sylvie] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada.
   [de Blois, Sylvie] McGill Univ, McGill Sch Environm, Ste Anne De Bellevue, PQ, Canada.
RP de Blois, S (reprint author), McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada.
EM sylvie.deblois@mcgill.ca
FU Fonds de Recherche du Quebec - Natures et Technologies; Natural Sciences
   and Engineering Research Council of Canada
FX The authors acknowledge funding from the Fonds de Recherche du Quebec -
   Natures et Technologies (www.fqrnt.gouv.qc.ca) to F. Beauregard and from
   the Natural Sciences and Engineering Research Council of Canada
   (http://www.nserc-crsng.gc.ca) to S. de Blois. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aranda SC, 2011, ECOGRAPHY, V34, P31, DOI 10.1111/j.1600-0587.2010.06134.x
   Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.001000.x
   Ascher J, 2012, BIOL FERT SOILS, V48, P709, DOI 10.1007/s00374-012-0670-9
   Attorre F, 2011, APPL VEG SCI, V14, P242, DOI 10.1111/j.1654-109X.2010.01114.x
   Austin MP, 2011, J BIOGEOGR, V38, P9, DOI 10.1111/j.1365-2699.2010.02415.x
   Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x
   Berger J.-P., 1994, POINT OBSERVATION EC
   Berteaux Dominique, 2010, Diversity, V2, P1181, DOI 10.3390/d2111181
   Bertrand R, 2012, GLOBAL CHANGE BIOL, V18, P2648, DOI 10.1111/j.1365-2486.2012.02679.x
   Chambers D, 2013, FOREST ECOL MANAG, V291, P20, DOI 10.1016/j.foreco.2012.10.046
   COTE B, 1994, CAN J FOREST RES, V24, P192, DOI 10.1139/x94-027
   Coudun C, 2006, J BIOGEOGR, V33, P1750, DOI 10.1111/j.1365-2699.2005.01443.x
   de Blois S, 2001, LANDSCAPE ECOL, V16, P421, DOI 10.1023/A:1017548003345
   Dengler J, 2011, J VEG SCI, V22, P582, DOI 10.1111/j.1654-1103.2011.01265.x
   Dubuis A, 2013, J VEG SCI, V24, P593, DOI 10.1111/jvs.12002
   Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159
   Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088
   Franklin J., 2009, MAPPING SPECIES DIST
   Gosselin Jocelyn, 2012, Biodiversity Ecol, V4, P432, DOI 10.7809/b-e.00219
   Hanspach J, 2010, PERSPECT PLANT ECOL, V12, P219, DOI 10.1016/j.ppees.2010.04.002
   Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957
   Hutchinson M. F, 2002, ANUSPLIN VERSION 4 2
   Jones CC, 2010, ECOL APPL, V20, P311, DOI 10.1890/08-2261.1
   Lafleur B, 2010, ENVIRON REV, V18, P279, DOI 10.1139/A10-013
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831
   Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x
   Marage D, 2009, GLOBAL ECOL BIOGEOGR, V18, P88, DOI 10.1111/j.1466-8238.2008.00428.x
   Mateo RG, 2010, DIVERS DISTRIB, V16, P84, DOI 10.1111/j.1472-4642.2009.00617.x
   McKenney DW, 2011, GLOBAL CHANGE BIOL, V17, P2720, DOI 10.1111/j.1365-2486.2011.02413.x
   Nelson B. D, 2001, P 26 ANN SAS US GROU
   Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2
   Philips D. W., 1991, CANADA PRECIPITATION
   Ponge JF, 2003, SOIL BIOL BIOCHEM, V35, P935, DOI 10.1016/S0038-0717(03)00149-4
   Rehfeldt G. E., 2006, SPLINE MODEL CLIMATE
   Rousseau C., 1974, GEOGRAPHIE FLORISTIQ
   Rupprecht F, 2011, J VEG SCI, V22, P647, DOI 10.1111/j.1654-1103.2011.01269.x
   Saucier J. P., 2003, VEGETATION ZONES BIO
   Sormunen H, 2011, POLAR BIOL, V34, P883, DOI 10.1007/s00300-010-0945-2
   Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X
   SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615
   Syphard AD, 2009, ECOGRAPHY, V32, P907, DOI 10.1111/j.1600-0587.2009.05883.x
   Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102
   Thuiller W, 2013, J VEG SCI, V24, P591, DOI 10.1111/jvs.12076
   Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x
   Wang TL, 2012, FOREST ECOL MANAG, V279, P128, DOI 10.1016/j.foreco.2012.05.034
   Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x
   Young NE, 2012, ENVIRON MONIT ASSESS, V184, P5439, DOI 10.1007/s10661-011-2351-9
NR 48
TC 26
Z9 27
U1 0
U2 38
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 21
PY 2014
VL 9
IS 3
AR e92642
DI 10.1371/journal.pone.0092642
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AD6GL
UT WOS:000333355300110
PM 24658097
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Madai, VI
   Galinovic, I
   Grittner, U
   Zaro-Weber, O
   Schneider, A
   Martin, SZ
   Samson-Himmelstjerna, FCV
   Stengl, KL
   Mutke, MA
   Moeller-Hartmann, W
   Ebinger, M
   Fiebach, JB
   Sobesky, J
AF Madai, Vince I.
   Galinovic, Ivana
   Grittner, Ulrike
   Zaro-Weber, Olivier
   Schneider, Alice
   Martin, Steve Z.
   Samson-Himmelstjerna, Federico C. v.
   Stengl, Katharina L.
   Mutke, Matthias A.
   Moeller-Hartmann, Walter
   Ebinger, Martin
   Fiebach, Jochen B.
   Sobesky, Jan
TI DWI Intensity Values Predict FLAIR Lesions in Acute Ischemic Stroke
SO PLOS ONE
LA English
DT Article
ID APPARENT DIFFUSION-COEFFICIENT; ATTENUATED INVERSION-RECOVERY; UNKNOWN
   ONSET TIME; SIGNAL INTENSITY; SYMPTOM ONSET; EVOLUTION; MISMATCH; BRAIN;
   GUIDELINES; MANAGEMENT
AB Background and Purpose: In acute stroke, the DWI-FLAIR mismatch allows for the allocation of patients to the thrombolysis window (<4.5 hours). FLAIR-lesions, however, may be challenging to assess. In comparison, DWI may be a useful bio-marker owing to high lesion contrast. We investigated the performance of a relative DWI signal intensity (rSI) threshold to predict the presence of FLAIR-lesions in acute stroke and analyzed its association with time-from-stroke-onset.
   Methods: In a retrospective, dual-center MR-imaging study we included patients with acute stroke and time-from-stroke-onset <= 12 hours (group A: n = 49, 1.5T; group B: n = 48, 3T). DW- and FLAIR-images were coregistered. The largest lesion extent in DWI defined the slice for further analysis. FLAIR-lesions were identified by 3 raters, delineated as regions-of-interest (ROIs) and copied on the DW-images. Circular ROIs were placed within the DWI-lesion and labeled according to the FLAIR-pattern (FLAIR+ or FLAIR-). ROI-values were normalized to the unaffected hemisphere. Adjusted and nonadjusted receiver-operating-characteristics (ROC) curve analysis on patient level was performed to analyze the ability of a DWI- and ADC-rSI threshold to predict the presence of FLAIR-lesions. Spearman correlation and adjusted linear regression analysis was performed to assess the relationship between DWI-intensity and time-from-stroke-onset.
   Results: DWI-rSI performed well in predicting lesions in FLAIR-imaging (mean area under the curve (AUC): group A: 0.84; group B: 0.85). An optimal mean DWI-rSI threshold was identified (A: 162%; B: 161%). ADC-maps performed worse (mean AUC: A: 0.58; B: 0.77). Adjusted regression models confirmed the superior performance of DWI-rSI. Correlation coefficents and linear regression showed a good association with time-from-stroke-onset for DWI-rSI, but not for ADC-rSI.
   Conclusion: An easily assessable DWI-rSI threshold identifies the presence of lesions in FLAIR-imaging with good accuracy and is associated with time-from-stroke-onset in acute stroke. This finding underlines the potential of a DWI-rSI threshold as a marker of lesion age.
C1 [Madai, Vince I.; Galinovic, Ivana; Grittner, Ulrike; Zaro-Weber, Olivier; Schneider, Alice; Martin, Steve Z.; Samson-Himmelstjerna, Federico C. v.; Stengl, Katharina L.; Mutke, Matthias A.; Ebinger, Martin; Fiebach, Jochen B.; Sobesky, Jan] Charite, Ctr Stroke Res Berlin CSB, D-13353 Berlin, Germany.
   [Zaro-Weber, Olivier] Max Planck Inst Neurol Res, D-50931 Cologne, Germany.
   [Samson-Himmelstjerna, Federico C. v.] Fraunhofer MEVIS, Bremen, Germany.
   [Moeller-Hartmann, Walter] Krankenhaus Ludmillenstift, Dept Radiol, Meppen, Germany.
   [Madai, Vince I.; Stengl, Katharina L.; Mutke, Matthias A.; Ebinger, Martin; Sobesky, Jan] Charite, Dept Neurol, D-13353 Berlin, Germany.
   [Grittner, Ulrike; Schneider, Alice] Charite, Dept Clin Epidemiol & Biostat, D-13353 Berlin, Germany.
RP Sobesky, J (reprint author), Charite, Ctr Stroke Res Berlin CSB, D-13353 Berlin, Germany.
EM jan.sobesky@charite.de
RI Grittner, Ulrike/I-2026-2019
OI Grittner, Ulrike/0000-0003-2595-0224; Madai, Vince/0000-0002-8552-6954;
   Martin, Steve/0000-0003-0653-6458; Fiebach, Jochen
   B./0000-0002-7936-6958
FU German Federal Ministry of Education and Research via the grant "Center
   for Stroke Research Berlin'' [01 EO 0801]
FX The research leading to these results has received funding from the
   German Federal Ministry of Education and Research via the grant "Center
   for Stroke Research Berlin'' (01 EO 0801; http://www.bmbf.de). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486
   Aoki J, 2010, J NEUROL SCI, V293, P39, DOI 10.1016/j.jns.2010.03.011
   BRENNAN RL, 1981, EDUC PSYCHOL MEAS, V41, P687, DOI 10.1177/001316448104100307
   Cheng B, 2012, J CEREB BLOOD FLOW M
   Cizek J, 2004, NEUROIMAGE, V22, P434, DOI 10.1016/j.neuroimage.2004.01.016
   DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
   Eastwood JD, 2003, AM J NEURORADIOL, V24, P680
   Ebinger M, 2010, STROKE, V41, P250, DOI 10.1161/STROKEAHA.109.568410
   Elliott WJ, 1998, STROKE, V29, P992, DOI 10.1161/01.STR.29.5.992
   Emeriau S, 2013, STROKE, V44, P1647, DOI 10.1161/STROKEAHA.113.001001
   Fiebach JB, 2002, NEURORADIOLOGY, V44, P294, DOI 10.1007/s00234-001-0720-8
   Galinovic I, 2014, STROKE          0220
   Heiss WD, 2004, STROKE, V35, P1892, DOI 10.1161/01.STR.0000134746.93535.9b
   Khademi A, 2012, IEEE T BIO-MED ENG, V59, P860, DOI 10.1109/TBME.2011.2181167
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lansberg MG, 2011, STROKE, V42, P1608, DOI 10.1161/STROKEAHA.110.609008
   Lansberg MG, 2001, AM J NEURORADIOL, V22, P637
   Petkova M, 2010, RADIOLOGY, V257, P782, DOI 10.1148/radiol.10100461
   Randolph JJ, 2005, JOENS U LEARN INSTR
   Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331
   Schlaug G, 1997, NEUROLOGY, V49, P113, DOI 10.1212/WNL.49.1.113
   Schwamm LH, 1998, STROKE, V29, P2268, DOI 10.1161/01.STR.29.11.2268
   Sobesky J, 2012, J CEREBR BLOOD F MET, V32, P1416, DOI 10.1038/jcbfm.2012.54
   Song SS, 2012, STROKE, V43, P2331, DOI 10.1161/STROKEAHA.111.630947
   Srivastava AK, 2008, J MED PHYS, V33, P162, DOI 10.4103/0971-6203.44479
   Thomalla G, 2011, LANCET NEUROL, V10, P978, DOI 10.1016/S1474-4422(11)70192-2
   WARACH S, 1995, ANN NEUROL, V37, P231, DOI 10.1002/ana.410370214
   YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
   Ziegler A, 2011, J NEUROL
   2008, CEREBROVASC DIS, V25, P457, DOI DOI 10.1159/000131083
NR 30
TC 15
Z9 16
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 21
PY 2014
VL 9
IS 3
AR e92295
DI 10.1371/journal.pone.0092295
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AD6GL
UT WOS:000333355300070
PM 24658092
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Takx, RAP
   de Jong, PA
   Leiner, T
   Oudkerk, M
   de Koning, HJ
   Mol, CP
   Viergever, MA
   Isgum, I
AF Takx, Richard A. P.
   de Jong, Pim A.
   Leiner, Tim
   Oudkerk, Matthijs
   de Koning, Harry J.
   Mol, Christian P.
   Viergever, Max A.
   Isgum, Ivana
TI Automated Coronary Artery Calcification Scoring in Non-Gated Chest CT:
   Agreement and Reliability
SO PLOS ONE
LA English
DT Article
ID ELECTRON-BEAM CT; ALL-CAUSE MORTALITY; LUNG-CANCER; CALCIUM SCORE;
   RISK-FACTORS; DISEASE; PREDICTION; GUIDELINES; MDCT
AB Objective: To determine the agreement and reliability of fully automated coronary artery calcium (CAC) scoring in a lung cancer screening population.
   Materials and Methods: 1793 low-dose chest CT scans were analyzed (non-contrast-enhanced, non-gated). To establish the reference standard for CAC, first automated calcium scoring was performed using a preliminary version of a method employing coronary calcium atlas and machine learning approach. Thereafter, each scan was inspected by one of four trained raters. When needed, the raters corrected initially automaticity-identified results. In addition, an independent observer subsequently inspected manually corrected results and discarded scans with gross segmentation errors. Subsequently, fully automatic coronary calcium scoring was performed. Agatston score, CAC volume and number of calcifications were computed. Agreement was determined by calculating proportion of agreement and examining Bland-Altman plots. Reliability was determined by calculating linearly weighted kappa (k) for Agatston strata and intraclass correlation coefficient (ICC) for continuous values.
   Results: 44 (2.5%) scans were excluded due to metal artifacts or gross segmentation errors. In the remaining 1749 scans, median Agatston score was 39.6 (P25-P75:0-345.9), median volume score was 60.4 mm(3) (P25-P75:0-361.4) and median number of calcifications was 2 (P25-P75:0-4) for the automated scores. The k demonstrated very good reliability (0.85) for Agatston risk categories between the automated and reference scores. The Bland-Altman plots showed underestimation of calcium score values by automated quantification. Median difference was 2.5 (p25-p75:0.0-53.2) for Agatston score, 7.6 (p25-p75:0.0-94.4) for CAC volume and 1 (p25-p75:0-5) for number of calcifications. The ICC was very good for Agatston score (0.90), very good for calcium volume (0.88) and good for number of calcifications (0.64).
   Discussion: Fully automated coronary calcium scoring in a lung cancer screening setting is feasible with acceptable reliability and agreement despite an underestimation of the amount of calcium when compared to reference scores.
C1 [Takx, Richard A. P.; de Jong, Pim A.; Leiner, Tim] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.
   [Oudkerk, Matthijs] Ctr Med Imaging North East, Groningen, Netherlands.
   [Oudkerk, Matthijs] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands.
   [de Koning, Harry J.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.
   [Mol, Christian P.; Viergever, Max A.; Isgum, Ivana] Univ Med Ctr Utrecht, Images Sci Inst, Utrecht, Netherlands.
RP Isgum, I (reprint author), Univ Med Ctr Utrecht, Images Sci Inst, Utrecht, Netherlands.
EM ivana@isi.uu.nl
RI de Jong, Pim/G-7220-2014; Viergever, Max A/J-1215-2014; Isgum,
   Ivana/H-8659-2014
OI de Jong, Pim/0000-0003-4840-6854; Isgum, Ivana/0000-0003-1869-5034
FU Netherlands Organisation for Health Research and Development (ZonMw)
   [22000130]; Dutch Cancer Society Koningin Wilhelmina Fonds; Stichting
   Centraal Fonds Reserves van Voormalig Vrijwillige
   Ziekenfondsverzekeringen (RVVZ); Siemens Germany provided 4 digital
   workstations and LungCARE for the performance of 3D measurements;
   Rotterdam Oncologic Thoracic Steering Committee; G. Ph. Verhagen Trust,
   Flemish League Against Cancer, Foundation Against Cancer, and Erasmus
   Trust Fund; project Care4Me (Cooperative Advanced Research for Medical
   Efficiency [ITEA2 Call3-08004]
FX The NELSON-trial was supported by the Netherlands Organisation for
   Health Research and Development (ZonMw, grant number 22000130, http://
   www.zonmw.nl/); Dutch Cancer Society Koningin Wilhelmina Fonds;
   Stichting Centraal Fonds Reserves van Voormalig Vrijwillige
   Ziekenfondsverzekeringen (RVVZ); Siemens Germany provided 4 digital
   workstations and LungCARE for the performance of 3D measurements;
   Rotterdam Oncologic Thoracic Steering Committee; and the G. Ph. Verhagen
   Trust, Flemish League Against Cancer, Foundation Against Cancer, and
   Erasmus Trust Fund. The contribution of I. Isgum was financially partly
   supported by the project Care4Me (Cooperative Advanced Research for
   Medical Efficiency, grant number ITEA2 Call3-08004,
   http://www.compassis.com/care4me/) in the framework of the EU research
   programme ITEA (Information Technology for European Advancement). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873
   Achenbach S, 2000, RADIOLOGY, V216, P457, DOI 10.1148/radiology.216.2.r00au19457
   BIELAK LF, 1994, RADIOLOGY, V192, P631, DOI 10.1148/radiology.192.3.8058926
   Bland JM, 2005, HLF NORMAL DIS UNPUB
   Buckens CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071204
   Budoff MJ, 2011, J CARDIOVASC COMPUT, V5, P113, DOI 10.1016/j.jcct.2010.11.002
   Callister TQ, 1998, RADIOLOGY, V208, P807, DOI 10.1148/radiology.208.3.9722864
   Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430
   Hokanson JE, 2004, AM J ROENTGENOL, V182, P1327, DOI 10.2214/ajr.182.5.1821327
   Isgum I, 2010, SPIE MEDIMAG, V7624
   Isgum I, 2012, IEEE T MED IMAGING, V31, P2322, DOI 10.1109/TMI.2012.2216889
   Jacobs PC, 2012, AM J ROENTGENOL, V198, P505, DOI 10.2214/AJR.10.5577
   Jacobs PCA, 2010, AM J ROENTGENOL, V194, P1244, DOI 10.2214/AJR.09.3047
   Kim SM, 2008, AM J ROENTGENOL, V190, P917, DOI 10.2214/AJR.07.2979
   Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liu YC, 2013, BIOMED RES INT, DOI 10.1155/2013/472347
   Ma SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012036
   McEvoy John W, 2012, Curr Treat Options Cardiovasc Med, V14, P69, DOI 10.1007/s11936-011-0154-5
   Mets OM, 2013, JACC CARDIOVASC IMAG
   Mets OM, 2013, JACC-CARDIOVASC IMAG, V6, P899, DOI 10.1016/j.jcmg.2013.02.008
   Mets OM, 2012, JAMA-J AM MED ASSOC, V308, P1433, DOI 10.1001/jama.2012.12656
   Nasir K, 2012, CIRC-CARDIOVASC IMAG, V5, P467, DOI 10.1161/CIRCIMAGING.111.964528
   Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461
   Rumberger JA, 1999, MAYO CLIN PROC, V74, P243, DOI 10.4065/74.3.243
   Rutten A, 2011, EUR J RADIOL, V80, P83, DOI 10.1016/j.ejrad.2010.06.009
   Schmermund A, 2011, LANCET, V378, P641, DOI 10.1016/S0140-6736(11)61129-X
   Sevrukov AB, 2005, AM J ROENTGENOL, V185, P1546, DOI 10.2214/AJR.04.1589
   Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006
   Shemesh J, 2006, CLIN IMAG, V30, P181, DOI 10.1016/j.clinimag.2005.11.002
   van den Bergh KAM, 2010, BRIT J CANCER, V102, P27, DOI 10.1038/sj.bjc.6605459
   Wender R, 2013, CA-CANCER J CLIN, V63, P107, DOI 10.3322/caac.21172
   Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175
   Winkelmann BR, 2009, BIOMARK MED, V3, P617, DOI [10.2217/BMM.09.51, 10.2217/bmm.09.51]
   Wu MT, 2008, AM J ROENTGENOL, V190, P923, DOI 10.2214/AJR.07.2974
   Xie X, 2013, VALIDAITON PROGNOSIS
   Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624
NR 37
TC 21
Z9 21
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 13
PY 2014
VL 9
IS 3
AR e91239
DI 10.1371/journal.pone.0091239
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AC9JS
UT WOS:000332851300068
PM 24625525
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Brons, S
   van Beusichem, ME
   Bronkhorst, EM
   Draaisma, JM
   Berge, SJ
   Schols, JG
   Kuijpers-Jagtman, AM
AF Brons, Sander
   van Beusichem, Machteld E.
   Bronkhorst, Ewald M.
   Draaisma, Jos M.
   Berge, Stefaan J.
   Schols, Jan G.
   Kuijpers-Jagtman, Anne Marie
TI Methods to Quantify Soft Tissue-Based Cranial Growth and Treatment
   Outcomes in Children: A Systematic Review
SO PLOS ONE
LA English
DT Review
ID LOW-BIRTH-WEIGHT; RANDOMIZED CONTROLLED-TRIAL; MOLDING HELMET THERAPY;
   EARLY HEAD GROWTH; LONG-TERM GROWTH; CATCH-UP GROWTH; 1ST 2 YEARS;
   PRETERM INFANTS; FOLLOW-UP; PREMATURE-INFANTS
AB Context: Longitudinal assessment of cranial dimensions of growing children provides healthcare professionals with information about normal and deviating growth as well as treatment outcome.
   Objective: To give an overview of soft tissue-based methods for quantitative longitudinal assessment of cranial dimensions in children until age 6 years and to assess the reliability of these methods in studies with good methodological quality.
   Data source: PubMed, EMBASE, Cochrane Library, Web of Science, Scopus, and CINAHL were searched. A manual search was performed to check for additional relevant studies.
   Study selection: Primary publications on facial growth and treatment outcomes in children younger than age 6 years were included.
   Data extraction: Independent data extraction was performed by two observers. A quality assessment instrument was used to determine methodological quality. Methods used in studies with good methodological quality were assessed for reliability expressed as the magnitude of the measurement error and the correlation coefficient between repeated measurements.
   Results: In total, 165 studies were included, forming three groups of methods: head circumference anthropometry, direct anthropometry, and 2D photography and 3D imaging techniques (surface laser scanning and stereophotogrammetry). In general, the measurement error was below 2 mm, and correlation coefficients were very good.
   Conclusion: Various methods for measuring cranial dimensions have shown to be reliable. Stereophotogrammetry is the most versatile method for quantitative longitudinal assessment of cranial dimensions and shapes in children. However, direct anthropometry continues to be the best method for routine clinical assessments of linear cranial dimensions in growing children until age 6 years.
C1 [Brons, Sander; van Beusichem, Machteld E.; Schols, Jan G.; Kuijpers-Jagtman, Anne Marie] Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands.
   [Bronkhorst, Ewald M.] Radboud Univ Nijmegen, Med Ctr, Dept Prevent & Curat Dent, NL-6525 ED Nijmegen, Netherlands.
   [Draaisma, Jos M.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6525 ED Nijmegen, Netherlands.
   [Berge, Stefaan J.] Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands.
RP Brons, S (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands.
EM orthodontics@dent.umcn.nl
RI Bronkhorst, Ewald M/L-4230-2015; Berge, S.J./H-8011-2014; Brons,
   Sander/I-2714-2018; Kuijpers-Jagtman, Anne Marie/A-9413-2008; Schols,
   J.G.J.H./L-4635-2015; Draaisma, J.M.T./L-4283-2015
OI Brons, Sander/0000-0001-5263-4804; Kuijpers-Jagtman, Anne
   Marie/0000-0001-8172-0090; Bronkhorst, Ewald/0000-0003-0953-8053;
   Draaisma, Jos/0000-0003-4829-6173
FU Dutch Technology Foundation [10315]
FX This work was supported by a grant from the Dutch Technology Foundation
   to STW (grant number 10315). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Agrawal D, 2006, J NEUROSURG, V105, P357, DOI 10.3171/ped.2006.105.5.357
   Aldridge K, 2005, AM J MED GENET A, V138A, P247, DOI 10.1002/ajmg.a.30959
   Ayoub A, 2003, CLEFT PALATE-CRAN J, V40, P523, DOI 10.1597/02-067
   Bartzela TN, 2011, INT J ORAL IN PRESS
   Belfort MB, 2011, PEDIATRICS, V128, pE899, DOI 10.1542/peds.2011-0282
   Bendersky M, 1998, CLIN PEDIATR, V37, P469, DOI 10.1177/000992289803700802
   Berry MA, 1997, PEDIATRICS, V100, P647, DOI 10.1542/peds.100.4.647
   Bhalla A K, 1993, Indian Pediatr, V30, P41
   Binns HJ, 1996, ARCH PEDIAT ADOL MED, V150, P842, DOI 10.1001/archpedi.1996.02170330068012
   Boluyt N, 2008, ARCH PEDIAT ADOL MED, V162, P111, DOI 10.1001/archpediatrics.2007.40
   Boros CA, 2007, ARTHRIT RHEUM-ARTHR, V57, P261, DOI 10.1002/art.22543
   Bouthoorn SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039798
   Bracewell MA, 2008, ARCH DIS CHILD-FETAL, V93, pF108, DOI 10.1136/adc.2007.118596
   Broadbent BH, 1931, ANGLE ORTHOD, V1, P45, DOI DOI 10.1043/0003-3219(1931)001<0045:ANXTAI>2.0.CO;2
   Brons S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041898
   Butz AM, 2005, J CHILD ADOLES SUBST, V14, P15, DOI 10.1300/J029vl4n04_02
   Cardoso LE, 2007, NUTR HOSP, P22322
   Carlson SE, 1996, AM J CLIN NUTR, V63, P687
   Cevidanes LH, 2011, ORAL SURG O IN PRESS
   Chan FC, 2013, J CRANIOFAC SURG, V24, P416, DOI 10.1097/SCS.0b013e31827ff296
   Chatterjee JS, 2009, J PLAST RECONSTR AES, V62, P211, DOI 10.1016/j.bjps.2007.10.042
   Chaudhari S, 2012, INDIAN PEDIATR, V49, P727, DOI 10.1007/s13312-012-0165-7
   Clark HD, 1999, CONTROL CLIN TRIALS, V20, P448, DOI 10.1016/S0197-2456(99)00026-4
   Collett BR, 2012, J PEDIATR-US, V160, P673, DOI 10.1016/j.jpeds.2011.09.059
   Davis JP, 2010, FORENSIC SCI INT, V200, P165, DOI 10.1016/j.forsciint.2010.04.012
   de Bruin NC, 1998, AM J CLIN NUTR, P67885
   deRegnier RAO, 1996, J NUTR, V126, P168
   Desmyttere S, 2009, EARLY HUM DEV, V85, P755, DOI 10.1016/j.earlhumdev.2009.10.003
   Desmyttere S, 2009, HUM REPROD, V24, P470, DOI 10.1093/humrep/den402
   Djordjevic J, 2011, EUR J ORTHOD
   Donma MM, 1997, BRAIN DEV-JPN, V19, P393, DOI 10.1016/S0387-7604(97)00041-7
   DSOUZA SW, 1986, ARCH DIS CHILD, V61, P1090, DOI 10.1136/adc.61.11.1090
   Durmus B, 2011, AM J CLIN NUTR, V94, P164, DOI 10.3945/ajcn.110.009225
   Ekblad M, 2010, J PEDIATR-US, V156, P185, DOI 10.1016/j.jpeds.2009.07.061
   Elwood PC, 1987, ANN HUM BIOL, P14543
   Erasmus HD, 2002, J PEDIATR-US, V141, P532, DOI 10.1067/mpd.2002.127499
   Eregie CO, 2001, J TROP PEDIATRICS, V47, P329, DOI 10.1093/tropej/47.6.329
   ERNST JA, 1990, J PEDIATR-US, V117, pS156, DOI 10.1016/S0022-3476(05)80014-9
   FARKAS LG, 1980, PLAST RECONSTR SURG, V66, P346, DOI 10.1097/00006534-198066030-00004
   Farkas LG, 1994, ANTHROPOMETRY HEAD F
   Farooqi A, 2006, PEDIATRICS, V118, pE1452, DOI 10.1542/peds.2006-1069
   Fearon JA, 2006, PLAST RECONSTR SURG, V117, P532, DOI 10.1097/01.prs.0000200774.31311.09
   Fearon JA, 2009, PLAST RECONSTR SURG, V123, P635, DOI 10.1097/PRS.0b013e318195661a
   FORD G, 1986, EARLY HUM DEV, V13, P329, DOI 10.1016/0378-3782(86)90068-X
   Ford GW, 2000, ARCH PEDIAT ADOL MED, V154, P778, DOI 10.1001/archpedi.154.8.778
   FRIEL JK, 1993, J PEDIATR GASTR NUTR, V17, P97, DOI 10.1097/00005176-199307000-00015
   Fukumoto A, 2008, J AUTISM DEV DISORD, V38, P411, DOI 10.1007/s10803-007-0405-1
   Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629
   Gale CR, 2004, BRAIN, V127, P321, DOI 10.1093/brain/awh034
   GEORGIEFF MK, 1985, J PEDIATR-US, V107, P581, DOI 10.1016/S0022-3476(85)80028-7
   GEORGIEFF MK, 1989, J PEDIATR-US, V114, P288, DOI 10.1016/S0022-3476(89)80799-1
   Gordon JM, 2009, ANGLE ORTHOD, V79, P1000, DOI 10.2319/082108-441.1
   GROSS SJ, 1983, J PEDIATR-US, V103, P946, DOI 10.1016/S0022-3476(83)80727-6
   GROSS SJ, 1983, PEDIATRICS, V71, P70
   GUO S, 1988, J PEDIATR-US, V113, P490, DOI 10.1016/S0022-3476(88)80634-6
   HAGELBERG S, 1990, ACTA PAEDIATR SCAND, V79, P1163
   Hansen-Pupp I, 2011, PEDIATR RES, V69, P448, DOI 10.1203/PDR.0b013e3182115000
   Herrmann KR, 2010, NUTR CLIN PRACT, V25, P69, DOI 10.1177/0884533609359001
   Hutchison BL, 2011, ARCH DIS CHILD, V96, P85, DOI 10.1136/adc.2010.190934
   Hutchison BL, 2010, ACTA PAEDIATR, V99, P1556, DOI 10.1111/j.1651-2227.2010.01872.x
   Hutchison BL, 2004, PEDIATRICS, V114, P970, DOI 10.1542/peds.2003-0668-F
   ISHIKAWA T, 1987, ACTA PAEDIATR SCAND, V76, P824, DOI 10.1111/j.1651-2227.1987.tb10571.x
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   JAFFE M, 1992, PEDIATRICS, V90, P190
   Jaldin Maria da Graa M, 2011, Rev. paul. pediatr., V29, P509, DOI 10.1590/S0103-05822011000400007
   Jaruratanasirikul Somchit, 1999, Journal of the Medical Association of Thailand, V82, P325
   Kan E, 2008, EARLY HUM DEV, V84, P409, DOI 10.1016/j.earlhumdev.2007.11.002
   Karatza AA, 2003, CLIN PEDIATR, V42, P533, DOI 10.1177/000992280304200608
   Kau CH, 2011, AM J ORTHOD DENTOFAC, V139, pE285, DOI 10.1016/j.ajodo.2009.03.054
   Kiran PSS, 2007, INDIAN J PEDIATR, V74, P463, DOI 10.1007/s12098-007-0079-x
   Kitchen WH, 1992, AM J DIS CHILD, P14646
   Koo WWK, 2006, AM J CLIN NUTR, V84, P1357
   Lagravere MO, 2005, ANGLE ORTHOD, V75, P1046
   Lainhart JE, 1997, J AM ACAD CHILD PSY, V36, P282, DOI 10.1097/00004583-199702000-00019
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lasekan JB, 2006, J AM COLL NUTR, V25, P12, DOI 10.1080/07315724.2006.10719509
   Lasekan JB, 2011, CLIN PEDIATR, V50, P330, DOI 10.1177/0009922810390511
   Lee RP, 2008, CLEFT PALATE-CRAN J, V45, P240, DOI 10.1597/06-210.1
   Lee WT, 2006, J CRANIOFAC SURG, V17, P139, DOI 10.1097/01.scs.0000195375.24754.38
   Lipira AB, 2010, PEDIATRICS, V126, pE936, DOI 10.1542/peds.2009-1249
   Lira PIC, 2010, DEV MED CHILD NEUROL, V52, P40, DOI 10.1111/j.1469-8749.2009.03353.x
   Littlefield TR, 1998, J CRANIOFAC SURG, V9, P11, DOI 10.1097/00001665-199801000-00004
   Lucas A, 2001, PEDIATRICS, V108, P703, DOI 10.1542/peds.108.3.703
   Maal TJJ, 2010, J ORAL MAXIL SURG, V68, P2391, DOI 10.1016/j.joms.2009.10.017
   Maguire CM, 2008, PEDIATRICS, V121, pE239, DOI 10.1542/peds.2007-1189
   Makrides M, 2000, AM J CLIN NUTR, V71, P120
   Makrides M, 1999, PEDIATRICS, V104, P468, DOI 10.1542/peds.104.3.468
   Mamabolo RL, 2004, NUTRITION, V20, P327, DOI 10.1016/j.nut.2003.11.011
   MARKS KH, 1979, J PEDIATR-US, V94, P282, DOI 10.1016/S0022-3476(79)80844-6
   Masarei AG, 2007, CLEFT PALATE-CRAN J, V44, P182, DOI 10.1597/05-184.1
   Mathur NB, 2009, INDIAN J PEDIATR, V76, P1003, DOI 10.1007/s12098-009-0204-0
   McCowan L, 1999, EARLY HUM DEV, V56, P205, DOI 10.1016/S0378-3782(99)00044-4
   McGarry A, 2008, DEV MED CHILD NEUROL, V50, P568, DOI 10.1111/j.1469-8749.2008.03017.x
   McLeod G, 2011, J PAEDIATR CHILD H, V47, P127, DOI 10.1111/j.1440-1754.2010.01900.x
   Mercuri E, 2000, PEDIATRICS, V106, P235, DOI 10.1542/peds.106.2.235
   Meyer-Marcotty P, 2012, J OROFAC ORTHOP, V73, P151, DOI 10.1007/s00056-011-0070-z
   MOORE WMO, 1995, EARLY HUM DEV, V42, P111, DOI 10.1016/0378-3782(95)01643-H
   Morhardt DR, 2013, J CHILD NEUROL
   Moye J, 1996, J PEDIATR-US, V128, P58, DOI 10.1016/S0022-3476(96)70428-6
   Mulliken JB, 1999, PLAST RECONSTR SURG, V103, P371, DOI 10.1097/00006534-199902000-00003
   Nada RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016520
   Nelson KG, 1997, ACTA OBSTET GYN SCAN, V76, P87
   Nollet PJPM, 2008, INT J ORAL MAX SURG, V37, P123, DOI 10.1016/j.ijom.2007.09.168
   Ochiai M, 2008, J PERINAT MED, V36, P341, DOI 10.1515/JPM.2008.042
   Olivan G, 2003, CHILD ABUSE NEGLECT, V27, P103, DOI 10.1016/S0145-2134(02)00513-6
   Oliveira MG, 2008, J TROP PEDIATRICS, V54, P36, DOI 10.1093/tropej/fmm103
   Padilla N, 2010, ACTA PAEDIAT
   Paul B, 2008, Indian J Public Health, V52, P16
   Pedroso SF, 2008, J CHILD NEUROL, V23, P1419
   Peng YM, 2005, ACTA PAEDIATR, V94, P843, DOI 10.1080/08035250510027589
   Piemontese P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028010
   Plank LH, 2006, J CRANIOFAC SURG, V17, P1084, DOI 10.1097/01.scs.0000244920.07383.85
   Polberger S, 1999, J PEDIATR GASTR NUTR, V29, P332, DOI 10.1097/00005176-199909000-00017
   Rijken M, 2007, EARLY HUM DEV, V83, P527, DOI 10.1016/j.earlhumdev.2006.10.002
   Roberfroid D, 2012, AM J CLIN NUTR, V95, P916, DOI 10.3945/ajcn.111.029033
   Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150
   ROCHE AF, 1987, PEDIATRICS, V79, P706
   Rodriguez Garcia J, 2003, An Pediatr (Barc), V58, P241
   Rollins JD, 2010, J PEDIATR-US, V156, P907, DOI 10.1016/j.jpeds.2010.01.009
   Ross GS, 2012, EARLY HUM DEV, V88, P753, DOI 10.1016/j.earlhumdev.2012.04.001
   Rothenberg SJ, 1999, NEUROTOXICOL TERATOL, V21, P1, DOI 10.1016/S0892-0362(98)00034-8
   SALIBA E, 1990, ARCH DIS CHILD, V65, P1029, DOI 10.1136/adc.65.10_Spec_No.1029
   Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018
   Sawada A, 2010, PEDIATR INT, V52, P343, DOI 10.1111/j.1442-200X.2009.03002.x
   Schaaf H, 2010, J CRANIOFAC SURG, V21, P1677, DOI 10.1097/SCS.0b013e3181f3c630
   SCHAEFER F, 1994, ACTA PAEDIATR, V83, P534, DOI 10.1111/j.1651-2227.1994.tb13075.x
   Sharma PK, 2011, INDIAN J PEDIATR, V78, P1485, DOI 10.1007/s12098-011-0442-9
   Shaw WC, 1999, CLEFT PALATE-CRAN J, V36, P262, DOI 10.1597/1545-1569(1999)036<0262:AFIMRF>2.3.CO;2
   SHETH RD, 1995, ARCH PEDIAT ADOL MED, V149, P1358, DOI 10.1001/archpedi.1995.02170250064011
   Shortland GJ, 1998, ARCH DIS CHILD, V78, pF185, DOI 10.1136/fn.78.3.F185
   Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z
   Swennen GRJ, 2004, J CRANIOFAC SURG, V15, P399, DOI 10.1097/00001665-200405000-00010
   Tan M, 2008, ARCH DIS CHILD-FETAL, V93, pF342, DOI 10.1136/adc.2007.124255
   Teichgraeber JF, 2004, J CRANIOFAC SURG, V15, P118, DOI 10.1097/00001665-200401000-00031
   Teichgraeber JF, 2002, CLEFT PALATE-CRAN J, V39, P582, DOI 10.1597/1545-1569(2002)039<0582:DPPDAT>2.0.CO;2
   Tinoco SMB, 2009, LIPIDS HLTH DIS, V8
   Toma AM, 2008, ORTHOD CRANIOFAC RES, V11, P180, DOI 10.1111/j.1601-6343.2008.00428.x
   Toma R, 2010, J CRANIOFAC SURG, V21, P637, DOI 10.1097/SCS.0b013e3181d841d9
   Touwslager RNH, 2008, HORM RES, V70, P273, DOI 10.1159/000157873
   Vaidya A, 2008, LANCET, V371, P492, DOI 10.1016/S0140-6736(08)60172-5
   van Daalen E, 2007, PEDIATR NEUROL, V37, P324, DOI 10.1016/j.pediatrneurol.2007.06.006
   van Loon B, 2011, RHINOLOGY, V49, P121, DOI 10.4193/Rhino10.056
   van Vlijmen OJC, 2012, J AM DENT ASSOC, V143, P241, DOI 10.14219/jada.archive.2012.0148
   van Vlimmeren LA, 2008, ARCH PEDIAT ADOL MED, V162, P712, DOI 10.1001/archpedi.162.8.712
   van Vlimmeren LA, 2007, PEDIATRICS, V119, pE408, DOI 10.1542/peds.2006-2012
   Whitehouse AJO, 2010, DEV MED CHILD NEUROL, V52, pE73, DOI 10.1111/j.1469-8749.2009.03546.x
   Wong JY, 2008, CLEFT PALATE-CRAN J, V45, P232, DOI [10.1597/06-175, 10.1597/06-175.1]
   Wood NS, 2003, ARCH DIS CHILD, V88, pF492, DOI 10.1136/fn.88.6.F492
   Zabaneh R, 2012, AM J PERINAT, V29, P203, DOI 10.1055/s-0031-1285094
NR 149
TC 5
Z9 5
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 27
PY 2014
VL 9
IS 2
AR e89602
DI 10.1371/journal.pone.0089602
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AC3BU
UT WOS:000332390800029
PM 24586904
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gupta, S
   Wilejto, M
   Pole, JD
   Guttmann, A
   Sung, LL
AF Gupta, Sumit
   Wilejto, Marta
   Pole, Jason D.
   Guttmann, Astrid
   Sung, Lillian
TI Low Socioeconomic Status Is Associated with Worse Survival in Children
   with Cancer: A Systematic Review
SO PLOS ONE
LA English
DT Review
ID ACUTE LYMPHOBLASTIC-LEUKEMIA; MINIMAL RESIDUAL DISEASE; CLINICAL-TRIALS;
   CHILDHOOD; ABANDONMENT; PREDICTORS; MORTALITY; HODGKINS; INEQUALITIES;
   PREVALENCE
AB Background: While low socioeconomic status (SES) has been associated with inferior cancer outcome among adults, its impact in pediatric oncology is unclear. Our objective was therefore to conduct a systematic review to determine the impact of SES upon outcome in children with cancer.
   Methods: We searched Ovid Medline, EMBASE and CINAHL from inception to December 2012. Studies for which survival-related outcomes were reported by socioeconomic subgroups were eligible for inclusion. Two reviewers independently assessed articles and extracted data. Given anticipated heterogeneity, no quantitative meta-analyses were planned a priori.
   Results: Of 7,737 publications, 527 in ten languages met criteria for full review; 36 studies met final inclusion criteria. In low-and middle-income countries (LMIC), lower SES was uniformly associated with inferior survival, regardless of the measure chosen. The majority of associations were statistically significant. Of 52 associations between socioeconomic variables and outcome among high-income country (HIC) children, 38 (73.1%) found low SES to be associated with worse survival, 15 of which were statistically significant. Of the remaining 14 (no association or high SES associated with worse survival), only one was statistically significant. Both HIC studies examining the effect of insurance found uninsured status to be statistically associated with inferior survival.
   Conclusions: Socioeconomic gradients in which low SES is associated with inferior childhood cancer survival are ubiquitous in LMIC and common in HIC. Future studies should elucidate mechanisms underlying these gradients, allowing the design of interventions mediating socioeconomic effects. Targeting the effect of low SES will allow for further improvements in childhood cancer survival.
C1 [Gupta, Sumit; Wilejto, Marta; Sung, Lillian] Hosp Sick Children, Div Haematol Oncol, Toronto, ON M5G 1X8, Canada.
   [Gupta, Sumit; Guttmann, Astrid; Sung, Lillian] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada.
   [Pole, Jason D.] Pediat Oncol Grp Ontario, Toronto, ON, Canada.
   [Pole, Jason D.; Guttmann, Astrid] Inst Clin & Evaluat Sci, Toronto, ON, Canada.
   [Guttmann, Astrid] Hosp Sick Children, Div Paediat Med, Toronto, ON M5G 1X8, Canada.
   [Gupta, Sumit; Wilejto, Marta; Sung, Lillian] Hosp Sick Children, Program Child Hlth Evaluat Sci, Toronto, ON M5G 1X8, Canada.
   [Gupta, Sumit; Guttmann, Astrid; Sung, Lillian] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
RP Gupta, S (reprint author), Hosp Sick Children, Div Haematol Oncol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
EM sumit.gupta@sickkids.ca
OI Gupta, Sumit/0000-0003-1334-3670
CR Bhatia S, 2002, BLOOD, V100, P1957, DOI 10.1182/blood-2002-02-0395
   Bhatia S, 2012, J CLIN ONCOL, V30, P2094, DOI 10.1200/JCO.2011.38.9924
   Birch JM, 2008, BRIT J CANCER, V99, P830, DOI 10.1038/sj.bjc.6604460
   Bonilla M, 2010, EUR J CANCER, V46, P3280, DOI 10.1016/j.ejca.2010.07.001
   Bonilla M, 2009, INT J CANCER, V125, P2144, DOI 10.1002/ijc.24534
   Borowitz MJ, 2008, BLOOD, V111, P5477, DOI 10.1182/blood-2008-01-132837
   Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879
   Carlos LL, 2002, MED PEDIATR ONCOL, V38, P211, DOI 10.1002/mpo.1314
   Charalampopoulou A, 2004, EUR J CANCER PREV, V13, P397, DOI 10.1097/00008469-200410000-00007
   Chen IM, 2012, BLOOD, V119, P3512, DOI 10.1182/blood-2011-11-394221
   Croucher C, 2009, CLIN ONCOL-UK, V21, P417, DOI 10.1016/j.clon.2009.02.006
   Dinand V, 2007, EUR J CANCER, V43, P161, DOI 10.1016/j.ejca.2006.08.036
   Drotar D, 2004, ETHICS BEHAV, V14, P1, DOI 10.1207/s15327019eb1401_1
   Frederiksen BL, 2009, EUR J CANCER, V45, P1248, DOI 10.1016/j.ejca.2008.11.035
   Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001
   Gupta S, 2009, BRIT J CANCER, V100, P1026, DOI 10.1038/sj.bjc.6604895
   Harvey RC, 2010, BLOOD, V115, P5312, DOI 10.1182/blood-2009-09-245944
   Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010
   Hord MH, 1996, CANCER-AM CANCER SOC, V77, P563
   Hsieh MH, 2009, J PEDIAT HEMATOL ONC, V31, P942, DOI 10.1097/MPH.0b013e3181bcc809
   Kent EE, 2009, CANCER CAUSE CONTROL, V20, P1409, DOI 10.1007/s10552-009-9367-2
   Kulkarni KP, 2010, ASIAN PAC J CANCER P, V11, P1435
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lightfoot TJ, 2012, EUR J CANCER, V48, P263, DOI 10.1016/j.ejca.2011.10.007
   Luo ZC, 2006, CAN MED ASSOC J, V174, P1415, DOI 10.1503/cmaj.051096
   Marmot MG, 2003, PERSPECT BIOL MED, V46, pS9, DOI 10.1353/pbm.2003.0056
   MCWHIRTER WR, 1983, MED J AUSTRALIA, V2, P319
   Metzger ML, 2008, J CLIN ONCOL, V26, P1282, DOI 10.1200/JCO.2007.14.0699
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Mostert S, 2010, ARCH DIS CHILD, V95, P20, DOI 10.1136/adc.2008.154138
   Mostert S, 2006, PEDIATRICS, V118, pE1600, DOI 10.1542/ped.2005-3015
   Mostert S, 2011, LANCET ONCOL, V12, P719, DOI 10.1016/S1470-2045(11)70128-0
   Pedrosa MF, 2007, J PEDIAT-BRAZIL, V83, P547, DOI [10.2223/JPED.1726, 10.1590/S0021-75572007000800012]
   PETRIDOU E, 1994, ONCOLOGY, V51, P391
   Rabi DM, 2010, CIRC-CARDIOVASC QUAL, V3, P48, DOI 10.1161/CIRCOUTCOMES.108.840611
   Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15
   Rondelli R, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-44
   Schillinger JA, 1999, ARCH DIS CHILD, V80, P311, DOI 10.1136/adc.80.4.311
   Simon C, 2003, J CLIN ONCOL, V21, P2173, DOI 10.1200/JCO.2003.03.003
   Stiller CA, 2008, BRIT J CANCER, V98, P1006, DOI 10.1038/sj.bjc.6604237
   Syse A, 1870, INT J CANCER, V130, P1870
   SZKLO M, 1978, CANCER, V42, P59, DOI 10.1002/1097-0142(197807)42:1<59::AID-CNCR2820420109>3.0.CO;2-J
   Tang YM, 2008, PEDIATR BLOOD CANCER, V51, P380, DOI 10.1002/pbc.21629
   The World Bank, 2012, DAT SHORT HIST
   Viana MB, 1998, INT J CANCER, V78, P56, DOI 10.1002/(SICI)1097-0215(1998)78:11+<56::AID-IJC16>3.0.CO;2-X
   WALTERS TR, 1972, CANCER, V29, P210, DOI 10.1002/1097-0142(197201)29:1<210::AID-CNCR2820290131>3.0.CO;2-U
   Wang YR, 2011, LEUKEMIA RES, V35, P1628, DOI 10.1016/j.leukres.2011.07.004
   Woods LM, 2006, ANN ONCOL, V17, P5, DOI 10.1093/annonc/mdj007
   Youlden DR, 1649, CANCER EPIDEM BIOMAR, V20, P1649
NR 49
TC 29
Z9 29
U1 1
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 26
PY 2014
VL 9
IS 2
AR e89482
DI 10.1371/journal.pone.0089482
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AC3BC
UT WOS:000332389000048
PM 24586813
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Graff, I
   Goldschmidt, B
   Glien, P
   Bogdanow, M
   Fimmers, R
   Hoeft, A
   Kim, SC
   Grigutsch, D
AF Graeff, Ingo
   Goldschmidt, Bernd
   Glien, Procula
   Bogdanow, Manuela
   Fimmers, Rolf
   Hoeft, Andreas
   Kim, Se-Chan
   Grigutsch, Daniel
TI The German Version of the Manchester Triage System and Its Quality
   Criteria - First Assessment of Validity and Reliability
SO PLOS ONE
LA English
DT Article
ID EMERGENCY SEVERITY INDEX; OBSERVER AGREEMENT; SIMULATION; MORTALITY;
   ADMISSION
AB Background: The German Version of the Manchester Triage System (MTS) has found widespread use in EDs across Germans-peaking Europe. Studies about the quality criteria validity and reliability of the MTS currently only exist for the English-language version. Most importantly, the content of the German version differs from the English version with respect to presentation diagrams and change indicators, which have a significant impact on the category assigned. This investigation offers a preliminary assessment in terms of validity and inter-rater reliability of the German MTS.
   Methods: Construct validity of assigned MTS level was assessed based on comparisons to hospitalization (general / intensive care), mortality, ED and hospital length of stay, level of prehospital care and number of invasive diagnostics. A sample of 45,469 patients was used. Inter-rater agreement between an expert and triage nurses (reliability) was calculated separately for a subset group of 167 emergency patients.
   Results: For general hospital admission the area under the curve (AUC) of the receiver operating characteristic was 0.749; for admission to ICU it was 0.871. An examination of MTS-level and number o`f deceased patients showed that the higher the priority derived from MTS, the higher the number of deaths (p<0.0001 / chi(2) Test). There was a substantial difference in the 30-day survival among the 5 MTS categories (p<0.0001 / log-rank test). The AUC for the predict 30-day mortality was 0.613. Categories orange and red had the highest numbers of heart catheter and endoscopy. Category red and orange were mostly accompanied by an emergency physician, whereas categories blue and green were walk-in patients. Inter-rater agreement between expert triage nurses was almost perfect (kappa = 0.954).
   Conclusion: The German version of the MTS is a reliable and valid instrument for a first assessment of emergency patients in the emergency department.
C1 [Graeff, Ingo; Glien, Procula] Univ Bonn, Emergency Dept, Bonn, Germany.
   [Goldschmidt, Bernd] Univ Bonn, Bonn, Germany.
   [Bogdanow, Manuela; Fimmers, Rolf] Univ Bonn, Inst Med Biometry Informat & Epidemiol, German Ctr Neurodegenerat Dis, Bonn, Germany.
   [Hoeft, Andreas; Kim, Se-Chan; Grigutsch, Daniel] Univ Bonn, Dept Anesthesiol, Bonn, Germany.
RP Graff, I (reprint author), Univ Bonn, Emergency Dept, Bonn, Germany.
EM info@medingo.de
OI Kim, Se-Chan/0000-0003-3456-5440
CR Australasian College for Emergency Medicine, 2002, Emerg Med (Fremantle), V14, P335
   Bey TA, 2008, INT J EMERG MED, V1, P273, DOI 10.1007/s12245-008-0076-5
   Christ M, 2010, DTSCH ARZTEBL INT, V107, P892, DOI 10.3238/arztebl.2010.0892
   Cooke MW, 1999, J ACCID EMERG MED, V16, P179
   Fernandes CMB, 2005, J EMERG NURS, V31, P39, DOI 10.1016/j.jen.2004.11.002
   Graff I, 2011, NOTFALL RETTUNGSMED, V14, P202, DOI 10.1007/s10049-010-1286-y
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mackway-Jones K, 2006, ERSTEINSCHATZUNG NOT
   Martins HMG, 2009, EMERG MED J, V26, P183, DOI 10.1136/emj.2008.060780
   Murray Michael, 2004, CJEM, V6, P421
   Pinto D, 2012, REV LAT-AM ENFERM, V20, P1041, DOI 10.1590/S0104-11692012000600005
   Schopke T, 2011, NOTFALL RETTUNGSMED, V14, P371, DOI 10.1007/s10049-011-1435-y
   Sieber R, 2008, ANN EMERG MED, V51, P531, DOI 10.1016/j.annemergmed.2008.01.168
   Storm-Versloot MN, 2009, EMERG MED J, V26, P556, DOI 10.1136/emj.2008.059378
   Storm-Versloot MN, 2011, ACAD EMERG MED, V18, P822, DOI 10.1111/j.1553-2712.2011.01122.x
   van der Wulp I, 2008, EMERG MED J, V25, P431, DOI 10.1136/emj.2007.055228
   van der Wulp I, 2009, EMERG MED J, V26, P506, DOI 10.1136/emj.2008.063768
NR 17
TC 28
Z9 29
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 24
PY 2014
VL 9
IS 2
AR e88995
DI 10.1371/journal.pone.0088995
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AB6EP
UT WOS:000331880700017
PM 24586477
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wolfe, F
   Walitt, BT
   Katz, RS
   Hauser, W
AF Wolfe, Frederick
   Walitt, Brian T.
   Katz, Robert S.
   Haeuser, Winfried
TI Symptoms, the Nature of Fibromyalgia, and Diagnostic and Statistical
   Manual 5 (DSM-5) Defined Mental Illness in Patients with Rheumatoid
   Arthritis and Fibromyalgia
SO PLOS ONE
LA English
DT Article
ID FUNCTIONAL SOMATIC SYNDROMES; HEALTH SURVEY SF-36; SOMATOFORM DISORDERS;
   PRIMARY-CARE; UNITED-STATES; FIELD TRIALS; SOMATIZATION; CRITERIA;
   CLASSIFICATION; RELIABILITY
AB Purpose: To describe and evaluate somatic symptoms in patients with rheumatoid arthritis (RA) and fibromyalgia, determine the relation between somatization syndromes and fibromyalgia, and evaluate symptom data in light of the Diagnostic and Statistical Manual-5 (DSM-5) criteria for somatic symptom disorder.
   Methods: We administered the Patient Health Questionnaire-15 (PHQ-15), a measure of somatic symptom severity to 6,233 persons with fibromyalgia, RA, and osteoarthritis. PHQ-15 scores of 5, 10, and 15 represent low, medium, and high somatic symptom severity cut-points. A likely somatization syndrome was diagnosed when PHQ-15 score was >= 10. The intensity of fibromyalgia diagnostic symptoms was measured by the polysymptomatic distress (PSD) scale.
   Results: 26.4% of RA patients and 88.9% with fibromyalgia had PHQ-15 scores >= 10 compared with 9.3% in the general population. With each step-wise increase in PHQ-15 category, more abnormal mental and physical health status scores were observed. RA patients satisfying fibromyalgia criteria increased from 1.2% in the PHQ-15 low category to 88.9% in the high category. The sensitivity and specificity of PHQ-15 >= 10 for fibromyalgia diagnosis was 80.9% and 80.0% (correctly classified = 80.3%) compared with 84.3% and 93.7% (correctly classified = 91.7%) for the PSD scale. 51.4% of fibromyalgia patients and 14.8% with RA had fatigue, sleep or cognitive problems that were severe, continuous, and life-disturbing; and almost all fibromyalgia patients had severe impairments of function and quality of life.
   Conclusions: All patients with fibromyalgia will satisfy the DSM-5 "A'' criterion for distressing somatic symptoms, and most would seem to satisfy DSM-5 "B'' criterion because symptom impact is life-disturbing or associated with substantial impairment of function and quality of life. But the "B'' designation requires special knowledge that symptoms are "disproportionate'' or "excessive,'' something that is uncertain and controversial. The reliability and validity of DSM-5 criteria in this population is likely to be low.
C1 [Wolfe, Frederick] Natl Data Bank Rheumat Dis, Wichita, KS 67214 USA.
   [Wolfe, Frederick] Univ Kansas, Sch Med, Wichita, KS 67214 USA.
   [Walitt, Brian T.] Washington Hosp Ctr, Washington, DC 20010 USA.
   [Katz, Robert S.] Rush Univ, Med Ctr, Chicago, IL 60612 USA.
   [Haeuser, Winfried] Tech Univ Munich, Dept Psychosomat Med & Psychotherapy, D-80290 Munich, Germany.
   [Haeuser, Winfried] Klinikum Saarbrucken, Dept Internal Med 1, Saarbrucken, Germany.
RP Wolfe, F (reprint author), Natl Data Bank Rheumat Dis, Wichita, KS 67214 USA.
EM fwolfe@arthritis-research.org
OI Hauser, Winfried/0000-0002-3742-729X
CR American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Association AP, 1980, DIAGN STAT MAN MENT
   Barker KK, 2005, FIBROMYALGIA STORY M
   Barker KK, 2011, SOCIAL SCI MED
   Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016
   Clarke DE, 2013, AM J PSYCHIAT, V170, P43, DOI 10.1176/appi.ajp.2012.12070998
   Creed FH, 2012, J PSYCHOSOMATIC RES
   Crombez G, 2009, PAIN, V145, P31, DOI 10.1016/j.pain.2009.04.006
   Dimsdale JE, 2013, J PSYCHOSOMATIC RES
   Fink P, 2005, PSYCHOSOMATICS, V46, P540, DOI 10.1176/appi.psy.46.6.540
   Fink P, 1999, PSYCHOSOMATICS, V40, P330, DOI 10.1016/S0033-3182(99)71228-4
   Fink P, 2010, J PSYCHOSOM RES, V68, P415, DOI 10.1016/j.jpsychores.2010.02.004
   Frances A, 2013, AUST NZ J PSYCHIAT, V47, P483, DOI 10.1177/0004867413484525
   Frances A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1580
   FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202
   Gervais RO, 2001, J RHEUMATOL, V28, P1892
   Grabe HJ, 2003, PSYCHOSOMATICS, V44, P304, DOI 10.1176/appi.psy.44.4.304
   Gross M, 2013, CURR BIOL, V23, pR295, DOI 10.1016/j.cub.2013.04.009
   HIDDING A, 1994, J RHEUMATOL, V21, P818
   Houtveen JH, 2003, J PSYCHOSOM RES, V55, P481, DOI 10.1016/S0022-3999(03)00011-4
   Kocalevent RD, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-91
   Korber S, 2011, J PSYCHOSOM RES, V71, P142, DOI 10.1016/j.jpsychores.2011.01.006
   Kroenke K, 2006, J PSYCHOSOM RES, V60, P335, DOI 10.1016/j.jpsychores.2006.01.022
   Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008
   Kroenke K, 2007, PSYCHIAT CLIN N AM, V30, P593, DOI 10.1016/j.psc.2007.08.002
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leeb BF, 2004, RHEUMATOLOGY, V43, P1504, DOI 10.1093/rheumatology/keh322
   LIPOWSKI ZJ, 1988, AM J PSYCHIAT, V145, P1358
   MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004
   Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379
   Obradovic M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-110
   Regier DA, 2013, AM J PSYCHIAT, V170, P59, DOI 10.1176/appi.ajp.2012.12070999
   Sharpe M, 2001, ANN INTERN MED, V134, P926, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00018
   Speckens AEM, 1996, J PSYCHOSOM RES, V40, P95, DOI 10.1016/0022-3999(95)00561-7
   van Ravesteijn H, 2009, ANN FAM MED, V7, P232, DOI 10.1370/afm.985
   VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916
   Walitt B, 2011, J RHEUMATOLOGY
   Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X
   WARE JE, 1994, INT J MENT HEALTH, V23, P49, DOI 10.1080/00207411.1994.11449283
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2
   Wessely S, 2004, BRIT J PSYCHIAT, V185, P95, DOI 10.1192/bjp.185.2.95
   WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203
   Wolfe F, 2013, NATURE REV RHEUMATOL
   Wolfe F, 2013, ARTHRIT CARE RES, V65, P777, DOI 10.1002/acr.21931
   Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594
   Wolfe F, 2011, RHEUMATOLOGY, V50, P16, DOI 10.1093/rheumatology/keq155
   Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140
   Wolfe F, 2010, ARTHRIT CARE RES, V62, P583, DOI 10.1002/acr.20156
   YUNUS M, 1981, SEMIN ARTHRITIS RHEU, V11, P151, DOI 10.1016/0049-0172(81)90096-2
NR 52
TC 30
Z9 31
U1 0
U2 24
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 14
PY 2014
VL 9
IS 2
AR e88740
DI 10.1371/journal.pone.0088740
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AA7IR
UT WOS:000331271500061
PM 24551146
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Alvarez-Simon, D
   Cruz, MJ
   Untoria, MD
   Munoz, X
   Villalbi, JR
   Morell, F
   Gomez-Olles, S
AF Alvarez-Simon, Daniel
   Cruz, Maria-Jesus
   Untoria, Maria-Dolores
   Munoz, Xavier
   Villalbi, Joan R.
   Morell, Ferran
   Gomez-Olles, Susana
TI A Rapid Test for Soy Aeroallergens Exposure Assessment
SO PLOS ONE
LA English
DT Article
ID EPIDEMIC ASTHMA; SOYBEAN DUST; BARCELONA; OUTBREAKS; ALLERGENS; SPAIN
AB Background: Determining soy aeroallergens levels is extremely important in the assessment of health risks due to these airborne substances. Currently, soy aeroallergens exposure in the environment is monitored using enzyme immunoassays (EIA) which must be evaluated in a specialized laboratory by skilled personnel.
   Objective: To describe the development and performance of a rapid immunochromatography assay for the detection of soy aeroallergens in environmental samples.
   Methods: A test strip using gold labeled anti-soy hull low molecular weight extract (SHLMWE) antibody for the rapid detection of soy aeroallergens in environmental samples was developed. One hundred nineteen airborne samples were analysed in parallel by the strip assay and the anti-SHLMWE sandwich EIA. The assay results were visually analysed by three independent observers who ranked samples as: -, + or ++. Strips were also scanned and analysed by densitometry.
   Results: The rapid test detected a range of concentrations from 6.25 to 25 ng/mL. Agreement in strip assay interpretations between evaluators was substantial (Kappa = 0.63; CI 0.544-0.715). Visual interpretation also gave a good concordance with EIA results, with sensitivity ranging from 77.3 to 100 and specificity from 65 to 83.5 depending on the observer. Furthermore, a strong correlation was observed between densitometry results of strip assay and EIA determinations.
   Conclusions: The strip assay developed is rapid, simple, and sensitive and does not require expensive equipment or specific skills. It has considerable potential in the environmental monitoring field for screening soy aeroallergens levels in port cities where allergen measurements are not currently performed. Due to its simplicity, the test will improve the management of soy allergic patients by controlling environmental allergen exposure without the need for apparatus or skilled personnel.
C1 [Alvarez-Simon, Daniel; Cruz, Maria-Jesus; Untoria, Maria-Dolores; Munoz, Xavier; Morell, Ferran; Gomez-Olles, Susana] Hosp Univ Vall dHebron, Serv Neumol, Barcelona, Spain.
   [Alvarez-Simon, Daniel; Cruz, Maria-Jesus; Munoz, Xavier; Morell, Ferran; Gomez-Olles, Susana] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain.
   [Cruz, Maria-Jesus; Untoria, Maria-Dolores; Munoz, Xavier; Morell, Ferran; Gomez-Olles, Susana] CIBER Enfermedades Resp CIBERES, Barcelona, Spain.
   [Munoz, Xavier] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, E-08193 Barcelona, Spain.
   [Villalbi, Joan R.] Agencia Salut Publ Barcelona, Barcelona, Spain.
   [Villalbi, Joan R.] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Barcelona, Spain.
   [Villalbi, Joan R.] Inst Invest Biomed St Pau, Barcelona, Spain.
RP Cruz, MJ (reprint author), Hosp Univ Vall dHebron, Serv Neumol, Barcelona, Spain.
EM mj.cruz@vhir.org
RI Alvarez-Simon, Daniel/C-4901-2014; Cruz, Maria Jesus/I-9073-2014; Munoz,
   Xavier/I-9009-2014
OI Alvarez-Simon, Daniel/0000-0002-3464-0909; Cruz, Maria
   Jesus/0000-0001-9759-5466; Munoz, Xavier/0000-0002-8693-022X; Villalbi,
   Joan/0000-0001-6915-2545; Morell Brotad, Ferran/0000-0002-7206-4543
FU Beatriu de Pinos programme from El Comissionat per a Universitats i
   Recerca del Departament d'Innovacio, Universitats i Empresa, Generalitat
   de Catalunya; Miguel Servet programme from Instituto de Salud Carlos III
   [CP12/03101]
FX SGO is a postdoctoral fellow supported by the Beatriu de Pinos programme
   from El Comissionat per a Universitats i Recerca del Departament
   d'Innovacio, Universitats i Empresa, Generalitat de Catalunya. MJC is a
   researcher supported by the Miguel Servet programme from Instituto de
   Salud Carlos III (CP12/03101). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ANTO JM, 1993, NEW ENGL J MED, V329, P1760, DOI 10.1056/NEJM199312093292402
   ANTO JM, 1989, NEW ENGL J MED, V320, P1097, DOI 10.1056/NEJM198904273201701
   Ballester F, 1999, AM J EPIDEMIOL, V149, P315
   Bogdanovic J, 2006, J ALLERGY CLIN IMMUN, V118, P1157, DOI 10.1016/j.jaci.2006.07.004
   Cruz MJ, 2000, INT ARCH ALLERGY IMM, V122, P42, DOI 10.1159/000024357
   Cummings KJ, 2010, EUR RESPIR J, V36, P1007, DOI 10.1183/09031936.00151109
   FLEISS JL, 1979, PSYCHOL BULL, V86, P974, DOI 10.1037/0033-2909.86.5.974
   GarciaOrtega P, 1997, MED CLIN-BARCELONA, V108, P677
   Gillet P, 2009, MALAR J, V8
   Gomez-Olles S, 2006, CLIN EXP ALLERGY, V36, P1176, DOI 10.1111/j.1365-2222.2006.02542.x
   Harris-Roberts J, 2012, AM J IND MED, V55, P458, DOI 10.1002/ajim.22009
   Koets M, 2011, J ENVIRON MONITOR, V13, P3475, DOI 10.1039/c1em10658a
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   NAVARRO C, 1993, EPIDEMIOLOGY, V4, P76, DOI 10.1097/00001648-199301000-00014
   Rodrigo MJ, 2004, INT ARCH ALLERGY IMM, V134, P158, DOI 10.1159/000078649
   Tsay A., 2002, Clinical and Experimental Allergy, V32, P1596, DOI 10.1046/j.1365-2222.2002.01533.x
   Villalbi JR, 2011, GAC SANIT, V25, P542, DOI 10.1016/j.gaceta.2011.05.011
   Villalbi JR, 2004, J EPIDEMIOL COMMUN H, V58, P461, DOI 10.1136/jech.2003.009001
   White MC, 1997, AM J EPIDEMIOL, V145, P432
   ZUBELDIA JM, 1995, J ALLERGY CLIN IMMUN, V95, P622, DOI 10.1016/S0091-6749(95)70325-X
   ZUSKIN E, 1991, Arhiv za Higijenu Rada i Toksikologiju, V42, P267
NR 21
TC 0
Z9 0
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 12
PY 2014
VL 9
IS 2
AR e88676
DI 10.1371/journal.pone.0088676
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AA7FJ
UT WOS:000331262600092
PM 24533134
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Sun, ZH
   Fu, P
   Wei, K
   Zhang, HY
   Zhang, YW
   Xu, J
   Jiang, F
   Liu, X
   Xu, W
   Wu, WX
AF Sun, Zhenhong
   Fu, Ping
   Wei, Kai
   Zhang, Haiyan
   Zhang, Yuewei
   Xu, Jian
   Jiang, Fei
   Liu, Xu
   Xu, Wei
   Wu, Wenxue
TI Identification of Novel Immunogenic Proteins from Mycoplasma bovis and
   Establishment of an Indirect ELISA Based on Recombinant E1 Beta Subunit
   of the Pyruvate Dehydrogenase Complex
SO PLOS ONE
LA English
DT Article
ID VARIABLE SURFACE LIPOPROTEINS; ELONGATION-FACTOR TU;
   GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PROTEOME; INFECTIONS;
   GENITALIUM; PNEUMONIA; DIAGNOSIS; MASTITIS; GENES
AB The pathogen Mycoplasma bovis (M. bovis) is a major cause of respiratory disease, mastitis, and arthritis in cattle. Screening the key immunogenic proteins and updating rapid diagnostic techniques are necessary to the prevention and control of M. bovis infection. In this study, 19 highly immunogenic proteins from M. bovis strain PD were identified using 2-dimensional gel electrophoresis, immunoblotting and MALDI-TOF/TOF MS. Of these 19 proteins, pyruvate dehydrogenase E1 component beta subunit (PDHB) showed excellent immune reactivity and repeatability. PDHB was found to be conserved in different M. bovis isolates, as indicated by Western blot analysis. On the basis of these results, a rPDHB-based indirect ELISA (iELISA) was established for the detection of serum antibodies using prokaryotically expressed recombinant PDHB protein as the coating antigen. The specificity analysis result showed that rPDHB-based iELISA did not react with other pathogens assessed in our study except M. agalactiae (which infects sheep and goats). Moreover, 358 serum samples from several disease-affected cattle feedlots were tested using this iELISA system and a commercial kit, which gave positive rates of 50.8% and 39.9%, respectively. The estimated Kappa agreement coefficient between the two methods was 0.783. Notably, 39 positive serum samples that had been missed by the commercial kit were all found to be positive by Western blot analysis. The detection rate of rPDHB-based iELISA was significantly higher than that of the commercial kit at a serum dilution ratio of 1: 5120 to 1: 10,240 (P<0.05). Taken together, these results provide important information regarding the novel immunogenic proteins of M. bovis. The established rPDHB-based iELISA may be suitable for use as a new method of antibody detection in M. bovis.
C1 [Sun, Zhenhong; Fu, Ping; Wei, Kai; Zhang, Haiyan; Zhang, Yuewei; Xu, Jian; Jiang, Fei; Liu, Xu; Xu, Wei; Wu, Wenxue] China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Coll Vet Med, Beijing 100094, Peoples R China.
RP Wu, WX (reprint author), China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Coll Vet Med, Beijing 100094, Peoples R China.
EM wuwenxue@cau.edu.cn
FU Agricultural Finance Program, Ministry of Agriculture of China; New
   Century Excellent Talents in University of Ministry of Education of
   China
FX This work was supported by Agricultural Finance Program, Ministry of
   Agriculture of China and Program for New Century Excellent Talents in
   University of Ministry of Education of China. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alonso JMM, 2002, VET MICROBIOL, V89, P277, DOI 10.1016/S0378-1135(02)00258-4
   Alvarez RA, 2003, MOL MICROBIOL, V48, P1417, DOI 10.1046/j.1365-2958.2003.03518.x
   Bashiruddin JB, 2005, VET J, V169, P268, DOI 10.1016/j.tvjl.2004.01.018
   Caswell Jeff L., 2007, Animal Health Research Reviews, V8, P161, DOI 10.1017/S1466252307001351
   Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x
   Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031
   HALE HH, 1962, CORNELL VET, V52, P582
   Hou Xuan, 2012, Journal of Agricultural Biotechnology, V20, P218
   Jaffe JD, 2004, PROTEOMICS, V4, P59, DOI 10.1002/pmic.200300511
   Jores J, 2009, VET IMMUNOL IMMUNOP, V131, P238, DOI 10.1016/j.vetimm.2009.04.016
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lysnyansky I, 1996, J BACTERIOL, V178, P5395, DOI 10.1128/jb.178.18.5395-5401.1996
   Maunsell FP, 2011, J VET INTERN MED, V25, P772, DOI 10.1111/j.1939-1676.2011.0750.x
   Maunsell FP, 2009, VET CLIN N AM-FOOD A, V25, P139, DOI 10.1016/j.cvfa.2008.10.011
   Nicholas RAJ, 2003, RES VET SCI, V74, P105, DOI 10.1016/S0034-5288(02)00155-8
   Nussbaum S, 2002, INFECT IMMUN, V70, P2220, DOI 10.1128/IAI.70.4.2220-2225.2002
   Perez-Casal J, 2007, MICROB PATHOGENESIS, V43, P189, DOI 10.1016/j.micpath.2007.05.009
   Pfutzner H, 1996, REV SCI TECH OIE, V15, P1477, DOI 10.20506/rst.15.4.987
   Pinto PM, 2007, VET MICROBIOL, V121, P83, DOI 10.1016/j.vetmic.2006.11.018
   Prysliak T, 2013, MICROB PATHOGENESIS, V55, P1, DOI 10.1016/j.micpath.2012.12.001
   Regula JT, 2000, ELECTROPHORESIS, V21, P3765, DOI 10.1002/1522-2683(200011)21:17<3765::AID-ELPS3765>3.0.CO;2-6
   Robino P, 2005, VET MICROBIOL, V109, P201, DOI 10.1016/j.vetmic.2005.05.007
   SACHSE K, 1993, VET MICROBIOL, V36, P307, DOI 10.1016/0378-1135(93)90097-Q
   Scherm B, 2002, VET MICROBIOL, V89, P141, DOI 10.1016/S0378-1135(02)00158-X
   Soehnlen MK, 2011, VACCINE, V29, P5347, DOI 10.1016/j.vaccine.2011.05.092
   Su HC, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-63
   Sun XM, 2012, J PROTEOMICS, V77, P423, DOI 10.1016/j.jprot.2012.09.018
   Tenk M, 2006, ACTA VET HUNG, V54, P427, DOI 10.1556/AVet.54.2006.4.1
   Thomas A, 2005, RES MICROBIOL, V156, P713, DOI 10.1016/j.resmic.2005.02.008
   Tiwari S, 2013, CLIN VACCINE IMMUNOL, V20, P1217, DOI 10.1128/CVI.00111-13
   Tschopp R, 2001, SCHWEIZ ARCH TIERH, V143, P461
   Ueberle B, 2002, PROTEOMICS, V2, P754, DOI 10.1002/1615-9861(200206)2:6<754::AID-PROT754>3.0.CO;2-2
   Wasinger VC, 2000, EUR J BIOCHEM, V267, P1571, DOI 10.1046/j.1432-1327.2000.01183.x
   Webster KA, 1997, VET PARASITOL, V68, P155, DOI 10.1016/S0304-4017(96)01062-X
   [ XIN Jiuqing], 2008, [, Chinase Journal of Preventive Veterinary Medicine], V30, P661
   Yang YL, 2011, MOL IMMUNOL, V49, P175, DOI 10.1016/j.molimm.2011.08.009
   Zhao P, 2012, J VET MED SCI, V74, P1109, DOI 10.1292/jvms.12-0095
NR 37
TC 17
Z9 18
U1 0
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 10
PY 2014
VL 9
IS 2
AR e88328
DI 10.1371/journal.pone.0088328
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AA7CL
UT WOS:000331254600060
PM 24520369
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Finitsis, DJ
   Pellowski, JA
   Johnson, BT
AF Finitsis, David J.
   Pellowski, Jennifer A.
   Johnson, Blair T.
TI Text Message Intervention Designs to Promote Adherence to Antiretroviral
   Therapy (ART): A Meta-Analysis of Randomized Controlled Trials
SO PLOS ONE
LA English
DT Article
ID INHIBITOR THERAPY; SELF-REPORT; OUTCOMES; NONADHERENCE; FEASIBILITY;
   SUPPRESSION; REMINDERS; SUPPORT; QUALITY; SYSTEM
AB Background: The efficacy of antiretroviral therapy depends on patient adherence to a daily medication regimen, yet many patients fail to adhere at high enough rates to maintain health and reduce the risk of transmitting HIV. Given the explosive global growth of cellular-mobile phone use, text-messaging interventions to promote adherence are especially appropriate. This meta-analysis synthesized available text messaging interventions to promote antiretroviral therapy adherence in people living with HIV.
   Methods: We performed Boolean searches of electronic databases, hand searches of recent year conference abstracts and reverse searches. Included studies (1) targeted antiretroviral therapy adherence in a sample of people living with HIV, (2) used a randomized-controlled trial design to examine a text messaging intervention, and (3) reported at least one adherence measurement or clinical outcome.
   Results: Eight studies, including 9 interventions, met inclusion criteria. Text-messaging interventions yielded significantly higher adherence than control conditions (OR = 1.39; 95% CI = 1.18, 1.64). Sensitivity analyses of intervention characteristics suggested that studies had larger effects when interventions (1) were sent less frequently than daily, (2) supported bidirectional communication, (3) included personalized message content, and (4) were matched to participants' antiretroviral therapy dosing schedule. Interventions were also associated with improved viral load and/or CD4+ count (k = 3; OR = 1.56; 95% CI = 1.11, 2.20).
   Conclusions: Text-messaging can support antiretroviral therapy adherence. Researchers should consider the adoption of less frequent messaging interventions with content and timing that is individually tailored and designed to evoke a reply from the recipient. Future research is needed in order to determine how best to optimize efficacy.
C1 [Finitsis, David J.; Pellowski, Jennifer A.; Johnson, Blair T.] Univ Connecticut, Ctr Hlth Intervent & Prevent, Dept Psychol, Storrs, CT 06269 USA.
RP Finitsis, DJ (reprint author), Univ Connecticut, Ctr Hlth Intervent & Prevent, Dept Psychol, Storrs, CT 06269 USA.
EM david.finitsis@uconn.edu
OI Finitsis, David/0000-0003-1988-008X
FU U.S. Public Health Service Institutional National Research Service Award
   [T32-MH074387, R01-MH58563]
FX This research was supported by U.S. Public Health Service Institutional
   National Research Service Award T32-MH074387 (PI: Seth C. Kalichman;
   trainees: David J. Finitsis and Jennifer A. Pellowski) and grant
   R01-MH58563 (PI: Blair T. Johnson). http://www.nimh.nih.gov/. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292
   Amico K Rivet, 2013, J Int Assoc Provid AIDS Care, V12, P128, DOI 10.1177/1545109712459041
   Amico KR, 2006, JAIDS-J ACQ IMM DEF, V41, P285
   Assoumou L, 2013, J ANTIMICROB CHEMOTH, V68, P1400, DOI 10.1093/jac/dkt033
   Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5
   Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526
   Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015
   Berg KM, 2012, AIDS BEHAV, V16, P461, DOI 10.1007/s10461-010-9864-z
   Brion J, 2013, J ASS NURSE IN PRESS, DOI DOI 10.1016/J.JANA.2013.01.006.ACCESSED
   Buscher A, 2011, HIV CLIN TRIALS, V12, P244, DOI 10.1310/hct1205-244
   Card N. A., 2012, APPL METAANALYSIS SO
   Coomes CM, 2012, AIDS CARE, V24, P348, DOI 10.1080/09540121.2011.608421
   Crankshaw T, 2010, AIDS PATIENT CARE ST, V24, P729, DOI 10.1089/apc.2010.0146
   Curioso Walter H, 2009, AMIA Annu Symp Proc, V2009, P129
   da Costa TM, 2012, INT J MED INFORM, V81, P257, DOI 10.1016/j.ijmedinf.2011.10.002
   de Bruin M, 2010, ARCH INTERN MED, V170, P240, DOI 10.1001/archinternmed.2009.536
   Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377
   Friedman SR, 2007, AIDS BEHAV, V11, P641, DOI 10.1007/s10461-006-9166-7
   Goggin G., 2006, CELL PHONE CULTURE M
   Hardy H, 2011, AIDS PATIENT CARE ST, V25, P153, DOI 10.1089/apc.2010.0006
   Harris LT, 2010, TELEMED J E-HEALTH, V16, P1024, DOI 10.1089/tmj.2010.0050
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184
   Horvath T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009756
   Huedo-Medina T, 2011, ESTIMATING STANDARDI
   Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193
   International Association of Providers in AIDS Care, 2013, 8 INT C HIV TREATM P
   Johnson BT, 2010, AIDS BEHAV, V14, pS204, DOI 10.1007/s10461-010-9803-z
   Johnson BT, 2012, EHC201201001R2 AG HE
   Kalichman Seth C, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P367, DOI 10.1177/1545109709352884
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6
   Lima VD, 2010, JAIDS-J ACQ IMM DEF, V55, P460, DOI 10.1097/QAI.0b013e3181f2ac87
   Mbuagbaw L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002954
   Mbuagbaw L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046909
   Mihalko SL, 2004, CONTROL CLIN TRIALS, V25, P447, DOI 10.1016/j.cct.2004.07.003
   Miller WR, 2013, MOTIVATIONAL INTERVI
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Musser D, 2001, THESIS U MISSOURI ST
   Ortego C, 2011, AIDS BEHAV, V15, P1381, DOI 10.1007/s10461-011-9942-x
   Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014
   Park-Wyllie LY, 2009, ANN PHARMACOTHER, V43, P1036, DOI 10.1345/aph.1L663
   Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004
   Ferreira JLP, 2013, ADV VIROL, DOI 10.1155/2013/878237
   Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1
   Russell J, 2004, J ASSOC NURSE AIDS C, V15, P40, DOI 10.1177/1055329004269283
   Safren SA, 2003, AIDS CARE, V15, P787, DOI 10.1080/09540120310001618630
   Sahay S, 2011, INDIAN J MED RES, V134, P835, DOI 10.4103/0971-5916.92629
   Samet JH, 2001, AIDS BEHAV, V5, P21, DOI DOI 10.1023/A:1009503320498
   Sanchez-Meca J, 2003, PSYCHOL METHODS, V8, P448, DOI 10.1037/1082-989X.8.4.448
   Sanou B., 2013, WORLD 2013 ICT FACTS
   Sherr L, 2010, AIDS CARE, V22, P939, DOI 10.1080/09540121.2010.482126
   Shi LZ, 2010, PHARMACOECONOMICS, V28, P1097, DOI 10.2165/11537400-000000000-00000
   Shuter J, 2007, JAIDS-J ACQ IMM DEF, V45, P4, DOI 10.1097/QAI.0b013e318050d8c2
   Simoni Jane M, 2003, Top HIV Med, V11, P185
   Simoni JM, 2009, JAIDS-J ACQ IMM DEF, V52, P465, DOI 10.1097/QAI.0b013e3181b9300c
   Sinha S, 2012, AIDS RES TREAT, DOI 10.1155/2012/905823
   Thao VP, 2012, ANTIVIR THER, DOI [10.3851/IMP2092, DOI 10.3851/IMP2092;10.3851/IMP2092]
   Walsh JC, 2002, AIDS, V16, P269, DOI 10.1097/00002030-200201250-00017
   Wilson DB, 2002, METAANALYSIS MACROS
   Wilson Ira B, 2009, Curr HIV/AIDS Rep, V6, P177
   Wise J, 2008, AIDS PATIENT CARE ST, V22, P495, DOI 10.1089/apc.2007.0180
   World Health Organization, 2006, WORK TOG HLTH WORLD
   World Health Organization, 2013, CONS GUID GEN HIV CA
NR 64
TC 137
Z9 139
U1 1
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 5
PY 2014
VL 9
IS 2
AR e88166
DI 10.1371/journal.pone.0088166
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AA1AT
UT WOS:000330829200125
PM 24505411
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Grenfell, RFQ
   Coelho, PMZ
   Taboada, D
   de Mattos, ACA
   Davis, R
   Harn, DA
AF Queiroz Grenfell, Rafaella Fortini
   Zech Coelho, Paulo Marcos
   Taboada, Diana
   Alves de Mattos, Ana Carolina
   Davis, Ruth
   Harn, Donald A.
TI Newly Established Monoclonal Antibody Diagnostic Assays for Schistosoma
   mansoni Direct Detection in Areas of Low Endemicity
SO PLOS ONE
LA English
DT Article
ID CIRCULATING CATHODIC ANTIGEN; ANODIC ANTIGEN; LOW-TRANSMISSION; ELISA
   SYSTEM; URINE; INFECTION; SERUM; INDIVIDUALS; PRAZIQUANTEL; PREVALENCE
AB Background: Current available methods for diagnosis of schistosomiasis mansoni lack sufficient sensitivity, which results in underreporting of infectious in areas of low endemicity.
   Methodology/Principal Findings: We developed three novel diagnostic methodologies for the direct detection of schistosome infection in serum samples. These three new methods were evaluated with positive patients from a low endemicity area in southeast Brazil. The basis of the assay was the production of monoclonal antibodies against the protein backbone of heavily glycosylated Circulating Cathodic Antigen (CCA). The antibodies were also selected for having no specificity to repeating poly-Lewis x units. Assays based on the detection CCA-protein should not encounter a limitation in sensitivity due to a biological background of this particular epitope. Three diagnostic methodologies were developed and validated, (i) Immunomagnetic Separation based on improved incubation steps of non-diluted serum, (ii) Direct Enzymelinked Immunosorbent Assay and (iii) Fluorescent Microscopy Analysis as a qualitative assay. The two quantitative assays presented high sensitivity (94% and 92%, respectively) and specificity (100%), equivalent to the analysis of 3 stool samples and 16 slides by Kato-Katz, showing promising results on the determination of cure.
   Conclusions/Significance: The Immunomagnetic Separation technique showed excellent correlation with parasite burden by Cohen coefficient. The qualitative method detected 47 positive individuals out of 50 with the analysis of 3 slides. This easy-to-do method was capable of discriminating positive from negative cases, even for patients with low parasite burden.
C1 [Queiroz Grenfell, Rafaella Fortini; Zech Coelho, Paulo Marcos; Taboada, Diana; Alves de Mattos, Ana Carolina] Oswaldo Cruz Fdn Fiocruz, Schistosomiasis Lab, Rene Rachou Res Ctr, Belo Horizonte, MG, Brazil.
   [Queiroz Grenfell, Rafaella Fortini; Harn, Donald A.] Univ Georgia UGA, Dept Infect Dis, Coll Vet Med, Athens, GA USA.
   [Queiroz Grenfell, Rafaella Fortini; Harn, Donald A.] Univ Georgia UGA, Ctr Trop & Emerging Global Dis, Athens, GA USA.
   [Davis, Ruth] Univ Georgia UGA, Monoclonal Antibody Facil, Coll Vet Med, Athens, GA USA.
RP Coelho, PMZ (reprint author), Oswaldo Cruz Fdn Fiocruz, Schistosomiasis Lab, Rene Rachou Res Ctr, Belo Horizonte, MG, Brazil.
EM coelhopm@cpqrr.fiocruz.br
FU National Counsel of Technological and Scientific Development (CNPq);
   Oswaldo Cruz Foundation (Fiocruz)/Rene Rachou Research Center (CPqRR);
   Coordination for the Improvement of Higher Level Education Personnel
   (Capes); Council of the International Educational Exchange of Scholars
   (Fulbright, U.S. Department of State)
FX This work was supported by The National Counsel of Technological and
   Scientific Development (CNPq), Oswaldo Cruz Foundation (Fiocruz)/Rene
   Rachou Research Center (CPqRR), Coordination for the Improvement of
   Higher Level Education Personnel (Capes), The Council of the
   International Educational Exchange of Scholars (Fulbright, U.S.
   Department of State). National Institutes of Health AI R01 AI068109A to
   DAH. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Allam AF, 2009, TROP MED INT HEALTH, V14, P316, DOI 10.1111/j.1365-3156.2009.02225.x
   Ashton RA, 2011, TROP MED INT HEALTH, V16, P1099, DOI 10.1111/j.1365-3156.2011.02815.x
   Bergquist NR, 2002, TRENDS PARASITOL, V18, P309, DOI 10.1016/S1471-4922(02)02301-2
   Berhe N, 2004, ACTA TROP, V92, P205, DOI 10.1016/j.actatropica.2004.06.011
   Chen LL, 2007, BIOSENS BIOELECTRON, V22, P1487, DOI 10.1016/j.bios.2006.06.038
   Chick H, 1913, BIOCHEM J, V7, P380, DOI 10.1042/bj0070380
   COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256
   Colley DG, 2013, AM J TROP MED HYG, V88, P426, DOI 10.4269/ajtmh.12-0639
   Corstjens PLAM, 2008, J CLIN MICROBIOL, V46, P171, DOI 10.1128/JCM.00877-07
   Coulibaly JT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002109
   Coulibaly JT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001384
   DEELDER AM, 1994, TROP GEOGR MED, V46, P233
   DEELDER AM, 1989, AM J TROP MED HYG, V40, P268, DOI 10.4269/ajtmh.1989.40.268
   DEJONGE N, 1990, T ROY SOC TROP MED H, V84, P815, DOI 10.1016/0035-9203(90)90094-U
   DEJONGE N, 1989, T ROY SOC TROP MED H, V83, P659, DOI 10.1016/0035-9203(89)90391-X
   DEVLAS SJ, 1992, PARASITOL TODAY, V8, P274, DOI 10.1016/0169-4758(92)90144-Q
   Dissanayake S, 2007, MOL IMMUNOL, V44, P1623, DOI 10.1016/j.molimm.2006.08.019
   Doenhoff MJ, 2004, TRENDS PARASITOL, V20, P35, DOI 10.1016/j.pt.2003.10.019
   EDUNGBOLA L D, 1988, African Journal of Medicine and Medical Sciences, V17, P187
   Enk MJ, 2008, ACTA TROP, V108, P222, DOI 10.1016/j.actatropica.2008.09.016
   Erko B, 2013, TROP MED INT HEALTH, V18, P1029, DOI 10.1111/tmi.12117
   FELDMEIER H, 1986, CLIN EXP IMMUNOL, V65, P232
   Gomes JF, 2004, J CLIN LAB ANAL, V18, P132, DOI 10.1002/jcla.20011
   Gomes LI, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000664
   Grenfell R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002054
   HAKOMORI S, 1984, J BIOL CHEM, V259, P4672
   Haslam SM, 2000, GLYCOBIOLOGY, V10, P223, DOI 10.1093/glycob/10.2.223
   Hassan Sel D, 2011, DIAGN PATHOL, V6, P88
   Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397
   Kongs A, 2001, TROP MED INT HEALTH, V6, P163, DOI 10.1046/j.1365-3156.2001.00687.x
   KREMSNER PG, 1993, T ROY SOC TROP MED H, V87, P167, DOI 10.1016/0035-9203(93)90474-5
   KREMSNER PG, 1994, CLIN INFECT DIS, V18, P408, DOI 10.1093/clinids/18.3.408
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   McCarthy JS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001601
   Nagasaki Y, 2007, J COLLOID INTERF SCI, V309, P524, DOI 10.1016/j.jcis.2006.12.079
   Ndhlovu P, 1996, AM J TROP MED HYG, V54, P537, DOI 10.4269/ajtmh.1996.54.537
   Shane HL, 2001, PLOS NEGLECT TROP D, V5, pe951
   Solomon AW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001746
   SPOONCER E, 1984, J BIOL CHEM, V259, P4792
   Tarp B, 2000, TROP MED INT HEALTH, V5, P185, DOI 10.1046/j.1365-3156.2000.00539.x
   vanEtten L, 1996, AM J TROP MED HYG, V54, P348, DOI 10.4269/ajtmh.1996.54.348
   VANETTEN L, 1994, J CLIN MICROBIOL, V32, P2404
   VANLIESHOUT L, 1992, AM J TROP MED HYG, V47, P463, DOI 10.4269/ajtmh.1992.47.463
   VANLIESHOUT L, 1994, PARASITOLOGY, V108, P519, DOI 10.1017/S0031182000077386
   VANTWOUT AB, 1992, T ROY SOC TROP MED H, V86, P410, DOI 10.1016/0035-9203(92)90243-6
   Siqueira LMV, 2011, MEM I OSWALDO CRUZ, V106, P844, DOI 10.1590/S0074-02762011000700010
NR 46
TC 7
Z9 7
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 31
PY 2014
VL 9
IS 1
AR e87777
DI 10.1371/journal.pone.0087777
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 302RF
UT WOS:000330621900169
PM 24498191
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Biere, L
   Donal, E
   Terrien, G
   Kervio, G
   Willoteaux, S
   Furber, A
   Prunier, F
AF Biere, Loic
   Donal, Erwan
   Terrien, Gwenola
   Kervio, Gaelle
   Willoteaux, Serge
   Furber, Alain
   Prunier, Fabrice
TI Longitudinal Strain Is a Marker of Microvascular Obstruction and Infarct
   Size in Patients with Acute ST-Segment Elevation Myocardial Infarction
SO PLOS ONE
LA English
DT Article
ID SPECKLE TRACKING ECHOCARDIOGRAPHY; LEFT-VENTRICULAR FUNCTION;
   WALL-MOTION SCORE; 2-DIMENSIONAL STRAIN; CLINICAL-IMPLICATIONS; EJECTION
   FRACTION; QUANTIFICATION; REPERFUSION; VALIDATION; ANGIOPLASTY
AB Objectives: We assessed the value of speckle tracking imaging performed early after a first ST-segment elevation myocardial infarction (STEMI) in order to predict infarct size and functional recovery at 3-month follow-up.
   Methods: 44 patients with STEMI who underwent revascularization within 12 h of symptom onset were prospectively enrolled. Echocardiography was performed 3.9 +/- 1.2 days after myocardial reperfusion, assessing circumferential (CGS), radial (RGS), and longitudinal global (GLS) strains. Late gadolinium-enhanced cardiac magnetic imaging (CMR), for assessing cardiac function, infarct size, and microvascular obstruction (MVO), was conducted 5.6 +/- 2.5 days and 99.4 +/- 4.6 days after myocardial reperfusion.
   Results: GLS was evaluable in 97% of the patients, while CGS and RGS could be assessed in 85%. Infarct size significantly correlated with GLS (R = 0.601, p < 0.001), RGS (R = -0.405, p = 0.010), CGS (R = 0.526, p = 0.001), ejection fraction (R = -0.699, p < 0.001), wall motion score index (WMSI) (R = 0.539, p = 0.001), and left atrial volume (R = 0.510, p < 0.001). Baseline ejection fraction and GLS were independent predictors of 3-month infarct size. MVO mass significantly correlated with GLS (R = 0.376, p = 0.010), WMSI (R = 0.387, p = 0.011), and ejection fraction (R = -0.389, p = 0.011). In multivariate analysis, GLS was the only independent predictor of MVO mass (p = 0.015). Longitudinal strain >-6.0% within the infarcted area exhibited 96% specificity and 61% sensitivity for predicting the persistence of akinesia (>= 3 segments) at 3-month follow-up.
   Conclusions: Speckle-tracking strain imaging performed early after a STEMI is easy-to-use as a marker for persistent akinetic territories at 3 months. In addition, GLS correlated significantly with MVO and final infarct size, both parameters being relevant post-MI prognostic factors, usually obtained via CMR.
C1 [Biere, Loic; Terrien, Gwenola; Willoteaux, Serge; Furber, Alain; Prunier, Fabrice] LUNAM Univ, Angers, France.
   [Biere, Loic; Terrien, Gwenola; Furber, Alain; Prunier, Fabrice] Univ Angers, CHU Angers, Lab Cardioprotect Remodelage & Thrombose, UPRES,EA3860,Serv Cardiol, Angers, France.
   [Donal, Erwan; Kervio, Gaelle] CHU Rennes, Serv Cardiol, Rennes, France.
   [Donal, Erwan; Kervio, Gaelle] CHU Rennes, CIC IT 804, Rennes, France.
   [Donal, Erwan; Kervio, Gaelle] INSERM, U1099, Lab Traitement Signal & Image, Rennes, France.
   [Willoteaux, Serge] Univ Angers, CHU Angers, Lab Cardioprotect Remodelage & Thrombose, UPRES,EA3860,Serv Radiol, Angers, France.
RP Prunier, F (reprint author), LUNAM Univ, Angers, France.
EM FaPrunier@chu-angers.fr
RI Prunier, Fabrice/A-5210-2011
CR Amundsen BH, 2006, J AM COLL CARDIOL, V47, P789, DOI 10.1016/j.jacc.2005.10.040
   Antoni ML, 2010, EUR HEART J, V31, P1640, DOI 10.1093/eurheartj/ehq105
   Bergerot C, 2010, EUR HEART J, V31, P1060
   BLAND JM, 1986, LANCET, V1, P307
   Bolognese L, 2002, CIRCULATION, V106, P2351, DOI 10.1161/01.CIR.0000036014.90197.FA
   Burns RJ, 2002, J AM COLL CARDIOL, V39, P30, DOI 10.1016/S0735-1097(01)01711-9
   Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975
   Chan J, 2006, J AM COLL CARDIOL, V48, P2026, DOI 10.1016/j.jacc.2006.07.050
   Cimino S, 2013, EUR HEART J-CARD IMG, V14, P805, DOI 10.1093/ehjci/jes295
   Gerber B L, 2000, Top Magn Reson Imaging, V11, P372, DOI 10.1097/00002142-200012000-00006
   Gerber BL, 2000, CIRCULATION, V101, P2734, DOI 10.1161/01.CIR.101.23.2734
   Gerber BL, 2002, CIRCULATION, V106, P1083, DOI 10.1161/01.CIR.0000027818.15792.1E
   Gibbons RJ, 2004, J AM COLL CARDIOL, V44, P1533, DOI 10.1016/j.jacc.2004.06.071
   Grabka M, 2013, CORONARY ARTERY DIS, V24, P127, DOI 10.1097/MCA.0b013e32835b6798
   Hanekom L, 2005, CIRCULATION, V112, P3892, DOI 10.1161/CIRCULATIONAHA.104.489310
   Hung CL, 2010, J AM COLL CARDIOL, V56, P1812, DOI 10.1016/j.jacc.2010.06.044
   Ingul CB, 2005, J AM SOC ECHOCARDIOG, V18, P411, DOI 10.1016/j.echo.2005.01.032
   KAN G, 1986, BRIT HEART J, V56, P422
   Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Leitman M, 2004, J AM SOC ECHOCARDIOG, V17, P1021, DOI 10.1016/j.echo.2004.06.019
   Mollema SA, 2009, HEART, V95, P1732, DOI 10.1136/hrt.2008.161836
   Mollema SA, 2010, CIRC-CARDIOVASC IMAG, V3, P15, DOI 10.1161/CIRCIMAGING.108.802785
   Moller JE, 2006, AM HEART J, V151, P419, DOI 10.1016/j.ahj.2005.03.042
   Munk K, 2010, CIRC-CARDIOVASC IMAG, V3, P656, DOI 10.1161/CIRCIMAGING.110.957340
   Ortiz-Perez JT, 2008, JACC-CARDIOVASC IMAG, V1, P282, DOI 10.1016/j.jcmg.2008.01.014
   Park YH, 2008, J AM SOC ECHOCARDIOG, V21, P262, DOI 10.1016/j.echo.2007.08.026
   PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161
   Reant P, 2008, J AM COLL CARDIOL, V51, P149, DOI 10.1016/j.jacc.2007.07.088
   Reant P, 2012, J AM SOC ECHOCARDIOG, V25, P68, DOI 10.1016/j.echo.2011.10.009
   Savoye C, 2006, AM J CARDIOL, V98, P1144, DOI 10.1016/j.amjcard.2006.06.011
   Sjoli B, 2009, JACC-CARDIOVASC IMAG, V2, P24, DOI 10.1016/j.jcmg.2008.10.007
   Solomon SD, 2005, CIRCULATION, V111, P3411, DOI 10.1161/CIRCULATIONAHA.104.508093
   SUTTON JM, 1994, CIRCULATION, V89, P1126, DOI 10.1161/01.CIR.89.3.1126
   Torrent-Guasp F, 2005, EUR J CARDIO-THORAC, V27, P191, DOI 10.1016/j.ejects.2004.11.026
   Vartdal T, 2007, J AM COLL CARDIOL, V49, P1715, DOI 10.1016/j.jacc.2006.12.047
   Wu KC, 1998, J AM COLL CARDIOL, V32, P1756, DOI 10.1016/S0735-1097(98)00429-X
   Wu KC, 1999, CURR OPIN CARDIOL, V14, P480, DOI 10.1097/00001573-199911000-00005
   Wu KC, 1998, CIRCULATION, V97, P765, DOI 10.1161/01.CIR.97.8.765
   Zhang Y, 2005, J AM COLL CARDIOL, V46, P864, DOI 10.1016/j.jacc.2005.05.054
NR 41
TC 15
Z9 18
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 28
PY 2014
VL 9
IS 1
AR e86959
DI 10.1371/journal.pone.0086959
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 301CJ
UT WOS:000330510000094
PM 24489816
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lodder, SS
   Askamp, J
   van Putten, MJAM
AF Lodder, Shaun S.
   Askamp, Jessica
   van Putten, Michel J. A. M.
TI Computer-Assisted Interpretation of the EEG Background Pattern: A
   Clinical Evaluation
SO PLOS ONE
LA English
DT Article
ID QUANTITATIVE EEG; SPIKE DETECTION; AUTOMATIC EEG; BRAIN; DATABASE;
   ELECTROENCEPHALOGRAM; RELIABILITY; EPILEPSY; SYSTEM
AB Objective: Interpretation of the EEG background pattern in routine recordings is an important part of clinical reviews. We evaluated the feasibility of an automated analysis system to assist reviewers with evaluation of the general properties in the EEG background pattern.
   Methods: Quantitative EEG methods were used to describe the following five background properties: posterior dominant rhythm frequency and reactivity, anterior-posterior gradients, presence of diffuse slow-wave activity and asymmetry. Software running the quantitative methods were given to ten experienced electroencephalographers together with 45 routine EEG recordings and computer-generated reports. Participants were asked to review the EEGs by visual analysis first, and afterwards to compare their findings with the generated reports and correct mistakes made by the system. Corrected reports were returned for comparison.
   Results: Using a gold-standard derived from the consensus of reviewers, inter-rater agreement was calculated for all reviewers and for automated interpretation. Automated interpretation together with most participants showed high (kappa > 0.6) agreement with the gold standard. In some cases, automated analysis showed higher agreement with the gold standard than participants. When asked in a questionnaire after the study, all participants considered computer-assisted interpretation to be useful for every day use in routine reviews.
   Conclusions: Automated interpretation methods proved to be accurate and were considered to be useful by all participants.
   Significance: Computer-assisted interpretation of the EEG background pattern can bring consistency to reviewing and improve efficiency and inter-rater agreement.
C1 [Lodder, Shaun S.; Askamp, Jessica; van Putten, Michel J. A. M.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands.
   [van Putten, Michel J. A. M.] Med Spectrum, Dept Neurol & Clin Neurophysiol, Enschede, Netherlands.
RP Lodder, SS (reprint author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, POB 217, NL-7500 AE Enschede, Netherlands.
EM s.s.lodder@utwente.nl
RI van Putten, Michel J.A.M./D-6519-2018
OI van Putten, Michel J.A.M./0000-0001-8319-3626
CR Anderson NR, 2010, J CLIN NEUROPHYSIOL, V27, P453, DOI 10.1097/WNP.0b013e3181fe0b6f
   Anderson Nicholas R, 2008, Am J Electroneurodiagnostic Technol, V48, P166
   Aurlien H, 2007, CLIN NEUROPHYSIOL, V118, P1369, DOI 10.1016/j.clinph.2007.02.027
   Aurlien H, 2004, CLIN NEUROPHYSIOL, V115, P665, DOI 10.1016/j.clinph.2003.10.019
   Aurlien H, 1999, CLIN NEUROPHYSIOL, V110, P986, DOI 10.1016/S1388-2457(99)00037-1
   Azuma H, 2003, PSYCHIAT CLIN NEUROS, V57, P485, DOI 10.1046/j.1440-1819.2003.01152.x
   Babiloni C, 2011, J ALZHEIMERS DIS, V26, P331, DOI 10.3233/JAD-2011-101710
   Beniczky S, 2013, EPILEPSIA, V54, P1112, DOI 10.1111/epi.12135
   Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575
   Burke JF, 2013, ANN NEUROL, V73, P679, DOI 10.1002/ana.23865
   Cloostermans MC, 2011, CLIN NEUROPHYSIOL, V122, P2100, DOI 10.1016/j.clinph.2011.02.035
   Coburn KL, 2006, J NEUROPSYCH CLIN N, V18, P460, DOI 10.1176/appi.neuropsych.18.4.460
   Foreman B, 2012, ANN UPDATE INTENSIVE
   Friedman D, 2010, CURR CLIN NEUROL, P21, DOI 10.1007/978-1-60327-532-3_2
   Gudmundsson S, 2007, CLIN NEUROPHYSIOL, V118, P2162, DOI 10.1016/j.clinph.2007.06.018
   Halford JJ, 2009, CLIN NEUROPHYSIOL, V120, P1909, DOI 10.1016/j.clinph.2009.08.007
   Kannathal N, 2005, COMPUT METH PROG BIO, V80, P187, DOI 10.1016/j.cmpb.2005.06.012
   Kurtz P, 2009, CURR OPIN CRIT CARE, V15, P99, DOI 10.1097/MCC.0b013e3283294947
   Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lodder SS, 2013, CLIN NEUROPHYSIOL, V124, P228, DOI 10.1016/j.clinph.2012.07.007
   Moretti D V, 2012, Int J Alzheimers Dis, V2012, P917537, DOI 10.1155/2012/917537
   Mukhopadhyay S, 1998, IEEE T BIO-MED ENG, V45, P180, DOI 10.1109/10.661266
   NAKAMURA M, 1992, ELECTROEN CLIN NEURO, V82, P423, DOI 10.1016/0013-4694(92)90047-L
   Nakamura M, 2002, INT J ADAPT CONTROL, V16, P25, DOI 10.1002/acs.662
   Petit D, 2004, J PSYCHOSOM RES, V56, P487, DOI 10.1016/j.jpsychores.2004.02.001
   Scherg M, 2012, EPILEPSIA, V53, P1196, DOI 10.1111/j.1528-1167.2012.03503.x
   SIGL JC, 1994, J CLIN MONITOR, V10, P392, DOI 10.1007/BF01618421
   Snaedal J, 2012, DEMENT GERIATR COGN, V34, P51, DOI 10.1159/000339996
   Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127
   Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011
   Stevenson NJ, 2013, ANN BIOMED ENG, V41, P775, DOI 10.1007/s10439-012-0710-5
   Strzelczyk A, 2012, EPILEPSY BEHAV, V23, P451, DOI 10.1016/j.yebeh.2012.01.021
   van Putten MJAM, 2008, J CLIN NEUROPHYSIOL, V25, P63, DOI 10.1097/WNP.0b013e31816bdf85
   van Putten MJAM, 2004, CLIN NEUROPHYSIOL, V115, P1189, DOI 10.1016/j.clinph.2003.12.002
   van Putten MJAM, 2003, J CLIN NEUROPHYSIOL, V20, P320, DOI 10.1097/00004691-200309000-00004
   Wilson SB, 2002, CLIN NEUROPHYSIOL, V113, P1873, DOI 10.1016/S1388-2457(02)00297-3
   Zhang X, 2011, MED BIOL ENG COMPUT, V49, P171, DOI 10.1007/s11517-010-0688-9
NR 38
TC 3
Z9 3
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 24
PY 2014
VL 9
IS 1
AR e85966
DI 10.1371/journal.pone.0085966
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 298QQ
UT WOS:000330339800020
PM 24475064
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Poor, EE
   Jakes, A
   Loucks, C
   Suitor, M
AF Poor, Erin E.
   Jakes, Andrew
   Loucks, Colby
   Suitor, Mike
TI Modeling Fence Location and Density at a Regional Scale for Use in
   Wildlife Management
SO PLOS ONE
LA English
DT Article
ID WILDEBEEST; MAMMALS; SITE; DEER
AB Barbed and woven wire fences, common structures across western North America, act as impediments to wildlife movements. In particular, fencing influences pronghorn (Antilocapra americana) daily and seasonal movements, as well as modifying habitat selection. Because of fencing's impacts to pronghorn and other wildlife, it is a potentially important factor in both wildlife movement and habitat selection models. At this time, no geospatial fencing data is available at regional scales. Consequently, we constructed a regional fence model using a series of land tenure assumptions for the Hi-Line region of northern Montana - an area consisting of 13 counties over 103,400 km(2). Randomized 3.2 km long transects (n = 738) on both paved and unpaved roads were driven to collect information on habitat, fence densities and fence type. Using GIS, we constructed a fence location and a density model incorporating ownership, size, neighboring parcels, township boundaries and roads. Local knowledge of land ownership and land use assisted in improving the final models. We predict there is greater than 263,300 km of fencing in the Hi-Line region, with a maximum density of 6.8 km of fencing per km(2) and mean density of 2.4 km of fencing per km(2). Using field data to assess model accuracy, Cohen's Kappa was measured at 0.40. On-the-ground fence modification or removal could be prioritized by identifying high fence densities in critical wildlife areas such as pronghorn migratory pathways or sage grouse lekking habitat. Such novel fence data can assist wildlife and land managers to assess effects of anthropogenic features to wildlife at various scales; which in turn may help conserve declining grassland species and overall ecological functionality.
C1 [Poor, Erin E.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.
   [Poor, Erin E.; Loucks, Colby] World Wildlife Fund, Conservat Sci Program, Washington, DC 20037 USA.
   [Jakes, Andrew; Suitor, Mike] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada.
RP Poor, EE (reprint author), Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.
EM erinpoor@vt.edu
FU Kathryn Fuller Science for Nature Fund; Alberta Conservation Association
   [030-00-40-106-4000]; U.S. Bureau of Land Management [090-50778];
   Montana Fish, Wildlife Parks [080018]; Saskatchewan Ministry of
   Environment [08FW111]; University of Calgary
FX The work was supported by: Kathryn Fuller Science for Nature Fund, (no
   grant number)
   (http://worldwildlife.org/initiatives/fuller-science-for-nature-fund);
   Alberta Conservation Association, 030-00-40-106-4000
   (http://www.ab-conservation.com/); U.S. Bureau of Land Management,
   090-50778 (http://www.blm.gov/wo/st/en.html); Montana Fish, Wildlife &
   Parks, Cooperative Agreement 080018 (http://fwp.mt.gov/); Saskatchewan
   Ministry of Environment, Permit 08FW111
   (http://www.environment.gov.sk.ca/); University of Calgary, (no grant
   number) (http://www.ucalgary.com/). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Baines D, 1997, J APPL ECOL, V34, P941, DOI 10.2307/2405284
   Balmord A., 2003, ECOL LETT, V37, P238
   BENSHAHAR R, 1993, J TROP ECOL, V9, P249, DOI 10.1017/S0266467400007252
   Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x
   Berger J, 2008, PLOS BIOL, V6, P1365, DOI 10.1371/journal.pbio.0060165
   Berry H. H., 1997, Madoqua, V20, P137
   Boone Randall B., 2004, African Journal of Range & Forage Science, V21, P147, DOI 10.2989/10220110409485847
   Congalton RG, 1981, THESIS VIRGINIA POLY
   Estes R, 1967, ZOOL TIERPSHYCH, V26, P284
   Harrington JL, 2006, WILDLIFE SOC B, V34, P1295, DOI 10.2193/0091-7648(2006)34[1295:COUBAM]2.0.CO;2
   Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173
   Hayter Earl W., 1939, AGR HIST, V13, P189
   JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156
   Kie JG, 2002, ECOLOGY, V83, P530, DOI 10.2307/2680033
   Knick ST, 2011, STUD AVIAN BIOL, P203
   Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Moss R, 2001, BIOL CONSERV, V101, P255, DOI 10.1016/S0006-3207(01)00066-0
   Nakazawa M, 2013, FUNCTIONS MED STAT B
   Ockenfels RA, 1994, 13 AR GAM FISH DEP
   Sawyer H, 2013, J APPL ECOL, V50, P68, DOI 10.1111/1365-2664.12013
   Schaefer JA, 2000, LANDSCAPE ECOL, V15, P731, DOI 10.1023/A:1008160408257
   Sheldon DP, 2005, PRONGHORN MOVEMENT D
   SPINAGE C A, 1992, Oryx, V26, P147
   Stevens BS, 2012, J WILDLIFE MANAGE, V76, P1370, DOI 10.1002/jwmg.397
   Thirgood S, 2004, ANIM CONSERV, V7, P113, DOI 10.1017/S1367943004001404
   Tufford W, 1960, MONTANA, V10, P62
   WHYTE IJ, 1988, S AFR J WILDL RES, V18, P78
   Williamson D., 1985, Parks, V10, P5
NR 29
TC 5
Z9 5
U1 0
U2 46
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 8
PY 2014
VL 9
IS 1
AR e83912
DI 10.1371/journal.pone.0083912
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 291WL
UT WOS:000329862500083
PM 24416180
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wrede, KH
   Dammann, P
   Monninghoff, C
   Johst, S
   Maderwald, S
   Sandalcioglu, IE
   Muller, O
   Ozkan, N
   Ladd, ME
   Forsting, M
   Schlamann, MU
   Sure, U
   Umutlu, L
AF Wrede, Karsten H.
   Dammann, Philipp
   Moenninghoff, Christoph
   Johst, Soeren
   Maderwald, Stefan
   Sandalcioglu, I. Erol
   Mueller, Oliver
   Oezkan, Neriman
   Ladd, Mark E.
   Forsting, Michael
   Schlamann, Marc U.
   Sure, Ulrich
   Umutlu, Lale
TI Non-Enhanced MR Imaging of Cerebral Aneurysms: 7 Tesla versus 1.5 Tesla
SO PLOS ONE
LA English
DT Article
ID TIME-OF-FLIGHT; DIGITAL-SUBTRACTION-ANGIOGRAPHY; MAGNETIC-RESONANCE
   ANGIOGRAPHY; INTRACRANIAL ANEURYSMS; INITIAL-EXPERIENCE; FOLLOW-UP;
   COMPLICATIONS; AGREEMENT; COILS; 3.0-T
AB Purpose: To prospectively evaluate 7 Tesla time-of-flight (TOF) magnetic resonance angiography (MRA) in comparison to 1.5 Tesla TOF MRA and 7 Tesla non-contrast enhanced magnetization-prepared rapid acquisition gradient-echo (MPRAGE) for delineation of unruptured intracranial aneurysms (UIA).
   Material and Methods: Sixteen neurosurgical patients (male n = 5, female n = 11) with single or multiple UIA were enrolled in this trial. All patients were accordingly examined at 7 Tesla and 1.5 Tesla MRI utilizing dedicated head coils. The following sequences were obtained: 7 Tesla TOF MRA, 1.5 Tesla TOF MRA and 7 Tesla non-contrast enhanced MPRAGE. Image analysis was performed by two radiologists with regard to delineation of aneurysm features (dome, neck, parent vessel), presence of artifacts, vessel-tissue-contrast and overall image quality. Interobserver accordance and intermethod comparisons were calculated by kappa coefficient and Lin's concordance correlation coefficient.
   Results: A total of 20 intracranial aneurysms were detected in 16 patients, with two patients showing multiple aneurysms (n = 2, n = 4). Out of 20 intracranial aneurysms, 14 aneurysms were located in the anterior circulation and 6 aneurysms in the posterior circulation. 7 Tesla MPRAGE imaging was superior over 1.5 and 7 Tesla TOF MRA in the assessment of all considered aneurysm and image quality features (e. g. image quality: mean MPRAGE7T: 5.0; mean TOF7T: 4.3; mean TOF1.5T: 4.3). Ratings for 7 Tesla TOF MRA were equal or higher over 1.5 Tesla TOF MRA for all assessed features except for artifact delineation (mean TOF7T: 4.3; mean TOF1.5T 4.4). Interobserver accordance was good to excellent for most ratings.
   Conclusion: 7 Tesla MPRAGE imaging demonstrated its superiority in the detection and assessment of UIA as well as overall imaging features, offering excellent interobserver accordance and highest scores for all ratings. Hence, it may bear the potential to serve as a high-quality diagnostic tool for pretherapeutic assessment and follow-up of untreated UIA.
C1 [Wrede, Karsten H.; Dammann, Philipp; Johst, Soeren; Maderwald, Stefan; Ladd, Mark E.; Umutlu, Lale] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany.
   [Wrede, Karsten H.; Dammann, Philipp; Sandalcioglu, I. Erol; Mueller, Oliver; Oezkan, Neriman; Sure, Ulrich] Univ Hosp Essen, Dept Neurosurg, Essen, Germany.
   [Moenninghoff, Christoph; Johst, Soeren; Maderwald, Stefan; Ladd, Mark E.; Forsting, Michael; Schlamann, Marc U.; Umutlu, Lale] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.
RP Wrede, KH (reprint author), Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany.
EM karsten.wrede@uk-essen.de
RI Maderwald, Stefan/B-4241-2011; Mueller, Oliver Marcus/E-3419-2014
OI Mueller, Oliver Marcus/0000-0003-4690-370X
FU IFORES grant from the University Duisburg-Essen
FX An IFORES grant to KHW from the University Duisburg-Essen supported the
   research
   [http://www.uni-due.de/med/forschung/forschungsfoerderung/ifores.shtml].
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adams WM, 2000, AM J NEURORADIOL, V21, P1618
   Chung TS, 1999, AM J NEURORADIOL, V20, P229
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   EDELSTEIN WA, 1986, MAGNET RESON MED, V3, P604, DOI 10.1002/mrm.1910030413
   Ferre JC, 2009, EUR J RADIOL, V72, P365, DOI 10.1016/j.ejrad.2008.08.005
   Fischer A, 2013, INVEST RADIOL, V48, P525, DOI 10.1097/RLI.0b013e3182839c2b
   FOGELHOLM R, 1993, STROKE, V24, P1649, DOI 10.1161/01.STR.24.11.1649
   Gaa J, 2004, ACTA RADIOL, V45, P327, DOI 10.1080/02841850410004229
   Gibbs GF, 2004, AM J NEURORADIOL, V25, P84
   Heverhagen JT, 2008, INVEST RADIOL, V43, P568, DOI 10.1097/RLI.0b013e31817e9b2c
   Hoult DI, 2000, CONCEPT MAGNETIC RES, V12, P173, DOI 10.1002/1099-0534(2000)12:4<173::AID-CMR1>3.0.CO;2-Q
   Johst S, 2012, INVEST RADIOL, V47, P445, DOI 10.1097/RLI.0b013e31824ef21f
   Kashiwazaki D, 2013, STROKE
   Kaufmann TJ, 2007, RADIOLOGY, V243, P812, DOI 10.1148/radiol.2433060536
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lawson MF, 2013, WORLD NEUROSURG, V79, P472, DOI 10.1016/j.wneu.2012.01.038
   Lin L, 2000, BIOMETRICS, V56, P324, DOI DOI 10.1111/J.0006-341X.2000.00324.X
   LIN L I K, 1989, BIOMETRICS, V43, P255
   Maderwald S, 2008, MAGN RESON MATER PHY, V21, P159, DOI 10.1007/s10334-007-0096-9
   Majoie CBLM, 2005, AM J NEURORADIOL, V26, P1349
   Monninghoff C, 2009, ROFO-FORTSCHR RONTG, V181, P16, DOI 10.1055/s-2008-1027863
   Nakiri GS, 2011, CLINICS, V66, P641, DOI 10.1590/S1807-59322011000400020
   Nowinski WL, 2013, J NEUROIMAGING, V23, P86, DOI 10.1111/j.1552-6569.2011.00597.x
   Okahara M, 2002, STROKE, V33, P1803, DOI 10.1161/01.STR0000019510.32145.A9
   Schar M, 2004, MAGN RESON MED, V51, P799, DOI 10.1002/mrm.20024
   Shahzad R, 2011, JCPSP-J COLL PHYSICI, V21, P325, DOI 07.2011/JCPSP.325329
   Steinberg GK, 2013, STROKE, V44, pS97, DOI 10.1161/STROKEAHA.113.001786
   Umutlu L, 2013, EUR RADIOL
   Umutlu L, 2012, J MAGN RESON IMAGING
   Umutlu L, 2013, ACAD RADIOL
   White PM, 2001, RADIOLOGY, V219, P739, DOI 10.1148/radiology.219.3.r01ma16739
   White PM, 2001, J NEUROL NEUROSUR PS, V71, P322, DOI 10.1136/jnnp.71.3.322
   Willinek WA, 2003, RADIOLOGY, V229, P913, DOI 10.1148/radiol.2293020782
   Willinsky RA, 2003, RADIOLOGY, V227, P522, DOI 10.1148/radiol.2272012071
   Wrede KH, 2012, ACAD RADIOL, V19, P172, DOI 10.1016/j.acra.2011.10.004
   Zwanenburg JJM, 2008, J MAGN RESON IMAGING, V28, P1519, DOI [10.1002/jmri.21591, 10.1002/jmri.21541]
NR 36
TC 20
Z9 21
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 6
PY 2014
VL 9
IS 1
AR e84562
DI 10.1371/journal.pone.0084562
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 286IW
UT WOS:000329462700034
PM 24400100
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Mongi, AS
   Baisley, K
   Ao, TTH
   Chilongani, J
   Aguirre-Andreasen, A
   Francis, SC
   Shao, J
   Hayes, R
   Kapiga, S
AF Mongi, Aika S.
   Baisley, Kathy
   Trong Thanh-Hoang Ao
   Chilongani, Joseph
   Aguirre-Andreasen, Aura
   Francis, Suzanna C.
   Shao, John
   Hayes, Richard
   Kapiga, Saidi
TI Factors Associated with Problem Drinking among Women Employed in Food
   and Recreational Facilities in Northern Tanzania
SO PLOS ONE
LA English
DT Article
ID SIMPLEX-VIRUS TYPE-2; SUB-SAHARAN AFRICA; ALCOHOL-USE; SEXUAL-BEHAVIOR;
   HOTEL WORKERS; RISK-FACTORS; HIV-INFECTION; CAGE QUESTIONNAIRE; GLOBAL
   BURDEN; FEMALE BAR
AB Background: There is growing evidence that alcohol consumption is associated with increased risk of HIV infection. To determine factors associated with problem drinking, we analyzed data collected in two prospective cohorts of at-risk female food and recreational facility workers in northern Tanzania.
   Methods: We enrolled HIV seronegative women aged 18-44 years and employed in the towns of Geita, Kahama, Moshi, and Shinyanga. At enrolment, women were interviewed to obtain information about alcohol use, using CAGE and AUDIT screening scales, and risk factors for HIV infection. Blood and genital samples were collected for detection of HIV and sexually transmitted infections (STIs). We characterized alcohol use, concordance, and agreement of the scales, and examined the associations between characteristics of participants and problem drinking as defined by both scales using logistic regression. Lastly, we assessed problem drinking as a risk factor for recent sexual behavior and prevalent STIs.
   Results: Among enrollees, 68% women reported ever drinking alcohol; of these 76% reported drinking alcohol in the past 12 months. The prevalence of problem drinking was 20% using CAGE and 13% using AUDIT. Overall concordance between the scales was 75.0% with a Kappa statistic of 0.58. After adjusting for age, independent factors associated with problem drinking, on both scales, were marital status, occupation, facility type, increasing number of lifetime sexual partners, and transactional sex in the past 12 months. In addition, women who were problem drinkers on either scale were more likely to report having >= 1 sexual partner (CAGE: aOR = 1.56, 95% confidence interval, CI: 1.10-2.23; AUDIT: aOR = 2.00, 95% CI: 1.34-3.00) and transactional sex (CAGE: aOR = 1.79, 95% CI: 1.26-2.56; AUDIT: aOR = 1.51, 95% CI: 1.04-2.18), in the past 3 months.
   Conclusion: These findings suggest that interventions to reduce problem drinking in this population may reduce high-risk sexual behaviors and contribute in lowering the risk of HIV infection.
C1 [Mongi, Aika S.; Trong Thanh-Hoang Ao; Francis, Suzanna C.; Kapiga, Saidi] Mwanza Intervent Trials Unit, Mwanza, Tanzania.
   [Baisley, Kathy; Trong Thanh-Hoang Ao; Aguirre-Andreasen, Aura; Francis, Suzanna C.; Hayes, Richard; Kapiga, Saidi] London Sch Hyg & Trop Med, London WC1, England.
   [Chilongani, Joseph] Natl Inst Med Res, Mwanza, Tanzania.
   [Shao, John] Kilimanjaro Christian Med Ctr, Moshi, Tanzania.
RP Kapiga, S (reprint author), Mwanza Intervent Trials Unit, Mwanza, Tanzania.
EM Saidi.Kapiga@lshtm.ac.uk
OI Kapiga, Saidi/0000-0003-1753-4060; Francis, Suzanna
   Carter/0000-0002-3724-4813; Hayes, Richard/0000-0002-1729-9892
FU European and Developing Countries Clinical Trials Partnership (EDCTP)
   [CT_ct_05_ 32070_002]; EDCTP; Bill and Melinda Gates Foundation
   [CG_ct_06_33111]; UK aid from the Department of International
   Development [PHGHHD7610]; Medical Research Council [G0701039, G1002369,
   MR/K012126/1]
FX The microbicide preparedness study was funded by the European and
   Developing Countries Clinical Trials Partnership (EDCTP; project code:
   CT_ct_05_ 32070_002) and the HIV vaccines feasibility cohort was funded
   by EDCTP and the Bill and Melinda Gates Foundation (project code:
   CG_ct_06_33111). Partial support for drafting the manuscript was
   provided by STRIVE RPC with funding from the UK aid from the Department
   of International Development (DFID; project code: PHGHHD7610). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Ao T, 2003, INT J STD AIDS, V14, P688, DOI 10.1258/095646203322387956
   Ao TTH, 2006, SEX TRANSM DIS, V33, P163, DOI 10.1097/01.olq.0000187204.57006.b3
   Babor T. F., 2001, AUDIT ALCOHOL USE DI
   Baliunas D, 2010, INT J PUBLIC HEALTH, V55, P159, DOI 10.1007/s00038-009-0095-x
   Bradley KA, 1998, JAMA-J AM MED ASSOC, V280, P166, DOI 10.1001/jama.280.2.166
   Chersich MF, 2010, INT J STD AIDS, V21, P2, DOI [10.1258/ijsa.2009.009432, 10.1258/ijsa.2000.009432]
   Clift S, 2003, SEX TRANSM INFECT, V79, P307, DOI 10.1136/sti.79.4.307
   Ewing JA, 1998, BRIT MED J, V316, P1827, DOI 10.1136/bmj.316.7147.1827
   EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905
   Ewing JA, 1998, JAMA-J AM MED ASSOC, V280, P1904, DOI 10.1001/jama.280.22.1904
   Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977
   Fisher JC, 2008, SEX TRANSM DIS, V35, P537, DOI 10.1097/OLQ.0b013e3181677547
   Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd
   Fritz K, 2010, LANCET, V376, P398, DOI 10.1016/S0140-6736(10)60884-7
   Ghebremichael M, 2009, SEX TRANSM DIS, V36, P102, DOI 10.1097/OLQ.0b013e31818b20e6
   Hahn Judith A, 2011, Curr HIV/AIDS Rep, V8, P172, DOI 10.1007/s11904-011-0088-2
   Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2
   Kapiga SH, 2007, J INFECT DIS, V195, P1260, DOI 10.1086/513566
   Kapiga SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068825
   Kapiga SH, 2006, AIDS CARE, V18, P379, DOI 10.1080/09540120500465012
   Kapiga SH, 2003, SEX TRANSM DIS, V30, P187, DOI 10.1097/00007435-200303000-00001
   Kapiga SH, 2002, J ACQ IMMUN DEF SYND, V29, P409
   Kapiga SH, 1998, AIDS, V12, P75, DOI 10.1097/00002030-199801000-00009
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Mahony JB, 2001, J CLIN MICROBIOL, V39, P1429, DOI 10.1128/JCM.39.4.1429-1435.2001
   MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121
   Montgomery CM, 2008, AIDS CARE, V20, P733, DOI 10.1080/09540120701693974
   Norris AH, 2009, SOC SCI MED, V69, P1167, DOI 10.1016/j.socscimed.2009.07.015
   Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7
   Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x
   SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x
   STEELE CM, 1990, AM PSYCHOL, V45, P921, DOI 10.1037/0003-066X.45.8.921
   Tassiopoulos KK, 2006, AIDS BEHAV, V10, P405, DOI 10.1007/s10461-006-9112-8
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   Walker Robert, 2004, Trauma Violence Abuse, V5, P143, DOI 10.1177/1524838003262333
   Watson-Jones D, 2009, AIDS, V23, P415, DOI 10.1097/QAD.0b013e32831ef523
   Watson-Jones D, 2007, JAIDS-J ACQ IMM DEF, V46, P631, DOI 10.1097/QAI.0b013e31815b2d9c
   Watt MH, 2012, SOC SCI MED, V74, P1005, DOI 10.1016/j.socscimed.2011.12.022
   Weinhardt LS, 1998, ARCH SEX BEHAV, V27, P155, DOI 10.1023/A:1018682530519
   Woolf-King SE, 2011, ARCH SEX BEHAV, V40, P17, DOI 10.1007/s10508-009-9516-4
   World Health Organization, 2011, GLOB STAT REP ALC HL
NR 42
TC 6
Z9 6
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 31
PY 2013
VL 8
IS 12
AR e84447
DI 10.1371/journal.pone.0084447
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 284MV
UT WOS:000329323900099
PM 24391956
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Al-Janabi, S
   van Slooten, HJ
   Visser, M
   van der Ploeg, T
   van Diest, PJ
   Jiwa, M
AF Al-Janabi, Shaimaa
   van Slooten, Henk-Jan
   Visser, Mike
   van der Ploeg, Tjeerd
   van Diest, Paul J.
   Jiwa, Mehdi
TI Evaluation of Mitotic Activity Index in Breast Cancer Using Whole Slide
   Digital Images
SO PLOS ONE
LA English
DT Article
ID INTEROBSERVER AGREEMENT; PROGNOSTIC VALUE; PRIMARY DIAGNOSTICS; SURGICAL
   PATHOLOGY; VIRTUAL MICROSCOPY; CARCINOMA; PROLIFERATION; FEASIBILITY;
   SPECIMENS; ROUTINE
AB Introduction: Mitotic Activity Index (MAI) is an important independent prognostic factor and an integral part of the breast cancer grading system. Thus, correct estimation of this prognostically relevant feature is essential for guiding treatment decision and assessing patient prognosis. The aim of this study was to validate the use of high resolution Whole Slide Images (WSI) in estimating MAI in breast cancer specimens.
   Methods: MAI was evaluated in 100 consecutive breast cancer specimens by three observers on two occasions, microscopically and on WSI with a wash out period of 4 months. MAI was also translated to mitotic scores as in grading. Inter-and intra-observer agreement between microscopic and digital MAI counts and scores was measured.
   Results: Almost perfect inter-observer agreements were obtained from counting MAI using a conventional microscope (intra-class correlation coefficient (ICCC) 0.879) as well as on WSI (ICCC 0.924). K coefficients reflected good inter-observer agreements among observers' microscopic mitotic scores (average kappa 0.642). Comparable results were also observed among digital mitotic scores (average kappa 0.635). There was strong to perfect intra-observer agreements between MAI counts and mitotic scores for the two diagnostic modalities (ICCC 0.716-0.863, kappa 0.506-0.617). There were no significant differences in mitotic scores using both diagnostic modalities.
   Conclusion: Scoring mitoses using WSI in breast cancer seems to be just as reliable and reproducible as when using a microscope. Further development of software and image quality will definitely encourage the use of WSI in routine pathology practice.
C1 [Al-Janabi, Shaimaa; van Slooten, Henk-Jan; Jiwa, Mehdi] Symbiant Pathol Expert Ctr, Alkmaar, Netherlands.
   [Visser, Mike] Symbiant Pathol Expert Ctr, Zaandam, Netherlands.
   [van der Ploeg, Tjeerd] Med Ctr Alkmaar, Alkmaar, Netherlands.
   [van Diest, Paul J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands.
RP Jiwa, M (reprint author), Symbiant Pathol Expert Ctr, Alkmaar, Netherlands.
EM m.jiwa@symbiant.nl
CR Al-Janabi S, 2012, HUM PATHOL, V43, P2318, DOI 10.1016/j.humpath.2012.03.027
   Al-Janabi S, 2013, J CLIN PATHOL, V66, P218, DOI 10.1136/jclinpath-2012-201104
   Al-Janabi S, 2012, J CLIN PATHOL, V65, P1107, DOI 10.1136/jclinpath-2012-200878
   Al-Janabi S, 2012, HISTOPATHOLOGY, V61, P1, DOI 10.1111/j.1365-2559.2011.03814.x
   Al-Janabi S, 2012, HUM PATHOL, V43, P702, DOI 10.1016/j.humpath.2011.06.017
   Al-Janabi S, 2012, J CLIN PATHOL, V65, P152, DOI 10.1136/jclinpath-2011-200277
   Baak JPA, 2005, J CLIN ONCOL, V23, P5993, DOI 10.1200/JCO.2005.05.511
   BAAK JPA, 1993, J CELL BIOCHEM, P220
   BECK JS, 1985, J CLIN PATHOL, V38, P1358, DOI 10.1136/jcp.38.12.1358
   Beresford MJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1618
   CLAYTON F, 1991, CANCER, V68, P1309, DOI 10.1002/1097-0142(19910915)68:6<1309::AID-CNCR2820680621>3.0.CO;2-I
   Cornish TC, 2012, ADV ANAT PATHOL, V19, P152, DOI 10.1097/PAP.0b013e318253459e
   Dee FR, 2009, HUM PATHOL, V40, P1112, DOI 10.1016/j.humpath.2009.04.010
   Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966
   Gilbertson JR, 2006, BMC CLIN PATHOL, V6, DOI 10.1186/1472-6890-6-4
   Ho J, 2006, HUM PATHOL, V37, P322, DOI 10.1016/j.humpath.2005.11.005
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lange H, 2011, LABMEDICINE, V42, P587, DOI 10.1309/LMA2M9NQQFOZCVHC
   Lester SC, 2009, ARCH PATHOL LAB MED, V133, P1515, DOI 10.1043/1543-2165-133.10.1515
   Li XX, 2007, HUM PATHOL, V38, P1842, DOI 10.1016/j.humpath.2007.04.019
   Longacre TA, 2006, MODERN PATHOL, V19, P195, DOI 10.1038/modpathol.3800496
   Martin DT, 2011, ACTA CYTOL, V55, P271, DOI 10.1159/000324029
   Medri L, 2003, MODERN PATHOL, V16, P1067, DOI 10.1097/01.MP.0000093625.20366.9D
   Meyer JS, 2005, MODERN PATHOL, V18, P1067, DOI 10.1038/modpathol.3800388
   Molnar B, 2003, J CLIN PATHOL, V56, P433, DOI 10.1136/jcp.56.6.433
   Nielsen PS, 2010, HUM PATHOL, V41, P1770, DOI 10.1016/j.humpath.2010.05.015
   Pantanowitz Liron, 2011, J Pathol Inform, V2, P36, DOI 10.4103/2153-3539.83746
   Pietilainen T, 1996, J CANCER RES CLIN, V122, P687, DOI 10.1007/BF01209033
   ROBBINS P, 1995, HUM PATHOL, V26, P873, DOI 10.1016/0046-8177(95)90010-1
   Rocha R, 2009, PATHOL RES PRACT, V205, P735, DOI 10.1016/j.prp.2009.05.004
   Tsuda H, 2000, JPN J CANCER RES, V91, P451, DOI 10.1111/j.1349-7006.2000.tb00966.x
   van Diest PJ, 2004, J CLIN PATHOL, V57, P675, DOI 10.1136/jcp.2003.010777
   van Diest PJ, 1998, J CLIN PATHOL, V51, P716, DOI 10.1136/jcp.51.10.716
   VANDIEST PJ, 1992, HUM PATHOL, V23, P603, DOI 10.1016/0046-8177(92)90313-R
   Veta M, 2012, MODERN PATHOL, V25, P1559, DOI 10.1038/modpathol.2012.126
   Viera AJ, 2005, FAM MED, V37, P360
NR 36
TC 13
Z9 13
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 30
PY 2013
VL 8
IS 12
AR e82576
DI 10.1371/journal.pone.0082576
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 282SX
UT WOS:000329194700010
PM 24386102
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Christe, A
   Szucs-Farkas, Z
   Huber, A
   Steiger, P
   Leidolt, L
   Roos, JE
   Heverhagen, J
   Ebner, L
AF Christe, Andreas
   Szucs-Farkas, Zsolt
   Huber, Adrian
   Steiger, Philipp
   Leidolt, Lars
   Roos, Justus E.
   Heverhagen, Johannes
   Ebner, Lukas
TI Optimal Dose Levels in Screening Chest CT for Unimpaired Detection and
   Volumetry of Lung Nodules, with and without Computer Assisted Detection
   at Minimal Patient Radiation
SO PLOS ONE
LA English
DT Article
ID SUBSOLID PULMONARY NODULES; AIDED DETECTION; MULTIDETECTOR CT;
   CONTRAST-MEDIUM; TOMOGRAPHY; ANGIOGRAPHY; PERFORMANCE; ACCURACY;
   GUIDELINES; PATTERNS
AB Objectives: The aim of this phantom study was to minimize the radiation dose by finding the best combination of low tube current and low voltage that would result in accurate volume measurements when compared to standard CT imaging without significantly decreasing the sensitivity of detecting lung nodules both with and without the assistance of CAD.
   Methods: An anthropomorphic chest phantom containing artificial solid and ground glass nodules (GGNs, 5-12 mm) was examined with a 64-row multi-detector CT scanner with three tube currents of 100, 50 and 25 mAs in combination with three tube voltages of 120, 100 and 80 kVp. This resulted in eight different protocols that were then compared to standard CT sensitivity (100 mAs/120 kVp). For each protocol, at least 127 different nodules were scanned in 21-25 phantoms. The nodules were analyzed in two separate sessions by three independent, blinded radiologists and computer-aided detection (CAD) software.
   Results: The mean sensitivity of the radiologists for identifying solid lung nodules on a standard CT was 89.7%+/- 4.9%. The sensitivity was not significantly impaired when the tube and current voltage were lowered at the same time, except at the lowest exposure level of 25 mAs/80 kVp [80.6%+/- 4.3% (p = 0.031)]. Compared to the standard CT, the sensitivity for detecting GGNs was significantly lower at all dose levels when the voltage was 80 kVp; this result was independent of the tube current. The CAD significantly increased the radiologists' sensitivity for detecting solid nodules at all dose levels (5-11%). No significant volume measurement errors (VMEs) were documented for the radiologists or the CAD software at any dose level.
   Conclusions: Our results suggest a CT protocol with 25 mAs and 100 kVp is optimal for detecting solid and ground glass nodules in lung cancer screening. The use of CAD software is highly recommended at all dose levels.
C1 [Christe, Andreas; Huber, Adrian; Steiger, Philipp; Leidolt, Lars; Heverhagen, Johannes; Ebner, Lukas] Hosp & Univ Bern, Inselspital, Dept Radiol, Bern, Switzerland.
   [Szucs-Farkas, Zsolt] Hosp Ctr Biel, Dept Radiol, Biel, Switzerland.
   [Roos, Justus E.] Duke Univ, Dept Radiol, Durham, NC 27710 USA.
RP Christe, A (reprint author), Hosp & Univ Bern, Inselspital, Dept Radiol, Bern, Switzerland.
EM andreas.christe@insel.ch
RI Huber, Adrian/N-5713-2016
OI Huber, Adrian/0000-0001-6146-8238; Steiger, Philipp/0000-0001-5886-5216
FU Bernese Cancer League; Jubilee Foundation Swisslife; Swiss Fight Against
   Cancer Foundation
FX This study was financed by the Bernese Cancer League, the Jubilee
   Foundation Swisslife and the Swiss Fight Against Cancer Foundation. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Armato SG, 2002, RADIOLOGY, V225, P685, DOI 10.1148/radiol.2553011376
   Aroua A, 2004, RADIAT PROT DOSIM, V111, P289, DOI 10.1093/rpd/nch343
   Awai K, 2004, RADIOLOGY, V230, P347, DOI 10.1148/radiol.2302030049
   Bankier AA, 2007, RADIOLOGY, V242, P898, DOI 10.1148/radiol.2423060196
   Bongartz G, 2004, EUROPEAN GUIDELINES
   Christe A, 2013, EUR J RADIOL, V82, pE142, DOI 10.1016/j.ejrad.2012.09.025
   Christe A, 2012, EUR J RADIOL, V81, P2860, DOI 10.1016/j.ejrad.2011.06.059
   Christe A, 2011, AM J ROENTGENOL, V197, P623, DOI 10.2214/AJR.10.5288
   Das M, 2008, BRIT J RADIOL, V81, P841, DOI 10.1259/bjr/50635688
   Das M, 2006, RADIOLOGY, V241, P564, DOI 10.1148/radiol.2412051139
   Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026
   FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619
   Fleiss JL, 1981, STAT METHODS RATES P, P38
   Godoy MCB, 2009, RADIOLOGY, V253, P606, DOI 10.1148/radiol.2533090179
   Goldman RN, 1985, STAT INTRO, P334
   Hein PA, 2009, ROFO-FORTSCHR RONTG, V181, P1056, DOI 10.1055/s-0028-1109394
   Holmquist F, 2006, EUR RADIOL, V16, P1165, DOI 10.1007/s00330-005-0117-x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee JW, 2004, INVEST RADIOL, V39, P649, DOI 10.1097/00004424-200411000-00001
   Li F, 2005, RADIOLOGY, V237, P684, DOI 10.1148/radiol.2372041555
   Michel JL, 2001, J RADIOL, V82, P922
   Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628
   Paul NS, 2007, MED PHYS, V34, P3587, DOI 10.1118/1.2768866
   Rizzi EB, 2007, CLIN IMAG, V31, P178, DOI 10.1016/j.clinimag.2006.09.026
   Roos JE, 2010, EUR RADIOL, V20, P549, DOI 10.1007/s00330-009-1596-y
   Rusinek H, 1998, RADIOLOGY, V209, P243, DOI 10.1148/radiology.209.1.9769838
   Schueller-Weidekamm C, 2006, RADIOLOGY, V241, P899, DOI 10.1148/radiol.2413040128
   Szucs-Farkas Z, 2011, AM J ROENTGENOL, V197, pW852, DOI 10.2214/AJR.11.6750
   Tack D, 2005, RADIOLOGY, V236, P318, DOI 10.1148/radiol.2361040190
   Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205
   Thomas CK, 2006, INVEST RADIOL, V41, P668, DOI 10.1097/01.rli.0000233324.09603.dd
   White CS, 2008, ACAD RADIOL, V15, P326, DOI 10.1016/j.acra.2007.09.027
   Willemink MJ, 2012, AM J ROENTGENOL, V199, P1241, DOI 10.2214/AJR.12.8727
   Xie XQ, 2013, EUR RADIOL, V23, P139, DOI 10.1007/s00330-012-2570-7
   Yamada T, 2004, EUR J RADIOL, V51, P169, DOI 10.1016/j.ejrad.2003.09.017
   Yi CA, 2003, AM J ROENTGENOL, V181, P501, DOI 10.2214/ajr.181.2.1810501
   Yu Lifeng, 2009, Imaging Med, V1, P65, DOI 10.2217/iim.09.5
   Zar JH, 2010, BIOSTAT ANAL, P543
   Zompatori M, 2002, Radiol Med, V104, P13
NR 39
TC 4
Z9 7
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 26
PY 2013
VL 8
IS 12
AR e82919
DI 10.1371/journal.pone.0082919
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 281QS
UT WOS:000329116700020
PM 24386126
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Snoek, JA
   van Berkel, S
   van Meeteren, N
   Backx, FJG
   Daanen, HAM
AF Snoek, Johan A.
   van Berkel, Sietske
   van Meeteren, Nico
   Backx, Frank J. G.
   Daanen, Hein A. M.
TI Effect of Aerobic Training on Heart Rate Recovery in Patients with
   Established Heart Disease; a Systematic Review
SO PLOS ONE
LA English
DT Review
ID ACUTE MYOCARDIAL-INFARCTION; CARDIAC REHABILITATION; EXERCISE
   INTOLERANCE; SECONDARY PREVENTION; FAILURE MECHANISMS; ASSOCIATION;
   METAANALYSES; STATEMENT; IMPACT; TRIALS
AB Background: Although a delayed decrease in heart rate during the first minute after graded exercise has been identified as a powerful predictor of overall mortality in cardiac patients, the potential to influence this risk factor by aerobic training remains to be proven.
   Objective: The aim was to study the relationship between aerobic training and Heart Rate Recovery (HRR) in patients with established heart disease.
   Methods: (Quasi) randomized clinical trials on aerobic exercise training in adults with established heart disease were identified through electronic database and reference screening. Two reviewers extracted data and assessed the risk of bias and therapeutic validity. Methodological validity was evaluated using an adapted version of the Cochrane Collaboration's tool for assessing risk of bias and the therapeutic validity of the interventions was assessed with a nine-itemed, expert-based rating scale (CONTENT). Scores range from 0 to 9 (score >= 6 reflecting therapeutic validity).
   Results: Of the 384 articles retrieved, 8 studies (449 patients) were included. Three of the included studies demonstrated adequate therapeutic validity and five demonstrated low risk of bias. Two studies showed both adequate therapeutic validity and a low risk of bias. For cardiac patients aerobic exercise training was associated with more improvement in HRR compared to usual care.
   Conclusion: The present systematic review shows a level 1A evidence that aerobic training increases HRR in patients with established heart disease.
C1 [Snoek, Johan A.; van Berkel, Sietske] Isala, Sports Med Dept, Zwolle, Netherlands.
   [van Meeteren, Nico; Daanen, Hein A. M.] TNO Hlth Living, Leiden, Netherlands.
   [van Meeteren, Nico] Ctr Care Technol Res, Maastricht, Netherlands.
   [Backx, Frank J. G.] UMC Utrecht, Rehabil Nursing Sci & Sports Dept, Utrecht, Netherlands.
   [Daanen, Hein A. M.] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.
   [Daanen, Hein A. M.] Vrije Univ Amsterdam, Fac Human Movement Sci, Amsterdam, Netherlands.
RP Snoek, JA (reprint author), Isala, Sports Med Dept, Zwolle, Netherlands.
EM j.a.snoek@isala.nl
RI van Berkel, Sietske/Y-6277-2018
OI van Berkel, Sietske/0000-0001-7275-0677
CR Anderson L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001800.pub3
   Borresen J, 2007, EUR J APPL PHYSIOL, V101, P503, DOI 10.1007/s00421-007-0516-6
   Buchheit M, 2010, EUR J APPL PHYSIOL, V109, P869, DOI 10.1007/s00421-010-1422-x
   Chen YF, 1997, AM J PHYSIOL-HEART C, V272, pH1412
   Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804
   Daanen HAM, 2012, INT J SPORT PHYSIOL, V7, P251, DOI 10.1123/ijspp.7.3.251
   Giallauria F, 2011, J CARD FAIL, V17, P108, DOI 10.1016/j.cardfail.2010.09.001
   Goldsmith RL, 2000, CORONARY ARTERY DIS, V11, P129, DOI 10.1097/00019501-200003000-00007
   Hoogeboom TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038031
   Jolly MA, 2011, CIRCULATION, V124, P1520, DOI 10.1161/CIRCULATIONAHA.110.005009
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Legramante JM, 2007, AM J PHYSIOL-HEART C, V292, pH510, DOI 10.1152/ajpheart.00748.2006
   Leon AS, 2005, CIRCULATION, V111, P369, DOI 10.1161/01.CIR.0000151788.08740.5C
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700
   Maeder MT, 2009, EUR J APPL PHYSIOL, V105, P247, DOI 10.1007/s00421-008-0896-2
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   Moholdt T, 2012, CLIN REHABIL, V26, P33, DOI 10.1177/0269215511405229
   Myers J, 2007, AM HEART J, V153, P1056, DOI 10.1016/j.ahj.2007.02.038
   OCONNOR GT, 1989, CIRCULATION, V80, P234, DOI 10.1161/01.CIR.80.2.234
   OLDRIDGE NB, 1988, JAMA-J AM MED ASSOC, V260, P945, DOI 10.1001/jama.260.7.945
   Piepoli MF, 2010, EUR J CARDIOV PREV R, V17, P637, DOI 10.1097/HJR.0b013e3283361dc5
   Piepoli MF, 2010, EUR J CARDIOV PREV R, V17, P643, DOI 10.1097/HJR.0b013e32833f3aa5
   Piepoli MF, 2010, EUR J CARDIOV PREV R, V17, P1, DOI 10.1097/HJR.0b013e3283313592
   Ribeiro F, 2012, REV PORT CARDIOL, V31, P135, DOI 10.1016/j.repc.2011.12.009
   Shetler K, 2001, J AM COLL CARDIOL, V38, P1980, DOI 10.1016/S0735-1097(01)01652-7
   Tsai SW, 2005, CLIN REHABIL, V19, P843, DOI 10.1191/0269215505cr915oa
   van Rijn RM, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5688
   van Tulder MW, 2009, SPINE, V34, P1685, DOI 10.1097/BRS.0b013e3181ab6a78
   Wu SK, 2006, AM J PHYS MED REHAB, V85, P711, DOI 10.1097/01.phm.0000228597.64057.66
   Zheng H, 2008, J REHABIL MED, V40, P776, DOI 10.2340/16501977-0254
NR 30
TC 14
Z9 14
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 18
PY 2013
VL 8
IS 12
AR e83907
DI 10.1371/journal.pone.0083907
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 276HL
UT WOS:000328740300120
PM 24367618
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Bohr, I
   Read, JCA
AF Bohr, Iwo
   Read, Jenny C. A.
TI Stereoacuity with Frisby and Revised FD2 Stereo Tests
SO PLOS ONE
LA English
DT Article
ID DISTANCE STEREOACUITY; VISUAL-ACUITY; AGE; CHILDREN; RANDOT; NORMS; BLUR
AB We compared near stereoacuity, measured with the Frisby test, and distance stereoacuity, measured with the revised Frisby-Davis (FD2) test, enabling a comparison with the original version of the FD2. In the revised version of the FD2 test, a white background is used instead of a backlit background. We also examined the effect of age, gender and visual problems. We used the Frisby test at distances ranging from 30-80 cm and FD2 at 6 m. The best possible score was 20 seconds of arc (arcsec) on the Frisby and 5 arcsec on the FD2; participants who could not perform a test despite demonstrating understanding of it were classed as stereonegative. We examined both the whole population recruited, and a subpopulation screened so as to exclude visual problems. We analysed our results in three age-groups: "visually developing" (36 children aged 5-10 years); "visually mature" (300 participants aged 11-49 years) and "older" (29 participants aged 50-82). In the whole population, the median stereoacuity on the Frisby test was 25, 20 and 85 arcsec in the three age-groups. In the sub-population with no visual problems, median Frisby stereoacuity was similar at 20, 20 and 80 arcsec respectively. On the FD2, the medians were 10, 10, 20 arcsec for the whole population and 7.5, 10 and 12.5 for the sub-population. Children were more likely than adults to be stereonegative on the FD2, although none of the children were stereonegative on the Frisby. The two tests showed fair agreement when used to classify people into three categories of stereovision. Poor stereovision was often associated with binocular problems such as tropia, but with many exceptions. In line with previous studies, we found improvements in measured stereoacuity in childhood and declines in late adulthood. The new FD2 test gives comparable values to the original FD2.
C1 [Bohr, Iwo; Read, Jenny C. A.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
RP Bohr, I (reprint author), Newcastle Univ, Inst Neurosci, Henry Welcome Bldg Neuroecol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM iwo.bohr@newcastle.ac.uk
RI Bohr, Iwo/E-9339-2017; Read, Jenny/A-7493-2013
OI Read, Jenny/0000-0002-9029-5185
FU British Sky Broadcasting Limited (BSkyB); Royal Society [UF041260]
FX The work was funded by British Sky Broadcasting Limited (BSkyB,
   http://corporate.sky.com/). The design of the study was discussed with
   BSkyB before funding was agreed. A copy of this manuscript was given to
   the funder before submission. They did not request any changes. JCAR was
   funded by Royal Society University Research Fellowship UF041260.
CR Adams WE, 2005, BRIT J OPHTHALMOL, V89, P1438, DOI 10.1136/bjo.2005.071761
   Adams WE, 2008, J AAPOS, V12, P141, DOI 10.1016/j.jaapos.2007.09.015
   Adams WE, 2009, OPHTHALMOLOGY, V116, P281, DOI 10.1016/j.ophtha.2008.09.012
   BIRCH EE, 1982, VISION RES, V22, P507, DOI 10.1016/0042-6989(82)90108-0
   Braddick O, 1983, Hum Neurobiol, V2, P65
   BROWN B, 1993, OPHTHAL PHYSL OPT, V13, P138, DOI 10.1111/j.1475-1313.1993.tb00442.x
   Buck D, 2007, BRIT J OPHTHALMOL, V91, P215, DOI 10.1136/bjo.2006.097790
   Ciner EB, 1996, OPTOMETRY VISION SCI, V73, P43, DOI 10.1097/00006324-199601000-00007
   CINER EB, 1991, OPTOMETRY VISION SCI, V68, P533, DOI 10.1097/00006324-199107000-00004
   COOPER J, 1979, J AM OPTOM ASSOC, V50, P807
   Costa MF, 2010, OPHTHAL PHYSL OPT, V30, P660, DOI 10.1111/j.1475-1313.2010.00750.x
   FOX R, 1986, INVEST OPHTH VIS SCI, V27, P598
   Frisby JP, 1996, EYE, V10, P286, DOI 10.1038/eye.1996.60
   Garnham L, 2006, BRIT J OPHTHALMOL, V90, P91, DOI 10.1136/bjo.2005.077719
   Hatt SR, 2007, BRIT J OPHTHALMOL, V91, P219, DOI 10.1136/bjo.2006.099465
   HELD R, 1980, P NATL ACAD SCI-BIOL, V77, P5572, DOI 10.1073/pnas.77.9.5572
   Holmes JM, 2005, AM J OPHTHALMOL, V139, P193, DOI 10.1016/j.ajo.2004.07.008
   Holmes JM, 2007, OPHTHALMOLOGY, V114, P1215, DOI 10.1016/j.ophtha.2006.06.066
   Hong SW, 2008, BRIT J OPHTHALMOL, V92, P1186, DOI 10.1136/bjo.2008.138362
   Laird PW, 2008, J AAPOS, V12, P370, DOI 10.1016/j.jaapos.2008.01.013
   Laird PW, 2007, J AAPOS, V11, P362, DOI 10.1016/j.jaapos.2007.01.116
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leat SJ, 2001, J PEDIAT OPHTH STRAB, V38, P284
   Lee Se-Youp, 2005, Korean J Ophthalmol, V19, P136
   Odell NV, 2009, J AAPOS, V13, P136, DOI 10.1016/j.jaapos.2008.09.005
   Oduntan AO, 1998, CLIN EXP OPTOM, V81, P193
   Ohlsson J, 2001, J AAPOS, V5, P316, DOI 10.1067/mpa.2001.118669
   Rahi JS, 2009, OPHTHALMOLOGY, V116, P270, DOI 10.1016/j.ophtha.2008.09.018
   ROMANO PE, 1975, AM J OPHTHALMOL, V79, P966, DOI 10.1016/0002-9394(75)90679-0
   Rosner J, 1984, J Am Optom Assoc, V55, P505
   Saxena R, 2011, BRIT J OPHTHALMOL, V95, P1098, DOI 10.1136/bjo.2010.182139
   SCHMID M, 1986, EUR J PEDIATR, V145, P475, DOI 10.1007/BF02429046
   Schneck ME, 2000, OPTOMETRY VISION SCI, V77, P531, DOI 10.1097/00006324-200010000-00007
   Serrano-Pedraza I, 2011, INVEST OPHTH VIS SCI, V52, P2352, DOI 10.1167/iovs.10-6144
   Sharma P, 2008, INDIAN J OPHTHALMOL, V56, P121, DOI 10.4103/0301-4738.39116
   SIMONS K, 1981, ARCH OPHTHALMOL-CHIC, V99, P439
   Smith J, 1988, PERCEPTION, V17, P365
   Takai Y, 2005, JPN J OPHTHALMOL, V49, P1, DOI 10.1007/s10384-004-0141-4
   Taroyan NA, 2004, DOC OPHTHALMOL, V108, P185, DOI 10.1007/s10633-004-4061-x
   Wattam-Bell J, 2009, J VISION, V9, DOI 10.1167/9.6.9
   WRIGHT LA, 1992, EYE, V6, P473, DOI 10.1038/eye.1992.100
   Young BJ, 2009, J OPHTHALMOL, DOI 10.1155/2009/343827
   Zaroff CM, 2003, INVEST OPHTH VIS SCI, V44, P891, DOI 10.1167/iovs.02-0361
NR 43
TC 22
Z9 22
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 12
PY 2013
VL 8
IS 12
AR e82999
DI 10.1371/journal.pone.0082999
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 276EU
UT WOS:000328731800090
PM 24349416
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Royan, A
   Hannah, DM
   Reynolds, SJ
   Noble, DG
   Sadler, JP
AF Royan, Alexander
   Hannah, David M.
   Reynolds, S. James
   Noble, David G.
   Sadler, Jonathan P.
TI Avian Community Responses to Variability in River Hydrology
SO PLOS ONE
LA English
DT Article
ID CLIMATE-CHANGE; FLOW REGIMES; BIODIVERSITY; SELECTION; IMPACTS;
   POPULATIONS; DISTURBANCE; DISPERSAL; DYNAMICS; CINCLUS
AB River flow is a major driver of morphological structure and community dynamics in riverine-floodplain ecosystems. Flow influences in-stream communities through changes in water velocity, depth, temperature, turbidity and nutrient fluxes, and perturbations in the organisation of lower trophic levels are cascaded through the food web, resulting in shifts in food availability for consumer species. River birds are sensitive to spatial and phenological mismatches with aquatic prey following flow disturbances; however, the role of flow as a determinant of riparian ecological structure remains poorly known. This knowledge is crucial to help to predict if, and how, riparian communities will be influenced by climate-induced changes in river flow characterised by more extreme high (i.e. flood) and/or low (i.e. drought) flow events. Here, we combine national-scale datasets of river bird surveys and river flow archives to understand how hydrological disturbance has affected the distribution of riparian species at higher trophic levels. Data were analysed for 71 river locations using a Generalized Additive Model framework and a model averaging procedure. Species had complex but biologically interpretable associations with hydrological indices, with species' responses consistent with their ecology, indicating that hydrological-disturbance has implications for higher trophic levels in riparian food webs. Our quantitative analysis of river flow-bird relationships demonstrates the potential vulnerability of riparian species to the impacts of changing flow variability and represents an important contribution in helping to understand how bird communities might respond to a climate change-induced increase in the intensity of floods and droughts. Moreover, the success in relating parameters of river flow variability to species' distributions highlights the need to include river flow data in climate change impact models of species' distributions.
C1 [Royan, Alexander; Hannah, David M.; Sadler, Jonathan P.] Univ Birmingham, Coll Life & Environm Sci, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England.
   [Reynolds, S. James; Sadler, Jonathan P.] Univ Birmingham, Coll Life & Environm Sci, Ctr Ornithol, Sch Biosci, Birmingham, W Midlands, England.
   [Noble, David G.] British Trust Ornithol, Thetford, Norfolk, England.
RP Royan, A (reprint author), Univ Birmingham, Coll Life & Environm Sci, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England.
EM axr196@bham.ac.uk; j.p.sadler@bham.ac.uk
RI Hannah, David M./B-9221-2015
OI Hannah, David M./0000-0003-1714-1240; Sadler,
   Jonathan/0000-0003-0443-4458
FU National Environment Research Council (NERC) [NE/J500240/1]; British
   Trust for Ornithology; Natural Environment Research Council [1118595]
FX This research was made possible by financial support to AR from a
   National Environment Research Council (NERC) studentship (NE/J500240/1)
   with support from the British Trust for Ornithology. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Arthur AD, 2012, WETLANDS, V32, P257, DOI 10.1007/s13157-011-0235-y
   Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3
   Bates AJ, 2006, OECOLOGIA, V150, P50, DOI 10.1007/s00442-006-0508-y
   Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x
   Bower D, 2004, HYDROL PROCESS, V18, P2515, DOI 10.1002/hyp.1479
   Brook BW, 2009, BIOL LETTERS, V5, P723, DOI 10.1098/rsbl.2009.0480
   Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0
   Burnham K. P, 2002, MODEL SELECTION MULT
   Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644
   Chiu MC, 2008, FRESHWATER BIOL, V53, P1335, DOI 10.1111/j.1365-2427.2008.01968.x
   Chiu MC, 2013, IBIS, V155, P377, DOI 10.1111/ibi.12035
   Cumming GS, 2012, FRESHWATER BIOL, V57, P1202, DOI 10.1111/j.1365-2427.2012.02789.x
   Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106
   Davey CM, 2012, GLOBAL ECOL BIOGEOGR, V21, P568, DOI 10.1111/j.1466-8238.2011.00693.x
   Durack PJ, 2012, SCIENCE, V336, P455, DOI 10.1126/science.1212222
   Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114
   Henshall SE, 2011, ECOHYDROLOGY, V4, P512, DOI 10.1002/eco.188
   Huntley B., 2007, CLIMATIC ATLAS EUROP
   Jenouvrier S, 2013, GLOBAL CHANGE BIOL, V19, P2036, DOI 10.1111/gcb.12195
   Jonsson M, 2013, RIVER RES APPL, V29, P537, DOI 10.1002/rra.2559
   Jonsson M, 2012, ECOL RES, V27, P945, DOI 10.1007/s11284-012-0974-0
   JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110
   Lambeets K, 2009, BIOL CONSERV, V142, P625, DOI 10.1016/j.biocon.2008.11.015
   Lambeets K, 2008, J ANIM ECOL, V77, P1162, DOI 10.1111/j.1365-2656.2008.01443.x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Ledger ME, 2013, NAT CLIM CHANGE, V3, P223, DOI [10.1038/nclimate1684, 10.1038/NCLIMATE1684]
   Min SK, 2011, NATURE, V470, P378, DOI 10.1038/nature09763
   Monk WA, 2008, RIVER RES APPL, V24, P988, DOI 10.1002/rra.1120
   Monk WA, 2007, RIVER RES APPL, V23, P113, DOI 10.1002/rra.964
   Murakami M, 2001, ECOL RES, V16, P913, DOI 10.1046/j.1440-1703.2001.00448.x
   Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166
   O'Callaghan MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061866
   Olden JD, 2003, RIVER RES APPL, V19, P101, DOI 10.1002/rra.700
   Pall P, 2011, NATURE, V470, P382, DOI 10.1038/nature09762
   Palmer MA, 1996, OECOLOGIA, V105, P247, DOI 10.1007/BF00328554
   Palmer MA, 2009, ENVIRON MANAGE, V44, P1053, DOI 10.1007/s00267-009-9329-1
   Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099
   Prudhomme C, 2012, HYDROL PROCESS, V26, P1115, DOI 10.1002/hyp.8434
   Roche EA, 2012, AUK, V129, P296, DOI 10.1525/auk.2012.11196
   SMITH KG, 1982, ECOLOGY, V63, P952, DOI 10.2307/1937235
   Stephens PA, 2005, J APPL ECOL, V42, P4, DOI 10.1111/j.1365-2664.2005.01002.x
   Strasevicius D, 2013, IBIS, V155, P348, DOI 10.1111/ibi.12024
   SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615
   Taylor AJ, 2001, BIRD STUDY, V48, P173, DOI 10.1080/00063650109461215
   Vaughan IP, 2007, FRESHWATER BIOL, V52, P2270, DOI 10.1111/j.1365-2427.2007.01837.x
   Warren R, 2013, NAT CLIM CHANGE, V3, P678, DOI [10.1038/nclimate1887, 10.1038/NCLIMATE1887]
   Whittingham MJ, 2005, J APPL ECOL, V42, P270, DOI 10.1111/j.1365-2664.2005.01007.x
   Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325
   Wilson J, 2006, ANIM CONSERV, V9, P463, DOI 10.1111/j.1469-1795.2006.00063.x
   WOOD S, 2006, GEN ADDITIVE MODELS
   Woodward G, 2012, PHILOS T R SOC B, V367, P2990, DOI 10.1098/rstb.2012.0245
   Woodward G, 2010, ADV ECOL RES, V42, P71, DOI 10.1016/S0065-2504(10)42002-4
   Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x
NR 53
TC 12
Z9 14
U1 0
U2 66
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 10
PY 2013
VL 8
IS 12
AR e83221
DI 10.1371/journal.pone.0083221
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 275VW
UT WOS:000328707400128
PM 24340094
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wang, J
   Azziz, A
   Fan, B
   Malkov, S
   Klifa, C
   Newitt, D
   Yitta, S
   Hylton, N
   Kerlikowske, K
   Shepherd, JA
AF Wang, Jeff
   Azziz, Ania
   Fan, Bo
   Malkov, Serghei
   Klifa, Catherine
   Newitt, David
   Yitta, Silaja
   Hylton, Nola
   Kerlikowske, Karla
   Shepherd, John A.
TI Agreement of Mammographic Measures of Volumetric Breast Density to MRI
SO PLOS ONE
LA English
DT Article
ID CANCER RISK; SCREENING MAMMOGRAPHY; TISSUE COMPOSITION;
   BODY-COMPOSITION; TAMOXIFEN; WOMEN; MODEL; REDUCTION; PATTERNS; INDEX
AB Background: Clinical scores of mammographic breast density are highly subjective. Automated technologies for mammography exist to quantify breast density objectively, but the technique that most accurately measures the quantity of breast fibroglandular tissue is not known.
   Purpose: To compare the agreement of three automated mammographic techniques for measuring volumetric breast density with a quantitative volumetric MRI-based technique in a screening population.
   Materials and Methods: Women were selected from the UCSF Medical Center screening population that had received both a screening MRI and digital mammogram within one year of each other, had Breast Imaging Reporting and Data System (BI-RADS) assessments of normal or benign finding, and no history of breast cancer or surgery. Agreement was assessed of three mammographic techniques (Single-energy X-ray Absorptiometry [SXA], Quantra, and Volpara) with MRI for percent fibroglandular tissue volume, absolute fibroglandular tissue volume, and total breast volume.
   Results: Among 99 women, the automated mammographic density techniques were correlated with MRI measures with R-2 values ranging from 0.40 (log fibroglandular volume) to 0.91 (total breast volume). Substantial agreement measured by kappa statistic was found between all percent fibroglandular tissue measures (0.72 to 0.63), but only moderate agreement for log fibroglandular volumes. The kappa statistics for all percent density measures were highest in the comparisons of the SXA and MRI results. The largest error source between MRI and the mammography techniques was found to be differences in measures of total breast volume.
   Conclusion: Automated volumetric fibroglandular tissue measures from screening digital mammograms were in substantial agreement with MRI and if associated with breast cancer could be used in clinical practice to enhance risk assessment and prevention.
C1 [Wang, Jeff; Azziz, Ania; Fan, Bo; Malkov, Serghei; Newitt, David; Yitta, Silaja; Hylton, Nola; Shepherd, John A.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.
   [Klifa, Catherine] Synarc Inc, Newark, CA USA.
   [Kerlikowske, Karla] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
   [Kerlikowske, Karla] Univ Calif San Francisco, Dept Epidemiol Biostat, San Francisco, CA 94143 USA.
RP Shepherd, JA (reprint author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.
EM john.shepherd@ucsf.edu
OI Malkov, Serghei/0000-0003-0548-6022
FU NIH [21CA157254, 1R01CA166945, P01CA154292]; California Breast Cancer
   Research Program (CBCRP) [18IB-0042]
FX Funding sources include the NIH and the California Breast Cancer
   Research Program (CBCRP). NIH Funding sources: 1) R21CA157254
   (http://projectreporter.nih.gov/project_info_details.cfm?aid =
   8436160&icde = 16530215&ddparam = &ddvalue = &ddsub = &cr = 1&csb =
   default&cs = ASC). 2) 1R01CA166945
   (http://projectreporter.nih.gov/project_info_details.cfm? aid =
   8439678&icde = 16530236&ddparam = &ddvalue = &ddsub = &cr = 1&csb =
   default&cs = ASC). 3) P01CA154292
   (http://projectreporter.nih.gov/project_info_details.cfm?aid =
   8555529&icde = 16530253&ddparam = &ddvalue = &ddsub = &cr = 1&csb =
   default&cs = ASC). CBCRP Funding sources: 18IB-0042
   (http://cbcrp.org.127.seekdotnet.com/research/PageGrant.asp? grant_id =
   18020). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Aitken Z, 2010, CANCER EPIDEM BIOMAR, V19, P418, DOI 10.1158/1055-9965.EPI-09-1059
   American College of Radiology (ACR), 2003, ILL BREAST IM REP DA
   Barlow WE, 2006, J NATL CANCER I, V98, P1204, DOI 10.1093/jnci/djj331
   Boyd N, 2009, LANCET ONCOL, V10, P569, DOI 10.1016/S1470-2045(09)70078-6
   Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008
   Chen JH, 2011, MAGN RESON IMAGING, V29, P91, DOI 10.1016/j.mri.2010.07.009
   Chlebowski RT, 2003, J NATL CANCER I, V95, P4, DOI 10.1093/jnci/95.1.4
   Chow CK, 2000, CANCER EPIDEM BIOMAR, V9, P917
   Cummings SR, 2009, JNCI-J NATL CANCER I, V101, P384, DOI 10.1093/jnci/djp018
   Cuzick J, 2004, JNCI-J NATL CANCER I, V96, P621, DOI 10.1093/jnci/djh106
   Cuzick J, 2011, J NATL CANCER I, V103, P744, DOI 10.1093/jnci/djr079
   Hartman K, 2008, LECT NOTES COMPUT SC, V5116, P33, DOI 10.1007/978-3-540-70538-3_5
   Heine JJ, 2011, ACAD RADIOL, V18, P547, DOI 10.1016/j.acra.2010.12.007
   Highnam R, 2010, LECT NOTES COMPUT SC, V6136, P342, DOI 10.1007/978-3-642-13666-5_46
   Kallenberg MGJ, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/16/5155
   Kelly TL, 1998, APPL RADIAT ISOTOPES, V49, P511, DOI 10.1016/S0969-8043(97)00226-1
   Kerlikowske K, 2007, J NATL CANCER I, V99, P386, DOI 10.1093/jnci/djk066
   Kerlikowske K, 2011, ANN INTERN MED, V155, P493, DOI 10.7326/0003-4819-155-8-201110180-00005
   Khazen M, 2008, CANCER EPIDEM BIOMAR, V17, P2268, DOI 10.1158/1055-9965.EPI-07-2547
   Klifa C, 2004, P ANN INT IEEE EMBS, V26, P1667
   Klifa C, 2010, MAGN RESON IMAGING, V28, P8, DOI 10.1016/j.mri.2009.05.040
   Kontos D, 2010, P SPIE MED IMAGING 2
   Kopans DB, 2008, RADIOLOGY, V246, P348, DOI 10.1148/radiol.2461070309
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leung J, 2006, SINGLE XRAY ABSORPTI
   Malkov S, 2009, MED PHYS, V36, P5525, DOI 10.1118/1.3253972
   McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965-EPI-06-0034
   Pawluczyk O, 2003, MED PHYS, V30, P352, DOI 10.1118/1.1539038
   Pietrobelli A, 1996, AM J PHYSIOL-ENDOC M, V271, pE941
   Shepherd JA, 2006, MED PHYS, V33, P1490, DOI 10.1118/1.2193691
   Shepherd JA, 2011, CANCER EPIDEM BIOMAR, V20, P1473, DOI 10.1158/1055-9965.EPI-10-1150
   Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004
   Ursin G, 1996, JNCI-J NATL CANCER I, V88, P129
   van Engeland S, 2006, IEEE T MED IMAGING, V25, P273, DOI 10.1109/TMI.2005.862741
   WOLFE JN, 1976, CANCER, V37, P2486, DOI 10.1002/1097-0142(197605)37:5<2486::AID-CNCR2820370542>3.0.CO;2-8
   WOLFE JN, 1976, AM J ROENTGENOL, V126, P1130, DOI 10.2214/ajr.126.6.1130
   Wu S., 2012, FULLY AUTOMATED FIBR, V7361, P244
NR 37
TC 12
Z9 13
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 4
PY 2013
VL 8
IS 12
AR e81653
DI 10.1371/journal.pone.0081653
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 265KD
UT WOS:000327949300101
PM 24324712
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Bertin, D
   Grimaud, JC
   Lesavre, N
   Benelmouloud, C
   Desjeux, A
   Garcia, S
   Desplat-Jego, S
AF Bertin, Daniel
   Grimaud, Jean-Charles
   Lesavre, Nathalie
   Benelmouloud, Chahine
   Desjeux, Ariadne
   Garcia, Stephane
   Desplat-Jego, Sophie
TI Targeting Tissular Immune Response Improves Diagnostic Performance of
   Anti-Saccharomyces cerevisiae Antibodies (ASCA) in Crohn's Disease
SO PLOS ONE
LA English
DT Article
ID INFLAMMATORY-BOWEL-DISEASE; SEROLOGICAL MARKERS; ULCERATIVE-COLITIS;
   METAANALYSIS; PROGRESSION; BIOMARKERS; PHENOTYPES; EPITOPES; BEHAVIOR;
   SURGERY
AB Antibodies against Saccharomyces cerevisiae (ASCA) and Escherichia coli outer membrane porin C (anti-OmpC) are known to be detectable in the serum of patients with Crohn's disease (CD) but display a very poor sensitivity for the disease especially in forms with isolated colonic involvement. In this study we aimed at evaluating performances of these markers in supernatant of cultured colonic biopsies. Patients with colonic CD (n = 67), ulcerative colitis (UC) (n = 35) and control individuals (n = 37) were prospectively recruited for colonoscopy pinch biopsies and blood sampling. Serum and supernatant of culture tissues were analyzed for ASCA and anti-OmpC. Direct immunofluorescence was also performed on colonic tissues for total IgA detection. We detected for the first time ASCA IgA/IgG and anti-OmpC IgA in cultured colonic tissue supernatants. For both markers, sensitivities for diagnosing CD were better in supernatants (ASCA: 53.7%, anti-OmpC: 28.4%) than in serum (ASCA: 31.3%, anti-OmpC: 22.4%). Combination of results from a panel of these tests gave the greatest sensitivity ever described for CD diagnosis in colonic forms (70.2%). In this study, we described, for the first time, ASCA in supernatant of colonic tissue cultures. This assaying approach in CD diagnosis should be taken into consideration in the future especially in CD forms with isolated colonic involvement.
C1 [Bertin, Daniel; Benelmouloud, Chahine; Desplat-Jego, Sophie] Hop Conception, Assistance Publ Hop Marseille, Serv Immunol Biol, Marseille, France.
   [Grimaud, Jean-Charles; Desjeux, Ariadne] Hop Nord Marseille, Assistance Publ Hop Marseille, Serv Gastroenterol, Marseille, France.
   [Lesavre, Nathalie] Hop Nord Marseille, Assistance Publ Hop Marseille, Ctr Invest Clin, Marseille, France.
   [Garcia, Stephane] Hop Nord Marseille, Assistance Publ Hop Marseille, Lab Anat Pathol, Marseille, France.
RP Desplat-Jego, S (reprint author), Hop Conception, Assistance Publ Hop Marseille, Serv Immunol Biol, Marseille, France.
EM sophie.jego-desplat@ap-hm.fr
FU grant AORC from Assistance Publique-Hopitaux de Marseille, France (Appel
   d'Offre de Recherche Clinique) [UF8040]; Aix-Marseille Universite;
   Centre National de la Recherche Scientifique
FX This study was supported by a grant AORC from Assistance
   Publique-Hopitaux de Marseille, France (Appel d'Offre de Recherche
   Clinique UF8040, to SDJ). This work was also supported in part by
   Aix-Marseille Universite and the Centre National de la Recherche
   Scientifique. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012
   BEST WR, 1976, GASTROENTEROLOGY, V70, P439
   Carroccio A, 2002, SCAND J GASTROENTERO, V37, P32, DOI 10.1080/003655202753387329
   Cohavy O, 2000, INFECT IMMUN, V68, P1542, DOI 10.1128/IAI.68.3.1542-1548.2000
   Desplat-Jego S, 2007, WORLD J GASTROENTERO, V13, P2312, DOI 10.3748/wjg.v13.i16.2312
   Dubinsky MC, 2006, AM J GASTROENTEROL, V101, P360, DOI 10.1111/j.1572-0241.2006.00456.x
   Ferrante M, 2007, GUT, V56, P1394, DOI 10.1136/gut.2006.108043
   Gologan S, 2012, J GASTROINTEST LIVER, V21, P39
   Israeli E, 2005, GUT, V54, P1232, DOI 10.1136/gut.2004.060228
   Kaul A, 2012, INFLAMM BOWEL DIS, V18, P1872, DOI 10.1002/ibd.22862
   Krause I, 2007, ANN NY ACAD SCI, V1108, P481, DOI 10.1196/annals.1422.051
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   MALCHOW H, 1984, GASTROENTEROLOGY, V86, P249
   Nascimbeni R, 2005, MODERN PATHOL, V18, P681, DOI 10.1038/modpathol.3800343
   Papp M, 2008, AM J GASTROENTEROL, V103, P665, DOI 10.1111/j.1572-0241.2007.01652.x
   Petersen AM, 2012, SCAND J GASTROENTERO, V47, P155, DOI 10.3109/00365521.2011.639080
   Prideaux L, 2012, INFLAMM BOWEL DIS, V18, P1340, DOI 10.1002/ibd.21903
   Quinton JF, 1998, GUT, V42, P788, DOI 10.1136/gut.42.6.788
   Reumaux D, 2003, BEST PRACT RES CL GA, V17, P19, DOI 10.1053/bega.2002.0347
   Rinaldi M, 2013, CLIN REV ALLERG IMMU, V45, P152, DOI 10.1007/s12016-012-8344-9
   Ruemmele FM, 1998, GASTROENTEROLOGY, V115, P822, DOI 10.1016/S0016-5085(98)70252-5
   Sendid B, 1996, CLIN DIAGN LAB IMMUN, V3, P219
   Sipos F, 2011, WORLD J GASTROENTERO, V17, P1666, DOI 10.3748/wjg.v17.i13.1666
   Tang LY, 2012, INT J COLORECTAL DIS, V27, P1455, DOI 10.1007/s00384-012-1444-4
   TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041
   Vasiliauskas EA, 2000, GUT, V47, P487, DOI 10.1136/gut.47.4.487
   Walker LJ, 2004, CLIN EXP IMMUNOL, V135, P490, DOI 10.1111/j.1365-2249.2003.02392.x
   Zhang ZX, 2012, DIGEST DIS SCI, V57, P2944, DOI 10.1007/s10620-012-2244-y
NR 28
TC 5
Z9 6
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 26
PY 2013
VL 8
IS 11
AR e80433
DI 10.1371/journal.pone.0080433
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 259SK
UT WOS:000327546400030
PM 24303014
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Duran, C
   Nato, F
   Dartevelle, S
   Phuong, LNT
   Taneja, N
   Ungeheuer, MN
   Soza, G
   Anderson, L
   Benadof, D
   Zamorano, A
   Diep, TT
   Nguyen, TQ
   Nguyen, VH
   Ottone, C
   Begaud, E
   Pahil, S
   Prado, V
   Sansonetti, P
   Germani, Y
AF Duran, Claudia
   Nato, Faridabano
   Dartevelle, Sylvie
   Lan Nguyen Thi Phuong
   Taneja, Neelam
   Ungeheuer, Marie Noelle
   Soza, Guillermo
   Anderson, Leslie
   Benadof, Dona
   Zamorano, Agustin
   Tai The Diep
   Truong Quang Nguyen
   Vu Hoang Nguyen
   Ottone, Catherine
   Begaud, Evelyne
   Pahil, Sapna
   Prado, Valeria
   Sansonetti, Philippe
   Germani, Yves
TI Rapid Diagnosis of Diarrhea Caused by Shigella sonnei Using Dipsticks;
   Comparison of Rectal Swabs, Direct Stool and Stool Culture
SO PLOS ONE
LA English
DT Article
ID ENTEROINVASIVE ESCHERICHIA-COLI; POLYMERASE-CHAIN-REACTION;
   ENVIRONMENTAL WATER SAMPLES; B-CELL EPITOPES; DYSENTERY PATIENTS;
   FLEXNERI; PCR; INFECTIONS; INVASION; ASSAY
AB Background: We evaluated a dipstick test for rapid detection of Shigella sonnei on bacterial colonies, directly on stools and from rectal swabs because in actual field situations, most pathologic specimens for diagnosis correspond to stool samples or rectal swabs.
   Methodology/Principal Findings: The test is based on the detection of S. sonnei lipopolysaccharide (LPS) O-side chains using phase I-specific monoclonal antibodies coupled to gold particles, and displayed on a one-step immunochromatographic dipstick. A concentration as low as 5 ng/ml of LPS was detected in distilled water and in reconstituted stools in 6 minutes. This is the optimal time for lecture to avoid errors of interpretation. In distilled water and in reconstituted stools, an unequivocal positive reaction was obtained with 4 x 106 CFU/ml of S. sonnei. The specificity was 100% when tested with a battery of Shigella and different unrelated strains. When tested on 342 rectal swabs in Chile, specificity (281/295) was 95.3% (95% CI: 92.9% - 97.7%) and sensitivity (47/47) was 100%. Stool cultures and the immunochromatographic test showed concordant results in 95.5 % of cases (328/342) in comparative studies. Positive and negative predictive values were 77% (95% CI: 65% - 86.5%) and 100% respectively. When tested on 219 stools in Chile, Vietnam, India and France, specificity (190/198) was 96% (95% CI 92%-98%) and sensitivity (21/21) was 100%. Stool cultures and the immunochromatographic test showed concordant results in 96.3 % of cases (211/219) in comparative studies. Positive and negative predictive values were 72.4% (95% CI 56.1%-88.6%) and 100 %, respectively.
   Conclusion: This one-step dipstick test performed well for diagnosis of S. sonnei both on stools and on rectal swabs. These data confirm a preliminary study done in Chile.
C1 [Duran, Claudia; Prado, Valeria] Univ Chile, Fac Med, Santiago, Chile.
   [Nato, Faridabano; Dartevelle, Sylvie; Ungeheuer, Marie Noelle] Inst Pasteur, F-75724 Paris, France.
   [Lan Nguyen Thi Phuong; Tai The Diep] Pasteur Inst Ho Chi Minh City, Dept Immunol & Microbiol, Ho Chi Minh City, Vietnam.
   [Taneja, Neelam; Pahil, Sapna] Postgrad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh 160012, India.
   [Soza, Guillermo; Anderson, Leslie] Hosp Dr Hernan Henriquez, Temuco, Chile.
   [Benadof, Dona; Zamorano, Agustin] Hosp Roberto del Rio Santiago, Region Metropolitana, Chile.
   [Truong Quang Nguyen; Vu Hoang Nguyen] Paediat Hosp I, Ho Chi Minh City, Vietnam.
   [Begaud, Evelyne] Inst Pasteur, Ctr Ressources Biol, F-75724 Paris, France.
   [Sansonetti, Philippe; Germani, Yves] Inst Pasteur, INSERM, Unite Pathogenie Microbienne Mol, U786, F-75724 Paris, France.
RP Germani, Y (reprint author), Inst Pasteur, INSERM, Unite Pathogenie Microbienne Mol, U786, F-75724 Paris, France.
EM yves.germani@pasteur.fr
FU Institut Pasteur [PTR 179]; TOTAL SA; Banque Nationale de Paris (BNP)
   Paribas at Santiago (Chile)
FX This work was supported by the Institut Pasteur (grant PTR 179). Part of
   the work was supported by a grant from TOTAL SA
   (http://www.total.com/en/home-page-940596.html) and Banque Nationale de
   Paris (BNP) Paribas at Santiago (Chile). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102
   BARZU S, 1993, INFECT IMMUN, V61, P3825
   Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1
   BRENNER DJ, 1984, INT J SYST BACTERIOL, V34, P87, DOI 10.1099/00207713-34-1-87
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Dykman LA, 2000, FEMS IMMUNOL MED MIC, V27, P135, DOI 10.1016/S0928-8244(99)00178-9
   ECHEVERRIA P, 1991, REV INFECT DIS, V13, pS220
   FRANKEL G, 1990, J INFECT DIS, V161, P1252, DOI 10.1093/infdis/161.6.1252
   Gaudio PA, 1997, J INFECT DIS, V176, P1013, DOI 10.1086/516531
   Germani Y, 1998, AM J TROP MED HYG, V59, P1008, DOI 10.4269/ajtmh.1998.59.1008
   Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X
   Gupta A, 2004, CLIN INFECT DIS, V38, P1372, DOI 10.1086/386326
   Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369
   Houng HSH, 1997, DIAGN MICR INFEC DIS, V28, P19, DOI 10.1016/S0732-8893(97)89154-7
   Hsu WB, 2007, FEMS MICROBIOL LETT, V270, P291, DOI 10.1111/j.1574-6968.2007.00686.x
   ISLAM D, 1992, J CLIN MICROBIOL, V30, P2801
   Islam MS, 1998, J DIARRHOEAL DIS RES, V16, P248
   JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703
   KENNE L, 1980, CARBOHYD RES, V78, P119, DOI 10.1016/S0008-6215(00)83665-4
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   KOPECKO DJ, 1980, INFECT IMMUN, V29, P207
   Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651
   LAMPEL KA, 1990, APPL ENVIRON MICROB, V56, P1536
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662
   Liang SY, 2007, J CLIN MICROBIOL, V45, P3574, DOI 10.1128/JCM.00675-07
   Maheux AF, 2009, WATER RES, V43, P3019, DOI 10.1016/j.watres.2009.04.017
   McDonnell J, 2013, CODESIGN, V9, P1, DOI 10.1080/15710882.2013.782994
   Nato F, 2003, CLIN DIAGN LAB IMMUN, V10, P476, DOI 10.1128/CDLI.10.3.476-478.2003
   Nato F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000361
   Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E
   Oyofo BA, 1996, J DIARRHOEAL DIS RES, V14, P207
   Paek SH, 2000, METHODS, V22, P53, DOI 10.1006/meth.2000.1036
   PHALIPON A, 1992, INFECT IMMUN, V60, P1919
   Prado V, 1999, PEDIATR INFECT DIS J, V18, P500, DOI 10.1097/00006454-199906000-00005
   Qu F, 2012, DIAGN MICR INFEC DIS, V74, P166, DOI 10.1016/j.diagmicrobio.2012.06.026
   Ricci Karen A, 2006, Nature, V444 Suppl 1, P29
   SANSONETTI PJ, 1981, INFECT IMMUN, V34, P75
   Sansonetti PJ, 1999, CLIN INFECT DIS, V28, P466, DOI 10.1086/515150
   SETHABUTR O, 1994, J DIARRHOEAL DIS RES, V12, P265
   SETHABUTR O, 1993, J INFECT DIS, V167, P458, DOI 10.1093/infdis/167.2.458
   Shears P, 1996, ANN TROP MED PARASIT, V90, P105, DOI 10.1080/00034983.1996.11813034
   Szakal D, 2003, DIAGN MICR INFEC DIS, V45, P165, DOI 10.1016/S0732-8893(02)00512-6
   Taneja N, 2007, J CLIN MICROBIOL, V45, P678, DOI 10.1128/JCM.02247-06
   Taneja N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024830
   TAYLOR WI, 1975, J CLIN MICROBIOL, V2, P281
   Theron J, 2001, WATER RES, V35, P869, DOI 10.1016/S0043-1354(00)00348-1
   THIEM DV, 2004, VIETNAM J CLIN MICRO, V42, P2031, DOI DOI 10.1128/JCM.42.5.2031-2035.2004
   Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448
   Villalobo E, 1998, APPL ENVIRON MICROB, V64, P1242
   Warren BR, 2005, J FOOD PROTECT, V68, P621, DOI 10.4315/0362-028X-68.3.621
   Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83
   *WHO, 2005, WEEKLY EPIDEMIOLOGIC, V80, P93
   YE LY, 1993, J DIARRHOEAL DIS RES, V11, P38
NR 54
TC 8
Z9 8
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 22
PY 2013
VL 8
IS 11
AR UNSP e80267
DI 10.1371/journal.pone.0080267
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 259QP
UT WOS:000327541700026
PM 24278267
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Mern, DS
   Fontana, J
   Beierfuss, A
   Thome, C
   Hegewald, AA
AF Mern, Demissew S.
   Fontana, Johann
   Beierfuss, Anja
   Thome, Claudius
   Hegewald, Aldemar A.
TI A Combinatorial Relative Mass Value Evaluation of Endogenous Bioactive
   Proteins in Three-Dimensional Cultured Nucleus Pulposus Cells of
   Herniated Intervertebral Discs: Identification of Potential Target
   Proteins for Gene Therapeutic Approaches
SO PLOS ONE
LA English
DT Article
ID AGE-RELATED-CHANGES; EXTRACELLULAR-MATRIX; IN-VIVO; AGGRECAN
   DEGRADATION; GROWTH-FACTORS; END-PLATE; EXPRESSION; DIFFUSION;
   TRANSPLANTATION; BIOSYNTHESIS
AB Painful degenerative disc diseases have been targeted by different biological treatment approaches. Nucleus pulposus (NP) cells play a central role in intervertebral disc (IVD) maintenance by orchestrating catabolic, anabolic and inflammatory factors that affect the extracellular matrix. IVD degeneration is associated with imbalances of these factors, resulting in a catabolic inflammatory metabolism. Therefore, accurate knowledge about their quantity and quality with regard to matrix synthesis is vital for a rational gene therapeutic approach. NP cells were isolated from 63 patients operated due to lumbar disc herniation (mean age 56 / range 29 - 84 years). Then, three-dimensional culture with low-glucose was completed in a collagen type I scaffold for four weeks. Subsequently cell proliferation evaluation was performed using 3-(4, 5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide and intracellular concentration of 28 endogenously expressed anabolic, catabolic, inflammatory factors and relevant matrix proteins was determined by enzyme-linked immunosorbent assay. Specimen-related grades of degeneration were confirmed by preoperative magnetic resonance imaging. Independent from gender, age and grade of degeneration proliferation rates remained similar in all groups of NP cells. Progressive grades of degeneration, however, showed a significant influence on accumulation of selective groups of factors such as disintegrin and metalloproteinase with thrombospondin motifs 4 and 5, matrix metalloproteinase 3, metalloproteinase inhibitor 1 and 2, interleukin-1 beta and interleukin-1 receptor. Along with these changes, the key NP matrix proteins aggrecan and collagen II decreased significantly. The concentration of anabolic factors bone morphogenetic proteins 2, 4, 6 and 7, insulin-like growth factor 1, transforming growth factor beta 1 and 3, however, remained below the minimal detectable quantities. These findings indicate that progressive degenerative changes in NP may be problematic with regard to biologic treatment strategies. Hence, gene therapeutic interventions regulating relevant bioactive factors identified in this work might contribute to the development of regenerative treatment approaches for degenerative disc diseases.
C1 [Mern, Demissew S.; Thome, Claudius; Hegewald, Aldemar A.] Med Univ Innsbruck, Dept Neurosurg, A-6020 Innsbruck, Austria.
   [Mern, Demissew S.; Fontana, Johann; Beierfuss, Anja; Hegewald, Aldemar A.] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neurosurg, Mannheim, Germany.
RP Mern, DS (reprint author), Med Univ Innsbruck, Dept Neurosurg, A-6020 Innsbruck, Austria.
EM demissew.shenegelegn-mern@uki.at
RI , Hegewald/H-2847-2019
OI , Hegewald/0000-0002-2022-2060
FU University Medical Center Mannheim, Heidelberg University
FX The study is financed by University Medical Center Mannheim, Heidelberg
   University. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Antoniou J, 1996, SPINE, V21, P1153, DOI 10.1097/00007632-199605150-00006
   Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884
   Bachmeier BE, 2009, EUR SPINE J, V18, P1573, DOI 10.1007/s00586-009-1031-8
   Bibby SRS, 2004, EUR SPINE J, V13, P695, DOI 10.1007/s00586-003-0616-x
   Gruber HE, 2003, SPINE, V28, P186, DOI 10.1097/00007632-200301150-00017
   Gruber HE, 2002, SPINE, V27, P798, DOI 10.1097/00007632-200204150-00004
   Hastreiter D, 2001, J ORTHOP RES, V19, P597, DOI 10.1016/S0736-0266(00)00069-3
   Hegewald AA, 2008, FRONT BIOSCI-LANDMRK, V13, P1507, DOI 10.2741/2777
   Kalb S, 2012, WORLD NEUROSURG, V77, P491, DOI 10.1016/j.wneu.2011.07.014
   Kanemoto M, 1996, SPINE, V21, P1, DOI 10.1097/00007632-199601010-00001
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275
   Le Maitre CL, 2005, J PATHOL, V207, P445, DOI 10.1002/path.1862
   Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732
   Le Maitre CL, 2004, J PATHOL, V204, P47, DOI 10.1002/path.1608
   Liebscher T, 2011, SPINE, V36, P153, DOI 10.1097/BRS.0b013e3181cd588c
   Malfait AM, 2002, J BIOL CHEM, V277, P22201, DOI 10.1074/jbc.M200431200
   MAROUDAS A, 1975, J ANAT, V120, P113
   Masuda K, 2004, SPINE, V29, P2757, DOI 10.1097/01.brs.0000146048.14946.af
   Meisel HJ, 2007, BIOMOL ENG, V24, P5, DOI 10.1016/j.bioeng.2006.07.002
   Mern DS, 2012, J TISSUE ENG REGEN M, DOI [10.1002/term 1583, DOI 10.1002/TERM]
   Millward-Sadler SJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2693
   Naito S, 2007, PATHOL INT, V57, P703, DOI 10.1111/j.1440-1827.2007.02167.x
   Nerlich AG, 1997, SPINE, V22, P2781, DOI 10.1097/00007632-199712150-00001
   Nerlich AG, 2007, EUR SPINE J, V16, P547, DOI 10.1007/s00586-006-0213-x
   Nishida K, 1999, SPINE, V24, P2419, DOI 10.1097/00007632-199912010-00002
   Nishida K, 2006, SPINE, V31, P1415, DOI 10.1097/01.brs.0000219945.70675.dd
   Nomura T, 2001, CLIN ORTHOP RELAT R, P94
   Okuma M, 2000, J ORTHOPAED RES, V18, P988, DOI 10.1002/jor.1100180620
   Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011
   Rajasekaran S, 2004, SPINE, V29, P2654, DOI 10.1097/01.brs.0000148014.15210.64
   Revell PA, 2007, J MATER SCI-MATER M, V18, P303, DOI 10.1007/s10856-006-0693-6
   Roberts S, 2000, SPINE, V25, P3005, DOI 10.1097/00007632-200012010-00007
   Roberts S, 2006, EUR SPINE J, V15, pS312, DOI 10.1007/s00586-006-0126-8
   Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9
   Seki S, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2851
   Selard E, 2003, SPINE, V28, P1945, DOI 10.1097/01.BRS.0000087210.93541.23
   Singh K, 2009, SPINE, V34, P10, DOI 10.1097/BRS.0b013e31818e5ddd
   Sive JI, 2002, J CLIN PATHOL-MOL PA, V55, P91, DOI 10.1136/mp.55.2.91
   Soukane DM, 2007, J BIOMECH, V40, P2645, DOI 10.1016/j.jbiomech.2007.01.003
   Tolonen J, 2006, EUR SPINE J, V15, P588, DOI 10.1007/s00586-005-0930-6
   Wallach CJ, 2003, SPINE, V28, P2331, DOI 10.1097/01.BRS.0000085303.67942.94
   Wang JR, 2011, J BIOL CHEM, V286, P39738, DOI 10.1074/jbc.M111.264549
   Wang ZH, 2008, ACTA PHARMACOL SIN, V29, P1215, DOI 10.1111/j.1745-7254.2008.00856.x
   Wang ZH, 2010, BIOTECHNOL BIOENG, V107, P730, DOI 10.1002/bit.22862
   Zhao CQ, 2007, AGEING RES REV, V6, P247, DOI 10.1016/j.arr.2007.08.001
   Zhao CQ, 2011, J ORTHOP RES, V29, P718, DOI 10.1002/jor.21285
NR 47
TC 13
Z9 14
U1 1
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 21
PY 2013
VL 8
IS 11
AR e81467
DI 10.1371/journal.pone.0081467
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 259PW
UT WOS:000327539800132
PM 24278441
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Costa, P
   Ferreira, AS
   Amaro, A
   Albuquerque, T
   Botelho, A
   Couto, I
   Cunha, MV
   Viveiros, M
   Inacio, J
AF Costa, Pedro
   Ferreira, Ana S.
   Amaro, Ana
   Albuquerque, Teresa
   Botelho, Ana
   Couto, Isabel
   Cunha, Monica V.
   Viveiros, Miguel
   Inacio, Joao
TI Enhanced Detection of Tuberculous Mycobacteria in Animal Tissues Using a
   Semi-Nested Probe-Based Real-Time PCR
SO PLOS ONE
LA English
DT Article
ID PARAFFIN-EMBEDDED TISSUES; COMPLEX ORGANISMS; BOVIS; CATTLE; IS6110;
   DIFFERENTIATION; SPECIMENS; SEQUENCE; CAPRAE; DNA
AB Bovine tuberculosis has been tackled for decades by costly eradication programs in most developed countries, involving the laboratory testing of tissue samples from allegedly infected animals for detection of Mycobacterium tuberculosis complex (MTC) members, namely Mycobacterium bovis. Definitive diagnosis is usually achieved by bacteriological culture, which may take up to 6-12 weeks, during which the suspect animal carcass and herd are under sanitary arrest. In this work, a user-friendly DNA extraction protocol adapted for tissues was coupled with an IS6110-targeted semi-nested duplex real-time PCR assay to enhance the direct detection of MTC bacteria in animal specimens, reducing the time to achieve a diagnosis and, thus, potentially limiting the herd restriction period. The duplex use of a novel beta-actin gene targeted probe, with complementary targets in most mammals, allowed the assessment of amplification inhibitors in the tissue samples. The assay was evaluated with a group of 128 fresh tissue specimens collected from bovines, wild boars, deer and foxes. Mycobacterium bovis was cultured from 57 of these samples. Overall, the full test performance corresponds to a diagnostic sensitivity and specificity of 98.2% (CIP95% 89.4-99.9%) and 88.7% (CIP95% 78.5-94.7%), respectively. An observed kappa coefficient was estimated in 0.859 (CIP95% 0.771-0.948) for the overall agreement between the semi-nested PCR assay and the bacteriological culture. Considering only bovine samples (n = 69), the diagnostic sensitivity and specificity were estimated in 100% (CIP95% 84.0-100%) and 97.7% (CIP95% 86.2-99.9%), respectively. Eight negative culture samples exhibiting TB-like lesions were detected by the semi-nested real-time PCR, thus emphasizing the increased potential of this molecular approach to detect MTC-infected animal tissues. This novel IS6110-targeted assay allows the fast detection of tuberculous mycobacteria in animal specimens with very high sensitivity and specificity, being amenable and cost effective for use in the routine veterinary diagnostic laboratory with further automation possibilities.
C1 [Costa, Pedro; Ferreira, Ana S.; Amaro, Ana; Albuquerque, Teresa; Botelho, Ana; Cunha, Monica V.; Inacio, Joao] INIAV, IP, Unidade Estrateg Invest & Serv Prod & Saude Anim, Lisbon, Portugal.
   [Costa, Pedro; Couto, Isabel; Viveiros, Miguel] Univ Nova Lisboa, Inst Higiene & Med Trop, Grp Micobacterias, Unidade Ensino & Invest Microbiol Med, P-1200 Lisbon, Portugal.
   [Ferreira, Ana S.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal.
   [Couto, Isabel] Univ Nova Lisboa, Ctr Recursos Microbiol CREM, P-1200 Lisbon, Portugal.
   [Viveiros, Miguel] Univ Nova Lisboa, Inst Higiene & Med Trop, Ctr Malaria & Outras Doencas Trop, P-1200 Lisbon, Portugal.
RP Inacio, J (reprint author), INIAV, IP, Unidade Estrateg Invest & Serv Prod & Saude Anim, Lisbon, Portugal.
EM joao.inacio@iniav.pt
RI Ferreira, AnaS/O-6745-2019; Couto, Isabel/I-2640-2012; Inacio,
   Joao/D-5762-2011; Viveiros, Miguel/A-7326-2008; Ferreira,
   Ana/O-3755-2014; Cunha, Monica/D-5544-2011
OI Ferreira, AnaS/0000-0001-7222-9101; Couto, Isabel/0000-0003-3536-2733;
   Inacio, Joao/0000-0001-7367-5007; Viveiros, Miguel/0000-0001-9676-6251;
   Ferreira, Ana/0000-0001-7222-9101; Cunha, Monica/0000-0003-0401-0276;
   Amaro, Ana/0000-0002-5139-3268; Botelho, Ana/0000-0002-1843-9455
FU Fundacao para a Ciencia e Tecnologia (FCT), Portugal
   [PTDC/CVT/117794/2010]; FCT, Portugal [PTDC/CVT/111634/2009]; FCT
   [SFRH/BD/64136/2009, SFRH/BD/62317/2009]
FX MVC acknowledges funding from Fundacao para a Ciencia e Tecnologia
   (FCT), Portugal ("Ciencia 2008" research contract and
   PTDC/CVT/117794/2010 research project); JI acknowledges funding from
   FCT, Portugal ("Ciencia 2007" research contract and PTDC/CVT/111634/2009
   research project); PC and ASF are a recipients of PhD grants from FCT
   (SFRH/BD/64136/2009 and SFRH/BD/62317/2009, respectively). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Amaro A, 2008, LETT APPL MICROBIOL, V47, P8, DOI 10.1111/j.1472-765X.2008.02372.x
   Coetsier C, 2000, J CLIN MICROBIOL, V38, P3048
   Corner LAL, 2012, VET MICROBIOL, V156, P162, DOI 10.1016/j.vetmic.2011.10.016
   Coros A, 2008, J BACTERIOL, V190, P3408, DOI 10.1128/JB.00009-08
   Costa P, 2010, CLIN MICROBIOL INFEC, V16, P1464, DOI [10.1111/j.1469-0691.2010.03120.x, 10.1111/j.1469-0691.2009.03120.x]
   Cunha MV, 2012, RES VET SCI, V92, P225, DOI 10.1016/j.rvsc.2011.03.009
   Cunha MV, 2011, VET MED INT, V2011, DOI [10.4061/2011/795165, DOI 10.4061/2011/795165.PUBMED:21776353]
   Duarte EL, 2008, VET MICROBIOL, V130, P415, DOI 10.1016/j.vetmic.2008.02.012
   Duarte EL, 2010, VET MICROBIOL, V143, P299, DOI 10.1016/j.vetmic.2009.11.027
   Kubica T, 2003, J CLIN MICROBIOL, V41, P3070, DOI 10.1128/JCM.41.7.3070-3077.2003
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   LIEBANA E, 1995, J CLIN MICROBIOL, V33, P33
   Miller J, 1997, J VET DIAGN INVEST, V9, P244, DOI 10.1177/104063879700900304
   Niemann S, 2000, J CLIN MICROBIOL, V38, P3231
   OIE, 2013, MAN DIAGN TESTS VACC
   Parra A, 2008, VET MICROBIOL, V127, P315, DOI 10.1016/j.vetmic.2007.09.001
   Pounder JI, 2010, DIAGN MICR INFEC DIS, V67, P101, DOI 10.1016/j.diagmicrobio.2009.12.014
   Reddington K, 2012, J CLIN MICROBIOL, V50, P2203, DOI 10.1128/JCM.00718-12
   Restrepo BI, 2006, J MICROBIOL METH, V67, P220, DOI 10.1016/j.mimet.2006.03.016
   Rodriguez E, 2009, INT J TUBERC LUNG D, V13, P1536
   Roring S, 2000, VET MICROBIOL, V74, P227, DOI 10.1016/S0378-1135(00)00189-9
   RUADOMENECH R, 2006, TUBERCULOSIS, V86, P77, DOI DOI 10.1016/J.TUBE.2005.05.002.PUBMED:16257579
   Santos N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012663
   Savelkoul PHM, 2006, J MICROBIOL METH, V66, P177, DOI 10.1016/j.mimet.2005.12.003
   Stewart LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058374
   Stewart LD, 2012, J CLIN MICROBIOL, V50, P1598, DOI 10.1128/JCM.05747-11
   Sunder S, 2009, J CLIN MICROBIOL, V47, P1249, DOI 10.1128/JCM.02042-08
   Taylor G Michael, 2007, BMC Vet Res, V3, P12, DOI 10.1186/1746-6148-3-12
   Taylor MJ, 2001, J CLIN MICROBIOL, V39, P1272, DOI 10.1128/JCM.39.4.1272-1278.2001
   Thacker TC, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-50
   Torres-Gonzalez P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002177
   van Ingen J, 2012, EMERG INFECT DIS, V18, P653, DOI 10.3201/eid1804.110888
   WARDS BJ, 1995, VET MICROBIOL, V43, P227, DOI 10.1016/0378-1135(94)00096-F
   Whelan AO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008527
NR 35
TC 14
Z9 17
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 21
PY 2013
VL 8
IS 11
AR e81337
DI 10.1371/journal.pone.0081337
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 259PW
UT WOS:000327539800124
PM 24278425
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Barros, MHM
   Hauck, F
   Dreyer, JH
   Kempkes, B
   Niedobitek, G
AF Barros, Mario Henrique M.
   Hauck, Franziska
   Dreyer, Johannes H.
   Kempkes, Bettina
   Niedobitek, Gerald
TI Macrophage Polarisation: an Immunohistochemical Approach for Identifying
   M1 and M2 Macrophages
SO PLOS ONE
LA English
DT Article
ID TUMOR-ASSOCIATED MACROPHAGES; EPSTEIN-BARR-VIRUS; SCAVENGER RECEPTOR;
   HUMAN MONOCYTES; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CD163;
   MICROENVIRONMENT; IDENTIFICATION; ACTIVATION
AB Macrophage polarization is increasingly recognised as an important pathogenetic factor in inflammatory and neoplastic diseases. Proinflammatory M1 macrophages promote T helper (Th) 1 responses and show tumoricidal activity. M2 macrophages contribute to tissue repair and promote Th2 responses. CD68 and CD163 are used to identify macrophages in tissue sections. However, characterisation of polarised macrophages in situ has remained difficult. Macrophage polarisation is regulated by transcription factors, pSTAT1 and RBP-J for M1, and CMAF for M2. We reasoned that double-labelling immunohistochemistry for the detection of macrophage markers together with transcription factors may be suitable to characterise macrophage polarisation in situ. To test this hypothesis, we have studied conditions associated with Th1- and Th2-predominant immune responses: infectious mononucleosis and Crohn's disease for Th1 and allergic nasal polyps, oxyuriasis, wound healing and foreign body granulomas for predominant Th2 response. In all situations, CD163+ cells usually outnumbered CD68+ cells. Moreover, CD163+ cells, usually considered as M2 macrophages, co-expressing pSTAT1 and RBP-J were found in all conditions examined. The numbers of putative M1 macrophages were higher in Th1-than in Th2-associated diseases, while more M2 macrophages were seen in Th2-than in Th1 related disorders. In most Th1-related diseases, the balance of M1 over M2 cells was shifted towards M1 cells, while the reverse was observed for Th2-related conditions. Hierarchical cluster analysis revealed two distinct clusters: cluster I included Th1 diseases together with cases with high numbers of CD163+pSTAT1+, CD68+pSTAT1+, CD163+RBP-J+ and CD68+RBP-J+ macrophages; cluster II comprised Th2 conditions together with cases displaying high numbers of CD163+CMAF+ and CD68+CMAF+ macrophages. These results suggest that the detection of pSTAT1, RBP-J, and CMAF in the context of CD68 or CD163 expression is a suitable tool for the characterisation of macrophage polarisation in situ. Furthermore, CD163 cannot be considered a reliable M2 marker when used on its own.
C1 [Barros, Mario Henrique M.; Dreyer, Johannes H.; Niedobitek, Gerald] Unfallkrankenhaus, Inst Pathol, Berlin, Germany.
   [Hauck, Franziska] Sana Klinikum Lichtenberg, Inst Pathol, Berlin, Germany.
   [Kempkes, Bettina] Natl Res Ctr Environm Hlth, Helmholtz Zentrum, Dept Gene Vectors, Munich, Germany.
RP Barros, MHM (reprint author), Unfallkrankenhaus, Inst Pathol, Berlin, Germany.
EM mario.barros@ukb.de
RI Kempkes, Bettina/B-3322-2013
OI Niedobitek, Gerald/0000-0003-4474-1882; Barros,
   Mario/0000-0001-6826-9565
FU Wilhelm Sander Foundation [2012.029.1]; Alexander von Humboldt
   Foundation
FX This work was supported by a grant from the Wilhelm Sander Foundation
   (2012.029.1). MB was supported by the Alexander von Humboldt Foundation.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Barros MHM, 2012, CLIN CANCER RES, V18, P3762, DOI 10.1158/1078-0432.CCR-12-0129
   Bonilla FA, 2010, J ALLERGY CLIN IMMUN, V125, pS33, DOI 10.1016/j.jaci.2009.09.017
   Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97
   Cao SJ, 2005, J IMMUNOL, V174, P3484, DOI 10.4049/jimmunol.174.6.3484
   Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980
   Crawford DH, 2001, PHILOS T R SOC B, V356, P461, DOI 10.1098/rstb.2000.0783
   Deonarine K, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-11
   Edin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047045
   Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007
   Hardison SE, 2012, J IMMUNOL, V189, P4060, DOI 10.4049/jimmunol.1103455
   Herrera M, 2013, CANCER SCI, V104, P437, DOI 10.1111/cas.12096
   Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216
   Hogger P, 1998, J IMMUNOL, V161, P1883
   Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32
   Janeway Jr C, 2005, IMMUNOBIOLOGY IMMUNE
   Kamper P, 2011, HAEMATOL-HEMATOL J, V96, P269, DOI 10.3324/haematol.2010.031542
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888
   LAN C, 2012, TECHNOL CANCER RES T, V259
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6
   Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356
   Maier S, 2005, J VIROL, V79, P8784, DOI 10.1128/JVI.79.14.8784-8792.2005
   Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133
   Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009
   Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306
   Nguyen TDT, 2005, AM J SURG PATHOL, V29, P617, DOI 10.1097/01.pas.0000157940.80538.ec
   Noel W, 2004, TRENDS PARASITOL, V20, P126, DOI 10.1016/j.pt.2004.01.004
   Pettersen JS, 2011, J INVEST DERMATOL, V131, P1322, DOI [10.1038/jid.2011.9, 10.103/jid.2011.9]
   Reinartz S, 2014, INT J CANCER, V134, P32, DOI 10.1002/ijc.28335
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Sulahian TH, 2000, CYTOKINE, V12, P1312, DOI 10.1006/cyto.2000.0720
   Vakkila J, 2005, PEDIATR DEVEL PATHOL, V8, P43, DOI 10.1007/s10024-004-5045-2
   van Steenwijk PJD, 2013, INT J CANCER, V133, P2884, DOI 10.1002/ijc.28309
   Verbeke CS, 2000, CLIN EXP IMMUNOL, V120, P294, DOI 10.1046/j.1365-2249.2000.01181.x
   Waidmann O, 2013, J HEPATOL, V59, P769, DOI 10.1016/j.jhep.2013.06.008
   Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5
   Wang YC, 2010, CANCER RES, V70, P4840, DOI 10.1158/0008-5472.CAN-10-0269
   WARREN KS, 1976, ANN NY ACAD SCI, V278, P7, DOI 10.1111/j.1749-6632.1976.tb47011.x
   Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354
   Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304
   Zaki MAA, 2011, VIRCHOWS ARCH, V459, P361, DOI 10.1007/s00428-011-1140-8
NR 43
TC 161
Z9 165
U1 1
U2 49
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 15
PY 2013
VL 8
IS 11
AR UNSP e80908
DI 10.1371/journal.pone.0080908
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 255RX
UT WOS:000327258600095
PM 24260507
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Rischen, RJ
   Breuning, KH
   Bronkhorst, EM
   Kuijpers-Jagtman, AM
AF Rischen, Robine J.
   Breuning, K. Hero
   Bronkhorst, Ewald M.
   Kuijpers-Jagtman, Anne Marie
TI Records Needed for Orthodontic Diagnosis and Treatment Planning: A
   Systematic Review
SO PLOS ONE
LA English
DT Review
ID BEAM COMPUTED-TOMOGRAPHY; MODELS; CEPHALOMETRICS; RADIOGRAPHS;
   DECISIONS; PLASTER
AB Background: Traditionally, dental models, facial and intra-oral photographs and a set of two-dimensional radiographs are used for orthodontic diagnosis and treatment planning. As evidence is lacking, the discussion is ongoing which specific records are needed for the process of making an orthodontic treatment plan.
   Objective: To estimate the contribution and importance of different diagnostic records for making an orthodontic diagnosis and treatment plan.
   Data sources: An electronic search in PubMed (1948-July 2012), EMBASE Excerpta Medica (1980-July 2012), CINAHL (1982-July 2012), Web of Science (1945-July 2012), Scopus (1996-July 2012), and Cochrane Library (1993-July 2012) was performed. Additionally, a hand search of the reference lists of included studies was performed to identify potentially eligible studies. There was no language restriction.
   Study selection: The patient, intervention, comparator, outcome (PICO) question formulated for this study was as follows: for patients who need orthodontic treatment (P), will the use of record set X (I) compared with record set Y (C) change the treatment plan (O)? Only primary publications were included.
   Data extraction: Independent extraction of data and quality assessment was performed by two observers.
   Results: Of the 1041 publications retrieved, 17 met the inclusion criteria. Of these, 4 studies were of high quality. Because of the limited number of high quality studies and the differences in study designs, patient characteristics, and reference standard or index test, a meta-analysis was not possible.
   Conclusion: Cephalograms are not routinely needed for orthodontic treatment planning in Class II malocclusions, digital models can be used to replace plaster casts, and cone-beam computed tomography radiographs can be indicated for impacted canines. Based on the findings. of this review, the minimum record set required for orthodontic diagnosis and treatment planning could not be defined.
C1 [Rischen, Robine J.; Breuning, K. Hero; Kuijpers-Jagtman, Anne Marie] Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands.
   [Bronkhorst, Ewald M.] Radboud Univ Nijmegen, Med Ctr, Dept Prevent & Curat Dent, NL-6525 ED Nijmegen, Netherlands.
RP Kuijpers-Jagtman, AM (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands.
EM orthodontics@dent.umcn.nl
RI Breuning, K.H./L-4228-2015; Kuijpers-Jagtman, Anne Marie/A-9413-2008;
   Bronkhorst, Ewald M/L-4230-2015
OI Kuijpers-Jagtman, Anne Marie/0000-0001-8172-0090; Bronkhorst,
   Ewald/0000-0003-0953-8053
CR ATCHISON KA, 1992, AM J ORTHOD DENTOFAC, V102, P29, DOI 10.1016/0889-5406(92)70012-Y
   ATCHISON KA, 1991, ORAL SURG ORAL MED O, V71, P238, DOI 10.1016/0030-4220(91)90477-T
   Bjerklin K, 2006, ANGLE ORTHOD, V76, P43
   Bjerklin K, 2008, ANGLE ORTHOD, V78, P852, DOI 10.2319/070307-306.1
   Botticelli S, 2011, EUR J ORTHODONT, V33, P344, DOI 10.1093/ejo/cjq102
   Bruks A, 1999, SWED DENT J, V23, P77
   Cobourne MT, 2011, HDB ORTHODONTICS, P125
   Ellis P E, 2003, J Orthod, V30, P45, DOI 10.1093/ortho/30.1.45
   Fleming PS, 2011, ORTHOD CRANIOFAC RES, V14, P1, DOI 10.1111/j.1601-6343.2010.01503.x
   Silva MAG, 2008, AM J ORTHOD DENTOFAC, V133, DOI 10.1016/j.ajodo.2007.11.019
   Graber TM, 2000, ORTHODONTICS CURRENT, P3
   Greenhill R, 1979, Aust Orthod J, V6, P55
   HAN UK, 1991, AM J ORTHOD DENTOFAC, V100, P212, DOI 10.1016/0889-5406(91)70058-5
   Haney E, 2010, AM J ORTHOD DENTOFAC, V137, P590, DOI 10.1016/j.ajodo.2008.06.035
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700
   Ludlow JB, 2006, DENTOMAXILLOFAC RAD, V35, P219, DOI 10.1259/dmfr/14340323
   Nijkamp PG, 2008, EUR J ORTHODONT, V30, P630, DOI 10.1093/ejo/cjn059
   Pae EK, 2001, AM J ORTHOD DENTOFAC, V120, P254, DOI 10.1067/mod.2001.116825
   Proffit WR, 2007, CONT ORTHODONTICS, P167
   Rheude B, 2005, ANGLE ORTHOD, V75, P300
   SILLING G, 1979, ANGLE ORTHOD, V49, P259
   van Vlijmen OJC, 2012, J AM DENT ASSOC, V143, P241, DOI 10.14219/jada.archive.2012.0148
   Whetten JL, 2006, AM J ORTHOD DENTOFAC, V130, P485, DOI 10.1016/j.ajodo.2005.02.022
   Whiting Penny, 2005, BMC Med Res Methodol, V5, P19, DOI 10.1186/1471-2288-5-19
   Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25
   Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009
   Wriedt S, 2012, J OROFAC ORTHOP, V73, P28, DOI 10.1007/s00056-011-0058-8
NR 28
TC 20
Z9 20
U1 0
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 12
PY 2013
VL 8
IS 11
AR e74186
DI 10.1371/journal.pone.0074186
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 255PK
UT WOS:000327252100001
PM 24265669
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Encarnacion-Luevano, A
   Rojas-Soto, OR
   Sigala-Rodriguez, JJ
AF Encarnacion-Luevano, Alondra
   Rojas-Soto, Octavio R.
   Jesus Sigala-Rodriguez, J.
TI Activity Response to Climate Seasonality in Species with Fossorial
   Habits: A Niche Modeling Approach Using the Lowland Burrowing Treefrog
   (Smilisca fodiens)
SO PLOS ONE
LA English
DT Article
ID ECOLOGICAL NICHES; ANURAN AMPHIBIANS; DISTRIBUTIONS; EVOLUTION;
   BEHAVIOR; BIRDS; EXTINCTIONS; ECTOTHERMS; PHYSIOLOGY; PATTERNS
AB The importance of climatic conditions in shaping the geographic distribution of amphibian species is mainly associated to their high sensitivity to environmental conditions. How they cope with climate gradients through behavioral adaptations throughout their distribution is an important issue due to the ecological and evolutionary implications for population viability. Given their low dispersal abilities, the response to seasonal climate changes may not be migration, but behavioral and physiological adaptations. Here we tested whether shifts in climatic seasonality can predict the temporal variation of surface activity of the fossorial Lowland Burrowing Treefrog (Smilisca fodiens) across its geographical distribution. We employed Ecological Niche Modeling (ENM) to perform a monthly analysis of spatial variation of suitable climatic conditions (defined by the July conditions, the month of greatest activity), and then evaluated the geographical correspondence of monthly projections with the occurrence data per month. We found that the species activity, based on the species' occurrence data, corresponds with the latitudinal variation of suitable climatic conditions. Due to the behavioral response of this fossorial frog to seasonal climate variation, we suggest that precipitation and temperature have played a major role in the definition of geographical and temporal distribution patterns, as well as in shaping behavioral adaptations to local climatic conditions. This highlights the influence of macroclimate on shaping activity patterns and the important role of fossorials habits to meet the environmental requirements necessary for survival.
C1 [Encarnacion-Luevano, Alondra; Jesus Sigala-Rodriguez, J.] Univ Autonoma Aguascalientes, Dept Biol, Aguascalientes, Mexico.
   [Rojas-Soto, Octavio R.] Inst Ecol AC, Red Biol Evolut, Xalapa, Veracruz, Mexico.
RP Rojas-Soto, OR (reprint author), Inst Ecol AC, Red Biol Evolut, Xalapa, Veracruz, Mexico.
EM octavio.rojas@inecol.edu.mx
RI Sigala-Rodriguez, J. Jesus/B-3617-2013; Rojas-Soto, Octavio/Q-6252-2018
OI Sigala-Rodriguez, J. Jesus/0000-0002-5895-1568; Rojas-Soto,
   Octavio/0000-0002-0201-1454
FU Consejo Nacional de Ciencia y Tecnologia [373460]; Universidad Autonoma
   de Aguascalientes
FX Funding provided by Consejo Nacional de Ciencia y Tecnologia Grant
   number 373460(http://www.conacyt.gob.mx) and Universidad Autonoma de
   Aguascalientes (www.uaa.mx). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6
   Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8
   Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x
   Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155
   Bailey R. G., 1998, ECOREGIONS ECOSYSTEM
   Barve N., 2008, TOOL PARTIAL ROC
   BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x
   Booth DT, 2006, CAN J ZOOL, V84, P832, DOI 10.1139/Z06-062
   BRATTSTROM BH, 1968, COMP BIOCHEM PHYSIOL, V24, P93, DOI 10.1016/0010-406X(68)90961-4
   Dore MHI, 2005, ENVIRON INT, V31, P1167, DOI 10.1016/j.envint.2005.03.004
   Duellman WE, 1966, NEOTROPICAL HYLID FR
   Duellman WE, 1999, PATTERNS DISTRIBUTIO
   Duellman WE, 1986, BIOL AMPHIBIANS
   ESRI, 1999, ARCVIEWGIS V 3 2
   Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2
   Gabriel W, 2005, J EVOLUTION BIOL, V18, P873, DOI 10.1111/j.1420-9101.2005.00959.x
   GABRIEL W, 1992, J EVOLUTION BIOL, V5, P41, DOI 10.1046/j.1420-9101.1992.5010041.x
   Garmer M, 2010, IRR VARIOUS COEFFICI
   Grinnell J., 1917, Auk Cambridge Mass, V34
   Hawkins BA, 2004, ECOGRAPHY, V27, P268, DOI 10.1111/j.0906-7590.2004.03883.x
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   HOFFMAN J, 1989, OECOLOGIA, V81, P510, DOI 10.1007/BF00378961
   Jackson ST, 2000, QUATERNARY SCI REV, V19, P489, DOI 10.1016/S0277-3791(99)00093-1
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lawler JJ, 2010, CONSERV BIOL, V24, P38, DOI 10.1111/j.1523-1739.2009.01403.x
   Lutterschmidt DI, 2006, CAN J ZOOL, V84, P771, DOI 10.1139/Z06-043
   Martinez-Gordillo D, 2010, J EVOLUTION BIOL, V23, P259, DOI 10.1111/j.1420-9101.2009.01897.x
   Martinez-Meyer E, 2004, P ROY SOC B-BIOL SCI, V271, P1151, DOI 10.1098/rspb.2003.2564
   Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x
   Nakazawa Y, 2004, AUK, V121, P610, DOI 10.1642/0004-8038(2004)121[0610:SNONMB]2.0.CO;2
   Navas CA, 2008, COMP BIOCHEM PHYS A, V151, P344, DOI 10.1016/j.cbpa.2007.07.003
   Niehaus AC, 2012, J EXP BIOL, V215, P694, DOI 10.1242/jeb.058032
   Nomura F, 2009, J ETHOL, V27, P195, DOI 10.1007/s10164-008-0112-1
   Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2
   Parra JL, 2004, ECOGRAPHY, V27, P350, DOI 10.1111/j.0906-7590.2004.03822.x
   Peterson A. T., 2011, ECOLOGICAL NICHES GE
   Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008
   Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x
   Peterson AT, 2002, IBIS, V144, pE27, DOI 10.1046/j.0019-1019.2001.00031.x
   R Development Core Team, 2011, R LANG ENV STAT COMP
   Rojas-Soto OR, 2003, J BIOGEOGR, V30, P449, DOI 10.1046/j.1365-2699.2003.00836.x
   Santos-Barrera G, 2010, IUCN 2012 IUCN RED L
   SCACHETTIPEREIR.R, 2002, DESKTOP GARP
   Sears MW, 2011, INTEGR COMP BIOL, V51, P662, DOI 10.1093/icb/icr113
   Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x
   Solomon S., 2007, CONTRIBUTION WORKING
   STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913
   Sullivan BK, 1996, GREAT BASIN NAT, V56, P38, DOI 10.5962/bhl.part.4107
   Weatherhead PJ, 2012, J THERM BIOL, V37, P273, DOI 10.1016/j.jtherbio.2011.03.008
   WELLS KD, 2007, ECOLOGY BEHAV AMPHIB
   Whitton FJS, 2012, GLOBAL ECOL BIOGEOGR, V21, P179, DOI 10.1111/j.1466-8238.2011.00660.x
   Wiens JJ, 2006, AM NAT, V168, P579, DOI 10.1086/507882
NR 52
TC 1
Z9 1
U1 1
U2 31
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 11
PY 2013
VL 8
IS 11
AR e78290
DI 10.1371/journal.pone.0078290
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 255EG
UT WOS:000327221600024
PM 24244301
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Atzema, CL
   Austin, PC
   Wu, LB
   Brzozowski, M
   Feldman, MJ
   McDonnell, M
   Mazurik, L
AF Atzema, Clare L.
   Austin, Peter C.
   Wu, Libo
   Brzozowski, Michael
   Feldman, Michael J.
   McDonnell, Michael
   Mazurik, Laurie
TI Speak Fast, Use Jargon, and Don't Repeat Yourself: A Randomized Trial
   Assessing the Effectiveness of Online Videos to Supplement Emergency
   Department Discharge Instructions
SO PLOS ONE
LA English
DT Article
ID CARE; COMPREHENSION; INFORMATION; QUALITY
AB Background: Emergency department discharge instructions are variably understood by patients, and in the setting of emergency department crowding, innovations are needed to counteract shortened interaction times with the physician. We evaluated the effect of viewing an online video of diagnosis-specific discharge instructions on patient comprehension and recall of instructions.
   Methods: In this prospective, single-center, randomized controlled trial conducted between November 2011 and January 2012, we randomized emergency department patients who were discharged with one of 38 diagnoses to either view (after they left the emergency department) a vetted online video of diagnosis-specific discharge instructions, or to usual care. Patients were subsequently contacted by telephone and asked three standardized questions about their discharge instructions; one point was awarded for each correct answer. Using an intention-to-treat analysis, differences between groups were assessed using univariate testing, and with logistic regression that accounted for clustering on managing physician. A secondary outcome measure was patient satisfaction with the videos, on a 10-point scale.
   Results: Among 133 patients enrolled, mean age was 46.1 (s.d.D. 21.5) and 55% were female. Patients in the video group had 19% higher mean scores (2.5, s.d. 0.7) than patients in the control group (2.1, s.d. 0.8) (p=0.002). After adjustment for patient age, sex, first language, triage acuity score, and clustering, the odds of achieving a fully correct score (3 out of 3) were 3.5 (95% CI, 1.7 to 7.2) times higher in the video group, compared to the control group. Among those who viewed the videos, median rating of the videos was 10 (IQR 8 to 10).
   Conclusions: In this single-center trial, patients who viewed an online video of their discharge instructions scored higher on their understanding of key concepts around their diagnosis and subsequent care. Those who viewed the videos found them to be a helpful addition to standard care.
C1 [Atzema, Clare L.; Brzozowski, Michael; Feldman, Michael J.; McDonnell, Michael; Mazurik, Laurie] Univ Toronto, Dept Med, Div Emergency Med, Toronto, ON, Canada.
   [Atzema, Clare L.; Wu, Libo; Brzozowski, Michael; Feldman, Michael J.; McDonnell, Michael; Mazurik, Laurie] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada.
   [Atzema, Clare L.; Austin, Peter C.] Inst Clin Evaluat Sci, Toronto, ON, Canada.
RP Atzema, CL (reprint author), Univ Toronto, Dept Med, Div Emergency Med, Toronto, ON, Canada.
EM clare.atzema@ices.on.ca
OI Austin, Peter/0000-0003-3337-233X; Atzema, Clare/0000-0002-7236-5522
FU Academic Physician's Fund (AFP); Department of Emergency Services at
   Sunnybrook Health Sciences Centre; Department of Medicine, University of
   Toronto; Sunnybrook Research Institute; Heart and Stroke Foundation
FX This project was supported by a grant from the Academic Physician's Fund
   (AFP). Dr. Atzema is supported by the Practice Plan of the Department of
   Emergency Services at Sunnybrook Health Sciences Centre, the Department
   of Medicine, University of Toronto, and the Sunnybrook Research
   Institute. Dr. Austin is supported by a Career Investigator award from
   the Heart and Stroke Foundation. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ambulatory and Hospital Care Statistics Branch, 2013, NAT HOSP AMB MED CAR
   Atzema CL, 2012, INT J CLIN MED, V3, P758, DOI [10.4236/ijcm.2012.37A133, DOI 10.4236/IJCM.2012.37A133]
   AUSTIN PE, 1995, ANN EMERG MED, V25, P317, DOI 10.1016/S0196-0644(95)70286-5
   Beveridge R, 1998, IMPLEMENTATION GUIDE
   Chan B, 2001, ATLAS REPORT EMERGEN
   Choi S, 2009, SOUTH MED J, V102, P239, DOI 10.1097/SMJ.0b013e318197f319
   Clark PA, 2005, PATIENT EDUC COUNS, V59, P56, DOI 10.1016/j.pec.2004.09.010
   Clarke Collin, 2005, CJEM, V7, P5
   Dalkey NC, 1969, DELPHI METHOD EXPT A
   Department of Health & Human Services (DHHS) Centers for Medicare & Medicaid Services (CMS), 2008, REV APP A INT GUID H
   Derlet RW, 2001, ACAD EMERG MED, V8, P151, DOI 10.1111/j.1553-2712.2001.tb01280.x
   Engel KG, 2009, ANN EMERG MED, V53, P454, DOI 10.1016/j.annemergmed.2008.05.016
   Fatovich DM, 2005, EMERG MED J, V22, P351, DOI 10.1136/emj.2004.018002
   Institute of Medicine, 2006, HOSP BAS EM CAR BREA
   Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007
   Johnson A, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003716, DOI 10.1002/14651858.CD003716]
   Kawano T, 2013, EMERG MED J
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lindsay P, 2002, ACAD EMERG MED, V9, P1131, DOI 10.1111/j.1553-2712.2002.tb01567.x
   Mace CA, 1962, PSYCHOL STUDY
   Miro O, 1999, Eur J Emerg Med, V6, P105
   Papa L, 2008, CAN J EMERG MED, V10, P347
   Rhodes KV, 2004, ANN EMERG MED, V44, P262, DOI 10.1016/j.annemergmed.2004.02.035
   Rowe B, 2006, FREQUENCY DETERMINEN
   SPANDORFER JM, 1995, ANN EMERG MED, V25, P71, DOI 10.1016/S0196-0644(95)70358-6
   the World Bank, 2012, INT US PER 100 PEOPL
   VanSuch M, 2006, QUAL SAF HEALTH CARE, V15, P414, DOI 10.1136/qshc.2005.017640
   Waisman Y, 2003, ISRAEL MED ASSOC J, V5, P567
   Waisman Y, 2005, EUR J EMERG MED, V12, P159, DOI 10.1097/00063110-200508000-00003
NR 29
TC 12
Z9 12
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 11
PY 2013
VL 8
IS 11
AR e77057
DI 10.1371/journal.pone.0077057
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 255EG
UT WOS:000327221600006
PM 24244272
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Breece, MW
   Oliver, MJ
   Cimino, MA
   Fox, DA
AF Breece, Matthew W.
   Oliver, Matthew J.
   Cimino, Megan A.
   Fox, Dewayne A.
TI Shifting Distributions of Adult Atlantic Sturgeon Amidst
   Post-Industrialization and Future Impacts in the Delaware River: a
   Maximum Entropy Approach
SO PLOS ONE
LA English
DT Article
ID ACIPENSER-OXYRINCHUS; ESTUARY; BIOLOGY
AB Atlantic sturgeon (Acipenser oxyrinchus oxyrinchus) experienced severe declines due to habitat destruction and overfishing beginning in the late 19th century. Subsequent to the boom and bust period of exploitation, there has been minimal fishing pressure and improving habitats. However, lack of recovery led to the 2012 listing of Atlantic sturgeon under the Endangered Species Act. Although habitats may be improving, the availability of high quality spawning habitat, essential for the survival and development of eggs and larvae may still be a limiting factor in the recovery of Atlantic sturgeon. To estimate adult Atlantic sturgeon spatial distributions during riverine occupancy in the Delaware River, we utilized a maximum entropy (MaxEnt) approach along with passive biotelemetry during the likely spawning season. We found that substrate composition and distance from the salt front significantly influenced the locations of adult Atlantic sturgeon in the Delaware River. To broaden the scope of this study we projected our model onto four scenarios depicting varying locations of the salt front in the Delaware River: the contemporary location of the salt front during the likely spawning season, the location of the salt front during the historic fishery in the late 19th century, an estimated shift in the salt front by the year 2100 due to climate change, and an extreme drought scenario, similar to that which occurred in the 1960's. The movement of the salt front upstream as a result of dredging and climate change likely eliminated historic spawning habitats and currently threatens areas where Atlantic sturgeon spawning may be taking place. Identifying where suitable spawning substrate and water chemistry intersect with the likely occurrence of adult Atlantic sturgeon in the Delaware River highlights essential spawning habitats, enhancing recovery prospects for this imperiled species.
C1 [Breece, Matthew W.; Oliver, Matthew J.; Cimino, Megan A.] Univ Delaware, Lewes, DE 19958 USA.
   [Fox, Dewayne A.] Delaware State Univ, Dover, DE USA.
RP Breece, MW (reprint author), Univ Delaware, Lewes, DE 19958 USA.
EM mwbreece@udel.edu
FU NOAA NMFS Anadromous Fish Conservation Act (NOAA Award)
   [NA08NMF4050611]; NOAA NMFS Species Recovery Grants to States (NOAA
   Award) [NA10NMF4720030]; DuPont Clear into the Future Fellowship Program
FX Funding was provided by the following: NOAA NMFS Anadromous Fish
   Conservation Act (NOAA Award NA08NMF4050611;
   http://www.nmfs.noaa.gov/sfa/state_federal/State-Federal-WEB/afca.htm),
   NOAA NMFS Species Recovery Grants to States (NOAA Award NA10NMF4720030;
   http://www.nmfs.noaa.gov/pr/conservation/states/grant.htm), and DuPont
   Clear into the Future Fellowship Program
   (http://clearintothefuture.com/). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bain M, 2000, HARVEST HABITATS ATL, P43
   Balazik MT, 2012, N AM J FISH MANAGE, V32, P1062, DOI 10.1080/02755947.2012.716016
   Bemis WE, 1997, ENVIRON BIOL FISH, V48, P167, DOI 10.1023/A:1007312524792
   Billard R, 2001, REV FISH BIOL FISHER, V10, P355
   Borodin N., 1925, T AM FISH SOC, V55, P184, DOI DOI 10.1577/1548-8659(1925)55[
   Cobb JN, 1900, REP COMMISSIONER FIS, V25, P369
   Cook TL, 2007, ESTUAR COAST SHELF S, V72, P235, DOI 10.1016/j.ecss.2006.10.014
   DiLorenzo JL, 1993, EFFECTS HIST D UNPUB, P124
   Economic League of; Greater Philadelphia, 2008, MAR COMM GREAT PHIL, P78
   Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x
   Fisher M. A, 2011, STATE DELAWARE ANN C, P19
   Fox DA, 2000, T AM FISH SOC, V129, P811, DOI 10.1577/1548-8659(2000)129<0811:GSSMAH>2.3.CO;2
   Gilbert CR, 1989, US DEP INTERIOR BIOL, V82, P28
   Hatin D, 2002, J APPL ICHTHYOL, V18, P586, DOI 10.1046/j.1439-0426.2002.00395.x
   Hull CHJ, 1986, GREENHOUSE EFFECT SE, P36
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LARNTZ K, 1978, J AM STAT ASSOC, V73, P253, DOI 10.2307/2286650
   NOAA (National Oceanic and Atmospheric Administration), 2012, FED REGISTER, V77, P5880
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Redon M., 2010, 6 SAPT AN GEOM INT C, P42
   Rodrigue J.P., 2010, FACTORS IMPACTING N, P64
   RYDER JA, 1890, B US FISH COMM, V8, P231
   Secor DH, 1999, AM FISH S S, V23, P203
   Simpson P. C., 2009, CONT UNDERSTANDING D, V69, P1
   Simpson PC, 2008, THESIS, P141
   SMITH TIJ, 1985, ENVIRON BIOL FISH, V14, P61, DOI 10.1007/BF00001577
   SOMMERFIELD CK, 2003, SEDIMENTOLOGICAL GEO
   Sturgeon Atlantic Status Review Team, 2007, STAT REV ATL STURG A, P175
   United States Army Corp of Engineers, 2009, DEL RIV MAIN CHANN D, P131
   VanEenennaam JP, 1996, ESTUARIES, V19, P769, DOI 10.2307/1352296
   Walsh DR, 2004, THESIS, P85
NR 31
TC 8
Z9 8
U1 2
U2 43
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 8
PY 2013
VL 8
IS 11
AR e81321
DI 10.1371/journal.pone.0081321
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 255CG
UT WOS:000327216200120
PM 24260570
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wang, Y
   Jiang, D
   Zhuang, DF
   Huang, YH
   Wang, W
   Yu, XF
AF Wang, Yong
   Jiang, Dong
   Zhuang, Dafang
   Huang, Yaohuan
   Wang, Wei
   Yu, Xinfang
TI Effective Key Parameter Determination for an Automatic Approach to Land
   Cover Classification Based on Multispectral Remote Sensing Imagery
SO PLOS ONE
LA English
DT Article
ID SPATIAL-PATTERN; IDENTIFICATION; LANDSCAPE; AGREEMENT; ACCURACY;
   DATABASE; KAPPA; CHINA
AB The classification of land cover based on satellite data is important for many areas of scientific research. Unfortunately, some traditional land cover classification methods (e. g. known as supervised classification) are very labor-intensive and subjective because of the required human involvement. Jiang et al. proposed a simple but robust method for land cover classification using a prior classification map and a current multispectral remote sensing image. This new method has proven to be a suitable classification method; however, its drawback is that it is a semi-automatic method because the key parameters cannot be selected automatically. In this study, we propose an approach in which the two key parameters are chosen automatically. The proposed method consists primarily of the following three interdependent parts: the selection procedure for the pure-pixel training-sample dataset, the method to determine the key parameters, and the optimal combination model. In this study, the proposed approach employs both overall accuracy and their Kappa Coefficients (KC), and Time-Consumings (TC, unit: second) in order to select the two key parameters automatically instead of using a test-decision, which avoids subjective bias. A case study of Weichang District of Hebei Province, China, using Landsat-5/TM data of 2010 with 30 m spatial resolution and prior classification map of 2005 recognised as relatively precise data, was conducted to test the performance of this method. The experimental results show that the methodology determining the key parameters uses the portfolio optimisation model and increases the degree of automation of Jiang et al.'s classification method, which may have a wide scope of scientific application.
C1 [Wang, Yong; Jiang, Dong; Zhuang, Dafang; Huang, Yaohuan; Yu, Xinfang] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.
   [Wang, Wei] Beijing Technol & Business Univ, Sch Comp & Informat Engn, Beijing, Peoples R China.
RP Jiang, D (reprint author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.
EM jiangd@igsnrr.ac.cn
FU China Postdoctoral Science Foundation [20060400496]; Chinese Academy of
   Sciences [KZZD-EW-08]; National Natural Science Foundation of China
   [41001279]; National Scientific and Technological Support Projects of
   China [2011BAJ07B01]
FX This study was partially funded by the China Postdoctoral Science
   Foundation (20060400496), the Chinese Academy of Sciences (KZZD-EW-08),
   the National Natural Science Foundation of China (41001279), and the
   National Scientific and Technological Support Projects of China
   (2011BAJ07B01). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Abdullah SA, 2006, LANDSCAPE URBAN PLAN, V77, P263, DOI 10.1016/j.landurbplan.2005.03.003
   Aitkenhead MJ, 2011, REMOTE SENS ENVIRON, V115, P1285, DOI 10.1016/j.rse.2011.01.012
   Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x
   Baidu, INTR MONG WEICH MANC
   Berberoglu S, 2010, INT J REMOTE SENS, V31, P2793, DOI 10.1080/01431160903111077
   Blackman NJM, 2000, STAT MED, V19, P723, DOI 10.1002/(SICI)1097-0258(20000315)19:5<723::AID-SIM379>3.0.CO;2-A
   Canty MJ, 2006, IMAGE ANAL CLASSIFIC, P77
   Chen J, 2003, PHOTOGRAMM ENG REM S, V69, P369, DOI 10.14358/PERS.69.4.369
   Chen J, 2011, IEEE GEOSCI REMOTE S, V8, P317, DOI 10.1109/LGRS.2010.2068537
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Congalton R. G., 1999, ASSESSING ACCURACY R
   CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B
   De Santiago FF, 2013, INT J REMOTE SENS, V34, P563, DOI 10.1080/01431161.2012.715773
   Denis R, 2011, INT J REMOTE SENS, V32, P1747
   Foody GM, 2007, PROG PHYS GEOG, V31, P439, DOI 10.1177/0309133307081294
   Foody GM, 1997, INT J REMOTE SENS, V18, P937, DOI 10.1080/014311697218845
   Fortier J, 2011, PHOTOGRAMM ENG REM S, V77, P181, DOI 10.14358/PERS.77.2.181
   Fraser R, 2012, POLAR REC, V48, P83, DOI 10.1017/S0032247411000477
   Geneletti D, 2003, INT J REMOTE SENS, V24, P1273, DOI 10.1080/01431160210144499
   Gong P, 2003, INT J REMOTE SENS, V24, P1303, DOI 10.1080/01431160110115870
   Gupta M, 2010, WATER INT, V35, P233, DOI 10.1080/02508061003664419
   Gutman G, 2004, LAND CHANGE SCI OBSE, P108
   Hansen M, 1996, INT J REMOTE SENS, V17, P1075, DOI 10.1080/01431169608949069
   Jensen JR, 2005, INTRO DIGITAL IMAGE, P495
   Jiang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045889
   Lambin EF, 2006, LAND USE LAND COVER, P38
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liu Jiyuan, 2002, Journal of Geographical Sciences, V12, P275
   Liu JY, 2010, CHINESE SCI BULL, V55, P1354, DOI 10.1007/s11434-009-0733-y
   Liu JY, 2003, SCI CHINA SER D, V46, P373
   Liu JY, 2005, REMOTE SENS ENVIRON, V98, P442, DOI 10.1016/j.rse.2005.08.012
   LOVELAND TR, 1991, PHOTOGRAMM ENG REM S, V57, P1453
   Orenstein DE, 2011, INT J REMOTE SENS, V32, P2621, DOI 10.1080/01431161003713036
   Paneque-Galvez J, 2013, INT J APPL EARTH OBS, V23, P372, DOI 10.1016/j.jag.2012.10.007
   Pouteau R, 2013, REMOTE SENS LETT, V4, P686, DOI 10.1080/2150704X.2013.784848
   Richards JA, 1999, REMOTE SENSING DIGIT, P102
   Schneider A, 2010, REMOTE SENS ENVIRON, V114, P1733, DOI 10.1016/j.rse.2010.03.003
   Veldkamp A, 2001, AGR ECOSYST ENVIRON, V85, P1, DOI 10.1016/S0167-8809(01)00199-2
   Wang YC, 2011, INT J REMOTE SENS, V32, P3765, DOI 10.1080/01431161.2010.540590
   Weng Q, 2011, T&F SER REMOTE SENS, P1, DOI 10.1201/b10599
   Xian G, 2009, REMOTE SENS ENVIRON, V113, P1133, DOI 10.1016/j.rse.2009.02.004
   Xie YC, 2010, ISPRS J PHOTOGRAMM, V65, P182, DOI 10.1016/j.isprsjprs.2009.10.007
   Yvonne MMB, 1975, DISCRETE MULTIVARIAT, P58
   Zhao Y, 2003, APPL PRINCIPLE METHO, P57
NR 44
TC 1
Z9 2
U1 0
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 28
PY 2013
VL 8
IS 10
AR e75852
DI 10.1371/journal.pone.0075852
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 242KW
UT WOS:000326241200008
PM 24204582
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Phillips, CM
   Dillon, C
   Harrington, JM
   McCarthy, VJC
   Kearney, PM
   Fitzgerald, AP
   Perry, IJ
AF Phillips, Catherine M.
   Dillon, Christina
   Harrington, Janas M.
   McCarthy, Vera J. C.
   Kearney, Patricia M.
   Fitzgerald, Anthony P.
   Perry, Ivan J.
TI Defining Metabolically Healthy Obesity: Role of Dietary and Lifestyle
   Factors
SO PLOS ONE
LA English
DT Article
ID BODY-MASS INDEX; NORMAL-WEIGHT; CARDIOVASCULAR-DISEASE; MHO INDIVIDUALS;
   WOMEN; RISK; POPULATION; MEN; IDENTIFICATION; INFLAMMATION
AB Background: There is a current lack of consensus on defining metabolically healthy obesity (MHO). Limited data on dietary and lifestyle factors and MHO exist. The aim of this study is to compare the prevalence, dietary factors and lifestyle behaviours of metabolically healthy and unhealthy obese and non-obese subjects according to different metabolic health criteria.
   Method: Cross-sectional sample of 1,008 men and 1,039 women aged 45-74 years participated in the study. Participants were classified as obese (BMI >= 30kg/m(2)) and non-obese (BMI <30kg/m(2)). Metabolic health status was defined using five existing MH definitions based on a range of cardiometabolic abnormalities. Dietary composition and quality, food pyramid servings, physical activity, alcohol and smoking behaviours were examined.
   Results: The prevalence of MHO varied considerably between definitions (2.2% to 11.9%), was higher among females and generally increased with age. Agreement between MHO classifications was poor. Among the obese, prevalence of MH was 6.8% to 36.6%. Among the non-obese, prevalence of metabolically unhealthy subjects was 21.8% to 87%. Calorie intake, dietary macronutrient composition, physical activity, alcohol and smoking behaviours were similar between the metabolically healthy and unhealthy regardless of BMI. Greater compliance with food pyramid recommendations and higher dietary quality were positively associated with metabolic health in obese (OR 1.45-1.53 unadjusted model) and non-obese subjects (OR 1.37-1.39 unadjusted model), respectively. Physical activity was associated with MHO defined by insulin resistance (OR 1.87, 95% CI 1.19-2.92, p = 0.006).
   Conclusion: A standard MHO definition is required. Moderate and high levels of physical activity and compliance with food pyramid recommendations increase the likelihood of MHO. Stratification of obese individuals based on their metabolic health phenotype may be important in ascertaining the appropriate therapeutic or intervention strategy.
C1 [Phillips, Catherine M.; Dillon, Christina; Harrington, Janas M.; McCarthy, Vera J. C.; Kearney, Patricia M.; Fitzgerald, Anthony P.; Perry, Ivan J.] Natl Univ Ireland Univ Coll Cork, Hlth Res Board Ctr Diet & Hlth Res, Dept Epidemiol & Publ Hlth, Cork, Ireland.
   [Fitzgerald, Anthony P.] Natl Univ Ireland Univ Coll Cork, Dept Stat, Cork, Ireland.
RP Phillips, CM (reprint author), Natl Univ Ireland Univ Coll Cork, Hlth Res Board Ctr Diet & Hlth Res, Dept Epidemiol & Publ Hlth, Cork, Ireland.
EM c.phillips@ucc.ie
OI Phillips, Catherine/0000-0003-4916-4463; Perry, Ivan/0000-0002-4965-9792
FU Irish Health Research Board [HRC/2007/13]
FX This work was supported by a research grant from the Irish Health
   Research Board (reference HRC/2007/13). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aguilar-Salinas CA, 2008, J CLIN ENDOCR METAB, V93, P4075, DOI 10.1210/jc.2007-2724
   Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc
   Cena H, 2011, NUTR REV, V69, P745, DOI 10.1111/j.1753-4887.2011.00446.x
   Choi J, 2012, NUTR METAB CARDIOVAS, V22, P567, DOI 10.1016/j.numecd.2010.09.001
   Ekelund U, 2011, AM J CLIN NUTR, V93, P826, DOI 10.3945/ajcn.110.006593
   Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905
   Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713
   Gomez-Ambrosi J, 2012, DIABETES CARE, V35, P383, DOI 10.2337/dc11-1334
   Hankinson AL, 2012, OBESITY SILVER SPRIN
   Harrington J, 2013, CURR DIAB REP
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   International Physical Activity Questionnaire Group, GUID DAT PROC AN INT
   Janiszewski PM, 2010, DIABETES CARE, V33, P1957, DOI 10.2337/dc10-0547
   Kantartzis K, 2011, DIABETOLOGIA, V54, P864, DOI 10.1007/s00125-010-2006-3
   Karelis A, 2004, DIABETES METAB, V30, P569, DOI 10.1016/S1262-3636(07)70156-8
   Karelis AD, 2008, DIABETOLOGIA, V51, P1752, DOI 10.1007/s00125-008-1038-4
   Karelis AD, 2008, DIABETES METAB, V34, P183, DOI 10.1016/j.diabet.2007.11.004
   Karelis AD, 2008, LANCET, V372, P1281, DOI 10.1016/S0140-6736(08)61531-7
   Kearney PM, 2012, INT J EPIDEMIOL
   Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102
   Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lynch LA, 2009, OBESITY, V17, P601, DOI 10.1038/oby.2008.565
   Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067
   Manu P, 2012, OBES RES CLIN PRACT, V6, pE9, DOI 10.1016/j.orcp.2011.04.003
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594
   Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76
   NHLBI Obesity Education Initiative Expert Panel, 1998, CLIN GUID ID EV TREA
   Pajunen P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-754
   Pataky Z, 2010, INT J OBESITY, V34, pS18, DOI 10.1038/ijo.2010.235
   Phillips C, 2013, J CLIN ENDOCRIN 0826, V26
   Phillips CM, 2013, OBESITY, V21, pE154, DOI [10.1002/oby.20263, 10.1038/oby.2012.188]
   Phillips CM, 2013, NUTRIENTS, V5, P32, DOI 10.3390/nu5010032
   Phillips CM, 2013, REV ENDOCR METAB DIS
   RUDERMAN NB, 1981, AM J CLIN NUTR, V34, P1617
   Shin MJ, 2006, INT J OBESITY, V30, P1529, DOI 10.1038/sj.ijo.0803304
   Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487
   Velho S, 2010, EUR J CLIN NUTR, V64, P1043, DOI 10.1038/ejcn.2010.114
   Villegas R, 2004, PUBLIC HEALTH NUTR, V7, P1017, DOI 10.1079/PHN2004638
   Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617
   Wildman RP, 2009, CURR OPIN CLIN NUTR, V12, P438, DOI 10.1097/MCO.0b013e32832c6db7
   Yoo HK, 2013, KOREAN J FAM MED, V34, P19, DOI 10.4082/kjfm.2013.34.1.19
NR 45
TC 102
Z9 103
U1 0
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 17
PY 2013
VL 8
IS 10
AR e76188
DI 10.1371/journal.pone.0076188
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 239KL
UT WOS:000326022200011
PM 24146838
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hebden, L
   Kostan, E
   O'Leary, F
   Hodge, A
   Allman-Farinelli, M
AF Hebden, Lana
   Kostan, Engracia
   O'Leary, Fiona
   Hodge, Allison
   Allman-Farinelli, Margaret
TI Validity and Reproducibility of a Food Frequency Questionnaire as a
   Measure of Recent Dietary Intake in Young Adults
SO PLOS ONE
LA English
DT Article
ID VALIDATION; AGREEMENT; HABITS; AGE
AB This research assessed the relative validity and reproducibility of the Dietary Questionnaire for Epidemiological Studies (DQESV2) over one month in young adults, given the lack of concise and convenient instruments for assessing recent dietary intake in this population. Participants were recruited from a large Australian university (N = 102; 35% male; age 18-34 years; body mass index 16-37 kg/m(2)). Five one-day weighed food records (WFR) were administered over one month followed by the DQESV2. Estimates for nutrients (energy, protein, total fat, saturated fat, carbohydrate, sugars, dietary fibre, and alcohol) and fruit and vegetable servings were compared between methods using correlation coefficients, 95% limits of agreement, and quintile classifications. One week later, a second DQESV2 was completed by n = 77 of the participants to assess reproducibility using intra-class correlations (ICC) and weighted kappa. Comparing methods, all nutrients and fruit and vegetable servings showed significant positive correlations (P<0.05) except protein intake in males; over 60% of participants were within one quintile classification except total fat and dietary fibre intakes in males (55% and 56%, respectively); and differences in nutrient and food intakes between methods were all within +/-20% of the mean WFR values except alcohol intake in females. Between first and second administrations of the DQESV2 all ICC coefficients were positive (P<0.01) and weighted kappa coefficients ranged from 0.54 for fruit servings (including fruit juice) in males to 0.91 for protein intake in females. Over a one month period, the DQESV2 demonstrated good reproducibility for the studied nutrients and for fruit and vegetable servings and provided a valid measure of the studied nutrients, except alcohol in females, and of fruit servings (including fruit juice) in both genders, at the group level in this young adult population.
C1 [Hebden, Lana; Kostan, Engracia; O'Leary, Fiona; Allman-Farinelli, Margaret] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
   [Hodge, Allison] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia.
RP Hebden, L (reprint author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
EM lana.hebden@sydney.edu.au
OI Hodge, Allison/0000-0001-5464-2197
CR Allman-Farinelli MA, 2008, EUR J CLIN NUTR, V62, P898, DOI 10.1038/sj.ejcn.1602769
   Australian Bureau of Statistics, 2012, AUSTR HLTH SURV 1 RE
   Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204
   Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318
   Cade JE, 2004, NUTR RES REV, V17, P5, DOI 10.1079/NRR200370
   Cashel K, 1994, CORE FOOD GROUPS SCI
   Duffey KJ, 2010, AM J CLIN NUTR, V92, P954, DOI 10.3945/ajcn.2010.29478
   Food Standards Australia New Zealand, 2008, AUSNUT 2007 MEAS DAT
   Food Standards Australia New Zealand, 2011, NUTTAB 2010 AUSTR FO
   Giles GG, 1996, DIETARY QUESTIONNAIR
   Hodge A, 2000, AUST NZ J PUBL HEAL, V24, P567
   Ibiebele TI, 2009, PUBLIC HEALTH NUTR, V12, P2359, DOI 10.1017/S1368980009005023
   Ireland P, 1994, Asia Pac J Clin Nutr, V3, P19
   Kimmons Joel, 2009, Medscape J Med, V11, P26
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Marks GC, 2006, J NUTR, V136, P459
   McLennan W, 1999, NATL NUTR SURVEY SEL
   National Health and Medical Research Council, 2013, ED GUID
   Pedisic Z, 2008, COLLEGIUM ANTROPOL, V32, P1069
   Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0
   Rosalind SG, 2005, PRINCIPLES NUTR ASSE, P149
   Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5
   Watson JF, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-62
   Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S
   Willett WC, 1998, NUTR EPIDEMIOLOGY
   Woods RK, 2002, ASIA PAC J CLIN NUTR, V11, P56, DOI 10.1046/j.1440-6047.2002.00273.x
   Xinying PX, 2004, ASIA PAC J CLIN NUTR, V13, P318
NR 27
TC 25
Z9 25
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 18
PY 2013
VL 8
IS 9
AR e75156
DI 10.1371/journal.pone.0075156
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 221YD
UT WOS:000324695900097
PM 24058660
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Katz, IT
   Nkala, B
   Dietrich, J
   Wallace, M
   Bekker, LG
   Pollenz, K
   Bogart, LM
   Wright, AA
   Tsai, AC
   Bangsberg, DR
   Gray, GE
AF Katz, Ingrid T.
   Nkala, Busisiwe
   Dietrich, Janan
   Wallace, Melissa
   Bekker, Linda-Gail
   Pollenz, Kathryn
   Bogart, Laura M.
   Wright, Alexi A.
   Tsai, Alexander C.
   Bangsberg, David R.
   Gray, Glenda E.
TI A Qualitative Analysis of Factors Influencing HPV Vaccine Uptake in
   Soweto, South Africa among Adolescents and Their Caregivers
SO PLOS ONE
LA English
DT Article
ID HUMAN-PAPILLOMAVIRUS VACCINATION; CERVICAL-CANCER PREVENTION;
   DECISION-MAKING; WOMEN; ACCEPTABILITY; ACCEPTANCE; VIRUS; RISK;
   IMMUNOGENICITY; JOHANNESBURG
AB Background: In South Africa, the prevalence of oncogenic Human Papillomavirus (HPV) may be as high as 64%, and cervical cancer is the leading cause of cancer-related death among women. The development of efficacious prophylactic vaccines has provided an opportunity for primary prevention. Given the importance of psycho-social forces in vaccine uptake, we sought to elucidate factors influencing HPV vaccination among a sample of low-income South African adolescents receiving the vaccine for the first time in Soweto.
   Methods: The HPV vaccine was introduced to adolescents in low-income townships throughout South Africa as part of a nationwide trial to understand adolescent involvement in future vaccine research targeting human immunodeficiency virus (HIV). We performed in-depth semi-structured interviews with purposively-sampled adolescents and their care providers to understand what forces shaped HPV vaccine uptake. Interviews were recorded, transcribed, translated, and examined using thematic analysis.
   Results: Of 224 adolescents recruited, 201 initiated the vaccine; 192 (95.5%) received a second immunization; and 164 (81.6%) completed three doses. In our qualitative study of 39 adolescent-caregiver dyads, we found that factors driving vaccine uptake reflected a socio-cultural backdrop of high HIV endemnicity, sexual violence, poverty, and an abundance of female-headed households. Adolescents exercised a high level of autonomy and often initiated decision-making. Healthcare providers and peers provided support and guidance that was absent at home. The impact of the HIV epidemic on decision-making was substantial, leading participants to mistakenly conflate HPV and HIV.
   Conclusions: In a setting of perceived rampant sexual violence and epidemic levels of HIV, adolescents and caregivers sought to decrease harm by seeking a vaccine targeting a sexually transmitted infection (STI). Despite careful consenting, there was confusion regarding the vaccine's target. Future interventions promoting STI vaccines will need to provide substantial information for participants, particularly adolescents who may exercise a significant level of autonomy in decision-making.
C1 [Katz, Ingrid T.] Brigham & Womens Hosp, Boston, MA 02115 USA.
   [Katz, Ingrid T.; Pollenz, Kathryn; Bogart, Laura M.; Wright, Alexi A.; Tsai, Alexander C.; Bangsberg, David R.] Harvard Univ, Sch Med, Boston, MA USA.
   [Katz, Ingrid T.; Tsai, Alexander C.; Bangsberg, David R.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA.
   [Nkala, Busisiwe; Dietrich, Janan; Gray, Glenda E.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa.
   [Wallace, Melissa; Bekker, Linda-Gail] Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa.
   [Bogart, Laura M.] Childrens Hosp Boston, Boston, MA USA.
   [Wright, Alexi A.] Dana Farber Canc Inst, Boston, MA 02115 USA.
   [Bangsberg, David R.] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA.
   [Bangsberg, David R.] Harvard Univ, Boston, MA 02115 USA.
RP Katz, IT (reprint author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.
EM ikatz2@partners.org
OI Katz, Ingrid/0000-0002-3014-238X; Tsai, Alexander/0000-0001-6397-7917
FU KL2 MeRIT program of Harvard Catalyst \ The Harvard Clinical and
   Translational Science Center [UL1 RR 025758]; Harvard University;
   National Institute of Mental Health [1K23MH097667-01, K23 MH-096620,
   5K24AA015287-06]; Harvard University Center for AIDS Research (HU CFAR
   HIV/NIAID) [5P30A1060354-08]; European & Developing Countries Clinical
   Trials Partnership; South African AIDS Vaccine Initiative (SAAVI)
FX This qualitative study was funded by a grant to Dr. Katz, MD, MHS, from
   the KL2 MeRIT program of Harvard Catalyst vertical bar The Harvard
   Clinical and Translational Science Center (Award #UL1 RR 025758), and by
   financial contributions from Harvard University and its affiliated
   academic health care centers. Dr. Katz currently receives salary support
   through the National Institute of Mental Health (1K23MH097667-01) and
   the Harvard University Center for AIDS Research (HU CFAR HIV/NIAID, Fund
   5P30A1060354-08. Ms. Nkala received support from The European &
   Developing Countries Clinical Trials Partnership. Ms. Dietrich receives
   partial salary support through The South African AIDS Vaccine Initiative
   (SAAVI). Dr. Tsai receives salary support through The National Institute
   of Mental Health (K23 MH-096620). Dr. Bangsberg receives salary support
   through The National Institute of Mental Health (5K24AA015287-06). The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of Harvard Catalyst, Harvard
   University and its affiliated academic health care centers or the
   National Institutes of Health. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adar J, 2000, S AFRICAN HLTH REV, P411
   Alexander AB, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-192
   Bartolini RM, 2010, SALUD PUBLICA MEXICO, V52, P226, DOI 10.1590/S0036-36342010000300007
   Bekker LG, 2009, COMMUNITY ATTITUDES
   Bingham A, 2009, ARCH PEDIAT ADOL MED, V163, P455, DOI 10.1001/archpediatrics.2009.50
   Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244
   Botha MH, 2012, VACCINE, V30, pC28, DOI 10.1016/j.vaccine.2012.03.032
   Brabin L, 2006, VACCINE, V24, P3087, DOI 10.1016/j.vaccine.2006.01.048
   Conroy K, 2009, J WOMENS HEALTH, V18, P1679, DOI 10.1089/jwh.2008.1329
   Corbin J., 2008, BASICS QUALITATIVE R
   Cover JK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-629
   Crabtree B, 1999, DOING QUALITATIVE RE
   Creswell J, 1998, QUALITATIVE INQUIRY
   Crime Information Analysis Center, 2001, REP SER CRIM SIT S A
   De Vuyst H, 2012, INT J CANCER, V131, P949, DOI 10.1002/ijc.26470
   Denny L, 2006, INT J GYNECOL OBSTET, V95, pS211, DOI 10.1016/S0020-7292(06)60036-2
   Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173
   Denny L, 2008, REPROD HEALTH MATTER, V16, P18, DOI 10.1016/S0968-8080(08)32397-0
   Denny LA, 2012, VACCINE, V30, pF168, DOI 10.1016/j.vaccine.2012.06.045
   Department of Health, 2011, NAT ANT SENT HIV SYP
   Fazekas KI, 2008, J WOMENS HEALTH, V17, P539, DOI 10.1089/jwh.2007.0489
   Fife KH, 2004, VACCINE, V22, P2943, DOI 10.1016/j.vaccine.2003.11.058
   Firnhaber C, 2010, CANCER CAUSE CONTROL, V21, P433, DOI 10.1007/s10552-009-9475-z
   Forster AS, 2012, VACCINE, V30, P4505, DOI 10.1016/j.vaccine.2012.04.066
   Francis SA, 2012, MATERN CHILD HLTH J
   Francis SA, 2011, VACCINE, V29, P8760, DOI 10.1016/j.vaccine.2011.07.116
   Francis SA, 2010, VACCINE, V28, P8026, DOI 10.1016/j.vaccine.2010.08.090
   Gerend MA, 2013, SEX TRANSM DIS, V40, P401, DOI 10.1097/OLQ.0b013e318283c8a8
   Gerend MA, 2013, HEALTH PSYCHOL, V32, P361, DOI 10.1037/a0026248
   Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4
   Harries J, 2009, VACCINE, V27, P38, DOI 10.1016/j.vaccine.2008.10.033
   Hilton S, 2013, VACCINE
   Human Rights Watch, 1995, VIOL WOM S AFR STAT
   Hung KJ, 2012, OBSTET GYNECOL, V119, P975, DOI 10.1097/AOG.0b013e31824fc9a0
   Jewkes R, 2002, SOC SCI MED, V55, P1231, DOI 10.1016/S0277-9536(01)00242-8
   Jones HE, 2007, J CLIN MICROBIOL, V45, P1679, DOI 10.1128/JCM.02369-06
   Katahoire AR, 2008, FORMATIVE RES REPORT
   Katz IT, 2010, SEX HEALTH, V7, P279, DOI 10.1071/SH09130
   Katz IT, 2006, NEW ENGL J MED, V354, P1110, DOI 10.1056/NEJMp068031
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Laz TH, 2013, CANCER-AM CANCER SOC, V119, P1386, DOI 10.1002/cncr.27894
   Mosavel M, 2005, SOC SCI MED, V61, P2577, DOI 10.1016/j.socscimed.2005.04.041
   Motsoaledi A, 2013, COMMUNICATION
   Nelson JA, 2010, SEX REPROD HEALTHC, V1, P195, DOI 10.1016/j.srhc.2010.07.004
   Nguyen QN, 2010, SEX HEALTH, V7, P262, DOI 10.1071/SH09123
   Omar T, 2011, AIDS, V25, P87, DOI 10.1097/QAD.0b013e328340fd99
   Otwombe KN, 2011, JAIDS-J ACQ IMM DEF, V58, P211, DOI 10.1097/QAI.0b013e31822b7702
   Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4
   PATH National AIDS Research Institute (NARI), 2008, ASS INTR HPV VACC IN
   Population Reference Bureau PATH, 2004, PREV CERV CANC WORLD
   Rehle TM, 2010, PLOS ONE, V5, DOI [10.1371/j.ournal.pone.0011094, 10.1371/journal.pone.0011094]
   Reiter PL, 2010, VACCINE, V28, P6292, DOI 10.1016/j.vaccine.2010.06.114
   Romanowski B, 2009, LANCET, V374, P1975, DOI 10.1016/S0140-6736(09)61567-1
   Shisana O, 2010, J WOMENS HEALTH, V19, P39, DOI 10.1089/jwh.2008.1200
   Smith JS, 2008, J ADOLESCENT HEALTH, V43, pS5, DOI 10.1016/j.jadohealth.2008.07.009
   Smith K, 2010, J CHILD SEX ABUS, V19, P255, DOI 10.1080/10538711003781269
   Statistics South Africa, 2011, DAT MET SET VICT CRI
   Tsai AC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001440
   Tsai AC, 2012, AIDS, V26, P381, DOI 10.1097/QAD.0b013e32834e1ccb
   UNAIDS, 2011, S AFRICA
   WILLMS DG, 1990, MED ANTHROPOL Q, V4, P391, DOI 10.1525/maq.1990.4.4.02a00020
   Wong CA, 2011, CANCER-AM CANCER SOC, V117, P5612, DOI 10.1002/cncr.26246
   World Health Organization/London School of Hygiene and Tropical Medicine, 2010, PREV INT PARTN VIOL
   Wright TC, 2006, VACCINE, V24, P251, DOI 10.1016/j.vaccine.2006.06.064
NR 64
TC 20
Z9 20
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 30
PY 2013
VL 8
IS 8
AR e72094
DI 10.1371/journal.pone.0072094
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 211BX
UT WOS:000323880200008
PM 24023613
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zhao, K
   Yan, WJ
   Chen, YH
   Zuo, XN
   Fu, XL
AF Zhao, Ke
   Yan, Wen-Jing
   Chen, Yu-Hsin
   Zuo, Xi-Nian
   Fu, Xiaolan
TI Amygdala Volume Predicts Inter-Individual Differences in Fearful Face
   Recognition
SO PLOS ONE
LA English
DT Article
ID HAPPY FACIAL EXPRESSIONS; HUMAN CEREBRAL-CORTEX; HUMAN BRAIN; EMOTIONAL
   STIMULI; SOCIAL-BEHAVIOR; RESPONSES; ANXIETY; DAMAGE; MRI; SEGMENTATION
AB The present study investigates the relationship between inter-individual differences in fearful face recognition and amygdala volume. Thirty normal adults were recruited and each completed two identical facial expression recognition tests offline and two magnetic resonance imaging (MRI) scans. Linear regression indicated that the left amygdala volume negatively correlated with the accuracy of recognizing fearful facial expressions and positively correlated with the probability of misrecognizing fear as surprise. Further exploratory analyses revealed that this relationship did not exist for any other subcortical or cortical regions. Nor did such a relationship exist between the left amygdala volume and performance recognizing the other five facial expressions. These mind-brain associations highlight the importance of the amygdala in recognizing fearful faces and provide insights regarding inter-individual differences in sensitivity toward fear-relevant stimuli.
C1 [Zhao, Ke; Yan, Wen-Jing; Chen, Yu-Hsin; Fu, Xiaolan] Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China.
   [Zhao, Ke; Yan, Wen-Jing; Chen, Yu-Hsin] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Magnet Resonance Imaging Res Ctr, Beijing 100101, Peoples R China.
RP Fu, XL (reprint author), Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China.
EM fuxl@psych.ac.cn
RI Zuo, Xi-Nian/A-7273-2009
OI Zuo, Xi-Nian/0000-0001-9110-585X
FU 973 Program [2011CB302201]; National Natural Science Foundation of China
   [61075042, 81171409, 81220108014]
FX This research was supported in part by grants from 973 Program (No.
   2011CB302201) and the National Natural Science Foundation of China (Nos.
   61075042, 81171409, 81220108014). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244
   ADOLPHS R, 1995, J NEUROSCI, V15, P5879
   ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0
   Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006
   Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003
   Amaral DG, 2002, BIOL PSYCHIAT, V51, P11, DOI 10.1016/S0006-3223(01)01307-5
   Anderson AK, 2000, PSYCHOL SCI, V11, P106, DOI 10.1111/1467-9280.00224
   Anderson AK, 2003, J NEUROSCI, V23, P5627
   ARNDT S, 1991, PSYCHIAT RES-NEUROIM, V40, P79
   Bickart KC, 2010, NAT NEUROSCI, V14, P163, DOI DOI 10.1038/NN.2724
   Bickart KC, 2012, J NEUROSCI, V32, P14729, DOI 10.1523/JNEUROSCI.1599-12.2012
   Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6
   Broks P, 1998, NEUROPSYCHOLOGIA, V36, P59, DOI 10.1016/S0028-3932(97)00105-X
   Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890
   Calder AJ, 2003, NEUROPSYCHOLOGIA, V41, P195, DOI 10.1016/S0028-3932(02)00149-5
   Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012
   Cremers H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028421
   Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395
   Darwin C., 2002, EXPRESSION EMOTIONS
   DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.ne.15.030192.002033
   Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021
   DICKS D, 1969, SCIENCE, V165, P69, DOI 10.1126/science.165.3888.69
   Du S, 2011, J VIS, V11, P1425
   EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068
   EKMAN P, 1974, J PERS SOC PSYCHOL, V29, P288, DOI 10.1037/h0036006
   EKMAN P, 1986, MOTIV EMOTION, V10, P159, DOI 10.1007/BF00992253
   Feinstein JS, 2011, CURR BIOL, V21, P34, DOI 10.1016/j.cub.2010.11.042
   Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087
   Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X
   Fisler MS, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-70
   Fox E, 2002, COGN AFFECT BEHAV NE, V2, P52, DOI 10.3758/CABN.2.1.52
   Gosselin P, 1999, J GENET PSYCHOL, V160, P181, DOI 10.1080/00221329909595391
   Hadj-Bouziane F, 2012, P NAT ACAD SCI, V109, P3640
   Hadj-Bouziane F, 2008, P NATL ACAD SCI USA, V105, P5591, DOI 10.1073/pnas.0800489105
   Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179
   Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004
   Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071
   Hooker CI, 2008, NEUROPSYCHOLOGIA, V46, P2709, DOI 10.1016/j.neuropsychologia.2008.05.005
   Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051
   Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000
   Kling AS, 1992, AMYGDALA NEUROBIOLOG
   Kohavi R., 1998, MACH LEARN, V30, P271, DOI DOI 10.1023/A:1017181826899
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lissek S, 2008, AM J PSYCHIAT, V165, P124, DOI 10.1176/appi.ajp.2007.06091513
   Milad MR, 2005, P NATL ACAD SCI USA, V102, P10706, DOI 10.1073/pnas.050441102
   Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0
   Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47
   Mueller SC, 2013, J AM ACAD CHILD PSY, V52, P184, DOI 10.1016/j.jaac.2012.11.016
   Park HJ, 2012, PSYCHIAT RES, V197, P237, DOI 10.1016/j.psychres.2011.11.001
   Phillips ML, 2001, HUM BRAIN MAPP, V12, P193, DOI 10.1002/1097-0193(200104)12:4<193::AID-HBM1015>3.0.CO;2-A
   Rapcsak SZ, 2000, NEUROLOGY, V54, P575, DOI 10.1212/WNL.54.3.575
   Rogers MA, 2009, PSYCHIAT RES-NEUROIM, V174, P210, DOI 10.1016/j.pscychresns.2009.06.001
   Rolls E. T., 1999, BRAIN EMOTION
   Seeck M, 1997, NEUROREPORT, V8, P2749, DOI 10.1097/00001756-199708180-00021
   Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032
   Spielberger C. D., 1983, MANUAL STATE TRAIT A
   Sprengelmeyer R, 1999, P ROY SOC B-BIOL SCI, V266, P2451, DOI 10.1098/rspb.1999.0945
   Thomas KM, 2001, BIOL PSYCHIAT, V49, P309, DOI 10.1016/S0006-3223(00)01066-0
   Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006
   Tsuchiya N, 2009, NAT NEUROSCI, V12, P1224, DOI 10.1038/nn.2380
   van der Zwaag W, 2012, BRAIN TOPOGR, V25, P125, DOI 10.1007/s10548-012-0219-0
   Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70
   Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912
   Williams MA, 2008, EUR J NEUROSCI, V27, P3074, DOI 10.1111/j.1460-9568.2008.06264.x
   Woon FL, 2008, HIPPOCAMPUS, V18, P729, DOI 10.1002/hipo.20437
   Xing XX, 2011, MAGN RESON IMAGING, V29, P731, DOI 10.1016/j.mri.2011.02.007
   Yan CG, 2013, NEUROIMAGE IN PRESS
   Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017
   Zuo XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026703
NR 69
TC 15
Z9 15
U1 0
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 29
PY 2013
VL 8
IS 8
AR e74096
DI 10.1371/journal.pone.0074096
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 209DO
UT WOS:000323734600080
PM 24009767
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Yang, CH
   Chan, PC
   Liao, ST
   Cheng, SH
   Wong, WW
   Huang, LM
   Hsueh, PR
   Chiou, HY
AF Yang, Chin-Hui
   Chan, Pei-Chun
   Liao, Say-Tsung
   Cheng, Shu-Hsing
   Wong, Wing-Wai
   Huang, Li-Min
   Hsueh, Po-Ren
   Chiou, Hung-Yi
TI Strategy to Better Select HIV-Infected Individuals for Latent TB
   Treatment in BCG-Vaccinated Population
SO PLOS ONE
LA English
DT Article
ID GAMMA RELEASE ASSAY; MYCOBACTERIUM-TUBERCULOSIS INFECTION; ACTIVE
   ANTIRETROVIRAL THERAPY; ISONIAZID PREVENTIVE THERAPY; CELL-BASED ASSAYS;
   SOUTH-AFRICA; SKIN-TEST; PREDICTIVE-VALUE; UNITED-STATES; TAIWAN
AB Objective: To evaluate the T-SPOT. TB interferon-gamma releasing assay and the tuberculin skin test (TST), for the diagnosis of latent tuberculosis infection(LTBI) and the development of subsequent active tuberculosis, in BCG-vaccinated HIV-infected individuals.
   Methods: HIV-infected individuals without clinical suspicion of active TB or a past history of TB were enrolled from 1 January 2008 to 30 November 2010. Both T-SPOT. TB test and TST were offered to the participants whom were followed up prospectively until April 30, 2012 for development of TB.
   Results: Among the 909 participants, 25% had positive TST reactions with cut-off point of 5 mm and 15% had positive T-SPOT. TB results. After a median follow-up of 2.97 years, there were 5 cases developed culture-confirmed active TB (all had dual positive TST and T-SPOT. TB results), and the incidence was 0.17 per 100 person-years. The relative risks (RRs) for subsequent active TB in HIV-infected individuals with positive TST results, positive T-SPOT. TB results and dual positive results compared with the risk for individuals with negative results were 40.6 (95% CI 2.1-767.9), 73.9 (95% CI 3.9-1397.7) and 226.5 (95% CI 12.0-4284), respectively. The number needed to treat to prevent one subsequent TB case among patients with a positive TST, a positive T-SPOT. TB and dual positive results was 35, 22 and 8 respectively.
   Conclusions: Adopting positive results of the TST and T-SPOT. TB to screen LTBI among BCG-vaccinated HIV-infected individuals might be feasible. Number needed to treat for isoniazid preventive therapy could be reduced significantly by using dual positive strategy.
C1 [Yang, Chin-Hui; Chan, Pei-Chun] Ctr Dis Control, Dept Hlth, Taipei, Taiwan.
   [Yang, Chin-Hui] Taipei Med Univ, Sch Publ Hlth, PhD Program, Taipei, Taiwan.
   [Yang, Chin-Hui] Taipei Med Univ, Taipei Med Univ Hosp, Dept Internal Med, Div Infect Dis, Taipei, Taiwan.
   [Liao, Say-Tsung] Taipei Med Univ, Taipei Med Univ Hosp, Dept Internal Med, Div Rheumatol, Taipei, Taiwan.
   [Cheng, Shu-Hsing] Taoyuan Gen Hosp, Dept Internal Med, Div Infect Dis, Tao Yuan, Taiwan.
   [Wong, Wing-Wai] Taipei Vet Gen Hosp, Dept Med, Div Infect Dis, Taipei, Taiwan.
   [Huang, Li-Min] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, Taipei, Taiwan.
   [Hsueh, Po-Ren] Natl Taiwan Univ, Coll Med, Dept Lab Med, Natl Taiwan Univ Hosp, Taipei, Taiwan.
   [Hsueh, Po-Ren] Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei, Taiwan.
   [Chiou, Hung-Yi] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan.
RP Chiou, HY (reprint author), Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan.
EM hychiou@tmu.edu.tw
OI HSUEH, PO-REN/0000-0002-7502-9225; Chiou, Hung Yi/0000-0002-4545-9697;
   HUANG, LI-MIN/0000-0002-9291-260X
FU Centers for Disease Control, Taiwan [DOH97-DC-1502]
FX This study was supported by the Centers for Disease Control, Taiwan
   (grant DOH97-DC-1502), to which interim progress reports were submitted.
   The funding body had no role in the study design, data analysis, data
   interpretation or writing of the report but was involved in data
   collection.
CR Aichelburg MC, 2009, CLIN INFECT DIS, V48, P954, DOI 10.1086/597351
   Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3
   Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3
   Black GF, 2001, J INFECT DIS, V184, P322, DOI 10.1086/322042
   Chan PC, 2008, J FORMOS MED ASSOC, V107, P195, DOI 10.1016/S0929-6646(08)60137-0
   Chan PC, 2013, THORAX, V68, P263, DOI 10.1136/thoraxjnl-2012-202208
   Dheda K, 2005, AIDS, V19, P2038, DOI 10.1097/01.aids.0000191923.08938.5b
   Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC
   Elzi L, 2007, CLIN INFECT DIS, V44, P94, DOI 10.1086/510080
   Elzi L, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-319
   Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f
   GUELAR A, 1993, AIDS, V7, P1345, DOI 10.1097/00002030-199310000-00007
   Hawken MP, 1997, AIDS, V11, P875, DOI 10.1097/00002030-199707000-00006
   Hoffmann M, 2007, AIDS, V21, P390, DOI 10.1097/QAD.0b013e328012164b
   Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667
   Jiang WM, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-31
   Jonnalagadda S, 2010, J INFECT DIS, V202, P1826, DOI 10.1086/657411
   Karam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001441
   Kik SV, 2010, EUR RESPIR J, V35, P1346, DOI 10.1183/09031936.00098509
   Lacombe K, 2012, GUT, V61, P47, DOI 10.1136/gutjnl-2012-302062
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac
   Leidl L, 2009, EUR RESPIR J, V35, P619
   Lo HY, 2011, J FORMOS MED ASSOC, V110, P501, DOI 10.1016/S0929-6646(11)60076-4
   Luetkemeyer AF, 2007, AM J RESP CRIT CARE, V175, P737, DOI 10.1164/rccm.200608-1088OC
   Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1
   National Institute of Health and Clinical Excellence, 2011, NEW NICE GUID UPD RE
   Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241
   Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC
   Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST
   Stephan C, 2008, AIDS, V22, P2471, DOI 10.1097/QAD.0b013e3283188415
   Sun HY, 2006, JPN J INFECT DIS, V59, P311
   Sun HY, 2009, AM J GASTROENTEROL, V104, P877, DOI 10.1038/ajg.2008.159
   Taiwan Center for Disease Control, 2010, GUID DIAGN TREATM HI
   Taiwan Centers for Disease Control, 2011, TAIW GUID TB DIAGN T
   Taiwan Centers for Disease Control, 2013, TAIW HIV AIDS MONTHL
   US CDC, 2000, MMWR-MORBID MORTAL W, V49, P1
   Wang JY, 2007, J INFECT DIS, V196, P281, DOI 10.1086/518898
   World Health Organization, 2011, US TUB INT GAMM REL
   Yang CH, 2008, INT J DRUG POLICY, V19, P317, DOI 10.1016/j.drugpo.2006.11.016
NR 40
TC 9
Z9 9
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 27
PY 2013
VL 8
IS 8
AR e73069
DI 10.1371/journal.pone.0073069
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 210FR
UT WOS:000323815200064
PM 24015285
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU McConville, A
   Law, BS
   Mahony, MJ
AF McConville, Anna
   Law, Bradley S.
   Mahony, Michael J.
TI Are Regional Habitat Models Useful at a Local-Scale? A Case Study of
   Threatened and Common Insectivorous Bats in South-Eastern Australia
SO PLOS ONE
LA English
DT Article
ID SPECIES DISTRIBUTION MODELS; PIPISTRELLUS-PIPISTRELLUS; LANDSCAPE
   STRUCTURE; CONSERVATION; DISTRIBUTIONS; PREDICTION; SELECTION; ECOLOGY;
   COEFFICIENT; PREFERENCES
AB Habitat modelling and predictive mapping are important tools for conservation planning, particularly for lesser known species such as many insectivorous bats. However, the scale at which modelling is undertaken can affect the predictive accuracy and restrict the use of the model at different scales. We assessed the validity of existing regional-scale habitat models at a local-scale and contrasted the habitat use of two morphologically similar species with differing conservation status (Mormopterus norfolkensis and Mormopterus species 2). We used negative binomial generalised linear models created from indices of activity and environmental variables collected from systematic acoustic surveys. We found that habitat type (based on vegetation community) best explained activity of both species, which were more active in floodplain areas, with most foraging activity recorded in the freshwater wetland habitat type. The threatened M. norfolkensis avoided urban areas, which contrasts with M. species 2 which occurred frequently in urban bushland. We found that the broad habitat types predicted from local-scale models were generally consistent with those from regional-scale models. However, threshold-dependent accuracy measures indicated a poor fit and we advise caution be applied when using the regional models at a fine scale, particularly when the consequences of false negatives or positives are severe. Additionally, our study illustrates that habitat type classifications can be important predictors and we suggest they are more practical for conservation than complex combinations of raw variables, as they are easily communicated to land managers.
C1 [McConville, Anna; Mahony, Michael J.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia.
   [Law, Bradley S.] Forest Sci Ctr, Dept Primary Ind, Beecroft, NSW, Australia.
RP McConville, A (reprint author), Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia.
EM anna.mcconville@uon.edu.au
OI Law, Bradley/0000-0002-3991-3865
FU Tom Farrell Institute for the Environment; Donaldson Conservation Trust;
   Hunter-Central Rivers Catchment Management Authority; Royal Zoological
   Society of NSW (Ethel Mary Read Award); Wambo Coal Pty Ltd.; Australian
   Geographic Society
FX Funding for this PhD project (A. McConville) was sourced from the
   following: The Tom Farrell Institute for the Environment; Donaldson
   Conservation Trust; Hunter-Central Rivers Catchment Management
   Authority; Royal Zoological Society of NSW (Ethel Mary Read Award);
   Wambo Coal Pty Ltd.; and Australian Geographic Society. B. Law is
   employed by Department Primary Industries (a government department).
   Whilst these organisations have generously provided funding for this
   research as part of an overall PhD, they have had no input into research
   design, direction, methodology or writing of this manuscript.
CR ADAMS M, 1988, AUST J BIOL SCI, V41, P315, DOI 10.1071/BI9880315
   Adams MD, 2009, FOREST ECOL MANAG, V258, P2090, DOI 10.1016/j.foreco.2009.08.002
   Akaike H., 1973, INT S INF THEOR, P267, DOI DOI 10.2307/2334537
   Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x
   Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x
   Arlettaz R, 1999, J ANIM ECOL, V68, P460, DOI 10.1046/j.1365-2656.1999.00293.x
   Avila-Flores R, 2005, J MAMMAL, V86, P1193, DOI 10.1644/04-MAMM-A-085R1.1
   Basham R., 2010, AUSTRAL ECOLOGY, V36, P663
   Brambilla M, 2009, BIOL CONSERV, V142, P2033, DOI 10.1016/j.biocon.2009.03.033
   Breheny P., 2012, VISUALIZING REGRESSI
   Bureau of Meteorology, 2012, CLIM DAT ONL
   Burnham K. P, 2002, MODEL SELECTION MULT
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Corben C, 2008, ANALOOKW 3 5M
   DEOLIVEIRA MC, 1998, ANABAT SYSTEM PRACTI
   Elith J, 2002, ECOL MODEL, V157, P313, DOI 10.1016/S0304-3800(02)00202-8
   Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x
   Ferrier S, 2002, BIODIVERS CONSERV, V11, P2275, DOI 10.1023/A:1021302930424
   Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088
   Flaquer C, 2009, ACTA CHIROPTEROL, V11, P149, DOI 10.3161/150811009X465767
   Franklin J., 2009, MAPPING SPECIES DIST
   Freeman EA, 2008, J STAT SOFTW, V23, P1
   Geoscience Australia, 2012, OZCOASTS AUSTR ONL C
   Gibson LA, 2004, J APPL ECOL, V41, P213, DOI 10.1111/j.0021-8901.2004.00896.x
   Gonsalves Leroy, 2012, Pacific Conservation Biology, V18, P282
   Greaves GJ, 2006, BIOL CONSERV, V132, P211, DOI 10.1016/j.biocon.2006.04.016
   Grindal SD, 1999, CAN J ZOOL, V77, P972, DOI 10.1139/cjz-77-6-972
   Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9
   Hayes JP, 1997, J MAMMAL, V78, P541
   Hourigan C. L., 2006, Urban Ecosystems, V9, P67, DOI 10.1007/s11252-006-7902-4
   House S., 2003, LOWER HUNTER CENTRAL
   IUCN, 2009, IUCN RED LIST THREAT
   Jaberg C, 2001, J APPL ECOL, V38, P1169, DOI 10.1046/j.0021-8901.2001.00668.x
   Januchowski Stephanie R., 2008, Ecological Management & Restoration, V9, P134, DOI 10.1111/j.1442-8903.2008.00405.x
   Keith DA, 2004, OECAN SHORES DESERT
   Knott Tiffany, 1998, Pacific Conservation Biology, V4, P354
   Krebs C.J., 2001, ECOLOGY
   Laegdsgaard P., 2004, WETLANDS, V22, P29
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Law BS, 2011, WILDLIFE RES, V38, P173, DOI 10.1071/WR10204
   Lloyd A, 2006, BIOL CONSERV, V129, P207, DOI 10.1016/j.biocon.2005.10.035
   Lunney Daniel, 1998, Pacific Conservation Biology, V4, P186
   Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x
   Manning AD, 2007, J BIOGEOGR, V34, P289, DOI 10.1111/j.1365-2699.2006.01603.x
   McAlpine CA, 2007, J APPL ECOL, V45, P558
   Mcconville A, 2014, AUSTRAL ECOL, V39, P83, DOI 10.1111/aec.12047
   McConville A, 2013, WILDLIFE RES, V40, P318, DOI 10.1071/WR12222
   MCGARIGAL K, 1995, ECOL MONOGR, V65, P235, DOI 10.2307/2937059
   MCKENZIE NL, 1986, J ANIM ECOL, V55, P401, DOI 10.2307/4727
   Menzel JM, 2005, WETLANDS, V25, P542, DOI 10.1672/0277-5212(2005)025[0542:BRTCBA]2.0.CO;2
   Mills DJ, 1996, FOREST ECOL MANAG, V85, P149, DOI 10.1016/S0378-1127(96)03756-5
   MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142
   Mouton AM, 2010, ECOL MODEL, V221, P1995, DOI 10.1016/j.ecolmodel.2010.04.017
   NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691
   NCAR - Research Application Program, 2012, VERF FOR VER UT 1 32
   Nicholls B, 2006, ECOGRAPHY, V29, P697, DOI 10.1111/j.2006.0906-7590.04575.x
   NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030
   Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7
   Pearce JL, 2001, J APPL ECOL, V38, P412, DOI 10.1046/j.1365-2664.2001.00608.x
   Pennay M., 2004, BAT CALLS NSW REGION
   R Development Core Team, 2012, R LANG ENV STAT COMP
   RACEY PA, 1985, J ANIM ECOL, V54, P205, DOI 10.2307/4631
   Razgour O, 2011, BIOL CONSERV, V144, P2922, DOI 10.1016/j.biocon.2011.08.010
   Rempel RS, 2011, PATCH ANAL PATCH GRI
   Reside AE, 2011, BIOLOGY AND CONSERVATION OF AUSTRALASIAN BATS, P155
   Rhodes JR, 2006, CONSERV BIOL, V20, P449, DOI 10.1111/j.1523-1739.2006.00330.x
   Rhodes MP, 2002, CAN J ZOOL, V80, P450, DOI 10.1139/Z02-029
   Swets K. A., 1988, SCIENCE, V240, P1285
   Threlfall C, 2011, CONSERVING BIODIVERS
   Threlfall C, 2011, ECOGRAPHY, V34, P814, DOI 10.1111/j.1600-0587.2010.06939.x
   Thuiller W, 2003, J VEG SCI, V14, P669, DOI 10.1658/1100-9233(2003)014[0669:GMVCTA]2.0.CO;2
   Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078
   Venables W. N, 2002, MODERN APPL STAT S
   Walsh AL, 1996, J APPL ECOL, V33, P508, DOI 10.2307/2404980
   Watrous KS, 2006, J WILDLIFE MANAGE, V70, P1228, DOI 10.2193/0022-541X(2006)70[1228:PMHCFT]2.0.CO;2
   Wintle BA, 2005, AUSTRAL ECOL, V30, P719, DOI 10.1111/j.1442-9993.2005.01514.x
NR 76
TC 4
Z9 5
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 19
PY 2013
VL 8
IS 8
AR e72420
DI 10.1371/journal.pone.0072420
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 205ER
UT WOS:000323425700168
PM 23977296
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Sgolastra, F
   Petrucci, A
   Severino, M
   Gatto, R
   Monaco, A
AF Sgolastra, Fabrizio
   Petrucci, Ambra
   Severino, Marco
   Gatto, Roberto
   Monaco, Annalisa
TI Relationship between Periodontitis and Pre-Eclampsia: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID ADVERSE PREGNANCY OUTCOMES; RISK-FACTOR; MATERNAL PERIODONTITIS;
   SYSTEMIC AMOXICILLIN/METRONIDAZOLE; ADJUNCTIVE THERAPY; PRETERM BIRTH;
   ORAL-HEALTH; DISEASE; WOMEN; ASSOCIATION
AB Background: Studies have suggested controversial results regarding a possible association between pre-eclampsia (PE) and periodontal disease (PD) and no meta-analysis has been performed to clarify this issue.
   Methods: A literature search of electronic databases was performed for articles published through March 24, 2013, followed by a manual search of several dental and medical journals. The meta-analysis was conducted according to the recommendations of the Cochrane Collaboration and PRISMA. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Heterogeneity was assessed with the chi(2)-based Cochran Q test and I-2 statistic. The level of significance was set at P<0.05.
   Results: Fifteen studies were included, including three cohort and 12 case-control studies. A positive association was found between PE and PD (OR 2.17, 95% CI 1.38-3.41, P = 0.0008). However, a high and significant heterogeneity was found (chi(2) = 62.42, P<0.00001, I-2 = 75%). In most cases, subgroup analysis had low power to detect significant differences between PE and non-PE groups.
   Conclusion: Based on the findings of the meta-analysis, PD appears to be a possible risk factor for PE. However, given the important differences in the definitions and diagnoses of PD and PE among the studies, as well as their lack of good methodological quality, future trials are needed to confirm the results of the present meta-analysis.
C1 [Sgolastra, Fabrizio; Petrucci, Ambra; Severino, Marco; Gatto, Roberto; Monaco, Annalisa] Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy.
RP Sgolastra, F (reprint author), Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy.
EM fabrizio.sgolastra@gmail.com
OI Monaco, Annalisa/0000-0002-9567-4459; Sgolastra,
   Fabrizio/0000-0002-0527-388X; Gatto, Roberto/0000-0002-1965-6080
CR Abati S, 2012, J MATERN FE IN PRESS
   Abenhaim Haim A., 2007, Archives of Gynecology and Obstetrics, V275, P39, DOI 10.1007/s00404-006-0219-y
   Boggess KA, 2006, AM J OBSTET GYNECOL, V194, P1316, DOI 10.1016/j.ajog.2005.11.059
   Boggess KA, 2003, OBSTET GYNECOL, V101, P227, DOI 10.1016/S0029-7844(02)02314-1
   Boggess KA, 2012, J PERIODONT IN PRESS
   Canakci V, 2004, AUST NZ J OBSTET GYN, V44, P568, DOI 10.1111/j.1479-828X.2004.00323.x
   Canakci V, 2007, J PERIODONTOL, V78, P1602, DOI 10.1902/jop.2007.060469
   Canakci V, 2007, J CLIN PERIODONTOL, V34, P639, DOI 10.1111/j.1600-051X.2007.01105.x
   Castaldi JL, 2006, REV PANAM SALUD PUBL, V19, P253, DOI 10.1590/S1020-49892006000400005
   Cetin I, 2012, REPROD SCI, V19, P633, DOI 10.1177/1933719111432871
   Chaparro A, 2012, J PERIODONT IN PRESS
   Conde-Agudelo A, 2008, AM J OBSTET GYNECOL, V198, P7, DOI 10.1016/j.ajog.2007.07.040
   Contreras A, 2006, J PERIODONTOL, V77, P182, DOI 10.1902/jop.2006.050020
   da Silva GM, 2012, J PERIODONTOL, V83, P1388, DOI 10.1902/jop.2012.110256
   Darmochwal-Kolarz D, 2002, AM J REPROD IMMUNOL, V48, P381, DOI 10.1034/j.1600-0897.2002.01089.x
   Dasanayake Ananda P, 2007, J Evid Based Dent Pract, V7, P176, DOI 10.1016/j.jebdp.2007.09.008
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Gibbs R S, 2001, Ann Periodontol, V6, P153, DOI 10.1902/annals.2001.6.1.153
   GIBBS RS, 1992, AM J OBSTET GYNECOL, V166, P1515, DOI 10.1016/0002-9378(92)91628-N
   Gilbert WM, 2007, J REPROD MED, V52, P1046
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Ha JE, 2011, J PERIODONTOL, V82, P1685, DOI 10.1902/jop.2011.110035
   Hirano E, 2012, J CLIN PERIODONTOL, V39, P229, DOI 10.1111/j.1600-051X.2011.01845.x
   Horton AL, 2010, J PERIODONTOL, V81, P199, DOI 10.1902/jop.2009.090437
   Khader YS, 2006, J PERIODONTOL, V77, P1681, DOI 10.1902/jop.2006.050463
   Kumar A, 2012, J OBSTET GY IN PRESS
   Kunnen A, 2007, J CLIN PERIODONTOL, V34, P202, DOI 10.1111/j.1600-051X.2006.01036.x
   Kunnen A, 2010, J CLIN PERIODONTOL, V37, P1075, DOI 10.1111/j.1600-051X.2010.01636.x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786
   Lohsoonthorn V, 2009, AM J HYPERTENS, V22, P457, DOI 10.1038/ajh.2008.365
   Lopez-Jaramillo P, 2011, J HYPERTENS, V29, P1020, DOI 10.1097/HJH.0b013e328344b6e8
   Matevosyan NR, 2011, ARCH GYNECOL OBSTET, V283, P675, DOI 10.1007/s00404-010-1774-9
   Meurman JH, 2006, CLIN ORAL INVEST, V10, P96, DOI 10.1007/s00784-006-0037-4
   Cota LOM, 2006, J PERIODONTOL, V77, P2063, DOI 10.1902/jop.2006.060061
   Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135
   Nabet C, 2010, J CLIN PERIODONTOL, V37, P37, DOI 10.1111/j.1600-051X.2009.01503.x
   Nibali L, 2013, J CLIN ENDOCR METAB, V98, P913, DOI 10.1210/jc.2012-3552
   Noris M, 2005, NAT CLIN PRACT NEPHR, V1, P98, DOI 10.1038/ncpneph0035
   Oettinger-Barak O, 2005, J PERIODONTOL, V76, P134, DOI 10.1902/jop.2005.76.1.134
   Offenbacher S, 2006, OBSTET GYNECOL, V107, P29, DOI 10.1097/01.AOG.0000190212.87012.96
   Offenbacher S, 2001, Ann Periodontol, V6, P164, DOI 10.1902/annals.2001.6.1.164
   Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8
   Piscoya MDBV, 2012, PEDIATR INT, V54, P68, DOI 10.1111/j.1442-200X.2011.03502.x
   Politano GT, 2011, J PERIODONTAL RES, V46, P505, DOI 10.1111/j.1600-0765.2011.01368.x
   ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0
   Ruma M, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.12.002
   Sayar F, 2011, IRAN J PUBLIC HEALTH, V40, P122
   Sgolastra F, 2013, LASERS MED SCI
   Sgolastra F, 2013, J PERIODONTAL RES
   Sgolastra F, 2013, J CLIN PERIODONTOL, V40, P514, DOI 10.1111/jcpe.12094
   Sgolastra F, 2012, J PERIODONTOL, V83, P1257, DOI 10.1902/jop.2012.110625
   Sgolastra F, 2012, J PERIODONTOL, V83, P731, DOI 10.1902/jop.2011.110432
   Sgolastra F, 2011, J PERIODONTOL, V82, P1570, DOI 10.1902/jop.2011.110026
   Shetty M, 2010, ACTA OBSTET GYN SCAN, V89, P718, DOI 10.3109/00016341003623738
   Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)17987-2
   Sibai BM, 1997, AM J OBSTET GYNECOL, V177, P1003, DOI 10.1016/S0002-9378(97)70004-8
   Siqueira FM, 2008, J PERIODONTOL, V79, P207, DOI [10.1902/jop.2008.070174, 10.1902/jop.2008.070174 ]
   Srinivas SK, 2009, AM J OBSTET GYNECOL, V200
   Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8
   Sun Y, 2008, INT J GYNECOL OBSTET, V101, P74, DOI 10.1016/j.ijgo.2007.10.008
   Swati P, 2012, ARCH GYNECOL OBSTET, V285, P613, DOI 10.1007/s00404-011-2012-9
   Swati P, 2012, J PERIODONT IN PRESS
   Taghzouti N, 2012, J PERIODONTOL, V83, P871, DOI 10.1902/jop.2011.110342
   Trogstad LIS, 2001, ACTA OBSTET GYN SCAN, V80, P1036, DOI 10.1034/j.1600-0412.2001.801112.x
   Vergnes Jean-Noel, 2008, Evid Based Dent, V9, P46, DOI 10.1038/sj.ebd.6400580
   von Dadelszen P, 2002, ACTA OBSTET GYN SCAN, V81, P642, DOI 10.1034/j.1600-0412.2002.810710.x
   Wang Y, 2012, INT J IMMUNOGENET, V39, P492, DOI 10.1111/j.1744-313X.2012.01124.x
   Xiong X, 2006, BJOG-INT J OBSTET GY, V113, P135, DOI 10.1111/j.1471-0528.2005.00827.x
NR 70
TC 15
Z9 15
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 19
PY 2013
VL 8
IS 8
AR e71387
DI 10.1371/journal.pone.0071387
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 205ER
UT WOS:000323425700043
PM 23990948
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zhang, AQ
   Yue, CL
   Gu, W
   Du, J
   Wang, HY
   Jiang, JX
AF Zhang, An-qiang
   Yue, Cai-li
   Gu, Wei
   Du, Juan
   Wang, Hai-yan
   Jiang, Jianxin
TI Association between CD14 Promoter-159C/T Polymorphism and the Risk of
   Sepsis and Mortality: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID TUMOR-NECROSIS-FACTOR; LIPOPOLYSACCHARIDE RECEPTOR CD14;
   CD14-260C-GREATER-THAN-T POLYMORPHISM; CLINICAL-RELEVANCE; GENE
   POLYMORPHISMS; SOLUBLE CD14; TNF-ALPHA; TLR4; EXPRESSION; SHOCK
AB Background: Recent studies on the association between CD14-159C/T polymorphism and sepsis showed inconclusive results. Accordingly, we conducted a comprehensive literature search and a meta-analysis to determine whether the CD14-159C/T polymorphism conferred susceptibility to sepsis or was associated with increased risk of death from sepsis.
   Methodology: Data were collected from the following electronic databases: PubMed, Embase, Medline, Web of Knowledge, and HuGE Navigator, with the last report up to June 15, 2012. The odds ratio (OR) and 95% confidence interval (CI) were used to assess the strength of association. We summarized the data on the association between CD14-159C/T polymorphism and sepsis in the overall population and subgroup by ethnicity and sepsis subtype.
   Principal Findings: A total of 16 studies on sepsis morbidity (1369 cases and 2382 controls) and 4 studies on sepsis mortality (731 sepsis patients) met the inclusion criteria for meta-analysis. Overall analysis showed no strong evidences of association with sepsis susceptibility under any genetic model. However, slight associations were found in Asian populations (dominant model: OR = 1.38, 95% CI = 0.96-1.98, P = 0.08) and septic shock patients (dominant model: OR = 1.72, 95% CI 1.05-2.83, P = 0.03; allelic model: OR = 1.52, 95% CI 1.09-2.12, P = 0.01) in the stratified analysis. Moreover, there was borderline association between CD14-159C/T and sepsis mortality under the dominant genetic model (OR = 1.44, 95% CI = 0.98-2.11, P = 0.06).
   Conclusions/Significance: This meta-analysis suggests that the CD14-159C/T polymorphism may not be a significant susceptibility factor in the risk of sepsis and mortality. Only weak associations were observed in Asian populations and septic shock patients. More studies based on larger sample sizes and homogeneous sepsis patients are needed to confirm these findings.
C1 [Zhang, An-qiang; Yue, Cai-li; Gu, Wei; Du, Juan; Wang, Hai-yan; Jiang, Jianxin] Third Mil Med Univ, Inst Surg Res, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China.
RP Jiang, JX (reprint author), Third Mil Med Univ, Inst Surg Res, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China.
EM hellojjx@126.com
FU National Key Technology R D Program [2012BAI11B01]; Major State Basic
   Research Development Program of China [2012CB518104]; Open fund of State
   Key Laboratory of Trauma, Burns and Combined Injury, Third Military
   Medical University [SKLZZ201104, SKLZZ201002]
FX This work is supported by National Key Technology R & D Program
   (2012BAI11B01), the Major State Basic Research Development Program of
   China (2012CB518104), Open fund of State Key Laboratory of Trauma, Burns
   and Combined Injury, Third Military Medical University (SKLZZ201104,
   SKLZZ201002). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Abu-Maziad A, 2010, PEDIATR RES, V68, P323, DOI 10.1203/00006450-201011001-00632
   Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893
   Ahrens P, 2004, PEDIATR RES, V55, P652, DOI 10.1203/01.PDR.0000112100.61253.85
   Attia J, 2003, J CLIN EPIDEMIOL, V56, P297, DOI 10.1016/S0895-4356(03)00011-8
   Baier RJ, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-10
   Barber RC, 2004, J MED GENET, V41, P808, DOI 10.1136/jmg.2004.021600
   Barber RC, 2008, J BURN CARE RES, V29, P168, DOI 10.1097/BCR.0b013e31815f59f4
   Barber RC, 2006, CLIN MED RES, V4, P250, DOI 10.3121/cmr.4.4.250
   Barber RC, 2007, SHOCK, V27, P232, DOI 10.1097/01.shk.0000239770.10528.9a
   Biebl A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007374
   Burgmann H, 1996, CLIN IMMUNOL IMMUNOP, V80, P307, DOI 10.1006/clin.1996.0128
   D'Avila LC, 2006, IMMUNOL CELL BIOL, V84, P342, DOI 10.1111/j.1440-1711.2006.01432.x
   Davis SM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.006
   de Aguiar BB, 2008, IMMUNOL INVEST, V37, P752, DOI 10.1080/08820130802403242
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Durlik M, 2010, CENT EUR J IMMUNOL, V35, P73
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Fallavena PRV, 2009, IMMUNOL INVEST, V38, P797, DOI 10.3109/08820130903258818
   Gibot S, 2002, CRIT CARE MED, V30, P969, DOI 10.1097/00003246-200205000-00003
   Gu W, 2008, CRIT CARE MED, V36, P2274, DOI 10.1097/CCM.0b013e318180b1ed
   Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X
   Heesen M, 2002, INTENS CARE MED, V28, P1161, DOI 10.1007/s00134-002-1389-0
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hildebrand F, 2011, SHOCK, V35, P440, DOI 10.1097/SHK.0b013e31820e2152
   Hubacek JA, 2000, GENES IMMUN, V1, P405, DOI 10.1038/sj.gene.6363691
   Huebinger R, 2009, SHOCK, V31, P4
   Huebinger RM, 2010, BURNS, V36, P787, DOI 10.1016/j.burns.2010.02.001
   Jessen KM, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-108
   Jiang JX, 2003, WORLD J SURG, V27, P1, DOI 10.1007/s00268-002-6548-5
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LANDMANN R, 1995, J INFECT DIS, V171, P639, DOI 10.1093/infdis/171.3.639
   Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B
   Lin J, 2007, SHOCK, V28, P148, DOI 10.1097/shk.0b013e3180341d35
   Lin J, 2009, BURNS, V35, P365, DOI 10.1016/j.burns.2008.07.014
   Liu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031251
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Nakada T, 2005, J SURG RES, V129, P322, DOI 10.1016/j.jss.2005.05.020
   Namath A, 2011, CRIT CARE NURS CLIN, V23, P181, DOI 10.1016/j.ccell.2010.12.011
   Reinhart K, 2004, CRIT CARE MED, V32, P1100, DOI 10.1097/01.CCM.0000124870.42312.C4
   Shalhub S, 2009, J TRAUMA, V66, P115, DOI 10.1097/TA.0b013e3181938d50
   Shalhub S, 2009, J BURN CARE RES, V30, P105, DOI 10.1097/BCR.0b013e3181921f60
   Shimada T, 2011, CYTOKINE, V54, P79, DOI 10.1016/j.cyto.2010.12.001
   SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202
   Surbatovic M, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2009.12.003
   Sutherland AM, 2005, CRIT CARE MED, V33, P638, DOI 10.1097/01.ccm.0000156242.44356.c5
   Sutton AJ, 2000, BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574
   Watanabe E, 2010, CRIT CARE MED, V38, P181, DOI 10.1097/CCM.0b013e3181bc805d
   WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311
   Yuan FF, 2008, IMMUNOL CELL BIOL, V86, P268, DOI 10.1038/sj.icb.7100155
   Zhang DL, 2005, WORLD J GASTROENTERO, V11, P4409
NR 51
TC 18
Z9 18
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 19
PY 2013
VL 8
IS 8
AR e71237
DI 10.1371/journal.pone.0071237
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 205ER
UT WOS:000323425700030
PM 23990939
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Teder, M
   Morelius, E
   Nordwall, M
   Bolme, P
   Ekberg, J
   Wilhelm, E
   Timpka, T
AF Teder, Marie
   Morelius, Evalotte
   Nordwall, Maria
   Bolme, Per
   Ekberg, Joakim
   Wilhelm, Elisabeth
   Timpka, Toomas
TI Family-Based Behavioural Intervention Program for Obese Children: An
   Observational Study of Child and Parent Lifestyle Interpretations
SO PLOS ONE
LA English
DT Article
ID THERAPEUTIC ALLIANCE; HIGH AGREEMENT; LOW KAPPA; OVERWEIGHT; HEALTH;
   ADOLESCENTS; PREVENTION; WORLDWIDE; PATTERNS
AB Background: Family-based behavioural intervention programs (FBIPs) against childhood obesity have shown promising results, but the mediating mechanisms have not been identified. The aim of this study was to examine changes in obese childrens lifestyle habits during a 2-year FBIP according to their own and parents' reports, the concordance between these reports and the correlations to change in post-intervention z-BMI.
   Methods: An observational study of 26 children (8.3-12.0 years) and their parents participating in a 2-year FBIP was performed. Weight and height were measured from baseline to 12 months after the end of the program. Eating habits and physical-and sedentary activity were reported separately by children and parents. Data were analysed with regard to concordance between parents' and children's reports and association between the lifestyle reports and change in z-BMI at the study endpoint using descriptive statistics and parametric and non-parametric tests.
   Results: According to both children's and parents' reports, the level of physical activity among the children had increased after the intervention as well as the agreement between the informants' reports. According to the children, eating habits had improved, while the parents' reports showed an improvement only with regard to binge eating. The concordance between children and parents regarding eating habits was slight to fair also after the intervention. No statistically significant associations between changes in lifestyle reports and changes in z-BMI were observed.
   Conclusions: Child and parent reports of physical activity were found to converge and display an improvement in a 2-year FBIP, while the reports on eating habits showed a more refractory pattern. Changes in concordance and agreement between children and parents reports did not correlate with weight reduction. Further methods development and studies of the processes during family-based interventions against childhood obesity are warranted.
C1 [Teder, Marie; Morelius, Evalotte] Linkoping Univ, Fac Hlth Sci, Dept Social & Welf Studies, Div Hlth Act & Care, Norrkoping, Sweden.
   [Nordwall, Maria; Bolme, Per] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Paediat, Linkoping, Sweden.
   [Nordwall, Maria; Bolme, Per] Vrinnevi Hosp, Paediat Clin, Norrkoping, Sweden.
   [Ekberg, Joakim] Skovde Univ, Sch Life Sci, Skovde, Sweden.
   [Wilhelm, Elisabeth; Timpka, Toomas] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Social Med & Publ Hlth, Linkoping, Sweden.
RP Timpka, T (reprint author), Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Social Med & Publ Hlth, Linkoping, Sweden.
EM toomas.timpka@liu.se
RI Timpka, Toomas/E-8065-2018
OI Morelius, Evalotte/0000-0002-3256-5407
FU Crown Princess Lovisa's Foundation for Paediatric Care; Carl and Albert
   Molins Memorial Foundation; Novo Nordisk Scandinavia; Eli Lilly; Faculty
   of Health Sciences and Department of Social and Welfare Studies
   Linkoping University Sweden; Procter Gamble
FX This work was supported by Crown Princess Lovisa's Foundation for
   Paediatric Care, Procter & Gamble, the Carl and Albert Molins Memorial
   Foundation, Novo Nordisk Scandinavia, Eli Lilly, Faculty of Health
   Sciences and Department of Social and Welfare Studies Linkoping
   University Sweden. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR [Anonymous], 2002, NURS ETHICS, V9, P105
   [Anonymous], 2000, OB PREV MAN GLOB EP
   August GP, 2008, J CLIN ENDOCR METAB, V93, P4576, DOI 10.1210/jc.2007-2458
   Belton S, 2010, PREV MED, V50, P189, DOI 10.1016/j.ypmed.2010.01.009
   Bonnedal U, 2004, GRUPPBEHANDLING BARN
   Bonnedal U, 2004, INSTRUKTIONER UTREDN
   Borra ST, 2003, J AM DIET ASSOC, V103, P721, DOI 10.1053/jada.2003.50140
   BRONFENBRENNER U, 1974, TEACH COLL REC, V76, P279
   CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Cole TJ, 2000, BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240
   FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L
   Friedlander ML, 2006, J COUNS PSYCHOL, V53, P214, DOI 10.1037/0022-0167.53.2.214
   Friedlander ML, 2012, J COUNS PSYCHOL, V59, P168, DOI 10.1037/a0024199
   Isserlin L, 2012, PSYCHOTHERAPY, V49, P46, DOI 10.1037/a0023905
   Karlberg J, 2001, ACTA PAEDIATR, V90, P1427, DOI 10.1080/08035250152708851
   Kitzmann KA, 2010, HEALTH PSYCHOL, V29, P91, DOI [10.1037/0017437, 10.1037/a0017437]
   Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Oude Luttikhuis Hiltje, 2009, Cochrane Database Syst Rev, pCD001872, DOI 10.1002/14651858.CD001872.pub2
   Pereira T, 2006, INT J EAT DISORDER, V39, P677, DOI 10.1002/eat.20303
   Pocock M, 2010, OBES REV, V11, P338, DOI 10.1111/j.1467-789X.2009.00648.x
   Rah MJ, 2002, OPHTHALMIC EPIDEMIOL, V9, P191, DOI 10.1076/opep.9.3.191.1514
   Reinehr T, 2010, AM J CLIN NUTR, V91, P1165, DOI 10.3945/ajcn.2009.28705
   Robbins MS, 2003, J FAM PSYCHOL, V17, P534, DOI 10.1037/0893-3200.17.4.534
   Rothausen BW, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.12221
   Sithole Fortune, 2008, Health Rep, V19, P19
   Statens folkhalsoinstitut, 2013, REK FYS AKT
   Steinberg E, 2004, INT J EAT DISORDER, V36, P183, DOI 10.1002/eat.20022
   Tanofsky-Kraff Marian, 2005, Eat Behav, V6, P95, DOI 10.1016/j.eatbeh.2004.03.001
   Teder M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000268
   Uauy R., 2004, OBES REV, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]
   van Avendonk MJP, 2012, FAM PRACT, V29, pi31, DOI 10.1093/fampra/cmr095
   von Elm E, 2007, PLOS MED, V4, P1623, DOI 10.1371/journal.pmed.0040296
   Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747
   Whiteman D, 1997, INT J EPIDEMIOL, V26, P855, DOI 10.1093/ije/26.4.855
   Wilfley DE, 1997, BEHAV RES THER, V35, P1151, DOI 10.1016/S0005-7967(97)80010-1
   World Health Organization, 2013, GLOB STRAT DIET PHYS
   Yackobovitch-Gavan M, 2009, NUTR RES, V29, P397, DOI 10.1016/j.nutres.2009.05.007
NR 39
TC 7
Z9 7
U1 0
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 7
PY 2013
VL 8
IS 8
AR e71482
DI 10.1371/journal.pone.0071482
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 200ZE
UT WOS:000323109700105
PM 23940762
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Buckens, CF
   de Jong, PA
   Mol, C
   Bakker, E
   Stallman, HP
   Mali, WP
   van der Graaf, Y
   Verkooijen, HM
AF Buckens, Constantinus F.
   de Jong, Pim A.
   Mol, Christian
   Bakker, Eric
   Stallman, Hein P.
   Mali, Willem P.
   van der Graaf, Yolanda
   Verkooijen, Helena M.
TI Intra and Interobserver Reliability and Agreement of Semiquantitative
   Vertebral Fracture Assessment on Chest Computed Tomography
SO PLOS ONE
LA English
DT Article
ID OSTEOPOROTIC FRACTURES; CT; PREVALENCE
AB Objectives: To evaluate the reliability of semiquantitative Vertebral Fracture Assessment (VFA) on chest Computed Tomography (CT).
   Methods: Four observers performed VFA twice upon sagittal reconstructions of 50 routine clinical chest CTs. Intra- and interobserver agreement (absolute agreement or 95% Limits of Agreement) and reliability (Cohen's kappa or intraclass correlation coefficient(ICC)) were calculated for the visual VFA measures (fracture present, worst fracture grade, cumulative fracture grade on patient level) and for percentage height loss of each fractured vertebra compared to the adjacent vertebrae.
   Results: Observers classified 24-38% patients as having at least one vertebral fracture, giving rise to kappa's of 0.73-0.84 (intraobserver) and 0.56-0.81 (interobserver). For worst fracture grade we found good intraobserver (76-88%) and interobserver (74-88%) agreement, and excellent reliability with square-weighted kappa's of 0.84-0.90 (intraobserver) and 0.84-0.94 (interobserver). For cumulative fracture grade the 95% Limits of Agreement were maximally +/- 1,99 (intraobserver) and +/- 2,69 (interobserver) and the reliability (ICC) varied from 0.84-0.94 (intraobserver) and 0.74-0.94 (interobserver). For percentage height-loss on a vertebral level the 95% Limits of Agreement were maximally +/- 11,75% (intraobserver) and +/- 12,53% (interobserver). The ICC was 0.59-0.90 (intraobserver) and 0.53-0-82 (interobserver). Further investigation is needed to evaluate the prognostic value of this approach.
   Conclusion: In conclusion, these results demonstrate acceptable reproducibility of VFA on CT.
C1 [Buckens, Constantinus F.; van der Graaf, Yolanda] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [Buckens, Constantinus F.; de Jong, Pim A.; Bakker, Eric; Stallman, Hein P.; Mali, Willem P.; Verkooijen, Helena M.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.
   [Mol, Christian] Univ Med Ctr Utrecht, Imaging Sci Inst, Utrecht, Netherlands.
RP de Jong, PA (reprint author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.
EM P.deJong-8@umcutrecht.nl
RI Mali, Willem/I-1123-2014; de Jong, Pim/G-7220-2014
OI Mali, Willem/0000-0003-4391-0904; de Jong, Pim/0000-0003-4840-6854;
   Buckens, Constantinus F/0000-0002-3190-258X
FU Netherlands Organization for Scientific Research-Medical Sciences
   (NOW-MW) [40-00812-98-07-005]
FX This work was supported by a program grant from The Netherlands
   Organization for Scientific Research-Medical Sciences (NOW-MW project
   no. 40-00812-98-07-005). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Bartalena T, 2009, EUR J RADIOL, V69, P555, DOI 10.1016/j.ejrad.2007.11.036
   Bazzocchi A, 2012, EUR J RADIOL, V81, P2353, DOI 10.1016/j.ejrad.2011.08.015
   Binkley N, 2005, OSTEOPOROSIS INT, V16, P1513, DOI 10.1007/s00198-005-1891-7
   Blake GM, 2007, POSTGRAD MED J, V83, P509, DOI 10.1136/pgmj.2007.057505
   Buehring B, 2010, OSTEOPOROSIS INT, V21, P487, DOI 10.1007/s00198-009-0972-4
   de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015
   Gamer M, 2012, IRR VARIOUS COEFFICI
   GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915
   Gondrie MJA, 2010, EUR J EPIDEMIOL, V25, P751, DOI 10.1007/s10654-010-9514-9
   Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4
   Kanis JA, 2004, TECHNICAL REPORT
   Keen Richard W, 2003, Curr Osteoporos Rep, V1, P66, DOI 10.1007/s11914-003-0011-x
   Kim YM, 2011, OSTEOPOROSIS INT, V22, P2677, DOI 10.1007/s00198-011-1530-4
   KLEEREKOPER M, 1992, BONE, V13, pS29, DOI 10.1016/S8756-3282(09)80007-0
   Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Muller D, 2008, EUR RADIOL, V18, P1696, DOI 10.1007/s00330-008-0920-2
   Nunnally J, 1994, PSYCHOMETRIC THEORY
   Reed WM, 2011, RADIOLOGY, V258, P938, DOI 10.1148/radiol.10101090
   Singer AJ, 2008, CURR MED RES OPIN, V24, P1789, DOI 10.1185/03007990802115887
   Siris ES, 2007, OSTEOPOROSIS INT, V18, P761, DOI 10.1007/s00198-006-0306-8
   Takada M, 1998, OSTEOPOROSIS INT, V8, P197, DOI 10.1007/s001980050054
   The R Foundation, 2012, R FDN LANG ENV STAT
   Van der Jagt-Willems HC, 2004, AGE AGEING, V41, P200
   Williams AL, 2009, EUR J RADIOL, V69, P179, DOI 10.1016/j.ejrad.2007.08.028
   Wintermark M, 2003, RADIOLOGY, V227, P681, DOI 10.1148/
   Woo EK, 2008, CLIN RADIOL, V63, P160, DOI 10.1016/j.crad.2007.01.031
NR 27
TC 13
Z9 13
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 5
PY 2013
VL 8
IS 8
AR e71204
DI 10.1371/journal.pone.0071204
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 218XC
UT WOS:000324465000193
PM 23940719
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU el Barzouhi, A
   Vleggeert-Lankamp, CLAM
   Nijeholt, GJLA
   Van der Kallen, BF
   Van den Hout, WB
   Verwoerd, AJH
   Koes, BW
   Peul, WC
AF el Barzouhi, Abdelilah
   Vleggeert-Lankamp, Carmen L. A. M.
   Nijeholt, Geert J. Lycklama A.
   Van der Kallen, Bas F.
   Van den Hout, Wilbert B.
   Verwoerd, Annemieke J. H.
   Koes, Bart W.
   Peul, Wilco C.
CA Leiden-The Hague Spine Interventio
TI Magnetic Resonance Imaging Interpretation in Patients with Sciatica Who
   Are Potential Candidates for Lumbar Disc Surgery
SO PLOS ONE
LA English
DT Article
ID PROLONGED CONSERVATIVE TREATMENT; OBSERVER VARIABILITY; BACK-PAIN;
   SPINE; RELIABILITY; HERNIATION; AGREEMENT; DISEASE; CLASSIFICATION;
   DIAGNOSIS
AB Background: Magnetic Resonance Imaging (MRI) is considered the mainstay imaging investigation in patients suspected of lumbar disc herniations. Both imaging and clinical findings determine the final decision of surgery. The objective of this study was to assess MRI observer variation in patients with sciatica who are potential candidates for lumbar disc surgery.
   Methods: Patients for this study were potential candidates (n = 395) for lumbar disc surgery who underwent MRI to assess eligibility for a randomized trial. Two neuroradiologists and one neurosurgeon independently evaluated all MRIs. A four point scale was used for both probability of disc herniation and root compression, ranging from definitely present to definitely absent. Multiple characteristics of the degenerated disc herniation were scored. For inter-agreement analysis absolute agreements and kappa coefficients were used. Kappa coefficients were categorized as poor (<0.00), slight (0.00-0.20), fair (0.21-0.40), moderate (0.41-0.60), substantial (0.61-0.80) and excellent (0.81-1.00) agreement.
   Results: Excellent agreement was found on the affected disc level (kappa range 0.81-0.86) and the nerve root that most likely caused the sciatic symptoms (kappa range 0.86-0.89). Interobserver agreement was moderate to substantial for the probability of disc herniation (kappa range 0.57-0.77) and the probability of nerve root compression (kappa range 0.42-0.69). Absolute pairwise agreement among the readers ranged from 90-94% regarding the question whether the probability of disc herniation on MRI was above or below 50%. Generally, moderate agreement was observed regarding the characteristics of the symptomatic disc level and of the herniated disc.
   Conclusion: The observer variation of MRI interpretation in potential candidates for lumbar disc surgery is satisfactory regarding characteristics most important in decision for surgery. However, there is considerable variation between observers in specific characteristics of the symptomatic disc level and herniated disc.
C1 [el Barzouhi, Abdelilah; Vleggeert-Lankamp, Carmen L. A. M.; Peul, Wilco C.] Leiden Univ Med Ctr, Dept Neurosurg, Leiden, Netherlands.
   [Nijeholt, Geert J. Lycklama A.; Van der Kallen, Bas F.] Med Ctr Haaglanden, Dept Radiol, The Hague, Netherlands.
   [Van den Hout, Wilbert B.] Leiden Univ Med Ctr, Dept Med Decis Making, Leiden, Netherlands.
   [Verwoerd, Annemieke J. H.; Koes, Bart W.] Univ Med Ctr, ErasmusMC, Dept Gen Practice, Rotterdam, Netherlands.
   [Peul, Wilco C.] Med Ctr Haaglanden, Dept Neurosurg, The Hague, Netherlands.
RP el Barzouhi, A (reprint author), Leiden Univ Med Ctr, Dept Neurosurg, Leiden, Netherlands.
EM A.el_barzouhi@lumc.nl
RI Koes, Bart w/K-4614-2016
OI Koes, Bart w/0000-0002-0450-9969; van den Hout, Wilbert
   B./0000-0002-6425-0135
FU Netherlands Organisation for Health Research and Development (ZonMW);
   Hoelen Foundation, The Hague
FX Sponsors of the study: a grant from the Netherlands Organisation for
   Health Research and Development (ZonMW) and the Hoelen Foundation, The
   Hague. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR [Anonymous], 1994, NEUROLOGY, V44, P767
   Arana E, 2010, RADIOLOGY, V254, P809, DOI 10.1148/radiol.09090706
   Bejia I, 2004, JOINT BONE SPINE, V71, P567, DOI 10.1016/j.jbspin.2004.01.008
   BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013
   Boos N, 1995, SPINE, V20, P2613, DOI 10.1097/00007632-199512150-00002
   BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491
   Brouwer S, 2003, J OCCUP REHABIL, V13, P207, DOI 10.1023/A:1026264519996
   Carlisle Elliot, 2005, Spine J, V5, P608, DOI 10.1016/j.spinee.2005.05.384
   Carragee EJ, 1997, SPINE, V22, P1650, DOI 10.1097/00007632-199707150-00025
   Carrino JA, 2009, RADIOLOGY, V250, P161, DOI 10.1148/radiol.2493071999
   Cheng F, 2010, CAN FAM PHYSICIAN, V56, pE323
   Cihangiroglu M, 2004, EUR J RADIOL, V51, P202, DOI 10.1016/j.ejrad.2003.08.004
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Fardon D F, 2001, Spine (Phila Pa 1976), V26, pE93, DOI 10.1097/00007632-200103010-00006
   FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L
   Findlay GF, 1998, SPINE, V23, P1168, DOI 10.1097/00007632-199805150-00019
   Fleiss J, 2003, STAT METHODS RATES P
   GJORUP T, 1988, METHOD INFORM MED, V27, P184
   Jarvik JG, 2009, RADIOLOGY, V250, P15, DOI 10.1148/radiol.2493081458
   Jarvik JG, 1996, ACAD RADIOL, V3, P537, DOI 10.1016/S1076-6332(96)80214-5
   Jarvik JJ, 2001, SPINE, V26, P1158, DOI 10.1097/00007632-200105150-00014
   JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201
   Kim SW, 2009, CLIN ORTHOP SURG, V1, P34, DOI 10.4055/cios.2009.1.1.34
   Koes BW, 2007, BRIT MED J, V334, P1313, DOI 10.1136/bmj.39223428495.BE
   Korres D S, 1992, Eur Spine J, V1, P20, DOI 10.1007/BF00302137
   Kovacs FM, 2009, ACTA RADIOL, V50, P497, DOI 10.1080/02841850902838074
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lurie JD, 2008, SPINE, V33, P991, DOI 10.1097/BRS.0b013e31816c8379
   Lurie JD, 2009, SPINE, V34, P701, DOI 10.1097/BRS.0b013e31819b390e
   LYNN MR, 1986, NURS RES, V35, P382
   Milette PC, 2001, AM J NEURORADIOL, V22, P428
   MODIC MT, 1988, RADIOLOGY, V168, P177, DOI 10.1148/radiology.168.1.3289089
   MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678
   Mulconrey Daniel S, 2006, Spine J, V6, P177, DOI 10.1016/j.spinee.2005.08.011
   Peul WC, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-8
   Peul WC, 2008, BRIT MED J, V336, P1355, DOI 10.1136/bmj.a143
   Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039
   Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011
   Ross JS, 2010, RADIOLOGY, V254, P640, DOI 10.1148/radiol.09092250
   Sim J, 2005, PHYS THER, V85, P257
   Sorensen JS, 2006, ACTA RADIOL, V47, P947, DOI 10.1080/02841850600965062
   van Rijn JC, 2006, BRIT J RADIOL, V79, P372, DOI 10.1259/bjr/26216335
   van Rijn JC, 2005, AM J ROENTGENOL, V184, P299, DOI 10.2214/ajr.184.1.01840299
   Vucetic N, 1999, CLIN ORTHOP RELAT R, P116
NR 44
TC 4
Z9 4
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 10
PY 2013
VL 8
IS 7
AR e68411
DI 10.1371/journal.pone.0068411
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 182SU
UT WOS:000321765300048
PM 23874616
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Birgand, G
   Lepelletier, D
   Baron, G
   Barrett, S
   Breier, AC
   Buke, C
   Markovic-Denic, L
   Gastmeier, P
   Kluytmans, J
   Lyytikainen, O
   Sheridan, E
   Szilagyi, E
   Tacconelli, E
   Troillet, N
   Ravaud, P
   Lucet, JC
AF Birgand, Gabriel
   Lepelletier, Didier
   Baron, Gabriel
   Barrett, Steve
   Breier, Ann-Christin
   Buke, Cagri
   Markovic-Denic, Ljiljana
   Gastmeier, Petra
   Kluytmans, Jan
   Lyytikainen, Outi
   Sheridan, Elizabeth
   Szilagyi, Emese
   Tacconelli, Evelina
   Troillet, Nicolas
   Ravaud, Philippe
   Lucet, Jean-Christophe
TI Agreement among Healthcare Professionals in Ten European Countries in
   Diagnosing Case-Vignettes of Surgical-Site Infections
SO PLOS ONE
LA English
DT Article
ID NOSOCOMIAL INFECTIONS; WOUND-INFECTION; HOSPITALS; SURVEILLANCE;
   PERFORMANCE; RATES; REQUIREMENTS; PREVENTION; PREVALENCE; QUALITY
AB Objective: Although surgical-site infection (SSI) rates are advocated as a major evaluation criterion, the reproducibility of SSI diagnosis is unknown. We assessed agreement in diagnosing SSI among specialists involved in SSI surveillance in Europe.
   Methods: Twelve case-vignettes based on suspected SSI were submitted to 100 infection-control physicians (ICPs) and 86 surgeons in 10 European countries. Each participant scored eight randomly-assigned case-vignettes on a secure online relational database. The intra-class correlation coefficient (ICC) was used to assess agreement for SSI diagnosis on a 7-point Likert scale and the kappa coefficient to assess agreement for SSI depth on a three-point scale.
   Results: Intra-specialty agreement for SSI diagnosis ranged across countries and specialties from 0.00 (95% CI, 0.00-0.35) to 0.65 (0.45-0.82). Inter-specialty agreement varied from 0.04 (0.00-0.62) in to 0.55 (0.37-0.74) in Germany. For all countries pooled, intra-specialty agreement was poor for surgeons (0.24, 0.14-0.42) and good for ICPs (0.41, 0.28-0.61). Reading SSI definitions improved agreement among ICPs (0.57) but not surgeons (0.09). Intra-specialty agreement for SSI depth ranged across countries and specialties from 0.05 (0.00-0.10) to 0.50 (0.45-0.55) and was not improved by reading SSI definition.
   Conclusion: Among ICPs and surgeons evaluating case-vignettes of suspected SSI, considerable disagreement occurred regarding the diagnosis, with variations across specialties and countries.
C1 [Birgand, Gabriel; Lucet, Jean-Christophe] Bichat Claude Bernard Hosp, Infect Control Unit, Paris, France.
   [Lepelletier, Didier] Nantes Univ Hosp, Bacteriol & Hyg Dept, Nantes, France.
   [Baron, Gabriel; Ravaud, Philippe] Hop Hotel Dieu, Ctr Epidemiol Clin, F-75181 Paris, France.
   [Breier, Ann-Christin; Gastmeier, Petra] Charite, Inst Hyg & Environm Med, D-13353 Berlin, Germany.
   [Buke, Cagri] Ege Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Izmir, Turkey.
   [Markovic-Denic, Ljiljana] Sch Med, Inst Epidemiol, Belgrade, Serbia.
   [Kluytmans, Jan] Amphia Hosp Breda, Lab Microbiol & Infect Control, Breda, Netherlands.
   [Lyytikainen, Outi] Natl Publ Hlth Inst, Dept Infect Dis, Helsinki, Finland.
   [Sheridan, Elizabeth] HPA Ctr Infect, Dept Healthcare Associated Infect & Antimicrobial, London, England.
   [Szilagyi, Emese] Off Chief Med Officer, Dept Epidemiol, Gyali, Hungary.
   [Tacconelli, Evelina] Univ Cattolica Sacro Cuore, Dept Infect Dis, Rome, Italy.
   [Troillet, Nicolas] Cent Inst Valais Hosp, Div Infect Dis, Sion, Switzerland.
RP Birgand, G (reprint author), Bichat Claude Bernard Hosp, Infect Control Unit, Paris, France.
EM gbirgand@gmail.com
RI ravaud, philippe/C-1694-2009
OI Ravaud, Philippe/0000-0001-8264-9206
FU French Ministry of Health [PREQHOS 0901]
FX This study was supported by the French Ministry of Health (national
   grant PREQHOS 0901). This grant was used to finance a part of the salary
   of the first author. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Beaujean D, 2002, EUR J CLIN MICROBIOL, V21, P444, DOI 10.1007/s10096-002-0745-x
   Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108
   CULVER DH, 1991, AM J MED, V91, pS152, DOI 10.1016/0002-9343(91)90361-Z
   Emmerson AM, 1996, J HOSP INFECT, V32, P175, DOI 10.1016/S0195-6701(96)90144-9
   Eriksen HM, 2005, J HOSP INFECT, V60, P40, DOI 10.1016/j.jhin.2004.09.038
   Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006
   Gastmeier P, 2005, ARCH ORTHOP TRAUM SU, V125, P526, DOI 10.1007/s00402-005-0036-y
   Gastmeier P, 2008, J HOSP INFECT, V70, P11, DOI 10.1016/S0195-6701(08)60005-5
   Geubbels ELPE, 2004, AM J INFECT CONTROL, V32, P424, DOI 10.1016/j.ajic.2004.07.001
   HALEY RW, 1985, AM J EPIDEMIOL, V121, P182, DOI 10.1093/oxfordjournals.aje.a113990
   Haustein T, 2011, LANCET INFECT DIS, V11, P471, DOI 10.1016/S1473-3099(10)70315-7
   Hejblum G, 2008, CHEST, V133, P1107, DOI 10.1378/chest.06-3014
   Hospital in Europe Link for Infection Control through Surveillance (HELICS), 2004, SURV SURG SIT INF
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lepelletier D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035131
   Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620
   McKibben L, 2005, AM J INFECT CONTROL, V33, P217, DOI 10.1016/j.ajic.2005.04.001
   Mertens R, 1996, Euro Surveill, V1, P28
   Nunnaly JC, 1994, PSYCHOMETRIC THEORY
   Perla RJ, 2009, AM J INFECT CONTROL, V37, P615, DOI 10.1016/j.ajic.2009.03.003
   Pittet D, 2004, ANN INTERN MED, V141, P1, DOI 10.7326/0003-4819-141-1-200407060-00008
   Rosenthal R, 2010, J HOSP INFECT, V75, P178, DOI 10.1016/j.jhin.2009.10.028
   TAYLOR G, 1990, AM J INFECT CONTROL, V18, P295, DOI 10.1016/0196-6553(90)90228-K
   Thibon P, 2002, INFECT CONT HOSP EP, V23, P368, DOI 10.1086/502067
   Wachter RM, 2008, ANN INTERN MED, V149, P29, DOI 10.7326/0003-4819-149-1-200807010-00007
   Wilson APR, 2004, BRIT MED J, V329, P720, DOI 10.1136/bmj.38232.646227.DE
   Wilson J, 2007, J HOSP INFECT, V65, P165, DOI 10.1016/S0195-6701(07)60037-1
NR 27
TC 12
Z9 13
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 9
PY 2013
VL 8
IS 7
AR e68618
DI 10.1371/journal.pone.0068618
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 182JD
UT WOS:000321736900097
PM 23874690
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gritti, ES
   Gaucherel, C
   Crespo-Perez, MV
   Chuine, I
AF Gritti, Emmanuel Stephan
   Gaucherel, Cedric
   Crespo-Perez, Maria-Veronica
   Chuine, Isabelle
TI How Can Model Comparison Help Improving Species Distribution Models?
SO PLOS ONE
LA English
DT Article
ID FAGUS-SYLVATICA L.; PLANT FUNCTIONAL TYPES; CLIMATE-CHANGE IMPACTS;
   VEGETATION DYNAMICS; ADAPTIVE EVOLUTION; RANGE SHIFTS; UNCERTAINTY;
   ECOSYSTEMS; NICHE; VULNERABILITY
AB Today, more than ever, robust projections of potential species range shifts are needed to anticipate and mitigate the impacts of climate change on biodiversity and ecosystem services. Such projections are so far provided almost exclusively by correlative species distribution models (correlative SDMs). However, concerns regarding the reliability of their predictive power are growing and several authors call for the development of process-based SDMs. Still, each of these methods presents strengths and weakness which have to be estimated if they are to be reliably used by decision makers. In this study we compare projections of three different SDMs (STASH, LPJ and PHENOFIT) that lie in the continuum between correlative models and process-based models for the current distribution of three major European tree species, Fagus sylvatica L., Quercus robur L. and Pinus sylvestris L. We compare the consistency of the model simulations using an innovative comparison map profile method, integrating local and multi-scale comparisons. The three models simulate relatively accurately the current distribution of the three species. The process-based model performs almost as well as the correlative model, although parameters of the former are not fitted to the observed species distributions. According to our simulations, species range limits are triggered, at the European scale, by establishment and survival through processes primarily related to phenology and resistance to abiotic stress rather than to growth efficiency. The accuracy of projections of the hybrid and process-based model could however be improved by integrating a more realistic representation of the species resistance to water stress for instance, advocating for pursuing efforts to understand and formulate explicitly the impact of climatic conditions and variations on these processes.
C1 [Gritti, Emmanuel Stephan; Crespo-Perez, Maria-Veronica; Chuine, Isabelle] Univ Montpellier 2, CNRS, CEFE, UMR 5175, F-34293 Montpellier, France.
   [Gritti, Emmanuel Stephan] Montpellier SupAgro, UMR Syst, F-34060 Montpellier 1, France.
   [Gaucherel, Cedric] UMR AMAP INRA, Montpellier, France.
   [Gaucherel, Cedric] IFP CNRS, French Inst Pondicherry, Pondicherry, India.
RP Gritti, ES (reprint author), Univ Montpellier 2, CNRS, CEFE, UMR 5175, 1919 Route Mende, F-34293 Montpellier, France.
EM emmanuel.gritti@supagro.inra.fr
OI Crespo-Perez, Veronica/0000-0002-8811-1965
FU Agence Nationale de la Recherche [ANR-05-BDIV-009, ANR-2009 PEXT 001105]
FX The authors acknowledge with thanks financial support from the Agence
   Nationale de la Recherche (Projects ANR-05-BDIV-009; ANR-2009 PEXT
   001105). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Ackerly DD, 2003, INT J PLANT SCI, V164, pS165, DOI 10.1086/368401
   BEAUMONT LJ, 2005, ECOLOGICAL MODELLING, V186, P251, DOI DOI 10.1016/J.ECOLMODEL.2005.01.030
   Bohn U., 2003, MAP NATURAL VEGETATI
   Brus DJ, 2012, EUR J FOREST RES, V131, P145, DOI 10.1007/s10342-011-0513-5
   Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x
   Cheaib A, 2012, ECOL LETT, V15, P533, DOI 10.1111/j.1461-0248.2012.01764.x
   Chuine I, 2001, ECOL LETT, V4, P500, DOI 10.1046/j.1461-0248.2001.00261.x
   de Noblet-Ducoudre N, 2004, AGRONOMIE, V24, P397, DOI 10.1051/agro:2004038
   Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x
   Dufrene E, 2005, ECOL MODEL, V185, P407, DOI 10.1016/j.ecolmodel.2005.01.004
   Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656
   Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088
   Garreta V, 2010, CLIM DYNAM, V35, P371, DOI 10.1007/s00382-009-0629-1
   Gaston K. J., 2003, STRUCTURE DYNAMICS G
   Gaucherel C, 2010, J ZOOL, V280, P185, DOI 10.1111/j.1469-7998.2009.00652.x
   Gaucherel C, 2008, IEEE T GEOSCI REMOTE, V46, P2708, DOI 10.1109/TGRS.2008.919379
   Grinnell J, 1914, AM NAT, V48, P248, DOI 10.1086/279402
   Gritti ES, 2013, METHODS ECOL EVOL, V4, P442, DOI 10.1111/2041-210X.12032
   Gritti ES, 2006, J BIOGEOGR, V33, P145, DOI 10.1111/j.1365-2699.2005.01377.x
   Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x
   Haxeltine A, 1996, GLOBAL BIOGEOCHEM CY, V10, P693, DOI 10.1029/96GB02344
   Herbette S, 2010, TREE PHYSIOL, V30, P1448, DOI 10.1093/treephys/tpq079
   Hickler T, 2004, ECOLOGY, V85, P519, DOI 10.1890/02-0344
   Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106
   HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039
   Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x
   Keenan T, 2011, GLOBAL CHANGE BIOL, V17, P565, DOI 10.1111/j.1365-2486.2010.02254.x
   Koca D, 2006, CLIMATIC CHANGE, V78, P381, DOI 10.1007/s10584-005-9030-1
   Kramer K, 2010, FOREST ECOL MANAG, V259, P2213, DOI 10.1016/j.foreco.2009.12.023
   Lamy JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023476
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Laurent JM, 2004, J VEG SCI, V15, P739, DOI 10.1658/1100-9233(2004)015[0739:RVSMFP]2.0.CO;2
   Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023
   Miller PA, 2008, J ECOL, V96, P247, DOI 10.1111/j.1365-2745.2007.01342.x
   MITCHELL TD, 2004, COMPREHENSIVE SET HI, P30
   Morin X, 2008, J ECOL, V96, P784, DOI 10.1111/j.1365-2745.2008.01369.x
   Morin X, 2007, ECOLOGY, V88, P2280, DOI 10.1890/06-1591.1
   Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1
   Nicks AD, 1995, DC FLANAGANMA NEARIN, P21
   Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x
   Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624
   PRENTICE IC, 1991, FOREST ECOL MANAG, V42, P79
   Rehfeldt GE, 2002, GLOBAL CHANGE BIOL, V8, P912, DOI 10.1046/j.1365-2486.2002.00516.x
   Reich PB, 2008, ECOL LETT, V11, P588, DOI 10.1111/j.1461-0248.2008.01172.x
   Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937
   Rosenzweig ML, 1987, EVOL ECOL, V1, P1, DOI 10.1007/BF02067263
   Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x
   Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x
   Smith B, 2001, GLOBAL ECOL BIOGEOGR, V10, P621, DOI 10.1046/j.1466-822X.2001.00256.x
   Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106
   Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x
   SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615
   Sykes MT, 1996, J BIOGEOGR, V23, P203
   TEEB, 2010, EC ECOSYSTEMS BIODIV, P410
   Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102
   Tutin T. G., 1964, FLORA EUROPAEAE
   Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104
   Woodward F., 1987, CLIMATE PLANT DISTRI
   Wortemann R, 2011, TREE PHYSIOL, V31, P1175, DOI 10.1093/treephys/tpr101
NR 59
TC 17
Z9 18
U1 0
U2 84
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 9
PY 2013
VL 8
IS 7
AR e68823
DI 10.1371/journal.pone.0068823
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 182JD
UT WOS:000321736900116
PM 23874779
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Axelsson, J
   Rylander, L
   Rignell-Hydbom, A
   Silfver, KA
   Stenqvist, A
   Giwercman, A
AF Axelsson, Jonatan
   Rylander, Lars
   Rignell-Hydbom, Anna
   Silfver, Karl Agren
   Stenqvist, Amelie
   Giwercman, Aleksander
TI The Impact of Paternal and Maternal Smoking on Semen Quality of
   Adolescent Men
SO PLOS ONE
LA English
DT Article
ID EPOXIDE-DNA ADDUCTS; ACUTE LYMPHOBLASTIC-LEUKEMIA; CONGENITAL
   HEART-DISEASE; RISK-FACTORS; SPERM COUNTS; CIGARETTE-SMOKING;
   AIR-POLLUTION; YOUNG MEN; TOBACCO CONSUMPTION; GENERAL-POPULATION
AB Background: Maternal smoking during pregnancy has been reported to negatively impact sperm counts of the sons. Sufficient data on the effect of paternal smoking is lacking.
   Objectives: We wished to elucidate the impact of maternal and paternal smoking during pregnancy and current own smoking on reproductive function of the male offspring.
   Methods: Semen parameters including sperm DNA integrity were analyzed in 295 adolescents from the general population close to Malmo, Sweden, recruited for the study during 2008-2010. Information on maternal smoking was obtained from the Swedish Medical Birth Register, and regarding own and paternal smoking from questionnaires. The impacts of maternal, paternal and own smoking were evaluated in a multivariate regression model and by use of models including interaction terms. Totally, three exposures and five outcomes were evaluated.
   Results: In maternally unexposed men, paternal smoking was associated with 46% lower total sperm count (95%CI: 21%, 64%) in maternally unexposed men. Both paternal and maternal smoking were associated with a lower sperm concentration (mean differences: 35%; 95%CI: 8.1%, 55% and 36%; 95%CI: 3.9%, 57%, respectively) if the other parent was a non-smoker. No statistically significant impact of own smoking on semen parameters was seen.
   Conclusions: Prenatal both maternal and paternal smoking were separately associated with some decrease in sperm count in men of whom the other parent was not reported to smoke.
C1 [Axelsson, Jonatan; Silfver, Karl Agren; Stenqvist, Amelie; Giwercman, Aleksander] Skane Univ Hosp, Reprod Med Ctr, Malmo, Sweden.
   [Axelsson, Jonatan; Rylander, Lars; Rignell-Hydbom, Anna] Lund Univ, Div Occupat & Environm Med, Lund, Sweden.
RP Axelsson, J (reprint author), Skane Univ Hosp, Reprod Med Ctr, Malmo, Sweden.
EM jonatan.axelsson@med.lu.se
OI Rylander, Lars/0000-0001-8288-8207
FU Swedish Cancer Society [CAN 2012/661]; Swedish Governmental funding for
   medical training and research; Skane University Hospital Funds; Swedish
   Childhood Cancer Society [PROJ10/030]
FX The study was supported by grants from the Swedish Cancer Society (CAN
   2012/661), Swedish Governmental funding for medical training and
   research, Skane University Hospital Funds and Swedish Childhood Cancer
   Society (PROJ10/030). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aitken RJ, 1999, J REPROD FERTIL, V115, P1
   Aitken RJ, 2004, NATURE, V432, P48, DOI 10.1038/432048a
   Aitken RJ, 2001, REPRODUCTION, V122, P497, DOI 10.1530/rep.0.1220497
   Andersen AG, 2000, HUM REPROD, V15, P366, DOI 10.1093/humrep/15.2.366
   Castro-Jimenez MA, 2011, PREV CHRONIC DIS, V8
   Axelsson J, 2011, HUM REPROD, V26, P1012, DOI 10.1093/humrep/der045
   Blanco-Munoz J, 2009, PUBLIC HEALTH REP, V124, P317, DOI 10.1177/003335490912400220
   Brouwers MM, 2007, EUR J PEDIATR, V166, P671, DOI 10.1007/s00431-006-0304-z
   Brouwers MM, 2010, BJU INT, V105, P254, DOI 10.1111/j.1464-410X.2009.08772.x
   Bungum M, 2011, ASIAN J ANDROL, V13, P69, DOI 10.1038/aja.2010.73
   Carbone P, 2007, INT J ANDROL, V30, P3, DOI 10.1111/j.1365-2605.2006.00703.x
   Chang Jeffrey S., 2009, V472, P103, DOI 10.1007/978-1-60327-492-0_5
   Chen D, 2009, PHARMACOGENET GENOM, V19, P25, DOI [10.1097/FPC.0b013e328316d8d8, 10.1097/FPC.01b013e328316d8d8]
   CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209
   Cresci M, 2011, AM J CARDIOL, V108, P1625, DOI 10.1016/j.amjcard.2011.07.022
   Danielsson M, 2012, SCAND J PUBLIC HEALT, V40, P176, DOI 10.1177/1403494812459600
   DAVIS DL, 1991, LANCET, V337, P123
   Edraki M., 2011, Eastern Mediterranean Health Journal, V17, P303
   ESHRE, 2002, ESHRE MONOGR, P1
   Fraga CG, 1996, MUTAT RES-FUND MOL M, V351, P199, DOI 10.1016/0027-5107(95)00251-0
   Fukuda M, 2011, FERTIL STERIL, V95, P2542, DOI 10.1016/j.fertnstert.2011.04.069
   Gianicolo EAL, 2010, CURR PHARM DESIGN, V16, P2572
   Hughes IA, 2001, ENDOCRINOLOGY, V142, P3281, DOI 10.1210/en.142.8.3281
   Jensen MS, 2007, EPIDEMIOLOGY, V18, P220, DOI 10.1097/01.ede.0000254061.90686.9f
   Jensen MS, 2005, HUM REPROD, V20, P2559, DOI 10.1093/humrep/dei110
   Jensen TK, 2004, AM J EPIDEMIOL, V159, P49, DOI 10.1093/aje/kwh002
   Jensen TK, 1997, J CLIN ENDOCR METAB, V82, P4059, DOI 10.1210/jc.82.12.4059
   Jorgensen N, 2011, INT J ANDROL, V34, pE37, DOI 10.1111/j.1365-2605.2010.01133.x
   Kuciene R, 2010, MED LITH, V46, P635, DOI 10.3390/medicina46090090
   Kurahashi N, 2005, MED SCI MONITOR, V11, pCR274
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Laubenthal J, 2012, FASEB J
   Liu RL, 2011, J ONCOL, DOI 10.1155/2011/854584
   Milne E, 2012, AM J EPIDEMIOL, V175, P43, DOI 10.1093/aje/kwr275
   Olsen Ann-Karin, 2005, Toxicol Appl Pharmacol, V207, P521, DOI 10.1016/j.taap.2005.01.060
   Paasch U, 2008, INT J ANDROL, V31, P93, DOI 10.1111/j.1365-2605.2007.00860.x
   Peat JK, 2002, HLTH SCI RES HDB QUA, Vxiv
   Perrin J, 2011, FERTIL STERIL, V95, P2013, DOI 10.1016/j.fertnstert.2011.02.021
   Pierik FH, 2004, ENVIRON HEALTH PERSP, V112, P1570, DOI 10.1289/ehp.7234
   Ramlau-Hansen CH, 2007, AM J EPIDEMIOL, V165, P1372, DOI 10.1093/aje/kwm032
   RATCLIFFE JM, 1992, REPROD TOXICOL, V6, P297, DOI 10.1016/0890-6238(92)90192-V
   Ravnborg TL, 2011, HUM REPROD, V26, P1000, DOI 10.1093/humrep/der011
   Richthoff J, 2002, HUM REPROD, V17, P2468, DOI 10.1093/humrep/17.9.2468
   Richthoff J, 2008, INT J ANDROL, V31, P31, DOI 10.1111/j.1365-2605.2007.00752.x
   Rothman KJ, 2008, MODERN EPIDEMIOLOGY
   Sanchez-Pozo MC, 2013, HUM REPROD, V28, P10, DOI 10.1093/humrep/des355
   Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2
   Shen HM, 1997, REPROD TOXICOL, V11, P675, DOI 10.1016/S0890-6238(97)00032-4
   Socialstyrelsen, 2009, PREGN DEL NEWB INF S
   Somers CM, 2011, SYST BIOL REPROD MEC, V57, P63, DOI 10.3109/19396368.2010.500440
   Somers CM, 2002, P NATL ACAD SCI USA, V99, P15904, DOI 10.1073/pnas.252499499
   Storgaard L, 2003, EPIDEMIOLOGY, V14, P278, DOI 10.1097/00001648-200305000-00006
   Venners SA, 2004, AM J EPIDEMIOL, V159, P993, DOI 10.1093/aje/kwh128
   Virtanen HE, 2012, CURR OPIN ENDOCRINOL, V19, P228, DOI 10.1097/MED.0b013e3283537cb8
   Wagner-Mahler K, 2011, INT J ANDROL, V34, pE499, DOI 10.1111/j.1365-2605.2011.01211.x
   World Health Organization, 1999, WHO LAB MAN EX HUM S, Vx
   WYROBEK AJ, 1993, REPROD TOXICOL, V7, P3, DOI 10.1016/0890-6238(93)90064-E
   Yauk C, 2008, P NATL ACAD SCI USA, V105, P605, DOI 10.1073/pnas.0705896105
   Yauk CL, 2007, CANCER RES, V67, P5103, DOI 10.1158/0008-5472.CAN-07-0279
   Zenzes MT, 1999, FERTIL STERIL, V72, P330, DOI 10.1016/S0015-0282(99)00230-7
   Zenzes MT, 1999, MOL HUM REPROD, V5, P125, DOI 10.1093/molehr/5.2.125
   Zhang B, 2011, J CRANIO MAXILL SURG, V39, P313, DOI 10.1016/j.jcms.2010.07.005
   ZHANG J, 1992, INT J EPIDEMIOL, V21, P273, DOI 10.1093/ije/21.2.273
   Zitzmann M, 2003, FERTIL STERIL, V79, P1550, DOI 10.1016/S0015-0282(03)
   Zwink N, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-25
NR 65
TC 17
Z9 18
U1 1
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 26
PY 2013
VL 8
IS 6
AR e66766
DI 10.1371/journal.pone.0066766
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 178DN
UT WOS:000321424400040
PM 23840528
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tulloch-Reid, MK
   Younger, NO
   Ferguson, TS
   Francis, DK
   Abdulkadri, AO
   Gordon-Strachan, GM
   McFarlane, SR
   Cunningham-Myrie, CA
   Wilks, RJ
   Anderson, SG
AF Tulloch-Reid, Marshall K.
   Younger, Novie O.
   Ferguson, Trevor S.
   Francis, Damian K.
   Abdulkadri, Abdullahi O.
   Gordon-Strachan, Georgiana M.
   McFarlane, Shelly R.
   Cunningham-Myrie, Colette A.
   Wilks, Rainford J.
   Anderson, Simon G.
TI Excess Cardiovascular Risk Burden in Jamaican Women Does Not Influence
   Predicted 10-Year CVD Risk Profiles of Jamaica Adults: An Analysis of
   the 2007/08 Jamaica Health and Lifestyle Survey
SO PLOS ONE
LA English
DT Article
ID METABOLIC SYNDROME; EUROPEAN-SOCIETY; BLOOD-PRESSURE; HEART-DISEASE;
   CASE-FATALITY; PREVALENCE; PREVENTION; POPULATION; INCOME
AB Background: Black Caribbean women have a higher burden of cardiovascular disease (CVD) risk factors than their male counterparts. Whether this results in a difference in incident cardiovascular events is unknown. The aim of this study was to estimate the 10 year World Health Organization/International Society for Hypertension (WHO/ISH) CVD risk score for Jamaica and explore the effect of sex as well as obesity, physical activity and socioeconomic status on these estimates.
   Methods and Findings: Data from 40-74 year old participants in the 2007/08 Jamaica Health and Lifestyle Survey were used. Trained interviewers administered questionnaires and measured anthropometrics, blood pressure, fasting glucose and cholesterol. Education and occupation were used to assess socioeconomic status. The Americas B tables were used to estimate the WHO/ISH 10 year CVD risk scores for the population. Weighted prevalence estimates were calculated. Data from 1,432 (450 men, 982 women) participants were analysed, after excluding those with self-reported heart attack and stroke. The women had a higher prevalence of diabetes (19% W; 12% M), hypertension (49% W; 47% M), hypercholesterolemia (25% W; 11% M), obesity (46% W; 15% M) and physical inactivity (59% W; 29% M). More men smoked (6% W; 31% M). There was good agreement between the 10-year cardiovascular risk estimates whether or not cholesterol measurements were utilized for calculation (kappa -0.61). While 90% had a 10 year WHO/ISH CVD risk of less than 10%, approximately 2% of the population or 14,000 persons had a 10 year WHO/ISH CVD risk of >= 30%. As expected CVD risk increased with age but there was no sex difference in CVD risk distribution despite women having a greater risk factor burden. Women with low socioeconomic status had the most adverse CVD risk profile.
   Conclusion: Despite women having a higher prevalence of CVD risk factors there was no sex difference in 10-year WHO/ISH CVD risk in Jamaican adults.
C1 [Tulloch-Reid, Marshall K.; Younger, Novie O.; Ferguson, Trevor S.; Francis, Damian K.; McFarlane, Shelly R.; Wilks, Rainford J.] Univ W Indies, Res Inst Trop Med, Kingston 7, Jamaica.
   [Abdulkadri, Abdullahi O.] Univ W Indies, Dept Econ, Kingston 7, Jamaica.
   [Gordon-Strachan, Georgiana M.] Univ W Indies, Fac Med Sci, Deans Off, Kingston 7, Jamaica.
   [Cunningham-Myrie, Colette A.] Univ W Indies, Dept Community Hlth & Psychiat, Kingston 7, Jamaica.
   [Anderson, Simon G.] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England.
RP Tulloch-Reid, MK (reprint author), Univ W Indies, Res Inst Trop Med, Kingston 7, Jamaica.
EM marshall.tullochreid@uwimona.edu.jm
RI Ferguson, Trevor/Q-7209-2019
OI Ferguson, Trevor/0000-0002-2393-1452; Anderson,
   Simon/0000-0002-8896-073X
FU National Health Fund; National Institute for Health Research [513, 2685]
FX The project was funded by the National Health Fund
   (http://www.nhf.org.jm/). The funders had no role in data collection and
   analysis, decision to publish, or preparation of the manuscript. The
   funders did request that questions to evaluate the efficacy of a
   medication subsidy programme be included in the survey questionnaire.
   These questions were designed by the investigators. The funders had no
   role in the decision to use the survey design, sampling or how
   additional data were collected.
CR Ataman SL, 1996, J CLIN EPIDEMIOL, V49, P869, DOI 10.1016/0895-4356(96)00111-4
   Berger JS, 2010, J AM COLL CARDIOL, V55, P1169, DOI 10.1016/j.jacc.2009.09.066
   Block RC, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110167
   Cai ZJ, 1999, WHO TECH REP SER, V887, P1
   Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560
   Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3
   Cooney MT, 2011, CURR OPIN CARDIOL, V26, P429, DOI 10.1097/HCO.0b013e3283499f06
   Corbin DOC, 2004, STROKE, V35, P1254, DOI 10.1161/01.STR.0000127371.24658.df
   D'Agostino RB, 2000, AM HEART J, V139, P272, DOI 10.1016/S0002-8703(00)90236-9
   Ferguson TS, 2011, W INDIAN MED J, V60, P422
   Ferguson TS, 2010, W INDIAN MED J, V59, P265
   Ferguson T, 2010, CURR CARDIOVASC RISK, V4, P76, DOI 10.1007/s12170-009-0076-x
   Ferguson TS, 2010, RES REP CLIN CARDIOL, V1, P23, DOI 10.2147/RRCC.S13649
   Ferguson TS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-307
   Kaduka LU, 2012, DIABETES CARE, V35, P887, DOI 10.2337/dc11-0537
   KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leeder S, 2004, RACE TIME CHALLENGE
   Marmot M, 1997, IARC SCI PUBL, V207-228
   Mendis S, 2007, J HYPERTENS, V25, P1578, DOI 10.1097/HJH.0b013e3282861fd3
   Mendis S, 2011, J CLIN EPIDEMIOL, V64, P1451, DOI 10.1016/j.jclinepi.2011.02.001
   Molokhia M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014588
   Morales A, 2011, MEDICC REV, V13, P23
   Ndindjock R, 2011, B WORLD HEALTH ORGAN, V89, P286, DOI 10.2471/BLT.10.082370
   Njelekela MA, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-30
   RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391
   Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]
   The Statistical Institute of Jamaica, 2009, DEM STAT 2008
   The Statistical Institute of Jamaica, 1991, JAM STAND OCC CLASS
   Vaccarino V, 2011, CARDIOVASC RES, V90, P9, DOI 10.1093/cvr/cvq394
   van Lennep JER, 2002, CARDIOVASC RES, V53, P538
   Wilks R, 1998, W INDIAN MED J, V47, P40
   Wilks R., 2008, JAMAICA HLTH LIFESTY
   World Health Organization, 2011, CARD DIS CVDS FACT S
   World Health Organization World Heart Federation World Stroke Organization, 2011, GLOB ATL CARD DIS PR
NR 35
TC 10
Z9 10
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 21
PY 2013
VL 8
IS 6
AR e66625
DI 10.1371/journal.pone.0066625
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 170JP
UT WOS:000320846500080
PM 23805252
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Manchia, M
   Adli, M
   Akula, N
   Ardau, R
   Aubry, JM
   Backlund, L
   Banzato, CEM
   Baune, BT
   Bellivier, F
   Bengesser, S
   Biernacka, JM
   Brichant-Petitjean, C
   Bui, E
   Calkin, CV
   Cheng, ATA
   Chillotti, C
   Cichon, S
   Clark, S
   Czerski, PM
   Dantas, C
   Del Zompo, M
   DePaulo, JR
   Detera-Wadleigh, SD
   Etain, B
   Falkai, P
   Frisen, L
   Frye, MA
   Fullerton, J
   Gard, S
   Garnham, J
   Goes, FS
   Grof, P
   Gruber, O
   Hashimoto, R
   Hauser, J
   Heilbronner, U
   Hoban, R
   Hou, LP
   Jamain, S
   Kahn, JP
   Kassem, L
   Kato, T
   Kelsoe, JR
   Kittel-Schneider, S
   Kliwicki, S
   Kuo, PH
   Kusumi, I
   Laje, G
   Lavebratt, C
   Leboyer, M
   Leckband, SG
   Jaramillo, CAL
   Maj, M
   Malafosse, A
   Martinsson, L
   Masui, T
   Mitchell, PB
   Mondimore, F
   Monteleone, P
   Nallet, A
   Neuner, M
   Novak, T
   O'Donovan, C
   Osby, U
   Ozaki, N
   Perlis, RH
   Pfennig, A
   Potash, JB
   Reich-Erkelenz, D
   Reif, A
   Reininghaus, E
   Richardson, S
   Rouleau, GA
   Rybakowski, JK
   Schalling, M
   Schofield, PR
   Schubert, OK
   Schweizer, B
   Seemuller, F
   Grigoroiu-Serbanescu, M
   Severino, G
   Seymour, LR
   Slaney, C
   Smoller, JW
   Squassina, A
   Stamm, T
   Steele, J
   Stopkova, P
   Tighe, SK
   Tortorella, A
   Turecki, G
   Wray, NR
   Wright, A
   Zandi, PP
   Zilles, D
   Bauer, M
   Rietschel, M
   McMahon, FJ
   Schulze, TG
   Alda, M
AF Manchia, Mirko
   Adli, Mazda
   Akula, Nirmala
   Ardau, Raffaella
   Aubry, Jean-Michel
   Backlund, Lena
   Banzato, Claudio E. M.
   Baune, Bernhard T.
   Bellivier, Frank
   Bengesser, Susanne
   Biernacka, Joanna M.
   Brichant-Petitjean, Clara
   Bui, Elise
   Calkin, Cynthia V.
   Cheng, Andrew Tai Ann
   Chillotti, Caterina
   Cichon, Sven
   Clark, Scott
   Czerski, Piotr M.
   Dantas, Clarissa
   Del Zompo, Maria
   DePaulo, J. Raymond
   Detera-Wadleigh, Sevilla D.
   Etain, Bruno
   Falkai, Peter
   Frisen, Louise
   Frye, Mark A.
   Fullerton, Jan
   Gard, Sebastien
   Garnham, Julie
   Goes, Fernando S.
   Grof, Paul
   Gruber, Oliver
   Hashimoto, Ryota
   Hauser, Joanna
   Heilbronner, Urs
   Hoban, Rebecca
   Hou, Liping
   Jamain, Stephane
   Kahn, Jean-Pierre
   Kassem, Layla
   Kato, Tadafumi
   Kelsoe, John R.
   Kittel-Schneider, Sarah
   Kliwicki, Sebastian
   Kuo, Po-Hsiu
   Kusumi, Ichiro
   Laje, Gonzalo
   Lavebratt, Catharina
   Leboyer, Marion
   Leckband, Susan G.
   Lopez Jaramillo, Carlos A.
   Maj, Mario
   Malafosse, Alain
   Martinsson, Lina
   Masui, Takuya
   Mitchell, Philip B.
   Mondimore, Frank
   Monteleone, Palmiero
   Nallet, Audrey
   Neuner, Maria
   Novak, Tomas
   O'Donovan, Claire
   Osby, Urban
   Ozaki, Norio
   Perlis, Roy H.
   Pfennig, Andrea
   Potash, James B.
   Reich-Erkelenz, Daniela
   Reif, Andreas
   Reininghaus, Eva
   Richardson, Sara
   Rouleau, Guy A.
   Rybakowski, Janusz K.
   Schalling, Martin
   Schofield, Peter R.
   Schubert, Oliver K.
   Schweizer, Barbara
   Seemueller, Florian
   Grigoroiu-Serbanescu, Maria
   Severino, Giovanni
   Seymour, Lisa R.
   Slaney, Claire
   Smoller, Jordan W.
   Squassina, Alessio
   Stamm, Thomas
   Steele, Jo
   Stopkova, Pavla
   Tighe, Sarah K.
   Tortorella, Alfonso
   Turecki, Gustavo
   Wray, Naomi R.
   Wright, Adam
   Zandi, Peter P.
   Zilles, David
   Bauer, Michael
   Rietschel, Marcella
   McMahon, Francis J.
   Schulze, Thomas G.
   Alda, Martin
TI Assessment of Response to Lithium Maintenance Treatment in Bipolar
   Disorder: A Consortium on Lithium Genetics (ConLiGen) Report
SO PLOS ONE
LA English
DT Article
ID MAPPING SUSCEPTIBILITY GENES; PROPHYLACTIC LITHIUM; OBSERVER AGREEMENT;
   MOOD DISORDERS; ONSET; ASSOCIATION; RELIABILITY; MORTALITY; ILLNESS; AGE
AB Objective: The assessment of response to lithium maintenance treatment in bipolar disorder (BD) is complicated by variable length of treatment, unpredictable clinical course, and often inconsistent compliance. Prospective and retrospective methods of assessment of lithium response have been proposed in the literature. In this study we report the key phenotypic measures of the "Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder" scale currently used in the Consortium on Lithium Genetics (ConLiGen) study.
   Materials and Methods: Twenty-nine ConLiGen sites took part in a two-stage case-vignette rating procedure to examine inter-rater agreement [Kappa (kappa)] and reliability [intra-class correlation coefficient (ICC)] of lithium response. Annotated first-round vignettes and rating guidelines were circulated to expert research clinicians for training purposes between the two stages. Further, we analyzed the distributional properties of the treatment response scores available for 1,308 patients using mixture modeling.
   Results: Substantial and moderate agreement was shown across sites in the first and second sets of vignettes (kappa = 0.66 and kappa = 0.54, respectively), without significant improvement from training. However, definition of response using the A score as a quantitative trait and selecting cases with B criteria of 4 or less showed an improvement between the two stages (ICC1 = 0.71 and ICC2 = 0.75, respectively). Mixture modeling of score distribution indicated three subpopulations (full responders, partial responders, non responders).
   Conclusions: We identified two definitions of lithium response, one dichotomous and the other continuous, with moderate to substantial inter-rater agreement and reliability. Accurate phenotypic measurement of lithium response is crucial for the ongoing ConLiGen pharmacogenomic study.
C1 [Manchia, Mirko; Calkin, Cynthia V.; Garnham, Julie; O'Donovan, Claire; Slaney, Claire; Alda, Martin] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada.
   [Adli, Mazda; Stamm, Thomas] Charite, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany.
   [Akula, Nirmala; Bui, Elise; Detera-Wadleigh, Sevilla D.; Hou, Liping; Kassem, Layla; Laje, Gonzalo; Richardson, Sara; Steele, Jo; McMahon, Francis J.; Schulze, Thomas G.] NIMH, Human Genet Branch, Div Intramural Res Programs, NIH, Bethesda, MD 20892 USA.
   [Ardau, Raffaella; Chillotti, Caterina; Del Zompo, Maria] Univ Hosp Cagliari, Clin Pharmacol Unit, Cagliari, Italy.
   [Aubry, Jean-Michel; Malafosse, Alain; Nallet, Audrey] Hop Univ Geneve, Dept Mental Hlth & Psychiat, Geneva, Switzerland.
   [Backlund, Lena; Frisen, Louise; Martinsson, Lina] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.
   [Banzato, Claudio E. M.; Dantas, Clarissa] Univ Estadual Campinas, Dept Psychiat, Campinas, Brazil.
   [Baune, Bernhard T.; Clark, Scott; Schubert, Oliver K.] Univ Adelaide, Dept Psychiat, Adelaide, SA, Australia.
   [Bellivier, Frank; Brichant-Petitjean, Clara] Grp Hosp Lariboisiere F Widal, AP HP, Paris, France.
   [Bengesser, Susanne; Reininghaus, Eva] Med Univ Graz, Dept Psychiat, Graz, Austria.
   [Biernacka, Joanna M.; Frye, Mark A.; Seymour, Lisa R.] Mayo Clin, Dept Psychiat, Rochester, MN USA.
   [Cheng, Andrew Tai Ann] Acad Sinica, Inst Biomed Sci, Div Epidemiol & Genet, Taipei, Taiwan.
   [Cichon, Sven] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany.
   [Cichon, Sven] Univ Bonn, Inst Human Genet, Bonn, Germany.
   [Czerski, Piotr M.] Poznan Univ Med Sci, Psychiat Genet Unit, Poznan, Poland.
   [Del Zompo, Maria; Severino, Giovanni; Squassina, Alessio] Univ Cagliari, Dept Biomed Sci, Sect Neurosci & Clin Pharmacol, Cagliari, Italy.
   [DePaulo, J. Raymond; Goes, Fernando S.; Mondimore, Frank; Potash, James B.; Schweizer, Barbara; Tighe, Sarah K.; Schulze, Thomas G.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
   [Etain, Bruno; Jamain, Stephane; Leboyer, Marion] Fac Med, Equipe 15, Inst Mondor Rech Biomed, INSERM,Unite 955, Creteil, France.
   [Falkai, Peter; Seemueller, Florian] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany.
   [Fullerton, Jan; Schofield, Peter R.] Neurosci Res Australia Genet Mental Illness & Bra, Sydney, NSW, Australia.
   [Gard, Sebastien] Hop Charles Perrens, Psychiat Serv, Bordeaux, France.
   [Grof, Paul] Mood Disorders Ctr Ottawa, Ottawa, ON, Canada.
   [Grof, Paul] Univ Toronto, Dept Psychiat, Toronto, ON, Canada.
   [Gruber, Oliver; Heilbronner, Urs; Reich-Erkelenz, Daniela; Zilles, David; Schulze, Thomas G.] Univ Gottingen, Dept Psychiat & Psychotherapy, D-37073 Gottingen, Germany.
   [Hashimoto, Ryota] Osaka Univ, Grad Sch Med, Osaka, Japan.
   [Hauser, Joanna] Poznan Univ Med Sci, Psychiat Genet Unit, Poznan, Poland.
   [Hoban, Rebecca; Kelsoe, John R.; Leckband, Susan G.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.
   [Hoban, Rebecca; Kelsoe, John R.] Vet Affairs San Diego Healthcare Syst, Dept Psychiat, San Diego, CA USA.
   [Kahn, Jean-Pierre] Ctr Hosp Univ Nancy, Serv Psychiat & Psychol Clin, Nancy, France.
   [Kato, Tadafumi; Kusumi, Ichiro] RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Saitama, Japan.
   [Kittel-Schneider, Sarah; Neuner, Maria; Reif, Andreas] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, D-97070 Wurzburg, Germany.
   [Kliwicki, Sebastian; Rybakowski, Janusz K.] Poznan Univ Med Sci, Dept Adult Psychiat, Poznan, Poland.
   [Kuo, Po-Hsiu] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.
   [Kusumi, Ichiro; Masui, Takuya] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan.
   [Lavebratt, Catharina; Osby, Urban; Schalling, Martin] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.
   [Lavebratt, Catharina; Osby, Urban; Schalling, Martin] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden.
   [Leckband, Susan G.] Vet Affairs San Diego Healthcare Syst, Dept Pharm, San Diego, CA USA.
   [Leckband, Susan G.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA.
   [Lopez Jaramillo, Carlos A.] Univ Antioquia, Dept Psychiat, Medellin, Colombia.
   [Maj, Mario; Monteleone, Palmiero; Tortorella, Alfonso] Univ Naples Federico II, Dept Psychiat, Naples, Italy.
   [Mitchell, Philip B.; Wright, Adam] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia.
   [Mitchell, Philip B.; Wright, Adam] Black Dog Inst, Sydney, NSW, Australia.
   [Novak, Tomas; Stopkova, Pavla] Univ Prague, Prague Psychiat Ctr, Prague, Czech Republic.
   [Ozaki, Norio] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan.
   [Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan.
   [Perlis, Roy H.; Smoller, Jordan W.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.
   [Perlis, Roy H.; Smoller, Jordan W.] Harvard Univ, Sch Med, Boston, MA USA.
   [Pfennig, Andrea; Bauer, Michael] Tech Univ Dresden, Dept Psychiat & Psychotherapy, Dresden, Germany.
   [Potash, James B.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA.
   [Rouleau, Guy A.] Univ Montreal, Ctr Hosp Univ Montreal, Ctr Excellence Neurosci, Montreal, PQ, Canada.
   [Rouleau, Guy A.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada.
   [Grigoroiu-Serbanescu, Maria] Alexandru Obregia Psychiat Hosp, Biometr Psychiat Genet Res Unit, Bucharest, Romania.
   [Turecki, Gustavo] Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada.
   [Wray, Naomi R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.
   [Zandi, Peter P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA.
   [Rietschel, Marcella; Schulze, Thomas G.] Heidelberg Univ, Univ Med Ctr Mannheim, Cent Inst Mental Hlth Mannheim, Dept Genet Epidemiol Psychiat, Mannheim, Germany.
RP Schulze, TG (reprint author), NIMH, Human Genet Branch, Div Intramural Res Programs, NIH, Bethesda, MD 20892 USA.
EM thomas.schulze@med.uni-goettingen.de; malda@dal.ca
RI Stopkova, Pavla/C-6000-2019; McMahon, Francis/A-7290-2009; Jamain,
   Stephane/L-1822-2019; Cichon, Sven/B-9618-2014; Kato,
   Tadafumi/J-3583-2014; Hou, Liping/G-1648-2011; Wray, Naomi/C-8639-2015;
   Serbanescu, Maria/D-4306-2011; Fullerton, Janice/F-8485-2013; Cheng,
   Andrew/O-1159-2018; Etain, Bruno/L-6647-2017; Kuo, Po-Hsiu/H-9882-2013;
   Hashimoto, Ryota/P-8572-2014; Manchia, Mirko/A-2907-2010; Ozaki,
   Norio/M-8908-2014; Falkai, Peter/E-3273-2017; Jamain,
   Stephane/P-3710-2017; Novak, Tomas/B-8008-2017; BELLIVIER,
   FRANK/H-5197-2012; Reich-Erkelenz, Daniela/D-9736-2018; Cichon,
   Sven/H-8803-2013; Alda, Martin/F-5812-2010; Banzato,
   Claudio/B-2517-2008; Schofield, Peter/C-9669-2011
OI Stopkova, Pavla/0000-0003-2712-3652; McMahon,
   Francis/0000-0002-9469-305X; Jamain, Stephane/0000-0002-4321-4100;
   Cichon, Sven/0000-0002-9475-086X; Kato, Tadafumi/0000-0001-7856-3952;
   Hou, Liping/0000-0003-3972-245X; Wray, Naomi/0000-0001-7421-3357;
   Serbanescu, Maria/0000-0002-1304-6687; Fullerton,
   Janice/0000-0003-4014-4490; Cheng, Andrew/0000-0002-2698-0516; Etain,
   Bruno/0000-0002-5377-1488; Hashimoto, Ryota/0000-0002-5941-4238;
   Manchia, Mirko/0000-0003-4175-6413; Ozaki, Norio/0000-0002-7360-4898;
   Falkai, Peter/0000-0003-2873-8667; Jamain, Stephane/0000-0002-4321-4100;
   Novak, Tomas/0000-0001-9156-9654; Reich-Erkelenz,
   Daniela/0000-0001-7818-539X; Cichon, Sven/0000-0002-9475-086X; Alda,
   Martin/0000-0001-9544-3944; Kittel-Schneider, Sarah/0000-0003-3057-6150;
   Lavebratt, Catharina/0000-0003-4987-2718; DePaulo, J
   Raymond/0000-0001-9221-9226; Mitchell, Philip/0000-0002-7954-5235; Kuo,
   Po-Hsiu/0000-0003-0365-3587; Banzato, Claudio/0000-0002-8556-3982;
   LEBOYER, Marion/0000-0001-5473-3697; Lopez, Carlos/0000-0002-1875-1369;
   Martinsson, Lina/0000-0002-2938-2773; Seemuller,
   Florian/0000-0002-3557-1343; Schofield, Peter/0000-0003-2967-9662;
   Backlund, Lena/0000-0001-9399-5024; BELLIVIER,
   FRANK/0000-0002-3660-6640; Heilbronner, Urs/0000-0001-7135-762X;
   Reininghaus, Eva/0000-0001-5964-4087; Garnham, Julie/0000-0002-7987-4995
FU Canadian Institutes of Health Research [64410]; Unitatea Executiva
   pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si
   Inovarii (UEFISCDI), Bucharest, Romania [89/2012]; Swiss National
   Foundation [32003B_125469/1]; National Institute of Mental Health (NIMH)
   at the National Institutes of Health (NIH), Department of Health and
   Human Services, United States Government; Deutsche
   Forschungsgemeinschaft [RI 908/7-1]
FX The work on assessment of lithium response has been supported by a grant
   from Canadian Institutes of Health Research #64410 to MA. MG-S was
   supported by Unitatea Executiva pentru Finantarea Invatamantului
   Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI), Bucharest,
   Romania (grant no. 89/2012). JMA and AN were supported by a grant from
   the Swiss National Foundation (#32003B_125469/1 to JM Aubry). ConLiGen
   is in part supported by funds from the Intramural Research Program of
   the National Institute of Mental Health (NIMH) at the National
   Institutes of Health (NIH), Department of Health and Human Services,
   United States Government. It is further supported by a grant from the
   Deutsche Forschungsgemeinschaft to MR, MB, and TGS (RI 908/7-1). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alda M, 2005, PROG NEURO-PSYCHOPH, V29, P1038, DOI 10.1016/j.pnpbp.2005.03.021
   Alda M, 2001, BIPOLAR DISORD, V3, P318, DOI 10.1034/j.1399-5618.2001.30606.x
   Angst J, 2000, BIOL PSYCHIAT, V48, P445, DOI 10.1016/S0006-3223(00)00909-4
   Baldessarini RJ, 2000, ARCH GEN PSYCHIAT, V57, P187, DOI 10.1001/archpsyc.57.2.187
   Bellivier F, 2003, AM J PSYCHIAT, V160, P999, DOI 10.1176/appi.ajp.160.5.999
   BURDOCK EI, 1963, PERS PSYCHOL, V16, P373, DOI 10.1111/j.1744-6570.1963.tb01283.x
   Cheniaux E, 2009, PSYCHOPATHOLOGY, V42, P293, DOI 10.1159/000228838
   Chillotti C, 2009, RIV PSICHIATR, V44, P28
   Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   COPPEN A, 1973, PSYCHIAT NEUROL NEUR, V76, P501
   Cruceanu C, 2009, GENOME MED, V1, DOI 10.1186/gm79
   Daly AK, 2010, NAT REV GENET, V11, P241, DOI 10.1038/nrg2751
   de Lara CL, 2010, INT J NEUROPSYCHOPH, V13, P1397, DOI 10.1017/S1461145710000714
   Duffy A, 2007, CAN J PSYCHIAT, V52, P369, DOI 10.1177/070674370705200606
   Etain B, 2006, MOL PSYCHIATR, V11, P685, DOI 10.1038/sj.mp.4001515
   Fountoulakis KN, 2012, EUR ARCH PSY CLIN N, V262, pS1, DOI 10.1007/s00406-012-0323-x
   Garnham J, 2007, J AFFECT DISORDERS, V104, P185, DOI 10.1016/j.jad.2007.03.003
   Goodwin FK, 2007, MANIC DEPRESSIVE ILL
   GROF P, 1993, BRIT J PSYCHIAT, V163, P16, DOI 10.1192/S000712500029243X
   Grof P, 2002, J CLIN PSYCHIAT, V63, P942, DOI 10.4088/JCP.v63n1013
   Hamshere ML, 2009, J AFFECT DISORDERS, V116, P23, DOI 10.1016/j.jad.2008.10.021
   Kleindienst N, 2005, BIPOLAR DISORD, V7, P404, DOI 10.1111/j.1399-5618.2005.00244.x
   Komarek A, 2011, MIXTURE METHODS INCL
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lubke G, 2008, MULTIVAR BEHAV RES, V43, P592, DOI 10.1080/00273170802490673
   MAJ M, 1984, ACTA PSYCHIAT SCAND, V69, P37, DOI 10.1111/j.1600-0447.1984.tb04514.x
   Maj M, 1998, AM J PSYCHIAT, V155, P30, DOI 10.1176/ajp.155.1.30
   McCarthy MJ, 2010, PHARMACOGENOMICS, V11, P1439, DOI 10.2217/PGS.10.127
   Motsinger-Reif AA, 2010, PHARMACOGENET GENOMI
   Muller-Oerlinghausen Bruno, 2005, Arch Suicide Res, V9, P307, DOI 10.1080/13811110590929550
   MULLEROERLINGHAUSEN B, 1992, ACTA PSYCHIAT SCAND, V86, P218, DOI 10.1111/j.1600-0447.1992.tb03255.x
   PRIEN RF, 1974, ARCH GEN PSYCHIAT, V31, P189
   Rybakowski JK, 2001, BIPOLAR DISORD, V3, P63, DOI 10.1034/j.1399-5618.2001.030203.x
   Sachs GS, 2003, J CLIN PSYCHIAT, V64, P18
   Schulze TG, 2010, NEUROPSYCHOBIOLOGY, V62, P72, DOI 10.1159/000314708
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   SOLOMON DA, 1995, J CLIN PSYCHIAT, V56, P5
   Squassina A, 2009, MOL PSYCHIATR, V14, P350, DOI 10.1038/mp.2008.93
   Squassina A, 2011, PHARMACOGENOMICS, V12, P1559, DOI [10.2217/pgs.11.102, 10.2217/PGS.11.102]
   Turecki G, 2001, MOL PSYCHIATR, V6, P570, DOI 10.1038/sj.mp.4000888
   Wallace CS, 2000, STAT COMPUT, V10, P73, DOI 10.1023/A:1008992619036
   WALLACE CS, 1968, COMPUT J, V11, P185, DOI 10.1093/comjnl/11.2.185
   Yatham LN, 2005, BIPOLAR DISORD, V7, P5, DOI 10.1111/j.1399-5618.2005.00219.x
NR 44
TC 53
Z9 54
U1 3
U2 40
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 19
PY 2013
VL 8
IS 6
AR e65636
DI 10.1371/journal.pone.0065636
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 190ST
UT WOS:000322361200028
PM 23840348
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Solari, A
   Giordano, A
   Kasper, J
   Drulovic, J
   van Nunen, A
   Vahter, L
   Viala, F
   Pietrolongo, E
   Pugliatti, M
   Antozzi, C
   Radice, D
   Kopke, S
   Heesen, C
AF Solari, Alessandra
   Giordano, Andrea
   Kasper, Jurgen
   Drulovic, Jelena
   van Nunen, An
   Vahter, Liina
   Viala, Frederique
   Pietrolongo, Erika
   Pugliatti, Maura
   Antozzi, Carlo
   Radice, Davide
   Koepke, Sascha
   Heesen, Christoph
CA AutoMS Project
TI Role Preferences of People with Multiple Sclerosis: Image-Revised,
   Computerized Self-Administered Version of the Control Preference Scale
SO PLOS ONE
LA English
DT Article
ID TREATMENT DECISION-MAKING; PARTICIPATION; IMMUNOTHERAPY; WANT
AB Background: The Control Preference Scale (CPS) is the most frequently used measure of patients' preferred roles in treatment decisions. We revised the original CPS and developed a new computerized patient self-administered version (eCPS). We used the eCPS to assess role preferences, and their determinants, in Italian and German people with multiple sclerosis (MS).
   Methods: New cartoons were produced, based on MS health professional and patient input/feedback and previous findings, and pilot tested on 26 Italian and German MS patients. eCPS acceptability and reliability (weighted kappa statistic, wK) in comparison to the original tool, was determined in 92 MS patients who received both CPS versions in random order.
   Results: The new cartoons were well accepted and easily interpreted by patients, who reported they based their choices mainly on the text and considered the images of secondary importance. eCPS reliability was moderate (wK 0.53, 95% confidence interval [CI] 0.40-0.65) and similar to the test-retest reliability of face-to-face administration assessed in a previous publication (wK 0.65, 95% CI 0.45-0.81). Higher education (odds ratio [OR] 3.74, 95% CI 1.00-14.05) and German nationality (OR 10.30, 95% CI 3.10-34.15) were associated with preference for an active role in the logistic model.
   Conclusions: The newly devised eCPS was well received and considered easy to use by MS patients. Reliability was in line with that of the original version. Role preference appears affected by cultural characteristics and (borderline statistical significance) education.
C1 [Solari, Alessandra; Giordano, Andrea] Fdn Ist Ricovero & Cura Carattere Sci Neurol Inst, Unit Neuroepidemiol, Milan, Italy.
   [Kasper, Jurgen] Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany.
   [Drulovic, Jelena] Univ Belgrade, Sch Med, Inst Neurol, Belgrade, Serbia.
   [van Nunen, An] Natl MS Ctr, Melsbroek, Belgium.
   [Vahter, Liina] West Tallinn Cent Hosp, Dept Neurol, Tallinn, Estonia.
   [Viala, Frederique] Purpan Univ Hosp, Dept Neurol, Toulouse, France.
   [Pietrolongo, Erika] Univ G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy.
   [Pugliatti, Maura] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy.
   [Antozzi, Carlo] Fdn Ist Ricovero & Cura Carattere Sci Neurol Inst, Dept Neuromuscular Dis, Milan, Italy.
   [Radice, Davide] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy.
   [Koepke, Sascha] Med Univ Lubeck, Nursing Res Grp, Inst Social Med, D-23538 Lubeck, Germany.
   [Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res Inims, Hamburg, Germany.
RP Solari, A (reprint author), Fdn Ist Ricovero & Cura Carattere Sci Neurol Inst, Unit Neuroepidemiol, Milan, Italy.
EM solari@istituto-besta.it
OI pietrolongo, erika/0000-0002-6311-5994; Giordano,
   Andrea/0000-0003-4466-9788
FU Fondazione Italiana Sclerosi Multipla (FISM) [2010/R/37]; German Hertie
   Foundation, AutoMS project; Novartis; Ritchter Gedeon; Bayer Schering;
   Biogen Idec; Merck Serono; Sanofi Aventis; Teva
FX This study was supported by grants from the Fondazione Italiana Sclerosi
   Multipla (FISM) (grant No. 2010/R/37) and by the German Hertie
   Foundation as part of the AutoMS project. The FISM also supported AG
   with a research fellowship. The funding sources had no role in study
   design, data collection, data analysis, data interpretation, or report
   writing.; AS was a board member for Biogen Idec and Novartis, and has
   received speaker honoraria from Genzyme and Merck Serono. JD has
   received honoraria for consultancy from Bayer Healthcare
   Pharmaceuticals, and speker's fees from Novartis and Ritchter Gedeon. AL
   was a board member for Bayer Schering, Biogen Idec, and Merck Serono;
   she has received travel grants and honoraria from Bayer Schering, Biogen
   Idec, Merck Serono, Novartis, Sanofi Aventis and Teva. MP has received
   speaker honoraria from Sanofi Aventis, and travel support from Biogen
   Idec, Merck-Serono, Novartis, Sanofi Aventis and Teva. CH has received
   financial support from Bayer Schering, Biogen Idec, Merck Serono and
   Teva. All other authors declare that they have no conflicts of interest.
   This does not alter the authors' adherence to all the PLOS ONE policies
   on sharing data and materials.
CR Arora NK, 2000, MED CARE, V38, P335, DOI 10.1097/00005650-200003000-00010
   Berry DL, 2010, J MED INTERNET RES, V12, P109, DOI 10.2196/jmir.1576
   Bruce JM, 2011, NAT REV NEUROL, V7, P421, DOI 10.1038/nrneurol.2011.106
   Charles C, 2006, PATIENT EDUC COUNS, V63, P262, DOI 10.1016/j.pec.2006.06.018
   Coons SJ, 2009, VALUE HEALTH, V12, P419, DOI 10.1111/j.1524-4733.2008.00470.x
   Davison B Joyce, 2007, Cancer Nurs, V30, pE7
   Davison B Joyce, 2003, Oncol Nurs Forum, V30, P107, DOI 10.1188/03.ONF.107-114
   Deber RB, 2007, HEALTH EXPECT, V10, P248, DOI 10.1111/j.1369-7625.2007.00441.x
   Degner L F, 1997, Can J Nurs Res, V29, P21
   European Commission, 2007, TOG HLTH STRAT APPR
   Frosch DL, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-73
   Giordano A, 2008, J NEUROL SCI, V275, P86, DOI 10.1016/j.jns.2008.07.026
   Hamann J, 2012, EUR J PUBLIC HEALTH, V22, P469, DOI 10.1093/eurpub/ckr112
   Heesen C, 2004, MULT SCLER, V10, P643, DOI 10.1191/1352458504ms1112oa
   Heesen C, 2011, J NEUROL SCI, V306, P192, DOI 10.1016/j.jns.2010.09.012
   Hong F, 2011, UROL ONCOL, DOI [10.1016/j.uro-lonc.2011.10.004, DOI 10.1016/J.UR0-L0NC.2011.10.004]
   Hosmer D. W., 1989, APPL LOGISTIC REGRES
   Institute of Medicine, 2001, CROSS QUAL CHASM NEW
   Kagawa-Singer M, 2006, J CANCER EDUC, V21, pS22, DOI 10.1207/s15430154jce2101s_6
   Kasper J, 2008, EUR J NEUROL, V15, P1345, DOI 10.1111/j.1468-1331.2008.02313.x
   Kasper J, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-60
   Kremer H, 2008, MED DECIS MAKING, V28, P899, DOI 10.1177/0272989X08317014
   Kryworuchko J, 2008, PATIENT EDUC COUNS, V73, P497, DOI 10.1016/j.pec.2008.07.011
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Levinson W, 2005, J GEN INTERN MED, V20, P531, DOI 10.1111/j.1525-1497.2005.0088.x
   LEVINSON W, 1994, JAMA-J AM MED ASSOC, V272, P1619, DOI 10.1001/jama.272.20.1619
   Mansell D, 2000, ARCH INTERN MED, V160, P2991, DOI 10.1001/archinte.160.19.2991
   Melbourne E, 2011, PATIENT EDUC COUNS, V83, P55, DOI 10.1016/j.pec.2010.04.019
   O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub4, 10.1002/14651858.CD001431.pub3]
   Pietrolongo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060721
   Solari A, 2007, MULT SCLER J, V13, P763, DOI 10.1177/1352458506074689
   Terry K, 1994, Med Econ, V71, ppassim
   UK Department of Health, 2012, INV PAT PUBL HEALTHC
   Wallberg B, 2000, ACTA ONCOL, V39, P467
   Yadav V, 2012, CURR NEUROL NEUROSCI, V12, P489, DOI 10.1007/s11910-012-0295-2
   Yennurajalingam S, 2013, J PAIN SYMPTOM MANAG, V46, P376, DOI 10.1016/j.jpainsymman.2012.08.015
NR 36
TC 14
Z9 14
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 18
PY 2013
VL 8
IS 6
AR e66127
DI 10.1371/journal.pone.0066127
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 166SA
UT WOS:000320576400055
PM 23823627
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Liu, YH
   Chen, HJ
   Liang, L
   Wang, YF
AF Liu, Yinghui
   Chen, Hsin-jen
   Liang, Lan
   Wang, Youfa
TI Parent-Child Resemblance in Weight Status and Its Correlates in the
   United States
SO PLOS ONE
LA English
DT Article
ID BODY-MASS INDEX; SELF-REPORTED WEIGHT; LIFE-STYLE FACTORS; FAMILIAL
   RESEMBLANCE; CATEGORICAL-DATA; QUEBEC FAMILY; HEALTH-SURVEY; OBESITY;
   OVERWEIGHT; ADIPOSITY
AB Background: Few studies have examined parent-child resemblance in body weight status using nationally representative data for the US.
   Design: We analyzed Body Mass Index (BMI), weight status, and related correlates for 4,846 boys, 4,725 girls, and their parents based on US nationally representative data from the 2006 and 2007 Medical Expenditure Panel Survey (MEPS). Pearson partial correlation coefficients, percent agreement, weighted kappa coefficients, and binary and multinomial logistic regression were used to examine parent-child resemblance, adjusted for complex sampling design.
   Results: Pearson partial correlation coefficients between parent and child's BMI measures were 0.15 for father-son pairs, 0.17 for father-daughter pairs, 0.20 for mother-son pairs, and 0.23 for mother-daughter pairs. The weighted kappa coefficients between BMI quintiles of parent and child ranged from -0.02 to 0.25. Odds ratio analyses found children were 2.1 (95% confidence interval (CI): 1.6, 2.8) times more likely to be obese if only their father was obese, 1.9 (95% CI: 1.5, 2.4) times more likely if only their mother was obese, and 3.2 (95% CI: 2.5, 4.2) times more likely if both parents were obese.
   Conclusions: Parent-child resemblance in BMI appears weak and may vary across parent-child dyad types in the US population. However, parental obesity status is associated with children's obesity status. Use of different measures of parent-child resemblance in body weight status can lead to different conclusions.
C1 [Liu, Yinghui; Chen, Hsin-jen; Wang, Youfa] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Global Ctr Childhood Obes, Baltimore, MD USA.
   [Liu, Yinghui; Chen, Hsin-jen; Wang, Youfa] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, Dept Int Hlth, Baltimore, MD USA.
   [Liang, Lan] Agcy Healthcare Res & Qual, Ctr Financing Access & Cost Trends, Rockville, MD USA.
RP Wang, YF (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Global Ctr Childhood Obes, Baltimore, MD USA.
EM ywang@jhsph.edu
RI Chen, Hsin-Jen/H-8393-2014
OI Chen, Hsin-Jen/0000-0003-4876-634X
FU NIH/NICHD [1R03HD058077-01A1, R03HD058077-01A1S1, 1R01HD064685-01A1]
FX The study was supported by research grants from the NIH/NICHD
   (1R03HD058077-01A1, R03HD058077-01A1S1; 1R01HD064685-01A1). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Basterra-Gortari FJ, 2007, AN SIST SANIT NAVAR, V30, P373, DOI 10.4321/s1137-66272007000500006
   Beydoun MA, 2009, SOC SCI MED, V68, P2137, DOI 10.1016/j.socscimed.2009.03.029
   Bjelland M, 2010, SCAND J PUBLIC HEALT, V38, P19, DOI 10.1177/1403494810385036
   Brown KA, 2008, APPETITE, V50, P252, DOI 10.1016/j.appet.2007.07.010
   Burke V, 2001, INT J OBESITY, V25, P147, DOI 10.1038/sj.ijo.0801538
   Cohen J, 1997, REPORT 1 DESIGN METH
   Cooper R, 2010, AM J CLIN NUTR, V92, P946, DOI 10.3945/ajcn.2010.29477
   CYR L, 1992, COMPUT BIOL MED, V22, P239, DOI 10.1016/0010-4825(92)90063-S
   Davis MM, 2008, J AM BOARD FAM MED, V21, P549, DOI 10.3122/jabfm.2008.06.070140
   Elgar FJ, 2008, CAN J PUBLIC HEALTH, V99, P423
   Peixoto MDG, 2006, REV SAUDE PUBL, V40, P1065, DOI 10.1590/S0034-89102006000700015
   Goodman E, 2000, PEDIATRICS, V106, P52, DOI 10.1542/peds.106.1.52
   Hunt MS, 2002, OBES RES, V10, P507, DOI 10.1038/oby.2002.69
   Jaaskelainen A, 2011, INT J OBESITY, V35, P1289, DOI 10.1038/ijo.2011.150
   Khan Laura Kettel, 2009, Morbidity and Mortality Weekly Report, V58, P1
   KHOURY P, 1983, METABOLISM, V32, P82, DOI 10.1016/0026-0495(83)90161-0
   Kuczmarski Robert J, 2002, Vital Health Stat 11, P1
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lazarou C, 2008, APPETITE, V51, P690, DOI 10.1016/j.appet.2008.06.006
   Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927
   Magnusson PKE, 2002, INT J OBESITY, V26, P1225, DOI 10.1038/sj.ijo.0802041
   Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401
   Pahkala K, 2008, SCAND J MED SCI SPOR
   Perez-Cueto FJA, 2009, NUTR HOSP, V24, P366
   Price RA, 2000, OBES RES, V8, P360, DOI 10.1038/oby.2000.43
   Rebato E, 2005, ANN HUM BIOL, V32, P339, DOI 10.1080/03014460500087857
   Rice T, 1999, GENET EPIDEMIOL, V16, P316
   Robl M, 2008, DEUT MED WOCHENSCHR, V133, P2448, DOI 10.1055/s-0028-1100937
   Rosenkranz Richard R, 2010, Int J Adolesc Med Health, V22, P477
   Scaglioni S, 2008, BRIT J NUTR, V99, pS22, DOI 10.1017/S0007114508892471
   Silventoinen K, 2009, INT J OBES LOND
   Simonen RL, 2002, MED SCI SPORT EXER, V34, P1137, DOI 10.1097/00005768-200207000-00014
   Treuth MS, 2001, AM J CLIN NUTR, V74, P529
   Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007
   Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301
   Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x
   Wolter KM, 2007, INTRO VARIANCE ESTIM, P107
   Wu DM, 2003, EUR J EPIDEMIOL, V18, P221, DOI 10.1023/A:1023337917377
   Xi Bo, 2009, Zhonghua Yufang Yixue Zazhi, V43, P122, DOI 10.3760/cma.j.issn.0253-9624.2009.02.008
NR 39
TC 5
Z9 5
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 10
PY 2013
VL 8
IS 6
AR e65361
DI 10.1371/journal.pone.0065361
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 164VY
UT WOS:000320440500033
PM 23762352
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Sanchez, M
   Bousquet, J
   Le Moual, N
   Jacquemin, B
   Clavel-Chapelon, F
   Humbert, M
   Kauffmann, F
   Tubert-Bitter, P
   Varraso, R
AF Sanchez, Margaux
   Bousquet, Jean
   Le Moual, Nicole
   Jacquemin, Benedicte
   Clavel-Chapelon, Francoise
   Humbert, Marc
   Kauffmann, Francine
   Tubert-Bitter, Pascale
   Varraso, Raphaelle
TI Temporal Asthma Patterns Using Repeated Questionnaires over 13 Years in
   a Large French Cohort of Women
SO PLOS ONE
LA English
DT Article
ID ONSET; E3N; ADULTHOOD; CHILDHOOD; RISK; AGE
AB Variable expression is one aspect of the heterogeneity of asthma. We aimed to define a variable pattern, which is relevant in general health epidemiological cohorts. Our objectives were to assess whether: 1) asthma patterns defined using simple asthma questions through repeated measurements could reflect disease variability 2) these patterns may further be classified according to asthma severity/control. Among 70,428 French women, we used seven questionnaires (1992-2005) and a comprehensive reimbursement database (2004-2009) to define three reliable asthma patterns based on repeated positive answers to the ever asthma attack question: "never asthma'' (n = 64,061); "inconsistent'' ("yes'' followed by "no'', n = 3,514); "consistent'' (fully consistent positive answers, n = 2,853). The "Inconsistent'' pattern was related to both long-term (childhood-onset asthma with remission in adulthood) and short-term (reported asthma attack in the last 12 months, associated with asthma medication) asthma variability, showing that repeated questions are relevant markers of the variable expression of asthma. Furthermore, in this pattern, the number of positive responses (1992-2005) predicted asthma drug consumption in subsequent years, a marker of disease severity. The "Inconsistent'' pattern is a phenotype that may capture the variable expression of asthma. Repeated answers, even to a simple question, are too often neglected.
C1 [Sanchez, Margaux; Bousquet, Jean; Le Moual, Nicole; Jacquemin, Benedicte; Kauffmann, Francine; Varraso, Raphaelle] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Resp & Environm Epidemiol Team, F-94807 Villejuif, France.
   [Sanchez, Margaux; Le Moual, Nicole; Jacquemin, Benedicte; Clavel-Chapelon, Francoise; Kauffmann, Francine; Tubert-Bitter, Pascale; Varraso, Raphaelle] Univ Paris Sud, UMRS1018, F-94807 Villejuif, France.
   [Bousquet, Jean] Univ Hosp, Dept Resp Dis, Hop Arnaud Villeneuve, Montpellier, France.
   [Jacquemin, Benedicte] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain.
   [Clavel-Chapelon, Francoise] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Nutr Hormones & Womens Hlth Team, F-94807 Villejuif, France.
   [Humbert, Marc] Hop Bicetre, Assistance Publ Ho Paris, DHU Thorax Innovat Serv Pneumol & Reanimat Respir, Le Kremlin Bicetre, France.
   [Humbert, Marc] Ctr Chirurg Marie Lannelongue, INSERM U999, LabEX LERMIT, F-92350 Le Plessis Robinson, France.
   [Humbert, Marc] Univ Paris Sud, Fac Med, F-94276 Le Kremlin Bicetre, France.
   [Tubert-Bitter, Pascale] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Biostat Team, F-94807 Villejuif, France.
RP Sanchez, M (reprint author), INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Resp & Environm Epidemiol Team, F-94807 Villejuif, France.
EM margaux.sanchez@inserm.fr
RI Varraso, Raphaelle/R-8740-2016; Clavel-Chapelon, Francoise/G-6733-2014;
   Tubert-Bitter, Pascale/E-6118-2016; Jacquemin, Benedicte/D-8948-2018;
   LeMoual, Nicole/R-8976-2016; Bousquet, Jean/O-4221-2019
OI Varraso, Raphaelle/0000-0002-3338-7825; Jacquemin,
   Benedicte/0000-0003-1273-9892; LeMoual, Nicole/0000-0002-2723-5569;
   Humbert, Marc/0000-0003-0703-2892; /0000-0002-1923-6393
FU Mutuelle Generale de l'Education Nationale (MGEN); European Community;
   French League against Cancer (LNCC); Gustave Roussy Institute (IGR);
   National Institute for Health and Medical Research (Inserm); General
   Councils of France; Fonds de dotation "Recherche en Sante Respiratoire''
FX The E3N study is supported by the Mutuelle Generale de l'Education
   Nationale (MGEN), the European Community, the French League against
   Cancer (LNCC), the Gustave Roussy Institute (IGR), the National
   Institute for Health and Medical Research (Inserm) and General Councils
   of France. The specific respiratory health survey in the E3N study was
   supported by the Fonds de dotation "Recherche en Sante Respiratoire''.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Ballardini N, 2012, ALLERGY, V67, P537, DOI 10.1111/j.1398-9995.2012.02786.x
   Brille D, 1971, COMMENTAIRES RELATIF
   Burgess JA, 2006, J ASTHMA, V43, P727, DOI 10.1080/02770900601028587
   Clavel-Chapelon F, 1997, EUR J CANCER PREV, V6, P473
   FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1
   Frey U, 2005, NATURE, V438, P667, DOI 10.1038/nature04176
   Janson C, 2001, EUR RESPIR J, V18, P598, DOI 10.1183/09031936.01.00205801
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   OSBORNE ML, 1995, J CLIN EPIDEMIOL, V48, P1393, DOI 10.1016/0895-4356(95)00065-8
   Pattaro C, 2007, J CLIN EPIDEMIOL, V60, P704, DOI 10.1016/j.jclinepi.2006.10.010
   Romieu I, 2010, THORAX, V65, P292, DOI 10.1136/thx.2009.116079
   Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363
   Suissa S, 2002, THORAX, V57, P880, DOI 10.1136/thorax.57.10.880
   TOREN K, 1993, CHEST, V104, P600, DOI 10.1378/chest.104.2.600
   Toren K, 2006, J CLIN EPIDEMIOL, V59, P90, DOI 10.1016/j.jclinepi.2005.03.019
   Varraso R, 2009, EUR RESPIR J, V33, P33, DOI 10.1183/09031936.00130807
   Varraso R, 2012, EUR RESPIR J, V39, P67, DOI 10.1183/09031936.00115010
   Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678
   WHO Collaborating Centre for Drug Statistics Methodology, 2011, GUID ATC CLASS DDD A
NR 19
TC 9
Z9 9
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 31
PY 2013
VL 8
IS 5
AR e65090
DI 10.1371/journal.pone.0065090
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 156DC
UT WOS:000319799900179
PM 23741466
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Luth, W
   Jardine, C
   Bubela, T
AF Luth, Westerly
   Jardine, Cindy
   Bubela, Tania
TI When Pictures Waste a Thousand Words: Analysis of the 2009 H1N1 Pandemic
   on Television News
SO PLOS ONE
LA English
DT Article
ID VACCINATION; MEDIA; RISK; PERCEPTION; ATTENTION; ATTITUDES; COVERAGE;
   CHILDREN; PROGRAM; ADULTS
AB Objectives: Effective communication by public health agencies during a pandemic promotes the adoption of recommended health behaviours. However, more information is not always the solution. Rather, attention must be paid to how information is communicated. Our study examines the television news, which combines video and audio content. We analyse (1) the content of television news about the H1N1 pandemic and vaccination campaign in Alberta, Canada; (2) the extent to which television news content conveyed key public health agency messages; (3) the extent of discrepancies in audio versus visual content.
   Methods: We searched for "swine flu'' and "H1N1'' in local English news broadcasts from the CTV online video archive. We coded the audio and visual content of 47 news clips during the peak period of coverage from April to November 2009 and identified discrepancies between audio and visual content.
   Results: The dominant themes on CTV news were the vaccination rollout, vaccine shortages, long line-ups (queues) at vaccination clinics and defensive responses by public health officials. There were discrepancies in the priority groups identified by the provincial health agency (Alberta Health and Wellness) and television news coverage as well as discrepancies between audio and visual content of news clips. Public health officials were presented in official settings rather than as public health practitioners.
   Conclusion: The news footage did not match the main public health messages about risk levels and priority groups. Public health agencies lost control of their message as the media focused on failures in the rollout of the vaccination campaign. Spokespeople can enhance their local credibility by emphasizing their role as public health practitioners. Public health agencies need to learn from the H1N1 pandemic so that future television communications do not add to public confusion, demonstrate bureaucratic ineffectiveness and contribute to low vaccination rates.
C1 [Luth, Westerly; Bubela, Tania] Univ Alberta, Sch Publ Hlth, Dept Publ Hlth Sci, Edmonton, AB, Canada.
   [Jardine, Cindy] Univ Alberta, Sch Publ Hlth, Ctr Hlth Promot Studies, Edmonton, AB, Canada.
RP Bubela, T (reprint author), Univ Alberta, Sch Publ Hlth, Dept Publ Hlth Sci, Edmonton, AB, Canada.
EM tbubela@ualberta.ca
RI Bubela, Tania/F-4860-2014
OI Bubela, Tania/0000-0002-0807-2899
FU Operating Grant on Health Systems Research on H1N1 (Institute for
   Population and Public Health) from the Canadian Institutes of Health
   Research (CIHR) [RES0008252]; Frederick Banting & Charles Best CIHR
   Master's Award [GSM-123188]
FX This study was supported by an Operating Grant on Health Systems
   Research on H1N1 (Institute for Population and Public Health) (Project
   No. RES0008252) from the Canadian Institutes of Health Research (CIHR).
   Westerly Luth is supported by a Frederick Banting & Charles Best CIHR
   Master's Award (Funding reference number: GSM-123188). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Alberta Health and Wellness, 2008, INFL SELF CAR CAR PR
   Alberta Health and Wellness, 2009, ALB PLAN PAND INFL
   Alberta Health and Wellness Alberta Health Services, 2010, PAND H1N1 2009 ALB E
   Barrett MS, 2005, COMMUN Q, V6, P59
   Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107
   Brase GL, 2004, J APPL SOC PSYCHOL, V34, P2469, DOI 10.1111/j.1559-1816.2004.tb01987.x
   BRAUN CC, 1995, ERGONOMICS, V38, P2207, DOI 10.1080/00140139508925263
   Brown KF, 2010, VACCINE, V28, P4181, DOI 10.1016/j.vaccine.2010.04.012
   Bubela T, 2009, NAT BIOTECHNOL, V27, P514, DOI 10.1038/nbt0609-514
   Cappella JN, 1996, ANN AM ACAD POLIT SS, V546, P71, DOI 10.1177/0002716296546001007
   Carducci A, 2011, PATIENT EDUC COUNS, V82, P475, DOI 10.1016/j.pec.2010.12.025
   Charmaz Kathy., 2006, CONSTRUCTING GROUNDE
   Chen N.-T. N., 2011, INT PUBLIC HLTH J, V3, P45
   Covello V. T., 1992, COMMUNICATION YB, V15, P359, DOI DOI 10.1080/23808985.1992.11678816
   CSA Standards, 2010, VIUC H1N1 INFL PAND
   Driedger SM, 2007, RISK ANAL, V27, P775, DOI 10.1111/j.1539-6924.2007.00922.x
   Fogarty AS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-181
   Gallup, 2011, REC  64 RAT HON ETH
   Hawkins RP, 2005, HUM COMMUN RES, V31, P162, DOI 10.1093/hcr/31.1.162
   Health Quality Council of Alberta, 2010, REV ALB RESP 2009 IN
   Henrich N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018479
   Henrich N, 2011, HEALTH PROMOT PRACT, V12, P610, DOI 10.1177/1524839910363536
   Hidiroglu S, 2010, VACCINE, V28, P8120, DOI 10.1016/j.vaccine.2010.09.104
   Higgins JW, 2006, J HEALTH COMMUN, V11, P343, DOI 10.1080/10810730600614110
   Hilton S, 2011, J EPIDEMIOL COMMUN H, V65, P941, DOI 10.1136/jech.2010.119875
   Ipsos, 2012, WHAT DO PHARM DOCT S
   Ipsos MORI, 2011, DOCT MOST TRUST
   Landau J, 2009, PUBLIC UNDERST SCI, V18, P325, DOI 10.1177/0963662507080551
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lefevere J, 2011, COMMUN RES, V39, P104
   Linc Group Corp, 2009, ACT REV ALB HLTH WEL
   Lynch MM, 2011, MATERN CHILD HLTH J, DOI [10.1007/s10995-011-0865-y, DOI 10.1007/S10995-011-0865-Y]
   Maurer J, 2010, PREV MED, V51, P185, DOI 10.1016/j.ypmed.2010.05.008
   Mayo Ann M, 2004, J Am Acad Nurse Pract, V16, P402, DOI 10.1111/j.1745-7599.2004.tb00390.x
   McHugh ML, 2012, BIOCHEM MEDICA, V22, P276
   Nisbet MC, 2007, SCIENTIST, V21, P38
   Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011292
   Ofri D, 2009, NEW ENGL J MED, V361, P2594, DOI 10.1056/NEJMp0911047
   Pew Research Center for the People and the Press, 2009, FEW HALF WOULD GET V
   QSR International, 2011, NVIVO 9
   Rachiotis G, 2010, EURO SURVEILL, V15
   Rachul CM, 2011, CAN J PUBLIC HEALTH, V102, P200
   Reader's Digest Australia, 2010, AUSTR MOST TRUST
   Rogers WA, 2009, HEALTH EXPECT, V12, P331, DOI 10.1111/j.1369-7625.2009.00562.x
   Schmitt KL, 2003, J COMMUN, V53, P265, DOI 10.1111/j.1460-2466.2003.tb02590.x
   Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99
   Shih TJ, 2008, MASS COMMUN SOC, V11, P141, DOI 10.1080/15205430701668121
   Siegrist M, 2005, J RISK RES, V8, P145, DOI 10.1080/1366987032000105315
   Statistics Canada, 2012, POP DWELL COUNTS CAN
   Statistics Canada, 2010, DAIL CAN COMM HLTH S
   To KW, 2010, AM J INFECT CONTROL, V38, P623, DOI 10.1016/j.ajic.2010.05.015
   Walter D, 2012, EUROSURVEILLANCE, V17, P9
   World Health Organization, 2009, WHO PAND PHAS DESCR
   World Health Organization, 2009, WHAT IS PHAS 6
NR 54
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 17
PY 2013
VL 8
IS 5
AR e64070
DI 10.1371/journal.pone.0064070
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 146RJ
UT WOS:000319107900077
PM 23691150
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Setterfield, SA
   Rossiter-Rachor, NA
   Douglas, MM
   Wainger, L
   Petty, AM
   Barrow, P
   Shepherd, IJ
   Ferdinands, KB
AF Setterfield, Samantha A.
   Rossiter-Rachor, Natalie A.
   Douglas, Michael M.
   Wainger, Lisa
   Petty, Aaron M.
   Barrow, Piers
   Shepherd, Ian J.
   Ferdinands, Keith B.
TI Adding Fuel to the Fire: The Impacts of Non-Native Grass Invasion on
   Fire Management at a Regional Scale
SO PLOS ONE
LA English
DT Article
ID GAYANUS GAMBA GRASS; NORTHERN AUSTRALIA; TROPICAL SAVANNAS; BIOLOGICAL
   INVASIONS; AGREEMENT; DYNAMICS; BEHAVIOR; PLANTS; CYCLE
AB Background: Widespread invasion by non-native plants has resulted in substantial change in fire-fuel characteristics and fire-behaviour in many of the world's ecosystems, with a subsequent increase in the risk of fire damage to human life, property and the environment. Models used by fire management agencies to assess fire risk are dependent on accurate assessments of fuel characteristics but there is little evidence that they have been modified to reflect landscape-scale invasions. There is also a paucity of information documenting other changes in fire management activities that have occurred to mitigate changed fire regimes. This represents an important limitation in information for both fire and weed risk management.
   Methodology/Principal Findings: We undertook an aerial survey to estimate changes to landscape fuel loads in northern Australia resulting from invasion by Andropogon gayanus (gamba grass). Fuel load within the most densely invaded area had increased from 6 to 10 t ha(-1) in the past two decades. Assessment of the effect of calculating the Grassland Fire Danger Index (GFDI) for the 2008 and 2009 fire seasons demonstrated that an increase from 6 to 10 t ha(-1) resulted in an increase from five to 38 days with fire risk in the 'severe' category in 2008 and from 11 to 67 days in 2009. The season of severe fire weather increased by six weeks. Our assessment of the effect of increased fuel load on fire management practices showed that fire management costs in the region have increased markedly (similar to 9 times) in the past decade due primarily to A. gayanus invasion.
   Conclusions/Significance: This study demonstrated the high economic cost of mitigating fire impacts of an invasive grass. This study demonstrates the need to quantify direct and indirect invasion costs to assess the risk of further invasion and to appropriately fund fire and weed management strategies.
C1 [Setterfield, Samantha A.; Rossiter-Rachor, Natalie A.; Douglas, Michael M.; Petty, Aaron M.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia.
   [Wainger, Lisa] Univ Maryland, Ctr Environm Sci, Solomons, MD USA.
   [Barrow, Piers; Ferdinands, Keith B.] Northern Terr Dept Land Resource Management, Weed Management Branch, Darwin, NT, Australia.
   [Shepherd, Ian J.] Australian Bur Meteorol, Casuarina, NT, Australia.
RP Setterfield, SA (reprint author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia.
EM samantha.setterfield@cdu.edu.au
RI Douglas, Michael/I-3149-2012
OI Douglas, Michael/0000-0003-3650-3374; Wainger, Lisa/0000-0002-3983-8850
FU Land and Water Australia [PN22423]; Commonwealth Environmental Research
   Fund; Australian Weeds Research Centre [AWRC08-10]
FX Funding was provided by Land and Water Australia (Project PN22423), the
   Commonwealth Environmental Research Fund and the Australian Weeds
   Research Centre (AWRC08-10). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Andersen AN, 2005, AUSTRAL ECOL, V30, P155, DOI 10.1111/j.1442-9993.2005.01441.x
   Andison R, 1990, DARWIN
   [Anonymous], 2008, NO REGIONAL MANAGEME
   [Anonymous], 2009, LISTING ADVICE KEY T
   Australian Emergency Management Committee (AEMC) National Bushfires Warnings Taskforce, 2009, RESP75000010001 VICT
   Balch Jennifer K., 2009, P481, DOI 10.1007/978-3-540-77381-8_17
   Barrow P, 1995, ECOLOGY MANAGEMENT G
   Bowman DMJS, 2011, J BIOGEOGR, V38, P2223, DOI 10.1111/j.1365-2699.2011.02595.x
   Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886
   BOWMAN DMJS, 1988, J BIOGEOGR, V15, P807, DOI 10.2307/2845341
   Brooks KJ, 2010, RESTOR ECOL, V18, P188, DOI 10.1111/j.1526-100X.2008.00470.x
   Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2
   Bureau of Meteorology, 2010, FIRE WEATHER WARNING
   CHENEY NP, 1993, INT J WILDLAND FIRE, V3, P31, DOI 10.1071/WF9930031
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Cook GD, 2003, ECOL STU AN, V169, P47
   D'Antonio Carla M., 2009, V5, P123
   D'Antonio CM, 2004, FRONT ECOL ENVIRON, V2, P513
   DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431
   Ehrenfeld JG, 2010, ANNU REV ECOL EVOL S, V41, P59, DOI 10.1146/annurev-ecolsys-102209-144650
   Erdody TL, 2010, REMOTE SENS ENVIRON, V114, P725, DOI 10.1016/j.rse.2009.11.002
   Flores TA, 2005, AUST J BOT, V53, P243, DOI 10.1071/BT03154
   Foxcroft LC, 2010, BIOL INVASIONS, V12, P3913, DOI 10.1007/s10530-010-9823-7
   Garden G, 2006, SIMPLE METHODS CALCU
   Gill AM, 2010, INT J WILDLAND FIRE, V19, P338, DOI 10.1071/WF09023
   Hulme PE, 2012, J APPL ECOL, V49, P10, DOI 10.1111/j.1365-2664.2011.02069.x
   Hutley L. B., 2008, ENCY ECOLOGY, P3143, DOI DOI 10.1016/B978-008045405-4.00358-X
   Kean L, 2003, BIOLOGY, V8, P1
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lippincott CL, 2000, NAT AREA J, V20, P140
   Luke R. H., 1978, BUSHFIRES AUSTR
   Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x
   McArthur A. G., 1973, GRASSLAND FIRE DANGE
   McNaught I., 2006, FIELD MANUAL SURVEYI
   Northern Territory Government, 2009, WEEK RISK ASS REP AN
   Northern Territory Government, 2010, BUSHF NT STAND OP PR
   ORAM R, 1987, J AUST I AGR SCI, V53, P123
   Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016
   Petty AM, 2012, J APPL ECOL, V49, P742, DOI 10.1111/j.1365-2664.2012.02128.x
   Price O, 2003, NATURAL RESOURCE STR
   Purton C, 1982, EQUATIONS MCARTHUR M
   Rossiter NA, 2003, DIVERS DISTRIB, V9, P169, DOI 10.1046/j.1472-4642.2003.00020.x
   Rossiter-Rachor NA, 2009, ECOL APPL, V19, P1546, DOI 10.1890/08-0265.1
   Russell-Smith J, 2003, ECOL MONOGR, V73, P349, DOI 10.1890/01-4021
   Setterfield SA, 2010, DIVERS DISTRIB, V16, P854, DOI 10.1111/j.1472-4642.2010.00688.x
   Varga TA, 2008, ECOL APPL, V18, P613, DOI 10.1890/07-1280.1
   Whitehead PJ, 2008, PUBLIC ADMIN DEVELOP, V28, P374, DOI 10.1002/pad.512
   Williams Richard J., 2002, P281
   Williams RJ, 2003, ECOL STU AN, V169, P33
   Woinarski J, 2007, NATURE OF NORTHERN AUSTRALIA: NATURAL VALUES, ECOLOGICAL PROCESSES AND FUTURE PROSPECTS, P1
NR 50
TC 28
Z9 30
U1 1
U2 70
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 14
PY 2013
VL 8
IS 5
AR e59144
DI 10.1371/journal.pone.0059144
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 146RE
UT WOS:000319107400003
PM 23690917
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Werner, MU
   Petersen, KL
   Rowbotham, MC
   Dahl, JB
AF Werner, Mads U.
   Petersen, Karin L.
   Rowbotham, Michael C.
   Dahl, Jorgen B.
TI Healthy Volunteers Can Be Phenotyped Using Cutaneous Sensitization Pain
   Models
SO PLOS ONE
LA English
DT Article
ID HEAT-CAPSAICIN SENSITIZATION; ACUTE INFLAMMATORY PAIN; HYPERALGESIA;
   GABAPENTIN; ANALGESIA; AGREEMENT; MORPHINE; TWIN
AB Background: Human experimental pain models leading to development of secondary hyperalgesia are used to estimate efficacy of analgesics and antihyperalgesics. The ability to develop an area of secondary hyperalgesia varies substantially between subjects, but little is known about the agreement following repeated measurements. The aim of this study was to determine if the areas of secondary hyperalgesia were consistently robust to be useful for phenotyping subjects, based on their pattern of sensitization by the heat pain models.
   Methods: We performed post-hoc analyses of 10 completed healthy volunteer studies (n = 342 [409 repeated measurements]). Three different models were used to induce secondary hyperalgesia to monofilament stimulation: the heat/capsaicin sensitization (H/C), the brief thermal sensitization (BTS), and the burn injury (BI) models. Three studies included both the H/C and BTS models.
   Results: Within-subject compared to between-subject variability was low, and there was substantial strength of agreement between repeated induction-sessions in most studies. The intraclass correlation coefficient (ICC) improved little with repeated testing beyond two sessions. There was good agreement in categorizing subjects into 'small area' (1st quartile [<25%]) and 'large area' (4th quartile [>75%]) responders: 56-76% of subjects consistently fell into same 'small-area' or 'large-area' category on two consecutive study days. There was moderate to substantial agreement between the areas of secondary hyperalgesia induced on the same day using the H/C (forearm) and BTS (thigh) models.
   Conclusion: Secondary hyperalgesia induced by experimental heat pain models seem a consistent measure of sensitization in pharmacodynamic and physiological research. The analysis indicates that healthy volunteers can be phenotyped based on their pattern of sensitization by the heat [and heat plus capsaicin] pain models.
C1 [Werner, Mads U.] Copenhagen Univ Hosp, Rigshosp, Ctr Multidisciplinary Pain, Neurosci Ctr, Copenhagen, Denmark.
   [Petersen, Karin L.; Rowbotham, Michael C.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA.
   [Dahl, Jorgen B.] Rigshosp, Copenhagen Univ Hosp, Ctr Head & Orthopaed, Dept Anaesthesia, DK-2100 Copenhagen, Denmark.
RP Werner, MU (reprint author), Copenhagen Univ Hosp, Rigshosp, Ctr Multidisciplinary Pain, Neurosci Ctr, Copenhagen, Denmark.
EM mads.u.werner@gmail.com
OI Werner, Mads/0000-0003-1540-8845
FU Schwab Gift Fund at University of California, San Francisco (UCSF);
   Neuropathic Pain Research Gift Fund at California Pacific Medical Center
   Research Institute (CPMCRI)
FX Support was provided from institutional and departmental sources at
   Copenhagen University Hospital, from the Schwab Gift Fund at University
   of California, San Francisco (UCSF), and the Neuropathic Pain Research
   Gift Fund at California Pacific Medical Center Research Institute
   (CPMCRI). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Angst MS, 2012, PAIN, V153, P1397, DOI 10.1016/j.pain.2012.02.022
   Armitage P, 2002, STAT METHODS MED RES, P648
   Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204
   Dirks J, 2000, ANESTH ANALG, V91, P967, DOI 10.1097/00000539-200010000-00037
   Dirks J, 2003, J PAIN, V4, P122, DOI 10.1054/jpai.2003.10
   Dirks J, 2002, ANESTHESIOLOGY, V97, P102, DOI 10.1097/00000542-200207000-00015
   Dirks J, 2001, REGION ANESTH PAIN M, V26, P414, DOI 10.1053/rapm.2001.22256
   Frymoyer AR, 2007, J PAIN, V8, P19, DOI 10.1016/j.jpain.2006.05.010
   Geber C, 2011, PAIN, V152, P548, DOI 10.1016/j.pain.2010.11.013
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Martinez V, 2012, PAIN, V153, P1478, DOI 10.1016/j.pain.2012.04.004
   Mikkelsen S, 2001, BRIT J ANAESTH, V86, P871, DOI 10.1093/bja/86.6.871
   Norbury TA, 2007, BRAIN, V130, P3041, DOI 10.1093/brain/awm233
   Pedersen JL, 1998, PAIN, V74, P139, DOI 10.1016/S0304-3959(97)00160-7
   Petersen KL, 2008, PAIN, V137, P395, DOI 10.1016/j.pain.2007.09.019
   Petersen KL, 2001, ANESTHESIOLOGY, V94, P15, DOI 10.1097/00000542-200101000-00008
   Pfau DB, 2011, PAIN, V152, P1532, DOI 10.1016/j.pain.2011.02.037
   Ravn Pernille, 2012, J Pain Res, V5, P313, DOI 10.2147/JPR.S33925
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Werner MU, 2004, ANESTHESIOLOGY, V100, P115, DOI 10.1097/00000542-200401000-00020
   Werner MU, REG ANESTH PAIN MED, V26, P322
   Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030
NR 22
TC 23
Z9 23
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 9
PY 2013
VL 8
IS 5
AR e62733
DI 10.1371/journal.pone.0062733
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 155HD
UT WOS:000319737700020
PM 23671631
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lobsien, D
   Dreyer, AY
   Stroh, A
   Boltze, J
   Hoffmann, KT
AF Lobsien, Donald
   Dreyer, Antje Y.
   Stroh, Albrecht
   Boltze, Johannes
   Hoffmann, Karl-Titus
TI Imaging of VSOP Labeled Stem Cells in Agarose Phantoms with
   Susceptibility Weighted and T2*Weighted MR Imaging
SO PLOS ONE
LA English
DT Article
ID IRON-OXIDE PARTICLES; IN-VIVO; CLINICAL-APPLICATIONS; ISCHEMIC-STROKE;
   BRAIN; TRACKING; NANOPARTICLES; RAT; GUIDELINES; MANAGEMENT
AB Objective: This study aimed to evaluate the detectability of stem cells labeled with very small iron oxide particles (VSOP) at 3T with susceptibility weighted (SWI) and T2* weighted imaging as a methodological basis for subsequent examinations in a large animal stroke model (sheep).
   Materials and Methods: We examined ovine mesenchymal stem cells labeled with VSOP in agarose layer phantoms. The experiments were performed in 2 different groups, with quantities of 0-100,000 labeled cells per layer. 15 different SWI-and T2*-weighted sequences and 3 RF coils were used. All measurements were carried out on a clinical 3T MRI. Images of Group A were analyzed by four radiologists blinded for the number of cells, and rated for detectability according to a four-step scale. Images of Group B were subject to a ROI-based analysis of signal intensities. Signal deviations of more than the 0.95 confidence interval in cell containing layers as compared to the mean of the signal intensity of non cell bearing layers were considered significant.
   Results: Group A: 500 or more labeled cells were judged as confidently visible when examined with a SWI-sequence with 0.15 mm slice thickness. Group B: 500 or more labeled cells showed a significant signal reduction in SWI sequences with a slice thickness of 0.25 mm. Slice thickness and cell number per layer had a significant influence on the amount of detected signal reduction.
   Conclusion: 500 VSOP labeled stem cells could be detected with SWI imaging at 3 Tesla using an experimental design suitable for large animal models.
C1 [Lobsien, Donald; Hoffmann, Karl-Titus] Univ Hosp Leipzig, Dept Neuroradiol, Leipzig, Germany.
   [Dreyer, Antje Y.; Boltze, Johannes] Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany.
   [Dreyer, Antje Y.; Boltze, Johannes] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany.
   [Stroh, Albrecht] Johannes Gutenberg Univ Mainz, Res Grp Mol Imaging & Optogenet, Inst Microscop Anat & Neurobiol, Focus Program Translat Neurosci, D-55122 Mainz, Germany.
   [Boltze, Johannes] Massachusetts Gen Hosp, Charlestown, MA USA.
   [Boltze, Johannes] Harvard Univ, Sch Med, Ctr Neurosci, Charlestown, MA USA.
RP Lobsien, D (reprint author), Univ Hosp Leipzig, Dept Neuroradiol, Leipzig, Germany.
EM donald.lobsien@medizin.uni-leipzig.de
CR Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486
   Berman SMC, 2011, WIRES NANOMED NANOBI, V3, P343, DOI 10.1002/wnan.140
   Boltze J, 2008, J CEREBR BLOOD F MET, V28, P1951, DOI 10.1038/jcbfm.2008.89
   Burns TC, 2011, EXPERT OPIN BIOL TH, V11, P447, DOI 10.1517/14712598.2011.552883
   Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038
   Carpenter CR, 2011, J EMERG MED, V40, P82, DOI 10.1016/j.jemermed.2010.05.009
   Chavhan GB, 2009, RADIOGRAPHICS, V29, P1433, DOI 10.1148/rg.295095034
   Chen CL, 2011, MOL IMAGING BIOL, V13, P825, DOI 10.1007/s11307-010-0430-x
   Daadi MM, 2012, CELL TRANSPLANT
   Dai YM, 2011, J MAGN RESON IMAGING, V34, P318, DOI 10.1002/jmri.22607
   Deistung A, 2006, Z MED PHYS, V16, P261, DOI 10.1078/0939-3889-00324
   Denic A, 2011, NEUROTHERAPEUTICS, V8, P3, DOI 10.1007/s13311-010-0002-4
   Dreyer A, 2012, ADV PRECLINICAL STUD, P21
   Eibofner F, 2010, MAGN RESON MED, V64, P1027, DOI 10.1002/mrm.22498
   England T, 2009, INT J STROKE, V4, P101, DOI 10.1111/j.1747-4949.2009.00253.x
   Fleige G, 2002, INVEST RADIOL, V37, P482, DOI 10.1097/00004424-200209000-00002
   Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400
   Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083
   Heymer A, 2008, BIOMATERIALS, V29, P1473, DOI 10.1016/j.biomaterials.2007.12.003
   Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499
   Jendelova P, 2003, MAGNET RESON MED, V50, P767, DOI 10.1002/mrm.10585
   Kalladka D, 2011, NEUROCHEM INT, V59, P367, DOI 10.1016/j.neuint.2011.03.016
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5
   Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6
   Liu W, 2009, EUR J RADIOL, V70, P258, DOI 10.1016/j.ejrad.2008.09.021
   Liu YP, 2009, ACTA NEUROPATHOL, V117, P469, DOI 10.1007/s00401-009-0516-1
   Magnitsky S, 2005, NEUROIMAGE, V26, P744, DOI 10.1016/j.neuroimage.2005.02.029
   Mahmoudi M, 2011, CHEM REV, V111, P253, DOI 10.1021/cr1001832
   Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461
   Pillai DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016091
   Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404
   Stroh A, 2005, NEUROIMAGE, V24, P635, DOI 10.1016/j.neuroimage.2004.09.014
   Stroh A, 2004, FREE RADICAL BIO MED, V36, P976, DOI 10.1016/j.freeradbiomed.2004.01.016
   Stroh A, 2006, NEUROIMAGE, V33, P886, DOI 10.1016/j.neuroimage.2006.07.009
   Takahashi M, 2003, EUR J RADIOL, V46, P45, DOI 10.1016/S0720-048X(02)00331-5
   Taupitz M, 2000, J MAGN RESON IMAGING, V12, P905, DOI 10.1002/1522-2586(200012)12:6<905::AID-JMRI14>3.0.CO;2-5
   The STEPS Participants, 2008, STROKE, V40, P510
   Weissleder R, 1997, J MAGN RESON IMAGING, V7, P258, DOI 10.1002/jmri.1880070140
   Wu SY, 2010, CYTOTHERAPY, V12, P859, DOI 10.3109/14653241003587652
NR 40
TC 8
Z9 8
U1 0
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 8
PY 2013
VL 8
IS 5
AR e62644
DI 10.1371/journal.pone.0062644
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 145YI
UT WOS:000319055600037
PM 23667503
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Khazaei, H
   Street, K
   Bari, A
   Mackay, M
   Stoddard, FL
AF Khazaei, Hamid
   Street, Kenneth
   Bari, Abdallah
   Mackay, Michael
   Stoddard, Frederick L.
TI The FIGS (Focused Identification of Germplasm Strategy) Approach
   Identifies Traits Related to Drought Adaptation in Vicia faba Genetic
   Resources
SO PLOS ONE
LA English
DT Article
ID WATER-USE EFFICIENCY; CORE COLLECTION; RANDOM FORESTS; PREDICTIVE
   ASSOCIATION; ARABIDOPSIS-THALIANA; SAMPLING STRATEGY; BARLEY LANDRACES;
   WHEAT; RESISTANCE; CLASSIFICATION
AB Efficient methods to explore plant agro-biodiversity for climate change adaptive traits are urgently required. The focused identification of germplasm strategy (FIGS) is one such approach. FIGS works on the premise that germplasm is likely to reflect the selection pressures of the environment in which it developed. Environmental parameters describing plant germplasm collection sites are used as selection criteria to improve the probability of uncovering useful variation. This study was designed to test the effectiveness of FIGS to search a large faba bean (Vicia faba L.) collection for traits related to drought adaptation. Two sets of faba bean accessions were created, one from moisture-limited environments, and the other from wetter sites. The two sets were grown under well watered conditions and leaf morpho-physiological traits related to plant water use were measured. Machine-learning algorithms split the accessions into two groups based on the evaluation data and the groups created by this process were compared to the original climate-based FIGS sets. The sets defined by trait data were in almost perfect agreement to the FIGS sets, demonstrating that ecotypic differentiation driven by moisture availability has occurred within the faba bean genepool. Leaflet and canopy temperature as well as relative water content contributed more than other traits to the discrimination between sets, indicating that their utility as drought-tolerance selection criteria for faba bean germplasm. This study supports the assertion that FIGS could be an effective tool to enhance the discovery of new genes for abiotic stress adaptation.
C1 [Khazaei, Hamid; Stoddard, Frederick L.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland.
   [Street, Kenneth; Bari, Abdallah] Int Ctr Agr Res Dry Areas, Aleppo, Syria.
   [Mackay, Michael] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia.
RP Khazaei, H (reprint author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.
EM hamid.khazaei@helsinki.fi
RI Stoddard, Fred/E-6436-2015; Khazaei, Hamid/E-8195-2018
OI Stoddard, Fred/0000-0002-8097-5750; Khazaei, Hamid/0000-0002-5202-8764
FU CIMO (Centre for International Mobility); Emil Aaltonen Foundation (Emil
   Aaltosen Saatio) fellowship; University of Helsinki and Legume Futures
   [KBBE 2009-1-2-01, 245216]
FX HK was supported by CIMO (Centre for International Mobility) and is
   currently supported by Emil Aaltonen Foundation (Emil Aaltosen Saatio)
   fellowship. The project was also supported by the University of Helsinki
   and Legume Futures (KBBE 2009-1-2-01, contract 245216 CP-FP 'Legume
   Futures: Legume supported cropping systems for Europe'). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR [Anonymous], 2010, 2 FAO
   Avola G, 2008, J PLANT PHYSIOL, V165, P796, DOI 10.1016/j.jplph.2007.09.004
   Bari A, 2012, GENET RESOUR CROP EV, V59, P1465, DOI 10.1007/s10722-011-9775-5
   Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x
   BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413
   Bartish GI, 2000, AGR FOOD SCI FINLAND, V9, P279, DOI 10.23986/afsci.5669
   Bhullar NK, 2009, P NATL ACAD SCI USA, V106, P9519, DOI 10.1073/pnas.0904152106
   Blum A, 2011, PLANT BREEDING FOR WATER-LIMITED ENVIRONMENTS, P1, DOI 10.1007/978-1-4419-7491-4
   Blum A, 2009, FIELD CROP RES, V112, P119, DOI 10.1016/j.fcr.2009.03.009
   Blum A, 2011, FUNCT PLANT BIOL, V38, P753, DOI 10.1071/FP11101
   Bouchabke O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001705
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Brown A. H. D., 1989, The use of plant genetic resources., P136
   Brown A. H. D., 1999, Core collections for today and tomorrow., P1
   BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144
   CASLER MD, 1995, CROP SCI, V35, P1169, DOI 10.2135/cropsci1995.0011183X003500040043x
   Crepon K, 2010, FIELD CROP RES, V115, P329, DOI 10.1016/j.fcr.2009.09.016
   CUBERO JI, 1974, THEOR APPL GENET, V45, P47, DOI 10.1007/BF00283475
   Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1
   Dimitriadou E, 2010, R LIB E1071
   Drake JM, 2006, J APPL ECOL, V43, P424, DOI 10.1111/j.1365-2664.2006.01141.x
   Duc G, 1997, FIELD CROP RES, V53, P99, DOI 10.1016/S0378-4290(97)00025-7
   Duc G, 2011, CROP ADAPTATION TO CLIMATE CHANGE, P269
   Dwivedi SL, 2008, PLANT BREED REV, V30, P180
   El Bouhssini M, 2011, PLANT BREEDING, V130, P96, DOI 10.1111/j.1439-0523.2010.01814.x
   El Bouhssini M, 2009, GENET RESOUR CROP EV, V56, P1065, DOI 10.1007/s10722-009-9427-1
   Endresen DTF, 2011, CROP SCI, V51, P2036, DOI 10.2135/cropsci2010.12.0717
   Endresen DTF, 2010, CROP SCI, V50, P2418, DOI 10.2135/cropsci2010.03.0174
   EPPERSON BK, 1990, GENETICS, V124, P757
   Fan JW, 2012, CROP SCI, V52, P2341, DOI 10.2135/cropsci2011.11.0603
   Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010
   Field C. B., 2012, MANAGING RISKS EXTRE
   Fischer RA, 1998, CROP SCI, V38, P1467, DOI 10.2135/cropsci1998.0011183X003800060011x
   Frankel O. H., 1984, Genetic manipulation: impact on man and society., P161
   Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015
   Fu YB, 2005, THEOR APPL GENET, V111, P530, DOI 10.1007/s00122-005-2044-2
   Furman Bonnie J., 2006, Plant Genetic Resources Characterization and Utilization, V4, P2, DOI 10.1079/PGR200599
   Gepts P, 2006, CROP SCI, V46, P2278, DOI 10.2135/cropsci2006.03.0169gas
   Gollin D, 2000, AM J AGR ECON, V82, P812, DOI 10.1111/0002-9092.00083
   Guerin GR, 2012, BIOL LETTERS, V8, P882, DOI 10.1098/rsbl.2012.0458
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Hodgkin T., 1995, CORE COLLECTIONS PLA
   HOLBROOK CC, 1993, CROP SCI, V33, P859, DOI 10.2135/cropsci1993.0011183X003300040044x
   Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933
   Hu J, 2000, THEOR APPL GENET, V101, P264, DOI 10.1007/s001220051478
   Karatzoglou A, 2006, J STAT SOFTW, V15
   Kaur N, 2008, EUR J PLANT PATHOL, V121, P387, DOI 10.1007/s10658-007-9252-3
   Khan HR, 2010, FIELD CROP RES, V115, P279, DOI 10.1016/j.fcr.2009.09.003
   Khan HUR, 2007, PLANT SOIL, V292, P205, DOI 10.1007/s11104-007-9217-5
   Kuhn M, 2008, J STAT SOFTW, V28
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liknes GC, 2009, FOR INV AN FIA S 200
   Lin W, 1975, HEREDITY, V34, P165, DOI [10.1038/hdy.1975.28, DOI 10.1038/HDY.1975.28]
   Mackay M., 2005, Czech Journal of Genetics and Plant Breeding, V41, P335
   Mackay M. C., 1995, P199
   MACKAY MC, 1990, WHEAT GENETIC RESOURCES : MEETING DIVERSE NEEDS, P21
   Mackay MC, 2004, P 54 AUSTR CER CHEM, P138
   Malosetti M, 2001, GENET RESOUR CROP EV, V48, P381, DOI 10.1023/A:1012003611371
   Masi CEA, 1998, J AGR SCI, V131, P259, DOI 10.1017/S0021859698005826
   Mba C, 2012, AGR FOOD SECUR, V1, P7, DOI DOI 10.1186/2048-7010-1-7
   McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x
   Muratova V., 1931, B APPL BOT GENET P S, V50, P1
   Mut Z, 2010, BULG J AGRIC SCI, V16, P459
   Ortiz R, 1998, THEOR APPL GENET, V96, P475, DOI 10.1007/s001220050764
   Parra-Quijano M, 2012, GENET RESOUR CROP EV, V59, P205, DOI 10.1007/s10722-011-9676-7
   Peleg Z, 2005, PLANT CELL ENVIRON, V28, P176, DOI 10.1111/j.1365-3040.2005.01259.x
   Pessoa-Filho M, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-127
   Polignano G. B., 2001, PLANT GENETIC RESOUR, V125, P33
   Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1
   R Development Core Team, 2012, R LANG ENV STAT COMP
   SPIETH PT, 1979, AM NAT, V113, P247, DOI 10.1086/283383
   Steinberg D, 2009, CART CLASSIFICATION
   Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973
   Swets JA, 2000, SCI AM, V283, P82, DOI 10.1038/scientificamerican1000-82
   Therneau T, 1997, 61 MAYO CLIN SECT BI
   Tirelli T, 2009, ECOL INFORM, V4, P234, DOI 10.1016/j.ecoinf.2009.07.003
   Tohme J, 1996, CROP SCI, V36, P1375, DOI 10.2135/cropsci1996.0011183X003600050048x
   Upadhyaya HD, 2001, THEOR APPL GENET, V102, P1292, DOI 10.1007/s00122-001-0556-y
   Vavilov N.I., 1926, T BYURO PRIKL BOT, V16, P139
   WANG H, 1993, CAN J PLANT SCI, V73, P671, DOI 10.4141/cjps93-088
   Xu F, 2009, PROG NAT SCI-MATER, V19, P1789, DOI 10.1016/j.pnsc.2009.10.001
   Xu Y, 2010, MOL PLANT BREEDING, P15
NR 82
TC 36
Z9 37
U1 1
U2 40
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 8
PY 2013
VL 8
IS 5
AR e63107
DI 10.1371/journal.pone.0063107
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 145YI
UT WOS:000319055600055
PM 23667581
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Baethge, C
   Franklin, J
   Mertens, S
AF Baethge, Christopher
   Franklin, Jeremy
   Mertens, Stephan
TI Substantial Agreement of Referee Recommendations at a General Medical
   Journal - A Peer Review Evaluation at Deutsches Arzteblatt International
SO PLOS ONE
LA English
DT Review
ID LOW KAPPA; PARADOXES
AB Background: Peer review is the mainstay of editorial decision making for medical journals. There is a dearth of evaluations of journal peer review with regard to reliability and validity, particularly in the light of the wide variety of medical journals. Studies carried out so far indicate low agreement among reviewers. We present an analysis of the peer review process at a general medical journal, Deutsches Arzteblatt International.
   Methodology/Principal Findings: 554 reviewer recommendations on 206 manuscripts submitted between 7/2008 and 12/2009 were analyzed: 7% recommended acceptance, 74% revision and 19% rejection. Concerning acceptance (with or without revision) versus rejection, there was a substantial agreement among reviewers (74.3% of pairs of recommendations) that was not reflected by Fleiss' or Cohen's kappa (<0.2). The agreement rate amounted to 84% for acceptance, but was only 31% for rejection. An alternative kappa-statistic, however, Gwet's kappa (AC1), indicated substantial agreement (0.63). Concordance between reviewer recommendation and editorial decision was almost perfect when reviewer recommendations were unanimous. The correlation of reviewer recommendations and citations as counted by Web of Science was low (partial correlation adjusted for year of publication: -0.03, n.s.).
   Conclusions/Significance: Although our figures are similar to those reported in the literature our conclusion differs from the widely held view that reviewer agreement is low: Based on overall agreement we consider the concordance among reviewers sufficient for the purposes of editorial decision making. We believe that various measures, such as positive and negative agreement or alternative Kappa values are superior to the application of Cohen's or Fleiss' Kappa in the analysis of nominal or ordinal level data regarding reviewer agreement. Also, reviewer recommendations seem to be a poor proxy for citations because, for example, manuscripts will be changed considerably during the revision process.
C1 [Baethge, Christopher; Mertens, Stephan] Deutsch Arzteblatt Int, Editorial Off, Cologne, Germany.
   [Baethge, Christopher] Univ Cologne, Sch Med, Dept Psychiat & Psychotherapy, D-50931 Cologne, Germany.
   [Franklin, Jeremy] Univ Cologne, Sch Med, Inst Med Stat, D-50931 Cologne, Germany.
RP Baethge, C (reprint author), Deutsch Arzteblatt Int, Editorial Off, Cologne, Germany.
EM baethge@aerzteblatt.de
CR Adler Robert, 2008, CITATION STAT REPORT
   Baethge C, 2012, DTSCH ARZTEBL INT, V109, P267, DOI 10.3238/arztebl.2012.0267
   Bornmann L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014331
   Bornmann L, 2009, RES EVALUAT, V18, P262, DOI 10.3152/095820209X477520
   BURNHAM JC, 1990, JAMA-J AM MED ASSOC, V263, P1323, DOI 10.1001/jama.263.10.1323
   CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M
   FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L
   Fleiss JL, 1981, STAT METHODS RATES P
   Gwet K. L., 2002, STAT METHODS INTERRA
   Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600
   Horobin DF, 1990, JAMA-J AM MED ASSOC, V263, P1438
   Kravitz RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010072
   KRONICK DA, 1990, JAMA-J AM MED ASSOC, V263, P1321, DOI 10.1001/jama.263.10.1321
   Kulkarni AV, 2009, JAMA-J AM MED ASSOC, V302, P1092, DOI 10.1001/jama.2009.1307
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Marusic A, 2002, CROAT MED J, V43, P286
   Mertens S, 2012, DTSCH ARZTEBL INT, V109, P900, DOI 10.3238/arztebl.2012.0900
   Opthof T, 2002, CARDIOVASC RES, V56, P339, DOI 10.1016/S0008-6363(02)00712-5
   Rothwell PM, 2000, BRAIN, V123, P1964, DOI 10.1093/brain/123.9.1964
   Yadollahie M, 2004, SAUDI MED J S1, V25, pS36
NR 20
TC 19
Z9 19
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 2
PY 2013
VL 8
IS 5
AR e61401
DI 10.1371/journal.pone.0061401
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 175AF
UT WOS:000321200500007
PM 23658692
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Serlin, Y
   Tal, G
   Chassidim, Y
   Parmet, Y
   Tomkins, O
   Knyazer, B
   Friedman, A
   Levy, J
AF Serlin, Yonatan
   Tal, Geva
   Chassidim, Yoash
   Parmet, Yisrael
   Tomkins, Oren
   Knyazer, Boris
   Friedman, Alon
   Levy, Jaime
TI Novel Fluorescein Angiography-Based Computer-Aided Algorithm for
   Assessment of Retinal Vessel Permeability
SO PLOS ONE
LA English
DT Article
ID AGREEMENT
AB Purpose: To present a novel method for quantitative assessment of retinal vessel permeability using a fluorescein angiography-based computer algorithm.
   Methods: Twenty-one subjects (13 with diabetic retinopathy, 8 healthy volunteers) underwent fluorescein angiography (FA). Image pre-processing included removal of non-retinal and noisy images and registration to achieve spatial and temporal pixel-based analysis. Permeability was assessed for each pixel by computing intensity kinetics normalized to arterial values. A linear curve was fitted and the slope value was assigned, color-coded and displayed. The initial FA studies and the computed permeability maps were interpreted in a masked and randomized manner by three experienced ophthalmologists for statistical validation of diagnosis accuracy and efficacy.
   Results: Permeability maps were successfully generated for all subjects. For healthy volunteers permeability values showed a normal distribution with a comparable range between subjects. Based on the mean cumulative histogram for the healthy population a threshold (99.5%) for pathological permeability was determined. Clear differences were found between patients and healthy subjects in the number and spatial distribution of pixels with pathological vascular leakage. The computed maps improved the discrimination between patients and healthy subjects, achieved sensitivity and specificity of 0.974 and 0.833 respectively, and significantly improved the consensus among raters for the localization of pathological regions.
   Conclusion: The new algorithm allows quantification of retinal vessel permeability and provides objective, more sensitive and accurate evaluation than the present subjective clinical diagnosis. Future studies with a larger patients' cohort and different retinal pathologies are awaited to further validate this new approach and its role in diagnosis and treatment follow-up. Successful evaluation of vasculature permeability may be used for the early diagnosis of brain microvascular pathology and potentially predict associated neurological sequelae. Finally, the algorithm could be implemented for intraoperative evaluation of micovascular integrity in other organs or during animal experiments.
C1 [Serlin, Yonatan; Chassidim, Yoash; Friedman, Alon] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Dept Physiol & Neurobiol, IL-84105 Beer Sheva, Israel.
   [Tal, Geva] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Dept Biomed Engn, IL-84105 Beer Sheva, Israel.
   [Parmet, Yisrael] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Dept Ind Engn & Management, IL-84105 Beer Sheva, Israel.
   [Tomkins, Oren] Moorfields Eye Hosp, London, England.
   [Tomkins, Oren] Royal Surrey Cty Hosp, Guildford, Surrey, England.
   [Knyazer, Boris; Levy, Jaime] Soroka Univ, Med Ctr, Dept Ophthalmol, Beer Sheva, Israel.
   [Knyazer, Boris; Levy, Jaime] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel.
   [Friedman, Alon] Charite, Neurocure Res Ctr, Inst Neurophysiol, D-13353 Berlin, Germany.
RP Friedman, A (reprint author), Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Dept Physiol & Neurobiol, IL-84105 Beer Sheva, Israel.
EM alonf@bgu.ac.il
RI Knyazer, Boris/D-8969-2014; PARMET, YISRAEL/F-1982-2012
OI Knyazer, Boris/0000-0002-9246-3226; PARMET, YISRAEL/0000-0002-2071-7338;
   Tomkins-Netzer, Oren/0000-0002-1015-1641
FU BG Negev Technologies, Beer-Sheva, Israel; BG Negev Technologies
FX This study was partially supported by Fakheri funds for applied
   research, BG Negev Technologies, Beer-Sheva, Israel. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript. No additional external funding
   received for this study.; The authors have the following interests. This
   study was partially supported by BG Negev Technologies. There are no
   patents, products in development or marketed products to declare. This
   does not alter the authors' adherence to all the PLOS ONE policies on
   sharing data and materials, as detailed online in the guide for authors.
CR Bennett TJ, 2009, CLIN EXP OPHTHALMOL, V37, P2, DOI 10.1111/j.1442-9071.2008.01812.x
   Berger JW, 2000, INVEST OPHTH VIS SCI, V41, P2286
   Chakravarthy U, 2007, INVEST OPHTH VIS SCI, V48, P349, DOI 10.1167/iovs.06-0493
   Cheung N, 2010, BRAIN, V133, P1987, DOI 10.1093/brain/awq127
   Ding J, 2010, DIABETES, V59, P2883, DOI 10.2337/db10-0752
   Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156
   Kaiser RS, 2002, RETINA-J RET VIT DIS, V22, P683, DOI 10.1097/00006982-200212000-00001
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lobo CL, 1999, ARCH OPHTHALMOL-CHIC, V117, P631
   McKenzie DP, 1996, J PSYCHIAT RES, V30, P483, DOI 10.1016/S0022-3956(96)00033-7
   Nguyen TT, 2010, PSYCHOSOM MED, V72, P535, DOI 10.1097/PSY.0b013e3181da90f4
   NOVOTNY HR, 1961, CIRCULATION, V24, P82, DOI 10.1161/01.CIR.24.1.82
   Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6
   Prager O, 2010, NEUROIMAGE, V49, P337, DOI 10.1016/j.neuroimage.2009.08.009
   Serlin Yonatan, 2011, Cardiovasc Psychiatry Neurol, V2011, P609202, DOI 10.1155/2011/609202
NR 15
TC 4
Z9 5
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 23
PY 2013
VL 8
IS 4
AR e61599
DI 10.1371/journal.pone.0061599
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 131QH
UT WOS:000318008400065
PM 23626701
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Puissant, C
   Abraham, P
   Durand, S
   Humeau-Heurtier, A
   Faure, S
   Leftheriotis, G
   Rousseau, P
   Mahe, G
AF Puissant, Cyril
   Abraham, Pierre
   Durand, Sylvain
   Humeau-Heurtier, Anne
   Faure, Sebastien
   Leftheriotis, Georges
   Rousseau, Pascal
   Mahe, Guillaume
TI Reproducibility of Non-Invasive Assessment of Skin Endothelial Function
   Using Laser Doppler Flowmetry and Laser Speckle Contrast Imaging
SO PLOS ONE
LA English
DT Article
ID BLOOD-FLOW; MICROVASCULAR FUNCTION; SODIUM-NITROPRUSSIDE; ACETYLCHOLINE
   IONTOPHORESIS; CUTANEOUS VASODILATION; NITRIC-OXIDE; IN-VIVO; HUMANS;
   DYSFUNCTION; RESISTANCE
AB Background: Endothelial dysfunction precedes atherosclerosis. Vasodilation induced by acetylcholine (ACh) is a specific test of endothelial function. Reproducibility of laser techniques such as laser-Doppler-flowmetry (LDF) and Laser-speckle-contrast-imaging (LSCI) to detect ACh vasodilation is debated and results expressions lack standardization. We aimed to study at a 7-day interval (i) the inter-subject reproducibility, (ii) the intra-subjects reproducibility, and (iii) the effect of the results expressions over variability.
   Methods and Results: Using LDF and LSCI simultaneously, we performed two different ACh-iontophoresis protocols. The maximal ACh vasodilation (peak-ACh) was expressed as absolute or normalized flow or conductance values. Inter-subject reproducibility was expressed as coefficient of variation (inter-CV,%). Intra-subject reproducibility was expressed as within subject coefficients of variation (intra-CV,%), and intra-class correlation coefficients (ICC). Fifteen healthy subjects were included. The inter-subject reproducibility of peak-ACh depended upon the expression of the results and ranged from 55% to 162% for LDF and from 17% to 83% for LSCI. The intra-subject reproducibility (intra-CV/ICC) of peak-ACh was reduced when assessed with LSCI compared to LDF no matter how the results were expressed and whatever the protocol used. The highest intra-subject reproducibility was found using LSCI. It was 18.7%/0.87 for a single current stimulation (expressed as cutaneous vascular conductance) and 11.4%/0.61 for multiple current stimulations (expressed as absolute value).
   Conclusion: ACh-iontophoresis coupled with LSCI is a promising test to assess endothelial function because it is reproducible, safe, and non-invasive. No: NCT01664572.
C1 [Puissant, Cyril; Abraham, Pierre; Leftheriotis, Georges; Mahe, Guillaume] Univ Hosp, Lab Vasc Invest, Angers, France.
   [Abraham, Pierre; Leftheriotis, Georges; Rousseau, Pascal; Mahe, Guillaume] LUNAM Univ, Fac Med, Biol Neurovasc & Mitochondriale Integree BNMI Uni, INSERM U1083, Angers, France.
   [Durand, Sylvain] Univ Maine, LUNAM Univ, EA Motr Interact & Performance 4334, F-72017 Le Mans, France.
   [Humeau-Heurtier, Anne] Univ Angers, LUNAM Univ, LISA, Angers, France.
   [Faure, Sebastien] Univ Angers, LUNAM Univ, INSERM Stress Oxydant & Pathol Metab SOPAM U1063, Angers, France.
   [Rousseau, Pascal] Univ Hosp, Dept Plast Surg, Angers, France.
RP Mahe, G (reprint author), Univ Hosp, Lab Vasc Invest, Angers, France.
EM gumahe@chu-angers.fr
RI Clere, Nicolas/K-4414-2015; FAURE, Sebastien/K-4444-2015
FU "INTERFACE" grant from the "Institut National de la Sante et de la
   Recherche Medicale" (INSERM)
FX The study was supported in part by an "INTERFACE" grant from the
   "Institut National de la Sante et de la Recherche Medicale" (INSERM) and
   was promoted by the University Hospital of Angers. No additional
   external funding was received for this study. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Agarwal SC, 2012, MICROVASC RES, V84, P55, DOI 10.1016/j.mvr.2012.02.002
   Agarwal SC, 2010, PHYSIOL MEAS, V31, P1, DOI 10.1088/0967-3334/31/1/001
   Belch JJ, 2012, MICROVASC RES
   BLAND M, 2000, INTRO MED STAT
   Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504
   Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC
   Briers J. D., 2007, OPTICA APPL, V37, P1
   Briers JD, 2001, PHYSIOL MEAS, V22, pR35, DOI 10.1088/0967-3334/22/4/201
   Brunt VE, 2012, J PHYSIOL-LONDON, V590, P3523, DOI 10.1113/jphysiol.2012.236398
   CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F
   Cordovil I, 2012, MICROVASC RES, V83, P376, DOI 10.1016/j.mvr.2012.01.004
   Cracowski JL, 2006, TRENDS PHARMACOL SCI, V27, P503, DOI 10.1016/j.tips.2006.07.008
   Cracowski JL, 2013, J APPL PHYSIOL, V114, P245, DOI 10.1152/japplphysiol.01085.2012
   de Jongh RT, 2004, CIRCULATION, V109, P2529, DOI 10.1161/01.CIR.0000129772.26647.6F
   Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859
   Debbabi H, 2010, AM J HYPERTENS, V23, P541, DOI 10.1038/ajh.2010.10
   desJongh RT, 2003, EUR J CLIN INVEST, V33, P536
   Donald AE, 2008, J AM COLL CARDIOL, V51, P1959, DOI 10.1016/j.jacc.2008.02.044
   Droog EJ, 2004, MICROVASC RES, V67, P197, DOI 10.1016/j.mvr.2003.12.003
   Durand S, 2004, J PHYSIOL-LONDON, V561, P811, DOI 10.1113/jphysiol.2004.069997
   Flammer AJ, 2012, CIRCULATION, V126, P753, DOI 10.1161/CIRCULATIONAHA.112.093245
   Gaubert ML, 2007, J PHYSIOL-LONDON, V585, P617, DOI 10.1113/jphysiol.2007.143750
   Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001
   Humeau-Heurtier A, 2013, IEEE T BIOMED ENG
   Joannides R, 2006, FUND CLIN PHARMACOL, V20, P311, DOI 10.1111/j.1472-8206.2006.00406.x
   Kellogg DL, 2005, J APPL PHYSIOL, V98, P629, DOI 10.1152/japplphysiol.00728.2004
   Ketel IJG, 2009, MICROCIRCULATION, V16, P714, DOI 10.3109/10739680903199186
   Khan F, 2004, J APPL PHYSIOL, V97, P883, DOI 10.1152/japplphysiol.00373.2004
   Khan F, 2008, CLIN SCI, V115, P295, DOI 10.1042/CS20070431
   Kubli S, 2000, J CARDIOVASC PHARM, V36, P640, DOI 10.1097/00005344-200011000-00014
   Kubli S, 2001, CLIN PHARMACOL THER, V69, P238, DOI 10.1067/mcp.2001.114670
   Kuvin JT, 2003, AM HEART J, V146, P168, DOI 10.1016/S0002-8703(03)00094-2
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Le Faucheur A, PFLUGERS AR IN PRESS
   Lekakis J, 2011, EUR J CARDIOVASC PRE
   Mahe G, 2013, J ATHEROSCLER THROMB
   Mahe G, 2012, MICROCIRCULATION, V19, P669, DOI 10.1111/j.1549-8719.2012.00205.x
   Mahe G, 2012, CIRC-CARDIOVASC IMAG, V5, P155, DOI 10.1161/CIRCIMAGING.111.970418
   Mahe G, 2011, MICROVASC RES, V82, P439, DOI 10.1016/j.mvr.2011.06.014
   Mahe G, 2011, MICROVASC RES, V81, P183, DOI 10.1016/j.mvr.2010.11.013
   Millet C, 2011, MICROVASC RES, V82, P147, DOI 10.1016/j.mvr.2011.06.006
   Morris SJ, 1996, J PHYSIOL-LONDON, V496, P531, DOI 10.1113/jphysiol.1996.sp021704
   Noon JP, 1998, BRIT J CLIN PHARMACO, V45, P545, DOI 10.1046/j.1365-2125.1998.00718.x
   OLEARY DS, 1991, AM J PHYSIOL, V260, pH632
   Onkelinx S, 2012, VASC MED, V17, P79, DOI 10.1177/1358863X12436708
   Poredos P., 2012, J ATHEROSCLER THROMB
   ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0
   Rossi M, 1997, J CARDIOVASC PHARM, V29, P406, DOI 10.1097/00005344-199703000-00015
   Rousseau P, 2011, MICROVASC RES, V82, P88, DOI 10.1016/j.mvr.2011.03.009
   Roustit M, 2010, MICROVASC RES, V80, P505, DOI 10.1016/j.mvr.2010.05.012
   Roustit M, 2012, MICROCIRCULATION, V19, P47, DOI 10.1111/j.1549-8719.2011.00129.x
   Sauvet F, 2011, MICROVASC RES
   Tesselaar E, 2012, PACE, V35, P377, DOI 10.1111/j.1540-8159.2011.03313.x
   Tesselaar E, 2011, MICROVASC RES, V81, P88, DOI 10.1016/j.mvr.2010.11.002
   Tew GA, 2011, MICROVASC RES, V82, P326, DOI 10.1016/j.mvr.2011.07.007
   Tibirica E, 2011, CLINICS, V66, P599, DOI 10.1590/S1807-59322011000400013
   Trzepizur W, 2009, SLEEP MED, V10, P746, DOI 10.1016/j.sleep.2008.06.013
   WHO, 2007, REC PREV CARD DIS GU
NR 58
TC 38
Z9 39
U1 0
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 19
PY 2013
VL 8
IS 4
AR e61320
DI 10.1371/journal.pone.0061320
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 130JA
UT WOS:000317909500022
PM 23620742
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Cusimano, MD
   Cho, N
   Amin, K
   Shirazi, M
   McFaull, SR
   Do, MT
   Wong, MC
   Russell, K
AF Cusimano, Michael D.
   Cho, Newton
   Amin, Khizer
   Shirazi, Mariam
   McFaull, Steven R.
   Do, Minh T.
   Wong, Matthew C.
   Russell, Kelly
TI Mechanisms of Team-Sport-Related Brain Injuries in Children 5 to 19
   Years Old: Opportunities for Prevention
SO PLOS ONE
LA English
DT Article
ID ICE HOCKEY; HEAD-INJURIES; BODY-CHECKING; SOCCER; EPIDEMIOLOGY;
   CONCUSSIONS; AGREEMENT; EMERGENCY; FOOTBALL; PLAYERS
AB Background: There is a gap in knowledge about the mechanisms of sports-related brain injuries. The objective of this study was to determine the mechanisms of brain injuries among children and youth participating in team sports.
   Methods: We conducted a retrospective case series of brain injuries suffered by children participating in team sports. The Canadian Hospitals Injury Reporting and Prevention Program (CHIRPP) database was searched for brain injury cases among 5-19 year-olds playing ice hockey, soccer, American football (football), basketball, baseball, or rugby between 1990 and 2009. Mechanisms of injury were classified as "struck by player,'' "struck by object,'' "struck by sport implement,'' "struck surface,'' and "other.'' A descriptive analysis was performed.
   Results: There were 12,799 brain injuries related to six team sports (16.2% of all brain injuries registered in CHIRPP). Males represented 81% of injuries and the mean age was 13.2 years. Ice hockey accounted for the greatest number of brain injuries (44.3%), followed by soccer (19.0%) and football (12.9%). In ice hockey, rugby, and basketball, striking another player was the most common injury mechanism. Football, basketball, and soccer also demonstrated high proportions of injuries due to contact with an object (e.g., post) among younger players. In baseball, a common mechanism in the 5-9 year-old group was being hit with a bat as a result of standing too close to the batter (26.1% males, 28.3% females).
   Interpretation: Many sports-related brain injury mechanisms are preventable. The results suggest that further efforts aimed at universal rule changes, safer playing environments, and the education of coaches, players, and parents should be targeted in maximizing prevention of sport-related brain injury using a multifaceted approach.
C1 [Cusimano, Michael D.; Cho, Newton; Amin, Khizer; Shirazi, Mariam; Wong, Matthew C.; Russell, Kelly] Univ Toronto, St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada.
   [Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada.
   [McFaull, Steven R.; Do, Minh T.] Publ Hlth Agcy Canada, Hlth Surveillance & Epidemiol Div, Ottawa, ON, Canada.
RP Cusimano, MD (reprint author), Univ Toronto, St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada.
EM cusimanom@smh.ca
OI Russell, Kelly/0000-0002-9159-9201; Cusimano,
   Michael/0000-0002-9989-0650
FU Canadian Institute of Health Research Strategic Team Grant in Applied
   Injury Research [TIR-103946]
FX This research was supported by Canadian Institute of Health Research
   Strategic Team Grant in Applied Injury Research #TIR-103946. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
   http://www.cihr-irsc.gc.ca/e/193.html
CR Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469
   Benz B, 1999, RESTOR NEUROL NEUROS, V14, P135
   Canadian Fitness & Lifestyle Research Institute, 2011, GETT KIDS ACT 2010 P
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Cusimano Michael D, 2011, Open Med, V5, pe57
   Cusimano MD, 2010, NEUROSURGERY, V67, P1404, DOI 10.1227/NEU.0b013e3181f209f1
   Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013
   Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005
   Emery CA, 2009, INJURY PREV, V16, P113
   Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061
   Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755
   Giannotti M, 2010, INJURY, V41, P907, DOI 10.1016/j.injury.2009.09.040
   Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005
   Hassan A, 2009, CAN J CARDIOL, V25, P207, DOI 10.1016/S0828-282X(09)70062-5
   Juhn MS, 2002, CLIN J SPORT MED, V12, P46, DOI 10.1097/00042752-200201000-00014
   Kang J., 2012, INT J INJ CONTROL SA, P1
   Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001
   Macarthur C, 1997, AM J EPIDEMIOL, V145, P834
   Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005.1163
   Pickett W, 2000, Inj Prev, V6, P9, DOI 10.1136/ip.6.1.9
   Statistics Canada, 2010, AGE SEX
   Turk EE, 2008, BRIT J SPORT MED, V42, P604, DOI 10.1136/bjsm.2007.038505
   Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351
NR 25
TC 26
Z9 26
U1 2
U2 40
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 28
PY 2013
VL 8
IS 3
AR e58868
DI 10.1371/journal.pone.0058868
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 121RP
UT WOS:000317262200007
PM 23555602
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Morrison, SD
   Rashidi, V
   Banushi, VH
   Barbhaiya, NJ
   Gashi, VH
   Sarnquist, C
   Maldonado, Y
   Harxhi, A
AF Morrison, Shane D.
   Rashidi, Vania
   Banushi, Vilson H.
   Barbhaiya, Namrata J.
   Gashi, Valbona H.
   Sarnquist, Clea
   Maldonado, Yvonne
   Harxhi, Arjan
TI Cultural Adaptation of a Survey to Assess Medical Providers' Knowledge
   of and Attitudes towards HIV/AIDS in Albania
SO PLOS ONE
LA English
DT Article
ID HIV; KAPPA; CARE; VALIDATION; GUIDELINES; PHYSICIANS; AGREEMENT;
   WORKERS; RISK
AB Though the HIV/AIDS epidemic in Southeastern Europe is one of low reported prevalence, numerous studies have described the pervasiveness of medical providers' lack of knowledge of HIV/AIDS in the Balkans. This study sought to culturally adapt an instrument to assess medical providers' knowledge of and attitudes towards HIV/AIDS in Albania. Cultural adaptation was completed through development of a survey from previously validated instruments, translation of the survey into Albanian, blinded back translation, expert committee review of the draft instrument, focus group pre-testing with community- and University Hospital Center of Tirana-based physicians and nurses, and test-retest reliability testing. Blinded back translation of the instrument supported the initial translation with slight changes to the idiomatic and conceptual equivalences. Focus group pre-testing generally supported the instrument, yet some experiential and idiomatic changes were implemented. Based on unweighted kappa and/or prevalence adjusted bias adjusted kappa (PABAK), 20 of the 43 questions were deemed statistically significant at kappa and/or PABAK >= 0.5, while 12 others did not cross zero on the 95% confidence interval for kappa, indicating their probable significance. Subsequently, an instrument to assess medical providers' knowledge of and attitudes toward HIV/AIDS for an Albanian population was developed which can be expanded within Albania and potentially to other countries within the Balkans, which have an Albanian-speaking population.
C1 [Morrison, Shane D.; Sarnquist, Clea; Maldonado, Yvonne] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.
   [Rashidi, Vania; Barbhaiya, Namrata J.] Stanford Univ, Sch Med, Stanford, CA 94305 USA.
   [Banushi, Vilson H.; Gashi, Valbona H.; Harxhi, Arjan] Univ Tirana, Fac Med, Dept Infect Dis, Tirana, Albania.
RP Morrison, SD (reprint author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.
EM shanem@stanford.edu; bonniem@stanford.edu
OI Morrison, Shane/0000-0003-3868-3532
FU Center for East Europe and Eurasia Studies at Stanford University Summer
   Research Fellowship; Infectious Diseases Society of America; Stanford
   University Goodrich Traveling Medical Scholars grant
FX Funding for this study was provided by the Center for East Europe and
   Eurasia Studies at Stanford University Summer Research Fellowship,
   Medical Scholars Grant from the Infectious Diseases Society of America,
   and the Stanford University Goodrich Traveling Medical Scholars grant to
   Shane D. Morrison. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47
   Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014
   Bino S, 2006, ALBANIA BEHAV BIOL S
   Boulle A, 2007, SEX TRANSM INFECT, V83, P503, DOI 10.1136/sti.2007.027748
   Brachman P, 1996, ARCH INTERN MED, V156, P761, DOI 10.1001/archinte.156.7.761
   Brusaferro S, 1997, Med Lav, V88, P495
   BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V
   Ciccozzi M, 2005, J INFECT DIS, V192, P475, DOI 10.1086/431599
   Devroey D, 2003, AIDS, V17, P641, DOI 10.1097/01.aids.0000050848.71999.52
   FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L
   Grudens-Schuck N, 2004, FOCUS GROUP FUNDAMEN, VPM1969b
   GUILLEMIN F, 1995, SCAND J RHEUMATOL, V24, P61, DOI 10.3109/03009749509099285
   GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N
   Harxhi A, 2002, RAPID ASSESSMENT RES
   International Organization for Migration, 2007, REP ALB MIGR PROF
   Jovic-Vranes A, 2006, OCCUP MED-OXFORD, V56, P275, DOI 10.1093/occmed/kql019
   Kocic Biljana, 2008, Central European Journal of Public Health, V16, P134
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lohrer H, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-134
   MACLURE M, 1987, AM J EPIDEMIOL, V126, P161, DOI 10.1093/aje/126.2.161
   Mann Jonathan M, 1994, Health Hum Rights, V1, P6
   Ministry of Health Kenya, 2004, ADH ANT THER AD GUID
   Ministry of Health (Republic of Albania), 2003, LETS KEEP ALB LOW HI
   Ministry of Health (Republic of Albania), 2012, NAT STRAT P IN PRESS
   Ministry of Health (Republic of Albania), 2007, ALB COUNTR PROGR REP
   Morrison SD, 2011, CENT EUR J PUBL HEAL, V19, P91, DOI 10.21101/cejph.a3644
   Quach L, 2005, AIDS PATIENT CARE ST, V19, P335, DOI 10.1089/apc.2005.19.335
   Reis C, 2005, PLOS MED, V2, P743, DOI 10.1371/journal.pmed.0020246
   Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390
   Sim J, 2005, PHYS THER, V85, P257
   Stepanoya E, 2004, 15 INT C AIDS BANGK
   Tesic V, 2006, COLLEGIUM ANTROPOL, V30, P89
   The World Bank, 2008, ALB KEY IND
   TIRELLI U, 1991, BRIT MED J, V303, P582, DOI 10.1136/bmj.303.6802.582
   UNAIDS, 1999, UN AIDS EP UPD
   UNAIDS, 2011, UNAIDS DAT TABL
   UNAIDS, 2010, GLOB REP UNAIDS REP
   *UNAIDS WHO, 2007, 2007 AIDS EP UPD
   UNAIDS/World Health Organization, 2009, FACT SHEET GLOB HIV
   UNAIDS/World Health Organization, 2007, FACT SHEET HIV AIDS
   UNICEF, 2004, RAP ASS RESP TIR
   WHO, 2008, WORLD HLTH STAT 2008
   World Health Organization, 2003, ADHERENCE LONG TERM
   World Health Organization, 2008, EP HIV AIDS 2008 UPD
   World Health Organziation UNAIDS UNICEF, 2011, GLOB HIV AIDS RESP E
NR 45
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 27
PY 2013
VL 8
IS 3
AR e59816
DI 10.1371/journal.pone.0059816
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 124QO
UT WOS:000317480700061
PM 23544101
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wood, LJ
   Dautenhahn, K
   Rainer, A
   Robins, B
   Lehmann, H
   Syrdal, DS
AF Wood, Luke Jai
   Dautenhahn, Kerstin
   Rainer, Austen
   Robins, Ben
   Lehmann, Hagen
   Syrdal, Dag Sverre
TI Robot-Mediated Interviews - How Effective Is a Humanoid Robot as a Tool
   for Interviewing Young Children?
SO PLOS ONE
LA English
DT Article
ID PERSONALITY; CONSISTENCY; LISTENERS; BEHAVIOR
AB Robots have been used in a variety of education, therapy or entertainment contexts. This paper introduces the novel application of using humanoid robots for robot-mediated interviews. An experimental study examines how children's responses towards the humanoid robot KASPAR in an interview context differ in comparison to their interaction with a human in a similar setting. Twenty-one children aged between 7 and 9 took part in this study. Each child participated in two interviews, one with an adult and one with a humanoid robot. Measures include the behavioural coding of the children's behaviour during the interviews and questionnaire data. The questions in these interviews focused on a special event that had recently taken place in the school. The results reveal that the children interacted with KASPAR very similar to how they interacted with a human interviewer. The quantitative behaviour analysis reveal that the most notable difference between the interviews with KASPAR and the human were the duration of the interviews, the eye gaze directed towards the different interviewers, and the response time of the interviewers. These results are discussed in light of future work towards developing KASPAR as an 'interviewer' for young children in application areas where a robot may have advantages over a human interviewer, e. g. in police, social services, or healthcare applications.
C1 [Wood, Luke Jai; Dautenhahn, Kerstin; Rainer, Austen; Robins, Ben; Lehmann, Hagen; Syrdal, Dag Sverre] Univ Hertfordshire, Sch Comp Sci, Hatfield AL10 9AB, Herts, England.
RP Wood, LJ (reprint author), Univ Hertfordshire, Sch Comp Sci, Hatfield AL10 9AB, Herts, England.
EM l.wood@herts.ac.uk
RI Lehmann, Hagen/D-8782-2018
OI Wood, Luke/0000-0003-1037-3727; Dautenhahn, Kerstin/0000-0002-9263-3897;
   Syrdal, Dag Sverre/0000-0002-1339-4382
CR Barlett B., 2004, 5 AUSTR US INT C AUI
   Becker-Asano C, 2010, EXPLORING UNCANNY VA, P121
   BERLYNE DE, 1958, J EXP PSYCHOL, V55, P289, DOI 10.1037/h0043555
   Bethel CL, 2011, SHARING SECRET INTER
   BOOMER DS, 1965, LANG SPEECH, V8, P148, DOI 10.1177/002383096500800302
   BRENNAN SE, 1995, J MEM LANG, V34, P383, DOI 10.1006/jmla.1995.1017
   Brennan SE, 2001, J MEM LANG, V44, P274, DOI 10.1006/jmla.2000.2753
   Clark H. H., 1991, PERSPECTIVES SOCIALL, V13, P127, DOI DOI 10.1037/10096-006
   CLARK HH, 1994, SPEECH COMMUN, V15, P243, DOI 10.1016/0167-6393(94)90075-2
   DAHLBACK N, 1993, KNOWL-BASED SYST, V6, P258, DOI 10.1016/0950-7051(93)90017-N
   Dautenhahn Kerstin, 2009, Applied Bionics and Biomechanics, V6, P369, DOI 10.1080/11762320903123567
   Dautenhahn K, 2007, PHILOS T R SOC B, V362, P679, DOI 10.1098/rstb.2006.2004
   Docherty S, 1999, RES NURS HEALTH, V22, P177, DOI 10.1002/(SICI)1098-240X(199904)22:2<177::AID-NUR9>3.0.CO;2-H
   Eklundh KS, 2004, APPL WIZARD OF OZ FR, P575
   Francois D, 2005, SUSTAINING INTERACTI
   Ghosh M, 2011, IMPLEMENTATION CARE
   Goetz J., 2003, MATCHING ROBOT APPEA, P55
   Goris K, 2009, PROBO TESTBED HUMAN
   GOULD JD, 1983, COMMUN ACM, V26, P295, DOI 10.1145/2163.358100
   Kanda T, 2004, HUM-COMPUT INTERACT, V19, P61, DOI 10.1207/s15327051hci1901&2_4
   Kerepesi A, 2006, BEHAV PROCESS, V73, P92, DOI 10.1016/j.beproc.2006.04.001
   Kose-Bagci H, 2007, DRUM MATE HUMAN HUMA
   Kose-Bagci H, 2010, CONNECT SCI, V22, P103, DOI 10.1080/09540090903383189
   Kose-Bagci H, 2009, ADV ROBOTICS, V23, P1951, DOI 10.1163/016918609X12518783330360
   Kozima H, 2009, INT J SOC ROBOT, V1, P3, DOI 10.1007/s12369-008-0009-8
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leite I, 2008, ICAT AFFECTIVE GAME, P1229
   MacDorman KF, 2006, INTERACT STUD, V7, P297, DOI 10.1075/is.7.3.03mac
   Mahl G. F, 1987, EXPLORATIONS NONVERB
   Melson GF, 2009, J APPL DEV PSYCHOL, V30, P92, DOI 10.1016/j.appdev.2008.10.011
   NAO Robot, 2011, NAO ROB
   Nishio S., 2007, REPRESENTING PERSONA
   Observer XT, 2011, OBS XT
   Ramirez-Serrano A, 2010, J PHYS AGENTS, P4
   Robins B., 2009, INT C ADV COMP HUM I, P205, DOI DOI 10.1109/ACHI.2009.32
   Robins B, 2008, 2008 17TH IEEE INTERNATIONAL SYMPOSIUM ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, VOLS 1 AND 2, P180, DOI 10.1109/ROMAN.2008.4600663
   Roebers CM, 2002, COGNITIVE DEV, V17, P1085, DOI 10.1016/S0885-2014(02)00075-8
   Saldien J., 2008, J PHYS AGENTS, P3
   Saldien J., 2006, ANTY DEV INTELLIGENT
   Scheeff M, 2002, MU S ART SOC SIM ORG, V3, P173
   Shahid S, 2010, CHILD ROBOT INTERACT
   Shriberg EE, 1992, INTONATION CLAUSE IN, V1992
   SMITH VL, 1993, J MEM LANG, V32, P25, DOI 10.1006/jmla.1993.1002
   Spratling R, 2010, APPL NURSING RES
   Swerts M, 2011, CHI 2011 VANC BC CAN
   Swerts M, 2010, PLAYING ICAT INVESTI
   Tapus A., 2008, INTELLIGENT SERVICE, V1, P169, DOI DOI 10.1007/S11370-008-0017-4
   Te Boekhorst R, 2008, BEHAV DELAY ROBOT EX, P17
   UK Government, 2007, ACH BEST EV CRIM P G, P27
   UK Government, 2007, ACH BEST EV CRIM P G, P1
   UK Government, 2011, ACH BEST EV CRIM P G, V49, P229
   UK Government, 2011, ACH BEST EV CRIM P G, P196
   UK Government, 2011, ACH BEST EV CRIM P G, P66
   UK Government, 2011, ACH BEST EV CRIM P G
   Wainer J., 2010, COLLABORATING KASPAR, P631
   Walters ML, 2008, AUTON ROBOT, V24, P159, DOI 10.1007/s10514-007-9058-3
   Woods S, 2007, INTERACT STUD, V8, P281, DOI 10.1075/is.8.2.06woo
NR 57
TC 27
Z9 27
U1 0
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 22
PY 2013
VL 8
IS 3
AR e59448
DI 10.1371/journal.pone.0059448
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 111VQ
UT WOS:000316549400062
PM 23533625
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Neumann, H
   Gunther, C
   Vieth, M
   Grauer, M
   Wittkopf, N
   Mudter, J
   Becker, C
   Schoerner, C
   Atreya, R
   Neurath, MF
AF Neumann, Helmut
   Guenther, Claudia
   Vieth, Michael
   Grauer, Martin
   Wittkopf, Nadine
   Mudter, Jonas
   Becker, Christoph
   Schoerner, Christoph
   Atreya, Raja
   Neurath, Markus F.
TI Confocal Laser Endomicroscopy for In Vivo Diagnosis of Clostridium
   difficile Associated Colitis - A Pilot Study
SO PLOS ONE
LA English
DT Article
ID EPITHELIAL GAPS; DISEASE; IDENTIFICATION; CLASSIFICATION; ENDOSCOPY;
   CELLS
AB Background: Clostridium difficile infection (CDI) is one of the most dreaded causes of hospital-acquired diarrhea. Main objective was to investigate whether confocal laser endomicroscopy (CLE) has the capability for in vivo diagnosis of C. difficile associated histological changes. Second objective was to prove the presence of intramucosal bacteria using CLE.
   Methods: 80 patients were prospectively included, 10 patients were diagnosed with CDI based on toxigenic culture. To validate the presence of intramucosal bacteria ex vivo, CLE was performed in pure C. difficile culture; additionally fluorescence in situ hybridization (FISH) was performed. Finally, CLE with fluorescence labelled oligonucleotide probe specific for C. difficile was performed ex vivo in order to prove the presence of bacteria.
   Results: CLE identified CDI-associated histological changes in vivo (sensitivity and accuracy of 88.9% and 96.3%). In addition, intramucosal bacteria were visualized. The presence of these bacteria could be proven by CLE with labeled, specific molecular C. difficile probe and FISH-technique. Based on comparison between CLE and FISH analyses, sensitivity and specificity for the presence of intramucosal bacteria were 100%.
   Conclusion: CLE has the potential for in vivo diagnosis of CDI associated colitis. In addition, CLE allowed the detection of intramucosal bacteria in vivo.
C1 [Neumann, Helmut; Guenther, Claudia; Grauer, Martin; Wittkopf, Nadine; Mudter, Jonas; Becker, Christoph; Atreya, Raja; Neurath, Markus F.] Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Germany.
   [Vieth, Michael] Klinikum Bayreuth, Inst Pathol, Bayreuth, Germany.
   [Schoerner, Christoph] Univ Erlangen Nurnberg, Inst Microbiol Immunol & Hyg, Erlangen, Germany.
RP Neumann, H (reprint author), Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Germany.
EM helmut.neumann@uk-erlangen.de
RI Becker, Christoph/L-2996-2016
CR AMANN RI, 1995, MICROBIOL REV, V59, P143
   Bartlett J.G., 2008, CLIN INFECT DIS   S1, V46, P12
   Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JC1200317464
   Bloedt K, 2009, J MED MICROBIOL, V58, P874, DOI 10.1099/jmm.0.009811-0
   Buchner AM, 2010, GASTROENTEROLOGY, V138, P834, DOI 10.1053/j.gastro.2009.10.053
   *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P1201
   Crobach MJT, 2009, CLIN MICROBIOL INFEC, V15, P1053, DOI 10.1111/j.1469-0691.2009.03098.x
   Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295
   Gunther U, 2008, GUT, V57, P1331
   Huang HH, 2009, INT J ANTIMICROB AG, V34, P516, DOI 10.1016/j.ijantimicag.2009.09.012
   Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500
   Kiesslich R, 2005, GASTROENTEROLOGY, V128, P2119, DOI 10.1053/j.gastro.2004.12.035
   Kiesslich R, 2004, GASTROENTEROLOGY, V127, P706, DOI 10.1053/j.gastro.2004.06.050
   Kiesslich R, 2007, GASTROENTEROLOGY, V133, P1769, DOI 10.1053/j.gastro.2007.09.011
   Kiesslich R, 2006, CLIN GASTROENTEROL H, V4, P979, DOI 10.1016/j.cgh.2006.05.010
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leong RWL, 2008, GASTROENTEROLOGY, V135, P1870, DOI 10.1053/j.gastro.2008.08.054
   Liu JJ, 2011, GASTROINTEST ENDOSC, V73, P1174, DOI 10.1016/j.gie.2011.01.018
   Monkemuller K, 2006, ENDOSCOPY, V38, P546, DOI 10.1055/s-2006-925343
   Monaghan T, 2008, GUT, V57, P850, DOI 10.1136/gut.2007.128157
   Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4
   Moussata D, 2011, GUT, V60, P26, DOI 10.1136/gut.2010.213264
   Neumann H, 2013, GUT, V62, P333, DOI 10.1136/gutjnl-2012-303121
   Neumann H, 2012, INFLAMM BOWEL DIS, V18, P2261, DOI 10.1002/ibd.22907
   Neumann H, 2010, GASTROENTEROLOGY, V139, P388, DOI 10.1053/j.gastro.2010.06.029
   Wallace M, 2011, ENDOSCOPY, V43, P882, DOI 10.1055/s-0030-1256632
NR 26
TC 9
Z9 10
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 19
PY 2013
VL 8
IS 3
AR e58753
DI 10.1371/journal.pone.0058753
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 125SR
UT WOS:000317562100039
PM 23527018
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zheng, MJ
   Schaal, M
   Chen, Y
   Li, XK
   Shentu, WH
   Zhang, PY
   Ashraf, M
   Ge, SP
   Sahn, DJ
AF Zheng, Minjuan
   Schaal, Micheal
   Chen, Yan
   Li, Xiaokui
   Shentu, Weihui
   Zhang, Pengyuan
   Ashraf, Muhammad
   Ge, Shuping
   Sahn, David J.
TI Real-Time 3-Dimensional Echocardiographic Assessment of Ventricular
   Volume, Mass, and Function in Human Fetuses
SO PLOS ONE
LA English
DT Article
ID FETAL CARDIAC-OUTPUT; COMPUTER-AIDED ANALYSIS; EJECTION FRACTION;
   2-DIMENSIONAL ECHOCARDIOGRAPHY; 4-DIMENSIONAL ULTRASOUND; PICTORIAL
   ESSAY; 4D ULTRASOUND; STROKE VOLUME; HEART-VOLUME; MATRIX-ARRAY
AB Objectives: We sought to determine the feasibility and reproducibility of real-time 3-dimensional echocardiography (RT3DE) for evaluation of cardiac volume, mass, and function and to characterize maturational changes of these measurements in human fetuses.
   Methods: Eighty pregnant women in the 2nd and 3rd trimesters (59 with normal fetuses and 21 with fetuses with congenital heart disease [CHD]) were enrolled. We acquired RT3DE images using a matrix-array transducer. RT3DE measurements of volume, mass, stroke volume (SV), combined cardiac output (CCO), and ejection fraction (EF) were obtained. Images were scored and analyzed by two blinded independent observers. Inter-and intraobserver variabilities and correlations between fetal cardiac indices and gestational age were determined.
   Results: Fifty-two of 59 normal data sets (88%) and 9 of 21 CHD data sets (43%) were feasible for analysis. In normal fetuses, the right ventricle (RV) is larger than the left ventricle (LV) (P<0.05), but no difference exists between the LV and RV in mass, SV, CO, and CO/CCO. The EFs for the LV and RV were diminished; the RVSV/LVSV was reduced in CHD fetuses compared with normal fetuses (P<0.05). Fetal ventricular volumes, mass, SV, and CCO fit best into exponential curves with gestational age, but LVEF, RVEF, and RVSV/LVSV remain relatively constant.
   Conclusions: RT3DE is feasible and reproducible for assessment of LV and RV volume, mass, and function, especially in normal fetuses. Gestational growth of these measures, except for EF, is exponential in normal and CHD fetuses. CHD fetuses exhibit diminished LV and RV EFs.
C1 [Zheng, Minjuan; Schaal, Micheal; Li, Xiaokui; Shentu, Weihui; Zhang, Pengyuan; Ashraf, Muhammad; Sahn, David J.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
   [Zheng, Minjuan] Fourth Mil Med Univ, Xijing Hosp, Dept Ultrasound, Xian 710032, Peoples R China.
   [Chen, Yan] Fourth Mil Med Univ, Xijing Hosp, Dept Oncol, Xian 710032, Peoples R China.
   [Ge, Shuping] Drexel Univ, St Christophers Hosp Children, Coll Med, Cardiol Sect, Philadelphia, PA 19104 USA.
RP Ge, SP (reprint author), Drexel Univ, St Christophers Hosp Children, Coll Med, Cardiol Sect, Philadelphia, PA 19104 USA.
EM shuping.ge@tenethealth.com; sahnd@ohsu.edu
FU Oregon Health and Science University
FX This work was supported by Oregon Health and Science University
   (http://www.ohsu.edu/xd/). The funder had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Acar P, 2005, PRENATAL DIAG, V25, P370, DOI 10.1002/pd.1159
   Bhat AH, 2004, CIRCULATION, V110, P1054, DOI 10.1161/01.CIR.0000139848.33468.22
   Chang FM, 1997, ULTRASOUND OBST GYN, V9, P42, DOI 10.1046/j.1469-0705.1997.09010042.x
   Barreto EQD, 2012, J ULTRAS MED, V31, P673
   DeKoninck P, 2012, FETAL DIAGN THER, V32, P72, DOI 10.1159/000336128
   DESMEDT MCH, 1987, AM J CARDIOL, V60, P338, DOI 10.1016/0002-9149(87)90238-4
   DEVORE GR, 1985, J ULTRAS MED, V4, P335
   Goncalves LF, 2006, J ULTRAS MED, V25, P745, DOI 10.7863/jum.2006.25.6.745
   Goncalves LF, 2006, J ULTRAS MED, V25, P691, DOI 10.7863/jum.2006.25.6.691
   GRAHAM TP, 1973, CIRCULATION, V47, P144, DOI 10.1161/01.CIR.47.1.144
   Hung J, 2007, J AM SOC ECHOCARDIOG, V20, P213, DOI 10.1016/j.echo.2007.01.010
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lu XZ, 2008, AM HEART J, V155, P946, DOI 10.1016/j.ahj.2007.11.034
   Lu XZ, 2008, J AM SOC ECHOCARDIOG, V21, P84, DOI 10.1016/j.echo.2007.05.009
   Messing B, 2007, ULTRASOUND OBST GYN, V30, P142, DOI 10.1002/uog.4036
   Messing B, 2011, ULTRASOUND OBST GYN, V38, P191, DOI 10.1002/uog.8980
   Mielke G, 2001, CIRCULATION, V103, P1662, DOI 10.1161/01.CIR.103.12.1662
   Molina FS, 2008, ULTRASOUND OBST GYN, V32, P181, DOI 10.1002/uog.5374
   Myerson SG, 2002, HYPERTENSION, V40, P673, DOI 10.1161/01.HYP.0000036401.99908.DB
   Rizzo G, 2007, PRENATAL DIAG, V27, P1147, DOI 10.1002/pd.1870
   Rizzo G, 2010, J ULTRAS MED, V29, P261, DOI 10.7863/jum.2010.29.2.261
   RUDOLPH AM, 1976, AM J OBSTET GYNECOL, V124, P183, DOI 10.1016/S0002-9378(16)33296-3
   Sapin PM, 1996, AM J HYPERTENS, V9, P467, DOI 10.1016/0895-7061(95)00394-0
   SCHMIDT KG, 1995, AM J CARDIOL, V76, P1313, DOI 10.1016/S0002-9149(99)80365-8
   SCHMIDT KG, 1990, CIRCULATION, V81, P325, DOI 10.1161/01.CIR.81.1.325
   SIIMES ASI, 1978, AM J OBSTET GYNECOL, V132, P42, DOI 10.1016/0002-9378(78)90796-2
   Simioni C, 2012, REV BRAS CIR CARDIOV, V27, P275, DOI 10.5935/1678-9741.20120058
   Simioni C, 2011, J MATERN-FETAL NEO M, V24, P1159, DOI 10.3109/14767058.2010.545921
   Simpson JM, 2002, ULTRASOUND OBST GYN, V20, P332, DOI 10.1046/j.1469-0705.2002.00799.x
   Sklansky MS, 2004, J ULTRAS MED, V23, P283, DOI 10.7863/jum.2004.23.2.283
   Soriano BD, 2008, CIRCULATION, V117, P1842, DOI 10.1161/CIRCULATIONAHA.107.715854
   Yagel S, 2007, ULTRASOUND OBST GYN, V29, P81, DOI 10.1002/uog.3912
NR 32
TC 9
Z9 11
U1 1
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 14
PY 2013
VL 8
IS 3
AR e58494
DI 10.1371/journal.pone.0058494
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 109YM
UT WOS:000316407400035
PM 23516490
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Craft, ME
   Beyer, HL
   Haydon, DT
AF Craft, Meggan E.
   Beyer, Hawthorne L.
   Haydon, Daniel T.
TI Estimating the Probability of a Major Outbreak from the Timing of Early
   Cases: An Indeterminate Problem?
SO PLOS ONE
LA English
DT Article
ID INFECTIOUS PERIODS; DISEASE; MODELS; DISTRIBUTIONS; EPIDEMICS; DYNAMICS;
   MEASLES
AB Conservation biologists, as well as veterinary and public health officials, would benefit greatly from being able to forecast whether outbreaks of infectious disease will be major. For values of the basic reproductive number (R-0) between one and two, infectious disease outbreaks have a reasonable chance of either fading out at an early stage or, in the absence of intervention, spreading widely within the population. If it were possible to predict when fadeout was likely to occur, the need for costly precautionary control strategies could be minimized. However, the predictability of even simple epidemic processes remains largely unexplored. Here we conduct an examination of simulated data from the early stages of a fatal disease outbreak and explore how observable information might be useful for predicting major outbreaks. Specifically, would knowing the time of deaths for the first few cases allow us to predict whether an outbreak will be major? Using two approaches, trajectory matching and discriminant function analysis, we find that even in our best-case scenario (with accurate knowledge of epidemiological parameters, and precise times of death), it was not possible to reliably predict the outcome of a stochastic Susceptible-Exposed-Infectious-Recovered (SEIR) process.
C1 [Craft, Meggan E.; Beyer, Hawthorne L.; Haydon, Daniel T.] Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow, Lanark, Scotland.
   [Craft, Meggan E.] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA.
   [Beyer, Hawthorne L.] Univ Queensland, ARC Ctr Excellence Environm Decis, Brisbane, Qld, Australia.
RP Craft, ME (reprint author), Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow, Lanark, Scotland.
EM craft@umn.edu
RI Craft, Meggan/A-9393-2012; Beyer, Hawthorne/F-8050-2013
OI Craft, Meggan/0000-0001-5333-8513; Beyer, Hawthorne/0000-0002-5430-0784;
   Haydon, Daniel/0000-0002-1240-1886
FU National Science Foundation [OISE-0804186]; Leverhulme Trust
FX Financial support for MC was provided by the National Science Foundation
   (OISE-0804186) and for HLB was provided by the Leverhulme Trust. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR ANDERSON D, 1980, BIOMETRIKA, V67, P191
   ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005
   Anderson RM, 1992, INFECT DIS HUMANS DY
   BAILEY NTJ, 1953, BIOMETRIKA, V40, P279
   Barlow ND, 1996, J APPL ECOL, V33, P303, DOI 10.2307/2404752
   BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553
   Conlan AJK, 2010, J R SOC INTERFACE, V7, P623, DOI 10.1098/rsif.2009.0284
   Cox D. R., 1965, THEORY STOCHASTIC PR
   DRAKE JM, 2005, PLOS MED, V0003
   GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008
   Hampson K, 2009, PLOS BIOL, V7, P462, DOI 10.1371/journal.pbio.1000053
   Handel A, 2007, P R SOC B, V274, P833, DOI 10.1098/rspb.2006.0015
   Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830
   Haydon DT, 2006, NATURE, V443, P692, DOI 10.1038/nature05177
   Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P121, DOI 10.1098/rspb.2002.2191
   Keeling M. J., 2008, MODELING INFECT DIS
   Kenah E, 2011, INTERDISCIPLINARY PE, V2011
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P985, DOI 10.1098/rspb.2001.1599
   Meyers LA, 2006, J THEOR BIOL, V240, P400, DOI 10.1016/j.jtbi.2005.10.004
   MOLLISON D, 1994, J ROY STAT SOC A STA, V157, P115, DOI 10.2307/2983509
   R Development Core Team, 2012, R LANG ENV STAT COMP
   Trapman P, 2009, MATH BIOSCI, V219, P15, DOI 10.1016/j.mbs.2009.02.001
   Venables W. N, 2002, MODERN APPL STAT S
NR 24
TC 6
Z9 6
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 6
PY 2013
VL 8
IS 3
AR e57878
DI 10.1371/journal.pone.0057878
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 117EP
UT WOS:000316936100050
PM 23483934
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chaudhuri, KR
   Rojo, JM
   Schapira, AHV
   Brooks, DJ
   Stocchi, F
   Odin, P
   Antonini, A
   Brown, RJ
   Martinez-Martin, P
AF Chaudhuri, Kallol Ray
   Manuel Rojo, Jose
   Schapira, Anthony H. V.
   Brooks, David J.
   Stocchi, Fabrizio
   Odin, Per
   Antonini, Angelo
   Brown, Richard J.
   Martinez-Martin, Pablo
TI A Proposal for a Comprehensive Grading of Parkinson's Disease Severity
   Combining Motor and Non-Motor Assessments: Meeting an Unmet Need
SO PLOS ONE
LA English
DT Article
ID QUALITY-OF-LIFE; SYMPTOMS QUESTIONNAIRE; SCALE; MULTICENTER;
   PROGRESSION; VALIDATION; IMPRESSION; SUBTYPES; INDEX
AB Background: Non-motor symptoms are present in Parkinson's disease (PD) and a key determinant of quality of life. The Non-motor Symptoms Scale (NMSS) is a validated scale that allows quantifying frequency and severity (burden) of NMS. We report a proposal for using NMSS scores to determine levels of NMS burden (NMSB) and to complete PD patient classification.
   Methods: This was an observational, cross-sectional international study of 935 consecutive patients. Using a distribution of NMSS scores by quartiles, a classification based on levels from 0 (no NMSB at all) to 4 (very severe NMSB) was obtained and its relation with Hoehn and Yahr (HY) staging, motor and health-related quality of life scales was analyzed. Concordance between NMSB levels and grouping based on clinician's global impression of severity, using categorical regression, was determined. Disability and HRQoL predictors were identified by multiple regression models.
   Results: The distribution of motor and QoL scales scores by HY and NMSB levels was significantly discriminative. The difference in the classification of cases for both methods, HY and NMSB, was significant (gamma = 0.45; ASE = 0.032). Concordance between NMSB and global severity-based levels from categorical regression was 91.8%, (kappa(w) = 0.97). NMS score was predictor of disability and QoL.
   Conclusions: Current clinical practice does not address a need for inclusion of non-motor scores in routine assessment of PD in spite of the overwhelming influence of NMS on disability and quality of life. Our data overcome the problems of "pure motor assessment'' and we propose a combined approach with addition of NMSB levels to standard motor assessments.
C1 [Chaudhuri, Kallol Ray] Kings Coll Hosp London, Natl Parkinson Fdn Ctr Excellence, London, England.
   [Chaudhuri, Kallol Ray] Kings Coll London, London WC2R 2LS, England.
   [Chaudhuri, Kallol Ray] Univ Hosp Lewisham, London, England.
   [Manuel Rojo, Jose] Spanish Council Sci Res, Ctr Human & Social Sci, Dept Stat, Madrid, Spain.
   [Schapira, Anthony H. V.] UCL, Inst Neurol, London, England.
   [Brooks, David J.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England.
   [Stocchi, Fabrizio] IRCCS San Raffaele, Dept Neurol, Rome, Italy.
   [Odin, Per] Univ Lund Hosp, Dept Neurol, S-22185 Lund, Sweden.
   [Antonini, Angelo] IRCCS San Camillo, Dept Parkinsons Dis, Venice, Italy.
   [Brown, Richard J.] Kings Coll London, Inst Psychiat, Dept Psychol, London WC2R 2LS, England.
   [Martinez-Martin, Pablo] Alzheimer Ctr Reina Sofia Fdn, Carlos Inst Hlth 3, CIEN Fdn, Alzheimer Dis Res Unit, Madrid, Spain.
   [Martinez-Martin, Pablo] Alzheimer Ctr Reina Sofia Fdn, Carlos Inst Hlth 3, CIEN Fdn, CIBERNED, Madrid, Spain.
RP Martinez-Martin, P (reprint author), Alzheimer Ctr Reina Sofia Fdn, Carlos Inst Hlth 3, CIEN Fdn, Alzheimer Dis Res Unit, Madrid, Spain.
EM pmartinez@isciii.es
RI Martinez-Martin, Pablo/N-9909-2019; Antonini, Angelo/H-9726-2019;
   Schapira, Anthony/A-1245-2010
OI Martinez-Martin, Pablo/0000-0003-0837-5280; Antonini,
   Angelo/0000-0003-1040-2807; Schapira, Anthony/0000-0002-3018-3966;
   Brooks, David/0000-0003-2602-2518; Ray Chaudhuri, K/0000-0003-2815-0505;
   Brown, Richard/0000-0001-9021-0172; Stocchi,
   Fabrizio/0000-0002-5763-0033
FU Parkinson's disease non motor group, a non profit academic society;
   Parkinson's UK; Britannia Pharma; Boehriger-Ingelheim; Abbott; UCB
   pharma; Movement Disorders Society; European Parkinson's Disease
   Association
FX Funding for this study came from various sources and includes peer
   reviewed funding from Parkinson's disease non motor group, a non profit
   academic society as well as Parkinson's UK through support of steering
   group meetings and data collection. The study had also been supported by
   unrestricted academic educational grants from Britannia Pharma,
   Boehriger-Ingelheim, Abbott and UCB pharma. No additional external
   funding was received for this study. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.; The authors have the following
   interests. This study was partly supported by unrestricted academic
   educational grants from Britannia Pharma, Boehriger-Ingelheim, Abbott
   and UCB pharma. There are no patents, products in development or
   marketed products to declare. This does not alter the authors' adherence
   to all the PLOS ONE policies on sharing data and materials, as detailed
   online in the guide for authors.; We acknowledge all contributors to the
   non-motor scale validation programmes which generated the data for this
   analytical study (Annex S1). The original non-motor symptoms scale was
   developed by the international Parkinson's disease non-motor group also
   supported by Parkinson's UK and the Movement Disorders Society. Current
   work was also supported by the European Parkinson's Disease Association.
   The work has also been reviewed as relevant to patient lives and
   management by an expert patient group CRISP recognised by the UK
   Department of Health research network. We thank Miss Kristina Rokenes
   Karlsen for editorial help with manuscript and figures. We would also
   like to thank Dr. Antoniya Todorova for her help with references and
   submission of the manuscript.
CR Antonini A, 2012, J NEUROL, V259, P2621, DOI 10.1007/s00415-012-6557-8
   Berg Daniela, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS195, DOI 10.1016/S1353-8020(11)70061-X
   Bowling A., 2005, MEASURING HLTH REV Q
   Burn DJ, 2012, MOVEMENT DISORD, V27, P379, DOI 10.1002/mds.24041
   Calne D, 2005, PARKINSONISM RELAT D, V11, pS39, DOI 10.1016/j.parkreldis.2005.01.008
   Chaudhuri KR, 2010, MOVEMENT DISORD, V25, P704, DOI 10.1002/mds.22868
   Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7
   Chaudhuri KR, 2007, MOVEMENT DISORD, V22, P1901, DOI 10.1002/mds.21596
   Chaudhuri KR, 2006, MOVEMENT DISORD, V21, P916, DOI 10.1002/mds.20844
   Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8
   Damiano AM, 1999, QUAL LIFE RES, V8, P235, DOI 10.1023/A:1008823222574
   Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956
   HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427
   HUGHES AJ, 1993, ARCH NEUROL-CHICAGO, V50, P140, DOI 10.1001/archneur.1993.00540020018011
   Jellinger KA, 2012, MOVEMENT DISORD, V27, P8, DOI 10.1002/mds.23795
   Jenkinson C, 1997, PSYCHOL HEALTH, V12, P805, DOI 10.1080/08870449708406741
   Kingsbury AE, 2010, MOVEMENT DISORD, V25, P2508, DOI 10.1002/mds.23305
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X
   Marinus J, 2004, J NEUROL NEUROSUR PS, V75, P388, DOI 10.1136/jnnp.2003.017509
   Martinez-Martin P, 2006, MOVEMENT DISORD, V21, P208, DOI 10.1002/mds.20697
   Martinez-Martin P, 2005, J CLIN EPIDEMIOL, V58, P674, DOI 10.1016/j.jclinepi.2004.09.014
   Martinez-Martin P, 2009, NEUROLOGY, V73, P1584, DOI 10.1212/WNL.0b013e3181c0d416
   Martinez-Martin P, 2007, MOVEMENT DISORD, V22, P1623, DOI 10.1002/mds.21586
   Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P2371, DOI 10.1002/mds.23834
   Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462
   Martinez-Martin P, 2009, MOVEMENT DISORD, V24, P211, DOI 10.1002/mds.22320
   Mavandadi S, 2009, AM J GERIAT PSYCHIAT, V17, P986, DOI 10.1097/JGP.0b013e3181b215ec
   Muller B, 2011, MOVEMENT DISORD, V26, P65, DOI 10.1002/mds.23387
   Politis M, 2010, MOVEMENT DISORD, V25, P1646, DOI 10.1002/mds.23135
   Schapira AHV, 2011, NAT REV NEUROL, V7, P247, DOI 10.1038/nrneurol.2011.40
   Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308
   Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P67, DOI 10.1136/jnnp.69.1.67
   Sherbourne CD, 1999, J GEN INTERN MED, V14, P357, DOI 10.1046/j.1525-1497.1999.00354.x
   Shulman LM, 2002, PARKINSONISM RELAT D, V8, P193, DOI 10.1016/S1353-8020(01)00015-3
   Stern MB, 2012, MOVEMENT DISORD, V27, P54, DOI 10.1002/mds.24051
   van Rooden SM, 2011, MOVEMENT DISORD, V26, P51, DOI 10.1002/mds.23346
   Wickremaratchi MM, 2011, MOVEMENT DISORD, V26, P457, DOI [10.1002/mds.23469, 10.1002/23469]
   WILLIAMS A, 1990, HEALTH POLICY, V16, P199
NR 39
TC 38
Z9 41
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 27
PY 2013
VL 8
IS 2
AR e57221
DI 10.1371/journal.pone.0057221
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 098BN
UT WOS:000315519000079
PM 23468940
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Jensen, CB
   Thorne-Lyman, AL
   Hansen, LV
   Strom, M
   Nielsen, NO
   Cohen, A
   Olsen, SF
AF Jensen, Camilla Bjorn
   Thorne-Lyman, Andrew L.
   Hansen, Linda Vadgard
   Strom, Marin
   Nielsen, Nina Odgaard
   Cohen, Arieh
   Olsen, Sjurdur Frodi
TI Development and Validation of a Vitamin D Status Prediction Model in
   Danish Pregnant Women: A Study of the Danish National Birth Cohort
SO PLOS ONE
LA English
DT Article
ID 25-HYDROXYVITAMIN D; D INSUFFICIENCY; PLASMA 25-HYDROXYVITAMIN-D; D
   DEFICIENCY; POPULATION; DETERMINANTS; HEALTH; RISK; METAANALYSIS;
   ADOLESCENTS
AB Vitamin D has been hypothesized to reduce risk of pregnancy complications such as preeclampsia, gestational diabetes mellitus, and preterm delivery. However, many of these outcomes are rare and require a large sample size to study, representing a challenge for cohorts with a limited number of preserved samples. The aims of this study were to (1) identify predictors of serum 25-hydroxy-vitamin D (25(OH)D) among pregnant women in a subsample (N = 1494) of the Danish National Birth Cohort (DNBC) and (2) develop and validate a score predicting 25(OH)D-status in order to explore associations between vitamin D and maternal and offspring health outcomes in the DNBC. In our study sample, 42.3% of the population had deficient levels of vitamin D (<50 nmol/L 25(OH)D) and average levels of 25(OH)D-status were 56.7(s.d. 24.6) nmol/L. A prediction model consisting of intake of vitamin D from diet and supplements, outdoor physical activity, tanning bed use, smoking, and month of blood draw explained 40.1% of the variance in 25(OH)D and mean measured 25(OH)D-level increased linearly by decile of predicted 25(OH)D-score. In total 32.2% of the women were placed in the same quintile by both measured and predicted 25(OH)D-values and 69.9% were placed in the same or adjacent quintile by both methods. Cohen's weighted kappa coefficient (K = 0.3) reflected fair agreement between measured 25(OH)D-levels and predicted 25(OH)D-score. These results are comparable to other settings in which vitamin D scores have shown similar associations with disease outcomes as measured 25(OH)D-levels. Our findings suggest that predicted 25(OH)D-scores may be a useful alternative to measured 25(OH)D for examining associations between vitamin D and disease outcomes in the DNBC cohort, but cannot substitute for measured 25(OH)D-levels for estimates of prevalence.
C1 [Jensen, Camilla Bjorn; Hansen, Linda Vadgard; Strom, Marin; Olsen, Sjurdur Frodi] Statens Serum Inst, Dept Epidemiol Res, Ctr Fetal Programming, DK-2300 Copenhagen, Denmark.
   [Thorne-Lyman, Andrew L.; Olsen, Sjurdur Frodi] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [Nielsen, Nina Odgaard] Univ So Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.
   [Cohen, Arieh] Statens Serum Inst, Dept Clin Biochem, DK-2300 Copenhagen, Denmark.
RP Strom, M (reprint author), Statens Serum Inst, Dept Epidemiol Res, Ctr Fetal Programming, DK-2300 Copenhagen, Denmark.
EM mrm@ssi.dk
OI Strom, Marin/0000-0003-1926-6610
FU Danish National Research Foundation; March of Dimes Birth Defects
   Foundation; Pharmacy Foundation; Egmont Foundation; Augustinus
   Foundation; Health Foundation; European Union [QLK1-2000-00 083];
   Lundbeck Foundation [R13-A907]; Danish Council [09-067124]; U.S.
   National Institutes of Health (NIH) [T32 DK 007703]
FX The DNBC was funded by the Danish National Research Foundation, March of
   Dimes Birth Defects Foundation, Pharmacy Foundation, Egmont Foundation,
   Augustinus Foundation, the Health Foundation and the European Union
   (QLK1-2000-00 083). We would like to acknowledge the Managerial Team of
   the Danish National Birth Cohort. The study was supported by the
   Lundbeck Foundation (R13-A907). The study is a part of the research
   program of the Centre for Fetal Programming (CFP). CFP is supported by
   the Danish Council for Strategic Research (grant 09-067124). Andrew
   Thorne-Lyman is supported by training grant T32 #DK 007703 from the U.S.
   National Institutes of Health (NIH). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Andersen R, 2005, EUR J CLIN NUTR, V59, P533, DOI 10.1038/sj.ejcn.1602108
   Bertrand KA, 2012, BR J NUTR, P1
   Bodnar LM, 2010, OBSTET GYNECOL SURV, V65, P273, DOI 10.1097/OGX.0b013e3181dbc55b
   Bodnar LM, 2010, J NUTR, V140, P999, DOI 10.3945/jn.109.119636
   Bodnar LM, 2009, BRIT J NUTR, V101, P278, DOI 10.1017/S0007114508981460
   Brot C, 2001, BRJ NUTR S1, V86, pS97
   BRUINSE HW, 1995, EUR J OBSTET GYN R B, V61, P31, DOI 10.1016/0028-2243(95)02150-Q
   Chan J, 2010, CANCER CAUSE CONTROL, V21, P501, DOI 10.1007/s10552-009-9481-1
   Davis LM, 2010, J PEDIATR ADOL GYNEC, V23, P45, DOI 10.1016/j.jpag.2009.05.005
   Egan KM, 2008, CANCER CAUSE CONTROL, V19, P527, DOI 10.1007/s10552-008-9115-z
   Gozdzik A, 2008, BMC PUBLIC HEALTH, V8, P1471
   Hill TR, 2008, BRIT J NUTR, V99, P1061, DOI 10.1017/S0007114507842826
   Hirani V, 2009, BRIT J NUTR, V101, P760, DOI 10.1017/S0007114508023416
   Holick MF, 2011, JINVESTIGMED
   Holick MF, 2008, AM J CLIN NUTR, V87, P1080
   Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553
   Holick MF, 2011, J INVEST MED, V59, P872, DOI 10.2310/JIM.0b013e318214ea2d
   Holmes VA, 2009, BRIT J NUTR, V102, P876, DOI 10.1017/S0007114509297236
   Husemoen LL, 2012, DIABETES CARE, P1935
   Jacobs ET, 2008, AM J CLIN NUTR, V87, P608
   Jacques PF, 1997, AM J CLIN NUTR, V66, P929
   Kaludjerovic J, 2010, J MIDWIFERY WOM HEAL, V55, P550, DOI 10.1016/j.jmwh.2010.02.016
   KUMAR R, 1994, SOC PSYCH PSYCH EPID, V29, P250, DOI 10.1007/BF00802048
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lappe JM, 2006, J AM COLL NUTR, V25, P395, DOI 10.1080/07315724.2006.10719551
   Li WY, 2011, CAN J PUBLIC HEALTH, V102, P308
   McCullough ML, 2010, AM J EPIDEMIOL, V172, P21, DOI 10.1093/aje/kwq113
   McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110
   McKinney K, 2008, CLIN ENDOCRINOL, V69, P535, DOI 10.1111/j.1365-2265.2008.03233.x
   OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816
   Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201
   Olsen SF, 2007, PAEDIATR PERINAT EP, V21, P76, DOI 10.1111/j.1365-3016.2007.00777.x
   Pazaitou-Panayiotou K, 2012, EXP CLIN ENDOCR DIAB, V120, P14, DOI 10.1055/s-0031-1285912
   Rock CL, 1999, J NUTR, V129, P855
   Roth DE, 2011, J PERINATOL, V31, P449, DOI 10.1038/jp.2010.203
   Thorne-Lyman A, 2012, PAEDIATR PERINAT EP, V26, P75, DOI 10.1111/j.1365-3016.2012.01283.x
   Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016
   van der Meer IM, 2008, CLIN ENDOCRINOL, V68, P466, DOI 10.1111/j.1365-2265.2007.03066.x
   Wu K, 2007, J NATL CANCER I, V99, P1120, DOI 10.1093/jnci/djm038
NR 39
TC 29
Z9 29
U1 0
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 9
PY 2013
VL 8
IS 1
AR e53059
DI 10.1371/journal.pone.0053059
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 070YR
UT WOS:000313551500046
PM 23326380
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Sandeu, MM
   Moussiliou, A
   Moiroux, N
   Padonou, GG
   Massougbodji, A
   Corbel, V
   Ndam, NT
AF Sandeu, Maurice Marcel
   Moussiliou, Azizath
   Moiroux, Nicolas
   Padonou, Gilles G.
   Massougbodji, Achille
   Corbel, Vincent
   Ndam, Nicaise Tuikue
TI Optimized Pan-species and Speciation Duplex Real-time PCR Assays for
   Plasmodium Parasites Detection in Malaria Vectors
SO PLOS ONE
LA English
DT Article
ID POLYMERASE-CHAIN-REACTION; LINKED IMMUNOSORBENT-ASSAY; CIRCUMSPOROZOITE
   PROTEIN; ANOPHELES-GAMBIAE; FALCIPARUM; ELISA; SPOROZOITES; MOSQUITOS;
   SENSITIVITY; BLOOD
AB Background: An accurate method for detecting malaria parasites in the mosquito's vector remains an essential component in the vector control. The Enzyme linked immunosorbent assay specific for circumsporozoite protein (ELISA-CSP) is the gold standard method for the detection of malaria parasites in the vector even if it presents some limitations. Here, we optimized multiplex real-time PCR assays to accurately detect minor populations in mixed infection with multiple Plasmodium species in the African malaria vectors Anopheles gambiae and Anopheles funestus.
   Methods: Complementary TaqMan-based real-time PCR assays that detect Plasmodium species using specific primers and probes were first evaluated on artificial mixtures of different targets inserted in plasmid constructs. The assays were further validated in comparison with the ELISA-CSP on 200 field caught Anopheles gambiae and Anopheles funestus mosquitoes collected in two localities in southern Benin.
   Results: The validation of the duplex real-time PCR assays on the plasmid mixtures demonstrated robust specificity and sensitivity for detecting distinct targets. Using a panel of mosquito specimen, the real-time PCR showed a relatively high sensitivity (88.6%) and specificity (98%), compared to ELISA-CSP as the referent standard. The agreement between both methods was "excellent'' (k = 0.8, P < 0.05). The relative quantification of Plasmodium DNA between the two Anopheles species analyzed showed no significant difference (P = 0, 2). All infected mosquito samples contained Plasmodium falciparum DNA and mixed infections with P. malariae and/or P. ovale were observed in 18.6% and 13.6% of An. gambiae and An. funestus respectively. Plasmodium vivax was found in none of the mosquito samples analyzed.
   Conclusion: This study presents an optimized method for detecting the four Plasmodium species in the African malaria vectors. The study highlights substantial discordance with traditional ELISA-CSP pointing out the utility of employing an accurate molecular diagnostic tool for detecting malaria parasites in field mosquito populations.
C1 [Sandeu, Maurice Marcel; Moussiliou, Azizath; Massougbodji, Achille; Ndam, Nicaise Tuikue] FSS, CERPAGE, Cotonou, Benin.
   [Sandeu, Maurice Marcel; Moiroux, Nicolas; Padonou, Gilles G.; Corbel, Vincent] Univ Abomey Calavi, CREC, Cotonou, Benin.
   [Sandeu, Maurice Marcel; Moiroux, Nicolas; Corbel, Vincent] Inst Rech Dev IRD 224, Cotonou, Benin.
   [Moussiliou, Azizath; Ndam, Nicaise Tuikue] Inst Rech Dev IRD 216, Cotonou, Benin.
   [Ndam, Nicaise Tuikue] Univ Paris 05, Fac Pharm, PRES Sorbonne Paris Cite, Paris, France.
RP Ndam, NT (reprint author), FSS, CERPAGE, Cotonou, Benin.
EM nicaise.ndam@ird.fr
RI Corbel, VIncent/G-9576-2016
OI Moiroux, Nicolas/0000-0001-6755-6167; Tuikue Ndam,
   Nicaise/0000-0003-2646-2513
FU LMI LLIP "Laboratoire de lutte integree contre le paludisme: Institut de
   recherche pour le developpement; Institut des sciences biomedicales -
   ISBA (Cotonou, BENIN); Faculte des sciences de la sante - FSS (Cotonou,
   BENIN); Centre de Recherche Entomologique de Cotonou - CREC (Cotonou,
   BENIN) -(USAID); DPF/IRD
FX The current study was financially supported by the LMI LLIP "Laboratoire
   de lutte integree contre le paludisme: Institut de recherche pour le
   developpement, Institut des sciences biomedicales - ISBA (Cotonou,
   BENIN), Faculte des sciences de la sante - FSS (Cotonou, BENIN), Centre
   de Recherche Entomologique de Cotonou - CREC (Cotonou, BENIN) -(USAID).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.; Plasmodium
   genomic DNAs of P. vivax, P. malariae or P. ovale and plasmids
   containing insert of the 18S gene of each of those species were kindly
   provided by Dr Stephanie Yanow at the Provincial Laboratory for Public
   Health, Edmonton, Alberta, Canada. We thank all the inhabitants of the
   districts (Adjarra, Adjohoun, Dangbo, Misserete, and Seme) who agreed to
   participate in the study. We are very grateful to the mosquito
   collectors staff. MS was supported by PhD studentships from DPF/IRD.
CR Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1
   Arez AP, 2000, EXP PARASITOL, V94, P269, DOI 10.1006/expr.2000.4496
   BEIER JC, 1991, MED VET ENTOMOL, V5, P81, DOI 10.1111/j.1365-2915.1991.tb00524.x
   Bigoga JD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-5
   BURKOT TR, 1984, AM J TROP MED HYG, V33, P783, DOI 10.4269/ajtmh.1984.33.783
   COLLINS FH, 1988, AM J TROP MED HYG, V38, P283, DOI 10.4269/ajtmh.1988.38.283
   Damien GB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-380
   Dana AN, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-5
   de Monbrison F, 2003, J MICROBIOL METH, V54, P391, DOI 10.1016/s0167-7012(03)00086-1
   Diallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031100
   Dicko A, 2011, LANCET INFECT DIS, V11, P722, DOI 10.1016/S1473-3099(11)70186-4
   Durnez L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-195
   Edwards FR, 1941, BRIT MED J, V1941, P901, DOI 10.1136/bmj.2.4225.901
   Figtree M, 2010, EMERG INFECT DIS, V16, P672, DOI 10.3201/eid1604.091624
   Gillies MT, 1987, SUPPLEMENT ANOPHELIN
   Gillies MT, 1968, ANOPHELINAE AFRICA S
   Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lochouarn L, 1999, T ROY SOC TROP MED H, V93, P101, DOI 10.1016/S0035-9203(99)90198-0
   Moiroux N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030558
   Mouatcho JC, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-30
   POSTHUMA G, 1989, EUR J CELL BIOL, V49, P66
   Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004
   SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520
   Shokoples SE, 2009, J CLIN MICROBIOL, V47, P975, DOI 10.1128/JCM.01858-08
   SNIGS, 2010, RAPP ACT 2010 IRD BE
   SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B
   SNOUNOU G, 1993, T ROY SOC TROP MED H, V87, P649, DOI 10.1016/0035-9203(93)90274-T
   SOMBOON P, 1993, T ROY SOC TROP MED H, V87, P322, DOI 10.1016/0035-9203(93)90148-J
   Sylla EHK, 2000, T ROY SOC TROP MED H, V94, P652, DOI 10.1016/S0035-9203(00)90219-0
   TASSANAKAJON A, 1993, T ROY SOC TROP MED H, V87, P273, DOI 10.1016/0035-9203(93)90124-9
   Vo TKD, 2007, T ROY SOC TROP MED H, V101, P422, DOI 10.1016/j.trstmh.2006.09.004
   WHO, 2011, WORLD MALARIA REPORT 2011, P1
   *WHO UN CHILDR FUN, 2005, WORLD MAL REP 2005
   WIRTZ RA, 1987, B WORLD HEALTH ORGAN, V65, P39
NR 35
TC 16
Z9 16
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 28
PY 2012
VL 7
IS 12
AR e52719
DI 10.1371/journal.pone.0052719
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 064DQ
UT WOS:000313051500052
PM 23285168
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Huerga, H
   Varaine, F
   Okwaro, E
   Bastard, M
   Ardizzoni, E
   Sitienei, J
   Chakaya, J
   Bonnet, M
AF Huerga, Helena
   Varaine, Francis
   Okwaro, Eric
   Bastard, Mathieu
   Ardizzoni, Elisa
   Sitienei, Joseph
   Chakaya, Jeremiah
   Bonnet, Maryline
TI Performance of the 2007 WHO Algorithm to Diagnose Smear-Negative
   Pulmonary Tuberculosis in a HIV Prevalent Setting
SO PLOS ONE
LA English
DT Article
ID MYCOBACTERIUM-TUBERCULOSIS; FLUORESCENCE MICROSCOPY; DEVELOPING-COUNTRY;
   COST-EFFECTIVENESS; CULTURE; INFECTION; IMPLEMENTATION; PEOPLE; UGANDA;
   MEDIA
AB Background: The 2007 WHO algorithm for diagnosis of smear-negative pulmonary tuberculosis (PTB) including Mycobacterium tuberculosis (MTB) culture was evaluated in a HIV prevalent area of Kenya.
   Methods: PTB smear-negative adult suspects were included in a prospective diagnostic study (2009-2011). In addition, program data (2008-2009) were retrospectively analysed. At the first consultation, clinical examination, chest X-ray, and sputum culture (Thin-Layer-Agar and Lowenstein-Jensen) were performed. Patients not started on TB treatment were clinically re-assessed after antibiotic course. The algorithm performance was calculated using culture as reference standard.
   Results: 380 patients were included prospectively and 406 analyzed retrospectively. Culture was positive for MTB in 17.5% (61/348) and 21.8% (72/330) of cases. Sensitivity of the clinical-radiological algorithm was 55.0% and 31.9% in the prospective study and the program data analysis, respectively. Specificity, positive and negative predictive values were 72.9%, 29.7% and 88.6% in the prospective study and 79.8%, 30.7% and 80.8% in the program data analysis. Performing culture increased the number of confirmed TB patients started on treatment by 43.3% in the prospective study and by 44.4% in the program data analysis. Median time to treatment of confirmed TB patients was 6 days in the prospective study and 27 days in the retrospective study. Inter-reader agreement for X-ray interpretation between the study clinician and a radiologist was low (Kappa coefficient = 0.11, 95%CI: 0.09-0.12). In a multivariate logistic analysis, past TB history, number of symptoms and signs at the clinical exam were independently associated with risk of overtreatment.
   Conclusion: The clinical-radiological algorithm is suboptimal to diagnose smear-negative PTB. Culture increases significantly the proportion of confirmed TB cases started on treatment. Better access to rapid MTB culture and development of new diagnostic tests is necessary.
C1 [Huerga, Helena; Bastard, Mathieu; Bonnet, Maryline] Epictr, Dept Clin Res, Paris, France.
   [Varaine, Francis; Ardizzoni, Elisa] Med Sans Frontieres, Dept Med, Paris, France.
   [Okwaro, Eric] Med Sans Frontieres, Dist Hosp Lab, Homa Bay, Kenya.
   [Ardizzoni, Elisa] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium.
   [Sitienei, Joseph] Minist Hlth, Div Leprosy TB & Lung Dis, Nairobi, Kenya.
   [Chakaya, Jeremiah] Kenya Govt Med Res Ctr, Ctr Resp Dis Res, Nairobi, Kenya.
RP Huerga, H (reprint author), Epictr, Dept Clin Res, Paris, France.
EM helena.huerga@epicentre.msf.org
RI jingjing, cai/M-2687-2013
FU Medecins Sans Frontieres
FX This work was supported by Medecins Sans Frontieres. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript. However, some of the co-investigators
   and authors of this study work for this institution.
CR Bah B, 2002, INT J TUBERC LUNG D, V6, P592
   Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847
   Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488
   Cattamanchi A, 2009, INT J TUBERC LUNG D, V13, P1130
   Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024
   Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97
   Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859
   Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0
   Hepple P, 2011, INT J TUBERC LUNG D, V15, P405
   Kivihya-Ndugga LEA, 2003, INT J TUBERC LUNG D, V7, P1163
   Koole O, 2001, PLOS ONE, V6
   Kudjawu Y, 2006, INT J TUBERC LUNG D, V10, P441
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Martin A, 2009, J CLIN MICROBIOL, V47, P2632, DOI 10.1128/JCM.00264-09
   Martin A, 2009, J MICROBIOL METH, V78, P107, DOI 10.1016/j.mimet.2009.05.001
   Mejia GI, 1999, INT J TUBERC LUNG D, V3, P138
   Meja Gloria Isabel, 2004, Biomdica, V24, P52
   Ministry of Public Health and Sanitation, 2009, GUID MAN LEPR TUB
   Mueller DH, 2008, INT J TUBERC LUNG D, V12, P1196
   Nackers F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032140
   Pardini M, 2007, J CLIN MICROBIOL, V45, P575, DOI 10.1128/JCM.01985-06
   Rishi S, 2007, Indian J Med Microbiol, V25, P383
   Robledo JA, 2006, INT J TUBERC LUNG D, V10, P613
   Saranchuk P, 2007, SAMJ S AFR MED J, V97, P517
   Satti L, 2010, INT J TUBERC LUNG D, V14, P1354
   Siddiqi K, 2006, TROP MED INT HEALTH, V11, P323, DOI 10.1111/j.1365-3156.2006.01559.x
   Soto A, 2009, INT J INFECT DIS, V13, P40, DOI 10.1016/j.ijid.2008.03.023
   Soto A, 2011, TROP MED INT HEALTH, V16, P424, DOI 10.1111/j.1365-3156.2010.02715.x
   Swai Hedwiga F, 2011, BMC Res Notes, V4, P475, DOI 10.1186/1756-0500-4-475
   Tamhane A, 2009, INT J TUBERC LUNG D, V13, P347
   van Cleeff MRA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-111
   Walley J, 2011, JAIDS-J ACQ IMM DEF, V57, pE93, DOI 10.1097/QAI.0b013e3182243a8c
   Wilkinson D, 2000, INT J TUBERC LUNG D, V4, P513
   Wilson D, 2011, INT J TUBERC LUNG D, V15, P919, DOI 10.5588/ijtld.10.0440
   World Health Organization, 2012, TUB DIAGN XPERT MTB
   World Health Organization, 1998, LAB SERV TUB CONTR 2
   World Health Organization, 2007, IMPR DIAGN TREATM SM
   World Health Organization, 2010, REP CONCL REC STRAT
NR 38
TC 17
Z9 17
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 19
PY 2012
VL 7
IS 12
AR e51336
DI 10.1371/journal.pone.0051336
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 059HF
UT WOS:000312694300019
PM 23284681
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ebrahim, S
   Montoya, L
   Truong, W
   Hsu, S
   el Din, MK
   Carrasco-Labra, A
   Busse, JW
   Walter, SD
   Heels-Ansdell, D
   Couban, R
   Patelis-Siotis, I
   Bellman, M
   de Graaf, LE
   Dozois, DJA
   Bieling, PJ
   Guyatt, GH
AF Ebrahim, Shanil
   Montoya, Luis
   Wanda Truong
   Hsu, Sandy
   el Din, Mostafa Kamal
   Carrasco-Labra, Alonso
   Busse, Jason W.
   Walter, Stephen D.
   Heels-Ansdell, Diane
   Couban, Rachel
   Patelis-Siotis, Irene
   Bellman, Marg
   de Graaf, L. Esther
   Dozois, David J. A.
   Bieling, Peter J.
   Guyatt, Gordon H.
TI Effectiveness of Cognitive Behavioral Therapy for Depression in Patients
   Receiving Disability Benefits: A Systematic Review and Individual
   Patient Data Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID RANDOMIZED CONTROLLED-TRIAL; MONEY MATTERS; PRIMARY-CARE; COMPENSATION;
   DISORDER; ANXIETY; WORKERS; PSYCHOPATHOLOGY; ASSOCIATION; EFFICACY
AB Objectives: To systematically summarize the randomized trial evidence regarding the relative effectiveness of cognitive behavioural therapy (CBT) in patients with depression in receipt of disability benefits in comparison to those not receiving disability benefits.
   Data Sources: All relevant RCTs from a database of randomized controlled and comparative studies examining the effects of psychotherapy for adult depression (http://www.evidencebasedpsychotherapies.org), electronic databases (MEDLINE, EMBASE, PSYCINFO, AMED, CINAHL and CENTRAL) to June 2011, and bibliographies of all relevant articles.
   Study Eligibility Criteria, Participants and Intervention: Adult patients with major depression, randomly assigned to CBT versus minimal/no treatment or care-as-usual.
   Study Appraisal and Synthesis Methods: Three teams of reviewers, independently and in duplicate, completed title and abstract screening, full text review and data extraction. We performed an individual patient data meta-analysis to summarize data.
   Results: Of 92 eligible trials, 70 provided author contact information; of these 56 (80%) were successfully contacted to establish if they captured receipt of benefits as a baseline characteristic; 8 recorded benefit status, and 3 enrolled some patients in receipt of benefits, of which 2 provided individual patient data. Including both patients receiving and not receiving disability benefits, 2 trials (227 patients) suggested a possible reduction in depression with CBT, as measured by the Beck Depression Inventory, mean difference [MD] (95% confidence interval [CI]) = -2.61 (-5.28, 0.07), p = 0.06; minimally important difference of 5. The effect appeared larger, though not significantly, in those in receipt of benefits (34 patients) versus not receiving benefits (193 patients); MD (95% CI) = -4.46 (-12.21, 3.30), p = 0.26.
   Conclusions: Our data does not support the hypothesis that CBT has smaller effects in depressed patients receiving disability benefits versus other patients. Given that the confidence interval is wide, a decreased effect is still possible, though if the difference exists, it is likely to be small.
C1 [Ebrahim, Shanil; Carrasco-Labra, Alonso; Walter, Stephen D.; Heels-Ansdell, Diane; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.
   [Montoya, Luis] Santo Tomas Univ, Dept Dent, Bogota, Colombia.
   [Wanda Truong] McMaster Univ, McMaster Integrat Neurosci Discovery & Study Prog, Hamilton, ON, Canada.
   [Hsu, Sandy] McMaster Univ, Dept Oncol, Hamilton, ON, Canada.
   [el Din, Mostafa Kamal] Ain Shams Univ, Fac Med, Cairo, Egypt.
   [Carrasco-Labra, Alonso] Univ Chile, Fac Dent, Evidence Based Dent Unit, Santiago, Chile.
   [Busse, Jason W.; Couban, Rachel] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada.
   [Walter, Stephen D.] McMaster Univ, Dept Math & Stat, Hamilton, ON, Canada.
   [Patelis-Siotis, Irene] St Josephs Healthcare, Mood Disorders Program, Hamilton, ON, Canada.
   [Bellman, Marg] Sun Life Financial, Natl Disabil Serv, Policy & Procedure Dept, Toronto, ON, Canada.
   [de Graaf, L. Esther] Erasmus MC Univ, Med Ctr, Dept Med Psychol & Psychotherapy, Rotterdam, Netherlands.
   [Dozois, David J. A.] Univ Western Ontario, Dept Psychol, London, ON, Canada.
   [Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON, Canada.
RP Ebrahim, S (reprint author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.
EM shanil.ebrahim@utoronto.ca
OI Busse, Jason/0000-0002-0178-8712
FU Sun Life; MITACS Accelerate scholarship; Canadian Institutes of Health
   Research Doctoral Award; Canadian Institutes of Health Research;
   Canadian Chiropractic Research Foundation
FX The authors have read the journal's policy and have the following
   conflicts. Sun Life was supporting the MITACS scholarship for Shanil
   Ebrahim, and did not have a role in the study design, data collection
   and analysis, or preparation of the manuscript. Jason W. Busse acts as a
   consultant to Prisma Health Canada, a private incorporated company
   funded by employers and insurers that consults on and manages long-term
   disability claims. Marg Bellman is the assistant vice-president of the
   National Disability Services, Policy & Procedure department at Sun Life
   Financial. This does not alter the authors' adherence to all the PLOS
   ONE policies on sharing data and materials. All other authors have no
   affiliations with or involvement in any organization or entity with a
   direct interest of any kind in the subject matter or materials discussed
   in the manuscript. No financial support has been received for the
   creation of this manuscript.; There were no funds received for this
   study. Shanil Ebrahim was supported by MITACS Accelerate scholarship
   (partnered with Sun Life Financial Assurance Company of Canada) and the
   Canadian Institutes of Health Research Doctoral Award during the
   completion of this study. Jason W. Busse is supported by a New
   Investigator Award from the Canadian Institutes of Health Research and
   Canadian Chiropractic Research Foundation. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Akl EA, 2011, J CLIN EPIDEMIOL
   Almeida Alexander Moreira de, 2003, Rev. Bras. Psiquiatr., V25, P239, DOI 10.1590/S1516-44462003000400011
   American Psychiatry Association, 2010, DIAGN STAT MAN
   [Anonymous], 2002, MENT HLTH NEW UND NE
   Binder LM, 1996, AM J PSYCHIAT, V153, P7
   Bortolotti B, 2008, GEN HOSP PSYCHIAT, V30, P293, DOI 10.1016/j.genhosppsych.2008.04.001
   Churchill R, 2001, Health Technol Assess, V5, P1
   Cuijpers P, 2011, PSYCHOTHERAPY RANDOM
   Cuijpers P, 2008, BMC PSYCHIAT, V8
   Cuijpers P, 2010, BRIT J PSYCHIAT, V196, P173, DOI 10.1192/bjp.bp.109.066001
   Cuijpers P, 2009, BRIT J GEN PRACT, V59, P120, DOI 10.3399/bjgp09X395139
   de Graaf LE, 2009, BRIT J PSYCHIAT, V195, P73, DOI 10.1192/bjp.bp.108.054429
   Dewa CS, 2003, PSYCHIAT SERV, V54, P724, DOI 10.1176/appi.ps.54.5.724
   Dobson K. S., 2001, HDB COGNITIVE BEHAV, P3
   Dozois DJA, 2009, J CONSULT CLIN PSYCH, V77, P1078, DOI 10.1037/a0016886
   Ebrahim S, 2012, ASS PSYCHOT IN PRESS
   Faramarzi M, 2008, J AFFECT DISORDERS, V108, P159, DOI 10.1016/j.jad.2007.09.002
   Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943
   Gloaguen V, 1998, J AFFECT DISORDERS, V49, P59, DOI 10.1016/S0165-0327(97)00199-7
   Haby MM, 2006, AUST NZ J PSYCHIAT, V40, P9, DOI 10.1080/j.1440-1614.2006.01736.x
   Harrington R, 1998, BRIT MED J, V316, P1559, DOI 10.1136/bmj.316.7144.1559
   Harris I, 2005, JAMA-J AM MED ASSOC, V293, P1644, DOI 10.1001/jama.293.13.1644
   Higgins JPT, 2011, COCHRANE HDB SYSTEMA
   Hirschfeld RMA, 2000, J CLIN PSYCHIAT, V61, P268, DOI 10.4088/JCP.v61n0405
   HOLLON SD, 1992, ARCH GEN PSYCHIAT, V49, P774
   JPT Higgins, 2009, COCHRANE HDB SYSTEMA
   Kaltenthaler E, 2008, BRIT J PSYCHIAT, V193, P181, DOI 10.1192/bjp.bp.106.025981
   Kouzis AC, 2000, PSYCHIATR SERV, V51, P908, DOI 10.1176/appi.ps.51.7.908
   Kouzis AC, 1997, SOC PSYCH PSYCH EPID, V32, P379
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leahy R, 2003, ROADBLOCKS COGNITIVE
   Miranda J, 2003, JAMA-J AM MED ASSOC, V290, P57, DOI 10.1001/jama.290.1.57
   Misri S, 2004, J CLIN PSYCHIAT, V65, P1236, DOI 10.4088/JCP.v65n0913
   Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005
   Naeem F, 2011, BEHAV COGN PSYCHOTH, V39, P165, DOI 10.1017/S1352465810000822
   NICE, 2009, DEPR TREATM MAN DEPR
   Oei TPS, 2008, J AFFECT DISORDERS, V107, P5, DOI 10.1016/j.jad.2007.07.018
   Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81
   Olney J R, 1999, Iowa Orthop J, V19, P111
   Peng XD, 2009, J INT MED RES, V37, P975, DOI 10.1177/147323000903700401
   Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2
   Riley RD, 2007, J CLIN EPIDEMIOL, V60, P431, DOI 10.1016/j.jclinepi.2006.09.009
   ROHLING ML, 1995, HEALTH PSYCHOL, V14, P537, DOI 10.1037/0278-6133.14.6.537
   Salkever DS, 2000, MILBANK Q, V78, P79, DOI 10.1111/1468-0009.00162
   Snijders T., 1999, MULTILEVEL ANAL INTR
   Stewart WF, 2003, JAMA-J AM MED ASSOC, V289, P3135, DOI 10.1001/jama.289.23.3135
   Tendal B, 2011, BMJ, V343
   Thorlund K, 2012, RES SYNTHES IN PRESS
   Wampold BE, 2002, J AFFECT DISORDERS, V68, P159, DOI 10.1016/S0165-0327(00)00287-1
   WEIGHILL VE, 1983, J PSYCHOSOM RES, V27, P97, DOI 10.1016/0022-3999(83)90085-5
   Young JN, 1997, SURG NEUROL, V48, P552, DOI 10.1016/S0090-3019(97)00393-5
NR 51
TC 5
Z9 5
U1 1
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 29
PY 2012
VL 7
IS 11
AR e50202
DI 10.1371/journal.pone.0050202
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 051DI
UT WOS:000312104900033
PM 23209672
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Rialland, P
   Authier, S
   Guillot, M
   del Castillo, JRE
   Veilleux-Lemieux, D
   Frank, D
   Gauvin, D
   Troncy, E
AF Rialland, Pascale
   Authier, Simon
   Guillot, Martin
   del Castillo, Jerome R. E.
   Veilleux-Lemieux, Daphnee
   Frank, Diane
   Gauvin, Dominique
   Troncy, Eric
TI Validation of Orthopedic Postoperative Pain Assessment Methods for Dogs:
   A Prospective, Blinded, Randomized, Placebo-Controlled Study
SO PLOS ONE
LA English
DT Article
ID GENERALIZED ESTIMATING EQUATIONS; TOTAL KNEE REPLACEMENT; INDUCED
   SYNOVITIS; GAIT ANALYSIS; KINETIC GAIT; CARPROFEN; ANALGESIA; MORPHINE;
   SURGERY; MODEL
AB In the context of translational research, there is growing interest in studying surgical orthopedic pain management approaches that are common to humans and dogs. The validity of postoperative pain assessment methods is uncertain with regards to responsiveness and the potential interference of analgesia. The hypothesis was that video analysis (as a reference), electrodermal activity, and two subjective pain scales (VAS and 4A-VET) would detect different levels of pain intensity in dogs after a standardized trochleoplasty procedure. In this prospective, blinded, randomized study, postoperative pain was assessed in 25 healthy dogs during a 48-hour time frame (T). Pain was managed with placebo (Group 1, n = 10), preemptive and multimodal analgesia (Group 2, n = 5), or preemptive analgesia consisting in oral tramadol (Group 3, n = 10). Changes over time among groups were analyzed using generalized estimating equations. Multivariate regression tested the significance of relationships between pain scales and video analysis. Video analysis identified that one orthopedic behavior, namely 'Walking with full weight bearing' of the operated leg, decreased more in Group 1 at T24 (indicative of pain), whereas three behaviors indicative of sedation decreased in Group 2 at T24 (all p<0.004). Electrodermal activity was higher in Group 1 than in Groups 2 and 3 until T1 (p<0.0003). The VAS was not responsive. 4A-VET showed divergent results as its orthopedic component (4A-VETleg) detected lower pain in Group 2 until T12 (p<0.0009), but its interactive component (4A-VETbeh) was increased in Group 2 from T12 to T48 (p<0.001). Concurrent validity established that 4A-VETleg scores the painful orthopedic condition accurately and that pain assessment through 4A-VETbeh and VAS was severely biased by the sedative side-effect of the analgesics. Finally, the video analysis offered a concise template for assessment in dogs with acute orthopedic pain. However, subjective pain quantification methods and electrodermal activity need further investigation.
C1 [Rialland, Pascale; Authier, Simon; Guillot, Martin; del Castillo, Jerome R. E.; Veilleux-Lemieux, Daphnee; Gauvin, Dominique; Troncy, Eric] Univ Montreal, Fac Vet Med, Dept Biomed Sci, Grp Rech Pharmacol Anim Quebec GREPAQ, St Hyacinthe, PQ J2S 7C6, Canada.
   [Authier, Simon] CiToxLAB N Amer, Laval, PQ, Canada.
   [Frank, Diane] Univ Montreal, Fac Vet Med, Dept Clin Sci, St Hyacinthe, PQ J2S 7C6, Canada.
RP Troncy, E (reprint author), Univ Montreal, Fac Vet Med, Dept Biomed Sci, Grp Rech Pharmacol Anim Quebec GREPAQ, St Hyacinthe, PQ J2S 7C6, Canada.
EM eric.troncy@umontreal.ca
RI del Castillo, Jerome/J-6976-2013; Troncy, Eric/J-6650-2013
OI del Castillo, Jerome/0000-0001-5046-7926; Troncy,
   Eric/0000-0003-0209-5261
FU Vetoquinol Laboratories, Lure, France; Canada Foundation for Innovation
   [9483]; Natural Sciences and Engineering Research Council of Canada
   [327158-2008]; Vetoquinol Laboratories
FX This study was supported in part by a grant from Vetoquinol
   Laboratories, Lure, France (http://www.vetoquinol.fr/); an ongoing New
   Opportunities Fund grant from the Canada Foundation for Innovation
   (#9483) for the pain/function equipment (http://www.innovation.ca); a
   Discovery grant from the Natural Sciences and Engineering Research
   Council of Canada (#327158-2008) as operating fund for pain biomarkers
   (http://www.nserc-crsng.gc.ca). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.; The authors received funding for this work from a
   commercial source (Vetoquinol Laboratories) and with regards to their
   agreement with this company, this does not alter the authors' adherence
   to all the PLOS ONE policies on sharing data and materials. Moreover,
   the authors contracted the realization of the experiments in a Contract
   Research Organization, named CiToxLAB North America, and one author,
   Simon Authier at the time a Ph.D. student under supervision and actually
   Head of Veterinary Services at this company, participated actively in
   the study's realization as well as edition of the manuscript. For this
   reason, this does not alter the authors' adherence to all the PLOS ONE
   policies on sharing data and materials.
CR BERK RA, 1979, AM J MENT DEF, V83, P460
   Borer LR, 2003, AM J VET RES, V64, P1429, DOI 10.2460/ajvr.2003.64.1429
   BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491
   Brennan Timothy J, 2005, Anesthesiol Clin North Am, V23, P1, DOI 10.1016/j.atc.2004.11.009
   Budsberg SC, 2011, AM J VET RES, V72, P757, DOI 10.2460/ajvr.72.6.757
   Buvanendran A, 2008, ANESTH ANALG, V107, P300, DOI 10.1213/ane.0b013e3181732f21
   Cohen LL, 2008, J PEDIATR PSYCHOL, V33, P911, DOI 10.1093/jpepsy/jsj115
   Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209
   Dzikiti TB, 2006, J S AFR VET ASSOC, V77, P120
   Firth AM, 1999, J AM VET MED ASSOC, V214, P651
   Fox SM, 2000, RES VET SCI, V68, P265, DOI 10.1053/rvsc.2000.0375
   Gruet P, 2011, AM J VET RES, V72, P184, DOI 10.2460/ajvr.72.2.184
   Guedes AGP, 2007, J VET PHARMACOL THER, V30, P224, DOI 10.1111/j.1365-2885.2007.00849.x
   Guillot M, 2011, J VET INTERN MED, V25, P1050, DOI 10.1111/j.1939-1676.2011.00786.x
   Hadjistavropoulos T, 2002, BEHAV RES THER, V40, P551, DOI 10.1016/S0005-7967(01)00072-9
   Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215
   Hansen BD, 2003, ILAR J, V44, P197, DOI 10.1093/ilar.44.3.197
   Hazewinkel HAW, 2003, VET REC, V152, P11, DOI 10.1136/vr.152.1.11
   Hazewinkel HAW, 2008, RES VET SCI, V84, P74, DOI 10.1016/j.rvsc.2007.02.005
   Hoelzler MG, 2004, VET SURG, V33, P146, DOI 10.1111/j.1532-950X.2004.04022.x
   Holton L, 2001, VET REC, V148, P525, DOI 10.1136/vr.148.17.525
   Horstman CL, 2004, VET SURG, V33, P286, DOI 10.1111/j.1532-950X.2004.04042.x
   Hosmer D. W., 1989, APPL LOGISTIC REGRES
   Hugonnard M, 2004, VET ANAESTH ANALG, V31, P154, DOI 10.1111/j.1467-2987.2004.00175.x
   Ji ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030505
   Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x
   Kona-Boun JJ, 2006, JAVMA-J AM VET MED A, V229, P1103, DOI 10.2460/javma.229.7.1103
   Kyles AE, 1998, RES VET SCI, V65, P245, DOI 10.1016/S0034-5288(98)90151-5
   Laboissiere B, 2006, THESIS ECOLE NATL VE
   Lafuente MP, 2005, JAVMA-J AM VET MED A, V227, P1768, DOI 10.2460/javma.2005.227.1768
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]
   LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267
   Lipscomb VJ, 2002, VET REC, V150, P684, DOI 10.1136/vr.150.22.684
   Liska WD, 2009, VET SURG, V38, P568, DOI 10.1111/j.1532-950X.2009.00531.x
   Mann KA, 2012, VET COMP ORTHOPAED, V25, P1, DOI 10.3415/VCOT-11-01-0014
   Marucio RL, 2008, AM J VET RES, V69, P854, DOI 10.2460/ajvr.69.7.854
   MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971
   Moreau M, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3373
   Oosterlinck M, 2011, AM J VET RES, V72, P820, DOI 10.2460/ajvr.72.6.820
   Pacharinsak C, 2003, J VET PHARMACOL THER, V26, P71, DOI 10.1046/j.1365-2885.2003.00452.x
   Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x
   Punke JP, 2007, AM J VET RES, V68, P704, DOI 10.2460/ajvr.68.7.704
   Quessy SN, 2010, J PAIN, V11, P698, DOI 10.1016/j.jpain.2010.05.001
   Quinn MM, 2007, VET SURG, V36, P360, DOI 10.1111/j.1532-950X.2007.00276.x
   Reid J, 2007, ANIM WELFARE, V16, P97
   Richardson CA, 2007, LAB ANIM-UK, V41, P46, DOI 10.1258/002367707779399455
   Roughan JV, 2006, APPL ANIM BEHAV SCI, V96, P327, DOI 10.1016/j.applanim.2005.06.012
   SCHUMACHER HR, 1974, J RHEUMATOL, V1, P102
   Shih AC, 2008, VET ANAESTH ANALG, V35, P69, DOI 10.1111/j.1467-2995.2007.00352.x
   Stokes ME, 2000, CATEGORICAL DATA ANA
   Storm H, 2008, CURR OPIN ANESTHESIO, V21, P796, DOI 10.1097/ACO.0b013e3283183fe4
   Streiner DL, 2003, HLTH MEASUREMENT SCA
   Vaisanen MAM, 2008, J SMALL ANIM PRACT, V49, P626, DOI 10.1111/j.1748-5827.2008.00626.x
   Valtolina C, 2009, VET ANAESTH ANALG, V36, P369, DOI 10.1111/j.1467-2995.2009.00461.x
   Vettorato E, 2010, VET J, V183, P310, DOI 10.1016/j.tvjl.2008.11.002
   Waxman AS, 2008, VET SURG, V37, P241, DOI 10.1111/j.1532-950X.2008.00372.x
   Williams VM, 2005, NEW ZEAL VET J, V53, P193, DOI 10.1080/00480169.2005.36504
   Xu J, 2009, PAIN, V144, P329, DOI 10.1016/j.pain.2009.05.019
   Ziegler A, 1998, BIOMETRICAL J, V40, P115, DOI 10.1002/(SICI)1521-4036(199806)40:2<115::AID-BIMJ115>3.0.CO;2-6
   ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4
NR 61
TC 21
Z9 21
U1 0
U2 29
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 16
PY 2012
VL 7
IS 11
AR e49480
DI 10.1371/journal.pone.0049480
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 048BN
UT WOS:000311885300045
PM 23166681
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Alshurafa, M
   Briel, M
   Akl, EA
   Haines, T
   Moayyedi, P
   Gentles, SJ
   Rios, L
   Tran, C
   Bhatnagar, N
   Lamontagne, F
   Walter, SD
   Guyatt, GH
AF Alshurafa, Mohamad
   Briel, Matthias
   Akl, Elie A.
   Haines, Ted
   Moayyedi, Paul
   Gentles, Stephen J.
   Rios, Lorena
   Tran, Chau
   Bhatnagar, Neera
   Lamontagne, Francois
   Walter, Stephen D.
   Guyatt, Gordon H.
TI Inconsistent Definitions for Intention-To-Treat in Relation to Missing
   Outcome Data: Systematic Review of the Methods Literature
SO PLOS ONE
LA English
DT Review
ID RANDOMIZED CONTROLLED-TRIALS; FOLLOW-UP; LOST-IT; INFORMATION; PROTOCOL
AB Background: Authors of randomized trial reports seem to hold a variety of views regarding the relationship between missing outcome data (MOD) and intention to treat (ITT). The objectives of this study were to systematically investigate how authors of methodology articles define ITT in the presence of MOD, how they recommend handling MOD under ITT, and to make a proposal for potential improvement in the definition and use of ITT in relation to MOD.
   Methods and Findings: We systematically searched MEDLINE in February 2009 for methodological articles written in English that devoted at least one paragraph to ITT and two other paragraphs to either ITT or MOD. We excluded original trial reports, observational studies, and clinical systematic reviews. Working in teams of two, we independently extracted relevant information from each eligible article. Of 1007 titles and abstracts reviewed, 66 articles met eligibility criteria. Five (8%) did not provide a definition of ITT; 25 (38%) mentioned MOD but did not discuss its relationship to ITT; and 36 (55%) discussed the relationship of MOD with ITT. These 36 articles described one or more of three statements: complete follow-up is required for ITT (58%); ITT and MOD are separate issues (17%); and ITT requires a specific strategy for handling MOD (78%); 17 (47%) endorsed more than one relationship. The most frequently mentioned strategies for handling MOD within ITT were: using the last outcome carried forward (50%); sensitivity analysis (50%); and use of available data to impute missing data (46%).
   Conclusion: We found that there is no consensus on the definition of ITT in relation to MOD. For conceptual clarity, we suggest that both reports of randomized trials and systematic reviews separately consider and describe how they deal with participants with complete data and those with MOD.
C1 [Alshurafa, Mohamad; Briel, Matthias; Akl, Elie A.; Haines, Ted; Moayyedi, Paul; Gentles, Stephen J.; Rios, Lorena; Bhatnagar, Neera; Walter, Stephen D.; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.
   [Briel, Matthias] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland.
   [Akl, Elie A.] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA.
   [Akl, Elie A.] SUNY Buffalo, Dept Family Med, Buffalo, NY 14260 USA.
   [Moayyedi, Paul; Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON, Canada.
   [Tran, Chau] Chau Tran Consulting, Toronto, ON, Canada.
   [Lamontagne, Francois] Univ Sherbrooke, Ctr Rech Clin Etienne Le Bel, Sherbrooke, PQ J1K 2R1, Canada.
RP Briel, M (reprint author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.
EM brielm@uhbs.ch
RI Moayyedi, Paul/M-6178-2014; Akl, Elie/K-5269-2019
OI Moayyedi, Paul/0000-0002-3616-9292; Gentles,
   Stephen/0000-0003-2004-1451; Briel, Matthias/0000-0002-2070-5230
FU Santesuisse, Solothurn, Switzerland; Gottfried and Julia
   Bangerter-Rhyner-Foundation, Berne, Switzerland; Canadian Institutes for
   Health Research
FX None specific to the project. MB is supported by Santesuisse, Solothurn,
   Switzerland, and the Gottfried and Julia Bangerter-Rhyner-Foundation,
   Berne, Switzerland. FL is supported by a Canadian Institutes for Health
   Research RCT Mentoring Award. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Akl EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2809
   Akl EA, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-40
   FDA, 1988, GUID FORM CONT CLIN
   Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652
   Ferrari J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000964.pub3
   Fisher LD, 1990, STAT ISSUES DRUG RES, P331
   Gravel J, 2007, CLIN TRIALS, V4, P350, DOI 10.1177/1740774507081223
   Guyatt GH, 2008, USERS GUIDES MED LIT, P167
   Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670
   Kruse RL, 2002, J FAM PRACTICE, V51, P969
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Moher D, 2001, ANN INTERN MED, V134, P657, DOI 10.7326/0003-4819-134-8-200104170-00011
   Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1016/j.jclinepi.2010.03.004]
   Montori VM, 2001, CAN MED ASSOC J, V165, P1339
   Nordic Council on Medicine, 1989, NLN PUBL
   Panel on handling missing data in clinical trials National Research Council, 2010, PREV TREATM MISS DAT
   Porta N, 2007, J CLIN EPIDEMIOL, V60, P663, DOI 10.1016/j.jclinepi.2006.09.013
   Ruiz-Canela M, 2000, BRIT MED J, V320, P1007, DOI 10.1136/bmj.320.7240.1007
   Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G
   Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332
   Soares Isabel, 2002, Rev Port Cardiol, V21, P1191
   Unnebrink K, 2001, STAT MED, V20, P3931, DOI 10.1002/sim.1149
   White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40
NR 23
TC 62
Z9 62
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 15
PY 2012
VL 7
IS 11
AR e49163
DI 10.1371/journal.pone.0049163
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 039UP
UT WOS:000311272300024
PM 23166608
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Akmatov, MK
   Gatzemeier, A
   Schughart, K
   Pessler, F
AF Akmatov, Manas K.
   Gatzemeier, Anja
   Schughart, Klaus
   Pessler, Frank
TI Equivalence of Self- and Staff-Collected Nasal Swabs for the Detection
   of Viral Respiratory Pathogens
SO PLOS ONE
LA English
DT Article
ID INFECTION; VIRUS; VALIDATION; TOOL
AB Background: The need for the timely collection of diagnostic biosamples during symptomatic episodes represents a major obstacle to large-scale studies on acute respiratory infection (ARI) epidemiology. This may be circumvented by having the participants collect their own nasal swabs. We compared self- and staff-collected swabs in terms of swabbing quality and detection of viral respiratory pathogens.
   Methodology/Principal Findings: We conducted a prospective study among employees of our institution during the ARI season 2010/2011 (December-March). Weekly emails were sent to the participants (n = 84), reminding them to come to the study center in case of new symptoms. The participants self-collected an anterior nasal swab from one nostril, and trained study personnel collected one from the other nostril. The participants self-collected another two swabs (one from each nostril) on a subsequent day. Human beta-actin DNA concentration was determined in the swabs as a quality control. Viral respiratory pathogens were detected by multiplex RT-PCR (Seeplex RV15 kit, Seegene, Eschborn, Germany). Of 84 participants, 56 (67%) reported at least one ARI episode, 18 participants two, and one participant three. Self-swabbing was highly accepted by the participants. The amount of beta-actin DNA per swab was higher in the self-than in the staff-collected swabs (p = 0.008). beta-actin concentration was lower in the self-swabs collected on day 1 than in those collected on a subsequent day (p < 0.0001). A respiratory viral pathogen was detected in 31% (23/75) of staff- and in 35% (26/75) of self-collected swabs (p = 0.36). With both approaches, the most frequently identified pathogens were human rhinoviruses A/B/C (12/75 swabs, 16%) and human coronavirus OC43 (4/75 swabs, 5%). There was almost perfect agreement between self- and staff-collected swabs in terms of pathogen detection (agreement = 93%, kappa = 0.85, p < 0.0001).
   Conclusions/Significance: Nasal self-swabbing for identification of viral ARI pathogens proved to be equivalent to staff-swabbing in this population in terms of acceptance and pathogen detection.
C1 [Akmatov, Manas K.; Gatzemeier, Anja; Pessler, Frank] Helmholtz Ctr Infect Res, Dept Epidemiol, Braunschweig, Germany.
RP Akmatov, MK (reprint author), Helmholtz Ctr Infect Res, Dept Epidemiol, Braunschweig, Germany.
EM manas.akmatov@helmholtz-hzi.de
OI Schughart, Klaus/0000-0002-6824-7523
CR Akmatov MK, 2011, INT J INFECT DIS, V15, pE589, DOI 10.1016/j.ijid.2011.04.009
   Akmatov MK, 2011, INT J INFECT DIS, V15, pE799, DOI 10.1016/j.ijid.2011.07.005
   Esposito S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-85
   Ip DKM, 2012, J INFECT DIS, V205, P631, DOI 10.1093/infdis/jir803
   Jobin C, 1997, J IMMUNOL, V158, P226
   Lambert SB, 2008, VACCINE, V26, P1826, DOI 10.1016/j.vaccine.2008.01.055
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Larios OE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021335
   Luinstra K, 2011, J CLIN MICROBIOL, V49, P2138, DOI 10.1128/JCM.00327-11
   Smieja M, 2010, J CLIN MICROBIOL, V48, P3340, DOI 10.1128/JCM.02235-09
NR 10
TC 24
Z9 24
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 14
PY 2012
VL 7
IS 11
AR e48508
DI 10.1371/journal.pone.0048508
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 038CD
UT WOS:000311151900021
PM 23155387
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Nkurunungi, G
   Lutangira, JE
   Lule, SA
   Akurut, H
   Kizindo, R
   Fitchett, JR
   Kizito, D
   Sebina, I
   Muhangi, L
   Webb, EL
   Cose, S
   Elliott, AM
AF Nkurunungi, Gyaviira
   Lutangira, Jimreeves E.
   Lule, Swaib A.
   Akurut, Hellen
   Kizindo, Robert
   Fitchett, Joseph R.
   Kizito, Dennison
   Sebina, Ismail
   Muhangi, Lawrence
   Webb, Emily L.
   Cose, Stephen
   Elliott, Alison M.
TI Determining Mycobacterium tuberculosis Infection among BCG-Immunised
   Ugandan Children by T-SPOT.TB and Tuberculin Skin Testing
SO PLOS ONE
LA English
DT Article
ID GAMMA RELEASE ASSAYS; CALMETTE-GUERIN VACCINATION; ENZYME-LINKED
   IMMUNOSPOT; HEALTH-CARE WORKERS; IN-TUBE ASSAY; BLOOD-TESTS; DIAGNOSIS;
   CONTACT; DISEASE; REPRODUCIBILITY
AB Background: Children with latent tuberculosis infection (LTBI) represent a huge reservoir for future disease. We wished to determine Mycobacterium tuberculosis (M.tb) infection prevalence among BCG-immunised five-year-old children in Entebbe, Uganda, but there are limited data on the performance of immunoassays for diagnosis of tuberculosis infection in children in endemic settings. We therefore evaluated agreement between a commercial interferon gamma release assay (T-SPOT.TB) and the tuberculin skin test (TST; 2 units RT-23 tuberculin; positive defined as diameter >= 10 mm), along with the reproducibility of T-SPOT. TB on short-term follow-up, in this population.
   Methodology/Principal Findings: We recruited 907 children of which 56 were household contacts of TB patients. They were tested with T-SPOT. TB at age five years and then re-examined with T-SPOT. TB (n = 405) and TST (n = 319) approximately three weeks later. The principal outcome measures were T-SPOT. TB and TST positivity. At five years, 88 (9.7%) children tested positive by T-SPOT. TB. More than half of those that were T-SPOT. TB positive at five years were negative at follow-up, whereas 96% of baseline negatives were consistently negative. We observed somewhat better agreement between initial and follow-up T-SPOT. TB results among household TB contacts (kappa = 0.77) than among non-contacts (kappa = 0.39). Agreement between T-SPOT. TB and TST was weak (kappa = 0.28 and kappa = 0.40 for T-SPOT. TB at 5 years and follow-up, respectively). Of 28 children who were positive on both T-SPOT. TB tests, 14 (50%) had a negative TST. Analysis of spot counts showed high levels of instability in responses between baseline and follow-up, indicating variability in circulating numbers of T cells specific for certain M.tb antigens.
   Conclusions/Significance: We found that T-SPOT. TB positives are unstable over a three-week follow-up interval, and that TST compares poorly with T-SPOT. TB, making the categorisation of children as TB-infected or TB-uninfected difficult. Existing tools for the diagnosis of TB infection are unsatisfactory in determining infection among children in this setting.
C1 [Nkurunungi, Gyaviira; Lutangira, Jimreeves E.; Lule, Swaib A.; Akurut, Hellen; Kizindo, Robert; Kizito, Dennison; Sebina, Ismail; Muhangi, Lawrence; Cose, Stephen; Elliott, Alison M.] MRC, Coinfect Studies Programme, Uganda Virus Res Inst Uganda Res Unit AIDS, Entebbe, Uganda.
   [Fitchett, Joseph R.; Cose, Stephen; Elliott, Alison M.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England.
   [Webb, Emily L.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England.
RP Nkurunungi, G (reprint author), MRC, Coinfect Studies Programme, Uganda Virus Res Inst Uganda Res Unit AIDS, Entebbe, Uganda.
EM gyaviira.nkurunungi@mrcuganda.org
RI Cose, Stephen/H-4851-2019; Nkurunungi, Gyaviira/L-6558-2019
OI Cose, Stephen/0000-0002-5156-037X; Nkurunungi,
   Gyaviira/0000-0003-4062-9105; Sebina, Ismail/0000-0003-3232-3472; Lule,
   Swaib/0000-0002-6271-2033; Webb, Emily/0000-0002-4019-7456; Elliott,
   Alison/0000-0003-2818-9549
FU Wellcome Trust [064693, 079110, 086801]; UK Medical Research Council;
   Medical Research Council [G0700837]
FX The study was funded by Wellcome Trust (www.wellcome.ac.uk) grant
   numbers 064693, 079110 and 086801. E. Webb was supported in part by the
   UK Medical Research Council (www.mrc.ac.uk). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Anderson EJ, 2012, VACCINE, V30, P2083, DOI 10.1016/j.vaccine.2012.01.053
   Bakir M, 2008, ANN INTERN MED, V149, P777, DOI 10.7326/0003-4819-149-11-200812020-00248
   Barnes PF, 2001, AM J RESP CRIT CARE, V163, P807, DOI 10.1164/ajrccm.163.4.ed0201c
   Canadian Tuberculosis Committee (CTC), 2008, Can Commun Dis Rep, V34, P1
   Chee CBE, 2001, AM J RESP CRIT CARE, V164, P958, DOI 10.1164/ajrccm.164.6.2101093
   Chee CBE, 2007, AM J RESP CRIT CARE, V175, P282, DOI 10.1164/rccm.200608-1109OC
   Codecasa L, 2006, J CLIN MICROBIOL, V44, P1944, DOI 10.1128/JCM.02265-05
   Cruz AT, 2011, PEDIATRICS, V127, pE31, DOI 10.1542/peds.2010-1725
   Detjen AK, 2009, CLIN VACCINE IMMUNOL, V16, P1170, DOI 10.1128/CVI.00168-09
   Doberne D, 2011, J CLIN MICROBIOL, V49, P3061, DOI 10.1128/JCM.01136-11
   Elliott AM, 2007, CLIN TRIALS, V4, P42, DOI 10.1177/1740774506075248
   Elliott AM, 2010, VACCINE, V29, P247, DOI 10.1016/j.vaccine.2010.10.047
   Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9
   Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6
   FINE PEM, 1994, LANCET, V344, P1245, DOI 10.1016/S0140-6736(94)90748-X
   Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068
   Hesseling AC, 2009, THORAX, V64, P840, DOI 10.1136/thx.2007.085340
   Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192
   Joshi R, 2011, EUR RESPIR J, V38, P1475, DOI 10.1183/09031936.00014611
   Kakkar F, 2010, CAN J INFECT DIS MED, V21, pE111, DOI 10.1155/2010/129616
   Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081
   Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1
   Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lucas M, 2010, THORAX, V65, P442, DOI 10.1136/thx.2009.127555
   Machingaidze S, 2011, PEDIATR INFECT DIS J, V30, P694, DOI 10.1097/INF.0b013e318214b915
   Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1
   Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006
   MIGLIORI GB, 1994, EUR RESPIR J, V7, P946
   Mutsvangwa J, 2010, THORAX, V65, P315, DOI 10.1136/thx.2009.124891
   National Tuberculosis and Leprosy Program, 2005, UG NAT PROGR SURV RE
   Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8
   Okada K, 2008, EPIDEMIOL INFECT, V136, P1179, DOI 10.1017/S0950268807009831
   Pai M, 2009, INT J TUBERC LUNG D, V13, P84
   Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208
   Pai M, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-7
   Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC
   Perry S, 2008, CLIN VACCINE IMMUNOL, V15, P425, DOI 10.1128/CVI.00398-07
   Sauzullo I, 2011, TUBERCULOSIS, V91, P322, DOI 10.1016/j.tube.2011.05.004
   Shams H, 2005, AM J RESP CRIT CARE, V172, P1161, DOI 10.1164/rccm.200505-748OC
   Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4
   Stein CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004094
   Stott H, 1973, Tubercle, V54, P1
   Tissot F, 2005, CLIN INFECT DIS, V40, P211, DOI 10.1086/426434
   Uganda MoH, 2006, NAT POL GUID TB HIV
   Uganda MoH, 2010, MAN NAT TUB LEPR PRO
   van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517
   Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804
   World Health Organization, 2011, US TUB INT GAMM REL
   World Health Organization, 2011, GLOB TUB CONTR WHO R
NR 50
TC 14
Z9 16
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 15
PY 2012
VL 7
IS 10
AR e47340
DI 10.1371/journal.pone.0047340
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 022WO
UT WOS:000309995100094
PM 23077594
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Jiang, D
   Huang, YH
   Zhuang, DF
   Zhu, YQ
   Xu, XL
   Ren, HY
AF Jiang, Dong
   Huang, Yaohuan
   Zhuang, Dafang
   Zhu, Yunqiang
   Xu, Xinliang
   Ren, Hongyan
TI A Simple Semi-Automatic Approach for Land Cover Classification from
   Multispectral Remote Sensing Imagery
SO PLOS ONE
LA English
DT Article
ID COMPONENTS; AGREEMENT; CHINA
AB Land cover data represent a fundamental data source for various types of scientific research. The classification of land cover based on satellite data is a challenging task, and an efficient classification method is needed. In this study, an automatic scheme is proposed for the classification of land use using multispectral remote sensing images based on change detection and a semi-supervised classifier. The satellite image can be automatically classified using only the prior land cover map and existing images; therefore human involvement is reduced to a minimum, ensuring the operability of the method. The method was tested in the Qingpu District of Shanghai, China. Using Environment Satellite 1(HJ-1) images of 2009 with 30 m spatial resolution, the areas were classified into five main types of land cover based on previous land cover data and spectral features. The results agreed on validation of land cover maps well with a Kappa value of 0.79 and statistical area biases in proportion less than 6%. This study proposed a simple semi-automatic approach for land cover classification by using prior maps with satisfied accuracy, which integrated the accuracy of visual interpretation and performance of automatic classification methods. The method can be used for land cover mapping in areas lacking ground reference information or identifying rapid variation of land cover regions (such as rapid urbanization) with convenience.
C1 [Jiang, Dong; Huang, Yaohuan; Zhuang, Dafang; Zhu, Yunqiang; Xu, Xinliang; Ren, Hongyan] Chinese Acad Sci, State Key Lab Resources & Environm Informat Syst, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.
RP Huang, YH (reprint author), Chinese Acad Sci, State Key Lab Resources & Environm Informat Syst, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.
EM huangyh@lreis.ac.cn
FU Chinese Academy of Sciences [KZZD-EW-08]; China Postdoctoral Science
   Foundation [20100480437, 201104133]
FX This work was financially supported by the Chinese Academy of Sciences
   (grant KZZD-EW-08), and the China Postdoctoral Science Foundation
   (20100480437, 201104133). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Blackman NJM, 2000, STAT MED, V19, P723, DOI 10.1002/(SICI)1097-0258(20000315)19:5<723::AID-SIM379>3.0.CO;2-A
   Bovolo F, 2009, IEEE GEOSCI REMOTE S, V6, P33, DOI 10.1109/LGRS.2008.2007429
   Chen S, 1998, STUDY INFORM MECH RE
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Compton J, 1985, SCIENCE, V227, P369, DOI DOI 10.1126/SCIENCE.1111772
   DOLMAN A, 2003, GLOBAL ENV CHANGE LA
   EASTMENT HT, 1982, TECHNOMETRICS, V24, P73, DOI 10.2307/1267581
   EKLUNDH L, 1993, INT J REMOTE SENS, V14, P1359, DOI 10.1080/01431169308953962
   Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772
   Foody GM, 2007, PROG PHYS GEOG, V31, P439, DOI 10.1177/0309133307081294
   Fortier J, 2011, PHOTOGRAMM ENG REM S, V77, P181, DOI 10.14358/PERS.77.2.181
   Friedl MA, 1997, REMOTE SENS ENVIRON, V61, P399, DOI 10.1016/S0034-4257(97)00049-7
   Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0
   Gong P, 2003, INT J REMOTE SENS, V24, P1303, DOI 10.1080/01431160110115870
   Guo Y, 2007, STUDY LAND USE LANDS
   Hansen M, 1996, INT J REMOTE SENS, V17, P1075, DOI 10.1080/01431169608949069
   Jia XP, 1999, IEEE T GEOSCI REMOTE, V37, P538, DOI 10.1109/36.739109
   Lambin E., 2006, LAND USE LAND COVER
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liu J, 2010, CHINESE SCI BULL, V53, P1
   Liu J Y, 2005, STUDY SPATIAL TEMPOR
   Liu Jiyuan, 2002, Journal of Geographical Sciences, V12, P275
   Liu JY, 2003, SCI CHINA SER D, V46, P373
   Liu JY, 2005, REMOTE SENS ENVIRON, V98, P442, DOI 10.1016/j.rse.2005.08.012
   LOVELAND TR, 1991, PHOTOGRAMM ENG REM S, V57, P1453
   Ran YH, 2010, INT J REMOTE SENS, V31, P391, DOI 10.1080/01431160902893451
   Rogan J, 2004, PROG PLANN, V61, P301, DOI 10.1016/S0305-9006(03)00066-7
   Schneider A, 2010, REMOTE SENS ENVIRON, V114, P1733, DOI 10.1016/j.rse.2010.03.003
   Shanghai Bureau of Statistics, 2006, COMP SHANGH 2 AGR CE
   Tax DMJ, 2004, MACH LEARN, V54, P45, DOI 10.1023/B:MACH.0000008084.60811.49
   Yan HM, 2009, GLOBAL PLANET CHANGE, V67, P13, DOI 10.1016/j.gloplacha.2008.12.012
   Zhang B, 2005, J TIANJIN NORMAL U N, V25, P69
   ZHANG YS, 2003, J NANJING U, V39, P806
   Zhao Y, 2003, APPL PRINCIPLE METHO
NR 34
TC 12
Z9 14
U1 0
U2 44
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 26
PY 2012
VL 7
IS 9
AR e45889
DI 10.1371/journal.pone.0045889
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 016KP
UT WOS:000309517300061
PM 23049886
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chino, K
   Akagi, R
   Dohi, M
   Fukashiro, S
   Takahashi, H
AF Chino, Kentaro
   Akagi, Ryota
   Dohi, Michiko
   Fukashiro, Senshi
   Takahashi, Hideyuki
TI Reliability and Validity of Quantifying Absolute Muscle Hardness Using
   Ultrasound Elastography
SO PLOS ONE
LA English
DT Article
ID MAGNETIC-RESONANCE ELASTOGRAPHY; ACOUSTIC STRAIN WAVES; MR ELASTOGRAPHY;
   CONTRACTION; VISUALIZATION; FEASIBILITY; EXERCISE
AB Muscle hardness is a mechanical property that represents transverse muscle stiffness. A quantitative method that uses ultrasound elastography for quantifying absolute human muscle hardness has been previously devised; however, its reliability and validity have not been completely verified. This study aimed to verify the reliability and validity of this quantitative method. The Young's moduli of seven tissue-mimicking materials (in vitro; Young's modulus range, 20-80 kPa; increments of 10 kPa) and the human medial gastrocnemius muscle (in vivo) were quantified using ultrasound elastography. On the basis of the strain/Young's modulus ratio of two reference materials, one hard and one soft (Young's moduli of 7 and 30 kPa, respectively), the Young's moduli of the tissue-mimicking materials and medial gastrocnemius muscle were calculated. The intra-and inter-investigator reliability of the method was confirmed on the basis of acceptably low coefficient of variations (<= 6.9%) and substantially high intraclass correlation coefficients (>= 0.77) obtained from all measurements. The correlation coefficient between the Young's moduli of the tissue-mimicking materials obtained using a mechanical method and ultrasound elastography was 0.996, which was equivalent to values previously obtained using magnetic resonance elastography. The Young's moduli of the medial gastrocnemius muscle obtained using ultrasound elastography were within the range of values previously obtained using magnetic resonance elastography. The reliability and validity of the quantitative method for measuring absolute muscle hardness using ultrasound elastography were thus verified.
C1 [Chino, Kentaro; Fukashiro, Senshi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Sports Sci, Meguro Ku, Tokyo, Japan.
   [Akagi, Ryota; Takahashi, Hideyuki] Japan Inst Sports Sci, Dept Sports Sci, Kita Ku, Tokyo, Japan.
   [Dohi, Michiko] Japan Inst Sports Sci, Dept Sports Med, Kita Ku, Tokyo, Japan.
RP Chino, K (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Sports Sci, Meguro Ku, Tokyo, Japan.
EM chinokentaro@idaten.c.u-tokyo.ac.jp
FU Sports Medicine/Science Research Program (Conditioning Research Project)
   at Japan Institute of Sports Sciences; Ministry of Education, Culture,
   Sports, Science, and Technology, Japan
FX This study was supported by the Sports Medicine/Science Research Program
   (Conditioning Research Project) at Japan Institute of Sports Sciences
   and a Grant-in-Aid for Young Scientists (B) from the Ministry of
   Education, Culture, Sports, Science, and Technology, Japan. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Akagi R, 2012, ACTA RADIOL, V53, P307, DOI 10.1258/ar.2011.110481
   Ariji Y, 2009, J ORAL REHABIL, V36, P627, DOI 10.1111/j.1365-2842.2009.01977.x
   Ashina M, 1998, CEPHALALGIA, V18, P106, DOI 10.1046/j.1468-2982.1998.1802106.x
   Basford JR, 2002, ARCH PHYS MED REHAB, V83, P1530, DOI 10.1053/apmr.2002.35472
   CHILIBECK P, 1994, CAN ASSOC RADIOL J, V45, P297
   Chino K, 2009, J APPL BIOMECH, V25, P111, DOI 10.1123/jab.25.2.111
   Drakonaki EE, 2010, SKELETAL RADIOL, V39, P391, DOI 10.1007/s00256-009-0861-0
   Friedrich-Rust M, 2007, AM J ROENTGENOL, V188, P758, DOI 10.2214/AJR.06.0322
   Gennisson JL, 2005, J BIOMECH, V38, P1543, DOI 10.1016/j.jbiomech.2004.07.013
   Holbrook EA, 2009, MED SCI SPORT EXER, V41, P669, DOI 10.1249/MSS.0b013e3181886095
   Jenkyn TR, 2003, J BIOMECH, V36, P1917, DOI 10.1016/S0021-9290(03)00005-8
   Kawakami Y, 1998, J APPL PHYSIOL, V85, P398
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mariappan YK, 2010, CLIN ANAT, V23, P497, DOI 10.1002/ca.21006
   McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30
   Murayama M, 2000, EUR J APPL PHYSIOL, V82, P361, DOI 10.1007/s004210000242
   MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924
   Muthupillai R, 1996, MAGN RESON MED, V36, P266, DOI 10.1002/mrm.1910360214
   Niitsu M, 2011, ACTA RADIOL, V52, P99, DOI 10.1258/ar.2010.100190
   Nussbaumer S, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-194
   Shiina T, 2007, J MED ULTRASON, V29, P119
   Shinohara M, 2010, MUSCLE NERVE, V42, P438, DOI 10.1002/mus.21723
   Suga M, 2001, ST HEAL T, V84, P933
   Suga M, 2003, STUD HLTH TECHNOL IN, V84, P933
   Uffmann K, 2004, NMR BIOMED, V17, P181, DOI 10.1002/nbm.887
   Yamakawa M, 2003, JPN J APPL PHYS 1, V42, P3265, DOI 10.1143/JJAP.42.3265
   Yanagisawa O, 2011, CLIN RADIOL, V66, P815, DOI 10.1016/j.crad.2011.03.012
NR 27
TC 45
Z9 50
U1 0
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 21
PY 2012
VL 7
IS 9
AR e45764
DI 10.1371/journal.pone.0045764
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 014RG
UT WOS:000309392800094
PM 23029231
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lian, M
   Struthers, J
   Schootman, M
AF Lian, Min
   Struthers, James
   Schootman, Mario
TI Comparing GIS-Based Measures in Access to Mammography and Their Validity
   in Predicting Neighborhood Risk of Late-Stage Breast Cancer
SO PLOS ONE
LA English
DT Article
ID MEASURING SPATIAL ACCESSIBILITY; ALCOHOL OUTLET DENSITY; LOS-ANGELES;
   GEOGRAPHIC ACCESS; PHYSICAL-ACTIVITY; FOOD ENVIRONMENT; TRAVEL DISTANCE;
   UNITED-STATES; SOCIOECONOMIC DEPRIVATION; SOCIODEMOGRAPHIC FACTORS
AB Background: Assessing neighborhood environment in access to mammography remains a challenge when investigating its contextual effect on breast cancer-related outcomes. Studies using different Geographic Information Systems (GIS)-based measures reported inconsistent findings.
   Methods: We compared GIS-based measures (travel time, service density, and a two-Step Floating Catchment Area method [2SFCA]) of access to FDA-accredited mammography facilities in terms of their Spearman correlation, agreement (Kappa) and spatial patterns. As an indicator of predictive validity, we examined their association with the odds of late-stage breast cancer using cancer registry data.
   Results: The accessibility measures indicated considerable variation in correlation, Kappa and spatial pattern. Measures using shortest travel time (or average) and service density showed low correlations, no agreement, and different spatial patterns. Both types of measures showed low correlations and little agreement with the 2SFCA measures. Of all measures, only the two measures using 6-timezone-weighted 2SFCA method were associated with increased odds of late-stage breast cancer (quick-distance-decay: odds ratio [OR] = 1.15, 95% confidence interval [CI] = 1.01-1.32; slow-distance-decay: OR = 1.19, 95% CI = 1.03-1.37) after controlling for demographics and neighborhood socioeconomic deprivation.
   Conclusions: Various GIS-based measures of access to mammography facilities exist and are not identical in principle and their association with late-stage breast cancer risk. Only the two measures using the 2SFCA method with 6-timezone weighting were associated with increased odds of late-stage breast cancer. These measures incorporate both travel barriers and service competition. Studies may observe different results depending on the measure of accessibility used.
C1 [Lian, Min; Struthers, James; Schootman, Mario] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
RP Lian, M (reprint author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
EM mlian@dom.wustl.edu
OI Schootman, Mario/0000-0003-1162-8824
FU National Cancer Institute at the National Institutes of Health [R01
   CA109675]; CDC; Missouri Department of Health and Senior Services (DHSS)
   [U58/DP000820-05]; DHSS; University of Missouri
FX This research was supported in part by a grant (R01 CA109675) from the
   National Cancer Institute at the National Institutes of Health. Cancer
   incidence data are collected by the Missouri Cancer Registry and
   Research Center (MCR-ARC) participating in the National Program of
   Cancer Registries (NPCR) of the Centers for Disease Control and
   Prevention (CDC). MCR-ARC is supported in part by a cooperative
   agreement between the CDC and the Missouri Department of Health and
   Senior Services (DHSS) (# U58/DP000820-05) and a Surveillance Contract
   between DHSS and the University of Missouri. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR [Anonymous], 2009, ARCGIS DESKT HELP VE
   Arndt V, 2002, BRIT J CANCER, V86, P1034, DOI 10.1038/sj/bjc/6600209
   Arndt V, 2001, J CLIN EPIDEMIOL, V54, P719, DOI 10.1016/S0895-4356(00)00351-6
   Astell-Burt T, 2011, SOC SCI MED
   Athas WF, 2000, J NATL CANCER I, V92, P269, DOI 10.1093/jnci/92.3.269
   AYANIAN JZ, 1993, NEW ENGL J MED, V329, P326, DOI 10.1056/NEJM199307293290507
   Bell S, ANN ASS AM IN PRESS
   Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518
   Bissonnette L, 2012, HEALTH PLACE, V18, P841, DOI 10.1016/j.healthplace.2012.03.007
   Bluthenthal RN, 2008, J URBAN HEALTH, V85, P191, DOI 10.1007/s11524-008-9255-1
   Burns CM, 2007, HEALTH PLACE, V13, P877, DOI 10.1016/j.healthplace.2007.02.005
   Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008
   Campbell CA, 2009, AM J PREV MED, V37, P556, DOI 10.1016/j.amepre.2009.09.028
   Catalano RA, 1998, AM J PUBLIC HEALTH, V88, P586, DOI 10.2105/AJPH.88.4.586
   Celaya MO, 2010, RURAL REMOTE HEALTH, V10
   Celaya MO, 2006, CANCER CAUSE CONTROL, V17, P851, DOI 10.1007/s10552-006-0025-7
   Cerin E, 2011, APPETITE, V56, P693, DOI 10.1016/j.appet.2011.02.006
   Cohen DA, 2006, SOC SCI MED, V62, P3062, DOI 10.1016/j.socscimed.2005.11.060
   Cummins SCJ, 2005, AM J PREV MED, V29, P308, DOI 10.1016/j.amepre.2005.06.011
   Dai DJ, 2010, HEALTH PLACE, V16, P1038, DOI 10.1016/j.healthplace.2010.06.012
   Elkin EB, 2010, MED CARE, V48, P349, DOI 10.1097/MLR.0b013e3181ca3ecb
   Elting LS, 2009, AM J PREV MED, V37, P102, DOI 10.1016/j.amepre.2009.03.017
   Engelman KK, 2002, J AM GERIATR SOC, V50, P62, DOI 10.1046/j.1532-5415.2002.50009.x
   FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L
   Fu LY, 2009, PEDIATRICS, V124, P1579, DOI 10.1542/peds.2009-0233
   Gatrell AC, 2012, HEALTH PLACE, V18, P832, DOI 10.1016/j.healthplace.2012.03.009
   GUAGLIARDO MF, 2004, INT J HEALTH GEOGR, V3, P3, DOI DOI 10.1186/1476-072X-3-3
   Gumpertz ML, 2006, CANCER CAUSE CONTROL, V17, P325, DOI 10.1007/s10552-005-0513-1
   Hyndman JCG, 2000, J MED SCREEN, V7, P141, DOI 10.1136/jms.7.3.141
   Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]
   Jennings A, 2011, AM J PREV MED, V40, P405, DOI 10.1016/j.amepre.2010.12.014
   Kwate NOA, 2010, PREV MED, V51, P153, DOI 10.1016/j.ypmed.2010.04.020
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lian M, 2011, AM J EPIDEMIOL, V174, P828, DOI 10.1093/aje/kwr162
   Lovett A, 2002, SOC SCI MED, V55, P97, DOI 10.1016/S0277-9536(01)00212-X
   Luo W, 2012, HEALTH PLACE, V18, P789, DOI 10.1016/j.healthplace.2012.04.002
   Luo W, 2009, HEALTH PLACE, V15, P1100, DOI 10.1016/j.healthplace.2009.06.002
   Malqvist M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-762
   Marchick J, 2005, CANCER-AM CANCER SOC, V103, P1571, DOI 10.1002/cncr.20915
   Maroko AR, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-34
   McLafferty S, 2009, CANCER-AM CANCER SOC, V115, P2755, DOI 10.1002/cncr.24306
   Meden T, 2002, JAMA-J AM MED ASSOC, V287, P111, DOI 10.1001/jama.287.1.111
   Meersman SC, 2009, CANCER CAUSE CONTROL, V20, P1469, DOI 10.1007/s10552-009-9373-4
   Mobley LR, 2009, CANCER CAUSE CONTROL, V20, P1017, DOI 10.1007/s10552-009-9295-1
   Moore LV, 2008, AM J PREV MED, V34, P16, DOI 10.1016/j.amepre.2007.09.021
   Moore LV, 2008, J URBAN HEALTH, V85, P206, DOI 10.1007/s11524-008-9259-x
   Moore LV, 2006, AM J PUBLIC HEALTH, V96, P325, DOI 10.2105/AJPH.2004.058040
   Nattinger AB, 2001, J NATL CANCER I, V93, P1344, DOI 10.1093/jnci/93.17.1344
   NAYERI K, 1992, NEW YORK STATE J MED, V92, P8
   Pearce J, 2008, J EPIDEMIOL COMMUN H, V62, P862, DOI 10.1136/jech.2007.068114
   Pearce J, 2008, J EPIDEMIOL COMMUN H, V62, P198, DOI 10.1136/jech.2006.059196
   Pearce JMS, 2009, EUR NEUROL, V61, P63, DOI 10.1159/000175125
   Pearce J, 2007, AM J PREV MED, V32, P375, DOI 10.1016/j.amepre.2007.01.009
   Peipins LA, 2011, J COMMUNITY HLTH
   Roux AVD, 2007, AM J PUBLIC HEALTH, V97, P493, DOI 10.2105/AJPH.2006.087734
   Schonlau M, 2008, GEOSPATIAL HEALTH, V3, P91, DOI 10.4081/gh.2008.235
   Schootman M, 2006, J EPIDEMIOL COMMUN H, V60, P202, DOI 10.1136/jech.2005.041020
   Schootman M, 2007, ANN EPIDEMIOL, V17, P704, DOI 10.1016/j.annepidem.2007.03.017
   Scribner RA, 1998, SEX TRANSM DIS, V25, P544, DOI 10.1097/00007435-199811000-00009
   Scribner R, 2007, J STUD ALCOHOL DRUGS, V68, P934, DOI 10.15288/jsad.2007.68.934
   Sharkey JR, 2008, J NUTR, V138, P620
   Smith DM, 2010, INT J EPIDEMIOL, V39, P277, DOI 10.1093/ije/dyp221
   Smith RA, 2010, CA-CANCER J CLIN, V60, P99, DOI 10.3322/caac.20063
   Teach SJ, 2006, PEDIATRICS, V117, pS78, DOI 10.1542/peds.2005-2000E
   Theall KP, 2009, GEOSPATIAL HEALTH, V3, P241, DOI 10.4081/gh.2009.224
   Wang FH, 2005, HEALTH PLACE, V11, P131, DOI 10.1016/j.healthplace.2004.02.003
   Wang L, 2007, HEALTH PLACE, V13, P656, DOI 10.1016/j.healthplace.2006.10.001
   Witten K, 2008, PREV MED, V47, P299, DOI 10.1016/j.ypmed.2008.04.010
   Wong LY, 2010, INT J HLTH PLANN MAN
   Yang Duck-Hye, 2006, J Med Syst, V30, P23, DOI 10.1007/s10916-006-7400-5
   Zenk SN, 2008, HEALTH PLACE, V14, P336, DOI 10.1016/j.healthplace.2007.08.003
   Zenk SN, 2006, J URBAN HEALTH, V83, P195, DOI 10.1007/s11524-005-9023-4
   Zenk SN, 2005, AM J PUBLIC HEALTH, V95, P660, DOI 10.2105/AJPH.2004.042150
NR 73
TC 25
Z9 25
U1 0
U2 34
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 28
PY 2012
VL 7
IS 8
AR e43000
DI 10.1371/journal.pone.0043000
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 998CA
UT WOS:000308213600012
PM 22952626
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Miret, M
   Caballero, FF
   Mathur, A
   Naidoo, N
   Kowal, P
   Ayuso-Mateos, JL
   Chatterji, S
AF Miret, Marta
   Felix Caballero, Francisco
   Mathur, Arvind
   Naidoo, Nirmala
   Kowal, Paul
   Luis Ayuso-Mateos, Jose
   Chatterji, Somnath
TI Validation of a Measure of Subjective Well-Being: An Abbreviated Version
   of the Day Reconstruction Method
SO PLOS ONE
LA English
DT Article
ID RELIABILITY; AGREEMENT; EXPERIENCE; VALIDITY
AB Background: The study of well-being is becoming a priority in social sciences. The Day Reconstruction Method (DRM) was developed to assess affective states. The aim of the present study was to validate an abbreviated version of the DRM designed for administration in population studies, and to assess its test-retest properties.
   Principal Findings: 1560 adults from Jodhpur (India) were interviewed using an abbreviated version of the DRM, and a week later they were re-interviewed using the original long version of the DRM, after which the abbreviated version of the DRM was compared with the original version. A regression model considering interaction terms was employed to analyse the impact of sociodemographic characteristics on net affect. Test-retest reliability was assessed, and found to be moderate. Positive affect showed more test-retest reliability than negative affect, while net affect had more temporal stability than U-index. The affect of sets A, B, and C, taken together, had a moderate predictive ability compared with the affect obtained using the full version of the DRM: AUC = 0.67 for positive affect; 0.66 for net affect; 0.61 for negative affect; and 0.60 for the U-index. Household income, gender, and setting all had a significant impact on net affect.
   Conclusions: Net affect and positive affect showed moderate temporal stability, whereas negative affect and the U-index showed fair temporal stability. Evaluating the affective state using the abbreviated version of the DRM provides a profile of the population similar to that of the full version. The results provide considerable support for using the short version of the DRM as an instrument to measure subjective well-being in large population surveys.
C1 [Miret, Marta; Felix Caballero, Francisco; Luis Ayuso-Mateos, Jose] CIBERSAM, Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental, Madrid, Spain.
   [Miret, Marta; Felix Caballero, Francisco; Luis Ayuso-Mateos, Jose] Hosp Univ La Princesa, Dept Psychiat, Inst Invest Sanitaria Princesa, Madrid, Spain.
   [Miret, Marta; Felix Caballero, Francisco; Luis Ayuso-Mateos, Jose] Univ Autonoma Madrid, Dept Psychiat, Madrid, Spain.
   [Mathur, Arvind] Dr Sampurnanand Med Coll, Jodhpur, Rajasthan, India.
   [Naidoo, Nirmala; Kowal, Paul; Chatterji, Somnath] World Hlth Org, Dept Hlth Stat & Informat Syst, Geneva, Switzerland.
   [Kowal, Paul] Univ Newcastle, Fac Hlth, Res Ctr Gender Hlth & Ageing, Newcastle, NSW 2300, Australia.
RP Miret, M (reprint author), CIBERSAM, Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental, Madrid, Spain.
EM chatterjis@who.int
RI ; Miret, Marta/C-6103-2019
OI Kowal, Paul/0000-0002-6314-8753; Miret, Marta/0000-0003-3252-854X
FU United States National Institute on Aging through Interagency Agreements
   [OGHA 04034785, YA1323-08-CN-0020, Y1-AG-1005-01, R01-AG034479];
   Instituto de Salud Carlos III-FIS [PS09/00295]; Spanish Ministry of
   Science and Innovation: ACI-Promociona [ACI2009-1010]; Centro de
   Investigacion Biomedica Red de Salud Mental (CIBERSAM), Instituto de
   Salud Carlos III
FX This paper uses data from WHO SAGE. WHO's Study on Global Ageing and
   Adult Health is supported by the US National Institute on Aging through
   Interagency Agreements (OGHA 04034785; YA1323-08-CN-0020; Y1-AG-1005-01)
   and through a research grant (R01-AG034479). The research leading to
   these results received also funding from the Spanish Ministry of Science
   and Innovation ACI-Promociona (ACI2009-1010) and was supported by the
   Centro de Investigacion Biomedica Red de Salud Mental (CIBERSAM),
   Instituto de Salud Carlos III.; This paper uses data from World Health
   Organization (WHO) Study on global AGEing and adult health (SAGE). WHO's
   SAGE is supported by the United States National Institute on Aging
   through Interagency Agreements (OGHA 04034785; YA1323-08-CN-0020;
   Y1-AG-1005-01) and through a research grant (R01-AG034479). The paper
   was supported by the Instituto de Salud Carlos III-FIS research grant
   number PS09/00295, the Spanish Ministry of Science and Innovation:
   ACI-Promociona (ACI2009-1010), and the Centro de Investigacion Biomedica
   Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Andres AM, 2004, BRIT J MATH STAT PSY, V57, P1, DOI 10.1348/000711004849268
   Andres AM, 2008, COMMUN STAT-THEOR M, V37, P760, DOI 10.1080/03610920701669884
   Bylsma LM, 2011, J ABNORM PSYCHOL, V120, P155, DOI 10.1037/a0021662
   CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004
   DEYO RA, 1991, CONTROL CLIN TRIALS, V12, pS142, DOI 10.1016/S0197-2456(05)80019-4
   Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037/0033-2909.125.2.276
   Diener E, 2010, J PERS SOC PSYCHOL, V99, P52, DOI 10.1037/a0018066
   Dockray S, 2010, SOC INDIC RES, V99, P269, DOI 10.1007/s11205-010-9578-7
   Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170
   FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L
   Kahneman D, 2006, J ECON PERSPECT, V20, P3, DOI 10.1257/089533006776526030
   Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572
   Krueger AB, 2008, J PUBLIC ECON, V92, P1833, DOI 10.1016/j.jpubeco.2007.12.015
   Krueger AB, 2008, LANCET, V371, P1519, DOI 10.1016/S0140-6736(08)60656-X
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Layard R, 2010, SCIENCE, V327, P534, DOI 10.1126/science.1186315
   Nguyen P, 2007, J STAT SOFTW, V21, P1
   Obuchowski NA, 2006, STAT MED, V25, P481, DOI 10.1002/sim.2228
   Prieto L, 1998, MED CLIN-BARCELONA, V110, P142
   R Development Core Team, 2008, R LANG ENV STAT COMP
   Rosner B., 2006, FUNDAMENTALS BIOSTAT
   Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00
   StataCorp, 2010, STAT STAT SOFTW REL
   Stiglitz JE, 2009, REPORT COMMISSION ME
   White MP, 2009, PSYCHOL SCI, V20, P1000, DOI 10.1111/j.1467-9280.2009.02392.x
NR 25
TC 17
Z9 17
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 27
PY 2012
VL 7
IS 8
AR e43887
DI 10.1371/journal.pone.0043887
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 995WH
UT WOS:000308044800073
PM 22952801
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zwerling, A
   Cojocariu, M
   McIntosh, F
   Pietrangelo, F
   Behr, MA
   Schwartzman, K
   Benedetti, A
   Dendukuri, N
   Menzies, D
   Pai, M
AF Zwerling, Alice
   Cojocariu, Mihaela
   McIntosh, Fiona
   Pietrangelo, Filomena
   Behr, Marcel A.
   Schwartzman, Kevin
   Benedetti, Andrea
   Dendukuri, Nandini
   Menzies, Dick
   Pai, Madhukar
TI TB Screening in Canadian Health Care Workers Using Interferon-Gamma
   Release Assays
SO PLOS ONE
LA English
DT Article
ID LATENT TUBERCULOSIS INFECTION; WITHIN-SUBJECT VARIABILITY; CELL ASSAYS;
   TESTS; DIAGNOSIS; RISK
AB Background: While many North American healthcare institutions are switching from Tuberculin Skin Test (TST) to Interferon-gamma release assays (IGRAs), there is relatively limited data on association between occupational tuberculosis (TB) risk factors and test positivity and/or patterns of test discordance.
   Methods: We recruited a cohort of Canadian health care workers (HCWs) in Montreal, and performed both TST and QuantiFERON-TB Gold In Tube (QFT) tests, and assessed risk factors and occupational exposure.
   Results: In a cross-sectional analysis of baseline results, the prevalence of TST positivity using the 10 mm cut-off was 5.7% (22/388, 95% CI: 3.6-8.5%), while QFT positivity was 6.2% (24/388, 95% CI: 4-9.1%). Overall agreement between the tests was poor (kappa = 0.26), and 8.3% of HCWs had discordant test results, most frequently TST2/QFT+ (17/388, 4.4%). TST positivity was associated with total years worked in health care, non-occupational exposure to TB and BCG vaccination received after infancy or on multiple occasions. QFT positivity was associated with having worked as a HCW in a foreign country.
   Conclusions: Our results suggest that LTBI prevalence as measured by either the TST or the QFT is low in this HCW population. Of concern is the high frequency of unexplainable test discordance, namely: TST-/QFT+ subjects, and the lack of any association between QFT positivity and clear-cut recent TB exposure. If these discordant results are indeed false positives, the use of QFT in lieu of TST in low TB incidence settings could result in overtreatment of uninfected individuals.
C1 [Zwerling, Alice; Behr, Marcel A.; Benedetti, Andrea; Dendukuri, Nandini; Menzies, Dick; Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.
   [Zwerling, Alice; Cojocariu, Mihaela; Behr, Marcel A.; Schwartzman, Kevin; Benedetti, Andrea; Menzies, Dick; Pai, Madhukar] Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada.
   [Behr, Marcel A.; Schwartzman, Kevin; Menzies, Dick] McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ, Canada.
   [Pietrangelo, Filomena] McGill Univ, Dept Occupat Hlth & Safety, Ctr Hlth, Montreal, PQ, Canada.
   [Cojocariu, Mihaela; McIntosh, Fiona] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada.
RP Zwerling, A (reprint author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.
EM madhukar.pai@mcgill.ca
OI Pai, Madhukar/0000-0003-3667-4536
FU Canadian Institutes of Health Research (CIHR) [81362]; Fonds de
   recherche du Quebec-Sante
FX This work was supported by the Canadian Institutes of Health Research
   (CIHR) grant 81362. AZ received a doctoral fellowship from CIHR, and MP
   received a New Investigator Award from CIHR. MP also received a salary
   award from Fonds de recherche du Quebec-Sante. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR American Thoracic Society (ATS), 2000, AM J RESP CRIT CARE, V161, pS221
   Canadian Tuberculosis Committee, 2010, CAN COMMUN DIS REP, V36, P1
   CanadianTuberculosisCommittee, 2008, CAN COMMUN DIS REP, V34, P1
   Chan ED, 2008, CURR OPIN INFECT DIS, V21, P587, DOI 10.1097/QCO.0b013e328319bce6
   Ciaschetti A, 2007, G Ital Med Lav Ergon, V29, P406
   Cummings KJ, 2009, INFECT CONT HOSP EP, V30, P1123, DOI 10.1086/644754
   Dorman S, 2009, AM J RESP CRIT CARE, pA1010
   Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192
   Fleiss JL, 1981, STAT METHODS RATES P
   Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6
   Jensen PA, 2005, MMWR RECOMM REP, V54, P1
   Joshi R, 2011, EUR RESPIR J, V38, P1475, DOI 10.1183/09031936.00014611
   Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LONG R, 2007, CANADIAN TUBERCULOSI
   Menzies D, 2007, INT J TUBERC LUNG D, V11, P593
   Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120
   MENZIES D, 1995, NEW ENGL J MED, V332, P92, DOI 10.1056/NEJM199501123320206
   Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006
   Mirtskhulava V, 2008, INT J TUBERC LUNG D, V12, P513
   Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X
   Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241
   Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5
   Reichman L, 2000, TUBERCULOSIS COMPREH
   Ringshausen FC, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-6
   Ringshausen FC, 2011, CLIN VACCINE IMMUNOL, V18, P1176, DOI 10.1128/CVI.05058-11
   SSSQ, 2009, EP TUB QUEB 2004 200
   van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517
   Veerapathran A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001850
   Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180
NR 30
TC 24
Z9 25
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 20
PY 2012
VL 7
IS 8
AR e43014
DI 10.1371/journal.pone.0043014
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 991WJ
UT WOS:000307733800041
PM 22916197
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Singh, JP
   Volavka, J
   Czobor, P
   Van Dorn, RA
AF Singh, Jay P.
   Volavka, Jan
   Czobor, Pal
   Van Dorn, Richard A.
TI A Meta-Analysis of the Val158Met COMT Polymorphism and Violent Behavior
   in Schizophrenia
SO PLOS ONE
LA English
DT Article
ID METHYLTRANSFERASE GENE POLYMORPHISM; AGGRESSIVE-BEHAVIOR;
   SUICIDAL-BEHAVIOR; SUBSTANCE-ABUSE; ASSOCIATION; RISK; HETEROGENEITY;
   NEUROBIOLOGY; ADHERENCE; PATHWAYS
AB We conducted a meta-analysis of studies examining the association between the Val158Met COMT polymorphism and violence against others in schizophrenia. A systematic search current to November 1, 2011 was conducted using MEDLINE, EMBASE, CINAHL, PsycINFO, ProQuest, and the National Criminal Justice Reference Service and identified 15 studies comprising 2,370 individuals with schizophrenia for inclusion. Bivariate analyses of study sensitivities and specificities were conducted. This methodology allowed for the calculation of pooled diagnostic odds ratios (DOR). Evidence of a significant association between the presence of a Met allele and violence was found such that men's violence risk increased by approximately 50% for those with at least one Met allele compared with homozygous Val individuals (DOR = 1.45; 95% CI = 1.05-2.00; z = 2.37, p = 0.02). No significant association between the presence of a Met allele and violence was found for women or when outcome was restricted to homicide. We conclude that male schizophrenia patients who carry the low activity Met allele in the COMT gene are at a modestly elevated risk of violence. This finding has potential implications for the pharmacogenetics of violent behavior in schizophrenia.
C1 [Singh, Jay P.; Van Dorn, Richard A.] Univ S Florida, Dept Mental Hlth Law & Policy, Tampa, FL 33620 USA.
   [Volavka, Jan] NYU, Sch Med, Dept Psychiat, New York, NY USA.
   [Czobor, Pal] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA.
   [Czobor, Pal] Semmelweis Univ, Dept Psychiat & Psychotherapy, H-1085 Budapest, Hungary.
   [Van Dorn, Richard A.] Res Triangle Inst Int, Durham, NC USA.
RP Singh, JP (reprint author), Univ S Florida, Dept Mental Hlth Law & Policy, Tampa, FL 33620 USA.
EM jaysingh@usf.edu
RI Volavka, Jan/E-9529-2019
OI Volavka, Jan/0000-0002-4178-8207
CR Alia-Klein N, 2007, AGGRESSIVE BEHAV, V33, P86, DOI 10.1002/ab.20170
   Allan ER, 1996, J CLIN PSYCHIAT, V57, P455, DOI 10.4088/JCP.v57n1003
   Ascher-Svanum H, 2006, J CLIN PSYCHIAT, V67, P453, DOI 10.4088/JCP.v67n0317
   Barnett JH, 2007, MOL PSYCHIATR, V12, P502, DOI 10.1038/sj.mp.4001973
   Collip D, 2011, CNS NEUROSCI THER, V17, P612, DOI 10.1111/j.1755-5949.2010.00213.x
   Comai S, 2012, J CLIN PSYCHOPHARM, V32, P83, DOI 10.1097/JCP.0b013e31823f8770
   Costas J, 2011, J PSYCHIATR RES, V45, P7, DOI 10.1016/j.jpsychires.2010.04.021
   Fazel S, 2009, J CLIN PSYCHIAT, V70, P362, DOI 10.4088/JCP.08m04274
   Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120
   Fazel S, 2009, JAMA-J AM MED ASSOC, V301, P2016, DOI 10.1001/jama.2009.675
   Fernandes C, 2004, EUR J NEUROSCI, V19, P2576, DOI 10.1111/j.1460-9568.2004.03358.x
   Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X
   Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991
   Graves PM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000974.pub2
   Gu Y, 2009, MED SCI MONITOR, V15, pCR484
   Han DH, 2006, NEUROREPORT, V17, P95, DOI 10.1097/01.wnr.0000192740.38653.91
   Han DH, 2004, PSYCHIAT RES, V129, P29, DOI 10.1016/j.psychres.2004.06.013
   Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hodgins S, 2005, SCHIZOPHR RES, V78, P323, DOI 10.1016/j.schres.2005.05.021
   Hong JP, 2008, AM J MED GENET B, V147B, P658, DOI 10.1002/ajmg.b.30649
   Iancu I, 2010, PSYCHOPATHOLOGY, V43, P223, DOI 10.1159/000313520
   Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80
   Jones G, 2001, BRIT J PSYCHIAT, V179, P351, DOI 10.1192/bjp.179.4.351
   KAY SR, 1988, J NERV MENT DIS, V176, P539, DOI 10.1097/00005053-198809000-00007
   Kim YR, 2008, EUR NEUROPSYCHOPHARM, V18, P820, DOI 10.1016/j.euroneuro.2008.07.009
   Kim-Cohen J, 2006, MOL PSYCHIATR, V11, P903, DOI 10.1038/sj.mp.4001851
   Koen L, 2004, AUST NZ J PSYCHIAT, V38, P254, DOI 10.1080/j.1440-1614.2004.01338.x
   Koh KB, 2012, J CLIN PSYCHIAT, V73, P159, DOI 10.4088/JCP.10m06443
   Kotler M, 1999, AM J MED GENET, V88, P628, DOI 10.1002/(SICI)1096-8628(19991215)88:6<628::AID-AJMG10>3.3.CO;2-5
   Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liou YJ, 2001, NEUROPSYCHOBIOLOGY, V43, P11, DOI 10.1159/000054858
   Meltzer HY, 2003, ARCH GEN PSYCHIAT, V60, P82, DOI 10.1001/archpsyc.60.1.82
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Munafo MR, 2007, MOL PSYCHIATR, V12, P454, DOI 10.1038/sj.mp.4001938
   Nedic G, 2011, INT J NEUROPSYCHOPH, V14, P377, DOI 10.1017/S1461145710001057
   Nolan KA, 2003, PSYCHIAT SERV, V54, P1012, DOI 10.1176/appi.ps.54.7.1012
   Nolan KA, 2000, PSYCHIAT GENET, V10, P117, DOI 10.1097/00041444-200010030-00003
   Park TW, 2002, EUR NEUROPSYCHOPHARM, V12, P299, DOI 10.1016/S0924-977X(02)00030-5
   Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022
   Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1
   Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942
   Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774
   Silver JM, 1999, J NEUROPSYCH CLIN N, V11, P328, DOI 10.1176/jnp.11.3.328
   Soyka M, 2011, SCHIZOPHRENIA BULL, V37, P913, DOI 10.1093/schbul/sbr103
   Strous RD, 2003, AM J MED GENET B, V120B, P29, DOI 10.1002/ajmg.b.20021
   Strous RD, 1997, BIOL PSYCHIAT, V41, P493, DOI 10.1016/S0006-3223(96)00474-X
   Strous RD, 1997, PSYCHIAT RES, V69, P71, DOI 10.1016/S0165-1781(96)03111-3
   Swanson JW, 2008, LAW HUMAN BEHAV, V32, P228, DOI 10.1007/s10979-007-9095-7
   Swartz MS, 1998, SOC PSYCH PSYCH EPID, V33, pS75, DOI 10.1007/s001270050213
   Thompson JMD, 2012, DEV MED CHILD NEUROL, V54, P148, DOI 10.1111/j.1469-8749.2011.04129.x
   Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187
   Tosato S, 2011, NEUROSCI LETT, V495, P17, DOI 10.1016/j.neulet.2011.03.018
   Tovilla-Zarate C, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-151
   Velligan DI, 2009, J CLIN PSYCHIAT, V70, P6
   Volavka J, 2002, NEUROBIOLOGY VIOLENC
   Volavka J, 2012, COMPREHENSIVE CARE S, P262
   Volavka J, 2012, INT J NEUROPSYCHOPH, V15, P1201, DOI 10.1017/S1461145712000284
   Volavka J, 2011, SCHIZOPHRENIA BULL, V37, P921, DOI 10.1093/schbul/sbr041
   Xiong H, 2010, GUANGDONG MED J, V31, P82
   YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35
   Zammit S, 2004, AM J MED GENET B, V128B, P19, DOI 10.1002/ajmg.b.30021
NR 64
TC 27
Z9 32
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 14
PY 2012
VL 7
IS 8
AR e43423
DI 10.1371/journal.pone.0043423
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 988OQ
UT WOS:000307500800082
PM 22905266
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Pajula, J
   Kauppi, JP
   Tohka, J
AF Pajula, Juha
   Kauppi, Jukka-Pekka
   Tohka, Jussi
TI Inter-Subject Correlation in fMRI: Method Validation against
   Stimulus-Model Based Analysis
SO PLOS ONE
LA English
DT Article
ID FALSE DISCOVERY RATE; HUMAN BRAIN; INTERSUBJECT CORRELATIONS;
   DEFAULT-MODE; BOLD FMRI; IMAGES; CORTEX; ROBUST; OPTIMIZATION;
   REGISTRATION
AB Within functional magnetic resonance imaging (fMRI), the use of the traditional general linear model (GLM) based analysis methods is often restricted to strictly controlled research setups requiring a parametric activation model. Instead, Inter-Subject Correlation (ISC) method is based on voxel-wise correlation between the time series of the subjects, which makes it completely non-parametric and thus suitable for naturalistic stimulus paradigms such as movie watching. In this study, we compared an ISC based analysis results with those of a GLM based in five distinct controlled research setups. We used International Consortium for Brain Mapping functional reference battery (FRB) fMRI data available from the Laboratory of Neuro Imaging image data archive. The selected data included measurements from 37 right-handed subjects, who all had performed the same five tasks from FRB. The GLM was expected to locate activations accurately in FRB data and thus provide good grounds for investigating relationship between ISC and stimulus induced fMRI activation. The statistical maps of ISC and GLM were compared with two measures. The first measure was the Pearson's correlation between the non-thresholded ISC test-statistics and absolute values of the GLM Z-statistics. The average correlation value over five tasks was 0.74. The second was the Dice index between the activation regions of the methods. The average Dice value over the tasks and three threshold levels was 0.73. The results of this study indicated how the data driven ISC analysis found the same foci as the model-based GLM analysis. The agreement of the results is highly interesting, because ISC is applicable in situations where GLM is not suitable, for example, when analyzing data from a naturalistic stimuli experiment.
C1 [Pajula, Juha; Tohka, Jussi] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland.
   [Kauppi, Jukka-Pekka] Univ Helsinki, Dept Comp Sci, SF-00510 Helsinki, Finland.
RP Pajula, J (reprint author), Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland.
EM juha.pajula@tut.fi
RI Tohka, Jussi/D-2385-2013
OI Tohka, Jussi/0000-0002-1048-5860; Tohka, Jussi/0000-0002-6748-5116
FU International Consortium for Brain Mapping (ICBM); National Institute of
   Biomedical Imaging and BioEngineering; Academy of Finland [129657];
   Finnish Programme for Centres of Excellence in Research [130275]
FX Data collection and sharing for this project was provided by the
   International Consortium for Brain Mapping (ICBM; Principal
   Investigator: John Mazziotta, MD, PhD). ICBM funding was provided by the
   National Institute of Biomedical Imaging and BioEngineering. ICBM data
   are disseminated by the Laboratory of Neuro Imaging at the University of
   California, Los Angeles.; This research was supported by the Academy of
   Finland (application number 129657, Finnish Programme for Centres of
   Excellence in Research, 2006 2011 and grant number 130275). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X
   Bellec P, 2009, MAGN RESON IMAGING, V27, P1382, DOI 10.1016/j.mri.2009.05.034
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Calhoun VD, 2012, NEUROIMAGE, V59, P25, DOI 10.1016/j.neuroimage.2011.06.037
   Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004
   DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409
   Finch H, 2005, J DATA SCI, V3, P85
   Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037
   Golland Y, 2007, CEREB CORTEX, V17, P766, DOI 10.1093/cercor/bhk030
   Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101
   Hamilton LS, 2009, HUM BRAIN MAPP, V30, P3958, DOI 10.1002/hbm.20820
   Hanson SJ, 2009, J COMPUT NEUROSCI, V27, P103, DOI 10.1007/s10827-008-0129-z
   Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506
   Hasson U, 2008, NEURON, V57, P452, DOI 10.1016/j.neuron.2007.12.009
   Hasson U, 2010, TRENDS COGN SCI, V14, P40, DOI 10.1016/j.tics.2009.10.011
   Hasson U, 2009, AUTISM RES, V2, P220, DOI 10.1002/aur.89
   Hejnar MR, 2007, HUM BRAIN MAPP, V28, P860, DOI 10.1002/hbm.20321
   Jaaskelainen Iiro P, 2008, Open Neuroimag J, V2, P14, DOI 10.2174/1874440000802010014
   Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132
   Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6
   Kauppi J, 2010, INF TECHN APPL BIOM, P1, DOI DOI 10.1109/ITAB.2010.5687650
   Kauppi Jukka-Pekka, 2010, Front Neuroinform, V4, P5, DOI 10.3389/fninf.2010.00005
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lerner Y, 2011, J NEUROSCI, V31, P2906, DOI 10.1523/JNEUROSCI.3684-10.2011
   Logan BR, 2004, NEUROIMAGE, V22, P95, DOI 10.1016/j.neuroimage.2003.12.047
   Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915
   Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913
   Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066
   Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676
   Smith J. O., SPECTRAL AUDIO SIGNA
   Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062
   Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051
   Spiers HJ, 2007, TRENDS COGN SCI, V11, P356, DOI 10.1016/j.tics.2007.06.002
   Wilson SM, 2008, CEREB CORTEX, V18, P230, DOI 10.1093/cercor/bhm049
   Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023
   Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931
   Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263
   ZIJDENBOS AP, 1994, IEEE T MED IMAGING, V13, P716, DOI 10.1109/42.363096
NR 38
TC 27
Z9 28
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 8
PY 2012
VL 7
IS 8
AR e41196
DI 10.1371/journal.pone.0041196
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 986GX
UT WOS:000307331100011
PM 22924089
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Brons, S
   van Beusichem, ME
   Bronkhorst, EM
   Draaisma, J
   Berge, SJ
   Maal, TJ
   Kuijpers-Jagtman, AM
AF Brons, Sander
   van Beusichem, Machteld E.
   Bronkhorst, Ewald M.
   Draaisma, Jos
   Berge, Stefaan J.
   Maal, Thomas J.
   Kuijpers-Jagtman, Anne Marie
TI Methods to Quantify Soft-Tissue Based Facial Growth and Treatment
   Outcomes in Children: A Systematic Review
SO PLOS ONE
LA English
DT Article
ID UNILATERAL CLEFT-LIP; EARLY CRANIOFACIAL MORPHOLOGY; RAPID MAXILLARY
   EXPANSION; OSLO CLP TEAM; FOLLOW-UP; PROFILE CHANGES; IMAGING-SYSTEM;
   DISTRACTION OSTEOGENESIS; PHOTOGRAMMETRIC IMAGES; CEPHALOMETRIC ANALYSIS
AB Context: Technological advancements have led craniofacial researchers and clinicians into the era of three-dimensional digital imaging for quantitative evaluation of craniofacial growth and treatment outcomes.
   Objective: To give an overview of soft-tissue based methods for quantitative longitudinal assessment of facial dimensions in children until six years of age and to assess the reliability of these methods in studies with good methodological quality.
   Data Source: PubMed, EMBASE, Cochrane Library, Web of Science, Scopus and CINAHL were searched. A hand search was performed to check for additional relevant studies.
   Study Selection: Primary publications on facial growth and treatment outcomes in children younger than six years of age were included.
   Data Extraction: Independent data extraction by two observers. A quality assessment instrument was used to determine the methodological quality. Methods, used in studies with good methodological quality, were assessed for reliability expressed as the magnitude of the measurement error and the correlation coefficient between repeated measurements.
   Results: In total, 47 studies were included describing 4 methods: 2D x-ray cephalometry; 2D photography; anthropometry; 3D imaging techniques (surface laser scanning, stereophotogrammetry and cone beam computed tomography). In general the measurement error was below 1 mm and 1 degrees and correlation coefficients range from 0.65 to 1.0.
   Conclusion: Various methods have shown to be reliable. However, at present stereophotogrammetry seems to be the best 3D method for quantitative longitudinal assessment of facial dimensions in children until six years of age due to its millisecond fast image capture, archival capabilities, high resolution and no exposure to ionizing radiation.
C1 [Brons, Sander; van Beusichem, Machteld E.; Kuijpers-Jagtman, Anne Marie] Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands.
   [Bronkhorst, Ewald M.] Radboud Univ Nijmegen, Med Ctr, Dept Prevent & Curat Dent, NL-6525 ED Nijmegen, Netherlands.
   [Draaisma, Jos] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Med, NL-6525 ED Nijmegen, Netherlands.
   [Berge, Stefaan J.; Maal, Thomas J.] Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands.
RP Brons, S (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands.
EM orthodontics@dent.umcn.nl
RI Berge, S.J./H-8011-2014; Draaisma, J.M.T./L-4283-2015; Brons,
   Sander/I-2714-2018; Maal, Thomas/L-4497-2015; Kuijpers-Jagtman, Anne
   Marie/A-9413-2008; Bronkhorst, Ewald M/L-4230-2015
OI Brons, Sander/0000-0001-5263-4804; Maal, Thomas/0000-0002-1702-4733;
   Kuijpers-Jagtman, Anne Marie/0000-0001-8172-0090; Bronkhorst,
   Ewald/0000-0003-0953-8053; Draaisma, Jos/0000-0003-4829-6173
FU Dutch Technology Foundation [10315]
FX This work was supported by a grant from the Dutch Technology Foundation
   to STW (grant no. 10315). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR AlBarakati SF, 2012, DENTOMAXILLOFAC RAD, V41, P11, DOI 10.1259/dmfr/37010910
   Aldridge K, 2005, AM J MED GENET A, V138A, P247, DOI 10.1002/ajmg.a.30959
   Altug-Atac AT, 2008, PLAST RECONSTR SURG, V121, P1751, DOI 10.1097/PRS.0b013e31816aa003
   Aynechi N, 2011, ANGLE ORTHOD, V81, P245, DOI 10.2319/041810-210.1
   Ayoub A, 2003, CLEFT PALATE-CRAN J, V40, P523, DOI 10.1597/02-067
   Bartzela TN, 2011, INT J ORAL MAX SURG, V40, P782, DOI 10.1016/j.ijom.2011.02.029
   Bennun RD, 1999, PLAST RECONSTR SURG, V104, P616, DOI 10.1097/00006534-199909030-00002
   BISHARA SE, 1985, AM J ORTHOD DENTOFAC, V88, P466, DOI 10.1016/S0002-9416(85)80046-4
   Bishara SE, 1997, ANGLE ORTHOD, V67, P55
   Bishara SE, 1998, AM J ORTHOD DENTOFAC, V114, P698, DOI 10.1016/S0889-5406(98)70203-3
   BISHARA SE, 1984, AM J ORTHOD DENTOFAC, V85, P238, DOI 10.1016/0002-9416(84)90063-0
   BISHARA SE, 1985, AM J ORTHOD DENTOFAC, V88, P209, DOI 10.1016/S0002-9416(85)90216-7
   Boluyt N, 2008, ARCH PEDIAT ADOL MED, V162, P111, DOI 10.1001/archpediatrics.2007.40
   Bongaarts CAM, 2009, CLEFT PALATE-CRAN J, V46, P654, DOI 10.1597/08-034.1
   Broadbent BH, 1931, ANGLE ORTHOD, V1, P45, DOI DOI 10.1043/0003-3219(1931)001<0045:ANXTAI>2.0.CO;2
   Castelo PM, 2010, ANN ANAT, V192, P23, DOI 10.1016/j.aanat.2009.10.002
   Cevidanes LHS, 2011, ORAL SURG ORAL MED O, V111, P757, DOI 10.1016/j.tripleo.2011.02.002
   Chien-Jung B, 2005, CLEFT PALATE-CRAN J, V42, P658, DOI 10.1597/04-126.1
   Clark HD, 1999, CONTROL CLIN TRIALS, V20, P448, DOI 10.1016/S0197-2456(99)00026-4
   COCCARO P J, 1965, Cleft Palate J, V45, P1
   Cole TJ, 2011, ANN HUM BIOL, V38, P7, DOI 10.3109/03014460.2011.544139
   Cruz AAV, 2008, J CRANIOFAC SURG, V19, P106, DOI 10.1097/scs.0b013e31815c94e1
   Daskalogiannakis J, 2006, CLEFT PALATE-CRAN J, V43, P471
   Davis JP, 2010, FORENSIC SCI INT, V200, P165, DOI 10.1016/j.forsciint.2010.04.012
   de Menezes M, 2010, J ORAL MAXIL SURG, V68, P2129, DOI 10.1016/j.joms.2009.09.036
   Djordjevic J, 2011, EUR J ORTHOD
   El-Beialy AR, 2011, AM J ORTHOD DENTOFAC, V140, P157, DOI 10.1016/j.ajodo.2010.03.030
   Ezzat CF, 2007, CLEFT PALATE-CRAN J, V44, P8, DOI 10.1597/06-009
   FARKAS LG, 1980, PLAST RECONSTR SURG, V66, P346, DOI 10.1097/00006534-198066030-00004
   Farkas LG, 1994, ANTHROPOMETRY HEAD F
   Ferring V, 2008, AM J ORTHOD DENTOFAC, V134, P472, DOI 10.1016/j.ajodo.2007.03.027
   Gordon JM, 2009, ANGLE ORTHOD, V79, P1000, DOI 10.2319/082108-441.1
   GRABER LW, 1977, AM J ORTHOD DENTOFAC, V72, P23, DOI 10.1016/0002-9416(77)90122-1
   Hajeer M Y, 2004, J Orthod, V31, P62, DOI 10.1179/146531204225011346
   HANADA K, 1975, AM J ORTHOD DENTOFAC, V67, P363, DOI 10.1016/0002-9416(75)90019-6
   Hansen M, 1997, PLAST RECONSTR SURG, V100, P1387, DOI 10.1097/00006534-199711000-00002
   Heimer MV, 2008, EUR J ORTHODONT, V30, P580, DOI 10.1093/ejo/cjn035
   Hermann NV, 2004, CLEFT PALATE-CRAN J, V41, P424, DOI 10.1597/03-056.1
   Hermann NV, 2003, CLEFT PALATE-CRAN J, V40, P373, DOI 10.1597/1545-1569(2003)040<0373:CMAGCI>2.0.CO;2
   Hermann NV, 2003, CLEFT PALATE-CRAN J, V40, P131, DOI 10.1597/1545-1569(2003)040<0131:ECMAGI>2.0.CO;2
   Hermann NV, 2002, CLEFT PALATE-CRAN J, V39, P604, DOI 10.1597/1545-1569(2002)039<0604:ECMAGI>2.0.CO;2
   Hermann NV, 1999, J CRAN GENET DEV BIO, V19, P135
   Hodges JS, 2004, J EVID-BASED DENT PR, V4, P24
   Hoefert CS, 2010, J OROFAC ORTHOP, V71, P136, DOI 10.1007/s00056-010-9931-0
   HOLDAWAY RA, 1983, AM J ORTHOD DENTOFAC, V84, P1, DOI 10.1016/0002-9416(83)90144-6
   Hood C A, 2003, Int J Paediatr Dent, V13, P404, DOI 10.1046/j.1365-263X.2003.00496.x
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   Kau CH, 2011, AM J ORTHOD DENTOFAC, V139, pE285, DOI 10.1016/j.ajodo.2009.03.054
   Ko EW, 2004, CLEFT PALATE-CRAN J, V41, P5, DOI 10.1597/02-132
   Ko EWC, 2000, J ORAL MAXIL SURG, V58, P959, DOI 10.1053/joms.2000.8735
   Kohout MP, 1998, PLAST RECONSTR SURG, V102, P1339, DOI 10.1097/00006534-199810000-00004
   Lagravere MO, 2005, ANGLE ORTHOD, V75, P1046
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liou EJW, 2007, PLAST RECONSTR SURG, V119, P642, DOI 10.1097/01.prs.0000239600.79638.6f
   Littlefield TR, 2004, J CRANIOFAC SURG, V15, P175, DOI 10.1097/00001665-200401000-00042
   Maal TJJ, 2010, J ORAL MAXIL SURG, V68, P2391, DOI 10.1016/j.joms.2009.10.017
   Nada RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016520
   Nollet PJPM, 2008, INT J ORAL MAX SURG, V37, P123, DOI 10.1016/j.ijom.2007.09.168
   Padwa BL, 1999, PLAST RECONSTR SURG, V104, P1261, DOI 10.1097/00006534-199910000-00004
   POSEN JM, 1967, AMER J ORTHODONTICS, V53, P746, DOI 10.1016/0002-9416(67)90119-4
   Primozic J, 2009, EUR J ORTHODONT, V31, P352, DOI 10.1093/ejo/cjp041
   RAS F, 1995, CLEFT PALATE-CRAN J, V32, P463, DOI 10.1597/1545-1569(1995)032<0463:LSOTDC>2.3.CO;2
   Ridgway EB, 2011, J CRANIOFAC SURG, V22, P455, DOI 10.1097/SCS.0b013e3182077d93
   Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150
   SADOWSKY C, 1973, ANGLE ORTHOD, V43, P233
   Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018
   Schuler G, 2007, ANTHROPOL ANZ, V65, P203, DOI 10.1127/anthranz/65/2007/203
   Schwenzer-Zimmerer K, 2008, J CRANIO MAXILL SURG, V36, P431, DOI 10.1016/j.jcms.2008.05.003
   Seidenstricker-Kink LM, 2008, CLEFT PALATE-CRAN J, V45, P511, DOI 10.1597/07-001.1
   SEMB G, 1991, CLEFT PALATE-CRAN J, V28, P22, DOI 10.1597/1545-1569(1991)028<0022:ASOFGI>2.3.CO;2
   SEMB G, 1991, CLEFT PALATE-CRAN J, V28, P1, DOI 10.1597/1545-1569(1991)028<0001:ASOFGI>2.3.CO;2
   Singh GD, 2005, CLEFT PALATE-CRAN J, V42, P403, DOI 10.1597/04-063.1
   SMAHEL Z, 1995, J CRAN GENET DEV BIO, V15, P72
   Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z
   Subtelny JD, 1959, AM J ORTHOD, V45, P481
   Sultana R, 2000, PLAST RECONSTR SURG, V106, P563, DOI 10.1097/00006534-200009030-00006
   Swennen GRJ, 2004, J CRANIOFAC SURG, V15, P399, DOI 10.1097/00001665-200405000-00010
   Toma AM, 2008, ORTHOD CRANIOFAC RES, V11, P180, DOI 10.1111/j.1601-6343.2008.00428.x
   van Loon B, 2010, INT J ORAL MAX SURG, V39, P534, DOI 10.1016/j.ijom.2010.03.022
   van Loon B, 2011, RHINOLOGY, V49, P121, DOI 10.4193/Rhino10.056
   VanderWoude DL, 1997, PLAST RECONSTR SURG, V100, P567, DOI 10.1097/00006534-199709000-00001
   Wen-Ching Ko E, 2000, J ORAL MAXILLOFAC SU, V58, P969
   Wong JY, 2008, CLEFT PALATE-CRAN J, V45, P232, DOI [10.1597/06-175, 10.1597/06-175.1]
   Yang XX, 2009, J CRANIOFAC SURG, V20, P718, DOI 10.1097/SCS.0b013e3181a2de32
   Zettergren-Wijk L, 2006, EUR J ORTHODONT, V28, P319, DOI 10.1093/ejo/cji119
NR 85
TC 20
Z9 21
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 6
PY 2012
VL 7
IS 8
AR e41898
DI 10.1371/journal.pone.0041898
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 992WD
UT WOS:000307810000011
PM 22879898
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Saintrain, MVD
   Vieira, APGF
AF de Lima Saintrain, Maria Vieira
   Gomes Fernandes Vieira, Anya Pimentel
TI Application of the Community Oral Health Indicator by Non-Dental
   Personnel and Its Contribution to Oral Healthcare
SO PLOS ONE
LA English
DT Article
ID VALIDATION; AGREEMENT; SCALE; KAPPA
AB Objective: To validate the Community Oral Health Indicator- COHI by non- dental personnel.
   Methods: Risk assessment is an essential component in the decision-making process. Therefore, the COHI, an instrument to evaluate population oral health situation in a simple manner, was created. Community Health Agents (CHA) were trained to use the COHI (variables as number of teeth, presence of cavities, residual dental roots, oral lesions, etc.), while dentists for the COHI and DMFT. 60 individuals were examined, by CHA and DS, with these indicators in order to validate the use of COHI by non-dental personnel.
   Results: Dental and soft tissues problems were well spread among those individuals. People with and without soft tissue damage, as well as with and without use and/or need for prostheses were found in the sample, proving it to be a heterogeneous population for the evaluated factors and representing the real population. The results of examinations performed by dentists using the COHI and DMF-T/dmf-t presented strong agreement when comparing the two instruments. When COHI and DMFT were compared, the results showed a concordance of 0.86 for the number of present teeth, and 0.85 for the number of residual roots. Likewise, when analyzing the data comparing the use of the COHI by DS and CHA a high agreement level, specificity and sensitivity was found.
   Conclusion: The COHI has shown to be useful for detecting problems in oral health. Therefore, COHI may be used, after training, by non-dental personnel, contributing to the planning and organization of the community dental assistance.
C1 [de Lima Saintrain, Maria Vieira; Gomes Fernandes Vieira, Anya Pimentel] Univ Fortaleza UNIFOR, Sch Dent, Fortaleza, Ceara, Brazil.
   [de Lima Saintrain, Maria Vieira; Gomes Fernandes Vieira, Anya Pimentel] Univ Fortaleza UNIFOR, Publ Hlth Master Program, Fortaleza, Ceara, Brazil.
   [Gomes Fernandes Vieira, Anya Pimentel] Fundacao Oswaldo Cruz, Fortaleza, Ceara, Brazil.
RP Saintrain, MVD (reprint author), Univ Fortaleza UNIFOR, Sch Dent, Fortaleza, Ceara, Brazil.
EM mvlsaintrain@yahoo.com.br
FU Health Management CNPq-process [409392/2006-5]
FX Funding provided by the announcement number 232,006 Health Management
   CNPq-process 409392/2006-5. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256
   Correa-Carhuachin Violeta, 2011, Rev. gastroenterol. Per, V31, P351
   Frazao P, 2003, PUBLIC HLTH DENT PLA, P64
   Gruebbel Allen 0., 1944, JOUR DENTAL RES, V23, P163, DOI 10.1177/00220345440230030201
   Hugoson A, 2008, INT J PAEDIATR DENT, V18, P18, DOI 10.1111/j.1365-263X.2007.00874.x
   IBICIT. Brazilian Institute of Information Science and Technology, 2004, NAT NETW MERG TRANSF
   KLEIN H., 1938, Public Health Reports, V53, P751, DOI 10.2307/4582532
   Klein H, 1937, PUBL HLTH B, P239
   Lamontagne V, 2012, MED PROBL PERFORM AR, V27, P37
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786
   LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240
   Mahmood MA, 2012, J SEX MED, V9, P1883, DOI 10.1111/j.1743-6109.2012.02714.x
   Milne D, 2013, PSYCHO-ONCOLOGY, V22, P940, DOI 10.1002/pon.3071
   Narvai PC, 2008, ORAL HLTH BRAZIL FAR
   Noorani AM, 2012, INT J SHOULDER SURG, V6, P9, DOI 10.4103/0973-6042.94307
   Norman GR, 2000, BIOSTATISTICS BARE E
   Honorio RPP, 2011, REV BRAS ENFERM, V64, P882, DOI 10.1590/S0034-71672011000500013
   Petersson GH, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-5
   Saintrain MVL, 2007, REV BRAS PROM SAUDE, V20, P199
   Streiner D. L., 1995, HLTH MEASUREMENT SCA
   Vieira APGF, 2005, J AM DENT ASSOC, V136, P895, DOI 10.14219/jada.archive.2005.0290
   WHO, 1999, ORAL HLTH SURV BAS M
   World Health Organization (WHO), 1991, EP SURV OR HLTH ED I
NR 24
TC 4
Z9 4
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 27
PY 2012
VL 7
IS 7
AR e39733
DI 10.1371/journal.pone.0039733
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 981ER
UT WOS:000306950200012
PM 22848360
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Eisler, MC
   Magona, JW
   Revie, CW
AF Eisler, Mark C.
   Magona, Joseph W.
   Revie, Crawford W.
TI Diagnosis of Cattle Diseases Endemic to Sub-Saharan Africa: Evaluating a
   Low Cost Decision Support Tool in Use by Veterinary Personnel
SO PLOS ONE
LA English
DT Article
ID TRYPANOSOMA-CONGOLENSE; AGROECOLOGICAL ZONE; UGANDA; INFECTIONS;
   PREVALENCE; DISTRICTS; LIVESTOCK; SYSTEM; CALVES; MBALE
AB Background: Diagnosis is key to control and prevention of livestock diseases. In areas of sub-Saharan Africa where private practitioners rarely replace Government veterinary services reduced in effectiveness by structural adjustment programmes, those who remain lack resources for diagnosis and might benefit from decision support.
   Methodology/Principal Findings: We evaluated whether a low-cost diagnostic decision support tool would lead to changes in clinical diagnostic practice by fifteen veterinary and animal health officers undertaking primary animal healthcare in Uganda. The eight diseases covered by the tool included 98% of all bovine diagnoses made before or after its introduction. It may therefore inform proportional morbidity in the area; breed, age and geographic location effects were consistent with current epidemiological understanding. Trypanosomosis, theileriosis, anaplasmosis, and parasitic gastroenteritis were the most common conditions among 713 bovine clinical cases diagnosed prior to introduction of the tool. Thereafter, in 747 bovine clinical cases estimated proportional morbidity of fasciolosis doubled, while theileriosis and parasitic gastroenteritis were diagnosed less commonly and the average number of clinical signs increased from 3.5 to 4.9 per case, with 28% of cases reporting six or more signs compared to 3% beforehand. Anaemia/pallor, weakness and staring coat contributed most to this increase, approximately doubling in number and were recorded in over half of all cases. Finally, although lack of a gold standard hindered objective assessment of whether the tool improved the reliability of diagnosis, informative concordance and misclassification matrices yielded useful insights into its role in the diagnostic process.
   Conclusions/Significance: The diagnostic decision support tool covered the majority of diagnoses made before or after its introduction, leading to a significant increase in the number of clinical signs recorded, suggesting this as a key beneficial consequence of its use. It may also inform approximate proportional morbidity and represent a useful epidemiological tool in poorly resourced areas.
C1 [Eisler, Mark C.] Univ Bristol, Sch Vet Sci, Fac Med & Vet Med, Bristol BS18 7DU, Avon, England.
   [Magona, Joseph W.] Bulindi Zonal Agr Res & Dev, Hoima, Uganda.
   [Revie, Crawford W.] Univ PEI, Atlantic Vet Coll, Charlottetown, PE, Canada.
RP Eisler, MC (reprint author), Univ Bristol, Sch Vet Sci, Fac Med & Vet Med, Bristol BS18 7DU, Avon, England.
EM mark.eisler@bristol.ac.uk
RI Revie, Crawford/B-5002-2011
OI Revie, Crawford/0000-0002-5018-0340; Eisler, Mark/0000-0001-6843-3345
FU UK Department for International Development (DFID) under RNRRS [R7597,
   R8318]
FX The authors would like to thank the UK Department for International
   Development (DFID) for funding under RNRRS Projects R7597 and R8318. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Babes V., 1888, CR HEBD ACAD SCI, V107, P692
   Bett B, 2004, PREV VET MED, V63, P29, DOI 10.1016/j.prevetmed.2004.02.004
   Bruce D, 1910, P R SOC LOND B-CONTA, V82, P256, DOI 10.1098/rspb.1910.0016
   Chenyambuga S. W., 2010, Livestock Research for Rural Development, V22, P135
   Cowdry EV, 1925, J EXP MED, V42, P231, DOI 10.1084/jem.42.2.231
   De Bont J, 1998, ADV PARASIT, V41, P285, DOI 10.1016/S0065-308X(08)60426-1
   DWINGER RH, 1994, VET PARASITOL, V54, P353, DOI 10.1016/0304-4017(94)90002-7
   Eisler MC, 2007, EPIDEMIOL INFECT, V135, P67, DOI 10.1017/S0950268806006571
   Eisler MC, 2003, TRENDS PARASITOL, V19, P341, DOI 10.1016/S1471-4922(03)00164-8
   Ely JW, 2011, ACAD MED, V86, P307, DOI 10.1097/ACM.0b013e31820824cd
   Fiennes R. N. T.-W., 1970, P729
   Ford J, 1976, ATLAS UGANDA, P16
   Goossens B, 1997, INT J PARASITOL, V27, P1579, DOI 10.1016/S0020-7519(97)00094-5
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Machila N, 2003, ACTA TROP, V86, P25, DOI 10.1016/S0001-706X(02)00288-7
   Magona JW, 2008, VET PARASITOL, V155, P273, DOI 10.1016/j.vetpar.2008.05.022
   Magona J. W., 1999, Bulletin of Animal Health and Production in Africa, V47, P9
   Magona J. W., 2004, Bulletin of Animal Health and Production in Africa, V52, P130
   Magona JW, 2004, J S AFR VET ASSOC, V75, P189
   Magona JW, 2004, ANN TROP MED PARASIT, V98, P785, DOI 10.1179/000349804225021532
   Magona JW, 2004, ONDERSTEPOORT J VET, V71, P231
   Magona JW, 2002, ONDERSTEPOORT J VET, V69, P133
   Makundi AE, 1998, VET PARASITOL, V75, P59, DOI 10.1016/S0304-4017(97)00179-9
   Norval RAI, 1992, EPIDEMIOLOGY THEILER, V481, P20
   Ocaido M., 2005, Livestock Research for Rural Development, V17, P93
   Rubaire-Akiiki C, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.8
   Rubaire-Akiiki CM, 2006, PREV VET MED, V75, P251, DOI 10.1016/j.prevetmed.2006.04.015
   Seidel M, 2003, AGR SYST, V76, P527, DOI 10.1016/S0308-521X(02)00035-5
   Uilenberg G., 1981, Diseases of cattle in the tropics, P345
   Van den Bossche P, 2000, ACTA TROP, V75, P247, DOI 10.1016/S0001-706X(00)00059-0
   WEINBREN B. M., 1960, JOUR COMP PATHOL AND THERAP, V70, P176
NR 31
TC 8
Z9 8
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 12
PY 2012
VL 7
IS 7
AR e40687
DI 10.1371/journal.pone.0040687
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 973NH
UT WOS:000306366400047
PM 22808233
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Llupia, A
   Garcia-Basteiro, AL
   Mena, G
   Rios, J
   Puig, J
   Bayas, JM
   Trilla, A
AF Llupia, Anna
   Garcia-Basteiro, Alberto L.
   Mena, Guillermo
   Rios, Jose
   Puig, Joaquim
   Bayas, Jose M.
   Trilla, Antoni
TI Vaccination Behaviour Influences Self-Report of Influenza Vaccination
   Status: A Cross-Sectional Study among Health Care Workers
SO PLOS ONE
LA English
DT Article
ID ELDERLY OUTPATIENTS; COVERAGE; VALIDATION; PROGRAM; QUESTIONNAIRE;
   PERSONNEL; ACCURACY; VALIDITY
AB Background: Published influenza vaccination coverage in health care workers (HCW) are calculated using two sources: self-report and vaccination records. The objective of this study was to determine whether self-report is a good proxy for recorded vaccination in HCW, as the degree of the relationship is not known, and whether vaccine behaviour influences self-reporting.
   Methods: A cross-sectional study was conducted using a self-administered survey during September 2010. Considering the vaccination record as the gold standard of vaccination, the properties of self-report as a proxy of the record (sensitivity, specificity, positive predictive value, negative predictive value) were calculated. Concordance between the vaccination campaigns studied (2007-2010) was made using the Kappa index, and discordance was analyzed using McNemar's test.
   Results: 248 HCW responded. The 95% confidence intervals of coverage according to the vaccination record and to self-report overlapped, except for 2007, and the Kappa index showed a substantial concordance, except for 2007. McNemar's test suggested that differences between discordant cases were not due to chance and it was found that the proportion of unvaccinated discordant cases was higher than that of vaccinated discordant cases.
   Conclusions: In our study population, self-reported influenza vaccination coverage in HCW in the previous two years is a good proxy of the vaccination record. However, vaccination behaviour influences the self-report and explains a trend to overestimate coverage in self-reporting compared to the vaccination record. The sources of coverage should be taken into account whenever comparisons are made.
C1 [Llupia, Anna; Garcia-Basteiro, Alberto L.; Mena, Guillermo; Bayas, Jose M.; Trilla, Antoni] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, Prevent Med & Epidemiol Unit, Barcelona, Catalonia, Spain.
   [Rios, Jose] Hosp Clin Barcelona, Clin Pharmacol Serv, Barcelona, Catalonia, Spain.
   [Rios, Jose] Univ Autonoma Barcelona, Biostat Unit, E-08193 Barcelona, Catalonia, Spain.
   [Puig, Joaquim] Univ Politecn Cataluna, Dept Appl Math 1, Barcelona, Catalonia, Spain.
RP Llupia, A (reprint author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, Prevent Med & Epidemiol Unit, Barcelona, Catalonia, Spain.
EM annallupia@gmail.com
RI Trilla, Antoni/G-2446-2018; Puig, Joaquim/G-1573-2015
OI Puig, Joaquim/0000-0003-0600-1023; Rios, Jose/0000-0002-0716-8784;
   Llupia, Anna/0000-0001-8284-7560
FU Solvay-Abbott Influenza Research Grant; GlaxoSmithKline; Sanofi Pasteur
   MSD;  [MTM2009-06973]
FX This study was funded by the Solvay-Abbott Influenza Research Grant
   2010. J Puig is funded by MTM2009-06973. The investigators were
   contracted by their institutions. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.; JMB has received fees for lectures,
   advice and participation in working groups funded by the pharmaceutical
   industry. He has participated as principal investigator in clinical
   trials of vaccines (influenza vaccines, and others) promoted by
   GlaxoSmithKline and Sanofi Pasteur MSD. All other authors declare they
   have no competing interests. This does not alter the authors' adherence
   to all the PLoS ONE policies on sharing data and materials.
CR Andrews RM, 2005, VACCINE, V23, P2756, DOI 10.1016/j.vaccine.2004.11.039
   Babcock HM, 2010, CLIN INFECT DIS, V50, P459, DOI 10.1086/650752
   Bertin M, 2007, AM J INFECT CONTROL, V35, P33, DOI 10.1016/j.ajic.2006.10.005
   Blank PR, 2009, INFECTION, V37, P390, DOI 10.1007/s15010-009-8467-y
   Bryant KA, 2004, INFECT CONT HOSP EP, V25, P912, DOI 10.1086/502319
   de Juanes JR, 2007, VACCINE, V25, P201, DOI 10.1016/j.vaccine.2005.10.057
   Fiore Anthony E., 2010, Morbidity and Mortality Weekly Report, V59, P1
   Greene SK, 2009, AM J PREV MED, V37, P552, DOI 10.1016/j.amepre.2009.08.022
   HUTCHISON BG, 1989, CAN J PUBLIC HEALTH, V80, P271
   Irving SA, 2009, VACCINE, V27, P6546, DOI 10.1016/j.vaccine.2009.08.050
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Llupia A, 2010, AM J INFECT CONTROL, V38, P476, DOI 10.1016/j.ajic.2010.01.013
   Mac Donald R, 1999, AM J PREV MED, V16, P173, DOI 10.1016/S0749-3797(98)00159-7
   Mangtani P, 2007, EPIDEMIOL INFECT, V135, P139, DOI 10.1017/S0950268806006479
   National Health and Medical Research Council (Australia), 1997, AUSTR IMM HDB
   NICHOL KL, 1991, AM J PREV MED, V7, P199
   Russell ML, 2003, AM J INFECT CONTROL, V31, P457, DOI 10.1016/S0196-6553(03)00085-3
   SALISBURY D, 2006, IMMUNISATION INFECT
   Sartor C, 2004, INFECT CONT HOSP EP, V25, P918, DOI 10.1086/502320
   Skull SA, 2007, VACCINE, V25, P4775, DOI 10.1016/j.vaccine.2007.04.015
   Sy LS, 2010, VACCINE, V28, P5254, DOI 10.1016/j.vaccine.2010.05.061
   Virseda S, 2010, VACCINE, V28, P4751, DOI 10.1016/j.vaccine.2010.04.101
   Walker FJ, 2006, INFECT CONT HOSP EP, V27, P257, DOI 10.1086/501538
   Zimmerman RK, 2003, VACCINE, V21, P1486, DOI 10.1016/S0264-410X(02)00700-4
NR 24
TC 30
Z9 30
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 11
PY 2012
VL 7
IS 7
AR e39496
DI 10.1371/journal.pone.0039496
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 973LU
UT WOS:000306362400011
PM 22808039
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ayele, FT
   Hailu, E
   Finan, C
   Aseffa, A
   Davey, G
   Newport, MJ
   Rotimi, CN
   Adeyemo, A
AF Ayele, Fasil Tekola
   Hailu, Elena
   Finan, Chris
   Aseffa, Abraham
   Davey, Gail
   Newport, Melanie J.
   Rotimi, Charles N.
   Adeyemo, Adebowale
TI Prediction of HLA Class II Alleles Using SNPs in an African Population
SO PLOS ONE
LA English
DT Article
ID MAJOR HISTOCOMPATIBILITY COMPLEX; SYMPATRIC ETHNIC-GROUPS; TYPING
   IDENTIFIED 2; EXTENDED HUMAN MHC; ASSOCIATION ANALYSIS; KENYAN
   POPULATION; GENOME-WIDE; GENE MAP; PODOCONIOSIS; SEQUENCE
AB Background: Despite the importance of the human leukocyte antigen (HLA) gene locus in research and clinical practice, direct HLA typing is laborious and expensive. Furthermore, the analysis requires specialized software and expertise which are unavailable in most developing country settings. Recently, in silico methods have been developed for predicting HLA alleles using single nucleotide polymorphisms (SNPs). However, the utility of these methods in African populations has not been systematically evaluated.
   Methodology/Principal Findings: In the present study, we investigate prediction of HLA class II (HLA-DRB1 and HLA-DQB1) alleles using SNPs in the Wolaita population, southern Ethiopia. The subjects comprised 297 Ethiopians with genome-wide SNP data, of whom 188 had also been HLA typed and were used for training and testing the model. The 109 subjects with SNP data alone were used for empirical prediction using the multi-allelic gene prediction method. We evaluated accuracy of the prediction, agreement between predicted and HLA typed alleles, and discriminative ability of the prediction probability supplied by the model. We found that the model predicted intermediate (two-digit) resolution for HLA-DRB1 and HLA-DQB1 alleles at accuracy levels of 96% and 87%, respectively. All measures of performance showed high accuracy and reliability for prediction. The distribution of the majority of HLA alleles in the study was similar to that previously reported for the Oromo and Amhara ethnic groups from Ethiopia.
   Conclusions/Significance: We demonstrate that HLA class II alleles can be predicted from SNP genotype data with a high level of accuracy at intermediate (two-digit) resolution in an African population. This finding offers new opportunities for HLA studies of disease epidemiology and population genetics in developing countries.
C1 [Ayele, Fasil Tekola; Rotimi, Charles N.; Adeyemo, Adebowale] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA.
   [Hailu, Elena; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia.
   [Finan, Chris; Davey, Gail; Newport, Melanie J.] Brighton & Sussex Med Sch, Brighton, E Sussex, England.
RP Ayele, FT (reprint author), NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA.
EM ayeleft@mail.nih.gov
RI Aseffa, Abraham/J-3248-2016; m, sf001/E-2385-2013
OI Aseffa, Abraham/0000-0002-8028-1150; m, sf001/0000-0003-4662-6917;
   Davey, Gail/0000-0003-2796-7468; Tekola-Ayele,
   Fasil/0000-0003-4194-9370; Adeyemo, Adebowale/0000-0002-3105-3231;
   Newport, Melanie/0000-0002-8946-7525
FU Wellcome Trust [079791]; National Human Genome Research Institute,
   National Institutes of Health, in the Center for Research on Genomics
   and Global Health
FX This work was supported by the Wellcome Trust [grant number 079791]; and
   the Intramural Research Program of the National Human Genome Research
   Institute, National Institutes of Health, in the Center for Research on
   Genomics and Global Health. The funders had no role in the study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alemu G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001184
   Ayele FT, 2012, NEW ENGL J MED, V366, P1200, DOI 10.1056/NEJMoa1108448
   Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853
   Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08
   BUYSE I, 1993, TISSUE ANTIGENS, V41, P1, DOI 10.1111/j.1399-0039.1993.tb01970.x
   Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258
   CARRINGTON M, 1992, HUM IMMUNOL, V33, P208, DOI 10.1016/0198-8859(92)90073-V
   Cesbron-Gautier A, 2004, ANN BIOL CLIN-PARIS, V62, P93
   CSA (Central Statistical Agency of Ethiopia), 2007, 2007 POP HOUS CENS E
   Davey G, 2007, T ROY SOC TROP MED H, V101, P1175, DOI 10.1016/j.trstmh.2007.08.013
   de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885
   [Department DPaC Federal Ministry of Health], 2006, NAT 5 YEAR STRAT PLA, P3
   Destas K, 2003, TROP DOCT, V33, P217, DOI 10.1177/004947550303300410
   Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061
   Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024
   Fort M, 1998, TISSUE ANTIGENS, V51, P327
   Geshere G, 2009, IDENTIFICATION ETIOL
   Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128
   Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627
   Hall M., 2009, SIGKDD EXPLORATIONS, V11
   HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747
   Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489
   Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388
   Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001
   Li SYS, 2011, GENET EPIDEMIOL, V35, P85, DOI 10.1002/gepi.20549
   Lulli P, 2009, HUM IMMUNOL, V70, P903, DOI 10.1016/j.humimm.2009.07.025
   Luo M, 2005, TISSUE ANTIGENS, V65, P120, DOI 10.1111/j.1399-0039.2004.00339.x
   Luo M, 2004, TISSUE ANTIGENS, V63, P609, DOI 10.1111/j.0001-2815.2004.00231.x
   Luo M, 2003, TISSUE ANTIGENS, V62, P182, DOI 10.1034/j.1399-0039.2003.00066.x
   Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x
   Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393
   Modiano D, 1998, AM J TROP MED HYG, V58, P220, DOI 10.4269/ajtmh.1998.58.220
   Modiano D, 1996, P NATL ACAD SCI USA, V93, P13206, DOI 10.1073/pnas.93.23.13206
   Modiano D, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P193
   OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x
   Peterson TA, 2008, HUM IMMUNOL, V69, P885, DOI 10.1016/j.humimm.2008.09.001
   Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050
   Setty MN, 2011, J COMPUT BIOL, V18, P483, DOI 10.1089/cmb.2010.0258
   Solberg OD, 2008, HUM IMMUNOL, V69, P443, DOI 10.1016/j.humimm.2008.05.001
   Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731
   THURSZ MR, 1995, NEW ENGL J MED, V332, P1065, DOI 10.1056/NEJM199504203321604
   Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865
   World Health Organization, 2008, GLOB BURD DIS 2004 U
   Xie MZ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S10
   Zhang XC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-39
NR 47
TC 4
Z9 4
U1 2
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 28
PY 2012
VL 7
IS 6
AR e40206
DI 10.1371/journal.pone.0040206
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 966GR
UT WOS:000305826400061
PM 22761960
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-07-16
ER

PT J
AU Granieri, L
   Marnetto, F
   Valentino, P
   Frau, J
   Patanella, AK
   Nytrova, P
   Sola, P
   Capobianco, M
   Jarius, S
   Bertolotto, A
AF Granieri, Letizia
   Marnetto, Fabiana
   Valentino, Paola
   Frau, Jessica
   Patanella, Agata Katia
   Nytrova, Petra
   Sola, Patrizia
   Capobianco, Marco
   Jarius, Sven
   Bertolotto, Antonio
TI Evaluation of a Multiparametric Immunofluorescence Assay for
   Standardization of Neuromyelitis Optica Serology
SO PLOS ONE
LA English
DT Article
ID EXTENSIVE TRANSVERSE MYELITIS; MULTIPLE-SCLEROSIS; NMO-IGG;
   DIAGNOSTIC-CRITERIA; OBSERVER AGREEMENT; AQUAPORIN-4; ANTIBODIES;
   RITUXIMAB; SPECTRUM; DISORDERS
AB Background: Neuromyelitis optica (NMO) is a severely disabling autoimmune disorder of the central nervous system, which predominantly affects the optic nerves and spinal cord. In a majority of cases, NMO is associated with antibodies to aquaporin-4 (AQP4) (termed NMO-IgG).
   Aims: In this study, we evaluated a new multiparametric indirect immunofluorescence (IIF) assay for NMO serology.
   Methods: Sera from 20 patients with NMO, 41 patients with multiple sclerosis (MS), 30 healthy subjects, and a commercial anti-AQP4 IgG antibody were tested in a commercial composite immunofluorescence assay ("Neurology Mosaic 17"; Euroimmun, Germany), consisting of five different diagnostic substrates (HEK cells transfected with AQP4, non-transfected HEK cells, primate cerebellum, cerebrum, and optic nerve tissue sections).
   Results: We identified AQP4 specific and non-specific fluorescence staining patterns and established positivity criteria. Based on these criteria, this kit yielded a high sensitivity (95%) and specificity (100%) for NMO and had a significant positive and negative likelihood ratio (LR+=infinity, LR-=0.05). Moreover, a 100% inter- and intra-laboratory reproducibility was found.
   Conclusions: The biochip mosaic assay tested in this study is a powerful tool for NMO serology, fast to perform, highly sensitive and specific for NMO, reproducible, and suitable for inter-laboratory standardization as required for multi-centre clinical trials.
C1 [Granieri, Letizia; Marnetto, Fabiana; Valentino, Paola; Capobianco, Marco; Bertolotto, Antonio] Univ Hosp San Luigi Gonzaga, Clin Neurobiol Unit, Reg Referring Multiple Sclerosis Ctr CReSM, Turin, Italy.
   [Granieri, Letizia; Marnetto, Fabiana; Valentino, Paola; Bertolotto, Antonio] Univ Turin, Neurosci Inst Cavalieri Ottolenghi NICO, Turin, Italy.
   [Frau, Jessica] Univ Cagliari, Multiple Sclerosis Ctr, Dept Cardiovasc & Neurol Sci, Cagliari, Italy.
   [Patanella, Agata Katia] Gemelli Hosp, Multiple Sclerosis Ctr, Dept Neurosci, Rome, Italy.
   [Nytrova, Petra] Gen Univ Hosp Prague, Dept Neurol, Prague, Czech Republic.
   [Nytrova, Petra] Gen Univ Hosp Prague, Ctr Clin Neurosci, Prague, Czech Republic.
   [Nytrova, Petra] Charles Univ Prague, Fac Med 1, Prague, Czech Republic.
   [Sola, Patrizia] S Agostino Estense Hosp, Multiple Sclerosis Ctr, Modena, Italy.
   [Jarius, Sven] Univ Heidelberg, Div Mol Neuroimmunol, Dept Neurol, Heidelberg, Germany.
RP Granieri, L (reprint author), Univ Hosp San Luigi Gonzaga, Clin Neurobiol Unit, Reg Referring Multiple Sclerosis Ctr CReSM, Turin, Italy.
EM letiziagranieri@libero.it
RI Bertolotto, Antonio/K-8346-2015; Nytrova, Petra/O-9099-2017
OI Bertolotto, Antonio/0000-0002-7052-1907; Nytrova,
   Petra/0000-0003-4885-602X
FU Alenia Areonautica S.p.A.; FORB (Fondazione per la Ricerca Biomedica,
   ONLUS); Fondazione San Luigi ONLUS; Czech Ministry of Education [MSM
   0021620849]; Grant Agency of Charles University [GAUK 132010]; Committee
   for Treatment and Research in Multiple Sclerosis (ECTRIMS); Bayer Vital;
   Merck Serono; Alenia Aeronautica Spa; Euroimmun, Luebeck, Germany;
   Biogen Idec; Novartis; Roche; Bayer Schering; Sanofi-Aventis
FX We also thank Alenia Areonautica S.p.A. for supporting the fellowship of
   FM.; Financial supports were obtained from the FORB (Fondazione per la
   Ricerca Biomedica, ONLUS) and from Fondazione San Luigi ONLUS. The work
   of PN was supported by the Czech Ministry of Education, Research Program
   MSM 0021620849 and Grant Agency of Charles University (grant GAUK
   132010). The work of SJ was supported by a research grant from the
   Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and
   by grants from Bayer Vital and from Merck Serono. The work of FM was
   supported by Alenia Aeronautica Spa. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.; LG and PV received a contribution for
   attending a scientific meeting from Euroimmun, Luebeck, Germany. PN
   received a contribution for a fellowship in Oxford by Euroimmun,
   Luebeck, Germany. LG, FM and PV received consultation fees from Biogen
   Idec and Merck Serono. MC received consultation fees from Biogen Idec,
   Merck Serono and Novartis. AB has been on steering committees in
   clinical trials sponsored by Biogen Idec, Roche, and has received
   speaker honoraria from Biogen Idec, Merck Serono, TEVA, Bayer Schering,
   Sanofi-aventis, and Novartis; and his institution has received grant
   support from Biogen Idec, Bayer Schering, Merck Serono and
   Sanofi-Aventis. There are no patents, products in development or
   marketed products to declare. This does not alter the authors' adherence
   to all the PLoS ONE policies on sharing data and materials, as detailed
   online in the guide for authors. The other authors have no financial
   links with Euroimmun, and they have no competing financial interests.
CR Banwell B, 2008, NEUROLOGY, V70, P344, DOI 10.1212/01.wnl.0000284600.80782.d5
   Barnett MH, 2012, MULT SCLER J, V18, P108, DOI 10.1177/1352458511421185
   Bedi GS, 2011, MULT SCLER J, V17, P1225, DOI 10.1177/1352458511404586
   Costanzi C, 2011, NEUROLOGY, V77, P659, DOI 10.1212/WNL.0b013e31822a2780
   Cree BAC, 2005, NEUROLOGY, V64, P1270, DOI 10.1212/01.WNL.0000159399.81861.D5
   De Vidi I, 2011, CLIN IMMUNOL, V138, P239, DOI 10.1016/j.clim.2010.11.012
   Fazio R, 2009, MULT SCLER J, V15, P1153, DOI 10.1177/1352458509106851
   Fazio R, 2010, J NEUROIMMUNOL, V231, P100
   Hayakawa S, 2008, J NEUROIMMUNOL, V196, P181, DOI 10.1016/j.jneuroim.2008.03.009
   Hilliam RA, 2005, STAT MED, V24, P1219, DOI 10.1002/sim.1998
   Jacob A, 2008, ARCH NEUROL-CHICAGO, V65, P1443, DOI 10.1001/archneur.65.11.noc80069
   Jarius S, 2008, BRAIN, V131, P3072, DOI 10.1093/brain/awn240
   Jarius S, 2007, NEUROLOGY, V68, P1076, DOI 10.1212/01.wnl.0000256822.01222.bd
   Jarius S, 2012, CLIN NEUROL NEUROSUR, V114, P331, DOI 10.1016/j.clineuro.2011.10.048
   Jarius S, 2010, J NEUROL SCI, V291, P52, DOI 10.1016/j.jns.2010.01.002
   Jarius S, 2011, MULT SCLER J, V17, P1067, DOI 10.1177/1352458511403958
   Jarius S, 2010, J NEUROL SCI, V298, P158, DOI 10.1016/j.jns.2010.07.011
   Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72
   Kalluri SR, 2010, ARCH NEUROL-CHICAGO, V67, P1201, DOI 10.1001/archneurol.2010.269
   Kim SH, 2011, ARCH NEUROL-CHICAGO, V68, P1412, DOI 10.1001/archneurol.2011.154
   Kim W, 2011, MULT S IN PRESS 0930
   Kleiter I, 2012, ARCH NEUROL-CHICAGO, V69, P239, DOI 10.1001/archneurol.2011.216
   Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X
   Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304
   Lotze TE, 2008, PEDIATRICS, V122, pE1039, DOI 10.1542/peds.2007-2758
   Marignier R, 2008, MULT SCLER, V14, P440, DOI 10.1177/1352458507084595
   Marnetto F, 2009, J NEUROIMMUNOL, V217, P74, DOI 10.1016/j.jneuroim.2009.10.002
   Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da
   McKeon A, 2009, ARCH NEUROL-CHICAGO, V66, P1134, DOI 10.1001/archneurol.2009.178
   Min JH, 2012, MULT SCLER J, V18, P113, DOI 10.1177/1352458511431973
   Palace J, 2010, ARCH NEUROL-CHICAGO, V67, P1016, DOI 10.1001/archneurol.2010.188
   Paul F, 2007, PLOS MED, V4, P669, DOI 10.1371/journal.pmed.0040133
   Petzold A, 2010, J NEUROL NEUROSUR PS, V81, P109, DOI 10.1136/jnnp.2008.146894
   Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P78, DOI 10.1001/archneurol.2007.17
   Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.206703
   Shimizu J, 2010, NEUROLOGY, V75, P1423, DOI 10.1212/WNL.0b013e3181f8832e
   Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062
   Wandinger KP, 2010, ARTHRITIS RHEUM-US, V62, P1198, DOI 10.1002/art.27337
   Waters PJ, 2012, NEUROLOGY, V78, P665, DOI 10.1212/WNL.0b013e318248dec1
   Waters P, 2008, ARCH NEUROL-CHICAGO, V65, P913, DOI 10.1001/archneur.65.7.913
   Weinshenker BG, 2006, ANN NEUROL, V59, P566, DOI 10.1002/ana.20770
   Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74
   Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107
NR 45
TC 12
Z9 12
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 12
PY 2012
VL 7
IS 6
AR e38896
DI 10.1371/journal.pone.0038896
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959UJ
UT WOS:000305340000052
PM 22719979
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hudelson, P
   Perneger, T
   Kolly, V
   Perron, NJ
AF Hudelson, Patricia
   Perneger, Thomas
   Kolly, Veronique
   Perron, Noelle Junod
TI Self-Assessed Competency at Working with a Medical Interpreter Is Not
   Associated with Knowledge of Good Practice
SO PLOS ONE
LA English
DT Article
ID OVERCOMING LANGUAGE BARRIERS; LIMITED ENGLISH PROFICIENCY; CULTURAL
   COMPETENCE; RESIDENT PHYSICIANS; HEALTH-CARE; SERVICES; STUDENTS;
   PREPAREDNESS; ATTITUDES; QUALITY
AB Background: Specific knowledge and skills are needed to work effectively with an interpreter, but most doctors have received limited training. Self-assessed competency may not accurately identify training needs.
   Purposes: The purpose of this study is to explore the association between self-assessed competency at working with an interpreter and the ability to identify elements of good practice, using a written vignette.
   Methods: A mailed questionnaire was sent to 619 doctors and medical students in Geneva, Switzerland.
   Results: 58.6% of respondents considered themselves to be highly competent at working with a professional interpreter, but 22% failed to mention even one element of good practice in response to the vignette, and only 39% could name more than one. There was no association between self-rated competency and number of elements mentioned.
   Conclusions: Training efforts should challenge the assumption that working with an interpreter is intuitive. Evaluation of clinicians' ability to work with an interpreter should not be limited to self-ratings. In the context of large-scale surveys, written vignettes may provide a simple method for identifying knowledge of good practice and topics requiring further training.
C1 [Hudelson, Patricia; Perron, Noelle Junod] Univ Hosp Geneva, Dept Community Med Primary Care & Emergency Med, Geneva, Switzerland.
   [Perneger, Thomas] Univ Geneva, Fac Med, Dept Community Hlth & Med, Geneva, Switzerland.
   [Kolly, Veronique] Univ Hosp Geneva, Espace Mediat, Geneva, Switzerland.
RP Hudelson, P (reprint author), Univ Hosp Geneva, Dept Community Med Primary Care & Emergency Med, Geneva, Switzerland.
EM Patricia.Hudelson@hcuge.ch
FU Swiss Federal Public Health Office [04.000929]
FX The study was funded by the Swiss Federal Public Health Office, contract
   04.000929. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR [Anonymous], JOINT COMM 2009 REQ
   [Anonymous], NAT HLTH LAW PROGR L
   Bischoff A, 1998, MOTS OUVERTS GUIDE E
   Bischoff A, 2010, J TRAVEL MED, V17, P15, DOI 10.1111/j.1708-8305.2009.00314.x
   Davis DA, 2006, JAMA-J AM MED ASSOC, V296, P1094, DOI 10.1001/jama.296.9.1094
   Diamond LC, 2009, J GEN INTERN MED, V24, P256, DOI 10.1007/s11606-008-0875-7
   Divi C, 2007, INT J QUAL HEALTH C, V19, P60, DOI 10.1093/intqhc/mz1069
   Flores G, 2005, MED CARE RES REV, V62, P255, DOI 10.1177/1077558905275416
   Greater New York Hospital Association, NYS DOH REL FIN HOSP
   Ho MJ, 2008, MED EDUC, V42, P525, DOI 10.1111/j.1365-2923.2008.03048.x
   Hudelson P, 2011, SURVEY CARE IMMIGRAN
   Hudelson P, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-63
   Hudelson P, 2010, EVAL HEALTH PROF, V33, P452, DOI 10.1177/0163278710370157
   Hudelson P, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-187
   ISM Interpretariat, COMM TRAV AV INT
   Jacobs EA, 2004, AM J PUBLIC HEALTH, V94, P866, DOI 10.2105/AJPH.94.5.866
   Jacobs EA, 2010, PATIENT EDUC COUNS, V78, P149, DOI 10.1016/j.pec.2009.12.001
   Kalet Adina, 2002, Acad Med, V77, P927, DOI 10.1097/00001888-200209000-00029
   Karliner LS, 2007, HEALTH SERV RES, V42, P727, DOI 10.1111/j.1475-6773.2006.00629.x
   Kumas-Tan Z, 2007, ACAD MED, V82, P548, DOI 10.1097/ACM.0b013e3180555a2d
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee KC, 2006, JAMA-J AM MED ASSOC, V296, P1050, DOI 10.1001/jama.296.9.1050
   Lie D, 2009, ACAD MED, V84, P643, DOI 10.1097/ACM.0b013e31819faec8
   McEvoy Mimi, 2009, Med Educ Online, V14, P12, DOI 10.3885/meo.2009.Res00309
   Ngo-Metzger Q, 2007, J GEN INTERN MED, V22, P324, DOI 10.1007/s11606-007-0340-z
   Nokes KM, 2005, J NURS EDUC, V44, P65
   O'Leary SCB, 2003, PEDIATRICS, V111, pE569, DOI 10.1542/peds.111.5.e569
   PHELAN M, 1995, BRIT MED J, V311, P555, DOI 10.1136/bmj.311.7004.555
   Phillips C, 2010, AUST FAM PHYSICIAN, V39, P188
   Queensland Health Interpreter Service, 2007, WORK INT GUID
   Rodriguez F, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-26
   Schenker Y, 2011, J GEN INTERN MED, V26, P712, DOI 10.1007/s11606-010-1619-z
   Smith-Campbell Betty, 2005, J Allied Health, V34, P56
   Thompson B, 2008, STUDENT PERCEPTIONS
   Weissman JS, 2005, JAMA-J AM MED ASSOC, V294, P1058, DOI 10.1001/jama.294.9.1058
   Woloshin S, 1997, J GEN INTERN MED, V12, P472, DOI 10.1046/j.1525-1497.1997.00085.x
NR 36
TC 7
Z9 7
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 8
PY 2012
VL 7
IS 6
AR e38973
DI 10.1371/journal.pone.0038973
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959TQ
UT WOS:000305336800063
PM 22715421
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hoogeboom, TJ
   Oosting, E
   Vriezekolk, JE
   Veenhof, C
   Siemonsma, PC
   de Bie, RA
   van den Ende, CHM
   van Meeteren, NLU
AF Hoogeboom, Thomas J.
   Oosting, Ellen
   Vriezekolk, Johanna E.
   Veenhof, Cindy
   Siemonsma, Petra C.
   de Bie, Rob A.
   van den Ende, Cornelia H. M.
   van Meeteren, Nico L. U.
TI Therapeutic Validity and Effectiveness of Preoperative Exercise on
   Functional Recovery after Joint Replacement: A Systematic Review and
   Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID QUALITY-OF-LIFE; TOTAL KNEE ARTHROPLASTY; TOTAL HIP-REPLACEMENT; PATIENT
   CHARACTERISTICS; RANDOMIZED-TRIALS; CONSORT STATEMENT;
   PHYSICAL-ACTIVITY; EFFECT SIZE; SURGERY; OSTEOARTHRITIS
AB Background: Our aim was to develop a rating scale to assess the therapeutic validity of therapeutic exercise programmes. By use of this rating scale we investigated the therapeutic validity of therapeutic exercise in patients awaiting primary total joint replacement (TJR). Finally, we studied the association between therapeutic validity of preoperative therapeutic exercise and its effectiveness in terms of postoperative functional recovery.
   Methods: (Quasi) randomised clinical trials on preoperative therapeutic exercise in adults awaiting TJR on postoperative recovery of functioning within three months after surgery were identified through database and reference screening. Two reviewers extracted data and assessed the risk of bias and therapeutic validity. Therapeutic validity of the interventions was assessed with a nine-itemed, expert-based rating scale (scores range from 0 to 9; score >= 6 reflecting therapeutic validity), developed in a four-round Delphi study. Effects were pooled using a random-effects model and meta-regression was used to study the influence of therapeutic validity.
   Results: Of the 7,492 articles retrieved, 12 studies (737 patients) were included. None of the included studies demonstrated therapeutic validity and two demonstrated low risk of bias. Therapeutic exercise was not associated with 1) observed functional recovery during the hospital stay (Standardised Mean Difference [SMD]: -1.19; 95%-confidence interval [CI], -2.46 to 0.08); 2) observed recovery within three months of surgery (SMD: -0.15; 95%-CI, -0.42 to 0.12); and 3) self-reported recovery within three months of surgery (SMD -0.07; 95%-CI, -0.35 to 0.21) compared with control participants. Meta-regression showed no statistically significant relationship between therapeutic validity and pooled-effects.
   Conclusion: Preoperative therapeutic exercise for TJR did not demonstrate beneficial effects on postoperative functional recovery. However, poor therapeutic validity of the therapeutic exercise programmes may have hampered potentially beneficial effects, since none of the studies met the predetermined quality criteria. Future review studies on therapeutic exercise should address therapeutic validity.
C1 [Hoogeboom, Thomas J.; Vriezekolk, Johanna E.; van den Ende, Cornelia H. M.] Sint Maartensklin, Dept Rheumatol, Nijmegen, Netherlands.
   [Hoogeboom, Thomas J.; de Bie, Rob A.] Maastricht Univ, Sch Publ Hlth & Primary Care Caphri, Dept Epidemiol, Maastricht, Netherlands.
   [Oosting, Ellen] Gelderse Vallei Hosp, Dept Physiotherapy, Ede, Netherlands.
   [Veenhof, Cindy] NIVEL, Dept Allied Hlth Care, Utrecht, Netherlands.
   [Siemonsma, Petra C.] TNO, Expertise Ctr Life Style, Leiden, Netherlands.
   [van Meeteren, Nico L. U.] TNO, Innovat Area Healthy Life, Leiden, Netherlands.
   [van Meeteren, Nico L. U.] Ctr Care Technol Res, Maastricht, Netherlands.
RP Hoogeboom, TJ (reprint author), Sint Maartensklin, Dept Rheumatol, Nijmegen, Netherlands.
EM thomashoogeboom@gmail.com
RI van den Ende, Cornelia/G-9559-2011; Hoogeboom, Thomas/G-8767-2015;
   Vriezekolk, Johanna/J-8684-2016
OI van den Ende, Cornelia/0000-0002-4352-2824; Hoogeboom,
   Thomas/0000-0003-2103-419X; 
FU Ministry of Health, The Netherlands
FX This study was funded by the Ministry of Health, The Netherlands. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Ackerman IN, 2004, AUST J PHYSIOTHER, V50, P25, DOI 10.1016/S0004-9514(14)60245-2
   Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12
   Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012
   Anderson JG, 1996, J ARTHROPLASTY, V11, P831, DOI 10.1016/S0883-5403(96)80183-5
   Barbay K, 2009, ORTHOP NURS, V28, P127, DOI 10.1097/NOR.0b013e3181a46a09
   Beaupre LA, 2004, J RHEUMATOL, V31, P1166
   Boule NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218
   Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008
   Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M
   Chodzko-Zajko WJ, 2009, MED SCI SPORT EXER, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c
   Coudeyre E., 2007, Annales de Readaptation et de Medecine Physique, V50, P189, DOI 10.1016/j.annrmp.2007.02.002
   Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655
   Daanen HA, 2012, INT J SPORTS PH 0215
   Dauty M, 2007, Ann Readapt Med Phys, V50, P462, DOI 10.1016/j.annrmp.2007.04.012
   Ditmyer Marcia M, 2002, Orthop Nurs, V21, P43
   DLima DD, 1996, CLIN ORTHOP RELAT R, P174
   Escobar A, 2007, RHEUMATOLOGY, V46, P112, DOI 10.1093/rheumatology/kel184
   Evgeniadis G, 2008, J BACK MUSCULOSKELET, V21, P161, DOI 10.3233/BMR-2008-21303
   Ewald FC, 1999, J ARTHROPLASTY, V14, P473, DOI 10.1016/S0883-5403(99)90104-3
   Ferrara PE, 2008, CLIN REHABIL, V22, P977, DOI 10.1177/0269215508094714
   Fitz Gerald JD, 2004, ARTHRIT RHEUM-ARTHR, V51, P100, DOI 10.1002/art.20090
   Gilbey HJ, 2003, CLIN ORTHOP RELAT R, P193, DOI 10.1097/01.blo.0000053168.71678.2b
   Glasziou P, 2005, BMJ-BRIT MED J, V330, P644, DOI 10.1136/bmj.330.7492.644
   Gocen Z, 2004, CLIN REHABIL, V18, P353, DOI 10.1191/0269215504cr758oa
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011
   Hawker GA, 2006, CURR OPIN RHEUMATOL, V18, P526
   Herbert RD, 2005, BMJ-BRIT MED J, V331, P507, DOI 10.1136/bmj.331.7515.507
   Hoeksma HL, 2005, RHEUMATOLOGY, V44, P461, DOI 10.1093/rheumatology/keh482
   Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670
   Hoogeboom TJ, 2009, OSTEOARTHR CARTILAGE, V17, P1420, DOI 10.1016/j.joca.2009.05.008
   Hoogeboom TJ, 2010, CLIN REHABIL, V24, P901, DOI 10.1177/0269215510371427
   Hulzebos EHJ, 2006, JAMA-J AM MED ASSOC, V296, P1851, DOI 10.1001/jama.296.15.1851
   JACK S, 2011, CLIN ANAESTHESIOL, V25, P461
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   Kennedy LG, 2003, KNEE, V10, P161, DOI 10.1016/S0968-0160(02)00138-2
   Kettunen JA, 2004, SCAND J MED SCI SPOR, V14, P138, DOI 10.1111/j.1600-0838.2004.0396.x
   Kraemer WJ, 2002, MED SCI SPORT EXER, V34, P364, DOI 10.1249/MSS.0b013e3181915670
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700
   Lingard EA, 2004, J BONE JOINT SURG AM, V86A, P2179, DOI 10.2106/00004623-200410000-00008
   Liu CK, 2011, CLIN GERIATR MED, V27, P101, DOI 10.1016/j.cger.2010.08.001
   Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3
   Mahomed NN, 2002, J RHEUMATOL, V29, P1273
   McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   Pasquina P, 2003, BRIT MED J, V327, P1379, DOI 10.1136/bmj.327.7428.1379
   Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150
   Rodgers JA, 1998, J ARTHROPLASTY, V13, P414, DOI 10.1016/S0883-5403(98)90007-9
   Rooks DS, 2006, ARTHRIT RHEUM-ARTHR, V55, P700, DOI 10.1002/art.22223
   Santaguida PL, 2008, CAN J SURG, V51, P428
   Schmidt H, 2010, MED LAW, V29, P565
   Sutton AJ, 2000, BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574
   Topp R, 2009, PM&R, V1, P729, DOI 10.1016/j.pmrj.2009.06.003
   Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576
   Valkenet K, 2011, CLIN REHABIL, V25, P99, DOI 10.1177/0269215510380830
   van Rijn RM, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5688
   van Tulder MW, 2009, SPINE, V34, P1685, DOI 10.1097/BRS.0b013e3181ab6a78
   Veenhof C, 2007, INT J BEHAV MED, V14, P86, DOI 10.1007/BF03004173
   Wallis JA, 2011, OSTEOARTHR CARTILAGE, V19, P1381, DOI 10.1016/j.joca.2011.09.001
   WEIDENHIELM L, 1993, SCAND J REHABIL MED, V25, P25
   Williamson L, 2007, RHEUMATOLOGY, V46, P1445, DOI 10.1093/rheumatology/kem119
   Wright AA, 2011, PHYS THER, V91, P510, DOI 10.2522/ptj.20100171
   Wylde V, 2007, KNEE, V14, P417, DOI 10.1016/j.knee.2007.06.001
   Yates SL, 2005, PAIN, V117, P314, DOI 10.1016/j.pain.2005.06.018
   Zeni JA, 2010, J BONE JOINT SURG AM, V92A, P1130, DOI 10.2106/JBJS.I.00299
NR 65
TC 75
Z9 75
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 31
PY 2012
VL 7
IS 5
AR e38031
DI 10.1371/journal.pone.0038031
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959TY
UT WOS:000305338500076
PM 22675429
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Liang, Y
   Zhang, LL
   Gao, J
   Hu, D
   Ai, Y
AF Liang, Yi
   Zhang, Lingli
   Gao, Ju
   Hu, Die
   Ai, Yuan
TI Rituximab for Children with Immune Thrombocytopenia: A Systematic Review
SO PLOS ONE
LA English
DT Review
ID MONOCLONAL-ANTIBODY RITUXIMAB; B-CELL DEPLETION; AUTOIMMUNE CYTOPENIAS;
   ANTI-CD20 RITUXIMAB; SERUM SICKNESS; PURPURA ITP; CHILDHOOD; THERAPY;
   ADULTS; METAANALYSIS
AB Background: Rituximab has been widely used off-label as a second line treatment for children with immune thrombocytopenia (ITP). However, its role in the management of pediatric ITP requires clarification. To understand and interpret the available evidence, we conducted a systematic review to assess the efficacy and safety of rituximab for children with ITP.
   Methodology/Principal Findings: We searched MEDLINE, EMBASE, Cochrane Library, CBM, CNKI, abstract databases of American Society of Hematology, American Society of Clinical Oncology and Pediatric Academic Society. Clinical studies published in full text or abstract only in any language that met predefined inclusion criteria were eligible. Efficacy analysis was restricted to studies enrolling 5 or more patients. Safety was evaluated from all studies that reported data of toxicity. 14 studies (323 patients) were included for efficacy assessment in children with primary ITP. The pooled complete response (platelet count >= 100 x 10(9)/L) and response (platelet count >= 30 x 10(9)/L) rate after rituximab treatment were 39% (95% CI, 30% to 49%) and 68% (95% CI, 58% to 77%), respectively, with median response duration of 12.8 month. 4 studies (29 patients) were included for efficacy assessment in children with secondary ITP. 11 (64.7%) of 17 patients associated with Evans syndrome achieved response. All 6 patients with systemic lupus erythematosus associated ITP and all 6 patients with autoimmune lymphoproliferative syndrome associated ITP achieved response. 91 patients experienced 108 adverse events associated with rituximab, among that, 91 (84.3%) were mild to moderate, and no death was reported.
   Conclusions/Significance: Randomized controlled studies on effect of rituximab for children with ITP are urgently needed, although a series of uncontrolled studies found that rituximab resulted in a good platelet count response both in children with primary and children secondary ITP. Most adverse events associated with rituximab were mild to moderate, and no death was reported.
C1 [Liang, Yi; Zhang, Lingli; Hu, Die] Sichuan Univ, W China Univ Hosp 2, Dept Pharm, Chengdu 610064, Peoples R China.
   [Liang, Yi; Hu, Die] Sichuan Univ, W China Sch Pharm, Chengdu 610064, Peoples R China.
   [Gao, Ju; Ai, Yuan] Sichuan Univ, W China Univ Hosp 2, Dept Pediat Hematol & Oncol, Chengdu 610064, Peoples R China.
RP Liang, Y (reprint author), Sichuan Univ, W China Univ Hosp 2, Dept Pharm, Chengdu 610064, Peoples R China.
EM zhlingli@sina.com
CR Adeli MMG, 2009, PEDIATR HEMAT ONCOL, V26, P566, DOI 10.3109/08880010903271697
   Arnold DM, 2007, ANN INTERN MED, V146, P25, DOI 10.7326/0003-4819-146-1-200701020-00006
   Bader-Meunier B, 2007, HAEMATOL-HEMATOL J, V92, P1691, DOI 10.3324/haematol.11540
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Bengtson KL, 2003, J PEDIATR-US, V143, P670, DOI 10.1067/S0022-3476(03)00446-3
   Bennett CM, 2006, BLOOD, V107, P2639, DOI 10.1182/blood-2005-08-3518
   Bisogno G, 2007, EUR J PEDIATR, V166, P85, DOI 10.1007/s00431-006-0222-0
   Carson KR, 2009, BLOOD, V113, P4834, DOI 10.1182/blood-2008-10-186999
   Citak EC, 2011, J TROP PEDIATRICS, V57, P71, DOI 10.1093/tropej/fmq033
   Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795
   Cooper Nichola, 2010, Curr Rheumatol Rep, V12, P94, DOI 10.1007/s11926-010-0090-5
   Cooper N, 2009, BRIT J HAEMATOL, V146, P120, DOI 10.1111/j.1365-2141.2009.07715.x
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Di Gaetano N, 2003, J IMMUNOL, V171, P1581, DOI 10.4049/jimmunol.171.3.1581
   Dogan M, 2009, INDIAN J PEDIATR, V76, P1141, DOI 10.1007/s12098-009-0230-y
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Eupropean Medicine Agency website, SUMM EUR PUBL ASS RE
   Gentner Jennifer, 2008, Pediatric Asthma Allergy & Immunology, V21, P99, DOI 10.1089/pai.2008.0003
   Golay J, 2000, BLOOD, V95, P3900
   Goto S, 2009, INT J HEMATOL, V89, P305, DOI 10.1007/s12185-009-0269-6
   Grace RF, 2011, PEDIAT BLOOD CA 0614
   Kim JJ, 2007, BRIT J HAEMATOL, V138, P94, DOI 10.1111/j.1365-2141.2007.06616.x
   Kim JY, 2009, BLOOD, V114, P4461
   Kuhne T, 2003, J PEDIATR-US, V143, P605, DOI 10.1067/S0022-3476(03)00535-3
   Kumar S, 2009, PEDIATRICS, V123, pE159, DOI 10.1542/peds.2008-2361
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lorenzana AN, 2002, THERAPEUTIC EFFECT R, P1043
   National Cancer Institute, 2009, NAT CANC I COMM TERM
   National Institute for Health and Clinical Excellence (NICE) website, QUAL ASS CAS SER
   Parodi E, 2008, BRIT J HAEMATOL, V144, P552
   Pescovitz MD, 2006, AM J TRANSPLANT, V6, P859, DOI 10.1111/j.1600-6143.2006.01288.x
   Pospisilova D, 2010, ANN HEMATOL S1, V89, pS105
   Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565
   Pusiol A, 2004, EUR J PEDIATR, V163, P305, DOI 10.1007/s00431-004-1417-x
   Quartier P, 2003, CLIN INFECT DIS, V36, pE47, DOI 10.1086/345746
   Rafailidis PI, 2007, CANCER, V109, P2182, DOI 10.1002/cncr.22666
   Rao A, 2008, PEDIATR BLOOD CANCER, V50, P822, DOI 10.1002/pbc.21264
   Rao VK, 2009, PEDIATR BLOOD CANCER, V52, P847, DOI 10.1002/pbc.21965
   Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503
   Romanos-Sirakis E, 2011, J ALLERGY CLIN IMMUN, V127, pAB198, DOI 10.1016/j.jaci.2010.12.789
   Sampaio I, 2010, HAEMATOL-HEMATOL J, V95, P750
   Sharma A, 2005, BLOOD, V106, p82B
   Taube T, 2005, HAEMATOLOGICA, V90, P281
   Terrell DR, 2010, AM J HEMATOL, V85, P174, DOI 10.1002/ajh.21616
   Wang H-M, 2011, J PEDIAT, V146, P330
   Wang J, 2005, J PEDIATR-US, V146, P217, DOI 10.1016/j.jpeds.2004.09.004
   Xu S, 2011, J CHINA PEDIAT BLOOD, V16, P129
   Yadav SP, 2006, BLOOD, V108, p50B
   Yang J, 2011, CHINESE J OBSTET GYN, V7, P474
NR 49
TC 40
Z9 40
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 30
PY 2012
VL 7
IS 5
AR e36698
DI 10.1371/journal.pone.0036698
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959YF
UT WOS:000305353400011
PM 22666325
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wang, B
   Zhang, SG
   Wang, XF
   Tan, M
   Xi, YG
AF Wang, Bin
   Zhang, Shu-Guang
   Wang, Xiao-Feng
   Tan, Ming
   Xi, Yaguang
TI Testing for Differentially-Expressed MicroRNAs with Errors-in-Variables
   Nonparametric Regression
SO PLOS ONE
LA English
DT Article
ID WEIGHTED KAPPA; MODEL; COEFFICIENT; AGREEMENT; VARIANCE; ARRAYS; GENES
AB MicroRNA is a set of small RNA molecules mediating gene expression at post-transcriptional/translational levels. Most of well-established high throughput discovery platforms, such as microarray, real time quantitative PCR, and sequencing, have been adapted to study microRNA in various human diseases. The total number of microRNAs in humans is approximately 1,800, which challenges some analytical methodologies requiring a large number of entries. Unlike messenger RNA, the majority of microRNA (>60%) maintains relatively low abundance in the cells. When analyzed using microarray, the signals of these low-expressed microRNAs are influenced by other non-specific signals including the background noise. It is crucial to distinguish the true microRNA signals from measurement errors in microRNA array data analysis. In this study, we propose a novel measurement error model-based normalization method and differentially-expressed microRNA detection method for microRNA profiling data acquired from locked nucleic acids (LNA) microRNA array. Compared with some existing methods, the proposed method significantly improves the detection among low-expressed microRNAs when assessed by quantitative real-time PCR assay.
C1 [Wang, Bin] Univ S Alabama, Dept Math & Stat, Mobile, AL 36688 USA.
   [Zhang, Shu-Guang] Univ Sci & Technol China, Dept Stat & Finance, Hefei 230026, Anhui, Peoples R China.
   [Wang, Xiao-Feng] Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA.
   [Tan, Ming; Xi, Yaguang] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA.
RP Wang, B (reprint author), Univ S Alabama, Dept Math & Stat, Mobile, AL 36688 USA.
EM bwang@jaguar1.usouthal.edu; xi@usouthal.edu
OI Tan, Ming/0000-0003-2007-9898; Xi, Yaguang/0000-0003-3681-9352
FU NCI NIH HHS [R21 CA160280]
CR Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Bruheim S, 2009, CLIN CANCER RES, V15, P7161, DOI 10.1158/1078-0432.CCR-08-2816
   Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102
   Chen Y, 1997, J Biomed Opt, V2, P364, DOI 10.1117/12.281504
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Delaigle A, 2011, STAT SINICA, V21, P1023, DOI 10.5705/ss.2009.039
   Delaigle A, 2009, J AM STAT ASSOC, V104, P348, DOI 10.1198/jasa.2009.0114
   Dudoit S, 2002, STAT SINICA, V12, P111
   Faraway JJ, 1995, J AM STAT ASSOC, V90, P1119
   FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309
   FLEISS JL, 1969, PSYCHOL BULL, V72, P323, DOI 10.1037/h0028106
   Fleiss JL, 1981, STAT METHODS RATES P
   Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105
   HUBER W, 2002, BIOINFORMATICS, V18, P96, DOI DOI 10.1093/BI0INF0RMATICS/18.SUPPL_
   Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mascellani N, 2008, MINERVA BIOTECNOL, V20, P23
   Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z
   Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710
   Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509
   Qi R, 2011, HEPATOLOGY
   Rao YL, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1287
   Risso D, 2009, BIOINFORMATICS, V25, P2685, DOI 10.1093/bioinformatics/btp443
   Rocke DM, 2001, J COMPUT BIOL, V8, P557, DOI 10.1089/106652701753307485
   ROCKE DM, 1995, TECHNOMETRICS, V37, P176, DOI 10.2307/1269619
   Silverman B., 1986, MONOGRAPHS STAT APPL
   SUN JY, 1994, ANN STAT, V22, P1328, DOI 10.1214/aos/1176325631
   Wang B, 2011, BIOINFORMATICS, V27, P1506, DOI 10.1093/bioinformatics/btr180
   Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017167
   Wang B, 2010, BIOINFORMATICS, V26, P228, DOI 10.1093/bioinformatics/btp655
   Wang XF, 2011, J NONPARAMETR STAT, V24, P153
   Wang XF, 2011, J STAT SOFTW, V39, P1
   Wang XF, 2010, COMPUT STAT DATA AN, V54, P25, DOI 10.1016/j.csda.2009.08.012
   Wasserman Larry, 2006, ALL NONPARAMETRIC ST
   Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907
NR 35
TC 1
Z9 1
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 24
PY 2012
VL 7
IS 5
AR e37537
DI 10.1371/journal.pone.0037537
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959UB
UT WOS:000305338900031
PM 22655055
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zaveri, A
   Shah, J
   Pradhan, S
   Rodrigues, C
   Barros, J
   Ang, BT
   Pietrobon, R
AF Zaveri, Amrapali
   Shah, Jatin
   Pradhan, Shreyasee
   Rodrigues, Clarissa
   Barros, Jacson
   Ang, Beng Ti
   Pietrobon, Ricardo
TI Center of Excellence in Research Reporting in Neurosurgery - Diagnostic
   Ontology
SO PLOS ONE
LA English
DT Article
ID SYSTEMATIC REVIEWS; QUALITY; ACCURACY
AB Motivation: Evidence-based medicine (EBM), in the field of neurosurgery, relies on diagnostic studies since Randomized Controlled Trials (RCTs) are uncommon. However, diagnostic study reporting is less standardized which increases the difficulty in reliably aggregating results. Although there have been several initiatives to standardize reporting, they have shown to be sub-optimal. Additionally, there is no central repository for storing and retrieving related articles. Results: In our approach we formulate a computational diagnostic ontology containing 91 elements, including classes and sub-classes, which are required to conduct Systematic Reviews - Meta Analysis (SR-MA) for diagnostic studies, which will assist in standardized reporting of diagnostic articles. SR-MA are studies that aggregate several studies to come to one conclusion for a particular research question. We also report high percentage of agreement among five observers as a result of the interobserver agreement test that we conducted among them to annotate 13 articles using the diagnostic ontology. Moreover, we extend our existing repository CERR-N to include diagnostic studies. Availability: The ontology is available for download as an. owl file at: http://bioportal.bioontology.org/ontologies/3013.
C1 [Zaveri, Amrapali] Univ Leipzig, Inst Informat, Leipzig, Saxony, Germany.
   [Zaveri, Amrapali; Shah, Jatin; Pradhan, Shreyasee; Rodrigues, Clarissa; Barros, Jacson; Pietrobon, Ricardo] Duke Univ, Res Res Grp, Durham, NC USA.
   [Rodrigues, Clarissa] Inst Cardiol RS, Porto Alegre, RS, Brazil.
   [Ang, Beng Ti] Natl Inst Neurosci, Singapore, Singapore.
   [Ang, Beng Ti] Duke NUS Grad Med Sch, Singapore, Singapore.
RP Zaveri, A (reprint author), Univ Leipzig, Inst Informat, Leipzig, Saxony, Germany.
EM rpietro@duke.edu
RI ; Shah, Jatin/B-6039-2011
OI Zaveri, Amrapali/0000-0003-3239-4588; Shah, Jatin/0000-0002-2457-491X
CR Bossuyt PM, 2003, RADIOLOGY, V226, P24, DOI 10.1148/radiol.2261021292
   Bossuyt PMM, 2004, CLIN CHEM, V50, P465, DOI 10.1373/clinchem.2003.029736
   Bruns DE, 2003, CLIN CHEM, V49, P19, DOI 10.1373/49.1.19
   CHALMERS I, 1994, BMJ-BRIT MED J, V309, P862, DOI 10.1136/bmj.309.6958.862
   Cook Chad, 2007, Account Res, V14, P1, DOI 10.1080/08989620601003471
   Crippa JAS, 2002, BRAZ J MED BIOL RES, V35, P1209, DOI 10.1590/S0100-879X2002001000014
   Fonseca F, 2007, J ASSOC INF SYST, V8, P129
   Jarlais D, 2004, IMPROVING REPORTING, V94, P361
   JPT Higgins, 2009, COCHRANE HDB SYSTEMA
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008
   Mahoney J, 2007, CLIN CHEM, V53, P1122, DOI 10.1373/clinchem.2006.083493
   Mol BW, 2003, SEMIN REPROD MED, V21, P17
   Noy N. F., 2001, SMI20010880
   Pai M, 2005, Indian J Med Microbiol, V23, P210
   Rifai N, 2008, CLIN CHEM, P54
   Rogers JE, 2006, METHOD INFORM MED, V45, P267
   Schoeller K, 2009, ACTA NEUROCHIR, V151, P519, DOI 10.1007/s00701-009-0280-y
   Sim I, 2005, PLOS MED, V2, P1090, DOI 10.1371/journal.pmed.0020365
   Sim I, 2004, J BIOMED INFORM, V37, P108, DOI 10.1016/j.jbi.2004.03.001
   Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511
   Wilczynski N, 2008, RADIOLOGY, V284, P817
   Zaveri A, 2010, NEUROINFORMATICS, V8, P261, DOI 10.1007/s12021-010-9079-5
NR 23
TC 0
Z9 0
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 14
PY 2012
VL 7
IS 5
AR e36759
DI 10.1371/journal.pone.0036759
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959UF
UT WOS:000305339400033
PM 22629329
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Williams, LJ
   Dunlop, JP
   Abdi, H
AF Williams, Lynne J.
   Dunlop, Joseph P.
   Abdi, Herve
TI Effect of Age on Variability in the Production of Text-Based Global
   Inferences
SO PLOS ONE
LA English
DT Article
ID INTRAINDIVIDUAL VARIABILITY; INDIVIDUAL VARIABILITY; MEMORY PERFORMANCE;
   OLD-AGE; BOOTSTRAP; DISCOURSE; SPEED; GIST; RECOGNITION; CONFIDENCE
AB As we age, our differences in cognitive skills become more visible, an effect especially true for memory and problem solving skills (i.e., fluid intelligence). However, by contrast with fluid intelligence, few studies have examined variability in measures that rely on one's world knowledge (i.e., crystallized intelligence). The current study investigated whether age increased the variability in text based global inference generation-a measure of crystallized intelligence. Global inference generation requires the integration of textual information and world knowledge and can be expressed as a gist or lesson. Variability in generating two global inferences for a single text was examined in young-old (62 to 69 years), middle-old (70 to 76 years) and old-old (77 to 94 years) adults. The older two groups showed greater variability, with the middle elderly group being most variable. These findings suggest that variability may be a characteristic of both fluid and crystallized intelligence in aging.
C1 [Williams, Lynne J.] Rotman Res Inst Baycrest, Ctr Brain Fitness, Toronto, ON, Canada.
   [Dunlop, Joseph P.; Abdi, Herve] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA.
RP Williams, LJ (reprint author), Rotman Res Inst Baycrest, Ctr Brain Fitness, Toronto, ON, Canada.
EM lwilliams@research.baycrest.org; herve@utdallas.edu
RI Williams, Lynne/P-4799-2019
OI Williams, Lynne/0000-0001-6790-1362
CR Abdi H., 2007, ENCY MEASUREMENT STA, P651, DOI DOI 10.4135/9781412952644.NV-3
   Abdi H, 2007, ENCY MEASUREMENT STA, P270
   Abdi H, 2010, ENCY RES DESIGN, P655
   Abdi H, 2012, COMPUTATIONAL MATH M
   Abdi H, 1985, B PSYCHOL, V38, P633
   Abdi H, 2010, ENCY RES DESIGN, P267
   Abdi H, 1990, CUMFID, V16, P99
   Abdi H, 2012, WIRES COMPUT STAT, V4, P124, DOI 10.1002/wics.198
   Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101
   Abdi H, 2010, WIRES COMPUT STAT, V2, P97, DOI 10.1002/wics.51
   Abdi H, 2009, NEUROIMAGE, V45, P89, DOI 10.1016/j.neuroimage.2008.11.008
   Adam S, 2007, EC STAT, V403, P83
   ADAMS C, 1990, J GERONTOL, V45, pP17, DOI 10.1093/geronj/45.1.P17
   ADAMS C, 1991, PSYCHOL AGING, V6, P323, DOI 10.1037/0882-7974.6.3.323
   Allaire JC, 2005, PSYCHOL AGING, V20, P390, DOI 10.1037/0882-7974.20.3.390
   Anstey Kaarin J, 2004, Aust Fam Physician, V33, P783
   Benzecri J. -P., 1973, ANAL DONNEES, V2
   Benzecri JP, 1973, ANAL DONNEES
   Bielak AAM, 2010, NEUROPSYCHOLOGY, V24, P731, DOI 10.1037/a0019802
   Bielak AAM, 2010, PSYCHOL AGING, V25, P575, DOI 10.1037/a0019503
   Blasius J, 2006, STAT SOC BEHAV SCI, P3
   Bonsang E, DOES RETIREMENT AFFE
   Brose A, 2010, RES HUM DEV, V7, P61, DOI 10.1080/15427600903578177
   Burke Deborah M., 2006, LIFESPAN COGNITION M, P193
   CARNES P., 1988, PROVERBIA FABULA ESS
   Caskie GIL, 1999, GER SOC AM C
   Chastaing M, 1980, J PSYCHOL NORMALE PA, V77, P31
   Chesneau S, 2007, PSYCHOL NEUROPSYCHIA, V5, P47, DOI 10.1684/pnv.2007.0037
   Chi YY, 2011, WILEY INTERDISCIPLIN, V4, P35
   Christensen H, 2005, NEUROPSYCHOLOGY, V19, P309, DOI 10.1037/0894-4105.19.3.309
   Christensen H, 2001, AUST NZ J PSYCHIAT, V35, P768, DOI 10.1046/j.1440-1614.2001.00966.x
   Clausen S. E., 1998, APPL CORRES ANAL INT
   Daly DL, 1963, INTELLIGENCE, P33
   DIXON RA, 1993, NARRATIVE DISCOURSE IN NEUROLOGICALLY IMPAIRED AND NORMAL AGING ADULTS, P77
   Dixon RA, 2007, NEUROPSYCHOLOGY, V21, P381, DOI 10.1037/0894-4105.21.3.381
   Dolby-Stahl SK, 1980, FOLKLORE 2 CONTINENT, P160
   DORFMAN MH, 1994, DISCOURSE PROCESS, V17, P105, DOI 10.1080/01638539409544861
   EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144
   EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552
   EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844
   Efron B, 1993, INTRO BOOTSTRAP
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149
   FISKE DW, 1957, EDUC PSYCHOL MEAS, V17, P317, DOI 10.1177/001316445701700301
   Garrett DD, 2011, J NEUROSCI, V31, P4496, DOI 10.1523/JNEUROSCI.5641-10.2011
   GAUDREAULT R, 1994, SEMIOTICA, V99, P297, DOI 10.1515/semi.1994.99.3-4.297
   GRAESSER AC, 1994, PSYCHOL REV, V101, P371, DOI 10.1037/0033-295X.101.3.371
   Greenacre M., 2007, CORRES ANAL PRACTICE
   Greenacre M. J., 1984, THEORY APPL CORRES A
   Gutchess AH, 2012, NEUROIMAGE, V59, P3418, DOI 10.1016/j.neuroimage.2011.11.078
   HAMM VP, 1992, PSYCHOL AGING, V7, P56, DOI 10.1037/0882-7974.7.1.56
   Hanauer DI, 2000, DISCOURSE PROCESS, V30, P107, DOI 10.1207/S15326950DP3002_02
   HART R. P., 1988, CLIN NEUROPSYCHOL, V2, P49
   HERTZOG C, 1992, BRAIN LANG, V42, P248, DOI 10.1016/0093-934X(92)90100-S
   Hilborn JV, 2009, J CLIN EXP NEUROPSYC, V31, P412, DOI 10.1080/13803390802232659
   Hosokawa A, 2006, JPN PSYCHOL RES, V48, P77, DOI 10.1111/j.0021-5368.2006.00308.x
   Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101
   Hultsch DF, 2005, MEASURING MIND SPEED
   Hwang DH, 2002, BIOINFORMATICS, V18, P1184, DOI 10.1093/bioinformatics/18.9.1184
   Jackson JD, 2012, NEUROPSYCHOLOGIA, V50, P357, DOI 10.1016/j.neuropsychologia.2011.11.024
   Jamet MC, 1988, LINGUE MONDO, V53, P79
   Kintsch W., 1998, COMPREHENSION PARADI
   Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LAVER GD, 1993, PSYCHOL AGING, V8, P34, DOI 10.1037/0882-7974.8.1.34
   Le Roux B., 2010, MULTIPLE CORRES ANAL
   Lebart L, 2006, JOURNEES INT ANAL ST, V8
   Li SC, 2001, GERONTOLOGY, V47, P100, DOI 10.1159/000052782
   Lindenberger U, 1997, PSYCHOL AGING, V12, P410, DOI 10.1037/0882-7974.12.3.410
   LINDENBERGER U, 1993, PSYCHOL AGING, V8, P207, DOI 10.1037/0882-7974.8.2.207
   Luszcz MA, 2004, GERONTOLOGY, V50, P5, DOI 10.1159/000074381
   MacDonald SWS, 2003, PSYCHOL AGING, V18, P510, DOI 10.1037/0882-7974.18.3.510
   MAGLIANO JP, 1991, POETICS, V20, P193, DOI 10.1016/0304-422X(91)90007-C
   Martin M, 2004, GERONTOLOGY, V50, P7, DOI 10.1159/000074382
   MCKOON G, 1992, PSYCHOL REV, V99, P440, DOI 10.1037/0033-295X.99.3.440
   Meyer BI, 1987, ANN REV GERONTOLOGY, V7
   Miller MB, 2007, INT J PSYCHOPHYSIOL, V63, P205, DOI 10.1016/j.ijpsycho.2006.03.019
   Nesselroade J. R., 2004, RES HUMAN DEV, V1, P9, DOI [DOI 10.1080/15427609.2004.9683328, 10.1207/s15427617rhd0101&2_3]
   NORTH AJ, 1986, INT J AGING HUM DEV, V23, P267, DOI 10.2190/BPF0-2BWD-BGNQ-HWCW
   Olness G, 2000, THESIS U TEXAS DALLA
   Papenberg G, 2011, NEUROPSYCHOLOGIA, V49, P1879, DOI 10.1016/j.neuropsychologia.2011.03.013
   Park DC, 1999, COGNITIVE AGING PRIM
   Pinkham AE, J ABNORMAL IN PRESS, P121
   Radvansky GA, 2001, PSYCHOL AGING, V16, P145, DOI 10.1037//0882-7974.16.1.145
   Ram N, 2005, PSYCHOL AGING, V20, P623, DOI 10.1037/0882-7974.20.4.623
   REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271
   REYNA VF, 1994, DEV PSYCHOL, V30, P178, DOI 10.1037/0012-1649.30.2.178
   Salthouse TA, 2003, PSYCHOL AGING, V18, P91, DOI 10.1037/0882-7974.18.1.91
   Salthouse TA, 1998, PSYCHOL AGING, V13, P445, DOI 10.1037/0882-7974.13.3.445
   Salthouse TA, 2001, PSYCHOL AGING, V16, P251, DOI 10.1037//0882-7974.16.2.251
   Saporta G, 2006, STAT SOC BEHAV SCI, P371
   Schank R., 1977, SCRIPTS PLANS GOALS
   SEIFERT CM, 1985, J MEM LANG, V24, P405, DOI 10.1016/0749-596X(85)90037-3
   Shammi P, 1998, AGING NEUROPSYCHOL C, V5, P1, DOI 10.1076/anec.5.1.1.23
   SIEGLER RS, 1994, CURR DIR PSYCHOL SCI, V3, P1, DOI 10.1111/1467-8721.ep10769817
   Sims DG, 1975, J ACADEMY REHABILITA, V8, P70
   Smith ME, 1915, J ENGLISH GERMANIC P, V14, P519
   Solomon P R, 1998, Fam Med, V30, P265
   Solomon PR, 1998, ARCH NEUROL-CHICAGO, V55, P349, DOI 10.1001/archneur.55.3.349
   Stahl C, 2008, J EXP PSYCHOL LEARN, V34, P570, DOI 10.1037/0278-7393.34.3.570
   Tucker-Drob EA, 2008, PSYCHOL AGING, V23, P453, DOI 10.1037/0882-7974.23.1453
   Ulatowska HK, 2005, BRAIN LANG, V95, P109, DOI 10.1016/j.bandl.2005.07.059
   Ulatowska HK, 1998, APHASIOLOGY, V12, P619, DOI 10.1080/02687039808249562
   Ulatowska HK, 2000, APHASIOLOGY, V14, P227, DOI 10.1080/026870300401450
   Van Dijk T., 1980, MACROSTRUCTURES
   Van Dijk T. A., 1983, STRATEGIES DISCOURSE
   van Dijk TA, 1977, COGNITIVE PROCESSES
   Wechsler D, 1998, WECHSLER ADULT INTEL
   Wechsler D, 1998, WECHSLER MEMORY SCAL
   Williams LJ, 2010, J SPEECH LANG HEAR R, V53, P1372, DOI 10.1044/1092-4388(2010/08-0141)
   Zacks RT, 1988, LANGUAGE MEMORY AGIN, P117
NR 111
TC 2
Z9 2
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 8
PY 2012
VL 7
IS 5
AR e36161
DI 10.1371/journal.pone.0036161
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959TF
UT WOS:000305335500008
PM 22590523
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tewarie, P
   Balk, L
   Costello, F
   Green, A
   Martin, R
   Schippling, S
   Petzold, A
AF Tewarie, Prejaas
   Balk, Lisanne
   Costello, Fiona
   Green, Ari
   Martin, Roland
   Schippling, Sven
   Petzold, Axel
TI The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment
SO PLOS ONE
LA English
DT Article
ID OPTICAL COHERENCE TOMOGRAPHY; FIBER LAYER THICKNESS; MULTIPLE-SCLEROSIS
AB Background: Retinal optical coherence tomography (OCT) is an imaging biomarker for neurodegeneration in multiple sclerosis (MS). In order to become validated as an outcome measure in multicenter studies, reliable quality control (QC) criteria with high inter-rater agreement are required.
   Methods/Principal Findings: A prospective multicentre study on developing consensus QC criteria for retinal OCT in MS: (1) a literature review on OCT QC criteria; (2) application of these QC criteria to a training set of 101 retinal OCT scans from patients with MS; (3) kappa statistics for inter-rater agreement; (4) identification reasons for inter-rater disagreement; (5) development of new consensus QC criteria; (6) testing of the new QC criteria on the training set and (7) prospective validation on a new set of 159 OCT scans from patients with MS. The inter-rater agreement for acceptable scans among OCT readers (n = 3) was moderate (kappa 0.45) based on the non-validated QC criteria which were entirely based on the ophthalmological literature. A new set of QC criteria was developed based on recognition of: (O) obvious problems, (S) poor signal strength, (C) centration of scan, (A) algorithm failure, (R) retinal pathology other than MS related, (I) illumination and (B) beam placement. Adhering to these OSCAR-IB QC criteria increased the inter-rater agreement to kappa from moderate to substantial (0.61 training set and 0.61 prospective validation).
   Conclusions: This study presents the first validated consensus QC criteria for retinal OCT reading in MS. The high inter-rater agreement suggests the OSCAR-IB QC criteria to be considered in the context of multicentre studies and trials in MS.
C1 [Tewarie, Prejaas; Balk, Lisanne] Vrije Univ Amsterdam, Med Ctr, MS Ctr Amsterdam, Amsterdam, Netherlands.
   [Costello, Fiona] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada.
   [Costello, Fiona] Univ Calgary, Dept Surg, Calgary, AB, Canada.
   [Green, Ari] Univ Calif San Francisco, Dept Neurol, Multiple Sclerosis Ctr, San Francisco, CA USA.
   [Martin, Roland; Schippling, Sven] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin Multiple Sclerosis Res I, Hamburg, Germany.
   [Petzold, Axel] UCL Inst Neurol, London, England.
RP Tewarie, P (reprint author), Vrije Univ Amsterdam, Med Ctr, MS Ctr Amsterdam, Amsterdam, Netherlands.
EM a.petzold@vumc.nl
RI Petzold, Axel/C-1090-2009
OI Petzold, Axel/0000-0002-0344-9749
FU Dutch MS Research Foundation [09 - 358 d MS]; Gemeinnuetzige
   Hertie-Stiftung
FX The MS Center VUMC is funded by a program grant of the Dutch MS Research
   Foundation (grant 09 - 358 d MS). The Institute for Neuroimmunology and
   Clinical Multiple Sclerosis is supported by an unrestricted grant of the
   Gemeinnuetzige Hertie-Stiftung. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Balk L, 2011, RETINA IN PRESS
   Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41
   Cheung CYL, 2008, OPHTHALMOLOGY, V115, P1347, DOI 10.1016/j.ophtha.2007.11.027
   Costello F, 2011, MULT SCLER INT, DOI 10.1155/2011/148394
   Domalpally A, 2009, RETINA-J RET VIT DIS, V29, P775, DOI 10.1097/IAE.0b013e3181a0848b
   Fleiss JL, 2003, STAT METHODS RATES P, P618
   Frohman E, 2006, LANCET NEUROL, V5, P853, DOI 10.1016/S1474-4422(06)70573-7
   Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080
   Huang JJ, 2011, OPHTHAL SURG LAS IM, V42, P216, DOI 10.3928/15428877-20110324-01
   Jindahra P, 2010, CURR OPIN NEUROL, V23, P16, DOI 10.1097/WCO.0b013e328334e99b
   Kanamori A, 2003, AM J OPHTHALMOL, V135, P513, DOI 10.1016/S0002-9394(02)02003-2
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Otani T, 2011, RETINA-J RET VIT DIS, V31, P497, DOI 10.1097/IAE.0b013e3181ed8dae
   Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X
   Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005
   Vizzeri G, 2009, AM J OPHTHALMOL, V148, P245
NR 16
TC 146
Z9 146
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 19
PY 2012
VL 7
IS 4
AR e34823
DI 10.1371/journal.pone.0034823
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959TL
UT WOS:000305336200009
PM 22536333
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-07-16
ER

PT J
AU Lepelletier, D
   Ravaud, P
   Baron, G
   Lucet, JC
AF Lepelletier, Didier
   Ravaud, Philippe
   Baron, Gabriel
   Lucet, Jean-Christophe
TI Agreement among Health Care Professionals in Diagnosing Case
   Vignette-Based Surgical Site Infections
SO PLOS ONE
LA English
DT Article
ID QUALITY-OF-CARE; SURVEILLANCE METHODS; RATES; PERFORMANCE; INPATIENTS;
   PNEUMONIA; HELICS
AB Objective: To assess agreement in diagnosing surgical site infection (SSI) among healthcare professionals involved in SSI surveillance.
   Methods: Case-vignette study done in 2009 in 140 healthcare professionals from seven specialties (20 in each specialty, Anesthesiologists, Surgeons, Public health specialists, Infection control physicians, Infection control nurses, Infectious diseases specialists, Microbiologists) in 29 University and 36 non-University hospitals in France. We developed 40 case-vignettes based on cardiac and gastrointestinal surgery patients with suspected SSI. Each participant scored six randomly assigned case-vignettes before and after reading the SSI definition on an online secure relational database. The intraclass correlation coefficient (ICC) was used to assess agreement regarding SSI diagnosis on a seven-point Likert scale and the kappa coefficient to assess agreement for superficial or deep SSI on a three-point scale.
   Results: Based on a consensus, SSI was present in 21 of 40 vignettes (52.5%). Intraspecialty agreement for SSI diagnosis ranged across specialties from 0.15 (95% confidence interval, 0.00-0.59) (anesthesiologists and infection control nurses) to 0.73 (0.32-0.90) (infectious diseases specialists). Reading the SSI definition improved agreement in the specialties with poor initial agreement. Intraspecialty agreement for superficial or deep SSI ranged from 0.10 (-0.19-0.38) to 0.54 (0.25-0.83) (surgeons) and increased after reading the SSI definition only among the infection control nurses from 0.10 (-0.19-0.38) to 0.41 (-0.09-0.72). Interspecialty agreement for SSI diagnosis was 0.36 (0.22-0.54) and increased to 0.47 (0.31-0.64) after reading the SSI definition.
   Conclusion: Among healthcare professionals evaluating case-vignettes for possible surgical site infection, there was large disagreement in diagnosis that varied both between and within specialties.
C1 [Lepelletier, Didier; Lucet, Jean-Christophe] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Infect Control Unit, F-75877 Paris 18, France.
   [Lepelletier, Didier; Ravaud, Philippe; Baron, Gabriel; Lucet, Jean-Christophe] Univ Paris Diderot, Paris, France.
   [Ravaud, Philippe; Baron, Gabriel] Hop Hotel Dieu, Assistance Publ Hop Paris, Ctr Epidemiol Clin, Paris, France.
   [Ravaud, Philippe; Baron, Gabriel] INSERM, U738, Paris, France.
RP Lepelletier, D (reprint author), Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Infect Control Unit, F-75877 Paris 18, France.
EM jean-christophe.lucet@bch.aphp.fr
RI ravaud, philippe/C-1694-2009
OI Ravaud, Philippe/0000-0001-8264-9206
FU French Ministry of Health [PREQHOS 0901]
FX This study was supported by the French Ministry of Health (national
   grant PREQHOS 0901). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Astagneau P, 2010, CURR OPIN INFECT DIS, V23, P306, DOI 10.1097/QCO.0b013e32833ae7e3
   Beaujean D, 2002, EUR J CLIN MICROBIOL, V21, P444, DOI 10.1007/s10096-002-0745-x
   Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108
   Chalfine A, 2006, INFECT CONT HOSP EP, V27, P794, DOI 10.1086/506393
   CULVER DH, 1991, AM J MED S3B, V91, P152, DOI DOI 10.1016/0002-9343(91)90361-Z
   Edmond MB, 2007, J HOSP INFECT, V65, P182, DOI 10.1016/S0195-6701(07)60040-1
   Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001
   Fleiss J, 2003, STAT METHODS RATES P
   Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006
   GLENISTER HM, 1993, J HOSP INFECT, V23, P229, DOI 10.1016/0195-6701(93)90028-X
   Haustein T, 2011, LANCET INFECT DIS, V11, P471, DOI 10.1016/S1473-3099(10)70315-7
   Hejblum G, 2008, CHEST, V133, P1107, DOI 10.1378/chest.06-3014
   HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606
   Hospital in Europe Link for Infection Control through Surveillance, 2004, SURV SURG SIT INF
   Klompas M, 2008, CLIN INFECT DIS, V46, P1443, DOI 10.1086/587103
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lin MY, 2010, JAMA-J AM MED ASSOC, V304, P2035, DOI 10.1001/jama.2010.1637
   Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620
   McKibben L, 2005, INFECT CONT HOSP EP, V26, P580, DOI 10.1086/502585
   Niedner MF, 2010, AM J INFECT CONTROL, V38, P585, DOI 10.1016/j.ajic.2010.04.211
   Nunnaly JC, PSYCHOMETRIC THEORY
   Perla RJ, 2009, AM J INFECT CONTROL, V37, P615, DOI 10.1016/j.ajic.2009.03.003
   Pittet D, 2004, ANN INTERN MED, V141, P1, DOI 10.7326/0003-4819-141-1-200407060-00008
   Rosenthal R, 2010, J HOSP INFECT, V75, P178, DOI 10.1016/j.jhin.2009.10.028
   Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619
   Suetens C, 2007, J HOSP INFECT, V65, P171, DOI 10.1016/S0195-6701(07)60038-3
   TAYLOR G, 1990, AM J INFECT CONTROL, V18, P295, DOI 10.1016/0196-6553(90)90228-K
   Wachter RM, 2008, ANN INTERN MED, V149, P29, DOI 10.7326/0003-4819-149-1-200807010-00007
   Wilson AP, 2004, BRIT MED J, V14, P14
   Wilson J, 2007, J HOSP INFECT, V65, P165, DOI 10.1016/S0195-6701(07)60037-1
   WONG ES, 2004, HOSP EPIDEMIOLOGY IN, P287
   Yokoe DS, 2004, EMERG INFECT DIS, V10, P1924, DOI 10.3201/eid1011.040572
NR 32
TC 10
Z9 10
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 17
PY 2012
VL 7
IS 4
AR e35131
DI 10.1371/journal.pone.0035131
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959WC
UT WOS:000305347400032
PM 22529980
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hartling, L
   Fernandes, RM
   Seida, J
   Vandermeer, B
   Dryden, DM
AF Hartling, Lisa
   Fernandes, Ricardo M.
   Seida, Jennifer
   Vandermeer, Ben
   Dryden, Donna M.
TI From the Trenches: A Cross-Sectional Study Applying the GRADE Tool in
   Systematic Reviews of Healthcare Interventions
SO PLOS ONE
LA English
DT Review
ID QUALITY; RECOMMENDATIONS; STRENGTH
AB Background: GRADE was developed to address shortcomings of tools to rate the quality of a body of evidence. While much has been published about GRADE, there are few empirical and systematic evaluations. Objective: To assess GRADE for systematic reviews (SRs) in terms of inter-rater agreement and identify areas of uncertainty. Design: Cross-sectional, descriptive study.
   Methods: We applied GRADE to three SRs (n = 48, 66, and 75 studies, respectively) with 29 comparisons and 12 outcomes overall. Two reviewers graded evidence independently for outcomes deemed clinically important a priori. Inter-rater reliability was assessed using kappas for four main domains (risk of bias, consistency, directness, and precision) and overall quality of evidence.
   Results: For the first review, reliability was: kappa = 0.41 for risk of bias; 0.84 consistency; 0.18 precision; and 0.44 overall quality. Kappa could not be calculated for directness as one rater assessed all items as direct; assessors agreed in 41% of cases. For the second review reliability was: 0.37 consistency and 0.19 precision. Kappa could not be assessed for other items; assessors agreed in 33% of cases for risk of bias; 100% directness; and 58% overall quality. For the third review, reliability was: 0.06 risk of bias; 0.79 consistency; 0.21 precision; and 0.18 overall quality. Assessors agreed in 100% of cases for directness. Precision created the most uncertainty due to difficulties in identifying "optimal'' information size and "clinical decision threshold'', as well as making assessments when there was no meta-analysis. The risk of bias domain created uncertainty, particularly for nonrandomized studies.
   Conclusions: As researchers with varied levels of training and experience use GRADE, there is risk for variability in interpretation and application. This study shows variable agreement across the GRADE domains, reflecting areas where further guidance is required.
C1 [Hartling, Lisa; Seida, Jennifer; Vandermeer, Ben; Dryden, Donna M.] Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada.
   [Hartling, Lisa] Univ Alberta, Dept Pediat, Cochrane Child Hlth Field, Edmonton, AB, Canada.
   [Fernandes, Ricardo M.] Hosp Santa Maria, Gulbenkian Programme Adv Med Educ, Lisbon, Portugal.
   [Fernandes, Ricardo M.] Hosp Santa Maria, Child & Family Dept, Lisbon, Portugal.
   [Fernandes, Ricardo M.] Inst Mol Med, Lab Farmacol Clin & Terapeut, Lisbon, Portugal.
RP Hartling, L (reprint author), Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada.
EM hartling@ualberta.ca
RI Fernandes, Ricardo M/C-7501-2015
OI Fernandes, Ricardo M/0000-0002-7253-6475
CR Abou-Setta AM, 2011, ANN INTERN MED, V155, P234, DOI 10.7326/0003-4819-155-4-201108160-00346
   Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
   Atkins D, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-25
   Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
   Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI 10.1016/j.jclinepi.2011.06.004
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1303, DOI 10.1016/j.jclinepi.2011.04.014
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P395, DOI 10.1016/j.jclinepi.2010.09.012
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011
   Hartling L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1714
   Higgins JPT, 2011, COCHRANE HDB SYSTEMA
   Institute of Medicine (IOM), 2011, FIND WHAT WORKS HLTH
   Jamtvedt G, 2008, PHYS THER, V88, P123, DOI 10.2522/ptj.20070043
   Kavanagh BP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000094
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009
   Schunemann H., 2009, GRADE HDB GRADING QU
   Schunemann HJ, 2003, CAN MED ASSOC J, V169, P677
   Seida J, 2011, ANN INTERN MED, V153, P246
   Wells G, 2003, 11 COCHR C EV HLTH C
NR 24
TC 9
Z9 9
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 5
PY 2012
VL 7
IS 4
AR e34697
DI 10.1371/journal.pone.0034697
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 955IH
UT WOS:000305010500023
PM 22496843
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Montgomery, AL
   Morris, SK
   Bassani, DG
   Kumar, R
   Jotkar, R
   Jha, P
AF Montgomery, Ann L.
   Morris, Shaun K.
   Bassani, Diego G.
   Kumar, Rajesh
   Jotkar, Raju
   Jha, Prabhat
TI Factors Associated with Physician Agreement and Coding Choices of Cause
   of Death Using Verbal Autopsies for 1130 Maternal Deaths in India
SO PLOS ONE
LA English
DT Article
ID POLITICAL PRIORITY; SAFE MOTHERHOOD; MORTALITY; STANDARDS
AB Background: The Indian Sample Registration System (SRS) with verbal autopsy methods provides estimations of cause specific mortality for maternal deaths, where the majority of deaths occur at home, unregistered. We aim to examine factors that influence physician agreement and coding choices in assigning causes of death from verbal autopsies.
   Methodology/Principal Findings: Among adult deaths identified in the SRS, pregnancy-related deaths recorded in 2001-2003 were assigned ICD-10 codes by two independent physicians. Inter-rater reliability was estimated using Landis Koch Kappa classification <= 4-poor to fair agreement; >0.4 <= 0.6-moderate agreement; >0.6 <= 0.8-substantial agreement; >0.8-high agreement. We identified factors associated with physician agreement using multivariate logistic regression. A central consensus panel reviewed cases for errors and reclassified as needed based on 2011 ICD-10 coding guidelines. Of 1130 pregnancy-related deaths, 1040 were assigned ICD-10 codes by two physicians. We found substantial agreement regardless of the woman's residence, whether the death was registered, religion, respondent's or deceased's education, age, hospital admission or gestational age. Physician agreement was not influenced by the above variables, with the exception of greater agreement in cases where the respondent did not live with the deceased, or early gestational age at the time of death. A central consensus panel reviewed all cases and recoded 10% of cases due to insufficient use of information in the verbal autopsy by the coding physicians and rationale for this reclassification are discussed.
   Conclusion: In the absence of complete vital registration and universal healthcare services, physician coded verbal autopsies continues to be heavily relied upon to ascertain pregnancy-related death. From this study, two independent physicians had good inter-rater reliability for assigning pregnancy-related causes of death in a nationally-represented sample, and physician coding does not appear to be heavily influenced by case characteristics or demographics.
C1 [Montgomery, Ann L.; Morris, Shaun K.; Jotkar, Raju; Jha, Prabhat] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada.
   [Montgomery, Ann L.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada.
   [Morris, Shaun K.] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Infect Dis, Toronto, ON M5G 1X8, Canada.
   [Bassani, Diego G.; Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Kumar, Rajesh] Post Grad Inst Med Educ, Sch Publ Hlth, Chandigarh, India.
RP Montgomery, AL (reprint author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, 30 Bond St, Toronto, ON M5B 1W8, Canada.
EM ann.montgomery@utoronto.ca
RI Bassani, Diego/G-2827-2015
OI Bassani, Diego/0000-0001-6704-3820; Jha, Prabhat/0000-0001-7067-8341
FU US National Institutes of Health; Canadian Institute of Health Research;
   International Development Research Centre; Sick Kids Foundation;
   Paediatric Chairs of Canada; March of Dimes
FX This work was supported by the US National Institutes of Health,
   Canadian Institute of Health Research, International Development
   Research Centre, and Li Ka Shing Knowledge Institute. Shaun K. Morris is
   a Fellow of the Pediatric Scientist Development Program. The project
   described was also supported by grants from Sick Kids Foundation,
   Paediatric Chairs of Canada, and the March of Dimes. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Baiden F, 2007, B WORLD HEALTH ORGAN, V85, P570, DOI 10.2471/BLT.07.043745
   Byass P, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-1
   CGHR, 2003, MILL DEATH STUD
   Chan M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000223
   Cross S, 2010, B WORLD HEALTH ORGAN, V88, P147, DOI 10.2471/BLT.09.063537
   Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8
   Fottrell Edward, 2007, Popul Health Metr, V5, P1, DOI 10.1186/1478-7954-5-1
   Fottrell E, 2010, EPIDEMIOL REV, V32, P38, DOI 10.1093/epirev/mxq003
   Ganatra BR, 1998, B WORLD HEALTH ORGAN, V76, P591
   Graham WJ, 2007, AM J PUBLIC HEALTH, V97, P978, DOI 10.2105/AJPH.2005.073692
   Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018
   Joshi R, 2009, B WORLD HEALTH ORGAN, V87, P678, DOI 10.2471/BLT.07.049288
   Kumar R, 2006, Indian J Public Health, V50, P90
   Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lopez AD, 2007, LANCET, V370, P1744, DOI 10.1016/S0140-6736(07)61419-6
   Lozano R, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-32
   Midhet F, 2008, INT J HEALTH SCI-IJH, V2, P91
   Montgomery AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014637
   Morris SK, 2010, PLOS ONE, V5, pA170, DOI 10.1371/journal.pone.0009583
   National Committee on Confidential Enquiries into Maternal Deaths [NCCEMD], 2009, SAV MOTH 2005 2007 4
   Ordi J, 2009, PLOS MED, V6, P174, DOI 10.1371/journal.pmed.1000036
   Reichenheim ME, 2004, STATA J, V4, P421
   RGI, 2009, SPEC B MAT MORT IND
   RGI CGHR, 2005, PROSP STUD SRS VERB
   RGI-CGHR SC, 2006, PROSP STUD ONE MILL
   Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x
   Shiffman J, 2007, BJOG-INT J OBSTET GY, V114, P785, DOI 10.1111/j.1471-0528.2007.01374.x
   Shiffman J, 2007, AM J PUBLIC HEALTH, V97, P796, DOI 10.2105/AJPH.2006.095455
   White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067
   WHO, 2010, TRENDS MAT MORT 1990
NR 31
TC 8
Z9 8
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 28
PY 2012
VL 7
IS 3
AR e33075
DI 10.1371/journal.pone.0033075
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 948FM
UT WOS:000304489000014
PM 22470436
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Sun, WY
   Zaboli, D
   Liu, Y
   Arnaoutakis, D
   Khan, T
   Wang, H
   Koch, W
   Khan, Z
   Califano, JA
AF Sun, Wenyue
   Zaboli, David
   Liu, Yan
   Arnaoutakis, Demetri
   Khan, Tanbir
   Wang, Hao
   Koch, Wayne
   Khan, Zubair
   Califano, Joseph A.
TI Comparison of Promoter Hypermethylation Pattern in Salivary Rinses
   Collected with and without an Exfoliating Brush from Patients with HNSCC
SO PLOS ONE
LA English
DT Article
ID SQUAMOUS-CELL CARCINOMA; NECK-CANCER; ORAL-CANCER; HEAD; METHYLATION;
   BIOMARKERS; PROTEOMICS; DISCOVERY; AGREEMENT; MARKER
AB Background: Salivary rinses have been recently proposed as a valuable resource for the development of epigenetic biomarkers for detection and monitoring of head and neck squamous cell carcinoma (HNSCC). Both salivary rinses collected with and without an exfoliating brush from patients with HNSCC are used in detection of promoter hypermethylation, yet their correlation of promoter hypermethylation has not been evaluated. This study was to evaluate the concordance of promoter hypermethylation between salivary rinses collected with and without an exfoliating brush from patients with HNSCC.
   Methodolgy: 57 paired salivary rinses collected with or without an exfoliating brush from identical HNSCC patients were evaluated for promoter hypermethylation status using Quantitative Methylation-Specific PCR. Target tumor suppressor gene promoter regions were selected based on our previous studies describing a panel for HNSCC screening and surveillance, including P16, CCNA1, DCC, TIMP3, MGMT, DAPK and MINT31.
   Principal Findings: In salivary rinses collected with and without brush, frequent methylation was detected in P16 (8.8% vs. 5.2%), CCNA1 (26.3% vs. 22.8%), DCC (33.3% vs. 29.8%), TIMP3 (31.6% vs. 36.8%), MGMT (29.8% vs. 38.6%), DAPK (14.0% vs. 19.2%), and MINT31 (10.5% vs. 8.8%). Spearman's rank correlation coefficient showed a positive correlation between salivary rinses collected with and without brush for P16 (rho = 0.79), CCNA1 (rho = 0.61), DCC (rho = 0.58), TIMP3 (rho = 0.10), MGMT (rho = 0.70), DAPK (rho = 0.51) and MINT31 (rho = 0.72) (P < 0.01). The percent agreement of promoter methylation between salivary rinses with brush and without brush were 96.5% for P16, 82.5% for CCNA1, 78.9% for DCC, 59.7% for TIMP3, 84.2% for MGMT, 84.2% for DAPK, and 94.7% for MINT31.
   Conclusions: Our study demonstrated strong correlations of gene promoter hypermethylation between salivary rinses collected with and without an exfoliating brush. Salivary rinse collection without using an exfoliating brush may offer a cost effective, rapid, non-invasive, and reliable means for development of epigenetic salivary rinse biomarkers.
C1 [Sun, Wenyue; Zaboli, David; Arnaoutakis, Demetri; Khan, Tanbir; Koch, Wayne; Khan, Zubair; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21205 USA.
   [Liu, Yan] Johns Hopkins Med Inst, Dept Surg, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21205 USA.
   [Wang, Hao] Johns Hopkins Med Inst, Dept Oncol, Div Oncol Biostat, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21205 USA.
   [Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA.
RP Sun, WY (reprint author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21205 USA.
EM jcalifa@jhmi.edu
OI Sun, Wenyue/0000-0003-1673-0895
FU National Institute of Dental and Craniofacial Research (NIDCR); NIH
   [P50DE019032]; NIDCR/NIH [U54DE14257]; Early Detection Research Network
   [U01-CA084986]; Challenge Grant [RC1DE020324, RC2DE020789]; Damon Runyon
   Cancer Research Foundation; Flight Attendant Medical Research Institute
FX This work received Grant Support from the National Institute of Dental
   and Craniofacial Research (NIDCR) and NIH Specialized Program of
   Research Excellence grant P50DE019032, NIDCR/NIH grant U54DE14257, Early
   Detection Research Network grant U01-CA084986 and Challenge Grant
   RC1DE020324 and RC2DE020789. Dr. Califano is a Damon Runyon-Lilly
   Clinical Investigator supported by the Damon Runyon Cancer Research
   Foundation (CI- # 9), a Clinical Innovator Award from the Flight
   Attendant Medical Research Institute. J.A. Califano is the Director of
   Research of the Milton J. Dance Head and Neck Endowment. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Begum S, 2011, CLIN CANCER RES, V17, P4494, DOI 10.1158/1078-0432.CCR-10-3436
   Brinkmann O, 2011, ORAL ONCOL, V47, P51, DOI 10.1016/j.oraloncology.2010.10.009
   Carvalho AL, 2008, CLIN CANCER RES, V14, P97, DOI 10.1158/1078-0432.CCR-07-0722
   Demokan S, 2010, INT J CANCER, V127, P2351, DOI 10.1002/ijc.25248
   Franzmann EJ, 2007, CANCER EPIDEM BIOMAR, V16, P1348, DOI 10.1158/1055-9965.EPI-06-0011
   Guerrero-Preston R, 2011, CANCER PREV RES, V4, P1061, DOI 10.1158/1940-6207.CAPR-11-0006
   Ha PK, 2006, LANCET ONCOL, V7, P77, DOI 10.1016/S1470-2045(05)70540-4
   Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975
   Harden SV, 2003, CLIN CANCER RES, V9, P1370
   Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821
   Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037
   Kaur J, 2010, INT J CANCER, V127, P2367, DOI 10.1002/ijc.25377
   KVALSETH TO, 1991, EDUC PSYCHOL MEAS, V51, P95, DOI 10.1177/0013164491511008
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982
   Li Y, 2004, J DENT RES, V83, P199, DOI 10.1177/154405910408300303
   Lingen MW, 2010, CANCER PREV RES, V3, P1056, DOI 10.1158/1940-6207.CAPR-10-0173
   Carvalho AL, 2011, CLIN CANCER RES, V17, P4782, DOI 10.1158/1078-0432.CCR-11-0324
   Nagler R, 2006, CLIN CANCER RES, V12, P3979, DOI 10.1158/1078-0432.CCR-05-2412
   Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736
   Pattani KM, 2011, ANN SURG ONCOL, V18, P2709, DOI 10.1245/s10434-011-1785-1
   Rosas SLB, 2001, CANCER RES, V61, P939
   Spafford MF, 2001, CLIN CANCER RES, V7, P607
   Sun WY, 2012, CLIN CANCER RES, V18, P1082, DOI 10.1158/1078-0432.CCR-11-2392
   Tavassoli M, 1998, INT J CANCER, V78, P390, DOI 10.1002/(SICI)1097-0215(19981029)78:3<390::AID-IJC23>3.0.CO;2-9
   Xie HW, 2008, MOL CELL PROTEOMICS, V7, P486, DOI 10.1074/mcp.M700146-MCP200
   Zhao M, 2005, INT J CANCER, V117, P605, DOI 10.1002/ijc.21216
NR 27
TC 9
Z9 9
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 16
PY 2012
VL 7
IS 3
AR e33642
DI 10.1371/journal.pone.0033642
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 932RV
UT WOS:000303309100078
PM 22438973
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kaulard, K
   Cunningham, DW
   Bulthoff, HH
   Wallraven, C
AF Kaulard, Kathrin
   Cunningham, Douglas W.
   Buelthoff, Heinrich H.
   Wallraven, Christian
TI The MPI Facial Expression Database - A Validated Database of Emotional
   and Conversational Facial Expressions
SO PLOS ONE
LA English
DT Article
ID OF-THE-ART; FACE RECOGNITION; PERCEPTION; IDENTITY; MOTION;
   COMMUNICATION; INTENSITY; ACCURACY; DYNAMICS; DISPLAYS
AB The ability to communicate is one of the core aspects of human life. For this, we use not only verbal but also nonverbal signals of remarkable complexity. Among the latter, facial expressions belong to the most important information channels. Despite the large variety of facial expressions we use in daily life, research on facial expressions has so far mostly focused on the emotional aspect. Consequently, most databases of facial expressions available to the research community also include only emotional expressions, neglecting the largely unexplored aspect of conversational expressions. To fill this gap, we present the MPI facial expression database, which contains a large variety of natural emotional and conversational expressions. The database contains 55 different facial expressions performed by 19 German participants. Expressions were elicited with the help of a method-acting protocol, which guarantees both well-defined and natural facial expressions. The method-acting protocol was based on every-day scenarios, which are used to define the necessary context information for each expression. All facial expressions are available in three repetitions, in two intensities, as well as from three different camera angles. A detailed frame annotation is provided, from which a dynamic and a static version of the database have been created. In addition to describing the database in detail, we also present the results of an experiment with two conditions that serve to validate the context scenarios as well as the naturalness and recognizability of the video sequences. Our results provide clear evidence that conversational expressions can be recognized surprisingly well from visual information alone. The MPI facial expression database will enable researchers from different research fields ( including the perceptual and cognitive sciences, but also affective computing, as well as computer vision) to investigate the processing of a wider range of natural facial expressions.
C1 [Kaulard, Kathrin; Buelthoff, Heinrich H.] Max Planck Inst Biol Cybernet, Dept Human Cognit Percept & Act, Tubingen, Germany.
   [Cunningham, Douglas W.] Brandenburg Tech Univ Cottbus, D-03044 Cottbus, Germany.
   [Buelthoff, Heinrich H.; Wallraven, Christian] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea.
RP Kaulard, K (reprint author), Max Planck Inst Biol Cybernet, Dept Human Cognit Percept & Act, Tubingen, Germany.
EM wallraven@korea.ac.kr
RI Bulthoff, Heinrich/J-6579-2012
OI Bulthoff, Heinrich/0000-0003-2568-0607; Cunningham, Douglas
   William/0000-0003-1419-2552; Wallraven, Christian/0000-0002-2604-9115
FU European Project POETICON [215843]; WCU (World Class University) through
   the National Research Foundation of Korea; Ministry of Education,
   Science and Technology [R31-2008-000-10008-0, 2010-0011569]
FX This research was supported by the European Project POETICON (grant
   number 215843). Part of this research was supported by the WCU (World
   Class University) program through the National Research Foundation of
   Korea funded by the Ministry of Education, Science and Technology
   (R31-2008-000-10008-0) and through the National Research Foundation of
   Korea funded by the Ministry of Education, Science and Technology
   (2010-0011569). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003
   Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x
   Baron-Cohen S., 2004, MIND READING INTERAC
   BaronCohen S, 1996, VIS COGN, V3, P39, DOI 10.1080/713756728
   BASSILI JN, 1978, J EXP PSYCHOL HUMAN, V4, P373, DOI 10.1037/0096-1523.4.3.373
   Battocchi A, 2004, SLI GSCP WORKSH COM
   Bavelas JB, 2000, J PERS SOC PSYCHOL, V79, P941, DOI 10.1037//0022-3514.79.6.941
   Bavelas JB, HDB NONVERBAL COMMUN, P97
   Benton CP, 2007, P ROY SOC B-BIOL SCI, V274, P2131, DOI 10.1098/rspb.2007.0473
   Bickmore T., 2005, ADV NATURAL MULTIMOD
   Borod J, 2004, EXP AGING RES, V30, P305, DOI 10.1080/03610730490484399
   BRAVE S, 2003, HUM FAC ER, P81
   Bridwhistell R., 1970, KINESICS CONTEXT
   BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x
   Bull P, 2001, PSYCHOLOGIST, V14, P644
   Calder A, 2011, OXFORD HDB FACE PERC, P427, DOI DOI 10.1093/0XFORDHB/9780199559053.013.0022
   Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724
   Cassell J, 2000, EMBODIED CONVERSATIONAL AGENTS, P1
   Cassell J, 2000, COMMUN ACM, V43, P70, DOI 10.1145/332051.332075
   COHN JF, 2004, INT J WAVELETS MULTI, V2, P1, DOI DOI 10.1142/S0219691304000317
   Cowie R, 2005, NEURAL NETWORKS, V18, P371, DOI 10.1016/j.neunet.2005.03.002
   Cunningham DW, 2009, J VISION, V9, DOI 10.1167/9.13.7
   Cunningham DW, 2005, ACM T APPL PERCEPT, V2, P251, DOI DOI 10.1145/1077399.1077404
   Darwin C, 1965, EXPRESSION EMOTION M
   DeCarlo D, 2002, COMP ANIM CONF PROC, P11, DOI 10.1109/CA.2002.1017501
   Dornaika F, 2011, PATTERN RECOGN LETT, V32, P740, DOI 10.1016/j.patrec.2010.12.010
   Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351
   Edwards K, 1998, PSYCHOL SCI, V9, P270, DOI 10.1111/1467-9280.00054
   EKMAN P, 1994, PSYCHOL BULL, V115, P268, DOI 10.1037/0033-2909.115.2.268
   Ekman P., 1979, HUMAN ETHOLOGY CLAIM, P169, DOI DOI 10.1007/978-1-4020-2783-33
   Ekman P, 1989, HDB SOCIAL PSYCHOL
   Ekman P., 1999, HDB COGNITION EMOTIO, P301, DOI DOI 10.1002/0470013494.CH16
   Ekman P, 1978, FACIAL ACTION CODING
   Ekman Paul, 1998, EXPRESSION EMOTIONS, P363
   Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203
   Elfenbein HA, 2007, EMOTION, V7, P131, DOI 10.1037/1528-3542.7.1.131
   Fasel B, 2003, PATTERN RECOGN, V36, P259, DOI 10.1016/S0031-3203(02)00052-3
   Fox CJ, 2009, HUM BRAIN MAPP, V30, P1637, DOI 10.1002/hbm.20630
   Frank MG, 2001, J PERS SOC PSYCHOL, V80, P75, DOI 10.1037/0022-3514.80.1.75
   Fridlund A. J., 1994, HUMAN FACIAL EXPRESS
   FRIDLUND AJ, 1985, SCIENCE, V230, P607, DOI 10.1126/science.4048950
   Fujimura T, 2010, PERCEPTION, V39, P543, DOI 10.1068/p6257
   FUJITA BN, 1980, J NONVERBAL BEHAV, V4, P131, DOI 10.1007/BF00986815
   Gross R., 2005, HDB FACE RECOGNITION
   Gur RC, 2002, J NEUROSCI METH, V115, P137, DOI 10.1016/S0165-0270(02)00006-7
   Harwood NK, 1999, AM J MENT RETARD, V104, P270, DOI 10.1352/0895-8017(1999)104<0270:ROFEEF>2.0.CO;2
   Hawk ST, 2009, EMOTION, V9, P293, DOI 10.1037/a0015178
   Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0
   Hess U, 1997, J NONVERBAL BEHAV, V21, P241, DOI 10.1023/A:1024952730333
   Hunt WA, 1941, PSYCHOL BULL, V38, P249, DOI 10.1037/h0054615
   IZARD CE, 1994, PSYCHOL BULL, V115, P288, DOI 10.1037/0033-2909.115.2.288
   Jack R., 2009, CURR BIOL, V19, P1, DOI DOI 10.1016/J.CUB.2009.07.051
   Kamachi M, 2001, PERCEPTION, V30, P875, DOI 10.1068/p3131
   Kilts CD, 2003, NEUROIMAGE, V18, P4156
   Kleiner M, 2007, PERCEPTION, V36, P14
   Kleiner M., 2004, MPI VIDEOLAB SYSTEM
   LaBar KS, 2003, CEREB CORTEX, V13, P1023, DOI 10.1093/cercor/13.10.1023
   Lamont AC, 2005, MEM COGNITION, V33, P1017, DOI 10.3758/BF03193209
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   McCullough S, 2009, COGNITION, V110, P208, DOI 10.1016/j.cognition.2008.11.007
   MEHRABIAN A, 1968, PSYCHOL TODAY, V2, P53
   Mesquita B, HDB CROSS CULTURAL P, P254
   Motley M. T., 1988, W J SPEECH COMMUNICA, V52, P1, DOI DOI 10.1080/10570318809389622
   MOTLEY MT, 1993, HUM COMMUN RES, V20, P3, DOI 10.1111/j.1468-2958.1993.tb00314.x
   Nickerson R, 1976, P US OR DES INT GRAP
   Nusseck M, 2008, J VISION, V8, DOI 10.1167/8.8.1
   O'Toole AJ, 2002, TRENDS COGN SCI, V6, P261, DOI 10.1016/S1364-6613(02)01908-3
   ORTONY A, 1990, PSYCHOL REV, V97, P315, DOI 10.1037/0033-295X.97.3.315
   Pantic M, 2000, IEEE T PATTERN ANAL, V22, P1424, DOI 10.1109/34.895976
   Parrott W. G., 2001, EMOTIONS SOCIAL PSYC
   Pelachaud C, 2002, J VISUAL COMP ANIMAT, V13, P301, DOI 10.1002/vis.299
   Plutchik R, 2001, AM SCI, V89, P344, DOI 10.1511/2001.4.344
   Poggi I, 2000, EMBODIED CONVERSATIO
   Reilly J, HDB AFFECTIVE SCI, P535
   Reisenzein R, 2003, EINFUHRUNG EMOTIONPS, VIII
   Rhodes G, 1996, SUPERPORTRAITS CARIC
   Riediger M, POSING EMOTION UNPUB
   Rosch E, 1988, READINGS COGNITIVE S, P27
   RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102
   Russell JA, 1997, PSYCHOL FACIAL EXPRE
   Salovey P, HDB AFFECTIVE SCI, P747
   Sato W, 2004, COGNITIVE BRAIN RES, V20, P81, DOI 10.1016/j.cogbrainres.2004.01.008
   Sayette MA, 2001, J NONVERBAL BEHAV, V25, P167, DOI 10.1023/A:1010671109788
   Scherer K. R., 2010, BLUEPRINT AFFECTIVEL
   Scherer KR, 2004, SOC SCI INFORM, V43, P499, DOI 10.1177/0539018404047701
   Schmidt KL, 2006, J NONVERBAL BEHAV, V30, P37, DOI 10.1007/s10919-005-0003-x
   Schultz J, 2009, EXP BRAIN RES, V194, P465, DOI 10.1007/s00221-009-1721-9
   Schweinberger SR, 1998, J EXP PSYCHOL HUMAN, V24, P1748, DOI 10.1037/0096-1523.24.6.1748
   Sebe N, 2004, INT WORKSH HUM COMP, P1
   SHAVER P, 1987, J PERS SOC PSYCHOL, V52, P1061, DOI 10.1037//0022-3514.52.6.1061
   Smith C. A., 1997, PSYCHOL FACIAL EXPRE, P229, DOI DOI 10.1017/CB09780511659911.012
   Sprengelmeyer R, 2006, NEUROPSYCHOLOGIA, V44, P2899, DOI 10.1016/j.neuropsychologia.2006.06.020
   Tcherkassof A, 2007, EUR J SOC PSYCHOL, V37, P1325, DOI 10.1002/ejsp.427
   Trautmann SA, 2009, BRAIN RES, V1284, P100, DOI 10.1016/j.brainres.2009.05.075
   Troje NF, 1996, VISION RES, V36, P1761, DOI 10.1016/0042-6989(95)00230-8
   Trucker JS, 1988, J NONVERBAL BEHAV, V12, P87
   Wallraven C, 2004, VIEW DEPENDENCE COMP, P181, DOI [10.1145/1012551.1012603, DOI 10.1145/1012551.1012603]
   Wehrle T, 2000, J PERS SOC PSYCHOL, V78, P105, DOI 10.1037/0022-3514.78.1.105
   Wright DB, 2002, LAW HUMAN BEHAV, V26, P641, DOI 10.1023/A:1020981501383
   Yngve V, 1970, 6 REG M CHIC LING SO, P567
   Zeng ZH, 2009, IEEE T PATTERN ANAL, V31, P39, DOI 10.1109/TPAMI.2008.52
   Zhao W, 2003, ACM COMPUT SURV, V35, P399, DOI 10.1145/954339.954342
NR 102
TC 36
Z9 36
U1 1
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 15
PY 2012
VL 7
IS 3
AR e32321
DI 10.1371/journal.pone.0032321
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 932RU
UT WOS:000303309000007
PM 22438875
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hsiao, M
   Morris, SK
   Bassani, DG
   Montgomery, AL
   Thakur, JS
   Jha, P
AF Hsiao, Marvin
   Morris, Shaun K.
   Bassani, Diego G.
   Montgomery, Ann L.
   Thakur, J. S.
   Jha, Prabhat
TI Factors Associated with Physician Agreement on Verbal Autopsy of over
   11500 Injury Deaths in India
SO PLOS ONE
LA English
DT Article
ID ADULT DEATHS; VALIDATION
AB Introduction: Worldwide, injuries account for 9.8% of all deaths. The majority of these deaths occur in low-and middle-income countries where vital registration systems are often inadequate. Verbal autopsy (VA) is a tool used to ascertain cause of death in such settings. Validation studies for VA using hospital diagnosed causes of death as comparisons have shown that injury deaths can be reliably diagnosed by VA. However, no study has assessed the factors that may affect physicians' abilities to code specific causes of injury death using VA.
   Method/Principal Findings: This study used data from over 11 500 verbal autopsies of injury deaths from the Million Death Study (MDS) in which 6.3 million people in India were monitored from 2001-2003 for vital events. Deaths that occurred in the MDS were coded by two independent physicians. This study focused on whether physician agreement on the classification of injury deaths was affected by characteristics of the deceased and respondent. Agreement was analyzed using three primary methods: 1) kappa statistic; 2) sensitivity and specificity analysis using the final VA diagnosed category of injury death as gold standard; and 3) multivariate logistic regression using a conceptual hierarchical model. The overall agreement for all injury deaths was 77.9% with a kappa of 0.74 (99% CI 0.74-0.75). Deaths in the injury categories of "transport'', "falls'', "drowning'' and "other unintentional injury'' occurring outside the home were associated with greater physician agreement than those occurring at home. In contrast, self-inflicted injury deaths that occurred outside the home were associated with lower physician agreement.
   Conclusions/Significance: With few exceptions, most characteristics of the deceased and the respondent did not influence physician agreement on the classification of injury deaths. Physician training and continued adaptation of the VA tool should focus on the reasons these factors influenced physician agreement.
C1 [Hsiao, Marvin; Morris, Shaun K.; Bassani, Diego G.; Montgomery, Ann L.; Thakur, J. S.; Jha, Prabhat] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada.
   [Hsiao, Marvin] Univ Toronto, St Michaels Hosp, Dept Surg, Toronto, ON M5B 1W8, Canada.
   [Morris, Shaun K.] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Infect Dis, Toronto, ON M5B 1W8, Canada.
   [Bassani, Diego G.; Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5B 1W8, Canada.
   [Bassani, Diego G.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada.
   [Thakur, J. S.] Post Grad Inst Med Educ & Res PGIMER, Dept Community Med, Chandigarh, India.
RP Hsiao, M (reprint author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada.
EM marvin.my.hsiao@gmail.com
RI Bassani, Diego/G-2827-2015
OI Bassani, Diego/0000-0001-6704-3820; Jha, Prabhat/0000-0001-7067-8341
CR Byass P, 2006, SCAND J PUBLIC HEALT, V34, P26, DOI 10.1080/14034940510032202
   BYASS P, 2003, SCAND J PUBLIC HLT S, V62, P32
   Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x
   Gajalakshmi V, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-47
   Gajalakshmi V, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-7
   Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018
   Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x
   Khademi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011183
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Morris SK, 2010, PLOS ONE, V5, pA170, DOI 10.1371/journal.pone.0009583
   Murray CJL, 2007, PLOS MED, V4, P1739, DOI 10.1371/journal.pmed.0040327
   Quigley MA, 1999, INT J EPIDEMIOL, V28, P1081, DOI 10.1093/ije/28.6.1081
   Reichenheim ME, 2004, STATA J, V4, P421
   Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x
   Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003
   StataCorp, 2007, STAT STAT SOFTW REL
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   World Health Organization, 2008, GLOB BURD DIS 2004 U
   World Health Organization, 2007, INT STAT CLASS DIS R
   Yang GH, 2006, INT J EPIDEMIOL, V35, P741, DOI 10.1093/ije/dyi181
NR 20
TC 4
Z9 4
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 17
PY 2012
VL 7
IS 1
AR e30336
DI 10.1371/journal.pone.0030336
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 907XU
UT WOS:000301454400116
PM 22272338
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Bernstein, J
   Long, JS
   Veillette, C
   Ahn, J
AF Bernstein, Joseph
   Long, Joy S.
   Veillette, Christian
   Ahn, Jaimo
TI Crowd Intelligence for the Classification of Fractures and Beyond
SO PLOS ONE
LA English
DT Article
ID FEMORAL-NECK FRACTURES
AB Background: Medical diagnosis, like all products of human cognition, is subject to error. We tested the hypothesis that errors of diagnosis in the realm of fracture classification can be reduced by a consensus (group) diagnosis; and that digital imaging and Internet access makes feasible the compilation of a diagnostic consensus in real time.
   Methods: Twelve orthopaedic surgeons were asked to evaluate 20 hip radiographs demonstrating a femoral neck fracture. The surgeons were asked to determine if the fractures were displaced or not. Because no reference standard is available, the maximal accuracy of the diagnosis of displacement can be inferred from inter-observer reliability: if two readers disagree about displacement, one of them must be wrong. That method was employed here. Additionally, virtual reader groups of 3 and 5 individual members were amalgamated, with the response of those groups defined by majority vote. The purpose of this step was to see if increasing the number of readers would improve accuracy. In a second experiment, to study the feasibility of amassing a reader group on the Internet in real time, 40 volunteers were sent 10 periodic email requests to answer questions and their response times were assessed.
   Results: The mean kappa coefficient for individual inter-observer reliability for the diagnosis of displacement was 0.69, comparable to prior published values. For 3-member virtual reader groups, inter-observer reliability was 0.77; and for 5-member groups, it was 0.80. In the experiment studying the feasibility of amassing a reader group in real time, the mean response time was 594 minutes. For all cases, a 9-member group (theoretically 99% accurate) was amassed in 135.8 minutes or less.
   Conclusions: Consensus may improve diagnosis. Amassing a group for this purpose on the Internet is feasible.
C1 [Bernstein, Joseph] Vet Hosp, Dept Orthoped Surg, Philadelphia, PA USA.
   [Bernstein, Joseph; Long, Joy S.; Ahn, Jaimo] Univ Penn, Sch Med, Dept Orthoped Surg, Philadelphia, PA 19104 USA.
   [Veillette, Christian] Univ Toronto, Dept Orthoped Surg, Toronto, ON, Canada.
RP Bernstein, J (reprint author), Vet Hosp, Dept Orthoped Surg, Philadelphia, PA USA.
EM orthodoc@uphs.upenn.edu
FU Orthopaedic Trauma Association; Orthopaedic Research and Education
   Foundation
FX This study was funded, in part, by research grants from the Orthopaedic
   Trauma Association (to JA, JB, CV) and the Orthopaedic Research and
   Education Foundation (to JB). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR BURSTEIN AH, 1993, J BONE JOINT SURG AM, V75A, P1743, DOI 10.2106/00004623-199312000-00001
   Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0
   Garbuz Donald S, 2002, J Am Acad Orthop Surg, V10, P290
   GARDEN RS, 1961, J BONE JOINT SURG BR, V43, P647
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mackay C., 1995, EXTRAORDINARY POPULA
   Oakes DA, 2003, CLIN ORTHOP RELAT R, P232, DOI 10.1097/01.blo.0000059583.08469.e5
   Schmidt Andrew H, 2005, Instr Course Lect, V54, P417
   Surowiecki J., 2004, WISDOM CROWDS WHY MA
   Thomsen NOB, 1996, INT ORTHOP, V20, P326, DOI 10.1007/s002640050087
   Totterman A, 2007, ARCH ORTHOP TRAUM SU, V127, P185, DOI 10.1007/s00402-006-0276-5
   Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147
   Zlowodzki M, 2005, ARCH ORTHOP TRAUM SU, V125, P503, DOI 10.1007/s00402-005-0022-4
NR 13
TC 3
Z9 3
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 23
PY 2011
VL 6
IS 11
AR e27620
DI 10.1371/journal.pone.0027620
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 863KL
UT WOS:000298162000030
PM 22132118
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Carnero-Pardo, C
   Espejo-Martinez, B
   Lopez-Alcalde, S
   Espinosa-Garcia, M
   Saez-Zea, C
   Hernandez-Torres, E
   Navarro-Espigares, JL
   Vilchez-Carrillo, R
AF Carnero-Pardo, Cristobal
   Espejo-Martinez, Beatriz
   Lopez-Alcalde, Samuel
   Espinosa-Garcia, Maria
   Saez-Zea, Carmen
   Hernandez-Torres, Elisa
   Luis Navarro-Espigares, Jose
   Vilchez-Carrillo, Rosa
TI Diagnostic Accuracy, Effectiveness and Cost for Cognitive Impairment and
   Dementia Screening of Three Short Cognitive Tests Applicable to
   Illiterates
SO PLOS ONE
LA English
DT Article
ID MINI-MENTAL-STATE; CLINICAL-DIAGNOSIS; ALZHEIMERS-DISEASE;
   QUESTIONNAIRE; VALIDATION; BATTERY; TOOL
AB Background: Illiteracy, a universal problem, limits the utilization of the most widely used short cognitive tests. Our objective was to assess and compare the effectiveness and cost for cognitive impairment (CI) and dementia (DEM) screening of three short cognitive tests applicable to illiterates.
   Methods: Phase III diagnostic test evaluation study was performed during one year in four Primary Care centers, prospectively including individuals with suspicion of CI or DEM. All underwent the Eurotest, Memory Alteration Test (M@T), and Phototest, applied in a balanced manner. Clinical, functional, and cognitive studies were independently performed in a blinded fashion in a Cognitive Behavioral Neurology Unit, and the gold standard diagnosis was established by consensus of expert neurologists on the basis of these results. Effectiveness of tests was assessed as the proportion of correct diagnoses (diagnostic accuracy [DA]) and the kappa index of concordance (k) with respect to gold standard diagnoses. Costs were based on public prices at the time and hospital accounts.
   Results: The study included 139 individuals: 47 with DEM, 36 with CI, and 56 without CI. No significant differences in effectiveness were found among the tests. For DEM screening: Eurotest (k = 0.71 [0.59-0.83], DA = 0.87 [0.80-0.92]), M@T (k = 0.72 [0.60-0.84], DA = 0.87 [0.80-0.92]), Phototest (k = 0.70 [0.57-0.82], DA = 0.86 [0.79-0.91]). For CI screening: Eurotest (k = 0.67 [0.55-0.79]; DA = 0.83 [0.76-0.89]), M@T (k = 0.52 [0.37-0.67]; DA = 0.80 [0.72-0.86]), Phototest (k = 0.59 [0.46-0.72]; DA = 0.79 [0.71-0.86]). There were no differences in the cost of DEM screening, but the cost of CI screening was significantly higher with M@T (330.7 +/- 177.1(sic), mean +/- sd) than with Eurotest (294.1 +/- 195.0(sic)) or Phototest (296.0 +/- 196.5(sic)). Application time was shorter with Phototest (2.8 +/- 0.8 min) than with Eurotest (7.1 +/- 1.8 min) or M@T (6.8 +/- 2.2 min).
   Conclusions: Eurotest, M@T, and Phototest are equally effective. Eurotest and Phototest are both less expensive options but Phototest is the most efficient, requiring the shortest application time.
C1 [Carnero-Pardo, Cristobal; Lopez-Alcalde, Samuel; Espinosa-Garcia, Maria; Saez-Zea, Carmen; Vilchez-Carrillo, Rosa] Hosp Univ Virgen Nieves, Serv Neurol, Granada, Spain.
   [Carnero-Pardo, Cristobal; Espinosa-Garcia, Maria] FIDYAN Neuroctr, Granada, Spain.
   [Espejo-Martinez, Beatriz] Complejo Hosp La Mancha Ctr, Serv Neurol, Alcazar De San Juan, Spain.
   [Saez-Zea, Carmen] Univ Jaen, Dept Psicol, Jaen, Spain.
   [Hernandez-Torres, Elisa; Luis Navarro-Espigares, Jose] Hosp Univ Virgen Nieves, Subdirecc Control Gest, Granada, Spain.
RP Carnero-Pardo, C (reprint author), Hosp Univ Virgen Nieves, Serv Neurol, Granada, Spain.
EM ccarnero@neurocenter.es
RI Navarro Espigares, Jose Luis/L-7643-2014; Carnero-Pardo,
   Cristobal/I-6777-2018
OI Navarro Espigares, Jose Luis/0000-0003-3509-7810; Carnero-Pardo,
   Cristobal/0000-0003-3415-6727; Saez Zea, Carmen/0000-0003-3719-4948;
   HERNANDEZ-TORRES, ELISA/0000-0002-7266-7408
FU Carlos III National Health Research Institute [PI06/90034]
FX Funding was provided by the Carlos III National Health Research
   Institute (grant PI06/90034). The funder had no role in the study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Basil R., 2005, PRACTICAL NEUROLOGY, V5, P298, DOI DOI 10.1111/J.1474-7766.2005.00333.X
   Boada M, 2002, NEUROLOGIA, V17, P317
   Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6
   Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41
   Bossuyt PM, 2006, BRIT MED J, V332, P1089, DOI 10.1136/bmj.332.7549.1089
   Brodaty H, 2006, AM J GERIAT PSYCHIAT, V14, P391, DOI 10.1097/01.JGP.0000216181.20416.b2
   Brodaty H, 2002, J AM GERIATR SOC, V50, P530, DOI 10.1046/j.1532-5415.2002.50122.x
   Buschke H, 1999, NEUROLOGY, V52, P231, DOI 10.1212/WNL.52.2.231
   Carnero-Pardo C, 2007, NEUROLOGIA, V22, P860
   Carnero-Pardo C, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-15
   Carnero-Pardo C, 2004, REV NEUROLOGIA, V39, P801, DOI 10.33588/rn.3909.2004095
   Carnero-Pardo C, 2011, NEUROLOGIA, V26, P20, DOI 10.1016/j.nrl.2010.09.021
   Carnero-Pardo C, 2004, REV NEUROLOGIA, V38, P201, DOI 10.33588/rn.3803.2003489
   Carnero-Pardo C, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-92
   CARNEROPARDO C, 2011, NEUROLOGIA
   CARNEROPARDO C, 2009, ALZH REAL INVEST DEM, V42, P14
   CARNEROPARDO C, 2005, THESIS U GRANADA GRA
   *CONS EC INN CIENC, 2001, CENS POBL
   de Yebenes MJG, 2003, INT J GERIATR PSYCH, V18, P925, DOI 10.1002/gps.947
   Deveugele M, 2002, BRIT MED J, V325, P472, DOI 10.1136/bmj.325.7362.472
   *EPT MON REP TEAM, 2010, REP 2010 REACH MARG
   Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Gold MR, 1996, COST EFFECTIVENESS H
   Hall KS, 2000, INT J GERIATR PSYCH, V15, P521, DOI 10.1002/1099-1166(200006)15:6<521::AID-GPS182>3.0.CO;2-F
   HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233
   Ismail Z, 2010, INT J GERIATR PSYCH, V25, P111, DOI 10.1002/gps.2306
   Iturra-Mena Ann Mary, 2007, Rev. chil. neuro-psiquiatr., V45, P296, DOI 10.4067/S0717-92272007000400005
   Kutner M., 2007, 2007480 NCES
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9
   Lonie JA, 2009, INT J GERIATR PSYCH, V24, P902, DOI 10.1002/gps.2208
   MAHONEY F I, 1965, Md State Med J, V14, P61
   Mathuranath PS, 2000, NEUROLOGY, V55, P1613
   Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014
   Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x
   PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323
   PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x
   Prince M, 2000, INT J GERIATR PSYCH, V15, P14, DOI 10.1002/(SICI)1099-1166(200001)15:1<14::AID-GPS70>3.0.CO;2-8
   Prince M, 2011, INT J GERIATR PSYCH, V26, P899, DOI 10.1002/gps.2622
   Rami L, 2007, INT J GERIATR PSYCH, V22, P294, DOI 10.1002/gps.1672
   Rami L, 2010, ARCH GERONTOL GERIAT, V50, P171, DOI 10.1016/j.archger.2009.03.005
   Robles A, 2002, NEUROLOGIA, V17, P17
   Rosselli D, 2000, REV NEUROLOGIA, V30, P428, DOI 10.33588/rn.3005.99125
   Sackett DL, 2002, BRIT MED J, V324, P539, DOI 10.1136/bmj.324.7336.539
   Saez-Zea C, 2008, NEUROLOGIA, V23, P356
   Scazufca M, 2009, EUR ARCH PSY CLIN N, V259, P8, DOI 10.1007/s00406-008-0827-6
   Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.3.CO;2-L
   Solomon PR, 1998, ARCH NEUROL-CHICAGO, V55, P349, DOI 10.1001/archneur.55.3.349
   Storey JE, 2004, INT PSYCHOGERIATR, V16, P13, DOI 10.1017/S1041610204000043
   *US FDA, 2003, STAT GUID REP RES ST
   Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25
NR 53
TC 19
Z9 19
U1 1
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 2
PY 2011
VL 6
IS 11
AR e27069
DI 10.1371/journal.pone.0027069
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 849WB
UT WOS:000297154900070
PM 22073256
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Nogaro, SI
   Hafalla, JC
   Walther, B
   Remarque, EJ
   Tetteh, KKA
   Conway, DJ
   Riley, EM
   Walther, M
AF Nogaro, Sarah I.
   Hafalla, Julius C.
   Walther, Brigitte
   Remarque, Edmond J.
   Tetteh, Kevin K. A.
   Conway, David J.
   Riley, Eleanor M.
   Walther, Michael
TI The Breadth, but Not the Magnitude, of Circulating Memory B Cell
   Responses to P. falciparum Increases with Age/Exposure in an Area of Low
   Transmission
SO PLOS ONE
LA English
DT Article
ID MEROZOITE SURFACE PROTEIN-1; APICAL MEMBRANE ANTIGEN-1; MALARIA-ENDEMIC
   AREA; PLASMODIUM-FALCIPARUM; SERUM ANTIBODIES; ACQUIRED-IMMUNITY;
   NATURAL-SELECTION; GAMBIAN CHILDREN; INDIVIDUALS; RECOGNITION
AB Background: Malaria caused by Plasmodium falciparum remains a major cause of death in sub-Saharan Africa. Immunity against symptoms of malaria requires repeated exposure, suggesting either that the parasite is poorly immunogenic or that the development of effective immune responses to malaria may be impaired.
   Methods: We carried out two age-stratified cross-sectional surveys of anti-malarial humoral immune responses in a Gambian village where P. falciparum malaria transmission is low and sporadic. Circulating antibodies and memory B cells (MBC) to four malarial antigens were measured using ELISA and cultured B cell ELISpot.
   Findings and Conclusions: The proportion of individuals with malaria-specific MBC and antibodies, and the average number of antigens recognised by each individual, increased with age but the magnitude of these responses did not. Malaria-specific antibody levels did not correlate with either the prevalence or median number of MBC, indicating that these two assays are measuring different aspects of the humoral immune response. Among those with immunological evidence of malaria exposure (defined as a positive response to at least one malarial antigen either by ELISA or ELISPOT), the median number of malaria-specific MBC was similar to median numbers of diphtheria-specific MBC, suggesting that the circulating memory cell pool for malaria antigens is of similar size to that for other antigens.
C1 [Nogaro, Sarah I.; Walther, Brigitte; Conway, David J.; Walther, Michael] MRC Labs, Banjul, Gambia.
   [Nogaro, Sarah I.; Hafalla, Julius C.; Riley, Eleanor M.] London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, London WC1, England.
   [Remarque, Edmond J.] Biomed Primate Res Ctr, Dept Parasitol, Gj Rijswijk, Netherlands.
   [Tetteh, Kevin K. A.; Conway, David J.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, Fac Infect & Trop Dis, London WC1, England.
RP Nogaro, SI (reprint author), MRC Labs, Banjul, Gambia.
EM Michael.Walther@nih.gov
RI Riley, Eleanor/C-8960-2013
OI Riley, Eleanor/0000-0003-3447-3570; Conway, David/0000-0002-8711-3037
FU Medical Research Council (UK), The Gambia; Wellcome Trust [079920];
   Royal Society (UK); Medical Research Council [MC_U190081993,
   MC_U190081986, MC_U190097907]
FX This work was funded by the Medical Research Council (UK), The Gambia.
   J.C.H. was a recipient of a Wellcome Trust Visiting Fellowship (grant
   reference number 079920) and is currently supported by a University
   Research Fellowship from The Royal Society (UK). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Achtman AH, 2005, CURR TOP MICROBIOL, V297, P71
   Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07
   Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358
   BURGHAUS PA, 1994, MOL BIOCHEM PARASIT, V67, P343, DOI 10.1016/0166-6851(94)90026-4
   Cavanagh DR, 1998, J IMMUNOL, V161, P347
   Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2
   Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242
   Chelimo K, 2005, PEDIATR INFECT DIS J, V24, P680, DOI 10.1097/01.inf.0000172151.28851.fd
   Clarke SE, 2002, T ROY SOC TROP MED H, V96, P499, DOI 10.1016/S0035-9203(02)90419-0
   Cockburn IA, 2007, CURR OPIN IMMUNOL, V19, P424, DOI 10.1016/j.coi.2007.05.008
   COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0
   Conway DJ, 1997, PARASITOL TODAY, V13, P26, DOI 10.1016/S0169-4758(96)10077-6
   Crompton PD, 2009, J IMMUNOL, V182, P3318, DOI 10.4049/jimmunol.0803596
   Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969
   Crotty S, 2004, SEMIN IMMUNOL, V16, P197, DOI 10.1016/j.smim.2004.02.008
   Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015
   Donati D, 2004, INFECT IMMUN, V72, P5412, DOI 10.1128/IAI.72.9.5412-5418.2004
   Dorfman JR, 2005, J INFECT DIS, V191, P1623, DOI 10.1086/429671
   Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102
   Egan A, 1997, INFECT IMMUN, V65, P3024
   EGAN AF, 1995, INFECT IMMUN, V63, P456
   Finney OC, 2009, EUR J IMMUNOL, V39, P1288, DOI 10.1002/eji.200839112
   Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218
   Gomez-Escobar N, 2010, J INFECT DIS, V201, P444, DOI 10.1086/649902
   GREENWOOD BM, 1974, LANCET, V1, P435
   GREENWOOD BM, 1975, NATURE, V257, P592, DOI 10.1038/257592a0
   Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001
   Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683
   Okech BA, 2004, INFECT IMMUN, V72, P1557, DOI 10.1128/IAI.72.3.1557-1567.2004
   OSIER FH, 2011, INFECT IMMU IN PRESS, P1
   Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030
   Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806
   RAMASAMY R, 1994, AM J TROP MED HYG, V50, P537, DOI 10.4269/ajtmh.1994.50.537
   Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08
   SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297
   Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274
   Schofield L, 2006, CURR MOL MED, V6, P205, DOI 10.2174/156652406776055221
   SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B
   Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x
   Taylor RR, 1996, INT IMMUNOL, V8, P905, DOI 10.1093/intimm/8.6.905
   THOMSON MC, 1994, T ROY SOC TROP MED H, V88, P638, DOI 10.1016/0035-9203(94)90204-6
   Traore B, 2009, VACCINE, V27, P7299, DOI 10.1016/j.vaccine.2009.08.023
   Udhayakumar V, 2001, AM J TROP MED HYG, V65, P100, DOI 10.4269/ajtmh.2001.65.100
   UNICEF, 2011, INF COUNTR
   Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364
   Weiss GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015983
   Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912
   Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297
   WHITTLE HC, 1990, CLIN EXP IMMUNOL, V80, P213
   WHO/UNICEF, 2009, REV NAT IMM COV 1980
   Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770
NR 53
TC 44
Z9 44
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 4
PY 2011
VL 6
IS 10
AR e25582
DI 10.1371/journal.pone.0025582
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 834MB
UT WOS:000295963300013
PM 21991321
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-07-16
ER

PT J
AU Taneja, N
   Nato, F
   Dartevelle, S
   Sire, JM
   Garin, B
   Lan, NTP
   Diep, TT
   Shako, JC
   Bimet, F
   Filliol, I
   Muyembe, JJ
   Ungeheuer, MN
   Ottone, C
   Sansonetti, P
   Germani, Y
AF Taneja, Neelam
   Nato, Faridabano
   Dartevelle, Sylvie
   Sire, Jean Marie
   Garin, Benoit
   Lan Nguyen Thi Phuong
   Tai The Diep
   Shako, Jean Christophe
   Bimet, Francois
   Filliol, Ingrid
   Muyembe, Jean-Jacques
   Ungeheuer, Marie Noelle
   Ottone, Catherine
   Sansonetti, Philippe
   Germani, Yves
TI Dipstick Test for Rapid Diagnosis of Shigella dysenteriae 1 in Bacterial
   Cultures and Its Potential Use on Stool Samples
SO PLOS ONE
LA English
DT Article
ID ENTEROINVASIVE ESCHERICHIA-COLI; SHIGA-BACILLUS DYSENTERY; B-CELL
   EPITOPES; ANTIMICROBIAL RESISTANCE; CONJUGATE VACCINES; VIBRIO-CHOLERAE;
   CENTRAL-AMERICA; EPIDEMIC; TYPE-1; FLEXNERI
AB Background: We describe a test for rapid detection of S. dysenteriae 1 in bacterial cultures and in stools, at the bedside of patients.
   Methodology/Principal Findings: The test is based on the detection of S. dysenteriae 1 lipopolysaccharide (LPS) using serotype 1-specific monoclonal antibodies coupled to gold particles and displayed on a one-step immunochromatographic dipstick. A concentration as low as 15 ng/ml of LPS was detected in distilled water and in reconstituted stools in 10 minutes. In distilled water and in reconstituted stools, an unequivocal positive reaction was obtained with 1.6x10(6) CFU/ml and 4.9x10(6) CFU/ml of S. dysenteriae 1, respectively. Optimal conditions to read the test have been determined to limit the risk of ambiguous results due to appearance of a faint yellow test band in some negative samples. The specificity was 100% when tested with a battery of Shigella and unrelated strains in culture. When tested on 328 clinical samples in India, Vietnam, Senegal and France by laboratory technicians and in Democratic Republic of Congo by a field technician, the specificity (312/316) was 98.7% (95% CI: 96.6-99.6%) and the sensitivity (11/12) was 91.7% (95% CI: 59.8-99.6%). Stool cultures and the immunochromatographic test showed concordant results in 98.4 % of cases (323/328) in comparative studies. Positive and negative predictive values were 73.3% (95% CI: 44.8-91.1%) and 99.7% (95% CI: 98-100%).
   Conclusion: The initial findings presented here for a simple dipstick-based test to diagnose S. dysenteriae 1 demonstrates its promising potential to become a powerful tool for case management and epidemiological surveys.
C1 [Taneja, Neelam] Postgrad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh 160012, India.
   [Sire, Jean Marie; Garin, Benoit] Inst Pasteur, Med Biol Lab, Dakar, Senegal.
   [Lan Nguyen Thi Phuong; Tai The Diep] Pasteur Inst Ho Chi Minh City, Dept Immunol & Microbiol, Ho Chi Minh City, Vietnam.
   [Bimet, Francois] Inst Pasteur, Ctr Ressources Biol, Paris, France.
   [Shako, Jean Christophe] Antenne Med Bunia, Bunia, Zaire.
   [Filliol, Ingrid] Inst Pasteur, Ctr Natl Reference Escherichia Coli & Shigella, Unite Rech & Expertise Bacteries Pathogenes Enter, Paris, France.
   [Muyembe, Jean-Jacques] Inst Natl Rech Biomed, Kinshasa, Zaire.
   [Sansonetti, Philippe; Germani, Yves] Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France.
   [Germani, Yves] BioSpeedia Soc Act Simplifee, Orsay, France.
RP Taneja, N (reprint author), Postgrad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh 160012, India.
EM ygermani@pasteur.fr
FU Institute Pasteur [PTR 179]; TOTAL Societe Anonyme
FX This work was supported by the Institute Pasteur (grant PTR 179).
   Additionally, part of the work was supported by a grant from TOTAL
   Societe Anonyme (http://www.total.com/en/home-page-940596.html). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Agtini MD, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-89
   BARZU S, 1993, INFECT IMMUN, V61, P3825
   BENNISH ML, 1990, NEW ENGL J MED, V322, P1357, DOI 10.1056/NEJM199005103221905
   BENNISH ML, 1992, CLIN INFECT DIS, V14, P1055, DOI 10.1093/clinids/14.5.1055
   BENNISH ML, 1991, REV INFECT DIS, V13, pS245
   BLACK RE, 1986, DEV VACCINES DRUGS D, P23
   Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1
   BRENNER DJ, 1984, INT J SYST BACTERIOL, V34, P87, DOI 10.1099/00207713-34-1-87
   Chanteau S, 2003, LANCET, V361, P211, DOI 10.1016/S0140-6736(03)12270-2
   Chanteau S, 2006, PLOS MED, V3, P1579, DOI 10.1371/journal.pmed.0030337
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Dutta P, 1995, Indian Pediatr, V32, P313
   Dykman LA, 2000, FEMS IMMUNOL MED MIC, V27, P135, DOI 10.1016/S0928-8244(99)00178-9
   ECHEVERRIA P, 1991, REV INFECT DIS, V13, P220
   Engels D, 1995, B WORLD HEALTH ORGAN, V73, P787
   Feng L, 2007, MICROBIOL-SGM, V153, P139, DOI 10.1099/mic.0.2006/001107-0
   Germani Y, 1998, AM J TROP MED HYG, V59, P1008, DOI 10.4269/ajtmh.1998.59.1008
   Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X
   Guerin PJ, 2003, LANCET, V362, P705, DOI 10.1016/S0140-6736(03)14227-4
   IIJIMA Y, 1995, LANCET, V345, P69, DOI 10.1016/S0140-6736(95)91197-9
   JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703
   Kalluri P, 2006, TROP MED INT HEALTH, V11, P49, DOI 10.1111/j.1365-3156.2005.01539.x
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Legros D, 1999, TROP MED INT HEALTH, V4, P428, DOI 10.1046/j.1365-3156.1999.00413.x
   LINDBERG AA, 1991, REV INFECT DIS, V13, pS279
   MATA LJ, 1970, J INFECT DIS, V122, P170, DOI 10.1093/infdis/122.3.170
   MENDIZAB.CA, 1971, AM J TROP MED HYG, V20, P927, DOI 10.4269/ajtmh.1971.20.927
   Nato F, 2003, CLIN DIAGN LAB IMMUN, V10, P476, DOI 10.1128/CDLI.10.3.476-478.2003
   Nato F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000361
   Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E
   Niyogi SK, 2003, JPN J INFECT DIS, V56, P33
   Paek SH, 2000, METHODS, V22, P53, DOI 10.1006/meth.2000.1036
   Passwell JH, 2001, INFECT IMMUN, V69, P1351, DOI 10.1128/IAI.69.3.1351-1357.2001
   Pazhani GP, 2004, ANTIMICROB AGENTS CH, V48, P681, DOI 10.1128/AAC.48.2.681-684.2004
   Peruski AH, 2003, CLIN DIAGN LAB IMMUN, V10, P506, DOI 10.1128/CDLI.10.4.506-513.2003
   PHALIPON A, 1992, INFECT IMMUN, V60, P1919
   POLLARD DR, 1990, J CLIN MICROBIOL, V28, P540
   Ricci Karen A, 2006, Nature, V444 Suppl 1, P29
   RIES AA, 1994, J INFECT DIS, V169, P1035, DOI 10.1093/infdis/169.5.1035
   Rollins NC, 1995, J TROP PEDIATRICS, V41, P281, DOI 10.1093/tropej/41.5.281
   RONSMANS C, 1988, LANCET, V2, P552
   Sansonetti PJ, 1999, CLIN INFECT DIS, V28, P466, DOI 10.1086/515150
   SETHABUTR O, 1993, J INFECT DIS, V167, P458, DOI 10.1093/infdis/167.2.458
   Szakal D, 2003, DIAGN MICR INFEC DIS, V45, P165, DOI 10.1016/S0732-8893(02)00512-6
   Taneja N, 2007, J CLIN MICROBIOL, V45, P678, DOI 10.1128/JCM.02247-06
   TAYLOR DN, 1993, INFECT IMMUN, V61, P3678
   TOOLE MJ, 1995, LANCET, V345, P339
   Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448
   Wang XY, 2005, AM J TROP MED HYG, V73, P416, DOI 10.4269/ajtmh.2005.73.416
   WANG XY, 2006, BMC INFECT DIS, V1, P6
   Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83
   2005, WHO WEEKLY EPIDEMIOL, V80, P93
   1994, MMWR MORB MORTAL WKL, V43, P701
NR 55
TC 7
Z9 7
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 3
PY 2011
VL 6
IS 10
AR e24830
DI 10.1371/journal.pone.0024830
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 834EU
UT WOS:000295943000005
PM 21984895
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Mbaye, PS
   Sarr, A
   Sire, JM
   Evra, ML
   Ba, A
   Daveiga, J
   Diallo, A
   Fall, F
   Chartier, L
   Simon, F
   Vray, M
AF Mbaye, Papa Saliou
   Sarr, Anna
   Sire, Jean-Marie
   Evra, Marie-Louise
   Ba, Adama
   Daveiga, Jean
   Diallo, Aboubakry
   Fall, Fatou
   Chartier, Loic
   Simon, Francois
   Vray, Muriel
TI Liver Stiffness Measurement and Biochemical Markers in Senegalese
   Chronic Hepatitis B Patients with Normal ALT and High Viral Load
SO PLOS ONE
LA English
DT Article
ID BLOOD-TESTS; TRANSIENT ELASTOGRAPHY; NONINVASIVE ASSESSMENT; PREDICTIVE
   MODEL; FIBROSIS; BIOPSY; VIRUS; INFECTION; DIAGNOSIS; TRANSAMINASES
AB Background and Aims: Despite the high prevalence of chronic hepatitis B (CHB) in Africa, few studies have been performed among African patients. We sought to evaluate liver stiffness measurement by FibroScan (R) (LSM) and two biochemical scores (FibroTest (R), Fibrometer (R)) to diagnose liver fibrosis in Senegalese CHB patients with HBV plasma DNA load >= 3.2 log(10) IU/mL and normal alanine aminotransferase (ALT) values.
   Methods: LSM and liver fibrosis biochemical markers were performed on 225 consecutive HBV infected Senegalese patients with high viral load. Patients with an LSM range between 7 and 13 kPa underwent liver biopsy (LB). Two experienced liver pathologists performed histological grading using Metavir and Ishak scoring.
   Results: 225 patients were evaluated (84% male) and LB was performed in 69 patients, showing F2 and F3 fibrosis in 17% and 10% respectively. In these patients with a 7-13 kPa range of LSM, accuracy for diagnosis of significant fibrosis according to LB was unsatisfactory for all non-invasive markers with AUROCs below 0.70. For patients with LSM values below 7 kPa, FibroTest (R) (FT), and Fibrometer (R) (FM) using the cut-offs recommended by the test promoters suggested a fibrosis in 18% of cases for FT (8% severe fibrosis) and 8% for FM. For patients with LSM values greater than 13 kPa, FT, FM suggested a possible fibrosis in 73% and 70%, respectively.
   Conclusion: In highly replicative HBV-infected African patients with normal ALT and LSM value below 13 kPa, FibroScan (R), FibroTest (R) or Fibrometer (R) were unsuitable to predict the histological liver status of fibrosis.
C1 [Mbaye, Papa Saliou; Ba, Adama; Fall, Fatou] Principal Hosp, Dept Gastroenterol & Hepatol, Dakar, Senegal.
   [Sarr, Anna; Evra, Marie-Louise] Abass Ndao Hosp, Dept Gastroenterol & Hepatol, Dakar, Senegal.
   [Sire, Jean-Marie; Simon, Francois] Univ Med Paris Diderot, St Louis Hosp, INSERM, U941, Paris, France.
   [Sire, Jean-Marie] Inst Pasteur, Med Lab, Dakar, Senegal.
   [Daveiga, Jean] St Jean Dieu Hosp, Dept Gastroenterol & Hepatol, Thies, Senegal.
   [Diallo, Aboubakry] Grand Yoff Hosp, Dept Gastroenterol & Hepatol, Dakar, Senegal.
   [Chartier, Loic; Vray, Muriel] Inst Pasteur, INSERM, Epidemiol Unit Infect Dis, F-75724 Paris, France.
RP Mbaye, PS (reprint author), Principal Hosp, Dept Gastroenterol & Hepatol, Dakar, Senegal.
EM vray@pasteur.fr
RI Vray, Muriel/M-7947-2018
FU ANRS (National Institute of Research on AIDS and Viral Hepatitis)
FX The ANRS (National Institute of Research on AIDS and Viral Hepatitis)
   funded this study. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389
   Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201
   Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022
   Bonnard P, 2010, AM J TROP MED HYG, V82, P454, DOI 10.4269/ajtmh.2010.09-0088
   Boursier J, 2009, LIVER INT, V29, P1507, DOI 10.1111/j.1478-3231.2009.02101.x
   Boursier J, 2009, EUR J GASTROEN HEPAT, V21, P28, DOI [10.1097/MEG.0b013e32830cebd7, 10.1097/MEG-0b013e32830cebd7]
   Cadranel JF, 2000, HEPATOLOGY, V32, P477, DOI 10.1053/jhep.2000.16602
   Cales P, 2005, HEPATOLOGY, V42, P1373, DOI 10.1002/hep.20935
   Cales P, 2008, LIVER INT, V28, P1352, DOI 10.1111/j.1478-3231.2008.01789.x
   Castera L, 1999, HEPATOLOGY, V30, P1529, DOI 10.1002/hep.510300624
   Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008
   Castera L, 2009, J VIRAL HEPATITIS, V16, P300, DOI 10.1111/j.1365-2893.2009.01087.x
   de Ledinghen V, 2008, GASTROEN CLIN BIOL, V32, pS90, DOI 10.1016/S0399-8320(08)73271-8
   DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
   Diallo Sall, 2004, DAKAR MED, V49, P136
   Fung J, 2008, LIVER INT, V28, P1408, DOI 10.1111/j.1478-3231.2008.01784.x
   Ganne-Carrie N, 2006, J MED VIROL, V78, P335, DOI 10.1002/jmv.20545
   Halfon P, 2007, J HEPATOL, V46, P395, DOI 10.1016/j.jhep.2006.09.020
   Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6
   Lai CL, 2007, J VIRAL HEPATITIS, V14, P6, DOI 10.1111/j.1365-2893.2007.00909.x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x
   Leroy V, 2007, J HEPATOL, V46, P775, DOI 10.1016/j.jhep.2006.12.013
   Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x
   McMahon Brian J, 2008, Medscape J Med, V10, P91
   Nousbaum JB, 2002, GASTROEN CLIN BIOL, V26, P848
   Oliveri F, 2008, WORLD J GASTROENTERO, V14, P6154, DOI 10.3748/wjg.14.6154
   Poynard T, 2004, CLIN CHEM, V50, P1344, DOI 10.1373/clinchem.2004.032227
   Poynard T, 2008, ADV CLIN CHEM, V46, P131, DOI 10.1016/S0065-2423(08)00404-6
   Regev A, 2002, AM J GASTROENTEROL, V97, P2614
   Sebastian G, 2008, J VIRAL HEPATITIS, V15, P212, DOI 10.1111/j.1365-2893.2007.00932.x
   Sebastiani G, 2007, WORLD J GASTROENTERO, V13, P525, DOI 10.3748/wjg.v13.i4.525
   Vray M, 2006, J MED VIROL, V78, P329, DOI 10.1002/jmv.20544
   Wu SD, 2010, WORLD J GASTROENTERO, V16, P501, DOI 10.3748/wjg.v16.i4.501
   Zeng MD, 2005, HEPATOLOGY, V42, P1437, DOI 10.1002/hep.20960
   Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506
   2009, J HEPATOL, V50, P227
   2009, HEPATOLOGY, V50, P1
NR 38
TC 16
Z9 16
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 25
PY 2011
VL 6
IS 7
AR e22291
DI 10.1371/journal.pone.0022291
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 798AP
UT WOS:000293172900020
PM 21799814
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Boillot, A
   El Halabi, B
   Batty, GD
   Range, H
   Czernichow, S
   Bouchard, P
AF Boillot, Adrien
   El Halabi, Bechara
   Batty, George David
   Range, Helene
   Czernichow, Sebastien
   Bouchard, Philippe
TI Education as a Predictor of Chronic Periodontitis: A Systematic Review
   with Meta-Analysis Population-Based Studies
SO PLOS ONE
LA English
DT Review
ID ORAL-HEALTH; ATTACHMENT LOSS; RISK INDICATORS; OSLO CITIZENS; TOOTH
   LOSS; DISEASE; ADULTS; ASSOCIATION; INEQUALITIES; PERSPECTIVE
AB Background: The impact of socioeconomic inequalities on health is well-documented. Despite the links of periodontal disease with cardiovascular diseases, adverse pregnancy outcomes and diabetes, no meta-analysis of socioeconomic variations in periodontal disease exists. This meta-analytic review was conducted to determine the extent to which education attainment influences risk of periodontitis in adults aged 35+ years in the general population.
   Methods: The authors searched studies published until November 2010 using EMBASE and MEDLINE databases. References listed were then scrutinised, our own files were checked, and, finally, we contacted experts in the field. The authors included only general population-based studies conducted in adults aged 35 years and more. All articles were blind reviewed by two investigators. In the case of disagreement, a third investigator arbitrated. Using PRISMA statement, two reviewers independently extracted papers of interest.
   Results: Relative to the higher education group, people with low education attainment experience a greater risk of periodontitis (OR: 1.86 [1.66-2.10]; p<0.00001). The association was partially attenuated after adjustment for covariates (OR: 1.55 [1.30-1.86]; p<0.00001). Sensitivity analyses showed that methods used to assess periodontitis, definition of cases, study country and categorization of education are largely responsible for the heterogeneity between studies. No significant bias of publication was shown using both the Egger (p = 0.16) and rank correlation tests (p = 0.35).
   Conclusions: In the studies reviewed, low educational attainment was associated with an increased risk of periodontitis. Although this evidence should be cautiously interpreted due to methodological problems in selected studies, efforts to eliminate educational inequalities in periodontitis should focus on early life interventions.
C1 [Boillot, Adrien; El Halabi, Bechara; Range, Helene; Bouchard, Philippe] Univ Paris 07, Rothschild Hosp, AP HP, Dept Periodontol,Serv Odontol,UFR Odontol, Paris, France.
   [Czernichow, Sebastien] Univ Versailles St Quentin, Ambroise Pare Hosp, Dept Nutr, Boulogne, France.
   [Czernichow, Sebastien] Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Villejuif, France.
   [Batty, George David] UCL, Dept Epidemiol & Publ Hlth, London, England.
RP Boillot, A (reprint author), Univ Paris 07, Rothschild Hosp, AP HP, Dept Periodontol,Serv Odontol,UFR Odontol, Paris, France.
EM phbouch@noos.fr
RI Batty, GD/Y-4401-2018
OI Batty, GD/0000-0003-1822-5753; Range, Helene/0000-0002-4761-0805
CR Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219
   Alwaeli H A, 2005, Int J Dent Hyg, V3, P74, DOI 10.1111/j.1601-5037.2005.00121.x
   BECK JD, 1990, J PERIODONTOL, V61, P521, DOI 10.1902/jop.1990.61.8.521
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Bergstrom Jan, 2006, J Evid Based Dent Pract, V6, P33, DOI 10.1016/j.jebdp.2005.12.018
   Borges-Yanez SA, 2004, J CLIN PERIODONTOL, V31, P112
   Borrell LN, 2006, AM J PUBLIC HEALTH, V96, P332, DOI 10.2105/AJPH.2004.055277
   Borrell LN, 2006, J PERIODONTOL, V77, P444, DOI 10.1902/jop.2006.050158
   Brennan DS, 2007, AUST DENT J, V52, P55, DOI 10.1111/j.1834-7819.2007.tb00466.x
   BROWN LF, 1994, J PERIODONTOL, V65, P316, DOI 10.1902/jop.1994.65.4.316
   Cascaes AM, 2009, J CLIN PERIODONTOL, V36, P25, DOI 10.1111/j.1600-051X.2008.01337.x
   Chaffee BW, 2010, J PERIODONTOL, V81, P1708, DOI 10.1902/jop.2010.100321
   Chang-Quan H, 2010, INT J PSYCHIAT MED, V40, P109, DOI 10.2190/PM.40.1.i
   Christensen U, 2006, SCAND J PUBLIC HEALT, V34, P363, DOI 10.1080/14034940500489339
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Conway DI, 2008, INT J CANCER, V122, P2811, DOI 10.1002/ijc.23430
   D'Aiuto F, 2008, J CLIN ENDOCR METAB, V93, P3989, DOI 10.1210/jc.2007-2522
   Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337
   Dietrich T, 2006, J DENT RES, V85, P1134, DOI 10.1177/154405910608501213
   Dolan TA, 1997, J CLIN PERIODONTOL, V24, P223, DOI 10.1111/j.1600-051X.1997.tb01835.x
   Dye BA, 2009, J PERIODONTOL, V80, P634, DOI 10.1902/jop.2009.080474
   Eaton KA, 2001, J PERIODONTOL, V72, P140, DOI 10.1902/jop.2001.72.2.140
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Famili P, 2005, J PERIODONTOL, V76, P11, DOI 10.1902/jop.2005.76.1.11
   Garcia R I, 2001, Ann Periodontol, V6, P71, DOI 10.1902/annals.2001.6.1.71
   Gilbert GH, 2005, J PERIODONTOL, V76, P1161, DOI 10.1902/jop.2005.76.7.1161
   Graham H, 2002, SOC SCI MED, V55, P2005, DOI 10.1016/S0277-9536(01)00343-4
   HANSEN BF, 1993, J CLIN PERIODONTOL, V20, P584, DOI 10.1111/j.1600-051X.1993.tb00775.x
   HANSEN BF, 1995, J PERIODONTAL RES, V30, P410, DOI 10.1111/j.1600-0765.1995.tb01295.x
   HANSEN BF, 1990, J CLIN PERIODONTOL, V17, P249, DOI 10.1111/j.1600-051X.1990.tb00021.x
   Hessari H, 2007, MED PRIN PRACT, V16, P280, DOI 10.1159/000102150
   Hessari H, 2009, ORAL HLTH PREV DENT, V7, P61
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   HUISMAN M, 2011, EUR J PUBLI IN PRESS
   Kavanagh A, 2010, SOC SCI MED, V71, P1150, DOI 10.1016/j.socscimed.2010.05.038
   Kerr GD, 2011, CEREBROVASC DIS, V31, P57, DOI 10.1159/000320855
   Klinge B, 2005, J CLIN PERIODONTOL, V32, P314, DOI 10.1111/j.1600-051X.2005.00801.x
   Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381
   Krustrup U, 2006, ACTA ODONTOL SCAND, V64, P65, DOI 10.1080/00016350500377859
   Lai H, 2007, J CLIN PERIODONTOL, V34, P851, DOI 10.1111/j.1600-051X.2007.01121.x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lang IA, 2008, J PUBLIC HEALTH-UK, V30, P472, DOI 10.1093/pubmed/fdn047
   Lang NP, 1999, ANN PERIODONTOL, V4, P53, DOI DOI 10.1902/ANNALS.1999.4.1.53
   Li Q, 2010, DIABETOLOGIA, V53, P2320, DOI 10.1007/s00125-010-1862-1
   LOCKER D, 1993, J DENT RES, V72, P9, DOI 10.1177/00220345930720011501
   MOHER D, 2009, PLOS MED, V6
   Molarius A, 2000, AM J PUBLIC HEALTH, V90, P1260, DOI 10.2105/AJPH.90.8.1260
   Mucci LA, 2004, AM J EPIDEMIOL, V159, P499, DOI 10.1093/aje/kwh063
   Nicolau B, 2007, J CLIN PERIODONTOL, V34, P844, DOI 10.1111/j.1600-051X.2007.01123.x
   Paulander J, 2004, ACTA ODONTOL SCAND, V62, P199, DOI 10.1080/00016350410001621
   Peres MA, 2007, J CLIN PERIODONTOL, V34, P196, DOI 10.1111/j.1600-051X.2006.01043.x
   Petersen PE, 2000, ACTA ODONTOL SCAND, V58, P243, DOI 10.1080/00016350050217073
   Phipps KR, 2009, GERODONTOLOGY, V26, P122, DOI 10.1111/j.1741-2358.2008.00231.x
   Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8
   Ribet C, 2007, REV EPIDEMIOL SANTE, V55, P285, DOI 10.1016/j.respe.2007.04.001
   Shankar A, 2010, AM J PREV MED, V38, P39, DOI 10.1016/j.amepre.2009.08.026
   TAYLOR GW, 2010, ANN PERIODONTOL, V6, P99
   Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186
   Torrungruang K, 2005, J PERIODONTOL, V76, P558, DOI 10.1902/jop.2005.76.4.558
   Torrungruang K, 2009, J PERIODONTOL, V80, P122, DOI [10.1902/jop.2009.080248, 10.1902/jop.2009.080248 ]
   Tsai C, 2002, COMMUNITY DENT ORAL, V30, P182, DOI 10.1034/j.1600-0528.2002.300304.x
   Watt RG, 2002, COMMUNITY DENT ORAL, V30, P241, DOI 10.1034/j.1600-0528.2002.300401.x
   Wimmer G, 2008, J CLIN PERIODONTOL, V35, P380, DOI 10.1111/j.1600-051X.2008.01284.x
   Zini A, 2011, J CLIN PERIODONTOL, V38, P229, DOI 10.1111/j.1600-051X.2010.01689.x
NR 64
TC 35
Z9 35
U1 0
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 21
PY 2011
VL 6
IS 7
AR e21508
DI 10.1371/journal.pone.0021508
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 795FA
UT WOS:000292956800004
PM 21814546
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Minion, J
   Pai, M
   Ramsay, A
   Menzies, D
   Greenaway, C
AF Minion, Jessica
   Pai, Madhukar
   Ramsay, Andrew
   Menzies, Dick
   Greenaway, Christina
TI Comparison of LED and Conventional Fluorescence Microscopy for Detection
   of Acid Fast Bacilli in a Low-Incidence Setting
SO PLOS ONE
LA English
DT Article
ID SMEAR MICROSCOPY; MYCOBACTERIUM-TUBERCULOSIS; DIAGNOSIS; SPUTUM
AB Introduction: Light emitting diode fluorescence microscopes have many practical advantages over conventional mercury vapour fluorescence microscopes, which would make them the preferred choice for laboratories in both low- and high-resource settings, provided performance is equivalent.
   Methods: In a nested case-control study, we compared diagnostic accuracy and time required to read slides with the Zeiss PrimoStar iLED, LW Scientific Lumin, and a conventional fluorescence microscope (Leica DMLS). Mycobacterial culture was used as the reference standard, and subgroup analysis by specimen source and organism isolated were performed.
   Results: There was no difference in sensitivity or specificity between the three microscopes, and agreement was high for all comparisons and subgroups. The Lumin and the conventional fluorescence microscope were equivalent with respect to time required to read smears, but the Zeiss iLED was significantly time saving compared to both.
   Conclusions: Light emitting diode microscopy should be considered by all tuberculosis diagnostic laboratories, including those in high income countries, as a replacement for conventional fluorescence microscopes. Our findings provide support to the recent World Health Organization policy recommending that conventional fluorescence microscopy be replaced by light emitting diode microscopy using auramine staining in all settings where fluorescence microscopy is currently used.
C1 [Minion, Jessica; Pai, Madhukar; Menzies, Dick] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.
   [Minion, Jessica; Pai, Madhukar; Menzies, Dick] Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada.
   [Minion, Jessica] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.
   [Ramsay, Andrew] WHO, WHO Special Programme Res & Training Trop Dis, World Bank, UNDP,UNICEF, CH-1211 Geneva, Switzerland.
   [Greenaway, Christina] McGill Univ, Jewish Gen Hosp, SMBD, Dept Diagnost Med,Div Infect Dis, Montreal, PQ H3T 1E2, Canada.
RP Minion, J (reprint author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.
EM madhukar.pai@mcgill.ca
OI Pai, Madhukar/0000-0003-3667-4536
FU Canadian Institutes for Health Research [CIHR MOP-89918]; European
   Commission (EU); EDCTP (TB-NEAT); Fonds de Recherche en Sante de Quebec;
   Quebec Respiratory Health Training Fellowship
FX This project was supported in part by grants from the Canadian
   Institutes for Health Research (CIHR MOP-89918), the European Commission
   (EU-FP7; TBSusgent), and the EDCTP (TB-NEAT). MP is supported by a CIHR
   New Investigator Award, DM by a Chercheur-national award, CG by a
   Chercheur Boursier Clinicen award from the Fonds de Recherche en Sante
   de Quebec, and JM by a Quebec Respiratory Health Training Fellowship.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Affolabi D, 2010, INT J TUBERC LUNG D, V14, P160
   Albert H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015206
   Anthony RM, 2006, INT J TUBERC LUNG D, V10, P1060
   BENNEDSEN J, 1966, SCAND J RESPIR DIS, V47, P114
   Bonnet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017214
   *CARL ZEISS MICR G, PRIM STAR ILED
   Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.1093/biomet/26.4.404
   Ellis E, 2010, TUBERCULOSIS CANADA
   Hanscheid T, 2008, T ROY SOC TROP MED H, V102, P520, DOI 10.1016/j.trstmh.2008.02.020
   Isenberg HD, 2004, CLIN MICROBIOLOGY PR
   KUHN, 2010, OPEN MICROBIOLOGY J, V4, P30
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lehman LG, 2010, AM J TROP MED HYG, V83, P906, DOI 10.4269/ajtmh.2010.10-0153
   Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248
   Mase SR, 2007, INT J TUBERC LUNG D, V11, P485
   MINION J, 2009, WHO APPR IMPR SPUT S
   Minion J, 2011, J CLIN MICROBIOL, V49, P2024, DOI 10.1128/JCM.00507-11
   Minion J, 2009, EXPERT REV MED DEVIC, V6, P341, DOI [10.1586/erd.09.26, 10.1586/ERD.09.26]
   Public Health Agency of Canada, 2010, HIV AIDS CAN SURV RE
   Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3
   Shenai S, 2011, INT J TUBERC LUNG D, V15, P483, DOI 10.5588/ijtld.10.0229
   Small PM, 2010, NEW ENGL J MED, V363, P1070, DOI 10.1056/NEJMe1008496
   Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8
   Trusov A, 2009, INT J TUBERC LUNG D, V13, P836
   Van Deun A, 2008, INT J TUBERC LUNG D, V12, P1009
   Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5
   World Health Organization, 2007, US LIQ MED CULT DST
   World Health Organization, 2010, FLUOR LIGHT EM DIOD
   World Health Organization, 2010, GLOB TUB CONTR
NR 29
TC 28
Z9 28
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 21
PY 2011
VL 6
IS 7
AR e22495
DI 10.1371/journal.pone.0022495
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 795FA
UT WOS:000292956800062
PM 21811622
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kim, C
   Ahmed, JA
   Eidex, RB
   Nyoka, R
   Waiboci, LW
   Erdman, D
   Tepo, A
   Mahamud, AS
   Kabura, W
   Nguhi, M
   Muthoka, P
   Burton, W
   Breiman, RF
   Njenga, MK
   Katz, MA
AF Kim, Curi
   Ahmed, Jamal A.
   Eidex, Rachel B.
   Nyoka, Raymond
   Waiboci, Lilian W.
   Erdman, Dean
   Tepo, Adan
   Mahamud, Abdirahman S.
   Kabura, Wamburu
   Nguhi, Margaret
   Muthoka, Philip
   Burton, Wagacha
   Breiman, Robert F.
   Njenga, M. Kariuki
   Katz, Mark A.
TI Comparison of Nasopharyngeal and Oropharyngeal Swabs for the Diagnosis
   of Eight Respiratory Viruses by Real-Time Reverse Transcription-PCR
   Assays
SO PLOS ONE
LA English
DT Article
ID POLYMERASE-CHAIN-REACTION; CHILDREN; INFECTIONS; SPECIMENS; H5N1
AB Background: Many acute respiratory illness surveillance systems collect and test nasopharyngeal (NP) and/or oropharyngeal (OP) swab specimens, yet there are few studies assessing the relative measures of performance for NP versus OP specimens.
   Methods: We collected paired NP and OP swabs separately from pediatric and adult patients with influenza-like illness or severe acute respiratory illness at two respiratory surveillance sites in Kenya. The specimens were tested for eight respiratory viruses by real-time reverse transcription-polymerase chain reaction (qRT-PCR). Positivity for a specific virus was defined as detection of viral nucleic acid in either swab.
   Results: Of 2,331 paired NP/OP specimens, 1,402 (60.1%) were positive for at least one virus, and 393 (16.9%) were positive for more than one virus. Overall, OP swabs were significantly more sensitive than NP swabs for adenovirus (72.4% vs. 57.6%, p < 0.01) and 2009 pandemic influenza A (H1N1) virus (91.2% vs. 70.4%, p < 0.01). NP specimens were more sensitive for influenza B virus (83.3% vs. 61.5%, p = 0.02), parainfluenza virus 2 (85.7%, vs. 39.3%, p < 0.01), and parainfluenza virus 3 (83.9% vs. 67.4%, p < 0.01). The two methods did not differ significantly for human metapneumovirus, influenza A (H3N2) virus, parainfluenza virus 1, or respiratory syncytial virus.
   Conclusions: The sensitivities were variable among the eight viruses tested; neither specimen was consistently more effective than the other. For respiratory disease surveillance programs using qRT-PCR that aim to maximize sensitivity for a large number of viruses, collecting combined NP and OP specimens would be the most effective approach.
C1 [Kim, Curi; Erdman, Dean] US Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Ahmed, Jamal A.; Eidex, Rachel B.; Nyoka, Raymond; Waiboci, Lilian W.; Tepo, Adan; Mahamud, Abdirahman S.; Breiman, Robert F.; Njenga, M. Kariuki; Katz, Mark A.] Ctr Dis Control & Prevent Kenya, Nairobi, Kenya.
   [Kabura, Wamburu] Kenya Govt Med Res Ctr, Nairobi, Kenya.
   [Nguhi, Margaret] Int Rescue Comm, Nairobi, Kenya.
   [Muthoka, Philip] Minist Publ Hlth & Sanitat, Nairobi, Kenya.
   [Burton, Wagacha] United Nations High Commissioner Refugees, Nairobi, Kenya.
RP Kim, C (reprint author), US Ctr Dis Control & Prevent, Atlanta, GA USA.
EM mkatz@ke.cdc.gov
CR Beigel H, 2005, NEW ENGL J MED, V353, P1374
   Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003
   Covalciuc KA, 1999, J CLIN MICROBIOL, V37, P3971
   Echavarria M., 2009, Principles and practice of clinical virology, P463, DOI 10.1002/9780470741405.ch19
   Guarner J, 2009, ARCH MED RES, V40, P655, DOI 10.1016/j.arcmed.2009.10.001
   Henrickson KJ, 2003, CLIN MICROBIOL REV, V16, P242, DOI 10.1128/CMR.16.2.242-264.2003
   HERNES S, 2010, EUR J CLIN MICROBIOL
   Jennings LC, 2004, PEDIATR INFECT DIS J, V23, P1003, DOI 10.1097/01.inf.0000143648.04673.6c
   Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930
   Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10
   Lambert SB, 2008, PEDIATRICS, V122, pE615, DOI 10.1542/peds.2008-0691
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lieberman D, 2009, J CLIN MICROBIOL, V47, P3439, DOI 10.1128/JCM.00886-09
   Loens K, 2009, J CLIN MICROBIOL, V47, P21, DOI 10.1128/JCM.02037-08
   Meerhoff TJ, 2010, EUR J CLIN MICROBIOL, V29, P365, DOI 10.1007/s10096-009-0865-7
   de la Tabla VO, 2010, J CLIN MICROBIOL, V48, P3492, DOI 10.1128/JCM.01105-10
   Robinson JL, 2008, CLIN INFECT DIS, V46, pE61, DOI 10.1086/529386
   Sung RYT, 2008, J CLIN MICROBIOL, V46, P3073, DOI 10.1128/JCM.01209-08
   *US CDCP, 2009, CDC PROT REALT RTPCR
   WHO, 2005, HDB IMCI INT MAN CHI
   WHO, 2009, WHO REG OFF EUR GUID
   Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0
   WOLD WSM, 2007, FIELDS VIROLOGY, P2395
   World Health Organization, 2008, PRACT GUID HARM VIR
   World Health Organization (WHO), 2006, COLL PRES SHIPP SPEC
NR 25
TC 54
Z9 56
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 30
PY 2011
VL 6
IS 6
AR e21610
DI 10.1371/journal.pone.0021610
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 786GP
UT WOS:000292291800026
PM 21738731
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Latronico, N
   Manenti, O
   Baini, L
   Rasulo, FA
AF Latronico, Nicola
   Manenti, Ottavia
   Baini, Luca
   Rasulo, Frank A.
TI Quality of Reporting on the Vegetative State in Italian Newspapers. The
   Case of Eluana Englaro
SO PLOS ONE
LA English
DT Article
ID MINIMALLY CONSCIOUS STATE; NEWS MEDIA; BRAIN; DISORDERS; DIAGNOSIS;
   COVERAGE; LEGAL; CARE
AB Background: Media coverage of the vegetative state (VS) includes refutations of the VS diagnosis and describes behaviors inconsistent with VS. We used a quality score to assess the reporting in articles describing the medical characteristics of VS in Italian newspapers.
   Methodology/Principal Findings: Our search covered a 7-month period from July 1, 2008, to February 28, 2009, using the online searchable databases of four major Italian newspapers: Corriere della Sera, La Repubblica, La Stampa, and Avvenire. Medical reporting was judged as complete if three core VS characteristics were described: patient unawareness of self and the environment, preserved wakefulness (eyes open), and spontaneous respiration (artificial ventilator not needed). We retrieved 2,099 articles, and 967 were dedicated to VS. Of these, 853 (88.2%) were non-medical and mainly focused on describing the political, legal, and ethical aspects of VS. Of the 114 (11.8%) medical articles, 53 (5.5%) discussed other medical problems such as death by dehydration, artificial nutrition, neuroimaging, brain death, or uterine hemorrhage, and 61 (6.3%) described VS. Of these 61, only 18 (1.9%) reported all three CORE characteristics and were judged complete. We found no differences among the four investigated newspapers (Fisher's exact = 0.798), and incomplete articles were equally distributed between journalistic pieces and expert opinions (chi(2) = 1.8854, P = 0.170). Incorrect descriptions of VS were significantly more common among incomplete articles (13 of 43 vs. 1 of 18; Fisher's exact P = 0.047).
   Conclusions/Significance: Core VS characteristics are rarely reported in Italian newspaper articles, which can alter adequate comprehension of new developments and (mis) inform political, legal, and ethical decisions.
C1 [Latronico, Nicola; Manenti, Ottavia; Baini, Luca; Rasulo, Frank A.] Univ Brescia, Spedali Civili, Dept Neuroanesthesia & Neurointens Care, Brescia, Italy.
RP Latronico, N (reprint author), Univ Brescia, Spedali Civili, Dept Neuroanesthesia & Neurointens Care, Brescia, Italy.
EM nicola.latronico@med.unibs.it
RI ; LATRONICO, Nicola/F-1557-2010
OI RASULO, Francesco Antonio/0000-0002-7187-5168; LATRONICO,
   Nicola/0000-0002-2521-5871
FU University of Brescia
FX The study was funded with internal funds of the University of Brescia.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR *AM AC NEUR, 1989, NEUROLOGY, V39, P125
   Annas George J, 1996, Duquesne Law Rev, V34, P875
   Annas GJ, 2005, NEW ENGL J MED, V352, P1710, DOI 10.1056/NEJMlim050643
   ANNAS GJ, 1990, NEW ENGL J MED, V323, P670, DOI 10.1056/NEJM199009063231010
   ASHWAL S, 1994, NEW ENGL J MED, V330, P1499
   ASHWAL S, 1994, NEW ENGL J MED, V330, P1572
   Bartlett C, 2002, BRIT MED J, V325, P81, DOI 10.1136/bmj.325.7355.81
   Bernat JL, 2008, NEUROLOGY, V71, P964, DOI 10.1212/01.wnl.0000324281.33381.15
   Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5
   Biondi S, 2009, MED LAW REV, V17, P447, DOI 10.1093/medlaw/fwp020
   BROOKS D, 2005, NY TIMES         MAR, V26, pA13
   Cantor NL, 2001, J LAW MED ETHICS, V29, P182
   DEMERTZI A, 2009, PROGR BRAIN RES
   Dentzer S, 2009, NEW ENGL J MED, V360, P1, DOI 10.1056/NEJMp0805753
   ENTWISTLE V, 1995, BRIT MED J, V310, P920, DOI 10.1136/bmj.310.6984.920
   Fins JJ, 2004, ARCH NEUROL-CHICAGO, V61, P1354, DOI 10.1001/archneur.61.9.1354
   Fins JJ, 2000, NEUROL RES, V22, P273
   Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349
   Jennett B, 2005, PROG BRAIN RES, V150, P537, DOI 10.1016/S0079-6123(05)50037-2
   JENNETT B, 1972, LANCET, V1, P734
   Jennett B, 2002, J NEUROL NEUROSUR PS, V73, P355, DOI 10.1136/jnnp.73.4.355
   JOHNP II, 2004, ISSUES LAW MED, V20, P167
   KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101
   Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028
   Kuriya B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002828
   Lai WYY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006856
   Lai WYY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006103
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X
   Laureys S, 2005, CURR OPIN NEUROL, V18, P726, DOI 10.1097/01.wco.0000189874.92362.12
   Luchetti M, 2010, J MED ETHICS, V36, P333, DOI 10.1136/jme.2009.034835
   MacKenzie R, 2007, MED J AUSTRALIA, V187, P507
   Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370
   Moratti S, 2010, CAMB Q HEALTHC ETHIC, V19, P372, DOI 10.1017/S0963180110000150
   Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206
   *OBS, 2009, FATH PLEA LET MY DAU
   Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197
   OXMAN AD, 1993, J CLIN EPIDEMIOL, V46, P987, DOI 10.1016/0895-4356(93)90166-X
   Perry JE, 2005, ANN INTERN MED, V143, P744, DOI 10.7326/0003-4819-143-10-200511150-00012
   *PRES CONS MIN, 2005, COM NAZ BIOET DIC
   Racine E, 2008, NEUROLOGY, V71, P1027, DOI 10.1212/01.wnl.0000320507.64683.ee
   Racine E, 2010, CAN J NEUROL SCI, V37, P758, DOI 10.1017/S0317167100051416
   Rubulotta F, 2010, MINERVA ANESTESIOL, V76, P203
   Sancisi E, 2009, BRAIN INJURY, V23, P163, DOI 10.1080/02699050802660446
   Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35
   Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251
   Schwitzer G, 2008, PLOS MED, V5, P700, DOI 10.1371/journal.pmed.0050095
   Shewmon DA, 2004, NEUROREHABILITATION, V19, P343
   *SINPE SOC IT NUTR, 2007, PREC MER IMPL BIOET
   Striano P, 2009, INTENS CARE MED, V35, P1129, DOI 10.1007/s00134-009-1484-6
   Timmer Antje, 2003, BMC Med Res Methodol, V3, P2, DOI 10.1186/1471-2288-3-2
   TRESCH DD, 1991, J AM GERIATR SOC, V39, P17, DOI 10.1111/j.1532-5415.1991.tb05900.x
   *UUAR UN DEGL AT D, 2011, ARCH ACC OM CONTR BE
   VERONESI U, 2000, GRUPPO LAVORO NUTR I
   Wade DT, 2001, BMJ-BRIT MED J, V322, P352, DOI 10.1136/bmj.322.7282.352
   Wells J, 2001, ANN INTERN MED, V135, P1029, DOI 10.7326/0003-4819-135-12-200112180-00006
   Wijdicks EFM, 2006, MAYO CLIN PROC, V81, P1155, DOI 10.4065/81.9.1155
   Wilson A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004831
NR 58
TC 3
Z9 3
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 12
PY 2011
VL 6
IS 4
AR e18706
DI 10.1371/journal.pone.0018706
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 748QE
UT WOS:000289404700028
PM 21533275
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Koole, O
   Thai, S
   Khun, KE
   Pe, R
   van Griensven, J
   Apers, L
   Van den Ende, J
   Mao, TE
   Lynen, L
AF Koole, Olivier
   Thai, Sopheak
   Khun, Kim Eam
   Pe, Reaksmey
   van Griensven, Johan
   Apers, Ludwig
   Van den Ende, Jef
   Mao, Tan Eang
   Lynen, Lutgarde
TI Evaluation of the 2007 WHO Guideline to Improve the Diagnosis of
   Tuberculosis in Ambulatory HIV-Positive Adults
SO PLOS ONE
LA English
DT Article
ID NEGATIVE PULMONARY TUBERCULOSIS; RESOURCE-LIMITED SETTINGS; INFECTED
   PERSONS; AFRICA; PEOPLE; DEATH; CAMBODIA; RATES
AB Background: In 2007 WHO issued a guideline to improve the diagnosis of smear-negative and extrapulmonary tuberculosis (EPTB) in HIV-positive patients. This guideline relies heavily on the acceptance of HIV-testing and availability of chest X-rays.
   Methods and Findings: Cohort study of TB suspects in four tuberculosis (TB) clinics in Phnom Penh, Cambodia. We assessed the operational performance of the guideline, the incremental yield of investigations, and the diagnostic accuracy for smear-negative tuberculosis in HIV-positive patients using culture positivity as reference standard. 1,147 (68.9%) of 1,665 TB suspects presented with unknown HIV status, 1,124 (98.0%) agreed to be tested, 79 (7.0%) were HIV-positive. Compliance with the guideline for chest X-rays and sputum culture requests was 97.1% and 98.3% respectively. Only 35 of 79 HIV-positive patients (44.3%) with a chest X-ray suggestive of TB started TB treatment within 10 days. 105 of 442 HIV-positive TB suspects started TB treatment (56.2% smear-negative pulmonary TB (PTB), 28.6% smear-positive PTB, 15.2% EPTB). The median time to TB treatment initiation was 5 days (IQR: 2-13 days), ranging from 2 days (IQR: 1-11.5 days) for EPTB, over 2.5 days (IQR: 1-4 days) for smear-positive PTB to 9 days (IQR: 3-17 days) for smear-negative PTB. Among the 34 smear-negative TB patients with a confirmed diagnosis, the incremental yield of chest X-ray, clinical suspicion or abdominal ultrasound, and culture was 41.2%, 17.6% and 41.2% respectively. The sensitivity and specificity of the algorithm to diagnose smear-negative TB in HIV-positive TB suspects was 58.8% (95% CI: 42.2%-73.6%) and 79.4% (95% CI: 74.8%-82.4%) respectively.
   Conclusions: Pending point-of-care rapid diagnostic tests for TB disease, diagnostic algorithms are needed. The diagnostic accuracy of the 2007 WHO guideline to diagnose smear-negative TB is acceptable. There is, however, reluctance to comply with the guideline in terms of immediate treatment initiation.
C1 [Koole, Olivier; van Griensven, Johan; Apers, Ludwig; Van den Ende, Jef; Lynen, Lutgarde] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Thai, Sopheak; Pe, Reaksmey] Sihanouk Hosp Ctr HOPE SHCH, Phnom Penh, Cambodia.
   [Khun, Kim Eam; Mao, Tan Eang] Natl Ctr TB & Leprosy Control CENAT, Phnom Penh, Cambodia.
RP Koole, O (reprint author), Inst Trop Med, B-2000 Antwerp, Belgium.
EM okoole@itg.be
RI Lynen, Lutgarde/A-1212-2014
OI Lynen, Lutgarde/0000-0001-7183-4895; Koole, Olivier/0000-0002-1122-5382
FU WHO [T9-181-298]; Belgian Development cooperation (DGDC); Institute of
   Tropical Medicine in Antwerp [920800]; Belgian National Association
   against Tuberculosis (BNBTTB)
FX The study was funded by WHO (WHO registry file number T9-181-298), with
   additional funding from the Belgian Development cooperation (DGDC)
   through a framework agreement with the Institute of Tropical Medicine in
   Antwerp (institutional strengthening project 920800) and the Belgian
   National Association against Tuberculosis (BNBTTB). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55
   Banda H, 2000, INT J TUBERC LUNG D, V4, P968
   Bassett IV, 2010, CLIN INFECT DIS, V51, P823, DOI 10.1086/656282
   Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847
   Cain KR, 2007, INT J TUBERC LUNG D, V11, P1008
   Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488
   Cain KP, 2009, EMERG INFECT DIS, V15, P258, DOI 10.3201/eid1502.080942
   Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296
   Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97
   Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009
   Deribew A, 2010, INT J TUBERC LUNG D, V14, P1442
   Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0
   Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391
   GREENBERG AE, 1995, AIDS, V9, P1251, DOI 10.1097/00002030-199511000-00006
   Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847
   Harries AD, 1998, T ROY SOC TROP MED H, V92, P343, DOI 10.1016/S0035-9203(98)91036-7
   Johnson JL, 1998, INT J TUBERC LUNG D, V2, P397
   Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LUCAS SB, 1994, BRIT MED J, V308, P1531, DOI 10.1136/bmj.308.6943.1531
   *MIN HLTH CAMB, 2008, TUB REP
   MONKONGDEE P, 2009, AM J RESP CRIT CARE
   Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002
   National AIDS Authority, 2008, UNGASS COUNTR PROGR
   Organization WH, 2009, GLOB TUB CONTR 2009
   Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656
   Post FA, 1995, TUBERCLE LUNG DIS, V76, P518, DOI 10.1016/0962-8479(95)90527-8
   Ralph AP, 2009, CLIN INFECT DIS, V49, P574, DOI 10.1086/600889
   Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X
   Sculier D, 2010, JAIDS-J ACQ IMM DEF, V55, P500, DOI 10.1097/QAI.0b013e3181e6a703
   Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1
   Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91
   TRINH TT, 2007, PLOS ONE, V2, pE507
   WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1
   WHO, 2009, STRAT TECHN ADV GROU
   Wilson D, 2006, INT J TUBERC LUNG D, V10, P31
   World Health Organization, 2009, GLOB TUB CONTR SHORT
   World Health Organization, 2007, IMPR DIAGN TREATM SM
   World Health Organization, 2003, TREATM TUB GUID NAT
NR 39
TC 21
Z9 21
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 6
PY 2011
VL 6
IS 4
AR e18502
DI 10.1371/journal.pone.0018502
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 745UM
UT WOS:000289192400032
PM 21494694
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Miranda, JJ
   Bernabe-Ortiz, A
   Stanojevic, S
   Malaga, G
   Gilman, RH
   Smeeth, L
AF Jaime Miranda, J.
   Bernabe-Ortiz, Antonio
   Stanojevic, Sanja
   Malaga, German
   Gilman, Robert H.
   Smeeth, Liam
TI A1C as a Diagnostic Criteria for Diabetes in Low- and Middle-Income
   Settings: Evidence from Peru
SO PLOS ONE
LA English
DT Article
ID HEMOGLOBIN A(1C) LEVELS; GLUCOSE; MORTALITY; AMERICAN; MELLITUS;
   DISEASES; ADULTS; RISK
AB Objectives: To determine the prevalence of type 2 diabetes mellitus, in three groups of Peruvian adults, using fasting glucose and glycosylated hemoglobin (A1C).
   Methodology/Principal Findings: This study included adults from the PERU MIGRANT Study who had fasted >= 8 h. Fasting glucose >= 126 mg/dL and A1C >= 6.5% were used, separately, to define diabetes. Subjects with a current diagnosis of diabetes were excluded. 964 of 988 subjects were included in this analysis. Overall, 0.9% (95% CI 0.3-1.5) and 3.5% (95% CI 2.4-4.7) had diabetes using fasting glucose and A1C criteria, respectively. Compared to those classified as having diabetes using fasting glucose, newly classified subjects with diabetes using A1C (n = 25), were older, poorer, thinner and more likely to come from rural areas. Of these, 40% (10/25) had impaired fasting glucose (IFG).
   Conclusions: This study shows that the use of A1C as diagnostic criteria for type 2 diabetes mellitus identifies people of different characteristics than fasting glucose. In the PERU MIGRANT population using A1C to define diabetes tripled the prevalence; the increase was more marked among poorer and rural populations. More than half the newly diagnosed people with diabetes using A1C had normal fasting glucose.
C1 [Jaime Miranda, J.; Bernabe-Ortiz, Antonio; Stanojevic, Sanja; Malaga, German; Gilman, Robert H.; Smeeth, Liam] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.
   [Jaime Miranda, J.; Malaga, German] Univ Peruana Cayetano Heredia, Sch Med, Dept Med, Lima, Peru.
   [Jaime Miranda, J.; Smeeth, Liam] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.
   [Bernabe-Ortiz, Antonio] Univ Peruana Cayetano Heredia, Sch Publ Hlth, Epidemiol Unit, Lima, Peru.
   [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Gilman, Robert H.] A B PRISMA, Area Invest & Desarrollo, Lima, Peru.
RP Miranda, JJ (reprint author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.
EM Jaime.Miranda@upch.pe
RI Miranda, J. Jaime/A-8482-2008
OI Miranda, J. Jaime/0000-0002-4738-5468; Bernabe-Ortiz,
   Antonio/0000-0002-6834-1376; Malaga, German/0000-0002-7828-300X
FU Wellcome Trust [GR074833MA]; National Heart, Lung and Blood Institute
   (NHLBI), National Institutes of Health, Department of Health and Human
   Services [HHSN268200900033C]; National Institute for Health Research
   [NF-SI-0510-10090]
FX This work was funded in whole by the Wellcome Trust (GR074833MA). LS is
   supported by a Wellcome Trust Senior Research Fellowship in Clinical
   Science. The CRONICAS Center of Excellence in Chronic Diseases at UPCH
   is funded by the National Heart, Lung and Blood Institute (NHLBI),
   National Institutes of Health, Department of Health and Human Services,
   under contract No. HHSN268200900033C. The funder had no role in study
   design, data collection, analysis, or interpretation, in writing the
   report, or in the decision to submit the article for publication. The
   researchers are all independent from the funding source.
CR Borch-Johnsen K, 1998, BRIT MED J, V317, P371
   Borch-Johnsen K, 1999, LANCET, V354, P617
   Carson AP, 2010, DIABETES CARE, V33, P95, DOI 10.2337/dc09-1227
   Gama R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5648
   Genuth S, 2003, DIABETES CARE, V26, P3160
   Gilchrist JM, 2009, J CLIN EPIDEMIOL, V62, P1045, DOI 10.1016/j.jclinepi.2008.11.012
   Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940
   International Diabetes Federation, 2009, DIAB ATL
   Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x
   Miranda JJ, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-23
   Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033
   Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577
   Qiao Q, 2003, DIABETES CARE, V26, P688
   Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359
   Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502
   Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487
   *WHO, 1999, DEF DIAGN CLASS DIAB
   Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
NR 21
TC 6
Z9 7
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 25
PY 2011
VL 6
IS 3
AR e18069
DI 10.1371/journal.pone.0018069
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 740SE
UT WOS:000288813900034
PM 21464957
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Seghier, ML
   Kolanko, MA
   Leff, AP
   Jager, HR
   Gregoire, SM
   Werring, DJ
AF Seghier, Mohamed L.
   Kolanko, Magdalena A.
   Leff, Alexander P.
   Jaeger, Hans R.
   Gregoire, Simone M.
   Werring, David J.
TI Microbleed Detection Using Automated Segmentation (MIDAS): A New Method
   Applicable to Standard Clinical MR Images
SO PLOS ONE
LA English
DT Article
ID CEREBRAL AMYLOID ANGIOPATHY; BRAIN MICROBLEEDS; UNIFIED SEGMENTATION;
   PREVALENCE; AGREEMENT; RISK
AB Background: Cerebral microbleeds, visible on gradient-recalled echo (GRE) T2* MRI, have generated increasing interest as an imaging marker of small vessel diseases, with relevance for intracerebral bleeding risk or brain dysfunction.
   Methodology/Principal Findings: Manual rating methods have limited reliability and are time-consuming. We developed a new method for microbleed detection using automated segmentation (MIDAS) and compared it with a validated visual rating system. In thirty consecutive stroke service patients, standard GRE T2* images were acquired and manually rated for microbleeds by a trained observer. After spatially normalizing each patient's GRE T2* images into a standard stereotaxic space, the automated microbleed detection algorithm (MIDAS) identified cerebral microbleeds by explicitly incorporating an "extra" tissue class for abnormal voxels within a unified segmentation-normalization model. The agreement between manual and automated methods was assessed using the intraclass correlation coefficient (ICC) and Kappa statistic. We found that MIDAS had generally moderate to good agreement with the manual reference method for the presence of lobar microbleeds (Kappa = 0.43, improved to 0.65 after manual exclusion of obvious artefacts). Agreement for the number of microbleeds was very good for lobar regions: (ICC = 0.71, improved to ICC = 0.87). MIDAS successfully detected all patients with multiple (>= 2) lobar microbleeds.
   Conclusions/Significance: MIDAS can identify microbleeds on standard MR datasets, and with an additional rapid editing step shows good agreement with a validated visual rating system. MIDAS may be useful in screening for multiple lobar microbleeds.
C1 [Seghier, Mohamed L.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England.
   [Kolanko, Magdalena A.; Jaeger, Hans R.; Gregoire, Simone M.; Werring, David J.] UCL, Inst Neurol, Stroke Res Grp, Dept Brain Repair & Rehabil, London, England.
   [Leff, Alexander P.] UCL, Inst Cognit Neurosci, London, England.
RP Seghier, ML (reprint author), UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England.
EM d.werring@ion.ucl.ac.uk
RI Werring, David/Q-8435-2019; Jager, Hans Rolf/K-1868-2013; Seghier,
   Mohamed/O-8634-2019; Seghier, Mohamed/C-6314-2009
OI Werring, David/0000-0003-2074-1861; Jager, Hans
   Rolf/0000-0002-6403-4184; Seghier, Mohamed/0000-0002-1146-8800; Seghier,
   Mohamed/0000-0002-1146-8800; Leff, Alexander/0000-0002-0831-3541
FU Wellcome Trust; The Stroke Association; Department of Health and Higher
   Educational and Funding Council; UK Department of Health's National
   Institute for Health Research Biomedical Research Center (UCLH/UCL
   Comprehensive Biomedical Research Trust); Stroke Association [TSA BHF
   2009/01]
FX Mohamed Seghier and Alex Leff were funded by the Wellcome Trust. Simone
   Gregoire was supported by a grant from The Stroke Association. David
   Werring is supported by a Department of Health and Higher Educational
   and Funding Council for England Clinical Senior Lectureship Award. This
   work was undertaken at UCLH/UCL, which received a proportion of funding
   from the UK Department of Health's National Institute for Health
   Research Biomedical Research Centers funding scheme (UCLH/UCL
   Comprehensive Biomedical Research Trust). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018
   BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491
   Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/aw1387
   EVANS AC, 1993, NUCL SCI S MED IM C, V3, P1813, DOI DOI 10.1109/NSSMIC.1993.373602
   Filippi M, 1995, BRAIN, V118, P1593, DOI 10.1093/brain/118.6.1593
   Ghazel M, 2006, 2006 IEEE INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND INFORMATION TECHNOLOGY, VOLS 1 AND 2, P6, DOI 10.1109/ISSPIT.2006.270760
   Greenberg SM, 2009, STROKE, V40, P2382, DOI 10.1161/STROKEAHA.109.548974
   Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4
   Gregoire SM, 2010, J NEUROL NEUROSUR PS, V81, P679, DOI 10.1136/jnnp.2009.198994
   Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d
   Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198
   Knudsen KA, 2001, NEUROLOGY, V56, P537, DOI 10.1212/WNL.56.4.537
   Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355
   Rosand J, 2005, ANN NEUROL, V58, P459, DOI 10.1002/ana.20596
   Rouainia M, 2006, PROC WRLD ACAD SCI E, V17, P301
   Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382
   Seghier ML, 2008, NEUROIMAGE, V41, P1253, DOI 10.1016/j.neuroimage.2008.03.028
   Soille P., 2003, MORPHOLOGICAL IMAGE
   Soo YOY, 2008, J NEUROL, V255, P1679, DOI 10.1007/s00415-008-0967-7
   Stehling C, 2008, ACAD RADIOL, V15, P895, DOI 10.1016/j.acra.2008.01.013
   VERMERSCH P, 1992, CLIN NEUROL NEUROSUR, V94, P213, DOI 10.1016/0303-8467(92)90091-G
   Viswanathan A, 2006, STROKE, V37, P550, DOI 10.1161/01.STR.0000199847.96188.12
   Werring DJ, 2004, BRAIN, V127, P2265, DOI 10.1093/brain/awh253
NR 25
TC 29
Z9 33
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 23
PY 2011
VL 6
IS 3
AR e17547
DI 10.1371/journal.pone.0017547
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 740QW
UT WOS:000288810500007
PM 21448456
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Shuval, K
   Harker, K
   Roudsari, B
   Groce, NE
   Mills, B
   Siddiqi, Z
   Shachak, A
AF Shuval, Kerem
   Harker, Karen
   Roudsari, Bahman
   Groce, Nora E.
   Mills, Britain
   Siddiqi, Zoveen
   Shachak, Aviv
TI Is Qualitative Research Second Class Science? A Quantitative
   Longitudinal Examination of Qualitative Research in Medical Journals
SO PLOS ONE
LA English
DT Article
ID HEALTH-CARE; HELP
AB Background: Qualitative research appears to be gaining acceptability in medical journals. Yet, little is actually known about the proportion of qualitative research and factors affecting its publication. This study describes the proportion of qualitative research over a 10 year period and correlates associated with its publication.
   Design: A quantitative longitudinal examination of the proportion of original qualitative research in 67 journals of general medicine during a 10 year period (1998-2007). The proportion of qualitative research was determined by dividing original qualitative studies published (numerator) by all original research articles published (denominator). We used a generalized estimating equations approach to assess the longitudinal association between the proportion of qualitative studies and independent variables (i.e. journals' country of publication and impact factor; editorial/methodological papers discussing qualitative research; and specific journal guidelines pertaining to qualitative research).
   Findings: A 2.9% absolute increase and 3.4-fold relative increase in qualitative research publications occurred over a 10 year period (1.2% in 1998 vs. 4.1% in 2007). The proportion of original qualitative research was independently and significantly associated with the publication of editorial/methodological papers in the journal (b = 3.688, P = 0.012); and with qualitative research specifically mentioned in guidelines for authors (b = 6.847, P < 0.001). Additionally, a higher proportion of qualitative research was associated only with journals published in the UK in comparison to other countries, yet with borderline statistical significance (b = 1.776, P = 0.075). The journals' impact factor was not associated with the publication of qualitative research.
   Conclusions: Despite an increase in the proportion of qualitative research in medical journals over a 10 year period, the proportion remains low. Journals' policies pertaining to qualitative research, as expressed by the appearance of specific guidelines and editorials/methodological papers on the subject, are independently associated with the publication of original qualitative research; irrespective of the journals' impact factor.
C1 [Shuval, Kerem; Harker, Karen; Roudsari, Bahman; Mills, Britain; Siddiqi, Zoveen] Univ Texas Dallas, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Dallas, TX 75230 USA.
   [Harker, Karen] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.
   [Groce, Nora E.] UCL, Leonard Cheshire Disabil & Inclus Dev Ctr, Dept Epidemiol & Publ Hlth, London, England.
   [Shachak, Aviv] Univ Toronto, Fac Informat, Toronto, ON, Canada.
   [Shachak, Aviv] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada.
RP Shuval, K (reprint author), Univ Texas Dallas, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Dallas, TX 75230 USA.
EM kerem.shuval@UTSouthwestern.edu
RI Mills, Britain/B-1225-2012
OI Shachak, Aviv/0000-0002-1166-609X; Groce, Nora/0000-0002-7885-7042
CR Bailie R, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-129
   Bengtsson L., 1997, SCAND J MANAG, V13, P473
   Britten N, 2005, MED EDUC, V39, P5, DOI 10.1111/j.1365-2929.2004.02024.x
   Creswell J., 2008, RES DESIGN QUALITATI
   Ebell MH, 2004, J AM BOARD FAM PRACT, V17, P59, DOI 10.3122/jabfm.17.1.59
   Finkelstein A, 2005, J FAM PRACTICE, V54, P1032
   Gault I, 2009, HEALTH SOC CARE COMM, V17, P504, DOI 10.1111/j.1365-2524.2009.00847.x
   Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P478, DOI 10.1001/jama.284.4.478
   Green J, 1998, BMJ-BRIT MED J, V316, P1230, DOI 10.1136/bmj.316.7139.1230
   Greenhalgh T, 1997, BMJ-BRIT MED J, V315, P740, DOI 10.1136/bmj.315.7110.740
   Grypdonck MHE, 2006, QUAL HEALTH RES, V16, P1371, DOI 10.1177/1049732306294089
   Hardin J. W., 2003, GEN ESTIMATING EQUAT
   JONES R, 1995, BRIT MED J, V311, P2, DOI 10.1136/bmj.311.6996.2
   Kuper A, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a288
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lewin S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3496
   Lyytinen K, 2007, EUR J INFORM SYST, V16, P317, DOI 10.1057/palgrave.ejis.3000695
   Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6
   MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109
   McKibbon Kathleen Ann, 2004, BMC Med Inform Decis Mak, V4, P11, DOI 10.1186/1472-6947-4-11
   Morse JM, 2003, QUAL HEALTH RES, V13, P739, DOI 10.1177/1049732303255449
   Petticrew M, 2008, J EPIDEMIOL COMMUN H, V62, P552, DOI 10.1136/jech.2006.059394
   Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114
   Pope C, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3425
   Reeves S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1020
   Reeves S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a949
   SANDELOWSKI M, 2003, SAGE ENCY SOCIAL SCI
   Shachak A, 2009, J GEN INTERN MED, V24, P341, DOI 10.1007/s11606-008-0892-6
   Shuval K, 2007, J GEN INTERN MED, V22, P327, DOI 10.1007/s11606-006-0055-6
   *THOMS REUT, SCOP NOT SCI CIT IND
   Yamazaki H, 2009, BIOSCI TRENDS, V3, P202
NR 31
TC 30
Z9 31
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 24
PY 2011
VL 6
IS 2
AR e16937
DI 10.1371/journal.pone.0016937
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 726XY
UT WOS:000287761700020
PM 21383987
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Womack, JA
   Goulet, JL
   Gibert, C
   Brandt, C
   Chang, CC
   Gulanski, B
   Fraenkel, L
   Mattocks, K
   Rimland, D
   Rodriguez-Barradas, MC
   Tate, J
   Yin, MT
   Justice, AC
AF Womack, Julie A.
   Goulet, Joseph L.
   Gibert, Cynthia
   Brandt, Cynthia
   Chang, Chung Chou
   Gulanski, Barbara
   Fraenkel, Liana
   Mattocks, Kristin
   Rimland, David
   Rodriguez-Barradas, Maria C.
   Tate, Janet
   Yin, Michael T.
   Justice, Amy C.
CA Vet Aging Cohort Study Project
TI Increased Risk of Fragility Fractures among HIV Infected Compared to
   Uninfected Male Veterans
SO PLOS ONE
LA English
DT Article
ID BONE-MINERAL DENSITY; HUMAN-IMMUNODEFICIENCY-VIRUS; OSTEOPOROSIS CARE
   GAP; ANTIRETROVIRAL THERAPY; MISSING DATA; ELDERLY-MEN; WOMEN;
   OSTEOPENIA; PREVALENCE; CORTICOSTEROIDS
AB Background: HIV infection has been associated with an increased risk of fragility fracture. We explored whether or not this increased risk persisted in HIV infected and uninfected men when controlling for traditional fragility fracture risk factors.
   Methodology/Principal Findings: Cox regression models were used to assess the association of HIV infection with the risk for incident hip, vertebral, or upper arm fracture in male Veterans enrolled in the Veterans Aging Cohort Study Virtual Cohort (VACS-VC). We calculated adjusted hazard ratios comparing HIV status and controlling for demographics and other established risk factors. The sample consisted of 119,318 men, 33% of whom were HIV infected (34% aged 50 years or older at baseline, and 55% black or Hispanic). Median body mass index (BMI) was lower in HIV infected compared with uninfected men (25 vs. 28 kg/m(2); p<0.0001). Unadjusted risk for fracture was higher among HIV infected compared with uninfected men [HR: 1.32 (95% CI: 1.20, 1.47)]. After adjusting for demographics, comorbid disease, smoking and alcohol abuse, HIV infection remained associated with an increased fracture risk [HR: 1.24 (95% CI: 1.11, 1.39)]. However, adjusting for BMI attenuated this association [HR: 1.10 (95% CI: 0.97, 1.25)]. The only HIV-specific factor associated with fragility fracture was current protease inhibitor use [HR: 1.41 (95% CI: 1.16, 1.70)].
   Conclusions/Significance: HIV infection is associated with fragility fracture risk. This risk is attenuated by BMI.
C1 [Womack, Julie A.; Goulet, Joseph L.; Brandt, Cynthia; Gulanski, Barbara; Fraenkel, Liana; Mattocks, Kristin; Tate, Janet; Justice, Amy C.] VA Connecticut Healthcare Syst, West Haven, CT 06516 USA.
   [Gibert, Cynthia] George Washington Univ, Vet Affairs Med Ctr, Washington, DC USA.
   [Gibert, Cynthia] George Washington Univ, Dept Med, Washington, DC USA.
   [Brandt, Cynthia] Yale Univ, Yale Ctr Med Informat, New Haven, CT USA.
   [Chang, Chung Chou] Univ Pittsburgh, Sch Med, Sect Decis Sci & Clin Syst Modeling, Pittsburgh, PA USA.
   [Gulanski, Barbara; Mattocks, Kristin; Justice, Amy C.] Yale Univ, Sch Med, Dept Internal Med, Gen Internal Med Sect, New Haven, CT 06510 USA.
   [Fraenkel, Liana] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06510 USA.
   [Rimland, David] Vet Affairs Med Ctr, Atlanta, GA 30033 USA.
   [Rimland, David] Emory Univ, Sch Med, Atlanta, GA USA.
   [Rodriguez-Barradas, Maria C.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
   [Rodriguez-Barradas, Maria C.] Baylor Coll Med, Med Serv, Michael E De Bakey Vet Affairs VA Med Ctr, Houston, TX 77030 USA.
   [Yin, Michael T.] Columbia Univ, Dept Med, Div Infect Dis, Med Ctr, New York, NY USA.
RP Womack, JA (reprint author), VA Connecticut Healthcare Syst, West Haven, CT 06516 USA.
EM julie.womack@va.gov
OI Goulet, Joseph/0000-0002-0842-804X
FU VA Office, Academic Affiliations, Information Research & Development
   Medical Informatics; National Institute on Alcohol Abuse and Alcoholism
   [U10 AA 13566]; VHA Public Health Strategic Health Core Group
FX Funding: Dr. Womack is funded by the VA Office, Academic Affiliations,
   Information Research & Development Medical Informatics Fellowship
   Program. Veterans Aging Cohort Study funded by the National Institute on
   Alcohol Abuse and Alcoholism (U10 AA 13566) and VHA Public Health
   Strategic Health Core Group. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Allison PD, 2001, MISSING DATA
   Amiel C, 2004, J BONE MINER RES, V19, P402, DOI 10.1359/JBMR.0301246
   Arnsten JH, 2006, CLIN INFECT DIS, V42, P1014, DOI 10.1086/501015
   Arnsten JH, 2007, AIDS, V21, P617, DOI 10.1097/QAD.0b013e3280148c05
   Bolland MJ, 2007, J CLIN ENDOCR METAB, V92, P4522, DOI 10.1210/jc.2007-1660
   Bolland MJ, 2007, CLIN ENDOCRINOL, V67, P270, DOI 10.1111/j.1365-2265.2007.02875.x
   Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb
   Bruera D, 2003, AIDS, V17, P1917, DOI 10.1097/01.aids.0000076322.42412.6f
   BUHR AJ, 1959, LANCET, V1, P531
   Calmy A, 2009, J INFECT DIS, V200, P1746, DOI 10.1086/644785
   Cazanave C, 2008, AIDS, V22, P395, DOI 10.1097/QAD.0b013e3282f423dd
   *CDC, 2004, HIV AIDS SURV REP
   Cheung AM, 2008, JAMA-J AM MED ASSOC, V299, P1468, DOI 10.1001/jama.299.12.1468
   Collin F, 2009, AIDS, V23, P1021, DOI 10.1097/QAD.0b013e3283292195
   Collins TC, 2009, CIRCULATION, V119, P2305, DOI 10.1161/CIRCULATIONAHA.108.820993
   CRAWFORD SL, 1995, J CLIN EPIDEMIOL, V48, P209, DOI 10.1016/0895-4356(94)00124-9
   Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326
   De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y
   Duvivier C, 2009, AIDS, V23, P817, DOI 10.1097/QAD.0b013e328328f789
   Fultz SL, 2006, MED CARE, V44, P25
   Gallant JE, 1998, CHEST, V114, P1258, DOI 10.1378/chest.114.5.1258
   Giangregorio L, 2006, SEMIN ARTHRITIS RHEU, V35, P293, DOI 10.1016/j.semarthrit.2005.11.001
   Grund B, 2009, AIDS, V23, P1519, DOI 10.1097/QAD.0b013e32832c1792
   Hajcsar EE, 2000, CAN MED ASSOC J, V163, P819
   Hippisley-Cox J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4229
   Hoffmann M, 2000, J NEUROVIROL, V6, P229, DOI 10.3109/13550280009015825
   JUSTICE AC, 2006, MED CARE, V44, P52
   Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5
   Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1734-y
   Kanis JA, 2000, OSTEOPOROSIS INT, V11, P669, DOI 10.1007/s001980070064
   Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lindau TR, 1999, ACTA ORTHOP SCAND, V70, P124, DOI 10.3109/17453679909011248
   McComsey Grace A, 2004, J Int Assoc Physicians AIDS Care (Chic), V3, P86, DOI 10.1177/154510970400300303
   McQueen MM, 2003, CURR ORTHOPAED, V17, P360, DOI 10.1016/S0268-0890(03)00097-5
   Nguyen TV, 2001, AM J EPIDEMIOL, V153, P587, DOI 10.1093/aje/153.6.587
   Osnes EK, 2004, OSTEOPOROSIS INT, V15, P567, DOI 10.1007/s00198-003-1583-0
   Papaioannou A, 2008, OSTEOPOROSIS INT, V19, P581, DOI 10.1007/s00198-007-0483-0
   Pasco JA, 2006, OSTEOPOROSIS INT, V17, P1404, DOI 10.1007/s00198-006-0135-9
   Piliero PJ, 2002, AIDS, V16, P1565, DOI 10.1097/00002030-200207260-00019
   Prior J, 2007, OSTEOPOROSIS INT, V18, P1345, DOI 10.1007/s00198-007-0428-7
   RAY M, AIDS, V24, P123
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Siris ES, 2004, ARCH INTERN MED, V164, P1108, DOI 10.1001/archinte.164.10.1108
   Sornay-Rendu E, 2005, J BONE MINER RES, V20, P1813, DOI 10.1359/JBMR.050609
   Steinke DT, 2002, GUT, V50, P100, DOI 10.1136/gut.50.1.100
   STELLBRINK H, 2009, ASSESSMENT SAFETY EF
   Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393
   Szulc P, 2005, OSTEOPOROSIS INT, V16, P1184, DOI 10.1007/s00198-005-1970-9
   Targownik LE, 2008, CAN MED ASSOC J, V179, P319, DOI 10.1503/cmaj.071330
   TEBAS P, 2000, AIDS, V14, P63
   Teichmann J, 2003, J INFECTION, V46, P221, DOI 10.1053/jinf.2002.1109
   Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828
   van Diepen S, 2008, CIRCULATION, V118, P1946, DOI 10.1161/CIRCULATIONAHA.108.784009
   Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993
   WANG GC, AM J EPIDEMIOL, V171, P1144
   WARRINER AH, CURR RHEUMATOL REP, V12, P163
   Weber R, 2006, ARCH INTERN MED, V166, P1632
   2008, LANCET, V372, P293
NR 59
TC 160
Z9 161
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 16
PY 2011
VL 6
IS 2
AR e17217
DI 10.1371/journal.pone.0017217
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 721YC
UT WOS:000287392700061
PM 21359191
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Bornmann, L
   Mutz, R
   Daniel, HD
AF Bornmann, Lutz
   Mutz, Ruediger
   Daniel, Hans-Dieter
TI A Reliability-Generalization Study of Journal Peer Reviews: A Multilevel
   Meta-Analysis of Inter-Rater Reliability and Its Determinants
SO PLOS ONE
LA English
DT Review
ID EDITORIAL DECISION-MAKING; AMERICAN-PSYCHOLOGIST; SCIENTIFIC ABSTRACTS;
   MANUSCRIPT REVIEWS; REFEREE AGREEMENT; ANGEWANDTE-CHEMIE;
   CLINICAL-TRIALS; META-REGRESSION; EFFECTS MODELS; STANDS TODAY
AB Background: This paper presents the first meta-analysis for the inter-rater reliability (IRR) of journal peer reviews. IRR is defined as the extent to which two or more independent reviews of the same scientific document agree.
   Methodology/Principal Findings: Altogether, 70 reliability coefficients (Cohen's Kappa, intra-class correlation [ICC], and Pearson product-moment correlation [r]) from 48 studies were taken into account in the meta- analysis. The studies were based on a total of 19,443 manuscripts; on average, each study had a sample size of 311 manuscripts (minimum: 28, maximum: 1983). The results of the meta- analysis confirmed the findings of the narrative literature reviews published to date: The level of IRR (mean ICC/r(2) = .34, mean Cohen's Kappa = .17) was low. To explain the study-to-study variation of the IRR coefficients, meta- regression analyses were calculated using seven covariates. Two covariates that emerged in the meta-regression analyses as statistically significant to gain an approximate homogeneity of the intra-class correlations indicated that, firstly, the more manuscripts that a study is based on, the smaller the reported IRR coefficients are. Secondly, if the information of the rating system for reviewers was reported in a study, then this was associated with a smaller IRR coefficient than if the information was not conveyed.
   Conclusions/Significance: Studies that report a high level of IRR are to be considered less credible than those with a low level of IRR. According to our meta- analysis the IRR of peer assessments is quite limited and needs improvement (e. g., reader system).
C1 [Bornmann, Lutz] Max Planck Soc, Munich, Germany.
   [Mutz, Ruediger; Daniel, Hans-Dieter] ETH, Zurich, Switzerland.
   [Daniel, Hans-Dieter] Univ Zurich, Evaluat Off, Zurich, Switzerland.
RP Bornmann, L (reprint author), Max Planck Soc, Munich, Germany.
EM bornmann@gv.mpg.de
RI White, Howard D/A-7034-2009; Bornmann, Lutz/A-3926-2008; Mutz,
   Ruediger/A-2226-2009; Daniel, Hans-Dieter/A-2419-2013
OI Bornmann, Lutz/0000-0003-0810-7091; 
CR BAILAR JC, 1991, BEHAV BRAIN SCI, V14, P137, DOI 10.1017/S0140525X00065705
   BAKANIC V, 1987, AM SOCIOL REV, V52, P631, DOI 10.2307/2095599
   Baker WL, 2009, INT J CLIN PRACT, V63, P1426, DOI 10.1111/j.1742-1241.2009.02168.x
   Bateman IJ, 2003, LAND ECON, V79, P235, DOI 10.2307/3146869
   Beretvas SN, 2003, EDUC PSYCHOL MEAS, V63, P75, DOI 10.1177/0013164402239318
   BEYER JM, 1995, ACAD MANAGE J, V38, P1219, DOI 10.2307/256856
   Bhandari M, 2004, CLIN ORTHOP RELAT R, P217, DOI 10.1097/01.blo.0000127584.02606.00
   Blackburn JL, 2006, PSYCHOL SCI, V17, P378, DOI 10.1111/j.1467-9280.2006.01715.x
   BOHANNON RW, 1986, PHYS THER, V66, P1431, DOI 10.1093/ptj/66.9.1431a
   Borenstein M., 2009, INTRO METAANALYSIS
   Bornmann L, 2008, ANGEW CHEM INT EDIT, V47, P7173, DOI 10.1002/anie.200800513
   Bornmann L, 2007, J INFORMETR, V1, P226, DOI 10.1016/j.joi.2007.03.001
   Callaham ML, 1998, JAMA-J AM MED ASSOC, V280, P229, DOI 10.1001/jama.280.3.229
   Campanario JM, 1998, SCI COMMUN, V19, P277, DOI 10.1177/1075547098019004002
   Campanario JM, 1998, SCI COMMUN, V19, P181, DOI 10.1177/1075547098019003002
   Cho MK, 1998, JAMA-J AM MED ASSOC, V280, P243, DOI 10.1001/jama.280.3.243
   Cicchetti D., 1979, P AM STAT ASS, V22, P596
   CICCHETTI DV, 1976, YALE J BIOL MED, V49, P373
   CICCHETTI DV, 1980, AM PSYCHOL, V35, P300, DOI 10.1037/0003-066X.35.3.300
   CICCHETTI DV, 1991, BEHAV BRAIN SCI, V14, P119, DOI 10.1017/S0140525X00065675
   CICCHETTI DV, 1978, BIOMETRICS, V34, P728
   Cohen IT, 2006, ANESTH ANALG, V102, P1501, DOI 10.1213/01.ane.0000200314.73035.4d
   COHEN IT, 2005, J ED PERIOPERATIVE M, V7
   COLE JR, 2000, WEB KNOWLEDGE FESTSC, P109
   CONN HO, 1974, CLIN RES, V22, P128
   Daniel H.-D., 1993, GUARDIANS SCI FAIRNE
   DANIEL HD, 1993, ANGEW CHEM INT EDIT, V32, P234, DOI 10.1002/anie.199302341
   DERSIMONIAN R, 1983, HARVARD EDUC REV, V53, P1
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004
   DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385
   EBEL RL, 1951, PSYCHOMETRIKA, V16, P407
   Eckes T, 2004, DIAGNOSTICA, V50, P65, DOI 10.1026/0012-1924.50.2.65
   Egger M, 2002, INT J EPIDEMIOL, V31, P1, DOI 10.1093/ije/31.1.1
   Falagas ME, 2006, MAYO CLIN PROC, V81, P705, DOI 10.4065/81.5.705
   Field AP, 2001, PSYCHOL METHODS, V6, P161, DOI 10.1037/1082-989X.6.2.161
   FISKE DW, 1990, AM PSYCHOL, V45, P591, DOI 10.1037/0003-066X.45.5.591
   Glass G.V., 1977, REV RES EDUC, V5, P351, DOI [10.2307/1167179, DOI 10.3102/0091732X005001351]
   GLIDEWELL JC, 1988, AM J COMMUN PSYCHOL, V16, P759, DOI 10.1007/BF00930891
   Godlee F, 2002, JAMA-J AM MED ASSOC, V287, P2762, DOI 10.1001/jama.287.21.2762
   GOLDMAN RL, 1994, EVAL HEALTH PROF, V17, P3, DOI 10.1177/016327879401700101
   Goldstein H, 2000, J ROY STAT SOC C-APP, V49, P399, DOI 10.1111/1467-9876.00200
   GOOD CD, 1999, S AFR MED J, V4, P397
   GOTTFREDSON SD, 1978, AM PSYCHOL, V33, P920
   Gupta P, 2006, INDIAN PEDIATR, V43, P479
   HARGENS LL, 1990, SOC SCI RES, V19, P1, DOI 10.1016/0049-089X(90)90012-8
   Hedges L.V., 1994, HDB RES SYNTHESIS, P285
   Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486
   Hemlin S, 2006, SCI TECHNOL HUM VAL, V31, P173, DOI 10.1177/0162243905283639
   HENDRICK C, 1976, PERSONALITY SOCIAL P, V2, P207
   HENDRIK C, 1977, PERSONALITY SOCIAL P, V3, P1
   Herzog HA, 2005, ANTHROZOOS, V18, P175, DOI 10.2752/089279305785594180
   Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3
   Howard L, 1998, BRIT J PSYCHIAT, V173, P110, DOI 10.1192/bjp.173.2.110
   Hox J. J., 2002, MULTILEVEL ANAL
   Hunter J, 1990, METHODS METAANALYSIS
   Hunter J. E, 2004, METHODS METAANALYSIS
   Hunter JE, 2000, INT J SELECT ASSESS, V8, P275, DOI 10.1111/1468-2389.00156
   Jayasinghe UW, 2006, SCIENTOMETRICS, V69, P591, DOI 10.1007/s11192-006-0171-4
   JUSTICE AC, 1994, JAMA-J AM MED ASSOC, V272, P117, DOI 10.1001/jama.272.2.117
   Kemp S, 2005, J ECON PSYCHOL, V26, P779, DOI 10.1016/j.joep.2005.05.004
   Kemper KJ, 1996, ARCH PEDIAT ADOL MED, V150, P380, DOI 10.1001/archpedi.1996.02170290046007
   Kirk SA, 1997, SOC WORK RES, V21, P121, DOI 10.1093/swr/21.2.121
   LaFollette Marcel Chotkowski, 1992, STEALING PRINT FRAUD
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Langfeldt L, 2001, SOC STUD SCI, V31, P820, DOI 10.1177/030631201031006002
   LeBreton JM, 2008, ORGAN RES METHODS, V11, P815, DOI 10.1177/1094428106296642
   LEMPERT RO, 1985, LAW SOC REV, V19, P529
   Lienert G. A., 1987, SCHULNOTEN EVALUATIO
   LINDEN W, 1992, CAN J BEHAV SCI, V24, P433, DOI 10.1037/h0078757
   LINDSEY D, 1988, SCIENTOMETRICS, V14, P75, DOI 10.1007/BF02020243
   Little R. C., 2007, SAS MIXED MODELS
   Marsh HW, 2008, AM PSYCHOL, V63, P160, DOI 10.1037/0003-066X.63.3.160
   Marsh HW, 2007, AUST PSYCHOL, V42, P33, DOI 10.1080/00050060600823275
   Marsh HW, 2009, REV EDUC RES, V79, P1290, DOI 10.3102/0034654309334143
   MARSH HW, 1981, J EDUC PSYCHOL, V73, P872, DOI 10.1037/0022-0663.73.6.872
   Marusic A, 2002, CROAT MED J, V43, P286
   MCREYNOLDS P, 1971, AM PSYCHOL, V26, P400, DOI 10.1037/h0037937
   MONTGOMERY AA, 2002, BMC HLTH SERVICES RE, V2
   MORROW JR, 1992, RES Q EXERCISE SPORT, V63, P200, DOI 10.1080/02701367.1992.10607582
   MUNLEY PH, 1988, J COUNS PSYCHOL, V35, P198, DOI 10.1037/0022-0167.35.2.198
   Muthen LK, 1998, MPLUS USERS GUIDE
   Neff BD, 2006, BIOSCIENCE, V56, P333, DOI 10.1641/0006-3568(2006)56[333:IPRAGO]2.0.CO;2
   OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P91, DOI 10.1016/0895-4356(91)90205-N
   Petty RE, 1999, PERS SOC PSYCHOL B, V25, P188, DOI 10.1177/0146167299025002005
   PLUG C, 1993, S AFR J PSYCHOL, V23, P43, DOI 10.1177/008124639302300108
   Rothwell PM, 2000, BRAIN, V123, P1964, DOI 10.1093/brain/123.9.1964
   RUBIN HR, 1993, J GEN INTERN MED, V8, P255, DOI 10.1007/BF02600092
   RUBIN HR, 1992, CLIN RES, V40, pA589
   SCARR S, 1978, AM PSYCHOL, V33, P935, DOI 10.1037/h0078544
   SCOTT JR, 2005, 5 INT C PEER REV BIO
   SCOTT WA, 1974, AM PSYCHOL, V29, P698, DOI 10.1037/h0037631
   Shadish W. R., 2002, EXPT QUASIEXPERIMENT
   SIEGELMAN SS, 1991, RADIOLOGY, V178, P637, DOI 10.1148/radiology.178.3.1994394
   Smith R, 2006, J ROY SOC MED, V99, P178, DOI 10.1258/jrsm.99.4.178
   Snodgrass R, 2006, SIGMOD REC, V35, P8
   STRAYHORN J, 1993, AM J PSYCHIAT, V150, P947
   The British Academy, 2007, PEER REV CHALL HUM S
   Thompson B, 2000, EDUC PSYCHOL MEAS, V60, P174, DOI 10.1177/00131640021970448
   Timmer Antje, 2003, BMC Med Res Methodol, V3, P2, DOI 10.1186/1471-2288-3-2
   Vacha-Haase T, 1998, EDUC PSYCHOL MEAS, V58, P6, DOI 10.1177/0013164498058001002
   Van den Noortgate W, 2003, EDUC PSYCHOL MEAS, V63, P765, DOI 10.1177/0013164402251027
   van der Steen LPE, 2003, PLAST RECONSTR SURG, V111, P2215, DOI 10.1097/01.PRS.0000061092.88629.82
   van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040
   WELLER A. C., 2002, EDITORIAL PEER REV I
   White H. D., 2005, P 10 INT C INT SOC S, P442
   WHITEHURST GJ, 1983, DEV REV, V3, P73, DOI 10.1016/0273-2297(83)90009-6
   Wood M, 2004, J INFORM SCI, V30, P2, DOI 10.1177/016551504041673
   YADOLLAHIE M, 2004, SAUDI MED J SS44, V25
   Ziman J., 2000, REAL SCI WHAT IT IS
NR 110
TC 52
Z9 53
U1 0
U2 42
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 14
PY 2010
VL 5
IS 12
AR e14331
DI 10.1371/journal.pone.0014331
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 694JH
UT WOS:000285292500009
PM 21179459
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Regueiro, BJ
   Varela-Ledo, E
   Martinez-Lamas, L
   Rodriguez-Calvino, J
   Aguilera, A
   Santos, A
   Gomez-Tato, A
   Alvarez-Escudero, J
AF Regueiro, Benito J.
   Varela-Ledo, Eduardo
   Martinez-Lamas, Lucia
   Rodriguez-Calvino, Javier
   Aguilera, Antonio
   Santos, Antonio
   Gomez-Tato, Antonio
   Alvarez-Escudero, Julian
TI Automated Extraction Improves Multiplex Molecular Detection of Infection
   in Septic Patients
SO PLOS ONE
LA English
DT Article
ID INADEQUATE ANTIMICROBIAL TREATMENT; VENTILATOR-ASSOCIATED PNEUMONIA;
   POLYMERASE-CHAIN-REACTION; BLOOD-STREAM INFECTIONS; SEVERE SEPSIS; PCR
   ASSAY; DIAGNOSIS; THERAPY; MORTALITY; OUTCOMES
AB Sepsis is one of the leading causes of morbidity and mortality in hospitalized patients worldwide. Molecular technologies for rapid detection of microorganisms in patients with sepsis have only recently become available. LightCycler SeptiFast test M-grade (Roche Diagnostics GmbH) is a multiplex PCR analysis able to detect DNA of the 25 most frequent pathogens in bloodstream infections. The time and labor saved while avoiding excessive laboratory manipulation is the rationale for selecting the automated MagNA Pure compact nucleic acid isolation kit-I (Roche Applied Science, GmbH) as an alternative to conventional SeptiFast extraction. For the purposes of this study, we evaluate extraction in order to demonstrate the feasibility of automation. Finally, a prospective observational study was done using 106 clinical samples obtained from 76 patients in our ICU. Both extraction methods were used in parallel to test the samples. When molecular detection test results using both manual and automated extraction were compared with the data from blood cultures obtained at the same time, the results show that SeptiFast with the alternative MagNA Pure compact extraction not only shortens the complete workflow to 3.57 hrs., but also increases sensitivity of the molecular assay for detecting infection as defined by positive blood culture confirmation.
C1 [Regueiro, Benito J.; Varela-Ledo, Eduardo; Martinez-Lamas, Lucia; Rodriguez-Calvino, Javier; Aguilera, Antonio] Complejo Hosp Univ Santiago, Dept Clin Microbiol, Santiago De Compostela, Spain.
   [Santos, Antonio] Complejo Hosp Univ Santiago, Dept Intens Care, Hosp Conxo, Santiago De Compostela, Spain.
   [Gomez-Tato, Antonio] Univ Santiago, Sch Math, Santiago De Compostela, Spain.
   [Alvarez-Escudero, Julian] Complejo Hosp Univ Santiago, Dept Anesthesiol, Santiago De Compostela, Spain.
RP Regueiro, BJ (reprint author), Complejo Hosp Univ Santiago, Dept Clin Microbiol, Santiago De Compostela, Spain.
EM benito.regueiro@usc.es
RI Alvarez, Julian/S-2215-2019; Regueiro, Benito/H-4264-2014; Tato, Antonio
   Gomez/N-3202-2013; Aguilera, Antonio/L-6586-2018
OI Alvarez, Julian/0000-0002-2518-0891; Regueiro,
   Benito/0000-0002-4009-7922; Tato, Antonio Gomez/0000-0003-2465-3500;
   Aguilera, Antonio/0000-0001-6940-241X; Rodriguez Calvino, Jose
   Javier/0000-0003-2358-7468
FU Spanish Ministerio de Ciencia e Innovacion [MAT2008-06503]
FX The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. This work was
   partially supported by the Spanish Ministerio de Ciencia e Innovacion
   (MAT2008-06503) which supported Javier Rodriguez Calvino's fellowship.
CR Abe Al-Soud W, 2000, J CLIN MICROBIOL, V38, P4463
   Abu Al-Soud W, 2000, J CLIN MICROBIOL, V38, P345
   Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001
   ALVAREZ M, 2008, 18 ECCMID 26 ICC 200, pS578
   Angus DC, 2001, CRIT CARE MED, V29, P1303, DOI 10.1097/00003246-200107000-00002
   Baron RM, 2006, AM J RESP CELL MOL, V34, P129, DOI 10.1165/rcmb.F308
   CASALTA JP, 2008, EUR J CLIN MICROBIOL
   Celard M., 2008, Annales de Cardiologie et d'Angeiologie, V57, P78, DOI 10.1016/j.ancard.2008.02.007
   Garnacho-Montero J, 2008, J ANTIMICROB CHEMOTH, V61, P436, DOI 10.1093/jac/dkm460
   Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/S0002-9343(03)00505-9
   Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146
   Jahan Ali, 2006, Cleve Clin J Med, V73 Suppl 1, pS67
   Kollef MH, 2006, NEW ENGL J MED, V355, P2691, DOI 10.1056/NEJMe068231
   Kollef MH, 2006, AM J RESP CRIT CARE, V173, P1182, DOI 10.1164/rccm.2603004
   Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462
   Kumar S, 2008, J CLIN MICROBIOL, V46, P3063, DOI 10.1128/JCM.00625-08
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0
   Lehmann LE, 2009, CRIT CARE MED, V37, P3085, DOI 10.1097/CCM.0b013e3181b033d7
   Louie RF, 2008, CRIT CARE MED, V36, P1487, DOI 10.1097/CCM.0b013e31816f487c
   Mancini N, 2008, J MED MICROBIOL, V57, P601, DOI 10.1099/jmm.0.47732-0
   Miller DN, 1999, APPL ENVIRON MICROB, V65, P4715
   Morata P, 1998, J CLIN MICROBIOL, V36, P2443
   Mussap M, 2007, J Chemother, V19 Suppl 2, P31
   REGUEIRO B, 2008, SEPS 2008 GRAN CR S5, V12, pS5
   Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632
   Schrenzel J, 2007, INT J ANTIMICROB AG, V30, pS2, DOI 10.1016/j.ijantimicag.2007.06.030
   Stormer M, 2007, CLIN CHEM, V53, P104, DOI 10.1373/clinchem.2006.070987
   Uhl JR, 2003, J CLIN MICROBIOL, V41, P242, DOI 10.1128/JCM.41.1.242-249.2003
   Vince A, 2008, J MED MICROBIOL, V57, P1306, DOI 10.1099/jmm.0.47797-0
NR 30
TC 26
Z9 26
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 13
PY 2010
VL 5
IS 10
AR e13387
DI 10.1371/journal.pone.0013387
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 663FZ
UT WOS:000282869800048
PM 20967222
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Beissner, F
   Brandau, A
   Henke, C
   Felden, L
   Baumgartner, U
   Treede, RD
   Oertel, BG
   Lotsch, J
AF Beissner, Florian
   Brandau, Amadeus
   Henke, Christian
   Felden, Lisa
   Baumgaertner, Ulf
   Treede, Rolf-Detlef
   Oertel, Bruno G.
   Loetsch, Joern
TI Quick Discrimination of A(delta) and C Fiber Mediated Pain Based on
   Three Verbal Descriptors
SO PLOS ONE
LA English
DT Article
ID A-FIBER; SECONDARY HYPERALGESIA; NEUROPATHIC PAIN; STIMULATION;
   PERCEPTION; HUMANS; QUESTIONNAIRE; SKIN; PREVALENCE; ACTIVATION
AB Background: Ad and C fibers are the major pain-conducting nerve fibers, activate only partly the same brain areas, and are differently involved in pain syndromes. Whether a stimulus excites predominantly Ad or C fibers is a commonly asked question in basic pain research but a quick test was lacking so far.
   Methodology/Principal Findings: Of 77 verbal descriptors of pain sensations, "pricking'', "dull'' and "pressing'' distinguished best (95% cases correctly) between Ad fiber mediated (punctate pressure produced by means of von Frey hairs) and C fiber mediated (blunt pressure) pain, applied to healthy volunteers in experiment 1. The sensation was assigned to Ad fibers when "pricking'' but neither "dull'' nor "pressing'' were chosen, and to C fibers when the sum of the selections of "dull'' or "pressing'' was greater than that of the selection of "pricking''. In experiment 2, with an independent cohort, the three-descriptor questionnaire achieved sensitivity and specificity above 0.95 for distinguishing fiber preferential non-mechanical induced pain (laser heat, exciting Ad fibers, and 5-Hz electric stimulation, exciting C fibers).
   Conclusion: A three-item verbal rating test using the words "pricking'', "dull'', and "pressing'' may provide sufficient information to characterize a pain sensation evoked by a physical stimulus as transmitted via Ad or via C fibers. It meets the criteria of a screening test by being easy to administer, taking little time, being comfortable in handling, and inexpensive while providing high specificity for relevant information.
C1 [Beissner, Florian; Henke, Christian] Goethe Univ Frankfurt, Neurol Clin, Frankfurt, Germany.
   [Brandau, Amadeus; Felden, Lisa; Oertel, Bruno G.; Loetsch, Joern] Goethe Univ Frankfurt, Inst Clin Pharmacol, Ctr Drug Res Dev & Safety ZAFES, Pharmazentrum Frankfurt, Frankfurt, Germany.
   [Baumgaertner, Ulf; Treede, Rolf-Detlef] Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Div Neurophysiol, D-6800 Mannheim, Germany.
RP Beissner, F (reprint author), Goethe Univ Frankfurt, Neurol Clin, Frankfurt, Germany.
EM j.loetsch@em.uni-frankfurt.de
RI Baumgartner, Ulf/L-4149-2019; Beissner, Florian/I-3474-2019; Treede,
   Rolf-Detlef/I-3632-2014
OI Baumgartner, Ulf/0000-0001-6371-3073; Beissner,
   Florian/0000-0003-0513-7551; Treede, Rolf-Detlef/0000-0001-8065-1708;
   Lotsch, Jorn/0000-0002-5818-6958
FU Horst Goertz Foundation
FX FB was financially supported by the Horst Goertz Foundation. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552
   ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102
   Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001
   Bennett MI, 2007, PAIN, V127, P199, DOI 10.1016/j.pain.2006.10.034
   BLUMBERG H, 1991, REFLEX SYMPATHETIC D, P29
   BOWSHER D, 1991, ACUPUNCT MED, V9, P58
   BROMM B, 1984, HUM NEUROBIOL, V3, P33
   Chen A, 1998, J PAIN, V7, P159
   CHEN ACN, 1985, PAIN, V22, P67, DOI 10.1016/0304-3959(85)90149-6
   COOPER BY, 1986, PAIN, V24, P93, DOI 10.1016/0304-3959(86)90030-8
   Cordell WH, 2002, AM J EMERG MED, V20, P165, DOI 10.1053/ajem.2002.32643
   HANCOCK GR, 1993, EDUC PSYCHOL MEAS, V53, P651, DOI 10.1177/0013164493053003006
   Hasselstrom J, 2002, EUR J PAIN, V6, P375, DOI 10.1016/S1090-3801(02)00025-3
   HOBSON AR, 2010, AM J PHYSIOL-GASTR L, V298, P631
   Hui Kathleen K S, 2007, BMC Complement Altern Med, V7, P33, DOI 10.1186/1472-6882-7-33
   HUIJER HA, 2010, LEBAN MED J, V58, P21
   KOLTZENBURG M, 1992, PAIN, V51, P207, DOI 10.1016/0304-3959(92)90262-A
   KOLTZENBURG M, 1993, PAIN, V53, P363, DOI 10.1016/0304-3959(93)90238-K
   Kong J, 2007, J ALTERN COMPLEM MED, V13, P1059, DOI 10.1089/acm.2007.0524
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Laursen RJ, 1999, MUSCLE NERVE, V22, P1564, DOI 10.1002/(SICI)1097-4598(199911)22:11<1564::AID-MUS12>3.3.CO;2-V
   LEBARS D, 1976, BRAIN RES, V115, P518, DOI 10.1016/0006-8993(76)90370-X
   LEEM JW, 1993, J NEUROPHYSIOL, V70, P2411
   Liu SS, 1996, ANESTH ANALG, V82, P98, DOI 10.1097/00000539-199601000-00017
   Lotsch J, 2003, PAIN, V102, P151, DOI 10.1016/S0304-3959(02)00349-4
   MASSON EA, 1989, DIABETOLOGIA, V32, P724, DOI 10.1007/BF00274531
   MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5
   Nahra H, 2003, EUR J PAIN, V7, P189, DOI 10.1016/S1090-3801(02)00099-X
   PITEI DL, 1994, DIABETIC MED, V11, P872, DOI 10.1111/j.1464-5491.1994.tb00371.x
   Plaghki L, 2003, NEUROPHYSIOL CLIN, V33, P269, DOI 10.1016/j.neucli.2003.10.003
   STEIN C, 1988, PAIN, V32, P251, DOI 10.1016/0304-3959(88)90074-7
   Sumitani M, 2008, RHEUMATOLOGY, V47, P1038, DOI 10.1093/rheumatology/ken170
   TOREBJORK HE, 1973, EXP BRAIN RES, V16, P321
   TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069
   Truini A, 2008, PAIN, V140, P405, DOI 10.1016/j.pain.2008.08.018
   VEVES A, 1994, DIABETES CARE, V17, P1200, DOI 10.2337/diacare.17.10.1200
   Weiss T, 2008, NEUROIMAGE, V41, P1372, DOI 10.1016/j.neuroimage.2008.03.047
   Wilkie DJ, 2001, J PAIN SYMPTOM MANAG, V22, P899, DOI 10.1016/S0885-3924(01)00351-7
   Ziegler EA, 1999, BRAIN, V122, P2245, DOI 10.1093/brain/122.12.2245
NR 39
TC 45
Z9 45
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 23
PY 2010
VL 5
IS 9
AR e12944
DI 10.1371/journal.pone.0012944
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 653KV
UT WOS:000282091100042
PM 20886070
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Boddaert, N
   Zilbovicius, M
   Philipe, A
   Robel, L
   Bourgeois, M
   Barthelemy, C
   Seidenwurm, D
   Meresse, I
   Laurier, L
   Desguerre, I
   Bahi-Buisson, N
   Brunelle, F
   Munnich, A
   Samson, Y
   Mouren, MC
   Chabane, N
AF Boddaert, Nathalie
   Zilbovicius, Monica
   Philipe, Anne
   Robel, Laurence
   Bourgeois, Marie
   Barthelemy, Catherine
   Seidenwurm, David
   Meresse, Isabelle
   Laurier, Laurence
   Desguerre, Isabelle
   Bahi-Buisson, Nadia
   Brunelle, Francis
   Munnich, Arnold
   Samson, Yves
   Mouren, Marie-Christine
   Chabane, Nadia
TI MRI Findings in 77 Children with Non-Syndromic Autistic Disorder
SO PLOS ONE
LA English
DT Article
ID CREATINE DEFICIENCY SYNDROMES; VIRCHOW-ROBIN SPACES; DEVELOPMENTAL
   DISORDERS; INCIDENTAL FINDINGS; MENTAL-RETARDATION; BRAIN; DIAGNOSIS
AB Background: The clinical relevance of MR scanning in children with autism is still an open question and must be considered in light of the evolution of this technology. MRI was judged to be of insufficient value to be included in the standard clinical evaluation of autism according to the guidelines of the American Academy of Neurology and Child Neurology Society in 2000 [1]. However, this statement was based on results obtained from small samples of patients and, more importantly, included mostly insufficient MRI sequences. Our main objective was to evaluate the prevalence of brain abnormalities in a large group of children with a non-syndromic autistic disorder (AD) using T1, T2 and FLAIR MRI sequences.
   Methodology: MRI inspection of 77 children and adolescents with non-syndromic AD (mean age 7.463.6) was performed. All met the DSM-IV and ADI -R criteria for autism. Based on recommended clinical and biological screenings, we excluded patients with infectious, metabolic or genetic diseases, seizures or any other neurological symptoms. Identical MRI inspections of 77 children (mean age 7.064.2) without AD, developmental or neurological disorders were also performed. All MRIs were acquired with a 1.5-T Signa GE (3-D T1-FSPGR, T2, FLAIR coronal and axial sequences). Two neuroradiologists independently inspected cortical and sub-cortical regions. MRIs were reported to be normal, abnormal or uninterpretable.
   Principal Findings: MRIs were judged as uninterpretable in 10% (8/77) of the cases. In 48% of the children (33/69 patients), abnormalities were reported. Three predominant abnormalities were observed, including white matter signal abnormalities (19/69), major dilated Virchow-Robin spaces (12/69) and temporal lobe abnormalities (20/69). In all, 52% of the MRIs were interpreted as normal (36/69 patients).
   Conclusions: An unexpectedly high rate of MRI abnormalities was found in the first large series of clinical MRI investigations in non-syndromic autism. These results could contribute to further etiopathogenetic research into autism.
C1 [Boddaert, Nathalie; Zilbovicius, Monica; Meresse, Isabelle; Laurier, Laurence; Brunelle, Francis] CEA, Serv Hosp Frederic Joliot, INSERM, U797, F-91406 Orsay, France.
   [Boddaert, Nathalie; Zilbovicius, Monica; Seidenwurm, David; Brunelle, Francis] Univ Paris 05, AP HP, Hop Necker Enfants Malades, Serv Radiol Pediat, U 797, F-75270 Paris, France.
   [Mouren, Marie-Christine; Chabane, Nadia] AP HP, Hop Robert Debre, Serv Pedopsychiat, Paris, France.
   [Philipe, Anne; Munnich, Arnold] Univ Paris 05, Hop Necker Enfants Malades, Genet Clin & Res Unit, INSERM 781, F-75270 Paris, France.
   [Robel, Laurence] Univ Paris 05, AP HP, Hop Necker Enfants Malades, Serv Pedopsychiat, F-75270 Paris, France.
   [Bourgeois, Marie; Desguerre, Isabelle; Bahi-Buisson, Nadia] Univ Paris 05, AP HP, Hop Necker Enfants Malades, Serv Neurol Metabolisme, F-75270 Paris, France.
   [Barthelemy, Catherine] CHU Bretonneau, INSERM, U 916, Tours, France.
   [Meresse, Isabelle; Samson, Yves] AP HP, Serv Urgences Cerebro Vasculaires, Grp Hosp Pitie Salpetriere, Paris, France.
RP Boddaert, N (reprint author), CEA, Serv Hosp Frederic Joliot, INSERM, U797, F-91406 Orsay, France.
EM nathalie.boddaert@nck.aphp.fr
RI samson, yves/C-5647-2013
OI boddaert, nathalie/0000-0003-0991-7774; samson, yves/0000-0002-8080-1427
FU France Foundation; Orange Foundation
FX France Foundation and Orange Foundation. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Arias-Dimas A, 2006, REV NEUROLOGIA, V43, P302, DOI 10.33588/rn.4305.2005519
   Barkovich AJ, 2000, AM J NEURORADIOL, V21, P1099
   Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602
   Cheillan A, 2005, REV NEUROL-FRANCE, V161, P284, DOI 10.1016/S0035-3787(05)85034-9
   Decobert F, 2005, PEDIATR RADIOL, V35, P587, DOI 10.1007/s00247-005-1406-x
   Filipek PA, 1999, J CHILD PSYCHOL PSYC, V40, P113, DOI 10.1111/1469-7610.00426
   Filipek PA, 2000, NEUROLOGY, V55, P468, DOI 10.1212/WNL.55.4.468
   Gillberg C, 1996, DEV MED CHILD NEUROL, V38, P191
   HEIER LA, 1989, AM J NEURORADIOL, V10, P929
   Kanner L, 1943, NERV CHILD, V2, P217
   Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36
   Kim BS, 2002, AM J NEURORADIOL, V23, P1674
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145
   Matheus MG, 2004, NEURORADIOLOGY, V46, P666, DOI 10.1007/s00234-004-1215-1
   PIVEN J, 1990, AM J PSYCHIAT, V147, P734
   SCHIFTER T, 1994, J CHILD NEUROL, V9, P155, DOI 10.1177/088307389400900210
   Soto-Ares G, 2003, PEDIATR RADIOL, V33, P334, DOI 10.1007/s00247-003-0891-z
   STANFIELD AC, 2007, EUR PSYCHIAT
   Steiner CE, 2004, J AUTISM DEV DISORD, V34, P723
   Taber KH, 2004, J COMPUT ASSIST TOMO, V28, P263, DOI 10.1097/00004728-200403000-00017
   van der Knaap MS, 2004, RADIOLOGY, V230, P529, DOI 10.1148/radiol.2302021459
   VANDERKNAAP, 2005, MAGNETIC RESONANCE M
   Zeegers M, 2006, BRAIN DEV-JPN, V28, P495, DOI 10.1016/j.braindev.2006.02.006
   Zilbovicius M, 2006, TRENDS NEUROSCI, V29, P359, DOI 10.1016/j.tins.2006.06.004
NR 25
TC 52
Z9 53
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 10
PY 2009
VL 4
IS 2
AR e4415
DI 10.1371/journal.pone.0004415
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 437JO
UT WOS:000265484000006
PM 19204795
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Poynard, T
   Ingiliz, P
   Elkrief, L
   Munteanu, M
   Lebray, P
   Morra, R
   Messous, D
   Bismut, FI
   Roulot, D
   Benhamou, Y
   Thabut, D
   Ratziu, V
AF Poynard, Thierry
   Ingiliz, Patrick
   Elkrief, Laure
   Munteanu, Mona
   Lebray, Pascal
   Morra, Rachel
   Messous, Djamila
   Bismut, Francoise Imbert
   Roulot, Dominique
   Benhamou, Yves
   Thabut, Dominique
   Ratziu, Vlad
TI Concordance in a World without a Gold Standard: A New Non-Invasive
   Methodology for Improving Accuracy of Fibrosis Markers
SO PLOS ONE
LA English
DT Article
ID CHRONIC HEPATITIS-C; OPERATING CHARACTERISTIC CURVES; CHRONIC
   LIVER-DISEASE; TRANSIENT ELASTOGRAPHY; BIOCHEMICAL MARKERS; DIAGNOSTIC
   EVALUATION; FIBROTEST; BIOPSY; STIFFNESS; VARIABILITY
AB Background: Assessing liver fibrosis is traditionally performed by biopsy, an imperfect gold standard. Non-invasive techniques, liver stiffness measurements (LSM) and biomarkers [FibroTest (R) (FT)], are widely used in countries where they are available. The aim was to identify factors associated with LSM accuracy using FT as a non-invasive endpoint and vice versa.
   Methods: The proof of concept was taken using the manufacturers recommendations for excluding patients at high risk of false negative/positive. The hypothesis was that the concordance between LSM and FT, would be improved by excluding high-risk patients. Thereafter, the impact of potential variability factors was assessed by the same methods. Liver biopsy and independent endpoints were used to validate the results.
   Results: Applying manufacturers' recommendations in 2,004 patients increased the strength of concordance between LSM and FT (P<0.00001). Among the 1,338 patients satisfying recommendations, the methodology identified a significant LSM operator effect (P = 0.001) and the following variability factors (all P<0.01), related to LSM: male gender, older age, and NAFLD as a cause of liver disease. Biopsy confirmed in 391 patients these results.
   Conclusion: This study has validated the concept of using the strength of concordance between non-invasive estimates of liver fibrosis for the identification of factors associated with variability and precautions of use.
C1 [Poynard, Thierry; Ingiliz, Patrick; Elkrief, Laure; Lebray, Pascal; Morra, Rachel; Messous, Djamila; Bismut, Francoise Imbert; Benhamou, Yves; Thabut, Dominique; Ratziu, Vlad] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, CNRS UMR, Paris, France.
   [Munteanu, Mona] Biopredictive, Paris, France.
   [Roulot, Dominique] APHP Hop Avicennes, Bobigny, France.
RP Poynard, T (reprint author), Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, CNRS UMR, Paris, France.
EM tpoynard@teaser.fr
RI Roulot, Dominique/U-1732-2018; Poynard, Thierry/C-1355-2010
OI Roulot, Dominique/0000-0003-0926-3563; Poynard,
   Thierry/0000-0002-3726-7230; Poynard, Thierry/0000-0002-2050-640X;
   Munteanu, Mona/0000-0003-4517-2757
FU Association de Recherche sur les Maladies Virales et Hepatiques
FX The study has funding support from the Association de Recherche sur les
   Maladies Virales et Hepatiques providing part of secretary assistance
   and biochemical kits. The funder had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201
   Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022
   Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1016/S0002-9270(99)00433-5
   Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018
   Castera L, 2007, J HEPATOL, V46, P528, DOI 10.1016/j.jhep.2006.12.002
   Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x
   Corpechot C, 2006, HEPATOLOGY, V44, P513, DOI 10.1002/hep.21306
   DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
   Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153
   Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302
   Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034
   *HAS FRANC, HAS REC MAN CHRON HE
   HINTZE JL, 2007, NCSS 2007 USER GUIDE, P200
   Hui S L, 1998, Stat Methods Med Res, V7, P354, DOI 10.1191/096228098671192352
   Imbert-Bismut F, 2004, CLIN CHEM LAB MED, V42, P323, DOI 10.1515/CCLM.2004.058
   Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6
   Kettaneh A, 2007, J HEPATOL, V46, P628, DOI 10.1016/j.jhep.2006.11.010
   Kim KM, 2007, J GASTROENTEROL, V42, P382, DOI 10.1007/s00535-007-2016-1
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lin L, 2007, J BIOPHARM STAT, V17, P629, DOI 10.1080/10543400701376498
   Lucidarme D, 2007, HEPATOLOGY, V46, p318A
   MUNTEANU M, 2006, GASTROENTEROLOGY, V130, P195
   Ngo Y, 2006, CLIN CHEM, V52, P1887, DOI 10.1373/clinchem.2006.070961
   Pouillot R, 2002, PREV VET MED, V53, P67, DOI 10.1016/S0167-5877(01)00272-0
   Poynard T, 2007, ALIMENT PHARM THERAP, V25, P733, DOI 10.1111/j.1365-2036.2007.03252.x
   Poynard T, 2005, GASTROENTEROLOGY, V128, P1146, DOI 10.1053/j.gastro.2005.02.056
   Poynard T, 2004, CLIN CHEM, V50, P1344, DOI 10.1373/clinchem.2004.032227
   Poynard T, 2004, COMP HEPATOL, V3, P8, DOI DOI 10.1186/1476-5926-3-8
   Poynard T, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-40
   Poynard T, 2007, CLIN CHEM, V53, P1615, DOI 10.1373/clinchem.2007.085795
   Poynard Thierry, 2005, Comp Hepatol, V4, P10
   Ratziu V, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-6
   Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020
   Sebastiani G, 2006, WORLD J GASTROENTERO, V12, P3682, DOI 10.3748/wjg.v12.i23.3682
   Zhou X, 2002, STAT METHODS DIAGNOS, P235
   Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506
NR 36
TC 61
Z9 63
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 4
PY 2008
VL 3
IS 12
AR e3857
DI 10.1371/journal.pone.0003857
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 436YO
UT WOS:000265452200009
PM 19052646
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Prady, SL
   Richmond, SJ
   Morton, VM
   MacPherson, H
AF Prady, Stephanie L.
   Richmond, Stewart J.
   Morton, Veronica M.
   MacPherson, Hugh
TI A Systematic Evaluation of the Impact of STRICTA and CONSORT
   Recommendations on Quality of Reporting for Acupuncture Trials
SO PLOS ONE
LA English
DT Article
AB Background: We investigated whether there had been an improvement in quality of reporting for randomised controlled trials of acupuncture since the publication of the STRICTA and CONSORT statements. We conducted a before-and-after study, comparing ratings for quality of reporting following the publication of both STRICTA and CONSORT recommendations.
   Methodology and Principal Findings: Ninety peer reviewed journal articles reporting the results of acupuncture trials were selected at random from a wider sample frame of 266 papers. Papers published in three distinct time periods (1994-1995, 1999-2000 and 2004-2005) were compared. Assessment criteria were developed directly from CONSORT and STRICTA checklists. Papers were independently assessed for quality of reporting by two assessors, one of whom was blind to information which could have introduced systematic bias (e.g. date of publication). We detected a statistically significant increase in the reporting of CONSORT items for papers published in each time period measured. We did not, however, find a difference between the number of STRICTA items reported in journal articles published before and 3 to 4 years following the introduction of STRICTA recommendations.
   Conclusions and Significance: The results of this study suggest that general standards of reporting for acupuncture trials have significantly improved since the introduction of the CONSORT statement in 1996, but that quality in reporting details specific to acupuncture interventions has yet to change following the more recent introduction of STRICTA recommendations. Wider targeting and revision of the guidelines is recommended.
C1 [Prady, Stephanie L.; Richmond, Stewart J.; Morton, Veronica M.; MacPherson, Hugh] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.
RP Prady, SL (reprint author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.
EM slp505@york.ac.uk
OI MacPherson, Hugh/0000-0003-4255-4768
FU Foundation for Traditional Chinese Medicine; Department of Health NCC
   RCD
FX Stephanie Prady was funded by the Foundation for Traditional Chinese
   Medicine to carry out this study. Both Stewart Richmond and Hugh
   MacPherson are funded by personal awards from the Department of Health
   NCC RCD. No funder played any part in the design, conduct and analysis
   of this study, analysing the results or the decision to publish.
CR Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637
   Devereaux PJ, 2002, CONTROL CLIN TRIALS, V23, P380, DOI 10.1016/S0197-2456(02)00214-3
   Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996
   EGGER M, 2003, HLTH TECHNOL ASSESS, V7
   Halpern SH, 2004, INT J OBSTET ANESTH, V13, P207, DOI 10.1016/j.ijoa.2004.03.009
   Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670
   Huwiler-Muntener K, 2002, JAMA-J AM MED ASSOC, V287, P2801, DOI 10.1001/jama.287.21.2801
   Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   MacPherson H, 2002, J ALTERN COMPLEM MED, V8, P85, DOI 10.1089/107555302753507212
   MacPherson H, 2001, COMPLEMENT THER MED, V9, P246, DOI 10.1054/ctim.2001.0488
   MacPherson Hugh, 2002, Acupunct Med, V20, P22
   Mills E, 2005, J CLIN EPIDEMIOL, V58, P662, DOI 10.1016/j.jclinepi.2005.01.004
   Mills EJ, 2005, CONTEMP CLIN TRIALS, V26, P480, DOI 10.1016/j.cct.2005.02.008
   Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992
   Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987
   MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W
   Moher D., 2002, BMC PEDIAT, V2
   Montori VM, 2002, J CLIN EPIDEMIOL, V55, P787, DOI 10.1016/S0895-4356(02)00446-8
   Prady SL, 2007, J ALTERN COMPLEM MED, V13, P939, DOI 10.1089/acm.2007.7186
   SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408
   Vickers A, 1998, CONTROL CLIN TRIALS, V19, P159, DOI 10.1016/S0197-2456(97)00150-5
NR 22
TC 93
Z9 97
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 13
PY 2008
VL 3
IS 2
AR e1577
DI 10.1371/journal.pone.0001577
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 367ES
UT WOS:000260535900013
PM 18270568
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

EF